id	sid	tid	token	lemma	pos
cord-005453-4057qib7	1	1	key	key	JJ
cord-005453-4057qib7	1	2	:	:	:
cord-005453-4057qib7	1	3	cord-005453	cord-005453	NNP
cord-005453-4057qib7	1	4	-	-	HYPH
cord-005453-4057qib7	1	5	4057qib7	4057qib7	CD
cord-005453-4057qib7	1	6	authors	author	NNS
cord-005453-4057qib7	1	7	:	:	:
cord-005453-4057qib7	2	1	nan	nan	NNP
cord-005453-4057qib7	2	2	title	title	NN
cord-005453-4057qib7	2	3	:	:	:
cord-005453-4057qib7	2	4	The	the	DT
cord-005453-4057qib7	2	5	45th	45th	JJ
cord-005453-4057qib7	2	6	Annual	Annual	NNP
cord-005453-4057qib7	2	7	Meeting	Meeting	NNP
cord-005453-4057qib7	2	8	of	of	IN
cord-005453-4057qib7	2	9	the	the	DT
cord-005453-4057qib7	2	10	European	European	NNP
cord-005453-4057qib7	2	11	Society	Society	NNP
cord-005453-4057qib7	2	12	for	for	IN
cord-005453-4057qib7	2	13	Blood	blood	NN
cord-005453-4057qib7	2	14	and	and	CC
cord-005453-4057qib7	2	15	Marrow	marrow	NN
cord-005453-4057qib7	2	16	Transplantation	transplantation	NN
cord-005453-4057qib7	2	17	:	:	:
cord-005453-4057qib7	2	18	Physicians	physician	NNS
cord-005453-4057qib7	2	19	–	–	:
cord-005453-4057qib7	2	20	Poster	poster	NN
cord-005453-4057qib7	2	21	Session	Session	NNP
cord-005453-4057qib7	2	22	date	date	NN
cord-005453-4057qib7	2	23	:	:	:
cord-005453-4057qib7	2	24	2019	2019	CD
cord-005453-4057qib7	2	25	-	-	HYPH
cord-005453-4057qib7	2	26	07	07	CD
cord-005453-4057qib7	2	27	-	-	HYPH
cord-005453-4057qib7	2	28	03	03	CD
cord-005453-4057qib7	2	29	journal	journal	NN
cord-005453-4057qib7	2	30	:	:	:
cord-005453-4057qib7	3	1	Bone	Bone	NNP
cord-005453-4057qib7	3	2	Marrow	marrow	NN
cord-005453-4057qib7	3	3	Transplant	transplant	NN
cord-005453-4057qib7	3	4	DOI	doi	NN
cord-005453-4057qib7	3	5	:	:	:
cord-005453-4057qib7	3	6	10.1038	10.1038	CD
cord-005453-4057qib7	3	7	/	/	SYM
cord-005453-4057qib7	3	8	s41409	s41409	JJ
cord-005453-4057qib7	3	9	-	-	HYPH
cord-005453-4057qib7	3	10	019	019	CD
cord-005453-4057qib7	3	11	-	-	HYPH
cord-005453-4057qib7	3	12	0559	0559	CD
cord-005453-4057qib7	3	13	-	-	SYM
cord-005453-4057qib7	3	14	4	4	CD
cord-005453-4057qib7	3	15	sha	sha	NNP
cord-005453-4057qib7	3	16	:	:	:
cord-005453-4057qib7	4	1	913db7c5d4ab48567de0304fdcc1f1b343d98aa1	913db7c5d4ab48567de0304fdcc1f1b343d98aa1	CD
cord-005453-4057qib7	4	2	doc_id	doc_id	CD
cord-005453-4057qib7	4	3	:	:	:
cord-005453-4057qib7	4	4	5453	5453	CD
cord-005453-4057qib7	4	5	cord_uid	cord_uid	FW
cord-005453-4057qib7	4	6	:	:	:
cord-005453-4057qib7	5	1	4057qib7	4057qib7	.
cord-005453-4057qib7	6	1	nan	nan	NNP
cord-005453-4057qib7	6	2	Background	Background	NNP
cord-005453-4057qib7	6	3	:	:	:
cord-005453-4057qib7	7	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	7	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7	3	stem	stem	NN
cord-005453-4057qib7	7	4	cell	cell	NN
cord-005453-4057qib7	7	5	transplantation	transplantation	NN
cord-005453-4057qib7	7	6	is	be	VBZ
cord-005453-4057qib7	7	7	routinely	routinely	RB
cord-005453-4057qib7	7	8	offered	offer	VBN
cord-005453-4057qib7	7	9	to	to	IN
cord-005453-4057qib7	7	10	patients	patient	NNS
cord-005453-4057qib7	7	11	with	with	IN
cord-005453-4057qib7	7	12	high	high	JJ
cord-005453-4057qib7	7	13	-	-	HYPH
cord-005453-4057qib7	7	14	risk	risk	NN
cord-005453-4057qib7	7	15	or	or	CC
cord-005453-4057qib7	7	16	advanced	advance	VBD
cord-005453-4057qib7	7	17	ALL	all	DT
cord-005453-4057qib7	7	18	in	in	IN
cord-005453-4057qib7	7	19	the	the	DT
cord-005453-4057qib7	7	20	hopes	hope	NNS
cord-005453-4057qib7	7	21	of	of	IN
cord-005453-4057qib7	7	22	improving	improve	VBG
cord-005453-4057qib7	7	23	outcomes	outcome	NNS
cord-005453-4057qib7	7	24	.	.	.
cord-005453-4057qib7	8	1	Use	Use	NNP
cord-005453-4057qib7	8	2	of	of	IN
cord-005453-4057qib7	8	3	truly	truly	RB
cord-005453-4057qib7	8	4	non	non	JJ
cord-005453-4057qib7	8	5	-	-	JJ
cord-005453-4057qib7	8	6	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8	7	(	(	-LRB-
cord-005453-4057qib7	8	8	NMA	NMA	NNP
cord-005453-4057qib7	8	9	)	)	-RRB-
cord-005453-4057qib7	8	10	conditioning	conditioning	NN
cord-005453-4057qib7	8	11	reduces	reduce	VBZ
cord-005453-4057qib7	8	12	toxicity	toxicity	NN
cord-005453-4057qib7	8	13	in	in	IN
cord-005453-4057qib7	8	14	other	other	JJ
cord-005453-4057qib7	8	15	contexts	context	NNS
cord-005453-4057qib7	8	16	but	but	CC
cord-005453-4057qib7	8	17	outcome	outcome	NN
cord-005453-4057qib7	8	18	data	datum	NNS
cord-005453-4057qib7	8	19	for	for	IN
cord-005453-4057qib7	8	20	ALL	all	DT
cord-005453-4057qib7	8	21	patients	patient	NNS
cord-005453-4057qib7	8	22	after	after	IN
cord-005453-4057qib7	8	23	NMA	NMA	NNP
cord-005453-4057qib7	8	24	transplants	transplant	NNS
cord-005453-4057qib7	8	25	is	be	VBZ
cord-005453-4057qib7	8	26	lacking	lack	VBG
cord-005453-4057qib7	8	27	.	.	.
cord-005453-4057qib7	9	1	We	-PRON-	PRP
cord-005453-4057qib7	9	2	report	report	VBP
cord-005453-4057qib7	9	3	the	the	DT
cord-005453-4057qib7	9	4	outcomes	outcome	NNS
cord-005453-4057qib7	9	5	of	of	IN
cord-005453-4057qib7	9	6	31	31	CD
cord-005453-4057qib7	9	7	patients	patient	NNS
cord-005453-4057qib7	9	8	with	with	IN
cord-005453-4057qib7	9	9	ALL	all	DT
cord-005453-4057qib7	9	10	transplanted	transplanted	JJ
cord-005453-4057qib7	9	11	using	use	VBG
cord-005453-4057qib7	9	12	a	a	DT
cord-005453-4057qib7	9	13	NMA	NMA	NNP
cord-005453-4057qib7	9	14	conditioning	conditioning	NN
cord-005453-4057qib7	9	15	without	without	IN
cord-005453-4057qib7	9	16	T	t	NN
cord-005453-4057qib7	9	17	cell	cell	NN
cord-005453-4057qib7	9	18	depletion	depletion	NN
cord-005453-4057qib7	9	19	.	.	.
cord-005453-4057qib7	10	1	Methods	method	NNS
cord-005453-4057qib7	10	2	:	:	:
cord-005453-4057qib7	10	3	First	first	JJ
cord-005453-4057qib7	10	4	transplant	transplant	NN
cord-005453-4057qib7	10	5	patients	patient	NNS
cord-005453-4057qib7	10	6	between	between	IN
cord-005453-4057qib7	10	7	October	October	NNP
cord-005453-4057qib7	10	8	2006	2006	CD
cord-005453-4057qib7	10	9	and	and	CC
cord-005453-4057qib7	10	10	June	June	NNP
cord-005453-4057qib7	10	11	2018	2018	CD
cord-005453-4057qib7	10	12	were	be	VBD
cord-005453-4057qib7	10	13	reviewed	review	VBN
cord-005453-4057qib7	10	14	.	.	.
cord-005453-4057qib7	11	1	These	these	DT
cord-005453-4057qib7	11	2	were	be	VBD
cord-005453-4057qib7	11	3	consecutive	consecutive	JJ
cord-005453-4057qib7	11	4	patients	patient	NNS
cord-005453-4057qib7	11	5	until	until	IN
cord-005453-4057qib7	11	6	2015	2015	CD
cord-005453-4057qib7	11	7	then	then	RB
cord-005453-4057qib7	11	8	only	only	RB
cord-005453-4057qib7	11	9	those	those	DT
cord-005453-4057qib7	11	10	considered	consider	VBN
cord-005453-4057qib7	11	11	unfit	unfit	JJ
cord-005453-4057qib7	11	12	for	for	IN
cord-005453-4057qib7	11	13	FMC	FMC	NNP
cord-005453-4057qib7	11	14	conditioning	conditioning	NN
cord-005453-4057qib7	11	15	as	as	IN
cord-005453-4057qib7	11	16	per	per	IN
cord-005453-4057qib7	11	17	the	the	DT
cord-005453-4057qib7	11	18	UKALL	UKALL	NNP
cord-005453-4057qib7	11	19	2014	2014	CD
cord-005453-4057qib7	11	20	protocol	protocol	NN
cord-005453-4057qib7	11	21	.	.	.
cord-005453-4057qib7	12	1	All	all	DT
cord-005453-4057qib7	12	2	patients	patient	NNS
cord-005453-4057qib7	12	3	were	be	VBD
cord-005453-4057qib7	12	4	conditioned	condition	VBN
cord-005453-4057qib7	12	5	with	with	IN
cord-005453-4057qib7	12	6	fludarabine	fludarabine	NN
cord-005453-4057qib7	12	7	25mg	25mg	NNP
cord-005453-4057qib7	12	8	/	/	SYM
cord-005453-4057qib7	12	9	m	m	CD
cord-005453-4057qib7	12	10	2	2	CD
cord-005453-4057qib7	12	11	/day	/day	.
cord-005453-4057qib7	12	12	for	for	IN
cord-005453-4057qib7	12	13	5	5	CD
cord-005453-4057qib7	12	14	days	day	NNS
cord-005453-4057qib7	12	15	and	and	CC
cord-005453-4057qib7	12	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12	17	1g	1g	CD
cord-005453-4057qib7	12	18	/	/	SYM
cord-005453-4057qib7	12	19	m	m	NN
cord-005453-4057qib7	12	20	2	2	CD
cord-005453-4057qib7	12	21	/day	/day	.
cord-005453-4057qib7	12	22	for	for	IN
cord-005453-4057qib7	12	23	2	2	CD
cord-005453-4057qib7	12	24	days	day	NNS
cord-005453-4057qib7	12	25	.	.	.
cord-005453-4057qib7	13	1	Short	short	JJ
cord-005453-4057qib7	13	2	course	course	NN
cord-005453-4057qib7	13	3	MTX	MTX	NNP
cord-005453-4057qib7	13	4	and	and	CC
cord-005453-4057qib7	13	5	ciclosporin	ciclosporin	NN
cord-005453-4057qib7	13	6	were	be	VBD
cord-005453-4057qib7	13	7	used	use	VBN
cord-005453-4057qib7	13	8	for	for	IN
cord-005453-4057qib7	13	9	GVHD	GVHD	NNP
cord-005453-4057qib7	13	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13	11	.	.	.
cord-005453-4057qib7	14	1	Standard	standard	JJ
cord-005453-4057qib7	14	2	supportive	supportive	JJ
cord-005453-4057qib7	14	3	care	care	NN
cord-005453-4057qib7	14	4	was	be	VBD
cord-005453-4057qib7	14	5	employed	employ	VBN
cord-005453-4057qib7	14	6	.	.	.
cord-005453-4057qib7	15	1	Thirty	thirty	CD
cord-005453-4057qib7	15	2	-	-	HYPH
cord-005453-4057qib7	15	3	one	one	CD
cord-005453-4057qib7	15	4	patients	patient	NNS
cord-005453-4057qib7	15	5	with	with	IN
cord-005453-4057qib7	15	6	a	a	DT
cord-005453-4057qib7	15	7	median	median	JJ
cord-005453-4057qib7	15	8	age	age	NN
cord-005453-4057qib7	15	9	of	of	IN
cord-005453-4057qib7	15	10	43	43	CD
cord-005453-4057qib7	15	11	(	(	-LRB-
cord-005453-4057qib7	15	12	23	23	CD
cord-005453-4057qib7	15	13	-	-	SYM
cord-005453-4057qib7	15	14	67	67	CD
cord-005453-4057qib7	15	15	)	)	-RRB-
cord-005453-4057qib7	15	16	met	meet	VBD
cord-005453-4057qib7	15	17	the	the	DT
cord-005453-4057qib7	15	18	criteria	criterion	NNS
cord-005453-4057qib7	15	19	for	for	IN
cord-005453-4057qib7	15	20	this	this	DT
cord-005453-4057qib7	15	21	case	case	NN
cord-005453-4057qib7	15	22	review	review	NN
cord-005453-4057qib7	15	23	.	.	.
cord-005453-4057qib7	16	1	30	30	CD
cord-005453-4057qib7	16	2	had	have	VBD
cord-005453-4057qib7	16	3	B	b	NN
cord-005453-4057qib7	16	4	-	-	HYPH
cord-005453-4057qib7	16	5	ALL	all	DT
cord-005453-4057qib7	16	6	and	and	CC
cord-005453-4057qib7	16	7	10	10	CD
cord-005453-4057qib7	16	8	were	be	VBD
cord-005453-4057qib7	16	9	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	16	10	chromosome	chromosome	NN
cord-005453-4057qib7	16	11	positive	positive	JJ
cord-005453-4057qib7	16	12	.	.	.
cord-005453-4057qib7	17	1	24	24	CD
cord-005453-4057qib7	17	2	patients	patient	NNS
cord-005453-4057qib7	17	3	(	(	-LRB-
cord-005453-4057qib7	17	4	77	77	CD
cord-005453-4057qib7	17	5	%	%	NN
cord-005453-4057qib7	17	6	)	)	-RRB-
cord-005453-4057qib7	17	7	had	have	VBD
cord-005453-4057qib7	17	8	high	high	JJ
cord-005453-4057qib7	17	9	risk	risk	NN
cord-005453-4057qib7	17	10	disease	disease	NN
cord-005453-4057qib7	17	11	by	by	IN
cord-005453-4057qib7	17	12	standard	standard	JJ
cord-005453-4057qib7	17	13	diagnostic	diagnostic	JJ
cord-005453-4057qib7	17	14	criteria	criterion	NNS
cord-005453-4057qib7	17	15	.	.	.
cord-005453-4057qib7	18	1	27	27	CD
cord-005453-4057qib7	18	2	(	(	-LRB-
cord-005453-4057qib7	18	3	87	87	CD
cord-005453-4057qib7	18	4	%	%	NN
cord-005453-4057qib7	18	5	)	)	-RRB-
cord-005453-4057qib7	18	6	were	be	VBD
cord-005453-4057qib7	18	7	in	in	IN
cord-005453-4057qib7	18	8	first	first	JJ
cord-005453-4057qib7	18	9	complete	complete	JJ
cord-005453-4057qib7	18	10	remission	remission	NN
cord-005453-4057qib7	18	11	(	(	-LRB-
cord-005453-4057qib7	18	12	CR1	CR1	NNP
cord-005453-4057qib7	18	13	)	)	-RRB-
cord-005453-4057qib7	18	14	.	.	.
cord-005453-4057qib7	19	1	Matched	matched	JJ
cord-005453-4057qib7	19	2	sibling	sibling	NN
cord-005453-4057qib7	19	3	donors	donor	NNS
cord-005453-4057qib7	19	4	were	be	VBD
cord-005453-4057qib7	19	5	used	use	VBN
cord-005453-4057qib7	19	6	in	in	IN
cord-005453-4057qib7	19	7	13	13	CD
cord-005453-4057qib7	19	8	instances	instance	NNS
cord-005453-4057qib7	19	9	with	with	IN
cord-005453-4057qib7	19	10	the	the	DT
cord-005453-4057qib7	19	11	remaining	remain	VBG
cord-005453-4057qib7	19	12	being	be	VBG
cord-005453-4057qib7	19	13	fully	fully	RB
cord-005453-4057qib7	19	14	matched	match	VBN
cord-005453-4057qib7	19	15	unrelated	unrelated	JJ
cord-005453-4057qib7	19	16	donors	donor	NNS
cord-005453-4057qib7	19	17	.	.	.
cord-005453-4057qib7	20	1	58	58	CD
cord-005453-4057qib7	20	2	%	%	NN
cord-005453-4057qib7	20	3	of	of	IN
cord-005453-4057qib7	20	4	patients	patient	NNS
cord-005453-4057qib7	20	5	had	have	VBD
cord-005453-4057qib7	20	6	a	a	DT
cord-005453-4057qib7	20	7	HCT	HCT	NNP
cord-005453-4057qib7	20	8	-	-	HYPH
cord-005453-4057qib7	20	9	CI	ci	NN
cord-005453-4057qib7	20	10	score	score	NN
cord-005453-4057qib7	20	11	of	of	IN
cord-005453-4057qib7	20	12	0	0	CD
cord-005453-4057qib7	20	13	,	,	,
cord-005453-4057qib7	20	14	32	32	CD
cord-005453-4057qib7	20	15	%	%	NN
cord-005453-4057qib7	20	16	a	a	DT
cord-005453-4057qib7	20	17	score	score	NN
cord-005453-4057qib7	20	18	of	of	IN
cord-005453-4057qib7	20	19	1	1	CD
cord-005453-4057qib7	20	20	or	or	CC
cord-005453-4057qib7	20	21	2	2	CD
cord-005453-4057qib7	20	22	with	with	IN
cord-005453-4057qib7	20	23	3	3	CD
cord-005453-4057qib7	20	24	patients	patient	NNS
cord-005453-4057qib7	20	25	having	have	VBG
cord-005453-4057qib7	20	26	a	a	DT
cord-005453-4057qib7	20	27	score	score	NN
cord-005453-4057qib7	20	28	of	of	IN
cord-005453-4057qib7	20	29	3	3	CD
cord-005453-4057qib7	20	30	or	or	CC
cord-005453-4057qib7	20	31	higher	high	JJR
cord-005453-4057qib7	20	32	.	.	.
cord-005453-4057qib7	21	1	Median	median	JJ
cord-005453-4057qib7	21	2	CD34	CD34	NNP
cord-005453-4057qib7	21	3	dose	dose	NN
cord-005453-4057qib7	21	4	was	be	VBD
cord-005453-4057qib7	21	5	5.3	5.3	CD
cord-005453-4057qib7	21	6	x	x	SYM
cord-005453-4057qib7	21	7	10	10	CD
cord-005453-4057qib7	21	8	6	6	CD
cord-005453-4057qib7	21	9	/kg	/kg	.
cord-005453-4057qib7	21	10	(	(	-LRB-
cord-005453-4057qib7	21	11	0.93	0.93	CD
cord-005453-4057qib7	21	12	-	-	SYM
cord-005453-4057qib7	21	13	34.12	34.12	CD
cord-005453-4057qib7	21	14	)	)	-RRB-
cord-005453-4057qib7	21	15	with	with	IN
cord-005453-4057qib7	21	16	a	a	DT
cord-005453-4057qib7	21	17	median	median	JJ
cord-005453-4057qib7	21	18	CD3	CD3	NNP
cord-005453-4057qib7	21	19	dose	dose	NN
cord-005453-4057qib7	21	20	of	of	IN
cord-005453-4057qib7	21	21	2.13	2.13	CD
cord-005453-4057qib7	21	22	x	x	SYM
cord-005453-4057qib7	21	23	10	10	CD
cord-005453-4057qib7	21	24	8	8	CD
cord-005453-4057qib7	21	25	/	/	SYM
cord-005453-4057qib7	21	26	kg	kg	NN
cord-005453-4057qib7	21	27	(	(	-LRB-
cord-005453-4057qib7	21	28	0.12	0.12	CD
cord-005453-4057qib7	21	29	-	-	SYM
cord-005453-4057qib7	21	30	7.37	7.37	CD
cord-005453-4057qib7	21	31	)	)	-RRB-
cord-005453-4057qib7	21	32	Results	result	NNS
cord-005453-4057qib7	21	33	:	:	:
cord-005453-4057qib7	22	1	TRM	TRM	NNP
cord-005453-4057qib7	22	2	was	be	VBD
cord-005453-4057qib7	22	3	low	low	JJ
cord-005453-4057qib7	22	4	at	at	IN
cord-005453-4057qib7	22	5	7	7	CD
cord-005453-4057qib7	22	6	%	%	NN
cord-005453-4057qib7	22	7	at	at	IN
cord-005453-4057qib7	22	8	1	1	CD
cord-005453-4057qib7	22	9	year	year	NN
cord-005453-4057qib7	22	10	and	and	CC
cord-005453-4057qib7	22	11	11	11	CD
cord-005453-4057qib7	22	12	%	%	NN
cord-005453-4057qib7	22	13	at	at	IN
cord-005453-4057qib7	22	14	2	2	CD
cord-005453-4057qib7	22	15	and	and	CC
cord-005453-4057qib7	22	16	3	3	CD
cord-005453-4057qib7	22	17	years	year	NNS
cord-005453-4057qib7	22	18	respectively	respectively	RB
cord-005453-4057qib7	22	19	.	.	.
cord-005453-4057qib7	23	1	No	no	DT
cord-005453-4057qib7	23	2	factors	factor	NNS
cord-005453-4057qib7	23	3	included	include	VBN
cord-005453-4057qib7	23	4	in	in	IN
cord-005453-4057qib7	23	5	a	a	DT
cord-005453-4057qib7	23	6	univariate	univariate	JJ
cord-005453-4057qib7	23	7	analysis	analysis	NN
cord-005453-4057qib7	23	8	(	(	-LRB-
cord-005453-4057qib7	23	9	which	which	WDT
cord-005453-4057qib7	23	10	included	include	VBD
cord-005453-4057qib7	23	11	age	age	NN
cord-005453-4057qib7	23	12	,	,	,
cord-005453-4057qib7	23	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	23	14	,	,	,
cord-005453-4057qib7	23	15	disease	disease	NN
cord-005453-4057qib7	23	16	status	status	NN
cord-005453-4057qib7	23	17	,	,	,
cord-005453-4057qib7	23	18	HCT	HCT	NNP
cord-005453-4057qib7	23	19	-	-	HYPH
cord-005453-4057qib7	23	20	CI	ci	NN
cord-005453-4057qib7	23	21	,	,	,
cord-005453-4057qib7	23	22	donor	donor	NN
cord-005453-4057qib7	23	23	type	type	NN
cord-005453-4057qib7	23	24	,	,	,
cord-005453-4057qib7	23	25	CMV	CMV	NNP
cord-005453-4057qib7	23	26	risk	risk	NN
cord-005453-4057qib7	23	27	and	and	CC
cord-005453-4057qib7	23	28	cell	cell	NN
cord-005453-4057qib7	23	29	dose	dose	NN
cord-005453-4057qib7	23	30	)	)	-RRB-
cord-005453-4057qib7	23	31	significantly	significantly	RB
cord-005453-4057qib7	23	32	impacted	impact	VBD
cord-005453-4057qib7	23	33	TRM	TRM	NNP
cord-005453-4057qib7	23	34	.	.	.
cord-005453-4057qib7	24	1	The	the	DT
cord-005453-4057qib7	24	2	incidence	incidence	NN
cord-005453-4057qib7	24	3	of	of	IN
cord-005453-4057qib7	24	4	classical	classical	JJ
cord-005453-4057qib7	24	5	acute	acute	NN
cord-005453-4057qib7	24	6	(	(	-LRB-
cord-005453-4057qib7	24	7	a	a	DT
cord-005453-4057qib7	24	8	)	)	-RRB-
cord-005453-4057qib7	24	9	GVHD	gvhd	JJ
cord-005453-4057qib7	24	10	grade	grade	NN
cord-005453-4057qib7	24	11	2	2	CD
cord-005453-4057qib7	24	12	-	-	SYM
cord-005453-4057qib7	24	13	4	4	CD
cord-005453-4057qib7	24	14	and	and	CC
cord-005453-4057qib7	24	15	3	3	CD
cord-005453-4057qib7	24	16	-	-	SYM
cord-005453-4057qib7	24	17	4	4	CD
cord-005453-4057qib7	24	18	was	be	VBD
cord-005453-4057qib7	24	19	18	18	CD
cord-005453-4057qib7	24	20	%	%	NN
cord-005453-4057qib7	24	21	and	and	CC
cord-005453-4057qib7	24	22	8	8	CD
cord-005453-4057qib7	24	23	%	%	NN
cord-005453-4057qib7	24	24	by	by	IN
cord-005453-4057qib7	24	25	day	day	NN
cord-005453-4057qib7	24	26	100	100	CD
cord-005453-4057qib7	24	27	and	and	CC
cord-005453-4057qib7	24	28	29	29	CD
cord-005453-4057qib7	24	29	%	%	NN
cord-005453-4057qib7	24	30	and	and	CC
cord-005453-4057qib7	24	31	13	13	CD
cord-005453-4057qib7	24	32	%	%	NN
cord-005453-4057qib7	24	33	by	by	IN
cord-005453-4057qib7	24	34	day	day	NN
cord-005453-4057qib7	24	35	180	180	CD
cord-005453-4057qib7	24	36	if	if	IN
cord-005453-4057qib7	24	37	late	late	JJ
cord-005453-4057qib7	24	38	onset	onset	NN
cord-005453-4057qib7	24	39	aGVHD	aGVHD	NNP
cord-005453-4057qib7	24	40	is	be	VBZ
cord-005453-4057qib7	24	41	included	include	VBN
cord-005453-4057qib7	24	42	.	.	.
cord-005453-4057qib7	25	1	24	24	CD
cord-005453-4057qib7	25	2	out	out	IN
cord-005453-4057qib7	25	3	of	of	IN
cord-005453-4057qib7	25	4	30	30	CD
cord-005453-4057qib7	25	5	eligible	eligible	JJ
cord-005453-4057qib7	25	6	patients	patient	NNS
cord-005453-4057qib7	25	7	developed	develop	VBD
cord-005453-4057qib7	25	8	chronic	chronic	JJ
cord-005453-4057qib7	25	9	GVHD	GVHD	NNP
cord-005453-4057qib7	25	10	of	of	IN
cord-005453-4057qib7	25	11	any	any	DT
cord-005453-4057qib7	25	12	stage	stage	NN
cord-005453-4057qib7	25	13	.	.	.
cord-005453-4057qib7	26	1	Relapse	relapse	NN
cord-005453-4057qib7	26	2	incidence	incidence	NN
cord-005453-4057qib7	26	3	was	be	VBD
cord-005453-4057qib7	26	4	low	low	JJ
cord-005453-4057qib7	26	5	(	(	-LRB-
cord-005453-4057qib7	26	6	22	22	CD
cord-005453-4057qib7	26	7	%	%	NN
cord-005453-4057qib7	26	8	at	at	IN
cord-005453-4057qib7	26	9	3	3	CD
cord-005453-4057qib7	26	10	years	year	NNS
cord-005453-4057qib7	26	11	in	in	IN
cord-005453-4057qib7	26	12	all	all	DT
cord-005453-4057qib7	26	13	patients	patient	NNS
cord-005453-4057qib7	26	14	,	,	,
cord-005453-4057qib7	26	15	17	17	CD
cord-005453-4057qib7	26	16	%	%	NN
cord-005453-4057qib7	26	17	in	in	IN
cord-005453-4057qib7	26	18	CR1	CR1	NNP
cord-005453-4057qib7	26	19	patients	patient	NNS
cord-005453-4057qib7	26	20	)	)	-RRB-
cord-005453-4057qib7	26	21	and	and	CC
cord-005453-4057qib7	26	22	was	be	VBD
cord-005453-4057qib7	26	23	not	not	RB
cord-005453-4057qib7	26	24	impacted	impact	VBN
cord-005453-4057qib7	26	25	by	by	IN
cord-005453-4057qib7	26	26	any	any	DT
cord-005453-4057qib7	26	27	pre	pre	JJ
cord-005453-4057qib7	26	28	-	-	JJ
cord-005453-4057qib7	26	29	transplant	transplant	JJ
cord-005453-4057qib7	26	30	factors	factor	NNS
cord-005453-4057qib7	26	31	including	include	VBG
cord-005453-4057qib7	26	32	positive	positive	JJ
cord-005453-4057qib7	26	33	MRD	MRD	NNP
cord-005453-4057qib7	26	34	post	post	NN
cord-005453-4057qib7	26	35	phase	phase	NN
cord-005453-4057qib7	26	36	2	2	CD
cord-005453-4057qib7	26	37	induction	induction	NN
cord-005453-4057qib7	26	38	(	(	-LRB-
cord-005453-4057qib7	26	39	present	present	JJ
cord-005453-4057qib7	26	40	in	in	IN
cord-005453-4057qib7	26	41	6	6	CD
cord-005453-4057qib7	26	42	patients	patient	NNS
cord-005453-4057qib7	26	43	)	)	-RRB-
cord-005453-4057qib7	26	44	.	.	.
cord-005453-4057qib7	27	1	Notably	notably	RB
cord-005453-4057qib7	27	2	,	,	,
cord-005453-4057qib7	27	3	in	in	IN
cord-005453-4057qib7	27	4	univariate	univariate	JJ
cord-005453-4057qib7	27	5	analysis	analysis	NN
cord-005453-4057qib7	27	6	relapse	relapse	NN
cord-005453-4057qib7	27	7	was	be	VBD
cord-005453-4057qib7	27	8	significantly	significantly	RB
cord-005453-4057qib7	27	9	lower	low	JJR
cord-005453-4057qib7	27	10	in	in	IN
cord-005453-4057qib7	27	11	patients	patient	NNS
cord-005453-4057qib7	27	12	who	who	WP
cord-005453-4057qib7	27	13	developed	develop	VBD
cord-005453-4057qib7	27	14	chronic	chronic	JJ
cord-005453-4057qib7	27	15	GvHD	GvHD	NNP
cord-005453-4057qib7	27	16	.	.	.
cord-005453-4057qib7	28	1	Background	background	NN
cord-005453-4057qib7	28	2	:	:	:
cord-005453-4057qib7	29	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	29	2	stem	stem	VBP
cord-005453-4057qib7	29	3	cell	cell	NN
cord-005453-4057qib7	29	4	transplantation	transplantation	NN
cord-005453-4057qib7	29	5	(	(	-LRB-
cord-005453-4057qib7	29	6	alloSCT	alloSCT	NNP
cord-005453-4057qib7	29	7	)	)	-RRB-
cord-005453-4057qib7	29	8	is	be	VBZ
cord-005453-4057qib7	29	9	the	the	DT
cord-005453-4057qib7	29	10	treatment	treatment	NN
cord-005453-4057qib7	29	11	of	of	IN
cord-005453-4057qib7	29	12	choice	choice	NN
cord-005453-4057qib7	29	13	for	for	IN
cord-005453-4057qib7	29	14	many	many	JJ
cord-005453-4057qib7	29	15	patients	patient	NNS
cord-005453-4057qib7	29	16	(	(	-LRB-
cord-005453-4057qib7	29	17	pts	pts	NN
cord-005453-4057qib7	29	18	)	)	-RRB-
cord-005453-4057qib7	29	19	suffering	suffer	VBG
cord-005453-4057qib7	29	20	from	from	IN
cord-005453-4057qib7	29	21	acute	acute	JJ
cord-005453-4057qib7	29	22	myeloid	myeloid	NN
cord-005453-4057qib7	29	23	leukemia	leukemia	NN
cord-005453-4057qib7	29	24	(	(	-LRB-
cord-005453-4057qib7	29	25	AML	AML	NNP
cord-005453-4057qib7	29	26	)	)	-RRB-
cord-005453-4057qib7	29	27	.	.	.
cord-005453-4057qib7	30	1	The	the	DT
cord-005453-4057qib7	30	2	graft	graft	NN
cord-005453-4057qib7	30	3	vs.	vs.	FW
cord-005453-4057qib7	30	4	leukemia	leukemia	NN
cord-005453-4057qib7	30	5	effect	effect	NN
cord-005453-4057qib7	30	6	(	(	-LRB-
cord-005453-4057qib7	30	7	GvL	gvl	NN
cord-005453-4057qib7	30	8	)	)	-RRB-
cord-005453-4057qib7	30	9	,	,	,
cord-005453-4057qib7	30	10	applied	apply	VBN
cord-005453-4057qib7	30	11	by	by	IN
cord-005453-4057qib7	30	12	immunocompetent	immunocompetent	JJ
cord-005453-4057qib7	30	13	cells	cell	NNS
cord-005453-4057qib7	30	14	of	of	IN
cord-005453-4057qib7	30	15	donor	donor	NN
cord-005453-4057qib7	30	16	origin	origin	NN
cord-005453-4057qib7	30	17	,	,	,
cord-005453-4057qib7	30	18	is	be	VBZ
cord-005453-4057qib7	30	19	the	the	DT
cord-005453-4057qib7	30	20	most	most	RBS
cord-005453-4057qib7	30	21	important	important	JJ
cord-005453-4057qib7	30	22	effector	effector	NN
cord-005453-4057qib7	30	23	mechanism	mechanism	NN
cord-005453-4057qib7	30	24	for	for	IN
cord-005453-4057qib7	30	25	the	the	DT
cord-005453-4057qib7	30	26	eradication	eradication	NN
cord-005453-4057qib7	30	27	of	of	IN
cord-005453-4057qib7	30	28	leukemia	leukemia	NN
cord-005453-4057qib7	30	29	,	,	,
cord-005453-4057qib7	30	30	The	the	DT
cord-005453-4057qib7	30	31	presentation	presentation	NN
cord-005453-4057qib7	30	32	of	of	IN
cord-005453-4057qib7	30	33	leukemic	leukemic	JJ
cord-005453-4057qib7	30	34	or	or	CC
cord-005453-4057qib7	30	35	allospecific	allospecific	NN
cord-005453-4057qib7	30	36	antigens	antigen	NNS
cord-005453-4057qib7	30	37	by	by	IN
cord-005453-4057qib7	30	38	malignant	malignant	JJ
cord-005453-4057qib7	30	39	blasts	blast	NNS
cord-005453-4057qib7	30	40	is	be	VBZ
cord-005453-4057qib7	30	41	regarded	regard	VBN
cord-005453-4057qib7	30	42	as	as	IN
cord-005453-4057qib7	30	43	a	a	DT
cord-005453-4057qib7	30	44	crucial	crucial	JJ
cord-005453-4057qib7	30	45	trigger	trigger	NN
cord-005453-4057qib7	30	46	for	for	IN
cord-005453-4057qib7	30	47	an	an	DT
cord-005453-4057qib7	30	48	effective	effective	JJ
cord-005453-4057qib7	30	49	allogeneic	allogeneic	NN
cord-005453-4057qib7	30	50	immune	immune	JJ
cord-005453-4057qib7	30	51	response	response	NN
cord-005453-4057qib7	30	52	.	.	.
cord-005453-4057qib7	31	1	Conversely	conversely	RB
cord-005453-4057qib7	31	2	,	,	,
cord-005453-4057qib7	31	3	insufficient	insufficient	JJ
cord-005453-4057qib7	31	4	stimulatory	stimulatory	JJ
cord-005453-4057qib7	31	5	capacity	capacity	NN
cord-005453-4057qib7	31	6	by	by	IN
cord-005453-4057qib7	31	7	the	the	DT
cord-005453-4057qib7	31	8	leukemic	leukemic	JJ
cord-005453-4057qib7	31	9	blasts	blast	NNS
cord-005453-4057qib7	31	10	is	be	VBZ
cord-005453-4057qib7	31	11	thought	think	VBN
cord-005453-4057qib7	31	12	to	to	TO
cord-005453-4057qib7	31	13	be	be	VB
cord-005453-4057qib7	31	14	a	a	DT
cord-005453-4057qib7	31	15	relevant	relevant	JJ
cord-005453-4057qib7	31	16	escape	escape	NN
cord-005453-4057qib7	31	17	mechanism	mechanism	NN
cord-005453-4057qib7	31	18	from	from	IN
cord-005453-4057qib7	31	19	cellular	cellular	JJ
cord-005453-4057qib7	31	20	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	31	21	(	(	-LRB-
cord-005453-4057qib7	31	22	alloSCT	alloSCT	NNP
cord-005453-4057qib7	31	23	or	or	CC
cord-005453-4057qib7	31	24	donor	donor	NN
cord-005453-4057qib7	31	25	-	-	HYPH
cord-005453-4057qib7	31	26	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	31	27	infusion	infusion	NN
cord-005453-4057qib7	31	28	(	(	-LRB-
cord-005453-4057qib7	31	29	DLI	DLI	NNP
cord-005453-4057qib7	31	30	)	)	-RRB-
cord-005453-4057qib7	31	31	)	)	-RRB-
cord-005453-4057qib7	31	32	.	.	.
cord-005453-4057qib7	32	1	The	the	DT
cord-005453-4057qib7	32	2	purpose	purpose	NN
cord-005453-4057qib7	32	3	was	be	VBD
cord-005453-4057qib7	32	4	to	to	TO
cord-005453-4057qib7	32	5	test	test	VB
cord-005453-4057qib7	32	6	,	,	,
cord-005453-4057qib7	32	7	whether	whether	IN
cord-005453-4057qib7	32	8	the	the	DT
cord-005453-4057qib7	32	9	ability	ability	NN
cord-005453-4057qib7	32	10	of	of	IN
cord-005453-4057qib7	32	11	malignant	malignant	JJ
cord-005453-4057qib7	32	12	blasts	blast	NNS
cord-005453-4057qib7	32	13	to	to	TO
cord-005453-4057qib7	32	14	differentiate	differentiate	VB
cord-005453-4057qib7	32	15	in	in	IN
cord-005453-4057qib7	32	16	vitro	vitro	FW
cord-005453-4057qib7	32	17	towards	towards	IN
cord-005453-4057qib7	32	18	dendritic	dendritic	JJ
cord-005453-4057qib7	32	19	cells	cell	NNS
cord-005453-4057qib7	32	20	of	of	IN
cord-005453-4057qib7	32	21	leukemic	leukemic	JJ
cord-005453-4057qib7	32	22	origin	origin	NN
cord-005453-4057qib7	32	23	(	(	-LRB-
cord-005453-4057qib7	32	24	DC	DC	NNP
cord-005453-4057qib7	32	25	leu	leu	NNP
cord-005453-4057qib7	32	26	)	)	-RRB-
cord-005453-4057qib7	32	27	is	be	VBZ
cord-005453-4057qib7	32	28	associated	associate	VBN
cord-005453-4057qib7	32	29	with	with	IN
cord-005453-4057qib7	32	30	response	response	NN
cord-005453-4057qib7	32	31	to	to	IN
cord-005453-4057qib7	32	32	alloSCT	alloSCT	NNP
cord-005453-4057qib7	32	33	or	or	CC
cord-005453-4057qib7	32	34	outcome	outcome	NN
cord-005453-4057qib7	32	35	after	after	IN
cord-005453-4057qib7	32	36	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	32	37	(	(	-LRB-
cord-005453-4057qib7	32	38	second	second	JJ
cord-005453-4057qib7	32	39	alloSCT	alloSCT	NNP
cord-005453-4057qib7	32	40	or	or	CC
cord-005453-4057qib7	32	41	DLI	DLI	NNP
cord-005453-4057qib7	32	42	)	)	-RRB-
cord-005453-4057qib7	32	43	for	for	IN
cord-005453-4057qib7	32	44	post	post	JJ
cord-005453-4057qib7	32	45	-	-	JJ
cord-005453-4057qib7	32	46	transplant	transplant	JJ
cord-005453-4057qib7	32	47	relapse	relapse	NN
cord-005453-4057qib7	32	48	in	in	IN
cord-005453-4057qib7	32	49	AML	AML	NNP
cord-005453-4057qib7	32	50	.	.	.
cord-005453-4057qib7	33	1	Methods	method	NNS
cord-005453-4057qib7	33	2	:	:	:
cord-005453-4057qib7	34	1	Leukemic	leukemic	JJ
cord-005453-4057qib7	34	2	blasts	blast	NNS
cord-005453-4057qib7	34	3	were	be	VBD
cord-005453-4057qib7	34	4	isolated	isolate	VBN
cord-005453-4057qib7	34	5	from	from	IN
cord-005453-4057qib7	34	6	peripheral	peripheral	JJ
cord-005453-4057qib7	34	7	blood	blood	NN
cord-005453-4057qib7	34	8	(	(	-LRB-
cord-005453-4057qib7	34	9	PB	PB	NNP
cord-005453-4057qib7	34	10	)	)	-RRB-
cord-005453-4057qib7	34	11	or	or	CC
cord-005453-4057qib7	34	12	bone	bone	NN
cord-005453-4057qib7	34	13	marrow	marrow	NN
cord-005453-4057qib7	34	14	(	(	-LRB-
cord-005453-4057qib7	34	15	BM	BM	NNP
cord-005453-4057qib7	34	16	)	)	-RRB-
cord-005453-4057qib7	34	17	samples	sample	NNS
cord-005453-4057qib7	34	18	of	of	IN
cord-005453-4057qib7	34	19	AML	AML	NNP
cord-005453-4057qib7	34	20	patients	patient	NNS
cord-005453-4057qib7	34	21	before	before	IN
cord-005453-4057qib7	34	22	alloSCT	alloSCT	NNP
cord-005453-4057qib7	34	23	(	(	-LRB-
cord-005453-4057qib7	34	24	n=47	n=47	NN
cord-005453-4057qib7	34	25	)	)	-RRB-
cord-005453-4057qib7	34	26	or	or	CC
cord-005453-4057qib7	34	27	at	at	IN
cord-005453-4057qib7	34	28	relapse	relapse	NN
cord-005453-4057qib7	34	29	after	after	IN
cord-005453-4057qib7	34	30	alloSCT	alloSCT	NNP
cord-005453-4057qib7	34	31	(	(	-LRB-
cord-005453-4057qib7	34	32	n=22	n=22	NNP
cord-005453-4057qib7	34	33	)	)	-RRB-
cord-005453-4057qib7	34	34	.	.	.
cord-005453-4057qib7	35	1	A	a	DT
cord-005453-4057qib7	35	2	panel	panel	NN
cord-005453-4057qib7	35	3	of	of	IN
cord-005453-4057qib7	35	4	6	6	CD
cord-005453-4057qib7	35	5	different	different	JJ
cord-005453-4057qib7	35	6	assays	assay	NNS
cord-005453-4057qib7	35	7	was	be	VBD
cord-005453-4057qib7	35	8	used	use	VBN
cord-005453-4057qib7	35	9	to	to	TO
cord-005453-4057qib7	35	10	generate	generate	VB
cord-005453-4057qib7	35	11	DC	DC	NNP
cord-005453-4057qib7	35	12	leu	leu	NNP
cord-005453-4057qib7	35	13	in	in	IN
cord-005453-4057qib7	35	14	vitro	vitro	FW
cord-005453-4057qib7	35	15	(	(	-LRB-
cord-005453-4057qib7	35	16	5	5	CD
cord-005453-4057qib7	35	17	of	of	IN
cord-005453-4057qib7	35	18	them	-PRON-	PRP
cord-005453-4057qib7	35	19	containing	contain	VBG
cord-005453-4057qib7	35	20	GM	GM	NNP
cord-005453-4057qib7	35	21	-	-	HYPH
cord-005453-4057qib7	35	22	CSF	CSF	NNP
cord-005453-4057qib7	35	23	)	)	-RRB-
cord-005453-4057qib7	35	24	.	.	.
cord-005453-4057qib7	36	1	Finally	finally	RB
cord-005453-4057qib7	36	2	,	,	,
cord-005453-4057qib7	36	3	in	in	IN
cord-005453-4057qib7	36	4	vitro	vitro	FW
cord-005453-4057qib7	36	5	results	result	NNS
cord-005453-4057qib7	36	6	were	be	VBD
cord-005453-4057qib7	36	7	correlated	correlate	VBN
cord-005453-4057qib7	36	8	with	with	IN
cord-005453-4057qib7	36	9	clinical	clinical	JJ
cord-005453-4057qib7	36	10	characteristics	characteristic	NNS
cord-005453-4057qib7	36	11	and	and	CC
cord-005453-4057qib7	36	12	outcome	outcome	NN
cord-005453-4057qib7	36	13	of	of	IN
cord-005453-4057qib7	36	14	patients	patient	NNS
cord-005453-4057qib7	36	15	treated	treat	VBN
cord-005453-4057qib7	36	16	with	with	IN
cord-005453-4057qib7	36	17	donor	donor	NN
cord-005453-4057qib7	36	18	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	36	19	infusion	infusion	NN
cord-005453-4057qib7	36	20	and/or	and/or	CC
cord-005453-4057qib7	37	1	alloSCT	alloSCT	NNP
cord-005453-4057qib7	37	2	.	.	.
cord-005453-4057qib7	38	1	Results	result	NNS
cord-005453-4057qib7	38	2	:	:	:
cord-005453-4057qib7	39	1	DC	DC	NNP
cord-005453-4057qib7	39	2	leu	leu	NNP
cord-005453-4057qib7	39	3	could	could	MD
cord-005453-4057qib7	39	4	be	be	VB
cord-005453-4057qib7	39	5	generated	generate	VBN
cord-005453-4057qib7	39	6	in	in	IN
cord-005453-4057qib7	39	7	vitro	vitro	FW
cord-005453-4057qib7	39	8	from	from	IN
cord-005453-4057qib7	39	9	all	all	DT
cord-005453-4057qib7	39	10	69	69	CD
cord-005453-4057qib7	39	11	samples	sample	NNS
cord-005453-4057qib7	39	12	.	.	.
cord-005453-4057qib7	40	1	When	when	WRB
cord-005453-4057qib7	40	2	correlating	correlate	VBG
cord-005453-4057qib7	40	3	proportions	proportion	NNS
cord-005453-4057qib7	40	4	of	of	IN
cord-005453-4057qib7	40	5	DC	DC	NNP
cord-005453-4057qib7	40	6	-	-	HYPH
cord-005453-4057qib7	40	7	subtypes	subtype	NNS
cord-005453-4057qib7	40	8	generated	generate	VBD
cord-005453-4057qib7	40	9	ex	ex	FW
cord-005453-4057qib7	40	10	vivo	vivo	FW
cord-005453-4057qib7	40	11	with	with	IN
cord-005453-4057qib7	40	12	clinical	clinical	JJ
cord-005453-4057qib7	40	13	data	datum	NNS
cord-005453-4057qib7	40	14	,	,	,
cord-005453-4057qib7	40	15	significantly	significantly	RB
cord-005453-4057qib7	40	16	higher	high	JJR
cord-005453-4057qib7	40	17	mean	mean	JJ
cord-005453-4057qib7	40	18	proportions	proportion	NNS
cord-005453-4057qib7	40	19	of	of	IN
cord-005453-4057qib7	40	20	DC	DC	NNP
cord-005453-4057qib7	40	21	leu	leu	NNP
cord-005453-4057qib7	40	22	in	in	IN
cord-005453-4057qib7	40	23	the	the	DT
cord-005453-4057qib7	40	24	DC	DC	NNP
cord-005453-4057qib7	40	25	-	-	HYPH
cord-005453-4057qib7	40	26	fraction	fraction	NN
cord-005453-4057qib7	40	27	were	be	VBD
cord-005453-4057qib7	40	28	found	find	VBN
cord-005453-4057qib7	40	29	in	in	IN
cord-005453-4057qib7	40	30	responders	responder	NNS
cord-005453-4057qib7	40	31	vs.	vs.	IN
cord-005453-4057qib7	40	32	non	non	NNS
cord-005453-4057qib7	40	33	-	-	NNS
cord-005453-4057qib7	40	34	responders	responder	NNS
cord-005453-4057qib7	40	35	to	to	IN
cord-005453-4057qib7	40	36	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	40	37	(	(	-LRB-
cord-005453-4057qib7	40	38	76.8	76.8	CD
cord-005453-4057qib7	40	39	%	%	NN
cord-005453-4057qib7	40	40	vs	vs	IN
cord-005453-4057qib7	40	41	58.8%,p=0.006	58.8%,p=0.006	CD
cord-005453-4057qib7	40	42	,	,	,
cord-005453-4057qib7	40	43	range:13%-99	range:13%-99	NNP
cord-005453-4057qib7	40	44	%	%	NN
cord-005453-4057qib7	40	45	)	)	-RRB-
cord-005453-4057qib7	40	46	.	.	.
cord-005453-4057qib7	41	1	Vice	Vice	NNP
cord-005453-4057qib7	41	2	versa	versa	RB
cord-005453-4057qib7	41	3	,	,	,
cord-005453-4057qib7	41	4	the	the	DT
cord-005453-4057qib7	41	5	chance	chance	NN
cord-005453-4057qib7	41	6	for	for	IN
cord-005453-4057qib7	41	7	response	response	NN
cord-005453-4057qib7	41	8	to	to	IN
cord-005453-4057qib7	41	9	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	41	10	was	be	VBD
cord-005453-4057qib7	41	11	significantly	significantly	RB
cord-005453-4057qib7	41	12	higher	high	JJR
cord-005453-4057qib7	41	13	,	,	,
cord-005453-4057qib7	41	14	if	if	IN
cord-005453-4057qib7	41	15	a	a	DT
cord-005453-4057qib7	41	16	DC	DC	NNP
cord-005453-4057qib7	41	17	leu	leu	NNP
cord-005453-4057qib7	41	18	/DC	/DC	:
cord-005453-4057qib7	41	19	ratio	ratio	NN
cord-005453-4057qib7	41	20	of	of	IN
cord-005453-4057qib7	41	21	>	>	XX
cord-005453-4057qib7	41	22	=	=	SYM
cord-005453-4057qib7	41	23	50	50	CD
cord-005453-4057qib7	41	24	%	%	NN
cord-005453-4057qib7	41	25	could	could	MD
cord-005453-4057qib7	41	26	be	be	VB
cord-005453-4057qib7	41	27	reached	reach	VBN
cord-005453-4057qib7	41	28	in	in	IN
cord-005453-4057qib7	41	29	vivo	vivo	FW
cord-005453-4057qib7	41	30	(	(	-LRB-
cord-005453-4057qib7	41	31	p=0.004	p=0.004	NNP
cord-005453-4057qib7	41	32	)	)	-RRB-
cord-005453-4057qib7	41	33	.	.	.
cord-005453-4057qib7	42	1	Those	those	DT
cord-005453-4057qib7	42	2	patientswere	patientswere	RB
cord-005453-4057qib7	42	3	characterized	characterize	VBN
cord-005453-4057qib7	42	4	by	by	IN
cord-005453-4057qib7	42	5	a	a	DT
cord-005453-4057qib7	42	6	longer	long	JJR
cord-005453-4057qib7	42	7	time	time	NN
cord-005453-4057qib7	42	8	to	to	TO
cord-005453-4057qib7	42	9	relapse	relapse	VB
cord-005453-4057qib7	42	10	(	(	-LRB-
cord-005453-4057qib7	42	11	p=0.04	p=0.04	NN
cord-005453-4057qib7	42	12	)	)	-RRB-
cord-005453-4057qib7	42	13	and	and	CC
cord-005453-4057qib7	42	14	by	by	IN
cord-005453-4057qib7	42	15	a	a	DT
cord-005453-4057qib7	42	16	higher	high	JJR
cord-005453-4057qib7	42	17	probability	probability	NN
cord-005453-4057qib7	42	18	for	for	IN
cord-005453-4057qib7	42	19	leukemia	leukemia	NN
cord-005453-4057qib7	42	20	-	-	HYPH
cord-005453-4057qib7	42	21	free	free	JJ
cord-005453-4057qib7	42	22	survival	survival	NN
cord-005453-4057qib7	42	23	(	(	-LRB-
cord-005453-4057qib7	42	24	p=0.005	p=0.005	NNP
cord-005453-4057qib7	42	25	)	)	-RRB-
cord-005453-4057qib7	42	26	.	.	.
cord-005453-4057qib7	43	1	Similarly	similarly	RB
cord-005453-4057qib7	43	2	,	,	,
cord-005453-4057qib7	43	3	generation	generation	NN
cord-005453-4057qib7	43	4	of	of	IN
cord-005453-4057qib7	43	5	higher	high	JJR
cord-005453-4057qib7	43	6	amounts	amount	NNS
cord-005453-4057qib7	43	7	(	(	-LRB-
cord-005453-4057qib7	43	8	>	>	NFP
cord-005453-4057qib7	43	9	8	8	CD
cord-005453-4057qib7	43	10	%	%	NN
cord-005453-4057qib7	43	11	,	,	,
cord-005453-4057qib7	43	12	p=0.04	p=0.04	NNP
cord-005453-4057qib7	43	13	)	)	-RRB-
cord-005453-4057qib7	43	14	of	of	IN
cord-005453-4057qib7	43	15	DC	DC	NNP
cord-005453-4057qib7	43	16	leu	leu	NNP
cord-005453-4057qib7	43	17	in	in	IN
cord-005453-4057qib7	43	18	the	the	DT
cord-005453-4057qib7	43	19	MNC	MNC	NNP
cord-005453-4057qib7	43	20	-	-	HYPH
cord-005453-4057qib7	43	21	fraction	fraction	NN
cord-005453-4057qib7	43	22	,	,	,
cord-005453-4057qib7	43	23	and	and	CC
cord-005453-4057qib7	43	24	generation	generation	NN
cord-005453-4057qib7	43	25	of	of	IN
cord-005453-4057qib7	43	26	more	more	JJR
cord-005453-4057qib7	43	27	mature	mature	JJ
cord-005453-4057qib7	43	28	DC	DC	NNP
cord-005453-4057qib7	43	29	(	(	-LRB-
cord-005453-4057qib7	43	30	>	>	NFP
cord-005453-4057qib7	43	31	47	47	CD
cord-005453-4057qib7	43	32	%	%	NN
cord-005453-4057qib7	44	1	CD83	CD83	NNP
cord-005453-4057qib7	44	2	+	+	CC
cord-005453-4057qib7	44	3	,	,	,
cord-005453-4057qib7	44	4	p=0.03	p=0.03	NN
cord-005453-4057qib7	44	5	using	use	VBG
cord-005453-4057qib7	44	6	the	the	DT
cord-005453-4057qib7	44	7	best	good	JJS
cord-005453-4057qib7	44	8	GM	GM	NNP
cord-005453-4057qib7	44	9	-	-	HYPH
cord-005453-4057qib7	44	10	CSF	CSF	NNP
cord-005453-4057qib7	44	11	containing	contain	VBG
cord-005453-4057qib7	44	12	assay	assay	NN
cord-005453-4057qib7	44	13	)	)	-RRB-
cord-005453-4057qib7	44	14	were	be	VBD
cord-005453-4057qib7	44	15	associated	associate	VBN
cord-005453-4057qib7	44	16	with	with	IN
cord-005453-4057qib7	44	17	a	a	DT
cord-005453-4057qib7	44	18	longer	long	JJR
cord-005453-4057qib7	44	19	time	time	NN
cord-005453-4057qib7	44	20	to	to	TO
cord-005453-4057qib7	44	21	relapse	relapse	VB
cord-005453-4057qib7	44	22	in	in	IN
cord-005453-4057qib7	44	23	the	the	DT
cord-005453-4057qib7	44	24	respective	respective	JJ
cord-005453-4057qib7	44	25	patients	patient	NNS
cord-005453-4057qib7	44	26	.	.	.
cord-005453-4057qib7	45	1	Moreover	moreover	RB
cord-005453-4057qib7	45	2	,	,	,
cord-005453-4057qib7	45	3	overall	overall	JJ
cord-005453-4057qib7	45	4	survival	survival	NN
cord-005453-4057qib7	45	5	was	be	VBD
cord-005453-4057qib7	45	6	improved	improve	VBN
cord-005453-4057qib7	45	7	,	,	,
cord-005453-4057qib7	45	8	if	if	IN
cord-005453-4057qib7	45	9	>	>	XX
cord-005453-4057qib7	45	10	70	70	CD
cord-005453-4057qib7	45	11	%	%	NN
cord-005453-4057qib7	45	12	DC	DC	NNP
cord-005453-4057qib7	45	13	leu	leu	NNP
cord-005453-4057qib7	45	14	/DC	/DC	NNP
cord-005453-4057qib7	45	15	could	could	MD
cord-005453-4057qib7	45	16	be	be	VB
cord-005453-4057qib7	45	17	generated	generate	VBN
cord-005453-4057qib7	45	18	with	with	IN
cord-005453-4057qib7	45	19	the	the	DT
cord-005453-4057qib7	45	20	best	good	JJS
cord-005453-4057qib7	45	21	GM	GM	NNP
cord-005453-4057qib7	45	22	-	-	HYPH
cord-005453-4057qib7	45	23	CSF	CSF	NNP
cord-005453-4057qib7	45	24	containing	contain	VBG
cord-005453-4057qib7	45	25	assay	assay	NN
cord-005453-4057qib7	45	26	(	(	-LRB-
cord-005453-4057qib7	45	27	p=0.048	p=0.048	NNP
cord-005453-4057qib7	45	28	)	)	-RRB-
cord-005453-4057qib7	45	29	.	.	.
cord-005453-4057qib7	46	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	46	2	:	:	:
cord-005453-4057qib7	47	1	In	in	IN
cord-005453-4057qib7	47	2	vitro	vitro	FW
cord-005453-4057qib7	47	3	generation	generation	NN
cord-005453-4057qib7	47	4	of	of	IN
cord-005453-4057qib7	47	5	DC	DC	NNP
cord-005453-4057qib7	47	6	/	/	SYM
cord-005453-4057qib7	47	7	DC	DC	NNP
cord-005453-4057qib7	47	8	leu	leu	NNP
cord-005453-4057qib7	47	9	from	from	IN
cord-005453-4057qib7	47	10	leukemic	leukemic	JJ
cord-005453-4057qib7	47	11	blasts	blast	NNS
cord-005453-4057qib7	47	12	obtained	obtain	VBN
cord-005453-4057qib7	47	13	in	in	IN
cord-005453-4057qib7	47	14	active	active	JJ
cord-005453-4057qib7	47	15	stages	stage	NNS
cord-005453-4057qib7	47	16	of	of	IN
cord-005453-4057qib7	47	17	AML	AML	NNP
cord-005453-4057qib7	47	18	before	before	IN
cord-005453-4057qib7	47	19	alloSCT	alloSCT	NNP
cord-005453-4057qib7	47	20	or	or	CC
cord-005453-4057qib7	47	21	at	at	IN
cord-005453-4057qib7	47	22	relapse	relapse	NN
cord-005453-4057qib7	47	23	post	post	NN
cord-005453-4057qib7	47	24	transplant	transplant	NN
cord-005453-4057qib7	47	25	were	be	VBD
cord-005453-4057qib7	47	26	associated	associate	VBN
cord-005453-4057qib7	47	27	with	with	IN
cord-005453-4057qib7	47	28	clinical	clinical	JJ
cord-005453-4057qib7	47	29	outcome	outcome	NN
cord-005453-4057qib7	47	30	.	.	.
cord-005453-4057qib7	48	1	This	this	DT
cord-005453-4057qib7	48	2	observation	observation	NN
cord-005453-4057qib7	48	3	supports	support	VBZ
cord-005453-4057qib7	48	4	a	a	DT
cord-005453-4057qib7	48	5	role	role	NN
cord-005453-4057qib7	48	6	of	of	IN
cord-005453-4057qib7	48	7	antigen	antigen	NN
cord-005453-4057qib7	48	8	presentation	presentation	NN
cord-005453-4057qib7	48	9	by	by	IN
cord-005453-4057qib7	48	10	leukemic	leukemic	JJ
cord-005453-4057qib7	48	11	cells	cell	NNS
cord-005453-4057qib7	48	12	for	for	IN
cord-005453-4057qib7	48	13	an	an	DT
cord-005453-4057qib7	48	14	allogeneic	allogeneic	JJ
cord-005453-4057qib7	48	15	immune	immune	JJ
cord-005453-4057qib7	48	16	response	response	NN
cord-005453-4057qib7	48	17	in	in	IN
cord-005453-4057qib7	48	18	AML	AML	NNP
cord-005453-4057qib7	48	19	.	.	.
cord-005453-4057qib7	49	1	Disclosure	disclosure	NN
cord-005453-4057qib7	49	2	:	:	:
cord-005453-4057qib7	49	3	Nothing	nothing	NN
cord-005453-4057qib7	49	4	to	to	TO
cord-005453-4057qib7	49	5	declare	declare	VB
cord-005453-4057qib7	49	6	Background	background	NN
cord-005453-4057qib7	49	7	:	:	:
cord-005453-4057qib7	50	1	The	the	DT
cord-005453-4057qib7	50	2	role	role	NN
cord-005453-4057qib7	50	3	of	of	IN
cord-005453-4057qib7	50	4	autologous	autologous	JJ
cord-005453-4057qib7	50	5	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	50	6	cell	cell	NN
cord-005453-4057qib7	50	7	transplantation	transplantation	NN
cord-005453-4057qib7	50	8	(	(	-LRB-
cord-005453-4057qib7	50	9	HCT	HCT	NNP
cord-005453-4057qib7	50	10	)	)	-RRB-
cord-005453-4057qib7	50	11	in	in	IN
cord-005453-4057qib7	50	12	the	the	DT
cord-005453-4057qib7	50	13	treatment	treatment	NN
cord-005453-4057qib7	50	14	of	of	IN
cord-005453-4057qib7	50	15	AML	AML	NNP
cord-005453-4057qib7	50	16	is	be	VBZ
cord-005453-4057qib7	50	17	not	not	RB
cord-005453-4057qib7	50	18	clear	clear	JJ
cord-005453-4057qib7	50	19	.	.	.
cord-005453-4057qib7	51	1	Trials	trial	NNS
cord-005453-4057qib7	51	2	in	in	IN
cord-005453-4057qib7	51	3	the	the	DT
cord-005453-4057qib7	51	4	past	past	NN
cord-005453-4057qib7	51	5	have	have	VBP
cord-005453-4057qib7	51	6	shown	show	VBN
cord-005453-4057qib7	51	7	that	that	IN
cord-005453-4057qib7	51	8	autologous	autologous	JJ
cord-005453-4057qib7	51	9	HCT	hct	NN
cord-005453-4057qib7	51	10	consolidation	consolidation	NN
cord-005453-4057qib7	51	11	lowers	lower	VBZ
cord-005453-4057qib7	51	12	the	the	DT
cord-005453-4057qib7	51	13	risk	risk	NN
cord-005453-4057qib7	51	14	of	of	IN
cord-005453-4057qib7	51	15	relapse	relapse	NN
cord-005453-4057qib7	51	16	,	,	,
cord-005453-4057qib7	51	17	however	however	RB
cord-005453-4057qib7	51	18	the	the	DT
cord-005453-4057qib7	51	19	magnitude	magnitude	NN
cord-005453-4057qib7	51	20	of	of	IN
cord-005453-4057qib7	51	21	this	this	DT
cord-005453-4057qib7	51	22	effect	effect	NN
cord-005453-4057qib7	51	23	is	be	VBZ
cord-005453-4057qib7	51	24	limited	limit	VBN
cord-005453-4057qib7	51	25	.	.	.
cord-005453-4057qib7	52	1	Autologous	autologous	JJ
cord-005453-4057qib7	52	2	HCT	HCT	NNP
cord-005453-4057qib7	52	3	is	be	VBZ
cord-005453-4057qib7	52	4	advocated	advocate	VBN
cord-005453-4057qib7	52	5	in	in	IN
cord-005453-4057qib7	52	6	patients	patient	NNS
cord-005453-4057qib7	52	7	with	with	IN
cord-005453-4057qib7	52	8	AML	AML	NNP
cord-005453-4057qib7	52	9	with	with	IN
cord-005453-4057qib7	52	10	lower	low	JJR
cord-005453-4057qib7	52	11	genetic	genetic	JJ
cord-005453-4057qib7	52	12	risk	risk	NN
cord-005453-4057qib7	52	13	in	in	IN
cord-005453-4057qib7	52	14	CR1.Many	CR1.Many	NNP
cord-005453-4057qib7	52	15	of	of	IN
cord-005453-4057qib7	52	16	these	these	DT
cord-005453-4057qib7	52	17	patients	patient	NNS
cord-005453-4057qib7	52	18	will	will	MD
cord-005453-4057qib7	52	19	eventually	eventually	RB
cord-005453-4057qib7	52	20	relapse	relapse	VB
cord-005453-4057qib7	52	21	and	and	CC
cord-005453-4057qib7	52	22	will	will	MD
cord-005453-4057qib7	52	23	undergo	undergo	VB
cord-005453-4057qib7	52	24	reinduction	reinduction	NN
cord-005453-4057qib7	52	25	followed	follow	VBN
cord-005453-4057qib7	52	26	by	by	IN
cord-005453-4057qib7	52	27	allogeneic	allogeneic	NN
cord-005453-4057qib7	52	28	HCT	hct	NN
cord-005453-4057qib7	52	29	in	in	IN
cord-005453-4057qib7	52	30	CR2	CR2	NNP
cord-005453-4057qib7	52	31	.	.	.
cord-005453-4057qib7	53	1	Methods	method	NNS
cord-005453-4057qib7	53	2	:	:	:
cord-005453-4057qib7	54	1	The	the	DT
cord-005453-4057qib7	54	2	aims	aim	NNS
cord-005453-4057qib7	54	3	of	of	IN
cord-005453-4057qib7	54	4	this	this	DT
cord-005453-4057qib7	54	5	study	study	NN
cord-005453-4057qib7	54	6	is	be	VBZ
cord-005453-4057qib7	54	7	to	to	TO
cord-005453-4057qib7	54	8	analyze	analyze	VB
cord-005453-4057qib7	54	9	outcome	outcome	NN
cord-005453-4057qib7	54	10	of	of	IN
cord-005453-4057qib7	54	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	54	12	HCT	HCT	NNP
cord-005453-4057qib7	54	13	performed	perform	VBN
cord-005453-4057qib7	54	14	in	in	IN
cord-005453-4057qib7	54	15	CR2	CR2	NNP
cord-005453-4057qib7	54	16	comparing	compare	VBG
cord-005453-4057qib7	54	17	patients	patient	NNS
cord-005453-4057qib7	54	18	with	with	IN
cord-005453-4057qib7	54	19	prior	prior	JJ
cord-005453-4057qib7	54	20	consolidation	consolidation	NN
cord-005453-4057qib7	54	21	by	by	IN
cord-005453-4057qib7	54	22	autologous	autologous	JJ
cord-005453-4057qib7	54	23	HCT	hct	NN
cord-005453-4057qib7	54	24	vs.	vs.	IN
cord-005453-4057qib7	54	25	patients	patient	NNS
cord-005453-4057qib7	54	26	with	with	IN
cord-005453-4057qib7	54	27	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	54	28	consolidation	consolidation	NN
cord-005453-4057qib7	54	29	.	.	.
cord-005453-4057qib7	55	1	Primary	primary	JJ
cord-005453-4057qib7	55	2	outcome	outcome	NN
cord-005453-4057qib7	55	3	is	be	VBZ
cord-005453-4057qib7	55	4	Non	non	JJ
cord-005453-4057qib7	55	5	relapse	relapse	NN
cord-005453-4057qib7	55	6	mortality	mortality	NN
cord-005453-4057qib7	55	7	(	(	-LRB-
cord-005453-4057qib7	55	8	NRM	NRM	NNP
cord-005453-4057qib7	55	9	)	)	-RRB-
cord-005453-4057qib7	55	10	of	of	IN
cord-005453-4057qib7	55	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	55	12	HCT	hct	NN
cord-005453-4057qib7	55	13	in	in	IN
cord-005453-4057qib7	55	14	CR2	CR2	NNP
cord-005453-4057qib7	55	15	in	in	IN
cord-005453-4057qib7	55	16	patients	patient	NNS
cord-005453-4057qib7	55	17	with	with	IN
cord-005453-4057qib7	55	18	,	,	,
cord-005453-4057qib7	55	19	or	or	CC
cord-005453-4057qib7	55	20	without	without	IN
cord-005453-4057qib7	55	21	prior	prior	JJ
cord-005453-4057qib7	55	22	autologous	autologous	JJ
cord-005453-4057qib7	55	23	HCT	hct	NN
cord-005453-4057qib7	55	24	in	in	IN
cord-005453-4057qib7	55	25	CR1	CR1	NNP
cord-005453-4057qib7	55	26	.	.	.
cord-005453-4057qib7	56	1	Secondary	secondary	JJ
cord-005453-4057qib7	56	2	outcomes	outcome	NNS
cord-005453-4057qib7	56	3	include	include	VBP
cord-005453-4057qib7	56	4	leukemia	leukemia	NN
cord-005453-4057qib7	56	5	free	free	JJ
cord-005453-4057qib7	56	6	survival	survival	NN
cord-005453-4057qib7	56	7	(	(	-LRB-
cord-005453-4057qib7	56	8	LFS	LFS	NNP
cord-005453-4057qib7	56	9	)	)	-RRB-
cord-005453-4057qib7	56	10	,	,	,
cord-005453-4057qib7	56	11	relapse	relapse	NN
cord-005453-4057qib7	56	12	rate	rate	NN
cord-005453-4057qib7	56	13	(	(	-LRB-
cord-005453-4057qib7	56	14	RI	RI	NNP
cord-005453-4057qib7	56	15	)	)	-RRB-
cord-005453-4057qib7	56	16	,	,	,
cord-005453-4057qib7	56	17	graft	graft	NN
cord-005453-4057qib7	56	18	versus	versus	IN
cord-005453-4057qib7	56	19	host	host	NN
cord-005453-4057qib7	56	20	disease	disease	NN
cord-005453-4057qib7	56	21	free	free	JJ
cord-005453-4057qib7	56	22	relapse	relapse	NN
cord-005453-4057qib7	56	23	free	free	JJ
cord-005453-4057qib7	56	24	survival	survival	NN
cord-005453-4057qib7	56	25	(	(	-LRB-
cord-005453-4057qib7	56	26	GRFS	GRFS	NNP
cord-005453-4057qib7	56	27	)	)	-RRB-
cord-005453-4057qib7	56	28	,	,	,
cord-005453-4057qib7	56	29	overall	overall	JJ
cord-005453-4057qib7	56	30	survival	survival	NN
cord-005453-4057qib7	56	31	(	(	-LRB-
cord-005453-4057qib7	56	32	OS	OS	NNP
cord-005453-4057qib7	56	33	)	)	-RRB-
cord-005453-4057qib7	56	34	,	,	,
cord-005453-4057qib7	56	35	and	and	CC
cord-005453-4057qib7	56	36	treatment	treatment	NN
cord-005453-4057qib7	56	37	related	relate	VBN
cord-005453-4057qib7	56	38	toxicities	toxicity	NNS
cord-005453-4057qib7	56	39	.	.	.
cord-005453-4057qib7	57	1	Results	result	NNS
cord-005453-4057qib7	57	2	:	:	:
cord-005453-4057qib7	58	1	2619	2619	CD
cord-005453-4057qib7	58	2	adult	adult	NN
cord-005453-4057qib7	58	3	patients	patient	NNS
cord-005453-4057qib7	58	4	reigstered	reigstere	VBD
cord-005453-4057qib7	58	5	with	with	IN
cord-005453-4057qib7	58	6	the	the	DT
cord-005453-4057qib7	58	7	ALWP	ALWP	NNP
cord-005453-4057qib7	58	8	of	of	IN
cord-005453-4057qib7	58	9	the	the	DT
cord-005453-4057qib7	58	10	EBMT	EBMT	NNP
cord-005453-4057qib7	58	11	with	with	IN
cord-005453-4057qib7	58	12	de	de	NNP
cord-005453-4057qib7	58	13	novo	novo	NNP
cord-005453-4057qib7	58	14	AML	AML	NNP
cord-005453-4057qib7	58	15	were	be	VBD
cord-005453-4057qib7	58	16	included	include	VBN
cord-005453-4057qib7	58	17	,	,	,
cord-005453-4057qib7	58	18	receiving	receive	VBG
cord-005453-4057qib7	58	19	a	a	DT
cord-005453-4057qib7	58	20	first	first	JJ
cord-005453-4057qib7	58	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	58	22	HCT	hct	NN
cord-005453-4057qib7	58	23	in	in	IN
cord-005453-4057qib7	58	24	CR2	CR2	NNP
cord-005453-4057qib7	58	25	,	,	,
cord-005453-4057qib7	58	26	in	in	IN
cord-005453-4057qib7	58	27	2000	2000	CD
cord-005453-4057qib7	58	28	CR2	CR2	NNP
cord-005453-4057qib7	58	29	,	,	,
cord-005453-4057qib7	58	30	in	in	IN
cord-005453-4057qib7	58	31	-2017	-2017	:
cord-005453-4057qib7	58	32	or	or	CC
cord-005453-4057qib7	58	33	without	without	IN
cord-005453-4057qib7	58	34	(	(	-LRB-
cord-005453-4057qib7	58	35	n=2202	n=2202	CD
cord-005453-4057qib7	58	36	)	)	-RRB-
cord-005453-4057qib7	58	37	prior	prior	JJ
cord-005453-4057qib7	58	38	autologous	autologous	JJ
cord-005453-4057qib7	58	39	HCT	hct	NN
cord-005453-4057qib7	58	40	.	.	.
cord-005453-4057qib7	59	1	Patient	patient	JJ
cord-005453-4057qib7	59	2	and	and	CC
cord-005453-4057qib7	59	3	transplant	transplant	NN
cord-005453-4057qib7	59	4	characteristics	characteristic	NNS
cord-005453-4057qib7	59	5	are	be	VBP
cord-005453-4057qib7	59	6	shown	show	VBN
cord-005453-4057qib7	59	7	in	in	IN
cord-005453-4057qib7	59	8	the	the	DT
cord-005453-4057qib7	59	9	Table	table	NN
cord-005453-4057qib7	59	10	.	.	.
cord-005453-4057qib7	60	1	Patient	patient	JJ
cord-005453-4057qib7	60	2	groups	group	NNS
cord-005453-4057qib7	60	3	were	be	VBD
cord-005453-4057qib7	60	4	not	not	RB
cord-005453-4057qib7	60	5	entirely	entirely	RB
cord-005453-4057qib7	60	6	comparable	comparable	JJ
cord-005453-4057qib7	60	7	,	,	,
cord-005453-4057qib7	60	8	patients	patient	NNS
cord-005453-4057qib7	60	9	with	with	IN
cord-005453-4057qib7	60	10	prior	prior	JJ
cord-005453-4057qib7	60	11	autologous	autologous	JJ
cord-005453-4057qib7	60	12	HCT	HCT	NNP
cord-005453-4057qib7	60	13	were	be	VBD
cord-005453-4057qib7	60	14	younger	young	JJR
cord-005453-4057qib7	60	15	,	,	,
cord-005453-4057qib7	60	16	had	have	VBD
cord-005453-4057qib7	60	17	less	less	RBR
cord-005453-4057qib7	60	18	often	often	RB
cord-005453-4057qib7	60	19	a	a	DT
cord-005453-4057qib7	60	20	favorable	favorable	JJ
cord-005453-4057qib7	60	21	cytogenetic	cytogenetic	NN
cord-005453-4057qib7	60	22	profile	profile	NN
cord-005453-4057qib7	60	23	,	,	,
cord-005453-4057qib7	60	24	had	have	VBD
cord-005453-4057qib7	60	25	more	more	RBR
cord-005453-4057qib7	60	26	commonly	commonly	RB
cord-005453-4057qib7	60	27	donors	donor	NNS
cord-005453-4057qib7	60	28	other	other	JJ
cord-005453-4057qib7	60	29	than	than	IN
cord-005453-4057qib7	60	30	matched	matched	JJ
cord-005453-4057qib7	60	31	siblings	sibling	NNS
cord-005453-4057qib7	60	32	and	and	CC
cord-005453-4057qib7	60	33	more	more	RBR
cord-005453-4057qib7	60	34	often	often	RB
cord-005453-4057qib7	60	35	received	receive	VBN
cord-005453-4057qib7	60	36	reduced	reduced	JJ
cord-005453-4057qib7	60	37	intensity	intensity	NN
cord-005453-4057qib7	60	38	conditioning	conditioning	NN
cord-005453-4057qib7	60	39	(	(	-LRB-
cord-005453-4057qib7	60	40	RIC	RIC	NNP
cord-005453-4057qib7	60	41	)	)	-RRB-
cord-005453-4057qib7	60	42	as	as	IN
cord-005453-4057qib7	60	43	compared	compare	VBN
cord-005453-4057qib7	60	44	to	to	IN
cord-005453-4057qib7	60	45	MAC	MAC	NNP
cord-005453-4057qib7	60	46	conditioning	conditioning	NN
cord-005453-4057qib7	60	47	.	.	.
cord-005453-4057qib7	61	1	Univariate	univariate	JJ
cord-005453-4057qib7	61	2	outcomes	outcome	NNS
cord-005453-4057qib7	61	3	are	be	VBP
cord-005453-4057qib7	61	4	shown	show	VBN
cord-005453-4057qib7	61	5	in	in	IN
cord-005453-4057qib7	61	6	the	the	DT
cord-005453-4057qib7	61	7	Table	table	NN
cord-005453-4057qib7	61	8	with	with	IN
cord-005453-4057qib7	61	9	slightly	slightly	RB
cord-005453-4057qib7	61	10	higher	high	JJR
cord-005453-4057qib7	61	11	NRM	NRM	NNP
cord-005453-4057qib7	61	12	risks	risk	NNS
cord-005453-4057qib7	61	13	in	in	IN
cord-005453-4057qib7	61	14	patients	patient	NNS
cord-005453-4057qib7	61	15	with	with	IN
cord-005453-4057qib7	61	16	prior	prior	JJ
cord-005453-4057qib7	61	17	autologous	autologous	JJ
cord-005453-4057qib7	61	18	HCT	hct	NN
cord-005453-4057qib7	61	19	consolidation	consolidation	NN
cord-005453-4057qib7	61	20	.	.	.
cord-005453-4057qib7	62	1	In	in	IN
cord-005453-4057qib7	62	2	multivariate	multivariate	JJ
cord-005453-4057qib7	62	3	analysis	analysis	NN
cord-005453-4057qib7	62	4	NRM	NRM	NNP
cord-005453-4057qib7	62	5	risks	risk	NNS
cord-005453-4057qib7	62	6	in	in	IN
cord-005453-4057qib7	62	7	patients	patient	NNS
cord-005453-4057qib7	62	8	with	with	IN
cord-005453-4057qib7	62	9	prior	prior	JJ
cord-005453-4057qib7	62	10	autologous	autologous	JJ
cord-005453-4057qib7	62	11	HCT	HCT	NNP
cord-005453-4057qib7	62	12	were	be	VBD
cord-005453-4057qib7	62	13	1.34	1.34	CD
cord-005453-4057qib7	62	14	(	(	-LRB-
cord-005453-4057qib7	62	15	1.07	1.07	CD
cord-005453-4057qib7	62	16	-	-	SYM
cord-005453-4057qib7	62	17	1.67	1.67	CD
cord-005453-4057qib7	62	18	)	)	-RRB-
cord-005453-4057qib7	62	19	,	,	,
cord-005453-4057qib7	62	20	p=0.01	p=0.01	VBN
cord-005453-4057qib7	62	21	after	after	IN
cord-005453-4057qib7	62	22	adjustment	adjustment	NN
cord-005453-4057qib7	62	23	for	for	IN
cord-005453-4057qib7	62	24	patient	patient	JJ
cord-005453-4057qib7	62	25	age	age	NN
cord-005453-4057qib7	62	26	,	,	,
cord-005453-4057qib7	62	27	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	62	28	risk	risk	NN
cord-005453-4057qib7	62	29	category	category	NN
cord-005453-4057qib7	62	30	,	,	,
cord-005453-4057qib7	62	31	year	year	NN
cord-005453-4057qib7	62	32	of	of	IN
cord-005453-4057qib7	62	33	transplant	transplant	NN
cord-005453-4057qib7	62	34	,	,	,
cord-005453-4057qib7	62	35	donor	donor	NN
cord-005453-4057qib7	62	36	type	type	NN
cord-005453-4057qib7	62	37	,	,	,
cord-005453-4057qib7	62	38	conditioning	conditioning	NN
cord-005453-4057qib7	62	39	intensity	intensity	NN
cord-005453-4057qib7	62	40	,	,	,
cord-005453-4057qib7	62	41	sex	sex	NN
cord-005453-4057qib7	62	42	matching	matching	NN
cord-005453-4057qib7	62	43	,	,	,
cord-005453-4057qib7	62	44	time	time	NN
cord-005453-4057qib7	62	45	from	from	IN
cord-005453-4057qib7	62	46	diagnosis	diagnosis	NN
cord-005453-4057qib7	62	47	to	to	IN
cord-005453-4057qib7	62	48	relapse	relapse	NN
cord-005453-4057qib7	62	49	and	and	CC
cord-005453-4057qib7	62	50	time	time	NN
cord-005453-4057qib7	62	51	from	from	IN
cord-005453-4057qib7	62	52	relapse	relapse	NN
cord-005453-4057qib7	62	53	to	to	IN
cord-005453-4057qib7	62	54	allogeneic	allogeneic	NN
cord-005453-4057qib7	62	55	HCT	hct	NN
cord-005453-4057qib7	62	56	as	as	IN
cord-005453-4057qib7	62	57	compared	compare	VBN
cord-005453-4057qib7	62	58	to	to	IN
cord-005453-4057qib7	62	59	patients	patient	NNS
cord-005453-4057qib7	62	60	with	with	IN
cord-005453-4057qib7	62	61	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	62	62	consolidation	consolidation	NN
cord-005453-4057qib7	62	63	.	.	.
cord-005453-4057qib7	63	1	Similarly	similarly	RB
cord-005453-4057qib7	63	2	,	,	,
cord-005453-4057qib7	63	3	risks	risk	NNS
cord-005453-4057qib7	63	4	of	of	IN
cord-005453-4057qib7	63	5	events	event	NNS
cord-005453-4057qib7	63	6	in	in	IN
cord-005453-4057qib7	63	7	LFS	lfs	NN
cord-005453-4057qib7	63	8	and	and	CC
cord-005453-4057qib7	63	9	GRFS	GRFS	NNP
cord-005453-4057qib7	63	10	were	be	VBD
cord-005453-4057qib7	63	11	higher	high	JJR
cord-005453-4057qib7	63	12	with	with	IN
cord-005453-4057qib7	63	13	prior	prior	JJ
cord-005453-4057qib7	63	14	autologous	autologous	JJ
cord-005453-4057qib7	63	15	HCT	hct	NN
cord-005453-4057qib7	63	16	,	,	,
cord-005453-4057qib7	63	17	1.17	1.17	CD
cord-005453-4057qib7	63	18	(	(	-LRB-
cord-005453-4057qib7	63	19	1.01	1.01	CD
cord-005453-4057qib7	63	20	-	-	SYM
cord-005453-4057qib7	63	21	1.35	1.35	CD
cord-005453-4057qib7	63	22	)	)	-RRB-
cord-005453-4057qib7	63	23	,	,	,
cord-005453-4057qib7	63	24	p=0.03	p=0.03	NNP
cord-005453-4057qib7	63	25	and	and	CC
cord-005453-4057qib7	63	26	1.18	1.18	CD
cord-005453-4057qib7	63	27	(	(	-LRB-
cord-005453-4057qib7	63	28	1.03	1.03	CD
cord-005453-4057qib7	63	29	-	-	SYM
cord-005453-4057qib7	63	30	1.35	1.35	CD
cord-005453-4057qib7	63	31	)	)	-RRB-
cord-005453-4057qib7	63	32	p=	p=	NN
cord-005453-4057qib7	63	33	0.02	0.02	CD
cord-005453-4057qib7	63	34	,	,	,
cord-005453-4057qib7	63	35	respectively	respectively	RB
cord-005453-4057qib7	63	36	,	,	,
cord-005453-4057qib7	63	37	risk	risk	NN
cord-005453-4057qib7	63	38	of	of	IN
cord-005453-4057qib7	63	39	death	death	NN
cord-005453-4057qib7	63	40	was	be	VBD
cord-005453-4057qib7	63	41	also	also	RB
cord-005453-4057qib7	63	42	higher	high	JJR
cord-005453-4057qib7	63	43	1.13	1.13	CD
cord-005453-4057qib7	64	1	(	(	-LRB-
cord-005453-4057qib7	64	2	0.974	0.974	CD
cord-005453-4057qib7	64	3	-	-	SYM
cord-005453-4057qib7	64	4	1.32	1.32	CD
cord-005453-4057qib7	64	5	)	)	-RRB-
cord-005453-4057qib7	64	6	p=0.1	p=0.1	NNS
cord-005453-4057qib7	65	1	but	but	CC
cord-005453-4057qib7	65	2	this	this	DT
cord-005453-4057qib7	65	3	was	be	VBD
cord-005453-4057qib7	65	4	not	not	RB
cord-005453-4057qib7	65	5	statistically	statistically	RB
cord-005453-4057qib7	65	6	significant	significant	JJ
cord-005453-4057qib7	65	7	.	.	.
cord-005453-4057qib7	66	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	66	2	:	:	:
cord-005453-4057qib7	67	1	We	-PRON-	PRP
cord-005453-4057qib7	67	2	may	may	MD
cord-005453-4057qib7	67	3	conclude	conclude	VB
cord-005453-4057qib7	67	4	that	that	IN
cord-005453-4057qib7	67	5	some	some	DT
cord-005453-4057qib7	67	6	of	of	IN
cord-005453-4057qib7	67	7	the	the	DT
cord-005453-4057qib7	67	8	advantages	advantage	NNS
cord-005453-4057qib7	67	9	of	of	IN
cord-005453-4057qib7	67	10	potentially	potentially	RB
cord-005453-4057qib7	67	11	higher	high	JJR
cord-005453-4057qib7	67	12	anti	anti	JJ
cord-005453-4057qib7	67	13	-	-	JJ
cord-005453-4057qib7	67	14	leukemic	leukemic	JJ
cord-005453-4057qib7	67	15	activity	activity	NN
cord-005453-4057qib7	67	16	of	of	IN
cord-005453-4057qib7	67	17	high	high	JJ
cord-005453-4057qib7	67	18	dose	dose	NN
cord-005453-4057qib7	67	19	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	67	20	and	and	CC
cord-005453-4057qib7	67	21	autologous	autologous	JJ
cord-005453-4057qib7	67	22	HCT	hct	NN
cord-005453-4057qib7	67	23	when	when	WRB
cord-005453-4057qib7	67	24	given	give	VBN
cord-005453-4057qib7	67	25	to	to	IN
cord-005453-4057qib7	67	26	patients	patient	NNS
cord-005453-4057qib7	67	27	with	with	IN
cord-005453-4057qib7	67	28	AML	AML	NNP
cord-005453-4057qib7	67	29	in	in	IN
cord-005453-4057qib7	67	30	CR1(as	cr1(as	NN
cord-005453-4057qib7	67	31	was	be	VBD
cord-005453-4057qib7	67	32	shown	show	VBN
cord-005453-4057qib7	67	33	in	in	IN
cord-005453-4057qib7	67	34	a	a	DT
cord-005453-4057qib7	67	35	randomized	randomized	JJ
cord-005453-4057qib7	67	36	trial	trial	NN
cord-005453-4057qib7	67	37	by	by	IN
cord-005453-4057qib7	67	38	Vellenga	Vellenga	NNP
cord-005453-4057qib7	67	39	E	E	NNP
cord-005453-4057qib7	67	40	et	et	FW
cord-005453-4057qib7	67	41	al	al	NNP
cord-005453-4057qib7	67	42	with	with	IN
cord-005453-4057qib7	67	43	lower	low	JJR
cord-005453-4057qib7	67	44	relapse	relapse	NN
cord-005453-4057qib7	67	45	and	and	CC
cord-005453-4057qib7	67	46	higher	high	JJR
cord-005453-4057qib7	67	47	LFS	lfs	NN
cord-005453-4057qib7	67	48	by	by	IN
cord-005453-4057qib7	67	49	approximately	approximately	RB
cord-005453-4057qib7	67	50	10	10	CD
cord-005453-4057qib7	67	51	%	%	NN
cord-005453-4057qib7	67	52	but	but	CC
cord-005453-4057qib7	67	53	no	no	DT
cord-005453-4057qib7	67	54	significant	significant	JJ
cord-005453-4057qib7	67	55	differences	difference	NNS
cord-005453-4057qib7	67	56	in	in	IN
cord-005453-4057qib7	67	57	overall	overall	JJ
cord-005453-4057qib7	67	58	survival	survival	NN
cord-005453-4057qib7	67	59	)	)	-RRB-
cord-005453-4057qib7	67	60	may	may	MD
cord-005453-4057qib7	67	61	be	be	VB
cord-005453-4057qib7	67	62	lost	lose	VBN
cord-005453-4057qib7	67	63	by	by	IN
cord-005453-4057qib7	67	64	higher	high	JJR
cord-005453-4057qib7	67	65	toxicity	toxicity	NN
cord-005453-4057qib7	67	66	of	of	IN
cord-005453-4057qib7	67	67	allogeneic	allogeneic	NN
cord-005453-4057qib7	67	68	HCT	hct	NN
cord-005453-4057qib7	67	69	in	in	IN
cord-005453-4057qib7	67	70	CR2	CR2	NNP
cord-005453-4057qib7	67	71	in	in	IN
cord-005453-4057qib7	67	72	case	case	NN
cord-005453-4057qib7	67	73	of	of	IN
cord-005453-4057qib7	67	74	subsequent	subsequent	JJ
cord-005453-4057qib7	67	75	relapse	relapse	NN
cord-005453-4057qib7	67	76	.	.	.
cord-005453-4057qib7	68	1	Background	background	NN
cord-005453-4057qib7	68	2	:	:	:
cord-005453-4057qib7	69	1	Although	although	IN
cord-005453-4057qib7	69	2	relapse	relapse	NN
cord-005453-4057qib7	69	3	is	be	VBZ
cord-005453-4057qib7	69	4	a	a	DT
cord-005453-4057qib7	69	5	major	major	JJ
cord-005453-4057qib7	69	6	cause	cause	NN
cord-005453-4057qib7	69	7	of	of	IN
cord-005453-4057qib7	69	8	mortality	mortality	NN
cord-005453-4057qib7	69	9	in	in	IN
cord-005453-4057qib7	69	10	patients	patient	NNS
cord-005453-4057qib7	69	11	receiving	receive	VBG
cord-005453-4057qib7	69	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	69	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	69	14	cell	cell	NN
cord-005453-4057qib7	69	15	transplantation	transplantation	NN
cord-005453-4057qib7	69	16	(	(	-LRB-
cord-005453-4057qib7	69	17	HCT	HCT	NNP
cord-005453-4057qib7	69	18	)	)	-RRB-
cord-005453-4057qib7	69	19	for	for	IN
cord-005453-4057qib7	69	20	acute	acute	JJ
cord-005453-4057qib7	69	21	leukemia	leukemia	NN
cord-005453-4057qib7	69	22	,	,	,
cord-005453-4057qib7	70	1	limited	limited	JJ
cord-005453-4057qib7	70	2	and	and	CC
cord-005453-4057qib7	70	3	conflicting	conflicting	JJ
cord-005453-4057qib7	70	4	data	datum	NNS
cord-005453-4057qib7	70	5	exist	exist	VBP
cord-005453-4057qib7	70	6	on	on	IN
cord-005453-4057qib7	70	7	extramedullary	extramedullary	JJ
cord-005453-4057qib7	70	8	relapse	relapse	NN
cord-005453-4057qib7	70	9	(	(	-LRB-
cord-005453-4057qib7	70	10	EMR	EMR	NNP
cord-005453-4057qib7	70	11	)	)	-RRB-
cord-005453-4057qib7	70	12	.	.	.
cord-005453-4057qib7	71	1	We	-PRON-	PRP
cord-005453-4057qib7	71	2	aimed	aim	VBD
cord-005453-4057qib7	71	3	to	to	TO
cord-005453-4057qib7	71	4	describe	describe	VB
cord-005453-4057qib7	71	5	the	the	DT
cord-005453-4057qib7	71	6	incidence	incidence	NN
cord-005453-4057qib7	71	7	,	,	,
cord-005453-4057qib7	71	8	risk	risk	NN
cord-005453-4057qib7	71	9	factors	factor	NNS
cord-005453-4057qib7	71	10	,	,	,
cord-005453-4057qib7	71	11	outcomes	outcome	NNS
cord-005453-4057qib7	71	12	and	and	CC
cord-005453-4057qib7	71	13	prognosis	prognosis	NN
cord-005453-4057qib7	71	14	in	in	IN
cord-005453-4057qib7	71	15	relapsed	relapse	VBN
cord-005453-4057qib7	71	16	HCT	HCT	NNP
cord-005453-4057qib7	71	17	recipients	recipient	NNS
cord-005453-4057qib7	71	18	.	.	.
cord-005453-4057qib7	72	1	Methods	method	NNS
cord-005453-4057qib7	72	2	:	:	:
cord-005453-4057qib7	72	3	We	-PRON-	PRP
cord-005453-4057qib7	72	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	72	5	reviewed	review	VBD
cord-005453-4057qib7	72	6	charts	chart	NNS
cord-005453-4057qib7	72	7	of	of	IN
cord-005453-4057qib7	72	8	consecutive	consecutive	JJ
cord-005453-4057qib7	72	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	72	10	HCT	hct	NN
cord-005453-4057qib7	72	11	recipients	recipient	NNS
cord-005453-4057qib7	72	12	transplanted	transplant	VBN
cord-005453-4057qib7	72	13	in	in	IN
cord-005453-4057qib7	72	14	our	-PRON-	PRP$
cord-005453-4057qib7	72	15	center	center	NN
cord-005453-4057qib7	72	16	with	with	IN
cord-005453-4057qib7	72	17	the	the	DT
cord-005453-4057qib7	72	18	indication	indication	NN
cord-005453-4057qib7	72	19	of	of	IN
cord-005453-4057qib7	72	20	acute	acute	JJ
cord-005453-4057qib7	72	21	leukemia	leukemia	NN
cord-005453-4057qib7	72	22	(	(	-LRB-
cord-005453-4057qib7	72	23	7/1990	7/1990	CD
cord-005453-4057qib7	72	24	-	-	HYPH
cord-005453-4057qib7	72	25	7/	7/	CD
cord-005453-4057qib7	72	26	2018	2018	CD
cord-005453-4057qib7	72	27	)	)	-RRB-
cord-005453-4057qib7	72	28	.	.	.
cord-005453-4057qib7	73	1	We	-PRON-	PRP
cord-005453-4057qib7	73	2	recorded	record	VBD
cord-005453-4057qib7	73	3	:	:	:
cord-005453-4057qib7	73	4	age	age	NN
cord-005453-4057qib7	73	5	,	,	,
cord-005453-4057qib7	73	6	gender	gender	NN
cord-005453-4057qib7	73	7	,	,	,
cord-005453-4057qib7	73	8	disease	disease	NN
cord-005453-4057qib7	73	9	,	,	,
cord-005453-4057qib7	73	10	previous	previous	JJ
cord-005453-4057qib7	73	11	extramedullary	extramedullary	JJ
cord-005453-4057qib7	73	12	involvement	involvement	NN
cord-005453-4057qib7	73	13	,	,	,
cord-005453-4057qib7	73	14	phase	phase	NN
cord-005453-4057qib7	73	15	at	at	IN
cord-005453-4057qib7	73	16	transplant	transplant	NN
cord-005453-4057qib7	73	17	,	,	,
cord-005453-4057qib7	73	18	type	type	NN
cord-005453-4057qib7	73	19	of	of	IN
cord-005453-4057qib7	73	20	transplant	transplant	NN
cord-005453-4057qib7	73	21	,	,	,
cord-005453-4057qib7	73	22	donor	donor	NN
cord-005453-4057qib7	73	23	,	,	,
cord-005453-4057qib7	73	24	conditioning	conditioning	NN
cord-005453-4057qib7	73	25	,	,	,
cord-005453-4057qib7	73	26	graft	graft	NN
cord-005453-4057qib7	73	27	-	-	HYPH
cord-005453-4057qib7	73	28	versus	versus	IN
cord-005453-4057qib7	73	29	-	-	HYPH
cord-005453-4057qib7	73	30	host	host	NN
cord-005453-4057qib7	73	31	-	-	HYPH
cord-005453-4057qib7	73	32	disease	disease	NN
cord-005453-4057qib7	73	33	(	(	-LRB-
cord-005453-4057qib7	73	34	GVHD	GVHD	NNP
cord-005453-4057qib7	73	35	)	)	-RRB-
cord-005453-4057qib7	73	36	,	,	,
cord-005453-4057qib7	73	37	infections	infection	NNS
cord-005453-4057qib7	73	38	,	,	,
cord-005453-4057qib7	73	39	treatment	treatment	NN
cord-005453-4057qib7	73	40	-	-	HYPH
cord-005453-4057qib7	73	41	related	relate	VBN
cord-005453-4057qib7	73	42	mortality	mortality	NN
cord-005453-4057qib7	73	43	and	and	CC
cord-005453-4057qib7	73	44	relapse	relapse	NN
cord-005453-4057qib7	73	45	mortality	mortality	NN
cord-005453-4057qib7	73	46	.	.	.
cord-005453-4057qib7	74	1	In	in	IN
cord-005453-4057qib7	74	2	patients	patient	NNS
cord-005453-4057qib7	74	3	with	with	IN
cord-005453-4057qib7	74	4	extramedullary	extramedullary	JJ
cord-005453-4057qib7	74	5	relapses	relapse	NNS
cord-005453-4057qib7	74	6	,	,	,
cord-005453-4057qib7	74	7	additional	additional	JJ
cord-005453-4057qib7	74	8	data	datum	NNS
cord-005453-4057qib7	74	9	on	on	IN
cord-005453-4057qib7	74	10	clinical	clinical	JJ
cord-005453-4057qib7	74	11	manifestations	manifestation	NNS
cord-005453-4057qib7	74	12	,	,	,
cord-005453-4057qib7	74	13	imaging	imaging	NN
cord-005453-4057qib7	74	14	,	,	,
cord-005453-4057qib7	74	15	cerebrospinal	cerebrospinal	JJ
cord-005453-4057qib7	74	16	fluid	fluid	JJ
cord-005453-4057qib7	74	17	testing	testing	NN
cord-005453-4057qib7	74	18	,	,	,
cord-005453-4057qib7	74	19	histopathology	histopathology	NN
cord-005453-4057qib7	74	20	and	and	CC
cord-005453-4057qib7	74	21	management	management	NN
cord-005453-4057qib7	74	22	were	be	VBD
cord-005453-4057qib7	74	23	additionally	additionally	RB
cord-005453-4057qib7	74	24	documented	document	VBN
cord-005453-4057qib7	74	25	.	.	.
cord-005453-4057qib7	75	1	Incidence	incidence	NN
cord-005453-4057qib7	75	2	of	of	IN
cord-005453-4057qib7	75	3	isolated	isolate	VBN
cord-005453-4057qib7	75	4	EMR	EMR	NNP
cord-005453-4057qib7	75	5	(	(	-LRB-
cord-005453-4057qib7	75	6	iEMR	iemr	NN
cord-005453-4057qib7	75	7	)	)	-RRB-
cord-005453-4057qib7	75	8	and	and	CC
cord-005453-4057qib7	75	9	bone	bone	NN
cord-005453-4057qib7	75	10	marrow	marrow	NN
cord-005453-4057qib7	75	11	relapse	relapse	NN
cord-005453-4057qib7	75	12	(	(	-LRB-
cord-005453-4057qib7	75	13	BMR	BMR	NNP
cord-005453-4057qib7	75	14	)	)	-RRB-
cord-005453-4057qib7	75	15	was	be	VBD
cord-005453-4057qib7	75	16	calculated	calculate	VBN
cord-005453-4057qib7	75	17	using	use	VBG
cord-005453-4057qib7	75	18	cumulative	cumulative	JJ
cord-005453-4057qib7	75	19	incidence	incidence	NN
cord-005453-4057qib7	75	20	(	(	-LRB-
cord-005453-4057qib7	75	21	CI	CI	NNP
cord-005453-4057qib7	75	22	)	)	-RRB-
cord-005453-4057qib7	75	23	analysis	analysis	NN
cord-005453-4057qib7	75	24	,	,	,
cord-005453-4057qib7	75	25	with	with	IN
cord-005453-4057qib7	75	26	each	each	DT
cord-005453-4057qib7	75	27	and	and	CC
cord-005453-4057qib7	75	28	treatment	treatment	NN
cord-005453-4057qib7	75	29	-	-	HYPH
cord-005453-4057qib7	75	30	related	relate	VBN
cord-005453-4057qib7	75	31	mortality	mortality	NN
cord-005453-4057qib7	75	32	considered	consider	VBD
cord-005453-4057qib7	75	33	a	a	DT
cord-005453-4057qib7	75	34	competing	compete	VBG
cord-005453-4057qib7	75	35	risk	risk	NN
cord-005453-4057qib7	75	36	.	.	.
cord-005453-4057qib7	76	1	Results	result	NNS
cord-005453-4057qib7	76	2	:	:	:
cord-005453-4057qib7	77	1	Among	among	IN
cord-005453-4057qib7	77	2	554	554	CD
cord-005453-4057qib7	77	3	alloHCT	allohct	XX
cord-005453-4057qib7	78	1	recipients	recipient	NNS
cord-005453-4057qib7	78	2	followed	follow	VBD
cord-005453-4057qib7	78	3	for	for	IN
cord-005453-4057qib7	78	4	1.8	1.8	CD
cord-005453-4057qib7	78	5	(	(	-LRB-
cord-005453-4057qib7	78	6	0.04	0.04	CD
cord-005453-4057qib7	78	7	-	-	SYM
cord-005453-4057qib7	78	8	27.75	27.75	CD
cord-005453-4057qib7	78	9	)	)	-RRB-
cord-005453-4057qib7	78	10	years	year	NNS
cord-005453-4057qib7	78	11	,	,	,
cord-005453-4057qib7	78	12	61	61	CD
cord-005453-4057qib7	78	13	(	(	-LRB-
cord-005453-4057qib7	78	14	11	11	CD
cord-005453-4057qib7	78	15	%	%	NN
cord-005453-4057qib7	78	16	)	)	-RRB-
cord-005453-4057qib7	78	17	patients	patient	NNS
cord-005453-4057qib7	78	18	presented	present	VBN
cord-005453-4057qib7	78	19	with	with	IN
cord-005453-4057qib7	78	20	EMR	EMR	NNP
cord-005453-4057qib7	78	21	.	.	.
cord-005453-4057qib7	79	1	The	the	DT
cord-005453-4057qib7	79	2	majority	majority	NN
cord-005453-4057qib7	79	3	of	of	IN
cord-005453-4057qib7	79	4	EMRs	emr	NNS
cord-005453-4057qib7	79	5	involved	involve	VBD
cord-005453-4057qib7	79	6	the	the	DT
cord-005453-4057qib7	79	7	central	central	JJ
cord-005453-4057qib7	79	8	nervous	nervous	JJ
cord-005453-4057qib7	79	9	system	system	NN
cord-005453-4057qib7	79	10	(	(	-LRB-
cord-005453-4057qib7	79	11	CNS	CNS	NNP
cord-005453-4057qib7	79	12	,	,	,
cord-005453-4057qib7	79	13	56	56	CD
cord-005453-4057qib7	79	14	%	%	NN
cord-005453-4057qib7	79	15	)	)	-RRB-
cord-005453-4057qib7	79	16	.	.	.
cord-005453-4057qib7	80	1	Isolated	isolated	JJ
cord-005453-4057qib7	80	2	EMR	EMR	NNP
cord-005453-4057qib7	80	3	was	be	VBD
cord-005453-4057qib7	80	4	observed	observe	VBN
cord-005453-4057qib7	80	5	in	in	IN
cord-005453-4057qib7	80	6	38	38	CD
cord-005453-4057qib7	80	7	patients	patient	NNS
cord-005453-4057qib7	80	8	at	at	IN
cord-005453-4057qib7	80	9	9.5	9.5	CD
cord-005453-4057qib7	80	10	(	(	-LRB-
cord-005453-4057qib7	80	11	1.8	1.8	CD
cord-005453-4057qib7	80	12	-	-	HYPH
cord-005453-4057qib7	80	13	67.3	67.3	CD
cord-005453-4057qib7	80	14	)	)	-RRB-
cord-005453-4057qib7	80	15	months	month	NNS
cord-005453-4057qib7	80	16	.	.	.
cord-005453-4057qib7	81	1	10-year	10-year	CD
cord-005453-4057qib7	81	2	cumulative	cumulative	JJ
cord-005453-4057qib7	81	3	incidence	incidence	NN
cord-005453-4057qib7	81	4	(	(	-LRB-
cord-005453-4057qib7	81	5	CI	CI	NNP
cord-005453-4057qib7	81	6	)	)	-RRB-
cord-005453-4057qib7	81	7	of	of	IN
cord-005453-4057qib7	81	8	10.5	10.5	CD
cord-005453-4057qib7	81	9	%	%	NN
cord-005453-4057qib7	81	10	for	for	IN
cord-005453-4057qib7	81	11	iEMR	iemr	NN
cord-005453-4057qib7	81	12	was	be	VBD
cord-005453-4057qib7	81	13	associated	associate	VBN
cord-005453-4057qib7	81	14	only	only	RB
cord-005453-4057qib7	81	15	with	with	IN
cord-005453-4057qib7	81	16	pre	pre	JJ
cord-005453-4057qib7	81	17	-	-	JJ
cord-005453-4057qib7	81	18	transplant	transplant	JJ
cord-005453-4057qib7	81	19	advanced	advanced	JJ
cord-005453-4057qib7	81	20	disease	disease	NN
cord-005453-4057qib7	81	21	phase	phase	NN
cord-005453-4057qib7	81	22	(	(	-LRB-
cord-005453-4057qib7	81	23	p	p	NN
cord-005453-4057qib7	81	24	<	<	XX
cord-005453-4057qib7	81	25	0.001	0.001	CD
cord-005453-4057qib7	81	26	)	)	-RRB-
cord-005453-4057qib7	81	27	.	.	.
cord-005453-4057qib7	82	1	BMR	BMR	NNP
cord-005453-4057qib7	82	2	was	be	VBD
cord-005453-4057qib7	82	3	observed	observe	VBN
cord-005453-4057qib7	82	4	in	in	IN
cord-005453-4057qib7	82	5	149	149	CD
cord-005453-4057qib7	82	6	patients	patient	NNS
cord-005453-4057qib7	82	7	at	at	IN
cord-005453-4057qib7	82	8	9	9	CD
cord-005453-4057qib7	82	9	(	(	-LRB-
cord-005453-4057qib7	82	10	0.3	0.3	CD
cord-005453-4057qib7	82	11	-	-	SYM
cord-005453-4057qib7	82	12	276	276	CD
cord-005453-4057qib7	82	13	months	month	NNS
cord-005453-4057qib7	82	14	)	)	-RRB-
cord-005453-4057qib7	82	15	,	,	,
cord-005453-4057qib7	82	16	with	with	IN
cord-005453-4057qib7	82	17	a	a	DT
cord-005453-4057qib7	82	18	10-year	10-year	CD
cord-005453-4057qib7	82	19	CI	CI	NNP
cord-005453-4057qib7	82	20	of	of	IN
cord-005453-4057qib7	82	21	34.8	34.8	CD
cord-005453-4057qib7	82	22	%	%	NN
cord-005453-4057qib7	82	23	.	.	.
cord-005453-4057qib7	83	1	In	in	IN
cord-005453-4057qib7	83	2	the	the	DT
cord-005453-4057qib7	83	3	multivariate	multivariate	JJ
cord-005453-4057qib7	83	4	analysis	analysis	NN
cord-005453-4057qib7	83	5	,	,	,
cord-005453-4057qib7	83	6	BMR	BMR	NNP
cord-005453-4057qib7	83	7	CI	CI	NNP
cord-005453-4057qib7	83	8	was	be	VBD
cord-005453-4057qib7	83	9	independently	independently	RB
cord-005453-4057qib7	83	10	associated	associate	VBN
cord-005453-4057qib7	83	11	with	with	IN
cord-005453-4057qib7	83	12	fungal	fungal	JJ
cord-005453-4057qib7	83	13	infections	infection	NNS
cord-005453-4057qib7	83	14	(	(	-LRB-
cord-005453-4057qib7	83	15	p	p	NN
cord-005453-4057qib7	83	16	<	<	XX
cord-005453-4057qib7	83	17	0.001	0.001	CD
cord-005453-4057qib7	83	18	)	)	-RRB-
cord-005453-4057qib7	83	19	,	,	,
cord-005453-4057qib7	83	20	pre	pre	JJ
cord-005453-4057qib7	83	21	-	-	JJ
cord-005453-4057qib7	83	22	transplant	transplant	JJ
cord-005453-4057qib7	83	23	disease	disease	NN
cord-005453-4057qib7	83	24	phase	phase	NN
cord-005453-4057qib7	83	25	(	(	-LRB-
cord-005453-4057qib7	83	26	p	p	NN
cord-005453-4057qib7	83	27	<	<	XX
cord-005453-4057qib7	83	28	0.001	0.001	CD
cord-005453-4057qib7	83	29	)	)	-RRB-
cord-005453-4057qib7	83	30	and	and	CC
cord-005453-4057qib7	83	31	lines	line	NNS
cord-005453-4057qib7	83	32	of	of	IN
cord-005453-4057qib7	83	33	treatment	treatment	NN
cord-005453-4057qib7	83	34	(	(	-LRB-
cord-005453-4057qib7	83	35	p=0.042	p=0.042	NNP
cord-005453-4057qib7	83	36	)	)	-RRB-
cord-005453-4057qib7	83	37	.	.	.
cord-005453-4057qib7	84	1	10-year	10-year	CD
cord-005453-4057qib7	84	2	TRM	TRM	NNP
cord-005453-4057qib7	84	3	of	of	IN
cord-005453-4057qib7	84	4	our	-PRON-	PRP$
cord-005453-4057qib7	84	5	whole	whole	JJ
cord-005453-4057qib7	84	6	cohort	cohort	NN
cord-005453-4057qib7	84	7	was	be	VBD
cord-005453-4057qib7	84	8	33.2	33.2	CD
cord-005453-4057qib7	84	9	%	%	NN
cord-005453-4057qib7	84	10	.	.	.
cord-005453-4057qib7	85	1	The	the	DT
cord-005453-4057qib7	85	2	majority	majority	NN
cord-005453-4057qib7	85	3	of	of	IN
cord-005453-4057qib7	85	4	iEMR	iemr	NN
cord-005453-4057qib7	85	5	and	and	CC
cord-005453-4057qib7	85	6	BMR	BMR	NNP
cord-005453-4057qib7	85	7	(	(	-LRB-
cord-005453-4057qib7	85	8	75	75	CD
cord-005453-4057qib7	85	9	%	%	NN
cord-005453-4057qib7	85	10	and	and	CC
cord-005453-4057qib7	85	11	81	81	CD
cord-005453-4057qib7	85	12	%	%	NN
cord-005453-4057qib7	85	13	,	,	,
cord-005453-4057qib7	85	14	respectively	respectively	RB
cord-005453-4057qib7	85	15	)	)	-RRB-
cord-005453-4057qib7	85	16	patients	patient	NNS
cord-005453-4057qib7	85	17	received	receive	VBD
cord-005453-4057qib7	85	18	systemic	systemic	JJ
cord-005453-4057qib7	85	19	treatment	treatment	NN
cord-005453-4057qib7	85	20	combined	combine	VBN
cord-005453-4057qib7	85	21	with	with	IN
cord-005453-4057qib7	85	22	local	local	JJ
cord-005453-4057qib7	85	23	radiation	radiation	NN
cord-005453-4057qib7	85	24	for	for	IN
cord-005453-4057qib7	85	25	iEMR	iemr	NN
cord-005453-4057qib7	85	26	(	(	-LRB-
cord-005453-4057qib7	85	27	26	26	CD
cord-005453-4057qib7	85	28	%	%	NN
cord-005453-4057qib7	85	29	)	)	-RRB-
cord-005453-4057qib7	85	30	and	and	CC
cord-005453-4057qib7	85	31	donor	donor	NN
cord-005453-4057qib7	85	32	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	85	33	infusions	infusion	NNS
cord-005453-4057qib7	85	34	(	(	-LRB-
cord-005453-4057qib7	85	35	DLIs	dli	NNS
cord-005453-4057qib7	85	36	,	,	,
cord-005453-4057qib7	85	37	16	16	CD
cord-005453-4057qib7	85	38	%	%	NN
cord-005453-4057qib7	85	39	and	and	CC
cord-005453-4057qib7	85	40	28	28	CD
cord-005453-4057qib7	85	41	%	%	NN
cord-005453-4057qib7	85	42	respectively	respectively	RB
cord-005453-4057qib7	85	43	)	)	-RRB-
cord-005453-4057qib7	85	44	when	when	WRB
cord-005453-4057qib7	85	45	feasible	feasible	JJ
cord-005453-4057qib7	85	46	.	.	.
cord-005453-4057qib7	86	1	Extensive	extensive	JJ
cord-005453-4057qib7	86	2	chronic	chronic	JJ
cord-005453-4057qib7	86	3	GVHD	GVHD	NNP
cord-005453-4057qib7	86	4	was	be	VBD
cord-005453-4057qib7	86	5	recorded	record	VBN
cord-005453-4057qib7	86	6	in	in	IN
cord-005453-4057qib7	86	7	47	47	CD
cord-005453-4057qib7	86	8	%	%	NN
cord-005453-4057qib7	86	9	of	of	IN
cord-005453-4057qib7	86	10	iEMR	iemr	NN
cord-005453-4057qib7	86	11	and	and	CC
cord-005453-4057qib7	86	12	48	48	CD
cord-005453-4057qib7	86	13	%	%	NN
cord-005453-4057qib7	86	14	of	of	IN
cord-005453-4057qib7	86	15	BMR	BMR	NNP
cord-005453-4057qib7	86	16	patients	patient	NNS
cord-005453-4057qib7	86	17	.	.	.
cord-005453-4057qib7	87	1	Outcomes	outcome	NNS
cord-005453-4057qib7	87	2	were	be	VBD
cord-005453-4057qib7	87	3	poor	poor	JJ
cord-005453-4057qib7	87	4	in	in	IN
cord-005453-4057qib7	87	5	iEMR	iemr	NN
cord-005453-4057qib7	87	6	,	,	,
cord-005453-4057qib7	87	7	with	with	IN
cord-005453-4057qib7	87	8	10-year	10-year	CD
cord-005453-4057qib7	87	9	overall	overall	JJ
cord-005453-4057qib7	87	10	survival	survival	NN
cord-005453-4057qib7	87	11	(	(	-LRB-
cord-005453-4057qib7	87	12	OS	OS	NNP
cord-005453-4057qib7	87	13	)	)	-RRB-
cord-005453-4057qib7	87	14	of	of	IN
cord-005453-4057qib7	87	15	18.3	18.3	CD
cord-005453-4057qib7	87	16	%	%	NN
cord-005453-4057qib7	87	17	.	.	.
cord-005453-4057qib7	88	1	Favorable	favorable	JJ
cord-005453-4057qib7	88	2	OS	os	NN
cord-005453-4057qib7	88	3	in	in	IN
cord-005453-4057qib7	88	4	iEMR	iemr	NN
cord-005453-4057qib7	88	5	was	be	VBD
cord-005453-4057qib7	88	6	associated	associate	VBN
cord-005453-4057qib7	88	7	only	only	RB
cord-005453-4057qib7	88	8	with	with	IN
cord-005453-4057qib7	88	9	sibling	sibling	NN
cord-005453-4057qib7	88	10	donors	donor	NNS
cord-005453-4057qib7	88	11	(	(	-LRB-
cord-005453-4057qib7	88	12	p=0.049	p=0.049	NNP
cord-005453-4057qib7	88	13	)	)	-RRB-
cord-005453-4057qib7	88	14	and	and	CC
cord-005453-4057qib7	88	15	not	not	RB
cord-005453-4057qib7	88	16	with	with	IN
cord-005453-4057qib7	88	17	other	other	JJ
cord-005453-4057qib7	88	18	factors	factor	NNS
cord-005453-4057qib7	88	19	,	,	,
cord-005453-4057qib7	88	20	such	such	JJ
cord-005453-4057qib7	88	21	as	as	IN
cord-005453-4057qib7	88	22	treatment	treatment	NN
cord-005453-4057qib7	88	23	with	with	IN
cord-005453-4057qib7	88	24	DLIs	dli	NNS
cord-005453-4057qib7	88	25	or	or	CC
cord-005453-4057qib7	88	26	presence	presence	NN
cord-005453-4057qib7	88	27	of	of	IN
cord-005453-4057qib7	88	28	chronic	chronic	JJ
cord-005453-4057qib7	88	29	GVHD	GVHD	NNP
cord-005453-4057qib7	88	30	.	.	.
cord-005453-4057qib7	89	1	Similarly	similarly	RB
cord-005453-4057qib7	89	2	poor	poor	JJ
cord-005453-4057qib7	89	3	outcomes	outcome	NNS
cord-005453-4057qib7	89	4	(	(	-LRB-
cord-005453-4057qib7	90	1	10year	10year	JJ
cord-005453-4057qib7	90	2	OS	os	NN
cord-005453-4057qib7	90	3	of	of	IN
cord-005453-4057qib7	90	4	19.1	19.1	CD
cord-005453-4057qib7	90	5	%	%	NN
cord-005453-4057qib7	90	6	)	)	-RRB-
cord-005453-4057qib7	90	7	were	be	VBD
cord-005453-4057qib7	90	8	observed	observe	VBN
cord-005453-4057qib7	90	9	in	in	IN
cord-005453-4057qib7	90	10	BMR	BMR	NNP
cord-005453-4057qib7	90	11	.	.	.
cord-005453-4057qib7	91	1	Favorable	favorable	JJ
cord-005453-4057qib7	91	2	OS	OS	NNP
cord-005453-4057qib7	91	3	was	be	VBD
cord-005453-4057qib7	91	4	independently	independently	RB
cord-005453-4057qib7	91	5	associated	associate	VBN
cord-005453-4057qib7	91	6	only	only	RB
cord-005453-4057qib7	91	7	with	with	IN
cord-005453-4057qib7	91	8	the	the	DT
cord-005453-4057qib7	91	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	91	10	of	of	IN
cord-005453-4057qib7	91	11	AML	AML	NNP
cord-005453-4057qib7	91	12	(	(	-LRB-
cord-005453-4057qib7	91	13	p=0.050	p=0.050	NNP
cord-005453-4057qib7	91	14	)	)	-RRB-
cord-005453-4057qib7	92	1	and	and	CC
cord-005453-4057qib7	92	2	absence	absence	NN
cord-005453-4057qib7	92	3	of	of	IN
cord-005453-4057qib7	92	4	bacterial	bacterial	JJ
cord-005453-4057qib7	92	5	infections	infection	NNS
cord-005453-4057qib7	92	6	(	(	-LRB-
cord-005453-4057qib7	92	7	p=0.049	p=0.049	NNP
cord-005453-4057qib7	92	8	)	)	-RRB-
cord-005453-4057qib7	92	9	.	.	.
cord-005453-4057qib7	93	1	In	in	IN
cord-005453-4057qib7	93	2	the	the	DT
cord-005453-4057qib7	93	3	whole	whole	JJ
cord-005453-4057qib7	93	4	cohort	cohort	NN
cord-005453-4057qib7	93	5	,	,	,
cord-005453-4057qib7	93	6	both	both	DT
cord-005453-4057qib7	93	7	iEMR	iemr	NN
cord-005453-4057qib7	93	8	and	and	CC
cord-005453-4057qib7	93	9	BMR	BMR	NNP
cord-005453-4057qib7	93	10	were	be	VBD
cord-005453-4057qib7	93	11	independent	independent	JJ
cord-005453-4057qib7	93	12	unfavorable	unfavorable	JJ
cord-005453-4057qib7	93	13	predictors	predictor	NNS
cord-005453-4057qib7	93	14	of	of	IN
cord-005453-4057qib7	93	15	OS	OS	NNP
cord-005453-4057qib7	93	16	(	(	-LRB-
cord-005453-4057qib7	93	17	p	p	NN
cord-005453-4057qib7	93	18	<	<	XX
cord-005453-4057qib7	93	19	0.001	0.001	CD
cord-005453-4057qib7	93	20	)	)	-RRB-
cord-005453-4057qib7	93	21	along	along	IN
cord-005453-4057qib7	93	22	with	with	IN
cord-005453-4057qib7	93	23	extensive	extensive	JJ
cord-005453-4057qib7	93	24	chronic	chronic	JJ
cord-005453-4057qib7	93	25	GVHD	GVHD	NNP
cord-005453-4057qib7	93	26	(	(	-LRB-
cord-005453-4057qib7	93	27	p=0.012	p=0.012	NNP
cord-005453-4057qib7	93	28	)	)	-RRB-
cord-005453-4057qib7	93	29	.	.	.
cord-005453-4057qib7	94	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	94	2	:	:	:
cord-005453-4057qib7	95	1	In	in	IN
cord-005453-4057qib7	95	2	a	a	DT
cord-005453-4057qib7	95	3	large	large	JJ
cord-005453-4057qib7	95	4	population	population	NN
cord-005453-4057qib7	95	5	with	with	IN
cord-005453-4057qib7	95	6	long	long	JJ
cord-005453-4057qib7	95	7	-	-	HYPH
cord-005453-4057qib7	95	8	term	term	NN
cord-005453-4057qib7	95	9	follow	follow	NN
cord-005453-4057qib7	95	10	-	-	HYPH
cord-005453-4057qib7	95	11	up	up	NN
cord-005453-4057qib7	95	12	,	,	,
cord-005453-4057qib7	95	13	incidence	incidence	NN
cord-005453-4057qib7	95	14	of	of	IN
cord-005453-4057qib7	95	15	iEMR	iemr	NN
cord-005453-4057qib7	95	16	was	be	VBD
cord-005453-4057qib7	95	17	relatively	relatively	RB
cord-005453-4057qib7	95	18	high	high	JJ
cord-005453-4057qib7	95	19	,	,	,
cord-005453-4057qib7	95	20	developed	develop	VBN
cord-005453-4057qib7	95	21	at	at	IN
cord-005453-4057qib7	95	22	the	the	DT
cord-005453-4057qib7	95	23	late	late	JJ
cord-005453-4057qib7	95	24	post	post	JJ
cord-005453-4057qib7	95	25	-	-	JJ
cord-005453-4057qib7	95	26	transplant	transplant	JJ
cord-005453-4057qib7	95	27	period	period	NN
cord-005453-4057qib7	95	28	and	and	CC
cord-005453-4057qib7	95	29	associated	associate	VBN
cord-005453-4057qib7	95	30	only	only	RB
cord-005453-4057qib7	95	31	with	with	IN
cord-005453-4057qib7	95	32	disease	disease	NN
cord-005453-4057qib7	95	33	phase	phase	NN
cord-005453-4057qib7	95	34	at	at	IN
cord-005453-4057qib7	95	35	transplant	transplant	NN
cord-005453-4057qib7	95	36	.	.	.
cord-005453-4057qib7	96	1	Furthermore	furthermore	RB
cord-005453-4057qib7	96	2	,	,	,
cord-005453-4057qib7	96	3	iEMR	iemr	NN
cord-005453-4057qib7	96	4	and	and	CC
cord-005453-4057qib7	96	5	BMR	BMR	NNP
cord-005453-4057qib7	96	6	conferred	confer	VBD
cord-005453-4057qib7	96	7	similarly	similarly	RB
cord-005453-4057qib7	96	8	poor	poor	JJ
cord-005453-4057qib7	96	9	outcomes	outcome	NNS
cord-005453-4057qib7	96	10	despite	despite	IN
cord-005453-4057qib7	96	11	systemic	systemic	JJ
cord-005453-4057qib7	96	12	treatment	treatment	NN
cord-005453-4057qib7	96	13	or	or	CC
cord-005453-4057qib7	96	14	extensive	extensive	JJ
cord-005453-4057qib7	96	15	chronic	chronic	JJ
cord-005453-4057qib7	96	16	GVHD	GVHD	NNP
cord-005453-4057qib7	96	17	.	.	.
cord-005453-4057qib7	97	1	These	these	DT
cord-005453-4057qib7	97	2	independent	independent	JJ
cord-005453-4057qib7	97	3	predictors	predictor	NNS
cord-005453-4057qib7	97	4	of	of	IN
cord-005453-4057qib7	97	5	survival	survival	NN
cord-005453-4057qib7	97	6	highlight	highlight	VBP
cord-005453-4057qib7	97	7	the	the	DT
cord-005453-4057qib7	97	8	unmet	unmet	JJ
cord-005453-4057qib7	97	9	clinical	clinical	JJ
cord-005453-4057qib7	97	10	need	need	NN
cord-005453-4057qib7	97	11	of	of	IN
cord-005453-4057qib7	97	12	novel	novel	JJ
cord-005453-4057qib7	97	13	approaches	approach	NNS
cord-005453-4057qib7	97	14	either	either	CC
cord-005453-4057qib7	97	15	as	as	IN
cord-005453-4057qib7	97	16	maintenance	maintenance	NN
cord-005453-4057qib7	97	17	or	or	CC
cord-005453-4057qib7	97	18	treatment	treatment	NN
cord-005453-4057qib7	97	19	to	to	TO
cord-005453-4057qib7	97	20	reduce	reduce	VB
cord-005453-4057qib7	97	21	extramedullary	extramedullary	JJ
cord-005453-4057qib7	97	22	or	or	CC
cord-005453-4057qib7	97	23	systemic	systemic	JJ
cord-005453-4057qib7	97	24	relapse	relapse	NN
cord-005453-4057qib7	97	25	post	post	NN
cord-005453-4057qib7	97	26	alloHCT	allohct	XX
cord-005453-4057qib7	97	27	for	for	IN
cord-005453-4057qib7	97	28	acute	acute	JJ
cord-005453-4057qib7	97	29	leukemia	leukemia	NN
cord-005453-4057qib7	97	30	.	.	.
cord-005453-4057qib7	98	1	Disclosure	disclosure	NN
cord-005453-4057qib7	98	2	:	:	:
cord-005453-4057qib7	98	3	No	no	DT
cord-005453-4057qib7	98	4	competing	compete	VBG
cord-005453-4057qib7	98	5	financial	financial	JJ
cord-005453-4057qib7	98	6	interest	interest	NN
cord-005453-4057qib7	98	7	.	.	.
cord-005453-4057qib7	99	1	Impact	impact	NN
cord-005453-4057qib7	99	2	of	of	IN
cord-005453-4057qib7	99	3	T	t	NN
cord-005453-4057qib7	99	4	-	-	HYPH
cord-005453-4057qib7	99	5	cell	cell	NN
cord-005453-4057qib7	99	6	depletion	depletion	NN
cord-005453-4057qib7	99	7	on	on	IN
cord-005453-4057qib7	99	8	outcome	outcome	NN
cord-005453-4057qib7	99	9	in	in	IN
cord-005453-4057qib7	99	10	patients	patient	NNS
cord-005453-4057qib7	99	11	undergoing	undergo	VBG
cord-005453-4057qib7	99	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	99	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	99	14	stem	stem	NN
cord-005453-4057qib7	99	15	cell	cell	NN
cord-005453-4057qib7	99	16	transplantation	transplantation	NN
cord-005453-4057qib7	99	17	for	for	IN
cord-005453-4057qib7	99	18	acute	acute	JJ
cord-005453-4057qib7	99	19	myeloid	myeloid	NN
cord-005453-4057qib7	99	20	leukemia	leukemia	NN
cord-005453-4057qib7	99	21	Background	background	NN
cord-005453-4057qib7	99	22	:	:	:
cord-005453-4057qib7	100	1	After	after	IN
cord-005453-4057qib7	100	2	a	a	DT
cord-005453-4057qib7	100	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	100	4	of	of	IN
cord-005453-4057qib7	100	5	acute	acute	JJ
cord-005453-4057qib7	100	6	myeloid	myeloid	NN
cord-005453-4057qib7	100	7	leukemia	leukemia	NN
cord-005453-4057qib7	100	8	(	(	-LRB-
cord-005453-4057qib7	100	9	AML	AML	NNP
cord-005453-4057qib7	100	10	)	)	-RRB-
cord-005453-4057qib7	101	1	the	the	DT
cord-005453-4057qib7	101	2	majority	majority	NN
cord-005453-4057qib7	101	3	of	of	IN
cord-005453-4057qib7	101	4	patients	patient	NNS
cord-005453-4057qib7	101	5	(	(	-LRB-
cord-005453-4057qib7	101	6	pts	pts	NNP
cord-005453-4057qib7	101	7	)	)	-RRB-
cord-005453-4057qib7	101	8	who	who	WP
cord-005453-4057qib7	101	9	achieve	achieve	VBP
cord-005453-4057qib7	101	10	complete	complete	JJ
cord-005453-4057qib7	101	11	remission	remission	NN
cord-005453-4057qib7	101	12	(	(	-LRB-
cord-005453-4057qib7	101	13	CR	cr	NN
cord-005453-4057qib7	101	14	)	)	-RRB-
cord-005453-4057qib7	101	15	eventually	eventually	RB
cord-005453-4057qib7	101	16	relapse	relapse	VB
cord-005453-4057qib7	101	17	,	,	,
cord-005453-4057qib7	101	18	with	with	IN
cord-005453-4057qib7	101	19	only	only	RB
cord-005453-4057qib7	101	20	approximately	approximately	RB
cord-005453-4057qib7	101	21	30	30	CD
cord-005453-4057qib7	101	22	%	%	NN
cord-005453-4057qib7	101	23	of	of	IN
cord-005453-4057qib7	101	24	pts	pt	NNS
cord-005453-4057qib7	101	25	maintaining	maintain	VBG
cord-005453-4057qib7	101	26	CR	CR	NNP
cord-005453-4057qib7	101	27	for	for	IN
cord-005453-4057qib7	101	28	3	3	CD
cord-005453-4057qib7	101	29	years	year	NNS
cord-005453-4057qib7	101	30	or	or	CC
cord-005453-4057qib7	101	31	longer	long	JJR
cord-005453-4057qib7	101	32	.	.	.
cord-005453-4057qib7	102	1	Late	late	JJ
cord-005453-4057qib7	102	2	relapses	relapse	NNS
cord-005453-4057qib7	102	3	(	(	-LRB-
cord-005453-4057qib7	102	4	after	after	IN
cord-005453-4057qib7	102	5	3	3	CD
cord-005453-4057qib7	102	6	years	year	NNS
cord-005453-4057qib7	102	7	in	in	IN
cord-005453-4057qib7	102	8	CR	CR	NNP
cord-005453-4057qib7	102	9	)	)	-RRB-
cord-005453-4057qib7	102	10	occur	occur	VBP
cord-005453-4057qib7	102	11	rarely	rarely	RB
cord-005453-4057qib7	102	12	(	(	-LRB-
cord-005453-4057qib7	102	13	6	6	CD
cord-005453-4057qib7	102	14	-	-	SYM
cord-005453-4057qib7	102	15	10	10	CD
cord-005453-4057qib7	102	16	%	%	NN
cord-005453-4057qib7	102	17	)	)	-RRB-
cord-005453-4057qib7	102	18	in	in	IN
cord-005453-4057qib7	102	19	pts	pt	NNS
cord-005453-4057qib7	102	20	receiving	receive	VBG
cord-005453-4057qib7	102	21	HSCT	HSCT	NNP
cord-005453-4057qib7	102	22	in	in	IN
cord-005453-4057qib7	102	23	CR1	CR1	NNP
cord-005453-4057qib7	102	24	and	and	CC
cord-005453-4057qib7	102	25	late	late	JJ
cord-005453-4057qib7	102	26	effects	effect	NNS
cord-005453-4057qib7	102	27	are	be	VBP
cord-005453-4057qib7	102	28	followed	follow	VBN
cord-005453-4057qib7	102	29	up	up	RP
cord-005453-4057qib7	102	30	by	by	IN
cord-005453-4057qib7	102	31	routine	routine	JJ
cord-005453-4057qib7	102	32	surveillance	surveillance	NN
cord-005453-4057qib7	102	33	as	as	RB
cord-005453-4057qib7	102	34	well	well	RB
cord-005453-4057qib7	102	35	as	as	IN
cord-005453-4057qib7	102	36	preventative	preventative	JJ
cord-005453-4057qib7	102	37	measures	measure	NNS
cord-005453-4057qib7	102	38	.	.	.
cord-005453-4057qib7	103	1	The	the	DT
cord-005453-4057qib7	103	2	purpose	purpose	NN
cord-005453-4057qib7	103	3	of	of	IN
cord-005453-4057qib7	103	4	this	this	DT
cord-005453-4057qib7	103	5	study	study	NN
cord-005453-4057qib7	103	6	was	be	VBD
cord-005453-4057qib7	103	7	to	to	TO
cord-005453-4057qib7	103	8	investigate	investigate	VB
cord-005453-4057qib7	103	9	long	long	JJ
cord-005453-4057qib7	103	10	-	-	HYPH
cord-005453-4057qib7	103	11	term	term	NN
cord-005453-4057qib7	103	12	outcomes	outcome	NNS
cord-005453-4057qib7	103	13	in	in	IN
cord-005453-4057qib7	103	14	pts	pts	NN
cord-005453-4057qib7	103	15	with	with	IN
cord-005453-4057qib7	103	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	103	17	of	of	IN
cord-005453-4057qib7	103	18	AML	AML	NNP
cord-005453-4057qib7	103	19	undergoing	undergo	VBG
cord-005453-4057qib7	103	20	HSCT	HSCT	NNP
cord-005453-4057qib7	103	21	at	at	IN
cord-005453-4057qib7	103	22	our	-PRON-	PRP$
cord-005453-4057qib7	103	23	Institution	Institution	NNP
cord-005453-4057qib7	103	24	in	in	IN
cord-005453-4057qib7	103	25	CR1	CR1	NNP
cord-005453-4057qib7	103	26	.	.	.
cord-005453-4057qib7	104	1	Methods	method	NNS
cord-005453-4057qib7	104	2	:	:	:
cord-005453-4057qib7	105	1	A	a	DT
cord-005453-4057qib7	105	2	standardized	standardized	JJ
cord-005453-4057qib7	105	3	follow	follow	NN
cord-005453-4057qib7	105	4	-	-	HYPH
cord-005453-4057qib7	105	5	up	up	NN
cord-005453-4057qib7	105	6	of	of	IN
cord-005453-4057qib7	105	7	HSCT	HSCT	NNP
cord-005453-4057qib7	105	8	-	-	HYPH
cord-005453-4057qib7	105	9	survivors	survivor	NNS
cord-005453-4057qib7	105	10	is	be	VBZ
cord-005453-4057qib7	105	11	applied	apply	VBN
cord-005453-4057qib7	105	12	at	at	IN
cord-005453-4057qib7	105	13	our	-PRON-	PRP$
cord-005453-4057qib7	105	14	center	center	NN
cord-005453-4057qib7	105	15	.	.	.
cord-005453-4057qib7	106	1	We	-PRON-	PRP
cord-005453-4057qib7	106	2	analyzed	analyze	VBD
cord-005453-4057qib7	106	3	116	116	CD
cord-005453-4057qib7	106	4	adult	adult	NN
cord-005453-4057qib7	106	5	pts	pt	NNS
cord-005453-4057qib7	106	6	with	with	IN
cord-005453-4057qib7	106	7	AML	AML	NNP
cord-005453-4057qib7	106	8	in	in	IN
cord-005453-4057qib7	106	9	CR1	CR1	NNP
cord-005453-4057qib7	106	10	consecutively	consecutively	RB
cord-005453-4057qib7	106	11	transplanted	transplant	VBN
cord-005453-4057qib7	106	12	between	between	IN
cord-005453-4057qib7	106	13	January	January	NNP
cord-005453-4057qib7	106	14	2004	2004	CD
cord-005453-4057qib7	106	15	and	and	CC
cord-005453-4057qib7	106	16	December	December	NNP
cord-005453-4057qib7	106	17	2016	2016	CD
cord-005453-4057qib7	106	18	at	at	IN
cord-005453-4057qib7	106	19	our	-PRON-	PRP$
cord-005453-4057qib7	106	20	Institution	Institution	NNP
cord-005453-4057qib7	106	21	.	.	.
cord-005453-4057qib7	107	1	A	a	DT
cord-005453-4057qib7	107	2	written	write	VBN
cord-005453-4057qib7	107	3	consent	consent	NN
cord-005453-4057qib7	107	4	was	be	VBD
cord-005453-4057qib7	107	5	given	give	VBN
cord-005453-4057qib7	107	6	for	for	IN
cord-005453-4057qib7	107	7	the	the	DT
cord-005453-4057qib7	107	8	use	use	NN
cord-005453-4057qib7	107	9	of	of	IN
cord-005453-4057qib7	107	10	medical	medical	JJ
cord-005453-4057qib7	107	11	records	record	NNS
cord-005453-4057qib7	107	12	for	for	IN
cord-005453-4057qib7	107	13	research	research	NN
cord-005453-4057qib7	107	14	.	.	.
cord-005453-4057qib7	108	1	A	a	DT
cord-005453-4057qib7	108	2	landmark	landmark	NN
cord-005453-4057qib7	108	3	analysis	analysis	NN
cord-005453-4057qib7	108	4	was	be	VBD
cord-005453-4057qib7	108	5	adopted	adopt	VBN
cord-005453-4057qib7	108	6	for	for	IN
cord-005453-4057qib7	108	7	patients	patient	NNS
cord-005453-4057qib7	108	8	in	in	IN
cord-005453-4057qib7	108	9	CR	CR	NNP
cord-005453-4057qib7	108	10	at	at	IN
cord-005453-4057qib7	108	11	2-y	2-y	CD
cord-005453-4057qib7	108	12	after	after	IN
cord-005453-4057qib7	108	13	HSCT	HSCT	NNP
cord-005453-4057qib7	108	14	(	(	-LRB-
cord-005453-4057qib7	108	15	LTCR	LTCR	NNP
cord-005453-4057qib7	108	16	-long	-long	JJ
cord-005453-4057qib7	108	17	-	-	HYPH
cord-005453-4057qib7	108	18	term	term	NN
cord-005453-4057qib7	108	19	CR	cr	NN
cord-005453-4057qib7	108	20	)	)	-RRB-
cord-005453-4057qib7	108	21	.	.	.
cord-005453-4057qib7	109	1	Results	result	NNS
cord-005453-4057qib7	109	2	:	:	:
cord-005453-4057qib7	110	1	LTCR	LTCR	NNP
cord-005453-4057qib7	110	2	was	be	VBD
cord-005453-4057qib7	110	3	achieved	achieve	VBN
cord-005453-4057qib7	110	4	after	after	IN
cord-005453-4057qib7	110	5	HSCT	HSCT	NNP
cord-005453-4057qib7	110	6	in	in	IN
cord-005453-4057qib7	110	7	91/116	91/116	CD
cord-005453-4057qib7	110	8	patients	patient	NNS
cord-005453-4057qib7	110	9	(	(	-LRB-
cord-005453-4057qib7	110	10	male	male	JJ
cord-005453-4057qib7	110	11	55	55	CD
cord-005453-4057qib7	110	12	,	,	,
cord-005453-4057qib7	110	13	female	female	JJ
cord-005453-4057qib7	110	14	36	36	CD
cord-005453-4057qib7	110	15	)	)	-RRB-
cord-005453-4057qib7	110	16	transplanted	transplant	VBN
cord-005453-4057qib7	110	17	in	in	IN
cord-005453-4057qib7	110	18	CR1	CR1	NNP
cord-005453-4057qib7	110	19	.	.	.
cord-005453-4057qib7	111	1	The	the	DT
cord-005453-4057qib7	111	2	median	median	JJ
cord-005453-4057qib7	111	3	follow	follow	NN
cord-005453-4057qib7	111	4	-	-	HYPH
cord-005453-4057qib7	111	5	up	up	NN
cord-005453-4057qib7	111	6	was	be	VBD
cord-005453-4057qib7	111	7	6	6	CD
cord-005453-4057qib7	111	8	years	year	NNS
cord-005453-4057qib7	111	9	and	and	CC
cord-005453-4057qib7	111	10	the	the	DT
cord-005453-4057qib7	111	11	median	median	JJ
cord-005453-4057qib7	111	12	age	age	NN
cord-005453-4057qib7	111	13	at	at	IN
cord-005453-4057qib7	111	14	transplant	transplant	NN
cord-005453-4057qib7	111	15	52	52	CD
cord-005453-4057qib7	111	16	years	year	NNS
cord-005453-4057qib7	112	1	(	(	-LRB-
cord-005453-4057qib7	112	2	r	r	NN
cord-005453-4057qib7	112	3	20	20	CD
cord-005453-4057qib7	112	4	-	-	SYM
cord-005453-4057qib7	112	5	72	72	CD
cord-005453-4057qib7	112	6	)	)	-RRB-
cord-005453-4057qib7	112	7	.	.	.
cord-005453-4057qib7	113	1	The	the	DT
cord-005453-4057qib7	113	2	selected	select	VBN
cord-005453-4057qib7	113	3	donor	donor	NN
cord-005453-4057qib7	113	4	was	be	VBD
cord-005453-4057qib7	113	5	a	a	DT
cord-005453-4057qib7	113	6	family	family	NN
cord-005453-4057qib7	113	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	113	8	relative	relative	NN
cord-005453-4057qib7	113	9	in	in	IN
cord-005453-4057qib7	113	10	29	29	CD
cord-005453-4057qib7	113	11	cases	case	NNS
cord-005453-4057qib7	113	12	,	,	,
cord-005453-4057qib7	113	13	an	an	DT
cord-005453-4057qib7	113	14	HLA	HLA	NNP
cord-005453-4057qib7	113	15	identical	identical	JJ
cord-005453-4057qib7	113	16	relative	relative	NN
cord-005453-4057qib7	113	17	in	in	IN
cord-005453-4057qib7	113	18	21	21	CD
cord-005453-4057qib7	113	19	,	,	,
cord-005453-4057qib7	113	20	a	a	DT
cord-005453-4057qib7	113	21	match	match	NN
cord-005453-4057qib7	113	22	unrelated	unrelated	JJ
cord-005453-4057qib7	113	23	donor	donor	NN
cord-005453-4057qib7	113	24	in	in	IN
cord-005453-4057qib7	113	25	39	39	CD
cord-005453-4057qib7	113	26	and	and	CC
cord-005453-4057qib7	113	27	a	a	DT
cord-005453-4057qib7	113	28	cordblood	cordblood	NN
cord-005453-4057qib7	113	29	in	in	IN
cord-005453-4057qib7	113	30	2	2	CD
cord-005453-4057qib7	113	31	.	.	.
cord-005453-4057qib7	114	1	In	in	IN
cord-005453-4057qib7	114	2	this	this	DT
cord-005453-4057qib7	114	3	cohort	cohort	NN
cord-005453-4057qib7	114	4	of	of	IN
cord-005453-4057qib7	114	5	LTCR	LTCR	NNP
cord-005453-4057qib7	114	6	,	,	,
cord-005453-4057qib7	114	7	the	the	DT
cord-005453-4057qib7	114	8	5-year	5-year	CD
cord-005453-4057qib7	114	9	overall	overall	JJ
cord-005453-4057qib7	114	10	survival	survival	NN
cord-005453-4057qib7	114	11	was	be	VBD
cord-005453-4057qib7	114	12	92	92	CD
cord-005453-4057qib7	114	13	%	%	NN
cord-005453-4057qib7	114	14	(	(	-LRB-
cord-005453-4057qib7	114	15	95	95	CD
cord-005453-4057qib7	114	16	%	%	NN
cord-005453-4057qib7	114	17	CI	CI	NNP
cord-005453-4057qib7	114	18	83	83	CD
cord-005453-4057qib7	114	19	-	-	SYM
cord-005453-4057qib7	114	20	96	96	CD
cord-005453-4057qib7	114	21	)	)	-RRB-
cord-005453-4057qib7	114	22	.	.	.
cord-005453-4057qib7	115	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	115	2	incidence	incidence	NN
cord-005453-4057qib7	115	3	of	of	IN
cord-005453-4057qib7	115	4	relapseevaluated	relapseevaluated	JJ
cord-005453-4057qib7	115	5	in	in	IN
cord-005453-4057qib7	115	6	competing	compete	VBG
cord-005453-4057qib7	115	7	risk	risk	NN
cord-005453-4057qib7	115	8	with	with	IN
cord-005453-4057qib7	115	9	transplant	transplant	NN
cord-005453-4057qib7	115	10	related	relate	VBN
cord-005453-4057qib7	115	11	mortality	mortality	NN
cord-005453-4057qib7	115	12	(	(	-LRB-
cord-005453-4057qib7	115	13	TRM	TRM	NNP
cord-005453-4057qib7	115	14	)	)	-RRB-
cord-005453-4057qib7	116	1	-and	-and	:
cord-005453-4057qib7	117	1	TRM	TRM	NNP
cord-005453-4057qib7	117	2	-evaluated	-evaluate	VBN
cord-005453-4057qib7	117	3	in	in	IN
cord-005453-4057qib7	117	4	competing	compete	VBG
cord-005453-4057qib7	117	5	risk	risk	NN
cord-005453-4057qib7	117	6	with	with	IN
cord-005453-4057qib7	117	7	relapse	relapse	NN
cord-005453-4057qib7	117	8	-were	-were	RBR
cord-005453-4057qib7	117	9	respectively	respectively	RB
cord-005453-4057qib7	117	10	7	7	CD
cord-005453-4057qib7	117	11	%	%	NN
cord-005453-4057qib7	117	12	(	(	-LRB-
cord-005453-4057qib7	117	13	95	95	CD
cord-005453-4057qib7	117	14	%	%	NN
cord-005453-4057qib7	117	15	CI	CI	NNP
cord-005453-4057qib7	117	16	1	1	CD
cord-005453-4057qib7	117	17	-	-	SYM
cord-005453-4057qib7	117	18	23	23	CD
cord-005453-4057qib7	117	19	)	)	-RRB-
cord-005453-4057qib7	117	20	and	and	CC
cord-005453-4057qib7	117	21	2	2	CD
cord-005453-4057qib7	117	22	%	%	NN
cord-005453-4057qib7	117	23	for	for	IN
cord-005453-4057qib7	117	24	the	the	DT
cord-005453-4057qib7	117	25	CR1	CR1	NNP
cord-005453-4057qib7	117	26	cohort	cohort	NN
cord-005453-4057qib7	117	27	.	.	.
cord-005453-4057qib7	118	1	The	the	DT
cord-005453-4057qib7	118	2	event	event	NN
cord-005453-4057qib7	118	3	-	-	HYPH
cord-005453-4057qib7	118	4	free	free	JJ
cord-005453-4057qib7	118	5	-	-	HYPH
cord-005453-4057qib7	118	6	survival	survival	NN
cord-005453-4057qib7	118	7	(	(	-LRB-
cord-005453-4057qib7	118	8	EFS	EFS	NNP
cord-005453-4057qib7	118	9	)	)	-RRB-
cord-005453-4057qib7	118	10	was	be	VBD
cord-005453-4057qib7	118	11	91	91	CD
cord-005453-4057qib7	118	12	%	%	NN
cord-005453-4057qib7	118	13	(	(	-LRB-
cord-005453-4057qib7	118	14	95	95	CD
cord-005453-4057qib7	118	15	%	%	NN
cord-005453-4057qib7	118	16	CI	CI	NNP
cord-005453-4057qib7	118	17	83	83	CD
cord-005453-4057qib7	118	18	-	-	SYM
cord-005453-4057qib7	118	19	95	95	CD
cord-005453-4057qib7	118	20	)	)	-RRB-
cord-005453-4057qib7	118	21	.	.	.
cord-005453-4057qib7	119	1	The	the	DT
cord-005453-4057qib7	119	2	causes	cause	NNS
cord-005453-4057qib7	119	3	of	of	IN
cord-005453-4057qib7	119	4	death	death	NN
cord-005453-4057qib7	119	5	were	be	VBD
cord-005453-4057qib7	119	6	relapse	relapse	NN
cord-005453-4057qib7	119	7	(	(	-LRB-
cord-005453-4057qib7	119	8	6/10	6/10	CD
cord-005453-4057qib7	119	9	pts	pt	NNS
cord-005453-4057qib7	119	10	)	)	-RRB-
cord-005453-4057qib7	119	11	,	,	,
cord-005453-4057qib7	119	12	second	second	JJ
cord-005453-4057qib7	119	13	cancer	cancer	NN
cord-005453-4057qib7	119	14	(	(	-LRB-
cord-005453-4057qib7	119	15	3/10	3/10	CD
cord-005453-4057qib7	119	16	pts	pt	NNS
cord-005453-4057qib7	119	17	)	)	-RRB-
cord-005453-4057qib7	119	18	and	and	CC
cord-005453-4057qib7	119	19	sepsis	sepsis	NN
cord-005453-4057qib7	119	20	(	(	-LRB-
cord-005453-4057qib7	119	21	1/10	1/10	CD
cord-005453-4057qib7	119	22	pts	pts	NN
cord-005453-4057qib7	119	23	)	)	-RRB-
cord-005453-4057qib7	119	24	.	.	.
cord-005453-4057qib7	120	1	The	the	DT
cord-005453-4057qib7	120	2	5-year	5-year	CD
cord-005453-4057qib7	120	3	incidence	incidence	NN
cord-005453-4057qib7	120	4	of	of	IN
cord-005453-4057qib7	120	5	dyslipidemia	dyslipidemia	NN
cord-005453-4057qib7	120	6	-defined	-define	VBN
cord-005453-4057qib7	120	7	as	as	IN
cord-005453-4057qib7	120	8	cholesterol	cholesterol	NN
cord-005453-4057qib7	120	9	>	>	XX
cord-005453-4057qib7	120	10	/=	/=	.
cord-005453-4057qib7	121	1	200	200	CD
cord-005453-4057qib7	121	2	mg	mg	NNP
cord-005453-4057qib7	121	3	/	/	SYM
cord-005453-4057qib7	121	4	dl	dl	NNP
cord-005453-4057qib7	121	5	,	,	,
cord-005453-4057qib7	121	6	and/or	and/or	CC
cord-005453-4057qib7	122	1	LDL	ldl	NN
cord-005453-4057qib7	123	1	>	>	XX
cord-005453-4057qib7	123	2	/=	/=	CD
cord-005453-4057qib7	123	3	115	115	CD
cord-005453-4057qib7	123	4	mg	mg	NNP
cord-005453-4057qib7	123	5	/	/	SYM
cord-005453-4057qib7	123	6	dl	dl	NNP
cord-005453-4057qib7	123	7	,	,	,
cord-005453-4057qib7	123	8	and/or	and/or	CC
cord-005453-4057qib7	123	9	triglycerides	triglyceride	NNS
cord-005453-4057qib7	124	1	>	>	XX
cord-005453-4057qib7	125	1	/=	/=	CD
cord-005453-4057qib7	125	2	150	150	CD
cord-005453-4057qib7	125	3	mg	mg	NNP
cord-005453-4057qib7	125	4	/	/	SYM
cord-005453-4057qib7	125	5	dl	dl	NNP
cord-005453-4057qib7	125	6	or	or	CC
cord-005453-4057qib7	125	7	need	need	VB
cord-005453-4057qib7	125	8	for	for	IN
cord-005453-4057qib7	125	9	specific	specific	JJ
cord-005453-4057qib7	125	10	treatment	treatment	NN
cord-005453-4057qib7	125	11	-was	-was	:
cord-005453-4057qib7	125	12	24	24	CD
cord-005453-4057qib7	125	13	%	%	NN
cord-005453-4057qib7	125	14	.	.	.
cord-005453-4057qib7	126	1	The	the	DT
cord-005453-4057qib7	126	2	5-year	5-year	CD
cord-005453-4057qib7	126	3	incidence	incidence	NN
cord-005453-4057qib7	126	4	of	of	IN
cord-005453-4057qib7	126	5	osteopenia	osteopenia	NN
cord-005453-4057qib7	126	6	/	/	SYM
cord-005453-4057qib7	126	7	osteoporosisdefined	osteoporosisdefine	VBN
cord-005453-4057qib7	126	8	as	as	IN
cord-005453-4057qib7	126	9	T	t	NN
cord-005453-4057qib7	126	10	-	-	HYPH
cord-005453-4057qib7	126	11	score	score	NN
cord-005453-4057qib7	126	12	lower	low	JJR
cord-005453-4057qib7	126	13	than	than	IN
cord-005453-4057qib7	126	14	-1	-1	NN
cord-005453-4057qib7	126	15	and	and	CC
cord-005453-4057qib7	126	16	greater	great	JJR
cord-005453-4057qib7	126	17	than	than	IN
cord-005453-4057qib7	126	18	-2.5	-2.5	NNP
cord-005453-4057qib7	126	19	and	and	CC
cord-005453-4057qib7	126	20	T	t	NN
cord-005453-4057qib7	126	21	-	-	HYPH
cord-005453-4057qib7	126	22	score	score	NN
cord-005453-4057qib7	126	23	lower	low	JJR
cord-005453-4057qib7	126	24	than	than	IN
cord-005453-4057qib7	126	25	2.5	2.5	CD
cord-005453-4057qib7	126	26	respectively	respectively	RB
cord-005453-4057qib7	126	27	-was	-was	:
cord-005453-4057qib7	126	28	38	38	CD
cord-005453-4057qib7	126	29	%	%	NN
cord-005453-4057qib7	126	30	.	.	.
cord-005453-4057qib7	127	1	The	the	DT
cord-005453-4057qib7	127	2	5-year	5-year	CD
cord-005453-4057qib7	127	3	incidence	incidence	NN
cord-005453-4057qib7	127	4	of	of	IN
cord-005453-4057qib7	127	5	second	second	JJ
cord-005453-4057qib7	127	6	cancer	cancer	NN
cord-005453-4057qib7	127	7	was	be	VBD
cord-005453-4057qib7	127	8	11	11	CD
cord-005453-4057qib7	127	9	%	%	NN
cord-005453-4057qib7	127	10	:	:	:
cord-005453-4057qib7	127	11	10	10	CD
cord-005453-4057qib7	127	12	nonmelanoma	nonmelanoma	NN
cord-005453-4057qib7	127	13	skin	skin	NN
cord-005453-4057qib7	127	14	cancer	cancer	NN
cord-005453-4057qib7	127	15	,	,	,
cord-005453-4057qib7	127	16	2	2	CD
cord-005453-4057qib7	127	17	lung	lung	NN
cord-005453-4057qib7	127	18	carcinoma	carcinoma	NN
cord-005453-4057qib7	127	19	,	,	,
cord-005453-4057qib7	127	20	3	3	CD
cord-005453-4057qib7	127	21	cervical	cervical	JJ
cord-005453-4057qib7	127	22	intraepithelial	intraepithelial	JJ
cord-005453-4057qib7	127	23	neoplasm	neoplasm	NN
cord-005453-4057qib7	127	24	,	,	,
cord-005453-4057qib7	127	25	1	1	CD
cord-005453-4057qib7	127	26	thyroid	thyroid	NN
cord-005453-4057qib7	127	27	cancer	cancer	NN
cord-005453-4057qib7	127	28	,	,	,
cord-005453-4057qib7	127	29	1	1	CD
cord-005453-4057qib7	127	30	gastric	gastric	JJ
cord-005453-4057qib7	127	31	cancer	cancer	NN
cord-005453-4057qib7	127	32	and	and	CC
cord-005453-4057qib7	127	33	1	1	CD
cord-005453-4057qib7	127	34	colon	colon	NN
cord-005453-4057qib7	127	35	cancer	cancer	NN
cord-005453-4057qib7	127	36	.	.	.
cord-005453-4057qib7	128	1	The	the	DT
cord-005453-4057qib7	128	2	2-year	2-year	CD
cord-005453-4057qib7	128	3	incidence	incidence	NN
cord-005453-4057qib7	128	4	of	of	IN
cord-005453-4057qib7	128	5	chronic	chronic	JJ
cord-005453-4057qib7	128	6	moderate	moderate	JJ
cord-005453-4057qib7	128	7	-	-	HYPH
cord-005453-4057qib7	128	8	severe	severe	JJ
cord-005453-4057qib7	128	9	GvHD	gvhd	NN
cord-005453-4057qib7	128	10	was	be	VBD
cord-005453-4057qib7	128	11	27	27	CD
cord-005453-4057qib7	128	12	%	%	NN
cord-005453-4057qib7	128	13	(	(	-LRB-
cord-005453-4057qib7	128	14	95	95	CD
cord-005453-4057qib7	128	15	%	%	NN
cord-005453-4057qib7	128	16	CI	CI	NNP
cord-005453-4057qib7	128	17	13	13	CD
cord-005453-4057qib7	128	18	-	-	SYM
cord-005453-4057qib7	128	19	38	38	CD
cord-005453-4057qib7	128	20	)	)	-RRB-
cord-005453-4057qib7	128	21	,	,	,
cord-005453-4057qib7	128	22	with	with	IN
cord-005453-4057qib7	128	23	the	the	DT
cord-005453-4057qib7	128	24	latest	late	JJS
cord-005453-4057qib7	128	25	diagnosis	diagnosis	NN
cord-005453-4057qib7	128	26	performed	perform	VBN
cord-005453-4057qib7	128	27	on	on	IN
cord-005453-4057qib7	128	28	day	day	NN
cord-005453-4057qib7	128	29	570	570	CD
cord-005453-4057qib7	128	30	.	.	.
cord-005453-4057qib7	129	1	Of	of	IN
cord-005453-4057qib7	129	2	note	note	NN
cord-005453-4057qib7	129	3	,	,	,
cord-005453-4057qib7	129	4	4/24	4/24	CD
cord-005453-4057qib7	129	5	pts	pt	NNS
cord-005453-4057qib7	129	6	are	be	VBP
cord-005453-4057qib7	129	7	still	still	RB
cord-005453-4057qib7	129	8	on	on	IN
cord-005453-4057qib7	129	9	active	active	JJ
cord-005453-4057qib7	129	10	treatment	treatment	NN
cord-005453-4057qib7	129	11	at	at	IN
cord-005453-4057qib7	129	12	last	last	JJ
cord-005453-4057qib7	129	13	follow	follow	NN
cord-005453-4057qib7	129	14	-	-	HYPH
cord-005453-4057qib7	129	15	up	up	NN
cord-005453-4057qib7	129	16	.	.	.
cord-005453-4057qib7	130	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	130	2	:	:	:
cord-005453-4057qib7	131	1	Relapse	relapse	NN
cord-005453-4057qib7	131	2	incidence	incidence	NN
cord-005453-4057qib7	131	3	is	be	VBZ
cord-005453-4057qib7	131	4	low	low	JJ
cord-005453-4057qib7	131	5	for	for	IN
cord-005453-4057qib7	131	6	patient	patient	NN
cord-005453-4057qib7	131	7	that	that	WDT
cord-005453-4057qib7	131	8	reached	reach	VBD
cord-005453-4057qib7	131	9	LTCR	LTCR	NNP
cord-005453-4057qib7	131	10	:	:	:
cord-005453-4057qib7	131	11	patients	patient	NNS
cord-005453-4057qib7	131	12	in	in	IN
cord-005453-4057qib7	131	13	CR1	CR1	NNP
cord-005453-4057qib7	131	14	at	at	IN
cord-005453-4057qib7	131	15	transplant	transplant	NN
cord-005453-4057qib7	131	16	can	can	MD
cord-005453-4057qib7	131	17	obtain	obtain	VB
cord-005453-4057qib7	131	18	excellent	excellent	JJ
cord-005453-4057qib7	131	19	OS	os	NN
cord-005453-4057qib7	131	20	and	and	CC
cord-005453-4057qib7	131	21	EFS	efs	NN
cord-005453-4057qib7	131	22	once	once	RB
cord-005453-4057qib7	131	23	reached	reach	VBD
cord-005453-4057qib7	131	24	the	the	DT
cord-005453-4057qib7	131	25	target	target	NN
cord-005453-4057qib7	131	26	of	of	IN
cord-005453-4057qib7	131	27	LTCR	LTCR	NNP
cord-005453-4057qib7	131	28	.	.	.
cord-005453-4057qib7	132	1	A	a	DT
cord-005453-4057qib7	132	2	proactive	proactive	JJ
cord-005453-4057qib7	132	3	long	long	JJ
cord-005453-4057qib7	132	4	-	-	HYPH
cord-005453-4057qib7	132	5	term	term	NN
cord-005453-4057qib7	132	6	follow	follow	NN
cord-005453-4057qib7	132	7	-	-	HYPH
cord-005453-4057qib7	132	8	up	up	NN
cord-005453-4057qib7	132	9	and	and	CC
cord-005453-4057qib7	132	10	strategy	strategy	NN
cord-005453-4057qib7	132	11	of	of	IN
cord-005453-4057qib7	132	12	counseling	counseling	NN
cord-005453-4057qib7	132	13	are	be	VBP
cord-005453-4057qib7	132	14	essential	essential	JJ
cord-005453-4057qib7	132	15	to	to	TO
cord-005453-4057qib7	132	16	keep	keep	VB
cord-005453-4057qib7	132	17	at	at	IN
cord-005453-4057qib7	132	18	best	good	JJS
cord-005453-4057qib7	132	19	quality	quality	NN
cord-005453-4057qib7	132	20	the	the	DT
cord-005453-4057qib7	132	21	survival	survival	NN
cord-005453-4057qib7	132	22	advantage	advantage	NN
cord-005453-4057qib7	132	23	offered	offer	VBN
cord-005453-4057qib7	132	24	by	by	IN
cord-005453-4057qib7	132	25	HSCT	HSCT	NNP
cord-005453-4057qib7	132	26	in	in	IN
cord-005453-4057qib7	132	27	patients	patient	NNS
cord-005453-4057qib7	132	28	with	with	IN
cord-005453-4057qib7	132	29	AML	AML	NNP
cord-005453-4057qib7	132	30	in	in	IN
cord-005453-4057qib7	132	31	CR1	CR1	NNP
cord-005453-4057qib7	132	32	.	.	.
cord-005453-4057qib7	133	1	Disclosure	disclosure	NN
cord-005453-4057qib7	133	2	:	:	:
cord-005453-4057qib7	134	1	Chiara	Chiara	NNP
cord-005453-4057qib7	134	2	Bonini	Bonini	NNP
cord-005453-4057qib7	134	3	has	have	VBZ
cord-005453-4057qib7	134	4	research	research	NN
cord-005453-4057qib7	134	5	contract	contract	NN
cord-005453-4057qib7	134	6	with	with	IN
cord-005453-4057qib7	134	7	Intellia	Intellia	NNP
cord-005453-4057qib7	134	8	Therapeutics	Therapeutics	NNP
cord-005453-4057qib7	134	9	.	.	.
cord-005453-4057qib7	135	1	The	the	DT
cord-005453-4057qib7	135	2	other	other	JJ
cord-005453-4057qib7	135	3	authors	author	NNS
cord-005453-4057qib7	135	4	declare	declare	VBP
cord-005453-4057qib7	135	5	that	that	IN
cord-005453-4057qib7	135	6	they	-PRON-	PRP
cord-005453-4057qib7	135	7	have	have	VBP
cord-005453-4057qib7	135	8	no	no	DT
cord-005453-4057qib7	135	9	conflicts	conflict	NNS
cord-005453-4057qib7	135	10	of	of	IN
cord-005453-4057qib7	135	11	interest	interest	NN
cord-005453-4057qib7	135	12	.	.	.
cord-005453-4057qib7	136	1	Background	background	NN
cord-005453-4057qib7	136	2	:	:	:
cord-005453-4057qib7	137	1	Relapse	relapse	NN
cord-005453-4057qib7	137	2	,	,	,
cord-005453-4057qib7	137	3	graft	graft	NN
cord-005453-4057qib7	137	4	-	-	HYPH
cord-005453-4057qib7	137	5	versus	versus	IN
cord-005453-4057qib7	137	6	-	-	HYPH
cord-005453-4057qib7	137	7	host	host	NN
cord-005453-4057qib7	137	8	disease	disease	NN
cord-005453-4057qib7	137	9	(	(	-LRB-
cord-005453-4057qib7	137	10	GvHD	GvHD	NNP
cord-005453-4057qib7	137	11	)	)	-RRB-
cord-005453-4057qib7	137	12	and	and	CC
cord-005453-4057qib7	137	13	GvHD	gvhd	NN
cord-005453-4057qib7	137	14	-	-	HYPH
cord-005453-4057qib7	137	15	associated	associate	VBN
cord-005453-4057qib7	137	16	mortality	mortality	NN
cord-005453-4057qib7	137	17	are	be	VBP
cord-005453-4057qib7	137	18	major	major	JJ
cord-005453-4057qib7	137	19	obstacles	obstacle	NNS
cord-005453-4057qib7	137	20	to	to	IN
cord-005453-4057qib7	137	21	success	success	NN
cord-005453-4057qib7	137	22	of	of	IN
cord-005453-4057qib7	137	23	transplantation	transplantation	NN
cord-005453-4057qib7	137	24	from	from	IN
cord-005453-4057qib7	137	25	unrelated	unrelated	JJ
cord-005453-4057qib7	137	26	(	(	-LRB-
cord-005453-4057qib7	137	27	MUD	mud	NN
cord-005453-4057qib7	137	28	)	)	-RRB-
cord-005453-4057qib7	137	29	donors	donor	NNS
cord-005453-4057qib7	137	30	in	in	IN
cord-005453-4057qib7	137	31	children	child	NNS
cord-005453-4057qib7	137	32	with	with	IN
cord-005453-4057qib7	137	33	acute	acute	JJ
cord-005453-4057qib7	137	34	leukemia	leukemia	NN
cord-005453-4057qib7	137	35	(	(	-LRB-
cord-005453-4057qib7	137	36	AL	AL	NNP
cord-005453-4057qib7	137	37	)	)	-RRB-
cord-005453-4057qib7	137	38	.	.	.
cord-005453-4057qib7	138	1	Negative	negative	JJ
cord-005453-4057qib7	138	2	depletion	depletion	NN
cord-005453-4057qib7	138	3	of	of	IN
cord-005453-4057qib7	138	4	αβ	αβ	FW
cord-005453-4057qib7	138	5	T	t	NN
cord-005453-4057qib7	138	6	cells	cell	NNS
cord-005453-4057qib7	138	7	and	and	CC
cord-005453-4057qib7	138	8	CD19	CD19	NNP
cord-005453-4057qib7	138	9	+	+	CC
cord-005453-4057qib7	138	10	B	b	NN
cord-005453-4057qib7	138	11	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	138	12	,	,	,
cord-005453-4057qib7	138	13	conserves	conserve	VBZ
cord-005453-4057qib7	138	14	the	the	DT
cord-005453-4057qib7	138	15	mature	mature	JJ
cord-005453-4057qib7	138	16	donor	donor	NN
cord-005453-4057qib7	138	17	-	-	HYPH
cord-005453-4057qib7	138	18	derived	derive	VBN
cord-005453-4057qib7	138	19	natural	natural	JJ
cord-005453-4057qib7	138	20	killer	killer	NN
cord-005453-4057qib7	138	21	cells	cell	NNS
cord-005453-4057qib7	138	22	and	and	CC
cord-005453-4057qib7	138	23	γδ	γδ	NN
cord-005453-4057qib7	138	24	T	t	NN
cord-005453-4057qib7	138	25	cells	cell	NNS
cord-005453-4057qib7	138	26	in	in	IN
cord-005453-4057qib7	138	27	the	the	DT
cord-005453-4057qib7	138	28	graft	graft	NN
cord-005453-4057qib7	138	29	,	,	,
cord-005453-4057qib7	138	30	may	may	MD
cord-005453-4057qib7	138	31	improve	improve	VB
cord-005453-4057qib7	138	32	GvHD	GvHD	NNP
cord-005453-4057qib7	138	33	control	control	NN
cord-005453-4057qib7	138	34	,	,	,
cord-005453-4057qib7	138	35	immune	immune	JJ
cord-005453-4057qib7	138	36	reconstitution	reconstitution	NN
cord-005453-4057qib7	138	37	and	and	CC
cord-005453-4057qib7	138	38	prevent	prevent	VB
cord-005453-4057qib7	138	39	the	the	DT
cord-005453-4057qib7	138	40	relapse	relapse	NN
cord-005453-4057qib7	138	41	.	.	.
cord-005453-4057qib7	139	1	We	-PRON-	PRP
cord-005453-4057qib7	139	2	present	present	VBP
cord-005453-4057qib7	139	3	a	a	DT
cord-005453-4057qib7	139	4	retrospect	retrospect	JJ
cord-005453-4057qib7	139	5	analyses	analysis	NNS
cord-005453-4057qib7	139	6	of	of	IN
cord-005453-4057qib7	139	7	a	a	DT
cord-005453-4057qib7	139	8	cohort	cohort	NN
cord-005453-4057qib7	139	9	of	of	IN
cord-005453-4057qib7	139	10	pts	pts	NN
cord-005453-4057qib7	139	11	with	with	IN
cord-005453-4057qib7	139	12	AL	AL	NNP
cord-005453-4057qib7	139	13	in	in	IN
cord-005453-4057qib7	139	14	CR	CR	NNP
cord-005453-4057qib7	139	15	transplanted	transplant	VBN
cord-005453-4057qib7	139	16	from	from	IN
cord-005453-4057qib7	139	17	MUD	mud	NN
cord-005453-4057qib7	139	18	with	with	IN
cord-005453-4057qib7	139	19	depletion	depletion	NN
cord-005453-4057qib7	139	20	.	.	.
cord-005453-4057qib7	140	1	Methods	method	NNS
cord-005453-4057qib7	140	2	:	:	:
cord-005453-4057qib7	141	1	A	a	DT
cord-005453-4057qib7	141	2	total	total	NN
cord-005453-4057qib7	141	3	of	of	IN
cord-005453-4057qib7	141	4	59	59	CD
cord-005453-4057qib7	141	5	children	child	NNS
cord-005453-4057qib7	141	6	with	with	IN
cord-005453-4057qib7	141	7	acute	acute	JJ
cord-005453-4057qib7	141	8	leukemia	leukemia	NN
cord-005453-4057qib7	141	9	(	(	-LRB-
cord-005453-4057qib7	141	10	34	34	CD
cord-005453-4057qib7	141	11	AML	AML	NNP
cord-005453-4057qib7	141	12	,	,	,
cord-005453-4057qib7	141	13	25	25	CD
cord-005453-4057qib7	141	14	ALL	all	DT
cord-005453-4057qib7	141	15	,	,	,
cord-005453-4057qib7	141	16	21	21	CD
cord-005453-4057qib7	141	17	female	female	NN
cord-005453-4057qib7	141	18	,	,	,
cord-005453-4057qib7	141	19	38	38	CD
cord-005453-4057qib7	141	20	male	male	NN
cord-005453-4057qib7	141	21	,	,	,
cord-005453-4057qib7	141	22	median	median	JJ
cord-005453-4057qib7	141	23	age	age	NN
cord-005453-4057qib7	141	24	8,5y	8,5y	CD
cord-005453-4057qib7	141	25	)	)	-RRB-
cord-005453-4057qib7	141	26	underwent	undergo	VBD
cord-005453-4057qib7	141	27	allo	allo	NNP
cord-005453-4057qib7	141	28	HSCT	HSCT	NNP
cord-005453-4057qib7	141	29	from	from	IN
cord-005453-4057qib7	141	30	matched	match	VBN
cord-005453-4057qib7	141	31	unrelated	unrelated	JJ
cord-005453-4057qib7	141	32	donor	donor	NN
cord-005453-4057qib7	141	33	between	between	IN
cord-005453-4057qib7	141	34	June	June	NNP
cord-005453-4057qib7	141	35	2012	2012	CD
cord-005453-4057qib7	141	36	and	and	CC
cord-005453-4057qib7	141	37	July	July	NNP
cord-005453-4057qib7	141	38	2017	2017	CD
cord-005453-4057qib7	141	39	.	.	.
cord-005453-4057qib7	142	1	All	all	DT
cord-005453-4057qib7	142	2	pts	pt	NNS
cord-005453-4057qib7	142	3	were	be	VBD
cord-005453-4057qib7	142	4	in	in	IN
cord-005453-4057qib7	142	5	complete	complete	JJ
cord-005453-4057qib7	142	6	remission	remission	NN
cord-005453-4057qib7	142	7	(	(	-LRB-
cord-005453-4057qib7	142	8	CR1=34	cr1=34	NN
cord-005453-4057qib7	142	9	,	,	,
cord-005453-4057qib7	142	10	CR2=23	cr2=23	NN
cord-005453-4057qib7	142	11	,	,	,
cord-005453-4057qib7	142	12	CR>2=2	CR>2=2	NNP
cord-005453-4057qib7	142	13	)	)	-RRB-
cord-005453-4057qib7	142	14	.	.	.
cord-005453-4057qib7	143	1	All	all	DT
cord-005453-4057qib7	143	2	pts	pt	NNS
cord-005453-4057qib7	143	3	,	,	,
cord-005453-4057qib7	143	4	except	except	IN
cord-005453-4057qib7	143	5	one	one	CD
cord-005453-4057qib7	143	6	,	,	,
cord-005453-4057qib7	143	7	received	receive	VBD
cord-005453-4057qib7	143	8	treosulfan	treosulfan	NNP
cord-005453-4057qib7	143	9	-	-	HYPH
cord-005453-4057qib7	143	10	based	base	VBN
cord-005453-4057qib7	143	11	conditioning	conditioning	NN
cord-005453-4057qib7	143	12	.	.	.
cord-005453-4057qib7	144	1	Either	either	CC
cord-005453-4057qib7	144	2	melphalan	melphalan	NNP
cord-005453-4057qib7	144	3	(	(	-LRB-
cord-005453-4057qib7	144	4	n=56	n=56	NNP
cord-005453-4057qib7	144	5	)	)	-RRB-
cord-005453-4057qib7	144	6	or	or	CC
cord-005453-4057qib7	144	7	thiophosphamide	thiophosphamide	NNP
cord-005453-4057qib7	144	8	(	(	-LRB-
cord-005453-4057qib7	144	9	n=2	n=2	NNS
cord-005453-4057qib7	144	10	)	)	-RRB-
cord-005453-4057qib7	144	11	or	or	CC
cord-005453-4057qib7	144	12	etoposide	etoposide	JJ
cord-005453-4057qib7	144	13	(	(	-LRB-
cord-005453-4057qib7	144	14	n=1	n=1	NN
cord-005453-4057qib7	144	15	)	)	-RRB-
cord-005453-4057qib7	144	16	were	be	VBD
cord-005453-4057qib7	144	17	added	add	VBN
cord-005453-4057qib7	144	18	as	as	IN
cord-005453-4057qib7	144	19	a	a	DT
cord-005453-4057qib7	144	20	second	second	JJ
cord-005453-4057qib7	144	21	agent	agent	NN
cord-005453-4057qib7	144	22	.	.	.
cord-005453-4057qib7	145	1	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	145	2	was	be	VBD
cord-005453-4057qib7	145	3	used	use	VBN
cord-005453-4057qib7	145	4	in	in	IN
cord-005453-4057qib7	145	5	all	all	DT
cord-005453-4057qib7	145	6	pts	pt	NNS
cord-005453-4057qib7	145	7	.	.	.
cord-005453-4057qib7	146	1	Two	two	CD
cord-005453-4057qib7	146	2	types	type	NNS
cord-005453-4057qib7	146	3	of	of	IN
cord-005453-4057qib7	146	4	GVHD	GVHD	NNP
cord-005453-4057qib7	146	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	146	6	were	be	VBD
cord-005453-4057qib7	146	7	used	use	VBN
cord-005453-4057qib7	146	8	:	:	:
cord-005453-4057qib7	146	9	Type	type	NN
cord-005453-4057qib7	146	10	1	1	CD
cord-005453-4057qib7	146	11	(	(	-LRB-
cord-005453-4057qib7	146	12	n=35	n=35	NNP
cord-005453-4057qib7	146	13	)	)	-RRB-
cord-005453-4057qib7	146	14	:	:	:
cord-005453-4057qib7	146	15	hATG	hatg	ADD
cord-005453-4057qib7	147	1	50	50	CD
cord-005453-4057qib7	148	1	mg	mg	NNP
cord-005453-4057qib7	148	2	/	/	SYM
cord-005453-4057qib7	148	3	kg	kg	NNP
cord-005453-4057qib7	148	4	and	and	CC
cord-005453-4057qib7	148	5	post	post	JJ
cord-005453-4057qib7	148	6	-	-	JJ
cord-005453-4057qib7	148	7	HSCT	HSCT	NNP
cord-005453-4057qib7	148	8	tacro	tacro	NNP
cord-005453-4057qib7	148	9	/	/	SYM
cord-005453-4057qib7	148	10	mtx	mtx	NNP
cord-005453-4057qib7	148	11	(	(	-LRB-
cord-005453-4057qib7	148	12	n=30	n=30	NNP
cord-005453-4057qib7	148	13	)	)	-RRB-
cord-005453-4057qib7	148	14	or	or	CC
cord-005453-4057qib7	148	15	without	without	IN
cord-005453-4057qib7	148	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	148	17	(	(	-LRB-
cord-005453-4057qib7	148	18	n=5	n=5	NNP
cord-005453-4057qib7	148	19	)	)	-RRB-
cord-005453-4057qib7	148	20	;	;	.
cord-005453-4057qib7	149	1	type	type	NN
cord-005453-4057qib7	149	2	2	2	CD
cord-005453-4057qib7	150	1	(	(	-LRB-
cord-005453-4057qib7	150	2	n=24	n=24	NNP
cord-005453-4057qib7	150	3	)	)	-RRB-
cord-005453-4057qib7	151	1	:	:	:
cord-005453-4057qib7	151	2	thymoglobulin(rATG	thymoglobulin(rATG	NNP
cord-005453-4057qib7	151	3	)	)	-RRB-
cord-005453-4057qib7	151	4	5	5	CD
cord-005453-4057qib7	151	5	mg	mg	NN
cord-005453-4057qib7	152	1	/kg	/kg	NFP
cord-005453-4057qib7	152	2	,	,	,
cord-005453-4057qib7	152	3	rituximab	rituximab	VBG
cord-005453-4057qib7	152	4	200mg/	200mg/	CD
cord-005453-4057qib7	152	5	m	m	CD
cord-005453-4057qib7	152	6	2	2	CD
cord-005453-4057qib7	152	7	with	with	IN
cord-005453-4057qib7	152	8	either	either	DT
cord-005453-4057qib7	152	9	bortezomib	bortezomib	NNP
cord-005453-4057qib7	152	10	on	on	IN
cord-005453-4057qib7	152	11	days	day	NNS
cord-005453-4057qib7	152	12	+2	+2	NN
cord-005453-4057qib7	152	13	,	,	,
cord-005453-4057qib7	152	14	+5	+5	FW
cord-005453-4057qib7	152	15	(	(	-LRB-
cord-005453-4057qib7	152	16	n=21	n=21	NNP
cord-005453-4057qib7	152	17	)	)	-RRB-
cord-005453-4057qib7	152	18	or	or	CC
cord-005453-4057qib7	152	19	tacro/	tacro/	NN
cord-005453-4057qib7	152	20	mtx	mtx	NN
cord-005453-4057qib7	152	21	(	(	-LRB-
cord-005453-4057qib7	152	22	n=3	n=3	NN
cord-005453-4057qib7	152	23	)	)	-RRB-
cord-005453-4057qib7	152	24	.	.	.
cord-005453-4057qib7	153	1	aβ	aβ	NNP
cord-005453-4057qib7	153	2	T	t	NN
cord-005453-4057qib7	153	3	cell	cell	NN
cord-005453-4057qib7	153	4	depletion	depletion	NN
cord-005453-4057qib7	153	5	with	with	IN
cord-005453-4057qib7	153	6	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	153	7	was	be	VBD
cord-005453-4057qib7	153	8	used	use	VBN
cord-005453-4057qib7	153	9	in	in	IN
cord-005453-4057qib7	153	10	all	all	DT
cord-005453-4057qib7	153	11	cases	case	NNS
cord-005453-4057qib7	153	12	.	.	.
cord-005453-4057qib7	154	1	The	the	DT
cord-005453-4057qib7	154	2	median	median	JJ
cord-005453-4057qib7	154	3	dose	dose	NN
cord-005453-4057qib7	154	4	of	of	IN
cord-005453-4057qib7	154	5	CD34	CD34	NNP
cord-005453-4057qib7	154	6	+	+	CC
cord-005453-4057qib7	154	7	cells	cell	NNS
cord-005453-4057qib7	154	8	was	be	VBD
cord-005453-4057qib7	154	9	9	9	CD
cord-005453-4057qib7	154	10	x10	x10	CD
cord-005453-4057qib7	154	11	6	6	CD
cord-005453-4057qib7	154	12	/	/	SYM
cord-005453-4057qib7	154	13	kg	kg	NNS
cord-005453-4057qib7	154	14	,	,	,
cord-005453-4057qib7	154	15	aβ	aβ	NNP
cord-005453-4057qib7	154	16	T	t	NN
cord-005453-4057qib7	154	17	cells	cell	NNS
cord-005453-4057qib7	155	1	-15	-15	CD
cord-005453-4057qib7	156	1	x10	x10	NN
cord-005453-4057qib7	156	2	3	3	CD
cord-005453-4057qib7	157	1	/kg	/kg	NFP
cord-005453-4057qib7	157	2	.	.	.
cord-005453-4057qib7	158	1	Median	median	JJ
cord-005453-4057qib7	158	2	time	time	NN
cord-005453-4057qib7	158	3	of	of	IN
cord-005453-4057qib7	158	4	follow	follow	NN
cord-005453-4057qib7	158	5	-	-	HYPH
cord-005453-4057qib7	158	6	up	up	NN
cord-005453-4057qib7	158	7	for	for	IN
cord-005453-4057qib7	158	8	survivors	survivor	NNS
cord-005453-4057qib7	158	9	was	be	VBD
cord-005453-4057qib7	158	10	5,3	5,3	CD
cord-005453-4057qib7	158	11	years	year	NNS
cord-005453-4057qib7	158	12	(	(	-LRB-
cord-005453-4057qib7	158	13	range	range	NN
cord-005453-4057qib7	158	14	,	,	,
cord-005453-4057qib7	158	15	2	2	CD
cord-005453-4057qib7	158	16	,	,	,
cord-005453-4057qib7	158	17	3	3	CD
cord-005453-4057qib7	158	18	-6,5	-6,5	NN
cord-005453-4057qib7	158	19	)	)	-RRB-
cord-005453-4057qib7	158	20	.	.	.
cord-005453-4057qib7	159	1	Results	result	NNS
cord-005453-4057qib7	159	2	:	:	:
cord-005453-4057qib7	160	1	Primary	primary	JJ
cord-005453-4057qib7	160	2	engraftment	engraftment	NN
cord-005453-4057qib7	160	3	was	be	VBD
cord-005453-4057qib7	160	4	achieved	achieve	VBN
cord-005453-4057qib7	160	5	in	in	IN
cord-005453-4057qib7	160	6	100	100	CD
cord-005453-4057qib7	160	7	%	%	NN
cord-005453-4057qib7	160	8	pts	pt	NNS
cord-005453-4057qib7	160	9	.	.	.
cord-005453-4057qib7	161	1	,	,	,
cord-005453-4057qib7	161	2	the	the	DT
cord-005453-4057qib7	161	3	median	median	JJ
cord-005453-4057qib7	161	4	time	time	NN
cord-005453-4057qib7	161	5	to	to	IN
cord-005453-4057qib7	161	6	neutrophil	neutrophil	NN
cord-005453-4057qib7	161	7	and	and	CC
cord-005453-4057qib7	161	8	platelet	platelet	NN
cord-005453-4057qib7	161	9	recovery	recovery	NN
cord-005453-4057qib7	161	10	was	be	VBD
cord-005453-4057qib7	161	11	15	15	CD
cord-005453-4057qib7	161	12	and	and	CC
cord-005453-4057qib7	161	13	14	14	CD
cord-005453-4057qib7	161	14	days	day	NNS
cord-005453-4057qib7	161	15	,	,	,
cord-005453-4057qib7	161	16	respectively	respectively	RB
cord-005453-4057qib7	161	17	.	.	.
cord-005453-4057qib7	162	1	All	all	DT
cord-005453-4057qib7	162	2	evaluable	evaluable	JJ
cord-005453-4057qib7	162	3	pts	pts	NN
cord-005453-4057qib7	162	4	achieved	achieve	VBN
cord-005453-4057qib7	162	5	sustained	sustain	VBN
cord-005453-4057qib7	162	6	complete	complete	JJ
cord-005453-4057qib7	162	7	donor	donor	NN
cord-005453-4057qib7	162	8	chimerism	chimerism	NN
cord-005453-4057qib7	162	9	by	by	IN
cord-005453-4057qib7	162	10	day	day	NN
cord-005453-4057qib7	162	11	+30	+30	CD
cord-005453-4057qib7	162	12	.	.	.
cord-005453-4057qib7	163	1	Early	early	RB
cord-005453-4057qib7	163	2	(	(	-LRB-
cord-005453-4057qib7	163	3	100	100	CD
cord-005453-4057qib7	163	4	day	day	NN
cord-005453-4057qib7	163	5	)	)	-RRB-
cord-005453-4057qib7	163	6	mortality	mortality	NN
cord-005453-4057qib7	163	7	was	be	VBD
cord-005453-4057qib7	163	8	3,4	3,4	CD
cord-005453-4057qib7	163	9	%	%	NN
cord-005453-4057qib7	163	10	(	(	-LRB-
cord-005453-4057qib7	163	11	1pt	1pt	JJ
cord-005453-4057qib7	163	12	-bacterial	-bacterial	JJ
cord-005453-4057qib7	163	13	sepsis	sepsis	NN
cord-005453-4057qib7	163	14	,	,	,
cord-005453-4057qib7	163	15	1pt	1pt	JJ
cord-005453-4057qib7	163	16	-ADV	-ADV	-LRB-
cord-005453-4057qib7	163	17	fulminant	fulminant	JJ
cord-005453-4057qib7	163	18	hepatitis	hepatitis	NN
cord-005453-4057qib7	163	19	)	)	-RRB-
cord-005453-4057qib7	163	20	,	,	,
cord-005453-4057qib7	164	1	5-years	5-years	CD
cord-005453-4057qib7	164	2	overall	overall	RB
cord-005453-4057qib7	164	3	pTRM	ptrm	JJ
cord-005453-4057qib7	164	4	at	at	IN
cord-005453-4057qib7	164	5	4	4	CD
cord-005453-4057qib7	164	6	years	year	NNS
cord-005453-4057qib7	164	7	was	be	VBD
cord-005453-4057qib7	164	8	13,5	13,5	CD
cord-005453-4057qib7	164	9	%	%	NN
cord-005453-4057qib7	164	10	(	(	-LRB-
cord-005453-4057qib7	164	11	95%CI:7	95%ci:7	CD
cord-005453-4057qib7	164	12	-	-	SYM
cord-005453-4057qib7	164	13	26	26	CD
cord-005453-4057qib7	164	14	)	)	-RRB-
cord-005453-4057qib7	164	15	.	.	.
cord-005453-4057qib7	165	1	Six	six	CD
cord-005453-4057qib7	165	2	late	late	JJ
cord-005453-4057qib7	165	3	TRM	TRM	NNP
cord-005453-4057qib7	165	4	events	event	NNS
cord-005453-4057qib7	165	5	were	be	VBD
cord-005453-4057qib7	165	6	due	due	JJ
cord-005453-4057qib7	165	7	to	to	IN
cord-005453-4057qib7	165	8	:	:	:
cord-005453-4057qib7	165	9	viral	viral	JJ
cord-005453-4057qib7	165	10	infection	infection	NN
cord-005453-4057qib7	165	11	in	in	IN
cord-005453-4057qib7	165	12	2	2	CD
cord-005453-4057qib7	165	13	pts	pt	NNS
cord-005453-4057qib7	165	14	(	(	-LRB-
cord-005453-4057qib7	165	15	CMV=1	CMV=1	NNP
cord-005453-4057qib7	165	16	,	,	,
cord-005453-4057qib7	165	17	ADV+CMV=1	ADV+CMV=1	NNP
cord-005453-4057qib7	165	18	)	)	-RRB-
cord-005453-4057qib7	166	1	,	,	,
cord-005453-4057qib7	166	2	bacterial	bacterial	JJ
cord-005453-4057qib7	166	3	sepsis	sepsis	NN
cord-005453-4057qib7	166	4	in	in	IN
cord-005453-4057qib7	166	5	2	2	CD
cord-005453-4057qib7	166	6	pts	pt	NNS
cord-005453-4057qib7	166	7	and	and	CC
cord-005453-4057qib7	166	8	2	2	CD
cord-005453-4057qib7	166	9	pts	pt	NNS
cord-005453-4057qib7	166	10	had	have	VBD
cord-005453-4057qib7	166	11	bacterial	bacterial	JJ
cord-005453-4057qib7	166	12	and	and	CC
cord-005453-4057qib7	166	13	viral	viral	JJ
cord-005453-4057qib7	166	14	infection	infection	NN
cord-005453-4057qib7	166	15	,	,	,
cord-005453-4057qib7	166	16	all	all	DT
cord-005453-4057qib7	166	17	late	late	JJ
cord-005453-4057qib7	166	18	deaths	death	NNS
cord-005453-4057qib7	166	19	were	be	VBD
cord-005453-4057qib7	166	20	associated	associate	VBN
cord-005453-4057qib7	166	21	with	with	IN
cord-005453-4057qib7	166	22	cGvHD	cgvhd	NN
cord-005453-4057qib7	166	23	and	and	CC
cord-005453-4057qib7	166	24	prolonged	prolong	VBN
cord-005453-4057qib7	166	25	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	166	26	therapy	therapy	NN
cord-005453-4057qib7	166	27	.	.	.
cord-005453-4057qib7	167	1	CI	CI	NNP
cord-005453-4057qib7	167	2	of	of	IN
cord-005453-4057qib7	167	3	acute	acute	JJ
cord-005453-4057qib7	167	4	GvHD	GvHD	NNP
cord-005453-4057qib7	167	5	grades	grade	NNS
cord-005453-4057qib7	167	6	II	II	NNP
cord-005453-4057qib7	167	7	-	-	HYPH
cord-005453-4057qib7	167	8	IV	IV	NNP
cord-005453-4057qib7	167	9	was	be	VBD
cord-005453-4057qib7	167	10	36	36	CD
cord-005453-4057qib7	167	11	%	%	NN
cord-005453-4057qib7	167	12	(	(	-LRB-
cord-005453-4057qib7	167	13	95	95	CD
cord-005453-4057qib7	167	14	%	%	NN
cord-005453-4057qib7	167	15	CI	ci	NN
cord-005453-4057qib7	167	16	:	:	:
cord-005453-4057qib7	167	17	25	25	CD
cord-005453-4057qib7	167	18	-	-	SYM
cord-005453-4057qib7	167	19	50	50	CD
cord-005453-4057qib7	167	20	)	)	-RRB-
cord-005453-4057qib7	167	21	,	,	,
cord-005453-4057qib7	167	22	acute	acute	JJ
cord-005453-4057qib7	167	23	GvHD	GvHD	NNP
cord-005453-4057qib7	167	24	grades	grade	NNS
cord-005453-4057qib7	167	25	III	III	NNP
cord-005453-4057qib7	167	26	-	-	HYPH
cord-005453-4057qib7	167	27	IV	IV	NNP
cord-005453-4057qib7	167	28	3,7	3,7	CD
cord-005453-4057qib7	167	29	%	%	NN
cord-005453-4057qib7	167	30	(	(	-LRB-
cord-005453-4057qib7	167	31	95	95	CD
cord-005453-4057qib7	167	32	%	%	NN
cord-005453-4057qib7	167	33	CI	ci	NN
cord-005453-4057qib7	167	34	:	:	:
cord-005453-4057qib7	167	35	1,5	1,5	CD
cord-005453-4057qib7	167	36	-	-	HYPH
cord-005453-4057qib7	167	37	14,5	14,5	CD
cord-005453-4057qib7	167	38	)	)	-RRB-
cord-005453-4057qib7	167	39	.	.	.
cord-005453-4057qib7	168	1	CI	CI	NNP
cord-005453-4057qib7	168	2	of	of	IN
cord-005453-4057qib7	168	3	cGvHD	cGvHD	NNP
cord-005453-4057qib7	168	4	was	be	VBD
cord-005453-4057qib7	168	5	27%(95%CI:18	27%(95%ci:18	CD
cord-005453-4057qib7	168	6	-	-	SYM
cord-005453-4057qib7	168	7	41	41	CD
cord-005453-4057qib7	168	8	)	)	-RRB-
cord-005453-4057qib7	168	9	.	.	.
cord-005453-4057qib7	169	1	Regimen	regimen	NN
cord-005453-4057qib7	169	2	2	2	CD
cord-005453-4057qib7	169	3	was	be	VBD
cord-005453-4057qib7	169	4	more	more	RBR
cord-005453-4057qib7	169	5	effective	effective	JJ
cord-005453-4057qib7	169	6	in	in	IN
cord-005453-4057qib7	169	7	prevention	prevention	NN
cord-005453-4057qib7	169	8	of	of	IN
cord-005453-4057qib7	169	9	aGvHD	aGvHD	NNP
cord-005453-4057qib7	169	10	II	II	NNP
cord-005453-4057qib7	169	11	-	-	HYPH
cord-005453-4057qib7	169	12	IV	IV	NNP
cord-005453-4057qib7	169	13	in	in	IN
cord-005453-4057qib7	169	14	comparison	comparison	NN
cord-005453-4057qib7	169	15	with	with	IN
cord-005453-4057qib7	169	16	regimen	regimen	NN
cord-005453-4057qib7	169	17	1	1	CD
cord-005453-4057qib7	169	18	:	:	SYM
cord-005453-4057qib7	169	19	8	8	CD
cord-005453-4057qib7	169	20	%	%	NN
cord-005453-4057qib7	169	21	(	(	-LRB-
cord-005453-4057qib7	169	22	95	95	CD
cord-005453-4057qib7	169	23	%	%	NN
cord-005453-4057qib7	169	24	CI	ci	NN
cord-005453-4057qib7	169	25	:	:	:
cord-005453-4057qib7	169	26	2,2	2,2	CD
cord-005453-4057qib7	169	27	-	-	SYM
cord-005453-4057qib7	169	28	30	30	CD
cord-005453-4057qib7	169	29	)	)	-RRB-
cord-005453-4057qib7	169	30	vs	vs	IN
cord-005453-4057qib7	169	31	45,7	45,7	CD
cord-005453-4057qib7	169	32	%	%	NN
cord-005453-4057qib7	169	33	,	,	,
cord-005453-4057qib7	169	34	respectively	respectively	RB
cord-005453-4057qib7	169	35	,	,	,
cord-005453-4057qib7	169	36	p=0,04	p=0,04	NNP
cord-005453-4057qib7	169	37	.	.	.
cord-005453-4057qib7	170	1	All	all	DT
cord-005453-4057qib7	170	2	events	event	NNS
cord-005453-4057qib7	170	3	with	with	IN
cord-005453-4057qib7	170	4	acute	acute	JJ
cord-005453-4057qib7	170	5	GvHD	GvHD	NNP
cord-005453-4057qib7	170	6	grades	grade	NNS
cord-005453-4057qib7	170	7	III	III	NNP
cord-005453-4057qib7	170	8	-	-	HYPH
cord-005453-4057qib7	170	9	IV	IV	NNP
cord-005453-4057qib7	170	10	had	have	VBD
cord-005453-4057qib7	170	11	pts	pt	NNS
cord-005453-4057qib7	170	12	with	with	IN
cord-005453-4057qib7	170	13	regimen	regimen	NN
cord-005453-4057qib7	170	14	1	1	CD
cord-005453-4057qib7	170	15	.	.	.
cord-005453-4057qib7	171	1	rATG	rATG	NNP
cord-005453-4057qib7	171	2	was	be	VBD
cord-005453-4057qib7	171	3	also	also	RB
cord-005453-4057qib7	171	4	effective	effective	JJ
cord-005453-4057qib7	171	5	in	in	IN
cord-005453-4057qib7	171	6	prevention	prevention	NN
cord-005453-4057qib7	171	7	of	of	IN
cord-005453-4057qib7	171	8	cGvHD	cgvhd	NN
cord-005453-4057qib7	171	9	:	:	:
cord-005453-4057qib7	172	1	CI	CI	NNP
cord-005453-4057qib7	172	2	at	at	IN
cord-005453-4057qib7	172	3	4	4	CD
cord-005453-4057qib7	172	4	years	year	NNS
cord-005453-4057qib7	172	5	after	after	IN
cord-005453-4057qib7	172	6	HSCT	HSCT	NNP
cord-005453-4057qib7	172	7	was	be	VBD
cord-005453-4057qib7	172	8	12,5	12,5	CD
cord-005453-4057qib7	172	9	%	%	NN
cord-005453-4057qib7	172	10	vs.	vs.	NN
cord-005453-4057qib7	172	11	37	37	CD
cord-005453-4057qib7	172	12	%	%	NN
cord-005453-4057qib7	172	13	,	,	,
cord-005453-4057qib7	172	14	respectively	respectively	RB
cord-005453-4057qib7	172	15	,	,	,
cord-005453-4057qib7	172	16	p=0,04	p=0,04	NNP
cord-005453-4057qib7	172	17	.	.	.
cord-005453-4057qib7	173	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	173	2	incidence	incidence	NN
cord-005453-4057qib7	173	3	of	of	IN
cord-005453-4057qib7	173	4	relapse	relapse	NN
cord-005453-4057qib7	173	5	was	be	VBD
cord-005453-4057qib7	173	6	25	25	CD
cord-005453-4057qib7	173	7	%	%	NN
cord-005453-4057qib7	173	8	(	(	-LRB-
cord-005453-4057qib7	173	9	95%CI	95%ci	CD
cord-005453-4057qib7	173	10	:	:	:
cord-005453-4057qib7	173	11	14	14	CD
cord-005453-4057qib7	173	12	-	-	SYM
cord-005453-4057qib7	173	13	50	50	CD
cord-005453-4057qib7	173	14	)	)	-RRB-
cord-005453-4057qib7	173	15	without	without	IN
cord-005453-4057qib7	173	16	difference	difference	NN
cord-005453-4057qib7	173	17	between	between	IN
cord-005453-4057qib7	173	18	rATG	ratg	NN
cord-005453-4057qib7	173	19	and	and	CC
cord-005453-4057qib7	173	20	hATG	hATG	VBN
cord-005453-4057qib7	173	21	.	.	.
cord-005453-4057qib7	174	1	Event	event	NN
cord-005453-4057qib7	174	2	-	-	HYPH
cord-005453-4057qib7	174	3	free	free	JJ
cord-005453-4057qib7	174	4	survival	survival	NN
cord-005453-4057qib7	174	5	(	(	-LRB-
cord-005453-4057qib7	174	6	EFS	efs	NN
cord-005453-4057qib7	174	7	)	)	-RRB-
cord-005453-4057qib7	175	1	(	(	-LRB-
cord-005453-4057qib7	175	2	event	event	NN
cord-005453-4057qib7	175	3	=	=	SYM
cord-005453-4057qib7	175	4	death	death	NN
cord-005453-4057qib7	175	5	or	or	CC
cord-005453-4057qib7	175	6	relapse	relapse	NN
cord-005453-4057qib7	175	7	)	)	-RRB-
cord-005453-4057qib7	175	8	at	at	IN
cord-005453-4057qib7	175	9	4	4	CD
cord-005453-4057qib7	175	10	years	year	NNS
cord-005453-4057qib7	175	11	was	be	VBD
cord-005453-4057qib7	175	12	61	61	CD
cord-005453-4057qib7	175	13	%	%	NN
cord-005453-4057qib7	175	14	(	(	-LRB-
cord-005453-4057qib7	175	15	95%CI	95%ci	CD
cord-005453-4057qib7	175	16	:	:	:
cord-005453-4057qib7	175	17	48	48	CD
cord-005453-4057qib7	175	18	-	-	SYM
cord-005453-4057qib7	175	19	73	73	CD
cord-005453-4057qib7	175	20	)	)	-RRB-
cord-005453-4057qib7	175	21	,	,	,
cord-005453-4057qib7	175	22	overall	overall	JJ
cord-005453-4057qib7	175	23	survival	survival	NN
cord-005453-4057qib7	175	24	59%(95	59%(95	CD
cord-005453-4057qib7	175	25	%	%	NN
cord-005453-4057qib7	175	26	CI:47	CI:47	NNP
cord-005453-4057qib7	175	27	-	-	HYPH
cord-005453-4057qib7	175	28	72	72	NNP
cord-005453-4057qib7	175	29	)	)	-RRB-
cord-005453-4057qib7	175	30	,	,	,
cord-005453-4057qib7	175	31	there	there	EX
cord-005453-4057qib7	175	32	were	be	VBD
cord-005453-4057qib7	175	33	no	no	DT
cord-005453-4057qib7	175	34	difference	difference	NN
cord-005453-4057qib7	175	35	between	between	IN
cord-005453-4057qib7	175	36	age	age	NN
cord-005453-4057qib7	175	37	and	and	CC
cord-005453-4057qib7	175	38	diagnosis	diagnosis	NN
cord-005453-4057qib7	175	39	.	.	.
cord-005453-4057qib7	176	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	176	2	:	:	:
cord-005453-4057qib7	177	1	We	-PRON-	PRP
cord-005453-4057qib7	177	2	confirm	confirm	VBP
cord-005453-4057qib7	177	3	that	that	IN
cord-005453-4057qib7	177	4	the	the	DT
cord-005453-4057qib7	177	5	depletion	depletion	NN
cord-005453-4057qib7	177	6	of	of	IN
cord-005453-4057qib7	177	7	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	177	8	+	+	CC
cord-005453-4057qib7	178	1	/CD19	/CD19	.
cord-005453-4057qib7	179	1	+	+	CC
cord-005453-4057qib7	179	2	T	t	NN
cord-005453-4057qib7	179	3	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	179	4	from	from	IN
cord-005453-4057qib7	179	5	the	the	DT
cord-005453-4057qib7	179	6	graft	graft	NN
cord-005453-4057qib7	179	7	ensures	ensure	VBZ
cord-005453-4057qib7	179	8	high	high	JJ
cord-005453-4057qib7	179	9	engraftment	engraftment	NN
cord-005453-4057qib7	179	10	rate	rate	NN
cord-005453-4057qib7	179	11	.	.	.
cord-005453-4057qib7	180	1	Transplant	transplant	NN
cord-005453-4057qib7	180	2	-	-	HYPH
cord-005453-4057qib7	180	3	related	relate	VBN
cord-005453-4057qib7	180	4	mortality	mortality	NN
cord-005453-4057qib7	180	5	is	be	VBZ
cord-005453-4057qib7	180	6	caused	cause	VBN
cord-005453-4057qib7	180	7	by	by	IN
cord-005453-4057qib7	180	8	infections	infection	NNS
cord-005453-4057qib7	180	9	,	,	,
cord-005453-4057qib7	180	10	mostly	mostly	RB
cord-005453-4057qib7	180	11	associated	associate	VBN
cord-005453-4057qib7	180	12	with	with	IN
cord-005453-4057qib7	180	13	cases	case	NNS
cord-005453-4057qib7	180	14	of	of	IN
cord-005453-4057qib7	180	15	chronic	chronic	JJ
cord-005453-4057qib7	180	16	GVHD	GVHD	NNP
cord-005453-4057qib7	180	17	.	.	.
cord-005453-4057qib7	181	1	GvHD	GvHD	NNP
cord-005453-4057qib7	181	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	181	3	including	include	VBG
cord-005453-4057qib7	181	4	rATG	ratg	JJ
cord-005453-4057qib7	181	5	/	/	SYM
cord-005453-4057qib7	181	6	Rituximab/	Rituximab/	NNP
cord-005453-4057qib7	181	7	Bortezomib	Bortezomib	NNP
cord-005453-4057qib7	181	8	improves	improve	VBZ
cord-005453-4057qib7	181	9	GvHD	GvHD	NNP
cord-005453-4057qib7	181	10	control	control	NN
cord-005453-4057qib7	181	11	in	in	IN
cord-005453-4057qib7	181	12	recipients	recipient	NNS
cord-005453-4057qib7	181	13	of	of	IN
cord-005453-4057qib7	181	14	TCRαβ+/CD19+depleted	tcrαβ+/cd19+deplete	VBN
cord-005453-4057qib7	181	15	grafts	graft	NNS
cord-005453-4057qib7	181	16	in	in	IN
cord-005453-4057qib7	181	17	comparison	comparison	NN
cord-005453-4057qib7	181	18	to	to	IN
cord-005453-4057qib7	181	19	hATG/	hATG/	NNP
cord-005453-4057qib7	181	20	Tacro	Tacro	NNP
cord-005453-4057qib7	181	21	/	/	SYM
cord-005453-4057qib7	181	22	MTX	MTX	NNP
cord-005453-4057qib7	181	23	apparently	apparently	RB
cord-005453-4057qib7	181	24	without	without	IN
cord-005453-4057qib7	181	25	loss	loss	NN
cord-005453-4057qib7	181	26	of	of	IN
cord-005453-4057qib7	181	27	anti	anti	JJ
cord-005453-4057qib7	181	28	-	-	JJ
cord-005453-4057qib7	181	29	leukemic	leukemic	JJ
cord-005453-4057qib7	181	30	activity	activity	NN
cord-005453-4057qib7	181	31	.	.	.
cord-005453-4057qib7	182	1	Disclosure	disclosure	NN
cord-005453-4057qib7	182	2	Results	result	NNS
cord-005453-4057qib7	182	3	:	:	:
cord-005453-4057qib7	183	1	At	at	IN
cord-005453-4057qib7	183	2	baseline	baseline	NN
cord-005453-4057qib7	183	3	,	,	,
cord-005453-4057qib7	183	4	R	r	NN
cord-005453-4057qib7	183	5	/	/	SYM
cord-005453-4057qib7	183	6	R	r	NN
cord-005453-4057qib7	183	7	ALL	all	DT
cord-005453-4057qib7	183	8	with	with	IN
cord-005453-4057qib7	183	9	EMD	EMD	NNP
cord-005453-4057qib7	183	10	and	and	CC
cord-005453-4057qib7	183	11	LBL	LBL	NNP
cord-005453-4057qib7	183	12	were	be	VBD
cord-005453-4057qib7	183	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	183	14	in	in	IN
cord-005453-4057qib7	183	15	7	7	CD
cord-005453-4057qib7	183	16	and	and	CC
cord-005453-4057qib7	183	17	11	11	CD
cord-005453-4057qib7	183	18	InO	InO	NNP
cord-005453-4057qib7	183	19	patients	patient	NNS
cord-005453-4057qib7	183	20	and	and	CC
cord-005453-4057qib7	183	21	5	5	CD
cord-005453-4057qib7	183	22	and	and	CC
cord-005453-4057qib7	183	23	6	6	CD
cord-005453-4057qib7	183	24	SC	SC	NNP
cord-005453-4057qib7	183	25	patients	patient	NNS
cord-005453-4057qib7	183	26	.	.	.
cord-005453-4057qib7	184	1	Median	median	JJ
cord-005453-4057qib7	184	2	(	(	-LRB-
cord-005453-4057qib7	184	3	range	range	NN
cord-005453-4057qib7	184	4	)	)	-RRB-
cord-005453-4057qib7	184	5	age	age	NN
cord-005453-4057qib7	184	6	of	of	IN
cord-005453-4057qib7	184	7	the	the	DT
cord-005453-4057qib7	184	8	InO	InO	NNP
cord-005453-4057qib7	184	9	and	and	CC
cord-005453-4057qib7	184	10	SC	SC	NNP
cord-005453-4057qib7	184	11	patients	patient	NNS
cord-005453-4057qib7	184	12	was	be	VBD
cord-005453-4057qib7	184	13	55.5	55.5	CD
cord-005453-4057qib7	184	14	(	(	-LRB-
cord-005453-4057qib7	184	15	20	20	CD
cord-005453-4057qib7	184	16	-	-	SYM
cord-005453-4057qib7	184	17	78	78	CD
cord-005453-4057qib7	184	18	)	)	-RRB-
cord-005453-4057qib7	184	19	and	and	CC
cord-005453-4057qib7	184	20	47.0	47.0	CD
cord-005453-4057qib7	184	21	(	(	-LRB-
cord-005453-4057qib7	184	22	28	28	CD
cord-005453-4057qib7	184	23	-	-	SYM
cord-005453-4057qib7	184	24	64	64	CD
cord-005453-4057qib7	184	25	)	)	-RRB-
cord-005453-4057qib7	184	26	years	year	NNS
cord-005453-4057qib7	184	27	,	,	,
cord-005453-4057qib7	184	28	with	with	IN
cord-005453-4057qib7	184	29	8/18	8/18	CD
cord-005453-4057qib7	184	30	(	(	-LRB-
cord-005453-4057qib7	184	31	44.4	44.4	CD
cord-005453-4057qib7	184	32	%	%	NN
cord-005453-4057qib7	184	33	)	)	-RRB-
cord-005453-4057qib7	184	34	and	and	CC
cord-005453-4057qib7	184	35	8/11	8/11	CD
cord-005453-4057qib7	184	36	(	(	-LRB-
cord-005453-4057qib7	184	37	72.7	72.7	CD
cord-005453-4057qib7	184	38	%	%	NN
cord-005453-4057qib7	184	39	)	)	-RRB-
cord-005453-4057qib7	184	40	males	male	NNS
cord-005453-4057qib7	184	41	,	,	,
cord-005453-4057qib7	184	42	respectively	respectively	RB
cord-005453-4057qib7	184	43	.	.	.
cord-005453-4057qib7	185	1	The	the	DT
cord-005453-4057qib7	185	2	rate	rate	NN
cord-005453-4057qib7	185	3	of	of	IN
cord-005453-4057qib7	185	4	CR	cr	NN
cord-005453-4057qib7	185	5	/	/	SYM
cord-005453-4057qib7	185	6	CRi	CRi	NNS
cord-005453-4057qib7	185	7	was	be	VBD
cord-005453-4057qib7	185	8	significantly	significantly	RB
cord-005453-4057qib7	185	9	higher	high	JJR
cord-005453-4057qib7	185	10	in	in	IN
cord-005453-4057qib7	185	11	the	the	DT
cord-005453-4057qib7	185	12	InO	InO	NNP
cord-005453-4057qib7	185	13	group	group	NN
cord-005453-4057qib7	185	14	(	(	-LRB-
cord-005453-4057qib7	185	15	12/18	12/18	CD
cord-005453-4057qib7	185	16	[	[	-LRB-
cord-005453-4057qib7	185	17	66.7	66.7	CD
cord-005453-4057qib7	185	18	%	%	NN
cord-005453-4057qib7	185	19	]	]	-RRB-
cord-005453-4057qib7	185	20	,	,	,
cord-005453-4057qib7	185	21	95	95	CD
cord-005453-4057qib7	185	22	%	%	NN
cord-005453-4057qib7	185	23	confidence	confidence	NN
cord-005453-4057qib7	185	24	interval	interval	NN
cord-005453-4057qib7	185	25	[	[	-LRB-
cord-005453-4057qib7	185	26	CI	CI	NNP
cord-005453-4057qib7	185	27	]	]	-RRB-
cord-005453-4057qib7	185	28	:	:	:
cord-005453-4057qib7	185	29	41.0	41.0	CD
cord-005453-4057qib7	185	30	-	-	HYPH
cord-005453-4057qib7	185	31	86.7	86.7	CD
cord-005453-4057qib7	185	32	)	)	-RRB-
cord-005453-4057qib7	185	33	compared	compare	VBN
cord-005453-4057qib7	185	34	with	with	IN
cord-005453-4057qib7	185	35	SC	SC	NNP
cord-005453-4057qib7	185	36	(	(	-LRB-
cord-005453-4057qib7	185	37	2/11	2/11	CD
cord-005453-4057qib7	185	38	[	[	-LRB-
cord-005453-4057qib7	185	39	18.2	18.2	CD
cord-005453-4057qib7	185	40	%	%	NN
cord-005453-4057qib7	185	41	]	]	-RRB-
cord-005453-4057qib7	185	42	,	,	,
cord-005453-4057qib7	185	43	95	95	CD
cord-005453-4057qib7	185	44	%	%	NN
cord-005453-4057qib7	185	45	CI	ci	NN
cord-005453-4057qib7	185	46	:	:	:
cord-005453-4057qib7	185	47	2.3	2.3	CD
cord-005453-4057qib7	185	48	-	-	SYM
cord-005453-4057qib7	185	49	51.8	51.8	CD
cord-005453-4057qib7	185	50	;	;	:
cord-005453-4057qib7	185	51	P=0.0144	p=0.0144	NN
cord-005453-4057qib7	185	52	)	)	-RRB-
cord-005453-4057qib7	185	53	(	(	-LRB-
cord-005453-4057qib7	185	54	Table	table	NN
cord-005453-4057qib7	185	55	)	)	-RRB-
cord-005453-4057qib7	185	56	.	.	.
cord-005453-4057qib7	186	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	186	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	186	3	stem	stem	NN
cord-005453-4057qib7	186	4	cell	cell	NN
cord-005453-4057qib7	186	5	transplantation	transplantation	NN
cord-005453-4057qib7	186	6	was	be	VBD
cord-005453-4057qib7	186	7	carried	carry	VBN
cord-005453-4057qib7	186	8	out	out	RP
cord-005453-4057qib7	186	9	in	in	IN
cord-005453-4057qib7	186	10	6/	6/	CD
cord-005453-4057qib7	186	11	18	18	CD
cord-005453-4057qib7	186	12	(	(	-LRB-
cord-005453-4057qib7	186	13	33.3	33.3	CD
cord-005453-4057qib7	186	14	%	%	NN
cord-005453-4057qib7	186	15	)	)	-RRB-
cord-005453-4057qib7	187	1	InO	InO	NNP
cord-005453-4057qib7	187	2	and	and	CC
cord-005453-4057qib7	187	3	2/11	2/11	CD
cord-005453-4057qib7	187	4	(	(	-LRB-
cord-005453-4057qib7	187	5	18.2	18.2	CD
cord-005453-4057qib7	187	6	%	%	NN
cord-005453-4057qib7	187	7	)	)	-RRB-
cord-005453-4057qib7	188	1	SC	SC	NNP
cord-005453-4057qib7	188	2	patients	patient	NNS
cord-005453-4057qib7	188	3	prior	prior	RB
cord-005453-4057qib7	188	4	to	to	IN
cord-005453-4057qib7	188	5	any	any	DT
cord-005453-4057qib7	188	6	post	post	JJ
cord-005453-4057qib7	188	7	-	-	JJ
cord-005453-4057qib7	188	8	study	study	JJ
cord-005453-4057qib7	188	9	induction	induction	NN
cord-005453-4057qib7	188	10	therapy	therapy	NN
cord-005453-4057qib7	188	11	.	.	.
cord-005453-4057qib7	189	1	The	the	DT
cord-005453-4057qib7	189	2	PFS	PFS	NNP
cord-005453-4057qib7	189	3	hazard	hazard	NN
cord-005453-4057qib7	189	4	ratio	ratio	NN
cord-005453-4057qib7	189	5	[	[	-LRB-
cord-005453-4057qib7	189	6	HR	HR	NNP
cord-005453-4057qib7	189	7	]	]	-RRB-
cord-005453-4057qib7	189	8	was	be	VBD
cord-005453-4057qib7	189	9	0.502	0.502	CD
cord-005453-4057qib7	189	10	(	(	-LRB-
cord-005453-4057qib7	189	11	97.5	97.5	CD
cord-005453-4057qib7	189	12	%	%	NN
cord-005453-4057qib7	189	13	CI	CI	NNP
cord-005453-4057qib7	189	14	:	:	:
cord-005453-4057qib7	189	15	0.203	0.203	CD
cord-005453-4057qib7	189	16	-	-	HYPH
cord-005453-4057qib7	189	17	1.240	1.240	CD
cord-005453-4057qib7	189	18	;	;	:
cord-005453-4057qib7	189	19	P=0.0410	P=0.0410	NNP
cord-005453-4057qib7	189	20	)	)	-RRB-
cord-005453-4057qib7	189	21	,	,	,
cord-005453-4057qib7	189	22	with	with	IN
cord-005453-4057qib7	189	23	median	median	JJ
cord-005453-4057qib7	189	24	PFS	PFS	NNP
cord-005453-4057qib7	189	25	of	of	IN
cord-005453-4057qib7	189	26	4.4	4.4	CD
cord-005453-4057qib7	189	27	(	(	-LRB-
cord-005453-4057qib7	189	28	95	95	CD
cord-005453-4057qib7	189	29	%	%	NN
cord-005453-4057qib7	189	30	CI	ci	NN
cord-005453-4057qib7	189	31	:	:	:
cord-005453-4057qib7	189	32	1.9	1.9	CD
cord-005453-4057qib7	189	33	-	-	HYPH
cord-005453-4057qib7	189	34	7.1	7.1	CD
cord-005453-4057qib7	189	35	)	)	-RRB-
cord-005453-4057qib7	189	36	months	month	NNS
cord-005453-4057qib7	189	37	among	among	IN
cord-005453-4057qib7	189	38	InO	InO	NNP
cord-005453-4057qib7	189	39	and	and	CC
cord-005453-4057qib7	189	40	1.6	1.6	CD
cord-005453-4057qib7	189	41	(	(	-LRB-
cord-005453-4057qib7	189	42	95	95	CD
cord-005453-4057qib7	189	43	%	%	NN
cord-005453-4057qib7	190	1	CI	CI	NNP
cord-005453-4057qib7	190	2	:	:	:
cord-005453-4057qib7	190	3	0.8	0.8	CD
cord-005453-4057qib7	190	4	-	-	HYPH
cord-005453-4057qib7	190	5	3.7	3.7	CD
cord-005453-4057qib7	190	6	)	)	-RRB-
cord-005453-4057qib7	190	7	months	month	NNS
cord-005453-4057qib7	190	8	in	in	IN
cord-005453-4057qib7	190	9	SC	SC	NNP
cord-005453-4057qib7	190	10	patients	patient	NNS
cord-005453-4057qib7	190	11	.	.	.
cord-005453-4057qib7	191	1	The	the	DT
cord-005453-4057qib7	191	2	OS	OS	NNP
cord-005453-4057qib7	191	3	HR	HR	NNP
cord-005453-4057qib7	191	4	was	be	VBD
cord-005453-4057qib7	191	5	0.661	0.661	CD
cord-005453-4057qib7	192	1	(	(	-LRB-
cord-005453-4057qib7	192	2	97.5	97.5	CD
cord-005453-4057qib7	192	3	%	%	NN
cord-005453-4057qib7	192	4	CI	CI	NNP
cord-005453-4057qib7	192	5	:	:	:
cord-005453-4057qib7	192	6	0.269	0.269	CD
cord-005453-4057qib7	192	7	-	-	HYPH
cord-005453-4057qib7	192	8	1.621	1.621	CD
cord-005453-4057qib7	192	9	;	;	:
cord-005453-4057qib7	192	10	P=0.1478	P=0.1478	NNP
cord-005453-4057qib7	192	11	)	)	-RRB-
cord-005453-4057qib7	192	12	,	,	,
cord-005453-4057qib7	192	13	with	with	IN
cord-005453-4057qib7	192	14	median	median	JJ
cord-005453-4057qib7	192	15	OS	os	NN
cord-005453-4057qib7	192	16	of	of	IN
cord-005453-4057qib7	192	17	5.9	5.9	CD
cord-005453-4057qib7	192	18	(	(	-LRB-
cord-005453-4057qib7	192	19	95	95	CD
cord-005453-4057qib7	192	20	%	%	NN
cord-005453-4057qib7	192	21	CI	ci	NN
cord-005453-4057qib7	192	22	:	:	:
cord-005453-4057qib7	192	23	3.4	3.4	CD
cord-005453-4057qib7	192	24	-	-	SYM
cord-005453-4057qib7	192	25	9.4	9.4	CD
cord-005453-4057qib7	192	26	)	)	-RRB-
cord-005453-4057qib7	192	27	months	month	NNS
cord-005453-4057qib7	192	28	in	in	IN
cord-005453-4057qib7	192	29	InO	InO	NNP
cord-005453-4057qib7	192	30	versus	versus	IN
cord-005453-4057qib7	192	31	5.5	5.5	CD
cord-005453-4057qib7	192	32	(	(	-LRB-
cord-005453-4057qib7	192	33	95	95	CD
cord-005453-4057qib7	192	34	%	%	NN
cord-005453-4057qib7	192	35	CI	ci	NN
cord-005453-4057qib7	192	36	:	:	:
cord-005453-4057qib7	192	37	2.1	2.1	CD
cord-005453-4057qib7	192	38	-	-	SYM
cord-005453-4057qib7	192	39	6.7	6.7	CD
cord-005453-4057qib7	192	40	)	)	-RRB-
cord-005453-4057qib7	192	41	months	month	NNS
cord-005453-4057qib7	192	42	in	in	IN
cord-005453-4057qib7	192	43	SC	SC	NNP
cord-005453-4057qib7	192	44	patients	patient	NNS
cord-005453-4057qib7	192	45	(	(	-LRB-
cord-005453-4057qib7	192	46	Figure	figure	NN
cord-005453-4057qib7	192	47	)	)	-RRB-
cord-005453-4057qib7	192	48	.	.	.
cord-005453-4057qib7	193	1	All	all	DT
cord-005453-4057qib7	193	2	patients	patient	NNS
cord-005453-4057qib7	193	3	had	have	VBD
cord-005453-4057qib7	193	4	adverse	adverse	JJ
cord-005453-4057qib7	193	5	events	event	NNS
cord-005453-4057qib7	193	6	(	(	-LRB-
cord-005453-4057qib7	193	7	AEs	AEs	NNP
cord-005453-4057qib7	193	8	)	)	-RRB-
cord-005453-4057qib7	193	9	.	.	.
cord-005453-4057qib7	194	1	Serious	serious	JJ
cord-005453-4057qib7	194	2	AEs	AEs	NNPS
cord-005453-4057qib7	194	3	occurred	occur	VBD
cord-005453-4057qib7	194	4	in	in	IN
cord-005453-4057qib7	194	5	10/18	10/18	CD
cord-005453-4057qib7	194	6	(	(	-LRB-
cord-005453-4057qib7	194	7	55.6	55.6	CD
cord-005453-4057qib7	194	8	%	%	NN
cord-005453-4057qib7	194	9	)	)	-RRB-
cord-005453-4057qib7	195	1	InO	InO	NNP
cord-005453-4057qib7	195	2	and	and	CC
cord-005453-4057qib7	195	3	5/11	5/11	CD
cord-005453-4057qib7	195	4	(	(	-LRB-
cord-005453-4057qib7	195	5	45.5	45.5	CD
cord-005453-4057qib7	195	6	%	%	NN
cord-005453-4057qib7	195	7	)	)	-RRB-
cord-005453-4057qib7	196	1	SC	SC	NNP
cord-005453-4057qib7	196	2	patients	patient	NNS
cord-005453-4057qib7	196	3	;	;	:
cord-005453-4057qib7	196	4	4	4	CD
cord-005453-4057qib7	196	5	(	(	-LRB-
cord-005453-4057qib7	196	6	22.2	22.2	CD
cord-005453-4057qib7	196	7	%	%	NN
cord-005453-4057qib7	196	8	)	)	-RRB-
cord-005453-4057qib7	196	9	InO	ino	NN
cord-005453-4057qib7	196	10	and	and	CC
cord-005453-4057qib7	196	11	0	0	CD
cord-005453-4057qib7	196	12	SC	SC	NNP
cord-005453-4057qib7	196	13	patients	patient	NNS
cord-005453-4057qib7	196	14	had	have	VBD
cord-005453-4057qib7	196	15	grade	grade	NN
cord-005453-4057qib7	196	16	5	5	CD
cord-005453-4057qib7	196	17	AE	AE	NNP
cord-005453-4057qib7	196	18	.	.	.
cord-005453-4057qib7	197	1	One	one	CD
cord-005453-4057qib7	197	2	(	(	-LRB-
cord-005453-4057qib7	197	3	1/15	1/15	CD
cord-005453-4057qib7	197	4	,	,	,
cord-005453-4057qib7	197	5	6	6	CD
cord-005453-4057qib7	197	6	.7	.7	CD
cord-005453-4057qib7	197	7	%	%	NN
cord-005453-4057qib7	197	8	)	)	-RRB-
cord-005453-4057qib7	198	1	patient	patient	JJ
cord-005453-4057qib7	198	2	in	in	IN
cord-005453-4057qib7	198	3	the	the	DT
cord-005453-4057qib7	198	4	InO	InO	NNP
cord-005453-4057qib7	198	5	group	group	NN
cord-005453-4057qib7	198	6	died	die	VBD
cord-005453-4057qib7	198	7	from	from	IN
cord-005453-4057qib7	198	8	veno	veno	NNP
cord-005453-4057qib7	198	9	occlusive	occlusive	JJ
cord-005453-4057qib7	198	10	disease	disease	NN
cord-005453-4057qib7	198	11	.	.	.
cord-005453-4057qib7	199	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	199	2	:	:	:
cord-005453-4057qib7	200	1	Among	among	IN
cord-005453-4057qib7	201	1	R	r	NN
cord-005453-4057qib7	201	2	/	/	SYM
cord-005453-4057qib7	201	3	R	r	NN
cord-005453-4057qib7	201	4	ALL	all	DT
cord-005453-4057qib7	201	5	patients	patient	NNS
cord-005453-4057qib7	201	6	with	with	IN
cord-005453-4057qib7	201	7	EMD	EMD	NNP
cord-005453-4057qib7	201	8	and	and	CC
cord-005453-4057qib7	201	9	LBL	LBL	NNP
cord-005453-4057qib7	201	10	,	,	,
cord-005453-4057qib7	201	11	improvement	improvement	NN
cord-005453-4057qib7	201	12	in	in	IN
cord-005453-4057qib7	201	13	remission	remission	NN
cord-005453-4057qib7	201	14	rates	rate	NNS
cord-005453-4057qib7	201	15	,	,	,
cord-005453-4057qib7	201	16	transplant	transplant	NN
cord-005453-4057qib7	201	17	rates	rate	NNS
cord-005453-4057qib7	201	18	,	,	,
cord-005453-4057qib7	201	19	and	and	CC
cord-005453-4057qib7	201	20	progression	progression	NN
cord-005453-4057qib7	201	21	free	free	JJ
cord-005453-4057qib7	201	22	survival	survival	NN
cord-005453-4057qib7	201	23	was	be	VBD
cord-005453-4057qib7	201	24	shown	show	VBN
cord-005453-4057qib7	201	25	in	in	IN
cord-005453-4057qib7	201	26	the	the	DT
cord-005453-4057qib7	201	27	InO	InO	NNP
cord-005453-4057qib7	201	28	group	group	NNP
cord-005453-4057qib7	201	29	versus	versus	IN
cord-005453-4057qib7	201	30	the	the	DT
cord-005453-4057qib7	201	31	SC	SC	NNP
cord-005453-4057qib7	201	32	group	group	NN
cord-005453-4057qib7	201	33	.	.	.
cord-005453-4057qib7	202	1	Although	although	IN
cord-005453-4057qib7	202	2	patient	patient	JJ
cord-005453-4057qib7	202	3	numbers	number	NNS
cord-005453-4057qib7	202	4	were	be	VBD
cord-005453-4057qib7	202	5	small	small	JJ
cord-005453-4057qib7	202	6	and	and	CC
cord-005453-4057qib7	202	7	limited	limit	VBD
cord-005453-4057qib7	202	8	the	the	DT
cord-005453-4057qib7	202	9	ability	ability	NN
cord-005453-4057qib7	202	10	for	for	IN
cord-005453-4057qib7	202	11	a	a	DT
cord-005453-4057qib7	202	12	robust	robust	JJ
cord-005453-4057qib7	202	13	comparison	comparison	NN
cord-005453-4057qib7	202	14	,	,	,
cord-005453-4057qib7	202	15	these	these	DT
cord-005453-4057qib7	202	16	results	result	NNS
cord-005453-4057qib7	202	17	support	support	VBP
cord-005453-4057qib7	202	18	the	the	DT
cord-005453-4057qib7	202	19	use	use	NN
cord-005453-4057qib7	202	20	of	of	IN
cord-005453-4057qib7	202	21	InO	ino	NN
cord-005453-4057qib7	202	22	in	in	IN
cord-005453-4057qib7	202	23	patients	patient	NNS
cord-005453-4057qib7	202	24	in	in	IN
cord-005453-4057qib7	202	25	this	this	DT
cord-005453-4057qib7	202	26	difficult	difficult	JJ
cord-005453-4057qib7	202	27	to	to	TO
cord-005453-4057qib7	202	28	treat	treat	VB
cord-005453-4057qib7	202	29	population	population	NN
cord-005453-4057qib7	202	30	with	with	IN
cord-005453-4057qib7	202	31	R	r	NN
cord-005453-4057qib7	202	32	/	/	SYM
cord-005453-4057qib7	202	33	R	r	NN
cord-005453-4057qib7	202	34	ALL	ALL	NNP
cord-005453-4057qib7	202	35	and	and	CC
cord-005453-4057qib7	202	36	EMD	EMD	NNP
cord-005453-4057qib7	202	37	or	or	CC
cord-005453-4057qib7	202	38	LBL	LBL	NNP
cord-005453-4057qib7	202	39	.	.	.
cord-005453-4057qib7	203	1	Background	background	NN
cord-005453-4057qib7	203	2	:	:	:
cord-005453-4057qib7	203	3	BCR	BCR	NNP
cord-005453-4057qib7	203	4	-	-	HYPH
cord-005453-4057qib7	203	5	ABL	ABL	NNP
cord-005453-4057qib7	203	6	-	-	HYPH
cord-005453-4057qib7	203	7	targeted	target	VBN
cord-005453-4057qib7	203	8	tyrosine	tyrosine	NN
cord-005453-4057qib7	203	9	kinase	kinase	NN
cord-005453-4057qib7	203	10	inhibitors	inhibitor	NNS
cord-005453-4057qib7	203	11	(	(	-LRB-
cord-005453-4057qib7	203	12	TKI	TKI	NNP
cord-005453-4057qib7	203	13	)	)	-RRB-
cord-005453-4057qib7	203	14	revolutionized	revolutionize	VBD
cord-005453-4057qib7	203	15	the	the	DT
cord-005453-4057qib7	203	16	outcome	outcome	NN
cord-005453-4057qib7	203	17	of	of	IN
cord-005453-4057qib7	203	18	patients	patient	NNS
cord-005453-4057qib7	203	19	inflicted	inflict	VBN
cord-005453-4057qib7	203	20	with	with	IN
cord-005453-4057qib7	203	21	Ph+	Ph+	NNP
cord-005453-4057qib7	203	22	B	b	NN
cord-005453-4057qib7	203	23	-	-	,
cord-005453-4057qib7	203	24	ALL	all	DT
cord-005453-4057qib7	203	25	.	.	.
cord-005453-4057qib7	204	1	Moreover	moreover	RB
cord-005453-4057qib7	204	2	,	,	,
cord-005453-4057qib7	204	3	addition	addition	NN
cord-005453-4057qib7	204	4	of	of	IN
cord-005453-4057qib7	204	5	TKI	TKI	NNP
cord-005453-4057qib7	204	6	may	may	MD
cord-005453-4057qib7	204	7	be	be	VB
cord-005453-4057qib7	204	8	relevant	relevant	JJ
cord-005453-4057qib7	204	9	strategy	strategy	NN
cord-005453-4057qib7	204	10	for	for	IN
cord-005453-4057qib7	204	11	Ph	Ph	NNP
cord-005453-4057qib7	204	12	-	-	NNP
cord-005453-4057qib7	204	13	like	like	IN
cord-005453-4057qib7	204	14	ALL	all	DT
cord-005453-4057qib7	204	15	patients	patient	NNS
cord-005453-4057qib7	204	16	.	.	.
cord-005453-4057qib7	205	1	Methods	method	NNS
cord-005453-4057qib7	205	2	:	:	:
cord-005453-4057qib7	205	3	We	-PRON-	PRP
cord-005453-4057qib7	205	4	hypothesized	hypothesize	VBD
cord-005453-4057qib7	205	5	that	that	IN
cord-005453-4057qib7	205	6	overcoming	overcome	VBG
cord-005453-4057qib7	205	7	the	the	DT
cord-005453-4057qib7	205	8	BM	BM	NNP
cord-005453-4057qib7	205	9	microenvironment	microenvironment	NN
cord-005453-4057qib7	205	10	-	-	HYPH
cord-005453-4057qib7	205	11	mediated	mediate	VBN
cord-005453-4057qib7	205	12	protection	protection	NN
cord-005453-4057qib7	205	13	of	of	IN
cord-005453-4057qib7	205	14	ALL	all	DT
cord-005453-4057qib7	205	15	cells	cell	NNS
cord-005453-4057qib7	205	16	from	from	IN
cord-005453-4057qib7	205	17	TKI	TKI	NNP
cord-005453-4057qib7	205	18	-	-	HYPH
cord-005453-4057qib7	205	19	mediated	mediate	VBN
cord-005453-4057qib7	205	20	apoptosis	apoptosis	NN
cord-005453-4057qib7	205	21	may	may	MD
cord-005453-4057qib7	205	22	further	further	RB
cord-005453-4057qib7	205	23	enhance	enhance	VB
cord-005453-4057qib7	205	24	the	the	DT
cord-005453-4057qib7	205	25	responsiveness	responsiveness	NN
cord-005453-4057qib7	205	26	to	to	IN
cord-005453-4057qib7	205	27	TKI	TKI	NNP
cord-005453-4057qib7	205	28	therapy	therapy	NN
cord-005453-4057qib7	205	29	.	.	.
cord-005453-4057qib7	206	1	Results	result	NNS
cord-005453-4057qib7	206	2	:	:	:
cord-005453-4057qib7	207	1	In	in	IN
cord-005453-4057qib7	207	2	vitro	vitro	FW
cord-005453-4057qib7	207	3	treatment	treatment	NN
cord-005453-4057qib7	207	4	of	of	IN
cord-005453-4057qib7	207	5	BCR	BCR	NNP
cord-005453-4057qib7	207	6	-	-	HYPH
cord-005453-4057qib7	207	7	ABL	ABL	NNP
cord-005453-4057qib7	207	8	-	-	HYPH
cord-005453-4057qib7	207	9	positive	positive	JJ
cord-005453-4057qib7	207	10	ALL	all	DT
cord-005453-4057qib7	207	11	cell	cell	NN
cord-005453-4057qib7	207	12	lines	line	NNS
cord-005453-4057qib7	207	13	NALM1	NALM1	NNP
cord-005453-4057qib7	207	14	and	and	CC
cord-005453-4057qib7	207	15	NALM20	NALM20	NNP
cord-005453-4057qib7	207	16	)	)	-RRB-
cord-005453-4057qib7	207	17	with	with	IN
cord-005453-4057qib7	207	18	dasatinib	dasatinib	NNP
cord-005453-4057qib7	207	19	resulted	result	VBD
cord-005453-4057qib7	207	20	in	in	IN
cord-005453-4057qib7	207	21	significant	significant	JJ
cord-005453-4057qib7	207	22	dose	dose	NN
cord-005453-4057qib7	207	23	-	-	HYPH
cord-005453-4057qib7	207	24	dependent	dependent	JJ
cord-005453-4057qib7	207	25	cell	cell	NN
cord-005453-4057qib7	207	26	growth	growth	NN
cord-005453-4057qib7	207	27	inhibition	inhibition	NN
cord-005453-4057qib7	207	28	,	,	,
cord-005453-4057qib7	207	29	with	with	IN
cord-005453-4057qib7	207	30	IC50	IC50	NNP
cord-005453-4057qib7	207	31	of	of	IN
cord-005453-4057qib7	207	32	10	10	CD
cord-005453-4057qib7	207	33	-	-	SYM
cord-005453-4057qib7	207	34	15	15	CD
cord-005453-4057qib7	207	35	nM	nm	NN
cord-005453-4057qib7	207	36	(	(	-LRB-
cord-005453-4057qib7	207	37	p	p	NN
cord-005453-4057qib7	207	38	<	<	XX
cord-005453-4057qib7	207	39	0.01	0.01	CD
cord-005453-4057qib7	207	40	)	)	-RRB-
cord-005453-4057qib7	207	41	.	.	.
cord-005453-4057qib7	208	1	Furthermore	furthermore	RB
cord-005453-4057qib7	208	2	,	,	,
cord-005453-4057qib7	208	3	dasatinib	dasatinib	NNP
cord-005453-4057qib7	208	4	exhibited	exhibit	VBD
cord-005453-4057qib7	208	5	significant	significant	JJ
cord-005453-4057qib7	208	6	growth	growth	NN
cord-005453-4057qib7	208	7	suppression	suppression	NN
cord-005453-4057qib7	208	8	of	of	IN
cord-005453-4057qib7	208	9	BCR	BCR	NNP
cord-005453-4057qib7	208	10	-	-	HYPH
cord-005453-4057qib7	208	11	ABL	ABL	NNP
cord-005453-4057qib7	208	12	-negative	-negative	NN
cord-005453-4057qib7	209	1	ALL	all	DT
cord-005453-4057qib7	209	2	cells	cell	NNS
cord-005453-4057qib7	209	3	(	(	-LRB-
cord-005453-4057qib7	209	4	NALM6	nalm6	XX
cord-005453-4057qib7	209	5	and	and	CC
cord-005453-4057qib7	209	6	REH	REH	NNP
cord-005453-4057qib7	209	7	)	)	-RRB-
cord-005453-4057qib7	209	8	,	,	,
cord-005453-4057qib7	209	9	with	with	IN
cord-005453-4057qib7	209	10	IC50	IC50	NNP
cord-005453-4057qib7	209	11	of	of	IN
cord-005453-4057qib7	209	12	250	250	CD
cord-005453-4057qib7	209	13	nM	nm	NN
cord-005453-4057qib7	209	14	and	and	CC
cord-005453-4057qib7	209	15	185	185	CD
cord-005453-4057qib7	209	16	nM	nm	NN
cord-005453-4057qib7	209	17	,	,	,
cord-005453-4057qib7	209	18	respectively	respectively	RB
cord-005453-4057qib7	209	19	.	.	.
cord-005453-4057qib7	210	1	However	however	RB
cord-005453-4057qib7	210	2	,	,	,
cord-005453-4057qib7	210	3	when	when	WRB
cord-005453-4057qib7	210	4	cocultured	coculture	VBN
cord-005453-4057qib7	210	5	with	with	IN
cord-005453-4057qib7	210	6	bone	bone	NN
cord-005453-4057qib7	210	7	marrow	marrow	NN
cord-005453-4057qib7	210	8	stromal	stromal	NN
cord-005453-4057qib7	210	9	cells	cell	NNS
cord-005453-4057qib7	210	10	(	(	-LRB-
cord-005453-4057qib7	210	11	BMSCs	bmsc	NNS
cord-005453-4057qib7	210	12	)	)	-RRB-
cord-005453-4057qib7	210	13	,	,	,
cord-005453-4057qib7	210	14	dasatinib	dasatinib	NN
cord-005453-4057qib7	210	15	-	-	HYPH
cord-005453-4057qib7	210	16	mediated	mediate	VBN
cord-005453-4057qib7	210	17	effect	effect	NN
cord-005453-4057qib7	210	18	was	be	VBD
cord-005453-4057qib7	210	19	abrogated	abrogate	VBN
cord-005453-4057qib7	210	20	in	in	IN
cord-005453-4057qib7	210	21	both	both	DT
cord-005453-4057qib7	210	22	Ph	Ph	NNP
cord-005453-4057qib7	210	23	-	-	:
cord-005453-4057qib7	210	24	and	and	CC
cord-005453-4057qib7	210	25	Ph+	Ph+	NNP
cord-005453-4057qib7	210	26	ALL	all	DT
cord-005453-4057qib7	210	27	cells	cell	NNS
cord-005453-4057qib7	210	28	.	.	.
cord-005453-4057qib7	211	1	Furthermore	furthermore	RB
cord-005453-4057qib7	211	2	,	,	,
cord-005453-4057qib7	211	3	dasatinib	dasatinib	JJ
cord-005453-4057qib7	211	4	treatment	treatment	NN
cord-005453-4057qib7	211	5	promoted	promote	VBD
cord-005453-4057qib7	211	6	significant	significant	JJ
cord-005453-4057qib7	211	7	upregulation	upregulation	NN
cord-005453-4057qib7	211	8	of	of	IN
cord-005453-4057qib7	211	9	chemokine	chemokine	NN
cord-005453-4057qib7	211	10	receptor	receptor	NN
cord-005453-4057qib7	211	11	CXCR4	CXCR4	NNP
cord-005453-4057qib7	211	12	,	,	,
cord-005453-4057qib7	211	13	on	on	IN
cord-005453-4057qib7	211	14	both	both	CC
cord-005453-4057qib7	211	15	mRNA	mrna	NN
cord-005453-4057qib7	211	16	and	and	CC
cord-005453-4057qib7	211	17	cell	cell	NN
cord-005453-4057qib7	211	18	surface	surface	NN
cord-005453-4057qib7	211	19	levels	level	NNS
cord-005453-4057qib7	211	20	.	.	.
cord-005453-4057qib7	212	1	Elevated	elevated	JJ
cord-005453-4057qib7	212	2	CXCR4	cxcr4	NN
cord-005453-4057qib7	212	3	expression	expression	NN
cord-005453-4057qib7	212	4	was	be	VBD
cord-005453-4057qib7	212	5	accompanied	accompany	VBN
cord-005453-4057qib7	212	6	by	by	IN
cord-005453-4057qib7	212	7	increased	increase	VBN
cord-005453-4057qib7	212	8	responsiveness	responsiveness	NN
cord-005453-4057qib7	212	9	of	of	IN
cord-005453-4057qib7	212	10	ALL	all	DT
cord-005453-4057qib7	212	11	cells	cell	NNS
cord-005453-4057qib7	212	12	to	to	IN
cord-005453-4057qib7	212	13	CXCL12	CXCL12	VBG
cord-005453-4057qib7	212	14	stimulation	stimulation	NN
cord-005453-4057qib7	212	15	,	,	,
cord-005453-4057qib7	212	16	resulting	result	VBG
cord-005453-4057qib7	212	17	in	in	IN
cord-005453-4057qib7	212	18	strong	strong	JJ
cord-005453-4057qib7	212	19	and	and	CC
cord-005453-4057qib7	212	20	sustained	sustained	JJ
cord-005453-4057qib7	212	21	phosphorylation	phosphorylation	NN
cord-005453-4057qib7	212	22	of	of	IN
cord-005453-4057qib7	212	23	Erk1/2	Erk1/2	NNP
cord-005453-4057qib7	212	24	and	and	CC
cord-005453-4057qib7	212	25	Akt	Akt	NNP
cord-005453-4057qib7	212	26	and	and	CC
cord-005453-4057qib7	212	27	increased	increase	VBD
cord-005453-4057qib7	212	28	adhesion	adhesion	NN
cord-005453-4057qib7	212	29	capacity	capacity	NN
cord-005453-4057qib7	212	30	to	to	IN
cord-005453-4057qib7	212	31	BMSCs	bmscs	VB
cord-005453-4057qib7	212	32	.	.	.
cord-005453-4057qib7	213	1	Therefore	therefore	RB
cord-005453-4057qib7	213	2	,	,	,
cord-005453-4057qib7	213	3	dasatinib	dasatinib	NN
cord-005453-4057qib7	213	4	-	-	HYPH
cord-005453-4057qib7	213	5	induced	induce	VBN
cord-005453-4057qib7	213	6	upregulation	upregulation	NN
cord-005453-4057qib7	213	7	of	of	IN
cord-005453-4057qib7	213	8	CXCR4	cxcr4	NN
cord-005453-4057qib7	213	9	promotes	promote	VBZ
cord-005453-4057qib7	213	10	stroma	stroma	NN
cord-005453-4057qib7	213	11	-	-	HYPH
cord-005453-4057qib7	213	12	mediated	mediate	VBN
cord-005453-4057qib7	213	13	survival	survival	NN
cord-005453-4057qib7	213	14	advantage	advantage	NN
cord-005453-4057qib7	213	15	of	of	IN
cord-005453-4057qib7	213	16	ALL	all	DT
cord-005453-4057qib7	213	17	cells	cell	NNS
cord-005453-4057qib7	213	18	upon	upon	IN
cord-005453-4057qib7	213	19	TKI	TKI	NNP
cord-005453-4057qib7	213	20	therapy	therapy	NN
cord-005453-4057qib7	213	21	.	.	.
cord-005453-4057qib7	214	1	Next	next	RB
cord-005453-4057qib7	214	2	,	,	,
cord-005453-4057qib7	214	3	in	in	IN
cord-005453-4057qib7	214	4	order	order	NN
cord-005453-4057qib7	214	5	to	to	TO
cord-005453-4057qib7	214	6	overcome	overcome	VB
cord-005453-4057qib7	214	7	the	the	DT
cord-005453-4057qib7	214	8	CXCR4-mediated	CXCR4-mediated	NNP
cord-005453-4057qib7	214	9	stromal	stromal	JJ
cord-005453-4057qib7	214	10	protection	protection	NN
cord-005453-4057qib7	214	11	,	,	,
cord-005453-4057qib7	214	12	we	-PRON-	PRP
cord-005453-4057qib7	214	13	choose	choose	VBP
cord-005453-4057qib7	214	14	to	to	TO
cord-005453-4057qib7	214	15	combine	combine	VB
cord-005453-4057qib7	214	16	dasatinib	dasatinib	NN
cord-005453-4057qib7	214	17	with	with	IN
cord-005453-4057qib7	214	18	the	the	DT
cord-005453-4057qib7	214	19	histone	histone	NN
cord-005453-4057qib7	214	20	deacetylase	deacetylase	NN
cord-005453-4057qib7	214	21	inhibitor	inhibitor	NN
cord-005453-4057qib7	214	22	panobinostat	panobinostat	NNP
cord-005453-4057qib7	214	23	,	,	,
cord-005453-4057qib7	214	24	for	for	IN
cord-005453-4057qib7	214	25	its	-PRON-	PRP$
cord-005453-4057qib7	214	26	known	know	VBN
cord-005453-4057qib7	214	27	ability	ability	NN
cord-005453-4057qib7	214	28	to	to	TO
cord-005453-4057qib7	214	29	deplete	deplete	VB
cord-005453-4057qib7	214	30	CXCR4	CXCR4	NNS
cord-005453-4057qib7	214	31	in	in	IN
cord-005453-4057qib7	214	32	AML	AML	NNP
cord-005453-4057qib7	214	33	cells	cell	NNS
cord-005453-4057qib7	214	34	.	.	.
cord-005453-4057qib7	215	1	Single	single	JJ
cord-005453-4057qib7	215	2	-	-	HYPH
cord-005453-4057qib7	215	3	agent	agent	NN
cord-005453-4057qib7	215	4	treatment	treatment	NN
cord-005453-4057qib7	215	5	with	with	IN
cord-005453-4057qib7	215	6	panobinostat	panobinostat	NNP
cord-005453-4057qib7	215	7	demonstrated	demonstrate	VBD
cord-005453-4057qib7	215	8	significant	significant	JJ
cord-005453-4057qib7	215	9	inhibition	inhibition	NN
cord-005453-4057qib7	215	10	of	of	IN
cord-005453-4057qib7	215	11	Ph	Ph	NNP
cord-005453-4057qib7	215	12	-	-	:
cord-005453-4057qib7	215	13	and	and	CC
cord-005453-4057qib7	215	14	Ph+	Ph+	NNP
cord-005453-4057qib7	215	15	ALL	all	DT
cord-005453-4057qib7	215	16	cell	cell	NN
cord-005453-4057qib7	215	17	growth	growth	NN
cord-005453-4057qib7	215	18	at	at	IN
cord-005453-4057qib7	215	19	low	low	JJ
cord-005453-4057qib7	215	20	nanomolar	nanomolar	NNP
cord-005453-4057qib7	215	21	concentrations	concentration	NNS
cord-005453-4057qib7	215	22	(	(	-LRB-
cord-005453-4057qib7	215	23	p	p	NN
cord-005453-4057qib7	215	24	<	<	XX
cord-005453-4057qib7	215	25	0.01	0.01	CD
cord-005453-4057qib7	215	26	)	)	-RRB-
cord-005453-4057qib7	215	27	.	.	.
cord-005453-4057qib7	216	1	Importantly	importantly	RB
cord-005453-4057qib7	216	2	,	,	,
cord-005453-4057qib7	216	3	combination	combination	NN
cord-005453-4057qib7	216	4	of	of	IN
cord-005453-4057qib7	216	5	panobinostat	panobinostat	NN
cord-005453-4057qib7	216	6	with	with	IN
cord-005453-4057qib7	216	7	dasatinib	dasatinib	NNP
cord-005453-4057qib7	216	8	synergized	synergize	VBN
cord-005453-4057qib7	216	9	(	(	-LRB-
cord-005453-4057qib7	216	10	CI	CI	NNP
cord-005453-4057qib7	216	11	<	<	XX
cord-005453-4057qib7	216	12	0.5	0.5	CD
cord-005453-4057qib7	216	13	)	)	-RRB-
cord-005453-4057qib7	216	14	,	,	,
cord-005453-4057qib7	216	15	effectively	effectively	RB
cord-005453-4057qib7	216	16	overcoming	overcome	VBG
cord-005453-4057qib7	216	17	the	the	DT
cord-005453-4057qib7	216	18	protection	protection	NN
cord-005453-4057qib7	216	19	provided	provide	VBN
cord-005453-4057qib7	216	20	by	by	IN
cord-005453-4057qib7	216	21	BMSCs	bmsc	NNS
cord-005453-4057qib7	216	22	and	and	CC
cord-005453-4057qib7	216	23	inducing	induce	VBG
cord-005453-4057qib7	216	24	the	the	DT
cord-005453-4057qib7	216	25	apoptosis	apoptosis	NN
cord-005453-4057qib7	216	26	of	of	IN
cord-005453-4057qib7	216	27	Ph	Ph	NNP
cord-005453-4057qib7	216	28	-	-	:
cord-005453-4057qib7	216	29	and	and	CC
cord-005453-4057qib7	216	30	Ph+	Ph+	NNP
cord-005453-4057qib7	216	31	ALL	all	DT
cord-005453-4057qib7	216	32	cells	cell	NNS
cord-005453-4057qib7	216	33	,	,	,
cord-005453-4057qib7	216	34	as	as	IN
cord-005453-4057qib7	216	35	demonstrated	demonstrate	VBN
cord-005453-4057qib7	216	36	by	by	IN
cord-005453-4057qib7	216	37	phosphatidylserine	phosphatidylserine	NN
cord-005453-4057qib7	216	38	externalization	externalization	NN
cord-005453-4057qib7	216	39	,	,	,
cord-005453-4057qib7	216	40	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	216	41	depolarization	depolarization	NN
cord-005453-4057qib7	216	42	and	and	CC
cord-005453-4057qib7	216	43	DNA	dna	NN
cord-005453-4057qib7	216	44	fragmentation	fragmentation	NN
cord-005453-4057qib7	216	45	.	.	.
cord-005453-4057qib7	217	1	Furthermore	furthermore	RB
cord-005453-4057qib7	217	2	,	,	,
cord-005453-4057qib7	217	3	combining	combine	VBG
cord-005453-4057qib7	217	4	panobinostat	panobinostat	NNP
cord-005453-4057qib7	217	5	with	with	IN
cord-005453-4057qib7	217	6	dasatinib	dasatinib	NNP
cord-005453-4057qib7	217	7	significantly	significantly	RB
cord-005453-4057qib7	217	8	reduced	reduce	VBD
cord-005453-4057qib7	217	9	CXCR4	cxcr4	NN
cord-005453-4057qib7	217	10	surface	surface	NN
cord-005453-4057qib7	217	11	levels	level	NNS
cord-005453-4057qib7	217	12	in	in	IN
cord-005453-4057qib7	217	13	Ph	Ph	NNP
cord-005453-4057qib7	217	14	-	-	:
cord-005453-4057qib7	217	15	and	and	CC
cord-005453-4057qib7	217	16	Ph+	Ph+	NNP
cord-005453-4057qib7	217	17	ALL	all	DT
cord-005453-4057qib7	217	18	cells	cell	NNS
cord-005453-4057qib7	217	19	.	.	.
cord-005453-4057qib7	218	1	Accordingly	accordingly	RB
cord-005453-4057qib7	218	2	,	,	,
cord-005453-4057qib7	218	3	CXCL12mediated	cxcl12mediated	JJ
cord-005453-4057qib7	218	4	responses	response	NNS
cord-005453-4057qib7	218	5	,	,	,
cord-005453-4057qib7	218	6	including	include	VBG
cord-005453-4057qib7	218	7	Erk1/2	Erk1/2	NNP
cord-005453-4057qib7	218	8	and	and	CC
cord-005453-4057qib7	218	9	Akt	Akt	NNP
cord-005453-4057qib7	218	10	activation	activation	NN
cord-005453-4057qib7	218	11	and	and	CC
cord-005453-4057qib7	218	12	adhesion	adhesion	NN
cord-005453-4057qib7	218	13	to	to	IN
cord-005453-4057qib7	218	14	BMSCs	bmsc	NNS
cord-005453-4057qib7	218	15	were	be	VBD
cord-005453-4057qib7	218	16	significantly	significantly	RB
cord-005453-4057qib7	218	17	reduced	reduce	VBN
cord-005453-4057qib7	218	18	upon	upon	IN
cord-005453-4057qib7	218	19	combined	combine	VBN
cord-005453-4057qib7	218	20	panobinostat	panobinostat	NN
cord-005453-4057qib7	218	21	/	/	SYM
cord-005453-4057qib7	218	22	dasatinib	dasatinib	NN
cord-005453-4057qib7	218	23	treatment	treatment	NN
cord-005453-4057qib7	218	24	.	.	.
cord-005453-4057qib7	219	1	These	these	DT
cord-005453-4057qib7	219	2	data	datum	NNS
cord-005453-4057qib7	219	3	indicate	indicate	VBP
cord-005453-4057qib7	219	4	that	that	IN
cord-005453-4057qib7	219	5	panobinostat	panobinostat	NNP
cord-005453-4057qib7	219	6	effectively	effectively	RB
cord-005453-4057qib7	219	7	suppresses	suppress	VBZ
cord-005453-4057qib7	219	8	both	both	DT
cord-005453-4057qib7	219	9	basal	basal	NN
cord-005453-4057qib7	219	10	and	and	CC
cord-005453-4057qib7	219	11	dasatinib	dasatinib	NN
cord-005453-4057qib7	219	12	-	-	HYPH
cord-005453-4057qib7	219	13	induced	induce	VBN
cord-005453-4057qib7	219	14	CXCR4	cxcr4	NN
cord-005453-4057qib7	219	15	expression	expression	NN
cord-005453-4057qib7	219	16	and	and	CC
cord-005453-4057qib7	219	17	function	function	NN
cord-005453-4057qib7	219	18	in	in	IN
cord-005453-4057qib7	219	19	ALL	all	DT
cord-005453-4057qib7	219	20	cells	cell	NNS
cord-005453-4057qib7	219	21	overcoming	overcome	VBG
cord-005453-4057qib7	219	22	stroma	stroma	NN
cord-005453-4057qib7	219	23	-	-	HYPH
cord-005453-4057qib7	219	24	mediated	mediate	VBN
cord-005453-4057qib7	219	25	resistance	resistance	NN
cord-005453-4057qib7	219	26	to	to	IN
cord-005453-4057qib7	219	27	dasatinib	dasatinib	NNP
cord-005453-4057qib7	219	28	.	.	.
cord-005453-4057qib7	220	1	To	to	TO
cord-005453-4057qib7	220	2	determine	determine	VB
cord-005453-4057qib7	220	3	the	the	DT
cord-005453-4057qib7	220	4	molecular	molecular	JJ
cord-005453-4057qib7	220	5	mechanism	mechanism	NN
cord-005453-4057qib7	220	6	,	,	,
cord-005453-4057qib7	220	7	we	-PRON-	PRP
cord-005453-4057qib7	220	8	performed	perform	VBD
cord-005453-4057qib7	220	9	gene	gene	NN
cord-005453-4057qib7	220	10	and	and	CC
cord-005453-4057qib7	220	11	protein	protein	NN
cord-005453-4057qib7	220	12	expression	expression	NN
cord-005453-4057qib7	220	13	analysis	analysis	NN
cord-005453-4057qib7	220	14	.	.	.
cord-005453-4057qib7	221	1	Panobinostat	Panobinostat	NNP
cord-005453-4057qib7	221	2	,	,	,
cord-005453-4057qib7	221	3	alone	alone	JJ
cord-005453-4057qib7	221	4	or	or	CC
cord-005453-4057qib7	221	5	in	in	IN
cord-005453-4057qib7	221	6	combination	combination	NN
cord-005453-4057qib7	221	7	with	with	IN
cord-005453-4057qib7	221	8	dasatinib	dasatinib	NN
cord-005453-4057qib7	221	9	,	,	,
cord-005453-4057qib7	221	10	significantly	significantly	RB
cord-005453-4057qib7	221	11	down	down	RB
cord-005453-4057qib7	221	12	-	-	HYPH
cord-005453-4057qib7	221	13	regulated	regulate	VBD
cord-005453-4057qib7	221	14	the	the	DT
cord-005453-4057qib7	221	15	protein	protein	NN
cord-005453-4057qib7	221	16	levels	level	NNS
cord-005453-4057qib7	221	17	of	of	IN
cord-005453-4057qib7	221	18	calcineurin	calcineurin	NN
cord-005453-4057qib7	221	19	,	,	,
cord-005453-4057qib7	221	20	a	a	DT
cord-005453-4057qib7	221	21	serine	serine	NN
cord-005453-4057qib7	221	22	-	-	HYPH
cord-005453-4057qib7	221	23	threonine	threonine	NN
cord-005453-4057qib7	221	24	protein	protein	NN
cord-005453-4057qib7	221	25	phosphatase	phosphatase	NN
cord-005453-4057qib7	221	26	previously	previously	RB
cord-005453-4057qib7	221	27	implicated	implicate	VBN
cord-005453-4057qib7	221	28	in	in	IN
cord-005453-4057qib7	221	29	T	T	NNP
cord-005453-4057qib7	221	30	-	-	HYPH
cord-005453-4057qib7	221	31	ALL	ALL	NNP
cord-005453-4057qib7	221	32	and	and	CC
cord-005453-4057qib7	221	33	B	b	NN
cord-005453-4057qib7	221	34	-	-	:
cord-005453-4057qib7	221	35	ALL	all	DT
cord-005453-4057qib7	221	36	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	221	37	,	,	,
cord-005453-4057qib7	221	38	as	as	RB
cord-005453-4057qib7	221	39	well	well	RB
cord-005453-4057qib7	221	40	as	as	IN
cord-005453-4057qib7	221	41	of	of	IN
cord-005453-4057qib7	221	42	NFATc1	NFATc1	NNP
cord-005453-4057qib7	221	43	,	,	,
cord-005453-4057qib7	221	44	a	a	DT
cord-005453-4057qib7	221	45	critical	critical	JJ
cord-005453-4057qib7	221	46	effector	effector	NN
cord-005453-4057qib7	221	47	of	of	IN
cord-005453-4057qib7	221	48	the	the	DT
cord-005453-4057qib7	221	49	calcineurin	calcineurin	NN
cord-005453-4057qib7	221	50	signaling	signal	VBG
cord-005453-4057qib7	221	51	cascade	cascade	NN
cord-005453-4057qib7	221	52	,	,	,
cord-005453-4057qib7	221	53	and	and	CC
cord-005453-4057qib7	221	54	NFATc1-regulated	nfatc1-regulated	JJ
cord-005453-4057qib7	221	55	target	target	NN
cord-005453-4057qib7	221	56	genes	gene	NNS
cord-005453-4057qib7	221	57	.	.	.
cord-005453-4057qib7	222	1	It	-PRON-	PRP
cord-005453-4057qib7	222	2	was	be	VBD
cord-005453-4057qib7	222	3	previously	previously	RB
cord-005453-4057qib7	222	4	found	find	VBN
cord-005453-4057qib7	222	5	that	that	IN
cord-005453-4057qib7	222	6	calcineurin	calcineurin	NN
cord-005453-4057qib7	222	7	signaling	signal	VBG
cord-005453-4057qib7	222	8	positively	positively	RB
cord-005453-4057qib7	222	9	regulates	regulate	VBZ
cord-005453-4057qib7	222	10	CXCR4	cxcr4	NN
cord-005453-4057qib7	222	11	expression	expression	NN
cord-005453-4057qib7	222	12	in	in	IN
cord-005453-4057qib7	222	13	T	t	NN
cord-005453-4057qib7	222	14	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	222	15	.	.	.
cord-005453-4057qib7	223	1	Additionally	additionally	RB
cord-005453-4057qib7	223	2	,	,	,
cord-005453-4057qib7	223	3	cyclosporin	cyclosporin	VB
cord-005453-4057qib7	223	4	A	a	DT
cord-005453-4057qib7	223	5	(	(	-LRB-
cord-005453-4057qib7	223	6	CsA	csa	NN
cord-005453-4057qib7	223	7	)	)	-RRB-
cord-005453-4057qib7	223	8	decreased	decrease	VBD
cord-005453-4057qib7	223	9	both	both	DT
cord-005453-4057qib7	223	10	basal	basal	NN
cord-005453-4057qib7	223	11	and	and	CC
cord-005453-4057qib7	223	12	dasatinib	dasatinib	NN
cord-005453-4057qib7	223	13	-	-	HYPH
cord-005453-4057qib7	223	14	induced	induce	VBN
cord-005453-4057qib7	223	15	CXCR4	cxcr4	NN
cord-005453-4057qib7	223	16	surface	surface	NN
cord-005453-4057qib7	223	17	levels	level	NNS
cord-005453-4057qib7	223	18	in	in	IN
cord-005453-4057qib7	223	19	ALL	all	DT
cord-005453-4057qib7	223	20	cells	cell	NNS
cord-005453-4057qib7	223	21	,	,	,
cord-005453-4057qib7	223	22	overcoming	overcome	VBG
cord-005453-4057qib7	223	23	the	the	DT
cord-005453-4057qib7	223	24	protection	protection	NN
cord-005453-4057qib7	223	25	of	of	IN
cord-005453-4057qib7	223	26	the	the	DT
cord-005453-4057qib7	223	27	BMSCs	bmsc	NNS
cord-005453-4057qib7	223	28	which	which	WDT
cord-005453-4057qib7	223	29	result	result	VBP
cord-005453-4057qib7	223	30	in	in	IN
cord-005453-4057qib7	223	31	potentiation	potentiation	NN
cord-005453-4057qib7	223	32	of	of	IN
cord-005453-4057qib7	223	33	the	the	DT
cord-005453-4057qib7	223	34	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	223	35	effect	effect	NN
cord-005453-4057qib7	223	36	of	of	IN
cord-005453-4057qib7	223	37	dasatininb	dasatininb	NNP
cord-005453-4057qib7	223	38	and	and	CC
cord-005453-4057qib7	223	39	panobinostat	panobinostat	NNP
cord-005453-4057qib7	223	40	.	.	.
cord-005453-4057qib7	224	1	Combining	combine	VBG
cord-005453-4057qib7	224	2	CsA	csa	NN
cord-005453-4057qib7	224	3	with	with	IN
cord-005453-4057qib7	224	4	panobinostat	panobinostat	NNP
cord-005453-4057qib7	224	5	resulted	result	VBD
cord-005453-4057qib7	224	6	in	in	IN
cord-005453-4057qib7	224	7	deeper	deep	JJR
cord-005453-4057qib7	224	8	suppression	suppression	NN
cord-005453-4057qib7	224	9	of	of	IN
cord-005453-4057qib7	224	10	NFATc1-regulated	nfatc1-regulated	JJ
cord-005453-4057qib7	224	11	target	target	NN
cord-005453-4057qib7	224	12	genes	gene	NNS
cord-005453-4057qib7	224	13	.	.	.
cord-005453-4057qib7	225	1	We	-PRON-	PRP
cord-005453-4057qib7	225	2	thus	thus	RB
cord-005453-4057qib7	225	3	link	link	VBP
cord-005453-4057qib7	225	4	the	the	DT
cord-005453-4057qib7	225	5	effect	effect	NN
cord-005453-4057qib7	225	6	of	of	IN
cord-005453-4057qib7	225	7	panobinostat	panobinostat	NNP
cord-005453-4057qib7	225	8	with	with	IN
cord-005453-4057qib7	225	9	calcineurin	calcineurin	NN
cord-005453-4057qib7	225	10	-	-	HYPH
cord-005453-4057qib7	225	11	dependent	dependent	JJ
cord-005453-4057qib7	225	12	downregulation	downregulation	NN
cord-005453-4057qib7	225	13	of	of	IN
cord-005453-4057qib7	225	14	CXCR4	CXCR4	NNS
cord-005453-4057qib7	225	15	,	,	,
cord-005453-4057qib7	225	16	blocking	block	VBG
cord-005453-4057qib7	225	17	the	the	DT
cord-005453-4057qib7	225	18	ability	ability	NN
cord-005453-4057qib7	225	19	of	of	IN
cord-005453-4057qib7	225	20	the	the	DT
cord-005453-4057qib7	225	21	leukemic	leukemic	JJ
cord-005453-4057qib7	225	22	cells	cell	NNS
cord-005453-4057qib7	225	23	to	to	TO
cord-005453-4057qib7	225	24	respond	respond	VB
cord-005453-4057qib7	225	25	to	to	IN
cord-005453-4057qib7	225	26	CXCL12mediated	cxcl12mediated	JJ
cord-005453-4057qib7	225	27	stromal	stromal	JJ
cord-005453-4057qib7	225	28	support	support	NN
cord-005453-4057qib7	225	29	.	.	.
cord-005453-4057qib7	226	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	226	2	:	:	:
cord-005453-4057qib7	227	1	Taken	take	VBN
cord-005453-4057qib7	227	2	together	together	RB
cord-005453-4057qib7	227	3	,	,	,
cord-005453-4057qib7	227	4	our	-PRON-	PRP$
cord-005453-4057qib7	227	5	results	result	NNS
cord-005453-4057qib7	227	6	identify	identify	VBP
cord-005453-4057qib7	227	7	calcineurin	calcineurin	NN
cord-005453-4057qib7	227	8	signaling	signal	VBG
cord-005453-4057qib7	227	9	pathway	pathway	NN
cord-005453-4057qib7	227	10	as	as	IN
cord-005453-4057qib7	227	11	a	a	DT
cord-005453-4057qib7	227	12	novel	novel	JJ
cord-005453-4057qib7	227	13	target	target	NN
cord-005453-4057qib7	227	14	of	of	IN
cord-005453-4057qib7	227	15	panobinostat	panobinostat	NN
cord-005453-4057qib7	227	16	in	in	IN
cord-005453-4057qib7	227	17	ALL	all	DT
cord-005453-4057qib7	227	18	cells	cell	NNS
cord-005453-4057qib7	227	19	and	and	CC
cord-005453-4057qib7	227	20	indicate	indicate	VBP
cord-005453-4057qib7	227	21	that	that	IN
cord-005453-4057qib7	227	22	HDAC	HDAC	NNP
cord-005453-4057qib7	227	23	inhibition	inhibition	NN
cord-005453-4057qib7	227	24	with	with	IN
cord-005453-4057qib7	227	25	panobinostat	panobinostat	NNP
cord-005453-4057qib7	227	26	may	may	MD
cord-005453-4057qib7	227	27	be	be	VB
cord-005453-4057qib7	227	28	effective	effective	JJ
cord-005453-4057qib7	227	29	strategy	strategy	NN
cord-005453-4057qib7	227	30	for	for	IN
cord-005453-4057qib7	227	31	facilitating	facilitate	VBG
cord-005453-4057qib7	227	32	the	the	DT
cord-005453-4057qib7	227	33	anti	anti	JJ
cord-005453-4057qib7	227	34	-	-	JJ
cord-005453-4057qib7	227	35	leukemic	leukemic	JJ
cord-005453-4057qib7	227	36	activity	activity	NN
cord-005453-4057qib7	227	37	of	of	IN
cord-005453-4057qib7	227	38	TKI	TKI	NNP
cord-005453-4057qib7	227	39	therapy	therapy	NN
cord-005453-4057qib7	227	40	.	.	.
cord-005453-4057qib7	228	1	Disclosure	disclosure	NN
cord-005453-4057qib7	228	2	:	:	:
cord-005453-4057qib7	228	3	nothing	nothing	NN
cord-005453-4057qib7	228	4	to	to	TO
cord-005453-4057qib7	228	5	disclose	disclose	VB
cord-005453-4057qib7	228	6	Background	background	NN
cord-005453-4057qib7	228	7	:	:	:
cord-005453-4057qib7	229	1	The	the	DT
cord-005453-4057qib7	229	2	treatment	treatment	NN
cord-005453-4057qib7	229	3	of	of	IN
cord-005453-4057qib7	229	4	relapsed	relapse	VBN
cord-005453-4057qib7	229	5	/	/	SYM
cord-005453-4057qib7	229	6	refractory	refractory	JJ
cord-005453-4057qib7	229	7	acute	acute	JJ
cord-005453-4057qib7	229	8	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	229	9	leukemia	leukemia	NN
cord-005453-4057qib7	229	10	(	(	-LRB-
cord-005453-4057qib7	229	11	RR	rr	NN
cord-005453-4057qib7	229	12	-	-	HYPH
cord-005453-4057qib7	229	13	ALL	ALL	NNP
cord-005453-4057qib7	229	14	)	)	-RRB-
cord-005453-4057qib7	229	15	remains	remain	VBZ
cord-005453-4057qib7	229	16	a	a	DT
cord-005453-4057qib7	229	17	clinical	clinical	JJ
cord-005453-4057qib7	229	18	challenge	challenge	NN
cord-005453-4057qib7	229	19	with	with	IN
cord-005453-4057qib7	229	20	a	a	DT
cord-005453-4057qib7	229	21	generally	generally	RB
cord-005453-4057qib7	229	22	dismal	dismal	JJ
cord-005453-4057qib7	229	23	prognosis	prognosis	NN
cord-005453-4057qib7	229	24	.	.	.
cord-005453-4057qib7	230	1	Allo	Allo	NNP
cord-005453-4057qib7	230	2	-	-	HYPH
cord-005453-4057qib7	230	3	SCT	SCT	NNP
cord-005453-4057qib7	230	4	using	use	VBG
cord-005453-4057qib7	230	5	a	a	DT
cord-005453-4057qib7	230	6	sequential	sequential	JJ
cord-005453-4057qib7	230	7	conditioning	conditioning	NN
cord-005453-4057qib7	230	8	(	(	-LRB-
cord-005453-4057qib7	230	9	"	"	``
cord-005453-4057qib7	230	10	FLAMSA"-like	flamsa"-like	IN
cord-005453-4057qib7	230	11	regimen	regimen	NN
cord-005453-4057qib7	230	12	)	)	-RRB-
cord-005453-4057qib7	230	13	has	have	VBZ
cord-005453-4057qib7	230	14	shown	show	VBN
cord-005453-4057qib7	230	15	promising	promising	JJ
cord-005453-4057qib7	230	16	results	result	NNS
cord-005453-4057qib7	230	17	in	in	IN
cord-005453-4057qib7	230	18	relapsed	relapse	VBN
cord-005453-4057qib7	230	19	/	/	SYM
cord-005453-4057qib7	230	20	refractory	refractory	JJ
cord-005453-4057qib7	230	21	AML	AML	NNP
cord-005453-4057qib7	230	22	,	,	,
cord-005453-4057qib7	230	23	but	but	CC
cord-005453-4057qib7	230	24	little	little	JJ
cord-005453-4057qib7	230	25	is	be	VBZ
cord-005453-4057qib7	230	26	known	know	VBN
cord-005453-4057qib7	230	27	about	about	IN
cord-005453-4057qib7	230	28	the	the	DT
cord-005453-4057qib7	230	29	efficacy	efficacy	NN
cord-005453-4057qib7	230	30	of	of	IN
cord-005453-4057qib7	230	31	this	this	DT
cord-005453-4057qib7	230	32	procedure	procedure	NN
cord-005453-4057qib7	230	33	in	in	IN
cord-005453-4057qib7	230	34	RR	rr	NN
cord-005453-4057qib7	230	35	-	-	HYPH
cord-005453-4057qib7	230	36	ALL	ALL	NNP
cord-005453-4057qib7	230	37	.	.	.
cord-005453-4057qib7	231	1	Methods	method	NNS
cord-005453-4057qib7	231	2	:	:	:
cord-005453-4057qib7	231	3	We	-PRON-	PRP
cord-005453-4057qib7	231	4	identified	identify	VBD
cord-005453-4057qib7	231	5	115	115	CD
cord-005453-4057qib7	231	6	adult	adult	NN
cord-005453-4057qib7	231	7	patients	patient	NNS
cord-005453-4057qib7	231	8	(	(	-LRB-
cord-005453-4057qib7	231	9	45	45	CD
cord-005453-4057qib7	231	10	%	%	NN
cord-005453-4057qib7	231	11	females	female	NNS
cord-005453-4057qib7	231	12	;	;	:
cord-005453-4057qib7	231	13	median	median	JJ
cord-005453-4057qib7	231	14	age	age	NN
cord-005453-4057qib7	231	15	:	:	:
cord-005453-4057qib7	231	16	38	38	CD
cord-005453-4057qib7	231	17	y	y	NN
cord-005453-4057qib7	231	18	;	;	:
cord-005453-4057qib7	231	19	range	range	NN
cord-005453-4057qib7	231	20	,	,	,
cord-005453-4057qib7	231	21	18	18	CD
cord-005453-4057qib7	231	22	-	-	SYM
cord-005453-4057qib7	231	23	66	66	CD
cord-005453-4057qib7	231	24	)	)	-RRB-
cord-005453-4057qib7	231	25	with	with	IN
cord-005453-4057qib7	231	26	ALL	all	DT
cord-005453-4057qib7	231	27	in	in	IN
cord-005453-4057qib7	231	28	primary	primary	JJ
cord-005453-4057qib7	231	29	refractory	refractory	JJ
cord-005453-4057qib7	231	30	phase	phase	NN
cord-005453-4057qib7	231	31	(	(	-LRB-
cord-005453-4057qib7	231	32	26	26	CD
cord-005453-4057qib7	231	33	%	%	NN
cord-005453-4057qib7	231	34	)	)	-RRB-
cord-005453-4057qib7	231	35	or	or	CC
cord-005453-4057qib7	231	36	in	in	IN
cord-005453-4057qib7	231	37	relapse	relapse	NN
cord-005453-4057qib7	231	38	(	(	-LRB-
cord-005453-4057qib7	231	39	74	74	CD
cord-005453-4057qib7	231	40	%	%	NN
cord-005453-4057qib7	231	41	)	)	-RRB-
cord-005453-4057qib7	231	42	,	,	,
cord-005453-4057qib7	231	43	allografted	allografte	VBN
cord-005453-4057qib7	231	44	between	between	IN
cord-005453-4057qib7	231	45	2000	2000	CD
cord-005453-4057qib7	231	46	and	and	CC
cord-005453-4057qib7	231	47	2017	2017	CD
cord-005453-4057qib7	231	48	from	from	IN
cord-005453-4057qib7	231	49	a	a	DT
cord-005453-4057qib7	231	50	matched	match	VBN
cord-005453-4057qib7	231	51	sibling	sibling	NN
cord-005453-4057qib7	231	52	(	(	-LRB-
cord-005453-4057qib7	231	53	31	31	CD
cord-005453-4057qib7	231	54	%	%	NN
cord-005453-4057qib7	231	55	)	)	-RRB-
cord-005453-4057qib7	231	56	,	,	,
cord-005453-4057qib7	231	57	matched	match	VBN
cord-005453-4057qib7	231	58	unrelated	unrelated	JJ
cord-005453-4057qib7	231	59	(	(	-LRB-
cord-005453-4057qib7	231	60	58	58	CD
cord-005453-4057qib7	231	61	%	%	NN
cord-005453-4057qib7	231	62	)	)	-RRB-
cord-005453-4057qib7	231	63	or	or	CC
cord-005453-4057qib7	231	64	haploidentical	haploidentical	JJ
cord-005453-4057qib7	231	65	donor	donor	NN
cord-005453-4057qib7	231	66	(	(	-LRB-
cord-005453-4057qib7	231	67	11	11	CD
cord-005453-4057qib7	231	68	%	%	NN
cord-005453-4057qib7	231	69	)	)	-RRB-
cord-005453-4057qib7	231	70	at	at	IN
cord-005453-4057qib7	231	71	EBMT	EBMT	NNP
cord-005453-4057qib7	231	72	participating	participate	VBG
cord-005453-4057qib7	231	73	centers	center	NNS
cord-005453-4057qib7	231	74	.	.	.
cord-005453-4057qib7	232	1	Almost	almost	RB
cord-005453-4057qib7	232	2	half	half	NN
cord-005453-4057qib7	232	3	(	(	-LRB-
cord-005453-4057qib7	232	4	49	49	CD
cord-005453-4057qib7	232	5	%	%	NN
cord-005453-4057qib7	232	6	)	)	-RRB-
cord-005453-4057qib7	232	7	of	of	IN
cord-005453-4057qib7	232	8	the	the	DT
cord-005453-4057qib7	232	9	patients	patient	NNS
cord-005453-4057qib7	232	10	had	have	VBD
cord-005453-4057qib7	232	11	T	T	NNP
cord-005453-4057qib7	232	12	-	-	HYPH
cord-005453-4057qib7	232	13	ALL	all	DT
cord-005453-4057qib7	232	14	and	and	CC
cord-005453-4057qib7	232	15	23	23	CD
cord-005453-4057qib7	232	16	%	%	NN
cord-005453-4057qib7	232	17	had	have	VBD
cord-005453-4057qib7	232	18	a	a	DT
cord-005453-4057qib7	232	19	positive	positive	JJ
cord-005453-4057qib7	232	20	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	232	21	chromosome	chromosome	NN
cord-005453-4057qib7	232	22	.	.	.
cord-005453-4057qib7	233	1	Six	six	CD
cord-005453-4057qib7	233	2	patients	patient	NNS
cord-005453-4057qib7	233	3	(	(	-LRB-
cord-005453-4057qib7	233	4	5	5	CD
cord-005453-4057qib7	233	5	%	%	NN
cord-005453-4057qib7	233	6	)	)	-RRB-
cord-005453-4057qib7	233	7	underwent	undergo	VBD
cord-005453-4057qib7	233	8	a	a	DT
cord-005453-4057qib7	233	9	previous	previous	JJ
cord-005453-4057qib7	233	10	autotransplant	autotransplant	NN
cord-005453-4057qib7	233	11	.	.	.
cord-005453-4057qib7	234	1	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	234	2	score	score	NN
cord-005453-4057qib7	234	3	was	be	VBD
cord-005453-4057qib7	234	4	above	above	IN
cord-005453-4057qib7	234	5	90	90	CD
cord-005453-4057qib7	234	6	in	in	IN
cord-005453-4057qib7	234	7	52	52	CD
cord-005453-4057qib7	234	8	%	%	NN
cord-005453-4057qib7	234	9	of	of	IN
cord-005453-4057qib7	234	10	patients	patient	NNS
cord-005453-4057qib7	234	11	.	.	.
cord-005453-4057qib7	235	1	Conditioning	conditioning	NN
cord-005453-4057qib7	235	2	was	be	VBD
cord-005453-4057qib7	235	3	myeloablative	myeloablative	JJ
cord-005453-4057qib7	235	4	(	(	-LRB-
cord-005453-4057qib7	235	5	MAC	MAC	NNP
cord-005453-4057qib7	235	6	)	)	-RRB-
cord-005453-4057qib7	235	7	with	with	IN
cord-005453-4057qib7	235	8	high	high	JJ
cord-005453-4057qib7	235	9	dose	dose	NN
cord-005453-4057qib7	235	10	TBI	TBI	NNP
cord-005453-4057qib7	235	11	in	in	IN
cord-005453-4057qib7	235	12	30	30	CD
cord-005453-4057qib7	235	13	%	%	NN
cord-005453-4057qib7	235	14	of	of	IN
cord-005453-4057qib7	235	15	patients	patient	NNS
cord-005453-4057qib7	235	16	,	,	,
cord-005453-4057qib7	235	17	reduced	reduce	VBN
cord-005453-4057qib7	235	18	intensity	intensity	NN
cord-005453-4057qib7	235	19	(	(	-LRB-
cord-005453-4057qib7	235	20	RIC	RIC	NNP
cord-005453-4057qib7	235	21	)	)	-RRB-
cord-005453-4057qib7	235	22	including	include	VBG
cord-005453-4057qib7	235	23	low	low	JJ
cord-005453-4057qib7	235	24	dose	dose	NN
cord-005453-4057qib7	235	25	TBI	TBI	NNP
cord-005453-4057qib7	235	26	in	in	IN
cord-005453-4057qib7	235	27	22	22	CD
cord-005453-4057qib7	235	28	%	%	NN
cord-005453-4057qib7	235	29	,	,	,
cord-005453-4057qib7	235	30	or	or	CC
cord-005453-4057qib7	235	31	with	with	IN
cord-005453-4057qib7	235	32	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	235	33	alone	alone	JJ
cord-005453-4057qib7	235	34	in	in	IN
cord-005453-4057qib7	235	35	48	48	CD
cord-005453-4057qib7	235	36	%	%	NN
cord-005453-4057qib7	235	37	.	.	.
cord-005453-4057qib7	236	1	In	in	IN
cord-005453-4057qib7	236	2	vivo	vivo	FW
cord-005453-4057qib7	236	3	T	t	NN
cord-005453-4057qib7	236	4	cell	cell	NN
cord-005453-4057qib7	236	5	depletion	depletion	NN
cord-005453-4057qib7	236	6	was	be	VBD
cord-005453-4057qib7	236	7	performed	perform	VBN
cord-005453-4057qib7	236	8	in	in	IN
cord-005453-4057qib7	236	9	77	77	CD
cord-005453-4057qib7	236	10	cases	case	NNS
cord-005453-4057qib7	236	11	(	(	-LRB-
cord-005453-4057qib7	236	12	69	69	CD
cord-005453-4057qib7	236	13	%	%	NN
cord-005453-4057qib7	236	14	)	)	-RRB-
cord-005453-4057qib7	236	15	.	.	.
cord-005453-4057qib7	237	1	Most	Most	JJS
cord-005453-4057qib7	237	2	patients	patient	NNS
cord-005453-4057qib7	237	3	(	(	-LRB-
cord-005453-4057qib7	237	4	74	74	CD
cord-005453-4057qib7	237	5	%	%	NN
cord-005453-4057qib7	237	6	)	)	-RRB-
cord-005453-4057qib7	237	7	and	and	CC
cord-005453-4057qib7	237	8	about	about	IN
cord-005453-4057qib7	237	9	half	half	NN
cord-005453-4057qib7	237	10	of	of	IN
cord-005453-4057qib7	237	11	the	the	DT
cord-005453-4057qib7	237	12	donors	donor	NNS
cord-005453-4057qib7	237	13	(	(	-LRB-
cord-005453-4057qib7	237	14	47	47	CD
cord-005453-4057qib7	237	15	%	%	NN
cord-005453-4057qib7	237	16	)	)	-RRB-
cord-005453-4057qib7	237	17	were	be	VBD
cord-005453-4057qib7	237	18	CMV	CMV	NNP
cord-005453-4057qib7	237	19	positive	positive	JJ
cord-005453-4057qib7	237	20	.	.	.
cord-005453-4057qib7	238	1	14	14	CD
cord-005453-4057qib7	238	2	%	%	NN
cord-005453-4057qib7	238	3	of	of	IN
cord-005453-4057qib7	238	4	patients	patient	NNS
cord-005453-4057qib7	238	5	were	be	VBD
cord-005453-4057qib7	238	6	males	male	NNS
cord-005453-4057qib7	238	7	who	who	WP
cord-005453-4057qib7	238	8	received	receive	VBD
cord-005453-4057qib7	238	9	a	a	DT
cord-005453-4057qib7	238	10	graft	graft	NN
cord-005453-4057qib7	238	11	from	from	IN
cord-005453-4057qib7	238	12	a	a	DT
cord-005453-4057qib7	238	13	female	female	JJ
cord-005453-4057qib7	238	14	donor	donor	NN
cord-005453-4057qib7	238	15	.	.	.
cord-005453-4057qib7	239	1	The	the	DT
cord-005453-4057qib7	239	2	median	median	JJ
cord-005453-4057qib7	239	3	follow	follow	NN
cord-005453-4057qib7	239	4	-	-	HYPH
cord-005453-4057qib7	239	5	up	up	NN
cord-005453-4057qib7	239	6	was	be	VBD
cord-005453-4057qib7	239	7	37	37	CD
cord-005453-4057qib7	240	1	(	(	-LRB-
cord-005453-4057qib7	240	2	range	range	NN
cord-005453-4057qib7	240	3	,	,	,
cord-005453-4057qib7	240	4	13	13	CD
cord-005453-4057qib7	240	5	-	-	SYM
cord-005453-4057qib7	240	6	111	111	CD
cord-005453-4057qib7	240	7	)	)	-RRB-
cord-005453-4057qib7	240	8	months	month	NNS
cord-005453-4057qib7	240	9	.	.	.
cord-005453-4057qib7	241	1	Results	result	NNS
cord-005453-4057qib7	241	2	:	:	:
cord-005453-4057qib7	242	1	Overall	overall	RB
cord-005453-4057qib7	242	2	,	,	,
cord-005453-4057qib7	242	3	14	14	CD
cord-005453-4057qib7	242	4	patients	patient	NNS
cord-005453-4057qib7	242	5	(	(	-LRB-
cord-005453-4057qib7	242	6	13	13	CD
cord-005453-4057qib7	242	7	%	%	NN
cord-005453-4057qib7	242	8	)	)	-RRB-
cord-005453-4057qib7	242	9	failed	fail	VBD
cord-005453-4057qib7	242	10	to	to	TO
cord-005453-4057qib7	242	11	engraft	engraft	VB
cord-005453-4057qib7	242	12	,	,	,
cord-005453-4057qib7	242	13	18	18	CD
cord-005453-4057qib7	242	14	(	(	-LRB-
cord-005453-4057qib7	242	15	16	16	CD
cord-005453-4057qib7	242	16	%	%	NN
cord-005453-4057qib7	242	17	)	)	-RRB-
cord-005453-4057qib7	242	18	died	die	VBD
cord-005453-4057qib7	242	19	within	within	IN
cord-005453-4057qib7	242	20	100	100	CD
cord-005453-4057qib7	242	21	days	day	NNS
cord-005453-4057qib7	242	22	after	after	IN
cord-005453-4057qib7	242	23	allo	allo	NN
cord-005453-4057qib7	242	24	-	-	HYPH
cord-005453-4057qib7	242	25	SCT	SCT	NNP
cord-005453-4057qib7	242	26	without	without	IN
cord-005453-4057qib7	242	27	relapse	relapse	NN
cord-005453-4057qib7	242	28	,	,	,
cord-005453-4057qib7	242	29	and	and	CC
cord-005453-4057qib7	242	30	64	64	CD
cord-005453-4057qib7	242	31	(	(	-LRB-
cord-005453-4057qib7	242	32	56	56	CD
cord-005453-4057qib7	242	33	%	%	NN
cord-005453-4057qib7	242	34	)	)	-RRB-
cord-005453-4057qib7	242	35	could	could	MD
cord-005453-4057qib7	242	36	achieve	achieve	VB
cord-005453-4057qib7	242	37	complete	complete	JJ
cord-005453-4057qib7	242	38	remission	remission	NN
cord-005453-4057qib7	242	39	.	.	.
cord-005453-4057qib7	243	1	At	at	IN
cord-005453-4057qib7	243	2	day	day	NN
cord-005453-4057qib7	243	3	100	100	CD
cord-005453-4057qib7	243	4	,	,	,
cord-005453-4057qib7	243	5	the	the	DT
cord-005453-4057qib7	243	6	cumulative	cumulative	JJ
cord-005453-4057qib7	243	7	incidences	incidence	NNS
cord-005453-4057qib7	243	8	of	of	IN
cord-005453-4057qib7	243	9	grade	grade	NN
cord-005453-4057qib7	243	10	II	II	NNP
cord-005453-4057qib7	243	11	-	-	HYPH
cord-005453-4057qib7	243	12	IV	IV	NNP
cord-005453-4057qib7	243	13	and	and	CC
cord-005453-4057qib7	243	14	grade	grade	NN
cord-005453-4057qib7	243	15	III	III	NNP
cord-005453-4057qib7	243	16	-	-	HYPH
cord-005453-4057qib7	243	17	IV	IV	NNP
cord-005453-4057qib7	243	18	acute	acute	JJ
cord-005453-4057qib7	243	19	GVHD	GVHD	NNP
cord-005453-4057qib7	243	20	were	be	VBD
cord-005453-4057qib7	243	21	30	30	CD
cord-005453-4057qib7	243	22	%	%	NN
cord-005453-4057qib7	243	23	and	and	CC
cord-005453-4057qib7	243	24	17	17	CD
cord-005453-4057qib7	243	25	%	%	NN
cord-005453-4057qib7	243	26	,	,	,
cord-005453-4057qib7	243	27	respectively	respectively	RB
cord-005453-4057qib7	243	28	.	.	.
cord-005453-4057qib7	244	1	The	the	DT
cord-005453-4057qib7	244	2	2year	2year	JJ
cord-005453-4057qib7	244	3	cumulative	cumulative	JJ
cord-005453-4057qib7	244	4	incidences	incidence	NNS
cord-005453-4057qib7	244	5	of	of	IN
cord-005453-4057qib7	244	6	chronic	chronic	JJ
cord-005453-4057qib7	244	7	and	and	CC
cord-005453-4057qib7	244	8	extensive	extensive	JJ
cord-005453-4057qib7	244	9	chronic	chronic	JJ
cord-005453-4057qib7	244	10	GVHD	GVHD	NNP
cord-005453-4057qib7	244	11	were	be	VBD
cord-005453-4057qib7	244	12	25	25	CD
cord-005453-4057qib7	244	13	%	%	NN
cord-005453-4057qib7	244	14	and	and	CC
cord-005453-4057qib7	244	15	11	11	CD
cord-005453-4057qib7	244	16	%	%	NN
cord-005453-4057qib7	244	17	,	,	,
cord-005453-4057qib7	244	18	respectively	respectively	RB
cord-005453-4057qib7	244	19	.	.	.
cord-005453-4057qib7	245	1	The	the	DT
cord-005453-4057qib7	245	2	2-year	2-year	CD
cord-005453-4057qib7	245	3	relapse	relapse	NN
cord-005453-4057qib7	245	4	incidence	incidence	NN
cord-005453-4057qib7	245	5	(	(	-LRB-
cord-005453-4057qib7	245	6	RI	RI	NNP
cord-005453-4057qib7	245	7	)	)	-RRB-
cord-005453-4057qib7	245	8	and	and	CC
cord-005453-4057qib7	245	9	non	non	JJ
cord-005453-4057qib7	245	10	-	-	JJ
cord-005453-4057qib7	245	11	relapse	relapse	JJ
cord-005453-4057qib7	245	12	mortality	mortality	NN
cord-005453-4057qib7	245	13	(	(	-LRB-
cord-005453-4057qib7	245	14	NRM	NRM	NNP
cord-005453-4057qib7	245	15	)	)	-RRB-
cord-005453-4057qib7	245	16	were	be	VBD
cord-005453-4057qib7	245	17	45	45	CD
cord-005453-4057qib7	245	18	%	%	NN
cord-005453-4057qib7	245	19	and	and	CC
cord-005453-4057qib7	245	20	41	41	CD
cord-005453-4057qib7	245	21	%	%	NN
cord-005453-4057qib7	245	22	,	,	,
cord-005453-4057qib7	245	23	respectively	respectively	RB
cord-005453-4057qib7	245	24	.	.	.
cord-005453-4057qib7	246	1	The	the	DT
cord-005453-4057qib7	246	2	2-year	2-year	CD
cord-005453-4057qib7	246	3	leukemia	leukemia	NN
cord-005453-4057qib7	246	4	free	free	JJ
cord-005453-4057qib7	246	5	survival	survival	NN
cord-005453-4057qib7	246	6	(	(	-LRB-
cord-005453-4057qib7	246	7	LFS	LFS	NNP
cord-005453-4057qib7	246	8	)	)	-RRB-
cord-005453-4057qib7	246	9	,	,	,
cord-005453-4057qib7	246	10	overall	overall	JJ
cord-005453-4057qib7	246	11	survival	survival	NN
cord-005453-4057qib7	246	12	(	(	-LRB-
cord-005453-4057qib7	246	13	OS	OS	NNP
cord-005453-4057qib7	246	14	)	)	-RRB-
cord-005453-4057qib7	246	15	and	and	CC
cord-005453-4057qib7	246	16	GVHD	GVHD	NNP
cord-005453-4057qib7	246	17	relapsefree	relapsefree	JJ
cord-005453-4057qib7	246	18	survival	survival	NN
cord-005453-4057qib7	246	19	(	(	-LRB-
cord-005453-4057qib7	246	20	GRFS	GRFS	NNP
cord-005453-4057qib7	246	21	)	)	-RRB-
cord-005453-4057qib7	246	22	were	be	VBD
cord-005453-4057qib7	246	23	14	14	CD
cord-005453-4057qib7	246	24	%	%	NN
cord-005453-4057qib7	246	25	,	,	,
cord-005453-4057qib7	246	26	17	17	CD
cord-005453-4057qib7	246	27	%	%	NN
cord-005453-4057qib7	246	28	and	and	CC
cord-005453-4057qib7	246	29	12	12	CD
cord-005453-4057qib7	246	30	%	%	NN
cord-005453-4057qib7	246	31	,	,	,
cord-005453-4057qib7	246	32	respectively	respectively	RB
cord-005453-4057qib7	246	33	.	.	.
cord-005453-4057qib7	247	1	In	in	IN
cord-005453-4057qib7	247	2	a	a	DT
cord-005453-4057qib7	247	3	multivariable	multivariable	JJ
cord-005453-4057qib7	247	4	Cox	Cox	NNP
cord-005453-4057qib7	247	5	analysis	analysis	NN
cord-005453-4057qib7	247	6	,	,	,
cord-005453-4057qib7	247	7	Karnofosky	Karnofosky	NNP
cord-005453-4057qib7	247	8	score	score	VBP
cord-005453-4057qib7	247	9	below	below	IN
cord-005453-4057qib7	247	10	90	90	CD
cord-005453-4057qib7	247	11	negatively	negatively	RB
cord-005453-4057qib7	247	12	affected	affect	VBN
cord-005453-4057qib7	247	13	RI	RI	NNP
cord-005453-4057qib7	247	14	,	,	,
cord-005453-4057qib7	247	15	LFS	lfs	NN
cord-005453-4057qib7	247	16	,	,	,
cord-005453-4057qib7	247	17	OS	OS	NNP
cord-005453-4057qib7	247	18	and	and	CC
cord-005453-4057qib7	247	19	GRFS	GRFS	NNP
cord-005453-4057qib7	247	20	.	.	.
cord-005453-4057qib7	248	1	Also	also	RB
cord-005453-4057qib7	248	2	,	,	,
cord-005453-4057qib7	248	3	conditioning	condition	VBG
cord-005453-4057qib7	248	4	with	with	IN
cord-005453-4057qib7	248	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	248	6	alone	alone	RB
cord-005453-4057qib7	248	7	,	,	,
cord-005453-4057qib7	248	8	compared	compare	VBN
cord-005453-4057qib7	248	9	to	to	IN
cord-005453-4057qib7	248	10	TBIbased	tbibase	VBN
cord-005453-4057qib7	248	11	conditioning	conditioning	NN
cord-005453-4057qib7	248	12	,	,	,
cord-005453-4057qib7	248	13	negatively	negatively	RB
cord-005453-4057qib7	248	14	affected	affect	VBN
cord-005453-4057qib7	248	15	relapse	relapse	NN
cord-005453-4057qib7	248	16	rates	rate	NNS
cord-005453-4057qib7	248	17	(	(	-LRB-
cord-005453-4057qib7	248	18	HR=4.13	HR=4.13	NNP
cord-005453-4057qib7	248	19	;	;	:
cord-005453-4057qib7	248	20	p=0.0006	p=0.0006	ADD
cord-005453-4057qib7	248	21	)	)	-RRB-
cord-005453-4057qib7	248	22	,	,	,
cord-005453-4057qib7	248	23	LFS	LFS	NNP
cord-005453-4057qib7	248	24	(	(	-LRB-
cord-005453-4057qib7	248	25	HR=2.32	hr=2.32	XX
cord-005453-4057qib7	248	26	;	;	:
cord-005453-4057qib7	248	27	p=0.004	p=0.004	NNP
cord-005453-4057qib7	248	28	)	)	-RRB-
cord-005453-4057qib7	248	29	and	and	CC
cord-005453-4057qib7	248	30	OS	OS	NNP
cord-005453-4057qib7	248	31	(	(	-LRB-
cord-005453-4057qib7	248	32	HR=2.29	hr=2.29	UH
cord-005453-4057qib7	248	33	;	;	:
cord-005453-4057qib7	248	34	p=0.006	p=0.006	NNS
cord-005453-4057qib7	248	35	)	)	-RRB-
cord-005453-4057qib7	248	36	.	.	.
cord-005453-4057qib7	249	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	249	2	:	:	:
cord-005453-4057qib7	250	1	Allo	Allo	NNP
cord-005453-4057qib7	250	2	-	-	HYPH
cord-005453-4057qib7	250	3	SCT	SCT	NNP
cord-005453-4057qib7	250	4	using	use	VBG
cord-005453-4057qib7	250	5	a	a	DT
cord-005453-4057qib7	250	6	sequential	sequential	JJ
cord-005453-4057qib7	250	7	conditioning	conditioning	NN
cord-005453-4057qib7	250	8	regimen	regimen	NN
cord-005453-4057qib7	250	9	is	be	VBZ
cord-005453-4057qib7	250	10	proposed	propose	VBN
cord-005453-4057qib7	250	11	by	by	IN
cord-005453-4057qib7	250	12	different	different	JJ
cord-005453-4057qib7	250	13	teams	team	NNS
cord-005453-4057qib7	250	14	in	in	IN
cord-005453-4057qib7	250	15	RR	rr	NN
cord-005453-4057qib7	250	16	-	-	HYPH
cord-005453-4057qib7	250	17	ALL	ALL	NNP
cord-005453-4057qib7	250	18	,	,	,
cord-005453-4057qib7	250	19	and	and	CC
cord-005453-4057qib7	250	20	could	could	MD
cord-005453-4057qib7	250	21	be	be	VB
cord-005453-4057qib7	250	22	an	an	DT
cord-005453-4057qib7	250	23	option	option	NN
cord-005453-4057qib7	250	24	,	,	,
cord-005453-4057qib7	250	25	especially	especially	RB
cord-005453-4057qib7	250	26	when	when	WRB
cord-005453-4057qib7	250	27	considering	consider	VBG
cord-005453-4057qib7	250	28	a	a	DT
cord-005453-4057qib7	250	29	TBIbased	tbibase	VBN
cord-005453-4057qib7	250	30	regimen	regimen	NN
cord-005453-4057qib7	250	31	.	.	.
cord-005453-4057qib7	251	1	However	however	RB
cord-005453-4057qib7	251	2	,	,	,
cord-005453-4057qib7	251	3	the	the	DT
cord-005453-4057qib7	251	4	overall	overall	JJ
cord-005453-4057qib7	251	5	2-year	2-year	CD
cord-005453-4057qib7	251	6	LFS	lfs	NN
cord-005453-4057qib7	251	7	of	of	IN
cord-005453-4057qib7	251	8	14	14	CD
cord-005453-4057qib7	251	9	%	%	NN
cord-005453-4057qib7	251	10	suggests	suggest	VBZ
cord-005453-4057qib7	251	11	that	that	IN
cord-005453-4057qib7	251	12	these	these	DT
cord-005453-4057qib7	251	13	patients	patient	NNS
cord-005453-4057qib7	251	14	still	still	RB
cord-005453-4057qib7	251	15	face	face	VBP
cord-005453-4057qib7	251	16	extremely	extremely	RB
cord-005453-4057qib7	251	17	dismal	dismal	JJ
cord-005453-4057qib7	251	18	outcomes	outcome	NNS
cord-005453-4057qib7	251	19	,	,	,
cord-005453-4057qib7	251	20	highlighting	highlight	VBG
cord-005453-4057qib7	251	21	that	that	IN
cord-005453-4057qib7	251	22	other	other	JJ
cord-005453-4057qib7	251	23	therapies	therapy	NNS
cord-005453-4057qib7	251	24	(	(	-LRB-
cord-005453-4057qib7	252	1	e.g.	e.g.	IN
cord-005453-4057qib7	252	2	BITE	bite	NN
cord-005453-4057qib7	252	3	antibodies	antibody	NNS
cord-005453-4057qib7	252	4	,	,	,
cord-005453-4057qib7	252	5	inotuzumab	inotuzumab	NNS
cord-005453-4057qib7	252	6	,	,	,
cord-005453-4057qib7	252	7	CAR	car	NN
cord-005453-4057qib7	252	8	T	t	NN
cord-005453-4057qib7	252	9	cells	cell	NNS
cord-005453-4057qib7	252	10	)	)	-RRB-
cord-005453-4057qib7	252	11	need	need	VBP
cord-005453-4057qib7	252	12	to	to	TO
cord-005453-4057qib7	252	13	be	be	VB
cord-005453-4057qib7	252	14	combined	combine	VBN
cord-005453-4057qib7	252	15	prior	prior	RB
cord-005453-4057qib7	252	16	and/or	and/or	CC
cord-005453-4057qib7	252	17	after	after	IN
cord-005453-4057qib7	252	18	allo	allo	NN
cord-005453-4057qib7	252	19	-	-	HYPH
cord-005453-4057qib7	252	20	SCT	SCT	NNP
cord-005453-4057qib7	252	21	in	in	IN
cord-005453-4057qib7	252	22	order	order	NN
cord-005453-4057qib7	252	23	to	to	TO
cord-005453-4057qib7	252	24	further	further	RB
cord-005453-4057qib7	252	25	improve	improve	VB
cord-005453-4057qib7	252	26	outcome	outcome	NN
cord-005453-4057qib7	252	27	.	.	.
cord-005453-4057qib7	253	1	Disclosure	disclosure	NN
cord-005453-4057qib7	253	2	:	:	:
cord-005453-4057qib7	253	3	no	no	DT
cord-005453-4057qib7	253	4	conflict	conflict	NN
cord-005453-4057qib7	253	5	of	of	IN
cord-005453-4057qib7	253	6	interest	interest	NN
cord-005453-4057qib7	253	7	,	,	,
cord-005453-4057qib7	253	8	no	no	DT
cord-005453-4057qib7	253	9	funding	funding	NN
cord-005453-4057qib7	253	10	received	receive	VBD
cord-005453-4057qib7	253	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	253	12	courses	course	NNS
cord-005453-4057qib7	253	13	,	,	,
cord-005453-4057qib7	253	14	only	only	RB
cord-005453-4057qib7	253	15	2	2	CD
cord-005453-4057qib7	253	16	pts	pt	NNS
cord-005453-4057qib7	253	17	were	be	VBD
cord-005453-4057qib7	253	18	not	not	RB
cord-005453-4057qib7	253	19	treated	treat	VBN
cord-005453-4057qib7	253	20	:	:	:
cord-005453-4057qib7	253	21	1	1	CD
cord-005453-4057qib7	253	22	pts	pt	NNS
cord-005453-4057qib7	253	23	for	for	IN
cord-005453-4057qib7	253	24	the	the	DT
cord-005453-4057qib7	253	25	worsening	worsening	NN
cord-005453-4057qib7	253	26	of	of	IN
cord-005453-4057qib7	253	27	the	the	DT
cord-005453-4057qib7	253	28	general	general	JJ
cord-005453-4057qib7	253	29	status	status	NN
cord-005453-4057qib7	253	30	and	and	CC
cord-005453-4057qib7	253	31	the	the	DT
cord-005453-4057qib7	253	32	other	other	JJ
cord-005453-4057qib7	253	33	for	for	IN
cord-005453-4057qib7	253	34	invasive	invasive	JJ
cord-005453-4057qib7	253	35	fungal	fungal	JJ
cord-005453-4057qib7	253	36	infection	infection	NN
cord-005453-4057qib7	253	37	.	.	.
cord-005453-4057qib7	254	1	Results	result	NNS
cord-005453-4057qib7	254	2	:	:	:
cord-005453-4057qib7	254	3	Forty	forty	CD
cord-005453-4057qib7	254	4	-	-	HYPH
cord-005453-4057qib7	254	5	three	three	CD
cord-005453-4057qib7	254	6	pts	pt	NNS
cord-005453-4057qib7	254	7	(	(	-LRB-
cord-005453-4057qib7	254	8	42	42	CD
cord-005453-4057qib7	254	9	%	%	NN
cord-005453-4057qib7	254	10	)	)	-RRB-
cord-005453-4057qib7	254	11	were	be	VBD
cord-005453-4057qib7	254	12	in	in	IN
cord-005453-4057qib7	254	13	complete	complete	JJ
cord-005453-4057qib7	254	14	remission	remission	NN
cord-005453-4057qib7	254	15	(	(	-LRB-
cord-005453-4057qib7	254	16	CR	CR	NNP
cord-005453-4057qib7	254	17	)	)	-RRB-
cord-005453-4057qib7	254	18	and	and	CC
cord-005453-4057qib7	254	19	negative	negative	JJ
cord-005453-4057qib7	254	20	minimal	minimal	JJ
cord-005453-4057qib7	254	21	residual	residual	JJ
cord-005453-4057qib7	254	22	disease	disease	NN
cord-005453-4057qib7	254	23	(	(	-LRB-
cord-005453-4057qib7	254	24	MRD	MRD	NNP
cord-005453-4057qib7	254	25	)	)	-RRB-
cord-005453-4057qib7	254	26	at	at	IN
cord-005453-4057qib7	254	27	the	the	DT
cord-005453-4057qib7	254	28	time	time	NN
cord-005453-4057qib7	254	29	of	of	IN
cord-005453-4057qib7	254	30	HSCT	HSCT	NNP
cord-005453-4057qib7	254	31	;	;	:
cord-005453-4057qib7	254	32	16	16	CD
cord-005453-4057qib7	254	33	pts	pt	NNS
cord-005453-4057qib7	254	34	were	be	VBD
cord-005453-4057qib7	254	35	in	in	IN
cord-005453-4057qib7	254	36	active	active	JJ
cord-005453-4057qib7	254	37	disease	disease	NN
cord-005453-4057qib7	254	38	(	(	-LRB-
cord-005453-4057qib7	254	39	16	16	CD
cord-005453-4057qib7	254	40	%	%	NN
cord-005453-4057qib7	254	41	)	)	-RRB-
cord-005453-4057qib7	254	42	,	,	,
cord-005453-4057qib7	254	43	and	and	CC
cord-005453-4057qib7	254	44	44	44	CD
cord-005453-4057qib7	254	45	(	(	-LRB-
cord-005453-4057qib7	254	46	42	42	CD
cord-005453-4057qib7	254	47	%	%	NN
cord-005453-4057qib7	254	48	)	)	-RRB-
cord-005453-4057qib7	254	49	showed	show	VBD
cord-005453-4057qib7	254	50	a	a	DT
cord-005453-4057qib7	254	51	morphological	morphological	JJ
cord-005453-4057qib7	254	52	CR	cr	NN
cord-005453-4057qib7	254	53	with	with	IN
cord-005453-4057qib7	254	54	positive	positive	JJ
cord-005453-4057qib7	254	55	MRD	MRD	NNP
cord-005453-4057qib7	254	56	.	.	.
cord-005453-4057qib7	254	57	41pts	41pts	CD
cord-005453-4057qib7	254	58	(	(	-LRB-
cord-005453-4057qib7	254	59	40	40	CD
cord-005453-4057qib7	254	60	%	%	NN
cord-005453-4057qib7	254	61	)	)	-RRB-
cord-005453-4057qib7	254	62	developed	develop	VBN
cord-005453-4057qib7	254	63	chronic	chronic	NN
cord-005453-4057qib7	254	64	Graft	graft	NN
cord-005453-4057qib7	254	65	Versus	Versus	NNP
cord-005453-4057qib7	254	66	-	-	HYPH
cord-005453-4057qib7	254	67	Host	Host	NNP
cord-005453-4057qib7	254	68	Disease	Disease	NNP
cord-005453-4057qib7	254	69	(	(	-LRB-
cord-005453-4057qib7	254	70	cGVHD	cGVHD	NNP
cord-005453-4057qib7	254	71	)	)	-RRB-
cord-005453-4057qib7	254	72	as	as	IN
cord-005453-4057qib7	254	73	followed	follow	VBN
cord-005453-4057qib7	254	74	:	:	:
cord-005453-4057qib7	255	1	23pts	23pts	NNP
cord-005453-4057qib7	255	2	(	(	-LRB-
cord-005453-4057qib7	255	3	22	22	CD
cord-005453-4057qib7	255	4	%	%	NN
cord-005453-4057qib7	255	5	)	)	-RRB-
cord-005453-4057qib7	255	6	mild	mild	JJ
cord-005453-4057qib7	255	7	,	,	,
cord-005453-4057qib7	255	8	17pts	17pts	JJ
cord-005453-4057qib7	255	9	(	(	-LRB-
cord-005453-4057qib7	255	10	16	16	CD
cord-005453-4057qib7	255	11	%	%	NN
cord-005453-4057qib7	255	12	)	)	-RRB-
cord-005453-4057qib7	255	13	moderate	moderate	JJ
cord-005453-4057qib7	255	14	,	,	,
cord-005453-4057qib7	255	15	and	and	CC
cord-005453-4057qib7	255	16	only	only	RB
cord-005453-4057qib7	255	17	1	1	CD
cord-005453-4057qib7	255	18	sever	sever	NN
cord-005453-4057qib7	255	19	grade	grade	NN
cord-005453-4057qib7	255	20	respectfully	respectfully	RB
cord-005453-4057qib7	255	21	.	.	.
cord-005453-4057qib7	256	1	Only	only	RB
cord-005453-4057qib7	256	2	1	1	CD
cord-005453-4057qib7	256	3	patient	patient	NN
cord-005453-4057qib7	256	4	developed	develop	VBD
cord-005453-4057qib7	256	5	cGVHD	cgvhd	NN
cord-005453-4057qib7	256	6	after	after	IN
cord-005453-4057qib7	256	7	DLI	DLI	NNP
cord-005453-4057qib7	256	8	.	.	.
cord-005453-4057qib7	257	1	The	the	DT
cord-005453-4057qib7	257	2	overall	overall	JJ
cord-005453-4057qib7	257	3	Leukemia	Leukemia	NNP
cord-005453-4057qib7	257	4	Free	Free	NNP
cord-005453-4057qib7	257	5	Survival	Survival	NNP
cord-005453-4057qib7	257	6	(	(	-LRB-
cord-005453-4057qib7	257	7	LFS	LFS	NNP
cord-005453-4057qib7	257	8	)	)	-RRB-
cord-005453-4057qib7	257	9	time	time	NN
cord-005453-4057qib7	257	10	was	be	VBD
cord-005453-4057qib7	257	11	16	16	CD
cord-005453-4057qib7	257	12	months	month	NNS
cord-005453-4057qib7	257	13	,	,	,
cord-005453-4057qib7	257	14	the	the	DT
cord-005453-4057qib7	257	15	absence	absence	NN
cord-005453-4057qib7	257	16	of	of	IN
cord-005453-4057qib7	257	17	cGVHD	cGVHD	NNP
cord-005453-4057qib7	258	1	(	(	-LRB-
cord-005453-4057qib7	258	2	Hazard	Hazard	NNP
cord-005453-4057qib7	258	3	Ratio	Ratio	NNP
cord-005453-4057qib7	258	4	-HR	-hr	NN
cord-005453-4057qib7	258	5	:	:	:
cord-005453-4057qib7	258	6	5,968	5,968	CD
cord-005453-4057qib7	258	7	;	;	:
cord-005453-4057qib7	258	8	p	p	NN
cord-005453-4057qib7	258	9	=	=	SYM
cord-005453-4057qib7	258	10	0,01	0,01	NN
cord-005453-4057qib7	258	11	)	)	-RRB-
cord-005453-4057qib7	259	1	and	and	CC
cord-005453-4057qib7	259	2	the	the	DT
cord-005453-4057qib7	259	3	pre	pre	JJ
cord-005453-4057qib7	259	4	-	-	JJ
cord-005453-4057qib7	259	5	HSCT	hsct	JJ
cord-005453-4057qib7	259	6	disease	disease	NN
cord-005453-4057qib7	259	7	status	status	NN
cord-005453-4057qib7	259	8	(	(	-LRB-
cord-005453-4057qib7	259	9	HR	HR	NNP
cord-005453-4057qib7	259	10	2,353	2,353	CD
cord-005453-4057qib7	259	11	;	;	:
cord-005453-4057qib7	259	12	p	p	NN
cord-005453-4057qib7	259	13	=	=	SYM
cord-005453-4057qib7	259	14	0,028	0,028	CD
cord-005453-4057qib7	259	15	)	)	-RRB-
cord-005453-4057qib7	259	16	were	be	VBD
cord-005453-4057qib7	259	17	the	the	DT
cord-005453-4057qib7	259	18	most	most	RBS
cord-005453-4057qib7	259	19	important	important	JJ
cord-005453-4057qib7	259	20	factors	factor	NNS
cord-005453-4057qib7	259	21	on	on	IN
cord-005453-4057qib7	259	22	LFS	LFS	NNP
cord-005453-4057qib7	259	23	.	.	.
cord-005453-4057qib7	260	1	All	all	DT
cord-005453-4057qib7	260	2	pts	pt	NNS
cord-005453-4057qib7	260	3	treated	treat	VBN
cord-005453-4057qib7	260	4	with	with	IN
cord-005453-4057qib7	260	5	chemo	chemo	NN
cord-005453-4057qib7	260	6	-	-	HYPH
cord-005453-4057qib7	260	7	based	base	VBN
cord-005453-4057qib7	260	8	regimens	regimen	NNS
cord-005453-4057qib7	260	9	died	die	VBD
cord-005453-4057qib7	260	10	due	due	JJ
cord-005453-4057qib7	260	11	to	to	IN
cord-005453-4057qib7	260	12	progression	progression	NN
cord-005453-4057qib7	260	13	or	or	CC
cord-005453-4057qib7	260	14	infective	infective	JJ
cord-005453-4057qib7	260	15	complications	complication	NNS
cord-005453-4057qib7	260	16	.	.	.
cord-005453-4057qib7	261	1	1	1	CD
cord-005453-4057qib7	261	2	patient	patient	NN
cord-005453-4057qib7	261	3	of	of	IN
cord-005453-4057qib7	261	4	Aza	Aza	NNP
cord-005453-4057qib7	261	5	/	/	SYM
cord-005453-4057qib7	261	6	DLI	DLI	NNP
cord-005453-4057qib7	261	7	group	group	NN
cord-005453-4057qib7	261	8	is	be	VBZ
cord-005453-4057qib7	261	9	still	still	RB
cord-005453-4057qib7	261	10	alive	alive	JJ
cord-005453-4057qib7	261	11	with	with	IN
cord-005453-4057qib7	261	12	a	a	DT
cord-005453-4057qib7	261	13	extramedullary	extramedullary	JJ
cord-005453-4057qib7	261	14	relapse	relapse	NN
cord-005453-4057qib7	261	15	;	;	:
cord-005453-4057qib7	261	16	2	2	CD
cord-005453-4057qib7	261	17	pts	pt	NNS
cord-005453-4057qib7	261	18	treated	treat	VBN
cord-005453-4057qib7	261	19	with	with	IN
cord-005453-4057qib7	261	20	Bl	Bl	NNP
cord-005453-4057qib7	261	21	/	/	SYM
cord-005453-4057qib7	261	22	DLI	DLI	NNP
cord-005453-4057qib7	261	23	are	be	VBP
cord-005453-4057qib7	261	24	in	in	IN
cord-005453-4057qib7	261	25	CR	CR	NNP
cord-005453-4057qib7	261	26	.	.	.
cord-005453-4057qib7	262	1	OS	OS	NNP
cord-005453-4057qib7	262	2	was	be	VBD
cord-005453-4057qib7	262	3	better	well	JJR
cord-005453-4057qib7	262	4	for	for	IN
cord-005453-4057qib7	262	5	the	the	DT
cord-005453-4057qib7	262	6	DLI	DLI	NNP
cord-005453-4057qib7	262	7	group	group	NN
cord-005453-4057qib7	262	8	compared	compare	VBN
cord-005453-4057qib7	262	9	to	to	IN
cord-005453-4057qib7	262	10	the	the	DT
cord-005453-4057qib7	262	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	262	12	group	group	NN
cord-005453-4057qib7	262	13	(	(	-LRB-
cord-005453-4057qib7	262	14	28	28	CD
cord-005453-4057qib7	262	15	vs	vs	IN
cord-005453-4057qib7	262	16	2	2	CD
cord-005453-4057qib7	262	17	months	month	NNS
cord-005453-4057qib7	262	18	respectfully	respectfully	RB
cord-005453-4057qib7	262	19	;	;	:
cord-005453-4057qib7	262	20	p	p	XX
cord-005453-4057qib7	262	21	<	<	XX
cord-005453-4057qib7	262	22	0,001	0,001	CD
cord-005453-4057qib7	262	23	)	)	-RRB-
cord-005453-4057qib7	262	24	.	.	.
cord-005453-4057qib7	263	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	263	2	:	:	:
cord-005453-4057qib7	264	1	DLI	DLI	NNP
cord-005453-4057qib7	264	2	after	after	IN
cord-005453-4057qib7	264	3	allo	allo	NN
cord-005453-4057qib7	264	4	-	-	HYPH
cord-005453-4057qib7	264	5	HSCT	HSCT	NNP
cord-005453-4057qib7	264	6	has	have	VBZ
cord-005453-4057qib7	264	7	exhibited	exhibit	VBN
cord-005453-4057qib7	264	8	definite	definite	JJ
cord-005453-4057qib7	264	9	anti	anti	JJ
cord-005453-4057qib7	264	10	-	-	JJ
cord-005453-4057qib7	264	11	leukemic	leukemic	JJ
cord-005453-4057qib7	264	12	effects	effect	NNS
cord-005453-4057qib7	264	13	in	in	IN
cord-005453-4057qib7	264	14	post	post	JJ
cord-005453-4057qib7	264	15	-	-	JJ
cord-005453-4057qib7	264	16	transplant	transplant	JJ
cord-005453-4057qib7	264	17	patients	patient	NNS
cord-005453-4057qib7	264	18	.	.	.
cord-005453-4057qib7	265	1	Bl	Bl	NNP
cord-005453-4057qib7	265	2	and	and	CC
cord-005453-4057qib7	265	3	Aza	Aza	NNP
cord-005453-4057qib7	265	4	were	be	VBD
cord-005453-4057qib7	265	5	reported	report	VBN
cord-005453-4057qib7	265	6	to	to	TO
cord-005453-4057qib7	265	7	increase	increase	VB
cord-005453-4057qib7	265	8	DLI	DLI	NNP
cord-005453-4057qib7	265	9	's	's	POS
cord-005453-4057qib7	265	10	Graft	Graft	NNP
cord-005453-4057qib7	265	11	vs	vs	IN
cord-005453-4057qib7	265	12	-	-	HYPH
cord-005453-4057qib7	265	13	Leukemia	leukemia	NN
cord-005453-4057qib7	265	14	(	(	-LRB-
cord-005453-4057qib7	265	15	GVL	GVL	NNP
cord-005453-4057qib7	265	16	)	)	-RRB-
cord-005453-4057qib7	265	17	effect	effect	NN
cord-005453-4057qib7	265	18	.	.	.
cord-005453-4057qib7	266	1	Although	although	IN
cord-005453-4057qib7	266	2	cGVHD	cGVHD	NNP
cord-005453-4057qib7	266	3	could	could	MD
cord-005453-4057qib7	266	4	be	be	VB
cord-005453-4057qib7	266	5	the	the	DT
cord-005453-4057qib7	266	6	most	most	RBS
cord-005453-4057qib7	266	7	important	important	JJ
cord-005453-4057qib7	266	8	protective	protective	JJ
cord-005453-4057qib7	266	9	factor	factor	NN
cord-005453-4057qib7	266	10	against	against	IN
cord-005453-4057qib7	266	11	the	the	DT
cord-005453-4057qib7	266	12	relapse	relapse	NN
cord-005453-4057qib7	266	13	but	but	CC
cord-005453-4057qib7	266	14	it	-PRON-	PRP
cord-005453-4057qib7	266	15	remains	remain	VBZ
cord-005453-4057qib7	266	16	the	the	DT
cord-005453-4057qib7	266	17	main	main	JJ
cord-005453-4057qib7	266	18	cause	cause	NN
cord-005453-4057qib7	266	19	of	of	IN
cord-005453-4057qib7	266	20	morbidity	morbidity	NN
cord-005453-4057qib7	266	21	.	.	.
cord-005453-4057qib7	267	1	Maximising	maximise	VBG
cord-005453-4057qib7	267	2	the	the	DT
cord-005453-4057qib7	267	3	GVL	GVL	NNP
cord-005453-4057qib7	267	4	effect	effect	NN
cord-005453-4057qib7	267	5	without	without	IN
cord-005453-4057qib7	267	6	putting	put	VBG
cord-005453-4057qib7	267	7	the	the	DT
cord-005453-4057qib7	267	8	patient	patient	NN
cord-005453-4057qib7	267	9	at	at	IN
cord-005453-4057qib7	267	10	risk	risk	NN
cord-005453-4057qib7	267	11	of	of	IN
cord-005453-4057qib7	267	12	GVHD	GVHD	NNP
cord-005453-4057qib7	267	13	still	still	RB
cord-005453-4057qib7	267	14	represents	represent	VBZ
cord-005453-4057qib7	267	15	an	an	DT
cord-005453-4057qib7	267	16	unmet	unmet	JJ
cord-005453-4057qib7	267	17	need	need	NN
cord-005453-4057qib7	267	18	.	.	.
cord-005453-4057qib7	268	1	Our	-PRON-	PRP$
cord-005453-4057qib7	268	2	data	datum	NNS
cord-005453-4057qib7	268	3	show	show	VBP
cord-005453-4057qib7	268	4	that	that	IN
cord-005453-4057qib7	268	5	the	the	DT
cord-005453-4057qib7	268	6	combination	combination	NN
cord-005453-4057qib7	268	7	of	of	IN
cord-005453-4057qib7	268	8	either	either	DT
cord-005453-4057qib7	268	9	Bl	Bl	NNP
cord-005453-4057qib7	268	10	or	or	CC
cord-005453-4057qib7	268	11	Aza	Aza	NNP
cord-005453-4057qib7	268	12	with	with	IN
cord-005453-4057qib7	268	13	DLI	DLI	NNP
cord-005453-4057qib7	268	14	infusion	infusion	NN
cord-005453-4057qib7	268	15	is	be	VBZ
cord-005453-4057qib7	268	16	safe	safe	JJ
cord-005453-4057qib7	268	17	and	and	CC
cord-005453-4057qib7	268	18	might	may	MD
cord-005453-4057qib7	268	19	represent	represent	VB
cord-005453-4057qib7	268	20	an	an	DT
cord-005453-4057qib7	268	21	improvement	improvement	NN
cord-005453-4057qib7	268	22	in	in	IN
cord-005453-4057qib7	268	23	disease	disease	NN
cord-005453-4057qib7	268	24	control	control	NN
cord-005453-4057qib7	268	25	in	in	IN
cord-005453-4057qib7	268	26	the	the	DT
cord-005453-4057qib7	268	27	early	early	JJ
cord-005453-4057qib7	268	28	phase	phase	NN
cord-005453-4057qib7	268	29	of	of	IN
cord-005453-4057qib7	268	30	relapse	relapse	NN
cord-005453-4057qib7	268	31	.	.	.
cord-005453-4057qib7	269	1	Disclosure	disclosure	NN
cord-005453-4057qib7	269	2	:	:	:
cord-005453-4057qib7	269	3	Nothing	nothing	NN
cord-005453-4057qib7	269	4	to	to	TO
cord-005453-4057qib7	269	5	declare	declare	VB
cord-005453-4057qib7	269	6	P018	p018	CD
cord-005453-4057qib7	269	7	Increased	increase	VBN
cord-005453-4057qib7	269	8	detection	detection	NN
cord-005453-4057qib7	269	9	of	of	IN
cord-005453-4057qib7	269	10	(	(	-LRB-
cord-005453-4057qib7	269	11	Leukemiaspecific	Leukemiaspecific	NNP
cord-005453-4057qib7	269	12	)	)	-RRB-
cord-005453-4057qib7	269	13	adaptive	adaptive	JJ
cord-005453-4057qib7	269	14	and	and	CC
cord-005453-4057qib7	269	15	innate	innate	JJ
cord-005453-4057qib7	269	16	immune	immune	JJ
cord-005453-4057qib7	269	17	-	-	HYPH
cord-005453-4057qib7	269	18	reactive	reactive	JJ
cord-005453-4057qib7	269	19	cells	cell	NNS
cord-005453-4057qib7	269	20	under	under	IN
cord-005453-4057qib7	269	21	treatment	treatment	NN
cord-005453-4057qib7	269	22	of	of	IN
cord-005453-4057qib7	269	23	AMLdiseased	amldisease	VBN
cord-005453-4057qib7	269	24	rats	rat	NNS
cord-005453-4057qib7	269	25	and	and	CC
cord-005453-4057qib7	269	26	one	one	CD
cord-005453-4057qib7	269	27	therapy	therapy	NN
cord-005453-4057qib7	269	28	-	-	HYPH
cord-005453-4057qib7	269	29	refractory	refractory	JJ
cord-005453-4057qib7	269	30	AML	aml	NN
cord-005453-4057qib7	269	31	-	-	HYPH
cord-005453-4057qib7	269	32	patient	patient	JJ
cord-005453-4057qib7	269	33	with	with	IN
cord-005453-4057qib7	269	34	blastmodulating	blastmodulating	NN
cord-005453-4057qib7	269	35	,	,	,
cord-005453-4057qib7	269	36	clinically	clinically	RB
cord-005453-4057qib7	269	37	approved	approve	VBN
cord-005453-4057qib7	269	38	response	response	NN
cord-005453-4057qib7	269	39	modifiers	modifier	NNS
cord-005453-4057qib7	269	40	(	(	-LRB-
cord-005453-4057qib7	269	41	PG	PG	NNP
cord-005453-4057qib7	269	42	-	-	HYPH
cord-005453-4057qib7	269	43	E2,Kit	E2,Kit	NNP
cord-005453-4057qib7	269	44	-	-	HYPH
cord-005453-4057qib7	269	45	K	K	NNP
cord-005453-4057qib7	269	46	)	)	-RRB-
cord-005453-4057qib7	269	47	or	or	CC
cord-005453-4057qib7	269	48	+	+	.
cord-005453-4057qib7	270	1	PGE1	PGE1	NNP
cord-005453-4057qib7	270	2	(	(	-LRB-
cord-005453-4057qib7	270	3	Kit	kit	NN
cord-005453-4057qib7	270	4	-	-	HYPH
cord-005453-4057qib7	270	5	M),patent	M),patent	NNP
cord-005453-4057qib7	270	6	102014014993	102014014993	CD
cord-005453-4057qib7	270	7	)	)	-RRB-
cord-005453-4057qib7	270	8	convert	convert	VBP
cord-005453-4057qib7	270	9	myeloid	myeloid	NN
cord-005453-4057qib7	270	10	blasts	blast	NNS
cord-005453-4057qib7	270	11	into	into	IN
cord-005453-4057qib7	270	12	dendritic	dendritic	JJ
cord-005453-4057qib7	270	13	cells	cell	NNS
cord-005453-4057qib7	270	14	of	of	IN
cord-005453-4057qib7	270	15	leukemic	leukemic	JJ
cord-005453-4057qib7	270	16	origin	origin	NN
cord-005453-4057qib7	270	17	(	(	-LRB-
cord-005453-4057qib7	270	18	DC	DC	NNP
cord-005453-4057qib7	270	19	leu	leu	NNP
cord-005453-4057qib7	270	20	)	)	-RRB-
cord-005453-4057qib7	270	21	.	.	.
cord-005453-4057qib7	271	1	After	after	IN
cord-005453-4057qib7	271	2	stimulation	stimulation	NN
cord-005453-4057qib7	271	3	with	with	IN
cord-005453-4057qib7	271	4	DC	DC	NNP
cord-005453-4057qib7	271	5	leu	leu	NNP
cord-005453-4057qib7	271	6	,	,	,
cord-005453-4057qib7	271	7	antileukemic	antileukemic	NNP
cord-005453-4057qib7	271	8	Tcells	Tcells	NNP
cord-005453-4057qib7	271	9	can	can	MD
cord-005453-4057qib7	271	10	be	be	VB
cord-005453-4057qib7	271	11	generated	generate	VBN
cord-005453-4057qib7	271	12	ex	ex	FW
cord-005453-4057qib7	271	13	vivo	vivo	NN
cord-005453-4057qib7	271	14	.	.	.
cord-005453-4057qib7	272	1	The	the	DT
cord-005453-4057qib7	272	2	compounds	compound	NNS
cord-005453-4057qib7	272	3	are	be	VBP
cord-005453-4057qib7	272	4	approved	approve	VBN
cord-005453-4057qib7	272	5	for	for	IN
cord-005453-4057qib7	272	6	clinical	clinical	JJ
cord-005453-4057qib7	272	7	use	use	NN
cord-005453-4057qib7	272	8	and	and	CC
cord-005453-4057qib7	272	9	are	be	VBP
cord-005453-4057qib7	272	10	therefore	therefore	RB
cord-005453-4057qib7	272	11	attractive	attractive	JJ
cord-005453-4057qib7	272	12	tools	tool	NNS
cord-005453-4057qib7	272	13	for	for	IN
cord-005453-4057qib7	272	14	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	272	15	in	in	IN
cord-005453-4057qib7	272	16	myeloid	myeloid	JJ
cord-005453-4057qib7	272	17	leukemia	leukemia	NN
cord-005453-4057qib7	272	18	.	.	.
cord-005453-4057qib7	273	1	Methods	method	NNS
cord-005453-4057qib7	273	2	:	:	:
cord-005453-4057qib7	273	3	DC	DC	NNP
cord-005453-4057qib7	273	4	/	/	SYM
cord-005453-4057qib7	273	5	DCleu	DCleu	NNP
cord-005453-4057qib7	273	6	-	-	HYPH
cord-005453-4057qib7	273	7	culture	culture	NN
cord-005453-4057qib7	273	8	from	from	IN
cord-005453-4057qib7	273	9	rats'/patients	rats'/patient	NNS
cord-005453-4057qib7	273	10	'	'	POS
cord-005453-4057qib7	273	11	wholeblood	wholeblood	NN
cord-005453-4057qib7	273	12	(	(	-LRB-
cord-005453-4057qib7	273	13	WB	WB	NNP
cord-005453-4057qib7	273	14	)	)	-RRB-
cord-005453-4057qib7	273	15	with	with	IN
cord-005453-4057qib7	273	16	kits	kit	NNS
cord-005453-4057qib7	273	17	,	,	,
cord-005453-4057qib7	273	18	mixed	mixed	JJ
cord-005453-4057qib7	273	19	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	273	20	culture	culture	NN
cord-005453-4057qib7	273	21	(	(	-LRB-
cord-005453-4057qib7	273	22	MLC	MLC	NNP
cord-005453-4057qib7	273	23	)	)	-RRB-
cord-005453-4057qib7	273	24	of	of	IN
cord-005453-4057qib7	273	25	Tcells	Tcells	NNP
cord-005453-4057qib7	273	26	with	with	IN
cord-005453-4057qib7	273	27	kit	kit	NN
cord-005453-4057qib7	273	28	-	-	HYPH
cord-005453-4057qib7	273	29	treated	treat	VBN
cord-005453-4057qib7	273	30	blood	blood	NN
cord-005453-4057qib7	273	31	,	,	,
cord-005453-4057qib7	273	32	functional	functional	JJ
cord-005453-4057qib7	273	33	blast	blast	NN
cord-005453-4057qib7	273	34	-	-	HYPH
cord-005453-4057qib7	273	35	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	273	36	and	and	CC
cord-005453-4057qib7	273	37	leukemia	leukemia	NN
cord-005453-4057qib7	273	38	-	-	HYPH
cord-005453-4057qib7	273	39	specificity	specificity	NN
cord-005453-4057qib7	273	40	assays	assay	NNS
cord-005453-4057qib7	273	41	(	(	-LRB-
cord-005453-4057qib7	273	42	CSA	CSA	NNP
cord-005453-4057qib7	273	43	/	/	SYM
cord-005453-4057qib7	273	44	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	273	45	/	/	SYM
cord-005453-4057qib7	273	46	Degranulation	Degranulation	NNP
cord-005453-4057qib7	273	47	/	/	,
cord-005453-4057qib7	273	48	intracellular	intracellular	JJ
cord-005453-4057qib7	273	49	cytokine	cytokine	NN
cord-005453-4057qib7	273	50	-	-	HYPH
cord-005453-4057qib7	273	51	assays	assay	NNS
cord-005453-4057qib7	273	52	)	)	-RRB-
cord-005453-4057qib7	273	53	.	.	.
cord-005453-4057qib7	274	1	In	in	IN
cord-005453-4057qib7	274	2	addition	addition	NN
cord-005453-4057qib7	274	3	flowcytometric	flowcytometric	JJ
cord-005453-4057qib7	274	4	evaluations	evaluation	NNS
cord-005453-4057qib7	274	5	of	of	IN
cord-005453-4057qib7	274	6	cellular	cellular	JJ
cord-005453-4057qib7	274	7	and	and	CC
cord-005453-4057qib7	274	8	(	(	-LRB-
cord-005453-4057qib7	274	9	leukemia	leukemia	NN
cord-005453-4057qib7	274	10	-	-	HYPH
cord-005453-4057qib7	274	11	specific	specific	JJ
cord-005453-4057qib7	274	12	)	)	-RRB-
cord-005453-4057qib7	274	13	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	274	14	compositions	composition	NNS
cord-005453-4057qib7	274	15	were	be	VBD
cord-005453-4057qib7	274	16	performed	perform	VBN
cord-005453-4057qib7	274	17	from	from	IN
cord-005453-4057qib7	274	18	rats'/pts	rats'/pt	NNS
cord-005453-4057qib7	274	19	'	'	POS
cord-005453-4057qib7	274	20	blood	blood	NN
cord-005453-4057qib7	274	21	in	in	IN
cord-005453-4057qib7	274	22	the	the	DT
cord-005453-4057qib7	274	23	course	course	NN
cord-005453-4057qib7	274	24	of	of	IN
cord-005453-4057qib7	274	25	the	the	DT
cord-005453-4057qib7	274	26	disease	disease	NN
cord-005453-4057qib7	274	27	.	.	.
cord-005453-4057qib7	275	1	Results	result	NNS
cord-005453-4057qib7	275	2	:	:	:
cord-005453-4057qib7	275	3	1	1	LS
cord-005453-4057qib7	275	4	)	)	-RRB-
cord-005453-4057qib7	275	5	AML	AML	NNP
cord-005453-4057qib7	275	6	-	-	HYPH
cord-005453-4057qib7	275	7	diseased	disease	VBN
cord-005453-4057qib7	275	8	rats	rat	NNS
cord-005453-4057qib7	275	9	:	:	:
cord-005453-4057qib7	275	10	each	each	DT
cord-005453-4057qib7	275	11	3rats	3rats	CD
cord-005453-4057qib7	275	12	were	be	VBD
cord-005453-4057qib7	275	13	treated	treat	VBN
cord-005453-4057qib7	275	14	with	with	IN
cord-005453-4057qib7	275	15	"	"	``
cord-005453-4057qib7	275	16	I	-PRON-	PRP
cord-005453-4057qib7	275	17	"	"	''
cord-005453-4057qib7	275	18	,	,	,
cord-005453-4057qib7	275	19	"	"	``
cord-005453-4057qib7	275	20	K	K	NNP
cord-005453-4057qib7	275	21	"	"	''
cord-005453-4057qib7	275	22	or	or	CC
cord-005453-4057qib7	275	23	"	"	``
cord-005453-4057qib7	275	24	M	M	NNP
cord-005453-4057qib7	275	25	"	"	''
cord-005453-4057qib7	275	26	or	or	CC
cord-005453-4057qib7	275	27	were	be	VBD
cord-005453-4057qib7	275	28	untreated	untreated	JJ
cord-005453-4057qib7	275	29	(	(	-LRB-
cord-005453-4057qib7	275	30	controls	control	NNS
cord-005453-4057qib7	275	31	)	)	-RRB-
cord-005453-4057qib7	275	32	.	.	.
cord-005453-4057qib7	276	1	A	a	DT
cord-005453-4057qib7	276	2	significant	significant	JJ
cord-005453-4057qib7	276	3	increase	increase	NN
cord-005453-4057qib7	276	4	of	of	IN
cord-005453-4057qib7	276	5	DCleu	DCleu	NNP
cord-005453-4057qib7	276	6	could	could	MD
cord-005453-4057qib7	276	7	be	be	VB
cord-005453-4057qib7	276	8	detected	detect	VBN
cord-005453-4057qib7	276	9	in	in	IN
cord-005453-4057qib7	276	10	spleen	spleen	NN
cord-005453-4057qib7	276	11	/	/	SYM
cord-005453-4057qib7	276	12	PB	PB	NNP
cord-005453-4057qib7	276	13	in	in	IN
cord-005453-4057qib7	276	14	kit-(esp	kit-(esp	NNP
cord-005453-4057qib7	276	15	.	.	.
cord-005453-4057qib7	277	1	M	M	NNP
cord-005453-4057qib7	277	2	)	)	-RRB-
cord-005453-4057qib7	277	3	treated	treat	VBD
cord-005453-4057qib7	277	4	compared	compare	VBN
cord-005453-4057qib7	277	5	to	to	IN
cord-005453-4057qib7	277	6	untreated	untreated	JJ
cord-005453-4057qib7	277	7	animals	animal	NNS
cord-005453-4057qib7	277	8	without	without	IN
cord-005453-4057qib7	277	9	induction	induction	NN
cord-005453-4057qib7	277	10	of	of	IN
cord-005453-4057qib7	277	11	blasts	blast	NNS
cord-005453-4057qib7	277	12	'	'	POS
cord-005453-4057qib7	277	13	proliferation	proliferation	NN
cord-005453-4057qib7	277	14	(	(	-LRB-
cord-005453-4057qib7	277	15	Ki67positivity	ki67positivity	NN
cord-005453-4057qib7	277	16	)	)	-RRB-
cord-005453-4057qib7	278	1	:	:	:
cord-005453-4057qib7	278	2	a	a	DT
cord-005453-4057qib7	278	3	significant	significant	JJ
cord-005453-4057qib7	278	4	reduction	reduction	NN
cord-005453-4057qib7	278	5	of	of	IN
cord-005453-4057qib7	278	6	blasts	blast	NNS
cord-005453-4057qib7	278	7	was	be	VBD
cord-005453-4057qib7	278	8	seen	see	VBN
cord-005453-4057qib7	278	9	with	with	IN
cord-005453-4057qib7	278	10	"	"	``
cord-005453-4057qib7	278	11	M	M	NNP
cord-005453-4057qib7	278	12	"	"	''
cord-005453-4057qib7	278	13	(	(	-LRB-
cord-005453-4057qib7	278	14	p=0.03/	p=0.03/	NNP
cord-005453-4057qib7	278	15	0.0001	0.0001	CD
cord-005453-4057qib7	278	16	in	in	IN
cord-005453-4057qib7	278	17	spleen	spleen	NN
cord-005453-4057qib7	278	18	/	/	SYM
cord-005453-4057qib7	278	19	PB	PB	NNP
cord-005453-4057qib7	278	20	)	)	-RRB-
cord-005453-4057qib7	278	21	and	and	CC
cord-005453-4057qib7	278	22	"	"	``
cord-005453-4057qib7	278	23	I	-PRON-	PRP
cord-005453-4057qib7	278	24	"	"	''
cord-005453-4057qib7	278	25	,	,	,
cord-005453-4057qib7	278	26	but	but	CC
cord-005453-4057qib7	278	27	not	not	RB
cord-005453-4057qib7	278	28	"	"	``
cord-005453-4057qib7	278	29	K	K	NNP
cord-005453-4057qib7	278	30	"	"	''
cord-005453-4057qib7	278	31	.	.	.
cord-005453-4057qib7	279	1	Successful	successful	JJ
cord-005453-4057qib7	279	2	treatment	treatment	NN
cord-005453-4057qib7	279	3	correlated	correlate	VBD
cord-005453-4057qib7	279	4	with	with	IN
cord-005453-4057qib7	279	5	an	an	DT
cord-005453-4057qib7	279	6	increase	increase	NN
cord-005453-4057qib7	279	7	of	of	IN
cord-005453-4057qib7	279	8	CD62L+Tcells	CD62L+Tcells	NNPS
cord-005453-4057qib7	279	9	,	,	,
cord-005453-4057qib7	279	10	most	most	RBS
cord-005453-4057qib7	279	11	likely	likely	RB
cord-005453-4057qib7	279	12	representing	represent	VBG
cord-005453-4057qib7	279	13	Tmem	Tmem	NNP
cord-005453-4057qib7	279	14	-	-	HYPH
cord-005453-4057qib7	279	15	cells	cell	NNS
cord-005453-4057qib7	279	16	,	,	,
cord-005453-4057qib7	279	17	(	(	-LRB-
cord-005453-4057qib7	279	18	p=0.07	p=0.07	NNP
cord-005453-4057qib7	279	19	)	)	-RRB-
cord-005453-4057qib7	279	20	and	and	CC
cord-005453-4057qib7	279	21	a	a	DT
cord-005453-4057qib7	279	22	reduction	reduction	NN
cord-005453-4057qib7	279	23	of	of	IN
cord-005453-4057qib7	279	24	CD4+Treg	CD4+Treg	NNP
cord-005453-4057qib7	279	25	(	(	-LRB-
cord-005453-4057qib7	279	26	p=0.037	p=0.037	NNP
cord-005453-4057qib7	279	27	)	)	-RRB-
cord-005453-4057qib7	279	28	.	.	.
cord-005453-4057qib7	280	1	2	2	LS
cord-005453-4057qib7	280	2	)	)	-RRB-
cord-005453-4057qib7	280	3	6	6	CD
cord-005453-4057qib7	280	4	therapy	therapy	NN
cord-005453-4057qib7	280	5	-	-	HYPH
cord-005453-4057qib7	280	6	refractory	refractory	JJ
cord-005453-4057qib7	280	7	AML	AML	NNP
cord-005453-4057qib7	280	8	-	-	HYPH
cord-005453-4057qib7	280	9	patients	patient	NNS
cord-005453-4057qib7	280	10	(	(	-LRB-
cord-005453-4057qib7	280	11	during	during	IN
cord-005453-4057qib7	280	12	the	the	DT
cord-005453-4057qib7	280	13	course	course	NN
cord-005453-4057qib7	280	14	of	of	IN
cord-005453-4057qib7	280	15	decitabine	decitabine	NNP
cord-005453-4057qib7	280	16	/	/	SYM
cord-005453-4057qib7	280	17	LD	LD	NNP
cord-005453-4057qib7	280	18	-	-	HYPH
cord-005453-4057qib7	280	19	AraCtreatment	AraCtreatment	NNP
cord-005453-4057qib7	280	20	)	)	-RRB-
cord-005453-4057qib7	280	21	:	:	:
cord-005453-4057qib7	280	22	kit	kit	NN
cord-005453-4057qib7	280	23	-	-	HYPH
cord-005453-4057qib7	280	24	M	M	NNP
cord-005453-4057qib7	280	25	was	be	VBD
cord-005453-4057qib7	280	26	shown	show	VBN
cord-005453-4057qib7	280	27	to	to	IN
cord-005453-4057qib7	280	28	ex	ex	FW
cord-005453-4057qib7	280	29	vivo	vivo	NN
cord-005453-4057qib7	280	30	generate	generate	VB
cord-005453-4057qib7	280	31	DCleu	DCleu	NNP
cord-005453-4057qib7	280	32	,	,	,
cord-005453-4057qib7	280	33	activate	activate	VB
cord-005453-4057qib7	280	34	immunereactive	immunereactive	JJ
cord-005453-4057qib7	280	35	cells	cell	NNS
cord-005453-4057qib7	280	36	and	and	CC
cord-005453-4057qib7	280	37	mediate	mediate	VB
cord-005453-4057qib7	280	38	leukemia	leukemia	NN
cord-005453-4057qib7	280	39	-	-	HYPH
cord-005453-4057qib7	280	40	specific	specific	JJ
cord-005453-4057qib7	280	41	/	/	SYM
cord-005453-4057qib7	280	42	antileukemic	antileukemic	JJ
cord-005453-4057qib7	280	43	response	response	NN
cord-005453-4057qib7	280	44	.	.	.
cord-005453-4057qib7	281	1	Activated	activate	VBN
cord-005453-4057qib7	281	2	or	or	CC
cord-005453-4057qib7	281	3	leukemia	leukemia	NN
cord-005453-4057qib7	281	4	-	-	HYPH
cord-005453-4057qib7	281	5	specific	specific	JJ
cord-005453-4057qib7	281	6	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	281	7	were	be	VBD
cord-005453-4057qib7	281	8	monitored	monitor	VBN
cord-005453-4057qib7	281	9	in	in	IN
cord-005453-4057qib7	281	10	low	low	JJ
cord-005453-4057qib7	281	11	proportions	proportion	NNS
cord-005453-4057qib7	281	12	in	in	IN
cord-005453-4057qib7	281	13	active	active	JJ
cord-005453-4057qib7	281	14	stages	stage	NNS
cord-005453-4057qib7	281	15	of	of	IN
cord-005453-4057qib7	281	16	the	the	DT
cord-005453-4057qib7	281	17	disease	disease	NN
cord-005453-4057qib7	281	18	as	as	RB
cord-005453-4057qib7	281	19	well	well	RB
cord-005453-4057qib7	281	20	as	as	IN
cord-005453-4057qib7	281	21	of	of	IN
cord-005453-4057qib7	281	22	two	two	CD
cord-005453-4057qib7	281	23	patients	patient	NNS
cord-005453-4057qib7	281	24	during	during	IN
cord-005453-4057qib7	281	25	the	the	DT
cord-005453-4057qib7	281	26	further	further	JJ
cord-005453-4057qib7	281	27	course	course	NN
cord-005453-4057qib7	281	28	of	of	IN
cord-005453-4057qib7	281	29	persisting	persist	VBG
cord-005453-4057qib7	281	30	disease	disease	NN
cord-005453-4057qib7	281	31	.	.	.
cord-005453-4057qib7	282	1	One	one	CD
cord-005453-4057qib7	282	2	of	of	IN
cord-005453-4057qib7	282	3	these	these	DT
cord-005453-4057qib7	282	4	patients	patient	NNS
cord-005453-4057qib7	282	5	(	(	-LRB-
cord-005453-4057qib7	282	6	72	72	CD
cord-005453-4057qib7	282	7	yo	yo	NNP
cord-005453-4057qib7	282	8	male	male	NNP
cord-005453-4057qib7	282	9	)	)	-RRB-
cord-005453-4057qib7	282	10	,	,	,
cord-005453-4057qib7	282	11	was	be	VBD
cord-005453-4057qib7	282	12	offered	offer	VBN
cord-005453-4057qib7	282	13	an	an	DT
cord-005453-4057qib7	282	14	individual	individual	JJ
cord-005453-4057qib7	282	15	systemic	systemic	JJ
cord-005453-4057qib7	282	16	salvage	salvage	NN
cord-005453-4057qib7	282	17	-	-	HYPH
cord-005453-4057qib7	282	18	treatment	treatment	NN
cord-005453-4057qib7	282	19	(	(	-LRB-
cord-005453-4057qib7	282	20	Kit	Kit	NNP
cord-005453-4057qib7	282	21	-	-	HYPH
cord-005453-4057qib7	282	22	M	M	NNP
cord-005453-4057qib7	282	23	,	,	,
cord-005453-4057qib7	282	24	applied	apply	VBD
cord-005453-4057qib7	282	25	as	as	IN
cord-005453-4057qib7	282	26	continuous	continuous	JJ
cord-005453-4057qib7	282	27	infusions	infusion	NNS
cord-005453-4057qib7	282	28	)	)	-RRB-
cord-005453-4057qib7	282	29	for	for	IN
cord-005453-4057qib7	282	30	refractory	refractory	JJ
cord-005453-4057qib7	282	31	leukemia	leukemia	NN
cord-005453-4057qib7	282	32	.	.	.
cord-005453-4057qib7	283	1	after	after	IN
cord-005453-4057qib7	283	2	approval	approval	NN
cord-005453-4057qib7	283	3	from	from	IN
cord-005453-4057qib7	283	4	the	the	DT
cord-005453-4057qib7	283	5	local	local	JJ
cord-005453-4057qib7	283	6	ethical	ethical	JJ
cord-005453-4057qib7	283	7	commitee	commitee	NN
cord-005453-4057qib7	283	8	,	,	,
cord-005453-4057qib7	283	9	extensive	extensive	JJ
cord-005453-4057qib7	283	10	information	information	NN
cord-005453-4057qib7	283	11	of	of	IN
cord-005453-4057qib7	283	12	the	the	DT
cord-005453-4057qib7	283	13	patient	patient	NN
cord-005453-4057qib7	283	14	about	about	IN
cord-005453-4057qib7	283	15	the	the	DT
cord-005453-4057qib7	283	16	experimental	experimental	JJ
cord-005453-4057qib7	283	17	nature	nature	NN
cord-005453-4057qib7	283	18	of	of	IN
cord-005453-4057qib7	283	19	the	the	DT
cord-005453-4057qib7	283	20	treatment	treatment	NN
cord-005453-4057qib7	283	21	and	and	CC
cord-005453-4057qib7	283	22	obtaining	obtain	VBG
cord-005453-4057qib7	283	23	his	-PRON-	PRP$
cord-005453-4057qib7	283	24	written	write	VBN
cord-005453-4057qib7	283	25	informed	informed	JJ
cord-005453-4057qib7	283	26	consent	consent	NN
cord-005453-4057qib7	283	27	.	.	.
cord-005453-4057qib7	284	1	Clinically	clinically	RB
cord-005453-4057qib7	284	2	the	the	DT
cord-005453-4057qib7	284	3	treatment	treatment	NN
cord-005453-4057qib7	284	4	was	be	VBD
cord-005453-4057qib7	284	5	well	well	RB
cord-005453-4057qib7	284	6	tolerated	tolerate	VBN
cord-005453-4057qib7	284	7	and	and	CC
cord-005453-4057qib7	284	8	the	the	DT
cord-005453-4057qib7	284	9	patient	patient	NN
cord-005453-4057qib7	284	10	improved	improve	VBD
cord-005453-4057qib7	284	11	clinically	clinically	RB
cord-005453-4057qib7	284	12	.	.	.
cord-005453-4057qib7	285	1	Neutrophils	Neutrophils	NNP
cord-005453-4057qib7	285	2	in	in	IN
cord-005453-4057qib7	285	3	WBC	WBC	NNP
cord-005453-4057qib7	285	4	increased	increase	VBD
cord-005453-4057qib7	285	5	from	from	IN
cord-005453-4057qib7	285	6	10	10	CD
cord-005453-4057qib7	285	7	%	%	NN
cord-005453-4057qib7	285	8	to	to	IN
cord-005453-4057qib7	285	9	50	50	CD
cord-005453-4057qib7	285	10	%	%	NN
cord-005453-4057qib7	285	11	,	,	,
cord-005453-4057qib7	285	12	thrombocytes	thrombocyte	NNS
cord-005453-4057qib7	285	13	reached	reach	VBD
cord-005453-4057qib7	285	14	100	100	CD
cord-005453-4057qib7	285	15	G	g	NN
cord-005453-4057qib7	285	16	/	/	SYM
cord-005453-4057qib7	285	17	l	l	NN
cord-005453-4057qib7	285	18	after	after	IN
cord-005453-4057qib7	285	19	24	24	CD
cord-005453-4057qib7	285	20	days	day	NNS
cord-005453-4057qib7	285	21	.	.	.
cord-005453-4057qib7	286	1	After	after	IN
cord-005453-4057qib7	286	2	4	4	CD
cord-005453-4057qib7	286	3	weeks	week	NNS
cord-005453-4057qib7	286	4	of	of	IN
cord-005453-4057qib7	286	5	treatment	treatment	NN
cord-005453-4057qib7	286	6	,	,	,
cord-005453-4057qib7	286	7	the	the	DT
cord-005453-4057qib7	286	8	patient	patient	NN
cord-005453-4057qib7	286	9	was	be	VBD
cord-005453-4057qib7	286	10	discharged	discharge	VBN
cord-005453-4057qib7	286	11	in	in	IN
cord-005453-4057qib7	286	12	good	good	JJ
cord-005453-4057qib7	286	13	clinical	clinical	JJ
cord-005453-4057qib7	286	14	conditions	condition	NNS
cord-005453-4057qib7	286	15	.	.	.
cord-005453-4057qib7	287	1	12	12	CD
cord-005453-4057qib7	287	2	days	day	NNS
cord-005453-4057qib7	287	3	later	later	RB
cord-005453-4057qib7	287	4	,	,	,
cord-005453-4057qib7	287	5	progression	progression	NN
cord-005453-4057qib7	287	6	of	of	IN
cord-005453-4057qib7	287	7	AML	AML	NNP
cord-005453-4057qib7	287	8	was	be	VBD
cord-005453-4057qib7	287	9	seen	see	VBN
cord-005453-4057qib7	287	10	with	with	IN
cord-005453-4057qib7	287	11	high	high	JJ
cord-005453-4057qib7	287	12	blast	blast	NN
cord-005453-4057qib7	287	13	counts	count	NNS
cord-005453-4057qib7	287	14	in	in	IN
cord-005453-4057qib7	287	15	PB	PB	NNP
cord-005453-4057qib7	287	16	and	and	CC
cord-005453-4057qib7	287	17	BM	BM	NNP
cord-005453-4057qib7	287	18	.	.	.
cord-005453-4057qib7	288	1	The	the	DT
cord-005453-4057qib7	288	2	patient	patient	NN
cord-005453-4057qib7	288	3	developed	develop	VBD
cord-005453-4057qib7	288	4	severe	severe	JJ
cord-005453-4057qib7	288	5	sepsis	sepsis	NN
cord-005453-4057qib7	288	6	and	and	CC
cord-005453-4057qib7	288	7	died	die	VBD
cord-005453-4057qib7	288	8	few	few	JJ
cord-005453-4057qib7	288	9	days	day	NNS
cord-005453-4057qib7	288	10	later	later	RB
cord-005453-4057qib7	288	11	.	.	.
cord-005453-4057qib7	289	1	Immune	immune	JJ
cord-005453-4057qib7	289	2	monitoring	monitoring	NN
cord-005453-4057qib7	289	3	showed	show	VBD
cord-005453-4057qib7	289	4	(	(	-LRB-
cord-005453-4057qib7	289	5	other	other	JJ
cord-005453-4057qib7	289	6	than	than	IN
cord-005453-4057qib7	289	7	before	before	IN
cord-005453-4057qib7	289	8	treatment	treatment	NN
cord-005453-4057qib7	289	9	and	and	CC
cord-005453-4057qib7	289	10	in	in	IN
cord-005453-4057qib7	289	11	the	the	DT
cord-005453-4057qib7	289	12	patients	patient	NNS
cord-005453-4057qib7	289	13	without	without	IN
cord-005453-4057qib7	289	14	kit	kit	NN
cord-005453-4057qib7	289	15	-	-	HYPH
cord-005453-4057qib7	289	16	M	m	NN
cord-005453-4057qib7	289	17	-	-	HYPH
cord-005453-4057qib7	289	18	treatment	treatment	NN
cord-005453-4057qib7	289	19	)	)	-RRB-
cord-005453-4057qib7	289	20	a	a	DT
cord-005453-4057qib7	289	21	continuous	continuous	JJ
cord-005453-4057qib7	289	22	increase	increase	NN
cord-005453-4057qib7	289	23	of	of	IN
cord-005453-4057qib7	289	24	proliferating	proliferate	VBG
cord-005453-4057qib7	289	25	and	and	CC
cord-005453-4057qib7	289	26	non	non	JJ
cord-005453-4057qib7	289	27	-	-	JJ
cord-005453-4057qib7	289	28	naïve	naïve	JJ
cord-005453-4057qib7	289	29	Tcells	Tcells	NNP
cord-005453-4057qib7	289	30	,	,	,
cord-005453-4057qib7	289	31	NK	NK	NNP
cord-005453-4057qib7	289	32	,	,	,
cord-005453-4057qib7	290	1	CIKand	CIKand	NNP
cord-005453-4057qib7	290	2	NKT-	NKT-	NNP
cord-005453-4057qib7	290	3	,	,	,
cord-005453-4057qib7	290	4	TH17	TH17	NNP
cord-005453-4057qib7	290	5	cells	cell	NNS
cord-005453-4057qib7	290	6	,	,	,
cord-005453-4057qib7	290	7	Bmem	Bmem	NNP
cord-005453-4057qib7	290	8	-	-	HYPH
cord-005453-4057qib7	290	9	cells	cell	NNS
cord-005453-4057qib7	290	10	and	and	CC
cord-005453-4057qib7	290	11	DC	DC	NNP
cord-005453-4057qib7	290	12	in	in	IN
cord-005453-4057qib7	290	13	PB	PB	NNP
cord-005453-4057qib7	290	14	.	.	.
cord-005453-4057qib7	291	1	The	the	DT
cord-005453-4057qib7	291	2	production	production	NN
cord-005453-4057qib7	291	3	of	of	IN
cord-005453-4057qib7	291	4	IFNƔ	IFNƔ	NNP
cord-005453-4057qib7	291	5	producing	produce	VBG
cord-005453-4057qib7	291	6	T-	T-	NNP
cord-005453-4057qib7	291	7	,	,	,
cord-005453-4057qib7	291	8	CIK	CIK	NNP
cord-005453-4057qib7	291	9	and	and	CC
cord-005453-4057qib7	291	10	NKT	NKT	NNP
cord-005453-4057qib7	291	11	-	-	HYPH
cord-005453-4057qib7	291	12	cells	cell	NNS
cord-005453-4057qib7	291	13	was	be	VBD
cord-005453-4057qib7	291	14	demonstrated	demonstrate	VBN
cord-005453-4057qib7	291	15	,	,	,
cord-005453-4057qib7	291	16	suggesting	suggest	VBG
cord-005453-4057qib7	291	17	an	an	DT
cord-005453-4057qib7	291	18	in	in	IN
cord-005453-4057qib7	291	19	vivo	vivo	NN
cord-005453-4057qib7	291	20	production	production	NN
cord-005453-4057qib7	291	21	/	/	SYM
cord-005453-4057qib7	291	22	activation	activation	NN
cord-005453-4057qib7	291	23	of	of	IN
cord-005453-4057qib7	291	24	(	(	-LRB-
cord-005453-4057qib7	291	25	potentially	potentially	RB
cord-005453-4057qib7	291	26	leukemia	leukemia	NN
cord-005453-4057qib7	291	27	-	-	HYPH
cord-005453-4057qib7	291	28	specific	specific	JJ
cord-005453-4057qib7	291	29	)	)	-RRB-
cord-005453-4057qib7	291	30	cells	cell	NNS
cord-005453-4057qib7	291	31	.	.	.
cord-005453-4057qib7	292	1	Immune	immune	JJ
cord-005453-4057qib7	292	2	stimulatory	stimulatory	JJ
cord-005453-4057qib7	292	3	effects	effect	NNS
cord-005453-4057qib7	292	4	decreased	decrease	VBD
cord-005453-4057qib7	292	5	after	after	IN
cord-005453-4057qib7	292	6	discontinuation	discontinuation	NN
cord-005453-4057qib7	292	7	of	of	IN
cord-005453-4057qib7	292	8	therapy	therapy	NN
cord-005453-4057qib7	292	9	.	.	.
cord-005453-4057qib7	293	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	293	2	:	:	:
cord-005453-4057qib7	294	1	Treatment	treatment	NN
cord-005453-4057qib7	294	2	of	of	IN
cord-005453-4057qib7	294	3	WB	WB	NNP
cord-005453-4057qib7	294	4	as	as	RB
cord-005453-4057qib7	294	5	well	well	RB
cord-005453-4057qib7	294	6	as	as	IN
cord-005453-4057qib7	294	7	leukemically	leukemically	RB
cord-005453-4057qib7	294	8	diseased	disease	VBN
cord-005453-4057qib7	294	9	organisms	organism	NNS
cord-005453-4057qib7	294	10	with	with	IN
cord-005453-4057qib7	294	11	blast	blast	NN
cord-005453-4057qib7	294	12	-	-	HYPH
cord-005453-4057qib7	294	13	modulating	modulate	VBG
cord-005453-4057qib7	294	14	kits	kit	NNS
cord-005453-4057qib7	294	15	(	(	-LRB-
cord-005453-4057qib7	294	16	especially	especially	RB
cord-005453-4057qib7	294	17	GM	GM	NNP
cord-005453-4057qib7	294	18	-	-	HYPH
cord-005453-4057qib7	294	19	CSF	CSF	NNP
cord-005453-4057qib7	294	20	and	and	CC
cord-005453-4057qib7	294	21	PGE1	PGE1	NNP
cord-005453-4057qib7	294	22	)	)	-RRB-
cord-005453-4057qib7	294	23	was	be	VBD
cord-005453-4057qib7	294	24	well	well	RB
cord-005453-4057qib7	294	25	tolerated	tolerate	VBN
cord-005453-4057qib7	294	26	and	and	CC
cord-005453-4057qib7	294	27	induced	induce	VBN
cord-005453-4057qib7	294	28	clinical	clinical	JJ
cord-005453-4057qib7	294	29	and	and	CC
cord-005453-4057qib7	294	30	immunological	immunological	JJ
cord-005453-4057qib7	294	31	improvement	improvement	NN
cord-005453-4057qib7	294	32	(	(	-LRB-
cord-005453-4057qib7	294	33	adaptive	adaptive	JJ
cord-005453-4057qib7	294	34	and	and	CC
cord-005453-4057qib7	294	35	innate	innate	JJ
cord-005453-4057qib7	294	36	immune	immune	JJ
cord-005453-4057qib7	294	37	system	system	NN
cord-005453-4057qib7	294	38	)	)	-RRB-
cord-005453-4057qib7	294	39	,	,	,
cord-005453-4057qib7	294	40	whereas	whereas	IN
cord-005453-4057qib7	294	41	low	low	JJ
cord-005453-4057qib7	294	42	counts	count	NNS
cord-005453-4057qib7	294	43	of	of	IN
cord-005453-4057qib7	294	44	(	(	-LRB-
cord-005453-4057qib7	294	45	leukemiaspecific	leukemiaspecific	NN
cord-005453-4057qib7	294	46	)	)	-RRB-
cord-005453-4057qib7	294	47	activated	activate	VBN
cord-005453-4057qib7	294	48	immune	immune	NN
cord-005453-4057qib7	294	49	-	-	HYPH
cord-005453-4057qib7	294	50	reactive	reactive	JJ
cord-005453-4057qib7	294	51	cells	cell	NNS
cord-005453-4057qib7	294	52	were	be	VBD
cord-005453-4057qib7	294	53	found	find	VBN
cord-005453-4057qib7	294	54	in	in	IN
cord-005453-4057qib7	294	55	non	non	JJ
cord-005453-4057qib7	294	56	-	-	JJ
cord-005453-4057qib7	294	57	kit	kit	RB
cord-005453-4057qib7	294	58	-	-	HYPH
cord-005453-4057qib7	294	59	treated	treat	VBN
cord-005453-4057qib7	294	60	organisms	organism	NNS
cord-005453-4057qib7	294	61	.	.	.
cord-005453-4057qib7	295	1	Disclosure	disclosure	NN
cord-005453-4057qib7	295	2	:	:	:
cord-005453-4057qib7	295	3	Nothing	nothing	NN
cord-005453-4057qib7	295	4	to	to	TO
cord-005453-4057qib7	295	5	declare	declare	VB
cord-005453-4057qib7	295	6	P019	P019	NNP
cord-005453-4057qib7	295	7	Long	long	JJ
cord-005453-4057qib7	295	8	-	-	HYPH
cord-005453-4057qib7	295	9	term	term	NN
cord-005453-4057qib7	295	10	outcomes	outcome	NNS
cord-005453-4057qib7	295	11	after	after	IN
cord-005453-4057qib7	295	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	295	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	295	14	stem	stem	NN
cord-005453-4057qib7	295	15	cell	cell	NN
cord-005453-4057qib7	295	16	transplantation	transplantation	NN
cord-005453-4057qib7	295	17	for	for	IN
cord-005453-4057qib7	295	18	acute	acute	JJ
cord-005453-4057qib7	295	19	myeloid	myeloid	JJ
cord-005453-4057qib7	295	20	leukemia	leukemia	NN
cord-005453-4057qib7	295	21	with	with	IN
cord-005453-4057qib7	295	22	non	non	JJ
cord-005453-4057qib7	295	23	-	-	JJ
cord-005453-4057qib7	295	24	myeloablative	myeloablative	JJ
cord-005453-4057qib7	295	25	and	and	CC
cord-005453-4057qib7	295	26	myeloablative	myeloablative	JJ
cord-005453-4057qib7	295	27	conditioning	conditioning	NN
cord-005453-4057qib7	295	28	:	:	:
cord-005453-4057qib7	295	29	A	a	DT
cord-005453-4057qib7	295	30	single	single	JJ
cord-005453-4057qib7	295	31	-	-	HYPH
cord-005453-4057qib7	295	32	center	center	NN
cord-005453-4057qib7	295	33	cohort	cohort	NN
cord-005453-4057qib7	295	34	study	study	NN
cord-005453-4057qib7	295	35	of	of	IN
cord-005453-4057qib7	295	36	438	438	CD
cord-005453-4057qib7	295	37	consecutive	consecutive	JJ
cord-005453-4057qib7	295	38	patients	patient	NNS
cord-005453-4057qib7	295	39	1Lars	1lars	CD
cord-005453-4057qib7	295	40	Klingen	Klingen	NNP
cord-005453-4057qib7	295	41	Gjaerde	Gjaerde	NNP
cord-005453-4057qib7	295	42	,	,	,
cord-005453-4057qib7	295	43	Niels	Niels	NNP
cord-005453-4057qib7	295	44	Smedegaard	Smedegaard	NNP
cord-005453-4057qib7	295	45	Andersen	Andersen	NNP
cord-005453-4057qib7	295	46	1	1	CD
cord-005453-4057qib7	295	47	,	,	,
cord-005453-4057qib7	295	48	Lone	Lone	NNP
cord-005453-4057qib7	295	49	Smidstrup	Smidstrup	NNP
cord-005453-4057qib7	295	50	Friis	Friis	NNP
cord-005453-4057qib7	295	51	1	1	CD
cord-005453-4057qib7	295	52	,	,	,
cord-005453-4057qib7	295	53	Brian	Brian	NNP
cord-005453-4057qib7	295	54	Thomas	Thomas	NNP
cord-005453-4057qib7	295	55	Kornblit	Kornblit	NNP
cord-005453-4057qib7	295	56	1	1	CD
cord-005453-4057qib7	295	57	,	,	,
cord-005453-4057qib7	295	58	Søren	Søren	NNP
cord-005453-4057qib7	295	59	Lykke	Lykke	NNP
cord-005453-4057qib7	295	60	Petersen	Petersen	NNP
cord-005453-4057qib7	295	61	1	1	CD
cord-005453-4057qib7	295	62	,	,	,
cord-005453-4057qib7	295	63	Ida	Ida	NNP
cord-005453-4057qib7	295	64	Schjødt	Schjødt	NNP
cord-005453-4057qib7	295	65	1	1	CD
cord-005453-4057qib7	295	66	,	,	,
cord-005453-4057qib7	295	67	Henrik	Henrik	NNP
cord-005453-4057qib7	295	68	Sengeløv	Sengeløv	NNP
cord-005453-4057qib7	296	1	1	1	CD
cord-005453-4057qib7	296	2	1	1	CD
cord-005453-4057qib7	296	3	Rigshospitalet	Rigshospitalet	NNP
cord-005453-4057qib7	296	4	,	,	,
cord-005453-4057qib7	296	5	Copenhagen	Copenhagen	NNP
cord-005453-4057qib7	296	6	,	,	,
cord-005453-4057qib7	296	7	Denmark	Denmark	NNP
cord-005453-4057qib7	296	8	Background	Background	NNP
cord-005453-4057qib7	296	9	:	:	:
cord-005453-4057qib7	296	10	Since	since	IN
cord-005453-4057qib7	296	11	2000	2000	CD
cord-005453-4057qib7	296	12	,	,	,
cord-005453-4057qib7	296	13	we	-PRON-	PRP
cord-005453-4057qib7	296	14	have	have	VBP
cord-005453-4057qib7	296	15	at	at	IN
cord-005453-4057qib7	296	16	our	-PRON-	PRP$
cord-005453-4057qib7	296	17	institution	institution	NN
cord-005453-4057qib7	296	18	used	use	VBD
cord-005453-4057qib7	296	19	a	a	DT
cord-005453-4057qib7	296	20	non	non	JJ
cord-005453-4057qib7	296	21	-	-	JJ
cord-005453-4057qib7	296	22	myeloablative	myeloablative	JJ
cord-005453-4057qib7	296	23	(	(	-LRB-
cord-005453-4057qib7	296	24	NMA	NMA	NNP
cord-005453-4057qib7	296	25	)	)	-RRB-
cord-005453-4057qib7	296	26	conditioning	conditioning	NN
cord-005453-4057qib7	296	27	regimen	regimen	NN
cord-005453-4057qib7	296	28	for	for	IN
cord-005453-4057qib7	296	29	older	old	JJR
cord-005453-4057qib7	296	30	(	(	-LRB-
cord-005453-4057qib7	296	31	>	>	NFP
cord-005453-4057qib7	296	32	50	50	CD
cord-005453-4057qib7	296	33	years	year	NNS
cord-005453-4057qib7	296	34	)	)	-RRB-
cord-005453-4057qib7	296	35	or	or	CC
cord-005453-4057qib7	296	36	significantly	significantly	RB
cord-005453-4057qib7	296	37	comorbid	comorbid	VBG
cord-005453-4057qib7	296	38	younger	young	JJR
cord-005453-4057qib7	296	39	patients	patient	NNS
cord-005453-4057qib7	296	40	undergoing	undergo	VBG
cord-005453-4057qib7	296	41	allogeneic	allogeneic	IN
cord-005453-4057qib7	296	42	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	296	43	stem	stem	NN
cord-005453-4057qib7	296	44	cell	cell	NN
cord-005453-4057qib7	296	45	transplantation	transplantation	NN
cord-005453-4057qib7	296	46	(	(	-LRB-
cord-005453-4057qib7	296	47	allo	allo	NN
cord-005453-4057qib7	296	48	-	-	HYPH
cord-005453-4057qib7	296	49	HSCT	HSCT	NNP
cord-005453-4057qib7	296	50	)	)	-RRB-
cord-005453-4057qib7	296	51	for	for	IN
cord-005453-4057qib7	296	52	acute	acute	JJ
cord-005453-4057qib7	296	53	myeloid	myeloid	JJ
cord-005453-4057qib7	296	54	leukemia	leukemia	NN
cord-005453-4057qib7	296	55	(	(	-LRB-
cord-005453-4057qib7	296	56	AML	AML	NNP
cord-005453-4057qib7	296	57	)	)	-RRB-
cord-005453-4057qib7	296	58	.	.	.
cord-005453-4057qib7	297	1	We	-PRON-	PRP
cord-005453-4057qib7	297	2	aimed	aim	VBD
cord-005453-4057qib7	297	3	to	to	TO
cord-005453-4057qib7	297	4	compare	compare	VB
cord-005453-4057qib7	297	5	the	the	DT
cord-005453-4057qib7	297	6	long	long	JJ
cord-005453-4057qib7	297	7	-	-	HYPH
cord-005453-4057qib7	297	8	term	term	NN
cord-005453-4057qib7	297	9	outcomes	outcome	NNS
cord-005453-4057qib7	297	10	of	of	IN
cord-005453-4057qib7	297	11	NMA	NMA	NNP
cord-005453-4057qib7	297	12	conditioned	condition	VBD
cord-005453-4057qib7	297	13	patients	patient	NNS
cord-005453-4057qib7	297	14	with	with	IN
cord-005453-4057qib7	297	15	myeloablative	myeloablative	NNP
cord-005453-4057qib7	297	16	(	(	-LRB-
cord-005453-4057qib7	297	17	MA	MA	NNP
cord-005453-4057qib7	297	18	)	)	-RRB-
cord-005453-4057qib7	297	19	conditioned	condition	VBD
cord-005453-4057qib7	297	20	patients	patient	NNS
cord-005453-4057qib7	297	21	.	.	.
cord-005453-4057qib7	298	1	Methods	method	NNS
cord-005453-4057qib7	298	2	:	:	:
cord-005453-4057qib7	299	1	We	-PRON-	PRP
cord-005453-4057qib7	299	2	studied	study	VBD
cord-005453-4057qib7	299	3	220	220	CD
cord-005453-4057qib7	299	4	NMA	NMA	NNP
cord-005453-4057qib7	299	5	and	and	CC
cord-005453-4057qib7	299	6	218	218	CD
cord-005453-4057qib7	299	7	MA	MA	NNP
cord-005453-4057qib7	299	8	conditioned	condition	VBN
cord-005453-4057qib7	299	9	adult	adult	NN
cord-005453-4057qib7	299	10	(	(	-LRB-
cord-005453-4057qib7	299	11	>	>	NFP
cord-005453-4057qib7	299	12	15	15	CD
cord-005453-4057qib7	299	13	years	year	NNS
cord-005453-4057qib7	299	14	)	)	-RRB-
cord-005453-4057qib7	299	15	consecutive	consecutive	JJ
cord-005453-4057qib7	299	16	patients	patient	NNS
cord-005453-4057qib7	299	17	receiving	receive	VBG
cord-005453-4057qib7	299	18	their	-PRON-	PRP$
cord-005453-4057qib7	299	19	first	first	JJ
cord-005453-4057qib7	299	20	allo	allo	NN
cord-005453-4057qib7	299	21	-	-	HYPH
cord-005453-4057qib7	299	22	HSCT	HSCT	NNP
cord-005453-4057qib7	299	23	for	for	IN
cord-005453-4057qib7	299	24	AML	AML	NNP
cord-005453-4057qib7	299	25	from	from	IN
cord-005453-4057qib7	299	26	2000	2000	CD
cord-005453-4057qib7	299	27	to	to	IN
cord-005453-4057qib7	299	28	2017	2017	CD
cord-005453-4057qib7	299	29	at	at	IN
cord-005453-4057qib7	299	30	Rigshospitalet	Rigshospitalet	NNP
cord-005453-4057qib7	299	31	.	.	.
cord-005453-4057qib7	300	1	NMA	NMA	NNP
cord-005453-4057qib7	300	2	conditioning	conditioning	NN
cord-005453-4057qib7	300	3	consisted	consist	VBD
cord-005453-4057qib7	300	4	mainly	mainly	RB
cord-005453-4057qib7	300	5	of	of	IN
cord-005453-4057qib7	300	6	2	2	CD
cord-005453-4057qib7	300	7	Gy	Gy	NNP
cord-005453-4057qib7	300	8	total	total	JJ
cord-005453-4057qib7	300	9	body	body	NN
cord-005453-4057qib7	300	10	irradiation	irradiation	NN
cord-005453-4057qib7	300	11	(	(	-LRB-
cord-005453-4057qib7	300	12	TBI	TBI	NNP
cord-005453-4057qib7	300	13	)	)	-RRB-
cord-005453-4057qib7	300	14	and	and	CC
cord-005453-4057qib7	300	15	fludarabine	fludarabine	VBP
cord-005453-4057qib7	300	16	90	90	CD
cord-005453-4057qib7	300	17	mg	mg	NNP
cord-005453-4057qib7	300	18	/	/	SYM
cord-005453-4057qib7	300	19	m	m	NN
cord-005453-4057qib7	300	20	2	2	CD
cord-005453-4057qib7	300	21	(	(	-LRB-
cord-005453-4057qib7	300	22	95	95	CD
cord-005453-4057qib7	300	23	%	%	NN
cord-005453-4057qib7	300	24	of	of	IN
cord-005453-4057qib7	300	25	cases	case	NNS
cord-005453-4057qib7	300	26	)	)	-RRB-
cord-005453-4057qib7	300	27	.	.	.
cord-005453-4057qib7	301	1	MA	MA	NNP
cord-005453-4057qib7	301	2	conditioning	conditioning	NN
cord-005453-4057qib7	301	3	consisted	consist	VBD
cord-005453-4057qib7	301	4	mainly	mainly	RB
cord-005453-4057qib7	301	5	of	of	IN
cord-005453-4057qib7	301	6	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	301	7	120	120	CD
cord-005453-4057qib7	301	8	mg/	mg/	NN
cord-005453-4057qib7	301	9	kg	kg	NN
cord-005453-4057qib7	301	10	and	and	CC
cord-005453-4057qib7	301	11	either	either	DT
cord-005453-4057qib7	301	12	12	12	CD
cord-005453-4057qib7	301	13	Gy	Gy	NNP
cord-005453-4057qib7	301	14	TBI	TBI	NNP
cord-005453-4057qib7	301	15	(	(	-LRB-
cord-005453-4057qib7	301	16	86	86	CD
cord-005453-4057qib7	301	17	%	%	NN
cord-005453-4057qib7	301	18	of	of	IN
cord-005453-4057qib7	301	19	cases	case	NNS
cord-005453-4057qib7	301	20	)	)	-RRB-
cord-005453-4057qib7	301	21	or	or	CC
cord-005453-4057qib7	301	22	busulfan	busulfan	NNP
cord-005453-4057qib7	301	23	12.8	12.8	CD
cord-005453-4057qib7	301	24	mg/	mg/	NNP
cord-005453-4057qib7	301	25	kg	kg	NNP
cord-005453-4057qib7	301	26	(	(	-LRB-
cord-005453-4057qib7	301	27	5	5	CD
cord-005453-4057qib7	301	28	%	%	NN
cord-005453-4057qib7	301	29	of	of	IN
cord-005453-4057qib7	301	30	cases	case	NNS
cord-005453-4057qib7	301	31	)	)	-RRB-
cord-005453-4057qib7	301	32	,	,	,
cord-005453-4057qib7	301	33	or	or	CC
cord-005453-4057qib7	301	34	fludarabine	fludarabine	VB
cord-005453-4057qib7	301	35	150	150	CD
cord-005453-4057qib7	301	36	mg	mg	NNP
cord-005453-4057qib7	301	37	/	/	SYM
cord-005453-4057qib7	301	38	m	m	NNP
cord-005453-4057qib7	301	39	2	2	CD
cord-005453-4057qib7	301	40	and	and	CC
cord-005453-4057qib7	301	41	treosulfan	treosulfan	NNP
cord-005453-4057qib7	301	42	42	42	CD
cord-005453-4057qib7	301	43	mg	mg	NNP
cord-005453-4057qib7	301	44	/	/	SYM
cord-005453-4057qib7	301	45	m	m	NN
cord-005453-4057qib7	301	46	2	2	CD
cord-005453-4057qib7	301	47	(	(	-LRB-
cord-005453-4057qib7	301	48	6	6	CD
cord-005453-4057qib7	301	49	%	%	NN
cord-005453-4057qib7	301	50	of	of	IN
cord-005453-4057qib7	301	51	cases	case	NNS
cord-005453-4057qib7	301	52	)	)	-RRB-
cord-005453-4057qib7	301	53	.	.	.
cord-005453-4057qib7	302	1	Five	five	CD
cord-005453-4057qib7	302	2	percent	percent	NN
cord-005453-4057qib7	302	3	and	and	CC
cord-005453-4057qib7	302	4	19	19	CD
cord-005453-4057qib7	302	5	%	%	NN
cord-005453-4057qib7	302	6	of	of	IN
cord-005453-4057qib7	302	7	NMA	NMA	NNP
cord-005453-4057qib7	302	8	and	and	CC
cord-005453-4057qib7	302	9	MA	MA	NNP
cord-005453-4057qib7	302	10	conditioned	condition	VBD
cord-005453-4057qib7	302	11	patients	patient	NNS
cord-005453-4057qib7	302	12	,	,	,
cord-005453-4057qib7	302	13	respectively	respectively	RB
cord-005453-4057qib7	302	14	,	,	,
cord-005453-4057qib7	302	15	received	receive	VBD
cord-005453-4057qib7	302	16	anti	anti	JJ
cord-005453-4057qib7	302	17	-	-	JJ
cord-005453-4057qib7	302	18	thymocyte	thymocyte	JJ
cord-005453-4057qib7	302	19	globulin	globulin	NN
cord-005453-4057qib7	302	20	.	.	.
cord-005453-4057qib7	303	1	Patients	patient	NNS
cord-005453-4057qib7	303	2	were	be	VBD
cord-005453-4057qib7	303	3	followed	follow	VBN
cord-005453-4057qib7	303	4	until	until	IN
cord-005453-4057qib7	303	5	death	death	NN
cord-005453-4057qib7	303	6	or	or	CC
cord-005453-4057qib7	303	7	end	end	NN
cord-005453-4057qib7	303	8	-	-	HYPH
cord-005453-4057qib7	303	9	of	of	IN
cord-005453-4057qib7	303	10	-	-	HYPH
cord-005453-4057qib7	303	11	followup	followup	NN
cord-005453-4057qib7	303	12	on	on	IN
cord-005453-4057qib7	303	13	October	October	NNP
cord-005453-4057qib7	303	14	31	31	CD
cord-005453-4057qib7	303	15	st	st	NNP
cord-005453-4057qib7	303	16	,	,	,
cord-005453-4057qib7	303	17	2018	2018	CD
cord-005453-4057qib7	303	18	.	.	.
cord-005453-4057qib7	304	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	304	2	incidences	incidence	NNS
cord-005453-4057qib7	304	3	with	with	IN
cord-005453-4057qib7	304	4	95	95	CD
cord-005453-4057qib7	304	5	%	%	NN
cord-005453-4057qib7	304	6	confidence	confidence	NN
cord-005453-4057qib7	304	7	intervals	interval	NNS
cord-005453-4057qib7	304	8	(	(	-LRB-
cord-005453-4057qib7	304	9	CI	CI	NNP
cord-005453-4057qib7	304	10	)	)	-RRB-
cord-005453-4057qib7	304	11	of	of	IN
cord-005453-4057qib7	304	12	acute	acute	JJ
cord-005453-4057qib7	304	13	graft	graft	NN
cord-005453-4057qib7	304	14	-	-	HYPH
cord-005453-4057qib7	304	15	versus	versus	IN
cord-005453-4057qib7	304	16	-	-	HYPH
cord-005453-4057qib7	304	17	host	host	NN
cord-005453-4057qib7	304	18	disease	disease	NN
cord-005453-4057qib7	304	19	(	(	-LRB-
cord-005453-4057qib7	304	20	aGVHD	aGVHD	NNP
cord-005453-4057qib7	304	21	)	)	-RRB-
cord-005453-4057qib7	304	22	grade	grade	NN
cord-005453-4057qib7	304	23	II	II	NNP
cord-005453-4057qib7	304	24	-	-	HYPH
cord-005453-4057qib7	304	25	IV	IV	NNP
cord-005453-4057qib7	304	26	,	,	,
cord-005453-4057qib7	304	27	chronic	chronic	JJ
cord-005453-4057qib7	304	28	graft	graft	NN
cord-005453-4057qib7	304	29	-	-	HYPH
cord-005453-4057qib7	304	30	versus	versus	IN
cord-005453-4057qib7	304	31	-	-	HYPH
cord-005453-4057qib7	304	32	host	host	NN
cord-005453-4057qib7	304	33	disease	disease	NN
cord-005453-4057qib7	304	34	(	(	-LRB-
cord-005453-4057qib7	304	35	cGVHD	cGVHD	NNP
cord-005453-4057qib7	304	36	)	)	-RRB-
cord-005453-4057qib7	304	37	,	,	,
cord-005453-4057qib7	304	38	relapse	relapse	NN
cord-005453-4057qib7	304	39	and	and	CC
cord-005453-4057qib7	304	40	non	non	JJ
cord-005453-4057qib7	304	41	-	-	JJ
cord-005453-4057qib7	304	42	relapse	relapse	JJ
cord-005453-4057qib7	304	43	mortality	mortality	NN
cord-005453-4057qib7	304	44	(	(	-LRB-
cord-005453-4057qib7	304	45	NRM	NRM	NNP
cord-005453-4057qib7	304	46	)	)	-RRB-
cord-005453-4057qib7	304	47	were	be	VBD
cord-005453-4057qib7	304	48	calculated	calculate	VBN
cord-005453-4057qib7	304	49	and	and	CC
cord-005453-4057qib7	304	50	compared	compare	VBN
cord-005453-4057qib7	304	51	between	between	IN
cord-005453-4057qib7	304	52	NMA	NMA	NNP
cord-005453-4057qib7	304	53	and	and	CC
cord-005453-4057qib7	304	54	MA	MA	NNP
cord-005453-4057qib7	304	55	conditioned	condition	VBD
cord-005453-4057qib7	304	56	patients	patient	NNS
cord-005453-4057qib7	304	57	using	use	VBG
cord-005453-4057qib7	304	58	Gray	Gray	NNP
cord-005453-4057qib7	304	59	's	's	POS
cord-005453-4057qib7	304	60	test	test	NN
cord-005453-4057qib7	304	61	with	with	IN
cord-005453-4057qib7	304	62	death	death	NN
cord-005453-4057qib7	304	63	as	as	IN
cord-005453-4057qib7	304	64	a	a	DT
cord-005453-4057qib7	304	65	competing	compete	VBG
cord-005453-4057qib7	304	66	risk	risk	NN
cord-005453-4057qib7	304	67	(	(	-LRB-
cord-005453-4057qib7	304	68	or	or	CC
cord-005453-4057qib7	304	69	relapse	relapse	VB
cord-005453-4057qib7	304	70	when	when	WRB
cord-005453-4057qib7	304	71	comparing	compare	VBG
cord-005453-4057qib7	304	72	NRM	NRM	NNP
cord-005453-4057qib7	304	73	)	)	-RRB-
cord-005453-4057qib7	304	74	.	.	.
cord-005453-4057qib7	305	1	Overall	overall	JJ
cord-005453-4057qib7	305	2	survival	survival	NN
cord-005453-4057qib7	305	3	(	(	-LRB-
cord-005453-4057qib7	305	4	OS	OS	NNP
cord-005453-4057qib7	305	5	)	)	-RRB-
cord-005453-4057qib7	305	6	was	be	VBD
cord-005453-4057qib7	305	7	estimated	estimate	VBN
cord-005453-4057qib7	305	8	by	by	IN
cord-005453-4057qib7	305	9	the	the	DT
cord-005453-4057qib7	305	10	Kaplan	Kaplan	NNP
cord-005453-4057qib7	305	11	-	-	HYPH
cord-005453-4057qib7	305	12	Meier	Meier	NNP
cord-005453-4057qib7	305	13	method	method	NN
cord-005453-4057qib7	305	14	.	.	.
cord-005453-4057qib7	306	1	Results	result	NNS
cord-005453-4057qib7	306	2	:	:	:
cord-005453-4057qib7	307	1	NMA	NMA	NNP
cord-005453-4057qib7	307	2	and	and	CC
cord-005453-4057qib7	307	3	MA	MA	NNP
cord-005453-4057qib7	307	4	conditioned	condition	VBD
cord-005453-4057qib7	307	5	patients	patient	NNS
cord-005453-4057qib7	307	6	were	be	VBD
cord-005453-4057qib7	307	7	comparable	comparable	JJ
cord-005453-4057qib7	307	8	when	when	WRB
cord-005453-4057qib7	307	9	regarding	regard	VBG
cord-005453-4057qib7	307	10	sex	sex	NN
cord-005453-4057qib7	307	11	(	(	-LRB-
cord-005453-4057qib7	307	12	49	49	CD
cord-005453-4057qib7	307	13	%	%	NN
cord-005453-4057qib7	307	14	and	and	CC
cord-005453-4057qib7	307	15	48	48	CD
cord-005453-4057qib7	307	16	%	%	NN
cord-005453-4057qib7	307	17	female	female	NN
cord-005453-4057qib7	307	18	,	,	,
cord-005453-4057qib7	307	19	respectively	respectively	RB
cord-005453-4057qib7	307	20	)	)	-RRB-
cord-005453-4057qib7	307	21	and	and	CC
cord-005453-4057qib7	307	22	donor	donor	NN
cord-005453-4057qib7	307	23	(	(	-LRB-
cord-005453-4057qib7	307	24	matched	match	VBN
cord-005453-4057qib7	307	25	related	related	JJ
cord-005453-4057qib7	307	26	donor	donor	NN
cord-005453-4057qib7	307	27	in	in	IN
cord-005453-4057qib7	307	28	34	34	CD
cord-005453-4057qib7	307	29	%	%	NN
cord-005453-4057qib7	307	30	and	and	CC
cord-005453-4057qib7	307	31	36	36	CD
cord-005453-4057qib7	307	32	%	%	NN
cord-005453-4057qib7	307	33	,	,	,
cord-005453-4057qib7	307	34	respectively	respectively	RB
cord-005453-4057qib7	307	35	)	)	-RRB-
cord-005453-4057qib7	307	36	,	,	,
cord-005453-4057qib7	307	37	but	but	CC
cord-005453-4057qib7	307	38	differed	differ	VBD
cord-005453-4057qib7	307	39	,	,	,
cord-005453-4057qib7	307	40	as	as	IN
cord-005453-4057qib7	307	41	expected	expect	VBN
cord-005453-4057qib7	307	42	by	by	IN
cord-005453-4057qib7	307	43	indication	indication	NN
cord-005453-4057qib7	307	44	,	,	,
cord-005453-4057qib7	307	45	with	with	IN
cord-005453-4057qib7	307	46	regards	regard	NNS
cord-005453-4057qib7	307	47	to	to	IN
cord-005453-4057qib7	307	48	age	age	NN
cord-005453-4057qib7	307	49	(	(	-LRB-
cord-005453-4057qib7	307	50	median	median	NN
cord-005453-4057qib7	307	51	of	of	IN
cord-005453-4057qib7	307	52	60	60	CD
cord-005453-4057qib7	307	53	versus	versus	IN
cord-005453-4057qib7	307	54	42	42	CD
cord-005453-4057qib7	307	55	years	year	NNS
cord-005453-4057qib7	307	56	,	,	,
cord-005453-4057qib7	307	57	respectively	respectively	RB
cord-005453-4057qib7	307	58	)	)	-RRB-
cord-005453-4057qib7	307	59	and	and	CC
cord-005453-4057qib7	307	60	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	307	61	score	score	NN
cord-005453-4057qib7	307	62	(	(	-LRB-
cord-005453-4057qib7	308	1	<	<	XX
cord-005453-4057qib7	308	2	90	90	CD
cord-005453-4057qib7	308	3	in	in	IN
cord-005453-4057qib7	308	4	18	18	CD
cord-005453-4057qib7	308	5	%	%	NN
cord-005453-4057qib7	308	6	and	and	CC
cord-005453-4057qib7	308	7	11	11	CD
cord-005453-4057qib7	308	8	%	%	NN
cord-005453-4057qib7	308	9	,	,	,
cord-005453-4057qib7	308	10	respectively	respectively	RB
cord-005453-4057qib7	308	11	)	)	-RRB-
cord-005453-4057qib7	308	12	.	.	.
cord-005453-4057qib7	309	1	NMA	NMA	NNP
cord-005453-4057qib7	309	2	conditioned	condition	VBD
cord-005453-4057qib7	309	3	patients	patient	NNS
cord-005453-4057qib7	309	4	had	have	VBD
cord-005453-4057qib7	309	5	generally	generally	RB
cord-005453-4057qib7	309	6	a	a	DT
cord-005453-4057qib7	309	7	lower	low	JJR
cord-005453-4057qib7	309	8	AML	AML	NNP
cord-005453-4057qib7	309	9	stage	stage	NN
cord-005453-4057qib7	309	10	at	at	IN
cord-005453-4057qib7	309	11	transplant	transplant	NN
cord-005453-4057qib7	309	12	(	(	-LRB-
cord-005453-4057qib7	309	13	1	1	CD
cord-005453-4057qib7	309	14	st	st	NNP
cord-005453-4057qib7	309	15	complete	complete	JJ
cord-005453-4057qib7	309	16	remission	remission	NN
cord-005453-4057qib7	309	17	in	in	IN
cord-005453-4057qib7	309	18	68	68	CD
cord-005453-4057qib7	309	19	%	%	NN
cord-005453-4057qib7	309	20	versus	versus	IN
cord-005453-4057qib7	309	21	49	49	CD
cord-005453-4057qib7	309	22	%	%	NN
cord-005453-4057qib7	309	23	of	of	IN
cord-005453-4057qib7	309	24	MA	MA	NNP
cord-005453-4057qib7	309	25	conditioned	condition	VBN
cord-005453-4057qib7	309	26	patients	patient	NNS
cord-005453-4057qib7	309	27	)	)	-RRB-
cord-005453-4057qib7	309	28	and	and	CC
cord-005453-4057qib7	309	29	a	a	DT
cord-005453-4057qib7	309	30	lower	low	JJR
cord-005453-4057qib7	309	31	AML	AML	NNP
cord-005453-4057qib7	309	32	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	309	33	risk	risk	NN
cord-005453-4057qib7	309	34	(	(	-LRB-
cord-005453-4057qib7	309	35	adverse	adverse	JJ
cord-005453-4057qib7	309	36	risk	risk	NN
cord-005453-4057qib7	309	37	in	in	IN
cord-005453-4057qib7	309	38	17	17	CD
cord-005453-4057qib7	309	39	%	%	NN
cord-005453-4057qib7	309	40	versus	versus	IN
cord-005453-4057qib7	309	41	21	21	CD
cord-005453-4057qib7	309	42	%	%	NN
cord-005453-4057qib7	309	43	of	of	IN
cord-005453-4057qib7	309	44	MA	MA	NNP
cord-005453-4057qib7	309	45	conditioned	condition	VBN
cord-005453-4057qib7	309	46	patients	patient	NNS
cord-005453-4057qib7	309	47	)	)	-RRB-
cord-005453-4057qib7	309	48	.	.	.
cord-005453-4057qib7	310	1	Patients	patient	NNS
cord-005453-4057qib7	310	2	were	be	VBD
cord-005453-4057qib7	310	3	followed	follow	VBN
cord-005453-4057qib7	310	4	for	for	IN
cord-005453-4057qib7	310	5	a	a	DT
cord-005453-4057qib7	310	6	total	total	NN
cord-005453-4057qib7	310	7	of	of	IN
cord-005453-4057qib7	310	8	2090	2090	CD
cord-005453-4057qib7	310	9	person	person	NN
cord-005453-4057qib7	310	10	-	-	HYPH
cord-005453-4057qib7	310	11	years	year	NNS
cord-005453-4057qib7	310	12	(	(	-LRB-
cord-005453-4057qib7	310	13	median	median	JJ
cord-005453-4057qib7	310	14	follow	follow	NN
cord-005453-4057qib7	310	15	-	-	HYPH
cord-005453-4057qib7	310	16	up	up	NN
cord-005453-4057qib7	310	17	in	in	IN
cord-005453-4057qib7	310	18	surviving	survive	VBG
cord-005453-4057qib7	310	19	patients	patient	NNS
cord-005453-4057qib7	310	20	was	be	VBD
cord-005453-4057qib7	310	21	6.2	6.2	CD
cord-005453-4057qib7	310	22	years	year	NNS
cord-005453-4057qib7	310	23	)	)	-RRB-
cord-005453-4057qib7	310	24	.	.	.
cord-005453-4057qib7	311	1	aGVHD	aGVHD	NNP
cord-005453-4057qib7	311	2	grade	grade	NNP
cord-005453-4057qib7	311	3	II	II	NNP
cord-005453-4057qib7	311	4	-	-	HYPH
cord-005453-4057qib7	311	5	IV	IV	NNP
cord-005453-4057qib7	311	6	occurred	occur	VBD
cord-005453-4057qib7	311	7	less	less	RBR
cord-005453-4057qib7	311	8	frequently	frequently	RB
cord-005453-4057qib7	311	9	in	in	IN
cord-005453-4057qib7	311	10	NMA	NMA	NNP
cord-005453-4057qib7	311	11	conditioned	condition	VBD
cord-005453-4057qib7	311	12	patients	patient	NNS
cord-005453-4057qib7	311	13	(	(	-LRB-
cord-005453-4057qib7	311	14	20	20	CD
cord-005453-4057qib7	311	15	%	%	NN
cord-005453-4057qib7	311	16	[	[	-LRB-
cord-005453-4057qib7	311	17	CI	CI	NNP
cord-005453-4057qib7	311	18	:	:	:
cord-005453-4057qib7	311	19	15%-26	15%-26	CD
cord-005453-4057qib7	311	20	%	%	NN
cord-005453-4057qib7	311	21	]	]	-RRB-
cord-005453-4057qib7	311	22	versus	versus	IN
cord-005453-4057qib7	311	23	38	38	CD
cord-005453-4057qib7	311	24	%	%	NN
cord-005453-4057qib7	311	25	[	[	-LRB-
cord-005453-4057qib7	311	26	CI	CI	NNP
cord-005453-4057qib7	311	27	:	:	:
cord-005453-4057qib7	311	28	32%-45	32%-45	CD
cord-005453-4057qib7	311	29	%	%	NN
cord-005453-4057qib7	311	30	]	]	-RRB-
cord-005453-4057qib7	311	31	in	in	IN
cord-005453-4057qib7	311	32	MA	MA	NNP
cord-005453-4057qib7	311	33	conditioned	condition	VBD
cord-005453-4057qib7	311	34	patients	patient	NNS
cord-005453-4057qib7	311	35	,	,	,
cord-005453-4057qib7	312	1	p	p	NN
cord-005453-4057qib7	312	2	<	<	NNP
cord-005453-4057qib7	312	3	0.01	0.01	CD
cord-005453-4057qib7	312	4	)	)	-RRB-
cord-005453-4057qib7	312	5	,	,	,
cord-005453-4057qib7	312	6	while	while	IN
cord-005453-4057qib7	312	7	cGVHD	cGVHD	NNP
cord-005453-4057qib7	312	8	occurred	occur	VBD
cord-005453-4057qib7	312	9	in	in	IN
cord-005453-4057qib7	312	10	similar	similar	JJ
cord-005453-4057qib7	312	11	rates	rate	NNS
cord-005453-4057qib7	312	12	(	(	-LRB-
cord-005453-4057qib7	312	13	50	50	CD
cord-005453-4057qib7	312	14	%	%	NN
cord-005453-4057qib7	312	15	[	[	-LRB-
cord-005453-4057qib7	312	16	CI	CI	NNP
cord-005453-4057qib7	312	17	:	:	:
cord-005453-4057qib7	312	18	43%-56	43%-56	CD
cord-005453-4057qib7	312	19	%	%	NN
cord-005453-4057qib7	312	20	]	]	-RRB-
cord-005453-4057qib7	312	21	in	in	IN
cord-005453-4057qib7	312	22	NMA	NMA	NNP
cord-005453-4057qib7	312	23	conditioned	condition	VBD
cord-005453-4057qib7	312	24	patients	patient	NNS
cord-005453-4057qib7	312	25	and	and	CC
cord-005453-4057qib7	312	26	51	51	CD
cord-005453-4057qib7	312	27	%	%	NN
cord-005453-4057qib7	312	28	[	[	-LRB-
cord-005453-4057qib7	312	29	CI	CI	NNP
cord-005453-4057qib7	312	30	:	:	:
cord-005453-4057qib7	312	31	44%-58	44%-58	CD
cord-005453-4057qib7	312	32	%	%	NN
cord-005453-4057qib7	312	33	]	]	-RRB-
cord-005453-4057qib7	312	34	in	in	IN
cord-005453-4057qib7	312	35	MA	MA	NNP
cord-005453-4057qib7	312	36	conditioned	condition	VBD
cord-005453-4057qib7	312	37	patients	patient	NNS
cord-005453-4057qib7	312	38	,	,	,
cord-005453-4057qib7	312	39	p	p	NN
cord-005453-4057qib7	312	40	=	=	SYM
cord-005453-4057qib7	312	41	0.77	0.77	CD
cord-005453-4057qib7	312	42	)	)	-RRB-
cord-005453-4057qib7	312	43	.	.	.
cord-005453-4057qib7	313	1	There	there	EX
cord-005453-4057qib7	313	2	was	be	VBD
cord-005453-4057qib7	313	3	a	a	DT
cord-005453-4057qib7	313	4	trend	trend	NN
cord-005453-4057qib7	313	5	towards	towards	IN
cord-005453-4057qib7	313	6	a	a	DT
cord-005453-4057qib7	313	7	higher	high	JJR
cord-005453-4057qib7	313	8	relapse	relapse	NN
cord-005453-4057qib7	313	9	rate	rate	NN
cord-005453-4057qib7	313	10	in	in	IN
cord-005453-4057qib7	313	11	NMA	NMA	NNP
cord-005453-4057qib7	313	12	conditioned	condition	VBD
cord-005453-4057qib7	313	13	patients	patient	NNS
cord-005453-4057qib7	313	14	(	(	-LRB-
cord-005453-4057qib7	313	15	34	34	CD
cord-005453-4057qib7	313	16	%	%	NN
cord-005453-4057qib7	313	17	[	[	-LRB-
cord-005453-4057qib7	313	18	CI	CI	NNP
cord-005453-4057qib7	313	19	:	:	:
cord-005453-4057qib7	313	20	28%-40	28%-40	CD
cord-005453-4057qib7	313	21	%	%	NN
cord-005453-4057qib7	313	22	]	]	-RRB-
cord-005453-4057qib7	313	23	versus	versus	IN
cord-005453-4057qib7	313	24	28	28	CD
cord-005453-4057qib7	313	25	%	%	NN
cord-005453-4057qib7	313	26	[	[	-LRB-
cord-005453-4057qib7	313	27	CI	CI	NNP
cord-005453-4057qib7	313	28	:	:	:
cord-005453-4057qib7	313	29	22%-34	22%-34	CD
cord-005453-4057qib7	313	30	%	%	NN
cord-005453-4057qib7	313	31	]	]	-RRB-
cord-005453-4057qib7	313	32	in	in	IN
cord-005453-4057qib7	313	33	MA	MA	NNP
cord-005453-4057qib7	313	34	conditioned	condition	VBD
cord-005453-4057qib7	313	35	patients	patient	NNS
cord-005453-4057qib7	313	36	,	,	,
cord-005453-4057qib7	313	37	p	p	NN
cord-005453-4057qib7	313	38	=	=	SYM
cord-005453-4057qib7	313	39	0.07	0.07	CD
cord-005453-4057qib7	313	40	)	)	-RRB-
cord-005453-4057qib7	313	41	,	,	,
cord-005453-4057qib7	313	42	and	and	CC
cord-005453-4057qib7	313	43	NMA	NMA	NNP
cord-005453-4057qib7	313	44	conditioned	condition	VBD
cord-005453-4057qib7	313	45	patients	patient	NNS
cord-005453-4057qib7	313	46	had	have	VBD
cord-005453-4057qib7	313	47	,	,	,
cord-005453-4057qib7	313	48	however	however	RB
cord-005453-4057qib7	313	49	not	not	RB
cord-005453-4057qib7	313	50	with	with	IN
cord-005453-4057qib7	313	51	statistical	statistical	JJ
cord-005453-4057qib7	313	52	significance	significance	NN
cord-005453-4057qib7	313	53	,	,	,
cord-005453-4057qib7	313	54	lower	low	JJR
cord-005453-4057qib7	313	55	NRM	NRM	NNP
cord-005453-4057qib7	313	56	(	(	-LRB-
cord-005453-4057qib7	313	57	20	20	CD
cord-005453-4057qib7	313	58	%	%	NN
cord-005453-4057qib7	313	59	[	[	-LRB-
cord-005453-4057qib7	313	60	CI	CI	NNP
cord-005453-4057qib7	313	61	:	:	:
cord-005453-4057qib7	313	62	14%-25	14%-25	CD
cord-005453-4057qib7	313	63	%	%	NN
cord-005453-4057qib7	313	64	]	]	-RRB-
cord-005453-4057qib7	314	1	versus	versus	IN
cord-005453-4057qib7	314	2	25	25	CD
cord-005453-4057qib7	314	3	%	%	NN
cord-005453-4057qib7	314	4	in	in	IN
cord-005453-4057qib7	314	5	MA	MA	NNP
cord-005453-4057qib7	314	6	conditioned	condition	VBN
cord-005453-4057qib7	314	7	patients	patient	NNS
cord-005453-4057qib7	314	8	,	,	,
cord-005453-4057qib7	314	9	p	p	NN
cord-005453-4057qib7	314	10	=	=	SYM
cord-005453-4057qib7	314	11	0.27	0.27	CD
cord-005453-4057qib7	314	12	)	)	-RRB-
cord-005453-4057qib7	314	13	.	.	.
cord-005453-4057qib7	315	1	OS	OS	NNP
cord-005453-4057qib7	315	2	(	(	-LRB-
cord-005453-4057qib7	315	3	Figure	figure	NN
cord-005453-4057qib7	315	4	)	)	-RRB-
cord-005453-4057qib7	315	5	was	be	VBD
cord-005453-4057qib7	315	6	comparable	comparable	JJ
cord-005453-4057qib7	315	7	,	,	,
cord-005453-4057qib7	315	8	with	with	IN
cord-005453-4057qib7	315	9	5-year	5-year	CD
cord-005453-4057qib7	315	10	OS	OS	NNP
cord-005453-4057qib7	315	11	rates	rate	NNS
cord-005453-4057qib7	315	12	of	of	IN
cord-005453-4057qib7	315	13	55	55	CD
cord-005453-4057qib7	315	14	%	%	NN
cord-005453-4057qib7	315	15	(	(	-LRB-
cord-005453-4057qib7	315	16	CI	ci	NN
cord-005453-4057qib7	315	17	:	:	:
cord-005453-4057qib7	315	18	48%-62	48%-62	CD
cord-005453-4057qib7	315	19	%	%	NN
cord-005453-4057qib7	315	20	)	)	-RRB-
cord-005453-4057qib7	315	21	in	in	IN
cord-005453-4057qib7	315	22	NMA	NMA	NNP
cord-005453-4057qib7	315	23	conditioned	condition	VBD
cord-005453-4057qib7	315	24	patients	patient	NNS
cord-005453-4057qib7	315	25	and	and	CC
cord-005453-4057qib7	315	26	54	54	CD
cord-005453-4057qib7	315	27	%	%	NN
cord-005453-4057qib7	316	1	(	(	-LRB-
cord-005453-4057qib7	316	2	CI	CI	NNP
cord-005453-4057qib7	316	3	:	:	:
cord-005453-4057qib7	316	4	47%-61	47%-61	CD
cord-005453-4057qib7	316	5	%	%	NN
cord-005453-4057qib7	316	6	)	)	-RRB-
cord-005453-4057qib7	316	7	in	in	IN
cord-005453-4057qib7	316	8	MA	MA	NNP
cord-005453-4057qib7	316	9	conditioned	condition	VBD
cord-005453-4057qib7	316	10	patients	patient	NNS
cord-005453-4057qib7	316	11	.	.	.
cord-005453-4057qib7	317	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	317	2	:	:	:
cord-005453-4057qib7	318	1	Patients	patient	NNS
cord-005453-4057qib7	318	2	with	with	IN
cord-005453-4057qib7	318	3	AML	AML	NNP
cord-005453-4057qib7	318	4	undergoing	undergo	VBG
cord-005453-4057qib7	318	5	allo	allo	NN
cord-005453-4057qib7	318	6	-	-	HYPH
cord-005453-4057qib7	318	7	HSCT	HSCT	NNP
cord-005453-4057qib7	318	8	with	with	IN
cord-005453-4057qib7	318	9	NMA	NMA	NNP
cord-005453-4057qib7	318	10	conditioning	conditioning	NN
cord-005453-4057qib7	318	11	at	at	IN
cord-005453-4057qib7	318	12	our	-PRON-	PRP$
cord-005453-4057qib7	318	13	institution	institution	NN
cord-005453-4057qib7	318	14	were	be	VBD
cord-005453-4057qib7	318	15	older	old	JJR
cord-005453-4057qib7	318	16	and	and	CC
cord-005453-4057qib7	318	17	frailer	frail	JJR
cord-005453-4057qib7	318	18	than	than	IN
cord-005453-4057qib7	318	19	MA	MA	NNP
cord-005453-4057qib7	318	20	conditioned	condition	VBD
cord-005453-4057qib7	318	21	patients	patient	NNS
cord-005453-4057qib7	318	22	,	,	,
cord-005453-4057qib7	318	23	but	but	CC
cord-005453-4057qib7	318	24	their	-PRON-	PRP$
cord-005453-4057qib7	318	25	overall	overall	JJ
cord-005453-4057qib7	318	26	survival	survival	NN
cord-005453-4057qib7	318	27	after	after	IN
cord-005453-4057qib7	318	28	transplantation	transplantation	NN
cord-005453-4057qib7	318	29	was	be	VBD
cord-005453-4057qib7	318	30	comparable	comparable	JJ
cord-005453-4057qib7	318	31	.	.	.
cord-005453-4057qib7	319	1	This	this	DT
cord-005453-4057qib7	319	2	might	may	MD
cord-005453-4057qib7	319	3	be	be	VB
cord-005453-4057qib7	319	4	explained	explain	VBN
cord-005453-4057qib7	319	5	by	by	IN
cord-005453-4057qib7	319	6	a	a	DT
cord-005453-4057qib7	319	7	generally	generally	RB
cord-005453-4057qib7	319	8	lower	low	JJR
cord-005453-4057qib7	319	9	AML	AML	NNP
cord-005453-4057qib7	319	10	stage	stage	NN
cord-005453-4057qib7	319	11	and	and	CC
cord-005453-4057qib7	319	12	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	319	13	risk	risk	NN
cord-005453-4057qib7	319	14	at	at	IN
cord-005453-4057qib7	319	15	transplant	transplant	NN
cord-005453-4057qib7	319	16	in	in	IN
cord-005453-4057qib7	319	17	NMA	NMA	NNP
cord-005453-4057qib7	319	18	conditioned	condition	VBD
cord-005453-4057qib7	319	19	patients	patient	NNS
cord-005453-4057qib7	319	20	.	.	.
cord-005453-4057qib7	320	1	Jedlickova	jedlickova	RB
cord-005453-4057qib7	320	2	1	1	CD
cord-005453-4057qib7	320	3	,	,	,
cord-005453-4057qib7	320	4	Saskia	Saskia	NNP
cord-005453-4057qib7	320	5	Güller	Güller	NNP
cord-005453-4057qib7	320	6	1	1	CD
cord-005453-4057qib7	320	7	,	,	,
cord-005453-4057qib7	320	8	Rosa	Rosa	NNP
cord-005453-4057qib7	320	9	Toenges	Toenges	NNP
cord-005453-4057qib7	320	10	1	1	CD
cord-005453-4057qib7	320	11	,	,	,
cord-005453-4057qib7	320	12	Juliane	Juliane	NNP
cord-005453-4057qib7	320	13	Steinmann	Steinmann	NNP
cord-005453-4057qib7	320	14	1	1	CD
cord-005453-4057qib7	320	15	,	,	,
cord-005453-4057qib7	320	16	Hans	Hans	NNP
cord-005453-4057qib7	320	17	Martin	Martin	NNP
cord-005453-4057qib7	320	18	1	1	CD
cord-005453-4057qib7	320	19	,	,	,
cord-005453-4057qib7	320	20	Hubert	Hubert	NNP
cord-005453-4057qib7	320	21	Serve	Serve	NNP
cord-005453-4057qib7	320	22	1	1	CD
cord-005453-4057qib7	320	23	,	,	,
cord-005453-4057qib7	320	24	Gesine	Gesine	NNP
cord-005453-4057qib7	320	25	Bug	bug	NN
cord-005453-4057qib7	320	26	1	1	CD
cord-005453-4057qib7	320	27	Background	Background	NNP
cord-005453-4057qib7	320	28	:	:	:
cord-005453-4057qib7	321	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	321	2	HSCT	HSCT	NNP
cord-005453-4057qib7	321	3	is	be	VBZ
cord-005453-4057qib7	321	4	urgently	urgently	RB
cord-005453-4057qib7	321	5	indicated	indicate	VBN
cord-005453-4057qib7	321	6	in	in	IN
cord-005453-4057qib7	321	7	patients	patient	NNS
cord-005453-4057qib7	321	8	with	with	IN
cord-005453-4057qib7	321	9	AML	AML	NNP
cord-005453-4057qib7	321	10	in	in	IN
cord-005453-4057qib7	321	11	first	first	JJ
cord-005453-4057qib7	321	12	complete	complete	JJ
cord-005453-4057qib7	321	13	hematologic	hematologic	JJ
cord-005453-4057qib7	321	14	remission	remission	NN
cord-005453-4057qib7	321	15	(	(	-LRB-
cord-005453-4057qib7	321	16	CHR	CHR	NNP
cord-005453-4057qib7	321	17	)	)	-RRB-
cord-005453-4057qib7	321	18	after	after	IN
cord-005453-4057qib7	321	19	intensive	intensive	JJ
cord-005453-4057qib7	321	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	321	21	with	with	IN
cord-005453-4057qib7	321	22	increasing	increase	VBG
cord-005453-4057qib7	321	23	or	or	CC
cord-005453-4057qib7	321	24	recurrent	recurrent	JJ
cord-005453-4057qib7	321	25	minimal	minimal	JJ
cord-005453-4057qib7	321	26	residual	residual	JJ
cord-005453-4057qib7	321	27	disease	disease	NN
cord-005453-4057qib7	321	28	(	(	-LRB-
cord-005453-4057qib7	321	29	MRD	MRD	NNP
cord-005453-4057qib7	321	30	)	)	-RRB-
cord-005453-4057qib7	321	31	.	.	.
cord-005453-4057qib7	322	1	These	these	DT
cord-005453-4057qib7	322	2	patients	patient	NNS
cord-005453-4057qib7	322	3	are	be	VBP
cord-005453-4057qib7	322	4	at	at	IN
cord-005453-4057qib7	322	5	high	high	JJ
cord-005453-4057qib7	322	6	risk	risk	NN
cord-005453-4057qib7	322	7	of	of	IN
cord-005453-4057qib7	322	8	hematologic	hematologic	JJ
cord-005453-4057qib7	322	9	relapse	relapse	NN
cord-005453-4057qib7	322	10	(	(	-LRB-
cord-005453-4057qib7	322	11	HR	HR	NNP
cord-005453-4057qib7	322	12	)	)	-RRB-
cord-005453-4057qib7	322	13	during	during	IN
cord-005453-4057qib7	322	14	preparation	preparation	NN
cord-005453-4057qib7	322	15	of	of	IN
cord-005453-4057qib7	322	16	their	-PRON-	PRP$
cord-005453-4057qib7	322	17	transplant	transplant	NN
cord-005453-4057qib7	322	18	and	and	CC
cord-005453-4057qib7	322	19	HSCT	HSCT	NNP
cord-005453-4057qib7	322	20	with	with	IN
cord-005453-4057qib7	322	21	active	active	JJ
cord-005453-4057qib7	322	22	AML	AML	NNP
cord-005453-4057qib7	322	23	was	be	VBD
cord-005453-4057qib7	322	24	found	find	VBN
cord-005453-4057qib7	322	25	associated	associate	VBN
cord-005453-4057qib7	322	26	with	with	IN
cord-005453-4057qib7	322	27	poor	poor	JJ
cord-005453-4057qib7	322	28	outcome	outcome	NN
cord-005453-4057qib7	322	29	.	.	.
cord-005453-4057qib7	323	1	Azacitidine	Azacitidine	NNP
cord-005453-4057qib7	323	2	has	have	VBZ
cord-005453-4057qib7	323	3	recently	recently	RB
cord-005453-4057qib7	323	4	been	be	VBN
cord-005453-4057qib7	323	5	shown	show	VBN
cord-005453-4057qib7	323	6	to	to	TO
cord-005453-4057qib7	323	7	substantially	substantially	RB
cord-005453-4057qib7	323	8	delay	delay	VB
cord-005453-4057qib7	323	9	or	or	CC
cord-005453-4057qib7	323	10	even	even	RB
cord-005453-4057qib7	323	11	prevent	prevent	VB
cord-005453-4057qib7	323	12	HR	hr	NN
cord-005453-4057qib7	323	13	in	in	IN
cord-005453-4057qib7	323	14	>	>	$
cord-005453-4057qib7	323	15	50	50	CD
cord-005453-4057qib7	323	16	%	%	NN
cord-005453-4057qib7	323	17	of	of	IN
cord-005453-4057qib7	323	18	patients	patient	NNS
cord-005453-4057qib7	323	19	(	(	-LRB-
cord-005453-4057qib7	323	20	RELAZA2	RELAZA2	NNS
cord-005453-4057qib7	323	21	trial	trial	NN
cord-005453-4057qib7	323	22	,	,	,
cord-005453-4057qib7	323	23	Platzbecker	Platzbecker	NNP
cord-005453-4057qib7	323	24	et	et	NNP
cord-005453-4057qib7	323	25	al	al	NNP
cord-005453-4057qib7	323	26	.	.	.
cord-005453-4057qib7	324	1	,	,	,
cord-005453-4057qib7	324	2	Lancet	Lancet	NNP
cord-005453-4057qib7	324	3	Oncology	Oncology	NNP
cord-005453-4057qib7	324	4	2018	2018	CD
cord-005453-4057qib7	324	5	)	)	-RRB-
cord-005453-4057qib7	324	6	.	.	.
cord-005453-4057qib7	325	1	We	-PRON-	PRP
cord-005453-4057qib7	325	2	here	here	RB
cord-005453-4057qib7	325	3	present	present	VBP
cord-005453-4057qib7	325	4	the	the	DT
cord-005453-4057qib7	325	5	outcome	outcome	NN
cord-005453-4057qib7	325	6	of	of	IN
cord-005453-4057qib7	325	7	a	a	DT
cord-005453-4057qib7	325	8	small	small	JJ
cord-005453-4057qib7	325	9	cohort	cohort	NN
cord-005453-4057qib7	325	10	of	of	IN
cord-005453-4057qib7	325	11	consecutive	consecutive	JJ
cord-005453-4057qib7	325	12	patients	patient	NNS
cord-005453-4057qib7	325	13	with	with	IN
cord-005453-4057qib7	325	14	MRD	MRD	NNP
cord-005453-4057qib7	325	15	-	-	HYPH
cord-005453-4057qib7	325	16	positive	positive	JJ
cord-005453-4057qib7	325	17	AML	AML	NNP
cord-005453-4057qib7	325	18	who	who	WP
cord-005453-4057qib7	325	19	received	receive	VBD
cord-005453-4057qib7	325	20	low	low	JJ
cord-005453-4057qib7	325	21	dose	dose	NN
cord-005453-4057qib7	325	22	cytarabine	cytarabine	NN
cord-005453-4057qib7	325	23	(	(	-LRB-
cord-005453-4057qib7	325	24	LDARAC	LDARAC	NNP
cord-005453-4057qib7	325	25	)	)	-RRB-
cord-005453-4057qib7	325	26	as	as	IN
cord-005453-4057qib7	325	27	bridging	bridge	VBG
cord-005453-4057qib7	325	28	therapy	therapy	NN
cord-005453-4057qib7	325	29	prior	prior	RB
cord-005453-4057qib7	325	30	to	to	IN
cord-005453-4057qib7	325	31	HSCT	HSCT	NNP
cord-005453-4057qib7	325	32	.	.	.
cord-005453-4057qib7	326	1	Methods	method	NNS
cord-005453-4057qib7	326	2	:	:	:
cord-005453-4057qib7	327	1	MRD	MRD	NNP
cord-005453-4057qib7	327	2	was	be	VBD
cord-005453-4057qib7	327	3	assessed	assess	VBN
cord-005453-4057qib7	327	4	by	by	IN
cord-005453-4057qib7	327	5	quantitative	quantitative	JJ
cord-005453-4057qib7	327	6	polymerase	polymerase	NN
cord-005453-4057qib7	327	7	chain	chain	NN
cord-005453-4057qib7	327	8	reaction	reaction	NN
cord-005453-4057qib7	327	9	(	(	-LRB-
cord-005453-4057qib7	327	10	qPCR	qPCR	NNP
cord-005453-4057qib7	327	11	)	)	-RRB-
cord-005453-4057qib7	327	12	using	use	VBG
cord-005453-4057qib7	327	13	mutated	mutate	VBN
cord-005453-4057qib7	327	14	NPM1	NPM1	NNP
cord-005453-4057qib7	327	15	(	(	-LRB-
cord-005453-4057qib7	327	16	n=5	n=5	NNP
cord-005453-4057qib7	327	17	)	)	-RRB-
cord-005453-4057qib7	327	18	,	,	,
cord-005453-4057qib7	327	19	RUNX1-RUNX1T1	runx1-runx1t1	NN
cord-005453-4057qib7	327	20	(	(	-LRB-
cord-005453-4057qib7	327	21	n=2	n=2	NNS
cord-005453-4057qib7	327	22	)	)	-RRB-
cord-005453-4057qib7	327	23	,	,	,
cord-005453-4057qib7	327	24	CBFB	CBFB	NNP
cord-005453-4057qib7	327	25	-	-	HYPH
cord-005453-4057qib7	327	26	MYH11	MYH11	NNP
cord-005453-4057qib7	327	27	(	(	-LRB-
cord-005453-4057qib7	327	28	n=1	n=1	NNP
cord-005453-4057qib7	327	29	)	)	-RRB-
cord-005453-4057qib7	327	30	or	or	CC
cord-005453-4057qib7	327	31	KMT2A	KMT2A	NNP
cord-005453-4057qib7	327	32	-	-	HYPH
cord-005453-4057qib7	327	33	PTD	PTD	NNP
cord-005453-4057qib7	327	34	(	(	-LRB-
cord-005453-4057qib7	327	35	n=1	n=1	NN
cord-005453-4057qib7	327	36	)	)	-RRB-
cord-005453-4057qib7	327	37	.	.	.
cord-005453-4057qib7	328	1	MRD	MRD	NNP
cord-005453-4057qib7	328	2	negativity	negativity	NN
cord-005453-4057qib7	328	3	was	be	VBD
cord-005453-4057qib7	328	4	defined	define	VBN
cord-005453-4057qib7	328	5	as	as	IN
cord-005453-4057qib7	328	6	ratio	ratio	NN
cord-005453-4057qib7	328	7	of	of	IN
cord-005453-4057qib7	328	8	oncogene	oncogene	NN
cord-005453-4057qib7	328	9	to	to	TO
cord-005453-4057qib7	328	10	control	control	VB
cord-005453-4057qib7	328	11	gene	gene	NN
cord-005453-4057qib7	328	12	(	(	-LRB-
cord-005453-4057qib7	328	13	ABL1	ABL1	NNP
cord-005453-4057qib7	328	14	)	)	-RRB-
cord-005453-4057qib7	329	1	≤0,01	≤0,01	NNP
cord-005453-4057qib7	329	2	%	%	NN
cord-005453-4057qib7	330	1	while	while	IN
cord-005453-4057qib7	330	2	increased	increase	VBN
cord-005453-4057qib7	330	3	or	or	CC
cord-005453-4057qib7	330	4	recurrent	recurrent	JJ
cord-005453-4057qib7	330	5	MRD	MRD	NNP
cord-005453-4057qib7	330	6	required	require	VBD
cord-005453-4057qib7	330	7	a	a	DT
cord-005453-4057qib7	330	8	ratio	ratio	NN
cord-005453-4057qib7	330	9	>	>	XX
cord-005453-4057qib7	330	10	1	1	CD
cord-005453-4057qib7	330	11	%	%	NN
cord-005453-4057qib7	331	1	(	(	-LRB-
cord-005453-4057qib7	331	2	Shayegi	Shayegi	NNP
cord-005453-4057qib7	331	3	et	et	NNP
cord-005453-4057qib7	331	4	al	al	NNP
cord-005453-4057qib7	331	5	.	.	NNP
cord-005453-4057qib7	331	6	,	,	,
cord-005453-4057qib7	331	7	Blood	blood	NN
cord-005453-4057qib7	331	8	2013	2013	CD
cord-005453-4057qib7	331	9	)	)	-RRB-
cord-005453-4057qib7	331	10	.	.	.
cord-005453-4057qib7	332	1	Primary	primary	JJ
cord-005453-4057qib7	332	2	endpoint	endpoint	NN
cord-005453-4057qib7	332	3	of	of	IN
cord-005453-4057qib7	332	4	our	-PRON-	PRP$
cord-005453-4057qib7	332	5	retrospective	retrospective	JJ
cord-005453-4057qib7	332	6	analysis	analysis	NN
cord-005453-4057qib7	332	7	was	be	VBD
cord-005453-4057qib7	332	8	progression	progression	NN
cord-005453-4057qib7	332	9	to	to	IN
cord-005453-4057qib7	332	10	HR	HR	NNP
cord-005453-4057qib7	332	11	(	(	-LRB-
cord-005453-4057qib7	332	12	≥5	≥5	NNP
cord-005453-4057qib7	332	13	%	%	NN
cord-005453-4057qib7	332	14	bone	bone	NN
cord-005453-4057qib7	332	15	marrow	marrow	NN
cord-005453-4057qib7	332	16	blasts	blast	NNS
cord-005453-4057qib7	332	17	or	or	CC
cord-005453-4057qib7	332	18	extramedullary	extramedullary	JJ
cord-005453-4057qib7	332	19	disease	disease	NN
cord-005453-4057qib7	332	20	)	)	-RRB-
cord-005453-4057qib7	332	21	;	;	,
cord-005453-4057qib7	332	22	secondary	secondary	JJ
cord-005453-4057qib7	332	23	endpoints	endpoint	NNS
cord-005453-4057qib7	332	24	were	be	VBD
cord-005453-4057qib7	332	25	achievement	achievement	NN
cord-005453-4057qib7	332	26	of	of	IN
cord-005453-4057qib7	332	27	molecular	molecular	JJ
cord-005453-4057qib7	332	28	remission	remission	NN
cord-005453-4057qib7	332	29	prior	prior	RB
cord-005453-4057qib7	332	30	to	to	IN
cord-005453-4057qib7	332	31	HSCT	HSCT	NNP
cord-005453-4057qib7	332	32	,	,	,
cord-005453-4057qib7	333	1	neutropenia	neutropenia	NNP
cord-005453-4057qib7	333	2	G4	G4	NNP
cord-005453-4057qib7	333	3	according	accord	VBG
cord-005453-4057qib7	333	4	to	to	IN
cord-005453-4057qib7	333	5	CTCAE	CTCAE	NNP
cord-005453-4057qib7	333	6	,	,	,
cord-005453-4057qib7	333	7	thrombocytopenia	thrombocytopenia	VBD
cord-005453-4057qib7	333	8	G4	G4	NNP
cord-005453-4057qib7	333	9	,	,	,
cord-005453-4057qib7	333	10	anemia	anemia	NN
cord-005453-4057qib7	333	11	≥G3	≥G3	NNP
cord-005453-4057qib7	333	12	,	,	,
cord-005453-4057qib7	333	13	admission	admission	NN
cord-005453-4057qib7	333	14	to	to	IN
cord-005453-4057qib7	333	15	hospital	hospital	NN
cord-005453-4057qib7	333	16	,	,	,
cord-005453-4057qib7	333	17	OS	OS	NNP
cord-005453-4057qib7	333	18	and	and	CC
cord-005453-4057qib7	333	19	RFS	RFS	NNP
cord-005453-4057qib7	333	20	.	.	.
cord-005453-4057qib7	334	1	OS	OS	NNP
cord-005453-4057qib7	334	2	and	and	CC
cord-005453-4057qib7	334	3	RFS	RFS	NNP
cord-005453-4057qib7	334	4	were	be	VBD
cord-005453-4057qib7	334	5	calculated	calculate	VBN
cord-005453-4057qib7	334	6	from	from	IN
cord-005453-4057qib7	334	7	the	the	DT
cord-005453-4057qib7	334	8	first	first	JJ
cord-005453-4057qib7	334	9	dose	dose	NN
cord-005453-4057qib7	334	10	of	of	IN
cord-005453-4057qib7	334	11	LDARAC	LDARAC	NNP
cord-005453-4057qib7	334	12	.	.	.
cord-005453-4057qib7	335	1	LDARAC	LDARAC	NNP
cord-005453-4057qib7	335	2	was	be	VBD
cord-005453-4057qib7	335	3	self	self	NN
cord-005453-4057qib7	335	4	-	-	HYPH
cord-005453-4057qib7	335	5	administered	administer	VBN
cord-005453-4057qib7	335	6	subcutaneously	subcutaneously	RB
cord-005453-4057qib7	335	7	by	by	IN
cord-005453-4057qib7	335	8	the	the	DT
cord-005453-4057qib7	335	9	patients	patient	NNS
cord-005453-4057qib7	335	10	at	at	IN
cord-005453-4057qib7	335	11	home	home	NN
cord-005453-4057qib7	335	12	at	at	IN
cord-005453-4057qib7	335	13	a	a	DT
cord-005453-4057qib7	335	14	flat	flat	JJ
cord-005453-4057qib7	335	15	dose	dose	NN
cord-005453-4057qib7	335	16	of	of	IN
cord-005453-4057qib7	335	17	20	20	CD
cord-005453-4057qib7	335	18	mg	mg	NNP
cord-005453-4057qib7	335	19	BID	BID	VBN
cord-005453-4057qib7	335	20	over	over	IN
cord-005453-4057qib7	335	21	10	10	CD
cord-005453-4057qib7	335	22	days	day	NNS
cord-005453-4057qib7	335	23	and	and	CC
cord-005453-4057qib7	335	24	repeated	repeat	VBN
cord-005453-4057qib7	335	25	after	after	IN
cord-005453-4057qib7	335	26	4	4	CD
cord-005453-4057qib7	335	27	weeks	week	NNS
cord-005453-4057qib7	335	28	if	if	IN
cord-005453-4057qib7	335	29	necessary	necessary	JJ
cord-005453-4057qib7	335	30	.	.	.
cord-005453-4057qib7	336	1	Results	result	NNS
cord-005453-4057qib7	336	2	:	:	:
cord-005453-4057qib7	337	1	Between	between	IN
cord-005453-4057qib7	337	2	12/2015	12/2015	CD
cord-005453-4057qib7	337	3	and	and	CC
cord-005453-4057qib7	337	4	10/2018	10/2018	CD
cord-005453-4057qib7	337	5	,	,	,
cord-005453-4057qib7	337	6	nine	nine	CD
cord-005453-4057qib7	337	7	patients	patient	NNS
cord-005453-4057qib7	337	8	(	(	-LRB-
cord-005453-4057qib7	337	9	median	median	JJ
cord-005453-4057qib7	337	10	age	age	NN
cord-005453-4057qib7	337	11	55	55	CD
cord-005453-4057qib7	337	12	,	,	,
cord-005453-4057qib7	337	13	range	range	NN
cord-005453-4057qib7	337	14	,	,	,
cord-005453-4057qib7	337	15	22	22	CD
cord-005453-4057qib7	337	16	-	-	SYM
cord-005453-4057qib7	337	17	68	68	CD
cord-005453-4057qib7	337	18	years	year	NNS
cord-005453-4057qib7	337	19	)	)	-RRB-
cord-005453-4057qib7	337	20	with	with	IN
cord-005453-4057qib7	337	21	low	low	JJ
cord-005453-4057qib7	337	22	(	(	-LRB-
cord-005453-4057qib7	337	23	n=7	n=7	NNS
cord-005453-4057qib7	337	24	)	)	-RRB-
cord-005453-4057qib7	337	25	,	,	,
cord-005453-4057qib7	337	26	intermediate	intermediate	JJ
cord-005453-4057qib7	337	27	(	(	-LRB-
cord-005453-4057qib7	337	28	n=1	n=1	JJ
cord-005453-4057qib7	337	29	)	)	-RRB-
cord-005453-4057qib7	337	30	or	or	CC
cord-005453-4057qib7	337	31	high	high	JJ
cord-005453-4057qib7	337	32	-	-	HYPH
cord-005453-4057qib7	337	33	risk	risk	NN
cord-005453-4057qib7	337	34	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	337	35	(	(	-LRB-
cord-005453-4057qib7	337	36	n=1	n=1	FW
cord-005453-4057qib7	337	37	)	)	-RRB-
cord-005453-4057qib7	337	38	according	accord	VBG
cord-005453-4057qib7	337	39	to	to	IN
cord-005453-4057qib7	337	40	ELN	ELN	NNP
cord-005453-4057qib7	337	41	criteria	criterion	NNS
cord-005453-4057qib7	337	42	2017	2017	CD
cord-005453-4057qib7	337	43	were	be	VBD
cord-005453-4057qib7	337	44	treated	treat	VBN
cord-005453-4057qib7	337	45	in	in	IN
cord-005453-4057qib7	337	46	continuous	continuous	JJ
cord-005453-4057qib7	337	47	CHR	CHR	NNP
cord-005453-4057qib7	337	48	for	for	IN
cord-005453-4057qib7	337	49	increasing	increase	VBG
cord-005453-4057qib7	337	50	(	(	-LRB-
cord-005453-4057qib7	337	51	n=2	n=2	NNS
cord-005453-4057qib7	337	52	)	)	-RRB-
cord-005453-4057qib7	337	53	or	or	CC
cord-005453-4057qib7	337	54	recurrent	recurrent	JJ
cord-005453-4057qib7	337	55	MRD	MRD	NNP
cord-005453-4057qib7	337	56	(	(	-LRB-
cord-005453-4057qib7	337	57	n=7	n=7	NN
cord-005453-4057qib7	337	58	)	)	-RRB-
cord-005453-4057qib7	337	59	starting	start	VBG
cord-005453-4057qib7	337	60	at	at	IN
cord-005453-4057qib7	337	61	a	a	DT
cord-005453-4057qib7	337	62	median	median	NN
cord-005453-4057qib7	337	63	of	of	IN
cord-005453-4057qib7	337	64	260	260	CD
cord-005453-4057qib7	338	1	(	(	-LRB-
cord-005453-4057qib7	338	2	range	range	NN
cord-005453-4057qib7	338	3	,	,	,
cord-005453-4057qib7	338	4	154	154	CD
cord-005453-4057qib7	338	5	-	-	SYM
cord-005453-4057qib7	338	6	651	651	CD
cord-005453-4057qib7	338	7	)	)	-RRB-
cord-005453-4057qib7	338	8	days	day	NNS
cord-005453-4057qib7	338	9	after	after	IN
cord-005453-4057qib7	338	10	the	the	DT
cord-005453-4057qib7	338	11	last	last	JJ
cord-005453-4057qib7	338	12	consolidation	consolidation	NN
cord-005453-4057qib7	338	13	therapy	therapy	NN
cord-005453-4057qib7	338	14	,	,	,
cord-005453-4057qib7	338	15	i.e.	i.e.	FW
cord-005453-4057qib7	338	16	,	,	,
cord-005453-4057qib7	338	17	duration	duration	NN
cord-005453-4057qib7	338	18	of	of	IN
cord-005453-4057qib7	338	19	CHR	CHR	NNP
cord-005453-4057qib7	338	20	was	be	VBD
cord-005453-4057qib7	338	21	>	>	NFP
cord-005453-4057qib7	338	22	6	6	CD
cord-005453-4057qib7	338	23	months	month	NNS
cord-005453-4057qib7	338	24	in	in	IN
cord-005453-4057qib7	338	25	all	all	DT
cord-005453-4057qib7	338	26	pts	pt	NNS
cord-005453-4057qib7	338	27	.	.	.
cord-005453-4057qib7	339	1	Patients	patient	NNS
cord-005453-4057qib7	339	2	received	receive	VBD
cord-005453-4057qib7	339	3	one	one	CD
cord-005453-4057qib7	339	4	(	(	-LRB-
cord-005453-4057qib7	339	5	n=4	n=4	NNS
cord-005453-4057qib7	339	6	)	)	-RRB-
cord-005453-4057qib7	339	7	,	,	,
cord-005453-4057qib7	339	8	two	two	CD
cord-005453-4057qib7	339	9	(	(	-LRB-
cord-005453-4057qib7	339	10	n=2	n=2	NNS
cord-005453-4057qib7	339	11	)	)	-RRB-
cord-005453-4057qib7	339	12	or	or	CC
cord-005453-4057qib7	339	13	three	three	CD
cord-005453-4057qib7	339	14	cycles	cycle	NNS
cord-005453-4057qib7	339	15	(	(	-LRB-
cord-005453-4057qib7	339	16	n=3	n=3	NN
cord-005453-4057qib7	339	17	)	)	-RRB-
cord-005453-4057qib7	339	18	of	of	IN
cord-005453-4057qib7	339	19	LDARAC	LDARAC	NNP
cord-005453-4057qib7	339	20	prior	prior	RB
cord-005453-4057qib7	339	21	to	to	IN
cord-005453-4057qib7	339	22	HSCT	HSCT	NNP
cord-005453-4057qib7	339	23	.	.	.
cord-005453-4057qib7	340	1	In	in	IN
cord-005453-4057qib7	340	2	three	three	CD
cord-005453-4057qib7	340	3	patients	patient	NNS
cord-005453-4057qib7	340	4	,	,	,
cord-005453-4057qib7	340	5	neutropenia	neutropenia	NN
cord-005453-4057qib7	340	6	G4	G4	NNP
cord-005453-4057qib7	340	7	occurred	occur	VBD
cord-005453-4057qib7	340	8	and	and	CC
cord-005453-4057qib7	340	9	one	one	CD
cord-005453-4057qib7	340	10	patient	patient	NN
cord-005453-4057qib7	340	11	needed	need	VBD
cord-005453-4057qib7	340	12	platelet	platelet	NN
cord-005453-4057qib7	340	13	transfusion	transfusion	NN
cord-005453-4057qib7	340	14	.	.	.
cord-005453-4057qib7	341	1	All	all	DT
cord-005453-4057qib7	341	2	patients	patient	NNS
cord-005453-4057qib7	341	3	were	be	VBD
cord-005453-4057qib7	341	4	managed	manage	VBN
cord-005453-4057qib7	341	5	in	in	IN
cord-005453-4057qib7	341	6	the	the	DT
cord-005453-4057qib7	341	7	outpatient	outpatient	NN
cord-005453-4057qib7	341	8	setting	setting	NN
cord-005453-4057qib7	341	9	.	.	.
cord-005453-4057qib7	342	1	In	in	IN
cord-005453-4057qib7	342	2	eight	eight	CD
cord-005453-4057qib7	342	3	out	out	IN
cord-005453-4057qib7	342	4	of	of	IN
cord-005453-4057qib7	342	5	nine	nine	CD
cord-005453-4057qib7	342	6	patients	patient	NNS
cord-005453-4057qib7	342	7	(	(	-LRB-
cord-005453-4057qib7	342	8	89	89	CD
cord-005453-4057qib7	342	9	%	%	NN
cord-005453-4057qib7	342	10	)	)	-RRB-
cord-005453-4057qib7	342	11	,	,	,
cord-005453-4057qib7	342	12	HR	HR	NNP
cord-005453-4057qib7	342	13	was	be	VBD
cord-005453-4057qib7	342	14	successfully	successfully	RB
cord-005453-4057qib7	342	15	prevented	prevent	VBN
cord-005453-4057qib7	342	16	and	and	CC
cord-005453-4057qib7	342	17	3	3	CD
cord-005453-4057qib7	342	18	patients	patient	NNS
cord-005453-4057qib7	342	19	(	(	-LRB-
cord-005453-4057qib7	342	20	33	33	CD
cord-005453-4057qib7	342	21	%	%	NN
cord-005453-4057qib7	342	22	)	)	-RRB-
cord-005453-4057qib7	342	23	even	even	RB
cord-005453-4057qib7	342	24	became	become	VBD
cord-005453-4057qib7	342	25	MRD	MRD	NNP
cord-005453-4057qib7	342	26	negative	negative	JJ
cord-005453-4057qib7	342	27	prior	prior	RB
cord-005453-4057qib7	342	28	to	to	IN
cord-005453-4057qib7	342	29	HSCT	HSCT	NNP
cord-005453-4057qib7	342	30	.	.	.
cord-005453-4057qib7	343	1	One	one	CD
cord-005453-4057qib7	343	2	patient	patient	NN
cord-005453-4057qib7	343	3	(	(	-LRB-
cord-005453-4057qib7	343	4	RUNX1-RUNX1T1	runx1-runx1t1	CD
cord-005453-4057qib7	343	5	positive	positive	JJ
cord-005453-4057qib7	343	6	AML	AML	NNP
cord-005453-4057qib7	343	7	)	)	-RRB-
cord-005453-4057qib7	343	8	progressed	progress	VBD
cord-005453-4057qib7	343	9	to	to	IN
cord-005453-4057qib7	343	10	HR	hr	NN
cord-005453-4057qib7	343	11	after	after	IN
cord-005453-4057qib7	343	12	one	one	CD
cord-005453-4057qib7	343	13	cycle	cycle	NN
cord-005453-4057qib7	343	14	of	of	IN
cord-005453-4057qib7	343	15	LDARAC	LDARAC	NNP
cord-005453-4057qib7	343	16	and	and	CC
cord-005453-4057qib7	343	17	received	receive	VBD
cord-005453-4057qib7	343	18	salvage	salvage	NN
cord-005453-4057qib7	343	19	therapy	therapy	NN
cord-005453-4057qib7	343	20	with	with	IN
cord-005453-4057qib7	343	21	high	high	JJ
cord-005453-4057qib7	343	22	-	-	HYPH
cord-005453-4057qib7	343	23	dose	dose	NN
cord-005453-4057qib7	343	24	ARAC	ARAC	NNP
cord-005453-4057qib7	343	25	and	and	CC
cord-005453-4057qib7	343	26	mitoxantrone	mitoxantrone	NN
cord-005453-4057qib7	343	27	(	(	-LRB-
cord-005453-4057qib7	343	28	HAM	HAM	NNP
cord-005453-4057qib7	343	29	)	)	-RRB-
cord-005453-4057qib7	343	30	prior	prior	RB
cord-005453-4057qib7	343	31	to	to	IN
cord-005453-4057qib7	343	32	HSCT	HSCT	NNP
cord-005453-4057qib7	343	33	.	.	.
cord-005453-4057qib7	344	1	All	all	DT
cord-005453-4057qib7	344	2	patients	patient	NNS
cord-005453-4057qib7	344	3	proceeded	proceed	VBD
cord-005453-4057qib7	344	4	to	to	IN
cord-005453-4057qib7	344	5	HSCT	HSCT	NNP
cord-005453-4057qib7	344	6	from	from	IN
cord-005453-4057qib7	344	7	a	a	DT
cord-005453-4057qib7	344	8	matched	match	VBN
cord-005453-4057qib7	344	9	related	relate	VBN
cord-005453-4057qib7	344	10	(	(	-LRB-
cord-005453-4057qib7	344	11	n=1	n=1	CD
cord-005453-4057qib7	344	12	)	)	-RRB-
cord-005453-4057qib7	344	13	,	,	,
cord-005453-4057qib7	344	14	unrelated	unrelated	JJ
cord-005453-4057qib7	344	15	(	(	-LRB-
cord-005453-4057qib7	344	16	n=7	n=7	NNS
cord-005453-4057qib7	344	17	)	)	-RRB-
cord-005453-4057qib7	344	18	or	or	CC
cord-005453-4057qib7	344	19	haploidentical	haploidentical	JJ
cord-005453-4057qib7	344	20	donor	donor	NN
cord-005453-4057qib7	344	21	(	(	-LRB-
cord-005453-4057qib7	344	22	n=1	n=1	FW
cord-005453-4057qib7	344	23	)	)	-RRB-
cord-005453-4057qib7	344	24	and	and	CC
cord-005453-4057qib7	344	25	are	be	VBP
cord-005453-4057qib7	344	26	still	still	RB
cord-005453-4057qib7	344	27	alive	alive	JJ
cord-005453-4057qib7	344	28	(	(	-LRB-
cord-005453-4057qib7	344	29	median	median	JJ
cord-005453-4057qib7	344	30	follow	follow	NN
cord-005453-4057qib7	344	31	-	-	HYPH
cord-005453-4057qib7	344	32	up	up	NN
cord-005453-4057qib7	344	33	of	of	IN
cord-005453-4057qib7	344	34	666	666	CD
cord-005453-4057qib7	344	35	days	day	NNS
cord-005453-4057qib7	344	36	)	)	-RRB-
cord-005453-4057qib7	344	37	.	.	.
cord-005453-4057qib7	345	1	Conditioning	conditioning	NN
cord-005453-4057qib7	345	2	regimens	regimen	NNS
cord-005453-4057qib7	345	3	included	include	VBD
cord-005453-4057qib7	345	4	fludarabine	fludarabine	NN
cord-005453-4057qib7	345	5	(	(	-LRB-
cord-005453-4057qib7	345	6	FLU)/melphalan	FLU)/melphalan	NNP
cord-005453-4057qib7	345	7	(	(	-LRB-
cord-005453-4057qib7	345	8	MEL)/TBI	MEL)/TBI	NNP
cord-005453-4057qib7	345	9	(	(	-LRB-
cord-005453-4057qib7	345	10	n=5	n=5	NNP
cord-005453-4057qib7	345	11	)	)	-RRB-
cord-005453-4057qib7	345	12	,	,	,
cord-005453-4057qib7	345	13	FLU	FLU	NNP
cord-005453-4057qib7	345	14	/	/	SYM
cord-005453-4057qib7	345	15	MEL	MEL	NNP
cord-005453-4057qib7	345	16	(	(	-LRB-
cord-005453-4057qib7	345	17	n=1	n=1	NNP
cord-005453-4057qib7	345	18	)	)	-RRB-
cord-005453-4057qib7	345	19	,	,	,
cord-005453-4057qib7	345	20	FLU	FLU	NNP
cord-005453-4057qib7	345	21	/	/	SYM
cord-005453-4057qib7	345	22	TBI	TBI	NNP
cord-005453-4057qib7	345	23	(	(	-LRB-
cord-005453-4057qib7	345	24	n=1	n=1	NNP
cord-005453-4057qib7	345	25	)	)	-RRB-
cord-005453-4057qib7	345	26	,	,	,
cord-005453-4057qib7	345	27	FLU	FLU	NNP
cord-005453-4057qib7	345	28	/	/	SYM
cord-005453-4057qib7	345	29	busulfan	busulfan	NN
cord-005453-4057qib7	346	1	(	(	-LRB-
cord-005453-4057qib7	346	2	BU)4	bu)4	NN
cord-005453-4057qib7	346	3	(	(	-LRB-
cord-005453-4057qib7	346	4	n=1	n=1	NNP
cord-005453-4057qib7	346	5	)	)	-RRB-
cord-005453-4057qib7	346	6	and	and	CC
cord-005453-4057qib7	346	7	thiotepa	thiotepa	JJ
cord-005453-4057qib7	346	8	/	/	SYM
cord-005453-4057qib7	346	9	BU3	BU3	NNP
cord-005453-4057qib7	346	10	/	/	SYM
cord-005453-4057qib7	346	11	FLU	FLU	NNP
cord-005453-4057qib7	346	12	(	(	-LRB-
cord-005453-4057qib7	346	13	n=1	n=1	NN
cord-005453-4057qib7	346	14	)	)	-RRB-
cord-005453-4057qib7	346	15	.	.	.
cord-005453-4057qib7	347	1	After	after	IN
cord-005453-4057qib7	347	2	HSCT	HSCT	NNP
cord-005453-4057qib7	347	3	,	,	,
cord-005453-4057qib7	347	4	only	only	RB
cord-005453-4057qib7	347	5	the	the	DT
cord-005453-4057qib7	347	6	LDARAC	ldarac	JJ
cord-005453-4057qib7	347	7	-	-	HYPH
cord-005453-4057qib7	347	8	refractory	refractory	JJ
cord-005453-4057qib7	347	9	patient	patient	NN
cord-005453-4057qib7	347	10	relapsed	relapse	VBD
cord-005453-4057qib7	347	11	,	,	,
cord-005453-4057qib7	347	12	resulting	result	VBG
cord-005453-4057qib7	347	13	in	in	IN
cord-005453-4057qib7	347	14	a	a	DT
cord-005453-4057qib7	347	15	probability	probability	NN
cord-005453-4057qib7	347	16	of	of	IN
cord-005453-4057qib7	347	17	RFS	RFS	NNP
cord-005453-4057qib7	347	18	of	of	IN
cord-005453-4057qib7	347	19	88	88	CD
cord-005453-4057qib7	347	20	%	%	NN
cord-005453-4057qib7	347	21	at	at	IN
cord-005453-4057qib7	347	22	2	2	CD
cord-005453-4057qib7	347	23	years	year	NNS
cord-005453-4057qib7	347	24	.	.	.
cord-005453-4057qib7	348	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	348	2	:	:	:
cord-005453-4057qib7	349	1	Our	-PRON-	PRP$
cord-005453-4057qib7	349	2	data	datum	NNS
cord-005453-4057qib7	349	3	suggest	suggest	VBP
cord-005453-4057qib7	349	4	that	that	IN
cord-005453-4057qib7	349	5	a	a	DT
cord-005453-4057qib7	349	6	bridging	bridge	VBG
cord-005453-4057qib7	349	7	therapy	therapy	NN
cord-005453-4057qib7	349	8	with	with	IN
cord-005453-4057qib7	349	9	up	up	IN
cord-005453-4057qib7	349	10	to	to	TO
cord-005453-4057qib7	349	11	three	three	CD
cord-005453-4057qib7	349	12	cycles	cycle	NNS
cord-005453-4057qib7	349	13	of	of	IN
cord-005453-4057qib7	349	14	LDARAC	LDARAC	NNP
cord-005453-4057qib7	349	15	prior	prior	RB
cord-005453-4057qib7	349	16	to	to	IN
cord-005453-4057qib7	349	17	HSCT	HSCT	NNP
cord-005453-4057qib7	349	18	is	be	VBZ
cord-005453-4057qib7	349	19	feasible	feasible	JJ
cord-005453-4057qib7	349	20	and	and	CC
cord-005453-4057qib7	349	21	was	be	VBD
cord-005453-4057qib7	349	22	associated	associate	VBN
cord-005453-4057qib7	349	23	with	with	IN
cord-005453-4057qib7	349	24	favorable	favorable	JJ
cord-005453-4057qib7	349	25	outcomes	outcome	NNS
cord-005453-4057qib7	349	26	in	in	IN
cord-005453-4057qib7	349	27	patients	patient	NNS
cord-005453-4057qib7	349	28	with	with	IN
cord-005453-4057qib7	349	29	NPM1-mutated	npm1-mutated	JJ
cord-005453-4057qib7	349	30	or	or	CC
cord-005453-4057qib7	349	31	core	core	NN
cord-005453-4057qib7	349	32	binding	binding	NN
cord-005453-4057qib7	349	33	factor	factor	NN
cord-005453-4057qib7	349	34	AML	AML	NNP
cord-005453-4057qib7	349	35	and	and	CC
cord-005453-4057qib7	349	36	molecular	molecular	JJ
cord-005453-4057qib7	349	37	relapse	relapse	NN
cord-005453-4057qib7	349	38	>	>	XX
cord-005453-4057qib7	349	39	6	6	CD
cord-005453-4057qib7	349	40	months	month	NNS
cord-005453-4057qib7	349	41	after	after	IN
cord-005453-4057qib7	349	42	achieving	achieve	VBG
cord-005453-4057qib7	349	43	a	a	DT
cord-005453-4057qib7	349	44	first	first	JJ
cord-005453-4057qib7	349	45	CHR	CHR	NNP
cord-005453-4057qib7	349	46	.	.	.
cord-005453-4057qib7	350	1	The	the	DT
cord-005453-4057qib7	350	2	treatment	treatment	NN
cord-005453-4057qib7	350	3	has	have	VBZ
cord-005453-4057qib7	350	4	low	low	JJ
cord-005453-4057qib7	350	5	costs	cost	NNS
cord-005453-4057qib7	350	6	,	,	,
cord-005453-4057qib7	350	7	can	can	MD
cord-005453-4057qib7	350	8	be	be	VB
cord-005453-4057qib7	350	9	administered	administer	VBN
cord-005453-4057qib7	350	10	on	on	IN
cord-005453-4057qib7	350	11	an	an	DT
cord-005453-4057qib7	350	12	outpatient	outpatient	NN
cord-005453-4057qib7	350	13	basis	basis	NN
cord-005453-4057qib7	350	14	and	and	CC
cord-005453-4057qib7	350	15	is	be	VBZ
cord-005453-4057qib7	350	16	very	very	RB
cord-005453-4057qib7	350	17	well	well	RB
cord-005453-4057qib7	350	18	tolerated	tolerate	VBN
cord-005453-4057qib7	350	19	.	.	.
cord-005453-4057qib7	351	1	Clinical	clinical	JJ
cord-005453-4057qib7	351	2	Background	background	NN
cord-005453-4057qib7	351	3	:	:	:
cord-005453-4057qib7	352	1	Allogenic	allogenic	JJ
cord-005453-4057qib7	352	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	352	3	stem	stem	NN
cord-005453-4057qib7	352	4	cell	cell	NN
cord-005453-4057qib7	352	5	transplant	transplant	NN
cord-005453-4057qib7	352	6	(	(	-LRB-
cord-005453-4057qib7	352	7	HSCT	HSCT	NNP
cord-005453-4057qib7	352	8	)	)	-RRB-
cord-005453-4057qib7	352	9	is	be	VBZ
cord-005453-4057qib7	352	10	the	the	DT
cord-005453-4057qib7	352	11	only	only	JJ
cord-005453-4057qib7	352	12	curative	curative	JJ
cord-005453-4057qib7	352	13	treatment	treatment	NN
cord-005453-4057qib7	352	14	for	for	IN
cord-005453-4057qib7	352	15	all	all	PDT
cord-005453-4057qib7	352	16	the	the	DT
cord-005453-4057qib7	352	17	patients	patient	NNS
cord-005453-4057qib7	352	18	with	with	IN
cord-005453-4057qib7	352	19	AML	AML	NNP
cord-005453-4057qib7	352	20	.	.	.
cord-005453-4057qib7	353	1	High	high	JJ
cord-005453-4057qib7	353	2	risk	risk	NN
cord-005453-4057qib7	353	3	disease	disease	NN
cord-005453-4057qib7	353	4	qualifies	qualify	VBZ
cord-005453-4057qib7	353	5	for	for	IN
cord-005453-4057qib7	353	6	upfront	upfront	JJ
cord-005453-4057qib7	353	7	HSCT	HSCT	NNP
cord-005453-4057qib7	353	8	irrespective	irrespective	RB
cord-005453-4057qib7	353	9	of	of	IN
cord-005453-4057qib7	353	10	the	the	DT
cord-005453-4057qib7	353	11	presence	presence	NN
cord-005453-4057qib7	353	12	of	of	IN
cord-005453-4057qib7	353	13	matched	match	VBN
cord-005453-4057qib7	353	14	sibling	sibling	NN
cord-005453-4057qib7	353	15	donor	donor	NN
cord-005453-4057qib7	353	16	(	(	-LRB-
cord-005453-4057qib7	353	17	MSD	MSD	NNP
cord-005453-4057qib7	353	18	)	)	-RRB-
cord-005453-4057qib7	353	19	.	.	.
cord-005453-4057qib7	354	1	In	in	IN
cord-005453-4057qib7	354	2	the	the	DT
cord-005453-4057qib7	354	3	absence	absence	NN
cord-005453-4057qib7	354	4	of	of	IN
cord-005453-4057qib7	354	5	MSD	MSD	NNP
cord-005453-4057qib7	354	6	,	,	,
cord-005453-4057qib7	354	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	354	8	stem	stem	NN
cord-005453-4057qib7	354	9	cell	cell	NN
cord-005453-4057qib7	354	10	transplant	transplant	NN
cord-005453-4057qib7	354	11	is	be	VBZ
cord-005453-4057qib7	354	12	easier	easy	JJR
cord-005453-4057qib7	354	13	option	option	NN
cord-005453-4057qib7	354	14	with	with	IN
cord-005453-4057qib7	354	15	success	success	NN
cord-005453-4057qib7	354	16	rates	rate	NNS
cord-005453-4057qib7	354	17	as	as	RB
cord-005453-4057qib7	354	18	high	high	JJ
cord-005453-4057qib7	354	19	as	as	IN
cord-005453-4057qib7	354	20	MSD	MSD	NNP
cord-005453-4057qib7	354	21	in	in	IN
cord-005453-4057qib7	354	22	a	a	DT
cord-005453-4057qib7	354	23	high	high	JJ
cord-005453-4057qib7	354	24	volume	volume	NN
cord-005453-4057qib7	354	25	transplant	transplant	NN
cord-005453-4057qib7	354	26	centre	centre	NN
cord-005453-4057qib7	354	27	.	.	.
cord-005453-4057qib7	355	1	We	-PRON-	PRP
cord-005453-4057qib7	355	2	present	present	VBP
cord-005453-4057qib7	355	3	our	-PRON-	PRP$
cord-005453-4057qib7	355	4	experience	experience	NN
cord-005453-4057qib7	355	5	from	from	IN
cord-005453-4057qib7	355	6	a	a	DT
cord-005453-4057qib7	355	7	single	single	JJ
cord-005453-4057qib7	355	8	centre	centre	NN
cord-005453-4057qib7	355	9	.	.	.
cord-005453-4057qib7	356	1	Methods	method	NNS
cord-005453-4057qib7	356	2	:	:	:
cord-005453-4057qib7	356	3	We	-PRON-	PRP
cord-005453-4057qib7	356	4	analyzed	analyze	VBD
cord-005453-4057qib7	356	5	retrospective	retrospective	JJ
cord-005453-4057qib7	356	6	data	datum	NNS
cord-005453-4057qib7	356	7	of	of	IN
cord-005453-4057qib7	356	8	AML	AML	NNP
cord-005453-4057qib7	356	9	patients	patient	NNS
cord-005453-4057qib7	356	10	who	who	WP
cord-005453-4057qib7	356	11	have	have	VBP
cord-005453-4057qib7	356	12	undergone	undergo	VBN
cord-005453-4057qib7	356	13	HSCT	HSCT	NNP
cord-005453-4057qib7	356	14	at	at	IN
cord-005453-4057qib7	356	15	our	-PRON-	PRP$
cord-005453-4057qib7	356	16	centre	centre	NN
cord-005453-4057qib7	356	17	between	between	IN
cord-005453-4057qib7	356	18	January-2013	January-2013	NNP
cord-005453-4057qib7	356	19	and	and	CC
cord-005453-4057qib7	356	20	August-2018	August-2018	NNP
cord-005453-4057qib7	356	21	.	.	.
cord-005453-4057qib7	357	1	For	for	IN
cord-005453-4057qib7	357	2	MSD	MSD	NNP
cord-005453-4057qib7	357	3	transplant	transplant	NN
cord-005453-4057qib7	357	4	we	-PRON-	PRP
cord-005453-4057qib7	357	5	used	use	VBD
cord-005453-4057qib7	357	6	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	357	7	+	+	CC
cord-005453-4057qib7	357	8	Busulfan	Busulfan	NNP
cord-005453-4057qib7	357	9	or	or	CC
cord-005453-4057qib7	357	10	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	357	11	+	+	SYM
cord-005453-4057qib7	357	12	Melphalan	Melphalan	NNP
cord-005453-4057qib7	357	13	conditioning	conditioning	NN
cord-005453-4057qib7	357	14	regimen	regimen	NN
cord-005453-4057qib7	357	15	,	,	,
cord-005453-4057qib7	357	16	in	in	IN
cord-005453-4057qib7	357	17	matched	match	VBN
cord-005453-4057qib7	357	18	unrelated	unrelated	JJ
cord-005453-4057qib7	357	19	donor	donor	NN
cord-005453-4057qib7	357	20	transplant	transplant	NN
cord-005453-4057qib7	357	21	(	(	-LRB-
cord-005453-4057qib7	357	22	MUD	mud	NN
cord-005453-4057qib7	357	23	)	)	-RRB-
cord-005453-4057qib7	357	24	regime	regime	NN
cord-005453-4057qib7	357	25	used	use	VBN
cord-005453-4057qib7	357	26	was	be	VBD
cord-005453-4057qib7	357	27	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	357	28	+	+	CC
cord-005453-4057qib7	357	29	Busulfan	Busulfan	NNP
cord-005453-4057qib7	357	30	+	+	SYM
cord-005453-4057qib7	357	31	ATG	ATG	NNP
cord-005453-4057qib7	357	32	.	.	.
cord-005453-4057qib7	358	1	We	-PRON-	PRP
cord-005453-4057qib7	358	2	followed	follow	VBD
cord-005453-4057qib7	358	3	John	John	NNP
cord-005453-4057qib7	358	4	Hopkins	Hopkins	NNP
cord-005453-4057qib7	358	5	's	's	POS
cord-005453-4057qib7	358	6	protocol	protocol	NN
cord-005453-4057qib7	358	7	for	for	IN
cord-005453-4057qib7	358	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	358	9	HSCT	HSCT	NNP
cord-005453-4057qib7	358	10	.	.	.
cord-005453-4057qib7	359	1	Cyclosporine	cyclosporine	NN
cord-005453-4057qib7	359	2	+	+	CC
cord-005453-4057qib7	359	3	methotrexate	methotrexate	NNP
cord-005453-4057qib7	359	4	was	be	VBD
cord-005453-4057qib7	359	5	used	use	VBN
cord-005453-4057qib7	359	6	as	as	IN
cord-005453-4057qib7	359	7	GVHD	GVHD	NNP
cord-005453-4057qib7	359	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	359	9	in	in	IN
cord-005453-4057qib7	359	10	MSD	MSD	NNP
cord-005453-4057qib7	359	11	and	and	CC
cord-005453-4057qib7	359	12	unrelated	unrelated	JJ
cord-005453-4057qib7	359	13	donor	donor	NN
cord-005453-4057qib7	359	14	group	group	NN
cord-005453-4057qib7	359	15	and	and	CC
cord-005453-4057qib7	359	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	359	17	+	+	CC
cord-005453-4057qib7	359	18	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	359	19	+	+	CC
cord-005453-4057qib7	359	20	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	359	21	was	be	VBD
cord-005453-4057qib7	359	22	used	use	VBN
cord-005453-4057qib7	359	23	for	for	IN
cord-005453-4057qib7	359	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	359	25	post	post	JJ
cord-005453-4057qib7	359	26	-	-	NN
cord-005453-4057qib7	359	27	transplant	transplant	NN
cord-005453-4057qib7	359	28	.	.	.
cord-005453-4057qib7	360	1	Day	day	NN
cord-005453-4057qib7	360	2	100	100	CD
cord-005453-4057qib7	360	3	Survival	Survival	NNP
cord-005453-4057qib7	360	4	,	,	,
cord-005453-4057qib7	360	5	overall	overall	JJ
cord-005453-4057qib7	360	6	survival	survival	NN
cord-005453-4057qib7	360	7	(	(	-LRB-
cord-005453-4057qib7	360	8	OS	OS	NNP
cord-005453-4057qib7	360	9	)	)	-RRB-
cord-005453-4057qib7	360	10	,	,	,
cord-005453-4057qib7	360	11	incidence	incidence	NN
cord-005453-4057qib7	360	12	of	of	IN
cord-005453-4057qib7	360	13	GVHD	GVHD	NNP
cord-005453-4057qib7	360	14	and	and	CC
cord-005453-4057qib7	360	15	CMV	CMV	NNP
cord-005453-4057qib7	360	16	reactivation	reactivation	NN
cord-005453-4057qib7	360	17	was	be	VBD
cord-005453-4057qib7	360	18	computed	compute	VBN
cord-005453-4057qib7	360	19	.	.	.
cord-005453-4057qib7	361	1	Results	result	NNS
cord-005453-4057qib7	361	2	:	:	:
cord-005453-4057qib7	362	1	A	a	DT
cord-005453-4057qib7	362	2	total	total	NN
cord-005453-4057qib7	362	3	of	of	IN
cord-005453-4057qib7	362	4	96	96	CD
cord-005453-4057qib7	362	5	AML	AML	NNP
cord-005453-4057qib7	362	6	patients	patient	NNS
cord-005453-4057qib7	362	7	underwent	undergo	VBD
cord-005453-4057qib7	362	8	HSCT	HSCT	NNP
cord-005453-4057qib7	362	9	during	during	IN
cord-005453-4057qib7	362	10	the	the	DT
cord-005453-4057qib7	362	11	study	study	NN
cord-005453-4057qib7	362	12	period	period	NN
cord-005453-4057qib7	362	13	,	,	,
cord-005453-4057qib7	362	14	the	the	DT
cord-005453-4057qib7	362	15	basic	basic	JJ
cord-005453-4057qib7	362	16	and	and	CC
cord-005453-4057qib7	362	17	clinical	clinical	JJ
cord-005453-4057qib7	362	18	characteristics	characteristic	NNS
cord-005453-4057qib7	362	19	of	of	IN
cord-005453-4057qib7	362	20	the	the	DT
cord-005453-4057qib7	362	21	study	study	NN
cord-005453-4057qib7	362	22	patients	patient	NNS
cord-005453-4057qib7	362	23	are	be	VBP
cord-005453-4057qib7	362	24	presented	present	VBN
cord-005453-4057qib7	362	25	in	in	IN
cord-005453-4057qib7	362	26	Table	Table	NNP
cord-005453-4057qib7	362	27	1	1	CD
cord-005453-4057qib7	362	28	.	.	.
cord-005453-4057qib7	363	1	Conditioning	conditioning	NN
cord-005453-4057qib7	363	2	regime	regime	NN
cord-005453-4057qib7	363	3	did	do	VBD
cord-005453-4057qib7	363	4	not	not	RB
cord-005453-4057qib7	363	5	have	have	VB
cord-005453-4057qib7	363	6	significant	significant	JJ
cord-005453-4057qib7	363	7	impact	impact	NN
cord-005453-4057qib7	363	8	on	on	IN
cord-005453-4057qib7	363	9	OS	OS	NNP
cord-005453-4057qib7	363	10	.	.	.
cord-005453-4057qib7	364	1	Survival	survival	NN
cord-005453-4057qib7	364	2	at	at	IN
cord-005453-4057qib7	364	3	day	day	NN
cord-005453-4057qib7	364	4	100	100	CD
cord-005453-4057qib7	364	5	was	be	VBD
cord-005453-4057qib7	364	6	78	78	CD
cord-005453-4057qib7	364	7	%	%	NN
cord-005453-4057qib7	364	8	.	.	.
cord-005453-4057qib7	365	1	The	the	DT
cord-005453-4057qib7	365	2	OS	OS	NNP
cord-005453-4057qib7	365	3	function	function	NN
cord-005453-4057qib7	365	4	and	and	CC
cord-005453-4057qib7	365	5	relapse	relapse	VB
cord-005453-4057qib7	365	6	free	free	JJ
cord-005453-4057qib7	365	7	survival	survival	NN
cord-005453-4057qib7	366	1	(	(	-LRB-
cord-005453-4057qib7	366	2	RFS	RFS	NNP
cord-005453-4057qib7	366	3	)	)	-RRB-
cord-005453-4057qib7	366	4	function	function	NN
cord-005453-4057qib7	366	5	did	do	VBD
cord-005453-4057qib7	366	6	not	not	RB
cord-005453-4057qib7	366	7	significantly	significantly	RB
cord-005453-4057qib7	366	8	differ	differ	VB
cord-005453-4057qib7	366	9	between	between	IN
cord-005453-4057qib7	366	10	MSD	MSD	NNP
cord-005453-4057qib7	366	11	and	and	CC
cord-005453-4057qib7	366	12	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	366	13	transplantation	transplantation	NN
cord-005453-4057qib7	366	14	(	(	-LRB-
cord-005453-4057qib7	366	15	68.3	68.3	CD
cord-005453-4057qib7	366	16	%	%	NN
cord-005453-4057qib7	366	17	vs	vs	IN
cord-005453-4057qib7	366	18	60.0	60.0	CD
cord-005453-4057qib7	366	19	%	%	NN
cord-005453-4057qib7	366	20	;	;	:
cord-005453-4057qib7	366	21	p=0.225	p=0.225	NNP
cord-005453-4057qib7	366	22	)	)	-RRB-
cord-005453-4057qib7	366	23	and	and	CC
cord-005453-4057qib7	366	24	(	(	-LRB-
cord-005453-4057qib7	366	25	68.3	68.3	CD
cord-005453-4057qib7	366	26	%	%	NN
cord-005453-4057qib7	366	27	vs	vs	IN
cord-005453-4057qib7	366	28	75.0	75.0	CD
cord-005453-4057qib7	366	29	%	%	NN
cord-005453-4057qib7	366	30	;	;	:
cord-005453-4057qib7	366	31	p=0.760	p=0.760	NNP
cord-005453-4057qib7	366	32	)	)	-RRB-
cord-005453-4057qib7	367	1	(	(	-LRB-
cord-005453-4057qib7	367	2	Graph	graph	NN
cord-005453-4057qib7	367	3	1	1	CD
cord-005453-4057qib7	367	4	)	)	-RRB-
cord-005453-4057qib7	367	5	.	.	.
cord-005453-4057qib7	368	1	Disease	disease	NN
cord-005453-4057qib7	368	2	status	status	NN
cord-005453-4057qib7	368	3	at	at	IN
cord-005453-4057qib7	368	4	latest	late	JJS
cord-005453-4057qib7	368	5	follow	follow	NN
cord-005453-4057qib7	368	6	up	up	RP
cord-005453-4057qib7	368	7	showed	show	VBD
cord-005453-4057qib7	368	8	that	that	IN
cord-005453-4057qib7	368	9	82	82	CD
cord-005453-4057qib7	368	10	%	%	NN
cord-005453-4057qib7	368	11	were	be	VBD
cord-005453-4057qib7	368	12	in	in	IN
cord-005453-4057qib7	368	13	remission	remission	NN
cord-005453-4057qib7	368	14	and	and	CC
cord-005453-4057qib7	368	15	18	18	CD
cord-005453-4057qib7	368	16	%	%	NN
cord-005453-4057qib7	368	17	had	have	VBD
cord-005453-4057qib7	368	18	relapsed	relapse	VBN
cord-005453-4057qib7	368	19	.	.	.
cord-005453-4057qib7	369	1	Overall	overall	RB
cord-005453-4057qib7	369	2	one	one	CD
cord-005453-4057qib7	369	3	year	year	NN
cord-005453-4057qib7	369	4	survival	survival	NN
cord-005453-4057qib7	369	5	and	and	CC
cord-005453-4057qib7	369	6	five	five	CD
cord-005453-4057qib7	369	7	year	year	NN
cord-005453-4057qib7	369	8	survival	survival	NN
cord-005453-4057qib7	369	9	in	in	IN
cord-005453-4057qib7	369	10	the	the	DT
cord-005453-4057qib7	369	11	entire	entire	JJ
cord-005453-4057qib7	369	12	cohort	cohort	NN
cord-005453-4057qib7	369	13	was	be	VBD
cord-005453-4057qib7	369	14	68	68	CD
cord-005453-4057qib7	369	15	%	%	NN
cord-005453-4057qib7	369	16	and	and	CC
cord-005453-4057qib7	369	17	58	58	CD
cord-005453-4057qib7	369	18	%	%	NN
cord-005453-4057qib7	369	19	respectively	respectively	RB
cord-005453-4057qib7	369	20	.	.	.
cord-005453-4057qib7	370	1	The	the	DT
cord-005453-4057qib7	370	2	average	average	JJ
cord-005453-4057qib7	370	3	cost	cost	NN
cord-005453-4057qib7	370	4	of	of	IN
cord-005453-4057qib7	370	5	MSD	MSD	NNP
cord-005453-4057qib7	370	6	transplant	transplant	NN
cord-005453-4057qib7	370	7	at	at	IN
cord-005453-4057qib7	370	8	our	-PRON-	PRP$
cord-005453-4057qib7	370	9	centre	centre	NN
cord-005453-4057qib7	370	10	is	be	VBZ
cord-005453-4057qib7	370	11	INR	INR	NNP
cord-005453-4057qib7	370	12	10,00,000	10,00,000	CD
cord-005453-4057qib7	371	1	(	(	-LRB-
cord-005453-4057qib7	371	2	€	€	$
cord-005453-4057qib7	371	3	10000	10000	CD
cord-005453-4057qib7	371	4	-	-	HYPH
cord-005453-4057qib7	371	5	12000	12000	CD
cord-005453-4057qib7	371	6	)	)	-RRB-
cord-005453-4057qib7	371	7	,	,	,
cord-005453-4057qib7	371	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	371	9	transplant	transplant	NN
cord-005453-4057qib7	371	10	is	be	VBZ
cord-005453-4057qib7	371	11	INR	INR	NNP
cord-005453-4057qib7	371	12	20,00,000	20,00,000	CD
cord-005453-4057qib7	372	1	(	(	-LRB-
cord-005453-4057qib7	372	2	€	€	$
cord-005453-4057qib7	372	3	25000	25000	CD
cord-005453-4057qib7	372	4	-	-	HYPH
cord-005453-4057qib7	372	5	27000	27000	CD
cord-005453-4057qib7	372	6	)	)	-RRB-
cord-005453-4057qib7	373	1	and	and	CC
cord-005453-4057qib7	373	2	MUD	mud	NN
cord-005453-4057qib7	373	3	transplant	transplant	NN
cord-005453-4057qib7	373	4	is	be	VBZ
cord-005453-4057qib7	373	5	INR	INR	NNP
cord-005453-4057qib7	373	6	32,00,000	32,00,000	CD
cord-005453-4057qib7	374	1	(	(	-LRB-
cord-005453-4057qib7	374	2	€	€	$
cord-005453-4057qib7	374	3	30,000	30,000	CD
cord-005453-4057qib7	374	4	+	+	SYM
cord-005453-4057qib7	374	5	10000	10000	CD
cord-005453-4057qib7	374	6	for	for	IN
cord-005453-4057qib7	374	7	stem	stem	NN
cord-005453-4057qib7	374	8	cell	cell	NN
cord-005453-4057qib7	374	9	procurement	procurement	NN
cord-005453-4057qib7	374	10	)	)	-RRB-
cord-005453-4057qib7	374	11	.	.	.
cord-005453-4057qib7	375	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	375	2	:	:	:
cord-005453-4057qib7	376	1	Our	-PRON-	PRP$
cord-005453-4057qib7	376	2	study	study	NN
cord-005453-4057qib7	376	3	showed	show	VBD
cord-005453-4057qib7	376	4	comparable	comparable	JJ
cord-005453-4057qib7	376	5	outcomes	outcome	NNS
cord-005453-4057qib7	376	6	in	in	IN
cord-005453-4057qib7	376	7	MSD	MSD	NNP
cord-005453-4057qib7	376	8	and	and	CC
cord-005453-4057qib7	376	9	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	376	10	transplant	transplant	NN
cord-005453-4057qib7	376	11	with	with	IN
cord-005453-4057qib7	376	12	respect	respect	NN
cord-005453-4057qib7	376	13	to	to	IN
cord-005453-4057qib7	376	14	Day100	day100	JJ
cord-005453-4057qib7	376	15	survival	survival	NN
cord-005453-4057qib7	376	16	,	,	,
cord-005453-4057qib7	376	17	OS	OS	NNP
cord-005453-4057qib7	376	18	,	,	,
cord-005453-4057qib7	376	19	and	and	CC
cord-005453-4057qib7	376	20	rate	rate	NN
cord-005453-4057qib7	376	21	of	of	IN
cord-005453-4057qib7	376	22	GVHD	GVHD	NNP
cord-005453-4057qib7	376	23	.	.	.
cord-005453-4057qib7	377	1	In	in	IN
cord-005453-4057qib7	377	2	a	a	DT
cord-005453-4057qib7	377	3	developing	develop	VBG
cord-005453-4057qib7	377	4	country	country	NN
cord-005453-4057qib7	377	5	like	like	IN
cord-005453-4057qib7	377	6	India	India	NNP
cord-005453-4057qib7	377	7	where	where	WRB
cord-005453-4057qib7	377	8	patients	patient	NNS
cord-005453-4057qib7	377	9	are	be	VBP
cord-005453-4057qib7	377	10	not	not	RB
cord-005453-4057qib7	377	11	covered	cover	VBN
cord-005453-4057qib7	377	12	under	under	IN
cord-005453-4057qib7	377	13	state	state	NN
cord-005453-4057qib7	377	14	health	health	NN
cord-005453-4057qib7	377	15	insurance	insurance	NN
cord-005453-4057qib7	377	16	,	,	,
cord-005453-4057qib7	377	17	the	the	DT
cord-005453-4057qib7	377	18	additional	additional	JJ
cord-005453-4057qib7	377	19	cost	cost	NN
cord-005453-4057qib7	377	20	of	of	IN
cord-005453-4057qib7	377	21	procurement	procurement	NN
cord-005453-4057qib7	377	22	of	of	IN
cord-005453-4057qib7	377	23	stem	stem	NN
cord-005453-4057qib7	377	24	cells	cell	NNS
cord-005453-4057qib7	377	25	in	in	IN
cord-005453-4057qib7	377	26	a	a	DT
cord-005453-4057qib7	377	27	MUD	mud	NN
cord-005453-4057qib7	377	28	transplant	transplant	NN
cord-005453-4057qib7	377	29	would	would	MD
cord-005453-4057qib7	377	30	add	add	VB
cord-005453-4057qib7	377	31	to	to	IN
cord-005453-4057qib7	377	32	the	the	DT
cord-005453-4057qib7	377	33	financial	financial	JJ
cord-005453-4057qib7	377	34	burden	burden	NN
cord-005453-4057qib7	377	35	to	to	IN
cord-005453-4057qib7	377	36	the	the	DT
cord-005453-4057qib7	377	37	patients	patient	NNS
cord-005453-4057qib7	377	38	.	.	.
cord-005453-4057qib7	378	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	378	2	transplant	transplant	NN
cord-005453-4057qib7	378	3	is	be	VBZ
cord-005453-4057qib7	378	4	a	a	DT
cord-005453-4057qib7	378	5	feasible	feasible	JJ
cord-005453-4057qib7	378	6	option	option	NN
cord-005453-4057qib7	378	7	in	in	IN
cord-005453-4057qib7	378	8	case	case	NN
cord-005453-4057qib7	378	9	of	of	IN
cord-005453-4057qib7	378	10	non	non	JJ
cord-005453-4057qib7	378	11	-	-	JJ
cord-005453-4057qib7	378	12	availability	availability	NN
cord-005453-4057qib7	378	13	of	of	IN
cord-005453-4057qib7	378	14	MSD	MSD	NNP
cord-005453-4057qib7	378	15	,	,	,
cord-005453-4057qib7	378	16	due	due	JJ
cord-005453-4057qib7	378	17	to	to	IN
cord-005453-4057qib7	378	18	ease	ease	NN
cord-005453-4057qib7	378	19	of	of	IN
cord-005453-4057qib7	378	20	donor	donor	NN
cord-005453-4057qib7	378	21	availability	availability	NN
cord-005453-4057qib7	378	22	and	and	CC
cord-005453-4057qib7	378	23	strong	strong	JJ
cord-005453-4057qib7	378	24	motivation	motivation	NN
cord-005453-4057qib7	378	25	from	from	IN
cord-005453-4057qib7	378	26	the	the	DT
cord-005453-4057qib7	378	27	family	family	NN
cord-005453-4057qib7	378	28	donor	donor	NN
cord-005453-4057qib7	378	29	to	to	TO
cord-005453-4057qib7	378	30	donate	donate	VB
cord-005453-4057qib7	378	31	the	the	DT
cord-005453-4057qib7	378	32	stem	stem	NN
cord-005453-4057qib7	378	33	cells	cell	NNS
cord-005453-4057qib7	378	34	.	.	.
cord-005453-4057qib7	379	1	Background	background	NN
cord-005453-4057qib7	379	2	:	:	:
cord-005453-4057qib7	380	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	380	2	stem	stem	VBP
cord-005453-4057qib7	380	3	cell	cell	NN
cord-005453-4057qib7	380	4	transplantation	transplantation	NN
cord-005453-4057qib7	380	5	(	(	-LRB-
cord-005453-4057qib7	380	6	allo	allo	NN
cord-005453-4057qib7	380	7	-	-	HYPH
cord-005453-4057qib7	380	8	HSCT	HSCT	NNP
cord-005453-4057qib7	380	9	)	)	-RRB-
cord-005453-4057qib7	380	10	is	be	VBZ
cord-005453-4057qib7	380	11	not	not	RB
cord-005453-4057qib7	380	12	indicated	indicate	VBN
cord-005453-4057qib7	380	13	as	as	IN
cord-005453-4057qib7	380	14	consolidation	consolidation	NN
cord-005453-4057qib7	380	15	of	of	IN
cord-005453-4057qib7	380	16	first	first	JJ
cord-005453-4057qib7	380	17	complete	complete	JJ
cord-005453-4057qib7	380	18	remission	remission	NN
cord-005453-4057qib7	380	19	(	(	-LRB-
cord-005453-4057qib7	380	20	CR1	CR1	NNP
cord-005453-4057qib7	380	21	)	)	-RRB-
cord-005453-4057qib7	380	22	in	in	IN
cord-005453-4057qib7	380	23	favorable	favorable	JJ
cord-005453-4057qib7	380	24	-	-	HYPH
cord-005453-4057qib7	380	25	risk	risk	NN
cord-005453-4057qib7	380	26	acute	acute	JJ
cord-005453-4057qib7	380	27	myeloid	myeloid	NN
cord-005453-4057qib7	380	28	leukemia	leukemia	NN
cord-005453-4057qib7	380	29	(	(	-LRB-
cord-005453-4057qib7	380	30	AML	AML	NNP
cord-005453-4057qib7	380	31	)	)	-RRB-
cord-005453-4057qib7	380	32	bearing	bearing	NN
cord-005453-4057qib7	380	33	mutations	mutation	NNS
cord-005453-4057qib7	380	34	in	in	IN
cord-005453-4057qib7	380	35	nucleophosmin	nucleophosmin	NNP
cord-005453-4057qib7	380	36	(	(	-LRB-
cord-005453-4057qib7	380	37	NPM1	NPM1	NNP
cord-005453-4057qib7	380	38	)	)	-RRB-
cord-005453-4057qib7	380	39	in	in	IN
cord-005453-4057qib7	380	40	the	the	DT
cord-005453-4057qib7	380	41	absence	absence	NN
cord-005453-4057qib7	380	42	of	of	IN
cord-005453-4057qib7	380	43	FLT3	FLT3	NNP
cord-005453-4057qib7	380	44	internal	internal	JJ
cord-005453-4057qib7	380	45	tandem	tandem	NN
cord-005453-4057qib7	380	46	duplication	duplication	NN
cord-005453-4057qib7	380	47	(	(	-LRB-
cord-005453-4057qib7	380	48	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	380	49	)	)	-RRB-
cord-005453-4057qib7	380	50	.	.	.
cord-005453-4057qib7	381	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	381	2	,	,	,
cord-005453-4057qib7	381	3	a	a	DT
cord-005453-4057qib7	381	4	substantial	substantial	JJ
cord-005453-4057qib7	381	5	proportion	proportion	NN
cord-005453-4057qib7	381	6	of	of	IN
cord-005453-4057qib7	381	7	patients	patient	NNS
cord-005453-4057qib7	381	8	eventually	eventually	RB
cord-005453-4057qib7	381	9	proceed	proceed	VBP
cord-005453-4057qib7	381	10	to	to	TO
cord-005453-4057qib7	381	11	allo	allo	VB
cord-005453-4057qib7	381	12	-	-	HYPH
cord-005453-4057qib7	381	13	HSCT	HSCT	NNP
cord-005453-4057qib7	381	14	beyond	beyond	IN
cord-005453-4057qib7	381	15	CR1	CR1	NNP
cord-005453-4057qib7	381	16	or	or	CC
cord-005453-4057qib7	381	17	for	for	IN
cord-005453-4057qib7	381	18	chemoresistant	chemoresistant	JJ
cord-005453-4057qib7	381	19	minimal	minimal	JJ
cord-005453-4057qib7	381	20	residual	residual	JJ
cord-005453-4057qib7	381	21	disease	disease	NN
cord-005453-4057qib7	381	22	(	(	-LRB-
cord-005453-4057qib7	381	23	MRD	MRD	NNP
cord-005453-4057qib7	381	24	)	)	-RRB-
cord-005453-4057qib7	381	25	while	while	IN
cord-005453-4057qib7	381	26	in	in	IN
cord-005453-4057qib7	381	27	CR1	CR1	NNP
cord-005453-4057qib7	381	28	,	,	,
cord-005453-4057qib7	381	29	which	which	WDT
cord-005453-4057qib7	381	30	might	may	MD
cord-005453-4057qib7	381	31	compromise	compromise	VB
cord-005453-4057qib7	381	32	transplantation	transplantation	NN
cord-005453-4057qib7	381	33	outcomes	outcome	NNS
cord-005453-4057qib7	381	34	.	.	.
cord-005453-4057qib7	382	1	The	the	DT
cord-005453-4057qib7	382	2	study	study	NN
cord-005453-4057qib7	382	3	aimed	aim	VBN
cord-005453-4057qib7	382	4	at	at	IN
cord-005453-4057qib7	382	5	examining	examine	VBG
cord-005453-4057qib7	382	6	the	the	DT
cord-005453-4057qib7	382	7	characteristics	characteristic	NNS
cord-005453-4057qib7	382	8	and	and	CC
cord-005453-4057qib7	382	9	results	result	NNS
cord-005453-4057qib7	382	10	of	of	IN
cord-005453-4057qib7	382	11	allo	allo	NN
cord-005453-4057qib7	382	12	-	-	HYPH
cord-005453-4057qib7	382	13	HSCT	HSCT	NNP
cord-005453-4057qib7	382	14	in	in	IN
cord-005453-4057qib7	382	15	AML	AML	NNP
cord-005453-4057qib7	382	16	cases	case	NNS
cord-005453-4057qib7	382	17	with	with	IN
cord-005453-4057qib7	382	18	mutated	mutate	VBN
cord-005453-4057qib7	382	19	NPM1	NPM1	NNP
cord-005453-4057qib7	382	20	and	and	CC
cord-005453-4057qib7	382	21	wild	wild	JJ
cord-005453-4057qib7	382	22	-	-	HYPH
cord-005453-4057qib7	382	23	type	type	NN
cord-005453-4057qib7	382	24	FLT3	FLT3	NNP
cord-005453-4057qib7	383	1	(	(	-LRB-
cord-005453-4057qib7	383	2	NPM1mut	NPM1mut	NNP
cord-005453-4057qib7	383	3	/	/	SYM
cord-005453-4057qib7	383	4	FLT3wt	FLT3wt	NNP
cord-005453-4057qib7	383	5	)	)	-RRB-
cord-005453-4057qib7	383	6	,	,	,
cord-005453-4057qib7	383	7	with	with	IN
cord-005453-4057qib7	383	8	special	special	JJ
cord-005453-4057qib7	383	9	focus	focus	NN
cord-005453-4057qib7	383	10	on	on	IN
cord-005453-4057qib7	383	11	molecular	molecular	JJ
cord-005453-4057qib7	383	12	monitoring	monitoring	NN
cord-005453-4057qib7	383	13	of	of	IN
cord-005453-4057qib7	383	14	MRD	MRD	NNP
cord-005453-4057qib7	383	15	following	follow	VBG
cord-005453-4057qib7	383	16	transplantation	transplantation	NN
cord-005453-4057qib7	383	17	.	.	.
cord-005453-4057qib7	384	1	Methods	method	NNS
cord-005453-4057qib7	384	2	:	:	:
cord-005453-4057qib7	385	1	From	from	IN
cord-005453-4057qib7	385	2	11/2010	11/2010	CD
cord-005453-4057qib7	385	3	until	until	IN
cord-005453-4057qib7	385	4	04/2018	04/2018	CD
cord-005453-4057qib7	385	5	,	,	,
cord-005453-4057qib7	385	6	16	16	CD
cord-005453-4057qib7	385	7	patients	patient	NNS
cord-005453-4057qib7	385	8	(	(	-LRB-
cord-005453-4057qib7	385	9	women	woman	NNS
cord-005453-4057qib7	385	10	/	/	SYM
cord-005453-4057qib7	385	11	men	man	NNS
cord-005453-4057qib7	385	12	,	,	,
cord-005453-4057qib7	385	13	9/7	9/7	CD
cord-005453-4057qib7	385	14	)	)	-RRB-
cord-005453-4057qib7	385	15	underwent	undergo	VBD
cord-005453-4057qib7	385	16	allo	allo	NN
cord-005453-4057qib7	385	17	-	-	HYPH
cord-005453-4057qib7	385	18	HSCT	HSCT	NNP
cord-005453-4057qib7	385	19	for	for	IN
cord-005453-4057qib7	385	20	NPM1mut/	NPM1mut/	NNP
cord-005453-4057qib7	386	1	FLT3wt	FLT3wt	NNP
cord-005453-4057qib7	386	2	AML	AML	NNP
cord-005453-4057qib7	386	3	.	.	.
cord-005453-4057qib7	387	1	At	at	IN
cord-005453-4057qib7	387	2	transplant	transplant	NN
cord-005453-4057qib7	387	3	,	,	,
cord-005453-4057qib7	387	4	median	median	JJ
cord-005453-4057qib7	387	5	age	age	NN
cord-005453-4057qib7	387	6	of	of	IN
cord-005453-4057qib7	387	7	patients	patient	NNS
cord-005453-4057qib7	387	8	was	be	VBD
cord-005453-4057qib7	387	9	44.5	44.5	CD
cord-005453-4057qib7	387	10	years	year	NNS
cord-005453-4057qib7	388	1	(	(	-LRB-
cord-005453-4057qib7	388	2	range	range	NN
cord-005453-4057qib7	388	3	,	,	,
cord-005453-4057qib7	388	4	35	35	CD
cord-005453-4057qib7	388	5	-	-	SYM
cord-005453-4057qib7	388	6	63	63	CD
cord-005453-4057qib7	388	7	)	)	-RRB-
cord-005453-4057qib7	388	8	,	,	,
cord-005453-4057qib7	388	9	and	and	CC
cord-005453-4057qib7	389	1	disease	disease	NNP
cord-005453-4057qib7	389	2	phase	phase	NN
cord-005453-4057qib7	389	3	was	be	VBD
cord-005453-4057qib7	389	4	CR1	CR1	NNP
cord-005453-4057qib7	389	5	(	(	-LRB-
cord-005453-4057qib7	389	6	n=5	n=5	NNP
cord-005453-4057qib7	389	7	)	)	-RRB-
cord-005453-4057qib7	389	8	,	,	,
cord-005453-4057qib7	389	9	CR2	CR2	NNP
cord-005453-4057qib7	389	10	(	(	-LRB-
cord-005453-4057qib7	389	11	n=9	n=9	NN
cord-005453-4057qib7	389	12	)	)	-RRB-
cord-005453-4057qib7	389	13	,	,	,
cord-005453-4057qib7	389	14	or	or	CC
cord-005453-4057qib7	389	15	primary	primary	JJ
cord-005453-4057qib7	389	16	refractory	refractory	NN
cord-005453-4057qib7	389	17	(	(	-LRB-
cord-005453-4057qib7	389	18	n=2	n=2	NNS
cord-005453-4057qib7	389	19	)	)	-RRB-
cord-005453-4057qib7	389	20	.	.	.
cord-005453-4057qib7	390	1	Among	among	IN
cord-005453-4057qib7	390	2	the	the	DT
cord-005453-4057qib7	390	3	13	13	CD
cord-005453-4057qib7	390	4	patients	patient	NNS
cord-005453-4057qib7	390	5	who	who	WP
cord-005453-4057qib7	390	6	were	be	VBD
cord-005453-4057qib7	390	7	transplanted	transplant	VBN
cord-005453-4057qib7	390	8	in	in	IN
cord-005453-4057qib7	390	9	CR	CR	NNP
cord-005453-4057qib7	390	10	and	and	CC
cord-005453-4057qib7	390	11	had	have	VBD
cord-005453-4057qib7	390	12	available	available	JJ
cord-005453-4057qib7	390	13	molecular	molecular	JJ
cord-005453-4057qib7	390	14	MRD	MRD	NNP
cord-005453-4057qib7	390	15	assessments	assessment	NNS
cord-005453-4057qib7	390	16	,	,	,
cord-005453-4057qib7	390	17	10	10	CD
cord-005453-4057qib7	390	18	had	have	VBD
cord-005453-4057qib7	390	19	detectable	detectable	JJ
cord-005453-4057qib7	390	20	mutant	mutant	JJ
cord-005453-4057qib7	390	21	NPM1	NPM1	NNP
cord-005453-4057qib7	390	22	transcripts	transcript	NNS
cord-005453-4057qib7	390	23	by	by	IN
cord-005453-4057qib7	390	24	real	real	JJ
cord-005453-4057qib7	390	25	-	-	HYPH
cord-005453-4057qib7	390	26	time	time	NN
cord-005453-4057qib7	390	27	quantitative	quantitative	JJ
cord-005453-4057qib7	390	28	PCR	PCR	NNP
cord-005453-4057qib7	390	29	(	(	-LRB-
cord-005453-4057qib7	390	30	RQ	RQ	NNP
cord-005453-4057qib7	390	31	-	-	HYPH
cord-005453-4057qib7	390	32	RCR	RCR	NNP
cord-005453-4057qib7	390	33	)	)	-RRB-
cord-005453-4057qib7	390	34	.	.	.
cord-005453-4057qib7	391	1	Also	also	RB
cord-005453-4057qib7	391	2	,	,	,
cord-005453-4057qib7	391	3	4	4	CD
cord-005453-4057qib7	391	4	patients	patient	NNS
cord-005453-4057qib7	391	5	fulfilled	fulfil	VBD
cord-005453-4057qib7	391	6	criteria	criterion	NNS
cord-005453-4057qib7	391	7	of	of	IN
cord-005453-4057qib7	391	8	molecular	molecular	JJ
cord-005453-4057qib7	391	9	relapse	relapse	NN
cord-005453-4057qib7	391	10	(	(	-LRB-
cord-005453-4057qib7	391	11	increasing	increase	VBG
cord-005453-4057qib7	391	12	levels	level	NNS
cord-005453-4057qib7	391	13	of	of	IN
cord-005453-4057qib7	391	14	NPM1-mutated	npm1-mutated	JJ
cord-005453-4057qib7	391	15	transcripts	transcript	NNS
cord-005453-4057qib7	391	16	in	in	IN
cord-005453-4057qib7	391	17	two	two	CD
cord-005453-4057qib7	391	18	successive	successive	JJ
cord-005453-4057qib7	391	19	bone	bone	NN
cord-005453-4057qib7	391	20	marrow	marrow	NN
cord-005453-4057qib7	391	21	samples	sample	NNS
cord-005453-4057qib7	391	22	)	)	-RRB-
cord-005453-4057qib7	391	23	,	,	,
cord-005453-4057qib7	391	24	with	with	IN
cord-005453-4057qib7	391	25	mutant	mutant	JJ
cord-005453-4057qib7	391	26	NPM1	NPM1	NNP
cord-005453-4057qib7	391	27	load	load	NN
cord-005453-4057qib7	391	28	of	of	IN
cord-005453-4057qib7	391	29	386	386	CD
cord-005453-4057qib7	391	30	-	-	SYM
cord-005453-4057qib7	391	31	4,900	4,900	CD
cord-005453-4057qib7	391	32	transcripts/10,000	transcripts/10,000	NNP
cord-005453-4057qib7	391	33	ABL	ABL	NNP
cord-005453-4057qib7	391	34	transcripts	transcript	NNS
cord-005453-4057qib7	391	35	)	)	-RRB-
cord-005453-4057qib7	391	36	.	.	.
cord-005453-4057qib7	392	1	The	the	DT
cord-005453-4057qib7	392	2	conditioning	conditioning	NN
cord-005453-4057qib7	392	3	regimen	regimen	NN
cord-005453-4057qib7	392	4	was	be	VBD
cord-005453-4057qib7	392	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	392	6	in	in	IN
cord-005453-4057qib7	392	7	the	the	DT
cord-005453-4057qib7	392	8	majority	majority	NN
cord-005453-4057qib7	392	9	of	of	IN
cord-005453-4057qib7	392	10	cases	case	NNS
cord-005453-4057qib7	392	11	(	(	-LRB-
cord-005453-4057qib7	392	12	n=14	n=14	JJ
cord-005453-4057qib7	392	13	)	)	-RRB-
cord-005453-4057qib7	392	14	or	or	CC
cord-005453-4057qib7	392	15	reduced	reduce	VBN
cord-005453-4057qib7	392	16	-	-	HYPH
cord-005453-4057qib7	392	17	intensity	intensity	NN
cord-005453-4057qib7	392	18	(	(	-LRB-
cord-005453-4057qib7	392	19	n=2	n=2	NNS
cord-005453-4057qib7	392	20	)	)	-RRB-
cord-005453-4057qib7	392	21	.	.	.
cord-005453-4057qib7	393	1	The	the	DT
cord-005453-4057qib7	393	2	type	type	NN
cord-005453-4057qib7	393	3	of	of	IN
cord-005453-4057qib7	393	4	donor	donor	NN
cord-005453-4057qib7	393	5	varied	vary	VBN
cord-005453-4057qib7	393	6	,	,	,
cord-005453-4057qib7	393	7	namely	namely	RB
cord-005453-4057qib7	393	8	HLA	HLA	NNP
cord-005453-4057qib7	393	9	-	-	HYPH
cord-005453-4057qib7	393	10	identical	identical	JJ
cord-005453-4057qib7	393	11	sibling	sibling	NN
cord-005453-4057qib7	393	12	(	(	-LRB-
cord-005453-4057qib7	393	13	n=6	n=6	NNP
cord-005453-4057qib7	393	14	)	)	-RRB-
cord-005453-4057qib7	393	15	,	,	,
cord-005453-4057qib7	393	16	matched	match	VBN
cord-005453-4057qib7	393	17	unrelated	unrelated	JJ
cord-005453-4057qib7	393	18	(	(	-LRB-
cord-005453-4057qib7	393	19	n=5	n=5	NNP
cord-005453-4057qib7	393	20	)	)	-RRB-
cord-005453-4057qib7	393	21	,	,	,
cord-005453-4057qib7	393	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	393	23	relative	relative	NN
cord-005453-4057qib7	393	24	(	(	-LRB-
cord-005453-4057qib7	393	25	n=3	n=3	NN
cord-005453-4057qib7	393	26	)	)	-RRB-
cord-005453-4057qib7	393	27	,	,	,
cord-005453-4057qib7	393	28	or	or	CC
cord-005453-4057qib7	393	29	double	double	JJ
cord-005453-4057qib7	393	30	umbilical	umbilical	JJ
cord-005453-4057qib7	393	31	cord	cord	NN
cord-005453-4057qib7	393	32	blood	blood	NN
cord-005453-4057qib7	393	33	(	(	-LRB-
cord-005453-4057qib7	393	34	n=2	n=2	NNS
cord-005453-4057qib7	393	35	)	)	-RRB-
cord-005453-4057qib7	393	36	.	.	.
cord-005453-4057qib7	394	1	Results	result	NNS
cord-005453-4057qib7	394	2	:	:	:
cord-005453-4057qib7	395	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	395	2	was	be	VBD
cord-005453-4057qib7	395	3	achieved	achieve	VBN
cord-005453-4057qib7	395	4	in	in	IN
cord-005453-4057qib7	395	5	all	all	DT
cord-005453-4057qib7	395	6	cases	case	NNS
cord-005453-4057qib7	395	7	,	,	,
cord-005453-4057qib7	395	8	with	with	IN
cord-005453-4057qib7	395	9	a	a	DT
cord-005453-4057qib7	395	10	median	median	JJ
cord-005453-4057qib7	395	11	time	time	NN
cord-005453-4057qib7	395	12	to	to	IN
cord-005453-4057qib7	395	13	absolute	absolute	JJ
cord-005453-4057qib7	395	14	neutrophil	neutrophil	NN
cord-005453-4057qib7	395	15	count	count	NN
cord-005453-4057qib7	395	16	>	>	XX
cord-005453-4057qib7	396	1	500	500	CD
cord-005453-4057qib7	396	2	/	/	SYM
cord-005453-4057qib7	396	3	uL	ul	NN
cord-005453-4057qib7	396	4	of	of	IN
cord-005453-4057qib7	396	5	16	16	CD
cord-005453-4057qib7	396	6	days	day	NNS
cord-005453-4057qib7	396	7	(	(	-LRB-
cord-005453-4057qib7	396	8	range	range	NN
cord-005453-4057qib7	396	9	,	,	,
cord-005453-4057qib7	396	10	12	12	CD
cord-005453-4057qib7	396	11	-	-	SYM
cord-005453-4057qib7	396	12	29	29	CD
cord-005453-4057qib7	396	13	)	)	-RRB-
cord-005453-4057qib7	396	14	.	.	.
cord-005453-4057qib7	397	1	Among	among	IN
cord-005453-4057qib7	397	2	the	the	DT
cord-005453-4057qib7	397	3	13	13	CD
cord-005453-4057qib7	397	4	patients	patient	NNS
cord-005453-4057qib7	397	5	with	with	IN
cord-005453-4057qib7	397	6	posttransplant	posttransplant	NN
cord-005453-4057qib7	397	7	monitoring	monitoring	NN
cord-005453-4057qib7	397	8	of	of	IN
cord-005453-4057qib7	397	9	MRD	MRD	NNP
cord-005453-4057qib7	397	10	by	by	IN
cord-005453-4057qib7	397	11	RQ	RQ	NNP
cord-005453-4057qib7	397	12	-	-	HYPH
cord-005453-4057qib7	397	13	PCR	PCR	NNP
cord-005453-4057qib7	397	14	,	,	,
cord-005453-4057qib7	397	15	9	9	CD
cord-005453-4057qib7	397	16	exhibited	exhibit	VBD
cord-005453-4057qib7	397	17	a	a	DT
cord-005453-4057qib7	397	18	stable	stable	JJ
cord-005453-4057qib7	397	19	molecular	molecular	JJ
cord-005453-4057qib7	397	20	remission	remission	NN
cord-005453-4057qib7	397	21	whereas	whereas	IN
cord-005453-4057qib7	397	22	a	a	DT
cord-005453-4057qib7	397	23	rising	rise	VBG
cord-005453-4057qib7	397	24	level	level	NN
cord-005453-4057qib7	397	25	of	of	IN
cord-005453-4057qib7	397	26	NPM1mutated	npm1mutated	JJ
cord-005453-4057qib7	397	27	transcripts	transcript	NNS
cord-005453-4057qib7	397	28	was	be	VBD
cord-005453-4057qib7	397	29	observed	observe	VBN
cord-005453-4057qib7	397	30	in	in	IN
cord-005453-4057qib7	397	31	4	4	CD
cord-005453-4057qib7	397	32	cases	case	NNS
cord-005453-4057qib7	397	33	due	due	JJ
cord-005453-4057qib7	397	34	to	to	IN
cord-005453-4057qib7	397	35	either	either	CC
cord-005453-4057qib7	397	36	hematologic	hematologic	JJ
cord-005453-4057qib7	397	37	(	(	-LRB-
cord-005453-4057qib7	397	38	n=3	n=3	NN
cord-005453-4057qib7	397	39	)	)	-RRB-
cord-005453-4057qib7	397	40	or	or	CC
cord-005453-4057qib7	397	41	molecular	molecular	JJ
cord-005453-4057qib7	397	42	(	(	-LRB-
cord-005453-4057qib7	397	43	n=1	n=1	CD
cord-005453-4057qib7	397	44	)	)	-RRB-
cord-005453-4057qib7	397	45	relapse	relapse	NN
cord-005453-4057qib7	397	46	of	of	IN
cord-005453-4057qib7	397	47	disease	disease	NN
cord-005453-4057qib7	397	48	.	.	.
cord-005453-4057qib7	398	1	The	the	DT
cord-005453-4057qib7	398	2	cumulative	cumulative	JJ
cord-005453-4057qib7	398	3	incidences	incidence	NNS
cord-005453-4057qib7	398	4	(	(	-LRB-
cord-005453-4057qib7	398	5	CIN	CIN	NNP
cord-005453-4057qib7	398	6	)	)	-RRB-
cord-005453-4057qib7	398	7	of	of	IN
cord-005453-4057qib7	398	8	hematologic	hematologic	JJ
cord-005453-4057qib7	398	9	relapse	relapse	NN
cord-005453-4057qib7	398	10	and	and	CC
cord-005453-4057qib7	398	11	non	non	JJ
cord-005453-4057qib7	398	12	-	-	JJ
cord-005453-4057qib7	398	13	relapse	relapse	JJ
cord-005453-4057qib7	398	14	mortality	mortality	NN
cord-005453-4057qib7	398	15	(	(	-LRB-
cord-005453-4057qib7	398	16	NRM	NRM	NNP
cord-005453-4057qib7	398	17	)	)	-RRB-
cord-005453-4057qib7	398	18	were	be	VBD
cord-005453-4057qib7	398	19	18.75	18.75	CD
cord-005453-4057qib7	398	20	%	%	NN
cord-005453-4057qib7	398	21	and	and	CC
cord-005453-4057qib7	398	22	25	25	CD
cord-005453-4057qib7	398	23	%	%	NN
cord-005453-4057qib7	398	24	at	at	IN
cord-005453-4057qib7	398	25	12	12	CD
cord-005453-4057qib7	398	26	months	month	NNS
cord-005453-4057qib7	398	27	,	,	,
cord-005453-4057qib7	398	28	respectively	respectively	RB
cord-005453-4057qib7	398	29	.	.	.
cord-005453-4057qib7	399	1	No	no	DT
cord-005453-4057qib7	399	2	events	event	NNS
cord-005453-4057qib7	399	3	of	of	IN
cord-005453-4057qib7	399	4	relapse	relapse	NN
cord-005453-4057qib7	399	5	or	or	CC
cord-005453-4057qib7	399	6	NRM	NRM	NNP
cord-005453-4057qib7	399	7	were	be	VBD
cord-005453-4057qib7	399	8	encountered	encounter	VBN
cord-005453-4057qib7	399	9	beyond	beyond	IN
cord-005453-4057qib7	399	10	6	6	CD
cord-005453-4057qib7	399	11	months	month	NNS
cord-005453-4057qib7	399	12	from	from	IN
cord-005453-4057qib7	399	13	allo	allo	NN
cord-005453-4057qib7	399	14	-	-	HYPH
cord-005453-4057qib7	399	15	HSCT	HSCT	NNP
cord-005453-4057qib7	399	16	.	.	.
cord-005453-4057qib7	400	1	Out	out	IN
cord-005453-4057qib7	400	2	of	of	IN
cord-005453-4057qib7	400	3	3	3	CD
cord-005453-4057qib7	400	4	patients	patient	NNS
cord-005453-4057qib7	400	5	with	with	IN
cord-005453-4057qib7	400	6	hematologic	hematologic	JJ
cord-005453-4057qib7	400	7	relapse	relapse	NN
cord-005453-4057qib7	400	8	post	post	NN
cord-005453-4057qib7	400	9	transplant	transplant	NN
cord-005453-4057qib7	400	10	,	,	,
cord-005453-4057qib7	400	11	2	2	CD
cord-005453-4057qib7	400	12	died	die	VBD
cord-005453-4057qib7	400	13	of	of	IN
cord-005453-4057qib7	400	14	disease	disease	NN
cord-005453-4057qib7	400	15	whereas	whereas	IN
cord-005453-4057qib7	400	16	one	one	CD
cord-005453-4057qib7	400	17	achieved	achieve	VBD
cord-005453-4057qib7	400	18	a	a	DT
cord-005453-4057qib7	400	19	stable	stable	JJ
cord-005453-4057qib7	400	20	complete	complete	JJ
cord-005453-4057qib7	400	21	remission	remission	NN
cord-005453-4057qib7	400	22	after	after	IN
cord-005453-4057qib7	400	23	withdrawal	withdrawal	NN
cord-005453-4057qib7	400	24	of	of	IN
cord-005453-4057qib7	400	25	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	400	26	.	.	.
cord-005453-4057qib7	401	1	At	at	IN
cord-005453-4057qib7	401	2	a	a	DT
cord-005453-4057qib7	401	3	median	median	JJ
cord-005453-4057qib7	401	4	follow	follow	NN
cord-005453-4057qib7	401	5	-	-	HYPH
cord-005453-4057qib7	401	6	up	up	NN
cord-005453-4057qib7	401	7	time	time	NN
cord-005453-4057qib7	401	8	of	of	IN
cord-005453-4057qib7	401	9	40	40	CD
cord-005453-4057qib7	401	10	months	month	NNS
cord-005453-4057qib7	401	11	(	(	-LRB-
cord-005453-4057qib7	401	12	range	range	NN
cord-005453-4057qib7	401	13	,	,	,
cord-005453-4057qib7	401	14	14	14	CD
cord-005453-4057qib7	401	15	-	-	SYM
cord-005453-4057qib7	401	16	89	89	CD
cord-005453-4057qib7	401	17	)	)	-RRB-
cord-005453-4057qib7	401	18	,	,	,
cord-005453-4057qib7	401	19	10/16	10/16	CD
cord-005453-4057qib7	401	20	patients	patient	NNS
cord-005453-4057qib7	401	21	continue	continue	VBP
cord-005453-4057qib7	401	22	to	to	TO
cord-005453-4057qib7	401	23	be	be	VB
cord-005453-4057qib7	401	24	alive	alive	JJ
cord-005453-4057qib7	401	25	in	in	IN
cord-005453-4057qib7	401	26	CR	CR	NNP
cord-005453-4057qib7	401	27	.	.	.
cord-005453-4057qib7	402	1	The	the	DT
cord-005453-4057qib7	402	2	estimated	estimate	VBN
cord-005453-4057qib7	402	3	disease	disease	NN
cord-005453-4057qib7	402	4	-	-	HYPH
cord-005453-4057qib7	402	5	free	free	JJ
cord-005453-4057qib7	402	6	Background	background	NN
cord-005453-4057qib7	402	7	:	:	:
cord-005453-4057qib7	402	8	CPX-351	cpx-351	NN
cord-005453-4057qib7	403	1	(	(	-LRB-
cord-005453-4057qib7	403	2	Vyxeos	Vyxeos	NNP
cord-005453-4057qib7	403	3	®	®	.
cord-005453-4057qib7	403	4	)	)	-RRB-
cord-005453-4057qib7	403	5	is	be	VBZ
cord-005453-4057qib7	403	6	an	an	DT
cord-005453-4057qib7	403	7	advanced	advanced	JJ
cord-005453-4057qib7	403	8	liposomal	liposomal	IN
cord-005453-4057qib7	403	9	encapsulation	encapsulation	NN
cord-005453-4057qib7	403	10	of	of	IN
cord-005453-4057qib7	403	11	cytarabine	cytarabine	NN
cord-005453-4057qib7	403	12	/	/	SYM
cord-005453-4057qib7	403	13	daunorubicin	daunorubicin	NNS
cord-005453-4057qib7	403	14	at	at	IN
cord-005453-4057qib7	403	15	a	a	DT
cord-005453-4057qib7	403	16	synergistic	synergistic	JJ
cord-005453-4057qib7	403	17	5:1	5:1	CD
cord-005453-4057qib7	403	18	molar	molar	JJ
cord-005453-4057qib7	403	19	ratio	ratio	NN
cord-005453-4057qib7	403	20	.	.	.
cord-005453-4057qib7	404	1	CPX-351	CPX-351	NNP
cord-005453-4057qib7	404	2	is	be	VBZ
cord-005453-4057qib7	404	3	approved	approve	VBN
cord-005453-4057qib7	404	4	by	by	IN
cord-005453-4057qib7	404	5	the	the	DT
cord-005453-4057qib7	404	6	US	US	NNP
cord-005453-4057qib7	404	7	FDA	FDA	NNP
cord-005453-4057qib7	404	8	and	and	CC
cord-005453-4057qib7	404	9	EMA	EMA	NNP
cord-005453-4057qib7	404	10	for	for	IN
cord-005453-4057qib7	404	11	the	the	DT
cord-005453-4057qib7	404	12	treatment	treatment	NN
cord-005453-4057qib7	404	13	of	of	IN
cord-005453-4057qib7	404	14	adults	adult	NNS
cord-005453-4057qib7	404	15	with	with	IN
cord-005453-4057qib7	404	16	newly	newly	RB
cord-005453-4057qib7	404	17	diagnosed	diagnose	VBN
cord-005453-4057qib7	404	18	,	,	,
cord-005453-4057qib7	404	19	therapy	therapy	NN
cord-005453-4057qib7	404	20	-	-	HYPH
cord-005453-4057qib7	404	21	related	relate	VBN
cord-005453-4057qib7	404	22	AML	AML	NNP
cord-005453-4057qib7	404	23	or	or	CC
cord-005453-4057qib7	404	24	AML	AML	NNP
cord-005453-4057qib7	404	25	with	with	IN
cord-005453-4057qib7	404	26	myelodysplasia	myelodysplasia	NNP
cord-005453-4057qib7	404	27	-	-	HYPH
cord-005453-4057qib7	404	28	related	relate	VBN
cord-005453-4057qib7	404	29	changes	change	NNS
cord-005453-4057qib7	404	30	.	.	.
cord-005453-4057qib7	405	1	Methods	method	NNS
cord-005453-4057qib7	405	2	:	:	:
cord-005453-4057qib7	405	3	Safety	safety	NN
cord-005453-4057qib7	405	4	data	datum	NNS
cord-005453-4057qib7	405	5	were	be	VBD
cord-005453-4057qib7	405	6	pooled	pool	VBN
cord-005453-4057qib7	405	7	from	from	IN
cord-005453-4057qib7	405	8	5	5	CD
cord-005453-4057qib7	405	9	studies	study	NNS
cord-005453-4057qib7	405	10	of	of	IN
cord-005453-4057qib7	405	11	CPX-351	cpx-351	NN
cord-005453-4057qib7	405	12	in	in	IN
cord-005453-4057qib7	405	13	adults	adult	NNS
cord-005453-4057qib7	405	14	aged	age	VBN
cord-005453-4057qib7	405	15	18	18	CD
cord-005453-4057qib7	405	16	-	-	SYM
cord-005453-4057qib7	405	17	75	75	CD
cord-005453-4057qib7	405	18	years	year	NNS
cord-005453-4057qib7	405	19	with	with	IN
cord-005453-4057qib7	405	20	newly	newly	RB
cord-005453-4057qib7	405	21	diagnosed	diagnose	VBN
cord-005453-4057qib7	405	22	or	or	CC
cord-005453-4057qib7	405	23	relapsed	relapse	VBN
cord-005453-4057qib7	405	24	/	/	SYM
cord-005453-4057qib7	405	25	refractory	refractory	JJ
cord-005453-4057qib7	405	26	AML	AML	NNP
cord-005453-4057qib7	405	27	.	.	.
cord-005453-4057qib7	406	1	CPX-351	cpx-351	UH
cord-005453-4057qib7	407	1	induction	induction	NN
cord-005453-4057qib7	407	2	consisted	consist	VBD
cord-005453-4057qib7	407	3	of	of	IN
cord-005453-4057qib7	407	4	100	100	CD
cord-005453-4057qib7	407	5	units	unit	NNS
cord-005453-4057qib7	407	6	/	/	SYM
cord-005453-4057qib7	407	7	m	m	NN
cord-005453-4057qib7	407	8	2	2	CD
cord-005453-4057qib7	407	9	(	(	-LRB-
cord-005453-4057qib7	407	10	cytarabine	cytarabine	NNP
cord-005453-4057qib7	407	11	100	100	CD
cord-005453-4057qib7	407	12	mg	mg	NNP
cord-005453-4057qib7	407	13	/	/	SYM
cord-005453-4057qib7	407	14	m	m	NN
cord-005453-4057qib7	407	15	2	2	CD
cord-005453-4057qib7	408	1	+	+	CC
cord-005453-4057qib7	408	2	daunorubicin	daunorubicin	NNS
cord-005453-4057qib7	408	3	44	44	CD
cord-005453-4057qib7	408	4	mg	mg	NNP
cord-005453-4057qib7	408	5	/	/	SYM
cord-005453-4057qib7	408	6	m	m	NNP
cord-005453-4057qib7	408	7	2	2	CD
cord-005453-4057qib7	408	8	)	)	-RRB-
cord-005453-4057qib7	408	9	on	on	IN
cord-005453-4057qib7	408	10	Days	day	NNS
cord-005453-4057qib7	408	11	1	1	CD
cord-005453-4057qib7	408	12	,	,	,
cord-005453-4057qib7	408	13	3	3	CD
cord-005453-4057qib7	408	14	,	,	,
cord-005453-4057qib7	408	15	and	and	CC
cord-005453-4057qib7	408	16	5	5	LS
cord-005453-4057qib7	408	17	(	(	-LRB-
cord-005453-4057qib7	408	18	second	second	JJ
cord-005453-4057qib7	408	19	induction	induction	NN
cord-005453-4057qib7	408	20	:	:	:
cord-005453-4057qib7	408	21	Days	day	NNS
cord-005453-4057qib7	408	22	1	1	CD
cord-005453-4057qib7	408	23	and	and	CC
cord-005453-4057qib7	408	24	3	3	CD
cord-005453-4057qib7	408	25	)	)	-RRB-
cord-005453-4057qib7	408	26	.	.	.
cord-005453-4057qib7	409	1	CPX-351	CPX-351	NNP
cord-005453-4057qib7	409	2	consolidation	consolidation	NN
cord-005453-4057qib7	409	3	consisted	consist	VBD
cord-005453-4057qib7	409	4	of	of	IN
cord-005453-4057qib7	409	5	65	65	CD
cord-005453-4057qib7	409	6	or	or	CC
cord-005453-4057qib7	409	7	100	100	CD
cord-005453-4057qib7	409	8	units	unit	NNS
cord-005453-4057qib7	409	9	/	/	SYM
cord-005453-4057qib7	409	10	m	m	NN
cord-005453-4057qib7	409	11	2	2	CD
cord-005453-4057qib7	409	12	(	(	-LRB-
cord-005453-4057qib7	409	13	varying	vary	VBG
cord-005453-4057qib7	409	14	by	by	IN
cord-005453-4057qib7	409	15	study	study	NN
cord-005453-4057qib7	409	16	)	)	-RRB-
cord-005453-4057qib7	409	17	on	on	IN
cord-005453-4057qib7	409	18	Days	day	NNS
cord-005453-4057qib7	409	19	1	1	CD
cord-005453-4057qib7	409	20	and	and	CC
cord-005453-4057qib7	409	21	3	3	CD
cord-005453-4057qib7	409	22	.	.	.
cord-005453-4057qib7	410	1	CPX-351	CPX-351	NNP
cord-005453-4057qib7	410	2	was	be	VBD
cord-005453-4057qib7	410	3	evaluated	evaluate	VBN
cord-005453-4057qib7	410	4	against	against	IN
cord-005453-4057qib7	410	5	standard	standard	JJ
cord-005453-4057qib7	410	6	-	-	HYPH
cord-005453-4057qib7	410	7	of	of	IN
cord-005453-4057qib7	410	8	-	-	HYPH
cord-005453-4057qib7	410	9	care	care	NN
cord-005453-4057qib7	410	10	controls	control	NNS
cord-005453-4057qib7	410	11	.	.	.
cord-005453-4057qib7	411	1	Results	result	NNS
cord-005453-4057qib7	411	2	:	:	:
cord-005453-4057qib7	412	1	Baseline	baseline	JJ
cord-005453-4057qib7	412	2	characteristics	characteristic	NNS
cord-005453-4057qib7	412	3	were	be	VBD
cord-005453-4057qib7	412	4	generally	generally	RB
cord-005453-4057qib7	412	5	balanced	balance	VBN
cord-005453-4057qib7	412	6	between	between	IN
cord-005453-4057qib7	412	7	CPX-351	cpx-351	NN
cord-005453-4057qib7	412	8	(	(	-LRB-
cord-005453-4057qib7	412	9	n=375	n=375	NNP
cord-005453-4057qib7	412	10	)	)	-RRB-
cord-005453-4057qib7	412	11	and	and	CC
cord-005453-4057qib7	412	12	controls	control	NNS
cord-005453-4057qib7	412	13	(	(	-LRB-
cord-005453-4057qib7	412	14	n=236	n=236	UH
cord-005453-4057qib7	412	15	)	)	-RRB-
cord-005453-4057qib7	412	16	;	;	:
cord-005453-4057qib7	412	17	the	the	DT
cord-005453-4057qib7	412	18	majority	majority	NN
cord-005453-4057qib7	412	19	of	of	IN
cord-005453-4057qib7	412	20	patients	patient	NNS
cord-005453-4057qib7	412	21	were	be	VBD
cord-005453-4057qib7	412	22	aged	age	VBN
cord-005453-4057qib7	412	23	≥60	≥60	JJ
cord-005453-4057qib7	412	24	years	year	NNS
cord-005453-4057qib7	412	25	(	(	-LRB-
cord-005453-4057qib7	412	26	78	78	CD
cord-005453-4057qib7	412	27	%	%	NN
cord-005453-4057qib7	412	28	;	;	:
cord-005453-4057qib7	412	29	87	87	CD
cord-005453-4057qib7	412	30	%	%	NN
cord-005453-4057qib7	412	31	)	)	-RRB-
cord-005453-4057qib7	412	32	and	and	CC
cord-005453-4057qib7	412	33	had	have	VBD
cord-005453-4057qib7	412	34	secondary	secondary	JJ
cord-005453-4057qib7	412	35	AML	AML	NNP
cord-005453-4057qib7	412	36	(	(	-LRB-
cord-005453-4057qib7	412	37	55	55	CD
cord-005453-4057qib7	412	38	%	%	NN
cord-005453-4057qib7	412	39	;	;	:
cord-005453-4057qib7	412	40	72	72	CD
cord-005453-4057qib7	412	41	%	%	NN
cord-005453-4057qib7	412	42	)	)	-RRB-
cord-005453-4057qib7	412	43	.	.	.
cord-005453-4057qib7	413	1	Controls	control	NNS
cord-005453-4057qib7	413	2	included	include	VBD
cord-005453-4057qib7	413	3	7	7	CD
cord-005453-4057qib7	413	4	+	+	SYM
cord-005453-4057qib7	413	5	3	3	CD
cord-005453-4057qib7	413	6	(	(	-LRB-
cord-005453-4057qib7	413	7	n=192	n=192	NNP
cord-005453-4057qib7	413	8	)	)	-RRB-
cord-005453-4057qib7	413	9	and	and	CC
cord-005453-4057qib7	413	10	salvage	salvage	VB
cord-005453-4057qib7	413	11	therapy	therapy	NN
cord-005453-4057qib7	413	12	with	with	IN
cord-005453-4057qib7	413	13	mitoxantrone	mitoxantrone	NN
cord-005453-4057qib7	413	14	/	/	SYM
cord-005453-4057qib7	413	15	etoposide/	etoposide/	NNP
cord-005453-4057qib7	413	16	cytarabine	cytarabine	RB
cord-005453-4057qib7	414	1	(	(	-LRB-
cord-005453-4057qib7	414	2	n=23	n=23	NNP
cord-005453-4057qib7	414	3	)	)	-RRB-
cord-005453-4057qib7	414	4	,	,	,
cord-005453-4057qib7	414	5	idarubicin	idarubicin	NNP
cord-005453-4057qib7	414	6	/	/	SYM
cord-005453-4057qib7	414	7	cytarabine	cytarabine	NNP
cord-005453-4057qib7	414	8	(	(	-LRB-
cord-005453-4057qib7	414	9	n=8	n=8	NNP
cord-005453-4057qib7	414	10	)	)	-RRB-
cord-005453-4057qib7	414	11	,	,	,
cord-005453-4057qib7	414	12	other	other	JJ
cord-005453-4057qib7	414	13	cytarabine	cytarabine	NN
cord-005453-4057qib7	414	14	-	-	HYPH
cord-005453-4057qib7	414	15	based	base	VBN
cord-005453-4057qib7	414	16	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	414	17	(	(	-LRB-
cord-005453-4057qib7	414	18	n=12	n=12	NNP
cord-005453-4057qib7	414	19	)	)	-RRB-
cord-005453-4057qib7	414	20	,	,	,
cord-005453-4057qib7	414	21	and	and	CC
cord-005453-4057qib7	414	22	mitoxantrone/	mitoxantrone/	CD
cord-005453-4057qib7	414	23	etoposide	etoposide	JJ
cord-005453-4057qib7	414	24	(	(	-LRB-
cord-005453-4057qib7	414	25	n=1	n=1	CD
cord-005453-4057qib7	414	26	)	)	-RRB-
cord-005453-4057qib7	414	27	.	.	.
cord-005453-4057qib7	415	1	The	the	DT
cord-005453-4057qib7	415	2	treatment	treatment	NN
cord-005453-4057qib7	415	3	-	-	HYPH
cord-005453-4057qib7	415	4	emergent	emergent	JJ
cord-005453-4057qib7	415	5	adverse	adverse	JJ
cord-005453-4057qib7	415	6	event	event	NN
cord-005453-4057qib7	415	7	(	(	-LRB-
cord-005453-4057qib7	415	8	TEAE	TEAE	NNP
cord-005453-4057qib7	415	9	)	)	-RRB-
cord-005453-4057qib7	415	10	profile	profile	NN
cord-005453-4057qib7	415	11	of	of	IN
cord-005453-4057qib7	415	12	CPX-351	CPX-351	NNP
cord-005453-4057qib7	415	13	100	100	CD
cord-005453-4057qib7	415	14	units	unit	NNS
cord-005453-4057qib7	415	15	/	/	SYM
cord-005453-4057qib7	415	16	m	m	NN
cord-005453-4057qib7	415	17	2	2	CD
cord-005453-4057qib7	415	18	was	be	VBD
cord-005453-4057qib7	415	19	comparable	comparable	JJ
cord-005453-4057qib7	415	20	to	to	IN
cord-005453-4057qib7	415	21	induction	induction	NN
cord-005453-4057qib7	415	22	controls	control	NNS
cord-005453-4057qib7	415	23	,	,	,
cord-005453-4057qib7	415	24	but	but	CC
cord-005453-4057qib7	415	25	associated	associate	VBN
cord-005453-4057qib7	415	26	with	with	IN
cord-005453-4057qib7	415	27	a	a	DT
cord-005453-4057qib7	415	28	greater	great	JJR
cord-005453-4057qib7	415	29	proportion	proportion	NN
cord-005453-4057qib7	415	30	of	of	IN
cord-005453-4057qib7	415	31	patients	patient	NNS
cord-005453-4057qib7	415	32	with	with	IN
cord-005453-4057qib7	415	33	TEAEs	teae	NNS
cord-005453-4057qib7	415	34	,	,	,
cord-005453-4057qib7	415	35	grade	grade	NN
cord-005453-4057qib7	415	36	≥3	≥3	NNP
cord-005453-4057qib7	415	37	TEAEs	TEAEs	NNPS
cord-005453-4057qib7	415	38	,	,	,
cord-005453-4057qib7	415	39	and	and	CC
cord-005453-4057qib7	415	40	serious	serious	JJ
cord-005453-4057qib7	415	41	TEAEs	teae	NNS
cord-005453-4057qib7	415	42	during	during	IN
cord-005453-4057qib7	415	43	consolidation	consolidation	NN
cord-005453-4057qib7	415	44	(	(	-LRB-
cord-005453-4057qib7	415	45	Table	table	NN
cord-005453-4057qib7	415	46	)	)	-RRB-
cord-005453-4057qib7	415	47	.	.	.
cord-005453-4057qib7	416	1	Therefore	therefore	RB
cord-005453-4057qib7	416	2	,	,	,
cord-005453-4057qib7	416	3	the	the	DT
cord-005453-4057qib7	416	4	CPX-351	cpx-351	NN
cord-005453-4057qib7	416	5	consolidation	consolidation	NN
cord-005453-4057qib7	416	6	dose	dose	NN
cord-005453-4057qib7	416	7	was	be	VBD
cord-005453-4057qib7	416	8	reduced	reduce	VBN
cord-005453-4057qib7	416	9	to	to	IN
cord-005453-4057qib7	416	10	65	65	CD
cord-005453-4057qib7	416	11	units	unit	NNS
cord-005453-4057qib7	416	12	/	/	SYM
cord-005453-4057qib7	416	13	m	m	CD
cord-005453-4057qib7	416	14	2	2	CD
cord-005453-4057qib7	416	15	in	in	IN
cord-005453-4057qib7	416	16	latter	latter	JJ
cord-005453-4057qib7	416	17	studies	study	NNS
cord-005453-4057qib7	416	18	;	;	:
cord-005453-4057qib7	416	19	this	this	DT
cord-005453-4057qib7	416	20	dose	dose	NN
cord-005453-4057qib7	416	21	demonstrated	demonstrate	VBD
cord-005453-4057qib7	416	22	an	an	DT
cord-005453-4057qib7	416	23	improved	improve	VBN
cord-005453-4057qib7	416	24	TEAE	TEAE	NNP
cord-005453-4057qib7	416	25	profile	profile	NN
cord-005453-4057qib7	416	26	similar	similar	JJ
cord-005453-4057qib7	416	27	to	to	IN
cord-005453-4057qib7	416	28	consolidation	consolidation	NN
cord-005453-4057qib7	416	29	controls	control	NNS
cord-005453-4057qib7	416	30	.	.	.
cord-005453-4057qib7	417	1	The	the	DT
cord-005453-4057qib7	417	2	most	most	RBS
cord-005453-4057qib7	417	3	frequent	frequent	JJ
cord-005453-4057qib7	417	4	system	system	NN
cord-005453-4057qib7	417	5	organ	organ	NN
cord-005453-4057qib7	417	6	class	class	NN
cord-005453-4057qib7	417	7	was	be	VBD
cord-005453-4057qib7	417	8	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	417	9	disorders	disorder	NNS
cord-005453-4057qib7	417	10	for	for	IN
cord-005453-4057qib7	417	11	both	both	CC
cord-005453-4057qib7	417	12	CPX-351	cpx-351	NN
cord-005453-4057qib7	417	13	and	and	CC
cord-005453-4057qib7	417	14	controls	control	NNS
cord-005453-4057qib7	417	15	;	;	:
cord-005453-4057qib7	417	16	a	a	DT
cord-005453-4057qib7	417	17	lower	low	JJR
cord-005453-4057qib7	417	18	incidence	incidence	NN
cord-005453-4057qib7	417	19	was	be	VBD
cord-005453-4057qib7	417	20	reported	report	VBN
cord-005453-4057qib7	417	21	for	for	IN
cord-005453-4057qib7	417	22	CPX-351	cpx-351	NN
cord-005453-4057qib7	417	23	(	(	-LRB-
cord-005453-4057qib7	417	24	90	90	CD
cord-005453-4057qib7	417	25	%	%	NN
cord-005453-4057qib7	417	26	)	)	-RRB-
cord-005453-4057qib7	417	27	versus	versus	IN
cord-005453-4057qib7	417	28	controls	control	NNS
cord-005453-4057qib7	417	29	(	(	-LRB-
cord-005453-4057qib7	417	30	95	95	CD
cord-005453-4057qib7	417	31	%	%	NN
cord-005453-4057qib7	417	32	)	)	-RRB-
cord-005453-4057qib7	417	33	,	,	,
cord-005453-4057qib7	417	34	with	with	IN
cord-005453-4057qib7	417	35	this	this	DT
cord-005453-4057qib7	417	36	difference	difference	NN
cord-005453-4057qib7	417	37	driven	drive	VBN
cord-005453-4057qib7	417	38	by	by	IN
cord-005453-4057qib7	417	39	the	the	DT
cord-005453-4057qib7	417	40	lower	low	JJR
cord-005453-4057qib7	417	41	incidence	incidence	NN
cord-005453-4057qib7	417	42	of	of	IN
cord-005453-4057qib7	417	43	diarrhea	diarrhea	NN
cord-005453-4057qib7	417	44	for	for	IN
cord-005453-4057qib7	417	45	CPX-351	cpx-351	NN
cord-005453-4057qib7	417	46	(	(	-LRB-
cord-005453-4057qib7	417	47	46	46	CD
cord-005453-4057qib7	417	48	%	%	NN
cord-005453-4057qib7	417	49	)	)	-RRB-
cord-005453-4057qib7	417	50	versus	versus	IN
cord-005453-4057qib7	417	51	controls	control	NNS
cord-005453-4057qib7	417	52	(	(	-LRB-
cord-005453-4057qib7	417	53	66	66	CD
cord-005453-4057qib7	417	54	%	%	NN
cord-005453-4057qib7	417	55	)	)	-RRB-
cord-005453-4057qib7	417	56	.	.	.
cord-005453-4057qib7	418	1	The	the	DT
cord-005453-4057qib7	418	2	most	most	RBS
cord-005453-4057qib7	418	3	frequently	frequently	RB
cord-005453-4057qib7	418	4	reported	report	VBN
cord-005453-4057qib7	418	5	grade	grade	NN
cord-005453-4057qib7	418	6	≥3	≥3	NNP
cord-005453-4057qib7	418	7	TEAEs	teae	NNS
cord-005453-4057qib7	418	8	were	be	VBD
cord-005453-4057qib7	418	9	febrile	febrile	JJ
cord-005453-4057qib7	418	10	neutropenia	neutropenia	NN
cord-005453-4057qib7	419	1	(	(	-LRB-
cord-005453-4057qib7	419	2	CPX-351	cpx-351	NN
cord-005453-4057qib7	419	3	:	:	:
cord-005453-4057qib7	419	4	62	62	CD
cord-005453-4057qib7	419	5	%	%	NN
cord-005453-4057qib7	419	6	;	;	,
cord-005453-4057qib7	419	7	controls	control	NNS
cord-005453-4057qib7	419	8	:	:	:
cord-005453-4057qib7	419	9	59	59	CD
cord-005453-4057qib7	419	10	%	%	NN
cord-005453-4057qib7	419	11	)	)	-RRB-
cord-005453-4057qib7	419	12	,	,	,
cord-005453-4057qib7	419	13	pneumonia	pneumonia	NN
cord-005453-4057qib7	419	14	(	(	-LRB-
cord-005453-4057qib7	419	15	16	16	CD
cord-005453-4057qib7	419	16	%	%	NN
cord-005453-4057qib7	419	17	;	;	:
cord-005453-4057qib7	419	18	13	13	CD
cord-005453-4057qib7	419	19	%	%	NN
cord-005453-4057qib7	419	20	)	)	-RRB-
cord-005453-4057qib7	419	21	,	,	,
cord-005453-4057qib7	419	22	hypoxia	hypoxia	NN
cord-005453-4057qib7	419	23	(	(	-LRB-
cord-005453-4057qib7	419	24	10	10	CD
cord-005453-4057qib7	419	25	%	%	NN
cord-005453-4057qib7	419	26	;	;	:
cord-005453-4057qib7	419	27	11	11	CD
cord-005453-4057qib7	419	28	%	%	NN
cord-005453-4057qib7	419	29	)	)	-RRB-
cord-005453-4057qib7	419	30	,	,	,
cord-005453-4057qib7	419	31	and	and	CC
cord-005453-4057qib7	419	32	bacteremia	bacteremia	NN
cord-005453-4057qib7	419	33	(	(	-LRB-
cord-005453-4057qib7	419	34	10	10	CD
cord-005453-4057qib7	419	35	%	%	NN
cord-005453-4057qib7	419	36	;	;	:
cord-005453-4057qib7	419	37	3	3	CD
cord-005453-4057qib7	419	38	%	%	NN
cord-005453-4057qib7	419	39	)	)	-RRB-
cord-005453-4057qib7	419	40	.	.	.
cord-005453-4057qib7	420	1	Early	early	JJ
cord-005453-4057qib7	420	2	mortality	mortality	NN
cord-005453-4057qib7	420	3	rates	rate	NNS
cord-005453-4057qib7	420	4	,	,	,
cord-005453-4057qib7	420	5	both	both	DT
cord-005453-4057qib7	420	6	overall	overall	JJ
cord-005453-4057qib7	420	7	and	and	CC
cord-005453-4057qib7	420	8	by	by	IN
cord-005453-4057qib7	420	9	treatment	treatment	NN
cord-005453-4057qib7	420	10	period	period	NN
cord-005453-4057qib7	420	11	,	,	,
cord-005453-4057qib7	420	12	appeared	appear	VBD
cord-005453-4057qib7	420	13	lower	lower	RBR
cord-005453-4057qib7	420	14	with	with	IN
cord-005453-4057qib7	421	1	CPX-351	cpx-351	RB
cord-005453-4057qib7	421	2	versus	versus	IN
cord-005453-4057qib7	421	3	controls	control	NNS
cord-005453-4057qib7	421	4	at	at	IN
cord-005453-4057qib7	421	5	Day	day	NN
cord-005453-4057qib7	421	6	30	30	CD
cord-005453-4057qib7	421	7	and	and	CC
cord-005453-4057qib7	421	8	Day	day	NN
cord-005453-4057qib7	421	9	60	60	CD
cord-005453-4057qib7	421	10	(	(	-LRB-
cord-005453-4057qib7	421	11	Table	table	NN
cord-005453-4057qib7	421	12	)	)	-RRB-
cord-005453-4057qib7	421	13	;	;	:
cord-005453-4057qib7	421	14	the	the	DT
cord-005453-4057qib7	421	15	majority	majority	NN
cord-005453-4057qib7	421	16	of	of	IN
cord-005453-4057qib7	421	17	early	early	JJ
cord-005453-4057qib7	421	18	deaths	death	NNS
cord-005453-4057qib7	421	19	were	be	VBD
cord-005453-4057qib7	421	20	attributable	attributable	JJ
cord-005453-4057qib7	421	21	to	to	IN
cord-005453-4057qib7	421	22	TEAEs	teae	NNS
cord-005453-4057qib7	421	23	.	.	.
cord-005453-4057qib7	422	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	422	2	:	:	:
cord-005453-4057qib7	423	1	Across	across	IN
cord-005453-4057qib7	423	2	the	the	DT
cord-005453-4057qib7	423	3	5	5	CD
cord-005453-4057qib7	423	4	studies	study	NNS
cord-005453-4057qib7	423	5	comprising	comprise	VBG
cord-005453-4057qib7	423	6	the	the	DT
cord-005453-4057qib7	423	7	CPX-351	CPX-351	NNP
cord-005453-4057qib7	423	8	clinical	clinical	JJ
cord-005453-4057qib7	423	9	development	development	NN
cord-005453-4057qib7	423	10	program	program	NN
cord-005453-4057qib7	423	11	,	,	,
cord-005453-4057qib7	423	12	CPX-351	CPX-351	NNP
cord-005453-4057qib7	423	13	demonstrated	demonstrate	VBD
cord-005453-4057qib7	423	14	a	a	DT
cord-005453-4057qib7	423	15	safety	safety	NN
cord-005453-4057qib7	423	16	profile	profile	NN
cord-005453-4057qib7	423	17	comparable	comparable	JJ
cord-005453-4057qib7	423	18	to	to	IN
cord-005453-4057qib7	423	19	conventional	conventional	JJ
cord-005453-4057qib7	423	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	423	21	in	in	IN
cord-005453-4057qib7	423	22	adults	adult	NNS
cord-005453-4057qib7	423	23	with	with	IN
cord-005453-4057qib7	423	24	newly	newly	RB
cord-005453-4057qib7	423	25	diagnosed	diagnose	VBN
cord-005453-4057qib7	423	26	or	or	CC
cord-005453-4057qib7	423	27	relapsed	relapse	VBN
cord-005453-4057qib7	423	28	/	/	SYM
cord-005453-4057qib7	423	29	refractory	refractory	JJ
cord-005453-4057qib7	423	30	AML	AML	NNP
cord-005453-4057qib7	423	31	.	.	.
cord-005453-4057qib7	424	1	Background	background	NN
cord-005453-4057qib7	424	2	:	:	:
cord-005453-4057qib7	425	1	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	425	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	425	3	stem	stem	NN
cord-005453-4057qib7	425	4	cell	cell	NN
cord-005453-4057qib7	425	5	transplantation	transplantation	NN
cord-005453-4057qib7	425	6	(	(	-LRB-
cord-005453-4057qib7	425	7	HSCT	HSCT	NNP
cord-005453-4057qib7	425	8	)	)	-RRB-
cord-005453-4057qib7	425	9	with	with	IN
cord-005453-4057qib7	425	10	post	post	JJ
cord-005453-4057qib7	425	11	-	-	JJ
cord-005453-4057qib7	425	12	transplantation	transplantation	JJ
cord-005453-4057qib7	425	13	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	425	14	(	(	-LRB-
cord-005453-4057qib7	425	15	PGCY	PGCY	NNP
cord-005453-4057qib7	425	16	)	)	-RRB-
cord-005453-4057qib7	425	17	marked	mark	VBD
cord-005453-4057qib7	425	18	improved	improved	JJ
cord-005453-4057qib7	425	19	clinical	clinical	JJ
cord-005453-4057qib7	425	20	outcome	outcome	NN
cord-005453-4057qib7	425	21	.	.	.
cord-005453-4057qib7	426	1	Recent	recent	JJ
cord-005453-4057qib7	426	2	studies	study	NNS
cord-005453-4057qib7	426	3	comparing	compare	VBG
cord-005453-4057qib7	426	4	allogeneic	allogeneic	JJ
cord-005453-4057qib7	426	5	HSCT	HSCT	NNP
cord-005453-4057qib7	426	6	using	use	VBG
cord-005453-4057qib7	426	7	unrelated	unrelated	JJ
cord-005453-4057qib7	426	8	donors	donor	NNS
cord-005453-4057qib7	426	9	versus	versus	IN
cord-005453-4057qib7	426	10	haplo	haplo	NNP
cord-005453-4057qib7	426	11	donors	donor	NNS
cord-005453-4057qib7	426	12	in	in	IN
cord-005453-4057qib7	426	13	patients	patient	NNS
cord-005453-4057qib7	426	14	with	with	IN
cord-005453-4057qib7	426	15	acute	acute	JJ
cord-005453-4057qib7	426	16	leukemia	leukemia	NN
cord-005453-4057qib7	426	17	have	have	VBP
cord-005453-4057qib7	426	18	suggested	suggest	VBN
cord-005453-4057qib7	426	19	equivalent	equivalent	JJ
cord-005453-4057qib7	426	20	outcomes	outcome	NNS
cord-005453-4057qib7	426	21	.	.	.
cord-005453-4057qib7	427	1	The	the	DT
cord-005453-4057qib7	427	2	depletion	depletion	NN
cord-005453-4057qib7	427	3	of	of	IN
cord-005453-4057qib7	427	4	Tcells	Tcells	NNP
cord-005453-4057qib7	427	5	with	with	IN
cord-005453-4057qib7	427	6	PGCY	PGCY	NNP
cord-005453-4057qib7	427	7	was	be	VBD
cord-005453-4057qib7	427	8	subsequently	subsequently	RB
cord-005453-4057qib7	427	9	applied	apply	VBN
cord-005453-4057qib7	427	10	for	for	IN
cord-005453-4057qib7	427	11	unrelated	unrelated	JJ
cord-005453-4057qib7	427	12	HSCT	HSCT	NNP
cord-005453-4057qib7	427	13	setting	set	VBG
cord-005453-4057qib7	427	14	for	for	IN
cord-005453-4057qib7	427	15	patients	patient	NNS
cord-005453-4057qib7	427	16	with	with	IN
cord-005453-4057qib7	427	17	unrelated	unrelated	JJ
cord-005453-4057qib7	427	18	donor	donor	NN
cord-005453-4057qib7	427	19	.	.	.
cord-005453-4057qib7	428	1	Methods	method	NNS
cord-005453-4057qib7	428	2	:	:	:
cord-005453-4057qib7	428	3	We	-PRON-	PRP
cord-005453-4057qib7	428	4	performed	perform	VBD
cord-005453-4057qib7	428	5	a	a	DT
cord-005453-4057qib7	428	6	retrospective	retrospective	JJ
cord-005453-4057qib7	428	7	study	study	NN
cord-005453-4057qib7	428	8	on	on	IN
cord-005453-4057qib7	428	9	90	90	CD
cord-005453-4057qib7	428	10	patients	patient	NNS
cord-005453-4057qib7	428	11	with	with	IN
cord-005453-4057qib7	428	12	acute	acute	JJ
cord-005453-4057qib7	428	13	leukemia	leukemia	NN
cord-005453-4057qib7	428	14	in	in	IN
cord-005453-4057qib7	428	15	order	order	NN
cord-005453-4057qib7	428	16	to	to	TO
cord-005453-4057qib7	428	17	compare	compare	VB
cord-005453-4057qib7	428	18	the	the	DT
cord-005453-4057qib7	428	19	outcome	outcome	NN
cord-005453-4057qib7	428	20	after	after	IN
cord-005453-4057qib7	428	21	HLA	HLA	NNP
cord-005453-4057qib7	428	22	haploidentical	haploidentical	NNP
cord-005453-4057qib7	428	23	(	(	-LRB-
cord-005453-4057qib7	428	24	n=30	n=30	NNP
cord-005453-4057qib7	428	25	)	)	-RRB-
cord-005453-4057qib7	428	26	and	and	CC
cord-005453-4057qib7	428	27	unrelated	unrelated	JJ
cord-005453-4057qib7	428	28	HSCT	HSCT	NNP
cord-005453-4057qib7	428	29	(	(	-LRB-
cord-005453-4057qib7	428	30	n=60	n=60	JJ
cord-005453-4057qib7	428	31	)	)	-RRB-
cord-005453-4057qib7	428	32	with	with	IN
cord-005453-4057qib7	428	33	PGCY	PGCY	NNP
cord-005453-4057qib7	428	34	.	.	.
cord-005453-4057qib7	429	1	The	the	DT
cord-005453-4057qib7	429	2	main	main	JJ
cord-005453-4057qib7	429	3	characteristics	characteristic	NNS
cord-005453-4057qib7	429	4	of	of	IN
cord-005453-4057qib7	429	5	patients	patient	NNS
cord-005453-4057qib7	429	6	were	be	VBD
cord-005453-4057qib7	429	7	similar	similar	JJ
cord-005453-4057qib7	429	8	in	in	IN
cord-005453-4057qib7	429	9	both	both	DT
cord-005453-4057qib7	429	10	groups	group	NNS
cord-005453-4057qib7	429	11	.	.	.
cord-005453-4057qib7	430	1	Baseline	baseline	JJ
cord-005453-4057qib7	430	2	disease	disease	NN
cord-005453-4057qib7	430	3	were	be	VBD
cord-005453-4057qib7	430	4	:	:	:
cord-005453-4057qib7	430	5	19	19	CD
cord-005453-4057qib7	430	6	AML	AML	NNP
cord-005453-4057qib7	430	7	(	(	-LRB-
cord-005453-4057qib7	430	8	63	63	CD
cord-005453-4057qib7	430	9	%	%	NN
cord-005453-4057qib7	430	10	)	)	-RRB-
cord-005453-4057qib7	430	11	and	and	CC
cord-005453-4057qib7	430	12	11	11	CD
cord-005453-4057qib7	430	13	ALL	all	DT
cord-005453-4057qib7	430	14	(	(	-LRB-
cord-005453-4057qib7	430	15	37	37	CD
cord-005453-4057qib7	430	16	%	%	NN
cord-005453-4057qib7	430	17	)	)	-RRB-
cord-005453-4057qib7	430	18	for	for	IN
cord-005453-4057qib7	430	19	Haplo	Haplo	NNP
cord-005453-4057qib7	430	20	group	group	NN
cord-005453-4057qib7	430	21	and	and	CC
cord-005453-4057qib7	430	22	33	33	CD
cord-005453-4057qib7	430	23	AML	AML	NNP
cord-005453-4057qib7	430	24	(	(	-LRB-
cord-005453-4057qib7	430	25	55	55	CD
cord-005453-4057qib7	430	26	%	%	NN
cord-005453-4057qib7	430	27	)	)	-RRB-
cord-005453-4057qib7	430	28	and	and	CC
cord-005453-4057qib7	430	29	27	27	CD
cord-005453-4057qib7	430	30	ALL	all	DT
cord-005453-4057qib7	430	31	(	(	-LRB-
cord-005453-4057qib7	430	32	45	45	CD
cord-005453-4057qib7	430	33	%	%	NN
cord-005453-4057qib7	430	34	)	)	-RRB-
cord-005453-4057qib7	430	35	for	for	IN
cord-005453-4057qib7	430	36	unrelated	unrelated	JJ
cord-005453-4057qib7	430	37	group	group	NN
cord-005453-4057qib7	430	38	.	.	.
cord-005453-4057qib7	431	1	Disease	Disease	NNP
cord-005453-4057qib7	431	2	state	state	NN
cord-005453-4057qib7	431	3	at	at	IN
cord-005453-4057qib7	431	4	time	time	NN
cord-005453-4057qib7	431	5	of	of	IN
cord-005453-4057qib7	431	6	haplo	haplo	NN
cord-005453-4057qib7	431	7	and	and	CC
cord-005453-4057qib7	431	8	unrelated	unrelated	JJ
cord-005453-4057qib7	431	9	-	-	HYPH
cord-005453-4057qib7	431	10	HSCT	HSCT	NNP
cord-005453-4057qib7	431	11	were	be	VBD
cord-005453-4057qib7	431	12	following	follow	VBG
cord-005453-4057qib7	431	13	:	:	:
cord-005453-4057qib7	431	14	19	19	CD
cord-005453-4057qib7	431	15	and	and	CC
cord-005453-4057qib7	431	16	50	50	CD
cord-005453-4057qib7	431	17	patients	patient	NNS
cord-005453-4057qib7	431	18	in	in	IN
cord-005453-4057qib7	431	19	CR1	CR1	NNP
cord-005453-4057qib7	431	20	(	(	-LRB-
cord-005453-4057qib7	431	21	63	63	CD
cord-005453-4057qib7	431	22	%	%	NN
cord-005453-4057qib7	431	23	and	and	CC
cord-005453-4057qib7	431	24	83	83	CD
cord-005453-4057qib7	431	25	%	%	NN
cord-005453-4057qib7	431	26	)	)	-RRB-
cord-005453-4057qib7	431	27	and	and	CC
cord-005453-4057qib7	431	28	11	11	CD
cord-005453-4057qib7	431	29	and	and	CC
cord-005453-4057qib7	431	30	10	10	CD
cord-005453-4057qib7	431	31	non	non	JJ
cord-005453-4057qib7	431	32	CR1	CR1	NNP
cord-005453-4057qib7	431	33	(	(	-LRB-
cord-005453-4057qib7	431	34	37	37	CD
cord-005453-4057qib7	431	35	%	%	NN
cord-005453-4057qib7	431	36	and	and	CC
cord-005453-4057qib7	431	37	17	17	CD
cord-005453-4057qib7	431	38	%	%	NN
cord-005453-4057qib7	431	39	)	)	-RRB-
cord-005453-4057qib7	431	40	.	.	.
cord-005453-4057qib7	432	1	For	for	IN
cord-005453-4057qib7	432	2	AML	AML	NNP
cord-005453-4057qib7	432	3	recipients	recipient	NNS
cord-005453-4057qib7	432	4	mainly	mainly	RB
cord-005453-4057qib7	432	5	received	receive	VBD
cord-005453-4057qib7	432	6	thiotepa	thiotepa	NNS
cord-005453-4057qib7	432	7	,	,	,
cord-005453-4057qib7	432	8	busulfan	busulfan	NN
cord-005453-4057qib7	432	9	and	and	CC
cord-005453-4057qib7	432	10	fludarabine	fludarabine	NN
cord-005453-4057qib7	432	11	and	and	CC
cord-005453-4057qib7	432	12	for	for	IN
cord-005453-4057qib7	432	13	ALL	all	DT
cord-005453-4057qib7	432	14	recipients	recipient	NNS
cord-005453-4057qib7	432	15	received	receive	VBD
cord-005453-4057qib7	432	16	TBI	TBI	NNP
cord-005453-4057qib7	432	17	and	and	CC
cord-005453-4057qib7	432	18	Etoposide	Etoposide	NNP
cord-005453-4057qib7	432	19	conditioning	conditioning	NN
cord-005453-4057qib7	432	20	.	.	.
cord-005453-4057qib7	433	1	All	all	DT
cord-005453-4057qib7	433	2	patients	patient	NNS
cord-005453-4057qib7	433	3	who	who	WP
cord-005453-4057qib7	433	4	received	receive	VBD
cord-005453-4057qib7	433	5	PBSC	PBSC	NNP
cord-005453-4057qib7	433	6	graft	graft	NN
cord-005453-4057qib7	433	7	were	be	VBD
cord-005453-4057qib7	433	8	treated	treat	VBN
cord-005453-4057qib7	433	9	with	with	IN
cord-005453-4057qib7	433	10	rabbit	rabbit	NN
cord-005453-4057qib7	433	11	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	433	12	globulin	globulin	NN
cord-005453-4057qib7	433	13	(	(	-LRB-
cord-005453-4057qib7	433	14	ATG	ATG	NNP
cord-005453-4057qib7	433	15	)	)	-RRB-
cord-005453-4057qib7	433	16	on	on	IN
cord-005453-4057qib7	433	17	days	day	NNS
cord-005453-4057qib7	433	18	-2	-2	XX
cord-005453-4057qib7	434	1	and	and	CC
cord-005453-4057qib7	434	2	-1	-1	NN
cord-005453-4057qib7	434	3	.	.	.
cord-005453-4057qib7	435	1	Results	result	NNS
cord-005453-4057qib7	435	2	:	:	:
cord-005453-4057qib7	436	1	At	at	IN
cord-005453-4057qib7	436	2	the	the	DT
cord-005453-4057qib7	436	3	time	time	NN
cord-005453-4057qib7	436	4	of	of	IN
cord-005453-4057qib7	436	5	analysis	analysis	NN
cord-005453-4057qib7	436	6	,	,	,
cord-005453-4057qib7	436	7	the	the	DT
cord-005453-4057qib7	436	8	OS	OS	NNP
cord-005453-4057qib7	436	9	and	and	CC
cord-005453-4057qib7	436	10	DFS	DFS	NNP
cord-005453-4057qib7	436	11	did	do	VBD
cord-005453-4057qib7	436	12	not	not	RB
cord-005453-4057qib7	436	13	differ	differ	VB
cord-005453-4057qib7	436	14	between	between	IN
cord-005453-4057qib7	436	15	the	the	DT
cord-005453-4057qib7	436	16	Haplo	Haplo	NNP
cord-005453-4057qib7	436	17	and	and	CC
cord-005453-4057qib7	436	18	unrelated	unrelated	JJ
cord-005453-4057qib7	436	19	groups	group	NNS
cord-005453-4057qib7	436	20	(	(	-LRB-
cord-005453-4057qib7	436	21	67	67	CD
cord-005453-4057qib7	436	22	%	%	NN
cord-005453-4057qib7	436	23	vs	vs	IN
cord-005453-4057qib7	436	24	63	63	CD
cord-005453-4057qib7	436	25	%	%	NN
cord-005453-4057qib7	436	26	,	,	,
cord-005453-4057qib7	436	27	and	and	CC
cord-005453-4057qib7	436	28	63	63	CD
cord-005453-4057qib7	436	29	%	%	NN
cord-005453-4057qib7	436	30	vs	vs	IN
cord-005453-4057qib7	436	31	56	56	CD
cord-005453-4057qib7	436	32	%	%	NN
cord-005453-4057qib7	436	33	)	)	-RRB-
cord-005453-4057qib7	436	34	.	.	.
cord-005453-4057qib7	437	1	Incidence	incidence	NN
cord-005453-4057qib7	437	2	of	of	IN
cord-005453-4057qib7	437	3	severe	severe	JJ
cord-005453-4057qib7	437	4	(	(	-LRB-
cord-005453-4057qib7	437	5	grade	grade	NN
cord-005453-4057qib7	437	6	[	[	-LRB-
cord-005453-4057qib7	437	7	3	3	CD
cord-005453-4057qib7	437	8	]	]	-RRB-
cord-005453-4057qib7	437	9	[	[	-LRB-
cord-005453-4057qib7	437	10	4	4	CD
cord-005453-4057qib7	437	11	]	]	-RRB-
cord-005453-4057qib7	437	12	acute	acute	JJ
cord-005453-4057qib7	437	13	GVHD	GVHD	NNP
cord-005453-4057qib7	437	14	was	be	VBD
cord-005453-4057qib7	437	15	the	the	DT
cord-005453-4057qib7	437	16	same	same	JJ
cord-005453-4057qib7	437	17	in	in	IN
cord-005453-4057qib7	437	18	two	two	CD
cord-005453-4057qib7	437	19	groups	group	NNS
cord-005453-4057qib7	437	20	(	(	-LRB-
cord-005453-4057qib7	437	21	10	10	CD
cord-005453-4057qib7	437	22	%	%	NN
cord-005453-4057qib7	437	23	versus	versus	IN
cord-005453-4057qib7	437	24	8	8	CD
cord-005453-4057qib7	437	25	%	%	NN
cord-005453-4057qib7	437	26	)	)	-RRB-
cord-005453-4057qib7	437	27	.	.	.
cord-005453-4057qib7	438	1	Recipients	recipient	NNS
cord-005453-4057qib7	438	2	of	of	IN
cord-005453-4057qib7	438	3	Haplo	Haplo	NNP
cord-005453-4057qib7	438	4	-	-	HYPH
cord-005453-4057qib7	438	5	HSCT	HSCT	NNP
cord-005453-4057qib7	438	6	transplant	transplant	NN
cord-005453-4057qib7	438	7	were	be	VBD
cord-005453-4057qib7	438	8	statistical	statistical	JJ
cord-005453-4057qib7	438	9	significance	significance	NN
cord-005453-4057qib7	438	10	less	less	RBR
cord-005453-4057qib7	438	11	likely	likely	JJ
cord-005453-4057qib7	438	12	to	to	TO
cord-005453-4057qib7	438	13	experience	experience	VB
cord-005453-4057qib7	438	14	disease	disease	NN
cord-005453-4057qib7	438	15	relapse	relapse	NN
cord-005453-4057qib7	438	16	(	(	-LRB-
cord-005453-4057qib7	438	17	3	3	CD
cord-005453-4057qib7	438	18	%	%	NN
cord-005453-4057qib7	438	19	vs	vs	IN
cord-005453-4057qib7	438	20	28	28	CD
cord-005453-4057qib7	438	21	%	%	NN
cord-005453-4057qib7	438	22	)	)	-RRB-
cord-005453-4057qib7	438	23	and	and	CC
cord-005453-4057qib7	438	24	chronic	chronic	JJ
cord-005453-4057qib7	438	25	GVHD	GVHD	NNP
cord-005453-4057qib7	438	26	(	(	-LRB-
cord-005453-4057qib7	438	27	20	20	CD
cord-005453-4057qib7	438	28	%	%	NN
cord-005453-4057qib7	438	29	vs	vs	IN
cord-005453-4057qib7	438	30	47,5	47,5	CD
cord-005453-4057qib7	438	31	%	%	NN
cord-005453-4057qib7	438	32	)	)	-RRB-
cord-005453-4057qib7	438	33	.	.	.
cord-005453-4057qib7	439	1	However	however	RB
cord-005453-4057qib7	439	2	,	,	,
cord-005453-4057qib7	439	3	GVHD	GVHD	NNP
cord-005453-4057qib7	439	4	free	free	JJ
cord-005453-4057qib7	439	5	relapse	relapse	NN
cord-005453-4057qib7	439	6	free	free	JJ
cord-005453-4057qib7	439	7	survival	survival	NN
cord-005453-4057qib7	440	1	(	(	-LRB-
cord-005453-4057qib7	440	2	GRFS	GRFS	NNP
cord-005453-4057qib7	440	3	)	)	-RRB-
cord-005453-4057qib7	440	4	rate	rate	NN
cord-005453-4057qib7	440	5	was	be	VBD
cord-005453-4057qib7	440	6	slightly	slightly	RB
cord-005453-4057qib7	440	7	higher	high	JJR
cord-005453-4057qib7	440	8	after	after	IN
cord-005453-4057qib7	440	9	Haplo	Haplo	NNP
cord-005453-4057qib7	440	10	-	-	HYPH
cord-005453-4057qib7	440	11	HSCT	HSCT	NNP
cord-005453-4057qib7	440	12	(	(	-LRB-
cord-005453-4057qib7	440	13	77	77	CD
cord-005453-4057qib7	440	14	%	%	NN
cord-005453-4057qib7	440	15	vs	vs	IN
cord-005453-4057qib7	440	16	64	64	CD
cord-005453-4057qib7	440	17	%	%	NN
cord-005453-4057qib7	440	18	)	)	-RRB-
cord-005453-4057qib7	440	19	.	.	.
cord-005453-4057qib7	441	1	Addition	addition	NN
cord-005453-4057qib7	441	2	,	,	,
cord-005453-4057qib7	441	3	cumulative	cumulative	JJ
cord-005453-4057qib7	441	4	incidence	incidence	NN
cord-005453-4057qib7	441	5	of	of	IN
cord-005453-4057qib7	441	6	TRM	TRM	NNP
cord-005453-4057qib7	441	7	rate	rate	NN
cord-005453-4057qib7	441	8	was	be	VBD
cord-005453-4057qib7	441	9	higher	high	JJR
cord-005453-4057qib7	441	10	after	after	IN
cord-005453-4057qib7	441	11	Haplo	Haplo	NNP
cord-005453-4057qib7	441	12	-	-	HYPH
cord-005453-4057qib7	441	13	HSCT	HSCT	NNP
cord-005453-4057qib7	441	14	(	(	-LRB-
cord-005453-4057qib7	441	15	30	30	CD
cord-005453-4057qib7	441	16	%	%	NN
cord-005453-4057qib7	441	17	vs	vs	IN
cord-005453-4057qib7	441	18	15%).For	15%).for	CD
cord-005453-4057qib7	441	19	Haplo	Haplo	NNP
cord-005453-4057qib7	441	20	and	and	CC
cord-005453-4057qib7	441	21	unrelated	unrelated	JJ
cord-005453-4057qib7	441	22	groups	group	NNS
cord-005453-4057qib7	441	23	who	who	WP
cord-005453-4057qib7	441	24	underwent	undergo	VBD
cord-005453-4057qib7	441	25	HSCT	HSCT	NNP
cord-005453-4057qib7	441	26	in	in	IN
cord-005453-4057qib7	441	27	CR1	CR1	NNP
cord-005453-4057qib7	441	28	,	,	,
cord-005453-4057qib7	441	29	the	the	DT
cord-005453-4057qib7	441	30	OS	OS	NNP
cord-005453-4057qib7	441	31	were	be	VBD
cord-005453-4057qib7	441	32	84	84	CD
cord-005453-4057qib7	441	33	%	%	NN
cord-005453-4057qib7	441	34	and	and	CC
cord-005453-4057qib7	441	35	67	67	CD
cord-005453-4057qib7	441	36	%	%	NN
cord-005453-4057qib7	441	37	versus	versus	IN
cord-005453-4057qib7	441	38	22	22	CD
cord-005453-4057qib7	441	39	%	%	NN
cord-005453-4057qib7	441	40	and	and	CC
cord-005453-4057qib7	441	41	45	45	CD
cord-005453-4057qib7	441	42	%	%	NN
cord-005453-4057qib7	441	43	for	for	IN
cord-005453-4057qib7	441	44	those	those	DT
cord-005453-4057qib7	441	45	in	in	IN
cord-005453-4057qib7	441	46	non	non	JJ
cord-005453-4057qib7	441	47	CR1	CR1	NNP
cord-005453-4057qib7	441	48	.	.	.
cord-005453-4057qib7	442	1	For	for	IN
cord-005453-4057qib7	442	2	AML	AML	NNP
cord-005453-4057qib7	442	3	,	,	,
cord-005453-4057qib7	442	4	the	the	DT
cord-005453-4057qib7	442	5	OS	OS	NNP
cord-005453-4057qib7	442	6	was	be	VBD
cord-005453-4057qib7	442	7	same	same	JJ
cord-005453-4057qib7	442	8	in	in	IN
cord-005453-4057qib7	442	9	two	two	CD
cord-005453-4057qib7	442	10	groups	group	NNS
cord-005453-4057qib7	442	11	(	(	-LRB-
cord-005453-4057qib7	442	12	Haplo	Haplo	NNP
cord-005453-4057qib7	442	13	63	63	CD
cord-005453-4057qib7	442	14	%	%	NN
cord-005453-4057qib7	442	15	versus	versus	IN
cord-005453-4057qib7	442	16	unrelated	unrelated	JJ
cord-005453-4057qib7	442	17	67	67	CD
cord-005453-4057qib7	442	18	%	%	NN
cord-005453-4057qib7	442	19	)	)	-RRB-
cord-005453-4057qib7	442	20	.	.	.
cord-005453-4057qib7	443	1	However	however	RB
cord-005453-4057qib7	443	2	patients	patient	NNS
cord-005453-4057qib7	443	3	with	with	IN
cord-005453-4057qib7	443	4	ALL	all	DT
cord-005453-4057qib7	443	5	,	,	,
cord-005453-4057qib7	443	6	the	the	DT
cord-005453-4057qib7	443	7	OS	OS	NNP
cord-005453-4057qib7	443	8	was	be	VBD
cord-005453-4057qib7	443	9	higher	high	JJR
cord-005453-4057qib7	443	10	in	in	IN
cord-005453-4057qib7	443	11	Haplo	Haplo	NNP
cord-005453-4057qib7	443	12	group	group	NN
cord-005453-4057qib7	443	13	compared	compare	VBN
cord-005453-4057qib7	443	14	with	with	IN
cord-005453-4057qib7	443	15	unrelated	unrelated	JJ
cord-005453-4057qib7	443	16	group	group	NN
cord-005453-4057qib7	443	17	(	(	-LRB-
cord-005453-4057qib7	443	18	72	72	CD
cord-005453-4057qib7	443	19	%	%	NN
cord-005453-4057qib7	443	20	versus	versus	IN
cord-005453-4057qib7	443	21	59	59	CD
cord-005453-4057qib7	443	22	%	%	NN
cord-005453-4057qib7	443	23	)	)	-RRB-
cord-005453-4057qib7	443	24	.	.	.
cord-005453-4057qib7	444	1	The	the	DT
cord-005453-4057qib7	444	2	impact	impact	NN
cord-005453-4057qib7	444	3	of	of	IN
cord-005453-4057qib7	444	4	pretransplant	pretransplant	JJ
cord-005453-4057qib7	444	5	disease	disease	NN
cord-005453-4057qib7	444	6	state	state	NN
cord-005453-4057qib7	444	7	have	have	VBP
cord-005453-4057qib7	444	8	a	a	DT
cord-005453-4057qib7	444	9	more	more	RBR
cord-005453-4057qib7	444	10	powerfull	powerfull	JJ
cord-005453-4057qib7	444	11	effect	effect	NN
cord-005453-4057qib7	444	12	on	on	IN
cord-005453-4057qib7	444	13	survival	survival	NN
cord-005453-4057qib7	444	14	in	in	IN
cord-005453-4057qib7	444	15	the	the	DT
cord-005453-4057qib7	444	16	Haplo	Haplo	NNP
cord-005453-4057qib7	444	17	-	-	HYPH
cord-005453-4057qib7	444	18	HSCT	HSCT	NNP
cord-005453-4057qib7	444	19	setting	setting	NN
cord-005453-4057qib7	444	20	(	(	-LRB-
cord-005453-4057qib7	444	21	for	for	IN
cord-005453-4057qib7	444	22	AML	AML	NNP
cord-005453-4057qib7	444	23	CR1	CR1	NNP
cord-005453-4057qib7	444	24	77	77	CD
cord-005453-4057qib7	444	25	%	%	NN
cord-005453-4057qib7	444	26	versus	versus	IN
cord-005453-4057qib7	444	27	non	non	FW
cord-005453-4057qib7	444	28	CR1	CR1	NNP
cord-005453-4057qib7	444	29	33	33	CD
cord-005453-4057qib7	444	30	%	%	NN
cord-005453-4057qib7	444	31	and	and	CC
cord-005453-4057qib7	444	32	for	for	IN
cord-005453-4057qib7	444	33	ALL	all	DT
cord-005453-4057qib7	444	34	CR1	CR1	NNP
cord-005453-4057qib7	444	35	100	100	CD
cord-005453-4057qib7	444	36	%	%	NN
cord-005453-4057qib7	444	37	versus	versus	IN
cord-005453-4057qib7	444	38	non	non	FW
cord-005453-4057qib7	444	39	CR1	CR1	NNP
cord-005453-4057qib7	444	40	0	0	CD
cord-005453-4057qib7	444	41	%	%	NN
cord-005453-4057qib7	444	42	)	)	-RRB-
cord-005453-4057qib7	444	43	.	.	.
cord-005453-4057qib7	445	1	Viral	viral	JJ
cord-005453-4057qib7	445	2	reactivations	reactivation	NNS
cord-005453-4057qib7	445	3	were	be	VBD
cord-005453-4057qib7	445	4	significant	significant	JJ
cord-005453-4057qib7	445	5	concern	concern	NN
cord-005453-4057qib7	445	6	in	in	IN
cord-005453-4057qib7	445	7	both	both	DT
cord-005453-4057qib7	445	8	groups	group	NNS
cord-005453-4057qib7	445	9	.	.	.
cord-005453-4057qib7	446	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	446	2	:	:	:
cord-005453-4057qib7	447	1	Our	-PRON-	PRP$
cord-005453-4057qib7	447	2	retrospective	retrospective	JJ
cord-005453-4057qib7	447	3	analysis	analysis	NN
cord-005453-4057qib7	447	4	suggests	suggest	VBZ
cord-005453-4057qib7	447	5	largerly	largerly	RB
cord-005453-4057qib7	447	6	similar	similar	JJ
cord-005453-4057qib7	447	7	OS	OS	NNP
cord-005453-4057qib7	447	8	and	and	CC
cord-005453-4057qib7	447	9	DFS	DFS	NNP
cord-005453-4057qib7	447	10	with	with	IN
cord-005453-4057qib7	447	11	Haplo	Haplo	NNP
cord-005453-4057qib7	447	12	versus	versus	IN
cord-005453-4057qib7	447	13	unrelated	unrelated	JJ
cord-005453-4057qib7	447	14	transplants	transplant	NNS
cord-005453-4057qib7	447	15	with	with	IN
cord-005453-4057qib7	447	16	PGCY	PGCY	NNP
cord-005453-4057qib7	447	17	for	for	IN
cord-005453-4057qib7	447	18	acute	acute	JJ
cord-005453-4057qib7	447	19	leukemia	leukemia	NN
cord-005453-4057qib7	447	20	.	.	.
cord-005453-4057qib7	448	1	Our	-PRON-	PRP$
cord-005453-4057qib7	448	2	data	datum	NNS
cord-005453-4057qib7	448	3	indicate	indicate	VBP
cord-005453-4057qib7	448	4	that	that	IN
cord-005453-4057qib7	448	5	Haplo	Haplo	NNP
cord-005453-4057qib7	448	6	-	-	HYPH
cord-005453-4057qib7	448	7	HSCT	HSCT	NNP
cord-005453-4057qib7	448	8	results	result	NNS
cord-005453-4057qib7	448	9	in	in	IN
cord-005453-4057qib7	448	10	a	a	DT
cord-005453-4057qib7	448	11	lower	low	JJR
cord-005453-4057qib7	448	12	incidence	incidence	NN
cord-005453-4057qib7	448	13	relapse	relapse	NN
cord-005453-4057qib7	448	14	and	and	CC
cord-005453-4057qib7	448	15	of	of	IN
cord-005453-4057qib7	448	16	chronic	chronic	JJ
cord-005453-4057qib7	448	17	GVHD	GVHD	NNP
cord-005453-4057qib7	448	18	and	and	CC
cord-005453-4057qib7	448	19	higher	high	JJR
cord-005453-4057qib7	448	20	GRFS	grfs	NN
cord-005453-4057qib7	448	21	compared	compare	VBN
cord-005453-4057qib7	448	22	with	with	IN
cord-005453-4057qib7	448	23	unrelated	unrelated	JJ
cord-005453-4057qib7	448	24	HSCT	HSCT	NNP
cord-005453-4057qib7	448	25	.	.	.
cord-005453-4057qib7	449	1	In	in	IN
cord-005453-4057qib7	449	2	addtion	addtion	NN
cord-005453-4057qib7	449	3	,	,	,
cord-005453-4057qib7	449	4	the	the	DT
cord-005453-4057qib7	449	5	pretransplant	pretransplant	JJ
cord-005453-4057qib7	449	6	disease	disease	NN
cord-005453-4057qib7	449	7	state	state	NN
cord-005453-4057qib7	449	8	have	have	VBP
cord-005453-4057qib7	449	9	the	the	DT
cord-005453-4057qib7	449	10	important	important	JJ
cord-005453-4057qib7	449	11	effect	effect	NN
cord-005453-4057qib7	449	12	on	on	IN
cord-005453-4057qib7	449	13	the	the	DT
cord-005453-4057qib7	449	14	outcomes	outcome	NNS
cord-005453-4057qib7	449	15	in	in	IN
cord-005453-4057qib7	449	16	both	both	DT
cord-005453-4057qib7	449	17	groups	group	NNS
cord-005453-4057qib7	449	18	.	.	.
cord-005453-4057qib7	450	1	Allo	Allo	NNP
cord-005453-4057qib7	450	2	-	-	HYPH
cord-005453-4057qib7	450	3	PBSC	PBSC	NNP
cord-005453-4057qib7	450	4	with	with	IN
cord-005453-4057qib7	450	5	ATG	ATG	NNP
cord-005453-4057qib7	450	6	can	can	MD
cord-005453-4057qib7	450	7	be	be	VB
cord-005453-4057qib7	450	8	used	use	VBN
cord-005453-4057qib7	450	9	safely	safely	RB
cord-005453-4057qib7	450	10	and	and	CC
cord-005453-4057qib7	450	11	effective	effective	JJ
cord-005453-4057qib7	450	12	as	as	IN
cord-005453-4057qib7	450	13	graft	graft	NN
cord-005453-4057qib7	450	14	source	source	NN
cord-005453-4057qib7	450	15	in	in	IN
cord-005453-4057qib7	450	16	Haplo	Haplo	NNP
cord-005453-4057qib7	450	17	-	-	HYPH
cord-005453-4057qib7	450	18	HSCT	HSCT	NNP
cord-005453-4057qib7	450	19	with	with	IN
cord-005453-4057qib7	450	20	acceptable	acceptable	JJ
cord-005453-4057qib7	450	21	post	post	JJ
cord-005453-4057qib7	450	22	-	-	JJ
cord-005453-4057qib7	450	23	transplant	transplant	JJ
cord-005453-4057qib7	450	24	outcomes	outcome	NNS
cord-005453-4057qib7	450	25	and	and	CC
cord-005453-4057qib7	450	26	replaced	replace	VBN
cord-005453-4057qib7	450	27	BM	BM	NNP
cord-005453-4057qib7	450	28	in	in	IN
cord-005453-4057qib7	450	29	this	this	DT
cord-005453-4057qib7	450	30	settings	setting	NNS
cord-005453-4057qib7	450	31	.	.	.
cord-005453-4057qib7	451	1	More	More	JJR
cord-005453-4057qib7	451	2	statistical	statistical	JJ
cord-005453-4057qib7	451	3	data	datum	NNS
cord-005453-4057qib7	451	4	for	for	IN
cord-005453-4057qib7	451	5	transplant	transplant	NN
cord-005453-4057qib7	451	6	related	relate	VBN
cord-005453-4057qib7	451	7	characteristics	characteristic	NNS
cord-005453-4057qib7	451	8	will	will	MD
cord-005453-4057qib7	451	9	be	be	VB
cord-005453-4057qib7	451	10	provided	provide	VBN
cord-005453-4057qib7	451	11	at	at	IN
cord-005453-4057qib7	451	12	the	the	DT
cord-005453-4057qib7	451	13	presentation	presentation	NN
cord-005453-4057qib7	451	14	.	.	.
cord-005453-4057qib7	452	1	We	-PRON-	PRP
cord-005453-4057qib7	452	2	emphasize	emphasize	VBP
cord-005453-4057qib7	452	3	that	that	IN
cord-005453-4057qib7	452	4	use	use	VBP
cord-005453-4057qib7	452	5	the	the	DT
cord-005453-4057qib7	452	6	same	same	JJ
cord-005453-4057qib7	452	7	PGCY	pgcy	JJ
cord-005453-4057qib7	452	8	GVHD	GVHD	NNP
cord-005453-4057qib7	452	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	452	10	for	for	IN
cord-005453-4057qib7	452	11	all	all	DT
cord-005453-4057qib7	452	12	types	type	NNS
cord-005453-4057qib7	452	13	of	of	IN
cord-005453-4057qib7	452	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	452	15	transplant	transplant	NN
cord-005453-4057qib7	452	16	.	.	.
cord-005453-4057qib7	453	1	Based	base	VBN
cord-005453-4057qib7	453	2	on	on	IN
cord-005453-4057qib7	453	3	our	-PRON-	PRP$
cord-005453-4057qib7	453	4	results	result	NNS
cord-005453-4057qib7	453	5	,	,	,
cord-005453-4057qib7	453	6	we	-PRON-	PRP
cord-005453-4057qib7	453	7	recommend	recommend	VBP
cord-005453-4057qib7	453	8	Haplo	Haplo	NNP
cord-005453-4057qib7	453	9	-	-	HYPH
cord-005453-4057qib7	453	10	HSCT	HSCT	NNP
cord-005453-4057qib7	453	11	with	with	IN
cord-005453-4057qib7	453	12	PGCY	PGCY	NNP
cord-005453-4057qib7	453	13	against	against	IN
cord-005453-4057qib7	453	14	unrelated	unrelated	JJ
cord-005453-4057qib7	453	15	transplant	transplant	NN
cord-005453-4057qib7	453	16	for	for	IN
cord-005453-4057qib7	453	17	patients	patient	NNS
cord-005453-4057qib7	453	18	with	with	IN
cord-005453-4057qib7	453	19	acute	acute	JJ
cord-005453-4057qib7	453	20	leukemia	leukemia	NN
cord-005453-4057qib7	453	21	.	.	.
cord-005453-4057qib7	454	1	Disclosure	disclosure	NN
cord-005453-4057qib7	454	2	:	:	:
cord-005453-4057qib7	454	3	Disclosure	disclosure	NN
cord-005453-4057qib7	454	4	of	of	IN
cord-005453-4057qib7	454	5	conflict	conflict	NN
cord-005453-4057qib7	454	6	of	of	IN
cord-005453-4057qib7	454	7	interest	interest	NN
cord-005453-4057qib7	454	8	:	:	:
cord-005453-4057qib7	454	9	None	none	NN
cord-005453-4057qib7	454	10	.	.	.
cord-005453-4057qib7	455	1	Excellent	excellent	JJ
cord-005453-4057qib7	455	2	efficacy	efficacy	NN
cord-005453-4057qib7	455	3	and	and	CC
cord-005453-4057qib7	455	4	tolerability	tolerability	NN
cord-005453-4057qib7	455	5	of	of	IN
cord-005453-4057qib7	455	6	inotuzumab	inotuzumab	NNS
cord-005453-4057qib7	455	7	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	455	8	in	in	IN
cord-005453-4057qib7	455	9	B	b	NN
cord-005453-4057qib7	455	10	-	-	HYPH
cord-005453-4057qib7	455	11	cell	cell	NN
cord-005453-4057qib7	455	12	all	all	DT
cord-005453-4057qib7	455	13	relapsed	relapse	VBD
cord-005453-4057qib7	455	14	after	after	IN
cord-005453-4057qib7	455	15	allo	allo	NN
cord-005453-4057qib7	455	16	-	-	HYPH
cord-005453-4057qib7	455	17	HSCT	HSCT	NNP
cord-005453-4057qib7	455	18	Background	background	NN
cord-005453-4057qib7	455	19	:	:	:
cord-005453-4057qib7	456	1	Donor	donor	NN
cord-005453-4057qib7	456	2	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	456	3	infusion	infusion	NN
cord-005453-4057qib7	456	4	(	(	-LRB-
cord-005453-4057qib7	456	5	DLI	DLI	NNP
cord-005453-4057qib7	456	6	)	)	-RRB-
cord-005453-4057qib7	456	7	could	could	MD
cord-005453-4057qib7	456	8	be	be	VB
cord-005453-4057qib7	456	9	used	use	VBN
cord-005453-4057qib7	456	10	prophylactically	prophylactically	RB
cord-005453-4057qib7	456	11	to	to	TO
cord-005453-4057qib7	456	12	reduce	reduce	VB
cord-005453-4057qib7	456	13	relapse	relapse	NN
cord-005453-4057qib7	456	14	after	after	IN
cord-005453-4057qib7	456	15	allogeneic	allogeneic	JJ
cord-005453-4057qib7	456	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	456	17	stem	stem	NN
cord-005453-4057qib7	456	18	cell	cell	NN
cord-005453-4057qib7	456	19	transplantation	transplantation	NN
cord-005453-4057qib7	456	20	for	for	IN
cord-005453-4057qib7	456	21	very	very	RB
cord-005453-4057qib7	456	22	high	high	JJ
cord-005453-4057qib7	456	23	-	-	HYPH
cord-005453-4057qib7	456	24	risk	risk	NN
cord-005453-4057qib7	456	25	leukemia	leukemia	NN
cord-005453-4057qib7	456	26	/	/	SYM
cord-005453-4057qib7	456	27	lymphoma	lymphoma	NN
cord-005453-4057qib7	456	28	without	without	IN
cord-005453-4057qib7	456	29	effective	effective	JJ
cord-005453-4057qib7	456	30	targeted	target	VBN
cord-005453-4057qib7	456	31	therapy	therapy	NN
cord-005453-4057qib7	456	32	.	.	.
cord-005453-4057qib7	457	1	To	to	TO
cord-005453-4057qib7	457	2	compare	compare	VB
cord-005453-4057qib7	457	3	the	the	DT
cord-005453-4057qib7	457	4	safety	safety	NN
cord-005453-4057qib7	457	5	and	and	CC
cord-005453-4057qib7	457	6	efficacy	efficacy	NN
cord-005453-4057qib7	457	7	of	of	IN
cord-005453-4057qib7	457	8	prophylactic	prophylactic	JJ
cord-005453-4057qib7	457	9	DLI	DLI	NNP
cord-005453-4057qib7	457	10	for	for	IN
cord-005453-4057qib7	457	11	prevention	prevention	NN
cord-005453-4057qib7	457	12	of	of	IN
cord-005453-4057qib7	457	13	relapse	relapse	NN
cord-005453-4057qib7	457	14	after	after	IN
cord-005453-4057qib7	457	15	allogeneic	allogeneic	IN
cord-005453-4057qib7	457	16	peripheral	peripheral	JJ
cord-005453-4057qib7	457	17	blood	blood	NN
cord-005453-4057qib7	457	18	stem	stem	NN
cord-005453-4057qib7	457	19	cell	cell	NN
cord-005453-4057qib7	457	20	transplantation	transplantation	NN
cord-005453-4057qib7	457	21	from	from	IN
cord-005453-4057qib7	457	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	457	23	donors	donor	NNS
cord-005453-4057qib7	457	24	(	(	-LRB-
cord-005453-4057qib7	457	25	HID	HID	NNP
cord-005453-4057qib7	457	26	-	-	HYPH
cord-005453-4057qib7	457	27	SCT	SCT	NNP
cord-005453-4057qib7	457	28	)	)	-RRB-
cord-005453-4057qib7	457	29	and	and	CC
cord-005453-4057qib7	457	30	matched	match	VBN
cord-005453-4057qib7	457	31	-	-	HYPH
cord-005453-4057qib7	457	32	sibling	sibling	NN
cord-005453-4057qib7	457	33	donors	donor	NNS
cord-005453-4057qib7	457	34	(	(	-LRB-
cord-005453-4057qib7	457	35	MSD	MSD	NNP
cord-005453-4057qib7	457	36	-	-	HYPH
cord-005453-4057qib7	457	37	SCT	SCT	NNP
cord-005453-4057qib7	457	38	)	)	-RRB-
cord-005453-4057qib7	457	39	in	in	IN
cord-005453-4057qib7	457	40	patients	patient	NNS
cord-005453-4057qib7	457	41	with	with	IN
cord-005453-4057qib7	457	42	very	very	RB
cord-005453-4057qib7	457	43	high	high	JJ
cord-005453-4057qib7	457	44	-	-	HYPH
cord-005453-4057qib7	457	45	risk	risk	NN
cord-005453-4057qib7	457	46	acute	acute	JJ
cord-005453-4057qib7	457	47	myeloid	myeloid	NN
cord-005453-4057qib7	457	48	leukemia	leukemia	NN
cord-005453-4057qib7	457	49	(	(	-LRB-
cord-005453-4057qib7	457	50	AML	AML	NNP
cord-005453-4057qib7	457	51	)	)	-RRB-
cord-005453-4057qib7	457	52	,	,	,
cord-005453-4057qib7	457	53	we	-PRON-	PRP
cord-005453-4057qib7	457	54	performed	perform	VBD
cord-005453-4057qib7	457	55	a	a	DT
cord-005453-4057qib7	457	56	retrospective	retrospective	JJ
cord-005453-4057qib7	457	57	,	,	,
cord-005453-4057qib7	457	58	observational	observational	JJ
cord-005453-4057qib7	457	59	cohort	cohort	NN
cord-005453-4057qib7	457	60	study	study	NN
cord-005453-4057qib7	457	61	enrolled	enrol	VBD
cord-005453-4057qib7	457	62	in	in	IN
cord-005453-4057qib7	457	63	21	21	CD
cord-005453-4057qib7	457	64	HID	HID	NNP
cord-005453-4057qib7	457	65	-	-	HYPH
cord-005453-4057qib7	457	66	SCT	SCT	NNP
cord-005453-4057qib7	457	67	and	and	CC
cord-005453-4057qib7	457	68	13	13	CD
cord-005453-4057qib7	457	69	MSD	MSD	NNP
cord-005453-4057qib7	457	70	-	-	HYPH
cord-005453-4057qib7	457	71	SCT	SCT	NNP
cord-005453-4057qib7	457	72	recipients	recipient	NNS
cord-005453-4057qib7	457	73	.	.	.
cord-005453-4057qib7	458	1	Methods	method	NNS
cord-005453-4057qib7	458	2	:	:	:
cord-005453-4057qib7	458	3	The	the	DT
cord-005453-4057qib7	458	4	very	very	RB
cord-005453-4057qib7	458	5	high	high	JJ
cord-005453-4057qib7	458	6	-	-	HYPH
cord-005453-4057qib7	458	7	risk	risk	NN
cord-005453-4057qib7	458	8	features	feature	NNS
cord-005453-4057qib7	458	9	were	be	VBD
cord-005453-4057qib7	458	10	defined	define	VBN
cord-005453-4057qib7	458	11	as	as	IN
cord-005453-4057qib7	458	12	:	:	:
cord-005453-4057qib7	458	13	(	(	-LRB-
cord-005453-4057qib7	458	14	i	i	NN
cord-005453-4057qib7	458	15	)	)	-RRB-
cord-005453-4057qib7	458	16	in	in	IN
cord-005453-4057qib7	458	17	the	the	DT
cord-005453-4057qib7	458	18	non	non	JJ
cord-005453-4057qib7	458	19	-	-	JJ
cord-005453-4057qib7	458	20	remission	remission	JJ
cord-005453-4057qib7	458	21	(	(	-LRB-
cord-005453-4057qib7	458	22	NR	NR	NNP
cord-005453-4057qib7	458	23	)	)	-RRB-
cord-005453-4057qib7	458	24	state	state	NN
cord-005453-4057qib7	458	25	prior	prior	RB
cord-005453-4057qib7	458	26	to	to	IN
cord-005453-4057qib7	458	27	transplantation	transplantation	NN
cord-005453-4057qib7	458	28	,	,	,
cord-005453-4057qib7	458	29	including	include	VBG
cord-005453-4057qib7	458	30	primary	primary	JJ
cord-005453-4057qib7	458	31	induction	induction	NN
cord-005453-4057qib7	458	32	failure	failure	NN
cord-005453-4057qib7	458	33	,	,	,
cord-005453-4057qib7	458	34	relapse	relapse	NN
cord-005453-4057qib7	458	35	untreated	untreated	JJ
cord-005453-4057qib7	458	36	or	or	CC
cord-005453-4057qib7	458	37	refractory	refractory	JJ
cord-005453-4057qib7	458	38	to	to	IN
cord-005453-4057qib7	458	39	reinduction	reinduction	NN
cord-005453-4057qib7	458	40	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	458	41	,	,	,
cord-005453-4057qib7	458	42	or	or	CC
cord-005453-4057qib7	458	43	untreated	untreated	JJ
cord-005453-4057qib7	458	44	AML	AML	NNP
cord-005453-4057qib7	458	45	evolution	evolution	NN
cord-005453-4057qib7	458	46	from	from	IN
cord-005453-4057qib7	458	47	MDS	MDS	NNP
cord-005453-4057qib7	458	48	;	;	:
cord-005453-4057qib7	458	49	(	(	-LRB-
cord-005453-4057qib7	458	50	ii	ii	NN
cord-005453-4057qib7	458	51	)	)	-RRB-
cord-005453-4057qib7	458	52	achieving	achieve	VBG
cord-005453-4057qib7	458	53	complete	complete	JJ
cord-005453-4057qib7	458	54	remission	remission	NN
cord-005453-4057qib7	458	55	1	1	CD
cord-005453-4057qib7	458	56	with	with	IN
cord-005453-4057qib7	458	57	≥3	≥3	NNP
cord-005453-4057qib7	458	58	cycles	cycle	NNS
cord-005453-4057qib7	458	59	of	of	IN
cord-005453-4057qib7	458	60	induction	induction	NN
cord-005453-4057qib7	458	61	of	of	IN
cord-005453-4057qib7	458	62	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	458	63	;	;	:
cord-005453-4057qib7	458	64	(	(	-LRB-
cord-005453-4057qib7	458	65	iii	iii	NN
cord-005453-4057qib7	458	66	)	)	-RRB-
cord-005453-4057qib7	458	67	carrying	carry	VBG
cord-005453-4057qib7	458	68	TP53	TP53	NNP
cord-005453-4057qib7	458	69	,	,	,
cord-005453-4057qib7	458	70	DNMT3a	dnmt3a	UH
cord-005453-4057qib7	458	71	,	,	,
cord-005453-4057qib7	458	72	TET2	TET2	NNP
cord-005453-4057qib7	458	73	or	or	CC
cord-005453-4057qib7	458	74	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	458	75	gene	gene	NN
cord-005453-4057qib7	458	76	mutation	mutation	NN
cord-005453-4057qib7	458	77	.	.	.
cord-005453-4057qib7	459	1	The	the	DT
cord-005453-4057qib7	459	2	scheduled	schedule	VBN
cord-005453-4057qib7	459	3	time	time	NN
cord-005453-4057qib7	459	4	of	of	IN
cord-005453-4057qib7	459	5	the	the	DT
cord-005453-4057qib7	459	6	prophylactic	prophylactic	JJ
cord-005453-4057qib7	459	7	DLI	DLI	NNP
cord-005453-4057qib7	459	8	was	be	VBD
cord-005453-4057qib7	459	9	+30	+30	CD
cord-005453-4057qib7	459	10	-	-	SYM
cord-005453-4057qib7	459	11	60	60	CD
cord-005453-4057qib7	459	12	days	day	NNS
cord-005453-4057qib7	459	13	after	after	IN
cord-005453-4057qib7	459	14	transplantation	transplantation	NN
cord-005453-4057qib7	459	15	for	for	IN
cord-005453-4057qib7	459	16	MSD	MSD	NNP
cord-005453-4057qib7	459	17	-	-	HYPH
cord-005453-4057qib7	459	18	SCT	SCT	NNP
cord-005453-4057qib7	459	19	recipients	recipient	NNS
cord-005453-4057qib7	459	20	and	and	CC
cord-005453-4057qib7	459	21	+60	+60	CD
cord-005453-4057qib7	459	22	-	-	SYM
cord-005453-4057qib7	459	23	90	90	CD
cord-005453-4057qib7	459	24	days	day	NNS
cord-005453-4057qib7	459	25	for	for	IN
cord-005453-4057qib7	459	26	HID	HID	NNP
cord-005453-4057qib7	459	27	-	-	HYPH
cord-005453-4057qib7	459	28	SCT	SCT	NNP
cord-005453-4057qib7	459	29	recipients	recipient	NNS
cord-005453-4057qib7	459	30	.	.	.
cord-005453-4057qib7	460	1	The	the	DT
cord-005453-4057qib7	460	2	G	g	NN
cord-005453-4057qib7	460	3	-	-	HYPH
cord-005453-4057qib7	460	4	CSFmobilized	csfmobilize	VBN
cord-005453-4057qib7	460	5	peripheral	peripheral	JJ
cord-005453-4057qib7	460	6	blood	blood	NN
cord-005453-4057qib7	460	7	stem	stem	NN
cord-005453-4057qib7	460	8	cells	cell	NNS
cord-005453-4057qib7	460	9	were	be	VBD
cord-005453-4057qib7	460	10	infused	infuse	VBN
cord-005453-4057qib7	460	11	to	to	IN
cord-005453-4057qib7	460	12	the	the	DT
cord-005453-4057qib7	460	13	recipient	recipient	NN
cord-005453-4057qib7	460	14	at	at	IN
cord-005453-4057qib7	460	15	a	a	DT
cord-005453-4057qib7	460	16	dose	dose	NN
cord-005453-4057qib7	460	17	of	of	IN
cord-005453-4057qib7	460	18	2×10	2×10	CD
cord-005453-4057qib7	460	19	7	7	CD
cord-005453-4057qib7	460	20	CD3	CD3	NNS
cord-005453-4057qib7	460	21	+	+	CC
cord-005453-4057qib7	460	22	cells	cell	NNS
cord-005453-4057qib7	460	23	/	/	SYM
cord-005453-4057qib7	460	24	kg	kg	NNS
cord-005453-4057qib7	460	25	.	.	.
cord-005453-4057qib7	461	1	CsA	CsA	NNP
cord-005453-4057qib7	461	2	was	be	VBD
cord-005453-4057qib7	461	3	given	give	VBN
cord-005453-4057qib7	461	4	at	at	IN
cord-005453-4057qib7	461	5	2	2	CD
cord-005453-4057qib7	461	6	mg	mg	NNP
cord-005453-4057qib7	461	7	/	/	SYM
cord-005453-4057qib7	461	8	kg	kg	NNP
cord-005453-4057qib7	461	9	b.i.d	b.i.d	NNP
cord-005453-4057qib7	461	10	from	from	IN
cord-005453-4057qib7	461	11	day	day	NN
cord-005453-4057qib7	461	12	-3	-3	NNP
cord-005453-4057qib7	461	13	to	to	IN
cord-005453-4057qib7	461	14	day	day	NN
cord-005453-4057qib7	461	15	+90	+90	CD
cord-005453-4057qib7	461	16	(	(	-LRB-
cord-005453-4057qib7	461	17	HID	HID	NNP
cord-005453-4057qib7	461	18	-	-	HYPH
cord-005453-4057qib7	461	19	SCT	SCT	NNP
cord-005453-4057qib7	461	20	)	)	-RRB-
cord-005453-4057qib7	461	21	or	or	CC
cord-005453-4057qib7	461	22	to	to	IN
cord-005453-4057qib7	461	23	day	day	NN
cord-005453-4057qib7	461	24	+60	+60	CD
cord-005453-4057qib7	461	25	(	(	-LRB-
cord-005453-4057qib7	461	26	MSD	MSD	NNP
cord-005453-4057qib7	461	27	-	-	HYPH
cord-005453-4057qib7	461	28	SCT	SCT	NNP
cord-005453-4057qib7	461	29	)	)	-RRB-
cord-005453-4057qib7	461	30	,	,	,
cord-005453-4057qib7	461	31	and	and	CC
cord-005453-4057qib7	461	32	then	then	RB
cord-005453-4057qib7	461	33	tapered	taper	VBD
cord-005453-4057qib7	461	34	at	at	IN
cord-005453-4057qib7	461	35	33	33	CD
cord-005453-4057qib7	461	36	%	%	NN
cord-005453-4057qib7	461	37	per	per	IN
cord-005453-4057qib7	461	38	month	month	NN
cord-005453-4057qib7	461	39	to	to	TO
cord-005453-4057qib7	461	40	be	be	VB
cord-005453-4057qib7	461	41	discontinued	discontinue	VBN
cord-005453-4057qib7	461	42	on	on	IN
cord-005453-4057qib7	461	43	day	day	NN
cord-005453-4057qib7	461	44	+150	+150	NNP
cord-005453-4057qib7	461	45	-	-	HYPH
cord-005453-4057qib7	461	46	180	180	CD
cord-005453-4057qib7	461	47	(	(	-LRB-
cord-005453-4057qib7	461	48	HID	HID	NNP
cord-005453-4057qib7	461	49	-	-	HYPH
cord-005453-4057qib7	461	50	SCT	SCT	NNP
cord-005453-4057qib7	461	51	)	)	-RRB-
cord-005453-4057qib7	461	52	or	or	CC
cord-005453-4057qib7	461	53	on	on	IN
cord-005453-4057qib7	461	54	day	day	NN
cord-005453-4057qib7	461	55	+120	+120	NNP
cord-005453-4057qib7	461	56	-	-	HYPH
cord-005453-4057qib7	461	57	150	150	CD
cord-005453-4057qib7	461	58	(	(	-LRB-
cord-005453-4057qib7	461	59	MSD	MSD	NNP
cord-005453-4057qib7	461	60	-	-	HYPH
cord-005453-4057qib7	461	61	SCT	SCT	NNP
cord-005453-4057qib7	461	62	)	)	-RRB-
cord-005453-4057qib7	461	63	unless	unless	IN
cord-005453-4057qib7	461	64	graft	graft	NN
cord-005453-4057qib7	461	65	-	-	HYPH
cord-005453-4057qib7	461	66	versus	versus	IN
cord-005453-4057qib7	461	67	-	-	HYPH
cord-005453-4057qib7	461	68	host	host	NN
cord-005453-4057qib7	461	69	disease	disease	NN
cord-005453-4057qib7	461	70	(	(	-LRB-
cord-005453-4057qib7	461	71	GVHD	GVHD	NNP
cord-005453-4057qib7	461	72	)	)	-RRB-
cord-005453-4057qib7	461	73	developed	develop	VBD
cord-005453-4057qib7	461	74	.	.	.
cord-005453-4057qib7	462	1	If	if	IN
cord-005453-4057qib7	462	2	the	the	DT
cord-005453-4057qib7	462	3	patients	patient	NNS
cord-005453-4057qib7	462	4	received	receive	VBD
cord-005453-4057qib7	462	5	DLI	DLI	NNP
cord-005453-4057qib7	462	6	before	before	IN
cord-005453-4057qib7	462	7	day	day	NN
cord-005453-4057qib7	462	8	+90	+90	NFP
cord-005453-4057qib7	462	9	(	(	-LRB-
cord-005453-4057qib7	462	10	HID	HID	NNP
cord-005453-4057qib7	462	11	-	-	HYPH
cord-005453-4057qib7	462	12	SCT	SCT	NNP
cord-005453-4057qib7	462	13	)	)	-RRB-
cord-005453-4057qib7	462	14	or	or	CC
cord-005453-4057qib7	462	15	day	day	NN
cord-005453-4057qib7	462	16	+60	+60	NNP
cord-005453-4057qib7	462	17	(	(	-LRB-
cord-005453-4057qib7	462	18	MSD	MSD	NNP
cord-005453-4057qib7	462	19	-	-	HYPH
cord-005453-4057qib7	462	20	SCT	SCT	NNP
cord-005453-4057qib7	462	21	)	)	-RRB-
cord-005453-4057qib7	462	22	,	,	,
cord-005453-4057qib7	462	23	CsA	CsA	NNP
cord-005453-4057qib7	462	24	was	be	VBD
cord-005453-4057qib7	462	25	given	give	VBN
cord-005453-4057qib7	462	26	8	8	CD
cord-005453-4057qib7	462	27	weeks	week	NNS
cord-005453-4057qib7	462	28	after	after	IN
cord-005453-4057qib7	462	29	DLI	DLI	NNP
cord-005453-4057qib7	462	30	in	in	IN
cord-005453-4057qib7	462	31	HID	HID	NNP
cord-005453-4057qib7	462	32	group	group	NN
cord-005453-4057qib7	462	33	and	and	CC
cord-005453-4057qib7	462	34	4	4	CD
cord-005453-4057qib7	462	35	weeks	week	NNS
cord-005453-4057qib7	462	36	in	in	IN
cord-005453-4057qib7	462	37	MSD	MSD	NNP
cord-005453-4057qib7	462	38	group	group	NN
cord-005453-4057qib7	462	39	at	at	IN
cord-005453-4057qib7	462	40	a	a	DT
cord-005453-4057qib7	462	41	though	though	JJ
cord-005453-4057qib7	462	42	concentration	concentration	NN
cord-005453-4057qib7	462	43	of	of	IN
cord-005453-4057qib7	462	44	150	150	CD
cord-005453-4057qib7	462	45	-	-	SYM
cord-005453-4057qib7	462	46	250	250	CD
cord-005453-4057qib7	462	47	ng	ng	NN
cord-005453-4057qib7	462	48	/	/	SYM
cord-005453-4057qib7	462	49	ml	ml	NN
cord-005453-4057qib7	462	50	for	for	IN
cord-005453-4057qib7	462	51	DLIassociated	dliassociated	JJ
cord-005453-4057qib7	462	52	GVHD	GVHD	NNP
cord-005453-4057qib7	462	53	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	462	54	,	,	,
cord-005453-4057qib7	462	55	and	and	CC
cord-005453-4057qib7	462	56	then	then	RB
cord-005453-4057qib7	462	57	tapered	taper	VBD
cord-005453-4057qib7	462	58	and	and	CC
cord-005453-4057qib7	462	59	discontinued	discontinue	VBD
cord-005453-4057qib7	462	60	within	within	IN
cord-005453-4057qib7	462	61	2	2	CD
cord-005453-4057qib7	462	62	weeks	week	NNS
cord-005453-4057qib7	462	63	unless	unless	IN
cord-005453-4057qib7	462	64	GVHD	GVHD	NNP
cord-005453-4057qib7	462	65	developed	develop	VBD
cord-005453-4057qib7	462	66	.	.	.
cord-005453-4057qib7	463	1	If	if	IN
cord-005453-4057qib7	463	2	GVHD	GVHD	NNP
cord-005453-4057qib7	463	3	occurred	occur	VBD
cord-005453-4057qib7	463	4	before	before	IN
cord-005453-4057qib7	463	5	the	the	DT
cord-005453-4057qib7	463	6	scheduled	schedule	VBN
cord-005453-4057qib7	463	7	time	time	NN
cord-005453-4057qib7	463	8	of	of	IN
cord-005453-4057qib7	463	9	prophylactic	prophylactic	JJ
cord-005453-4057qib7	463	10	DLI	DLI	NNP
cord-005453-4057qib7	463	11	,	,	,
cord-005453-4057qib7	463	12	it	-PRON-	PRP
cord-005453-4057qib7	463	13	would	would	MD
cord-005453-4057qib7	463	14	be	be	VB
cord-005453-4057qib7	463	15	delayed	delay	VBN
cord-005453-4057qib7	463	16	for	for	IN
cord-005453-4057qib7	463	17	8	8	CD
cord-005453-4057qib7	463	18	weeks	week	NNS
cord-005453-4057qib7	463	19	when	when	WRB
cord-005453-4057qib7	463	20	GVHD	GVHD	NNP
cord-005453-4057qib7	463	21	was	be	VBD
cord-005453-4057qib7	463	22	well	well	RB
cord-005453-4057qib7	463	23	controlled	control	VBN
cord-005453-4057qib7	463	24	.	.	.
cord-005453-4057qib7	464	1	Results	result	NNS
cord-005453-4057qib7	464	2	:	:	:
cord-005453-4057qib7	465	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	465	2	DLI	DLI	NNP
cord-005453-4057qib7	465	3	was	be	VBD
cord-005453-4057qib7	465	4	administered	administer	VBN
cord-005453-4057qib7	465	5	at	at	IN
cord-005453-4057qib7	465	6	a	a	DT
cord-005453-4057qib7	465	7	median	median	NN
cord-005453-4057qib7	465	8	of	of	IN
cord-005453-4057qib7	465	9	71	71	CD
cord-005453-4057qib7	465	10	(	(	-LRB-
cord-005453-4057qib7	465	11	34	34	CD
cord-005453-4057qib7	465	12	-	-	SYM
cord-005453-4057qib7	465	13	240	240	CD
cord-005453-4057qib7	465	14	)	)	-RRB-
cord-005453-4057qib7	465	15	days	day	NNS
cord-005453-4057qib7	465	16	for	for	IN
cord-005453-4057qib7	465	17	HID	HID	NNP
cord-005453-4057qib7	465	18	-	-	HYPH
cord-005453-4057qib7	465	19	SCT	SCT	NNP
cord-005453-4057qib7	465	20	recipients	recipient	NNS
cord-005453-4057qib7	465	21	and	and	CC
cord-005453-4057qib7	465	22	53	53	CD
cord-005453-4057qib7	465	23	(	(	-LRB-
cord-005453-4057qib7	465	24	35	35	CD
cord-005453-4057qib7	465	25	-	-	SYM
cord-005453-4057qib7	465	26	97	97	CD
cord-005453-4057qib7	465	27	)	)	-RRB-
cord-005453-4057qib7	465	28	days	day	NNS
cord-005453-4057qib7	465	29	for	for	IN
cord-005453-4057qib7	465	30	MSD	MSD	NNP
cord-005453-4057qib7	465	31	-	-	HYPH
cord-005453-4057qib7	465	32	SCT	SCT	NNP
cord-005453-4057qib7	465	33	recipients	recipient	NNS
cord-005453-4057qib7	465	34	(	(	-LRB-
cord-005453-4057qib7	465	35	p=0.008	p=0.008	NNP
cord-005453-4057qib7	465	36	)	)	-RRB-
cord-005453-4057qib7	465	37	,	,	,
cord-005453-4057qib7	465	38	and	and	CC
cord-005453-4057qib7	465	39	both	both	DT
cord-005453-4057qib7	465	40	groups	group	NNS
cord-005453-4057qib7	465	41	displayed	display	VBD
cord-005453-4057qib7	465	42	similar	similar	JJ
cord-005453-4057qib7	465	43	baseline	baseline	JJ
cord-005453-4057qib7	465	44	characteristics	characteristic	NNS
cord-005453-4057qib7	465	45	except	except	IN
cord-005453-4057qib7	465	46	for	for	IN
cord-005453-4057qib7	465	47	donor	donor	NN
cord-005453-4057qib7	465	48	's	's	POS
cord-005453-4057qib7	465	49	gender	gender	NN
cord-005453-4057qib7	465	50	distribution	distribution	NN
cord-005453-4057qib7	465	51	(	(	-LRB-
cord-005453-4057qib7	465	52	Table	table	NN
cord-005453-4057qib7	465	53	1	1	CD
cord-005453-4057qib7	465	54	)	)	-RRB-
cord-005453-4057qib7	465	55	.	.	.
cord-005453-4057qib7	466	1	Grade	grade	NN
cord-005453-4057qib7	466	2	2	2	CD
cord-005453-4057qib7	466	3	-	-	SYM
cord-005453-4057qib7	466	4	4	4	CD
cord-005453-4057qib7	466	5	acute	acute	JJ
cord-005453-4057qib7	466	6	graft	graft	NN
cord-005453-4057qib7	466	7	-	-	HYPH
cord-005453-4057qib7	466	8	versushost	versushost	NN
cord-005453-4057qib7	466	9	disease	disease	NN
cord-005453-4057qib7	466	10	(	(	-LRB-
cord-005453-4057qib7	466	11	GVHD	GVHD	NNP
cord-005453-4057qib7	466	12	)	)	-RRB-
cord-005453-4057qib7	466	13	at	at	IN
cord-005453-4057qib7	466	14	100-day	100-day	CD
cord-005453-4057qib7	466	15	post	post	NNP
cord-005453-4057qib7	466	16	-	-	NNP
cord-005453-4057qib7	466	17	DLI	DLI	NNP
cord-005453-4057qib7	466	18	was	be	VBD
cord-005453-4057qib7	466	19	higher	high	JJR
cord-005453-4057qib7	466	20	in	in	IN
cord-005453-4057qib7	466	21	HID	HID	NNP
cord-005453-4057qib7	466	22	-	-	HYPH
cord-005453-4057qib7	466	23	SCT	SCT	NNP
cord-005453-4057qib7	466	24	group	group	NN
cord-005453-4057qib7	466	25	than	than	IN
cord-005453-4057qib7	466	26	that	that	DT
cord-005453-4057qib7	466	27	in	in	IN
cord-005453-4057qib7	466	28	MSD	MSD	NNP
cord-005453-4057qib7	466	29	-	-	HYPH
cord-005453-4057qib7	466	30	SCT	SCT	NNP
cord-005453-4057qib7	466	31	group	group	NN
cord-005453-4057qib7	466	32	(	(	-LRB-
cord-005453-4057qib7	466	33	59.5	59.5	CD
cord-005453-4057qib7	466	34	%	%	NN
cord-005453-4057qib7	466	35	vs.	vs.	CC
cord-005453-4057qib7	466	36	30.8	30.8	CD
cord-005453-4057qib7	466	37	%	%	NN
cord-005453-4057qib7	466	38	,	,	,
cord-005453-4057qib7	466	39	p=0.05	p=0.05	NNP
cord-005453-4057qib7	466	40	)	)	-RRB-
cord-005453-4057qib7	466	41	.	.	.
cord-005453-4057qib7	467	1	Grade	grade	NN
cord-005453-4057qib7	467	2	3	3	CD
cord-005453-4057qib7	467	3	-	-	SYM
cord-005453-4057qib7	467	4	4	4	CD
cord-005453-4057qib7	467	5	acute	acute	JJ
cord-005453-4057qib7	467	6	GVHD	GVHD	NNP
cord-005453-4057qib7	467	7	(	(	-LRB-
cord-005453-4057qib7	467	8	17.5	17.5	CD
cord-005453-4057qib7	467	9	%	%	NN
cord-005453-4057qib7	467	10	vs.	vs.	CC
cord-005453-4057qib7	467	11	7.7	7.7	CD
cord-005453-4057qib7	467	12	%	%	NN
cord-005453-4057qib7	467	13	)	)	-RRB-
cord-005453-4057qib7	467	14	,	,	,
cord-005453-4057qib7	467	15	1-year	1-year	CD
cord-005453-4057qib7	467	16	chronic	chronic	JJ
cord-005453-4057qib7	467	17	GVHD	GVHD	NNP
cord-005453-4057qib7	467	18	(	(	-LRB-
cord-005453-4057qib7	467	19	36.6	36.6	CD
cord-005453-4057qib7	467	20	%	%	NN
cord-005453-4057qib7	467	21	vs.	vs.	NN
cord-005453-4057qib7	467	22	33.2	33.2	CD
cord-005453-4057qib7	467	23	%	%	NN
cord-005453-4057qib7	467	24	)	)	-RRB-
cord-005453-4057qib7	467	25	and	and	CC
cord-005453-4057qib7	467	26	severe	severe	JJ
cord-005453-4057qib7	467	27	chronic	chronic	JJ
cord-005453-4057qib7	467	28	GVHD	GVHD	NNP
cord-005453-4057qib7	467	29	(	(	-LRB-
cord-005453-4057qib7	467	30	15.3	15.3	CD
cord-005453-4057qib7	467	31	%	%	NN
cord-005453-4057qib7	467	32	vs.	vs.	CC
cord-005453-4057qib7	467	33	27.3	27.3	CD
cord-005453-4057qib7	467	34	%	%	NN
cord-005453-4057qib7	467	35	)	)	-RRB-
cord-005453-4057qib7	467	36	were	be	VBD
cord-005453-4057qib7	467	37	similar	similar	JJ
cord-005453-4057qib7	467	38	between	between	IN
cord-005453-4057qib7	467	39	two	two	CD
cord-005453-4057qib7	467	40	groups	group	NNS
cord-005453-4057qib7	467	41	(	(	-LRB-
cord-005453-4057qib7	467	42	p>0.05	p>0.05	NNP
cord-005453-4057qib7	467	43	)	)	-RRB-
cord-005453-4057qib7	467	44	.	.	.
cord-005453-4057qib7	468	1	One	one	CD
cord-005453-4057qib7	468	2	-	-	HYPH
cord-005453-4057qib7	468	3	year	year	NN
cord-005453-4057qib7	468	4	non	non	JJ
cord-005453-4057qib7	468	5	-	-	JJ
cord-005453-4057qib7	468	6	relapse	relapse	JJ
cord-005453-4057qib7	468	7	mortality	mortality	NN
cord-005453-4057qib7	468	8	was	be	VBD
cord-005453-4057qib7	468	9	higher	high	JJR
cord-005453-4057qib7	468	10	in	in	IN
cord-005453-4057qib7	468	11	HID	HID	NNP
cord-005453-4057qib7	468	12	-	-	HYPH
cord-005453-4057qib7	468	13	SCT	SCT	NNP
cord-005453-4057qib7	468	14	group	group	NN
cord-005453-4057qib7	468	15	than	than	IN
cord-005453-4057qib7	468	16	that	that	DT
cord-005453-4057qib7	468	17	in	in	IN
cord-005453-4057qib7	468	18	MSD	MSD	NNP
cord-005453-4057qib7	468	19	-	-	HYPH
cord-005453-4057qib7	468	20	SCT	SCT	NNP
cord-005453-4057qib7	468	21	group	group	NN
cord-005453-4057qib7	468	22	with	with	IN
cord-005453-4057qib7	468	23	marginal	marginal	JJ
cord-005453-4057qib7	468	24	significance	significance	NN
cord-005453-4057qib7	468	25	(	(	-LRB-
cord-005453-4057qib7	468	26	27.9	27.9	CD
cord-005453-4057qib7	468	27	%	%	NN
cord-005453-4057qib7	468	28	vs.	vs.	IN
cord-005453-4057qib7	468	29	0.0	0.0	CD
cord-005453-4057qib7	468	30	%	%	NN
cord-005453-4057qib7	468	31	,	,	,
cord-005453-4057qib7	468	32	p=0.061	p=0.061	NNP
cord-005453-4057qib7	468	33	)	)	-RRB-
cord-005453-4057qib7	468	34	.	.	.
cord-005453-4057qib7	469	1	One	one	CD
cord-005453-4057qib7	469	2	-	-	HYPH
cord-005453-4057qib7	469	3	year	year	NN
cord-005453-4057qib7	469	4	relapse	relapse	NN
cord-005453-4057qib7	469	5	rate	rate	NN
cord-005453-4057qib7	469	6	was	be	VBD
cord-005453-4057qib7	469	7	similar	similar	JJ
cord-005453-4057qib7	469	8	between	between	IN
cord-005453-4057qib7	469	9	HID	HID	NNP
cord-005453-4057qib7	469	10	-	-	HYPH
cord-005453-4057qib7	469	11	SCT	SCT	NNP
cord-005453-4057qib7	469	12	group	group	NN
cord-005453-4057qib7	469	13	and	and	CC
cord-005453-4057qib7	469	14	MSD	MSD	NNP
cord-005453-4057qib7	469	15	-	-	HYPH
cord-005453-4057qib7	469	16	SCT	SCT	NNP
cord-005453-4057qib7	469	17	group	group	NN
cord-005453-4057qib7	469	18	(	(	-LRB-
cord-005453-4057qib7	469	19	21.6	21.6	CD
cord-005453-4057qib7	469	20	%	%	NN
cord-005453-4057qib7	469	21	vs.	vs.	CC
cord-005453-4057qib7	469	22	36.5	36.5	CD
cord-005453-4057qib7	469	23	%	%	NN
cord-005453-4057qib7	469	24	,	,	,
cord-005453-4057qib7	469	25	p>0.05	p>0.05	NNP
cord-005453-4057qib7	469	26	)	)	-RRB-
cord-005453-4057qib7	469	27	.	.	.
cord-005453-4057qib7	470	1	Estimated	estimate	VBN
cord-005453-4057qib7	470	2	1-year	1-year	CD
cord-005453-4057qib7	470	3	overall	overall	JJ
cord-005453-4057qib7	470	4	survival	survival	NN
cord-005453-4057qib7	470	5	(	(	-LRB-
cord-005453-4057qib7	470	6	OS	OS	NNP
cord-005453-4057qib7	470	7	,	,	,
cord-005453-4057qib7	470	8	55.1	55.1	CD
cord-005453-4057qib7	470	9	%	%	NN
cord-005453-4057qib7	470	10	vs.	vs.	IN
cord-005453-4057qib7	470	11	83.9	83.9	CD
cord-005453-4057qib7	470	12	%	%	NN
cord-005453-4057qib7	470	13	)	)	-RRB-
cord-005453-4057qib7	470	14	and	and	CC
cord-005453-4057qib7	471	1	relapsefree	relapsefree	NNP
cord-005453-4057qib7	471	2	survival	survival	NNP
cord-005453-4057qib7	471	3	(	(	-LRB-
cord-005453-4057qib7	471	4	RFS	RFS	NNP
cord-005453-4057qib7	471	5	,	,	,
cord-005453-4057qib7	471	6	50.1	50.1	CD
cord-005453-4057qib7	471	7	%	%	NN
cord-005453-4057qib7	471	8	vs.	vs.	NN
cord-005453-4057qib7	471	9	74.0	74.0	CD
cord-005453-4057qib7	471	10	%	%	NN
cord-005453-4057qib7	471	11	)	)	-RRB-
cord-005453-4057qib7	471	12	rates	rate	NNS
cord-005453-4057qib7	471	13	were	be	VBD
cord-005453-4057qib7	471	14	both	both	DT
cord-005453-4057qib7	471	15	similar	similar	JJ
cord-005453-4057qib7	471	16	between	between	IN
cord-005453-4057qib7	471	17	HID	HID	NNP
cord-005453-4057qib7	471	18	-	-	HYPH
cord-005453-4057qib7	471	19	SCT	SCT	NNP
cord-005453-4057qib7	471	20	group	group	NN
cord-005453-4057qib7	471	21	and	and	CC
cord-005453-4057qib7	471	22	MSD	MSD	NNP
cord-005453-4057qib7	471	23	-	-	HYPH
cord-005453-4057qib7	471	24	SCT	SCT	NNP
cord-005453-4057qib7	471	25	group	group	NN
cord-005453-4057qib7	471	26	(	(	-LRB-
cord-005453-4057qib7	471	27	p>0.05	p>0.05	NNP
cord-005453-4057qib7	471	28	)	)	-RRB-
cord-005453-4057qib7	471	29	.	.	.
cord-005453-4057qib7	472	1	In	in	IN
cord-005453-4057qib7	472	2	multivariate	multivariate	JJ
cord-005453-4057qib7	472	3	analyses	analysis	NNS
cord-005453-4057qib7	472	4	,	,	,
cord-005453-4057qib7	472	5	non	non	JJ
cord-005453-4057qib7	472	6	-	-	JJ
cord-005453-4057qib7	472	7	remission	remission	JJ
cord-005453-4057qib7	472	8	status	status	NN
cord-005453-4057qib7	473	1	prior	prior	RB
cord-005453-4057qib7	473	2	to	to	IN
cord-005453-4057qib7	473	3	transplant	transplant	NN
cord-005453-4057qib7	473	4	,	,	,
cord-005453-4057qib7	473	5	poor	poor	JJ
cord-005453-4057qib7	473	6	-	-	HYPH
cord-005453-4057qib7	473	7	risk	risk	NN
cord-005453-4057qib7	473	8	gene	gene	NN
cord-005453-4057qib7	473	9	mutations	mutation	NNS
cord-005453-4057qib7	473	10	and	and	CC
cord-005453-4057qib7	473	11	donor	donor	NN
cord-005453-4057qib7	473	12	's	's	POS
cord-005453-4057qib7	473	13	age	age	NN
cord-005453-4057qib7	473	14	≥	≥	CD
cord-005453-4057qib7	473	15	48	48	CD
cord-005453-4057qib7	473	16	years	year	NNS
cord-005453-4057qib7	473	17	predicted	predict	VBD
cord-005453-4057qib7	473	18	a	a	DT
cord-005453-4057qib7	473	19	higher	high	JJR
cord-005453-4057qib7	473	20	risk	risk	NN
cord-005453-4057qib7	473	21	of	of	IN
cord-005453-4057qib7	473	22	relapse	relapse	NN
cord-005453-4057qib7	473	23	after	after	IN
cord-005453-4057qib7	473	24	DLI	DLI	NNP
cord-005453-4057qib7	473	25	.	.	.
cord-005453-4057qib7	474	1	Nonremission	nonremission	NN
cord-005453-4057qib7	474	2	status	status	NN
cord-005453-4057qib7	474	3	prior	prior	RB
cord-005453-4057qib7	474	4	to	to	IN
cord-005453-4057qib7	474	5	transplant	transplant	NN
cord-005453-4057qib7	474	6	predicted	predict	VBD
cord-005453-4057qib7	474	7	inferior	inferior	JJ
cord-005453-4057qib7	474	8	OS	OS	NNP
cord-005453-4057qib7	474	9	and	and	CC
cord-005453-4057qib7	474	10	RFS	RFS	NNP
cord-005453-4057qib7	474	11	.	.	.
cord-005453-4057qib7	475	1	Patient	Patient	NNP
cord-005453-4057qib7	475	2	's	's	POS
cord-005453-4057qib7	475	3	age	age	NN
cord-005453-4057qib7	475	4	≥	≥	CD
cord-005453-4057qib7	475	5	40	40	CD
cord-005453-4057qib7	475	6	years	year	NNS
cord-005453-4057qib7	475	7	also	also	RB
cord-005453-4057qib7	475	8	predicted	predict	VBD
cord-005453-4057qib7	475	9	an	an	DT
cord-005453-4057qib7	475	10	inferior	inferior	JJ
cord-005453-4057qib7	475	11	OS	os	NN
cord-005453-4057qib7	475	12	.	.	.
cord-005453-4057qib7	476	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	476	2	:	:	:
cord-005453-4057qib7	477	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	477	2	DLI	DLI	NNP
cord-005453-4057qib7	477	3	after	after	IN
cord-005453-4057qib7	477	4	HID	HID	NNP
cord-005453-4057qib7	477	5	-	-	HYPH
cord-005453-4057qib7	477	6	SCT	SCT	NNP
cord-005453-4057qib7	477	7	demonstrated	demonstrate	VBD
cord-005453-4057qib7	477	8	similar	similar	JJ
cord-005453-4057qib7	477	9	tolerance	tolerance	NN
cord-005453-4057qib7	477	10	and	and	CC
cord-005453-4057qib7	477	11	efficacy	efficacy	NN
cord-005453-4057qib7	477	12	for	for	IN
cord-005453-4057qib7	477	13	reducing	reduce	VBG
cord-005453-4057qib7	477	14	relapse	relapse	NN
cord-005453-4057qib7	477	15	compared	compare	VBN
cord-005453-4057qib7	477	16	to	to	IN
cord-005453-4057qib7	477	17	that	that	DT
cord-005453-4057qib7	477	18	after	after	IN
cord-005453-4057qib7	477	19	MSD	MSD	NNP
cord-005453-4057qib7	477	20	-	-	HYPH
cord-005453-4057qib7	477	21	SCT	SCT	NNP
cord-005453-4057qib7	477	22	for	for	IN
cord-005453-4057qib7	477	23	very	very	RB
cord-005453-4057qib7	477	24	high	high	JJ
cord-005453-4057qib7	477	25	-	-	HYPH
cord-005453-4057qib7	477	26	risk	risk	NN
cord-005453-4057qib7	477	27	AML	AML	NNP
cord-005453-4057qib7	477	28	.	.	.
cord-005453-4057qib7	478	1	Disclosure	disclosure	NN
cord-005453-4057qib7	478	2	:	:	:
cord-005453-4057qib7	479	1	The	the	DT
cord-005453-4057qib7	479	2	authors	author	NNS
cord-005453-4057qib7	479	3	declare	declare	VBP
cord-005453-4057qib7	479	4	no	no	DT
cord-005453-4057qib7	479	5	conflict	conflict	NN
cord-005453-4057qib7	479	6	of	of	IN
cord-005453-4057qib7	479	7	interest	interest	NN
cord-005453-4057qib7	479	8	.	.	.
cord-005453-4057qib7	480	1	Prognostic	prognostic	JJ
cord-005453-4057qib7	480	2	impact	impact	NN
cord-005453-4057qib7	480	3	of	of	IN
cord-005453-4057qib7	480	4	pre	pre	JJ
cord-005453-4057qib7	480	5	-	-	JJ
cord-005453-4057qib7	480	6	transplant	transplant	JJ
cord-005453-4057qib7	480	7	TIM3	TIM3	NNP
cord-005453-4057qib7	480	8	levels	level	NNS
cord-005453-4057qib7	480	9	on	on	IN
cord-005453-4057qib7	480	10	transplant	transplant	NN
cord-005453-4057qib7	480	11	outcome	outcome	NN
cord-005453-4057qib7	480	12	in	in	IN
cord-005453-4057qib7	480	13	acute	acute	JJ
cord-005453-4057qib7	480	14	leukemia	leukemia	NN
cord-005453-4057qib7	480	15	patients	patient	NNS
cord-005453-4057qib7	481	1	Background	background	NN
cord-005453-4057qib7	481	2	:	:	:
cord-005453-4057qib7	481	3	T	t	NN
cord-005453-4057qib7	481	4	cell	cell	NN
cord-005453-4057qib7	481	5	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	481	6	and	and	CC
cord-005453-4057qib7	481	7	mucin	mucin	NN
cord-005453-4057qib7	481	8	domaincontaining	domaincontaining	NN
cord-005453-4057qib7	481	9	protein-3	protein-3	NNP
cord-005453-4057qib7	482	1	(	(	-LRB-
cord-005453-4057qib7	482	2	TIM3	TIM3	NNP
cord-005453-4057qib7	482	3	)	)	-RRB-
cord-005453-4057qib7	482	4	,	,	,
cord-005453-4057qib7	482	5	a	a	DT
cord-005453-4057qib7	482	6	negative	negative	JJ
cord-005453-4057qib7	482	7	regulator	regulator	NN
cord-005453-4057qib7	482	8	of	of	IN
cord-005453-4057qib7	482	9	T	T	NNP
cord-005453-4057qib7	482	10	cells	cell	NNS
cord-005453-4057qib7	482	11	,	,	,
cord-005453-4057qib7	482	12	is	be	VBZ
cord-005453-4057qib7	482	13	expressed	express	VBN
cord-005453-4057qib7	482	14	on	on	IN
cord-005453-4057qib7	482	15	a	a	DT
cord-005453-4057qib7	482	16	variety	variety	NN
cord-005453-4057qib7	482	17	of	of	IN
cord-005453-4057qib7	482	18	tumors	tumor	NNS
cord-005453-4057qib7	482	19	including	include	VBG
cord-005453-4057qib7	482	20	hematological	hematological	JJ
cord-005453-4057qib7	482	21	malignancies	malignancy	NNS
cord-005453-4057qib7	482	22	like	like	IN
cord-005453-4057qib7	482	23	acute	acute	JJ
cord-005453-4057qib7	482	24	myeloid	myeloid	NN
cord-005453-4057qib7	482	25	leukemia	leukemia	NN
cord-005453-4057qib7	482	26	(	(	-LRB-
cord-005453-4057qib7	482	27	AML	AML	NNP
cord-005453-4057qib7	482	28	)	)	-RRB-
cord-005453-4057qib7	482	29	and	and	CC
cord-005453-4057qib7	482	30	some	some	DT
cord-005453-4057qib7	482	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	482	32	types	type	NNS
cord-005453-4057qib7	482	33	in	in	IN
cord-005453-4057qib7	482	34	which	which	WDT
cord-005453-4057qib7	482	35	it	-PRON-	PRP
cord-005453-4057qib7	482	36	was	be	VBD
cord-005453-4057qib7	482	37	shown	show	VBN
cord-005453-4057qib7	482	38	to	to	TO
cord-005453-4057qib7	482	39	be	be	VB
cord-005453-4057qib7	482	40	associated	associate	VBN
cord-005453-4057qib7	482	41	with	with	IN
cord-005453-4057qib7	482	42	an	an	DT
cord-005453-4057qib7	482	43	adverse	adverse	JJ
cord-005453-4057qib7	482	44	prognosis	prognosis	NN
cord-005453-4057qib7	482	45	.	.	.
cord-005453-4057qib7	483	1	The	the	DT
cord-005453-4057qib7	483	2	aim	aim	NN
cord-005453-4057qib7	483	3	of	of	IN
cord-005453-4057qib7	483	4	this	this	DT
cord-005453-4057qib7	483	5	study	study	NN
cord-005453-4057qib7	483	6	is	be	VBZ
cord-005453-4057qib7	483	7	to	to	TO
cord-005453-4057qib7	483	8	identify	identify	VB
cord-005453-4057qib7	483	9	the	the	DT
cord-005453-4057qib7	483	10	prognostic	prognostic	JJ
cord-005453-4057qib7	483	11	impact	impact	NN
cord-005453-4057qib7	483	12	of	of	IN
cord-005453-4057qib7	483	13	pre	pre	JJ
cord-005453-4057qib7	483	14	-	-	JJ
cord-005453-4057qib7	483	15	transplant	transplant	JJ
cord-005453-4057qib7	483	16	TIM3	TIM3	NNP
cord-005453-4057qib7	483	17	levels	level	NNS
cord-005453-4057qib7	483	18	on	on	IN
cord-005453-4057qib7	483	19	early	early	JJ
cord-005453-4057qib7	483	20	and	and	CC
cord-005453-4057qib7	483	21	late	late	JJ
cord-005453-4057qib7	483	22	transplant	transplant	NN
cord-005453-4057qib7	483	23	related	relate	VBN
cord-005453-4057qib7	483	24	complications	complication	NNS
cord-005453-4057qib7	483	25	as	as	RB
cord-005453-4057qib7	483	26	well	well	RB
cord-005453-4057qib7	483	27	as	as	IN
cord-005453-4057qib7	483	28	post	post	JJ
cord-005453-4057qib7	483	29	-	-	JJ
cord-005453-4057qib7	483	30	transplant	transplant	JJ
cord-005453-4057qib7	483	31	relapse	relapse	NN
cord-005453-4057qib7	483	32	and	and	CC
cord-005453-4057qib7	483	33	survival	survival	NN
cord-005453-4057qib7	483	34	Methods	method	NNS
cord-005453-4057qib7	483	35	:	:	:
cord-005453-4057qib7	483	36	A	a	DT
cord-005453-4057qib7	483	37	total	total	NN
cord-005453-4057qib7	483	38	of	of	IN
cord-005453-4057qib7	483	39	177	177	CD
cord-005453-4057qib7	483	40	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	483	41	stem	stem	NN
cord-005453-4057qib7	483	42	cell	cell	NN
cord-005453-4057qib7	483	43	transplantation	transplantation	NN
cord-005453-4057qib7	483	44	(	(	-LRB-
cord-005453-4057qib7	483	45	HSCT	HSCT	NNP
cord-005453-4057qib7	483	46	)	)	-RRB-
cord-005453-4057qib7	483	47	recipients	recipient	NNS
cord-005453-4057qib7	483	48	with	with	IN
cord-005453-4057qib7	483	49	an	an	DT
cord-005453-4057qib7	483	50	initial	initial	JJ
cord-005453-4057qib7	483	51	diagnosis	diagnosis	NN
cord-005453-4057qib7	483	52	of	of	IN
cord-005453-4057qib7	483	53	acute	acute	JJ
cord-005453-4057qib7	483	54	leukemia	leukemia	NN
cord-005453-4057qib7	483	55	[	[	-LRB-
cord-005453-4057qib7	483	56	median	median	NN
cord-005453-4057qib7	483	57	age	age	NN
cord-005453-4057qib7	483	58	:	:	:
cord-005453-4057qib7	483	59	36(16	36(16	CD
cord-005453-4057qib7	483	60	-	-	SYM
cord-005453-4057qib7	483	61	66	66	CD
cord-005453-4057qib7	483	62	)	)	-RRB-
cord-005453-4057qib7	483	63	years	year	NNS
cord-005453-4057qib7	483	64	;	;	,
cord-005453-4057qib7	483	65	male/	male/	CD
cord-005453-4057qib7	483	66	female	female	NN
cord-005453-4057qib7	483	67	:	:	:
cord-005453-4057qib7	483	68	111/66	111/66	CD
cord-005453-4057qib7	483	69	]	]	-RRB-
cord-005453-4057qib7	483	70	were	be	VBD
cord-005453-4057qib7	483	71	included	include	VBN
cord-005453-4057qib7	483	72	in	in	IN
cord-005453-4057qib7	483	73	the	the	DT
cord-005453-4057qib7	483	74	study	study	NN
cord-005453-4057qib7	483	75	.	.	.
cord-005453-4057qib7	484	1	AML	AML	NNP
cord-005453-4057qib7	484	2	was	be	VBD
cord-005453-4057qib7	484	3	the	the	DT
cord-005453-4057qib7	484	4	initial	initial	JJ
cord-005453-4057qib7	484	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	484	6	in	in	IN
cord-005453-4057qib7	484	7	99	99	CD
cord-005453-4057qib7	484	8	patients	patient	NNS
cord-005453-4057qib7	484	9	(	(	-LRB-
cord-005453-4057qib7	484	10	55.9	55.9	CD
cord-005453-4057qib7	484	11	%	%	NN
cord-005453-4057qib7	484	12	)	)	-RRB-
cord-005453-4057qib7	484	13	,	,	,
cord-005453-4057qib7	484	14	acute	acute	JJ
cord-005453-4057qib7	484	15	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	484	16	leukemia	leukemia	NN
cord-005453-4057qib7	484	17	(	(	-LRB-
cord-005453-4057qib7	484	18	ALL	all	DT
cord-005453-4057qib7	484	19	)	)	-RRB-
cord-005453-4057qib7	484	20	in	in	IN
cord-005453-4057qib7	484	21	74	74	CD
cord-005453-4057qib7	484	22	patients	patient	NNS
cord-005453-4057qib7	484	23	(	(	-LRB-
cord-005453-4057qib7	484	24	41.8	41.8	CD
cord-005453-4057qib7	484	25	%	%	NN
cord-005453-4057qib7	484	26	)	)	-RRB-
cord-005453-4057qib7	484	27	,	,	,
cord-005453-4057qib7	484	28	mixed	mixed	JJ
cord-005453-4057qib7	484	29	phenotype	phenotype	NN
cord-005453-4057qib7	484	30	acute	acute	JJ
cord-005453-4057qib7	484	31	leukemia	leukemia	NN
cord-005453-4057qib7	484	32	in	in	IN
cord-005453-4057qib7	484	33	3	3	CD
cord-005453-4057qib7	484	34	patients	patient	NNS
cord-005453-4057qib7	484	35	(	(	-LRB-
cord-005453-4057qib7	484	36	1.7	1.7	CD
cord-005453-4057qib7	484	37	%	%	NN
cord-005453-4057qib7	484	38	)	)	-RRB-
cord-005453-4057qib7	484	39	and	and	CC
cord-005453-4057qib7	484	40	blastic	blastic	JJ
cord-005453-4057qib7	484	41	plasmacytoid	plasmacytoid	NNP
cord-005453-4057qib7	484	42	dendritic	dendritic	JJ
cord-005453-4057qib7	484	43	cell	cell	NN
cord-005453-4057qib7	484	44	neoplasm	neoplasm	NN
cord-005453-4057qib7	484	45	in	in	IN
cord-005453-4057qib7	484	46	1	1	CD
cord-005453-4057qib7	484	47	patient	patient	NN
cord-005453-4057qib7	484	48	(	(	-LRB-
cord-005453-4057qib7	484	49	0.6	0.6	CD
cord-005453-4057qib7	484	50	%	%	NN
cord-005453-4057qib7	484	51	)	)	-RRB-
cord-005453-4057qib7	484	52	.	.	.
cord-005453-4057qib7	485	1	Soluble	soluble	JJ
cord-005453-4057qib7	485	2	TIM-3	tim-3	JJ
cord-005453-4057qib7	485	3	levels	level	NNS
cord-005453-4057qib7	485	4	in	in	IN
cord-005453-4057qib7	485	5	pre	pre	JJ
cord-005453-4057qib7	485	6	-	-	JJ
cord-005453-4057qib7	485	7	transplant	transplant	JJ
cord-005453-4057qib7	485	8	serum	serum	NN
cord-005453-4057qib7	485	9	samples	sample	NNS
cord-005453-4057qib7	485	10	were	be	VBD
cord-005453-4057qib7	485	11	measured	measure	VBN
cord-005453-4057qib7	485	12	with	with	IN
cord-005453-4057qib7	485	13	Enzyme	Enzyme	NNP
cord-005453-4057qib7	485	14	Linked	link	VBN
cord-005453-4057qib7	485	15	Immunosorbent	Immunosorbent	NNP
cord-005453-4057qib7	485	16	Assay	Assay	NNP
cord-005453-4057qib7	485	17	(	(	-LRB-
cord-005453-4057qib7	485	18	ELISA	ELISA	NNP
cord-005453-4057qib7	485	19	)	)	-RRB-
cord-005453-4057qib7	485	20	.	.	.
cord-005453-4057qib7	486	1	Results	result	NNS
cord-005453-4057qib7	486	2	:	:	:
cord-005453-4057qib7	487	1	Median	median	JJ
cord-005453-4057qib7	487	2	pre	pre	JJ
cord-005453-4057qib7	487	3	-	-	JJ
cord-005453-4057qib7	487	4	transplant	transplant	JJ
cord-005453-4057qib7	487	5	TIM3	TIM3	NNP
cord-005453-4057qib7	487	6	level	level	NN
cord-005453-4057qib7	487	7	was	be	VBD
cord-005453-4057qib7	487	8	955.6	955.6	CD
cord-005453-4057qib7	487	9	(	(	-LRB-
cord-005453-4057qib7	487	10	65.8	65.8	CD
cord-005453-4057qib7	487	11	-	-	HYPH
cord-005453-4057qib7	487	12	3784.4	3784.4	CD
cord-005453-4057qib7	487	13	)	)	-RRB-
cord-005453-4057qib7	488	1	pg	pg	NNP
cord-005453-4057qib7	488	2	/	/	SYM
cord-005453-4057qib7	488	3	mL	ml	NN
cord-005453-4057qib7	488	4	in	in	IN
cord-005453-4057qib7	488	5	the	the	DT
cord-005453-4057qib7	488	6	whole	whole	JJ
cord-005453-4057qib7	488	7	cohort	cohort	NN
cord-005453-4057qib7	488	8	.	.	.
cord-005453-4057qib7	489	1	Pre	pre	JJ
cord-005453-4057qib7	489	2	-	-	JJ
cord-005453-4057qib7	489	3	transplant	transplant	NN
cord-005453-4057qib7	489	4	TIM3	TIM3	NNP
cord-005453-4057qib7	489	5	levels	level	NNS
cord-005453-4057qib7	489	6	were	be	VBD
cord-005453-4057qib7	489	7	significantly	significantly	RB
cord-005453-4057qib7	489	8	higher	high	JJR
cord-005453-4057qib7	489	9	in	in	IN
cord-005453-4057qib7	489	10	AML	AML	NNP
cord-005453-4057qib7	489	11	patients	patient	NNS
cord-005453-4057qib7	489	12	when	when	WRB
cord-005453-4057qib7	489	13	compared	compare	VBN
cord-005453-4057qib7	489	14	to	to	IN
cord-005453-4057qib7	489	15	ALL	all	DT
cord-005453-4057qib7	489	16	[	[	-LRB-
cord-005453-4057qib7	489	17	1063.7(409.5	1063.7(409.5	CD
cord-005453-4057qib7	489	18	-	-	HYPH
cord-005453-4057qib7	489	19	3784.4	3784.4	CD
cord-005453-4057qib7	489	20	)	)	-RRB-
cord-005453-4057qib7	489	21	vs	vs	IN
cord-005453-4057qib7	489	22	831.4	831.4	CD
cord-005453-4057qib7	489	23	(	(	-LRB-
cord-005453-4057qib7	489	24	65.8	65.8	CD
cord-005453-4057qib7	489	25	-	-	HYPH
cord-005453-4057qib7	489	26	3254.4	3254.4	CD
cord-005453-4057qib7	489	27	)	)	-RRB-
cord-005453-4057qib7	489	28	;	;	:
cord-005453-4057qib7	489	29	p=0.01	p=0.01	NNP
cord-005453-4057qib7	489	30	]	]	-RRB-
cord-005453-4057qib7	489	31	.	.	.
cord-005453-4057qib7	490	1	TIM3	tim3	JJ
cord-005453-4057qib7	490	2	levels	level	NNS
cord-005453-4057qib7	490	3	were	be	VBD
cord-005453-4057qib7	490	4	significantly	significantly	RB
cord-005453-4057qib7	490	5	lower	low	JJR
cord-005453-4057qib7	490	6	in	in	IN
cord-005453-4057qib7	490	7	patients	patient	NNS
cord-005453-4057qib7	490	8	with	with	IN
cord-005453-4057qib7	490	9	abnormal	abnormal	JJ
cord-005453-4057qib7	490	10	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	490	11	when	when	WRB
cord-005453-4057qib7	490	12	compared	compare	VBN
cord-005453-4057qib7	490	13	to	to	IN
cord-005453-4057qib7	490	14	normal	normal	JJ
cord-005453-4057qib7	490	15	karyotype	karyotype	NN
cord-005453-4057qib7	490	16	(	(	-LRB-
cord-005453-4057qib7	490	17	p=0.017	p=0.017	NNS
cord-005453-4057qib7	490	18	)	)	-RRB-
cord-005453-4057qib7	490	19	.	.	.
cord-005453-4057qib7	491	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	491	2	abnormalities	abnormality	NNS
cord-005453-4057qib7	491	3	,	,	,
cord-005453-4057qib7	491	4	including	include	VBG
cord-005453-4057qib7	491	5	mainly	mainly	RB
cord-005453-4057qib7	491	6	a	a	DT
cord-005453-4057qib7	491	7	complex	complex	JJ
cord-005453-4057qib7	491	8	karyotype	karyotype	NN
cord-005453-4057qib7	491	9	or	or	CC
cord-005453-4057qib7	491	10	chromosome	chromosome	NN
cord-005453-4057qib7	491	11	8	8	CD
cord-005453-4057qib7	491	12	abnormalities	abnormality	NNS
cord-005453-4057qib7	491	13	,	,	,
cord-005453-4057qib7	491	14	were	be	VBD
cord-005453-4057qib7	491	15	more	more	RBR
cord-005453-4057qib7	491	16	frequent	frequent	JJ
cord-005453-4057qib7	491	17	in	in	IN
cord-005453-4057qib7	491	18	patients	patient	NNS
cord-005453-4057qib7	491	19	with	with	IN
cord-005453-4057qib7	491	20	low	low	JJ
cord-005453-4057qib7	491	21	TIM3	tim3	JJ
cord-005453-4057qib7	491	22	levels	level	NNS
cord-005453-4057qib7	491	23	(	(	-LRB-
cord-005453-4057qib7	491	24	p=0.053	p=0.053	NN
cord-005453-4057qib7	491	25	)	)	-RRB-
cord-005453-4057qib7	491	26	.	.	.
cord-005453-4057qib7	492	1	Pre	pre	JJ
cord-005453-4057qib7	492	2	-	-	JJ
cord-005453-4057qib7	492	3	transplant	transplant	NN
cord-005453-4057qib7	492	4	TIM3	TIM3	NNP
cord-005453-4057qib7	492	5	levels	level	NNS
cord-005453-4057qib7	492	6	were	be	VBD
cord-005453-4057qib7	492	7	significantly	significantly	RB
cord-005453-4057qib7	492	8	higher	high	JJR
cord-005453-4057qib7	492	9	in	in	IN
cord-005453-4057qib7	492	10	patients	patient	NNS
cord-005453-4057qib7	492	11	who	who	WP
cord-005453-4057qib7	492	12	developed	develop	VBD
cord-005453-4057qib7	492	13	post	post	JJ
cord-005453-4057qib7	492	14	-	-	JJ
cord-005453-4057qib7	492	15	transplant	transplant	JJ
cord-005453-4057qib7	492	16	viral	viral	JJ
cord-005453-4057qib7	492	17	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	492	18	cystitis	cystitis	NN
cord-005453-4057qib7	492	19	(	(	-LRB-
cord-005453-4057qib7	492	20	p=0.034	p=0.034	NNP
cord-005453-4057qib7	492	21	)	)	-RRB-
cord-005453-4057qib7	492	22	.	.	.
cord-005453-4057qib7	493	1	A	a	DT
cord-005453-4057qib7	493	2	positive	positive	JJ
cord-005453-4057qib7	493	3	correlation	correlation	NN
cord-005453-4057qib7	493	4	was	be	VBD
cord-005453-4057qib7	493	5	demonstrated	demonstrate	VBN
cord-005453-4057qib7	493	6	between	between	IN
cord-005453-4057qib7	493	7	TIM3	TIM3	NNP
cord-005453-4057qib7	493	8	levels	level	NNS
cord-005453-4057qib7	493	9	and	and	CC
cord-005453-4057qib7	493	10	acute	acute	JJ
cord-005453-4057qib7	493	11	graft	graft	NN
cord-005453-4057qib7	493	12	versus	versus	IN
cord-005453-4057qib7	493	13	host	host	NN
cord-005453-4057qib7	493	14	disease	disease	NN
cord-005453-4057qib7	493	15	(	(	-LRB-
cord-005453-4057qib7	493	16	GvHD	GvHD	NNP
cord-005453-4057qib7	493	17	)	)	-RRB-
cord-005453-4057qib7	493	18	grade	grade	NN
cord-005453-4057qib7	493	19	(	(	-LRB-
cord-005453-4057qib7	493	20	p=0.013	p=0.013	NN
cord-005453-4057qib7	493	21	;	;	:
cord-005453-4057qib7	493	22	r=0.299	r=0.299	ADD
cord-005453-4057qib7	493	23	)	)	-RRB-
cord-005453-4057qib7	493	24	.	.	.
cord-005453-4057qib7	494	1	At	at	IN
cord-005453-4057qib7	494	2	a	a	DT
cord-005453-4057qib7	494	3	median	median	JJ
cord-005453-4057qib7	494	4	follow	follow	NN
cord-005453-4057qib7	494	5	-	-	HYPH
cord-005453-4057qib7	494	6	up	up	NN
cord-005453-4057qib7	494	7	of	of	IN
cord-005453-4057qib7	494	8	14.6	14.6	CD
cord-005453-4057qib7	494	9	(	(	-LRB-
cord-005453-4057qib7	494	10	0.2	0.2	CD
cord-005453-4057qib7	494	11	-	-	SYM
cord-005453-4057qib7	494	12	160.9	160.9	CD
cord-005453-4057qib7	494	13	)	)	-RRB-
cord-005453-4057qib7	494	14	months	month	NNS
cord-005453-4057qib7	494	15	,	,	,
cord-005453-4057qib7	494	16	overall	overall	JJ
cord-005453-4057qib7	494	17	survival	survival	NN
cord-005453-4057qib7	494	18	(	(	-LRB-
cord-005453-4057qib7	494	19	OS	OS	NNP
cord-005453-4057qib7	494	20	)	)	-RRB-
cord-005453-4057qib7	494	21	was	be	VBD
cord-005453-4057qib7	494	22	found	find	VBN
cord-005453-4057qib7	494	23	to	to	TO
cord-005453-4057qib7	494	24	be	be	VB
cord-005453-4057qib7	494	25	better	well	JJR
cord-005453-4057qib7	494	26	in	in	IN
cord-005453-4057qib7	494	27	low	low	JJ
cord-005453-4057qib7	494	28	-	-	HYPH
cord-005453-4057qib7	494	29	TIM3	tim3	JJ
cord-005453-4057qib7	494	30	group	group	NN
cord-005453-4057qib7	494	31	when	when	WRB
cord-005453-4057qib7	494	32	compared	compare	VBN
cord-005453-4057qib7	494	33	to	to	IN
cord-005453-4057qib7	494	34	high	high	JJ
cord-005453-4057qib7	494	35	-	-	HYPH
cord-005453-4057qib7	494	36	TIM3	tim3	JJ
cord-005453-4057qib7	494	37	group	group	NN
cord-005453-4057qib7	494	38	,	,	,
cord-005453-4057qib7	494	39	without	without	IN
cord-005453-4057qib7	494	40	statistical	statistical	JJ
cord-005453-4057qib7	494	41	significance	significance	NN
cord-005453-4057qib7	494	42	(	(	-LRB-
cord-005453-4057qib7	494	43	%	%	NN
cord-005453-4057qib7	494	44	35.2	35.2	CD
cord-005453-4057qib7	494	45	vs	vs	IN
cord-005453-4057qib7	494	46	%	%	NN
cord-005453-4057qib7	494	47	20.4	20.4	CD
cord-005453-4057qib7	494	48	;	;	:
cord-005453-4057qib7	494	49	p>0.05	p>0.05	NNP
cord-005453-4057qib7	494	50	)	)	-RRB-
cord-005453-4057qib7	495	1	(	(	-LRB-
cord-005453-4057qib7	495	2	Figure	figure	NN
cord-005453-4057qib7	495	3	1	1	CD
cord-005453-4057qib7	495	4	)	)	-RRB-
cord-005453-4057qib7	495	5	.	.	.
cord-005453-4057qib7	496	1	Probability	probability	NN
cord-005453-4057qib7	496	2	of	of	IN
cord-005453-4057qib7	496	3	OS	OS	NNP
cord-005453-4057qib7	496	4	was	be	VBD
cord-005453-4057qib7	496	5	relatively	relatively	RB
cord-005453-4057qib7	496	6	better	well	JJR
cord-005453-4057qib7	496	7	in	in	IN
cord-005453-4057qib7	496	8	both	both	CC
cord-005453-4057qib7	496	9	AML	AML	NNP
cord-005453-4057qib7	496	10	(	(	-LRB-
cord-005453-4057qib7	496	11	42.6	42.6	CD
cord-005453-4057qib7	496	12	%	%	NN
cord-005453-4057qib7	496	13	vs	vs	IN
cord-005453-4057qib7	496	14	26.7	26.7	CD
cord-005453-4057qib7	496	15	%	%	NN
cord-005453-4057qib7	496	16	;	;	:
cord-005453-4057qib7	496	17	p>0.05	p>0.05	NNP
cord-005453-4057qib7	496	18	)	)	-RRB-
cord-005453-4057qib7	496	19	and	and	CC
cord-005453-4057qib7	496	20	ALL	all	DT
cord-005453-4057qib7	496	21	patients	patient	NNS
cord-005453-4057qib7	496	22	(	(	-LRB-
cord-005453-4057qib7	496	23	29.5	29.5	CD
cord-005453-4057qib7	496	24	%	%	NN
cord-005453-4057qib7	496	25	vs	vs	IN
cord-005453-4057qib7	496	26	19	19	CD
cord-005453-4057qib7	496	27	%	%	NN
cord-005453-4057qib7	496	28	;	;	:
cord-005453-4057qib7	496	29	p>0.05	p>0.05	NNP
cord-005453-4057qib7	496	30	)	)	-RRB-
cord-005453-4057qib7	496	31	representing	represent	VBG
cord-005453-4057qib7	496	32	low	low	JJ
cord-005453-4057qib7	496	33	pretransplant	pretransplant	NN
cord-005453-4057qib7	496	34	TIM3	TIM3	NNP
cord-005453-4057qib7	496	35	levels	level	NNS
cord-005453-4057qib7	496	36	in	in	IN
cord-005453-4057qib7	496	37	the	the	DT
cord-005453-4057qib7	496	38	subgroup	subgroup	NN
cord-005453-4057qib7	496	39	analysis	analysis	NN
cord-005453-4057qib7	496	40	Conclusions	conclusion	NNS
cord-005453-4057qib7	496	41	:	:	:
cord-005453-4057qib7	497	1	In	in	IN
cord-005453-4057qib7	497	2	this	this	DT
cord-005453-4057qib7	497	3	study	study	NN
cord-005453-4057qib7	497	4	,	,	,
cord-005453-4057qib7	497	5	elevated	elevated	JJ
cord-005453-4057qib7	497	6	levels	level	NNS
cord-005453-4057qib7	497	7	of	of	IN
cord-005453-4057qib7	497	8	pretransplant	pretransplant	JJ
cord-005453-4057qib7	497	9	TIM3	TIM3	NNP
cord-005453-4057qib7	497	10	levels	level	NNS
cord-005453-4057qib7	497	11	in	in	IN
cord-005453-4057qib7	497	12	AML	AML	NNP
cord-005453-4057qib7	497	13	patients	patient	NNS
cord-005453-4057qib7	497	14	were	be	VBD
cord-005453-4057qib7	497	15	compatible	compatible	JJ
cord-005453-4057qib7	497	16	with	with	IN
cord-005453-4057qib7	497	17	the	the	DT
cord-005453-4057qib7	497	18	previous	previous	JJ
cord-005453-4057qib7	497	19	reports	report	NNS
cord-005453-4057qib7	497	20	which	which	WDT
cord-005453-4057qib7	497	21	had	have	VBD
cord-005453-4057qib7	497	22	underlined	underline	VBN
cord-005453-4057qib7	497	23	an	an	DT
cord-005453-4057qib7	497	24	increased	increase	VBN
cord-005453-4057qib7	497	25	TIM3	TIM3	NNP
cord-005453-4057qib7	497	26	expression	expression	NN
cord-005453-4057qib7	497	27	on	on	IN
cord-005453-4057qib7	497	28	AML	AML	NNP
cord-005453-4057qib7	497	29	stem	stem	NN
cord-005453-4057qib7	497	30	cells	cell	NNS
cord-005453-4057qib7	497	31	.	.	.
cord-005453-4057qib7	498	1	The	the	DT
cord-005453-4057qib7	498	2	possible	possible	JJ
cord-005453-4057qib7	498	3	association	association	NN
cord-005453-4057qib7	498	4	of	of	IN
cord-005453-4057qib7	498	5	TIM3	TIM3	NNP
cord-005453-4057qib7	498	6	expression	expression	NN
cord-005453-4057qib7	498	7	with	with	IN
cord-005453-4057qib7	498	8	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	498	9	features	feature	NNS
cord-005453-4057qib7	498	10	should	should	MD
cord-005453-4057qib7	498	11	be	be	VB
cord-005453-4057qib7	498	12	confirmed	confirm	VBN
cord-005453-4057qib7	498	13	with	with	IN
cord-005453-4057qib7	498	14	further	further	JJ
cord-005453-4057qib7	498	15	studies	study	NNS
cord-005453-4057qib7	498	16	as	as	IN
cord-005453-4057qib7	498	17	there	there	EX
cord-005453-4057qib7	498	18	is	be	VBZ
cord-005453-4057qib7	498	19	no	no	DT
cord-005453-4057qib7	498	20	adequate	adequate	JJ
cord-005453-4057qib7	498	21	data	datum	NNS
cord-005453-4057qib7	498	22	except	except	IN
cord-005453-4057qib7	498	23	its	-PRON-	PRP$
cord-005453-4057qib7	498	24	relationship	relationship	NN
cord-005453-4057qib7	498	25	with	with	IN
cord-005453-4057qib7	498	26	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	498	27	mutational	mutational	JJ
cord-005453-4057qib7	498	28	status	status	NN
cord-005453-4057qib7	498	29	.	.	.
cord-005453-4057qib7	499	1	TIM-3	tim-3	JJ
cord-005453-4057qib7	499	2	is	be	VBZ
cord-005453-4057qib7	499	3	also	also	RB
cord-005453-4057qib7	499	4	expressed	express	VBN
cord-005453-4057qib7	499	5	on	on	IN
cord-005453-4057qib7	499	6	exhausted	exhaust	VBN
cord-005453-4057qib7	499	7	T	t	NN
cord-005453-4057qib7	499	8	cells	cell	NNS
cord-005453-4057qib7	499	9	in	in	IN
cord-005453-4057qib7	499	10	patients	patient	NNS
cord-005453-4057qib7	499	11	with	with	IN
cord-005453-4057qib7	499	12	viral	viral	JJ
cord-005453-4057qib7	499	13	infections	infection	NNS
cord-005453-4057qib7	499	14	,	,	,
cord-005453-4057qib7	499	15	including	include	VBG
cord-005453-4057qib7	499	16	human	human	JJ
cord-005453-4057qib7	499	17	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	499	18	virus	virus	NN
cord-005453-4057qib7	499	19	,	,	,
cord-005453-4057qib7	499	20	hepatitis	hepatitis	NNP
cord-005453-4057qib7	499	21	B	B	NNP
cord-005453-4057qib7	499	22	and	and	CC
cord-005453-4057qib7	499	23	hepatitis	hepatitis	NN
cord-005453-4057qib7	499	24	C	C	NNP
cord-005453-4057qib7	499	25	virus	virus	NN
cord-005453-4057qib7	499	26	.	.	.
cord-005453-4057qib7	500	1	It	-PRON-	PRP
cord-005453-4057qib7	500	2	plays	play	VBZ
cord-005453-4057qib7	500	3	an	an	DT
cord-005453-4057qib7	500	4	essential	essential	JJ
cord-005453-4057qib7	500	5	role	role	NN
cord-005453-4057qib7	500	6	in	in	IN
cord-005453-4057qib7	500	7	the	the	DT
cord-005453-4057qib7	500	8	regulation	regulation	NN
cord-005453-4057qib7	500	9	of	of	IN
cord-005453-4057qib7	500	10	antiviral	antiviral	JJ
cord-005453-4057qib7	500	11	and	and	CC
cord-005453-4057qib7	500	12	antitumor	antitumor	JJ
cord-005453-4057qib7	500	13	immune	immune	JJ
cord-005453-4057qib7	500	14	responses	response	NNS
cord-005453-4057qib7	500	15	which	which	WDT
cord-005453-4057qib7	500	16	may	may	MD
cord-005453-4057qib7	500	17	be	be	VB
cord-005453-4057qib7	500	18	an	an	DT
cord-005453-4057qib7	500	19	explanation	explanation	NN
cord-005453-4057qib7	500	20	for	for	IN
cord-005453-4057qib7	500	21	the	the	DT
cord-005453-4057qib7	500	22	increased	increase	VBN
cord-005453-4057qib7	500	23	frequency	frequency	NN
cord-005453-4057qib7	500	24	of	of	IN
cord-005453-4057qib7	500	25	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	500	26	cystitis	cystitis	NN
cord-005453-4057qib7	500	27	in	in	IN
cord-005453-4057qib7	500	28	patients	patient	NNS
cord-005453-4057qib7	500	29	with	with	IN
cord-005453-4057qib7	500	30	higher	high	JJR
cord-005453-4057qib7	500	31	TIM-3	tim-3	JJ
cord-005453-4057qib7	500	32	levels	level	NNS
cord-005453-4057qib7	500	33	.	.	.
cord-005453-4057qib7	501	1	The	the	DT
cord-005453-4057qib7	501	2	adverse	adverse	JJ
cord-005453-4057qib7	501	3	prognostic	prognostic	JJ
cord-005453-4057qib7	501	4	impact	impact	NN
cord-005453-4057qib7	501	5	of	of	IN
cord-005453-4057qib7	501	6	TIM3	TIM3	NNP
cord-005453-4057qib7	501	7	on	on	IN
cord-005453-4057qib7	501	8	GvHD	GvHD	NNP
cord-005453-4057qib7	501	9	and	and	CC
cord-005453-4057qib7	501	10	OS	OS	NNP
cord-005453-4057qib7	501	11	was	be	VBD
cord-005453-4057qib7	501	12	confirmed	confirm	VBN
cord-005453-4057qib7	501	13	without	without	IN
cord-005453-4057qib7	501	14	statistical	statistical	JJ
cord-005453-4057qib7	501	15	significance	significance	NN
cord-005453-4057qib7	501	16	which	which	WDT
cord-005453-4057qib7	501	17	may	may	MD
cord-005453-4057qib7	501	18	be	be	VB
cord-005453-4057qib7	501	19	related	relate	VBN
cord-005453-4057qib7	501	20	to	to	IN
cord-005453-4057qib7	501	21	small	small	JJ
cord-005453-4057qib7	501	22	sample	sample	NN
cord-005453-4057qib7	501	23	size	size	NN
cord-005453-4057qib7	501	24	.	.	.
cord-005453-4057qib7	502	1	As	as	IN
cord-005453-4057qib7	502	2	TIM3	TIM3	NNP
cord-005453-4057qib7	502	3	has	have	VBZ
cord-005453-4057qib7	502	4	a	a	DT
cord-005453-4057qib7	502	5	wide	wide	JJ
cord-005453-4057qib7	502	6	spectrum	spectrum	NN
cord-005453-4057qib7	502	7	of	of	IN
cord-005453-4057qib7	502	8	action	action	NN
cord-005453-4057qib7	502	9	in	in	IN
cord-005453-4057qib7	502	10	the	the	DT
cord-005453-4057qib7	502	11	tumor	tumor	NN
cord-005453-4057qib7	502	12	microenvironment	microenvironment	NN
cord-005453-4057qib7	502	13	including	include	VBG
cord-005453-4057qib7	502	14	stimulatory	stimulatory	JJ
cord-005453-4057qib7	502	15	and	and	CC
cord-005453-4057qib7	502	16	inhibitory	inhibitory	JJ
cord-005453-4057qib7	502	17	activities	activity	NNS
cord-005453-4057qib7	502	18	,	,	,
cord-005453-4057qib7	502	19	further	further	JJ
cord-005453-4057qib7	502	20	clues	clue	NNS
cord-005453-4057qib7	502	21	are	be	VBP
cord-005453-4057qib7	502	22	required	require	VBN
cord-005453-4057qib7	502	23	to	to	TO
cord-005453-4057qib7	502	24	define	define	VB
cord-005453-4057qib7	502	25	the	the	DT
cord-005453-4057qib7	502	26	exact	exact	JJ
cord-005453-4057qib7	502	27	role	role	NN
cord-005453-4057qib7	502	28	of	of	IN
cord-005453-4057qib7	502	29	this	this	DT
cord-005453-4057qib7	502	30	molecule	molecule	NN
cord-005453-4057qib7	502	31	in	in	IN
cord-005453-4057qib7	502	32	the	the	DT
cord-005453-4057qib7	502	33	clinical	clinical	JJ
cord-005453-4057qib7	502	34	course	course	NN
cord-005453-4057qib7	502	35	of	of	IN
cord-005453-4057qib7	502	36	allogeneic	allogeneic	NN
cord-005453-4057qib7	502	37	HSCT	HSCT	NNP
cord-005453-4057qib7	502	38	in	in	IN
cord-005453-4057qib7	502	39	order	order	NN
cord-005453-4057qib7	502	40	to	to	TO
cord-005453-4057qib7	502	41	develop	develop	VB
cord-005453-4057qib7	502	42	targeted	target	VBN
cord-005453-4057qib7	502	43	therapeutic	therapeutic	JJ
cord-005453-4057qib7	502	44	strategies	strategy	NNS
cord-005453-4057qib7	502	45	Clinical	Clinical	NNP
cord-005453-4057qib7	502	46	Trial	Trial	NNP
cord-005453-4057qib7	502	47	Registry	Registry	NNP
cord-005453-4057qib7	502	48	:	:	:
cord-005453-4057qib7	503	1	N	N	NNP
cord-005453-4057qib7	503	2	/	/	SYM
cord-005453-4057qib7	503	3	A	a	DT
cord-005453-4057qib7	503	4	Disclosure	disclosure	NN
cord-005453-4057qib7	503	5	:	:	:
cord-005453-4057qib7	503	6	Nothing	nothing	NN
cord-005453-4057qib7	503	7	to	to	TO
cord-005453-4057qib7	503	8	declare	declare	VB
cord-005453-4057qib7	503	9	P029	p029	PRP
cord-005453-4057qib7	504	1	Homozygous	Homozygous	NNP
cord-005453-4057qib7	504	2	HLA	HLA	NNP
cord-005453-4057qib7	504	3	-	-	HYPH
cord-005453-4057qib7	504	4	C1	C1	NNP
cord-005453-4057qib7	504	5	is	be	VBZ
cord-005453-4057qib7	504	6	associated	associate	VBN
cord-005453-4057qib7	504	7	with	with	IN
cord-005453-4057qib7	504	8	increased	increase	VBN
cord-005453-4057qib7	504	9	risk	risk	NN
cord-005453-4057qib7	504	10	of	of	IN
cord-005453-4057qib7	504	11	relapse	relapse	NN
cord-005453-4057qib7	504	12	after	after	IN
cord-005453-4057qib7	504	13	HLA	HLA	NNP
cord-005453-4057qib7	504	14	-	-	HYPH
cord-005453-4057qib7	504	15	matched	match	VBN
cord-005453-4057qib7	504	16	transplantation	transplantation	NN
cord-005453-4057qib7	504	17	in	in	IN
cord-005453-4057qib7	504	18	recipients	recipient	NNS
cord-005453-4057qib7	504	19	with	with	IN
cord-005453-4057qib7	504	20	acute	acute	JJ
cord-005453-4057qib7	504	21	lymphoid	lymphoid	JJ
cord-005453-4057qib7	504	22	leukemia	leukemia	NN
cord-005453-4057qib7	504	23	:	:	:
cord-005453-4057qib7	505	1	A	a	DT
cord-005453-4057qib7	505	2	Japanese	japanese	JJ
cord-005453-4057qib7	505	3	national	national	JJ
cord-005453-4057qib7	505	4	registry	registry	NN
cord-005453-4057qib7	505	5	study	study	NN
cord-005453-4057qib7	505	6	Background	background	NN
cord-005453-4057qib7	505	7	:	:	:
cord-005453-4057qib7	506	1	After	after	IN
cord-005453-4057qib7	506	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	506	3	stem	stem	NN
cord-005453-4057qib7	506	4	cell	cell	NN
cord-005453-4057qib7	506	5	transplantation	transplantation	NN
cord-005453-4057qib7	506	6	(	(	-LRB-
cord-005453-4057qib7	506	7	HSCT	HSCT	NNP
cord-005453-4057qib7	506	8	)	)	-RRB-
cord-005453-4057qib7	506	9	,	,	,
cord-005453-4057qib7	506	10	the	the	DT
cord-005453-4057qib7	506	11	role	role	NN
cord-005453-4057qib7	506	12	of	of	IN
cord-005453-4057qib7	506	13	natural	natural	JJ
cord-005453-4057qib7	506	14	killer	killer	NN
cord-005453-4057qib7	506	15	(	(	-LRB-
cord-005453-4057qib7	506	16	NK	NK	NNP
cord-005453-4057qib7	506	17	)	)	-RRB-
cord-005453-4057qib7	506	18	cells	cell	NNS
cord-005453-4057qib7	506	19	which	which	WDT
cord-005453-4057qib7	506	20	express	express	VBP
cord-005453-4057qib7	506	21	killer	killer	NN
cord-005453-4057qib7	506	22	-	-	HYPH
cord-005453-4057qib7	506	23	cells	cell	NNS
cord-005453-4057qib7	506	24	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	506	25	-	-	HYPH
cord-005453-4057qib7	506	26	like	like	JJ
cord-005453-4057qib7	506	27	receptors	receptor	NNS
cord-005453-4057qib7	506	28	(	(	-LRB-
cord-005453-4057qib7	506	29	KIRs	kir	NNS
cord-005453-4057qib7	506	30	)	)	-RRB-
cord-005453-4057qib7	506	31	and	and	CC
cord-005453-4057qib7	506	32	recognize	recognize	VB
cord-005453-4057qib7	506	33	HLA	HLA	NNP
cord-005453-4057qib7	506	34	-	-	HYPH
cord-005453-4057qib7	506	35	class	class	NN
cord-005453-4057qib7	506	36	1	1	CD
cord-005453-4057qib7	506	37	ligands	ligand	NNS
cord-005453-4057qib7	506	38	is	be	VBZ
cord-005453-4057qib7	506	39	important	important	JJ
cord-005453-4057qib7	506	40	.	.	.
cord-005453-4057qib7	507	1	KIR2DL1	KIR2DL1	NNP
cord-005453-4057qib7	507	2	recognizes	recognize	VBZ
cord-005453-4057qib7	507	3	not	not	RB
cord-005453-4057qib7	507	4	HLA	HLA	NNP
cord-005453-4057qib7	507	5	-	-	HYPH
cord-005453-4057qib7	507	6	C	C	NNP
cord-005453-4057qib7	507	7	Asp80	Asp80	NNP
cord-005453-4057qib7	507	8	(	(	-LRB-
cord-005453-4057qib7	507	9	C1	C1	NNP
cord-005453-4057qib7	507	10	)	)	-RRB-
cord-005453-4057qib7	507	11	,	,	,
cord-005453-4057qib7	507	12	but	but	CC
cord-005453-4057qib7	508	1	HLA	HLA	NNP
cord-005453-4057qib7	508	2	-	-	HYPH
cord-005453-4057qib7	508	3	C	C	NNP
cord-005453-4057qib7	508	4	Lys80	Lys80	NNP
cord-005453-4057qib7	508	5	(	(	-LRB-
cord-005453-4057qib7	508	6	C2	C2	NNP
cord-005453-4057qib7	508	7	)	)	-RRB-
cord-005453-4057qib7	508	8	and	and	CC
cord-005453-4057qib7	508	9	has	have	VBZ
cord-005453-4057qib7	508	10	polymorphism	polymorphism	NN
cord-005453-4057qib7	508	11	based	base	VBN
cord-005453-4057qib7	508	12	on	on	IN
cord-005453-4057qib7	508	13	the	the	DT
cord-005453-4057qib7	508	14	245	245	CD
cord-005453-4057qib7	508	15	th	th	XX
cord-005453-4057qib7	508	16	amino	amino	NN
cord-005453-4057qib7	508	17	acid	acid	NN
cord-005453-4057qib7	508	18	of	of	IN
cord-005453-4057qib7	508	19	the	the	DT
cord-005453-4057qib7	508	20	transmembrane	transmembrane	NN
cord-005453-4057qib7	508	21	domain	domain	NN
cord-005453-4057qib7	508	22	.	.	.
cord-005453-4057qib7	509	1	Low	low	JJ
cord-005453-4057qib7	509	2	frequency	frequency	NN
cord-005453-4057qib7	509	3	of	of	IN
cord-005453-4057qib7	509	4	C2	c2	NN
cord-005453-4057qib7	509	5	and	and	CC
cord-005453-4057qib7	509	6	high	high	JJ
cord-005453-4057qib7	509	7	frequency	frequency	NN
cord-005453-4057qib7	509	8	of	of	IN
cord-005453-4057qib7	509	9	strong	strong	JJ
cord-005453-4057qib7	509	10	KIR2DL1	KIR2DL1	NNP
cord-005453-4057qib7	509	11	are	be	VBP
cord-005453-4057qib7	509	12	characteristics	characteristic	NNS
cord-005453-4057qib7	509	13	observed	observe	VBN
cord-005453-4057qib7	509	14	in	in	IN
cord-005453-4057qib7	509	15	Japanese	Japanese	NNP
cord-005453-4057qib7	509	16	.	.	.
cord-005453-4057qib7	510	1	By	by	IN
cord-005453-4057qib7	510	2	using	use	VBG
cord-005453-4057qib7	510	3	large	large	JJ
cord-005453-4057qib7	510	4	transplant	transplant	NN
cord-005453-4057qib7	510	5	database	database	NN
cord-005453-4057qib7	510	6	,	,	,
cord-005453-4057qib7	510	7	we	-PRON-	PRP
cord-005453-4057qib7	510	8	reported	report	VBD
cord-005453-4057qib7	510	9	that	that	IN
cord-005453-4057qib7	510	10	homozygous	homozygous	JJ
cord-005453-4057qib7	510	11	HLA	HLA	NNP
cord-005453-4057qib7	510	12	-	-	HYPH
cord-005453-4057qib7	510	13	C1	C1	NNP
cord-005453-4057qib7	510	14	(	(	-LRB-
cord-005453-4057qib7	510	15	C1	C1	NNP
cord-005453-4057qib7	510	16	/	/	SYM
cord-005453-4057qib7	510	17	C1	C1	NNP
cord-005453-4057qib7	510	18	)	)	-RRB-
cord-005453-4057qib7	510	19	recipients	recipient	NNS
cord-005453-4057qib7	510	20	displayed	display	VBD
cord-005453-4057qib7	510	21	lower	low	JJR
cord-005453-4057qib7	510	22	relapse	relapse	NN
cord-005453-4057qib7	510	23	rates	rate	NNS
cord-005453-4057qib7	510	24	than	than	IN
cord-005453-4057qib7	510	25	did	do	VBD
cord-005453-4057qib7	510	26	C1	C1	NNP
cord-005453-4057qib7	510	27	/	/	SYM
cord-005453-4057qib7	510	28	C2	C2	NNP
cord-005453-4057qib7	510	29	recipients	recipient	NNS
cord-005453-4057qib7	510	30	after	after	IN
cord-005453-4057qib7	510	31	HLA	HLA	NNP
cord-005453-4057qib7	510	32	-	-	HYPH
cord-005453-4057qib7	510	33	matched	match	VBN
cord-005453-4057qib7	510	34	HSCT	HSCT	NNP
cord-005453-4057qib7	510	35	for	for	IN
cord-005453-4057qib7	510	36	acute	acute	JJ
cord-005453-4057qib7	510	37	myeloid	myeloid	NN
cord-005453-4057qib7	510	38	leukemia	leukemia	NN
cord-005453-4057qib7	510	39	(	(	-LRB-
cord-005453-4057qib7	510	40	AML	AML	NNP
cord-005453-4057qib7	510	41	;	;	:
cord-005453-4057qib7	511	1	HR	hr	NN
cord-005453-4057qib7	511	2	=	=	SYM
cord-005453-4057qib7	511	3	.79	.79	.
cord-005453-4057qib7	512	1	,	,	,
cord-005453-4057qib7	512	2	P	p	NN
cord-005453-4057qib7	512	3	=	=	SYM
cord-005453-4057qib7	512	4	.006	.006	CD
cord-005453-4057qib7	512	5	)	)	-RRB-
cord-005453-4057qib7	512	6	or	or	CC
cord-005453-4057qib7	512	7	chronic	chronic	JJ
cord-005453-4057qib7	512	8	myeloid	myeloid	NN
cord-005453-4057qib7	512	9	leukemia	leukemia	NN
cord-005453-4057qib7	512	10	(	(	-LRB-
cord-005453-4057qib7	512	11	CML	CML	NNP
cord-005453-4057qib7	512	12	;	;	:
cord-005453-4057qib7	512	13	HR	hr	NN
cord-005453-4057qib7	512	14	=	=	SYM
cord-005453-4057qib7	512	15	.48	.48	.
cord-005453-4057qib7	513	1	,	,	,
cord-005453-4057qib7	513	2	P	p	NN
cord-005453-4057qib7	513	3	=	=	SYM
cord-005453-4057qib7	513	4	.025	.025	CD
cord-005453-4057qib7	513	5	)	)	-RRB-
cord-005453-4057qib7	513	6	.	.	.
cord-005453-4057qib7	514	1	This	this	DT
cord-005453-4057qib7	514	2	effect	effect	NN
cord-005453-4057qib7	514	3	seemed	seem	VBD
cord-005453-4057qib7	514	4	to	to	TO
cord-005453-4057qib7	514	5	be	be	VB
cord-005453-4057qib7	514	6	independent	independent	JJ
cord-005453-4057qib7	514	7	of	of	IN
cord-005453-4057qib7	514	8	acute	acute	JJ
cord-005453-4057qib7	514	9	graft	graft	NN
cord-005453-4057qib7	514	10	-	-	HYPH
cord-005453-4057qib7	514	11	versus	versus	IN
cord-005453-4057qib7	514	12	-	-	HYPH
cord-005453-4057qib7	514	13	host	host	NN
cord-005453-4057qib7	514	14	disease	disease	NN
cord-005453-4057qib7	514	15	(	(	-LRB-
cord-005453-4057qib7	514	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	514	17	)	)	-RRB-
cord-005453-4057qib7	514	18	or	or	CC
cord-005453-4057qib7	514	19	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	514	20	reactivation	reactivation	NN
cord-005453-4057qib7	514	21	occurrence	occurrence	NN
cord-005453-4057qib7	514	22	(	(	-LRB-
cord-005453-4057qib7	514	23	Arima	Arima	NNP
cord-005453-4057qib7	514	24	N	N	NNP
cord-005453-4057qib7	514	25	et	et	NNP
cord-005453-4057qib7	514	26	al	al	NNP
cord-005453-4057qib7	514	27	BBMT	BBMT	NNP
cord-005453-4057qib7	514	28	2018	2018	CD
cord-005453-4057qib7	514	29	)	)	-RRB-
cord-005453-4057qib7	514	30	.	.	.
cord-005453-4057qib7	515	1	Methods	method	NNS
cord-005453-4057qib7	515	2	:	:	:
cord-005453-4057qib7	516	1	Relapse	relapse	NN
cord-005453-4057qib7	516	2	rates	rate	NNS
cord-005453-4057qib7	516	3	of	of	IN
cord-005453-4057qib7	516	4	Japanese	japanese	JJ
cord-005453-4057qib7	516	5	recipients	recipient	NNS
cord-005453-4057qib7	516	6	who	who	WP
cord-005453-4057qib7	516	7	first	first	RB
cord-005453-4057qib7	516	8	underwent	undergo	VBD
cord-005453-4057qib7	516	9	HLA	HLA	NNP
cord-005453-4057qib7	516	10	-	-	HYPH
cord-005453-4057qib7	516	11	matched	match	VBN
cord-005453-4057qib7	516	12	HSCT	HSCT	NNP
cord-005453-4057qib7	516	13	between	between	IN
cord-005453-4057qib7	516	14	1996	1996	CD
cord-005453-4057qib7	516	15	and	and	CC
cord-005453-4057qib7	516	16	2016	2016	CD
cord-005453-4057qib7	516	17	for	for	IN
cord-005453-4057qib7	516	18	the	the	DT
cord-005453-4057qib7	516	19	treatment	treatment	NN
cord-005453-4057qib7	516	20	of	of	IN
cord-005453-4057qib7	516	21	acute	acute	JJ
cord-005453-4057qib7	516	22	lymphoid	lymphoid	JJ
cord-005453-4057qib7	516	23	leukemia	leukemia	NN
cord-005453-4057qib7	516	24	(	(	-LRB-
cord-005453-4057qib7	516	25	ALL	all	DT
cord-005453-4057qib7	516	26	)	)	-RRB-
cord-005453-4057qib7	516	27	were	be	VBD
cord-005453-4057qib7	516	28	compared	compare	VBN
cord-005453-4057qib7	516	29	between	between	IN
cord-005453-4057qib7	516	30	C1	C1	NNP
cord-005453-4057qib7	516	31	/	/	SYM
cord-005453-4057qib7	516	32	C1	C1	NNP
cord-005453-4057qib7	516	33	pairs	pair	NNS
cord-005453-4057qib7	516	34	and	and	CC
cord-005453-4057qib7	516	35	C1	C1	NNP
cord-005453-4057qib7	516	36	/	/	SYM
cord-005453-4057qib7	516	37	C2	C2	NNP
cord-005453-4057qib7	516	38	pairs	pair	NNS
cord-005453-4057qib7	516	39	,	,	,
cord-005453-4057qib7	516	40	using	use	VBG
cord-005453-4057qib7	516	41	data	datum	NNS
cord-005453-4057qib7	516	42	from	from	IN
cord-005453-4057qib7	516	43	Japanese	Japanese	NNP
cord-005453-4057qib7	516	44	Data	Data	NNP
cord-005453-4057qib7	516	45	Center	Center	NNP
cord-005453-4057qib7	516	46	for	for	IN
cord-005453-4057qib7	516	47	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	516	48	Cell	Cell	NNP
cord-005453-4057qib7	516	49	Transplantation	Transplantation	NNP
cord-005453-4057qib7	516	50	and	and	CC
cord-005453-4057qib7	516	51	adjusting	adjust	VBG
cord-005453-4057qib7	516	52	for	for	IN
cord-005453-4057qib7	516	53	transplant	transplant	NN
cord-005453-4057qib7	516	54	characteristics	characteristic	NNS
cord-005453-4057qib7	516	55	.	.	.
cord-005453-4057qib7	517	1	Cord	cord	NN
cord-005453-4057qib7	517	2	blood	blood	NN
cord-005453-4057qib7	517	3	transplantation	transplantation	NN
cord-005453-4057qib7	517	4	was	be	VBD
cord-005453-4057qib7	517	5	excluded	exclude	VBN
cord-005453-4057qib7	517	6	.	.	.
cord-005453-4057qib7	518	1	Multivariable	multivariable	JJ
cord-005453-4057qib7	518	2	competing	compete	VBG
cord-005453-4057qib7	518	3	risk	risk	NN
cord-005453-4057qib7	518	4	regression	regression	NN
cord-005453-4057qib7	518	5	analyses	analysis	NNS
cord-005453-4057qib7	518	6	were	be	VBD
cord-005453-4057qib7	518	7	performed	perform	VBN
cord-005453-4057qib7	518	8	to	to	TO
cord-005453-4057qib7	518	9	evaluate	evaluate	VB
cord-005453-4057qib7	518	10	relapses	relapse	NNS
cord-005453-4057qib7	518	11	and	and	CC
cord-005453-4057qib7	518	12	relapse	relapse	NN
cord-005453-4057qib7	518	13	-	-	HYPH
cord-005453-4057qib7	518	14	free	free	JJ
cord-005453-4057qib7	518	15	survival	survival	NN
cord-005453-4057qib7	518	16	(	(	-LRB-
cord-005453-4057qib7	518	17	RFS	RFS	NNP
cord-005453-4057qib7	518	18	)	)	-RRB-
cord-005453-4057qib7	518	19	was	be	VBD
cord-005453-4057qib7	518	20	estimated	estimate	VBN
cord-005453-4057qib7	518	21	using	use	VBG
cord-005453-4057qib7	518	22	Kaplan	Kaplan	NNP
cord-005453-4057qib7	518	23	-	-	HYPH
cord-005453-4057qib7	518	24	Meier	Meier	NNP
cord-005453-4057qib7	518	25	method	method	NN
cord-005453-4057qib7	518	26	.	.	.
cord-005453-4057qib7	519	1	Results	result	NNS
cord-005453-4057qib7	519	2	:	:	:
cord-005453-4057qib7	520	1	After	after	IN
cord-005453-4057qib7	520	2	61	61	CD
cord-005453-4057qib7	520	3	recipients	recipient	NNS
cord-005453-4057qib7	520	4	who	who	WP
cord-005453-4057qib7	520	5	did	do	VBD
cord-005453-4057qib7	520	6	not	not	RB
cord-005453-4057qib7	520	7	achieve	achieve	VB
cord-005453-4057qib7	520	8	remission	remission	NN
cord-005453-4057qib7	520	9	or	or	CC
cord-005453-4057qib7	520	10	experienced	experience	VBN
cord-005453-4057qib7	520	11	graft	graft	NN
cord-005453-4057qib7	520	12	failure	failure	NN
cord-005453-4057qib7	520	13	and	and	CC
cord-005453-4057qib7	520	14	41	41	CD
cord-005453-4057qib7	520	15	recipients	recipient	NNS
cord-005453-4057qib7	520	16	not	not	RB
cord-005453-4057qib7	520	17	-	-	HYPH
cord-005453-4057qib7	520	18	expressing	express	VBG
cord-005453-4057qib7	520	19	C1	C1	NNP
cord-005453-4057qib7	520	20	were	be	VBD
cord-005453-4057qib7	520	21	excluded	exclude	VBN
cord-005453-4057qib7	520	22	,	,	,
cord-005453-4057qib7	520	23	resting	rest	VBG
cord-005453-4057qib7	520	24	2779	2779	CD
cord-005453-4057qib7	520	25	recipients	recipient	NNS
cord-005453-4057qib7	520	26	aged	aged	JJ
cord-005453-4057qib7	520	27	0	0	CD
cord-005453-4057qib7	520	28	-	-	SYM
cord-005453-4057qib7	520	29	72	72	CD
cord-005453-4057qib7	520	30	years	year	NNS
cord-005453-4057qib7	520	31	(	(	-LRB-
cord-005453-4057qib7	520	32	median	median	NN
cord-005453-4057qib7	520	33	,	,	,
cord-005453-4057qib7	520	34	31.2	31.2	CD
cord-005453-4057qib7	520	35	years	year	NNS
cord-005453-4057qib7	520	36	)	)	-RRB-
cord-005453-4057qib7	520	37	were	be	VBD
cord-005453-4057qib7	520	38	analyzed	analyze	VBN
cord-005453-4057qib7	520	39	.	.	.
cord-005453-4057qib7	521	1	The	the	DT
cord-005453-4057qib7	521	2	median	median	JJ
cord-005453-4057qib7	521	3	follow	follow	NN
cord-005453-4057qib7	521	4	-	-	HYPH
cord-005453-4057qib7	521	5	up	up	NN
cord-005453-4057qib7	521	6	period	period	NN
cord-005453-4057qib7	521	7	for	for	IN
cord-005453-4057qib7	521	8	survivors	survivor	NNS
cord-005453-4057qib7	521	9	was	be	VBD
cord-005453-4057qib7	521	10	5.0	5.0	CD
cord-005453-4057qib7	521	11	years	year	NNS
cord-005453-4057qib7	521	12	.	.	.
cord-005453-4057qib7	522	1	There	there	EX
cord-005453-4057qib7	522	2	were	be	VBD
cord-005453-4057qib7	522	3	2447	2447	CD
cord-005453-4057qib7	522	4	recipients	recipient	NNS
cord-005453-4057qib7	522	5	expressing	express	VBG
cord-005453-4057qib7	522	6	C1	C1	NNP
cord-005453-4057qib7	522	7	/	/	SYM
cord-005453-4057qib7	522	8	C1	C1	NNP
cord-005453-4057qib7	522	9	and	and	CC
cord-005453-4057qib7	522	10	332	332	CD
cord-005453-4057qib7	522	11	recipients	recipient	NNS
cord-005453-4057qib7	522	12	expressing	express	VBG
cord-005453-4057qib7	522	13	C1	C1	NNP
cord-005453-4057qib7	522	14	/	/	SYM
cord-005453-4057qib7	522	15	C2	C2	NNP
cord-005453-4057qib7	522	16	,	,	,
cord-005453-4057qib7	522	17	respectively	respectively	RB
cord-005453-4057qib7	522	18	.	.	.
cord-005453-4057qib7	523	1	After	after	IN
cord-005453-4057qib7	523	2	HLA	HLA	NNP
cord-005453-4057qib7	523	3	-	-	HYPH
cord-005453-4057qib7	523	4	matched	match	VBN
cord-005453-4057qib7	523	5	HSCT	HSCT	NNP
cord-005453-4057qib7	523	6	,	,	,
cord-005453-4057qib7	523	7	C1	C1	NNP
cord-005453-4057qib7	523	8	/	/	SYM
cord-005453-4057qib7	523	9	C1	C1	NNP
cord-005453-4057qib7	523	10	recipients	recipient	NNS
cord-005453-4057qib7	523	11	had	have	VBD
cord-005453-4057qib7	523	12	higher	high	JJR
cord-005453-4057qib7	523	13	relapse	relapse	NN
cord-005453-4057qib7	523	14	rates	rate	NNS
cord-005453-4057qib7	523	15	than	than	IN
cord-005453-4057qib7	523	16	C1/	C1/	NNP
cord-005453-4057qib7	523	17	C2	C2	NNP
cord-005453-4057qib7	523	18	recipients	recipient	NNS
cord-005453-4057qib7	523	19	(	(	-LRB-
cord-005453-4057qib7	523	20	HR	hr	NN
cord-005453-4057qib7	523	21	=	=	SYM
cord-005453-4057qib7	523	22	1.55	1.55	CD
cord-005453-4057qib7	523	23	,	,	,
cord-005453-4057qib7	523	24	P	p	NN
cord-005453-4057qib7	523	25	=	=	SYM
cord-005453-4057qib7	523	26	.003	.003	CD
cord-005453-4057qib7	523	27	)	)	-RRB-
cord-005453-4057qib7	523	28	,	,	,
cord-005453-4057qib7	523	29	resulting	result	VBG
cord-005453-4057qib7	523	30	in	in	IN
cord-005453-4057qib7	523	31	worse	bad	JJR
cord-005453-4057qib7	523	32	RFS	RFS	NNP
cord-005453-4057qib7	523	33	among	among	IN
cord-005453-4057qib7	523	34	C1	C1	NNP
cord-005453-4057qib7	523	35	/	/	SYM
cord-005453-4057qib7	523	36	C1	C1	NNP
cord-005453-4057qib7	523	37	recipients	recipient	NNS
cord-005453-4057qib7	523	38	(	(	-LRB-
cord-005453-4057qib7	523	39	HR	hr	NN
cord-005453-4057qib7	523	40	=	=	SYM
cord-005453-4057qib7	523	41	1.27	1.27	CD
cord-005453-4057qib7	523	42	,	,	,
cord-005453-4057qib7	523	43	P	p	NN
cord-005453-4057qib7	523	44	=	=	SYM
cord-005453-4057qib7	523	45	.034	.034	CD
cord-005453-4057qib7	523	46	)	)	-RRB-
cord-005453-4057qib7	523	47	.	.	.
cord-005453-4057qib7	524	1	The	the	DT
cord-005453-4057qib7	524	2	frequent	frequent	JJ
cord-005453-4057qib7	524	3	relapse	relapse	NN
cord-005453-4057qib7	524	4	in	in	IN
cord-005453-4057qib7	524	5	C1	C1	NNP
cord-005453-4057qib7	524	6	/	/	SYM
cord-005453-4057qib7	524	7	C1	C1	NNP
cord-005453-4057qib7	524	8	recipients	recipient	NNS
cord-005453-4057qib7	524	9	than	than	IN
cord-005453-4057qib7	524	10	in	in	IN
cord-005453-4057qib7	524	11	C1	C1	NNP
cord-005453-4057qib7	524	12	/	/	SYM
cord-005453-4057qib7	524	13	C2	C2	NNP
cord-005453-4057qib7	524	14	was	be	VBD
cord-005453-4057qib7	524	15	noticeable	noticeable	JJ
cord-005453-4057qib7	524	16	among	among	IN
cord-005453-4057qib7	524	17	recipients	recipient	NNS
cord-005453-4057qib7	524	18	with	with	IN
cord-005453-4057qib7	524	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	525	1	(	(	-LRB-
cord-005453-4057qib7	525	2	HR	hr	NN
cord-005453-4057qib7	525	3	=	=	SYM
cord-005453-4057qib7	525	4	1.89	1.89	CD
cord-005453-4057qib7	525	5	,	,	,
cord-005453-4057qib7	525	6	P	p	NN
cord-005453-4057qib7	525	7	=	=	SYM
cord-005453-4057qib7	525	8	.002	.002	CD
cord-005453-4057qib7	525	9	)	)	-RRB-
cord-005453-4057qib7	525	10	,	,	,
cord-005453-4057qib7	525	11	those	those	DT
cord-005453-4057qib7	525	12	without	without	IN
cord-005453-4057qib7	525	13	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	525	14	reactivation	reactivation	NN
cord-005453-4057qib7	525	15	(	(	-LRB-
cord-005453-4057qib7	525	16	HR	hr	NN
cord-005453-4057qib7	525	17	=	=	SYM
cord-005453-4057qib7	525	18	1.84	1.84	CD
cord-005453-4057qib7	525	19	,	,	,
cord-005453-4057qib7	525	20	P	p	NN
cord-005453-4057qib7	525	21	=	=	SYM
cord-005453-4057qib7	525	22	.002	.002	CD
cord-005453-4057qib7	525	23	)	)	-RRB-
cord-005453-4057qib7	525	24	,	,	,
cord-005453-4057qib7	525	25	and	and	CC
cord-005453-4057qib7	525	26	those	those	DT
cord-005453-4057qib7	525	27	with	with	IN
cord-005453-4057qib7	525	28	Ph	Ph	NNP
cord-005453-4057qib7	525	29	-	-	JJ
cord-005453-4057qib7	525	30	negative	negative	JJ
cord-005453-4057qib7	525	31	ALL	all	DT
cord-005453-4057qib7	525	32	(	(	-LRB-
cord-005453-4057qib7	525	33	HR	hr	NN
cord-005453-4057qib7	525	34	=	=	SYM
cord-005453-4057qib7	525	35	1.88	1.88	CD
cord-005453-4057qib7	525	36	,	,	,
cord-005453-4057qib7	525	37	P	p	NN
cord-005453-4057qib7	525	38	=	=	SYM
cord-005453-4057qib7	525	39	.001	.001	CD
cord-005453-4057qib7	525	40	)	)	-RRB-
cord-005453-4057qib7	525	41	.	.	.
cord-005453-4057qib7	526	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	526	2	:	:	:
cord-005453-4057qib7	526	3	KIR2DL1-positive	kir2dl1-positive	JJ
cord-005453-4057qib7	526	4	NK	NK	NNP
cord-005453-4057qib7	526	5	cells	cell	NNS
cord-005453-4057qib7	526	6	may	may	MD
cord-005453-4057qib7	526	7	promote	promote	VB
cord-005453-4057qib7	526	8	graft	graft	NN
cord-005453-4057qib7	526	9	-	-	HYPH
cord-005453-4057qib7	526	10	versus	versus	IN
cord-005453-4057qib7	526	11	-	-	HYPH
cord-005453-4057qib7	526	12	leukemia	leukemia	NN
cord-005453-4057qib7	526	13	(	(	-LRB-
cord-005453-4057qib7	526	14	GVL	GVL	NNP
cord-005453-4057qib7	526	15	)	)	-RRB-
cord-005453-4057qib7	526	16	in	in	IN
cord-005453-4057qib7	526	17	C1	C1	NNP
cord-005453-4057qib7	526	18	/	/	SYM
cord-005453-4057qib7	526	19	C1	C1	NNP
cord-005453-4057qib7	526	20	recipients	recipient	NNS
cord-005453-4057qib7	526	21	with	with	IN
cord-005453-4057qib7	526	22	AML	AML	NNP
cord-005453-4057qib7	526	23	or	or	CC
cord-005453-4057qib7	526	24	CML	CML	NNP
cord-005453-4057qib7	526	25	but	but	CC
cord-005453-4057qib7	526	26	suppress	suppress	VB
cord-005453-4057qib7	526	27	GVL	GVL	NNP
cord-005453-4057qib7	526	28	in	in	IN
cord-005453-4057qib7	526	29	C1	C1	NNP
cord-005453-4057qib7	526	30	/	/	SYM
cord-005453-4057qib7	526	31	C1	C1	NNP
cord-005453-4057qib7	526	32	recipients	recipient	NNS
cord-005453-4057qib7	526	33	with	with	IN
cord-005453-4057qib7	526	34	ALL	all	DT
cord-005453-4057qib7	526	35	.	.	.
cord-005453-4057qib7	527	1	One	one	CD
cord-005453-4057qib7	527	2	interpretation	interpretation	NN
cord-005453-4057qib7	527	3	is	be	VBZ
cord-005453-4057qib7	527	4	that	that	IN
cord-005453-4057qib7	527	5	transplant	transplant	NN
cord-005453-4057qib7	527	6	-	-	HYPH
cord-005453-4057qib7	527	7	activated	activate	VBN
cord-005453-4057qib7	527	8	NK	NK	NNP
cord-005453-4057qib7	527	9	cells	cell	NNS
cord-005453-4057qib7	527	10	impair	impair	VBP
cord-005453-4057qib7	527	11	antigen	antigen	NN
cord-005453-4057qib7	527	12	-	-	HYPH
cord-005453-4057qib7	527	13	presenting	present	VBG
cord-005453-4057qib7	527	14	cells	cell	NNS
cord-005453-4057qib7	527	15	or	or	CC
cord-005453-4057qib7	527	16	deprive	deprive	VB
cord-005453-4057qib7	527	17	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	527	18	Tlymphocytes	Tlymphocytes	NNPS
cord-005453-4057qib7	527	19	of	of	IN
cord-005453-4057qib7	527	20	their	-PRON-	PRP$
cord-005453-4057qib7	527	21	GVL	GVL	NNP
cord-005453-4057qib7	527	22	effects	effect	NNS
cord-005453-4057qib7	527	23	on	on	IN
cord-005453-4057qib7	527	24	ALL	all	DT
cord-005453-4057qib7	527	25	cells	cell	NNS
cord-005453-4057qib7	527	26	.	.	.
cord-005453-4057qib7	528	1	This	this	DT
cord-005453-4057qib7	528	2	hypothesis	hypothesis	NN
cord-005453-4057qib7	528	3	may	may	MD
cord-005453-4057qib7	528	4	be	be	VB
cord-005453-4057qib7	528	5	explained	explain	VBN
cord-005453-4057qib7	528	6	by	by	IN
cord-005453-4057qib7	528	7	the	the	DT
cord-005453-4057qib7	528	8	fact	fact	NN
cord-005453-4057qib7	528	9	that	that	IN
cord-005453-4057qib7	528	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	528	11	was	be	VBD
cord-005453-4057qib7	528	12	necessary	necessary	JJ
cord-005453-4057qib7	528	13	for	for	IN
cord-005453-4057qib7	528	14	the	the	DT
cord-005453-4057qib7	528	15	recessive	recessive	JJ
cord-005453-4057qib7	528	16	relapse	relapse	NN
cord-005453-4057qib7	528	17	in	in	IN
cord-005453-4057qib7	528	18	C1	C1	NNP
cord-005453-4057qib7	528	19	/	/	SYM
cord-005453-4057qib7	528	20	C1	C1	NNP
cord-005453-4057qib7	528	21	recipients	recipient	NNS
cord-005453-4057qib7	528	22	with	with	IN
cord-005453-4057qib7	528	23	ALL	all	DT
cord-005453-4057qib7	528	24	.	.	.
cord-005453-4057qib7	529	1	Furthermore	furthermore	RB
cord-005453-4057qib7	529	2	,	,	,
cord-005453-4057qib7	529	3	Ph	Ph	NNP
cord-005453-4057qib7	529	4	-	-	NN
cord-005453-4057qib7	529	5	positive	positive	JJ
cord-005453-4057qib7	529	6	ALL	all	DT
cord-005453-4057qib7	529	7	cells	cell	NNS
cord-005453-4057qib7	529	8	sometimes	sometimes	RB
cord-005453-4057qib7	529	9	mimic	mimic	VBP
cord-005453-4057qib7	529	10	AML	AML	NNP
cord-005453-4057qib7	529	11	cells	cell	NNS
cord-005453-4057qib7	529	12	in	in	IN
cord-005453-4057qib7	529	13	terms	term	NNS
cord-005453-4057qib7	529	14	of	of	IN
cord-005453-4057qib7	529	15	their	-PRON-	PRP$
cord-005453-4057qib7	529	16	frequent	frequent	JJ
cord-005453-4057qib7	529	17	myeloid	myeloid	JJ
cord-005453-4057qib7	529	18	antigen	antigen	NN
cord-005453-4057qib7	529	19	expression	expression	NN
cord-005453-4057qib7	529	20	and	and	CC
cord-005453-4057qib7	529	21	might	may	MD
cord-005453-4057qib7	529	22	be	be	VB
cord-005453-4057qib7	529	23	directly	directly	RB
cord-005453-4057qib7	529	24	targeted	target	VBN
cord-005453-4057qib7	529	25	by	by	IN
cord-005453-4057qib7	529	26	NK	NK	NNP
cord-005453-4057qib7	529	27	cells	cell	NNS
cord-005453-4057qib7	529	28	.	.	.
cord-005453-4057qib7	530	1	It	-PRON-	PRP
cord-005453-4057qib7	530	2	would	would	MD
cord-005453-4057qib7	530	3	be	be	VB
cord-005453-4057qib7	530	4	necessary	necessary	JJ
cord-005453-4057qib7	530	5	to	to	TO
cord-005453-4057qib7	530	6	further	further	RB
cord-005453-4057qib7	530	7	clarify	clarify	VB
cord-005453-4057qib7	530	8	in	in	IN
cord-005453-4057qib7	530	9	vitro	vitro	FW
cord-005453-4057qib7	530	10	the	the	DT
cord-005453-4057qib7	530	11	character	character	NN
cord-005453-4057qib7	530	12	of	of	IN
cord-005453-4057qib7	530	13	NK	NK	NNP
cord-005453-4057qib7	530	14	cell	cell	NN
cord-005453-4057qib7	530	15	-	-	HYPH
cord-005453-4057qib7	530	16	affecting	affect	VBG
cord-005453-4057qib7	530	17	in	in	IN
cord-005453-4057qib7	530	18	the	the	DT
cord-005453-4057qib7	530	19	transplant	transplant	NN
cord-005453-4057qib7	530	20	immunity	immunity	NN
cord-005453-4057qib7	530	21	against	against	IN
cord-005453-4057qib7	530	22	residual	residual	JJ
cord-005453-4057qib7	530	23	leukemia	leukemia	NN
cord-005453-4057qib7	530	24	cells	cell	NNS
cord-005453-4057qib7	530	25	.	.	.
cord-005453-4057qib7	531	1	Disclosure	disclosure	NN
cord-005453-4057qib7	531	2	:	:	:
cord-005453-4057qib7	532	1	Authors	author	NNS
cord-005453-4057qib7	532	2	have	have	VBP
cord-005453-4057qib7	532	3	nothing	nothing	NN
cord-005453-4057qib7	532	4	to	to	TO
cord-005453-4057qib7	532	5	declare	declare	VB
cord-005453-4057qib7	532	6	.	.	.
cord-005453-4057qib7	533	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	533	2	stem	stem	NN
cord-005453-4057qib7	533	3	cell	cell	NN
cord-005453-4057qib7	533	4	transplantation	transplantation	NN
cord-005453-4057qib7	533	5	with	with	IN
cord-005453-4057qib7	533	6	sequential	sequential	JJ
cord-005453-4057qib7	533	7	conditioning	conditioning	NN
cord-005453-4057qib7	533	8	for	for	IN
cord-005453-4057qib7	533	9	children	child	NNS
cord-005453-4057qib7	533	10	with	with	IN
cord-005453-4057qib7	533	11	relapsed	relapse	VBN
cord-005453-4057qib7	533	12	/	/	SYM
cord-005453-4057qib7	533	13	refractory	refractory	JJ
cord-005453-4057qib7	533	14	acute	acute	JJ
cord-005453-4057qib7	533	15	leukemia	leukemia	NN
cord-005453-4057qib7	534	1	Nao	Nao	NNP
cord-005453-4057qib7	534	2	Yoshida	Yoshida	NNP
cord-005453-4057qib7	534	3	1	1	CD
cord-005453-4057qib7	534	4	,	,	,
cord-005453-4057qib7	534	5	Kazuki	Kazuki	NNP
cord-005453-4057qib7	534	6	Matsumoto	Matsumoto	NNP
cord-005453-4057qib7	534	7	1	1	CD
cord-005453-4057qib7	534	8	,	,	,
cord-005453-4057qib7	534	9	Daiki	Daiki	NNP
cord-005453-4057qib7	534	10	Yamashita	Yamashita	NNP
cord-005453-4057qib7	534	11	1	1	CD
cord-005453-4057qib7	534	12	,	,	,
cord-005453-4057qib7	534	13	Yiqing	Yiqing	NNP
cord-005453-4057qib7	534	14	Zhu	Zhu	NNP
cord-005453-4057qib7	534	15	1	1	CD
cord-005453-4057qib7	534	16	,	,	,
cord-005453-4057qib7	534	17	Daichi	Daichi	NNP
cord-005453-4057qib7	534	18	Sajiki	Sajiki	NNP
cord-005453-4057qib7	534	19	1	1	CD
cord-005453-4057qib7	534	20	,	,	,
cord-005453-4057qib7	534	21	Ryo	Ryo	NNP
cord-005453-4057qib7	534	22	Maemura	Maemura	NNP
cord-005453-4057qib7	534	23	1	1	CD
cord-005453-4057qib7	534	24	,	,	,
cord-005453-4057qib7	534	25	Hirotoshi	Hirotoshi	NNP
cord-005453-4057qib7	534	26	Sakaguchi	Sakaguchi	NNP
cord-005453-4057qib7	534	27	1	1	CD
cord-005453-4057qib7	535	1	,	,	,
cord-005453-4057qib7	535	2	Asahito	Asahito	NNP
cord-005453-4057qib7	535	3	Hama	Hama	NNP
cord-005453-4057qib7	535	4	1	1	CD
cord-005453-4057qib7	535	5	1	1	CD
cord-005453-4057qib7	535	6	Children	Children	NNPS
cord-005453-4057qib7	535	7	's	's	POS
cord-005453-4057qib7	535	8	Medical	Medical	NNP
cord-005453-4057qib7	535	9	Center	Center	NNP
cord-005453-4057qib7	535	10	,	,	,
cord-005453-4057qib7	535	11	Japanese	Japanese	NNP
cord-005453-4057qib7	535	12	Red	Red	NNP
cord-005453-4057qib7	535	13	Cross	Cross	NNP
cord-005453-4057qib7	535	14	Nagoya	Nagoya	NNP
cord-005453-4057qib7	535	15	First	First	NNP
cord-005453-4057qib7	535	16	Hospital	Hospital	NNP
cord-005453-4057qib7	535	17	,	,	,
cord-005453-4057qib7	535	18	Nagoya	Nagoya	NNP
cord-005453-4057qib7	535	19	,	,	,
cord-005453-4057qib7	536	1	Japan	Japan	NNP
cord-005453-4057qib7	536	2	Background	Background	NNP
cord-005453-4057qib7	536	3	:	:	:
cord-005453-4057qib7	537	1	Patients	patient	NNS
cord-005453-4057qib7	537	2	with	with	IN
cord-005453-4057qib7	537	3	acute	acute	JJ
cord-005453-4057qib7	537	4	leukemia	leukemia	NN
cord-005453-4057qib7	537	5	who	who	WP
cord-005453-4057qib7	537	6	fail	fail	VBP
cord-005453-4057qib7	537	7	to	to	TO
cord-005453-4057qib7	537	8	achieve	achieve	VB
cord-005453-4057qib7	537	9	complete	complete	JJ
cord-005453-4057qib7	537	10	remission	remission	NN
cord-005453-4057qib7	537	11	show	show	VBP
cord-005453-4057qib7	537	12	a	a	DT
cord-005453-4057qib7	537	13	dismal	dismal	JJ
cord-005453-4057qib7	537	14	prognosis	prognosis	NN
cord-005453-4057qib7	537	15	even	even	RB
cord-005453-4057qib7	537	16	with	with	IN
cord-005453-4057qib7	537	17	allogeneic	allogeneic	JJ
cord-005453-4057qib7	537	18	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	537	19	stem	stem	NN
cord-005453-4057qib7	537	20	cell	cell	NN
cord-005453-4057qib7	537	21	transplantation	transplantation	NN
cord-005453-4057qib7	537	22	(	(	-LRB-
cord-005453-4057qib7	537	23	HSCT	HSCT	NNP
cord-005453-4057qib7	537	24	)	)	-RRB-
cord-005453-4057qib7	537	25	.	.	.
cord-005453-4057qib7	538	1	This	this	DT
cord-005453-4057qib7	538	2	study	study	NN
cord-005453-4057qib7	538	3	evaluated	evaluate	VBD
cord-005453-4057qib7	538	4	whether	whether	IN
cord-005453-4057qib7	538	5	sequential	sequential	JJ
cord-005453-4057qib7	538	6	conditioning	conditioning	NN
cord-005453-4057qib7	538	7	approach	approach	NN
cord-005453-4057qib7	538	8	that	that	WDT
cord-005453-4057qib7	538	9	is	be	VBZ
cord-005453-4057qib7	538	10	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	538	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	538	12	applied	apply	VBN
cord-005453-4057qib7	538	13	shortly	shortly	RB
cord-005453-4057qib7	538	14	prior	prior	RB
cord-005453-4057qib7	538	15	to	to	IN
cord-005453-4057qib7	538	16	the	the	DT
cord-005453-4057qib7	538	17	main	main	JJ
cord-005453-4057qib7	538	18	conditioning	conditioning	NN
cord-005453-4057qib7	538	19	followed	follow	VBN
cord-005453-4057qib7	538	20	by	by	IN
cord-005453-4057qib7	538	21	HSCT	HSCT	NNP
cord-005453-4057qib7	538	22	can	can	MD
cord-005453-4057qib7	538	23	improve	improve	VB
cord-005453-4057qib7	538	24	prognosis	prognosis	NN
cord-005453-4057qib7	538	25	in	in	IN
cord-005453-4057qib7	538	26	such	such	JJ
cord-005453-4057qib7	538	27	high	high	JJ
cord-005453-4057qib7	538	28	-	-	HYPH
cord-005453-4057qib7	538	29	risk	risk	NN
cord-005453-4057qib7	538	30	patients	patient	NNS
cord-005453-4057qib7	538	31	.	.	.
cord-005453-4057qib7	539	1	Methods	method	NNS
cord-005453-4057qib7	539	2	:	:	:
cord-005453-4057qib7	539	3	We	-PRON-	PRP
cord-005453-4057qib7	539	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	539	5	analyzed	analyze	VBD
cord-005453-4057qib7	539	6	the	the	DT
cord-005453-4057qib7	539	7	outcomes	outcome	NNS
cord-005453-4057qib7	539	8	of	of	IN
cord-005453-4057qib7	539	9	90	90	CD
cord-005453-4057qib7	539	10	children	child	NNS
cord-005453-4057qib7	539	11	(	(	-LRB-
cord-005453-4057qib7	539	12	median	median	JJ
cord-005453-4057qib7	539	13	8	8	CD
cord-005453-4057qib7	539	14	,	,	,
cord-005453-4057qib7	539	15	range	range	VBP
cord-005453-4057qib7	539	16	0	0	CD
cord-005453-4057qib7	539	17	-	-	SYM
cord-005453-4057qib7	539	18	18	18	CD
cord-005453-4057qib7	539	19	years	year	NNS
cord-005453-4057qib7	539	20	old	old	JJ
cord-005453-4057qib7	539	21	)	)	-RRB-
cord-005453-4057qib7	539	22	with	with	IN
cord-005453-4057qib7	539	23	primary	primary	JJ
cord-005453-4057qib7	539	24	refractory	refractory	NN
cord-005453-4057qib7	539	25	(	(	-LRB-
cord-005453-4057qib7	539	26	n	n	NN
cord-005453-4057qib7	539	27	=	=	SYM
cord-005453-4057qib7	539	28	11	11	CD
cord-005453-4057qib7	539	29	)	)	-RRB-
cord-005453-4057qib7	539	30	or	or	CC
cord-005453-4057qib7	539	31	refractory	refractory	JJ
cord-005453-4057qib7	539	32	relapsed	relapse	VBD
cord-005453-4057qib7	539	33	(	(	-LRB-
cord-005453-4057qib7	539	34	n	n	NN
cord-005453-4057qib7	539	35	=	=	SYM
cord-005453-4057qib7	539	36	79	79	CD
cord-005453-4057qib7	539	37	)	)	-RRB-
cord-005453-4057qib7	539	38	acute	acute	JJ
cord-005453-4057qib7	539	39	leukemia	leukemia	NN
cord-005453-4057qib7	539	40	(	(	-LRB-
cord-005453-4057qib7	539	41	AML	AML	NNP
cord-005453-4057qib7	539	42	n	n	CC
cord-005453-4057qib7	539	43	=	=	SYM
cord-005453-4057qib7	539	44	43	43	CD
cord-005453-4057qib7	539	45	,	,	,
cord-005453-4057qib7	539	46	ALL	all	DT
cord-005453-4057qib7	539	47	n	n	NN
cord-005453-4057qib7	539	48	=	=	SYM
cord-005453-4057qib7	539	49	47	47	CD
cord-005453-4057qib7	539	50	)	)	-RRB-
cord-005453-4057qib7	539	51	who	who	WP
cord-005453-4057qib7	539	52	received	receive	VBD
cord-005453-4057qib7	539	53	HSCT	HSCT	NNP
cord-005453-4057qib7	539	54	in	in	IN
cord-005453-4057qib7	539	55	our	-PRON-	PRP$
cord-005453-4057qib7	539	56	department	department	NN
cord-005453-4057qib7	539	57	between	between	IN
cord-005453-4057qib7	539	58	1990	1990	CD
cord-005453-4057qib7	539	59	and	and	CC
cord-005453-4057qib7	539	60	2016	2016	CD
cord-005453-4057qib7	539	61	.	.	.
cord-005453-4057qib7	540	1	The	the	DT
cord-005453-4057qib7	540	2	stem	stem	NN
cord-005453-4057qib7	540	3	cell	cell	NN
cord-005453-4057qib7	540	4	source	source	NN
cord-005453-4057qib7	540	5	was	be	VBD
cord-005453-4057qib7	540	6	related	relate	VBN
cord-005453-4057qib7	540	7	peripheral	peripheral	JJ
cord-005453-4057qib7	540	8	blood	blood	NN
cord-005453-4057qib7	540	9	(	(	-LRB-
cord-005453-4057qib7	540	10	PB	PB	NNP
cord-005453-4057qib7	540	11	)	)	-RRB-
cord-005453-4057qib7	540	12	in	in	IN
cord-005453-4057qib7	540	13	4	4	CD
cord-005453-4057qib7	540	14	patients	patient	NNS
cord-005453-4057qib7	540	15	,	,	,
cord-005453-4057qib7	540	16	related	related	JJ
cord-005453-4057qib7	540	17	bone	bone	NN
cord-005453-4057qib7	540	18	marrow	marrow	NN
cord-005453-4057qib7	540	19	in	in	IN
cord-005453-4057qib7	540	20	31	31	CD
cord-005453-4057qib7	540	21	,	,	,
cord-005453-4057qib7	540	22	unrelated	unrelated	JJ
cord-005453-4057qib7	540	23	bone	bone	NN
cord-005453-4057qib7	540	24	marrow	marrow	NN
cord-005453-4057qib7	540	25	in	in	IN
cord-005453-4057qib7	540	26	40	40	CD
cord-005453-4057qib7	540	27	,	,	,
cord-005453-4057qib7	540	28	or	or	CC
cord-005453-4057qib7	540	29	unrelated	unrelated	JJ
cord-005453-4057qib7	540	30	cord	cord	NN
cord-005453-4057qib7	540	31	blood	blood	NN
cord-005453-4057qib7	540	32	in	in	IN
cord-005453-4057qib7	540	33	15	15	CD
cord-005453-4057qib7	540	34	.	.	.
cord-005453-4057qib7	541	1	The	the	DT
cord-005453-4057qib7	541	2	grafts	graft	NNS
cord-005453-4057qib7	541	3	were	be	VBD
cord-005453-4057qib7	541	4	HLA	HLA	NNP
cord-005453-4057qib7	541	5	serologically	serologically	RB
cord-005453-4057qib7	541	6	matched	match	VBN
cord-005453-4057qib7	541	7	(	(	-LRB-
cord-005453-4057qib7	541	8	n	n	NN
cord-005453-4057qib7	541	9	=	=	SYM
cord-005453-4057qib7	541	10	63	63	CD
cord-005453-4057qib7	541	11	)	)	-RRB-
cord-005453-4057qib7	541	12	or	or	CC
cord-005453-4057qib7	541	13	mismatched	mismatch	VBN
cord-005453-4057qib7	541	14	(	(	-LRB-
cord-005453-4057qib7	541	15	n	n	NN
cord-005453-4057qib7	541	16	=	=	SYM
cord-005453-4057qib7	541	17	27	27	CD
cord-005453-4057qib7	541	18	)	)	-RRB-
cord-005453-4057qib7	541	19	with	with	IN
cord-005453-4057qib7	541	20	the	the	DT
cord-005453-4057qib7	541	21	recipient	recipient	NN
cord-005453-4057qib7	541	22	.	.	.
cord-005453-4057qib7	542	1	In	in	IN
cord-005453-4057qib7	542	2	total	total	NN
cord-005453-4057qib7	542	3	,	,	,
cord-005453-4057qib7	542	4	29	29	CD
cord-005453-4057qib7	542	5	patients	patient	NNS
cord-005453-4057qib7	542	6	received	receive	VBD
cord-005453-4057qib7	542	7	the	the	DT
cord-005453-4057qib7	542	8	sequential	sequential	JJ
cord-005453-4057qib7	542	9	conditioning	conditioning	NN
cord-005453-4057qib7	542	10	approach	approach	NN
cord-005453-4057qib7	542	11	.	.	.
cord-005453-4057qib7	543	1	As	as	IN
cord-005453-4057qib7	543	2	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	543	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	543	4	,	,	,
cord-005453-4057qib7	543	5	fludarabine	fludarabine	NN
cord-005453-4057qib7	543	6	/	/	SYM
cord-005453-4057qib7	543	7	cytarabine	cytarabine	NNP
cord-005453-4057qib7	543	8	/	/	SYM
cord-005453-4057qib7	543	9	idarubicin	idarubicin	NNS
cord-005453-4057qib7	543	10	/	/	SYM
cord-005453-4057qib7	543	11	G	G	NNP
cord-005453-4057qib7	543	12	-	-	HYPH
cord-005453-4057qib7	543	13	CSF	CSF	NNP
cord-005453-4057qib7	543	14	(	(	-LRB-
cord-005453-4057qib7	543	15	FLAG	FLAG	NNP
cord-005453-4057qib7	543	16	-	-	HYPH
cord-005453-4057qib7	543	17	IDA	IDA	NNP
cord-005453-4057qib7	543	18	)	)	-RRB-
cord-005453-4057qib7	543	19	was	be	VBD
cord-005453-4057qib7	543	20	used	use	VBN
cord-005453-4057qib7	543	21	in	in	IN
cord-005453-4057qib7	543	22	12	12	CD
cord-005453-4057qib7	543	23	patients	patient	NNS
cord-005453-4057qib7	543	24	,	,	,
cord-005453-4057qib7	543	25	mitoxantrone	mitoxantrone	NN
cord-005453-4057qib7	543	26	or	or	CC
cord-005453-4057qib7	543	27	daunorubicin	daunorubicin	NNS
cord-005453-4057qib7	543	28	/	/	SYM
cord-005453-4057qib7	543	29	cytarabin	cytarabin	NN
cord-005453-4057qib7	543	30	in	in	IN
cord-005453-4057qib7	543	31	10	10	CD
cord-005453-4057qib7	543	32	,	,	,
cord-005453-4057qib7	543	33	or	or	CC
cord-005453-4057qib7	543	34	other	other	JJ
cord-005453-4057qib7	543	35	regimens	regimen	NNS
cord-005453-4057qib7	543	36	in	in	IN
cord-005453-4057qib7	543	37	7	7	CD
cord-005453-4057qib7	543	38	,	,	,
cord-005453-4057qib7	543	39	and	and	CC
cord-005453-4057qib7	543	40	6	6	CD
cord-005453-4057qib7	543	41	of	of	IN
cord-005453-4057qib7	543	42	them	-PRON-	PRP
cord-005453-4057qib7	543	43	were	be	VBD
cord-005453-4057qib7	543	44	combined	combine	VBN
cord-005453-4057qib7	543	45	with	with	IN
cord-005453-4057qib7	543	46	gemtuzumab	gemtuzumab	JJ
cord-005453-4057qib7	543	47	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	543	48	.	.	.
cord-005453-4057qib7	544	1	Without	without	IN
cord-005453-4057qib7	544	2	waiting	wait	VBG
cord-005453-4057qib7	544	3	for	for	IN
cord-005453-4057qib7	544	4	hematological	hematological	JJ
cord-005453-4057qib7	544	5	recovery	recovery	NN
cord-005453-4057qib7	544	6	,	,	,
cord-005453-4057qib7	544	7	the	the	DT
cord-005453-4057qib7	544	8	patients	patient	NNS
cord-005453-4057qib7	544	9	promptly	promptly	RB
cord-005453-4057qib7	544	10	underwent	undergo	VBD
cord-005453-4057qib7	544	11	HSCT	HSCT	NNP
cord-005453-4057qib7	544	12	;	;	:
cord-005453-4057qib7	544	13	therefore	therefore	RB
cord-005453-4057qib7	544	14	,	,	,
cord-005453-4057qib7	544	15	the	the	DT
cord-005453-4057qib7	544	16	median	median	JJ
cord-005453-4057qib7	544	17	interval	interval	NN
cord-005453-4057qib7	544	18	between	between	IN
cord-005453-4057qib7	544	19	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	544	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	544	21	and	and	CC
cord-005453-4057qib7	544	22	main	main	JJ
cord-005453-4057qib7	544	23	conditioning	conditioning	NN
cord-005453-4057qib7	544	24	was	be	VBD
cord-005453-4057qib7	544	25	11	11	CD
cord-005453-4057qib7	544	26	days	day	NNS
cord-005453-4057qib7	544	27	.	.	.
cord-005453-4057qib7	545	1	The	the	DT
cord-005453-4057qib7	545	2	main	main	JJ
cord-005453-4057qib7	545	3	conditioning	conditioning	NN
cord-005453-4057qib7	545	4	regimens	regimen	NNS
cord-005453-4057qib7	545	5	were	be	VBD
cord-005453-4057qib7	545	6	total	total	JJ
cord-005453-4057qib7	545	7	body	body	NN
cord-005453-4057qib7	545	8	irradiation	irradiation	NN
cord-005453-4057qib7	545	9	-	-	HYPH
cord-005453-4057qib7	545	10	based	base	VBN
cord-005453-4057qib7	545	11	myeloablative	myeloablative	NNP
cord-005453-4057qib7	545	12	(	(	-LRB-
cord-005453-4057qib7	545	13	n	n	NN
cord-005453-4057qib7	545	14	=	=	SYM
cord-005453-4057qib7	545	15	22	22	CD
cord-005453-4057qib7	545	16	)	)	-RRB-
cord-005453-4057qib7	545	17	,	,	,
cord-005453-4057qib7	545	18	busulfan	busulfan	NN
cord-005453-4057qib7	545	19	-	-	HYPH
cord-005453-4057qib7	545	20	based	base	VBN
cord-005453-4057qib7	545	21	myeloablative	myeloablative	NNP
cord-005453-4057qib7	545	22	(	(	-LRB-
cord-005453-4057qib7	545	23	n	n	NN
cord-005453-4057qib7	545	24	=	=	SYM
cord-005453-4057qib7	545	25	4	4	CD
cord-005453-4057qib7	545	26	)	)	-RRB-
cord-005453-4057qib7	545	27	,	,	,
cord-005453-4057qib7	545	28	or	or	CC
cord-005453-4057qib7	545	29	reduced	reduce	VBN
cord-005453-4057qib7	545	30	intensity	intensity	NN
cord-005453-4057qib7	545	31	(	(	-LRB-
cord-005453-4057qib7	545	32	n	n	NN
cord-005453-4057qib7	545	33	=	=	SYM
cord-005453-4057qib7	545	34	3	3	CD
cord-005453-4057qib7	545	35	)	)	-RRB-
cord-005453-4057qib7	545	36	.	.	.
cord-005453-4057qib7	546	1	Results	result	NNS
cord-005453-4057qib7	546	2	:	:	:
cord-005453-4057qib7	547	1	In	in	IN
cord-005453-4057qib7	547	2	90	90	CD
cord-005453-4057qib7	547	3	children	child	NNS
cord-005453-4057qib7	547	4	with	with	IN
cord-005453-4057qib7	547	5	relapsed	relapse	VBN
cord-005453-4057qib7	547	6	/	/	SYM
cord-005453-4057qib7	547	7	refractory	refractory	JJ
cord-005453-4057qib7	547	8	acute	acute	JJ
cord-005453-4057qib7	547	9	leukemia	leukemia	NN
cord-005453-4057qib7	547	10	,	,	,
cord-005453-4057qib7	547	11	the	the	DT
cord-005453-4057qib7	547	12	5-year	5-year	CD
cord-005453-4057qib7	547	13	overall	overall	JJ
cord-005453-4057qib7	547	14	survival	survival	NN
cord-005453-4057qib7	547	15	(	(	-LRB-
cord-005453-4057qib7	547	16	OS	OS	NNP
cord-005453-4057qib7	547	17	)	)	-RRB-
cord-005453-4057qib7	547	18	,	,	,
cord-005453-4057qib7	547	19	leukemia	leukemia	NN
cord-005453-4057qib7	547	20	-	-	HYPH
cord-005453-4057qib7	547	21	free	free	JJ
cord-005453-4057qib7	547	22	survival	survival	NN
cord-005453-4057qib7	547	23	(	(	-LRB-
cord-005453-4057qib7	547	24	LFS	LFS	NNP
cord-005453-4057qib7	547	25	)	)	-RRB-
cord-005453-4057qib7	547	26	,	,	,
cord-005453-4057qib7	547	27	cumulative	cumulative	JJ
cord-005453-4057qib7	547	28	incidence	incidence	NN
cord-005453-4057qib7	547	29	of	of	IN
cord-005453-4057qib7	547	30	relapse	relapse	NN
cord-005453-4057qib7	547	31	(	(	-LRB-
cord-005453-4057qib7	547	32	RI	RI	NNP
cord-005453-4057qib7	547	33	)	)	-RRB-
cord-005453-4057qib7	547	34	,	,	,
cord-005453-4057qib7	547	35	and	and	CC
cord-005453-4057qib7	547	36	transplantation	transplantation	NN
cord-005453-4057qib7	547	37	-	-	HYPH
cord-005453-4057qib7	547	38	related	relate	VBN
cord-005453-4057qib7	547	39	mortality	mortality	NN
cord-005453-4057qib7	547	40	(	(	-LRB-
cord-005453-4057qib7	547	41	TRM	TRM	NNP
cord-005453-4057qib7	547	42	)	)	-RRB-
cord-005453-4057qib7	547	43	were	be	VBD
cord-005453-4057qib7	547	44	24	24	CD
cord-005453-4057qib7	547	45	%	%	NN
cord-005453-4057qib7	547	46	,	,	,
cord-005453-4057qib7	547	47	21	21	CD
cord-005453-4057qib7	547	48	%	%	NN
cord-005453-4057qib7	547	49	,	,	,
cord-005453-4057qib7	547	50	53	53	CD
cord-005453-4057qib7	547	51	%	%	NN
cord-005453-4057qib7	547	52	,	,	,
cord-005453-4057qib7	547	53	and	and	CC
cord-005453-4057qib7	547	54	26	26	CD
cord-005453-4057qib7	547	55	%	%	NN
cord-005453-4057qib7	547	56	,	,	,
cord-005453-4057qib7	547	57	respectively	respectively	RB
cord-005453-4057qib7	547	58	.	.	.
cord-005453-4057qib7	548	1	In	in	IN
cord-005453-4057qib7	548	2	multivariate	multivariate	JJ
cord-005453-4057qib7	548	3	analysis	analysis	NN
cord-005453-4057qib7	548	4	,	,	,
cord-005453-4057qib7	548	5	the	the	DT
cord-005453-4057qib7	548	6	use	use	NN
cord-005453-4057qib7	548	7	of	of	IN
cord-005453-4057qib7	548	8	sequential	sequential	JJ
cord-005453-4057qib7	548	9	conditioning	conditioning	NN
cord-005453-4057qib7	548	10	was	be	VBD
cord-005453-4057qib7	548	11	identified	identify	VBN
cord-005453-4057qib7	548	12	as	as	IN
cord-005453-4057qib7	548	13	the	the	DT
cord-005453-4057qib7	548	14	most	most	RBS
cord-005453-4057qib7	548	15	favorable	favorable	JJ
cord-005453-4057qib7	548	16	factor	factor	NN
cord-005453-4057qib7	548	17	for	for	IN
cord-005453-4057qib7	548	18	LFS	LFS	NNP
cord-005453-4057qib7	548	19	(	(	-LRB-
cord-005453-4057qib7	548	20	hazard	hazard	NN
cord-005453-4057qib7	548	21	ratio	ratio	NN
cord-005453-4057qib7	548	22	[	[	-LRB-
cord-005453-4057qib7	548	23	HR	HR	NNP
cord-005453-4057qib7	548	24	]	]	-RRB-
cord-005453-4057qib7	548	25	0.37	0.37	CD
cord-005453-4057qib7	548	26	;	;	:
cord-005453-4057qib7	549	1	P	p	NN
cord-005453-4057qib7	549	2	=	=	SYM
cord-005453-4057qib7	549	3	0.001	0.001	CD
cord-005453-4057qib7	549	4	)	)	-RRB-
cord-005453-4057qib7	549	5	,	,	,
cord-005453-4057qib7	549	6	although	although	IN
cord-005453-4057qib7	549	7	there	there	EX
cord-005453-4057qib7	549	8	were	be	VBD
cord-005453-4057qib7	549	9	no	no	DT
cord-005453-4057qib7	549	10	differences	difference	NNS
cord-005453-4057qib7	549	11	in	in	IN
cord-005453-4057qib7	549	12	the	the	DT
cord-005453-4057qib7	549	13	outcomes	outcome	NNS
cord-005453-4057qib7	549	14	according	accord	VBG
cord-005453-4057qib7	549	15	to	to	IN
cord-005453-4057qib7	549	16	the	the	DT
cord-005453-4057qib7	549	17	types	type	NNS
cord-005453-4057qib7	549	18	of	of	IN
cord-005453-4057qib7	549	19	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	549	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	549	21	or	or	CC
cord-005453-4057qib7	549	22	the	the	DT
cord-005453-4057qib7	549	23	main	main	JJ
cord-005453-4057qib7	549	24	conditioning	conditioning	NN
cord-005453-4057qib7	549	25	regimen	regimen	NN
cord-005453-4057qib7	549	26	.	.	.
cord-005453-4057qib7	550	1	HLA	HLA	NNP
cord-005453-4057qib7	550	2	-	-	HYPH
cord-005453-4057qib7	550	3	matched	match	VBN
cord-005453-4057qib7	550	4	donor	donor	NN
cord-005453-4057qib7	550	5	(	(	-LRB-
cord-005453-4057qib7	550	6	HR	hr	NN
cord-005453-4057qib7	550	7	0.46	0.46	CD
cord-005453-4057qib7	550	8	;	;	:
cord-005453-4057qib7	550	9	P	p	NN
cord-005453-4057qib7	550	10	=	=	SYM
cord-005453-4057qib7	550	11	0.005	0.005	CD
cord-005453-4057qib7	550	12	)	)	-RRB-
cord-005453-4057qib7	550	13	and	and	CC
cord-005453-4057qib7	550	14	PB	PB	NNP
cord-005453-4057qib7	550	15	blasts	blast	NNS
cord-005453-4057qib7	550	16	-	-	HYPH
cord-005453-4057qib7	550	17	negative	negative	JJ
cord-005453-4057qib7	550	18	at	at	IN
cord-005453-4057qib7	550	19	the	the	DT
cord-005453-4057qib7	550	20	beginning	beginning	NN
cord-005453-4057qib7	550	21	of	of	IN
cord-005453-4057qib7	550	22	conditioning	conditioning	NN
cord-005453-4057qib7	550	23	(	(	-LRB-
cord-005453-4057qib7	550	24	HR	HR	NNP
cord-005453-4057qib7	550	25	0.49	0.49	CD
cord-005453-4057qib7	550	26	;	;	:
cord-005453-4057qib7	550	27	P	p	NN
cord-005453-4057qib7	550	28	=	=	SYM
cord-005453-4057qib7	550	29	0.02	0.02	CD
cord-005453-4057qib7	550	30	)	)	-RRB-
cord-005453-4057qib7	550	31	were	be	VBD
cord-005453-4057qib7	550	32	also	also	RB
cord-005453-4057qib7	550	33	independently	independently	RB
cord-005453-4057qib7	550	34	associated	associate	VBN
cord-005453-4057qib7	550	35	with	with	IN
cord-005453-4057qib7	550	36	better	well	JJR
cord-005453-4057qib7	550	37	LFS	lfs	NN
cord-005453-4057qib7	550	38	.	.	.
cord-005453-4057qib7	551	1	With	with	IN
cord-005453-4057qib7	551	2	sequential	sequential	JJ
cord-005453-4057qib7	551	3	conditioning	conditioning	NN
cord-005453-4057qib7	551	4	,	,	,
cord-005453-4057qib7	551	5	leukemia	leukemia	NN
cord-005453-4057qib7	551	6	burden	burden	NN
cord-005453-4057qib7	551	7	prior	prior	RB
cord-005453-4057qib7	551	8	to	to	IN
cord-005453-4057qib7	551	9	the	the	DT
cord-005453-4057qib7	551	10	HSCT	HSCT	NNP
cord-005453-4057qib7	551	11	was	be	VBD
cord-005453-4057qib7	551	12	significantly	significantly	RB
cord-005453-4057qib7	551	13	reduced	reduce	VBN
cord-005453-4057qib7	551	14	;	;	:
cord-005453-4057qib7	551	15	PB	PB	NNP
cord-005453-4057qib7	551	16	blasts	blast	NNS
cord-005453-4057qib7	551	17	became	become	VBD
cord-005453-4057qib7	551	18	undetectable	undetectable	JJ
cord-005453-4057qib7	551	19	at	at	IN
cord-005453-4057qib7	551	20	the	the	DT
cord-005453-4057qib7	551	21	beginning	beginning	NN
cord-005453-4057qib7	551	22	of	of	IN
cord-005453-4057qib7	551	23	conditioning	conditioning	NN
cord-005453-4057qib7	551	24	in	in	IN
cord-005453-4057qib7	551	25	66	66	CD
cord-005453-4057qib7	551	26	%	%	NN
cord-005453-4057qib7	551	27	patients	patient	NNS
cord-005453-4057qib7	551	28	given	give	VBN
cord-005453-4057qib7	551	29	the	the	DT
cord-005453-4057qib7	551	30	approach	approach	NN
cord-005453-4057qib7	551	31	,	,	,
cord-005453-4057qib7	551	32	while	while	IN
cord-005453-4057qib7	551	33	in	in	IN
cord-005453-4057qib7	551	34	38	38	CD
cord-005453-4057qib7	551	35	%	%	NN
cord-005453-4057qib7	551	36	patients	patient	NNS
cord-005453-4057qib7	551	37	without	without	IN
cord-005453-4057qib7	551	38	the	the	DT
cord-005453-4057qib7	551	39	approach	approach	NN
cord-005453-4057qib7	551	40	(	(	-LRB-
cord-005453-4057qib7	551	41	P	p	NN
cord-005453-4057qib7	551	42	=	=	SYM
cord-005453-4057qib7	551	43	0.02	0.02	CD
cord-005453-4057qib7	551	44	)	)	-RRB-
cord-005453-4057qib7	551	45	.	.	.
cord-005453-4057qib7	552	1	Notably	notably	RB
cord-005453-4057qib7	552	2	,	,	,
cord-005453-4057qib7	552	3	the	the	DT
cord-005453-4057qib7	552	4	outcomes	outcome	NNS
cord-005453-4057qib7	552	5	in	in	IN
cord-005453-4057qib7	552	6	the	the	DT
cord-005453-4057qib7	552	7	patients	patient	NNS
cord-005453-4057qib7	552	8	without	without	IN
cord-005453-4057qib7	552	9	PB	PB	NNP
cord-005453-4057qib7	552	10	blasts	blast	NNS
cord-005453-4057qib7	552	11	at	at	IN
cord-005453-4057qib7	552	12	the	the	DT
cord-005453-4057qib7	552	13	beginning	beginning	NN
cord-005453-4057qib7	552	14	of	of	IN
cord-005453-4057qib7	552	15	conditioning	conditioning	NN
cord-005453-4057qib7	552	16	who	who	WP
cord-005453-4057qib7	552	17	received	receive	VBD
cord-005453-4057qib7	552	18	sequential	sequential	JJ
cord-005453-4057qib7	552	19	conditioning	conditioning	NN
cord-005453-4057qib7	552	20	were	be	VBD
cord-005453-4057qib7	552	21	promising	promising	JJ
cord-005453-4057qib7	552	22	;	;	:
cord-005453-4057qib7	552	23	the	the	DT
cord-005453-4057qib7	552	24	5-year	5-year	CD
cord-005453-4057qib7	552	25	OS	OS	NNP
cord-005453-4057qib7	552	26	and	and	CC
cord-005453-4057qib7	552	27	LFS	lfs	NN
cord-005453-4057qib7	552	28	reached	reach	VBD
cord-005453-4057qib7	552	29	73	73	CD
cord-005453-4057qib7	552	30	%	%	NN
cord-005453-4057qib7	552	31	and	and	CC
cord-005453-4057qib7	552	32	62	62	CD
cord-005453-4057qib7	552	33	%	%	NN
cord-005453-4057qib7	552	34	and	and	CC
cord-005453-4057qib7	552	35	the	the	DT
cord-005453-4057qib7	552	36	5-year	5-year	CD
cord-005453-4057qib7	552	37	RI	RI	NNP
cord-005453-4057qib7	552	38	and	and	CC
cord-005453-4057qib7	552	39	TRM	TRM	NNP
cord-005453-4057qib7	552	40	were	be	VBD
cord-005453-4057qib7	552	41	33	33	CD
cord-005453-4057qib7	552	42	%	%	NN
cord-005453-4057qib7	552	43	and	and	CC
cord-005453-4057qib7	552	44	5	5	CD
cord-005453-4057qib7	552	45	%	%	NN
cord-005453-4057qib7	552	46	,	,	,
cord-005453-4057qib7	552	47	respectively	respectively	RB
cord-005453-4057qib7	552	48	.	.	.
cord-005453-4057qib7	553	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	553	2	:	:	:
cord-005453-4057qib7	554	1	Our	-PRON-	PRP$
cord-005453-4057qib7	554	2	study	study	NN
cord-005453-4057qib7	554	3	reveals	reveal	VBZ
cord-005453-4057qib7	554	4	that	that	IN
cord-005453-4057qib7	554	5	HSCT	HSCT	NNP
cord-005453-4057qib7	554	6	with	with	IN
cord-005453-4057qib7	554	7	sequential	sequential	JJ
cord-005453-4057qib7	554	8	conditioning	conditioning	NN
cord-005453-4057qib7	554	9	can	can	MD
cord-005453-4057qib7	554	10	be	be	VB
cord-005453-4057qib7	554	11	an	an	DT
cord-005453-4057qib7	554	12	effective	effective	JJ
cord-005453-4057qib7	554	13	and	and	CC
cord-005453-4057qib7	554	14	tolerable	tolerable	JJ
cord-005453-4057qib7	554	15	treatment	treatment	NN
cord-005453-4057qib7	554	16	option	option	NN
cord-005453-4057qib7	554	17	for	for	IN
cord-005453-4057qib7	554	18	children	child	NNS
cord-005453-4057qib7	554	19	with	with	IN
cord-005453-4057qib7	554	20	relapsed	relapse	VBN
cord-005453-4057qib7	554	21	/	/	SYM
cord-005453-4057qib7	554	22	refractory	refractory	JJ
cord-005453-4057qib7	554	23	acute	acute	JJ
cord-005453-4057qib7	554	24	leukemia	leukemia	NN
cord-005453-4057qib7	554	25	.	.	.
cord-005453-4057qib7	555	1	The	the	DT
cord-005453-4057qib7	555	2	treatment	treatment	NN
cord-005453-4057qib7	555	3	strategies	strategy	NNS
cord-005453-4057qib7	555	4	that	that	WDT
cord-005453-4057qib7	555	5	focus	focus	VBP
cord-005453-4057qib7	555	6	on	on	IN
cord-005453-4057qib7	555	7	the	the	DT
cord-005453-4057qib7	555	8	reduction	reduction	NN
cord-005453-4057qib7	555	9	of	of	IN
cord-005453-4057qib7	555	10	leukemia	leukemia	NN
cord-005453-4057qib7	555	11	burden	burden	NN
cord-005453-4057qib7	555	12	immediately	immediately	RB
cord-005453-4057qib7	555	13	prior	prior	RB
cord-005453-4057qib7	555	14	to	to	IN
cord-005453-4057qib7	555	15	HSCT	HSCT	NNP
cord-005453-4057qib7	555	16	may	may	MD
cord-005453-4057qib7	555	17	contribute	contribute	VB
cord-005453-4057qib7	555	18	to	to	IN
cord-005453-4057qib7	555	19	the	the	DT
cord-005453-4057qib7	555	20	induction	induction	NN
cord-005453-4057qib7	555	21	of	of	IN
cord-005453-4057qib7	555	22	long	long	JJ
cord-005453-4057qib7	555	23	-	-	HYPH
cord-005453-4057qib7	555	24	term	term	NN
cord-005453-4057qib7	555	25	remissions	remission	NNS
cord-005453-4057qib7	555	26	in	in	IN
cord-005453-4057qib7	555	27	patients	patient	NNS
cord-005453-4057qib7	555	28	with	with	IN
cord-005453-4057qib7	555	29	high	high	JJ
cord-005453-4057qib7	555	30	-	-	HYPH
cord-005453-4057qib7	555	31	risk	risk	NN
cord-005453-4057qib7	555	32	acute	acute	JJ
cord-005453-4057qib7	555	33	leukemia	leukemia	NN
cord-005453-4057qib7	555	34	.	.	.
cord-005453-4057qib7	556	1	Disclosure	disclosure	NN
cord-005453-4057qib7	556	2	:	:	:
cord-005453-4057qib7	557	1	This	this	DT
cord-005453-4057qib7	557	2	research	research	NN
cord-005453-4057qib7	557	3	was	be	VBD
cord-005453-4057qib7	557	4	funded	fund	VBN
cord-005453-4057qib7	557	5	by	by	IN
cord-005453-4057qib7	557	6	Japanese	Japanese	NNP
cord-005453-4057qib7	557	7	Red	Red	NNP
cord-005453-4057qib7	557	8	Cross	Cross	NNP
cord-005453-4057qib7	557	9	,	,	,
cord-005453-4057qib7	557	10	Nagoya	Nagoya	NNP
cord-005453-4057qib7	557	11	1st	1st	NN
cord-005453-4057qib7	557	12	.	.	.
cord-005453-4057qib7	558	1	Hospital	hospital	NN
cord-005453-4057qib7	558	2	Research	Research	NNP
cord-005453-4057qib7	558	3	Grant	Grant	NNP
cord-005453-4057qib7	558	4	NFRCH18	NFRCH18	NNP
cord-005453-4057qib7	558	5	-	-	HYPH
cord-005453-4057qib7	558	6	0028	0028	CD
cord-005453-4057qib7	558	7	.	.	.
cord-005453-4057qib7	559	1	Use	Use	NNP
cord-005453-4057qib7	559	2	of	of	IN
cord-005453-4057qib7	559	3	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	559	4	to	to	TO
cord-005453-4057qib7	559	5	achieve	achieve	VB
cord-005453-4057qib7	559	6	remission	remission	NN
cord-005453-4057qib7	559	7	and	and	CC
cord-005453-4057qib7	559	8	consolidation	consolidation	NN
cord-005453-4057qib7	559	9	with	with	IN
cord-005453-4057qib7	559	10	haploidentical	haploidentical	JJ
cord-005453-4057qib7	559	11	transplant	transplant	NN
cord-005453-4057qib7	559	12	with	with	IN
cord-005453-4057qib7	559	13	cyclophosphamide	cyclophosphamide	NNP
cord-005453-4057qib7	559	14	post	post	NN
cord-005453-4057qib7	559	15	for	for	IN
cord-005453-4057qib7	559	16	the	the	DT
cord-005453-4057qib7	559	17	treatment	treatment	NN
cord-005453-4057qib7	559	18	of	of	IN
cord-005453-4057qib7	559	19	children	child	NNS
cord-005453-4057qib7	559	20	with	with	IN
cord-005453-4057qib7	559	21	refractory	refractory	JJ
cord-005453-4057qib7	559	22	acute	acute	JJ
cord-005453-4057qib7	559	23	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	559	24	leukemia	leukemia	NN
cord-005453-4057qib7	559	25	(	(	-LRB-
cord-005453-4057qib7	559	26	ALL	all	DT
cord-005453-4057qib7	559	27	)	)	-RRB-
cord-005453-4057qib7	560	1	Background	background	NN
cord-005453-4057qib7	560	2	:	:	:
cord-005453-4057qib7	561	1	Most	Most	JJS
cord-005453-4057qib7	561	2	of	of	IN
cord-005453-4057qib7	561	3	patients	patient	NNS
cord-005453-4057qib7	561	4	with	with	IN
cord-005453-4057qib7	561	5	ALL	all	DT
cord-005453-4057qib7	561	6	in	in	IN
cord-005453-4057qib7	561	7	relapse	relapse	NN
cord-005453-4057qib7	561	8	or	or	CC
cord-005453-4057qib7	561	9	refractory	refractory	JJ
cord-005453-4057qib7	561	10	to	to	IN
cord-005453-4057qib7	561	11	conventional	conventional	JJ
cord-005453-4057qib7	561	12	treatment	treatment	NN
cord-005453-4057qib7	561	13	have	have	VBP
cord-005453-4057qib7	561	14	only	only	RB
cord-005453-4057qib7	561	15	30	30	CD
cord-005453-4057qib7	561	16	%	%	NN
cord-005453-4057qib7	561	17	possibilities	possibility	NNS
cord-005453-4057qib7	561	18	to	to	TO
cord-005453-4057qib7	561	19	achieve	achieve	VB
cord-005453-4057qib7	561	20	long	long	JJ
cord-005453-4057qib7	561	21	term	term	NN
cord-005453-4057qib7	561	22	remission	remission	NN
cord-005453-4057qib7	561	23	.	.	.
cord-005453-4057qib7	562	1	This	this	DT
cord-005453-4057qib7	562	2	report	report	NN
cord-005453-4057qib7	562	3	refers	refer	VBZ
cord-005453-4057qib7	562	4	to	to	IN
cord-005453-4057qib7	562	5	the	the	DT
cord-005453-4057qib7	562	6	therapeutic	therapeutic	JJ
cord-005453-4057qib7	562	7	efficacy	efficacy	NN
cord-005453-4057qib7	562	8	and	and	CC
cord-005453-4057qib7	562	9	adverse	adverse	JJ
cord-005453-4057qib7	562	10	events	event	NNS
cord-005453-4057qib7	562	11	from	from	IN
cord-005453-4057qib7	562	12	the	the	DT
cord-005453-4057qib7	562	13	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	562	14	to	to	TO
cord-005453-4057qib7	562	15	achieve	achieve	VB
cord-005453-4057qib7	562	16	molecular	molecular	JJ
cord-005453-4057qib7	562	17	remission	remission	NN
cord-005453-4057qib7	562	18	in	in	IN
cord-005453-4057qib7	562	19	patients	patient	NNS
cord-005453-4057qib7	562	20	with	with	IN
cord-005453-4057qib7	562	21	pre	pre	JJ
cord-005453-4057qib7	562	22	-	-	NN
cord-005453-4057qib7	562	23	B	B	NNP
cord-005453-4057qib7	562	24	CD19	CD19	NNP
cord-005453-4057qib7	562	25	+	+	CC
cord-005453-4057qib7	562	26	which	which	WDT
cord-005453-4057qib7	562	27	lead	lead	VBP
cord-005453-4057qib7	562	28	to	to	IN
cord-005453-4057qib7	562	29	haploidentical	haploidentical	VB
cord-005453-4057qib7	562	30	with	with	IN
cord-005453-4057qib7	562	31	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	562	32	post	post	NN
cord-005453-4057qib7	562	33	transplant	transplant	NN
cord-005453-4057qib7	562	34	as	as	IN
cord-005453-4057qib7	562	35	a	a	DT
cord-005453-4057qib7	562	36	consolidation	consolidation	NN
cord-005453-4057qib7	562	37	.	.	.
cord-005453-4057qib7	563	1	Methods	method	NNS
cord-005453-4057qib7	563	2	:	:	:
cord-005453-4057qib7	564	1	A	a	DT
cord-005453-4057qib7	564	2	pilot	pilot	NN
cord-005453-4057qib7	564	3	study	study	NN
cord-005453-4057qib7	564	4	was	be	VBD
cord-005453-4057qib7	564	5	conducted	conduct	VBN
cord-005453-4057qib7	564	6	in	in	IN
cord-005453-4057qib7	564	7	children	child	NNS
cord-005453-4057qib7	564	8	with	with	IN
cord-005453-4057qib7	564	9	refractory	refractory	JJ
cord-005453-4057qib7	564	10	ALL	all	DT
cord-005453-4057qib7	564	11	preB	preB	NNS
cord-005453-4057qib7	564	12	-	-	:
cord-005453-4057qib7	564	13	CD19	CD19	NNP
cord-005453-4057qib7	564	14	+	+	CC
cord-005453-4057qib7	564	15	.	.	.
cord-005453-4057qib7	565	1	As	as	IN
cord-005453-4057qib7	565	2	a	a	DT
cord-005453-4057qib7	565	3	strategy	strategy	NN
cord-005453-4057qib7	565	4	to	to	TO
cord-005453-4057qib7	565	5	achieved	achieve	VBN
cord-005453-4057qib7	565	6	remission	remission	NN
cord-005453-4057qib7	565	7	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	565	8	was	be	VBD
cord-005453-4057qib7	565	9	used	use	VBN
cord-005453-4057qib7	565	10	at	at	IN
cord-005453-4057qib7	565	11	a	a	DT
cord-005453-4057qib7	565	12	dose	dose	NN
cord-005453-4057qib7	565	13	10	10	CD
cord-005453-4057qib7	565	14	μg	μg	NNP
cord-005453-4057qib7	565	15	/	/	SYM
cord-005453-4057qib7	565	16	m2	m2	NNP
cord-005453-4057qib7	565	17	for	for	IN
cord-005453-4057qib7	565	18	continous	continous	JJ
cord-005453-4057qib7	565	19	infusion	infusion	NN
cord-005453-4057qib7	565	20	of	of	IN
cord-005453-4057qib7	565	21	48	48	CD
cord-005453-4057qib7	565	22	hours	hour	NNS
cord-005453-4057qib7	565	23	,	,	,
cord-005453-4057qib7	565	24	increasing	increase	VBG
cord-005453-4057qib7	565	25	the	the	DT
cord-005453-4057qib7	565	26	dose	dose	NN
cord-005453-4057qib7	565	27	to	to	IN
cord-005453-4057qib7	565	28	15	15	CD
cord-005453-4057qib7	565	29	μg	μg	NNP
cord-005453-4057qib7	565	30	/	/	SYM
cord-005453-4057qib7	565	31	m2	m2	NNP
cord-005453-4057qib7	565	32	during	during	IN
cord-005453-4057qib7	565	33	28	28	CD
cord-005453-4057qib7	565	34	days	day	NNS
cord-005453-4057qib7	565	35	,	,	,
cord-005453-4057qib7	565	36	patients	patient	NNS
cord-005453-4057qib7	565	37	with	with	IN
cord-005453-4057qib7	565	38	a	a	DT
cord-005453-4057qib7	565	39	MRD	MRD	NNP
cord-005453-4057qib7	565	40	of	of	IN
cord-005453-4057qib7	565	41	<	<	XX
cord-005453-4057qib7	565	42	0.002	0.002	CD
cord-005453-4057qib7	565	43	Log	Log	NNP
cord-005453-4057qib7	565	44	,	,	,
cord-005453-4057qib7	565	45	after	after	IN
cord-005453-4057qib7	565	46	2	2	CD
cord-005453-4057qib7	565	47	cycles	cycle	NNS
cord-005453-4057qib7	565	48	received	receive	VBD
cord-005453-4057qib7	565	49	an	an	DT
cord-005453-4057qib7	565	50	haploidentical	haploidentical	JJ
cord-005453-4057qib7	565	51	bone	bone	NN
cord-005453-4057qib7	565	52	marrow	marrow	NN
cord-005453-4057qib7	565	53	transplant	transplant	NN
cord-005453-4057qib7	565	54	as	as	IN
cord-005453-4057qib7	565	55	a	a	DT
cord-005453-4057qib7	565	56	consolidation	consolidation	NN
cord-005453-4057qib7	565	57	,	,	,
cord-005453-4057qib7	565	58	the	the	DT
cord-005453-4057qib7	565	59	conditioning	conditioning	NN
cord-005453-4057qib7	565	60	regimen	regimen	NN
cord-005453-4057qib7	565	61	was	be	VBD
cord-005453-4057qib7	565	62	with	with	IN
cord-005453-4057qib7	565	63	total	total	JJ
cord-005453-4057qib7	565	64	body	body	NN
cord-005453-4057qib7	565	65	irradiation	irradiation	NN
cord-005453-4057qib7	565	66	scheme	scheme	NN
cord-005453-4057qib7	565	67	at	at	IN
cord-005453-4057qib7	565	68	200	200	CD
cord-005453-4057qib7	565	69	cGy	cGy	NNS
cord-005453-4057qib7	565	70	/	/	SYM
cord-005453-4057qib7	565	71	day/3	day/3	JJ
cord-005453-4057qib7	565	72	days	day	NNS
cord-005453-4057qib7	565	73	,	,	,
cord-005453-4057qib7	565	74	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	565	75	and	and	CC
cord-005453-4057qib7	565	76	etoposide	etoposide	RB
cord-005453-4057qib7	565	77	.	.	.
cord-005453-4057qib7	566	1	Receiving	receive	VBG
cord-005453-4057qib7	566	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	566	3	for	for	IN
cord-005453-4057qib7	566	4	GVHD	GVHD	NNP
cord-005453-4057qib7	566	5	with	with	IN
cord-005453-4057qib7	566	6	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	566	7	.	.	.
cord-005453-4057qib7	567	1	Results	result	NNS
cord-005453-4057qib7	567	2	:	:	:
cord-005453-4057qib7	568	1	A	a	DT
cord-005453-4057qib7	568	2	total	total	NN
cord-005453-4057qib7	568	3	of	of	IN
cord-005453-4057qib7	568	4	10	10	CD
cord-005453-4057qib7	568	5	patients	patient	NNS
cord-005453-4057qib7	568	6	were	be	VBD
cord-005453-4057qib7	568	7	included	include	VBN
cord-005453-4057qib7	568	8	,	,	,
cord-005453-4057qib7	568	9	seven	seven	CD
cord-005453-4057qib7	568	10	of	of	IN
cord-005453-4057qib7	568	11	them	-PRON-	PRP
cord-005453-4057qib7	568	12	achieved	achieve	VBD
cord-005453-4057qib7	568	13	complete	complete	JJ
cord-005453-4057qib7	568	14	remission	remission	NN
cord-005453-4057qib7	568	15	after	after	IN
cord-005453-4057qib7	568	16	2	2	CD
cord-005453-4057qib7	568	17	cycles	cycle	NNS
cord-005453-4057qib7	568	18	of	of	IN
cord-005453-4057qib7	568	19	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	568	20	,	,	,
cord-005453-4057qib7	568	21	one	one	CD
cord-005453-4057qib7	568	22	with	with	IN
cord-005453-4057qib7	568	23	partial	partial	JJ
cord-005453-4057qib7	568	24	remission	remission	NN
cord-005453-4057qib7	568	25	(	(	-LRB-
cord-005453-4057qib7	568	26	Table	table	NN
cord-005453-4057qib7	568	27	1	1	CD
cord-005453-4057qib7	568	28	)	)	-RRB-
cord-005453-4057qib7	568	29	,	,	,
cord-005453-4057qib7	568	30	these	these	DT
cord-005453-4057qib7	568	31	seven	seven	CD
cord-005453-4057qib7	568	32	patients	patient	NNS
cord-005453-4057qib7	568	33	,	,	,
cord-005453-4057qib7	568	34	six	six	CD
cord-005453-4057qib7	568	35	received	receive	VBD
cord-005453-4057qib7	568	36	an	an	DT
cord-005453-4057qib7	568	37	haploidentic	haploidentic	JJ
cord-005453-4057qib7	568	38	transplant	transplant	NN
cord-005453-4057qib7	568	39	achieving	achieve	VBG
cord-005453-4057qib7	568	40	graft	graft	NN
cord-005453-4057qib7	568	41	in	in	IN
cord-005453-4057qib7	568	42	6	6	CD
cord-005453-4057qib7	568	43	of	of	IN
cord-005453-4057qib7	568	44	the	the	DT
cord-005453-4057qib7	568	45	transplanted	transplanted	JJ
cord-005453-4057qib7	568	46	patients	patient	NNS
cord-005453-4057qib7	568	47	.	.	.
cord-005453-4057qib7	569	1	One	one	CD
cord-005453-4057qib7	569	2	patient	patient	NN
cord-005453-4057qib7	569	3	had	have	VBD
cord-005453-4057qib7	569	4	a	a	DT
cord-005453-4057qib7	569	5	bone	bone	NN
cord-005453-4057qib7	569	6	marrow	marrow	NN
cord-005453-4057qib7	569	7	relapse	relapse	NN
cord-005453-4057qib7	569	8	in	in	IN
cord-005453-4057qib7	569	9	the	the	DT
cord-005453-4057qib7	569	10	first	first	JJ
cord-005453-4057qib7	569	11	6	6	CD
cord-005453-4057qib7	569	12	months	month	NNS
cord-005453-4057qib7	569	13	of	of	IN
cord-005453-4057qib7	569	14	the	the	DT
cord-005453-4057qib7	569	15	follow	follow	NN
cord-005453-4057qib7	569	16	-	-	HYPH
cord-005453-4057qib7	569	17	up	up	NN
cord-005453-4057qib7	569	18	and	and	CC
cord-005453-4057qib7	569	19	5	5	CD
cord-005453-4057qib7	569	20	patients	patient	NNS
cord-005453-4057qib7	569	21	are	be	VBP
cord-005453-4057qib7	569	22	free	free	JJ
cord-005453-4057qib7	569	23	of	of	IN
cord-005453-4057qib7	569	24	disease	disease	NN
cord-005453-4057qib7	569	25	with	with	IN
cord-005453-4057qib7	569	26	a	a	DT
cord-005453-4057qib7	569	27	follow	follow	NN
cord-005453-4057qib7	569	28	-	-	HYPH
cord-005453-4057qib7	569	29	up	up	NN
cord-005453-4057qib7	569	30	to	to	TO
cord-005453-4057qib7	569	31	20	20	CD
cord-005453-4057qib7	569	32	months	month	NNS
cord-005453-4057qib7	569	33	(	(	-LRB-
cord-005453-4057qib7	569	34	figure	figure	NN
cord-005453-4057qib7	569	35	1	1	CD
cord-005453-4057qib7	569	36	)	)	-RRB-
cord-005453-4057qib7	569	37	.	.	.
cord-005453-4057qib7	570	1	As	as	IN
cord-005453-4057qib7	570	2	a	a	DT
cord-005453-4057qib7	570	3	acute	acute	JJ
cord-005453-4057qib7	570	4	complication	complication	NN
cord-005453-4057qib7	570	5	the	the	DT
cord-005453-4057qib7	570	6	10	10	CD
cord-005453-4057qib7	570	7	patients	patient	NNS
cord-005453-4057qib7	570	8	presented	present	VBD
cord-005453-4057qib7	570	9	cytokine	cytokine	NN
cord-005453-4057qib7	570	10	release	release	NN
cord-005453-4057qib7	570	11	syndrome	syndrome	NN
cord-005453-4057qib7	570	12	,	,	,
cord-005453-4057qib7	570	13	during	during	IN
cord-005453-4057qib7	570	14	the	the	DT
cord-005453-4057qib7	570	15	infusion	infusion	NN
cord-005453-4057qib7	570	16	of	of	IN
cord-005453-4057qib7	570	17	blinatumumab	blinatumumab	NNP
cord-005453-4057qib7	570	18	10	10	CD
cord-005453-4057qib7	570	19	patients	patient	NNS
cord-005453-4057qib7	570	20	presented	present	VBD
cord-005453-4057qib7	570	21	tachycardia	tachycardia	NN
cord-005453-4057qib7	570	22	(	(	-LRB-
cord-005453-4057qib7	570	23	Table	Table	NNP
cord-005453-4057qib7	570	24	3	3	CD
cord-005453-4057qib7	570	25	)	)	-RRB-
cord-005453-4057qib7	570	26	and	and	CC
cord-005453-4057qib7	570	27	the	the	DT
cord-005453-4057qib7	570	28	6	6	CD
cord-005453-4057qib7	570	29	patients	patient	NNS
cord-005453-4057qib7	570	30	presented	present	VBD
cord-005453-4057qib7	570	31	aGVHD	agvhd	NN
cord-005453-4057qib7	570	32	after	after	IN
cord-005453-4057qib7	570	33	HSCT	HSCT	NNP
cord-005453-4057qib7	570	34	(	(	-LRB-
cord-005453-4057qib7	570	35	5	5	CD
cord-005453-4057qib7	570	36	grade	grade	NN
cord-005453-4057qib7	570	37	I	I	NNP
cord-005453-4057qib7	570	38	-	-	HYPH
cord-005453-4057qib7	570	39	II	II	NNP
cord-005453-4057qib7	570	40	and	and	CC
cord-005453-4057qib7	570	41	I	-PRON-	PRP
cord-005453-4057qib7	570	42	grade	grade	NN
cord-005453-4057qib7	570	43	IV	IV	NNP
cord-005453-4057qib7	570	44	)	)	-RRB-
cord-005453-4057qib7	570	45	.	.	.
cord-005453-4057qib7	571	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	571	2	:	:	:
cord-005453-4057qib7	572	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	572	2	bone	bone	NN
cord-005453-4057qib7	572	3	marrow	marrow	NN
cord-005453-4057qib7	572	4	transplant	transplant	NN
cord-005453-4057qib7	572	5	constitutes	constitute	VBZ
cord-005453-4057qib7	572	6	a	a	DT
cord-005453-4057qib7	572	7	treatment	treatment	NN
cord-005453-4057qib7	572	8	option	option	NN
cord-005453-4057qib7	572	9	on	on	IN
cord-005453-4057qib7	572	10	those	those	DT
cord-005453-4057qib7	572	11	patients	patient	NNS
cord-005453-4057qib7	572	12	that	that	IN
cord-005453-4057qib7	572	13	relapse	relapse	VBP
cord-005453-4057qib7	572	14	or	or	CC
cord-005453-4057qib7	572	15	become	become	VBP
cord-005453-4057qib7	572	16	refractory	refractory	JJ
cord-005453-4057qib7	572	17	to	to	IN
cord-005453-4057qib7	572	18	treatment	treatment	NN
cord-005453-4057qib7	572	19	,	,	,
cord-005453-4057qib7	572	20	one	one	CD
cord-005453-4057qib7	572	21	of	of	IN
cord-005453-4057qib7	572	22	the	the	DT
cord-005453-4057qib7	572	23	major	major	JJ
cord-005453-4057qib7	572	24	problem	problem	NN
cord-005453-4057qib7	572	25	is	be	VBZ
cord-005453-4057qib7	572	26	basically	basically	RB
cord-005453-4057qib7	572	27	to	to	TO
cord-005453-4057qib7	572	28	identify	identify	VB
cord-005453-4057qib7	572	29	a	a	DT
cord-005453-4057qib7	572	30	HLA	HLA	NNP
cord-005453-4057qib7	572	31	-	-	HYPH
cord-005453-4057qib7	572	32	identical	identical	JJ
cord-005453-4057qib7	572	33	donor	donor	NN
cord-005453-4057qib7	572	34	,	,	,
cord-005453-4057qib7	572	35	the	the	DT
cord-005453-4057qib7	572	36	alternative	alternative	NN
cord-005453-4057qib7	572	37	is	be	VBZ
cord-005453-4057qib7	572	38	an	an	DT
cord-005453-4057qib7	572	39	haploidentical	haploidentical	JJ
cord-005453-4057qib7	572	40	donor	donor	NN
cord-005453-4057qib7	572	41	.	.	.
cord-005453-4057qib7	573	1	The	the	DT
cord-005453-4057qib7	573	2	most	most	RBS
cord-005453-4057qib7	573	3	important	important	JJ
cord-005453-4057qib7	573	4	factor	factor	NN
cord-005453-4057qib7	573	5	to	to	TO
cord-005453-4057qib7	573	6	get	get	VB
cord-005453-4057qib7	573	7	these	these	DT
cord-005453-4057qib7	573	8	results	result	NNS
cord-005453-4057qib7	573	9	is	be	VBZ
cord-005453-4057qib7	573	10	the	the	DT
cord-005453-4057qib7	573	11	disease	disease	NN
cord-005453-4057qib7	573	12	status	status	NN
cord-005453-4057qib7	573	13	before	before	IN
cord-005453-4057qib7	573	14	transplant	transplant	NN
cord-005453-4057qib7	573	15	.	.	.
cord-005453-4057qib7	574	1	The	the	DT
cord-005453-4057qib7	574	2	use	use	NN
cord-005453-4057qib7	574	3	of	of	IN
cord-005453-4057qib7	574	4	blinatumomab	blinatumomab	NN
cord-005453-4057qib7	574	5	has	have	VBZ
cord-005453-4057qib7	574	6	proven	prove	VBN
cord-005453-4057qib7	574	7	to	to	TO
cord-005453-4057qib7	574	8	be	be	VB
cord-005453-4057qib7	574	9	effective	effective	JJ
cord-005453-4057qib7	574	10	in	in	IN
cord-005453-4057qib7	574	11	achieving	achieve	VBG
cord-005453-4057qib7	574	12	remission	remission	NN
cord-005453-4057qib7	574	13	in	in	IN
cord-005453-4057qib7	574	14	relapse	relapse	NN
cord-005453-4057qib7	575	1	Acute	acute	JJ
cord-005453-4057qib7	575	2	Linfoblastic	Linfoblastic	NNP
cord-005453-4057qib7	575	3	Leukemia	Leukemia	NNP
cord-005453-4057qib7	575	4	pre	pre	NN
cord-005453-4057qib7	575	5	-	-	JJ
cord-005453-4057qib7	575	6	B	b	NN
cord-005453-4057qib7	575	7	CD	CD	NNP
cord-005453-4057qib7	575	8	19	19	CD
cord-005453-4057qib7	575	9	+	+	CC
cord-005453-4057qib7	575	10	or	or	CC
cord-005453-4057qib7	575	11	refractory	refractory	JJ
cord-005453-4057qib7	575	12	to	to	IN
cord-005453-4057qib7	575	13	treatment	treatment	NN
cord-005453-4057qib7	575	14	.	.	.
cord-005453-4057qib7	576	1	CHARACTERISTICS	CHARACTERISTICS	NNP
cord-005453-4057qib7	576	2	Nº	Nº	NNP
cord-005453-4057qib7	576	3	%	%	NN
cord-005453-4057qib7	577	1	Male	male	JJ
cord-005453-4057qib7	577	2	4	4	CD
cord-005453-4057qib7	577	3	40	40	CD
cord-005453-4057qib7	577	4	%	%	NN
cord-005453-4057qib7	577	5	Median	median	JJ
cord-005453-4057qib7	577	6	age	age	NN
cord-005453-4057qib7	577	7	at	at	IN
cord-005453-4057qib7	577	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	577	9	,	,	,
cord-005453-4057qib7	577	10	(	(	-LRB-
cord-005453-4057qib7	577	11	range	range	NN
cord-005453-4057qib7	577	12	)	)	-RRB-
cord-005453-4057qib7	577	13	,	,	,
cord-005453-4057qib7	577	14	years	year	NNS
cord-005453-4057qib7	577	15	9	9	CD
cord-005453-4057qib7	577	16	.	.	.
cord-005453-4057qib7	577	17	22	22	CD
cord-005453-4057qib7	578	1	(	(	-LRB-
cord-005453-4057qib7	578	2	7	7	CD
cord-005453-4057qib7	578	3	-	-	SYM
cord-005453-4057qib7	578	4	12	12	CD
cord-005453-4057qib7	578	5	)	)	-RRB-
cord-005453-4057qib7	578	6	Status	status	NN
cord-005453-4057qib7	578	7	of	of	IN
cord-005453-4057qib7	578	8	disease	disease	NN
cord-005453-4057qib7	578	9	2	2	CD
cord-005453-4057qib7	578	10	o	o	NN
cord-005453-4057qib7	578	11	+	+	SYM
cord-005453-4057qib7	578	12	3	3	CD
cord-005453-4057qib7	578	13	relapse	relapse	NN
cord-005453-4057qib7	578	14	6	6	CD
cord-005453-4057qib7	578	15	60	60	CD
cord-005453-4057qib7	578	16	%	%	NN
cord-005453-4057qib7	578	17	Refractory	refractory	JJ
cord-005453-4057qib7	578	18	to	to	IN
cord-005453-4057qib7	578	19	primary	primary	JJ
cord-005453-4057qib7	578	20	or	or	CC
cord-005453-4057qib7	578	21	salvage	salvage	VB
cord-005453-4057qib7	578	22	therapy	therapy	NN
cord-005453-4057qib7	579	1	4	4	CD
cord-005453-4057qib7	579	2	40	40	CD
cord-005453-4057qib7	579	3	%	%	NN
cord-005453-4057qib7	579	4	Complete	complete	JJ
cord-005453-4057qib7	579	5	remission	remission	NN
cord-005453-4057qib7	579	6	after	after	IN
cord-005453-4057qib7	579	7	Blinatumomab	Blinatumomab	NNP
cord-005453-4057qib7	580	1	7	7	CD
cord-005453-4057qib7	580	2	70	70	CD
cord-005453-4057qib7	580	3	%	%	NN
cord-005453-4057qib7	580	4	Partial	partial	JJ
cord-005453-4057qib7	580	5	remission	remission	NN
cord-005453-4057qib7	580	6	after	after	IN
cord-005453-4057qib7	580	7	Blinatumomab	Blinatumomab	NNP
cord-005453-4057qib7	580	8	1	1	CD
cord-005453-4057qib7	580	9	10	10	CD
cord-005453-4057qib7	580	10	%	%	NN
cord-005453-4057qib7	580	11	Active	active	JJ
cord-005453-4057qib7	580	12	disease	disease	NN
cord-005453-4057qib7	580	13	2	2	CD
cord-005453-4057qib7	580	14	20	20	CD
cord-005453-4057qib7	580	15	%	%	NN
cord-005453-4057qib7	580	16	[	[	-LRB-
cord-005453-4057qib7	580	17	[	[	-LRB-
cord-005453-4057qib7	580	18	P031	P031	NNP
cord-005453-4057qib7	580	19	Table	table	NN
cord-005453-4057qib7	580	20	]	]	-RRB-
cord-005453-4057qib7	581	1	1	1	LS
cord-005453-4057qib7	581	2	.	.	.
cord-005453-4057qib7	582	1	Table	table	NN
cord-005453-4057qib7	582	2	N	n	CD
cord-005453-4057qib7	582	3	°	°	NN
cord-005453-4057qib7	582	4	1	1	CD
cord-005453-4057qib7	582	5	.	.	.
cord-005453-4057qib7	583	1	Demographic	demographic	JJ
cord-005453-4057qib7	583	2	characteristics	characteristic	NNS
cord-005453-4057qib7	583	3	of	of	IN
cord-005453-4057qib7	583	4	patients	patient	NNS
cord-005453-4057qib7	583	5	undergoing	undergo	VBG
cord-005453-4057qib7	583	6	Blinatumomab	Blinatumomab	NNP
cord-005453-4057qib7	583	7	(	(	-LRB-
cord-005453-4057qib7	583	8	n=10	n=10	NNP
cord-005453-4057qib7	583	9	)	)	-RRB-
cord-005453-4057qib7	583	10	]	]	-RRB-
cord-005453-4057qib7	584	1	Disclosure	disclosure	NN
cord-005453-4057qib7	584	2	:	:	:
cord-005453-4057qib7	584	3	A.	A.	NNP
cord-005453-4057qib7	584	4	Olaya	Olaya	NNP
cord-005453-4057qib7	584	5	-	-	HYPH
cord-005453-4057qib7	584	6	Vargas	Vargas	NNP
cord-005453-4057qib7	584	7	,	,	,
cord-005453-4057qib7	584	8	R.	R.	NNP
cord-005453-4057qib7	584	9	Rivera	Rivera	NNP
cord-005453-4057qib7	584	10	-	-	HYPH
cord-005453-4057qib7	584	11	Luna	Luna	NNP
cord-005453-4057qib7	584	12	,	,	,
cord-005453-4057qib7	584	13	Y.	Y.	NNP
cord-005453-4057qib7	584	14	Melchor	Melchor	NNP
cord-005453-4057qib7	584	15	-	-	HYPH
cord-005453-4057qib7	584	16	Vidal	Vidal	NNP
cord-005453-4057qib7	584	17	,	,	,
cord-005453-4057qib7	584	18	H.	H.	NNP
cord-005453-4057qib7	584	19	Salazar	Salazar	NNP
cord-005453-4057qib7	584	20	-	-	HYPH
cord-005453-4057qib7	584	21	Rosales	Rosales	NNP
cord-005453-4057qib7	584	22	,	,	,
cord-005453-4057qib7	584	23	G.	G.	NNP
cord-005453-4057qib7	584	24	Lopez	Lopez	NNP
cord-005453-4057qib7	584	25	-	-	HYPH
cord-005453-4057qib7	584	26	Hernandez	Hernandez	NNP
cord-005453-4057qib7	584	27	,	,	,
cord-005453-4057qib7	584	28	N.	N.	NNP
cord-005453-4057qib7	584	29	Ramirez	Ramirez	NNP
cord-005453-4057qib7	584	30	-	-	HYPH
cord-005453-4057qib7	584	31	Uribe	Uribe	NNP
cord-005453-4057qib7	584	32	.	.	.
cord-005453-4057qib7	585	1	We	-PRON-	PRP
cord-005453-4057qib7	585	2	wish	wish	VBP
cord-005453-4057qib7	585	3	to	to	TO
cord-005453-4057qib7	585	4	confirm	confirm	VB
cord-005453-4057qib7	585	5	that	that	IN
cord-005453-4057qib7	585	6	there	there	EX
cord-005453-4057qib7	585	7	are	be	VBP
cord-005453-4057qib7	585	8	no	no	DT
cord-005453-4057qib7	585	9	known	know	VBN
cord-005453-4057qib7	585	10	conflicts	conflict	NNS
cord-005453-4057qib7	585	11	of	of	IN
cord-005453-4057qib7	585	12	interest	interest	NN
cord-005453-4057qib7	585	13	associated	associate	VBN
cord-005453-4057qib7	585	14	with	with	IN
cord-005453-4057qib7	585	15	this	this	DT
cord-005453-4057qib7	585	16	abstact	abstact	JJ
cord-005453-4057qib7	585	17	,	,	,
cord-005453-4057qib7	585	18	the	the	DT
cord-005453-4057qib7	585	19	only	only	JJ
cord-005453-4057qib7	585	20	financial	financial	JJ
cord-005453-4057qib7	585	21	support	support	NN
cord-005453-4057qib7	585	22	was	be	VBD
cord-005453-4057qib7	585	23	provided	provide	VBN
cord-005453-4057qib7	585	24	by	by	IN
cord-005453-4057qib7	585	25	Mexican	Mexican	NNP
cord-005453-4057qib7	585	26	Associations	Associations	NNPS
cord-005453-4057qib7	585	27	that	that	IN
cord-005453-4057qib7	585	28	helping	help	VBG
cord-005453-4057qib7	585	29	children	child	NNS
cord-005453-4057qib7	585	30	wiht	wiht	VB
cord-005453-4057qib7	585	31	cancer	cancer	NN
cord-005453-4057qib7	585	32	in	in	IN
cord-005453-4057qib7	585	33	a	a	DT
cord-005453-4057qib7	585	34	few	few	JJ
cord-005453-4057qib7	585	35	patients	patient	NNS
cord-005453-4057qib7	585	36	.	.	.
cord-005453-4057qib7	586	1	Sequential	sequential	JJ
cord-005453-4057qib7	586	2	high	high	JJ
cord-005453-4057qib7	586	3	-	-	HYPH
cord-005453-4057qib7	586	4	dose	dose	NN
cord-005453-4057qib7	586	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	586	6	reinduction	reinduction	NN
cord-005453-4057qib7	586	7	followed	follow	VBN
cord-005453-4057qib7	586	8	by	by	IN
cord-005453-4057qib7	586	9	myeloablative	myeloablative	NNP
cord-005453-4057qib7	586	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	586	11	transplant	transplant	NN
cord-005453-4057qib7	586	12	for	for	IN
cord-005453-4057qib7	586	13	active	active	JJ
cord-005453-4057qib7	586	14	acute	acute	JJ
cord-005453-4057qib7	586	15	myeloid	myeloid	NN
cord-005453-4057qib7	586	16	leukemias	leukemias	RB
cord-005453-4057qib7	586	17	Methods	method	NNS
cord-005453-4057qib7	586	18	:	:	:
cord-005453-4057qib7	586	19	At	at	IN
cord-005453-4057qib7	586	20	our	-PRON-	PRP$
cord-005453-4057qib7	586	21	Center	Center	NNP
cord-005453-4057qib7	586	22	,	,	,
cord-005453-4057qib7	586	23	27	27	CD
cord-005453-4057qib7	586	24	relapsed	relapse	VBD
cord-005453-4057qib7	586	25	/	/	SYM
cord-005453-4057qib7	586	26	refractory	refractory	JJ
cord-005453-4057qib7	586	27	AML	AML	NNP
cord-005453-4057qib7	586	28	patients	patient	NNS
cord-005453-4057qib7	586	29	were	be	VBD
cord-005453-4057qib7	586	30	transplanted	transplant	VBN
cord-005453-4057qib7	586	31	during	during	IN
cord-005453-4057qib7	586	32	chemo	chemo	NN
cord-005453-4057qib7	586	33	-	-	HYPH
cord-005453-4057qib7	586	34	induced	induce	VBN
cord-005453-4057qib7	586	35	neutropenia	neutropenia	NN
cord-005453-4057qib7	586	36	after	after	IN
cord-005453-4057qib7	586	37	high	high	JJ
cord-005453-4057qib7	586	38	-	-	HYPH
cord-005453-4057qib7	586	39	dose	dose	NN
cord-005453-4057qib7	586	40	salvage	salvage	NN
cord-005453-4057qib7	586	41	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	586	42	.	.	.
cord-005453-4057qib7	587	1	Median	median	JJ
cord-005453-4057qib7	587	2	age	age	NN
cord-005453-4057qib7	587	3	at	at	IN
cord-005453-4057qib7	587	4	transplant	transplant	NN
cord-005453-4057qib7	587	5	was	be	VBD
cord-005453-4057qib7	587	6	52	52	CD
cord-005453-4057qib7	587	7	years	year	NNS
cord-005453-4057qib7	588	1	(	(	-LRB-
cord-005453-4057qib7	588	2	range	range	NNP
cord-005453-4057qib7	588	3	21	21	CD
cord-005453-4057qib7	588	4	-	-	SYM
cord-005453-4057qib7	588	5	62	62	CD
cord-005453-4057qib7	588	6	)	)	-RRB-
cord-005453-4057qib7	588	7	.	.	.
cord-005453-4057qib7	589	1	Patients	patient	NNS
cord-005453-4057qib7	589	2	suffered	suffer	VBD
cord-005453-4057qib7	589	3	from	from	IN
cord-005453-4057qib7	589	4	de	de	NNP
cord-005453-4057qib7	589	5	novo	novo	NNP
cord-005453-4057qib7	589	6	(	(	-LRB-
cord-005453-4057qib7	589	7	n=	n=	NNP
cord-005453-4057qib7	589	8	18/27	18/27	CD
cord-005453-4057qib7	589	9	,	,	,
cord-005453-4057qib7	589	10	67	67	CD
cord-005453-4057qib7	589	11	%	%	NN
cord-005453-4057qib7	589	12	)	)	-RRB-
cord-005453-4057qib7	589	13	or	or	CC
cord-005453-4057qib7	589	14	secondary	secondary	JJ
cord-005453-4057qib7	589	15	AML	AML	NNP
cord-005453-4057qib7	589	16	(	(	-LRB-
cord-005453-4057qib7	589	17	n=9/	n=9/	NNP
cord-005453-4057qib7	589	18	27	27	CD
cord-005453-4057qib7	589	19	,	,	,
cord-005453-4057qib7	589	20	33	33	CD
cord-005453-4057qib7	589	21	%	%	NN
cord-005453-4057qib7	589	22	)	)	-RRB-
cord-005453-4057qib7	589	23	.	.	.
cord-005453-4057qib7	590	1	Genetic	genetic	JJ
cord-005453-4057qib7	590	2	risk	risk	NN
cord-005453-4057qib7	590	3	stratification	stratification	NN
cord-005453-4057qib7	590	4	was	be	VBD
cord-005453-4057qib7	590	5	reported	report	VBN
cord-005453-4057qib7	590	6	using	use	VBG
cord-005453-4057qib7	590	7	stardardized	stardardize	VBN
cord-005453-4057qib7	590	8	groups	group	NNS
cord-005453-4057qib7	590	9	proposed	propose	VBN
cord-005453-4057qib7	590	10	by	by	IN
cord-005453-4057qib7	590	11	the	the	DT
cord-005453-4057qib7	590	12	European	European	NNP
cord-005453-4057qib7	590	13	Leukemia	Leukemia	NNP
cord-005453-4057qib7	590	14	Net	Net	NNP
cord-005453-4057qib7	590	15	(	(	-LRB-
cord-005453-4057qib7	590	16	ELN	ELN	NNP
cord-005453-4057qib7	590	17	)	)	-RRB-
cord-005453-4057qib7	590	18	in	in	IN
cord-005453-4057qib7	590	19	2010	2010	CD
cord-005453-4057qib7	590	20	.	.	.
cord-005453-4057qib7	591	1	Favorable	favorable	JJ
cord-005453-4057qib7	591	2	,	,	,
cord-005453-4057qib7	591	3	Intermediate	Intermediate	NNP
cord-005453-4057qib7	591	4	I	I	NNP
cord-005453-4057qib7	591	5	and	and	CC
cord-005453-4057qib7	591	6	II	II	NNP
cord-005453-4057qib7	591	7	and	and	CC
cord-005453-4057qib7	591	8	Adverse	adverse	JJ
cord-005453-4057qib7	591	9	risk	risk	NN
cord-005453-4057qib7	591	10	category	category	NN
cord-005453-4057qib7	591	11	at	at	IN
cord-005453-4057qib7	591	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	591	13	was	be	VBD
cord-005453-4057qib7	591	14	observed	observe	VBN
cord-005453-4057qib7	591	15	in	in	IN
cord-005453-4057qib7	591	16	1/27	1/27	CD
cord-005453-4057qib7	591	17	(	(	-LRB-
cord-005453-4057qib7	591	18	4	4	CD
cord-005453-4057qib7	591	19	%	%	NN
cord-005453-4057qib7	591	20	)	)	-RRB-
cord-005453-4057qib7	591	21	,	,	,
cord-005453-4057qib7	591	22	19/27	19/27	CD
cord-005453-4057qib7	591	23	(	(	-LRB-
cord-005453-4057qib7	591	24	70	70	CD
cord-005453-4057qib7	591	25	%	%	NN
cord-005453-4057qib7	591	26	)	)	-RRB-
cord-005453-4057qib7	591	27	,	,	,
cord-005453-4057qib7	591	28	7/27	7/27	CD
cord-005453-4057qib7	591	29	patients	patient	NNS
cord-005453-4057qib7	591	30	(	(	-LRB-
cord-005453-4057qib7	591	31	26	26	CD
cord-005453-4057qib7	591	32	%	%	NN
cord-005453-4057qib7	591	33	)	)	-RRB-
cord-005453-4057qib7	591	34	respectively	respectively	RB
cord-005453-4057qib7	591	35	.	.	.
cord-005453-4057qib7	592	1	All	all	DT
cord-005453-4057qib7	592	2	patients	patient	NNS
cord-005453-4057qib7	592	3	had	have	VBD
cord-005453-4057qib7	592	4	active	active	JJ
cord-005453-4057qib7	592	5	disease	disease	NN
cord-005453-4057qib7	592	6	at	at	IN
cord-005453-4057qib7	592	7	the	the	DT
cord-005453-4057qib7	592	8	time	time	NN
cord-005453-4057qib7	592	9	of	of	IN
cord-005453-4057qib7	592	10	Sequential	Sequential	NNP
cord-005453-4057qib7	592	11	Therapy	therapy	NN
cord-005453-4057qib7	592	12	and	and	CC
cord-005453-4057qib7	592	13	median	median	JJ
cord-005453-4057qib7	592	14	marrow	marrow	NN
cord-005453-4057qib7	592	15	blast	blast	NN
cord-005453-4057qib7	592	16	count	count	NN
cord-005453-4057qib7	592	17	was	be	VBD
cord-005453-4057qib7	592	18	25	25	CD
cord-005453-4057qib7	592	19	%	%	NN
cord-005453-4057qib7	592	20	(	(	-LRB-
cord-005453-4057qib7	592	21	range	range	NNP
cord-005453-4057qib7	592	22	7	7	CD
cord-005453-4057qib7	592	23	-	-	SYM
cord-005453-4057qib7	592	24	88	88	CD
cord-005453-4057qib7	592	25	%	%	NN
cord-005453-4057qib7	592	26	)	)	-RRB-
cord-005453-4057qib7	592	27	.	.	.
cord-005453-4057qib7	593	1	Patients	patient	NNS
cord-005453-4057qib7	593	2	received	receive	VBD
cord-005453-4057qib7	593	3	a	a	DT
cord-005453-4057qib7	593	4	high	high	JJ
cord-005453-4057qib7	593	5	-	-	HYPH
cord-005453-4057qib7	593	6	dose	dose	NN
cord-005453-4057qib7	593	7	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	593	8	based	base	VBN
cord-005453-4057qib7	593	9	(	(	-LRB-
cord-005453-4057qib7	593	10	MEC	MEC	NNP
cord-005453-4057qib7	593	11	in	in	IN
cord-005453-4057qib7	593	12	17/	17/	CD
cord-005453-4057qib7	593	13	27	27	CD
cord-005453-4057qib7	593	14	,	,	,
cord-005453-4057qib7	593	15	63	63	CD
cord-005453-4057qib7	593	16	%	%	NN
cord-005453-4057qib7	593	17	)	)	-RRB-
cord-005453-4057qib7	593	18	regimen	regimen	NN
cord-005453-4057qib7	593	19	as	as	IN
cord-005453-4057qib7	593	20	salvage	salvage	NN
cord-005453-4057qib7	593	21	therapy	therapy	NN
cord-005453-4057qib7	593	22	.	.	.
cord-005453-4057qib7	594	1	Donors	donor	NNS
cord-005453-4057qib7	594	2	were	be	VBD
cord-005453-4057qib7	594	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	594	4	relatives	relative	NNS
cord-005453-4057qib7	594	5	for	for	IN
cord-005453-4057qib7	594	6	15/27	15/27	CD
cord-005453-4057qib7	594	7	(	(	-LRB-
cord-005453-4057qib7	594	8	56	56	CD
cord-005453-4057qib7	594	9	%	%	NN
cord-005453-4057qib7	594	10	)	)	-RRB-
cord-005453-4057qib7	594	11	patients	patient	NNS
cord-005453-4057qib7	594	12	,	,	,
cord-005453-4057qib7	594	13	identical	identical	JJ
cord-005453-4057qib7	594	14	siblings	sibling	NNS
cord-005453-4057qib7	594	15	and	and	CC
cord-005453-4057qib7	594	16	matched	match	VBN
cord-005453-4057qib7	594	17	-	-	HYPH
cord-005453-4057qib7	594	18	unrelated	unrelated	JJ
cord-005453-4057qib7	594	19	for	for	IN
cord-005453-4057qib7	594	20	6/27	6/27	CD
cord-005453-4057qib7	594	21	patients	patient	NNS
cord-005453-4057qib7	594	22	(	(	-LRB-
cord-005453-4057qib7	594	23	22	22	CD
cord-005453-4057qib7	594	24	%	%	NN
cord-005453-4057qib7	594	25	)	)	-RRB-
cord-005453-4057qib7	594	26	and	and	CC
cord-005453-4057qib7	594	27	6/27	6/27	CD
cord-005453-4057qib7	594	28	(	(	-LRB-
cord-005453-4057qib7	594	29	22	22	CD
cord-005453-4057qib7	594	30	%	%	NN
cord-005453-4057qib7	594	31	)	)	-RRB-
cord-005453-4057qib7	594	32	,	,	,
cord-005453-4057qib7	594	33	respectively	respectively	RB
cord-005453-4057qib7	594	34	.	.	.
cord-005453-4057qib7	595	1	A	a	DT
cord-005453-4057qib7	595	2	myeloablative	myeloablative	JJ
cord-005453-4057qib7	595	3	conditioning	conditioning	NN
cord-005453-4057qib7	595	4	was	be	VBD
cord-005453-4057qib7	595	5	used	use	VBN
cord-005453-4057qib7	595	6	to	to	TO
cord-005453-4057qib7	595	7	further	further	RB
cord-005453-4057qib7	595	8	implement	implement	VB
cord-005453-4057qib7	595	9	anti	anti	JJ
cord-005453-4057qib7	595	10	-	-	JJ
cord-005453-4057qib7	595	11	leukemic	leukemic	JJ
cord-005453-4057qib7	595	12	effects	effect	NNS
cord-005453-4057qib7	595	13	.	.	.
cord-005453-4057qib7	596	1	Conditioning	conditioning	NN
cord-005453-4057qib7	596	2	,	,	,
cord-005453-4057qib7	596	3	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	596	4	-	-	HYPH
cord-005453-4057qib7	596	5	Busulfan	Busulfan	NNP
cord-005453-4057qib7	596	6	-	-	HYPH
cord-005453-4057qib7	596	7	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	596	8	in	in	IN
cord-005453-4057qib7	596	9	89	89	CD
cord-005453-4057qib7	596	10	%	%	NN
cord-005453-4057qib7	596	11	patients	patient	NNS
cord-005453-4057qib7	596	12	,	,	,
cord-005453-4057qib7	596	13	was	be	VBD
cord-005453-4057qib7	596	14	started	start	VBN
cord-005453-4057qib7	596	15	at	at	IN
cord-005453-4057qib7	596	16	a	a	DT
cord-005453-4057qib7	596	17	median	median	NN
cord-005453-4057qib7	596	18	of	of	IN
cord-005453-4057qib7	596	19	8	8	CD
cord-005453-4057qib7	596	20	days	day	NNS
cord-005453-4057qib7	596	21	(	(	-LRB-
cord-005453-4057qib7	596	22	range	range	VBP
cord-005453-4057qib7	596	23	[	[	-LRB-
cord-005453-4057qib7	596	24	3	3	CD
cord-005453-4057qib7	596	25	]	]	-RRB-
cord-005453-4057qib7	596	26	[	[	-LRB-
cord-005453-4057qib7	596	27	4	4	CD
cord-005453-4057qib7	596	28	]	]	-RRB-
cord-005453-4057qib7	596	29	[	[	-LRB-
cord-005453-4057qib7	596	30	5	5	CD
cord-005453-4057qib7	596	31	]	]	-RRB-
cord-005453-4057qib7	596	32	[	[	-LRB-
cord-005453-4057qib7	596	33	6	6	CD
cord-005453-4057qib7	596	34	]	]	-RRB-
cord-005453-4057qib7	596	35	[	[	-LRB-
cord-005453-4057qib7	596	36	7	7	CD
cord-005453-4057qib7	596	37	]	]	-RRB-
cord-005453-4057qib7	596	38	[	[	-LRB-
cord-005453-4057qib7	596	39	8	8	CD
cord-005453-4057qib7	596	40	]	]	-RRB-
cord-005453-4057qib7	596	41	[	[	-LRB-
cord-005453-4057qib7	596	42	9	9	CD
cord-005453-4057qib7	596	43	]	]	-RRB-
cord-005453-4057qib7	596	44	[	[	-LRB-
cord-005453-4057qib7	596	45	10	10	CD
cord-005453-4057qib7	596	46	]	]	-RRB-
cord-005453-4057qib7	596	47	[	[	-LRB-
cord-005453-4057qib7	596	48	11	11	CD
cord-005453-4057qib7	596	49	]	]	-RRB-
cord-005453-4057qib7	596	50	[	[	-LRB-
cord-005453-4057qib7	596	51	12	12	CD
cord-005453-4057qib7	596	52	]	]	-RRB-
cord-005453-4057qib7	596	53	[	[	-LRB-
cord-005453-4057qib7	596	54	13	13	CD
cord-005453-4057qib7	596	55	]	]	-RRB-
cord-005453-4057qib7	597	1	[	[	-LRB-
cord-005453-4057qib7	597	2	14	14	CD
cord-005453-4057qib7	597	3	]	]	-RRB-
cord-005453-4057qib7	597	4	after	after	IN
cord-005453-4057qib7	597	5	the	the	DT
cord-005453-4057qib7	597	6	last	last	JJ
cord-005453-4057qib7	597	7	day	day	NN
cord-005453-4057qib7	597	8	of	of	IN
cord-005453-4057qib7	597	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	597	10	.	.	.
cord-005453-4057qib7	598	1	Bone	bone	NN
cord-005453-4057qib7	598	2	marrow	marrow	NN
cord-005453-4057qib7	598	3	and	and	CC
cord-005453-4057qib7	598	4	peripheral	peripheral	JJ
cord-005453-4057qib7	598	5	blood	blood	NN
cord-005453-4057qib7	598	6	stem	stem	NN
cord-005453-4057qib7	598	7	cells	cell	NNS
cord-005453-4057qib7	598	8	were	be	VBD
cord-005453-4057qib7	598	9	used	use	VBN
cord-005453-4057qib7	598	10	as	as	IN
cord-005453-4057qib7	598	11	graft	graft	NN
cord-005453-4057qib7	598	12	source	source	NN
cord-005453-4057qib7	598	13	in	in	IN
cord-005453-4057qib7	598	14	11/27	11/27	CD
cord-005453-4057qib7	598	15	(	(	-LRB-
cord-005453-4057qib7	598	16	41	41	CD
cord-005453-4057qib7	598	17	%	%	NN
cord-005453-4057qib7	598	18	)	)	-RRB-
cord-005453-4057qib7	598	19	and	and	CC
cord-005453-4057qib7	598	20	16/27	16/27	CD
cord-005453-4057qib7	598	21	(	(	-LRB-
cord-005453-4057qib7	598	22	59	59	CD
cord-005453-4057qib7	598	23	%	%	NN
cord-005453-4057qib7	598	24	)	)	-RRB-
cord-005453-4057qib7	598	25	patients	patient	NNS
cord-005453-4057qib7	598	26	.	.	.
cord-005453-4057qib7	599	1	Graft	graft	NN
cord-005453-4057qib7	599	2	-	-	HYPH
cord-005453-4057qib7	599	3	versus	versus	IN
cord-005453-4057qib7	599	4	-	-	HYPH
cord-005453-4057qib7	599	5	host	host	NN
cord-005453-4057qib7	599	6	disease	disease	NN
cord-005453-4057qib7	599	7	(	(	-LRB-
cord-005453-4057qib7	599	8	GVHD	GVHD	NNP
cord-005453-4057qib7	599	9	)	)	-RRB-
cord-005453-4057qib7	599	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	599	11	and	and	CC
cord-005453-4057qib7	599	12	supportive	supportive	JJ
cord-005453-4057qib7	599	13	care	care	NN
cord-005453-4057qib7	599	14	were	be	VBD
cord-005453-4057qib7	599	15	administered	administer	VBN
cord-005453-4057qib7	599	16	accordingly	accordingly	RB
cord-005453-4057qib7	599	17	to	to	IN
cord-005453-4057qib7	599	18	each	each	DT
cord-005453-4057qib7	599	19	HSCT	HSCT	NNP
cord-005453-4057qib7	599	20	platform	platform	NN
cord-005453-4057qib7	599	21	.	.	.
cord-005453-4057qib7	600	1	Results	result	NNS
cord-005453-4057qib7	600	2	:	:	:
cord-005453-4057qib7	601	1	All	all	DT
cord-005453-4057qib7	601	2	patients	patient	NNS
cord-005453-4057qib7	601	3	engrafted	engraft	VBD
cord-005453-4057qib7	601	4	.	.	.
cord-005453-4057qib7	602	1	Median	median	JJ
cord-005453-4057qib7	602	2	day	day	NN
cord-005453-4057qib7	602	3	of	of	IN
cord-005453-4057qib7	602	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	602	5	recovery	recovery	NN
cord-005453-4057qib7	602	6	was	be	VBD
cord-005453-4057qib7	602	7	day	day	NN
cord-005453-4057qib7	602	8	+16	+16	CD
cord-005453-4057qib7	603	1	(	(	-LRB-
cord-005453-4057qib7	603	2	range	range	NNP
cord-005453-4057qib7	603	3	12	12	CD
cord-005453-4057qib7	603	4	-	-	SYM
cord-005453-4057qib7	603	5	23	23	CD
cord-005453-4057qib7	603	6	)	)	-RRB-
cord-005453-4057qib7	603	7	.	.	.
cord-005453-4057qib7	604	1	Median	median	JJ
cord-005453-4057qib7	604	2	follow	follow	NN
cord-005453-4057qib7	604	3	-	-	HYPH
cord-005453-4057qib7	604	4	up	up	NN
cord-005453-4057qib7	604	5	of	of	IN
cord-005453-4057qib7	604	6	survivors	survivor	NNS
cord-005453-4057qib7	604	7	was	be	VBD
cord-005453-4057qib7	604	8	31	31	CD
cord-005453-4057qib7	604	9	months	month	NNS
cord-005453-4057qib7	605	1	(	(	-LRB-
cord-005453-4057qib7	605	2	range	range	NNP
cord-005453-4057qib7	605	3	4	4	CD
cord-005453-4057qib7	605	4	-	-	SYM
cord-005453-4057qib7	605	5	125	125	CD
cord-005453-4057qib7	605	6	)	)	-RRB-
cord-005453-4057qib7	605	7	.	.	.
cord-005453-4057qib7	606	1	Non	non	JJ
cord-005453-4057qib7	606	2	Relapse	Relapse	NNP
cord-005453-4057qib7	606	3	Mortality	mortality	NN
cord-005453-4057qib7	606	4	and	and	CC
cord-005453-4057qib7	606	5	Relapse	Relapse	NNP
cord-005453-4057qib7	606	6	Incidences	Incidences	NNPS
cord-005453-4057qib7	606	7	(	(	-LRB-
cord-005453-4057qib7	606	8	NRM	NRM	NNP
cord-005453-4057qib7	606	9	,	,	,
cord-005453-4057qib7	606	10	RI	RI	NNP
cord-005453-4057qib7	606	11	)	)	-RRB-
cord-005453-4057qib7	606	12	were	be	VBD
cord-005453-4057qib7	606	13	16	16	CD
cord-005453-4057qib7	606	14	%	%	NN
cord-005453-4057qib7	606	15	and	and	CC
cord-005453-4057qib7	606	16	48	48	CD
cord-005453-4057qib7	606	17	%	%	NN
cord-005453-4057qib7	606	18	at	at	IN
cord-005453-4057qib7	606	19	1	1	CD
cord-005453-4057qib7	606	20	year	year	NN
cord-005453-4057qib7	606	21	and	and	CC
cord-005453-4057qib7	606	22	16	16	CD
cord-005453-4057qib7	606	23	%	%	NN
cord-005453-4057qib7	606	24	and	and	CC
cord-005453-4057qib7	606	25	58	58	CD
cord-005453-4057qib7	606	26	%	%	NN
cord-005453-4057qib7	606	27	at	at	IN
cord-005453-4057qib7	606	28	3	3	CD
cord-005453-4057qib7	606	29	years	year	NNS
cord-005453-4057qib7	606	30	,	,	,
cord-005453-4057qib7	606	31	respectively	respectively	RB
cord-005453-4057qib7	606	32	.	.	.
cord-005453-4057qib7	607	1	Overall	overall	JJ
cord-005453-4057qib7	607	2	cumulative	cumulative	JJ
cord-005453-4057qib7	607	3	incidences	incidence	NNS
cord-005453-4057qib7	607	4	of	of	IN
cord-005453-4057qib7	607	5	acute	acute	JJ
cord-005453-4057qib7	607	6	and	and	CC
cord-005453-4057qib7	607	7	chronic	chronic	JJ
cord-005453-4057qib7	607	8	GVHD	GVHD	NNP
cord-005453-4057qib7	607	9	were	be	VBD
cord-005453-4057qib7	607	10	48	48	CD
cord-005453-4057qib7	607	11	%	%	NN
cord-005453-4057qib7	607	12	and	and	CC
cord-005453-4057qib7	607	13	43	43	CD
cord-005453-4057qib7	607	14	%	%	NN
cord-005453-4057qib7	607	15	at	at	IN
cord-005453-4057qib7	607	16	day	day	NN
cord-005453-4057qib7	607	17	+100	+100	NNS
cord-005453-4057qib7	607	18	and	and	CC
cord-005453-4057qib7	607	19	+	+	SYM
cord-005453-4057qib7	607	20	400	400	CD
cord-005453-4057qib7	607	21	.	.	.
cord-005453-4057qib7	608	1	One	one	CD
cord-005453-4057qib7	608	2	and	and	CC
cord-005453-4057qib7	608	3	3	3	CD
cord-005453-4057qib7	608	4	year	year	NN
cord-005453-4057qib7	609	1	Overall	Overall	NNP
cord-005453-4057qib7	609	2	Survival	Survival	NNP
cord-005453-4057qib7	609	3	(	(	-LRB-
cord-005453-4057qib7	609	4	OS	OS	NNP
cord-005453-4057qib7	609	5	)	)	-RRB-
cord-005453-4057qib7	609	6	were	be	VBD
cord-005453-4057qib7	609	7	58	58	CD
cord-005453-4057qib7	609	8	%	%	NN
cord-005453-4057qib7	609	9	and	and	CC
cord-005453-4057qib7	609	10	34	34	CD
cord-005453-4057qib7	609	11	%	%	NN
cord-005453-4057qib7	609	12	,	,	,
cord-005453-4057qib7	609	13	while	while	IN
cord-005453-4057qib7	609	14	1	1	CD
cord-005453-4057qib7	609	15	and	and	CC
cord-005453-4057qib7	609	16	3	3	CD
cord-005453-4057qib7	609	17	year	year	NN
cord-005453-4057qib7	609	18	Event	event	NN
cord-005453-4057qib7	609	19	-	-	HYPH
cord-005453-4057qib7	609	20	Free	Free	NNP
cord-005453-4057qib7	609	21	Survival	Survival	NNP
cord-005453-4057qib7	609	22	(	(	-LRB-
cord-005453-4057qib7	609	23	EFS	EFS	NNP
cord-005453-4057qib7	609	24	)	)	-RRB-
cord-005453-4057qib7	609	25	were	be	VBD
cord-005453-4057qib7	609	26	35	35	CD
cord-005453-4057qib7	609	27	%	%	NN
cord-005453-4057qib7	609	28	and	and	CC
cord-005453-4057qib7	609	29	26	26	CD
cord-005453-4057qib7	609	30	%	%	NN
cord-005453-4057qib7	609	31	.	.	.
cord-005453-4057qib7	610	1	Significant	significant	JJ
cord-005453-4057qib7	610	2	better	well	JJR
cord-005453-4057qib7	610	3	OS	OS	NNP
cord-005453-4057qib7	610	4	and	and	CC
cord-005453-4057qib7	610	5	EFS	EFS	NNP
cord-005453-4057qib7	610	6	were	be	VBD
cord-005453-4057qib7	610	7	observed	observe	VBN
cord-005453-4057qib7	610	8	in	in	IN
cord-005453-4057qib7	610	9	patients	patient	NNS
cord-005453-4057qib7	610	10	with	with	IN
cord-005453-4057qib7	610	11	Favorable	favorable	JJ
cord-005453-4057qib7	610	12	-	-	HYPH
cord-005453-4057qib7	610	13	Intermediate	Intermediate	NNP
cord-005453-4057qib7	610	14	I	I	NNP
cord-005453-4057qib7	610	15	-	-	HYPH
cord-005453-4057qib7	610	16	II	II	NNP
cord-005453-4057qib7	610	17	versus	versus	IN
cord-005453-4057qib7	610	18	Adverse	adverse	JJ
cord-005453-4057qib7	610	19	risk	risk	NN
cord-005453-4057qib7	610	20	score	score	NN
cord-005453-4057qib7	610	21	(	(	-LRB-
cord-005453-4057qib7	610	22	1	1	CD
cord-005453-4057qib7	610	23	-	-	SYM
cord-005453-4057qib7	610	24	3	3	CD
cord-005453-4057qib7	610	25	years	year	NNS
cord-005453-4057qib7	610	26	OS	OS	NNP
cord-005453-4057qib7	610	27	64	64	CD
cord-005453-4057qib7	610	28	%	%	NN
cord-005453-4057qib7	610	29	and	and	CC
cord-005453-4057qib7	610	30	50	50	CD
cord-005453-4057qib7	610	31	%	%	NN
cord-005453-4057qib7	610	32	vs	vs	IN
cord-005453-4057qib7	610	33	43	43	CD
cord-005453-4057qib7	610	34	%	%	NN
cord-005453-4057qib7	610	35	and	and	CC
cord-005453-4057qib7	610	36	0	0	CD
cord-005453-4057qib7	610	37	%	%	NN
cord-005453-4057qib7	610	38	p=0.022	p=0.022	NN
cord-005453-4057qib7	610	39	;	;	:
cord-005453-4057qib7	610	40	1	1	CD
cord-005453-4057qib7	610	41	-	-	SYM
cord-005453-4057qib7	610	42	3	3	CD
cord-005453-4057qib7	610	43	years	year	NNS
cord-005453-4057qib7	610	44	EFS	EFS	NNP
cord-005453-4057qib7	610	45	43	43	CD
cord-005453-4057qib7	610	46	%	%	NN
cord-005453-4057qib7	610	47	and	and	CC
cord-005453-4057qib7	610	48	36	36	CD
cord-005453-4057qib7	610	49	%	%	NN
cord-005453-4057qib7	610	50	vs	vs	IN
cord-005453-4057qib7	610	51	14	14	CD
cord-005453-4057qib7	610	52	%	%	NN
cord-005453-4057qib7	610	53	and	and	CC
cord-005453-4057qib7	610	54	0	0	CD
cord-005453-4057qib7	610	55	%	%	NN
cord-005453-4057qib7	610	56	p=0.013	p=0.013	NN
cord-005453-4057qib7	610	57	)	)	-RRB-
cord-005453-4057qib7	610	58	.	.	.
cord-005453-4057qib7	611	1	Adverse	adverse	JJ
cord-005453-4057qib7	611	2	risk	risk	NN
cord-005453-4057qib7	611	3	had	have	VBD
cord-005453-4057qib7	611	4	a	a	DT
cord-005453-4057qib7	611	5	significant	significant	JJ
cord-005453-4057qib7	611	6	impact	impact	NN
cord-005453-4057qib7	611	7	on	on	IN
cord-005453-4057qib7	611	8	OS	OS	NNP
cord-005453-4057qib7	611	9	(	(	-LRB-
cord-005453-4057qib7	611	10	HR	HR	NNP
cord-005453-4057qib7	611	11	3.24	3.24	CD
cord-005453-4057qib7	611	12	,	,	,
cord-005453-4057qib7	611	13	p=0.030	p=0.030	NNP
cord-005453-4057qib7	611	14	)	)	-RRB-
cord-005453-4057qib7	611	15	and	and	CC
cord-005453-4057qib7	611	16	EFS	EFS	NNP
cord-005453-4057qib7	611	17	(	(	-LRB-
cord-005453-4057qib7	611	18	HR	HR	NNP
cord-005453-4057qib7	611	19	3.33	3.33	CD
cord-005453-4057qib7	611	20	,	,	,
cord-005453-4057qib7	611	21	p=0	p=0	NNP
cord-005453-4057qib7	611	22	.018	.018	CD
cord-005453-4057qib7	611	23	)	)	-RRB-
cord-005453-4057qib7	611	24	by	by	IN
cord-005453-4057qib7	611	25	univariate	univariate	JJ
cord-005453-4057qib7	611	26	analysis	analysis	NN
cord-005453-4057qib7	611	27	and	and	CC
cord-005453-4057qib7	611	28	on	on	IN
cord-005453-4057qib7	611	29	RI	RI	NNP
cord-005453-4057qib7	611	30	(	(	-LRB-
cord-005453-4057qib7	611	31	SDHR	SDHR	NNP
cord-005453-4057qib7	611	32	3.02	3.02	CD
cord-005453-4057qib7	611	33	,	,	,
cord-005453-4057qib7	611	34	p=0.031	p=0.031	NNP
cord-005453-4057qib7	611	35	)	)	-RRB-
cord-005453-4057qib7	611	36	by	by	IN
cord-005453-4057qib7	611	37	Fine	Fine	NNP
cord-005453-4057qib7	611	38	and	and	CC
cord-005453-4057qib7	611	39	Gray	Gray	NNP
cord-005453-4057qib7	611	40	Test	Test	NNP
cord-005453-4057qib7	611	41	.	.	.
cord-005453-4057qib7	612	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	612	2	:	:	:
cord-005453-4057qib7	613	1	Though	though	IN
cord-005453-4057qib7	613	2	small	small	JJ
cord-005453-4057qib7	613	3	the	the	DT
cord-005453-4057qib7	613	4	patient	patient	JJ
cord-005453-4057qib7	613	5	cohort	cohort	NN
cord-005453-4057qib7	613	6	,	,	,
cord-005453-4057qib7	613	7	our	-PRON-	PRP$
cord-005453-4057qib7	613	8	findings	finding	NNS
cord-005453-4057qib7	613	9	suggest	suggest	VBP
cord-005453-4057qib7	613	10	that	that	IN
cord-005453-4057qib7	613	11	sequential	sequential	JJ
cord-005453-4057qib7	613	12	therapy	therapy	NN
cord-005453-4057qib7	613	13	with	with	IN
cord-005453-4057qib7	613	14	a	a	DT
cord-005453-4057qib7	613	15	myeloablative	myeloablative	JJ
cord-005453-4057qib7	613	16	HSCT	HSCT	NNP
cord-005453-4057qib7	613	17	is	be	VBZ
cord-005453-4057qib7	613	18	feasible	feasible	JJ
cord-005453-4057qib7	613	19	in	in	IN
cord-005453-4057qib7	613	20	treating	treat	VBG
cord-005453-4057qib7	613	21	relapsed	relapse	VBN
cord-005453-4057qib7	613	22	/	/	SYM
cord-005453-4057qib7	613	23	refractory	refractory	JJ
cord-005453-4057qib7	613	24	AML	AML	NNP
cord-005453-4057qib7	613	25	.	.	.
cord-005453-4057qib7	614	1	Transplant	transplant	NN
cord-005453-4057qib7	614	2	-	-	HYPH
cord-005453-4057qib7	614	3	related	relate	VBN
cord-005453-4057qib7	614	4	toxicity	toxicity	NN
cord-005453-4057qib7	614	5	was	be	VBD
cord-005453-4057qib7	614	6	low	low	JJ
cord-005453-4057qib7	614	7	(	(	-LRB-
cord-005453-4057qib7	614	8	16	16	CD
cord-005453-4057qib7	614	9	%	%	NN
cord-005453-4057qib7	614	10	)	)	-RRB-
cord-005453-4057qib7	614	11	and	and	CC
cord-005453-4057qib7	614	12	relapse	relapse	NN
cord-005453-4057qib7	614	13	was	be	VBD
cord-005453-4057qib7	614	14	the	the	DT
cord-005453-4057qib7	614	15	major	major	JJ
cord-005453-4057qib7	614	16	treatment	treatment	NN
cord-005453-4057qib7	614	17	-	-	HYPH
cord-005453-4057qib7	614	18	failure	failure	NN
cord-005453-4057qib7	614	19	.	.	.
cord-005453-4057qib7	615	1	However	however	RB
cord-005453-4057qib7	615	2	,	,	,
cord-005453-4057qib7	615	3	even	even	RB
cord-005453-4057qib7	615	4	with	with	IN
cord-005453-4057qib7	615	5	this	this	DT
cord-005453-4057qib7	615	6	approach	approach	NN
cord-005453-4057qib7	615	7	,	,	,
cord-005453-4057qib7	615	8	patients	patient	NNS
cord-005453-4057qib7	615	9	with	with	IN
cord-005453-4057qib7	615	10	adverse	adverse	JJ
cord-005453-4057qib7	615	11	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	615	12	features	feature	NNS
cord-005453-4057qib7	615	13	have	have	VBP
cord-005453-4057qib7	615	14	a	a	DT
cord-005453-4057qib7	615	15	very	very	RB
cord-005453-4057qib7	615	16	dismal	dismal	JJ
cord-005453-4057qib7	615	17	prognosis	prognosis	NN
cord-005453-4057qib7	615	18	.	.	.
cord-005453-4057qib7	616	1	For	for	IN
cord-005453-4057qib7	616	2	these	these	DT
cord-005453-4057qib7	616	3	patients	patient	NNS
cord-005453-4057qib7	616	4	,	,	,
cord-005453-4057qib7	616	5	the	the	DT
cord-005453-4057qib7	616	6	use	use	NN
cord-005453-4057qib7	616	7	of	of	IN
cord-005453-4057qib7	616	8	new	new	JJ
cord-005453-4057qib7	616	9	drugs	drug	NNS
cord-005453-4057qib7	616	10	before	before	IN
cord-005453-4057qib7	616	11	HSCT	HSCT	NNP
cord-005453-4057qib7	616	12	and/or	and/or	CC
cord-005453-4057qib7	616	13	maintenance	maintenance	NN
cord-005453-4057qib7	616	14	therapy	therapy	NN
cord-005453-4057qib7	616	15	after	after	IN
cord-005453-4057qib7	616	16	transplant	transplant	NN
cord-005453-4057qib7	616	17	is	be	VBZ
cord-005453-4057qib7	616	18	highly	highly	RB
cord-005453-4057qib7	616	19	encouraged	encouraged	JJ
cord-005453-4057qib7	616	20	to	to	TO
cord-005453-4057qib7	616	21	improve	improve	VB
cord-005453-4057qib7	616	22	outcomes	outcome	NNS
cord-005453-4057qib7	616	23	.	.	.
cord-005453-4057qib7	617	1	Disclosure	disclosure	NN
cord-005453-4057qib7	617	2	:	:	:
cord-005453-4057qib7	617	3	Alessandro	Alessandro	NNP
cord-005453-4057qib7	617	4	Busca	Busca	NNP
cord-005453-4057qib7	617	5	:	:	:
cord-005453-4057qib7	617	6	Honoraria	Honoraria	NNP
cord-005453-4057qib7	617	7	from	from	IN
cord-005453-4057qib7	617	8	Gilead	Gilead	NNP
cord-005453-4057qib7	617	9	Sciences	Sciences	NNPS
cord-005453-4057qib7	617	10	,	,	,
cord-005453-4057qib7	617	11	Merck	Merck	NNP
cord-005453-4057qib7	617	12	,	,	,
cord-005453-4057qib7	617	13	Pfizer	Pfizer	NNP
cord-005453-4057qib7	617	14	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	617	15	and	and	CC
cord-005453-4057qib7	617	16	Jazz	Jazz	NNP
cord-005453-4057qib7	617	17	Background	background	NN
cord-005453-4057qib7	617	18	:	:	:
cord-005453-4057qib7	618	1	In	in	IN
cord-005453-4057qib7	618	2	spite	spite	NN
cord-005453-4057qib7	618	3	of	of	IN
cord-005453-4057qib7	618	4	satisfactory	satisfactory	JJ
cord-005453-4057qib7	618	5	results	result	NNS
cord-005453-4057qib7	618	6	of	of	IN
cord-005453-4057qib7	618	7	overall	overall	JJ
cord-005453-4057qib7	618	8	survival	survival	NN
cord-005453-4057qib7	618	9	(	(	-LRB-
cord-005453-4057qib7	618	10	OS	OS	NNP
cord-005453-4057qib7	618	11	)	)	-RRB-
cord-005453-4057qib7	618	12	after	after	IN
cord-005453-4057qib7	618	13	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	618	14	in	in	IN
cord-005453-4057qib7	618	15	1	1	CD
cord-005453-4057qib7	618	16	st	st	NNP
cord-005453-4057qib7	618	17	and	and	CC
cord-005453-4057qib7	618	18	2	2	CD
cord-005453-4057qib7	618	19	nd	nd	NNP
cord-005453-4057qib7	618	20	CR	CR	NNP
cord-005453-4057qib7	618	21	AML	AML	NNP
cord-005453-4057qib7	618	22	,	,	,
cord-005453-4057qib7	618	23	relapse	relapse	VB
cord-005453-4057qib7	618	24	free	free	JJ
cord-005453-4057qib7	618	25	survival	survival	NN
cord-005453-4057qib7	618	26	(	(	-LRB-
cord-005453-4057qib7	618	27	RFS	RFS	NNP
cord-005453-4057qib7	618	28	)	)	-RRB-
cord-005453-4057qib7	618	29	and	and	CC
cord-005453-4057qib7	618	30	graft	graft	NN
cord-005453-4057qib7	618	31	-	-	HYPH
cord-005453-4057qib7	618	32	versus	versus	IN
cord-005453-4057qib7	618	33	-	-	HYPH
cord-005453-4057qib7	618	34	host	host	NN
cord-005453-4057qib7	618	35	-	-	HYPH
cord-005453-4057qib7	618	36	disease	disease	NN
cord-005453-4057qib7	618	37	free	free	JJ
cord-005453-4057qib7	618	38	/	/	NFP
cord-005453-4057qib7	618	39	relapse	relapse	VB
cord-005453-4057qib7	618	40	free	free	JJ
cord-005453-4057qib7	618	41	survival	survival	NN
cord-005453-4057qib7	618	42	(	(	-LRB-
cord-005453-4057qib7	618	43	GRFS	GRFS	NNP
cord-005453-4057qib7	618	44	)	)	-RRB-
cord-005453-4057qib7	618	45	require	require	VBP
cord-005453-4057qib7	618	46	further	further	JJ
cord-005453-4057qib7	618	47	improvement	improvement	NN
cord-005453-4057qib7	618	48	.	.	.
cord-005453-4057qib7	619	1	The	the	DT
cord-005453-4057qib7	619	2	detection	detection	NN
cord-005453-4057qib7	619	3	of	of	IN
cord-005453-4057qib7	619	4	MRD	MRD	NNP
cord-005453-4057qib7	619	5	is	be	VBZ
cord-005453-4057qib7	619	6	one	one	CD
cord-005453-4057qib7	619	7	of	of	IN
cord-005453-4057qib7	619	8	the	the	DT
cord-005453-4057qib7	619	9	factors	factor	NNS
cord-005453-4057qib7	619	10	which	which	WDT
cord-005453-4057qib7	619	11	influence	influence	VBP
cord-005453-4057qib7	619	12	on	on	IN
cord-005453-4057qib7	619	13	the	the	DT
cord-005453-4057qib7	619	14	outcome	outcome	NN
cord-005453-4057qib7	619	15	of	of	IN
cord-005453-4057qib7	619	16	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	619	17	in	in	IN
cord-005453-4057qib7	619	18	AML	AML	NNP
cord-005453-4057qib7	619	19	is	be	VBZ
cord-005453-4057qib7	619	20	unclear	unclear	JJ
cord-005453-4057qib7	619	21	but	but	CC
cord-005453-4057qib7	619	22	identification	identification	NN
cord-005453-4057qib7	619	23	is	be	VBZ
cord-005453-4057qib7	619	24	important	important	JJ
cord-005453-4057qib7	619	25	to	to	TO
cord-005453-4057qib7	619	26	improve	improve	VB
cord-005453-4057qib7	619	27	risk	risk	NN
cord-005453-4057qib7	619	28	-	-	HYPH
cord-005453-4057qib7	619	29	adapted	adapt	VBN
cord-005453-4057qib7	619	30	relapse	relapse	NN
cord-005453-4057qib7	619	31	prophylactic	prophylactic	JJ
cord-005453-4057qib7	619	32	treatment	treatment	NN
cord-005453-4057qib7	619	33	after	after	IN
cord-005453-4057qib7	619	34	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	619	35	.	.	.
cord-005453-4057qib7	620	1	Aim	aim	VB
cord-005453-4057qib7	620	2	.	.	.
cord-005453-4057qib7	621	1	To	to	TO
cord-005453-4057qib7	621	2	evaluate	evaluate	VB
cord-005453-4057qib7	621	3	outcomes	outcome	NNS
cord-005453-4057qib7	621	4	of	of	IN
cord-005453-4057qib7	621	5	AlloHCST	AlloHCST	NNP
cord-005453-4057qib7	621	6	in	in	IN
cord-005453-4057qib7	621	7	1	1	CD
cord-005453-4057qib7	621	8	st	st	NNP
cord-005453-4057qib7	621	9	and	and	CC
cord-005453-4057qib7	621	10	2	2	CD
cord-005453-4057qib7	621	11	nd	nd	NNP
cord-005453-4057qib7	621	12	CR	CR	NNP
cord-005453-4057qib7	621	13	pediatric	pediatric	JJ
cord-005453-4057qib7	621	14	AML	AML	NNP
cord-005453-4057qib7	621	15	depending	depend	VBG
cord-005453-4057qib7	621	16	on	on	IN
cord-005453-4057qib7	621	17	the	the	DT
cord-005453-4057qib7	621	18	level	level	NN
cord-005453-4057qib7	621	19	of	of	IN
cord-005453-4057qib7	621	20	MRD	MRD	NNP
cord-005453-4057qib7	621	21	status	status	NN
cord-005453-4057qib7	621	22	before	before	IN
cord-005453-4057qib7	621	23	myeloablative	myeloablative	NNP
cord-005453-4057qib7	621	24	(	(	-LRB-
cord-005453-4057qib7	621	25	MAC	MAC	NNP
cord-005453-4057qib7	621	26	)	)	-RRB-
cord-005453-4057qib7	621	27	or	or	CC
cord-005453-4057qib7	621	28	reduced	reduce	VBN
cord-005453-4057qib7	621	29	intensity	intensity	NN
cord-005453-4057qib7	621	30	conditioning	conditioning	NN
cord-005453-4057qib7	621	31	regimens	regimen	NNS
cord-005453-4057qib7	621	32	(	(	-LRB-
cord-005453-4057qib7	621	33	RIC	RIC	NNP
cord-005453-4057qib7	621	34	)	)	-RRB-
cord-005453-4057qib7	621	35	.	.	.
cord-005453-4057qib7	622	1	Methods	method	NNS
cord-005453-4057qib7	622	2	:	:	:
cord-005453-4057qib7	623	1	The	the	DT
cord-005453-4057qib7	623	2	data	datum	NNS
cord-005453-4057qib7	623	3	of	of	IN
cord-005453-4057qib7	623	4	72	72	CD
cord-005453-4057qib7	623	5	children	child	NNS
cord-005453-4057qib7	623	6	with	with	IN
cord-005453-4057qib7	623	7	AML	AML	NNP
cord-005453-4057qib7	623	8	in	in	IN
cord-005453-4057qib7	623	9	1	1	CD
cord-005453-4057qib7	623	10	st	st	NNP
cord-005453-4057qib7	623	11	and	and	CC
cord-005453-4057qib7	623	12	2	2	CD
cord-005453-4057qib7	623	13	nd	nd	NNP
cord-005453-4057qib7	623	14	CR	CR	NNP
cord-005453-4057qib7	623	15	underwent	undergo	VBD
cord-005453-4057qib7	623	16	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	623	17	between	between	IN
cord-005453-4057qib7	623	18	2008	2008	CD
cord-005453-4057qib7	623	19	and	and	CC
cord-005453-4057qib7	623	20	2018	2018	CD
cord-005453-4057qib7	623	21	were	be	VBD
cord-005453-4057qib7	623	22	analyzed	analyze	VBN
cord-005453-4057qib7	623	23	.	.	.
cord-005453-4057qib7	624	1	Median	median	JJ
cord-005453-4057qib7	624	2	age	age	NN
cord-005453-4057qib7	624	3	at	at	IN
cord-005453-4057qib7	624	4	the	the	DT
cord-005453-4057qib7	624	5	moment	moment	NN
cord-005453-4057qib7	624	6	of	of	IN
cord-005453-4057qib7	624	7	AlloHCST	AlloHCST	NNP
cord-005453-4057qib7	624	8	was	be	VBD
cord-005453-4057qib7	624	9	8	8	CD
cord-005453-4057qib7	624	10	years	year	NNS
cord-005453-4057qib7	624	11	old	old	JJ
cord-005453-4057qib7	624	12	(	(	-LRB-
cord-005453-4057qib7	624	13	2	2	CD
cord-005453-4057qib7	624	14	-	-	SYM
cord-005453-4057qib7	624	15	18	18	CD
cord-005453-4057qib7	624	16	)	)	-RRB-
cord-005453-4057qib7	624	17	.	.	.
cord-005453-4057qib7	625	1	MRD	MRD	NNP
cord-005453-4057qib7	625	2	negative	negative	JJ
cord-005453-4057qib7	625	3	status	status	NN
cord-005453-4057qib7	625	4	had	have	VBD
cord-005453-4057qib7	625	5	42	42	CD
cord-005453-4057qib7	625	6	(	(	-LRB-
cord-005453-4057qib7	625	7	58	58	CD
cord-005453-4057qib7	625	8	%	%	NN
cord-005453-4057qib7	625	9	)	)	-RRB-
cord-005453-4057qib7	625	10	patients	patient	NNS
cord-005453-4057qib7	625	11	,	,	,
cord-005453-4057qib7	625	12	30	30	CD
cord-005453-4057qib7	625	13	(	(	-LRB-
cord-005453-4057qib7	625	14	42	42	CD
cord-005453-4057qib7	625	15	%	%	NN
cord-005453-4057qib7	625	16	)	)	-RRB-
cord-005453-4057qib7	625	17	were	be	VBD
cord-005453-4057qib7	625	18	MRD	MRD	NNP
cord-005453-4057qib7	625	19	positive	positive	JJ
cord-005453-4057qib7	625	20	by	by	IN
cord-005453-4057qib7	625	21	flow	flow	NN
cord-005453-4057qib7	625	22	cytometry	cytometry	NN
cord-005453-4057qib7	625	23	.	.	.
cord-005453-4057qib7	626	1	MAC	MAC	NNP
cord-005453-4057qib7	626	2	based	base	VBN
cord-005453-4057qib7	626	3	on	on	IN
cord-005453-4057qib7	626	4	busulfan	busulfan	NN
cord-005453-4057qib7	626	5	(	(	-LRB-
cord-005453-4057qib7	626	6	16	16	CD
cord-005453-4057qib7	626	7	mg	mg	NNP
cord-005453-4057qib7	626	8	/	/	SYM
cord-005453-4057qib7	626	9	b.w	b.w	NNP
cord-005453-4057qib7	626	10	.	.	NNP
cord-005453-4057qib7	626	11	)	)	-RRB-
cord-005453-4057qib7	626	12	received	receive	VBD
cord-005453-4057qib7	626	13	27	27	CD
cord-005453-4057qib7	626	14	(	(	-LRB-
cord-005453-4057qib7	626	15	37	37	CD
cord-005453-4057qib7	626	16	%	%	NN
cord-005453-4057qib7	626	17	)	)	-RRB-
cord-005453-4057qib7	626	18	patients	patient	NNS
cord-005453-4057qib7	626	19	,	,	,
cord-005453-4057qib7	626	20	on	on	IN
cord-005453-4057qib7	626	21	treosulfan	treosulfan	NNP
cord-005453-4057qib7	626	22	-7	-7	.
cord-005453-4057qib7	627	1	(	(	-LRB-
cord-005453-4057qib7	627	2	10	10	CD
cord-005453-4057qib7	627	3	%	%	NN
cord-005453-4057qib7	627	4	)	)	-RRB-
cord-005453-4057qib7	627	5	patients	patient	NNS
cord-005453-4057qib7	627	6	.	.	.
cord-005453-4057qib7	628	1	RIC	RIC	NNP
cord-005453-4057qib7	628	2	based	base	VBN
cord-005453-4057qib7	628	3	on	on	IN
cord-005453-4057qib7	628	4	melphalan	melphalan	NNP
cord-005453-4057qib7	628	5	received	receive	VBD
cord-005453-4057qib7	628	6	20	20	CD
cord-005453-4057qib7	628	7	(	(	-LRB-
cord-005453-4057qib7	628	8	28	28	CD
cord-005453-4057qib7	628	9	%	%	NN
cord-005453-4057qib7	628	10	)	)	-RRB-
cord-005453-4057qib7	628	11	patients	patient	NNS
cord-005453-4057qib7	628	12	,	,	,
cord-005453-4057qib7	628	13	based	base	VBN
cord-005453-4057qib7	628	14	on	on	IN
cord-005453-4057qib7	628	15	busulfan	busulfan	NN
cord-005453-4057qib7	628	16	(	(	-LRB-
cord-005453-4057qib7	628	17	8	8	CD
cord-005453-4057qib7	628	18	mg	mg	NNP
cord-005453-4057qib7	628	19	/	/	SYM
cord-005453-4057qib7	628	20	b.w	b.w	NNP
cord-005453-4057qib7	628	21	.	.	NNP
cord-005453-4057qib7	628	22	)	)	-RRB-
cord-005453-4057qib7	628	23	-18	-18	CD
cord-005453-4057qib7	628	24	(	(	-LRB-
cord-005453-4057qib7	628	25	25	25	CD
cord-005453-4057qib7	628	26	%	%	NN
cord-005453-4057qib7	628	27	)	)	-RRB-
cord-005453-4057qib7	628	28	patients	patient	NNS
cord-005453-4057qib7	628	29	.	.	.
cord-005453-4057qib7	629	1	Patients	patient	NNS
cord-005453-4057qib7	629	2	received	receive	VBD
cord-005453-4057qib7	629	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	629	4	of	of	IN
cord-005453-4057qib7	629	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	629	6	by	by	IN
cord-005453-4057qib7	629	7	ATG	ATG	NNP
cord-005453-4057qib7	629	8	20	20	CD
cord-005453-4057qib7	629	9	(	(	-LRB-
cord-005453-4057qib7	629	10	28	28	CD
cord-005453-4057qib7	629	11	%	%	NN
cord-005453-4057qib7	629	12	)	)	-RRB-
cord-005453-4057qib7	629	13	or	or	CC
cord-005453-4057qib7	629	14	PTCy	PTCy	NNS
cord-005453-4057qib7	629	15	-48	-48	NNP
cord-005453-4057qib7	629	16	(	(	-LRB-
cord-005453-4057qib7	629	17	66	66	CD
cord-005453-4057qib7	629	18	%	%	NN
cord-005453-4057qib7	629	19	)	)	-RRB-
cord-005453-4057qib7	629	20	patients	patient	NNS
cord-005453-4057qib7	629	21	plus	plus	CC
cord-005453-4057qib7	629	22	CsA	CsA	NNP
cord-005453-4057qib7	629	23	-23	-23	NN
cord-005453-4057qib7	629	24	(	(	-LRB-
cord-005453-4057qib7	629	25	32	32	CD
cord-005453-4057qib7	629	26	%	%	NN
cord-005453-4057qib7	629	27	)	)	-RRB-
cord-005453-4057qib7	629	28	or	or	CC
cord-005453-4057qib7	629	29	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	629	30	±	±	NNP
cord-005453-4057qib7	629	31	sirolimus	sirolimus	NNP
cord-005453-4057qib7	629	32	-43	-43	NNP
cord-005453-4057qib7	629	33	(	(	-LRB-
cord-005453-4057qib7	629	34	60	60	CD
cord-005453-4057qib7	629	35	%	%	NN
cord-005453-4057qib7	629	36	)	)	-RRB-
cord-005453-4057qib7	629	37	patients	patient	NNS
cord-005453-4057qib7	629	38	that	that	WDT
cord-005453-4057qib7	629	39	depended	depend	VBD
cord-005453-4057qib7	629	40	on	on	IN
cord-005453-4057qib7	629	41	source	source	NN
cord-005453-4057qib7	629	42	of	of	IN
cord-005453-4057qib7	629	43	transplant	transplant	NN
cord-005453-4057qib7	629	44	(	(	-LRB-
cord-005453-4057qib7	629	45	related	relate	VBN
cord-005453-4057qib7	629	46	,	,	,
cord-005453-4057qib7	629	47	unrelated	unrelated	JJ
cord-005453-4057qib7	629	48	or	or	CC
cord-005453-4057qib7	629	49	haplo	haplo	NN
cord-005453-4057qib7	629	50	donor	donor	NN
cord-005453-4057qib7	629	51	)	)	-RRB-
cord-005453-4057qib7	629	52	.	.	.
cord-005453-4057qib7	630	1	Results	result	NNS
cord-005453-4057qib7	630	2	:	:	:
cord-005453-4057qib7	631	1	At	at	IN
cord-005453-4057qib7	631	2	the	the	DT
cord-005453-4057qib7	631	3	median	median	NN
cord-005453-4057qib7	631	4	follow	follow	VBP
cord-005453-4057qib7	631	5	up	up	RB
cord-005453-4057qib7	631	6	3	3	CD
cord-005453-4057qib7	631	7	years	year	NNS
cord-005453-4057qib7	631	8	in	in	IN
cord-005453-4057qib7	631	9	the	the	DT
cord-005453-4057qib7	631	10	cohort	cohort	NN
cord-005453-4057qib7	631	11	of	of	IN
cord-005453-4057qib7	631	12	MRD	MRD	NNP
cord-005453-4057qib7	631	13	positive	positive	JJ
cord-005453-4057qib7	631	14	patients	patient	NNS
cord-005453-4057qib7	632	1	OS	OS	NNP
cord-005453-4057qib7	632	2	is	be	VBZ
cord-005453-4057qib7	632	3	66	66	CD
cord-005453-4057qib7	632	4	%	%	NN
cord-005453-4057qib7	632	5	vs	vs	IN
cord-005453-4057qib7	632	6	72	72	CD
cord-005453-4057qib7	632	7	%	%	NN
cord-005453-4057qib7	632	8	in	in	IN
cord-005453-4057qib7	632	9	MRD	MRD	NNP
cord-005453-4057qib7	632	10	negative	negative	JJ
cord-005453-4057qib7	632	11	(	(	-LRB-
cord-005453-4057qib7	632	12	p>0,05	p>0,05	RB
cord-005453-4057qib7	632	13	)	)	-RRB-
cord-005453-4057qib7	632	14	.	.	.
cord-005453-4057qib7	633	1	RFS	RFS	NNP
cord-005453-4057qib7	633	2	is	be	VBZ
cord-005453-4057qib7	633	3	56	56	CD
cord-005453-4057qib7	633	4	%	%	NN
cord-005453-4057qib7	633	5	vs	vs	IN
cord-005453-4057qib7	633	6	83	83	CD
cord-005453-4057qib7	633	7	%	%	NN
cord-005453-4057qib7	633	8	accordingly	accordingly	RB
cord-005453-4057qib7	633	9	(	(	-LRB-
cord-005453-4057qib7	633	10	p=0,01	p=0,01	NN
cord-005453-4057qib7	633	11	)	)	-RRB-
cord-005453-4057qib7	633	12	.	.	.
cord-005453-4057qib7	634	1	Graft	graft	NN
cord-005453-4057qib7	634	2	-	-	HYPH
cord-005453-4057qib7	634	3	versus	versus	IN
cord-005453-4057qib7	634	4	-	-	HYPH
cord-005453-4057qib7	634	5	host	host	NN
cord-005453-4057qib7	634	6	-	-	HYPH
cord-005453-4057qib7	634	7	disease	disease	NN
cord-005453-4057qib7	634	8	free	free	JJ
cord-005453-4057qib7	634	9	/	/	NFP
cord-005453-4057qib7	634	10	relapse	relapse	VB
cord-005453-4057qib7	634	11	free	free	JJ
cord-005453-4057qib7	634	12	survival	survival	NN
cord-005453-4057qib7	634	13	(	(	-LRB-
cord-005453-4057qib7	634	14	GRFS	GRFS	NNP
cord-005453-4057qib7	634	15	)	)	-RRB-
cord-005453-4057qib7	634	16	in	in	IN
cord-005453-4057qib7	634	17	MRD	MRD	NNP
cord-005453-4057qib7	634	18	positive	positive	JJ
cord-005453-4057qib7	634	19	patients	patient	NNS
cord-005453-4057qib7	634	20	is	be	VBZ
cord-005453-4057qib7	634	21	37	37	CD
cord-005453-4057qib7	634	22	%	%	NN
cord-005453-4057qib7	634	23	vs	vs	IN
cord-005453-4057qib7	634	24	51	51	CD
cord-005453-4057qib7	634	25	%	%	NN
cord-005453-4057qib7	634	26	in	in	IN
cord-005453-4057qib7	634	27	MRD	MRD	NNP
cord-005453-4057qib7	634	28	negative	negative	JJ
cord-005453-4057qib7	634	29	(	(	-LRB-
cord-005453-4057qib7	634	30	p>0,05	p>0,05	RB
cord-005453-4057qib7	634	31	)	)	-RRB-
cord-005453-4057qib7	634	32	.	.	.
cord-005453-4057qib7	635	1	OS	OS	NNP
cord-005453-4057qib7	635	2	,	,	,
cord-005453-4057qib7	635	3	RFS	RFS	NNP
cord-005453-4057qib7	635	4	,	,	,
cord-005453-4057qib7	635	5	GRFS	GRFS	NNP
cord-005453-4057qib7	635	6	in	in	IN
cord-005453-4057qib7	635	7	MRD	MRD	NNP
cord-005453-4057qib7	635	8	positive	positive	JJ
cord-005453-4057qib7	635	9	patients	patient	NNS
cord-005453-4057qib7	635	10	after	after	IN
cord-005453-4057qib7	635	11	MAC	MAC	NNP
cord-005453-4057qib7	635	12	is	be	VBZ
cord-005453-4057qib7	635	13	57	57	CD
cord-005453-4057qib7	635	14	%	%	NN
cord-005453-4057qib7	635	15	,	,	,
cord-005453-4057qib7	635	16	42	42	CD
cord-005453-4057qib7	635	17	%	%	NN
cord-005453-4057qib7	635	18	,	,	,
cord-005453-4057qib7	635	19	30	30	CD
cord-005453-4057qib7	635	20	%	%	NN
cord-005453-4057qib7	635	21	vs	vs	IN
cord-005453-4057qib7	635	22	75	75	CD
cord-005453-4057qib7	635	23	%	%	NN
cord-005453-4057qib7	635	24	,	,	,
cord-005453-4057qib7	635	25	68	68	CD
cord-005453-4057qib7	635	26	%	%	NN
cord-005453-4057qib7	635	27	,	,	,
cord-005453-4057qib7	635	28	43	43	CD
cord-005453-4057qib7	635	29	%	%	NN
cord-005453-4057qib7	635	30	after	after	IN
cord-005453-4057qib7	635	31	RIC	RIC	NNP
cord-005453-4057qib7	635	32	accordingly	accordingly	RB
cord-005453-4057qib7	635	33	(	(	-LRB-
cord-005453-4057qib7	635	34	p>0,05	p>0,05	RB
cord-005453-4057qib7	635	35	)	)	-RRB-
cord-005453-4057qib7	635	36	.	.	.
cord-005453-4057qib7	636	1	OS	OS	NNP
cord-005453-4057qib7	636	2	,	,	,
cord-005453-4057qib7	636	3	RFS	RFS	NNP
cord-005453-4057qib7	636	4	,	,	,
cord-005453-4057qib7	636	5	GRFS	GRFS	NNP
cord-005453-4057qib7	636	6	in	in	IN
cord-005453-4057qib7	636	7	MRD	MRD	NNP
cord-005453-4057qib7	636	8	negative	negative	JJ
cord-005453-4057qib7	636	9	patients	patient	NNS
cord-005453-4057qib7	636	10	after	after	IN
cord-005453-4057qib7	636	11	MAC	MAC	NNP
cord-005453-4057qib7	636	12	is	be	VBZ
cord-005453-4057qib7	636	13	75	75	CD
cord-005453-4057qib7	636	14	%	%	NN
cord-005453-4057qib7	636	15	,	,	,
cord-005453-4057qib7	636	16	85	85	CD
cord-005453-4057qib7	636	17	%	%	NN
cord-005453-4057qib7	636	18	,	,	,
cord-005453-4057qib7	636	19	55	55	CD
cord-005453-4057qib7	636	20	%	%	NN
cord-005453-4057qib7	636	21	vs	vs	IN
cord-005453-4057qib7	636	22	65	65	CD
cord-005453-4057qib7	636	23	%	%	NN
cord-005453-4057qib7	636	24	,	,	,
cord-005453-4057qib7	636	25	82	82	CD
cord-005453-4057qib7	636	26	%	%	NN
cord-005453-4057qib7	636	27	,	,	,
cord-005453-4057qib7	636	28	47	47	CD
cord-005453-4057qib7	636	29	%	%	NN
cord-005453-4057qib7	636	30	after	after	IN
cord-005453-4057qib7	636	31	RIC	RIC	NNP
cord-005453-4057qib7	636	32	accordingly	accordingly	RB
cord-005453-4057qib7	636	33	(	(	-LRB-
cord-005453-4057qib7	636	34	p>0,05	p>0,05	RB
cord-005453-4057qib7	636	35	)	)	-RRB-
cord-005453-4057qib7	636	36	.	.	.
cord-005453-4057qib7	637	1	OS	OS	NNP
cord-005453-4057qib7	637	2	,	,	,
cord-005453-4057qib7	637	3	RFS	RFS	NNP
cord-005453-4057qib7	637	4	in	in	IN
cord-005453-4057qib7	637	5	MRD	MRD	NNP
cord-005453-4057qib7	637	6	negative	negative	JJ
cord-005453-4057qib7	637	7	patients	patient	NNS
cord-005453-4057qib7	637	8	with	with	IN
cord-005453-4057qib7	637	9	/	/	SYM
cord-005453-4057qib7	637	10	without	without	IN
cord-005453-4057qib7	637	11	PTCy	PTCy	NNS
cord-005453-4057qib7	637	12	is	be	VBZ
cord-005453-4057qib7	637	13	82	82	CD
cord-005453-4057qib7	637	14	%	%	NN
cord-005453-4057qib7	637	15	,	,	,
cord-005453-4057qib7	637	16	86	86	CD
cord-005453-4057qib7	637	17	%	%	NN
cord-005453-4057qib7	637	18	vs	vs	IN
cord-005453-4057qib7	637	19	42	42	CD
cord-005453-4057qib7	637	20	%	%	NN
cord-005453-4057qib7	637	21	,	,	,
cord-005453-4057qib7	637	22	78	78	CD
cord-005453-4057qib7	637	23	%	%	NN
cord-005453-4057qib7	637	24	(	(	-LRB-
cord-005453-4057qib7	637	25	p>0,05	p>0,05	NNP
cord-005453-4057qib7	637	26	)	)	-RRB-
cord-005453-4057qib7	637	27	;	;	:
cord-005453-4057qib7	637	28	GRFS	GRFS	NNP
cord-005453-4057qib7	637	29	is	be	VBZ
cord-005453-4057qib7	637	30	62	62	CD
cord-005453-4057qib7	637	31	%	%	NN
cord-005453-4057qib7	637	32	vs	vs	IN
cord-005453-4057qib7	637	33	28	28	CD
cord-005453-4057qib7	637	34	%	%	NN
cord-005453-4057qib7	637	35	accordingly	accordingly	RB
cord-005453-4057qib7	637	36	(	(	-LRB-
cord-005453-4057qib7	637	37	p=0,042	p=0,042	NNP
cord-005453-4057qib7	637	38	)	)	-RRB-
cord-005453-4057qib7	637	39	.	.	.
cord-005453-4057qib7	638	1	OS	OS	NNP
cord-005453-4057qib7	638	2	,	,	,
cord-005453-4057qib7	638	3	RFS	RFS	NNP
cord-005453-4057qib7	638	4	,	,	,
cord-005453-4057qib7	638	5	GRFS	GRFS	NNP
cord-005453-4057qib7	638	6	in	in	IN
cord-005453-4057qib7	638	7	MRD	MRD	NNP
cord-005453-4057qib7	638	8	positive	positive	JJ
cord-005453-4057qib7	638	9	patients	patient	NNS
cord-005453-4057qib7	638	10	with	with	IN
cord-005453-4057qib7	638	11	/	/	SYM
cord-005453-4057qib7	638	12	without	without	IN
cord-005453-4057qib7	638	13	PTCy	PTCy	NNS
cord-005453-4057qib7	638	14	is	be	VBZ
cord-005453-4057qib7	638	15	66	66	CD
cord-005453-4057qib7	638	16	%	%	NN
cord-005453-4057qib7	638	17	,	,	,
cord-005453-4057qib7	638	18	55	55	CD
cord-005453-4057qib7	638	19	%	%	NN
cord-005453-4057qib7	638	20	,	,	,
cord-005453-4057qib7	638	21	54	54	CD
cord-005453-4057qib7	638	22	%	%	NN
cord-005453-4057qib7	638	23	vs	vs	IN
cord-005453-4057qib7	638	24	66	66	CD
cord-005453-4057qib7	638	25	%	%	NN
cord-005453-4057qib7	638	26	,	,	,
cord-005453-4057qib7	638	27	57	57	CD
cord-005453-4057qib7	638	28	%	%	NN
cord-005453-4057qib7	638	29	,	,	,
cord-005453-4057qib7	638	30	27	27	CD
cord-005453-4057qib7	638	31	%	%	NN
cord-005453-4057qib7	638	32	(	(	-LRB-
cord-005453-4057qib7	638	33	p>0,05	p>0,05	NNP
cord-005453-4057qib7	638	34	)	)	-RRB-
cord-005453-4057qib7	638	35	.	.	.
cord-005453-4057qib7	639	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	639	2	:	:	:
cord-005453-4057qib7	640	1	MRD	MRD	NNP
cord-005453-4057qib7	640	2	status	status	NN
cord-005453-4057qib7	640	3	does	do	VBZ
cord-005453-4057qib7	640	4	not	not	RB
cord-005453-4057qib7	640	5	statistically	statistically	RB
cord-005453-4057qib7	640	6	significant	significant	JJ
cord-005453-4057qib7	640	7	affect	affect	NN
cord-005453-4057qib7	640	8	on	on	IN
cord-005453-4057qib7	640	9	OS	OS	NNP
cord-005453-4057qib7	640	10	that	that	WDT
cord-005453-4057qib7	640	11	can	can	MD
cord-005453-4057qib7	640	12	be	be	VB
cord-005453-4057qib7	640	13	related	relate	VBN
cord-005453-4057qib7	640	14	to	to	IN
cord-005453-4057qib7	640	15	different	different	JJ
cord-005453-4057qib7	640	16	approaches	approach	NNS
cord-005453-4057qib7	640	17	to	to	IN
cord-005453-4057qib7	640	18	the	the	DT
cord-005453-4057qib7	640	19	treatment	treatment	NN
cord-005453-4057qib7	640	20	of	of	IN
cord-005453-4057qib7	640	21	relapse	relapse	NN
cord-005453-4057qib7	640	22	after	after	IN
cord-005453-4057qib7	640	23	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	640	24	.	.	.
cord-005453-4057qib7	641	1	MRD	MRD	NNP
cord-005453-4057qib7	641	2	positive	positive	JJ
cord-005453-4057qib7	641	3	status	status	NN
cord-005453-4057qib7	641	4	statistically	statistically	RB
cord-005453-4057qib7	641	5	significant	significant	JJ
cord-005453-4057qib7	641	6	decreases	decrease	VBZ
cord-005453-4057qib7	641	7	RFS	RFS	NNP
cord-005453-4057qib7	641	8	that	that	WDT
cord-005453-4057qib7	641	9	underline	underline	VBP
cord-005453-4057qib7	641	10	the	the	DT
cord-005453-4057qib7	641	11	necessity	necessity	NN
cord-005453-4057qib7	641	12	of	of	IN
cord-005453-4057qib7	641	13	posttransplant	posttransplant	NN
cord-005453-4057qib7	641	14	therapy	therapy	NN
cord-005453-4057qib7	641	15	improvement	improvement	NN
cord-005453-4057qib7	641	16	.	.	.
cord-005453-4057qib7	642	1	RIC	RIC	NNP
cord-005453-4057qib7	642	2	vs	vs	IN
cord-005453-4057qib7	642	3	MAC	MAC	NNP
cord-005453-4057qib7	642	4	in	in	IN
cord-005453-4057qib7	642	5	all	all	DT
cord-005453-4057qib7	642	6	patients	patient	NNS
cord-005453-4057qib7	642	7	in	in	IN
cord-005453-4057qib7	642	8	first	first	JJ
cord-005453-4057qib7	642	9	and	and	CC
cord-005453-4057qib7	642	10	second	second	JJ
cord-005453-4057qib7	642	11	remission	remission	NN
cord-005453-4057qib7	642	12	do	do	VBP
cord-005453-4057qib7	642	13	not	not	RB
cord-005453-4057qib7	642	14	show	show	VB
cord-005453-4057qib7	642	15	statistically	statistically	RB
cord-005453-4057qib7	642	16	significant	significant	JJ
cord-005453-4057qib7	642	17	impact	impact	NN
cord-005453-4057qib7	642	18	on	on	IN
cord-005453-4057qib7	642	19	OS	OS	NNP
cord-005453-4057qib7	642	20	,	,	,
cord-005453-4057qib7	642	21	RFS	RFS	NNP
cord-005453-4057qib7	642	22	,	,	,
cord-005453-4057qib7	642	23	GRFS	GRFS	NNP
cord-005453-4057qib7	642	24	.	.	.
cord-005453-4057qib7	643	1	PTCy	PTCy	NNP
cord-005453-4057qib7	643	2	significantly	significantly	RB
cord-005453-4057qib7	643	3	improves	improve	VBZ
cord-005453-4057qib7	643	4	GRFS	grfs	NN
cord-005453-4057qib7	643	5	in	in	IN
cord-005453-4057qib7	643	6	MRD	MRD	NNP
cord-005453-4057qib7	643	7	negative	negative	JJ
cord-005453-4057qib7	643	8	patients	patient	NNS
cord-005453-4057qib7	643	9	.	.	.
cord-005453-4057qib7	644	1	Disclosure	disclosure	NN
cord-005453-4057qib7	644	2	:	:	:
cord-005453-4057qib7	644	3	None	none	NN
cord-005453-4057qib7	644	4	of	of	IN
cord-005453-4057qib7	644	5	the	the	DT
cord-005453-4057qib7	644	6	authors	author	NNS
cord-005453-4057qib7	644	7	has	have	VBZ
cord-005453-4057qib7	644	8	anything	anything	NN
cord-005453-4057qib7	644	9	to	to	TO
cord-005453-4057qib7	644	10	disclose	disclose	VB
cord-005453-4057qib7	644	11	.	.	.
cord-005453-4057qib7	645	1	Background	background	NN
cord-005453-4057qib7	645	2	:	:	:
cord-005453-4057qib7	646	1	With	with	IN
cord-005453-4057qib7	646	2	increasing	increase	VBG
cord-005453-4057qib7	646	3	overall	overall	JJ
cord-005453-4057qib7	646	4	-	-	HYPH
cord-005453-4057qib7	646	5	survival	survival	NN
cord-005453-4057qib7	646	6	(	(	-LRB-
cord-005453-4057qib7	646	7	OS	OS	NNP
cord-005453-4057qib7	646	8	)	)	-RRB-
cord-005453-4057qib7	646	9	of	of	IN
cord-005453-4057qib7	646	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	646	11	patients	patient	NNS
cord-005453-4057qib7	646	12	,	,	,
cord-005453-4057qib7	646	13	higher	high	JJR
cord-005453-4057qib7	646	14	incidences	incidence	NNS
cord-005453-4057qib7	646	15	of	of	IN
cord-005453-4057qib7	646	16	therapy	therapy	NN
cord-005453-4057qib7	646	17	-	-	HYPH
cord-005453-4057qib7	646	18	related	relate	VBN
cord-005453-4057qib7	646	19	clonal	clonal	JJ
cord-005453-4057qib7	646	20	bone	bone	NN
cord-005453-4057qib7	646	21	marrow	marrow	NN
cord-005453-4057qib7	646	22	diseases	disease	NNS
cord-005453-4057qib7	646	23	,	,	,
cord-005453-4057qib7	646	24	such	such	JJ
cord-005453-4057qib7	646	25	as	as	IN
cord-005453-4057qib7	646	26	acute	acute	JJ
cord-005453-4057qib7	646	27	myeloid	myeloid	NN
cord-005453-4057qib7	646	28	leukemia	leukemia	NN
cord-005453-4057qib7	646	29	(	(	-LRB-
cord-005453-4057qib7	646	30	AML	AML	NNP
cord-005453-4057qib7	646	31	)	)	-RRB-
cord-005453-4057qib7	646	32	and	and	CC
cord-005453-4057qib7	646	33	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	646	34	syndrome	syndrome	NN
cord-005453-4057qib7	646	35	(	(	-LRB-
cord-005453-4057qib7	646	36	MDS	MDS	NNP
cord-005453-4057qib7	646	37	)	)	-RRB-
cord-005453-4057qib7	646	38	are	be	VBP
cord-005453-4057qib7	646	39	occuring	occur	VBG
cord-005453-4057qib7	646	40	.	.	.
cord-005453-4057qib7	647	1	Generally	generally	RB
cord-005453-4057qib7	647	2	,	,	,
cord-005453-4057qib7	647	3	the	the	DT
cord-005453-4057qib7	647	4	outcome	outcome	NN
cord-005453-4057qib7	647	5	is	be	VBZ
cord-005453-4057qib7	647	6	considered	consider	VBN
cord-005453-4057qib7	647	7	poor	poor	JJ
cord-005453-4057qib7	647	8	.	.	.
cord-005453-4057qib7	648	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	648	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	648	3	stem	stem	NN
cord-005453-4057qib7	648	4	cell	cell	NN
cord-005453-4057qib7	648	5	transplantation	transplantation	NN
cord-005453-4057qib7	648	6	(	(	-LRB-
cord-005453-4057qib7	648	7	allo	allo	NNP
cord-005453-4057qib7	648	8	HSCT	HSCT	NNP
cord-005453-4057qib7	648	9	)	)	-RRB-
cord-005453-4057qib7	648	10	often	often	RB
cord-005453-4057qib7	648	11	remains	remain	VBZ
cord-005453-4057qib7	648	12	the	the	DT
cord-005453-4057qib7	648	13	only	only	JJ
cord-005453-4057qib7	648	14	potentially	potentially	RB
cord-005453-4057qib7	648	15	curative	curative	JJ
cord-005453-4057qib7	648	16	treatment	treatment	NN
cord-005453-4057qib7	648	17	option	option	NN
cord-005453-4057qib7	648	18	.	.	.
cord-005453-4057qib7	649	1	Nonetheless	nonetheless	RB
cord-005453-4057qib7	649	2	,	,	,
cord-005453-4057qib7	649	3	there	there	EX
cord-005453-4057qib7	649	4	is	be	VBZ
cord-005453-4057qib7	649	5	only	only	RB
cord-005453-4057qib7	649	6	little	little	JJ
cord-005453-4057qib7	649	7	data	datum	NNS
cord-005453-4057qib7	649	8	available	available	JJ
cord-005453-4057qib7	649	9	concerning	concern	VBG
cord-005453-4057qib7	649	10	this	this	DT
cord-005453-4057qib7	649	11	patient	patient	NN
cord-005453-4057qib7	649	12	group	group	NN
cord-005453-4057qib7	649	13	.	.	.
cord-005453-4057qib7	650	1	Methods	method	NNS
cord-005453-4057qib7	650	2	:	:	:
cord-005453-4057qib7	650	3	We	-PRON-	PRP
cord-005453-4057qib7	650	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	650	5	collected	collect	VBD
cord-005453-4057qib7	650	6	data	datum	NNS
cord-005453-4057qib7	650	7	from	from	IN
cord-005453-4057qib7	650	8	33	33	CD
cord-005453-4057qib7	650	9	patients	patient	NNS
cord-005453-4057qib7	650	10	with	with	IN
cord-005453-4057qib7	650	11	therapy	therapy	NN
cord-005453-4057qib7	650	12	-	-	HYPH
cord-005453-4057qib7	650	13	related	relate	VBN
cord-005453-4057qib7	650	14	AML	AML	NNP
cord-005453-4057qib7	650	15	(	(	-LRB-
cord-005453-4057qib7	650	16	tAML	taml	NN
cord-005453-4057qib7	650	17	)	)	-RRB-
cord-005453-4057qib7	650	18	and	and	CC
cord-005453-4057qib7	650	19	MDS	MDS	NNP
cord-005453-4057qib7	650	20	(	(	-LRB-
cord-005453-4057qib7	650	21	tMDS	tmds	NN
cord-005453-4057qib7	650	22	)	)	-RRB-
cord-005453-4057qib7	650	23	after	after	IN
cord-005453-4057qib7	650	24	treatment	treatment	NN
cord-005453-4057qib7	650	25	for	for	IN
cord-005453-4057qib7	650	26	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	650	27	's	's	POS
cord-005453-4057qib7	650	28	lymphoma	lymphoma	NN
cord-005453-4057qib7	650	29	(	(	-LRB-
cord-005453-4057qib7	650	30	HL	HL	NNP
cord-005453-4057qib7	650	31	;	;	:
cord-005453-4057qib7	650	32	n=7	n=7	NNS
cord-005453-4057qib7	650	33	and	and	CC
cord-005453-4057qib7	650	34	n=2	n=2	NNS
cord-005453-4057qib7	650	35	)	)	-RRB-
cord-005453-4057qib7	650	36	or	or	CC
cord-005453-4057qib7	650	37	non	non	JJ
cord-005453-4057qib7	650	38	-	-	JJ
cord-005453-4057qib7	650	39	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	650	40	's	's	POS
cord-005453-4057qib7	650	41	lymphoma	lymphoma	NN
cord-005453-4057qib7	650	42	(	(	-LRB-
cord-005453-4057qib7	650	43	NHL	NHL	NNP
cord-005453-4057qib7	650	44	;	;	:
cord-005453-4057qib7	650	45	n=10	n=10	NNP
cord-005453-4057qib7	650	46	and	and	CC
cord-005453-4057qib7	650	47	n=14	n=14	NNP
cord-005453-4057qib7	650	48	)	)	-RRB-
cord-005453-4057qib7	650	49	,	,	,
cord-005453-4057qib7	650	50	who	who	WP
cord-005453-4057qib7	650	51	received	receive	VBD
cord-005453-4057qib7	650	52	an	an	DT
cord-005453-4057qib7	650	53	allo	allo	NN
cord-005453-4057qib7	650	54	HSCT	HSCT	NNP
cord-005453-4057qib7	650	55	between	between	IN
cord-005453-4057qib7	650	56	2000	2000	CD
cord-005453-4057qib7	650	57	and	and	CC
cord-005453-4057qib7	650	58	2018	2018	CD
cord-005453-4057qib7	650	59	.	.	.
cord-005453-4057qib7	651	1	Median	median	JJ
cord-005453-4057qib7	651	2	follow	follow	NN
cord-005453-4057qib7	651	3	-	-	HYPH
cord-005453-4057qib7	651	4	up	up	NN
cord-005453-4057qib7	651	5	of	of	IN
cord-005453-4057qib7	651	6	surviving	survive	VBG
cord-005453-4057qib7	651	7	patients	patient	NNS
cord-005453-4057qib7	651	8	was	be	VBD
cord-005453-4057qib7	651	9	3.1	3.1	CD
cord-005453-4057qib7	651	10	years	year	NNS
cord-005453-4057qib7	651	11	(	(	-LRB-
cord-005453-4057qib7	651	12	range	range	VBP
cord-005453-4057qib7	651	13	2.6	2.6	CD
cord-005453-4057qib7	651	14	months-9.4	months-9.4	CD
cord-005453-4057qib7	651	15	years	year	NNS
cord-005453-4057qib7	651	16	)	)	-RRB-
cord-005453-4057qib7	651	17	.	.	.
cord-005453-4057qib7	652	1	Background	background	NN
cord-005453-4057qib7	652	2	:	:	:
cord-005453-4057qib7	653	1	The	the	DT
cord-005453-4057qib7	653	2	prognosis	prognosis	NN
cord-005453-4057qib7	653	3	of	of	IN
cord-005453-4057qib7	653	4	relapsed	relapse	VBN
cord-005453-4057qib7	653	5	/	/	SYM
cord-005453-4057qib7	653	6	refractory	refractory	JJ
cord-005453-4057qib7	653	7	acute	acute	JJ
cord-005453-4057qib7	653	8	leukemia	leukemia	NN
cord-005453-4057qib7	653	9	(	(	-LRB-
cord-005453-4057qib7	653	10	R	r	NN
cord-005453-4057qib7	653	11	/	/	SYM
cord-005453-4057qib7	653	12	R	R	NNP
cord-005453-4057qib7	653	13	AL	AL	NNP
cord-005453-4057qib7	653	14	)	)	-RRB-
cord-005453-4057qib7	653	15	is	be	VBZ
cord-005453-4057qib7	653	16	poor	poor	JJ
cord-005453-4057qib7	653	17	and	and	CC
cord-005453-4057qib7	653	18	the	the	DT
cord-005453-4057qib7	653	19	treatment	treatment	NN
cord-005453-4057qib7	653	20	is	be	VBZ
cord-005453-4057qib7	653	21	challenging	challenging	JJ
cord-005453-4057qib7	653	22	.	.	.
cord-005453-4057qib7	654	1	In	in	IN
cord-005453-4057qib7	654	2	this	this	DT
cord-005453-4057qib7	654	3	setting	setting	NN
cord-005453-4057qib7	654	4	,	,	,
cord-005453-4057qib7	654	5	allogeneic	allogeneic	IN
cord-005453-4057qib7	654	6	stem	stem	NN
cord-005453-4057qib7	654	7	cell	cell	NN
cord-005453-4057qib7	654	8	transplantation	transplantation	NN
cord-005453-4057qib7	654	9	(	(	-LRB-
cord-005453-4057qib7	654	10	allo	allo	FW
cord-005453-4057qib7	654	11	-	-	HYPH
cord-005453-4057qib7	654	12	SCT	SCT	NNP
cord-005453-4057qib7	654	13	)	)	-RRB-
cord-005453-4057qib7	654	14	constitutes	constitute	VBZ
cord-005453-4057qib7	654	15	the	the	DT
cord-005453-4057qib7	654	16	only	only	JJ
cord-005453-4057qib7	654	17	curative	curative	JJ
cord-005453-4057qib7	654	18	option	option	NN
cord-005453-4057qib7	654	19	although	although	IN
cord-005453-4057qib7	654	20	the	the	DT
cord-005453-4057qib7	654	21	high	high	JJ
cord-005453-4057qib7	654	22	relapse	relapse	NN
cord-005453-4057qib7	654	23	rate	rate	NN
cord-005453-4057qib7	654	24	and	and	CC
cord-005453-4057qib7	654	25	non	non	JJ
cord-005453-4057qib7	654	26	-	-	JJ
cord-005453-4057qib7	654	27	relapse	relapse	JJ
cord-005453-4057qib7	654	28	mortality	mortality	NN
cord-005453-4057qib7	654	29	(	(	-LRB-
cord-005453-4057qib7	654	30	NRM	NRM	NNP
cord-005453-4057qib7	654	31	)	)	-RRB-
cord-005453-4057qib7	654	32	.	.	.
cord-005453-4057qib7	655	1	The	the	DT
cord-005453-4057qib7	655	2	sequential	sequential	JJ
cord-005453-4057qib7	655	3	conditioning	conditioning	NN
cord-005453-4057qib7	655	4	regimen	regimen	NN
cord-005453-4057qib7	655	5	followed	follow	VBN
cord-005453-4057qib7	655	6	by	by	IN
cord-005453-4057qib7	655	7	allo	allo	NNP
cord-005453-4057qib7	655	8	-	-	HYPH
cord-005453-4057qib7	655	9	SCT	SCT	NNP
cord-005453-4057qib7	655	10	has	have	VBZ
cord-005453-4057qib7	655	11	been	be	VBN
cord-005453-4057qib7	655	12	used	use	VBN
cord-005453-4057qib7	655	13	for	for	IN
cord-005453-4057qib7	655	14	persistent	persistent	JJ
cord-005453-4057qib7	655	15	disease	disease	NN
cord-005453-4057qib7	655	16	and	and	CC
cord-005453-4057qib7	655	17	aims	aim	VBZ
cord-005453-4057qib7	655	18	to	to	TO
cord-005453-4057qib7	655	19	improve	improve	VB
cord-005453-4057qib7	655	20	disease	disease	NN
cord-005453-4057qib7	655	21	control	control	NN
cord-005453-4057qib7	655	22	by	by	IN
cord-005453-4057qib7	655	23	intensified	intensify	VBN
cord-005453-4057qib7	655	24	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	655	25	,	,	,
cord-005453-4057qib7	655	26	thus	thus	RB
cord-005453-4057qib7	655	27	conceding	concede	VBG
cord-005453-4057qib7	655	28	more	more	JJR
cord-005453-4057qib7	655	29	time	time	NN
cord-005453-4057qib7	655	30	for	for	IN
cord-005453-4057qib7	655	31	the	the	DT
cord-005453-4057qib7	655	32	presumed	presume	VBN
cord-005453-4057qib7	655	33	graft	graft	NN
cord-005453-4057qib7	655	34	-	-	HYPH
cord-005453-4057qib7	655	35	versus	versus	IN
cord-005453-4057qib7	655	36	-	-	HYPH
cord-005453-4057qib7	655	37	leukemia	leukemia	NN
cord-005453-4057qib7	655	38	effect	effect	NN
cord-005453-4057qib7	655	39	to	to	TO
cord-005453-4057qib7	655	40	occur	occur	VB
cord-005453-4057qib7	655	41	.	.	.
cord-005453-4057qib7	656	1	Methods	method	NNS
cord-005453-4057qib7	656	2	:	:	:
cord-005453-4057qib7	657	1	The	the	DT
cord-005453-4057qib7	657	2	clinical	clinical	JJ
cord-005453-4057qib7	657	3	outcome	outcome	NN
cord-005453-4057qib7	657	4	of	of	IN
cord-005453-4057qib7	657	5	R	r	NN
cord-005453-4057qib7	657	6	/	/	SYM
cord-005453-4057qib7	657	7	R	R	NNP
cord-005453-4057qib7	657	8	AL	AL	NNP
cord-005453-4057qib7	657	9	with	with	IN
cord-005453-4057qib7	657	10	the	the	DT
cord-005453-4057qib7	657	11	sequential	sequential	JJ
cord-005453-4057qib7	657	12	conditioning	conditioning	NN
cord-005453-4057qib7	657	13	regimen	regimen	NN
cord-005453-4057qib7	657	14	combining	combine	VBG
cord-005453-4057qib7	657	15	a	a	DT
cord-005453-4057qib7	657	16	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	657	17	rescue	rescue	NN
cord-005453-4057qib7	657	18	followed	follow	VBN
cord-005453-4057qib7	657	19	by	by	IN
cord-005453-4057qib7	657	20	RIC	RIC	NNP
cord-005453-4057qib7	657	21	allo	allo	NNP
cord-005453-4057qib7	657	22	-	-	HYPH
cord-005453-4057qib7	657	23	SCT	SCT	NNP
cord-005453-4057qib7	657	24	in	in	IN
cord-005453-4057qib7	657	25	our	-PRON-	PRP$
cord-005453-4057qib7	657	26	center	center	NN
cord-005453-4057qib7	657	27	is	be	VBZ
cord-005453-4057qib7	657	28	described	describe	VBN
cord-005453-4057qib7	657	29	.	.	.
cord-005453-4057qib7	658	1	Patients	patient	NNS
cord-005453-4057qib7	658	2	who	who	WP
cord-005453-4057qib7	658	3	underwent	undergo	VBD
cord-005453-4057qib7	658	4	a	a	DT
cord-005453-4057qib7	658	5	sequential	sequential	JJ
cord-005453-4057qib7	658	6	allo	allo	NN
cord-005453-4057qib7	658	7	-	-	HYPH
cord-005453-4057qib7	658	8	SCT	SCT	NNP
cord-005453-4057qib7	658	9	from	from	IN
cord-005453-4057qib7	658	10	2005	2005	CD
cord-005453-4057qib7	658	11	to	to	IN
cord-005453-4057qib7	658	12	2017	2017	CD
cord-005453-4057qib7	658	13	are	be	VBP
cord-005453-4057qib7	658	14	included	include	VBN
cord-005453-4057qib7	658	15	.	.	.
cord-005453-4057qib7	659	1	The	the	DT
cord-005453-4057qib7	659	2	primary	primary	JJ
cord-005453-4057qib7	659	3	endpoint	endpoint	NN
cord-005453-4057qib7	659	4	was	be	VBD
cord-005453-4057qib7	659	5	progression	progression	NN
cord-005453-4057qib7	659	6	free	free	JJ
cord-005453-4057qib7	659	7	survival	survival	NN
cord-005453-4057qib7	659	8	(	(	-LRB-
cord-005453-4057qib7	659	9	PFS	PFS	NNP
cord-005453-4057qib7	659	10	)	)	-RRB-
cord-005453-4057qib7	659	11	and	and	CC
cord-005453-4057qib7	659	12	overall	overall	JJ
cord-005453-4057qib7	659	13	survival	survival	NN
cord-005453-4057qib7	659	14	(	(	-LRB-
cord-005453-4057qib7	659	15	OS	OS	NNP
cord-005453-4057qib7	659	16	)	)	-RRB-
cord-005453-4057qib7	659	17	that	that	WDT
cord-005453-4057qib7	659	18	were	be	VBD
cord-005453-4057qib7	659	19	estimated	estimate	VBN
cord-005453-4057qib7	659	20	by	by	IN
cord-005453-4057qib7	659	21	the	the	DT
cord-005453-4057qib7	659	22	Kaplan	Kaplan	NNP
cord-005453-4057qib7	659	23	-	-	HYPH
cord-005453-4057qib7	659	24	Meier	Meier	NNP
cord-005453-4057qib7	659	25	method	method	NN
cord-005453-4057qib7	659	26	.	.	.
cord-005453-4057qib7	660	1	Secondary	secondary	JJ
cord-005453-4057qib7	660	2	endpoints	endpoint	NNS
cord-005453-4057qib7	660	3	were	be	VBD
cord-005453-4057qib7	660	4	non	non	JJ
cord-005453-4057qib7	660	5	-	-	JJ
cord-005453-4057qib7	660	6	relapse	relapse	JJ
cord-005453-4057qib7	660	7	mortality	mortality	NN
cord-005453-4057qib7	660	8	(	(	-LRB-
cord-005453-4057qib7	660	9	NRM	NRM	NNP
cord-005453-4057qib7	660	10	)	)	-RRB-
cord-005453-4057qib7	660	11	.	.	.
cord-005453-4057qib7	661	1	Background	background	NN
cord-005453-4057qib7	661	2	:	:	:
cord-005453-4057qib7	662	1	Recommendations	recommendation	NNS
cord-005453-4057qib7	662	2	of	of	IN
cord-005453-4057qib7	662	3	the	the	DT
cord-005453-4057qib7	662	4	2017	2017	CD
cord-005453-4057qib7	662	5	European	European	NNP
cord-005453-4057qib7	662	6	Leukemia	Leukemia	NNP
cord-005453-4057qib7	662	7	Net	Net	NNP
cord-005453-4057qib7	662	8	(	(	-LRB-
cord-005453-4057qib7	662	9	ELN	ELN	NNP
cord-005453-4057qib7	662	10	)	)	-RRB-
cord-005453-4057qib7	662	11	for	for	IN
cord-005453-4057qib7	662	12	favorable	favorable	JJ
cord-005453-4057qib7	662	13	-	-	HYPH
cord-005453-4057qib7	662	14	risk	risk	NN
cord-005453-4057qib7	662	15	genetics	genetic	NNS
cord-005453-4057qib7	662	16	(	(	-LRB-
cord-005453-4057qib7	662	17	FRG	FRG	NNP
cord-005453-4057qib7	662	18	)	)	-RRB-
cord-005453-4057qib7	662	19	acute	acute	JJ
cord-005453-4057qib7	662	20	myeloid	myeloid	NN
cord-005453-4057qib7	662	21	leukemia	leukemia	NN
cord-005453-4057qib7	662	22	(	(	-LRB-
cord-005453-4057qib7	662	23	AML	AML	NNP
cord-005453-4057qib7	662	24	)	)	-RRB-
cord-005453-4057qib7	662	25	favor	favor	VBP
cord-005453-4057qib7	662	26	consolidation	consolidation	NN
cord-005453-4057qib7	662	27	over	over	IN
cord-005453-4057qib7	662	28	transplantation	transplantation	NN
cord-005453-4057qib7	662	29	,	,	,
cord-005453-4057qib7	662	30	although	although	IN
cord-005453-4057qib7	662	31	reviews	review	NNS
cord-005453-4057qib7	662	32	suggest	suggest	VBP
cord-005453-4057qib7	662	33	advantage	advantage	NN
cord-005453-4057qib7	662	34	of	of	IN
cord-005453-4057qib7	662	35	autologous	autologous	JJ
cord-005453-4057qib7	662	36	stem	stem	NN
cord-005453-4057qib7	662	37	cell	cell	NN
cord-005453-4057qib7	662	38	transplant	transplant	NN
cord-005453-4057qib7	662	39	(	(	-LRB-
cord-005453-4057qib7	662	40	ASCT	ASCT	NNP
cord-005453-4057qib7	662	41	)	)	-RRB-
cord-005453-4057qib7	662	42	in	in	IN
cord-005453-4057qib7	662	43	event	event	NN
cord-005453-4057qib7	662	44	free	free	JJ
cord-005453-4057qib7	662	45	survival	survival	NN
cord-005453-4057qib7	662	46	.	.	.
cord-005453-4057qib7	663	1	Our	-PRON-	PRP$
cord-005453-4057qib7	663	2	objective	objective	NN
cord-005453-4057qib7	663	3	was	be	VBD
cord-005453-4057qib7	663	4	to	to	TO
cord-005453-4057qib7	663	5	compare	compare	VB
cord-005453-4057qib7	663	6	the	the	DT
cord-005453-4057qib7	663	7	progression	progression	NN
cord-005453-4057qib7	663	8	free	free	JJ
cord-005453-4057qib7	663	9	survival	survival	NN
cord-005453-4057qib7	663	10	(	(	-LRB-
cord-005453-4057qib7	663	11	PFS	PFS	NNP
cord-005453-4057qib7	663	12	)	)	-RRB-
cord-005453-4057qib7	663	13	and	and	CC
cord-005453-4057qib7	663	14	overall	overall	JJ
cord-005453-4057qib7	663	15	survival	survival	NN
cord-005453-4057qib7	663	16	(	(	-LRB-
cord-005453-4057qib7	663	17	OS	OS	NNP
cord-005453-4057qib7	663	18	)	)	-RRB-
cord-005453-4057qib7	663	19	of	of	IN
cord-005453-4057qib7	663	20	normal	normal	JJ
cord-005453-4057qib7	663	21	karyotype	karyotype	NN
cord-005453-4057qib7	663	22	NPM1	NPM1	NNP
cord-005453-4057qib7	663	23	mutated	mutate	VBN
cord-005453-4057qib7	663	24	without	without	IN
cord-005453-4057qib7	663	25	FLT3	FLT3	NNP
cord-005453-4057qib7	663	26	ITD	ITD	NNP
cord-005453-4057qib7	663	27	or	or	CC
cord-005453-4057qib7	663	28	allelic	allelic	JJ
cord-005453-4057qib7	663	29	ratio	ratio	NN
cord-005453-4057qib7	663	30	<	<	XX
cord-005453-4057qib7	663	31	0.5	0.5	CD
cord-005453-4057qib7	664	1	(	(	-LRB-
cord-005453-4057qib7	664	2	NPM1	NPM1	NNP
cord-005453-4057qib7	664	3	+	+	CD
cord-005453-4057qib7	664	4	)	)	-RRB-
cord-005453-4057qib7	665	1	AML	AML	NNP
cord-005453-4057qib7	665	2	patients	patient	NNS
cord-005453-4057qib7	665	3	treated	treat	VBN
cord-005453-4057qib7	665	4	with	with	IN
cord-005453-4057qib7	665	5	consolidation	consolidation	NN
cord-005453-4057qib7	665	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	665	7	alone	alone	JJ
cord-005453-4057qib7	665	8	(	(	-LRB-
cord-005453-4057qib7	665	9	CC	CC	NNP
cord-005453-4057qib7	665	10	)	)	-RRB-
cord-005453-4057qib7	665	11	,	,	,
cord-005453-4057qib7	665	12	ASCT	ASCT	NNP
cord-005453-4057qib7	665	13	or	or	CC
cord-005453-4057qib7	665	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	665	15	stem	stem	NN
cord-005453-4057qib7	665	16	cell	cell	NN
cord-005453-4057qib7	665	17	transplant	transplant	NN
cord-005453-4057qib7	665	18	(	(	-LRB-
cord-005453-4057qib7	665	19	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	665	20	)	)	-RRB-
cord-005453-4057qib7	665	21	.	.	.
cord-005453-4057qib7	666	1	Methods	method	NNS
cord-005453-4057qib7	666	2	:	:	:
cord-005453-4057qib7	666	3	Retrospective	retrospective	JJ
cord-005453-4057qib7	666	4	review	review	NN
cord-005453-4057qib7	666	5	of	of	IN
cord-005453-4057qib7	666	6	NPM1	NPM1	NNP
cord-005453-4057qib7	666	7	+	+	SYM
cord-005453-4057qib7	666	8	FRG	FRG	NNP
cord-005453-4057qib7	666	9	-	-	HYPH
cord-005453-4057qib7	666	10	AML	AML	NNP
cord-005453-4057qib7	666	11	patients	patient	NNS
cord-005453-4057qib7	666	12	,	,	,
cord-005453-4057qib7	666	13	treated	treat	VBN
cord-005453-4057qib7	666	14	in	in	IN
cord-005453-4057qib7	666	15	one	one	CD
cord-005453-4057qib7	666	16	institution	institution	NN
cord-005453-4057qib7	666	17	(	(	-LRB-
cord-005453-4057qib7	666	18	2008	2008	CD
cord-005453-4057qib7	666	19	to	to	IN
cord-005453-4057qib7	666	20	2017	2017	CD
cord-005453-4057qib7	666	21	)	)	-RRB-
cord-005453-4057qib7	666	22	with	with	IN
cord-005453-4057qib7	666	23	the	the	DT
cord-005453-4057qib7	666	24	following	following	JJ
cord-005453-4057qib7	666	25	induction	induction	NN
cord-005453-4057qib7	666	26	regimens	regimen	NNS
cord-005453-4057qib7	666	27	:	:	:
cord-005453-4057qib7	666	28	cytarabine	cytarabine	NNP
cord-005453-4057qib7	666	29	(	(	-LRB-
cord-005453-4057qib7	666	30	Ara	Ara	NNP
cord-005453-4057qib7	666	31	-	-	HYPH
cord-005453-4057qib7	666	32	C	C	NNP
cord-005453-4057qib7	666	33	)	)	-RRB-
cord-005453-4057qib7	666	34	and	and	CC
cord-005453-4057qib7	666	35	VP-16	VP-16	NNP
cord-005453-4057qib7	666	36	with	with	IN
cord-005453-4057qib7	666	37	daunorubicin	daunorubicin	NNS
cord-005453-4057qib7	666	38	(	(	-LRB-
cord-005453-4057qib7	666	39	ADE	ADE	NNP
cord-005453-4057qib7	666	40	)	)	-RRB-
cord-005453-4057qib7	666	41	or	or	CC
cord-005453-4057qib7	666	42	mitoxantrone	mitoxantrone	NNP
cord-005453-4057qib7	666	43	(	(	-LRB-
cord-005453-4057qib7	666	44	MiCE	MiCE	NNP
cord-005453-4057qib7	666	45	)	)	-RRB-
cord-005453-4057qib7	666	46	.	.	.
cord-005453-4057qib7	667	1	Consolidation	consolidation	NN
cord-005453-4057qib7	667	2	regimens	regimen	NNS
cord-005453-4057qib7	667	3	were	be	VBD
cord-005453-4057qib7	667	4	Ara	Ara	NNP
cord-005453-4057qib7	667	5	-	-	HYPH
cord-005453-4057qib7	667	6	C	C	NNP
cord-005453-4057qib7	667	7	with	with	IN
cord-005453-4057qib7	667	8	daunorubicin	daunorubicin	NNS
cord-005453-4057qib7	667	9	(	(	-LRB-
cord-005453-4057qib7	667	10	AC	ac	NN
cord-005453-4057qib7	667	11	-	-	HYPH
cord-005453-4057qib7	667	12	D	D	NNP
cord-005453-4057qib7	667	13	)	)	-RRB-
cord-005453-4057qib7	667	14	,	,	,
cord-005453-4057qib7	667	15	idarubicin	idarubicin	NNS
cord-005453-4057qib7	667	16	,	,	,
cord-005453-4057qib7	667	17	VP-16	VP-16	NNP
cord-005453-4057qib7	667	18	and	and	CC
cord-005453-4057qib7	667	19	Ara	Ara	NNP
cord-005453-4057qib7	667	20	-	-	HYPH
cord-005453-4057qib7	667	21	C	C	NNP
cord-005453-4057qib7	667	22	(	(	-LRB-
cord-005453-4057qib7	667	23	mini	mini	NN
cord-005453-4057qib7	667	24	-	-	NN
cord-005453-4057qib7	667	25	ICE	ice	NN
cord-005453-4057qib7	667	26	)	)	-RRB-
cord-005453-4057qib7	667	27	or	or	CC
cord-005453-4057qib7	667	28	highdose	highdose	NNP
cord-005453-4057qib7	667	29	Ara	Ara	NNP
cord-005453-4057qib7	667	30	-	-	HYPH
cord-005453-4057qib7	667	31	C	C	NNP
cord-005453-4057qib7	667	32	(	(	-LRB-
cord-005453-4057qib7	667	33	HiDAC	HiDAC	NNP
cord-005453-4057qib7	667	34	)	)	-RRB-
cord-005453-4057qib7	667	35	.	.	.
cord-005453-4057qib7	668	1	In	in	IN
cord-005453-4057qib7	668	2	ASCT	ASCT	NNP
cord-005453-4057qib7	668	3	,	,	,
cord-005453-4057qib7	668	4	conditioning	conditioning	NN
cord-005453-4057qib7	668	5	regimens	regimen	NNS
cord-005453-4057qib7	668	6	were	be	VBD
cord-005453-4057qib7	668	7	BuCy	BuCy	NNP
cord-005453-4057qib7	668	8	or	or	CC
cord-005453-4057qib7	668	9	BVAC	BVAC	NNP
cord-005453-4057qib7	668	10	and	and	CC
cord-005453-4057qib7	668	11	in	in	IN
cord-005453-4057qib7	668	12	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	668	13	were	be	VBD
cord-005453-4057qib7	668	14	BuCy	BuCy	NNP
cord-005453-4057qib7	668	15	or	or	CC
cord-005453-4057qib7	668	16	FluBu	flubu	NN
cord-005453-4057qib7	668	17	.	.	.
cord-005453-4057qib7	669	1	PFS	PFS	NNP
cord-005453-4057qib7	669	2	and	and	CC
cord-005453-4057qib7	669	3	OS	OS	NNP
cord-005453-4057qib7	669	4	were	be	VBD
cord-005453-4057qib7	669	5	calculated	calculate	VBN
cord-005453-4057qib7	669	6	from	from	IN
cord-005453-4057qib7	669	7	the	the	DT
cord-005453-4057qib7	669	8	start	start	NN
cord-005453-4057qib7	669	9	of	of	IN
cord-005453-4057qib7	669	10	the	the	DT
cord-005453-4057qib7	669	11	last	last	JJ
cord-005453-4057qib7	669	12	consolidation	consolidation	NN
cord-005453-4057qib7	669	13	or	or	CC
cord-005453-4057qib7	669	14	stem	stem	NN
cord-005453-4057qib7	669	15	cell	cell	NN
cord-005453-4057qib7	669	16	infusion	infusion	NN
cord-005453-4057qib7	669	17	.	.	.
cord-005453-4057qib7	670	1	Results	result	NNS
cord-005453-4057qib7	670	2	:	:	:
cord-005453-4057qib7	671	1	A	a	DT
cord-005453-4057qib7	671	2	total	total	NN
cord-005453-4057qib7	671	3	of	of	IN
cord-005453-4057qib7	671	4	39	39	CD
cord-005453-4057qib7	671	5	patients	patient	NNS
cord-005453-4057qib7	671	6	were	be	VBD
cord-005453-4057qib7	671	7	evaluated	evaluate	VBN
cord-005453-4057qib7	671	8	,	,	,
cord-005453-4057qib7	671	9	with	with	IN
cord-005453-4057qib7	671	10	a	a	DT
cord-005453-4057qib7	671	11	median	median	JJ
cord-005453-4057qib7	671	12	age	age	NN
cord-005453-4057qib7	671	13	of	of	IN
cord-005453-4057qib7	671	14	53	53	CD
cord-005453-4057qib7	671	15	years	year	NNS
cord-005453-4057qib7	671	16	(	(	-LRB-
cord-005453-4057qib7	671	17	y	y	NN
cord-005453-4057qib7	671	18	)	)	-RRB-
cord-005453-4057qib7	671	19	(	(	-LRB-
cord-005453-4057qib7	671	20	23	23	CD
cord-005453-4057qib7	671	21	-	-	SYM
cord-005453-4057qib7	671	22	68y	68y	CD
cord-005453-4057qib7	671	23	)	)	-RRB-
cord-005453-4057qib7	671	24	,	,	,
cord-005453-4057qib7	671	25	69	69	CD
cord-005453-4057qib7	671	26	%	%	NN
cord-005453-4057qib7	671	27	female	female	JJ
cord-005453-4057qib7	671	28	,	,	,
cord-005453-4057qib7	671	29	95	95	CD
cord-005453-4057qib7	671	30	%	%	NN
cord-005453-4057qib7	671	31	with	with	IN
cord-005453-4057qib7	671	32	ECOG	ECOG	NNP
cord-005453-4057qib7	671	33	performance	performance	NN
cord-005453-4057qib7	671	34	status	status	NN
cord-005453-4057qib7	671	35	(	(	-LRB-
cord-005453-4057qib7	671	36	PS	ps	NN
cord-005453-4057qib7	671	37	)	)	-RRB-
cord-005453-4057qib7	671	38	0	0	CD
cord-005453-4057qib7	671	39	-	-	SYM
cord-005453-4057qib7	671	40	1	1	CD
cord-005453-4057qib7	671	41	and	and	CC
cord-005453-4057qib7	671	42	36	36	CD
cord-005453-4057qib7	671	43	%	%	NN
cord-005453-4057qib7	671	44	with	with	IN
cord-005453-4057qib7	671	45	ageadjusted	ageadjuste	VBN
cord-005453-4057qib7	671	46	Charlson	Charlson	NNP
cord-005453-4057qib7	671	47	comorbidity	comorbidity	NN
cord-005453-4057qib7	671	48	index	index	NN
cord-005453-4057qib7	671	49	(	(	-LRB-
cord-005453-4057qib7	671	50	aaCII	aacii	NN
cord-005453-4057qib7	671	51	)	)	-RRB-
cord-005453-4057qib7	671	52	≥2	≥2	NNP
cord-005453-4057qib7	671	53	at	at	IN
cord-005453-4057qib7	671	54	diagnosis	diagnosis	NN
cord-005453-4057qib7	671	55	.	.	.
cord-005453-4057qib7	672	1	Patients	patient	NNS
cord-005453-4057qib7	672	2	were	be	VBD
cord-005453-4057qib7	672	3	treated	treat	VBN
cord-005453-4057qib7	672	4	with	with	IN
cord-005453-4057qib7	672	5	CC	CC	NNP
cord-005453-4057qib7	672	6	in	in	IN
cord-005453-4057qib7	672	7	33	33	CD
cord-005453-4057qib7	672	8	%	%	NN
cord-005453-4057qib7	672	9	(	(	-LRB-
cord-005453-4057qib7	672	10	n=13	n=13	NNP
cord-005453-4057qib7	672	11	)	)	-RRB-
cord-005453-4057qib7	672	12	,	,	,
cord-005453-4057qib7	672	13	ASCT	ASCT	NNP
cord-005453-4057qib7	672	14	in	in	IN
cord-005453-4057qib7	672	15	36	36	CD
cord-005453-4057qib7	672	16	%	%	NN
cord-005453-4057qib7	672	17	(	(	-LRB-
cord-005453-4057qib7	672	18	n=14	n=14	NNP
cord-005453-4057qib7	672	19	)	)	-RRB-
cord-005453-4057qib7	672	20	and	and	CC
cord-005453-4057qib7	672	21	AlloSCT	allosct	NN
cord-005453-4057qib7	672	22	in	in	IN
cord-005453-4057qib7	672	23	21	21	CD
cord-005453-4057qib7	672	24	%	%	NN
cord-005453-4057qib7	672	25	(	(	-LRB-
cord-005453-4057qib7	672	26	n=12	n=12	NNP
cord-005453-4057qib7	672	27	)	)	-RRB-
cord-005453-4057qib7	672	28	of	of	IN
cord-005453-4057qib7	672	29	cases	case	NNS
cord-005453-4057qib7	672	30	.	.	.
cord-005453-4057qib7	673	1	There	there	EX
cord-005453-4057qib7	673	2	were	be	VBD
cord-005453-4057qib7	673	3	no	no	DT
cord-005453-4057qib7	673	4	differences	difference	NNS
cord-005453-4057qib7	673	5	between	between	IN
cord-005453-4057qib7	673	6	groups	group	NNS
cord-005453-4057qib7	673	7	for	for	IN
cord-005453-4057qib7	673	8	age	age	NN
cord-005453-4057qib7	673	9	,	,	,
cord-005453-4057qib7	673	10	aaCII	aaCII	-RRB-
cord-005453-4057qib7	673	11	,	,	,
cord-005453-4057qib7	673	12	PS	PS	NNP
cord-005453-4057qib7	673	13	,	,	,
cord-005453-4057qib7	673	14	leucocytes	leucocyte	NNS
cord-005453-4057qib7	673	15	at	at	IN
cord-005453-4057qib7	673	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	673	17	or	or	CC
cord-005453-4057qib7	673	18	extra	extra	JJ
cord-005453-4057qib7	673	19	-	-	JJ
cord-005453-4057qib7	673	20	medullary	medullary	JJ
cord-005453-4057qib7	673	21	disease	disease	NN
cord-005453-4057qib7	673	22	.	.	.
cord-005453-4057qib7	674	1	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	674	2	was	be	VBD
cord-005453-4057qib7	674	3	more	more	RBR
cord-005453-4057qib7	674	4	frequent	frequent	JJ
cord-005453-4057qib7	674	5	in	in	IN
cord-005453-4057qib7	674	6	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	674	7	group	group	NN
cord-005453-4057qib7	674	8	(	(	-LRB-
cord-005453-4057qib7	674	9	64	64	CD
cord-005453-4057qib7	674	10	%	%	NN
cord-005453-4057qib7	674	11	)	)	-RRB-
cord-005453-4057qib7	674	12	than	than	IN
cord-005453-4057qib7	674	13	CC	CC	NNP
cord-005453-4057qib7	674	14	(	(	-LRB-
cord-005453-4057qib7	674	15	23	23	CD
cord-005453-4057qib7	674	16	%	%	NN
cord-005453-4057qib7	674	17	)	)	-RRB-
cord-005453-4057qib7	674	18	or	or	CC
cord-005453-4057qib7	674	19	ASCT	ASCT	NNP
cord-005453-4057qib7	674	20	(	(	-LRB-
cord-005453-4057qib7	674	21	8	8	CD
cord-005453-4057qib7	674	22	%	%	NN
cord-005453-4057qib7	674	23	;	;	:
cord-005453-4057qib7	674	24	p=0.07	p=0.07	NNP
cord-005453-4057qib7	674	25	)	)	-RRB-
cord-005453-4057qib7	674	26	.	.	.
cord-005453-4057qib7	675	1	At	at	IN
cord-005453-4057qib7	675	2	induction	induction	NN
cord-005453-4057qib7	675	3	,	,	,
cord-005453-4057qib7	675	4	ADE	ADE	NNP
cord-005453-4057qib7	675	5	was	be	VBD
cord-005453-4057qib7	675	6	used	use	VBN
cord-005453-4057qib7	675	7	in	in	IN
cord-005453-4057qib7	675	8	82	82	CD
cord-005453-4057qib7	675	9	%	%	NN
cord-005453-4057qib7	675	10	and	and	CC
cord-005453-4057qib7	675	11	MiCE	MiCE	NNP
cord-005453-4057qib7	675	12	in	in	IN
cord-005453-4057qib7	675	13	18	18	CD
cord-005453-4057qib7	675	14	%	%	NN
cord-005453-4057qib7	675	15	of	of	IN
cord-005453-4057qib7	675	16	patients	patient	NNS
cord-005453-4057qib7	675	17	,	,	,
cord-005453-4057qib7	675	18	with	with	IN
cord-005453-4057qib7	675	19	a	a	DT
cord-005453-4057qib7	675	20	complete	complete	JJ
cord-005453-4057qib7	675	21	remission	remission	NN
cord-005453-4057qib7	675	22	(	(	-LRB-
cord-005453-4057qib7	675	23	CR	cr	NN
cord-005453-4057qib7	675	24	)	)	-RRB-
cord-005453-4057qib7	675	25	rate	rate	NN
cord-005453-4057qib7	675	26	of	of	IN
cord-005453-4057qib7	675	27	95	95	CD
cord-005453-4057qib7	675	28	%	%	NN
cord-005453-4057qib7	675	29	.	.	.
cord-005453-4057qib7	676	1	There	there	EX
cord-005453-4057qib7	676	2	were	be	VBD
cord-005453-4057qib7	676	3	no	no	DT
cord-005453-4057qib7	676	4	differences	difference	NNS
cord-005453-4057qib7	676	5	between	between	IN
cord-005453-4057qib7	676	6	groups	group	NNS
cord-005453-4057qib7	676	7	for	for	IN
cord-005453-4057qib7	676	8	induction	induction	NN
cord-005453-4057qib7	676	9	regimen	regimen	NN
cord-005453-4057qib7	676	10	or	or	CC
cord-005453-4057qib7	676	11	CR	CR	NNP
cord-005453-4057qib7	676	12	.	.	.
cord-005453-4057qib7	677	1	In	in	IN
cord-005453-4057qib7	677	2	CC	CC	NNP
cord-005453-4057qib7	677	3	group	group	NN
cord-005453-4057qib7	677	4	,	,	,
cord-005453-4057qib7	677	5	consolidation	consolidation	NN
cord-005453-4057qib7	677	6	regimens	regimen	NNS
cord-005453-4057qib7	677	7	were	be	VBD
cord-005453-4057qib7	677	8	1	1	CD
cord-005453-4057qib7	677	9	cycle	cycle	NN
cord-005453-4057qib7	677	10	(	(	-LRB-
cord-005453-4057qib7	677	11	8	8	CD
cord-005453-4057qib7	677	12	%	%	NN
cord-005453-4057qib7	677	13	)	)	-RRB-
cord-005453-4057qib7	677	14	and	and	CC
cord-005453-4057qib7	677	15	2	2	CD
cord-005453-4057qib7	677	16	cycles	cycle	NNS
cord-005453-4057qib7	677	17	AC	ac	NN
cord-005453-4057qib7	677	18	-	-	HYPH
cord-005453-4057qib7	677	19	D	D	NNP
cord-005453-4057qib7	677	20	(	(	-LRB-
cord-005453-4057qib7	677	21	61	61	CD
cord-005453-4057qib7	677	22	%	%	NN
cord-005453-4057qib7	677	23	)	)	-RRB-
cord-005453-4057qib7	677	24	and	and	CC
cord-005453-4057qib7	677	25	2	2	CD
cord-005453-4057qib7	677	26	cycles	cycle	NNS
cord-005453-4057qib7	677	27	mini	mini	NN
cord-005453-4057qib7	677	28	-	-	HYPH
cord-005453-4057qib7	677	29	ICE	ice	NN
cord-005453-4057qib7	677	30	(	(	-LRB-
cord-005453-4057qib7	677	31	31	31	CD
cord-005453-4057qib7	677	32	%	%	NN
cord-005453-4057qib7	677	33	)	)	-RRB-
cord-005453-4057qib7	677	34	.	.	.
cord-005453-4057qib7	678	1	ASCT	ASCT	NNP
cord-005453-4057qib7	678	2	patients	patient	NNS
cord-005453-4057qib7	678	3	received	receive	VBD
cord-005453-4057qib7	678	4	consolidation	consolidation	NN
cord-005453-4057qib7	678	5	with	with	IN
cord-005453-4057qib7	678	6	1	1	CD
cord-005453-4057qib7	678	7	-	-	SYM
cord-005453-4057qib7	678	8	2	2	CD
cord-005453-4057qib7	678	9	cycles	cycle	NNS
cord-005453-4057qib7	678	10	AC	ac	NN
cord-005453-4057qib7	678	11	-	-	HYPH
cord-005453-4057qib7	678	12	D	D	NNP
cord-005453-4057qib7	678	13	(	(	-LRB-
cord-005453-4057qib7	678	14	78	78	CD
cord-005453-4057qib7	678	15	%	%	NN
cord-005453-4057qib7	678	16	)	)	-RRB-
cord-005453-4057qib7	678	17	and	and	CC
cord-005453-4057qib7	678	18	1	1	CD
cord-005453-4057qib7	678	19	cycle	cycle	NN
cord-005453-4057qib7	678	20	mini	mini	NN
cord-005453-4057qib7	678	21	-	-	HYPH
cord-005453-4057qib7	678	22	ICE	ice	NN
cord-005453-4057qib7	678	23	(	(	-LRB-
cord-005453-4057qib7	678	24	22	22	CD
cord-005453-4057qib7	678	25	%	%	NN
cord-005453-4057qib7	678	26	)	)	-RRB-
cord-005453-4057qib7	678	27	,	,	,
cord-005453-4057qib7	678	28	while	while	IN
cord-005453-4057qib7	678	29	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	678	30	patients	patient	NNS
cord-005453-4057qib7	678	31	received	receive	VBD
cord-005453-4057qib7	678	32	1	1	CD
cord-005453-4057qib7	678	33	-	-	SYM
cord-005453-4057qib7	678	34	2	2	CD
cord-005453-4057qib7	678	35	cycles	cycle	NNS
cord-005453-4057qib7	678	36	AC	ac	NN
cord-005453-4057qib7	678	37	-	-	HYPH
cord-005453-4057qib7	678	38	D	D	NNP
cord-005453-4057qib7	678	39	(	(	-LRB-
cord-005453-4057qib7	678	40	84	84	CD
cord-005453-4057qib7	678	41	%	%	NN
cord-005453-4057qib7	678	42	)	)	-RRB-
cord-005453-4057qib7	678	43	,	,	,
cord-005453-4057qib7	678	44	2	2	CD
cord-005453-4057qib7	678	45	cycles	cycle	NNS
cord-005453-4057qib7	678	46	HiDAC	HiDAC	NNP
cord-005453-4057qib7	678	47	(	(	-LRB-
cord-005453-4057qib7	678	48	8	8	CD
cord-005453-4057qib7	678	49	%	%	NN
cord-005453-4057qib7	678	50	)	)	-RRB-
cord-005453-4057qib7	678	51	and	and	CC
cord-005453-4057qib7	678	52	no	no	DT
cord-005453-4057qib7	678	53	consolidation	consolidation	NN
cord-005453-4057qib7	678	54	in	in	IN
cord-005453-4057qib7	678	55	8	8	CD
cord-005453-4057qib7	678	56	%	%	NN
cord-005453-4057qib7	678	57	.	.	.
cord-005453-4057qib7	679	1	[	[	-LRB-
cord-005453-4057qib7	679	2	[	[	-LRB-
cord-005453-4057qib7	679	3	P037	p037	CD
cord-005453-4057qib7	679	4	Image	image	NN
cord-005453-4057qib7	679	5	]	]	-RRB-
cord-005453-4057qib7	679	6	1	1	CD
cord-005453-4057qib7	679	7	.	.	.
cord-005453-4057qib7	680	1	Figure	figure	NN
cord-005453-4057qib7	680	2	1	1	CD
cord-005453-4057qib7	680	3	.	.	.
cord-005453-4057qib7	681	1	PFS	PFS	NNP
cord-005453-4057qib7	681	2	at	at	IN
cord-005453-4057qib7	681	3	3y	3y	CD
cord-005453-4057qib7	681	4	in	in	IN
cord-005453-4057qib7	681	5	CC	CC	NNP
cord-005453-4057qib7	681	6	,	,	,
cord-005453-4057qib7	681	7	ASCT	ASCT	NNP
cord-005453-4057qib7	681	8	and	and	CC
cord-005453-4057qib7	681	9	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	681	10	groups	group	NNS
cord-005453-4057qib7	681	11	.	.	.
cord-005453-4057qib7	681	12	]	]	-RRB-
cord-005453-4057qib7	682	1	Median	median	JJ
cord-005453-4057qib7	682	2	follow	follow	NN
cord-005453-4057qib7	682	3	-	-	HYPH
cord-005453-4057qib7	682	4	up	up	NN
cord-005453-4057qib7	682	5	was	be	VBD
cord-005453-4057qib7	682	6	39	39	CD
cord-005453-4057qib7	682	7	months	month	NNS
cord-005453-4057qib7	682	8	,	,	,
cord-005453-4057qib7	682	9	PFS	PFS	NNP
cord-005453-4057qib7	682	10	at	at	IN
cord-005453-4057qib7	682	11	3y	3y	CD
cord-005453-4057qib7	682	12	was	be	VBD
cord-005453-4057qib7	682	13	53	53	CD
cord-005453-4057qib7	682	14	%	%	NN
cord-005453-4057qib7	682	15	and	and	CC
cord-005453-4057qib7	682	16	OS	os	NN
cord-005453-4057qib7	682	17	at	at	IN
cord-005453-4057qib7	682	18	3y	3y	CD
cord-005453-4057qib7	682	19	was	be	VBD
cord-005453-4057qib7	682	20	64	64	CD
cord-005453-4057qib7	682	21	%	%	NN
cord-005453-4057qib7	682	22	.	.	.
cord-005453-4057qib7	683	1	PFS	PFS	NNP
cord-005453-4057qib7	683	2	at	at	IN
cord-005453-4057qib7	683	3	3y	3y	CD
cord-005453-4057qib7	683	4	for	for	IN
cord-005453-4057qib7	683	5	ASCT	ASCT	NNP
cord-005453-4057qib7	683	6	group	group	NN
cord-005453-4057qib7	683	7	was	be	VBD
cord-005453-4057qib7	683	8	superior	superior	JJ
cord-005453-4057qib7	683	9	then	then	RB
cord-005453-4057qib7	683	10	CC	CC	NNP
cord-005453-4057qib7	683	11	and	and	CC
cord-005453-4057qib7	683	12	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	683	13	groups	group	NNS
cord-005453-4057qib7	683	14	(	(	-LRB-
cord-005453-4057qib7	683	15	61	61	CD
cord-005453-4057qib7	683	16	%	%	NN
cord-005453-4057qib7	683	17	,	,	,
cord-005453-4057qib7	683	18	51	51	CD
cord-005453-4057qib7	683	19	%	%	NN
cord-005453-4057qib7	683	20	and	and	CC
cord-005453-4057qib7	683	21	44	44	CD
cord-005453-4057qib7	683	22	%	%	NN
cord-005453-4057qib7	683	23	,	,	,
cord-005453-4057qib7	683	24	respectively	respectively	RB
cord-005453-4057qib7	683	25	;	;	:
cord-005453-4057qib7	683	26	Figure	figure	NN
cord-005453-4057qib7	683	27	1	1	CD
cord-005453-4057qib7	683	28	)	)	-RRB-
cord-005453-4057qib7	683	29	,	,	,
cord-005453-4057qib7	683	30	although	although	IN
cord-005453-4057qib7	683	31	not	not	RB
cord-005453-4057qib7	683	32	statistically	statistically	RB
cord-005453-4057qib7	683	33	significant	significant	JJ
cord-005453-4057qib7	683	34	.	.	.
cord-005453-4057qib7	684	1	OS	OS	NNP
cord-005453-4057qib7	684	2	at	at	IN
cord-005453-4057qib7	684	3	3y	3y	CD
cord-005453-4057qib7	684	4	was	be	VBD
cord-005453-4057qib7	684	5	statistically	statistically	RB
cord-005453-4057qib7	684	6	similar	similar	JJ
cord-005453-4057qib7	684	7	between	between	IN
cord-005453-4057qib7	684	8	groups	group	NNS
cord-005453-4057qib7	684	9	,	,	,
cord-005453-4057qib7	684	10	although	although	IN
cord-005453-4057qib7	684	11	inferior	inferior	JJ
cord-005453-4057qib7	684	12	in	in	IN
cord-005453-4057qib7	684	13	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	684	14	comparing	compare	VBG
cord-005453-4057qib7	684	15	to	to	IN
cord-005453-4057qib7	684	16	CC	CC	NNP
cord-005453-4057qib7	684	17	and	and	CC
cord-005453-4057qib7	684	18	ASCT	ASCT	NNP
cord-005453-4057qib7	684	19	(	(	-LRB-
cord-005453-4057qib7	684	20	44	44	CD
cord-005453-4057qib7	684	21	%	%	NN
cord-005453-4057qib7	684	22	,	,	,
cord-005453-4057qib7	684	23	77	77	CD
cord-005453-4057qib7	684	24	%	%	NN
cord-005453-4057qib7	684	25	and	and	CC
cord-005453-4057qib7	684	26	70	70	CD
cord-005453-4057qib7	684	27	%	%	NN
cord-005453-4057qib7	684	28	,	,	,
cord-005453-4057qib7	684	29	respectively	respectively	RB
cord-005453-4057qib7	684	30	)	)	-RRB-
cord-005453-4057qib7	684	31	.	.	.
cord-005453-4057qib7	685	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	685	2	:	:	:
cord-005453-4057qib7	686	1	In	in	IN
cord-005453-4057qib7	686	2	this	this	DT
cord-005453-4057qib7	686	3	historical	historical	JJ
cord-005453-4057qib7	686	4	cohort	cohort	NN
cord-005453-4057qib7	686	5	review	review	NN
cord-005453-4057qib7	686	6	,	,	,
cord-005453-4057qib7	686	7	although	although	IN
cord-005453-4057qib7	686	8	there	there	EX
cord-005453-4057qib7	686	9	was	be	VBD
cord-005453-4057qib7	686	10	no	no	DT
cord-005453-4057qib7	686	11	advantage	advantage	NN
cord-005453-4057qib7	686	12	in	in	IN
cord-005453-4057qib7	686	13	OS	OS	NNP
cord-005453-4057qib7	686	14	for	for	IN
cord-005453-4057qib7	686	15	ASCT	ASCT	NNP
cord-005453-4057qib7	686	16	in	in	IN
cord-005453-4057qib7	686	17	NPM1	NPM1	NNP
cord-005453-4057qib7	686	18	+	+	SYM
cord-005453-4057qib7	686	19	FRG	FRG	NNP
cord-005453-4057qib7	686	20	AML	AML	NNP
cord-005453-4057qib7	686	21	,	,	,
cord-005453-4057qib7	686	22	our	-PRON-	PRP$
cord-005453-4057qib7	686	23	data	datum	NNS
cord-005453-4057qib7	686	24	suggests	suggest	VBZ
cord-005453-4057qib7	686	25	that	that	IN
cord-005453-4057qib7	686	26	there	there	EX
cord-005453-4057qib7	686	27	might	may	MD
cord-005453-4057qib7	686	28	be	be	VB
cord-005453-4057qib7	686	29	a	a	DT
cord-005453-4057qib7	686	30	PFS	PFS	NNP
cord-005453-4057qib7	686	31	improvement	improvement	NN
cord-005453-4057qib7	686	32	in	in	IN
cord-005453-4057qib7	686	33	ASCT	ASCT	NNP
cord-005453-4057qib7	686	34	over	over	IN
cord-005453-4057qib7	686	35	CC	CC	NNP
cord-005453-4057qib7	686	36	,	,	,
cord-005453-4057qib7	686	37	which	which	WDT
cord-005453-4057qib7	686	38	needs	need	VBZ
cord-005453-4057qib7	686	39	to	to	TO
cord-005453-4057qib7	686	40	be	be	VB
cord-005453-4057qib7	686	41	further	further	RB
cord-005453-4057qib7	686	42	addressed	address	VBN
cord-005453-4057qib7	686	43	in	in	IN
cord-005453-4057qib7	686	44	prospective	prospective	JJ
cord-005453-4057qib7	686	45	studies	study	NNS
cord-005453-4057qib7	686	46	.	.	.
cord-005453-4057qib7	687	1	Disclosure	disclosure	NN
cord-005453-4057qib7	687	2	:	:	:
cord-005453-4057qib7	687	3	Nothing	nothing	NN
cord-005453-4057qib7	687	4	to	to	TO
cord-005453-4057qib7	687	5	declare	declare	VB
cord-005453-4057qib7	687	6	Background	background	NN
cord-005453-4057qib7	687	7	:	:	:
cord-005453-4057qib7	688	1	Acute	acute	JJ
cord-005453-4057qib7	688	2	myeloid	myeloid	NN
cord-005453-4057qib7	688	3	leukemia	leukemia	NN
cord-005453-4057qib7	688	4	is	be	VBZ
cord-005453-4057qib7	688	5	a	a	DT
cord-005453-4057qib7	688	6	hematological	hematological	JJ
cord-005453-4057qib7	688	7	malignant	malignant	JJ
cord-005453-4057qib7	688	8	disease	disease	NN
cord-005453-4057qib7	688	9	that	that	WDT
cord-005453-4057qib7	688	10	motivates	motivate	VBZ
cord-005453-4057qib7	688	11	the	the	DT
cord-005453-4057qib7	688	12	persistent	persistent	JJ
cord-005453-4057qib7	688	13	struggle	struggle	NN
cord-005453-4057qib7	688	14	in	in	IN
cord-005453-4057qib7	688	15	the	the	DT
cord-005453-4057qib7	688	16	scientific	scientific	JJ
cord-005453-4057qib7	688	17	world	world	NN
cord-005453-4057qib7	688	18	to	to	TO
cord-005453-4057qib7	688	19	provide	provide	VB
cord-005453-4057qib7	688	20	effective	effective	JJ
cord-005453-4057qib7	688	21	cure	cure	NN
cord-005453-4057qib7	688	22	that	that	WDT
cord-005453-4057qib7	688	23	can	can	MD
cord-005453-4057qib7	688	24	establish	establish	VB
cord-005453-4057qib7	688	25	acceptable	acceptable	JJ
cord-005453-4057qib7	688	26	survival	survival	NN
cord-005453-4057qib7	688	27	rates	rate	NNS
cord-005453-4057qib7	688	28	in	in	IN
cord-005453-4057qib7	688	29	this	this	DT
cord-005453-4057qib7	688	30	group	group	NN
cord-005453-4057qib7	688	31	of	of	IN
cord-005453-4057qib7	688	32	patients	patient	NNS
cord-005453-4057qib7	688	33	.	.	.
cord-005453-4057qib7	689	1	Autologous	autologous	JJ
cord-005453-4057qib7	689	2	stem	stem	NN
cord-005453-4057qib7	689	3	cell	cell	NN
cord-005453-4057qib7	689	4	transplantation	transplantation	NN
cord-005453-4057qib7	689	5	with	with	IN
cord-005453-4057qib7	689	6	myeloablative	myeloablative	JJ
cord-005453-4057qib7	689	7	conditioning	conditioning	NN
cord-005453-4057qib7	689	8	is	be	VBZ
cord-005453-4057qib7	689	9	still	still	RB
cord-005453-4057qib7	689	10	a	a	DT
cord-005453-4057qib7	689	11	powerful	powerful	JJ
cord-005453-4057qib7	689	12	weapon	weapon	NN
cord-005453-4057qib7	689	13	that	that	WDT
cord-005453-4057qib7	689	14	can	can	MD
cord-005453-4057qib7	689	15	be	be	VB
cord-005453-4057qib7	689	16	used	use	VBN
cord-005453-4057qib7	689	17	against	against	IN
cord-005453-4057qib7	689	18	this	this	DT
cord-005453-4057qib7	689	19	entity	entity	NN
cord-005453-4057qib7	689	20	Methods	method	NNS
cord-005453-4057qib7	689	21	:	:	:
cord-005453-4057qib7	689	22	We	-PRON-	PRP
cord-005453-4057qib7	689	23	have	have	VBP
cord-005453-4057qib7	689	24	evaluated	evaluate	VBN
cord-005453-4057qib7	689	25	retrospectively	retrospectively	RB
cord-005453-4057qib7	689	26	patients	patient	NNS
cord-005453-4057qib7	689	27	with	with	IN
cord-005453-4057qib7	689	28	AML	AML	NNP
cord-005453-4057qib7	689	29	where	where	WRB
cord-005453-4057qib7	689	30	autologous	autologous	JJ
cord-005453-4057qib7	689	31	stem	stem	NN
cord-005453-4057qib7	689	32	cell	cell	NN
cord-005453-4057qib7	689	33	transplantation	transplantation	NN
cord-005453-4057qib7	689	34	was	be	VBD
cord-005453-4057qib7	689	35	performed	perform	VBN
cord-005453-4057qib7	689	36	in	in	IN
cord-005453-4057qib7	689	37	the	the	DT
cord-005453-4057qib7	689	38	period	period	NN
cord-005453-4057qib7	689	39	from	from	IN
cord-005453-4057qib7	689	40	2000	2000	CD
cord-005453-4057qib7	689	41	till	till	IN
cord-005453-4057qib7	689	42	2018	2018	CD
cord-005453-4057qib7	689	43	.	.	.
cord-005453-4057qib7	690	1	Our	-PRON-	PRP$
cord-005453-4057qib7	690	2	group	group	NN
cord-005453-4057qib7	690	3	consisted	consist	VBD
cord-005453-4057qib7	690	4	of	of	IN
cord-005453-4057qib7	690	5	94	94	CD
cord-005453-4057qib7	690	6	patients	patient	NNS
cord-005453-4057qib7	690	7	;	;	:
cord-005453-4057qib7	690	8	male	male	JJ
cord-005453-4057qib7	690	9	patients	patient	NNS
cord-005453-4057qib7	690	10	45	45	CD
cord-005453-4057qib7	690	11	(	(	-LRB-
cord-005453-4057qib7	690	12	47.8	47.8	CD
cord-005453-4057qib7	690	13	%	%	NN
cord-005453-4057qib7	690	14	)	)	-RRB-
cord-005453-4057qib7	690	15	,	,	,
cord-005453-4057qib7	690	16	female	female	JJ
cord-005453-4057qib7	690	17	patients	patient	NNS
cord-005453-4057qib7	690	18	49	49	CD
cord-005453-4057qib7	690	19	(	(	-LRB-
cord-005453-4057qib7	690	20	52.2	52.2	CD
cord-005453-4057qib7	690	21	%	%	NN
cord-005453-4057qib7	690	22	)	)	-RRB-
cord-005453-4057qib7	690	23	.	.	.
cord-005453-4057qib7	691	1	Median	median	JJ
cord-005453-4057qib7	691	2	age	age	NN
cord-005453-4057qib7	691	3	at	at	IN
cord-005453-4057qib7	691	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	691	5	was	be	VBD
cord-005453-4057qib7	691	6	44	44	CD
cord-005453-4057qib7	691	7	years	year	NNS
cord-005453-4057qib7	691	8	(	(	-LRB-
cord-005453-4057qib7	691	9	16	16	CD
cord-005453-4057qib7	691	10	-	-	SYM
cord-005453-4057qib7	691	11	68	68	CD
cord-005453-4057qib7	691	12	)	)	-RRB-
cord-005453-4057qib7	691	13	.	.	.
cord-005453-4057qib7	692	1	The	the	DT
cord-005453-4057qib7	692	2	average	average	JJ
cord-005453-4057qib7	692	3	period	period	NN
cord-005453-4057qib7	692	4	from	from	IN
cord-005453-4057qib7	692	5	time	time	NN
cord-005453-4057qib7	692	6	of	of	IN
cord-005453-4057qib7	692	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	692	8	to	to	IN
cord-005453-4057qib7	692	9	autologous	autologous	JJ
cord-005453-4057qib7	692	10	SCT	SCT	NNP
cord-005453-4057qib7	692	11	was	be	VBD
cord-005453-4057qib7	692	12	7.05	7.05	CD
cord-005453-4057qib7	692	13	months	month	NNS
cord-005453-4057qib7	692	14	.	.	.
cord-005453-4057qib7	693	1	Results	result	NNS
cord-005453-4057qib7	693	2	:	:	:
cord-005453-4057qib7	694	1	In	in	IN
cord-005453-4057qib7	694	2	the	the	DT
cord-005453-4057qib7	694	3	majority	majority	NN
cord-005453-4057qib7	694	4	of	of	IN
cord-005453-4057qib7	694	5	our	-PRON-	PRP$
cord-005453-4057qib7	694	6	group	group	NN
cord-005453-4057qib7	694	7	,	,	,
cord-005453-4057qib7	694	8	we	-PRON-	PRP
cord-005453-4057qib7	694	9	used	use	VBD
cord-005453-4057qib7	694	10	myeloablative	myeloablative	NNP
cord-005453-4057qib7	694	11	conditioning	conditioning	NN
cord-005453-4057qib7	694	12	regimen	regimen	NN
cord-005453-4057qib7	694	13	with	with	IN
cord-005453-4057qib7	694	14	Busulphan	Busulphan	NNP
cord-005453-4057qib7	694	15	-	-	HYPH
cord-005453-4057qib7	694	16	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	694	17	,	,	,
cord-005453-4057qib7	694	18	60	60	CD
cord-005453-4057qib7	694	19	patients	patient	NNS
cord-005453-4057qib7	694	20	(	(	-LRB-
cord-005453-4057qib7	694	21	63.8	63.8	CD
cord-005453-4057qib7	694	22	%	%	NN
cord-005453-4057qib7	694	23	)	)	-RRB-
cord-005453-4057qib7	694	24	,	,	,
cord-005453-4057qib7	694	25	in	in	IN
cord-005453-4057qib7	694	26	2	2	CD
cord-005453-4057qib7	694	27	patients	patient	NNS
cord-005453-4057qib7	694	28	(	(	-LRB-
cord-005453-4057qib7	694	29	2.1	2.1	CD
cord-005453-4057qib7	694	30	%	%	NN
cord-005453-4057qib7	694	31	)	)	-RRB-
cord-005453-4057qib7	694	32	we	-PRON-	PRP
cord-005453-4057qib7	694	33	have	have	VBP
cord-005453-4057qib7	694	34	added	add	VBN
cord-005453-4057qib7	694	35	melphalan	melphalan	NNP
cord-005453-4057qib7	694	36	to	to	IN
cord-005453-4057qib7	694	37	Bu	Bu	NNP
cord-005453-4057qib7	694	38	-	-	HYPH
cord-005453-4057qib7	694	39	Cy	Cy	NNP
cord-005453-4057qib7	694	40	conditioning	conditioning	NN
cord-005453-4057qib7	694	41	,	,	,
cord-005453-4057qib7	694	42	in	in	IN
cord-005453-4057qib7	694	43	22	22	CD
cord-005453-4057qib7	694	44	(	(	-LRB-
cord-005453-4057qib7	694	45	23.4	23.4	CD
cord-005453-4057qib7	694	46	%	%	NN
cord-005453-4057qib7	694	47	)	)	-RRB-
cord-005453-4057qib7	694	48	patients	patient	NNS
cord-005453-4057qib7	694	49	we	-PRON-	PRP
cord-005453-4057qib7	694	50	used	use	VBD
cord-005453-4057qib7	694	51	BEAM	beam	NN
cord-005453-4057qib7	694	52	conditioning	conditioning	NN
cord-005453-4057qib7	694	53	and	and	CC
cord-005453-4057qib7	694	54	in	in	IN
cord-005453-4057qib7	694	55	the	the	DT
cord-005453-4057qib7	694	56	rest	rest	NN
cord-005453-4057qib7	694	57	,	,	,
cord-005453-4057qib7	694	58	10	10	CD
cord-005453-4057qib7	694	59	patients	patient	NNS
cord-005453-4057qib7	694	60	(	(	-LRB-
cord-005453-4057qib7	694	61	10.6	10.6	CD
cord-005453-4057qib7	694	62	%	%	NN
cord-005453-4057qib7	694	63	)	)	-RRB-
cord-005453-4057qib7	694	64	we	-PRON-	PRP
cord-005453-4057qib7	694	65	used	use	VBD
cord-005453-4057qib7	694	66	BAM	BAM	NNP
cord-005453-4057qib7	694	67	conditioning	conditioning	NN
cord-005453-4057qib7	694	68	regimen	regimen	NN
cord-005453-4057qib7	694	69	.	.	.
cord-005453-4057qib7	695	1	As	as	IN
cord-005453-4057qib7	695	2	auto	auto	NN
cord-005453-4057qib7	695	3	graft	graft	NN
cord-005453-4057qib7	695	4	we	-PRON-	PRP
cord-005453-4057qib7	695	5	used	use	VBD
cord-005453-4057qib7	695	6	peripheral	peripheral	JJ
cord-005453-4057qib7	695	7	blood	blood	NN
cord-005453-4057qib7	695	8	stem	stem	NN
cord-005453-4057qib7	695	9	cells	cell	NNS
cord-005453-4057qib7	695	10	(	(	-LRB-
cord-005453-4057qib7	695	11	PBSC	PBSC	NNP
cord-005453-4057qib7	695	12	)	)	-RRB-
cord-005453-4057qib7	695	13	in	in	IN
cord-005453-4057qib7	695	14	78	78	CD
cord-005453-4057qib7	695	15	patients	patient	NNS
cord-005453-4057qib7	695	16	(	(	-LRB-
cord-005453-4057qib7	695	17	82.9	82.9	CD
cord-005453-4057qib7	695	18	%	%	NN
cord-005453-4057qib7	695	19	)	)	-RRB-
cord-005453-4057qib7	695	20	,	,	,
cord-005453-4057qib7	695	21	and	and	CC
cord-005453-4057qib7	695	22	in	in	IN
cord-005453-4057qib7	695	23	16	16	CD
cord-005453-4057qib7	695	24	patients	patient	NNS
cord-005453-4057qib7	695	25	(	(	-LRB-
cord-005453-4057qib7	695	26	17.1	17.1	CD
cord-005453-4057qib7	695	27	%	%	NN
cord-005453-4057qib7	695	28	)	)	-RRB-
cord-005453-4057qib7	695	29	we	-PRON-	PRP
cord-005453-4057qib7	695	30	used	use	VBD
cord-005453-4057qib7	695	31	bone	bone	NN
cord-005453-4057qib7	695	32	marrow	marrow	NN
cord-005453-4057qib7	695	33	.	.	.
cord-005453-4057qib7	696	1	The	the	DT
cord-005453-4057qib7	696	2	main	main	JJ
cord-005453-4057qib7	696	3	mobilising	mobilise	VBG
cord-005453-4057qib7	696	4	regimen	regimen	NN
cord-005453-4057qib7	696	5	for	for	IN
cord-005453-4057qib7	696	6	PBSC	PBSC	NNP
cord-005453-4057qib7	696	7	was	be	VBD
cord-005453-4057qib7	696	8	G	G	NNP
cord-005453-4057qib7	696	9	-	-	HYPH
cord-005453-4057qib7	696	10	CSF	csf	NN
cord-005453-4057qib7	696	11	+	+	CC
cord-005453-4057qib7	696	12	etoposide	etoposide	RB
cord-005453-4057qib7	697	1	and	and	CC
cord-005453-4057qib7	697	2	it	-PRON-	PRP
cord-005453-4057qib7	697	3	was	be	VBD
cord-005453-4057qib7	697	4	performed	perform	VBN
cord-005453-4057qib7	697	5	in	in	IN
cord-005453-4057qib7	697	6	44	44	CD
cord-005453-4057qib7	697	7	patients	patient	NNS
cord-005453-4057qib7	697	8	(	(	-LRB-
cord-005453-4057qib7	697	9	46.8	46.8	CD
cord-005453-4057qib7	697	10	%	%	NN
cord-005453-4057qib7	697	11	)	)	-RRB-
cord-005453-4057qib7	697	12	,	,	,
cord-005453-4057qib7	697	13	and	and	CC
cord-005453-4057qib7	697	14	in	in	IN
cord-005453-4057qib7	697	15	the	the	DT
cord-005453-4057qib7	697	16	remaining	remain	VBG
cord-005453-4057qib7	697	17	34	34	CD
cord-005453-4057qib7	697	18	patients	patient	NNS
cord-005453-4057qib7	697	19	(	(	-LRB-
cord-005453-4057qib7	697	20	36.1	36.1	CD
cord-005453-4057qib7	697	21	%	%	NN
cord-005453-4057qib7	697	22	)	)	-RRB-
cord-005453-4057qib7	697	23	mobilising	mobilising	NN
cord-005453-4057qib7	697	24	of	of	IN
cord-005453-4057qib7	697	25	PBSC	PBSC	NNP
cord-005453-4057qib7	697	26	was	be	VBD
cord-005453-4057qib7	697	27	performed	perform	VBN
cord-005453-4057qib7	697	28	only	only	RB
cord-005453-4057qib7	697	29	with	with	IN
cord-005453-4057qib7	697	30	G	G	NNP
cord-005453-4057qib7	697	31	-	-	HYPH
cord-005453-4057qib7	697	32	CSF	CSF	NNP
cord-005453-4057qib7	697	33	.	.	.
cord-005453-4057qib7	698	1	The	the	DT
cord-005453-4057qib7	698	2	mean	mean	JJ
cord-005453-4057qib7	698	3	number	number	NN
cord-005453-4057qib7	698	4	od	od	NNP
cord-005453-4057qib7	698	5	apheresis	apheresis	NN
cord-005453-4057qib7	698	6	procedures	procedure	NNS
cord-005453-4057qib7	698	7	done	do	VBN
cord-005453-4057qib7	698	8	in	in	IN
cord-005453-4057qib7	698	9	our	-PRON-	PRP$
cord-005453-4057qib7	698	10	group	group	NN
cord-005453-4057qib7	698	11	was	be	VBD
cord-005453-4057qib7	698	12	1.55	1.55	CD
cord-005453-4057qib7	698	13	,	,	,
cord-005453-4057qib7	698	14	and	and	CC
cord-005453-4057qib7	698	15	the	the	DT
cord-005453-4057qib7	698	16	mean	mean	JJ
cord-005453-4057qib7	698	17	number	number	NN
cord-005453-4057qib7	698	18	of	of	IN
cord-005453-4057qib7	698	19	collected	collect	VBN
cord-005453-4057qib7	698	20	mononuclear	mononuclear	JJ
cord-005453-4057qib7	698	21	cells	cell	NNS
cord-005453-4057qib7	698	22	was	be	VBD
cord-005453-4057qib7	698	23	3.05x10	3.05x10	CD
cord-005453-4057qib7	698	24	8	8	CD
cord-005453-4057qib7	698	25	/kg	/kg	NN
cord-005453-4057qib7	698	26	TT	TT	NNP
cord-005453-4057qib7	698	27	.	.	.
cord-005453-4057qib7	699	1	The	the	DT
cord-005453-4057qib7	699	2	mean	mean	JJ
cord-005453-4057qib7	699	3	time	time	NN
cord-005453-4057qib7	699	4	to	to	IN
cord-005453-4057qib7	699	5	engraftment	engraftment	NN
cord-005453-4057qib7	699	6	was	be	VBD
cord-005453-4057qib7	699	7	12.8	12.8	CD
cord-005453-4057qib7	699	8	days	day	NNS
cord-005453-4057qib7	699	9	(	(	-LRB-
cord-005453-4057qib7	699	10	9	9	CD
cord-005453-4057qib7	699	11	-	-	SYM
cord-005453-4057qib7	699	12	23	23	CD
cord-005453-4057qib7	699	13	)	)	-RRB-
cord-005453-4057qib7	699	14	.	.	.
cord-005453-4057qib7	700	1	The	the	DT
cord-005453-4057qib7	700	2	transplant	transplant	NN
cord-005453-4057qib7	700	3	related	relate	VBN
cord-005453-4057qib7	700	4	mortality	mortality	NN
cord-005453-4057qib7	700	5	(	(	-LRB-
cord-005453-4057qib7	700	6	TRM	TRM	NNP
cord-005453-4057qib7	700	7	)	)	-RRB-
cord-005453-4057qib7	700	8	was	be	VBD
cord-005453-4057qib7	700	9	2.1	2.1	CD
cord-005453-4057qib7	700	10	%	%	NN
cord-005453-4057qib7	700	11	.	.	.
cord-005453-4057qib7	701	1	The	the	DT
cord-005453-4057qib7	701	2	5	5	CD
cord-005453-4057qib7	701	3	year	year	NN
cord-005453-4057qib7	702	1	Overall	Overall	NNP
cord-005453-4057qib7	702	2	Survival	Survival	NNP
cord-005453-4057qib7	702	3	of	of	IN
cord-005453-4057qib7	702	4	our	-PRON-	PRP$
cord-005453-4057qib7	702	5	patients	patient	NNS
cord-005453-4057qib7	702	6	was	be	VBD
cord-005453-4057qib7	702	7	46.7	46.7	CD
cord-005453-4057qib7	702	8	patients	patient	NNS
cord-005453-4057qib7	702	9	.	.	.
cord-005453-4057qib7	703	1	The	the	DT
cord-005453-4057qib7	703	2	main	main	JJ
cord-005453-4057qib7	703	3	reason	reason	NN
cord-005453-4057qib7	703	4	for	for	IN
cord-005453-4057qib7	703	5	death	death	NN
cord-005453-4057qib7	703	6	was	be	VBD
cord-005453-4057qib7	703	7	relapse	relapse	NN
cord-005453-4057qib7	703	8	of	of	IN
cord-005453-4057qib7	703	9	the	the	DT
cord-005453-4057qib7	703	10	primary	primary	JJ
cord-005453-4057qib7	703	11	disease(73	disease(73	NNP
cord-005453-4057qib7	703	12	%	%	NN
cord-005453-4057qib7	703	13	)	)	-RRB-
cord-005453-4057qib7	703	14	.	.	.
cord-005453-4057qib7	704	1	20	20	CD
cord-005453-4057qib7	704	2	patients	patient	NNS
cord-005453-4057qib7	704	3	(	(	-LRB-
cord-005453-4057qib7	704	4	21%)were	21%)were	RB
cord-005453-4057qib7	704	5	treated	treat	VBN
cord-005453-4057qib7	704	6	with	with	IN
cord-005453-4057qib7	704	7	salvage	salvage	NN
cord-005453-4057qib7	704	8	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	704	9	regimen	regimen	NN
cord-005453-4057qib7	704	10	(	(	-LRB-
cord-005453-4057qib7	704	11	FLAG	FLAG	NNP
cord-005453-4057qib7	704	12	-	-	HYPH
cord-005453-4057qib7	704	13	Ida	Ida	NNP
cord-005453-4057qib7	704	14	)	)	-RRB-
cord-005453-4057qib7	704	15	because	because	IN
cord-005453-4057qib7	704	16	with	with	IN
cord-005453-4057qib7	704	17	the	the	DT
cord-005453-4057qib7	704	18	standard	standard	JJ
cord-005453-4057qib7	704	19	induction	induction	NN
cord-005453-4057qib7	704	20	regimen	regimen	NN
cord-005453-4057qib7	704	21	7	7	CD
cord-005453-4057qib7	704	22	+	+	SYM
cord-005453-4057qib7	704	23	3	3	CD
cord-005453-4057qib7	704	24	there	there	EX
cord-005453-4057qib7	704	25	was	be	VBD
cord-005453-4057qib7	704	26	absence	absence	NN
cord-005453-4057qib7	704	27	of	of	IN
cord-005453-4057qib7	704	28	adequate	adequate	JJ
cord-005453-4057qib7	704	29	therapeutic	therapeutic	JJ
cord-005453-4057qib7	704	30	response	response	NN
cord-005453-4057qib7	704	31	,	,	,
cord-005453-4057qib7	704	32	or	or	CC
cord-005453-4057qib7	704	33	predominantly	predominantly	RB
cord-005453-4057qib7	704	34	no	no	DT
cord-005453-4057qib7	704	35	Complete	complete	JJ
cord-005453-4057qib7	704	36	remission	remission	NN
cord-005453-4057qib7	704	37	was	be	VBD
cord-005453-4057qib7	704	38	achieved	achieve	VBN
cord-005453-4057qib7	704	39	.	.	.
cord-005453-4057qib7	705	1	All	all	DT
cord-005453-4057qib7	705	2	patients	patient	NNS
cord-005453-4057qib7	705	3	were	be	VBD
cord-005453-4057qib7	705	4	transplanted	transplant	VBN
cord-005453-4057qib7	705	5	in	in	IN
cord-005453-4057qib7	705	6	Complete	complete	JJ
cord-005453-4057qib7	705	7	Remission	remission	NN
cord-005453-4057qib7	705	8	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	705	9	:	:	:
cord-005453-4057qib7	706	1	Autologous	autologous	JJ
cord-005453-4057qib7	706	2	stem	stem	NN
cord-005453-4057qib7	706	3	cell	cell	NN
cord-005453-4057qib7	706	4	transplantation	transplantation	NN
cord-005453-4057qib7	706	5	could	could	MD
cord-005453-4057qib7	706	6	be	be	VB
cord-005453-4057qib7	706	7	an	an	DT
cord-005453-4057qib7	706	8	acceptable	acceptable	JJ
cord-005453-4057qib7	706	9	therapeutic	therapeutic	JJ
cord-005453-4057qib7	706	10	solution	solution	NN
cord-005453-4057qib7	706	11	for	for	IN
cord-005453-4057qib7	706	12	patients	patient	NNS
cord-005453-4057qib7	706	13	with	with	IN
cord-005453-4057qib7	706	14	AML	AML	NNP
cord-005453-4057qib7	706	15	as	as	IN
cord-005453-4057qib7	706	16	a	a	DT
cord-005453-4057qib7	706	17	consolidation	consolidation	NN
cord-005453-4057qib7	706	18	therapy	therapy	NN
cord-005453-4057qib7	706	19	,	,	,
cord-005453-4057qib7	706	20	where	where	WRB
cord-005453-4057qib7	706	21	neither	neither	CC
cord-005453-4057qib7	706	22	suitable	suitable	JJ
cord-005453-4057qib7	706	23	compatible	compatible	JJ
cord-005453-4057qib7	706	24	donor	donor	NN
cord-005453-4057qib7	706	25	is	be	VBZ
cord-005453-4057qib7	706	26	available	available	JJ
cord-005453-4057qib7	706	27	nor	nor	CC
cord-005453-4057qib7	706	28	allogeneic	allogeneic	IN
cord-005453-4057qib7	706	29	stem	stem	NN
cord-005453-4057qib7	706	30	cell	cell	NN
cord-005453-4057qib7	706	31	transplantation	transplantation	NN
cord-005453-4057qib7	706	32	could	could	MD
cord-005453-4057qib7	706	33	not	not	RB
cord-005453-4057qib7	706	34	be	be	VB
cord-005453-4057qib7	706	35	performed	perform	VBN
cord-005453-4057qib7	706	36	from	from	IN
cord-005453-4057qib7	706	37	various	various	JJ
cord-005453-4057qib7	706	38	reasons	reason	NNS
cord-005453-4057qib7	706	39	depending	depend	VBG
cord-005453-4057qib7	706	40	on	on	IN
cord-005453-4057qib7	706	41	the	the	DT
cord-005453-4057qib7	706	42	bone	bone	NN
cord-005453-4057qib7	706	43	marrow	marrow	NN
cord-005453-4057qib7	706	44	transplant	transplant	NN
cord-005453-4057qib7	706	45	unit	unit	NN
cord-005453-4057qib7	706	46	Disclosure	Disclosure	NNP
cord-005453-4057qib7	706	47	:	:	:
cord-005453-4057qib7	707	1	Nothing	nothing	NN
cord-005453-4057qib7	707	2	to	to	TO
cord-005453-4057qib7	707	3	declare	declare	VB
cord-005453-4057qib7	707	4	P040	P040	:
cord-005453-4057qib7	707	5	Prophylaxis	Prophylaxis	NNP
cord-005453-4057qib7	707	6	DLI	DLI	NNP
cord-005453-4057qib7	707	7	alone	alone	RB
cord-005453-4057qib7	707	8	may	may	MD
cord-005453-4057qib7	707	9	not	not	RB
cord-005453-4057qib7	707	10	prevent	prevent	VB
cord-005453-4057qib7	707	11	relapse	relapse	NN
cord-005453-4057qib7	707	12	of	of	IN
cord-005453-4057qib7	707	13	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	707	14	positive	positive	JJ
cord-005453-4057qib7	707	15	AML	AML	NNP
cord-005453-4057qib7	707	16	after	after	IN
cord-005453-4057qib7	707	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	707	18	HCT	HCT	NNP
cord-005453-4057qib7	707	19	Background	background	NN
cord-005453-4057qib7	707	20	:	:	:
cord-005453-4057qib7	708	1	One	one	CD
cord-005453-4057qib7	708	2	of	of	IN
cord-005453-4057qib7	708	3	the	the	DT
cord-005453-4057qib7	708	4	most	most	RBS
cord-005453-4057qib7	708	5	potent	potent	JJ
cord-005453-4057qib7	708	6	prognostic	prognostic	JJ
cord-005453-4057qib7	708	7	factors	factor	NNS
cord-005453-4057qib7	708	8	affecting	affect	VBG
cord-005453-4057qib7	708	9	outcomes	outcome	NNS
cord-005453-4057qib7	708	10	in	in	IN
cord-005453-4057qib7	708	11	AML	AML	NNP
cord-005453-4057qib7	708	12	is	be	VBZ
cord-005453-4057qib7	708	13	the	the	DT
cord-005453-4057qib7	708	14	presence	presence	NN
cord-005453-4057qib7	708	15	of	of	IN
cord-005453-4057qib7	708	16	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	708	17	and	and	CC
cord-005453-4057qib7	708	18	molecular	molecular	JJ
cord-005453-4057qib7	708	19	markers	marker	NNS
cord-005453-4057qib7	708	20	which	which	WDT
cord-005453-4057qib7	708	21	can	can	MD
cord-005453-4057qib7	708	22	guide	guide	VB
cord-005453-4057qib7	708	23	the	the	DT
cord-005453-4057qib7	708	24	selection	selection	NN
cord-005453-4057qib7	708	25	of	of	IN
cord-005453-4057qib7	708	26	post	post	JJ
cord-005453-4057qib7	708	27	-	-	JJ
cord-005453-4057qib7	708	28	remission	remission	JJ
cord-005453-4057qib7	708	29	therapies	therapy	NNS
cord-005453-4057qib7	708	30	.	.	.
cord-005453-4057qib7	709	1	Recently	recently	RB
cord-005453-4057qib7	709	2	,	,	,
cord-005453-4057qib7	709	3	favorable	favorable	JJ
cord-005453-4057qib7	709	4	outcomes	outcome	NNS
cord-005453-4057qib7	709	5	of	of	IN
cord-005453-4057qib7	709	6	NPM1	NPM1	NNP
cord-005453-4057qib7	709	7	wt	wt	NN
cord-005453-4057qib7	709	8	/FLT3-ITD	/FLT3-ITD	NNP
cord-005453-4057qib7	710	1	neg	neg	NNP
cord-005453-4057qib7	710	2	/non	/non	NNP
cord-005453-4057qib7	710	3	-	-	HYPH
cord-005453-4057qib7	710	4	CEBPA	CEBPA	NNP
cord-005453-4057qib7	710	5	dm	dm	NN
cord-005453-4057qib7	710	6	group	group	NN
cord-005453-4057qib7	710	7	after	after	IN
cord-005453-4057qib7	710	8	allogeneic	allogeneic	JJ
cord-005453-4057qib7	710	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	710	10	cell	cell	NN
cord-005453-4057qib7	710	11	transplantation	transplantation	NN
cord-005453-4057qib7	710	12	(	(	-LRB-
cord-005453-4057qib7	710	13	allo	allo	NN
cord-005453-4057qib7	710	14	-	-	HYPH
cord-005453-4057qib7	710	15	HCT	HCT	NNP
cord-005453-4057qib7	710	16	)	)	-RRB-
cord-005453-4057qib7	710	17	have	have	VBP
cord-005453-4057qib7	710	18	been	be	VBN
cord-005453-4057qib7	710	19	reported	report	VBN
cord-005453-4057qib7	710	20	,	,	,
cord-005453-4057qib7	710	21	that	that	DT
cord-005453-4057qib7	710	22	is	be	VBZ
cord-005453-4057qib7	710	23	similar	similar	JJ
cord-005453-4057qib7	710	24	to	to	IN
cord-005453-4057qib7	710	25	those	those	DT
cord-005453-4057qib7	710	26	of	of	IN
cord-005453-4057qib7	710	27	favorable	favorable	JJ
cord-005453-4057qib7	710	28	risk	risk	NN
cord-005453-4057qib7	710	29	by	by	IN
cord-005453-4057qib7	710	30	the	the	DT
cord-005453-4057qib7	710	31	ELN	ELN	NNP
cord-005453-4057qib7	710	32	risk	risk	NN
cord-005453-4057qib7	710	33	classification	classification	NN
cord-005453-4057qib7	710	34	.	.	.
cord-005453-4057qib7	711	1	However	however	RB
cord-005453-4057qib7	711	2	,	,	,
cord-005453-4057qib7	711	3	the	the	DT
cord-005453-4057qib7	711	4	role	role	NN
cord-005453-4057qib7	711	5	of	of	IN
cord-005453-4057qib7	711	6	allo	allo	NN
cord-005453-4057qib7	711	7	-	-	HYPH
cord-005453-4057qib7	711	8	HCT	hct	NN
cord-005453-4057qib7	711	9	compared	compare	VBN
cord-005453-4057qib7	711	10	to	to	IN
cord-005453-4057qib7	711	11	consolidation	consolidation	NN
cord-005453-4057qib7	711	12	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	711	13	has	have	VBZ
cord-005453-4057qib7	711	14	not	not	RB
cord-005453-4057qib7	711	15	yet	yet	RB
cord-005453-4057qib7	711	16	been	be	VBN
cord-005453-4057qib7	711	17	elucidated	elucidate	VBN
cord-005453-4057qib7	711	18	.	.	.
cord-005453-4057qib7	712	1	Methods	method	NNS
cord-005453-4057qib7	712	2	:	:	:
cord-005453-4057qib7	713	1	The	the	DT
cord-005453-4057qib7	713	2	data	datum	NNS
cord-005453-4057qib7	713	3	of	of	IN
cord-005453-4057qib7	713	4	88	88	CD
cord-005453-4057qib7	713	5	patients	patient	NNS
cord-005453-4057qib7	713	6	who	who	WP
cord-005453-4057qib7	713	7	were	be	VBD
cord-005453-4057qib7	713	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	713	9	with	with	IN
cord-005453-4057qib7	713	10	AML	AML	NNP
cord-005453-4057qib7	713	11	and	and	CC
cord-005453-4057qib7	713	12	received	receive	VBD
cord-005453-4057qib7	713	13	intensive	intensive	JJ
cord-005453-4057qib7	713	14	induction	induction	NN
cord-005453-4057qib7	713	15	therapy	therapy	NN
cord-005453-4057qib7	713	16	from	from	IN
cord-005453-4057qib7	713	17	2015	2015	CD
cord-005453-4057qib7	713	18	March	March	NNP
cord-005453-4057qib7	713	19	to	to	IN
cord-005453-4057qib7	713	20	2017	2017	CD
cord-005453-4057qib7	713	21	July	July	NNP
cord-005453-4057qib7	713	22	were	be	VBD
cord-005453-4057qib7	713	23	included	include	VBN
cord-005453-4057qib7	713	24	in	in	IN
cord-005453-4057qib7	713	25	the	the	DT
cord-005453-4057qib7	713	26	current	current	JJ
cord-005453-4057qib7	713	27	study	study	NN
cord-005453-4057qib7	713	28	.	.	.
cord-005453-4057qib7	714	1	To	to	TO
cord-005453-4057qib7	714	2	address	address	VB
cord-005453-4057qib7	714	3	the	the	DT
cord-005453-4057qib7	714	4	time	time	NN
cord-005453-4057qib7	714	5	dependence	dependence	NN
cord-005453-4057qib7	714	6	of	of	IN
cord-005453-4057qib7	714	7	the	the	DT
cord-005453-4057qib7	714	8	allo	allo	NN
cord-005453-4057qib7	714	9	-	-	HYPH
cord-005453-4057qib7	714	10	HCT	HCT	NNP
cord-005453-4057qib7	714	11	,	,	,
cord-005453-4057qib7	714	12	the	the	DT
cord-005453-4057qib7	714	13	Simon	Simon	NNP
cord-005453-4057qib7	714	14	and	and	CC
cord-005453-4057qib7	714	15	Makuch	Makuch	NNP
cord-005453-4057qib7	714	16	method	method	NN
cord-005453-4057qib7	714	17	was	be	VBD
cord-005453-4057qib7	714	18	used	use	VBN
cord-005453-4057qib7	714	19	in	in	IN
cord-005453-4057qib7	714	20	the	the	DT
cord-005453-4057qib7	714	21	graphical	graphical	JJ
cord-005453-4057qib7	714	22	representation	representation	NN
cord-005453-4057qib7	714	23	and	and	CC
cord-005453-4057qib7	714	24	the	the	DT
cord-005453-4057qib7	714	25	Mantel	Mantel	NNP
cord-005453-4057qib7	714	26	-	-	HYPH
cord-005453-4057qib7	714	27	Byar	Byar	NNP
cord-005453-4057qib7	714	28	test	test	NN
cord-005453-4057qib7	714	29	and	and	CC
cord-005453-4057qib7	714	30	Andersen	Andersen	NNP
cord-005453-4057qib7	714	31	and	and	CC
cord-005453-4057qib7	714	32	Gill	Gill	NNP
cord-005453-4057qib7	714	33	methods	method	NNS
cord-005453-4057qib7	714	34	for	for	IN
cord-005453-4057qib7	714	35	identifying	identify	VBG
cord-005453-4057qib7	714	36	risk	risk	NN
cord-005453-4057qib7	714	37	factors	factor	NNS
cord-005453-4057qib7	714	38	for	for	IN
cord-005453-4057qib7	714	39	long	long	JJ
cord-005453-4057qib7	714	40	-	-	HYPH
cord-005453-4057qib7	714	41	term	term	NN
cord-005453-4057qib7	714	42	survival	survival	NN
cord-005453-4057qib7	714	43	.	.	.
cord-005453-4057qib7	715	1	Results	result	NNS
cord-005453-4057qib7	715	2	:	:	:
cord-005453-4057qib7	716	1	Median	median	JJ
cord-005453-4057qib7	716	2	age	age	NN
cord-005453-4057qib7	716	3	of	of	IN
cord-005453-4057qib7	716	4	the	the	DT
cord-005453-4057qib7	716	5	patients	patient	NNS
cord-005453-4057qib7	716	6	were	be	VBD
cord-005453-4057qib7	716	7	53	53	CD
cord-005453-4057qib7	716	8	years	year	NNS
cord-005453-4057qib7	717	1	(	(	-LRB-
cord-005453-4057qib7	717	2	range	range	NNP
cord-005453-4057qib7	717	3	21	21	CD
cord-005453-4057qib7	717	4	-	-	SYM
cord-005453-4057qib7	717	5	69	69	CD
cord-005453-4057qib7	717	6	)	)	-RRB-
cord-005453-4057qib7	717	7	,	,	,
cord-005453-4057qib7	717	8	and	and	CC
cord-005453-4057qib7	717	9	49	49	CD
cord-005453-4057qib7	717	10	patients	patient	NNS
cord-005453-4057qib7	717	11	(	(	-LRB-
cord-005453-4057qib7	717	12	56	56	CD
cord-005453-4057qib7	717	13	%	%	NN
cord-005453-4057qib7	717	14	)	)	-RRB-
cord-005453-4057qib7	717	15	were	be	VBD
cord-005453-4057qib7	717	16	male	male	JJ
cord-005453-4057qib7	717	17	.	.	.
cord-005453-4057qib7	718	1	NPM1	NPM1	NNP
cord-005453-4057qib7	718	2	mutation	mutation	NN
cord-005453-4057qib7	718	3	was	be	VBD
cord-005453-4057qib7	718	4	detected	detect	VBN
cord-005453-4057qib7	718	5	in	in	IN
cord-005453-4057qib7	718	6	14	14	CD
cord-005453-4057qib7	718	7	patients	patient	NNS
cord-005453-4057qib7	718	8	(	(	-LRB-
cord-005453-4057qib7	718	9	16	16	CD
cord-005453-4057qib7	718	10	%	%	NN
cord-005453-4057qib7	718	11	)	)	-RRB-
cord-005453-4057qib7	718	12	,	,	,
cord-005453-4057qib7	718	13	and	and	CC
cord-005453-4057qib7	718	14	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	718	15	were	be	VBD
cord-005453-4057qib7	718	16	none	none	NN
cord-005453-4057qib7	718	17	,	,	,
cord-005453-4057qib7	718	18	low	low	JJ
cord-005453-4057qib7	718	19	,	,	,
cord-005453-4057qib7	718	20	and	and	CC
cord-005453-4057qib7	718	21	high	high	JJ
cord-005453-4057qib7	718	22	ratio	ratio	NN
cord-005453-4057qib7	718	23	in	in	IN
cord-005453-4057qib7	718	24	69	69	CD
cord-005453-4057qib7	718	25	patients	patient	NNS
cord-005453-4057qib7	718	26	(	(	-LRB-
cord-005453-4057qib7	718	27	78	78	CD
cord-005453-4057qib7	718	28	%	%	NN
cord-005453-4057qib7	718	29	)	)	-RRB-
cord-005453-4057qib7	718	30	,	,	,
cord-005453-4057qib7	718	31	9	9	CD
cord-005453-4057qib7	718	32	(	(	-LRB-
cord-005453-4057qib7	718	33	10	10	CD
cord-005453-4057qib7	718	34	%	%	NN
cord-005453-4057qib7	718	35	)	)	-RRB-
cord-005453-4057qib7	718	36	,	,	,
cord-005453-4057qib7	718	37	and	and	CC
cord-005453-4057qib7	718	38	10	10	CD
cord-005453-4057qib7	718	39	(	(	-LRB-
cord-005453-4057qib7	718	40	12	12	CD
cord-005453-4057qib7	718	41	%	%	NN
cord-005453-4057qib7	718	42	)	)	-RRB-
cord-005453-4057qib7	718	43	,	,	,
cord-005453-4057qib7	718	44	respectively	respectively	RB
cord-005453-4057qib7	718	45	.	.	.
cord-005453-4057qib7	719	1	The	the	DT
cord-005453-4057qib7	719	2	ELN	ELN	NNP
cord-005453-4057qib7	719	3	risk	risk	NN
cord-005453-4057qib7	719	4	classification	classification	NN
cord-005453-4057qib7	719	5	divided	divide	VBD
cord-005453-4057qib7	719	6	the	the	DT
cord-005453-4057qib7	719	7	patients	patient	NNS
cord-005453-4057qib7	719	8	into	into	IN
cord-005453-4057qib7	719	9	favorable	favorable	JJ
cord-005453-4057qib7	719	10	,	,	,
cord-005453-4057qib7	719	11	intermediate	intermediate	JJ
cord-005453-4057qib7	719	12	,	,	,
cord-005453-4057qib7	719	13	and	and	CC
cord-005453-4057qib7	719	14	adverse	adverse	JJ
cord-005453-4057qib7	719	15	risk	risk	NN
cord-005453-4057qib7	719	16	group	group	NN
cord-005453-4057qib7	719	17	in	in	IN
cord-005453-4057qib7	719	18	31	31	CD
cord-005453-4057qib7	719	19	patients	patient	NNS
cord-005453-4057qib7	719	20	(	(	-LRB-
cord-005453-4057qib7	719	21	35	35	CD
cord-005453-4057qib7	719	22	%	%	NN
cord-005453-4057qib7	719	23	)	)	-RRB-
cord-005453-4057qib7	719	24	,	,	,
cord-005453-4057qib7	719	25	38	38	CD
cord-005453-4057qib7	719	26	(	(	-LRB-
cord-005453-4057qib7	719	27	43	43	CD
cord-005453-4057qib7	719	28	%	%	NN
cord-005453-4057qib7	719	29	)	)	-RRB-
cord-005453-4057qib7	719	30	,	,	,
cord-005453-4057qib7	719	31	and	and	CC
cord-005453-4057qib7	719	32	19	19	CD
cord-005453-4057qib7	719	33	(	(	-LRB-
cord-005453-4057qib7	719	34	22	22	CD
cord-005453-4057qib7	719	35	%	%	NN
cord-005453-4057qib7	719	36	)	)	-RRB-
cord-005453-4057qib7	719	37	,	,	,
cord-005453-4057qib7	719	38	respectively	respectively	RB
cord-005453-4057qib7	719	39	.	.	.
cord-005453-4057qib7	720	1	NPN1	NPN1	NNP
cord-005453-4057qib7	720	2	and	and	CC
cord-005453-4057qib7	720	3	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	721	1	both	both	DT
cord-005453-4057qib7	721	2	negative	negative	JJ
cord-005453-4057qib7	721	3	group	group	NN
cord-005453-4057qib7	721	4	included	include	VBD
cord-005453-4057qib7	721	5	29	29	CD
cord-005453-4057qib7	721	6	patients	patient	NNS
cord-005453-4057qib7	721	7	(	(	-LRB-
cord-005453-4057qib7	721	8	33	33	CD
cord-005453-4057qib7	721	9	%	%	NN
cord-005453-4057qib7	721	10	)	)	-RRB-
cord-005453-4057qib7	721	11	.	.	.
cord-005453-4057qib7	722	1	Allo	Allo	NNP
cord-005453-4057qib7	722	2	-	-	HYPH
cord-005453-4057qib7	722	3	HCT	HCT	NNP
cord-005453-4057qib7	722	4	was	be	VBD
cord-005453-4057qib7	722	5	performed	perform	VBN
cord-005453-4057qib7	722	6	in	in	IN
cord-005453-4057qib7	722	7	48	48	CD
cord-005453-4057qib7	722	8	patients	patient	NNS
cord-005453-4057qib7	722	9	(	(	-LRB-
cord-005453-4057qib7	722	10	55	55	CD
cord-005453-4057qib7	722	11	%	%	NN
cord-005453-4057qib7	722	12	)	)	-RRB-
cord-005453-4057qib7	722	13	.	.	.
cord-005453-4057qib7	723	1	Overall	overall	RB
cord-005453-4057qib7	723	2	,	,	,
cord-005453-4057qib7	723	3	complete	complete	JJ
cord-005453-4057qib7	723	4	response	response	NN
cord-005453-4057qib7	723	5	(	(	-LRB-
cord-005453-4057qib7	723	6	CR	CR	NNP
cord-005453-4057qib7	723	7	)	)	-RRB-
cord-005453-4057qib7	723	8	after	after	IN
cord-005453-4057qib7	723	9	induction	induction	NN
cord-005453-4057qib7	723	10	therapy	therapy	NN
cord-005453-4057qib7	723	11	achieved	achieve	VBN
cord-005453-4057qib7	723	12	in	in	IN
cord-005453-4057qib7	723	13	63	63	CD
cord-005453-4057qib7	723	14	patients	patient	NNS
cord-005453-4057qib7	723	15	(	(	-LRB-
cord-005453-4057qib7	723	16	72	72	CD
cord-005453-4057qib7	723	17	%	%	NN
cord-005453-4057qib7	723	18	)	)	-RRB-
cord-005453-4057qib7	723	19	,	,	,
cord-005453-4057qib7	723	20	and	and	CC
cord-005453-4057qib7	723	21	7	7	CD
cord-005453-4057qib7	723	22	patients	patient	NNS
cord-005453-4057qib7	723	23	(	(	-LRB-
cord-005453-4057qib7	723	24	8	8	CD
cord-005453-4057qib7	723	25	%	%	NN
cord-005453-4057qib7	723	26	)	)	-RRB-
cord-005453-4057qib7	723	27	were	be	VBD
cord-005453-4057qib7	723	28	primary	primary	JJ
cord-005453-4057qib7	723	29	refractory	refractory	JJ
cord-005453-4057qib7	723	30	disease	disease	NN
cord-005453-4057qib7	723	31	.	.	.
cord-005453-4057qib7	724	1	CR	CR	NNP
cord-005453-4057qib7	724	2	rates	rate	NNS
cord-005453-4057qib7	724	3	did	do	VBD
cord-005453-4057qib7	724	4	not	not	RB
cord-005453-4057qib7	724	5	differ	differ	VB
cord-005453-4057qib7	724	6	between	between	IN
cord-005453-4057qib7	724	7	NPM1	NPM1	NNP
cord-005453-4057qib7	724	8	wt	wt	NN
cord-005453-4057qib7	724	9	/FLT3-ITD	/FLT3-ITD	NNP
cord-005453-4057qib7	724	10	negative	negative	JJ
cord-005453-4057qib7	724	11	group	group	NN
cord-005453-4057qib7	724	12	(	(	-LRB-
cord-005453-4057qib7	724	13	n=17/29	n=17/29	UH
cord-005453-4057qib7	724	14	,	,	,
cord-005453-4057qib7	724	15	58.6	58.6	CD
cord-005453-4057qib7	724	16	%	%	NN
cord-005453-4057qib7	724	17	)	)	-RRB-
cord-005453-4057qib7	724	18	and	and	CC
cord-005453-4057qib7	724	19	other	other	JJ
cord-005453-4057qib7	724	20	intermediate	intermediate	JJ
cord-005453-4057qib7	724	21	risk	risk	NN
cord-005453-4057qib7	724	22	group	group	NN
cord-005453-4057qib7	724	23	(	(	-LRB-
cord-005453-4057qib7	724	24	n=6/9	n=6/9	NNP
cord-005453-4057qib7	724	25	,	,	,
cord-005453-4057qib7	724	26	66.7	66.7	CD
cord-005453-4057qib7	724	27	%	%	NN
cord-005453-4057qib7	724	28	;	;	,
cord-005453-4057qib7	724	29	p=0.967	p=0.967	NN
cord-005453-4057qib7	724	30	)	)	-RRB-
cord-005453-4057qib7	724	31	.	.	.
cord-005453-4057qib7	725	1	With	with	IN
cord-005453-4057qib7	725	2	median	median	JJ
cord-005453-4057qib7	725	3	follow	follow	NN
cord-005453-4057qib7	725	4	-	-	HYPH
cord-005453-4057qib7	725	5	up	up	NN
cord-005453-4057qib7	725	6	duration	duration	NN
cord-005453-4057qib7	725	7	of	of	IN
cord-005453-4057qib7	725	8	12.9	12.9	CD
cord-005453-4057qib7	725	9	months	month	NNS
cord-005453-4057qib7	725	10	(	(	-LRB-
cord-005453-4057qib7	725	11	range	range	VBP
cord-005453-4057qib7	725	12	1.3	1.3	CD
cord-005453-4057qib7	725	13	-	-	HYPH
cord-005453-4057qib7	725	14	39.0	39.0	CD
cord-005453-4057qib7	725	15	months	month	NNS
cord-005453-4057qib7	725	16	)	)	-RRB-
cord-005453-4057qib7	725	17	,	,	,
cord-005453-4057qib7	725	18	one	one	CD
cord-005453-4057qib7	725	19	-	-	HYPH
cord-005453-4057qib7	725	20	year	year	NN
cord-005453-4057qib7	725	21	OS	os	NN
cord-005453-4057qib7	725	22	rate	rate	NN
cord-005453-4057qib7	725	23	were	be	VBD
cord-005453-4057qib7	725	24	100	100	CD
cord-005453-4057qib7	725	25	%	%	NN
cord-005453-4057qib7	725	26	,	,	,
cord-005453-4057qib7	725	27	83.5±6.9	83.5±6.9	CD
cord-005453-4057qib7	725	28	%	%	NN
cord-005453-4057qib7	725	29	,	,	,
cord-005453-4057qib7	725	30	56.1±12.8	56.1±12.8	CD
cord-005453-4057qib7	725	31	%	%	NN
cord-005453-4057qib7	725	32	in	in	IN
cord-005453-4057qib7	725	33	favorable	favorable	JJ
cord-005453-4057qib7	725	34	,	,	,
cord-005453-4057qib7	725	35	intermediate	intermediate	JJ
cord-005453-4057qib7	725	36	,	,	,
cord-005453-4057qib7	725	37	and	and	CC
cord-005453-4057qib7	725	38	adverse	adverse	JJ
cord-005453-4057qib7	725	39	risk	risk	NN
cord-005453-4057qib7	725	40	group	group	NN
cord-005453-4057qib7	725	41	(	(	-LRB-
cord-005453-4057qib7	725	42	p	p	NN
cord-005453-4057qib7	725	43	<	<	XX
cord-005453-4057qib7	725	44	0.001	0.001	CD
cord-005453-4057qib7	725	45	)	)	-RRB-
cord-005453-4057qib7	725	46	.	.	.
cord-005453-4057qib7	726	1	Among	among	IN
cord-005453-4057qib7	726	2	intermediate	intermediate	JJ
cord-005453-4057qib7	726	3	risk	risk	NN
cord-005453-4057qib7	726	4	group	group	NN
cord-005453-4057qib7	726	5	,	,	,
cord-005453-4057qib7	726	6	OS	OS	NNP
cord-005453-4057qib7	726	7	rate	rate	NN
cord-005453-4057qib7	726	8	of	of	IN
cord-005453-4057qib7	726	9	NPM1	NPM1	NNP
cord-005453-4057qib7	726	10	wt	wt	NN
cord-005453-4057qib7	726	11	/FLT3-ITD	/FLT3-ITD	NNP
cord-005453-4057qib7	726	12	negative	negative	JJ
cord-005453-4057qib7	726	13	group	group	NN
cord-005453-4057qib7	726	14	was	be	VBD
cord-005453-4057qib7	726	15	similar	similar	JJ
cord-005453-4057qib7	726	16	to	to	IN
cord-005453-4057qib7	726	17	other	other	JJ
cord-005453-4057qib7	726	18	intermediate	intermediate	JJ
cord-005453-4057qib7	726	19	risk	risk	NN
cord-005453-4057qib7	726	20	(	(	-LRB-
cord-005453-4057qib7	726	21	p=0.403	p=0.403	NNP
cord-005453-4057qib7	726	22	)	)	-RRB-
cord-005453-4057qib7	726	23	.	.	.
cord-005453-4057qib7	727	1	Allo	Allo	NNP
cord-005453-4057qib7	727	2	-	-	HYPH
cord-005453-4057qib7	727	3	HCT	HCT	NNP
cord-005453-4057qib7	727	4	was	be	VBD
cord-005453-4057qib7	727	5	performed	perform	VBN
cord-005453-4057qib7	727	6	in	in	IN
cord-005453-4057qib7	727	7	11	11	CD
cord-005453-4057qib7	727	8	patients	patient	NNS
cord-005453-4057qib7	727	9	of	of	IN
cord-005453-4057qib7	727	10	NPM1	NPM1	NNP
cord-005453-4057qib7	727	11	wt	wt	NNP
cord-005453-4057qib7	727	12	/FLT3-ITD	/FLT3-ITD	NNP
cord-005453-4057qib7	727	13	negative	negative	JJ
cord-005453-4057qib7	727	14	group	group	NN
cord-005453-4057qib7	727	15	.	.	.
cord-005453-4057qib7	728	1	One	one	CD
cord-005453-4057qib7	728	2	-	-	HYPH
cord-005453-4057qib7	728	3	year	year	NN
cord-005453-4057qib7	728	4	OS	os	NN
cord-005453-4057qib7	728	5	rates	rate	NNS
cord-005453-4057qib7	728	6	did	do	VBD
cord-005453-4057qib7	728	7	not	not	RB
cord-005453-4057qib7	728	8	differ	differ	VB
cord-005453-4057qib7	728	9	between	between	IN
cord-005453-4057qib7	728	10	NPM1	NPM1	NNP
cord-005453-4057qib7	728	11	wt	wt	NN
cord-005453-4057qib7	728	12	/FLT3-ITD	/FLT3-ITD	NNP
cord-005453-4057qib7	728	13	negative	negative	JJ
cord-005453-4057qib7	728	14	and	and	CC
cord-005453-4057qib7	728	15	other	other	JJ
cord-005453-4057qib7	728	16	for	for	IN
cord-005453-4057qib7	728	17	allogenic	allogenic	JJ
cord-005453-4057qib7	728	18	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	728	19	stem	stem	NN
cord-005453-4057qib7	728	20	cell	cell	NN
cord-005453-4057qib7	728	21	transplant	transplant	NN
cord-005453-4057qib7	728	22	(	(	-LRB-
cord-005453-4057qib7	728	23	allo	allo	NN
cord-005453-4057qib7	728	24	-	-	HYPH
cord-005453-4057qib7	728	25	HSCT	HSCT	NNP
cord-005453-4057qib7	728	26	)	)	-RRB-
cord-005453-4057qib7	728	27	,	,	,
cord-005453-4057qib7	728	28	as	as	IN
cord-005453-4057qib7	728	29	a	a	DT
cord-005453-4057qib7	728	30	strategy	strategy	NN
cord-005453-4057qib7	728	31	to	to	TO
cord-005453-4057qib7	728	32	prolong	prolong	VB
cord-005453-4057qib7	728	33	survival	survival	NN
cord-005453-4057qib7	728	34	.	.	.
cord-005453-4057qib7	729	1	Methods	method	NNS
cord-005453-4057qib7	729	2	:	:	:
cord-005453-4057qib7	729	3	Data	datum	NNS
cord-005453-4057qib7	729	4	from	from	IN
cord-005453-4057qib7	729	5	AML	AML	NNP
cord-005453-4057qib7	729	6	pts	pt	NNS
cord-005453-4057qib7	729	7	over	over	IN
cord-005453-4057qib7	729	8	60	60	CD
cord-005453-4057qib7	729	9	years	year	NNS
cord-005453-4057qib7	729	10	,	,	,
cord-005453-4057qib7	729	11	who	who	WP
cord-005453-4057qib7	729	12	underwent	undergo	VBD
cord-005453-4057qib7	729	13	RIC	RIC	NNP
cord-005453-4057qib7	729	14	allo	allo	NNP
cord-005453-4057qib7	729	15	-	-	HYPH
cord-005453-4057qib7	729	16	HSCT	HSCT	NNP
cord-005453-4057qib7	729	17	in	in	IN
cord-005453-4057qib7	729	18	our	-PRON-	PRP$
cord-005453-4057qib7	729	19	institution	institution	NN
cord-005453-4057qib7	729	20	between	between	IN
cord-005453-4057qib7	729	21	September	September	NNP
cord-005453-4057qib7	729	22	2011	2011	CD
cord-005453-4057qib7	729	23	and	and	CC
cord-005453-4057qib7	729	24	September	September	NNP
cord-005453-4057qib7	729	25	2017	2017	CD
cord-005453-4057qib7	729	26	,	,	,
cord-005453-4057qib7	729	27	was	be	VBD
cord-005453-4057qib7	729	28	retrospectively	retrospectively	RB
cord-005453-4057qib7	729	29	collected	collect	VBN
cord-005453-4057qib7	729	30	from	from	IN
cord-005453-4057qib7	729	31	clinical	clinical	JJ
cord-005453-4057qib7	729	32	files	file	NNS
cord-005453-4057qib7	729	33	to	to	TO
cord-005453-4057qib7	729	34	evaluate	evaluate	VB
cord-005453-4057qib7	729	35	the	the	DT
cord-005453-4057qib7	729	36	overall	overall	JJ
cord-005453-4057qib7	729	37	survival	survival	NN
cord-005453-4057qib7	729	38	(	(	-LRB-
cord-005453-4057qib7	729	39	OS	OS	NNP
cord-005453-4057qib7	729	40	)	)	-RRB-
cord-005453-4057qib7	729	41	up	up	IN
cord-005453-4057qib7	729	42	to	to	IN
cord-005453-4057qib7	729	43	November	November	NNP
cord-005453-4057qib7	729	44	2018	2018	CD
cord-005453-4057qib7	729	45	.	.	.
cord-005453-4057qib7	730	1	We	-PRON-	PRP
cord-005453-4057qib7	730	2	calculated	calculate	VBD
cord-005453-4057qib7	730	3	the	the	DT
cord-005453-4057qib7	730	4	OS	OS	NNP
cord-005453-4057qib7	730	5	using	use	VBG
cord-005453-4057qib7	730	6	Kaplan	Kaplan	NNP
cord-005453-4057qib7	730	7	-	-	HYPH
cord-005453-4057qib7	730	8	Meyer	Meyer	NNP
cord-005453-4057qib7	730	9	curves	curve	NNS
cord-005453-4057qib7	730	10	.	.	.
cord-005453-4057qib7	731	1	Results	result	NNS
cord-005453-4057qib7	731	2	:	:	:
cord-005453-4057qib7	732	1	We	-PRON-	PRP
cord-005453-4057qib7	732	2	identified	identify	VBD
cord-005453-4057qib7	732	3	15	15	CD
cord-005453-4057qib7	732	4	pts	pt	NNS
cord-005453-4057qib7	732	5	,	,	,
cord-005453-4057qib7	732	6	median	median	JJ
cord-005453-4057qib7	732	7	age	age	NN
cord-005453-4057qib7	732	8	62	62	CD
cord-005453-4057qib7	733	1	y.o	y.o	NNP
cord-005453-4057qib7	733	2	.	.	.
cord-005453-4057qib7	734	1	(	(	-LRB-
cord-005453-4057qib7	734	2	60	60	CD
cord-005453-4057qib7	734	3	-	-	SYM
cord-005453-4057qib7	734	4	67	67	CD
cord-005453-4057qib7	734	5	)	)	-RRB-
cord-005453-4057qib7	734	6	and	and	CC
cord-005453-4057qib7	735	1	median	median	JJ
cord-005453-4057qib7	735	2	HTC	HTC	NNP
cord-005453-4057qib7	735	3	-	-	:
cord-005453-4057qib7	735	4	I	-PRON-	PRP
cord-005453-4057qib7	735	5	score	score	VBP
cord-005453-4057qib7	735	6	2	2	CD
cord-005453-4057qib7	735	7	.	.	.
cord-005453-4057qib7	736	1	The	the	DT
cord-005453-4057qib7	736	2	median	median	JJ
cord-005453-4057qib7	736	3	follow	follow	NN
cord-005453-4057qib7	736	4	-	-	HYPH
cord-005453-4057qib7	736	5	up	up	NN
cord-005453-4057qib7	736	6	was	be	VBD
cord-005453-4057qib7	736	7	25	25	CD
cord-005453-4057qib7	736	8	months	month	NNS
cord-005453-4057qib7	736	9	.	.	.
cord-005453-4057qib7	737	1	One	one	CD
cord-005453-4057qib7	737	2	patient	patient	NN
cord-005453-4057qib7	737	3	(	(	-LRB-
cord-005453-4057qib7	737	4	pt	pt	NN
cord-005453-4057qib7	737	5	)	)	-RRB-
cord-005453-4057qib7	737	6	had	have	VBD
cord-005453-4057qib7	737	7	CML	CML	NNP
cord-005453-4057qib7	737	8	blast	blast	NN
cord-005453-4057qib7	737	9	crisis	crisis	NN
cord-005453-4057qib7	737	10	and	and	CC
cord-005453-4057qib7	737	11	was	be	VBD
cord-005453-4057qib7	737	12	on	on	IN
cord-005453-4057qib7	737	13	first	first	JJ
cord-005453-4057qib7	737	14	major	major	JJ
cord-005453-4057qib7	737	15	molecular	molecular	JJ
cord-005453-4057qib7	737	16	remission	remission	NN
cord-005453-4057qib7	737	17	.	.	.
cord-005453-4057qib7	738	1	Of	of	IN
cord-005453-4057qib7	738	2	the	the	DT
cord-005453-4057qib7	738	3	remaining	remain	VBG
cord-005453-4057qib7	738	4	14	14	CD
cord-005453-4057qib7	738	5	AML	AML	NNP
cord-005453-4057qib7	738	6	pts	pt	NNS
cord-005453-4057qib7	738	7	,	,	,
cord-005453-4057qib7	738	8	7	7	CD
cord-005453-4057qib7	738	9	were	be	VBD
cord-005453-4057qib7	738	10	in	in	IN
cord-005453-4057qib7	738	11	1	1	CD
cord-005453-4057qib7	738	12	st	st	NNP
cord-005453-4057qib7	738	13	complete	complete	JJ
cord-005453-4057qib7	738	14	remission	remission	NN
cord-005453-4057qib7	738	15	(	(	-LRB-
cord-005453-4057qib7	738	16	CR	CR	NNP
cord-005453-4057qib7	738	17	)	)	-RRB-
cord-005453-4057qib7	738	18	,	,	,
cord-005453-4057qib7	738	19	4	4	CD
cord-005453-4057qib7	738	20	in	in	IN
cord-005453-4057qib7	738	21	2	2	CD
cord-005453-4057qib7	738	22	nd	nd	NNP
cord-005453-4057qib7	738	23	CR	CR	NNP
cord-005453-4057qib7	738	24	and	and	CC
cord-005453-4057qib7	738	25	1	1	CD
cord-005453-4057qib7	738	26	with	with	IN
cord-005453-4057qib7	738	27	progressive	progressive	JJ
cord-005453-4057qib7	738	28	disease	disease	NN
cord-005453-4057qib7	738	29	(	(	-LRB-
cord-005453-4057qib7	738	30	PD	PD	NNP
cord-005453-4057qib7	738	31	)	)	-RRB-
cord-005453-4057qib7	738	32	;	;	:
cord-005453-4057qib7	738	33	the	the	DT
cord-005453-4057qib7	738	34	other	other	JJ
cord-005453-4057qib7	738	35	2	2	CD
cord-005453-4057qib7	738	36	pts	pts	NN
cord-005453-4057qib7	738	37	could	could	MD
cord-005453-4057qib7	738	38	be	be	VB
cord-005453-4057qib7	738	39	classified	classify	VBN
cord-005453-4057qib7	738	40	as	as	IN
cord-005453-4057qib7	738	41	MDS	MDS	NNP
cord-005453-4057qib7	738	42	according	accord	VBG
cord-005453-4057qib7	738	43	to	to	IN
cord-005453-4057qib7	738	44	2016	2016	CD
cord-005453-4057qib7	739	1	WHO	who	WP
cord-005453-4057qib7	739	2	diagnostic	diagnostic	JJ
cord-005453-4057qib7	739	3	criteria	criterion	NNS
cord-005453-4057qib7	739	4	and	and	CC
cord-005453-4057qib7	739	5	were	be	VBD
cord-005453-4057qib7	739	6	in	in	IN
cord-005453-4057qib7	739	7	CR1	CR1	NNP
cord-005453-4057qib7	739	8	.	.	.
cord-005453-4057qib7	740	1	Donors	donor	NNS
cord-005453-4057qib7	740	2	(	(	-LRB-
cord-005453-4057qib7	740	3	D	D	NNP
cord-005453-4057qib7	740	4	)	)	-RRB-
cord-005453-4057qib7	740	5	were	be	VBD
cord-005453-4057qib7	740	6	:	:	:
cord-005453-4057qib7	740	7	3	3	CD
cord-005453-4057qib7	740	8	matched	match	VBN
cord-005453-4057qib7	740	9	unrelated	unrelated	JJ
cord-005453-4057qib7	740	10	(	(	-LRB-
cord-005453-4057qib7	740	11	MUD	mud	NN
cord-005453-4057qib7	740	12	)	)	-RRB-
cord-005453-4057qib7	740	13	,	,	,
cord-005453-4057qib7	740	14	5	5	CD
cord-005453-4057qib7	740	15	mismatched	mismatched	JJ
cord-005453-4057qib7	740	16	unrelated	unrelated	JJ
cord-005453-4057qib7	740	17	(	(	-LRB-
cord-005453-4057qib7	740	18	MMUD	MMUD	NNP
cord-005453-4057qib7	740	19	-9/10	-9/10	NN
cord-005453-4057qib7	740	20	)	)	-RRB-
cord-005453-4057qib7	740	21	,	,	,
cord-005453-4057qib7	740	22	6	6	CD
cord-005453-4057qib7	740	23	matched	match	VBN
cord-005453-4057qib7	740	24	siblings	sibling	NNS
cord-005453-4057qib7	740	25	and	and	CC
cord-005453-4057qib7	740	26	1	1	CD
cord-005453-4057qib7	740	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	740	28	.	.	.
cord-005453-4057qib7	741	1	Thirteen	thirteen	CD
cord-005453-4057qib7	741	2	pts	pt	NNS
cord-005453-4057qib7	741	3	were	be	VBD
cord-005453-4057qib7	741	4	infused	infuse	VBN
cord-005453-4057qib7	741	5	with	with	IN
cord-005453-4057qib7	741	6	peripheral	peripheral	JJ
cord-005453-4057qib7	741	7	blood	blood	NN
cord-005453-4057qib7	741	8	HSC	HSC	NNP
cord-005453-4057qib7	741	9	and	and	CC
cord-005453-4057qib7	741	10	2	2	CD
cord-005453-4057qib7	741	11	with	with	IN
cord-005453-4057qib7	741	12	bone	bone	NN
cord-005453-4057qib7	741	13	marrow	marrow	NN
cord-005453-4057qib7	741	14	.	.	.
cord-005453-4057qib7	742	1	Conditionings	conditioning	NNS
cord-005453-4057qib7	742	2	were	be	VBD
cord-005453-4057qib7	742	3	:	:	:
cord-005453-4057qib7	742	4	FLUBCNUMEL	flubcnumel	VB
cord-005453-4057qib7	742	5	in	in	IN
cord-005453-4057qib7	742	6	5	5	CD
cord-005453-4057qib7	742	7	unrelated	unrelated	JJ
cord-005453-4057qib7	742	8	donor	donor	NN
cord-005453-4057qib7	742	9	(	(	-LRB-
cord-005453-4057qib7	742	10	UD	UD	NNP
cord-005453-4057qib7	742	11	)	)	-RRB-
cord-005453-4057qib7	742	12	pts	pts	NNP
cord-005453-4057qib7	742	13	and	and	CC
cord-005453-4057qib7	742	14	4	4	CD
cord-005453-4057qib7	742	15	siblings	sibling	NNS
cord-005453-4057qib7	742	16	,	,	,
cord-005453-4057qib7	742	17	FLUMEL	FLUMEL	NNP
cord-005453-4057qib7	742	18	in	in	IN
cord-005453-4057qib7	742	19	1	1	CD
cord-005453-4057qib7	742	20	UD	UD	NNP
cord-005453-4057qib7	742	21	pt	pt	NN
cord-005453-4057qib7	742	22	and	and	CC
cord-005453-4057qib7	742	23	1	1	CD
cord-005453-4057qib7	742	24	sibling	sibling	NN
cord-005453-4057qib7	742	25	,	,	,
cord-005453-4057qib7	742	26	FLUBU	FLUBU	NNP
cord-005453-4057qib7	742	27	in	in	IN
cord-005453-4057qib7	742	28	2	2	CD
cord-005453-4057qib7	742	29	UD	UD	NNP
cord-005453-4057qib7	742	30	pts	pt	NNS
cord-005453-4057qib7	742	31	and	and	CC
cord-005453-4057qib7	742	32	FLUTBI	FLUTBI	NNP
cord-005453-4057qib7	742	33	2Gy	2gy	NN
cord-005453-4057qib7	742	34	in	in	IN
cord-005453-4057qib7	742	35	1	1	CD
cord-005453-4057qib7	742	36	sibling	sibling	NN
cord-005453-4057qib7	742	37	and	and	CC
cord-005453-4057qib7	742	38	in	in	IN
cord-005453-4057qib7	742	39	the	the	DT
cord-005453-4057qib7	742	40	haploidentical	haploidentical	JJ
cord-005453-4057qib7	742	41	.	.	.
cord-005453-4057qib7	743	1	Graft	graft	NN
cord-005453-4057qib7	743	2	versus	versus	IN
cord-005453-4057qib7	743	3	host	host	NN
cord-005453-4057qib7	743	4	disease	disease	NN
cord-005453-4057qib7	743	5	(	(	-LRB-
cord-005453-4057qib7	743	6	GVHD	GVHD	NNP
cord-005453-4057qib7	743	7	)	)	-RRB-
cord-005453-4057qib7	743	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	743	9	was	be	VBD
cord-005453-4057qib7	743	10	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	743	11	(	(	-LRB-
cord-005453-4057qib7	743	12	TAC	TAC	NNP
cord-005453-4057qib7	743	13	)	)	-RRB-
cord-005453-4057qib7	743	14	+	+	CC
cord-005453-4057qib7	743	15	MMF	mmf	NN
cord-005453-4057qib7	743	16	in	in	IN
cord-005453-4057qib7	743	17	5	5	CD
cord-005453-4057qib7	743	18	UD	UD	NNP
cord-005453-4057qib7	743	19	pts	pt	NNS
cord-005453-4057qib7	743	20	and	and	CC
cord-005453-4057qib7	743	21	1	1	CD
cord-005453-4057qib7	743	22	sibling	sibling	NN
cord-005453-4057qib7	743	23	,	,	,
cord-005453-4057qib7	743	24	TAC	TAC	NNP
cord-005453-4057qib7	743	25	+	+	CC
cord-005453-4057qib7	743	26	MTX	MTX	NNP
cord-005453-4057qib7	743	27	in	in	IN
cord-005453-4057qib7	743	28	2	2	CD
cord-005453-4057qib7	743	29	UD	UD	NNP
cord-005453-4057qib7	743	30	pts	pt	NNS
cord-005453-4057qib7	743	31	and	and	CC
cord-005453-4057qib7	743	32	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	743	33	(	(	-LRB-
cord-005453-4057qib7	743	34	CyA	CyA	NNP
cord-005453-4057qib7	743	35	)	)	-RRB-
cord-005453-4057qib7	743	36	+	+	CC
cord-005453-4057qib7	743	37	MMF	mmf	NN
cord-005453-4057qib7	743	38	in	in	IN
cord-005453-4057qib7	743	39	1	1	CD
cord-005453-4057qib7	743	40	UD	UD	NNP
cord-005453-4057qib7	743	41	pt	pt	NN
cord-005453-4057qib7	743	42	and	and	CC
cord-005453-4057qib7	743	43	5	5	CD
cord-005453-4057qib7	743	44	siblings	sibling	NNS
cord-005453-4057qib7	743	45	.	.	.
cord-005453-4057qib7	744	1	All	all	DT
cord-005453-4057qib7	744	2	MMUD	MMUD	NNP
cord-005453-4057qib7	744	3	pts	pts	NNP
cord-005453-4057qib7	744	4	had	have	VBD
cord-005453-4057qib7	744	5	ATG	ATG	NNP
cord-005453-4057qib7	744	6	.	.	.
cord-005453-4057qib7	745	1	PTCy	PTCy	NNP
cord-005453-4057qib7	745	2	was	be	VBD
cord-005453-4057qib7	745	3	done	do	VBN
cord-005453-4057qib7	745	4	in	in	IN
cord-005453-4057qib7	745	5	the	the	DT
cord-005453-4057qib7	745	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	745	7	setting	setting	NN
cord-005453-4057qib7	745	8	with	with	IN
cord-005453-4057qib7	745	9	TAC	TAC	NNP
cord-005453-4057qib7	745	10	+	+	CC
cord-005453-4057qib7	745	11	MMF	mmf	NN
cord-005453-4057qib7	745	12	.	.	.
cord-005453-4057qib7	746	1	The	the	DT
cord-005453-4057qib7	746	2	median	median	JJ
cord-005453-4057qib7	746	3	time	time	NN
cord-005453-4057qib7	746	4	to	to	IN
cord-005453-4057qib7	746	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	746	6	and	and	CC
cord-005453-4057qib7	746	7	platelet	platelet	NN
cord-005453-4057qib7	746	8	engraftment	engraftment	NN
cord-005453-4057qib7	746	9	for	for	IN
cord-005453-4057qib7	746	10	the	the	DT
cord-005453-4057qib7	746	11	whole	whole	JJ
cord-005453-4057qib7	746	12	cohort	cohort	NN
cord-005453-4057qib7	746	13	was	be	VBD
cord-005453-4057qib7	746	14	14	14	CD
cord-005453-4057qib7	746	15	and	and	CC
cord-005453-4057qib7	746	16	11	11	CD
cord-005453-4057qib7	746	17	days	day	NNS
cord-005453-4057qib7	746	18	,	,	,
cord-005453-4057qib7	746	19	respectively	respectively	RB
cord-005453-4057qib7	746	20	.	.	.
cord-005453-4057qib7	747	1	One	one	CD
cord-005453-4057qib7	747	2	pt	pt	NN
cord-005453-4057qib7	747	3	with	with	IN
cord-005453-4057qib7	747	4	secondary	secondary	JJ
cord-005453-4057qib7	747	5	engraftment	engraftment	NN
cord-005453-4057qib7	747	6	failure	failure	NN
cord-005453-4057qib7	747	7	required	require	VBN
cord-005453-4057qib7	747	8	re	re	NN
cord-005453-4057qib7	747	9	-	-	NN
cord-005453-4057qib7	747	10	infusion	infusion	NN
cord-005453-4057qib7	747	11	of	of	IN
cord-005453-4057qib7	747	12	selected	select	VBN
cord-005453-4057qib7	747	13	CD34	CD34	NNP
cord-005453-4057qib7	747	14	+	+	CC
cord-005453-4057qib7	747	15	cells	cell	NNS
cord-005453-4057qib7	747	16	.	.	.
cord-005453-4057qib7	748	1	Ten	ten	CD
cord-005453-4057qib7	748	2	pts	pt	NNS
cord-005453-4057qib7	748	3	presented	present	VBN
cord-005453-4057qib7	748	4	with	with	IN
cord-005453-4057qib7	748	5	mild	mild	JJ
cord-005453-4057qib7	748	6	acute	acute	JJ
cord-005453-4057qib7	748	7	skin	skin	NN
cord-005453-4057qib7	748	8	GVHD	GVHD	NNP
cord-005453-4057qib7	748	9	.	.	.
cord-005453-4057qib7	749	1	Eleven	eleven	CD
cord-005453-4057qib7	749	2	pts	pt	NNS
cord-005453-4057qib7	749	3	had	have	VBD
cord-005453-4057qib7	749	4	chronic	chronic	JJ
cord-005453-4057qib7	749	5	GVHD	GVHD	NNP
cord-005453-4057qib7	749	6	,	,	,
cord-005453-4057qib7	749	7	2	2	CD
cord-005453-4057qib7	749	8	classified	classify	VBN
cord-005453-4057qib7	749	9	as	as	IN
cord-005453-4057qib7	749	10	severe	severe	JJ
cord-005453-4057qib7	749	11	;	;	:
cord-005453-4057qib7	749	12	7	7	CD
cord-005453-4057qib7	749	13	required	require	VBN
cord-005453-4057qib7	749	14	systemic	systemic	JJ
cord-005453-4057qib7	749	15	therapy	therapy	NN
cord-005453-4057qib7	749	16	,	,	,
cord-005453-4057qib7	749	17	5	5	CD
cord-005453-4057qib7	749	18	of	of	IN
cord-005453-4057qib7	749	19	those	those	DT
cord-005453-4057qib7	749	20	beyond	beyond	IN
cord-005453-4057qib7	749	21	1	1	CD
cord-005453-4057qib7	749	22	year	year	NN
cord-005453-4057qib7	749	23	.	.	.
cord-005453-4057qib7	750	1	The	the	DT
cord-005453-4057qib7	750	2	median	median	JJ
cord-005453-4057qib7	750	3	time	time	NN
cord-005453-4057qib7	750	4	on	on	IN
cord-005453-4057qib7	750	5	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	750	6	was	be	VBD
cord-005453-4057qib7	750	7	404	404	CD
cord-005453-4057qib7	750	8	days	day	NNS
cord-005453-4057qib7	750	9	.	.	.
cord-005453-4057qib7	751	1	At	at	IN
cord-005453-4057qib7	751	2	2	2	CD
cord-005453-4057qib7	751	3	years	year	NNS
cord-005453-4057qib7	751	4	the	the	DT
cord-005453-4057qib7	751	5	OS	OS	NNP
cord-005453-4057qib7	751	6	was	be	VBD
cord-005453-4057qib7	751	7	63.5	63.5	CD
cord-005453-4057qib7	751	8	%	%	NN
cord-005453-4057qib7	751	9	.	.	.
cord-005453-4057qib7	752	1	There	there	EX
cord-005453-4057qib7	752	2	were	be	VBD
cord-005453-4057qib7	752	3	6	6	CD
cord-005453-4057qib7	752	4	deaths	death	NNS
cord-005453-4057qib7	752	5	:	:	:
cord-005453-4057qib7	752	6	3	3	CD
cord-005453-4057qib7	752	7	disease	disease	NN
cord-005453-4057qib7	752	8	-	-	HYPH
cord-005453-4057qib7	752	9	related	relate	VBN
cord-005453-4057qib7	752	10	(	(	-LRB-
cord-005453-4057qib7	752	11	2	2	CD
cord-005453-4057qib7	752	12	relapses	relapse	NNS
cord-005453-4057qib7	752	13	at	at	IN
cord-005453-4057qib7	752	14	22	22	CD
cord-005453-4057qib7	752	15	and	and	CC
cord-005453-4057qib7	752	16	58	58	CD
cord-005453-4057qib7	752	17	months	month	NNS
cord-005453-4057qib7	752	18	and	and	CC
cord-005453-4057qib7	752	19	1	1	CD
cord-005453-4057qib7	752	20	PD	pd	NN
cord-005453-4057qib7	752	21	at	at	IN
cord-005453-4057qib7	752	22	d+30	d+30	NN
cord-005453-4057qib7	752	23	)	)	-RRB-
cord-005453-4057qib7	752	24	,	,	,
cord-005453-4057qib7	752	25	2	2	CD
cord-005453-4057qib7	752	26	infection	infection	NN
cord-005453-4057qib7	752	27	complications	complication	NNS
cord-005453-4057qib7	752	28	(	(	-LRB-
cord-005453-4057qib7	752	29	2	2	CD
cord-005453-4057qib7	752	30	septic	septic	JJ
cord-005453-4057qib7	752	31	shock	shock	NN
cord-005453-4057qib7	752	32	)	)	-RRB-
cord-005453-4057qib7	752	33	and	and	CC
cord-005453-4057qib7	752	34	1	1	CD
cord-005453-4057qib7	752	35	to	to	IN
cord-005453-4057qib7	752	36	secondary	secondary	JJ
cord-005453-4057qib7	752	37	neoplasia	neoplasia	NNS
cord-005453-4057qib7	752	38	.	.	.
cord-005453-4057qib7	753	1	Other	other	JJ
cord-005453-4057qib7	753	2	relevant	relevant	JJ
cord-005453-4057qib7	753	3	complications	complication	NNS
cord-005453-4057qib7	753	4	were	be	VBD
cord-005453-4057qib7	753	5	hypoxemic	hypoxemic	JJ
cord-005453-4057qib7	753	6	pneumonia	pneumonia	NN
cord-005453-4057qib7	753	7	in	in	IN
cord-005453-4057qib7	753	8	5	5	CD
cord-005453-4057qib7	753	9	pts	pt	NNS
cord-005453-4057qib7	753	10	,	,	,
cord-005453-4057qib7	753	11	1	1	CD
cord-005453-4057qib7	753	12	urinary	urinary	JJ
cord-005453-4057qib7	753	13	sepsis	sepsis	NN
cord-005453-4057qib7	753	14	,	,	,
cord-005453-4057qib7	753	15	CMV	CMV	NNP
cord-005453-4057qib7	753	16	and	and	CC
cord-005453-4057qib7	753	17	EBV	EBV	NNP
cord-005453-4057qib7	753	18	reactivation	reactivation	NN
cord-005453-4057qib7	753	19	respectively	respectively	RB
cord-005453-4057qib7	753	20	in	in	IN
cord-005453-4057qib7	753	21	8	8	CD
cord-005453-4057qib7	753	22	and	and	CC
cord-005453-4057qib7	753	23	4	4	CD
cord-005453-4057qib7	753	24	pts	pt	NNS
cord-005453-4057qib7	753	25	;	;	,
cord-005453-4057qib7	753	26	pulmonary	pulmonary	JJ
cord-005453-4057qib7	753	27	and	and	CC
cord-005453-4057qib7	753	28	renal	renal	JJ
cord-005453-4057qib7	753	29	toxicity	toxicity	NN
cord-005453-4057qib7	753	30	either	either	CC
cord-005453-4057qib7	753	31	in	in	IN
cord-005453-4057qib7	753	32	2	2	CD
cord-005453-4057qib7	753	33	pts	pts	NN
cord-005453-4057qib7	753	34	.	.	.
cord-005453-4057qib7	754	1	At	at	IN
cord-005453-4057qib7	754	2	end	end	NN
cord-005453-4057qib7	754	3	of	of	IN
cord-005453-4057qib7	754	4	follow	follow	NN
cord-005453-4057qib7	754	5	-	-	HYPH
cord-005453-4057qib7	754	6	up	up	NN
cord-005453-4057qib7	754	7	,	,	,
cord-005453-4057qib7	754	8	9	9	CD
cord-005453-4057qib7	754	9	pts	pt	NNS
cord-005453-4057qib7	754	10	were	be	VBD
cord-005453-4057qib7	754	11	in	in	IN
cord-005453-4057qib7	754	12	remission	remission	NN
cord-005453-4057qib7	754	13	,	,	,
cord-005453-4057qib7	754	14	8	8	CD
cord-005453-4057qib7	754	15	without	without	IN
cord-005453-4057qib7	754	16	negative	negative	JJ
cord-005453-4057qib7	754	17	measurable	measurable	JJ
cord-005453-4057qib7	754	18	residual	residual	JJ
cord-005453-4057qib7	754	19	disease	disease	NN
cord-005453-4057qib7	754	20	(	(	-LRB-
cord-005453-4057qib7	754	21	MRD	MRD	NNP
cord-005453-4057qib7	754	22	)	)	-RRB-
cord-005453-4057qib7	754	23	,	,	,
cord-005453-4057qib7	754	24	the	the	DT
cord-005453-4057qib7	754	25	other	other	JJ
cord-005453-4057qib7	754	26	MRD	MRD	NNP
cord-005453-4057qib7	754	27	negative	negative	JJ
cord-005453-4057qib7	754	28	pt	pt	NN
cord-005453-4057qib7	754	29	died	die	VBD
cord-005453-4057qib7	754	30	of	of	IN
cord-005453-4057qib7	754	31	septic	septic	JJ
cord-005453-4057qib7	754	32	shock	shock	NN
cord-005453-4057qib7	754	33	and	and	CC
cord-005453-4057qib7	754	34	severe	severe	JJ
cord-005453-4057qib7	754	35	intestinal	intestinal	JJ
cord-005453-4057qib7	754	36	GVHD	GVHD	NNP
cord-005453-4057qib7	754	37	.	.	.
cord-005453-4057qib7	755	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	755	2	:	:	:
cord-005453-4057qib7	756	1	In	in	IN
cord-005453-4057qib7	756	2	this	this	DT
cord-005453-4057qib7	756	3	small	small	JJ
cord-005453-4057qib7	756	4	cohort	cohort	NN
cord-005453-4057qib7	756	5	,	,	,
cord-005453-4057qib7	756	6	chronic	chronic	JJ
cord-005453-4057qib7	756	7	GVHD	GVHD	NNP
cord-005453-4057qib7	756	8	and	and	CC
cord-005453-4057qib7	756	9	infectious	infectious	JJ
cord-005453-4057qib7	756	10	complications	complication	NNS
cord-005453-4057qib7	756	11	were	be	VBD
cord-005453-4057qib7	756	12	major	major	JJ
cord-005453-4057qib7	756	13	causes	cause	NNS
cord-005453-4057qib7	756	14	of	of	IN
cord-005453-4057qib7	756	15	morbidity	morbidity	NN
cord-005453-4057qib7	756	16	but	but	CC
cord-005453-4057qib7	756	17	there	there	EX
cord-005453-4057qib7	756	18	were	be	VBD
cord-005453-4057qib7	756	19	no	no	DT
cord-005453-4057qib7	756	20	treatment	treatment	NN
cord-005453-4057qib7	756	21	related	relate	VBN
cord-005453-4057qib7	756	22	deaths	death	NNS
cord-005453-4057qib7	756	23	before	before	IN
cord-005453-4057qib7	756	24	d+100	d+100	NNS
cord-005453-4057qib7	756	25	.	.	.
cord-005453-4057qib7	757	1	Pts	Pts	NNP
cord-005453-4057qib7	757	2	maintaining	maintain	VBG
cord-005453-4057qib7	757	3	or	or	CC
cord-005453-4057qib7	757	4	achieving	achieve	VBG
cord-005453-4057qib7	757	5	MRD	MRD	NNP
cord-005453-4057qib7	757	6	negativity	negativity	NN
cord-005453-4057qib7	757	7	after	after	IN
cord-005453-4057qib7	757	8	transplant	transplant	NN
cord-005453-4057qib7	758	1	had	have	VBD
cord-005453-4057qib7	758	2	better	well	JJR
cord-005453-4057qib7	758	3	survival	survival	NN
cord-005453-4057qib7	758	4	.	.	.
cord-005453-4057qib7	759	1	Although	although	IN
cord-005453-4057qib7	759	2	with	with	IN
cord-005453-4057qib7	759	3	only	only	RB
cord-005453-4057qib7	759	4	15	15	CD
cord-005453-4057qib7	759	5	pts	pt	NNS
cord-005453-4057qib7	759	6	,	,	,
cord-005453-4057qib7	759	7	these	these	DT
cord-005453-4057qib7	759	8	results	result	NNS
cord-005453-4057qib7	759	9	suggest	suggest	VBP
cord-005453-4057qib7	759	10	that	that	IN
cord-005453-4057qib7	759	11	allo	allo	NN
cord-005453-4057qib7	759	12	-	-	HYPH
cord-005453-4057qib7	759	13	HSCT	HSCT	NNP
cord-005453-4057qib7	759	14	is	be	VBZ
cord-005453-4057qib7	759	15	feasible	feasible	JJ
cord-005453-4057qib7	759	16	as	as	IN
cord-005453-4057qib7	759	17	consolidation	consolidation	NN
cord-005453-4057qib7	759	18	strategy	strategy	NN
cord-005453-4057qib7	759	19	in	in	IN
cord-005453-4057qib7	759	20	selected	select	VBN
cord-005453-4057qib7	759	21	AML	AML	NNP
cord-005453-4057qib7	759	22	pts	pt	NNS
cord-005453-4057qib7	759	23	over	over	IN
cord-005453-4057qib7	759	24	60	60	CD
cord-005453-4057qib7	759	25	years	year	NNS
cord-005453-4057qib7	759	26	.	.	.
cord-005453-4057qib7	760	1	[	[	-LRB-
cord-005453-4057qib7	760	2	[	[	-LRB-
cord-005453-4057qib7	760	3	P043	P043	NNP
cord-005453-4057qib7	760	4	Image	image	NN
cord-005453-4057qib7	760	5	]	]	-RRB-
cord-005453-4057qib7	760	6	1	1	CD
cord-005453-4057qib7	760	7	.	.	.
cord-005453-4057qib7	761	1	Overall	Overall	NNP
cord-005453-4057qib7	761	2	Survival	Survival	NNP
cord-005453-4057qib7	761	3	]	]	-RRB-
cord-005453-4057qib7	761	4	Disclosure	disclosure	NN
cord-005453-4057qib7	761	5	:	:	:
cord-005453-4057qib7	761	6	Nothing	nothing	NN
cord-005453-4057qib7	761	7	to	to	TO
cord-005453-4057qib7	761	8	declare	declare	VB
cord-005453-4057qib7	761	9	.	.	.
cord-005453-4057qib7	762	1	Background	background	NN
cord-005453-4057qib7	762	2	:	:	:
cord-005453-4057qib7	763	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	763	2	stem	stem	NN
cord-005453-4057qib7	763	3	cell	cell	NN
cord-005453-4057qib7	763	4	transplantation	transplantation	NN
cord-005453-4057qib7	763	5	(	(	-LRB-
cord-005453-4057qib7	763	6	HSCT	HSCT	NNP
cord-005453-4057qib7	763	7	)	)	-RRB-
cord-005453-4057qib7	763	8	is	be	VBZ
cord-005453-4057qib7	763	9	the	the	DT
cord-005453-4057qib7	763	10	only	only	JJ
cord-005453-4057qib7	763	11	curative	curative	JJ
cord-005453-4057qib7	763	12	option	option	NN
cord-005453-4057qib7	763	13	for	for	IN
cord-005453-4057qib7	763	14	Fanconi	Fanconi	NNP
cord-005453-4057qib7	763	15	anaemia	anaemia	NN
cord-005453-4057qib7	763	16	(	(	-LRB-
cord-005453-4057qib7	763	17	FA	FA	NNP
cord-005453-4057qib7	763	18	)	)	-RRB-
cord-005453-4057qib7	763	19	;	;	:
cord-005453-4057qib7	763	20	an	an	DT
cord-005453-4057qib7	763	21	inherited	inherit	VBN
cord-005453-4057qib7	763	22	disorder	disorder	NN
cord-005453-4057qib7	763	23	characterized	characterize	VBN
cord-005453-4057qib7	763	24	by	by	IN
cord-005453-4057qib7	763	25	congenital	congenital	JJ
cord-005453-4057qib7	763	26	anomalies	anomaly	NNS
cord-005453-4057qib7	763	27	,	,	,
cord-005453-4057qib7	763	28	progressive	progressive	JJ
cord-005453-4057qib7	763	29	bone	bone	NN
cord-005453-4057qib7	763	30	marrow	marrow	NN
cord-005453-4057qib7	763	31	failure	failure	NN
cord-005453-4057qib7	763	32	(	(	-LRB-
cord-005453-4057qib7	763	33	BMF	BMF	NNP
cord-005453-4057qib7	763	34	)	)	-RRB-
cord-005453-4057qib7	763	35	and	and	CC
cord-005453-4057qib7	763	36	a	a	DT
cord-005453-4057qib7	763	37	predisposition	predisposition	NN
cord-005453-4057qib7	763	38	to	to	TO
cord-005453-4057qib7	763	39	develop	develop	VB
cord-005453-4057qib7	763	40	malignancies	malignancy	NNS
cord-005453-4057qib7	763	41	.	.	.
cord-005453-4057qib7	764	1	Methods	method	NNS
cord-005453-4057qib7	765	1	:	:	:
cord-005453-4057qib7	765	2	We	-PRON-	PRP
cord-005453-4057qib7	765	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	765	4	analysed	analyse	VBD
cord-005453-4057qib7	765	5	the	the	DT
cord-005453-4057qib7	765	6	data	datum	NNS
cord-005453-4057qib7	765	7	of	of	IN
cord-005453-4057qib7	765	8	27	27	CD
cord-005453-4057qib7	765	9	consecutive	consecutive	JJ
cord-005453-4057qib7	765	10	patients	patient	NNS
cord-005453-4057qib7	765	11	that	that	WDT
cord-005453-4057qib7	765	12	underwent	undergo	VBD
cord-005453-4057qib7	765	13	HSCT	HSCT	NNP
cord-005453-4057qib7	765	14	at	at	IN
cord-005453-4057qib7	765	15	this	this	DT
cord-005453-4057qib7	765	16	centre	centre	NN
cord-005453-4057qib7	765	17	from	from	IN
cord-005453-4057qib7	765	18	2001	2001	CD
cord-005453-4057qib7	765	19	till	till	IN
cord-005453-4057qib7	765	20	June	June	NNP
cord-005453-4057qib7	765	21	2018	2018	CD
cord-005453-4057qib7	765	22	.	.	.
cord-005453-4057qib7	766	1	The	the	DT
cord-005453-4057qib7	766	2	data	datum	NNS
cord-005453-4057qib7	766	3	was	be	VBD
cord-005453-4057qib7	766	4	analysed	analyse	VBN
cord-005453-4057qib7	766	5	for	for	IN
cord-005453-4057qib7	766	6	variables	variable	NNS
cord-005453-4057qib7	766	7	affecting	affect	VBG
cord-005453-4057qib7	766	8	the	the	DT
cord-005453-4057qib7	766	9	outcome	outcome	NN
cord-005453-4057qib7	766	10	in	in	IN
cord-005453-4057qib7	766	11	terms	term	NNS
cord-005453-4057qib7	766	12	of	of	IN
cord-005453-4057qib7	766	13	overall	overall	JJ
cord-005453-4057qib7	766	14	survival	survival	NN
cord-005453-4057qib7	766	15	(	(	-LRB-
cord-005453-4057qib7	766	16	OS	OS	NNP
cord-005453-4057qib7	766	17	)	)	-RRB-
cord-005453-4057qib7	766	18	.	.	.
cord-005453-4057qib7	767	1	Results	result	NNS
cord-005453-4057qib7	767	2	:	:	:
cord-005453-4057qib7	768	1	Median	median	JJ
cord-005453-4057qib7	768	2	age	age	NN
cord-005453-4057qib7	768	3	at	at	IN
cord-005453-4057qib7	768	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	768	5	was	be	VBD
cord-005453-4057qib7	768	6	10	10	CD
cord-005453-4057qib7	768	7	years	year	NNS
cord-005453-4057qib7	768	8	(	(	-LRB-
cord-005453-4057qib7	768	9	2	2	CD
cord-005453-4057qib7	768	10	-	-	SYM
cord-005453-4057qib7	768	11	20	20	CD
cord-005453-4057qib7	768	12	years	year	NNS
cord-005453-4057qib7	768	13	)	)	-RRB-
cord-005453-4057qib7	768	14	.	.	.
cord-005453-4057qib7	769	1	Median	median	JJ
cord-005453-4057qib7	769	2	age	age	NN
cord-005453-4057qib7	769	3	at	at	IN
cord-005453-4057qib7	769	4	transplant	transplant	NN
cord-005453-4057qib7	769	5	was	be	VBD
cord-005453-4057qib7	769	6	11.3	11.3	CD
cord-005453-4057qib7	769	7	years	year	NNS
cord-005453-4057qib7	769	8	(	(	-LRB-
cord-005453-4057qib7	769	9	4	4	CD
cord-005453-4057qib7	769	10	-	-	SYM
cord-005453-4057qib7	769	11	25	25	CD
cord-005453-4057qib7	769	12	yrs	yr	NNS
cord-005453-4057qib7	769	13	)	)	-RRB-
cord-005453-4057qib7	769	14	.	.	.
cord-005453-4057qib7	770	1	All	all	DT
cord-005453-4057qib7	770	2	patients	patient	NNS
cord-005453-4057qib7	770	3	at	at	IN
cord-005453-4057qib7	770	4	transplant	transplant	NN
cord-005453-4057qib7	770	5	were	be	VBD
cord-005453-4057qib7	770	6	in	in	IN
cord-005453-4057qib7	770	7	aplastic	aplastic	NN
cord-005453-4057qib7	770	8	phase	phase	NN
cord-005453-4057qib7	770	9	.	.	.
cord-005453-4057qib7	771	1	Male	male	JJ
cord-005453-4057qib7	771	2	to	to	IN
cord-005453-4057qib7	771	3	female	female	JJ
cord-005453-4057qib7	771	4	ratio	ratio	NN
cord-005453-4057qib7	771	5	was	be	VBD
cord-005453-4057qib7	771	6	1.2:1	1.2:1	CD
cord-005453-4057qib7	771	7	.	.	.
cord-005453-4057qib7	772	1	Twenty	twenty	CD
cord-005453-4057qib7	772	2	-	-	HYPH
cord-005453-4057qib7	772	3	four	four	CD
cord-005453-4057qib7	772	4	(	(	-LRB-
cord-005453-4057qib7	772	5	88.9	88.9	CD
cord-005453-4057qib7	772	6	%	%	NN
cord-005453-4057qib7	772	7	)	)	-RRB-
cord-005453-4057qib7	772	8	patients	patient	NNS
cord-005453-4057qib7	772	9	had	have	VBD
cord-005453-4057qib7	772	10	congenital	congenital	JJ
cord-005453-4057qib7	772	11	anomalies	anomaly	NNS
cord-005453-4057qib7	772	12	along	along	IN
cord-005453-4057qib7	772	13	with	with	IN
cord-005453-4057qib7	772	14	BMF	BMF	NNP
cord-005453-4057qib7	772	15	while	while	IN
cord-005453-4057qib7	772	16	3	3	CD
cord-005453-4057qib7	772	17	were	be	VBD
cord-005453-4057qib7	772	18	phenotypically	phenotypically	RB
cord-005453-4057qib7	772	19	normal	normal	JJ
cord-005453-4057qib7	772	20	.	.	.
cord-005453-4057qib7	773	1	Twenty	twenty	CD
cord-005453-4057qib7	773	2	-	-	HYPH
cord-005453-4057qib7	773	3	three	three	CD
cord-005453-4057qib7	773	4	(	(	-LRB-
cord-005453-4057qib7	773	5	85.2	85.2	CD
cord-005453-4057qib7	773	6	%	%	NN
cord-005453-4057qib7	773	7	)	)	-RRB-
cord-005453-4057qib7	773	8	patients	patient	NNS
cord-005453-4057qib7	773	9	were	be	VBD
cord-005453-4057qib7	773	10	10/10	10/10	CD
cord-005453-4057qib7	773	11	HLA	HLA	NNP
cord-005453-4057qib7	773	12	matched	match	VBN
cord-005453-4057qib7	773	13	with	with	IN
cord-005453-4057qib7	773	14	siblings	sibling	NNS
cord-005453-4057qib7	773	15	,	,	,
cord-005453-4057qib7	773	16	2	2	CD
cord-005453-4057qib7	773	17	with	with	IN
cord-005453-4057qib7	773	18	parents	parent	NNS
cord-005453-4057qib7	773	19	and	and	CC
cord-005453-4057qib7	773	20	2	2	CD
cord-005453-4057qib7	773	21	with	with	IN
cord-005453-4057qib7	773	22	cousins	cousin	NNS
cord-005453-4057qib7	773	23	.	.	.
cord-005453-4057qib7	774	1	Eleven	eleven	CD
cord-005453-4057qib7	774	2	(	(	-LRB-
cord-005453-4057qib7	774	3	40.7	40.7	CD
cord-005453-4057qib7	774	4	%	%	NN
cord-005453-4057qib7	774	5	)	)	-RRB-
cord-005453-4057qib7	774	6	patients	patient	NNS
cord-005453-4057qib7	774	7	had	have	VBD
cord-005453-4057qib7	774	8	gender	gender	NN
cord-005453-4057qib7	774	9	mismatch	mismatch	NN
cord-005453-4057qib7	774	10	transplant	transplant	NN
cord-005453-4057qib7	774	11	.	.	.
cord-005453-4057qib7	775	1	Three	three	CD
cord-005453-4057qib7	775	2	patients	patient	NNS
cord-005453-4057qib7	775	3	had	have	VBD
cord-005453-4057qib7	775	4	major	major	JJ
cord-005453-4057qib7	775	5	and	and	CC
cord-005453-4057qib7	775	6	6	6	CD
cord-005453-4057qib7	775	7	had	have	VBD
cord-005453-4057qib7	775	8	minor	minor	JJ
cord-005453-4057qib7	775	9	ABO	ABO	NNP
cord-005453-4057qib7	775	10	mismatch	mismatch	NN
cord-005453-4057qib7	775	11	.	.	.
cord-005453-4057qib7	776	1	Background	background	NN
cord-005453-4057qib7	776	2	:	:	:
cord-005453-4057qib7	777	1	Paroxysmal	Paroxysmal	NNP
cord-005453-4057qib7	777	2	nocturnal	nocturnal	JJ
cord-005453-4057qib7	777	3	hemoglobinuria	hemoglobinuria	NN
cord-005453-4057qib7	777	4	(	(	-LRB-
cord-005453-4057qib7	777	5	PNH	PNH	NNP
cord-005453-4057qib7	777	6	)	)	-RRB-
cord-005453-4057qib7	777	7	is	be	VBZ
cord-005453-4057qib7	777	8	a	a	DT
cord-005453-4057qib7	777	9	rare	rare	JJ
cord-005453-4057qib7	777	10	clonal	clonal	JJ
cord-005453-4057qib7	777	11	non	non	JJ
cord-005453-4057qib7	777	12	-	-	JJ
cord-005453-4057qib7	777	13	neoplastic	neoplastic	JJ
cord-005453-4057qib7	777	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	777	15	stem	stem	NN
cord-005453-4057qib7	777	16	cell	cell	NN
cord-005453-4057qib7	777	17	disease	disease	NN
cord-005453-4057qib7	777	18	whose	whose	WP$
cord-005453-4057qib7	777	19	incidence	incidence	NN
cord-005453-4057qib7	777	20	is	be	VBZ
cord-005453-4057qib7	777	21	1.5	1.5	CD
cord-005453-4057qib7	777	22	-	-	SYM
cord-005453-4057qib7	777	23	2.9	2.9	CD
cord-005453-4057qib7	777	24	cases	case	NNS
cord-005453-4057qib7	777	25	/	/	SYM
cord-005453-4057qib7	777	26	million	million	CD
cord-005453-4057qib7	777	27	of	of	IN
cord-005453-4057qib7	777	28	individuals	individual	NNS
cord-005453-4057qib7	777	29	worldwide	worldwide	RB
cord-005453-4057qib7	777	30	.	.	.
cord-005453-4057qib7	778	1	Disease	disease	NN
cord-005453-4057qib7	778	2	characteristics	characteristic	NNS
cord-005453-4057qib7	778	3	and	and	CC
cord-005453-4057qib7	778	4	natural	natural	JJ
cord-005453-4057qib7	778	5	history	history	NN
cord-005453-4057qib7	778	6	have	have	VBP
cord-005453-4057qib7	778	7	been	be	VBN
cord-005453-4057qib7	778	8	mostly	mostly	RB
cord-005453-4057qib7	778	9	analyzed	analyze	VBN
cord-005453-4057qib7	778	10	by	by	IN
cord-005453-4057qib7	778	11	multicenter	multicenter	JJ
cord-005453-4057qib7	778	12	,	,	,
cord-005453-4057qib7	778	13	retrospective	retrospective	JJ
cord-005453-4057qib7	778	14	studies	study	NNS
cord-005453-4057qib7	778	15	,	,	,
cord-005453-4057qib7	778	16	with	with	IN
cord-005453-4057qib7	778	17	the	the	DT
cord-005453-4057qib7	778	18	limit	limit	NN
cord-005453-4057qib7	778	19	of	of	IN
cord-005453-4057qib7	778	20	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	778	21	approaches	approach	NNS
cord-005453-4057qib7	778	22	.	.	.
cord-005453-4057qib7	779	1	Herein	herein	RB
cord-005453-4057qib7	779	2	we	-PRON-	PRP
cord-005453-4057qib7	779	3	report	report	VBP
cord-005453-4057qib7	779	4	the	the	DT
cord-005453-4057qib7	779	5	incidence	incidence	NN
cord-005453-4057qib7	779	6	of	of	IN
cord-005453-4057qib7	779	7	severe	severe	JJ
cord-005453-4057qib7	779	8	complications	complication	NNS
cord-005453-4057qib7	779	9	and	and	CC
cord-005453-4057qib7	779	10	outcome	outcome	NN
cord-005453-4057qib7	779	11	in	in	IN
cord-005453-4057qib7	779	12	a	a	DT
cord-005453-4057qib7	779	13	real	real	JJ
cord-005453-4057qib7	779	14	life	life	NN
cord-005453-4057qib7	779	15	setting	set	VBG
cord-005453-4057qib7	779	16	scenario	scenario	NN
cord-005453-4057qib7	779	17	of	of	IN
cord-005453-4057qib7	779	18	PNH	PNH	NNP
cord-005453-4057qib7	779	19	patients	patient	NNS
cord-005453-4057qib7	779	20	consecutively	consecutively	RB
cord-005453-4057qib7	779	21	diagnosed	diagnose	VBD
cord-005453-4057qib7	779	22	and	and	CC
cord-005453-4057qib7	779	23	managed	manage	VBD
cord-005453-4057qib7	779	24	at	at	IN
cord-005453-4057qib7	779	25	our	-PRON-	PRP$
cord-005453-4057qib7	779	26	PNH	PNH	NNP
cord-005453-4057qib7	779	27	referral	referral	NN
cord-005453-4057qib7	779	28	Center	Center	NNP
cord-005453-4057qib7	779	29	between	between	IN
cord-005453-4057qib7	779	30	January	January	NNP
cord-005453-4057qib7	779	31	1985	1985	CD
cord-005453-4057qib7	779	32	and	and	CC
cord-005453-4057qib7	779	33	June	June	NNP
cord-005453-4057qib7	779	34	2018	2018	CD
cord-005453-4057qib7	779	35	.	.	.
cord-005453-4057qib7	780	1	Methods	method	NNS
cord-005453-4057qib7	780	2	:	:	:
cord-005453-4057qib7	780	3	Patients	patient	NNS
cord-005453-4057qib7	780	4	received	receive	VBD
cord-005453-4057qib7	780	5	a	a	DT
cord-005453-4057qib7	780	6	homogeneous	homogeneous	JJ
cord-005453-4057qib7	780	7	diagnostic	diagnostic	JJ
cord-005453-4057qib7	780	8	and	and	CC
cord-005453-4057qib7	780	9	treatment	treatment	NN
cord-005453-4057qib7	780	10	approach	approach	NN
cord-005453-4057qib7	780	11	according	accord	VBG
cord-005453-4057qib7	780	12	to	to	IN
cord-005453-4057qib7	780	13	the	the	DT
cord-005453-4057qib7	780	14	period	period	NN
cord-005453-4057qib7	780	15	of	of	IN
cord-005453-4057qib7	780	16	observation	observation	NN
cord-005453-4057qib7	780	17	(	(	-LRB-
cord-005453-4057qib7	780	18	availability	availability	NN
cord-005453-4057qib7	780	19	of	of	IN
cord-005453-4057qib7	780	20	diagnostic	diagnostic	JJ
cord-005453-4057qib7	780	21	tests	test	NNS
cord-005453-4057qib7	780	22	and	and	CC
cord-005453-4057qib7	780	23	eculizumab	eculizumab	NNS
cord-005453-4057qib7	780	24	)	)	-RRB-
cord-005453-4057qib7	780	25	.	.	.
cord-005453-4057qib7	781	1	All	all	DT
cord-005453-4057qib7	781	2	patients	patient	NNS
cord-005453-4057qib7	781	3	treated	treat	VBN
cord-005453-4057qib7	781	4	with	with	IN
cord-005453-4057qib7	781	5	eculizumab	eculizumab	NNS
cord-005453-4057qib7	781	6	received	receive	VBD
cord-005453-4057qib7	781	7	vaccination	vaccination	NN
cord-005453-4057qib7	781	8	with	with	IN
cord-005453-4057qib7	781	9	conjugated	conjugated	JJ
cord-005453-4057qib7	781	10	anti	anti	JJ
cord-005453-4057qib7	781	11	-	-	JJ
cord-005453-4057qib7	781	12	meningococcus	meningococcus	JJ
cord-005453-4057qib7	781	13	ACWYserotypes	acwyserotype	NNS
cord-005453-4057qib7	781	14	and	and	CC
cord-005453-4057qib7	781	15	,	,	,
cord-005453-4057qib7	781	16	since	since	IN
cord-005453-4057qib7	781	17	2016	2016	CD
cord-005453-4057qib7	781	18	,	,	,
cord-005453-4057qib7	781	19	conjugated	conjugate	VBN
cord-005453-4057qib7	781	20	anti	anti	JJ
cord-005453-4057qib7	781	21	-	-	JJ
cord-005453-4057qib7	781	22	meningococcus	meningococcus	JJ
cord-005453-4057qib7	781	23	B	b	NN
cord-005453-4057qib7	781	24	-	-	HYPH
cord-005453-4057qib7	781	25	serotype	serotype	NN
cord-005453-4057qib7	781	26	.	.	.
cord-005453-4057qib7	782	1	In	in	IN
cord-005453-4057qib7	782	2	the	the	DT
cord-005453-4057qib7	782	3	event	event	NN
cord-005453-4057qib7	782	4	of	of	IN
cord-005453-4057qib7	782	5	any	any	DT
cord-005453-4057qib7	782	6	complication	complication	NN
cord-005453-4057qib7	782	7	,	,	,
cord-005453-4057qib7	782	8	patients	patient	NNS
cord-005453-4057qib7	782	9	could	could	MD
cord-005453-4057qib7	782	10	refer	refer	VB
cord-005453-4057qib7	782	11	to	to	IN
cord-005453-4057qib7	782	12	dedicated	dedicated	JJ
cord-005453-4057qib7	782	13	Hematology	Hematology	NNP
cord-005453-4057qib7	782	14	Emergency	Emergency	NNP
cord-005453-4057qib7	782	15	Rooms	room	NNS
cord-005453-4057qib7	782	16	(	(	-LRB-
cord-005453-4057qib7	782	17	ER	ER	NNP
cord-005453-4057qib7	782	18	)	)	-RRB-
cord-005453-4057qib7	782	19	24	24	CD
cord-005453-4057qib7	782	20	hours	hour	NNS
cord-005453-4057qib7	782	21	daily	daily	RB
cord-005453-4057qib7	782	22	.	.	.
cord-005453-4057qib7	783	1	The	the	DT
cord-005453-4057qib7	783	2	occurrence	occurrence	NN
cord-005453-4057qib7	783	3	of	of	IN
cord-005453-4057qib7	783	4	renal	renal	JJ
cord-005453-4057qib7	783	5	failure	failure	NN
cord-005453-4057qib7	783	6	and	and	CC
cord-005453-4057qib7	783	7	pulmonary	pulmonary	JJ
cord-005453-4057qib7	783	8	hypertension	hypertension	NN
cord-005453-4057qib7	783	9	was	be	VBD
cord-005453-4057qib7	783	10	specifically	specifically	RB
cord-005453-4057qib7	783	11	evaluated	evaluate	VBN
cord-005453-4057qib7	783	12	.	.	.
cord-005453-4057qib7	784	1	The	the	DT
cord-005453-4057qib7	784	2	renal	renal	JJ
cord-005453-4057qib7	784	3	function	function	NN
cord-005453-4057qib7	784	4	was	be	VBD
cord-005453-4057qib7	784	5	studied	study	VBN
cord-005453-4057qib7	784	6	according	accord	VBG
cord-005453-4057qib7	784	7	to	to	IN
cord-005453-4057qib7	784	8	the	the	DT
cord-005453-4057qib7	784	9	Cockcroft	Cockcroft	NNP
cord-005453-4057qib7	784	10	-	-	HYPH
cord-005453-4057qib7	784	11	Gault	Gault	NNP
cord-005453-4057qib7	784	12	formula	formula	NN
cord-005453-4057qib7	784	13	and	and	CC
cord-005453-4057qib7	784	14	the	the	DT
cord-005453-4057qib7	784	15	lung	lung	NN
cord-005453-4057qib7	784	16	function	function	NN
cord-005453-4057qib7	784	17	was	be	VBD
cord-005453-4057qib7	784	18	prospectively	prospectively	RB
cord-005453-4057qib7	784	19	monitored	monitor	VBN
cord-005453-4057qib7	784	20	by	by	IN
cord-005453-4057qib7	784	21	daytime	daytime	NN
cord-005453-4057qib7	784	22	-	-	HYPH
cord-005453-4057qib7	784	23	on	on	RP
cord-005453-4057qib7	784	24	exertion	exertion	NN
cord-005453-4057qib7	784	25	,	,	,
cord-005453-4057qib7	784	26	nocturnal	nocturnal	JJ
cord-005453-4057qib7	784	27	pulsoximetric	pulsoximetric	JJ
cord-005453-4057qib7	784	28	profiles	profile	NNS
cord-005453-4057qib7	784	29	and	and	CC
cord-005453-4057qib7	784	30	complete	complete	VB
cord-005453-4057qib7	784	31	spirometric	spirometric	JJ
cord-005453-4057qib7	784	32	tests	test	NNS
cord-005453-4057qib7	784	33	,	,	,
cord-005453-4057qib7	784	34	with	with	IN
cord-005453-4057qib7	784	35	DLCO	DLCO	NNP
cord-005453-4057qib7	784	36	measurement	measurement	NN
cord-005453-4057qib7	784	37	.	.	.
cord-005453-4057qib7	785	1	Results	result	NNS
cord-005453-4057qib7	785	2	:	:	:
cord-005453-4057qib7	786	1	Overall,48	Overall,48	NNP
cord-005453-4057qib7	786	2	PNH	PNH	NNP
cord-005453-4057qib7	786	3	patients	patient	NNS
cord-005453-4057qib7	786	4	,	,	,
cord-005453-4057qib7	786	5	median	median	JJ
cord-005453-4057qib7	786	6	age	age	NN
cord-005453-4057qib7	786	7	36	36	CD
cord-005453-4057qib7	786	8	years	year	NNS
cord-005453-4057qib7	787	1	(	(	-LRB-
cord-005453-4057qib7	787	2	range	range	NNP
cord-005453-4057qib7	787	3	17	17	CD
cord-005453-4057qib7	787	4	-	-	SYM
cord-005453-4057qib7	787	5	84	84	CD
cord-005453-4057qib7	787	6	)	)	-RRB-
cord-005453-4057qib7	787	7	,	,	,
cord-005453-4057qib7	787	8	were	be	VBD
cord-005453-4057qib7	787	9	analyzed	analyze	VBN
cord-005453-4057qib7	787	10	.	.	.
cord-005453-4057qib7	788	1	At	at	IN
cord-005453-4057qib7	788	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	788	3	,	,	,
cord-005453-4057qib7	788	4	26	26	CD
cord-005453-4057qib7	788	5	patients	patient	NNS
cord-005453-4057qib7	788	6	had	have	VBD
cord-005453-4057qib7	788	7	classic	classic	JJ
cord-005453-4057qib7	788	8	PNH	PNH	NNP
cord-005453-4057qib7	788	9	,	,	,
cord-005453-4057qib7	788	10	19	19	CD
cord-005453-4057qib7	788	11	aplastic	aplastic	NN
cord-005453-4057qib7	788	12	PNH	PNH	NNP
cord-005453-4057qib7	788	13	and	and	CC
cord-005453-4057qib7	788	14	3	3	CD
cord-005453-4057qib7	788	15	an	an	DT
cord-005453-4057qib7	788	16	intermediate	intermediate	JJ
cord-005453-4057qib7	788	17	form	form	NN
cord-005453-4057qib7	788	18	.	.	.
cord-005453-4057qib7	789	1	The	the	DT
cord-005453-4057qib7	789	2	cumulative	cumulative	JJ
cord-005453-4057qib7	789	3	incidences	incidence	NNS
cord-005453-4057qib7	789	4	(	(	-LRB-
cord-005453-4057qib7	789	5	CI	CI	NNP
cord-005453-4057qib7	789	6	)	)	-RRB-
cord-005453-4057qib7	789	7	of	of	IN
cord-005453-4057qib7	789	8	thrombosis	thrombosis	NN
cord-005453-4057qib7	789	9	,	,	,
cord-005453-4057qib7	789	10	and	and	CC
cord-005453-4057qib7	789	11	clonal	clonal	JJ
cord-005453-4057qib7	789	12	hematologic	hematologic	JJ
cord-005453-4057qib7	789	13	neoplasm	neoplasm	NN
cord-005453-4057qib7	789	14	were	be	VBD
cord-005453-4057qib7	789	15	29	29	CD
cord-005453-4057qib7	789	16	%	%	NN
cord-005453-4057qib7	789	17	,	,	,
cord-005453-4057qib7	789	18	and	and	CC
cord-005453-4057qib7	789	19	6	6	CD
cord-005453-4057qib7	789	20	%	%	NN
cord-005453-4057qib7	789	21	,	,	,
cord-005453-4057qib7	789	22	respectively	respectively	RB
cord-005453-4057qib7	789	23	.	.	.
cord-005453-4057qib7	790	1	CI	CI	NNP
cord-005453-4057qib7	790	2	of	of	IN
cord-005453-4057qib7	790	3	pancytopenia	pancytopenia	NNP
cord-005453-4057qib7	790	4	in	in	IN
cord-005453-4057qib7	790	5	the	the	DT
cord-005453-4057qib7	790	6	26	26	CD
cord-005453-4057qib7	790	7	patients	patient	NNS
cord-005453-4057qib7	790	8	with	with	IN
cord-005453-4057qib7	790	9	classic	classic	JJ
cord-005453-4057qib7	790	10	PNH	PNH	NNP
cord-005453-4057qib7	790	11	was	be	VBD
cord-005453-4057qib7	790	12	23	23	CD
cord-005453-4057qib7	790	13	%	%	NN
cord-005453-4057qib7	790	14	.	.	.
cord-005453-4057qib7	791	1	One	one	CD
cord-005453-4057qib7	791	2	patient	patient	NN
cord-005453-4057qib7	791	3	showed	show	VBD
cord-005453-4057qib7	791	4	a	a	DT
cord-005453-4057qib7	791	5	spontaneous	spontaneous	JJ
cord-005453-4057qib7	791	6	disappearance	disappearance	NN
cord-005453-4057qib7	791	7	of	of	IN
cord-005453-4057qib7	791	8	the	the	DT
cord-005453-4057qib7	791	9	PNH	PNH	NNP
cord-005453-4057qib7	791	10	clone	clone	NN
cord-005453-4057qib7	791	11	.	.	.
cord-005453-4057qib7	792	1	Since	since	IN
cord-005453-4057qib7	792	2	2005	2005	CD
cord-005453-4057qib7	792	3	,	,	,
cord-005453-4057qib7	792	4	eculizumab	eculizumab	NNP
cord-005453-4057qib7	792	5	was	be	VBD
cord-005453-4057qib7	792	6	administered	administer	VBN
cord-005453-4057qib7	792	7	in	in	IN
cord-005453-4057qib7	792	8	28	28	CD
cord-005453-4057qib7	792	9	patients	patient	NNS
cord-005453-4057qib7	792	10	.	.	.
cord-005453-4057qib7	793	1	After	after	IN
cord-005453-4057qib7	793	2	eculizumab	eculizumab	NNP
cord-005453-4057qib7	793	3	treatment	treatment	NN
cord-005453-4057qib7	793	4	50	50	CD
cord-005453-4057qib7	793	5	%	%	NN
cord-005453-4057qib7	793	6	and	and	CC
cord-005453-4057qib7	793	7	32	32	CD
cord-005453-4057qib7	793	8	%	%	NN
cord-005453-4057qib7	793	9	of	of	IN
cord-005453-4057qib7	793	10	patients	patient	NNS
cord-005453-4057qib7	793	11	reached	reach	VBD
cord-005453-4057qib7	793	12	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	793	13	level	level	NN
cord-005453-4057qib7	793	14	>	>	XX
cord-005453-4057qib7	793	15	11g	11g	CD
cord-005453-4057qib7	793	16	/	/	SYM
cord-005453-4057qib7	793	17	dL	dl	NN
cord-005453-4057qib7	793	18	and	and	CC
cord-005453-4057qib7	793	19	>	>	XX
cord-005453-4057qib7	794	1	8	8	CD
cord-005453-4057qib7	794	2	<	<	XX
cord-005453-4057qib7	794	3	11g/	11g/	CD
cord-005453-4057qib7	794	4	dL	dl	NN
cord-005453-4057qib7	794	5	without	without	IN
cord-005453-4057qib7	794	6	transfusion	transfusion	NN
cord-005453-4057qib7	794	7	,	,	,
cord-005453-4057qib7	794	8	respectively	respectively	RB
cord-005453-4057qib7	794	9	,	,	,
cord-005453-4057qib7	794	10	while	while	IN
cord-005453-4057qib7	794	11	18	18	CD
cord-005453-4057qib7	794	12	%	%	NN
cord-005453-4057qib7	794	13	were	be	VBD
cord-005453-4057qib7	794	14	nonresponsive	nonresponsive	JJ
cord-005453-4057qib7	794	15	.	.	.
cord-005453-4057qib7	795	1	During	during	IN
cord-005453-4057qib7	795	2	eculizumab	eculizumab	NNS
cord-005453-4057qib7	795	3	treatment	treatment	NN
cord-005453-4057qib7	795	4	no	no	DT
cord-005453-4057qib7	795	5	thrombotic	thrombotic	JJ
cord-005453-4057qib7	795	6	event	event	NN
cord-005453-4057qib7	795	7	was	be	VBD
cord-005453-4057qib7	795	8	observed	observe	VBN
cord-005453-4057qib7	795	9	while	while	IN
cord-005453-4057qib7	795	10	two	two	CD
cord-005453-4057qib7	795	11	severe	severe	JJ
cord-005453-4057qib7	795	12	infectious	infectious	JJ
cord-005453-4057qib7	795	13	episodes	episode	NNS
cord-005453-4057qib7	795	14	(	(	-LRB-
cord-005453-4057qib7	795	15	respiratory	respiratory	JJ
cord-005453-4057qib7	795	16	tract	tract	NN
cord-005453-4057qib7	795	17	and	and	CC
cord-005453-4057qib7	795	18	urinary	urinary	JJ
cord-005453-4057qib7	795	19	tract	tract	NN
cord-005453-4057qib7	795	20	infection	infection	NN
cord-005453-4057qib7	795	21	)	)	-RRB-
cord-005453-4057qib7	795	22	were	be	VBD
cord-005453-4057qib7	795	23	observed	observe	VBN
cord-005453-4057qib7	795	24	in	in	IN
cord-005453-4057qib7	795	25	only	only	RB
cord-005453-4057qib7	795	26	one	one	CD
cord-005453-4057qib7	795	27	of	of	IN
cord-005453-4057qib7	795	28	the	the	DT
cord-005453-4057qib7	795	29	28	28	CD
cord-005453-4057qib7	795	30	patients	patient	NNS
cord-005453-4057qib7	795	31	.	.	.
cord-005453-4057qib7	796	1	Extravascular	extravascular	JJ
cord-005453-4057qib7	796	2	hemolysis	hemolysis	NN
cord-005453-4057qib7	796	3	was	be	VBD
cord-005453-4057qib7	796	4	demonstrated	demonstrate	VBN
cord-005453-4057qib7	796	5	in	in	IN
cord-005453-4057qib7	796	6	50	50	CD
cord-005453-4057qib7	796	7	%	%	NN
cord-005453-4057qib7	796	8	of	of	IN
cord-005453-4057qib7	796	9	patients	patient	NNS
cord-005453-4057qib7	796	10	.	.	.
cord-005453-4057qib7	797	1	No	no	DT
cord-005453-4057qib7	797	2	patient	patient	NN
cord-005453-4057qib7	797	3	showed	show	VBD
cord-005453-4057qib7	797	4	a	a	DT
cord-005453-4057qib7	797	5	significant	significant	JJ
cord-005453-4057qib7	797	6	reduction	reduction	NN
cord-005453-4057qib7	797	7	of	of	IN
cord-005453-4057qib7	797	8	the	the	DT
cord-005453-4057qib7	797	9	renal	renal	JJ
cord-005453-4057qib7	797	10	function	function	NN
cord-005453-4057qib7	797	11	.	.	.
cord-005453-4057qib7	798	1	Out	out	IN
cord-005453-4057qib7	798	2	of	of	IN
cord-005453-4057qib7	798	3	24	24	CD
cord-005453-4057qib7	798	4	patients	patient	NNS
cord-005453-4057qib7	798	5	prospectively	prospectively	RB
cord-005453-4057qib7	798	6	monitored	monitor	VBN
cord-005453-4057qib7	798	7	for	for	IN
cord-005453-4057qib7	798	8	lung	lung	NN
cord-005453-4057qib7	798	9	function	function	NN
cord-005453-4057qib7	798	10	no	no	DT
cord-005453-4057qib7	798	11	pathological	pathological	JJ
cord-005453-4057qib7	798	12	alteration	alteration	NN
cord-005453-4057qib7	798	13	in	in	IN
cord-005453-4057qib7	798	14	any	any	DT
cord-005453-4057qib7	798	15	diurnal	diurnal	JJ
cord-005453-4057qib7	798	16	or	or	CC
cord-005453-4057qib7	798	17	nocturnal	nocturnal	JJ
cord-005453-4057qib7	798	18	pulseoximetric	pulseoximetric	NN
cord-005453-4057qib7	798	19	test	test	NN
cord-005453-4057qib7	798	20	was	be	VBD
cord-005453-4057qib7	798	21	observed	observe	VBN
cord-005453-4057qib7	798	22	.	.	.
cord-005453-4057qib7	799	1	No	no	DT
cord-005453-4057qib7	799	2	patient	patient	NN
cord-005453-4057qib7	799	3	showed	show	VBD
cord-005453-4057qib7	799	4	obstructive	obstructive	JJ
cord-005453-4057qib7	799	5	or	or	CC
cord-005453-4057qib7	799	6	restrictive	restrictive	JJ
cord-005453-4057qib7	799	7	ventilatory	ventilatory	JJ
cord-005453-4057qib7	799	8	deficiency	deficiency	NN
cord-005453-4057qib7	799	9	,	,	,
cord-005453-4057qib7	799	10	nor	nor	CC
cord-005453-4057qib7	799	11	reduced	reduce	VBN
cord-005453-4057qib7	799	12	DLCO	DLCO	NNP
cord-005453-4057qib7	799	13	values	value	NNS
cord-005453-4057qib7	799	14	.	.	.
cord-005453-4057qib7	800	1	30-years	30-years	CD
cord-005453-4057qib7	800	2	overall	overall	JJ
cord-005453-4057qib7	800	3	survival	survival	NN
cord-005453-4057qib7	800	4	(	(	-LRB-
cord-005453-4057qib7	800	5	OS	OS	NNP
cord-005453-4057qib7	800	6	)	)	-RRB-
cord-005453-4057qib7	800	7	was	be	VBD
cord-005453-4057qib7	800	8	90	90	CD
cord-005453-4057qib7	800	9	%	%	NN
cord-005453-4057qib7	800	10	(	(	-LRB-
cord-005453-4057qib7	800	11	4	4	CD
cord-005453-4057qib7	800	12	patients	patient	NNS
cord-005453-4057qib7	800	13	who	who	WP
cord-005453-4057qib7	800	14	died	die	VBD
cord-005453-4057qib7	800	15	for	for	IN
cord-005453-4057qib7	800	16	non	non	JJ
cord-005453-4057qib7	800	17	-	-	JJ
cord-005453-4057qib7	800	18	PNH	PNH	NNP
cord-005453-4057qib7	800	19	related	related	JJ
cord-005453-4057qib7	800	20	reasons	reason	NNS
cord-005453-4057qib7	800	21	were	be	VBD
cord-005453-4057qib7	800	22	censored	censor	VBN
cord-005453-4057qib7	800	23	at	at	IN
cord-005453-4057qib7	800	24	the	the	DT
cord-005453-4057qib7	800	25	last	last	JJ
cord-005453-4057qib7	800	26	follow	follow	NN
cord-005453-4057qib7	800	27	-	-	HYPH
cord-005453-4057qib7	800	28	up).A	up).a	NN
cord-005453-4057qib7	800	29	better	well	JJR
cord-005453-4057qib7	800	30	OS	OS	NNP
cord-005453-4057qib7	800	31	,	,	,
cord-005453-4057qib7	800	32	even	even	RB
cord-005453-4057qib7	800	33	if	if	IN
cord-005453-4057qib7	800	34	not	not	RB
cord-005453-4057qib7	800	35	statistically	statistically	RB
cord-005453-4057qib7	800	36	significant	significant	JJ
cord-005453-4057qib7	800	37	,	,	,
cord-005453-4057qib7	800	38	was	be	VBD
cord-005453-4057qib7	800	39	associated	associate	VBN
cord-005453-4057qib7	800	40	to	to	IN
cord-005453-4057qib7	800	41	the	the	DT
cord-005453-4057qib7	800	42	absence	absence	NN
cord-005453-4057qib7	800	43	of	of	IN
cord-005453-4057qib7	800	44	thrombotic	thrombotic	JJ
cord-005453-4057qib7	800	45	events	event	NNS
cord-005453-4057qib7	800	46	(	(	-LRB-
cord-005453-4057qib7	800	47	90%vs70	90%vs70	CD
cord-005453-4057qib7	800	48	%	%	NN
cord-005453-4057qib7	800	49	)	)	-RRB-
cord-005453-4057qib7	800	50	,	,	,
cord-005453-4057qib7	800	51	and	and	CC
cord-005453-4057qib7	800	52	the	the	DT
cord-005453-4057qib7	800	53	period	period	NN
cord-005453-4057qib7	800	54	of	of	IN
cord-005453-4057qib7	800	55	diagnosis	diagnosis	NN
cord-005453-4057qib7	800	56	(	(	-LRB-
cord-005453-4057qib7	800	57	100	100	CD
cord-005453-4057qib7	800	58	%	%	NN
cord-005453-4057qib7	800	59	in	in	IN
cord-005453-4057qib7	800	60	2006	2006	CD
cord-005453-4057qib7	800	61	-	-	SYM
cord-005453-4057qib7	800	62	2018	2018	CD
cord-005453-4057qib7	800	63	,	,	,
cord-005453-4057qib7	800	64	91	91	CD
cord-005453-4057qib7	800	65	%	%	NN
cord-005453-4057qib7	800	66	in	in	IN
cord-005453-4057qib7	800	67	1996	1996	CD
cord-005453-4057qib7	800	68	-	-	SYM
cord-005453-4057qib7	800	69	2005	2005	CD
cord-005453-4057qib7	800	70	,	,	,
cord-005453-4057qib7	800	71	75	75	CD
cord-005453-4057qib7	800	72	%	%	NN
cord-005453-4057qib7	800	73	in	in	IN
cord-005453-4057qib7	800	74	1985	1985	CD
cord-005453-4057qib7	800	75	-	-	SYM
cord-005453-4057qib7	800	76	1995	1995	CD
cord-005453-4057qib7	800	77	)	)	-RRB-
cord-005453-4057qib7	800	78	.	.	.
cord-005453-4057qib7	801	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	801	2	:	:	:
cord-005453-4057qib7	802	1	Our	-PRON-	PRP$
cord-005453-4057qib7	802	2	study	study	NN
cord-005453-4057qib7	802	3	reports	report	VBZ
cord-005453-4057qib7	802	4	a	a	DT
cord-005453-4057qib7	802	5	better	well	JJR
cord-005453-4057qib7	802	6	OS	os	NN
cord-005453-4057qib7	802	7	and	and	CC
cord-005453-4057qib7	802	8	lower	low	JJR
cord-005453-4057qib7	802	9	rate	rate	NN
cord-005453-4057qib7	802	10	of	of	IN
cord-005453-4057qib7	802	11	severe	severe	JJ
cord-005453-4057qib7	802	12	complications	complication	NNS
cord-005453-4057qib7	802	13	in	in	IN
cord-005453-4057qib7	802	14	PNH	PNH	NNP
cord-005453-4057qib7	802	15	compared	compare	VBN
cord-005453-4057qib7	802	16	to	to	IN
cord-005453-4057qib7	802	17	previous	previous	JJ
cord-005453-4057qib7	802	18	experiences	experience	NNS
cord-005453-4057qib7	802	19	.	.	.
cord-005453-4057qib7	803	1	Although	although	IN
cord-005453-4057qib7	803	2	renal	renal	JJ
cord-005453-4057qib7	803	3	failure	failure	NN
cord-005453-4057qib7	803	4	and	and	CC
cord-005453-4057qib7	803	5	lung	lung	NN
cord-005453-4057qib7	803	6	hypertension	hypertension	NN
cord-005453-4057qib7	803	7	have	have	VBP
cord-005453-4057qib7	803	8	been	be	VBN
cord-005453-4057qib7	803	9	reported	report	VBN
cord-005453-4057qib7	803	10	by	by	IN
cord-005453-4057qib7	803	11	other	other	JJ
cord-005453-4057qib7	803	12	groups	group	NNS
cord-005453-4057qib7	803	13	,	,	,
cord-005453-4057qib7	803	14	we	-PRON-	PRP
cord-005453-4057qib7	803	15	did	do	VBD
cord-005453-4057qib7	803	16	not	not	RB
cord-005453-4057qib7	803	17	observe	observe	VB
cord-005453-4057qib7	803	18	these	these	DT
cord-005453-4057qib7	803	19	complications	complication	NNS
cord-005453-4057qib7	803	20	along	along	IN
cord-005453-4057qib7	803	21	a	a	DT
cord-005453-4057qib7	803	22	prolonged	prolong	VBN
cord-005453-4057qib7	803	23	follow	follow	NN
cord-005453-4057qib7	803	24	-	-	HYPH
cord-005453-4057qib7	803	25	up	up	NN
cord-005453-4057qib7	803	26	.	.	.
cord-005453-4057qib7	804	1	We	-PRON-	PRP
cord-005453-4057qib7	804	2	can	can	MD
cord-005453-4057qib7	804	3	assume	assume	VB
cord-005453-4057qib7	804	4	that	that	IN
cord-005453-4057qib7	804	5	the	the	DT
cord-005453-4057qib7	804	6	availability	availability	NN
cord-005453-4057qib7	804	7	of	of	IN
cord-005453-4057qib7	804	8	a	a	DT
cord-005453-4057qib7	804	9	dedicated	dedicated	JJ
cord-005453-4057qib7	804	10	ER	ER	NNP
cord-005453-4057qib7	804	11	service	service	NN
cord-005453-4057qib7	804	12	enabled	enable	VBD
cord-005453-4057qib7	804	13	an	an	DT
cord-005453-4057qib7	804	14	early	early	JJ
cord-005453-4057qib7	804	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	804	16	and	and	CC
cord-005453-4057qib7	804	17	prompt	prompt	JJ
cord-005453-4057qib7	804	18	treatment	treatment	NN
cord-005453-4057qib7	804	19	in	in	IN
cord-005453-4057qib7	804	20	case	case	NN
cord-005453-4057qib7	804	21	of	of	IN
cord-005453-4057qib7	804	22	hemoglobinuria	hemoglobinuria	NNP
cord-005453-4057qib7	804	23	crises	crisis	NNS
cord-005453-4057qib7	804	24	(	(	-LRB-
cord-005453-4057qib7	804	25	reducing	reduce	VBG
cord-005453-4057qib7	804	26	the	the	DT
cord-005453-4057qib7	804	27	risk	risk	NN
cord-005453-4057qib7	804	28	or	or	CC
cord-005453-4057qib7	804	29	organ	organ	NN
cord-005453-4057qib7	804	30	damage	damage	NN
cord-005453-4057qib7	804	31	)	)	-RRB-
cord-005453-4057qib7	804	32	or	or	CC
cord-005453-4057qib7	804	33	other	other	JJ
cord-005453-4057qib7	804	34	complications	complication	NNS
cord-005453-4057qib7	804	35	.	.	.
cord-005453-4057qib7	805	1	The	the	DT
cord-005453-4057qib7	805	2	use	use	NN
cord-005453-4057qib7	805	3	of	of	IN
cord-005453-4057qib7	805	4	eculizumab	eculizumab	NNS
cord-005453-4057qib7	805	5	,	,	,
cord-005453-4057qib7	805	6	together	together	RB
cord-005453-4057qib7	805	7	with	with	IN
cord-005453-4057qib7	805	8	improved	improved	JJ
cord-005453-4057qib7	805	9	supportive	supportive	JJ
cord-005453-4057qib7	805	10	approaches	approach	NNS
cord-005453-4057qib7	805	11	,	,	,
cord-005453-4057qib7	805	12	presumably	presumably	RB
cord-005453-4057qib7	805	13	accounts	account	VBZ
cord-005453-4057qib7	805	14	for	for	IN
cord-005453-4057qib7	805	15	the	the	DT
cord-005453-4057qib7	805	16	trend	trend	NN
cord-005453-4057qib7	805	17	towards	towards	IN
cord-005453-4057qib7	805	18	a	a	DT
cord-005453-4057qib7	805	19	better	well	JJR
cord-005453-4057qib7	805	20	survival	survival	NN
cord-005453-4057qib7	805	21	witnessed	witness	VBN
cord-005453-4057qib7	805	22	over	over	IN
cord-005453-4057qib7	805	23	the	the	DT
cord-005453-4057qib7	805	24	last	last	JJ
cord-005453-4057qib7	805	25	decade	decade	NN
cord-005453-4057qib7	805	26	in	in	IN
cord-005453-4057qib7	805	27	the	the	DT
cord-005453-4057qib7	805	28	management	management	NN
cord-005453-4057qib7	805	29	of	of	IN
cord-005453-4057qib7	805	30	PNH	PNH	NNP
cord-005453-4057qib7	805	31	patients	patient	NNS
cord-005453-4057qib7	805	32	.	.	.
cord-005453-4057qib7	806	1	Disclosure	disclosure	NN
cord-005453-4057qib7	806	2	:	:	:
cord-005453-4057qib7	806	3	Nothing	nothing	NN
cord-005453-4057qib7	806	4	to	to	TO
cord-005453-4057qib7	806	5	declare	declare	VB
cord-005453-4057qib7	806	6	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	806	7	and	and	CC
cord-005453-4057qib7	806	8	unrelated	unrelated	JJ
cord-005453-4057qib7	806	9	allogeneic	allogeneic	IN
cord-005453-4057qib7	806	10	stem	stem	NN
cord-005453-4057qib7	806	11	cell	cell	NN
cord-005453-4057qib7	806	12	transplantation	transplantation	NN
cord-005453-4057qib7	806	13	in	in	IN
cord-005453-4057qib7	806	14	aplastic	aplastic	JJ
cord-005453-4057qib7	806	15	anemia	anemia	NN
cord-005453-4057qib7	806	16	:	:	:
cord-005453-4057qib7	806	17	Single	single	JJ
cord-005453-4057qib7	806	18	center	center	NN
cord-005453-4057qib7	806	19	experience	experience	NN
cord-005453-4057qib7	806	20	Zafer	Zafer	NNP
cord-005453-4057qib7	806	21	Gulbas	Gulbas	NNP
cord-005453-4057qib7	806	22	1	1	CD
cord-005453-4057qib7	806	23	,	,	,
cord-005453-4057qib7	806	24	Elif	Elif	NNP
cord-005453-4057qib7	806	25	Birtas	Birtas	NNP
cord-005453-4057qib7	806	26	Atesoglu	Atesoglu	NNP
cord-005453-4057qib7	806	27	1	1	CD
cord-005453-4057qib7	806	28	,	,	,
cord-005453-4057qib7	806	29	Meral	Meral	NNP
cord-005453-4057qib7	806	30	Sengezer	Sengezer	NNP
cord-005453-4057qib7	806	31	1	1	CD
cord-005453-4057qib7	806	32	,	,	,
cord-005453-4057qib7	806	33	İmran	İmran	NNP
cord-005453-4057qib7	806	34	Dora	Dora	NNP
cord-005453-4057qib7	806	35	1	1	CD
cord-005453-4057qib7	806	36	,	,	,
cord-005453-4057qib7	806	37	Cigdem	Cigdem	NNP
cord-005453-4057qib7	806	38	Eren	Eren	NNP
cord-005453-4057qib7	806	39	1	1	CD
cord-005453-4057qib7	806	40	,	,	,
cord-005453-4057qib7	806	41	Suat	Suat	NNP
cord-005453-4057qib7	806	42	Celik	Celik	NNP
cord-005453-4057qib7	806	43	1	1	CD
cord-005453-4057qib7	806	44	,	,	,
cord-005453-4057qib7	806	45	Demet	Demet	NNP
cord-005453-4057qib7	806	46	Cekdemir	Cekdemir	NNP
cord-005453-4057qib7	806	47	1	1	CD
cord-005453-4057qib7	806	48	Background	Background	NNP
cord-005453-4057qib7	806	49	:	:	:
cord-005453-4057qib7	807	1	Aplastic	aplastic	JJ
cord-005453-4057qib7	807	2	anemia	anemia	NN
cord-005453-4057qib7	807	3	is	be	VBZ
cord-005453-4057qib7	807	4	a	a	DT
cord-005453-4057qib7	807	5	syndrome	syndrome	NN
cord-005453-4057qib7	807	6	of	of	IN
cord-005453-4057qib7	807	7	bone	bone	NN
cord-005453-4057qib7	807	8	marrow	marrow	NN
cord-005453-4057qib7	807	9	failure	failure	NN
cord-005453-4057qib7	807	10	characterized	characterize	VBN
cord-005453-4057qib7	807	11	by	by	IN
cord-005453-4057qib7	807	12	peripheral	peripheral	JJ
cord-005453-4057qib7	807	13	pancytopenia	pancytopenia	NNS
cord-005453-4057qib7	807	14	and	and	CC
cord-005453-4057qib7	807	15	marrow	marrow	NN
cord-005453-4057qib7	807	16	hypoplasia	hypoplasia	NN
cord-005453-4057qib7	807	17	.	.	.
cord-005453-4057qib7	808	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	808	2	stem	stem	VBP
cord-005453-4057qib7	808	3	cell	cell	NN
cord-005453-4057qib7	808	4	transplantation	transplantation	NN
cord-005453-4057qib7	808	5	from	from	IN
cord-005453-4057qib7	808	6	HLAmatched	hlamatched	JJ
cord-005453-4057qib7	808	7	sibling	sibling	NN
cord-005453-4057qib7	808	8	is	be	VBZ
cord-005453-4057qib7	808	9	performed	perform	VBN
cord-005453-4057qib7	808	10	in	in	IN
cord-005453-4057qib7	808	11	the	the	DT
cord-005453-4057qib7	808	12	firstline	firstline	NN
cord-005453-4057qib7	808	13	setting	set	VBG
cord-005453-4057qib7	808	14	in	in	IN
cord-005453-4057qib7	808	15	young	young	JJ
cord-005453-4057qib7	808	16	aplastic	aplastic	JJ
cord-005453-4057qib7	808	17	anemia	anemia	NN
cord-005453-4057qib7	808	18	patients	patient	NNS
cord-005453-4057qib7	808	19	and	and	CC
cord-005453-4057qib7	808	20	in	in	IN
cord-005453-4057qib7	808	21	elderly	elderly	JJ
cord-005453-4057qib7	808	22	patients	patient	NNS
cord-005453-4057qib7	808	23	who	who	WP
cord-005453-4057qib7	808	24	are	be	VBP
cord-005453-4057qib7	808	25	refractory	refractory	JJ
cord-005453-4057qib7	808	26	to	to	IN
cord-005453-4057qib7	808	27	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	808	28	treatment	treatment	NN
cord-005453-4057qib7	808	29	.	.	.
cord-005453-4057qib7	809	1	But	but	CC
cord-005453-4057qib7	809	2	if	if	IN
cord-005453-4057qib7	809	3	the	the	DT
cord-005453-4057qib7	809	4	patient	patient	NN
cord-005453-4057qib7	809	5	does	do	VBZ
cord-005453-4057qib7	809	6	not	not	RB
cord-005453-4057qib7	809	7	have	have	VB
cord-005453-4057qib7	809	8	a	a	DT
cord-005453-4057qib7	809	9	HLA	HLA	NNP
cord-005453-4057qib7	809	10	-	-	HYPH
cord-005453-4057qib7	809	11	matched	match	VBN
cord-005453-4057qib7	809	12	sibling	sibling	NN
cord-005453-4057qib7	809	13	,	,	,
cord-005453-4057qib7	809	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	809	15	stem	stem	NN
cord-005453-4057qib7	809	16	cell	cell	NN
cord-005453-4057qib7	809	17	transplantation	transplantation	NN
cord-005453-4057qib7	809	18	is	be	VBZ
cord-005453-4057qib7	809	19	performed	perform	VBN
cord-005453-4057qib7	809	20	from	from	IN
cord-005453-4057qib7	809	21	unrelated	unrelated	JJ
cord-005453-4057qib7	809	22	and	and	CC
cord-005453-4057qib7	809	23	haploidentical	haploidentical	JJ
cord-005453-4057qib7	809	24	donors	donor	NNS
cord-005453-4057qib7	809	25	.	.	.
cord-005453-4057qib7	810	1	In	in	IN
cord-005453-4057qib7	810	2	this	this	DT
cord-005453-4057qib7	810	3	study	study	NN
cord-005453-4057qib7	810	4	,	,	,
cord-005453-4057qib7	810	5	we	-PRON-	PRP
cord-005453-4057qib7	810	6	analyzaed	analyzaed	VBP
cord-005453-4057qib7	810	7	and	and	CC
cord-005453-4057qib7	810	8	compared	compare	VBD
cord-005453-4057qib7	810	9	the	the	DT
cord-005453-4057qib7	810	10	results	result	NNS
cord-005453-4057qib7	810	11	of	of	IN
cord-005453-4057qib7	810	12	aplastic	aplastic	JJ
cord-005453-4057qib7	810	13	anemia	anemia	NN
cord-005453-4057qib7	810	14	patients	patient	NNS
cord-005453-4057qib7	810	15	who	who	WP
cord-005453-4057qib7	810	16	had	have	VBD
cord-005453-4057qib7	810	17	undergone	undergo	VBN
cord-005453-4057qib7	810	18	allogeneic	allogeneic	IN
cord-005453-4057qib7	810	19	stem	stem	NN
cord-005453-4057qib7	810	20	cell	cell	NN
cord-005453-4057qib7	810	21	transplantation	transplantation	NN
cord-005453-4057qib7	810	22	either	either	CC
cord-005453-4057qib7	810	23	from	from	IN
cord-005453-4057qib7	810	24	matched	match	VBN
cord-005453-4057qib7	810	25	unrelated	unrelated	JJ
cord-005453-4057qib7	810	26	or	or	CC
cord-005453-4057qib7	810	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	810	28	donors	donor	NNS
cord-005453-4057qib7	810	29	.	.	.
cord-005453-4057qib7	811	1	Methods	method	NNS
cord-005453-4057qib7	811	2	:	:	:
cord-005453-4057qib7	811	3	We	-PRON-	PRP
cord-005453-4057qib7	811	4	collected	collect	VBD
cord-005453-4057qib7	811	5	and	and	CC
cord-005453-4057qib7	811	6	analyzed	analyze	VBD
cord-005453-4057qib7	811	7	data	datum	NNS
cord-005453-4057qib7	811	8	of	of	IN
cord-005453-4057qib7	811	9	aplastic	aplastic	JJ
cord-005453-4057qib7	811	10	anemia	anemia	NN
cord-005453-4057qib7	811	11	patients	patient	NNS
cord-005453-4057qib7	811	12	who	who	WP
cord-005453-4057qib7	811	13	had	have	VBD
cord-005453-4057qib7	811	14	undergone	undergo	VBN
cord-005453-4057qib7	811	15	allogeneic	allogeneic	IN
cord-005453-4057qib7	811	16	stem	stem	NN
cord-005453-4057qib7	811	17	cell	cell	NN
cord-005453-4057qib7	811	18	transplantation	transplantation	NN
cord-005453-4057qib7	811	19	from	from	IN
cord-005453-4057qib7	811	20	matched	match	VBN
cord-005453-4057qib7	811	21	unrelated	unrelated	JJ
cord-005453-4057qib7	811	22	or	or	CC
cord-005453-4057qib7	811	23	haploidentical	haploidentical	JJ
cord-005453-4057qib7	811	24	donor	donor	NN
cord-005453-4057qib7	811	25	between	between	IN
cord-005453-4057qib7	811	26	2011	2011	CD
cord-005453-4057qib7	811	27	and	and	CC
cord-005453-4057qib7	811	28	2018	2018	CD
cord-005453-4057qib7	811	29	.	.	.
cord-005453-4057qib7	812	1	Results	result	NNS
cord-005453-4057qib7	812	2	:	:	:
cord-005453-4057qib7	813	1	There	there	EX
cord-005453-4057qib7	813	2	were	be	VBD
cord-005453-4057qib7	813	3	10	10	CD
cord-005453-4057qib7	813	4	patients	patient	NNS
cord-005453-4057qib7	813	5	who	who	WP
cord-005453-4057qib7	813	6	had	have	VBD
cord-005453-4057qib7	813	7	received	receive	VBN
cord-005453-4057qib7	813	8	allogeneic	allogeneic	JJ
cord-005453-4057qib7	813	9	stem	stem	NN
cord-005453-4057qib7	813	10	cell	cell	NN
cord-005453-4057qib7	813	11	transplantation	transplantation	NN
cord-005453-4057qib7	813	12	from	from	IN
cord-005453-4057qib7	813	13	unrelated	unrelated	JJ
cord-005453-4057qib7	813	14	donors	donor	NNS
cord-005453-4057qib7	813	15	and	and	CC
cord-005453-4057qib7	813	16	there	there	EX
cord-005453-4057qib7	813	17	were	be	VBD
cord-005453-4057qib7	813	18	10	10	CD
cord-005453-4057qib7	813	19	patients	patient	NNS
cord-005453-4057qib7	813	20	who	who	WP
cord-005453-4057qib7	813	21	had	have	VBD
cord-005453-4057qib7	813	22	undergone	undergo	VBN
cord-005453-4057qib7	813	23	haploidentical	haploidentical	JJ
cord-005453-4057qib7	813	24	transplantation	transplantation	NN
cord-005453-4057qib7	813	25	.	.	.
cord-005453-4057qib7	814	1	But	but	CC
cord-005453-4057qib7	814	2	in	in	IN
cord-005453-4057qib7	814	3	4	4	CD
cord-005453-4057qib7	814	4	patients	patient	NNS
cord-005453-4057qib7	814	5	who	who	WP
cord-005453-4057qib7	814	6	had	have	VBD
cord-005453-4057qib7	814	7	undergone	undergo	VBN
cord-005453-4057qib7	814	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	814	9	transplantation	transplantation	NN
cord-005453-4057qib7	814	10	,	,	,
cord-005453-4057qib7	814	11	engraftment	engraftment	NN
cord-005453-4057qib7	814	12	failure	failure	NN
cord-005453-4057qib7	814	13	had	have	VBD
cord-005453-4057qib7	814	14	occurred	occur	VBN
cord-005453-4057qib7	814	15	and	and	CC
cord-005453-4057qib7	814	16	they	-PRON-	PRP
cord-005453-4057qib7	814	17	were	be	VBD
cord-005453-4057qib7	814	18	transplanted	transplant	VBN
cord-005453-4057qib7	814	19	from	from	IN
cord-005453-4057qib7	814	20	different	different	JJ
cord-005453-4057qib7	814	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	814	22	donors	donor	NNS
cord-005453-4057qib7	814	23	fort	fort	NNP
cord-005453-4057qib7	814	24	he	-PRON-	PRP
cord-005453-4057qib7	814	25	second	second	JJ
cord-005453-4057qib7	814	26	time	time	NN
cord-005453-4057qib7	814	27	.	.	.
cord-005453-4057qib7	815	1	So	so	RB
cord-005453-4057qib7	815	2	a	a	DT
cord-005453-4057qib7	815	3	total	total	NN
cord-005453-4057qib7	815	4	of	of	IN
cord-005453-4057qib7	815	5	10	10	CD
cord-005453-4057qib7	815	6	unrelated	unrelated	JJ
cord-005453-4057qib7	815	7	and	and	CC
cord-005453-4057qib7	815	8	14	14	CD
cord-005453-4057qib7	815	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	815	10	transplants	transplant	NNS
cord-005453-4057qib7	815	11	were	be	VBD
cord-005453-4057qib7	815	12	performed	perform	VBN
cord-005453-4057qib7	815	13	.	.	.
cord-005453-4057qib7	816	1	The	the	DT
cord-005453-4057qib7	816	2	median	median	JJ
cord-005453-4057qib7	816	3	age	age	NN
cord-005453-4057qib7	816	4	of	of	IN
cord-005453-4057qib7	816	5	patients	patient	NNS
cord-005453-4057qib7	816	6	who	who	WP
cord-005453-4057qib7	816	7	had	have	VBD
cord-005453-4057qib7	816	8	undergone	undergo	VBN
cord-005453-4057qib7	816	9	unrelated	unrelated	JJ
cord-005453-4057qib7	816	10	transplantation	transplantation	NN
cord-005453-4057qib7	816	11	was	be	VBD
cord-005453-4057qib7	816	12	29(16	29(16	CD
cord-005453-4057qib7	816	13	-	-	SYM
cord-005453-4057qib7	816	14	55	55	CD
cord-005453-4057qib7	816	15	)	)	-RRB-
cord-005453-4057qib7	816	16	and	and	CC
cord-005453-4057qib7	816	17	the	the	DT
cord-005453-4057qib7	816	18	median	median	JJ
cord-005453-4057qib7	816	19	age	age	NN
cord-005453-4057qib7	816	20	of	of	IN
cord-005453-4057qib7	816	21	patients	patient	NNS
cord-005453-4057qib7	816	22	who	who	WP
cord-005453-4057qib7	816	23	had	have	VBD
cord-005453-4057qib7	816	24	undergone	undergo	VBN
cord-005453-4057qib7	816	25	unrelated	unrelated	JJ
cord-005453-4057qib7	816	26	transplantation	transplantation	NN
cord-005453-4057qib7	816	27	was	be	VBD
cord-005453-4057qib7	816	28	22(19	22(19	CD
cord-005453-4057qib7	816	29	-	-	SYM
cord-005453-4057qib7	816	30	61	61	CD
cord-005453-4057qib7	816	31	)	)	-RRB-
cord-005453-4057qib7	816	32	.	.	.
cord-005453-4057qib7	817	1	The	the	DT
cord-005453-4057qib7	817	2	results	result	NNS
cord-005453-4057qib7	817	3	of	of	IN
cord-005453-4057qib7	817	4	the	the	DT
cord-005453-4057qib7	817	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	817	6	and	and	CC
cord-005453-4057qib7	817	7	unrelated	unrelated	JJ
cord-005453-4057qib7	817	8	transplantations	transplantation	NNS
cord-005453-4057qib7	817	9	are	be	VBP
cord-005453-4057qib7	817	10	shown	show	VBN
cord-005453-4057qib7	817	11	in	in	IN
cord-005453-4057qib7	817	12	Table	Table	NNP
cord-005453-4057qib7	817	13	1	1	CD
cord-005453-4057qib7	817	14	.	.	.
cord-005453-4057qib7	818	1	The	the	DT
cord-005453-4057qib7	818	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	818	3	and	and	CC
cord-005453-4057qib7	818	4	platelet	platelet	NN
cord-005453-4057qib7	818	5	engraftment	engraftment	NN
cord-005453-4057qib7	818	6	times	time	NNS
cord-005453-4057qib7	818	7	were	be	VBD
cord-005453-4057qib7	818	8	significantly	significantly	RB
cord-005453-4057qib7	818	9	longer	long	RBR
cord-005453-4057qib7	818	10	in	in	IN
cord-005453-4057qib7	818	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	818	12	transplantations	transplantation	NNS
cord-005453-4057qib7	818	13	(	(	-LRB-
cord-005453-4057qib7	818	14	p=0,006	p=0,006	NNP
cord-005453-4057qib7	818	15	and	and	CC
cord-005453-4057qib7	818	16	p=0,005	p=0,005	NNP
cord-005453-4057qib7	818	17	,	,	,
cord-005453-4057qib7	818	18	respectively	respectively	RB
cord-005453-4057qib7	818	19	)	)	-RRB-
cord-005453-4057qib7	818	20	.	.	.
cord-005453-4057qib7	819	1	However	however	RB
cord-005453-4057qib7	819	2	,	,	,
cord-005453-4057qib7	819	3	VOD	VOD	NNP
cord-005453-4057qib7	819	4	,	,	,
cord-005453-4057qib7	819	5	GVHD	GVHD	NNP
cord-005453-4057qib7	819	6	and	and	CC
cord-005453-4057qib7	819	7	100	100	CD
cord-005453-4057qib7	819	8	day	day	NN
cord-005453-4057qib7	819	9	mortality	mortality	NN
cord-005453-4057qib7	819	10	rates	rate	NNS
cord-005453-4057qib7	819	11	were	be	VBD
cord-005453-4057qib7	819	12	not	not	RB
cord-005453-4057qib7	819	13	different	different	JJ
cord-005453-4057qib7	819	14	in	in	IN
cord-005453-4057qib7	819	15	the	the	DT
cord-005453-4057qib7	819	16	2	2	CD
cord-005453-4057qib7	819	17	groups	group	NNS
cord-005453-4057qib7	819	18	.	.	.
cord-005453-4057qib7	820	1	Similarly	similarly	RB
cord-005453-4057qib7	820	2	overall	overall	JJ
cord-005453-4057qib7	820	3	survival	survival	NN
cord-005453-4057qib7	820	4	(	(	-LRB-
cord-005453-4057qib7	820	5	OS	OS	NNP
cord-005453-4057qib7	820	6	)	)	-RRB-
cord-005453-4057qib7	820	7	of	of	IN
cord-005453-4057qib7	820	8	the	the	DT
cord-005453-4057qib7	820	9	patients	patient	NNS
cord-005453-4057qib7	820	10	who	who	WP
cord-005453-4057qib7	820	11	had	have	VBD
cord-005453-4057qib7	820	12	undergone	undergo	VBN
cord-005453-4057qib7	820	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	820	14	or	or	CC
cord-005453-4057qib7	820	15	unrelated	unrelated	JJ
cord-005453-4057qib7	820	16	transplantation	transplantation	NN
cord-005453-4057qib7	820	17	were	be	VBD
cord-005453-4057qib7	820	18	not	not	RB
cord-005453-4057qib7	820	19	significantly	significantly	RB
cord-005453-4057qib7	820	20	different	different	JJ
cord-005453-4057qib7	820	21	(	(	-LRB-
cord-005453-4057qib7	820	22	p=0,38	p=0,38	JJ
cord-005453-4057qib7	820	23	)	)	-RRB-
cord-005453-4057qib7	821	1	(	(	-LRB-
cord-005453-4057qib7	821	2	Figure	figure	NN
cord-005453-4057qib7	821	3	1	1	CD
cord-005453-4057qib7	821	4	)	)	-RRB-
cord-005453-4057qib7	821	5	.	.	.
cord-005453-4057qib7	822	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	822	2	:	:	:
cord-005453-4057qib7	823	1	Although	although	IN
cord-005453-4057qib7	823	2	the	the	DT
cord-005453-4057qib7	823	3	number	number	NN
cord-005453-4057qib7	823	4	of	of	IN
cord-005453-4057qib7	823	5	patients	patient	NNS
cord-005453-4057qib7	823	6	are	be	VBP
cord-005453-4057qib7	823	7	low	low	JJ
cord-005453-4057qib7	823	8	in	in	IN
cord-005453-4057qib7	823	9	this	this	DT
cord-005453-4057qib7	823	10	study	study	NN
cord-005453-4057qib7	823	11	,	,	,
cord-005453-4057qib7	823	12	we	-PRON-	PRP
cord-005453-4057qib7	823	13	can	can	MD
cord-005453-4057qib7	823	14	conclude	conclude	VB
cord-005453-4057qib7	823	15	that	that	IN
cord-005453-4057qib7	823	16	urelated	urelate	VBN
cord-005453-4057qib7	823	17	and	and	CC
cord-005453-4057qib7	823	18	haploidentical	haploidentical	JJ
cord-005453-4057qib7	823	19	transplantation	transplantation	NN
cord-005453-4057qib7	823	20	in	in	IN
cord-005453-4057qib7	823	21	aplastic	aplastic	JJ
cord-005453-4057qib7	823	22	anemia	anemia	NN
cord-005453-4057qib7	823	23	have	have	VBP
cord-005453-4057qib7	823	24	comparable	comparable	JJ
cord-005453-4057qib7	823	25	toxicity	toxicity	NN
cord-005453-4057qib7	823	26	and	and	CC
cord-005453-4057qib7	823	27	efficacy	efficacy	NN
cord-005453-4057qib7	823	28	.	.	.
cord-005453-4057qib7	824	1	Background	background	NN
cord-005453-4057qib7	824	2	:	:	:
cord-005453-4057qib7	825	1	Autologous	autologous	JJ
cord-005453-4057qib7	825	2	stem	stem	NN
cord-005453-4057qib7	825	3	cells	cell	NNS
cord-005453-4057qib7	825	4	transplantation	transplantation	NN
cord-005453-4057qib7	825	5	(	(	-LRB-
cord-005453-4057qib7	825	6	aHSCT	aHSCT	NNP
cord-005453-4057qib7	825	7	)	)	-RRB-
cord-005453-4057qib7	825	8	is	be	VBZ
cord-005453-4057qib7	825	9	an	an	DT
cord-005453-4057qib7	825	10	effective	effective	JJ
cord-005453-4057qib7	825	11	treatment	treatment	NN
cord-005453-4057qib7	825	12	for	for	IN
cord-005453-4057qib7	825	13	very	very	RB
cord-005453-4057qib7	825	14	aggressive	aggressive	JJ
cord-005453-4057qib7	825	15	autoimmune	autoimmune	JJ
cord-005453-4057qib7	825	16	diseases	disease	NNS
cord-005453-4057qib7	825	17	such	such	JJ
cord-005453-4057qib7	825	18	as	as	IN
cord-005453-4057qib7	825	19	multiple	multiple	JJ
cord-005453-4057qib7	825	20	sclerosis	sclerosis	NN
cord-005453-4057qib7	825	21	(	(	-LRB-
cord-005453-4057qib7	825	22	MS	MS	NNP
cord-005453-4057qib7	825	23	)	)	-RRB-
cord-005453-4057qib7	825	24	.	.	.
cord-005453-4057qib7	826	1	However	however	RB
cord-005453-4057qib7	826	2	,	,	,
cord-005453-4057qib7	826	3	toxicity	toxicity	NN
cord-005453-4057qib7	826	4	remains	remain	VBZ
cord-005453-4057qib7	826	5	the	the	DT
cord-005453-4057qib7	826	6	major	major	JJ
cord-005453-4057qib7	826	7	concern	concern	NN
cord-005453-4057qib7	826	8	to	to	IN
cord-005453-4057qib7	826	9	a	a	DT
cord-005453-4057qib7	826	10	wide	wide	JJ
cord-005453-4057qib7	826	11	application	application	NN
cord-005453-4057qib7	826	12	of	of	IN
cord-005453-4057qib7	826	13	this	this	DT
cord-005453-4057qib7	826	14	approach	approach	NN
cord-005453-4057qib7	826	15	.	.	.
cord-005453-4057qib7	827	1	Post	post	JJ
cord-005453-4057qib7	827	2	transplant	transplant	NN
cord-005453-4057qib7	827	3	viral	viral	JJ
cord-005453-4057qib7	827	4	reactivations	reactivation	NNS
cord-005453-4057qib7	827	5	may	may	MD
cord-005453-4057qib7	827	6	induce	induce	VB
cord-005453-4057qib7	827	7	severe	severe	JJ
cord-005453-4057qib7	827	8	complications	complication	NNS
cord-005453-4057qib7	827	9	and	and	CC
cord-005453-4057qib7	827	10	a	a	DT
cord-005453-4057qib7	827	11	rigorous	rigorous	JJ
cord-005453-4057qib7	827	12	monitoring	monitoring	NN
cord-005453-4057qib7	827	13	of	of	IN
cord-005453-4057qib7	827	14	peripheral	peripheral	JJ
cord-005453-4057qib7	827	15	blood	blood	NN
cord-005453-4057qib7	827	16	viral	viral	JJ
cord-005453-4057qib7	827	17	load	load	NN
cord-005453-4057qib7	827	18	for	for	IN
cord-005453-4057qib7	827	19	a	a	DT
cord-005453-4057qib7	827	20	prompt	prompt	JJ
cord-005453-4057qib7	827	21	and	and	CC
cord-005453-4057qib7	827	22	effective	effective	JJ
cord-005453-4057qib7	827	23	therapy	therapy	NN
cord-005453-4057qib7	827	24	is	be	VBZ
cord-005453-4057qib7	827	25	required	require	VBN
cord-005453-4057qib7	827	26	.	.	.
cord-005453-4057qib7	828	1	A	a	DT
cord-005453-4057qib7	828	2	higher	high	JJR
cord-005453-4057qib7	828	3	rate	rate	NN
cord-005453-4057qib7	828	4	of	of	IN
cord-005453-4057qib7	828	5	EBV	EBV	NNP
cord-005453-4057qib7	828	6	and	and	CC
cord-005453-4057qib7	828	7	CMV	CMV	NNP
cord-005453-4057qib7	828	8	reactivation	reactivation	NN
cord-005453-4057qib7	828	9	has	have	VBZ
cord-005453-4057qib7	828	10	been	be	VBN
cord-005453-4057qib7	828	11	observed	observe	VBN
cord-005453-4057qib7	828	12	in	in	IN
cord-005453-4057qib7	828	13	patients	patient	NNS
cord-005453-4057qib7	828	14	affected	affect	VBN
cord-005453-4057qib7	828	15	by	by	IN
cord-005453-4057qib7	828	16	MS	MS	NNP
cord-005453-4057qib7	828	17	and	and	CC
cord-005453-4057qib7	828	18	conditioned	condition	VBN
cord-005453-4057qib7	828	19	with	with	IN
cord-005453-4057qib7	828	20	BEAM	BEAM	NNP
cord-005453-4057qib7	828	21	plus	plus	CC
cord-005453-4057qib7	828	22	ATG	ATG	NNP
cord-005453-4057qib7	828	23	compared	compare	VBN
cord-005453-4057qib7	828	24	with	with	IN
cord-005453-4057qib7	828	25	a	a	DT
cord-005453-4057qib7	828	26	controlled	control	VBN
cord-005453-4057qib7	828	27	group	group	NN
cord-005453-4057qib7	828	28	of	of	IN
cord-005453-4057qib7	828	29	lymphoma	lymphoma	NN
cord-005453-4057qib7	828	30	patients	patient	NNS
cord-005453-4057qib7	828	31	without	without	IN
cord-005453-4057qib7	828	32	ATG	ATG	NNP
cord-005453-4057qib7	828	33	in	in	IN
cord-005453-4057qib7	828	34	the	the	DT
cord-005453-4057qib7	828	35	conditioning	conditioning	NN
cord-005453-4057qib7	828	36	regimen	regimen	NN
cord-005453-4057qib7	828	37	[	[	-LRB-
cord-005453-4057qib7	828	38	1	1	CD
cord-005453-4057qib7	828	39	]	]	-RRB-
cord-005453-4057qib7	828	40	.	.	.
cord-005453-4057qib7	829	1	We	-PRON-	PRP
cord-005453-4057qib7	829	2	report	report	VBP
cord-005453-4057qib7	829	3	here	here	RB
cord-005453-4057qib7	829	4	the	the	DT
cord-005453-4057qib7	829	5	policy	policy	NN
cord-005453-4057qib7	829	6	of	of	IN
cord-005453-4057qib7	829	7	our	-PRON-	PRP$
cord-005453-4057qib7	829	8	Center	Center	NNP
cord-005453-4057qib7	829	9	about	about	IN
cord-005453-4057qib7	829	10	both	both	DT
cord-005453-4057qib7	829	11	monitoring	monitoring	NN
cord-005453-4057qib7	829	12	and	and	CC
cord-005453-4057qib7	829	13	treatment	treatment	NN
cord-005453-4057qib7	829	14	of	of	IN
cord-005453-4057qib7	829	15	such	such	JJ
cord-005453-4057qib7	829	16	side	side	NN
cord-005453-4057qib7	829	17	effect	effect	NN
cord-005453-4057qib7	829	18	.	.	.
cord-005453-4057qib7	830	1	Methods	method	NNS
cord-005453-4057qib7	830	2	:	:	:
cord-005453-4057qib7	831	1	A	a	DT
cord-005453-4057qib7	831	2	series	series	NN
cord-005453-4057qib7	831	3	of	of	IN
cord-005453-4057qib7	831	4	37	37	CD
cord-005453-4057qib7	831	5	consecutive	consecutive	JJ
cord-005453-4057qib7	831	6	patients	patient	NNS
cord-005453-4057qib7	831	7	with	with	IN
cord-005453-4057qib7	831	8	MS	MS	NNP
cord-005453-4057qib7	831	9	,	,	,
cord-005453-4057qib7	831	10	transplanted	transplant	VBN
cord-005453-4057qib7	831	11	between	between	IN
cord-005453-4057qib7	831	12	2014	2014	CD
cord-005453-4057qib7	831	13	and	and	CC
cord-005453-4057qib7	831	14	2018	2018	CD
cord-005453-4057qib7	831	15	is	be	VBZ
cord-005453-4057qib7	831	16	included	include	VBN
cord-005453-4057qib7	831	17	in	in	IN
cord-005453-4057qib7	831	18	this	this	DT
cord-005453-4057qib7	831	19	analysis	analysis	NN
cord-005453-4057qib7	831	20	.	.	.
cord-005453-4057qib7	832	1	All	all	DT
cord-005453-4057qib7	832	2	patients	patient	NNS
cord-005453-4057qib7	832	3	were	be	VBD
cord-005453-4057qib7	832	4	mobilized	mobilize	VBN
cord-005453-4057qib7	832	5	with	with	IN
cord-005453-4057qib7	832	6	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	832	7	4g	4g	CD
cord-005453-4057qib7	832	8	/	/	SYM
cord-005453-4057qib7	832	9	sqm	sqm	NN
cord-005453-4057qib7	832	10	+	+	CC
cord-005453-4057qib7	832	11	G	G	NNP
cord-005453-4057qib7	832	12	-	-	HYPH
cord-005453-4057qib7	832	13	CSF	CSF	NNP
cord-005453-4057qib7	832	14	and	and	CC
cord-005453-4057qib7	832	15	conditioned	condition	VBN
cord-005453-4057qib7	832	16	with	with	IN
cord-005453-4057qib7	832	17	BEAM	beam	NN
cord-005453-4057qib7	832	18	plus	plus	CC
cord-005453-4057qib7	832	19	rabbit	rabbit	NN
cord-005453-4057qib7	832	20	ATG	ATG	NNP
cord-005453-4057qib7	832	21	(	(	-LRB-
cord-005453-4057qib7	832	22	Thymoglobulin	Thymoglobulin	NNP
cord-005453-4057qib7	832	23	©	©	NNP
cord-005453-4057qib7	832	24	,	,	,
cord-005453-4057qib7	832	25	7.5mg	7.5mg	CD
cord-005453-4057qib7	832	26	/	/	SYM
cord-005453-4057qib7	832	27	Kg	Kg	NNP
cord-005453-4057qib7	832	28	)	)	-RRB-
cord-005453-4057qib7	832	29	.	.	.
cord-005453-4057qib7	833	1	Monitoring	monitoring	NN
cord-005453-4057qib7	833	2	of	of	IN
cord-005453-4057qib7	833	3	CMV	CMV	NNP
cord-005453-4057qib7	833	4	/	/	SYM
cord-005453-4057qib7	833	5	EBV	EBV	NNP
cord-005453-4057qib7	833	6	DNA	DNA	NNP
cord-005453-4057qib7	833	7	on	on	IN
cord-005453-4057qib7	833	8	whole	whole	JJ
cord-005453-4057qib7	833	9	blood	blood	NN
cord-005453-4057qib7	833	10	by	by	IN
cord-005453-4057qib7	833	11	quantitative	quantitative	JJ
cord-005453-4057qib7	833	12	PCR	PCR	NNP
cord-005453-4057qib7	833	13	was	be	VBD
cord-005453-4057qib7	833	14	performed	perform	VBN
cord-005453-4057qib7	833	15	after	after	IN
cord-005453-4057qib7	833	16	the	the	DT
cord-005453-4057qib7	833	17	engraftment	engraftment	NN
cord-005453-4057qib7	833	18	,	,	,
cord-005453-4057qib7	833	19	weekly	weekly	RB
cord-005453-4057qib7	833	20	for	for	IN
cord-005453-4057qib7	833	21	at	at	RB
cord-005453-4057qib7	833	22	least	least	RBS
cord-005453-4057qib7	833	23	one	one	CD
cord-005453-4057qib7	833	24	month	month	NN
cord-005453-4057qib7	833	25	,	,	,
cord-005453-4057qib7	833	26	then	then	RB
cord-005453-4057qib7	833	27	at	at	IN
cord-005453-4057qib7	833	28	longer	long	JJR
cord-005453-4057qib7	833	29	intervals	interval	NNS
cord-005453-4057qib7	833	30	.	.	.
cord-005453-4057qib7	834	1	Pre	pre	JJ
cord-005453-4057qib7	834	2	-	-	JJ
cord-005453-4057qib7	834	3	emptive	emptive	JJ
cord-005453-4057qib7	834	4	treatment	treatment	NN
cord-005453-4057qib7	834	5	with	with	IN
cord-005453-4057qib7	834	6	valgancyclovir	valgancyclovir	NNS
cord-005453-4057qib7	834	7	was	be	VBD
cord-005453-4057qib7	834	8	started	start	VBN
cord-005453-4057qib7	834	9	in	in	IN
cord-005453-4057qib7	834	10	case	case	NN
cord-005453-4057qib7	834	11	of	of	IN
cord-005453-4057qib7	834	12	CMV	CMV	NNP
cord-005453-4057qib7	834	13	viral	viral	JJ
cord-005453-4057qib7	834	14	load	load	NN
cord-005453-4057qib7	834	15	³1x10	³1x10	CD
cord-005453-4057qib7	834	16	^	^	SYM
cord-005453-4057qib7	834	17	4	4	CD
cord-005453-4057qib7	834	18	copies	copy	NNS
cord-005453-4057qib7	834	19	/	/	SYM
cord-005453-4057qib7	834	20	mL.	mL.	NNS
cord-005453-4057qib7	834	21	In	in	IN
cord-005453-4057qib7	834	22	case	case	NN
cord-005453-4057qib7	834	23	of	of	IN
cord-005453-4057qib7	834	24	EBV	EBV	NNP
cord-005453-4057qib7	834	25	assay	assay	NN
cord-005453-4057qib7	834	26	between	between	IN
cord-005453-4057qib7	834	27	1x10	1x10	CD
cord-005453-4057qib7	834	28	^	^	SYM
cord-005453-4057qib7	834	29	4	4	CD
cord-005453-4057qib7	834	30	and	and	CC
cord-005453-4057qib7	835	1	1x10	1x10	CD
cord-005453-4057qib7	835	2	^	^	SYM
cord-005453-4057qib7	835	3	5	5	CD
cord-005453-4057qib7	835	4	copies	copy	NNS
cord-005453-4057qib7	835	5	/	/	SYM
cord-005453-4057qib7	835	6	mL	ml	NN
cord-005453-4057qib7	835	7	further	further	JJ
cord-005453-4057qib7	835	8	determinations	determination	NNS
cord-005453-4057qib7	835	9	were	be	VBD
cord-005453-4057qib7	835	10	performed	perform	VBN
cord-005453-4057qib7	835	11	and	and	CC
cord-005453-4057qib7	835	12	Rituximab	Rituximab	NNP
cord-005453-4057qib7	835	13	-	-	HYPH
cord-005453-4057qib7	835	14	based	base	VBN
cord-005453-4057qib7	835	15	treatment	treatment	NN
cord-005453-4057qib7	835	16	was	be	VBD
cord-005453-4057qib7	835	17	started	start	VBN
cord-005453-4057qib7	835	18	if	if	IN
cord-005453-4057qib7	835	19	the	the	DT
cord-005453-4057qib7	835	20	viral	viral	JJ
cord-005453-4057qib7	835	21	copies	copy	NNS
cord-005453-4057qib7	835	22	exceeded	exceed	VBD
cord-005453-4057qib7	835	23	1x10	1x10	CD
cord-005453-4057qib7	835	24	5	5	CD
cord-005453-4057qib7	835	25	copies	copy	NNS
cord-005453-4057qib7	835	26	.	.	.
cord-005453-4057qib7	836	1	Patients	patient	NNS
cord-005453-4057qib7	836	2	received	receive	VBD
cord-005453-4057qib7	836	3	treatment	treatment	NN
cord-005453-4057qib7	836	4	in	in	IN
cord-005453-4057qib7	836	5	case	case	NN
cord-005453-4057qib7	836	6	of	of	IN
cord-005453-4057qib7	836	7	symptomatic	symptomatic	JJ
cord-005453-4057qib7	836	8	disease	disease	NN
cord-005453-4057qib7	836	9	for	for	IN
cord-005453-4057qib7	836	10	any	any	DT
cord-005453-4057qib7	836	11	value	value	NN
cord-005453-4057qib7	836	12	of	of	IN
cord-005453-4057qib7	836	13	the	the	DT
cord-005453-4057qib7	836	14	PCR	PCR	NNP
cord-005453-4057qib7	836	15	of	of	IN
cord-005453-4057qib7	836	16	both	both	DT
cord-005453-4057qib7	836	17	viruses	virus	NNS
cord-005453-4057qib7	836	18	or	or	CC
cord-005453-4057qib7	836	19	EBV	EBV	NNP
cord-005453-4057qib7	836	20	titer	titer	NN
cord-005453-4057qib7	836	21	³1x10	³1x10	NNP
cord-005453-4057qib7	836	22	^	^	SYM
cord-005453-4057qib7	836	23	5	5	CD
cord-005453-4057qib7	836	24	copies/	copies/	XX
cord-005453-4057qib7	837	1	mL.	mL.	NNP
cord-005453-4057qib7	837	2	Results	result	NNS
cord-005453-4057qib7	837	3	:	:	:
cord-005453-4057qib7	838	1	Detectable	detectable	JJ
cord-005453-4057qib7	838	2	DNA	DNA	NNP
cord-005453-4057qib7	838	3	for	for	IN
cord-005453-4057qib7	838	4	CMV	CMV	NNP
cord-005453-4057qib7	838	5	was	be	VBD
cord-005453-4057qib7	838	6	observed	observe	VBN
cord-005453-4057qib7	838	7	in	in	IN
cord-005453-4057qib7	838	8	15/	15/	CD
cord-005453-4057qib7	838	9	37	37	CD
cord-005453-4057qib7	838	10	(	(	-LRB-
cord-005453-4057qib7	838	11	40,5	40,5	CD
cord-005453-4057qib7	838	12	%	%	NN
cord-005453-4057qib7	838	13	)	)	-RRB-
cord-005453-4057qib7	838	14	patients	patient	NNS
cord-005453-4057qib7	838	15	at	at	IN
cord-005453-4057qib7	838	16	a	a	DT
cord-005453-4057qib7	838	17	median	median	JJ
cord-005453-4057qib7	838	18	time	time	NN
cord-005453-4057qib7	838	19	from	from	IN
cord-005453-4057qib7	838	20	transplant	transplant	NN
cord-005453-4057qib7	838	21	of	of	IN
cord-005453-4057qib7	838	22	23	23	CD
cord-005453-4057qib7	838	23	days	day	NNS
cord-005453-4057qib7	838	24	(	(	-LRB-
cord-005453-4057qib7	838	25	range	range	VBP
cord-005453-4057qib7	838	26	12	12	CD
cord-005453-4057qib7	838	27	-	-	SYM
cord-005453-4057qib7	838	28	36	36	CD
cord-005453-4057qib7	838	29	)	)	-RRB-
cord-005453-4057qib7	838	30	and	and	CC
cord-005453-4057qib7	838	31	6/37	6/37	CD
cord-005453-4057qib7	838	32	(	(	-LRB-
cord-005453-4057qib7	838	33	16	16	CD
cord-005453-4057qib7	838	34	%	%	NN
cord-005453-4057qib7	838	35	)	)	-RRB-
cord-005453-4057qib7	839	1	required	require	VBN
cord-005453-4057qib7	839	2	pre	pre	JJ
cord-005453-4057qib7	839	3	-	-	JJ
cord-005453-4057qib7	839	4	emptive	emptive	JJ
cord-005453-4057qib7	839	5	treatment	treatment	NN
cord-005453-4057qib7	839	6	.	.	.
cord-005453-4057qib7	840	1	All	all	DT
cord-005453-4057qib7	840	2	patients	patient	NNS
cord-005453-4057qib7	840	3	promptly	promptly	RB
cord-005453-4057qib7	840	4	responded	respond	VBD
cord-005453-4057qib7	840	5	to	to	IN
cord-005453-4057qib7	840	6	treatment	treatment	NN
cord-005453-4057qib7	840	7	within	within	IN
cord-005453-4057qib7	840	8	2	2	CD
cord-005453-4057qib7	840	9	weeks	week	NNS
cord-005453-4057qib7	840	10	.	.	.
cord-005453-4057qib7	841	1	EBV	EBV	NNP
cord-005453-4057qib7	841	2	viral	viral	JJ
cord-005453-4057qib7	841	3	load	load	NN
cord-005453-4057qib7	841	4	was	be	VBD
cord-005453-4057qib7	841	5	detectable	detectable	JJ
cord-005453-4057qib7	841	6	in	in	IN
cord-005453-4057qib7	841	7	19/37	19/37	CD
cord-005453-4057qib7	841	8	patients	patient	NNS
cord-005453-4057qib7	841	9	(	(	-LRB-
cord-005453-4057qib7	841	10	51,3	51,3	CD
cord-005453-4057qib7	841	11	%	%	NN
cord-005453-4057qib7	841	12	)	)	-RRB-
cord-005453-4057qib7	841	13	at	at	IN
cord-005453-4057qib7	841	14	a	a	DT
cord-005453-4057qib7	841	15	median	median	JJ
cord-005453-4057qib7	841	16	time	time	NN
cord-005453-4057qib7	841	17	of	of	IN
cord-005453-4057qib7	841	18	22	22	CD
cord-005453-4057qib7	841	19	days	day	NNS
cord-005453-4057qib7	841	20	(	(	-LRB-
cord-005453-4057qib7	841	21	range	range	VBP
cord-005453-4057qib7	841	22	12	12	CD
cord-005453-4057qib7	841	23	-	-	SYM
cord-005453-4057qib7	841	24	52	52	CD
cord-005453-4057qib7	841	25	)	)	-RRB-
cord-005453-4057qib7	841	26	.	.	.
cord-005453-4057qib7	842	1	One	one	CD
cord-005453-4057qib7	842	2	patient	patient	NN
cord-005453-4057qib7	842	3	out	out	IN
cord-005453-4057qib7	842	4	of	of	IN
cord-005453-4057qib7	842	5	19	19	CD
cord-005453-4057qib7	842	6	started	start	VBD
cord-005453-4057qib7	842	7	the	the	DT
cord-005453-4057qib7	842	8	treatment	treatment	NN
cord-005453-4057qib7	842	9	on	on	IN
cord-005453-4057qib7	842	10	first	first	JJ
cord-005453-4057qib7	842	11	determination	determination	NN
cord-005453-4057qib7	842	12	for	for	IN
cord-005453-4057qib7	842	13	high	high	JJ
cord-005453-4057qib7	842	14	viral	viral	JJ
cord-005453-4057qib7	842	15	load	load	NN
cord-005453-4057qib7	842	16	(	(	-LRB-
cord-005453-4057qib7	842	17	>	>	NN
cord-005453-4057qib7	842	18	1x10	1x10	CD
cord-005453-4057qib7	842	19	^	^	SYM
cord-005453-4057qib7	842	20	6	6	CD
cord-005453-4057qib7	842	21	/	/	SYM
cord-005453-4057qib7	842	22	mL	ml	NN
cord-005453-4057qib7	842	23	)	)	-RRB-
cord-005453-4057qib7	842	24	;	;	:
cord-005453-4057qib7	842	25	nine	nine	CD
cord-005453-4057qib7	842	26	presented	present	VBD
cord-005453-4057qib7	842	27	an	an	DT
cord-005453-4057qib7	842	28	EBV	EBV	NNP
cord-005453-4057qib7	842	29	viral	viral	JJ
cord-005453-4057qib7	842	30	load	load	NN
cord-005453-4057qib7	842	31	over	over	IN
cord-005453-4057qib7	842	32	1x10	1x10	CD
cord-005453-4057qib7	842	33	^	^	SYM
cord-005453-4057qib7	842	34	4	4	CD
cord-005453-4057qib7	842	35	copies	copy	NNS
cord-005453-4057qib7	842	36	/	/	SYM
cord-005453-4057qib7	842	37	ml	ml	NN
cord-005453-4057qib7	842	38	,	,	,
cord-005453-4057qib7	842	39	three	three	CD
cord-005453-4057qib7	842	40	of	of	IN
cord-005453-4057qib7	842	41	them	-PRON-	PRP
cord-005453-4057qib7	842	42	were	be	VBD
cord-005453-4057qib7	842	43	treated	treat	VBN
cord-005453-4057qib7	842	44	thereafter	thereafter	RB
cord-005453-4057qib7	842	45	for	for	IN
cord-005453-4057qib7	842	46	the	the	DT
cord-005453-4057qib7	842	47	persistent	persistent	JJ
cord-005453-4057qib7	842	48	increase	increase	NN
cord-005453-4057qib7	842	49	of	of	IN
cord-005453-4057qib7	842	50	the	the	DT
cord-005453-4057qib7	842	51	viral	viral	JJ
cord-005453-4057qib7	842	52	load	load	NN
cord-005453-4057qib7	842	53	(	(	-LRB-
cord-005453-4057qib7	842	54	>	>	NFP
cord-005453-4057qib7	842	55	10	10	CD
cord-005453-4057qib7	842	56	5	5	CD
cord-005453-4057qib7	842	57	/ml	/ml	.
cord-005453-4057qib7	842	58	)	)	-RRB-
cord-005453-4057qib7	842	59	.	.	.
cord-005453-4057qib7	843	1	Six	six	CD
cord-005453-4057qib7	843	2	patients	patient	NNS
cord-005453-4057qib7	843	3	spontaneously	spontaneously	RB
cord-005453-4057qib7	843	4	recovered	recover	VBD
cord-005453-4057qib7	843	5	the	the	DT
cord-005453-4057qib7	843	6	EBV	EBV	NNP
cord-005453-4057qib7	843	7	reactivation	reactivation	NN
cord-005453-4057qib7	843	8	.	.	.
cord-005453-4057qib7	844	1	Previous	previous	JJ
cord-005453-4057qib7	844	2	treatments	treatment	NNS
cord-005453-4057qib7	844	3	were	be	VBD
cord-005453-4057qib7	844	4	not	not	RB
cord-005453-4057qib7	844	5	predictive	predictive	JJ
cord-005453-4057qib7	844	6	of	of	IN
cord-005453-4057qib7	844	7	any	any	DT
cord-005453-4057qib7	844	8	higher	high	JJR
cord-005453-4057qib7	844	9	risk	risk	NN
cord-005453-4057qib7	844	10	of	of	IN
cord-005453-4057qib7	844	11	viral	viral	JJ
cord-005453-4057qib7	844	12	reactivation	reactivation	NN
cord-005453-4057qib7	844	13	.	.	.
cord-005453-4057qib7	845	1	No	no	DT
cord-005453-4057qib7	845	2	impact	impact	NN
cord-005453-4057qib7	845	3	on	on	IN
cord-005453-4057qib7	845	4	engraftment	engraftment	NN
cord-005453-4057qib7	845	5	related	relate	VBN
cord-005453-4057qib7	845	6	to	to	IN
cord-005453-4057qib7	845	7	the	the	DT
cord-005453-4057qib7	845	8	reactivation	reactivation	NN
cord-005453-4057qib7	845	9	was	be	VBD
cord-005453-4057qib7	845	10	observed	observe	VBN
cord-005453-4057qib7	845	11	.	.	.
cord-005453-4057qib7	846	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	846	2	:	:	:
cord-005453-4057qib7	847	1	This	this	DT
cord-005453-4057qib7	847	2	policy	policy	NN
cord-005453-4057qib7	847	3	shows	show	VBZ
cord-005453-4057qib7	847	4	that	that	IN
cord-005453-4057qib7	847	5	,	,	,
cord-005453-4057qib7	847	6	despite	despite	IN
cord-005453-4057qib7	847	7	a	a	DT
cord-005453-4057qib7	847	8	high	high	JJ
cord-005453-4057qib7	847	9	rate	rate	NN
cord-005453-4057qib7	847	10	of	of	IN
cord-005453-4057qib7	847	11	CMV	CMV	NNP
cord-005453-4057qib7	847	12	and	and	CC
cord-005453-4057qib7	847	13	EBV	EBV	NNP
cord-005453-4057qib7	847	14	reactivation	reactivation	NN
cord-005453-4057qib7	847	15	,	,	,
cord-005453-4057qib7	847	16	no	no	DT
cord-005453-4057qib7	847	17	grade	grade	NN
cord-005453-4057qib7	847	18	III	III	NNP
cord-005453-4057qib7	847	19	-	-	HYPH
cord-005453-4057qib7	847	20	IV	IV	NNP
cord-005453-4057qib7	847	21	adverse	adverse	JJ
cord-005453-4057qib7	847	22	events	event	NNS
cord-005453-4057qib7	847	23	were	be	VBD
cord-005453-4057qib7	847	24	observed	observe	VBN
cord-005453-4057qib7	847	25	,	,	,
cord-005453-4057qib7	847	26	suggesting	suggest	VBG
cord-005453-4057qib7	847	27	the	the	DT
cord-005453-4057qib7	847	28	key	key	JJ
cord-005453-4057qib7	847	29	role	role	NN
cord-005453-4057qib7	847	30	of	of	IN
cord-005453-4057qib7	847	31	viral	viral	JJ
cord-005453-4057qib7	847	32	monitoring	monitoring	NN
cord-005453-4057qib7	847	33	in	in	IN
cord-005453-4057qib7	847	34	these	these	DT
cord-005453-4057qib7	847	35	patients	patient	NNS
cord-005453-4057qib7	847	36	and	and	CC
cord-005453-4057qib7	847	37	the	the	DT
cord-005453-4057qib7	847	38	efficacy	efficacy	NN
cord-005453-4057qib7	847	39	of	of	IN
cord-005453-4057qib7	847	40	the	the	DT
cord-005453-4057qib7	847	41	preemptive	preemptive	JJ
cord-005453-4057qib7	847	42	treatment	treatment	NN
cord-005453-4057qib7	847	43	.	.	.
cord-005453-4057qib7	848	1	EBV	EBV	NNP
cord-005453-4057qib7	848	2	reactivation	reactivation	NN
cord-005453-4057qib7	848	3	at	at	IN
cord-005453-4057qib7	848	4	low	low	JJ
cord-005453-4057qib7	848	5	titers	titer	NNS
cord-005453-4057qib7	848	6	should	should	MD
cord-005453-4057qib7	848	7	be	be	VB
cord-005453-4057qib7	848	8	monitored	monitor	VBN
cord-005453-4057qib7	848	9	to	to	TO
cord-005453-4057qib7	848	10	identify	identify	VB
cord-005453-4057qib7	848	11	those	those	DT
cord-005453-4057qib7	848	12	cases	case	NNS
cord-005453-4057qib7	848	13	that	that	WDT
cord-005453-4057qib7	848	14	could	could	MD
cord-005453-4057qib7	848	15	achieve	achieve	VB
cord-005453-4057qib7	848	16	a	a	DT
cord-005453-4057qib7	848	17	spontaneous	spontaneous	JJ
cord-005453-4057qib7	848	18	resolution	resolution	NN
cord-005453-4057qib7	848	19	and	and	CC
cord-005453-4057qib7	848	20	avoid	avoid	VB
cord-005453-4057qib7	848	21	the	the	DT
cord-005453-4057qib7	848	22	induction	induction	NN
cord-005453-4057qib7	848	23	of	of	IN
cord-005453-4057qib7	848	24	further	further	JJ
cord-005453-4057qib7	848	25	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	848	26	by	by	IN
cord-005453-4057qib7	848	27	Rituximab	Rituximab	NNP
cord-005453-4057qib7	848	28	.	.	.
cord-005453-4057qib7	849	1	These	these	DT
cord-005453-4057qib7	849	2	data	datum	NNS
cord-005453-4057qib7	849	3	confirm	confirm	VBP
cord-005453-4057qib7	849	4	that	that	IN
cord-005453-4057qib7	849	5	patients	patient	NNS
cord-005453-4057qib7	849	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	849	7	with	with	IN
cord-005453-4057qib7	849	8	AD	ad	NN
cord-005453-4057qib7	849	9	undergoing	undergo	VBG
cord-005453-4057qib7	849	10	autologous	autologous	JJ
cord-005453-4057qib7	849	11	HSCT	HSCT	NNP
cord-005453-4057qib7	849	12	need	need	VBP
cord-005453-4057qib7	849	13	a	a	DT
cord-005453-4057qib7	849	14	more	more	RBR
cord-005453-4057qib7	849	15	intense	intense	JJ
cord-005453-4057qib7	849	16	pattern	pattern	NN
cord-005453-4057qib7	849	17	of	of	IN
cord-005453-4057qib7	849	18	care	care	NN
cord-005453-4057qib7	849	19	than	than	IN
cord-005453-4057qib7	849	20	hematological	hematological	JJ
cord-005453-4057qib7	849	21	patients	patient	NNS
cord-005453-4057qib7	849	22	.	.	.
cord-005453-4057qib7	850	1	Background	background	NN
cord-005453-4057qib7	850	2	:	:	:
cord-005453-4057qib7	851	1	Autoimmune	autoimmune	JJ
cord-005453-4057qib7	851	2	diseases	disease	NNS
cord-005453-4057qib7	851	3	are	be	VBP
cord-005453-4057qib7	851	4	chronic	chronic	JJ
cord-005453-4057qib7	851	5	serious	serious	JJ
cord-005453-4057qib7	851	6	conditions	condition	NNS
cord-005453-4057qib7	851	7	that	that	WDT
cord-005453-4057qib7	851	8	are	be	VBP
cord-005453-4057qib7	851	9	often	often	RB
cord-005453-4057qib7	851	10	refractory	refractory	JJ
cord-005453-4057qib7	851	11	to	to	IN
cord-005453-4057qib7	851	12	standard	standard	JJ
cord-005453-4057qib7	851	13	therapies	therapy	NNS
cord-005453-4057qib7	851	14	.	.	.
cord-005453-4057qib7	852	1	Since	since	IN
cord-005453-4057qib7	852	2	1996	1996	CD
cord-005453-4057qib7	852	3	,	,	,
cord-005453-4057qib7	852	4	autologous	autologous	JJ
cord-005453-4057qib7	852	5	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	852	6	stem	stem	NN
cord-005453-4057qib7	852	7	cell	cell	NN
cord-005453-4057qib7	852	8	transplantation	transplantation	NN
cord-005453-4057qib7	852	9	(	(	-LRB-
cord-005453-4057qib7	852	10	HSCT	HSCT	NNP
cord-005453-4057qib7	852	11	)	)	-RRB-
cord-005453-4057qib7	852	12	has	have	VBZ
cord-005453-4057qib7	852	13	been	be	VBN
cord-005453-4057qib7	852	14	a	a	DT
cord-005453-4057qib7	852	15	very	very	RB
cord-005453-4057qib7	852	16	promising	promising	JJ
cord-005453-4057qib7	852	17	alternative	alternative	NN
cord-005453-4057qib7	852	18	that	that	WDT
cord-005453-4057qib7	852	19	has	have	VBZ
cord-005453-4057qib7	852	20	shown	show	VBN
cord-005453-4057qib7	852	21	satisfactory	satisfactory	JJ
cord-005453-4057qib7	852	22	long	long	JJ
cord-005453-4057qib7	852	23	-	-	HYPH
cord-005453-4057qib7	852	24	term	term	NN
cord-005453-4057qib7	852	25	results	result	NNS
cord-005453-4057qib7	852	26	.	.	.
cord-005453-4057qib7	853	1	The	the	DT
cord-005453-4057qib7	853	2	aim	aim	NN
cord-005453-4057qib7	853	3	of	of	IN
cord-005453-4057qib7	853	4	this	this	DT
cord-005453-4057qib7	853	5	study	study	NN
cord-005453-4057qib7	853	6	is	be	VBZ
cord-005453-4057qib7	853	7	to	to	TO
cord-005453-4057qib7	853	8	evaluate	evaluate	VB
cord-005453-4057qib7	853	9	immune	immune	JJ
cord-005453-4057qib7	853	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	853	11	and	and	CC
cord-005453-4057qib7	853	12	mortality	mortality	NN
cord-005453-4057qib7	853	13	following	follow	VBG
cord-005453-4057qib7	853	14	HSCT	HSCT	NNP
cord-005453-4057qib7	853	15	in	in	IN
cord-005453-4057qib7	853	16	patients	patient	NNS
cord-005453-4057qib7	853	17	with	with	IN
cord-005453-4057qib7	853	18	autoimmune	autoimmune	JJ
cord-005453-4057qib7	853	19	disease	disease	NN
cord-005453-4057qib7	853	20	.	.	.
cord-005453-4057qib7	854	1	Methods	method	NNS
cord-005453-4057qib7	854	2	:	:	:
cord-005453-4057qib7	854	3	A	a	DT
cord-005453-4057qib7	854	4	retrospective	retrospective	JJ
cord-005453-4057qib7	854	5	study	study	NN
cord-005453-4057qib7	854	6	was	be	VBD
cord-005453-4057qib7	854	7	conducted	conduct	VBN
cord-005453-4057qib7	854	8	on	on	IN
cord-005453-4057qib7	854	9	patients	patient	NNS
cord-005453-4057qib7	854	10	with	with	IN
cord-005453-4057qib7	854	11	diagnosis	diagnosis	NN
cord-005453-4057qib7	854	12	of	of	IN
cord-005453-4057qib7	854	13	autoimmune	autoimmune	JJ
cord-005453-4057qib7	854	14	diseases	disease	NNS
cord-005453-4057qib7	854	15	that	that	WDT
cord-005453-4057qib7	854	16	underwent	undergo	VBD
cord-005453-4057qib7	854	17	autologous	autologous	JJ
cord-005453-4057qib7	854	18	HSCT	HSCT	NNP
cord-005453-4057qib7	854	19	between	between	IN
cord-005453-4057qib7	854	20	July	July	NNP
cord-005453-4057qib7	854	21	2012	2012	CD
cord-005453-4057qib7	854	22	and	and	CC
cord-005453-4057qib7	854	23	January	January	NNP
cord-005453-4057qib7	854	24	2018	2018	CD
cord-005453-4057qib7	854	25	at	at	IN
cord-005453-4057qib7	854	26	a	a	DT
cord-005453-4057qib7	854	27	tertiary	tertiary	JJ
cord-005453-4057qib7	854	28	referral	referral	JJ
cord-005453-4057qib7	854	29	center	center	NN
cord-005453-4057qib7	854	30	in	in	IN
cord-005453-4057qib7	854	31	Colombia	Colombia	NNP
cord-005453-4057qib7	854	32	,	,	,
cord-005453-4057qib7	854	33	South	South	NNP
cord-005453-4057qib7	854	34	America	America	NNP
cord-005453-4057qib7	854	35	.	.	.
cord-005453-4057qib7	855	1	Descriptive	descriptive	JJ
cord-005453-4057qib7	855	2	statistics	statistic	NNS
cord-005453-4057qib7	855	3	were	be	VBD
cord-005453-4057qib7	855	4	used	use	VBN
cord-005453-4057qib7	855	5	to	to	TO
cord-005453-4057qib7	855	6	analyze	analyze	VB
cord-005453-4057qib7	855	7	patient	patient	NN
cord-005453-4057qib7	855	8	's	's	POS
cord-005453-4057qib7	855	9	demographic	demographic	JJ
cord-005453-4057qib7	855	10	and	and	CC
cord-005453-4057qib7	855	11	clinic	clinic	NN
cord-005453-4057qib7	855	12	characteristics	characteristic	NNS
cord-005453-4057qib7	855	13	.	.	.
cord-005453-4057qib7	856	1	Results	result	NNS
cord-005453-4057qib7	856	2	:	:	:
cord-005453-4057qib7	857	1	Seven	seven	CD
cord-005453-4057qib7	857	2	patients	patient	NNS
cord-005453-4057qib7	857	3	were	be	VBD
cord-005453-4057qib7	857	4	included	include	VBN
cord-005453-4057qib7	857	5	,	,	,
cord-005453-4057qib7	857	6	with	with	IN
cord-005453-4057qib7	857	7	a	a	DT
cord-005453-4057qib7	857	8	mean	mean	JJ
cord-005453-4057qib7	857	9	age	age	NN
cord-005453-4057qib7	857	10	of	of	IN
cord-005453-4057qib7	857	11	37	37	CD
cord-005453-4057qib7	857	12	years	year	NNS
cord-005453-4057qib7	857	13	(	(	-LRB-
cord-005453-4057qib7	857	14	range	range	VBP
cord-005453-4057qib7	857	15	26	26	CD
cord-005453-4057qib7	857	16	-	-	SYM
cord-005453-4057qib7	857	17	57	57	CD
cord-005453-4057qib7	857	18	)	)	-RRB-
cord-005453-4057qib7	857	19	.	.	.
cord-005453-4057qib7	858	1	Five	five	CD
cord-005453-4057qib7	858	2	patients	patient	NNS
cord-005453-4057qib7	858	3	were	be	VBD
cord-005453-4057qib7	858	4	female	female	JJ
cord-005453-4057qib7	858	5	(	(	-LRB-
cord-005453-4057qib7	858	6	71	71	CD
cord-005453-4057qib7	858	7	%	%	NN
cord-005453-4057qib7	858	8	)	)	-RRB-
cord-005453-4057qib7	858	9	.	.	.
cord-005453-4057qib7	859	1	The	the	DT
cord-005453-4057qib7	859	2	indications	indication	NNS
cord-005453-4057qib7	859	3	for	for	IN
cord-005453-4057qib7	859	4	HSCT	HSCT	NNP
cord-005453-4057qib7	859	5	were	be	VBD
cord-005453-4057qib7	859	6	systemic	systemic	JJ
cord-005453-4057qib7	859	7	sclerosis	sclerosis	NN
cord-005453-4057qib7	859	8	(	(	-LRB-
cord-005453-4057qib7	859	9	n=3	n=3	NN
cord-005453-4057qib7	859	10	)	)	-RRB-
cord-005453-4057qib7	859	11	,	,	,
cord-005453-4057qib7	859	12	multiple	multiple	JJ
cord-005453-4057qib7	859	13	sclerosis	sclerosis	NN
cord-005453-4057qib7	859	14	(	(	-LRB-
cord-005453-4057qib7	859	15	n=2	n=2	NNP
cord-005453-4057qib7	859	16	)	)	-RRB-
cord-005453-4057qib7	859	17	,	,	,
cord-005453-4057qib7	859	18	and	and	CC
cord-005453-4057qib7	859	19	myasthenia	myasthenia	NN
cord-005453-4057qib7	859	20	gravis	gravis	NN
cord-005453-4057qib7	859	21	(	(	-LRB-
cord-005453-4057qib7	859	22	n=2	n=2	NNS
cord-005453-4057qib7	859	23	)	)	-RRB-
cord-005453-4057qib7	859	24	.	.	.
cord-005453-4057qib7	860	1	The	the	DT
cord-005453-4057qib7	860	2	conditioning	conditioning	NN
cord-005453-4057qib7	860	3	regimen	regimen	NN
cord-005453-4057qib7	860	4	administered	administer	VBN
cord-005453-4057qib7	860	5	in	in	IN
cord-005453-4057qib7	860	6	patients	patient	NNS
cord-005453-4057qib7	860	7	with	with	IN
cord-005453-4057qib7	860	8	systemic	systemic	JJ
cord-005453-4057qib7	860	9	sclerosis	sclerosis	NN
cord-005453-4057qib7	860	10	was	be	VBD
cord-005453-4057qib7	860	11	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	860	12	+	+	CC
cord-005453-4057qib7	861	1	human	human	JJ
cord-005453-4057qib7	861	2	anti	anti	NNP
cord-005453-4057qib7	861	3	-	-	JJ
cord-005453-4057qib7	861	4	T	t	JJ
cord-005453-4057qib7	861	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	861	6	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	861	7	,	,	,
cord-005453-4057qib7	861	8	BEAM	BEAM	NNP
cord-005453-4057qib7	861	9	(	(	-LRB-
cord-005453-4057qib7	861	10	Carmustine	Carmustine	NNP
cord-005453-4057qib7	861	11	,	,	,
cord-005453-4057qib7	861	12	Etoposide	Etoposide	NNP
cord-005453-4057qib7	861	13	,	,	,
cord-005453-4057qib7	861	14	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	861	15	(	(	-LRB-
cord-005453-4057qib7	861	16	Ara	Ara	NNP
cord-005453-4057qib7	861	17	-	-	HYPH
cord-005453-4057qib7	861	18	C	C	NNP
cord-005453-4057qib7	861	19	)	)	-RRB-
cord-005453-4057qib7	861	20	,	,	,
cord-005453-4057qib7	861	21	and	and	CC
cord-005453-4057qib7	861	22	Melphalan	Melphalan	NNP
cord-005453-4057qib7	861	23	)	)	-RRB-
cord-005453-4057qib7	861	24	+	+	CC
cord-005453-4057qib7	861	25	Human	human	JJ
cord-005453-4057qib7	861	26	anti	anti	JJ
cord-005453-4057qib7	861	27	-	-	JJ
cord-005453-4057qib7	861	28	T	t	JJ
cord-005453-4057qib7	861	29	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	861	30	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	861	31	in	in	IN
cord-005453-4057qib7	861	32	patients	patient	NNS
cord-005453-4057qib7	861	33	with	with	IN
cord-005453-4057qib7	861	34	multiple	multiple	JJ
cord-005453-4057qib7	861	35	sclerosis	sclerosis	NN
cord-005453-4057qib7	861	36	,	,	,
cord-005453-4057qib7	861	37	and	and	CC
cord-005453-4057qib7	861	38	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	861	39	+	+	CC
cord-005453-4057qib7	861	40	Human	human	JJ
cord-005453-4057qib7	861	41	anti	anti	JJ
cord-005453-4057qib7	861	42	-	-	JJ
cord-005453-4057qib7	861	43	T	t	JJ
cord-005453-4057qib7	861	44	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	861	45	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	861	46	in	in	IN
cord-005453-4057qib7	861	47	myasthenia	myasthenia	NN
cord-005453-4057qib7	861	48	gravis	gravis	NN
cord-005453-4057qib7	861	49	.	.	.
cord-005453-4057qib7	862	1	Median	median	JJ
cord-005453-4057qib7	862	2	time	time	NN
cord-005453-4057qib7	862	3	to	to	IN
cord-005453-4057qib7	862	4	myeloid	myeloid	NN
cord-005453-4057qib7	862	5	engraftment	engraftment	NN
cord-005453-4057qib7	862	6	(	(	-LRB-
cord-005453-4057qib7	862	7	neutrophils>0.5×109	neutrophils>0.5×109	NNP
cord-005453-4057qib7	862	8	/	/	SYM
cord-005453-4057qib7	862	9	L	L	NNP
cord-005453-4057qib7	862	10	)	)	-RRB-
cord-005453-4057qib7	862	11	was	be	VBD
cord-005453-4057qib7	862	12	12	12	CD
cord-005453-4057qib7	862	13	days	day	NNS
cord-005453-4057qib7	862	14	post	post	NN
cord-005453-4057qib7	862	15	-	-	NN
cord-005453-4057qib7	862	16	transplantation	transplantation	NN
cord-005453-4057qib7	862	17	,	,	,
cord-005453-4057qib7	862	18	and	and	CC
cord-005453-4057qib7	862	19	platelet	platelet	NN
cord-005453-4057qib7	862	20	engraftment	engraftment	NN
cord-005453-4057qib7	862	21	,	,	,
cord-005453-4057qib7	862	22	defined	define	VBN
cord-005453-4057qib7	862	23	as	as	IN
cord-005453-4057qib7	862	24	>	>	XX
cord-005453-4057qib7	862	25	20,000	20,000	CD
cord-005453-4057qib7	862	26	platelets	platelet	NNS
cord-005453-4057qib7	862	27	/	/	SYM
cord-005453-4057qib7	862	28	mm	mm	NNP
cord-005453-4057qib7	862	29	3	3	CD
cord-005453-4057qib7	862	30	untransfused	untransfuse	VBD
cord-005453-4057qib7	862	31	,	,	,
cord-005453-4057qib7	862	32	was	be	VBD
cord-005453-4057qib7	862	33	11	11	CD
cord-005453-4057qib7	862	34	days	day	NNS
cord-005453-4057qib7	862	35	post	post	NN
cord-005453-4057qib7	862	36	-	-	JJ
cord-005453-4057qib7	862	37	HSCT	HSCT	NNP
cord-005453-4057qib7	862	38	.	.	.
cord-005453-4057qib7	863	1	Median	median	JJ
cord-005453-4057qib7	863	2	time	time	NN
cord-005453-4057qib7	863	3	of	of	IN
cord-005453-4057qib7	863	4	hospitalization	hospitalization	NN
cord-005453-4057qib7	863	5	was	be	VBD
cord-005453-4057qib7	863	6	21	21	CD
cord-005453-4057qib7	863	7	days	day	NNS
cord-005453-4057qib7	864	1	(	(	-LRB-
cord-005453-4057qib7	864	2	range	range	NNP
cord-005453-4057qib7	864	3	11	11	CD
cord-005453-4057qib7	864	4	-	-	SYM
cord-005453-4057qib7	864	5	66	66	CD
cord-005453-4057qib7	864	6	)	)	-RRB-
cord-005453-4057qib7	864	7	;	;	:
cord-005453-4057qib7	864	8	longer	long	RBR
cord-005453-4057qib7	864	9	in	in	IN
cord-005453-4057qib7	864	10	-	-	HYPH
cord-005453-4057qib7	864	11	patient	patient	NN
cord-005453-4057qib7	864	12	management	management	NN
cord-005453-4057qib7	864	13	was	be	VBD
cord-005453-4057qib7	864	14	due	due	JJ
cord-005453-4057qib7	864	15	to	to	IN
cord-005453-4057qib7	864	16	infectious	infectious	JJ
cord-005453-4057qib7	864	17	complications	complication	NNS
cord-005453-4057qib7	864	18	.	.	.
cord-005453-4057qib7	865	1	Infectious	infectious	JJ
cord-005453-4057qib7	865	2	complications	complication	NNS
cord-005453-4057qib7	865	3	included	include	VBD
cord-005453-4057qib7	865	4	bacteremia	bacteremia	NN
cord-005453-4057qib7	865	5	caused	cause	VBN
cord-005453-4057qib7	865	6	by	by	IN
cord-005453-4057qib7	865	7	E.	E.	NNP
cord-005453-4057qib7	865	8	Coli	Coli	NNP
cord-005453-4057qib7	865	9	and	and	CC
cord-005453-4057qib7	865	10	pneumocystis	pneumocystis	NN
cord-005453-4057qib7	865	11	pneumonia	pneumonia	NN
cord-005453-4057qib7	865	12	that	that	WDT
cord-005453-4057qib7	865	13	resulted	result	VBD
cord-005453-4057qib7	865	14	in	in	IN
cord-005453-4057qib7	865	15	septic	septic	JJ
cord-005453-4057qib7	865	16	shock	shock	NN
cord-005453-4057qib7	865	17	and	and	CC
cord-005453-4057qib7	865	18	acute	acute	JJ
cord-005453-4057qib7	865	19	respiratory	respiratory	JJ
cord-005453-4057qib7	865	20	failure	failure	NN
cord-005453-4057qib7	865	21	,	,	,
cord-005453-4057qib7	865	22	respectively	respectively	RB
cord-005453-4057qib7	865	23	.	.	.
cord-005453-4057qib7	866	1	Evaluating	evaluate	VBG
cord-005453-4057qib7	866	2	T	t	NN
cord-005453-4057qib7	866	3	-	-	HYPH
cord-005453-4057qib7	866	4	cell	cell	NN
cord-005453-4057qib7	866	5	immune	immune	JJ
cord-005453-4057qib7	866	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	866	7	,	,	,
cord-005453-4057qib7	866	8	none	none	NN
cord-005453-4057qib7	866	9	of	of	IN
cord-005453-4057qib7	866	10	the	the	DT
cord-005453-4057qib7	866	11	patients	patient	NNS
cord-005453-4057qib7	866	12	had	have	VBD
cord-005453-4057qib7	866	13	reached	reach	VBN
cord-005453-4057qib7	866	14	normal	normal	JJ
cord-005453-4057qib7	866	15	CD4	CD4	NNP
cord-005453-4057qib7	866	16	+	+	CC
cord-005453-4057qib7	866	17	cell	cell	NN
cord-005453-4057qib7	866	18	value	value	NN
cord-005453-4057qib7	866	19	after	after	IN
cord-005453-4057qib7	866	20	one	one	CD
cord-005453-4057qib7	866	21	year	year	NN
cord-005453-4057qib7	866	22	of	of	IN
cord-005453-4057qib7	866	23	HSCT	HSCT	NNP
cord-005453-4057qib7	866	24	follow	follow	NN
cord-005453-4057qib7	866	25	-	-	HYPH
cord-005453-4057qib7	866	26	up	up	NN
cord-005453-4057qib7	866	27	.	.	.
cord-005453-4057qib7	867	1	Four	four	CD
cord-005453-4057qib7	867	2	patients	patient	NNS
cord-005453-4057qib7	867	3	(	(	-LRB-
cord-005453-4057qib7	867	4	57.1	57.1	CD
cord-005453-4057qib7	867	5	%	%	NN
cord-005453-4057qib7	867	6	)	)	-RRB-
cord-005453-4057qib7	867	7	reached	reach	VBD
cord-005453-4057qib7	867	8	normal	normal	JJ
cord-005453-4057qib7	867	9	CD8	CD8	NNS
cord-005453-4057qib7	867	10	+	+	CC
cord-005453-4057qib7	867	11	cells	cell	NNS
cord-005453-4057qib7	867	12	value	value	NN
cord-005453-4057qib7	867	13	at	at	IN
cord-005453-4057qib7	867	14	3	3	CD
cord-005453-4057qib7	867	15	months	month	NNS
cord-005453-4057qib7	867	16	post	post	JJ
cord-005453-4057qib7	867	17	-	-	JJ
cord-005453-4057qib7	867	18	HSCT	HSCT	NNP
cord-005453-4057qib7	867	19	.	.	.
cord-005453-4057qib7	868	1	Regarding	regard	VBG
cord-005453-4057qib7	868	2	Bcell	Bcell	NNP
cord-005453-4057qib7	868	3	immune	immune	JJ
cord-005453-4057qib7	868	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	868	5	,	,	,
cord-005453-4057qib7	868	6	85.7	85.7	CD
cord-005453-4057qib7	868	7	%	%	NN
cord-005453-4057qib7	868	8	of	of	IN
cord-005453-4057qib7	868	9	the	the	DT
cord-005453-4057qib7	868	10	patients	patient	NNS
cord-005453-4057qib7	868	11	(	(	-LRB-
cord-005453-4057qib7	868	12	6/7	6/7	CD
cord-005453-4057qib7	868	13	)	)	-RRB-
cord-005453-4057qib7	868	14	had	have	VBD
cord-005453-4057qib7	868	15	reached	reach	VBN
cord-005453-4057qib7	868	16	both	both	DT
cord-005453-4057qib7	868	17	IgG	IgG	NNP
cord-005453-4057qib7	868	18	and	and	CC
cord-005453-4057qib7	868	19	IgA	IgA	NNP
cord-005453-4057qib7	868	20	normal	normal	JJ
cord-005453-4057qib7	868	21	levels	level	NNS
cord-005453-4057qib7	868	22	at	at	IN
cord-005453-4057qib7	868	23	one	one	CD
cord-005453-4057qib7	868	24	-	-	HYPH
cord-005453-4057qib7	868	25	month	month	NN
cord-005453-4057qib7	868	26	post	post	NN
cord-005453-4057qib7	868	27	-	-	JJ
cord-005453-4057qib7	868	28	HSCT	HSCT	NNP
cord-005453-4057qib7	868	29	,	,	,
cord-005453-4057qib7	868	30	and	and	CC
cord-005453-4057qib7	868	31	four	four	CD
cord-005453-4057qib7	868	32	patients	patient	NNS
cord-005453-4057qib7	868	33	(	(	-LRB-
cord-005453-4057qib7	868	34	57.1	57.1	CD
cord-005453-4057qib7	868	35	%	%	NN
cord-005453-4057qib7	868	36	)	)	-RRB-
cord-005453-4057qib7	868	37	had	have	VBD
cord-005453-4057qib7	868	38	achieved	achieve	VBN
cord-005453-4057qib7	868	39	normal	normal	JJ
cord-005453-4057qib7	868	40	IgM	igm	NN
cord-005453-4057qib7	868	41	Background	Background	NNP
cord-005453-4057qib7	868	42	:	:	:
cord-005453-4057qib7	868	43	Multiple	Multiple	NNP
cord-005453-4057qib7	868	44	sclerosis(MS	sclerosis(MS	NNPS
cord-005453-4057qib7	868	45	)	)	-RRB-
cord-005453-4057qib7	868	46	is	be	VBZ
cord-005453-4057qib7	868	47	an	an	DT
cord-005453-4057qib7	868	48	inflammatory	inflammatory	JJ
cord-005453-4057qib7	868	49	disease	disease	NN
cord-005453-4057qib7	868	50	caused	cause	VBN
cord-005453-4057qib7	868	51	by	by	IN
cord-005453-4057qib7	868	52	autoimmune	autoimmune	JJ
cord-005453-4057qib7	868	53	reactivity	reactivity	NN
cord-005453-4057qib7	868	54	of	of	IN
cord-005453-4057qib7	868	55	T	T	NNP
cord-005453-4057qib7	868	56	cells	cell	NNS
cord-005453-4057qib7	868	57	against	against	IN
cord-005453-4057qib7	868	58	myelin	myelin	NN
cord-005453-4057qib7	868	59	.	.	.
cord-005453-4057qib7	869	1	There	there	EX
cord-005453-4057qib7	869	2	is	be	VBZ
cord-005453-4057qib7	869	3	accumulating	accumulate	VBG
cord-005453-4057qib7	869	4	evidence	evidence	NN
cord-005453-4057qib7	869	5	of	of	IN
cord-005453-4057qib7	869	6	the	the	DT
cord-005453-4057qib7	869	7	efficacy	efficacy	NN
cord-005453-4057qib7	869	8	of	of	IN
cord-005453-4057qib7	869	9	highdose	highdose	NN
cord-005453-4057qib7	869	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	869	11	followed	follow	VBN
cord-005453-4057qib7	869	12	by	by	IN
cord-005453-4057qib7	869	13	autologous	autologous	JJ
cord-005453-4057qib7	869	14	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	869	15	stem	stem	NN
cord-005453-4057qib7	869	16	cell	cell	NN
cord-005453-4057qib7	869	17	transplantation(aHSCT	transplantation(aHSCT	NNP
cord-005453-4057qib7	869	18	)	)	-RRB-
cord-005453-4057qib7	869	19	in	in	IN
cord-005453-4057qib7	869	20	MS	MS	NNP
cord-005453-4057qib7	869	21	patients	patient	NNS
cord-005453-4057qib7	869	22	who	who	WP
cord-005453-4057qib7	869	23	failed	fail	VBD
cord-005453-4057qib7	869	24	response	response	NN
cord-005453-4057qib7	869	25	to	to	IN
cord-005453-4057qib7	869	26	standard	standard	JJ
cord-005453-4057qib7	869	27	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	869	28	,	,	,
cord-005453-4057qib7	869	29	despite	despite	IN
cord-005453-4057qib7	869	30	a	a	DT
cord-005453-4057qib7	869	31	variability	variability	NN
cord-005453-4057qib7	869	32	in	in	IN
cord-005453-4057qib7	869	33	eligibility	eligibility	NN
cord-005453-4057qib7	869	34	criteria	criterion	NNS
cord-005453-4057qib7	869	35	,	,	,
cord-005453-4057qib7	869	36	conditioning	conditioning	NN
cord-005453-4057qib7	869	37	regimens	regimen	NNS
cord-005453-4057qib7	869	38	and	and	CC
cord-005453-4057qib7	869	39	outcome	outcome	NN
cord-005453-4057qib7	869	40	.	.	.
cord-005453-4057qib7	870	1	Methods	method	NNS
cord-005453-4057qib7	871	1	:	:	:
cord-005453-4057qib7	871	2	We	-PRON-	PRP
cord-005453-4057qib7	871	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	871	4	reviewed	review	VBD
cord-005453-4057qib7	871	5	MS	MS	NNP
cord-005453-4057qib7	871	6	patients	patient	NNS
cord-005453-4057qib7	871	7	submitted	submit	VBN
cord-005453-4057qib7	871	8	to	to	IN
cord-005453-4057qib7	871	9	aHSCT	ahsct	VB
cord-005453-4057qib7	871	10	in	in	IN
cord-005453-4057qib7	871	11	our	-PRON-	PRP$
cord-005453-4057qib7	871	12	centre	centre	NN
cord-005453-4057qib7	871	13	(	(	-LRB-
cord-005453-4057qib7	871	14	2014	2014	CD
cord-005453-4057qib7	871	15	)	)	-RRB-
cord-005453-4057qib7	871	16	(	(	-LRB-
cord-005453-4057qib7	871	17	2015	2015	CD
cord-005453-4057qib7	871	18	)	)	-RRB-
cord-005453-4057qib7	871	19	(	(	-LRB-
cord-005453-4057qib7	871	20	2016	2016	CD
cord-005453-4057qib7	871	21	)	)	-RRB-
cord-005453-4057qib7	871	22	(	(	-LRB-
cord-005453-4057qib7	871	23	2017	2017	CD
cord-005453-4057qib7	871	24	)	)	-RRB-
cord-005453-4057qib7	871	25	(	(	-LRB-
cord-005453-4057qib7	871	26	2018	2018	CD
cord-005453-4057qib7	871	27	)	)	-RRB-
cord-005453-4057qib7	871	28	.	.	.
cord-005453-4057qib7	872	1	Patient	patient	JJ
cord-005453-4057qib7	872	2	eligibility	eligibility	NN
cord-005453-4057qib7	872	3	criteria	criterion	NNS
cord-005453-4057qib7	872	4	were	be	VBD
cord-005453-4057qib7	872	5	active	active	JJ
cord-005453-4057qib7	872	6	relapsing	relapse	VBG
cord-005453-4057qib7	872	7	remitting(RRMS	remitting(RRMS	-LRB-
cord-005453-4057qib7	872	8	)	)	-RRB-
cord-005453-4057qib7	872	9	or	or	CC
cord-005453-4057qib7	872	10	secondary	secondary	JJ
cord-005453-4057qib7	872	11	-	-	HYPH
cord-005453-4057qib7	872	12	progressive	progressive	JJ
cord-005453-4057qib7	872	13	MS	MS	NNP
cord-005453-4057qib7	872	14	(	(	-LRB-
cord-005453-4057qib7	872	15	SPMS	SPMS	NNP
cord-005453-4057qib7	872	16	)	)	-RRB-
cord-005453-4057qib7	872	17	,	,	,
cord-005453-4057qib7	872	18	with	with	IN
cord-005453-4057qib7	872	19	prior	prior	JJ
cord-005453-4057qib7	872	20	failure	failure	NN
cord-005453-4057qib7	872	21	to	to	IN
cord-005453-4057qib7	872	22	treatment	treatment	NN
cord-005453-4057qib7	872	23	with	with	IN
cord-005453-4057qib7	872	24	disease	disease	NN
cord-005453-4057qib7	872	25	-	-	HYPH
cord-005453-4057qib7	872	26	modifying	modify	VBG
cord-005453-4057qib7	872	27	therapies	therapy	NNS
cord-005453-4057qib7	872	28	and	and	CC
cord-005453-4057qib7	872	29	evidence	evidence	NN
cord-005453-4057qib7	872	30	of	of	IN
cord-005453-4057qib7	872	31	disease	disease	NN
cord-005453-4057qib7	872	32	activity	activity	NN
cord-005453-4057qib7	872	33	(	(	-LRB-
cord-005453-4057qib7	872	34	clinical	clinical	JJ
cord-005453-4057qib7	872	35	relapse	relapse	NN
cord-005453-4057qib7	872	36	or	or	CC
cord-005453-4057qib7	872	37	new	new	JJ
cord-005453-4057qib7	872	38	active	active	JJ
cord-005453-4057qib7	872	39	lesions	lesion	NNS
cord-005453-4057qib7	872	40	in	in	IN
cord-005453-4057qib7	872	41	magnetic	magnetic	JJ
cord-005453-4057qib7	872	42	resonance	resonance	NN
cord-005453-4057qib7	872	43	[	[	-LRB-
cord-005453-4057qib7	872	44	MR	MR	NNP
cord-005453-4057qib7	872	45	]	]	-RRB-
cord-005453-4057qib7	872	46	)	)	-RRB-
cord-005453-4057qib7	872	47	.	.	.
cord-005453-4057qib7	873	1	Mobilization	mobilization	NN
cord-005453-4057qib7	873	2	of	of	IN
cord-005453-4057qib7	873	3	CD34+cells	CD34+cells	NNPS
cord-005453-4057qib7	873	4	to	to	IN
cord-005453-4057qib7	873	5	peripheral	peripheral	JJ
cord-005453-4057qib7	873	6	blood	blood	NN
cord-005453-4057qib7	873	7	was	be	VBD
cord-005453-4057qib7	873	8	performed	perform	VBN
cord-005453-4057qib7	873	9	with	with	IN
cord-005453-4057qib7	873	10	granulocyte	granulocyte	NNP
cord-005453-4057qib7	873	11	colony	colony	NN
cord-005453-4057qib7	873	12	-	-	HYPH
cord-005453-4057qib7	873	13	stimulating	stimulate	VBG
cord-005453-4057qib7	873	14	factor(G	factor(G	NNP
cord-005453-4057qib7	873	15	-	-	HYPH
cord-005453-4057qib7	873	16	CSF	CSF	NNP
cord-005453-4057qib7	873	17	10μg	10μg	NN
cord-005453-4057qib7	873	18	/	/	SYM
cord-005453-4057qib7	873	19	kg	kg	NN
cord-005453-4057qib7	873	20	/	/	SYM
cord-005453-4057qib7	873	21	day	day	NN
cord-005453-4057qib7	873	22	)	)	-RRB-
cord-005453-4057qib7	873	23	and	and	CC
cord-005453-4057qib7	873	24	conditioning	conditioning	NN
cord-005453-4057qib7	873	25	regimen	regimen	NN
cord-005453-4057qib7	873	26	according	accord	VBG
cord-005453-4057qib7	873	27	to	to	IN
cord-005453-4057qib7	873	28	BEAM	beam	NN
cord-005453-4057qib7	873	29	protocol	protocol	NN
cord-005453-4057qib7	873	30	.	.	.
cord-005453-4057qib7	874	1	The	the	DT
cord-005453-4057qib7	874	2	severity	severity	NN
cord-005453-4057qib7	874	3	of	of	IN
cord-005453-4057qib7	874	4	MS	MS	NNP
cord-005453-4057qib7	874	5	disability	disability	NN
cord-005453-4057qib7	874	6	was	be	VBD
cord-005453-4057qib7	874	7	classified	classify	VBN
cord-005453-4057qib7	874	8	according	accord	VBG
cord-005453-4057qib7	874	9	to	to	IN
cord-005453-4057qib7	874	10	the	the	DT
cord-005453-4057qib7	874	11	Expanded	Expanded	NNP
cord-005453-4057qib7	874	12	Disability	Disability	NNP
cord-005453-4057qib7	874	13	-	-	HYPH
cord-005453-4057qib7	874	14	Status	Status	NNP
cord-005453-4057qib7	874	15	Scale	scale	NN
cord-005453-4057qib7	874	16	(	(	-LRB-
cord-005453-4057qib7	874	17	EDSS	EDSS	NNP
cord-005453-4057qib7	874	18	)	)	-RRB-
cord-005453-4057qib7	874	19	and	and	CC
cord-005453-4057qib7	874	20	aHSCT	ahsct	JJ
cord-005453-4057qib7	874	21	toxicity	toxicity	NN
cord-005453-4057qib7	874	22	was	be	VBD
cord-005453-4057qib7	874	23	evaluated	evaluate	VBN
cord-005453-4057qib7	874	24	by	by	IN
cord-005453-4057qib7	874	25	CTCAEv5.0	CTCAEv5.0	NNP
cord-005453-4057qib7	874	26	.	.	.
cord-005453-4057qib7	875	1	Results	result	NNS
cord-005453-4057qib7	875	2	:	:	:
cord-005453-4057qib7	876	1	Seven	seven	CD
cord-005453-4057qib7	876	2	MS	MS	NNP
cord-005453-4057qib7	876	3	patients	patient	NNS
cord-005453-4057qib7	876	4	had	have	VBD
cord-005453-4057qib7	876	5	undergone	undergo	VBN
cord-005453-4057qib7	876	6	aHSCT	ahsct	NN
cord-005453-4057qib7	876	7	(	(	-LRB-
cord-005453-4057qib7	876	8	4	4	CD
cord-005453-4057qib7	876	9	female/3	female/3	NNP
cord-005453-4057qib7	876	10	male	male	NNP
cord-005453-4057qib7	876	11	)	)	-RRB-
cord-005453-4057qib7	876	12	,	,	,
cord-005453-4057qib7	876	13	with	with	IN
cord-005453-4057qib7	876	14	a	a	DT
cord-005453-4057qib7	876	15	median	median	JJ
cord-005453-4057qib7	876	16	age	age	NN
cord-005453-4057qib7	876	17	at	at	IN
cord-005453-4057qib7	876	18	aHSCT	ahsct	NN
cord-005453-4057qib7	876	19	of	of	IN
cord-005453-4057qib7	876	20	39.9	39.9	CD
cord-005453-4057qib7	876	21	years	year	NNS
cord-005453-4057qib7	876	22	(	(	-LRB-
cord-005453-4057qib7	876	23	32	32	CD
cord-005453-4057qib7	876	24	)	)	-RRB-
cord-005453-4057qib7	877	1	(	(	-LRB-
cord-005453-4057qib7	877	2	33	33	CD
cord-005453-4057qib7	877	3	)	)	-RRB-
cord-005453-4057qib7	878	1	(	(	-LRB-
cord-005453-4057qib7	878	2	34	34	CD
cord-005453-4057qib7	878	3	)	)	-RRB-
cord-005453-4057qib7	879	1	(	(	-LRB-
cord-005453-4057qib7	879	2	35	35	CD
cord-005453-4057qib7	879	3	)	)	-RRB-
cord-005453-4057qib7	879	4	(	(	-LRB-
cord-005453-4057qib7	879	5	36	36	CD
cord-005453-4057qib7	879	6	)	)	-RRB-
cord-005453-4057qib7	879	7	(	(	-LRB-
cord-005453-4057qib7	879	8	37	37	CD
cord-005453-4057qib7	879	9	)	)	-RRB-
cord-005453-4057qib7	880	1	(	(	-LRB-
cord-005453-4057qib7	880	2	38	38	CD
cord-005453-4057qib7	880	3	)	)	-RRB-
cord-005453-4057qib7	881	1	(	(	-LRB-
cord-005453-4057qib7	881	2	39	39	CD
cord-005453-4057qib7	881	3	)	)	-RRB-
cord-005453-4057qib7	882	1	(	(	-LRB-
cord-005453-4057qib7	882	2	40	40	CD
cord-005453-4057qib7	882	3	)	)	-RRB-
cord-005453-4057qib7	882	4	(	(	-LRB-
cord-005453-4057qib7	882	5	41	41	CD
cord-005453-4057qib7	882	6	)	)	-RRB-
cord-005453-4057qib7	882	7	(	(	-LRB-
cord-005453-4057qib7	882	8	42	42	CD
cord-005453-4057qib7	882	9	)	)	-RRB-
cord-005453-4057qib7	882	10	.	.	.
cord-005453-4057qib7	883	1	Median	median	JJ
cord-005453-4057qib7	883	2	age	age	NN
cord-005453-4057qib7	883	3	at	at	IN
cord-005453-4057qib7	883	4	MS	MS	NNP
cord-005453-4057qib7	883	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	883	6	was	be	VBD
cord-005453-4057qib7	883	7	31.6	31.6	CD
cord-005453-4057qib7	883	8	years(27	years(27	NNP
cord-005453-4057qib7	883	9	-	-	HYPH
cord-005453-4057qib7	883	10	36	36	CD
cord-005453-4057qib7	883	11	)	)	-RRB-
cord-005453-4057qib7	883	12	and	and	CC
cord-005453-4057qib7	883	13	median	median	JJ
cord-005453-4057qib7	883	14	time	time	NN
cord-005453-4057qib7	883	15	from	from	IN
cord-005453-4057qib7	883	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	883	17	until	until	IN
cord-005453-4057qib7	883	18	aHSCT	aHSCT	NNP
cord-005453-4057qib7	883	19	was	be	VBD
cord-005453-4057qib7	883	20	6.8	6.8	CD
cord-005453-4057qib7	883	21	years	year	NNS
cord-005453-4057qib7	883	22	(	(	-LRB-
cord-005453-4057qib7	883	23	3	3	LS
cord-005453-4057qib7	883	24	)	)	-RRB-
cord-005453-4057qib7	883	25	(	(	-LRB-
cord-005453-4057qib7	883	26	4	4	LS
cord-005453-4057qib7	883	27	)	)	-RRB-
cord-005453-4057qib7	883	28	(	(	-LRB-
cord-005453-4057qib7	883	29	5	5	LS
cord-005453-4057qib7	883	30	)	)	-RRB-
cord-005453-4057qib7	883	31	(	(	-LRB-
cord-005453-4057qib7	883	32	6	6	LS
cord-005453-4057qib7	883	33	)	)	-RRB-
cord-005453-4057qib7	883	34	(	(	-LRB-
cord-005453-4057qib7	883	35	7	7	LS
cord-005453-4057qib7	883	36	)	)	-RRB-
cord-005453-4057qib7	883	37	(	(	-LRB-
cord-005453-4057qib7	883	38	8)	8)	NNP
cord-005453-4057qib7	883	39	(	(	-LRB-
cord-005453-4057qib7	883	40	9	9	CD
cord-005453-4057qib7	883	41	)	)	-RRB-
cord-005453-4057qib7	883	42	(	(	-LRB-
cord-005453-4057qib7	883	43	10	10	CD
cord-005453-4057qib7	883	44	)	)	-RRB-
cord-005453-4057qib7	883	45	(	(	-LRB-
cord-005453-4057qib7	883	46	11	11	CD
cord-005453-4057qib7	883	47	)	)	-RRB-
cord-005453-4057qib7	883	48	(	(	-LRB-
cord-005453-4057qib7	883	49	12	12	CD
cord-005453-4057qib7	883	50	)	)	-RRB-
cord-005453-4057qib7	883	51	(	(	-LRB-
cord-005453-4057qib7	883	52	13	13	CD
cord-005453-4057qib7	883	53	)	)	-RRB-
cord-005453-4057qib7	883	54	.	.	.
cord-005453-4057qib7	884	1	Four	four	CD
cord-005453-4057qib7	884	2	patients	patient	NNS
cord-005453-4057qib7	884	3	(	(	-LRB-
cord-005453-4057qib7	884	4	57.1	57.1	CD
cord-005453-4057qib7	884	5	%	%	NN
cord-005453-4057qib7	884	6	)	)	-RRB-
cord-005453-4057qib7	884	7	had	have	VBD
cord-005453-4057qib7	884	8	SPMS	SPMS	NNP
cord-005453-4057qib7	884	9	and	and	CC
cord-005453-4057qib7	884	10	3(42.9	3(42.9	CD
cord-005453-4057qib7	884	11	%	%	NN
cord-005453-4057qib7	884	12	)	)	-RRB-
cord-005453-4057qib7	884	13	had	have	VBD
cord-005453-4057qib7	884	14	RRMS	rrm	NNS
cord-005453-4057qib7	884	15	,	,	,
cord-005453-4057qib7	884	16	with	with	IN
cord-005453-4057qib7	884	17	4(57.1	4(57.1	CD
cord-005453-4057qib7	884	18	%	%	NN
cord-005453-4057qib7	884	19	)	)	-RRB-
cord-005453-4057qib7	884	20	having	have	VBG
cord-005453-4057qib7	884	21	MR	MR	NNP
cord-005453-4057qib7	884	22	active	active	JJ
cord-005453-4057qib7	884	23	lesions	lesion	NNS
cord-005453-4057qib7	884	24	.	.	.
cord-005453-4057qib7	885	1	Pre	pre	JJ
cord-005453-4057qib7	885	2	-	-	JJ
cord-005453-4057qib7	885	3	aHSCT	ahsct	JJ
cord-005453-4057qib7	885	4	relapse	relapse	NN
cord-005453-4057qib7	885	5	rate	rate	NN
cord-005453-4057qib7	885	6	per	per	IN
cord-005453-4057qib7	885	7	year	year	NN
cord-005453-4057qib7	885	8	was	be	VBD
cord-005453-4057qib7	885	9	2	2	CD
cord-005453-4057qib7	885	10	(	(	-LRB-
cord-005453-4057qib7	885	11	1	1	CD
cord-005453-4057qib7	885	12	)	)	-RRB-
cord-005453-4057qib7	885	13	(	(	-LRB-
cord-005453-4057qib7	885	14	2	2	LS
cord-005453-4057qib7	885	15	)	)	-RRB-
cord-005453-4057qib7	885	16	(	(	-LRB-
cord-005453-4057qib7	885	17	3	3	LS
cord-005453-4057qib7	885	18	)	)	-RRB-
cord-005453-4057qib7	885	19	(	(	-LRB-
cord-005453-4057qib7	885	20	4	4	LS
cord-005453-4057qib7	885	21	)	)	-RRB-
cord-005453-4057qib7	885	22	.	.	.
cord-005453-4057qib7	886	1	Median	median	JJ
cord-005453-4057qib7	886	2	baseline	baseline	JJ
cord-005453-4057qib7	886	3	EDSS	EDSS	NNP
cord-005453-4057qib7	886	4	was	be	VBD
cord-005453-4057qib7	886	5	6.5(5.5	6.5(5.5	CD
cord-005453-4057qib7	886	6	-	-	SYM
cord-005453-4057qib7	886	7	7.5	7.5	CD
cord-005453-4057qib7	886	8	)	)	-RRB-
cord-005453-4057qib7	886	9	.	.	.
cord-005453-4057qib7	887	1	Median	median	JJ
cord-005453-4057qib7	887	2	number	number	NN
cord-005453-4057qib7	887	3	of	of	IN
cord-005453-4057qib7	887	4	previous	previous	JJ
cord-005453-4057qib7	887	5	DMTs	dmt	NNS
cord-005453-4057qib7	887	6	was	be	VBD
cord-005453-4057qib7	887	7	6	6	CD
cord-005453-4057qib7	887	8	(	(	-LRB-
cord-005453-4057qib7	887	9	3	3	CD
cord-005453-4057qib7	887	10	)	)	-RRB-
cord-005453-4057qib7	887	11	(	(	-LRB-
cord-005453-4057qib7	887	12	4	4	LS
cord-005453-4057qib7	887	13	)	)	-RRB-
cord-005453-4057qib7	887	14	(	(	-LRB-
cord-005453-4057qib7	887	15	5	5	LS
cord-005453-4057qib7	887	16	)	)	-RRB-
cord-005453-4057qib7	887	17	(	(	-LRB-
cord-005453-4057qib7	887	18	6	6	LS
cord-005453-4057qib7	887	19	)	)	-RRB-
cord-005453-4057qib7	887	20	(	(	-LRB-
cord-005453-4057qib7	887	21	7	7	LS
cord-005453-4057qib7	887	22	)	)	-RRB-
cord-005453-4057qib7	887	23	(	(	-LRB-
cord-005453-4057qib7	887	24	8)	8)	NNP
cord-005453-4057qib7	887	25	(	(	-LRB-
cord-005453-4057qib7	887	26	9	9	CD
cord-005453-4057qib7	887	27	)	)	-RRB-
cord-005453-4057qib7	887	28	.	.	.
cord-005453-4057qib7	888	1	All	all	DT
cord-005453-4057qib7	888	2	patients	patient	NNS
cord-005453-4057qib7	888	3	had	have	VBD
cord-005453-4057qib7	888	4	been	be	VBN
cord-005453-4057qib7	888	5	treated	treat	VBN
cord-005453-4057qib7	888	6	with	with	IN
cord-005453-4057qib7	888	7	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	888	8	and	and	CC
cord-005453-4057qib7	888	9	copaxone	copaxone	NNP
cord-005453-4057qib7	888	10	,	,	,
cord-005453-4057qib7	888	11	5(71.4	5(71.4	CD
cord-005453-4057qib7	888	12	%	%	NN
cord-005453-4057qib7	888	13	)	)	-RRB-
cord-005453-4057qib7	888	14	received	receive	VBD
cord-005453-4057qib7	888	15	rituximab	rituximab	NN
cord-005453-4057qib7	888	16	,	,	,
cord-005453-4057qib7	888	17	6	6	CD
cord-005453-4057qib7	888	18	(	(	-LRB-
cord-005453-4057qib7	888	19	85.7	85.7	CD
cord-005453-4057qib7	888	20	%	%	NN
cord-005453-4057qib7	888	21	)	)	-RRB-
cord-005453-4057qib7	888	22	natalizumab	natalizumab	NNS
cord-005453-4057qib7	888	23	,	,	,
cord-005453-4057qib7	888	24	1	1	CD
cord-005453-4057qib7	888	25	(	(	-LRB-
cord-005453-4057qib7	888	26	14.3	14.3	CD
cord-005453-4057qib7	888	27	%	%	NN
cord-005453-4057qib7	888	28	)	)	-RRB-
cord-005453-4057qib7	888	29	alemtuzumab	alemtuzumab	NNP
cord-005453-4057qib7	888	30	,	,	,
cord-005453-4057qib7	888	31	2(28.6	2(28.6	CD
cord-005453-4057qib7	888	32	%	%	NN
cord-005453-4057qib7	888	33	)	)	-RRB-
cord-005453-4057qib7	888	34	fampridine	fampridine	NN
cord-005453-4057qib7	888	35	and	and	CC
cord-005453-4057qib7	888	36	2(28.6	2(28.6	CD
cord-005453-4057qib7	888	37	%	%	NN
cord-005453-4057qib7	888	38	)	)	-RRB-
cord-005453-4057qib7	888	39	fingolimod	fingolimod	NNP
cord-005453-4057qib7	888	40	.	.	.
cord-005453-4057qib7	889	1	All	all	DT
cord-005453-4057qib7	889	2	patients	patient	NNS
cord-005453-4057qib7	889	3	collected	collect	VBD
cord-005453-4057qib7	889	4	enough	enough	JJ
cord-005453-4057qib7	889	5	CD34	CD34	NNP
cord-005453-4057qib7	889	6	+	+	CC
cord-005453-4057qib7	889	7	cells	cell	NNS
cord-005453-4057qib7	889	8	in	in	IN
cord-005453-4057qib7	889	9	a	a	DT
cord-005453-4057qib7	889	10	single	single	JJ
cord-005453-4057qib7	889	11	apheresis	apheresis	NN
cord-005453-4057qib7	889	12	session	session	NN
cord-005453-4057qib7	889	13	.	.	.
cord-005453-4057qib7	890	1	Median	median	JJ
cord-005453-4057qib7	890	2	number	number	NN
cord-005453-4057qib7	890	3	of	of	IN
cord-005453-4057qib7	890	4	CD34	CD34	NNP
cord-005453-4057qib7	890	5	+	+	CC
cord-005453-4057qib7	890	6	cells	cell	NNS
cord-005453-4057qib7	890	7	infused	infuse	VBN
cord-005453-4057qib7	890	8	was	be	VBD
cord-005453-4057qib7	890	9	7.2±3.8x10	7.2±3.8x10	CD
cord-005453-4057qib7	890	10	^	^	SYM
cord-005453-4057qib7	890	11	6	6	CD
cord-005453-4057qib7	890	12	/	/	SYM
cord-005453-4057qib7	890	13	kg	kg	NNS
cord-005453-4057qib7	890	14	,	,	,
cord-005453-4057qib7	890	15	for	for	IN
cord-005453-4057qib7	890	16	a	a	DT
cord-005453-4057qib7	890	17	mean	mean	JJ
cord-005453-4057qib7	890	18	DMSO	DMSO	NNP
cord-005453-4057qib7	890	19	volume	volume	NN
cord-005453-4057qib7	890	20	of	of	IN
cord-005453-4057qib7	890	21	50.4	50.4	CD
cord-005453-4057qib7	890	22	±14.8	±14.8	NNP
cord-005453-4057qib7	890	23	mL.	mL.	.
cord-005453-4057qib7	890	24	Median	median	JJ
cord-005453-4057qib7	890	25	inpatient	inpatient	JJ
cord-005453-4057qib7	890	26	stay	stay	NN
cord-005453-4057qib7	890	27	during	during	IN
cord-005453-4057qib7	890	28	aHSCT	ahsct	NN
cord-005453-4057qib7	891	1	was	be	VBD
cord-005453-4057qib7	891	2	28	28	CD
cord-005453-4057qib7	892	1	days(21	days(21	NNP
cord-005453-4057qib7	892	2	-	-	:
cord-005453-4057qib7	892	3	47	47	CD
cord-005453-4057qib7	892	4	)	)	-RRB-
cord-005453-4057qib7	892	5	.	.	.
cord-005453-4057qib7	893	1	All	all	DT
cord-005453-4057qib7	893	2	patients	patient	NNS
cord-005453-4057qib7	893	3	developed	develop	VBD
cord-005453-4057qib7	893	4	febrile	febrile	JJ
cord-005453-4057qib7	893	5	neutropenia	neutropenia	NN
cord-005453-4057qib7	893	6	,	,	,
cord-005453-4057qib7	893	7	one	one	CD
cord-005453-4057qib7	893	8	was	be	VBD
cord-005453-4057qib7	893	9	admitted	admit	VBN
cord-005453-4057qib7	893	10	to	to	IN
cord-005453-4057qib7	893	11	intensive	intensive	JJ
cord-005453-4057qib7	893	12	care	care	NN
cord-005453-4057qib7	893	13	unit	unit	NN
cord-005453-4057qib7	893	14	due	due	JJ
cord-005453-4057qib7	893	15	to	to	IN
cord-005453-4057qib7	893	16	sepsis	sepsis	NN
cord-005453-4057qib7	893	17	.	.	.
cord-005453-4057qib7	894	1	One	one	CD
cord-005453-4057qib7	894	2	patient	patient	NN
cord-005453-4057qib7	894	3	developed	develop	VBD
cord-005453-4057qib7	894	4	an	an	DT
cord-005453-4057qib7	894	5	anaphylactic	anaphylactic	JJ
cord-005453-4057qib7	894	6	reaction	reaction	NN
cord-005453-4057qib7	894	7	to	to	IN
cord-005453-4057qib7	894	8	transfusion	transfusion	NN
cord-005453-4057qib7	894	9	and	and	CC
cord-005453-4057qib7	894	10	another	another	DT
cord-005453-4057qib7	894	11	a	a	DT
cord-005453-4057qib7	894	12	self	self	NN
cord-005453-4057qib7	894	13	-	-	HYPH
cord-005453-4057qib7	894	14	limited	limit	VBN
cord-005453-4057qib7	894	15	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	894	16	.	.	.
cord-005453-4057qib7	895	1	Two	two	CD
cord-005453-4057qib7	895	2	(	(	-LRB-
cord-005453-4057qib7	895	3	28.7	28.7	CD
cord-005453-4057qib7	895	4	%	%	NN
cord-005453-4057qib7	895	5	)	)	-RRB-
cord-005453-4057qib7	895	6	patients	patient	NNS
cord-005453-4057qib7	895	7	had	have	VBD
cord-005453-4057qib7	895	8	grade≥2	grade≥2	NNP
cord-005453-4057qib7	895	9	oral	oral	JJ
cord-005453-4057qib7	895	10	mucositis	mucositis	NN
cord-005453-4057qib7	895	11	,	,	,
cord-005453-4057qib7	895	12	and	and	CC
cord-005453-4057qib7	895	13	all	all	DT
cord-005453-4057qib7	895	14	had	have	VBD
cord-005453-4057qib7	895	15	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	895	16	toxicity	toxicity	NN
cord-005453-4057qib7	895	17	(	(	-LRB-
cord-005453-4057qib7	895	18	grade	grade	NN
cord-005453-4057qib7	895	19	2	2	CD
cord-005453-4057qib7	895	20	-	-	SYM
cord-005453-4057qib7	895	21	3	3	CD
cord-005453-4057qib7	895	22	)	)	-RRB-
cord-005453-4057qib7	895	23	.	.	.
cord-005453-4057qib7	896	1	Median	median	JJ
cord-005453-4057qib7	896	2	time	time	NN
cord-005453-4057qib7	896	3	until	until	IN
cord-005453-4057qib7	896	4	neutrophils>500	neutrophils>500	CD
cord-005453-4057qib7	897	1	/μL	/μL	:
cord-005453-4057qib7	897	2	was	be	VBD
cord-005453-4057qib7	897	3	11(6	11(6	CD
cord-005453-4057qib7	897	4	-	-	SYM
cord-005453-4057qib7	897	5	12	12	CD
cord-005453-4057qib7	897	6	)	)	-RRB-
cord-005453-4057qib7	897	7	days	day	NNS
cord-005453-4057qib7	897	8	,	,	,
cord-005453-4057qib7	897	9	to	to	IN
cord-005453-4057qib7	897	10	platelets>20,000	platelets>20,000	ADD
cord-005453-4057qib7	898	1	/μL	/μL	:
cord-005453-4057qib7	898	2	was	be	VBD
cord-005453-4057qib7	898	3	9	9	CD
cord-005453-4057qib7	898	4	days(5	days(5	CD
cord-005453-4057qib7	898	5	-	-	SYM
cord-005453-4057qib7	898	6	12	12	CD
cord-005453-4057qib7	898	7	)	)	-RRB-
cord-005453-4057qib7	898	8	,	,	,
cord-005453-4057qib7	898	9	and	and	CC
cord-005453-4057qib7	898	10	to	to	IN
cord-005453-4057qib7	898	11	engraftment	engraftment	NNP
cord-005453-4057qib7	898	12	was	be	VBD
cord-005453-4057qib7	898	13	13	13	CD
cord-005453-4057qib7	898	14	days	day	NNS
cord-005453-4057qib7	898	15	(	(	-LRB-
cord-005453-4057qib7	898	16	12	12	CD
cord-005453-4057qib7	898	17	)	)	-RRB-
cord-005453-4057qib7	899	1	(	(	-LRB-
cord-005453-4057qib7	899	2	13	13	CD
cord-005453-4057qib7	899	3	)	)	-RRB-
cord-005453-4057qib7	899	4	(	(	-LRB-
cord-005453-4057qib7	899	5	14	14	CD
cord-005453-4057qib7	899	6	)	)	-RRB-
cord-005453-4057qib7	899	7	.	.	.
cord-005453-4057qib7	900	1	Patients	patient	NNS
cord-005453-4057qib7	900	2	were	be	VBD
cord-005453-4057qib7	900	3	transfused	transfuse	VBN
cord-005453-4057qib7	900	4	with	with	IN
cord-005453-4057qib7	900	5	a	a	DT
cord-005453-4057qib7	900	6	median	median	NN
cord-005453-4057qib7	900	7	of	of	IN
cord-005453-4057qib7	900	8	1(0	1(0	CD
cord-005453-4057qib7	900	9	-	-	SYM
cord-005453-4057qib7	900	10	2	2	CD
cord-005453-4057qib7	900	11	)	)	-RRB-
cord-005453-4057qib7	900	12	unit	unit	NN
cord-005453-4057qib7	900	13	for	for	IN
cord-005453-4057qib7	900	14	erythrocytes	erythrocyte	NNS
cord-005453-4057qib7	900	15	and	and	CC
cord-005453-4057qib7	900	16	3(1	3(1	NNP
cord-005453-4057qib7	900	17	-	-	HYPH
cord-005453-4057qib7	900	18	8	8	CD
cord-005453-4057qib7	900	19	)	)	-RRB-
cord-005453-4057qib7	900	20	for	for	IN
cord-005453-4057qib7	900	21	platelets	platelet	NNS
cord-005453-4057qib7	900	22	.	.	.
cord-005453-4057qib7	901	1	There	there	EX
cord-005453-4057qib7	901	2	was	be	VBD
cord-005453-4057qib7	902	1	no	no	DT
cord-005453-4057qib7	902	2	treatment	treatment	NN
cord-005453-4057qib7	902	3	-	-	HYPH
cord-005453-4057qib7	902	4	related	relate	VBN
cord-005453-4057qib7	902	5	mortality	mortality	NN
cord-005453-4057qib7	902	6	and	and	CC
cord-005453-4057qib7	902	7	no	no	DT
cord-005453-4057qib7	902	8	long	long	JJ
cord-005453-4057qib7	902	9	term	term	NN
cord-005453-4057qib7	902	10	side	side	NN
cord-005453-4057qib7	902	11	effects	effect	NNS
cord-005453-4057qib7	902	12	have	have	VBP
cord-005453-4057qib7	902	13	been	be	VBN
cord-005453-4057qib7	902	14	observed	observe	VBN
cord-005453-4057qib7	902	15	so	so	RB
cord-005453-4057qib7	902	16	far	far	RB
cord-005453-4057qib7	902	17	.	.	.
cord-005453-4057qib7	903	1	For	for	IN
cord-005453-4057qib7	903	2	a	a	DT
cord-005453-4057qib7	903	3	median	median	JJ
cord-005453-4057qib7	903	4	post	post	JJ
cord-005453-4057qib7	903	5	-	-	JJ
cord-005453-4057qib7	903	6	aHSCT	ahsct	JJ
cord-005453-4057qib7	903	7	follow	follow	NN
cord-005453-4057qib7	903	8	-	-	HYPH
cord-005453-4057qib7	903	9	up	up	NN
cord-005453-4057qib7	903	10	of	of	IN
cord-005453-4057qib7	903	11	8.7	8.7	CD
cord-005453-4057qib7	903	12	months	month	NNS
cord-005453-4057qib7	903	13	,	,	,
cord-005453-4057qib7	903	14	no	no	DT
cord-005453-4057qib7	903	15	patient	patient	NN
cord-005453-4057qib7	903	16	developed	develop	VBD
cord-005453-4057qib7	903	17	new	new	JJ
cord-005453-4057qib7	903	18	lesions	lesion	NNS
cord-005453-4057qib7	903	19	in	in	IN
cord-005453-4057qib7	903	20	MR	MR	NNP
cord-005453-4057qib7	903	21	,	,	,
cord-005453-4057qib7	903	22	but	but	CC
cord-005453-4057qib7	903	23	2(28.6	2(28.6	CD
cord-005453-4057qib7	903	24	%	%	NN
cord-005453-4057qib7	903	25	)	)	-RRB-
cord-005453-4057qib7	903	26	experienced	experience	VBN
cord-005453-4057qib7	903	27	symptoms	symptom	NNS
cord-005453-4057qib7	903	28	consistent	consistent	JJ
cord-005453-4057qib7	903	29	with	with	IN
cord-005453-4057qib7	903	30	a	a	DT
cord-005453-4057qib7	903	31	clinical	clinical	JJ
cord-005453-4057qib7	903	32	relapse	relapse	NN
cord-005453-4057qib7	903	33	,	,	,
cord-005453-4057qib7	903	34	at	at	IN
cord-005453-4057qib7	903	35	a	a	DT
cord-005453-4057qib7	903	36	median	median	JJ
cord-005453-4057qib7	903	37	time	time	NN
cord-005453-4057qib7	903	38	of	of	IN
cord-005453-4057qib7	903	39	20.5(5	20.5(5	CD
cord-005453-4057qib7	903	40	-	-	SYM
cord-005453-4057qib7	903	41	35	35	CD
cord-005453-4057qib7	903	42	)	)	-RRB-
cord-005453-4057qib7	903	43	months	month	NNS
cord-005453-4057qib7	903	44	,	,	,
cord-005453-4057qib7	903	45	effectively	effectively	RB
cord-005453-4057qib7	903	46	rescued	rescue	VBN
cord-005453-4057qib7	903	47	with	with	IN
cord-005453-4057qib7	903	48	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	903	49	.	.	.
cord-005453-4057qib7	904	1	The	the	DT
cord-005453-4057qib7	904	2	absence	absence	NN
cord-005453-4057qib7	904	3	of	of	IN
cord-005453-4057qib7	904	4	evidence	evidence	NN
cord-005453-4057qib7	904	5	of	of	IN
cord-005453-4057qib7	904	6	disease	disease	NN
cord-005453-4057qib7	904	7	activity	activity	NN
cord-005453-4057qib7	904	8	at	at	IN
cord-005453-4057qib7	904	9	6-months	6-months	CD
cord-005453-4057qib7	904	10	was	be	VBD
cord-005453-4057qib7	904	11	71.4	71.4	CD
cord-005453-4057qib7	904	12	%	%	NN
cord-005453-4057qib7	904	13	.	.	.
cord-005453-4057qib7	905	1	Although	although	IN
cord-005453-4057qib7	905	2	there	there	EX
cord-005453-4057qib7	905	3	was	be	VBD
cord-005453-4057qib7	905	4	no	no	DT
cord-005453-4057qib7	905	5	variation	variation	NN
cord-005453-4057qib7	905	6	concerning	concern	VBG
cord-005453-4057qib7	905	7	EDSS	EDSS	NNP
cord-005453-4057qib7	905	8	punctuation	punctuation	NN
cord-005453-4057qib7	905	9	,	,	,
cord-005453-4057qib7	905	10	4(57.1	4(57.1	CD
cord-005453-4057qib7	905	11	%	%	NN
cord-005453-4057qib7	905	12	)	)	-RRB-
cord-005453-4057qib7	905	13	patients	patient	NNS
cord-005453-4057qib7	905	14	self	self	NN
cord-005453-4057qib7	905	15	-	-	HYPH
cord-005453-4057qib7	905	16	reported	report	VBN
cord-005453-4057qib7	905	17	significant	significant	JJ
cord-005453-4057qib7	905	18	benefits	benefit	NNS
cord-005453-4057qib7	905	19	,	,	,
cord-005453-4057qib7	905	20	especially	especially	RB
cord-005453-4057qib7	905	21	concerning	concern	VBG
cord-005453-4057qib7	905	22	limb	limb	NN
cord-005453-4057qib7	905	23	strength	strength	NN
cord-005453-4057qib7	905	24	and	and	CC
cord-005453-4057qib7	905	25	sphincter	sphincter	NN
cord-005453-4057qib7	905	26	continence	continence	NN
cord-005453-4057qib7	905	27	improving	improve	VBG
cord-005453-4057qib7	905	28	.	.	.
cord-005453-4057qib7	906	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	906	2	:	:	:
cord-005453-4057qib7	907	1	Our	-PRON-	PRP$
cord-005453-4057qib7	907	2	real	real	JJ
cord-005453-4057qib7	907	3	life	life	NN
cord-005453-4057qib7	907	4	results	result	NNS
cord-005453-4057qib7	907	5	claim	claim	VBP
cord-005453-4057qib7	907	6	a	a	DT
cord-005453-4057qib7	907	7	stabilization	stabilization	NN
cord-005453-4057qib7	907	8	effect	effect	NN
cord-005453-4057qib7	907	9	of	of	IN
cord-005453-4057qib7	907	10	MS	MS	NNP
cord-005453-4057qib7	907	11	patients	patient	NNS
cord-005453-4057qib7	907	12	with	with	IN
cord-005453-4057qib7	907	13	highly	highly	RB
cord-005453-4057qib7	907	14	active	active	JJ
cord-005453-4057qib7	907	15	/	/	SYM
cord-005453-4057qib7	907	16	progressive	progressive	JJ
cord-005453-4057qib7	907	17	disease	disease	NN
cord-005453-4057qib7	907	18	after	after	IN
cord-005453-4057qib7	907	19	aHSCT	aHSCT	NNP
cord-005453-4057qib7	907	20	,	,	,
cord-005453-4057qib7	907	21	with	with	IN
cord-005453-4057qib7	907	22	no	no	DT
cord-005453-4057qib7	907	23	significant	significant	JJ
cord-005453-4057qib7	907	24	toxicity	toxicity	NN
cord-005453-4057qib7	907	25	.	.	.
cord-005453-4057qib7	908	1	The	the	DT
cord-005453-4057qib7	908	2	failure	failure	NN
cord-005453-4057qib7	908	3	in	in	IN
cord-005453-4057qib7	908	4	reporting	report	VBG
cord-005453-4057qib7	908	5	benefits	benefit	NNS
cord-005453-4057qib7	908	6	in	in	IN
cord-005453-4057qib7	908	7	EDSS	EDSS	NNP
cord-005453-4057qib7	908	8	punctuation	punctuation	NN
cord-005453-4057qib7	908	9	is	be	VBZ
cord-005453-4057qib7	908	10	probably	probably	RB
cord-005453-4057qib7	908	11	due	due	JJ
cord-005453-4057qib7	908	12	to	to	IN
cord-005453-4057qib7	908	13	a	a	DT
cord-005453-4057qib7	908	14	small	small	JJ
cord-005453-4057qib7	908	15	sample	sample	NN
cord-005453-4057qib7	908	16	size	size	NN
cord-005453-4057qib7	908	17	and	and	CC
cord-005453-4057qib7	908	18	short	short	JJ
cord-005453-4057qib7	908	19	follow	follow	NN
cord-005453-4057qib7	908	20	-	-	HYPH
cord-005453-4057qib7	908	21	up	up	NN
cord-005453-4057qib7	908	22	.	.	.
cord-005453-4057qib7	909	1	More	More	JJR
cord-005453-4057qib7	909	2	studies	study	NNS
cord-005453-4057qib7	909	3	are	be	VBP
cord-005453-4057qib7	909	4	needed	need	VBN
cord-005453-4057qib7	909	5	to	to	TO
cord-005453-4057qib7	909	6	establish	establish	VB
cord-005453-4057qib7	909	7	the	the	DT
cord-005453-4057qib7	909	8	best	good	JJS
cord-005453-4057qib7	909	9	patient	patient	NN
cord-005453-4057qib7	909	10	selection	selection	NN
cord-005453-4057qib7	909	11	criteria	criterion	NNS
cord-005453-4057qib7	909	12	and	and	CC
cord-005453-4057qib7	909	13	define	define	VB
cord-005453-4057qib7	909	14	the	the	DT
cord-005453-4057qib7	909	15	ideal	ideal	JJ
cord-005453-4057qib7	909	16	time	time	NN
cord-005453-4057qib7	909	17	to	to	TO
cord-005453-4057qib7	909	18	include	include	VB
cord-005453-4057qib7	909	19	these	these	DT
cord-005453-4057qib7	909	20	patients	patient	NNS
cord-005453-4057qib7	909	21	in	in	IN
cord-005453-4057qib7	909	22	transplantation	transplantation	NN
cord-005453-4057qib7	909	23	programs	program	NNS
cord-005453-4057qib7	909	24	,	,	,
cord-005453-4057qib7	909	25	as	as	RB
cord-005453-4057qib7	909	26	well	well	RB
cord-005453-4057qib7	909	27	as	as	IN
cord-005453-4057qib7	909	28	to	to	TO
cord-005453-4057qib7	909	29	evaluate	evaluate	VB
cord-005453-4057qib7	909	30	its	-PRON-	PRP$
cord-005453-4057qib7	909	31	long	long	JJ
cord-005453-4057qib7	909	32	term	term	NN
cord-005453-4057qib7	909	33	outcome	outcome	NN
cord-005453-4057qib7	909	34	.	.	.
cord-005453-4057qib7	910	1	Disclosure	disclosure	NN
cord-005453-4057qib7	910	2	:	:	:
cord-005453-4057qib7	910	3	Nothing	nothing	NN
cord-005453-4057qib7	910	4	to	to	TO
cord-005453-4057qib7	910	5	declare	declare	VB
cord-005453-4057qib7	910	6	.	.	.
cord-005453-4057qib7	911	1	Elena	Elena	NNP
cord-005453-4057qib7	911	2	Poponina	Poponina	NNP
cord-005453-4057qib7	911	3	1	1	CD
cord-005453-4057qib7	911	4	,	,	,
cord-005453-4057qib7	911	5	Elena	Elena	NNP
cord-005453-4057qib7	911	6	Butina	Butina	NNP
cord-005453-4057qib7	911	7	1	1	CD
cord-005453-4057qib7	911	8	,	,	,
cord-005453-4057qib7	911	9	Anna	Anna	NNP
cord-005453-4057qib7	911	10	Yovdiy	Yovdiy	NNP
cord-005453-4057qib7	911	11	1	1	CD
cord-005453-4057qib7	911	12	,	,	,
cord-005453-4057qib7	911	13	Galina	Galina	NNP
cord-005453-4057qib7	911	14	Zaytseva	Zaytseva	NNP
cord-005453-4057qib7	911	15	1	1	CD
cord-005453-4057qib7	911	16	,	,	,
cord-005453-4057qib7	911	17	Natalia	Natalia	NNP
cord-005453-4057qib7	911	18	Minaeva	Minaeva	NNP
cord-005453-4057qib7	911	19	1	1	CD
cord-005453-4057qib7	911	20	,	,	,
cord-005453-4057qib7	911	21	Igor	Igor	NNP
cord-005453-4057qib7	911	22	Paramonov	Paramonov	NNP
cord-005453-4057qib7	911	23	1	1	CD
cord-005453-4057qib7	911	24	Background	Background	NNP
cord-005453-4057qib7	911	25	:	:	:
cord-005453-4057qib7	912	1	Reactivation	reactivation	NN
cord-005453-4057qib7	912	2	of	of	IN
cord-005453-4057qib7	912	3	Epstein	Epstein	NNP
cord-005453-4057qib7	912	4	-	-	HYPH
cord-005453-4057qib7	912	5	Barr	Barr	NNP
cord-005453-4057qib7	912	6	virus	virus	NN
cord-005453-4057qib7	912	7	(	(	-LRB-
cord-005453-4057qib7	912	8	EBV	EBV	NNP
cord-005453-4057qib7	912	9	)	)	-RRB-
cord-005453-4057qib7	912	10	represents	represent	VBZ
cord-005453-4057qib7	912	11	a	a	DT
cord-005453-4057qib7	912	12	potentially	potentially	RB
cord-005453-4057qib7	912	13	life	life	NN
cord-005453-4057qib7	912	14	-	-	HYPH
cord-005453-4057qib7	912	15	threatening	threaten	VBG
cord-005453-4057qib7	912	16	condition	condition	NN
cord-005453-4057qib7	912	17	in	in	IN
cord-005453-4057qib7	912	18	approximately	approximately	RB
cord-005453-4057qib7	912	19	30	30	CD
cord-005453-4057qib7	912	20	%	%	NN
cord-005453-4057qib7	912	21	of	of	IN
cord-005453-4057qib7	912	22	patients	patient	NNS
cord-005453-4057qib7	912	23	after	after	IN
cord-005453-4057qib7	912	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	912	25	stem	stem	NN
cord-005453-4057qib7	912	26	cell	cell	NN
cord-005453-4057qib7	912	27	transplantation	transplantation	NN
cord-005453-4057qib7	912	28	,	,	,
cord-005453-4057qib7	912	29	with	with	IN
cord-005453-4057qib7	912	30	no	no	DT
cord-005453-4057qib7	912	31	specific	specific	JJ
cord-005453-4057qib7	912	32	treatment	treatment	NN
cord-005453-4057qib7	912	33	available	available	JJ
cord-005453-4057qib7	912	34	.	.	.
cord-005453-4057qib7	913	1	Methods	method	NNS
cord-005453-4057qib7	913	2	:	:	:
cord-005453-4057qib7	913	3	We	-PRON-	PRP
cord-005453-4057qib7	913	4	have	have	VBP
cord-005453-4057qib7	913	5	previously	previously	RB
cord-005453-4057qib7	913	6	developed	develop	VBN
cord-005453-4057qib7	913	7	a	a	DT
cord-005453-4057qib7	913	8	manufacturing	manufacturing	NN
cord-005453-4057qib7	913	9	protocol	protocol	NN
cord-005453-4057qib7	913	10	for	for	IN
cord-005453-4057qib7	913	11	the	the	DT
cord-005453-4057qib7	913	12	expansion	expansion	NN
cord-005453-4057qib7	913	13	of	of	IN
cord-005453-4057qib7	913	14	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	913	15	(	(	-LRB-
cord-005453-4057qib7	913	16	CMV	CMV	NNP
cord-005453-4057qib7	913	17	)	)	-RRB-
cord-005453-4057qib7	913	18	and	and	CC
cord-005453-4057qib7	913	19	EBV	EBV	NNP
cord-005453-4057qib7	913	20	-	-	HYPH
cord-005453-4057qib7	913	21	specific	specific	JJ
cord-005453-4057qib7	913	22	T	t	NN
cord-005453-4057qib7	913	23	cells	cell	NNS
cord-005453-4057qib7	913	24	by	by	IN
cord-005453-4057qib7	913	25	stimulation	stimulation	NN
cord-005453-4057qib7	913	26	of	of	IN
cord-005453-4057qib7	913	27	G	g	NN
cord-005453-4057qib7	913	28	-	-	HYPH
cord-005453-4057qib7	913	29	CSFmobilized	csfmobilize	VBN
cord-005453-4057qib7	913	30	stem	stem	NN
cord-005453-4057qib7	913	31	cell	cell	NN
cord-005453-4057qib7	913	32	grafts	graft	NNS
cord-005453-4057qib7	913	33	with	with	IN
cord-005453-4057qib7	913	34	defined	define	VBN
cord-005453-4057qib7	913	35	peptide	peptide	NN
cord-005453-4057qib7	913	36	pools	pool	NNS
cord-005453-4057qib7	913	37	(	(	-LRB-
cord-005453-4057qib7	913	38	Gary	Gary	NNP
cord-005453-4057qib7	913	39	,	,	,
cord-005453-4057qib7	913	40	2018	2018	CD
cord-005453-4057qib7	913	41	)	)	-RRB-
cord-005453-4057qib7	913	42	.	.	.
cord-005453-4057qib7	914	1	This	this	DT
cord-005453-4057qib7	914	2	Advanced	Advanced	NNP
cord-005453-4057qib7	914	3	Therapeutic	Therapeutic	NNP
cord-005453-4057qib7	914	4	Medicinal	Medicinal	NNP
cord-005453-4057qib7	914	5	Product	Product	NNP
cord-005453-4057qib7	914	6	is	be	VBZ
cord-005453-4057qib7	914	7	currently	currently	RB
cord-005453-4057qib7	914	8	investigated	investigate	VBN
cord-005453-4057qib7	914	9	in	in	IN
cord-005453-4057qib7	914	10	an	an	DT
cord-005453-4057qib7	914	11	ongoing	ongoing	JJ
cord-005453-4057qib7	914	12	phase	phase	NN
cord-005453-4057qib7	914	13	I	I	NNP
cord-005453-4057qib7	914	14	/	/	SYM
cord-005453-4057qib7	914	15	IIa	IIa	NNP
cord-005453-4057qib7	914	16	trial	trial	NN
cord-005453-4057qib7	914	17	(	(	-LRB-
cord-005453-4057qib7	914	18	EudraCT	EudraCT	NNP
cord-005453-4057qib7	914	19	Number	number	NN
cord-005453-4057qib7	914	20	:	:	:
cord-005453-4057qib7	914	21	2012	2012	CD
cord-005453-4057qib7	914	22	-	-	HYPH
cord-005453-4057qib7	914	23	004240	004240	CD
cord-005453-4057qib7	914	24	-	-	SYM
cord-005453-4057qib7	914	25	30	30	CD
cord-005453-4057qib7	914	26	)	)	-RRB-
cord-005453-4057qib7	914	27	.	.	.
cord-005453-4057qib7	915	1	However	however	RB
cord-005453-4057qib7	915	2	,	,	,
cord-005453-4057qib7	915	3	the	the	DT
cord-005453-4057qib7	915	4	expansion	expansion	NN
cord-005453-4057qib7	915	5	of	of	IN
cord-005453-4057qib7	915	6	virus	virus	NN
cord-005453-4057qib7	915	7	-	-	HYPH
cord-005453-4057qib7	915	8	specific	specific	JJ
cord-005453-4057qib7	915	9	T	t	NN
cord-005453-4057qib7	915	10	cells	cell	NNS
cord-005453-4057qib7	915	11	relies	rely	VBZ
cord-005453-4057qib7	915	12	on	on	IN
cord-005453-4057qib7	915	13	a	a	DT
cord-005453-4057qib7	915	14	pre	pre	JJ
cord-005453-4057qib7	915	15	-	-	JJ
cord-005453-4057qib7	915	16	existing	existing	JJ
cord-005453-4057qib7	915	17	virusspecific	virusspecific	NN
cord-005453-4057qib7	915	18	memory	memory	NN
cord-005453-4057qib7	915	19	compartment	compartment	NN
cord-005453-4057qib7	915	20	in	in	IN
cord-005453-4057qib7	915	21	the	the	DT
cord-005453-4057qib7	915	22	stem	stem	NN
cord-005453-4057qib7	915	23	cell	cell	NN
cord-005453-4057qib7	915	24	donor	donor	NN
cord-005453-4057qib7	915	25	.	.	.
cord-005453-4057qib7	916	1	In	in	IN
cord-005453-4057qib7	916	2	virus	virus	NN
cord-005453-4057qib7	916	3	-	-	HYPH
cord-005453-4057qib7	916	4	seronegative	seronegative	JJ
cord-005453-4057qib7	916	5	donors	donor	NNS
cord-005453-4057qib7	916	6	,	,	,
cord-005453-4057qib7	916	7	no	no	DT
cord-005453-4057qib7	916	8	expansion	expansion	NN
cord-005453-4057qib7	916	9	can	can	MD
cord-005453-4057qib7	916	10	be	be	VB
cord-005453-4057qib7	916	11	achieved	achieve	VBN
cord-005453-4057qib7	916	12	.	.	.
cord-005453-4057qib7	917	1	We	-PRON-	PRP
cord-005453-4057qib7	917	2	therefore	therefore	RB
cord-005453-4057qib7	917	3	aim	aim	VBP
cord-005453-4057qib7	917	4	to	to	TO
cord-005453-4057qib7	917	5	identify	identify	VB
cord-005453-4057qib7	917	6	EBV	EBV	NNP
cord-005453-4057qib7	917	7	peptide	peptide	NN
cord-005453-4057qib7	917	8	-	-	HYPH
cord-005453-4057qib7	917	9	specific	specific	JJ
cord-005453-4057qib7	917	10	T	T	NNP
cord-005453-4057qib7	917	11	cell	cell	NN
cord-005453-4057qib7	917	12	receptors	receptor	NNS
cord-005453-4057qib7	917	13	(	(	-LRB-
cord-005453-4057qib7	917	14	TCRs	TCRs	NNP
cord-005453-4057qib7	917	15	)	)	-RRB-
cord-005453-4057qib7	917	16	that	that	WDT
cord-005453-4057qib7	917	17	can	can	MD
cord-005453-4057qib7	917	18	be	be	VB
cord-005453-4057qib7	917	19	translated	translate	VBN
cord-005453-4057qib7	917	20	into	into	IN
cord-005453-4057qib7	917	21	off	off	IN
cord-005453-4057qib7	917	22	-	-	HYPH
cord-005453-4057qib7	917	23	the	the	DT
cord-005453-4057qib7	917	24	-	-	HYPH
cord-005453-4057qib7	917	25	shelf	shelf	NN
cord-005453-4057qib7	917	26	cell	cell	NN
cord-005453-4057qib7	917	27	products	product	NNS
cord-005453-4057qib7	917	28	for	for	IN
cord-005453-4057qib7	917	29	the	the	DT
cord-005453-4057qib7	917	30	treatment	treatment	NN
cord-005453-4057qib7	917	31	and	and	CC
cord-005453-4057qib7	917	32	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	917	33	of	of	IN
cord-005453-4057qib7	917	34	EBV	EBV	NNP
cord-005453-4057qib7	917	35	infection	infection	NN
cord-005453-4057qib7	917	36	and	and	CC
cord-005453-4057qib7	917	37	EBV	EBV	NNP
cord-005453-4057qib7	917	38	-	-	HYPH
cord-005453-4057qib7	917	39	associated	associate	VBN
cord-005453-4057qib7	917	40	malignancies	malignancy	NNS
cord-005453-4057qib7	917	41	.	.	.
cord-005453-4057qib7	918	1	Leftover	leftover	JJ
cord-005453-4057qib7	918	2	cells	cell	NNS
cord-005453-4057qib7	918	3	from	from	IN
cord-005453-4057qib7	918	4	five	five	CD
cord-005453-4057qib7	918	5	allogeneic	allogeneic	NN
cord-005453-4057qib7	918	6	stem	stem	NN
cord-005453-4057qib7	918	7	cell	cell	NN
cord-005453-4057qib7	918	8	grafts	graft	NNS
cord-005453-4057qib7	918	9	were	be	VBD
cord-005453-4057qib7	918	10	expanded	expand	VBN
cord-005453-4057qib7	918	11	in	in	IN
cord-005453-4057qib7	918	12	vitro	vitro	FW
cord-005453-4057qib7	918	13	in	in	IN
cord-005453-4057qib7	918	14	the	the	DT
cord-005453-4057qib7	918	15	presence	presence	NN
cord-005453-4057qib7	918	16	of	of	IN
cord-005453-4057qib7	918	17	HLA	HLA	NNP
cord-005453-4057qib7	918	18	-	-	HYPH
cord-005453-4057qib7	918	19	B35	B35	NNP
cord-005453-4057qib7	918	20	*	*	NFP
cord-005453-4057qib7	918	21	01-restricted	01-restricted	CD
cord-005453-4057qib7	918	22	peptides	peptide	NNS
cord-005453-4057qib7	918	23	(	(	-LRB-
cord-005453-4057qib7	918	24	HPVGEADYFEY	HPVGEADYFEY	NNP
cord-005453-4057qib7	918	25	from	from	IN
cord-005453-4057qib7	918	26	EBNA1	EBNA1	NNS
cord-005453-4057qib7	918	27	,	,	,
cord-005453-4057qib7	918	28	EPLPQGQL	EPLPQGQL	NNP
cord-005453-4057qib7	918	29	-	-	HYPH
cord-005453-4057qib7	918	30	TAY	TAY	NNP
cord-005453-4057qib7	918	31	from	from	IN
cord-005453-4057qib7	918	32	BZLF1	BZLF1	NNP
cord-005453-4057qib7	918	33	)	)	-RRB-
cord-005453-4057qib7	918	34	associated	associate	VBN
cord-005453-4057qib7	918	35	with	with	IN
cord-005453-4057qib7	918	36	latent	latent	JJ
cord-005453-4057qib7	918	37	and	and	CC
cord-005453-4057qib7	918	38	lytic	lytic	JJ
cord-005453-4057qib7	918	39	EBV	EBV	NNP
cord-005453-4057qib7	918	40	infection	infection	NN
cord-005453-4057qib7	918	41	.	.	.
cord-005453-4057qib7	919	1	After	after	IN
cord-005453-4057qib7	919	2	expansion	expansion	NN
cord-005453-4057qib7	919	3	,	,	,
cord-005453-4057qib7	919	4	single	single	JJ
cord-005453-4057qib7	919	5	EBV	EBV	NNP
cord-005453-4057qib7	919	6	-	-	HYPH
cord-005453-4057qib7	919	7	specific	specific	JJ
cord-005453-4057qib7	919	8	T	t	NN
cord-005453-4057qib7	919	9	cells	cell	NNS
cord-005453-4057qib7	919	10	were	be	VBD
cord-005453-4057qib7	919	11	FACS	FACS	NNP
cord-005453-4057qib7	919	12	sorted	sort	VBD
cord-005453-4057qib7	919	13	using	use	VBG
cord-005453-4057qib7	919	14	peptide	peptide	NN
cord-005453-4057qib7	919	15	-	-	HYPH
cord-005453-4057qib7	919	16	MHC	MHC	NNP
cord-005453-4057qib7	919	17	(	(	-LRB-
cord-005453-4057qib7	919	18	pMHC	pmhc	NN
cord-005453-4057qib7	919	19	)	)	-RRB-
cord-005453-4057qib7	919	20	tetramers	tetramer	NNS
cord-005453-4057qib7	919	21	,	,	,
cord-005453-4057qib7	919	22	and	and	CC
cord-005453-4057qib7	919	23	individual	individual	JJ
cord-005453-4057qib7	919	24	TCR	TCR	NNP
cord-005453-4057qib7	919	25	αand	αand	NN
cord-005453-4057qib7	919	26	β	β	NN
cord-005453-4057qib7	919	27	-	-	HYPH
cord-005453-4057qib7	919	28	chain	chain	NN
cord-005453-4057qib7	919	29	pairs	pair	NNS
cord-005453-4057qib7	919	30	were	be	VBD
cord-005453-4057qib7	919	31	determined	determine	VBN
cord-005453-4057qib7	919	32	with	with	IN
cord-005453-4057qib7	919	33	single	single	JJ
cord-005453-4057qib7	919	34	cell	cell	NN
cord-005453-4057qib7	919	35	sequencing	sequencing	NN
cord-005453-4057qib7	919	36	(	(	-LRB-
cord-005453-4057qib7	919	37	Han	Han	NNP
cord-005453-4057qib7	919	38	2014	2014	CD
cord-005453-4057qib7	919	39	,	,	,
cord-005453-4057qib7	919	40	Penter	Penter	NNP
cord-005453-4057qib7	919	41	2018	2018	CD
cord-005453-4057qib7	919	42	.	.	.
cord-005453-4057qib7	920	1	To	to	TO
cord-005453-4057qib7	920	2	confirm	confirm	VB
cord-005453-4057qib7	920	3	peptide	peptide	JJ
cord-005453-4057qib7	920	4	specificity	specificity	NN
cord-005453-4057qib7	920	5	,	,	,
cord-005453-4057qib7	920	6	dominant	dominant	JJ
cord-005453-4057qib7	920	7	TCR	TCR	NNP
cord-005453-4057qib7	920	8	pairs	pair	NNS
cord-005453-4057qib7	920	9	were	be	VBD
cord-005453-4057qib7	920	10	transfected	transfecte	VBN
cord-005453-4057qib7	920	11	into	into	IN
cord-005453-4057qib7	920	12	a	a	DT
cord-005453-4057qib7	920	13	murine	murine	JJ
cord-005453-4057qib7	920	14	58αβreporter	58αβreporter	NN
cord-005453-4057qib7	920	15	T	t	NN
cord-005453-4057qib7	920	16	hybridoma	hybridoma	NN
cord-005453-4057qib7	920	17	cell	cell	NN
cord-005453-4057qib7	920	18	line	line	NN
cord-005453-4057qib7	920	19	with	with	IN
cord-005453-4057qib7	920	20	NFAT	NFAT	NNP
cord-005453-4057qib7	920	21	-	-	HYPH
cord-005453-4057qib7	920	22	driven	drive	VBN
cord-005453-4057qib7	920	23	GFP	GFP	NNP
cord-005453-4057qib7	920	24	expression	expression	NN
cord-005453-4057qib7	920	25	(	(	-LRB-
cord-005453-4057qib7	920	26	Siewert	Siewert	NNP
cord-005453-4057qib7	920	27	,	,	,
cord-005453-4057qib7	920	28	2012	2012	CD
cord-005453-4057qib7	920	29	)	)	-RRB-
cord-005453-4057qib7	920	30	.	.	.
cord-005453-4057qib7	921	1	Functional	Functional	NNP
cord-005453-4057qib7	921	2	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	921	3	candidates	candidate	NNS
cord-005453-4057qib7	921	4	were	be	VBD
cord-005453-4057qib7	921	5	transduced	transduce	VBN
cord-005453-4057qib7	921	6	into	into	IN
cord-005453-4057qib7	921	7	human	human	JJ
cord-005453-4057qib7	921	8	peripheral	peripheral	JJ
cord-005453-4057qib7	921	9	Background	background	NN
cord-005453-4057qib7	921	10	:	:	:
cord-005453-4057qib7	922	1	Lymphoid	lymphoid	JJ
cord-005453-4057qib7	922	2	and	and	CC
cord-005453-4057qib7	922	3	myeloid	myeloid	JJ
cord-005453-4057qib7	922	4	acute	acute	JJ
cord-005453-4057qib7	922	5	leukemia	leukemia	NN
cord-005453-4057qib7	922	6	are	be	VBP
cord-005453-4057qib7	922	7	the	the	DT
cord-005453-4057qib7	922	8	most	most	RBS
cord-005453-4057qib7	922	9	frequent	frequent	JJ
cord-005453-4057qib7	922	10	cause	cause	NN
cord-005453-4057qib7	922	11	of	of	IN
cord-005453-4057qib7	922	12	cancer	cancer	NN
cord-005453-4057qib7	922	13	related	relate	VBN
cord-005453-4057qib7	922	14	death	death	NN
cord-005453-4057qib7	922	15	in	in	IN
cord-005453-4057qib7	922	16	children	child	NNS
cord-005453-4057qib7	922	17	.	.	.
cord-005453-4057qib7	923	1	Interactions	interaction	NNS
cord-005453-4057qib7	923	2	between	between	IN
cord-005453-4057qib7	923	3	NKG2D	nkg2d	NN
cord-005453-4057qib7	923	4	receptor	receptor	NN
cord-005453-4057qib7	923	5	,	,	,
cord-005453-4057qib7	923	6	expressed	express	VBN
cord-005453-4057qib7	923	7	in	in	IN
cord-005453-4057qib7	923	8	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	923	9	immune	immune	JJ
cord-005453-4057qib7	923	10	cells	cell	NNS
cord-005453-4057qib7	923	11	,	,	,
cord-005453-4057qib7	923	12	and	and	CC
cord-005453-4057qib7	923	13	its	-PRON-	PRP$
cord-005453-4057qib7	923	14	ligands	ligand	NNS
cord-005453-4057qib7	923	15	(	(	-LRB-
cord-005453-4057qib7	923	16	NKG2DL	NKG2DL	NNP
cord-005453-4057qib7	923	17	)	)	-RRB-
cord-005453-4057qib7	923	18	,	,	,
cord-005453-4057qib7	923	19	that	that	WDT
cord-005453-4057qib7	923	20	are	be	VBP
cord-005453-4057qib7	923	21	upregulated	upregulate	VBN
cord-005453-4057qib7	923	22	in	in	IN
cord-005453-4057qib7	923	23	many	many	JJ
cord-005453-4057qib7	923	24	types	type	NNS
cord-005453-4057qib7	923	25	of	of	IN
cord-005453-4057qib7	923	26	tumor	tumor	NN
cord-005453-4057qib7	923	27	cells	cell	NNS
cord-005453-4057qib7	923	28	including	include	VBG
cord-005453-4057qib7	923	29	leukemic	leukemic	JJ
cord-005453-4057qib7	923	30	blasts	blast	NNS
cord-005453-4057qib7	923	31	,	,	,
cord-005453-4057qib7	923	32	are	be	VBP
cord-005453-4057qib7	923	33	important	important	JJ
cord-005453-4057qib7	923	34	for	for	IN
cord-005453-4057qib7	923	35	anti	anti	JJ
cord-005453-4057qib7	923	36	-	-	JJ
cord-005453-4057qib7	923	37	tumor	tumor	JJ
cord-005453-4057qib7	923	38	immune	immune	JJ
cord-005453-4057qib7	923	39	surveillance	surveillance	NN
cord-005453-4057qib7	923	40	.	.	.
cord-005453-4057qib7	924	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	924	2	,	,	,
cord-005453-4057qib7	924	3	tumor	tumor	NN
cord-005453-4057qib7	924	4	cells	cell	NNS
cord-005453-4057qib7	924	5	may	may	MD
cord-005453-4057qib7	924	6	develop	develop	VB
cord-005453-4057qib7	924	7	immune	immune	JJ
cord-005453-4057qib7	924	8	scape	scape	NN
cord-005453-4057qib7	924	9	strategies	strategy	NNS
cord-005453-4057qib7	924	10	like	like	IN
cord-005453-4057qib7	924	11	ligand	ligand	NN
cord-005453-4057qib7	924	12	shedding	shedding	NN
cord-005453-4057qib7	924	13	,	,	,
cord-005453-4057qib7	924	14	which	which	WDT
cord-005453-4057qib7	924	15	reduces	reduce	VBZ
cord-005453-4057qib7	924	16	NKG2DL	nkg2dl	JJ
cord-005453-4057qib7	924	17	expression	expression	NN
cord-005453-4057qib7	924	18	and	and	CC
cord-005453-4057qib7	924	19	may	may	MD
cord-005453-4057qib7	924	20	cause	cause	VB
cord-005453-4057qib7	924	21	NKG2D	nkg2d	JJ
cord-005453-4057qib7	924	22	receptor	receptor	NN
cord-005453-4057qib7	924	23	downregulation	downregulation	NN
cord-005453-4057qib7	924	24	.	.	.
cord-005453-4057qib7	925	1	Engineering	engineering	NN
cord-005453-4057qib7	925	2	T	t	CD
cord-005453-4057qib7	925	3	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	925	4	with	with	IN
cord-005453-4057qib7	925	5	NKG2D	nkg2d	JJ
cord-005453-4057qib7	925	6	CAR	car	NN
cord-005453-4057qib7	925	7	may	may	MD
cord-005453-4057qib7	925	8	overcome	overcome	VB
cord-005453-4057qib7	925	9	immune	immune	JJ
cord-005453-4057qib7	925	10	evasion	evasion	NN
cord-005453-4057qib7	925	11	and	and	CC
cord-005453-4057qib7	925	12	become	become	VB
cord-005453-4057qib7	925	13	an	an	DT
cord-005453-4057qib7	925	14	effective	effective	JJ
cord-005453-4057qib7	925	15	therapeutic	therapeutic	JJ
cord-005453-4057qib7	925	16	strategy	strategy	NN
cord-005453-4057qib7	925	17	.	.	.
cord-005453-4057qib7	926	1	Methods	method	NNS
cord-005453-4057qib7	926	2	:	:	:
cord-005453-4057qib7	926	3	CD45RA	cd45ra	NN
cord-005453-4057qib7	926	4	-T	-t	NN
cord-005453-4057qib7	926	5	cells	cell	NNS
cord-005453-4057qib7	926	6	were	be	VBD
cord-005453-4057qib7	926	7	obtained	obtain	VBN
cord-005453-4057qib7	926	8	by	by	IN
cord-005453-4057qib7	926	9	depletion	depletion	NN
cord-005453-4057qib7	926	10	of	of	IN
cord-005453-4057qib7	926	11	non	non	JJ
cord-005453-4057qib7	926	12	-	-	JJ
cord-005453-4057qib7	926	13	mobilized	mobilized	JJ
cord-005453-4057qib7	926	14	apheresis	apheresis	NN
cord-005453-4057qib7	926	15	with	with	IN
cord-005453-4057qib7	926	16	CD45RA	cd45ra	NN
cord-005453-4057qib7	926	17	magnetic	magnetic	JJ
cord-005453-4057qib7	926	18	beads	bead	NNS
cord-005453-4057qib7	926	19	using	use	VBG
cord-005453-4057qib7	926	20	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	926	21	.	.	.
cord-005453-4057qib7	927	1	NKG2D	nkg2d	NN
cord-005453-4057qib7	927	2	-	-	HYPH
cord-005453-4057qib7	927	3	CAR	car	NN
cord-005453-4057qib7	927	4	T	t	NN
cord-005453-4057qib7	927	5	cells	cell	NNS
cord-005453-4057qib7	927	6	were	be	VBD
cord-005453-4057qib7	927	7	generated	generate	VBN
cord-005453-4057qib7	927	8	by	by	IN
cord-005453-4057qib7	927	9	lentiviral	lentiviral	NNP
cord-005453-4057qib7	927	10	(	(	-LRB-
cord-005453-4057qib7	927	11	NKG2D-41BB	NKG2D-41BB	NNP
cord-005453-4057qib7	927	12	-	-	HYPH
cord-005453-4057qib7	927	13	CD3z	CD3z	NNP
cord-005453-4057qib7	927	14	)	)	-RRB-
cord-005453-4057qib7	927	15	transduction	transduction	NN
cord-005453-4057qib7	927	16	of	of	IN
cord-005453-4057qib7	927	17	CD45RA	cd45ra	NN
cord-005453-4057qib7	927	18	-T	-T	:
cord-005453-4057qib7	927	19	cells	cell	NNS
cord-005453-4057qib7	927	20	with	with	IN
cord-005453-4057qib7	927	21	MOI=2	MOI=2	NNP
cord-005453-4057qib7	927	22	.	.	.
cord-005453-4057qib7	928	1	The	the	DT
cord-005453-4057qib7	928	2	expression	expression	NN
cord-005453-4057qib7	928	3	of	of	IN
cord-005453-4057qib7	928	4	NKG2D	nkg2d	NN
cord-005453-4057qib7	928	5	ligands	ligand	NNS
cord-005453-4057qib7	928	6	was	be	VBD
cord-005453-4057qib7	928	7	analyzed	analyze	VBN
cord-005453-4057qib7	928	8	in	in	IN
cord-005453-4057qib7	928	9	peripheral	peripheral	JJ
cord-005453-4057qib7	928	10	blood	blood	NN
cord-005453-4057qib7	928	11	or	or	CC
cord-005453-4057qib7	928	12	bone	bone	NN
cord-005453-4057qib7	928	13	marrow	marrow	NN
cord-005453-4057qib7	928	14	samples	sample	NNS
cord-005453-4057qib7	928	15	from	from	IN
cord-005453-4057qib7	928	16	a	a	DT
cord-005453-4057qib7	928	17	total	total	NN
cord-005453-4057qib7	928	18	of	of	IN
cord-005453-4057qib7	928	19	97	97	CD
cord-005453-4057qib7	928	20	leukemia	leukemia	NN
cord-005453-4057qib7	928	21	patients	patient	NNS
cord-005453-4057qib7	928	22	(	(	-LRB-
cord-005453-4057qib7	928	23	AML=13	AML=13	NNP
cord-005453-4057qib7	928	24	,	,	,
cord-005453-4057qib7	928	25	B	b	NN
cord-005453-4057qib7	928	26	-	-	HYPH
cord-005453-4057qib7	928	27	ALL=52	all=52	NN
cord-005453-4057qib7	928	28	and	and	CC
cord-005453-4057qib7	928	29	T	T	NNP
cord-005453-4057qib7	928	30	-	-	HYPH
cord-005453-4057qib7	928	31	ALL=19	ALL=19	NNP
cord-005453-4057qib7	928	32	)	)	-RRB-
cord-005453-4057qib7	928	33	,	,	,
cord-005453-4057qib7	928	34	at	at	IN
cord-005453-4057qib7	928	35	different	different	JJ
cord-005453-4057qib7	928	36	status	status	NN
cord-005453-4057qib7	928	37	of	of	IN
cord-005453-4057qib7	928	38	the	the	DT
cord-005453-4057qib7	928	39	disease	disease	NN
cord-005453-4057qib7	928	40	(	(	-LRB-
cord-005453-4057qib7	928	41	Diagnosis	diagnosis	NN
cord-005453-4057qib7	928	42	,	,	,
cord-005453-4057qib7	928	43	Remission	remission	NN
cord-005453-4057qib7	928	44	,	,	,
cord-005453-4057qib7	928	45	Relapse	relapse	NN
cord-005453-4057qib7	928	46	/	/	SYM
cord-005453-4057qib7	928	47	refractory	refractory	NN
cord-005453-4057qib7	928	48	)	)	-RRB-
cord-005453-4057qib7	928	49	,	,	,
cord-005453-4057qib7	928	50	and	and	CC
cord-005453-4057qib7	928	51	in	in	IN
cord-005453-4057qib7	928	52	10	10	CD
cord-005453-4057qib7	928	53	different	different	JJ
cord-005453-4057qib7	928	54	leukemia	leukemia	NN
cord-005453-4057qib7	928	55	cell	cell	NN
cord-005453-4057qib7	928	56	lines	line	NNS
cord-005453-4057qib7	928	57	by	by	IN
cord-005453-4057qib7	928	58	qPCR	qPCR	NNP
cord-005453-4057qib7	928	59	and	and	CC
cord-005453-4057qib7	928	60	flow	flow	NN
cord-005453-4057qib7	928	61	cytometry	cytometry	NN
cord-005453-4057qib7	928	62	.	.	.
cord-005453-4057qib7	929	1	Cytotoxicity	Cytotoxicity	NNP
cord-005453-4057qib7	929	2	of	of	IN
cord-005453-4057qib7	929	3	NKG2D	nkg2d	NN
cord-005453-4057qib7	929	4	-	-	HYPH
cord-005453-4057qib7	929	5	CAR	car	NN
cord-005453-4057qib7	929	6	T	t	NN
cord-005453-4057qib7	929	7	cells	cell	NNS
cord-005453-4057qib7	929	8	against	against	IN
cord-005453-4057qib7	929	9	leukemia	leukemia	NN
cord-005453-4057qib7	929	10	cells	cell	NNS
cord-005453-4057qib7	929	11	was	be	VBD
cord-005453-4057qib7	929	12	evaluated	evaluate	VBN
cord-005453-4057qib7	929	13	by	by	IN
cord-005453-4057qib7	929	14	performing	perform	VBG
cord-005453-4057qib7	929	15	conventional-4	conventional-4	NNP
cord-005453-4057qib7	929	16	hours	hour	NNS
cord-005453-4057qib7	929	17	Europium	europium	NN
cord-005453-4057qib7	929	18	-	-	HYPH
cord-005453-4057qib7	929	19	TDA	TDA	NNP
cord-005453-4057qib7	929	20	assays	assay	NNS
cord-005453-4057qib7	929	21	.	.	.
cord-005453-4057qib7	930	1	Soluble	soluble	JJ
cord-005453-4057qib7	930	2	NKG2DL	NKG2DL	NNP
cord-005453-4057qib7	930	3	(	(	-LRB-
cord-005453-4057qib7	930	4	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	930	5	)	)	-RRB-
cord-005453-4057qib7	930	6	concentration	concentration	NN
cord-005453-4057qib7	930	7	was	be	VBD
cord-005453-4057qib7	930	8	measured	measure	VBN
cord-005453-4057qib7	930	9	in	in	IN
cord-005453-4057qib7	930	10	the	the	DT
cord-005453-4057qib7	930	11	sera	sera	NNP
cord-005453-4057qib7	930	12	of	of	IN
cord-005453-4057qib7	930	13	leukemia	leukemia	NN
cord-005453-4057qib7	930	14	patients	patient	NNS
cord-005453-4057qib7	930	15	by	by	IN
cord-005453-4057qib7	930	16	ELISA	ELISA	NNP
cord-005453-4057qib7	930	17	.	.	.
cord-005453-4057qib7	931	1	To	to	TO
cord-005453-4057qib7	931	2	evaluate	evaluate	VB
cord-005453-4057qib7	931	3	the	the	DT
cord-005453-4057qib7	931	4	effect	effect	NN
cord-005453-4057qib7	931	5	of	of	IN
cord-005453-4057qib7	931	6	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	931	7	on	on	IN
cord-005453-4057qib7	931	8	NKG2D	nkg2d	CD
cord-005453-4057qib7	931	9	-	-	HYPH
cord-005453-4057qib7	931	10	CAR	car	NN
cord-005453-4057qib7	931	11	T	t	NN
cord-005453-4057qib7	931	12	cells	cell	NNS
cord-005453-4057qib7	931	13	,	,	,
cord-005453-4057qib7	931	14	those	those	DT
cord-005453-4057qib7	931	15	were	be	VBD
cord-005453-4057qib7	931	16	cultured	culture	VBN
cord-005453-4057qib7	931	17	in	in	IN
cord-005453-4057qib7	931	18	the	the	DT
cord-005453-4057qib7	931	19	presence	presence	NN
cord-005453-4057qib7	931	20	or	or	CC
cord-005453-4057qib7	931	21	absence	absence	NN
cord-005453-4057qib7	931	22	of	of	IN
cord-005453-4057qib7	931	23	different	different	JJ
cord-005453-4057qib7	931	24	concentrations	concentration	NNS
cord-005453-4057qib7	931	25	of	of	IN
cord-005453-4057qib7	931	26	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	931	27	for	for	IN
cord-005453-4057qib7	931	28	7	7	CD
cord-005453-4057qib7	931	29	days	day	NNS
cord-005453-4057qib7	931	30	.	.	.
cord-005453-4057qib7	932	1	One	one	CD
cord-005453-4057qib7	932	2	week	week	NN
cord-005453-4057qib7	932	3	later	later	RB
cord-005453-4057qib7	932	4	,	,	,
cord-005453-4057qib7	932	5	cell	cell	NN
cord-005453-4057qib7	932	6	proliferation	proliferation	NN
cord-005453-4057qib7	932	7	and	and	CC
cord-005453-4057qib7	932	8	CAR	car	NN
cord-005453-4057qib7	932	9	downregulation	downregulation	NN
cord-005453-4057qib7	932	10	were	be	VBD
cord-005453-4057qib7	932	11	measured	measure	VBN
cord-005453-4057qib7	932	12	by	by	IN
cord-005453-4057qib7	932	13	flow	flow	NN
cord-005453-4057qib7	932	14	cytometry	cytometry	NN
cord-005453-4057qib7	932	15	using	use	VBG
cord-005453-4057qib7	932	16	Cell	Cell	NNP
cord-005453-4057qib7	932	17	Trace	Trace	NNP
cord-005453-4057qib7	932	18	Violet	Violet	NNP
cord-005453-4057qib7	932	19	and	and	CC
cord-005453-4057qib7	932	20	NKG2D	nkg2d	NN
cord-005453-4057qib7	932	21	labeling	labeling	NN
cord-005453-4057qib7	932	22	,	,	,
cord-005453-4057qib7	932	23	respectively	respectively	RB
cord-005453-4057qib7	932	24	.	.	.
cord-005453-4057qib7	933	1	The	the	DT
cord-005453-4057qib7	933	2	production	production	NN
cord-005453-4057qib7	933	3	of	of	IN
cord-005453-4057qib7	933	4	IFN	IFN	NNP
cord-005453-4057qib7	933	5	-	-	HYPH
cord-005453-4057qib7	933	6	g	g	NNP
cord-005453-4057qib7	933	7	and	and	CC
cord-005453-4057qib7	933	8	TNF	TNF	NNP
cord-005453-4057qib7	933	9	-	-	,
cord-005453-4057qib7	933	10	a	a	NNP
cord-005453-4057qib7	933	11	was	be	VBD
cord-005453-4057qib7	933	12	measured	measure	VBN
cord-005453-4057qib7	933	13	in	in	IN
cord-005453-4057qib7	933	14	the	the	DT
cord-005453-4057qib7	933	15	supernatants	supernatant	NNS
cord-005453-4057qib7	933	16	by	by	IN
cord-005453-4057qib7	933	17	ELISA	ELISA	NNP
cord-005453-4057qib7	933	18	.	.	.
cord-005453-4057qib7	934	1	The	the	DT
cord-005453-4057qib7	934	2	effect	effect	NN
cord-005453-4057qib7	934	3	on	on	IN
cord-005453-4057qib7	934	4	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	934	5	was	be	VBD
cord-005453-4057qib7	934	6	evaluated	evaluate	VBN
cord-005453-4057qib7	934	7	in	in	IN
cord-005453-4057qib7	934	8	a	a	DT
cord-005453-4057qib7	934	9	2	2	CD
cord-005453-4057qib7	934	10	hoursdegranulation	hoursdegranulation	NN
cord-005453-4057qib7	934	11	assay	assay	NN
cord-005453-4057qib7	934	12	by	by	IN
cord-005453-4057qib7	934	13	co	co	JJ
cord-005453-4057qib7	934	14	-	-	JJ
cord-005453-4057qib7	934	15	culturing	culture	VBG
cord-005453-4057qib7	934	16	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	934	17	pretreated	pretreate	VBD
cord-005453-4057qib7	934	18	NKG2D	nkg2d	NN
cord-005453-4057qib7	934	19	-	-	HYPH
cord-005453-4057qib7	934	20	CAR	car	NN
cord-005453-4057qib7	934	21	T	t	NN
cord-005453-4057qib7	934	22	cells	cell	NNS
cord-005453-4057qib7	934	23	against	against	IN
cord-005453-4057qib7	934	24	K562	k562	CD
cord-005453-4057qib7	934	25	cell	cell	NN
cord-005453-4057qib7	934	26	line	line	NN
cord-005453-4057qib7	934	27	.	.	.
cord-005453-4057qib7	935	1	Results	result	NNS
cord-005453-4057qib7	935	2	:	:	:
cord-005453-4057qib7	936	1	NKG2D	nkg2d	NN
cord-005453-4057qib7	936	2	ligands	ligand	NNS
cord-005453-4057qib7	936	3	were	be	VBD
cord-005453-4057qib7	936	4	expressed	express	VBN
cord-005453-4057qib7	936	5	in	in	IN
cord-005453-4057qib7	936	6	leukemia	leukemia	NN
cord-005453-4057qib7	936	7	cell	cell	NN
cord-005453-4057qib7	936	8	lines	line	NNS
cord-005453-4057qib7	936	9	and	and	CC
cord-005453-4057qib7	936	10	leukemic	leukemic	JJ
cord-005453-4057qib7	936	11	blasts	blast	NNS
cord-005453-4057qib7	936	12	.	.	.
cord-005453-4057qib7	937	1	NKG2DL	nkg2dl	JJ
cord-005453-4057qib7	937	2	expression	expression	NN
cord-005453-4057qib7	937	3	changed	change	VBD
cord-005453-4057qib7	937	4	with	with	IN
cord-005453-4057qib7	937	5	disease	disease	NN
cord-005453-4057qib7	937	6	status	status	NN
cord-005453-4057qib7	937	7	with	with	IN
cord-005453-4057qib7	937	8	a	a	DT
cord-005453-4057qib7	937	9	trend	trend	NN
cord-005453-4057qib7	937	10	to	to	TO
cord-005453-4057qib7	937	11	decrease	decrease	VB
cord-005453-4057qib7	937	12	at	at	IN
cord-005453-4057qib7	937	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	937	14	and	and	CC
cord-005453-4057qib7	937	15	relapse	relapse	NN
cord-005453-4057qib7	937	16	/	/	SYM
cord-005453-4057qib7	937	17	refractory	refractory	NN
cord-005453-4057qib7	937	18	compared	compare	VBN
cord-005453-4057qib7	937	19	to	to	IN
cord-005453-4057qib7	937	20	remission	remission	NN
cord-005453-4057qib7	937	21	.	.	.
cord-005453-4057qib7	938	1	NKG2D	nkg2d	NN
cord-005453-4057qib7	938	2	-	-	HYPH
cord-005453-4057qib7	938	3	CAR	car	NN
cord-005453-4057qib7	938	4	T	t	NN
cord-005453-4057qib7	938	5	cells	cell	NNS
cord-005453-4057qib7	938	6	were	be	VBD
cord-005453-4057qib7	938	7	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	938	8	against	against	IN
cord-005453-4057qib7	938	9	8/10	8/10	CD
cord-005453-4057qib7	938	10	leukemia	leukemia	NN
cord-005453-4057qib7	938	11	cell	cell	NN
cord-005453-4057qib7	938	12	lines	line	NNS
cord-005453-4057qib7	938	13	with	with	IN
cord-005453-4057qib7	938	14	a	a	DT
cord-005453-4057qib7	938	15	percentage	percentage	NN
cord-005453-4057qib7	938	16	of	of	IN
cord-005453-4057qib7	938	17	specific	specific	JJ
cord-005453-4057qib7	938	18	lysis	lysis	NN
cord-005453-4057qib7	938	19	over	over	IN
cord-005453-4057qib7	938	20	50	50	CD
cord-005453-4057qib7	938	21	%	%	NN
cord-005453-4057qib7	938	22	.	.	.
cord-005453-4057qib7	939	1	Myeloid	Myeloid	NNP
cord-005453-4057qib7	939	2	and	and	CC
cord-005453-4057qib7	939	3	T	t	NN
cord-005453-4057qib7	939	4	-	-	HYPH
cord-005453-4057qib7	939	5	ALL	all	DT
cord-005453-4057qib7	939	6	cell	cell	NN
cord-005453-4057qib7	939	7	lines	line	NNS
cord-005453-4057qib7	939	8	were	be	VBD
cord-005453-4057qib7	939	9	more	more	RBR
cord-005453-4057qib7	939	10	susceptible	susceptible	JJ
cord-005453-4057qib7	939	11	to	to	IN
cord-005453-4057qib7	939	12	NKG2D	nkg2d	NN
cord-005453-4057qib7	939	13	-	-	HYPH
cord-005453-4057qib7	939	14	CAR	car	NN
cord-005453-4057qib7	939	15	T	t	NN
cord-005453-4057qib7	939	16	cells	cell	NNS
cord-005453-4057qib7	939	17	(	(	-LRB-
cord-005453-4057qib7	939	18	specific	specific	JJ
cord-005453-4057qib7	939	19	lysis	lysis	NN
cord-005453-4057qib7	939	20	ranging	range	VBG
cord-005453-4057qib7	939	21	from	from	IN
cord-005453-4057qib7	939	22	50	50	CD
cord-005453-4057qib7	939	23	-	-	SYM
cord-005453-4057qib7	939	24	78	78	CD
cord-005453-4057qib7	939	25	%	%	NN
cord-005453-4057qib7	939	26	)	)	-RRB-
cord-005453-4057qib7	939	27	compared	compare	VBN
cord-005453-4057qib7	939	28	to	to	IN
cord-005453-4057qib7	939	29	B	b	NN
cord-005453-4057qib7	939	30	-	-	:
cord-005453-4057qib7	939	31	ALL	all	DT
cord-005453-4057qib7	939	32	cell	cell	NN
cord-005453-4057qib7	939	33	lines	line	NNS
cord-005453-4057qib7	939	34	(	(	-LRB-
cord-005453-4057qib7	939	35	19	19	CD
cord-005453-4057qib7	939	36	-	-	SYM
cord-005453-4057qib7	939	37	52	52	CD
cord-005453-4057qib7	939	38	%	%	NN
cord-005453-4057qib7	939	39	)	)	-RRB-
cord-005453-4057qib7	939	40	.	.	.
cord-005453-4057qib7	940	1	Physiological	physiological	JJ
cord-005453-4057qib7	940	2	concentrations	concentration	NNS
cord-005453-4057qib7	940	3	of	of	IN
cord-005453-4057qib7	940	4	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	940	5	caused	cause	VBD
cord-005453-4057qib7	940	6	an	an	DT
cord-005453-4057qib7	940	7	increase	increase	NN
cord-005453-4057qib7	940	8	in	in	IN
cord-005453-4057qib7	940	9	NKG2D	nkg2d	CD
cord-005453-4057qib7	940	10	-	-	HYPH
cord-005453-4057qib7	940	11	CAR	car	NN
cord-005453-4057qib7	940	12	expression	expression	NN
cord-005453-4057qib7	940	13	.	.	.
cord-005453-4057qib7	941	1	However	however	RB
cord-005453-4057qib7	941	2	,	,	,
cord-005453-4057qib7	941	3	supra	supra	JJ
cord-005453-4057qib7	941	4	-	-	HYPH
cord-005453-4057qib7	941	5	physiological	physiological	JJ
cord-005453-4057qib7	941	6	levels	level	NNS
cord-005453-4057qib7	941	7	of	of	IN
cord-005453-4057qib7	941	8	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	941	9	decreased	decrease	VBD
cord-005453-4057qib7	941	10	NKG2D	nkg2d	JJ
cord-005453-4057qib7	941	11	-	-	HYPH
cord-005453-4057qib7	941	12	CAR	car	NN
cord-005453-4057qib7	941	13	expression	expression	NN
cord-005453-4057qib7	941	14	up	up	IN
cord-005453-4057qib7	941	15	to	to	TO
cord-005453-4057qib7	941	16	5	5	CD
cord-005453-4057qib7	941	17	times	time	NNS
cord-005453-4057qib7	941	18	and	and	CC
cord-005453-4057qib7	941	19	increased	increased	JJ
cord-005453-4057qib7	941	20	cell	cell	NN
cord-005453-4057qib7	941	21	proliferation	proliferation	NN
cord-005453-4057qib7	941	22	up	up	IN
cord-005453-4057qib7	941	23	to	to	IN
cord-005453-4057qib7	941	24	4	4	CD
cord-005453-4057qib7	941	25	times	time	NNS
cord-005453-4057qib7	941	26	.	.	.
cord-005453-4057qib7	942	1	CD4	CD4	NNP
cord-005453-4057qib7	942	2	+	+	CC
cord-005453-4057qib7	942	3	subpopulation	subpopulation	NN
cord-005453-4057qib7	942	4	was	be	VBD
cord-005453-4057qib7	942	5	more	more	RBR
cord-005453-4057qib7	942	6	affected	affect	VBN
cord-005453-4057qib7	942	7	by	by	IN
cord-005453-4057qib7	942	8	downregulation	downregulation	NN
cord-005453-4057qib7	942	9	,	,	,
cord-005453-4057qib7	942	10	while	while	IN
cord-005453-4057qib7	942	11	proliferation	proliferation	NN
cord-005453-4057qib7	942	12	had	have	VBD
cord-005453-4057qib7	942	13	more	more	JJR
cord-005453-4057qib7	942	14	impact	impact	NN
cord-005453-4057qib7	942	15	on	on	IN
cord-005453-4057qib7	942	16	CD8	CD8	NNP
cord-005453-4057qib7	942	17	+	+	CC
cord-005453-4057qib7	942	18	subset	subset	NNP
cord-005453-4057qib7	942	19	.	.	.
cord-005453-4057qib7	943	1	The	the	DT
cord-005453-4057qib7	943	2	effects	effect	NNS
cord-005453-4057qib7	943	3	of	of	IN
cord-005453-4057qib7	943	4	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	943	5	were	be	VBD
cord-005453-4057qib7	943	6	dose	dose	NN
cord-005453-4057qib7	943	7	-	-	HYPH
cord-005453-4057qib7	943	8	dependent	dependent	JJ
cord-005453-4057qib7	943	9	and	and	CC
cord-005453-4057qib7	943	10	attenuated	attenuate	VBN
cord-005453-4057qib7	943	11	by	by	IN
cord-005453-4057qib7	943	12	IL-2	IL-2	NNP
cord-005453-4057qib7	943	13	.	.	.
cord-005453-4057qib7	943	14	Conclusions	conclusion	NNS
cord-005453-4057qib7	943	15	:	:	:
cord-005453-4057qib7	944	1	NKG2D	nkg2d	NN
cord-005453-4057qib7	944	2	-	-	HYPH
cord-005453-4057qib7	944	3	CAR	car	NN
cord-005453-4057qib7	944	4	T	t	NN
cord-005453-4057qib7	944	5	cells	cell	NNS
cord-005453-4057qib7	944	6	are	be	VBP
cord-005453-4057qib7	944	7	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	944	8	against	against	IN
cord-005453-4057qib7	944	9	leukemia	leukemia	NN
cord-005453-4057qib7	944	10	cells	cell	NNS
cord-005453-4057qib7	944	11	,	,	,
cord-005453-4057qib7	944	12	specially	specially	RB
cord-005453-4057qib7	944	13	AML	AML	NNP
cord-005453-4057qib7	944	14	and	and	CC
cord-005453-4057qib7	944	15	T	T	NNP
cord-005453-4057qib7	944	16	-	-	HYPH
cord-005453-4057qib7	944	17	ALL	ALL	NNP
cord-005453-4057qib7	944	18	,	,	,
cord-005453-4057qib7	944	19	and	and	CC
cord-005453-4057qib7	944	20	thus	thus	RB
cord-005453-4057qib7	944	21	could	could	MD
cord-005453-4057qib7	944	22	be	be	VB
cord-005453-4057qib7	944	23	a	a	DT
cord-005453-4057qib7	944	24	novel	novel	JJ
cord-005453-4057qib7	944	25	therapeutic	therapeutic	JJ
cord-005453-4057qib7	944	26	approach	approach	NN
cord-005453-4057qib7	944	27	for	for	IN
cord-005453-4057qib7	944	28	non	non	JJ
cord-005453-4057qib7	944	29	-	-	JJ
cord-005453-4057qib7	944	30	B	b	JJ
cord-005453-4057qib7	944	31	leukemia	leukemia	NN
cord-005453-4057qib7	944	32	,	,	,
cord-005453-4057qib7	944	33	or	or	CC
cord-005453-4057qib7	944	34	those	those	DT
cord-005453-4057qib7	944	35	B	b	NN
cord-005453-4057qib7	944	36	-	-	,
cord-005453-4057qib7	944	37	ALL	all	PDT
cord-005453-4057qib7	944	38	that	that	DT
cord-005453-4057qib7	944	39	relapse	relapse	VBP
cord-005453-4057qib7	944	40	with	with	IN
cord-005453-4057qib7	944	41	undetectable	undetectable	JJ
cord-005453-4057qib7	944	42	CD19	CD19	NNP
cord-005453-4057qib7	944	43	after	after	IN
cord-005453-4057qib7	944	44	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	944	45	treatment	treatment	NN
cord-005453-4057qib7	944	46	.	.	.
cord-005453-4057qib7	945	1	NKG2D	nkg2d	JJ
cord-005453-4057qib7	945	2	-	-	HYPH
cord-005453-4057qib7	945	3	CAR	car	NN
cord-005453-4057qib7	945	4	expression	expression	NN
cord-005453-4057qib7	945	5	may	may	MD
cord-005453-4057qib7	945	6	be	be	VB
cord-005453-4057qib7	945	7	downregulated	downregulate	VBN
cord-005453-4057qib7	945	8	only	only	RB
cord-005453-4057qib7	945	9	by	by	IN
cord-005453-4057qib7	945	10	supra	supra	JJ
cord-005453-4057qib7	945	11	-	-	HYPH
cord-005453-4057qib7	945	12	physiological	physiological	JJ
cord-005453-4057qib7	945	13	levels	level	NNS
cord-005453-4057qib7	945	14	of	of	IN
cord-005453-4057qib7	945	15	sNKG2DL	snkg2dl	NN
cord-005453-4057qib7	945	16	,	,	,
cord-005453-4057qib7	945	17	although	although	IN
cord-005453-4057qib7	945	18	antitumor	antitumor	JJ
cord-005453-4057qib7	945	19	activity	activity	NN
cord-005453-4057qib7	945	20	is	be	VBZ
cord-005453-4057qib7	945	21	not	not	RB
cord-005453-4057qib7	945	22	affected	affect	VBN
cord-005453-4057qib7	945	23	.	.	.
cord-005453-4057qib7	946	1	IL-2	IL-2	NNP
cord-005453-4057qib7	946	2	softens	soften	VBZ
cord-005453-4057qib7	946	3	the	the	DT
cord-005453-4057qib7	946	4	negative	negative	JJ
cord-005453-4057qib7	946	5	effects	effect	NNS
cord-005453-4057qib7	946	6	of	of	IN
cord-005453-4057qib7	946	7	sNKG2DL	snkg2dl	JJ
cord-005453-4057qib7	946	8	inducing	induce	VBG
cord-005453-4057qib7	946	9	NKG2D	nkg2d	JJ
cord-005453-4057qib7	946	10	expression	expression	NN
cord-005453-4057qib7	946	11	,	,	,
cord-005453-4057qib7	946	12	cell	cell	NN
cord-005453-4057qib7	946	13	proliferation	proliferation	NN
cord-005453-4057qib7	946	14	and	and	CC
cord-005453-4057qib7	946	15	cytokines	cytokine	NNS
cord-005453-4057qib7	946	16	production	production	NN
cord-005453-4057qib7	946	17	.	.	.
cord-005453-4057qib7	947	1	The	the	DT
cord-005453-4057qib7	947	2	changes	change	NNS
cord-005453-4057qib7	947	3	observed	observe	VBN
cord-005453-4057qib7	947	4	in	in	IN
cord-005453-4057qib7	947	5	NKG2DL	NKG2DL	NNP
cord-005453-4057qib7	947	6	surface	surface	NN
cord-005453-4057qib7	947	7	expression	expression	NN
cord-005453-4057qib7	947	8	at	at	IN
cord-005453-4057qib7	947	9	the	the	DT
cord-005453-4057qib7	947	10	different	different	JJ
cord-005453-4057qib7	947	11	stages	stage	NNS
cord-005453-4057qib7	947	12	of	of	IN
cord-005453-4057qib7	947	13	the	the	DT
cord-005453-4057qib7	947	14	disease	disease	NN
cord-005453-4057qib7	947	15	could	could	MD
cord-005453-4057qib7	947	16	be	be	VB
cord-005453-4057qib7	947	17	related	relate	VBN
cord-005453-4057qib7	947	18	to	to	IN
cord-005453-4057qib7	947	19	ligands	ligand	NNS
cord-005453-4057qib7	947	20	release	release	NN
cord-005453-4057qib7	947	21	and	and	CC
cord-005453-4057qib7	947	22	immune	immune	JJ
cord-005453-4057qib7	947	23	escape	escape	NN
cord-005453-4057qib7	947	24	.	.	.
cord-005453-4057qib7	948	1	Disclosure	disclosure	NN
cord-005453-4057qib7	948	2	:	:	:
cord-005453-4057qib7	948	3	Nothing	nothing	NN
cord-005453-4057qib7	948	4	to	to	TO
cord-005453-4057qib7	948	5	declare	declare	VB
cord-005453-4057qib7	948	6	Denis	Denis	NNP
cord-005453-4057qib7	948	7	-	-	HYPH
cord-005453-4057qib7	948	8	Claude	Claude	NNP
cord-005453-4057qib7	948	9	Roy	Roy	NNP
cord-005453-4057qib7	948	10	1,2	1,2	CD
cord-005453-4057qib7	948	11	,	,	,
cord-005453-4057qib7	948	12	Ines	Ines	NNP
cord-005453-4057qib7	948	13	Adassi	Adassi	NNP
cord-005453-4057qib7	948	14	1,2	1,2	CD
cord-005453-4057qib7	948	15	,	,	,
cord-005453-4057qib7	948	16	Céline	Céline	NNP
cord-005453-4057qib7	948	17	Leboeuf	Leboeuf	NNP
cord-005453-4057qib7	948	18	1,2	1,2	CD
cord-005453-4057qib7	948	19	,	,	,
cord-005453-4057qib7	948	20	Vibhuti	Vibhuti	NNP
cord-005453-4057qib7	948	21	P.	P.	NNP
cord-005453-4057qib7	948	22	Dave	Dave	NNP
cord-005453-4057qib7	948	23	1,2	1,2	CD
cord-005453-4057qib7	948	24	1	1	CD
cord-005453-4057qib7	948	25	Hôpital	Hôpital	NNP
cord-005453-4057qib7	948	26	Maisonneuve	Maisonneuve	NNP
cord-005453-4057qib7	948	27	-	-	HYPH
cord-005453-4057qib7	948	28	Rosemont	Rosemont	NNP
cord-005453-4057qib7	948	29	Research	Research	NNP
cord-005453-4057qib7	948	30	Center	Center	NNP
cord-005453-4057qib7	948	31	,	,	,
cord-005453-4057qib7	948	32	Montréal	Montréal	NNP
cord-005453-4057qib7	948	33	,	,	,
cord-005453-4057qib7	948	34	Canada	Canada	NNP
cord-005453-4057qib7	948	35	,	,	,
cord-005453-4057qib7	948	36	2	2	CD
cord-005453-4057qib7	948	37	University	University	NNP
cord-005453-4057qib7	948	38	of	of	IN
cord-005453-4057qib7	948	39	Montréal	Montréal	NNP
cord-005453-4057qib7	948	40	,	,	,
cord-005453-4057qib7	948	41	Montréal	Montréal	NNP
cord-005453-4057qib7	948	42	,	,	,
cord-005453-4057qib7	948	43	Canada	Canada	NNP
cord-005453-4057qib7	948	44	Background	Background	NNP
cord-005453-4057qib7	948	45	:	:	:
cord-005453-4057qib7	949	1	For	for	IN
cord-005453-4057qib7	949	2	patients	patient	NNS
cord-005453-4057qib7	949	3	with	with	IN
cord-005453-4057qib7	949	4	high	high	JJ
cord-005453-4057qib7	949	5	-	-	HYPH
cord-005453-4057qib7	949	6	risk	risk	NN
cord-005453-4057qib7	949	7	leukaemia	leukaemia	NN
cord-005453-4057qib7	949	8	,	,	,
cord-005453-4057qib7	949	9	allogeneic	allogeneic	IN
cord-005453-4057qib7	949	10	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	949	11	stem	stem	NN
cord-005453-4057qib7	949	12	cell	cell	NN
cord-005453-4057qib7	949	13	transplantation	transplantation	NN
cord-005453-4057qib7	949	14	is	be	VBZ
cord-005453-4057qib7	949	15	the	the	DT
cord-005453-4057qib7	949	16	only	only	JJ
cord-005453-4057qib7	949	17	curative	curative	JJ
cord-005453-4057qib7	949	18	treatment	treatment	NN
cord-005453-4057qib7	949	19	.	.	.
cord-005453-4057qib7	950	1	The	the	DT
cord-005453-4057qib7	950	2	presence	presence	NN
cord-005453-4057qib7	950	3	of	of	IN
cord-005453-4057qib7	950	4	alloreactive	alloreactive	NNP
cord-005453-4057qib7	950	5	T	T	NNP
cord-005453-4057qib7	950	6	cells	cell	NNS
cord-005453-4057qib7	950	7	in	in	IN
cord-005453-4057qib7	950	8	the	the	DT
cord-005453-4057qib7	950	9	donor	donor	NN
cord-005453-4057qib7	950	10	graft	graft	NN
cord-005453-4057qib7	950	11	,	,	,
cord-005453-4057qib7	950	12	however	however	RB
cord-005453-4057qib7	950	13	,	,	,
cord-005453-4057qib7	950	14	leads	lead	VBZ
cord-005453-4057qib7	950	15	to	to	IN
cord-005453-4057qib7	950	16	a	a	DT
cord-005453-4057qib7	950	17	high	high	JJ
cord-005453-4057qib7	950	18	probability	probability	NN
cord-005453-4057qib7	950	19	of	of	IN
cord-005453-4057qib7	950	20	developing	develop	VBG
cord-005453-4057qib7	950	21	graft	graft	NN
cord-005453-4057qib7	950	22	-	-	HYPH
cord-005453-4057qib7	950	23	versus	versus	IN
cord-005453-4057qib7	950	24	-	-	HYPH
cord-005453-4057qib7	950	25	host	host	NN
cord-005453-4057qib7	950	26	disease	disease	NN
cord-005453-4057qib7	950	27	(	(	-LRB-
cord-005453-4057qib7	950	28	GVHD	GVHD	NNP
cord-005453-4057qib7	950	29	)	)	-RRB-
cord-005453-4057qib7	950	30	.	.	.
cord-005453-4057qib7	951	1	T	t	NN
cord-005453-4057qib7	951	2	-	-	HYPH
cord-005453-4057qib7	951	3	cell	cell	NN
cord-005453-4057qib7	951	4	depletion	depletion	NN
cord-005453-4057qib7	951	5	minimises	minimise	VBZ
cord-005453-4057qib7	951	6	the	the	DT
cord-005453-4057qib7	951	7	presence	presence	NN
cord-005453-4057qib7	951	8	of	of	IN
cord-005453-4057qib7	951	9	GVHD	GVHD	NNP
cord-005453-4057qib7	951	10	-	-	HYPH
cord-005453-4057qib7	951	11	causing	cause	VBG
cord-005453-4057qib7	951	12	alloreactive	alloreactive	JJ
cord-005453-4057qib7	951	13	cells	cell	NNS
cord-005453-4057qib7	951	14	,	,	,
cord-005453-4057qib7	951	15	but	but	CC
cord-005453-4057qib7	951	16	often	often	RB
cord-005453-4057qib7	951	17	results	result	VBZ
cord-005453-4057qib7	951	18	in	in	IN
cord-005453-4057qib7	951	19	an	an	DT
cord-005453-4057qib7	951	20	increased	increase	VBN
cord-005453-4057qib7	951	21	incidence	incidence	NN
cord-005453-4057qib7	951	22	of	of	IN
cord-005453-4057qib7	951	23	infections	infection	NNS
cord-005453-4057qib7	951	24	and	and	CC
cord-005453-4057qib7	951	25	disease	disease	NN
cord-005453-4057qib7	951	26	relapse	relapse	NN
cord-005453-4057qib7	951	27	.	.	.
cord-005453-4057qib7	952	1	Photodepletion	photodepletion	NN
cord-005453-4057qib7	952	2	treatment	treatment	NN
cord-005453-4057qib7	952	3	(	(	-LRB-
cord-005453-4057qib7	952	4	PDT	PDT	NNP
cord-005453-4057qib7	952	5	)	)	-RRB-
cord-005453-4057qib7	952	6	can	can	MD
cord-005453-4057qib7	952	7	specifically	specifically	RB
cord-005453-4057qib7	952	8	deplete	deplete	VB
cord-005453-4057qib7	952	9	activated	activate	VBN
cord-005453-4057qib7	952	10	alloreactive	alloreactive	NNP
cord-005453-4057qib7	952	11	T	t	NN
cord-005453-4057qib7	952	12	cells	cell	NNS
cord-005453-4057qib7	952	13	while	while	IN
cord-005453-4057qib7	952	14	conserving	conserve	VBG
cord-005453-4057qib7	952	15	resting	rest	VBG
cord-005453-4057qib7	952	16	T	T	NNP
cord-005453-4057qib7	952	17	cells	cell	NNS
cord-005453-4057qib7	952	18	.	.	.
cord-005453-4057qib7	953	1	PDT	PDT	NNP
cord-005453-4057qib7	953	2	-	-	HYPH
cord-005453-4057qib7	953	3	treated	treat	VBN
cord-005453-4057qib7	953	4	cells	cell	NNS
cord-005453-4057qib7	953	5	have	have	VBP
cord-005453-4057qib7	953	6	been	be	VBN
cord-005453-4057qib7	953	7	utilised	utilise	VBN
cord-005453-4057qib7	953	8	after	after	IN
cord-005453-4057qib7	953	9	T	t	NN
cord-005453-4057qib7	953	10	-	-	HYPH
cord-005453-4057qib7	953	11	cell	cell	NN
cord-005453-4057qib7	953	12	-	-	HYPH
cord-005453-4057qib7	953	13	depleted	deplete	VBN
cord-005453-4057qib7	953	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	953	15	transplant	transplant	NN
cord-005453-4057qib7	953	16	to	to	TO
cord-005453-4057qib7	953	17	help	help	VB
cord-005453-4057qib7	953	18	reduce	reduce	VB
cord-005453-4057qib7	953	19	infection	infection	NN
cord-005453-4057qib7	953	20	and	and	CC
cord-005453-4057qib7	953	21	relapse	relapse	NN
cord-005453-4057qib7	953	22	.	.	.
cord-005453-4057qib7	954	1	The	the	DT
cord-005453-4057qib7	954	2	efficacy	efficacy	NN
cord-005453-4057qib7	954	3	and	and	CC
cord-005453-4057qib7	954	4	safety	safety	NN
cord-005453-4057qib7	954	5	of	of	IN
cord-005453-4057qib7	954	6	such	such	JJ
cord-005453-4057qib7	954	7	PDT	PDT	NNP
cord-005453-4057qib7	954	8	-	-	HYPH
cord-005453-4057qib7	954	9	treated	treat	VBN
cord-005453-4057qib7	954	10	cells	cell	NNS
cord-005453-4057qib7	954	11	is	be	VBZ
cord-005453-4057qib7	954	12	currently	currently	RB
cord-005453-4057qib7	954	13	under	under	IN
cord-005453-4057qib7	954	14	clinical	clinical	JJ
cord-005453-4057qib7	954	15	investigation	investigation	NN
cord-005453-4057qib7	954	16	in	in	IN
cord-005453-4057qib7	954	17	a	a	DT
cord-005453-4057qib7	954	18	phase	phase	NN
cord-005453-4057qib7	954	19	III	iii	CD
cord-005453-4057qib7	954	20	trial	trial	NN
cord-005453-4057qib7	954	21	(	(	-LRB-
cord-005453-4057qib7	954	22	HATCY	HATCY	NNP
cord-005453-4057qib7	954	23	,	,	,
cord-005453-4057qib7	954	24	NCT02999854	NCT02999854	NNP
cord-005453-4057qib7	954	25	;	;	:
cord-005453-4057qib7	954	26	Kiadis	Kiadis	NNP
cord-005453-4057qib7	954	27	Pharma	Pharma	NNP
cord-005453-4057qib7	954	28	)	)	-RRB-
cord-005453-4057qib7	954	29	.	.	.
cord-005453-4057qib7	955	1	Here	here	RB
cord-005453-4057qib7	955	2	the	the	DT
cord-005453-4057qib7	955	3	reactivity	reactivity	NN
cord-005453-4057qib7	955	4	of	of	IN
cord-005453-4057qib7	955	5	PDT	PDT	NNP
cord-005453-4057qib7	955	6	-	-	HYPH
cord-005453-4057qib7	955	7	treated	treat	VBN
cord-005453-4057qib7	955	8	donor	donor	NN
cord-005453-4057qib7	955	9	T	t	NN
cord-005453-4057qib7	955	10	cells	cell	NNS
cord-005453-4057qib7	955	11	was	be	VBD
cord-005453-4057qib7	955	12	assessed	assess	VBN
cord-005453-4057qib7	955	13	toward	toward	IN
cord-005453-4057qib7	955	14	tumour	tumour	NN
cord-005453-4057qib7	955	15	-	-	HYPH
cord-005453-4057qib7	955	16	associated	associate	VBN
cord-005453-4057qib7	955	17	and	and	CC
cord-005453-4057qib7	955	18	viral	viral	JJ
cord-005453-4057qib7	955	19	antigenic	antigenic	JJ
cord-005453-4057qib7	955	20	peptides	peptide	NNS
cord-005453-4057qib7	955	21	derived	derive	VBN
cord-005453-4057qib7	955	22	from	from	IN
cord-005453-4057qib7	955	23	Wilm	Wilm	NNP
cord-005453-4057qib7	955	24	's	's	POS
cord-005453-4057qib7	955	25	Tumour	tumour	NN
cord-005453-4057qib7	955	26	protein	protein	NN
cord-005453-4057qib7	955	27	1	1	CD
cord-005453-4057qib7	955	28	(	(	-LRB-
cord-005453-4057qib7	955	29	WT1p	WT1p	NNP
cord-005453-4057qib7	955	30	)	)	-RRB-
cord-005453-4057qib7	955	31	,	,	,
cord-005453-4057qib7	955	32	preferentially	preferentially	RB
cord-005453-4057qib7	955	33	expressed	express	VBD
cord-005453-4057qib7	955	34	antigen	antigen	NN
cord-005453-4057qib7	955	35	in	in	IN
cord-005453-4057qib7	955	36	melanoma	melanoma	NN
cord-005453-4057qib7	955	37	(	(	-LRB-
cord-005453-4057qib7	955	38	PRAMEp	PRAMEp	NNS
cord-005453-4057qib7	955	39	)	)	-RRB-
cord-005453-4057qib7	955	40	,	,	,
cord-005453-4057qib7	955	41	and	and	CC
cord-005453-4057qib7	955	42	from	from	IN
cord-005453-4057qib7	955	43	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	955	44	and	and	CC
cord-005453-4057qib7	955	45	Epstein	Epstein	NNP
cord-005453-4057qib7	955	46	-	-	HYPH
cord-005453-4057qib7	955	47	Barr	Barr	NNP
cord-005453-4057qib7	955	48	virus	virus	NN
cord-005453-4057qib7	955	49	(	(	-LRB-
cord-005453-4057qib7	955	50	CMV/	CMV/	NNP
cord-005453-4057qib7	955	51	EBVp	EBVp	NNPS
cord-005453-4057qib7	955	52	)	)	-RRB-
cord-005453-4057qib7	955	53	.	.	.
cord-005453-4057qib7	956	1	Methods	method	NNS
cord-005453-4057qib7	956	2	:	:	:
cord-005453-4057qib7	956	3	Healthy	healthy	JJ
cord-005453-4057qib7	956	4	donor	donor	NN
cord-005453-4057qib7	956	5	(	(	-LRB-
cord-005453-4057qib7	956	6	HLA	HLA	NNP
cord-005453-4057qib7	956	7	-	-	HYPH
cord-005453-4057qib7	956	8	A*0201	A*0201	NNP
cord-005453-4057qib7	956	9	)	)	-RRB-
cord-005453-4057qib7	956	10	peripheral	peripheral	JJ
cord-005453-4057qib7	956	11	blood	blood	NN
cord-005453-4057qib7	956	12	mononuclear	mononuclear	NN
cord-005453-4057qib7	956	13	cells	cell	NNS
cord-005453-4057qib7	956	14	(	(	-LRB-
cord-005453-4057qib7	956	15	PBMCs	pbmc	NNS
cord-005453-4057qib7	956	16	)	)	-RRB-
cord-005453-4057qib7	956	17	were	be	VBD
cord-005453-4057qib7	956	18	co	co	JJ
cord-005453-4057qib7	956	19	-	-	JJ
cord-005453-4057qib7	956	20	cultured	cultured	JJ
cord-005453-4057qib7	956	21	with	with	IN
cord-005453-4057qib7	956	22	irradiated	irradiated	JJ
cord-005453-4057qib7	956	23	PBMCs	pbmc	NNS
cord-005453-4057qib7	956	24	from	from	IN
cord-005453-4057qib7	956	25	another	another	DT
cord-005453-4057qib7	956	26	mismatched	mismatched	JJ
cord-005453-4057qib7	956	27	donor	donor	NN
cord-005453-4057qib7	956	28	(	(	-LRB-
cord-005453-4057qib7	956	29	1:1	1:1	LS
cord-005453-4057qib7	956	30	)	)	-RRB-
cord-005453-4057qib7	956	31	in	in	IN
cord-005453-4057qib7	956	32	a	a	DT
cord-005453-4057qib7	956	33	4-day	4-day	JJ
cord-005453-4057qib7	956	34	mixed	mixed	JJ
cord-005453-4057qib7	956	35	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	956	36	reaction	reaction	NN
cord-005453-4057qib7	956	37	.	.	.
cord-005453-4057qib7	957	1	TH9402	TH9402	NNP
cord-005453-4057qib7	957	2	,	,	,
cord-005453-4057qib7	957	3	a	a	DT
cord-005453-4057qib7	957	4	photoactive	photoactive	JJ
cord-005453-4057qib7	957	5	rhodamine	rhodamine	NN
cord-005453-4057qib7	957	6	derivative	derivative	JJ
cord-005453-4057qib7	957	7	,	,	,
cord-005453-4057qib7	957	8	was	be	VBD
cord-005453-4057qib7	957	9	added	add	VBN
cord-005453-4057qib7	957	10	and	and	CC
cord-005453-4057qib7	957	11	cells	cell	NNS
cord-005453-4057qib7	957	12	were	be	VBD
cord-005453-4057qib7	957	13	exposed	expose	VBN
cord-005453-4057qib7	957	14	to	to	IN
cord-005453-4057qib7	957	15	visible	visible	JJ
cord-005453-4057qib7	957	16	light	light	NN
cord-005453-4057qib7	957	17	to	to	TO
cord-005453-4057qib7	957	18	deplete	deplete	VB
cord-005453-4057qib7	957	19	the	the	DT
cord-005453-4057qib7	957	20	TH9402-containing	TH9402-containing	NNP
cord-005453-4057qib7	957	21	activated	activate	VBN
cord-005453-4057qib7	957	22	alloreactive	alloreactive	JJ
cord-005453-4057qib7	957	23	cells	cell	NNS
cord-005453-4057qib7	957	24	.	.	.
cord-005453-4057qib7	958	1	Elimination	elimination	NN
cord-005453-4057qib7	958	2	of	of	IN
cord-005453-4057qib7	958	3	alloreactive	alloreactive	JJ
cord-005453-4057qib7	958	4	cells	cell	NNS
cord-005453-4057qib7	958	5	post	post	VBP
cord-005453-4057qib7	958	6	-	-	NNP
cord-005453-4057qib7	958	7	PDT	PDT	NNP
cord-005453-4057qib7	958	8	was	be	VBD
cord-005453-4057qib7	958	9	assessed	assess	VBN
cord-005453-4057qib7	958	10	using	use	VBG
cord-005453-4057qib7	958	11	CD25	CD25	NNP
cord-005453-4057qib7	958	12	and	and	CC
cord-005453-4057qib7	958	13	HLA	HLA	NNP
cord-005453-4057qib7	958	14	-	-	HYPH
cord-005453-4057qib7	958	15	DR	DR	NNP
cord-005453-4057qib7	958	16	as	as	IN
cord-005453-4057qib7	958	17	activation	activation	NN
cord-005453-4057qib7	958	18	markers	marker	NNS
cord-005453-4057qib7	958	19	.	.	.
cord-005453-4057qib7	959	1	An	an	DT
cord-005453-4057qib7	959	2	ex	ex	FW
cord-005453-4057qib7	959	3	vivo	vivo	NN
cord-005453-4057qib7	959	4	expansion	expansion	NN
cord-005453-4057qib7	959	5	protocol	protocol	NN
cord-005453-4057qib7	959	6	was	be	VBD
cord-005453-4057qib7	959	7	exploited	exploit	VBN
cord-005453-4057qib7	959	8	to	to	TO
cord-005453-4057qib7	959	9	evaluate	evaluate	VB
cord-005453-4057qib7	959	10	the	the	DT
cord-005453-4057qib7	959	11	impact	impact	NN
cord-005453-4057qib7	959	12	of	of	IN
cord-005453-4057qib7	959	13	PDT	PDT	NNP
cord-005453-4057qib7	959	14	on	on	IN
cord-005453-4057qib7	959	15	reactivity	reactivity	NN
cord-005453-4057qib7	959	16	to	to	IN
cord-005453-4057qib7	959	17	tumour	tumour	NN
cord-005453-4057qib7	959	18	and	and	CC
cord-005453-4057qib7	959	19	viral	viral	JJ
cord-005453-4057qib7	959	20	antigenic	antigenic	JJ
cord-005453-4057qib7	959	21	peptides	peptide	NNS
cord-005453-4057qib7	959	22	.	.	.
cord-005453-4057qib7	960	1	Post	Post	NNP
cord-005453-4057qib7	960	2	-	-	JJ
cord-005453-4057qib7	960	3	PDT	PDT	NNP
cord-005453-4057qib7	960	4	T	t	NN
cord-005453-4057qib7	960	5	cells	cell	NNS
cord-005453-4057qib7	960	6	were	be	VBD
cord-005453-4057qib7	960	7	co	co	JJ
cord-005453-4057qib7	960	8	-	-	JJ
cord-005453-4057qib7	960	9	cultured	cultured	JJ
cord-005453-4057qib7	960	10	with	with	IN
cord-005453-4057qib7	960	11	irradiated	irradiate	VBN
cord-005453-4057qib7	960	12	autologous	autologous	JJ
cord-005453-4057qib7	960	13	monocyte	monocyte	NNP
cord-005453-4057qib7	960	14	-	-	HYPH
cord-005453-4057qib7	960	15	derived	derive	VBN
cord-005453-4057qib7	960	16	dendritic	dendritic	JJ
cord-005453-4057qib7	960	17	cells	cell	NNS
cord-005453-4057qib7	960	18	(	(	-LRB-
cord-005453-4057qib7	960	19	10:1	10:1	CD
cord-005453-4057qib7	960	20	)	)	-RRB-
cord-005453-4057qib7	960	21	pulsed	pulse	VBD
cord-005453-4057qib7	960	22	with	with	IN
cord-005453-4057qib7	960	23	WT1p	WT1p	NNP
cord-005453-4057qib7	960	24	,	,	,
cord-005453-4057qib7	960	25	PRAMEp	PRAMEp	NNS
cord-005453-4057qib7	960	26	or	or	CC
cord-005453-4057qib7	960	27	CMV	CMV	NNP
cord-005453-4057qib7	960	28	/	/	SYM
cord-005453-4057qib7	960	29	EBVp	EBVp	NNS
cord-005453-4057qib7	960	30	.	.	.
cord-005453-4057qib7	961	1	Antigen	antigen	NN
cord-005453-4057qib7	961	2	-	-	HYPH
cord-005453-4057qib7	961	3	specific	specific	JJ
cord-005453-4057qib7	961	4	T	t	NN
cord-005453-4057qib7	961	5	cells	cell	NNS
cord-005453-4057qib7	961	6	were	be	VBD
cord-005453-4057qib7	961	7	re	re	VBN
cord-005453-4057qib7	961	8	-	-	VBN
cord-005453-4057qib7	961	9	stimulated	stimulate	VBN
cord-005453-4057qib7	961	10	on	on	IN
cord-005453-4057qib7	961	11	Days	day	NNS
cord-005453-4057qib7	961	12	7	7	CD
cord-005453-4057qib7	961	13	and	and	CC
cord-005453-4057qib7	961	14	14	14	CD
cord-005453-4057qib7	961	15	with	with	IN
cord-005453-4057qib7	961	16	WT1p	WT1p	NNP
cord-005453-4057qib7	961	17	-	-	,
cord-005453-4057qib7	961	18	or	or	CC
cord-005453-4057qib7	961	19	PRAMEp	PRAMEp	NNS
cord-005453-4057qib7	961	20	-	-	HYPH
cord-005453-4057qib7	961	21	pulsed	pulse	VBN
cord-005453-4057qib7	961	22	autologous	autologous	JJ
cord-005453-4057qib7	961	23	PBMCs	pbmc	NNS
cord-005453-4057qib7	961	24	or	or	CC
cord-005453-4057qib7	961	25	with	with	IN
cord-005453-4057qib7	961	26	CMV	CMV	NNP
cord-005453-4057qib7	961	27	/	/	SYM
cord-005453-4057qib7	961	28	EBVp	EBVp	NNS
cord-005453-4057qib7	961	29	added	add	VBD
cord-005453-4057qib7	961	30	directly	directly	RB
cord-005453-4057qib7	961	31	to	to	IN
cord-005453-4057qib7	961	32	the	the	DT
cord-005453-4057qib7	961	33	culture	culture	NN
cord-005453-4057qib7	961	34	.	.	.
cord-005453-4057qib7	962	1	MHCtetramer	MHCtetramer	NNP
cord-005453-4057qib7	962	2	staining	staining	NN
cord-005453-4057qib7	962	3	was	be	VBD
cord-005453-4057qib7	962	4	performed	perform	VBN
cord-005453-4057qib7	962	5	on	on	IN
cord-005453-4057qib7	962	6	Days	day	NNS
cord-005453-4057qib7	962	7	14	14	CD
cord-005453-4057qib7	962	8	and	and	CC
cord-005453-4057qib7	962	9	21	21	CD
cord-005453-4057qib7	962	10	;	;	:
cord-005453-4057qib7	962	11	IFN	IFN	NNP
cord-005453-4057qib7	962	12	-	-	HYPH
cord-005453-4057qib7	962	13	γ	γ	NNP
cord-005453-4057qib7	962	14	ELISpot	elispot	NN
cord-005453-4057qib7	962	15	was	be	VBD
cord-005453-4057qib7	962	16	conducted	conduct	VBN
cord-005453-4057qib7	962	17	on	on	IN
cord-005453-4057qib7	962	18	Day	Day	NNP
cord-005453-4057qib7	962	19	21	21	CD
cord-005453-4057qib7	962	20	.	.	.
cord-005453-4057qib7	963	1	[	[	-LRB-
cord-005453-4057qib7	963	2	[	[	-LRB-
cord-005453-4057qib7	963	3	P057	P057	NNP
cord-005453-4057qib7	963	4	Image	image	NN
cord-005453-4057qib7	963	5	]	]	-RRB-
cord-005453-4057qib7	963	6	1	1	CD
cord-005453-4057qib7	963	7	.	.	.
cord-005453-4057qib7	964	1	Functional	functional	JJ
cord-005453-4057qib7	964	2	WT1-specific	wt1-specific	NN
cord-005453-4057qib7	964	3	and	and	CC
cord-005453-4057qib7	964	4	viralspecific	viralspecific	NNP
cord-005453-4057qib7	964	5	T	t	NN
cord-005453-4057qib7	964	6	cells	cell	NNS
cord-005453-4057qib7	964	7	can	can	MD
cord-005453-4057qib7	964	8	be	be	VB
cord-005453-4057qib7	964	9	expanded	expand	VBN
cord-005453-4057qib7	964	10	post	post	JJ
cord-005453-4057qib7	964	11	-	-	JJ
cord-005453-4057qib7	964	12	PDT	PDT	NNP
cord-005453-4057qib7	964	13	]	]	-RRB-
cord-005453-4057qib7	964	14	Results	result	NNS
cord-005453-4057qib7	964	15	:	:	:
cord-005453-4057qib7	964	16	PDT	PDT	NNP
cord-005453-4057qib7	964	17	resulted	result	VBD
cord-005453-4057qib7	964	18	in	in	IN
cord-005453-4057qib7	964	19	a	a	DT
cord-005453-4057qib7	964	20	drastic	drastic	JJ
cord-005453-4057qib7	964	21	decrease	decrease	NN
cord-005453-4057qib7	964	22	of	of	IN
cord-005453-4057qib7	964	23	CD25	CD25	NNP
cord-005453-4057qib7	964	24	and/	and/	NNP
cord-005453-4057qib7	964	25	or	or	CC
cord-005453-4057qib7	964	26	HLA	HLA	NNP
cord-005453-4057qib7	964	27	-	-	HYPH
cord-005453-4057qib7	964	28	DR	DR	NNP
cord-005453-4057qib7	964	29	activation	activation	NN
cord-005453-4057qib7	964	30	marker	marker	NN
cord-005453-4057qib7	964	31	-	-	HYPH
cord-005453-4057qib7	964	32	expressing	express	VBG
cord-005453-4057qib7	964	33	CD4	CD4	NNP
cord-005453-4057qib7	964	34	+	+	CC
cord-005453-4057qib7	964	35	and	and	CC
cord-005453-4057qib7	964	36	CD8	CD8	NNP
cord-005453-4057qib7	964	37	+	+	CC
cord-005453-4057qib7	964	38	T	T	NNP
cord-005453-4057qib7	964	39	cells	cell	NNS
cord-005453-4057qib7	964	40	.	.	.
cord-005453-4057qib7	965	1	PDT	PDT	NNP
cord-005453-4057qib7	965	2	-	-	HYPH
cord-005453-4057qib7	965	3	treated	treat	VBN
cord-005453-4057qib7	965	4	cells	cell	NNS
cord-005453-4057qib7	965	5	showed	show	VBD
cord-005453-4057qib7	965	6	a	a	DT
cord-005453-4057qib7	965	7	significant	significant	JJ
cord-005453-4057qib7	965	8	increase	increase	NN
cord-005453-4057qib7	965	9	in	in	IN
cord-005453-4057qib7	965	10	Background	background	NN
cord-005453-4057qib7	965	11	:	:	:
cord-005453-4057qib7	966	1	Acute	acute	JJ
cord-005453-4057qib7	966	2	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	966	3	leukemia	leukemia	NN
cord-005453-4057qib7	966	4	(	(	-LRB-
cord-005453-4057qib7	966	5	ALL	all	DT
cord-005453-4057qib7	966	6	)	)	-RRB-
cord-005453-4057qib7	966	7	is	be	VBZ
cord-005453-4057qib7	966	8	the	the	DT
cord-005453-4057qib7	966	9	most	most	RBS
cord-005453-4057qib7	966	10	common	common	JJ
cord-005453-4057qib7	966	11	childhood	childhood	NN
cord-005453-4057qib7	966	12	cancer	cancer	NN
cord-005453-4057qib7	966	13	and	and	CC
cord-005453-4057qib7	966	14	relapsed	relapse	VBN
cord-005453-4057qib7	966	15	or	or	CC
cord-005453-4057qib7	966	16	refractory	refractory	JJ
cord-005453-4057qib7	966	17	ALL	all	DT
cord-005453-4057qib7	966	18	is	be	VBZ
cord-005453-4057qib7	966	19	still	still	RB
cord-005453-4057qib7	966	20	difficult	difficult	JJ
cord-005453-4057qib7	966	21	to	to	TO
cord-005453-4057qib7	966	22	treat	treat	VB
cord-005453-4057qib7	966	23	.	.	.
cord-005453-4057qib7	967	1	Engineered	engineer	VBN
cord-005453-4057qib7	967	2	T	T	NNP
cord-005453-4057qib7	967	3	cells	cell	NNS
cord-005453-4057qib7	967	4	equipped	equip	VBN
cord-005453-4057qib7	967	5	with	with	IN
cord-005453-4057qib7	967	6	a	a	DT
cord-005453-4057qib7	967	7	synthetic	synthetic	JJ
cord-005453-4057qib7	967	8	chimeric	chimeric	JJ
cord-005453-4057qib7	967	9	antigen	antigen	NN
cord-005453-4057qib7	967	10	receptor	receptor	NN
cord-005453-4057qib7	967	11	(	(	-LRB-
cord-005453-4057qib7	967	12	CAR	car	NN
cord-005453-4057qib7	967	13	)	)	-RRB-
cord-005453-4057qib7	967	14	targeting	target	VBG
cord-005453-4057qib7	967	15	CD19	CD19	NNP
cord-005453-4057qib7	967	16	have	have	VBP
cord-005453-4057qib7	967	17	demonstrated	demonstrate	VBN
cord-005453-4057qib7	967	18	remarkable	remarkable	JJ
cord-005453-4057qib7	967	19	efficacy	efficacy	NN
cord-005453-4057qib7	967	20	to	to	TO
cord-005453-4057qib7	967	21	treat	treat	VB
cord-005453-4057qib7	967	22	ALL	all	DT
cord-005453-4057qib7	967	23	.	.	.
cord-005453-4057qib7	968	1	However	however	RB
cord-005453-4057qib7	968	2	natural	natural	JJ
cord-005453-4057qib7	968	3	killer	killer	NN
cord-005453-4057qib7	968	4	(	(	-LRB-
cord-005453-4057qib7	968	5	NK	NK	NNP
cord-005453-4057qib7	968	6	)	)	-RRB-
cord-005453-4057qib7	968	7	cells	cell	NNS
cord-005453-4057qib7	968	8	are	be	VBP
cord-005453-4057qib7	968	9	known	know	VBN
cord-005453-4057qib7	968	10	for	for	IN
cord-005453-4057qib7	968	11	their	-PRON-	PRP$
cord-005453-4057qib7	968	12	target	target	NN
cord-005453-4057qib7	968	13	-	-	HYPH
cord-005453-4057qib7	968	14	independent	independent	JJ
cord-005453-4057qib7	968	15	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	968	16	potential	potential	NN
cord-005453-4057qib7	968	17	without	without	IN
cord-005453-4057qib7	968	18	induction	induction	NN
cord-005453-4057qib7	968	19	of	of	IN
cord-005453-4057qib7	968	20	cytokine	cytokine	NN
cord-005453-4057qib7	968	21	release	release	NN
cord-005453-4057qib7	968	22	syndrome	syndrome	NN
cord-005453-4057qib7	968	23	(	(	-LRB-
cord-005453-4057qib7	968	24	CRS	CRS	NNP
cord-005453-4057qib7	968	25	)	)	-RRB-
cord-005453-4057qib7	968	26	or	or	CC
cord-005453-4057qib7	968	27	graft	graft	NN
cord-005453-4057qib7	968	28	-	-	HYPH
cord-005453-4057qib7	968	29	versus	versus	IN
cord-005453-4057qib7	968	30	-	-	HYPH
cord-005453-4057qib7	968	31	hostdisease	hostdisease	NN
cord-005453-4057qib7	968	32	(	(	-LRB-
cord-005453-4057qib7	968	33	GvHD	GvHD	NNP
cord-005453-4057qib7	968	34	)	)	-RRB-
cord-005453-4057qib7	968	35	,	,	,
cord-005453-4057qib7	968	36	CAR	CAR	NNP
cord-005453-4057qib7	968	37	-	-	HYPH
cord-005453-4057qib7	968	38	NK	NK	NNP
cord-005453-4057qib7	968	39	cells	cell	NNS
cord-005453-4057qib7	968	40	can	can	MD
cord-005453-4057qib7	968	41	overcome	overcome	VB
cord-005453-4057qib7	968	42	the	the	DT
cord-005453-4057qib7	968	43	persisting	persist	VBG
cord-005453-4057qib7	968	44	problem	problem	NN
cord-005453-4057qib7	968	45	in	in	IN
cord-005453-4057qib7	968	46	the	the	DT
cord-005453-4057qib7	968	47	therapy	therapy	NN
cord-005453-4057qib7	968	48	with	with	IN
cord-005453-4057qib7	968	49	CAR	CAR	NNP
cord-005453-4057qib7	968	50	T	T	NNP
cord-005453-4057qib7	968	51	cells	cell	NNS
cord-005453-4057qib7	968	52	.	.	.
cord-005453-4057qib7	969	1	As	as	IN
cord-005453-4057qib7	969	2	the	the	DT
cord-005453-4057qib7	969	3	use	use	NN
cord-005453-4057qib7	969	4	of	of	IN
cord-005453-4057qib7	969	5	viral	viral	JJ
cord-005453-4057qib7	969	6	vector	vector	NN
cord-005453-4057qib7	969	7	generated	generate	VBN
cord-005453-4057qib7	969	8	CAR	car	NN
cord-005453-4057qib7	969	9	NK	NK	NNP
cord-005453-4057qib7	969	10	cells	cell	NNS
cord-005453-4057qib7	969	11	is	be	VBZ
cord-005453-4057qib7	969	12	limited	limit	VBN
cord-005453-4057qib7	969	13	by	by	IN
cord-005453-4057qib7	969	14	theire	theire	JJ
cord-005453-4057qib7	969	15	genotoxicity	genotoxicity	NN
cord-005453-4057qib7	969	16	,	,	,
cord-005453-4057qib7	969	17	cost	cost	NN
cord-005453-4057qib7	969	18	and	and	CC
cord-005453-4057qib7	969	19	regulatory	regulatory	JJ
cord-005453-4057qib7	969	20	demands	demand	NNS
cord-005453-4057qib7	969	21	,	,	,
cord-005453-4057qib7	969	22	we	-PRON-	PRP
cord-005453-4057qib7	969	23	are	be	VBP
cord-005453-4057qib7	969	24	developing	develop	VBG
cord-005453-4057qib7	969	25	an	an	DT
cord-005453-4057qib7	969	26	innovative	innovative	JJ
cord-005453-4057qib7	969	27	protocol	protocol	NN
cord-005453-4057qib7	969	28	using	use	VBG
cord-005453-4057qib7	969	29	non	non	JJ
cord-005453-4057qib7	969	30	-	-	JJ
cord-005453-4057qib7	969	31	viral	viral	JJ
cord-005453-4057qib7	969	32	Sleeping	sleep	VBG
cord-005453-4057qib7	969	33	Beauty	Beauty	NNP
cord-005453-4057qib7	969	34	(	(	-LRB-
cord-005453-4057qib7	969	35	SB	SB	NNP
cord-005453-4057qib7	969	36	)	)	-RRB-
cord-005453-4057qib7	969	37	transposition	transposition	NN
cord-005453-4057qib7	969	38	of	of	IN
cord-005453-4057qib7	969	39	third	third	JJ
cord-005453-4057qib7	969	40	party	party	NN
cord-005453-4057qib7	969	41	NK	NK	NNP
cord-005453-4057qib7	969	42	cells	cell	NNS
cord-005453-4057qib7	969	43	as	as	IN
cord-005453-4057qib7	969	44	a	a	DT
cord-005453-4057qib7	969	45	source	source	NN
cord-005453-4057qib7	969	46	to	to	TO
cord-005453-4057qib7	969	47	produce	produce	VB
cord-005453-4057qib7	969	48	'	'	''
cord-005453-4057qib7	969	49	off	off	IN
cord-005453-4057qib7	969	50	the	the	DT
cord-005453-4057qib7	969	51	shelf	shelf	NN
cord-005453-4057qib7	969	52	'	'	''
cord-005453-4057qib7	969	53	CAR	car	NN
cord-005453-4057qib7	969	54	-	-	HYPH
cord-005453-4057qib7	969	55	engineered	engineer	VBN
cord-005453-4057qib7	969	56	cell	cell	NN
cord-005453-4057qib7	969	57	products	product	NNS
cord-005453-4057qib7	969	58	.	.	.
cord-005453-4057qib7	970	1	Methods	method	NNS
cord-005453-4057qib7	970	2	:	:	:
cord-005453-4057qib7	970	3	NK	NK	NNP
cord-005453-4057qib7	970	4	cells	cell	NNS
cord-005453-4057qib7	970	5	are	be	VBP
cord-005453-4057qib7	970	6	isolated	isolate	VBN
cord-005453-4057qib7	970	7	from	from	IN
cord-005453-4057qib7	970	8	peripheral	peripheral	JJ
cord-005453-4057qib7	970	9	blood	blood	NN
cord-005453-4057qib7	970	10	mononuclear	mononuclear	NN
cord-005453-4057qib7	970	11	cells	cell	NNS
cord-005453-4057qib7	970	12	(	(	-LRB-
cord-005453-4057qib7	970	13	PBMCs	pbmc	NNS
cord-005453-4057qib7	970	14	)	)	-RRB-
cord-005453-4057qib7	970	15	using	use	VBG
cord-005453-4057qib7	970	16	CD56	CD56	NNP
cord-005453-4057qib7	970	17	selection	selection	NN
cord-005453-4057qib7	970	18	kits	kit	NNS
cord-005453-4057qib7	970	19	.	.	.
cord-005453-4057qib7	971	1	They	-PRON-	PRP
cord-005453-4057qib7	971	2	are	be	VBP
cord-005453-4057qib7	971	3	successfully	successfully	RB
cord-005453-4057qib7	971	4	expanded	expand	VBN
cord-005453-4057qib7	971	5	ex	ex	FW
cord-005453-4057qib7	971	6	vivo	vivo	NN
cord-005453-4057qib7	971	7	with	with	IN
cord-005453-4057qib7	971	8	IL-15	IL-15	NNP
cord-005453-4057qib7	971	9	cytokine	cytokine	JJ
cord-005453-4057qib7	971	10	stimulation	stimulation	NN
cord-005453-4057qib7	971	11	under	under	IN
cord-005453-4057qib7	971	12	feeder	feeder	NN
cord-005453-4057qib7	971	13	-	-	HYPH
cord-005453-4057qib7	971	14	cell	cell	NN
cord-005453-4057qib7	971	15	free	free	JJ
cord-005453-4057qib7	971	16	conditions	condition	NNS
cord-005453-4057qib7	971	17	.	.	.
cord-005453-4057qib7	972	1	After	after	IN
cord-005453-4057qib7	972	2	few	few	JJ
cord-005453-4057qib7	972	3	days	day	NNS
cord-005453-4057qib7	972	4	of	of	IN
cord-005453-4057qib7	972	5	expansion	expansion	NN
cord-005453-4057qib7	972	6	NK	NK	NNP
cord-005453-4057qib7	972	7	cells	cell	NNS
cord-005453-4057qib7	972	8	are	be	VBP
cord-005453-4057qib7	972	9	electroporated	electroporate	VBN
cord-005453-4057qib7	972	10	using	use	VBG
cord-005453-4057qib7	972	11	pmaxGFP	pmaxgfp	NN
cord-005453-4057qib7	972	12	.	.	.
cord-005453-4057qib7	973	1	Transfection	transfection	NN
cord-005453-4057qib7	973	2	efficiency	efficiency	NN
cord-005453-4057qib7	973	3	and	and	CC
cord-005453-4057qib7	973	4	percent	percent	NN
cord-005453-4057qib7	973	5	of	of	IN
cord-005453-4057qib7	973	6	living	living	NN
cord-005453-4057qib7	973	7	cells	cell	NNS
cord-005453-4057qib7	973	8	after	after	IN
cord-005453-4057qib7	973	9	electroporation	electroporation	NN
cord-005453-4057qib7	973	10	is	be	VBZ
cord-005453-4057qib7	973	11	analyzed	analyze	VBN
cord-005453-4057qib7	973	12	by	by	IN
cord-005453-4057qib7	973	13	flow	flow	NN
cord-005453-4057qib7	973	14	cytometry	cytometry	NN
cord-005453-4057qib7	973	15	.	.	.
cord-005453-4057qib7	974	1	Transposition	transposition	NN
cord-005453-4057qib7	974	2	based	base	VBN
cord-005453-4057qib7	974	3	nucleofection	nucleofection	NN
cord-005453-4057qib7	974	4	using	use	VBG
cord-005453-4057qib7	974	5	an	an	DT
cord-005453-4057qib7	974	6	SB100X	sb100x	NN
cord-005453-4057qib7	974	7	mRNA	mrna	NN
cord-005453-4057qib7	974	8	and	and	CC
cord-005453-4057qib7	974	9	a	a	DT
cord-005453-4057qib7	974	10	minicircles	minicircles	FW
cord-005453-4057qib7	974	11	(	(	-LRB-
cord-005453-4057qib7	974	12	MC	MC	NNP
cord-005453-4057qib7	974	13	)	)	-RRB-
cord-005453-4057qib7	974	14	DNA	dna	NN
cord-005453-4057qib7	974	15	vector	vector	NN
cord-005453-4057qib7	974	16	is	be	VBZ
cord-005453-4057qib7	974	17	performed	perform	VBN
cord-005453-4057qib7	974	18	at	at	IN
cord-005453-4057qib7	974	19	different	different	JJ
cord-005453-4057qib7	974	20	time	time	NN
cord-005453-4057qib7	974	21	points	point	NNS
cord-005453-4057qib7	974	22	after	after	IN
cord-005453-4057qib7	974	23	NK	NK	NNP
cord-005453-4057qib7	974	24	cell	cell	NN
cord-005453-4057qib7	974	25	isolation	isolation	NN
cord-005453-4057qib7	974	26	.	.	.
cord-005453-4057qib7	975	1	The	the	DT
cord-005453-4057qib7	975	2	transient	transient	JJ
cord-005453-4057qib7	975	3	MC	MC	NNP
cord-005453-4057qib7	975	4	-	-	HYPH
cord-005453-4057qib7	975	5	Venus	Venus	NNP
cord-005453-4057qib7	975	6	longtime	longtime	JJ
cord-005453-4057qib7	975	7	expansion	expansion	NN
cord-005453-4057qib7	975	8	and	and	CC
cord-005453-4057qib7	975	9	the	the	DT
cord-005453-4057qib7	975	10	viability	viability	NN
cord-005453-4057qib7	975	11	after	after	IN
cord-005453-4057qib7	975	12	SB100X	sb100x	NN
cord-005453-4057qib7	975	13	based	base	VBN
cord-005453-4057qib7	975	14	nucleofection	nucleofection	NN
cord-005453-4057qib7	975	15	is	be	VBZ
cord-005453-4057qib7	975	16	measured	measure	VBN
cord-005453-4057qib7	975	17	over	over	IN
cord-005453-4057qib7	975	18	two	two	CD
cord-005453-4057qib7	975	19	weeks	week	NNS
cord-005453-4057qib7	975	20	.	.	.
cord-005453-4057qib7	976	1	Furthermore	furthermore	RB
cord-005453-4057qib7	976	2	,	,	,
cord-005453-4057qib7	976	3	α	α	NN
cord-005453-4057qib7	976	4	-	-	HYPH
cord-005453-4057qib7	976	5	retroviral	retroviral	JJ
cord-005453-4057qib7	976	6	(	(	-LRB-
cord-005453-4057qib7	976	7	α	α	NN
cord-005453-4057qib7	976	8	-	-	HYPH
cord-005453-4057qib7	976	9	RV	RV	NNP
cord-005453-4057qib7	976	10	)	)	-RRB-
cord-005453-4057qib7	976	11	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	976	12	transduction	transduction	NN
cord-005453-4057qib7	976	13	of	of	IN
cord-005453-4057qib7	976	14	NK	NK	NNP
cord-005453-4057qib7	976	15	cells	cell	NNS
cord-005453-4057qib7	976	16	with	with	IN
cord-005453-4057qib7	976	17	different	different	JJ
cord-005453-4057qib7	976	18	viral	viral	JJ
cord-005453-4057qib7	976	19	amounts	amount	NNS
cord-005453-4057qib7	976	20	(	(	-LRB-
cord-005453-4057qib7	976	21	MOI	MOI	NNP
cord-005453-4057qib7	976	22	)	)	-RRB-
cord-005453-4057qib7	976	23	is	be	VBZ
cord-005453-4057qib7	976	24	conducted	conduct	VBN
cord-005453-4057qib7	976	25	and	and	CC
cord-005453-4057qib7	976	26	the	the	DT
cord-005453-4057qib7	976	27	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	976	28	of	of	IN
cord-005453-4057qib7	976	29	the	the	DT
cord-005453-4057qib7	976	30	engineered	engineer	VBN
cord-005453-4057qib7	976	31	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	976	32	-	-	HYPH
cord-005453-4057qib7	976	33	NK	NK	NNP
cord-005453-4057qib7	976	34	cells	cell	NNS
cord-005453-4057qib7	976	35	against	against	IN
cord-005453-4057qib7	976	36	the	the	DT
cord-005453-4057qib7	976	37	CD19	CD19	NNP
cord-005453-4057qib7	976	38	positiv	positiv	JJ
cord-005453-4057qib7	976	39	cell	cell	NN
cord-005453-4057qib7	976	40	line	line	NN
cord-005453-4057qib7	976	41	SupB15	SupB15	NNP
cord-005453-4057qib7	976	42	is	be	VBZ
cord-005453-4057qib7	976	43	addressed	address	VBN
cord-005453-4057qib7	976	44	.	.	.
cord-005453-4057qib7	977	1	Results	result	NNS
cord-005453-4057qib7	977	2	:	:	:
cord-005453-4057qib7	978	1	For	for	IN
cord-005453-4057qib7	978	2	an	an	DT
cord-005453-4057qib7	978	3	α	α	NN
cord-005453-4057qib7	978	4	-	-	HYPH
cord-005453-4057qib7	978	5	RV	rv	NN
cord-005453-4057qib7	978	6	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	978	7	transduction	transduction	NN
cord-005453-4057qib7	978	8	of	of	IN
cord-005453-4057qib7	978	9	maximal	maximal	JJ
cord-005453-4057qib7	978	10	1x10	1x10	CD
cord-005453-4057qib7	978	11	4	4	CD
cord-005453-4057qib7	978	12	NK	NK	NNP
cord-005453-4057qib7	978	13	cells	cell	NNS
cord-005453-4057qib7	978	14	we	-PRON-	PRP
cord-005453-4057qib7	978	15	could	could	MD
cord-005453-4057qib7	978	16	show	show	VB
cord-005453-4057qib7	978	17	transduction	transduction	NN
cord-005453-4057qib7	978	18	efficiency	efficiency	NN
cord-005453-4057qib7	978	19	of	of	IN
cord-005453-4057qib7	978	20	68,96	68,96	CD
cord-005453-4057qib7	978	21	%	%	NN
cord-005453-4057qib7	978	22	for	for	IN
cord-005453-4057qib7	978	23	MOI10	MOI10	NNP
cord-005453-4057qib7	978	24	.	.	.
cord-005453-4057qib7	979	1	The	the	DT
cord-005453-4057qib7	979	2	α	α	NN
cord-005453-4057qib7	979	3	-	-	HYPH
cord-005453-4057qib7	979	4	RV	RV	NNP
cord-005453-4057qib7	979	5	CD19-CAR	cd19-car	NN
cord-005453-4057qib7	979	6	modified	modify	VBN
cord-005453-4057qib7	979	7	NK	NK	NNP
cord-005453-4057qib7	979	8	cells	cell	NNS
cord-005453-4057qib7	979	9	had	have	VBD
cord-005453-4057qib7	979	10	a	a	DT
cord-005453-4057qib7	979	11	high	high	JJ
cord-005453-4057qib7	979	12	killing	killing	NN
cord-005453-4057qib7	979	13	activity	activity	NN
cord-005453-4057qib7	979	14	against	against	IN
cord-005453-4057qib7	979	15	CD19	CD19	NNP
cord-005453-4057qib7	979	16	positiv	positiv	JJ
cord-005453-4057qib7	979	17	SupB15	SupB15	NNP
cord-005453-4057qib7	979	18	cells	cell	NNS
cord-005453-4057qib7	980	1	(	(	-LRB-
cord-005453-4057qib7	980	2	E	e	NN
cord-005453-4057qib7	980	3	:	:	:
cord-005453-4057qib7	980	4	T	t	NN
cord-005453-4057qib7	980	5	ration	ration	NN
cord-005453-4057qib7	980	6	1:1	1:1	CD
cord-005453-4057qib7	980	7	90,85	90,85	CD
cord-005453-4057qib7	980	8	%	%	NN
cord-005453-4057qib7	980	9	)	)	-RRB-
cord-005453-4057qib7	980	10	compared	compare	VBN
cord-005453-4057qib7	980	11	to	to	IN
cord-005453-4057qib7	980	12	CD19	CD19	NNP
cord-005453-4057qib7	980	13	negativ	negativ	NNP
cord-005453-4057qib7	980	14	K562	k562	CD
cord-005453-4057qib7	980	15	cell	cell	NN
cord-005453-4057qib7	980	16	lines	line	NNS
cord-005453-4057qib7	980	17	(	(	-LRB-
cord-005453-4057qib7	980	18	E	e	NN
cord-005453-4057qib7	980	19	:	:	:
cord-005453-4057qib7	980	20	T	t	NN
cord-005453-4057qib7	980	21	ration	ration	NN
cord-005453-4057qib7	980	22	1:1	1:1	CD
cord-005453-4057qib7	980	23	16,42	16,42	CD
cord-005453-4057qib7	980	24	%	%	NN
cord-005453-4057qib7	980	25	)	)	-RRB-
cord-005453-4057qib7	980	26	and	and	CC
cord-005453-4057qib7	980	27	the	the	DT
cord-005453-4057qib7	980	28	non	non	JJ
cord-005453-4057qib7	980	29	-	-	JJ
cord-005453-4057qib7	980	30	transduced	transduced	JJ
cord-005453-4057qib7	980	31	NK	NK	NNP
cord-005453-4057qib7	980	32	cells	cell	NNS
cord-005453-4057qib7	981	1	(	(	-LRB-
cord-005453-4057qib7	981	2	E	e	NN
cord-005453-4057qib7	981	3	:	:	:
cord-005453-4057qib7	981	4	T	t	NN
cord-005453-4057qib7	981	5	ratio	ratio	NN
cord-005453-4057qib7	981	6	1:1	1:1	CD
cord-005453-4057qib7	981	7	9,03	9,03	CD
cord-005453-4057qib7	981	8	%	%	NN
cord-005453-4057qib7	981	9	)	)	-RRB-
cord-005453-4057qib7	981	10	.	.	.
cord-005453-4057qib7	982	1	In	in	IN
cord-005453-4057qib7	982	2	first	first	JJ
cord-005453-4057qib7	982	3	experiments	experiment	NNS
cord-005453-4057qib7	982	4	with	with	IN
cord-005453-4057qib7	982	5	pmaxGFP	pmaxgfp	NN
cord-005453-4057qib7	982	6	vector	vector	NN
cord-005453-4057qib7	982	7	based	base	VBN
cord-005453-4057qib7	982	8	nucleofection	nucleofection	NN
cord-005453-4057qib7	982	9	,	,	,
cord-005453-4057qib7	982	10	we	-PRON-	PRP
cord-005453-4057qib7	982	11	could	could	MD
cord-005453-4057qib7	982	12	show	show	VB
cord-005453-4057qib7	982	13	an	an	DT
cord-005453-4057qib7	982	14	increasing	increase	VBG
cord-005453-4057qib7	982	15	efficiency	efficiency	NN
cord-005453-4057qib7	982	16	of	of	IN
cord-005453-4057qib7	982	17	55,9	55,9	CD
cord-005453-4057qib7	982	18	%	%	NN
cord-005453-4057qib7	982	19	48h	48h	CD
cord-005453-4057qib7	982	20	post	post	NN
cord-005453-4057qib7	982	21	electroporation	electroporation	NN
cord-005453-4057qib7	982	22	with	with	IN
cord-005453-4057qib7	982	23	a	a	DT
cord-005453-4057qib7	982	24	only	only	JJ
cord-005453-4057qib7	982	25	slightly	slightly	RB
cord-005453-4057qib7	982	26	decreas	decrea	NNS
cord-005453-4057qib7	982	27	of	of	IN
cord-005453-4057qib7	982	28	living	living	NN
cord-005453-4057qib7	982	29	cells	cell	NNS
cord-005453-4057qib7	982	30	(	(	-LRB-
cord-005453-4057qib7	982	31	21,5	21,5	CD
cord-005453-4057qib7	982	32	%	%	NN
cord-005453-4057qib7	982	33	)	)	-RRB-
cord-005453-4057qib7	982	34	comparing	compare	VBG
cord-005453-4057qib7	982	35	to	to	IN
cord-005453-4057qib7	982	36	the	the	DT
cord-005453-4057qib7	982	37	non	non	JJ
cord-005453-4057qib7	982	38	-	-	JJ
cord-005453-4057qib7	982	39	electroporated	electroporated	JJ
cord-005453-4057qib7	982	40	NK	NK	NNP
cord-005453-4057qib7	982	41	cell	cell	NN
cord-005453-4057qib7	982	42	viability	viability	NN
cord-005453-4057qib7	982	43	.	.	.
cord-005453-4057qib7	983	1	Using	use	VBG
cord-005453-4057qib7	983	2	SB100X	SB100X	NNP
cord-005453-4057qib7	983	3	mRNA	mRNA	NNP
cord-005453-4057qib7	983	4	with	with	IN
cord-005453-4057qib7	983	5	MC	MC	NNP
cord-005453-4057qib7	983	6	-	-	HYPH
cord-005453-4057qib7	983	7	Venus	Venus	NNP
cord-005453-4057qib7	983	8	DNA	DNA	NNP
cord-005453-4057qib7	983	9	we	-PRON-	PRP
cord-005453-4057qib7	983	10	electrotransfected	electrotransfecte	VBD
cord-005453-4057qib7	983	11	1x10	1x10	CD
cord-005453-4057qib7	983	12	6	6	CD
cord-005453-4057qib7	983	13	NK	NK	NNP
cord-005453-4057qib7	983	14	cells	cell	NNS
cord-005453-4057qib7	983	15	after	after	IN
cord-005453-4057qib7	983	16	fews	few	NNS
cord-005453-4057qib7	983	17	days	day	NNS
cord-005453-4057qib7	983	18	of	of	IN
cord-005453-4057qib7	983	19	cultivation	cultivation	NN
cord-005453-4057qib7	983	20	and	and	CC
cord-005453-4057qib7	983	21	we	-PRON-	PRP
cord-005453-4057qib7	983	22	reached	reach	VBD
cord-005453-4057qib7	983	23	36,6	36,6	CD
cord-005453-4057qib7	983	24	%	%	NN
cord-005453-4057qib7	983	25	of	of	IN
cord-005453-4057qib7	983	26	transfected	transfecte	VBN
cord-005453-4057qib7	983	27	NK	NK	NNP
cord-005453-4057qib7	983	28	cells	cell	NNS
cord-005453-4057qib7	983	29	24h	24h	NNS
cord-005453-4057qib7	983	30	post	post	NN
cord-005453-4057qib7	983	31	electroporation	electroporation	NN
cord-005453-4057qib7	983	32	and	and	CC
cord-005453-4057qib7	983	33	a	a	DT
cord-005453-4057qib7	983	34	transient	transient	JJ
cord-005453-4057qib7	983	35	expression	expression	NN
cord-005453-4057qib7	983	36	of	of	IN
cord-005453-4057qib7	983	37	MC	MC	NNP
cord-005453-4057qib7	983	38	-	-	HYPH
cord-005453-4057qib7	983	39	Venus	Venus	NNP
cord-005453-4057qib7	983	40	positive	positive	JJ
cord-005453-4057qib7	983	41	NK	NK	NNP
cord-005453-4057qib7	983	42	cells	cell	NNS
cord-005453-4057qib7	983	43	up	up	IN
cord-005453-4057qib7	983	44	to	to	IN
cord-005453-4057qib7	983	45	54,6	54,6	CD
cord-005453-4057qib7	983	46	%	%	NN
cord-005453-4057qib7	983	47	efficiency	efficiency	NN
cord-005453-4057qib7	983	48	with	with	IN
cord-005453-4057qib7	983	49	an	an	DT
cord-005453-4057qib7	983	50	increasing	increase	VBG
cord-005453-4057qib7	983	51	rate	rate	NN
cord-005453-4057qib7	983	52	of	of	IN
cord-005453-4057qib7	983	53	live	live	JJ
cord-005453-4057qib7	983	54	cells	cell	NNS
cord-005453-4057qib7	983	55	over	over	IN
cord-005453-4057qib7	983	56	14	14	CD
cord-005453-4057qib7	983	57	days	day	NNS
cord-005453-4057qib7	983	58	after	after	IN
cord-005453-4057qib7	983	59	electroporation	electroporation	NN
cord-005453-4057qib7	983	60	.	.	.
cord-005453-4057qib7	984	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	984	2	:	:	:
cord-005453-4057qib7	985	1	The	the	DT
cord-005453-4057qib7	985	2	Sleeping	sleep	VBG
cord-005453-4057qib7	985	3	Beauty	Beauty	NNP
cord-005453-4057qib7	985	4	based	base	VBN
cord-005453-4057qib7	985	5	nucleofection	nucleofection	NN
cord-005453-4057qib7	985	6	of	of	IN
cord-005453-4057qib7	985	7	NK	NK	NNP
cord-005453-4057qib7	985	8	cells	cell	NNS
cord-005453-4057qib7	985	9	is	be	VBZ
cord-005453-4057qib7	985	10	a	a	DT
cord-005453-4057qib7	985	11	very	very	RB
cord-005453-4057qib7	985	12	promising	promising	JJ
cord-005453-4057qib7	985	13	non	non	JJ
cord-005453-4057qib7	985	14	-	-	JJ
cord-005453-4057qib7	985	15	viral	viral	JJ
cord-005453-4057qib7	985	16	method	method	NN
cord-005453-4057qib7	985	17	to	to	TO
cord-005453-4057qib7	985	18	generate	generate	VB
cord-005453-4057qib7	985	19	more	more	RBR
cord-005453-4057qib7	985	20	easy	easy	JJ
cord-005453-4057qib7	985	21	,	,	,
cord-005453-4057qib7	985	22	safer	safe	JJR
cord-005453-4057qib7	985	23	and	and	CC
cord-005453-4057qib7	985	24	higher	high	JJR
cord-005453-4057qib7	985	25	amounts	amount	NNS
cord-005453-4057qib7	985	26	of	of	IN
cord-005453-4057qib7	985	27	genetically	genetically	RB
cord-005453-4057qib7	985	28	modified	modify	VBN
cord-005453-4057qib7	985	29	third	third	JJ
cord-005453-4057qib7	985	30	party	party	NN
cord-005453-4057qib7	985	31	NK	NK	NNP
cord-005453-4057qib7	985	32	cells	cell	NNS
cord-005453-4057qib7	985	33	for	for	IN
cord-005453-4057qib7	985	34	therapy	therapy	NN
cord-005453-4057qib7	985	35	of	of	IN
cord-005453-4057qib7	985	36	ALL	all	DT
cord-005453-4057qib7	985	37	and	and	CC
cord-005453-4057qib7	985	38	has	have	VBZ
cord-005453-4057qib7	985	39	also	also	RB
cord-005453-4057qib7	985	40	a	a	DT
cord-005453-4057qib7	985	41	broad	broad	JJ
cord-005453-4057qib7	985	42	range	range	NN
cord-005453-4057qib7	985	43	of	of	IN
cord-005453-4057qib7	985	44	clinical	clinical	JJ
cord-005453-4057qib7	985	45	applications	application	NNS
cord-005453-4057qib7	985	46	.	.	.
cord-005453-4057qib7	986	1	Disclosure	disclosure	NN
cord-005453-4057qib7	986	2	:	:	:
cord-005453-4057qib7	987	1	Winfried	Winfried	NNP
cord-005453-4057qib7	987	2	S.	S.	NNP
cord-005453-4057qib7	987	3	Wels	Wels	NNP
cord-005453-4057qib7	987	4	is	be	VBZ
cord-005453-4057qib7	987	5	an	an	DT
cord-005453-4057qib7	987	6	inventor	inventor	NN
cord-005453-4057qib7	987	7	on	on	IN
cord-005453-4057qib7	987	8	a	a	DT
cord-005453-4057qib7	987	9	patent	patent	NN
cord-005453-4057qib7	987	10	describing	describe	VBG
cord-005453-4057qib7	987	11	chimeric	chimeric	JJ
cord-005453-4057qib7	987	12	antigen	antigen	NN
cord-005453-4057qib7	987	13	receptors	receptor	NNS
cord-005453-4057qib7	987	14	with	with	IN
cord-005453-4057qib7	987	15	an	an	DT
cord-005453-4057qib7	987	16	optimized	optimize	VBN
cord-005453-4057qib7	987	17	hinge	hinge	NN
cord-005453-4057qib7	987	18	region	region	NN
cord-005453-4057qib7	987	19	.	.	.
cord-005453-4057qib7	988	1	Axel	Axel	NNP
cord-005453-4057qib7	988	2	Schambach	Schambach	NNP
cord-005453-4057qib7	988	3	is	be	VBZ
cord-005453-4057qib7	988	4	an	an	DT
cord-005453-4057qib7	988	5	inventor	inventor	NN
cord-005453-4057qib7	988	6	on	on	IN
cord-005453-4057qib7	988	7	a	a	DT
cord-005453-4057qib7	988	8	patent	patent	NN
cord-005453-4057qib7	988	9	describing	describe	VBG
cord-005453-4057qib7	988	10	alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	988	11	SIN	sin	NN
cord-005453-4057qib7	988	12	vectors	vector	NNS
cord-005453-4057qib7	988	13	.	.	.
cord-005453-4057qib7	989	1	Michael	Michael	NNP
cord-005453-4057qib7	989	2	Hudecek	Hudecek	NNP
cord-005453-4057qib7	989	3	and	and	CC
cord-005453-4057qib7	989	4	Zoltan	Zoltan	NNP
cord-005453-4057qib7	989	5	Ivics	Ivics	NNP
cord-005453-4057qib7	989	6	are	be	VBP
cord-005453-4057qib7	989	7	inventors	inventor	NNS
cord-005453-4057qib7	989	8	on	on	IN
cord-005453-4057qib7	989	9	patents	patent	NNS
cord-005453-4057qib7	989	10	related	relate	VBN
cord-005453-4057qib7	989	11	to	to	IN
cord-005453-4057qib7	989	12	Sleeping	sleep	VBG
cord-005453-4057qib7	989	13	Beaut	Beaut	NNP
cord-005453-4057qib7	989	14	gene	gene	NN
cord-005453-4057qib7	989	15	transfer	transfer	NN
cord-005453-4057qib7	989	16	technology	technology	NN
cord-005453-4057qib7	989	17	.	.	.
cord-005453-4057qib7	990	1	The	the	DT
cord-005453-4057qib7	990	2	remaining	remain	VBG
cord-005453-4057qib7	990	3	authors	author	NNS
cord-005453-4057qib7	990	4	have	have	VBP
cord-005453-4057qib7	990	5	nothing	nothing	NN
cord-005453-4057qib7	990	6	to	to	TO
cord-005453-4057qib7	990	7	disclose	disclose	VB
cord-005453-4057qib7	990	8	.	.	.
cord-005453-4057qib7	991	1	Background	background	NN
cord-005453-4057qib7	991	2	:	:	:
cord-005453-4057qib7	992	1	Mature	mature	JJ
cord-005453-4057qib7	992	2	immune	immune	JJ
cord-005453-4057qib7	992	3	cells	cell	NNS
cord-005453-4057qib7	992	4	from	from	IN
cord-005453-4057qib7	992	5	the	the	DT
cord-005453-4057qib7	992	6	stem	stem	NN
cord-005453-4057qib7	992	7	cell	cell	NN
cord-005453-4057qib7	992	8	graft	graft	NN
cord-005453-4057qib7	992	9	are	be	VBP
cord-005453-4057qib7	992	10	essential	essential	JJ
cord-005453-4057qib7	992	11	for	for	IN
cord-005453-4057qib7	992	12	the	the	DT
cord-005453-4057qib7	992	13	graft	graft	NN
cord-005453-4057qib7	992	14	-	-	HYPH
cord-005453-4057qib7	992	15	versus	versus	IN
cord-005453-4057qib7	992	16	-	-	HYPH
cord-005453-4057qib7	992	17	tumor	tumor	NN
cord-005453-4057qib7	992	18	(	(	-LRB-
cord-005453-4057qib7	992	19	GVT	GVT	NNP
cord-005453-4057qib7	992	20	)	)	-RRB-
cord-005453-4057qib7	992	21	effect	effect	NN
cord-005453-4057qib7	992	22	to	to	TO
cord-005453-4057qib7	992	23	eliminate	eliminate	VB
cord-005453-4057qib7	992	24	residual	residual	JJ
cord-005453-4057qib7	992	25	malignant	malignant	JJ
cord-005453-4057qib7	992	26	cells	cell	NNS
cord-005453-4057qib7	992	27	after	after	IN
cord-005453-4057qib7	992	28	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	992	29	stem	stem	NN
cord-005453-4057qib7	992	30	cell	cell	NN
cord-005453-4057qib7	992	31	transplantation	transplantation	NN
cord-005453-4057qib7	992	32	(	(	-LRB-
cord-005453-4057qib7	992	33	HSCT	HSCT	NNP
cord-005453-4057qib7	992	34	)	)	-RRB-
cord-005453-4057qib7	992	35	,	,	,
cord-005453-4057qib7	992	36	but	but	CC
cord-005453-4057qib7	992	37	donor	donor	NN
cord-005453-4057qib7	992	38	cells	cell	NNS
cord-005453-4057qib7	992	39	are	be	VBP
cord-005453-4057qib7	992	40	also	also	RB
cord-005453-4057qib7	992	41	involved	involve	VBN
cord-005453-4057qib7	992	42	in	in	IN
cord-005453-4057qib7	992	43	complications	complication	NNS
cord-005453-4057qib7	992	44	such	such	JJ
cord-005453-4057qib7	992	45	as	as	IN
cord-005453-4057qib7	992	46	graft	graft	NN
cord-005453-4057qib7	992	47	-	-	HYPH
cord-005453-4057qib7	992	48	versus	versus	IN
cord-005453-4057qib7	992	49	-	-	HYPH
cord-005453-4057qib7	992	50	host	host	NN
cord-005453-4057qib7	992	51	disease	disease	NN
cord-005453-4057qib7	992	52	(	(	-LRB-
cord-005453-4057qib7	992	53	GVHD	GVHD	NNP
cord-005453-4057qib7	992	54	)	)	-RRB-
cord-005453-4057qib7	992	55	.	.	.
cord-005453-4057qib7	993	1	Methods	method	NNS
cord-005453-4057qib7	993	2	:	:	:
cord-005453-4057qib7	994	1	We	-PRON-	PRP
cord-005453-4057qib7	994	2	performed	perform	VBD
cord-005453-4057qib7	994	3	a	a	DT
cord-005453-4057qib7	994	4	prospective	prospective	JJ
cord-005453-4057qib7	994	5	study	study	NN
cord-005453-4057qib7	994	6	of	of	IN
cord-005453-4057qib7	994	7	the	the	DT
cord-005453-4057qib7	994	8	detailed	detailed	JJ
cord-005453-4057qib7	994	9	graft	graft	NN
cord-005453-4057qib7	994	10	composition	composition	NN
cord-005453-4057qib7	994	11	in	in	IN
cord-005453-4057qib7	994	12	102	102	CD
cord-005453-4057qib7	994	13	recipients	recipient	NNS
cord-005453-4057qib7	994	14	of	of	IN
cord-005453-4057qib7	994	15	peripheral	peripheral	JJ
cord-005453-4057qib7	994	16	blood	blood	NN
cord-005453-4057qib7	994	17	stem	stem	NN
cord-005453-4057qib7	994	18	cells	cell	NNS
cord-005453-4057qib7	994	19	(	(	-LRB-
cord-005453-4057qib7	994	20	PBSC	PBSC	NNP
cord-005453-4057qib7	994	21	)	)	-RRB-
cord-005453-4057qib7	994	22	or	or	CC
cord-005453-4057qib7	994	23	bone	bone	NN
cord-005453-4057qib7	994	24	marrow	marrow	NN
cord-005453-4057qib7	994	25	(	(	-LRB-
cord-005453-4057qib7	994	26	BM	BM	NNP
cord-005453-4057qib7	994	27	)	)	-RRB-
cord-005453-4057qib7	994	28	in	in	IN
cord-005453-4057qib7	994	29	order	order	NN
cord-005453-4057qib7	994	30	to	to	TO
cord-005453-4057qib7	994	31	identify	identify	VB
cord-005453-4057qib7	994	32	correlations	correlation	NNS
cord-005453-4057qib7	994	33	to	to	IN
cord-005453-4057qib7	994	34	clinical	clinical	JJ
cord-005453-4057qib7	994	35	outcomes	outcome	NNS
cord-005453-4057qib7	994	36	,	,	,
cord-005453-4057qib7	994	37	table	table	NN
cord-005453-4057qib7	994	38	1	1	CD
cord-005453-4057qib7	994	39	.	.	.
cord-005453-4057qib7	995	1	Grafts	graft	NNS
cord-005453-4057qib7	995	2	were	be	VBD
cord-005453-4057qib7	995	3	characterized	characterize	VBN
cord-005453-4057qib7	995	4	with	with	IN
cord-005453-4057qib7	995	5	concentrations	concentration	NNS
cord-005453-4057qib7	995	6	of	of	IN
cord-005453-4057qib7	995	7	T	t	NN
cord-005453-4057qib7	995	8	cells	cell	NNS
cord-005453-4057qib7	995	9	and	and	CC
cord-005453-4057qib7	995	10	NK	NK	NNP
cord-005453-4057qib7	995	11	cells	cell	NNS
cord-005453-4057qib7	995	12	together	together	RB
cord-005453-4057qib7	995	13	with	with	IN
cord-005453-4057qib7	995	14	a	a	DT
cord-005453-4057qib7	995	15	multi	multi	JJ
cord-005453-4057qib7	995	16	-	-	JJ
cord-005453-4057qib7	995	17	color	color	JJ
cord-005453-4057qib7	995	18	flow	flow	NN
cord-005453-4057qib7	995	19	cytometry	cytometry	NN
cord-005453-4057qib7	995	20	panel	panel	NN
cord-005453-4057qib7	995	21	with	with	IN
cord-005453-4057qib7	995	22	staining	stain	VBG
cord-005453-4057qib7	995	23	for	for	IN
cord-005453-4057qib7	995	24	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	995	25	,	,	,
cord-005453-4057qib7	995	26	TCRγδ	TCRγδ	NNP
cord-005453-4057qib7	995	27	,	,	,
cord-005453-4057qib7	995	28	Vδ1	Vδ1	NNP
cord-005453-4057qib7	995	29	,	,	,
cord-005453-4057qib7	995	30	Vδ2	Vδ2	NNP
cord-005453-4057qib7	995	31	,	,	,
cord-005453-4057qib7	995	32	CD3	CD3	NNP
cord-005453-4057qib7	995	33	,	,	,
cord-005453-4057qib7	995	34	CD4	CD4	NNP
cord-005453-4057qib7	995	35	,	,	,
cord-005453-4057qib7	995	36	CD8	CD8	NNP
cord-005453-4057qib7	995	37	,	,	,
cord-005453-4057qib7	995	38	HLA	HLA	NNP
cord-005453-4057qib7	995	39	-	-	HYPH
cord-005453-4057qib7	995	40	DR	DR	NNP
cord-005453-4057qib7	995	41	,	,	,
cord-005453-4057qib7	995	42	CD196	CD196	NNP
cord-005453-4057qib7	995	43	,	,	,
cord-005453-4057qib7	995	44	CD45RO	CD45RO	NNP
cord-005453-4057qib7	995	45	,	,	,
cord-005453-4057qib7	995	46	CD45RA	CD45RA	NNP
cord-005453-4057qib7	995	47	,	,	,
cord-005453-4057qib7	995	48	CD16	CD16	NNP
cord-005453-4057qib7	995	49	,	,	,
cord-005453-4057qib7	995	50	CD56	CD56	NNP
cord-005453-4057qib7	995	51	,	,	,
cord-005453-4057qib7	995	52	CD337	CD337	NNP
cord-005453-4057qib7	995	53	and	and	CC
cord-005453-4057qib7	995	54	CD314	CD314	NNP
cord-005453-4057qib7	995	55	for	for	IN
cord-005453-4057qib7	995	56	detailed	detailed	JJ
cord-005453-4057qib7	995	57	immune	immune	JJ
cord-005453-4057qib7	995	58	phenotyping	phenotyping	NN
cord-005453-4057qib7	995	59	.	.	.
cord-005453-4057qib7	996	1	Cell	cell	NN
cord-005453-4057qib7	996	2	contents	content	NNS
cord-005453-4057qib7	996	3	in	in	IN
cord-005453-4057qib7	996	4	stem	stem	NN
cord-005453-4057qib7	996	5	cell	cell	NN
cord-005453-4057qib7	996	6	grafts	graft	NNS
cord-005453-4057qib7	996	7	were	be	VBD
cord-005453-4057qib7	996	8	analyzed	analyze	VBN
cord-005453-4057qib7	996	9	both	both	CC
cord-005453-4057qib7	996	10	as	as	IN
cord-005453-4057qib7	996	11	fractions	fraction	NNS
cord-005453-4057qib7	996	12	of	of	IN
cord-005453-4057qib7	996	13	CD45	CD45	NNP
cord-005453-4057qib7	996	14	positive	positive	JJ
cord-005453-4057qib7	996	15	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	996	16	and	and	CC
cord-005453-4057qib7	996	17	as	as	IN
cord-005453-4057qib7	996	18	absolute	absolute	JJ
cord-005453-4057qib7	996	19	concentrations	concentration	NNS
cord-005453-4057qib7	996	20	converted	convert	VBN
cord-005453-4057qib7	996	21	to	to	IN
cord-005453-4057qib7	996	22	transplanted	transplant	VBN
cord-005453-4057qib7	996	23	cells/	cells/	CD
cord-005453-4057qib7	996	24	kg	kg	NNS
cord-005453-4057qib7	996	25	.	.	.
cord-005453-4057qib7	997	1	Fractions	fraction	NNS
cord-005453-4057qib7	997	2	were	be	VBD
cord-005453-4057qib7	997	3	evaluated	evaluate	VBN
cord-005453-4057qib7	997	4	in	in	IN
cord-005453-4057qib7	997	5	patients	patient	NNS
cord-005453-4057qib7	997	6	receiving	receive	VBG
cord-005453-4057qib7	997	7	both	both	DT
cord-005453-4057qib7	997	8	BM	BM	NNP
cord-005453-4057qib7	997	9	and	and	CC
cord-005453-4057qib7	997	10	PBSC	PBSC	NNP
cord-005453-4057qib7	997	11	(	(	-LRB-
cord-005453-4057qib7	997	12	n=102	n=102	NNP
cord-005453-4057qib7	997	13	)	)	-RRB-
cord-005453-4057qib7	997	14	,	,	,
cord-005453-4057qib7	997	15	while	while	IN
cord-005453-4057qib7	997	16	concentrations	concentration	NNS
cord-005453-4057qib7	997	17	(	(	-LRB-
cord-005453-4057qib7	997	18	cells	cell	NNS
cord-005453-4057qib7	997	19	/	/	SYM
cord-005453-4057qib7	997	20	kg	kg	NN
cord-005453-4057qib7	997	21	)	)	-RRB-
cord-005453-4057qib7	997	22	were	be	VBD
cord-005453-4057qib7	997	23	only	only	RB
cord-005453-4057qib7	997	24	analyzed	analyze	VBN
cord-005453-4057qib7	997	25	in	in	IN
cord-005453-4057qib7	997	26	patients	patient	NNS
cord-005453-4057qib7	997	27	transplanted	transplant	VBN
cord-005453-4057qib7	997	28	with	with	IN
cord-005453-4057qib7	997	29	PBSC	PBSC	NNP
cord-005453-4057qib7	997	30	(	(	-LRB-
cord-005453-4057qib7	997	31	n=88	n=88	NN
cord-005453-4057qib7	997	32	)	)	-RRB-
cord-005453-4057qib7	997	33	.	.	.
cord-005453-4057qib7	998	1	Table	table	NN
cord-005453-4057qib7	998	2	]	]	-RRB-
cord-005453-4057qib7	998	3	1	1	CD
cord-005453-4057qib7	998	4	.	.	.
cord-005453-4057qib7	999	1	Table	table	NN
cord-005453-4057qib7	999	2	1	1	CD
cord-005453-4057qib7	999	3	]	]	-RRB-
cord-005453-4057qib7	999	4	[	[	-LRB-
cord-005453-4057qib7	999	5	[	[	-LRB-
cord-005453-4057qib7	999	6	P059	P059	NNP
cord-005453-4057qib7	999	7	Image	image	NN
cord-005453-4057qib7	999	8	]	]	-RRB-
cord-005453-4057qib7	999	9	1	1	CD
cord-005453-4057qib7	999	10	.	.	.
cord-005453-4057qib7	1000	1	Figure	figure	NN
cord-005453-4057qib7	1000	2	1	1	CD
cord-005453-4057qib7	1000	3	]	]	-RRB-
cord-005453-4057qib7	1000	4	Results	result	NNS
cord-005453-4057qib7	1001	1	:	:	:
cord-005453-4057qib7	1001	2	We	-PRON-	PRP
cord-005453-4057qib7	1001	3	found	find	VBD
cord-005453-4057qib7	1001	4	,	,	,
cord-005453-4057qib7	1002	1	that	that	IN
cord-005453-4057qib7	1002	2	patients	patient	NNS
cord-005453-4057qib7	1002	3	transplanted	transplant	VBN
cord-005453-4057qib7	1002	4	with	with	IN
cord-005453-4057qib7	1002	5	graft	graft	NN
cord-005453-4057qib7	1002	6	NK	nk	NN
cord-005453-4057qib7	1002	7	cell	cell	NN
cord-005453-4057qib7	1002	8	doses	dose	NNS
cord-005453-4057qib7	1002	9	above	above	IN
cord-005453-4057qib7	1002	10	the	the	DT
cord-005453-4057qib7	1002	11	median	median	NN
cord-005453-4057qib7	1002	12	of	of	IN
cord-005453-4057qib7	1002	13	27x10	27x10	CD
cord-005453-4057qib7	1002	14	6	6	CD
cord-005453-4057qib7	1002	15	/kg	/kg	NFP
cord-005453-4057qib7	1002	16	and	and	CC
cord-005453-4057qib7	1002	17	fractions	fraction	NNS
cord-005453-4057qib7	1002	18	of	of	IN
cord-005453-4057qib7	1002	19	NK	NK	NNP
cord-005453-4057qib7	1002	20	cells	cell	NNS
cord-005453-4057qib7	1002	21	out	out	IN
cord-005453-4057qib7	1002	22	of	of	IN
cord-005453-4057qib7	1002	23	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1002	24	above	above	IN
cord-005453-4057qib7	1002	25	the	the	DT
cord-005453-4057qib7	1002	26	median	median	NN
cord-005453-4057qib7	1002	27	of	of	IN
cord-005453-4057qib7	1002	28	8.1	8.1	CD
cord-005453-4057qib7	1002	29	%	%	NN
cord-005453-4057qib7	1003	1	had	have	VBD
cord-005453-4057qib7	1003	2	significantly	significantly	RB
cord-005453-4057qib7	1003	3	increased	increase	VBN
cord-005453-4057qib7	1003	4	relapse	relapse	NN
cord-005453-4057qib7	1003	5	-	-	HYPH
cord-005453-4057qib7	1003	6	free	free	JJ
cord-005453-4057qib7	1003	7	-	-	HYPH
cord-005453-4057qib7	1003	8	survival	survival	NN
cord-005453-4057qib7	1003	9	compared	compare	VBN
cord-005453-4057qib7	1003	10	to	to	IN
cord-005453-4057qib7	1003	11	patients	patient	NNS
cord-005453-4057qib7	1003	12	transplanted	transplant	VBN
cord-005453-4057qib7	1003	13	with	with	IN
cord-005453-4057qib7	1003	14	grafts	graft	NNS
cord-005453-4057qib7	1003	15	containing	contain	VBG
cord-005453-4057qib7	1003	16	NK	NK	NNP
cord-005453-4057qib7	1003	17	cell	cell	NN
cord-005453-4057qib7	1003	18	doses	dose	NNS
cord-005453-4057qib7	1003	19	below	below	IN
cord-005453-4057qib7	1003	20	these	these	DT
cord-005453-4057qib7	1003	21	values	value	NNS
cord-005453-4057qib7	1003	22	,	,	,
cord-005453-4057qib7	1003	23	figure	figure	NN
cord-005453-4057qib7	1003	24	1	1	CD
cord-005453-4057qib7	1003	25	;	;	:
cord-005453-4057qib7	1003	26	results	result	NNS
cord-005453-4057qib7	1003	27	stayed	stay	VBD
cord-005453-4057qib7	1003	28	significant	significant	JJ
cord-005453-4057qib7	1003	29	in	in	IN
cord-005453-4057qib7	1003	30	multivariate	multivariate	JJ
cord-005453-4057qib7	1003	31	analyses	analysis	NNS
cord-005453-4057qib7	1003	32	.	.	.
cord-005453-4057qib7	1004	1	Relapse	relapse	NN
cord-005453-4057qib7	1004	2	incidence	incidence	NN
cord-005453-4057qib7	1004	3	was	be	VBD
cord-005453-4057qib7	1004	4	significantly	significantly	RB
cord-005453-4057qib7	1004	5	lower	low	JJR
cord-005453-4057qib7	1004	6	in	in	IN
cord-005453-4057qib7	1004	7	uni	uni	JJ
cord-005453-4057qib7	1004	8	-	-	HYPH
cord-005453-4057qib7	1004	9	and	and	CC
cord-005453-4057qib7	1004	10	multivariate	multivariate	JJ
cord-005453-4057qib7	1004	11	analyses	analysis	NNS
cord-005453-4057qib7	1004	12	in	in	IN
cord-005453-4057qib7	1004	13	patients	patient	NNS
cord-005453-4057qib7	1004	14	receiving	receive	VBG
cord-005453-4057qib7	1004	15	grafts	graft	NNS
cord-005453-4057qib7	1004	16	with	with	IN
cord-005453-4057qib7	1004	17	high	high	JJ
cord-005453-4057qib7	1004	18	NK	NK	NNP
cord-005453-4057qib7	1004	19	cell	cell	NN
cord-005453-4057qib7	1004	20	fractions	fraction	NNS
cord-005453-4057qib7	1004	21	compared	compare	VBN
cord-005453-4057qib7	1004	22	with	with	IN
cord-005453-4057qib7	1004	23	low	low	JJ
cord-005453-4057qib7	1004	24	fractions	fraction	NNS
cord-005453-4057qib7	1004	25	,	,	,
cord-005453-4057qib7	1004	26	p=0.01	p=0.01	NNP
cord-005453-4057qib7	1004	27	,	,	,
cord-005453-4057qib7	1004	28	with	with	IN
cord-005453-4057qib7	1004	29	1-year	1-year	CD
cord-005453-4057qib7	1004	30	relapse	relapse	NN
cord-005453-4057qib7	1004	31	rates	rate	NNS
cord-005453-4057qib7	1004	32	of	of	IN
cord-005453-4057qib7	1004	33	8	8	CD
cord-005453-4057qib7	1004	34	%	%	NN
cord-005453-4057qib7	1004	35	versus	versus	IN
cord-005453-4057qib7	1004	36	27	27	CD
cord-005453-4057qib7	1004	37	%	%	NN
cord-005453-4057qib7	1004	38	in	in	IN
cord-005453-4057qib7	1004	39	patients	patient	NNS
cord-005453-4057qib7	1004	40	transplanted	transplant	VBN
cord-005453-4057qib7	1004	41	with	with	IN
cord-005453-4057qib7	1004	42	high	high	JJ
cord-005453-4057qib7	1004	43	versus	versus	IN
cord-005453-4057qib7	1004	44	low	low	JJ
cord-005453-4057qib7	1004	45	fractions	fraction	NNS
cord-005453-4057qib7	1004	46	of	of	IN
cord-005453-4057qib7	1004	47	NK	NK	NNP
cord-005453-4057qib7	1004	48	cells	cell	NNS
cord-005453-4057qib7	1004	49	,	,	,
cord-005453-4057qib7	1004	50	p=0.01	p=0.01	NNP
cord-005453-4057qib7	1004	51	.	.	.
cord-005453-4057qib7	1005	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	1005	2	blood	blood	NN
cord-005453-4057qib7	1005	3	concentrations	concentration	NNS
cord-005453-4057qib7	1005	4	of	of	IN
cord-005453-4057qib7	1005	5	NK	NK	NNP
cord-005453-4057qib7	1005	6	cells	cell	NNS
cord-005453-4057qib7	1005	7	obtained	obtain	VBN
cord-005453-4057qib7	1005	8	from	from	IN
cord-005453-4057qib7	1005	9	samples	sample	NNS
cord-005453-4057qib7	1005	10	from	from	IN
cord-005453-4057qib7	1005	11	17	17	CD
cord-005453-4057qib7	1005	12	PBSC	PBSC	NNP
cord-005453-4057qib7	1005	13	donors	donor	NNS
cord-005453-4057qib7	1005	14	before	before	IN
cord-005453-4057qib7	1005	15	G	G	NNP
cord-005453-4057qib7	1005	16	-	-	HYPH
cord-005453-4057qib7	1005	17	CSF	CSF	NNP
cord-005453-4057qib7	1005	18	mobilization	mobilization	NN
cord-005453-4057qib7	1005	19	were	be	VBD
cord-005453-4057qib7	1005	20	significantly	significantly	RB
cord-005453-4057qib7	1005	21	correlated	correlate	VBN
cord-005453-4057qib7	1005	22	to	to	IN
cord-005453-4057qib7	1005	23	graft	graft	NN
cord-005453-4057qib7	1005	24	concentrations	concentration	NNS
cord-005453-4057qib7	1005	25	-	-	:
cord-005453-4057qib7	1005	26	and	and	CC
cord-005453-4057qib7	1005	27	fractions	fraction	NNS
cord-005453-4057qib7	1005	28	of	of	IN
cord-005453-4057qib7	1005	29	NK	NK	NNP
cord-005453-4057qib7	1005	30	cells	cell	NNS
cord-005453-4057qib7	1005	31	..	..	.
cord-005453-4057qib7	1006	1	Analyses	analysis	NNS
cord-005453-4057qib7	1006	2	of	of	IN
cord-005453-4057qib7	1006	3	graft	graft	NN
cord-005453-4057qib7	1006	4	contents	content	NNS
cord-005453-4057qib7	1006	5	of	of	IN
cord-005453-4057qib7	1006	6	NKT	NKT	NNP
cord-005453-4057qib7	1006	7	cells	cell	NNS
cord-005453-4057qib7	1006	8	showed	show	VBD
cord-005453-4057qib7	1006	9	that	that	IN
cord-005453-4057qib7	1006	10	the	the	DT
cord-005453-4057qib7	1006	11	incidence	incidence	NN
cord-005453-4057qib7	1006	12	of	of	IN
cord-005453-4057qib7	1006	13	grade	grade	NN
cord-005453-4057qib7	1006	14	II	II	NNP
cord-005453-4057qib7	1006	15	-	-	HYPH
cord-005453-4057qib7	1006	16	IV	IV	NNP
cord-005453-4057qib7	1006	17	acute	acute	JJ
cord-005453-4057qib7	1006	18	GVHD	GVHD	NNP
cord-005453-4057qib7	1006	19	were	be	VBD
cord-005453-4057qib7	1006	20	significantly	significantly	RB
cord-005453-4057qib7	1006	21	lower	low	JJR
cord-005453-4057qib7	1006	22	in	in	IN
cord-005453-4057qib7	1006	23	patients	patient	NNS
cord-005453-4057qib7	1007	1	Background	background	NN
cord-005453-4057qib7	1007	2	:	:	:
cord-005453-4057qib7	1007	3	Extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	1007	4	photopheresis	photopheresis	NN
cord-005453-4057qib7	1007	5	(	(	-LRB-
cord-005453-4057qib7	1007	6	ECP	ECP	NNP
cord-005453-4057qib7	1007	7	)	)	-RRB-
cord-005453-4057qib7	1007	8	is	be	VBZ
cord-005453-4057qib7	1007	9	an	an	DT
cord-005453-4057qib7	1007	10	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	1007	11	treatment	treatment	NN
cord-005453-4057qib7	1007	12	that	that	WDT
cord-005453-4057qib7	1007	13	has	have	VBZ
cord-005453-4057qib7	1007	14	shown	show	VBN
cord-005453-4057qib7	1007	15	efficacy	efficacy	NN
cord-005453-4057qib7	1007	16	in	in	IN
cord-005453-4057qib7	1007	17	steroid	steroid	NN
cord-005453-4057qib7	1007	18	refractory	refractory	JJ
cord-005453-4057qib7	1007	19	acute	acute	JJ
cord-005453-4057qib7	1007	20	GvHD	GvHD	NNP
cord-005453-4057qib7	1007	21	,	,	,
cord-005453-4057qib7	1007	22	but	but	CC
cord-005453-4057qib7	1007	23	the	the	DT
cord-005453-4057qib7	1007	24	mechanism	mechanism	NN
cord-005453-4057qib7	1007	25	of	of	IN
cord-005453-4057qib7	1007	26	action	action	NN
cord-005453-4057qib7	1007	27	is	be	VBZ
cord-005453-4057qib7	1007	28	only	only	RB
cord-005453-4057qib7	1007	29	partially	partially	RB
cord-005453-4057qib7	1007	30	understood	understand	VBN
cord-005453-4057qib7	1007	31	.	.	.
cord-005453-4057qib7	1008	1	There	there	EX
cord-005453-4057qib7	1008	2	is	be	VBZ
cord-005453-4057qib7	1008	3	no	no	DT
cord-005453-4057qib7	1008	4	clear	clear	JJ
cord-005453-4057qib7	1008	5	relationship	relationship	NN
cord-005453-4057qib7	1008	6	between	between	IN
cord-005453-4057qib7	1008	7	the	the	DT
cord-005453-4057qib7	1008	8	ECP	ECP	NNP
cord-005453-4057qib7	1008	9	-	-	HYPH
cord-005453-4057qib7	1008	10	treated	treat	VBN
cord-005453-4057qib7	1008	11	mononuclear	mononuclear	JJ
cord-005453-4057qib7	1008	12	cells	cell	NNS
cord-005453-4057qib7	1008	13	(	(	-LRB-
cord-005453-4057qib7	1008	14	MNC	MNC	NNP
cord-005453-4057qib7	1008	15	)	)	-RRB-
cord-005453-4057qib7	1008	16	or	or	CC
cord-005453-4057qib7	1008	17	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1008	18	numbers	number	NNS
cord-005453-4057qib7	1008	19	and	and	CC
cord-005453-4057qib7	1008	20	response	response	NN
cord-005453-4057qib7	1008	21	to	to	IN
cord-005453-4057qib7	1008	22	ECP	ECP	NNP
cord-005453-4057qib7	1008	23	.	.	.
cord-005453-4057qib7	1009	1	The	the	DT
cord-005453-4057qib7	1009	2	objective	objective	NN
cord-005453-4057qib7	1009	3	of	of	IN
cord-005453-4057qib7	1009	4	the	the	DT
cord-005453-4057qib7	1009	5	study	study	NN
cord-005453-4057qib7	1009	6	was	be	VBD
cord-005453-4057qib7	1009	7	to	to	TO
cord-005453-4057qib7	1009	8	analyse	analyse	VB
cord-005453-4057qib7	1009	9	the	the	DT
cord-005453-4057qib7	1009	10	relationship	relationship	NN
cord-005453-4057qib7	1009	11	between	between	IN
cord-005453-4057qib7	1009	12	the	the	DT
cord-005453-4057qib7	1009	13	infused	infuse	VBN
cord-005453-4057qib7	1009	14	subpopulation	subpopulation	NN
cord-005453-4057qib7	1009	15	cellularity	cellularity	NN
cord-005453-4057qib7	1009	16	and	and	CC
cord-005453-4057qib7	1009	17	response	response	NN
cord-005453-4057qib7	1009	18	.	.	.
cord-005453-4057qib7	1010	1	Methods	method	NNS
cord-005453-4057qib7	1010	2	:	:	:
cord-005453-4057qib7	1010	3	65	65	CD
cord-005453-4057qib7	1010	4	patients	patient	NNS
cord-005453-4057qib7	1010	5	from	from	IN
cord-005453-4057qib7	1010	6	7	7	CD
cord-005453-4057qib7	1010	7	different	different	JJ
cord-005453-4057qib7	1010	8	centers	center	NNS
cord-005453-4057qib7	1010	9	with	with	IN
cord-005453-4057qib7	1010	10	a	a	DT
cord-005453-4057qib7	1010	11	total	total	NN
cord-005453-4057qib7	1010	12	of	of	IN
cord-005453-4057qib7	1010	13	1008	1008	CD
cord-005453-4057qib7	1010	14	ECP	ECP	NNP
cord-005453-4057qib7	1010	15	procedures	procedure	NNS
cord-005453-4057qib7	1010	16	were	be	VBD
cord-005453-4057qib7	1010	17	retrospectively	retrospectively	RB
cord-005453-4057qib7	1010	18	analized	analize	VBN
cord-005453-4057qib7	1010	19	.	.	.
cord-005453-4057qib7	1011	1	ECP	ECP	NNP
cord-005453-4057qib7	1011	2	procedures	procedure	NNS
cord-005453-4057qib7	1011	3	were	be	VBD
cord-005453-4057qib7	1011	4	performed	perform	VBN
cord-005453-4057qib7	1011	5	from	from	IN
cord-005453-4057qib7	1011	6	January-2011	January-2011	NNP
cord-005453-4057qib7	1011	7	to	to	IN
cord-005453-4057qib7	1011	8	June-2017	june-2017	ADD
cord-005453-4057qib7	1011	9	.	.	.
cord-005453-4057qib7	1012	1	All	all	DT
cord-005453-4057qib7	1012	2	ECP	ECP	NNP
cord-005453-4057qib7	1012	3	procedures	procedure	NNS
cord-005453-4057qib7	1012	4	were	be	VBD
cord-005453-4057qib7	1012	5	performed	perform	VBN
cord-005453-4057qib7	1012	6	with	with	IN
cord-005453-4057qib7	1012	7	the	the	DT
cord-005453-4057qib7	1012	8	off	off	JJ
cord-005453-4057qib7	1012	9	-	-	HYPH
cord-005453-4057qib7	1012	10	line	line	NN
cord-005453-4057qib7	1012	11	system	system	NN
cord-005453-4057qib7	1012	12	.	.	.
cord-005453-4057qib7	1013	1	The	the	DT
cord-005453-4057qib7	1013	2	response	response	NN
cord-005453-4057qib7	1013	3	was	be	VBD
cord-005453-4057qib7	1013	4	defined	define	VBN
cord-005453-4057qib7	1013	5	as	as	IN
cord-005453-4057qib7	1013	6	Responder	Responder	NNP
cord-005453-4057qib7	1013	7	(	(	-LRB-
cord-005453-4057qib7	1013	8	Complete	complete	JJ
cord-005453-4057qib7	1013	9	and	and	CC
cord-005453-4057qib7	1013	10	Partial	Partial	NNP
cord-005453-4057qib7	1013	11	Response	Response	NNP
cord-005453-4057qib7	1013	12	)	)	-RRB-
cord-005453-4057qib7	1013	13	and	and	CC
cord-005453-4057qib7	1013	14	Non	Non	NNP
cord-005453-4057qib7	1013	15	-	-	NN
cord-005453-4057qib7	1013	16	responder	responder	NN
cord-005453-4057qib7	1013	17	.	.	.
cord-005453-4057qib7	1014	1	Infused	infuse	VBN
cord-005453-4057qib7	1014	2	cell	cell	NN
cord-005453-4057qib7	1014	3	numbers	number	NNS
cord-005453-4057qib7	1014	4	for	for	IN
cord-005453-4057qib7	1014	5	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1014	6	,	,	,
cord-005453-4057qib7	1014	7	monocytes	monocyte	NNS
cord-005453-4057qib7	1014	8	and	and	CC
cord-005453-4057qib7	1014	9	mononuclear	mononuclear	NN
cord-005453-4057qib7	1014	10	cells	cell	NNS
cord-005453-4057qib7	1014	11	(	(	-LRB-
cord-005453-4057qib7	1014	12	Lym+Mon	Lym+Mon	NNP
cord-005453-4057qib7	1014	13	,	,	,
cord-005453-4057qib7	1014	14	MNC	MNC	NNP
cord-005453-4057qib7	1014	15	)	)	-RRB-
cord-005453-4057qib7	1014	16	were	be	VBD
cord-005453-4057qib7	1014	17	calculated	calculate	VBN
cord-005453-4057qib7	1014	18	.	.	.
cord-005453-4057qib7	1015	1	For	for	IN
cord-005453-4057qib7	1015	2	analytic	analytic	JJ
cord-005453-4057qib7	1015	3	purposes	purpose	NNS
cord-005453-4057qib7	1015	4	,	,	,
cord-005453-4057qib7	1015	5	the	the	DT
cord-005453-4057qib7	1015	6	median	median	JJ
cord-005453-4057qib7	1015	7	number	number	NN
cord-005453-4057qib7	1015	8	of	of	IN
cord-005453-4057qib7	1015	9	cells	cell	NNS
cord-005453-4057qib7	1015	10	infused	infuse	VBN
cord-005453-4057qib7	1015	11	per	per	IN
cord-005453-4057qib7	1015	12	procedure	procedure	NN
cord-005453-4057qib7	1015	13	until	until	IN
cord-005453-4057qib7	1015	14	response	response	NN
cord-005453-4057qib7	1015	15	(	(	-LRB-
cord-005453-4057qib7	1015	16	or	or	CC
cord-005453-4057qib7	1015	17	until	until	IN
cord-005453-4057qib7	1015	18	the	the	DT
cord-005453-4057qib7	1015	19	median	median	JJ
cord-005453-4057qib7	1015	20	number	number	NN
cord-005453-4057qib7	1015	21	of	of	IN
cord-005453-4057qib7	1015	22	procedures	procedure	NNS
cord-005453-4057qib7	1015	23	until	until	IN
cord-005453-4057qib7	1015	24	response	response	NN
cord-005453-4057qib7	1015	25	for	for	IN
cord-005453-4057qib7	1015	26	non	non	JJ
cord-005453-4057qib7	1015	27	-	-	JJ
cord-005453-4057qib7	1015	28	responding	respond	VBG
cord-005453-4057qib7	1015	29	patients	patient	NNS
cord-005453-4057qib7	1015	30	)	)	-RRB-
cord-005453-4057qib7	1015	31	and	and	CC
cord-005453-4057qib7	1015	32	the	the	DT
cord-005453-4057qib7	1015	33	cumulative	cumulative	JJ
cord-005453-4057qib7	1015	34	number	number	NN
cord-005453-4057qib7	1015	35	of	of	IN
cord-005453-4057qib7	1015	36	cells	cell	NNS
cord-005453-4057qib7	1015	37	infused	infuse	VBN
cord-005453-4057qib7	1015	38	until	until	IN
cord-005453-4057qib7	1015	39	response	response	NN
cord-005453-4057qib7	1015	40	(	(	-LRB-
cord-005453-4057qib7	1015	41	or	or	CC
cord-005453-4057qib7	1015	42	until	until	IN
cord-005453-4057qib7	1015	43	the	the	DT
cord-005453-4057qib7	1015	44	median	median	NN
cord-005453-4057qib7	1015	45	in	in	IN
cord-005453-4057qib7	1015	46	non	non	NNS
cord-005453-4057qib7	1015	47	-	-	NNS
cord-005453-4057qib7	1015	48	responders	responder	NNS
cord-005453-4057qib7	1015	49	)	)	-RRB-
cord-005453-4057qib7	1015	50	were	be	VBD
cord-005453-4057qib7	1015	51	calculated	calculate	VBN
cord-005453-4057qib7	1015	52	for	for	IN
cord-005453-4057qib7	1015	53	all	all	PDT
cord-005453-4057qib7	1015	54	the	the	DT
cord-005453-4057qib7	1015	55	subgroups	subgroup	NNS
cord-005453-4057qib7	1015	56	.	.	.
cord-005453-4057qib7	1016	1	Same	same	JJ
cord-005453-4057qib7	1016	2	procedures	procedure	NNS
cord-005453-4057qib7	1016	3	were	be	VBD
cord-005453-4057qib7	1016	4	performed	perform	VBN
cord-005453-4057qib7	1016	5	with	with	IN
cord-005453-4057qib7	1016	6	the	the	DT
cord-005453-4057qib7	1016	7	number	number	NN
cord-005453-4057qib7	1016	8	cells	cell	NNS
cord-005453-4057qib7	1016	9	infused	infuse	VBN
cord-005453-4057qib7	1016	10	until	until	IN
cord-005453-4057qib7	1016	11	day	day	NN
cord-005453-4057qib7	1016	12	30	30	CD
cord-005453-4057qib7	1016	13	of	of	IN
cord-005453-4057qib7	1016	14	ECP	ECP	NNP
cord-005453-4057qib7	1016	15	.	.	.
cord-005453-4057qib7	1017	1	Finally	finally	RB
cord-005453-4057qib7	1017	2	,	,	,
cord-005453-4057qib7	1017	3	the	the	DT
cord-005453-4057qib7	1017	4	response	response	NN
cord-005453-4057qib7	1017	5	and	and	CC
cord-005453-4057qib7	1017	6	survival	survival	NN
cord-005453-4057qib7	1017	7	impact	impact	NN
cord-005453-4057qib7	1017	8	of	of	IN
cord-005453-4057qib7	1017	9	infusing	infuse	VBG
cord-005453-4057qib7	1017	10	a	a	DT
cord-005453-4057qib7	1017	11	number	number	NN
cord-005453-4057qib7	1017	12	of	of	IN
cord-005453-4057qib7	1017	13	cells	cell	NNS
cord-005453-4057qib7	1017	14	above	above	IN
cord-005453-4057qib7	1017	15	or	or	CC
cord-005453-4057qib7	1017	16	below	below	IN
cord-005453-4057qib7	1017	17	the	the	DT
cord-005453-4057qib7	1017	18	median	median	NN
cord-005453-4057qib7	1017	19	and	and	CC
cord-005453-4057qib7	1017	20	in	in	IN
cord-005453-4057qib7	1017	21	different	different	JJ
cord-005453-4057qib7	1017	22	tertiles	tertile	NNS
cord-005453-4057qib7	1017	23	was	be	VBD
cord-005453-4057qib7	1017	24	assessed	assess	VBN
cord-005453-4057qib7	1017	25	until	until	IN
cord-005453-4057qib7	1017	26	the	the	DT
cord-005453-4057qib7	1017	27	median	median	JJ
cord-005453-4057qib7	1017	28	number	number	NN
cord-005453-4057qib7	1017	29	of	of	IN
cord-005453-4057qib7	1017	30	procedures	procedure	NNS
cord-005453-4057qib7	1017	31	needed	need	VBN
cord-005453-4057qib7	1017	32	to	to	TO
cord-005453-4057qib7	1017	33	achieve	achieve	VB
cord-005453-4057qib7	1017	34	a	a	DT
cord-005453-4057qib7	1017	35	response	response	NN
cord-005453-4057qib7	1017	36	.	.	.
cord-005453-4057qib7	1018	1	[	[	-LRB-
cord-005453-4057qib7	1018	2	[	[	-LRB-
cord-005453-4057qib7	1018	3	P060	P060	NNP
cord-005453-4057qib7	1018	4	Image	Image	NNP
cord-005453-4057qib7	1018	5	]	]	-RRB-
cord-005453-4057qib7	1018	6	1	1	CD
cord-005453-4057qib7	1018	7	.	.	.
cord-005453-4057qib7	1019	1	Results	result	NNS
cord-005453-4057qib7	1019	2	:	:	:
cord-005453-4057qib7	1020	1	The	the	DT
cord-005453-4057qib7	1020	2	median	median	JJ
cord-005453-4057qib7	1020	3	number	number	NN
cord-005453-4057qib7	1020	4	of	of	IN
cord-005453-4057qib7	1020	5	procedures	procedure	NNS
cord-005453-4057qib7	1020	6	until	until	IN
cord-005453-4057qib7	1020	7	response	response	NN
cord-005453-4057qib7	1020	8	was	be	VBD
cord-005453-4057qib7	1020	9	3	3	CD
cord-005453-4057qib7	1020	10	.	.	.
cord-005453-4057qib7	1021	1	We	-PRON-	PRP
cord-005453-4057qib7	1021	2	observed	observe	VBD
cord-005453-4057qib7	1021	3	a	a	DT
cord-005453-4057qib7	1021	4	trend	trend	NN
cord-005453-4057qib7	1021	5	towards	towards	IN
cord-005453-4057qib7	1021	6	a	a	DT
cord-005453-4057qib7	1021	7	higher	high	JJR
cord-005453-4057qib7	1021	8	median	median	JJ
cord-005453-4057qib7	1021	9	number	number	NN
cord-005453-4057qib7	1021	10	of	of	IN
cord-005453-4057qib7	1021	11	monocytes	monocyte	NNS
cord-005453-4057qib7	1021	12	per	per	IN
cord-005453-4057qib7	1021	13	procedure	procedure	NN
cord-005453-4057qib7	1021	14	and	and	CC
cord-005453-4057qib7	1021	15	cumulative	cumulative	JJ
cord-005453-4057qib7	1021	16	infused	infuse	VBN
cord-005453-4057qib7	1021	17	monocytes	monocyte	NNS
cord-005453-4057qib7	1021	18	in	in	IN
cord-005453-4057qib7	1021	19	responding	respond	VBG
cord-005453-4057qib7	1021	20	patients	patient	NNS
cord-005453-4057qib7	1021	21	(	(	-LRB-
cord-005453-4057qib7	1021	22	median	median	JJ
cord-005453-4057qib7	1021	23	number	number	NN
cord-005453-4057qib7	1021	24	infused	infuse	VBN
cord-005453-4057qib7	1021	25	19.0	19.0	CD
cord-005453-4057qib7	1021	26	vs	vs	IN
cord-005453-4057qib7	1021	27	13.5	13.5	CD
cord-005453-4057qib7	1021	28	x10	x10	CD
cord-005453-4057qib7	1021	29	6	6	CD
cord-005453-4057qib7	1021	30	/kg	/kg	.
cord-005453-4057qib7	1022	1	p=0.071	p=0.071	NNP
cord-005453-4057qib7	1022	2	,	,	,
cord-005453-4057qib7	1022	3	cumulative	cumulative	JJ
cord-005453-4057qib7	1022	4	infused	infuse	VBN
cord-005453-4057qib7	1022	5	median	median	JJ
cord-005453-4057qib7	1022	6	number	number	NN
cord-005453-4057qib7	1022	7	71.5	71.5	CD
cord-005453-4057qib7	1022	8	vs	vs	IN
cord-005453-4057qib7	1022	9	41	41	CD
cord-005453-4057qib7	1022	10	x10	x10	CD
cord-005453-4057qib7	1022	11	6	6	CD
cord-005453-4057qib7	1022	12	/kg	/kg	.
cord-005453-4057qib7	1022	13	p=0.067	p=0.067	NNP
cord-005453-4057qib7	1022	14	)	)	-RRB-
cord-005453-4057qib7	1022	15	that	that	WDT
cord-005453-4057qib7	1022	16	was	be	VBD
cord-005453-4057qib7	1022	17	lost	lose	VBN
cord-005453-4057qib7	1022	18	in	in	IN
cord-005453-4057qib7	1022	19	the	the	DT
cord-005453-4057qib7	1022	20	day	day	NN
cord-005453-4057qib7	1022	21	30	30	CD
cord-005453-4057qib7	1022	22	of	of	IN
cord-005453-4057qib7	1022	23	treatment	treatment	NN
cord-005453-4057qib7	1022	24	.	.	.
cord-005453-4057qib7	1023	1	There	there	EX
cord-005453-4057qib7	1023	2	was	be	VBD
cord-005453-4057qib7	1023	3	also	also	RB
cord-005453-4057qib7	1023	4	a	a	DT
cord-005453-4057qib7	1023	5	trend	trend	NN
cord-005453-4057qib7	1023	6	toward	toward	IN
cord-005453-4057qib7	1023	7	higher	high	JJR
cord-005453-4057qib7	1023	8	median	median	NN
cord-005453-4057qib7	1023	9	infused	infuse	VBN
cord-005453-4057qib7	1023	10	MNC	MNC	NNP
cord-005453-4057qib7	1023	11	until	until	IN
cord-005453-4057qib7	1023	12	response	response	NN
cord-005453-4057qib7	1023	13	for	for	IN
cord-005453-4057qib7	1023	14	responders	responder	NNS
cord-005453-4057qib7	1023	15	(	(	-LRB-
cord-005453-4057qib7	1023	16	54	54	CD
cord-005453-4057qib7	1023	17	vs	vs	IN
cord-005453-4057qib7	1023	18	37	37	CD
cord-005453-4057qib7	1023	19	x10	x10	CD
cord-005453-4057qib7	1023	20	6	6	CD
cord-005453-4057qib7	1023	21	/kg	/kg	.
cord-005453-4057qib7	1023	22	p=0.087	p=0.087	NNP
cord-005453-4057qib7	1023	23	)	)	-RRB-
cord-005453-4057qib7	1023	24	.	.	.
cord-005453-4057qib7	1024	1	We	-PRON-	PRP
cord-005453-4057qib7	1024	2	observed	observe	VBD
cord-005453-4057qib7	1024	3	no	no	DT
cord-005453-4057qib7	1024	4	differences	difference	NNS
cord-005453-4057qib7	1024	5	in	in	IN
cord-005453-4057qib7	1024	6	the	the	DT
cord-005453-4057qib7	1024	7	number	number	NN
cord-005453-4057qib7	1024	8	of	of	IN
cord-005453-4057qib7	1024	9	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1024	10	infused	infuse	VBN
cord-005453-4057qib7	1024	11	,	,	,
cord-005453-4057qib7	1024	12	but	but	CC
cord-005453-4057qib7	1024	13	patients	patient	NNS
cord-005453-4057qib7	1024	14	who	who	WP
cord-005453-4057qib7	1024	15	received	receive	VBD
cord-005453-4057qib7	1024	16	a	a	DT
cord-005453-4057qib7	1024	17	number	number	NN
cord-005453-4057qib7	1024	18	of	of	IN
cord-005453-4057qib7	1024	19	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1024	20	per	per	IN
cord-005453-4057qib7	1024	21	procedure	procedure	NN
cord-005453-4057qib7	1024	22	over	over	IN
cord-005453-4057qib7	1024	23	the	the	DT
cord-005453-4057qib7	1024	24	first	first	JJ
cord-005453-4057qib7	1024	25	tertile	tertile	NNP
cord-005453-4057qib7	1024	26	(	(	-LRB-
cord-005453-4057qib7	1024	27	31	31	CD
cord-005453-4057qib7	1024	28	x10	x10	CD
cord-005453-4057qib7	1024	29	6	6	CD
cord-005453-4057qib7	1024	30	/kg	/kg	NFP
cord-005453-4057qib7	1024	31	)	)	-RRB-
cord-005453-4057qib7	1024	32	presented	present	VBD
cord-005453-4057qib7	1024	33	higher	high	JJR
cord-005453-4057qib7	1024	34	response	response	NN
cord-005453-4057qib7	1024	35	rates	rate	NNS
cord-005453-4057qib7	1024	36	(	(	-LRB-
cord-005453-4057qib7	1024	37	75	75	CD
cord-005453-4057qib7	1024	38	%	%	NN
cord-005453-4057qib7	1024	39	vs	vs	IN
cord-005453-4057qib7	1024	40	45	45	CD
cord-005453-4057qib7	1024	41	%	%	NN
cord-005453-4057qib7	1024	42	,	,	,
cord-005453-4057qib7	1024	43	p=0.0317	p=0.0317	NNP
cord-005453-4057qib7	1024	44	)	)	-RRB-
cord-005453-4057qib7	1024	45	.	.	.
cord-005453-4057qib7	1025	1	None	none	NN
cord-005453-4057qib7	1025	2	of	of	IN
cord-005453-4057qib7	1025	3	the	the	DT
cord-005453-4057qib7	1025	4	other	other	JJ
cord-005453-4057qib7	1025	5	analysed	analyse	VBN
cord-005453-4057qib7	1025	6	parameters	parameter	NNS
cord-005453-4057qib7	1025	7	showed	show	VBD
cord-005453-4057qib7	1025	8	a	a	DT
cord-005453-4057qib7	1025	9	significant	significant	JJ
cord-005453-4057qib7	1025	10	impact	impact	NN
cord-005453-4057qib7	1025	11	in	in	IN
cord-005453-4057qib7	1025	12	overall	overall	JJ
cord-005453-4057qib7	1025	13	survival	survival	NN
cord-005453-4057qib7	1025	14	.	.	.
cord-005453-4057qib7	1026	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1026	2	:	:	:
cord-005453-4057qib7	1027	1	Patients	patient	NNS
cord-005453-4057qib7	1027	2	with	with	IN
cord-005453-4057qib7	1027	3	acute	acute	JJ
cord-005453-4057qib7	1027	4	GvHD	GvHD	NNP
cord-005453-4057qib7	1027	5	who	who	WP
cord-005453-4057qib7	1027	6	responded	respond	VBD
cord-005453-4057qib7	1027	7	to	to	IN
cord-005453-4057qib7	1027	8	ECP	ECP	NNP
cord-005453-4057qib7	1027	9	received	receive	VBD
cord-005453-4057qib7	1027	10	higher	high	JJR
cord-005453-4057qib7	1027	11	numbers	number	NNS
cord-005453-4057qib7	1027	12	of	of	IN
cord-005453-4057qib7	1027	13	monocytes	monocyte	NNS
cord-005453-4057qib7	1027	14	and	and	CC
cord-005453-4057qib7	1027	15	MNC	MNC	NNP
cord-005453-4057qib7	1027	16	in	in	IN
cord-005453-4057qib7	1027	17	the	the	DT
cord-005453-4057qib7	1027	18	early	early	JJ
cord-005453-4057qib7	1027	19	phase	phase	NN
cord-005453-4057qib7	1027	20	of	of	IN
cord-005453-4057qib7	1027	21	the	the	DT
cord-005453-4057qib7	1027	22	treatment	treatment	NN
cord-005453-4057qib7	1027	23	(	(	-LRB-
cord-005453-4057qib7	1027	24	a	a	DT
cord-005453-4057qib7	1027	25	median	median	NN
cord-005453-4057qib7	1027	26	of	of	IN
cord-005453-4057qib7	1027	27	the	the	DT
cord-005453-4057qib7	1027	28	first	first	JJ
cord-005453-4057qib7	1027	29	3	3	CD
cord-005453-4057qib7	1027	30	processes	process	NNS
cord-005453-4057qib7	1027	31	)	)	-RRB-
cord-005453-4057qib7	1027	32	.	.	.
cord-005453-4057qib7	1028	1	Also	also	RB
cord-005453-4057qib7	1028	2	the	the	DT
cord-005453-4057qib7	1028	3	patients	patient	NNS
cord-005453-4057qib7	1028	4	who	who	WP
cord-005453-4057qib7	1028	5	received	receive	VBD
cord-005453-4057qib7	1028	6	higher	high	JJR
cord-005453-4057qib7	1028	7	numbers	number	NNS
cord-005453-4057qib7	1028	8	of	of	IN
cord-005453-4057qib7	1028	9	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1028	10	in	in	IN
cord-005453-4057qib7	1028	11	the	the	DT
cord-005453-4057qib7	1028	12	first	first	JJ
cord-005453-4057qib7	1028	13	procedures	procedure	NNS
cord-005453-4057qib7	1028	14	achieved	achieve	VBD
cord-005453-4057qib7	1028	15	a	a	DT
cord-005453-4057qib7	1028	16	higher	high	JJR
cord-005453-4057qib7	1028	17	response	response	NN
cord-005453-4057qib7	1028	18	rate	rate	NN
cord-005453-4057qib7	1028	19	.	.	.
cord-005453-4057qib7	1029	1	These	these	DT
cord-005453-4057qib7	1029	2	findings	finding	NNS
cord-005453-4057qib7	1029	3	suggest	suggest	VBP
cord-005453-4057qib7	1029	4	the	the	DT
cord-005453-4057qib7	1029	5	possibility	possibility	NN
cord-005453-4057qib7	1029	6	that	that	IN
cord-005453-4057qib7	1029	7	higher	high	JJR
cord-005453-4057qib7	1029	8	number	number	NN
cord-005453-4057qib7	1029	9	of	of	IN
cord-005453-4057qib7	1029	10	treated	treat	VBN
cord-005453-4057qib7	1029	11	and	and	CC
cord-005453-4057qib7	1029	12	infused	infuse	VBN
cord-005453-4057qib7	1029	13	cells	cell	NNS
cord-005453-4057qib7	1029	14	could	could	MD
cord-005453-4057qib7	1029	15	influence	influence	VB
cord-005453-4057qib7	1029	16	the	the	DT
cord-005453-4057qib7	1029	17	response	response	NN
cord-005453-4057qib7	1029	18	to	to	IN
cord-005453-4057qib7	1029	19	ECP	ECP	NNP
cord-005453-4057qib7	1029	20	,	,	,
cord-005453-4057qib7	1029	21	but	but	CC
cord-005453-4057qib7	1029	22	specifically	specifically	RB
cord-005453-4057qib7	1029	23	designed	design	VBN
cord-005453-4057qib7	1029	24	prospective	prospective	JJ
cord-005453-4057qib7	1029	25	studies	study	NNS
cord-005453-4057qib7	1029	26	are	be	VBP
cord-005453-4057qib7	1029	27	need	nee	VBN
cord-005453-4057qib7	1029	28	to	to	IN
cord-005453-4057qib7	1029	29	asses	ass	NNS
cord-005453-4057qib7	1029	30	this	this	DT
cord-005453-4057qib7	1029	31	possibility	possibility	NN
cord-005453-4057qib7	1029	32	.	.	.
cord-005453-4057qib7	1030	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1030	2	:	:	:
cord-005453-4057qib7	1030	3	Nothing	nothing	NN
cord-005453-4057qib7	1030	4	to	to	TO
cord-005453-4057qib7	1030	5	declare	declare	VB
cord-005453-4057qib7	1030	6	Background	background	NN
cord-005453-4057qib7	1030	7	:	:	:
cord-005453-4057qib7	1031	1	The	the	DT
cord-005453-4057qib7	1031	2	field	field	NN
cord-005453-4057qib7	1031	3	of	of	IN
cord-005453-4057qib7	1031	4	kidney	kidney	NN
cord-005453-4057qib7	1031	5	transplantation	transplantation	NN
cord-005453-4057qib7	1031	6	has	have	VBZ
cord-005453-4057qib7	1031	7	made	make	VBN
cord-005453-4057qib7	1031	8	enormous	enormous	JJ
cord-005453-4057qib7	1031	9	progress	progress	NN
cord-005453-4057qib7	1031	10	over	over	IN
cord-005453-4057qib7	1031	11	the	the	DT
cord-005453-4057qib7	1031	12	last	last	JJ
cord-005453-4057qib7	1031	13	decades	decade	NNS
cord-005453-4057qib7	1031	14	towards	towards	IN
cord-005453-4057qib7	1031	15	being	be	VBG
cord-005453-4057qib7	1031	16	a	a	DT
cord-005453-4057qib7	1031	17	standard	standard	JJ
cord-005453-4057qib7	1031	18	treatment	treatment	NN
cord-005453-4057qib7	1031	19	for	for	IN
cord-005453-4057qib7	1031	20	patients	patient	NNS
cord-005453-4057qib7	1031	21	with	with	IN
cord-005453-4057qib7	1031	22	end	end	NN
cord-005453-4057qib7	1031	23	-	-	HYPH
cord-005453-4057qib7	1031	24	stage	stage	NN
cord-005453-4057qib7	1031	25	renal	renal	JJ
cord-005453-4057qib7	1031	26	disease	disease	NN
cord-005453-4057qib7	1031	27	.	.	.
cord-005453-4057qib7	1032	1	However	however	RB
cord-005453-4057qib7	1032	2	,	,	,
cord-005453-4057qib7	1032	3	administration	administration	NN
cord-005453-4057qib7	1032	4	of	of	IN
cord-005453-4057qib7	1032	5	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	1032	6	drugs	drug	NNS
cord-005453-4057qib7	1032	7	is	be	VBZ
cord-005453-4057qib7	1032	8	still	still	RB
cord-005453-4057qib7	1032	9	one	one	CD
cord-005453-4057qib7	1032	10	of	of	IN
cord-005453-4057qib7	1032	11	the	the	DT
cord-005453-4057qib7	1032	12	major	major	JJ
cord-005453-4057qib7	1032	13	limitations	limitation	NNS
cord-005453-4057qib7	1032	14	of	of	IN
cord-005453-4057qib7	1032	15	long	long	JJ
cord-005453-4057qib7	1032	16	-	-	HYPH
cord-005453-4057qib7	1032	17	term	term	NN
cord-005453-4057qib7	1032	18	allograft	allograft	NN
cord-005453-4057qib7	1032	19	survival	survival	NN
cord-005453-4057qib7	1032	20	.	.	.
cord-005453-4057qib7	1033	1	Therefore	therefore	RB
cord-005453-4057qib7	1033	2	,	,	,
cord-005453-4057qib7	1033	3	strategies	strategy	NNS
cord-005453-4057qib7	1033	4	for	for	IN
cord-005453-4057qib7	1033	5	induction	induction	NN
cord-005453-4057qib7	1033	6	of	of	IN
cord-005453-4057qib7	1033	7	donorspecific	donorspecific	NNP
cord-005453-4057qib7	1033	8	tolerance	tolerance	NN
cord-005453-4057qib7	1033	9	are	be	VBP
cord-005453-4057qib7	1033	10	highly	highly	RB
cord-005453-4057qib7	1033	11	desirable	desirable	JJ
cord-005453-4057qib7	1033	12	.	.	.
cord-005453-4057qib7	1034	1	To	to	IN
cord-005453-4057qib7	1034	2	this	this	DT
cord-005453-4057qib7	1034	3	aim	aim	NN
cord-005453-4057qib7	1034	4	,	,	,
cord-005453-4057qib7	1034	5	a	a	DT
cord-005453-4057qib7	1034	6	clinical	clinical	JJ
cord-005453-4057qib7	1034	7	phase	phase	NN
cord-005453-4057qib7	1034	8	I	-PRON-	PRP
cord-005453-4057qib7	1034	9	study	study	VBP
cord-005453-4057qib7	1034	10	with	with	IN
cord-005453-4057qib7	1034	11	donor	donor	NN
cord-005453-4057qib7	1034	12	-	-	HYPH
cord-005453-4057qib7	1034	13	derived	derive	VBN
cord-005453-4057qib7	1034	14	modulated	modulate	VBN
cord-005453-4057qib7	1034	15	immune	immune	JJ
cord-005453-4057qib7	1034	16	cells	cell	NNS
cord-005453-4057qib7	1034	17	(	(	-LRB-
cord-005453-4057qib7	1034	18	MICs	mic	NNS
cord-005453-4057qib7	1034	19	)	)	-RRB-
cord-005453-4057qib7	1034	20	was	be	VBD
cord-005453-4057qib7	1034	21	conducted	conduct	VBN
cord-005453-4057qib7	1034	22	.	.	.
cord-005453-4057qib7	1035	1	Methods	method	NNS
cord-005453-4057qib7	1035	2	:	:	:
cord-005453-4057qib7	1036	1	Donor	donor	NN
cord-005453-4057qib7	1036	2	-	-	HYPH
cord-005453-4057qib7	1036	3	derived	derive	VBN
cord-005453-4057qib7	1036	4	MICs	mic	NNS
cord-005453-4057qib7	1036	5	were	be	VBD
cord-005453-4057qib7	1036	6	manufactured	manufacture	VBN
cord-005453-4057qib7	1036	7	under	under	IN
cord-005453-4057qib7	1036	8	GMP	GMP	NNP
cord-005453-4057qib7	1036	9	conditions	condition	NNS
cord-005453-4057qib7	1036	10	.	.	.
cord-005453-4057qib7	1037	1	Potency	potency	NN
cord-005453-4057qib7	1037	2	of	of	IN
cord-005453-4057qib7	1037	3	MICs	mic	NNS
cord-005453-4057qib7	1037	4	was	be	VBD
cord-005453-4057qib7	1037	5	tested	test	VBN
cord-005453-4057qib7	1037	6	by	by	IN
cord-005453-4057qib7	1037	7	different	different	JJ
cord-005453-4057qib7	1037	8	in	in	IN
cord-005453-4057qib7	1037	9	vitro	vitro	FW
cord-005453-4057qib7	1037	10	bio	bio	NN
cord-005453-4057qib7	1037	11	-	-	HYPH
cord-005453-4057qib7	1037	12	assays	assay	NNS
cord-005453-4057qib7	1037	13	.	.	.
cord-005453-4057qib7	1038	1	MICs	mic	NNS
cord-005453-4057qib7	1038	2	were	be	VBD
cord-005453-4057qib7	1038	3	administered	administer	VBN
cord-005453-4057qib7	1038	4	to	to	IN
cord-005453-4057qib7	1038	5	patients	patient	NNS
cord-005453-4057qib7	1038	6	with	with	IN
cord-005453-4057qib7	1038	7	an	an	DT
cord-005453-4057qib7	1038	8	escalation	escalation	NN
cord-005453-4057qib7	1038	9	from	from	IN
cord-005453-4057qib7	1038	10	1.5	1.5	CD
cord-005453-4057qib7	1038	11	x	x	SYM
cord-005453-4057qib7	1038	12	10	10	CD
cord-005453-4057qib7	1038	13	6	6	CD
cord-005453-4057qib7	1038	14	MICs	mic	NNS
cord-005453-4057qib7	1038	15	/	/	SYM
cord-005453-4057qib7	1038	16	kg	kg	NNS
cord-005453-4057qib7	1038	17	on	on	IN
cord-005453-4057qib7	1038	18	day	day	NN
cord-005453-4057qib7	1038	19	-2	-2	CD
cord-005453-4057qib7	1039	1	(	(	-LRB-
cord-005453-4057qib7	1039	2	N=3	N=3	NNP
cord-005453-4057qib7	1039	3	,	,	,
cord-005453-4057qib7	1039	4	group	group	NN
cord-005453-4057qib7	1039	5	A	A	NNP
cord-005453-4057qib7	1039	6	)	)	-RRB-
cord-005453-4057qib7	1039	7	,	,	,
cord-005453-4057qib7	1039	8	to	to	IN
cord-005453-4057qib7	1039	9	1.5	1.5	CD
cord-005453-4057qib7	1039	10	x	x	SYM
cord-005453-4057qib7	1039	11	10	10	CD
cord-005453-4057qib7	1039	12	8	8	CD
cord-005453-4057qib7	1039	13	MICs	mic	NNS
cord-005453-4057qib7	1039	14	/	/	SYM
cord-005453-4057qib7	1039	15	kg	kg	NNS
cord-005453-4057qib7	1039	16	on	on	IN
cord-005453-4057qib7	1039	17	day	day	NN
cord-005453-4057qib7	1039	18	-2	-2	CD
cord-005453-4057qib7	1039	19	(	(	-LRB-
cord-005453-4057qib7	1039	20	N=3	n=3	NN
cord-005453-4057qib7	1039	21	,	,	,
cord-005453-4057qib7	1039	22	group	group	NN
cord-005453-4057qib7	1039	23	B	B	NNP
cord-005453-4057qib7	1039	24	)	)	-RRB-
cord-005453-4057qib7	1039	25	or	or	CC
cord-005453-4057qib7	1039	26	on	on	IN
cord-005453-4057qib7	1039	27	day	day	NN
cord-005453-4057qib7	1039	28	-7	-7	.
cord-005453-4057qib7	1040	1	(	(	-LRB-
cord-005453-4057qib7	1040	2	N=4	N=4	NNP
cord-005453-4057qib7	1040	3	,	,	,
cord-005453-4057qib7	1040	4	group	group	NN
cord-005453-4057qib7	1040	5	C	C	NNP
cord-005453-4057qib7	1040	6	)	)	-RRB-
cord-005453-4057qib7	1040	7	before	before	IN
cord-005453-4057qib7	1040	8	kidney	kidney	NN
cord-005453-4057qib7	1040	9	transplantation	transplantation	NN
cord-005453-4057qib7	1040	10	accompanied	accompany	VBN
cord-005453-4057qib7	1040	11	by	by	IN
cord-005453-4057qib7	1040	12	standard	standard	JJ
cord-005453-4057qib7	1040	13	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	1040	14	medication	medication	NN
cord-005453-4057qib7	1040	15	post	post	NN
cord-005453-4057qib7	1040	16	-	-	NN
cord-005453-4057qib7	1040	17	transplantation	transplantation	NN
cord-005453-4057qib7	1040	18	.	.	.
cord-005453-4057qib7	1041	1	Frequency	frequency	NN
cord-005453-4057qib7	1041	2	of	of	IN
cord-005453-4057qib7	1041	3	adverse	adverse	JJ
cord-005453-4057qib7	1041	4	events	event	NNS
cord-005453-4057qib7	1041	5	(	(	-LRB-
cord-005453-4057qib7	1041	6	AE	AE	NNP
cord-005453-4057qib7	1041	7	)	)	-RRB-
cord-005453-4057qib7	1041	8	was	be	VBD
cord-005453-4057qib7	1041	9	assessed	assess	VBN
cord-005453-4057qib7	1041	10	from	from	IN
cord-005453-4057qib7	1041	11	day	day	NN
cord-005453-4057qib7	1041	12	30	30	CD
cord-005453-4057qib7	1041	13	until	until	IN
cord-005453-4057qib7	1041	14	day	day	NN
cord-005453-4057qib7	1041	15	360	360	CD
cord-005453-4057qib7	1041	16	post	post	NN
cord-005453-4057qib7	1041	17	-	-	NN
cord-005453-4057qib7	1041	18	transplant	transplant	NN
cord-005453-4057qib7	1041	19	.	.	.
cord-005453-4057qib7	1042	1	Dynamic	dynamic	JJ
cord-005453-4057qib7	1042	2	changes	change	NNS
cord-005453-4057qib7	1042	3	of	of	IN
cord-005453-4057qib7	1042	4	various	various	JJ
cord-005453-4057qib7	1042	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1042	6	subsets	subset	NNS
cord-005453-4057qib7	1042	7	in	in	IN
cord-005453-4057qib7	1042	8	patients	patient	NNS
cord-005453-4057qib7	1042	9	after	after	IN
cord-005453-4057qib7	1042	10	MIC	mic	NN
cord-005453-4057qib7	1042	11	therapy	therapy	NN
cord-005453-4057qib7	1042	12	were	be	VBD
cord-005453-4057qib7	1042	13	detected	detect	VBN
cord-005453-4057qib7	1042	14	by	by	IN
cord-005453-4057qib7	1042	15	multicolor	multicolor	JJ
cord-005453-4057qib7	1042	16	flow	flow	NN
cord-005453-4057qib7	1042	17	cytometry	cytometry	NN
cord-005453-4057qib7	1042	18	.	.	.
cord-005453-4057qib7	1043	1	Donor	donor	NN
cord-005453-4057qib7	1043	2	-	-	HYPH
cord-005453-4057qib7	1043	3	specific	specific	JJ
cord-005453-4057qib7	1043	4	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1043	5	was	be	VBD
cord-005453-4057qib7	1043	6	assessed	assess	VBN
cord-005453-4057qib7	1043	7	by	by	IN
cord-005453-4057qib7	1043	8	measuring	measure	VBG
cord-005453-4057qib7	1043	9	anti	anti	JJ
cord-005453-4057qib7	1043	10	-	-	JJ
cord-005453-4057qib7	1043	11	donor	donor	JJ
cord-005453-4057qib7	1043	12	antibodies	antibody	NNS
cord-005453-4057qib7	1043	13	and	and	CC
cord-005453-4057qib7	1043	14	mixed	mixed	JJ
cord-005453-4057qib7	1043	15	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1043	16	reaction	reaction	NN
cord-005453-4057qib7	1043	17	(	(	-LRB-
cord-005453-4057qib7	1043	18	MLR	MLR	NNP
cord-005453-4057qib7	1043	19	)	)	-RRB-
cord-005453-4057qib7	1043	20	against	against	IN
cord-005453-4057qib7	1043	21	donor	donor	NN
cord-005453-4057qib7	1043	22	and	and	CC
cord-005453-4057qib7	1043	23	thirdparty	thirdparty	NN
cord-005453-4057qib7	1043	24	cells	cell	NNS
cord-005453-4057qib7	1043	25	.	.	.
cord-005453-4057qib7	1044	1	Results	result	NNS
cord-005453-4057qib7	1044	2	:	:	:
cord-005453-4057qib7	1045	1	In	in	IN
cord-005453-4057qib7	1045	2	all	all	DT
cord-005453-4057qib7	1045	3	kidney	kidney	NN
cord-005453-4057qib7	1045	4	transplant	transplant	NN
cord-005453-4057qib7	1045	5	recipients	recipient	NNS
cord-005453-4057qib7	1045	6	,	,	,
cord-005453-4057qib7	1045	7	we	-PRON-	PRP
cord-005453-4057qib7	1045	8	observed	observe	VBD
cord-005453-4057qib7	1045	9	a	a	DT
cord-005453-4057qib7	1045	10	median	median	JJ
cord-005453-4057qib7	1045	11	serum	serum	NN
cord-005453-4057qib7	1045	12	creatinine	creatinine	NN
cord-005453-4057qib7	1045	13	of	of	IN
cord-005453-4057qib7	1045	14	1.4	1.4	CD
cord-005453-4057qib7	1045	15	mg	mg	NNP
cord-005453-4057qib7	1045	16	/	/	SYM
cord-005453-4057qib7	1045	17	dL	dl	NN
cord-005453-4057qib7	1045	18	at	at	IN
cord-005453-4057qib7	1045	19	day	day	NN
cord-005453-4057qib7	1045	20	30	30	CD
cord-005453-4057qib7	1045	21	which	which	WDT
cord-005453-4057qib7	1045	22	remained	remain	VBD
cord-005453-4057qib7	1045	23	stable	stable	JJ
cord-005453-4057qib7	1045	24	until	until	IN
cord-005453-4057qib7	1045	25	day	day	NN
cord-005453-4057qib7	1045	26	360	360	CD
cord-005453-4057qib7	1045	27	(	(	-LRB-
cord-005453-4057qib7	1045	28	median	median	JJ
cord-005453-4057qib7	1045	29	creatinine	creatinine	NN
cord-005453-4057qib7	1045	30	of	of	IN
cord-005453-4057qib7	1045	31	1.4	1.4	CD
cord-005453-4057qib7	1045	32	mg/	mg/	NN
cord-005453-4057qib7	1045	33	dL	dl	NN
cord-005453-4057qib7	1045	34	)	)	-RRB-
cord-005453-4057qib7	1045	35	without	without	IN
cord-005453-4057qib7	1045	36	significant	significant	JJ
cord-005453-4057qib7	1045	37	proteinuria	proteinuria	NN
cord-005453-4057qib7	1045	38	.	.	.
cord-005453-4057qib7	1046	1	None	none	NN
cord-005453-4057qib7	1046	2	of	of	IN
cord-005453-4057qib7	1046	3	patients	patient	NNS
cord-005453-4057qib7	1046	4	experienced	experience	VBD
cord-005453-4057qib7	1046	5	rejection	rejection	NN
cord-005453-4057qib7	1046	6	episode	episode	NN
cord-005453-4057qib7	1046	7	.	.	.
cord-005453-4057qib7	1047	1	69	69	CD
cord-005453-4057qib7	1047	2	AEs	ae	NNS
cord-005453-4057qib7	1047	3	were	be	VBD
cord-005453-4057qib7	1047	4	observed	observe	VBN
cord-005453-4057qib7	1047	5	while	while	IN
cord-005453-4057qib7	1047	6	three	three	CD
cord-005453-4057qib7	1047	7	AEs	ae	NNS
cord-005453-4057qib7	1047	8	being	be	VBG
cord-005453-4057qib7	1047	9	severe	severe	JJ
cord-005453-4057qib7	1047	10	.	.	.
cord-005453-4057qib7	1048	1	Most	most	RBS
cord-005453-4057qib7	1048	2	importantly	importantly	RB
cord-005453-4057qib7	1048	3	,	,	,
cord-005453-4057qib7	1048	4	none	none	NN
cord-005453-4057qib7	1048	5	of	of	IN
cord-005453-4057qib7	1048	6	them	-PRON-	PRP
cord-005453-4057qib7	1048	7	was	be	VBD
cord-005453-4057qib7	1048	8	associated	associate	VBN
cord-005453-4057qib7	1048	9	with	with	IN
cord-005453-4057qib7	1048	10	MICs	mic	NNS
cord-005453-4057qib7	1048	11	transfusion	transfusion	NN
cord-005453-4057qib7	1048	12	.	.	.
cord-005453-4057qib7	1049	1	Besides	besides	IN
cord-005453-4057qib7	1049	2	two	two	CD
cord-005453-4057qib7	1049	3	infectious	infectious	JJ
cord-005453-4057qib7	1049	4	complications	complication	NNS
cord-005453-4057qib7	1049	5	,	,	,
cord-005453-4057qib7	1049	6	no	no	DT
cord-005453-4057qib7	1049	7	post	post	JJ
cord-005453-4057qib7	1049	8	-	-	JJ
cord-005453-4057qib7	1049	9	transplant	transplant	JJ
cord-005453-4057qib7	1049	10	positive	positive	JJ
cord-005453-4057qib7	1049	11	cross	cross	NN
cord-005453-4057qib7	1049	12	match	match	NN
cord-005453-4057qib7	1049	13	results	result	NNS
cord-005453-4057qib7	1049	14	against	against	IN
cord-005453-4057qib7	1049	15	the	the	DT
cord-005453-4057qib7	1049	16	donor	donor	NN
cord-005453-4057qib7	1049	17	or	or	CC
cord-005453-4057qib7	1049	18	titers	titer	NNS
cord-005453-4057qib7	1049	19	of	of	IN
cord-005453-4057qib7	1049	20	de	de	NNP
cord-005453-4057qib7	1049	21	novo	novo	NNP
cord-005453-4057qib7	1049	22	donorspecific	donorspecific	NNP
cord-005453-4057qib7	1049	23	antibodies	antibody	NNS
cord-005453-4057qib7	1049	24	were	be	VBD
cord-005453-4057qib7	1049	25	recorded	record	VBN
cord-005453-4057qib7	1049	26	.	.	.
cord-005453-4057qib7	1050	1	Notably	notably	RB
cord-005453-4057qib7	1050	2	,	,	,
cord-005453-4057qib7	1050	3	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	1050	4	therapy	therapy	NN
cord-005453-4057qib7	1050	5	could	could	MD
cord-005453-4057qib7	1050	6	be	be	VB
cord-005453-4057qib7	1050	7	reduced	reduce	VBN
cord-005453-4057qib7	1050	8	without	without	IN
cord-005453-4057qib7	1050	9	signs	sign	NNS
cord-005453-4057qib7	1050	10	of	of	IN
cord-005453-4057qib7	1050	11	rejection	rejection	NN
cord-005453-4057qib7	1050	12	in	in	IN
cord-005453-4057qib7	1050	13	group	group	NN
cord-005453-4057qib7	1050	14	C.	C.	NNP
cord-005453-4057qib7	1050	15	After	after	IN
cord-005453-4057qib7	1050	16	infusion	infusion	NN
cord-005453-4057qib7	1050	17	,	,	,
cord-005453-4057qib7	1050	18	we	-PRON-	PRP
cord-005453-4057qib7	1050	19	observed	observe	VBD
cord-005453-4057qib7	1050	20	a	a	DT
cord-005453-4057qib7	1050	21	dramatic	dramatic	JJ
cord-005453-4057qib7	1050	22	increase	increase	NN
cord-005453-4057qib7	1050	23	of	of	IN
cord-005453-4057qib7	1050	24	CD19	CD19	NNP
cord-005453-4057qib7	1050	25	+	+	CC
cord-005453-4057qib7	1050	26	B	b	NN
cord-005453-4057qib7	1050	27	cells	cell	NNS
cord-005453-4057qib7	1050	28	up	up	RP
cord-005453-4057qib7	1050	29	to	to	IN
cord-005453-4057qib7	1050	30	a	a	DT
cord-005453-4057qib7	1050	31	median	median	NN
cord-005453-4057qib7	1050	32	of	of	IN
cord-005453-4057qib7	1050	33	300	300	CD
cord-005453-4057qib7	1050	34	cells/	cells/	CD
cord-005453-4057qib7	1051	1	μL	μL	.
cord-005453-4057qib7	1052	1	until	until	IN
cord-005453-4057qib7	1052	2	day	day	NN
cord-005453-4057qib7	1052	3	30	30	CD
cord-005453-4057qib7	1052	4	,	,	,
cord-005453-4057qib7	1052	5	followed	follow	VBN
cord-005453-4057qib7	1052	6	by	by	IN
cord-005453-4057qib7	1052	7	a	a	DT
cord-005453-4057qib7	1052	8	reduction	reduction	NN
cord-005453-4057qib7	1052	9	to	to	IN
cord-005453-4057qib7	1052	10	35	35	CD
cord-005453-4057qib7	1052	11	cells/	cells/	CD
cord-005453-4057qib7	1053	1	μL	μL	.
cord-005453-4057qib7	1054	1	on	on	IN
cord-005453-4057qib7	1054	2	day	day	NN
cord-005453-4057qib7	1054	3	180	180	CD
cord-005453-4057qib7	1054	4	in	in	IN
cord-005453-4057qib7	1054	5	group	group	NN
cord-005453-4057qib7	1054	6	C.	C.	NNP
cord-005453-4057qib7	1054	7	Notably	notably	RB
cord-005453-4057qib7	1054	8	,	,	,
cord-005453-4057qib7	1054	9	regulatory	regulatory	JJ
cord-005453-4057qib7	1054	10	B	b	NN
cord-005453-4057qib7	1054	11	cells	cell	NNS
cord-005453-4057qib7	1054	12	significantly	significantly	RB
cord-005453-4057qib7	1054	13	increased	increase	VBD
cord-005453-4057qib7	1054	14	from	from	IN
cord-005453-4057qib7	1054	15	a	a	DT
cord-005453-4057qib7	1054	16	median	median	NN
cord-005453-4057qib7	1054	17	of	of	IN
cord-005453-4057qib7	1054	18	2	2	CD
cord-005453-4057qib7	1054	19	%	%	NN
cord-005453-4057qib7	1054	20	on	on	IN
cord-005453-4057qib7	1054	21	day	day	NN
cord-005453-4057qib7	1054	22	30	30	CD
cord-005453-4057qib7	1054	23	to	to	TO
cord-005453-4057qib7	1054	24	20	20	CD
cord-005453-4057qib7	1054	25	%	%	NN
cord-005453-4057qib7	1054	26	on	on	IN
cord-005453-4057qib7	1054	27	day	day	NN
cord-005453-4057qib7	1054	28	180	180	CD
cord-005453-4057qib7	1054	29	.	.	.
cord-005453-4057qib7	1055	1	In	in	IN
cord-005453-4057qib7	1055	2	parallel	parallel	NN
cord-005453-4057qib7	1055	3	,	,	,
cord-005453-4057qib7	1055	4	the	the	DT
cord-005453-4057qib7	1055	5	plasma	plasma	NN
cord-005453-4057qib7	1055	6	IL-10	IL-10	NNP
cord-005453-4057qib7	1055	7	/	/	SYM
cord-005453-4057qib7	1055	8	TNF	TNF	NNP
cord-005453-4057qib7	1055	9	-	-	HYPH
cord-005453-4057qib7	1055	10	α	α	NNP
cord-005453-4057qib7	1055	11	ratio	ratio	NN
cord-005453-4057qib7	1055	12	increased	increase	VBD
cord-005453-4057qib7	1055	13	from	from	IN
cord-005453-4057qib7	1055	14	a	a	DT
cord-005453-4057qib7	1055	15	median	median	NN
cord-005453-4057qib7	1055	16	of	of	IN
cord-005453-4057qib7	1055	17	0.05	0.05	CD
cord-005453-4057qib7	1055	18	before	before	IN
cord-005453-4057qib7	1055	19	cell	cell	NN
cord-005453-4057qib7	1055	20	therapy	therapy	NN
cord-005453-4057qib7	1055	21	to	to	IN
cord-005453-4057qib7	1055	22	0.11	0.11	CD
cord-005453-4057qib7	1055	23	on	on	IN
cord-005453-4057qib7	1055	24	day	day	NN
cord-005453-4057qib7	1055	25	180	180	CD
cord-005453-4057qib7	1055	26	.	.	.
cord-005453-4057qib7	1056	1	After	after	IN
cord-005453-4057qib7	1056	2	MIC	mic	NN
cord-005453-4057qib7	1056	3	cell	cell	NN
cord-005453-4057qib7	1056	4	therapy	therapy	NN
cord-005453-4057qib7	1056	5	recipient	recipient	NN
cord-005453-4057qib7	1056	6	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1056	7	showed	show	VBD
cord-005453-4057qib7	1056	8	no	no	DT
cord-005453-4057qib7	1056	9	or	or	CC
cord-005453-4057qib7	1056	10	only	only	JJ
cord-005453-4057qib7	1056	11	minimal	minimal	JJ
cord-005453-4057qib7	1056	12	reactivity	reactivity	NN
cord-005453-4057qib7	1056	13	against	against	IN
cord-005453-4057qib7	1056	14	irradiated	irradiate	VBN
cord-005453-4057qib7	1056	15	donor	donor	NN
cord-005453-4057qib7	1056	16	PBMCs	pbmc	NNS
cord-005453-4057qib7	1056	17	in	in	IN
cord-005453-4057qib7	1056	18	vitro	vitro	FW
cord-005453-4057qib7	1056	19	,	,	,
cord-005453-4057qib7	1056	20	while	while	IN
cord-005453-4057qib7	1056	21	reactivity	reactivity	NN
cord-005453-4057qib7	1056	22	against	against	IN
cord-005453-4057qib7	1056	23	3	3	CD
cord-005453-4057qib7	1056	24	rd	rd	NNP
cord-005453-4057qib7	1056	25	-party	-party	JJ
cord-005453-4057qib7	1056	26	-	-	HYPH
cord-005453-4057qib7	1056	27	donor	donor	NN
cord-005453-4057qib7	1056	28	PBMCs	pbmc	NNS
cord-005453-4057qib7	1056	29	was	be	VBD
cord-005453-4057qib7	1056	30	not	not	RB
cord-005453-4057qib7	1056	31	impaired	impaired	JJ
cord-005453-4057qib7	1056	32	.	.	.
cord-005453-4057qib7	1057	1	Moreover	moreover	RB
cord-005453-4057qib7	1057	2	,	,	,
cord-005453-4057qib7	1057	3	in	in	IN
cord-005453-4057qib7	1057	4	vitro	vitro	FW
cord-005453-4057qib7	1057	5	MICs	mic	NNS
cord-005453-4057qib7	1057	6	product	product	NN
cord-005453-4057qib7	1057	7	demonstrated	demonstrate	VBD
cord-005453-4057qib7	1057	8	their	-PRON-	PRP$
cord-005453-4057qib7	1057	9	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	1057	10	potency	potency	NN
cord-005453-4057qib7	1057	11	by	by	IN
cord-005453-4057qib7	1057	12	inducing	induce	VBG
cord-005453-4057qib7	1057	13	tolerogenic	tolerogenic	NNP
cord-005453-4057qib7	1057	14	dendritic	dendritic	JJ
cord-005453-4057qib7	1057	15	cells	cell	NNS
cord-005453-4057qib7	1057	16	(	(	-LRB-
cord-005453-4057qib7	1057	17	tDCs	tDCs	NNP
cord-005453-4057qib7	1057	18	)	)	-RRB-
cord-005453-4057qib7	1057	19	characterized	characterize	VBN
cord-005453-4057qib7	1057	20	by	by	IN
cord-005453-4057qib7	1057	21	low	low	JJ
cord-005453-4057qib7	1057	22	expression	expression	NN
cord-005453-4057qib7	1057	23	of	of	IN
cord-005453-4057qib7	1057	24	costimulatory	costimulatory	NNP
cord-005453-4057qib7	1057	25	(	(	-LRB-
cord-005453-4057qib7	1057	26	CD80	CD80	NNP
cord-005453-4057qib7	1057	27	,	,	,
cord-005453-4057qib7	1057	28	CD86	CD86	NNP
cord-005453-4057qib7	1057	29	)	)	-RRB-
cord-005453-4057qib7	1057	30	and	and	CC
cord-005453-4057qib7	1057	31	maturation	maturation	NN
cord-005453-4057qib7	1057	32	(	(	-LRB-
cord-005453-4057qib7	1057	33	CD83	CD83	NNP
cord-005453-4057qib7	1057	34	)	)	-RRB-
cord-005453-4057qib7	1057	35	as	as	RB
cord-005453-4057qib7	1057	36	well	well	RB
cord-005453-4057qib7	1057	37	as	as	IN
cord-005453-4057qib7	1057	38	high	high	JJ
cord-005453-4057qib7	1057	39	expression	expression	NN
cord-005453-4057qib7	1057	40	of	of	IN
cord-005453-4057qib7	1057	41	inhibitory	inhibitory	JJ
cord-005453-4057qib7	1057	42	marker	marker	NN
cord-005453-4057qib7	1057	43	CD103	CD103	NNP
cord-005453-4057qib7	1057	44	.	.	.
cord-005453-4057qib7	1058	1	Functionally	functionally	RB
cord-005453-4057qib7	1058	2	,	,	,
cord-005453-4057qib7	1058	3	tDCs	tdcs	PRP
cord-005453-4057qib7	1058	4	could	could	MD
cord-005453-4057qib7	1058	5	inhibit	inhibit	VB
cord-005453-4057qib7	1058	6	not	not	RB
cord-005453-4057qib7	1058	7	only	only	RB
cord-005453-4057qib7	1058	8	the	the	DT
cord-005453-4057qib7	1058	9	release	release	NN
cord-005453-4057qib7	1058	10	of	of	IN
cord-005453-4057qib7	1058	11	IFN	IFN	NNP
cord-005453-4057qib7	1058	12	-	-	HYPH
cord-005453-4057qib7	1058	13	γ	γ	NNP
cord-005453-4057qib7	1058	14	but	but	CC
cord-005453-4057qib7	1058	15	also	also	RB
cord-005453-4057qib7	1058	16	the	the	DT
cord-005453-4057qib7	1058	17	proliferation	proliferation	NN
cord-005453-4057qib7	1058	18	of	of	IN
cord-005453-4057qib7	1058	19	CMV	CMV	NNP
cord-005453-4057qib7	1058	20	specific	specific	JJ
cord-005453-4057qib7	1058	21	CD8	CD8	NNP
cord-005453-4057qib7	1058	22	+	+	CC
cord-005453-4057qib7	1058	23	T	t	NN
cord-005453-4057qib7	1058	24	cells	cell	NNS
cord-005453-4057qib7	1058	25	.	.	.
cord-005453-4057qib7	1059	1	Moreover	moreover	RB
cord-005453-4057qib7	1059	2	,	,	,
cord-005453-4057qib7	1059	3	MIC	MIC	NNP
cord-005453-4057qib7	1059	4	-	-	HYPH
cord-005453-4057qib7	1059	5	induced	induce	VBN
cord-005453-4057qib7	1059	6	tDCs	tDCs	NNP
cord-005453-4057qib7	1059	7	showed	show	VBD
cord-005453-4057qib7	1059	8	the	the	DT
cord-005453-4057qib7	1059	9	capacity	capacity	NN
cord-005453-4057qib7	1059	10	to	to	TO
cord-005453-4057qib7	1059	11	inhibit	inhibit	VB
cord-005453-4057qib7	1059	12	donor	donor	NN
cord-005453-4057qib7	1059	13	-	-	HYPH
cord-005453-4057qib7	1059	14	specific	specific	JJ
cord-005453-4057qib7	1059	15	allo	allo	NN
cord-005453-4057qib7	1059	16	-	-	HYPH
cord-005453-4057qib7	1059	17	reactive	reactive	JJ
cord-005453-4057qib7	1059	18	CD4	CD4	NNP
cord-005453-4057qib7	1059	19	+	+	CC
cord-005453-4057qib7	1059	20	and	and	CC
cord-005453-4057qib7	1059	21	CD8	CD8	NNP
cord-005453-4057qib7	1059	22	+	+	CC
cord-005453-4057qib7	1059	23	T	T	NNP
cord-005453-4057qib7	1059	24	cell	cell	NN
cord-005453-4057qib7	1059	25	proliferation	proliferation	NN
cord-005453-4057qib7	1059	26	.	.	.
cord-005453-4057qib7	1060	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1060	2	:	:	:
cord-005453-4057qib7	1061	1	MIC	mic	NN
cord-005453-4057qib7	1061	2	cell	cell	NN
cord-005453-4057qib7	1061	3	therapy	therapy	NN
cord-005453-4057qib7	1061	4	modulates	modulate	VBZ
cord-005453-4057qib7	1061	5	the	the	DT
cord-005453-4057qib7	1061	6	immune	immune	JJ
cord-005453-4057qib7	1061	7	system	system	NN
cord-005453-4057qib7	1061	8	of	of	IN
cord-005453-4057qib7	1061	9	kidney	kidney	NN
cord-005453-4057qib7	1061	10	transplant	transplant	NN
cord-005453-4057qib7	1061	11	recipients	recipient	NNS
cord-005453-4057qib7	1061	12	by	by	IN
cord-005453-4057qib7	1061	13	increasing	increase	VBG
cord-005453-4057qib7	1061	14	the	the	DT
cord-005453-4057qib7	1061	15	ratio	ratio	NN
cord-005453-4057qib7	1061	16	of	of	IN
cord-005453-4057qib7	1061	17	regulatory	regulatory	JJ
cord-005453-4057qib7	1061	18	B	b	NN
cord-005453-4057qib7	1061	19	cells	cell	NNS
cord-005453-4057qib7	1061	20	and	and	CC
cord-005453-4057qib7	1061	21	facilitates	facilitate	VBZ
cord-005453-4057qib7	1061	22	the	the	DT
cord-005453-4057qib7	1061	23	reduction	reduction	NN
cord-005453-4057qib7	1061	24	of	of	IN
cord-005453-4057qib7	1061	25	conventional	conventional	JJ
cord-005453-4057qib7	1061	26	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	1061	27	therapy	therapy	NN
cord-005453-4057qib7	1061	28	without	without	IN
cord-005453-4057qib7	1061	29	allograft	allograft	NN
cord-005453-4057qib7	1061	30	injury	injury	NN
cord-005453-4057qib7	1061	31	or	or	CC
cord-005453-4057qib7	1061	32	rejection	rejection	NN
cord-005453-4057qib7	1061	33	episodes	episode	NNS
cord-005453-4057qib7	1061	34	.	.	.
cord-005453-4057qib7	1062	1	Therefore	therefore	RB
cord-005453-4057qib7	1062	2	,	,	,
cord-005453-4057qib7	1062	3	MIC	mic	NN
cord-005453-4057qib7	1062	4	cell	cell	NN
cord-005453-4057qib7	1062	5	therapy	therapy	NN
cord-005453-4057qib7	1062	6	represents	represent	VBZ
cord-005453-4057qib7	1062	7	a	a	DT
cord-005453-4057qib7	1062	8	promising	promising	JJ
cord-005453-4057qib7	1062	9	strategy	strategy	NN
cord-005453-4057qib7	1062	10	in	in	IN
cord-005453-4057qib7	1062	11	transplantation	transplantation	NN
cord-005453-4057qib7	1062	12	medicine	medicine	NN
cord-005453-4057qib7	1062	13	.	.	.
cord-005453-4057qib7	1063	1	We	-PRON-	PRP
cord-005453-4057qib7	1063	2	currently	currently	RB
cord-005453-4057qib7	1063	3	prepare	prepare	VBP
cord-005453-4057qib7	1063	4	a	a	DT
cord-005453-4057qib7	1063	5	phase	phase	NN
cord-005453-4057qib7	1063	6	II	ii	CD
cord-005453-4057qib7	1063	7	trial	trial	NN
cord-005453-4057qib7	1063	8	with	with	IN
cord-005453-4057qib7	1063	9	MIC	mic	NN
cord-005453-4057qib7	1063	10	cell	cell	NN
cord-005453-4057qib7	1063	11	therapy	therapy	NN
cord-005453-4057qib7	1063	12	.	.	.
cord-005453-4057qib7	1064	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1064	2	:	:	:
cord-005453-4057qib7	1064	3	Nothing	nothing	NN
cord-005453-4057qib7	1064	4	to	to	TO
cord-005453-4057qib7	1064	5	declare	declare	VB
cord-005453-4057qib7	1064	6	P062	P062	NNP
cord-005453-4057qib7	1064	7	genome	genome	NN
cord-005453-4057qib7	1064	8	editing	editing	NN
cord-005453-4057qib7	1064	9	of	of	IN
cord-005453-4057qib7	1064	10	graft	graft	NN
cord-005453-4057qib7	1064	11	-	-	HYPH
cord-005453-4057qib7	1064	12	derived	derive	VBN
cord-005453-4057qib7	1064	13	T	t	NN
cord-005453-4057qib7	1064	14	cells	cell	NNS
cord-005453-4057qib7	1064	15	for	for	IN
cord-005453-4057qib7	1064	16	post-	post-	NN
cord-005453-4057qib7	1065	1	Background	background	NN
cord-005453-4057qib7	1065	2	:	:	:
cord-005453-4057qib7	1065	3	Immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1065	4	using	use	VBG
cord-005453-4057qib7	1065	5	CAR	CAR	NNP
cord-005453-4057qib7	1065	6	T	T	NNP
cord-005453-4057qib7	1065	7	cells	cell	NNS
cord-005453-4057qib7	1065	8	has	have	VBZ
cord-005453-4057qib7	1065	9	shown	show	VBN
cord-005453-4057qib7	1065	10	promising	promising	JJ
cord-005453-4057qib7	1065	11	results	result	NNS
cord-005453-4057qib7	1065	12	to	to	TO
cord-005453-4057qib7	1065	13	fight	fight	VB
cord-005453-4057qib7	1065	14	cancer	cancer	NN
cord-005453-4057qib7	1065	15	.	.	.
cord-005453-4057qib7	1066	1	However	however	RB
cord-005453-4057qib7	1066	2	,	,	,
cord-005453-4057qib7	1066	3	CAR	car	NN
cord-005453-4057qib7	1066	4	-	-	HYPH
cord-005453-4057qib7	1066	5	T	t	NN
cord-005453-4057qib7	1066	6	cell	cell	NN
cord-005453-4057qib7	1066	7	production	production	NN
cord-005453-4057qib7	1066	8	requires	require	VBZ
cord-005453-4057qib7	1066	9	specialized	specialized	JJ
cord-005453-4057qib7	1066	10	infrastructure	infrastructure	NN
cord-005453-4057qib7	1066	11	and	and	CC
cord-005453-4057qib7	1066	12	operators	operator	NNS
cord-005453-4057qib7	1066	13	,	,	,
cord-005453-4057qib7	1066	14	which	which	WDT
cord-005453-4057qib7	1066	15	implies	imply	VBZ
cord-005453-4057qib7	1066	16	high	high	JJ
cord-005453-4057qib7	1066	17	cost	cost	NN
cord-005453-4057qib7	1066	18	and	and	CC
cord-005453-4057qib7	1066	19	centralized	centralized	JJ
cord-005453-4057qib7	1066	20	production	production	NN
cord-005453-4057qib7	1066	21	.	.	.
cord-005453-4057qib7	1067	1	Automated	automate	VBN
cord-005453-4057qib7	1067	2	production	production	NN
cord-005453-4057qib7	1067	3	of	of	IN
cord-005453-4057qib7	1067	4	CAR	car	NN
cord-005453-4057qib7	1067	5	-	-	HYPH
cord-005453-4057qib7	1067	6	T	t	NN
cord-005453-4057qib7	1067	7	cells	cell	NNS
cord-005453-4057qib7	1067	8	in	in	IN
cord-005453-4057qib7	1067	9	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1067	10	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1067	11	device	device	NN
cord-005453-4057qib7	1067	12	allows	allow	VBZ
cord-005453-4057qib7	1067	13	clinical	clinical	JJ
cord-005453-4057qib7	1067	14	-	-	HYPH
cord-005453-4057qib7	1067	15	grade	grade	NN
cord-005453-4057qib7	1067	16	manufacturing	manufacturing	NN
cord-005453-4057qib7	1067	17	of	of	IN
cord-005453-4057qib7	1067	18	CAR	car	NN
cord-005453-4057qib7	1067	19	T	t	NN
cord-005453-4057qib7	1067	20	cells	cell	NNS
cord-005453-4057qib7	1067	21	.	.	.
cord-005453-4057qib7	1068	1	Methods	method	NNS
cord-005453-4057qib7	1068	2	:	:	:
cord-005453-4057qib7	1068	3	100	100	CD
cord-005453-4057qib7	1068	4	million	million	CD
cord-005453-4057qib7	1068	5	CD45RAmemory	cd45ramemory	CD
cord-005453-4057qib7	1068	6	T	t	NN
cord-005453-4057qib7	1068	7	cells	cell	NNS
cord-005453-4057qib7	1068	8	from	from	IN
cord-005453-4057qib7	1068	9	healthy	healthy	JJ
cord-005453-4057qib7	1068	10	donors	donor	NNS
cord-005453-4057qib7	1068	11	were	be	VBD
cord-005453-4057qib7	1068	12	cultured	culture	VBN
cord-005453-4057qib7	1068	13	in	in	IN
cord-005453-4057qib7	1068	14	TexMACS	texmacs	NN
cord-005453-4057qib7	1068	15	supplemented	supplement	VBN
cord-005453-4057qib7	1068	16	with	with	IN
cord-005453-4057qib7	1068	17	100	100	CD
cord-005453-4057qib7	1068	18	IU	IU	NNP
cord-005453-4057qib7	1068	19	/	/	,
cord-005453-4057qib7	1068	20	ml	ml	NN
cord-005453-4057qib7	1069	1	IL-2	IL-2	NNP
cord-005453-4057qib7	1069	2	.	.	.
cord-005453-4057qib7	1070	1	At	at	IN
cord-005453-4057qib7	1070	2	day	day	NN
cord-005453-4057qib7	1070	3	0	0	CD
cord-005453-4057qib7	1070	4	cells	cell	NNS
cord-005453-4057qib7	1070	5	were	be	VBD
cord-005453-4057qib7	1070	6	activated	activate	VBN
cord-005453-4057qib7	1070	7	with	with	IN
cord-005453-4057qib7	1070	8	T	T	NNP
cord-005453-4057qib7	1070	9	Cell	Cell	NNP
cord-005453-4057qib7	1070	10	TransAct	TransAct	NNP
cord-005453-4057qib7	1070	11	for	for	IN
cord-005453-4057qib7	1070	12	24h	24h	NNS
cord-005453-4057qib7	1070	13	.	.	.
cord-005453-4057qib7	1071	1	At	at	IN
cord-005453-4057qib7	1071	2	day	day	NN
cord-005453-4057qib7	1071	3	one	one	CD
cord-005453-4057qib7	1071	4	,	,	,
cord-005453-4057qib7	1071	5	activated	activate	VBN
cord-005453-4057qib7	1071	6	CD45RAmemory	CD45RAmemory	NNP
cord-005453-4057qib7	1071	7	T	t	NN
cord-005453-4057qib7	1071	8	cells	cell	NNS
cord-005453-4057qib7	1071	9	were	be	VBD
cord-005453-4057qib7	1071	10	transduced	transduce	VBN
cord-005453-4057qib7	1071	11	with	with	IN
cord-005453-4057qib7	1071	12	NKG2D	NKG2D	NNS
cord-005453-4057qib7	1071	13	-	-	HYPH
cord-005453-4057qib7	1071	14	CD8TM-41BB	cd8tm-41bb	CD
cord-005453-4057qib7	1071	15	-	-	HYPH
cord-005453-4057qib7	1071	16	CD3z	CD3z	NNP
cord-005453-4057qib7	1071	17	lentiviral	lentiviral	JJ
cord-005453-4057qib7	1071	18	vector	vector	NN
cord-005453-4057qib7	1071	19	at	at	IN
cord-005453-4057qib7	1071	20	MOI	MOI	NNP
cord-005453-4057qib7	1071	21	=	=	SYM
cord-005453-4057qib7	1071	22	2	2	CD
cord-005453-4057qib7	1071	23	.	.	.
cord-005453-4057qib7	1072	1	Then	then	RB
cord-005453-4057qib7	1072	2	,	,	,
cord-005453-4057qib7	1072	3	NKG2D	nkg2d	NN
cord-005453-4057qib7	1072	4	-	-	HYPH
cord-005453-4057qib7	1072	5	CAR	car	NN
cord-005453-4057qib7	1072	6	T	t	NN
cord-005453-4057qib7	1072	7	cells	cell	NNS
cord-005453-4057qib7	1072	8	were	be	VBD
cord-005453-4057qib7	1072	9	expanded	expand	VBN
cord-005453-4057qib7	1072	10	for	for	IN
cord-005453-4057qib7	1072	11	10	10	CD
cord-005453-4057qib7	1072	12	-	-	SYM
cord-005453-4057qib7	1072	13	13	13	CD
cord-005453-4057qib7	1072	14	days	day	NNS
cord-005453-4057qib7	1072	15	.	.	.
cord-005453-4057qib7	1073	1	NKG2D	nkg2d	NN
cord-005453-4057qib7	1073	2	-	-	HYPH
cord-005453-4057qib7	1073	3	CAR	car	NN
cord-005453-4057qib7	1073	4	T	t	NN
cord-005453-4057qib7	1073	5	cell	cell	NN
cord-005453-4057qib7	1073	6	products	product	NNS
cord-005453-4057qib7	1073	7	were	be	VBD
cord-005453-4057qib7	1073	8	next	next	RB
cord-005453-4057qib7	1073	9	harvested	harvest	VBN
cord-005453-4057qib7	1073	10	,	,	,
cord-005453-4057qib7	1073	11	counted	count	VBN
cord-005453-4057qib7	1073	12	and	and	CC
cord-005453-4057qib7	1073	13	analyzed	analyze	VBN
cord-005453-4057qib7	1073	14	for	for	IN
cord-005453-4057qib7	1073	15	viability	viability	NN
cord-005453-4057qib7	1073	16	,	,	,
cord-005453-4057qib7	1073	17	NKG2D	nkg2d	NN
cord-005453-4057qib7	1073	18	-	-	HYPH
cord-005453-4057qib7	1073	19	CAR	car	NN
cord-005453-4057qib7	1073	20	expression	expression	NN
cord-005453-4057qib7	1073	21	and	and	CC
cord-005453-4057qib7	1073	22	anti	anti	JJ
cord-005453-4057qib7	1073	23	-	-	JJ
cord-005453-4057qib7	1073	24	tumor	tumor	JJ
cord-005453-4057qib7	1073	25	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1073	26	.	.	.
cord-005453-4057qib7	1074	1	Different	different	JJ
cord-005453-4057qib7	1074	2	quality	quality	NN
cord-005453-4057qib7	1074	3	tests	test	NNS
cord-005453-4057qib7	1074	4	including	include	VBG
cord-005453-4057qib7	1074	5	sterility	sterility	NN
cord-005453-4057qib7	1074	6	,	,	,
cord-005453-4057qib7	1074	7	vector	vector	NN
cord-005453-4057qib7	1074	8	copy	copy	NN
cord-005453-4057qib7	1074	9	number	number	NN
cord-005453-4057qib7	1074	10	,	,	,
cord-005453-4057qib7	1074	11	genetic	genetic	JJ
cord-005453-4057qib7	1074	12	stability	stability	NN
cord-005453-4057qib7	1074	13	,	,	,
cord-005453-4057qib7	1074	14	quantification	quantification	NN
cord-005453-4057qib7	1074	15	of	of	IN
cord-005453-4057qib7	1074	16	viral	viral	JJ
cord-005453-4057qib7	1074	17	particles	particle	NNS
cord-005453-4057qib7	1074	18	in	in	IN
cord-005453-4057qib7	1074	19	the	the	DT
cord-005453-4057qib7	1074	20	supernatant	supernatant	NN
cord-005453-4057qib7	1074	21	,	,	,
cord-005453-4057qib7	1074	22	myc	myc	NNP
cord-005453-4057qib7	1074	23	/	/	SYM
cord-005453-4057qib7	1074	24	tert	tert	NNP
cord-005453-4057qib7	1074	25	expression	expression	NN
cord-005453-4057qib7	1074	26	and	and	CC
cord-005453-4057qib7	1074	27	endotoxin	endotoxin	NN
cord-005453-4057qib7	1074	28	detection	detection	NN
cord-005453-4057qib7	1074	29	were	be	VBD
cord-005453-4057qib7	1074	30	performed	perform	VBN
cord-005453-4057qib7	1074	31	.	.	.
cord-005453-4057qib7	1075	1	Spare	spare	JJ
cord-005453-4057qib7	1075	2	cells	cell	NNS
cord-005453-4057qib7	1075	3	were	be	VBD
cord-005453-4057qib7	1075	4	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	1075	5	either	either	CC
cord-005453-4057qib7	1075	6	in	in	IN
cord-005453-4057qib7	1075	7	autologous	autologous	JJ
cord-005453-4057qib7	1075	8	plasma	plasma	NN
cord-005453-4057qib7	1075	9	and	and	CC
cord-005453-4057qib7	1075	10	10	10	CD
cord-005453-4057qib7	1075	11	%	%	NN
cord-005453-4057qib7	1075	12	DMSO	DMSO	NNP
cord-005453-4057qib7	1075	13	,	,	,
cord-005453-4057qib7	1075	14	M199	m199	$
cord-005453-4057qib7	1075	15	35	35	CD
cord-005453-4057qib7	1075	16	%	%	NN
cord-005453-4057qib7	1075	17	Albumin	albumin	NN
cord-005453-4057qib7	1075	18	and	and	CC
cord-005453-4057qib7	1075	19	9%DMSO	9%dmso	CD
cord-005453-4057qib7	1075	20	or	or	CC
cord-005453-4057qib7	1075	21	Hypothermosol	Hypothermosol	NNP
cord-005453-4057qib7	1075	22	.	.	.
cord-005453-4057qib7	1076	1	After	after	IN
cord-005453-4057qib7	1076	2	12	12	CD
cord-005453-4057qib7	1076	3	months	month	NNS
cord-005453-4057qib7	1076	4	,	,	,
cord-005453-4057qib7	1076	5	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	1076	6	NKG2D	nkg2d	NN
cord-005453-4057qib7	1076	7	-	-	HYPH
cord-005453-4057qib7	1076	8	CAR	car	NN
cord-005453-4057qib7	1076	9	T	t	NN
cord-005453-4057qib7	1076	10	cell	cell	NN
cord-005453-4057qib7	1076	11	products	product	NNS
cord-005453-4057qib7	1076	12	were	be	VBD
cord-005453-4057qib7	1076	13	analyzed	analyze	VBN
cord-005453-4057qib7	1076	14	for	for	IN
cord-005453-4057qib7	1076	15	viability	viability	NN
cord-005453-4057qib7	1076	16	,	,	,
cord-005453-4057qib7	1076	17	NKG2D	nkg2d	NN
cord-005453-4057qib7	1076	18	-	-	HYPH
cord-005453-4057qib7	1076	19	CAR	car	NN
cord-005453-4057qib7	1076	20	expression	expression	NN
cord-005453-4057qib7	1076	21	and	and	CC
cord-005453-4057qib7	1076	22	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1076	23	.	.	.
cord-005453-4057qib7	1077	1	Results	result	NNS
cord-005453-4057qib7	1077	2	:	:	:
cord-005453-4057qib7	1078	1	NKG2D	nkg2d	JJ
cord-005453-4057qib7	1078	2	-	-	HYPH
cord-005453-4057qib7	1078	3	CAR	car	NN
cord-005453-4057qib7	1078	4	memory	memory	NN
cord-005453-4057qib7	1078	5	T	T	NNP
cord-005453-4057qib7	1078	6	cells	cell	NNS
cord-005453-4057qib7	1078	7	expanded	expand	VBD
cord-005453-4057qib7	1078	8	up	up	IN
cord-005453-4057qib7	1078	9	to	to	IN
cord-005453-4057qib7	1078	10	2076	2076	CD
cord-005453-4057qib7	1078	11	±	±	CD
cord-005453-4057qib7	1078	12	697	697	CD
cord-005453-4057qib7	1078	13	million	million	CD
cord-005453-4057qib7	1078	14	with	with	IN
cord-005453-4057qib7	1078	15	77,8	77,8	CD
cord-005453-4057qib7	1078	16	±	±	CD
cord-005453-4057qib7	1078	17	20	20	CD
cord-005453-4057qib7	1078	18	%	%	NN
cord-005453-4057qib7	1078	19	NKG2D	nkg2d	JJ
cord-005453-4057qib7	1078	20	-	-	HYPH
cord-005453-4057qib7	1078	21	CAR	car	NN
cord-005453-4057qib7	1078	22	expression	expression	NN
cord-005453-4057qib7	1078	23	and	and	CC
cord-005453-4057qib7	1078	24	76	76	CD
cord-005453-4057qib7	1078	25	±	±	CD
cord-005453-4057qib7	1078	26	10	10	CD
cord-005453-4057qib7	1078	27	%	%	NN
cord-005453-4057qib7	1078	28	viability	viability	NN
cord-005453-4057qib7	1078	29	.	.	.
cord-005453-4057qib7	1079	1	Harvested	harvest	VBN
cord-005453-4057qib7	1079	2	CAR	car	NN
cord-005453-4057qib7	1079	3	T	t	NN
cord-005453-4057qib7	1079	4	cells	cell	NNS
cord-005453-4057qib7	1079	5	showed	show	VBD
cord-005453-4057qib7	1079	6	90	90	CD
cord-005453-4057qib7	1079	7	±	±	CD
cord-005453-4057qib7	1079	8	14	14	CD
cord-005453-4057qib7	1079	9	%	%	NN
cord-005453-4057qib7	1079	10	of	of	IN
cord-005453-4057qib7	1079	11	specific	specific	JJ
cord-005453-4057qib7	1079	12	lysis	lysis	NN
cord-005453-4057qib7	1079	13	against	against	IN
cord-005453-4057qib7	1079	14	Jurkat	Jurkat	NNP
cord-005453-4057qib7	1079	15	cells	cell	NNS
cord-005453-4057qib7	1079	16	and	and	CC
cord-005453-4057qib7	1079	17	31	31	CD
cord-005453-4057qib7	1079	18	±	±	CD
cord-005453-4057qib7	1079	19	16	16	CD
cord-005453-4057qib7	1079	20	%	%	NN
cord-005453-4057qib7	1079	21	against	against	IN
cord-005453-4057qib7	1079	22	531MII	531mii	CD
cord-005453-4057qib7	1079	23	osteosarcoma	osteosarcoma	NN
cord-005453-4057qib7	1079	24	cell	cell	NN
cord-005453-4057qib7	1079	25	line	line	NN
cord-005453-4057qib7	1079	26	.	.	.
cord-005453-4057qib7	1080	1	No	no	DT
cord-005453-4057qib7	1080	2	microbiological	microbiological	JJ
cord-005453-4057qib7	1080	3	contamination	contamination	NN
cord-005453-4057qib7	1080	4	was	be	VBD
cord-005453-4057qib7	1080	5	observed	observe	VBN
cord-005453-4057qib7	1080	6	in	in	IN
cord-005453-4057qib7	1080	7	final	final	JJ
cord-005453-4057qib7	1080	8	CAR	car	NN
cord-005453-4057qib7	1080	9	T	T	NNP
cord-005453-4057qib7	1080	10	cells	cell	NNS
cord-005453-4057qib7	1080	11	products	product	NNS
cord-005453-4057qib7	1080	12	.	.	.
cord-005453-4057qib7	1081	1	Vector	Vector	NNP
cord-005453-4057qib7	1081	2	copy	copy	NN
cord-005453-4057qib7	1081	3	number	number	NN
cord-005453-4057qib7	1081	4	was	be	VBD
cord-005453-4057qib7	1081	5	≤5	≤5	NN
cord-005453-4057qib7	1081	6	in	in	IN
cord-005453-4057qib7	1081	7	all	all	DT
cord-005453-4057qib7	1081	8	validations	validation	NNS
cord-005453-4057qib7	1081	9	except	except	IN
cord-005453-4057qib7	1081	10	for	for	IN
cord-005453-4057qib7	1081	11	one	one	CD
cord-005453-4057qib7	1081	12	.	.	.
cord-005453-4057qib7	1082	1	CGH	CGH	NNP
cord-005453-4057qib7	1082	2	and	and	CC
cord-005453-4057qib7	1082	3	karyotype	karyotype	NN
cord-005453-4057qib7	1082	4	showed	show	VBD
cord-005453-4057qib7	1082	5	no	no	DT
cord-005453-4057qib7	1082	6	genetic	genetic	JJ
cord-005453-4057qib7	1082	7	alterations	alteration	NNS
cord-005453-4057qib7	1082	8	.	.	.
cord-005453-4057qib7	1083	1	Free	free	JJ
cord-005453-4057qib7	1083	2	viral	viral	JJ
cord-005453-4057qib7	1083	3	particles	particle	NNS
cord-005453-4057qib7	1083	4	were	be	VBD
cord-005453-4057qib7	1083	5	undetectable	undetectable	JJ
cord-005453-4057qib7	1083	6	in	in	IN
cord-005453-4057qib7	1083	7	the	the	DT
cord-005453-4057qib7	1083	8	supernatants	supernatant	NNS
cord-005453-4057qib7	1083	9	.	.	.
cord-005453-4057qib7	1084	1	No	no	DT
cord-005453-4057qib7	1084	2	overexpression	overexpression	NN
cord-005453-4057qib7	1084	3	of	of	IN
cord-005453-4057qib7	1084	4	myc	myc	NNP
cord-005453-4057qib7	1084	5	/	/	SYM
cord-005453-4057qib7	1084	6	tert	tert	NNP
cord-005453-4057qib7	1084	7	was	be	VBD
cord-005453-4057qib7	1084	8	found	find	VBN
cord-005453-4057qib7	1084	9	except	except	IN
cord-005453-4057qib7	1084	10	for	for	IN
cord-005453-4057qib7	1084	11	one	one	CD
cord-005453-4057qib7	1084	12	validation	validation	NN
cord-005453-4057qib7	1084	13	.	.	.
cord-005453-4057qib7	1085	1	Endotoxins	endotoxin	NNS
cord-005453-4057qib7	1085	2	were	be	VBD
cord-005453-4057qib7	1085	3	≤0.25EU	≤0.25eu	NN
cord-005453-4057qib7	1085	4	/	/	SYM
cord-005453-4057qib7	1085	5	ml	ml	NN
cord-005453-4057qib7	1085	6	.	.	.
cord-005453-4057qib7	1086	1	All	all	DT
cord-005453-4057qib7	1086	2	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	1086	3	NKG2D	nkg2d	NN
cord-005453-4057qib7	1086	4	-	-	HYPH
cord-005453-4057qib7	1086	5	CAR	car	NN
cord-005453-4057qib7	1086	6	T	t	NN
cord-005453-4057qib7	1086	7	cell	cell	NN
cord-005453-4057qib7	1086	8	products	product	NNS
cord-005453-4057qib7	1086	9	kept	keep	VBD
cord-005453-4057qib7	1086	10	NKG2D	nkg2d	CD
cord-005453-4057qib7	1086	11	-	-	HYPH
cord-005453-4057qib7	1086	12	CAR	car	NN
cord-005453-4057qib7	1086	13	expression	expression	NN
cord-005453-4057qib7	1086	14	one	one	CD
cord-005453-4057qib7	1086	15	year	year	NN
cord-005453-4057qib7	1086	16	after	after	IN
cord-005453-4057qib7	1086	17	freezing	freeze	VBG
cord-005453-4057qib7	1086	18	.	.	.
cord-005453-4057qib7	1087	1	However	however	RB
cord-005453-4057qib7	1087	2	,	,	,
cord-005453-4057qib7	1087	3	viability	viability	NN
cord-005453-4057qib7	1087	4	and	and	CC
cord-005453-4057qib7	1087	5	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1087	6	was	be	VBD
cord-005453-4057qib7	1087	7	best	well	RBS
cord-005453-4057qib7	1087	8	preserved	preserve	VBN
cord-005453-4057qib7	1087	9	using	use	VBG
cord-005453-4057qib7	1087	10	autologous	autologous	JJ
cord-005453-4057qib7	1087	11	plasma	plasma	NN
cord-005453-4057qib7	1087	12	10%DMSO	10%dmso	CD
cord-005453-4057qib7	1087	13	.	.	.
cord-005453-4057qib7	1088	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1088	2	:	:	:
cord-005453-4057qib7	1089	1	Automated	automate	VBN
cord-005453-4057qib7	1089	2	production	production	NN
cord-005453-4057qib7	1089	3	of	of	IN
cord-005453-4057qib7	1089	4	large	large	JJ
cord-005453-4057qib7	1089	5	-	-	HYPH
cord-005453-4057qib7	1089	6	scale	scale	NN
cord-005453-4057qib7	1089	7	clinical	clinical	JJ
cord-005453-4057qib7	1089	8	-	-	HYPH
cord-005453-4057qib7	1089	9	grade	grade	NN
cord-005453-4057qib7	1089	10	NKG2D	nkg2d	JJ
cord-005453-4057qib7	1089	11	-	-	HYPH
cord-005453-4057qib7	1089	12	CAR	car	NN
cord-005453-4057qib7	1089	13	T	t	NN
cord-005453-4057qib7	1089	14	cells	cell	NNS
cord-005453-4057qib7	1089	15	using	use	VBG
cord-005453-4057qib7	1089	16	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1089	17	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1089	18	is	be	VBZ
cord-005453-4057qib7	1089	19	feasible	feasible	JJ
cord-005453-4057qib7	1089	20	and	and	CC
cord-005453-4057qib7	1089	21	reproducible	reproducible	JJ
cord-005453-4057qib7	1089	22	,	,	,
cord-005453-4057qib7	1089	23	allowing	allow	VBG
cord-005453-4057qib7	1089	24	a	a	DT
cord-005453-4057qib7	1089	25	decentralized	decentralized	JJ
cord-005453-4057qib7	1089	26	protocol	protocol	NN
cord-005453-4057qib7	1089	27	to	to	TO
cord-005453-4057qib7	1089	28	generate	generate	VB
cord-005453-4057qib7	1089	29	CAR	car	NN
cord-005453-4057qib7	1089	30	T	t	NN
cord-005453-4057qib7	1089	31	cells	cell	NNS
cord-005453-4057qib7	1089	32	for	for	IN
cord-005453-4057qib7	1089	33	clinical	clinical	JJ
cord-005453-4057qib7	1089	34	use	use	NN
cord-005453-4057qib7	1089	35	.	.	.
cord-005453-4057qib7	1090	1	Background	background	NN
cord-005453-4057qib7	1090	2	:	:	:
cord-005453-4057qib7	1091	1	Immune	immune	JJ
cord-005453-4057qib7	1091	2	Reconstitution	reconstitution	NN
cord-005453-4057qib7	1091	3	(	(	-LRB-
cord-005453-4057qib7	1091	4	IR	IR	NNP
cord-005453-4057qib7	1091	5	)	)	-RRB-
cord-005453-4057qib7	1091	6	is	be	VBZ
cord-005453-4057qib7	1091	7	essential	essential	JJ
cord-005453-4057qib7	1091	8	to	to	TO
cord-005453-4057qib7	1091	9	control	control	VB
cord-005453-4057qib7	1091	10	severe	severe	JJ
cord-005453-4057qib7	1091	11	infections	infection	NNS
cord-005453-4057qib7	1091	12	after	after	IN
cord-005453-4057qib7	1091	13	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	1091	14	Stem	Stem	NNP
cord-005453-4057qib7	1091	15	Cell	Cell	NNP
cord-005453-4057qib7	1091	16	Transplantation	transplantation	NN
cord-005453-4057qib7	1091	17	(	(	-LRB-
cord-005453-4057qib7	1091	18	HSCT	HSCT	NNP
cord-005453-4057qib7	1091	19	)	)	-RRB-
cord-005453-4057qib7	1091	20	.	.	.
cord-005453-4057qib7	1092	1	Reconstitution	reconstitution	NN
cord-005453-4057qib7	1092	2	of	of	IN
cord-005453-4057qib7	1092	3	adaptive	adaptive	JJ
cord-005453-4057qib7	1092	4	immunity	immunity	NN
cord-005453-4057qib7	1092	5	may	may	MD
cord-005453-4057qib7	1092	6	take	take	VB
cord-005453-4057qib7	1092	7	up	up	IN
cord-005453-4057qib7	1092	8	to	to	TO
cord-005453-4057qib7	1092	9	2	2	CD
cord-005453-4057qib7	1092	10	years	year	NNS
cord-005453-4057qib7	1092	11	to	to	TO
cord-005453-4057qib7	1092	12	recover	recover	VB
cord-005453-4057qib7	1092	13	T	T	NNP
cord-005453-4057qib7	1092	14	-	-	HYPH
cord-005453-4057qib7	1092	15	Lymphocytes	Lymphocytes	NNP
cord-005453-4057qib7	1092	16	(	(	-LRB-
cord-005453-4057qib7	1092	17	LT	LT	NNP
cord-005453-4057qib7	1092	18	)	)	-RRB-
cord-005453-4057qib7	1092	19	.	.	.
cord-005453-4057qib7	1093	1	Delay	delay	VB
cord-005453-4057qib7	1093	2	in	in	IN
cord-005453-4057qib7	1093	3	early	early	JJ
cord-005453-4057qib7	1093	4	LT	LT	NNP
cord-005453-4057qib7	1093	5	recovery	recovery	NN
cord-005453-4057qib7	1093	6	increases	increase	VBZ
cord-005453-4057qib7	1093	7	the	the	DT
cord-005453-4057qib7	1093	8	risk	risk	NN
cord-005453-4057qib7	1093	9	of	of	IN
cord-005453-4057qib7	1093	10	relapse	relapse	NN
cord-005453-4057qib7	1093	11	,	,	,
cord-005453-4057qib7	1093	12	viral	viral	JJ
cord-005453-4057qib7	1093	13	infections	infection	NNS
cord-005453-4057qib7	1093	14	and	and	CC
cord-005453-4057qib7	1093	15	transplant	transplant	NN
cord-005453-4057qib7	1093	16	related	relate	VBN
cord-005453-4057qib7	1093	17	mortality	mortality	NN
cord-005453-4057qib7	1093	18	.	.	.
cord-005453-4057qib7	1094	1	Adoptive	adoptive	JJ
cord-005453-4057qib7	1094	2	transfer	transfer	NN
cord-005453-4057qib7	1094	3	of	of	IN
cord-005453-4057qib7	1094	4	selected	select	VBN
cord-005453-4057qib7	1094	5	T	t	NN
cord-005453-4057qib7	1094	6	cell	cell	NN
cord-005453-4057qib7	1094	7	subset	subset	VBN
cord-005453-4057qib7	1094	8	with	with	IN
cord-005453-4057qib7	1094	9	low	low	JJ
cord-005453-4057qib7	1094	10	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	1094	11	potential	potential	NN
cord-005453-4057qib7	1094	12	is	be	VBZ
cord-005453-4057qib7	1094	13	emerging	emerge	VBG
cord-005453-4057qib7	1094	14	as	as	IN
cord-005453-4057qib7	1094	15	a	a	DT
cord-005453-4057qib7	1094	16	strategy	strategy	NN
cord-005453-4057qib7	1094	17	to	to	TO
cord-005453-4057qib7	1094	18	improve	improve	VB
cord-005453-4057qib7	1094	19	IR	IR	NNP
cord-005453-4057qib7	1094	20	.	.	.
cord-005453-4057qib7	1095	1	Methods	method	NNS
cord-005453-4057qib7	1095	2	:	:	:
cord-005453-4057qib7	1095	3	Depletion	depletion	NN
cord-005453-4057qib7	1095	4	of	of	IN
cord-005453-4057qib7	1095	5	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	1095	6	naive	naive	JJ
cord-005453-4057qib7	1095	7	T	T	NNP
cord-005453-4057qib7	1095	8	cells	cell	NNS
cord-005453-4057qib7	1095	9	,	,	,
cord-005453-4057qib7	1095	10	preserving	preserve	VBG
cord-005453-4057qib7	1095	11	CD45RO+	cd45ro+	NN
cord-005453-4057qib7	1095	12	memory	memory	NN
cord-005453-4057qib7	1095	13	T	t	NN
cord-005453-4057qib7	1095	14	cells	cell	NNS
cord-005453-4057qib7	1095	15	could	could	MD
cord-005453-4057qib7	1095	16	provide	provide	VB
cord-005453-4057qib7	1095	17	functional	functional	JJ
cord-005453-4057qib7	1095	18	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1095	19	to	to	TO
cord-005453-4057qib7	1095	20	protect	protect	VB
cord-005453-4057qib7	1095	21	against	against	IN
cord-005453-4057qib7	1095	22	infection	infection	NN
cord-005453-4057qib7	1095	23	and	and	CC
cord-005453-4057qib7	1095	24	leukemia	leukemia	NN
cord-005453-4057qib7	1095	25	relapse	relapse	NN
cord-005453-4057qib7	1095	26	with	with	IN
cord-005453-4057qib7	1095	27	low	low	JJ
cord-005453-4057qib7	1095	28	risk	risk	NN
cord-005453-4057qib7	1095	29	of	of	IN
cord-005453-4057qib7	1095	30	graft	graft	NN
cord-005453-4057qib7	1095	31	versus	versus	IN
cord-005453-4057qib7	1095	32	host	host	NN
cord-005453-4057qib7	1095	33	disease	disease	NN
cord-005453-4057qib7	1095	34	(	(	-LRB-
cord-005453-4057qib7	1095	35	GvHD	GvHD	NNP
cord-005453-4057qib7	1095	36	)	)	-RRB-
cord-005453-4057qib7	1095	37	.	.	.
cord-005453-4057qib7	1096	1	We	-PRON-	PRP
cord-005453-4057qib7	1096	2	present	present	VBP
cord-005453-4057qib7	1096	3	our	-PRON-	PRP$
cord-005453-4057qib7	1096	4	experience	experience	NN
cord-005453-4057qib7	1096	5	with	with	IN
cord-005453-4057qib7	1096	6	high	high	JJ
cord-005453-4057qib7	1096	7	-	-	HYPH
cord-005453-4057qib7	1096	8	dose	dose	NN
cord-005453-4057qib7	1096	9	donor	donor	NN
cord-005453-4057qib7	1096	10	CD45RO	cd45ro	NN
cord-005453-4057qib7	1096	11	+	+	CC
cord-005453-4057qib7	1096	12	memory	memory	NN
cord-005453-4057qib7	1096	13	T	t	NN
cord-005453-4057qib7	1096	14	cell	cell	NN
cord-005453-4057qib7	1096	15	as	as	IN
cord-005453-4057qib7	1096	16	donor	donor	NN
cord-005453-4057qib7	1096	17	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1096	18	Infusions	infusion	NNS
cord-005453-4057qib7	1096	19	(	(	-LRB-
cord-005453-4057qib7	1096	20	DLI	DLI	NNP
cord-005453-4057qib7	1096	21	)	)	-RRB-
cord-005453-4057qib7	1096	22	to	to	TO
cord-005453-4057qib7	1096	23	assess	assess	VB
cord-005453-4057qib7	1096	24	safety	safety	NN
cord-005453-4057qib7	1096	25	and	and	CC
cord-005453-4057qib7	1096	26	outcome	outcome	NN
cord-005453-4057qib7	1096	27	.	.	.
cord-005453-4057qib7	1097	1	A	a	DT
cord-005453-4057qib7	1097	2	total	total	NN
cord-005453-4057qib7	1097	3	of	of	IN
cord-005453-4057qib7	1097	4	58	58	CD
cord-005453-4057qib7	1097	5	DLI	DLI	NNP
cord-005453-4057qib7	1097	6	of	of	IN
cord-005453-4057qib7	1097	7	CD45RO+	CD45RO+	NNP
cord-005453-4057qib7	1097	8	after	after	IN
cord-005453-4057qib7	1097	9	HSCT	HSCT	NNP
cord-005453-4057qib7	1097	10	was	be	VBD
cord-005453-4057qib7	1097	11	performed	perform	VBN
cord-005453-4057qib7	1097	12	in	in	IN
cord-005453-4057qib7	1097	13	cases	case	NNS
cord-005453-4057qib7	1097	14	of	of	IN
cord-005453-4057qib7	1097	15	CMV	CMV	NNP
cord-005453-4057qib7	1097	16	/	/	SYM
cord-005453-4057qib7	1097	17	EBV	EBV	NNP
cord-005453-4057qib7	1097	18	reactivation	reactivation	NN
cord-005453-4057qib7	1097	19	(	(	-LRB-
cord-005453-4057qib7	1097	20	50	50	CD
cord-005453-4057qib7	1097	21	%	%	NN
cord-005453-4057qib7	1097	22	)	)	-RRB-
cord-005453-4057qib7	1097	23	,	,	,
cord-005453-4057qib7	1097	24	mixed	mixed	JJ
cord-005453-4057qib7	1097	25	chimerism	chimerism	NN
cord-005453-4057qib7	1097	26	(	(	-LRB-
cord-005453-4057qib7	1097	27	26	26	CD
cord-005453-4057qib7	1097	28	%	%	NN
cord-005453-4057qib7	1097	29	)	)	-RRB-
cord-005453-4057qib7	1097	30	,	,	,
cord-005453-4057qib7	1097	31	persistent	persistent	JJ
cord-005453-4057qib7	1097	32	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	1097	33	(	(	-LRB-
cord-005453-4057qib7	1097	34	8,5	8,5	CD
cord-005453-4057qib7	1097	35	%	%	NN
cord-005453-4057qib7	1097	36	)	)	-RRB-
cord-005453-4057qib7	1097	37	,	,	,
cord-005453-4057qib7	1097	38	graft	graft	NN
cord-005453-4057qib7	1097	39	rejection	rejection	NN
cord-005453-4057qib7	1097	40	(	(	-LRB-
cord-005453-4057qib7	1097	41	3,5	3,5	CD
cord-005453-4057qib7	1097	42	%	%	NN
cord-005453-4057qib7	1097	43	)	)	-RRB-
cord-005453-4057qib7	1097	44	,	,	.
cord-005453-4057qib7	1098	1	relapse	relapse	NN
cord-005453-4057qib7	1098	2	(	(	-LRB-
cord-005453-4057qib7	1098	3	3	3	CD
cord-005453-4057qib7	1098	4	%	%	NN
cord-005453-4057qib7	1098	5	)	)	-RRB-
cord-005453-4057qib7	1098	6	or	or	CC
cord-005453-4057qib7	1098	7	to	to	TO
cord-005453-4057qib7	1098	8	boost	boost	VB
cord-005453-4057qib7	1098	9	IR	IR	NNP
cord-005453-4057qib7	1098	10	(	(	-LRB-
cord-005453-4057qib7	1098	11	7	7	CD
cord-005453-4057qib7	1098	12	%	%	NN
cord-005453-4057qib7	1098	13	)	)	-RRB-
cord-005453-4057qib7	1098	14	.	.	.
cord-005453-4057qib7	1099	1	DLI	DLI	NNP
cord-005453-4057qib7	1099	2	product	product	NN
cord-005453-4057qib7	1099	3	was	be	VBD
cord-005453-4057qib7	1099	4	obtained	obtain	VBN
cord-005453-4057qib7	1099	5	performing	perform	VBG
cord-005453-4057qib7	1099	6	a	a	DT
cord-005453-4057qib7	1099	7	CD45RA	cd45ra	NN
cord-005453-4057qib7	1099	8	depletion	depletion	NN
cord-005453-4057qib7	1099	9	on	on	IN
cord-005453-4057qib7	1099	10	donor	donor	NN
cord-005453-4057qib7	1099	11	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	1099	12	product	product	NN
cord-005453-4057qib7	1099	13	using	use	VBG
cord-005453-4057qib7	1099	14	the	the	DT
cord-005453-4057qib7	1099	15	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1099	16	®	®	NN
cord-005453-4057qib7	1099	17	device	device	NN
cord-005453-4057qib7	1099	18	.	.	.
cord-005453-4057qib7	1100	1	Results	result	NNS
cord-005453-4057qib7	1100	2	:	:	:
cord-005453-4057qib7	1101	1	Twenty	twenty	CD
cord-005453-4057qib7	1101	2	-	-	HYPH
cord-005453-4057qib7	1101	3	two	two	CD
cord-005453-4057qib7	1101	4	pediatric	pediatric	JJ
cord-005453-4057qib7	1101	5	patients	patient	NNS
cord-005453-4057qib7	1101	6	,	,	,
cord-005453-4057qib7	1101	7	median	median	JJ
cord-005453-4057qib7	1101	8	age	age	NN
cord-005453-4057qib7	1101	9	11	11	CD
cord-005453-4057qib7	1101	10	years	year	NNS
cord-005453-4057qib7	1101	11	(	(	-LRB-
cord-005453-4057qib7	1101	12	range	range	VBP
cord-005453-4057qib7	1101	13	3	3	CD
cord-005453-4057qib7	1101	14	-	-	SYM
cord-005453-4057qib7	1101	15	18	18	CD
cord-005453-4057qib7	1101	16	)	)	-RRB-
cord-005453-4057qib7	1101	17	,	,	,
cord-005453-4057qib7	1101	18	with	with	IN
cord-005453-4057qib7	1101	19	malignant	malignant	JJ
cord-005453-4057qib7	1101	20	(	(	-LRB-
cord-005453-4057qib7	1101	21	n=15	n=15	NNP
cord-005453-4057qib7	1101	22	)	)	-RRB-
cord-005453-4057qib7	1101	23	and	and	CC
cord-005453-4057qib7	1101	24	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	1101	25	diseases	disease	NNS
cord-005453-4057qib7	1101	26	(	(	-LRB-
cord-005453-4057qib7	1101	27	7	7	CD
cord-005453-4057qib7	1101	28	)	)	-RRB-
cord-005453-4057qib7	1101	29	,	,	,
cord-005453-4057qib7	1101	30	received	receive	VBD
cord-005453-4057qib7	1101	31	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	1101	32	(	(	-LRB-
cord-005453-4057qib7	1101	33	n=14	n=14	NNP
cord-005453-4057qib7	1101	34	)	)	-RRB-
cord-005453-4057qib7	1101	35	,	,	,
cord-005453-4057qib7	1101	36	TCR	TCR	NNP
cord-005453-4057qib7	1101	37	alpha	alpha	NN
cord-005453-4057qib7	1101	38	/	/	SYM
cord-005453-4057qib7	1101	39	beta	beta	NN
cord-005453-4057qib7	1101	40	(	(	-LRB-
cord-005453-4057qib7	1101	41	n=2	n=2	NNS
cord-005453-4057qib7	1101	42	)	)	-RRB-
cord-005453-4057qib7	1101	43	depleted	deplete	VBD
cord-005453-4057qib7	1101	44	grafts	graft	NNS
cord-005453-4057qib7	1101	45	from	from	IN
cord-005453-4057qib7	1101	46	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1101	47	and	and	CC
cord-005453-4057qib7	1101	48	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	1102	1	depleted	deplete	VBN
cord-005453-4057qib7	1102	2	grafts	graft	NNS
cord-005453-4057qib7	1102	3	from	from	IN
cord-005453-4057qib7	1102	4	match	match	NN
cord-005453-4057qib7	1102	5	unrelated	unrelated	JJ
cord-005453-4057qib7	1102	6	(	(	-LRB-
cord-005453-4057qib7	1102	7	n=6	n=6	JJ
cord-005453-4057qib7	1102	8	)	)	-RRB-
cord-005453-4057qib7	1102	9	and	and	CC
cord-005453-4057qib7	1102	10	match	match	VB
cord-005453-4057qib7	1102	11	related	relate	VBN
cord-005453-4057qib7	1102	12	(	(	-LRB-
cord-005453-4057qib7	1102	13	n=2	n=2	NNS
cord-005453-4057qib7	1102	14	)	)	-RRB-
cord-005453-4057qib7	1102	15	donors	donor	NNS
cord-005453-4057qib7	1102	16	.	.	.
cord-005453-4057qib7	1103	1	At	at	IN
cord-005453-4057qib7	1103	2	a	a	DT
cord-005453-4057qib7	1103	3	median	median	NN
cord-005453-4057qib7	1103	4	of	of	IN
cord-005453-4057qib7	1103	5	97	97	CD
cord-005453-4057qib7	1103	6	days	day	NNS
cord-005453-4057qib7	1103	7	(	(	-LRB-
cord-005453-4057qib7	1103	8	range	range	VBP
cord-005453-4057qib7	1103	9	15	15	CD
cord-005453-4057qib7	1103	10	-	-	SYM
cord-005453-4057qib7	1103	11	462	462	CD
cord-005453-4057qib7	1103	12	)	)	-RRB-
cord-005453-4057qib7	1103	13	after	after	IN
cord-005453-4057qib7	1103	14	transplantation	transplantation	NN
cord-005453-4057qib7	1103	15	,	,	,
cord-005453-4057qib7	1103	16	patients	patient	NNS
cord-005453-4057qib7	1103	17	received	receive	VBD
cord-005453-4057qib7	1103	18	a	a	DT
cord-005453-4057qib7	1103	19	total	total	NN
cord-005453-4057qib7	1103	20	of	of	IN
cord-005453-4057qib7	1103	21	58	58	CD
cord-005453-4057qib7	1103	22	DLI	DLI	NNP
cord-005453-4057qib7	1103	23	of	of	IN
cord-005453-4057qib7	1103	24	CD45RO+	CD45RO+	NNP
cord-005453-4057qib7	1103	25	cells	cell	NNS
cord-005453-4057qib7	1103	26	,	,	,
cord-005453-4057qib7	1103	27	median	median	JJ
cord-005453-4057qib7	1103	28	2	2	CD
cord-005453-4057qib7	1103	29	(	(	-LRB-
cord-005453-4057qib7	1103	30	range	range	NNP
cord-005453-4057qib7	1103	31	1	1	CD
cord-005453-4057qib7	1103	32	-	-	SYM
cord-005453-4057qib7	1103	33	6	6	CD
cord-005453-4057qib7	1103	34	)	)	-RRB-
cord-005453-4057qib7	1103	35	,	,	,
cord-005453-4057qib7	1103	36	containing	contain	VBG
cord-005453-4057qib7	1103	37	a	a	DT
cord-005453-4057qib7	1103	38	median	median	NN
cord-005453-4057qib7	1103	39	of	of	IN
cord-005453-4057qib7	1103	40	2.87x10	2.87x10	CD
cord-005453-4057qib7	1103	41	7	7	CD
cord-005453-4057qib7	1103	42	/Kg	/Kg	.
cord-005453-4057qib7	1104	1	(	(	-LRB-
cord-005453-4057qib7	1104	2	range	range	NN
cord-005453-4057qib7	1104	3	4.8x10	4.8x10	CD
cord-005453-4057qib7	1104	4	4	4	CD
cord-005453-4057qib7	1104	5	-2x10	-2x10	CD
cord-005453-4057qib7	1104	6	8	8	CD
cord-005453-4057qib7	1104	7	/Kg	/kg	NN
cord-005453-4057qib7	1104	8	)	)	-RRB-
cord-005453-4057qib7	1104	9	,	,	,
cord-005453-4057qib7	1104	10	CD3	CD3	NNP
cord-005453-4057qib7	1104	11	+	+	CC
cord-005453-4057qib7	1104	12	CD45RO+	CD45RO+	NNP
cord-005453-4057qib7	1104	13	1.05x10	1.05x10	CD
cord-005453-4057qib7	1104	14	7	7	CD
cord-005453-4057qib7	1105	1	/Kg	/Kg	.
cord-005453-4057qib7	1106	1	(	(	-LRB-
cord-005453-4057qib7	1106	2	range	range	NN
cord-005453-4057qib7	1106	3	4.8x10	4.8x10	CD
cord-005453-4057qib7	1106	4	4	4	CD
cord-005453-4057qib7	1106	5	-1.09x10	-1.09x10	CD
cord-005453-4057qib7	1106	6	8	8	CD
cord-005453-4057qib7	1106	7	/Kg	/kg	NN
cord-005453-4057qib7	1106	8	)	)	-RRB-
cord-005453-4057qib7	1106	9	and	and	CC
cord-005453-4057qib7	1106	10	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	1106	11	cells	cell	NNS
cord-005453-4057qib7	1106	12	5	5	CD
cord-005453-4057qib7	1106	13	x10	x10	CD
cord-005453-4057qib7	1106	14	2	2	CD
cord-005453-4057qib7	1107	1	/Kg	/Kg	.
cord-005453-4057qib7	1108	1	(	(	-LRB-
cord-005453-4057qib7	1108	2	range	range	NN
cord-005453-4057qib7	1108	3	0	0	CD
cord-005453-4057qib7	1108	4	-	-	HYPH
cord-005453-4057qib7	1108	5	9.8x10	9.8x10	CD
cord-005453-4057qib7	1108	6	4	4	CD
cord-005453-4057qib7	1108	7	/Kg	/kg	NN
cord-005453-4057qib7	1108	8	)	)	-RRB-
cord-005453-4057qib7	1108	9	.	.	.
cord-005453-4057qib7	1109	1	All	all	DT
cord-005453-4057qib7	1109	2	infusions	infusion	NNS
cord-005453-4057qib7	1109	3	were	be	VBD
cord-005453-4057qib7	1109	4	well	well	RB
cord-005453-4057qib7	1109	5	-	-	HYPH
cord-005453-4057qib7	1109	6	tolerated	tolerate	VBN
cord-005453-4057qib7	1109	7	and	and	CC
cord-005453-4057qib7	1109	8	did	do	VBD
cord-005453-4057qib7	1109	9	not	not	RB
cord-005453-4057qib7	1109	10	develop	develop	VB
cord-005453-4057qib7	1109	11	or	or	CC
cord-005453-4057qib7	1109	12	worsen	worsen	VB
cord-005453-4057qib7	1109	13	GvHD	GvHD	NNP
cord-005453-4057qib7	1109	14	.	.	.
cord-005453-4057qib7	1110	1	A	a	DT
cord-005453-4057qib7	1110	2	total	total	NN
cord-005453-4057qib7	1110	3	of	of	IN
cord-005453-4057qib7	1110	4	11/29	11/29	CD
cord-005453-4057qib7	1110	5	episodes	episode	NNS
cord-005453-4057qib7	1110	6	of	of	IN
cord-005453-4057qib7	1110	7	CMV	CMV	NNP
cord-005453-4057qib7	1110	8	/	/	SYM
cord-005453-4057qib7	1110	9	EBV	EBV	NNP
cord-005453-4057qib7	1110	10	viral	viral	JJ
cord-005453-4057qib7	1110	11	reactivations	reactivation	NNS
cord-005453-4057qib7	1110	12	decreased	decrease	VBD
cord-005453-4057qib7	1110	13	viral	viral	JJ
cord-005453-4057qib7	1110	14	load	load	NN
cord-005453-4057qib7	1110	15	,	,	,
cord-005453-4057qib7	1110	16	4/29	4/29	CD
cord-005453-4057qib7	1110	17	cleared	clear	VBN
cord-005453-4057qib7	1110	18	viral	viral	JJ
cord-005453-4057qib7	1110	19	load	load	NN
cord-005453-4057qib7	1110	20	and	and	CC
cord-005453-4057qib7	1110	21	5/29	5/29	CD
cord-005453-4057qib7	1110	22	showed	show	VBD
cord-005453-4057qib7	1110	23	a	a	DT
cord-005453-4057qib7	1110	24	clinical	clinical	JJ
cord-005453-4057qib7	1110	25	improvement	improvement	NN
cord-005453-4057qib7	1110	26	.	.	.
cord-005453-4057qib7	1111	1	A	a	DT
cord-005453-4057qib7	1111	2	total	total	NN
cord-005453-4057qib7	1111	3	of	of	IN
cord-005453-4057qib7	1111	4	4/5	4/5	CD
cord-005453-4057qib7	1111	5	patients	patient	NNS
cord-005453-4057qib7	1111	6	with	with	IN
cord-005453-4057qib7	1111	7	persistent	persistent	JJ
cord-005453-4057qib7	1111	8	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	1111	9	there	there	EX
cord-005453-4057qib7	1111	10	was	be	VBD
cord-005453-4057qib7	1111	11	a	a	DT
cord-005453-4057qib7	1111	12	slightly	slightly	RB
cord-005453-4057qib7	1111	13	increase	increase	NN
cord-005453-4057qib7	1111	14	in	in	IN
cord-005453-4057qib7	1111	15	total	total	JJ
cord-005453-4057qib7	1111	16	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1111	17	count	count	NN
cord-005453-4057qib7	1111	18	,	,	,
cord-005453-4057qib7	1111	19	but	but	CC
cord-005453-4057qib7	1111	20	not	not	RB
cord-005453-4057qib7	1111	21	to	to	IN
cord-005453-4057qib7	1111	22	normal	normal	JJ
cord-005453-4057qib7	1111	23	levels	level	NNS
cord-005453-4057qib7	1111	24	.	.	.
cord-005453-4057qib7	1112	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	1112	2	DLI	DLI	NNP
cord-005453-4057qib7	1112	3	of	of	IN
cord-005453-4057qib7	1112	4	CD45RO+	CD45RO+	NNS
cord-005453-4057qib7	1112	5	to	to	TO
cord-005453-4057qib7	1112	6	boost	boost	VB
cord-005453-4057qib7	1112	7	IR	IR	NNP
cord-005453-4057qib7	1112	8	increased	increase	VBN
cord-005453-4057qib7	1112	9	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1112	10	count	count	NN
cord-005453-4057qib7	1112	11	in	in	IN
cord-005453-4057qib7	1112	12	2	2	CD
cord-005453-4057qib7	1112	13	of	of	IN
cord-005453-4057qib7	1112	14	3	3	CD
cord-005453-4057qib7	1112	15	cases	case	NNS
cord-005453-4057qib7	1112	16	.	.	.
cord-005453-4057qib7	1113	1	None	none	NN
cord-005453-4057qib7	1113	2	of	of	IN
cord-005453-4057qib7	1113	3	the	the	DT
cord-005453-4057qib7	1113	4	DLI	DLI	NNP
cord-005453-4057qib7	1113	5	administered	administer	VBD
cord-005453-4057qib7	1113	6	in	in	IN
cord-005453-4057qib7	1113	7	cases	case	NNS
cord-005453-4057qib7	1113	8	of	of	IN
cord-005453-4057qib7	1113	9	mixed	mixed	JJ
cord-005453-4057qib7	1113	10	chimerism	chimerism	NN
cord-005453-4057qib7	1113	11	,	,	,
cord-005453-4057qib7	1113	12	graft	graft	NN
cord-005453-4057qib7	1113	13	failure	failure	NN
cord-005453-4057qib7	1113	14	or	or	CC
cord-005453-4057qib7	1113	15	relapse	relapse	NN
cord-005453-4057qib7	1113	16	were	be	VBD
cord-005453-4057qib7	1113	17	effective	effective	JJ
cord-005453-4057qib7	1113	18	in	in	IN
cord-005453-4057qib7	1113	19	reverting	revert	VBG
cord-005453-4057qib7	1113	20	those	those	DT
cord-005453-4057qib7	1113	21	situations	situation	NNS
cord-005453-4057qib7	1113	22	.	.	.
cord-005453-4057qib7	1114	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1114	2	:	:	:
cord-005453-4057qib7	1115	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1115	2	preliminary	preliminary	JJ
cord-005453-4057qib7	1115	3	data	datum	NNS
cord-005453-4057qib7	1115	4	suggest	suggest	VBP
cord-005453-4057qib7	1115	5	that	that	IN
cord-005453-4057qib7	1115	6	infusions	infusion	NNS
cord-005453-4057qib7	1115	7	of	of	IN
cord-005453-4057qib7	1115	8	high	high	JJ
cord-005453-4057qib7	1115	9	dose	dose	NN
cord-005453-4057qib7	1115	10	CD45RO+	cd45ro+	NN
cord-005453-4057qib7	1115	11	memory	memory	NN
cord-005453-4057qib7	1115	12	T	t	NN
cord-005453-4057qib7	1115	13	cells	cell	NNS
cord-005453-4057qib7	1115	14	are	be	VBP
cord-005453-4057qib7	1115	15	a	a	DT
cord-005453-4057qib7	1115	16	safe	safe	JJ
cord-005453-4057qib7	1115	17	adoptive	adoptive	JJ
cord-005453-4057qib7	1115	18	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1115	19	strategy	strategy	NN
cord-005453-4057qib7	1115	20	.	.	.
cord-005453-4057qib7	1116	1	Efficacy	efficacy	NN
cord-005453-4057qib7	1116	2	has	have	VBZ
cord-005453-4057qib7	1116	3	been	be	VBN
cord-005453-4057qib7	1116	4	observed	observe	VBN
cord-005453-4057qib7	1116	5	in	in	IN
cord-005453-4057qib7	1116	6	patients	patient	NNS
cord-005453-4057qib7	1116	7	with	with	IN
cord-005453-4057qib7	1116	8	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	1116	9	and	and	CC
cord-005453-4057qib7	1116	10	CMV	CMV	NNP
cord-005453-4057qib7	1116	11	/	/	SYM
cord-005453-4057qib7	1116	12	EBV	EBV	NNP
cord-005453-4057qib7	1116	13	reactivation	reactivation	NN
cord-005453-4057qib7	1116	14	,	,	,
cord-005453-4057qib7	1116	15	with	with	IN
cord-005453-4057qib7	1116	16	no	no	DT
cord-005453-4057qib7	1116	17	positive	positive	JJ
cord-005453-4057qib7	1116	18	results	result	NNS
cord-005453-4057qib7	1116	19	in	in	IN
cord-005453-4057qib7	1116	20	patients	patient	NNS
cord-005453-4057qib7	1116	21	with	with	IN
cord-005453-4057qib7	1116	22	mixed	mixed	JJ
cord-005453-4057qib7	1116	23	chimerism	chimerism	NN
cord-005453-4057qib7	1116	24	,	,	,
cord-005453-4057qib7	1116	25	graft	graft	NN
cord-005453-4057qib7	1116	26	failure	failure	NN
cord-005453-4057qib7	1116	27	and	and	CC
cord-005453-4057qib7	1116	28	relapse	relapse	NN
cord-005453-4057qib7	1116	29	.	.	.
cord-005453-4057qib7	1117	1	However	however	RB
cord-005453-4057qib7	1117	2	,	,	,
cord-005453-4057qib7	1117	3	to	to	TO
cord-005453-4057qib7	1117	4	determine	determine	VB
cord-005453-4057qib7	1117	5	the	the	DT
cord-005453-4057qib7	1117	6	real	real	JJ
cord-005453-4057qib7	1117	7	efficacy	efficacy	NN
cord-005453-4057qib7	1117	8	of	of	IN
cord-005453-4057qib7	1117	9	this	this	DT
cord-005453-4057qib7	1117	10	strategy	strategy	NN
cord-005453-4057qib7	1117	11	,	,	,
cord-005453-4057qib7	1117	12	prospective	prospective	JJ
cord-005453-4057qib7	1117	13	studies	study	NNS
cord-005453-4057qib7	1117	14	are	be	VBP
cord-005453-4057qib7	1117	15	required	require	VBN
cord-005453-4057qib7	1117	16	.	.	.
cord-005453-4057qib7	1118	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1118	2	:	:	:
cord-005453-4057qib7	1118	3	Nothing	nothing	NN
cord-005453-4057qib7	1118	4	to	to	TO
cord-005453-4057qib7	1118	5	declare	declare	VB
cord-005453-4057qib7	1118	6	.	.	.
cord-005453-4057qib7	1119	1	Background	background	NN
cord-005453-4057qib7	1119	2	:	:	:
cord-005453-4057qib7	1120	1	Increasing	increase	VBG
cord-005453-4057qib7	1120	2	clinical	clinical	JJ
cord-005453-4057qib7	1120	3	trials	trial	NNS
cord-005453-4057qib7	1120	4	have	have	VBP
cord-005453-4057qib7	1120	5	confirmed	confirm	VBN
cord-005453-4057qib7	1120	6	that	that	IN
cord-005453-4057qib7	1120	7	chimeric	chimeric	JJ
cord-005453-4057qib7	1120	8	antigen	antigen	NN
cord-005453-4057qib7	1120	9	receptor	receptor	NN
cord-005453-4057qib7	1120	10	T	t	NN
cord-005453-4057qib7	1120	11	cells	cell	NNS
cord-005453-4057qib7	1120	12	(	(	-LRB-
cord-005453-4057qib7	1120	13	CAR	car	NN
cord-005453-4057qib7	1120	14	-	-	HYPH
cord-005453-4057qib7	1120	15	T	T	NNP
cord-005453-4057qib7	1120	16	)	)	-RRB-
cord-005453-4057qib7	1120	17	targeting	target	VBG
cord-005453-4057qib7	1120	18	CD19	CD19	NNP
cord-005453-4057qib7	1120	19	antigen	antigen	NN
cord-005453-4057qib7	1120	20	(	(	-LRB-
cord-005453-4057qib7	1120	21	CAR	CAR	NNP
cord-005453-4057qib7	1120	22	-	-	HYPH
cord-005453-4057qib7	1120	23	T-19	T-19	NNP
cord-005453-4057qib7	1120	24	)	)	-RRB-
cord-005453-4057qib7	1120	25	is	be	VBZ
cord-005453-4057qib7	1120	26	a	a	DT
cord-005453-4057qib7	1120	27	promising	promising	JJ
cord-005453-4057qib7	1120	28	effective	effective	JJ
cord-005453-4057qib7	1120	29	approach	approach	NN
cord-005453-4057qib7	1120	30	for	for	IN
cord-005453-4057qib7	1120	31	the	the	DT
cord-005453-4057qib7	1120	32	treatment	treatment	NN
cord-005453-4057qib7	1120	33	of	of	IN
cord-005453-4057qib7	1120	34	relapsed	relapse	VBN
cord-005453-4057qib7	1120	35	/	/	SYM
cord-005453-4057qib7	1120	36	refractory(R	refractory(R	NNP
cord-005453-4057qib7	1120	37	/	/	SYM
cord-005453-4057qib7	1120	38	R	r	NN
cord-005453-4057qib7	1120	39	)	)	-RRB-
cord-005453-4057qib7	1120	40	B	b	NN
cord-005453-4057qib7	1120	41	-	-	HYPH
cord-005453-4057qib7	1120	42	cell	cell	NN
cord-005453-4057qib7	1120	43	lineage	lineage	NN
cord-005453-4057qib7	1120	44	malignancies	malignancy	NNS
cord-005453-4057qib7	1120	45	.	.	.
cord-005453-4057qib7	1121	1	Considering	consider	VBG
cord-005453-4057qib7	1121	2	CD19	CD19	NNP
cord-005453-4057qib7	1121	3	is	be	VBZ
cord-005453-4057qib7	1121	4	frequently	frequently	RB
cord-005453-4057qib7	1121	5	expressed	express	VBN
cord-005453-4057qib7	1121	6	in	in	IN
cord-005453-4057qib7	1121	7	large	large	JJ
cord-005453-4057qib7	1121	8	part	part	NN
cord-005453-4057qib7	1121	9	of	of	IN
cord-005453-4057qib7	1121	10	t(8;21	t(8;21	NNP
cord-005453-4057qib7	1121	11	)	)	-RRB-
cord-005453-4057qib7	1122	1	acute	acute	JJ
cord-005453-4057qib7	1122	2	myeloid	myeloid	NN
cord-005453-4057qib7	1122	3	leukemia	leukemia	NN
cord-005453-4057qib7	1122	4	(	(	-LRB-
cord-005453-4057qib7	1122	5	AML	AML	NNP
cord-005453-4057qib7	1122	6	)	)	-RRB-
cord-005453-4057qib7	1122	7	cells	cell	NNS
cord-005453-4057qib7	1122	8	,	,	,
cord-005453-4057qib7	1122	9	we	-PRON-	PRP
cord-005453-4057qib7	1122	10	suppose	suppose	VBP
cord-005453-4057qib7	1122	11	that	that	IN
cord-005453-4057qib7	1122	12	CAR	CAR	NNP
cord-005453-4057qib7	1122	13	-	-	HYPH
cord-005453-4057qib7	1122	14	T-19	T-19	NNP
cord-005453-4057qib7	1122	15	may	may	MD
cord-005453-4057qib7	1122	16	be	be	VB
cord-005453-4057qib7	1122	17	used	use	VBN
cord-005453-4057qib7	1122	18	as	as	IN
cord-005453-4057qib7	1122	19	an	an	DT
cord-005453-4057qib7	1122	20	approach	approach	NN
cord-005453-4057qib7	1122	21	to	to	IN
cord-005453-4057qib7	1122	22	rescuing	rescue	VBG
cord-005453-4057qib7	1122	23	R	r	NN
cord-005453-4057qib7	1122	24	/	/	SYM
cord-005453-4057qib7	1122	25	R	r	NN
cord-005453-4057qib7	1122	26	t(8;21	t(8;21	NNP
cord-005453-4057qib7	1122	27	)	)	-RRB-
cord-005453-4057qib7	1123	1	AML	AML	NNP
cord-005453-4057qib7	1123	2	patients	patient	NNS
cord-005453-4057qib7	1123	3	.	.	.
cord-005453-4057qib7	1124	1	Methods	method	NNS
cord-005453-4057qib7	1124	2	:	:	:
cord-005453-4057qib7	1125	1	Both	both	DT
cord-005453-4057qib7	1125	2	patients	patient	NNS
cord-005453-4057qib7	1125	3	received	receive	VBD
cord-005453-4057qib7	1125	4	lymphodepletion	lymphodepletion	NN
cord-005453-4057qib7	1125	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	1125	6	with	with	IN
cord-005453-4057qib7	1125	7	Decitabine	Decitabine	NNP
cord-005453-4057qib7	1125	8	20mg	20mg	NNP
cord-005453-4057qib7	1125	9	/	/	SYM
cord-005453-4057qib7	1125	10	m	m	NN
cord-005453-4057qib7	1125	11	2	2	CD
cord-005453-4057qib7	1125	12	×5d	×5d	CD
cord-005453-4057qib7	1125	13	,	,	,
cord-005453-4057qib7	1125	14	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	1125	15	30mg	30mg	NNP
cord-005453-4057qib7	1125	16	/	/	SYM
cord-005453-4057qib7	1125	17	m	m	NN
cord-005453-4057qib7	1125	18	2	2	CD
cord-005453-4057qib7	1125	19	×3d	×3d	NNS
cord-005453-4057qib7	1125	20	and	and	CC
cord-005453-4057qib7	1125	21	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	1126	1	300mg	300mg	NNP
cord-005453-4057qib7	1126	2	/	/	SYM
cord-005453-4057qib7	1126	3	m	m	NN
cord-005453-4057qib7	1126	4	2	2	CD
cord-005453-4057qib7	1127	1	×3d	×3d	LS
cord-005453-4057qib7	1127	2	(	(	-LRB-
cord-005453-4057qib7	1127	3	DAC	DAC	NNP
cord-005453-4057qib7	1127	4	+	+	CC
cord-005453-4057qib7	1127	5	FC	FC	NNP
cord-005453-4057qib7	1127	6	)	)	-RRB-
cord-005453-4057qib7	1127	7	.	.	.
cord-005453-4057qib7	1128	1	Two	two	CD
cord-005453-4057qib7	1128	2	days	day	NNS
cord-005453-4057qib7	1128	3	after	after	IN
cord-005453-4057qib7	1128	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	1128	5	,	,	,
cord-005453-4057qib7	1128	6	autologous	autologous	JJ
cord-005453-4057qib7	1128	7	/	/	SYM
cord-005453-4057qib7	1128	8	allogeneic	allogeneic	IN
cord-005453-4057qib7	1128	9	CART-19	cart-19	JJ
cord-005453-4057qib7	1128	10	cells	cell	NNS
cord-005453-4057qib7	1128	11	provided	provide	VBN
cord-005453-4057qib7	1128	12	by	by	IN
cord-005453-4057qib7	1128	13	the	the	DT
cord-005453-4057qib7	1128	14	unicar	unicar	JJ
cord-005453-4057qib7	1128	15	-	-	HYPH
cord-005453-4057qib7	1128	16	therapy	therapy	NN
cord-005453-4057qib7	1128	17	biomedicine	biomedicine	NN
cord-005453-4057qib7	1128	18	technology	technology	NN
cord-005453-4057qib7	1128	19	co.(Shanghai	co.(shanghai	CD
cord-005453-4057qib7	1128	20	,	,	,
cord-005453-4057qib7	1128	21	China	China	NNP
cord-005453-4057qib7	1128	22	)	)	-RRB-
cord-005453-4057qib7	1128	23	at	at	IN
cord-005453-4057qib7	1128	24	a	a	DT
cord-005453-4057qib7	1128	25	total	total	JJ
cord-005453-4057qib7	1128	26	dose	dose	NN
cord-005453-4057qib7	1128	27	of	of	IN
cord-005453-4057qib7	1128	28	5	5	CD
cord-005453-4057qib7	1128	29	-	-	SYM
cord-005453-4057qib7	1128	30	10×10	10×10	CD
cord-005453-4057qib7	1128	31	6	6	CD
cord-005453-4057qib7	1128	32	cells	cell	NNS
cord-005453-4057qib7	1128	33	per	per	IN
cord-005453-4057qib7	1128	34	kilogram(kg	kilogram(kg	CD
cord-005453-4057qib7	1128	35	)	)	-RRB-
cord-005453-4057qib7	1128	36	were	be	VBD
cord-005453-4057qib7	1128	37	infused	infuse	VBN
cord-005453-4057qib7	1128	38	dose	dose	NN
cord-005453-4057qib7	1128	39	escalation	escalation	NN
cord-005453-4057qib7	1128	40	within	within	IN
cord-005453-4057qib7	1128	41	2	2	CD
cord-005453-4057qib7	1128	42	to	to	TO
cord-005453-4057qib7	1128	43	3	3	CD
cord-005453-4057qib7	1128	44	days	day	NNS
cord-005453-4057qib7	1128	45	.	.	.
cord-005453-4057qib7	1129	1	The	the	DT
cord-005453-4057qib7	1129	2	research	research	NN
cord-005453-4057qib7	1129	3	protocol	protocol	NN
cord-005453-4057qib7	1129	4	was	be	VBD
cord-005453-4057qib7	1129	5	approved	approve	VBN
cord-005453-4057qib7	1129	6	by	by	IN
cord-005453-4057qib7	1129	7	the	the	DT
cord-005453-4057qib7	1129	8	institutional	institutional	JJ
cord-005453-4057qib7	1129	9	review	review	NN
cord-005453-4057qib7	1129	10	boards	board	NNS
cord-005453-4057qib7	1129	11	of	of	IN
cord-005453-4057qib7	1129	12	the	the	DT
cord-005453-4057qib7	1129	13	first	first	JJ
cord-005453-4057qib7	1129	14	affiliated	affiliated	JJ
cord-005453-4057qib7	1129	15	hospital	hospital	NN
cord-005453-4057qib7	1129	16	of	of	IN
cord-005453-4057qib7	1129	17	Soochow	Soochow	NNP
cord-005453-4057qib7	1129	18	University	University	NNP
cord-005453-4057qib7	1129	19	and	and	CC
cord-005453-4057qib7	1129	20	both	both	DT
cord-005453-4057qib7	1129	21	patients	patient	NNS
cord-005453-4057qib7	1129	22	gave	give	VBD
cord-005453-4057qib7	1129	23	written	write	VBN
cord-005453-4057qib7	1129	24	informed	informed	JJ
cord-005453-4057qib7	1129	25	consent	consent	NN
cord-005453-4057qib7	1129	26	.	.	.
cord-005453-4057qib7	1130	1	Results	result	NNS
cord-005453-4057qib7	1130	2	:	:	:
cord-005453-4057qib7	1131	1	Both	both	DT
cord-005453-4057qib7	1131	2	cases	case	NNS
cord-005453-4057qib7	1131	3	responded	respond	VBD
cord-005453-4057qib7	1131	4	well	well	RB
cord-005453-4057qib7	1131	5	with	with	IN
cord-005453-4057qib7	1131	6	transient	transient	JJ
cord-005453-4057qib7	1131	7	and	and	CC
cord-005453-4057qib7	1131	8	reversible	reversible	JJ
cord-005453-4057qib7	1131	9	toxicities	toxicity	NNS
cord-005453-4057qib7	1131	10	.	.	.
cord-005453-4057qib7	1132	1	Case	case	NN
cord-005453-4057qib7	1132	2	1	1	CD
cord-005453-4057qib7	1132	3	presented	present	VBD
cord-005453-4057qib7	1132	4	with	with	IN
cord-005453-4057qib7	1132	5	grade	grade	NN
cord-005453-4057qib7	1132	6	1	1	CD
cord-005453-4057qib7	1132	7	cytokine	cytokine	NN
cord-005453-4057qib7	1132	8	release	release	NN
cord-005453-4057qib7	1132	9	syndrome	syndrome	NN
cord-005453-4057qib7	1132	10	(	(	-LRB-
cord-005453-4057qib7	1132	11	CRS	CRS	NNP
cord-005453-4057qib7	1132	12	)	)	-RRB-
cord-005453-4057qib7	1132	13	,	,	,
cord-005453-4057qib7	1132	14	manifested	manifest	VBN
cord-005453-4057qib7	1132	15	by	by	IN
cord-005453-4057qib7	1132	16	intermittent	intermittent	JJ
cord-005453-4057qib7	1132	17	fever	fever	NN
cord-005453-4057qib7	1132	18	and	and	CC
cord-005453-4057qib7	1132	19	chill	chill	NN
cord-005453-4057qib7	1132	20	from	from	IN
cord-005453-4057qib7	1132	21	day	day	NN
cord-005453-4057qib7	1132	22	4	4	CD
cord-005453-4057qib7	1132	23	after	after	IN
cord-005453-4057qib7	1132	24	CAR	car	NN
cord-005453-4057qib7	1132	25	-	-	HYPH
cord-005453-4057qib7	1132	26	T-19	T-19	NNP
cord-005453-4057qib7	1132	27	infusion	infusion	NN
cord-005453-4057qib7	1132	28	for	for	IN
cord-005453-4057qib7	1132	29	half	half	JJ
cord-005453-4057qib7	1132	30	months	month	NNS
cord-005453-4057qib7	1132	31	associated	associate	VBN
cord-005453-4057qib7	1132	32	with	with	IN
cord-005453-4057qib7	1132	33	neutropenia	neutropenia	NN
cord-005453-4057qib7	1132	34	.	.	.
cord-005453-4057qib7	1133	1	CAR	car	NN
cord-005453-4057qib7	1133	2	-	-	HYPH
cord-005453-4057qib7	1133	3	T	t	NN
cord-005453-4057qib7	1133	4	cells	cell	NNS
cord-005453-4057qib7	1133	5	expansion	expansion	NN
cord-005453-4057qib7	1133	6	were	be	VBD
cord-005453-4057qib7	1133	7	observed	observe	VBN
cord-005453-4057qib7	1133	8	in	in	IN
cord-005453-4057qib7	1133	9	blood	blood	NN
cord-005453-4057qib7	1133	10	without	without	IN
cord-005453-4057qib7	1133	11	obvious	obvious	JJ
cord-005453-4057qib7	1133	12	increase	increase	NN
cord-005453-4057qib7	1133	13	of	of	IN
cord-005453-4057qib7	1133	14	cytokines	cytokine	NNS
cord-005453-4057qib7	1133	15	.	.	.
cord-005453-4057qib7	1134	1	After	after	IN
cord-005453-4057qib7	1134	2	infusion	infusion	NN
cord-005453-4057qib7	1134	3	,	,	,
cord-005453-4057qib7	1134	4	Case	case	NN
cord-005453-4057qib7	1134	5	1	1	CD
cord-005453-4057qib7	1134	6	achieved	achieve	VBD
cord-005453-4057qib7	1134	7	and	and	CC
cord-005453-4057qib7	1134	8	maintained	maintain	VBD
cord-005453-4057qib7	1134	9	molecular	molecular	JJ
cord-005453-4057qib7	1134	10	complete	complete	JJ
cord-005453-4057qib7	1134	11	remission	remission	NN
cord-005453-4057qib7	1134	12	(	(	-LRB-
cord-005453-4057qib7	1134	13	CR	CR	NNP
cord-005453-4057qib7	1134	14	)	)	-RRB-
cord-005453-4057qib7	1134	15	for	for	IN
cord-005453-4057qib7	1134	16	more	more	JJR
cord-005453-4057qib7	1134	17	than	than	IN
cord-005453-4057qib7	1134	18	10	10	CD
cord-005453-4057qib7	1134	19	months	month	NNS
cord-005453-4057qib7	1134	20	.	.	.
cord-005453-4057qib7	1135	1	Case	case	NN
cord-005453-4057qib7	1135	2	2	2	CD
cord-005453-4057qib7	1135	3	presented	present	VBN
cord-005453-4057qib7	1135	4	with	with	IN
cord-005453-4057qib7	1135	5	grade	grade	NN
cord-005453-4057qib7	1135	6	3	3	CD
cord-005453-4057qib7	1135	7	CRS	CRS	NNP
cord-005453-4057qib7	1135	8	manifested	manifest	VBN
cord-005453-4057qib7	1135	9	by	by	IN
cord-005453-4057qib7	1135	10	continuous	continuous	JJ
cord-005453-4057qib7	1135	11	high	high	JJ
cord-005453-4057qib7	1135	12	fever	fever	NN
cord-005453-4057qib7	1135	13	,	,	,
cord-005453-4057qib7	1135	14	hypotension	hypotension	NN
cord-005453-4057qib7	1135	15	and	and	CC
cord-005453-4057qib7	1135	16	grade	grade	NN
cord-005453-4057qib7	1135	17	1	1	CD
cord-005453-4057qib7	1135	18	liver	liver	NN
cord-005453-4057qib7	1135	19	disfunction	disfunction	NN
cord-005453-4057qib7	1135	20	from	from	IN
cord-005453-4057qib7	1135	21	day	day	NN
cord-005453-4057qib7	1135	22	1	1	CD
cord-005453-4057qib7	1135	23	after	after	IN
cord-005453-4057qib7	1135	24	CAR	car	NN
cord-005453-4057qib7	1135	25	-	-	HYPH
cord-005453-4057qib7	1135	26	T-19	T-19	NNP
cord-005453-4057qib7	1135	27	cell	cell	NN
cord-005453-4057qib7	1135	28	infusion	infusion	NN
cord-005453-4057qib7	1135	29	for	for	IN
cord-005453-4057qib7	1135	30	1	1	CD
cord-005453-4057qib7	1135	31	week	week	NN
cord-005453-4057qib7	1135	32	.	.	.
cord-005453-4057qib7	1136	1	Obvious	obvious	JJ
cord-005453-4057qib7	1136	2	cytokines	cytokine	NNS
cord-005453-4057qib7	1136	3	releasing	release	VBG
cord-005453-4057qib7	1136	4	(	(	-LRB-
cord-005453-4057qib7	1136	5	peak	peak	NNP
cord-005453-4057qib7	1136	6	IL-6	IL-6	NNP
cord-005453-4057qib7	1136	7	serum	serum	NN
cord-005453-4057qib7	1136	8	concentration	concentration	NN
cord-005453-4057qib7	1136	9	1774.5	1774.5	CD
cord-005453-4057qib7	1136	10	pg	pg	NNP
cord-005453-4057qib7	1136	11	/	/	SYM
cord-005453-4057qib7	1136	12	ml	ml	NN
cord-005453-4057qib7	1136	13	,	,	,
cord-005453-4057qib7	1136	14	peak	peak	NNP
cord-005453-4057qib7	1136	15	CRP	CRP	NNP
cord-005453-4057qib7	1136	16	serum	serum	NN
cord-005453-4057qib7	1136	17	concentration	concentration	NN
cord-005453-4057qib7	1136	18	367pg	367pg	NNP
cord-005453-4057qib7	1136	19	/	/	SYM
cord-005453-4057qib7	1136	20	ml	ml	NN
cord-005453-4057qib7	1136	21	)	)	-RRB-
cord-005453-4057qib7	1136	22	were	be	VBD
cord-005453-4057qib7	1136	23	detected	detect	VBN
cord-005453-4057qib7	1136	24	which	which	WDT
cord-005453-4057qib7	1136	25	were	be	VBD
cord-005453-4057qib7	1136	26	associated	associate	VBN
cord-005453-4057qib7	1136	27	with	with	IN
cord-005453-4057qib7	1136	28	CAR	car	NN
cord-005453-4057qib7	1136	29	-	-	HYPH
cord-005453-4057qib7	1136	30	T-19	T-19	NNP
cord-005453-4057qib7	1136	31	cell	cell	NN
cord-005453-4057qib7	1136	32	expansion	expansion	NN
cord-005453-4057qib7	1136	33	in	in	IN
cord-005453-4057qib7	1136	34	blood	blood	NN
cord-005453-4057qib7	1136	35	and	and	CC
cord-005453-4057qib7	1136	36	no	no	DT
cord-005453-4057qib7	1136	37	severe	severe	JJ
cord-005453-4057qib7	1136	38	off	off	JJ
cord-005453-4057qib7	1136	39	-	-	HYPH
cord-005453-4057qib7	1136	40	tumor	tumor	NN
cord-005453-4057qib7	1136	41	effect	effect	NN
cord-005453-4057qib7	1136	42	was	be	VBD
cord-005453-4057qib7	1136	43	observed	observe	VBN
cord-005453-4057qib7	1136	44	.	.	.
cord-005453-4057qib7	1137	1	After	after	IN
cord-005453-4057qib7	1137	2	infusion	infusion	NN
cord-005453-4057qib7	1137	3	,	,	,
cord-005453-4057qib7	1137	4	case	case	NN
cord-005453-4057qib7	1137	5	2	2	CD
cord-005453-4057qib7	1137	6	achieved	achieve	VBD
cord-005453-4057qib7	1137	7	hematological	hematological	JJ
cord-005453-4057qib7	1137	8	CR	cr	NN
cord-005453-4057qib7	1137	9	and	and	CC
cord-005453-4057qib7	1137	10	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	1137	11	CR	cr	NN
cord-005453-4057qib7	1137	12	and	and	CC
cord-005453-4057qib7	1137	13	got	get	VBD
cord-005453-4057qib7	1137	14	3	3	CD
cord-005453-4057qib7	1137	15	months	month	NNS
cord-005453-4057qib7	1137	16	disease	disease	NN
cord-005453-4057qib7	1137	17	free	free	JJ
cord-005453-4057qib7	1137	18	survival	survival	NN
cord-005453-4057qib7	1137	19	.	.	.
cord-005453-4057qib7	1138	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1138	2	:	:	:
cord-005453-4057qib7	1139	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1139	2	report	report	NN
cord-005453-4057qib7	1139	3	implicates	implicate	VBZ
cord-005453-4057qib7	1139	4	that	that	IN
cord-005453-4057qib7	1139	5	CAR	CAR	NNP
cord-005453-4057qib7	1139	6	-	-	HYPH
cord-005453-4057qib7	1139	7	T-19	T-19	NNP
cord-005453-4057qib7	1139	8	is	be	VBZ
cord-005453-4057qib7	1139	9	a	a	DT
cord-005453-4057qib7	1139	10	safe	safe	JJ
cord-005453-4057qib7	1139	11	and	and	CC
cord-005453-4057qib7	1139	12	promising	promising	JJ
cord-005453-4057qib7	1139	13	approach	approach	NN
cord-005453-4057qib7	1139	14	to	to	IN
cord-005453-4057qib7	1139	15	managing	manage	VBG
cord-005453-4057qib7	1139	16	R	r	NN
cord-005453-4057qib7	1139	17	/	/	SYM
cord-005453-4057qib7	1139	18	R	r	NN
cord-005453-4057qib7	1139	19	t(8;21)AML	t(8;21)aml	NN
cord-005453-4057qib7	1139	20	with	with	IN
cord-005453-4057qib7	1139	21	CD19	CD19	NNP
cord-005453-4057qib7	1139	22	expression	expression	NN
cord-005453-4057qib7	1139	23	,	,	,
cord-005453-4057qib7	1139	24	and	and	CC
cord-005453-4057qib7	1139	25	may	may	MD
cord-005453-4057qib7	1139	26	provide	provide	VB
cord-005453-4057qib7	1139	27	a	a	DT
cord-005453-4057qib7	1139	28	salvage	salvage	NN
cord-005453-4057qib7	1139	29	treatment	treatment	NN
cord-005453-4057qib7	1139	30	approach	approach	NN
cord-005453-4057qib7	1139	31	for	for	IN
cord-005453-4057qib7	1139	32	all	all	DT
cord-005453-4057qib7	1139	33	AML	AML	NNP
cord-005453-4057qib7	1139	34	patients	patient	NNS
cord-005453-4057qib7	1139	35	with	with	IN
cord-005453-4057qib7	1139	36	CD19	CD19	NNP
cord-005453-4057qib7	1139	37	expression	expression	NN
cord-005453-4057qib7	1139	38	and	and	CC
cord-005453-4057qib7	1139	39	benefit	benefit	VB
cord-005453-4057qib7	1139	40	a	a	DT
cord-005453-4057qib7	1139	41	certain	certain	JJ
cord-005453-4057qib7	1139	42	population	population	NN
cord-005453-4057qib7	1139	43	with	with	IN
cord-005453-4057qib7	1139	44	AML	AML	NNP
cord-005453-4057qib7	1139	45	besides	besides	IN
cord-005453-4057qib7	1139	46	B	b	NN
cord-005453-4057qib7	1139	47	-	-	HYPH
cord-005453-4057qib7	1139	48	linage	linage	NN
cord-005453-4057qib7	1139	49	malignancies	malignancy	NNS
cord-005453-4057qib7	1139	50	.	.	.
cord-005453-4057qib7	1140	1	Clinical	clinical	JJ
cord-005453-4057qib7	1140	2	Trial	Trial	NNP
cord-005453-4057qib7	1140	3	Registry	Registry	NNP
cord-005453-4057qib7	1140	4	:	:	:
cord-005453-4057qib7	1141	1	NA	NA	NNP
cord-005453-4057qib7	1141	2	Disclosure	disclosure	NN
cord-005453-4057qib7	1141	3	:	:	:
cord-005453-4057qib7	1141	4	Nothing	nothing	NN
cord-005453-4057qib7	1141	5	to	to	TO
cord-005453-4057qib7	1141	6	declare	declare	VB
cord-005453-4057qib7	1141	7	.	.	.
cord-005453-4057qib7	1142	1	This	this	DT
cord-005453-4057qib7	1142	2	work	work	NN
cord-005453-4057qib7	1142	3	was	be	VBD
cord-005453-4057qib7	1142	4	supported	support	VBN
cord-005453-4057qib7	1142	5	by	by	IN
cord-005453-4057qib7	1142	6	research	research	NN
cord-005453-4057qib7	1142	7	grants	grant	NNS
cord-005453-4057qib7	1142	8	from	from	IN
cord-005453-4057qib7	1142	9	the	the	DT
cord-005453-4057qib7	1142	10	National	National	NNP
cord-005453-4057qib7	1142	11	Key	Key	NNP
cord-005453-4057qib7	1142	12	R&D	R&D	NNP
cord-005453-4057qib7	1142	13	Program	Program	NNP
cord-005453-4057qib7	1142	14	of	of	IN
cord-005453-4057qib7	1142	15	China	China	NNP
cord-005453-4057qib7	1142	16	(	(	-LRB-
cord-005453-4057qib7	1142	17	2016YFC0902800	2016yfc0902800	CD
cord-005453-4057qib7	1142	18	)	)	-RRB-
cord-005453-4057qib7	1142	19	,	,	,
cord-005453-4057qib7	1142	20	National	National	NNP
cord-005453-4057qib7	1142	21	natural	natural	JJ
cord-005453-4057qib7	1142	22	science	science	NN
cord-005453-4057qib7	1142	23	Foundation	Foundation	NNP
cord-005453-4057qib7	1142	24	of	of	IN
cord-005453-4057qib7	1142	25	China	China	NNP
cord-005453-4057qib7	1142	26	(	(	-LRB-
cord-005453-4057qib7	1142	27	81873443	81873443	CD
cord-005453-4057qib7	1142	28	,	,	,
cord-005453-4057qib7	1142	29	81270645	81270645	CD
cord-005453-4057qib7	1142	30	,	,	,
cord-005453-4057qib7	1142	31	81400155	81400155	CD
cord-005453-4057qib7	1142	32	,	,	,
cord-005453-4057qib7	1142	33	81500146	81500146	CD
cord-005453-4057qib7	1142	34	)	)	-RRB-
cord-005453-4057qib7	1143	1	Background	background	NN
cord-005453-4057qib7	1143	2	:	:	:
cord-005453-4057qib7	1144	1	Chimeric	chimeric	JJ
cord-005453-4057qib7	1144	2	antigen	antigen	NN
cord-005453-4057qib7	1144	3	receptor	receptor	NN
cord-005453-4057qib7	1144	4	engineered	engineer	VBD
cord-005453-4057qib7	1144	5	T	T	NNP
cord-005453-4057qib7	1144	6	(	(	-LRB-
cord-005453-4057qib7	1144	7	CAR	CAR	NNP
cord-005453-4057qib7	1144	8	-	-	HYPH
cord-005453-4057qib7	1144	9	T	T	NNP
cord-005453-4057qib7	1144	10	)	)	-RRB-
cord-005453-4057qib7	1144	11	cells	cell	NNS
cord-005453-4057qib7	1144	12	have	have	VBP
cord-005453-4057qib7	1144	13	emerged	emerge	VBN
cord-005453-4057qib7	1144	14	as	as	IN
cord-005453-4057qib7	1144	15	a	a	DT
cord-005453-4057qib7	1144	16	powerful	powerful	JJ
cord-005453-4057qib7	1144	17	cellular	cellular	JJ
cord-005453-4057qib7	1144	18	therapy	therapy	NN
cord-005453-4057qib7	1144	19	to	to	TO
cord-005453-4057qib7	1144	20	treat	treat	VB
cord-005453-4057qib7	1144	21	malignant	malignant	JJ
cord-005453-4057qib7	1144	22	disease	disease	NN
cord-005453-4057qib7	1144	23	,	,	,
cord-005453-4057qib7	1144	24	which	which	WDT
cord-005453-4057qib7	1144	25	is	be	VBZ
cord-005453-4057qib7	1144	26	currently	currently	RB
cord-005453-4057qib7	1144	27	revolutionizing	revolutionize	VBG
cord-005453-4057qib7	1144	28	field	field	NN
cord-005453-4057qib7	1144	29	of	of	IN
cord-005453-4057qib7	1144	30	cancer	cancer	NN
cord-005453-4057qib7	1144	31	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1144	32	.	.	.
cord-005453-4057qib7	1145	1	A	a	DT
cord-005453-4057qib7	1145	2	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1145	3	step	step	NN
cord-005453-4057qib7	1145	4	postmanufacture	postmanufacture	NN
cord-005453-4057qib7	1145	5	is	be	VBZ
cord-005453-4057qib7	1145	6	not	not	RB
cord-005453-4057qib7	1145	7	only	only	RB
cord-005453-4057qib7	1145	8	a	a	DT
cord-005453-4057qib7	1145	9	logistical	logistical	JJ
cord-005453-4057qib7	1145	10	necessity	necessity	NN
cord-005453-4057qib7	1145	11	for	for	IN
cord-005453-4057qib7	1145	12	large	large	JJ
cord-005453-4057qib7	1145	13	scale	scale	NN
cord-005453-4057qib7	1145	14	cell	cell	NN
cord-005453-4057qib7	1145	15	manufacturing	manufacturing	NN
cord-005453-4057qib7	1145	16	processes	process	NNS
cord-005453-4057qib7	1145	17	but	but	CC
cord-005453-4057qib7	1145	18	also	also	RB
cord-005453-4057qib7	1145	19	a	a	DT
cord-005453-4057qib7	1145	20	mandatory	mandatory	JJ
cord-005453-4057qib7	1145	21	request	request	NN
cord-005453-4057qib7	1145	22	by	by	IN
cord-005453-4057qib7	1145	23	regulatory	regulatory	JJ
cord-005453-4057qib7	1145	24	authorities	authority	NNS
cord-005453-4057qib7	1145	25	.	.	.
cord-005453-4057qib7	1146	1	In	in	IN
cord-005453-4057qib7	1146	2	case	case	NN
cord-005453-4057qib7	1146	3	relapse	relapse	NN
cord-005453-4057qib7	1146	4	after	after	IN
cord-005453-4057qib7	1146	5	1	1	CD
cord-005453-4057qib7	1146	6	st	st	NNP
cord-005453-4057qib7	1146	7	CAR	CAR	NNP
cord-005453-4057qib7	1146	8	-	-	HYPH
cord-005453-4057qib7	1146	9	T	T	NNP
cord-005453-4057qib7	1146	10	cell	cell	NN
cord-005453-4057qib7	1146	11	transplantation	transplantation	NN
cord-005453-4057qib7	1146	12	,	,	,
cord-005453-4057qib7	1146	13	a	a	DT
cord-005453-4057qib7	1146	14	second	second	JJ
cord-005453-4057qib7	1146	15	application	application	NN
cord-005453-4057qib7	1146	16	,	,	,
cord-005453-4057qib7	1146	17	maybe	maybe	RB
cord-005453-4057qib7	1146	18	at	at	IN
cord-005453-4057qib7	1146	19	a	a	DT
cord-005453-4057qib7	1146	20	higher	high	JJR
cord-005453-4057qib7	1146	21	dose	dose	NN
cord-005453-4057qib7	1146	22	constitutes	constitute	VBZ
cord-005453-4057qib7	1146	23	a	a	DT
cord-005453-4057qib7	1146	24	therapeutical	therapeutical	JJ
cord-005453-4057qib7	1146	25	option	option	NN
cord-005453-4057qib7	1146	26	.	.	.
cord-005453-4057qib7	1147	1	However	however	RB
cord-005453-4057qib7	1147	2	,	,	,
cord-005453-4057qib7	1147	3	data	datum	NNS
cord-005453-4057qib7	1147	4	concerning	concern	VBG
cord-005453-4057qib7	1147	5	clinical	clinical	JJ
cord-005453-4057qib7	1147	6	grade	grade	NN
cord-005453-4057qib7	1147	7	CAR	CAR	NNP
cord-005453-4057qib7	1147	8	-	-	HYPH
cord-005453-4057qib7	1147	9	T	t	NN
cord-005453-4057qib7	1147	10	cell	cell	NN
cord-005453-4057qib7	1147	11	stability	stability	NN
cord-005453-4057qib7	1147	12	and	and	CC
cord-005453-4057qib7	1147	13	functionality	functionality	NN
cord-005453-4057qib7	1147	14	after	after	IN
cord-005453-4057qib7	1147	15	months	month	NNS
cord-005453-4057qib7	1147	16	of	of	IN
cord-005453-4057qib7	1147	17	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1147	18	have	have	VBP
cord-005453-4057qib7	1147	19	not	not	RB
cord-005453-4057qib7	1147	20	been	be	VBN
cord-005453-4057qib7	1147	21	released	release	VBN
cord-005453-4057qib7	1147	22	by	by	IN
cord-005453-4057qib7	1147	23	companies	company	NNS
cord-005453-4057qib7	1147	24	so	so	RB
cord-005453-4057qib7	1147	25	far	far	RB
cord-005453-4057qib7	1147	26	.	.	.
cord-005453-4057qib7	1148	1	To	to	TO
cord-005453-4057qib7	1148	2	investigate	investigate	VB
cord-005453-4057qib7	1148	3	the	the	DT
cord-005453-4057qib7	1148	4	effect	effect	NN
cord-005453-4057qib7	1148	5	of	of	IN
cord-005453-4057qib7	1148	6	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1148	7	on	on	IN
cord-005453-4057qib7	1148	8	CAR	car	NN
cord-005453-4057qib7	1148	9	-	-	HYPH
cord-005453-4057qib7	1148	10	T	t	NN
cord-005453-4057qib7	1148	11	cells	cell	NNS
cord-005453-4057qib7	1148	12	,	,	,
cord-005453-4057qib7	1148	13	we	-PRON-	PRP
cord-005453-4057qib7	1148	14	performed	perform	VBD
cord-005453-4057qib7	1148	15	this	this	DT
cord-005453-4057qib7	1148	16	study	study	NN
cord-005453-4057qib7	1148	17	.	.	.
cord-005453-4057qib7	1149	1	Methods	method	NNS
cord-005453-4057qib7	1149	2	:	:	:
cord-005453-4057qib7	1149	3	Different	different	JJ
cord-005453-4057qib7	1149	4	batches	batch	NNS
cord-005453-4057qib7	1149	5	of	of	IN
cord-005453-4057qib7	1149	6	CD19	CD19	NNP
cord-005453-4057qib7	1149	7	CAR	CAR	NNP
cord-005453-4057qib7	1149	8	-	-	HYPH
cord-005453-4057qib7	1149	9	T	t	NN
cord-005453-4057qib7	1149	10	cells	cell	NNS
cord-005453-4057qib7	1149	11	were	be	VBD
cord-005453-4057qib7	1149	12	manufactured	manufacture	VBN
cord-005453-4057qib7	1149	13	according	accord	VBG
cord-005453-4057qib7	1149	14	to	to	IN
cord-005453-4057qib7	1149	15	GMP	GMP	NNP
cord-005453-4057qib7	1149	16	requirements	requirement	NNS
cord-005453-4057qib7	1149	17	at	at	IN
cord-005453-4057qib7	1149	18	our	-PRON-	PRP$
cord-005453-4057qib7	1149	19	institution	institution	NN
cord-005453-4057qib7	1149	20	.	.	.
cord-005453-4057qib7	1150	1	Final	final	JJ
cord-005453-4057qib7	1150	2	CAR	CAR	NNP
cord-005453-4057qib7	1150	3	-	-	HYPH
cord-005453-4057qib7	1150	4	T	t	NN
cord-005453-4057qib7	1150	5	products	product	NNS
cord-005453-4057qib7	1150	6	were	be	VBD
cord-005453-4057qib7	1150	7	frozen	freeze	VBN
cord-005453-4057qib7	1150	8	at	at	IN
cord-005453-4057qib7	1150	9	concentrations	concentration	NNS
cord-005453-4057qib7	1150	10	of	of	IN
cord-005453-4057qib7	1150	11	1	1	CD
cord-005453-4057qib7	1150	12	x	x	SYM
cord-005453-4057qib7	1150	13	10	10	CD
cord-005453-4057qib7	1150	14	7	7	CD
cord-005453-4057qib7	1150	15	cells	cell	NNS
cord-005453-4057qib7	1150	16	/	/	SYM
cord-005453-4057qib7	1150	17	ml	ml	NN
cord-005453-4057qib7	1150	18	(	(	-LRB-
cord-005453-4057qib7	1150	19	high	high	JJ
cord-005453-4057qib7	1150	20	batch	batch	NN
cord-005453-4057qib7	1150	21	)	)	-RRB-
cord-005453-4057qib7	1150	22	and	and	CC
cord-005453-4057qib7	1150	23	2	2	CD
cord-005453-4057qib7	1150	24	x	x	SYM
cord-005453-4057qib7	1150	25	10	10	CD
cord-005453-4057qib7	1150	26	6	6	CD
cord-005453-4057qib7	1150	27	cells	cell	NNS
cord-005453-4057qib7	1150	28	/	/	SYM
cord-005453-4057qib7	1150	29	ml	ml	NN
cord-005453-4057qib7	1150	30	(	(	-LRB-
cord-005453-4057qib7	1150	31	low	low	JJ
cord-005453-4057qib7	1150	32	batch	batch	NN
cord-005453-4057qib7	1150	33	)	)	-RRB-
cord-005453-4057qib7	1150	34	by	by	IN
cord-005453-4057qib7	1150	35	a	a	DT
cord-005453-4057qib7	1150	36	controlled	control	VBN
cord-005453-4057qib7	1150	37	freezing	freezing	NN
cord-005453-4057qib7	1150	38	process	process	NN
cord-005453-4057qib7	1150	39	with	with	IN
cord-005453-4057qib7	1150	40	the	the	DT
cord-005453-4057qib7	1150	41	Biofreeze	Biofreeze	NNP
cord-005453-4057qib7	1150	42	BV40	BV40	NNP
cord-005453-4057qib7	1150	43	device	device	NN
cord-005453-4057qib7	1150	44	and	and	CC
cord-005453-4057qib7	1150	45	stored	store	VBN
cord-005453-4057qib7	1150	46	in	in	IN
cord-005453-4057qib7	1150	47	liquid	liquid	JJ
cord-005453-4057qib7	1150	48	nitrogen	nitrogen	NN
cord-005453-4057qib7	1150	49	tanks	tank	NNS
cord-005453-4057qib7	1150	50	below	below	IN
cord-005453-4057qib7	1150	51	-150	-150	NN
cord-005453-4057qib7	1150	52	°	°	NN
cord-005453-4057qib7	1150	53	C	C	NNP
cord-005453-4057qib7	1150	54	until	until	IN
cord-005453-4057qib7	1150	55	release	release	NN
cord-005453-4057qib7	1150	56	.	.	.
cord-005453-4057qib7	1151	1	Quality	quality	NN
cord-005453-4057qib7	1151	2	control	control	NN
cord-005453-4057qib7	1151	3	tests	test	NNS
cord-005453-4057qib7	1151	4	for	for	IN
cord-005453-4057qib7	1151	5	sterility	sterility	NN
cord-005453-4057qib7	1151	6	,	,	,
cord-005453-4057qib7	1151	7	endotoxin	endotoxin	NN
cord-005453-4057qib7	1151	8	and	and	CC
cord-005453-4057qib7	1151	9	mycoplasma	mycoplasma	NN
cord-005453-4057qib7	1151	10	were	be	VBD
cord-005453-4057qib7	1151	11	performed	perform	VBN
cord-005453-4057qib7	1151	12	for	for	IN
cord-005453-4057qib7	1151	13	each	each	DT
cord-005453-4057qib7	1151	14	batch	batch	NN
cord-005453-4057qib7	1151	15	according	accord	VBG
cord-005453-4057qib7	1151	16	to	to	IN
cord-005453-4057qib7	1151	17	European	European	NNP
cord-005453-4057qib7	1151	18	Pharmacopoeia	Pharmacopoeia	NNP
cord-005453-4057qib7	1151	19	and	and	CC
cord-005453-4057qib7	1151	20	United	United	NNP
cord-005453-4057qib7	1151	21	States	States	NNP
cord-005453-4057qib7	1151	22	Pharmacopoeia	Pharmacopoeia	NNP
cord-005453-4057qib7	1151	23	guidelines	guideline	NNS
cord-005453-4057qib7	1151	24	.	.	.
cord-005453-4057qib7	1152	1	Stability	stability	NN
cord-005453-4057qib7	1152	2	of	of	IN
cord-005453-4057qib7	1152	3	CD19	CD19	NNP
cord-005453-4057qib7	1152	4	CAR	CAR	NNP
cord-005453-4057qib7	1152	5	-	-	HYPH
cord-005453-4057qib7	1152	6	T	t	NN
cord-005453-4057qib7	1152	7	cells	cell	NNS
cord-005453-4057qib7	1152	8	in	in	IN
cord-005453-4057qib7	1152	9	terms	term	NNS
cord-005453-4057qib7	1152	10	of	of	IN
cord-005453-4057qib7	1152	11	viability	viability	NN
cord-005453-4057qib7	1152	12	,	,	,
cord-005453-4057qib7	1152	13	recovery	recovery	NN
cord-005453-4057qib7	1152	14	,	,	,
cord-005453-4057qib7	1152	15	transduction	transduction	NN
cord-005453-4057qib7	1152	16	efficiency	efficiency	NN
cord-005453-4057qib7	1152	17	and	and	CC
cord-005453-4057qib7	1152	18	functional	functional	JJ
cord-005453-4057qib7	1152	19	capacity	capacity	NN
cord-005453-4057qib7	1152	20	were	be	VBD
cord-005453-4057qib7	1152	21	determined	determine	VBN
cord-005453-4057qib7	1152	22	by	by	IN
cord-005453-4057qib7	1152	23	microscopy	microscopy	NNS
cord-005453-4057qib7	1152	24	,	,	,
cord-005453-4057qib7	1152	25	multi	multi	JJ
cord-005453-4057qib7	1152	26	-	-	JJ
cord-005453-4057qib7	1152	27	parametric	parametric	JJ
cord-005453-4057qib7	1152	28	flow	flow	NN
cord-005453-4057qib7	1152	29	cytometry	cytometry	NN
cord-005453-4057qib7	1152	30	as	as	RB
cord-005453-4057qib7	1152	31	well	well	RB
cord-005453-4057qib7	1152	32	as	as	IN
cord-005453-4057qib7	1152	33	chromium-51	chromium-51	NN
cord-005453-4057qib7	1152	34	release	release	NN
cord-005453-4057qib7	1152	35	tests	test	NNS
cord-005453-4057qib7	1152	36	following	follow	VBG
cord-005453-4057qib7	1152	37	our	-PRON-	PRP$
cord-005453-4057qib7	1152	38	SOPs	sop	NNS
cord-005453-4057qib7	1152	39	.	.	.
cord-005453-4057qib7	1153	1	Results	result	NNS
cord-005453-4057qib7	1153	2	:	:	:
cord-005453-4057qib7	1154	1	All	all	PDT
cord-005453-4057qib7	1154	2	the	the	DT
cord-005453-4057qib7	1154	3	results	result	NNS
cord-005453-4057qib7	1154	4	of	of	IN
cord-005453-4057qib7	1154	5	quality	quality	NN
cord-005453-4057qib7	1154	6	controls	control	NNS
cord-005453-4057qib7	1154	7	fully	fully	RB
cord-005453-4057qib7	1154	8	met	meet	VBD
cord-005453-4057qib7	1154	9	the	the	DT
cord-005453-4057qib7	1154	10	requirements	requirement	NNS
cord-005453-4057qib7	1154	11	of	of	IN
cord-005453-4057qib7	1154	12	the	the	DT
cord-005453-4057qib7	1154	13	regulatory	regulatory	JJ
cord-005453-4057qib7	1154	14	authorities	authority	NNS
cord-005453-4057qib7	1154	15	.	.	.
cord-005453-4057qib7	1155	1	Stability	stability	NN
cord-005453-4057qib7	1155	2	results	result	NNS
cord-005453-4057qib7	1155	3	were	be	VBD
cord-005453-4057qib7	1155	4	highly	highly	RB
cord-005453-4057qib7	1155	5	robust	robust	JJ
cord-005453-4057qib7	1155	6	and	and	CC
cord-005453-4057qib7	1155	7	reproducible	reproducible	JJ
cord-005453-4057qib7	1155	8	over	over	IN
cord-005453-4057qib7	1155	9	time	time	NN
cord-005453-4057qib7	1155	10	for	for	IN
cord-005453-4057qib7	1155	11	all	all	PDT
cord-005453-4057qib7	1155	12	our	-PRON-	PRP$
cord-005453-4057qib7	1155	13	GMP	GMP	NNP
cord-005453-4057qib7	1155	14	CAR	CAR	NNP
cord-005453-4057qib7	1155	15	-	-	HYPH
cord-005453-4057qib7	1155	16	T	t	NN
cord-005453-4057qib7	1155	17	batches	batch	NNS
cord-005453-4057qib7	1155	18	.	.	.
cord-005453-4057qib7	1156	1	Duration	duration	NN
cord-005453-4057qib7	1156	2	of	of	IN
cord-005453-4057qib7	1156	3	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1156	4	(	(	-LRB-
cord-005453-4057qib7	1156	5	up	up	IN
cord-005453-4057qib7	1156	6	to	to	TO
cord-005453-4057qib7	1156	7	90	90	CD
cord-005453-4057qib7	1156	8	days	day	NNS
cord-005453-4057qib7	1156	9	)	)	-RRB-
cord-005453-4057qib7	1156	10	had	have	VBD
cord-005453-4057qib7	1156	11	no	no	DT
cord-005453-4057qib7	1156	12	negative	negative	JJ
cord-005453-4057qib7	1156	13	influence	influence	NN
cord-005453-4057qib7	1156	14	on	on	IN
cord-005453-4057qib7	1156	15	cell	cell	NN
cord-005453-4057qib7	1156	16	viability	viability	NN
cord-005453-4057qib7	1156	17	,	,	,
cord-005453-4057qib7	1156	18	recovery	recovery	NN
cord-005453-4057qib7	1156	19	of	of	IN
cord-005453-4057qib7	1156	20	viable	viable	JJ
cord-005453-4057qib7	1156	21	CD19	CD19	NNP
cord-005453-4057qib7	1156	22	CAR	CAR	NNP
cord-005453-4057qib7	1156	23	-	-	HYPH
cord-005453-4057qib7	1156	24	T	t	NN
cord-005453-4057qib7	1156	25	cells	cell	NNS
cord-005453-4057qib7	1156	26	and	and	CC
cord-005453-4057qib7	1156	27	transduction	transduction	NN
cord-005453-4057qib7	1156	28	efficiency	efficiency	NN
cord-005453-4057qib7	1156	29	.	.	.
cord-005453-4057qib7	1157	1	However	however	RB
cord-005453-4057qib7	1157	2	,	,	,
cord-005453-4057qib7	1157	3	the	the	DT
cord-005453-4057qib7	1157	4	cell	cell	NN
cord-005453-4057qib7	1157	5	concentration	concentration	NN
cord-005453-4057qib7	1157	6	for	for	IN
cord-005453-4057qib7	1157	7	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1157	8	has	have	VBZ
cord-005453-4057qib7	1157	9	a	a	DT
cord-005453-4057qib7	1157	10	significant	significant	JJ
cord-005453-4057qib7	1157	11	impact	impact	NN
cord-005453-4057qib7	1157	12	on	on	IN
cord-005453-4057qib7	1157	13	the	the	DT
cord-005453-4057qib7	1157	14	post	post	JJ
cord-005453-4057qib7	1157	15	-	-	JJ
cord-005453-4057qib7	1157	16	thawing	thawing	JJ
cord-005453-4057qib7	1157	17	viability	viability	NN
cord-005453-4057qib7	1157	18	(	(	-LRB-
cord-005453-4057qib7	1157	19	low	low	JJ
cord-005453-4057qib7	1157	20	batches	batch	NNS
cord-005453-4057qib7	1157	21	vs.	vs.	IN
cord-005453-4057qib7	1157	22	high	high	JJ
cord-005453-4057qib7	1157	23	batches	batch	NNS
cord-005453-4057qib7	1157	24	:	:	:
cord-005453-4057qib7	1157	25	96.33	96.33	CD
cord-005453-4057qib7	1157	26	±	±	CD
cord-005453-4057qib7	1157	27	2.17	2.17	CD
cord-005453-4057qib7	1157	28	vs.	vs.	IN
cord-005453-4057qib7	1157	29	74.87	74.87	CD
cord-005453-4057qib7	1157	30	±	±	CD
cord-005453-4057qib7	1157	31	8.68	8.68	CD
cord-005453-4057qib7	1157	32	,	,	,
cord-005453-4057qib7	1157	33	p	p	NN
cord-005453-4057qib7	1157	34	<	<	XX
cord-005453-4057qib7	1157	35	0.05	0.05	CD
cord-005453-4057qib7	1157	36	)	)	-RRB-
cord-005453-4057qib7	1157	37	and	and	CC
cord-005453-4057qib7	1157	38	recovery	recovery	NN
cord-005453-4057qib7	1157	39	(	(	-LRB-
cord-005453-4057qib7	1157	40	low	low	JJ
cord-005453-4057qib7	1157	41	batches	batch	NNS
cord-005453-4057qib7	1157	42	vs.	vs.	IN
cord-005453-4057qib7	1157	43	high	high	JJ
cord-005453-4057qib7	1157	44	batches	batch	NNS
cord-005453-4057qib7	1157	45	:	:	:
cord-005453-4057qib7	1158	1	89.67	89.67	CD
cord-005453-4057qib7	1158	2	±	±	CD
cord-005453-4057qib7	1158	3	6.76	6.76	CD
cord-005453-4057qib7	1158	4	vs.	vs.	IN
cord-005453-4057qib7	1158	5	74.90	74.90	CD
cord-005453-4057qib7	1158	6	±	±	CD
cord-005453-4057qib7	1158	7	9.19	9.19	CD
cord-005453-4057qib7	1158	8	,	,	,
cord-005453-4057qib7	1158	9	p	p	NN
cord-005453-4057qib7	1158	10	<	<	XX
cord-005453-4057qib7	1158	11	0.05	0.05	CD
cord-005453-4057qib7	1158	12	)	)	-RRB-
cord-005453-4057qib7	1158	13	of	of	IN
cord-005453-4057qib7	1158	14	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	1158	15	CD19	CD19	NNP
cord-005453-4057qib7	1158	16	CAR	CAR	NNP
cord-005453-4057qib7	1158	17	-	-	HYPH
cord-005453-4057qib7	1158	18	T	t	NN
cord-005453-4057qib7	1158	19	cells	cell	NNS
cord-005453-4057qib7	1158	20	,	,	,
cord-005453-4057qib7	1158	21	but	but	CC
cord-005453-4057qib7	1158	22	not	not	RB
cord-005453-4057qib7	1158	23	the	the	DT
cord-005453-4057qib7	1158	24	transduction	transduction	NN
cord-005453-4057qib7	1158	25	efficiency	efficiency	NN
cord-005453-4057qib7	1158	26	.	.	.
cord-005453-4057qib7	1159	1	Moreover	moreover	RB
cord-005453-4057qib7	1159	2	,	,	,
cord-005453-4057qib7	1159	3	we	-PRON-	PRP
cord-005453-4057qib7	1159	4	observed	observe	VBD
cord-005453-4057qib7	1159	5	four	four	CD
cord-005453-4057qib7	1159	6	transient	transient	JJ
cord-005453-4057qib7	1159	7	side	side	NN
cord-005453-4057qib7	1159	8	-	-	HYPH
cord-005453-4057qib7	1159	9	effects	effect	NNS
cord-005453-4057qib7	1159	10	of	of	IN
cord-005453-4057qib7	1159	11	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1159	12	on	on	IN
cord-005453-4057qib7	1159	13	the	the	DT
cord-005453-4057qib7	1159	14	amount	amount	NN
cord-005453-4057qib7	1159	15	of	of	IN
cord-005453-4057qib7	1159	16	cytokines	cytokine	NNS
cord-005453-4057qib7	1159	17	released	release	VBN
cord-005453-4057qib7	1159	18	by	by	IN
cord-005453-4057qib7	1159	19	CAR	car	NN
cord-005453-4057qib7	1159	20	-	-	HYPH
cord-005453-4057qib7	1159	21	T	t	NN
cord-005453-4057qib7	1159	22	cells	cell	NNS
cord-005453-4057qib7	1159	23	,	,	,
cord-005453-4057qib7	1159	24	the	the	DT
cord-005453-4057qib7	1159	25	cytokine	cytokine	NN
cord-005453-4057qib7	1159	26	release	release	NN
cord-005453-4057qib7	1159	27	on	on	IN
cord-005453-4057qib7	1159	28	a	a	DT
cord-005453-4057qib7	1159	29	per	per	IN
cord-005453-4057qib7	1159	30	-	-	HYPH
cord-005453-4057qib7	1159	31	cell	cell	NN
cord-005453-4057qib7	1159	32	basis	basis	NN
cord-005453-4057qib7	1159	33	,	,	,
cord-005453-4057qib7	1159	34	the	the	DT
cord-005453-4057qib7	1159	35	multifunctionality	multifunctionality	NN
cord-005453-4057qib7	1159	36	of	of	IN
cord-005453-4057qib7	1159	37	CAR	CAR	NNP
cord-005453-4057qib7	1159	38	-	-	HYPH
cord-005453-4057qib7	1159	39	T	t	NN
cord-005453-4057qib7	1159	40	cells	cell	NNS
cord-005453-4057qib7	1159	41	and	and	CC
cord-005453-4057qib7	1159	42	the	the	DT
cord-005453-4057qib7	1159	43	killing	killing	NN
cord-005453-4057qib7	1159	44	capacity	capacity	NN
cord-005453-4057qib7	1159	45	.	.	.
cord-005453-4057qib7	1160	1	Of	of	IN
cord-005453-4057qib7	1160	2	note	note	VB
cord-005453-4057qib7	1160	3	,	,	,
cord-005453-4057qib7	1160	4	functional	functional	JJ
cord-005453-4057qib7	1160	5	capacity	capacity	NN
cord-005453-4057qib7	1160	6	of	of	IN
cord-005453-4057qib7	1160	7	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	1160	8	CAR	car	NN
cord-005453-4057qib7	1160	9	-	-	HYPH
cord-005453-4057qib7	1160	10	T	t	NN
cord-005453-4057qib7	1160	11	cells	cell	NNS
cord-005453-4057qib7	1160	12	after	after	IN
cord-005453-4057qib7	1160	13	overnight	overnight	JJ
cord-005453-4057qib7	1160	14	resting	resting	NN
cord-005453-4057qib7	1160	15	was	be	VBD
cord-005453-4057qib7	1160	16	comparable	comparable	JJ
cord-005453-4057qib7	1160	17	or	or	CC
cord-005453-4057qib7	1160	18	even	even	RB
cord-005453-4057qib7	1160	19	enhanced	enhance	VBN
cord-005453-4057qib7	1160	20	for	for	IN
cord-005453-4057qib7	1160	21	INF	INF	NNP
cord-005453-4057qib7	1160	22	-	-	HYPH
cord-005453-4057qib7	1160	23	γ	γ	NNP
cord-005453-4057qib7	1160	24	and	and	CC
cord-005453-4057qib7	1160	25	TNF	TNF	NNP
cord-005453-4057qib7	1160	26	-	-	HYPH
cord-005453-4057qib7	1160	27	α	α	NNP
cord-005453-4057qib7	1160	28	release	release	NN
cord-005453-4057qib7	1160	29	by	by	IN
cord-005453-4057qib7	1160	30	CD4	CD4	NNP
cord-005453-4057qib7	1160	31	+	+	CC
cord-005453-4057qib7	1161	1	and	and	CC
cord-005453-4057qib7	1161	2	CD8	CD8	NNP
cord-005453-4057qib7	1161	3	+	+	SYM
cord-005453-4057qib7	1161	4	CD19	CD19	NNP
cord-005453-4057qib7	1161	5	CAR	CAR	NNP
cord-005453-4057qib7	1161	6	-	-	HYPH
cord-005453-4057qib7	1161	7	T	t	NN
cord-005453-4057qib7	1161	8	cells	cell	NNS
cord-005453-4057qib7	1161	9	when	when	WRB
cord-005453-4057qib7	1161	10	compared	compare	VBN
cord-005453-4057qib7	1161	11	to	to	IN
cord-005453-4057qib7	1161	12	fresh	fresh	JJ
cord-005453-4057qib7	1161	13	CAR	car	NN
cord-005453-4057qib7	1161	14	-	-	HYPH
cord-005453-4057qib7	1161	15	T	t	NN
cord-005453-4057qib7	1161	16	cells	cell	NNS
cord-005453-4057qib7	1161	17	.	.	.
cord-005453-4057qib7	1162	1	The	the	DT
cord-005453-4057qib7	1162	2	multi	multi	JJ
cord-005453-4057qib7	1162	3	-	-	NN
cord-005453-4057qib7	1162	4	functionality	functionality	NN
cord-005453-4057qib7	1162	5	of	of	IN
cord-005453-4057qib7	1162	6	CAR	car	NN
cord-005453-4057qib7	1162	7	-	-	HYPH
cord-005453-4057qib7	1162	8	T	t	NN
cord-005453-4057qib7	1162	9	cells	cell	NNS
cord-005453-4057qib7	1162	10	could	could	MD
cord-005453-4057qib7	1162	11	be	be	VB
cord-005453-4057qib7	1162	12	preserved	preserve	VBN
cord-005453-4057qib7	1162	13	.	.	.
cord-005453-4057qib7	1163	1	Furthermore	furthermore	RB
cord-005453-4057qib7	1163	2	,	,	,
cord-005453-4057qib7	1163	3	the	the	DT
cord-005453-4057qib7	1163	4	killing	killing	NN
cord-005453-4057qib7	1163	5	capacity	capacity	NN
cord-005453-4057qib7	1163	6	of	of	IN
cord-005453-4057qib7	1163	7	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	1163	8	CD19	CD19	NNP
cord-005453-4057qib7	1163	9	CAR	CAR	NNP
cord-005453-4057qib7	1163	10	-	-	HYPH
cord-005453-4057qib7	1163	11	T	t	NN
cord-005453-4057qib7	1163	12	cells	cell	NNS
cord-005453-4057qib7	1163	13	after	after	IN
cord-005453-4057qib7	1163	14	overnight	overnight	JJ
cord-005453-4057qib7	1163	15	resting	resting	NN
cord-005453-4057qib7	1163	16	could	could	MD
cord-005453-4057qib7	1163	17	reach	reach	VB
cord-005453-4057qib7	1163	18	the	the	DT
cord-005453-4057qib7	1163	19	level	level	NN
cord-005453-4057qib7	1163	20	of	of	IN
cord-005453-4057qib7	1163	21	non	non	JJ
cord-005453-4057qib7	1163	22	-	-	JJ
cord-005453-4057qib7	1163	23	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	1163	24	/	/	SYM
cord-005453-4057qib7	1163	25	fresh	fresh	JJ
cord-005453-4057qib7	1163	26	CAR	car	NN
cord-005453-4057qib7	1163	27	-	-	HYPH
cord-005453-4057qib7	1163	28	T	t	NN
cord-005453-4057qib7	1163	29	cells	cell	NNS
cord-005453-4057qib7	1163	30	.	.	.
cord-005453-4057qib7	1164	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1164	2	:	:	:
cord-005453-4057qib7	1165	1	Cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1165	2	up	up	RB
cord-005453-4057qib7	1165	3	to	to	TO
cord-005453-4057qib7	1165	4	90	90	CD
cord-005453-4057qib7	1165	5	days	day	NNS
cord-005453-4057qib7	1165	6	has	have	VBZ
cord-005453-4057qib7	1165	7	no	no	DT
cord-005453-4057qib7	1165	8	harmful	harmful	JJ
cord-005453-4057qib7	1165	9	effect	effect	NN
cord-005453-4057qib7	1165	10	on	on	IN
cord-005453-4057qib7	1165	11	transduction	transduction	NN
cord-005453-4057qib7	1165	12	efficiency	efficiency	NN
cord-005453-4057qib7	1165	13	and	and	CC
cord-005453-4057qib7	1165	14	functionalities	functionality	NNS
cord-005453-4057qib7	1165	15	of	of	IN
cord-005453-4057qib7	1165	16	CAR	car	NN
cord-005453-4057qib7	1165	17	-	-	HYPH
cord-005453-4057qib7	1165	18	T	t	NN
cord-005453-4057qib7	1165	19	cells	cell	NNS
cord-005453-4057qib7	1165	20	.	.	.
cord-005453-4057qib7	1166	1	However	however	RB
cord-005453-4057qib7	1166	2	,	,	,
cord-005453-4057qib7	1166	3	the	the	DT
cord-005453-4057qib7	1166	4	cell	cell	NN
cord-005453-4057qib7	1166	5	number	number	NN
cord-005453-4057qib7	1166	6	per	per	IN
cord-005453-4057qib7	1166	7	milliliter	milliliter	NN
cord-005453-4057qib7	1166	8	freezing	freeze	VBG
cord-005453-4057qib7	1166	9	medium	medium	NN
cord-005453-4057qib7	1166	10	matters	matter	NNS
cord-005453-4057qib7	1166	11	.	.	.
cord-005453-4057qib7	1167	1	Dose	dose	NN
cord-005453-4057qib7	1167	2	over	over	IN
cord-005453-4057qib7	1167	3	1	1	CD
cord-005453-4057qib7	1167	4	x	x	SYM
cord-005453-4057qib7	1167	5	10	10	CD
cord-005453-4057qib7	1167	6	7	7	CD
cord-005453-4057qib7	1167	7	cells	cell	NNS
cord-005453-4057qib7	1167	8	/	/	SYM
cord-005453-4057qib7	1167	9	ml	ml	NNS
cord-005453-4057qib7	1167	10	should	should	MD
cord-005453-4057qib7	1167	11	be	be	VB
cord-005453-4057qib7	1167	12	avoided	avoid	VBN
cord-005453-4057qib7	1167	13	.	.	.
cord-005453-4057qib7	1168	1	For	for	IN
cord-005453-4057qib7	1168	2	the	the	DT
cord-005453-4057qib7	1168	3	conduction	conduction	NN
cord-005453-4057qib7	1168	4	of	of	IN
cord-005453-4057qib7	1168	5	in	in	FW
cord-005453-4057qib7	1168	6	vitro	vitro	FW
cord-005453-4057qib7	1168	7	bio	bio	NN
cord-005453-4057qib7	1168	8	-	-	HYPH
cord-005453-4057qib7	1168	9	assays	assay	NNS
cord-005453-4057qib7	1168	10	to	to	TO
cord-005453-4057qib7	1168	11	determine	determine	VB
cord-005453-4057qib7	1168	12	the	the	DT
cord-005453-4057qib7	1168	13	function	function	NN
cord-005453-4057qib7	1168	14	of	of	IN
cord-005453-4057qib7	1168	15	CAR	car	NN
cord-005453-4057qib7	1168	16	-	-	HYPH
cord-005453-4057qib7	1168	17	T	t	NN
cord-005453-4057qib7	1168	18	cells	cell	NNS
cord-005453-4057qib7	1168	19	,	,	,
cord-005453-4057qib7	1168	20	an	an	DT
cord-005453-4057qib7	1168	21	overnight	overnight	JJ
cord-005453-4057qib7	1168	22	resting	resting	NN
cord-005453-4057qib7	1168	23	process	process	NN
cord-005453-4057qib7	1168	24	could	could	MD
cord-005453-4057qib7	1168	25	mimic	mimic	VB
cord-005453-4057qib7	1168	26	the	the	DT
cord-005453-4057qib7	1168	27	situation	situation	NN
cord-005453-4057qib7	1168	28	after	after	IN
cord-005453-4057qib7	1168	29	clinical	clinical	JJ
cord-005453-4057qib7	1168	30	application	application	NN
cord-005453-4057qib7	1168	31	and	and	CC
cord-005453-4057qib7	1168	32	eliminate	eliminate	VB
cord-005453-4057qib7	1168	33	the	the	DT
cord-005453-4057qib7	1168	34	transient	transient	JJ
cord-005453-4057qib7	1168	35	side	side	NN
cord-005453-4057qib7	1168	36	-	-	HYPH
cord-005453-4057qib7	1168	37	effects	effect	NNS
cord-005453-4057qib7	1168	38	of	of	IN
cord-005453-4057qib7	1168	39	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1168	40	to	to	TO
cord-005453-4057qib7	1168	41	fully	fully	RB
cord-005453-4057qib7	1168	42	regain	regain	VB
cord-005453-4057qib7	1168	43	the	the	DT
cord-005453-4057qib7	1168	44	functional	functional	JJ
cord-005453-4057qib7	1168	45	potency	potency	NN
cord-005453-4057qib7	1168	46	of	of	IN
cord-005453-4057qib7	1168	47	CAR	car	NN
cord-005453-4057qib7	1168	48	-	-	HYPH
cord-005453-4057qib7	1168	49	T	t	NN
cord-005453-4057qib7	1168	50	cells	cell	NNS
cord-005453-4057qib7	1168	51	.	.	.
cord-005453-4057qib7	1169	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1169	2	:	:	:
cord-005453-4057qib7	1169	3	Nothing	nothing	NN
cord-005453-4057qib7	1169	4	to	to	TO
cord-005453-4057qib7	1169	5	declare	declare	VB
cord-005453-4057qib7	1169	6	Background	background	NN
cord-005453-4057qib7	1169	7	:	:	:
cord-005453-4057qib7	1169	8	DC	DC	NNP
cord-005453-4057qib7	1169	9	and	and	CC
cord-005453-4057qib7	1169	10	specific	specific	JJ
cord-005453-4057qib7	1169	11	T	t	NN
cord-005453-4057qib7	1169	12	-	-	HYPH
cord-005453-4057qib7	1169	13	cells	cell	NNS
cord-005453-4057qib7	1169	14	are	be	VBP
cord-005453-4057qib7	1169	15	important	important	JJ
cord-005453-4057qib7	1169	16	mediators	mediator	NNS
cord-005453-4057qib7	1169	17	of	of	IN
cord-005453-4057qib7	1169	18	CTL	CTL	NNP
cord-005453-4057qib7	1169	19	-	-	HYPH
cord-005453-4057qib7	1169	20	responses	response	NNS
cord-005453-4057qib7	1169	21	.	.	.
cord-005453-4057qib7	1170	1	We	-PRON-	PRP
cord-005453-4057qib7	1170	2	could	could	MD
cord-005453-4057qib7	1170	3	already	already	RB
cord-005453-4057qib7	1170	4	show	show	VB
cord-005453-4057qib7	1170	5	that	that	IN
cord-005453-4057qib7	1170	6	allogeneic	allogeneic	NN
cord-005453-4057qib7	1170	7	donor	donor	NN
cord-005453-4057qib7	1170	8	-	-	HYPH
cord-005453-4057qib7	1170	9	or	or	CC
cord-005453-4057qib7	1170	10	autologous	autologous	JJ
cord-005453-4057qib7	1170	11	T	t	NN
cord-005453-4057qib7	1170	12	-	-	HYPH
cord-005453-4057qib7	1170	13	cells	cell	NNS
cord-005453-4057qib7	1170	14	obtained	obtain	VBN
cord-005453-4057qib7	1170	15	from	from	IN
cord-005453-4057qib7	1170	16	AMLpatients	amlpatient	NNS
cord-005453-4057qib7	1170	17	can	can	MD
cord-005453-4057qib7	1170	18	be	be	VB
cord-005453-4057qib7	1170	19	stimulated	stimulate	VBN
cord-005453-4057qib7	1170	20	by	by	IN
cord-005453-4057qib7	1170	21	DC	DC	NNP
cord-005453-4057qib7	1170	22	leu	leu	NNP
cord-005453-4057qib7	1170	23	,	,	,
cord-005453-4057qib7	1170	24	resulting	result	VBG
cord-005453-4057qib7	1170	25	in	in	IN
cord-005453-4057qib7	1170	26	a	a	DT
cord-005453-4057qib7	1170	27	very	very	RB
cord-005453-4057qib7	1170	28	efficient	efficient	JJ
cord-005453-4057qib7	1170	29	lysis	lysis	NN
cord-005453-4057qib7	1170	30	of	of	IN
cord-005453-4057qib7	1170	31	naive	naive	JJ
cord-005453-4057qib7	1170	32	blasts	blast	NNS
cord-005453-4057qib7	1170	33	.	.	.
cord-005453-4057qib7	1171	1	Methods	method	NNS
cord-005453-4057qib7	1171	2	:	:	:
cord-005453-4057qib7	1171	3	Chemokine	Chemokine	NNP
cord-005453-4057qib7	1171	4	-	-	HYPH
cord-005453-4057qib7	1171	5	release	release	NN
cord-005453-4057qib7	1171	6	(	(	-LRB-
cord-005453-4057qib7	1171	7	CXCL8	CXCL8	NNP
cord-005453-4057qib7	1171	8	,	,	,
cord-005453-4057qib7	1171	9	-9	-9	NNP
cord-005453-4057qib7	1171	10	,	,	,
cord-005453-4057qib7	1171	11	-10	-10	NNP
cord-005453-4057qib7	1171	12	,	,	,
cord-005453-4057qib7	1171	13	CCL2	CCL2	NNP
cord-005453-4057qib7	1171	14	,	,	,
cord-005453-4057qib7	1171	15	-5	-5	NNP
cord-005453-4057qib7	1171	16	,	,	,
cord-005453-4057qib7	1171	17	and	and	CC
cord-005453-4057qib7	1171	18	IL-12	IL-12	NNP
cord-005453-4057qib7	1171	19	)	)	-RRB-
cord-005453-4057qib7	1171	20	was	be	VBD
cord-005453-4057qib7	1171	21	analysed	analyse	VBN
cord-005453-4057qib7	1171	22	by	by	IN
cord-005453-4057qib7	1171	23	cytometric	cytometric	NNP
cord-005453-4057qib7	1171	24	bead	bead	NN
cord-005453-4057qib7	1171	25	array	array	NN
cord-005453-4057qib7	1171	26	in	in	IN
cord-005453-4057qib7	1171	27	serum	serum	NN
cord-005453-4057qib7	1171	28	of	of	IN
cord-005453-4057qib7	1171	29	AML	AML	NNP
cord-005453-4057qib7	1171	30	/	/	SYM
cord-005453-4057qib7	1171	31	MDS	MDS	NNP
cord-005453-4057qib7	1171	32	-	-	HYPH
cord-005453-4057qib7	1171	33	pts	pts	NNP
cord-005453-4057qib7	1171	34	as	as	RB
cord-005453-4057qib7	1171	35	well	well	RB
cord-005453-4057qib7	1171	36	as	as	IN
cord-005453-4057qib7	1171	37	in	in	IN
cord-005453-4057qib7	1171	38	supernatants	supernatant	NNS
cord-005453-4057qib7	1171	39	from	from	IN
cord-005453-4057qib7	1171	40	5	5	CD
cord-005453-4057qib7	1171	41	different	different	JJ
cord-005453-4057qib7	1171	42	DC	DC	NNP
cord-005453-4057qib7	1171	43	-	-	HYPH
cord-005453-4057qib7	1171	44	generating	generate	VBG
cord-005453-4057qib7	1171	45	-	-	HYPH
cord-005453-4057qib7	1171	46	methods	method	NNS
cord-005453-4057qib7	1171	47	and	and	CC
cord-005453-4057qib7	1171	48	correlated	correlate	VBN
cord-005453-4057qib7	1171	49	with	with	IN
cord-005453-4057qib7	1171	50	pts	pts	NN
cord-005453-4057qib7	1171	51	'	'	POS
cord-005453-4057qib7	1171	52	clinical	clinical	JJ
cord-005453-4057qib7	1171	53	course	course	NN
cord-005453-4057qib7	1171	54	,	,	,
cord-005453-4057qib7	1171	55	DC	DC	NNP
cord-005453-4057qib7	1171	56	-	-	:
cord-005453-4057qib7	1171	57	and	and	CC
cord-005453-4057qib7	1171	58	T	t	NN
cord-005453-4057qib7	1171	59	-	-	HYPH
cord-005453-4057qib7	1171	60	cell	cell	NN
cord-005453-4057qib7	1171	61	-	-	HYPH
cord-005453-4057qib7	1171	62	interactions	interaction	NNS
cord-005453-4057qib7	1171	63	as	as	RB
cord-005453-4057qib7	1171	64	well	well	RB
cord-005453-4057qib7	1171	65	as	as	IN
cord-005453-4057qib7	1171	66	specific	specific	JJ
cord-005453-4057qib7	1171	67	T	t	NN
cord-005453-4057qib7	1171	68	-	-	HYPH
cord-005453-4057qib7	1171	69	cell	cell	NN
cord-005453-4057qib7	1171	70	-	-	HYPH
cord-005453-4057qib7	1171	71	reactions	reaction	NNS
cord-005453-4057qib7	1171	72	.	.	.
cord-005453-4057qib7	1172	1	The	the	DT
cord-005453-4057qib7	1172	2	lytic	lytic	JJ
cord-005453-4057qib7	1172	3	activity	activity	NN
cord-005453-4057qib7	1172	4	of	of	IN
cord-005453-4057qib7	1172	5	DCleu	DCleu	NNP
cord-005453-4057qib7	1172	6	/	/	SYM
cord-005453-4057qib7	1172	7	blast	blast	NN
cord-005453-4057qib7	1172	8	-stimulated	-stimulated	NNP
cord-005453-4057qib7	1172	9	T	T	NNP
cord-005453-4057qib7	1172	10	-	-	HYPH
cord-005453-4057qib7	1172	11	cells	cell	NNS
cord-005453-4057qib7	1172	12	in	in	IN
cord-005453-4057qib7	1172	13	MLC	MLC	NNP
cord-005453-4057qib7	1172	14	against	against	IN
cord-005453-4057qib7	1172	15	naive	naive	JJ
cord-005453-4057qib7	1172	16	blasts	blast	NNS
cord-005453-4057qib7	1172	17	was	be	VBD
cord-005453-4057qib7	1172	18	quantified	quantify	VBN
cord-005453-4057qib7	1172	19	in	in	IN
cord-005453-4057qib7	1172	20	a	a	DT
cord-005453-4057qib7	1172	21	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1172	22	assay	assay	NN
cord-005453-4057qib7	1172	23	.	.	.
cord-005453-4057qib7	1173	1	Results	result	NNS
cord-005453-4057qib7	1173	2	:	:	:
cord-005453-4057qib7	1174	1	Minimal	minimal	JJ
cord-005453-4057qib7	1174	2	differences	difference	NNS
cord-005453-4057qib7	1174	3	in	in	IN
cord-005453-4057qib7	1174	4	median	median	JJ
cord-005453-4057qib7	1174	5	chemokine	chemokine	NN
cord-005453-4057qib7	1174	6	-	-	HYPH
cord-005453-4057qib7	1174	7	levels	level	NNS
cord-005453-4057qib7	1174	8	in	in	IN
cord-005453-4057qib7	1174	9	pts	pts	NN
cord-005453-4057qib7	1174	10	'	'	POS
cord-005453-4057qib7	1174	11	serum	serum	NN
cord-005453-4057qib7	1174	12	subdivided	subdivide	VBN
cord-005453-4057qib7	1174	13	in	in	IN
cord-005453-4057qib7	1174	14	subtypes	subtype	NNS
cord-005453-4057qib7	1174	15	were	be	VBD
cord-005453-4057qib7	1174	16	seen	see	VBN
cord-005453-4057qib7	1174	17	,	,	,
cord-005453-4057qib7	1174	18	but	but	CC
cord-005453-4057qib7	1174	19	higher	high	JJR
cord-005453-4057qib7	1174	20	release	release	NN
cord-005453-4057qib7	1174	21	of	of	IN
cord-005453-4057qib7	1174	22	CXCL8	cxcl8	NN
cord-005453-4057qib7	1174	23	,	,	,
cord-005453-4057qib7	1174	24	-9	-9	NNP
cord-005453-4057qib7	1174	25	,	,	,
cord-005453-4057qib7	1174	26	-10	-10	NN
cord-005453-4057qib7	1174	27	and	and	CC
cord-005453-4057qib7	1174	28	lower	low	JJR
cord-005453-4057qib7	1174	29	release	release	NN
cord-005453-4057qib7	1174	30	of	of	IN
cord-005453-4057qib7	1174	31	CCL2	CCL2	NNP
cord-005453-4057qib7	1174	32	and	and	CC
cord-005453-4057qib7	1174	33	-5	-5	NNP
cord-005453-4057qib7	1175	1	tendentially	tendentially	RB
cord-005453-4057qib7	1175	2	correlated	correlate	VBD
cord-005453-4057qib7	1175	3	with	with	IN
cord-005453-4057qib7	1175	4	more	more	RBR
cord-005453-4057qib7	1175	5	favourable	favourable	JJ
cord-005453-4057qib7	1175	6	subtypes	subtype	NNS
cord-005453-4057qib7	1175	7	(	(	-LRB-
cord-005453-4057qib7	1175	8	<	<	XX
cord-005453-4057qib7	1175	9	50	50	CD
cord-005453-4057qib7	1175	10	years	year	NNS
cord-005453-4057qib7	1175	11	of	of	IN
cord-005453-4057qib7	1175	12	age	age	NN
cord-005453-4057qib7	1175	13	,	,	,
cord-005453-4057qib7	1175	14	<	<	XX
cord-005453-4057qib7	1175	15	80	80	CD
cord-005453-4057qib7	1175	16	%	%	NN
cord-005453-4057qib7	1175	17	blasts	blast	NNS
cord-005453-4057qib7	1175	18	in	in	IN
cord-005453-4057qib7	1175	19	PB	PB	NNP
cord-005453-4057qib7	1175	20	)	)	-RRB-
cord-005453-4057qib7	1175	21	.	.	.
cord-005453-4057qib7	1176	1	In	in	IN
cord-005453-4057qib7	1176	2	persisting	persist	VBG
cord-005453-4057qib7	1176	3	disease	disease	NN
cord-005453-4057qib7	1176	4	,	,	,
cord-005453-4057qib7	1176	5	a	a	DT
cord-005453-4057qib7	1176	6	higher	high	JJR
cord-005453-4057qib7	1176	7	serum	serum	NN
cord-005453-4057qib7	1176	8	-	-	HYPH
cord-005453-4057qib7	1176	9	release	release	NN
cord-005453-4057qib7	1176	10	of	of	IN
cord-005453-4057qib7	1176	11	CCL5	CCL5	NNP
cord-005453-4057qib7	1176	12	and	and	CC
cord-005453-4057qib7	1176	13	at	at	IN
cord-005453-4057qib7	1176	14	relapse	relapse	NN
cord-005453-4057qib7	1176	15	a	a	DT
cord-005453-4057qib7	1176	16	significantly	significantly	RB
cord-005453-4057qib7	1176	17	higher	high	JJR
cord-005453-4057qib7	1176	18	CCL2-release	CCL2-release	NNP
cord-005453-4057qib7	1176	19	were	be	VBD
cord-005453-4057qib7	1176	20	found	find	VBN
cord-005453-4057qib7	1176	21	compared	compare	VBN
cord-005453-4057qib7	1176	22	to	to	IN
cord-005453-4057qib7	1176	23	first	first	JJ
cord-005453-4057qib7	1176	24	diagnosis	diagnosis	NN
cord-005453-4057qib7	1176	25	-pointing	-pointe	VBG
cord-005453-4057qib7	1176	26	to	to	IN
cord-005453-4057qib7	1176	27	a	a	DT
cord-005453-4057qib7	1176	28	change	change	NN
cord-005453-4057qib7	1176	29	of	of	IN
cord-005453-4057qib7	1176	30	'	'	``
cord-005453-4057qib7	1176	31	disease	disease	NN
cord-005453-4057qib7	1176	32	activity	activity	NN
cord-005453-4057qib7	1176	33	'	'	''
cord-005453-4057qib7	1176	34	on	on	IN
cord-005453-4057qib7	1176	35	a	a	DT
cord-005453-4057qib7	1176	36	chemokine	chemokine	NN
cord-005453-4057qib7	1176	37	level	level	NN
cord-005453-4057qib7	1176	38	.	.	.
cord-005453-4057qib7	1177	1	Whereas	whereas	IN
cord-005453-4057qib7	1177	2	chemokine	chemokine	NN
cord-005453-4057qib7	1177	3	-	-	HYPH
cord-005453-4057qib7	1177	4	levels	level	NNS
cord-005453-4057qib7	1177	5	in	in	IN
cord-005453-4057qib7	1177	6	DC	DC	NNP
cord-005453-4057qib7	1177	7	-	-	HYPH
cord-005453-4057qib7	1177	8	culture	culture	NN
cord-005453-4057qib7	1177	9	supernatants	supernatant	NNS
cord-005453-4057qib7	1177	10	compared	compare	VBN
cord-005453-4057qib7	1177	11	to	to	IN
cord-005453-4057qib7	1177	12	serum	serum	NN
cord-005453-4057qib7	1177	13	were	be	VBD
cord-005453-4057qib7	1177	14	variable	variable	JJ
cord-005453-4057qib7	1177	15	,	,	,
cord-005453-4057qib7	1177	16	clear	clear	JJ
cord-005453-4057qib7	1177	17	correlations	correlation	NNS
cord-005453-4057qib7	1177	18	with	with	IN
cord-005453-4057qib7	1177	19	lateron	lateron	RB
cord-005453-4057qib7	1177	20	(	(	-LRB-
cord-005453-4057qib7	1177	21	after	after	IN
cord-005453-4057qib7	1177	22	stimulating	stimulate	VBG
cord-005453-4057qib7	1177	23	T	t	NN
cord-005453-4057qib7	1177	24	-	-	HYPH
cord-005453-4057qib7	1177	25	cells	cell	NNS
cord-005453-4057qib7	1177	26	with	with	IN
cord-005453-4057qib7	1177	27	DCleu	DCleu	NNP
cord-005453-4057qib7	1177	28	in	in	IN
cord-005453-4057qib7	1177	29	MLC	MLC	NNP
cord-005453-4057qib7	1177	30	)	)	-RRB-
cord-005453-4057qib7	1177	31	improved	improve	VBD
cord-005453-4057qib7	1177	32	antileukemic	antileukemic	NNP
cord-005453-4057qib7	1177	33	T	t	NN
cord-005453-4057qib7	1177	34	-	-	HYPH
cord-005453-4057qib7	1177	35	cell	cell	NN
cord-005453-4057qib7	1177	36	activity	activity	NN
cord-005453-4057qib7	1177	37	were	be	VBD
cord-005453-4057qib7	1177	38	seen	see	VBN
cord-005453-4057qib7	1177	39	:	:	:
cord-005453-4057qib7	1177	40	higher	high	JJR
cord-005453-4057qib7	1177	41	values	value	NNS
cord-005453-4057qib7	1177	42	of	of	IN
cord-005453-4057qib7	1177	43	all	all	DT
cord-005453-4057qib7	1177	44	chemokines	chemokine	NNS
cord-005453-4057qib7	1177	45	in	in	IN
cord-005453-4057qib7	1177	46	DC	DC	NNP
cord-005453-4057qib7	1177	47	-	-	HYPH
cord-005453-4057qib7	1177	48	culture	culture	NN
cord-005453-4057qib7	1177	49	supernatants	supernatant	NNS
cord-005453-4057qib7	1177	50	always	always	RB
cord-005453-4057qib7	1177	51	correlated	correlate	VBD
cord-005453-4057qib7	1177	52	with	with	IN
cord-005453-4057qib7	1177	53	improved	improved	JJ
cord-005453-4057qib7	1177	54	T	T	NNP
cord-005453-4057qib7	1177	55	-	-	HYPH
cord-005453-4057qib7	1177	56	cells	cell	NNS
cord-005453-4057qib7	1177	57	'	'	POS
cord-005453-4057qib7	1177	58	antileukemic	antileukemic	NN
cord-005453-4057qib7	1177	59	activity	activity	NN
cord-005453-4057qib7	1177	60	(	(	-LRB-
cord-005453-4057qib7	1177	61	compared	compare	VBN
cord-005453-4057qib7	1177	62	to	to	IN
cord-005453-4057qib7	1177	63	stimulation	stimulation	NN
cord-005453-4057qib7	1177	64	with	with	IN
cord-005453-4057qib7	1177	65	blast	blast	NN
cord-005453-4057qib7	1177	66	-	-	HYPH
cord-005453-4057qib7	1177	67	containing	contain	VBG
cord-005453-4057qib7	1177	68	MNC	MNC	NNP
cord-005453-4057qib7	1177	69	as	as	IN
cord-005453-4057qib7	1177	70	control	control	NN
cord-005453-4057qib7	1177	71	)	)	-RRB-
cord-005453-4057qib7	1178	1	-whereas	-whereas	RB
cord-005453-4057qib7	1179	1	with	with	IN
cord-005453-4057qib7	1179	2	respect	respect	NN
cord-005453-4057qib7	1179	3	to	to	IN
cord-005453-4057qib7	1179	4	the	the	DT
cord-005453-4057qib7	1179	5	corresponding	correspond	VBG
cord-005453-4057qib7	1179	6	serum	serum	NN
cord-005453-4057qib7	1179	7	values	value	NNS
cord-005453-4057qib7	1179	8	higher	high	JJR
cord-005453-4057qib7	1179	9	release	release	NN
cord-005453-4057qib7	1179	10	of	of	IN
cord-005453-4057qib7	1179	11	CXCL8	cxcl8	NN
cord-005453-4057qib7	1179	12	,	,	,
cord-005453-4057qib7	1179	13	-9	-9	NNP
cord-005453-4057qib7	1179	14	,	,	,
cord-005453-4057qib7	1179	15	and	and	CC
cord-005453-4057qib7	1179	16	-10	-10	NN
cord-005453-4057qib7	1180	1	but	but	CC
cord-005453-4057qib7	1180	2	lower	low	JJR
cord-005453-4057qib7	1180	3	values	value	NNS
cord-005453-4057qib7	1180	4	of	of	IN
cord-005453-4057qib7	1180	5	CCL5	CCL5	NNP
cord-005453-4057qib7	1180	6	and	and	CC
cord-005453-4057qib7	1181	1	-2	-2	NNP
cord-005453-4057qib7	1181	2	correlated	correlate	VBN
cord-005453-4057qib7	1181	3	with	with	IN
cord-005453-4057qib7	1181	4	higher	high	JJR
cord-005453-4057qib7	1181	5	probabilities	probability	NNS
cord-005453-4057qib7	1181	6	to	to	TO
cord-005453-4057qib7	1181	7	improve	improve	VB
cord-005453-4057qib7	1181	8	antileukemic	antileukemic	JJ
cord-005453-4057qib7	1181	9	activity	activity	NN
cord-005453-4057qib7	1181	10	of	of	IN
cord-005453-4057qib7	1181	11	DCleu	DCleu	NNP
cord-005453-4057qib7	1181	12	-	-	HYPH
cord-005453-4057qib7	1181	13	stimulated	stimulate	VBN
cord-005453-4057qib7	1181	14	(	(	-LRB-
cord-005453-4057qib7	1181	15	vs.	vs.	FW
cord-005453-4057qib7	1181	16	blaststimulated	blaststimulated	JJ
cord-005453-4057qib7	1181	17	)	)	-RRB-
cord-005453-4057qib7	1181	18	T	t	NN
cord-005453-4057qib7	1181	19	-	-	HYPH
cord-005453-4057qib7	1181	20	cells	cell	NNS
cord-005453-4057qib7	1181	21	.	.	.
cord-005453-4057qib7	1182	1	Predictive	predictive	JJ
cord-005453-4057qib7	1182	2	significant	significant	JJ
cord-005453-4057qib7	1182	3	cut	cut	VBN
cord-005453-4057qib7	1182	4	-	-	HYPH
cord-005453-4057qib7	1182	5	off	off	RP
cord-005453-4057qib7	1182	6	-	-	HYPH
cord-005453-4057qib7	1182	7	values	value	NNS
cord-005453-4057qib7	1182	8	could	could	MD
cord-005453-4057qib7	1182	9	be	be	VB
cord-005453-4057qib7	1182	10	evaluated	evaluate	VBN
cord-005453-4057qib7	1182	11	separating	separate	VBG
cord-005453-4057qib7	1182	12	the	the	DT
cord-005453-4057qib7	1182	13	groups	group	NNS
cord-005453-4057qib7	1182	14	compared	compare	VBN
cord-005453-4057qib7	1182	15	.	.	.
cord-005453-4057qib7	1183	1	Moreover	moreover	RB
cord-005453-4057qib7	1183	2	,	,	,
cord-005453-4057qib7	1183	3	correlations	correlation	NNS
cord-005453-4057qib7	1183	4	with	with	IN
cord-005453-4057qib7	1183	5	lateron	lateron	RB
cord-005453-4057qib7	1183	6	achieved	achieve	VBN
cord-005453-4057qib7	1183	7	response	response	NN
cord-005453-4057qib7	1183	8	to	to	IN
cord-005453-4057qib7	1183	9	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1183	10	and	and	CC
cord-005453-4057qib7	1183	11	occurrence	occurrence	NN
cord-005453-4057qib7	1183	12	of	of	IN
cord-005453-4057qib7	1183	13	GVHD	GVHD	NNP
cord-005453-4057qib7	1183	14	were	be	VBD
cord-005453-4057qib7	1183	15	seen	see	VBN
cord-005453-4057qib7	1183	16	:	:	:
cord-005453-4057qib7	1183	17	Higher	high	JJR
cord-005453-4057qib7	1183	18	serum	serum	NN
cord-005453-4057qib7	1183	19	values	value	NNS
cord-005453-4057qib7	1183	20	of	of	IN
cord-005453-4057qib7	1183	21	CXCL8	cxcl8	NN
cord-005453-4057qib7	1183	22	,	,	,
cord-005453-4057qib7	1183	23	-9	-9	NNP
cord-005453-4057qib7	1183	24	,	,	,
cord-005453-4057qib7	1183	25	-10	-10	NNP
cord-005453-4057qib7	1183	26	and	and	CC
cord-005453-4057qib7	1183	27	CCL2	CCL2	NNP
cord-005453-4057qib7	1183	28	and	and	CC
cord-005453-4057qib7	1183	29	lower	low	JJR
cord-005453-4057qib7	1183	30	values	value	NNS
cord-005453-4057qib7	1183	31	of	of	IN
cord-005453-4057qib7	1183	32	CCL5	CCL5	NNP
cord-005453-4057qib7	1183	33	correlated	correlate	VBN
cord-005453-4057qib7	1183	34	with	with	IN
cord-005453-4057qib7	1183	35	achieved	achieve	VBN
cord-005453-4057qib7	1183	36	response	response	NN
cord-005453-4057qib7	1183	37	to	to	IN
cord-005453-4057qib7	1183	38	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1183	39	.	.	.
cord-005453-4057qib7	1184	1	Predictive	predictive	JJ
cord-005453-4057qib7	1184	2	cut	cut	VBN
cord-005453-4057qib7	1184	3	-	-	HYPH
cord-005453-4057qib7	1184	4	off	off	RP
cord-005453-4057qib7	1184	5	-	-	HYPH
cord-005453-4057qib7	1184	6	values	value	NNS
cord-005453-4057qib7	1184	7	could	could	MD
cord-005453-4057qib7	1184	8	be	be	VB
cord-005453-4057qib7	1184	9	evaluated	evaluate	VBN
cord-005453-4057qib7	1184	10	separating	separate	VBG
cord-005453-4057qib7	1184	11	the	the	DT
cord-005453-4057qib7	1184	12	groups	group	NNS
cord-005453-4057qib7	1184	13	compared	compare	VBN
cord-005453-4057qib7	1184	14	in	in	RP
cord-005453-4057qib7	1184	15	'	'	``
cord-005453-4057qib7	1184	16	responders	responder	NNS
cord-005453-4057qib7	1184	17	'	'	POS
cord-005453-4057qib7	1184	18	and	and	CC
cord-005453-4057qib7	1184	19	'	'	``
cord-005453-4057qib7	1184	20	non	non	NNS
cord-005453-4057qib7	1184	21	-	-	NNS
cord-005453-4057qib7	1184	22	responders	responder	NNS
cord-005453-4057qib7	1184	23	'	'	''
cord-005453-4057qib7	1184	24	.	.	.
cord-005453-4057qib7	1185	1	Higher	high	JJR
cord-005453-4057qib7	1185	2	levels	level	NNS
cord-005453-4057qib7	1185	3	of	of	IN
cord-005453-4057qib7	1185	4	CCL2	CCL2	NNP
cord-005453-4057qib7	1185	5	and	and	CC
cord-005453-4057qib7	1185	6	-5	-5	NNP
cord-005453-4057qib7	1185	7	but	but	CC
cord-005453-4057qib7	1185	8	lower	low	JJR
cord-005453-4057qib7	1185	9	levels	level	NNS
cord-005453-4057qib7	1185	10	of	of	IN
cord-005453-4057qib7	1185	11	CXCL8	cxcl8	NN
cord-005453-4057qib7	1185	12	,	,	,
cord-005453-4057qib7	1185	13	-9	-9	NNP
cord-005453-4057qib7	1185	14	,	,	,
cord-005453-4057qib7	1185	15	-10	-10	NNP
cord-005453-4057qib7	1185	16	correlated	correlate	VBN
cord-005453-4057qib7	1185	17	with	with	IN
cord-005453-4057qib7	1185	18	occurrence	occurrence	NN
cord-005453-4057qib7	1185	19	of	of	IN
cord-005453-4057qib7	1185	20	GVHD	GVHD	NNP
cord-005453-4057qib7	1185	21	.	.	.
cord-005453-4057qib7	1186	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1186	2	:	:	:
cord-005453-4057qib7	1187	1	We	-PRON-	PRP
cord-005453-4057qib7	1187	2	conclude	conclude	VBP
cord-005453-4057qib7	1187	3	,	,	,
cord-005453-4057qib7	1187	4	that	that	IN
cord-005453-4057qib7	1187	5	in	in	IN
cord-005453-4057qib7	1187	6	AML	AML	NNP
cord-005453-4057qib7	1187	7	-	-	HYPH
cord-005453-4057qib7	1187	8	pts	pts	NNP
cord-005453-4057qib7	1187	9	'	'	POS
cord-005453-4057qib7	1187	10	serum	serum	NN
cord-005453-4057qib7	1187	11	higher	high	JJR
cord-005453-4057qib7	1187	12	values	value	NNS
cord-005453-4057qib7	1187	13	of	of	IN
cord-005453-4057qib7	1187	14	CXCL8	cxcl8	NN
cord-005453-4057qib7	1187	15	,	,	,
cord-005453-4057qib7	1187	16	-9	-9	NNP
cord-005453-4057qib7	1187	17	,	,	,
cord-005453-4057qib7	1187	18	-10	-10	NN
cord-005453-4057qib7	1187	19	and	and	CC
cord-005453-4057qib7	1187	20	lower	low	JJR
cord-005453-4057qib7	1187	21	values	value	NNS
cord-005453-4057qib7	1187	22	of	of	IN
cord-005453-4057qib7	1187	23	CCL5	CCL5	NNP
cord-005453-4057qib7	1187	24	and	and	CC
cord-005453-4057qib7	1187	25	in	in	IN
cord-005453-4057qib7	1187	26	part	part	NN
cord-005453-4057qib7	1187	27	of	of	IN
cord-005453-4057qib7	1187	28	CCL2	CCL2	NNP
cord-005453-4057qib7	1187	29	correlate	correlate	VBP
cord-005453-4057qib7	1187	30	with	with	IN
cord-005453-4057qib7	1187	31	more	more	RBR
cord-005453-4057qib7	1187	32	favorable	favorable	JJ
cord-005453-4057qib7	1187	33	subtypes	subtype	NNS
cord-005453-4057qib7	1187	34	and	and	CC
cord-005453-4057qib7	1187	35	improved	improve	VBN
cord-005453-4057qib7	1187	36	antitumor'-reactive	antitumor'-reactive	JJ
cord-005453-4057qib7	1187	37	function	function	NN
cord-005453-4057qib7	1187	38	.	.	.
cord-005453-4057qib7	1188	1	Since	since	IN
cord-005453-4057qib7	1188	2	in	in	IN
cord-005453-4057qib7	1188	3	DCculture	DCculture	NNP
cord-005453-4057qib7	1188	4	supernatants	supernatant	NNS
cord-005453-4057qib7	1188	5	higher	high	JJR
cord-005453-4057qib7	1188	6	values	value	NNS
cord-005453-4057qib7	1188	7	of	of	IN
cord-005453-4057qib7	1188	8	all	all	DT
cord-005453-4057qib7	1188	9	chemokines	chemokine	NNS
cord-005453-4057qib7	1188	10	correlated	correlate	VBN
cord-005453-4057qib7	1188	11	with	with	IN
cord-005453-4057qib7	1188	12	improved	improve	VBN
cord-005453-4057qib7	1188	13	antileukemic	antileukemic	NNP
cord-005453-4057qib7	1188	14	T	t	NN
cord-005453-4057qib7	1188	15	-	-	HYPH
cord-005453-4057qib7	1188	16	cell	cell	NN
cord-005453-4057qib7	1188	17	reactivity	reactivity	NN
cord-005453-4057qib7	1188	18	we	-PRON-	PRP
cord-005453-4057qib7	1188	19	conclude	conclude	VBP
cord-005453-4057qib7	1188	20	a	a	DT
cord-005453-4057qib7	1188	21	change	change	NN
cord-005453-4057qib7	1188	22	of	of	IN
cord-005453-4057qib7	1188	23	functionality	functionality	NN
cord-005453-4057qib7	1188	24	of	of	IN
cord-005453-4057qib7	1188	25	CCL5	CCL5	NNP
cord-005453-4057qib7	1188	26	and	and	CC
cord-005453-4057qib7	1188	27	-2	-2	CD
cord-005453-4057qib7	1188	28	from	from	IN
cord-005453-4057qib7	1188	29	an	an	DT
cord-005453-4057qib7	1188	30	'	'	``
cord-005453-4057qib7	1188	31	inflammatory	inflammatory	JJ
cord-005453-4057qib7	1188	32	'	'	''
cord-005453-4057qib7	1188	33	or	or	CC
cord-005453-4057qib7	1188	34	'	'	``
cord-005453-4057qib7	1188	35	tumor	tumor	NN
cord-005453-4057qib7	1188	36	-	-	HYPH
cord-005453-4057qib7	1188	37	promoting	promote	VBG
cord-005453-4057qib7	1188	38	'	'	''
cord-005453-4057qib7	1188	39	to	to	IN
cord-005453-4057qib7	1188	40	an	an	DT
cord-005453-4057qib7	1188	41	'	'	``
cord-005453-4057qib7	1188	42	antitumor'reactive	antitumor'reactive	NN
cord-005453-4057qib7	1188	43	function	function	NN
cord-005453-4057qib7	1188	44	.	.	.
cord-005453-4057qib7	1189	1	This	this	DT
cord-005453-4057qib7	1189	2	knowledge	knowledge	NN
cord-005453-4057qib7	1189	3	can	can	MD
cord-005453-4057qib7	1189	4	contribute	contribute	VB
cord-005453-4057qib7	1189	5	to	to	TO
cord-005453-4057qib7	1189	6	develop	develop	VB
cord-005453-4057qib7	1189	7	immune	immune	NN
cord-005453-4057qib7	1189	8	-	-	HYPH
cord-005453-4057qib7	1189	9	modifying	modify	VBG
cord-005453-4057qib7	1189	10	strategies	strategy	NNS
cord-005453-4057qib7	1189	11	that	that	WDT
cord-005453-4057qib7	1189	12	promote	promote	VBP
cord-005453-4057qib7	1189	13	antileukemic	antileukemic	JJ
cord-005453-4057qib7	1189	14	adaptive	adaptive	JJ
cord-005453-4057qib7	1189	15	immune	immune	NN
cord-005453-4057qib7	1189	16	-	-	HYPH
cord-005453-4057qib7	1189	17	responses	response	NNS
cord-005453-4057qib7	1189	18	.	.	.
cord-005453-4057qib7	1190	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1190	2	:	:	:
cord-005453-4057qib7	1190	3	Nothing	nothing	NN
cord-005453-4057qib7	1190	4	to	to	TO
cord-005453-4057qib7	1190	5	declare	declare	VB
cord-005453-4057qib7	1190	6	Background	background	NN
cord-005453-4057qib7	1190	7	:	:	:
cord-005453-4057qib7	1190	8	Allogeneic	allogeneic	NN
cord-005453-4057qib7	1190	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1190	10	cell	cell	NN
cord-005453-4057qib7	1190	11	transplantation	transplantation	NN
cord-005453-4057qib7	1190	12	(	(	-LRB-
cord-005453-4057qib7	1190	13	allo	allo	NN
cord-005453-4057qib7	1190	14	-	-	HYPH
cord-005453-4057qib7	1190	15	HCT	HCT	NNP
cord-005453-4057qib7	1190	16	)	)	-RRB-
cord-005453-4057qib7	1190	17	is	be	VBZ
cord-005453-4057qib7	1190	18	a	a	DT
cord-005453-4057qib7	1190	19	curative	curative	JJ
cord-005453-4057qib7	1190	20	treatment	treatment	NN
cord-005453-4057qib7	1190	21	option	option	NN
cord-005453-4057qib7	1190	22	for	for	IN
cord-005453-4057qib7	1190	23	patients	patient	NNS
cord-005453-4057qib7	1190	24	suffering	suffer	VBG
cord-005453-4057qib7	1190	25	from	from	IN
cord-005453-4057qib7	1190	26	hematologic	hematologic	JJ
cord-005453-4057qib7	1190	27	malignancies	malignancy	NNS
cord-005453-4057qib7	1190	28	.	.	.
cord-005453-4057qib7	1191	1	Infusion	infusion	NN
cord-005453-4057qib7	1191	2	of	of	IN
cord-005453-4057qib7	1191	3	donor	donor	NN
cord-005453-4057qib7	1191	4	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1191	5	(	(	-LRB-
cord-005453-4057qib7	1191	6	DLIs	DLIs	NNP
cord-005453-4057qib7	1191	7	)	)	-RRB-
cord-005453-4057qib7	1191	8	can	can	MD
cord-005453-4057qib7	1191	9	induce	induce	VB
cord-005453-4057qib7	1191	10	sustained	sustained	JJ
cord-005453-4057qib7	1191	11	remission	remission	NN
cord-005453-4057qib7	1191	12	in	in	IN
cord-005453-4057qib7	1191	13	case	case	NN
cord-005453-4057qib7	1191	14	of	of	IN
cord-005453-4057qib7	1191	15	minimal	minimal	JJ
cord-005453-4057qib7	1191	16	residual	residual	JJ
cord-005453-4057qib7	1191	17	disease	disease	NN
cord-005453-4057qib7	1191	18	or	or	CC
cord-005453-4057qib7	1191	19	relapse	relapse	VB
cord-005453-4057qib7	1191	20	through	through	IN
cord-005453-4057qib7	1191	21	potent	potent	JJ
cord-005453-4057qib7	1191	22	graftversus	graftversus	NN
cord-005453-4057qib7	1191	23	-	-	HYPH
cord-005453-4057qib7	1191	24	leukemia	leukemia	NN
cord-005453-4057qib7	1191	25	(	(	-LRB-
cord-005453-4057qib7	1191	26	GVL	gvl	NN
cord-005453-4057qib7	1191	27	)	)	-RRB-
cord-005453-4057qib7	1191	28	effects	effect	NNS
cord-005453-4057qib7	1191	29	,	,	,
cord-005453-4057qib7	1191	30	although	although	IN
cord-005453-4057qib7	1191	31	graft	graft	NN
cord-005453-4057qib7	1191	32	-	-	HYPH
cord-005453-4057qib7	1191	33	versus	versus	IN
cord-005453-4057qib7	1191	34	-	-	HYPH
cord-005453-4057qib7	1191	35	host	host	NN
cord-005453-4057qib7	1191	36	disease	disease	NN
cord-005453-4057qib7	1191	37	(	(	-LRB-
cord-005453-4057qib7	1191	38	GVHD	GVHD	NNP
cord-005453-4057qib7	1191	39	)	)	-RRB-
cord-005453-4057qib7	1191	40	represents	represent	VBZ
cord-005453-4057qib7	1191	41	a	a	DT
cord-005453-4057qib7	1191	42	common	common	JJ
cord-005453-4057qib7	1191	43	dose	dose	NN
cord-005453-4057qib7	1191	44	-	-	HYPH
cord-005453-4057qib7	1191	45	limiting	limit	VBG
cord-005453-4057qib7	1191	46	toxicity	toxicity	NN
cord-005453-4057qib7	1191	47	.	.	.
cord-005453-4057qib7	1192	1	As	as	IN
cord-005453-4057qib7	1192	2	invariant	invariant	JJ
cord-005453-4057qib7	1192	3	natural	natural	JJ
cord-005453-4057qib7	1192	4	killer	killer	NN
cord-005453-4057qib7	1192	5	T	t	NN
cord-005453-4057qib7	1192	6	(	(	-LRB-
cord-005453-4057qib7	1192	7	iNKT	iNKT	NNP
cord-005453-4057qib7	1192	8	)	)	-RRB-
cord-005453-4057qib7	1192	9	cells	cell	NNS
cord-005453-4057qib7	1192	10	are	be	VBP
cord-005453-4057qib7	1192	11	known	know	VBN
cord-005453-4057qib7	1192	12	to	to	TO
cord-005453-4057qib7	1192	13	prevent	prevent	VB
cord-005453-4057qib7	1192	14	GVHD	GVHD	NNP
cord-005453-4057qib7	1192	15	while	while	IN
cord-005453-4057qib7	1192	16	promoting	promote	VBG
cord-005453-4057qib7	1192	17	beneficial	beneficial	JJ
cord-005453-4057qib7	1192	18	anti	anti	JJ
cord-005453-4057qib7	1192	19	-	-	JJ
cord-005453-4057qib7	1192	20	tumor	tumor	JJ
cord-005453-4057qib7	1192	21	effects	effect	NNS
cord-005453-4057qib7	1192	22	,	,	,
cord-005453-4057qib7	1192	23	we	-PRON-	PRP
cord-005453-4057qib7	1192	24	investigated	investigate	VBD
cord-005453-4057qib7	1192	25	the	the	DT
cord-005453-4057qib7	1192	26	role	role	NN
cord-005453-4057qib7	1192	27	of	of	IN
cord-005453-4057qib7	1192	28	iNKT	inkt	JJ
cord-005453-4057qib7	1192	29	cells	cell	NNS
cord-005453-4057qib7	1192	30	for	for	IN
cord-005453-4057qib7	1192	31	successful	successful	JJ
cord-005453-4057qib7	1192	32	DLIs	dli	NNS
cord-005453-4057qib7	1192	33	.	.	.
cord-005453-4057qib7	1193	1	Methods	method	NNS
cord-005453-4057qib7	1193	2	:	:	:
cord-005453-4057qib7	1194	1	We	-PRON-	PRP
cord-005453-4057qib7	1194	2	analyzed	analyze	VBD
cord-005453-4057qib7	1194	3	DLI	DLI	NNP
cord-005453-4057qib7	1194	4	samples	sample	NNS
cord-005453-4057qib7	1194	5	by	by	IN
cord-005453-4057qib7	1194	6	flow	flow	NN
cord-005453-4057qib7	1194	7	cytometry	cytometry	NN
cord-005453-4057qib7	1194	8	.	.	.
cord-005453-4057qib7	1195	1	iNKT	inkt	JJ
cord-005453-4057qib7	1195	2	cells	cell	NNS
cord-005453-4057qib7	1195	3	were	be	VBD
cord-005453-4057qib7	1195	4	identified	identify	VBN
cord-005453-4057qib7	1195	5	by	by	IN
cord-005453-4057qib7	1195	6	staining	stain	VBG
cord-005453-4057qib7	1195	7	with	with	IN
cord-005453-4057qib7	1195	8	PBS57-loaded	pbs57-loaded	JJ
cord-005453-4057qib7	1195	9	CD1d	CD1d	NNP
cord-005453-4057qib7	1195	10	tetramers	tetramer	NNS
cord-005453-4057qib7	1195	11	.	.	.
cord-005453-4057qib7	1196	1	Culture	culture	NN
cord-005453-4057qib7	1196	2	-	-	HYPH
cord-005453-4057qib7	1196	3	expanded	expand	VBN
cord-005453-4057qib7	1196	4	and	and	CC
cord-005453-4057qib7	1196	5	purified	purify	VBN
cord-005453-4057qib7	1196	6	DLI	DLI	NNP
cord-005453-4057qib7	1196	7	-	-	HYPH
cord-005453-4057qib7	1196	8	iNKTs	iNKTs	NNP
cord-005453-4057qib7	1196	9	were	be	VBD
cord-005453-4057qib7	1196	10	then	then	RB
cord-005453-4057qib7	1196	11	tested	test	VBN
cord-005453-4057qib7	1196	12	against	against	IN
cord-005453-4057qib7	1196	13	tumor	tumor	NN
cord-005453-4057qib7	1196	14	cell	cell	NN
cord-005453-4057qib7	1196	15	lines	line	NNS
cord-005453-4057qib7	1196	16	and	and	CC
cord-005453-4057qib7	1196	17	primary	primary	JJ
cord-005453-4057qib7	1196	18	leukemia	leukemia	NN
cord-005453-4057qib7	1196	19	cells	cell	NNS
cord-005453-4057qib7	1196	20	in	in	IN
cord-005453-4057qib7	1196	21	an	an	DT
cord-005453-4057qib7	1196	22	ex	ex	FW
cord-005453-4057qib7	1196	23	vivo	vivo	NN
cord-005453-4057qib7	1196	24	tumor	tumor	NN
cord-005453-4057qib7	1196	25	control	control	NN
cord-005453-4057qib7	1196	26	model	model	NN
cord-005453-4057qib7	1196	27	.	.	.
cord-005453-4057qib7	1197	1	Tumor	tumor	NN
cord-005453-4057qib7	1197	2	cell	cell	NN
cord-005453-4057qib7	1197	3	viability	viability	NN
cord-005453-4057qib7	1197	4	after	after	IN
cord-005453-4057qib7	1197	5	coincubation	coincubation	NN
cord-005453-4057qib7	1197	6	with	with	IN
cord-005453-4057qib7	1197	7	DLI	DLI	NNP
cord-005453-4057qib7	1197	8	-	-	HYPH
cord-005453-4057qib7	1197	9	iNKTs	iNKTs	NNP
cord-005453-4057qib7	1197	10	was	be	VBD
cord-005453-4057qib7	1197	11	measured	measure	VBN
cord-005453-4057qib7	1197	12	by	by	IN
cord-005453-4057qib7	1197	13	flow	flow	NN
cord-005453-4057qib7	1197	14	cytometry	cytometry	NN
cord-005453-4057qib7	1197	15	using	use	VBG
cord-005453-4057qib7	1197	16	7-AAD	7-aad	CD
cord-005453-4057qib7	1197	17	.	.	.
cord-005453-4057qib7	1198	1	Results	result	NNS
cord-005453-4057qib7	1198	2	:	:	:
cord-005453-4057qib7	1199	1	iNKT	inkt	JJ
cord-005453-4057qib7	1199	2	cells	cell	NNS
cord-005453-4057qib7	1199	3	represent	represent	VBP
cord-005453-4057qib7	1199	4	0.05	0.05	CD
cord-005453-4057qib7	1199	5	%	%	NN
cord-005453-4057qib7	1199	6	(	(	-LRB-
cord-005453-4057qib7	1199	7	range	range	NN
cord-005453-4057qib7	1199	8	0.001	0.001	CD
cord-005453-4057qib7	1199	9	-	-	HYPH
cord-005453-4057qib7	1199	10	0.55	0.55	CD
cord-005453-4057qib7	1199	11	%	%	NN
cord-005453-4057qib7	1199	12	)	)	-RRB-
cord-005453-4057qib7	1199	13	of	of	IN
cord-005453-4057qib7	1199	14	donor	donor	NN
cord-005453-4057qib7	1199	15	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1199	16	and	and	CC
cord-005453-4057qib7	1199	17	can	can	MD
cord-005453-4057qib7	1199	18	be	be	VB
cord-005453-4057qib7	1199	19	expanded	expand	VBN
cord-005453-4057qib7	1199	20	300fold	300fold	NNP
cord-005453-4057qib7	1199	21	following	follow	VBG
cord-005453-4057qib7	1199	22	a	a	DT
cord-005453-4057qib7	1199	23	two	two	CD
cord-005453-4057qib7	1199	24	-	-	HYPH
cord-005453-4057qib7	1199	25	week	week	NN
cord-005453-4057qib7	1199	26	protocol	protocol	NN
cord-005453-4057qib7	1199	27	with	with	IN
cord-005453-4057qib7	1199	28	a	a	DT
cord-005453-4057qib7	1199	29	preferential	preferential	JJ
cord-005453-4057qib7	1199	30	expansion	expansion	NN
cord-005453-4057qib7	1199	31	of	of	IN
cord-005453-4057qib7	1199	32	CD4	CD4	NNP
cord-005453-4057qib7	1199	33	+	+	CC
cord-005453-4057qib7	1199	34	iNKT	inkt	JJ
cord-005453-4057qib7	1199	35	cells	cell	NNS
cord-005453-4057qib7	1199	36	.	.	.
cord-005453-4057qib7	1200	1	Tumor	tumor	NN
cord-005453-4057qib7	1200	2	cell	cell	NN
cord-005453-4057qib7	1200	3	lines	line	NNS
cord-005453-4057qib7	1200	4	such	such	JJ
cord-005453-4057qib7	1200	5	as	as	IN
cord-005453-4057qib7	1200	6	Jurkat	Jurkat	NNP
cord-005453-4057qib7	1200	7	were	be	VBD
cord-005453-4057qib7	1200	8	efficiently	efficiently	RB
cord-005453-4057qib7	1200	9	lysed	lyse	VBN
cord-005453-4057qib7	1200	10	after	after	IN
cord-005453-4057qib7	1200	11	coincubation	coincubation	NN
cord-005453-4057qib7	1200	12	with	with	IN
cord-005453-4057qib7	1200	13	DLI	DLI	NNP
cord-005453-4057qib7	1200	14	-	-	HYPH
cord-005453-4057qib7	1200	15	iNKTs	iNKTs	NNPS
cord-005453-4057qib7	1200	16	.	.	.
cord-005453-4057qib7	1201	1	CD107a	CD107a	NNP
cord-005453-4057qib7	1201	2	as	as	IN
cord-005453-4057qib7	1201	3	a	a	DT
cord-005453-4057qib7	1201	4	marker	marker	NN
cord-005453-4057qib7	1201	5	of	of	IN
cord-005453-4057qib7	1201	6	degranulation	degranulation	NN
cord-005453-4057qib7	1201	7	was	be	VBD
cord-005453-4057qib7	1201	8	significantly	significantly	RB
cord-005453-4057qib7	1201	9	upregulated	upregulate	VBN
cord-005453-4057qib7	1201	10	on	on	IN
cord-005453-4057qib7	1201	11	DLI	DLI	NNP
cord-005453-4057qib7	1201	12	-	-	HYPH
cord-005453-4057qib7	1201	13	iNKTs	iNKTs	NNP
cord-005453-4057qib7	1201	14	after	after	IN
cord-005453-4057qib7	1201	15	stimulation	stimulation	NN
cord-005453-4057qib7	1201	16	by	by	IN
cord-005453-4057qib7	1201	17	Jurkat	Jurkat	NNP
cord-005453-4057qib7	1201	18	.	.	.
cord-005453-4057qib7	1202	1	In	in	IN
cord-005453-4057qib7	1202	2	addition	addition	NN
cord-005453-4057qib7	1202	3	,	,	,
cord-005453-4057qib7	1202	4	increased	increase	VBN
cord-005453-4057qib7	1202	5	concentrations	concentration	NNS
cord-005453-4057qib7	1202	6	of	of	IN
cord-005453-4057qib7	1202	7	TNFα	TNFα	NNS
cord-005453-4057qib7	1202	8	,	,	,
cord-005453-4057qib7	1202	9	IFN	IFN	NNP
cord-005453-4057qib7	1202	10	-	-	HYPH
cord-005453-4057qib7	1202	11	γ	γ	NNP
cord-005453-4057qib7	1202	12	,	,	,
cord-005453-4057qib7	1202	13	sFasL	sFasL	NNP
cord-005453-4057qib7	1202	14	and	and	CC
cord-005453-4057qib7	1202	15	Perforin	Perforin	NNP
cord-005453-4057qib7	1202	16	were	be	VBD
cord-005453-4057qib7	1202	17	measured	measure	VBN
cord-005453-4057qib7	1202	18	after	after	IN
cord-005453-4057qib7	1202	19	coincubation	coincubation	NN
cord-005453-4057qib7	1202	20	of	of	IN
cord-005453-4057qib7	1202	21	DLI	DLI	NNP
cord-005453-4057qib7	1202	22	-	-	HYPH
cord-005453-4057qib7	1202	23	iNKTs	iNKTs	NNP
cord-005453-4057qib7	1202	24	with	with	IN
cord-005453-4057qib7	1202	25	Jurkat	Jurkat	NNP
cord-005453-4057qib7	1202	26	.	.	.
cord-005453-4057qib7	1203	1	We	-PRON-	PRP
cord-005453-4057qib7	1203	2	observed	observe	VBD
cord-005453-4057qib7	1203	3	that	that	DT
cord-005453-4057qib7	1203	4	tumor	tumor	NN
cord-005453-4057qib7	1203	5	cell	cell	NN
cord-005453-4057qib7	1203	6	lysis	lysis	NN
cord-005453-4057qib7	1203	7	correlated	correlate	VBN
cord-005453-4057qib7	1203	8	with	with	IN
cord-005453-4057qib7	1203	9	the	the	DT
cord-005453-4057qib7	1203	10	expression	expression	NN
cord-005453-4057qib7	1203	11	of	of	IN
cord-005453-4057qib7	1203	12	the	the	DT
cord-005453-4057qib7	1203	13	MHC	MHC	NNP
cord-005453-4057qib7	1203	14	-	-	HYPH
cord-005453-4057qib7	1203	15	I	I	NNP
cord-005453-4057qib7	1203	16	-	-	HYPH
cord-005453-4057qib7	1203	17	like	like	JJ
cord-005453-4057qib7	1203	18	molecule	molecule	NN
cord-005453-4057qib7	1203	19	CD1d	CD1d	NNP
cord-005453-4057qib7	1203	20	.	.	.
cord-005453-4057qib7	1204	1	Consequently	consequently	RB
cord-005453-4057qib7	1204	2	,	,	,
cord-005453-4057qib7	1204	3	adding	add	VBG
cord-005453-4057qib7	1204	4	a	a	DT
cord-005453-4057qib7	1204	5	CD1d	CD1d	NNP
cord-005453-4057qib7	1204	6	antibody	antibody	NN
cord-005453-4057qib7	1204	7	to	to	IN
cord-005453-4057qib7	1204	8	the	the	DT
cord-005453-4057qib7	1204	9	coculture	coculture	NN
cord-005453-4057qib7	1204	10	abrogated	abrogate	VBD
cord-005453-4057qib7	1204	11	the	the	DT
cord-005453-4057qib7	1204	12	DLI	DLI	NNP
cord-005453-4057qib7	1204	13	-	-	HYPH
cord-005453-4057qib7	1204	14	iNKTmediated	inktmediate	VBN
cord-005453-4057qib7	1204	15	kill	kill	NN
cord-005453-4057qib7	1204	16	of	of	IN
cord-005453-4057qib7	1204	17	tumor	tumor	NN
cord-005453-4057qib7	1204	18	cells	cell	NNS
cord-005453-4057qib7	1204	19	.	.	.
cord-005453-4057qib7	1205	1	DLI	DLI	NNP
cord-005453-4057qib7	1205	2	-	-	HYPH
cord-005453-4057qib7	1205	3	iNKTs	iNKTs	NNP
cord-005453-4057qib7	1205	4	also	also	RB
cord-005453-4057qib7	1205	5	efficiently	efficiently	RB
cord-005453-4057qib7	1205	6	lysed	lyse	VBN
cord-005453-4057qib7	1205	7	primary	primary	JJ
cord-005453-4057qib7	1205	8	leukemia	leukemia	NN
cord-005453-4057qib7	1205	9	cells	cell	NNS
cord-005453-4057qib7	1205	10	such	such	JJ
cord-005453-4057qib7	1205	11	as	as	IN
cord-005453-4057qib7	1205	12	AML	AML	NNP
cord-005453-4057qib7	1205	13	blasts	blast	NNS
cord-005453-4057qib7	1205	14	:	:	:
cord-005453-4057qib7	1205	15	expression	expression	NN
cord-005453-4057qib7	1205	16	of	of	IN
cord-005453-4057qib7	1205	17	CD1d	CD1d	NNP
cord-005453-4057qib7	1205	18	on	on	IN
cord-005453-4057qib7	1205	19	these	these	DT
cord-005453-4057qib7	1205	20	AML	AML	NNP
cord-005453-4057qib7	1205	21	blasts	blast	NNS
cord-005453-4057qib7	1205	22	significantly	significantly	RB
cord-005453-4057qib7	1205	23	correlated	correlate	VBD
cord-005453-4057qib7	1205	24	with	with	IN
cord-005453-4057qib7	1205	25	DLI	DLI	NNP
cord-005453-4057qib7	1205	26	-	-	HYPH
cord-005453-4057qib7	1205	27	iNKT	inkt	JJ
cord-005453-4057qib7	1205	28	-	-	HYPH
cord-005453-4057qib7	1205	29	mediated	mediate	VBN
cord-005453-4057qib7	1205	30	tumor	tumor	NN
cord-005453-4057qib7	1205	31	cell	cell	NN
cord-005453-4057qib7	1205	32	lysis	lysis	NN
cord-005453-4057qib7	1205	33	(	(	-LRB-
cord-005453-4057qib7	1205	34	r	r	NN
cord-005453-4057qib7	1205	35	2	2	CD
cord-005453-4057qib7	1205	36	=	=	SYM
cord-005453-4057qib7	1205	37	0.7	0.7	CD
cord-005453-4057qib7	1205	38	,	,	,
cord-005453-4057qib7	1205	39	p=0.03	p=0.03	NNP
cord-005453-4057qib7	1205	40	)	)	-RRB-
cord-005453-4057qib7	1205	41	.	.	.
cord-005453-4057qib7	1206	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1206	2	:	:	:
cord-005453-4057qib7	1207	1	Ex	Ex	NNP
cord-005453-4057qib7	1207	2	vivo	vivo	NN
cord-005453-4057qib7	1207	3	expansion	expansion	NN
cord-005453-4057qib7	1207	4	of	of	IN
cord-005453-4057qib7	1207	5	DLI	DLI	NNP
cord-005453-4057qib7	1207	6	-	-	HYPH
cord-005453-4057qib7	1207	7	iNKTs	iNKTs	NNPS
cord-005453-4057qib7	1207	8	and	and	CC
cord-005453-4057qib7	1207	9	subsequent	subsequent	JJ
cord-005453-4057qib7	1207	10	DLI	DLI	NNP
cord-005453-4057qib7	1207	11	enrichment	enrichment	NN
cord-005453-4057qib7	1207	12	is	be	VBZ
cord-005453-4057qib7	1207	13	an	an	DT
cord-005453-4057qib7	1207	14	immunotherapeutic	immunotherapeutic	JJ
cord-005453-4057qib7	1207	15	approach	approach	NN
cord-005453-4057qib7	1207	16	that	that	WDT
cord-005453-4057qib7	1207	17	could	could	MD
cord-005453-4057qib7	1207	18	improve	improve	VB
cord-005453-4057qib7	1207	19	leukemia	leukemia	NN
cord-005453-4057qib7	1207	20	control	control	NN
cord-005453-4057qib7	1207	21	and	and	CC
cord-005453-4057qib7	1207	22	thus	thus	RB
cord-005453-4057qib7	1207	23	,	,	,
cord-005453-4057qib7	1207	24	prevent	prevent	VB
cord-005453-4057qib7	1207	25	relapse	relapse	NN
cord-005453-4057qib7	1207	26	after	after	IN
cord-005453-4057qib7	1207	27	allo	allo	NN
cord-005453-4057qib7	1207	28	-	-	HYPH
cord-005453-4057qib7	1207	29	HCT	hct	NN
cord-005453-4057qib7	1207	30	without	without	IN
cord-005453-4057qib7	1207	31	exacerbating	exacerbate	VBG
cord-005453-4057qib7	1207	32	GVHD	GVHD	NNP
cord-005453-4057qib7	1207	33	.	.	.
cord-005453-4057qib7	1208	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1208	2	:	:	:
cord-005453-4057qib7	1208	3	Nothing	nothing	NN
cord-005453-4057qib7	1208	4	to	to	TO
cord-005453-4057qib7	1208	5	declare	declare	VB
cord-005453-4057qib7	1208	6	.	.	.
cord-005453-4057qib7	1209	1	Generation	generation	NN
cord-005453-4057qib7	1209	2	of	of	IN
cord-005453-4057qib7	1209	3	antigen	antigen	NN
cord-005453-4057qib7	1209	4	-	-	HYPH
cord-005453-4057qib7	1209	5	specific	specific	JJ
cord-005453-4057qib7	1209	6	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1209	7	T	t	NN
cord-005453-4057qib7	1209	8	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1209	9	targeting	target	VBG
cord-005453-4057qib7	1209	10	WT1	wt1	RB
cord-005453-4057qib7	1209	11	using	use	VBG
cord-005453-4057qib7	1209	12	activated	activate	VBN
cord-005453-4057qib7	1209	13	B	b	NN
cord-005453-4057qib7	1209	14	cells	cell	NNS
cord-005453-4057qib7	1209	15	Sun	Sun	NNP
cord-005453-4057qib7	1209	16	Ok	Ok	NNP
cord-005453-4057qib7	1209	17	Yun	Yun	NNP
cord-005453-4057qib7	1209	18	1	1	CD
cord-005453-4057qib7	1209	19	,	,	,
cord-005453-4057qib7	1209	20	Kyung	Kyung	NNP
cord-005453-4057qib7	1209	21	Won	Won	NNP
cord-005453-4057qib7	1209	22	Baek	Baek	NNP
cord-005453-4057qib7	1209	23	1	1	CD
cord-005453-4057qib7	1209	24	,	,	,
cord-005453-4057qib7	1210	1	Hee	hee	UH
cord-005453-4057qib7	1210	2	Young	Young	NNP
cord-005453-4057qib7	1210	3	Shin	Shin	NNP
cord-005453-4057qib7	1210	4	1	1	CD
cord-005453-4057qib7	1210	5	,	,	,
cord-005453-4057qib7	1210	6	Hyoung	Hyoung	NNP
cord-005453-4057qib7	1210	7	Jin	Jin	NNP
cord-005453-4057qib7	1210	8	Kang	Kang	NNP
cord-005453-4057qib7	1210	9	1	1	CD
cord-005453-4057qib7	1210	10	1	1	CD
cord-005453-4057qib7	1210	11	Seoul	Seoul	NNP
cord-005453-4057qib7	1210	12	National	National	NNP
cord-005453-4057qib7	1210	13	University	University	NNP
cord-005453-4057qib7	1210	14	,	,	,
cord-005453-4057qib7	1210	15	Seoul	Seoul	NNP
cord-005453-4057qib7	1210	16	,	,	,
cord-005453-4057qib7	1210	17	Korea	Korea	NNP
cord-005453-4057qib7	1210	18	,	,	,
cord-005453-4057qib7	1210	19	Republic	Republic	NNP
cord-005453-4057qib7	1210	20	of	of	IN
cord-005453-4057qib7	1210	21	Background	Background	NNP
cord-005453-4057qib7	1210	22	:	:	:
cord-005453-4057qib7	1211	1	The	the	DT
cord-005453-4057qib7	1211	2	Wilms	Wilms	NNP
cord-005453-4057qib7	1211	3	tumor	tumor	NN
cord-005453-4057qib7	1211	4	antigen	antigen	NN
cord-005453-4057qib7	1211	5	1	1	CD
cord-005453-4057qib7	1212	1	(	(	-LRB-
cord-005453-4057qib7	1212	2	WT1	wt1	NN
cord-005453-4057qib7	1212	3	)	)	-RRB-
cord-005453-4057qib7	1212	4	is	be	VBZ
cord-005453-4057qib7	1212	5	highly	highly	RB
cord-005453-4057qib7	1212	6	expressed	express	VBN
cord-005453-4057qib7	1212	7	in	in	IN
cord-005453-4057qib7	1212	8	many	many	JJ
cord-005453-4057qib7	1212	9	malignancies	malignancy	NNS
cord-005453-4057qib7	1212	10	including	include	VBG
cord-005453-4057qib7	1212	11	leukemia	leukemia	NN
cord-005453-4057qib7	1212	12	and	and	CC
cord-005453-4057qib7	1212	13	targeting	target	VBG
cord-005453-4057qib7	1212	14	WT1	wt1	RB
cord-005453-4057qib7	1212	15	as	as	IN
cord-005453-4057qib7	1212	16	a	a	DT
cord-005453-4057qib7	1212	17	Tumor	tumor	NN
cord-005453-4057qib7	1212	18	Associated	Associated	NNP
cord-005453-4057qib7	1212	19	Antigen	Antigen	NNP
cord-005453-4057qib7	1212	20	(	(	-LRB-
cord-005453-4057qib7	1212	21	TAA	TAA	NNP
cord-005453-4057qib7	1212	22	)	)	-RRB-
cord-005453-4057qib7	1212	23	in	in	IN
cord-005453-4057qib7	1212	24	cancer	cancer	NN
cord-005453-4057qib7	1212	25	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1212	26	is	be	VBZ
cord-005453-4057qib7	1212	27	attractive	attractive	JJ
cord-005453-4057qib7	1212	28	.	.	.
cord-005453-4057qib7	1213	1	In	in	IN
cord-005453-4057qib7	1213	2	this	this	DT
cord-005453-4057qib7	1213	3	study	study	NN
cord-005453-4057qib7	1213	4	,	,	,
cord-005453-4057qib7	1213	5	we	-PRON-	PRP
cord-005453-4057qib7	1213	6	generated	generate	VBD
cord-005453-4057qib7	1213	7	WT1-specific	wt1-specific	JJ
cord-005453-4057qib7	1213	8	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1213	9	T	t	NN
cord-005453-4057qib7	1213	10	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1213	11	to	to	TO
cord-005453-4057qib7	1213	12	confirm	confirm	VB
cord-005453-4057qib7	1213	13	if	if	IN
cord-005453-4057qib7	1213	14	activated	activate	VBN
cord-005453-4057qib7	1213	15	B	b	NN
cord-005453-4057qib7	1213	16	cells	cell	NNS
cord-005453-4057qib7	1213	17	can	can	MD
cord-005453-4057qib7	1213	18	act	act	VB
cord-005453-4057qib7	1213	19	as	as	IN
cord-005453-4057qib7	1213	20	a	a	DT
cord-005453-4057qib7	1213	21	cancer	cancer	NN
cord-005453-4057qib7	1213	22	antigen	antigen	NN
cord-005453-4057qib7	1213	23	presenting	present	VBG
cord-005453-4057qib7	1213	24	cell	cell	NN
cord-005453-4057qib7	1213	25	and	and	CC
cord-005453-4057qib7	1213	26	induce	induce	VB
cord-005453-4057qib7	1213	27	CTLs	ctl	NNS
cord-005453-4057qib7	1213	28	.	.	.
cord-005453-4057qib7	1214	1	Methods	method	NNS
cord-005453-4057qib7	1214	2	:	:	:
cord-005453-4057qib7	1214	3	For	for	IN
cord-005453-4057qib7	1214	4	the	the	DT
cord-005453-4057qib7	1214	5	induction	induction	NN
cord-005453-4057qib7	1214	6	of	of	IN
cord-005453-4057qib7	1214	7	CTLs	ctl	NNS
cord-005453-4057qib7	1214	8	against	against	IN
cord-005453-4057qib7	1214	9	WT1	WT1	NNP
cord-005453-4057qib7	1214	10	,	,	,
cord-005453-4057qib7	1214	11	activated	activate	VBN
cord-005453-4057qib7	1214	12	B	b	NN
cord-005453-4057qib7	1214	13	cells	cell	NNS
cord-005453-4057qib7	1214	14	were	be	VBD
cord-005453-4057qib7	1214	15	used	use	VBN
cord-005453-4057qib7	1214	16	as	as	IN
cord-005453-4057qib7	1214	17	an	an	DT
cord-005453-4057qib7	1214	18	antigen	antigen	NN
cord-005453-4057qib7	1214	19	presenting	present	VBG
cord-005453-4057qib7	1214	20	cells	cell	NNS
cord-005453-4057qib7	1214	21	.	.	.
cord-005453-4057qib7	1215	1	B	b	NN
cord-005453-4057qib7	1215	2	cells	cell	NNS
cord-005453-4057qib7	1215	3	were	be	VBD
cord-005453-4057qib7	1215	4	isolated	isolate	VBN
cord-005453-4057qib7	1215	5	from	from	IN
cord-005453-4057qib7	1215	6	PBMCs	pbmc	NNS
cord-005453-4057qib7	1215	7	of	of	IN
cord-005453-4057qib7	1215	8	normal	normal	JJ
cord-005453-4057qib7	1215	9	healthy	healthy	JJ
cord-005453-4057qib7	1215	10	donors	donor	NNS
cord-005453-4057qib7	1215	11	and	and	CC
cord-005453-4057qib7	1215	12	activated	activate	VBN
cord-005453-4057qib7	1215	13	with	with	IN
cord-005453-4057qib7	1215	14	α	α	NN
cord-005453-4057qib7	1215	15	-	-	HYPH
cord-005453-4057qib7	1215	16	galactosylceramide	galactosylceramide	NN
cord-005453-4057qib7	1215	17	(	(	-LRB-
cord-005453-4057qib7	1215	18	α	α	NN
cord-005453-4057qib7	1215	19	-	-	HYPH
cord-005453-4057qib7	1215	20	GalCer	galcer	NN
cord-005453-4057qib7	1215	21	)	)	-RRB-
cord-005453-4057qib7	1215	22	and	and	CC
cord-005453-4057qib7	1215	23	nucleofected	nucleofecte	VBD
cord-005453-4057qib7	1215	24	with	with	IN
cord-005453-4057qib7	1215	25	WT1-coding	wt1-code	VBG
cord-005453-4057qib7	1215	26	plasmid	plasmid	NN
cord-005453-4057qib7	1215	27	DNA	dna	NN
cord-005453-4057qib7	1215	28	.	.	.
cord-005453-4057qib7	1216	1	Activated	activate	VBN
cord-005453-4057qib7	1216	2	B	B	NNP
cord-005453-4057qib7	1216	3	cells	cell	NNS
cord-005453-4057qib7	1216	4	were	be	VBD
cord-005453-4057qib7	1216	5	the	the	DT
cord-005453-4057qib7	1216	6	cultured	cultured	JJ
cord-005453-4057qib7	1216	7	with	with	IN
cord-005453-4057qib7	1216	8	PBMCs	pbmc	NNS
cord-005453-4057qib7	1216	9	for	for	IN
cord-005453-4057qib7	1216	10	17days	17days	CD
cord-005453-4057qib7	1216	11	in	in	IN
cord-005453-4057qib7	1216	12	vitro	vitro	FW
cord-005453-4057qib7	1216	13	and	and	CC
cord-005453-4057qib7	1216	14	harvested	harvest	VBN
cord-005453-4057qib7	1216	15	for	for	IN
cord-005453-4057qib7	1216	16	assay	assay	NN
cord-005453-4057qib7	1216	17	.	.	.
cord-005453-4057qib7	1217	1	Results	result	NNS
cord-005453-4057qib7	1217	2	:	:	:
cord-005453-4057qib7	1218	1	Cells	cell	NNS
cord-005453-4057qib7	1218	2	expanded	expand	VBD
cord-005453-4057qib7	1218	3	about	about	IN
cord-005453-4057qib7	1218	4	3	3	CD
cord-005453-4057qib7	1218	5	times	time	NNS
cord-005453-4057qib7	1218	6	after	after	IN
cord-005453-4057qib7	1218	7	17	17	CD
cord-005453-4057qib7	1218	8	days	day	NNS
cord-005453-4057qib7	1218	9	of	of	IN
cord-005453-4057qib7	1218	10	culture	culture	NN
cord-005453-4057qib7	1218	11	.	.	.
cord-005453-4057qib7	1219	1	We	-PRON-	PRP
cord-005453-4057qib7	1219	2	examined	examine	VBD
cord-005453-4057qib7	1219	3	characteristic	characteristic	NN
cord-005453-4057qib7	1219	4	of	of	IN
cord-005453-4057qib7	1219	5	WT1-specific	wt1-specific	JJ
cord-005453-4057qib7	1219	6	CTLs	ctl	NNS
cord-005453-4057qib7	1219	7	by	by	IN
cord-005453-4057qib7	1219	8	their	-PRON-	PRP$
cord-005453-4057qib7	1219	9	surface	surface	NN
cord-005453-4057qib7	1219	10	markers	marker	NNS
cord-005453-4057qib7	1219	11	.	.	.
cord-005453-4057qib7	1220	1	WT1-specific	WT1-specific	NNP
cord-005453-4057qib7	1220	2	CTLs	CTLs	NNP
cord-005453-4057qib7	1220	3	had	have	VBD
cord-005453-4057qib7	1220	4	more	more	JJR
cord-005453-4057qib7	1220	5	than	than	IN
cord-005453-4057qib7	1220	6	90	90	CD
cord-005453-4057qib7	1220	7	%	%	NN
cord-005453-4057qib7	1220	8	CD3	cd3	NN
cord-005453-4057qib7	1220	9	+	+	CC
cord-005453-4057qib7	1220	10	marker	marker	NN
cord-005453-4057qib7	1220	11	,	,	,
cord-005453-4057qib7	1220	12	and	and	CC
cord-005453-4057qib7	1220	13	ratio	ratio	NN
cord-005453-4057qib7	1220	14	of	of	IN
cord-005453-4057qib7	1220	15	CD8	CD8	NNP
cord-005453-4057qib7	1220	16	to	to	IN
cord-005453-4057qib7	1220	17	CD4	CD4	NNP
cord-005453-4057qib7	1220	18	was	be	VBD
cord-005453-4057qib7	1220	19	1.7	1.7	CD
cord-005453-4057qib7	1220	20	-	-	SYM
cord-005453-4057qib7	1220	21	5.8	5.8	CD
cord-005453-4057qib7	1220	22	.	.	.
cord-005453-4057qib7	1221	1	We	-PRON-	PRP
cord-005453-4057qib7	1221	2	also	also	RB
cord-005453-4057qib7	1221	3	examined	examine	VBD
cord-005453-4057qib7	1221	4	NKT	NKT	NNP
cord-005453-4057qib7	1221	5	cell	cell	NN
cord-005453-4057qib7	1221	6	markers	marker	NNS
cord-005453-4057qib7	1221	7	to	to	TO
cord-005453-4057qib7	1221	8	see	see	VB
cord-005453-4057qib7	1221	9	if	if	IN
cord-005453-4057qib7	1221	10	NKT	NKT	NNP
cord-005453-4057qib7	1221	11	cells	cell	NNS
cord-005453-4057qib7	1221	12	were	be	VBD
cord-005453-4057qib7	1221	13	activated	activate	VBN
cord-005453-4057qib7	1221	14	by	by	IN
cord-005453-4057qib7	1221	15	IL-15	IL-15	NNP
cord-005453-4057qib7	1221	16	,	,	,
cord-005453-4057qib7	1221	17	a	a	DT
cord-005453-4057qib7	1221	18	cytokine	cytokine	NN
cord-005453-4057qib7	1221	19	used	use	VBN
cord-005453-4057qib7	1221	20	in	in	IN
cord-005453-4057qib7	1221	21	the	the	DT
cord-005453-4057qib7	1221	22	induction	induction	NN
cord-005453-4057qib7	1221	23	of	of	IN
cord-005453-4057qib7	1221	24	CTLs	CTLs	NNP
cord-005453-4057qib7	1221	25	,	,	,
cord-005453-4057qib7	1221	26	and	and	CC
cord-005453-4057qib7	1221	27	the	the	DT
cord-005453-4057qib7	1221	28	portion	portion	NN
cord-005453-4057qib7	1221	29	of	of	IN
cord-005453-4057qib7	1221	30	NKT	NKT	NNP
cord-005453-4057qib7	1221	31	cells	cell	NNS
cord-005453-4057qib7	1221	32	was	be	VBD
cord-005453-4057qib7	1221	33	about	about	RB
cord-005453-4057qib7	1221	34	2	2	CD
cord-005453-4057qib7	1221	35	%	%	NN
cord-005453-4057qib7	1221	36	.	.	.
cord-005453-4057qib7	1222	1	The	the	DT
cord-005453-4057qib7	1222	2	CTLs	ctl	NNS
cord-005453-4057qib7	1222	3	showed	show	VBD
cord-005453-4057qib7	1222	4	a	a	DT
cord-005453-4057qib7	1222	5	decrease	decrease	NN
cord-005453-4057qib7	1222	6	in	in	IN
cord-005453-4057qib7	1222	7	naïve	naïve	JJ
cord-005453-4057qib7	1222	8	cell	cell	NN
cord-005453-4057qib7	1222	9	(	(	-LRB-
cord-005453-4057qib7	1222	10	CD62L+CD45RA	CD62L+CD45RA	NNP
cord-005453-4057qib7	1222	11	+	+	SYM
cord-005453-4057qib7	1222	12	)	)	-RRB-
cord-005453-4057qib7	1222	13	and	and	CC
cord-005453-4057qib7	1222	14	an	an	DT
cord-005453-4057qib7	1222	15	increase	increase	NN
cord-005453-4057qib7	1222	16	in	in	IN
cord-005453-4057qib7	1222	17	effector	effector	NN
cord-005453-4057qib7	1222	18	memory	memory	NN
cord-005453-4057qib7	1222	19	(	(	-LRB-
cord-005453-4057qib7	1222	20	CD62L+CD45RA-	CD62L+CD45RA-	NNP
cord-005453-4057qib7	1222	21	)	)	-RRB-
cord-005453-4057qib7	1222	22	and	and	CC
cord-005453-4057qib7	1222	23	central	central	JJ
cord-005453-4057qib7	1222	24	memory	memory	NN
cord-005453-4057qib7	1222	25	(	(	-LRB-
cord-005453-4057qib7	1222	26	CD62L	cd62l	NN
cord-005453-4057qib7	1222	27	-	-	HYPH
cord-005453-4057qib7	1222	28	CD45RA-	CD45RA-	NNP
cord-005453-4057qib7	1222	29	)	)	-RRB-
cord-005453-4057qib7	1222	30	compared	compare	VBN
cord-005453-4057qib7	1222	31	with	with	IN
cord-005453-4057qib7	1222	32	non	non	JJ
cord-005453-4057qib7	1222	33	-	-	JJ
cord-005453-4057qib7	1222	34	stimulated	stimulated	JJ
cord-005453-4057qib7	1222	35	PBMCs	pbmc	NNS
cord-005453-4057qib7	1222	36	.	.	.
cord-005453-4057qib7	1223	1	Subsequently	subsequently	RB
cord-005453-4057qib7	1223	2	,	,	,
cord-005453-4057qib7	1223	3	the	the	DT
cord-005453-4057qib7	1223	4	IFN	IFN	NNP
cord-005453-4057qib7	1223	5	-	-	HYPH
cord-005453-4057qib7	1223	6	γ	γ	NN
cord-005453-4057qib7	1223	7	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1223	8	(	(	-LRB-
cord-005453-4057qib7	1223	9	Enzyme	enzyme	NN
cord-005453-4057qib7	1223	10	-	-	HYPH
cord-005453-4057qib7	1223	11	linked	link	VBN
cord-005453-4057qib7	1223	12	immunospot	immunospot	NN
cord-005453-4057qib7	1223	13	)	)	-RRB-
cord-005453-4057qib7	1223	14	assay	assay	NN
cord-005453-4057qib7	1223	15	was	be	VBD
cord-005453-4057qib7	1223	16	performed	perform	VBN
cord-005453-4057qib7	1223	17	to	to	TO
cord-005453-4057qib7	1223	18	confirm	confirm	VB
cord-005453-4057qib7	1223	19	the	the	DT
cord-005453-4057qib7	1223	20	response	response	NN
cord-005453-4057qib7	1223	21	of	of	IN
cord-005453-4057qib7	1223	22	the	the	DT
cord-005453-4057qib7	1223	23	induced	induce	VBN
cord-005453-4057qib7	1223	24	WT1-specific	wt1-specific	CD
cord-005453-4057qib7	1223	25	CTLs	ctl	NNS
cord-005453-4057qib7	1223	26	to	to	IN
cord-005453-4057qib7	1223	27	the	the	DT
cord-005453-4057qib7	1223	28	WT1	WT1	NNP
cord-005453-4057qib7	1223	29	antigen	antigen	NN
cord-005453-4057qib7	1223	30	.	.	.
cord-005453-4057qib7	1224	1	When	when	WRB
cord-005453-4057qib7	1224	2	WT1-specific	wt1-specific	JJ
cord-005453-4057qib7	1224	3	CTLs	CTLs	NNP
cord-005453-4057qib7	1224	4	encounters	encounter	VBZ
cord-005453-4057qib7	1224	5	a	a	DT
cord-005453-4057qib7	1224	6	target	target	NN
cord-005453-4057qib7	1224	7	that	that	WDT
cord-005453-4057qib7	1224	8	does	do	VBZ
cord-005453-4057qib7	1224	9	not	not	RB
cord-005453-4057qib7	1224	10	have	have	VB
cord-005453-4057qib7	1224	11	a	a	DT
cord-005453-4057qib7	1224	12	WT1	WT1	NNP
cord-005453-4057qib7	1224	13	antigen	antigen	NN
cord-005453-4057qib7	1224	14	,	,	,
cord-005453-4057qib7	1224	15	it	-PRON-	PRP
cord-005453-4057qib7	1224	16	did	do	VBD
cord-005453-4057qib7	1224	17	not	not	RB
cord-005453-4057qib7	1224	18	produce	produce	VB
cord-005453-4057qib7	1224	19	IFN	IFN	NNP
cord-005453-4057qib7	1224	20	-	-	HYPH
cord-005453-4057qib7	1224	21	γ	γ	NNP
cord-005453-4057qib7	1224	22	,	,	,
cord-005453-4057qib7	1224	23	but	but	CC
cord-005453-4057qib7	1224	24	when	when	WRB
cord-005453-4057qib7	1224	25	it	-PRON-	PRP
cord-005453-4057qib7	1224	26	encounters	encounter	VBZ
cord-005453-4057qib7	1224	27	a	a	DT
cord-005453-4057qib7	1224	28	target	target	NN
cord-005453-4057qib7	1224	29	cells	cell	NNS
cord-005453-4057qib7	1224	30	loaded	load	VBN
cord-005453-4057qib7	1224	31	WT1	WT1	NNP
cord-005453-4057qib7	1224	32	antigen	antigen	NN
cord-005453-4057qib7	1224	33	,	,	,
cord-005453-4057qib7	1224	34	it	-PRON-	PRP
cord-005453-4057qib7	1224	35	responded	respond	VBD
cord-005453-4057qib7	1224	36	to	to	TO
cord-005453-4057qib7	1224	37	secrete	secrete	VB
cord-005453-4057qib7	1224	38	IFN	IFN	NNP
cord-005453-4057qib7	1224	39	-	-	HYPH
cord-005453-4057qib7	1224	40	γ	γ	NNP
cord-005453-4057qib7	1224	41	.	.	.
cord-005453-4057qib7	1225	1	Killing	kill	VBG
cord-005453-4057qib7	1225	2	assays	assay	NNS
cord-005453-4057qib7	1225	3	were	be	VBD
cord-005453-4057qib7	1225	4	also	also	RB
cord-005453-4057qib7	1225	5	performed	perform	VBN
cord-005453-4057qib7	1225	6	to	to	TO
cord-005453-4057qib7	1225	7	determine	determine	VB
cord-005453-4057qib7	1225	8	the	the	DT
cord-005453-4057qib7	1225	9	immunogenicity	immunogenicity	NN
cord-005453-4057qib7	1225	10	of	of	IN
cord-005453-4057qib7	1225	11	induced	induce	VBN
cord-005453-4057qib7	1225	12	CTLs	CTLs	NNP
cord-005453-4057qib7	1225	13	.	.	.
cord-005453-4057qib7	1226	1	The	the	DT
cord-005453-4057qib7	1226	2	induced	induce	VBN
cord-005453-4057qib7	1226	3	WT1	WT1	NNP
cord-005453-4057qib7	1226	4	CTLs	CTLs	NNP
cord-005453-4057qib7	1226	5	was	be	VBD
cord-005453-4057qib7	1226	6	found	find	VBN
cord-005453-4057qib7	1226	7	to	to	TO
cord-005453-4057qib7	1226	8	be	be	VB
cord-005453-4057qib7	1226	9	killing	kill	VBG
cord-005453-4057qib7	1226	10	more	more	JJR
cord-005453-4057qib7	1226	11	than	than	IN
cord-005453-4057qib7	1226	12	90	90	CD
cord-005453-4057qib7	1226	13	%	%	NN
cord-005453-4057qib7	1226	14	when	when	WRB
cord-005453-4057qib7	1226	15	the	the	DT
cord-005453-4057qib7	1226	16	E	e	NN
cord-005453-4057qib7	1226	17	:	:	:
cord-005453-4057qib7	1226	18	T	t	NN
cord-005453-4057qib7	1226	19	ratio	ratio	NN
cord-005453-4057qib7	1226	20	was	be	VBD
cord-005453-4057qib7	1226	21	10:1	10:1	CD
cord-005453-4057qib7	1226	22	when	when	WRB
cord-005453-4057qib7	1226	23	the	the	DT
cord-005453-4057qib7	1226	24	autologous	autologous	JJ
cord-005453-4057qib7	1226	25	PBMC	PBMC	NNP
cord-005453-4057qib7	1226	26	met	meet	VBD
cord-005453-4057qib7	1226	27	the	the	DT
cord-005453-4057qib7	1226	28	target	target	NN
cord-005453-4057qib7	1226	29	with	with	IN
cord-005453-4057qib7	1226	30	WT1	wt1	JJ
cord-005453-4057qib7	1226	31	pepmix	pepmix	NNS
cord-005453-4057qib7	1226	32	.	.	.
cord-005453-4057qib7	1227	1	In	in	IN
cord-005453-4057qib7	1227	2	addition	addition	NN
cord-005453-4057qib7	1227	3	,	,	,
cord-005453-4057qib7	1227	4	we	-PRON-	PRP
cord-005453-4057qib7	1227	5	found	find	VBD
cord-005453-4057qib7	1227	6	that	that	IN
cord-005453-4057qib7	1227	7	WT1	WT1	NNP
cord-005453-4057qib7	1227	8	CTLs	CTLs	NNP
cord-005453-4057qib7	1227	9	has	have	VBZ
cord-005453-4057qib7	1227	10	killing	kill	VBG
cord-005453-4057qib7	1227	11	activity	activity	NN
cord-005453-4057qib7	1227	12	when	when	WRB
cord-005453-4057qib7	1227	13	it	-PRON-	PRP
cord-005453-4057qib7	1227	14	encounters	encounter	VBZ
cord-005453-4057qib7	1227	15	leukemia	leukemia	NN
cord-005453-4057qib7	1227	16	cell	cell	NN
cord-005453-4057qib7	1227	17	lines	line	NNS
cord-005453-4057qib7	1227	18	that	that	WDT
cord-005453-4057qib7	1227	19	express	express	VBP
cord-005453-4057qib7	1227	20	WT1	WT1	NNP
cord-005453-4057qib7	1227	21	and	and	CC
cord-005453-4057qib7	1227	22	matched	match	VBD
cord-005453-4057qib7	1227	23	HLA	HLA	NNP
cord-005453-4057qib7	1227	24	-	-	HYPH
cord-005453-4057qib7	1227	25	A*0201	A*0201	NNP
cord-005453-4057qib7	1227	26	.	.	.
cord-005453-4057qib7	1228	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1228	2	:	:	:
cord-005453-4057qib7	1229	1	In	in	IN
cord-005453-4057qib7	1229	2	this	this	DT
cord-005453-4057qib7	1229	3	study	study	NN
cord-005453-4057qib7	1229	4	,	,	,
cord-005453-4057qib7	1229	5	we	-PRON-	PRP
cord-005453-4057qib7	1229	6	can	can	MD
cord-005453-4057qib7	1229	7	induce	induce	VB
cord-005453-4057qib7	1229	8	antigenspecific	antigenspecific	NNP
cord-005453-4057qib7	1229	9	CTLs	ctl	NNS
cord-005453-4057qib7	1229	10	that	that	WDT
cord-005453-4057qib7	1229	11	specifically	specifically	RB
cord-005453-4057qib7	1229	12	react	react	VBP
cord-005453-4057qib7	1229	13	to	to	IN
cord-005453-4057qib7	1229	14	WT1	wt1	NN
cord-005453-4057qib7	1229	15	using	use	VBG
cord-005453-4057qib7	1229	16	activated	activate	VBN
cord-005453-4057qib7	1229	17	B	B	NNP
cord-005453-4057qib7	1229	18	cells	cell	NNS
cord-005453-4057qib7	1229	19	as	as	IN
cord-005453-4057qib7	1229	20	antigen	antigen	NN
cord-005453-4057qib7	1229	21	-	-	HYPH
cord-005453-4057qib7	1229	22	presenting	present	VBG
cord-005453-4057qib7	1229	23	cells	cell	NNS
cord-005453-4057qib7	1229	24	.	.	.
cord-005453-4057qib7	1230	1	These	these	DT
cord-005453-4057qib7	1230	2	observations	observation	NNS
cord-005453-4057qib7	1230	3	confirmed	confirm	VBD
cord-005453-4057qib7	1230	4	that	that	IN
cord-005453-4057qib7	1230	5	B	b	NN
cord-005453-4057qib7	1230	6	cells	cell	NNS
cord-005453-4057qib7	1230	7	activated	activate	VBN
cord-005453-4057qib7	1230	8	by	by	IN
cord-005453-4057qib7	1230	9	α	α	NN
cord-005453-4057qib7	1230	10	-	-	:
cord-005453-4057qib7	1230	11	GalCer	GalCer	NNP
cord-005453-4057qib7	1230	12	can	can	MD
cord-005453-4057qib7	1230	13	act	act	VB
cord-005453-4057qib7	1230	14	as	as	IN
cord-005453-4057qib7	1230	15	a	a	DT
cord-005453-4057qib7	1230	16	TAA	TAA	NNP
cord-005453-4057qib7	1230	17	presenting	present	VBG
cord-005453-4057qib7	1230	18	cell	cell	NN
cord-005453-4057qib7	1230	19	to	to	TO
cord-005453-4057qib7	1230	20	induce	induce	VB
cord-005453-4057qib7	1230	21	TAA	TAA	NNP
cord-005453-4057qib7	1230	22	specific	specific	JJ
cord-005453-4057qib7	1230	23	CTLs	ctl	NNS
cord-005453-4057qib7	1230	24	as	as	IN
cord-005453-4057qib7	1230	25	viral	viral	JJ
cord-005453-4057qib7	1230	26	antigen	antigen	NN
cord-005453-4057qib7	1230	27	,	,	,
cord-005453-4057qib7	1230	28	such	such	JJ
cord-005453-4057qib7	1230	29	as	as	IN
cord-005453-4057qib7	1230	30	pp65	pp65	NNP
cord-005453-4057qib7	1230	31	and	and	CC
cord-005453-4057qib7	1230	32	IE1	ie1	NN
cord-005453-4057qib7	1230	33	,	,	,
cord-005453-4057qib7	1230	34	and	and	CC
cord-005453-4057qib7	1230	35	consequently	consequently	RB
cord-005453-4057qib7	1230	36	WT1specific	wt1specific	JJ
cord-005453-4057qib7	1230	37	CTLs	ctl	NNS
cord-005453-4057qib7	1230	38	could	could	MD
cord-005453-4057qib7	1230	39	be	be	VB
cord-005453-4057qib7	1230	40	induced	induce	VBN
cord-005453-4057qib7	1230	41	.	.	.
cord-005453-4057qib7	1231	1	Moreover	moreover	RB
cord-005453-4057qib7	1231	2	,	,	,
cord-005453-4057qib7	1231	3	CTLs	CTLs	NNP
cord-005453-4057qib7	1231	4	induced	induce	VBD
cord-005453-4057qib7	1231	5	activated	activate	VBN
cord-005453-4057qib7	1231	6	B	B	NNP
cord-005453-4057qib7	1231	7	cells	cell	NNS
cord-005453-4057qib7	1231	8	had	have	VBD
cord-005453-4057qib7	1231	9	ability	ability	NN
cord-005453-4057qib7	1231	10	to	to	TO
cord-005453-4057qib7	1231	11	recognize	recognize	VB
cord-005453-4057qib7	1231	12	and	and	CC
cord-005453-4057qib7	1231	13	kill	kill	VB
cord-005453-4057qib7	1231	14	the	the	DT
cord-005453-4057qib7	1231	15	target	target	NN
cord-005453-4057qib7	1231	16	cells	cell	NNS
cord-005453-4057qib7	1231	17	expressing	express	VBG
cord-005453-4057qib7	1231	18	WT1	wt1	WP
cord-005453-4057qib7	1231	19	correctly	correctly	RB
cord-005453-4057qib7	1231	20	.	.	.
cord-005453-4057qib7	1232	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1232	2	results	result	NNS
cord-005453-4057qib7	1232	3	demonstrate	demonstrate	VBP
cord-005453-4057qib7	1232	4	that	that	IN
cord-005453-4057qib7	1232	5	these	these	DT
cord-005453-4057qib7	1232	6	in	in	IN
cord-005453-4057qib7	1232	7	vitro	vitro	FW
cord-005453-4057qib7	1232	8	expanded	expand	VBD
cord-005453-4057qib7	1232	9	WT1-specific	wt1-specific	CD
cord-005453-4057qib7	1232	10	CTLs	ctl	NNS
cord-005453-4057qib7	1232	11	using	use	VBG
cord-005453-4057qib7	1232	12	activated	activate	VBN
cord-005453-4057qib7	1232	13	B	b	NN
cord-005453-4057qib7	1232	14	cells	cell	NNS
cord-005453-4057qib7	1232	15	can	can	MD
cord-005453-4057qib7	1232	16	be	be	VB
cord-005453-4057qib7	1232	17	a	a	DT
cord-005453-4057qib7	1232	18	promising	promising	JJ
cord-005453-4057qib7	1232	19	candidate	candidate	NN
cord-005453-4057qib7	1232	20	for	for	IN
cord-005453-4057qib7	1232	21	adoptive	adoptive	JJ
cord-005453-4057qib7	1232	22	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1232	23	against	against	IN
cord-005453-4057qib7	1232	24	cancer	cancer	NN
cord-005453-4057qib7	1232	25	.	.	.
cord-005453-4057qib7	1233	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1233	2	:	:	:
cord-005453-4057qib7	1233	3	Nothing	nothing	NN
cord-005453-4057qib7	1233	4	to	to	TO
cord-005453-4057qib7	1233	5	declare	declare	VB
cord-005453-4057qib7	1233	6	Judith	Judith	NNP
cord-005453-4057qib7	1233	7	Böhringer	Böhringer	NNP
cord-005453-4057qib7	1233	8	1	1	CD
cord-005453-4057qib7	1233	9	,	,	,
cord-005453-4057qib7	1233	10	Michael	Michael	NNP
cord-005453-4057qib7	1233	11	Schumm	Schumm	NNP
cord-005453-4057qib7	1233	12	1	1	CD
cord-005453-4057qib7	1233	13	,	,	,
cord-005453-4057qib7	1233	14	Christiane	Christiane	NNP
cord-005453-4057qib7	1233	15	Braun	Braun	NNP
cord-005453-4057qib7	1233	16	1	1	CD
cord-005453-4057qib7	1233	17	,	,	,
cord-005453-4057qib7	1233	18	Marina	Marina	NNP
cord-005453-4057qib7	1233	19	Schmidt	Schmidt	NNP
cord-005453-4057qib7	1233	20	1	1	CD
cord-005453-4057qib7	1233	21	,	,	,
cord-005453-4057qib7	1233	22	Patrick	Patrick	NNP
cord-005453-4057qib7	1233	23	Schlegel	Schlegel	NNP
cord-005453-4057qib7	1233	24	1	1	CD
cord-005453-4057qib7	1233	25	,	,	,
cord-005453-4057qib7	1233	26	Christian	Christian	NNP
cord-005453-4057qib7	1233	27	Seitz	Seitz	NNP
cord-005453-4057qib7	1233	28	1	1	CD
cord-005453-4057qib7	1233	29	,	,	,
cord-005453-4057qib7	1233	30	Murat	Murat	NNP
cord-005453-4057qib7	1233	31	Aktas	Aktas	NNP
cord-005453-4057qib7	1233	32	2	2	CD
cord-005453-4057qib7	1233	33	,	,	,
cord-005453-4057qib7	1233	34	Georg	Georg	NNP
cord-005453-4057qib7	1233	35	Rauser	Rauser	NNP
cord-005453-4057qib7	1233	36	2	2	CD
cord-005453-4057qib7	1233	37	,	,	,
cord-005453-4057qib7	1233	38	Sandra	Sandra	NNP
cord-005453-4057qib7	1233	39	Karitzky	Karitzky	NNP
cord-005453-4057qib7	1233	40	2	2	CD
cord-005453-4057qib7	1233	41	,	,	,
cord-005453-4057qib7	1233	42	Peter	Peter	NNP
cord-005453-4057qib7	1233	43	Lang	Lang	NNP
cord-005453-4057qib7	1233	44	1	1	CD
cord-005453-4057qib7	1234	1	,	,	,
cord-005453-4057qib7	1234	2	Rupert	Rupert	NNP
cord-005453-4057qib7	1234	3	Handgretinger	Handgretinger	NNP
cord-005453-4057qib7	1234	4	1	1	CD
cord-005453-4057qib7	1234	5	1	1	CD
cord-005453-4057qib7	1234	6	University	University	NNP
cord-005453-4057qib7	1234	7	Children	Children	NNPS
cord-005453-4057qib7	1234	8	's	's	POS
cord-005453-4057qib7	1234	9	Hospital	Hospital	NNP
cord-005453-4057qib7	1234	10	Tübingen	Tübingen	NNP
cord-005453-4057qib7	1234	11	,	,	,
cord-005453-4057qib7	1234	12	Tübingen	Tübingen	NNP
cord-005453-4057qib7	1234	13	,	,	,
cord-005453-4057qib7	1234	14	Germany	Germany	NNP
cord-005453-4057qib7	1234	15	,	,	,
cord-005453-4057qib7	1234	16	2	2	CD
cord-005453-4057qib7	1234	17	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	1234	18	Biotec	Biotec	NNP
cord-005453-4057qib7	1234	19	GmbH	GmbH	NNP
cord-005453-4057qib7	1234	20	,	,	,
cord-005453-4057qib7	1234	21	Bergisch	Bergisch	NNP
cord-005453-4057qib7	1234	22	Gladbach	Gladbach	NNP
cord-005453-4057qib7	1234	23	,	,	,
cord-005453-4057qib7	1234	24	Germany	Germany	NNP
cord-005453-4057qib7	1234	25	Background	Background	NNP
cord-005453-4057qib7	1234	26	:	:	:
cord-005453-4057qib7	1234	27	T	t	NN
cord-005453-4057qib7	1234	28	cells	cell	NNS
cord-005453-4057qib7	1234	29	with	with	IN
cord-005453-4057qib7	1234	30	chimeric	chimeric	JJ
cord-005453-4057qib7	1234	31	antigen	antigen	NN
cord-005453-4057qib7	1234	32	receptors	receptor	NNS
cord-005453-4057qib7	1234	33	(	(	-LRB-
cord-005453-4057qib7	1234	34	CARs	car	NNS
cord-005453-4057qib7	1234	35	)	)	-RRB-
cord-005453-4057qib7	1234	36	on	on	IN
cord-005453-4057qib7	1234	37	their	-PRON-	PRP$
cord-005453-4057qib7	1234	38	surface	surface	NN
cord-005453-4057qib7	1234	39	facilitate	facilitate	VBP
cord-005453-4057qib7	1234	40	to	to	TO
cord-005453-4057qib7	1234	41	target	target	VB
cord-005453-4057qib7	1234	42	specific	specific	JJ
cord-005453-4057qib7	1234	43	surface	surface	NN
cord-005453-4057qib7	1234	44	expressed	express	VBD
cord-005453-4057qib7	1234	45	antigens	antigen	NNS
cord-005453-4057qib7	1234	46	.	.	.
cord-005453-4057qib7	1235	1	Research	research	NN
cord-005453-4057qib7	1235	2	and	and	CC
cord-005453-4057qib7	1235	3	clinical	clinical	JJ
cord-005453-4057qib7	1235	4	trials	trial	NNS
cord-005453-4057qib7	1235	5	with	with	IN
cord-005453-4057qib7	1235	6	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	1235	7	T	T	NNP
cord-005453-4057qib7	1235	8	cells	cell	NNS
cord-005453-4057qib7	1235	9	show	show	VBP
cord-005453-4057qib7	1235	10	impressive	impressive	JJ
cord-005453-4057qib7	1235	11	remission	remission	NN
cord-005453-4057qib7	1235	12	induction	induction	NN
cord-005453-4057qib7	1235	13	rates	rate	NNS
cord-005453-4057qib7	1235	14	and	and	CC
cord-005453-4057qib7	1235	15	increased	increase	VBN
cord-005453-4057qib7	1235	16	survival	survival	NN
cord-005453-4057qib7	1235	17	in	in	IN
cord-005453-4057qib7	1235	18	heavily	heavily	RB
cord-005453-4057qib7	1235	19	pretreated	pretreate	VBN
cord-005453-4057qib7	1235	20	patients	patient	NNS
cord-005453-4057qib7	1235	21	.	.	.
cord-005453-4057qib7	1236	1	Therefore	therefore	RB
cord-005453-4057qib7	1236	2	,	,	,
cord-005453-4057qib7	1236	3	CAR	car	NN
cord-005453-4057qib7	1236	4	T	t	NN
cord-005453-4057qib7	1236	5	cells	cell	NNS
cord-005453-4057qib7	1236	6	are	be	VBP
cord-005453-4057qib7	1236	7	introduced	introduce	VBN
cord-005453-4057qib7	1236	8	as	as	IN
cord-005453-4057qib7	1236	9	new	new	JJ
cord-005453-4057qib7	1236	10	potent	potent	JJ
cord-005453-4057qib7	1236	11	cellular	cellular	JJ
cord-005453-4057qib7	1236	12	therapeutics	therapeutic	NNS
cord-005453-4057qib7	1236	13	in	in	IN
cord-005453-4057qib7	1236	14	the	the	DT
cord-005453-4057qib7	1236	15	clinical	clinical	JJ
cord-005453-4057qib7	1236	16	routine	routine	NN
cord-005453-4057qib7	1236	17	.	.	.
cord-005453-4057qib7	1237	1	In	in	IN
cord-005453-4057qib7	1237	2	order	order	NN
cord-005453-4057qib7	1237	3	to	to	TO
cord-005453-4057qib7	1237	4	establish	establish	VB
cord-005453-4057qib7	1237	5	the	the	DT
cord-005453-4057qib7	1237	6	manufacture	manufacture	NN
cord-005453-4057qib7	1237	7	of	of	IN
cord-005453-4057qib7	1237	8	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	1237	9	T	T	NNP
cord-005453-4057qib7	1237	10	cells	cell	NNS
cord-005453-4057qib7	1237	11	,	,	,
cord-005453-4057qib7	1237	12	validation	validation	NN
cord-005453-4057qib7	1237	13	runs	run	VBZ
cord-005453-4057qib7	1237	14	with	with	IN
cord-005453-4057qib7	1237	15	the	the	DT
cord-005453-4057qib7	1237	16	fully	fully	RB
cord-005453-4057qib7	1237	17	automated	automate	VBN
cord-005453-4057qib7	1237	18	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1237	19	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1237	20	T	T	NNP
cord-005453-4057qib7	1237	21	cell	cell	NN
cord-005453-4057qib7	1237	22	transduction	transduction	NN
cord-005453-4057qib7	1237	23	process	process	NN
cord-005453-4057qib7	1237	24	have	have	VBP
cord-005453-4057qib7	1237	25	been	be	VBN
cord-005453-4057qib7	1237	26	performed	perform	VBN
cord-005453-4057qib7	1237	27	using	use	VBG
cord-005453-4057qib7	1237	28	the	the	DT
cord-005453-4057qib7	1237	29	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	1237	30	anti	anti	JJ
cord-005453-4057qib7	1237	31	-	-	JJ
cord-005453-4057qib7	1237	32	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	1237	33	lentiviral	lentiviral	JJ
cord-005453-4057qib7	1237	34	vector	vector	NN
cord-005453-4057qib7	1237	35	.	.	.
cord-005453-4057qib7	1238	1	Methods	method	NNS
cord-005453-4057qib7	1238	2	:	:	:
cord-005453-4057qib7	1239	1	Unmobilized	unmobilized	JJ
cord-005453-4057qib7	1239	2	leukaphereses	leukapherese	VBZ
cord-005453-4057qib7	1239	3	from	from	IN
cord-005453-4057qib7	1239	4	3	3	CD
cord-005453-4057qib7	1239	5	donors	donor	NNS
cord-005453-4057qib7	1239	6	(	(	-LRB-
cord-005453-4057qib7	1239	7	2	2	CD
cord-005453-4057qib7	1239	8	x	x	SYM
cord-005453-4057qib7	1239	9	healthy	healthy	JJ
cord-005453-4057qib7	1239	10	,	,	,
cord-005453-4057qib7	1239	11	1	1	CD
cord-005453-4057qib7	1239	12	x	x	NN
cord-005453-4057qib7	1239	13	ALL	all	DT
cord-005453-4057qib7	1239	14	)	)	-RRB-
cord-005453-4057qib7	1239	15	were	be	VBD
cord-005453-4057qib7	1239	16	used	use	VBN
cord-005453-4057qib7	1239	17	for	for	IN
cord-005453-4057qib7	1239	18	the	the	DT
cord-005453-4057qib7	1239	19	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1239	20	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1239	21	T	T	NNP
cord-005453-4057qib7	1239	22	cell	cell	NN
cord-005453-4057qib7	1239	23	transduction	transduction	NN
cord-005453-4057qib7	1239	24	process	process	NN
cord-005453-4057qib7	1239	25	.	.	.
cord-005453-4057qib7	1240	1	Leukocytes	leukocyte	NNS
cord-005453-4057qib7	1240	2	undergo	undergo	VBP
cord-005453-4057qib7	1240	3	a	a	DT
cord-005453-4057qib7	1240	4	CD4	CD4	NNP
cord-005453-4057qib7	1240	5	+	+	CC
cord-005453-4057qib7	1240	6	/	/	SYM
cord-005453-4057qib7	1240	7	CD8	CD8	NNP
cord-005453-4057qib7	1240	8	+	+	CC
cord-005453-4057qib7	1240	9	T	T	NNP
cord-005453-4057qib7	1240	10	cell	cell	NN
cord-005453-4057qib7	1240	11	enrichment	enrichment	NN
cord-005453-4057qib7	1240	12	via	via	IN
cord-005453-4057qib7	1240	13	magnetic	magnetic	JJ
cord-005453-4057qib7	1240	14	beads	bead	NNS
cord-005453-4057qib7	1240	15	,	,	,
cord-005453-4057qib7	1240	16	followed	follow	VBN
cord-005453-4057qib7	1240	17	by	by	IN
cord-005453-4057qib7	1240	18	stimulation	stimulation	NN
cord-005453-4057qib7	1240	19	with	with	IN
cord-005453-4057qib7	1240	20	MACS	mac	NNS
cord-005453-4057qib7	1241	1	®	®	,
cord-005453-4057qib7	1241	2	GMP	GMP	NNP
cord-005453-4057qib7	1241	3	T	T	NNP
cord-005453-4057qib7	1241	4	cell	cell	NN
cord-005453-4057qib7	1241	5	TransAct	TransAct	NNP
cord-005453-4057qib7	1241	6	™	™	NN
cord-005453-4057qib7	1241	7	,	,	,
cord-005453-4057qib7	1241	8	transduction	transduction	NN
cord-005453-4057qib7	1241	9	with	with	IN
cord-005453-4057qib7	1241	10	an	an	DT
cord-005453-4057qib7	1241	11	anti	anti	JJ
cord-005453-4057qib7	1241	12	-	-	JJ
cord-005453-4057qib7	1241	13	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	1241	14	lentiviral	lentiviral	JJ
cord-005453-4057qib7	1241	15	vector	vector	NN
cord-005453-4057qib7	1241	16	,	,	,
cord-005453-4057qib7	1241	17	expansion	expansion	NN
cord-005453-4057qib7	1241	18	with	with	IN
cord-005453-4057qib7	1241	19	IL7	IL7	NNS
cord-005453-4057qib7	1241	20	and	and	CC
cord-005453-4057qib7	1241	21	IL15	IL15	NNP
cord-005453-4057qib7	1241	22	,	,	,
cord-005453-4057qib7	1241	23	and	and	CC
cord-005453-4057qib7	1241	24	final	final	JJ
cord-005453-4057qib7	1241	25	formulation	formulation	NN
cord-005453-4057qib7	1241	26	to	to	IN
cord-005453-4057qib7	1241	27	the	the	DT
cord-005453-4057qib7	1241	28	cellular	cellular	JJ
cord-005453-4057qib7	1241	29	product	product	NN
cord-005453-4057qib7	1241	30	.	.	.
cord-005453-4057qib7	1242	1	During	during	IN
cord-005453-4057qib7	1242	2	and	and	CC
cord-005453-4057qib7	1242	3	after	after	IN
cord-005453-4057qib7	1242	4	the	the	DT
cord-005453-4057qib7	1242	5	manufacture	manufacture	NN
cord-005453-4057qib7	1242	6	,	,	,
cord-005453-4057qib7	1242	7	FACS	FACS	NNP
cord-005453-4057qib7	1242	8	analyses	analysis	NNS
cord-005453-4057qib7	1242	9	were	be	VBD
cord-005453-4057qib7	1242	10	performed	perform	VBN
cord-005453-4057qib7	1242	11	as	as	RB
cord-005453-4057qib7	1242	12	well	well	RB
cord-005453-4057qib7	1242	13	as	as	IN
cord-005453-4057qib7	1242	14	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1242	15	assays	assay	NNS
cord-005453-4057qib7	1242	16	after	after	IN
cord-005453-4057qib7	1242	17	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	1242	18	T	t	NN
cord-005453-4057qib7	1242	19	cell	cell	NN
cord-005453-4057qib7	1242	20	production	production	NN
cord-005453-4057qib7	1242	21	.	.	.
cord-005453-4057qib7	1243	1	Results	result	NNS
cord-005453-4057qib7	1243	2	:	:	:
cord-005453-4057qib7	1244	1	Total	total	JJ
cord-005453-4057qib7	1244	2	volumes	volume	NNS
cord-005453-4057qib7	1244	3	of	of	IN
cord-005453-4057qib7	1244	4	leukaphereses	leukapherese	NNS
cord-005453-4057qib7	1244	5	were	be	VBD
cord-005453-4057qib7	1244	6	between	between	IN
cord-005453-4057qib7	1244	7	60	60	CD
cord-005453-4057qib7	1244	8	and	and	CC
cord-005453-4057qib7	1244	9	280	280	CD
cord-005453-4057qib7	1244	10	ml	ml	NN
cord-005453-4057qib7	1244	11	with	with	IN
cord-005453-4057qib7	1244	12	2.6	2.6	CD
cord-005453-4057qib7	1244	13	-4.0	-4.0	NNP
cord-005453-4057qib7	1244	14	x	x	SYM
cord-005453-4057qib7	1244	15	10	10	CD
cord-005453-4057qib7	1244	16	9	9	CD
cord-005453-4057qib7	1244	17	total	total	JJ
cord-005453-4057qib7	1244	18	mononuclear	mononuclear	JJ
cord-005453-4057qib7	1244	19	cells	cell	NNS
cord-005453-4057qib7	1244	20	.	.	.
cord-005453-4057qib7	1245	1	After	after	IN
cord-005453-4057qib7	1245	2	enrichment	enrichment	NN
cord-005453-4057qib7	1245	3	100x10	100x10	CD
cord-005453-4057qib7	1245	4	6	6	CD
cord-005453-4057qib7	1245	5	CD4	CD4	NNS
cord-005453-4057qib7	1245	6	+	+	CC
cord-005453-4057qib7	1245	7	/	/	SYM
cord-005453-4057qib7	1245	8	CD8	CD8	NNP
cord-005453-4057qib7	1245	9	+	+	CC
cord-005453-4057qib7	1245	10	T	t	NN
cord-005453-4057qib7	1245	11	cells	cell	NNS
cord-005453-4057qib7	1245	12	were	be	VBD
cord-005453-4057qib7	1245	13	transduced	transduce	VBN
cord-005453-4057qib7	1245	14	with	with	IN
cord-005453-4057qib7	1245	15	anti	anti	JJ
cord-005453-4057qib7	1245	16	-	-	JJ
cord-005453-4057qib7	1245	17	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	1245	18	lentiviral	lentiviral	JJ
cord-005453-4057qib7	1245	19	vector	vector	NN
cord-005453-4057qib7	1245	20	and	and	CC
cord-005453-4057qib7	1245	21	were	be	VBD
cord-005453-4057qib7	1245	22	further	further	RB
cord-005453-4057qib7	1245	23	expanded	expand	VBN
cord-005453-4057qib7	1245	24	.	.	.
cord-005453-4057qib7	1246	1	Cells	cell	NNS
cord-005453-4057qib7	1246	2	were	be	VBD
cord-005453-4057qib7	1246	3	harvested	harvest	VBN
cord-005453-4057qib7	1246	4	on	on	IN
cord-005453-4057qib7	1246	5	day	day	NN
cord-005453-4057qib7	1246	6	12	12	CD
cord-005453-4057qib7	1246	7	.	.	.
cord-005453-4057qib7	1247	1	The	the	DT
cord-005453-4057qib7	1247	2	final	final	JJ
cord-005453-4057qib7	1247	3	cell	cell	NN
cord-005453-4057qib7	1247	4	counts	count	NNS
cord-005453-4057qib7	1247	5	of	of	IN
cord-005453-4057qib7	1247	6	the	the	DT
cord-005453-4057qib7	1247	7	cellular	cellular	JJ
cord-005453-4057qib7	1247	8	products	product	NNS
cord-005453-4057qib7	1247	9	were	be	VBD
cord-005453-4057qib7	1247	10	6.1	6.1	CD
cord-005453-4057qib7	1247	11	,	,	,
cord-005453-4057qib7	1247	12	7.2	7.2	CD
cord-005453-4057qib7	1247	13	and	and	CC
cord-005453-4057qib7	1247	14	5.0	5.0	CD
cord-005453-4057qib7	1247	15	x	x	SYM
cord-005453-4057qib7	1247	16	10	10	CD
cord-005453-4057qib7	1247	17	9	9	CD
cord-005453-4057qib7	1247	18	mononuclear	mononuclear	NN
cord-005453-4057qib7	1247	19	cells	cell	NNS
cord-005453-4057qib7	1247	20	from	from	IN
cord-005453-4057qib7	1247	21	two	two	CD
cord-005453-4057qib7	1247	22	healthy	healthy	JJ
cord-005453-4057qib7	1247	23	volunteers	volunteer	NNS
cord-005453-4057qib7	1247	24	and	and	CC
cord-005453-4057qib7	1247	25	the	the	DT
cord-005453-4057qib7	1247	26	ALL	all	RB
cord-005453-4057qib7	1247	27	-	-	HYPH
cord-005453-4057qib7	1247	28	patient	patient	JJ
cord-005453-4057qib7	1247	29	,	,	,
cord-005453-4057qib7	1247	30	respectively	respectively	RB
cord-005453-4057qib7	1247	31	.	.	.
cord-005453-4057qib7	1248	1	The	the	DT
cord-005453-4057qib7	1248	2	transduction	transduction	NN
cord-005453-4057qib7	1248	3	efficiency	efficiency	NN
cord-005453-4057qib7	1248	4	of	of	IN
cord-005453-4057qib7	1248	5	the	the	DT
cord-005453-4057qib7	1248	6	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	1248	7	T	T	NNP
cord-005453-4057qib7	1248	8	cells	cell	NNS
cord-005453-4057qib7	1248	9	was	be	VBD
cord-005453-4057qib7	1248	10	48.6	48.6	CD
cord-005453-4057qib7	1248	11	%	%	NN
cord-005453-4057qib7	1248	12	,	,	,
cord-005453-4057qib7	1248	13	43.4	43.4	CD
cord-005453-4057qib7	1248	14	%	%	NN
cord-005453-4057qib7	1248	15	and	and	CC
cord-005453-4057qib7	1248	16	32.0	32.0	CD
cord-005453-4057qib7	1248	17	%	%	NN
cord-005453-4057qib7	1248	18	among	among	IN
cord-005453-4057qib7	1248	19	viable	viable	JJ
cord-005453-4057qib7	1248	20	CD3	CD3	NNP
cord-005453-4057qib7	1248	21	+	+	CC
cord-005453-4057qib7	1248	22	cells	cell	NNS
cord-005453-4057qib7	1248	23	.	.	.
cord-005453-4057qib7	1249	1	The	the	DT
cord-005453-4057qib7	1249	2	final	final	JJ
cord-005453-4057qib7	1249	3	count	count	NN
cord-005453-4057qib7	1249	4	of	of	IN
cord-005453-4057qib7	1249	5	CAR	CAR	NNP
cord-005453-4057qib7	1249	6	T	t	NN
cord-005453-4057qib7	1249	7	cells	cell	NNS
cord-005453-4057qib7	1249	8	was	be	VBD
cord-005453-4057qib7	1249	9	therefore	therefore	RB
cord-005453-4057qib7	1249	10	2.9	2.9	CD
cord-005453-4057qib7	1249	11	,	,	,
cord-005453-4057qib7	1249	12	3.0	3.0	CD
cord-005453-4057qib7	1249	13	and	and	CC
cord-005453-4057qib7	1249	14	1.5	1.5	CD
cord-005453-4057qib7	1249	15	x	x	SYM
cord-005453-4057qib7	1249	16	10	10	CD
cord-005453-4057qib7	1249	17	9	9	CD
cord-005453-4057qib7	1249	18	cells	cell	NNS
cord-005453-4057qib7	1249	19	.	.	.
cord-005453-4057qib7	1250	1	The	the	DT
cord-005453-4057qib7	1250	2	final	final	JJ
cord-005453-4057qib7	1250	3	products	product	NNS
cord-005453-4057qib7	1250	4	exerted	exert	VBD
cord-005453-4057qib7	1250	5	excellent	excellent	JJ
cord-005453-4057qib7	1250	6	cytolytic	cytolytic	JJ
cord-005453-4057qib7	1250	7	activity	activity	NN
cord-005453-4057qib7	1250	8	against	against	IN
cord-005453-4057qib7	1250	9	CD19	CD19	NNP
cord-005453-4057qib7	1250	10	+	+	CC
cord-005453-4057qib7	1250	11	BCP	BCP	NNP
cord-005453-4057qib7	1250	12	-	-	:
cord-005453-4057qib7	1250	13	ALL	all	DT
cord-005453-4057qib7	1250	14	cell	cell	NN
cord-005453-4057qib7	1250	15	line	line	NN
cord-005453-4057qib7	1250	16	NALM-6	NALM-6	NNP
cord-005453-4057qib7	1250	17	.	.	.
cord-005453-4057qib7	1251	1	Importantly	importantly	RB
cord-005453-4057qib7	1251	2	,	,	,
cord-005453-4057qib7	1251	3	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	1251	4	T	t	NN
cord-005453-4057qib7	1251	5	cells	cell	NNS
cord-005453-4057qib7	1251	6	generated	generate	VBN
cord-005453-4057qib7	1251	7	from	from	IN
cord-005453-4057qib7	1251	8	the	the	DT
cord-005453-4057qib7	1251	9	ALL	all	DT
cord-005453-4057qib7	1251	10	patient	patient	NN
cord-005453-4057qib7	1251	11	demonstrated	demonstrate	VBD
cord-005453-4057qib7	1251	12	complete	complete	JJ
cord-005453-4057qib7	1251	13	eradication	eradication	NN
cord-005453-4057qib7	1251	14	of	of	IN
cord-005453-4057qib7	1251	15	autologous	autologous	JJ
cord-005453-4057qib7	1251	16	blasts	blast	NNS
cord-005453-4057qib7	1251	17	at	at	IN
cord-005453-4057qib7	1251	18	0.3	0.3	CD
cord-005453-4057qib7	1251	19	to	to	TO
cord-005453-4057qib7	1251	20	1	1	CD
cord-005453-4057qib7	1251	21	E	e	NN
cord-005453-4057qib7	1251	22	:	:	:
cord-005453-4057qib7	1251	23	T	t	NN
cord-005453-4057qib7	1251	24	ratio	ratio	NN
cord-005453-4057qib7	1251	25	after	after	IN
cord-005453-4057qib7	1251	26	24	24	CD
cord-005453-4057qib7	1251	27	hours	hour	NNS
cord-005453-4057qib7	1251	28	incubation	incubation	NN
cord-005453-4057qib7	1251	29	.	.	.
cord-005453-4057qib7	1252	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1252	2	:	:	:
cord-005453-4057qib7	1253	1	The	the	DT
cord-005453-4057qib7	1253	2	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1253	3	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1253	4	T	T	NNP
cord-005453-4057qib7	1253	5	cell	cell	NN
cord-005453-4057qib7	1253	6	transduction	transduction	NN
cord-005453-4057qib7	1253	7	process	process	NN
cord-005453-4057qib7	1253	8	has	have	VBZ
cord-005453-4057qib7	1253	9	been	be	VBN
cord-005453-4057qib7	1253	10	shown	show	VBN
cord-005453-4057qib7	1253	11	to	to	TO
cord-005453-4057qib7	1253	12	run	run	VB
cord-005453-4057qib7	1253	13	a	a	DT
cord-005453-4057qib7	1253	14	fully	fully	RB
cord-005453-4057qib7	1253	15	-	-	HYPH
cord-005453-4057qib7	1253	16	automated	automate	VBN
cord-005453-4057qib7	1253	17	manufacturing	manufacturing	NN
cord-005453-4057qib7	1253	18	process	process	NN
cord-005453-4057qib7	1253	19	over	over	IN
cord-005453-4057qib7	1253	20	12	12	CD
cord-005453-4057qib7	1253	21	days	day	NNS
cord-005453-4057qib7	1253	22	without	without	IN
cord-005453-4057qib7	1253	23	any	any	DT
cord-005453-4057qib7	1253	24	deviations	deviation	NNS
cord-005453-4057qib7	1253	25	in	in	IN
cord-005453-4057qib7	1253	26	a	a	DT
cord-005453-4057qib7	1253	27	clean	clean	JJ
cord-005453-4057qib7	1253	28	room	room	NN
cord-005453-4057qib7	1253	29	environment	environment	NN
cord-005453-4057qib7	1253	30	on	on	IN
cord-005453-4057qib7	1253	31	a	a	DT
cord-005453-4057qib7	1253	32	single	single	JJ
cord-005453-4057qib7	1253	33	device	device	NN
cord-005453-4057qib7	1253	34	.	.	.
cord-005453-4057qib7	1254	1	The	the	DT
cord-005453-4057qib7	1254	2	user	user	NN
cord-005453-4057qib7	1254	3	interaction	interaction	NN
cord-005453-4057qib7	1254	4	was	be	VBD
cord-005453-4057qib7	1254	5	reduced	reduce	VBN
cord-005453-4057qib7	1254	6	to	to	IN
cord-005453-4057qib7	1254	7	activities	activity	NNS
cord-005453-4057qib7	1254	8	at	at	IN
cord-005453-4057qib7	1254	9	only	only	RB
cord-005453-4057qib7	1254	10	3	3	CD
cord-005453-4057qib7	1254	11	days	day	NNS
cord-005453-4057qib7	1254	12	to	to	TO
cord-005453-4057qib7	1254	13	set	set	VB
cord-005453-4057qib7	1254	14	up	up	RP
cord-005453-4057qib7	1254	15	the	the	DT
cord-005453-4057qib7	1254	16	system	system	NN
cord-005453-4057qib7	1254	17	and	and	CC
cord-005453-4057qib7	1254	18	provide	provide	VB
cord-005453-4057qib7	1254	19	fresh	fresh	JJ
cord-005453-4057qib7	1254	20	medium	medium	NN
cord-005453-4057qib7	1254	21	and	and	CC
cord-005453-4057qib7	1254	22	reagents	reagent	NNS
cord-005453-4057qib7	1254	23	.	.	.
cord-005453-4057qib7	1255	1	The	the	DT
cord-005453-4057qib7	1255	2	transduction	transduction	NN
cord-005453-4057qib7	1255	3	process	process	NN
cord-005453-4057qib7	1255	4	yielded	yield	VBD
cord-005453-4057qib7	1255	5	a	a	DT
cord-005453-4057qib7	1255	6	high	high	JJ
cord-005453-4057qib7	1255	7	number	number	NN
cord-005453-4057qib7	1255	8	of	of	IN
cord-005453-4057qib7	1255	9	T	t	NN
cord-005453-4057qib7	1255	10	cells	cell	NNS
cord-005453-4057qib7	1255	11	with	with	IN
cord-005453-4057qib7	1255	12	a	a	DT
cord-005453-4057qib7	1255	13	high	high	JJ
cord-005453-4057qib7	1255	14	frequency	frequency	NN
cord-005453-4057qib7	1255	15	of	of	IN
cord-005453-4057qib7	1255	16	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	1255	17	T	T	NNP
cord-005453-4057qib7	1255	18	transduced	transduce	VBD
cord-005453-4057qib7	1255	19	cells	cell	NNS
cord-005453-4057qib7	1255	20	.	.	.
cord-005453-4057qib7	1256	1	The	the	DT
cord-005453-4057qib7	1256	2	results	result	NNS
cord-005453-4057qib7	1256	3	were	be	VBD
cord-005453-4057qib7	1256	4	comparable	comparable	JJ
cord-005453-4057qib7	1256	5	for	for	IN
cord-005453-4057qib7	1256	6	both	both	DT
cord-005453-4057qib7	1256	7	unmobilized	unmobilized	JJ
cord-005453-4057qib7	1256	8	leukaphereses	leukapherese	NNS
cord-005453-4057qib7	1256	9	from	from	IN
cord-005453-4057qib7	1256	10	healthy	healthy	JJ
cord-005453-4057qib7	1256	11	donors	donor	NNS
cord-005453-4057qib7	1256	12	and	and	CC
cord-005453-4057qib7	1256	13	showed	show	VBD
cord-005453-4057qib7	1256	14	expected	expect	VBN
cord-005453-4057qib7	1256	15	slightly	slightly	RB
cord-005453-4057qib7	1256	16	lower	low	JJR
cord-005453-4057qib7	1256	17	results	result	NNS
cord-005453-4057qib7	1256	18	in	in	IN
cord-005453-4057qib7	1256	19	the	the	DT
cord-005453-4057qib7	1256	20	patient	patient	NN
cord-005453-4057qib7	1256	21	.	.	.
cord-005453-4057qib7	1257	1	Finally	finally	RB
cord-005453-4057qib7	1257	2	,	,	,
cord-005453-4057qib7	1257	3	these	these	DT
cord-005453-4057qib7	1257	4	results	result	NNS
cord-005453-4057qib7	1257	5	demonstrate	demonstrate	VBP
cord-005453-4057qib7	1257	6	that	that	IN
cord-005453-4057qib7	1257	7	the	the	DT
cord-005453-4057qib7	1257	8	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1257	9	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1257	10	T	T	NNP
cord-005453-4057qib7	1257	11	cell	cell	NN
cord-005453-4057qib7	1257	12	transduction	transduction	NN
cord-005453-4057qib7	1257	13	process	process	NN
cord-005453-4057qib7	1257	14	is	be	VBZ
cord-005453-4057qib7	1257	15	well	well	RB
cord-005453-4057qib7	1257	16	suited	suited	JJ
cord-005453-4057qib7	1257	17	to	to	TO
cord-005453-4057qib7	1257	18	provide	provide	VB
cord-005453-4057qib7	1257	19	the	the	DT
cord-005453-4057qib7	1257	20	clinical	clinical	JJ
cord-005453-4057qib7	1257	21	MB	mb	NN
cord-005453-4057qib7	1257	22	-	-	HYPH
cord-005453-4057qib7	1257	23	CART19.1	CART19.1	NNP
cord-005453-4057qib7	1257	24	r	r	NN
cord-005453-4057qib7	1257	25	/	/	SYM
cord-005453-4057qib7	1257	26	r	r	NN
cord-005453-4057qib7	1257	27	CD19	CD19	NNP
cord-005453-4057qib7	1257	28	+	+	CC
cord-005453-4057qib7	1257	29	BCM	bcm	NN
cord-005453-4057qib7	1257	30	study	study	NN
cord-005453-4057qib7	1257	31	with	with	IN
cord-005453-4057qib7	1257	32	appropriate	appropriate	JJ
cord-005453-4057qib7	1257	33	investigational	investigational	JJ
cord-005453-4057qib7	1257	34	medical	medical	JJ
cord-005453-4057qib7	1257	35	products	product	NNS
cord-005453-4057qib7	1257	36	.	.	.
cord-005453-4057qib7	1258	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1258	2	Background	background	NN
cord-005453-4057qib7	1258	3	:	:	:
cord-005453-4057qib7	1259	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	1259	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1259	3	stem	stem	NN
cord-005453-4057qib7	1259	4	cell	cell	NN
cord-005453-4057qib7	1259	5	transplantation	transplantation	NN
cord-005453-4057qib7	1259	6	(	(	-LRB-
cord-005453-4057qib7	1259	7	alloHCT	alloHCT	NNP
cord-005453-4057qib7	1259	8	)	)	-RRB-
cord-005453-4057qib7	1259	9	is	be	VBZ
cord-005453-4057qib7	1259	10	an	an	DT
cord-005453-4057qib7	1259	11	effective	effective	JJ
cord-005453-4057qib7	1259	12	strategy	strategy	NN
cord-005453-4057qib7	1259	13	in	in	IN
cord-005453-4057qib7	1259	14	the	the	DT
cord-005453-4057qib7	1259	15	long	long	JJ
cord-005453-4057qib7	1259	16	term	term	NN
cord-005453-4057qib7	1259	17	control	control	NN
cord-005453-4057qib7	1259	18	of	of	IN
cord-005453-4057qib7	1259	19	several	several	JJ
cord-005453-4057qib7	1259	20	hematologic	hematologic	JJ
cord-005453-4057qib7	1259	21	diseases	disease	NNS
cord-005453-4057qib7	1259	22	,	,	,
cord-005453-4057qib7	1259	23	however	however	RB
cord-005453-4057qib7	1259	24	,	,	,
cord-005453-4057qib7	1259	25	patients	patient	NNS
cord-005453-4057qib7	1259	26	could	could	MD
cord-005453-4057qib7	1259	27	experience	experience	VB
cord-005453-4057qib7	1259	28	complications	complication	NNS
cord-005453-4057qib7	1259	29	,	,	,
cord-005453-4057qib7	1259	30	as	as	IN
cord-005453-4057qib7	1259	31	graft	graft	NN
cord-005453-4057qib7	1259	32	versus	versus	IN
cord-005453-4057qib7	1259	33	host	host	NN
cord-005453-4057qib7	1259	34	disease	disease	NN
cord-005453-4057qib7	1259	35	(	(	-LRB-
cord-005453-4057qib7	1259	36	GVHD	GVHD	NNP
cord-005453-4057qib7	1259	37	)	)	-RRB-
cord-005453-4057qib7	1259	38	and	and	CC
cord-005453-4057qib7	1259	39	disease	disease	NN
cord-005453-4057qib7	1259	40	relapse	relapse	NN
cord-005453-4057qib7	1259	41	.	.	.
cord-005453-4057qib7	1260	1	Recently	recently	RB
cord-005453-4057qib7	1260	2	,	,	,
cord-005453-4057qib7	1260	3	the	the	DT
cord-005453-4057qib7	1260	4	introduction	introduction	NN
cord-005453-4057qib7	1260	5	of	of	IN
cord-005453-4057qib7	1260	6	post	post	JJ
cord-005453-4057qib7	1260	7	-	-	JJ
cord-005453-4057qib7	1260	8	transplant	transplant	NN
cord-005453-4057qib7	1260	9	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	1260	10	(	(	-LRB-
cord-005453-4057qib7	1260	11	ptCy	ptcy	RB
cord-005453-4057qib7	1260	12	)	)	-RRB-
cord-005453-4057qib7	1260	13	allowed	allow	VBN
cord-005453-4057qib7	1260	14	to	to	TO
cord-005453-4057qib7	1260	15	significantly	significantly	RB
cord-005453-4057qib7	1260	16	reduce	reduce	VB
cord-005453-4057qib7	1260	17	GVHD	GVHD	NNP
cord-005453-4057qib7	1260	18	,	,	,
cord-005453-4057qib7	1260	19	but	but	CC
cord-005453-4057qib7	1260	20	disease	disease	NN
cord-005453-4057qib7	1260	21	relapse	relapse	NN
cord-005453-4057qib7	1260	22	remains	remain	VBZ
cord-005453-4057qib7	1260	23	an	an	DT
cord-005453-4057qib7	1260	24	important	important	JJ
cord-005453-4057qib7	1260	25	issue	issue	NN
cord-005453-4057qib7	1260	26	.	.	.
cord-005453-4057qib7	1261	1	Donor	donor	NN
cord-005453-4057qib7	1261	2	-	-	HYPH
cord-005453-4057qib7	1261	3	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1261	4	infusion	infusion	NN
cord-005453-4057qib7	1261	5	(	(	-LRB-
cord-005453-4057qib7	1261	6	DLI	DLI	NNP
cord-005453-4057qib7	1261	7	)	)	-RRB-
cord-005453-4057qib7	1261	8	is	be	VBZ
cord-005453-4057qib7	1261	9	an	an	DT
cord-005453-4057qib7	1261	10	established	establish	VBN
cord-005453-4057qib7	1261	11	adoptive	adoptive	JJ
cord-005453-4057qib7	1261	12	cell	cell	NN
cord-005453-4057qib7	1261	13	therapy	therapy	NN
cord-005453-4057qib7	1261	14	for	for	IN
cord-005453-4057qib7	1261	15	disease	disease	NN
cord-005453-4057qib7	1261	16	relapse	relapse	NN
cord-005453-4057qib7	1261	17	after	after	IN
cord-005453-4057qib7	1261	18	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	1261	19	,	,	,
cord-005453-4057qib7	1261	20	but	but	CC
cord-005453-4057qib7	1261	21	,	,	,
cord-005453-4057qib7	1261	22	in	in	IN
cord-005453-4057qib7	1261	23	order	order	NN
cord-005453-4057qib7	1261	24	to	to	TO
cord-005453-4057qib7	1261	25	be	be	VB
cord-005453-4057qib7	1261	26	efficient	efficient	JJ
cord-005453-4057qib7	1261	27	and	and	CC
cord-005453-4057qib7	1261	28	safe	safe	JJ
cord-005453-4057qib7	1261	29	,	,	,
cord-005453-4057qib7	1261	30	patients	patient	NNS
cord-005453-4057qib7	1261	31	have	have	VBP
cord-005453-4057qib7	1261	32	to	to	TO
cord-005453-4057qib7	1261	33	be	be	VB
cord-005453-4057qib7	1261	34	off	off	IN
cord-005453-4057qib7	1261	35	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1261	36	treatments	treatment	NNS
cord-005453-4057qib7	1261	37	and	and	CC
cord-005453-4057qib7	1261	38	GVDH	GVDH	NNP
cord-005453-4057qib7	1261	39	-	-	HYPH
cord-005453-4057qib7	1261	40	free	free	JJ
cord-005453-4057qib7	1261	41	.	.	.
cord-005453-4057qib7	1262	1	Here	here	RB
cord-005453-4057qib7	1262	2	we	-PRON-	PRP
cord-005453-4057qib7	1262	3	report	report	VBP
cord-005453-4057qib7	1262	4	our	-PRON-	PRP$
cord-005453-4057qib7	1262	5	data	datum	NNS
cord-005453-4057qib7	1262	6	about	about	IN
cord-005453-4057qib7	1262	7	efficacy	efficacy	NN
cord-005453-4057qib7	1262	8	and	and	CC
cord-005453-4057qib7	1262	9	safety	safety	NN
cord-005453-4057qib7	1262	10	of	of	IN
cord-005453-4057qib7	1262	11	DLI	DLI	NNP
cord-005453-4057qib7	1262	12	infusion	infusion	NN
cord-005453-4057qib7	1262	13	as	as	IN
cord-005453-4057qib7	1262	14	treatment	treatment	NN
cord-005453-4057qib7	1262	15	for	for	IN
cord-005453-4057qib7	1262	16	disease	disease	NN
cord-005453-4057qib7	1262	17	relapse	relapse	NN
cord-005453-4057qib7	1262	18	in	in	IN
cord-005453-4057qib7	1262	19	patients	patient	NNS
cord-005453-4057qib7	1262	20	who	who	WP
cord-005453-4057qib7	1262	21	received	receive	VBD
cord-005453-4057qib7	1262	22	peripheral	peripheral	JJ
cord-005453-4057qib7	1262	23	blood	blood	NN
cord-005453-4057qib7	1262	24	stem	stem	NN
cord-005453-4057qib7	1262	25	cell	cell	NN
cord-005453-4057qib7	1262	26	transplantation	transplantation	NN
cord-005453-4057qib7	1262	27	(	(	-LRB-
cord-005453-4057qib7	1262	28	alloPBSCT	alloPBSCT	NNP
cord-005453-4057qib7	1262	29	)	)	-RRB-
cord-005453-4057qib7	1262	30	from	from	IN
cord-005453-4057qib7	1262	31	HLA	HLA	NNP
cord-005453-4057qib7	1262	32	-	-	HYPH
cord-005453-4057qib7	1262	33	matched	match	VBN
cord-005453-4057qib7	1262	34	unrelated	unrelated	JJ
cord-005453-4057qib7	1262	35	/	/	SYM
cord-005453-4057qib7	1262	36	related	relate	VBN
cord-005453-4057qib7	1262	37	plus	plus	CC
cord-005453-4057qib7	1262	38	ptCy	ptcy	RB
cord-005453-4057qib7	1262	39	as	as	IN
cord-005453-4057qib7	1262	40	GVDH	GVDH	NNP
cord-005453-4057qib7	1262	41	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1262	42	in	in	IN
cord-005453-4057qib7	1262	43	our	-PRON-	PRP$
cord-005453-4057qib7	1262	44	clinical	clinical	JJ
cord-005453-4057qib7	1262	45	trial	trial	NN
cord-005453-4057qib7	1262	46	(	(	-LRB-
cord-005453-4057qib7	1262	47	NCT	NCT	NNP
cord-005453-4057qib7	1262	48	02300571	02300571	CD
cord-005453-4057qib7	1262	49	)	)	-RRB-
cord-005453-4057qib7	1262	50	.	.	.
cord-005453-4057qib7	1263	1	Methods	method	NNS
cord-005453-4057qib7	1263	2	:	:	:
cord-005453-4057qib7	1264	1	We	-PRON-	PRP
cord-005453-4057qib7	1264	2	collected	collect	VBD
cord-005453-4057qib7	1264	3	data	datum	NNS
cord-005453-4057qib7	1264	4	from	from	IN
cord-005453-4057qib7	1264	5	13	13	CD
cord-005453-4057qib7	1264	6	patients	patient	NNS
cord-005453-4057qib7	1264	7	,	,	,
cord-005453-4057qib7	1264	8	treated	treat	VBN
cord-005453-4057qib7	1264	9	with	with	IN
cord-005453-4057qib7	1264	10	ptCy	ptcy	RB
cord-005453-4057qib7	1265	1	(	(	-LRB-
cord-005453-4057qib7	1265	2	50	50	CD
cord-005453-4057qib7	1265	3	mg	mg	NNP
cord-005453-4057qib7	1265	4	/	/	SYM
cord-005453-4057qib7	1265	5	kg	kg	NNP
cord-005453-4057qib7	1265	6	/	/	SYM
cord-005453-4057qib7	1265	7	die	die	VBP
cord-005453-4057qib7	1265	8	,	,	,
cord-005453-4057qib7	1265	9	days	day	NNS
cord-005453-4057qib7	1265	10	+3	+3	NNP
cord-005453-4057qib7	1265	11	+	+	SYM
cord-005453-4057qib7	1265	12	4	4	CD
cord-005453-4057qib7	1265	13	)	)	-RRB-
cord-005453-4057qib7	1265	14	,	,	,
cord-005453-4057qib7	1265	15	mofetil	mofetil	NNP
cord-005453-4057qib7	1265	16	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	1265	17	(	(	-LRB-
cord-005453-4057qib7	1265	18	MMF	MMF	NNP
cord-005453-4057qib7	1265	19	)	)	-RRB-
cord-005453-4057qib7	1265	20	and	and	CC
cord-005453-4057qib7	1265	21	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	1265	22	(	(	-LRB-
cord-005453-4057qib7	1265	23	T	T	NNP
cord-005453-4057qib7	1265	24	)	)	-RRB-
cord-005453-4057qib7	1265	25	as	as	IN
cord-005453-4057qib7	1265	26	GVHD	GVHD	NNP
cord-005453-4057qib7	1265	27	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1265	28	after	after	IN
cord-005453-4057qib7	1265	29	allo	allo	NN
cord-005453-4057qib7	1265	30	-	-	HYPH
cord-005453-4057qib7	1265	31	PBSCT	PBSCT	NNP
cord-005453-4057qib7	1265	32	,	,	,
cord-005453-4057qib7	1265	33	who	who	WP
cord-005453-4057qib7	1265	34	received	receive	VBD
cord-005453-4057qib7	1265	35	DLI	DLI	NNP
cord-005453-4057qib7	1265	36	infusions	infusion	NNS
cord-005453-4057qib7	1265	37	.	.	.
cord-005453-4057qib7	1266	1	They	-PRON-	PRP
cord-005453-4057qib7	1266	2	were	be	VBD
cord-005453-4057qib7	1266	3	treated	treat	VBN
cord-005453-4057qib7	1266	4	between	between	IN
cord-005453-4057qib7	1266	5	January	January	NNP
cord-005453-4057qib7	1266	6	2013	2013	CD
cord-005453-4057qib7	1266	7	and	and	CC
cord-005453-4057qib7	1266	8	October	October	NNP
cord-005453-4057qib7	1266	9	2018	2018	CD
cord-005453-4057qib7	1266	10	.	.	.
cord-005453-4057qib7	1267	1	We	-PRON-	PRP
cord-005453-4057qib7	1267	2	report	report	VBP
cord-005453-4057qib7	1267	3	data	datum	NNS
cord-005453-4057qib7	1267	4	about	about	IN
cord-005453-4057qib7	1267	5	overall	overall	JJ
cord-005453-4057qib7	1267	6	response	response	NN
cord-005453-4057qib7	1267	7	rate	rate	NN
cord-005453-4057qib7	1267	8	(	(	-LRB-
cord-005453-4057qib7	1267	9	ORR	ORR	NNP
cord-005453-4057qib7	1267	10	)	)	-RRB-
cord-005453-4057qib7	1267	11	,	,	,
cord-005453-4057qib7	1267	12	disease	disease	NN
cord-005453-4057qib7	1267	13	control	control	NN
cord-005453-4057qib7	1267	14	rate	rate	NN
cord-005453-4057qib7	1267	15	(	(	-LRB-
cord-005453-4057qib7	1267	16	DCR	DCR	NNP
cord-005453-4057qib7	1267	17	)	)	-RRB-
cord-005453-4057qib7	1267	18	,	,	,
cord-005453-4057qib7	1267	19	and	and	CC
cord-005453-4057qib7	1267	20	DLI	DLI	NNP
cord-005453-4057qib7	1267	21	-	-	HYPH
cord-005453-4057qib7	1267	22	related	relate	VBN
cord-005453-4057qib7	1267	23	mortality	mortality	NN
cord-005453-4057qib7	1267	24	and	and	CC
cord-005453-4057qib7	1267	25	morbidity	morbidity	NN
cord-005453-4057qib7	1267	26	.	.	.
cord-005453-4057qib7	1268	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	1268	2	were	be	VBD
cord-005453-4057qib7	1268	3	as	as	IN
cord-005453-4057qib7	1268	4	follow	follow	NN
cord-005453-4057qib7	1268	5	:	:	:
cord-005453-4057qib7	1268	6	5	5	CD
cord-005453-4057qib7	1268	7	had	have	VBD
cord-005453-4057qib7	1268	8	multiple	multiple	JJ
cord-005453-4057qib7	1268	9	myeloma	myeloma	NN
cord-005453-4057qib7	1268	10	,	,	,
cord-005453-4057qib7	1268	11	3	3	CD
cord-005453-4057qib7	1268	12	had	have	VBD
cord-005453-4057qib7	1268	13	acute	acute	JJ
cord-005453-4057qib7	1268	14	myeloid	myeloid	JJ
cord-005453-4057qib7	1268	15	leukemia	leukemia	NN
cord-005453-4057qib7	1268	16	,	,	,
cord-005453-4057qib7	1268	17	3	3	CD
cord-005453-4057qib7	1268	18	had	have	VBD
cord-005453-4057qib7	1268	19	acute	acute	JJ
cord-005453-4057qib7	1268	20	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	1268	21	leukemia	leukemia	NN
cord-005453-4057qib7	1268	22	and	and	CC
cord-005453-4057qib7	1268	23	2	2	CD
cord-005453-4057qib7	1268	24	had	have	VBD
cord-005453-4057qib7	1268	25	lymphomas	lymphoma	NNS
cord-005453-4057qib7	1268	26	.	.	.
cord-005453-4057qib7	1269	1	All	all	DT
cord-005453-4057qib7	1269	2	patients	patient	NNS
cord-005453-4057qib7	1269	3	but	but	CC
cord-005453-4057qib7	1269	4	one	one	CD
cord-005453-4057qib7	1269	5	,	,	,
cord-005453-4057qib7	1269	6	who	who	WP
cord-005453-4057qib7	1269	7	had	have	VBD
cord-005453-4057qib7	1269	8	chimerism	chimerism	NN
cord-005453-4057qib7	1269	9	loss	loss	NN
cord-005453-4057qib7	1269	10	,	,	,
cord-005453-4057qib7	1269	11	received	receive	VBD
cord-005453-4057qib7	1269	12	DLI	DLI	NNP
cord-005453-4057qib7	1269	13	because	because	IN
cord-005453-4057qib7	1269	14	of	of	IN
cord-005453-4057qib7	1269	15	disease	disease	NN
cord-005453-4057qib7	1269	16	relapse	relapse	NN
cord-005453-4057qib7	1269	17	.	.	.
cord-005453-4057qib7	1270	1	Results	result	NNS
cord-005453-4057qib7	1270	2	:	:	:
cord-005453-4057qib7	1271	1	Median	median	JJ
cord-005453-4057qib7	1271	2	time	time	NN
cord-005453-4057qib7	1271	3	between	between	IN
cord-005453-4057qib7	1271	4	transplant	transplant	NN
cord-005453-4057qib7	1271	5	and	and	CC
cord-005453-4057qib7	1271	6	DLI	DLI	NNP
cord-005453-4057qib7	1271	7	was	be	VBD
cord-005453-4057qib7	1271	8	9	9	CD
cord-005453-4057qib7	1272	1	(	(	-LRB-
cord-005453-4057qib7	1272	2	range	range	NNP
cord-005453-4057qib7	1272	3	3	3	CD
cord-005453-4057qib7	1272	4	-	-	SYM
cord-005453-4057qib7	1272	5	87	87	CD
cord-005453-4057qib7	1272	6	)	)	-RRB-
cord-005453-4057qib7	1272	7	months	month	NNS
cord-005453-4057qib7	1272	8	.	.	.
cord-005453-4057qib7	1273	1	Median	median	JJ
cord-005453-4057qib7	1273	2	number	number	NN
cord-005453-4057qib7	1273	3	of	of	IN
cord-005453-4057qib7	1273	4	DLI	DLI	NNP
cord-005453-4057qib7	1273	5	infusions	infusion	NNS
cord-005453-4057qib7	1273	6	was	be	VBD
cord-005453-4057qib7	1273	7	2	2	CD
cord-005453-4057qib7	1274	1	(	(	-LRB-
cord-005453-4057qib7	1274	2	range	range	NNP
cord-005453-4057qib7	1274	3	1	1	CD
cord-005453-4057qib7	1274	4	-	-	SYM
cord-005453-4057qib7	1274	5	13	13	CD
cord-005453-4057qib7	1274	6	)	)	-RRB-
cord-005453-4057qib7	1274	7	.	.	.
cord-005453-4057qib7	1275	1	10	10	CD
cord-005453-4057qib7	1275	2	patients	patient	NNS
cord-005453-4057qib7	1275	3	(	(	-LRB-
cord-005453-4057qib7	1275	4	77	77	CD
cord-005453-4057qib7	1275	5	%	%	NN
cord-005453-4057qib7	1275	6	)	)	-RRB-
cord-005453-4057qib7	1275	7	received	receive	VBD
cord-005453-4057qib7	1275	8	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	1275	9	300	300	CD
cord-005453-4057qib7	1275	10	mg	mg	NNP
cord-005453-4057qib7	1275	11	/	/	SYM
cord-005453-4057qib7	1275	12	m2	m2	NNP
cord-005453-4057qib7	1275	13	preparative	preparative	JJ
cord-005453-4057qib7	1275	14	regimen	regimen	NN
cord-005453-4057qib7	1275	15	the	the	DT
cord-005453-4057qib7	1275	16	day	day	NN
cord-005453-4057qib7	1275	17	before	before	IN
cord-005453-4057qib7	1275	18	the	the	DT
cord-005453-4057qib7	1275	19	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	1275	20	DLI	DLI	NNP
cord-005453-4057qib7	1275	21	infusions	infusion	NNS
cord-005453-4057qib7	1275	22	,	,	,
cord-005453-4057qib7	1275	23	while	while	IN
cord-005453-4057qib7	1275	24	in	in	IN
cord-005453-4057qib7	1275	25	the	the	DT
cord-005453-4057qib7	1275	26	other	other	JJ
cord-005453-4057qib7	1275	27	3	3	CD
cord-005453-4057qib7	1275	28	cases	case	NNS
cord-005453-4057qib7	1275	29	DLI	DLI	NNP
cord-005453-4057qib7	1275	30	were	be	VBD
cord-005453-4057qib7	1275	31	associated	associate	VBN
cord-005453-4057qib7	1275	32	with	with	IN
cord-005453-4057qib7	1275	33	Lenalidomide	Lenalidomide	NNP
cord-005453-4057qib7	1275	34	,	,	,
cord-005453-4057qib7	1275	35	Ponatinib	Ponatinib	NNP
cord-005453-4057qib7	1275	36	and	and	CC
cord-005453-4057qib7	1275	37	5-Azacitidine	5-azacitidine	CD
cord-005453-4057qib7	1275	38	.	.	.
cord-005453-4057qib7	1276	1	The	the	DT
cord-005453-4057qib7	1276	2	overall	overall	JJ
cord-005453-4057qib7	1276	3	response	response	NN
cord-005453-4057qib7	1276	4	rate	rate	NN
cord-005453-4057qib7	1276	5	(	(	-LRB-
cord-005453-4057qib7	1276	6	ORR	ORR	NNP
cord-005453-4057qib7	1276	7	)	)	-RRB-
cord-005453-4057qib7	1276	8	was	be	VBD
cord-005453-4057qib7	1276	9	50	50	CD
cord-005453-4057qib7	1276	10	%	%	NN
cord-005453-4057qib7	1276	11	,	,	,
cord-005453-4057qib7	1276	12	while	while	IN
cord-005453-4057qib7	1276	13	disease	disease	NN
cord-005453-4057qib7	1276	14	control	control	NN
cord-005453-4057qib7	1276	15	rate	rate	NN
cord-005453-4057qib7	1276	16	(	(	-LRB-
cord-005453-4057qib7	1276	17	DCR	DCR	NNP
cord-005453-4057qib7	1276	18	)	)	-RRB-
cord-005453-4057qib7	1276	19	was	be	VBD
cord-005453-4057qib7	1276	20	achieved	achieve	VBN
cord-005453-4057qib7	1276	21	in	in	IN
cord-005453-4057qib7	1276	22	75	75	CD
cord-005453-4057qib7	1276	23	%	%	NN
cord-005453-4057qib7	1276	24	.	.	.
cord-005453-4057qib7	1277	1	The	the	DT
cord-005453-4057qib7	1277	2	patient	patient	NN
cord-005453-4057qib7	1277	3	who	who	WP
cord-005453-4057qib7	1277	4	received	receive	VBD
cord-005453-4057qib7	1277	5	DLI	DLI	NNP
cord-005453-4057qib7	1277	6	because	because	IN
cord-005453-4057qib7	1277	7	of	of	IN
cord-005453-4057qib7	1277	8	loss	loss	NN
cord-005453-4057qib7	1277	9	of	of	IN
cord-005453-4057qib7	1277	10	chimerism	chimerism	NN
cord-005453-4057qib7	1277	11	converted	convert	VBD
cord-005453-4057qib7	1277	12	it	-PRON-	PRP
cord-005453-4057qib7	1277	13	in	in	IN
cord-005453-4057qib7	1277	14	full	full	JJ
cord-005453-4057qib7	1277	15	donor	donor	NN
cord-005453-4057qib7	1277	16	after	after	IN
cord-005453-4057qib7	1277	17	2	2	CD
cord-005453-4057qib7	1277	18	infusions	infusion	NNS
cord-005453-4057qib7	1277	19	.	.	.
cord-005453-4057qib7	1278	1	After	after	IN
cord-005453-4057qib7	1278	2	DLI	DLI	NNP
cord-005453-4057qib7	1278	3	treatment	treatment	NN
cord-005453-4057qib7	1278	4	the	the	DT
cord-005453-4057qib7	1278	5	incidence	incidence	NN
cord-005453-4057qib7	1278	6	of	of	IN
cord-005453-4057qib7	1278	7	acute	acute	JJ
cord-005453-4057qib7	1278	8	GVHD	GVHD	NNP
cord-005453-4057qib7	1278	9	grade	grade	NN
cord-005453-4057qib7	1278	10	I	I	NNP
cord-005453-4057qib7	1278	11	-	-	HYPH
cord-005453-4057qib7	1278	12	III	III	NNP
cord-005453-4057qib7	1278	13	was	be	VBD
cord-005453-4057qib7	1278	14	54	54	CD
cord-005453-4057qib7	1278	15	%	%	NN
cord-005453-4057qib7	1278	16	,	,	,
cord-005453-4057qib7	1279	1	while	while	IN
cord-005453-4057qib7	1279	2	was	be	VBD
cord-005453-4057qib7	1279	3	46	46	CD
cord-005453-4057qib7	1279	4	%	%	NN
cord-005453-4057qib7	1279	5	for	for	IN
cord-005453-4057qib7	1279	6	grade	grade	NN
cord-005453-4057qib7	1279	7	II	II	NNP
cord-005453-4057qib7	1279	8	-	-	HYPH
cord-005453-4057qib7	1279	9	III	III	NNP
cord-005453-4057qib7	1279	10	and	and	CC
cord-005453-4057qib7	1279	11	patients	patient	NNS
cord-005453-4057qib7	1279	12	were	be	VBD
cord-005453-4057qib7	1279	13	started	start	VBN
cord-005453-4057qib7	1279	14	on	on	IN
cord-005453-4057qib7	1279	15	short	short	JJ
cord-005453-4057qib7	1279	16	course	course	NN
cord-005453-4057qib7	1279	17	of	of	IN
cord-005453-4057qib7	1279	18	systemic	systemic	JJ
cord-005453-4057qib7	1279	19	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1279	20	treatments	treatment	NNS
cord-005453-4057qib7	1279	21	.	.	.
cord-005453-4057qib7	1280	1	None	none	NN
cord-005453-4057qib7	1280	2	of	of	IN
cord-005453-4057qib7	1280	3	these	these	DT
cord-005453-4057qib7	1280	4	patients	patient	NNS
cord-005453-4057qib7	1280	5	died	die	VBD
cord-005453-4057qib7	1280	6	because	because	IN
cord-005453-4057qib7	1280	7	of	of	IN
cord-005453-4057qib7	1280	8	DLI	DLI	NNP
cord-005453-4057qib7	1280	9	adverse	adverse	JJ
cord-005453-4057qib7	1280	10	events	event	NNS
cord-005453-4057qib7	1280	11	.	.	.
cord-005453-4057qib7	1281	1	Estimated	estimate	VBN
cord-005453-4057qib7	1281	2	1-year	1-year	CD
cord-005453-4057qib7	1281	3	overall	overall	JJ
cord-005453-4057qib7	1281	4	survival	survival	NN
cord-005453-4057qib7	1281	5	was	be	VBD
cord-005453-4057qib7	1281	6	77	77	CD
cord-005453-4057qib7	1281	7	%	%	NN
cord-005453-4057qib7	1281	8	with	with	IN
cord-005453-4057qib7	1281	9	a	a	DT
cord-005453-4057qib7	1281	10	limited	limited	JJ
cord-005453-4057qib7	1281	11	follow	follow	NN
cord-005453-4057qib7	1281	12	-	-	HYPH
cord-005453-4057qib7	1281	13	up	up	NN
cord-005453-4057qib7	1281	14	length	length	NN
cord-005453-4057qib7	1281	15	(	(	-LRB-
cord-005453-4057qib7	1281	16	6	6	CD
cord-005453-4057qib7	1281	17	months	month	NNS
cord-005453-4057qib7	1281	18	)	)	-RRB-
cord-005453-4057qib7	1281	19	.	.	.
cord-005453-4057qib7	1282	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1282	2	:	:	:
cord-005453-4057qib7	1283	1	The	the	DT
cord-005453-4057qib7	1283	2	infusion	infusion	NN
cord-005453-4057qib7	1283	3	of	of	IN
cord-005453-4057qib7	1283	4	non	non	JJ
cord-005453-4057qib7	1283	5	-	-	JJ
cord-005453-4057qib7	1283	6	manipulated	manipulate	VBN
cord-005453-4057qib7	1283	7	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1283	8	from	from	IN
cord-005453-4057qib7	1283	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	1283	10	donors	donor	NNS
cord-005453-4057qib7	1283	11	is	be	VBZ
cord-005453-4057qib7	1283	12	a	a	DT
cord-005453-4057qib7	1283	13	valuable	valuable	JJ
cord-005453-4057qib7	1283	14	and	and	CC
cord-005453-4057qib7	1283	15	safe	safe	JJ
cord-005453-4057qib7	1283	16	strategy	strategy	NN
cord-005453-4057qib7	1283	17	of	of	IN
cord-005453-4057qib7	1283	18	treatment	treatment	NN
cord-005453-4057qib7	1283	19	for	for	IN
cord-005453-4057qib7	1283	20	patients	patient	NNS
cord-005453-4057qib7	1283	21	relapsing	relapse	VBG
cord-005453-4057qib7	1283	22	after	after	IN
cord-005453-4057qib7	1283	23	alloPBSCT	alloPBSCT	NNP
cord-005453-4057qib7	1283	24	with	with	IN
cord-005453-4057qib7	1283	25	ptCy	ptcy	RB
cord-005453-4057qib7	1283	26	.	.	.
cord-005453-4057qib7	1284	1	ptCy	ptcy	RB
cord-005453-4057qib7	1284	2	showed	show	VBD
cord-005453-4057qib7	1284	3	high	high	JJ
cord-005453-4057qib7	1284	4	efficacy	efficacy	NN
cord-005453-4057qib7	1284	5	in	in	IN
cord-005453-4057qib7	1284	6	GVHD	GVHD	NNP
cord-005453-4057qib7	1284	7	prevention	prevention	NN
cord-005453-4057qib7	1284	8	,	,	,
cord-005453-4057qib7	1284	9	allowing	allow	VBG
cord-005453-4057qib7	1284	10	early	early	JJ
cord-005453-4057qib7	1284	11	discontinuation	discontinuation	NN
cord-005453-4057qib7	1284	12	of	of	IN
cord-005453-4057qib7	1284	13	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1284	14	drugs	drug	NNS
cord-005453-4057qib7	1284	15	.	.	.
cord-005453-4057qib7	1285	1	Because	because	IN
cord-005453-4057qib7	1285	2	of	of	IN
cord-005453-4057qib7	1285	3	this	this	DT
cord-005453-4057qib7	1285	4	,	,	,
cord-005453-4057qib7	1285	5	we	-PRON-	PRP
cord-005453-4057qib7	1285	6	can	can	MD
cord-005453-4057qib7	1285	7	reach	reach	VB
cord-005453-4057qib7	1285	8	the	the	DT
cord-005453-4057qib7	1285	9	goal	goal	NN
cord-005453-4057qib7	1285	10	to	to	TO
cord-005453-4057qib7	1285	11	transform	transform	VB
cord-005453-4057qib7	1285	12	transplant	transplant	NN
cord-005453-4057qib7	1285	13	in	in	IN
cord-005453-4057qib7	1285	14	a	a	DT
cord-005453-4057qib7	1285	15	platform	platform	NN
cord-005453-4057qib7	1285	16	where	where	WRB
cord-005453-4057qib7	1285	17	we	-PRON-	PRP
cord-005453-4057qib7	1285	18	could	could	MD
cord-005453-4057qib7	1285	19	add	add	VB
cord-005453-4057qib7	1285	20	early	early	JJ
cord-005453-4057qib7	1285	21	DLI	DLI	NNP
cord-005453-4057qib7	1285	22	infusions	infusion	NNS
cord-005453-4057qib7	1285	23	as	as	IN
cord-005453-4057qib7	1285	24	a	a	DT
cord-005453-4057qib7	1285	25	new	new	JJ
cord-005453-4057qib7	1285	26	strategy	strategy	NN
cord-005453-4057qib7	1285	27	for	for	IN
cord-005453-4057qib7	1285	28	disease	disease	NNP
cord-005453-4057qib7	1285	29	control	control	NN
cord-005453-4057qib7	1285	30	.	.	.
cord-005453-4057qib7	1286	1	Clinical	clinical	JJ
cord-005453-4057qib7	1286	2	Trial	Trial	NNP
cord-005453-4057qib7	1286	3	Registry	Registry	NNP
cord-005453-4057qib7	1286	4	:	:	:
cord-005453-4057qib7	1287	1	NCT	NCT	NNP
cord-005453-4057qib7	1287	2	02300571	02300571	CD
cord-005453-4057qib7	1287	3	Disclosure	Disclosure	NNP
cord-005453-4057qib7	1287	4	:	:	:
cord-005453-4057qib7	1287	5	Nothing	nothing	NN
cord-005453-4057qib7	1287	6	to	to	TO
cord-005453-4057qib7	1287	7	declare	declare	VB
cord-005453-4057qib7	1287	8	P074	P074	VBN
cord-005453-4057qib7	1287	9	Extracorporeal	extracorporeal	NN
cord-005453-4057qib7	1287	10	photopheresis	photopheresis	NN
cord-005453-4057qib7	1287	11	in	in	IN
cord-005453-4057qib7	1287	12	the	the	DT
cord-005453-4057qib7	1287	13	treatment	treatment	NN
cord-005453-4057qib7	1287	14	of	of	IN
cord-005453-4057qib7	1287	15	refractory	refractory	JJ
cord-005453-4057qib7	1287	16	chronic	chronic	JJ
cord-005453-4057qib7	1287	17	GVHD	GVHD	NNP
cord-005453-4057qib7	1287	18	:	:	:
cord-005453-4057qib7	1288	1	Analysis	analysis	NN
cord-005453-4057qib7	1288	2	of	of	IN
cord-005453-4057qib7	1288	3	mononuclear	mononuclear	JJ
cord-005453-4057qib7	1288	4	cell	cell	NN
cord-005453-4057qib7	1288	5	infusion	infusion	NN
cord-005453-4057qib7	1288	6	Gillen	Gillen	NNP
cord-005453-4057qib7	1288	7	Oarbeascoa	Oarbeascoa	NNP
cord-005453-4057qib7	1288	8	1	1	CD
cord-005453-4057qib7	1288	9	,	,	,
cord-005453-4057qib7	1288	10	Maria	Maria	NNP
cord-005453-4057qib7	1288	11	Luisa	Luisa	NNP
cord-005453-4057qib7	1288	12	Lozano	Lozano	NNP
cord-005453-4057qib7	1288	13	2,3,4	2,3,4	CD
cord-005453-4057qib7	1288	14	,	,	,
cord-005453-4057qib7	1289	1	Luisa	Luisa	NNP
cord-005453-4057qib7	1289	2	Maria	Maria	NNP
cord-005453-4057qib7	1289	3	Guerra	Guerra	NNP
cord-005453-4057qib7	1289	4	5	5	CD
cord-005453-4057qib7	1289	5	,	,	,
cord-005453-4057qib7	1289	6	Cristina	Cristina	NNP
cord-005453-4057qib7	1289	7	Amunarriz	Amunarriz	NNP
cord-005453-4057qib7	1289	8	6	6	CD
cord-005453-4057qib7	1289	9	,	,	,
cord-005453-4057qib7	1289	10	Nuria	Nuria	NNP
cord-005453-4057qib7	1289	11	Revilla	Revilla	NNP
cord-005453-4057qib7	1289	12	2,3,4	2,3,4	CD
cord-005453-4057qib7	1289	13	,	,	,
cord-005453-4057qib7	1289	14	Pastora	Pastora	NNP
cord-005453-4057qib7	1289	15	Iniesta	Iniesta	NNP
cord-005453-4057qib7	1289	16	2,3,4	2,3,4	CD
cord-005453-4057qib7	1289	17	,	,	,
cord-005453-4057qib7	1289	18	Cynthia	Cynthia	NNP
cord-005453-4057qib7	1289	19	Acosta	Acosta	NNP
cord-005453-4057qib7	1289	20	Fleitas	Fleitas	NNP
cord-005453-4057qib7	1289	21	5	5	CD
cord-005453-4057qib7	1289	22	,	,	,
cord-005453-4057qib7	1289	23	Jose	Jose	NNP
cord-005453-4057qib7	1289	24	Luis	Luis	NNP
cord-005453-4057qib7	1289	25	Arroyo	Arroyo	NNP
cord-005453-4057qib7	1289	26	6	6	CD
cord-005453-4057qib7	1289	27	,	,	,
cord-005453-4057qib7	1289	28	Eva	Eva	NNP
cord-005453-4057qib7	1289	29	Martinez	Martinez	NNP
cord-005453-4057qib7	1290	1	Revuelta	Revuelta	NNP
cord-005453-4057qib7	1290	2	7	7	CD
cord-005453-4057qib7	1290	3	,	,	,
cord-005453-4057qib7	1290	4	Andrea	Andrea	NNP
cord-005453-4057qib7	1290	5	Galego	Galego	NNP
cord-005453-4057qib7	1290	6	8	8	CD
cord-005453-4057qib7	1290	7	,	,	,
cord-005453-4057qib7	1290	8	Dolores	Dolores	NNP
cord-005453-4057qib7	1290	9	Hernandez	Hernandez	NNP
cord-005453-4057qib7	1290	10	-	-	HYPH
cord-005453-4057qib7	1290	11	Maraver	Maraver	NNP
cord-005453-4057qib7	1290	12	9	9	CD
cord-005453-4057qib7	1290	13	,	,	,
cord-005453-4057qib7	1290	14	Mi	Mi	NNP
cord-005453-4057qib7	1290	15	Kwon	Kwon	NNP
cord-005453-4057qib7	1290	16	1,10	1,10	CD
cord-005453-4057qib7	1290	17	,	,	,
cord-005453-4057qib7	1290	18	Aurora	Aurora	NNP
cord-005453-4057qib7	1290	19	Viejo	Viejo	NNP
cord-005453-4057qib7	1290	20	9	9	CD
cord-005453-4057qib7	1290	21	,	,	,
cord-005453-4057qib7	1290	22	Jose	Jose	NNP
cord-005453-4057qib7	1290	23	Maria	Maria	NNP
cord-005453-4057qib7	1290	24	Garcia	Garcia	NNP
cord-005453-4057qib7	1290	25	Gala	Gala	NNP
cord-005453-4057qib7	1290	26	7	7	CD
cord-005453-4057qib7	1290	27	,	,	,
cord-005453-4057qib7	1290	28	Concepcion	Concepcion	NNP
cord-005453-4057qib7	1290	29	Andon	Andon	NNP
cord-005453-4057qib7	1290	30	Saavedra	Saavedra	NNP
cord-005453-4057qib7	1290	31	8	8	CD
cord-005453-4057qib7	1290	32	,	,	,
cord-005453-4057qib7	1290	33	Jose	Jose	NNP
cord-005453-4057qib7	1290	34	Luis	Luis	NNP
cord-005453-4057qib7	1290	35	Diez	Diez	NNP
cord-005453-4057qib7	1290	36	-	-	HYPH
cord-005453-4057qib7	1290	37	Martin	Martin	NNP
cord-005453-4057qib7	1290	38	1	1	CD
cord-005453-4057qib7	1290	39	,	,	,
cord-005453-4057qib7	1290	40	10	10	CD
cord-005453-4057qib7	1290	41	,	,	,
cord-005453-4057qib7	1290	42	11	11	CD
cord-005453-4057qib7	1290	43	Background	background	NN
cord-005453-4057qib7	1290	44	:	:	:
cord-005453-4057qib7	1291	1	Extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	1291	2	photopheresis	photopheresis	NN
cord-005453-4057qib7	1291	3	(	(	-LRB-
cord-005453-4057qib7	1291	4	ECP	ECP	NNP
cord-005453-4057qib7	1291	5	)	)	-RRB-
cord-005453-4057qib7	1291	6	is	be	VBZ
cord-005453-4057qib7	1291	7	an	an	DT
cord-005453-4057qib7	1291	8	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	1291	9	treatment	treatment	NN
cord-005453-4057qib7	1291	10	that	that	WDT
cord-005453-4057qib7	1291	11	has	have	VBZ
cord-005453-4057qib7	1291	12	shown	show	VBN
cord-005453-4057qib7	1291	13	efficacy	efficacy	NN
cord-005453-4057qib7	1291	14	in	in	IN
cord-005453-4057qib7	1291	15	steroid	steroid	JJ
cord-005453-4057qib7	1291	16	refractory	refractory	JJ
cord-005453-4057qib7	1291	17	chronic	chronic	NN
cord-005453-4057qib7	1291	18	GvHD	GvHD	NNP
cord-005453-4057qib7	1291	19	,	,	,
cord-005453-4057qib7	1291	20	but	but	CC
cord-005453-4057qib7	1291	21	the	the	DT
cord-005453-4057qib7	1291	22	mechanism	mechanism	NN
cord-005453-4057qib7	1291	23	of	of	IN
cord-005453-4057qib7	1291	24	action	action	NN
cord-005453-4057qib7	1291	25	is	be	VBZ
cord-005453-4057qib7	1291	26	only	only	RB
cord-005453-4057qib7	1291	27	partially	partially	RB
cord-005453-4057qib7	1291	28	understood	understand	VBN
cord-005453-4057qib7	1291	29	.	.	.
cord-005453-4057qib7	1292	1	In	in	IN
cord-005453-4057qib7	1292	2	some	some	DT
cord-005453-4057qib7	1292	3	studies	study	NNS
cord-005453-4057qib7	1292	4	,	,	,
cord-005453-4057qib7	1292	5	a	a	DT
cord-005453-4057qib7	1292	6	correlation	correlation	NN
cord-005453-4057qib7	1292	7	has	have	VBZ
cord-005453-4057qib7	1292	8	been	be	VBN
cord-005453-4057qib7	1292	9	suggested	suggest	VBN
cord-005453-4057qib7	1292	10	between	between	IN
cord-005453-4057qib7	1292	11	treated	treat	VBN
cord-005453-4057qib7	1292	12	Mononuclear	Mononuclear	NNP
cord-005453-4057qib7	1292	13	cells	cell	NNS
cord-005453-4057qib7	1292	14	(	(	-LRB-
cord-005453-4057qib7	1292	15	MNC	MNC	NNP
cord-005453-4057qib7	1292	16	)	)	-RRB-
cord-005453-4057qib7	1292	17	or	or	CC
cord-005453-4057qib7	1292	18	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1292	19	and	and	CC
cord-005453-4057qib7	1292	20	response	response	NN
cord-005453-4057qib7	1292	21	to	to	IN
cord-005453-4057qib7	1292	22	ECP	ECP	NNP
cord-005453-4057qib7	1292	23	.	.	.
cord-005453-4057qib7	1293	1	The	the	DT
cord-005453-4057qib7	1293	2	objective	objective	NN
cord-005453-4057qib7	1293	3	of	of	IN
cord-005453-4057qib7	1293	4	the	the	DT
cord-005453-4057qib7	1293	5	study	study	NN
cord-005453-4057qib7	1293	6	was	be	VBD
cord-005453-4057qib7	1293	7	to	to	TO
cord-005453-4057qib7	1293	8	analyze	analyze	VB
cord-005453-4057qib7	1293	9	the	the	DT
cord-005453-4057qib7	1293	10	relationship	relationship	NN
cord-005453-4057qib7	1293	11	between	between	IN
cord-005453-4057qib7	1293	12	the	the	DT
cord-005453-4057qib7	1293	13	infused	infuse	VBN
cord-005453-4057qib7	1293	14	cellularity	cellularity	NN
cord-005453-4057qib7	1293	15	and	and	CC
cord-005453-4057qib7	1293	16	response	response	NN
cord-005453-4057qib7	1293	17	in	in	IN
cord-005453-4057qib7	1293	18	chronic	chronic	JJ
cord-005453-4057qib7	1293	19	GvHD	GvHD	NNP
cord-005453-4057qib7	1293	20	.	.	.
cord-005453-4057qib7	1294	1	Methods	method	NNS
cord-005453-4057qib7	1294	2	:	:	:
cord-005453-4057qib7	1294	3	48	48	CD
cord-005453-4057qib7	1294	4	patients	patient	NNS
cord-005453-4057qib7	1294	5	from	from	IN
cord-005453-4057qib7	1294	6	7	7	CD
cord-005453-4057qib7	1294	7	different	different	JJ
cord-005453-4057qib7	1294	8	centers	center	NNS
cord-005453-4057qib7	1294	9	with	with	IN
cord-005453-4057qib7	1294	10	a	a	DT
cord-005453-4057qib7	1294	11	total	total	NN
cord-005453-4057qib7	1294	12	of	of	IN
cord-005453-4057qib7	1294	13	930	930	CD
cord-005453-4057qib7	1294	14	ECP	ECP	NNP
cord-005453-4057qib7	1294	15	procedures	procedure	NNS
cord-005453-4057qib7	1294	16	were	be	VBD
cord-005453-4057qib7	1294	17	retrospectively	retrospectively	RB
cord-005453-4057qib7	1294	18	analyzed	analyze	VBN
cord-005453-4057qib7	1294	19	.	.	.
cord-005453-4057qib7	1295	1	ECP	ECP	NNP
cord-005453-4057qib7	1295	2	procedures	procedure	NNS
cord-005453-4057qib7	1295	3	were	be	VBD
cord-005453-4057qib7	1295	4	performed	perform	VBN
cord-005453-4057qib7	1295	5	from	from	IN
cord-005453-4057qib7	1295	6	January-2011	January-2011	NNP
cord-005453-4057qib7	1295	7	to	to	IN
cord-005453-4057qib7	1295	8	June-2017	june-2017	ADD
cord-005453-4057qib7	1295	9	.	.	.
cord-005453-4057qib7	1296	1	All	all	DT
cord-005453-4057qib7	1296	2	ECP	ECP	NNP
cord-005453-4057qib7	1296	3	procedures	procedure	NNS
cord-005453-4057qib7	1296	4	were	be	VBD
cord-005453-4057qib7	1296	5	performed	perform	VBN
cord-005453-4057qib7	1296	6	with	with	IN
cord-005453-4057qib7	1296	7	the	the	DT
cord-005453-4057qib7	1296	8	off	off	JJ
cord-005453-4057qib7	1296	9	-	-	HYPH
cord-005453-4057qib7	1296	10	line	line	NN
cord-005453-4057qib7	1296	11	system	system	NN
cord-005453-4057qib7	1296	12	.	.	.
cord-005453-4057qib7	1297	1	The	the	DT
cord-005453-4057qib7	1297	2	response	response	NN
cord-005453-4057qib7	1297	3	was	be	VBD
cord-005453-4057qib7	1297	4	defined	define	VBN
cord-005453-4057qib7	1297	5	as	as	IN
cord-005453-4057qib7	1297	6	Responder	Responder	NNP
cord-005453-4057qib7	1297	7	(	(	-LRB-
cord-005453-4057qib7	1297	8	Complete	complete	JJ
cord-005453-4057qib7	1297	9	and	and	CC
cord-005453-4057qib7	1297	10	Partial	Partial	NNP
cord-005453-4057qib7	1297	11	Response	Response	NNP
cord-005453-4057qib7	1297	12	)	)	-RRB-
cord-005453-4057qib7	1297	13	and	and	CC
cord-005453-4057qib7	1297	14	Non	Non	NNP
cord-005453-4057qib7	1297	15	-	-	NN
cord-005453-4057qib7	1297	16	responder	responder	NN
cord-005453-4057qib7	1297	17	.	.	.
cord-005453-4057qib7	1298	1	Infused	infuse	VBN
cord-005453-4057qib7	1298	2	cell	cell	NN
cord-005453-4057qib7	1298	3	numbers	number	NNS
cord-005453-4057qib7	1298	4	for	for	IN
cord-005453-4057qib7	1298	5	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1298	6	,	,	,
cord-005453-4057qib7	1298	7	monocytes	monocyte	NNS
cord-005453-4057qib7	1298	8	and	and	CC
cord-005453-4057qib7	1298	9	mononuclear	mononuclear	NN
cord-005453-4057qib7	1298	10	cells	cell	NNS
cord-005453-4057qib7	1298	11	(	(	-LRB-
cord-005453-4057qib7	1298	12	Lym+Mon	Lym+Mon	NNP
cord-005453-4057qib7	1298	13	,	,	,
cord-005453-4057qib7	1298	14	MNC	MNC	NNP
cord-005453-4057qib7	1298	15	)	)	-RRB-
cord-005453-4057qib7	1298	16	were	be	VBD
cord-005453-4057qib7	1298	17	calculated	calculate	VBN
cord-005453-4057qib7	1298	18	.	.	.
cord-005453-4057qib7	1299	1	For	for	IN
cord-005453-4057qib7	1299	2	analytic	analytic	JJ
cord-005453-4057qib7	1299	3	purposes	purpose	NNS
cord-005453-4057qib7	1299	4	,	,	,
cord-005453-4057qib7	1299	5	the	the	DT
cord-005453-4057qib7	1299	6	median	median	JJ
cord-005453-4057qib7	1299	7	number	number	NN
cord-005453-4057qib7	1299	8	of	of	IN
cord-005453-4057qib7	1299	9	cells	cell	NNS
cord-005453-4057qib7	1299	10	infused	infuse	VBN
cord-005453-4057qib7	1299	11	per	per	IN
cord-005453-4057qib7	1299	12	procedure	procedure	NN
cord-005453-4057qib7	1299	13	until	until	IN
cord-005453-4057qib7	1299	14	response	response	NN
cord-005453-4057qib7	1299	15	(	(	-LRB-
cord-005453-4057qib7	1299	16	or	or	CC
cord-005453-4057qib7	1299	17	until	until	IN
cord-005453-4057qib7	1299	18	the	the	DT
cord-005453-4057qib7	1299	19	median	median	JJ
cord-005453-4057qib7	1299	20	number	number	NN
cord-005453-4057qib7	1299	21	of	of	IN
cord-005453-4057qib7	1299	22	procedures	procedure	NNS
cord-005453-4057qib7	1299	23	until	until	IN
cord-005453-4057qib7	1299	24	response	response	NN
cord-005453-4057qib7	1299	25	for	for	IN
cord-005453-4057qib7	1299	26	non	non	JJ
cord-005453-4057qib7	1299	27	-	-	JJ
cord-005453-4057qib7	1299	28	responding	respond	VBG
cord-005453-4057qib7	1299	29	patients	patient	NNS
cord-005453-4057qib7	1299	30	)	)	-RRB-
cord-005453-4057qib7	1299	31	and	and	CC
cord-005453-4057qib7	1299	32	the	the	DT
cord-005453-4057qib7	1299	33	cumulative	cumulative	JJ
cord-005453-4057qib7	1299	34	number	number	NN
cord-005453-4057qib7	1299	35	of	of	IN
cord-005453-4057qib7	1299	36	cells	cell	NNS
cord-005453-4057qib7	1299	37	infused	infuse	VBN
cord-005453-4057qib7	1299	38	until	until	IN
cord-005453-4057qib7	1299	39	response	response	NN
cord-005453-4057qib7	1299	40	(	(	-LRB-
cord-005453-4057qib7	1299	41	or	or	CC
cord-005453-4057qib7	1299	42	until	until	IN
cord-005453-4057qib7	1299	43	the	the	DT
cord-005453-4057qib7	1299	44	median	median	NN
cord-005453-4057qib7	1299	45	in	in	IN
cord-005453-4057qib7	1299	46	non	non	NNS
cord-005453-4057qib7	1299	47	-	-	NNS
cord-005453-4057qib7	1299	48	responders	responder	NNS
cord-005453-4057qib7	1299	49	)	)	-RRB-
cord-005453-4057qib7	1299	50	were	be	VBD
cord-005453-4057qib7	1299	51	calculated	calculate	VBN
cord-005453-4057qib7	1299	52	for	for	IN
cord-005453-4057qib7	1299	53	all	all	PDT
cord-005453-4057qib7	1299	54	the	the	DT
cord-005453-4057qib7	1299	55	subgroups	subgroup	NNS
cord-005453-4057qib7	1299	56	.	.	.
cord-005453-4057qib7	1300	1	Same	same	JJ
cord-005453-4057qib7	1300	2	procedures	procedure	NNS
cord-005453-4057qib7	1300	3	were	be	VBD
cord-005453-4057qib7	1300	4	performed	perform	VBN
cord-005453-4057qib7	1300	5	with	with	IN
cord-005453-4057qib7	1300	6	the	the	DT
cord-005453-4057qib7	1300	7	number	number	NN
cord-005453-4057qib7	1300	8	cells	cell	NNS
cord-005453-4057qib7	1300	9	infused	infuse	VBN
cord-005453-4057qib7	1300	10	until	until	IN
cord-005453-4057qib7	1300	11	day	day	NN
cord-005453-4057qib7	1300	12	30	30	CD
cord-005453-4057qib7	1300	13	of	of	IN
cord-005453-4057qib7	1300	14	ECP	ECP	NNP
cord-005453-4057qib7	1300	15	.	.	.
cord-005453-4057qib7	1301	1	Finally	finally	RB
cord-005453-4057qib7	1301	2	,	,	,
cord-005453-4057qib7	1301	3	the	the	DT
cord-005453-4057qib7	1301	4	response	response	NN
cord-005453-4057qib7	1301	5	and	and	CC
cord-005453-4057qib7	1301	6	survival	survival	NN
cord-005453-4057qib7	1301	7	impact	impact	NN
cord-005453-4057qib7	1301	8	of	of	IN
cord-005453-4057qib7	1301	9	infusing	infuse	VBG
cord-005453-4057qib7	1301	10	a	a	DT
cord-005453-4057qib7	1301	11	number	number	NN
cord-005453-4057qib7	1301	12	of	of	IN
cord-005453-4057qib7	1301	13	cells	cell	NNS
cord-005453-4057qib7	1301	14	over	over	IN
cord-005453-4057qib7	1301	15	or	or	CC
cord-005453-4057qib7	1301	16	below	below	IN
cord-005453-4057qib7	1301	17	the	the	DT
cord-005453-4057qib7	1301	18	median	median	NN
cord-005453-4057qib7	1301	19	and	and	CC
cord-005453-4057qib7	1301	20	in	in	IN
cord-005453-4057qib7	1301	21	different	different	JJ
cord-005453-4057qib7	1301	22	tertiles	tertile	NNS
cord-005453-4057qib7	1301	23	(	(	-LRB-
cord-005453-4057qib7	1301	24	T1	T1	NNP
cord-005453-4057qib7	1301	25	,	,	,
cord-005453-4057qib7	1301	26	T2	T2	NNP
cord-005453-4057qib7	1301	27	and	and	CC
cord-005453-4057qib7	1301	28	T3	T3	NNP
cord-005453-4057qib7	1301	29	)	)	-RRB-
cord-005453-4057qib7	1301	30	was	be	VBD
cord-005453-4057qib7	1301	31	assessed	assess	VBN
cord-005453-4057qib7	1301	32	until	until	IN
cord-005453-4057qib7	1301	33	the	the	DT
cord-005453-4057qib7	1301	34	median	median	JJ
cord-005453-4057qib7	1301	35	number	number	NN
cord-005453-4057qib7	1301	36	of	of	IN
cord-005453-4057qib7	1301	37	procedures	procedure	NNS
cord-005453-4057qib7	1301	38	needed	need	VBN
cord-005453-4057qib7	1301	39	to	to	TO
cord-005453-4057qib7	1301	40	achieve	achieve	VB
cord-005453-4057qib7	1301	41	a	a	DT
cord-005453-4057qib7	1301	42	response	response	NN
cord-005453-4057qib7	1301	43	.	.	.
cord-005453-4057qib7	1302	1	Results	result	NNS
cord-005453-4057qib7	1302	2	:	:	:
cord-005453-4057qib7	1303	1	The	the	DT
cord-005453-4057qib7	1303	2	median	median	JJ
cord-005453-4057qib7	1303	3	number	number	NN
cord-005453-4057qib7	1303	4	of	of	IN
cord-005453-4057qib7	1303	5	procedures	procedure	NNS
cord-005453-4057qib7	1303	6	until	until	IN
cord-005453-4057qib7	1303	7	response	response	NN
cord-005453-4057qib7	1303	8	was	be	VBD
cord-005453-4057qib7	1303	9	3	3	CD
cord-005453-4057qib7	1303	10	.	.	.
cord-005453-4057qib7	1304	1	We	-PRON-	PRP
cord-005453-4057qib7	1304	2	observed	observe	VBD
cord-005453-4057qib7	1304	3	no	no	DT
cord-005453-4057qib7	1304	4	differences	difference	NNS
cord-005453-4057qib7	1304	5	in	in	IN
cord-005453-4057qib7	1304	6	the	the	DT
cord-005453-4057qib7	1304	7	median	median	JJ
cord-005453-4057qib7	1304	8	number	number	NN
cord-005453-4057qib7	1304	9	of	of	IN
cord-005453-4057qib7	1304	10	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1304	11	,	,	,
cord-005453-4057qib7	1304	12	monocytes	monocyte	NNS
cord-005453-4057qib7	1304	13	or	or	CC
cord-005453-4057qib7	1304	14	MNCs	mnc	NNS
cord-005453-4057qib7	1304	15	infused	infuse	VBN
cord-005453-4057qib7	1304	16	until	until	IN
cord-005453-4057qib7	1304	17	response	response	NN
cord-005453-4057qib7	1304	18	or	or	CC
cord-005453-4057qib7	1304	19	until	until	IN
cord-005453-4057qib7	1304	20	day	day	NN
cord-005453-4057qib7	1304	21	30	30	CD
cord-005453-4057qib7	1304	22	between	between	IN
cord-005453-4057qib7	1304	23	responding	respond	VBG
cord-005453-4057qib7	1304	24	and	and	CC
cord-005453-4057qib7	1304	25	non	non	JJ
cord-005453-4057qib7	1304	26	-	-	JJ
cord-005453-4057qib7	1304	27	responding	respond	VBG
cord-005453-4057qib7	1304	28	patients	patient	NNS
cord-005453-4057qib7	1304	29	.	.	.
cord-005453-4057qib7	1305	1	There	there	EX
cord-005453-4057qib7	1305	2	were	be	VBD
cord-005453-4057qib7	1305	3	no	no	DT
cord-005453-4057qib7	1305	4	differences	difference	NNS
cord-005453-4057qib7	1305	5	in	in	IN
cord-005453-4057qib7	1305	6	response	response	NN
cord-005453-4057qib7	1305	7	if	if	IN
cord-005453-4057qib7	1305	8	patients	patient	NNS
cord-005453-4057qib7	1305	9	received	receive	VBD
cord-005453-4057qib7	1305	10	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1305	11	or	or	CC
cord-005453-4057qib7	1305	12	monocytes	monocyte	NNS
cord-005453-4057qib7	1305	13	above	above	IN
cord-005453-4057qib7	1305	14	or	or	CC
cord-005453-4057qib7	1305	15	below	below	IN
cord-005453-4057qib7	1305	16	the	the	DT
cord-005453-4057qib7	1305	17	median	median	JJ
cord-005453-4057qib7	1305	18	number	number	NN
cord-005453-4057qib7	1305	19	.	.	.
cord-005453-4057qib7	1306	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	1306	2	,	,	,
cord-005453-4057qib7	1306	3	patients	patient	NNS
cord-005453-4057qib7	1306	4	that	that	WDT
cord-005453-4057qib7	1306	5	received	receive	VBD
cord-005453-4057qib7	1306	6	a	a	DT
cord-005453-4057qib7	1306	7	total	total	JJ
cord-005453-4057qib7	1306	8	absolute	absolute	JJ
cord-005453-4057qib7	1306	9	number	number	NN
cord-005453-4057qib7	1306	10	of	of	IN
cord-005453-4057qib7	1306	11	MNCs	mnc	NNS
cord-005453-4057qib7	1306	12	above	above	IN
cord-005453-4057qib7	1306	13	the	the	DT
cord-005453-4057qib7	1306	14	median	median	NN
cord-005453-4057qib7	1306	15	(	(	-LRB-
cord-005453-4057qib7	1306	16	64x108	64x108	NN
cord-005453-4057qib7	1306	17	cells	cell	NNS
cord-005453-4057qib7	1306	18	)	)	-RRB-
cord-005453-4057qib7	1306	19	showed	show	VBD
cord-005453-4057qib7	1306	20	a	a	DT
cord-005453-4057qib7	1306	21	trend	trend	NN
cord-005453-4057qib7	1306	22	towards	towards	IN
cord-005453-4057qib7	1306	23	a	a	DT
cord-005453-4057qib7	1306	24	higher	high	JJR
cord-005453-4057qib7	1306	25	response	response	NN
cord-005453-4057qib7	1306	26	rate	rate	NN
cord-005453-4057qib7	1306	27	(	(	-LRB-
cord-005453-4057qib7	1306	28	75	75	CD
cord-005453-4057qib7	1306	29	%	%	NN
cord-005453-4057qib7	1306	30	vs	vs	IN
cord-005453-4057qib7	1306	31	61	61	CD
cord-005453-4057qib7	1306	32	%	%	NN
cord-005453-4057qib7	1306	33	,	,	,
cord-005453-4057qib7	1306	34	p=0.09	p=0.09	NNP
cord-005453-4057qib7	1306	35	)	)	-RRB-
cord-005453-4057qib7	1306	36	.	.	.
cord-005453-4057qib7	1307	1	The	the	DT
cord-005453-4057qib7	1307	2	patients	patient	NNS
cord-005453-4057qib7	1307	3	that	that	WDT
cord-005453-4057qib7	1307	4	received	receive	VBD
cord-005453-4057qib7	1307	5	a	a	DT
cord-005453-4057qib7	1307	6	cumulative	cumulative	JJ
cord-005453-4057qib7	1307	7	number	number	NN
cord-005453-4057qib7	1307	8	of	of	IN
cord-005453-4057qib7	1307	9	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1307	10	in	in	IN
cord-005453-4057qib7	1307	11	the	the	DT
cord-005453-4057qib7	1307	12	3	3	CD
cord-005453-4057qib7	1307	13	first	first	JJ
cord-005453-4057qib7	1307	14	ECP	ECP	NNP
cord-005453-4057qib7	1307	15	procedures	procedure	NNS
cord-005453-4057qib7	1307	16	above	above	IN
cord-005453-4057qib7	1307	17	the	the	DT
cord-005453-4057qib7	1307	18	median	median	NN
cord-005453-4057qib7	1307	19	showed	show	VBD
cord-005453-4057qib7	1307	20	improved	improved	JJ
cord-005453-4057qib7	1307	21	overall	overall	JJ
cord-005453-4057qib7	1307	22	survival	survival	NN
cord-005453-4057qib7	1307	23	(	(	-LRB-
cord-005453-4057qib7	1307	24	OS	OS	NNP
cord-005453-4057qib7	1307	25	)	)	-RRB-
cord-005453-4057qib7	1307	26	(	(	-LRB-
cord-005453-4057qib7	1307	27	2y	2y	NNP
cord-005453-4057qib7	1307	28	OS	OS	NNP
cord-005453-4057qib7	1307	29	85	85	CD
cord-005453-4057qib7	1307	30	%	%	NN
cord-005453-4057qib7	1307	31	vs	vs	IN
cord-005453-4057qib7	1307	32	55	55	CD
cord-005453-4057qib7	1307	33	%	%	NN
cord-005453-4057qib7	1307	34	,	,	,
cord-005453-4057qib7	1307	35	p=0.024	p=0.024	NNP
cord-005453-4057qib7	1307	36	)	)	-RRB-
cord-005453-4057qib7	1307	37	.	.	.
cord-005453-4057qib7	1308	1	Patients	patient	NNS
cord-005453-4057qib7	1308	2	that	that	WDT
cord-005453-4057qib7	1308	3	received	receive	VBD
cord-005453-4057qib7	1308	4	a	a	DT
cord-005453-4057qib7	1308	5	number	number	NN
cord-005453-4057qib7	1308	6	of	of	IN
cord-005453-4057qib7	1308	7	monocytes	monocyte	NNS
cord-005453-4057qib7	1308	8	above	above	IN
cord-005453-4057qib7	1308	9	the	the	DT
cord-005453-4057qib7	1308	10	median	median	NN
cord-005453-4057qib7	1308	11	showed	show	VBD
cord-005453-4057qib7	1308	12	a	a	DT
cord-005453-4057qib7	1308	13	trend	trend	NN
cord-005453-4057qib7	1308	14	towards	towards	IN
cord-005453-4057qib7	1308	15	better	well	JJR
cord-005453-4057qib7	1308	16	survival	survival	NN
cord-005453-4057qib7	1308	17	(	(	-LRB-
cord-005453-4057qib7	1308	18	p=0.09	p=0.09	NNP
cord-005453-4057qib7	1308	19	)	)	-RRB-
cord-005453-4057qib7	1308	20	,	,	,
cord-005453-4057qib7	1308	21	that	that	WDT
cord-005453-4057qib7	1308	22	was	be	VBD
cord-005453-4057qib7	1308	23	significant	significant	JJ
cord-005453-4057qib7	1308	24	when	when	WRB
cord-005453-4057qib7	1308	25	the	the	DT
cord-005453-4057qib7	1308	26	number	number	NN
cord-005453-4057qib7	1308	27	of	of	IN
cord-005453-4057qib7	1308	28	monocytes	monocyte	NNS
cord-005453-4057qib7	1308	29	infused	infuse	VBN
cord-005453-4057qib7	1308	30	surpassed	surpass	VBD
cord-005453-4057qib7	1308	31	the	the	DT
cord-005453-4057qib7	1308	32	first	first	JJ
cord-005453-4057qib7	1308	33	tertile	tertile	NNP
cord-005453-4057qib7	1308	34	(	(	-LRB-
cord-005453-4057qib7	1308	35	2y	2y	NNP
cord-005453-4057qib7	1308	36	OS	OS	NNP
cord-005453-4057qib7	1308	37	38	38	CD
cord-005453-4057qib7	1308	38	%	%	NN
cord-005453-4057qib7	1308	39	for	for	IN
cord-005453-4057qib7	1308	40	T1	T1	NNP
cord-005453-4057qib7	1308	41	,	,	,
cord-005453-4057qib7	1308	42	79	79	CD
cord-005453-4057qib7	1308	43	%	%	NN
cord-005453-4057qib7	1308	44	for	for	IN
cord-005453-4057qib7	1308	45	T2	T2	NNP
cord-005453-4057qib7	1308	46	,	,	,
cord-005453-4057qib7	1308	47	92	92	CD
cord-005453-4057qib7	1308	48	%	%	NN
cord-005453-4057qib7	1308	49	for	for	IN
cord-005453-4057qib7	1308	50	T3	T3	NNP
cord-005453-4057qib7	1308	51	,	,	,
cord-005453-4057qib7	1308	52	p=0.003	p=0.003	NNP
cord-005453-4057qib7	1308	53	)	)	-RRB-
cord-005453-4057qib7	1308	54	.	.	.
cord-005453-4057qib7	1309	1	Finally	finally	RB
cord-005453-4057qib7	1309	2	,	,	,
cord-005453-4057qib7	1309	3	the	the	DT
cord-005453-4057qib7	1309	4	patients	patient	NNS
cord-005453-4057qib7	1309	5	that	that	WDT
cord-005453-4057qib7	1309	6	received	receive	VBD
cord-005453-4057qib7	1309	7	a	a	DT
cord-005453-4057qib7	1309	8	cumulative	cumulative	JJ
cord-005453-4057qib7	1309	9	number	number	NN
cord-005453-4057qib7	1309	10	of	of	IN
cord-005453-4057qib7	1309	11	MNCs	mnc	NNS
cord-005453-4057qib7	1309	12	above	above	IN
cord-005453-4057qib7	1309	13	the	the	DT
cord-005453-4057qib7	1309	14	first	first	JJ
cord-005453-4057qib7	1309	15	tertile	tertile	NNP
cord-005453-4057qib7	1309	16	also	also	RB
cord-005453-4057qib7	1309	17	showed	show	VBD
cord-005453-4057qib7	1309	18	improved	improved	JJ
cord-005453-4057qib7	1309	19	survival	survival	NN
cord-005453-4057qib7	1309	20	(	(	-LRB-
cord-005453-4057qib7	1309	21	2y	2y	NNP
cord-005453-4057qib7	1309	22	OS	OS	NNP
cord-005453-4057qib7	1309	23	47	47	CD
cord-005453-4057qib7	1309	24	%	%	NN
cord-005453-4057qib7	1309	25	for	for	IN
cord-005453-4057qib7	1309	26	T1	T1	NNP
cord-005453-4057qib7	1309	27	,	,	,
cord-005453-4057qib7	1309	28	74	74	CD
cord-005453-4057qib7	1309	29	%	%	NN
cord-005453-4057qib7	1309	30	for	for	IN
cord-005453-4057qib7	1309	31	T2	T2	NNP
cord-005453-4057qib7	1309	32	,	,	,
cord-005453-4057qib7	1309	33	94	94	CD
cord-005453-4057qib7	1309	34	%	%	NN
cord-005453-4057qib7	1309	35	for	for	IN
cord-005453-4057qib7	1309	36	T3	T3	NNP
cord-005453-4057qib7	1309	37	,	,	,
cord-005453-4057qib7	1309	38	p=0.015	p=0.015	NNP
cord-005453-4057qib7	1309	39	)	)	-RRB-
cord-005453-4057qib7	1309	40	.	.	.
cord-005453-4057qib7	1310	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1310	2	:	:	:
cord-005453-4057qib7	1311	1	There	there	EX
cord-005453-4057qib7	1311	2	were	be	VBD
cord-005453-4057qib7	1311	3	no	no	DT
cord-005453-4057qib7	1311	4	differences	difference	NNS
cord-005453-4057qib7	1311	5	in	in	IN
cord-005453-4057qib7	1311	6	the	the	DT
cord-005453-4057qib7	1311	7	infused	infuse	VBN
cord-005453-4057qib7	1311	8	cellularity	cellularity	NN
cord-005453-4057qib7	1311	9	between	between	IN
cord-005453-4057qib7	1311	10	responding	respond	VBG
cord-005453-4057qib7	1311	11	and	and	CC
cord-005453-4057qib7	1311	12	non	non	JJ
cord-005453-4057qib7	1311	13	-	-	JJ
cord-005453-4057qib7	1311	14	responding	respond	VBG
cord-005453-4057qib7	1311	15	patients	patient	NNS
cord-005453-4057qib7	1311	16	with	with	IN
cord-005453-4057qib7	1311	17	chronic	chronic	JJ
cord-005453-4057qib7	1311	18	GvHD	GvHD	NNP
cord-005453-4057qib7	1311	19	.	.	.
cord-005453-4057qib7	1312	1	At	at	IN
cord-005453-4057qib7	1312	2	the	the	DT
cord-005453-4057qib7	1312	3	same	same	JJ
cord-005453-4057qib7	1312	4	time	time	NN
cord-005453-4057qib7	1312	5	,	,	,
cord-005453-4057qib7	1312	6	we	-PRON-	PRP
cord-005453-4057qib7	1312	7	found	find	VBD
cord-005453-4057qib7	1312	8	that	that	IN
cord-005453-4057qib7	1312	9	except	except	IN
cord-005453-4057qib7	1312	10	for	for	IN
cord-005453-4057qib7	1312	11	a	a	DT
cord-005453-4057qib7	1312	12	trend	trend	NN
cord-005453-4057qib7	1312	13	toward	toward	IN
cord-005453-4057qib7	1312	14	better	well	JJR
cord-005453-4057qib7	1312	15	response	response	NN
cord-005453-4057qib7	1312	16	with	with	IN
cord-005453-4057qib7	1312	17	higher	high	JJR
cord-005453-4057qib7	1312	18	MNCs	mnc	NNS
cord-005453-4057qib7	1312	19	infused	infuse	VBN
cord-005453-4057qib7	1312	20	,	,	,
cord-005453-4057qib7	1312	21	there	there	EX
cord-005453-4057qib7	1312	22	was	be	VBD
cord-005453-4057qib7	1312	23	no	no	DT
cord-005453-4057qib7	1312	24	relationship	relationship	NN
cord-005453-4057qib7	1312	25	between	between	IN
cord-005453-4057qib7	1312	26	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1312	27	and	and	CC
cord-005453-4057qib7	1312	28	monocytes	monocyte	NNS
cord-005453-4057qib7	1312	29	with	with	IN
cord-005453-4057qib7	1312	30	the	the	DT
cord-005453-4057qib7	1312	31	response	response	NN
cord-005453-4057qib7	1312	32	rate	rate	NN
cord-005453-4057qib7	1312	33	as	as	IN
cord-005453-4057qib7	1312	34	other	other	JJ
cord-005453-4057qib7	1312	35	previous	previous	JJ
cord-005453-4057qib7	1312	36	studies	study	NNS
cord-005453-4057qib7	1312	37	have	have	VBP
cord-005453-4057qib7	1312	38	suggested	suggest	VBN
cord-005453-4057qib7	1312	39	.	.	.
cord-005453-4057qib7	1313	1	However	however	RB
cord-005453-4057qib7	1313	2	,	,	,
cord-005453-4057qib7	1313	3	even	even	RB
cord-005453-4057qib7	1313	4	if	if	IN
cord-005453-4057qib7	1313	5	there	there	EX
cord-005453-4057qib7	1313	6	is	be	VBZ
cord-005453-4057qib7	1313	7	no	no	DT
cord-005453-4057qib7	1313	8	relationship	relationship	NN
cord-005453-4057qib7	1313	9	with	with	IN
cord-005453-4057qib7	1313	10	the	the	DT
cord-005453-4057qib7	1313	11	response	response	NN
cord-005453-4057qib7	1313	12	rate	rate	NN
cord-005453-4057qib7	1313	13	,	,	,
cord-005453-4057qib7	1313	14	the	the	DT
cord-005453-4057qib7	1313	15	patients	patient	NNS
cord-005453-4057qib7	1313	16	receiving	receive	VBG
cord-005453-4057qib7	1313	17	the	the	DT
cord-005453-4057qib7	1313	18	highest	high	JJS
cord-005453-4057qib7	1313	19	numbers	number	NNS
cord-005453-4057qib7	1313	20	of	of	IN
cord-005453-4057qib7	1313	21	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1313	22	,	,	,
cord-005453-4057qib7	1313	23	monocytes	monocyte	NNS
cord-005453-4057qib7	1313	24	and	and	CC
cord-005453-4057qib7	1313	25	MNCs	mnc	NNS
cord-005453-4057qib7	1313	26	in	in	IN
cord-005453-4057qib7	1313	27	the	the	DT
cord-005453-4057qib7	1313	28	cohort	cohort	NN
cord-005453-4057qib7	1313	29	showed	show	VBD
cord-005453-4057qib7	1313	30	an	an	DT
cord-005453-4057qib7	1313	31	improved	improved	JJ
cord-005453-4057qib7	1313	32	survival	survival	NN
cord-005453-4057qib7	1313	33	,	,	,
cord-005453-4057qib7	1313	34	suggesting	suggest	VBG
cord-005453-4057qib7	1313	35	that	that	IN
cord-005453-4057qib7	1313	36	larger	large	JJR
cord-005453-4057qib7	1313	37	quantities	quantity	NNS
cord-005453-4057qib7	1313	38	of	of	IN
cord-005453-4057qib7	1313	39	cells	cell	NNS
cord-005453-4057qib7	1313	40	could	could	MD
cord-005453-4057qib7	1313	41	exhibit	exhibit	VB
cord-005453-4057qib7	1313	42	a	a	DT
cord-005453-4057qib7	1313	43	protective	protective	JJ
cord-005453-4057qib7	1313	44	effect	effect	NN
cord-005453-4057qib7	1313	45	.	.	.
cord-005453-4057qib7	1314	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	1314	2	,	,	,
cord-005453-4057qib7	1314	3	prospective	prospective	JJ
cord-005453-4057qib7	1314	4	studies	study	NNS
cord-005453-4057qib7	1314	5	that	that	WDT
cord-005453-4057qib7	1314	6	address	address	VBP
cord-005453-4057qib7	1314	7	this	this	DT
cord-005453-4057qib7	1314	8	relationship	relationship	NN
cord-005453-4057qib7	1314	9	are	be	VBP
cord-005453-4057qib7	1314	10	needed	need	VBN
cord-005453-4057qib7	1314	11	.	.	.
cord-005453-4057qib7	1315	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1315	2	:	:	:
cord-005453-4057qib7	1315	3	Nothing	nothing	NN
cord-005453-4057qib7	1315	4	to	to	TO
cord-005453-4057qib7	1315	5	declare	declare	VB
cord-005453-4057qib7	1315	6	Comparative	comparative	JJ
cord-005453-4057qib7	1315	7	analysis	analysis	NN
cord-005453-4057qib7	1315	8	of	of	IN
cord-005453-4057qib7	1315	9	the	the	DT
cord-005453-4057qib7	1315	10	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1315	11	potential	potential	NN
cord-005453-4057qib7	1315	12	of	of	IN
cord-005453-4057qib7	1315	13	cytokine	cytokine	NN
cord-005453-4057qib7	1315	14	-	-	HYPH
cord-005453-4057qib7	1315	15	induced	induce	VBN
cord-005453-4057qib7	1315	16	killer	killer	NN
cord-005453-4057qib7	1315	17	and	and	CC
cord-005453-4057qib7	1315	18	natural	natural	JJ
cord-005453-4057qib7	1315	19	killer	killer	NN
cord-005453-4057qib7	1315	20	cells	cell	NNS
cord-005453-4057qib7	1315	21	for	for	IN
cord-005453-4057qib7	1315	22	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	1315	23	therapy	therapy	NN
cord-005453-4057qib7	1315	24	Annekathrin	Annekathrin	NNP
cord-005453-4057qib7	1315	25	Heinze	Heinze	NNP
cord-005453-4057qib7	1315	26	1	1	CD
cord-005453-4057qib7	1315	27	,	,	,
cord-005453-4057qib7	1315	28	Beatrice	Beatrice	NNP
cord-005453-4057qib7	1315	29	Grebe	Grebe	NNP
cord-005453-4057qib7	1315	30	1	1	CD
cord-005453-4057qib7	1315	31	,	,	,
cord-005453-4057qib7	1315	32	Eva	Eva	NNP
cord-005453-4057qib7	1315	33	Mudry	Mudry	NNP
cord-005453-4057qib7	1315	34	1	1	CD
cord-005453-4057qib7	1315	35	,	,	,
cord-005453-4057qib7	1315	36	Jochen	Jochen	NNP
cord-005453-4057qib7	1315	37	Früh	Früh	NNP
cord-005453-4057qib7	1315	38	1	1	CD
cord-005453-4057qib7	1315	39	,	,	,
cord-005453-4057qib7	1315	40	Bushra	Bushra	NNP
cord-005453-4057qib7	1315	41	Rais	Rais	NNP
cord-005453-4057qib7	1315	42	1	1	CD
cord-005453-4057qib7	1315	43	,	,	,
cord-005453-4057qib7	1315	44	Claudia	Claudia	NNP
cord-005453-4057qib7	1315	45	Cappel	Cappel	NNP
cord-005453-4057qib7	1315	46	1	1	CD
cord-005453-4057qib7	1315	47	,	,	,
cord-005453-4057qib7	1315	48	Sabine	Sabine	NNP
cord-005453-4057qib7	1315	49	Hünecke	Hünecke	NNP
cord-005453-4057qib7	1315	50	1	1	CD
cord-005453-4057qib7	1315	51	,	,	,
cord-005453-4057qib7	1315	52	Eva	Eva	NNP
cord-005453-4057qib7	1315	53	Rettinger	Rettinger	NNP
cord-005453-4057qib7	1315	54	1	1	CD
cord-005453-4057qib7	1315	55	,	,	,
cord-005453-4057qib7	1315	56	Thomas	Thomas	NNP
cord-005453-4057qib7	1315	57	Klingebiel	Klingebiel	NNP
cord-005453-4057qib7	1315	58	1	1	CD
cord-005453-4057qib7	1315	59	,	,	,
cord-005453-4057qib7	1315	60	Peter	Peter	NNP
cord-005453-4057qib7	1315	61	Bader	Bader	NNP
cord-005453-4057qib7	1315	62	1	1	CD
cord-005453-4057qib7	1315	63	,	,	,
cord-005453-4057qib7	1315	64	Evelyn	Evelyn	NNP
cord-005453-4057qib7	1315	65	Ullrich	Ullrich	NNP
cord-005453-4057qib7	1316	1	1,2	1,2	CD
cord-005453-4057qib7	1316	2	1	1	CD
cord-005453-4057qib7	1316	3	University	University	NNP
cord-005453-4057qib7	1316	4	Hospital	Hospital	NNP
cord-005453-4057qib7	1316	5	Frankfurt	Frankfurt	NNP
cord-005453-4057qib7	1316	6	,	,	,
cord-005453-4057qib7	1316	7	Frankfurt	Frankfurt	NNP
cord-005453-4057qib7	1316	8	,	,	,
cord-005453-4057qib7	1316	9	Germany	Germany	NNP
cord-005453-4057qib7	1316	10	,	,	,
cord-005453-4057qib7	1316	11	2	2	CD
cord-005453-4057qib7	1316	12	German	German	NNP
cord-005453-4057qib7	1316	13	Cancer	Cancer	NNP
cord-005453-4057qib7	1316	14	Consortium	Consortium	NNP
cord-005453-4057qib7	1316	15	(	(	-LRB-
cord-005453-4057qib7	1316	16	DKTK	DKTK	NNP
cord-005453-4057qib7	1316	17	)	)	-RRB-
cord-005453-4057qib7	1316	18	partner	partner	NN
cord-005453-4057qib7	1316	19	site	site	NN
cord-005453-4057qib7	1316	20	:	:	:
cord-005453-4057qib7	1316	21	,	,	,
cord-005453-4057qib7	1316	22	Frankfurt	Frankfurt	NNP
cord-005453-4057qib7	1316	23	,	,	,
cord-005453-4057qib7	1316	24	Germany	Germany	NNP
cord-005453-4057qib7	1316	25	Background	Background	NNP
cord-005453-4057qib7	1316	26	:	:	:
cord-005453-4057qib7	1316	27	Neuroblastoma	Neuroblastoma	NNP
cord-005453-4057qib7	1316	28	(	(	-LRB-
cord-005453-4057qib7	1316	29	NB	NB	NNP
cord-005453-4057qib7	1316	30	)	)	-RRB-
cord-005453-4057qib7	1316	31	is	be	VBZ
cord-005453-4057qib7	1316	32	the	the	DT
cord-005453-4057qib7	1316	33	most	most	RBS
cord-005453-4057qib7	1316	34	common	common	JJ
cord-005453-4057qib7	1316	35	solid	solid	JJ
cord-005453-4057qib7	1316	36	extracranial	extracranial	JJ
cord-005453-4057qib7	1316	37	tumor	tumor	NN
cord-005453-4057qib7	1316	38	in	in	IN
cord-005453-4057qib7	1316	39	childhood	childhood	NN
cord-005453-4057qib7	1316	40	.	.	.
cord-005453-4057qib7	1317	1	Despite	despite	IN
cord-005453-4057qib7	1317	2	therapeutic	therapeutic	JJ
cord-005453-4057qib7	1317	3	progress	progress	NN
cord-005453-4057qib7	1317	4	,	,	,
cord-005453-4057qib7	1317	5	prognosis	prognosis	NN
cord-005453-4057qib7	1317	6	for	for	IN
cord-005453-4057qib7	1317	7	high	high	JJ
cord-005453-4057qib7	1317	8	-	-	HYPH
cord-005453-4057qib7	1317	9	risk	risk	NN
cord-005453-4057qib7	1317	10	NB	NB	NNP
cord-005453-4057qib7	1317	11	is	be	VBZ
cord-005453-4057qib7	1317	12	poor	poor	JJ
cord-005453-4057qib7	1317	13	and	and	CC
cord-005453-4057qib7	1317	14	innovative	innovative	JJ
cord-005453-4057qib7	1317	15	therapies	therapy	NNS
cord-005453-4057qib7	1317	16	are	be	VBP
cord-005453-4057qib7	1317	17	of	of	IN
cord-005453-4057qib7	1317	18	medical	medical	JJ
cord-005453-4057qib7	1317	19	need	need	NN
cord-005453-4057qib7	1317	20	.	.	.
cord-005453-4057qib7	1318	1	Therefore	therefore	RB
cord-005453-4057qib7	1318	2	,	,	,
cord-005453-4057qib7	1318	3	we	-PRON-	PRP
cord-005453-4057qib7	1318	4	investigated	investigate	VBD
cord-005453-4057qib7	1318	5	the	the	DT
cord-005453-4057qib7	1318	6	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1318	7	potential	potential	NN
cord-005453-4057qib7	1318	8	of	of	IN
cord-005453-4057qib7	1318	9	interleukin	interleukin	NN
cord-005453-4057qib7	1318	10	(	(	-LRB-
cord-005453-4057qib7	1318	11	IL)-activated	il)-activated	CD
cord-005453-4057qib7	1318	12	natural	natural	JJ
cord-005453-4057qib7	1318	13	killer	killer	NN
cord-005453-4057qib7	1318	14	(	(	-LRB-
cord-005453-4057qib7	1318	15	NK	NK	NNP
cord-005453-4057qib7	1318	16	)	)	-RRB-
cord-005453-4057qib7	1318	17	cells	cell	NNS
cord-005453-4057qib7	1318	18	compared	compare	VBN
cord-005453-4057qib7	1318	19	to	to	IN
cord-005453-4057qib7	1318	20	activated	activate	VBN
cord-005453-4057qib7	1318	21	cytokine	cytokine	NN
cord-005453-4057qib7	1318	22	-	-	HYPH
cord-005453-4057qib7	1318	23	induced	induce	VBN
cord-005453-4057qib7	1318	24	killer	killer	NN
cord-005453-4057qib7	1318	25	(	(	-LRB-
cord-005453-4057qib7	1318	26	CIK	CIK	NNP
cord-005453-4057qib7	1318	27	)	)	-RRB-
cord-005453-4057qib7	1318	28	cells	cell	NNS
cord-005453-4057qib7	1318	29	against	against	IN
cord-005453-4057qib7	1318	30	different	different	JJ
cord-005453-4057qib7	1318	31	human	human	JJ
cord-005453-4057qib7	1318	32	NB	NB	NNP
cord-005453-4057qib7	1318	33	cell	cell	NN
cord-005453-4057qib7	1318	34	lines	line	NNS
cord-005453-4057qib7	1318	35	in	in	IN
cord-005453-4057qib7	1318	36	vitro	vitro	FW
cord-005453-4057qib7	1318	37	.	.	.
cord-005453-4057qib7	1319	1	Methods	method	NNS
cord-005453-4057qib7	1319	2	:	:	:
cord-005453-4057qib7	1319	3	NK	NK	NNP
cord-005453-4057qib7	1319	4	cells	cell	NNS
cord-005453-4057qib7	1319	5	were	be	VBD
cord-005453-4057qib7	1319	6	isolated	isolate	VBN
cord-005453-4057qib7	1319	7	from	from	IN
cord-005453-4057qib7	1319	8	peripheral	peripheral	JJ
cord-005453-4057qib7	1319	9	blood	blood	NN
cord-005453-4057qib7	1319	10	mononuclear	mononuclear	NN
cord-005453-4057qib7	1319	11	cells	cell	NNS
cord-005453-4057qib7	1319	12	(	(	-LRB-
cord-005453-4057qib7	1319	13	PBMCs	pbmc	NNS
cord-005453-4057qib7	1319	14	)	)	-RRB-
cord-005453-4057qib7	1319	15	using	use	VBG
cord-005453-4057qib7	1319	16	CD56	CD56	NNP
cord-005453-4057qib7	1319	17	enrichment	enrichment	NN
cord-005453-4057qib7	1319	18	or	or	CC
cord-005453-4057qib7	1319	19	CD3	CD3	NNP
cord-005453-4057qib7	1319	20	/	/	SYM
cord-005453-4057qib7	1319	21	CD19	CD19	NNP
cord-005453-4057qib7	1319	22	depletion	depletion	NN
cord-005453-4057qib7	1319	23	kits	kit	NNS
cord-005453-4057qib7	1319	24	.	.	.
cord-005453-4057qib7	1320	1	They	-PRON-	PRP
cord-005453-4057qib7	1320	2	were	be	VBD
cord-005453-4057qib7	1320	3	successfully	successfully	RB
cord-005453-4057qib7	1320	4	expanded	expand	VBN
cord-005453-4057qib7	1320	5	ex	ex	FW
cord-005453-4057qib7	1320	6	vivo	vivo	NN
cord-005453-4057qib7	1320	7	with	with	IN
cord-005453-4057qib7	1320	8	different	different	JJ
cord-005453-4057qib7	1320	9	cytokine	cytokine	NN
cord-005453-4057qib7	1320	10	combinations	combination	NNS
cord-005453-4057qib7	1320	11	such	such	JJ
cord-005453-4057qib7	1320	12	as	as	IN
cord-005453-4057qib7	1320	13	IL-2	IL-2	NNP
cord-005453-4057qib7	1320	14	,	,	,
cord-005453-4057qib7	1320	15	IL-15	IL-15	NNP
cord-005453-4057qib7	1320	16	,	,	,
cord-005453-4057qib7	1320	17	IL-18	IL-18	NNP
cord-005453-4057qib7	1320	18	and/or	and/or	CC
cord-005453-4057qib7	1320	19	IL-21	IL-21	NNP
cord-005453-4057qib7	1320	20	under	under	IN
cord-005453-4057qib7	1320	21	feeder	feeder	NN
cord-005453-4057qib7	1320	22	-	-	HYPH
cord-005453-4057qib7	1320	23	cell	cell	NN
cord-005453-4057qib7	1320	24	free	free	JJ
cord-005453-4057qib7	1320	25	conditions	condition	NNS
cord-005453-4057qib7	1320	26	.	.	.
cord-005453-4057qib7	1321	1	In	in	IN
cord-005453-4057qib7	1321	2	contrast	contrast	NN
cord-005453-4057qib7	1321	3	,	,	,
cord-005453-4057qib7	1321	4	CIK	CIK	NNP
cord-005453-4057qib7	1321	5	cells	cell	NNS
cord-005453-4057qib7	1321	6	were	be	VBD
cord-005453-4057qib7	1321	7	generated	generate	VBN
cord-005453-4057qib7	1321	8	from	from	IN
cord-005453-4057qib7	1321	9	PBMCs	pbmc	NNS
cord-005453-4057qib7	1321	10	by	by	IN
cord-005453-4057qib7	1321	11	ex	ex	FW
cord-005453-4057qib7	1321	12	vivo	vivo	NN
cord-005453-4057qib7	1321	13	stimulation	stimulation	NN
cord-005453-4057qib7	1321	14	with	with	IN
cord-005453-4057qib7	1321	15	interferon	interferon	NN
cord-005453-4057qib7	1321	16	-	-	HYPH
cord-005453-4057qib7	1321	17	γ	γ	NN
cord-005453-4057qib7	1321	18	,	,	,
cord-005453-4057qib7	1321	19	IL-2	IL-2	NNP
cord-005453-4057qib7	1321	20	,	,	,
cord-005453-4057qib7	1321	21	OKT-3	OKT-3	NNP
cord-005453-4057qib7	1321	22	and	and	CC
cord-005453-4057qib7	1321	23	IL-15	IL-15	NNP
cord-005453-4057qib7	1321	24	.	.	.
cord-005453-4057qib7	1322	1	A	a	DT
cord-005453-4057qib7	1322	2	comparative	comparative	JJ
cord-005453-4057qib7	1322	3	analysis	analysis	NN
cord-005453-4057qib7	1322	4	of	of	IN
cord-005453-4057qib7	1322	5	expansion	expansion	NN
cord-005453-4057qib7	1322	6	rate	rate	NN
cord-005453-4057qib7	1322	7	,	,	,
cord-005453-4057qib7	1322	8	purity	purity	NN
cord-005453-4057qib7	1322	9	,	,	,
cord-005453-4057qib7	1322	10	phenotype	phenotype	NN
cord-005453-4057qib7	1322	11	and	and	CC
cord-005453-4057qib7	1322	12	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1322	13	activity	activity	NN
cord-005453-4057qib7	1322	14	against	against	IN
cord-005453-4057qib7	1322	15	different	different	JJ
cord-005453-4057qib7	1322	16	NB	NB	NNP
cord-005453-4057qib7	1322	17	cell	cell	NN
cord-005453-4057qib7	1322	18	lines	line	NNS
cord-005453-4057qib7	1322	19	following	follow	VBG
cord-005453-4057qib7	1322	20	different	different	JJ
cord-005453-4057qib7	1322	21	culturing	culturing	NN
cord-005453-4057qib7	1322	22	protocols	protocol	NNS
cord-005453-4057qib7	1322	23	was	be	VBD
cord-005453-4057qib7	1322	24	performed	perform	VBN
cord-005453-4057qib7	1322	25	.	.	.
cord-005453-4057qib7	1323	1	Results	result	NNS
cord-005453-4057qib7	1323	2	:	:	:
cord-005453-4057qib7	1324	1	CD56	cd56	NN
cord-005453-4057qib7	1324	2	enriched	enrich	VBN
cord-005453-4057qib7	1324	3	NK	NK	NNP
cord-005453-4057qib7	1324	4	cells	cell	NNS
cord-005453-4057qib7	1324	5	showed	show	VBD
cord-005453-4057qib7	1324	6	a	a	DT
cord-005453-4057qib7	1324	7	median	median	JJ
cord-005453-4057qib7	1324	8	expansion	expansion	NN
cord-005453-4057qib7	1324	9	rate	rate	NN
cord-005453-4057qib7	1324	10	of	of	IN
cord-005453-4057qib7	1324	11	4.3-fold	4.3-fold	CD
cord-005453-4057qib7	1324	12	after	after	IN
cord-005453-4057qib7	1324	13	10	10	CD
cord-005453-4057qib7	1324	14	to	to	TO
cord-005453-4057qib7	1324	15	12	12	CD
cord-005453-4057qib7	1324	16	days	day	NNS
cord-005453-4057qib7	1324	17	in	in	IN
cord-005453-4057qib7	1324	18	culture	culture	NN
cord-005453-4057qib7	1324	19	with	with	IN
cord-005453-4057qib7	1324	20	a	a	DT
cord-005453-4057qib7	1324	21	final	final	JJ
cord-005453-4057qib7	1324	22	frequency	frequency	NN
cord-005453-4057qib7	1324	23	up	up	IN
cord-005453-4057qib7	1324	24	to	to	IN
cord-005453-4057qib7	1324	25	99.0	99.0	CD
cord-005453-4057qib7	1324	26	%	%	NN
cord-005453-4057qib7	1324	27	NK	NK	NNP
cord-005453-4057qib7	1324	28	cells	cell	NNS
cord-005453-4057qib7	1324	29	and	and	CC
cord-005453-4057qib7	1324	30	a	a	DT
cord-005453-4057qib7	1324	31	median	median	JJ
cord-005453-4057qib7	1324	32	frequency	frequency	NN
cord-005453-4057qib7	1324	33	of	of	IN
cord-005453-4057qib7	1324	34	0.5	0.5	CD
cord-005453-4057qib7	1324	35	%	%	NN
cord-005453-4057qib7	1324	36	CD3	CD3	NNP
cord-005453-4057qib7	1324	37	+	+	CC
cord-005453-4057qib7	1324	38	CD56	CD56	NNP
cord-005453-4057qib7	1324	39	-T	-T	:
cord-005453-4057qib7	1324	40	cells	cell	NNS
cord-005453-4057qib7	1324	41	.	.	.
cord-005453-4057qib7	1325	1	In	in	IN
cord-005453-4057qib7	1325	2	contrast	contrast	NN
cord-005453-4057qib7	1325	3	,	,	,
cord-005453-4057qib7	1325	4	the	the	DT
cord-005453-4057qib7	1325	5	starting	start	VBG
cord-005453-4057qib7	1325	6	cell	cell	NN
cord-005453-4057qib7	1325	7	product	product	NN
cord-005453-4057qib7	1325	8	after	after	IN
cord-005453-4057qib7	1325	9	CD3	CD3	NNP
cord-005453-4057qib7	1325	10	/	/	SYM
cord-005453-4057qib7	1325	11	CD19	CD19	NNP
cord-005453-4057qib7	1325	12	depletion	depletion	NN
cord-005453-4057qib7	1325	13	consisted	consist	VBD
cord-005453-4057qib7	1325	14	of	of	IN
cord-005453-4057qib7	1325	15	a	a	DT
cord-005453-4057qib7	1325	16	median	median	JJ
cord-005453-4057qib7	1325	17	frequency	frequency	NN
cord-005453-4057qib7	1325	18	of	of	IN
cord-005453-4057qib7	1325	19	43.5	43.5	CD
cord-005453-4057qib7	1325	20	%	%	NN
cord-005453-4057qib7	1325	21	NK	NK	NNP
cord-005453-4057qib7	1325	22	cells	cell	NNS
cord-005453-4057qib7	1325	23	that	that	WDT
cord-005453-4057qib7	1325	24	expanded	expand	VBD
cord-005453-4057qib7	1325	25	significantly	significantly	RB
cord-005453-4057qib7	1325	26	faster	fast	RBR
cord-005453-4057qib7	1325	27	with	with	IN
cord-005453-4057qib7	1325	28	7.5-fold	7.5-fold	CD
cord-005453-4057qib7	1325	29	and	and	CC
cord-005453-4057qib7	1325	30	also	also	RB
cord-005453-4057qib7	1325	31	reached	reach	VBD
cord-005453-4057qib7	1325	32	up	up	RP
cord-005453-4057qib7	1325	33	to	to	IN
cord-005453-4057qib7	1325	34	98.6	98.6	CD
cord-005453-4057qib7	1325	35	%	%	NN
cord-005453-4057qib7	1325	36	purity	purity	NN
cord-005453-4057qib7	1325	37	without	without	IN
cord-005453-4057qib7	1325	38	any	any	DT
cord-005453-4057qib7	1325	39	relevant	relevant	JJ
cord-005453-4057qib7	1325	40	T	t	NN
cord-005453-4057qib7	1325	41	cell	cell	NN
cord-005453-4057qib7	1325	42	contamination	contamination	NN
cord-005453-4057qib7	1325	43	.	.	.
cord-005453-4057qib7	1326	1	CIK	CIK	NNP
cord-005453-4057qib7	1326	2	cells	cell	NNS
cord-005453-4057qib7	1326	3	expanded	expand	VBN
cord-005453-4057qib7	1326	4	with	with	IN
cord-005453-4057qib7	1326	5	a	a	DT
cord-005453-4057qib7	1326	6	median	median	JJ
cord-005453-4057qib7	1326	7	rate	rate	NN
cord-005453-4057qib7	1326	8	of	of	IN
cord-005453-4057qib7	1326	9	30.8-fold	30.8-fold	CD
cord-005453-4057qib7	1326	10	and	and	CC
cord-005453-4057qib7	1326	11	contained	contain	VBD
cord-005453-4057qib7	1326	12	3.3	3.3	CD
cord-005453-4057qib7	1326	13	%	%	NN
cord-005453-4057qib7	1326	14	NK	NK	NNP
cord-005453-4057qib7	1326	15	,	,	,
cord-005453-4057qib7	1326	16	84.2	84.2	CD
cord-005453-4057qib7	1326	17	%	%	NN
cord-005453-4057qib7	1326	18	T	t	NN
cord-005453-4057qib7	1326	19	and	and	CC
cord-005453-4057qib7	1326	20	6.2	6.2	CD
cord-005453-4057qib7	1326	21	%	%	NN
cord-005453-4057qib7	1326	22	NK	nk	NN
cord-005453-4057qib7	1326	23	-	-	HYPH
cord-005453-4057qib7	1326	24	like	like	NNP
cord-005453-4057qib7	1326	25	T	t	NN
cord-005453-4057qib7	1326	26	cells	cell	NNS
cord-005453-4057qib7	1326	27	.	.	.
cord-005453-4057qib7	1327	1	Interestingly	interestingly	RB
cord-005453-4057qib7	1327	2	,	,	,
cord-005453-4057qib7	1327	3	NK	NK	NNP
cord-005453-4057qib7	1327	4	cells	cell	NNS
cord-005453-4057qib7	1327	5	,	,	,
cord-005453-4057qib7	1327	6	particularly	particularly	RB
cord-005453-4057qib7	1327	7	after	after	IN
cord-005453-4057qib7	1327	8	CD3	CD3	NNP
cord-005453-4057qib7	1327	9	/	/	SYM
cord-005453-4057qib7	1327	10	CD19	CD19	NNP
cord-005453-4057qib7	1327	11	,	,	,
cord-005453-4057qib7	1327	12	showed	show	VBD
cord-005453-4057qib7	1327	13	a	a	DT
cord-005453-4057qib7	1327	14	significantly	significantly	RB
cord-005453-4057qib7	1327	15	higher	high	JJR
cord-005453-4057qib7	1327	16	median	median	JJ
cord-005453-4057qib7	1327	17	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1327	18	capacity	capacity	NN
cord-005453-4057qib7	1327	19	against	against	IN
cord-005453-4057qib7	1327	20	NB	NB	NNP
cord-005453-4057qib7	1327	21	cells	cell	NNS
cord-005453-4057qib7	1327	22	depletion	depletion	NN
cord-005453-4057qib7	1327	23	(	(	-LRB-
cord-005453-4057qib7	1327	24	46.6	46.6	CD
cord-005453-4057qib7	1327	25	%	%	NN
cord-005453-4057qib7	1327	26	for	for	IN
cord-005453-4057qib7	1327	27	CD56	CD56	NNP
cord-005453-4057qib7	1327	28	enrichment	enrichment	NN
cord-005453-4057qib7	1327	29	,	,	,
cord-005453-4057qib7	1327	30	53.7	53.7	CD
cord-005453-4057qib7	1327	31	%	%	NN
cord-005453-4057qib7	1327	32	for	for	IN
cord-005453-4057qib7	1327	33	CD3	CD3	NNP
cord-005453-4057qib7	1327	34	/	/	SYM
cord-005453-4057qib7	1327	35	CD19	CD19	NNP
cord-005453-4057qib7	1327	36	depletion	depletion	NN
cord-005453-4057qib7	1327	37	)	)	-RRB-
cord-005453-4057qib7	1327	38	compared	compare	VBN
cord-005453-4057qib7	1327	39	to	to	IN
cord-005453-4057qib7	1327	40	CIK	CIK	NNP
cord-005453-4057qib7	1327	41	cells	cell	NNS
cord-005453-4057qib7	1327	42	that	that	WDT
cord-005453-4057qib7	1327	43	induced	induce	VBD
cord-005453-4057qib7	1327	44	7.2	7.2	CD
cord-005453-4057qib7	1327	45	%	%	NN
cord-005453-4057qib7	1327	46	killing	killing	NN
cord-005453-4057qib7	1327	47	of	of	IN
cord-005453-4057qib7	1327	48	NB	NB	NNP
cord-005453-4057qib7	1327	49	cells	cell	NNS
cord-005453-4057qib7	1327	50	with	with	IN
cord-005453-4057qib7	1327	51	E	e	NN
cord-005453-4057qib7	1327	52	:	:	:
cord-005453-4057qib7	1327	53	T	t	NN
cord-005453-4057qib7	1327	54	ratio	ratio	NN
cord-005453-4057qib7	1327	55	5:1	5:1	CD
cord-005453-4057qib7	1327	56	in	in	IN
cord-005453-4057qib7	1327	57	a	a	DT
cord-005453-4057qib7	1327	58	3	3	CD
cord-005453-4057qib7	1327	59	hours	hour	NNS
cord-005453-4057qib7	1327	60	'	'	POS
cord-005453-4057qib7	1327	61	co	co	NN
cord-005453-4057qib7	1327	62	-	-	JJ
cord-005453-4057qib7	1327	63	incubation	incubation	JJ
cord-005453-4057qib7	1327	64	assay	assay	NN
cord-005453-4057qib7	1327	65	.	.	.
cord-005453-4057qib7	1328	1	Interestingly	interestingly	RB
cord-005453-4057qib7	1328	2	,	,	,
cord-005453-4057qib7	1328	3	prolonging	prolong	VBG
cord-005453-4057qib7	1328	4	the	the	DT
cord-005453-4057qib7	1328	5	ex	ex	FW
cord-005453-4057qib7	1328	6	vivo	vivo	NN
cord-005453-4057qib7	1328	7	stimulation	stimulation	NN
cord-005453-4057qib7	1328	8	after	after	IN
cord-005453-4057qib7	1328	9	CD3	CD3	NNP
cord-005453-4057qib7	1328	10	/	/	SYM
cord-005453-4057qib7	1328	11	CD19	CD19	NNP
cord-005453-4057qib7	1328	12	depletion	depletion	NN
cord-005453-4057qib7	1328	13	to	to	IN
cord-005453-4057qib7	1328	14	15	15	CD
cord-005453-4057qib7	1328	15	days	day	NNS
cord-005453-4057qib7	1328	16	enhanced	enhance	VBD
cord-005453-4057qib7	1328	17	the	the	DT
cord-005453-4057qib7	1328	18	median	median	JJ
cord-005453-4057qib7	1328	19	expansion	expansion	NN
cord-005453-4057qib7	1328	20	rate	rate	NN
cord-005453-4057qib7	1328	21	to	to	IN
cord-005453-4057qib7	1328	22	12.3-fold	12.3-fold	CD
cord-005453-4057qib7	1328	23	with	with	IN
cord-005453-4057qib7	1328	24	a	a	DT
cord-005453-4057qib7	1328	25	slightly	slightly	RB
cord-005453-4057qib7	1328	26	reduced	reduce	VBN
cord-005453-4057qib7	1328	27	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1328	28	potential	potential	NN
cord-005453-4057qib7	1328	29	(	(	-LRB-
cord-005453-4057qib7	1328	30	40.9	40.9	CD
cord-005453-4057qib7	1328	31	%	%	NN
cord-005453-4057qib7	1328	32	for	for	IN
cord-005453-4057qib7	1328	33	11	11	CD
cord-005453-4057qib7	1328	34	days	day	NNS
cord-005453-4057qib7	1328	35	'	'	POS
cord-005453-4057qib7	1328	36	ex	ex	NN
cord-005453-4057qib7	1328	37	vivo	vivo	NN
cord-005453-4057qib7	1328	38	expansion	expansion	NN
cord-005453-4057qib7	1328	39	,	,	,
cord-005453-4057qib7	1328	40	31.1	31.1	CD
cord-005453-4057qib7	1328	41	%	%	NN
cord-005453-4057qib7	1328	42	for	for	IN
cord-005453-4057qib7	1328	43	15	15	CD
cord-005453-4057qib7	1328	44	days	day	NNS
cord-005453-4057qib7	1328	45	'	'	POS
cord-005453-4057qib7	1328	46	ex	ex	NN
cord-005453-4057qib7	1328	47	vivo	vivo	NN
cord-005453-4057qib7	1328	48	expansion	expansion	NN
cord-005453-4057qib7	1328	49	,	,	,
cord-005453-4057qib7	1328	50	comparison	comparison	NN
cord-005453-4057qib7	1328	51	of	of	IN
cord-005453-4057qib7	1328	52	the	the	DT
cord-005453-4057qib7	1328	53	same	same	JJ
cord-005453-4057qib7	1328	54	donors	donor	NNS
cord-005453-4057qib7	1328	55	)	)	-RRB-
cord-005453-4057qib7	1328	56	.	.	.
cord-005453-4057qib7	1329	1	The	the	DT
cord-005453-4057qib7	1329	2	addition	addition	NN
cord-005453-4057qib7	1329	3	of	of	IN
cord-005453-4057qib7	1329	4	an	an	DT
cord-005453-4057qib7	1329	5	IL21boost	IL21boost	NNP
cord-005453-4057qib7	1329	6	prior	prior	JJ
cord-005453-4057qib7	1329	7	harvesting	harvesting	NN
cord-005453-4057qib7	1329	8	increased	increase	VBD
cord-005453-4057qib7	1329	9	the	the	DT
cord-005453-4057qib7	1329	10	expansion	expansion	NN
cord-005453-4057qib7	1329	11	rate	rate	NN
cord-005453-4057qib7	1329	12	to	to	IN
cord-005453-4057qib7	1329	13	median	median	JJ
cord-005453-4057qib7	1329	14	12.6-fold	12.6-fold	CD
cord-005453-4057qib7	1329	15	(	(	-LRB-
cord-005453-4057qib7	1329	16	compared	compare	VBN
cord-005453-4057qib7	1329	17	to	to	IN
cord-005453-4057qib7	1329	18	11.7-fold	11.7-fold	CD
cord-005453-4057qib7	1329	19	for	for	IN
cord-005453-4057qib7	1329	20	the	the	DT
cord-005453-4057qib7	1329	21	same	same	JJ
cord-005453-4057qib7	1329	22	donors	donor	NNS
cord-005453-4057qib7	1329	23	)	)	-RRB-
cord-005453-4057qib7	1329	24	with	with	IN
cord-005453-4057qib7	1329	25	an	an	DT
cord-005453-4057qib7	1329	26	improved	improved	JJ
cord-005453-4057qib7	1329	27	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1329	28	of	of	IN
cord-005453-4057qib7	1329	29	51.5	51.5	CD
cord-005453-4057qib7	1329	30	%	%	NN
cord-005453-4057qib7	1329	31	(	(	-LRB-
cord-005453-4057qib7	1329	32	compared	compare	VBN
cord-005453-4057qib7	1329	33	to	to	IN
cord-005453-4057qib7	1329	34	45.8	45.8	CD
cord-005453-4057qib7	1329	35	%	%	NN
cord-005453-4057qib7	1329	36	)	)	-RRB-
cord-005453-4057qib7	1329	37	.	.	.
cord-005453-4057qib7	1330	1	Fortunately	fortunately	RB
cord-005453-4057qib7	1330	2	,	,	,
cord-005453-4057qib7	1330	3	all	all	DT
cord-005453-4057qib7	1330	4	NK	NK	NNP
cord-005453-4057qib7	1330	5	cell	cell	NN
cord-005453-4057qib7	1330	6	products	product	NNS
cord-005453-4057qib7	1330	7	showed	show	VBD
cord-005453-4057qib7	1330	8	a	a	DT
cord-005453-4057qib7	1330	9	high	high	JJ
cord-005453-4057qib7	1330	10	viability	viability	NN
cord-005453-4057qib7	1330	11	and	and	CC
cord-005453-4057qib7	1330	12	no	no	DT
cord-005453-4057qib7	1330	13	relevant	relevant	JJ
cord-005453-4057qib7	1330	14	T	t	NN
cord-005453-4057qib7	1330	15	or	or	CC
cord-005453-4057qib7	1330	16	B	b	NN
cord-005453-4057qib7	1330	17	cell	cell	NN
cord-005453-4057qib7	1330	18	contamination	contamination	NN
cord-005453-4057qib7	1330	19	(	(	-LRB-
cord-005453-4057qib7	1330	20	median	median	NN
cord-005453-4057qib7	1330	21	<	<	XX
cord-005453-4057qib7	1330	22	0.2	0.2	CD
cord-005453-4057qib7	1330	23	%	%	NN
cord-005453-4057qib7	1330	24	)	)	-RRB-
cord-005453-4057qib7	1330	25	.	.	.
cord-005453-4057qib7	1331	1	Interestingly	interestingly	RB
cord-005453-4057qib7	1331	2	,	,	,
cord-005453-4057qib7	1331	3	further	further	JJ
cord-005453-4057qib7	1331	4	optimization	optimization	NN
cord-005453-4057qib7	1331	5	of	of	IN
cord-005453-4057qib7	1331	6	the	the	DT
cord-005453-4057qib7	1331	7	culturing	culturing	NN
cord-005453-4057qib7	1331	8	procedure	procedure	NN
cord-005453-4057qib7	1331	9	with	with	IN
cord-005453-4057qib7	1331	10	use	use	NN
cord-005453-4057qib7	1331	11	of	of	IN
cord-005453-4057qib7	1331	12	another	another	DT
cord-005453-4057qib7	1331	13	cell	cell	NN
cord-005453-4057qib7	1331	14	culture	culture	NN
cord-005453-4057qib7	1331	15	medium	medium	NN
cord-005453-4057qib7	1331	16	led	lead	VBD
cord-005453-4057qib7	1331	17	to	to	IN
cord-005453-4057qib7	1331	18	an	an	DT
cord-005453-4057qib7	1331	19	improved	improved	JJ
cord-005453-4057qib7	1331	20	median	median	JJ
cord-005453-4057qib7	1331	21	24.4-fold	24.4-fold	CD
cord-005453-4057qib7	1331	22	(	(	-LRB-
cord-005453-4057qib7	1331	23	compared	compare	VBN
cord-005453-4057qib7	1331	24	to	to	IN
cord-005453-4057qib7	1331	25	9.6-fold	9.6-fold	CD
cord-005453-4057qib7	1331	26	)	)	-RRB-
cord-005453-4057qib7	1332	1	NK	NK	NNP
cord-005453-4057qib7	1332	2	cell	cell	NN
cord-005453-4057qib7	1332	3	expansion	expansion	NN
cord-005453-4057qib7	1332	4	rate	rate	NN
cord-005453-4057qib7	1332	5	in	in	IN
cord-005453-4057qib7	1332	6	15	15	CD
cord-005453-4057qib7	1332	7	days	day	NNS
cord-005453-4057qib7	1332	8	,	,	,
cord-005453-4057qib7	1332	9	also	also	RB
cord-005453-4057qib7	1332	10	resulting	result	VBG
cord-005453-4057qib7	1332	11	in	in	IN
cord-005453-4057qib7	1332	12	comparable	comparable	JJ
cord-005453-4057qib7	1332	13	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1332	14	of	of	IN
cord-005453-4057qib7	1332	15	52.5	52.5	CD
cord-005453-4057qib7	1332	16	%	%	NN
cord-005453-4057qib7	1332	17	.	.	.
cord-005453-4057qib7	1333	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1333	2	:	:	:
cord-005453-4057qib7	1334	1	NK	NK	NNP
cord-005453-4057qib7	1334	2	and	and	CC
cord-005453-4057qib7	1334	3	CIK	CIK	NNP
cord-005453-4057qib7	1334	4	cell	cell	NN
cord-005453-4057qib7	1334	5	products	product	NNS
cord-005453-4057qib7	1334	6	may	may	MD
cord-005453-4057qib7	1334	7	offer	offer	VB
cord-005453-4057qib7	1334	8	an	an	DT
cord-005453-4057qib7	1334	9	innovative	innovative	JJ
cord-005453-4057qib7	1334	10	immune	immune	JJ
cord-005453-4057qib7	1334	11	therapeutic	therapeutic	JJ
cord-005453-4057qib7	1334	12	option	option	NN
cord-005453-4057qib7	1334	13	for	for	IN
cord-005453-4057qib7	1334	14	patients	patient	NNS
cord-005453-4057qib7	1334	15	with	with	IN
cord-005453-4057qib7	1334	16	high	high	JJ
cord-005453-4057qib7	1334	17	-	-	HYPH
cord-005453-4057qib7	1334	18	risk	risk	NN
cord-005453-4057qib7	1334	19	NB	NB	NNP
cord-005453-4057qib7	1334	20	after	after	IN
cord-005453-4057qib7	1334	21	allogenic	allogenic	JJ
cord-005453-4057qib7	1334	22	stem	stem	NN
cord-005453-4057qib7	1334	23	cell	cell	NN
cord-005453-4057qib7	1334	24	transplantation	transplantation	NN
cord-005453-4057qib7	1334	25	.	.	.
cord-005453-4057qib7	1335	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1335	2	study	study	NN
cord-005453-4057qib7	1335	3	revealed	reveal	VBD
cord-005453-4057qib7	1335	4	that	that	IN
cord-005453-4057qib7	1335	5	NK	NK	NNP
cord-005453-4057qib7	1335	6	cells	cell	NNS
cord-005453-4057qib7	1335	7	have	have	VBP
cord-005453-4057qib7	1335	8	a	a	DT
cord-005453-4057qib7	1335	9	significantly	significantly	RB
cord-005453-4057qib7	1335	10	higher	high	JJR
cord-005453-4057qib7	1335	11	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	1335	12	potential	potential	NN
cord-005453-4057qib7	1335	13	to	to	TO
cord-005453-4057qib7	1335	14	combat	combat	NN
cord-005453-4057qib7	1335	15	NB	NB	NNP
cord-005453-4057qib7	1335	16	.	.	.
cord-005453-4057qib7	1336	1	Interestingly	interestingly	RB
cord-005453-4057qib7	1336	2	,	,	,
cord-005453-4057qib7	1336	3	the	the	DT
cord-005453-4057qib7	1336	4	use	use	NN
cord-005453-4057qib7	1336	5	of	of	IN
cord-005453-4057qib7	1336	6	IL-15	IL-15	NNP
cord-005453-4057qib7	1336	7	expanded	expand	VBD
cord-005453-4057qib7	1336	8	and	and	CC
cord-005453-4057qib7	1336	9	IL-21	IL-21	NNP
cord-005453-4057qib7	1336	10	activated	activate	VBD
cord-005453-4057qib7	1336	11	NK	NK	NNP
cord-005453-4057qib7	1336	12	cells	cell	NNS
cord-005453-4057qib7	1336	13	developed	develop	VBN
cord-005453-4057qib7	1336	14	from	from	IN
cord-005453-4057qib7	1336	15	a	a	DT
cord-005453-4057qib7	1336	16	CD3/19	cd3/19	NN
cord-005453-4057qib7	1336	17	depleted	deplete	VBN
cord-005453-4057qib7	1336	18	apheresis	apheresis	NN
cord-005453-4057qib7	1336	19	product	product	NN
cord-005453-4057qib7	1336	20	is	be	VBZ
cord-005453-4057qib7	1336	21	highly	highly	RB
cord-005453-4057qib7	1336	22	promising	promising	JJ
cord-005453-4057qib7	1336	23	as	as	IN
cord-005453-4057qib7	1336	24	additional	additional	JJ
cord-005453-4057qib7	1336	25	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	1336	26	in	in	IN
cord-005453-4057qib7	1336	27	combination	combination	NN
cord-005453-4057qib7	1336	28	with	with	IN
cord-005453-4057qib7	1336	29	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1336	30	stem	stem	NN
cord-005453-4057qib7	1336	31	cell	cell	NN
cord-005453-4057qib7	1336	32	transplantation	transplantation	NN
cord-005453-4057qib7	1336	33	of	of	IN
cord-005453-4057qib7	1336	34	children	child	NNS
cord-005453-4057qib7	1336	35	with	with	IN
cord-005453-4057qib7	1336	36	NB	NB	NNP
cord-005453-4057qib7	1336	37	.	.	.
cord-005453-4057qib7	1337	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1337	2	:	:	:
cord-005453-4057qib7	1337	3	Nothing	nothing	NN
cord-005453-4057qib7	1337	4	to	to	TO
cord-005453-4057qib7	1337	5	declare	declare	VB
cord-005453-4057qib7	1337	6	.	.	.
cord-005453-4057qib7	1338	1	Quantitative	quantitative	JJ
cord-005453-4057qib7	1338	2	determination	determination	NN
cord-005453-4057qib7	1338	3	of	of	IN
cord-005453-4057qib7	1338	4	donor	donor	NN
cord-005453-4057qib7	1338	5	allo	allo	NN
cord-005453-4057qib7	1338	6	-	-	HYPH
cord-005453-4057qib7	1338	7	reactive	reactive	JJ
cord-005453-4057qib7	1338	8	T	T	NNP
cord-005453-4057qib7	1338	9	-	-	HYPH
cord-005453-4057qib7	1338	10	cells	cell	NNS
cord-005453-4057qib7	1338	11	in	in	IN
cord-005453-4057qib7	1338	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1338	13	donor	donor	NN
cord-005453-4057qib7	1338	14	-	-	HYPH
cord-005453-4057qib7	1338	15	recipient	recipient	NN
cord-005453-4057qib7	1338	16	pairs	pair	NNS
cord-005453-4057qib7	1338	17	by	by	IN
cord-005453-4057qib7	1338	18	enzymelinked	enzymelinked	NNP
cord-005453-4057qib7	1338	19	immunospot	immunospot	NNP
cord-005453-4057qib7	1338	20	(	(	-LRB-
cord-005453-4057qib7	1338	21	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1338	22	)	)	-RRB-
cord-005453-4057qib7	1338	23	and	and	CC
cord-005453-4057qib7	1338	24	mixed	mixed	JJ
cord-005453-4057qib7	1338	25	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1338	26	culture	culture	NN
cord-005453-4057qib7	1339	1	(	(	-LRB-
cord-005453-4057qib7	1339	2	MLC	MLC	NNP
cord-005453-4057qib7	1339	3	)	)	-RRB-
cord-005453-4057qib7	1339	4	assays	assays	NNP
cord-005453-4057qib7	1340	1	Background	background	NN
cord-005453-4057qib7	1340	2	:	:	:
cord-005453-4057qib7	1341	1	T	t	NN
cord-005453-4057qib7	1341	2	-	-	HYPH
cord-005453-4057qib7	1341	3	cell	cell	NN
cord-005453-4057qib7	1341	4	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	1341	5	is	be	VBZ
cord-005453-4057qib7	1341	6	responsible	responsible	JJ
cord-005453-4057qib7	1341	7	not	not	RB
cord-005453-4057qib7	1341	8	only	only	RB
cord-005453-4057qib7	1341	9	for	for	IN
cord-005453-4057qib7	1341	10	graft	graft	NN
cord-005453-4057qib7	1341	11	versus	versus	IN
cord-005453-4057qib7	1341	12	host	host	NN
cord-005453-4057qib7	1341	13	disease	disease	NN
cord-005453-4057qib7	1341	14	and	and	CC
cord-005453-4057qib7	1341	15	morbidity	morbidity	NN
cord-005453-4057qib7	1341	16	,	,	,
cord-005453-4057qib7	1341	17	associated	associate	VBN
cord-005453-4057qib7	1341	18	with	with	IN
cord-005453-4057qib7	1341	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1341	20	stem	stem	NN
cord-005453-4057qib7	1341	21	cell	cell	NN
cord-005453-4057qib7	1341	22	transplantation	transplantation	NN
cord-005453-4057qib7	1341	23	(	(	-LRB-
cord-005453-4057qib7	1341	24	HSCT	HSCT	NNP
cord-005453-4057qib7	1341	25	)	)	-RRB-
cord-005453-4057qib7	1341	26	but	but	CC
cord-005453-4057qib7	1341	27	also	also	RB
cord-005453-4057qib7	1341	28	for	for	IN
cord-005453-4057qib7	1341	29	graft	graft	NN
cord-005453-4057qib7	1341	30	-	-	HYPH
cord-005453-4057qib7	1341	31	versus	versus	IN
cord-005453-4057qib7	1341	32	-	-	HYPH
cord-005453-4057qib7	1341	33	leukemia	leukemia	NN
cord-005453-4057qib7	1341	34	(	(	-LRB-
cord-005453-4057qib7	1341	35	GVL	gvl	NN
cord-005453-4057qib7	1341	36	)	)	-RRB-
cord-005453-4057qib7	1341	37	activity	activity	NN
cord-005453-4057qib7	1341	38	.	.	.
cord-005453-4057qib7	1342	1	In	in	IN
cord-005453-4057qib7	1342	2	this	this	DT
cord-005453-4057qib7	1342	3	regard	regard	NN
cord-005453-4057qib7	1342	4	,	,	,
cord-005453-4057qib7	1342	5	monitoring	monitoring	NN
cord-005453-4057qib7	1342	6	and	and	CC
cord-005453-4057qib7	1342	7	quantitation	quantitation	NN
cord-005453-4057qib7	1342	8	of	of	IN
cord-005453-4057qib7	1342	9	alloreactive	alloreactive	NNP
cord-005453-4057qib7	1342	10	T	T	NNP
cord-005453-4057qib7	1342	11	-	-	HYPH
cord-005453-4057qib7	1342	12	cells	cell	NNS
cord-005453-4057qib7	1342	13	(	(	-LRB-
cord-005453-4057qib7	1342	14	allo	allo	NN
cord-005453-4057qib7	1342	15	-	-	HYPH
cord-005453-4057qib7	1342	16	T	T	NNP
cord-005453-4057qib7	1342	17	)	)	-RRB-
cord-005453-4057qib7	1342	18	may	may	MD
cord-005453-4057qib7	1342	19	potentially	potentially	RB
cord-005453-4057qib7	1342	20	provide	provide	VB
cord-005453-4057qib7	1342	21	valuable	valuable	JJ
cord-005453-4057qib7	1342	22	information	information	NN
cord-005453-4057qib7	1342	23	for	for	IN
cord-005453-4057qib7	1342	24	individualized	individualized	JJ
cord-005453-4057qib7	1342	25	clinical	clinical	JJ
cord-005453-4057qib7	1342	26	management	management	NN
cord-005453-4057qib7	1342	27	of	of	IN
cord-005453-4057qib7	1342	28	transplant	transplant	NN
cord-005453-4057qib7	1342	29	recipients	recipient	NNS
cord-005453-4057qib7	1342	30	.	.	.
cord-005453-4057qib7	1343	1	The	the	DT
cord-005453-4057qib7	1343	2	aim	aim	NN
cord-005453-4057qib7	1343	3	of	of	IN
cord-005453-4057qib7	1343	4	this	this	DT
cord-005453-4057qib7	1343	5	study	study	NN
cord-005453-4057qib7	1343	6	was	be	VBD
cord-005453-4057qib7	1343	7	the	the	DT
cord-005453-4057qib7	1343	8	optimization	optimization	NN
cord-005453-4057qib7	1343	9	of	of	IN
cord-005453-4057qib7	1343	10	allo	allo	NN
cord-005453-4057qib7	1343	11	-	-	HYPH
cord-005453-4057qib7	1343	12	Т	т	NN
cord-005453-4057qib7	1343	13	detection	detection	NN
cord-005453-4057qib7	1343	14	and	and	CC
cord-005453-4057qib7	1343	15	comparison	comparison	NN
cord-005453-4057qib7	1343	16	of	of	IN
cord-005453-4057qib7	1343	17	the	the	DT
cord-005453-4057qib7	1343	18	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1343	19	and	and	CC
cord-005453-4057qib7	1343	20	MLC	MLC	NNP
cord-005453-4057qib7	1343	21	assays	assay	NNS
cord-005453-4057qib7	1343	22	.	.	.
cord-005453-4057qib7	1344	1	Methods	method	NNS
cord-005453-4057qib7	1344	2	:	:	:
cord-005453-4057qib7	1345	1	Allo	Allo	NNP
cord-005453-4057qib7	1345	2	-	-	HYPH
cord-005453-4057qib7	1345	3	T	T	NNP
cord-005453-4057qib7	1345	4	were	be	VBD
cord-005453-4057qib7	1345	5	determined	determine	VBN
cord-005453-4057qib7	1345	6	in	in	IN
cord-005453-4057qib7	1345	7	20	20	CD
cord-005453-4057qib7	1345	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1345	9	donor	donor	NN
cord-005453-4057qib7	1345	10	-	-	HYPH
cord-005453-4057qib7	1345	11	recipient	recipient	NN
cord-005453-4057qib7	1345	12	pairs	pair	NNS
cord-005453-4057qib7	1345	13	before	before	IN
cord-005453-4057qib7	1345	14	HSCT	HSCT	NNP
cord-005453-4057qib7	1345	15	.	.	.
cord-005453-4057qib7	1346	1	Donor	donor	NN
cord-005453-4057qib7	1346	2	mononuclear	mononuclear	NN
cord-005453-4057qib7	1346	3	cells	cell	NNS
cord-005453-4057qib7	1346	4	(	(	-LRB-
cord-005453-4057qib7	1346	5	MNC	MNC	NNP
cord-005453-4057qib7	1346	6	)	)	-RRB-
cord-005453-4057qib7	1346	7	served	serve	VBD
cord-005453-4057qib7	1346	8	as	as	IN
cord-005453-4057qib7	1346	9	effector	effector	NN
cord-005453-4057qib7	1346	10	cells	cell	NNS
cord-005453-4057qib7	1346	11	(	(	-LRB-
cord-005453-4057qib7	1346	12	EC	EC	NNP
cord-005453-4057qib7	1346	13	)	)	-RRB-
cord-005453-4057qib7	1346	14	.	.	.
cord-005453-4057qib7	1347	1	Patient	Patient	NNP
cord-005453-4057qib7	1347	2	CD3depleted	CD3depleted	NNP
cord-005453-4057qib7	1347	3	MNC	MNC	NNP
cord-005453-4057qib7	1347	4	were	be	VBD
cord-005453-4057qib7	1347	5	used	use	VBN
cord-005453-4057qib7	1347	6	as	as	IN
cord-005453-4057qib7	1347	7	stimulatory	stimulatory	JJ
cord-005453-4057qib7	1347	8	cells	cell	NNS
cord-005453-4057qib7	1347	9	(	(	-LRB-
cord-005453-4057qib7	1347	10	SC).The	SC).The	NNP
cord-005453-4057qib7	1347	11	ratio	ratio	NN
cord-005453-4057qib7	1347	12	EC	EC	NNP
cord-005453-4057qib7	1347	13	:	:	:
cord-005453-4057qib7	1347	14	SC	SC	NNP
cord-005453-4057qib7	1347	15	were	be	VBD
cord-005453-4057qib7	1347	16	5:1	5:1	CD
cord-005453-4057qib7	1347	17	and	and	CC
cord-005453-4057qib7	1347	18	10:1	10:1	CD
cord-005453-4057qib7	1347	19	.	.	.
cord-005453-4057qib7	1348	1	The	the	DT
cord-005453-4057qib7	1348	2	frequency	frequency	NN
cord-005453-4057qib7	1348	3	of	of	IN
cord-005453-4057qib7	1348	4	allo	allo	NN
cord-005453-4057qib7	1348	5	-	-	HYPH
cord-005453-4057qib7	1348	6	T	t	NN
cord-005453-4057qib7	1348	7	in	in	IN
cord-005453-4057qib7	1348	8	donor	donor	NN
cord-005453-4057qib7	1348	9	peripheral	peripheral	JJ
cord-005453-4057qib7	1348	10	blood	blood	NN
cord-005453-4057qib7	1348	11	was	be	VBD
cord-005453-4057qib7	1348	12	tested	test	VBN
cord-005453-4057qib7	1348	13	in	in	IN
cord-005453-4057qib7	1348	14	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1348	15	assay	assay	NN
cord-005453-4057qib7	1348	16	and	and	CC
cord-005453-4057qib7	1348	17	MLC	MLC	NNP
cord-005453-4057qib7	1348	18	.	.	.
cord-005453-4057qib7	1349	1	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1349	2	provides	provide	VBZ
cord-005453-4057qib7	1349	3	the	the	DT
cord-005453-4057qib7	1349	4	detection	detection	NN
cord-005453-4057qib7	1349	5	and	and	CC
cord-005453-4057qib7	1349	6	quantitation	quantitation	NN
cord-005453-4057qib7	1349	7	of	of	IN
cord-005453-4057qib7	1349	8	activated	activate	VBN
cord-005453-4057qib7	1349	9	T	T	NNP
cord-005453-4057qib7	1349	10	-	-	HYPH
cord-005453-4057qib7	1349	11	cells	cell	NNS
cord-005453-4057qib7	1349	12	on	on	IN
cord-005453-4057qib7	1349	13	the	the	DT
cord-005453-4057qib7	1349	14	basis	basis	NN
cord-005453-4057qib7	1349	15	of	of	IN
cord-005453-4057qib7	1349	16	cytokine	cytokine	NN
cord-005453-4057qib7	1349	17	secreted	secrete	VBN
cord-005453-4057qib7	1349	18	by	by	IN
cord-005453-4057qib7	1349	19	each	each	DT
cord-005453-4057qib7	1349	20	cell	cell	NN
cord-005453-4057qib7	1349	21	.	.	.
cord-005453-4057qib7	1350	1	The	the	DT
cord-005453-4057qib7	1350	2	co	co	NN
cord-005453-4057qib7	1350	3	-	-	JJ
cord-005453-4057qib7	1350	4	incubation	incubation	JJ
cord-005453-4057qib7	1350	5	time	time	NN
cord-005453-4057qib7	1350	6	was	be	VBD
cord-005453-4057qib7	1350	7	24	24	CD
cord-005453-4057qib7	1350	8	h	h	NN
cord-005453-4057qib7	1350	9	for	for	IN
cord-005453-4057qib7	1350	10	IFN	IFN	NNP
cord-005453-4057qib7	1350	11	-	-	HYPH
cord-005453-4057qib7	1350	12	gamma	gamma	NNP
cord-005453-4057qib7	1350	13	and	and	CC
cord-005453-4057qib7	1350	14	48	48	CD
cord-005453-4057qib7	1350	15	h	h	NN
cord-005453-4057qib7	1350	16	for	for	IN
cord-005453-4057qib7	1350	17	IL-2	IL-2	NNP
cord-005453-4057qib7	1350	18	detection	detection	NN
cord-005453-4057qib7	1350	19	.	.	.
cord-005453-4057qib7	1351	1	In	in	IN
cord-005453-4057qib7	1351	2	MCL	MCL	NNP
cord-005453-4057qib7	1351	3	assay	assay	NN
cord-005453-4057qib7	1351	4	donor	donor	NN
cord-005453-4057qib7	1351	5	MNC	MNC	NNP
cord-005453-4057qib7	1351	6	were	be	VBD
cord-005453-4057qib7	1351	7	labeled	label	VBN
cord-005453-4057qib7	1351	8	with	with	IN
cord-005453-4057qib7	1351	9	CFSE	CFSE	NNP
cord-005453-4057qib7	1351	10	and	and	CC
cord-005453-4057qib7	1351	11	allo	allo	NNP
cord-005453-4057qib7	1351	12	-	-	HYPH
cord-005453-4057qib7	1351	13	T	t	NN
cord-005453-4057qib7	1351	14	,	,	,
cord-005453-4057qib7	1351	15	proliferating	proliferate	VBG
cord-005453-4057qib7	1351	16	in	in	IN
cord-005453-4057qib7	1351	17	response	response	NN
cord-005453-4057qib7	1351	18	to	to	IN
cord-005453-4057qib7	1351	19	stimulation	stimulation	NN
cord-005453-4057qib7	1351	20	with	with	IN
cord-005453-4057qib7	1351	21	alloantigens	alloantigens	NNP
cord-005453-4057qib7	1351	22	,	,	,
cord-005453-4057qib7	1351	23	were	be	VBD
cord-005453-4057qib7	1351	24	determined	determine	VBN
cord-005453-4057qib7	1351	25	by	by	IN
cord-005453-4057qib7	1351	26	flow	flow	NN
cord-005453-4057qib7	1351	27	cytometry	cytometry	NN
cord-005453-4057qib7	1351	28	on	on	IN
cord-005453-4057qib7	1351	29	day	day	NN
cord-005453-4057qib7	1351	30	5	5	CD
cord-005453-4057qib7	1351	31	.	.	.
cord-005453-4057qib7	1352	1	Results	result	NNS
cord-005453-4057qib7	1352	2	:	:	:
cord-005453-4057qib7	1353	1	The	the	DT
cord-005453-4057qib7	1353	2	median	median	JJ
cord-005453-4057qib7	1353	3	number	number	NN
cord-005453-4057qib7	1353	4	of	of	IN
cord-005453-4057qib7	1353	5	IFN	IFN	NNP
cord-005453-4057qib7	1353	6	-	-	HYPH
cord-005453-4057qib7	1353	7	gamma	gamma	NN
cord-005453-4057qib7	1353	8	producing	produce	VBG
cord-005453-4057qib7	1353	9	allo	allo	NN
cord-005453-4057qib7	1353	10	-	-	HYPH
cord-005453-4057qib7	1353	11	T	t	NN
cord-005453-4057qib7	1353	12	per	per	IN
cord-005453-4057qib7	1353	13	300	300	CD
cord-005453-4057qib7	1353	14	000	000	CD
cord-005453-4057qib7	1353	15	donor	donor	NN
cord-005453-4057qib7	1353	16	MNC	MNC	NNP
cord-005453-4057qib7	1353	17	was	be	VBD
cord-005453-4057qib7	1353	18	143,5	143,5	CD
cord-005453-4057qib7	1354	1	(	(	-LRB-
cord-005453-4057qib7	1354	2	2	2	CD
cord-005453-4057qib7	1354	3	-	-	SYM
cord-005453-4057qib7	1354	4	1469	1469	CD
cord-005453-4057qib7	1354	5	;	;	:
cord-005453-4057qib7	1354	6	EC	EC	NNP
cord-005453-4057qib7	1354	7	:	:	:
cord-005453-4057qib7	1354	8	SC	SC	NNP
cord-005453-4057qib7	1354	9	ratio	ratio	NN
cord-005453-4057qib7	1354	10	-5:1	-5:1	NN
cord-005453-4057qib7	1354	11	)	)	-RRB-
cord-005453-4057qib7	1354	12	and	and	CC
cord-005453-4057qib7	1354	13	75,0	75,0	CD
cord-005453-4057qib7	1354	14	(	(	-LRB-
cord-005453-4057qib7	1354	15	1	1	CD
cord-005453-4057qib7	1354	16	-	-	SYM
cord-005453-4057qib7	1354	17	1440	1440	CD
cord-005453-4057qib7	1354	18	;	;	:
cord-005453-4057qib7	1354	19	EC	EC	NNP
cord-005453-4057qib7	1354	20	:	:	:
cord-005453-4057qib7	1354	21	SC	SC	NNP
cord-005453-4057qib7	1354	22	ratio	ratio	NN
cord-005453-4057qib7	1354	23	-10:1	-10:1	CD
cord-005453-4057qib7	1354	24	)	)	-RRB-
cord-005453-4057qib7	1354	25	.	.	.
cord-005453-4057qib7	1355	1	The	the	DT
cord-005453-4057qib7	1355	2	median	median	JJ
cord-005453-4057qib7	1355	3	frequency	frequency	NN
cord-005453-4057qib7	1355	4	of	of	IN
cord-005453-4057qib7	1355	5	allo	allo	NN
cord-005453-4057qib7	1355	6	-	-	HYPH
cord-005453-4057qib7	1355	7	T	T	NNP
cord-005453-4057qib7	1355	8	was	be	VBD
cord-005453-4057qib7	1355	9	0,056	0,056	CD
cord-005453-4057qib7	1355	10	%	%	NN
cord-005453-4057qib7	1355	11	(	(	-LRB-
cord-005453-4057qib7	1355	12	0,00076	0,00076	NNP
cord-005453-4057qib7	1355	13	-0,538	-0,538	NNP
cord-005453-4057qib7	1356	1	;	;	:
cord-005453-4057qib7	1356	2	EC	EC	NNP
cord-005453-4057qib7	1356	3	:	:	:
cord-005453-4057qib7	1356	4	SC	SC	NNP
cord-005453-4057qib7	1356	5	ratio	ratio	NN
cord-005453-4057qib7	1356	6	-5:1	-5:1	NN
cord-005453-4057qib7	1356	7	)	)	-RRB-
cord-005453-4057qib7	1356	8	and	and	CC
cord-005453-4057qib7	1356	9	0,019	0,019	CD
cord-005453-4057qib7	1356	10	%	%	NN
cord-005453-4057qib7	1356	11	(	(	-LRB-
cord-005453-4057qib7	1356	12	0,00019	0,00019	NNP
cord-005453-4057qib7	1356	13	-0,632	-0,632	NNP
cord-005453-4057qib7	1356	14	;	;	:
cord-005453-4057qib7	1356	15	EC	EC	NNP
cord-005453-4057qib7	1356	16	:	:	:
cord-005453-4057qib7	1356	17	SC	SC	NNP
cord-005453-4057qib7	1356	18	ratio	ratio	NN
cord-005453-4057qib7	1356	19	-10:1	-10:1	CD
cord-005453-4057qib7	1356	20	)	)	-RRB-
cord-005453-4057qib7	1356	21	among	among	IN
cord-005453-4057qib7	1356	22	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1356	23	.	.	.
cord-005453-4057qib7	1357	1	IL-2-producing	IL-2-producing	``
cord-005453-4057qib7	1357	2	allo	allo	NNP
cord-005453-4057qib7	1357	3	-	-	HYPH
cord-005453-4057qib7	1357	4	T	T	NNP
cord-005453-4057qib7	1357	5	were	be	VBD
cord-005453-4057qib7	1357	6	less	less	RBR
cord-005453-4057qib7	1357	7	frequent	frequent	JJ
cord-005453-4057qib7	1357	8	in	in	IN
cord-005453-4057qib7	1357	9	donor	donor	NN
cord-005453-4057qib7	1357	10	MNC	MNC	NNP
cord-005453-4057qib7	1357	11	in	in	IN
cord-005453-4057qib7	1357	12	comparison	comparison	NN
cord-005453-4057qib7	1357	13	with	with	IN
cord-005453-4057qib7	1357	14	IFNgamma	IFNgamma	NNP
cord-005453-4057qib7	1357	15	-	-	HYPH
cord-005453-4057qib7	1357	16	producing	produce	VBG
cord-005453-4057qib7	1357	17	allo	allo	NN
cord-005453-4057qib7	1357	18	-	-	HYPH
cord-005453-4057qib7	1357	19	T.	t.	NN
cord-005453-4057qib7	1358	1	The	the	DT
cord-005453-4057qib7	1358	2	median	median	JJ
cord-005453-4057qib7	1358	3	number	number	NN
cord-005453-4057qib7	1358	4	per	per	IN
cord-005453-4057qib7	1358	5	300	300	CD
cord-005453-4057qib7	1358	6	000	000	CD
cord-005453-4057qib7	1358	7	MNC	MNC	NNP
cord-005453-4057qib7	1358	8	was	be	VBD
cord-005453-4057qib7	1358	9	7,5	7,5	CD
cord-005453-4057qib7	1358	10	(	(	-LRB-
cord-005453-4057qib7	1358	11	0,5	0,5	CD
cord-005453-4057qib7	1358	12	-	-	HYPH
cord-005453-4057qib7	1358	13	356	356	CD
cord-005453-4057qib7	1358	14	;	;	:
cord-005453-4057qib7	1359	1	EC	EC	NNP
cord-005453-4057qib7	1359	2	:	:	:
cord-005453-4057qib7	1359	3	SC	SC	NNP
cord-005453-4057qib7	1359	4	ratio	ratio	NN
cord-005453-4057qib7	1359	5	-5:1	-5:1	NN
cord-005453-4057qib7	1359	6	)	)	-RRB-
cord-005453-4057qib7	1359	7	and	and	CC
cord-005453-4057qib7	1359	8	6,0	6,0	CD
cord-005453-4057qib7	1359	9	(	(	-LRB-
cord-005453-4057qib7	1359	10	0	0	CD
cord-005453-4057qib7	1359	11	-	-	SYM
cord-005453-4057qib7	1359	12	169	169	CD
cord-005453-4057qib7	1359	13	;	;	:
cord-005453-4057qib7	1359	14	EC	EC	NNP
cord-005453-4057qib7	1359	15	:	:	:
cord-005453-4057qib7	1359	16	SC	SC	NNP
cord-005453-4057qib7	1359	17	ratio	ratio	NN
cord-005453-4057qib7	1359	18	-10:1	-10:1	CD
cord-005453-4057qib7	1359	19	)	)	-RRB-
cord-005453-4057qib7	1359	20	.	.	.
cord-005453-4057qib7	1360	1	The	the	DT
cord-005453-4057qib7	1360	2	median	median	JJ
cord-005453-4057qib7	1360	3	frequency	frequency	NN
cord-005453-4057qib7	1360	4	of	of	IN
cord-005453-4057qib7	1360	5	IL-2-allo	IL-2-allo	NNP
cord-005453-4057qib7	1360	6	-	-	HYPH
cord-005453-4057qib7	1360	7	T	T	NNP
cord-005453-4057qib7	1360	8	was	be	VBD
cord-005453-4057qib7	1360	9	0,0028	0,0028	CD
cord-005453-4057qib7	1360	10	%	%	NN
cord-005453-4057qib7	1360	11	(	(	-LRB-
cord-005453-4057qib7	1360	12	0,0002	0,0002	NNP
cord-005453-4057qib7	1360	13	-0,130	-0,130	.
cord-005453-4057qib7	1361	1	;	;	:
cord-005453-4057qib7	1361	2	EC	EC	NNP
cord-005453-4057qib7	1361	3	:	:	:
cord-005453-4057qib7	1361	4	SC	SC	NNP
cord-005453-4057qib7	1361	5	ratio	ratio	NN
cord-005453-4057qib7	1361	6	-5:1	-5:1	NN
cord-005453-4057qib7	1361	7	)	)	-RRB-
cord-005453-4057qib7	1361	8	and	and	CC
cord-005453-4057qib7	1361	9	0,0022	0,0022	CD
cord-005453-4057qib7	1361	10	%	%	NN
cord-005453-4057qib7	1361	11	(	(	-LRB-
cord-005453-4057qib7	1361	12	0	0	NFP
cord-005453-4057qib7	1361	13	-0,0619	-0,0619	CD
cord-005453-4057qib7	1361	14	;	;	:
cord-005453-4057qib7	1361	15	EC	EC	NNP
cord-005453-4057qib7	1361	16	:	:	:
cord-005453-4057qib7	1361	17	SC	SC	NNP
cord-005453-4057qib7	1361	18	ratio	ratio	NN
cord-005453-4057qib7	1361	19	-10:1	-10:1	CD
cord-005453-4057qib7	1361	20	)	)	-RRB-
cord-005453-4057qib7	1361	21	among	among	IN
cord-005453-4057qib7	1361	22	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1361	23	.	.	.
cord-005453-4057qib7	1362	1	The	the	DT
cord-005453-4057qib7	1362	2	EC	EC	NNP
cord-005453-4057qib7	1362	3	:	:	:
cord-005453-4057qib7	1362	4	SC	SC	NNP
cord-005453-4057qib7	1362	5	ratio	ratio	NN
cord-005453-4057qib7	1362	6	10:1	10:1	CD
cord-005453-4057qib7	1362	7	is	be	VBZ
cord-005453-4057qib7	1362	8	enough	enough	JJ
cord-005453-4057qib7	1362	9	for	for	IN
cord-005453-4057qib7	1362	10	stimulation	stimulation	NN
cord-005453-4057qib7	1362	11	of	of	IN
cord-005453-4057qib7	1362	12	IL-2	il-2	NN
cord-005453-4057qib7	1362	13	producing	produce	VBG
cord-005453-4057qib7	1362	14	by	by	IN
cord-005453-4057qib7	1362	15	MNC	MNC	NNP
cord-005453-4057qib7	1362	16	in	in	IN
cord-005453-4057qib7	1362	17	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1362	18	assay	assay	NN
cord-005453-4057qib7	1362	19	,	,	,
cord-005453-4057qib7	1362	20	but	but	CC
cord-005453-4057qib7	1362	21	for	for	IN
cord-005453-4057qib7	1362	22	optimal	optimal	JJ
cord-005453-4057qib7	1362	23	stimulation	stimulation	NN
cord-005453-4057qib7	1362	24	of	of	IN
cord-005453-4057qib7	1362	25	IFN	IFN	NNP
cord-005453-4057qib7	1362	26	-	-	HYPH
cord-005453-4057qib7	1362	27	gamma	gamma	NN
cord-005453-4057qib7	1362	28	producing	produce	VBG
cord-005453-4057qib7	1362	29	cells	cell	NNS
cord-005453-4057qib7	1362	30	EC	EC	NNP
cord-005453-4057qib7	1362	31	:	:	:
cord-005453-4057qib7	1362	32	SC	SC	NNP
cord-005453-4057qib7	1362	33	ratio	ratio	NN
cord-005453-4057qib7	1362	34	5:1	5:1	CD
cord-005453-4057qib7	1362	35	is	be	VBZ
cord-005453-4057qib7	1362	36	preferable	preferable	JJ
cord-005453-4057qib7	1362	37	.	.	.
cord-005453-4057qib7	1363	1	This	this	DT
cord-005453-4057qib7	1363	2	suggests	suggest	VBZ
cord-005453-4057qib7	1363	3	that	that	IN
cord-005453-4057qib7	1363	4	allo	allo	NN
cord-005453-4057qib7	1363	5	-	-	HYPH
cord-005453-4057qib7	1363	6	T	T	NNP
cord-005453-4057qib7	1363	7	are	be	VBP
cord-005453-4057qib7	1363	8	predominantly	predominantly	RB
cord-005453-4057qib7	1363	9	IFN	IFN	NNP
cord-005453-4057qib7	1363	10	-	-	HYPH
cord-005453-4057qib7	1363	11	gamma	gamma	NN
cord-005453-4057qib7	1363	12	producing	produce	VBG
cord-005453-4057qib7	1363	13	cells	cell	NNS
cord-005453-4057qib7	1363	14	.	.	.
cord-005453-4057qib7	1364	1	Alloreactive	alloreactive	JJ
cord-005453-4057qib7	1364	2	proliferating	proliferate	VBG
cord-005453-4057qib7	1364	3	T	t	NN
cord-005453-4057qib7	1364	4	-	-	HYPH
cord-005453-4057qib7	1364	5	clones	clone	NNS
cord-005453-4057qib7	1364	6	were	be	VBD
cord-005453-4057qib7	1364	7	detected	detect	VBN
cord-005453-4057qib7	1364	8	in	in	IN
cord-005453-4057qib7	1364	9	MLC	MLC	NNP
cord-005453-4057qib7	1364	10	in	in	IN
cord-005453-4057qib7	1364	11	10	10	CD
cord-005453-4057qib7	1364	12	of	of	IN
cord-005453-4057qib7	1364	13	14	14	CD
cord-005453-4057qib7	1364	14	donor	donor	NN
cord-005453-4057qib7	1364	15	-	-	HYPH
cord-005453-4057qib7	1364	16	recipient	recipient	NN
cord-005453-4057qib7	1364	17	pairs	pair	NNS
cord-005453-4057qib7	1364	18	on	on	IN
cord-005453-4057qib7	1364	19	5	5	CD
cord-005453-4057qib7	1364	20	day	day	NN
cord-005453-4057qib7	1364	21	of	of	IN
cord-005453-4057qib7	1364	22	cocultivation	cocultivation	NN
cord-005453-4057qib7	1364	23	.	.	.
cord-005453-4057qib7	1365	1	Median	median	JJ
cord-005453-4057qib7	1365	2	percentage	percentage	NN
cord-005453-4057qib7	1365	3	of	of	IN
cord-005453-4057qib7	1365	4	proliferating	proliferate	VBG
cord-005453-4057qib7	1365	5	T	t	NN
cord-005453-4057qib7	1365	6	-	-	HYPH
cord-005453-4057qib7	1365	7	clones	clone	NNS
cord-005453-4057qib7	1365	8	were	be	VBD
cord-005453-4057qib7	1365	9	9,5	9,5	CD
cord-005453-4057qib7	1365	10	%	%	NN
cord-005453-4057qib7	1365	11	(	(	-LRB-
cord-005453-4057qib7	1365	12	2,1	2,1	CD
cord-005453-4057qib7	1365	13	-32,5	-32,5	UH
cord-005453-4057qib7	1365	14	;	;	:
cord-005453-4057qib7	1365	15	EC	EC	NNP
cord-005453-4057qib7	1365	16	:	:	:
cord-005453-4057qib7	1365	17	SC	SC	NNP
cord-005453-4057qib7	1365	18	ratio	ratio	NN
cord-005453-4057qib7	1365	19	-5:1	-5:1	NN
cord-005453-4057qib7	1365	20	)	)	-RRB-
cord-005453-4057qib7	1365	21	and	and	CC
cord-005453-4057qib7	1365	22	7,6	7,6	CD
cord-005453-4057qib7	1365	23	%	%	NN
cord-005453-4057qib7	1365	24	(	(	-LRB-
cord-005453-4057qib7	1365	25	3,0	3,0	NNP
cord-005453-4057qib7	1365	26	-24,1	-24,1	XX
cord-005453-4057qib7	1365	27	;	;	:
cord-005453-4057qib7	1365	28	EC	EC	NNP
cord-005453-4057qib7	1365	29	:	:	:
cord-005453-4057qib7	1365	30	SC	SC	NNP
cord-005453-4057qib7	1365	31	ratio	ratio	NN
cord-005453-4057qib7	1365	32	-10:1	-10:1	CD
cord-005453-4057qib7	1365	33	)	)	-RRB-
cord-005453-4057qib7	1365	34	among	among	IN
cord-005453-4057qib7	1365	35	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	1365	36	.	.	.
cord-005453-4057qib7	1366	1	However	however	RB
cord-005453-4057qib7	1366	2	,	,	,
cord-005453-4057qib7	1366	3	MLC	MLC	NNP
cord-005453-4057qib7	1366	4	assay	assay	NN
cord-005453-4057qib7	1366	5	only	only	RB
cord-005453-4057qib7	1366	6	permit	permit	VBP
cord-005453-4057qib7	1366	7	a	a	DT
cord-005453-4057qib7	1366	8	qualitative	qualitative	JJ
cord-005453-4057qib7	1366	9	analysis	analysis	NN
cord-005453-4057qib7	1366	10	that	that	WDT
cord-005453-4057qib7	1366	11	confirmed	confirm	VBD
cord-005453-4057qib7	1366	12	the	the	DT
cord-005453-4057qib7	1366	13	presence	presence	NN
cord-005453-4057qib7	1366	14	of	of	IN
cord-005453-4057qib7	1366	15	alloreactive	alloreactive	NNP
cord-005453-4057qib7	1366	16	T	T	NNP
cord-005453-4057qib7	1366	17	-	-	HYPH
cord-005453-4057qib7	1366	18	clones	clone	NNS
cord-005453-4057qib7	1366	19	,	,	,
cord-005453-4057qib7	1366	20	giving	give	VBG
cord-005453-4057qib7	1366	21	no	no	DT
cord-005453-4057qib7	1366	22	information	information	NN
cord-005453-4057qib7	1366	23	on	on	IN
cord-005453-4057qib7	1366	24	their	-PRON-	PRP$
cord-005453-4057qib7	1366	25	frequency	frequency	NN
cord-005453-4057qib7	1366	26	within	within	IN
cord-005453-4057qib7	1366	27	the	the	DT
cord-005453-4057qib7	1366	28	culture	culture	NN
cord-005453-4057qib7	1366	29	.	.	.
cord-005453-4057qib7	1367	1	Results	result	NNS
cord-005453-4057qib7	1367	2	of	of	IN
cord-005453-4057qib7	1367	3	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1367	4	and	and	CC
cord-005453-4057qib7	1367	5	MCL	MCL	NNP
cord-005453-4057qib7	1367	6	assay	assay	NN
cord-005453-4057qib7	1367	7	directly	directly	RB
cord-005453-4057qib7	1367	8	correlated	correlate	VBN
cord-005453-4057qib7	1367	9	.	.	.
cord-005453-4057qib7	1368	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1368	2	:	:	:
cord-005453-4057qib7	1369	1	Allo	Allo	NNP
cord-005453-4057qib7	1369	2	-	-	HYPH
cord-005453-4057qib7	1369	3	T	T	NNP
cord-005453-4057qib7	1369	4	were	be	VBD
cord-005453-4057qib7	1369	5	detected	detect	VBN
cord-005453-4057qib7	1369	6	in	in	IN
cord-005453-4057qib7	1369	7	100,0	100,0	CD
cord-005453-4057qib7	1369	8	%	%	NN
cord-005453-4057qib7	1369	9	of	of	IN
cord-005453-4057qib7	1369	10	assayed	assay	VBN
cord-005453-4057qib7	1369	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1369	12	donor	donor	NN
cord-005453-4057qib7	1369	13	-	-	HYPH
cord-005453-4057qib7	1369	14	recipient	recipient	NN
cord-005453-4057qib7	1369	15	pairs	pair	NNS
cord-005453-4057qib7	1369	16	by	by	IN
cord-005453-4057qib7	1369	17	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1369	18	and	and	CC
cord-005453-4057qib7	1369	19	only	only	RB
cord-005453-4057qib7	1369	20	in	in	IN
cord-005453-4057qib7	1369	21	71,4	71,4	CD
cord-005453-4057qib7	1369	22	%	%	NN
cord-005453-4057qib7	1369	23	by	by	IN
cord-005453-4057qib7	1369	24	MLC	MLC	NNP
cord-005453-4057qib7	1369	25	.	.	.
cord-005453-4057qib7	1370	1	This	this	DT
cord-005453-4057qib7	1370	2	difference	difference	NN
cord-005453-4057qib7	1370	3	in	in	IN
cord-005453-4057qib7	1370	4	detection	detection	NN
cord-005453-4057qib7	1370	5	is	be	VBZ
cord-005453-4057qib7	1370	6	due	due	JJ
cord-005453-4057qib7	1370	7	to	to	IN
cord-005453-4057qib7	1370	8	the	the	DT
cord-005453-4057qib7	1370	9	fact	fact	NN
cord-005453-4057qib7	1370	10	that	that	IN
cord-005453-4057qib7	1370	11	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	1370	12	allows	allow	VBZ
cord-005453-4057qib7	1370	13	to	to	TO
cord-005453-4057qib7	1370	14	detect	detect	VB
cord-005453-4057qib7	1370	15	single	single	JJ
cord-005453-4057qib7	1370	16	cytokine	cytokine	NN
cord-005453-4057qib7	1370	17	secreting	secrete	VBG
cord-005453-4057qib7	1370	18	cell	cell	NN
cord-005453-4057qib7	1370	19	whereas	whereas	IN
cord-005453-4057qib7	1370	20	MLC	MLC	NNP
cord-005453-4057qib7	1370	21	can	can	MD
cord-005453-4057qib7	1370	22	reveal	reveal	VB
cord-005453-4057qib7	1370	23	proliferating	proliferate	VBG
cord-005453-4057qib7	1370	24	аllo	аllo	NN
cord-005453-4057qib7	1370	25	-	-	HYPH
cord-005453-4057qib7	1370	26	T	T	NNP
cord-005453-4057qib7	1370	27	clones	clone	NNS
cord-005453-4057qib7	1370	28	.	.	.
cord-005453-4057qib7	1371	1	The	the	DT
cord-005453-4057qib7	1371	2	analysis	analysis	NN
cord-005453-4057qib7	1371	3	of	of	IN
cord-005453-4057qib7	1371	4	allo	allo	NN
cord-005453-4057qib7	1371	5	-	-	HYPH
cord-005453-4057qib7	1371	6	T	T	NNP
cord-005453-4057qib7	1371	7	in	in	IN
cord-005453-4057qib7	1371	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1371	9	donor	donor	NN
cord-005453-4057qib7	1371	10	-	-	HYPH
cord-005453-4057qib7	1371	11	recipient	recipient	NN
cord-005453-4057qib7	1371	12	pairs	pair	NNS
cord-005453-4057qib7	1371	13	may	may	MD
cord-005453-4057qib7	1371	14	provide	provide	VB
cord-005453-4057qib7	1371	15	rationale	rationale	NN
cord-005453-4057qib7	1371	16	to	to	TO
cord-005453-4057qib7	1371	17	manipulate	manipulate	VB
cord-005453-4057qib7	1371	18	the	the	DT
cord-005453-4057qib7	1371	19	allo	allo	NN
cord-005453-4057qib7	1371	20	-	-	HYPH
cord-005453-4057qib7	1371	21	immune	immune	JJ
cord-005453-4057qib7	1371	22	response	response	NN
cord-005453-4057qib7	1371	23	and	and	CC
cord-005453-4057qib7	1371	24	to	to	TO
cord-005453-4057qib7	1371	25	exploit	exploit	VB
cord-005453-4057qib7	1371	26	the	the	DT
cord-005453-4057qib7	1371	27	powerful	powerful	JJ
cord-005453-4057qib7	1371	28	ability	ability	NN
cord-005453-4057qib7	1371	29	of	of	IN
cord-005453-4057qib7	1371	30	allo	allo	NN
cord-005453-4057qib7	1371	31	-	-	HYPH
cord-005453-4057qib7	1371	32	T	t	NN
cord-005453-4057qib7	1371	33	to	to	TO
cord-005453-4057qib7	1371	34	control	control	VB
cord-005453-4057qib7	1371	35	hematologic	hematologic	JJ
cord-005453-4057qib7	1371	36	malignancies	malignancy	NNS
cord-005453-4057qib7	1371	37	.	.	.
cord-005453-4057qib7	1372	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1372	2	:	:	:
cord-005453-4057qib7	1372	3	Nothing	nothing	NN
cord-005453-4057qib7	1372	4	to	to	TO
cord-005453-4057qib7	1372	5	declare	declare	VB
cord-005453-4057qib7	1372	6	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	1372	7	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	1372	8	stromal	stromal	JJ
cord-005453-4057qib7	1372	9	cell	cell	NN
cord-005453-4057qib7	1372	10	as	as	IN
cord-005453-4057qib7	1372	11	rescue	rescue	NN
cord-005453-4057qib7	1372	12	therapy	therapy	NN
cord-005453-4057qib7	1372	13	in	in	IN
cord-005453-4057qib7	1372	14	an	an	DT
cord-005453-4057qib7	1372	15	infant	infant	NN
cord-005453-4057qib7	1372	16	with	with	IN
cord-005453-4057qib7	1372	17	life	life	NN
cord-005453-4057qib7	1372	18	-	-	HYPH
cord-005453-4057qib7	1372	19	threatening	threaten	VBG
cord-005453-4057qib7	1372	20	respiratory	respiratory	JJ
cord-005453-4057qib7	1372	21	syndrome	syndrome	NN
cord-005453-4057qib7	1372	22	due	due	IN
cord-005453-4057qib7	1372	23	to	to	IN
cord-005453-4057qib7	1372	24	a	a	DT
cord-005453-4057qib7	1372	25	filamin	filamin	NN
cord-005453-4057qib7	1373	1	a	a	DT
cord-005453-4057qib7	1373	2	mutation	mutation	NN
cord-005453-4057qib7	1373	3	Background	background	NN
cord-005453-4057qib7	1373	4	:	:	:
cord-005453-4057qib7	1374	1	Cell	cell	NN
cord-005453-4057qib7	1374	2	-	-	HYPH
cord-005453-4057qib7	1374	3	based	base	VBN
cord-005453-4057qib7	1374	4	therapy	therapy	NN
cord-005453-4057qib7	1374	5	has	have	VBZ
cord-005453-4057qib7	1374	6	gained	gain	VBN
cord-005453-4057qib7	1374	7	attention	attention	NN
cord-005453-4057qib7	1374	8	in	in	IN
cord-005453-4057qib7	1374	9	the	the	DT
cord-005453-4057qib7	1374	10	respiratory	respiratory	JJ
cord-005453-4057qib7	1374	11	system	system	NN
cord-005453-4057qib7	1374	12	diseases	disease	NNS
cord-005453-4057qib7	1374	13	and	and	CC
cord-005453-4057qib7	1374	14	encouraging	encouraging	JJ
cord-005453-4057qib7	1374	15	results	result	NNS
cord-005453-4057qib7	1374	16	are	be	VBP
cord-005453-4057qib7	1374	17	reported	report	VBN
cord-005453-4057qib7	1374	18	following	follow	VBG
cord-005453-4057qib7	1374	19	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	1374	20	stromal	stromal	NN
cord-005453-4057qib7	1374	21	cells	cell	NNS
cord-005453-4057qib7	1374	22	(	(	-LRB-
cord-005453-4057qib7	1374	23	MSCs	MSCs	NNP
cord-005453-4057qib7	1374	24	)	)	-RRB-
cord-005453-4057qib7	1374	25	administration	administration	NN
cord-005453-4057qib7	1374	26	.	.	.
cord-005453-4057qib7	1375	1	Due	due	IN
cord-005453-4057qib7	1375	2	to	to	IN
cord-005453-4057qib7	1375	3	their	-PRON-	PRP$
cord-005453-4057qib7	1375	4	capacity	capacity	NN
cord-005453-4057qib7	1375	5	to	to	TO
cord-005453-4057qib7	1375	6	produce	produce	VB
cord-005453-4057qib7	1375	7	and	and	CC
cord-005453-4057qib7	1375	8	secrete	secrete	VB
cord-005453-4057qib7	1375	9	a	a	DT
cord-005453-4057qib7	1375	10	variety	variety	NN
cord-005453-4057qib7	1375	11	of	of	IN
cord-005453-4057qib7	1375	12	paracrine	paracrine	JJ
cord-005453-4057qib7	1375	13	factors	factor	NNS
cord-005453-4057qib7	1375	14	and	and	CC
cord-005453-4057qib7	1375	15	bioactive	bioactive	JJ
cord-005453-4057qib7	1375	16	macromolecules	macromolecule	NNS
cord-005453-4057qib7	1375	17	,	,	,
cord-005453-4057qib7	1375	18	MSCs	msc	NNS
cord-005453-4057qib7	1375	19	became	become	VBD
cord-005453-4057qib7	1375	20	a	a	DT
cord-005453-4057qib7	1375	21	key	key	JJ
cord-005453-4057qib7	1375	22	player	player	NN
cord-005453-4057qib7	1375	23	in	in	IN
cord-005453-4057qib7	1375	24	lung	lung	NN
cord-005453-4057qib7	1375	25	tissue	tissue	NN
cord-005453-4057qib7	1375	26	injuries	injury	NNS
cord-005453-4057qib7	1375	27	and	and	CC
cord-005453-4057qib7	1375	28	function	function	NN
cord-005453-4057qib7	1375	29	,	,	,
cord-005453-4057qib7	1375	30	reducing	reduce	VBG
cord-005453-4057qib7	1375	31	fibrosis	fibrosis	NN
cord-005453-4057qib7	1375	32	,	,	,
cord-005453-4057qib7	1375	33	promoting	promote	VBG
cord-005453-4057qib7	1375	34	the	the	DT
cord-005453-4057qib7	1375	35	normal	normal	JJ
cord-005453-4057qib7	1375	36	development	development	NN
cord-005453-4057qib7	1375	37	of	of	IN
cord-005453-4057qib7	1375	38	alveoli	alveolus	NNS
cord-005453-4057qib7	1375	39	and	and	CC
cord-005453-4057qib7	1375	40	pulmonary	pulmonary	JJ
cord-005453-4057qib7	1375	41	vessels	vessel	NNS
cord-005453-4057qib7	1375	42	.	.	.
cord-005453-4057qib7	1376	1	For	for	IN
cord-005453-4057qib7	1376	2	the	the	DT
cord-005453-4057qib7	1376	3	first	first	JJ
cord-005453-4057qib7	1376	4	time	time	NN
cord-005453-4057qib7	1376	5	we	-PRON-	PRP
cord-005453-4057qib7	1376	6	used	use	VBD
cord-005453-4057qib7	1376	7	the	the	DT
cord-005453-4057qib7	1376	8	MSC	MSC	NNP
cord-005453-4057qib7	1376	9	infusions	infusion	NNS
cord-005453-4057qib7	1376	10	as	as	IN
cord-005453-4057qib7	1376	11	rescue	rescue	NN
cord-005453-4057qib7	1376	12	therapy	therapy	NN
cord-005453-4057qib7	1376	13	in	in	IN
cord-005453-4057qib7	1376	14	a	a	DT
cord-005453-4057qib7	1376	15	pediatric	pediatric	JJ
cord-005453-4057qib7	1376	16	patient	patient	NN
cord-005453-4057qib7	1376	17	with	with	IN
cord-005453-4057qib7	1376	18	FLNA	FLNA	NNP
cord-005453-4057qib7	1376	19	gene	gene	NN
cord-005453-4057qib7	1376	20	mutation	mutation	NN
cord-005453-4057qib7	1376	21	and	and	CC
cord-005453-4057qib7	1376	22	life	life	NN
cord-005453-4057qib7	1376	23	-	-	HYPH
cord-005453-4057qib7	1376	24	threatening	threaten	VBG
cord-005453-4057qib7	1376	25	respiratory	respiratory	JJ
cord-005453-4057qib7	1376	26	syndrome	syndrome	NN
cord-005453-4057qib7	1376	27	.	.	.
cord-005453-4057qib7	1377	1	Methods	method	NNS
cord-005453-4057qib7	1377	2	:	:	:
cord-005453-4057qib7	1377	3	A	a	DT
cord-005453-4057qib7	1377	4	child	child	NN
cord-005453-4057qib7	1377	5	with	with	IN
cord-005453-4057qib7	1377	6	a	a	DT
cord-005453-4057qib7	1377	7	new	new	JJ
cord-005453-4057qib7	1377	8	pathogenic	pathogenic	JJ
cord-005453-4057qib7	1377	9	variant	variant	NN
cord-005453-4057qib7	1377	10	of	of	IN
cord-005453-4057qib7	1377	11	the	the	DT
cord-005453-4057qib7	1377	12	FLNA	FLNA	NNP
cord-005453-4057qib7	1377	13	gene	gene	NN
cord-005453-4057qib7	1377	14	c.7391_7403del	c.7391_7403del	NN
cord-005453-4057qib7	1377	15	;	;	,
cord-005453-4057qib7	1377	16	(	(	-LRB-
cord-005453-4057qib7	1377	17	p.	p.	NN
cord-005453-4057qib7	1378	1	Val2464AlafsTer5	Val2464AlafsTer5	NNP
cord-005453-4057qib7	1378	2	)	)	-RRB-
cord-005453-4057qib7	1378	3	at	at	IN
cord-005453-4057qib7	1378	4	the	the	DT
cord-005453-4057qib7	1378	5	age	age	NN
cord-005453-4057qib7	1378	6	of	of	IN
cord-005453-4057qib7	1378	7	18	18	CD
cord-005453-4057qib7	1378	8	months	month	NNS
cord-005453-4057qib7	1378	9	,	,	,
cord-005453-4057qib7	1378	10	due	due	IN
cord-005453-4057qib7	1378	11	to	to	IN
cord-005453-4057qib7	1378	12	the	the	DT
cord-005453-4057qib7	1378	13	serious	serious	JJ
cord-005453-4057qib7	1378	14	and	and	CC
cord-005453-4057qib7	1378	15	irreversible	irreversible	JJ
cord-005453-4057qib7	1378	16	chronic	chronic	JJ
cord-005453-4057qib7	1378	17	respiratory	respiratory	JJ
cord-005453-4057qib7	1378	18	failure	failure	NN
cord-005453-4057qib7	1378	19	and	and	CC
cord-005453-4057qib7	1378	20	dismal	dismal	JJ
cord-005453-4057qib7	1378	21	prognosis	prognosis	NN
cord-005453-4057qib7	1378	22	,	,	,
cord-005453-4057qib7	1378	23	was	be	VBD
cord-005453-4057qib7	1378	24	treated	treat	VBN
cord-005453-4057qib7	1378	25	with	with	IN
cord-005453-4057qib7	1378	26	4	4	CD
cord-005453-4057qib7	1378	27	intravenous	intravenous	JJ
cord-005453-4057qib7	1378	28	infusions	infusion	NNS
cord-005453-4057qib7	1378	29	of	of	IN
cord-005453-4057qib7	1378	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	1378	31	bone	bone	NN
cord-005453-4057qib7	1378	32	marrow	marrow	NN
cord-005453-4057qib7	1379	1	(	(	-LRB-
cord-005453-4057qib7	1379	2	BM)-MSCs	BM)-MSCs	NNP
cord-005453-4057qib7	1379	3	at	at	IN
cord-005453-4057qib7	1379	4	the	the	DT
cord-005453-4057qib7	1379	5	dose	dose	NN
cord-005453-4057qib7	1379	6	of	of	IN
cord-005453-4057qib7	1379	7	1×10	1×10	CD
cord-005453-4057qib7	1379	8	6	6	CD
cord-005453-4057qib7	1379	9	MSCs	msc	NNS
cord-005453-4057qib7	1379	10	/	/	SYM
cord-005453-4057qib7	1379	11	kg	kg	NN
cord-005453-4057qib7	1379	12	body	body	NN
cord-005453-4057qib7	1379	13	weight	weight	NN
cord-005453-4057qib7	1379	14	.	.	.
cord-005453-4057qib7	1380	1	BM	BM	NNP
cord-005453-4057qib7	1380	2	-	-	HYPH
cord-005453-4057qib7	1380	3	MSCs	msc	NNS
cord-005453-4057qib7	1380	4	were	be	VBD
cord-005453-4057qib7	1380	5	produced	produce	VBN
cord-005453-4057qib7	1380	6	at	at	IN
cord-005453-4057qib7	1380	7	"	"	``
cord-005453-4057qib7	1380	8	Cell	Cell	NNP
cord-005453-4057qib7	1380	9	Factory	Factory	NNP
cord-005453-4057qib7	1380	10	"	"	''
cord-005453-4057qib7	1380	11	,	,	,
cord-005453-4057qib7	1380	12	Fondazione	Fondazione	NNP
cord-005453-4057qib7	1380	13	IRCCS	IRCCS	NNP
cord-005453-4057qib7	1380	14	Policlinico	Policlinico	NNP
cord-005453-4057qib7	1380	15	S.	S.	NNP
cord-005453-4057qib7	1380	16	Matteo	Matteo	NNP
cord-005453-4057qib7	1380	17	,	,	,
cord-005453-4057qib7	1380	18	Pavia	Pavia	NNP
cord-005453-4057qib7	1380	19	,	,	,
cord-005453-4057qib7	1380	20	isolated	isolated	JJ
cord-005453-4057qib7	1380	21	and	and	CC
cord-005453-4057qib7	1380	22	expanded	expand	VBN
cord-005453-4057qib7	1380	23	ex	ex	FW
cord-005453-4057qib7	1380	24	vivo	vivo	NN
cord-005453-4057qib7	1380	25	from	from	IN
cord-005453-4057qib7	1380	26	healthy	healthy	JJ
cord-005453-4057qib7	1380	27	donor	donor	NN
cord-005453-4057qib7	1380	28	BM	bm	NN
cord-005453-4057qib7	1380	29	,	,	,
cord-005453-4057qib7	1380	30	following	follow	VBG
cord-005453-4057qib7	1380	31	a	a	DT
cord-005453-4057qib7	1380	32	previously	previously	RB
cord-005453-4057qib7	1380	33	reported	report	VBN
cord-005453-4057qib7	1380	34	protocol	protocol	NN
cord-005453-4057qib7	1380	35	.	.	.
cord-005453-4057qib7	1381	1	Premedication	Premedication	NNP
cord-005453-4057qib7	1381	2	with	with	IN
cord-005453-4057qib7	1381	3	antistaminic	antistaminic	NNP
cord-005453-4057qib7	1381	4	drug	drug	NN
cord-005453-4057qib7	1381	5	,	,	,
cord-005453-4057qib7	1381	6	30	30	CD
cord-005453-4057qib7	1381	7	min	min	NN
cord-005453-4057qib7	1381	8	before	before	IN
cord-005453-4057qib7	1381	9	every	every	DT
cord-005453-4057qib7	1381	10	infusion	infusion	NN
cord-005453-4057qib7	1381	11	to	to	TO
cord-005453-4057qib7	1381	12	avoid	avoid	VB
cord-005453-4057qib7	1381	13	any	any	DT
cord-005453-4057qib7	1381	14	potential	potential	JJ
cord-005453-4057qib7	1381	15	reaction	reaction	NN
cord-005453-4057qib7	1381	16	was	be	VBD
cord-005453-4057qib7	1381	17	performed	perform	VBN
cord-005453-4057qib7	1381	18	.	.	.
cord-005453-4057qib7	1382	1	The	the	DT
cord-005453-4057qib7	1382	2	evolution	evolution	NN
cord-005453-4057qib7	1382	3	of	of	IN
cord-005453-4057qib7	1382	4	the	the	DT
cord-005453-4057qib7	1382	5	respiratory	respiratory	JJ
cord-005453-4057qib7	1382	6	condition	condition	NN
cord-005453-4057qib7	1382	7	was	be	VBD
cord-005453-4057qib7	1382	8	detected	detect	VBN
cord-005453-4057qib7	1382	9	.	.	.
cord-005453-4057qib7	1383	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	1383	2	blood	blood	NN
cord-005453-4057qib7	1383	3	were	be	VBD
cord-005453-4057qib7	1383	4	collected	collect	VBN
cord-005453-4057qib7	1383	5	before	before	IN
cord-005453-4057qib7	1383	6	each	each	DT
cord-005453-4057qib7	1383	7	MSC	MSC	NNP
cord-005453-4057qib7	1383	8	treatment	treatment	NN
cord-005453-4057qib7	1383	9	for	for	IN
cord-005453-4057qib7	1383	10	Treg	Treg	NNP
cord-005453-4057qib7	1383	11	and	and	CC
cord-005453-4057qib7	1383	12	Th17	Th17	NNP
cord-005453-4057qib7	1383	13	monitoring	monitoring	NN
cord-005453-4057qib7	1383	14	.	.	.
cord-005453-4057qib7	1384	1	Treg	Treg	NNP
cord-005453-4057qib7	1384	2	,	,	,
cord-005453-4057qib7	1384	3	defined	define	VBN
cord-005453-4057qib7	1384	4	as	as	IN
cord-005453-4057qib7	1384	5	CD4	CD4	NNP
cord-005453-4057qib7	1384	6	+	+	CC
cord-005453-4057qib7	1385	1	CD127neg	cd127neg	CD
cord-005453-4057qib7	1385	2	CD25	CD25	NNP
cord-005453-4057qib7	1385	3	+	+	CC
cord-005453-4057qib7	1385	4	cells	cell	NNS
cord-005453-4057qib7	1385	5	expressing	express	VBG
cord-005453-4057qib7	1385	6	the	the	DT
cord-005453-4057qib7	1385	7	forkhead	forkhead	NNP
cord-005453-4057qib7	1385	8	box	box	NN
cord-005453-4057qib7	1385	9	P3	P3	NNP
cord-005453-4057qib7	1385	10	(	(	-LRB-
cord-005453-4057qib7	1385	11	FoxP3	FoxP3	NNP
cord-005453-4057qib7	1385	12	)	)	-RRB-
cord-005453-4057qib7	1385	13	transcription	transcription	NN
cord-005453-4057qib7	1385	14	factor	factor	NN
cord-005453-4057qib7	1385	15	,	,	,
cord-005453-4057qib7	1385	16	and	and	CC
cord-005453-4057qib7	1386	1	Th17	Th17	NNP
cord-005453-4057qib7	1386	2	,	,	,
cord-005453-4057qib7	1386	3	defined	define	VBN
cord-005453-4057qib7	1386	4	as	as	IN
cord-005453-4057qib7	1386	5	CD4	CD4	NNP
cord-005453-4057qib7	1386	6	+	+	CC
cord-005453-4057qib7	1386	7	cells	cell	NNS
cord-005453-4057qib7	1386	8	expressing	express	VBG
cord-005453-4057qib7	1386	9	intracellular	intracellular	JJ
cord-005453-4057qib7	1386	10	IL-17	IL-17	NNP
cord-005453-4057qib7	1386	11	,	,	,
cord-005453-4057qib7	1386	12	evaluation	evaluation	NN
cord-005453-4057qib7	1386	13	was	be	VBD
cord-005453-4057qib7	1386	14	performed	perform	VBN
cord-005453-4057qib7	1386	15	by	by	IN
cord-005453-4057qib7	1386	16	flow	flow	NN
cord-005453-4057qib7	1386	17	cytometry	cytometry	NN
cord-005453-4057qib7	1386	18	(	(	-LRB-
cord-005453-4057qib7	1386	19	FACSCanto	FACSCanto	NNS
cord-005453-4057qib7	1386	20	;	;	:
cord-005453-4057qib7	1386	21	BD	BD	NNP
cord-005453-4057qib7	1386	22	Biosciences	Biosciences	NNP
cord-005453-4057qib7	1386	23	,	,	,
cord-005453-4057qib7	1386	24	San	San	NNP
cord-005453-4057qib7	1386	25	Diego	Diego	NNP
cord-005453-4057qib7	1386	26	,	,	,
cord-005453-4057qib7	1386	27	CA	CA	NNP
cord-005453-4057qib7	1386	28	)	)	-RRB-
cord-005453-4057qib7	1386	29	as	as	IN
cord-005453-4057qib7	1386	30	previously	previously	RB
cord-005453-4057qib7	1386	31	reported	report	VBN
cord-005453-4057qib7	1386	32	,	,	,
cord-005453-4057qib7	1386	33	following	follow	VBG
cord-005453-4057qib7	1386	34	standard	standard	JJ
cord-005453-4057qib7	1386	35	procedures	procedure	NNS
cord-005453-4057qib7	1386	36	.	.	.
cord-005453-4057qib7	1387	1	Results	result	NNS
cord-005453-4057qib7	1387	2	:	:	:
cord-005453-4057qib7	1388	1	No	no	DT
cord-005453-4057qib7	1388	2	acute	acute	JJ
cord-005453-4057qib7	1388	3	adverse	adverse	JJ
cord-005453-4057qib7	1388	4	events	event	NNS
cord-005453-4057qib7	1388	5	related	relate	VBN
cord-005453-4057qib7	1388	6	to	to	IN
cord-005453-4057qib7	1388	7	MSCs	mscs	JJ
cord-005453-4057qib7	1388	8	infusion	infusion	NN
cord-005453-4057qib7	1388	9	was	be	VBD
cord-005453-4057qib7	1388	10	recorded	record	VBN
cord-005453-4057qib7	1388	11	.	.	.
cord-005453-4057qib7	1389	1	During	during	IN
cord-005453-4057qib7	1389	2	follow	follow	NN
cord-005453-4057qib7	1389	3	-	-	HYPH
cord-005453-4057qib7	1389	4	up	up	NN
cord-005453-4057qib7	1389	5	,	,	,
cord-005453-4057qib7	1389	6	patient	patient	NN
cord-005453-4057qib7	1389	7	maintained	maintain	VBD
cord-005453-4057qib7	1389	8	a	a	DT
cord-005453-4057qib7	1389	9	good	good	JJ
cord-005453-4057qib7	1389	10	general	general	JJ
cord-005453-4057qib7	1389	11	condition	condition	NN
cord-005453-4057qib7	1389	12	and	and	CC
cord-005453-4057qib7	1389	13	showed	show	VBD
cord-005453-4057qib7	1389	14	a	a	DT
cord-005453-4057qib7	1389	15	regular	regular	JJ
cord-005453-4057qib7	1389	16	growth	growth	NN
cord-005453-4057qib7	1389	17	.	.	.
cord-005453-4057qib7	1390	1	No	no	DT
cord-005453-4057qib7	1390	2	systemic	systemic	JJ
cord-005453-4057qib7	1390	3	or	or	CC
cord-005453-4057qib7	1390	4	respiratory	respiratory	JJ
cord-005453-4057qib7	1390	5	infections	infection	NNS
cord-005453-4057qib7	1390	6	occurred	occur	VBD
cord-005453-4057qib7	1390	7	.	.	.
cord-005453-4057qib7	1391	1	After	after	IN
cord-005453-4057qib7	1391	2	the	the	DT
cord-005453-4057qib7	1391	3	second	second	JJ
cord-005453-4057qib7	1391	4	infusion	infusion	NN
cord-005453-4057qib7	1391	5	,	,	,
cord-005453-4057qib7	1391	6	the	the	DT
cord-005453-4057qib7	1391	7	child	child	NN
cord-005453-4057qib7	1391	8	experienced	experience	VBD
cord-005453-4057qib7	1391	9	a	a	DT
cord-005453-4057qib7	1391	10	progressive	progressive	JJ
cord-005453-4057qib7	1391	11	improvement	improvement	NN
cord-005453-4057qib7	1391	12	of	of	IN
cord-005453-4057qib7	1391	13	his	-PRON-	PRP$
cord-005453-4057qib7	1391	14	clinical	clinical	JJ
cord-005453-4057qib7	1391	15	respiratory	respiratory	JJ
cord-005453-4057qib7	1391	16	condition	condition	NN
cord-005453-4057qib7	1391	17	,	,	,
cord-005453-4057qib7	1391	18	with	with	IN
cord-005453-4057qib7	1391	19	a	a	DT
cord-005453-4057qib7	1391	20	good	good	JJ
cord-005453-4057qib7	1391	21	adaptation	adaptation	NN
cord-005453-4057qib7	1391	22	to	to	IN
cord-005453-4057qib7	1391	23	mechanical	mechanical	JJ
cord-005453-4057qib7	1391	24	ventilation	ventilation	NN
cord-005453-4057qib7	1391	25	,	,	,
cord-005453-4057qib7	1391	26	in	in	IN
cord-005453-4057qib7	1391	27	the	the	DT
cord-005453-4057qib7	1391	28	absence	absence	NN
cord-005453-4057qib7	1391	29	of	of	IN
cord-005453-4057qib7	1391	30	episodes	episode	NNS
cord-005453-4057qib7	1391	31	of	of	IN
cord-005453-4057qib7	1391	32	respiratory	respiratory	JJ
cord-005453-4057qib7	1391	33	exacerbations	exacerbation	NNS
cord-005453-4057qib7	1391	34	.	.	.
cord-005453-4057qib7	1392	1	The	the	DT
cord-005453-4057qib7	1392	2	baby	baby	NN
cord-005453-4057qib7	1392	3	maintains	maintain	VBZ
cord-005453-4057qib7	1392	4	adequate	adequate	JJ
cord-005453-4057qib7	1392	5	volumes	volume	NNS
cord-005453-4057qib7	1392	6	of	of	IN
cord-005453-4057qib7	1392	7	exchange	exchange	NN
cord-005453-4057qib7	1392	8	with	with	IN
cord-005453-4057qib7	1392	9	substantial	substantial	JJ
cord-005453-4057qib7	1392	10	reduction	reduction	NN
cord-005453-4057qib7	1392	11	of	of	IN
cord-005453-4057qib7	1392	12	the	the	DT
cord-005453-4057qib7	1392	13	inspiratory	inspiratory	JJ
cord-005453-4057qib7	1392	14	support	support	NN
cord-005453-4057qib7	1392	15	.	.	.
cord-005453-4057qib7	1393	1	A	a	DT
cord-005453-4057qib7	1393	2	reduction	reduction	NN
cord-005453-4057qib7	1393	3	of	of	IN
cord-005453-4057qib7	1393	4	trigger	trigger	NN
cord-005453-4057qib7	1393	5	sensitivity	sensitivity	NN
cord-005453-4057qib7	1393	6	was	be	VBD
cord-005453-4057qib7	1393	7	also	also	RB
cord-005453-4057qib7	1393	8	obtained	obtain	VBN
cord-005453-4057qib7	1393	9	.	.	.
cord-005453-4057qib7	1394	1	Thorax	Thorax	NNP
cord-005453-4057qib7	1394	2	CT	CT	NNP
cord-005453-4057qib7	1394	3	scan	scan	NN
cord-005453-4057qib7	1394	4	showed	show	VBD
cord-005453-4057qib7	1394	5	a	a	DT
cord-005453-4057qib7	1394	6	recovery	recovery	NN
cord-005453-4057qib7	1394	7	of	of	IN
cord-005453-4057qib7	1394	8	the	the	DT
cord-005453-4057qib7	1394	9	basal	basal	NN
cord-005453-4057qib7	1394	10	parenchyma	parenchyma	NN
cord-005453-4057qib7	1394	11	bilaterally	bilaterally	RB
cord-005453-4057qib7	1394	12	and	and	CC
cord-005453-4057qib7	1394	13	the	the	DT
cord-005453-4057qib7	1394	14	improvement	improvement	NN
cord-005453-4057qib7	1394	15	of	of	IN
cord-005453-4057qib7	1394	16	the	the	DT
cord-005453-4057qib7	1394	17	anatomical	anatomical	JJ
cord-005453-4057qib7	1394	18	-	-	HYPH
cord-005453-4057qib7	1394	19	functional	functional	JJ
cord-005453-4057qib7	1394	20	alignment	alignment	NN
cord-005453-4057qib7	1394	21	and	and	CC
cord-005453-4057qib7	1394	22	aerial	aerial	JJ
cord-005453-4057qib7	1394	23	penetration	penetration	NN
cord-005453-4057qib7	1394	24	.	.	.
cord-005453-4057qib7	1395	1	After	after	IN
cord-005453-4057qib7	1395	2	the	the	DT
cord-005453-4057qib7	1395	3	first	first	JJ
cord-005453-4057qib7	1395	4	MSC	MSC	NNP
cord-005453-4057qib7	1395	5	administration	administration	NN
cord-005453-4057qib7	1395	6	,	,	,
cord-005453-4057qib7	1395	7	an	an	DT
cord-005453-4057qib7	1395	8	enrichment	enrichment	NN
cord-005453-4057qib7	1395	9	of	of	IN
cord-005453-4057qib7	1395	10	Treg	Treg	NNP
cord-005453-4057qib7	1395	11	and	and	CC
cord-005453-4057qib7	1395	12	Th17	th17	CD
cord-005453-4057qib7	1395	13	percentage	percentage	NN
cord-005453-4057qib7	1395	14	in	in	IN
cord-005453-4057qib7	1395	15	peripheral	peripheral	JJ
cord-005453-4057qib7	1395	16	blood	blood	NN
cord-005453-4057qib7	1395	17	,	,	,
cord-005453-4057qib7	1395	18	was	be	VBD
cord-005453-4057qib7	1395	19	observed	observe	VBN
cord-005453-4057qib7	1395	20	.	.	.
cord-005453-4057qib7	1396	1	While	while	IN
cord-005453-4057qib7	1396	2	,	,	,
cord-005453-4057qib7	1396	3	after	after	IN
cord-005453-4057qib7	1396	4	the	the	DT
cord-005453-4057qib7	1396	5	second	second	JJ
cord-005453-4057qib7	1396	6	MSC	MSC	NNP
cord-005453-4057qib7	1396	7	infusion	infusion	NN
cord-005453-4057qib7	1396	8	a	a	DT
cord-005453-4057qib7	1396	9	significant	significant	JJ
cord-005453-4057qib7	1396	10	increase	increase	NN
cord-005453-4057qib7	1396	11	in	in	IN
cord-005453-4057qib7	1397	1	Treg	Treg	NNP
cord-005453-4057qib7	1397	2	/	/	SYM
cord-005453-4057qib7	1397	3	Th17	Th17	NNP
cord-005453-4057qib7	1397	4	ratio	ratio	NN
cord-005453-4057qib7	1397	5	was	be	VBD
cord-005453-4057qib7	1397	6	noted	note	VBN
cord-005453-4057qib7	1397	7	.	.	.
cord-005453-4057qib7	1398	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1398	2	:	:	:
cord-005453-4057qib7	1399	1	This	this	DT
cord-005453-4057qib7	1399	2	report	report	NN
cord-005453-4057qib7	1399	3	suggest	suggest	VBP
cord-005453-4057qib7	1399	4	that	that	IN
cord-005453-4057qib7	1399	5	MSC	MSC	NNP
cord-005453-4057qib7	1399	6	serial	serial	JJ
cord-005453-4057qib7	1399	7	infusions	infusion	NNS
cord-005453-4057qib7	1399	8	are	be	VBP
cord-005453-4057qib7	1399	9	a	a	DT
cord-005453-4057qib7	1399	10	promising	promising	JJ
cord-005453-4057qib7	1399	11	therapy	therapy	NN
cord-005453-4057qib7	1399	12	in	in	IN
cord-005453-4057qib7	1399	13	aiding	aid	VBG
cord-005453-4057qib7	1399	14	the	the	DT
cord-005453-4057qib7	1399	15	respiratory	respiratory	JJ
cord-005453-4057qib7	1399	16	failure	failure	NN
cord-005453-4057qib7	1399	17	,	,	,
cord-005453-4057qib7	1399	18	even	even	RB
cord-005453-4057qib7	1399	19	in	in	IN
cord-005453-4057qib7	1399	20	a	a	DT
cord-005453-4057qib7	1399	21	pediatric	pediatric	JJ
cord-005453-4057qib7	1399	22	patient	patient	NN
cord-005453-4057qib7	1399	23	with	with	IN
cord-005453-4057qib7	1399	24	FLNA	FLNA	NNP
cord-005453-4057qib7	1399	25	mutation	mutation	NN
cord-005453-4057qib7	1399	26	.	.	.
cord-005453-4057qib7	1400	1	Intravenous	intravenous	JJ
cord-005453-4057qib7	1400	2	administrations	administration	NNS
cord-005453-4057qib7	1400	3	of	of	IN
cord-005453-4057qib7	1400	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	1400	5	MSCs	msc	NNS
cord-005453-4057qib7	1400	6	are	be	VBP
cord-005453-4057qib7	1400	7	feasible	feasible	JJ
cord-005453-4057qib7	1400	8	and	and	CC
cord-005453-4057qib7	1400	9	safe	safe	JJ
cord-005453-4057qib7	1400	10	without	without	IN
cord-005453-4057qib7	1400	11	toxicity	toxicity	NN
cord-005453-4057qib7	1400	12	.	.	.
cord-005453-4057qib7	1401	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1401	2	results	result	NNS
cord-005453-4057qib7	1401	3	suggest	suggest	VBP
cord-005453-4057qib7	1401	4	that	that	IN
cord-005453-4057qib7	1401	5	to	to	TO
cord-005453-4057qib7	1401	6	mitigate	mitigate	VB
cord-005453-4057qib7	1401	7	lung	lung	NN
cord-005453-4057qib7	1401	8	injury	injury	NN
cord-005453-4057qib7	1401	9	,	,	,
cord-005453-4057qib7	1401	10	MSCs	MSCs	NNP
cord-005453-4057qib7	1401	11	may	may	MD
cord-005453-4057qib7	1401	12	act	act	VB
cord-005453-4057qib7	1401	13	as	as	IN
cord-005453-4057qib7	1401	14	regulators	regulator	NNS
cord-005453-4057qib7	1401	15	of	of	IN
cord-005453-4057qib7	1401	16	Treg	Treg	NNP
cord-005453-4057qib7	1401	17	and	and	CC
cord-005453-4057qib7	1401	18	Th17	Th17	NNP
cord-005453-4057qib7	1401	19	balance	balance	NN
cord-005453-4057qib7	1401	20	.	.	.
cord-005453-4057qib7	1402	1	Further	further	JJ
cord-005453-4057qib7	1402	2	investigations	investigation	NNS
cord-005453-4057qib7	1402	3	are	be	VBP
cord-005453-4057qib7	1402	4	upcoming	upcome	VBG
cord-005453-4057qib7	1402	5	to	to	TO
cord-005453-4057qib7	1402	6	establish	establish	VB
cord-005453-4057qib7	1402	7	the	the	DT
cord-005453-4057qib7	1402	8	useful	useful	NN
cord-005453-4057qib7	1402	9	of	of	IN
cord-005453-4057qib7	1402	10	this	this	DT
cord-005453-4057qib7	1402	11	therapeutic	therapeutic	JJ
cord-005453-4057qib7	1402	12	proposal	proposal	NN
cord-005453-4057qib7	1402	13	in	in	IN
cord-005453-4057qib7	1402	14	interstitial	interstitial	JJ
cord-005453-4057qib7	1402	15	lung	lung	NN
cord-005453-4057qib7	1402	16	diseases	disease	NNS
cord-005453-4057qib7	1402	17	in	in	IN
cord-005453-4057qib7	1402	18	children	child	NNS
cord-005453-4057qib7	1402	19	.	.	.
cord-005453-4057qib7	1403	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1403	2	:	:	:
cord-005453-4057qib7	1404	1	Nothig	Nothig	NNP
cord-005453-4057qib7	1404	2	to	to	TO
cord-005453-4057qib7	1404	3	declare	declare	VB
cord-005453-4057qib7	1404	4	P078	p078	PRP
cord-005453-4057qib7	1404	5	feasibility	feasibility	NN
cord-005453-4057qib7	1404	6	of	of	IN
cord-005453-4057qib7	1404	7	IL-15	IL-15	NNP
cord-005453-4057qib7	1404	8	stimulated	stimulate	VBD
cord-005453-4057qib7	1404	9	donor	donor	NN
cord-005453-4057qib7	1404	10	NK	NK	NNP
cord-005453-4057qib7	1404	11	cells	cell	NNS
cord-005453-4057qib7	1404	12	manufacturing	manufacture	VBG
cord-005453-4057qib7	1404	13	for	for	IN
cord-005453-4057qib7	1404	14	early	early	JJ
cord-005453-4057qib7	1404	15	infusion	infusion	NN
cord-005453-4057qib7	1404	16	in	in	IN
cord-005453-4057qib7	1404	17	patients	patient	NNS
cord-005453-4057qib7	1404	18	with	with	IN
cord-005453-4057qib7	1404	19	high	high	JJ
cord-005453-4057qib7	1404	20	risk	risk	NN
cord-005453-4057qib7	1404	21	acute	acute	JJ
cord-005453-4057qib7	1404	22	myeloid	myeloid	NN
cord-005453-4057qib7	1404	23	leukemia	leukemia	NN
cord-005453-4057qib7	1404	24	undergoing	undergo	VBG
cord-005453-4057qib7	1404	25	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1404	26	transplantation	transplantation	NN
cord-005453-4057qib7	1404	27	Background	Background	NNP
cord-005453-4057qib7	1404	28	:	:	:
cord-005453-4057qib7	1404	29	NK	NK	NNP
cord-005453-4057qib7	1404	30	cells	cell	NNS
cord-005453-4057qib7	1404	31	provide	provide	VBP
cord-005453-4057qib7	1404	32	a	a	DT
cord-005453-4057qib7	1404	33	potent	potent	JJ
cord-005453-4057qib7	1404	34	antitumor	antitumor	JJ
cord-005453-4057qib7	1404	35	effect	effect	NN
cord-005453-4057qib7	1404	36	in	in	IN
cord-005453-4057qib7	1404	37	the	the	DT
cord-005453-4057qib7	1404	38	setting	setting	NN
cord-005453-4057qib7	1404	39	of	of	IN
cord-005453-4057qib7	1404	40	manipulated	manipulate	VBN
cord-005453-4057qib7	1404	41	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1404	42	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1404	43	stem	stem	NN
cord-005453-4057qib7	1404	44	cell	cell	NN
cord-005453-4057qib7	1404	45	transplant	transplant	NN
cord-005453-4057qib7	1404	46	(	(	-LRB-
cord-005453-4057qib7	1404	47	Haplo	Haplo	NNP
cord-005453-4057qib7	1404	48	-	-	HYPH
cord-005453-4057qib7	1404	49	HSCT	HSCT	NNP
cord-005453-4057qib7	1404	50	)	)	-RRB-
cord-005453-4057qib7	1404	51	.	.	.
cord-005453-4057qib7	1405	1	We	-PRON-	PRP
cord-005453-4057qib7	1405	2	propose	propose	VBP
cord-005453-4057qib7	1405	3	a	a	DT
cord-005453-4057qib7	1405	4	novel	novel	JJ
cord-005453-4057qib7	1405	5	strategy	strategy	NN
cord-005453-4057qib7	1405	6	to	to	TO
cord-005453-4057qib7	1405	7	enhance	enhance	VB
cord-005453-4057qib7	1405	8	the	the	DT
cord-005453-4057qib7	1405	9	antitumor	antitumor	JJ
cord-005453-4057qib7	1405	10	effect	effect	NN
cord-005453-4057qib7	1405	11	of	of	IN
cord-005453-4057qib7	1405	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	1405	13	transplant	transplant	NN
cord-005453-4057qib7	1405	14	through	through	IN
cord-005453-4057qib7	1405	15	the	the	DT
cord-005453-4057qib7	1405	16	infusion	infusion	NN
cord-005453-4057qib7	1405	17	of	of	IN
cord-005453-4057qib7	1405	18	NK	NK	NNP
cord-005453-4057qib7	1405	19	cells	cell	NNS
cord-005453-4057qib7	1405	20	stimulated	stimulate	VBN
cord-005453-4057qib7	1405	21	with	with	IN
cord-005453-4057qib7	1405	22	IL-15	IL-15	NNP
cord-005453-4057qib7	1405	23	exvivo	exvivo	NN
cord-005453-4057qib7	1405	24	in	in	IN
cord-005453-4057qib7	1405	25	adult	adult	NN
cord-005453-4057qib7	1405	26	high	high	JJ
cord-005453-4057qib7	1405	27	-	-	HYPH
cord-005453-4057qib7	1405	28	risk	risk	NN
cord-005453-4057qib7	1405	29	acute	acute	JJ
cord-005453-4057qib7	1405	30	myeloid	myeloid	NN
cord-005453-4057qib7	1405	31	leukemia	leukemia	NN
cord-005453-4057qib7	1405	32	(	(	-LRB-
cord-005453-4057qib7	1405	33	AML	AML	NNP
cord-005453-4057qib7	1405	34	)	)	-RRB-
cord-005453-4057qib7	1405	35	patients	patient	NNS
cord-005453-4057qib7	1405	36	undergoing	undergo	VBG
cord-005453-4057qib7	1405	37	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	1405	38	Haplo	Haplo	NNP
cord-005453-4057qib7	1405	39	-	-	HYPH
cord-005453-4057qib7	1405	40	HSCT	HSCT	NNP
cord-005453-4057qib7	1405	41	.	.	.
cord-005453-4057qib7	1406	1	The	the	DT
cord-005453-4057qib7	1406	2	objective	objective	NN
cord-005453-4057qib7	1406	3	of	of	IN
cord-005453-4057qib7	1406	4	this	this	DT
cord-005453-4057qib7	1406	5	study	study	NN
cord-005453-4057qib7	1406	6	was	be	VBD
cord-005453-4057qib7	1406	7	to	to	TO
cord-005453-4057qib7	1406	8	provide	provide	VB
cord-005453-4057qib7	1406	9	efficiency	efficiency	NN
cord-005453-4057qib7	1406	10	and	and	CC
cord-005453-4057qib7	1406	11	productivity	productivity	NN
cord-005453-4057qib7	1406	12	data	datum	NNS
cord-005453-4057qib7	1406	13	obtained	obtain	VBN
cord-005453-4057qib7	1406	14	in	in	IN
cord-005453-4057qib7	1406	15	the	the	DT
cord-005453-4057qib7	1406	16	manufactured	manufactured	JJ
cord-005453-4057qib7	1406	17	cellular	cellular	JJ
cord-005453-4057qib7	1406	18	products	product	NNS
cord-005453-4057qib7	1406	19	infused	infuse	VBN
cord-005453-4057qib7	1406	20	.	.	.
cord-005453-4057qib7	1407	1	Methods	method	NNS
cord-005453-4057qib7	1407	2	:	:	:
cord-005453-4057qib7	1407	3	Selection	selection	NN
cord-005453-4057qib7	1407	4	criteria	criterion	NNS
cord-005453-4057qib7	1407	5	included	include	VBD
cord-005453-4057qib7	1407	6	patients	patient	NNS
cord-005453-4057qib7	1407	7	with	with	IN
cord-005453-4057qib7	1407	8	highrisk	highrisk	NNP
cord-005453-4057qib7	1407	9	AML	AML	NNP
cord-005453-4057qib7	1407	10	undergoing	undergo	VBG
cord-005453-4057qib7	1407	11	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	1407	12	Haplo	Haplo	NNP
cord-005453-4057qib7	1407	13	-	-	HYPH
cord-005453-4057qib7	1407	14	HSCT	HSCT	NNP
cord-005453-4057qib7	1407	15	.	.	.
cord-005453-4057qib7	1408	1	Lymphoapheresis	Lymphoapheresis	NNP
cord-005453-4057qib7	1408	2	of	of	IN
cord-005453-4057qib7	1408	3	the	the	DT
cord-005453-4057qib7	1408	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1408	5	donor	donor	NN
cord-005453-4057qib7	1408	6	was	be	VBD
cord-005453-4057qib7	1408	7	performed	perform	VBN
cord-005453-4057qib7	1408	8	using	use	VBG
cord-005453-4057qib7	1408	9	Spectra	Spectra	NNP
cord-005453-4057qib7	1408	10	Optia	Optia	NNP
cord-005453-4057qib7	1408	11	(	(	-LRB-
cord-005453-4057qib7	1408	12	Terumo	Terumo	NNP
cord-005453-4057qib7	1408	13	®	®	,
cord-005453-4057qib7	1408	14	BCT	BCT	NNP
cord-005453-4057qib7	1408	15	)	)	-RRB-
cord-005453-4057qib7	1408	16	on	on	IN
cord-005453-4057qib7	1408	17	days	day	NNS
cord-005453-4057qib7	1408	18	+6	+6	CD
cord-005453-4057qib7	1408	19	and	and	CC
cord-005453-4057qib7	1408	20	+13	+13	NN
cord-005453-4057qib7	1408	21	after	after	IN
cord-005453-4057qib7	1408	22	transplant	transplant	NN
cord-005453-4057qib7	1408	23	.	.	.
cord-005453-4057qib7	1409	1	From	from	IN
cord-005453-4057qib7	1409	2	the	the	DT
cord-005453-4057qib7	1409	3	obtained	obtain	VBN
cord-005453-4057qib7	1409	4	product	product	NN
cord-005453-4057qib7	1409	5	a	a	DT
cord-005453-4057qib7	1409	6	double	double	JJ
cord-005453-4057qib7	1409	7	immunomagnetic	immunomagnetic	JJ
cord-005453-4057qib7	1409	8	cellular	cellular	JJ
cord-005453-4057qib7	1409	9	selection	selection	NN
cord-005453-4057qib7	1409	10	with	with	IN
cord-005453-4057qib7	1409	11	Clinimacs	Clinimacs	NNP
cord-005453-4057qib7	1409	12	system	system	NN
cord-005453-4057qib7	1410	1	(	(	-LRB-
cord-005453-4057qib7	1410	2	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	1410	3	Biotec	Biotec	NNP
cord-005453-4057qib7	1410	4	®	®	NNP
cord-005453-4057qib7	1410	5	)	)	-RRB-
cord-005453-4057qib7	1410	6	was	be	VBD
cord-005453-4057qib7	1410	7	performed	perform	VBN
cord-005453-4057qib7	1410	8	in	in	IN
cord-005453-4057qib7	1410	9	two	two	CD
cord-005453-4057qib7	1410	10	steps	step	NNS
cord-005453-4057qib7	1410	11	:	:	:
cord-005453-4057qib7	1410	12	CD3	CD3	NNP
cord-005453-4057qib7	1410	13	+	+	CC
cord-005453-4057qib7	1410	14	depletion	depletion	NN
cord-005453-4057qib7	1410	15	followed	follow	VBN
cord-005453-4057qib7	1410	16	by	by	IN
cord-005453-4057qib7	1410	17	positive	positive	JJ
cord-005453-4057qib7	1410	18	CD56	CD56	NNP
cord-005453-4057qib7	1410	19	+	+	CC
cord-005453-4057qib7	1410	20	selection	selection	NN
cord-005453-4057qib7	1410	21	.	.	.
cord-005453-4057qib7	1411	1	The	the	DT
cord-005453-4057qib7	1411	2	obtained	obtain	VBD
cord-005453-4057qib7	1411	3	an	an	DT
cord-005453-4057qib7	1411	4	enriched	enriched	JJ
cord-005453-4057qib7	1411	5	cellular	cellular	JJ
cord-005453-4057qib7	1411	6	product	product	NN
cord-005453-4057qib7	1411	7	of	of	IN
cord-005453-4057qib7	1411	8	CD3-CD56	cd3-cd56	NN
cord-005453-4057qib7	1412	1	+	+	CC
cord-005453-4057qib7	1412	2	NK	NK	NNP
cord-005453-4057qib7	1412	3	cells	cell	NNS
cord-005453-4057qib7	1412	4	was	be	VBD
cord-005453-4057qib7	1412	5	incubated	incubate	VBN
cord-005453-4057qib7	1412	6	with	with	IN
cord-005453-4057qib7	1412	7	IL-15	IL-15	NNP
cord-005453-4057qib7	1412	8	(	(	-LRB-
cord-005453-4057qib7	1412	9	10	10	CD
cord-005453-4057qib7	1412	10	ng	ng	NN
cord-005453-4057qib7	1412	11	/	/	SYM
cord-005453-4057qib7	1412	12	mL	ml	NN
cord-005453-4057qib7	1412	13	)	)	-RRB-
cord-005453-4057qib7	1412	14	between	between	IN
cord-005453-4057qib7	1412	15	12	12	CD
cord-005453-4057qib7	1412	16	and	and	CC
cord-005453-4057qib7	1412	17	18	18	CD
cord-005453-4057qib7	1412	18	hours	hour	NNS
cord-005453-4057qib7	1412	19	at	at	IN
cord-005453-4057qib7	1412	20	37ºC	37ºc	CD
cord-005453-4057qib7	1412	21	and	and	CC
cord-005453-4057qib7	1412	22	5	5	CD
cord-005453-4057qib7	1412	23	%	%	NN
cord-005453-4057qib7	1412	24	CO2	co2	NN
cord-005453-4057qib7	1412	25	in	in	IN
cord-005453-4057qib7	1412	26	GMP	GMP	NNP
cord-005453-4057qib7	1412	27	conditions	condition	NNS
cord-005453-4057qib7	1412	28	.	.	.
cord-005453-4057qib7	1413	1	Quality	quality	NN
cord-005453-4057qib7	1413	2	and	and	CC
cord-005453-4057qib7	1413	3	microbiological	microbiological	JJ
cord-005453-4057qib7	1413	4	controls	control	NNS
cord-005453-4057qib7	1413	5	were	be	VBD
cord-005453-4057qib7	1413	6	performed	perform	VBN
cord-005453-4057qib7	1413	7	at	at	IN
cord-005453-4057qib7	1413	8	the	the	DT
cord-005453-4057qib7	1413	9	end	end	NN
cord-005453-4057qib7	1413	10	of	of	IN
cord-005453-4057qib7	1413	11	each	each	DT
cord-005453-4057qib7	1413	12	manufacturing	manufacturing	NN
cord-005453-4057qib7	1413	13	step	step	NN
cord-005453-4057qib7	1413	14	.	.	.
cord-005453-4057qib7	1414	1	DxH	DxH	NNP
cord-005453-4057qib7	1414	2	cellular	cellular	JJ
cord-005453-4057qib7	1414	3	counters	counter	NNS
cord-005453-4057qib7	1414	4	(	(	-LRB-
cord-005453-4057qib7	1414	5	Beckman	Beckman	NNP
cord-005453-4057qib7	1414	6	Coulter	Coulter	NNP
cord-005453-4057qib7	1414	7	®	®	POS
cord-005453-4057qib7	1414	8	)	)	-RRB-
cord-005453-4057qib7	1414	9	and	and	CC
cord-005453-4057qib7	1414	10	multiparametric	multiparametric	JJ
cord-005453-4057qib7	1414	11	flow	flow	NN
cord-005453-4057qib7	1414	12	cytometry	cytometry	NN
cord-005453-4057qib7	1414	13	were	be	VBD
cord-005453-4057qib7	1414	14	used	use	VBN
cord-005453-4057qib7	1414	15	for	for	IN
cord-005453-4057qib7	1414	16	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1414	17	subpopulations	subpopulation	NNS
cord-005453-4057qib7	1414	18	and	and	CC
cord-005453-4057qib7	1414	19	viability	viability	NN
cord-005453-4057qib7	1414	20	analysis	analysis	NN
cord-005453-4057qib7	1414	21	(	(	-LRB-
cord-005453-4057qib7	1414	22	Navios	Navios	NNP
cord-005453-4057qib7	1414	23	cytometer	cytometer	NN
cord-005453-4057qib7	1414	24	;	;	:
cord-005453-4057qib7	1414	25	Beckman	Beckman	NNP
cord-005453-4057qib7	1414	26	Coulter	Coulter	NNP
cord-005453-4057qib7	1414	27	®	®	NNP
cord-005453-4057qib7	1414	28	,	,	,
cord-005453-4057qib7	1414	29	conjugated	conjugate	VBN
cord-005453-4057qib7	1414	30	Monoclonal	monoclonal	JJ
cord-005453-4057qib7	1414	31	antibodies	antibody	NNS
cord-005453-4057qib7	1414	32	;	;	:
cord-005453-4057qib7	1414	33	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	1414	34	Biotec	Biotec	NNP
cord-005453-4057qib7	1414	35	®	®	NNP
cord-005453-4057qib7	1414	36	)	)	-RRB-
cord-005453-4057qib7	1414	37	.	.	.
cord-005453-4057qib7	1415	1	The	the	DT
cord-005453-4057qib7	1415	2	final	final	JJ
cord-005453-4057qib7	1415	3	product	product	NN
cord-005453-4057qib7	1415	4	was	be	VBD
cord-005453-4057qib7	1415	5	infused	infuse	VBN
cord-005453-4057qib7	1415	6	intravenously	intravenously	RB
cord-005453-4057qib7	1415	7	to	to	IN
cord-005453-4057qib7	1415	8	the	the	DT
cord-005453-4057qib7	1415	9	patient	patient	NN
cord-005453-4057qib7	1415	10	on	on	IN
cord-005453-4057qib7	1415	11	days	day	NNS
cord-005453-4057qib7	1415	12	+8	+8	NNS
cord-005453-4057qib7	1415	13	and	and	CC
cord-005453-4057qib7	1415	14	+15	+15	CD
cord-005453-4057qib7	1415	15	if	if	IN
cord-005453-4057qib7	1415	16	manufacturing	manufacturing	NN
cord-005453-4057qib7	1415	17	conditions	condition	NNS
cord-005453-4057qib7	1415	18	were	be	VBD
cord-005453-4057qib7	1415	19	met	meet	VBN
cord-005453-4057qib7	1415	20	(	(	-LRB-
cord-005453-4057qib7	1415	21	range	range	NN
cord-005453-4057qib7	1415	22	of	of	IN
cord-005453-4057qib7	1415	23	0.5	0.5	CD
cord-005453-4057qib7	1415	24	-	-	HYPH
cord-005453-4057qib7	1415	25	100x10	100x10	CD
cord-005453-4057qib7	1415	26	6	6	CD
cord-005453-4057qib7	1415	27	NK	NK	NNP
cord-005453-4057qib7	1415	28	/	/	SYM
cord-005453-4057qib7	1415	29	Kg	Kg	NNP
cord-005453-4057qib7	1415	30	,	,	,
cord-005453-4057qib7	1415	31	purity	purity	NN
cord-005453-4057qib7	1415	32	≥	≥	CD
cord-005453-4057qib7	1415	33	80	80	CD
cord-005453-4057qib7	1415	34	%	%	NN
cord-005453-4057qib7	1415	35	,	,	,
cord-005453-4057qib7	1415	36	viability≥	viability≥	NNP
cord-005453-4057qib7	1415	37	70	70	CD
cord-005453-4057qib7	1415	38	%	%	NN
cord-005453-4057qib7	1415	39	and	and	CC
cord-005453-4057qib7	1415	40	<	<	NNP
cord-005453-4057qib7	1415	41	1x10	1x10	CD
cord-005453-4057qib7	1415	42	4	4	CD
cord-005453-4057qib7	1415	43	CD3	CD3	NNP
cord-005453-4057qib7	1415	44	+	+	CC
cord-005453-4057qib7	1415	45	cells	cell	NNS
cord-005453-4057qib7	1415	46	/	/	SYM
cord-005453-4057qib7	1415	47	Kg	Kg	NNP
cord-005453-4057qib7	1415	48	)	)	-RRB-
cord-005453-4057qib7	1415	49	.	.	.
cord-005453-4057qib7	1416	1	If	if	IN
cord-005453-4057qib7	1416	2	not	not	RB
cord-005453-4057qib7	1416	3	,	,	,
cord-005453-4057qib7	1416	4	it	-PRON-	PRP
cord-005453-4057qib7	1416	5	was	be	VBD
cord-005453-4057qib7	1416	6	discarded	discard	VBN
cord-005453-4057qib7	1416	7	.	.	.
cord-005453-4057qib7	1417	1	NK	NK	NNP
cord-005453-4057qib7	1417	2	cell	cell	NN
cord-005453-4057qib7	1417	3	activation	activation	NN
cord-005453-4057qib7	1417	4	in	in	IN
cord-005453-4057qib7	1417	5	the	the	DT
cord-005453-4057qib7	1417	6	product	product	NN
cord-005453-4057qib7	1417	7	was	be	VBD
cord-005453-4057qib7	1417	8	measured	measure	VBN
cord-005453-4057qib7	1417	9	by	by	IN
cord-005453-4057qib7	1417	10	the	the	DT
cord-005453-4057qib7	1417	11	expression	expression	NN
cord-005453-4057qib7	1417	12	of	of	IN
cord-005453-4057qib7	1417	13	CD25	CD25	NNP
cord-005453-4057qib7	1417	14	and	and	CC
cord-005453-4057qib7	1417	15	CD69	CD69	NNP
cord-005453-4057qib7	1417	16	.	.	.
cord-005453-4057qib7	1418	1	Results	result	NNS
cord-005453-4057qib7	1418	2	:	:	:
cord-005453-4057qib7	1419	1	Between	between	IN
cord-005453-4057qib7	1419	2	November	November	NNP
cord-005453-4057qib7	1419	3	2017	2017	CD
cord-005453-4057qib7	1419	4	and	and	CC
cord-005453-4057qib7	1419	5	April	April	NNP
cord-005453-4057qib7	1419	6	2018	2018	CD
cord-005453-4057qib7	1419	7	,	,	,
cord-005453-4057qib7	1419	8	3	3	CD
cord-005453-4057qib7	1419	9	patients	patient	NNS
cord-005453-4057qib7	1419	10	were	be	VBD
cord-005453-4057qib7	1419	11	included	include	VBN
cord-005453-4057qib7	1419	12	in	in	IN
cord-005453-4057qib7	1419	13	this	this	DT
cord-005453-4057qib7	1419	14	ongoing	ongoing	JJ
cord-005453-4057qib7	1419	15	trial	trial	NN
cord-005453-4057qib7	1419	16	.	.	.
cord-005453-4057qib7	1420	1	Two	two	CD
cord-005453-4057qib7	1420	2	products	product	NNS
cord-005453-4057qib7	1420	3	were	be	VBD
cord-005453-4057qib7	1420	4	manufactured	manufacture	VBN
cord-005453-4057qib7	1420	5	for	for	IN
cord-005453-4057qib7	1420	6	2	2	CD
cord-005453-4057qib7	1420	7	of	of	IN
cord-005453-4057qib7	1420	8	the	the	DT
cord-005453-4057qib7	1420	9	patients	patient	NNS
cord-005453-4057qib7	1420	10	,	,	,
cord-005453-4057qib7	1420	11	and	and	CC
cord-005453-4057qib7	1420	12	only	only	RB
cord-005453-4057qib7	1420	13	one	one	CD
cord-005453-4057qib7	1420	14	for	for	IN
cord-005453-4057qib7	1420	15	the	the	DT
cord-005453-4057qib7	1420	16	first	first	JJ
cord-005453-4057qib7	1420	17	patient	patient	NN
cord-005453-4057qib7	1420	18	,	,	,
cord-005453-4057qib7	1420	19	due	due	IN
cord-005453-4057qib7	1420	20	to	to	IN
cord-005453-4057qib7	1420	21	transplant	transplant	NN
cord-005453-4057qib7	1420	22	complications	complication	NNS
cord-005453-4057qib7	1420	23	between	between	IN
cord-005453-4057qib7	1420	24	first	first	JJ
cord-005453-4057qib7	1420	25	and	and	CC
cord-005453-4057qib7	1420	26	second	second	JJ
cord-005453-4057qib7	1420	27	infusion	infusion	NN
cord-005453-4057qib7	1420	28	.	.	.
cord-005453-4057qib7	1421	1	One	one	CD
cord-005453-4057qib7	1421	2	product	product	NN
cord-005453-4057qib7	1421	3	did	do	VBD
cord-005453-4057qib7	1421	4	not	not	RB
cord-005453-4057qib7	1421	5	meet	meet	VB
cord-005453-4057qib7	1421	6	minimum	minimum	JJ
cord-005453-4057qib7	1421	7	viability	viability	NN
cord-005453-4057qib7	1421	8	criteria	criterion	NNS
cord-005453-4057qib7	1421	9	and	and	CC
cord-005453-4057qib7	1421	10	was	be	VBD
cord-005453-4057qib7	1421	11	discarded	discard	VBN
cord-005453-4057qib7	1421	12	.	.	.
cord-005453-4057qib7	1422	1	In	in	IN
cord-005453-4057qib7	1422	2	the	the	DT
cord-005453-4057qib7	1422	3	infused	infuse	VBN
cord-005453-4057qib7	1422	4	final	final	JJ
cord-005453-4057qib7	1422	5	products	product	NNS
cord-005453-4057qib7	1422	6	mean	mean	VBP
cord-005453-4057qib7	1422	7	and	and	CC
cord-005453-4057qib7	1422	8	SEM	SEM	NNP
cord-005453-4057qib7	1422	9	of	of	IN
cord-005453-4057qib7	1422	10	NK	NK	NNP
cord-005453-4057qib7	1422	11	cell	cell	NN
cord-005453-4057qib7	1422	12	purity	purity	NN
cord-005453-4057qib7	1422	13	,	,	,
cord-005453-4057qib7	1422	14	recovery	recovery	NN
cord-005453-4057qib7	1422	15	and	and	CC
cord-005453-4057qib7	1422	16	viability	viability	NN
cord-005453-4057qib7	1422	17	were	be	VBD
cord-005453-4057qib7	1422	18	83.7%±4.4	83.7%±4.4	CD
cord-005453-4057qib7	1422	19	,	,	,
cord-005453-4057qib7	1422	20	30.9%±4	30.9%±4	NNP
cord-005453-4057qib7	1422	21	and	and	CC
cord-005453-4057qib7	1422	22	76.3%±17.4	76.3%±17.4	CD
cord-005453-4057qib7	1422	23	,	,	,
cord-005453-4057qib7	1422	24	respectively	respectively	RB
cord-005453-4057qib7	1422	25	.	.	.
cord-005453-4057qib7	1423	1	Log	Log	NNP
cord-005453-4057qib7	1423	2	CD3	CD3	NNP
cord-005453-4057qib7	1423	3	+	+	CC
cord-005453-4057qib7	1423	4	depletion	depletion	NN
cord-005453-4057qib7	1423	5	ranged	range	VBN
cord-005453-4057qib7	1423	6	between	between	IN
cord-005453-4057qib7	1423	7	-5.48	-5.48	CD
cord-005453-4057qib7	1423	8	and	and	CC
cord-005453-4057qib7	1423	9	-6.03	-6.03	CD
cord-005453-4057qib7	1423	10	.	.	.
cord-005453-4057qib7	1424	1	Median	median	JJ
cord-005453-4057qib7	1424	2	infused	infuse	VBN
cord-005453-4057qib7	1424	3	doses	dose	NNS
cord-005453-4057qib7	1424	4	of	of	IN
cord-005453-4057qib7	1424	5	NK	NK	NNP
cord-005453-4057qib7	1424	6	cells	cell	NNS
cord-005453-4057qib7	1424	7	and	and	CC
cord-005453-4057qib7	1424	8	CD3	cd3	NN
cord-005453-4057qib7	1424	9	+	+	CC
cord-005453-4057qib7	1425	1	cells	cell	NNS
cord-005453-4057qib7	1425	2	per	per	IN
cord-005453-4057qib7	1425	3	kg	kg	NNS
cord-005453-4057qib7	1425	4	were	be	VBD
cord-005453-4057qib7	1425	5	3.78x10	3.78x10	CD
cord-005453-4057qib7	1425	6	6	6	CD
cord-005453-4057qib7	1425	7	(	(	-LRB-
cord-005453-4057qib7	1425	8	2.8x10	2.8x10	CD
cord-005453-4057qib7	1425	9	6	6	CD
cord-005453-4057qib7	1425	10	-4.57x10	-4.57x10	CD
cord-005453-4057qib7	1425	11	6	6	CD
cord-005453-4057qib7	1425	12	)	)	-RRB-
cord-005453-4057qib7	1425	13	and	and	CC
cord-005453-4057qib7	1425	14	114	114	CD
cord-005453-4057qib7	1425	15	(	(	-LRB-
cord-005453-4057qib7	1425	16	87	87	CD
cord-005453-4057qib7	1425	17	-	-	SYM
cord-005453-4057qib7	1425	18	532	532	CD
cord-005453-4057qib7	1425	19	)	)	-RRB-
cord-005453-4057qib7	1425	20	.	.	.
cord-005453-4057qib7	1426	1	Complete	complete	JJ
cord-005453-4057qib7	1426	2	manufacturing	manufacturing	NN
cord-005453-4057qib7	1426	3	data	datum	NNS
cord-005453-4057qib7	1426	4	of	of	IN
cord-005453-4057qib7	1426	5	all	all	DT
cord-005453-4057qib7	1426	6	5	5	CD
cord-005453-4057qib7	1426	7	procedures	procedure	NNS
cord-005453-4057qib7	1426	8	are	be	VBP
cord-005453-4057qib7	1426	9	shown	show	VBN
cord-005453-4057qib7	1426	10	in	in	IN
cord-005453-4057qib7	1426	11	Table	Table	NNP
cord-005453-4057qib7	1426	12	1	1	CD
cord-005453-4057qib7	1426	13	Background	Background	NNP
cord-005453-4057qib7	1426	14	:	:	:
cord-005453-4057qib7	1427	1	Cytokine	cytokine	NN
cord-005453-4057qib7	1427	2	-	-	HYPH
cord-005453-4057qib7	1427	3	induced	induce	VBN
cord-005453-4057qib7	1427	4	killer	killer	NN
cord-005453-4057qib7	1427	5	(	(	-LRB-
cord-005453-4057qib7	1427	6	CIK	CIK	NNP
cord-005453-4057qib7	1427	7	)	)	-RRB-
cord-005453-4057qib7	1427	8	cells	cell	NNS
cord-005453-4057qib7	1427	9	are	be	VBP
cord-005453-4057qib7	1427	10	a	a	DT
cord-005453-4057qib7	1427	11	promising	promising	JJ
cord-005453-4057qib7	1427	12	immunotherapeutic	immunotherapeutic	NN
cord-005453-4057qib7	1427	13	approach	approach	NN
cord-005453-4057qib7	1427	14	to	to	IN
cord-005453-4057qib7	1427	15	combat	combat	VB
cord-005453-4057qib7	1427	16	relapse	relapse	NN
cord-005453-4057qib7	1427	17	following	follow	VBG
cord-005453-4057qib7	1427	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	1427	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1427	20	stem	stem	NN
cord-005453-4057qib7	1427	21	cell	cell	NN
cord-005453-4057qib7	1427	22	transplantation	transplantation	NN
cord-005453-4057qib7	1427	23	(	(	-LRB-
cord-005453-4057qib7	1427	24	HSCT	HSCT	NNP
cord-005453-4057qib7	1427	25	)	)	-RRB-
cord-005453-4057qib7	1427	26	for	for	IN
cord-005453-4057qib7	1427	27	acute	acute	JJ
cord-005453-4057qib7	1427	28	leukemia	leukemia	NN
cord-005453-4057qib7	1427	29	or	or	CC
cord-005453-4057qib7	1427	30	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	1427	31	syndrome	syndrome	NN
cord-005453-4057qib7	1427	32	.	.	.
cord-005453-4057qib7	1428	1	To	to	TO
cord-005453-4057qib7	1428	2	show	show	VB
cord-005453-4057qib7	1428	3	safety	safety	NN
cord-005453-4057qib7	1428	4	and	and	CC
cord-005453-4057qib7	1428	5	efficacy	efficacy	NN
cord-005453-4057qib7	1428	6	,	,	,
cord-005453-4057qib7	1428	7	a	a	DT
cord-005453-4057qib7	1428	8	multicenter	multicenter	JJ
cord-005453-4057qib7	1428	9	clinical	clinical	JJ
cord-005453-4057qib7	1428	10	study	study	NN
cord-005453-4057qib7	1428	11	with	with	IN
cord-005453-4057qib7	1428	12	20	20	CD
cord-005453-4057qib7	1428	13	pediatric	pediatric	JJ
cord-005453-4057qib7	1428	14	and	and	CC
cord-005453-4057qib7	1428	15	20	20	CD
cord-005453-4057qib7	1428	16	adult	adult	NN
cord-005453-4057qib7	1428	17	patients	patient	NNS
cord-005453-4057qib7	1428	18	including	include	VBG
cord-005453-4057qib7	1428	19	up	up	IN
cord-005453-4057qib7	1428	20	to	to	TO
cord-005453-4057qib7	1428	21	eight	eight	CD
cord-005453-4057qib7	1428	22	CIK	CIK	NNP
cord-005453-4057qib7	1428	23	cell	cell	NN
cord-005453-4057qib7	1428	24	applications	application	NNS
cord-005453-4057qib7	1428	25	with	with	IN
cord-005453-4057qib7	1428	26	escalating	escalate	VBG
cord-005453-4057qib7	1428	27	doses	dose	NNS
cord-005453-4057qib7	1428	28	is	be	VBZ
cord-005453-4057qib7	1428	29	ongoing	ongoing	JJ
cord-005453-4057qib7	1428	30	.	.	.
cord-005453-4057qib7	1429	1	Methods	method	NNS
cord-005453-4057qib7	1429	2	:	:	:
cord-005453-4057qib7	1429	3	We	-PRON-	PRP
cord-005453-4057qib7	1429	4	favor	favor	VBP
cord-005453-4057qib7	1429	5	single	single	JJ
cord-005453-4057qib7	1429	6	large	large	JJ
cord-005453-4057qib7	1429	7	scale	scale	NN
cord-005453-4057qib7	1429	8	CIK	cik	NN
cord-005453-4057qib7	1429	9	cell	cell	NN
cord-005453-4057qib7	1429	10	generation	generation	NN
cord-005453-4057qib7	1429	11	with	with	IN
cord-005453-4057qib7	1429	12	the	the	DT
cord-005453-4057qib7	1429	13	aim	aim	NN
cord-005453-4057qib7	1429	14	to	to	TO
cord-005453-4057qib7	1429	15	apply	apply	VB
cord-005453-4057qib7	1429	16	fresh	fresh	JJ
cord-005453-4057qib7	1429	17	CIK	CIK	NNP
cord-005453-4057qib7	1429	18	cells	cell	NNS
cord-005453-4057qib7	1429	19	and	and	CC
cord-005453-4057qib7	1429	20	cryopreserve	cryopreserve	VB
cord-005453-4057qib7	1429	21	ready	ready	JJ
cord-005453-4057qib7	1429	22	-	-	HYPH
cord-005453-4057qib7	1429	23	for	for	IN
cord-005453-4057qib7	1429	24	-	-	HYPH
cord-005453-4057qib7	1429	25	use	use	NN
cord-005453-4057qib7	1429	26	doses	dose	NNS
cord-005453-4057qib7	1429	27	according	accord	VBG
cord-005453-4057qib7	1429	28	to	to	IN
cord-005453-4057qib7	1429	29	the	the	DT
cord-005453-4057qib7	1429	30	study	study	NN
cord-005453-4057qib7	1429	31	protocol	protocol	NN
cord-005453-4057qib7	1429	32	in	in	IN
cord-005453-4057qib7	1429	33	contrast	contrast	NN
cord-005453-4057qib7	1429	34	to	to	IN
cord-005453-4057qib7	1429	35	recurrent	recurrent	JJ
cord-005453-4057qib7	1429	36	manufacturing	manufacturing	NN
cord-005453-4057qib7	1429	37	.	.	.
cord-005453-4057qib7	1430	1	Therefore	therefore	RB
cord-005453-4057qib7	1430	2	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	1430	3	CIK	CIK	NNP
cord-005453-4057qib7	1430	4	cells	cell	NNS
cord-005453-4057qib7	1430	5	were	be	VBD
cord-005453-4057qib7	1430	6	tested	test	VBN
cord-005453-4057qib7	1430	7	against	against	IN
cord-005453-4057qib7	1430	8	freshly	freshly	RB
cord-005453-4057qib7	1430	9	generated	generate	VBN
cord-005453-4057qib7	1430	10	CIK	CIK	NNP
cord-005453-4057qib7	1430	11	cells	cell	NNS
cord-005453-4057qib7	1430	12	to	to	TO
cord-005453-4057qib7	1430	13	approve	approve	VB
cord-005453-4057qib7	1430	14	equivalence	equivalence	NN
cord-005453-4057qib7	1430	15	.	.	.
cord-005453-4057qib7	1431	1	Furthermore	furthermore	RB
cord-005453-4057qib7	1431	2	,	,	,
cord-005453-4057qib7	1431	3	an	an	DT
cord-005453-4057qib7	1431	4	alternative	alternative	JJ
cord-005453-4057qib7	1431	5	medium	medium	NN
cord-005453-4057qib7	1431	6	supplement	supplement	NN
cord-005453-4057qib7	1431	7	for	for	IN
cord-005453-4057qib7	1431	8	CIK	CIK	NNP
cord-005453-4057qib7	1431	9	cell	cell	NN
cord-005453-4057qib7	1431	10	culturing	culturing	NN
cord-005453-4057qib7	1431	11	was	be	VBD
cord-005453-4057qib7	1431	12	investigated	investigate	VBN
cord-005453-4057qib7	1431	13	to	to	TO
cord-005453-4057qib7	1431	14	avoid	avoid	VB
cord-005453-4057qib7	1431	15	supply	supply	NN
cord-005453-4057qib7	1431	16	bottlenecks	bottleneck	NNS
cord-005453-4057qib7	1431	17	in	in	IN
cord-005453-4057qib7	1431	18	AB	ab	NN
cord-005453-4057qib7	1431	19	-	-	HYPH
cord-005453-4057qib7	1431	20	Serum	serum	NN
cord-005453-4057qib7	1431	21	.	.	.
cord-005453-4057qib7	1432	1	Results	result	NNS
cord-005453-4057qib7	1432	2	:	:	:
cord-005453-4057qib7	1433	1	Fresh	Fresh	NNP
cord-005453-4057qib7	1433	2	Frozen	Frozen	NNP
cord-005453-4057qib7	1433	3	Plasma	Plasma	NNP
cord-005453-4057qib7	1433	4	(	(	-LRB-
cord-005453-4057qib7	1433	5	FFP	FFP	NNP
cord-005453-4057qib7	1433	6	)	)	-RRB-
cord-005453-4057qib7	1433	7	,	,	,
cord-005453-4057qib7	1433	8	platelet	platelet	NN
cord-005453-4057qib7	1433	9	lysate	lysate	NN
cord-005453-4057qib7	1433	10	(	(	-LRB-
cord-005453-4057qib7	1433	11	PL	pl	NN
cord-005453-4057qib7	1433	12	)	)	-RRB-
cord-005453-4057qib7	1433	13	and	and	CC
cord-005453-4057qib7	1433	14	AB	ab	NN
cord-005453-4057qib7	1433	15	-	-	HYPH
cord-005453-4057qib7	1433	16	serum	serum	NN
cord-005453-4057qib7	1433	17	in	in	IN
cord-005453-4057qib7	1433	18	CIK	CIK	NNP
cord-005453-4057qib7	1433	19	cell	cell	NN
cord-005453-4057qib7	1433	20	culture	culture	NN
cord-005453-4057qib7	1433	21	showed	show	VBD
cord-005453-4057qib7	1433	22	median	median	JJ
cord-005453-4057qib7	1433	23	expansion	expansion	NN
cord-005453-4057qib7	1433	24	rates	rate	NNS
cord-005453-4057qib7	1433	25	of	of	IN
cord-005453-4057qib7	1433	26	10-fold	10-fold	CD
cord-005453-4057qib7	1433	27	,	,	,
cord-005453-4057qib7	1433	28	whereas	whereas	IN
cord-005453-4057qib7	1433	29	cultivation	cultivation	NN
cord-005453-4057qib7	1433	30	without	without	IN
cord-005453-4057qib7	1433	31	medium	medium	JJ
cord-005453-4057qib7	1433	32	additive	additive	NN
cord-005453-4057qib7	1433	33	resulted	result	VBD
cord-005453-4057qib7	1433	34	in	in	IN
cord-005453-4057qib7	1433	35	significantly	significantly	RB
cord-005453-4057qib7	1433	36	lower	low	JJR
cord-005453-4057qib7	1433	37	proliferation	proliferation	NN
cord-005453-4057qib7	1433	38	(	(	-LRB-
cord-005453-4057qib7	1433	39	p	p	NN
cord-005453-4057qib7	1433	40	<	<	XX
cord-005453-4057qib7	1433	41	0.01	0.01	CD
cord-005453-4057qib7	1433	42	)	)	-RRB-
cord-005453-4057qib7	1433	43	.	.	.
cord-005453-4057qib7	1434	1	CIK	CIK	NNP
cord-005453-4057qib7	1434	2	cell	cell	NN
cord-005453-4057qib7	1434	3	composition	composition	NN
cord-005453-4057qib7	1434	4	including	include	VBG
cord-005453-4057qib7	1434	5	T	t	NN
cord-005453-4057qib7	1434	6	cells	cell	NNS
cord-005453-4057qib7	1434	7	,	,	,
cord-005453-4057qib7	1434	8	NK	NK	NNP
cord-005453-4057qib7	1434	9	like	like	IN
cord-005453-4057qib7	1434	10	T	t	NN
cord-005453-4057qib7	1434	11	cells	cell	NNS
cord-005453-4057qib7	1434	12	and	and	CC
cord-005453-4057qib7	1434	13	a	a	DT
cord-005453-4057qib7	1434	14	minor	minor	JJ
cord-005453-4057qib7	1434	15	part	part	NN
cord-005453-4057qib7	1434	16	of	of	IN
cord-005453-4057qib7	1434	17	NK	NK	NNP
cord-005453-4057qib7	1434	18	cells	cell	NNS
cord-005453-4057qib7	1434	19	was	be	VBD
cord-005453-4057qib7	1434	20	not	not	RB
cord-005453-4057qib7	1434	21	significantly	significantly	RB
cord-005453-4057qib7	1434	22	influenced	influence	VBN
cord-005453-4057qib7	1434	23	by	by	IN
cord-005453-4057qib7	1434	24	changing	change	VBG
cord-005453-4057qib7	1434	25	the	the	DT
cord-005453-4057qib7	1434	26	medium	medium	JJ
cord-005453-4057qib7	1434	27	additive	additive	NN
cord-005453-4057qib7	1434	28	.	.	.
cord-005453-4057qib7	1435	1	Moreover	moreover	RB
cord-005453-4057qib7	1435	2	,	,	,
cord-005453-4057qib7	1435	3	neither	neither	CC
cord-005453-4057qib7	1435	4	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1435	5	against	against	IN
cord-005453-4057qib7	1435	6	THP-1	THP-1	NNP
cord-005453-4057qib7	1435	7	cells	cell	NNS
cord-005453-4057qib7	1435	8	nor	nor	CC
cord-005453-4057qib7	1435	9	CD25	cd25	JJ
cord-005453-4057qib7	1435	10	expression	expression	NN
cord-005453-4057qib7	1435	11	on	on	IN
cord-005453-4057qib7	1435	12	NK	NK	NNP
cord-005453-4057qib7	1435	13	like	like	IN
cord-005453-4057qib7	1435	14	T	t	NN
cord-005453-4057qib7	1435	15	cells	cell	NNS
cord-005453-4057qib7	1435	16	were	be	VBD
cord-005453-4057qib7	1435	17	significantly	significantly	RB
cord-005453-4057qib7	1435	18	influenced	influence	VBN
cord-005453-4057qib7	1435	19	by	by	IN
cord-005453-4057qib7	1435	20	the	the	DT
cord-005453-4057qib7	1435	21	different	different	JJ
cord-005453-4057qib7	1435	22	medium	medium	JJ
cord-005453-4057qib7	1435	23	additives	additive	NNS
cord-005453-4057qib7	1435	24	.	.	.
cord-005453-4057qib7	1436	1	For	for	IN
cord-005453-4057qib7	1436	2	CIK	CIK	NNP
cord-005453-4057qib7	1436	3	cell	cell	NN
cord-005453-4057qib7	1436	4	generation	generation	NN
cord-005453-4057qib7	1436	5	either	either	CC
cord-005453-4057qib7	1436	6	ficollized	ficollize	VBD
cord-005453-4057qib7	1436	7	peripheral	peripheral	JJ
cord-005453-4057qib7	1436	8	blood	blood	NN
cord-005453-4057qib7	1436	9	(	(	-LRB-
cord-005453-4057qib7	1436	10	PB	PB	NNP
cord-005453-4057qib7	1436	11	)	)	-RRB-
cord-005453-4057qib7	1436	12	or	or	CC
cord-005453-4057qib7	1436	13	unstimulated	unstimulated	JJ
cord-005453-4057qib7	1436	14	leukapheresis	leukapheresis	NNP
cord-005453-4057qib7	1436	15	(	(	-LRB-
cord-005453-4057qib7	1436	16	LP	LP	NNP
cord-005453-4057qib7	1436	17	)	)	-RRB-
cord-005453-4057qib7	1436	18	products	product	NNS
cord-005453-4057qib7	1436	19	were	be	VBD
cord-005453-4057qib7	1436	20	utilized	utilize	VBN
cord-005453-4057qib7	1436	21	.	.	.
cord-005453-4057qib7	1437	1	With	with	IN
cord-005453-4057qib7	1437	2	regard	regard	NN
cord-005453-4057qib7	1437	3	to	to	IN
cord-005453-4057qib7	1437	4	repeated	repeat	VBN
cord-005453-4057qib7	1437	5	manufacturing	manufacturing	NN
cord-005453-4057qib7	1437	6	within	within	IN
cord-005453-4057qib7	1437	7	the	the	DT
cord-005453-4057qib7	1437	8	clinical	clinical	JJ
cord-005453-4057qib7	1437	9	study	study	NN
cord-005453-4057qib7	1437	10	,	,	,
cord-005453-4057qib7	1437	11	also	also	RB
cord-005453-4057qib7	1437	12	cryopreserved	cryopreserve	VBD
cord-005453-4057qib7	1437	13	LP	LP	NNP
cord-005453-4057qib7	1437	14	and	and	CC
cord-005453-4057qib7	1437	15	PBSC	PBSC	NNP
cord-005453-4057qib7	1437	16	as	as	IN
cord-005453-4057qib7	1437	17	starting	start	VBG
cord-005453-4057qib7	1437	18	material	material	NN
cord-005453-4057qib7	1437	19	came	come	VBD
cord-005453-4057qib7	1437	20	into	into	IN
cord-005453-4057qib7	1437	21	the	the	DT
cord-005453-4057qib7	1437	22	focus	focus	NN
cord-005453-4057qib7	1437	23	of	of	IN
cord-005453-4057qib7	1437	24	interest	interest	NN
cord-005453-4057qib7	1437	25	.	.	.
cord-005453-4057qib7	1438	1	Comparing	compare	VBG
cord-005453-4057qib7	1438	2	CIK	CIK	NNP
cord-005453-4057qib7	1438	3	cell	cell	NN
cord-005453-4057qib7	1438	4	expansion	expansion	NN
cord-005453-4057qib7	1438	5	rates	rate	NNS
cord-005453-4057qib7	1438	6	,	,	,
cord-005453-4057qib7	1438	7	no	no	DT
cord-005453-4057qib7	1438	8	significant	significant	JJ
cord-005453-4057qib7	1438	9	differences	difference	NNS
cord-005453-4057qib7	1438	10	for	for	IN
cord-005453-4057qib7	1438	11	the	the	DT
cord-005453-4057qib7	1438	12	entire	entire	JJ
cord-005453-4057qib7	1438	13	CIK	CIK	NNP
cord-005453-4057qib7	1438	14	cells	cell	NNS
cord-005453-4057qib7	1438	15	and	and	CC
cord-005453-4057qib7	1438	16	the	the	DT
cord-005453-4057qib7	1438	17	subgroup	subgroup	NN
cord-005453-4057qib7	1438	18	of	of	IN
cord-005453-4057qib7	1438	19	T	T	NNP
cord-005453-4057qib7	1438	20	cells	cell	NNS
cord-005453-4057qib7	1438	21	were	be	VBD
cord-005453-4057qib7	1438	22	detected	detect	VBN
cord-005453-4057qib7	1438	23	between	between	IN
cord-005453-4057qib7	1438	24	the	the	DT
cord-005453-4057qib7	1438	25	four	four	CD
cord-005453-4057qib7	1438	26	starting	start	VBG
cord-005453-4057qib7	1438	27	materials	material	NNS
cord-005453-4057qib7	1438	28	.	.	.
cord-005453-4057qib7	1439	1	Cryopreservation	Cryopreservation	NNP
cord-005453-4057qib7	1439	2	of	of	IN
cord-005453-4057qib7	1439	3	CIK	CIK	NNP
cord-005453-4057qib7	1439	4	cells	cell	NNS
cord-005453-4057qib7	1439	5	had	have	VBD
cord-005453-4057qib7	1439	6	no	no	DT
cord-005453-4057qib7	1439	7	significant	significant	JJ
cord-005453-4057qib7	1439	8	effect	effect	NN
cord-005453-4057qib7	1439	9	on	on	IN
cord-005453-4057qib7	1439	10	CIK	CIK	NNP
cord-005453-4057qib7	1439	11	cell	cell	NN
cord-005453-4057qib7	1439	12	composition	composition	NN
cord-005453-4057qib7	1439	13	,	,	,
cord-005453-4057qib7	1439	14	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	1439	15	and	and	CC
cord-005453-4057qib7	1439	16	CD25	cd25	JJ
cord-005453-4057qib7	1439	17	expression	expression	NN
cord-005453-4057qib7	1439	18	on	on	IN
cord-005453-4057qib7	1439	19	NK	NK	NNP
cord-005453-4057qib7	1439	20	like	like	IN
cord-005453-4057qib7	1439	21	T	t	NN
cord-005453-4057qib7	1439	22	cells	cell	NNS
cord-005453-4057qib7	1439	23	.	.	.
cord-005453-4057qib7	1440	1	A	a	DT
cord-005453-4057qib7	1440	2	small	small	JJ
cord-005453-4057qib7	1440	3	,	,	,
cord-005453-4057qib7	1440	4	albeit	albeit	IN
cord-005453-4057qib7	1440	5	not	not	RB
cord-005453-4057qib7	1440	6	significant	significant	JJ
cord-005453-4057qib7	1440	7	effect	effect	NN
cord-005453-4057qib7	1440	8	of	of	IN
cord-005453-4057qib7	1440	9	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1440	10	on	on	IN
cord-005453-4057qib7	1440	11	viability	viability	NN
cord-005453-4057qib7	1440	12	was	be	VBD
cord-005453-4057qib7	1440	13	detected	detect	VBN
cord-005453-4057qib7	1440	14	,	,	,
cord-005453-4057qib7	1440	15	which	which	WDT
cord-005453-4057qib7	1440	16	was	be	VBD
cord-005453-4057qib7	1440	17	86.1	86.1	CD
cord-005453-4057qib7	1440	18	%	%	NN
cord-005453-4057qib7	1440	19	before	before	RB
cord-005453-4057qib7	1440	20	and	and	CC
cord-005453-4057qib7	1440	21	79.4	79.4	CD
cord-005453-4057qib7	1440	22	%	%	NN
cord-005453-4057qib7	1440	23	after	after	IN
cord-005453-4057qib7	1440	24	freezing	freeze	VBG
cord-005453-4057qib7	1440	25	and	and	CC
cord-005453-4057qib7	1440	26	thawing	thawing	NN
cord-005453-4057qib7	1440	27	.	.	.
cord-005453-4057qib7	1441	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1441	2	:	:	:
cord-005453-4057qib7	1442	1	The	the	DT
cord-005453-4057qib7	1442	2	challenge	challenge	NN
cord-005453-4057qib7	1442	3	was	be	VBD
cord-005453-4057qib7	1442	4	an	an	DT
cord-005453-4057qib7	1442	5	efficient	efficient	JJ
cord-005453-4057qib7	1442	6	time-	time-	NN
cord-005453-4057qib7	1442	7	,	,	,
cord-005453-4057qib7	1442	8	personal	personal	JJ
cord-005453-4057qib7	1442	9	-	-	HYPH
cord-005453-4057qib7	1442	10	and	and	CC
cord-005453-4057qib7	1442	11	cost	cost	NN
cord-005453-4057qib7	1442	12	saving	saving	NN
cord-005453-4057qib7	1442	13	production	production	NN
cord-005453-4057qib7	1442	14	of	of	IN
cord-005453-4057qib7	1442	15	CIK	CIK	NNP
cord-005453-4057qib7	1442	16	cells	cell	NNS
cord-005453-4057qib7	1442	17	within	within	IN
cord-005453-4057qib7	1442	18	the	the	DT
cord-005453-4057qib7	1442	19	clinical	clinical	JJ
cord-005453-4057qib7	1442	20	study	study	NN
cord-005453-4057qib7	1442	21	.	.	.
cord-005453-4057qib7	1443	1	Introducing	introduce	VBG
cord-005453-4057qib7	1443	2	FFP	FFP	NNP
cord-005453-4057qib7	1443	3	enabled	enable	VBD
cord-005453-4057qib7	1443	4	CIK	CIK	NNP
cord-005453-4057qib7	1443	5	cell	cell	NN
cord-005453-4057qib7	1443	6	manufacturing	manufacturing	NN
cord-005453-4057qib7	1443	7	for	for	IN
cord-005453-4057qib7	1443	8	an	an	DT
cord-005453-4057qib7	1443	9	increased	increase	VBN
cord-005453-4057qib7	1443	10	patient	patient	JJ
cord-005453-4057qib7	1443	11	cohort	cohort	NN
cord-005453-4057qib7	1443	12	by	by	IN
cord-005453-4057qib7	1443	13	avoiding	avoid	VBG
cord-005453-4057qib7	1443	14	supply	supply	NN
cord-005453-4057qib7	1443	15	bottlenecks	bottleneck	NNS
cord-005453-4057qib7	1443	16	in	in	IN
cord-005453-4057qib7	1443	17	AB	ab	NN
cord-005453-4057qib7	1443	18	-	-	HYPH
cord-005453-4057qib7	1443	19	serum	serum	NN
cord-005453-4057qib7	1443	20	.	.	.
cord-005453-4057qib7	1444	1	Furthermore	furthermore	RB
cord-005453-4057qib7	1444	2	,	,	,
cord-005453-4057qib7	1444	3	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	1444	4	allows	allow	VBZ
cord-005453-4057qib7	1444	5	the	the	DT
cord-005453-4057qib7	1444	6	storage	storage	NN
cord-005453-4057qib7	1444	7	of	of	IN
cord-005453-4057qib7	1444	8	ready	ready	JJ
cord-005453-4057qib7	1444	9	-	-	HYPH
cord-005453-4057qib7	1444	10	for	for	IN
cord-005453-4057qib7	1444	11	-	-	HYPH
cord-005453-4057qib7	1444	12	use	use	NN
cord-005453-4057qib7	1444	13	CIK	CIK	NNP
cord-005453-4057qib7	1444	14	cell	cell	NN
cord-005453-4057qib7	1444	15	doses	dose	NNS
cord-005453-4057qib7	1444	16	fulfilling	fulfil	VBG
cord-005453-4057qib7	1444	17	the	the	DT
cord-005453-4057qib7	1444	18	demands	demand	NNS
cord-005453-4057qib7	1444	19	of	of	IN
cord-005453-4057qib7	1444	20	the	the	DT
cord-005453-4057qib7	1444	21	clinical	clinical	JJ
cord-005453-4057qib7	1444	22	study	study	NN
cord-005453-4057qib7	1444	23	.	.	.
cord-005453-4057qib7	1445	1	Clinical	clinical	JJ
cord-005453-4057qib7	1445	2	Trial	Trial	NNP
cord-005453-4057qib7	1445	3	Registry	Registry	NNP
cord-005453-4057qib7	1445	4	:	:	:
cord-005453-4057qib7	1446	1	EudraCT	EudraCT	NNP
cord-005453-4057qib7	1446	2	Number	Number	NNP
cord-005453-4057qib7	1446	3	2013	2013	CD
cord-005453-4057qib7	1446	4	-	-	HYPH
cord-005453-4057qib7	1446	5	005446	005446	CD
cord-005453-4057qib7	1446	6	-	-	HYPH
cord-005453-4057qib7	1446	7	11	11	CD
cord-005453-4057qib7	1446	8	Disclosure	disclosure	NN
cord-005453-4057qib7	1446	9	:	:	:
cord-005453-4057qib7	1446	10	Nothing	nothing	NN
cord-005453-4057qib7	1446	11	to	to	TO
cord-005453-4057qib7	1446	12	declare	declare	VB
cord-005453-4057qib7	1446	13	.	.	.
cord-005453-4057qib7	1447	1	Automated	automated	JJ
cord-005453-4057qib7	1447	2	generation	generation	NN
cord-005453-4057qib7	1447	3	of	of	IN
cord-005453-4057qib7	1447	4	CD45RA	CD45RA	NNP
cord-005453-4057qib7	1447	5	depleted	deplete	VBN
cord-005453-4057qib7	1447	6	donor	donor	NN
cord-005453-4057qib7	1447	7	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1447	8	infusion	infusion	NN
cord-005453-4057qib7	1447	9	(	(	-LRB-
cord-005453-4057qib7	1447	10	DLI	DLI	NNP
cord-005453-4057qib7	1447	11	)	)	-RRB-
cord-005453-4057qib7	1447	12	with	with	IN
cord-005453-4057qib7	1447	13	the	the	DT
cord-005453-4057qib7	1447	14	clinimacs	clinimacs	NNP
cord-005453-4057qib7	1447	15	prodigy	prodigy	NN
cord-005453-4057qib7	1448	1	®	®	.
cord-005453-4057qib7	1449	1	CD45RA	cd45ra	NN
cord-005453-4057qib7	1449	2	system	system	NN
cord-005453-4057qib7	1449	3	1	1	CD
cord-005453-4057qib7	1449	4	,	,	,
cord-005453-4057qib7	1449	5	2	2	CD
cord-005453-4057qib7	1449	6	Methods	method	NNS
cord-005453-4057qib7	1450	1	:	:	:
cord-005453-4057qib7	1450	2	The	the	DT
cord-005453-4057qib7	1450	3	current	current	JJ
cord-005453-4057qib7	1450	4	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1450	5	CD45RA	CD45RA	NNP
cord-005453-4057qib7	1450	6	System	System	NNP
cord-005453-4057qib7	1450	7	was	be	VBD
cord-005453-4057qib7	1450	8	developed	develop	VBN
cord-005453-4057qib7	1450	9	for	for	IN
cord-005453-4057qib7	1450	10	graft	graft	NN
cord-005453-4057qib7	1450	11	engineering	engineering	NN
cord-005453-4057qib7	1450	12	.	.	.
cord-005453-4057qib7	1451	1	Up	up	IN
cord-005453-4057qib7	1451	2	to	to	TO
cord-005453-4057qib7	1451	3	20x10e9	20x10e9	CD
cord-005453-4057qib7	1451	4	magnetically	magnetically	RB
cord-005453-4057qib7	1451	5	labeled	label	VBN
cord-005453-4057qib7	1451	6	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	1451	7	cells	cell	NNS
cord-005453-4057qib7	1451	8	from	from	IN
cord-005453-4057qib7	1451	9	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	1451	10	products	product	NNS
cord-005453-4057qib7	1451	11	can	can	MD
cord-005453-4057qib7	1451	12	be	be	VB
cord-005453-4057qib7	1451	13	depleted	deplete	VBN
cord-005453-4057qib7	1451	14	from	from	IN
cord-005453-4057qib7	1451	15	up	up	IN
cord-005453-4057qib7	1451	16	to	to	IN
cord-005453-4057qib7	1451	17	50x10e9	50x10e9	CD
cord-005453-4057qib7	1451	18	white	white	JJ
cord-005453-4057qib7	1451	19	blood	blood	NN
cord-005453-4057qib7	1451	20	cells	cell	NNS
cord-005453-4057qib7	1451	21	(	(	-LRB-
cord-005453-4057qib7	1451	22	WBC	WBC	NNP
cord-005453-4057qib7	1451	23	)	)	-RRB-
cord-005453-4057qib7	1451	24	.	.	.
cord-005453-4057qib7	1452	1	We	-PRON-	PRP
cord-005453-4057qib7	1452	2	developed	develop	VBD
cord-005453-4057qib7	1452	3	a	a	DT
cord-005453-4057qib7	1452	4	new	new	JJ
cord-005453-4057qib7	1452	5	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1452	6	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1452	7	®	®	NN
cord-005453-4057qib7	1452	8	process	process	NN
cord-005453-4057qib7	1452	9	in	in	IN
cord-005453-4057qib7	1452	10	order	order	NN
cord-005453-4057qib7	1452	11	to	to	TO
cord-005453-4057qib7	1452	12	ease	ease	VB
cord-005453-4057qib7	1452	13	the	the	DT
cord-005453-4057qib7	1452	14	procedure	procedure	NN
cord-005453-4057qib7	1452	15	for	for	IN
cord-005453-4057qib7	1452	16	routine	routine	JJ
cord-005453-4057qib7	1452	17	-	-	HYPH
cord-005453-4057qib7	1452	18	use	use	NN
cord-005453-4057qib7	1452	19	,	,	,
cord-005453-4057qib7	1452	20	to	to	TO
cord-005453-4057qib7	1452	21	reduce	reduce	VB
cord-005453-4057qib7	1452	22	the	the	DT
cord-005453-4057qib7	1452	23	specifications	specification	NNS
cord-005453-4057qib7	1452	24	according	accord	VBG
cord-005453-4057qib7	1452	25	to	to	IN
cord-005453-4057qib7	1452	26	reported	report	VBN
cord-005453-4057qib7	1452	27	cell	cell	NN
cord-005453-4057qib7	1452	28	numbers	number	NNS
cord-005453-4057qib7	1452	29	for	for	IN
cord-005453-4057qib7	1452	30	DLI	DLI	NNP
cord-005453-4057qib7	1452	31	applications	application	NNS
cord-005453-4057qib7	1452	32	,	,	,
cord-005453-4057qib7	1452	33	and	and	CC
cord-005453-4057qib7	1452	34	to	to	TO
cord-005453-4057qib7	1452	35	enable	enable	VB
cord-005453-4057qib7	1452	36	the	the	DT
cord-005453-4057qib7	1452	37	use	use	NN
cord-005453-4057qib7	1452	38	of	of	IN
cord-005453-4057qib7	1452	39	peripheral	peripheral	JJ
cord-005453-4057qib7	1452	40	blood	blood	NN
cord-005453-4057qib7	1452	41	products	product	NNS
cord-005453-4057qib7	1452	42	with	with	IN
cord-005453-4057qib7	1452	43	high	high	JJ
cord-005453-4057qib7	1452	44	amounts	amount	NNS
cord-005453-4057qib7	1452	45	of	of	IN
cord-005453-4057qib7	1452	46	red	red	JJ
cord-005453-4057qib7	1452	47	blood	blood	NN
cord-005453-4057qib7	1452	48	cells	cell	NNS
cord-005453-4057qib7	1452	49	(	(	-LRB-
cord-005453-4057qib7	1452	50	RBC	RBC	NNP
cord-005453-4057qib7	1452	51	)	)	-RRB-
cord-005453-4057qib7	1452	52	.	.	.
cord-005453-4057qib7	1453	1	The	the	DT
cord-005453-4057qib7	1453	2	new	new	JJ
cord-005453-4057qib7	1453	3	system	system	NN
cord-005453-4057qib7	1453	4	was	be	VBD
cord-005453-4057qib7	1453	5	tested	test	VBN
cord-005453-4057qib7	1453	6	by	by	IN
cord-005453-4057qib7	1453	7	performance	performance	NN
cord-005453-4057qib7	1453	8	runs	run	NNS
cord-005453-4057qib7	1453	9	.	.	.
cord-005453-4057qib7	1454	1	An	an	DT
cord-005453-4057qib7	1454	2	new	new	JJ
cord-005453-4057qib7	1454	3	fluorescent	fluorescent	JJ
cord-005453-4057qib7	1454	4	flow	flow	NN
cord-005453-4057qib7	1454	5	analysis	analysis	NN
cord-005453-4057qib7	1454	6	protocol	protocol	NN
cord-005453-4057qib7	1454	7	was	be	VBD
cord-005453-4057qib7	1454	8	developed	develop	VBN
cord-005453-4057qib7	1454	9	.	.	.
cord-005453-4057qib7	1455	1	Results	result	NNS
cord-005453-4057qib7	1455	2	:	:	:
cord-005453-4057qib7	1456	1	The	the	DT
cord-005453-4057qib7	1456	2	resulting	result	VBG
cord-005453-4057qib7	1456	3	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1456	4	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1456	5	PB-45RA	PB-45RA	NNP
cord-005453-4057qib7	1456	6	System	System	NNP
cord-005453-4057qib7	1456	7	is	be	VBZ
cord-005453-4057qib7	1456	8	an	an	DT
cord-005453-4057qib7	1456	9	automated	automate	VBN
cord-005453-4057qib7	1456	10	procedure	procedure	NN
cord-005453-4057qib7	1456	11	with	with	IN
cord-005453-4057qib7	1456	12	integrated	integrated	JJ
cord-005453-4057qib7	1456	13	labeling	labeling	NN
cord-005453-4057qib7	1456	14	and	and	CC
cord-005453-4057qib7	1456	15	washing	washing	NN
cord-005453-4057qib7	1456	16	steps	step	NNS
cord-005453-4057qib7	1456	17	.	.	.
cord-005453-4057qib7	1457	1	The	the	DT
cord-005453-4057qib7	1457	2	new	new	JJ
cord-005453-4057qib7	1457	3	application	application	NN
cord-005453-4057qib7	1457	4	software	software	NN
cord-005453-4057qib7	1457	5	PB-45RA	PB-45RA	NNP
cord-005453-4057qib7	1457	6	Depletion	Depletion	NNP
cord-005453-4057qib7	1457	7	enables	enable	VBZ
cord-005453-4057qib7	1457	8	to	to	TO
cord-005453-4057qib7	1457	9	deplete	deplete	VB
cord-005453-4057qib7	1457	10	up	up	RP
cord-005453-4057qib7	1457	11	to	to	IN
cord-005453-4057qib7	1457	12	1.8x10e9	1.8x10e9	CD
cord-005453-4057qib7	1457	13	CD45RA	cd45ra	NN
cord-005453-4057qib7	1457	14	+	+	CC
cord-005453-4057qib7	1457	15	cells	cell	NNS
cord-005453-4057qib7	1457	16	from	from	IN
cord-005453-4057qib7	1457	17	up	up	IN
cord-005453-4057qib7	1457	18	to	to	IN
cord-005453-4057qib7	1457	19	5x10e9	5x10e9	CD
cord-005453-4057qib7	1457	20	total	total	NN
cord-005453-4057qib7	1457	21	WBC	WBC	NNP
cord-005453-4057qib7	1457	22	from	from	IN
cord-005453-4057qib7	1457	23	peripheral	peripheral	JJ
cord-005453-4057qib7	1457	24	blood	blood	NN
cord-005453-4057qib7	1457	25	products	product	NNS
cord-005453-4057qib7	1457	26	.	.	.
cord-005453-4057qib7	1458	1	A	a	DT
cord-005453-4057qib7	1458	2	major	major	JJ
cord-005453-4057qib7	1458	3	difference	difference	NN
cord-005453-4057qib7	1458	4	of	of	IN
cord-005453-4057qib7	1458	5	this	this	DT
cord-005453-4057qib7	1458	6	process	process	NN
cord-005453-4057qib7	1458	7	is	be	VBZ
cord-005453-4057qib7	1458	8	the	the	DT
cord-005453-4057qib7	1458	9	RBC	RBC	NNP
cord-005453-4057qib7	1458	10	removal	removal	NN
cord-005453-4057qib7	1458	11	option	option	NN
cord-005453-4057qib7	1458	12	based	base	VBN
cord-005453-4057qib7	1458	13	on	on	IN
cord-005453-4057qib7	1458	14	an	an	DT
cord-005453-4057qib7	1458	15	integrated	integrate	VBN
cord-005453-4057qib7	1458	16	camera	camera	NN
cord-005453-4057qib7	1458	17	for	for	IN
cord-005453-4057qib7	1458	18	cell	cell	NN
cord-005453-4057qib7	1458	19	pellet	pellet	NN
cord-005453-4057qib7	1458	20	detection	detection	NN
cord-005453-4057qib7	1458	21	.	.	.
cord-005453-4057qib7	1459	1	The	the	DT
cord-005453-4057qib7	1459	2	final	final	JJ
cord-005453-4057qib7	1459	3	cell	cell	NN
cord-005453-4057qib7	1459	4	product	product	NN
cord-005453-4057qib7	1459	5	is	be	VBZ
cord-005453-4057qib7	1459	6	provided	provide	VBN
cord-005453-4057qib7	1459	7	in	in	IN
cord-005453-4057qib7	1459	8	physiologic	physiologic	JJ
cord-005453-4057qib7	1459	9	saline	saline	NN
cord-005453-4057qib7	1459	10	.	.	.
cord-005453-4057qib7	1460	1	Verification	verification	NN
cord-005453-4057qib7	1460	2	runs	run	VBZ
cord-005453-4057qib7	1460	3	with	with	IN
cord-005453-4057qib7	1460	4	peripheral	peripheral	JJ
cord-005453-4057qib7	1460	5	blood	blood	NN
cord-005453-4057qib7	1460	6	products	product	NNS
cord-005453-4057qib7	1460	7	(	(	-LRB-
cord-005453-4057qib7	1460	8	n=6	n=6	JJ
cord-005453-4057qib7	1460	9	in	in	IN
cord-005453-4057qib7	1460	10	total	total	JJ
cord-005453-4057qib7	1460	11	,	,	,
cord-005453-4057qib7	1460	12	n=3	n=3	NN
cord-005453-4057qib7	1460	13	with	with	IN
cord-005453-4057qib7	1460	14	whole	whole	JJ
cord-005453-4057qib7	1460	15	blood	blood	NN
cord-005453-4057qib7	1460	16	,	,	,
cord-005453-4057qib7	1460	17	n=3	n=3	NN
cord-005453-4057qib7	1460	18	with	with	IN
cord-005453-4057qib7	1460	19	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	1460	20	products	product	NNS
cord-005453-4057qib7	1460	21	)	)	-RRB-
cord-005453-4057qib7	1460	22	resulted	result	VBD
cord-005453-4057qib7	1460	23	in	in	IN
cord-005453-4057qib7	1460	24	a	a	DT
cord-005453-4057qib7	1460	25	mean	mean	JJ
cord-005453-4057qib7	1460	26	depletion	depletion	NN
cord-005453-4057qib7	1460	27	of	of	IN
cord-005453-4057qib7	1460	28	5.0	5.0	CD
cord-005453-4057qib7	1460	29	log	log	NN
cord-005453-4057qib7	1460	30	(	(	-LRB-
cord-005453-4057qib7	1460	31	range	range	VBP
cord-005453-4057qib7	1460	32	3.9	3.9	CD
cord-005453-4057qib7	1460	33	-5.7	-5.7	NFP
cord-005453-4057qib7	1460	34	)	)	-RRB-
cord-005453-4057qib7	1460	35	for	for	IN
cord-005453-4057qib7	1460	36	CD45RA	cd45ra	NN
cord-005453-4057qib7	1460	37	+	+	CC
cord-005453-4057qib7	1460	38	T	t	NN
cord-005453-4057qib7	1460	39	cells	cell	NNS
cord-005453-4057qib7	1460	40	in	in	IN
cord-005453-4057qib7	1460	41	the	the	DT
cord-005453-4057qib7	1460	42	CD45RA	cd45ra	NN
cord-005453-4057qib7	1460	43	depleted	deplete	VBN
cord-005453-4057qib7	1460	44	product	product	NN
cord-005453-4057qib7	1460	45	.	.	.
cord-005453-4057qib7	1461	1	Viability	viability	NN
cord-005453-4057qib7	1461	2	of	of	IN
cord-005453-4057qib7	1461	3	the	the	DT
cord-005453-4057qib7	1461	4	target	target	NN
cord-005453-4057qib7	1461	5	products	product	NNS
cord-005453-4057qib7	1461	6	was	be	VBD
cord-005453-4057qib7	1461	7	always	always	RB
cord-005453-4057qib7	1461	8	above	above	IN
cord-005453-4057qib7	1461	9	96	96	CD
cord-005453-4057qib7	1461	10	%	%	NN
cord-005453-4057qib7	1461	11	,	,	,
cord-005453-4057qib7	1461	12	and	and	CC
cord-005453-4057qib7	1461	13	mean	mean	VB
cord-005453-4057qib7	1461	14	WBC	WBC	NNP
cord-005453-4057qib7	1461	15	recovery	recovery	NN
cord-005453-4057qib7	1461	16	was	be	VBD
cord-005453-4057qib7	1461	17	66	66	CD
cord-005453-4057qib7	1461	18	%	%	NN
cord-005453-4057qib7	1461	19	.	.	.
cord-005453-4057qib7	1462	1	The	the	DT
cord-005453-4057qib7	1462	2	mean	mean	JJ
cord-005453-4057qib7	1462	3	process	process	NN
cord-005453-4057qib7	1462	4	time	time	NN
cord-005453-4057qib7	1462	5	was	be	VBD
cord-005453-4057qib7	1462	6	3h23min	3h23min	CD
cord-005453-4057qib7	1463	1	(	(	-LRB-
cord-005453-4057qib7	1463	2	range	range	NNP
cord-005453-4057qib7	1463	3	3h	3h	CD
cord-005453-4057qib7	1463	4	to	to	IN
cord-005453-4057qib7	1463	5	3h50min	3h50min	CD
cord-005453-4057qib7	1463	6	)	)	-RRB-
cord-005453-4057qib7	1463	7	without	without	IN
cord-005453-4057qib7	1463	8	including	include	VBG
cord-005453-4057qib7	1463	9	the	the	DT
cord-005453-4057qib7	1463	10	manual	manual	JJ
cord-005453-4057qib7	1463	11	steps	step	NNS
cord-005453-4057qib7	1463	12	,	,	,
cord-005453-4057qib7	1463	13	i.e.	i.e.	FW
cord-005453-4057qib7	1463	14	tubing	tubing	NN
cord-005453-4057qib7	1463	15	set	set	VBN
cord-005453-4057qib7	1463	16	installation	installation	NN
cord-005453-4057qib7	1463	17	and	and	CC
cord-005453-4057qib7	1463	18	downstream	downstream	JJ
cord-005453-4057qib7	1463	19	analysis	analysis	NN
cord-005453-4057qib7	1463	20	of	of	IN
cord-005453-4057qib7	1463	21	blood	blood	NN
cord-005453-4057qib7	1463	22	products	product	NNS
cord-005453-4057qib7	1463	23	by	by	IN
cord-005453-4057qib7	1463	24	flow	flow	NN
cord-005453-4057qib7	1463	25	cytometry	cytometry	NN
cord-005453-4057qib7	1463	26	.	.	.
cord-005453-4057qib7	1464	1	This	this	DT
cord-005453-4057qib7	1464	2	data	datum	NNS
cord-005453-4057qib7	1464	3	were	be	VBD
cord-005453-4057qib7	1464	4	in	in	IN
cord-005453-4057qib7	1464	5	line	line	NN
cord-005453-4057qib7	1464	6	with	with	IN
cord-005453-4057qib7	1464	7	preceding	precede	VBG
cord-005453-4057qib7	1464	8	evaluation	evaluation	NN
cord-005453-4057qib7	1464	9	runs	run	NNS
cord-005453-4057qib7	1464	10	(	(	-LRB-
cord-005453-4057qib7	1464	11	n=6	n=6	NNP
cord-005453-4057qib7	1464	12	)	)	-RRB-
cord-005453-4057qib7	1464	13	,	,	,
cord-005453-4057qib7	1464	14	and	and	CC
cord-005453-4057qib7	1464	15	results	result	NNS
cord-005453-4057qib7	1464	16	obtained	obtain	VBN
cord-005453-4057qib7	1464	17	in	in	IN
cord-005453-4057qib7	1464	18	cooperation	cooperation	NN
cord-005453-4057qib7	1464	19	with	with	IN
cord-005453-4057qib7	1464	20	an	an	DT
cord-005453-4057qib7	1464	21	external	external	JJ
cord-005453-4057qib7	1464	22	beta	beta	NN
cord-005453-4057qib7	1464	23	test	test	NN
cord-005453-4057qib7	1464	24	site	site	NN
cord-005453-4057qib7	1464	25	.	.	.
cord-005453-4057qib7	1465	1	3	3	LS
cord-005453-4057qib7	1466	1	The	the	DT
cord-005453-4057qib7	1466	2	performance	performance	NN
cord-005453-4057qib7	1466	3	results	result	NNS
cord-005453-4057qib7	1466	4	were	be	VBD
cord-005453-4057qib7	1466	5	furthermore	furthermore	RB
cord-005453-4057qib7	1466	6	in	in	IN
cord-005453-4057qib7	1466	7	line	line	NN
cord-005453-4057qib7	1466	8	with	with	IN
cord-005453-4057qib7	1466	9	results	result	NNS
cord-005453-4057qib7	1466	10	obtained	obtain	VBN
cord-005453-4057qib7	1466	11	on	on	IN
cord-005453-4057qib7	1466	12	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1466	13	Plus	plus	CC
cord-005453-4057qib7	1466	14	instrument	instrument	NN
cord-005453-4057qib7	1466	15	runs	run	VBZ
cord-005453-4057qib7	1466	16	.	.	.
cord-005453-4057qib7	1467	1	For	for	IN
cord-005453-4057qib7	1467	2	quality	quality	NN
cord-005453-4057qib7	1467	3	control	control	NN
cord-005453-4057qib7	1467	4	of	of	IN
cord-005453-4057qib7	1467	5	CD45RA	cd45ra	NN
cord-005453-4057qib7	1467	6	depleted	depleted	JJ
cord-005453-4057qib7	1467	7	products	product	NNS
cord-005453-4057qib7	1467	8	we	-PRON-	PRP
cord-005453-4057qib7	1467	9	developed	develop	VBD
cord-005453-4057qib7	1467	10	a	a	DT
cord-005453-4057qib7	1467	11	flow	flow	NN
cord-005453-4057qib7	1467	12	cytometric	cytometric	NNP
cord-005453-4057qib7	1467	13	analysis	analysis	NN
cord-005453-4057qib7	1467	14	strategy	strategy	NN
cord-005453-4057qib7	1467	15	for	for	IN
cord-005453-4057qib7	1467	16	fast	fast	JJ
cord-005453-4057qib7	1467	17	,	,	,
cord-005453-4057qib7	1467	18	accurate	accurate	JJ
cord-005453-4057qib7	1467	19	,	,	,
cord-005453-4057qib7	1467	20	and	and	CC
cord-005453-4057qib7	1467	21	convenient	convenient	JJ
cord-005453-4057qib7	1467	22	analysis	analysis	NN
cord-005453-4057qib7	1467	23	of	of	IN
cord-005453-4057qib7	1467	24	even	even	RB
cord-005453-4057qib7	1467	25	rare	rare	JJ
cord-005453-4057qib7	1467	26	counts	count	NNS
cord-005453-4057qib7	1467	27	of	of	IN
cord-005453-4057qib7	1467	28	remaining	remain	VBG
cord-005453-4057qib7	1467	29	unwanted	unwanted	JJ
cord-005453-4057qib7	1467	30	cells	cell	NNS
cord-005453-4057qib7	1467	31	.	.	.
cord-005453-4057qib7	1468	1	It	-PRON-	PRP
cord-005453-4057qib7	1468	2	allows	allow	VBZ
cord-005453-4057qib7	1468	3	to	to	TO
cord-005453-4057qib7	1468	4	determine	determine	VB
cord-005453-4057qib7	1468	5	naïve	naïve	JJ
cord-005453-4057qib7	1468	6	T	t	NN
cord-005453-4057qib7	1468	7	cells	cell	NNS
cord-005453-4057qib7	1468	8	at	at	IN
cord-005453-4057qib7	1468	9	two	two	CD
cord-005453-4057qib7	1468	10	different	different	JJ
cord-005453-4057qib7	1468	11	levels	level	NNS
cord-005453-4057qib7	1468	12	of	of	IN
cord-005453-4057qib7	1468	13	subset	subset	JJ
cord-005453-4057qib7	1468	14	staining	staining	NN
cord-005453-4057qib7	1468	15	.	.	.
cord-005453-4057qib7	1469	1	The	the	DT
cord-005453-4057qib7	1469	2	minimum	minimum	JJ
cord-005453-4057qib7	1469	3	requirement	requirement	NN
cord-005453-4057qib7	1469	4	for	for	IN
cord-005453-4057qib7	1469	5	the	the	DT
cord-005453-4057qib7	1469	6	flow	flow	NN
cord-005453-4057qib7	1469	7	cytometric	cytometric	NNP
cord-005453-4057qib7	1469	8	analysis	analysis	NN
cord-005453-4057qib7	1469	9	includes	include	VBZ
cord-005453-4057qib7	1469	10	4	4	CD
cord-005453-4057qib7	1469	11	colors	color	NNS
cord-005453-4057qib7	1469	12	to	to	TO
cord-005453-4057qib7	1469	13	define	define	VB
cord-005453-4057qib7	1469	14	viable	viable	JJ
cord-005453-4057qib7	1469	15	CD3+CD45RA+	cd3+cd45ra+	NN
cord-005453-4057qib7	1469	16	cells	cell	NNS
cord-005453-4057qib7	1469	17	.	.	.
cord-005453-4057qib7	1470	1	For	for	IN
cord-005453-4057qib7	1470	2	further	further	JJ
cord-005453-4057qib7	1470	3	evaluation	evaluation	NN
cord-005453-4057qib7	1470	4	of	of	IN
cord-005453-4057qib7	1470	5	the	the	DT
cord-005453-4057qib7	1470	6	naïve	naïve	JJ
cord-005453-4057qib7	1470	7	T	T	NNP
cord-005453-4057qib7	1470	8	cell	cell	NN
cord-005453-4057qib7	1470	9	subsets	subset	NNS
cord-005453-4057qib7	1470	10	3	3	CD
cord-005453-4057qib7	1470	11	additional	additional	JJ
cord-005453-4057qib7	1470	12	colors	color	NNS
cord-005453-4057qib7	1470	13	are	be	VBP
cord-005453-4057qib7	1470	14	used	use	VBN
cord-005453-4057qib7	1470	15	to	to	TO
cord-005453-4057qib7	1470	16	define	define	VB
cord-005453-4057qib7	1470	17	viable	viable	JJ
cord-005453-4057qib7	1470	18	CD3+CD45RO	cd3+cd45ro	NN
cord-005453-4057qib7	1470	19	-	-	HYPH
cord-005453-4057qib7	1470	20	CD95-CD62L+CD197	cd95-cd62l+cd197	NN
cord-005453-4057qib7	1470	21	+	+	CC
cord-005453-4057qib7	1470	22	cells	cell	NNS
cord-005453-4057qib7	1470	23	.	.	.
cord-005453-4057qib7	1471	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1471	2	:	:	:
cord-005453-4057qib7	1472	1	The	the	DT
cord-005453-4057qib7	1472	2	automated	automated	JJ
cord-005453-4057qib7	1472	3	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	1472	4	Prodigy	Prodigy	NNP
cord-005453-4057qib7	1472	5	PB-45RA	PB-45RA	NNP
cord-005453-4057qib7	1472	6	System	System	NNP
cord-005453-4057qib7	1472	7	process	process	NN
cord-005453-4057qib7	1472	8	is	be	VBZ
cord-005453-4057qib7	1472	9	capable	capable	JJ
cord-005453-4057qib7	1472	10	to	to	TO
cord-005453-4057qib7	1472	11	deplete	deplete	VB
cord-005453-4057qib7	1472	12	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	1472	13	cells	cell	NNS
cord-005453-4057qib7	1472	14	efficiently	efficiently	RB
cord-005453-4057qib7	1472	15	from	from	IN
cord-005453-4057qib7	1472	16	peripheral	peripheral	JJ
cord-005453-4057qib7	1472	17	blood	blood	NN
cord-005453-4057qib7	1472	18	products	product	NNS
cord-005453-4057qib7	1472	19	within	within	IN
cord-005453-4057qib7	1472	20	4	4	CD
cord-005453-4057qib7	1472	21	hours	hour	NNS
cord-005453-4057qib7	1472	22	.	.	.
cord-005453-4057qib7	1473	1	The	the	DT
cord-005453-4057qib7	1473	2	new	new	JJ
cord-005453-4057qib7	1473	3	process	process	NN
cord-005453-4057qib7	1473	4	is	be	VBZ
cord-005453-4057qib7	1473	5	a	a	DT
cord-005453-4057qib7	1473	6	fast	fast	JJ
cord-005453-4057qib7	1473	7	,	,	,
cord-005453-4057qib7	1473	8	convenient	convenient	JJ
cord-005453-4057qib7	1473	9	,	,	,
cord-005453-4057qib7	1473	10	and	and	CC
cord-005453-4057qib7	1473	11	regulatory	regulatory	JJ
cord-005453-4057qib7	1473	12	compliant	compliant	JJ
cord-005453-4057qib7	1473	13	method	method	NN
cord-005453-4057qib7	1473	14	for	for	IN
cord-005453-4057qib7	1473	15	the	the	DT
cord-005453-4057qib7	1473	16	preparation	preparation	NN
cord-005453-4057qib7	1473	17	of	of	IN
cord-005453-4057qib7	1473	18	ready	ready	JJ
cord-005453-4057qib7	1473	19	-	-	HYPH
cord-005453-4057qib7	1473	20	to	to	IN
cord-005453-4057qib7	1473	21	-	-	HYPH
cord-005453-4057qib7	1473	22	use	use	NN
cord-005453-4057qib7	1473	23	CD45RA	cd45ra	NN
cord-005453-4057qib7	1473	24	-	-	HYPH
cord-005453-4057qib7	1473	25	depleted	deplete	VBN
cord-005453-4057qib7	1473	26	cell	cell	NN
cord-005453-4057qib7	1473	27	products	product	NNS
cord-005453-4057qib7	1473	28	for	for	IN
cord-005453-4057qib7	1473	29	clinical	clinical	JJ
cord-005453-4057qib7	1473	30	applications	application	NNS
cord-005453-4057qib7	1473	31	.	.	.
cord-005453-4057qib7	1474	1	The	the	DT
cord-005453-4057qib7	1474	2	submission	submission	NN
cord-005453-4057qib7	1474	3	to	to	IN
cord-005453-4057qib7	1474	4	an	an	DT
cord-005453-4057qib7	1474	5	European	European	NNP
cord-005453-4057qib7	1474	6	notified	notify	VBN
cord-005453-4057qib7	1474	7	body	body	NN
cord-005453-4057qib7	1474	8	for	for	IN
cord-005453-4057qib7	1474	9	CE	CE	NNP
cord-005453-4057qib7	1474	10	certification	certification	NN
cord-005453-4057qib7	1474	11	is	be	VBZ
cord-005453-4057qib7	1474	12	an	an	DT
cord-005453-4057qib7	1474	13	important	important	JJ
cord-005453-4057qib7	1474	14	next	next	JJ
cord-005453-4057qib7	1474	15	step	step	NN
cord-005453-4057qib7	1474	16	.	.	.
cord-005453-4057qib7	1475	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	1475	2	conditioning	conditioning	NN
cord-005453-4057qib7	1475	3	regimen	regimen	NN
cord-005453-4057qib7	1475	4	was	be	VBD
cord-005453-4057qib7	1475	5	preferred	prefer	VBN
cord-005453-4057qib7	1475	6	for	for	IN
cord-005453-4057qib7	1475	7	24	24	CD
cord-005453-4057qib7	1475	8	patients	patient	NNS
cord-005453-4057qib7	1475	9	out	out	IN
cord-005453-4057qib7	1475	10	of	of	IN
cord-005453-4057qib7	1475	11	25	25	CD
cord-005453-4057qib7	1475	12	.	.	.
cord-005453-4057qib7	1476	1	GVHD	GVHD	NNP
cord-005453-4057qib7	1476	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1476	3	regimens	regimen	NNS
cord-005453-4057qib7	1476	4	are	be	VBP
cord-005453-4057qib7	1476	5	CSA	CSA	NNP
cord-005453-4057qib7	1476	6	+	+	CC
cord-005453-4057qib7	1476	7	MTX	MTX	NNP
cord-005453-4057qib7	1476	8	:	:	:
cord-005453-4057qib7	1476	9	20(%80	20(%80	CD
cord-005453-4057qib7	1476	10	)	)	-RRB-
cord-005453-4057qib7	1476	11	,	,	,
cord-005453-4057qib7	1476	12	CSA+MMF	CSA+MMF	NNP
cord-005453-4057qib7	1476	13	:	:	:
cord-005453-4057qib7	1477	1	2(%8	2(%8	LS
cord-005453-4057qib7	1477	2	)	)	-RRB-
cord-005453-4057qib7	1477	3	,	,	,
cord-005453-4057qib7	1477	4	CSA	CSA	NNP
cord-005453-4057qib7	1477	5	only	only	RB
cord-005453-4057qib7	1477	6	:	:	:
cord-005453-4057qib7	1477	7	1(%4	1(%4	LS
cord-005453-4057qib7	1477	8	)	)	-RRB-
cord-005453-4057qib7	1477	9	.	.	.
cord-005453-4057qib7	1478	1	ATG	ATG	NNP
cord-005453-4057qib7	1478	2	was	be	VBD
cord-005453-4057qib7	1478	3	given	give	VBN
cord-005453-4057qib7	1478	4	20	20	CD
cord-005453-4057qib7	1478	5	patients	patient	NNS
cord-005453-4057qib7	1478	6	.	.	.
cord-005453-4057qib7	1479	1	Despite	despite	IN
cord-005453-4057qib7	1479	2	been	be	VBN
cord-005453-4057qib7	1479	3	given	give	VBN
cord-005453-4057qib7	1480	1	GVHD	GVHD	NNP
cord-005453-4057qib7	1480	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1480	3	47(%27,1	47(%27,1	CD
cord-005453-4057qib7	1480	4	)	)	-RRB-
cord-005453-4057qib7	1480	5	patients	patient	NNS
cord-005453-4057qib7	1480	6	out	out	IN
cord-005453-4057qib7	1480	7	of	of	IN
cord-005453-4057qib7	1480	8	173	173	CD
cord-005453-4057qib7	1480	9	transplanted	transplant	VBN
cord-005453-4057qib7	1480	10	patients	patient	NNS
cord-005453-4057qib7	1480	11	had	have	VBD
cord-005453-4057qib7	1480	12	GVHD	GVHD	NNP
cord-005453-4057qib7	1480	13	features	feature	NNS
cord-005453-4057qib7	1480	14	.	.	.
cord-005453-4057qib7	1481	1	Of	of	IN
cord-005453-4057qib7	1481	2	47	47	CD
cord-005453-4057qib7	1481	3	patients	patient	NNS
cord-005453-4057qib7	1481	4	,	,	,
cord-005453-4057qib7	1481	5	25	25	CD
cord-005453-4057qib7	1481	6	had	have	VBD
cord-005453-4057qib7	1481	7	experienced	experience	VBN
cord-005453-4057qib7	1481	8	steroid	steroid	NN
cord-005453-4057qib7	1481	9	resistant	resistant	JJ
cord-005453-4057qib7	1481	10	GVHD	GVHD	NNP
cord-005453-4057qib7	1481	11	after	after	IN
cord-005453-4057qib7	1481	12	transplantation	transplantation	NN
cord-005453-4057qib7	1481	13	,	,	,
cord-005453-4057qib7	1481	14	including	include	VBG
cord-005453-4057qib7	1481	15	17	17	CD
cord-005453-4057qib7	1481	16	(	(	-LRB-
cord-005453-4057qib7	1481	17	%	%	NN
cord-005453-4057qib7	1481	18	68	68	CD
cord-005453-4057qib7	1481	19	)	)	-RRB-
cord-005453-4057qib7	1481	20	grade	grade	NN
cord-005453-4057qib7	1481	21	3	3	CD
cord-005453-4057qib7	1481	22	and	and	CC
cord-005453-4057qib7	1481	23	8	8	CD
cord-005453-4057qib7	1481	24	(	(	-LRB-
cord-005453-4057qib7	1481	25	%	%	NN
cord-005453-4057qib7	1481	26	32	32	CD
cord-005453-4057qib7	1481	27	)	)	-RRB-
cord-005453-4057qib7	1481	28	grade	grade	NN
cord-005453-4057qib7	1481	29	4	4	CD
cord-005453-4057qib7	1481	30	.	.	.
cord-005453-4057qib7	1482	1	ECP	ECP	NNP
cord-005453-4057qib7	1482	2	treatment	treatment	NN
cord-005453-4057qib7	1482	3	was	be	VBD
cord-005453-4057qib7	1482	4	started	start	VBN
cord-005453-4057qib7	1482	5	mean	mean	JJ
cord-005453-4057qib7	1482	6	11	11	CD
cord-005453-4057qib7	1482	7	days	day	NNS
cord-005453-4057qib7	1482	8	after	after	IN
cord-005453-4057qib7	1482	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	1482	10	of	of	IN
cord-005453-4057qib7	1482	11	steroid	steroid	NN
cord-005453-4057qib7	1482	12	resistant	resistant	JJ
cord-005453-4057qib7	1482	13	GVHD	GVHD	NNP
cord-005453-4057qib7	1482	14	and	and	CC
cord-005453-4057qib7	1482	15	2	2	CD
cord-005453-4057qib7	1482	16	(	(	-LRB-
cord-005453-4057qib7	1482	17	%	%	NN
cord-005453-4057qib7	1482	18	8	8	CD
cord-005453-4057qib7	1482	19	)	)	-RRB-
cord-005453-4057qib7	1482	20	patients	patient	NNS
cord-005453-4057qib7	1482	21	had	have	VBD
cord-005453-4057qib7	1482	22	complete	complete	JJ
cord-005453-4057qib7	1482	23	response	response	NN
cord-005453-4057qib7	1482	24	while	while	IN
cord-005453-4057qib7	1482	25	12	12	CD
cord-005453-4057qib7	1482	26	(	(	-LRB-
cord-005453-4057qib7	1482	27	%	%	NN
cord-005453-4057qib7	1482	28	48	48	CD
cord-005453-4057qib7	1482	29	)	)	-RRB-
cord-005453-4057qib7	1482	30	patients	patient	NNS
cord-005453-4057qib7	1482	31	had	have	VBD
cord-005453-4057qib7	1482	32	partial	partial	JJ
cord-005453-4057qib7	1482	33	and	and	CC
cord-005453-4057qib7	1482	34	11	11	CD
cord-005453-4057qib7	1482	35	(	(	-LRB-
cord-005453-4057qib7	1482	36	%	%	NN
cord-005453-4057qib7	1482	37	44	44	CD
cord-005453-4057qib7	1482	38	)	)	-RRB-
cord-005453-4057qib7	1483	1	patients	patient	NNS
cord-005453-4057qib7	1483	2	had	have	VBD
cord-005453-4057qib7	1483	3	no	no	DT
cord-005453-4057qib7	1483	4	response	response	NN
cord-005453-4057qib7	1483	5	to	to	IN
cord-005453-4057qib7	1483	6	ECP	ECP	NNP
cord-005453-4057qib7	1483	7	treatment	treatment	NN
cord-005453-4057qib7	1483	8	on	on	IN
cord-005453-4057qib7	1483	9	day	day	NN
cord-005453-4057qib7	1483	10	28	28	CD
cord-005453-4057qib7	1483	11	.	.	.
cord-005453-4057qib7	1484	1	Sixteen	sixteen	CD
cord-005453-4057qib7	1484	2	out	out	IN
cord-005453-4057qib7	1484	3	of	of	IN
cord-005453-4057qib7	1484	4	25	25	CD
cord-005453-4057qib7	1484	5	patients	patient	NNS
cord-005453-4057qib7	1484	6	had	have	VBD
cord-005453-4057qib7	1484	7	also	also	RB
cord-005453-4057qib7	1484	8	received	receive	VBN
cord-005453-4057qib7	1484	9	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	1484	10	stem	stem	NN
cord-005453-4057qib7	1484	11	cell	cell	NN
cord-005453-4057qib7	1484	12	therapy	therapy	NN
cord-005453-4057qib7	1484	13	as	as	IN
cord-005453-4057qib7	1484	14	salvage	salvage	NN
cord-005453-4057qib7	1484	15	therapy	therapy	NN
cord-005453-4057qib7	1484	16	.	.	.
cord-005453-4057qib7	1485	1	Only	only	RB
cord-005453-4057qib7	1485	2	one	one	CD
cord-005453-4057qib7	1485	3	patient	patient	NN
cord-005453-4057qib7	1485	4	had	have	VBD
cord-005453-4057qib7	1485	5	experienced	experience	VBN
cord-005453-4057qib7	1485	6	hypocalcemic	hypocalcemic	NNP
cord-005453-4057qib7	1485	7	tetany	tetany	NN
cord-005453-4057qib7	1485	8	,	,	,
cord-005453-4057qib7	1485	9	a	a	DT
cord-005453-4057qib7	1485	10	complication	complication	NN
cord-005453-4057qib7	1485	11	of	of	IN
cord-005453-4057qib7	1485	12	ECP	ECP	NNP
cord-005453-4057qib7	1485	13	procedure	procedure	NN
cord-005453-4057qib7	1485	14	.	.	.
cord-005453-4057qib7	1486	1	Thirteen	thirteen	CD
cord-005453-4057qib7	1486	2	patients	patient	NNS
cord-005453-4057qib7	1486	3	had	have	VBD
cord-005453-4057qib7	1486	4	died	die	VBN
cord-005453-4057qib7	1486	5	and	and	CC
cord-005453-4057qib7	1486	6	12	12	CD
cord-005453-4057qib7	1486	7	were	be	VBD
cord-005453-4057qib7	1486	8	directly	directly	RB
cord-005453-4057qib7	1486	9	related	relate	VBN
cord-005453-4057qib7	1486	10	with	with	IN
cord-005453-4057qib7	1486	11	steroid	steroid	NN
cord-005453-4057qib7	1486	12	resistant	resistant	JJ
cord-005453-4057qib7	1486	13	GVHD	GVHD	NNP
cord-005453-4057qib7	1486	14	.	.	.
cord-005453-4057qib7	1487	1	Other	other	JJ
cord-005453-4057qib7	1487	2	conditions	condition	NNS
cord-005453-4057qib7	1487	3	like	like	IN
cord-005453-4057qib7	1487	4	relapse	relapse	NN
cord-005453-4057qib7	1487	5	of	of	IN
cord-005453-4057qib7	1487	6	primary	primary	JJ
cord-005453-4057qib7	1487	7	disease	disease	NN
cord-005453-4057qib7	1487	8	or	or	CC
cord-005453-4057qib7	1487	9	PRES	PRES	NNP
cord-005453-4057qib7	1487	10	syndrome	syndrome	NN
cord-005453-4057qib7	1487	11	also	also	RB
cord-005453-4057qib7	1487	12	played	play	VBD
cord-005453-4057qib7	1487	13	role	role	NN
cord-005453-4057qib7	1487	14	in	in	IN
cord-005453-4057qib7	1487	15	death	death	NN
cord-005453-4057qib7	1487	16	.	.	.
cord-005453-4057qib7	1488	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1488	2	:	:	:
cord-005453-4057qib7	1489	1	Extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	1489	2	photopheresis	photopheresis	NN
cord-005453-4057qib7	1489	3	is	be	VBZ
cord-005453-4057qib7	1489	4	a	a	DT
cord-005453-4057qib7	1489	5	reliable	reliable	JJ
cord-005453-4057qib7	1489	6	and	and	CC
cord-005453-4057qib7	1489	7	effective	effective	JJ
cord-005453-4057qib7	1489	8	second	second	JJ
cord-005453-4057qib7	1489	9	line	line	NN
cord-005453-4057qib7	1489	10	treatment	treatment	NN
cord-005453-4057qib7	1489	11	modality	modality	NN
cord-005453-4057qib7	1489	12	in	in	IN
cord-005453-4057qib7	1489	13	steroid	steroid	NN
cord-005453-4057qib7	1489	14	resistant	resistant	JJ
cord-005453-4057qib7	1489	15	GVHD	GVHD	NNP
cord-005453-4057qib7	1489	16	.	.	.
cord-005453-4057qib7	1490	1	Starting	start	VBG
cord-005453-4057qib7	1490	2	ECP	ECP	NNP
cord-005453-4057qib7	1490	3	sessions	session	NNS
cord-005453-4057qib7	1490	4	as	as	RB
cord-005453-4057qib7	1490	5	soon	soon	RB
cord-005453-4057qib7	1490	6	as	as	IN
cord-005453-4057qib7	1490	7	GVHD	GVHD	NNP
cord-005453-4057qib7	1490	8	symptoms	symptom	NNS
cord-005453-4057qib7	1490	9	occur	occur	VBP
cord-005453-4057qib7	1490	10	increases	increase	VBZ
cord-005453-4057qib7	1490	11	its	-PRON-	PRP$
cord-005453-4057qib7	1490	12	effectivity	effectivity	NN
cord-005453-4057qib7	1490	13	.	.	.
cord-005453-4057qib7	1491	1	Mesenchymal	Mesenchymal	NNS
cord-005453-4057qib7	1491	2	stem	stem	VBP
cord-005453-4057qib7	1491	3	cell	cell	NN
cord-005453-4057qib7	1491	4	administration	administration	NN
cord-005453-4057qib7	1491	5	with	with	IN
cord-005453-4057qib7	1491	6	ECP	ECP	NNP
cord-005453-4057qib7	1491	7	for	for	IN
cord-005453-4057qib7	1491	8	16	16	CD
cord-005453-4057qib7	1491	9	(	(	-LRB-
cord-005453-4057qib7	1491	10	%	%	NN
cord-005453-4057qib7	1491	11	64	64	CD
cord-005453-4057qib7	1491	12	)	)	-RRB-
cord-005453-4057qib7	1491	13	patients	patient	NNS
cord-005453-4057qib7	1491	14	limits	limit	VBZ
cord-005453-4057qib7	1491	15	our	-PRON-	PRP$
cord-005453-4057qib7	1491	16	study	study	NN
cord-005453-4057qib7	1491	17	to	to	TO
cord-005453-4057qib7	1491	18	reach	reach	VB
cord-005453-4057qib7	1491	19	o	o	NN
cord-005453-4057qib7	1491	20	conclusion	conclusion	NN
cord-005453-4057qib7	1491	21	for	for	IN
cord-005453-4057qib7	1491	22	efficacy	efficacy	NN
cord-005453-4057qib7	1491	23	of	of	IN
cord-005453-4057qib7	1491	24	ECP	ECP	NNP
cord-005453-4057qib7	1491	25	itself	-PRON-	PRP
cord-005453-4057qib7	1491	26	.	.	.
cord-005453-4057qib7	1492	1	Need	need	VB
cord-005453-4057qib7	1492	2	for	for	IN
cord-005453-4057qib7	1492	3	hemodialysis	hemodialysis	NN
cord-005453-4057qib7	1492	4	catheters	catheter	NNS
cord-005453-4057qib7	1492	5	,	,	,
cord-005453-4057qib7	1492	6	the	the	DT
cord-005453-4057qib7	1492	7	prolonged	prolonged	JJ
cord-005453-4057qib7	1492	8	sessions	session	NNS
cord-005453-4057qib7	1492	9	while	while	IN
cord-005453-4057qib7	1492	10	adequate	adequate	JJ
cord-005453-4057qib7	1492	11	flow	flow	NN
cord-005453-4057qib7	1492	12	is	be	VBZ
cord-005453-4057qib7	1492	13	not	not	RB
cord-005453-4057qib7	1492	14	possible	possible	JJ
cord-005453-4057qib7	1492	15	and	and	CC
cord-005453-4057qib7	1492	16	catheter	catheter	NN
cord-005453-4057qib7	1492	17	related	related	JJ
cord-005453-4057qib7	1492	18	infections	infection	NNS
cord-005453-4057qib7	1492	19	are	be	VBP
cord-005453-4057qib7	1492	20	the	the	DT
cord-005453-4057qib7	1492	21	lmitations	lmitation	NNS
cord-005453-4057qib7	1492	22	for	for	IN
cord-005453-4057qib7	1492	23	feasibility	feasibility	NN
cord-005453-4057qib7	1492	24	of	of	IN
cord-005453-4057qib7	1492	25	ECP	ECP	NNP
cord-005453-4057qib7	1492	26	.	.	.
cord-005453-4057qib7	1493	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1493	2	:	:	:
cord-005453-4057qib7	1493	3	nothing	nothing	NN
cord-005453-4057qib7	1493	4	to	to	TO
cord-005453-4057qib7	1493	5	declare	declare	VB
cord-005453-4057qib7	1493	6	Donor	donor	NN
cord-005453-4057qib7	1493	7	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1493	8	infusion	infusion	NN
cord-005453-4057qib7	1493	9	administrations	administration	NNS
cord-005453-4057qib7	1493	10	after	after	IN
cord-005453-4057qib7	1493	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	1493	12	stem	stem	NN
cord-005453-4057qib7	1493	13	cell	cell	NN
cord-005453-4057qib7	1493	14	transplantations	transplantation	NNS
cord-005453-4057qib7	1493	15	in	in	IN
cord-005453-4057qib7	1493	16	pediatrics	pediatric	NNS
cord-005453-4057qib7	1493	17	:	:	:
cord-005453-4057qib7	1494	1	A	a	DT
cord-005453-4057qib7	1494	2	single	single	JJ
cord-005453-4057qib7	1494	3	center	center	NN
cord-005453-4057qib7	1494	4	experience	experience	NN
cord-005453-4057qib7	1495	1	Background	background	NN
cord-005453-4057qib7	1495	2	:	:	:
cord-005453-4057qib7	1496	1	Loss	loss	NN
cord-005453-4057qib7	1496	2	of	of	IN
cord-005453-4057qib7	1496	3	chimerism	chimerism	NN
cord-005453-4057qib7	1496	4	is	be	VBZ
cord-005453-4057qib7	1496	5	one	one	CD
cord-005453-4057qib7	1496	6	of	of	IN
cord-005453-4057qib7	1496	7	the	the	DT
cord-005453-4057qib7	1496	8	major	major	JJ
cord-005453-4057qib7	1496	9	problems	problem	NNS
cord-005453-4057qib7	1496	10	after	after	IN
cord-005453-4057qib7	1496	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	1496	12	stem	stem	NN
cord-005453-4057qib7	1496	13	cell	cell	NN
cord-005453-4057qib7	1496	14	transplantation(SCT	transplantation(sct	NN
cord-005453-4057qib7	1496	15	)	)	-RRB-
cord-005453-4057qib7	1496	16	.	.	.
cord-005453-4057qib7	1497	1	Donor	donor	NN
cord-005453-4057qib7	1497	2	-	-	HYPH
cord-005453-4057qib7	1497	3	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1497	4	infusions(DLI	infusions(DLI	NNS
cord-005453-4057qib7	1497	5	)	)	-RRB-
cord-005453-4057qib7	1497	6	are	be	VBP
cord-005453-4057qib7	1497	7	used	use	VBN
cord-005453-4057qib7	1497	8	as	as	IN
cord-005453-4057qib7	1497	9	a	a	DT
cord-005453-4057qib7	1497	10	treatment	treatment	NN
cord-005453-4057qib7	1497	11	after	after	IN
cord-005453-4057qib7	1497	12	taper	taper	NN
cord-005453-4057qib7	1497	13	or	or	CC
cord-005453-4057qib7	1497	14	stopping	stop	VBG
cord-005453-4057qib7	1497	15	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1497	16	.	.	.
cord-005453-4057qib7	1498	1	In	in	IN
cord-005453-4057qib7	1498	2	this	this	DT
cord-005453-4057qib7	1498	3	study	study	NN
cord-005453-4057qib7	1498	4	,	,	,
cord-005453-4057qib7	1498	5	DLI	DLI	NNP
cord-005453-4057qib7	1498	6	experience	experience	NN
cord-005453-4057qib7	1498	7	in	in	IN
cord-005453-4057qib7	1498	8	20	20	CD
cord-005453-4057qib7	1498	9	patients	patient	NNS
cord-005453-4057qib7	1498	10	with	with	IN
cord-005453-4057qib7	1498	11	loss	loss	NN
cord-005453-4057qib7	1498	12	of	of	IN
cord-005453-4057qib7	1498	13	chimerism	chimerism	NN
cord-005453-4057qib7	1498	14	after	after	IN
cord-005453-4057qib7	1498	15	SCT	SCT	NNP
cord-005453-4057qib7	1498	16	due	due	IN
cord-005453-4057qib7	1498	17	to	to	IN
cord-005453-4057qib7	1498	18	various	various	JJ
cord-005453-4057qib7	1498	19	benign	benign	JJ
cord-005453-4057qib7	1498	20	and	and	CC
cord-005453-4057qib7	1498	21	malign	malign	JJ
cord-005453-4057qib7	1498	22	hematological	hematological	JJ
cord-005453-4057qib7	1498	23	diseases	disease	NNS
cord-005453-4057qib7	1498	24	was	be	VBD
cord-005453-4057qib7	1498	25	presented	present	VBN
cord-005453-4057qib7	1498	26	.	.	.
cord-005453-4057qib7	1499	1	Methods	method	NNS
cord-005453-4057qib7	1499	2	:	:	:
cord-005453-4057qib7	1499	3	Between	between	IN
cord-005453-4057qib7	1499	4	July	July	NNP
cord-005453-4057qib7	1499	5	2015-August	2015-august	CD
cord-005453-4057qib7	1499	6	2018	2018	CD
cord-005453-4057qib7	1499	7	,	,	,
cord-005453-4057qib7	1499	8	twenty	twenty	CD
cord-005453-4057qib7	1499	9	patients	patient	NNS
cord-005453-4057qib7	1499	10	,	,	,
cord-005453-4057qib7	1499	11	detected	detect	VBD
cord-005453-4057qib7	1499	12	chimerism	chimerism	NN
cord-005453-4057qib7	1499	13	loss	loss	NN
cord-005453-4057qib7	1499	14	and	and	CC
cord-005453-4057qib7	1499	15	received	receive	VBD
cord-005453-4057qib7	1499	16	DLI	DLI	NNP
cord-005453-4057qib7	1499	17	after	after	IN
cord-005453-4057qib7	1499	18	SCT	SCT	NNP
cord-005453-4057qib7	1499	19	were	be	VBD
cord-005453-4057qib7	1499	20	evaluated	evaluate	VBN
cord-005453-4057qib7	1499	21	retrospectively	retrospectively	RB
cord-005453-4057qib7	1499	22	.	.	.
cord-005453-4057qib7	1500	1	Patients	patient	NNS
cord-005453-4057qib7	1500	2	received	receive	VBD
cord-005453-4057qib7	1500	3	myeloablative	myeloablative	JJ
cord-005453-4057qib7	1500	4	or	or	CC
cord-005453-4057qib7	1500	5	reduced	reduced	JJ
cord-005453-4057qib7	1500	6	intensity	intensity	NN
cord-005453-4057qib7	1500	7	conditioning	conditioning	NN
cord-005453-4057qib7	1500	8	,	,	,
cord-005453-4057qib7	1500	9	ATG	ATG	NNP
cord-005453-4057qib7	1500	10	,	,	,
cord-005453-4057qib7	1500	11	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	1500	12	A	a	NN
cord-005453-4057qib7	1500	13	and	and	CC
cord-005453-4057qib7	1500	14	methotrexate	methotrexate	NN
cord-005453-4057qib7	1500	15	for	for	IN
cord-005453-4057qib7	1500	16	GVHD	GVHD	NNP
cord-005453-4057qib7	1500	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1500	18	.	.	.
cord-005453-4057qib7	1501	1	Chimerism	chimerism	NN
cord-005453-4057qib7	1501	2	analyses	analysis	NNS
cord-005453-4057qib7	1501	3	were	be	VBD
cord-005453-4057qib7	1501	4	performed	perform	VBN
cord-005453-4057qib7	1501	5	with	with	IN
cord-005453-4057qib7	1501	6	short	short	JJ
cord-005453-4057qib7	1501	7	tandem	tandem	NN
cord-005453-4057qib7	1502	1	repeat(STR	repeat(str	LS
cord-005453-4057qib7	1502	2	)	)	-RRB-
cord-005453-4057qib7	1502	3	method	method	NN
cord-005453-4057qib7	1502	4	from	from	IN
cord-005453-4057qib7	1502	5	peripheral	peripheral	JJ
cord-005453-4057qib7	1502	6	blood	blood	NN
cord-005453-4057qib7	1502	7	.	.	.
cord-005453-4057qib7	1503	1	Results	result	NNS
cord-005453-4057qib7	1503	2	below	below	IN
cord-005453-4057qib7	1503	3	95	95	CD
cord-005453-4057qib7	1503	4	%	%	NN
cord-005453-4057qib7	1503	5	were	be	VBD
cord-005453-4057qib7	1503	6	considered	consider	VBN
cord-005453-4057qib7	1503	7	as	as	RB
cord-005453-4057qib7	1503	8	mixed	mixed	JJ
cord-005453-4057qib7	1503	9	chimeric	chimeric	JJ
cord-005453-4057qib7	1503	10	and	and	CC
cord-005453-4057qib7	1503	11	below	below	IN
cord-005453-4057qib7	1503	12	%	%	NN
cord-005453-4057qib7	1503	13	5	5	CD
cord-005453-4057qib7	1503	14	were	be	VBD
cord-005453-4057qib7	1503	15	nonchimeric	nonchimeric	JJ
cord-005453-4057qib7	1503	16	.	.	.
cord-005453-4057qib7	1504	1	When	when	WRB
cord-005453-4057qib7	1504	2	patients	patient	NNS
cord-005453-4057qib7	1504	3	considered	consider	VBN
cord-005453-4057qib7	1504	4	as	as	IN
cord-005453-4057qib7	1504	5	mixed	mixed	JJ
cord-005453-4057qib7	1504	6	chimeric	chimeric	JJ
cord-005453-4057qib7	1504	7	,	,	,
cord-005453-4057qib7	1504	8	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1504	9	therapy	therapy	NN
cord-005453-4057qib7	1504	10	was	be	VBD
cord-005453-4057qib7	1504	11	ceased	cease	VBN
cord-005453-4057qib7	1504	12	immediately	immediately	RB
cord-005453-4057qib7	1504	13	and	and	CC
cord-005453-4057qib7	1504	14	treated	treat	VBN
cord-005453-4057qib7	1504	15	with	with	IN
cord-005453-4057qib7	1504	16	DLI	DLI	NNP
cord-005453-4057qib7	1504	17	.	.	.
cord-005453-4057qib7	1505	1	Donor	donor	NN
cord-005453-4057qib7	1505	2	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1505	3	infusions	infusion	NNS
cord-005453-4057qib7	1505	4	were	be	VBD
cord-005453-4057qib7	1505	5	performed	perform	VBN
cord-005453-4057qib7	1505	6	at	at	IN
cord-005453-4057qib7	1505	7	two	two	CD
cord-005453-4057qib7	1505	8	-	-	HYPH
cord-005453-4057qib7	1505	9	week	week	NN
cord-005453-4057qib7	1505	10	intervals	interval	NNS
cord-005453-4057qib7	1505	11	with	with	IN
cord-005453-4057qib7	1505	12	chimerism	chimerism	NN
cord-005453-4057qib7	1505	13	follow	follow	NN
cord-005453-4057qib7	1505	14	-	-	HYPH
cord-005453-4057qib7	1505	15	up	up	NN
cord-005453-4057qib7	1505	16	.	.	.
cord-005453-4057qib7	1506	1	Student	student	NN
cord-005453-4057qib7	1506	2	T	T	NNP
cord-005453-4057qib7	1506	3	,	,	,
cord-005453-4057qib7	1506	4	Mann	Mann	NNP
cord-005453-4057qib7	1506	5	Whitney	Whitney	NNP
cord-005453-4057qib7	1506	6	U	U	NNP
cord-005453-4057qib7	1506	7	,	,	,
cord-005453-4057qib7	1506	8	Ki	Ki	NNP
cord-005453-4057qib7	1506	9	Kare	Kare	NNP
cord-005453-4057qib7	1506	10	tests	test	VBZ
cord-005453-4057qib7	1506	11	and	and	CC
cord-005453-4057qib7	1506	12	Kaplan	Kaplan	NNP
cord-005453-4057qib7	1506	13	-	-	HYPH
cord-005453-4057qib7	1506	14	Meier	Meier	NNP
cord-005453-4057qib7	1506	15	analysis	analysis	NN
cord-005453-4057qib7	1506	16	were	be	VBD
cord-005453-4057qib7	1506	17	used	use	VBN
cord-005453-4057qib7	1506	18	.	.	.
cord-005453-4057qib7	1507	1	Results	result	NNS
cord-005453-4057qib7	1507	2	:	:	:
cord-005453-4057qib7	1508	1	Between	between	IN
cord-005453-4057qib7	1508	2	1	1	CD
cord-005453-4057qib7	1508	3	-	-	SYM
cord-005453-4057qib7	1508	4	16	16	CD
cord-005453-4057qib7	1508	5	ages	age	NNS
cord-005453-4057qib7	1508	6	(	(	-LRB-
cord-005453-4057qib7	1508	7	median	median	NN
cord-005453-4057qib7	1508	8	4	4	CD
cord-005453-4057qib7	1508	9	)	)	-RRB-
cord-005453-4057qib7	1508	10	,	,	,
cord-005453-4057qib7	1508	11	7	7	CD
cord-005453-4057qib7	1508	12	female	female	JJ
cord-005453-4057qib7	1508	13	,	,	,
cord-005453-4057qib7	1508	14	13	13	CD
cord-005453-4057qib7	1508	15	male	male	JJ
cord-005453-4057qib7	1508	16	patients	patient	NNS
cord-005453-4057qib7	1508	17	were	be	VBD
cord-005453-4057qib7	1508	18	evaluated	evaluate	VBN
cord-005453-4057qib7	1508	19	.	.	.
cord-005453-4057qib7	1509	1	The	the	DT
cord-005453-4057qib7	1509	2	initial	initial	JJ
cord-005453-4057qib7	1509	3	diagnoses	diagnosis	NNS
cord-005453-4057qib7	1509	4	were	be	VBD
cord-005453-4057qib7	1509	5	thalassemia	thalassemia	NN
cord-005453-4057qib7	1509	6	major(10	major(10	NNP
cord-005453-4057qib7	1509	7	)	)	-RRB-
cord-005453-4057qib7	1509	8	,	,	,
cord-005453-4057qib7	1509	9	aplastic	aplastic	JJ
cord-005453-4057qib7	1509	10	anemia	anemia	NN
cord-005453-4057qib7	1509	11	(	(	-LRB-
cord-005453-4057qib7	1509	12	3),ALL(4	3),all(4	NN
cord-005453-4057qib7	1509	13	)	)	-RRB-
cord-005453-4057qib7	1509	14	,	,	,
cord-005453-4057qib7	1509	15	AML	AML	NNP
cord-005453-4057qib7	1509	16	(	(	-LRB-
cord-005453-4057qib7	1509	17	3	3	CD
cord-005453-4057qib7	1509	18	)	)	-RRB-
cord-005453-4057qib7	1509	19	.	.	.
cord-005453-4057qib7	1510	1	DLI	DLI	NNP
cord-005453-4057qib7	1510	2	initiation	initiation	NN
cord-005453-4057qib7	1510	3	time	time	NN
cord-005453-4057qib7	1510	4	was	be	VBD
cord-005453-4057qib7	1510	5	119.65	119.65	CD
cord-005453-4057qib7	1510	6	+	+	SYM
cord-005453-4057qib7	1510	7	-92.71	-92.71	NN
cord-005453-4057qib7	1510	8	days	day	NNS
cord-005453-4057qib7	1510	9	after	after	IN
cord-005453-4057qib7	1510	10	SCT	SCT	NNP
cord-005453-4057qib7	1510	11	,	,	,
cord-005453-4057qib7	1510	12	total	total	JJ
cord-005453-4057qib7	1510	13	number	number	NN
cord-005453-4057qib7	1510	14	of	of	IN
cord-005453-4057qib7	1510	15	DLI	DLI	NNP
cord-005453-4057qib7	1510	16	administrations	administration	NNS
cord-005453-4057qib7	1510	17	were	be	VBD
cord-005453-4057qib7	1510	18	3.5	3.5	CD
cord-005453-4057qib7	1510	19	+	+	CD
cord-005453-4057qib7	1510	20	-2.19	-2.19	CD
cord-005453-4057qib7	1510	21	.	.	.
cord-005453-4057qib7	1511	1	Dose	dose	NN
cord-005453-4057qib7	1511	2	of	of	IN
cord-005453-4057qib7	1511	3	DLI	DLI	NNP
cord-005453-4057qib7	1511	4	was	be	VBD
cord-005453-4057qib7	1511	5	1X10	1x10	CD
cord-005453-4057qib7	1511	6	5	5	CD
cord-005453-4057qib7	1511	7	-63.6x10	-63.6x10	CD
cord-005453-4057qib7	1511	8	6	6	CD
cord-005453-4057qib7	1512	1	/kg	/kg	.
cord-005453-4057qib7	1513	1	(	(	-LRB-
cord-005453-4057qib7	1513	2	mean	mean	VB
cord-005453-4057qib7	1513	3	20.5x10	20.5x10	CD
cord-005453-4057qib7	1513	4	6	6	CD
cord-005453-4057qib7	1513	5	/kg	/kg	.
cord-005453-4057qib7	1513	6	)	)	-RRB-
cord-005453-4057qib7	1513	7	.	.	.
cord-005453-4057qib7	1514	1	Nine	nine	CD
cord-005453-4057qib7	1514	2	patients	patient	NNS
cord-005453-4057qib7	1514	3	'	'	POS
cord-005453-4057qib7	1514	4	chimerism	chimerism	NN
cord-005453-4057qib7	1514	5	out	out	IN
cord-005453-4057qib7	1514	6	of	of	IN
cord-005453-4057qib7	1514	7	20	20	CD
cord-005453-4057qib7	1514	8	,	,	,
cord-005453-4057qib7	1514	9	fell	fall	VBD
cord-005453-4057qib7	1514	10	below	below	IN
cord-005453-4057qib7	1514	11	95	95	CD
cord-005453-4057qib7	1514	12	%	%	NN
cord-005453-4057qib7	1514	13	at	at	IN
cord-005453-4057qib7	1514	14	first	first	JJ
cord-005453-4057qib7	1514	15	month	month	NN
cord-005453-4057qib7	1514	16	after	after	IN
cord-005453-4057qib7	1514	17	transplant	transplant	NN
cord-005453-4057qib7	1514	18	;	;	:
cord-005453-4057qib7	1514	19	4	4	CD
cord-005453-4057qib7	1514	20	patients	patient	NNS
cord-005453-4057qib7	1514	21	were	be	VBD
cord-005453-4057qib7	1514	22	nonchimeric	nonchimeric	JJ
cord-005453-4057qib7	1514	23	,	,	,
cord-005453-4057qib7	1514	24	2	2	CD
cord-005453-4057qib7	1514	25	of	of	IN
cord-005453-4057qib7	1514	26	them	-PRON-	PRP
cord-005453-4057qib7	1514	27	were	be	VBD
cord-005453-4057qib7	1514	28	complet	complet	JJ
cord-005453-4057qib7	1514	29	chimeric	chimeric	JJ
cord-005453-4057qib7	1514	30	and	and	CC
cord-005453-4057qib7	1514	31	3	3	CD
cord-005453-4057qib7	1514	32	were	be	VBD
cord-005453-4057qib7	1514	33	mixed	mix	VBN
cord-005453-4057qib7	1514	34	chimeric	chimeric	JJ
cord-005453-4057qib7	1514	35	.	.	.
cord-005453-4057qib7	1515	1	Eleven	eleven	CD
cord-005453-4057qib7	1515	2	patients´chimerism	patients´chimerism	NN
cord-005453-4057qib7	1515	3	were	be	VBD
cord-005453-4057qib7	1515	4	below	below	IN
cord-005453-4057qib7	1515	5	95	95	CD
cord-005453-4057qib7	1515	6	%	%	NN
cord-005453-4057qib7	1515	7	between	between	IN
cord-005453-4057qib7	1515	8	1	1	CD
cord-005453-4057qib7	1515	9	-	-	SYM
cord-005453-4057qib7	1515	10	6	6	CD
cord-005453-4057qib7	1515	11	months	month	NNS
cord-005453-4057qib7	1515	12	after	after	IN
cord-005453-4057qib7	1515	13	SCT	SCT	NNP
cord-005453-4057qib7	1515	14	,	,	,
cord-005453-4057qib7	1515	15	5	5	CD
cord-005453-4057qib7	1515	16	patients	patient	NNS
cord-005453-4057qib7	1515	17	were	be	VBD
cord-005453-4057qib7	1515	18	nonchimeric	nonchimeric	JJ
cord-005453-4057qib7	1515	19	and	and	CC
cord-005453-4057qib7	1515	20	6	6	CD
cord-005453-4057qib7	1515	21	were	be	VBD
cord-005453-4057qib7	1515	22	mixed	mix	VBN
cord-005453-4057qib7	1515	23	chimeric	chimeric	JJ
cord-005453-4057qib7	1515	24	.	.	.
cord-005453-4057qib7	1516	1	Early	early	JJ
cord-005453-4057qib7	1516	2	mixed	mixed	JJ
cord-005453-4057qib7	1516	3	chimerism	chimerism	NN
cord-005453-4057qib7	1516	4	was	be	VBD
cord-005453-4057qib7	1516	5	found	find	VBN
cord-005453-4057qib7	1516	6	relevant	relevant	JJ
cord-005453-4057qib7	1516	7	with	with	IN
cord-005453-4057qib7	1516	8	graft	graft	NN
cord-005453-4057qib7	1516	9	rejections	rejection	NNS
cord-005453-4057qib7	1516	10	(	(	-LRB-
cord-005453-4057qib7	1516	11	p=0.04	p=0.04	NNP
cord-005453-4057qib7	1516	12	)	)	-RRB-
cord-005453-4057qib7	1516	13	.	.	.
cord-005453-4057qib7	1517	1	Patients	patient	NNS
cord-005453-4057qib7	1517	2	were	be	VBD
cord-005453-4057qib7	1517	3	followed	follow	VBN
cord-005453-4057qib7	1517	4	up	up	RP
cord-005453-4057qib7	1517	5	for	for	IN
cord-005453-4057qib7	1517	6	91	91	CD
cord-005453-4057qib7	1517	7	-	-	SYM
cord-005453-4057qib7	1517	8	645	645	CD
cord-005453-4057qib7	1517	9	days	day	NNS
cord-005453-4057qib7	1517	10	.	.	.
cord-005453-4057qib7	1518	1	Eight	eight	CD
cord-005453-4057qib7	1518	2	patients	patient	NNS
cord-005453-4057qib7	1518	3	'	'	POS
cord-005453-4057qib7	1518	4	chimerism	chimerism	NN
cord-005453-4057qib7	1518	5	increased	increase	VBD
cord-005453-4057qib7	1518	6	after	after	IN
cord-005453-4057qib7	1518	7	DLI	DLI	NNP
cord-005453-4057qib7	1518	8	infusion	infusion	NN
cord-005453-4057qib7	1518	9	and	and	CC
cord-005453-4057qib7	1518	10	continued	continue	VBD
cord-005453-4057qib7	1518	11	to	to	TO
cord-005453-4057qib7	1518	12	decrease	decrease	VB
cord-005453-4057qib7	1518	13	in	in	IN
cord-005453-4057qib7	1518	14	12	12	CD
cord-005453-4057qib7	1518	15	patients	patient	NNS
cord-005453-4057qib7	1518	16	.	.	.
cord-005453-4057qib7	1519	1	After	after	IN
cord-005453-4057qib7	1519	2	DLI	DLI	NNP
cord-005453-4057qib7	1519	3	,	,	,
cord-005453-4057qib7	1519	4	acute	acute	JJ
cord-005453-4057qib7	1519	5	GVHD	GVHD	NNP
cord-005453-4057qib7	1519	6	has	have	VBZ
cord-005453-4057qib7	1519	7	been	be	VBN
cord-005453-4057qib7	1519	8	seen	see	VBN
cord-005453-4057qib7	1519	9	in	in	IN
cord-005453-4057qib7	1519	10	both	both	DT
cord-005453-4057qib7	1519	11	group	group	NN
cord-005453-4057qib7	1519	12	.	.	.
cord-005453-4057qib7	1520	1	The	the	DT
cord-005453-4057qib7	1520	2	group	group	NN
cord-005453-4057qib7	1520	3	with	with	IN
cord-005453-4057qib7	1520	4	decreased	decrease	VBN
cord-005453-4057qib7	1520	5	chimerism	chimerism	NN
cord-005453-4057qib7	1520	6	after	after	IN
cord-005453-4057qib7	1520	7	DLI	DLI	NNP
cord-005453-4057qib7	1520	8	,	,	,
cord-005453-4057qib7	1520	9	dose	dose	NN
cord-005453-4057qib7	1520	10	was	be	VBD
cord-005453-4057qib7	1520	11	mean	mean	JJ
cord-005453-4057qib7	1520	12	12x10	12x10	CD
cord-005453-4057qib7	1520	13	6	6	CD
cord-005453-4057qib7	1520	14	±23x10	±23x10	CD
cord-005453-4057qib7	1520	15	6	6	CD
cord-005453-4057qib7	1521	1	/kg	/kg	NFP
cord-005453-4057qib7	1521	2	while	while	IN
cord-005453-4057qib7	1521	3	the	the	DT
cord-005453-4057qib7	1521	4	group	group	NN
cord-005453-4057qib7	1521	5	with	with	IN
cord-005453-4057qib7	1521	6	increased	increase	VBN
cord-005453-4057qib7	1521	7	chimerism	chimerism	NN
cord-005453-4057qib7	1521	8	had	have	VBD
cord-005453-4057qib7	1522	1	DLI	DLI	NNP
cord-005453-4057qib7	1522	2	dose	dose	NN
cord-005453-4057qib7	1522	3	mean	mean	JJ
cord-005453-4057qib7	1523	1	22x10	22x10	CD
cord-005453-4057qib7	1523	2	6	6	CD
cord-005453-4057qib7	1523	3	±19x10	±19x10	CD
cord-005453-4057qib7	1523	4	6	6	CD
cord-005453-4057qib7	1524	1	/kg	/kg	NFP
cord-005453-4057qib7	1524	2	.	.	.
cord-005453-4057qib7	1525	1	Although	although	IN
cord-005453-4057qib7	1525	2	the	the	DT
cord-005453-4057qib7	1525	3	difference	difference	NN
cord-005453-4057qib7	1525	4	was	be	VBD
cord-005453-4057qib7	1525	5	not	not	RB
cord-005453-4057qib7	1525	6	statistically	statistically	RB
cord-005453-4057qib7	1525	7	significant	significant	JJ
cord-005453-4057qib7	1525	8	,	,	,
cord-005453-4057qib7	1525	9	numerical	numerical	JJ
cord-005453-4057qib7	1525	10	value	value	NN
cord-005453-4057qib7	1525	11	revealed	reveal	VBD
cord-005453-4057qib7	1525	12	significantly	significantly	RB
cord-005453-4057qib7	1525	13	different	different	JJ
cord-005453-4057qib7	1525	14	.	.	.
cord-005453-4057qib7	1526	1	Eventually10	eventually10	NN
cord-005453-4057qib7	1526	2	patients	patient	NNS
cord-005453-4057qib7	1526	3	out	out	IN
cord-005453-4057qib7	1526	4	of	of	IN
cord-005453-4057qib7	1526	5	20	20	CD
cord-005453-4057qib7	1526	6	were	be	VBD
cord-005453-4057qib7	1526	7	mixed	mix	VBN
cord-005453-4057qib7	1526	8	chimeric	chimeric	JJ
cord-005453-4057qib7	1526	9	,	,	,
cord-005453-4057qib7	1526	10	6	6	CD
cord-005453-4057qib7	1526	11	patients	patient	NNS
cord-005453-4057qib7	1526	12	were	be	VBD
cord-005453-4057qib7	1526	13	complete	complete	JJ
cord-005453-4057qib7	1526	14	chimeric	chimeric	JJ
cord-005453-4057qib7	1526	15	and	and	CC
cord-005453-4057qib7	1526	16	4	4	CD
cord-005453-4057qib7	1526	17	were	be	VBD
cord-005453-4057qib7	1526	18	none	none	NN
cord-005453-4057qib7	1526	19	.	.	.
cord-005453-4057qib7	1527	1	In	in	IN
cord-005453-4057qib7	1527	2	thalassemic	thalassemic	JJ
cord-005453-4057qib7	1527	3	patients	patient	NNS
cord-005453-4057qib7	1527	4	,	,	,
cord-005453-4057qib7	1527	5	7	7	CD
cord-005453-4057qib7	1527	6	patients	patient	NNS
cord-005453-4057qib7	1527	7	with	with	IN
cord-005453-4057qib7	1527	8	thalassemia	thalassemia	NN
cord-005453-4057qib7	1527	9	-	-	HYPH
cord-005453-4057qib7	1527	10	trait	trait	NN
cord-005453-4057qib7	1527	11	donor	donor	NN
cord-005453-4057qib7	1527	12	were	be	VBD
cord-005453-4057qib7	1527	13	mixed	mix	VBN
cord-005453-4057qib7	1527	14	chimeric	chimeric	JJ
cord-005453-4057qib7	1527	15	,	,	,
cord-005453-4057qib7	1527	16	In	in	IN
cord-005453-4057qib7	1527	17	3	3	CD
cord-005453-4057qib7	1527	18	patients	patient	NNS
cord-005453-4057qib7	1527	19	whose	whose	WP$
cord-005453-4057qib7	1527	20	donors	donor	NNS
cord-005453-4057qib7	1527	21	were	be	VBD
cord-005453-4057qib7	1527	22	normal	normal	JJ
cord-005453-4057qib7	1527	23	,	,	,
cord-005453-4057qib7	1527	24	2	2	CD
cord-005453-4057qib7	1527	25	of	of	IN
cord-005453-4057qib7	1527	26	them	-PRON-	PRP
cord-005453-4057qib7	1527	27	were	be	VBD
cord-005453-4057qib7	1527	28	complete	complete	JJ
cord-005453-4057qib7	1527	29	chimeric	chimeric	JJ
cord-005453-4057qib7	1527	30	and	and	CC
cord-005453-4057qib7	1527	31	one	one	CD
cord-005453-4057qib7	1527	32	of	of	IN
cord-005453-4057qib7	1527	33	them	-PRON-	PRP
cord-005453-4057qib7	1527	34	was	be	VBD
cord-005453-4057qib7	1527	35	nonchimeric	nonchimeric	JJ
cord-005453-4057qib7	1527	36	.	.	.
cord-005453-4057qib7	1528	1	The	the	DT
cord-005453-4057qib7	1528	2	difference	difference	NN
cord-005453-4057qib7	1528	3	was	be	VBD
cord-005453-4057qib7	1528	4	significant	significant	JJ
cord-005453-4057qib7	1528	5	(	(	-LRB-
cord-005453-4057qib7	1528	6	p=0.02	p=0.02	NN
cord-005453-4057qib7	1528	7	)	)	-RRB-
cord-005453-4057qib7	1528	8	.	.	.
cord-005453-4057qib7	1529	1	The	the	DT
cord-005453-4057qib7	1529	2	CD34	CD34	NNP
cord-005453-4057qib7	1529	3	infusion	infusion	NN
cord-005453-4057qib7	1529	4	doses	dose	NNS
cord-005453-4057qib7	1529	5	revealed	reveal	VBD
cord-005453-4057qib7	1529	6	mean	mean	JJ
cord-005453-4057qib7	1529	7	6.61	6.61	CD
cord-005453-4057qib7	1529	8	±5.06x10	±5.06x10	NNS
cord-005453-4057qib7	1529	9	6	6	CD
cord-005453-4057qib7	1529	10	/kg	/kg	NN
cord-005453-4057qib7	1529	11	in	in	IN
cord-005453-4057qib7	1529	12	mixed	mixed	JJ
cord-005453-4057qib7	1529	13	chimeric	chimeric	JJ
cord-005453-4057qib7	1529	14	patients	patient	NNS
cord-005453-4057qib7	1529	15	,	,	,
cord-005453-4057qib7	1529	16	7.16±3.31x10	7.16±3.31x10	CD
cord-005453-4057qib7	1529	17	6	6	CD
cord-005453-4057qib7	1529	18	/kg	/kg	NFP
cord-005453-4057qib7	1529	19	in	in	IN
cord-005453-4057qib7	1529	20	complete	complete	JJ
cord-005453-4057qib7	1529	21	chimeric	chimeric	JJ
cord-005453-4057qib7	1529	22	patients	patient	NNS
cord-005453-4057qib7	1529	23	and	and	CC
cord-005453-4057qib7	1529	24	6.625±1.37x10	6.625±1.37x10	NN
cord-005453-4057qib7	1529	25	6	6	CD
cord-005453-4057qib7	1530	1	/kg	/kg	NFP
cord-005453-4057qib7	1530	2	in	in	IN
cord-005453-4057qib7	1530	3	the	the	DT
cord-005453-4057qib7	1530	4	patients	patient	NNS
cord-005453-4057qib7	1530	5	with	with	IN
cord-005453-4057qib7	1530	6	loss	loss	NN
cord-005453-4057qib7	1530	7	of	of	IN
cord-005453-4057qib7	1530	8	chimerism	chimerism	NN
cord-005453-4057qib7	1530	9	.	.	.
cord-005453-4057qib7	1531	1	CD34	CD34	NNP
cord-005453-4057qib7	1531	2	amount	amount	NN
cord-005453-4057qib7	1531	3	was	be	VBD
cord-005453-4057qib7	1531	4	seen	see	VBN
cord-005453-4057qib7	1531	5	high	high	JJ
cord-005453-4057qib7	1531	6	as	as	IN
cord-005453-4057qib7	1531	7	numerical	numerical	JJ
cord-005453-4057qib7	1531	8	value	value	NN
cord-005453-4057qib7	1531	9	in	in	IN
cord-005453-4057qib7	1531	10	complete	complete	JJ
cord-005453-4057qib7	1531	11	chimerics	chimeric	NNS
cord-005453-4057qib7	1531	12	but	but	CC
cord-005453-4057qib7	1531	13	no	no	DT
cord-005453-4057qib7	1531	14	statistical	statistical	JJ
cord-005453-4057qib7	1531	15	significance	significance	NN
cord-005453-4057qib7	1531	16	was	be	VBD
cord-005453-4057qib7	1531	17	found	find	VBN
cord-005453-4057qib7	1531	18	.	.	.
cord-005453-4057qib7	1532	1	Overall	overall	JJ
cord-005453-4057qib7	1532	2	survival	survival	NN
cord-005453-4057qib7	1532	3	was	be	VBD
cord-005453-4057qib7	1532	4	85	85	CD
cord-005453-4057qib7	1532	5	%	%	NN
cord-005453-4057qib7	1532	6	,	,	,
cord-005453-4057qib7	1532	7	disease	disease	NN
cord-005453-4057qib7	1532	8	-	-	HYPH
cord-005453-4057qib7	1532	9	free	free	JJ
cord-005453-4057qib7	1532	10	survival	survival	NN
cord-005453-4057qib7	1532	11	was	be	VBD
cord-005453-4057qib7	1532	12	25	25	CD
cord-005453-4057qib7	1532	13	%	%	NN
cord-005453-4057qib7	1532	14	.	.	.
cord-005453-4057qib7	1533	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1533	2	:	:	:
cord-005453-4057qib7	1534	1	We	-PRON-	PRP
cord-005453-4057qib7	1534	2	evaluated	evaluate	VBD
cord-005453-4057qib7	1534	3	the	the	DT
cord-005453-4057qib7	1534	4	efficacy	efficacy	NN
cord-005453-4057qib7	1534	5	of	of	IN
cord-005453-4057qib7	1534	6	DL	DL	NNP
cord-005453-4057qib7	1534	7	for	for	IN
cord-005453-4057qib7	1534	8	patients	patient	NNS
cord-005453-4057qib7	1534	9	with	with	IN
cord-005453-4057qib7	1534	10	mixed	mixed	JJ
cord-005453-4057qib7	1534	11	chimerism	chimerism	NN
cord-005453-4057qib7	1534	12	in	in	IN
cord-005453-4057qib7	1534	13	our	-PRON-	PRP$
cord-005453-4057qib7	1534	14	patient	patient	JJ
cord-005453-4057qib7	1534	15	group	group	NN
cord-005453-4057qib7	1534	16	.	.	.
cord-005453-4057qib7	1535	1	We	-PRON-	PRP
cord-005453-4057qib7	1535	2	concluded	conclude	VBD
cord-005453-4057qib7	1535	3	that	that	IN
cord-005453-4057qib7	1535	4	chimerism	chimerism	NN
cord-005453-4057qib7	1535	5	loss	loss	NN
cord-005453-4057qib7	1535	6	in	in	IN
cord-005453-4057qib7	1535	7	patients	patient	NNS
cord-005453-4057qib7	1535	8	with	with	IN
cord-005453-4057qib7	1535	9	early	early	JJ
cord-005453-4057qib7	1535	10	decreased	decreased	JJ
cord-005453-4057qib7	1535	11	chimerism	chimerism	NN
cord-005453-4057qib7	1535	12	is	be	VBZ
cord-005453-4057qib7	1535	13	similar	similar	JJ
cord-005453-4057qib7	1535	14	to	to	IN
cord-005453-4057qib7	1535	15	those	those	DT
cord-005453-4057qib7	1535	16	in	in	IN
cord-005453-4057qib7	1535	17	literature	literature	NN
cord-005453-4057qib7	1535	18	in	in	IN
cord-005453-4057qib7	1535	19	spite	spite	NN
cord-005453-4057qib7	1535	20	if	if	IN
cord-005453-4057qib7	1535	21	DLI	DLI	NNP
cord-005453-4057qib7	1535	22	practices	practice	NNS
cord-005453-4057qib7	1535	23	.	.	.
cord-005453-4057qib7	1536	1	Dose	dose	NN
cord-005453-4057qib7	1536	2	and	and	CC
cord-005453-4057qib7	1536	3	application	application	NN
cord-005453-4057qib7	1536	4	frequency	frequency	NN
cord-005453-4057qib7	1536	5	were	be	VBD
cord-005453-4057qib7	1536	6	greater	great	JJR
cord-005453-4057qib7	1536	7	in	in	IN
cord-005453-4057qib7	1536	8	patients	patient	NNS
cord-005453-4057qib7	1536	9	with	with	IN
cord-005453-4057qib7	1536	10	increased	increase	VBN
cord-005453-4057qib7	1536	11	chimerism	chimerism	NN
cord-005453-4057qib7	1536	12	.	.	.
cord-005453-4057qib7	1537	1	The	the	DT
cord-005453-4057qib7	1537	2	small	small	JJ
cord-005453-4057qib7	1537	3	number	number	NN
cord-005453-4057qib7	1537	4	and	and	CC
cord-005453-4057qib7	1537	5	the	the	DT
cord-005453-4057qib7	1537	6	heterogeneity	heterogeneity	NN
cord-005453-4057qib7	1537	7	of	of	IN
cord-005453-4057qib7	1537	8	the	the	DT
cord-005453-4057qib7	1537	9	patients	patient	NNS
cord-005453-4057qib7	1537	10	limited	limit	VBD
cord-005453-4057qib7	1537	11	our	-PRON-	PRP$
cord-005453-4057qib7	1537	12	study	study	NN
cord-005453-4057qib7	1537	13	.	.	.
cord-005453-4057qib7	1538	1	In	in	IN
cord-005453-4057qib7	1538	2	this	this	DT
cord-005453-4057qib7	1538	3	regard	regard	NN
cord-005453-4057qib7	1538	4	,	,	,
cord-005453-4057qib7	1538	5	studies	study	NNS
cord-005453-4057qib7	1538	6	with	with	IN
cord-005453-4057qib7	1538	7	larger	large	JJR
cord-005453-4057qib7	1538	8	series	series	NN
cord-005453-4057qib7	1538	9	and	and	CC
cord-005453-4057qib7	1538	10	homogeneous	homogeneous	JJ
cord-005453-4057qib7	1538	11	groups	group	NNS
cord-005453-4057qib7	1538	12	are	be	VBP
cord-005453-4057qib7	1538	13	acquired	acquire	VBN
cord-005453-4057qib7	1538	14	.	.	.
cord-005453-4057qib7	1539	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1539	2	:	:	:
cord-005453-4057qib7	1539	3	Nothing	nothing	NN
cord-005453-4057qib7	1539	4	to	to	TO
cord-005453-4057qib7	1539	5	declare	declare	VB
cord-005453-4057qib7	1539	6	Phase	phase	NN
cord-005453-4057qib7	1540	1	I	-PRON-	PRP
cord-005453-4057qib7	1540	2	clinical	clinical	JJ
cord-005453-4057qib7	1540	3	trial	trial	NN
cord-005453-4057qib7	1540	4	of	of	IN
cord-005453-4057qib7	1540	5	repeated	repeat	VBN
cord-005453-4057qib7	1540	6	administrations	administration	NNS
cord-005453-4057qib7	1540	7	of	of	IN
cord-005453-4057qib7	1540	8	bone	bone	NN
cord-005453-4057qib7	1540	9	-	-	HYPH
cord-005453-4057qib7	1540	10	marrow	marrow	NN
cord-005453-4057qib7	1540	11	derived	derive	VBN
cord-005453-4057qib7	1540	12	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	1540	13	stem	stem	NN
cord-005453-4057qib7	1540	14	cells	cell	NNS
cord-005453-4057qib7	1540	15	in	in	IN
cord-005453-4057qib7	1540	16	steroid	steroid	JJ
cord-005453-4057qib7	1540	17	-	-	HYPH
cord-005453-4057qib7	1540	18	refractory	refractory	JJ
cord-005453-4057qib7	1540	19	chronic	chronic	JJ
cord-005453-4057qib7	1540	20	graft	graft	NN
cord-005453-4057qib7	1540	21	-	-	HYPH
cord-005453-4057qib7	1540	22	versus	versus	IN
cord-005453-4057qib7	1540	23	-	-	HYPH
cord-005453-4057qib7	1540	24	host	host	NN
cord-005453-4057qib7	1540	25	disease	disease	NN
cord-005453-4057qib7	1540	26	patients	patient	NNS
cord-005453-4057qib7	1540	27	Nayoun	Nayoun	NNP
cord-005453-4057qib7	1540	28	Kim	Kim	NNP
cord-005453-4057qib7	1540	29	1	1	CD
cord-005453-4057qib7	1540	30	,	,	,
cord-005453-4057qib7	1540	31	Young	Young	NNP
cord-005453-4057qib7	1540	32	-	-	HYPH
cord-005453-4057qib7	1540	33	Woo	Woo	NNP
cord-005453-4057qib7	1540	34	Jeon	Jeon	NNP
cord-005453-4057qib7	1540	35	2	2	CD
cord-005453-4057qib7	1540	36	,	,	,
cord-005453-4057qib7	1540	37	Jae	Jae	NNP
cord-005453-4057qib7	1540	38	-	-	HYPH
cord-005453-4057qib7	1540	39	Deog	Deog	NNP
cord-005453-4057qib7	1540	40	Jang	Jang	NNP
cord-005453-4057qib7	1540	41	1	1	CD
cord-005453-4057qib7	1540	42	,	,	,
cord-005453-4057qib7	1540	43	Keon	Keon	NNP
cord-005453-4057qib7	1540	44	-	-	HYPH
cord-005453-4057qib7	1540	45	Il	Il	NNP
cord-005453-4057qib7	1541	1	I	-PRON-	PRP
cord-005453-4057qib7	1542	1	m	m	NNP
cord-005453-4057qib7	1542	2	1	1	CD
cord-005453-4057qib7	1542	3	,	,	,
cord-005453-4057qib7	1542	4	Nak	Nak	NNP
cord-005453-4057qib7	1542	5	-	-	HYPH
cord-005453-4057qib7	1542	6	Gyun	Gyun	NNP
cord-005453-4057qib7	1542	7	Chung	Chung	NNP
cord-005453-4057qib7	1542	8	2	2	CD
cord-005453-4057qib7	1542	9	,	,	,
cord-005453-4057qib7	1542	10	Young	Young	NNP
cord-005453-4057qib7	1542	11	-	-	HYPH
cord-005453-4057qib7	1542	12	Sun	Sun	NNP
cord-005453-4057qib7	1542	13	Nam	Nam	NNP
cord-005453-4057qib7	1542	14	1	1	CD
cord-005453-4057qib7	1542	15	,	,	,
cord-005453-4057qib7	1542	16	Yunejin	Yunejin	NNP
cord-005453-4057qib7	1542	17	Song	Song	NNP
cord-005453-4057qib7	1542	18	1	1	CD
cord-005453-4057qib7	1542	19	,	,	,
cord-005453-4057qib7	1542	20	Jun	Jun	NNP
cord-005453-4057qib7	1542	21	-	-	HYPH
cord-005453-4057qib7	1542	22	Seok	Seok	NNP
cord-005453-4057qib7	1542	23	Lee	Lee	NNP
cord-005453-4057qib7	1542	24	1	1	CD
cord-005453-4057qib7	1542	25	,	,	,
cord-005453-4057qib7	1542	26	Seok	Seok	NNP
cord-005453-4057qib7	1542	27	-	-	HYPH
cord-005453-4057qib7	1542	28	Goo	Goo	NNP
cord-005453-4057qib7	1542	29	Cho	Cho	NNP
cord-005453-4057qib7	1542	30	(	(	-LRB-
cord-005453-4057qib7	1542	31	cGHVD	cghvd	IN
cord-005453-4057qib7	1542	32	)	)	-RRB-
cord-005453-4057qib7	1542	33	is	be	VBZ
cord-005453-4057qib7	1542	34	the	the	DT
cord-005453-4057qib7	1542	35	most	most	RBS
cord-005453-4057qib7	1542	36	common	common	JJ
cord-005453-4057qib7	1542	37	long	long	JJ
cord-005453-4057qib7	1542	38	-	-	HYPH
cord-005453-4057qib7	1542	39	term	term	NN
cord-005453-4057qib7	1542	40	complication	complication	NN
cord-005453-4057qib7	1542	41	of	of	IN
cord-005453-4057qib7	1542	42	allogenic	allogenic	JJ
cord-005453-4057qib7	1542	43	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1542	44	stem	stem	NN
cord-005453-4057qib7	1542	45	cell	cell	NN
cord-005453-4057qib7	1542	46	transplantation	transplantation	NN
cord-005453-4057qib7	1542	47	which	which	WDT
cord-005453-4057qib7	1542	48	is	be	VBZ
cord-005453-4057qib7	1542	49	associated	associate	VBN
cord-005453-4057qib7	1542	50	with	with	IN
cord-005453-4057qib7	1542	51	poor	poor	JJ
cord-005453-4057qib7	1542	52	quality	quality	NN
cord-005453-4057qib7	1542	53	of	of	IN
cord-005453-4057qib7	1542	54	life	life	NN
cord-005453-4057qib7	1542	55	and	and	CC
cord-005453-4057qib7	1542	56	increased	increase	VBN
cord-005453-4057qib7	1542	57	risk	risk	NN
cord-005453-4057qib7	1542	58	of	of	IN
cord-005453-4057qib7	1542	59	morbidity	morbidity	NN
cord-005453-4057qib7	1542	60	and	and	CC
cord-005453-4057qib7	1542	61	mortality	mortality	NN
cord-005453-4057qib7	1542	62	.	.	.
cord-005453-4057qib7	1543	1	Currently	currently	RB
cord-005453-4057qib7	1543	2	,	,	,
cord-005453-4057qib7	1543	3	there	there	EX
cord-005453-4057qib7	1543	4	is	be	VBZ
cord-005453-4057qib7	1543	5	no	no	DT
cord-005453-4057qib7	1543	6	standardized	standardized	JJ
cord-005453-4057qib7	1543	7	treatment	treatment	NN
cord-005453-4057qib7	1543	8	available	available	JJ
cord-005453-4057qib7	1543	9	for	for	IN
cord-005453-4057qib7	1543	10	patients	patient	NNS
cord-005453-4057qib7	1543	11	who	who	WP
cord-005453-4057qib7	1543	12	do	do	VBP
cord-005453-4057qib7	1543	13	not	not	RB
cord-005453-4057qib7	1543	14	respond	respond	VB
cord-005453-4057qib7	1543	15	to	to	IN
cord-005453-4057qib7	1543	16	steroids	steroid	NNS
cord-005453-4057qib7	1543	17	.	.	.
cord-005453-4057qib7	1544	1	As	as	IN
cord-005453-4057qib7	1544	2	an	an	DT
cord-005453-4057qib7	1544	3	alternative	alternative	NN
cord-005453-4057qib7	1544	4	to	to	IN
cord-005453-4057qib7	1544	5	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	1544	6	drugs	drug	NNS
cord-005453-4057qib7	1544	7	,	,	,
cord-005453-4057qib7	1544	8	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	1544	9	stem	stem	NN
cord-005453-4057qib7	1544	10	cells	cell	NNS
cord-005453-4057qib7	1544	11	(	(	-LRB-
cord-005453-4057qib7	1544	12	MSCs	msc	NNS
cord-005453-4057qib7	1544	13	)	)	-RRB-
cord-005453-4057qib7	1544	14	have	have	VBP
cord-005453-4057qib7	1544	15	been	be	VBN
cord-005453-4057qib7	1544	16	used	use	VBN
cord-005453-4057qib7	1544	17	to	to	TO
cord-005453-4057qib7	1544	18	treat	treat	VB
cord-005453-4057qib7	1544	19	and	and	CC
cord-005453-4057qib7	1544	20	prevent	prevent	VB
cord-005453-4057qib7	1544	21	steroidrefractory	steroidrefractory	NN
cord-005453-4057qib7	1544	22	acute	acute	JJ
cord-005453-4057qib7	1544	23	GVHD	GVHD	NNP
cord-005453-4057qib7	1544	24	patients	patient	NNS
cord-005453-4057qib7	1544	25	.	.	.
cord-005453-4057qib7	1545	1	These	these	DT
cord-005453-4057qib7	1545	2	studies	study	NNS
cord-005453-4057qib7	1545	3	and	and	CC
cord-005453-4057qib7	1545	4	reports	report	NNS
cord-005453-4057qib7	1545	5	have	have	VBP
cord-005453-4057qib7	1545	6	also	also	RB
cord-005453-4057qib7	1545	7	provided	provide	VBN
cord-005453-4057qib7	1545	8	a	a	DT
cord-005453-4057qib7	1545	9	basis	basis	NN
cord-005453-4057qib7	1545	10	for	for	IN
cord-005453-4057qib7	1545	11	using	use	VBG
cord-005453-4057qib7	1545	12	MSCs	msc	NNS
cord-005453-4057qib7	1545	13	in	in	IN
cord-005453-4057qib7	1545	14	steroid	steroid	NN
cord-005453-4057qib7	1545	15	refractory	refractory	JJ
cord-005453-4057qib7	1545	16	cGVHD	cGVHD	NNP
cord-005453-4057qib7	1545	17	patients	patient	NNS
cord-005453-4057qib7	1545	18	.	.	.
cord-005453-4057qib7	1546	1	Methods	method	NNS
cord-005453-4057qib7	1546	2	:	:	:
cord-005453-4057qib7	1546	3	To	to	TO
cord-005453-4057qib7	1546	4	evaluate	evaluate	VB
cord-005453-4057qib7	1546	5	the	the	DT
cord-005453-4057qib7	1546	6	safety	safety	NN
cord-005453-4057qib7	1546	7	and	and	CC
cord-005453-4057qib7	1546	8	efficacy	efficacy	NN
cord-005453-4057qib7	1546	9	of	of	IN
cord-005453-4057qib7	1546	10	repeatedinfusions	repeatedinfusion	NNS
cord-005453-4057qib7	1546	11	of	of	IN
cord-005453-4057qib7	1546	12	MSCs	msc	NNS
cord-005453-4057qib7	1546	13	,	,	,
cord-005453-4057qib7	1546	14	we	-PRON-	PRP
cord-005453-4057qib7	1546	15	enrolled	enrol	VBD
cord-005453-4057qib7	1546	16	ten	ten	CD
cord-005453-4057qib7	1546	17	severe	severe	JJ
cord-005453-4057qib7	1546	18	steroid	steroid	NN
cord-005453-4057qib7	1546	19	-	-	HYPH
cord-005453-4057qib7	1546	20	refractory	refractory	JJ
cord-005453-4057qib7	1546	21	cGVHDs	cGVHDs	NNP
cord-005453-4057qib7	1546	22	patients	patient	NNS
cord-005453-4057qib7	1546	23	.	.	.
cord-005453-4057qib7	1547	1	Steroid	steroid	NN
cord-005453-4057qib7	1547	2	refractory	refractory	NN
cord-005453-4057qib7	1547	3	was	be	VBD
cord-005453-4057qib7	1547	4	defined	define	VBN
cord-005453-4057qib7	1547	5	as	as	IN
cord-005453-4057qib7	1547	6	either	either	CC
cord-005453-4057qib7	1547	7	no	no	DT
cord-005453-4057qib7	1547	8	response	response	NN
cord-005453-4057qib7	1547	9	to	to	IN
cord-005453-4057qib7	1547	10	steroids	steroid	NNS
cord-005453-4057qib7	1547	11	lasting	last	VBG
cord-005453-4057qib7	1547	12	at	at	RB
cord-005453-4057qib7	1547	13	least	least	JJS
cord-005453-4057qib7	1547	14	4	4	CD
cord-005453-4057qib7	1547	15	weeks	week	NNS
cord-005453-4057qib7	1547	16	or	or	CC
cord-005453-4057qib7	1547	17	progression	progression	NN
cord-005453-4057qib7	1547	18	of	of	IN
cord-005453-4057qib7	1547	19	disease	disease	NN
cord-005453-4057qib7	1547	20	during	during	IN
cord-005453-4057qib7	1547	21	treatment	treatment	NN
cord-005453-4057qib7	1547	22	or	or	CC
cord-005453-4057qib7	1547	23	tapering	taper	VBG
cord-005453-4057qib7	1547	24	lasting	last	VBG
cord-005453-4057qib7	1547	25	at	at	RB
cord-005453-4057qib7	1547	26	least	least	JJS
cord-005453-4057qib7	1547	27	2	2	CD
cord-005453-4057qib7	1547	28	weeks	week	NNS
cord-005453-4057qib7	1547	29	.	.	.
cord-005453-4057qib7	1548	1	Patients	patient	NNS
cord-005453-4057qib7	1548	2	were	be	VBD
cord-005453-4057qib7	1548	3	intravenously	intravenously	RB
cord-005453-4057qib7	1548	4	administered	administer	VBN
cord-005453-4057qib7	1548	5	with	with	IN
cord-005453-4057qib7	1548	6	MSCs	msc	NNS
cord-005453-4057qib7	1548	7	produced	produce	VBN
cord-005453-4057qib7	1548	8	from	from	IN
cord-005453-4057qib7	1548	9	third	third	JJ
cord-005453-4057qib7	1548	10	-	-	HYPH
cord-005453-4057qib7	1548	11	party	party	NN
cord-005453-4057qib7	1548	12	bone	bone	NN
cord-005453-4057qib7	1548	13	marrow	marrow	NN
cord-005453-4057qib7	1548	14	donors	donor	NNS
cord-005453-4057qib7	1548	15	at	at	IN
cord-005453-4057qib7	1548	16	a	a	DT
cord-005453-4057qib7	1548	17	2-week	2-week	CD
cord-005453-4057qib7	1548	18	interval	interval	NN
cord-005453-4057qib7	1548	19	for	for	IN
cord-005453-4057qib7	1548	20	a	a	DT
cord-005453-4057qib7	1548	21	total	total	NN
cord-005453-4057qib7	1548	22	of	of	IN
cord-005453-4057qib7	1548	23	four	four	CD
cord-005453-4057qib7	1548	24	doses	dose	NNS
cord-005453-4057qib7	1548	25	.	.	.
cord-005453-4057qib7	1549	1	Each	each	DT
cord-005453-4057qib7	1549	2	dose	dose	NN
cord-005453-4057qib7	1549	3	contained	contain	VBD
cord-005453-4057qib7	1549	4	1x10	1x10	CD
cord-005453-4057qib7	1549	5	6	6	CD
cord-005453-4057qib7	1549	6	cells	cell	NNS
cord-005453-4057qib7	1549	7	per	per	IN
cord-005453-4057qib7	1549	8	kg	kg	NN
cord-005453-4057qib7	1549	9	body	body	NN
cord-005453-4057qib7	1549	10	weight	weight	NN
cord-005453-4057qib7	1549	11	and	and	CC
cord-005453-4057qib7	1549	12	all	all	DT
cord-005453-4057qib7	1549	13	four	four	CD
cord-005453-4057qib7	1549	14	doses	dose	NNS
cord-005453-4057qib7	1549	15	consisted	consist	VBD
cord-005453-4057qib7	1549	16	of	of	IN
cord-005453-4057qib7	1549	17	MSCs	msc	NNS
cord-005453-4057qib7	1549	18	from	from	IN
cord-005453-4057qib7	1549	19	the	the	DT
cord-005453-4057qib7	1549	20	same	same	JJ
cord-005453-4057qib7	1549	21	donor	donor	NN
cord-005453-4057qib7	1549	22	and	and	CC
cord-005453-4057qib7	1549	23	same	same	JJ
cord-005453-4057qib7	1549	24	passage	passage	NN
cord-005453-4057qib7	1549	25	.	.	.
cord-005453-4057qib7	1550	1	Results	result	NNS
cord-005453-4057qib7	1550	2	:	:	:
cord-005453-4057qib7	1551	1	We	-PRON-	PRP
cord-005453-4057qib7	1551	2	enrolled	enrol	VBD
cord-005453-4057qib7	1551	3	ten	ten	CD
cord-005453-4057qib7	1551	4	patients	patient	NNS
cord-005453-4057qib7	1551	5	(	(	-LRB-
cord-005453-4057qib7	1551	6	3	3	CD
cord-005453-4057qib7	1551	7	female/	female/	CD
cord-005453-4057qib7	1551	8	7	7	CD
cord-005453-4057qib7	1551	9	male	male	NN
cord-005453-4057qib7	1551	10	,	,	,
cord-005453-4057qib7	1551	11	with	with	IN
cord-005453-4057qib7	1551	12	a	a	DT
cord-005453-4057qib7	1551	13	median	median	JJ
cord-005453-4057qib7	1551	14	age	age	NN
cord-005453-4057qib7	1551	15	of	of	IN
cord-005453-4057qib7	1551	16	41.5(range	41.5(range	CD
cord-005453-4057qib7	1551	17	17	17	CD
cord-005453-4057qib7	1551	18	-	-	SYM
cord-005453-4057qib7	1551	19	68	68	CD
cord-005453-4057qib7	1551	20	)	)	-RRB-
cord-005453-4057qib7	1551	21	.	.	.
cord-005453-4057qib7	1552	1	Median	Median	NNP
cord-005453-4057qib7	1552	2	of	of	IN
cord-005453-4057qib7	1552	3	cGVHD	cGVHD	NNP
cord-005453-4057qib7	1552	4	affected	affect	VBN
cord-005453-4057qib7	1552	5	organs	organ	NNS
cord-005453-4057qib7	1552	6	was	be	VBD
cord-005453-4057qib7	1552	7	3	3	CD
cord-005453-4057qib7	1553	1	(	(	-LRB-
cord-005453-4057qib7	1553	2	range	range	NNP
cord-005453-4057qib7	1553	3	2	2	CD
cord-005453-4057qib7	1553	4	-	-	SYM
cord-005453-4057qib7	1553	5	4	4	CD
cord-005453-4057qib7	1553	6	)	)	-RRB-
cord-005453-4057qib7	1553	7	including	include	VBG
cord-005453-4057qib7	1553	8	the	the	DT
cord-005453-4057qib7	1553	9	skin	skin	NN
cord-005453-4057qib7	1553	10	(	(	-LRB-
cord-005453-4057qib7	1553	11	n=4	n=4	NNS
cord-005453-4057qib7	1553	12	)	)	-RRB-
cord-005453-4057qib7	1553	13	,	,	,
cord-005453-4057qib7	1553	14	eyes	eye	NNS
cord-005453-4057qib7	1553	15	(	(	-LRB-
cord-005453-4057qib7	1553	16	n=8	n=8	NN
cord-005453-4057qib7	1553	17	)	)	-RRB-
cord-005453-4057qib7	1553	18	,	,	,
cord-005453-4057qib7	1553	19	oral	oral	JJ
cord-005453-4057qib7	1553	20	cavity	cavity	NN
cord-005453-4057qib7	1553	21	(	(	-LRB-
cord-005453-4057qib7	1553	22	n=9	n=9	NN
cord-005453-4057qib7	1553	23	)	)	-RRB-
cord-005453-4057qib7	1553	24	,	,	,
cord-005453-4057qib7	1553	25	lung	lung	NN
cord-005453-4057qib7	1553	26	(	(	-LRB-
cord-005453-4057qib7	1553	27	n=1	n=1	CD
cord-005453-4057qib7	1553	28	)	)	-RRB-
cord-005453-4057qib7	1553	29	,	,	,
cord-005453-4057qib7	1553	30	liver	liver	NN
cord-005453-4057qib7	1553	31	(	(	-LRB-
cord-005453-4057qib7	1553	32	n=2	n=2	NNS
cord-005453-4057qib7	1553	33	)	)	-RRB-
cord-005453-4057qib7	1553	34	and	and	CC
cord-005453-4057qib7	1553	35	joints	joint	NNS
cord-005453-4057qib7	1553	36	(	(	-LRB-
cord-005453-4057qib7	1553	37	n=6	n=6	NN
cord-005453-4057qib7	1553	38	)	)	-RRB-
cord-005453-4057qib7	1553	39	.	.	.
cord-005453-4057qib7	1554	1	All	all	DT
cord-005453-4057qib7	1554	2	ten	ten	CD
cord-005453-4057qib7	1554	3	patients	patient	NNS
cord-005453-4057qib7	1554	4	received	receive	VBD
cord-005453-4057qib7	1554	5	their	-PRON-	PRP$
cord-005453-4057qib7	1554	6	planned	plan	VBN
cord-005453-4057qib7	1554	7	four	four	CD
cord-005453-4057qib7	1554	8	doses	dose	NNS
cord-005453-4057qib7	1554	9	of	of	IN
cord-005453-4057qib7	1554	10	MSCs	msc	NNS
cord-005453-4057qib7	1554	11	,	,	,
cord-005453-4057qib7	1554	12	administering	administer	VBG
cord-005453-4057qib7	1554	13	a	a	DT
cord-005453-4057qib7	1554	14	total	total	NN
cord-005453-4057qib7	1554	15	of	of	IN
cord-005453-4057qib7	1554	16	40	40	CD
cord-005453-4057qib7	1554	17	infusions	infusion	NNS
cord-005453-4057qib7	1554	18	.	.	.
cord-005453-4057qib7	1555	1	Median	median	JJ
cord-005453-4057qib7	1555	2	time	time	NN
cord-005453-4057qib7	1555	3	from	from	IN
cord-005453-4057qib7	1555	4	initial	initial	JJ
cord-005453-4057qib7	1555	5	cGVHD	cgvhd	NN
cord-005453-4057qib7	1555	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	1555	7	to	to	IN
cord-005453-4057qib7	1555	8	first	first	JJ
cord-005453-4057qib7	1555	9	MSC	MSC	NNP
cord-005453-4057qib7	1555	10	treatment	treatment	NN
cord-005453-4057qib7	1555	11	was	be	VBD
cord-005453-4057qib7	1555	12	709	709	CD
cord-005453-4057qib7	1555	13	days	day	NNS
cord-005453-4057qib7	1556	1	(	(	-LRB-
cord-005453-4057qib7	1556	2	range	range	NNP
cord-005453-4057qib7	1556	3	222	222	CD
cord-005453-4057qib7	1556	4	-	-	HYPH
cord-005453-4057qib7	1556	5	4413	4413	CD
cord-005453-4057qib7	1556	6	)	)	-RRB-
cord-005453-4057qib7	1556	7	.	.	.
cord-005453-4057qib7	1557	1	MSC	MSC	NNP
cord-005453-4057qib7	1557	2	infusions	infusion	NNS
cord-005453-4057qib7	1557	3	were	be	VBD
cord-005453-4057qib7	1557	4	well	well	RB
cord-005453-4057qib7	1557	5	tolerated	tolerate	VBN
cord-005453-4057qib7	1557	6	with	with	IN
cord-005453-4057qib7	1557	7	no	no	DT
cord-005453-4057qib7	1557	8	immediate	immediate	JJ
cord-005453-4057qib7	1557	9	or	or	CC
cord-005453-4057qib7	1557	10	delayed	delay	VBN
cord-005453-4057qib7	1557	11	toxicities	toxicity	NNS
cord-005453-4057qib7	1557	12	.	.	.
cord-005453-4057qib7	1558	1	After	after	IN
cord-005453-4057qib7	1558	2	8	8	CD
cord-005453-4057qib7	1558	3	weeks	week	NNS
cord-005453-4057qib7	1558	4	of	of	IN
cord-005453-4057qib7	1558	5	the	the	DT
cord-005453-4057qib7	1558	6	first	first	JJ
cord-005453-4057qib7	1558	7	MSC	MSC	NNP
cord-005453-4057qib7	1558	8	infusion	infusion	NN
cord-005453-4057qib7	1558	9	,	,	,
cord-005453-4057qib7	1558	10	all	all	DT
cord-005453-4057qib7	1558	11	ten	ten	CD
cord-005453-4057qib7	1558	12	patients	patient	NNS
cord-005453-4057qib7	1558	13	showed	show	VBD
cord-005453-4057qib7	1558	14	partial	partial	JJ
cord-005453-4057qib7	1558	15	response	response	NN
cord-005453-4057qib7	1558	16	showing	show	VBG
cord-005453-4057qib7	1558	17	alleviation	alleviation	NN
cord-005453-4057qib7	1558	18	in	in	IN
cord-005453-4057qib7	1558	19	clinical	clinical	JJ
cord-005453-4057qib7	1558	20	symptoms	symptom	NNS
cord-005453-4057qib7	1558	21	and	and	CC
cord-005453-4057qib7	1558	22	increased	increase	VBN
cord-005453-4057qib7	1558	23	quality	quality	NN
cord-005453-4057qib7	1558	24	of	of	IN
cord-005453-4057qib7	1558	25	life	life	NN
cord-005453-4057qib7	1558	26	.	.	.
cord-005453-4057qib7	1559	1	Organ	organ	NN
cord-005453-4057qib7	1559	2	responses	response	NNS
cord-005453-4057qib7	1559	3	were	be	VBD
cord-005453-4057qib7	1559	4	seen	see	VBN
cord-005453-4057qib7	1559	5	in	in	IN
cord-005453-4057qib7	1559	6	skin	skin	NN
cord-005453-4057qib7	1559	7	(	(	-LRB-
cord-005453-4057qib7	1559	8	n=2	n=2	NNS
cord-005453-4057qib7	1559	9	)	)	-RRB-
cord-005453-4057qib7	1559	10	,	,	,
cord-005453-4057qib7	1559	11	eyes	eye	NNS
cord-005453-4057qib7	1559	12	(	(	-LRB-
cord-005453-4057qib7	1559	13	n=5	n=5	NNP
cord-005453-4057qib7	1559	14	)	)	-RRB-
cord-005453-4057qib7	1559	15	,	,	,
cord-005453-4057qib7	1559	16	oral	oral	JJ
cord-005453-4057qib7	1559	17	cavity	cavity	NN
cord-005453-4057qib7	1559	18	(	(	-LRB-
cord-005453-4057qib7	1559	19	n=8	n=8	NN
cord-005453-4057qib7	1559	20	)	)	-RRB-
cord-005453-4057qib7	1559	21	,	,	,
cord-005453-4057qib7	1559	22	liver	liver	NN
cord-005453-4057qib7	1559	23	(	(	-LRB-
cord-005453-4057qib7	1559	24	n=1	n=1	CD
cord-005453-4057qib7	1559	25	)	)	-RRB-
cord-005453-4057qib7	1559	26	,	,	,
cord-005453-4057qib7	1559	27	and	and	CC
cord-005453-4057qib7	1559	28	joint(n=5	joint(n=5	NNP
cord-005453-4057qib7	1559	29	)	)	-RRB-
cord-005453-4057qib7	1559	30	.	.	.
cord-005453-4057qib7	1560	1	However	however	RB
cord-005453-4057qib7	1560	2	,	,	,
cord-005453-4057qib7	1560	3	one	one	CD
cord-005453-4057qib7	1560	4	patient	patient	NN
cord-005453-4057qib7	1560	5	died	die	VBD
cord-005453-4057qib7	1560	6	of	of	IN
cord-005453-4057qib7	1560	7	progressive	progressive	JJ
cord-005453-4057qib7	1560	8	GVHD	GVHD	NNP
cord-005453-4057qib7	1560	9	and	and	CC
cord-005453-4057qib7	1560	10	one	one	CD
cord-005453-4057qib7	1560	11	patient	patient	NN
cord-005453-4057qib7	1560	12	relapsed	relapse	VBD
cord-005453-4057qib7	1560	13	from	from	IN
cord-005453-4057qib7	1560	14	primary	primary	JJ
cord-005453-4057qib7	1560	15	disease	disease	NN
cord-005453-4057qib7	1560	16	.	.	.
cord-005453-4057qib7	1561	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1561	2	:	:	:
cord-005453-4057qib7	1562	1	Repeated	repeat	VBN
cord-005453-4057qib7	1562	2	infusions	infusion	NNS
cord-005453-4057qib7	1562	3	of	of	IN
cord-005453-4057qib7	1562	4	MSCs	msc	NNS
cord-005453-4057qib7	1562	5	was	be	VBD
cord-005453-4057qib7	1562	6	feasible	feasible	JJ
cord-005453-4057qib7	1562	7	and	and	CC
cord-005453-4057qib7	1562	8	safe	safe	JJ
cord-005453-4057qib7	1562	9	and	and	CC
cord-005453-4057qib7	1562	10	may	may	MD
cord-005453-4057qib7	1562	11	be	be	VB
cord-005453-4057qib7	1562	12	an	an	DT
cord-005453-4057qib7	1562	13	effective	effective	JJ
cord-005453-4057qib7	1562	14	salvage	salvage	NN
cord-005453-4057qib7	1562	15	therapy	therapy	NN
cord-005453-4057qib7	1562	16	in	in	IN
cord-005453-4057qib7	1562	17	patients	patient	NNS
cord-005453-4057qib7	1562	18	with	with	IN
cord-005453-4057qib7	1562	19	steroid	steroid	JJ
cord-005453-4057qib7	1562	20	-	-	HYPH
cord-005453-4057qib7	1562	21	refractory	refractory	JJ
cord-005453-4057qib7	1562	22	cGVHD	cgvhd	NN
cord-005453-4057qib7	1562	23	.	.	.
cord-005453-4057qib7	1563	1	Further	further	JJ
cord-005453-4057qib7	1563	2	large	large	JJ
cord-005453-4057qib7	1563	3	-	-	HYPH
cord-005453-4057qib7	1563	4	scale	scale	NN
cord-005453-4057qib7	1563	5	clinical	clinical	JJ
cord-005453-4057qib7	1563	6	studies	study	NNS
cord-005453-4057qib7	1563	7	with	with	IN
cord-005453-4057qib7	1563	8	long	long	JJ
cord-005453-4057qib7	1563	9	-	-	HYPH
cord-005453-4057qib7	1563	10	term	term	NN
cord-005453-4057qib7	1563	11	follow	follow	VB
cord-005453-4057qib7	1563	12	up	up	RP
cord-005453-4057qib7	1563	13	is	be	VBZ
cord-005453-4057qib7	1563	14	needed	need	VBN
cord-005453-4057qib7	1563	15	in	in	IN
cord-005453-4057qib7	1563	16	the	the	DT
cord-005453-4057qib7	1563	17	future	future	NN
cord-005453-4057qib7	1563	18	to	to	TO
cord-005453-4057qib7	1563	19	determine	determine	VB
cord-005453-4057qib7	1563	20	the	the	DT
cord-005453-4057qib7	1563	21	role	role	NN
cord-005453-4057qib7	1563	22	of	of	IN
cord-005453-4057qib7	1563	23	MSCs	msc	NNS
cord-005453-4057qib7	1563	24	in	in	IN
cord-005453-4057qib7	1563	25	cGVHD	cGVHD	NNP
cord-005453-4057qib7	1563	26	.	.	.
cord-005453-4057qib7	1564	1	Background	background	NN
cord-005453-4057qib7	1564	2	:	:	:
cord-005453-4057qib7	1565	1	The	the	DT
cord-005453-4057qib7	1565	2	majority	majority	NN
cord-005453-4057qib7	1565	3	of	of	IN
cord-005453-4057qib7	1565	4	pregnant	pregnant	JJ
cord-005453-4057qib7	1565	5	Polish	polish	JJ
cord-005453-4057qib7	1565	6	women	woman	NNS
cord-005453-4057qib7	1565	7	(	(	-LRB-
cord-005453-4057qib7	1565	8	84	84	CD
cord-005453-4057qib7	1565	9	%	%	NN
cord-005453-4057qib7	1565	10	)	)	-RRB-
cord-005453-4057qib7	1565	11	have	have	VBP
cord-005453-4057qib7	1565	12	heard	hear	VBN
cord-005453-4057qib7	1565	13	of	of	IN
cord-005453-4057qib7	1565	14	cord	cord	NN
cord-005453-4057qib7	1565	15	blood	blood	NN
cord-005453-4057qib7	1565	16	banking	banking	NN
cord-005453-4057qib7	1565	17	.	.	.
cord-005453-4057qib7	1566	1	However	however	RB
cord-005453-4057qib7	1566	2	,	,	,
cord-005453-4057qib7	1566	3	most	most	JJS
cord-005453-4057qib7	1566	4	doctors	doctor	NNS
cord-005453-4057qib7	1566	5	do	do	VBP
cord-005453-4057qib7	1566	6	not	not	RB
cord-005453-4057qib7	1566	7	have	have	VB
cord-005453-4057qib7	1566	8	sufficient	sufficient	JJ
cord-005453-4057qib7	1566	9	knowledge	knowledge	NN
cord-005453-4057qib7	1566	10	about	about	IN
cord-005453-4057qib7	1566	11	the	the	DT
cord-005453-4057qib7	1566	12	possibility	possibility	NN
cord-005453-4057qib7	1566	13	of	of	IN
cord-005453-4057qib7	1566	14	using	use	VBG
cord-005453-4057qib7	1566	15	cord	cord	NN
cord-005453-4057qib7	1566	16	blood	blood	NN
cord-005453-4057qib7	1566	17	in	in	IN
cord-005453-4057qib7	1566	18	order	order	NN
cord-005453-4057qib7	1566	19	to	to	TO
cord-005453-4057qib7	1566	20	respond	respond	VB
cord-005453-4057qib7	1566	21	to	to	IN
cord-005453-4057qib7	1566	22	their	-PRON-	PRP$
cord-005453-4057qib7	1566	23	potential	potential	JJ
cord-005453-4057qib7	1566	24	concerns	concern	NNS
cord-005453-4057qib7	1566	25	.	.	.
cord-005453-4057qib7	1567	1	Only	only	RB
cord-005453-4057qib7	1567	2	16.5	16.5	CD
cord-005453-4057qib7	1567	3	%	%	NN
cord-005453-4057qib7	1567	4	of	of	IN
cord-005453-4057qib7	1567	5	healthcare	healthcare	NN
cord-005453-4057qib7	1567	6	professionals	professional	NNS
cord-005453-4057qib7	1567	7	were	be	VBD
cord-005453-4057qib7	1567	8	aware	aware	JJ
cord-005453-4057qib7	1567	9	that	that	IN
cord-005453-4057qib7	1567	10	cord	cord	NN
cord-005453-4057qib7	1567	11	blood	blood	NN
cord-005453-4057qib7	1567	12	could	could	MD
cord-005453-4057qib7	1567	13	be	be	VB
cord-005453-4057qib7	1567	14	used	use	VBN
cord-005453-4057qib7	1567	15	to	to	TO
cord-005453-4057qib7	1567	16	treat	treat	VB
cord-005453-4057qib7	1567	17	haematological	haematological	JJ
cord-005453-4057qib7	1567	18	diseases	disease	NNS
cord-005453-4057qib7	1567	19	.	.	.
cord-005453-4057qib7	1568	1	In	in	IN
cord-005453-4057qib7	1568	2	order	order	NN
cord-005453-4057qib7	1568	3	to	to	TO
cord-005453-4057qib7	1568	4	make	make	VB
cord-005453-4057qib7	1568	5	doctors	doctor	NNS
cord-005453-4057qib7	1568	6	aware	aware	JJ
cord-005453-4057qib7	1568	7	of	of	IN
cord-005453-4057qib7	1568	8	this	this	DT
cord-005453-4057qib7	1568	9	issue	issue	NN
cord-005453-4057qib7	1568	10	and	and	CC
cord-005453-4057qib7	1568	11	provide	provide	VB
cord-005453-4057qib7	1568	12	patients	patient	NNS
cord-005453-4057qib7	1568	13	with	with	IN
cord-005453-4057qib7	1568	14	the	the	DT
cord-005453-4057qib7	1568	15	information	information	NN
cord-005453-4057qib7	1568	16	they	-PRON-	PRP
cord-005453-4057qib7	1568	17	expect	expect	VBP
cord-005453-4057qib7	1568	18	,	,	,
cord-005453-4057qib7	1568	19	we	-PRON-	PRP
cord-005453-4057qib7	1568	20	would	would	MD
cord-005453-4057qib7	1568	21	like	like	VB
cord-005453-4057qib7	1568	22	to	to	TO
cord-005453-4057qib7	1568	23	present	present	VB
cord-005453-4057qib7	1568	24	data	datum	NNS
cord-005453-4057qib7	1568	25	on	on	IN
cord-005453-4057qib7	1568	26	the	the	DT
cord-005453-4057qib7	1568	27	use	use	NN
cord-005453-4057qib7	1568	28	of	of	IN
cord-005453-4057qib7	1568	29	cord	cord	NN
cord-005453-4057qib7	1568	30	blood	blood	NN
cord-005453-4057qib7	1568	31	stored	store	VBN
cord-005453-4057qib7	1568	32	in	in	IN
cord-005453-4057qib7	1568	33	our	-PRON-	PRP$
cord-005453-4057qib7	1568	34	blood	blood	NN
cord-005453-4057qib7	1568	35	bank	bank	NN
cord-005453-4057qib7	1568	36	for	for	IN
cord-005453-4057qib7	1568	37	haematological	haematological	JJ
cord-005453-4057qib7	1568	38	and	and	CC
cord-005453-4057qib7	1568	39	nonhaematological	nonhaematological	JJ
cord-005453-4057qib7	1568	40	therapies	therapy	NNS
cord-005453-4057qib7	1568	41	.	.	.
cord-005453-4057qib7	1569	1	Methods	method	NNS
cord-005453-4057qib7	1569	2	:	:	:
cord-005453-4057qib7	1570	1	The	the	DT
cord-005453-4057qib7	1570	2	table	table	NN
cord-005453-4057qib7	1570	3	presented	present	VBN
cord-005453-4057qib7	1570	4	below	below	RB
cord-005453-4057qib7	1570	5	has	have	VBZ
cord-005453-4057qib7	1570	6	been	be	VBN
cord-005453-4057qib7	1570	7	created	create	VBN
cord-005453-4057qib7	1570	8	using	use	VBG
cord-005453-4057qib7	1570	9	data	datum	NNS
cord-005453-4057qib7	1570	10	from	from	IN
cord-005453-4057qib7	1570	11	the	the	DT
cord-005453-4057qib7	1570	12	general	general	JJ
cord-005453-4057qib7	1570	13	database	database	NN
cord-005453-4057qib7	1570	14	of	of	IN
cord-005453-4057qib7	1570	15	the	the	DT
cord-005453-4057qib7	1570	16	Polish	Polish	NNP
cord-005453-4057qib7	1570	17	Stem	Stem	NNP
cord-005453-4057qib7	1570	18	Cell	Cell	NNP
cord-005453-4057qib7	1570	19	Bank	Bank	NNP
cord-005453-4057qib7	1570	20	,	,	,
cord-005453-4057qib7	1570	21	Warsaw	Warsaw	NNP
cord-005453-4057qib7	1570	22	,	,	,
cord-005453-4057qib7	1570	23	Poland	Poland	NNP
cord-005453-4057qib7	1570	24	.	.	.
cord-005453-4057qib7	1571	1	No	no	DT
cord-005453-4057qib7	1571	2	data	datum	NNS
cord-005453-4057qib7	1571	3	regarding	regard	VBG
cord-005453-4057qib7	1571	4	umbilical	umbilical	JJ
cord-005453-4057qib7	1571	5	cord	cord	NN
cord-005453-4057qib7	1571	6	blood	blood	NN
cord-005453-4057qib7	1571	7	data	datum	NNS
cord-005453-4057qib7	1571	8	have	have	VBP
cord-005453-4057qib7	1571	9	been	be	VBN
cord-005453-4057qib7	1571	10	excluded	exclude	VBN
cord-005453-4057qib7	1571	11	.	.	.
cord-005453-4057qib7	1572	1	All	all	DT
cord-005453-4057qib7	1572	2	patients	patient	NNS
cord-005453-4057qib7	1572	3	were	be	VBD
cord-005453-4057qib7	1572	4	planned	plan	VBN
cord-005453-4057qib7	1572	5	to	to	TO
cord-005453-4057qib7	1572	6	be	be	VB
cord-005453-4057qib7	1572	7	assessed	assess	VBN
cord-005453-4057qib7	1572	8	on	on	IN
cord-005453-4057qib7	1572	9	day	day	NN
cord-005453-4057qib7	1572	10	1	1	CD
cord-005453-4057qib7	1572	11	,	,	,
cord-005453-4057qib7	1572	12	day	day	NN
cord-005453-4057qib7	1572	13	28	28	CD
cord-005453-4057qib7	1572	14	,	,	,
cord-005453-4057qib7	1572	15	on	on	IN
cord-005453-4057qib7	1572	16	discharge	discharge	NN
cord-005453-4057qib7	1572	17	,	,	,
cord-005453-4057qib7	1572	18	100	100	CD
cord-005453-4057qib7	1572	19	days	day	NNS
cord-005453-4057qib7	1572	20	after	after	IN
cord-005453-4057qib7	1572	21	transplantation	transplantation	NN
cord-005453-4057qib7	1572	22	and	and	CC
cord-005453-4057qib7	1572	23	1	1	CD
cord-005453-4057qib7	1572	24	,	,	,
cord-005453-4057qib7	1572	25	2	2	CD
cord-005453-4057qib7	1572	26	,	,	,
cord-005453-4057qib7	1572	27	3	3	CD
cord-005453-4057qib7	1572	28	,	,	,
cord-005453-4057qib7	1572	29	4	4	CD
cord-005453-4057qib7	1572	30	,	,	,
cord-005453-4057qib7	1572	31	and	and	CC
cord-005453-4057qib7	1572	32	5	5	CD
cord-005453-4057qib7	1572	33	years	year	NNS
cord-005453-4057qib7	1572	34	after	after	IN
cord-005453-4057qib7	1572	35	transplantation	transplantation	NN
cord-005453-4057qib7	1572	36	,	,	,
cord-005453-4057qib7	1572	37	but	but	CC
cord-005453-4057qib7	1572	38	in	in	IN
cord-005453-4057qib7	1572	39	some	some	DT
cord-005453-4057qib7	1572	40	cases	case	NNS
cord-005453-4057qib7	1572	41	,	,	,
cord-005453-4057qib7	1572	42	patients	patient	NNS
cord-005453-4057qib7	1572	43	were	be	VBD
cord-005453-4057qib7	1572	44	lost	lose	VBN
cord-005453-4057qib7	1572	45	from	from	IN
cord-005453-4057qib7	1572	46	follow	follow	NN
cord-005453-4057qib7	1572	47	-	-	HYPH
cord-005453-4057qib7	1572	48	up	up	NN
cord-005453-4057qib7	1572	49	due	due	IN
cord-005453-4057qib7	1572	50	to	to	IN
cord-005453-4057qib7	1572	51	a	a	DT
cord-005453-4057qib7	1572	52	persistent	persistent	JJ
cord-005453-4057qib7	1572	53	lack	lack	NN
cord-005453-4057qib7	1572	54	of	of	IN
cord-005453-4057qib7	1572	55	reports	report	NNS
cord-005453-4057qib7	1572	56	from	from	IN
cord-005453-4057qib7	1572	57	transplantation	transplantation	NN
cord-005453-4057qib7	1572	58	centres	centre	NNS
cord-005453-4057qib7	1572	59	.	.	.
cord-005453-4057qib7	1573	1	Results	result	NNS
cord-005453-4057qib7	1573	2	:	:	:
cord-005453-4057qib7	1574	1	In	in	IN
cord-005453-4057qib7	1574	2	32	32	CD
cord-005453-4057qib7	1574	3	cases	case	NNS
cord-005453-4057qib7	1574	4	,	,	,
cord-005453-4057qib7	1574	5	the	the	DT
cord-005453-4057qib7	1574	6	therapeutic	therapeutic	JJ
cord-005453-4057qib7	1574	7	use	use	NN
cord-005453-4057qib7	1574	8	of	of	IN
cord-005453-4057qib7	1574	9	CB	CB	NNP
cord-005453-4057qib7	1574	10	was	be	VBD
cord-005453-4057qib7	1574	11	transplantation	transplantation	NN
cord-005453-4057qib7	1574	12	(	(	-LRB-
cord-005453-4057qib7	1574	13	replacement	replacement	NN
cord-005453-4057qib7	1574	14	of	of	IN
cord-005453-4057qib7	1574	15	patients	patient	NNS
cord-005453-4057qib7	1574	16	'	'	POS
cord-005453-4057qib7	1574	17	own	own	JJ
cord-005453-4057qib7	1574	18	tissue	tissue	NN
cord-005453-4057qib7	1574	19	)	)	-RRB-
cord-005453-4057qib7	1574	20	;	;	:
cord-005453-4057qib7	1574	21	in	in	IN
cord-005453-4057qib7	1574	22	13	13	CD
cord-005453-4057qib7	1574	23	cases	case	NNS
cord-005453-4057qib7	1574	24	it	-PRON-	PRP
cord-005453-4057qib7	1574	25	was	be	VBD
cord-005453-4057qib7	1574	26	administration	administration	NN
cord-005453-4057qib7	1574	27	(	(	-LRB-
cord-005453-4057qib7	1574	28	infusion	infusion	NN
cord-005453-4057qib7	1574	29	without	without	IN
cord-005453-4057qib7	1574	30	destruction	destruction	NN
cord-005453-4057qib7	1574	31	of	of	IN
cord-005453-4057qib7	1574	32	patients	patient	NNS
cord-005453-4057qib7	1574	33	'	'	POS
cord-005453-4057qib7	1574	34	own	own	JJ
cord-005453-4057qib7	1574	35	tissue	tissue	NN
cord-005453-4057qib7	1574	36	)	)	-RRB-
cord-005453-4057qib7	1574	37	.	.	.
cord-005453-4057qib7	1575	1	Thirty	thirty	CD
cord-005453-4057qib7	1575	2	-	-	HYPH
cord-005453-4057qib7	1575	3	three	three	CD
cord-005453-4057qib7	1575	4	were	be	VBD
cord-005453-4057qib7	1575	5	administered	administer	VBN
cord-005453-4057qib7	1575	6	as	as	IN
cord-005453-4057qib7	1575	7	standard	standard	JJ
cord-005453-4057qib7	1575	8	therapy	therapy	NN
cord-005453-4057qib7	1575	9	and	and	CC
cord-005453-4057qib7	1575	10	13	13	CD
cord-005453-4057qib7	1575	11	as	as	IN
cord-005453-4057qib7	1575	12	experimental	experimental	JJ
cord-005453-4057qib7	1575	13	therapy	therapy	NN
cord-005453-4057qib7	1575	14	.	.	.
cord-005453-4057qib7	1576	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1576	2	:	:	:
cord-005453-4057qib7	1577	1	The	the	DT
cord-005453-4057qib7	1577	2	survey	survey	NN
cord-005453-4057qib7	1577	3	study	study	NN
cord-005453-4057qib7	1577	4	cited	cite	VBN
cord-005453-4057qib7	1577	5	above	above	RB
cord-005453-4057qib7	1577	6	,	,	,
cord-005453-4057qib7	1577	7	indicated	indicate	VBD
cord-005453-4057qib7	1577	8	low	low	JJ
cord-005453-4057qib7	1577	9	awareness	awareness	NN
cord-005453-4057qib7	1577	10	of	of	IN
cord-005453-4057qib7	1577	11	cord	cord	NN
cord-005453-4057qib7	1577	12	blood	blood	NN
cord-005453-4057qib7	1577	13	use	use	NN
cord-005453-4057qib7	1577	14	among	among	IN
cord-005453-4057qib7	1577	15	healthcare	healthcare	NN
cord-005453-4057qib7	1577	16	professionals	professional	NNS
cord-005453-4057qib7	1577	17	.	.	.
cord-005453-4057qib7	1578	1	On	on	IN
cord-005453-4057qib7	1578	2	the	the	DT
cord-005453-4057qib7	1578	3	other	other	JJ
cord-005453-4057qib7	1578	4	hand	hand	NN
cord-005453-4057qib7	1578	5	,	,	,
cord-005453-4057qib7	1578	6	one	one	CD
cord-005453-4057qib7	1578	7	study	study	NN
cord-005453-4057qib7	1578	8	indicated	indicate	VBD
cord-005453-4057qib7	1578	9	that	that	IN
cord-005453-4057qib7	1578	10	the	the	DT
cord-005453-4057qib7	1578	11	expectations	expectation	NNS
cord-005453-4057qib7	1578	12	placed	place	VBN
cord-005453-4057qib7	1578	13	in	in	IN
cord-005453-4057qib7	1578	14	cord	cord	NN
cord-005453-4057qib7	1578	15	blood	blood	NN
cord-005453-4057qib7	1578	16	banking	banking	NN
cord-005453-4057qib7	1578	17	may	may	MD
cord-005453-4057qib7	1578	18	be	be	VB
cord-005453-4057qib7	1578	19	unreasonable	unreasonable	JJ
cord-005453-4057qib7	1578	20	.	.	.
cord-005453-4057qib7	1579	1	As	as	IN
cord-005453-4057qib7	1579	2	a	a	DT
cord-005453-4057qib7	1579	3	private	private	JJ
cord-005453-4057qib7	1579	4	cord	cord	NN
cord-005453-4057qib7	1579	5	blood	blood	NN
cord-005453-4057qib7	1579	6	bank	bank	NN
cord-005453-4057qib7	1579	7	,	,	,
cord-005453-4057qib7	1579	8	we	-PRON-	PRP
cord-005453-4057qib7	1579	9	support	support	VBP
cord-005453-4057qib7	1579	10	recommendations	recommendation	NNS
cord-005453-4057qib7	1579	11	which	which	WDT
cord-005453-4057qib7	1579	12	underline	underline	VBP
cord-005453-4057qib7	1579	13	the	the	DT
cord-005453-4057qib7	1579	14	importance	importance	NN
cord-005453-4057qib7	1579	15	of	of	IN
cord-005453-4057qib7	1579	16	patient	patient	JJ
cord-005453-4057qib7	1579	17	education	education	NN
cord-005453-4057qib7	1579	18	.	.	.
cord-005453-4057qib7	1580	1	In	in	IN
cord-005453-4057qib7	1580	2	Poland	Poland	NNP
cord-005453-4057qib7	1580	3	,	,	,
cord-005453-4057qib7	1580	4	cord	cord	NN
cord-005453-4057qib7	1580	5	blood	blood	NN
cord-005453-4057qib7	1580	6	has	have	VBZ
cord-005453-4057qib7	1580	7	been	be	VBN
cord-005453-4057qib7	1580	8	approved	approve	VBN
cord-005453-4057qib7	1580	9	as	as	IN
cord-005453-4057qib7	1580	10	standard	standard	JJ
cord-005453-4057qib7	1580	11	therapy	therapy	NN
cord-005453-4057qib7	1580	12	in	in	IN
cord-005453-4057qib7	1580	13	approx	approx	NN
cord-005453-4057qib7	1580	14	.	.	.
cord-005453-4057qib7	1581	1	80	80	CD
cord-005453-4057qib7	1581	2	diseases	disease	NNS
cord-005453-4057qib7	1581	3	;	;	:
cord-005453-4057qib7	1581	4	most	most	JJS
cord-005453-4057qib7	1581	5	of	of	IN
cord-005453-4057qib7	1581	6	them	-PRON-	PRP
cord-005453-4057qib7	1581	7	are	be	VBP
cord-005453-4057qib7	1581	8	rare	rare	JJ
cord-005453-4057qib7	1581	9	,	,	,
cord-005453-4057qib7	1581	10	but	but	CC
cord-005453-4057qib7	1581	11	Polish	polish	JJ
cord-005453-4057qib7	1581	12	law	law	NN
cord-005453-4057qib7	1581	13	allows	allow	VBZ
cord-005453-4057qib7	1581	14	the	the	DT
cord-005453-4057qib7	1581	15	use	use	NN
cord-005453-4057qib7	1581	16	of	of	IN
cord-005453-4057qib7	1581	17	cord	cord	NN
cord-005453-4057qib7	1581	18	blood	blood	NN
cord-005453-4057qib7	1581	19	for	for	IN
cord-005453-4057qib7	1581	20	the	the	DT
cord-005453-4057qib7	1581	21	siblings	sibling	NNS
cord-005453-4057qib7	1581	22	,	,	,
cord-005453-4057qib7	1581	23	parents	parent	NNS
cord-005453-4057qib7	1581	24	and	and	CC
cord-005453-4057qib7	1581	25	grandparents	grandparent	NNS
cord-005453-4057qib7	1581	26	of	of	IN
cord-005453-4057qib7	1581	27	a	a	DT
cord-005453-4057qib7	1581	28	donor	donor	NN
cord-005453-4057qib7	1581	29	.	.	.
cord-005453-4057qib7	1582	1	Additionally	additionally	RB
cord-005453-4057qib7	1582	2	,	,	,
cord-005453-4057qib7	1582	3	168	168	CD
cord-005453-4057qib7	1582	4	active	active	JJ
cord-005453-4057qib7	1582	5	and	and	CC
cord-005453-4057qib7	1582	6	planned	planned	JJ
cord-005453-4057qib7	1582	7	clinical	clinical	JJ
cord-005453-4057qib7	1582	8	trials	trial	NNS
cord-005453-4057qib7	1582	9	throughout	throughout	IN
cord-005453-4057qib7	1582	10	the	the	DT
cord-005453-4057qib7	1582	11	world	world	NN
cord-005453-4057qib7	1582	12	evaluate	evaluate	VBP
cord-005453-4057qib7	1582	13	the	the	DT
cord-005453-4057qib7	1582	14	therapeutic	therapeutic	JJ
cord-005453-4057qib7	1582	15	efficacy	efficacy	NN
cord-005453-4057qib7	1582	16	of	of	IN
cord-005453-4057qib7	1582	17	cord	cord	NN
cord-005453-4057qib7	1582	18	blood	blood	NN
cord-005453-4057qib7	1582	19	in	in	IN
cord-005453-4057qib7	1582	20	such	such	JJ
cord-005453-4057qib7	1582	21	areas	area	NNS
cord-005453-4057qib7	1582	22	as	as	IN
cord-005453-4057qib7	1582	23	haematology	haematology	NNP
cord-005453-4057qib7	1582	24	,	,	,
cord-005453-4057qib7	1582	25	neurology	neurology	NN
cord-005453-4057qib7	1582	26	,	,	,
cord-005453-4057qib7	1582	27	cardiology	cardiology	NN
cord-005453-4057qib7	1582	28	,	,	,
cord-005453-4057qib7	1582	29	diabetology	diabetology	NN
cord-005453-4057qib7	1582	30	,	,	,
cord-005453-4057qib7	1582	31	congenital	congenital	JJ
cord-005453-4057qib7	1582	32	paediatric	paediatric	JJ
cord-005453-4057qib7	1582	33	disorders	disorder	NNS
cord-005453-4057qib7	1582	34	,	,	,
cord-005453-4057qib7	1582	35	ophthalmology	ophthalmology	NN
cord-005453-4057qib7	1582	36	,	,	,
cord-005453-4057qib7	1582	37	dermatology	dermatology	NN
cord-005453-4057qib7	1582	38	,	,	,
cord-005453-4057qib7	1582	39	gastroenterology	gastroenterology	NN
cord-005453-4057qib7	1582	40	,	,	,
cord-005453-4057qib7	1582	41	HIV	HIV	NNP
cord-005453-4057qib7	1582	42	infection	infection	NN
cord-005453-4057qib7	1582	43	,	,	,
cord-005453-4057qib7	1582	44	and	and	CC
cord-005453-4057qib7	1582	45	the	the	DT
cord-005453-4057qib7	1582	46	quality	quality	NN
cord-005453-4057qib7	1582	47	of	of	IN
cord-005453-4057qib7	1582	48	life	life	NN
cord-005453-4057qib7	1582	49	during	during	IN
cord-005453-4057qib7	1582	50	aging	age	VBG
cord-005453-4057qib7	1582	51	.	.	.
cord-005453-4057qib7	1583	1	Therefore	therefore	RB
cord-005453-4057qib7	1583	2	,	,	,
cord-005453-4057qib7	1583	3	further	further	JJ
cord-005453-4057qib7	1583	4	indications	indication	NNS
cord-005453-4057qib7	1583	5	may	may	MD
cord-005453-4057qib7	1583	6	be	be	VB
cord-005453-4057qib7	1583	7	expected	expect	VBN
cord-005453-4057qib7	1583	8	in	in	IN
cord-005453-4057qib7	1583	9	the	the	DT
cord-005453-4057qib7	1583	10	future	future	NN
cord-005453-4057qib7	1583	11	.	.	.
cord-005453-4057qib7	1584	1	Background	background	NN
cord-005453-4057qib7	1584	2	:	:	:
cord-005453-4057qib7	1585	1	Cytokine	cytokine	NN
cord-005453-4057qib7	1585	2	release	release	NN
cord-005453-4057qib7	1585	3	syndrome	syndrome	NN
cord-005453-4057qib7	1585	4	(	(	-LRB-
cord-005453-4057qib7	1585	5	CRS	CRS	NNP
cord-005453-4057qib7	1585	6	)	)	-RRB-
cord-005453-4057qib7	1585	7	has	have	VBZ
cord-005453-4057qib7	1585	8	been	be	VBN
cord-005453-4057qib7	1585	9	identified	identify	VBN
cord-005453-4057qib7	1585	10	as	as	IN
cord-005453-4057qib7	1585	11	a	a	DT
cord-005453-4057qib7	1585	12	clinically	clinically	RB
cord-005453-4057qib7	1585	13	significant	significant	JJ
cord-005453-4057qib7	1585	14	,	,	,
cord-005453-4057qib7	1585	15	on	on	IN
cord-005453-4057qib7	1585	16	target	target	NN
cord-005453-4057qib7	1585	17	,	,	,
cord-005453-4057qib7	1585	18	off	off	IN
cord-005453-4057qib7	1585	19	tumour	tumour	NN
cord-005453-4057qib7	1585	20	side	side	NN
cord-005453-4057qib7	1585	21	effect	effect	NN
cord-005453-4057qib7	1585	22	of	of	IN
cord-005453-4057qib7	1585	23	the	the	DT
cord-005453-4057qib7	1585	24	chimeric	chimeric	JJ
cord-005453-4057qib7	1585	25	antigen	antigen	NN
cord-005453-4057qib7	1585	26	receptor	receptor	NN
cord-005453-4057qib7	1585	27	(	(	-LRB-
cord-005453-4057qib7	1585	28	CAR	car	NN
cord-005453-4057qib7	1585	29	)	)	-RRB-
cord-005453-4057qib7	1585	30	T	T	NNP
cord-005453-4057qib7	1585	31	-	-	HYPH
cord-005453-4057qib7	1585	32	Cell	cell	NN
cord-005453-4057qib7	1585	33	therapies	therapy	NNS
cord-005453-4057qib7	1585	34	.	.	.
cord-005453-4057qib7	1586	1	It	-PRON-	PRP
cord-005453-4057qib7	1586	2	is	be	VBZ
cord-005453-4057qib7	1586	3	clinically	clinically	RB
cord-005453-4057qib7	1586	4	increased	increase	VBN
cord-005453-4057qib7	1586	5	in	in	IN
cord-005453-4057qib7	1586	6	interkeukin	interkeukin	NNP
cord-005453-4057qib7	1586	7	6	6	CD
cord-005453-4057qib7	1586	8	and	and	CC
cord-005453-4057qib7	1586	9	elevations	elevation	NNS
cord-005453-4057qib7	1586	10	in	in	IN
cord-005453-4057qib7	1586	11	other	other	JJ
cord-005453-4057qib7	1586	12	cytokines	cytokine	NNS
cord-005453-4057qib7	1586	13	,	,	,
cord-005453-4057qib7	1586	14	lactate	lactate	NN
cord-005453-4057qib7	1586	15	dehydrogenase	dehydrogenase	NN
cord-005453-4057qib7	1586	16	(	(	-LRB-
cord-005453-4057qib7	1586	17	LDH	LDH	NNP
cord-005453-4057qib7	1586	18	)	)	-RRB-
cord-005453-4057qib7	1586	19	,	,	,
cord-005453-4057qib7	1586	20	C	C	NNP
cord-005453-4057qib7	1586	21	-	-	HYPH
cord-005453-4057qib7	1586	22	reactive	reactive	JJ
cord-005453-4057qib7	1586	23	protein	protein	NN
cord-005453-4057qib7	1586	24	(	(	-LRB-
cord-005453-4057qib7	1586	25	CRP	CRP	NNP
cord-005453-4057qib7	1586	26	)	)	-RRB-
cord-005453-4057qib7	1586	27	,	,	,
cord-005453-4057qib7	1586	28	and	and	CC
cord-005453-4057qib7	1586	29	ferritin	ferritin	NN
cord-005453-4057qib7	1586	30	.	.	.
cord-005453-4057qib7	1587	1	These	these	DT
cord-005453-4057qib7	1587	2	side	side	NN
cord-005453-4057qib7	1587	3	effects	effect	NNS
cord-005453-4057qib7	1587	4	can	can	MD
cord-005453-4057qib7	1587	5	include	include	VB
cord-005453-4057qib7	1587	6	fever	fever	NN
cord-005453-4057qib7	1587	7	,	,	,
cord-005453-4057qib7	1587	8	fatigue	fatigue	NN
cord-005453-4057qib7	1587	9	,	,	,
cord-005453-4057qib7	1587	10	headache	headache	NN
cord-005453-4057qib7	1587	11	,	,	,
cord-005453-4057qib7	1587	12	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	1587	13	,	,	,
cord-005453-4057qib7	1587	14	hypertension	hypertension	NN
cord-005453-4057qib7	1587	15	,	,	,
cord-005453-4057qib7	1587	16	tachycardia	tachycardia	NN
cord-005453-4057qib7	1587	17	,	,	,
cord-005453-4057qib7	1587	18	coagulopathy	coagulopathy	NN
cord-005453-4057qib7	1587	19	,	,	,
cord-005453-4057qib7	1587	20	nausea	nausea	NN
cord-005453-4057qib7	1587	21	,	,	,
cord-005453-4057qib7	1587	22	capillary	capillary	JJ
cord-005453-4057qib7	1587	23	leak	leak	NN
cord-005453-4057qib7	1587	24	and	and	CC
cord-005453-4057qib7	1587	25	multi	multi	JJ
cord-005453-4057qib7	1587	26	organ	organ	NN
cord-005453-4057qib7	1587	27	dysfunction	dysfunction	NN
cord-005453-4057qib7	1587	28	.	.	.
cord-005453-4057qib7	1588	1	CRS	CRS	NNP
cord-005453-4057qib7	1588	2	symptoms	symptom	NNS
cord-005453-4057qib7	1588	3	can	can	MD
cord-005453-4057qib7	1588	4	appear	appear	VB
cord-005453-4057qib7	1588	5	as	as	RB
cord-005453-4057qib7	1588	6	early	early	RB
cord-005453-4057qib7	1588	7	as	as	IN
cord-005453-4057qib7	1588	8	one	one	CD
cord-005453-4057qib7	1588	9	day	day	NN
cord-005453-4057qib7	1588	10	after	after	IN
cord-005453-4057qib7	1588	11	infusion	infusion	NN
cord-005453-4057qib7	1588	12	and	and	CC
cord-005453-4057qib7	1588	13	can	can	MD
cord-005453-4057qib7	1588	14	resolve	resolve	VB
cord-005453-4057qib7	1588	15	quickly	quickly	RB
cord-005453-4057qib7	1588	16	or	or	CC
cord-005453-4057qib7	1588	17	last	last	JJ
cord-005453-4057qib7	1588	18	for	for	IN
cord-005453-4057qib7	1588	19	weeks	week	NNS
cord-005453-4057qib7	1588	20	.	.	.
cord-005453-4057qib7	1589	1	It´s	It´s	NNP
cord-005453-4057qib7	1589	2	severity	severity	NN
cord-005453-4057qib7	1589	3	to	to	TO
cord-005453-4057qib7	1589	4	be	be	VB
cord-005453-4057qib7	1589	5	related	relate	VBN
cord-005453-4057qib7	1589	6	to	to	IN
cord-005453-4057qib7	1589	7	the	the	DT
cord-005453-4057qib7	1589	8	disease	disease	NN
cord-005453-4057qib7	1589	9	burden	burden	NN
cord-005453-4057qib7	1589	10	prior	prior	RB
cord-005453-4057qib7	1589	11	to	to	IN
cord-005453-4057qib7	1589	12	CAR	CAR	NNP
cord-005453-4057qib7	1589	13	T	T	NNP
cord-005453-4057qib7	1589	14	-	-	HYPH
cord-005453-4057qib7	1589	15	Cell	cell	NN
cord-005453-4057qib7	1589	16	therapy	therapy	NN
cord-005453-4057qib7	1589	17	.	.	.
cord-005453-4057qib7	1590	1	Methods	method	NNS
cord-005453-4057qib7	1590	2	:	:	:
cord-005453-4057qib7	1590	3	The	the	DT
cord-005453-4057qib7	1590	4	Bristol	Bristol	NNP
cord-005453-4057qib7	1590	5	Oncology	Oncology	NNP
cord-005453-4057qib7	1590	6	and	and	CC
cord-005453-4057qib7	1590	7	Haematology	Haematology	NNP
cord-005453-4057qib7	1590	8	centre	centre	NN
cord-005453-4057qib7	1590	9	will	will	MD
cord-005453-4057qib7	1590	10	be	be	VB
cord-005453-4057qib7	1590	11	providing	provide	VBG
cord-005453-4057qib7	1590	12	CAR	car	NN
cord-005453-4057qib7	1590	13	T	T	NNP
cord-005453-4057qib7	1590	14	-	-	HYPH
cord-005453-4057qib7	1590	15	Cell	cell	NN
cord-005453-4057qib7	1590	16	therapy	therapy	NN
cord-005453-4057qib7	1590	17	to	to	IN
cord-005453-4057qib7	1590	18	patients	patient	NNS
cord-005453-4057qib7	1590	19	in	in	IN
cord-005453-4057qib7	1590	20	early	early	JJ
cord-005453-4057qib7	1590	21	2019	2019	CD
cord-005453-4057qib7	1590	22	.	.	.
cord-005453-4057qib7	1591	1	On	on	IN
cord-005453-4057qib7	1591	2	collating	collate	VBG
cord-005453-4057qib7	1591	3	from	from	IN
cord-005453-4057qib7	1591	4	the	the	DT
cord-005453-4057qib7	1591	5	leading	lead	VBG
cord-005453-4057qib7	1591	6	consultant	consultant	NN
cord-005453-4057qib7	1591	7	on	on	IN
cord-005453-4057qib7	1591	8	the	the	DT
cord-005453-4057qib7	1591	9	ward	ward	NN
cord-005453-4057qib7	1591	10	and	and	CC
cord-005453-4057qib7	1591	11	fellow	fellow	JJ
cord-005453-4057qib7	1591	12	nursing	nursing	NN
cord-005453-4057qib7	1591	13	team	team	NN
cord-005453-4057qib7	1591	14	members	member	NNS
cord-005453-4057qib7	1591	15	it	-PRON-	PRP
cord-005453-4057qib7	1591	16	was	be	VBD
cord-005453-4057qib7	1591	17	apparent	apparent	JJ
cord-005453-4057qib7	1591	18	that	that	IN
cord-005453-4057qib7	1591	19	an	an	DT
cord-005453-4057qib7	1591	20	effective	effective	JJ
cord-005453-4057qib7	1591	21	way	way	NN
cord-005453-4057qib7	1591	22	at	at	IN
cord-005453-4057qib7	1591	23	managing	manage	VBG
cord-005453-4057qib7	1591	24	patients	patient	NNS
cord-005453-4057qib7	1591	25	post	post	VBP
cord-005453-4057qib7	1591	26	CAR	car	NN
cord-005453-4057qib7	1591	27	T	T	NNP
cord-005453-4057qib7	1591	28	-	-	HYPH
cord-005453-4057qib7	1591	29	Cell	cell	NN
cord-005453-4057qib7	1591	30	therapy	therapy	NN
cord-005453-4057qib7	1591	31	side	side	NN
cord-005453-4057qib7	1591	32	effects	effect	NNS
cord-005453-4057qib7	1591	33	is	be	VBZ
cord-005453-4057qib7	1591	34	to	to	TO
cord-005453-4057qib7	1591	35	provide	provide	VB
cord-005453-4057qib7	1591	36	an	an	DT
cord-005453-4057qib7	1591	37	educational	educational	JJ
cord-005453-4057qib7	1591	38	and	and	CC
cord-005453-4057qib7	1591	39	informative	informative	JJ
cord-005453-4057qib7	1591	40	poster	poster	NN
cord-005453-4057qib7	1591	41	depicting	depict	VBG
cord-005453-4057qib7	1591	42	a	a	DT
cord-005453-4057qib7	1591	43	flow	flow	NN
cord-005453-4057qib7	1591	44	chart	chart	NN
cord-005453-4057qib7	1591	45	that	that	WDT
cord-005453-4057qib7	1591	46	will	will	MD
cord-005453-4057qib7	1591	47	aid	aid	VB
cord-005453-4057qib7	1591	48	the	the	DT
cord-005453-4057qib7	1591	49	practitioner	practitioner	NN
cord-005453-4057qib7	1591	50	to	to	TO
cord-005453-4057qib7	1591	51	recognise	recognise	VB
cord-005453-4057qib7	1591	52	and	and	CC
cord-005453-4057qib7	1591	53	effectively	effectively	RB
cord-005453-4057qib7	1591	54	treat	treat	VB
cord-005453-4057qib7	1591	55	/	/	SYM
cord-005453-4057qib7	1591	56	manage	manage	VB
cord-005453-4057qib7	1591	57	a	a	DT
cord-005453-4057qib7	1591	58	patient	patient	NN
cord-005453-4057qib7	1591	59	with	with	IN
cord-005453-4057qib7	1591	60	CRS	CRS	NNP
cord-005453-4057qib7	1591	61	symptoms	symptom	NNS
cord-005453-4057qib7	1591	62	.	.	.
cord-005453-4057qib7	1592	1	Results	result	NNS
cord-005453-4057qib7	1592	2	:	:	:
cord-005453-4057qib7	1593	1	None	none	NN
cord-005453-4057qib7	1593	2	as	as	IN
cord-005453-4057qib7	1593	3	of	of	IN
cord-005453-4057qib7	1593	4	yet	yet	RB
cord-005453-4057qib7	1593	5	as	as	IN
cord-005453-4057qib7	1593	6	this	this	DT
cord-005453-4057qib7	1593	7	is	be	VBZ
cord-005453-4057qib7	1593	8	a	a	DT
cord-005453-4057qib7	1593	9	prospective	prospective	JJ
cord-005453-4057qib7	1593	10	tool	tool	NN
cord-005453-4057qib7	1593	11	ready	ready	JJ
cord-005453-4057qib7	1593	12	for	for	IN
cord-005453-4057qib7	1593	13	our	-PRON-	PRP$
cord-005453-4057qib7	1593	14	first	first	JJ
cord-005453-4057qib7	1593	15	patient	patient	NN
cord-005453-4057qib7	1593	16	in	in	IN
cord-005453-4057qib7	1593	17	early	early	JJ
cord-005453-4057qib7	1593	18	2019	2019	CD
cord-005453-4057qib7	1593	19	Conclusions	conclusion	NNS
cord-005453-4057qib7	1593	20	:	:	:
cord-005453-4057qib7	1594	1	Through	through	IN
cord-005453-4057qib7	1594	2	continuing	continue	VBG
cord-005453-4057qib7	1594	3	reading	reading	NN
cord-005453-4057qib7	1594	4	and	and	CC
cord-005453-4057qib7	1594	5	study	study	NN
cord-005453-4057qib7	1594	6	days	day	NNS
cord-005453-4057qib7	1594	7	prior	prior	RB
cord-005453-4057qib7	1594	8	to	to	IN
cord-005453-4057qib7	1594	9	the	the	DT
cord-005453-4057qib7	1594	10	ward	ward	NN
cord-005453-4057qib7	1594	11	receiving	receive	VBG
cord-005453-4057qib7	1594	12	its	-PRON-	PRP$
cord-005453-4057qib7	1594	13	first	first	JJ
cord-005453-4057qib7	1594	14	CAR	car	NN
cord-005453-4057qib7	1594	15	T	T	NNP
cord-005453-4057qib7	1594	16	-	-	HYPH
cord-005453-4057qib7	1594	17	Cell	cell	NN
cord-005453-4057qib7	1594	18	patient	patient	NN
cord-005453-4057qib7	1594	19	it	-PRON-	PRP
cord-005453-4057qib7	1594	20	is	be	VBZ
cord-005453-4057qib7	1594	21	increasingly	increasingly	RB
cord-005453-4057qib7	1594	22	important	important	JJ
cord-005453-4057qib7	1594	23	that	that	IN
cord-005453-4057qib7	1594	24	the	the	DT
cord-005453-4057qib7	1594	25	entire	entire	JJ
cord-005453-4057qib7	1594	26	multi	multi	JJ
cord-005453-4057qib7	1594	27	disciplinary	disciplinary	JJ
cord-005453-4057qib7	1594	28	team	team	NN
cord-005453-4057qib7	1594	29	recognise	recognise	VBP
cord-005453-4057qib7	1594	30	CRS	CRS	NNP
cord-005453-4057qib7	1594	31	and	and	CC
cord-005453-4057qib7	1594	32	understand	understand	VB
cord-005453-4057qib7	1594	33	the	the	DT
cord-005453-4057qib7	1594	34	importance	importance	NN
cord-005453-4057qib7	1594	35	of	of	IN
cord-005453-4057qib7	1594	36	early	early	JJ
cord-005453-4057qib7	1594	37	detection	detection	NN
cord-005453-4057qib7	1594	38	,	,	,
cord-005453-4057qib7	1594	39	careful	careful	JJ
cord-005453-4057qib7	1594	40	monitoring	monitoring	NN
cord-005453-4057qib7	1594	41	and	and	CC
cord-005453-4057qib7	1594	42	early	early	JJ
cord-005453-4057qib7	1594	43	intervention	intervention	NN
cord-005453-4057qib7	1594	44	.	.	.
cord-005453-4057qib7	1595	1	Background	background	NN
cord-005453-4057qib7	1595	2	:	:	:
cord-005453-4057qib7	1596	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	1596	2	stem	stem	VBP
cord-005453-4057qib7	1596	3	cell	cell	NN
cord-005453-4057qib7	1596	4	transplantation	transplantation	NN
cord-005453-4057qib7	1596	5	(	(	-LRB-
cord-005453-4057qib7	1596	6	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1596	7	)	)	-RRB-
cord-005453-4057qib7	1596	8	is	be	VBZ
cord-005453-4057qib7	1596	9	the	the	DT
cord-005453-4057qib7	1596	10	only	only	JJ
cord-005453-4057qib7	1596	11	curative	curative	JJ
cord-005453-4057qib7	1596	12	procedure	procedure	NN
cord-005453-4057qib7	1596	13	for	for	IN
cord-005453-4057qib7	1596	14	primary	primary	JJ
cord-005453-4057qib7	1596	15	and	and	CC
cord-005453-4057qib7	1596	16	secondary	secondary	JJ
cord-005453-4057qib7	1596	17	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	1596	18	(	(	-LRB-
cord-005453-4057qib7	1596	19	PMF	PMF	NNP
cord-005453-4057qib7	1596	20	,	,	,
cord-005453-4057qib7	1596	21	SMF	SMF	NNP
cord-005453-4057qib7	1596	22	)	)	-RRB-
cord-005453-4057qib7	1596	23	.	.	.
cord-005453-4057qib7	1597	1	Elderly	elderly	JJ
cord-005453-4057qib7	1597	2	people	people	NNS
cord-005453-4057qib7	1597	3	are	be	VBP
cord-005453-4057qib7	1597	4	mainly	mainly	RB
cord-005453-4057qib7	1597	5	affected	affect	VBN
cord-005453-4057qib7	1597	6	,	,	,
cord-005453-4057qib7	1597	7	limiting	limit	VBG
cord-005453-4057qib7	1597	8	the	the	DT
cord-005453-4057qib7	1597	9	feasibility	feasibility	NN
cord-005453-4057qib7	1597	10	of	of	IN
cord-005453-4057qib7	1597	11	intensive	intensive	JJ
cord-005453-4057qib7	1597	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	1597	13	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	1597	14	regimens	regimen	NNS
cord-005453-4057qib7	1597	15	.	.	.
cord-005453-4057qib7	1598	1	The	the	DT
cord-005453-4057qib7	1598	2	introduction	introduction	NN
cord-005453-4057qib7	1598	3	of	of	IN
cord-005453-4057qib7	1598	4	reduced	reduce	VBN
cord-005453-4057qib7	1598	5	-	-	HYPH
cord-005453-4057qib7	1598	6	intensity	intensity	NN
cord-005453-4057qib7	1598	7	conditioning	conditioning	NN
cord-005453-4057qib7	1598	8	(	(	-LRB-
cord-005453-4057qib7	1598	9	RIC	RIC	NNP
cord-005453-4057qib7	1598	10	)	)	-RRB-
cord-005453-4057qib7	1598	11	made	make	VBD
cord-005453-4057qib7	1598	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1598	13	feasible	feasible	JJ
cord-005453-4057qib7	1598	14	and	and	CC
cord-005453-4057qib7	1598	15	effective	effective	JJ
cord-005453-4057qib7	1598	16	for	for	IN
cord-005453-4057qib7	1598	17	old	old	JJ
cord-005453-4057qib7	1598	18	patients	patient	NNS
cord-005453-4057qib7	1598	19	.	.	.
cord-005453-4057qib7	1599	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	1599	2	,	,	,
cord-005453-4057qib7	1599	3	the	the	DT
cord-005453-4057qib7	1599	4	incidence	incidence	NN
cord-005453-4057qib7	1599	5	of	of	IN
cord-005453-4057qib7	1599	6	PMF	PMF	NNP
cord-005453-4057qib7	1599	7	and	and	CC
cord-005453-4057qib7	1599	8	SMF	SMF	NNP
cord-005453-4057qib7	1599	9	is	be	VBZ
cord-005453-4057qib7	1599	10	not	not	RB
cord-005453-4057qib7	1599	11	negligible	negligible	JJ
cord-005453-4057qib7	1599	12	in	in	IN
cord-005453-4057qib7	1599	13	young	young	JJ
cord-005453-4057qib7	1599	14	patients	patient	NNS
cord-005453-4057qib7	1599	15	,	,	,
cord-005453-4057qib7	1599	16	theoretically	theoretically	RB
cord-005453-4057qib7	1599	17	able	able	JJ
cord-005453-4057qib7	1599	18	to	to	TO
cord-005453-4057qib7	1599	19	tolerate	tolerate	VB
cord-005453-4057qib7	1599	20	also	also	RB
cord-005453-4057qib7	1599	21	high	high	JJ
cord-005453-4057qib7	1599	22	-	-	HYPH
cord-005453-4057qib7	1599	23	intensity	intensity	NN
cord-005453-4057qib7	1599	24	therapy	therapy	NN
cord-005453-4057qib7	1599	25	.	.	.
cord-005453-4057qib7	1600	1	Very	very	RB
cord-005453-4057qib7	1600	2	few	few	JJ
cord-005453-4057qib7	1600	3	data	datum	NNS
cord-005453-4057qib7	1600	4	are	be	VBP
cord-005453-4057qib7	1600	5	available	available	JJ
cord-005453-4057qib7	1600	6	about	about	IN
cord-005453-4057qib7	1600	7	the	the	DT
cord-005453-4057qib7	1600	8	efficacy	efficacy	NN
cord-005453-4057qib7	1600	9	of	of	IN
cord-005453-4057qib7	1600	10	RIC	RIC	NNP
cord-005453-4057qib7	1600	11	-	-	HYPH
cord-005453-4057qib7	1600	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1600	13	in	in	IN
cord-005453-4057qib7	1600	14	the	the	DT
cord-005453-4057qib7	1600	15	particular	particular	JJ
cord-005453-4057qib7	1600	16	setting	setting	NN
cord-005453-4057qib7	1600	17	of	of	IN
cord-005453-4057qib7	1600	18	young	young	JJ
cord-005453-4057qib7	1600	19	-	-	HYPH
cord-005453-4057qib7	1600	20	aged	aged	JJ
cord-005453-4057qib7	1600	21	MF	MF	NNP
cord-005453-4057qib7	1600	22	patients	patient	NNS
cord-005453-4057qib7	1600	23	.	.	.
cord-005453-4057qib7	1601	1	Methods	method	NNS
cord-005453-4057qib7	1601	2	:	:	:
cord-005453-4057qib7	1602	1	This	this	DT
cord-005453-4057qib7	1602	2	study	study	NN
cord-005453-4057qib7	1602	3	includes	include	VBZ
cord-005453-4057qib7	1602	4	56	56	CD
cord-005453-4057qib7	1602	5	Myelofibrosis	Myelofibrosis	NNP
cord-005453-4057qib7	1602	6	young	young	JJ
cord-005453-4057qib7	1602	7	patients	patient	NNS
cord-005453-4057qib7	1602	8	(	(	-LRB-
cord-005453-4057qib7	1602	9	age	age	NN
cord-005453-4057qib7	1602	10	<	<	XX
cord-005453-4057qib7	1602	11	55y	55y	CD
cord-005453-4057qib7	1602	12	)	)	-RRB-
cord-005453-4057qib7	1602	13	who	who	WP
cord-005453-4057qib7	1602	14	received	receive	VBD
cord-005453-4057qib7	1602	15	alloSCT	allosct	NN
cord-005453-4057qib7	1602	16	between	between	IN
cord-005453-4057qib7	1602	17	2002	2002	CD
cord-005453-4057qib7	1602	18	and	and	CC
cord-005453-4057qib7	1602	19	2016	2016	CD
cord-005453-4057qib7	1602	20	at	at	IN
cord-005453-4057qib7	1602	21	the	the	DT
cord-005453-4057qib7	1602	22	University	University	NNP
cord-005453-4057qib7	1602	23	Hospital	Hospital	NNP
cord-005453-4057qib7	1602	24	Hamburg	Hamburg	NNP
cord-005453-4057qib7	1602	25	/	/	SYM
cord-005453-4057qib7	1602	26	Germany	Germany	NNP
cord-005453-4057qib7	1602	27	.	.	.
cord-005453-4057qib7	1603	1	Four	four	CD
cord-005453-4057qib7	1603	2	patients	patient	NNS
cord-005453-4057qib7	1603	3	were	be	VBD
cord-005453-4057qib7	1603	4	previously	previously	RB
cord-005453-4057qib7	1603	5	splenectomized	splenectomize	VBN
cord-005453-4057qib7	1603	6	.	.	.
cord-005453-4057qib7	1604	1	Patients	patient	NNS
cord-005453-4057qib7	1604	2	mostly	mostly	RB
cord-005453-4057qib7	1604	3	fall	fall	VBP
cord-005453-4057qib7	1604	4	into	into	IN
cord-005453-4057qib7	1604	5	intermediate	intermediate	JJ
cord-005453-4057qib7	1604	6	risk	risk	NN
cord-005453-4057qib7	1604	7	groups	group	NNS
cord-005453-4057qib7	1604	8	according	accord	VBG
cord-005453-4057qib7	1604	9	to	to	IN
cord-005453-4057qib7	1604	10	DIPSS	DIPSS	NNP
cord-005453-4057qib7	1604	11	.	.	.
cord-005453-4057qib7	1605	1	Four	four	CD
cord-005453-4057qib7	1605	2	patients	patient	NNS
cord-005453-4057qib7	1605	3	belonged	belong	VBD
cord-005453-4057qib7	1605	4	to	to	IN
cord-005453-4057qib7	1605	5	the	the	DT
cord-005453-4057qib7	1605	6	high	high	JJ
cord-005453-4057qib7	1605	7	-	-	HYPH
cord-005453-4057qib7	1605	8	risk	risk	NN
cord-005453-4057qib7	1605	9	triple	triple	JJ
cord-005453-4057qib7	1605	10	-	-	HYPH
cord-005453-4057qib7	1605	11	negative	negative	JJ
cord-005453-4057qib7	1605	12	category	category	NN
cord-005453-4057qib7	1605	13	(	(	-LRB-
cord-005453-4057qib7	1605	14	JAK2	JAK2	NNP
cord-005453-4057qib7	1605	15	/	/	SYM
cord-005453-4057qib7	1605	16	CALR	CALR	NNP
cord-005453-4057qib7	1605	17	/	/	SYM
cord-005453-4057qib7	1605	18	MPL-	MPL-	NNP
cord-005453-4057qib7	1605	19	)	)	-RRB-
cord-005453-4057qib7	1605	20	.	.	.
cord-005453-4057qib7	1606	1	ASXL1-mut	ASXL1-mut	NNP
cord-005453-4057qib7	1606	2	was	be	VBD
cord-005453-4057qib7	1606	3	tested	test	VBN
cord-005453-4057qib7	1606	4	in	in	IN
cord-005453-4057qib7	1606	5	50	50	CD
cord-005453-4057qib7	1606	6	patients	patient	NNS
cord-005453-4057qib7	1606	7	(	(	-LRB-
cord-005453-4057qib7	1606	8	pos	pos	NNP
cord-005453-4057qib7	1606	9	:	:	:
cord-005453-4057qib7	1606	10	17	17	CD
cord-005453-4057qib7	1606	11	)	)	-RRB-
cord-005453-4057qib7	1606	12	.	.	.
cord-005453-4057qib7	1607	1	In	in	IN
cord-005453-4057qib7	1607	2	96	96	CD
cord-005453-4057qib7	1607	3	%	%	NN
cord-005453-4057qib7	1607	4	graft	graft	NN
cord-005453-4057qib7	1607	5	source	source	NN
cord-005453-4057qib7	1607	6	was	be	VBD
cord-005453-4057qib7	1607	7	PBSC	PBSC	NNP
cord-005453-4057qib7	1607	8	,	,	,
cord-005453-4057qib7	1607	9	2	2	CD
cord-005453-4057qib7	1607	10	patients	patient	NNS
cord-005453-4057qib7	1607	11	received	receive	VBD
cord-005453-4057qib7	1607	12	BMSC	BMSC	NNP
cord-005453-4057qib7	1607	13	.	.	.
cord-005453-4057qib7	1608	1	Only	only	RB
cord-005453-4057qib7	1608	2	30	30	CD
cord-005453-4057qib7	1608	3	%	%	NN
cord-005453-4057qib7	1608	4	of	of	IN
cord-005453-4057qib7	1608	5	patients	patient	NNS
cord-005453-4057qib7	1608	6	had	have	VBD
cord-005453-4057qib7	1608	7	a	a	DT
cord-005453-4057qib7	1608	8	10/10	10/10	CD
cord-005453-4057qib7	1608	9	HLA	HLA	NNP
cord-005453-4057qib7	1608	10	-	-	HYPH
cord-005453-4057qib7	1608	11	matched	match	VBN
cord-005453-4057qib7	1608	12	sibling	sibling	NN
cord-005453-4057qib7	1608	13	,	,	,
cord-005453-4057qib7	1608	14	the	the	DT
cord-005453-4057qib7	1608	15	others	other	NNS
cord-005453-4057qib7	1608	16	were	be	VBD
cord-005453-4057qib7	1608	17	transplanted	transplant	VBN
cord-005453-4057qib7	1608	18	from	from	IN
cord-005453-4057qib7	1608	19	fully	fully	RB
cord-005453-4057qib7	1608	20	-	-	HYPH
cord-005453-4057qib7	1608	21	matched	match	VBN
cord-005453-4057qib7	1608	22	(	(	-LRB-
cord-005453-4057qib7	1608	23	36	36	CD
cord-005453-4057qib7	1608	24	%	%	NN
cord-005453-4057qib7	1608	25	)	)	-RRB-
cord-005453-4057qib7	1608	26	or	or	CC
cord-005453-4057qib7	1608	27	partially	partially	RB
cord-005453-4057qib7	1608	28	-	-	HYPH
cord-005453-4057qib7	1608	29	matched	match	VBN
cord-005453-4057qib7	1608	30	(	(	-LRB-
cord-005453-4057qib7	1608	31	34	34	CD
cord-005453-4057qib7	1608	32	%	%	NN
cord-005453-4057qib7	1608	33	)	)	-RRB-
cord-005453-4057qib7	1608	34	unrelated	unrelated	JJ
cord-005453-4057qib7	1608	35	donor	donor	NN
cord-005453-4057qib7	1608	36	.	.	.
cord-005453-4057qib7	1609	1	All	all	DT
cord-005453-4057qib7	1609	2	transplants	transplant	NNS
cord-005453-4057qib7	1609	3	were	be	VBD
cord-005453-4057qib7	1609	4	conditioned	condition	VBN
cord-005453-4057qib7	1609	5	according	accord	VBG
cord-005453-4057qib7	1609	6	the	the	DT
cord-005453-4057qib7	1609	7	EBMT	EBMT	NNP
cord-005453-4057qib7	1609	8	protocol	protocol	NN
cord-005453-4057qib7	1609	9	with	with	IN
cord-005453-4057qib7	1609	10	Busulfan	Busulfan	NNP
cord-005453-4057qib7	1609	11	(	(	-LRB-
cord-005453-4057qib7	1609	12	10	10	CD
cord-005453-4057qib7	1609	13	mg	mg	NNP
cord-005453-4057qib7	1609	14	/	/	SYM
cord-005453-4057qib7	1609	15	Kg	Kg	NNP
cord-005453-4057qib7	1609	16	PO	PO	NNP
cord-005453-4057qib7	1609	17	or	or	CC
cord-005453-4057qib7	1609	18	8	8	CD
cord-005453-4057qib7	1609	19	mg	mg	NNP
cord-005453-4057qib7	1609	20	/	/	SYM
cord-005453-4057qib7	1609	21	Kg	Kg	NNP
cord-005453-4057qib7	1609	22	IV	IV	NNP
cord-005453-4057qib7	1609	23	)	)	-RRB-
cord-005453-4057qib7	1609	24	,	,	,
cord-005453-4057qib7	1609	25	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	1609	26	(	(	-LRB-
cord-005453-4057qib7	1609	27	150	150	CD
cord-005453-4057qib7	1609	28	mg	mg	NNP
cord-005453-4057qib7	1609	29	/	/	SYM
cord-005453-4057qib7	1609	30	m2	m2	NNP
cord-005453-4057qib7	1609	31	)	)	-RRB-
cord-005453-4057qib7	1609	32	,	,	,
cord-005453-4057qib7	1609	33	ATLG	ATLG	NNP
cord-005453-4057qib7	1609	34	(	(	-LRB-
cord-005453-4057qib7	1609	35	Grafalon	Grafalon	NNP
cord-005453-4057qib7	1609	36	®	®	.
cord-005453-4057qib7	1609	37	Neovii	Neovii	NNP
cord-005453-4057qib7	1609	38	,	,	,
cord-005453-4057qib7	1609	39	Germany	Germany	NNP
cord-005453-4057qib7	1609	40	)	)	-RRB-
cord-005453-4057qib7	1609	41	administered	administer	VBD
cord-005453-4057qib7	1609	42	in	in	IN
cord-005453-4057qib7	1609	43	3	3	CD
cord-005453-4057qib7	1609	44	days	day	NNS
cord-005453-4057qib7	1609	45	at	at	IN
cord-005453-4057qib7	1609	46	a	a	DT
cord-005453-4057qib7	1609	47	dose	dose	NN
cord-005453-4057qib7	1609	48	of	of	IN
cord-005453-4057qib7	1609	49	20	20	CD
cord-005453-4057qib7	1609	50	mg	mg	NNP
cord-005453-4057qib7	1609	51	/	/	SYM
cord-005453-4057qib7	1609	52	Kg	Kg	NNP
cord-005453-4057qib7	1609	53	die	die	VBP
cord-005453-4057qib7	1609	54	for	for	IN
cord-005453-4057qib7	1609	55	MUD	mud	NN
cord-005453-4057qib7	1609	56	,	,	,
cord-005453-4057qib7	1609	57	10	10	CD
cord-005453-4057qib7	1609	58	mg	mg	NNP
cord-005453-4057qib7	1609	59	/	/	SYM
cord-005453-4057qib7	1609	60	Kg	Kg	NNP
cord-005453-4057qib7	1609	61	die	die	VBP
cord-005453-4057qib7	1609	62	for	for	IN
cord-005453-4057qib7	1609	63	MRD	MRD	NNP
cord-005453-4057qib7	1609	64	transplants	transplant	NNS
cord-005453-4057qib7	1609	65	,	,	,
cord-005453-4057qib7	1609	66	followed	follow	VBN
cord-005453-4057qib7	1609	67	by	by	IN
cord-005453-4057qib7	1609	68	CylosporinA	cylosporina	RB
cord-005453-4057qib7	1609	69	,	,	,
cord-005453-4057qib7	1609	70	and	and	CC
cord-005453-4057qib7	1609	71	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	1609	72	in	in	IN
cord-005453-4057qib7	1609	73	the	the	DT
cord-005453-4057qib7	1609	74	first	first	JJ
cord-005453-4057qib7	1609	75	28	28	CD
cord-005453-4057qib7	1609	76	days	day	NNS
cord-005453-4057qib7	1609	77	.	.	.
cord-005453-4057qib7	1610	1	Results	result	NNS
cord-005453-4057qib7	1610	2	:	:	:
cord-005453-4057qib7	1611	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	1611	2	rate	rate	NN
cord-005453-4057qib7	1611	3	was	be	VBD
cord-005453-4057qib7	1611	4	98	98	CD
cord-005453-4057qib7	1611	5	%	%	NN
cord-005453-4057qib7	1611	6	,	,	,
cord-005453-4057qib7	1611	7	median	median	JJ
cord-005453-4057qib7	1611	8	neutrophil	neutrophil	NN
cord-005453-4057qib7	1611	9	engraftment	engraftment	NN
cord-005453-4057qib7	1611	10	time	time	NN
cord-005453-4057qib7	1611	11	15	15	CD
cord-005453-4057qib7	1611	12	days	day	NNS
cord-005453-4057qib7	1611	13	.	.	.
cord-005453-4057qib7	1612	1	Platelet	platelet	NN
cord-005453-4057qib7	1612	2	engraftment	engraftment	NN
cord-005453-4057qib7	1612	3	was	be	VBD
cord-005453-4057qib7	1612	4	reached	reach	VBN
cord-005453-4057qib7	1612	5	by	by	IN
cord-005453-4057qib7	1612	6	51	51	CD
cord-005453-4057qib7	1612	7	patients	patient	NNS
cord-005453-4057qib7	1612	8	(	(	-LRB-
cord-005453-4057qib7	1612	9	91	91	CD
cord-005453-4057qib7	1612	10	%	%	NN
cord-005453-4057qib7	1612	11	,	,	,
cord-005453-4057qib7	1612	12	median	median	JJ
cord-005453-4057qib7	1612	13	19	19	CD
cord-005453-4057qib7	1612	14	days	day	NNS
cord-005453-4057qib7	1612	15	)	)	-RRB-
cord-005453-4057qib7	1612	16	.	.	.
cord-005453-4057qib7	1613	1	Four	four	CD
cord-005453-4057qib7	1613	2	patients	patient	NNS
cord-005453-4057qib7	1613	3	(	(	-LRB-
cord-005453-4057qib7	1613	4	7	7	CD
cord-005453-4057qib7	1613	5	%	%	NN
cord-005453-4057qib7	1613	6	)	)	-RRB-
cord-005453-4057qib7	1613	7	developed	develop	VBD
cord-005453-4057qib7	1613	8	poor	poor	JJ
cord-005453-4057qib7	1613	9	graft	graft	NN
cord-005453-4057qib7	1613	10	function	function	NN
cord-005453-4057qib7	1613	11	,	,	,
cord-005453-4057qib7	1613	12	successfully	successfully	RB
cord-005453-4057qib7	1613	13	treated	treat	VBN
cord-005453-4057qib7	1613	14	with	with	IN
cord-005453-4057qib7	1613	15	CD34	CD34	NNP
cord-005453-4057qib7	1613	16	+	+	SYM
cord-005453-4057qib7	1613	17	selected	select	VBN
cord-005453-4057qib7	1613	18	PBSC	PBSC	NNP
cord-005453-4057qib7	1613	19	-	-	HYPH
cord-005453-4057qib7	1613	20	boost	boost	NN
cord-005453-4057qib7	1613	21	.	.	.
cord-005453-4057qib7	1614	1	After	after	IN
cord-005453-4057qib7	1614	2	a	a	DT
cord-005453-4057qib7	1614	3	median	median	NN
cord-005453-4057qib7	1614	4	follow	follow	NN
cord-005453-4057qib7	1614	5	up	up	IN
cord-005453-4057qib7	1614	6	of	of	IN
cord-005453-4057qib7	1614	7	8.6	8.6	CD
cord-005453-4057qib7	1614	8	years	year	NNS
cord-005453-4057qib7	1614	9	,	,	,
cord-005453-4057qib7	1614	10	estimated	estimate	VBN
cord-005453-4057qib7	1614	11	5y	5y	NN
cord-005453-4057qib7	1614	12	-	-	HYPH
cord-005453-4057qib7	1614	13	PFS	PFS	NNP
cord-005453-4057qib7	1614	14	and	and	CC
cord-005453-4057qib7	1614	15	OS	OS	NNP
cord-005453-4057qib7	1614	16	were	be	VBD
cord-005453-4057qib7	1614	17	68	68	CD
cord-005453-4057qib7	1614	18	%	%	NN
cord-005453-4057qib7	1614	19	and	and	CC
cord-005453-4057qib7	1614	20	82	82	CD
cord-005453-4057qib7	1614	21	%	%	NN
cord-005453-4057qib7	1614	22	respectively	respectively	RB
cord-005453-4057qib7	1614	23	.	.	.
cord-005453-4057qib7	1615	1	DIPSS	dipss	NN
cord-005453-4057qib7	1615	2	-	-	HYPH
cord-005453-4057qib7	1615	3	risk	risk	NN
cord-005453-4057qib7	1615	4	and	and	CC
cord-005453-4057qib7	1615	5	donor	donor	NN
cord-005453-4057qib7	1615	6	HLA	HLA	NNP
cord-005453-4057qib7	1615	7	-	-	HYPH
cord-005453-4057qib7	1615	8	matching	matching	NN
cord-005453-4057qib7	1615	9	resulted	result	VBD
cord-005453-4057qib7	1615	10	the	the	DT
cord-005453-4057qib7	1615	11	only	only	JJ
cord-005453-4057qib7	1615	12	significant	significant	JJ
cord-005453-4057qib7	1615	13	impacting	impact	VBG
cord-005453-4057qib7	1615	14	factors	factor	NNS
cord-005453-4057qib7	1615	15	on	on	IN
cord-005453-4057qib7	1615	16	OS	OS	NNP
cord-005453-4057qib7	1615	17	.	.	.
cord-005453-4057qib7	1616	1	Neither	neither	DT
cord-005453-4057qib7	1616	2	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	1616	3	nor	nor	CC
cord-005453-4057qib7	1616	4	molecular	molecular	JJ
cord-005453-4057qib7	1616	5	abnormalities	abnormality	NNS
cord-005453-4057qib7	1616	6	were	be	VBD
cord-005453-4057qib7	1616	7	significantly	significantly	RB
cord-005453-4057qib7	1616	8	related	relate	VBN
cord-005453-4057qib7	1616	9	to	to	IN
cord-005453-4057qib7	1616	10	OS	OS	NNP
cord-005453-4057qib7	1616	11	.	.	.
cord-005453-4057qib7	1617	1	Twenty	twenty	CD
cord-005453-4057qib7	1617	2	-	-	HYPH
cord-005453-4057qib7	1617	3	five	five	CD
cord-005453-4057qib7	1617	4	patients	patient	NNS
cord-005453-4057qib7	1617	5	(	(	-LRB-
cord-005453-4057qib7	1617	6	44	44	CD
cord-005453-4057qib7	1617	7	%	%	NN
cord-005453-4057qib7	1617	8	)	)	-RRB-
cord-005453-4057qib7	1617	9	experienced	experience	VBD
cord-005453-4057qib7	1617	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	1617	11	grade	grade	NN
cord-005453-4057qib7	1617	12	>	>	XX
cord-005453-4057qib7	1618	1	1	1	LS
cord-005453-4057qib7	1618	2	.	.	.
cord-005453-4057qib7	1619	1	C	C	NNP
cord-005453-4057qib7	1619	2	-	-	HYPH
cord-005453-4057qib7	1619	3	GVHD	GVHD	NNP
cord-005453-4057qib7	1619	4	was	be	VBD
cord-005453-4057qib7	1619	5	observed	observe	VBN
cord-005453-4057qib7	1619	6	in	in	IN
cord-005453-4057qib7	1619	7	34	34	CD
cord-005453-4057qib7	1619	8	patients	patient	NNS
cord-005453-4057qib7	1619	9	(	(	-LRB-
cord-005453-4057qib7	1619	10	65	65	CD
cord-005453-4057qib7	1619	11	%	%	NN
cord-005453-4057qib7	1619	12	)	)	-RRB-
cord-005453-4057qib7	1619	13	,	,	,
cord-005453-4057qib7	1619	14	mostly	mostly	RB
cord-005453-4057qib7	1619	15	(	(	-LRB-
cord-005453-4057qib7	1619	16	82	82	CD
cord-005453-4057qib7	1619	17	%	%	NN
cord-005453-4057qib7	1619	18	)	)	-RRB-
cord-005453-4057qib7	1619	19	beginning	begin	VBG
cord-005453-4057qib7	1619	20	in	in	IN
cord-005453-4057qib7	1619	21	the	the	DT
cord-005453-4057qib7	1619	22	first	first	JJ
cord-005453-4057qib7	1619	23	300	300	CD
cord-005453-4057qib7	1619	24	days	day	NNS
cord-005453-4057qib7	1619	25	after	after	IN
cord-005453-4057qib7	1619	26	transplantation	transplantation	NN
cord-005453-4057qib7	1619	27	.	.	.
cord-005453-4057qib7	1620	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	1620	2	incidence	incidence	NN
cord-005453-4057qib7	1620	3	of	of	IN
cord-005453-4057qib7	1620	4	TRM	TRM	NNP
cord-005453-4057qib7	1620	5	was	be	VBD
cord-005453-4057qib7	1620	6	7	7	CD
cord-005453-4057qib7	1620	7	%	%	NN
cord-005453-4057qib7	1620	8	at	at	IN
cord-005453-4057qib7	1620	9	1	1	CD
cord-005453-4057qib7	1620	10	year	year	NN
cord-005453-4057qib7	1620	11	,	,	,
cord-005453-4057qib7	1620	12	with	with	IN
cord-005453-4057qib7	1620	13	a	a	DT
cord-005453-4057qib7	1620	14	plateau	plateau	NN
cord-005453-4057qib7	1620	15	after	after	IN
cord-005453-4057qib7	1620	16	the	the	DT
cord-005453-4057qib7	1620	17	first	first	JJ
cord-005453-4057qib7	1620	18	year	year	NN
cord-005453-4057qib7	1621	1	(	(	-LRB-
cord-005453-4057qib7	1621	2	5y	5y	NNP
cord-005453-4057qib7	1621	3	TRM	TRM	NNP
cord-005453-4057qib7	1621	4	=	=	SYM
cord-005453-4057qib7	1621	5	12	12	CD
cord-005453-4057qib7	1621	6	%	%	NN
cord-005453-4057qib7	1621	7	)	)	-RRB-
cord-005453-4057qib7	1621	8	.	.	.
cord-005453-4057qib7	1622	1	TRM	TRM	NNP
cord-005453-4057qib7	1622	2	was	be	VBD
cord-005453-4057qib7	1622	3	observed	observe	VBN
cord-005453-4057qib7	1622	4	only	only	RB
cord-005453-4057qib7	1622	5	in	in	IN
cord-005453-4057qib7	1622	6	patients	patient	NNS
cord-005453-4057qib7	1622	7	with	with	IN
cord-005453-4057qib7	1622	8	maximal	maximal	JJ
cord-005453-4057qib7	1622	9	grade	grade	NN
cord-005453-4057qib7	1622	10	(	(	-LRB-
cord-005453-4057qib7	1622	11	3	3	CD
cord-005453-4057qib7	1622	12	)	)	-RRB-
cord-005453-4057qib7	1622	13	of	of	IN
cord-005453-4057qib7	1622	14	marrow	marrow	NN
cord-005453-4057qib7	1622	15	fibrosis	fibrosis	NN
cord-005453-4057qib7	1622	16	.	.	.
cord-005453-4057qib7	1623	1	Furthermore	furthermore	RB
cord-005453-4057qib7	1623	2	,	,	,
cord-005453-4057qib7	1623	3	TRM	TRM	NNP
cord-005453-4057qib7	1623	4	never	never	RB
cord-005453-4057qib7	1623	5	occurred	occur	VBD
cord-005453-4057qib7	1623	6	in	in	IN
cord-005453-4057qib7	1623	7	previously	previously	RB
cord-005453-4057qib7	1623	8	splenectomized	splenectomize	VBN
cord-005453-4057qib7	1623	9	patients	patient	NNS
cord-005453-4057qib7	1623	10	(	(	-LRB-
cord-005453-4057qib7	1623	11	p=0.00	p=0.00	NNP
cord-005453-4057qib7	1623	12	)	)	-RRB-
cord-005453-4057qib7	1623	13	,	,	,
cord-005453-4057qib7	1623	14	but	but	CC
cord-005453-4057qib7	1623	15	no	no	DT
cord-005453-4057qib7	1623	16	significant	significant	JJ
cord-005453-4057qib7	1623	17	impact	impact	NN
cord-005453-4057qib7	1623	18	from	from	IN
cord-005453-4057qib7	1623	19	splenectomy	splenectomy	NN
cord-005453-4057qib7	1623	20	on	on	IN
cord-005453-4057qib7	1623	21	OS	OS	NNP
cord-005453-4057qib7	1623	22	was	be	VBD
cord-005453-4057qib7	1623	23	observed	observe	VBN
cord-005453-4057qib7	1623	24	(	(	-LRB-
cord-005453-4057qib7	1623	25	p=0.32	p=0.32	RB
cord-005453-4057qib7	1623	26	)	)	-RRB-
cord-005453-4057qib7	1623	27	.	.	.
cord-005453-4057qib7	1624	1	After	after	IN
cord-005453-4057qib7	1624	2	transplant	transplant	NN
cord-005453-4057qib7	1624	3	,	,	,
cord-005453-4057qib7	1624	4	11	11	CD
cord-005453-4057qib7	1624	5	patients	patient	NNS
cord-005453-4057qib7	1624	6	(	(	-LRB-
cord-005453-4057qib7	1624	7	20	20	CD
cord-005453-4057qib7	1624	8	%	%	NN
cord-005453-4057qib7	1624	9	)	)	-RRB-
cord-005453-4057qib7	1624	10	relapsed	relapse	VBN
cord-005453-4057qib7	1624	11	:	:	:
cord-005453-4057qib7	1624	12	1	1	CD
cord-005453-4057qib7	1624	13	died	die	VBD
cord-005453-4057qib7	1624	14	without	without	IN
cord-005453-4057qib7	1624	15	any	any	DT
cord-005453-4057qib7	1624	16	treatment	treatment	NN
cord-005453-4057qib7	1624	17	because	because	IN
cord-005453-4057qib7	1624	18	of	of	IN
cord-005453-4057qib7	1624	19	infection	infection	NN
cord-005453-4057qib7	1624	20	,	,	,
cord-005453-4057qib7	1624	21	9	9	CD
cord-005453-4057qib7	1624	22	received	receive	VBD
cord-005453-4057qib7	1624	23	DLI	DLI	NNP
cord-005453-4057qib7	1624	24	(	(	-LRB-
cord-005453-4057qib7	1624	25	3	3	CD
cord-005453-4057qib7	1624	26	durable	durable	JJ
cord-005453-4057qib7	1624	27	CR	CR	NNP
cord-005453-4057qib7	1624	28	)	)	-RRB-
cord-005453-4057qib7	1624	29	,	,	,
cord-005453-4057qib7	1624	30	7	7	CD
cord-005453-4057qib7	1624	31	patients	patient	NNS
cord-005453-4057qib7	1624	32	(	(	-LRB-
cord-005453-4057qib7	1624	33	6	6	CD
cord-005453-4057qib7	1624	34	after	after	IN
cord-005453-4057qib7	1624	35	DLI	DLI	NNP
cord-005453-4057qib7	1624	36	)	)	-RRB-
cord-005453-4057qib7	1624	37	underwent	undergo	VBD
cord-005453-4057qib7	1624	38	a	a	DT
cord-005453-4057qib7	1624	39	second	second	JJ
cord-005453-4057qib7	1624	40	alloSCT	allosct	NN
cord-005453-4057qib7	1624	41	,	,	,
cord-005453-4057qib7	1624	42	with	with	IN
cord-005453-4057qib7	1624	43	long	long	JJ
cord-005453-4057qib7	1624	44	-	-	HYPH
cord-005453-4057qib7	1624	45	term	term	NN
cord-005453-4057qib7	1624	46	survival	survival	NN
cord-005453-4057qib7	1624	47	in	in	IN
cord-005453-4057qib7	1624	48	5	5	CD
cord-005453-4057qib7	1624	49	cases	case	NNS
cord-005453-4057qib7	1624	50	.	.	.
cord-005453-4057qib7	1625	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1625	2	:	:	:
cord-005453-4057qib7	1626	1	RIC	RIC	NNP
cord-005453-4057qib7	1626	2	followed	follow	VBD
cord-005453-4057qib7	1626	3	by	by	IN
cord-005453-4057qib7	1626	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	1626	5	SCT	SCT	NNP
cord-005453-4057qib7	1626	6	is	be	VBZ
cord-005453-4057qib7	1626	7	a	a	DT
cord-005453-4057qib7	1626	8	curative	curative	JJ
cord-005453-4057qib7	1626	9	treatment	treatment	NN
cord-005453-4057qib7	1626	10	approach	approach	NN
cord-005453-4057qib7	1626	11	for	for	IN
cord-005453-4057qib7	1626	12	younger	young	JJR
cord-005453-4057qib7	1626	13	patients	patient	NNS
cord-005453-4057qib7	1626	14	with	with	IN
cord-005453-4057qib7	1626	15	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1626	16	with	with	IN
cord-005453-4057qib7	1626	17	a	a	DT
cord-005453-4057qib7	1626	18	low	low	JJ
cord-005453-4057qib7	1626	19	NRM	NRM	NNP
cord-005453-4057qib7	1626	20	.	.	.
cord-005453-4057qib7	1627	1	The	the	DT
cord-005453-4057qib7	1627	2	most	most	RBS
cord-005453-4057qib7	1627	3	important	important	JJ
cord-005453-4057qib7	1627	4	outcome	outcome	NN
cord-005453-4057qib7	1627	5	-	-	HYPH
cord-005453-4057qib7	1627	6	determining	determine	VBG
cord-005453-4057qib7	1627	7	factor	factor	NN
cord-005453-4057qib7	1627	8	is	be	VBZ
cord-005453-4057qib7	1627	9	donor	donor	NN
cord-005453-4057qib7	1627	10	HLA	HLA	NNP
cord-005453-4057qib7	1627	11	-	-	HYPH
cord-005453-4057qib7	1627	12	matching	matching	NN
cord-005453-4057qib7	1627	13	.	.	.
cord-005453-4057qib7	1628	1	Interestingly	interestingly	RB
cord-005453-4057qib7	1628	2	,	,	,
cord-005453-4057qib7	1628	3	marrow	marrow	NN
cord-005453-4057qib7	1628	4	high	high	JJ
cord-005453-4057qib7	1628	5	grade	grade	NN
cord-005453-4057qib7	1628	6	fibrosis	fibrosis	NN
cord-005453-4057qib7	1628	7	showed	show	VBD
cord-005453-4057qib7	1628	8	to	to	IN
cord-005453-4057qib7	1628	9	significantly	significantly	RB
cord-005453-4057qib7	1628	10	impact	impact	VB
cord-005453-4057qib7	1628	11	TRM	TRM	NNP
cord-005453-4057qib7	1628	12	.	.	.
cord-005453-4057qib7	1629	1	Biological	biological	JJ
cord-005453-4057qib7	1629	2	markers	marker	NNS
cord-005453-4057qib7	1629	3	such	such	JJ
cord-005453-4057qib7	1629	4	as	as	IN
cord-005453-4057qib7	1629	5	ASXL1	asxl1	NN
cord-005453-4057qib7	1629	6	mutation	mutation	NN
cord-005453-4057qib7	1629	7	and	and	CC
cord-005453-4057qib7	1629	8	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	1629	9	,	,	,
cord-005453-4057qib7	1629	10	largely	largely	RB
cord-005453-4057qib7	1629	11	known	know	VBN
cord-005453-4057qib7	1629	12	as	as	IN
cord-005453-4057qib7	1629	13	highly	highly	RB
cord-005453-4057qib7	1629	14	predictive	predictive	JJ
cord-005453-4057qib7	1629	15	for	for	IN
cord-005453-4057qib7	1629	16	poor	poor	JJ
cord-005453-4057qib7	1629	17	prognosis	prognosis	NN
cord-005453-4057qib7	1629	18	in	in	IN
cord-005453-4057qib7	1629	19	the	the	DT
cord-005453-4057qib7	1629	20	disease	disease	NN
cord-005453-4057qib7	1629	21	natural	natural	JJ
cord-005453-4057qib7	1629	22	course	course	NN
cord-005453-4057qib7	1629	23	,	,	,
cord-005453-4057qib7	1629	24	did	do	VBD
cord-005453-4057qib7	1629	25	not	not	RB
cord-005453-4057qib7	1629	26	show	show	VB
cord-005453-4057qib7	1629	27	any	any	DT
cord-005453-4057qib7	1629	28	impact	impact	NN
cord-005453-4057qib7	1629	29	on	on	IN
cord-005453-4057qib7	1629	30	survival	survival	NN
cord-005453-4057qib7	1629	31	,	,	,
cord-005453-4057qib7	1629	32	suggesting	suggest	VBG
cord-005453-4057qib7	1629	33	that	that	IN
cord-005453-4057qib7	1629	34	patients	patient	NNS
cord-005453-4057qib7	1629	35	harboring	harbor	VBG
cord-005453-4057qib7	1629	36	these	these	DT
cord-005453-4057qib7	1629	37	abnormalities	abnormality	NNS
cord-005453-4057qib7	1629	38	could	could	MD
cord-005453-4057qib7	1629	39	get	get	VB
cord-005453-4057qib7	1629	40	the	the	DT
cord-005453-4057qib7	1629	41	greatest	great	JJS
cord-005453-4057qib7	1629	42	benefit	benefit	NN
cord-005453-4057qib7	1629	43	from	from	IN
cord-005453-4057qib7	1629	44	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1629	45	.	.	.
cord-005453-4057qib7	1630	1	Further	further	JJ
cord-005453-4057qib7	1630	2	data	datum	NNS
cord-005453-4057qib7	1630	3	collection	collection	NN
cord-005453-4057qib7	1630	4	,	,	,
cord-005453-4057qib7	1630	5	and	and	CC
cord-005453-4057qib7	1630	6	a	a	DT
cord-005453-4057qib7	1630	7	prospective	prospective	JJ
cord-005453-4057qib7	1630	8	randomized	randomized	JJ
cord-005453-4057qib7	1630	9	trial	trial	NN
cord-005453-4057qib7	1630	10	are	be	VBP
cord-005453-4057qib7	1630	11	needed	need	VBN
cord-005453-4057qib7	1630	12	to	to	TO
cord-005453-4057qib7	1630	13	confirm	confirm	VB
cord-005453-4057qib7	1630	14	our	-PRON-	PRP$
cord-005453-4057qib7	1630	15	conclusion	conclusion	NN
cord-005453-4057qib7	1630	16	.	.	.
cord-005453-4057qib7	1631	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1631	2	:	:	:
cord-005453-4057qib7	1631	3	Nothing	nothing	NN
cord-005453-4057qib7	1631	4	to	to	TO
cord-005453-4057qib7	1631	5	declare	declare	VB
cord-005453-4057qib7	1631	6	P087	P087	NNP
cord-005453-4057qib7	1631	7	Abstract	Abstract	NNP
cord-005453-4057qib7	1631	8	already	already	RB
cord-005453-4057qib7	1631	9	published	publish	VBN
cord-005453-4057qib7	1631	10	.	.	.
cord-005453-4057qib7	1632	1	Splenectomy	Splenectomy	NNP
cord-005453-4057qib7	1632	2	as	as	IN
cord-005453-4057qib7	1632	3	a	a	DT
cord-005453-4057qib7	1632	4	risk	risk	NN
cord-005453-4057qib7	1632	5	factor	factor	NN
cord-005453-4057qib7	1632	6	for	for	IN
cord-005453-4057qib7	1632	7	relapse	relapse	NN
cord-005453-4057qib7	1632	8	after	after	IN
cord-005453-4057qib7	1632	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	1632	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1632	11	stem	stem	NN
cord-005453-4057qib7	1632	12	cell	cell	NN
cord-005453-4057qib7	1632	13	transplantation	transplantation	NN
cord-005453-4057qib7	1632	14	in	in	IN
cord-005453-4057qib7	1632	15	patients	patient	NNS
cord-005453-4057qib7	1632	16	with	with	IN
cord-005453-4057qib7	1632	17	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1632	18	-retrospective	-retrospective	IN
cord-005453-4057qib7	1632	19	cohort	cohort	NN
cord-005453-4057qib7	1632	20	study	study	NN
cord-005453-4057qib7	1632	21	Background	Background	NNP
cord-005453-4057qib7	1632	22	:	:	:
cord-005453-4057qib7	1633	1	Splenectomy	Splenectomy	NNP
cord-005453-4057qib7	1633	2	is	be	VBZ
cord-005453-4057qib7	1633	3	a	a	DT
cord-005453-4057qib7	1633	4	common	common	JJ
cord-005453-4057qib7	1633	5	procedure	procedure	NN
cord-005453-4057qib7	1633	6	in	in	IN
cord-005453-4057qib7	1633	7	patients	patient	NNS
cord-005453-4057qib7	1633	8	(	(	-LRB-
cord-005453-4057qib7	1633	9	pts	pts	NNP
cord-005453-4057qib7	1633	10	)	)	-RRB-
cord-005453-4057qib7	1633	11	with	with	IN
cord-005453-4057qib7	1633	12	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1633	13	(	(	-LRB-
cord-005453-4057qib7	1633	14	MF	MF	NNP
cord-005453-4057qib7	1633	15	)	)	-RRB-
cord-005453-4057qib7	1633	16	performed	perform	VBD
cord-005453-4057qib7	1633	17	to	to	TO
cord-005453-4057qib7	1633	18	achieve	achieve	VB
cord-005453-4057qib7	1633	19	improvement	improvement	NN
cord-005453-4057qib7	1633	20	in	in	IN
cord-005453-4057qib7	1633	21	blood	blood	NN
cord-005453-4057qib7	1633	22	cell	cell	NN
cord-005453-4057qib7	1633	23	counts	count	NNS
cord-005453-4057qib7	1633	24	and	and	CC
cord-005453-4057qib7	1633	25	reduce	reduce	VB
cord-005453-4057qib7	1633	26	B	b	NN
cord-005453-4057qib7	1633	27	-	-	HYPH
cord-005453-4057qib7	1633	28	symptoms	symptom	NNS
cord-005453-4057qib7	1633	29	.	.	.
cord-005453-4057qib7	1634	1	However	however	RB
cord-005453-4057qib7	1634	2	,	,	,
cord-005453-4057qib7	1634	3	it	-PRON-	PRP
cord-005453-4057qib7	1634	4	has	have	VBZ
cord-005453-4057qib7	1634	5	also	also	RB
cord-005453-4057qib7	1634	6	been	be	VBN
cord-005453-4057qib7	1634	7	shown	show	VBN
cord-005453-4057qib7	1634	8	that	that	IN
cord-005453-4057qib7	1634	9	splenectomy	splenectomy	NN
cord-005453-4057qib7	1634	10	may	may	MD
cord-005453-4057qib7	1634	11	adversely	adversely	RB
cord-005453-4057qib7	1634	12	predispose	predispose	VB
cord-005453-4057qib7	1634	13	to	to	TO
cord-005453-4057qib7	1634	14	leukemic	leukemic	JJ
cord-005453-4057qib7	1634	15	transformation	transformation	NN
cord-005453-4057qib7	1634	16	in	in	IN
cord-005453-4057qib7	1634	17	this	this	DT
cord-005453-4057qib7	1634	18	setting	setting	NN
cord-005453-4057qib7	1634	19	.	.	.
cord-005453-4057qib7	1635	1	Aim	aim	VB
cord-005453-4057qib7	1635	2	:	:	:
cord-005453-4057qib7	1635	3	To	to	TO
cord-005453-4057qib7	1635	4	evaluate	evaluate	VB
cord-005453-4057qib7	1635	5	in	in	IN
cord-005453-4057qib7	1635	6	a	a	DT
cord-005453-4057qib7	1635	7	single	single	JJ
cord-005453-4057qib7	1635	8	-	-	HYPH
cord-005453-4057qib7	1635	9	center	center	NN
cord-005453-4057qib7	1635	10	retrospective	retrospective	JJ
cord-005453-4057qib7	1635	11	analysis	analysis	NN
cord-005453-4057qib7	1635	12	the	the	DT
cord-005453-4057qib7	1635	13	long	long	JJ
cord-005453-4057qib7	1635	14	-	-	HYPH
cord-005453-4057qib7	1635	15	term	term	NN
cord-005453-4057qib7	1635	16	impact	impact	NN
cord-005453-4057qib7	1635	17	of	of	IN
cord-005453-4057qib7	1635	18	pre	pre	JJ
cord-005453-4057qib7	1635	19	-	-	JJ
cord-005453-4057qib7	1635	20	or	or	CC
cord-005453-4057qib7	1635	21	post	post	JJ
cord-005453-4057qib7	1635	22	-	-	JJ
cord-005453-4057qib7	1635	23	transplant	transplant	JJ
cord-005453-4057qib7	1635	24	splenectomy	splenectomy	NN
cord-005453-4057qib7	1635	25	on	on	IN
cord-005453-4057qib7	1635	26	transplant	transplant	NN
cord-005453-4057qib7	1635	27	outcome	outcome	NN
cord-005453-4057qib7	1635	28	regarding	regard	VBG
cord-005453-4057qib7	1635	29	overall	overall	JJ
cord-005453-4057qib7	1635	30	survival	survival	NN
cord-005453-4057qib7	1635	31	and	and	CC
cord-005453-4057qib7	1635	32	relapse	relapse	NN
cord-005453-4057qib7	1635	33	risk	risk	NN
cord-005453-4057qib7	1635	34	.	.	.
cord-005453-4057qib7	1636	1	Methods	method	NNS
cord-005453-4057qib7	1636	2	:	:	:
cord-005453-4057qib7	1637	1	This	this	DT
cord-005453-4057qib7	1637	2	retrospective	retrospective	JJ
cord-005453-4057qib7	1637	3	analysis	analysis	NN
cord-005453-4057qib7	1637	4	comprises	comprise	VBZ
cord-005453-4057qib7	1637	5	the	the	DT
cord-005453-4057qib7	1637	6	data	datum	NNS
cord-005453-4057qib7	1637	7	of	of	IN
cord-005453-4057qib7	1637	8	163	163	CD
cord-005453-4057qib7	1637	9	pts	pt	NNS
cord-005453-4057qib7	1637	10	(	(	-LRB-
cord-005453-4057qib7	1637	11	93	93	CD
cord-005453-4057qib7	1637	12	male	male	NN
cord-005453-4057qib7	1637	13	and	and	CC
cord-005453-4057qib7	1637	14	70	70	CD
cord-005453-4057qib7	1637	15	female	female	NN
cord-005453-4057qib7	1637	16	)	)	-RRB-
cord-005453-4057qib7	1637	17	with	with	IN
cord-005453-4057qib7	1637	18	primary	primary	JJ
cord-005453-4057qib7	1637	19	(	(	-LRB-
cord-005453-4057qib7	1637	20	n=108	n=108	NNP
cord-005453-4057qib7	1637	21	)	)	-RRB-
cord-005453-4057qib7	1637	22	or	or	CC
cord-005453-4057qib7	1637	23	secondary	secondary	JJ
cord-005453-4057qib7	1637	24	(	(	-LRB-
cord-005453-4057qib7	1637	25	n=55	n=55	JJ
cord-005453-4057qib7	1637	26	)	)	-RRB-
cord-005453-4057qib7	1637	27	MF	mf	NN
cord-005453-4057qib7	1637	28	after	after	IN
cord-005453-4057qib7	1637	29	allo	allo	NN
cord-005453-4057qib7	1637	30	-	-	HYPH
cord-005453-4057qib7	1637	31	HSCT	HSCT	NNP
cord-005453-4057qib7	1637	32	from	from	IN
cord-005453-4057qib7	1637	33	HLA	HLA	NNP
cord-005453-4057qib7	1637	34	-	-	HYPH
cord-005453-4057qib7	1637	35	matched	match	VBN
cord-005453-4057qib7	1637	36	sibling	sibling	NN
cord-005453-4057qib7	1637	37	(	(	-LRB-
cord-005453-4057qib7	1637	38	n=48	n=48	NN
cord-005453-4057qib7	1637	39	)	)	-RRB-
cord-005453-4057qib7	1637	40	or	or	CC
cord-005453-4057qib7	1637	41	unrelated	unrelated	JJ
cord-005453-4057qib7	1637	42	(	(	-LRB-
cord-005453-4057qib7	1637	43	n=115	n=115	NNP
cord-005453-4057qib7	1637	44	)	)	-RRB-
cord-005453-4057qib7	1637	45	donors	donor	NNS
cord-005453-4057qib7	1637	46	in	in	IN
cord-005453-4057qib7	1637	47	our	-PRON-	PRP$
cord-005453-4057qib7	1637	48	center	center	NN
cord-005453-4057qib7	1637	49	between	between	IN
cord-005453-4057qib7	1637	50	1994	1994	CD
cord-005453-4057qib7	1637	51	and	and	CC
cord-005453-4057qib7	1637	52	2018	2018	CD
cord-005453-4057qib7	1637	53	.	.	.
cord-005453-4057qib7	1638	1	The	the	DT
cord-005453-4057qib7	1638	2	median	median	JJ
cord-005453-4057qib7	1638	3	age	age	NN
cord-005453-4057qib7	1638	4	was	be	VBD
cord-005453-4057qib7	1638	5	56	56	CD
cord-005453-4057qib7	1638	6	years	year	NNS
cord-005453-4057qib7	1638	7	(	(	-LRB-
cord-005453-4057qib7	1638	8	range	range	NN
cord-005453-4057qib7	1638	9	,	,	,
cord-005453-4057qib7	1638	10	22	22	CD
cord-005453-4057qib7	1638	11	to	to	TO
cord-005453-4057qib7	1638	12	75	75	CD
cord-005453-4057qib7	1638	13	years	year	NNS
cord-005453-4057qib7	1638	14	)	)	-RRB-
cord-005453-4057qib7	1638	15	.	.	.
cord-005453-4057qib7	1639	1	A	a	DT
cord-005453-4057qib7	1639	2	myeloablative	myeloablative	JJ
cord-005453-4057qib7	1639	3	conditioning	conditioning	NN
cord-005453-4057qib7	1639	4	regimen	regimen	NN
cord-005453-4057qib7	1639	5	was	be	VBD
cord-005453-4057qib7	1639	6	performed	perform	VBN
cord-005453-4057qib7	1639	7	in	in	IN
cord-005453-4057qib7	1639	8	142	142	CD
cord-005453-4057qib7	1639	9	pts	pt	NNS
cord-005453-4057qib7	1639	10	,	,	,
cord-005453-4057qib7	1639	11	while	while	IN
cord-005453-4057qib7	1639	12	21	21	CD
cord-005453-4057qib7	1639	13	pts	pt	NNS
cord-005453-4057qib7	1639	14	where	where	WRB
cord-005453-4057qib7	1639	15	treated	treat	VBN
cord-005453-4057qib7	1639	16	with	with	IN
cord-005453-4057qib7	1639	17	a	a	DT
cord-005453-4057qib7	1639	18	reduced	reduce	VBN
cord-005453-4057qib7	1639	19	intensity	intensity	NN
cord-005453-4057qib7	1639	20	conditioning	conditioning	NN
cord-005453-4057qib7	1639	21	.	.	.
cord-005453-4057qib7	1640	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	1640	2	blood	blood	NN
cord-005453-4057qib7	1640	3	stem	stem	NN
cord-005453-4057qib7	1640	4	cells	cell	NNS
cord-005453-4057qib7	1640	5	(	(	-LRB-
cord-005453-4057qib7	1640	6	n=154	n=154	NNP
cord-005453-4057qib7	1640	7	)	)	-RRB-
cord-005453-4057qib7	1640	8	or	or	CC
cord-005453-4057qib7	1640	9	bone	bone	NN
cord-005453-4057qib7	1640	10	marrow	marrow	NN
cord-005453-4057qib7	1640	11	(	(	-LRB-
cord-005453-4057qib7	1640	12	n=9	n=9	NN
cord-005453-4057qib7	1640	13	)	)	-RRB-
cord-005453-4057qib7	1640	14	with	with	IN
cord-005453-4057qib7	1640	15	a	a	DT
cord-005453-4057qib7	1640	16	median	median	NN
cord-005453-4057qib7	1640	17	of	of	IN
cord-005453-4057qib7	1640	18	7.0	7.0	CD
cord-005453-4057qib7	1640	19	x	x	SYM
cord-005453-4057qib7	1640	20	10	10	CD
cord-005453-4057qib7	1640	21	6	6	CD
cord-005453-4057qib7	1640	22	CD34	CD34	NNP
cord-005453-4057qib7	1640	23	+	+	CC
cord-005453-4057qib7	1640	24	cells/	cells/	CD
cord-005453-4057qib7	1641	1	kg	kg	NNP
cord-005453-4057qib7	1641	2	bodyweight	bodyweight	NN
cord-005453-4057qib7	1641	3	(	(	-LRB-
cord-005453-4057qib7	1641	4	BW	BW	NNP
cord-005453-4057qib7	1641	5	)	)	-RRB-
cord-005453-4057qib7	1642	1	(	(	-LRB-
cord-005453-4057qib7	1642	2	range	range	NN
cord-005453-4057qib7	1642	3	,	,	,
cord-005453-4057qib7	1642	4	1.0	1.0	CD
cord-005453-4057qib7	1642	5	to	to	TO
cord-005453-4057qib7	1642	6	30	30	CD
cord-005453-4057qib7	1642	7	)	)	-RRB-
cord-005453-4057qib7	1642	8	were	be	VBD
cord-005453-4057qib7	1642	9	transplanted	transplant	VBN
cord-005453-4057qib7	1642	10	.	.	.
cord-005453-4057qib7	1643	1	Splenectomy	Splenectomy	NNP
cord-005453-4057qib7	1643	2	was	be	VBD
cord-005453-4057qib7	1643	3	performed	perform	VBN
cord-005453-4057qib7	1643	4	in	in	IN
cord-005453-4057qib7	1643	5	41	41	CD
cord-005453-4057qib7	1643	6	of	of	IN
cord-005453-4057qib7	1643	7	163	163	CD
cord-005453-4057qib7	1643	8	pts	pt	NNS
cord-005453-4057qib7	1643	9	:	:	:
cord-005453-4057qib7	1643	10	21	21	CD
cord-005453-4057qib7	1643	11	pts	pt	NNS
cord-005453-4057qib7	1643	12	were	be	VBD
cord-005453-4057qib7	1643	13	splenectomized	splenectomize	VBN
cord-005453-4057qib7	1643	14	prior	prior	RB
cord-005453-4057qib7	1643	15	to	to	IN
cord-005453-4057qib7	1643	16	and	and	CC
cord-005453-4057qib7	1643	17	20	20	CD
cord-005453-4057qib7	1643	18	pts	pt	NNS
cord-005453-4057qib7	1643	19	after	after	IN
cord-005453-4057qib7	1643	20	allo	allo	NN
cord-005453-4057qib7	1643	21	-	-	HYPH
cord-005453-4057qib7	1643	22	HSCT	HSCT	NNP
cord-005453-4057qib7	1643	23	.	.	.
cord-005453-4057qib7	1644	1	Relapse	relapse	NN
cord-005453-4057qib7	1644	2	was	be	VBD
cord-005453-4057qib7	1644	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	1644	4	in	in	IN
cord-005453-4057qib7	1644	5	22	22	CD
cord-005453-4057qib7	1644	6	(	(	-LRB-
cord-005453-4057qib7	1644	7	14	14	CD
cord-005453-4057qib7	1644	8	%	%	NN
cord-005453-4057qib7	1644	9	)	)	-RRB-
cord-005453-4057qib7	1644	10	of	of	IN
cord-005453-4057qib7	1644	11	163	163	CD
cord-005453-4057qib7	1644	12	pts	pt	NNS
cord-005453-4057qib7	1644	13	.	.	.
cord-005453-4057qib7	1645	1	The	the	DT
cord-005453-4057qib7	1645	2	median	median	JJ
cord-005453-4057qib7	1645	3	duration	duration	NN
cord-005453-4057qib7	1645	4	to	to	TO
cord-005453-4057qib7	1645	5	relapse	relapse	NN
cord-005453-4057qib7	1645	6	after	after	IN
cord-005453-4057qib7	1645	7	transplantion	transplantion	NN
cord-005453-4057qib7	1645	8	was	be	VBD
cord-005453-4057qib7	1645	9	13	13	CD
cord-005453-4057qib7	1645	10	months	month	NNS
cord-005453-4057qib7	1645	11	(	(	-LRB-
cord-005453-4057qib7	1645	12	range	range	NN
cord-005453-4057qib7	1645	13	,	,	,
cord-005453-4057qib7	1645	14	3	3	CD
cord-005453-4057qib7	1645	15	-	-	SYM
cord-005453-4057qib7	1645	16	99	99	CD
cord-005453-4057qib7	1645	17	months	month	NNS
cord-005453-4057qib7	1645	18	)	)	-RRB-
cord-005453-4057qib7	1645	19	.	.	.
cord-005453-4057qib7	1646	1	Results	result	NNS
cord-005453-4057qib7	1646	2	:	:	:
cord-005453-4057qib7	1647	1	The	the	DT
cord-005453-4057qib7	1647	2	median	median	JJ
cord-005453-4057qib7	1647	3	duration	duration	NN
cord-005453-4057qib7	1647	4	of	of	IN
cord-005453-4057qib7	1647	5	follow	follow	NN
cord-005453-4057qib7	1647	6	-	-	HYPH
cord-005453-4057qib7	1647	7	up	up	NN
cord-005453-4057qib7	1647	8	of	of	IN
cord-005453-4057qib7	1647	9	this	this	DT
cord-005453-4057qib7	1647	10	cohort	cohort	NN
cord-005453-4057qib7	1647	11	was	be	VBD
cord-005453-4057qib7	1647	12	28	28	CD
cord-005453-4057qib7	1647	13	months	month	NNS
cord-005453-4057qib7	1647	14	(	(	-LRB-
cord-005453-4057qib7	1647	15	range	range	NN
cord-005453-4057qib7	1647	16	,	,	,
cord-005453-4057qib7	1647	17	2	2	CD
cord-005453-4057qib7	1647	18	-	-	SYM
cord-005453-4057qib7	1647	19	120	120	CD
cord-005453-4057qib7	1647	20	months	month	NNS
cord-005453-4057qib7	1647	21	)	)	-RRB-
cord-005453-4057qib7	1647	22	,	,	,
cord-005453-4057qib7	1647	23	the	the	DT
cord-005453-4057qib7	1647	24	10-year	10-year	CD
cord-005453-4057qib7	1647	25	overall	overall	JJ
cord-005453-4057qib7	1647	26	survival	survival	NN
cord-005453-4057qib7	1647	27	(	(	-LRB-
cord-005453-4057qib7	1647	28	OS	OS	NNP
cord-005453-4057qib7	1647	29	)	)	-RRB-
cord-005453-4057qib7	1647	30	was	be	VBD
cord-005453-4057qib7	1647	31	46	46	CD
cord-005453-4057qib7	1647	32	%	%	NN
cord-005453-4057qib7	1647	33	.	.	.
cord-005453-4057qib7	1648	1	74	74	CD
cord-005453-4057qib7	1648	2	pts	pt	NNS
cord-005453-4057qib7	1648	3	died	die	VBD
cord-005453-4057qib7	1648	4	,	,	,
cord-005453-4057qib7	1648	5	including	include	VBG
cord-005453-4057qib7	1648	6	7	7	CD
cord-005453-4057qib7	1648	7	pts	pt	NNS
cord-005453-4057qib7	1648	8	who	who	WP
cord-005453-4057qib7	1648	9	relapsed	relapse	VBD
cord-005453-4057qib7	1648	10	and	and	CC
cord-005453-4057qib7	1648	11	67	67	CD
cord-005453-4057qib7	1648	12	pts	pt	NNS
cord-005453-4057qib7	1648	13	who	who	WP
cord-005453-4057qib7	1648	14	died	die	VBD
cord-005453-4057qib7	1648	15	of	of	IN
cord-005453-4057qib7	1648	16	treatment	treatment	NN
cord-005453-4057qib7	1648	17	related	relate	VBN
cord-005453-4057qib7	1648	18	causes	cause	NNS
cord-005453-4057qib7	1648	19	.	.	.
cord-005453-4057qib7	1649	1	The	the	DT
cord-005453-4057qib7	1649	2	observed	observed	JJ
cord-005453-4057qib7	1649	3	probability	probability	NN
cord-005453-4057qib7	1649	4	of	of	IN
cord-005453-4057qib7	1649	5	relapse	relapse	NN
cord-005453-4057qib7	1649	6	was	be	VBD
cord-005453-4057qib7	1649	7	significantly	significantly	RB
cord-005453-4057qib7	1649	8	higher	high	JJR
cord-005453-4057qib7	1649	9	in	in	IN
cord-005453-4057qib7	1649	10	splenectomized	splenectomized	JJ
cord-005453-4057qib7	1649	11	pts	pts	NN
cord-005453-4057qib7	1649	12	than	than	IN
cord-005453-4057qib7	1649	13	in	in	IN
cord-005453-4057qib7	1649	14	non	non	JJ
cord-005453-4057qib7	1649	15	-	-	JJ
cord-005453-4057qib7	1649	16	splenectomized	splenectomized	JJ
cord-005453-4057qib7	1649	17	pts	pts	NN
cord-005453-4057qib7	1649	18	:	:	:
cord-005453-4057qib7	1649	19	37	37	CD
cord-005453-4057qib7	1649	20	%	%	NN
cord-005453-4057qib7	1649	21	versus	versus	IN
cord-005453-4057qib7	1649	22	10	10	CD
cord-005453-4057qib7	1649	23	%	%	NN
cord-005453-4057qib7	1649	24	(	(	-LRB-
cord-005453-4057qib7	1649	25	relative	relative	JJ
cord-005453-4057qib7	1649	26	risk	risk	NN
cord-005453-4057qib7	1649	27	(	(	-LRB-
cord-005453-4057qib7	1649	28	RR	RR	NNP
cord-005453-4057qib7	1649	29	)	)	-RRB-
cord-005453-4057qib7	1649	30	3.7	3.7	CD
cord-005453-4057qib7	1649	31	,	,	,
cord-005453-4057qib7	1649	32	95	95	CD
cord-005453-4057qib7	1649	33	%	%	NN
cord-005453-4057qib7	1649	34	CI	CI	NNP
cord-005453-4057qib7	1649	35	,	,	,
cord-005453-4057qib7	1649	36	1.5	1.5	CD
cord-005453-4057qib7	1649	37	-	-	SYM
cord-005453-4057qib7	1649	38	9.4	9.4	CD
cord-005453-4057qib7	1649	39	,	,	,
cord-005453-4057qib7	1649	40	p=0.007	p=0.007	NNP
cord-005453-4057qib7	1649	41	)	)	-RRB-
cord-005453-4057qib7	1649	42	.	.	.
cord-005453-4057qib7	1650	1	At	at	IN
cord-005453-4057qib7	1650	2	10	10	CD
cord-005453-4057qib7	1650	3	years	year	NNS
cord-005453-4057qib7	1650	4	,	,	,
cord-005453-4057qib7	1650	5	the	the	DT
cord-005453-4057qib7	1650	6	OS	OS	NNP
cord-005453-4057qib7	1650	7	was	be	VBD
cord-005453-4057qib7	1650	8	50	50	CD
cord-005453-4057qib7	1650	9	%	%	NN
cord-005453-4057qib7	1650	10	in	in	IN
cord-005453-4057qib7	1650	11	nonsplenectomised	nonsplenectomised	JJ
cord-005453-4057qib7	1650	12	and	and	CC
cord-005453-4057qib7	1650	13	39	39	CD
cord-005453-4057qib7	1650	14	%	%	NN
cord-005453-4057qib7	1650	15	in	in	IN
cord-005453-4057qib7	1650	16	splenectomised	splenectomised	JJ
cord-005453-4057qib7	1650	17	pts	pt	NNS
cord-005453-4057qib7	1650	18	(	(	-LRB-
cord-005453-4057qib7	1650	19	p=0.35	p=0.35	NNP
cord-005453-4057qib7	1650	20	)	)	-RRB-
cord-005453-4057qib7	1650	21	(	(	-LRB-
cord-005453-4057qib7	1650	22	Fig.1	Fig.1	NNP
cord-005453-4057qib7	1650	23	)	)	-RRB-
cord-005453-4057qib7	1650	24	.	.	.
cord-005453-4057qib7	1651	1	The	the	DT
cord-005453-4057qib7	1651	2	relapse	relapse	NN
cord-005453-4057qib7	1651	3	rate	rate	NN
cord-005453-4057qib7	1651	4	in	in	IN
cord-005453-4057qib7	1651	5	splenectomised	splenectomised	JJ
cord-005453-4057qib7	1651	6	pts	pts	NNP
cord-005453-4057qib7	1651	7	was	be	VBD
cord-005453-4057qib7	1651	8	independent	independent	JJ
cord-005453-4057qib7	1651	9	of	of	IN
cord-005453-4057qib7	1651	10	pre-(5	pre-(5	NNP
cord-005453-4057qib7	1651	11	of	of	IN
cord-005453-4057qib7	1651	12	21	21	CD
cord-005453-4057qib7	1651	13	pts	pt	NNS
cord-005453-4057qib7	1651	14	,	,	,
cord-005453-4057qib7	1651	15	24	24	CD
cord-005453-4057qib7	1651	16	%	%	NN
cord-005453-4057qib7	1651	17	)	)	-RRB-
cord-005453-4057qib7	1651	18	or	or	CC
cord-005453-4057qib7	1651	19	post	post	JJ
cord-005453-4057qib7	1651	20	-	-	JJ
cord-005453-4057qib7	1651	21	transplant	transplant	NN
cord-005453-4057qib7	1651	22	(	(	-LRB-
cord-005453-4057qib7	1651	23	6	6	CD
cord-005453-4057qib7	1651	24	of	of	IN
cord-005453-4057qib7	1651	25	20	20	CD
cord-005453-4057qib7	1651	26	pts	pt	NNS
cord-005453-4057qib7	1651	27	,	,	,
cord-005453-4057qib7	1651	28	30	30	CD
cord-005453-4057qib7	1651	29	%	%	NN
cord-005453-4057qib7	1651	30	)	)	-RRB-
cord-005453-4057qib7	1651	31	treatment	treatment	NN
cord-005453-4057qib7	1651	32	(	(	-LRB-
cord-005453-4057qib7	1651	33	RR	RR	NNP
cord-005453-4057qib7	1651	34	1.3	1.3	CD
cord-005453-4057qib7	1651	35	,	,	,
cord-005453-4057qib7	1651	36	95	95	CD
cord-005453-4057qib7	1651	37	%	%	NN
cord-005453-4057qib7	1651	38	CI	ci	NN
cord-005453-4057qib7	1651	39	,	,	,
cord-005453-4057qib7	1651	40	p=0.73	p=0.73	NNP
cord-005453-4057qib7	1651	41	)	)	-RRB-
cord-005453-4057qib7	1651	42	.	.	.
cord-005453-4057qib7	1652	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1652	2	:	:	:
cord-005453-4057qib7	1653	1	On	on	IN
cord-005453-4057qib7	1653	2	the	the	DT
cord-005453-4057qib7	1653	3	basis	basis	NN
cord-005453-4057qib7	1653	4	of	of	IN
cord-005453-4057qib7	1653	5	our	-PRON-	PRP$
cord-005453-4057qib7	1653	6	cohort	cohort	NN
cord-005453-4057qib7	1653	7	,	,	,
cord-005453-4057qib7	1653	8	we	-PRON-	PRP
cord-005453-4057qib7	1653	9	could	could	MD
cord-005453-4057qib7	1653	10	assert	assert	VB
cord-005453-4057qib7	1653	11	that	that	IN
cord-005453-4057qib7	1653	12	pre	pre	VB
cord-005453-4057qib7	1653	13	-	-	JJ
cord-005453-4057qib7	1653	14	and	and	CC
cord-005453-4057qib7	1653	15	post	post	VB
cord-005453-4057qib7	1653	16	-	-	JJ
cord-005453-4057qib7	1653	17	allo	allo	JJ
cord-005453-4057qib7	1653	18	-	-	HYPH
cord-005453-4057qib7	1653	19	HSCT	HSCT	NNP
cord-005453-4057qib7	1653	20	splenectomy	splenectomy	NN
cord-005453-4057qib7	1653	21	was	be	VBD
cord-005453-4057qib7	1653	22	equally	equally	RB
cord-005453-4057qib7	1653	23	and	and	CC
cord-005453-4057qib7	1653	24	significantly	significantly	RB
cord-005453-4057qib7	1653	25	associated	associate	VBN
cord-005453-4057qib7	1653	26	with	with	IN
cord-005453-4057qib7	1653	27	an	an	DT
cord-005453-4057qib7	1653	28	increased	increase	VBN
cord-005453-4057qib7	1653	29	relapse	relapse	NN
cord-005453-4057qib7	1653	30	ratio	ratio	NN
cord-005453-4057qib7	1653	31	in	in	IN
cord-005453-4057qib7	1653	32	patients	patient	NNS
cord-005453-4057qib7	1653	33	with	with	IN
cord-005453-4057qib7	1653	34	MF	MF	NNP
cord-005453-4057qib7	1653	35	,	,	,
cord-005453-4057qib7	1653	36	which	which	WDT
cord-005453-4057qib7	1653	37	also	also	RB
cord-005453-4057qib7	1653	38	tends	tend	VBZ
cord-005453-4057qib7	1653	39	to	to	TO
cord-005453-4057qib7	1653	40	negatively	negatively	RB
cord-005453-4057qib7	1653	41	affect	affect	VB
cord-005453-4057qib7	1653	42	overall	overall	JJ
cord-005453-4057qib7	1653	43	survival	survival	NN
cord-005453-4057qib7	1653	44	.	.	.
cord-005453-4057qib7	1654	1	[	[	-LRB-
cord-005453-4057qib7	1654	2	[	[	-LRB-
cord-005453-4057qib7	1654	3	P088	P088	NNP
cord-005453-4057qib7	1654	4	Image	image	NN
cord-005453-4057qib7	1654	5	]	]	-RRB-
cord-005453-4057qib7	1654	6	1	1	CD
cord-005453-4057qib7	1654	7	.	.	.
cord-005453-4057qib7	1655	1	Figure	figure	NN
cord-005453-4057qib7	1655	2	1	1	CD
cord-005453-4057qib7	1655	3	:	:	:
cord-005453-4057qib7	1656	1	The	the	DT
cord-005453-4057qib7	1656	2	overall	overall	JJ
cord-005453-4057qib7	1656	3	survival	survival	NN
cord-005453-4057qib7	1656	4	after	after	IN
cord-005453-4057qib7	1656	5	allo	allo	NN
cord-005453-4057qib7	1656	6	-	-	HYPH
cord-005453-4057qib7	1656	7	HSCT	HSCT	NNP
cord-005453-4057qib7	1656	8	in	in	IN
cord-005453-4057qib7	1656	9	patients	patient	NNS
cord-005453-4057qib7	1656	10	with	with	IN
cord-005453-4057qib7	1656	11	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1656	12	.	.	.
cord-005453-4057qib7	1656	13	]	]	-RRB-
cord-005453-4057qib7	1657	1	Background	background	NN
cord-005453-4057qib7	1657	2	:	:	:
cord-005453-4057qib7	1658	1	B	b	NN
cord-005453-4057qib7	1658	2	-	-	HYPH
cord-005453-4057qib7	1658	3	cell	cell	NN
cord-005453-4057qib7	1658	4	prolymphocytic	prolymphocytic	JJ
cord-005453-4057qib7	1658	5	leukemia	leukemia	NN
cord-005453-4057qib7	1658	6	(	(	-LRB-
cord-005453-4057qib7	1658	7	B	B	NNP
cord-005453-4057qib7	1658	8	-	-	HYPH
cord-005453-4057qib7	1658	9	PLL	PLL	NNP
cord-005453-4057qib7	1658	10	)	)	-RRB-
cord-005453-4057qib7	1658	11	is	be	VBZ
cord-005453-4057qib7	1658	12	a	a	DT
cord-005453-4057qib7	1658	13	very	very	RB
cord-005453-4057qib7	1658	14	rare	rare	JJ
cord-005453-4057qib7	1658	15	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	1658	16	disorder	disorder	NN
cord-005453-4057qib7	1658	17	.	.	.
cord-005453-4057qib7	1659	1	Although	although	IN
cord-005453-4057qib7	1659	2	allogeneic	allogeneic	JJ
cord-005453-4057qib7	1659	3	stem	stem	NN
cord-005453-4057qib7	1659	4	cell	cell	NN
cord-005453-4057qib7	1659	5	transplantation	transplantation	NN
cord-005453-4057qib7	1659	6	(	(	-LRB-
cord-005453-4057qib7	1659	7	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1659	8	)	)	-RRB-
cord-005453-4057qib7	1659	9	could	could	MD
cord-005453-4057qib7	1659	10	be	be	VB
cord-005453-4057qib7	1659	11	a	a	DT
cord-005453-4057qib7	1659	12	curative	curative	JJ
cord-005453-4057qib7	1659	13	option	option	NN
cord-005453-4057qib7	1659	14	,	,	,
cord-005453-4057qib7	1659	15	patients	patient	NNS
cord-005453-4057qib7	1659	16	often	often	RB
cord-005453-4057qib7	1659	17	do	do	VBP
cord-005453-4057qib7	1659	18	not	not	RB
cord-005453-4057qib7	1659	19	qualify	qualify	VB
cord-005453-4057qib7	1659	20	for	for	IN
cord-005453-4057qib7	1659	21	this	this	DT
cord-005453-4057qib7	1659	22	consolidation	consolidation	NN
cord-005453-4057qib7	1659	23	treatment	treatment	NN
cord-005453-4057qib7	1659	24	due	due	IN
cord-005453-4057qib7	1659	25	to	to	IN
cord-005453-4057qib7	1659	26	an	an	DT
cord-005453-4057qib7	1659	27	aggressive	aggressive	JJ
cord-005453-4057qib7	1659	28	course	course	NN
cord-005453-4057qib7	1659	29	of	of	IN
cord-005453-4057qib7	1659	30	disease	disease	NN
cord-005453-4057qib7	1659	31	.	.	.
cord-005453-4057qib7	1660	1	In	in	IN
cord-005453-4057qib7	1660	2	this	this	DT
cord-005453-4057qib7	1660	3	case	case	NN
cord-005453-4057qib7	1660	4	study	study	NN
cord-005453-4057qib7	1660	5	,	,	,
cord-005453-4057qib7	1660	6	we	-PRON-	PRP
cord-005453-4057qib7	1660	7	report	report	VBP
cord-005453-4057qib7	1660	8	on	on	IN
cord-005453-4057qib7	1660	9	three	three	CD
cord-005453-4057qib7	1660	10	patients	patient	NNS
cord-005453-4057qib7	1660	11	who	who	WP
cord-005453-4057qib7	1660	12	failed	fail	VBD
cord-005453-4057qib7	1660	13	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	1660	14	therapy	therapy	NN
cord-005453-4057qib7	1660	15	but	but	CC
cord-005453-4057qib7	1660	16	achieved	achieve	VBD
cord-005453-4057qib7	1660	17	complete	complete	JJ
cord-005453-4057qib7	1660	18	remission	remission	NN
cord-005453-4057qib7	1660	19	and	and	CC
cord-005453-4057qib7	1660	20	even	even	RB
cord-005453-4057qib7	1660	21	MRD	MRD	NNP
cord-005453-4057qib7	1660	22	negativity	negativity	NN
cord-005453-4057qib7	1660	23	after	after	IN
cord-005453-4057qib7	1660	24	treatment	treatment	NN
cord-005453-4057qib7	1660	25	with	with	IN
cord-005453-4057qib7	1660	26	the	the	DT
cord-005453-4057qib7	1660	27	chimeric	chimeric	JJ
cord-005453-4057qib7	1660	28	CD20-antibody	CD20-antibody	NNP
cord-005453-4057qib7	1660	29	Rituximab	Rituximab	NNP
cord-005453-4057qib7	1660	30	,	,	,
cord-005453-4057qib7	1660	31	enabling	enable	VBG
cord-005453-4057qib7	1660	32	them	-PRON-	PRP
cord-005453-4057qib7	1660	33	to	to	TO
cord-005453-4057qib7	1660	34	undergo	undergo	VB
cord-005453-4057qib7	1660	35	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1660	36	.	.	.
cord-005453-4057qib7	1661	1	Methods	method	NNS
cord-005453-4057qib7	1661	2	:	:	:
cord-005453-4057qib7	1661	3	Clinical	clinical	JJ
cord-005453-4057qib7	1661	4	data	datum	NNS
cord-005453-4057qib7	1661	5	and	and	CC
cord-005453-4057qib7	1661	6	follow	follow	VB
cord-005453-4057qib7	1661	7	-	-	HYPH
cord-005453-4057qib7	1661	8	up	up	RP
cord-005453-4057qib7	1661	9	data	datum	NNS
cord-005453-4057qib7	1661	10	were	be	VBD
cord-005453-4057qib7	1661	11	collected	collect	VBN
cord-005453-4057qib7	1661	12	by	by	IN
cord-005453-4057qib7	1661	13	chart	chart	NN
cord-005453-4057qib7	1661	14	review	review	NN
cord-005453-4057qib7	1661	15	.	.	.
cord-005453-4057qib7	1662	1	Results	result	NNS
cord-005453-4057qib7	1662	2	:	:	:
cord-005453-4057qib7	1663	1	All	all	DT
cord-005453-4057qib7	1663	2	three	three	CD
cord-005453-4057qib7	1663	3	patients	patient	NNS
cord-005453-4057qib7	1663	4	(	(	-LRB-
cord-005453-4057qib7	1663	5	pt#1	pt#1	NNP
cord-005453-4057qib7	1663	6	:	:	:
cord-005453-4057qib7	1663	7	male	male	NN
cord-005453-4057qib7	1663	8	,	,	,
cord-005453-4057qib7	1663	9	42	42	CD
cord-005453-4057qib7	1663	10	years	year	NNS
cord-005453-4057qib7	1663	11	;	;	:
cord-005453-4057qib7	1663	12	pt#2	pt#2	NNP
cord-005453-4057qib7	1663	13	:	:	:
cord-005453-4057qib7	1663	14	female	female	JJ
cord-005453-4057qib7	1663	15	,	,	,
cord-005453-4057qib7	1663	16	66	66	CD
cord-005453-4057qib7	1663	17	years	year	NNS
cord-005453-4057qib7	1663	18	;	;	:
cord-005453-4057qib7	1663	19	pt#3	pt#3	NN
cord-005453-4057qib7	1663	20	:	:	:
cord-005453-4057qib7	1663	21	female	female	JJ
cord-005453-4057qib7	1663	22	,	,	,
cord-005453-4057qib7	1663	23	64	64	CD
cord-005453-4057qib7	1663	24	years	year	NNS
cord-005453-4057qib7	1663	25	)	)	-RRB-
cord-005453-4057qib7	1663	26	were	be	VBD
cord-005453-4057qib7	1663	27	referred	refer	VBN
cord-005453-4057qib7	1663	28	with	with	IN
cord-005453-4057qib7	1663	29	B	B	NNP
cord-005453-4057qib7	1663	30	-	-	HYPH
cord-005453-4057qib7	1663	31	PLL	PLL	NNP
cord-005453-4057qib7	1663	32	harboring	harbor	VBG
cord-005453-4057qib7	1663	33	highly	highly	RB
cord-005453-4057qib7	1663	34	complex	complex	JJ
cord-005453-4057qib7	1663	35	aberrant	aberrant	JJ
cord-005453-4057qib7	1663	36	karyotypes	karyotype	NNS
cord-005453-4057qib7	1663	37	,	,	,
cord-005453-4057qib7	1663	38	including	include	VBG
cord-005453-4057qib7	1663	39	17p	17p	CD
cord-005453-4057qib7	1663	40	abnormalities	abnormality	NNS
cord-005453-4057qib7	1663	41	in	in	IN
cord-005453-4057qib7	1663	42	pt#1	pt#1	NNP
cord-005453-4057qib7	1663	43	and	and	CC
cord-005453-4057qib7	1663	44	pt#2	pt#2	NNP
cord-005453-4057qib7	1663	45	.	.	.
cord-005453-4057qib7	1664	1	A	a	DT
cord-005453-4057qib7	1664	2	TP53	TP53	NNP
cord-005453-4057qib7	1664	3	mutation	mutation	NN
cord-005453-4057qib7	1664	4	could	could	MD
cord-005453-4057qib7	1664	5	be	be	VB
cord-005453-4057qib7	1664	6	detected	detect	VBN
cord-005453-4057qib7	1664	7	in	in	IN
cord-005453-4057qib7	1664	8	pt#2	pt#2	NNP
cord-005453-4057qib7	1664	9	and	and	CC
cord-005453-4057qib7	1664	10	pt#3	pt#3	NNP
cord-005453-4057qib7	1664	11	.	.	.
cord-005453-4057qib7	1665	1	All	all	DT
cord-005453-4057qib7	1665	2	three	three	CD
cord-005453-4057qib7	1665	3	patients	patient	NNS
cord-005453-4057qib7	1665	4	had	have	VBD
cord-005453-4057qib7	1665	5	symptomatic	symptomatic	JJ
cord-005453-4057qib7	1665	6	disease	disease	NN
cord-005453-4057qib7	1665	7	with	with	IN
cord-005453-4057qib7	1665	8	rapidly	rapidly	RB
cord-005453-4057qib7	1665	9	increasing	increase	VBG
cord-005453-4057qib7	1665	10	hyperleukocytosis	hyperleukocytosis	NN
cord-005453-4057qib7	1665	11	and	and	CC
cord-005453-4057qib7	1665	12	massive	massive	JJ
cord-005453-4057qib7	1665	13	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	1665	14	.	.	.
cord-005453-4057qib7	1666	1	Two	two	CD
cord-005453-4057qib7	1666	2	of	of	IN
cord-005453-4057qib7	1666	3	them	-PRON-	PRP
cord-005453-4057qib7	1666	4	were	be	VBD
cord-005453-4057qib7	1666	5	treatment	treatment	NN
cord-005453-4057qib7	1666	6	-	-	HYPH
cord-005453-4057qib7	1666	7	naive	naive	JJ
cord-005453-4057qib7	1666	8	and	and	CC
cord-005453-4057qib7	1666	9	one	one	CD
cord-005453-4057qib7	1666	10	relapsed	relapse	VBD
cord-005453-4057qib7	1666	11	after	after	IN
cord-005453-4057qib7	1666	12	chemoimmunotherapy	chemoimmunotherapy	NNP
cord-005453-4057qib7	1666	13	.	.	.
cord-005453-4057qib7	1667	1	All	all	DT
cord-005453-4057qib7	1667	2	patients	patient	NNS
cord-005453-4057qib7	1667	3	were	be	VBD
cord-005453-4057qib7	1667	4	put	put	VBN
cord-005453-4057qib7	1667	5	on	on	IN
cord-005453-4057qib7	1667	6	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1667	7	420	420	CD
cord-005453-4057qib7	1667	8	mg	mg	NNP
cord-005453-4057qib7	1667	9	.	.	.
cord-005453-4057qib7	1668	1	Despite	despite	IN
cord-005453-4057qib7	1668	2	initial	initial	JJ
cord-005453-4057qib7	1668	3	response	response	NN
cord-005453-4057qib7	1668	4	to	to	IN
cord-005453-4057qib7	1668	5	treatment	treatment	NN
cord-005453-4057qib7	1668	6	,	,	,
cord-005453-4057qib7	1668	7	two	two	CD
cord-005453-4057qib7	1668	8	patients	patient	NNS
cord-005453-4057qib7	1668	9	developed	develop	VBD
cord-005453-4057qib7	1668	10	progressive	progressive	JJ
cord-005453-4057qib7	1668	11	disease	disease	NN
cord-005453-4057qib7	1668	12	after	after	IN
cord-005453-4057qib7	1668	13	4	4	CD
cord-005453-4057qib7	1668	14	(	(	-LRB-
cord-005453-4057qib7	1668	15	pt#1	pt#1	NNP
cord-005453-4057qib7	1668	16	)	)	-RRB-
cord-005453-4057qib7	1668	17	and	and	CC
cord-005453-4057qib7	1668	18	9	9	CD
cord-005453-4057qib7	1668	19	months	month	NNS
cord-005453-4057qib7	1668	20	(	(	-LRB-
cord-005453-4057qib7	1668	21	pt#2	pt#2	NNP
cord-005453-4057qib7	1668	22	)	)	-RRB-
cord-005453-4057qib7	1668	23	on	on	IN
cord-005453-4057qib7	1668	24	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	1668	25	,	,	,
cord-005453-4057qib7	1668	26	whereas	whereas	IN
cord-005453-4057qib7	1668	27	pt#3	pt#3	NNP
cord-005453-4057qib7	1668	28	remained	remain	VBD
cord-005453-4057qib7	1668	29	in	in	IN
cord-005453-4057qib7	1668	30	partial	partial	JJ
cord-005453-4057qib7	1668	31	remission	remission	NN
cord-005453-4057qib7	1668	32	with	with	IN
cord-005453-4057qib7	1668	33	persisting	persist	VBG
cord-005453-4057qib7	1668	34	leukocytosis	leukocytosis	NN
cord-005453-4057qib7	1668	35	,	,	,
cord-005453-4057qib7	1668	36	precluding	preclude	VBG
cord-005453-4057qib7	1668	37	consolidating	consolidate	VBG
cord-005453-4057qib7	1668	38	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1668	39	as	as	IN
cord-005453-4057qib7	1668	40	originally	originally	RB
cord-005453-4057qib7	1668	41	intended	intend	VBN
cord-005453-4057qib7	1668	42	.	.	.
cord-005453-4057qib7	1669	1	In	in	IN
cord-005453-4057qib7	1669	2	pt#1	pt#1	NNP
cord-005453-4057qib7	1669	3	,	,	,
cord-005453-4057qib7	1669	4	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1669	5	was	be	VBD
cord-005453-4057qib7	1669	6	replaced	replace	VBN
cord-005453-4057qib7	1669	7	by	by	IN
cord-005453-4057qib7	1669	8	venetoclax	venetoclax	NNP
cord-005453-4057qib7	1669	9	,	,	,
cord-005453-4057qib7	1669	10	but	but	CC
cord-005453-4057qib7	1669	11	without	without	IN
cord-005453-4057qib7	1669	12	response	response	NN
cord-005453-4057qib7	1669	13	.	.	.
cord-005453-4057qib7	1670	1	In	in	IN
cord-005453-4057qib7	1670	2	order	order	NN
cord-005453-4057qib7	1670	3	to	to	TO
cord-005453-4057qib7	1670	4	control	control	VB
cord-005453-4057qib7	1670	5	rapid	rapid	JJ
cord-005453-4057qib7	1670	6	lymphoproliferation	lymphoproliferation	NN
cord-005453-4057qib7	1670	7	,	,	,
cord-005453-4057qib7	1670	8	rituximab	rituximab	NNP
cord-005453-4057qib7	1670	9	was	be	VBD
cord-005453-4057qib7	1670	10	added	add	VBN
cord-005453-4057qib7	1670	11	to	to	IN
cord-005453-4057qib7	1670	12	venetoclax	venetoclax	NNP
cord-005453-4057qib7	1670	13	.	.	.
cord-005453-4057qib7	1671	1	Grade	grade	NN
cord-005453-4057qib7	1671	2	4	4	CD
cord-005453-4057qib7	1671	3	infusion	infusion	NN
cord-005453-4057qib7	1671	4	reaction	reaction	NN
cord-005453-4057qib7	1671	5	/	/	SYM
cord-005453-4057qib7	1671	6	tumor	tumor	NN
cord-005453-4057qib7	1671	7	lysis	lysis	NN
cord-005453-4057qib7	1671	8	syndrome	syndrome	NN
cord-005453-4057qib7	1671	9	(	(	-LRB-
cord-005453-4057qib7	1671	10	TLS	TLS	NNP
cord-005453-4057qib7	1671	11	)	)	-RRB-
cord-005453-4057qib7	1671	12	(	(	-LRB-
cord-005453-4057qib7	1671	13	fever	fever	NN
cord-005453-4057qib7	1671	14	,	,	,
cord-005453-4057qib7	1671	15	tachycardia	tachycardia	NN
cord-005453-4057qib7	1671	16	and	and	CC
cord-005453-4057qib7	1671	17	hypotonia	hypotonia	NNS
cord-005453-4057qib7	1671	18	requiring	require	VBG
cord-005453-4057qib7	1671	19	intravenous	intravenous	JJ
cord-005453-4057qib7	1671	20	vasopressors	vasopressor	NNS
cord-005453-4057qib7	1671	21	)	)	-RRB-
cord-005453-4057qib7	1671	22	followed	follow	VBD
cord-005453-4057qib7	1671	23	each	each	DT
cord-005453-4057qib7	1671	24	rituximab	rituximab	JJ
cord-005453-4057qib7	1671	25	administration	administration	NN
cord-005453-4057qib7	1671	26	despite	despite	IN
cord-005453-4057qib7	1671	27	fractionating	fractionate	VBG
cord-005453-4057qib7	1671	28	rituximab	rituximab	NN
cord-005453-4057qib7	1671	29	to	to	IN
cord-005453-4057qib7	1671	30	small	small	JJ
cord-005453-4057qib7	1671	31	doses	dose	NNS
cord-005453-4057qib7	1671	32	.	.	.
cord-005453-4057qib7	1672	1	However	however	RB
cord-005453-4057qib7	1672	2	,	,	,
cord-005453-4057qib7	1672	3	continuation	continuation	NN
cord-005453-4057qib7	1672	4	of	of	IN
cord-005453-4057qib7	1672	5	rituximab	rituximab	NN
cord-005453-4057qib7	1672	6	(	(	-LRB-
cord-005453-4057qib7	1672	7	100mg	100mg	NNP
cord-005453-4057qib7	1672	8	/	/	SYM
cord-005453-4057qib7	1672	9	d	d	XX
cord-005453-4057qib7	1672	10	over	over	IN
cord-005453-4057qib7	1672	11	10d	10d	NNS
cord-005453-4057qib7	1672	12	)	)	-RRB-
cord-005453-4057qib7	1672	13	led	lead	VBD
cord-005453-4057qib7	1672	14	to	to	TO
cord-005453-4057qib7	1672	15	complete	complete	VB
cord-005453-4057qib7	1672	16	and	and	CC
cord-005453-4057qib7	1672	17	durable	durable	JJ
cord-005453-4057qib7	1672	18	clearance	clearance	NN
cord-005453-4057qib7	1672	19	of	of	IN
cord-005453-4057qib7	1672	20	hyperleukocytosis	hyperleukocytosis	NNP
cord-005453-4057qib7	1672	21	(	(	-LRB-
cord-005453-4057qib7	1672	22	from	from	IN
cord-005453-4057qib7	1672	23	250	250	CD
cord-005453-4057qib7	1672	24	/	/	SYM
cord-005453-4057qib7	1672	25	nl	nl	NN
cord-005453-4057qib7	1672	26	to	to	IN
cord-005453-4057qib7	1672	27	MRD	MRD	NNP
cord-005453-4057qib7	1672	28	negativity	negativity	NN
cord-005453-4057qib7	1672	29	)	)	-RRB-
cord-005453-4057qib7	1672	30	despite	despite	IN
cord-005453-4057qib7	1672	31	venetoclax	venetoclax	NNP
cord-005453-4057qib7	1672	32	cessation	cessation	NN
cord-005453-4057qib7	1672	33	.	.	.
cord-005453-4057qib7	1673	1	A	a	DT
cord-005453-4057qib7	1673	2	similar	similar	JJ
cord-005453-4057qib7	1673	3	pattern	pattern	NN
cord-005453-4057qib7	1673	4	was	be	VBD
cord-005453-4057qib7	1673	5	observed	observe	VBN
cord-005453-4057qib7	1673	6	in	in	IN
cord-005453-4057qib7	1673	7	pt#2	pt#2	NNP
cord-005453-4057qib7	1673	8	,	,	,
cord-005453-4057qib7	1673	9	who	who	WP
cord-005453-4057qib7	1673	10	received	receive	VBD
cord-005453-4057qib7	1673	11	rituximab	rituximab	JJ
cord-005453-4057qib7	1673	12	while	while	IN
cord-005453-4057qib7	1673	13	showing	show	VBG
cord-005453-4057qib7	1673	14	rapidly	rapidly	RB
cord-005453-4057qib7	1673	15	increasing	increase	VBG
cord-005453-4057qib7	1673	16	leukocytosis	leukocytosis	NN
cord-005453-4057qib7	1673	17	upon	upon	IN
cord-005453-4057qib7	1673	18	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1673	19	.	.	.
cord-005453-4057qib7	1674	1	Again	again	RB
cord-005453-4057qib7	1674	2	,	,	,
cord-005453-4057qib7	1674	3	complete	complete	JJ
cord-005453-4057qib7	1674	4	clearance	clearance	NN
cord-005453-4057qib7	1674	5	of	of	IN
cord-005453-4057qib7	1674	6	B	b	NN
cord-005453-4057qib7	1674	7	-	-	HYPH
cord-005453-4057qib7	1674	8	PLL	PLL	NNP
cord-005453-4057qib7	1674	9	cells	cell	NNS
cord-005453-4057qib7	1674	10	in	in	IN
cord-005453-4057qib7	1674	11	the	the	DT
cord-005453-4057qib7	1674	12	peripheral	peripheral	JJ
cord-005453-4057qib7	1674	13	blood	blood	NN
cord-005453-4057qib7	1674	14	(	(	-LRB-
cord-005453-4057qib7	1674	15	from	from	IN
cord-005453-4057qib7	1674	16	148	148	CD
cord-005453-4057qib7	1674	17	/	/	SYM
cord-005453-4057qib7	1674	18	nl	nl	NN
cord-005453-4057qib7	1674	19	to	to	IN
cord-005453-4057qib7	1674	20	MRD	MRD	NNP
cord-005453-4057qib7	1674	21	negativity	negativity	NN
cord-005453-4057qib7	1674	22	)	)	-RRB-
cord-005453-4057qib7	1674	23	occurred	occur	VBD
cord-005453-4057qib7	1674	24	after	after	IN
cord-005453-4057qib7	1674	25	initial	initial	JJ
cord-005453-4057qib7	1674	26	grade	grade	NN
cord-005453-4057qib7	1674	27	4	4	CD
cord-005453-4057qib7	1674	28	TLS	TLS	NNP
cord-005453-4057qib7	1674	29	despite	despite	IN
cord-005453-4057qib7	1674	30	only	only	RB
cord-005453-4057qib7	1674	31	modest	modest	JJ
cord-005453-4057qib7	1674	32	CD20	CD20	NNP
cord-005453-4057qib7	1674	33	expression	expression	NN
cord-005453-4057qib7	1674	34	on	on	IN
cord-005453-4057qib7	1674	35	tumor	tumor	NN
cord-005453-4057qib7	1674	36	cells	cell	NNS
cord-005453-4057qib7	1674	37	in	in	IN
cord-005453-4057qib7	1674	38	this	this	DT
cord-005453-4057qib7	1674	39	patient	patient	NN
cord-005453-4057qib7	1674	40	.	.	.
cord-005453-4057qib7	1675	1	Also	also	RB
cord-005453-4057qib7	1675	2	,	,	,
cord-005453-4057qib7	1675	3	pt#3	pt#3	NNP
cord-005453-4057qib7	1675	4	achieved	achieve	VBD
cord-005453-4057qib7	1675	5	profound	profound	JJ
cord-005453-4057qib7	1675	6	B	b	NN
cord-005453-4057qib7	1675	7	-	-	HYPH
cord-005453-4057qib7	1675	8	PLL	pll	JJ
cord-005453-4057qib7	1675	9	cell	cell	NN
cord-005453-4057qib7	1675	10	depletion	depletion	NN
cord-005453-4057qib7	1675	11	(	(	-LRB-
cord-005453-4057qib7	1675	12	from	from	IN
cord-005453-4057qib7	1675	13	38	38	CD
cord-005453-4057qib7	1675	14	/	/	SYM
cord-005453-4057qib7	1675	15	nl	nl	NN
cord-005453-4057qib7	1675	16	to	to	IN
cord-005453-4057qib7	1675	17	a	a	DT
cord-005453-4057qib7	1675	18	MRD	MRD	NNP
cord-005453-4057qib7	1675	19	rate	rate	NN
cord-005453-4057qib7	1675	20	of	of	IN
cord-005453-4057qib7	1675	21	1.1	1.1	CD
cord-005453-4057qib7	1675	22	%	%	NN
cord-005453-4057qib7	1675	23	)	)	-RRB-
cord-005453-4057qib7	1675	24	upon	upon	IN
cord-005453-4057qib7	1675	25	addition	addition	NN
cord-005453-4057qib7	1675	26	of	of	IN
cord-005453-4057qib7	1675	27	rituximab	rituximab	NN
cord-005453-4057qib7	1675	28	to	to	IN
cord-005453-4057qib7	1675	29	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1675	30	(	(	-LRB-
cord-005453-4057qib7	1675	31	without	without	IN
cord-005453-4057qib7	1675	32	TLS	TLS	NNP
cord-005453-4057qib7	1675	33	in	in	IN
cord-005453-4057qib7	1675	34	this	this	DT
cord-005453-4057qib7	1675	35	case	case	NN
cord-005453-4057qib7	1675	36	)	)	-RRB-
cord-005453-4057qib7	1675	37	.	.	.
cord-005453-4057qib7	1676	1	Subsequently	subsequently	RB
cord-005453-4057qib7	1676	2	,	,	,
cord-005453-4057qib7	1676	3	all	all	DT
cord-005453-4057qib7	1676	4	three	three	CD
cord-005453-4057qib7	1676	5	patients	patient	NNS
cord-005453-4057qib7	1676	6	were	be	VBD
cord-005453-4057qib7	1676	7	able	able	JJ
cord-005453-4057qib7	1676	8	to	to	TO
cord-005453-4057qib7	1676	9	undergo	undergo	VB
cord-005453-4057qib7	1676	10	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1676	11	after	after	IN
cord-005453-4057qib7	1676	12	conditioning	conditioning	NN
cord-005453-4057qib7	1676	13	with	with	IN
cord-005453-4057qib7	1676	14	fludarabine	fludarabine	NN
cord-005453-4057qib7	1676	15	and	and	CC
cord-005453-4057qib7	1676	16	total	total	JJ
cord-005453-4057qib7	1676	17	body	body	NN
cord-005453-4057qib7	1676	18	irradiation	irradiation	NN
cord-005453-4057qib7	1676	19	with	with	IN
cord-005453-4057qib7	1676	20	8	8	CD
cord-005453-4057qib7	1676	21	Gy	Gy	NNP
cord-005453-4057qib7	1676	22	.	.	.
cord-005453-4057qib7	1677	1	Pt#1	Pt#1	NNP
cord-005453-4057qib7	1677	2	received	receive	VBD
cord-005453-4057qib7	1677	3	stem	stem	NN
cord-005453-4057qib7	1677	4	cells	cell	NNS
cord-005453-4057qib7	1677	5	from	from	IN
cord-005453-4057qib7	1677	6	a	a	DT
cord-005453-4057qib7	1677	7	HLA	HLA	NNP
cord-005453-4057qib7	1677	8	-	-	HYPH
cord-005453-4057qib7	1677	9	ident	ident	NN
cord-005453-4057qib7	1677	10	sibling	sibling	NN
cord-005453-4057qib7	1677	11	donor	donor	NN
cord-005453-4057qib7	1677	12	,	,	,
cord-005453-4057qib7	1677	13	whereas	whereas	IN
cord-005453-4057qib7	1677	14	Pt#2	Pt#2	NNS
cord-005453-4057qib7	1677	15	and	and	CC
cord-005453-4057qib7	1677	16	Pt#3	pt#3	PRP
cord-005453-4057qib7	1677	17	had	have	VBD
cord-005453-4057qib7	1677	18	unrelated	unrelated	JJ
cord-005453-4057qib7	1677	19	donors	donor	NNS
cord-005453-4057qib7	1677	20	(	(	-LRB-
cord-005453-4057qib7	1677	21	HLA	HLA	NNP
cord-005453-4057qib7	1677	22	-	-	HYPH
cord-005453-4057qib7	1677	23	ident	ident	NNP
cord-005453-4057qib7	1677	24	and	and	CC
cord-005453-4057qib7	1677	25	HLA	HLA	NNP
cord-005453-4057qib7	1677	26	-	-	HYPH
cord-005453-4057qib7	1677	27	matched	match	VBN
cord-005453-4057qib7	1677	28	respectively	respectively	RB
cord-005453-4057qib7	1677	29	)	)	-RRB-
cord-005453-4057qib7	1677	30	.	.	.
cord-005453-4057qib7	1678	1	With	with	IN
cord-005453-4057qib7	1678	2	follow	follow	NN
cord-005453-4057qib7	1678	3	-	-	HYPH
cord-005453-4057qib7	1678	4	up	up	NN
cord-005453-4057qib7	1678	5	times	time	NNS
cord-005453-4057qib7	1678	6	of	of	IN
cord-005453-4057qib7	1678	7	17	17	CD
cord-005453-4057qib7	1678	8	and	and	CC
cord-005453-4057qib7	1678	9	11	11	CD
cord-005453-4057qib7	1678	10	months	month	NNS
cord-005453-4057qib7	1678	11	post	post	JJ
cord-005453-4057qib7	1678	12	-	-	NN
cord-005453-4057qib7	1678	13	transplant	transplant	NN
cord-005453-4057qib7	1678	14	,	,	,
cord-005453-4057qib7	1678	15	pt#1	pt#1	NNP
cord-005453-4057qib7	1678	16	and	and	CC
cord-005453-4057qib7	1678	17	pt#2	pt#2	NNP
cord-005453-4057qib7	1678	18	are	be	VBP
cord-005453-4057qib7	1678	19	currently	currently	RB
cord-005453-4057qib7	1678	20	in	in	IN
cord-005453-4057qib7	1678	21	ongoing	ongoing	JJ
cord-005453-4057qib7	1678	22	MRD	MRD	NNP
cord-005453-4057qib7	1678	23	-	-	HYPH
cord-005453-4057qib7	1678	24	negative	negative	JJ
cord-005453-4057qib7	1678	25	remission	remission	NN
cord-005453-4057qib7	1678	26	.	.	.
cord-005453-4057qib7	1679	1	Pt#1	Pt#1	NNP
cord-005453-4057qib7	1679	2	developed	develop	VBD
cord-005453-4057qib7	1679	3	an	an	DT
cord-005453-4057qib7	1679	4	acute	acute	JJ
cord-005453-4057qib7	1679	5	graft	graft	NN
cord-005453-4057qib7	1679	6	-	-	HYPH
cord-005453-4057qib7	1679	7	versus	versus	IN
cord-005453-4057qib7	1679	8	-	-	HYPH
cord-005453-4057qib7	1679	9	host	host	NN
cord-005453-4057qib7	1679	10	disease	disease	NN
cord-005453-4057qib7	1679	11	(	(	-LRB-
cord-005453-4057qib7	1679	12	GvHD	GvHD	NNP
cord-005453-4057qib7	1679	13	)	)	-RRB-
cord-005453-4057qib7	1679	14	of	of	IN
cord-005453-4057qib7	1679	15	the	the	DT
cord-005453-4057qib7	1679	16	liver	liver	NN
cord-005453-4057qib7	1679	17	(	(	-LRB-
cord-005453-4057qib7	1679	18	grade	grade	NN
cord-005453-4057qib7	1679	19	3	3	CD
cord-005453-4057qib7	1679	20	)	)	-RRB-
cord-005453-4057qib7	1679	21	,	,	,
cord-005453-4057qib7	1679	22	nevertheless	nevertheless	RB
cord-005453-4057qib7	1679	23	the	the	DT
cord-005453-4057qib7	1679	24	clinical	clinical	JJ
cord-005453-4057qib7	1679	25	course	course	NN
cord-005453-4057qib7	1679	26	was	be	VBD
cord-005453-4057qib7	1679	27	well	well	RB
cord-005453-4057qib7	1679	28	controlled	control	VBN
cord-005453-4057qib7	1679	29	by	by	IN
cord-005453-4057qib7	1679	30	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1679	31	.	.	.
cord-005453-4057qib7	1680	1	In	in	IN
cord-005453-4057qib7	1680	2	pt#2	pt#2	NNP
cord-005453-4057qib7	1680	3	a	a	DT
cord-005453-4057qib7	1680	4	chronic	chronic	JJ
cord-005453-4057qib7	1680	5	GvHD	gvhd	NN
cord-005453-4057qib7	1680	6	of	of	IN
cord-005453-4057qib7	1680	7	the	the	DT
cord-005453-4057qib7	1680	8	skin	skin	NN
cord-005453-4057qib7	1680	9	occurred	occur	VBD
cord-005453-4057qib7	1680	10	.	.	.
cord-005453-4057qib7	1681	1	Pt#3	Pt#3	''
cord-005453-4057qib7	1682	1	,	,	,
cord-005453-4057qib7	1682	2	who	who	WP
cord-005453-4057qib7	1682	3	achieved	achieve	VBD
cord-005453-4057qib7	1682	4	MRD	MRD	NNP
cord-005453-4057qib7	1682	5	negativity	negativity	NN
cord-005453-4057qib7	1682	6	after	after	IN
cord-005453-4057qib7	1682	7	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1682	8	,	,	,
cord-005453-4057qib7	1682	9	developed	develop	VBD
cord-005453-4057qib7	1682	10	acute	acute	JJ
cord-005453-4057qib7	1682	11	and	and	CC
cord-005453-4057qib7	1682	12	chronic	chronic	JJ
cord-005453-4057qib7	1682	13	steroidrefractory	steroidrefractory	NNP
cord-005453-4057qib7	1682	14	GvHD	GvHD	NNP
cord-005453-4057qib7	1682	15	of	of	IN
cord-005453-4057qib7	1682	16	the	the	DT
cord-005453-4057qib7	1682	17	skin	skin	NN
cord-005453-4057qib7	1682	18	and	and	CC
cord-005453-4057qib7	1682	19	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	1682	20	tract	tract	NN
cord-005453-4057qib7	1682	21	.	.	.
cord-005453-4057qib7	1683	1	Nine	nine	CD
cord-005453-4057qib7	1683	2	months	month	NNS
cord-005453-4057qib7	1683	3	post	post	NN
cord-005453-4057qib7	1683	4	-	-	NN
cord-005453-4057qib7	1683	5	transplant	transplant	NN
cord-005453-4057qib7	1683	6	,	,	,
cord-005453-4057qib7	1683	7	GvHD	GvHD	NNP
cord-005453-4057qib7	1683	8	deteriorated	deteriorate	VBD
cord-005453-4057qib7	1683	9	and	and	CC
cord-005453-4057qib7	1683	10	after	after	IN
cord-005453-4057qib7	1683	11	further	further	JJ
cord-005453-4057qib7	1683	12	complications	complication	NNS
cord-005453-4057qib7	1683	13	the	the	DT
cord-005453-4057qib7	1683	14	patient	patient	NN
cord-005453-4057qib7	1683	15	died	die	VBD
cord-005453-4057qib7	1683	16	of	of	IN
cord-005453-4057qib7	1683	17	pneumonia	pneumonia	NN
cord-005453-4057qib7	1683	18	11	11	CD
cord-005453-4057qib7	1683	19	months	month	NNS
cord-005453-4057qib7	1683	20	post	post	JJ
cord-005453-4057qib7	1683	21	-	-	NN
cord-005453-4057qib7	1683	22	transplant	transplant	NN
cord-005453-4057qib7	1683	23	.	.	.
cord-005453-4057qib7	1684	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1684	2	:	:	:
cord-005453-4057qib7	1685	1	Supplementary	supplementary	JJ
cord-005453-4057qib7	1685	2	treatment	treatment	NN
cord-005453-4057qib7	1685	3	with	with	IN
cord-005453-4057qib7	1685	4	rituximab	rituximab	NN
cord-005453-4057qib7	1685	5	can	can	MD
cord-005453-4057qib7	1685	6	induce	induce	VB
cord-005453-4057qib7	1685	7	deep	deep	JJ
cord-005453-4057qib7	1685	8	remissions	remission	NNS
cord-005453-4057qib7	1685	9	in	in	IN
cord-005453-4057qib7	1685	10	patients	patient	NNS
cord-005453-4057qib7	1685	11	with	with	IN
cord-005453-4057qib7	1685	12	ibrutinibresistant	ibrutinibresistant	NNP
cord-005453-4057qib7	1685	13	,	,	,
cord-005453-4057qib7	1685	14	genetically	genetically	RB
cord-005453-4057qib7	1685	15	poor	poor	JJ
cord-005453-4057qib7	1685	16	-	-	HYPH
cord-005453-4057qib7	1685	17	risk	risk	NN
cord-005453-4057qib7	1685	18	B	B	NNP
cord-005453-4057qib7	1685	19	-	-	HYPH
cord-005453-4057qib7	1685	20	PLL	PLL	NNP
cord-005453-4057qib7	1685	21	,	,	,
cord-005453-4057qib7	1685	22	thereby	thereby	RB
cord-005453-4057qib7	1685	23	enabling	enable	VBG
cord-005453-4057qib7	1685	24	them	-PRON-	PRP
cord-005453-4057qib7	1685	25	to	to	TO
cord-005453-4057qib7	1685	26	undergo	undergo	VB
cord-005453-4057qib7	1685	27	successful	successful	JJ
cord-005453-4057qib7	1685	28	consolidation	consolidation	NN
cord-005453-4057qib7	1685	29	with	with	IN
cord-005453-4057qib7	1685	30	alloSCT	alloSCT	NNP
cord-005453-4057qib7	1685	31	.	.	.
cord-005453-4057qib7	1686	1	A	a	DT
cord-005453-4057qib7	1686	2	high	high	JJ
cord-005453-4057qib7	1686	3	risk	risk	NN
cord-005453-4057qib7	1686	4	of	of	IN
cord-005453-4057qib7	1686	5	life	life	NN
cord-005453-4057qib7	1686	6	-	-	HYPH
cord-005453-4057qib7	1686	7	threatening	threaten	VBG
cord-005453-4057qib7	1686	8	infusion	infusion	NN
cord-005453-4057qib7	1686	9	reactions	reaction	NNS
cord-005453-4057qib7	1686	10	/	/	SYM
cord-005453-4057qib7	1686	11	TLS	TLS	NNP
cord-005453-4057qib7	1686	12	associated	associate	VBN
cord-005453-4057qib7	1686	13	with	with	IN
cord-005453-4057qib7	1686	14	the	the	DT
cord-005453-4057qib7	1686	15	addition	addition	NN
cord-005453-4057qib7	1686	16	of	of	IN
cord-005453-4057qib7	1686	17	rituximab	rituximab	NN
cord-005453-4057qib7	1686	18	has	have	VBZ
cord-005453-4057qib7	1686	19	to	to	TO
cord-005453-4057qib7	1686	20	be	be	VB
cord-005453-4057qib7	1686	21	taken	take	VBN
cord-005453-4057qib7	1686	22	into	into	IN
cord-005453-4057qib7	1686	23	account	account	NN
cord-005453-4057qib7	1686	24	.	.	.
cord-005453-4057qib7	1687	1	Background	background	NN
cord-005453-4057qib7	1687	2	:	:	:
cord-005453-4057qib7	1688	1	There	there	EX
cord-005453-4057qib7	1688	2	is	be	VBZ
cord-005453-4057qib7	1688	3	little	little	JJ
cord-005453-4057qib7	1688	4	experience	experience	NN
cord-005453-4057qib7	1688	5	on	on	IN
cord-005453-4057qib7	1688	6	the	the	DT
cord-005453-4057qib7	1688	7	use	use	NN
cord-005453-4057qib7	1688	8	of	of	IN
cord-005453-4057qib7	1688	9	the	the	DT
cord-005453-4057qib7	1688	10	newer	new	JJR
cord-005453-4057qib7	1688	11	targeted	target	VBN
cord-005453-4057qib7	1688	12	therapies	therapy	NNS
cord-005453-4057qib7	1688	13	in	in	IN
cord-005453-4057qib7	1688	14	CLL	CLL	NNP
cord-005453-4057qib7	1688	15	patients	patient	NNS
cord-005453-4057qib7	1688	16	relapsed	relapse	VBD
cord-005453-4057qib7	1688	17	after	after	IN
cord-005453-4057qib7	1688	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	1688	19	stem	stem	NN
cord-005453-4057qib7	1688	20	cell	cell	NN
cord-005453-4057qib7	1688	21	transplantation	transplantation	NN
cord-005453-4057qib7	1688	22	(	(	-LRB-
cord-005453-4057qib7	1688	23	allo	allo	FW
cord-005453-4057qib7	1688	24	-	-	HYPH
cord-005453-4057qib7	1688	25	SCT	SCT	NNP
cord-005453-4057qib7	1688	26	)	)	-RRB-
cord-005453-4057qib7	1688	27	.	.	.
cord-005453-4057qib7	1689	1	Against	against	IN
cord-005453-4057qib7	1689	2	this	this	DT
cord-005453-4057qib7	1689	3	background	background	NN
cord-005453-4057qib7	1689	4	,	,	,
cord-005453-4057qib7	1689	5	we	-PRON-	PRP
cord-005453-4057qib7	1689	6	evaluate	evaluate	VBP
cord-005453-4057qib7	1689	7	the	the	DT
cord-005453-4057qib7	1689	8	safety	safety	NN
cord-005453-4057qib7	1689	9	and	and	CC
cord-005453-4057qib7	1689	10	efficacy	efficacy	NN
cord-005453-4057qib7	1689	11	of	of	IN
cord-005453-4057qib7	1689	12	the	the	DT
cord-005453-4057qib7	1689	13	BCR	BCR	NNP
cord-005453-4057qib7	1689	14	inhibitors	inhibitor	NNS
cord-005453-4057qib7	1689	15	(	(	-LRB-
cord-005453-4057qib7	1689	16	BCRi	BCRi	NNP
cord-005453-4057qib7	1689	17	)	)	-RRB-
cord-005453-4057qib7	1689	18	,	,	,
cord-005453-4057qib7	1689	19	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1689	20	and	and	CC
cord-005453-4057qib7	1689	21	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1689	22	,	,	,
cord-005453-4057qib7	1689	23	administered	administer	VBN
cord-005453-4057qib7	1689	24	after	after	IN
cord-005453-4057qib7	1689	25	allo	allo	NN
cord-005453-4057qib7	1689	26	-	-	HYPH
cord-005453-4057qib7	1689	27	SCT	SCT	NNP
cord-005453-4057qib7	1689	28	for	for	IN
cord-005453-4057qib7	1689	29	the	the	DT
cord-005453-4057qib7	1689	30	purpose	purpose	NN
cord-005453-4057qib7	1689	31	of	of	IN
cord-005453-4057qib7	1689	32	treating	treat	VBG
cord-005453-4057qib7	1689	33	the	the	DT
cord-005453-4057qib7	1689	34	CLL	CLL	NNP
cord-005453-4057qib7	1689	35	relapse	relapse	NN
cord-005453-4057qib7	1689	36	.	.	.
cord-005453-4057qib7	1690	1	Methods	method	NNS
cord-005453-4057qib7	1690	2	:	:	:
cord-005453-4057qib7	1691	1	Data	datum	NNS
cord-005453-4057qib7	1691	2	from	from	IN
cord-005453-4057qib7	1691	3	11	11	CD
cord-005453-4057qib7	1691	4	CLL	CLL	NNP
cord-005453-4057qib7	1691	5	pts	pts	NNP
cord-005453-4057qib7	1691	6	who	who	WP
cord-005453-4057qib7	1691	7	relapsed	relapse	VBD
cord-005453-4057qib7	1691	8	after	after	IN
cord-005453-4057qib7	1691	9	SCT	SCT	NNP
cord-005453-4057qib7	1691	10	,	,	,
cord-005453-4057qib7	1691	11	and	and	CC
cord-005453-4057qib7	1691	12	were	be	VBD
cord-005453-4057qib7	1691	13	subsequently	subsequently	RB
cord-005453-4057qib7	1691	14	treated	treat	VBN
cord-005453-4057qib7	1691	15	with	with	IN
cord-005453-4057qib7	1691	16	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1691	17	(	(	-LRB-
cord-005453-4057qib7	1691	18	n=6	n=6	NNP
cord-005453-4057qib7	1691	19	)	)	-RRB-
cord-005453-4057qib7	1691	20	,	,	,
cord-005453-4057qib7	1691	21	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1691	22	(	(	-LRB-
cord-005453-4057qib7	1691	23	n=3	n=3	NN
cord-005453-4057qib7	1691	24	)	)	-RRB-
cord-005453-4057qib7	1691	25	or	or	CC
cord-005453-4057qib7	1691	26	both	both	DT
cord-005453-4057qib7	1691	27	(	(	-LRB-
cord-005453-4057qib7	1691	28	n=2),were	n=2),were	RB
cord-005453-4057qib7	1691	29	retrospectively	retrospectively	RB
cord-005453-4057qib7	1691	30	collected	collect	VBN
cord-005453-4057qib7	1691	31	in	in	IN
cord-005453-4057qib7	1691	32	collaboration	collaboration	NN
cord-005453-4057qib7	1691	33	with	with	IN
cord-005453-4057qib7	1691	34	the	the	DT
cord-005453-4057qib7	1691	35	Spanish	spanish	JJ
cord-005453-4057qib7	1691	36	group	group	NN
cord-005453-4057qib7	1691	37	of	of	IN
cord-005453-4057qib7	1691	38	CLL	CLL	NNP
cord-005453-4057qib7	1691	39	(	(	-LRB-
cord-005453-4057qib7	1691	40	GELLC	GELLC	NNP
cord-005453-4057qib7	1691	41	)	)	-RRB-
cord-005453-4057qib7	1691	42	and	and	CC
cord-005453-4057qib7	1691	43	the	the	DT
cord-005453-4057qib7	1691	44	Spanish	spanish	JJ
cord-005453-4057qib7	1691	45	group	group	NN
cord-005453-4057qib7	1691	46	of	of	IN
cord-005453-4057qib7	1691	47	Stem	Stem	NNP
cord-005453-4057qib7	1691	48	Cell	Cell	NNP
cord-005453-4057qib7	1691	49	Transplantation	transplantation	NN
cord-005453-4057qib7	1691	50	(	(	-LRB-
cord-005453-4057qib7	1691	51	GETH	GETH	NNP
cord-005453-4057qib7	1691	52	)	)	-RRB-
cord-005453-4057qib7	1691	53	.	.	.
cord-005453-4057qib7	1692	1	Results	result	NNS
cord-005453-4057qib7	1692	2	:	:	:
cord-005453-4057qib7	1693	1	Transplant	transplant	NN
cord-005453-4057qib7	1693	2	characteristics	characteristic	NNS
cord-005453-4057qib7	1693	3	are	be	VBP
cord-005453-4057qib7	1693	4	summarized	summarize	VBN
cord-005453-4057qib7	1693	5	in	in	IN
cord-005453-4057qib7	1693	6	table	table	NN
cord-005453-4057qib7	1693	7	1	1	CD
cord-005453-4057qib7	1693	8	.	.	.
cord-005453-4057qib7	1694	1	Eight	eight	CD
cord-005453-4057qib7	1694	2	patients	patient	NNS
cord-005453-4057qib7	1694	3	received	receive	VBD
cord-005453-4057qib7	1694	4	the	the	DT
cord-005453-4057qib7	1694	5	BCRi	BCRi	NNS
cord-005453-4057qib7	1694	6	as	as	IN
cord-005453-4057qib7	1694	7	the	the	DT
cord-005453-4057qib7	1694	8	first	first	JJ
cord-005453-4057qib7	1694	9	salvage	salvage	NN
cord-005453-4057qib7	1694	10	treatment	treatment	NN
cord-005453-4057qib7	1694	11	after	after	IN
cord-005453-4057qib7	1694	12	SCT	SCT	NNP
cord-005453-4057qib7	1694	13	relapse	relapse	NN
cord-005453-4057qib7	1694	14	,	,	,
cord-005453-4057qib7	1694	15	whereas	whereas	IN
cord-005453-4057qib7	1694	16	3	3	CD
cord-005453-4057qib7	1694	17	patients	patient	NNS
cord-005453-4057qib7	1694	18	had	have	VBD
cord-005453-4057qib7	1694	19	received	receive	VBN
cord-005453-4057qib7	1694	20	≥2	≥2	NNP
cord-005453-4057qib7	1694	21	prior	prior	JJ
cord-005453-4057qib7	1694	22	lines	line	NNS
cord-005453-4057qib7	1694	23	of	of	IN
cord-005453-4057qib7	1694	24	treatment	treatment	NN
cord-005453-4057qib7	1694	25	.	.	.
cord-005453-4057qib7	1695	1	At	at	IN
cord-005453-4057qib7	1695	2	the	the	DT
cord-005453-4057qib7	1695	3	time	time	NN
cord-005453-4057qib7	1695	4	of	of	IN
cord-005453-4057qib7	1695	5	the	the	DT
cord-005453-4057qib7	1695	6	onset	onset	NN
cord-005453-4057qib7	1695	7	of	of	IN
cord-005453-4057qib7	1695	8	the	the	DT
cord-005453-4057qib7	1695	9	BCRi	BCRi	NNS
cord-005453-4057qib7	1695	10	,	,	,
cord-005453-4057qib7	1695	11	7	7	CD
cord-005453-4057qib7	1695	12	patients	patient	NNS
cord-005453-4057qib7	1695	13	had	have	VBD
cord-005453-4057qib7	1695	14	Rai	Rai	NNP
cord-005453-4057qib7	1695	15	4	4	CD
cord-005453-4057qib7	1695	16	stage	stage	NN
cord-005453-4057qib7	1695	17	and	and	CC
cord-005453-4057qib7	1695	18	6	6	CD
cord-005453-4057qib7	1695	19	patients	patient	NNS
cord-005453-4057qib7	1695	20	had	have	VBD
cord-005453-4057qib7	1695	21	a	a	DT
cord-005453-4057qib7	1695	22	lymph	lymph	NN
cord-005453-4057qib7	1695	23	node	node	NN
cord-005453-4057qib7	1695	24	size	size	NN
cord-005453-4057qib7	1695	25	≥5	≥5	NNP
cord-005453-4057qib7	1695	26	cm	cm	NNP
cord-005453-4057qib7	1695	27	.	.	.
cord-005453-4057qib7	1696	1	Del17p	Del17p	NNP
cord-005453-4057qib7	1696	2	was	be	VBD
cord-005453-4057qib7	1696	3	present	present	JJ
cord-005453-4057qib7	1696	4	in	in	IN
cord-005453-4057qib7	1696	5	4	4	CD
cord-005453-4057qib7	1696	6	patients	patient	NNS
cord-005453-4057qib7	1696	7	and	and	CC
cord-005453-4057qib7	1696	8	del11q	del11q	NNP
cord-005453-4057qib7	1696	9	and	and	CC
cord-005453-4057qib7	1696	10	complex	complex	JJ
cord-005453-4057qib7	1696	11	karyotype	karyotype	NN
cord-005453-4057qib7	1696	12	in	in	IN
cord-005453-4057qib7	1696	13	2	2	CD
cord-005453-4057qib7	1696	14	patients	patient	NNS
cord-005453-4057qib7	1696	15	,	,	,
cord-005453-4057qib7	1696	16	respectively	respectively	RB
cord-005453-4057qib7	1696	17	.	.	.
cord-005453-4057qib7	1697	1	TP53	TP53	NNP
cord-005453-4057qib7	1697	2	gene	gene	NN
cord-005453-4057qib7	1697	3	mutation	mutation	NN
cord-005453-4057qib7	1697	4	was	be	VBD
cord-005453-4057qib7	1697	5	detected	detect	VBN
cord-005453-4057qib7	1697	6	in	in	IN
cord-005453-4057qib7	1697	7	3	3	CD
cord-005453-4057qib7	1697	8	patients	patient	NNS
cord-005453-4057qib7	1697	9	(	(	-LRB-
cord-005453-4057qib7	1697	10	all	all	DT
cord-005453-4057qib7	1697	11	with	with	IN
cord-005453-4057qib7	1697	12	del17p13	del17p13	CD
cord-005453-4057qib7	1697	13	)	)	-RRB-
cord-005453-4057qib7	1697	14	.	.	.
cord-005453-4057qib7	1698	1	Median	median	JJ
cord-005453-4057qib7	1698	2	time	time	NN
cord-005453-4057qib7	1698	3	from	from	IN
cord-005453-4057qib7	1698	4	SCT	SCT	NNP
cord-005453-4057qib7	1698	5	to	to	IN
cord-005453-4057qib7	1698	6	BCRi	BCRi	NNP
cord-005453-4057qib7	1698	7	therapy	therapy	NN
cord-005453-4057qib7	1698	8	was	be	VBD
cord-005453-4057qib7	1698	9	53.9	53.9	CD
cord-005453-4057qib7	1698	10	months	month	NNS
cord-005453-4057qib7	1698	11	,	,	,
cord-005453-4057qib7	1698	12	being	be	VBG
cord-005453-4057qib7	1698	13	shorter	short	JJR
cord-005453-4057qib7	1698	14	in	in	IN
cord-005453-4057qib7	1698	15	patients	patient	NNS
cord-005453-4057qib7	1698	16	treated	treat	VBN
cord-005453-4057qib7	1698	17	with	with	IN
cord-005453-4057qib7	1698	18	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	1698	19	(	(	-LRB-
cord-005453-4057qib7	1698	20	n=8	n=8	NN
cord-005453-4057qib7	1698	21	,	,	,
cord-005453-4057qib7	1698	22	median	median	JJ
cord-005453-4057qib7	1698	23	51	51	CD
cord-005453-4057qib7	1698	24	months	month	NNS
cord-005453-4057qib7	1698	25	)	)	-RRB-
cord-005453-4057qib7	1698	26	than	than	IN
cord-005453-4057qib7	1698	27	in	in	IN
cord-005453-4057qib7	1698	28	those	those	DT
cord-005453-4057qib7	1698	29	treated	treat	VBN
cord-005453-4057qib7	1698	30	with	with	IN
cord-005453-4057qib7	1698	31	idealisib	idealisib	NNP
cord-005453-4057qib7	1698	32	(	(	-LRB-
cord-005453-4057qib7	1698	33	n=3	n=3	NN
cord-005453-4057qib7	1698	34	,	,	,
cord-005453-4057qib7	1698	35	median	median	NN
cord-005453-4057qib7	1698	36	111	111	CD
cord-005453-4057qib7	1698	37	months	month	NNS
cord-005453-4057qib7	1698	38	)	)	-RRB-
cord-005453-4057qib7	1698	39	.	.	.
cord-005453-4057qib7	1699	1	Median	median	JJ
cord-005453-4057qib7	1699	2	time	time	NN
cord-005453-4057qib7	1699	3	on	on	IN
cord-005453-4057qib7	1699	4	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1699	5	and	and	CC
cord-005453-4057qib7	1699	6	on	on	IN
cord-005453-4057qib7	1699	7	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1699	8	was	be	VBD
cord-005453-4057qib7	1699	9	7.3	7.3	CD
cord-005453-4057qib7	1699	10	months	month	NNS
cord-005453-4057qib7	1699	11	(	(	-LRB-
cord-005453-4057qib7	1699	12	4	4	CD
cord-005453-4057qib7	1699	13	.	.	.
cord-005453-4057qib7	1699	14	1	1	CD
cord-005453-4057qib7	1699	15	-	-	SYM
cord-005453-4057qib7	1699	16	18.8	18.8	CD
cord-005453-4057qib7	1699	17	)	)	-RRB-
cord-005453-4057qib7	1699	18	and	and	CC
cord-005453-4057qib7	1699	19	6	6	CD
cord-005453-4057qib7	1699	20	months	month	NNS
cord-005453-4057qib7	1699	21	(	(	-LRB-
cord-005453-4057qib7	1699	22	3.0	3.0	CD
cord-005453-4057qib7	1699	23	-	-	HYPH
cord-005453-4057qib7	1699	24	23.4	23.4	CD
cord-005453-4057qib7	1699	25	)	)	-RRB-
cord-005453-4057qib7	1699	26	,	,	,
cord-005453-4057qib7	1699	27	respectively	respectively	RB
cord-005453-4057qib7	1699	28	.	.	.
cord-005453-4057qib7	1700	1	The	the	DT
cord-005453-4057qib7	1700	2	best	good	JJS
cord-005453-4057qib7	1700	3	overall	overall	JJ
cord-005453-4057qib7	1700	4	response	response	NN
cord-005453-4057qib7	1700	5	rate	rate	NN
cord-005453-4057qib7	1700	6	(	(	-LRB-
cord-005453-4057qib7	1700	7	ORR	ORR	NNP
cord-005453-4057qib7	1700	8	)	)	-RRB-
cord-005453-4057qib7	1700	9	obtained	obtain	VBN
cord-005453-4057qib7	1700	10	with	with	IN
cord-005453-4057qib7	1700	11	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1700	12	was	be	VBD
cord-005453-4057qib7	1700	13	75	75	CD
cord-005453-4057qib7	1700	14	%	%	NN
cord-005453-4057qib7	1700	15	(	(	-LRB-
cord-005453-4057qib7	1700	16	1	1	CD
cord-005453-4057qib7	1700	17	CR	cr	NN
cord-005453-4057qib7	1700	18	,	,	,
cord-005453-4057qib7	1700	19	4	4	CD
cord-005453-4057qib7	1700	20	PR	pr	NN
cord-005453-4057qib7	1700	21	,	,	,
cord-005453-4057qib7	1700	22	1	1	CD
cord-005453-4057qib7	1700	23	PR+L	PR+L	NNP
cord-005453-4057qib7	1700	24	)	)	-RRB-
cord-005453-4057qib7	1700	25	whereas	whereas	IN
cord-005453-4057qib7	1700	26	it	-PRON-	PRP
cord-005453-4057qib7	1700	27	was	be	VBD
cord-005453-4057qib7	1700	28	of	of	IN
cord-005453-4057qib7	1700	29	40	40	CD
cord-005453-4057qib7	1700	30	%	%	NN
cord-005453-4057qib7	1700	31	for	for	IN
cord-005453-4057qib7	1700	32	patients	patient	NNS
cord-005453-4057qib7	1700	33	receiving	receive	VBG
cord-005453-4057qib7	1700	34	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1700	35	(	(	-LRB-
cord-005453-4057qib7	1700	36	1	1	CD
cord-005453-4057qib7	1700	37	CR	cr	NN
cord-005453-4057qib7	1700	38	,	,	,
cord-005453-4057qib7	1700	39	1	1	CD
cord-005453-4057qib7	1700	40	PR+L	PR+L	NNP
cord-005453-4057qib7	1700	41	)	)	-RRB-
cord-005453-4057qib7	1700	42	.	.	.
cord-005453-4057qib7	1701	1	Among	among	IN
cord-005453-4057qib7	1701	2	the	the	DT
cord-005453-4057qib7	1701	3	8	8	CD
cord-005453-4057qib7	1701	4	patients	patient	NNS
cord-005453-4057qib7	1701	5	treated	treat	VBN
cord-005453-4057qib7	1701	6	with	with	IN
cord-005453-4057qib7	1701	7	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1701	8	,	,	,
cord-005453-4057qib7	1701	9	7	7	CD
cord-005453-4057qib7	1701	10	(	(	-LRB-
cord-005453-4057qib7	1701	11	87.5	87.5	CD
cord-005453-4057qib7	1701	12	%	%	NN
cord-005453-4057qib7	1701	13	)	)	-RRB-
cord-005453-4057qib7	1701	14	presented	present	VBD
cord-005453-4057qib7	1701	15	an	an	DT
cord-005453-4057qib7	1701	16	adverse	adverse	JJ
cord-005453-4057qib7	1701	17	event	event	NN
cord-005453-4057qib7	1701	18	(	(	-LRB-
cord-005453-4057qib7	1701	19	AE	AE	NNP
cord-005453-4057qib7	1701	20	)	)	-RRB-
cord-005453-4057qib7	1701	21	,	,	,
cord-005453-4057qib7	1701	22	being	be	VBG
cord-005453-4057qib7	1701	23	diarrhea	diarrhea	NN
cord-005453-4057qib7	1701	24	(	(	-LRB-
cord-005453-4057qib7	1701	25	n=3	n=3	NN
cord-005453-4057qib7	1701	26	)	)	-RRB-
cord-005453-4057qib7	1701	27	,	,	,
cord-005453-4057qib7	1701	28	asthenia	asthenia	FW
cord-005453-4057qib7	1701	29	(	(	-LRB-
cord-005453-4057qib7	1701	30	n=2	n=2	NNS
cord-005453-4057qib7	1701	31	)	)	-RRB-
cord-005453-4057qib7	1701	32	and	and	CC
cord-005453-4057qib7	1701	33	infections	infection	NNS
cord-005453-4057qib7	1701	34	(	(	-LRB-
cord-005453-4057qib7	1701	35	n=5	n=5	RB
cord-005453-4057qib7	1701	36	)	)	-RRB-
cord-005453-4057qib7	1701	37	the	the	DT
cord-005453-4057qib7	1701	38	most	most	RBS
cord-005453-4057qib7	1701	39	frequent	frequent	JJ
cord-005453-4057qib7	1701	40	.	.	.
cord-005453-4057qib7	1702	1	Hypertension	hypertension	NN
cord-005453-4057qib7	1702	2	was	be	VBD
cord-005453-4057qib7	1702	3	seen	see	VBN
cord-005453-4057qib7	1702	4	in	in	IN
cord-005453-4057qib7	1702	5	1	1	CD
cord-005453-4057qib7	1702	6	patient	patient	NN
cord-005453-4057qib7	1702	7	and	and	CC
cord-005453-4057qib7	1702	8	none	none	NN
cord-005453-4057qib7	1702	9	patient	patient	NN
cord-005453-4057qib7	1702	10	developed	develop	VBD
cord-005453-4057qib7	1702	11	atrial	atrial	JJ
cord-005453-4057qib7	1702	12	fibrillation	fibrillation	NN
cord-005453-4057qib7	1702	13	.	.	.
cord-005453-4057qib7	1703	1	Five	five	CD
cord-005453-4057qib7	1703	2	patients	patient	NNS
cord-005453-4057qib7	1703	3	stopped	stop	VBD
cord-005453-4057qib7	1703	4	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	1703	5	treatment	treatment	NN
cord-005453-4057qib7	1703	6	,	,	,
cord-005453-4057qib7	1703	7	due	due	IN
cord-005453-4057qib7	1703	8	to	to	IN
cord-005453-4057qib7	1703	9	toxicity	toxicity	NN
cord-005453-4057qib7	1703	10	(	(	-LRB-
cord-005453-4057qib7	1703	11	n=4	n=4	NNS
cord-005453-4057qib7	1703	12	)	)	-RRB-
cord-005453-4057qib7	1703	13	or	or	CC
cord-005453-4057qib7	1703	14	progression	progression	NN
cord-005453-4057qib7	1703	15	(	(	-LRB-
cord-005453-4057qib7	1703	16	n=1	n=1	FW
cord-005453-4057qib7	1703	17	)	)	-RRB-
cord-005453-4057qib7	1703	18	.	.	.
cord-005453-4057qib7	1704	1	After	after	IN
cord-005453-4057qib7	1704	2	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	1704	3	discontinuation	discontinuation	NN
cord-005453-4057qib7	1704	4	,	,	,
cord-005453-4057qib7	1704	5	4	4	CD
cord-005453-4057qib7	1704	6	patients	patient	NNS
cord-005453-4057qib7	1704	7	were	be	VBD
cord-005453-4057qib7	1704	8	newly	newly	RB
cord-005453-4057qib7	1704	9	treated	treat	VBN
cord-005453-4057qib7	1704	10	with	with	IN
cord-005453-4057qib7	1704	11	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1704	12	(	(	-LRB-
cord-005453-4057qib7	1704	13	n=2	n=2	NNP
cord-005453-4057qib7	1704	14	)	)	-RRB-
cord-005453-4057qib7	1704	15	or	or	CC
cord-005453-4057qib7	1704	16	venetoclax	venetoclax	NNP
cord-005453-4057qib7	1704	17	(	(	-LRB-
cord-005453-4057qib7	1704	18	n=2	n=2	NNS
cord-005453-4057qib7	1704	19	)	)	-RRB-
cord-005453-4057qib7	1704	20	.	.	.
cord-005453-4057qib7	1705	1	All	all	DT
cord-005453-4057qib7	1705	2	patients	patient	NNS
cord-005453-4057qib7	1705	3	treated	treat	VBN
cord-005453-4057qib7	1705	4	with	with	IN
cord-005453-4057qib7	1705	5	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1705	6	developed	develop	VBD
cord-005453-4057qib7	1705	7	at	at	IN
cord-005453-4057qib7	1705	8	least	least	RBS
cord-005453-4057qib7	1705	9	one	one	CD
cord-005453-4057qib7	1705	10	AE	AE	NNP
cord-005453-4057qib7	1705	11	,	,	,
cord-005453-4057qib7	1705	12	being	be	VBG
cord-005453-4057qib7	1705	13	diarrhea	diarrhea	NN
cord-005453-4057qib7	1705	14	(	(	-LRB-
cord-005453-4057qib7	1705	15	n=3	n=3	NN
cord-005453-4057qib7	1705	16	)	)	-RRB-
cord-005453-4057qib7	1705	17	,	,	,
cord-005453-4057qib7	1705	18	pneumonitis	pneumonitis	NNP
cord-005453-4057qib7	1705	19	(	(	-LRB-
cord-005453-4057qib7	1705	20	n=2	n=2	NNS
cord-005453-4057qib7	1705	21	)	)	-RRB-
cord-005453-4057qib7	1705	22	and	and	CC
cord-005453-4057qib7	1705	23	neutropenia	neutropenia	NN
cord-005453-4057qib7	1705	24	(	(	-LRB-
cord-005453-4057qib7	1705	25	n=2	n=2	NNS
cord-005453-4057qib7	1705	26	)	)	-RRB-
cord-005453-4057qib7	1706	1	the	the	DT
cord-005453-4057qib7	1706	2	most	most	RBS
cord-005453-4057qib7	1706	3	common	common	JJ
cord-005453-4057qib7	1706	4	.	.	.
cord-005453-4057qib7	1707	1	Four	four	CD
cord-005453-4057qib7	1707	2	patients	patient	NNS
cord-005453-4057qib7	1707	3	discontinued	discontinue	VBD
cord-005453-4057qib7	1707	4	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1707	5	because	because	IN
cord-005453-4057qib7	1707	6	progression	progression	NN
cord-005453-4057qib7	1707	7	(	(	-LRB-
cord-005453-4057qib7	1707	8	n=3	n=3	NN
cord-005453-4057qib7	1707	9	)	)	-RRB-
cord-005453-4057qib7	1707	10	or	or	CC
cord-005453-4057qib7	1707	11	toxicity	toxicity	NN
cord-005453-4057qib7	1707	12	(	(	-LRB-
cord-005453-4057qib7	1707	13	n=1	n=1	FW
cord-005453-4057qib7	1707	14	)	)	-RRB-
cord-005453-4057qib7	1707	15	.	.	.
cord-005453-4057qib7	1708	1	Venetoclax	Venetoclax	NNP
cord-005453-4057qib7	1708	2	was	be	VBD
cord-005453-4057qib7	1708	3	given	give	VBN
cord-005453-4057qib7	1708	4	after	after	IN
cord-005453-4057qib7	1708	5	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1708	6	in	in	IN
cord-005453-4057qib7	1708	7	3	3	CD
cord-005453-4057qib7	1708	8	patients	patient	NNS
cord-005453-4057qib7	1708	9	.	.	.
cord-005453-4057qib7	1709	1	Although	although	IN
cord-005453-4057qib7	1709	2	acute	acute	JJ
cord-005453-4057qib7	1709	3	and/or	and/or	CC
cord-005453-4057qib7	1709	4	chronic	chronic	JJ
cord-005453-4057qib7	1709	5	GVHD	GVHD	NNP
cord-005453-4057qib7	1709	6	before	before	IN
cord-005453-4057qib7	1709	7	BCRi	BCRi	NNS
cord-005453-4057qib7	1709	8	was	be	VBD
cord-005453-4057qib7	1709	9	documented	document	VBN
cord-005453-4057qib7	1709	10	in	in	IN
cord-005453-4057qib7	1709	11	7	7	CD
cord-005453-4057qib7	1709	12	(	(	-LRB-
cord-005453-4057qib7	1709	13	63.6	63.6	CD
cord-005453-4057qib7	1709	14	%	%	NN
cord-005453-4057qib7	1709	15	)	)	-RRB-
cord-005453-4057qib7	1709	16	and	and	CC
cord-005453-4057qib7	1709	17	5	5	CD
cord-005453-4057qib7	1709	18	(	(	-LRB-
cord-005453-4057qib7	1709	19	45.5	45.5	CD
cord-005453-4057qib7	1709	20	%	%	NN
cord-005453-4057qib7	1709	21	)	)	-RRB-
cord-005453-4057qib7	1709	22	patients	patient	NNS
cord-005453-4057qib7	1709	23	,	,	,
cord-005453-4057qib7	1709	24	respectively	respectively	RB
cord-005453-4057qib7	1709	25	,	,	,
cord-005453-4057qib7	1709	26	only	only	RB
cord-005453-4057qib7	1709	27	one	one	CD
cord-005453-4057qib7	1709	28	patient	patient	NN
cord-005453-4057qib7	1709	29	(	(	-LRB-
cord-005453-4057qib7	1709	30	treated	treat	VBN
cord-005453-4057qib7	1709	31	with	with	IN
cord-005453-4057qib7	1709	32	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1709	33	)	)	-RRB-
cord-005453-4057qib7	1709	34	reactivated	reactivate	VBD
cord-005453-4057qib7	1709	35	a	a	DT
cord-005453-4057qib7	1709	36	mild	mild	JJ
cord-005453-4057qib7	1709	37	chronic	chronic	JJ
cord-005453-4057qib7	1709	38	GVHD	GVHD	NNP
cord-005453-4057qib7	1709	39	.	.	.
cord-005453-4057qib7	1710	1	None	none	NN
cord-005453-4057qib7	1710	2	patient	patient	NN
cord-005453-4057qib7	1710	3	received	receive	VBD
cord-005453-4057qib7	1710	4	infusion	infusion	NN
cord-005453-4057qib7	1710	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1710	6	from	from	IN
cord-005453-4057qib7	1710	7	donor	donor	NN
cord-005453-4057qib7	1710	8	after	after	IN
cord-005453-4057qib7	1710	9	BCRi	BCRi	NNS
cord-005453-4057qib7	1710	10	and	and	CC
cord-005453-4057qib7	1710	11	one	one	CD
cord-005453-4057qib7	1710	12	patient	patient	NN
cord-005453-4057qib7	1710	13	underwent	undergo	VBD
cord-005453-4057qib7	1710	14	a	a	DT
cord-005453-4057qib7	1710	15	second	second	JJ
cord-005453-4057qib7	1710	16	SCT	SCT	NNP
cord-005453-4057qib7	1710	17	.	.	.
cord-005453-4057qib7	1711	1	With	with	IN
cord-005453-4057qib7	1711	2	a	a	DT
cord-005453-4057qib7	1711	3	median	median	JJ
cord-005453-4057qib7	1711	4	follow	follow	NN
cord-005453-4057qib7	1711	5	-	-	HYPH
cord-005453-4057qib7	1711	6	up	up	NN
cord-005453-4057qib7	1711	7	of	of	IN
cord-005453-4057qib7	1711	8	14.3	14.3	CD
cord-005453-4057qib7	1711	9	months	month	NNS
cord-005453-4057qib7	1711	10	(	(	-LRB-
cord-005453-4057qib7	1711	11	5.9	5.9	CD
cord-005453-4057qib7	1711	12	-	-	SYM
cord-005453-4057qib7	1711	13	33.9	33.9	CD
cord-005453-4057qib7	1711	14	)	)	-RRB-
cord-005453-4057qib7	1711	15	after	after	IN
cord-005453-4057qib7	1711	16	the	the	DT
cord-005453-4057qib7	1711	17	onset	onset	NN
cord-005453-4057qib7	1711	18	of	of	IN
cord-005453-4057qib7	1711	19	the	the	DT
cord-005453-4057qib7	1711	20	BCRi	BCRi	NNP
cord-005453-4057qib7	1711	21	treatment	treatment	NN
cord-005453-4057qib7	1711	22	,	,	,
cord-005453-4057qib7	1711	23	4	4	CD
cord-005453-4057qib7	1711	24	patients	patient	NNS
cord-005453-4057qib7	1711	25	had	have	VBD
cord-005453-4057qib7	1711	26	died	die	VBN
cord-005453-4057qib7	1711	27	,	,	,
cord-005453-4057qib7	1711	28	all	all	DT
cord-005453-4057qib7	1711	29	of	of	IN
cord-005453-4057qib7	1711	30	them	-PRON-	PRP
cord-005453-4057qib7	1711	31	due	due	JJ
cord-005453-4057qib7	1711	32	to	to	IN
cord-005453-4057qib7	1711	33	CLL	CLL	NNP
cord-005453-4057qib7	1711	34	progression	progression	NN
cord-005453-4057qib7	1711	35	(	(	-LRB-
cord-005453-4057qib7	1711	36	3	3	CD
cord-005453-4057qib7	1711	37	Richter´s	richter´s	NN
cord-005453-4057qib7	1711	38	transformation	transformation	NN
cord-005453-4057qib7	1711	39	)	)	-RRB-
cord-005453-4057qib7	1711	40	,	,	,
cord-005453-4057qib7	1711	41	whereas	whereas	IN
cord-005453-4057qib7	1711	42	5	5	CD
cord-005453-4057qib7	1711	43	patients	patient	NNS
cord-005453-4057qib7	1711	44	remained	remain	VBD
cord-005453-4057qib7	1711	45	in	in	IN
cord-005453-4057qib7	1711	46	response	response	NN
cord-005453-4057qib7	1711	47	(	(	-LRB-
cord-005453-4057qib7	1711	48	3	3	CD
cord-005453-4057qib7	1711	49	CR	cr	NN
cord-005453-4057qib7	1711	50	,	,	,
cord-005453-4057qib7	1711	51	2	2	CD
cord-005453-4057qib7	1711	52	PR	pr	NN
cord-005453-4057qib7	1711	53	)	)	-RRB-
cord-005453-4057qib7	1711	54	.	.	.
cord-005453-4057qib7	1712	1	The	the	DT
cord-005453-4057qib7	1712	2	overall	overall	JJ
cord-005453-4057qib7	1712	3	survival	survival	NN
cord-005453-4057qib7	1712	4	probability	probability	NN
cord-005453-4057qib7	1712	5	of	of	IN
cord-005453-4057qib7	1712	6	the	the	DT
cord-005453-4057qib7	1712	7	whole	whole	JJ
cord-005453-4057qib7	1712	8	series	series	NN
cord-005453-4057qib7	1712	9	at	at	IN
cord-005453-4057qib7	1712	10	12	12	CD
cord-005453-4057qib7	1712	11	months	month	NNS
cord-005453-4057qib7	1712	12	was	be	VBD
cord-005453-4057qib7	1712	13	77.8	77.8	CD
cord-005453-4057qib7	1712	14	%	%	NN
cord-005453-4057qib7	1712	15	±13.9	±13.9	CD
cord-005453-4057qib7	1712	16	%	%	NN
cord-005453-4057qib7	1712	17	.	.	.
cord-005453-4057qib7	1713	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1713	2	:	:	:
cord-005453-4057qib7	1714	1	In	in	IN
cord-005453-4057qib7	1714	2	our	-PRON-	PRP$
cord-005453-4057qib7	1714	3	study	study	NN
cord-005453-4057qib7	1714	4	,	,	,
cord-005453-4057qib7	1714	5	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	1714	6	and	and	CC
cord-005453-4057qib7	1714	7	idelalisib	idelalisib	NNP
cord-005453-4057qib7	1714	8	,	,	,
cord-005453-4057qib7	1714	9	administered	administer	VBN
cord-005453-4057qib7	1714	10	in	in	IN
cord-005453-4057qib7	1714	11	CLL	CLL	NNP
cord-005453-4057qib7	1714	12	patients	patient	NNS
cord-005453-4057qib7	1714	13	relapsed	relapse	VBD
cord-005453-4057qib7	1714	14	after	after	IN
cord-005453-4057qib7	1714	15	SCT	SCT	NNP
cord-005453-4057qib7	1714	16	did	do	VBD
cord-005453-4057qib7	1714	17	not	not	RB
cord-005453-4057qib7	1714	18	increase	increase	VB
cord-005453-4057qib7	1714	19	the	the	DT
cord-005453-4057qib7	1714	20	risk	risk	NN
cord-005453-4057qib7	1714	21	of	of	IN
cord-005453-4057qib7	1714	22	GVHD	GVHD	NNP
cord-005453-4057qib7	1714	23	reactivation	reactivation	NN
cord-005453-4057qib7	1714	24	but	but	CC
cord-005453-4057qib7	1714	25	they	-PRON-	PRP
cord-005453-4057qib7	1714	26	show	show	VBP
cord-005453-4057qib7	1714	27	high	high	JJ
cord-005453-4057qib7	1714	28	incidence	incidence	NN
cord-005453-4057qib7	1714	29	of	of	IN
cord-005453-4057qib7	1714	30	adverse	adverse	JJ
cord-005453-4057qib7	1714	31	events	event	NNS
cord-005453-4057qib7	1714	32	.	.	.
cord-005453-4057qib7	1715	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	1715	2	,	,	,
cord-005453-4057qib7	1715	3	BCRi	BCRi	NNP
cord-005453-4057qib7	1715	4	offers	offer	VBZ
cord-005453-4057qib7	1715	5	a	a	DT
cord-005453-4057qib7	1715	6	possibility	possibility	NN
cord-005453-4057qib7	1715	7	of	of	IN
cord-005453-4057qib7	1715	8	disease	disease	NN
cord-005453-4057qib7	1715	9	control	control	NN
cord-005453-4057qib7	1715	10	in	in	IN
cord-005453-4057qib7	1715	11	these	these	DT
cord-005453-4057qib7	1715	12	patients	patient	NNS
cord-005453-4057qib7	1715	13	with	with	IN
cord-005453-4057qib7	1715	14	poor	poor	JJ
cord-005453-4057qib7	1715	15	prognosis	prognosis	NN
cord-005453-4057qib7	1715	16	.	.	.
cord-005453-4057qib7	1716	1	Further	further	JJ
cord-005453-4057qib7	1716	2	studies	study	NNS
cord-005453-4057qib7	1716	3	are	be	VBP
cord-005453-4057qib7	1716	4	needed	need	VBN
cord-005453-4057qib7	1716	5	to	to	TO
cord-005453-4057qib7	1716	6	confirm	confirm	VB
cord-005453-4057qib7	1716	7	these	these	DT
cord-005453-4057qib7	1716	8	data	datum	NNS
cord-005453-4057qib7	1716	9	.	.	.
cord-005453-4057qib7	1717	1	Background	background	NN
cord-005453-4057qib7	1717	2	:	:	:
cord-005453-4057qib7	1718	1	Prior	prior	RB
cord-005453-4057qib7	1718	2	to	to	IN
cord-005453-4057qib7	1718	3	the	the	DT
cord-005453-4057qib7	1718	4	introduction	introduction	NN
cord-005453-4057qib7	1718	5	of	of	IN
cord-005453-4057qib7	1718	6	tyrosine	tyrosine	NN
cord-005453-4057qib7	1718	7	kinase	kinase	NN
cord-005453-4057qib7	1718	8	inhibitors	inhibitor	NNS
cord-005453-4057qib7	1718	9	(	(	-LRB-
cord-005453-4057qib7	1718	10	TKI	TKI	NNP
cord-005453-4057qib7	1718	11	)	)	-RRB-
cord-005453-4057qib7	1718	12	,	,	,
cord-005453-4057qib7	1718	13	median	median	JJ
cord-005453-4057qib7	1718	14	survival	survival	NN
cord-005453-4057qib7	1718	15	of	of	IN
cord-005453-4057qib7	1718	16	chronic	chronic	JJ
cord-005453-4057qib7	1718	17	phase	phase	NN
cord-005453-4057qib7	1718	18	chronic	chronic	JJ
cord-005453-4057qib7	1718	19	myeloid	myeloid	NN
cord-005453-4057qib7	1718	20	leukemia	leukemia	NN
cord-005453-4057qib7	1719	1	(	(	-LRB-
cord-005453-4057qib7	1719	2	CP	CP	NNP
cord-005453-4057qib7	1719	3	-	-	HYPH
cord-005453-4057qib7	1719	4	CML	CML	NNP
cord-005453-4057qib7	1719	5	)	)	-RRB-
cord-005453-4057qib7	1719	6	patients	patient	NNS
cord-005453-4057qib7	1719	7	was	be	VBD
cord-005453-4057qib7	1719	8	approximately	approximately	RB
cord-005453-4057qib7	1719	9	60	60	CD
cord-005453-4057qib7	1719	10	months	month	NNS
cord-005453-4057qib7	1719	11	and	and	CC
cord-005453-4057qib7	1719	12	the	the	DT
cord-005453-4057qib7	1719	13	standard	standard	JJ
cord-005453-4057qib7	1719	14	treatment	treatment	NN
cord-005453-4057qib7	1719	15	with	with	IN
cord-005453-4057qib7	1719	16	interferon	interferon	NN
cord-005453-4057qib7	1719	17	-	-	HYPH
cord-005453-4057qib7	1719	18	alpha	alpha	NN
cord-005453-4057qib7	1719	19	resulted	result	VBD
cord-005453-4057qib7	1719	20	in	in	IN
cord-005453-4057qib7	1719	21	complete	complete	JJ
cord-005453-4057qib7	1719	22	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	1719	23	responses	response	NNS
cord-005453-4057qib7	1719	24	in	in	IN
cord-005453-4057qib7	1719	25	about	about	RB
cord-005453-4057qib7	1719	26	30	30	CD
cord-005453-4057qib7	1719	27	%	%	NN
cord-005453-4057qib7	1719	28	of	of	IN
cord-005453-4057qib7	1719	29	the	the	DT
cord-005453-4057qib7	1719	30	patients	patient	NNS
cord-005453-4057qib7	1719	31	.	.	.
cord-005453-4057qib7	1720	1	Autologous	autologous	JJ
cord-005453-4057qib7	1720	2	stem	stem	NN
cord-005453-4057qib7	1720	3	cell	cell	NN
cord-005453-4057qib7	1720	4	transplantation	transplantation	NN
cord-005453-4057qib7	1720	5	(	(	-LRB-
cord-005453-4057qib7	1720	6	auto	auto	NN
cord-005453-4057qib7	1720	7	-	-	HYPH
cord-005453-4057qib7	1720	8	SCT	SCT	NNP
cord-005453-4057qib7	1720	9	)	)	-RRB-
cord-005453-4057qib7	1720	10	was	be	VBD
cord-005453-4057qib7	1720	11	first	first	RB
cord-005453-4057qib7	1720	12	attempted	attempt	VBN
cord-005453-4057qib7	1720	13	for	for	IN
cord-005453-4057qib7	1720	14	patients	patient	NNS
cord-005453-4057qib7	1720	15	in	in	IN
cord-005453-4057qib7	1720	16	transformation	transformation	NN
cord-005453-4057qib7	1720	17	in	in	IN
cord-005453-4057qib7	1720	18	order	order	NN
cord-005453-4057qib7	1720	19	to	to	TO
cord-005453-4057qib7	1720	20	restore	restore	VB
cord-005453-4057qib7	1720	21	a	a	DT
cord-005453-4057qib7	1720	22	second	second	JJ
cord-005453-4057qib7	1720	23	CP	cp	NN
cord-005453-4057qib7	1720	24	and	and	CC
cord-005453-4057qib7	1720	25	was	be	VBD
cord-005453-4057qib7	1720	26	introduced	introduce	VBN
cord-005453-4057qib7	1720	27	secondarily	secondarily	RB
cord-005453-4057qib7	1720	28	in	in	IN
cord-005453-4057qib7	1720	29	CP	CP	NNP
cord-005453-4057qib7	1720	30	to	to	TO
cord-005453-4057qib7	1720	31	try	try	VB
cord-005453-4057qib7	1720	32	to	to	TO
cord-005453-4057qib7	1720	33	prolong	prolong	VB
cord-005453-4057qib7	1720	34	the	the	DT
cord-005453-4057qib7	1720	35	response	response	NN
cord-005453-4057qib7	1720	36	.	.	.
cord-005453-4057qib7	1721	1	The	the	DT
cord-005453-4057qib7	1721	2	main	main	JJ
cord-005453-4057qib7	1721	3	rational	rational	JJ
cord-005453-4057qib7	1721	4	for	for	IN
cord-005453-4057qib7	1721	5	autografting	autografte	VBG
cord-005453-4057qib7	1721	6	in	in	IN
cord-005453-4057qib7	1721	7	CP	CP	NNP
cord-005453-4057qib7	1721	8	resides	reside	VBZ
cord-005453-4057qib7	1721	9	on	on	IN
cord-005453-4057qib7	1721	10	the	the	DT
cord-005453-4057qib7	1721	11	reduction	reduction	NN
cord-005453-4057qib7	1721	12	of	of	IN
cord-005453-4057qib7	1721	13	the	the	DT
cord-005453-4057qib7	1721	14	tumor	tumor	NN
cord-005453-4057qib7	1721	15	burden	burden	NN
cord-005453-4057qib7	1721	16	and	and	CC
cord-005453-4057qib7	1721	17	the	the	DT
cord-005453-4057qib7	1721	18	number	number	NN
cord-005453-4057qib7	1721	19	of	of	IN
cord-005453-4057qib7	1721	20	leukemic	leukemic	JJ
cord-005453-4057qib7	1721	21	cells	cell	NNS
cord-005453-4057qib7	1721	22	at	at	IN
cord-005453-4057qib7	1721	23	risk	risk	NN
cord-005453-4057qib7	1721	24	of	of	IN
cord-005453-4057qib7	1721	25	developing	develop	VBG
cord-005453-4057qib7	1721	26	blastic	blastic	JJ
cord-005453-4057qib7	1721	27	transformation	transformation	NN
cord-005453-4057qib7	1721	28	.	.	.
cord-005453-4057qib7	1722	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	1722	2	,	,	,
cord-005453-4057qib7	1722	3	auto	auto	NN
cord-005453-4057qib7	1722	4	-	-	HYPH
cord-005453-4057qib7	1722	5	SCT	SCT	NNP
cord-005453-4057qib7	1722	6	alone	alone	RB
cord-005453-4057qib7	1722	7	was	be	VBD
cord-005453-4057qib7	1722	8	not	not	RB
cord-005453-4057qib7	1722	9	able	able	JJ
cord-005453-4057qib7	1722	10	to	to	TO
cord-005453-4057qib7	1722	11	maintain	maintain	VB
cord-005453-4057qib7	1722	12	a	a	DT
cord-005453-4057qib7	1722	13	long	long	JJ
cord-005453-4057qib7	1722	14	-	-	HYPH
cord-005453-4057qib7	1722	15	term	term	NN
cord-005453-4057qib7	1722	16	remission	remission	NN
cord-005453-4057qib7	1722	17	.	.	.
cord-005453-4057qib7	1723	1	Nowadays	nowadays	RB
cord-005453-4057qib7	1723	2	,	,	,
cord-005453-4057qib7	1723	3	TKIs	tki	NNS
cord-005453-4057qib7	1723	4	represent	represent	VBP
cord-005453-4057qib7	1723	5	the	the	DT
cord-005453-4057qib7	1723	6	state	state	NN
cord-005453-4057qib7	1723	7	-	-	HYPH
cord-005453-4057qib7	1723	8	of	of	IN
cord-005453-4057qib7	1723	9	-	-	HYPH
cord-005453-4057qib7	1723	10	the	the	DT
cord-005453-4057qib7	1723	11	-	-	HYPH
cord-005453-4057qib7	1723	12	art	art	NN
cord-005453-4057qib7	1723	13	therapy	therapy	NN
cord-005453-4057qib7	1723	14	for	for	IN
cord-005453-4057qib7	1723	15	CML	CML	NNP
cord-005453-4057qib7	1723	16	and	and	CC
cord-005453-4057qib7	1723	17	the	the	DT
cord-005453-4057qib7	1723	18	concept	concept	NN
cord-005453-4057qib7	1723	19	of	of	IN
cord-005453-4057qib7	1723	20	Auto	Auto	NNP
cord-005453-4057qib7	1723	21	-	-	HYPH
cord-005453-4057qib7	1723	22	SCT	SCT	NNP
cord-005453-4057qib7	1723	23	has	have	VBZ
cord-005453-4057qib7	1723	24	only	only	RB
cord-005453-4057qib7	1723	25	little	little	JJ
cord-005453-4057qib7	1723	26	interest	interest	NN
cord-005453-4057qib7	1723	27	while	while	IN
cord-005453-4057qib7	1723	28	long	long	JJ
cord-005453-4057qib7	1723	29	-	-	HYPH
cord-005453-4057qib7	1723	30	term	term	NN
cord-005453-4057qib7	1723	31	follow	follow	NN
cord-005453-4057qib7	1723	32	-	-	HYPH
cord-005453-4057qib7	1723	33	up	up	NN
cord-005453-4057qib7	1723	34	and	and	CC
cord-005453-4057qib7	1723	35	outcome	outcome	VB
cord-005453-4057qib7	1723	36	in	in	IN
cord-005453-4057qib7	1723	37	this	this	DT
cord-005453-4057qib7	1723	38	setting	setting	NN
cord-005453-4057qib7	1723	39	are	be	VBP
cord-005453-4057qib7	1723	40	currently	currently	RB
cord-005453-4057qib7	1723	41	unknown	unknown	JJ
cord-005453-4057qib7	1723	42	.	.	.
cord-005453-4057qib7	1724	1	The	the	DT
cord-005453-4057qib7	1724	2	aim	aim	NN
cord-005453-4057qib7	1724	3	of	of	IN
cord-005453-4057qib7	1724	4	our	-PRON-	PRP$
cord-005453-4057qib7	1724	5	study	study	NN
cord-005453-4057qib7	1724	6	is	be	VBZ
cord-005453-4057qib7	1724	7	to	to	TO
cord-005453-4057qib7	1724	8	evaluate	evaluate	VB
cord-005453-4057qib7	1724	9	at	at	IN
cord-005453-4057qib7	1724	10	a	a	DT
cord-005453-4057qib7	1724	11	first	first	JJ
cord-005453-4057qib7	1724	12	time	time	NN
cord-005453-4057qib7	1724	13	the	the	DT
cord-005453-4057qib7	1724	14	longterm	longterm	JJ
cord-005453-4057qib7	1724	15	outcome	outcome	NN
cord-005453-4057qib7	1724	16	of	of	IN
cord-005453-4057qib7	1724	17	CML	CML	NNP
cord-005453-4057qib7	1724	18	patients	patient	NNS
cord-005453-4057qib7	1724	19	who	who	WP
cord-005453-4057qib7	1724	20	received	receive	VBD
cord-005453-4057qib7	1724	21	auto	auto	NN
cord-005453-4057qib7	1724	22	-	-	HYPH
cord-005453-4057qib7	1724	23	SCT	sct	NN
cord-005453-4057qib7	1724	24	in	in	IN
cord-005453-4057qib7	1724	25	chronic	chronic	JJ
cord-005453-4057qib7	1724	26	phase	phase	NN
cord-005453-4057qib7	1724	27	,	,	,
cord-005453-4057qib7	1724	28	and	and	CC
cord-005453-4057qib7	1724	29	to	to	TO
cord-005453-4057qib7	1724	30	evaluate	evaluate	VB
cord-005453-4057qib7	1724	31	at	at	IN
cord-005453-4057qib7	1724	32	a	a	DT
cord-005453-4057qib7	1724	33	second	second	JJ
cord-005453-4057qib7	1724	34	time	time	NN
cord-005453-4057qib7	1724	35	in	in	IN
cord-005453-4057qib7	1724	36	a	a	DT
cord-005453-4057qib7	1724	37	subgroup	subgroup	NN
cord-005453-4057qib7	1724	38	analysis	analysis	NN
cord-005453-4057qib7	1724	39	,	,	,
cord-005453-4057qib7	1724	40	the	the	DT
cord-005453-4057qib7	1724	41	outcome	outcome	NN
cord-005453-4057qib7	1724	42	of	of	IN
cord-005453-4057qib7	1724	43	those	those	DT
cord-005453-4057qib7	1724	44	who	who	WP
cord-005453-4057qib7	1724	45	received	receive	VBD
cord-005453-4057qib7	1724	46	TKI	TKI	NNP
cord-005453-4057qib7	1724	47	after	after	IN
cord-005453-4057qib7	1724	48	having	have	VBG
cord-005453-4057qib7	1724	49	been	be	VBN
cord-005453-4057qib7	1724	50	auto	auto	NN
cord-005453-4057qib7	1724	51	-	-	HYPH
cord-005453-4057qib7	1724	52	transplanted	transplant	VBN
cord-005453-4057qib7	1724	53	,	,	,
cord-005453-4057qib7	1724	54	mainly	mainly	RB
cord-005453-4057qib7	1724	55	for	for	IN
cord-005453-4057qib7	1724	56	disease	disease	NN
cord-005453-4057qib7	1724	57	progression	progression	NN
cord-005453-4057qib7	1724	58	/	/	SYM
cord-005453-4057qib7	1724	59	loss	loss	NN
cord-005453-4057qib7	1724	60	of	of	IN
cord-005453-4057qib7	1724	61	response	response	NN
cord-005453-4057qib7	1724	62	and/or	and/or	CC
cord-005453-4057qib7	1724	63	to	to	TO
cord-005453-4057qib7	1724	64	enhance	enhance	VB
cord-005453-4057qib7	1724	65	disease	disease	NN
cord-005453-4057qib7	1724	66	response	response	NN
cord-005453-4057qib7	1724	67	.	.	.
cord-005453-4057qib7	1725	1	Methods	method	NNS
cord-005453-4057qib7	1725	2	:	:	:
cord-005453-4057qib7	1725	3	We	-PRON-	PRP
cord-005453-4057qib7	1725	4	found	find	VBD
cord-005453-4057qib7	1725	5	a	a	DT
cord-005453-4057qib7	1725	6	total	total	NN
cord-005453-4057qib7	1725	7	of	of	IN
cord-005453-4057qib7	1725	8	969	969	CD
cord-005453-4057qib7	1725	9	patients	patient	NNS
cord-005453-4057qib7	1725	10	who	who	WP
cord-005453-4057qib7	1725	11	received	receive	VBD
cord-005453-4057qib7	1725	12	auto	auto	NN
cord-005453-4057qib7	1725	13	-	-	HYPH
cord-005453-4057qib7	1725	14	SCT	SCT	NNP
cord-005453-4057qib7	1725	15	for	for	IN
cord-005453-4057qib7	1725	16	CP	CP	NNP
cord-005453-4057qib7	1725	17	-	-	HYPH
cord-005453-4057qib7	1725	18	CML	CML	NNP
cord-005453-4057qib7	1725	19	in	in	IN
cord-005453-4057qib7	1725	20	Europe	Europe	NNP
cord-005453-4057qib7	1725	21	between	between	IN
cord-005453-4057qib7	1725	22	years	year	NNS
cord-005453-4057qib7	1725	23	1989	1989	CD
cord-005453-4057qib7	1725	24	and	and	CC
cord-005453-4057qib7	1725	25	2004	2004	CD
cord-005453-4057qib7	1725	26	,	,	,
cord-005453-4057qib7	1725	27	578	578	CD
cord-005453-4057qib7	1725	28	(	(	-LRB-
cord-005453-4057qib7	1725	29	60	60	CD
cord-005453-4057qib7	1725	30	%	%	NN
cord-005453-4057qib7	1725	31	)	)	-RRB-
cord-005453-4057qib7	1725	32	were	be	VBD
cord-005453-4057qib7	1725	33	males	male	NNS
cord-005453-4057qib7	1725	34	,	,	,
cord-005453-4057qib7	1725	35	median	median	JJ
cord-005453-4057qib7	1725	36	age	age	NN
cord-005453-4057qib7	1725	37	at	at	IN
cord-005453-4057qib7	1725	38	auto	auto	NN
cord-005453-4057qib7	1725	39	-	-	HYPH
cord-005453-4057qib7	1725	40	SCT	SCT	NNP
cord-005453-4057qib7	1725	41	was	be	VBD
cord-005453-4057qib7	1725	42	47	47	CD
cord-005453-4057qib7	1725	43	years	year	NNS
cord-005453-4057qib7	1726	1	(	(	-LRB-
cord-005453-4057qib7	1726	2	range	range	NN
cord-005453-4057qib7	1726	3	:	:	:
cord-005453-4057qib7	1726	4	19	19	CD
cord-005453-4057qib7	1726	5	-	-	SYM
cord-005453-4057qib7	1726	6	67	67	CD
cord-005453-4057qib7	1726	7	)	)	-RRB-
cord-005453-4057qib7	1726	8	,	,	,
cord-005453-4057qib7	1726	9	the	the	DT
cord-005453-4057qib7	1726	10	median	median	JJ
cord-005453-4057qib7	1726	11	time	time	NN
cord-005453-4057qib7	1726	12	between	between	IN
cord-005453-4057qib7	1726	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	1726	14	and	and	CC
cord-005453-4057qib7	1726	15	auto	auto	NN
cord-005453-4057qib7	1726	16	-	-	HYPH
cord-005453-4057qib7	1726	17	SCT	SCT	NNP
cord-005453-4057qib7	1726	18	was	be	VBD
cord-005453-4057qib7	1726	19	19	19	CD
cord-005453-4057qib7	1726	20	months	month	NNS
cord-005453-4057qib7	1726	21	,	,	,
cord-005453-4057qib7	1726	22	stem	stem	NN
cord-005453-4057qib7	1726	23	cells	cell	NNS
cord-005453-4057qib7	1726	24	source	source	NN
cord-005453-4057qib7	1726	25	was	be	VBD
cord-005453-4057qib7	1726	26	peripheral	peripheral	JJ
cord-005453-4057qib7	1726	27	blood	blood	NN
cord-005453-4057qib7	1726	28	in	in	IN
cord-005453-4057qib7	1726	29	84	84	CD
cord-005453-4057qib7	1726	30	%	%	NN
cord-005453-4057qib7	1726	31	of	of	IN
cord-005453-4057qib7	1726	32	patients	patient	NNS
cord-005453-4057qib7	1726	33	,	,	,
cord-005453-4057qib7	1726	34	most	most	RBS
cord-005453-4057qib7	1726	35	frequent	frequent	JJ
cord-005453-4057qib7	1726	36	conditioning	conditioning	NN
cord-005453-4057qib7	1726	37	regimen	regimen	NN
cord-005453-4057qib7	1726	38	was	be	VBD
cord-005453-4057qib7	1726	39	busulfan	busulfan	NN
cord-005453-4057qib7	1726	40	4mg	4mg	NNP
cord-005453-4057qib7	1726	41	/	/	SYM
cord-005453-4057qib7	1726	42	Kg	Kg	NNP
cord-005453-4057qib7	1726	43	/	/	SYM
cord-005453-4057qib7	1726	44	day	day	NN
cord-005453-4057qib7	1726	45	4	4	CD
cord-005453-4057qib7	1726	46	days	day	NNS
cord-005453-4057qib7	1726	47	+	+	SYM
cord-005453-4057qib7	1726	48	1	1	CD
cord-005453-4057qib7	1726	49	day	day	NN
cord-005453-4057qib7	1726	50	of	of	IN
cord-005453-4057qib7	1726	51	melphalan	melphalan	NNP
cord-005453-4057qib7	1726	52	140	140	CD
cord-005453-4057qib7	1726	53	mg	mg	NNP
cord-005453-4057qib7	1726	54	/	/	SYM
cord-005453-4057qib7	1726	55	m²	m²	NNP
cord-005453-4057qib7	1726	56	one	one	CD
cord-005453-4057qib7	1726	57	day	day	NN
cord-005453-4057qib7	1726	58	prior	prior	RB
cord-005453-4057qib7	1726	59	to	to	IN
cord-005453-4057qib7	1726	60	the	the	DT
cord-005453-4057qib7	1726	61	cells	cell	NNS
cord-005453-4057qib7	1726	62	reinfusion	reinfusion	NN
cord-005453-4057qib7	1726	63	.	.	.
cord-005453-4057qib7	1727	1	Information	information	NN
cord-005453-4057qib7	1727	2	about	about	IN
cord-005453-4057qib7	1727	3	receiving	receive	VBG
cord-005453-4057qib7	1727	4	TKI	TKI	NNP
cord-005453-4057qib7	1727	5	post	post	NN
cord-005453-4057qib7	1727	6	auto	auto	NN
cord-005453-4057qib7	1727	7	-	-	HYPH
cord-005453-4057qib7	1727	8	SCT	SCT	NNP
cord-005453-4057qib7	1727	9	was	be	VBD
cord-005453-4057qib7	1727	10	available	available	JJ
cord-005453-4057qib7	1727	11	only	only	RB
cord-005453-4057qib7	1727	12	for	for	IN
cord-005453-4057qib7	1727	13	103	103	CD
cord-005453-4057qib7	1727	14	patients	patient	NNS
cord-005453-4057qib7	1727	15	,	,	,
cord-005453-4057qib7	1727	16	first	first	RB
cord-005453-4057qib7	1727	17	TKI	TKI	NNP
cord-005453-4057qib7	1727	18	was	be	VBD
cord-005453-4057qib7	1727	19	imatinib	imatinib	JJ
cord-005453-4057qib7	1727	20	for	for	IN
cord-005453-4057qib7	1727	21	89	89	CD
cord-005453-4057qib7	1727	22	(	(	-LRB-
cord-005453-4057qib7	1727	23	86	86	CD
cord-005453-4057qib7	1727	24	%	%	NN
cord-005453-4057qib7	1727	25	)	)	-RRB-
cord-005453-4057qib7	1727	26	patients	patient	NNS
cord-005453-4057qib7	1727	27	,	,	,
cord-005453-4057qib7	1727	28	dasatinib	dasatinib	NN
cord-005453-4057qib7	1727	29	for	for	IN
cord-005453-4057qib7	1727	30	8	8	CD
cord-005453-4057qib7	1727	31	(	(	-LRB-
cord-005453-4057qib7	1727	32	8	8	CD
cord-005453-4057qib7	1727	33	%	%	NN
cord-005453-4057qib7	1727	34	)	)	-RRB-
cord-005453-4057qib7	1727	35	,	,	,
cord-005453-4057qib7	1727	36	nilotinib	nilotinib	NNP
cord-005453-4057qib7	1727	37	for	for	IN
cord-005453-4057qib7	1727	38	6	6	CD
cord-005453-4057qib7	1727	39	(	(	-LRB-
cord-005453-4057qib7	1727	40	5	5	CD
cord-005453-4057qib7	1727	41	%	%	NN
cord-005453-4057qib7	1727	42	)	)	-RRB-
cord-005453-4057qib7	1727	43	and	and	CC
cord-005453-4057qib7	1727	44	ponatinib	ponatinib	NN
cord-005453-4057qib7	1727	45	for	for	IN
cord-005453-4057qib7	1727	46	one	one	CD
cord-005453-4057qib7	1727	47	(	(	-LRB-
cord-005453-4057qib7	1727	48	1	1	CD
cord-005453-4057qib7	1727	49	%	%	NN
cord-005453-4057qib7	1727	50	)	)	-RRB-
cord-005453-4057qib7	1727	51	patient	patient	NN
cord-005453-4057qib7	1727	52	.	.	.
cord-005453-4057qib7	1728	1	Results	result	NNS
cord-005453-4057qib7	1728	2	:	:	:
cord-005453-4057qib7	1729	1	After	after	IN
cord-005453-4057qib7	1729	2	a	a	DT
cord-005453-4057qib7	1729	3	median	median	JJ
cord-005453-4057qib7	1729	4	follow	follow	NN
cord-005453-4057qib7	1729	5	-	-	HYPH
cord-005453-4057qib7	1729	6	up	up	NN
cord-005453-4057qib7	1729	7	of	of	IN
cord-005453-4057qib7	1729	8	9.5	9.5	CD
cord-005453-4057qib7	1729	9	years	year	NNS
cord-005453-4057qib7	1729	10	(	(	-LRB-
cord-005453-4057qib7	1729	11	range	range	NN
cord-005453-4057qib7	1729	12	:	:	:
cord-005453-4057qib7	1729	13	1	1	CD
cord-005453-4057qib7	1729	14	-	-	SYM
cord-005453-4057qib7	1729	15	27	27	CD
cord-005453-4057qib7	1729	16	)	)	-RRB-
cord-005453-4057qib7	1729	17	from	from	IN
cord-005453-4057qib7	1729	18	time	time	NN
cord-005453-4057qib7	1729	19	of	of	IN
cord-005453-4057qib7	1729	20	auto	auto	NN
cord-005453-4057qib7	1729	21	-	-	HYPH
cord-005453-4057qib7	1729	22	SCT	SCT	NNP
cord-005453-4057qib7	1729	23	for	for	IN
cord-005453-4057qib7	1729	24	the	the	DT
cord-005453-4057qib7	1729	25	whole	whole	JJ
cord-005453-4057qib7	1729	26	population	population	NN
cord-005453-4057qib7	1729	27	,	,	,
cord-005453-4057qib7	1729	28	the	the	DT
cord-005453-4057qib7	1729	29	probability	probability	NN
cord-005453-4057qib7	1729	30	of	of	IN
cord-005453-4057qib7	1729	31	overall	overall	JJ
cord-005453-4057qib7	1729	32	survival	survival	NN
cord-005453-4057qib7	1729	33	(	(	-LRB-
cord-005453-4057qib7	1729	34	OS	OS	NNP
cord-005453-4057qib7	1729	35	)	)	-RRB-
cord-005453-4057qib7	1729	36	at	at	IN
cord-005453-4057qib7	1729	37	10	10	CD
cord-005453-4057qib7	1729	38	years	year	NNS
cord-005453-4057qib7	1729	39	was	be	VBD
cord-005453-4057qib7	1729	40	50	50	CD
cord-005453-4057qib7	1729	41	%	%	NN
cord-005453-4057qib7	1729	42	(	(	-LRB-
cord-005453-4057qib7	1729	43	95	95	CD
cord-005453-4057qib7	1729	44	%	%	NN
cord-005453-4057qib7	1729	45	CI	ci	NN
cord-005453-4057qib7	1729	46	:	:	:
cord-005453-4057qib7	1729	47	46	46	CD
cord-005453-4057qib7	1729	48	-	-	SYM
cord-005453-4057qib7	1729	49	53	53	CD
cord-005453-4057qib7	1729	50	)	)	-RRB-
cord-005453-4057qib7	1729	51	;	;	:
cord-005453-4057qib7	1729	52	there	there	EX
cord-005453-4057qib7	1729	53	was	be	VBD
cord-005453-4057qib7	1729	54	540	540	CD
cord-005453-4057qib7	1729	55	(	(	-LRB-
cord-005453-4057qib7	1729	56	56	56	CD
cord-005453-4057qib7	1729	57	%	%	NN
cord-005453-4057qib7	1729	58	)	)	-RRB-
cord-005453-4057qib7	1729	59	patients	patient	NNS
cord-005453-4057qib7	1729	60	who	who	WP
cord-005453-4057qib7	1729	61	relapsed	relapse	VBD
cord-005453-4057qib7	1729	62	after	after	IN
cord-005453-4057qib7	1729	63	a	a	DT
cord-005453-4057qib7	1729	64	median	median	JJ
cord-005453-4057qib7	1729	65	time	time	NN
cord-005453-4057qib7	1729	66	of	of	IN
cord-005453-4057qib7	1729	67	16	16	CD
cord-005453-4057qib7	1729	68	months	month	NNS
cord-005453-4057qib7	1729	69	after	after	IN
cord-005453-4057qib7	1729	70	auto	auto	NN
cord-005453-4057qib7	1729	71	-	-	HYPH
cord-005453-4057qib7	1729	72	SCT	SCT	NNP
cord-005453-4057qib7	1729	73	.	.	.
cord-005453-4057qib7	1730	1	There	there	EX
cord-005453-4057qib7	1730	2	was	be	VBD
cord-005453-4057qib7	1730	3	a	a	DT
cord-005453-4057qib7	1730	4	total	total	NN
cord-005453-4057qib7	1730	5	of	of	IN
cord-005453-4057qib7	1730	6	530	530	CD
cord-005453-4057qib7	1730	7	patients	patient	NNS
cord-005453-4057qib7	1730	8	transplanted	transplant	VBN
cord-005453-4057qib7	1730	9	before	before	IN
cord-005453-4057qib7	1730	10	the	the	DT
cord-005453-4057qib7	1730	11	TKI	TKI	NNP
cord-005453-4057qib7	1730	12	era	era	NN
cord-005453-4057qib7	1730	13	and	and	CC
cord-005453-4057qib7	1730	14	survived	survive	VBD
cord-005453-4057qib7	1730	15	until	until	IN
cord-005453-4057qib7	1730	16	the	the	DT
cord-005453-4057qib7	1730	17	availability	availability	NN
cord-005453-4057qib7	1730	18	of	of	IN
cord-005453-4057qib7	1730	19	TKIs	tki	NNS
cord-005453-4057qib7	1730	20	.	.	.
cord-005453-4057qib7	1731	1	When	when	WRB
cord-005453-4057qib7	1731	2	we	-PRON-	PRP
cord-005453-4057qib7	1731	3	performed	perform	VBD
cord-005453-4057qib7	1731	4	a	a	DT
cord-005453-4057qib7	1731	5	landmark	landmark	NN
cord-005453-4057qib7	1731	6	analysis	analysis	NN
cord-005453-4057qib7	1731	7	evaluating	evaluate	VBG
cord-005453-4057qib7	1731	8	the	the	DT
cord-005453-4057qib7	1731	9	outcome	outcome	NN
cord-005453-4057qib7	1731	10	of	of	IN
cord-005453-4057qib7	1731	11	patients	patient	NNS
cord-005453-4057qib7	1731	12	who	who	WP
cord-005453-4057qib7	1731	13	received	receive	VBD
cord-005453-4057qib7	1731	14	auto	auto	NN
cord-005453-4057qib7	1731	15	-	-	HYPH
cord-005453-4057qib7	1731	16	SCT	SCT	NNP
cord-005453-4057qib7	1731	17	,	,	,
cord-005453-4057qib7	1731	18	survived	survive	VBD
cord-005453-4057qib7	1731	19	until	until	IN
cord-005453-4057qib7	1731	20	the	the	DT
cord-005453-4057qib7	1731	21	TKI	TKI	NNP
cord-005453-4057qib7	1731	22	era	era	NN
cord-005453-4057qib7	1731	23	and	and	CC
cord-005453-4057qib7	1731	24	received	receive	VBD
cord-005453-4057qib7	1731	25	TKI	TKI	NNP
cord-005453-4057qib7	1731	26	(	(	-LRB-
cord-005453-4057qib7	1731	27	N=103	N=103	NNP
cord-005453-4057qib7	1731	28	)	)	-RRB-
cord-005453-4057qib7	1731	29	,	,	,
cord-005453-4057qib7	1731	30	the	the	DT
cord-005453-4057qib7	1731	31	10	10	CD
cord-005453-4057qib7	1731	32	years	year	NNS
cord-005453-4057qib7	1731	33	OS	os	NN
cord-005453-4057qib7	1731	34	probability	probability	NN
cord-005453-4057qib7	1731	35	of	of	IN
cord-005453-4057qib7	1731	36	these	these	DT
cord-005453-4057qib7	1731	37	patients	patient	NNS
cord-005453-4057qib7	1731	38	from	from	IN
cord-005453-4057qib7	1731	39	TKI	TKI	NNP
cord-005453-4057qib7	1731	40	treatment	treatment	NN
cord-005453-4057qib7	1731	41	was	be	VBD
cord-005453-4057qib7	1731	42	70	70	CD
cord-005453-4057qib7	1731	43	%	%	NN
cord-005453-4057qib7	1731	44	(	(	-LRB-
cord-005453-4057qib7	1731	45	95	95	CD
cord-005453-4057qib7	1731	46	%	%	NN
cord-005453-4057qib7	1731	47	CI	ci	NN
cord-005453-4057qib7	1731	48	:	:	:
cord-005453-4057qib7	1731	49	58	58	CD
cord-005453-4057qib7	1731	50	-	-	SYM
cord-005453-4057qib7	1731	51	78	78	CD
cord-005453-4057qib7	1731	52	)	)	-RRB-
cord-005453-4057qib7	1731	53	.	.	.
cord-005453-4057qib7	1732	1	Additional	additional	JJ
cord-005453-4057qib7	1732	2	data	data	NN
cord-005453-4057qib7	1732	3	requests	request	NNS
cord-005453-4057qib7	1732	4	will	will	MD
cord-005453-4057qib7	1732	5	be	be	VB
cord-005453-4057qib7	1732	6	sent	send	VBN
cord-005453-4057qib7	1732	7	to	to	IN
cord-005453-4057qib7	1732	8	centers	center	NNS
cord-005453-4057qib7	1732	9	querying	query	VBG
cord-005453-4057qib7	1732	10	about	about	IN
cord-005453-4057qib7	1732	11	prognosis	prognosis	NN
cord-005453-4057qib7	1732	12	,	,	,
cord-005453-4057qib7	1732	13	molecular	molecular	JJ
cord-005453-4057qib7	1732	14	responses	response	NNS
cord-005453-4057qib7	1732	15	,	,	,
cord-005453-4057qib7	1732	16	treatment	treatment	NN
cord-005453-4057qib7	1732	17	and	and	CC
cord-005453-4057qib7	1732	18	disease	disease	NN
cord-005453-4057qib7	1732	19	details	detail	NNS
cord-005453-4057qib7	1732	20	.	.	.
cord-005453-4057qib7	1733	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1733	2	:	:	:
cord-005453-4057qib7	1734	1	We	-PRON-	PRP
cord-005453-4057qib7	1734	2	demonstrate	demonstrate	VBP
cord-005453-4057qib7	1734	3	here	here	RB
cord-005453-4057qib7	1734	4	with	with	IN
cord-005453-4057qib7	1734	5	these	these	DT
cord-005453-4057qib7	1734	6	preliminary	preliminary	JJ
cord-005453-4057qib7	1734	7	results	result	NNS
cord-005453-4057qib7	1734	8	that	that	IN
cord-005453-4057qib7	1734	9	the	the	DT
cord-005453-4057qib7	1734	10	introduction	introduction	NN
cord-005453-4057qib7	1734	11	of	of	IN
cord-005453-4057qib7	1734	12	TKI	TKI	NNP
cord-005453-4057qib7	1734	13	has	have	VBZ
cord-005453-4057qib7	1734	14	improved	improve	VBN
cord-005453-4057qib7	1734	15	survival	survival	NN
cord-005453-4057qib7	1734	16	of	of	IN
cord-005453-4057qib7	1734	17	CML	CML	NNP
cord-005453-4057qib7	1734	18	patients	patient	NNS
cord-005453-4057qib7	1734	19	.	.	.
cord-005453-4057qib7	1735	1	In	in	IN
cord-005453-4057qib7	1735	2	addition	addition	NN
cord-005453-4057qib7	1735	3	,	,	,
cord-005453-4057qib7	1735	4	patients	patient	NNS
cord-005453-4057qib7	1735	5	who	who	WP
cord-005453-4057qib7	1735	6	received	receive	VBD
cord-005453-4057qib7	1735	7	auto	auto	NN
cord-005453-4057qib7	1735	8	-	-	HYPH
cord-005453-4057qib7	1735	9	SCT	SCT	NNP
cord-005453-4057qib7	1735	10	,	,	,
cord-005453-4057qib7	1735	11	survived	survive	VBD
cord-005453-4057qib7	1735	12	until	until	IN
cord-005453-4057qib7	1735	13	the	the	DT
cord-005453-4057qib7	1735	14	TKI	TKI	NNP
cord-005453-4057qib7	1735	15	era	era	NN
cord-005453-4057qib7	1735	16	and	and	CC
cord-005453-4057qib7	1735	17	also	also	RB
cord-005453-4057qib7	1735	18	received	receive	VBD
cord-005453-4057qib7	1735	19	TKI	TKI	NNP
cord-005453-4057qib7	1735	20	,	,	,
cord-005453-4057qib7	1735	21	had	have	VBD
cord-005453-4057qib7	1735	22	encouraging	encouraging	JJ
cord-005453-4057qib7	1735	23	rates	rate	NNS
cord-005453-4057qib7	1735	24	of	of	IN
cord-005453-4057qib7	1735	25	long	long	JJ
cord-005453-4057qib7	1735	26	-	-	HYPH
cord-005453-4057qib7	1735	27	term	term	NN
cord-005453-4057qib7	1735	28	survival	survival	NN
cord-005453-4057qib7	1735	29	.	.	.
cord-005453-4057qib7	1736	1	An	an	DT
cord-005453-4057qib7	1736	2	extensive	extensive	JJ
cord-005453-4057qib7	1736	3	analysis	analysis	NN
cord-005453-4057qib7	1736	4	will	will	MD
cord-005453-4057qib7	1736	5	be	be	VB
cord-005453-4057qib7	1736	6	performed	perform	VBN
cord-005453-4057qib7	1736	7	when	when	WRB
cord-005453-4057qib7	1736	8	additional	additional	JJ
cord-005453-4057qib7	1736	9	data	datum	NNS
cord-005453-4057qib7	1736	10	will	will	MD
cord-005453-4057qib7	1736	11	be	be	VB
cord-005453-4057qib7	1736	12	available	available	JJ
cord-005453-4057qib7	1736	13	and	and	CC
cord-005453-4057qib7	1736	14	the	the	DT
cord-005453-4057qib7	1736	15	study	study	NN
cord-005453-4057qib7	1736	16	will	will	MD
cord-005453-4057qib7	1736	17	be	be	VB
cord-005453-4057qib7	1736	18	updated	update	VBN
cord-005453-4057qib7	1736	19	with	with	IN
cord-005453-4057qib7	1736	20	more	more	JJR
cord-005453-4057qib7	1736	21	results	result	NNS
cord-005453-4057qib7	1736	22	.	.	.
cord-005453-4057qib7	1737	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1737	2	:	:	:
cord-005453-4057qib7	1737	3	Nothing	nothing	NN
cord-005453-4057qib7	1737	4	to	to	TO
cord-005453-4057qib7	1737	5	declare	declare	VB
cord-005453-4057qib7	1737	6	A	a	DT
cord-005453-4057qib7	1737	7	35	35	CD
cord-005453-4057qib7	1737	8	year	year	NN
cord-005453-4057qib7	1737	9	single	single	JJ
cord-005453-4057qib7	1737	10	center	center	NN
cord-005453-4057qib7	1737	11	transplant	transplant	NN
cord-005453-4057qib7	1737	12	experience	experience	NN
cord-005453-4057qib7	1737	13	in	in	IN
cord-005453-4057qib7	1737	14	chronic	chronic	JJ
cord-005453-4057qib7	1737	15	myeloid	myeloid	NN
cord-005453-4057qib7	1737	16	leukemia	leukemia	NN
cord-005453-4057qib7	1737	17	Background	background	NN
cord-005453-4057qib7	1737	18	:	:	:
cord-005453-4057qib7	1737	19	Allogeneic	allogeneic	NN
cord-005453-4057qib7	1737	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1737	21	stem	stem	NN
cord-005453-4057qib7	1737	22	cell	cell	NN
cord-005453-4057qib7	1737	23	transplantation	transplantation	NN
cord-005453-4057qib7	1737	24	(	(	-LRB-
cord-005453-4057qib7	1737	25	HSCT	HSCT	NNP
cord-005453-4057qib7	1737	26	)	)	-RRB-
cord-005453-4057qib7	1737	27	has	have	VBZ
cord-005453-4057qib7	1737	28	been	be	VBN
cord-005453-4057qib7	1737	29	considered	consider	VBN
cord-005453-4057qib7	1737	30	for	for	IN
cord-005453-4057qib7	1737	31	decades	decade	NNS
cord-005453-4057qib7	1737	32	the	the	DT
cord-005453-4057qib7	1737	33	only	only	JJ
cord-005453-4057qib7	1737	34	curative	curative	JJ
cord-005453-4057qib7	1737	35	approach	approach	NN
cord-005453-4057qib7	1737	36	for	for	IN
cord-005453-4057qib7	1737	37	patients	patient	NNS
cord-005453-4057qib7	1737	38	with	with	IN
cord-005453-4057qib7	1737	39	chronic	chronic	JJ
cord-005453-4057qib7	1737	40	myeloid	myeloid	NN
cord-005453-4057qib7	1737	41	leukemia	leukemia	NN
cord-005453-4057qib7	1737	42	(	(	-LRB-
cord-005453-4057qib7	1737	43	CML	CML	NNP
cord-005453-4057qib7	1737	44	)	)	-RRB-
cord-005453-4057qib7	1737	45	.	.	.
cord-005453-4057qib7	1738	1	In	in	IN
cord-005453-4057qib7	1738	2	the	the	DT
cord-005453-4057qib7	1738	3	tyrosine	tyrosine	NN
cord-005453-4057qib7	1738	4	kinase	kinase	NN
cord-005453-4057qib7	1738	5	inhibitors	inhibitor	NNS
cord-005453-4057qib7	1738	6	(	(	-LRB-
cord-005453-4057qib7	1738	7	TKIs	TKIs	NNP
cord-005453-4057qib7	1738	8	)	)	-RRB-
cord-005453-4057qib7	1738	9	era	era	NN
cord-005453-4057qib7	1738	10	,	,	,
cord-005453-4057qib7	1738	11	HSCT	HSCT	NNP
cord-005453-4057qib7	1738	12	for	for	IN
cord-005453-4057qib7	1738	13	CML	CML	NNP
cord-005453-4057qib7	1738	14	has	have	VBZ
cord-005453-4057qib7	1738	15	been	be	VBN
cord-005453-4057qib7	1738	16	reserved	reserve	VBN
cord-005453-4057qib7	1738	17	only	only	RB
cord-005453-4057qib7	1738	18	to	to	IN
cord-005453-4057qib7	1738	19	patients	patient	NNS
cord-005453-4057qib7	1738	20	not	not	RB
cord-005453-4057qib7	1738	21	achieving	achieve	VBG
cord-005453-4057qib7	1738	22	a	a	DT
cord-005453-4057qib7	1738	23	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	1738	24	remission	remission	NN
cord-005453-4057qib7	1738	25	or	or	CC
cord-005453-4057qib7	1738	26	showing	show	VBG
cord-005453-4057qib7	1738	27	progressive	progressive	JJ
cord-005453-4057qib7	1738	28	disease	disease	NN
cord-005453-4057qib7	1738	29	after	after	IN
cord-005453-4057qib7	1738	30	multiple	multiple	JJ
cord-005453-4057qib7	1738	31	TKI	TKI	NNP
cord-005453-4057qib7	1738	32	treatment	treatment	NN
cord-005453-4057qib7	1738	33	lines	line	NNS
cord-005453-4057qib7	1738	34	.	.	.
cord-005453-4057qib7	1739	1	However	however	RB
cord-005453-4057qib7	1739	2	,	,	,
cord-005453-4057qib7	1739	3	a	a	DT
cord-005453-4057qib7	1739	4	progressive	progressive	JJ
cord-005453-4057qib7	1739	5	improvement	improvement	NN
cord-005453-4057qib7	1739	6	in	in	IN
cord-005453-4057qib7	1739	7	the	the	DT
cord-005453-4057qib7	1739	8	long	long	JJ
cord-005453-4057qib7	1739	9	-	-	HYPH
cord-005453-4057qib7	1739	10	term	term	NN
cord-005453-4057qib7	1739	11	survival	survival	NN
cord-005453-4057qib7	1739	12	has	have	VBZ
cord-005453-4057qib7	1739	13	been	be	VBN
cord-005453-4057qib7	1739	14	obtained	obtain	VBN
cord-005453-4057qib7	1739	15	in	in	IN
cord-005453-4057qib7	1739	16	the	the	DT
cord-005453-4057qib7	1739	17	overall	overall	JJ
cord-005453-4057qib7	1739	18	HSCT	HSCT	NNP
cord-005453-4057qib7	1739	19	population	population	NN
cord-005453-4057qib7	1739	20	.	.	.
cord-005453-4057qib7	1740	1	The	the	DT
cord-005453-4057qib7	1740	2	present	present	JJ
cord-005453-4057qib7	1740	3	study	study	NN
cord-005453-4057qib7	1740	4	aimed	aim	VBN
cord-005453-4057qib7	1740	5	at	at	IN
cord-005453-4057qib7	1740	6	evaluating	evaluate	VBG
cord-005453-4057qib7	1740	7	whether	whether	IN
cord-005453-4057qib7	1740	8	in	in	IN
cord-005453-4057qib7	1740	9	CML	CML	NNP
cord-005453-4057qib7	1740	10	patients	patient	NNS
cord-005453-4057qib7	1740	11	transplanted	transplant	VBN
cord-005453-4057qib7	1740	12	at	at	IN
cord-005453-4057qib7	1740	13	our	-PRON-	PRP$
cord-005453-4057qib7	1740	14	Center	Center	NNP
cord-005453-4057qib7	1740	15	over	over	IN
cord-005453-4057qib7	1740	16	a	a	DT
cord-005453-4057qib7	1740	17	long	long	JJ
cord-005453-4057qib7	1740	18	time	time	NN
cord-005453-4057qib7	1740	19	period	period	NN
cord-005453-4057qib7	1741	1	-from	-from	JJ
cord-005453-4057qib7	1741	2	1983	1983	CD
cord-005453-4057qib7	1741	3	to	to	IN
cord-005453-4057qib7	1741	4	2018	2018	CD
cord-005453-4057qib7	1742	1	-the	-the	DT
cord-005453-4057qib7	1742	2	outcome	outcome	NN
cord-005453-4057qib7	1742	3	improved	improve	VBD
cord-005453-4057qib7	1742	4	over	over	IN
cord-005453-4057qib7	1742	5	time	time	NN
cord-005453-4057qib7	1742	6	.	.	.
cord-005453-4057qib7	1743	1	Methods	method	NNS
cord-005453-4057qib7	1743	2	:	:	:
cord-005453-4057qib7	1744	1	136	136	CD
cord-005453-4057qib7	1744	2	consecutive	consecutive	JJ
cord-005453-4057qib7	1744	3	patients	patient	NNS
cord-005453-4057qib7	1744	4	who	who	WP
cord-005453-4057qib7	1744	5	underwent	undergo	VBD
cord-005453-4057qib7	1744	6	a	a	DT
cord-005453-4057qib7	1744	7	transplant	transplant	NN
cord-005453-4057qib7	1744	8	between	between	IN
cord-005453-4057qib7	1744	9	1983	1983	CD
cord-005453-4057qib7	1744	10	and	and	CC
cord-005453-4057qib7	1744	11	1999	1999	CD
cord-005453-4057qib7	1744	12	were	be	VBD
cord-005453-4057qib7	1744	13	compared	compare	VBN
cord-005453-4057qib7	1744	14	to	to	IN
cord-005453-4057qib7	1744	15	43	43	CD
cord-005453-4057qib7	1744	16	patients	patient	NNS
cord-005453-4057qib7	1744	17	who	who	WP
cord-005453-4057qib7	1744	18	received	receive	VBD
cord-005453-4057qib7	1744	19	the	the	DT
cord-005453-4057qib7	1744	20	transplant	transplant	NN
cord-005453-4057qib7	1744	21	between	between	IN
cord-005453-4057qib7	1744	22	2000	2000	CD
cord-005453-4057qib7	1744	23	and	and	CC
cord-005453-4057qib7	1744	24	2018	2018	CD
cord-005453-4057qib7	1744	25	.	.	.
cord-005453-4057qib7	1745	1	Overall	overall	JJ
cord-005453-4057qib7	1745	2	survival	survival	NN
cord-005453-4057qib7	1745	3	(	(	-LRB-
cord-005453-4057qib7	1745	4	OS	OS	NNP
cord-005453-4057qib7	1745	5	)	)	-RRB-
cord-005453-4057qib7	1745	6	,	,	,
cord-005453-4057qib7	1745	7	leukemia	leukemia	NN
cord-005453-4057qib7	1745	8	-	-	HYPH
cord-005453-4057qib7	1745	9	free	free	JJ
cord-005453-4057qib7	1745	10	survival	survival	NN
cord-005453-4057qib7	1745	11	(	(	-LRB-
cord-005453-4057qib7	1745	12	LFS	LFS	NNP
cord-005453-4057qib7	1745	13	)	)	-RRB-
cord-005453-4057qib7	1745	14	and	and	CC
cord-005453-4057qib7	1745	15	graft	graft	NN
cord-005453-4057qib7	1745	16	-	-	HYPH
cord-005453-4057qib7	1745	17	leukemia	leukemia	NN
cord-005453-4057qib7	1745	18	-	-	HYPH
cord-005453-4057qib7	1745	19	free	free	JJ
cord-005453-4057qib7	1745	20	survival	survival	NN
cord-005453-4057qib7	1745	21	(	(	-LRB-
cord-005453-4057qib7	1745	22	GLFS	GLFS	NNP
cord-005453-4057qib7	1745	23	)	)	-RRB-
cord-005453-4057qib7	1745	24	were	be	VBD
cord-005453-4057qib7	1745	25	estimated	estimate	VBN
cord-005453-4057qib7	1745	26	using	use	VBG
cord-005453-4057qib7	1745	27	the	the	DT
cord-005453-4057qib7	1745	28	Kaplan	Kaplan	NNP
cord-005453-4057qib7	1745	29	-	-	HYPH
cord-005453-4057qib7	1745	30	Meier	Meier	NNP
cord-005453-4057qib7	1745	31	method	method	NN
cord-005453-4057qib7	1745	32	and	and	CC
cord-005453-4057qib7	1745	33	the	the	DT
cord-005453-4057qib7	1745	34	log	log	NN
cord-005453-4057qib7	1745	35	-	-	HYPH
cord-005453-4057qib7	1745	36	rank	rank	NN
cord-005453-4057qib7	1745	37	test	test	NN
cord-005453-4057qib7	1745	38	was	be	VBD
cord-005453-4057qib7	1745	39	used	use	VBN
cord-005453-4057qib7	1745	40	to	to	TO
cord-005453-4057qib7	1745	41	compare	compare	VB
cord-005453-4057qib7	1745	42	risk	risk	NN
cord-005453-4057qib7	1745	43	factors	factor	NNS
cord-005453-4057qib7	1745	44	categories	category	NNS
cord-005453-4057qib7	1745	45	.	.	.
cord-005453-4057qib7	1746	1	Results	result	NNS
cord-005453-4057qib7	1746	2	:	:	:
cord-005453-4057qib7	1747	1	Of	of	IN
cord-005453-4057qib7	1747	2	the	the	DT
cord-005453-4057qib7	1747	3	179	179	CD
cord-005453-4057qib7	1747	4	patients	patient	NNS
cord-005453-4057qib7	1747	5	[	[	-LRB-
cord-005453-4057qib7	1747	6	median	median	NN
cord-005453-4057qib7	1747	7	age	age	NN
cord-005453-4057qib7	1747	8	35	35	CD
cord-005453-4057qib7	1747	9	years	year	NNS
cord-005453-4057qib7	1747	10	(	(	-LRB-
cord-005453-4057qib7	1747	11	range7	range7	NN
cord-005453-4057qib7	1747	12	-	-	HYPH
cord-005453-4057qib7	1747	13	66	66	CD
cord-005453-4057qib7	1747	14	)	)	-RRB-
cord-005453-4057qib7	1747	15	]	]	-RRB-
cord-005453-4057qib7	1747	16	,	,	,
cord-005453-4057qib7	1747	17	148	148	CD
cord-005453-4057qib7	1747	18	(	(	-LRB-
cord-005453-4057qib7	1747	19	82.7	82.7	CD
cord-005453-4057qib7	1747	20	%	%	NN
cord-005453-4057qib7	1747	21	)	)	-RRB-
cord-005453-4057qib7	1747	22	were	be	VBD
cord-005453-4057qib7	1747	23	in	in	IN
cord-005453-4057qib7	1747	24	1	1	CD
cord-005453-4057qib7	1747	25	st	st	NNP
cord-005453-4057qib7	1747	26	or	or	CC
cord-005453-4057qib7	1747	27	2	2	CD
cord-005453-4057qib7	1747	28	nd	nd	NNP
cord-005453-4057qib7	1747	29	chronic	chronic	NN
cord-005453-4057qib7	1747	30	phase	phase	NN
cord-005453-4057qib7	1747	31	,	,	,
cord-005453-4057qib7	1747	32	25	25	CD
cord-005453-4057qib7	1747	33	(	(	-LRB-
cord-005453-4057qib7	1747	34	13.9	13.9	CD
cord-005453-4057qib7	1747	35	%	%	NN
cord-005453-4057qib7	1747	36	)	)	-RRB-
cord-005453-4057qib7	1747	37	in	in	IN
cord-005453-4057qib7	1747	38	accelerated	accelerated	JJ
cord-005453-4057qib7	1747	39	phase	phase	NN
cord-005453-4057qib7	1747	40	and	and	CC
cord-005453-4057qib7	1747	41	six	six	CD
cord-005453-4057qib7	1747	42	(	(	-LRB-
cord-005453-4057qib7	1747	43	3.4	3.4	CD
cord-005453-4057qib7	1747	44	%	%	NN
cord-005453-4057qib7	1747	45	)	)	-RRB-
cord-005453-4057qib7	1747	46	in	in	IN
cord-005453-4057qib7	1747	47	blast	blast	NN
cord-005453-4057qib7	1747	48	crisis	crisis	NN
cord-005453-4057qib7	1747	49	.	.	.
cord-005453-4057qib7	1748	1	Matched	match	VBN
cord-005453-4057qib7	1748	2	related	related	JJ
cord-005453-4057qib7	1748	3	donors	donor	NNS
cord-005453-4057qib7	1748	4	and	and	CC
cord-005453-4057qib7	1748	5	alternative	alternative	JJ
cord-005453-4057qib7	1748	6	donors	donor	NNS
cord-005453-4057qib7	1748	7	(	(	-LRB-
cord-005453-4057qib7	1748	8	matched	match	VBN
cord-005453-4057qib7	1748	9	unrelated	unrelated	JJ
cord-005453-4057qib7	1748	10	donors	donor	NNS
cord-005453-4057qib7	1748	11	,	,	,
cord-005453-4057qib7	1748	12	cord	cord	NN
cord-005453-4057qib7	1748	13	blood	blood	NN
cord-005453-4057qib7	1748	14	or	or	CC
cord-005453-4057qib7	1748	15	mismatched	mismatch	VBN
cord-005453-4057qib7	1748	16	related	related	JJ
cord-005453-4057qib7	1748	17	donors	donor	NNS
cord-005453-4057qib7	1748	18	)	)	-RRB-
cord-005453-4057qib7	1748	19	were	be	VBD
cord-005453-4057qib7	1748	20	used	use	VBN
cord-005453-4057qib7	1748	21	in	in	IN
cord-005453-4057qib7	1748	22	156	156	CD
cord-005453-4057qib7	1748	23	and	and	CC
cord-005453-4057qib7	1748	24	23	23	CD
cord-005453-4057qib7	1748	25	cases	case	NNS
cord-005453-4057qib7	1748	26	,	,	,
cord-005453-4057qib7	1748	27	respectively	respectively	RB
cord-005453-4057qib7	1748	28	.	.	.
cord-005453-4057qib7	1749	1	As	as	IN
cord-005453-4057qib7	1749	2	stem	stem	NN
cord-005453-4057qib7	1749	3	cell	cell	NN
cord-005453-4057qib7	1749	4	source	source	NN
cord-005453-4057qib7	1749	5	,	,	,
cord-005453-4057qib7	1749	6	bone	bone	NN
cord-005453-4057qib7	1749	7	marrow	marrow	NN
cord-005453-4057qib7	1749	8	was	be	VBD
cord-005453-4057qib7	1749	9	used	use	VBN
cord-005453-4057qib7	1749	10	in	in	IN
cord-005453-4057qib7	1749	11	142	142	CD
cord-005453-4057qib7	1749	12	patients	patient	NNS
cord-005453-4057qib7	1749	13	,	,	,
cord-005453-4057qib7	1749	14	peripheral	peripheral	JJ
cord-005453-4057qib7	1749	15	blood	blood	NN
cord-005453-4057qib7	1749	16	in	in	IN
cord-005453-4057qib7	1749	17	33	33	CD
cord-005453-4057qib7	1749	18	and	and	CC
cord-005453-4057qib7	1749	19	umbilical	umbilical	JJ
cord-005453-4057qib7	1749	20	cord	cord	NN
cord-005453-4057qib7	1749	21	blood	blood	NN
cord-005453-4057qib7	1749	22	in	in	IN
cord-005453-4057qib7	1749	23	4	4	CD
cord-005453-4057qib7	1749	24	.	.	.
cord-005453-4057qib7	1750	1	TBIbased	tbibase	VBN
cord-005453-4057qib7	1750	2	conditioning	conditioning	NN
cord-005453-4057qib7	1750	3	regimens	regimen	NNS
cord-005453-4057qib7	1750	4	were	be	VBD
cord-005453-4057qib7	1750	5	used	use	VBN
cord-005453-4057qib7	1750	6	in	in	IN
cord-005453-4057qib7	1750	7	89	89	CD
cord-005453-4057qib7	1750	8	patients	patient	NNS
cord-005453-4057qib7	1750	9	,	,	,
cord-005453-4057qib7	1750	10	while	while	IN
cord-005453-4057qib7	1750	11	in	in	IN
cord-005453-4057qib7	1750	12	the	the	DT
cord-005453-4057qib7	1750	13	other	other	JJ
cord-005453-4057qib7	1750	14	90	90	CD
cord-005453-4057qib7	1750	15	cases	case	NNS
cord-005453-4057qib7	1750	16	irradiation	irradiation	NN
cord-005453-4057qib7	1750	17	-	-	HYPH
cord-005453-4057qib7	1750	18	free	free	JJ
cord-005453-4057qib7	1750	19	conditioning	conditioning	NN
cord-005453-4057qib7	1750	20	regimens	regimen	NNS
cord-005453-4057qib7	1750	21	were	be	VBD
cord-005453-4057qib7	1750	22	used	use	VBN
cord-005453-4057qib7	1750	23	.	.	.
cord-005453-4057qib7	1751	1	Both	both	DT
cord-005453-4057qib7	1751	2	in	in	IN
cord-005453-4057qib7	1751	3	univariate	univariate	JJ
cord-005453-4057qib7	1751	4	and	and	CC
cord-005453-4057qib7	1751	5	multivariate	multivariate	JJ
cord-005453-4057qib7	1751	6	analysis	analysis	NN
cord-005453-4057qib7	1751	7	,	,	,
cord-005453-4057qib7	1751	8	irradiationfree	irradiationfree	JJ
cord-005453-4057qib7	1751	9	conditioning	conditioning	NN
cord-005453-4057qib7	1751	10	regimens	regimen	NNS
cord-005453-4057qib7	1751	11	(	(	-LRB-
cord-005453-4057qib7	1751	12	HR	HR	NNP
cord-005453-4057qib7	1751	13	1.8	1.8	CD
cord-005453-4057qib7	1751	14	;	;	:
cord-005453-4057qib7	1751	15	95%CI	95%ci	CD
cord-005453-4057qib7	1751	16	1.1	1.1	CD
cord-005453-4057qib7	1751	17	-	-	HYPH
cord-005453-4057qib7	1751	18	3.0	3.0	CD
cord-005453-4057qib7	1751	19	,	,	,
cord-005453-4057qib7	1751	20	p=.0014	p=.0014	NNS
cord-005453-4057qib7	1751	21	)	)	-RRB-
cord-005453-4057qib7	1751	22	and	and	CC
cord-005453-4057qib7	1751	23	transplants	transplant	NNS
cord-005453-4057qib7	1751	24	performed	perform	VBN
cord-005453-4057qib7	1751	25	in	in	IN
cord-005453-4057qib7	1751	26	1	1	CD
cord-005453-4057qib7	1751	27	st	st	NNP
cord-005453-4057qib7	1751	28	chronic	chronic	NNP
cord-005453-4057qib7	1751	29	phase	phase	NN
cord-005453-4057qib7	1751	30	(	(	-LRB-
cord-005453-4057qib7	1751	31	accelerate	accelerate	VB
cord-005453-4057qib7	1751	32	phase	phase	NN
cord-005453-4057qib7	1751	33	HR	HR	NNP
cord-005453-4057qib7	1751	34	2.1	2.1	CD
cord-005453-4057qib7	1751	35	;	;	:
cord-005453-4057qib7	1751	36	95%CI	95%ci	CD
cord-005453-4057qib7	1751	37	1.2	1.2	CD
cord-005453-4057qib7	1751	38	-	-	SYM
cord-005453-4057qib7	1751	39	3.8	3.8	CD
cord-005453-4057qib7	1751	40	,	,	,
cord-005453-4057qib7	1751	41	p=.008	p=.008	NNP
cord-005453-4057qib7	1751	42	-2	-2	NNP
cord-005453-4057qib7	1751	43	nd	nd	NNP
cord-005453-4057qib7	1751	44	chronic	chronic	NN
cord-005453-4057qib7	1751	45	phase	phase	NN
cord-005453-4057qib7	1751	46	HR	HR	NNP
cord-005453-4057qib7	1751	47	4.9	4.9	CD
cord-005453-4057qib7	1751	48	;	;	:
cord-005453-4057qib7	1751	49	95%CI	95%ci	CD
cord-005453-4057qib7	1751	50	2.3	2.3	CD
cord-005453-4057qib7	1751	51	-	-	HYPH
cord-005453-4057qib7	1751	52	10.3	10.3	CD
cord-005453-4057qib7	1751	53	,	,	,
cord-005453-4057qib7	1751	54	p=.0001	p=.0001	NNP
cord-005453-4057qib7	1751	55	-blast	-blast	NN
cord-005453-4057qib7	1751	56	crisis	crisis	NN
cord-005453-4057qib7	1751	57	HR	HR	NNP
cord-005453-4057qib7	1751	58	2.5	2.5	CD
cord-005453-4057qib7	1751	59	;	;	:
cord-005453-4057qib7	1751	60	95%CI	95%ci	CD
cord-005453-4057qib7	1751	61	1.0	1.0	CD
cord-005453-4057qib7	1751	62	-	-	HYPH
cord-005453-4057qib7	1751	63	6.4	6.4	CD
cord-005453-4057qib7	1751	64	,	,	,
cord-005453-4057qib7	1751	65	p	p	NN
cord-005453-4057qib7	1751	66	<	<	XX
cord-005453-4057qib7	1751	67	.05	.05	NFP
cord-005453-4057qib7	1751	68	)	)	-RRB-
cord-005453-4057qib7	1751	69	were	be	VBD
cord-005453-4057qib7	1751	70	associated	associate	VBN
cord-005453-4057qib7	1751	71	with	with	IN
cord-005453-4057qib7	1751	72	a	a	DT
cord-005453-4057qib7	1751	73	better	well	JJR
cord-005453-4057qib7	1751	74	OS	os	NN
cord-005453-4057qib7	1751	75	.	.	.
cord-005453-4057qib7	1752	1	Patients	patient	NNS
cord-005453-4057qib7	1752	2	transplanted	transplant	VBN
cord-005453-4057qib7	1752	3	before	before	IN
cord-005453-4057qib7	1752	4	2000	2000	CD
cord-005453-4057qib7	1752	5	had	have	VBD
cord-005453-4057qib7	1752	6	a	a	DT
cord-005453-4057qib7	1752	7	worse	bad	JJR
cord-005453-4057qib7	1752	8	OS	OS	NNP
cord-005453-4057qib7	1752	9	(	(	-LRB-
cord-005453-4057qib7	1752	10	HR	HR	NNP
cord-005453-4057qib7	1752	11	6.5	6.5	CD
cord-005453-4057qib7	1752	12	;	;	.
cord-005453-4057qib7	1753	1	95%CI	95%ci	CD
cord-005453-4057qib7	1753	2	2.7	2.7	CD
cord-005453-4057qib7	1753	3	-	-	SYM
cord-005453-4057qib7	1753	4	15.5	15.5	CD
cord-005453-4057qib7	1753	5	,	,	,
cord-005453-4057qib7	1753	6	p	p	NN
cord-005453-4057qib7	1753	7	<	<	XX
cord-005453-4057qib7	1753	8	.0001	.0001	NNP
cord-005453-4057qib7	1753	9	)	)	-RRB-
cord-005453-4057qib7	1753	10	and	and	CC
cord-005453-4057qib7	1753	11	DFS	DFS	NNP
cord-005453-4057qib7	1753	12	(	(	-LRB-
cord-005453-4057qib7	1753	13	HR	HR	NNP
cord-005453-4057qib7	1753	14	2.2	2.2	CD
cord-005453-4057qib7	1753	15	;	;	:
cord-005453-4057qib7	1753	16	95%CI	95%ci	CD
cord-005453-4057qib7	1753	17	1.0	1.0	CD
cord-005453-4057qib7	1753	18	-	-	SYM
cord-005453-4057qib7	1753	19	4.8	4.8	CD
cord-005453-4057qib7	1753	20	,	,	,
cord-005453-4057qib7	1753	21	p=.045	p=.045	NN
cord-005453-4057qib7	1753	22	)	)	-RRB-
cord-005453-4057qib7	1753	23	.	.	.
cord-005453-4057qib7	1754	1	A	a	DT
cord-005453-4057qib7	1754	2	trend	trend	NN
cord-005453-4057qib7	1754	3	for	for	IN
cord-005453-4057qib7	1754	4	a	a	DT
cord-005453-4057qib7	1754	5	worse	bad	JJR
cord-005453-4057qib7	1754	6	GLFS	GLFS	NNP
cord-005453-4057qib7	1754	7	was	be	VBD
cord-005453-4057qib7	1754	8	observed	observe	VBN
cord-005453-4057qib7	1754	9	in	in	IN
cord-005453-4057qib7	1754	10	univariate	univariate	JJ
cord-005453-4057qib7	1754	11	analysis	analysis	NN
cord-005453-4057qib7	1754	12	(	(	-LRB-
cord-005453-4057qib7	1754	13	HR	HR	NNP
cord-005453-4057qib7	1754	14	1.6	1.6	CD
cord-005453-4057qib7	1754	15	;	;	:
cord-005453-4057qib7	1754	16	95%CI	95%ci	CD
cord-005453-4057qib7	1754	17	1.0	1.0	CD
cord-005453-4057qib7	1754	18	-	-	SYM
cord-005453-4057qib7	1754	19	2.7	2.7	CD
cord-005453-4057qib7	1754	20	,	,	,
cord-005453-4057qib7	1754	21	p=0.05	p=0.05	NNP
cord-005453-4057qib7	1754	22	)	)	-RRB-
cord-005453-4057qib7	1754	23	,	,	,
cord-005453-4057qib7	1754	24	in	in	IN
cord-005453-4057qib7	1754	25	the	the	DT
cord-005453-4057qib7	1754	26	first	first	JJ
cord-005453-4057qib7	1754	27	period	period	NN
cord-005453-4057qib7	1754	28	of	of	IN
cord-005453-4057qib7	1754	29	observation	observation	NN
cord-005453-4057qib7	1754	30	.	.	.
cord-005453-4057qib7	1755	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1755	2	:	:	:
cord-005453-4057qib7	1756	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1756	2	single	single	JJ
cord-005453-4057qib7	1756	3	center	center	NN
cord-005453-4057qib7	1756	4	experience	experience	NN
cord-005453-4057qib7	1756	5	confirms	confirm	VBZ
cord-005453-4057qib7	1756	6	that	that	IN
cord-005453-4057qib7	1756	7	higher	high	JJR
cord-005453-4057qib7	1756	8	OS	OS	NNP
cord-005453-4057qib7	1756	9	,	,	,
cord-005453-4057qib7	1756	10	DFS	DFS	NNP
cord-005453-4057qib7	1756	11	and	and	CC
cord-005453-4057qib7	1756	12	GLFS	GLFS	NNP
cord-005453-4057qib7	1756	13	are	be	VBP
cord-005453-4057qib7	1756	14	observed	observe	VBN
cord-005453-4057qib7	1756	15	in	in	IN
cord-005453-4057qib7	1756	16	CML	CML	NNP
cord-005453-4057qib7	1756	17	patients	patient	NNS
cord-005453-4057qib7	1756	18	allografted	allografte	VBN
cord-005453-4057qib7	1756	19	in	in	IN
cord-005453-4057qib7	1756	20	more	more	JJR
cord-005453-4057qib7	1756	21	recent	recent	JJ
cord-005453-4057qib7	1756	22	years	year	NNS
cord-005453-4057qib7	1756	23	.	.	.
cord-005453-4057qib7	1757	1	Improvement	improvement	NN
cord-005453-4057qib7	1757	2	of	of	IN
cord-005453-4057qib7	1757	3	conditioning	conditioning	NN
cord-005453-4057qib7	1757	4	regimens	regimen	NNS
cord-005453-4057qib7	1757	5	,	,	,
cord-005453-4057qib7	1757	6	use	use	NN
cord-005453-4057qib7	1757	7	of	of	IN
cord-005453-4057qib7	1757	8	TBI	tbi	NN
cord-005453-4057qib7	1757	9	-	-	HYPH
cord-005453-4057qib7	1757	10	free	free	JJ
cord-005453-4057qib7	1757	11	conditioning	conditioning	NN
cord-005453-4057qib7	1757	12	regimens	regimen	NNS
cord-005453-4057qib7	1757	13	and	and	CC
cord-005453-4057qib7	1757	14	supportive	supportive	JJ
cord-005453-4057qib7	1757	15	therapy	therapy	NN
cord-005453-4057qib7	1757	16	,	,	,
cord-005453-4057qib7	1757	17	have	have	VBP
cord-005453-4057qib7	1757	18	presumably	presumably	RB
cord-005453-4057qib7	1757	19	contributed	contribute	VBN
cord-005453-4057qib7	1757	20	to	to	IN
cord-005453-4057qib7	1757	21	these	these	DT
cord-005453-4057qib7	1757	22	results	result	NNS
cord-005453-4057qib7	1757	23	,	,	,
cord-005453-4057qib7	1757	24	together	together	RB
cord-005453-4057qib7	1757	25	with	with	IN
cord-005453-4057qib7	1757	26	the	the	DT
cord-005453-4057qib7	1757	27	more	more	RBR
cord-005453-4057qib7	1757	28	recent	recent	JJ
cord-005453-4057qib7	1757	29	strategy	strategy	NN
cord-005453-4057qib7	1757	30	of	of	IN
cord-005453-4057qib7	1757	31	close	close	JJ
cord-005453-4057qib7	1757	32	monitoring	monitoring	NN
cord-005453-4057qib7	1757	33	of	of	IN
cord-005453-4057qib7	1757	34	minimal	minimal	JJ
cord-005453-4057qib7	1757	35	residual	residual	JJ
cord-005453-4057qib7	1757	36	disease	disease	NN
cord-005453-4057qib7	1757	37	,	,	,
cord-005453-4057qib7	1757	38	and	and	CC
cord-005453-4057qib7	1757	39	prompt	prompt	JJ
cord-005453-4057qib7	1757	40	use	use	NN
cord-005453-4057qib7	1757	41	of	of	IN
cord-005453-4057qib7	1757	42	TKI	TKI	NNP
cord-005453-4057qib7	1757	43	or	or	CC
cord-005453-4057qib7	1757	44	donor	donor	NN
cord-005453-4057qib7	1757	45	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1757	46	infusion	infusion	NN
cord-005453-4057qib7	1757	47	in	in	IN
cord-005453-4057qib7	1757	48	case	case	NN
cord-005453-4057qib7	1757	49	of	of	IN
cord-005453-4057qib7	1757	50	relapse	relapse	NN
cord-005453-4057qib7	1757	51	.	.	.
cord-005453-4057qib7	1758	1	HSCT	HSCT	NNP
cord-005453-4057qib7	1758	2	is	be	VBZ
cord-005453-4057qib7	1758	3	nowadays	nowadays	RB
cord-005453-4057qib7	1758	4	a	a	DT
cord-005453-4057qib7	1758	5	safer	safe	JJR
cord-005453-4057qib7	1758	6	therapeutic	therapeutic	JJ
cord-005453-4057qib7	1758	7	procedure	procedure	NN
cord-005453-4057qib7	1758	8	in	in	IN
cord-005453-4057qib7	1758	9	CML	CML	NNP
cord-005453-4057qib7	1758	10	patients	patient	NNS
cord-005453-4057qib7	1758	11	that	that	WDT
cord-005453-4057qib7	1758	12	should	should	MD
cord-005453-4057qib7	1758	13	be	be	VB
cord-005453-4057qib7	1758	14	considered	consider	VBN
cord-005453-4057qib7	1758	15	timely	timely	JJ
cord-005453-4057qib7	1758	16	in	in	IN
cord-005453-4057qib7	1758	17	TKI	TKI	NNP
cord-005453-4057qib7	1758	18	-	-	HYPH
cord-005453-4057qib7	1758	19	resistant	resistant	JJ
cord-005453-4057qib7	1758	20	patients	patient	NNS
cord-005453-4057qib7	1758	21	to	to	TO
cord-005453-4057qib7	1758	22	avoid	avoid	VB
cord-005453-4057qib7	1758	23	progression	progression	NN
cord-005453-4057qib7	1758	24	into	into	IN
cord-005453-4057qib7	1758	25	a	a	DT
cord-005453-4057qib7	1758	26	more	more	RBR
cord-005453-4057qib7	1758	27	advanced	advanced	JJ
cord-005453-4057qib7	1758	28	disease	disease	NN
cord-005453-4057qib7	1758	29	phase	phase	NN
cord-005453-4057qib7	1758	30	.	.	.
cord-005453-4057qib7	1759	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1759	2	:	:	:
cord-005453-4057qib7	1760	1	The	the	DT
cord-005453-4057qib7	1760	2	authors	author	NNS
cord-005453-4057qib7	1760	3	declare	declare	VBP
cord-005453-4057qib7	1760	4	no	no	DT
cord-005453-4057qib7	1760	5	conflict	conflict	NN
cord-005453-4057qib7	1760	6	of	of	IN
cord-005453-4057qib7	1760	7	interest	interest	NN
cord-005453-4057qib7	1760	8	.	.	.
cord-005453-4057qib7	1761	1	Reduced	reduce	VBN
cord-005453-4057qib7	1761	2	-	-	HYPH
cord-005453-4057qib7	1761	3	intensity	intensity	NN
cord-005453-4057qib7	1761	4	transplantation	transplantation	NN
cord-005453-4057qib7	1761	5	(	(	-LRB-
cord-005453-4057qib7	1761	6	RIT	RIT	NNP
cord-005453-4057qib7	1761	7	)	)	-RRB-
cord-005453-4057qib7	1761	8	in	in	IN
cord-005453-4057qib7	1761	9	patients	patient	NNS
cord-005453-4057qib7	1761	10	with	with	IN
cord-005453-4057qib7	1761	11	high	high	JJ
cord-005453-4057qib7	1761	12	-	-	HYPH
cord-005453-4057qib7	1761	13	risk	risk	NN
cord-005453-4057qib7	1761	14	or	or	CC
cord-005453-4057qib7	1761	15	advanced	advanced	JJ
cord-005453-4057qib7	1761	16	chronic	chronic	JJ
cord-005453-4057qib7	1761	17	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	1761	18	leukemia	leukemia	NN
cord-005453-4057qib7	1761	19	in	in	IN
cord-005453-4057qib7	1761	20	last	last	JJ
cord-005453-4057qib7	1761	21	5	5	CD
cord-005453-4057qib7	1761	22	years	year	NNS
cord-005453-4057qib7	1761	23	:	:	:
cord-005453-4057qib7	1761	24	Improvement	improvement	NN
cord-005453-4057qib7	1761	25	of	of	IN
cord-005453-4057qib7	1761	26	transplant	transplant	NN
cord-005453-4057qib7	1761	27	outcomessingle	outcomessingle	NNP
cord-005453-4057qib7	1761	28	centre	centre	NNP
cord-005453-4057qib7	1761	29	experience	experience	NN
cord-005453-4057qib7	1761	30	.	.	.
cord-005453-4057qib7	1762	1	HCT	HCT	NNP
cord-005453-4057qib7	1762	2	-	-	HYPH
cord-005453-4057qib7	1762	3	CI	CI	NNP
cord-005453-4057qib7	1762	4	≥	≥	NNP
cord-005453-4057qib7	1762	5	3	3	CD
cord-005453-4057qib7	1762	6	was	be	VBD
cord-005453-4057qib7	1762	7	in	in	IN
cord-005453-4057qib7	1762	8	20	20	CD
cord-005453-4057qib7	1762	9	%	%	NN
cord-005453-4057qib7	1762	10	of	of	IN
cord-005453-4057qib7	1762	11	pts	pt	NNS
cord-005453-4057qib7	1762	12	.	.	.
cord-005453-4057qib7	1763	1	Source	source	NN
cord-005453-4057qib7	1763	2	of	of	IN
cord-005453-4057qib7	1763	3	stem	stem	NN
cord-005453-4057qib7	1763	4	cells	cell	NNS
cord-005453-4057qib7	1763	5	was	be	VBD
cord-005453-4057qib7	1763	6	peripheral	peripheral	JJ
cord-005453-4057qib7	1763	7	blood	blood	NN
cord-005453-4057qib7	1763	8	in	in	IN
cord-005453-4057qib7	1763	9	80	80	CD
cord-005453-4057qib7	1763	10	%	%	NN
cord-005453-4057qib7	1763	11	and	and	CC
cord-005453-4057qib7	1763	12	bone	bone	NN
cord-005453-4057qib7	1763	13	marrow	marrow	NN
cord-005453-4057qib7	1763	14	in	in	IN
cord-005453-4057qib7	1763	15	20	20	CD
cord-005453-4057qib7	1763	16	%	%	NN
cord-005453-4057qib7	1763	17	of	of	IN
cord-005453-4057qib7	1763	18	pts	pt	NNS
cord-005453-4057qib7	1763	19	.	.	.
cord-005453-4057qib7	1764	1	The	the	DT
cord-005453-4057qib7	1764	2	median	median	NN
cord-005453-4057qib7	1764	3	of	of	IN
cord-005453-4057qib7	1764	4	infused	infuse	VBN
cord-005453-4057qib7	1764	5	CD	CD	NNP
cord-005453-4057qib7	1764	6	34	34	CD
cord-005453-4057qib7	1764	7	+	+	CC
cord-005453-4057qib7	1764	8	cells	cell	NNS
cord-005453-4057qib7	1764	9	was	be	VBD
cord-005453-4057qib7	1764	10	5,4x10	5,4x10	NN
cord-005453-4057qib7	1764	11	^	^	:
cord-005453-4057qib7	1764	12	6/	6/	CD
cord-005453-4057qib7	1764	13	kg	kg	NNS
cord-005453-4057qib7	1764	14	.	.	.
cord-005453-4057qib7	1765	1	The	the	DT
cord-005453-4057qib7	1765	2	conditioning	conditioning	NN
cord-005453-4057qib7	1765	3	regimen	regimen	NN
cord-005453-4057qib7	1765	4	consisted	consist	VBD
cord-005453-4057qib7	1765	5	of	of	IN
cord-005453-4057qib7	1765	6	fludarabine	fludarabine	NN
cord-005453-4057qib7	1765	7	and	and	CC
cord-005453-4057qib7	1765	8	melphalan	melphalan	NNP
cord-005453-4057qib7	1765	9	(	(	-LRB-
cord-005453-4057qib7	1765	10	+	+	CC
cord-005453-4057qib7	1765	11	ATG	ATG	NNP
cord-005453-4057qib7	1765	12	in	in	IN
cord-005453-4057qib7	1765	13	unrelated	unrelated	JJ
cord-005453-4057qib7	1765	14	donor	donor	NN
cord-005453-4057qib7	1765	15	)	)	-RRB-
cord-005453-4057qib7	1765	16	.	.	.
cord-005453-4057qib7	1766	1	GVHD	GVHD	NNP
cord-005453-4057qib7	1766	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1766	3	were	be	VBD
cord-005453-4057qib7	1766	4	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	1766	5	and	and	CC
cord-005453-4057qib7	1766	6	methotrexate	methotrexate	NNP
cord-005453-4057qib7	1766	7	.	.	.
cord-005453-4057qib7	1767	1	Results	result	NNS
cord-005453-4057qib7	1767	2	:	:	:
cord-005453-4057qib7	1768	1	All	all	DT
cord-005453-4057qib7	1768	2	pts	pt	NNS
cord-005453-4057qib7	1768	3	engrafted	engraft	VBD
cord-005453-4057qib7	1768	4	.	.	.
cord-005453-4057qib7	1769	1	None	none	NN
cord-005453-4057qib7	1769	2	of	of	IN
cord-005453-4057qib7	1769	3	3	3	CD
cord-005453-4057qib7	1769	4	pts	pt	NNS
cord-005453-4057qib7	1769	5	in	in	IN
cord-005453-4057qib7	1769	6	CR	cr	NN
cord-005453-4057qib7	1769	7	before	before	IN
cord-005453-4057qib7	1769	8	RIT	RIT	NNP
cord-005453-4057qib7	1769	9	progressed	progress	VBD
cord-005453-4057qib7	1769	10	at	at	IN
cord-005453-4057qib7	1769	11	day	day	NN
cord-005453-4057qib7	1769	12	+30	+30	CD
cord-005453-4057qib7	1769	13	after	after	IN
cord-005453-4057qib7	1769	14	RIT	RIT	NNP
cord-005453-4057qib7	1769	15	and	and	CC
cord-005453-4057qib7	1769	16	among	among	IN
cord-005453-4057qib7	1769	17	17	17	CD
cord-005453-4057qib7	1769	18	pts	pts	NN
cord-005453-4057qib7	1769	19	beyond	beyond	IN
cord-005453-4057qib7	1769	20	CR	CR	NNP
cord-005453-4057qib7	1769	21	before	before	IN
cord-005453-4057qib7	1769	22	RIT	RIT	NNP
cord-005453-4057qib7	1769	23	all	all	DT
cord-005453-4057qib7	1769	24	of	of	IN
cord-005453-4057qib7	1769	25	them	-PRON-	PRP
cord-005453-4057qib7	1769	26	achieved	achieve	VBD
cord-005453-4057qib7	1769	27	at	at	IN
cord-005453-4057qib7	1769	28	least	least	JJS
cord-005453-4057qib7	1769	29	PR	PR	NNP
cord-005453-4057qib7	1769	30	at	at	IN
cord-005453-4057qib7	1769	31	day	day	NN
cord-005453-4057qib7	1769	32	+30	+30	CD
cord-005453-4057qib7	1769	33	after	after	IN
cord-005453-4057qib7	1769	34	RIT	RIT	NNP
cord-005453-4057qib7	1769	35	.	.	.
cord-005453-4057qib7	1770	1	13	13	CD
cord-005453-4057qib7	1770	2	pts	pt	NNS
cord-005453-4057qib7	1770	3	(	(	-LRB-
cord-005453-4057qib7	1770	4	65	65	CD
cord-005453-4057qib7	1770	5	%	%	NN
cord-005453-4057qib7	1770	6	)	)	-RRB-
cord-005453-4057qib7	1770	7	developed	develop	VBN
cord-005453-4057qib7	1770	8	acute	acute	JJ
cord-005453-4057qib7	1770	9	GVHD	GVHD	NNP
cord-005453-4057qib7	1770	10	(	(	-LRB-
cord-005453-4057qib7	1770	11	2	2	CD
cord-005453-4057qib7	1770	12	pts	pts	NN
cord-005453-4057qib7	1770	13	grade	grade	NN
cord-005453-4057qib7	1770	14	III	III	NNP
cord-005453-4057qib7	1770	15	-	-	HYPH
cord-005453-4057qib7	1770	16	IV	IV	NNP
cord-005453-4057qib7	1770	17	)	)	-RRB-
cord-005453-4057qib7	1770	18	and	and	CC
cord-005453-4057qib7	1770	19	among	among	IN
cord-005453-4057qib7	1770	20	19	19	CD
cord-005453-4057qib7	1770	21	evaluable	evaluable	JJ
cord-005453-4057qib7	1770	22	pts	pt	NNS
cord-005453-4057qib7	1770	23	10	10	CD
cord-005453-4057qib7	1770	24	(	(	-LRB-
cord-005453-4057qib7	1770	25	53	53	CD
cord-005453-4057qib7	1770	26	%	%	NN
cord-005453-4057qib7	1770	27	)	)	-RRB-
cord-005453-4057qib7	1770	28	of	of	IN
cord-005453-4057qib7	1770	29	them	-PRON-	PRP
cord-005453-4057qib7	1770	30	developed	develop	VBD
cord-005453-4057qib7	1770	31	chronic	chronic	JJ
cord-005453-4057qib7	1770	32	GVHD	GVHD	NNP
cord-005453-4057qib7	1770	33	(	(	-LRB-
cord-005453-4057qib7	1770	34	6	6	CD
cord-005453-4057qib7	1770	35	mild	mild	JJ
cord-005453-4057qib7	1770	36	,	,	,
cord-005453-4057qib7	1770	37	2	2	CD
cord-005453-4057qib7	1770	38	moderate	moderate	JJ
cord-005453-4057qib7	1770	39	,	,	,
cord-005453-4057qib7	1770	40	2	2	CD
cord-005453-4057qib7	1770	41	severe	severe	NN
cord-005453-4057qib7	1770	42	)	)	-RRB-
cord-005453-4057qib7	1770	43	.	.	.
cord-005453-4057qib7	1771	1	With	with	IN
cord-005453-4057qib7	1771	2	median	median	JJ
cord-005453-4057qib7	1771	3	follow	follow	NN
cord-005453-4057qib7	1771	4	-	-	HYPH
cord-005453-4057qib7	1771	5	up	up	NN
cord-005453-4057qib7	1771	6	50	50	CD
cord-005453-4057qib7	1771	7	months	month	NNS
cord-005453-4057qib7	1772	1	(	(	-LRB-
cord-005453-4057qib7	1772	2	range	range	NNP
cord-005453-4057qib7	1772	3	6	6	CD
cord-005453-4057qib7	1772	4	-	-	SYM
cord-005453-4057qib7	1772	5	63	63	CD
cord-005453-4057qib7	1772	6	months	month	NNS
cord-005453-4057qib7	1772	7	)	)	-RRB-
cord-005453-4057qib7	1772	8	15	15	CD
cord-005453-4057qib7	1772	9	pts	pt	NNS
cord-005453-4057qib7	1772	10	(	(	-LRB-
cord-005453-4057qib7	1772	11	75	75	CD
cord-005453-4057qib7	1772	12	%	%	NN
cord-005453-4057qib7	1772	13	)	)	-RRB-
cord-005453-4057qib7	1772	14	are	be	VBP
cord-005453-4057qib7	1772	15	alive	alive	JJ
cord-005453-4057qib7	1772	16	in	in	IN
cord-005453-4057qib7	1772	17	CR	CR	NNP
cord-005453-4057qib7	1772	18	.	.	.
cord-005453-4057qib7	1773	1	3	3	CD
cord-005453-4057qib7	1773	2	pts	pts	NN
cord-005453-4057qib7	1773	3	(	(	-LRB-
cord-005453-4057qib7	1773	4	15	15	CD
cord-005453-4057qib7	1773	5	%	%	NN
cord-005453-4057qib7	1773	6	)	)	-RRB-
cord-005453-4057qib7	1773	7	relapsed	relapse	VBN
cord-005453-4057qib7	1773	8	or	or	CC
cord-005453-4057qib7	1773	9	progressed	progress	VBN
cord-005453-4057qib7	1773	10	5	5	CD
cord-005453-4057qib7	1773	11	,	,	,
cord-005453-4057qib7	1773	12	19	19	CD
cord-005453-4057qib7	1773	13	and	and	CC
cord-005453-4057qib7	1773	14	21	21	CD
cord-005453-4057qib7	1773	15	months	month	NNS
cord-005453-4057qib7	1773	16	after	after	IN
cord-005453-4057qib7	1773	17	RIT	RIT	NNP
cord-005453-4057qib7	1773	18	and	and	CC
cord-005453-4057qib7	1773	19	2	2	CD
cord-005453-4057qib7	1773	20	of	of	IN
cord-005453-4057qib7	1773	21	them	-PRON-	PRP
cord-005453-4057qib7	1773	22	died	die	VBD
cord-005453-4057qib7	1773	23	.	.	.
cord-005453-4057qib7	1774	1	Last	last	JJ
cord-005453-4057qib7	1774	2	relapsed	relapse	VBN
cord-005453-4057qib7	1774	3	patient	patient	NN
cord-005453-4057qib7	1774	4	achieved	achieve	VBN
cord-005453-4057qib7	1774	5	next	next	IN
cord-005453-4057qib7	1774	6	CR	CR	NNP
cord-005453-4057qib7	1774	7	after	after	IN
cord-005453-4057qib7	1774	8	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	1774	9	.	.	.
cord-005453-4057qib7	1775	1	3	3	CD
cord-005453-4057qib7	1775	2	pts	pts	NN
cord-005453-4057qib7	1775	3	(	(	-LRB-
cord-005453-4057qib7	1775	4	15	15	CD
cord-005453-4057qib7	1775	5	%	%	NN
cord-005453-4057qib7	1775	6	)	)	-RRB-
cord-005453-4057qib7	1775	7	died	die	VBD
cord-005453-4057qib7	1775	8	due	due	IN
cord-005453-4057qib7	1775	9	to	to	IN
cord-005453-4057qib7	1775	10	NRM	NRM	NNP
cord-005453-4057qib7	1775	11	.	.	.
cord-005453-4057qib7	1776	1	NRM	NRM	NNP
cord-005453-4057qib7	1776	2	till	till	IN
cord-005453-4057qib7	1776	3	day	day	NN
cord-005453-4057qib7	1776	4	+100	+100	NNS
cord-005453-4057qib7	1776	5	after	after	IN
cord-005453-4057qib7	1776	6	RIT	RIT	NNP
cord-005453-4057qib7	1776	7	was	be	VBD
cord-005453-4057qib7	1776	8	5	5	CD
cord-005453-4057qib7	1776	9	%	%	NN
cord-005453-4057qib7	1776	10	.	.	.
cord-005453-4057qib7	1777	1	The	the	DT
cord-005453-4057qib7	1777	2	estimated	estimate	VBN
cord-005453-4057qib7	1777	3	probabilities	probability	NNS
cord-005453-4057qib7	1777	4	of	of	IN
cord-005453-4057qib7	1777	5	2-years	2-years	CD
cord-005453-4057qib7	1777	6	CGRFS	CGRFS	NNP
cord-005453-4057qib7	1777	7	,	,	,
cord-005453-4057qib7	1777	8	PFS	PFS	NNP
cord-005453-4057qib7	1777	9	and	and	CC
cord-005453-4057qib7	1777	10	OS	OS	NNP
cord-005453-4057qib7	1777	11	are	be	VBP
cord-005453-4057qib7	1777	12	55	55	CD
cord-005453-4057qib7	1777	13	%	%	NN
cord-005453-4057qib7	1777	14	,	,	,
cord-005453-4057qib7	1777	15	73	73	CD
cord-005453-4057qib7	1777	16	%	%	NN
cord-005453-4057qib7	1777	17	and	and	CC
cord-005453-4057qib7	1777	18	83	83	CD
cord-005453-4057qib7	1777	19	%	%	NN
cord-005453-4057qib7	1777	20	.	.	.
cord-005453-4057qib7	1778	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1778	2	:	:	:
cord-005453-4057qib7	1779	1	In	in	IN
cord-005453-4057qib7	1779	2	spite	spite	NN
cord-005453-4057qib7	1779	3	of	of	IN
cord-005453-4057qib7	1779	4	relatively	relatively	RB
cord-005453-4057qib7	1779	5	small	small	JJ
cord-005453-4057qib7	1779	6	number	number	NN
cord-005453-4057qib7	1779	7	of	of	IN
cord-005453-4057qib7	1779	8	evaluated	evaluate	VBN
cord-005453-4057qib7	1779	9	pts	pts	NN
cord-005453-4057qib7	1779	10	and	and	CC
cord-005453-4057qib7	1779	11	retrospective	retrospective	JJ
cord-005453-4057qib7	1779	12	type	type	NN
cord-005453-4057qib7	1779	13	of	of	IN
cord-005453-4057qib7	1779	14	analysis	analysis	NN
cord-005453-4057qib7	1779	15	our	-PRON-	PRP$
cord-005453-4057qib7	1779	16	data	datum	NNS
cord-005453-4057qib7	1779	17	show	show	VBP
cord-005453-4057qib7	1779	18	that	that	IN
cord-005453-4057qib7	1779	19	RIT	RIT	NNP
cord-005453-4057qib7	1779	20	in	in	IN
cord-005453-4057qib7	1779	21	pts	pts	NN
cord-005453-4057qib7	1779	22	with	with	IN
cord-005453-4057qib7	1779	23	high	high	JJ
cord-005453-4057qib7	1779	24	-	-	HYPH
cord-005453-4057qib7	1779	25	risk	risk	NN
cord-005453-4057qib7	1779	26	or	or	CC
cord-005453-4057qib7	1779	27	advanced	advanced	JJ
cord-005453-4057qib7	1779	28	CLL	CLL	NNP
cord-005453-4057qib7	1779	29	has	have	VBZ
cord-005453-4057qib7	1779	30	achieved	achieve	VBN
cord-005453-4057qib7	1779	31	promising	promising	JJ
cord-005453-4057qib7	1779	32	results	result	NNS
cord-005453-4057qib7	1779	33	(	(	-LRB-
cord-005453-4057qib7	1780	1	2-and	2-and	CD
cord-005453-4057qib7	1780	2	5-years	5-years	CD
cord-005453-4057qib7	1780	3	PFS	PFS	NNP
cord-005453-4057qib7	1780	4	and	and	CC
cord-005453-4057qib7	1780	5	OS	OS	NNP
cord-005453-4057qib7	1780	6	73	73	CD
cord-005453-4057qib7	1780	7	%	%	NN
cord-005453-4057qib7	1780	8	and	and	CC
cord-005453-4057qib7	1780	9	55	55	CD
cord-005453-4057qib7	1780	10	%	%	NN
cord-005453-4057qib7	1780	11	resp	resp	NN
cord-005453-4057qib7	1780	12	.	.	.
cord-005453-4057qib7	1781	1	83	83	CD
cord-005453-4057qib7	1781	2	and	and	CC
cord-005453-4057qib7	1781	3	57	57	CD
cord-005453-4057qib7	1781	4	%	%	NN
cord-005453-4057qib7	1781	5	)	)	-RRB-
cord-005453-4057qib7	1782	1	in	in	IN
cord-005453-4057qib7	1782	2	recent	recent	JJ
cord-005453-4057qib7	1782	3	years	year	NNS
cord-005453-4057qib7	1782	4	and	and	CC
cord-005453-4057qib7	1782	5	these	these	DT
cord-005453-4057qib7	1782	6	results	result	NNS
cord-005453-4057qib7	1782	7	are	be	VBP
cord-005453-4057qib7	1782	8	better	well	JJR
cord-005453-4057qib7	1782	9	than	than	IN
cord-005453-4057qib7	1782	10	outcomes	outcome	NNS
cord-005453-4057qib7	1782	11	of	of	IN
cord-005453-4057qib7	1782	12	our	-PRON-	PRP$
cord-005453-4057qib7	1782	13	historical	historical	JJ
cord-005453-4057qib7	1782	14	patient	patient	JJ
cord-005453-4057qib7	1782	15	cohort	cohort	NN
cord-005453-4057qib7	1782	16	from	from	IN
cord-005453-4057qib7	1782	17	period	period	NN
cord-005453-4057qib7	1782	18	2010	2010	CD
cord-005453-4057qib7	1782	19	-	-	SYM
cord-005453-4057qib7	1782	20	2012	2012	CD
cord-005453-4057qib7	1783	1	(	(	-LRB-
cord-005453-4057qib7	1783	2	2-and	2-and	CD
cord-005453-4057qib7	1783	3	5-years	5-years	CD
cord-005453-4057qib7	1783	4	PFS	PFS	NNP
cord-005453-4057qib7	1783	5	41	41	CD
cord-005453-4057qib7	1783	6	%	%	NN
cord-005453-4057qib7	1783	7	and	and	CC
cord-005453-4057qib7	1783	8	26	26	CD
cord-005453-4057qib7	1783	9	%	%	NN
cord-005453-4057qib7	1783	10	resp	resp	NN
cord-005453-4057qib7	1783	11	.	.	.
cord-005453-4057qib7	1784	1	OS	OS	NNP
cord-005453-4057qib7	1784	2	56	56	CD
cord-005453-4057qib7	1784	3	%	%	NN
cord-005453-4057qib7	1784	4	and	and	CC
cord-005453-4057qib7	1784	5	35	35	CD
cord-005453-4057qib7	1784	6	%	%	NN
cord-005453-4057qib7	1784	7	,	,	,
cord-005453-4057qib7	1784	8	p=0.009	p=0.009	NN
cord-005453-4057qib7	1784	9	)	)	-RRB-
cord-005453-4057qib7	1784	10	or	or	CC
cord-005453-4057qib7	1784	11	EBMT	EBMT	NNP
cord-005453-4057qib7	1784	12	published	publish	VBD
cord-005453-4057qib7	1784	13	data	datum	NNS
cord-005453-4057qib7	1784	14	of	of	IN
cord-005453-4057qib7	1784	15	pts	pt	NNS
cord-005453-4057qib7	1784	16	transplanted	transplant	VBN
cord-005453-4057qib7	1784	17	for	for	IN
cord-005453-4057qib7	1784	18	CLL	CLL	NNP
cord-005453-4057qib7	1784	19	in	in	IN
cord-005453-4057qib7	1784	20	period	period	NN
cord-005453-4057qib7	1784	21	2000	2000	CD
cord-005453-4057qib7	1784	22	-	-	SYM
cord-005453-4057qib7	1784	23	2010	2010	CD
cord-005453-4057qib7	1785	1	(	(	-LRB-
cord-005453-4057qib7	1785	2	2and	2and	CD
cord-005453-4057qib7	1785	3	5-years	5-years	CD
cord-005453-4057qib7	1785	4	PFS	PFS	NNP
cord-005453-4057qib7	1785	5	46	46	CD
cord-005453-4057qib7	1785	6	%	%	NN
cord-005453-4057qib7	1785	7	and	and	CC
cord-005453-4057qib7	1785	8	35	35	CD
cord-005453-4057qib7	1785	9	%	%	NN
cord-005453-4057qib7	1785	10	resp	resp	NN
cord-005453-4057qib7	1785	11	.	.	.
cord-005453-4057qib7	1786	1	OS	OS	NNP
cord-005453-4057qib7	1786	2	62	62	CD
cord-005453-4057qib7	1786	3	%	%	NN
cord-005453-4057qib7	1786	4	and	and	CC
cord-005453-4057qib7	1786	5	45	45	CD
cord-005453-4057qib7	1786	6	%	%	NN
cord-005453-4057qib7	1786	7	)	)	-RRB-
cord-005453-4057qib7	1786	8	.	.	.
cord-005453-4057qib7	1787	1	Current	current	JJ
cord-005453-4057qib7	1787	2	results	result	NNS
cord-005453-4057qib7	1787	3	of	of	IN
cord-005453-4057qib7	1787	4	transplantation	transplantation	NN
cord-005453-4057qib7	1787	5	should	should	MD
cord-005453-4057qib7	1787	6	be	be	VB
cord-005453-4057qib7	1787	7	taken	take	VBN
cord-005453-4057qib7	1787	8	into	into	IN
cord-005453-4057qib7	1787	9	account	account	NN
cord-005453-4057qib7	1787	10	in	in	IN
cord-005453-4057qib7	1787	11	our	-PRON-	PRP$
cord-005453-4057qib7	1787	12	future	future	JJ
cord-005453-4057qib7	1787	13	decision	decision	NN
cord-005453-4057qib7	1787	14	-	-	HYPH
cord-005453-4057qib7	1787	15	making	make	VBG
cord-005453-4057qib7	1787	16	process	process	NN
cord-005453-4057qib7	1787	17	on	on	IN
cord-005453-4057qib7	1787	18	indications	indication	NNS
cord-005453-4057qib7	1787	19	for	for	IN
cord-005453-4057qib7	1787	20	transplantation	transplantation	NN
cord-005453-4057qib7	1787	21	in	in	IN
cord-005453-4057qib7	1787	22	pts	pts	NN
cord-005453-4057qib7	1787	23	with	with	IN
cord-005453-4057qib7	1787	24	high	high	JJ
cord-005453-4057qib7	1787	25	-	-	HYPH
cord-005453-4057qib7	1787	26	risk	risk	NN
cord-005453-4057qib7	1787	27	CLL	CLL	NNP
cord-005453-4057qib7	1787	28	,	,	,
cord-005453-4057qib7	1787	29	of	of	IN
cord-005453-4057qib7	1787	30	course	course	NN
cord-005453-4057qib7	1787	31	also	also	RB
cord-005453-4057qib7	1787	32	in	in	IN
cord-005453-4057qib7	1787	33	the	the	DT
cord-005453-4057qib7	1787	34	context	context	NN
cord-005453-4057qib7	1787	35	of	of	IN
cord-005453-4057qib7	1787	36	new	new	JJ
cord-005453-4057qib7	1787	37	or	or	CC
cord-005453-4057qib7	1787	38	updated	update	VBN
cord-005453-4057qib7	1787	39	results	result	NNS
cord-005453-4057qib7	1787	40	of	of	IN
cord-005453-4057qib7	1787	41	targeted	target	VBN
cord-005453-4057qib7	1787	42	CLL	CLL	NNP
cord-005453-4057qib7	1787	43	treatment	treatment	NN
cord-005453-4057qib7	1787	44	and	and	CC
cord-005453-4057qib7	1787	45	its	-PRON-	PRP$
cord-005453-4057qib7	1787	46	complications	complication	NNS
cord-005453-4057qib7	1787	47	.	.	.
cord-005453-4057qib7	1788	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1788	2	Methods	method	NNS
cord-005453-4057qib7	1788	3	:	:	:
cord-005453-4057qib7	1789	1	Retrospective	retrospective	JJ
cord-005453-4057qib7	1789	2	data	datum	NNS
cord-005453-4057qib7	1789	3	and	and	CC
cord-005453-4057qib7	1789	4	treatment	treatment	NN
cord-005453-4057qib7	1789	5	outcomes	outcome	NNS
cord-005453-4057qib7	1789	6	were	be	VBD
cord-005453-4057qib7	1789	7	collected	collect	VBN
cord-005453-4057qib7	1789	8	from	from	IN
cord-005453-4057qib7	1789	9	the	the	DT
cord-005453-4057qib7	1789	10	Singapore	Singapore	NNP
cord-005453-4057qib7	1789	11	Childhood	Childhood	NNP
cord-005453-4057qib7	1789	12	Cancer	Cancer	NNP
cord-005453-4057qib7	1789	13	Registry	Registry	NNP
cord-005453-4057qib7	1789	14	(	(	-LRB-
cord-005453-4057qib7	1789	15	SCCR	SCCR	NNP
cord-005453-4057qib7	1789	16	)	)	-RRB-
cord-005453-4057qib7	1789	17	.	.	.
cord-005453-4057qib7	1790	1	Most	Most	JJS
cord-005453-4057qib7	1790	2	children	child	NNS
cord-005453-4057qib7	1790	3	with	with	IN
cord-005453-4057qib7	1790	4	cancer	cancer	NN
cord-005453-4057qib7	1790	5	in	in	IN
cord-005453-4057qib7	1790	6	Singapore	Singapore	NNP
cord-005453-4057qib7	1790	7	receive	receive	VBP
cord-005453-4057qib7	1790	8	therapy	therapy	NN
cord-005453-4057qib7	1790	9	at	at	IN
cord-005453-4057qib7	1790	10	one	one	CD
cord-005453-4057qib7	1790	11	of	of	IN
cord-005453-4057qib7	1790	12	the	the	DT
cord-005453-4057qib7	1790	13	two	two	CD
cord-005453-4057qib7	1790	14	public	public	JJ
cord-005453-4057qib7	1790	15	paediatric	paediatric	JJ
cord-005453-4057qib7	1790	16	cancer	cancer	NN
cord-005453-4057qib7	1790	17	centers	center	NNS
cord-005453-4057qib7	1790	18	(	(	-LRB-
cord-005453-4057qib7	1790	19	KKH	KKH	NNP
cord-005453-4057qib7	1790	20	or	or	CC
cord-005453-4057qib7	1790	21	NUH	NUH	NNP
cord-005453-4057qib7	1790	22	)	)	-RRB-
cord-005453-4057qib7	1790	23	.	.	.
cord-005453-4057qib7	1791	1	A	a	DT
cord-005453-4057qib7	1791	2	total	total	NN
cord-005453-4057qib7	1791	3	of	of	IN
cord-005453-4057qib7	1791	4	thirty	thirty	CD
cord-005453-4057qib7	1791	5	two	two	CD
cord-005453-4057qib7	1791	6	cases	case	NNS
cord-005453-4057qib7	1791	7	were	be	VBD
cord-005453-4057qib7	1791	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	1791	9	with	with	IN
cord-005453-4057qib7	1791	10	CML	CML	NNP
cord-005453-4057qib7	1791	11	and	and	CC
cord-005453-4057qib7	1791	12	received	receive	VBD
cord-005453-4057qib7	1791	13	treatment	treatment	NN
cord-005453-4057qib7	1791	14	in	in	IN
cord-005453-4057qib7	1791	15	either	either	DT
cord-005453-4057qib7	1791	16	of	of	IN
cord-005453-4057qib7	1791	17	these	these	DT
cord-005453-4057qib7	1791	18	centers	center	NNS
cord-005453-4057qib7	1791	19	over	over	IN
cord-005453-4057qib7	1791	20	a	a	DT
cord-005453-4057qib7	1791	21	twenty	twenty	CD
cord-005453-4057qib7	1791	22	year	year	NN
cord-005453-4057qib7	1791	23	period	period	NN
cord-005453-4057qib7	1791	24	(	(	-LRB-
cord-005453-4057qib7	1791	25	1997	1997	CD
cord-005453-4057qib7	1791	26	)	)	-RRB-
cord-005453-4057qib7	1792	1	(	(	-LRB-
cord-005453-4057qib7	1792	2	1998	1998	CD
cord-005453-4057qib7	1792	3	)	)	-RRB-
cord-005453-4057qib7	1793	1	(	(	-LRB-
cord-005453-4057qib7	1793	2	1999	1999	CD
cord-005453-4057qib7	1793	3	)	)	-RRB-
cord-005453-4057qib7	1794	1	(	(	-LRB-
cord-005453-4057qib7	1794	2	2000	2000	CD
cord-005453-4057qib7	1794	3	)	)	-RRB-
cord-005453-4057qib7	1795	1	(	(	-LRB-
cord-005453-4057qib7	1795	2	2001	2001	CD
cord-005453-4057qib7	1795	3	)	)	-RRB-
cord-005453-4057qib7	1795	4	(	(	-LRB-
cord-005453-4057qib7	1795	5	2002	2002	CD
cord-005453-4057qib7	1795	6	)	)	-RRB-
cord-005453-4057qib7	1796	1	(	(	-LRB-
cord-005453-4057qib7	1796	2	2003	2003	CD
cord-005453-4057qib7	1796	3	)	)	-RRB-
cord-005453-4057qib7	1797	1	(	(	-LRB-
cord-005453-4057qib7	1797	2	2004	2004	CD
cord-005453-4057qib7	1797	3	)	)	-RRB-
cord-005453-4057qib7	1798	1	(	(	-LRB-
cord-005453-4057qib7	1798	2	2005	2005	CD
cord-005453-4057qib7	1798	3	)	)	-RRB-
cord-005453-4057qib7	1799	1	(	(	-LRB-
cord-005453-4057qib7	1799	2	2006	2006	CD
cord-005453-4057qib7	1799	3	)	)	-RRB-
cord-005453-4057qib7	1800	1	(	(	-LRB-
cord-005453-4057qib7	1800	2	2007	2007	CD
cord-005453-4057qib7	1800	3	)	)	-RRB-
cord-005453-4057qib7	1801	1	(	(	-LRB-
cord-005453-4057qib7	1801	2	2008	2008	CD
cord-005453-4057qib7	1801	3	)	)	-RRB-
cord-005453-4057qib7	1802	1	(	(	-LRB-
cord-005453-4057qib7	1802	2	2009	2009	CD
cord-005453-4057qib7	1802	3	)	)	-RRB-
cord-005453-4057qib7	1803	1	(	(	-LRB-
cord-005453-4057qib7	1803	2	2010	2010	CD
cord-005453-4057qib7	1803	3	)	)	-RRB-
cord-005453-4057qib7	1804	1	(	(	-LRB-
cord-005453-4057qib7	1804	2	2011	2011	CD
cord-005453-4057qib7	1804	3	)	)	-RRB-
cord-005453-4057qib7	1805	1	(	(	-LRB-
cord-005453-4057qib7	1805	2	2012	2012	CD
cord-005453-4057qib7	1805	3	)	)	-RRB-
cord-005453-4057qib7	1806	1	(	(	-LRB-
cord-005453-4057qib7	1806	2	2013	2013	CD
cord-005453-4057qib7	1806	3	)	)	-RRB-
cord-005453-4057qib7	1807	1	(	(	-LRB-
cord-005453-4057qib7	1807	2	2014	2014	CD
cord-005453-4057qib7	1807	3	)	)	-RRB-
cord-005453-4057qib7	1807	4	(	(	-LRB-
cord-005453-4057qib7	1807	5	2015	2015	CD
cord-005453-4057qib7	1807	6	)	)	-RRB-
cord-005453-4057qib7	1807	7	(	(	-LRB-
cord-005453-4057qib7	1807	8	2016	2016	CD
cord-005453-4057qib7	1807	9	)	)	-RRB-
cord-005453-4057qib7	1807	10	.	.	.
cord-005453-4057qib7	1808	1	Results	result	NNS
cord-005453-4057qib7	1808	2	:	:	:
cord-005453-4057qib7	1809	1	The	the	DT
cord-005453-4057qib7	1809	2	age	age	NN
cord-005453-4057qib7	1809	3	at	at	IN
cord-005453-4057qib7	1809	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	1809	5	of	of	IN
cord-005453-4057qib7	1809	6	the	the	DT
cord-005453-4057qib7	1809	7	thirty	thirty	CD
cord-005453-4057qib7	1809	8	two	two	CD
cord-005453-4057qib7	1809	9	children	child	NNS
cord-005453-4057qib7	1809	10	ranged	range	VBD
cord-005453-4057qib7	1809	11	from	from	IN
cord-005453-4057qib7	1809	12	4	4	CD
cord-005453-4057qib7	1809	13	to	to	TO
cord-005453-4057qib7	1809	14	17	17	CD
cord-005453-4057qib7	1809	15	years	year	NNS
cord-005453-4057qib7	1809	16	(	(	-LRB-
cord-005453-4057qib7	1809	17	median	median	JJ
cord-005453-4057qib7	1809	18	12.5years	12.5years	CD
cord-005453-4057qib7	1809	19	)	)	-RRB-
cord-005453-4057qib7	1809	20	.	.	.
cord-005453-4057qib7	1810	1	Six	six	CD
cord-005453-4057qib7	1810	2	patients	patient	NNS
cord-005453-4057qib7	1810	3	in	in	IN
cord-005453-4057qib7	1810	4	the	the	DT
cord-005453-4057qib7	1810	5	pre	pre	JJ
cord-005453-4057qib7	1810	6	-	-	JJ
cord-005453-4057qib7	1810	7	TKI	TKI	NNP
cord-005453-4057qib7	1810	8	era	era	NN
cord-005453-4057qib7	1810	9	were	be	VBD
cord-005453-4057qib7	1810	10	treated	treat	VBN
cord-005453-4057qib7	1810	11	with	with	IN
cord-005453-4057qib7	1810	12	an	an	DT
cord-005453-4057qib7	1810	13	upfront	upfront	JJ
cord-005453-4057qib7	1810	14	HSCT	HSCT	NNP
cord-005453-4057qib7	1810	15	.	.	.
cord-005453-4057qib7	1811	1	The	the	DT
cord-005453-4057qib7	1811	2	remainder	remainder	NN
cord-005453-4057qib7	1811	3	twenty	twenty	CD
cord-005453-4057qib7	1811	4	six	six	CD
cord-005453-4057qib7	1811	5	patients	patient	NNS
cord-005453-4057qib7	1811	6	were	be	VBD
cord-005453-4057qib7	1811	7	initially	initially	RB
cord-005453-4057qib7	1811	8	started	start	VBN
cord-005453-4057qib7	1811	9	on	on	IN
cord-005453-4057qib7	1811	10	a	a	DT
cord-005453-4057qib7	1811	11	TKI	TKI	NNP
cord-005453-4057qib7	1811	12	.	.	.
cord-005453-4057qib7	1812	1	Of	of	IN
cord-005453-4057qib7	1812	2	these	these	DT
cord-005453-4057qib7	1812	3	12/26	12/26	CD
cord-005453-4057qib7	1812	4	(	(	-LRB-
cord-005453-4057qib7	1812	5	46	46	CD
cord-005453-4057qib7	1812	6	%	%	NN
cord-005453-4057qib7	1812	7	)	)	-RRB-
cord-005453-4057qib7	1812	8	had	have	VBD
cord-005453-4057qib7	1812	9	a	a	DT
cord-005453-4057qib7	1812	10	HSCT	HSCT	NNP
cord-005453-4057qib7	1812	11	at	at	IN
cord-005453-4057qib7	1812	12	a	a	DT
cord-005453-4057qib7	1812	13	median	median	JJ
cord-005453-4057qib7	1812	14	period	period	NN
cord-005453-4057qib7	1812	15	of	of	IN
cord-005453-4057qib7	1812	16	22.5	22.5	CD
cord-005453-4057qib7	1812	17	months	month	NNS
cord-005453-4057qib7	1812	18	from	from	IN
cord-005453-4057qib7	1812	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	1812	20	(	(	-LRB-
cord-005453-4057qib7	1812	21	range	range	NNP
cord-005453-4057qib7	1812	22	5	5	CD
cord-005453-4057qib7	1812	23	-	-	SYM
cord-005453-4057qib7	1812	24	43	43	CD
cord-005453-4057qib7	1812	25	months	month	NNS
cord-005453-4057qib7	1812	26	)	)	-RRB-
cord-005453-4057qib7	1812	27	.	.	.
cord-005453-4057qib7	1813	1	The	the	DT
cord-005453-4057qib7	1813	2	reason	reason	NN
cord-005453-4057qib7	1813	3	for	for	IN
cord-005453-4057qib7	1813	4	HSCT	HSCT	NNP
cord-005453-4057qib7	1813	5	in	in	IN
cord-005453-4057qib7	1813	6	ten	ten	CD
cord-005453-4057qib7	1813	7	out	out	IN
cord-005453-4057qib7	1813	8	of	of	IN
cord-005453-4057qib7	1813	9	the	the	DT
cord-005453-4057qib7	1813	10	twelve	twelve	CD
cord-005453-4057qib7	1813	11	children	child	NNS
cord-005453-4057qib7	1813	12	was	be	VBD
cord-005453-4057qib7	1813	13	due	due	JJ
cord-005453-4057qib7	1813	14	to	to	IN
cord-005453-4057qib7	1813	15	high	high	JJ
cord-005453-4057qib7	1813	16	risk	risk	NN
cord-005453-4057qib7	1813	17	features	feature	NNS
cord-005453-4057qib7	1814	1	i.e.	i.e.	FW
cord-005453-4057qib7	1814	2	accelerated	accelerated	JJ
cord-005453-4057qib7	1814	3	/	/	SYM
cord-005453-4057qib7	1814	4	blastic	blastic	JJ
cord-005453-4057qib7	1815	1	phase/	phase/	NNP
cord-005453-4057qib7	1816	1	no	no	DT
cord-005453-4057qib7	1816	2	CCR	CCR	NNP
cord-005453-4057qib7	1816	3	/	/	,
cord-005453-4057qib7	1816	4	no	no	DT
cord-005453-4057qib7	1816	5	CMR	CMR	NNP
cord-005453-4057qib7	1816	6	.	.	.
cord-005453-4057qib7	1817	1	The	the	DT
cord-005453-4057qib7	1817	2	remaining	remain	VBG
cord-005453-4057qib7	1817	3	two	two	CD
cord-005453-4057qib7	1817	4	patients	patient	NNS
cord-005453-4057qib7	1817	5	had	have	VBD
cord-005453-4057qib7	1817	6	a	a	DT
cord-005453-4057qib7	1817	7	HSCT	HSCT	NNP
cord-005453-4057qib7	1817	8	due	due	IN
cord-005453-4057qib7	1817	9	to	to	IN
cord-005453-4057qib7	1817	10	parent	parent	NN
cord-005453-4057qib7	1817	11	and	and	CC
cord-005453-4057qib7	1817	12	patient	patient	JJ
cord-005453-4057qib7	1817	13	preference	preference	NN
cord-005453-4057qib7	1817	14	for	for	IN
cord-005453-4057qib7	1817	15	attempt	attempt	NN
cord-005453-4057qib7	1817	16	at	at	IN
cord-005453-4057qib7	1817	17	upfront	upfront	JJ
cord-005453-4057qib7	1817	18	cure	cure	NN
cord-005453-4057qib7	1817	19	rather	rather	RB
cord-005453-4057qib7	1817	20	than	than	IN
cord-005453-4057qib7	1817	21	the	the	DT
cord-005453-4057qib7	1817	22	use	use	NN
cord-005453-4057qib7	1817	23	of	of	IN
cord-005453-4057qib7	1817	24	life	life	NN
cord-005453-4057qib7	1817	25	-	-	HYPH
cord-005453-4057qib7	1817	26	long	long	JJ
cord-005453-4057qib7	1817	27	and	and	CC
cord-005453-4057qib7	1817	28	expensive	expensive	JJ
cord-005453-4057qib7	1817	29	TKI	TKI	NNP
cord-005453-4057qib7	1817	30	therapy	therapy	NN
cord-005453-4057qib7	1817	31	.	.	.
cord-005453-4057qib7	1818	1	Non	non	JJ
cord-005453-4057qib7	1818	2	-	-	NN
cord-005453-4057qib7	1818	3	compliance	compliance	NN
cord-005453-4057qib7	1818	4	to	to	IN
cord-005453-4057qib7	1818	5	TKI	TKI	NNP
cord-005453-4057qib7	1818	6	therapy	therapy	NN
cord-005453-4057qib7	1818	7	was	be	VBD
cord-005453-4057qib7	1818	8	a	a	DT
cord-005453-4057qib7	1818	9	major	major	JJ
cord-005453-4057qib7	1818	10	finding	finding	NN
cord-005453-4057qib7	1818	11	in	in	IN
cord-005453-4057qib7	1818	12	our	-PRON-	PRP$
cord-005453-4057qib7	1818	13	teenage	teenage	JJ
cord-005453-4057qib7	1818	14	cohort	cohort	NN
cord-005453-4057qib7	1818	15	.	.	.
cord-005453-4057qib7	1819	1	Eleven	eleven	CD
cord-005453-4057qib7	1819	2	of	of	IN
cord-005453-4057qib7	1819	3	the	the	DT
cord-005453-4057qib7	1819	4	eighteen	eighteen	CD
cord-005453-4057qib7	1819	5	transplants	transplant	NNS
cord-005453-4057qib7	1819	6	used	use	VBD
cord-005453-4057qib7	1819	7	a	a	DT
cord-005453-4057qib7	1819	8	matched	match	VBN
cord-005453-4057qib7	1819	9	sibling	sibling	NN
cord-005453-4057qib7	1819	10	donor	donor	NN
cord-005453-4057qib7	1819	11	.	.	.
cord-005453-4057qib7	1820	1	Three	three	CD
cord-005453-4057qib7	1820	2	patients	patient	NNS
cord-005453-4057qib7	1820	3	had	have	VBD
cord-005453-4057qib7	1820	4	cord	cord	NN
cord-005453-4057qib7	1820	5	blood	blood	NN
cord-005453-4057qib7	1820	6	as	as	IN
cord-005453-4057qib7	1820	7	their	-PRON-	PRP$
cord-005453-4057qib7	1820	8	stem	stem	NN
cord-005453-4057qib7	1820	9	cell	cell	NN
cord-005453-4057qib7	1820	10	source	source	NN
cord-005453-4057qib7	1820	11	.	.	.
cord-005453-4057qib7	1821	1	One	one	CD
cord-005453-4057qib7	1821	2	patient	patient	NN
cord-005453-4057qib7	1821	3	had	have	VBD
cord-005453-4057qib7	1821	4	a	a	DT
cord-005453-4057qib7	1821	5	single	single	JJ
cord-005453-4057qib7	1821	6	antigen	antigen	NN
cord-005453-4057qib7	1821	7	mismatched	mismatch	VBN
cord-005453-4057qib7	1821	8	related	related	JJ
cord-005453-4057qib7	1821	9	donor	donor	NN
cord-005453-4057qib7	1821	10	and	and	CC
cord-005453-4057qib7	1821	11	three	three	CD
cord-005453-4057qib7	1821	12	patients	patient	NNS
cord-005453-4057qib7	1821	13	had	have	VBD
cord-005453-4057qib7	1821	14	a	a	DT
cord-005453-4057qib7	1821	15	mismatched	mismatched	JJ
cord-005453-4057qib7	1821	16	unrelated	unrelated	JJ
cord-005453-4057qib7	1821	17	donor	donor	NN
cord-005453-4057qib7	1821	18	for	for	IN
cord-005453-4057qib7	1821	19	their	-PRON-	PRP$
cord-005453-4057qib7	1821	20	HSCT	HSCT	NNP
cord-005453-4057qib7	1821	21	.	.	.
cord-005453-4057qib7	1822	1	All	all	DT
cord-005453-4057qib7	1822	2	patients	patient	NNS
cord-005453-4057qib7	1822	3	except	except	IN
cord-005453-4057qib7	1822	4	one	one	PRP
cord-005453-4057qib7	1822	5	had	have	VBD
cord-005453-4057qib7	1822	6	myeloablative	myeloablative	JJ
cord-005453-4057qib7	1822	7	conditioning	conditioning	NN
cord-005453-4057qib7	1822	8	with	with	IN
cord-005453-4057qib7	1822	9	Busulfan	Busulfan	NNP
cord-005453-4057qib7	1822	10	and	and	CC
cord-005453-4057qib7	1822	11	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	1822	12	.	.	.
cord-005453-4057qib7	1823	1	ATG	ATG	NNP
cord-005453-4057qib7	1823	2	was	be	VBD
cord-005453-4057qib7	1823	3	added	add	VBN
cord-005453-4057qib7	1823	4	according	accord	VBG
cord-005453-4057qib7	1823	5	to	to	IN
cord-005453-4057qib7	1823	6	physician	physician	NN
cord-005453-4057qib7	1823	7	preference	preference	NN
cord-005453-4057qib7	1823	8	.	.	.
cord-005453-4057qib7	1824	1	One	one	CD
cord-005453-4057qib7	1824	2	patient	patient	NN
cord-005453-4057qib7	1824	3	had	have	VBD
cord-005453-4057qib7	1824	4	Cy	Cy	NNP
cord-005453-4057qib7	1824	5	/	/	SYM
cord-005453-4057qib7	1824	6	TBI	TBI	NNP
cord-005453-4057qib7	1824	7	conditioning	conditioning	NN
cord-005453-4057qib7	1824	8	because	because	IN
cord-005453-4057qib7	1824	9	of	of	IN
cord-005453-4057qib7	1824	10	pre	pre	JJ
cord-005453-4057qib7	1824	11	-	-	JJ
cord-005453-4057qib7	1824	12	transplant	transplant	JJ
cord-005453-4057qib7	1824	13	lymphoid	lymphoid	NN
cord-005453-4057qib7	1824	14	blast	blast	NN
cord-005453-4057qib7	1824	15	crisis	crisis	NN
cord-005453-4057qib7	1824	16	.	.	.
cord-005453-4057qib7	1825	1	Anti	anti	JJ
cord-005453-4057qib7	1825	2	GvHD	GvHD	NNP
cord-005453-4057qib7	1825	3	medications	medication	NNS
cord-005453-4057qib7	1825	4	included	include	VBD
cord-005453-4057qib7	1825	5	cyclosporine/	cyclosporine/	CD
cord-005453-4057qib7	1825	6	methotrexate	methotrexate	NNP
cord-005453-4057qib7	1825	7	or	or	CC
cord-005453-4057qib7	1825	8	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	1825	9	and	and	CC
cord-005453-4057qib7	1825	10	methylprednisolone	methylprednisolone	NN
cord-005453-4057qib7	1825	11	in	in	IN
cord-005453-4057qib7	1825	12	the	the	DT
cord-005453-4057qib7	1825	13	cord	cord	NN
cord-005453-4057qib7	1825	14	transplant	transplant	NN
cord-005453-4057qib7	1825	15	patients	patient	NNS
cord-005453-4057qib7	1825	16	.	.	.
cord-005453-4057qib7	1826	1	Six	six	CD
cord-005453-4057qib7	1826	2	of	of	IN
cord-005453-4057qib7	1826	3	the	the	DT
cord-005453-4057qib7	1826	4	eighteen	eighteen	CD
cord-005453-4057qib7	1826	5	(	(	-LRB-
cord-005453-4057qib7	1826	6	33	33	CD
cord-005453-4057qib7	1826	7	%	%	NN
cord-005453-4057qib7	1826	8	)	)	-RRB-
cord-005453-4057qib7	1826	9	patients	patient	NNS
cord-005453-4057qib7	1826	10	who	who	WP
cord-005453-4057qib7	1826	11	had	have	VBD
cord-005453-4057qib7	1826	12	a	a	DT
cord-005453-4057qib7	1826	13	HSCT	HSCT	NNP
cord-005453-4057qib7	1826	14	died	die	VBD
cord-005453-4057qib7	1826	15	.	.	.
cord-005453-4057qib7	1827	1	Four	four	CD
cord-005453-4057qib7	1827	2	died	die	VBD
cord-005453-4057qib7	1827	3	due	due	IN
cord-005453-4057qib7	1827	4	to	to	IN
cord-005453-4057qib7	1827	5	treatment	treatment	NN
cord-005453-4057qib7	1827	6	related	relate	VBN
cord-005453-4057qib7	1827	7	mortality	mortality	NN
cord-005453-4057qib7	1827	8	(	(	-LRB-
cord-005453-4057qib7	1827	9	2	2	CD
cord-005453-4057qib7	1827	10	infections	infection	NNS
cord-005453-4057qib7	1827	11	,	,	,
cord-005453-4057qib7	1827	12	1	1	CD
cord-005453-4057qib7	1827	13	Acute	acute	JJ
cord-005453-4057qib7	1827	14	GvHD	gvhd	NN
cord-005453-4057qib7	1827	15	and	and	CC
cord-005453-4057qib7	1827	16	1	1	CD
cord-005453-4057qib7	1827	17	pulmonary	pulmonary	JJ
cord-005453-4057qib7	1827	18	fibrosis	fibrosis	NN
cord-005453-4057qib7	1827	19	)	)	-RRB-
cord-005453-4057qib7	1827	20	.	.	.
cord-005453-4057qib7	1828	1	One	one	CD
cord-005453-4057qib7	1828	2	patient	patient	NN
cord-005453-4057qib7	1828	3	died	die	VBD
cord-005453-4057qib7	1828	4	due	due	IN
cord-005453-4057qib7	1828	5	to	to	IN
cord-005453-4057qib7	1828	6	an	an	DT
cord-005453-4057qib7	1828	7	early	early	JJ
cord-005453-4057qib7	1828	8	relapse	relapse	NN
cord-005453-4057qib7	1828	9	and	and	CC
cord-005453-4057qib7	1828	10	one	one	CD
cord-005453-4057qib7	1828	11	had	have	VBD
cord-005453-4057qib7	1828	12	a	a	DT
cord-005453-4057qib7	1828	13	late	late	JJ
cord-005453-4057qib7	1828	14	relapse	relapse	NN
cord-005453-4057qib7	1828	15	related	relate	VBN
cord-005453-4057qib7	1828	16	mortality	mortality	NN
cord-005453-4057qib7	1828	17	.	.	.
cord-005453-4057qib7	1829	1	For	for	IN
cord-005453-4057qib7	1829	2	the	the	DT
cord-005453-4057qib7	1829	3	pre	pre	JJ
cord-005453-4057qib7	1829	4	-	-	JJ
cord-005453-4057qib7	1829	5	TKI	TKI	NNP
cord-005453-4057qib7	1829	6	era	era	NN
cord-005453-4057qib7	1829	7	,	,	,
cord-005453-4057qib7	1829	8	HSCT	HSCT	NNP
cord-005453-4057qib7	1829	9	related	relate	VBD
cord-005453-4057qib7	1829	10	5	5	CD
cord-005453-4057qib7	1829	11	and	and	CC
cord-005453-4057qib7	1829	12	10	10	CD
cord-005453-4057qib7	1829	13	year	year	NN
cord-005453-4057qib7	1829	14	OS	OS	NNP
cord-005453-4057qib7	1829	15	was	be	VBD
cord-005453-4057qib7	1829	16	83	83	CD
cord-005453-4057qib7	1829	17	%	%	NN
cord-005453-4057qib7	1829	18	and	and	CC
cord-005453-4057qib7	1829	19	67	67	CD
cord-005453-4057qib7	1829	20	%	%	NN
cord-005453-4057qib7	1829	21	respectively	respectively	RB
cord-005453-4057qib7	1829	22	.	.	.
cord-005453-4057qib7	1830	1	Post	Post	NNP
cord-005453-4057qib7	1830	2	-	-	NNP
cord-005453-4057qib7	1830	3	TKI	TKI	NNP
cord-005453-4057qib7	1830	4	era	era	NN
cord-005453-4057qib7	1830	5	5	5	CD
cord-005453-4057qib7	1830	6	and	and	CC
cord-005453-4057qib7	1830	7	10	10	CD
cord-005453-4057qib7	1830	8	year	year	NN
cord-005453-4057qib7	1831	1	OS	OS	NNP
cord-005453-4057qib7	1831	2	was	be	VBD
cord-005453-4057qib7	1831	3	75	75	CD
cord-005453-4057qib7	1831	4	%	%	NN
cord-005453-4057qib7	1831	5	.	.	.
cord-005453-4057qib7	1832	1	For	for	IN
cord-005453-4057qib7	1832	2	the	the	DT
cord-005453-4057qib7	1832	3	entire	entire	JJ
cord-005453-4057qib7	1832	4	cohort	cohort	NN
cord-005453-4057qib7	1832	5	,	,	,
cord-005453-4057qib7	1832	6	the	the	DT
cord-005453-4057qib7	1832	7	10	10	CD
cord-005453-4057qib7	1832	8	year	year	NN
cord-005453-4057qib7	1832	9	OS	OS	NNP
cord-005453-4057qib7	1832	10	was	be	VBD
cord-005453-4057qib7	1832	11	70	70	CD
cord-005453-4057qib7	1832	12	%	%	NN
cord-005453-4057qib7	1832	13	.	.	.
cord-005453-4057qib7	1833	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1833	2	:	:	:
cord-005453-4057qib7	1834	1	The	the	DT
cord-005453-4057qib7	1834	2	post	post	JJ
cord-005453-4057qib7	1834	3	-	-	JJ
cord-005453-4057qib7	1834	4	TKI	tki	JJ
cord-005453-4057qib7	1834	5	era	era	NN
cord-005453-4057qib7	1834	6	transplant	transplant	NN
cord-005453-4057qib7	1834	7	outcomes	outcome	NNS
cord-005453-4057qib7	1834	8	from	from	IN
cord-005453-4057qib7	1834	9	our	-PRON-	PRP$
cord-005453-4057qib7	1834	10	two	two	CD
cord-005453-4057qib7	1834	11	centers	center	NNS
cord-005453-4057qib7	1834	12	is	be	VBZ
cord-005453-4057qib7	1834	13	comparable	comparable	JJ
cord-005453-4057qib7	1834	14	to	to	IN
cord-005453-4057qib7	1834	15	leading	lead	VBG
cord-005453-4057qib7	1834	16	centers	center	NNS
cord-005453-4057qib7	1834	17	in	in	IN
cord-005453-4057qib7	1834	18	the	the	DT
cord-005453-4057qib7	1834	19	world	world	NN
cord-005453-4057qib7	1834	20	.	.	.
cord-005453-4057qib7	1835	1	Outcomes	outcome	NNS
cord-005453-4057qib7	1835	2	for	for	IN
cord-005453-4057qib7	1835	3	patients	patient	NNS
cord-005453-4057qib7	1835	4	with	with	IN
cord-005453-4057qib7	1835	5	mismatched	mismatched	JJ
cord-005453-4057qib7	1835	6	unrelated	unrelated	JJ
cord-005453-4057qib7	1835	7	donors	donor	NNS
cord-005453-4057qib7	1835	8	was	be	VBD
cord-005453-4057qib7	1835	9	poor	poor	JJ
cord-005453-4057qib7	1835	10	in	in	IN
cord-005453-4057qib7	1835	11	our	-PRON-	PRP$
cord-005453-4057qib7	1835	12	cohort	cohort	NN
cord-005453-4057qib7	1835	13	.	.	.
cord-005453-4057qib7	1836	1	We	-PRON-	PRP
cord-005453-4057qib7	1836	2	recommend	recommend	VBP
cord-005453-4057qib7	1836	3	a	a	DT
cord-005453-4057qib7	1836	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1836	5	related	related	JJ
cord-005453-4057qib7	1836	6	donor	donor	NN
cord-005453-4057qib7	1836	7	transplant	transplant	NN
cord-005453-4057qib7	1836	8	or	or	CC
cord-005453-4057qib7	1836	9	an	an	DT
cord-005453-4057qib7	1836	10	unrelated	unrelated	JJ
cord-005453-4057qib7	1836	11	cord	cord	NN
cord-005453-4057qib7	1836	12	blood	blood	NN
cord-005453-4057qib7	1836	13	stem	stem	NN
cord-005453-4057qib7	1836	14	cell	cell	NN
cord-005453-4057qib7	1836	15	source	source	NN
cord-005453-4057qib7	1836	16	for	for	IN
cord-005453-4057qib7	1836	17	patients	patient	NNS
cord-005453-4057qib7	1836	18	when	when	WRB
cord-005453-4057qib7	1836	19	a	a	DT
cord-005453-4057qib7	1836	20	matched	match	VBN
cord-005453-4057qib7	1836	21	sibling	sibling	NN
cord-005453-4057qib7	1836	22	or	or	CC
cord-005453-4057qib7	1836	23	unrelated	unrelated	JJ
cord-005453-4057qib7	1836	24	donor	donor	NN
cord-005453-4057qib7	1836	25	is	be	VBZ
cord-005453-4057qib7	1836	26	not	not	RB
cord-005453-4057qib7	1836	27	available	available	JJ
cord-005453-4057qib7	1836	28	.	.	.
cord-005453-4057qib7	1837	1	Clinical	clinical	JJ
cord-005453-4057qib7	1837	2	Trial	Trial	NNP
cord-005453-4057qib7	1837	3	Registry	Registry	NNP
cord-005453-4057qib7	1837	4	:	:	:
cord-005453-4057qib7	1838	1	NA	NA	NNP
cord-005453-4057qib7	1838	2	Disclosure	Disclosure	NNP
cord-005453-4057qib7	1838	3	:	:	:
cord-005453-4057qib7	1839	1	We	-PRON-	PRP
cord-005453-4057qib7	1839	2	have	have	VBP
cord-005453-4057qib7	1839	3	nothing	nothing	NN
cord-005453-4057qib7	1839	4	to	to	TO
cord-005453-4057qib7	1839	5	disclose	disclose	VB
cord-005453-4057qib7	1839	6	.	.	.
cord-005453-4057qib7	1840	1	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	1840	2	,	,	,
cord-005453-4057qib7	1840	3	busulfan	busulfan	NN
cord-005453-4057qib7	1840	4	,	,	,
cord-005453-4057qib7	1840	5	and	and	CC
cord-005453-4057qib7	1840	6	thiotepa	thiotepa	NNP
cord-005453-4057qib7	1840	7	may	may	MD
cord-005453-4057qib7	1840	8	be	be	VB
cord-005453-4057qib7	1840	9	a	a	DT
cord-005453-4057qib7	1840	10	promising	promising	JJ
cord-005453-4057qib7	1840	11	conditioning	conditioning	NN
cord-005453-4057qib7	1840	12	regimen	regimen	NN
cord-005453-4057qib7	1840	13	for	for	IN
cord-005453-4057qib7	1840	14	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1840	15	patients	patient	NNS
cord-005453-4057qib7	1840	16	undergoing	undergo	VBG
cord-005453-4057qib7	1840	17	allogeneic	allogeneic	IN
cord-005453-4057qib7	1840	18	stem	stem	NN
cord-005453-4057qib7	1840	19	cell	cell	NN
cord-005453-4057qib7	1840	20	transplantation	transplantation	NN
cord-005453-4057qib7	1840	21	Background	background	NN
cord-005453-4057qib7	1840	22	:	:	:
cord-005453-4057qib7	1841	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	1841	2	stem	stem	NN
cord-005453-4057qib7	1841	3	-	-	HYPH
cord-005453-4057qib7	1841	4	cell	cell	NN
cord-005453-4057qib7	1841	5	transplantation	transplantation	NN
cord-005453-4057qib7	1841	6	(	(	-LRB-
cord-005453-4057qib7	1841	7	SCT	SCT	NNP
cord-005453-4057qib7	1841	8	)	)	-RRB-
cord-005453-4057qib7	1841	9	is	be	VBZ
cord-005453-4057qib7	1841	10	a	a	DT
cord-005453-4057qib7	1841	11	curative	curative	JJ
cord-005453-4057qib7	1841	12	therapy	therapy	NN
cord-005453-4057qib7	1841	13	for	for	IN
cord-005453-4057qib7	1841	14	patients	patient	NNS
cord-005453-4057qib7	1841	15	with	with	IN
cord-005453-4057qib7	1841	16	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1841	17	.	.	.
cord-005453-4057qib7	1842	1	However	however	RB
cord-005453-4057qib7	1842	2	,	,	,
cord-005453-4057qib7	1842	3	recurrent	recurrent	JJ
cord-005453-4057qib7	1842	4	disease	disease	NN
cord-005453-4057qib7	1842	5	and	and	CC
cord-005453-4057qib7	1842	6	non	non	JJ
cord-005453-4057qib7	1842	7	-	-	JJ
cord-005453-4057qib7	1842	8	relapse	relapse	JJ
cord-005453-4057qib7	1842	9	mortality	mortality	NN
cord-005453-4057qib7	1842	10	(	(	-LRB-
cord-005453-4057qib7	1842	11	NRM	NRM	NNP
cord-005453-4057qib7	1842	12	)	)	-RRB-
cord-005453-4057qib7	1842	13	are	be	VBP
cord-005453-4057qib7	1842	14	frequent	frequent	JJ
cord-005453-4057qib7	1842	15	causes	cause	NNS
cord-005453-4057qib7	1842	16	of	of	IN
cord-005453-4057qib7	1842	17	treatment	treatment	NN
cord-005453-4057qib7	1842	18	failure	failure	NN
cord-005453-4057qib7	1842	19	.	.	.
cord-005453-4057qib7	1843	1	The	the	DT
cord-005453-4057qib7	1843	2	optimal	optimal	JJ
cord-005453-4057qib7	1843	3	conditioning	conditioning	NN
cord-005453-4057qib7	1843	4	regimen	regimen	NN
cord-005453-4057qib7	1843	5	for	for	IN
cord-005453-4057qib7	1843	6	SCT	SCT	NNP
cord-005453-4057qib7	1843	7	in	in	IN
cord-005453-4057qib7	1843	8	this	this	DT
cord-005453-4057qib7	1843	9	disease	disease	NN
cord-005453-4057qib7	1843	10	has	have	VBZ
cord-005453-4057qib7	1843	11	not	not	RB
cord-005453-4057qib7	1843	12	been	be	VBN
cord-005453-4057qib7	1843	13	defined	define	VBN
cord-005453-4057qib7	1843	14	.	.	.
cord-005453-4057qib7	1844	1	Methods	method	NNS
cord-005453-4057qib7	1844	2	:	:	:
cord-005453-4057qib7	1844	3	We	-PRON-	PRP
cord-005453-4057qib7	1844	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	1844	5	analyzed	analyze	VBD
cord-005453-4057qib7	1844	6	transplantation	transplantation	NN
cord-005453-4057qib7	1844	7	outcomes	outcome	NNS
cord-005453-4057qib7	1844	8	of	of	IN
cord-005453-4057qib7	1844	9	all	all	DT
cord-005453-4057qib7	1844	10	adult	adult	NN
cord-005453-4057qib7	1844	11	patients	patient	NNS
cord-005453-4057qib7	1844	12	given	give	VBN
cord-005453-4057qib7	1844	13	SCT	SCT	NNP
cord-005453-4057qib7	1844	14	for	for	IN
cord-005453-4057qib7	1844	15	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	1844	16	between	between	IN
cord-005453-4057qib7	1844	17	2003	2003	CD
cord-005453-4057qib7	1844	18	and	and	CC
cord-005453-4057qib7	1844	19	2018	2018	CD
cord-005453-4057qib7	1844	20	at	at	IN
cord-005453-4057qib7	1844	21	a	a	DT
cord-005453-4057qib7	1844	22	single	single	JJ
cord-005453-4057qib7	1844	23	large	large	JJ
cord-005453-4057qib7	1844	24	academic	academic	JJ
cord-005453-4057qib7	1844	25	medical	medical	JJ
cord-005453-4057qib7	1844	26	center	center	NN
cord-005453-4057qib7	1844	27	.	.	.
cord-005453-4057qib7	1845	1	Patients	patient	NNS
cord-005453-4057qib7	1845	2	(	(	-LRB-
cord-005453-4057qib7	1845	3	n=59	n=59	NNP
cord-005453-4057qib7	1845	4	)	)	-RRB-
cord-005453-4057qib7	1845	5	were	be	VBD
cord-005453-4057qib7	1845	6	treated	treat	VBN
cord-005453-4057qib7	1845	7	with	with	IN
cord-005453-4057qib7	1845	8	several	several	JJ
cord-005453-4057qib7	1845	9	conditioning	conditioning	NN
cord-005453-4057qib7	1845	10	regimens	regimen	NNS
cord-005453-4057qib7	1845	11	that	that	WDT
cord-005453-4057qib7	1845	12	were	be	VBD
cord-005453-4057qib7	1845	13	grouped	group	VBN
cord-005453-4057qib7	1845	14	according	accord	VBG
cord-005453-4057qib7	1845	15	to	to	IN
cord-005453-4057qib7	1845	16	conditioning	conditioning	NN
cord-005453-4057qib7	1845	17	intensity	intensity	NN
cord-005453-4057qib7	1845	18	.	.	.
cord-005453-4057qib7	1846	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	1846	2	conditioning	conditioning	NN
cord-005453-4057qib7	1846	3	(	(	-LRB-
cord-005453-4057qib7	1846	4	MAC	MAC	NNP
cord-005453-4057qib7	1846	5	)	)	-RRB-
cord-005453-4057qib7	1846	6	included	include	VBD
cord-005453-4057qib7	1846	7	busulfan	busulfan	NNP
cord-005453-4057qib7	1846	8	12.8	12.8	CD
cord-005453-4057qib7	1846	9	mg	mg	NNP
cord-005453-4057qib7	1846	10	/	/	SYM
cord-005453-4057qib7	1846	11	kg	kg	NNP
cord-005453-4057qib7	1846	12	and	and	CC
cord-005453-4057qib7	1846	13	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	1846	14	120	120	CD
cord-005453-4057qib7	1846	15	mg	mg	NNP
cord-005453-4057qib7	1846	16	/	/	SYM
cord-005453-4057qib7	1846	17	kg	kg	NNP
cord-005453-4057qib7	1847	1	(	(	-LRB-
cord-005453-4057qib7	1847	2	BuCy	BuCy	NNP
cord-005453-4057qib7	1847	3	,	,	,
cord-005453-4057qib7	1847	4	n=10	n=10	NNP
cord-005453-4057qib7	1847	5	)	)	-RRB-
cord-005453-4057qib7	1847	6	,	,	,
cord-005453-4057qib7	1847	7	fludarabine	fludarabine	NN
cord-005453-4057qib7	1847	8	and	and	CC
cord-005453-4057qib7	1847	9	busulfan	busulfan	NN
cord-005453-4057qib7	1847	10	12.8	12.8	CD
cord-005453-4057qib7	1847	11	mg	mg	NNP
cord-005453-4057qib7	1847	12	/	/	SYM
cord-005453-4057qib7	1847	13	kg	kg	NNP
cord-005453-4057qib7	1847	14	(	(	-LRB-
cord-005453-4057qib7	1847	15	Flu/	Flu/	NNP
cord-005453-4057qib7	1847	16	Bu4	bu4	NN
cord-005453-4057qib7	1847	17	,	,	,
cord-005453-4057qib7	1847	18	n=9	n=9	NN
cord-005453-4057qib7	1847	19	)	)	-RRB-
cord-005453-4057qib7	1847	20	and	and	CC
cord-005453-4057qib7	1847	21	fludarabine	fludarabine	NN
cord-005453-4057qib7	1847	22	and	and	CC
cord-005453-4057qib7	1847	23	treosulfan	treosulfan	NNP
cord-005453-4057qib7	1847	24	30	30	CD
cord-005453-4057qib7	1847	25	-	-	SYM
cord-005453-4057qib7	1847	26	36	36	CD
cord-005453-4057qib7	1847	27	g	g	NN
cord-005453-4057qib7	1847	28	/	/	SYM
cord-005453-4057qib7	1847	29	m	m	NN
cord-005453-4057qib7	1847	30	2	2	CD
cord-005453-4057qib7	1848	1	(	(	-LRB-
cord-005453-4057qib7	1848	2	Flu/	Flu/	NNP
cord-005453-4057qib7	1848	3	Treo	Treo	NNP
cord-005453-4057qib7	1848	4	,	,	,
cord-005453-4057qib7	1848	5	n=6	n=6	NN
cord-005453-4057qib7	1848	6	)	)	-RRB-
cord-005453-4057qib7	1848	7	.	.	.
cord-005453-4057qib7	1849	1	Reduced	reduce	VBN
cord-005453-4057qib7	1849	2	-	-	HYPH
cord-005453-4057qib7	1849	3	intensity	intensity	NN
cord-005453-4057qib7	1849	4	conditioning	conditioning	NN
cord-005453-4057qib7	1849	5	included	include	VBD
cord-005453-4057qib7	1849	6	fludarabine	fludarabine	NN
cord-005453-4057qib7	1849	7	and	and	CC
cord-005453-4057qib7	1849	8	busulfan	busulfan	NN
cord-005453-4057qib7	1849	9	6.4	6.4	CD
cord-005453-4057qib7	1849	10	-	-	HYPH
cord-005453-4057qib7	1849	11	8.0	8.0	CD
cord-005453-4057qib7	1849	12	mg	mg	NN
cord-005453-4057qib7	1849	13	/	/	SYM
cord-005453-4057qib7	1849	14	kg	kg	NNP
cord-005453-4057qib7	1850	1	(	(	-LRB-
cord-005453-4057qib7	1850	2	Flu	flu	NN
cord-005453-4057qib7	1850	3	/	/	SYM
cord-005453-4057qib7	1850	4	Bu2	bu2	NN
cord-005453-4057qib7	1850	5	,	,	,
cord-005453-4057qib7	1850	6	n=22	n=22	NNP
cord-005453-4057qib7	1850	7	)	)	-RRB-
cord-005453-4057qib7	1850	8	.	.	.
cord-005453-4057qib7	1851	1	More	more	RBR
cord-005453-4057qib7	1851	2	recently	recently	RB
cord-005453-4057qib7	1851	3	we	-PRON-	PRP
cord-005453-4057qib7	1851	4	adopted	adopt	VBD
cord-005453-4057qib7	1851	5	the	the	DT
cord-005453-4057qib7	1851	6	TBF	tbf	NN
cord-005453-4057qib7	1851	7	regimen	regimen	NN
cord-005453-4057qib7	1851	8	including	include	VBG
cord-005453-4057qib7	1851	9	fludarabine	fludarabine	NN
cord-005453-4057qib7	1851	10	,	,	,
cord-005453-4057qib7	1851	11	busulfan	busulfan	NN
cord-005453-4057qib7	1851	12	6.4	6.4	CD
cord-005453-4057qib7	1851	13	-	-	HYPH
cord-005453-4057qib7	1851	14	9.6	9.6	CD
cord-005453-4057qib7	1851	15	mg	mg	NNP
cord-005453-4057qib7	1851	16	/	/	SYM
cord-005453-4057qib7	1851	17	kg	kg	NNP
cord-005453-4057qib7	1851	18	and	and	CC
cord-005453-4057qib7	1851	19	thiotepa	thiotepa	JJ
cord-005453-4057qib7	1851	20	5	5	CD
cord-005453-4057qib7	1851	21	-	-	SYM
cord-005453-4057qib7	1851	22	10	10	CD
cord-005453-4057qib7	1851	23	mg/	mg/	NN
cord-005453-4057qib7	1851	24	m2	m2	NNP
cord-005453-4057qib7	1851	25	(	(	-LRB-
cord-005453-4057qib7	1851	26	n=12	n=12	NNP
cord-005453-4057qib7	1851	27	)	)	-RRB-
cord-005453-4057qib7	1851	28	.	.	.
cord-005453-4057qib7	1852	1	All	all	DT
cord-005453-4057qib7	1852	2	patients	patient	NNS
cord-005453-4057qib7	1852	3	were	be	VBD
cord-005453-4057qib7	1852	4	also	also	RB
cord-005453-4057qib7	1852	5	given	give	VBN
cord-005453-4057qib7	1852	6	anti	anti	JJ
cord-005453-4057qib7	1852	7	-	-	JJ
cord-005453-4057qib7	1852	8	thymocyte	thymocyte	JJ
cord-005453-4057qib7	1852	9	globulin	globulin	NN
cord-005453-4057qib7	1852	10	during	during	IN
cord-005453-4057qib7	1852	11	conditioning	conditioning	NN
cord-005453-4057qib7	1852	12	,	,	,
cord-005453-4057qib7	1852	13	irrespective	irrespective	RB
cord-005453-4057qib7	1852	14	of	of	IN
cord-005453-4057qib7	1852	15	donor	donor	NN
cord-005453-4057qib7	1852	16	source	source	NN
cord-005453-4057qib7	1852	17	.	.	.
cord-005453-4057qib7	1853	1	Results	result	NNS
cord-005453-4057qib7	1853	2	:	:	:
cord-005453-4057qib7	1854	1	The	the	DT
cord-005453-4057qib7	1854	2	median	median	JJ
cord-005453-4057qib7	1854	3	age	age	NN
cord-005453-4057qib7	1854	4	was	be	VBD
cord-005453-4057qib7	1854	5	59	59	CD
cord-005453-4057qib7	1854	6	years	year	NNS
cord-005453-4057qib7	1854	7	(	(	-LRB-
cord-005453-4057qib7	1854	8	interquartile	interquartile	JJ
cord-005453-4057qib7	1854	9	range	range	NN
cord-005453-4057qib7	1854	10	[	[	-LRB-
cord-005453-4057qib7	1854	11	IQR	IQR	NNP
cord-005453-4057qib7	1854	12	]	]	-RRB-
cord-005453-4057qib7	1855	1	52	52	CD
cord-005453-4057qib7	1855	2	-	-	SYM
cord-005453-4057qib7	1855	3	63	63	CD
cord-005453-4057qib7	1855	4	)	)	-RRB-
cord-005453-4057qib7	1855	5	.	.	.
cord-005453-4057qib7	1856	1	The	the	DT
cord-005453-4057qib7	1856	2	majority	majority	NN
cord-005453-4057qib7	1856	3	of	of	IN
cord-005453-4057qib7	1856	4	patients	patient	NNS
cord-005453-4057qib7	1856	5	had	have	VBD
cord-005453-4057qib7	1856	6	documented	document	VBN
cord-005453-4057qib7	1856	7	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	1856	8	(	(	-LRB-
cord-005453-4057qib7	1856	9	81	81	CD
cord-005453-4057qib7	1856	10	%	%	NN
cord-005453-4057qib7	1856	11	)	)	-RRB-
cord-005453-4057qib7	1856	12	and	and	CC
cord-005453-4057qib7	1856	13	were	be	VBD
cord-005453-4057qib7	1856	14	not	not	RB
cord-005453-4057qib7	1856	15	previously	previously	RB
cord-005453-4057qib7	1856	16	exposed	expose	VBN
cord-005453-4057qib7	1856	17	to	to	IN
cord-005453-4057qib7	1856	18	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	1856	19	(	(	-LRB-
cord-005453-4057qib7	1856	20	71	71	CD
cord-005453-4057qib7	1856	21	%	%	NN
cord-005453-4057qib7	1856	22	)	)	-RRB-
cord-005453-4057qib7	1856	23	.	.	.
cord-005453-4057qib7	1857	1	Donor	donor	NN
cord-005453-4057qib7	1857	2	type	type	NN
cord-005453-4057qib7	1857	3	was	be	VBD
cord-005453-4057qib7	1857	4	an	an	DT
cord-005453-4057qib7	1857	5	HLA	HLA	NNP
cord-005453-4057qib7	1857	6	-	-	HYPH
cord-005453-4057qib7	1857	7	matched	match	VBN
cord-005453-4057qib7	1857	8	sibling	sibling	NN
cord-005453-4057qib7	1857	9	(	(	-LRB-
cord-005453-4057qib7	1857	10	41	41	CD
cord-005453-4057qib7	1857	11	%	%	NN
cord-005453-4057qib7	1857	12	)	)	-RRB-
cord-005453-4057qib7	1857	13	,	,	,
cord-005453-4057qib7	1857	14	10/10	10/10	CD
cord-005453-4057qib7	1857	15	(	(	-LRB-
cord-005453-4057qib7	1857	16	51	51	CD
cord-005453-4057qib7	1857	17	%	%	NN
cord-005453-4057qib7	1857	18	)	)	-RRB-
cord-005453-4057qib7	1857	19	or	or	CC
cord-005453-4057qib7	1857	20	9/10	9/10	CD
cord-005453-4057qib7	1857	21	(	(	-LRB-
cord-005453-4057qib7	1857	22	8	8	CD
cord-005453-4057qib7	1857	23	%	%	NN
cord-005453-4057qib7	1857	24	)	)	-RRB-
cord-005453-4057qib7	1857	25	matched	match	VBN
cord-005453-4057qib7	1857	26	unrelated	unrelated	JJ
cord-005453-4057qib7	1857	27	donor	donor	NN
cord-005453-4057qib7	1857	28	.	.	.
cord-005453-4057qib7	1858	1	The	the	DT
cord-005453-4057qib7	1858	2	DIPPS+	DIPPS+	NNP
cord-005453-4057qib7	1858	3	score	score	NN
cord-005453-4057qib7	1858	4	distribution	distribution	NN
cord-005453-4057qib7	1858	5	was	be	VBD
cord-005453-4057qib7	1858	6	intermediate-1	intermediate-1	NNP
cord-005453-4057qib7	1858	7	(	(	-LRB-
cord-005453-4057qib7	1858	8	16	16	CD
cord-005453-4057qib7	1858	9	%	%	NN
cord-005453-4057qib7	1858	10	)	)	-RRB-
cord-005453-4057qib7	1858	11	,	,	,
cord-005453-4057qib7	1858	12	intermediate-2	intermediate-2	NNP
cord-005453-4057qib7	1858	13	(	(	-LRB-
cord-005453-4057qib7	1858	14	45	45	CD
cord-005453-4057qib7	1858	15	%	%	NN
cord-005453-4057qib7	1858	16	)	)	-RRB-
cord-005453-4057qib7	1858	17	,	,	,
cord-005453-4057qib7	1858	18	or	or	CC
cord-005453-4057qib7	1858	19	high	high	JJ
cord-005453-4057qib7	1858	20	(	(	-LRB-
cord-005453-4057qib7	1858	21	n=39	n=39	NNP
cord-005453-4057qib7	1858	22	%	%	NN
cord-005453-4057qib7	1858	23	)	)	-RRB-
cord-005453-4057qib7	1858	24	.	.	.
cord-005453-4057qib7	1859	1	The	the	DT
cord-005453-4057qib7	1859	2	median	median	JJ
cord-005453-4057qib7	1859	3	followup	followup	NN
cord-005453-4057qib7	1859	4	was	be	VBD
cord-005453-4057qib7	1859	5	3.2	3.2	CD
cord-005453-4057qib7	1859	6	years	year	NNS
cord-005453-4057qib7	1859	7	Since	since	IN
cord-005453-4057qib7	1859	8	the	the	DT
cord-005453-4057qib7	1859	9	success	success	NN
cord-005453-4057qib7	1859	10	of	of	IN
cord-005453-4057qib7	1859	11	tyrosine	tyrosine	NN
cord-005453-4057qib7	1859	12	kinase	kinase	NN
cord-005453-4057qib7	1859	13	inhibitors	inhibitor	NNS
cord-005453-4057qib7	1859	14	(	(	-LRB-
cord-005453-4057qib7	1859	15	TKIs	TKIs	NNP
cord-005453-4057qib7	1859	16	)	)	-RRB-
cord-005453-4057qib7	1859	17	,	,	,
cord-005453-4057qib7	1859	18	transplant	transplant	NN
cord-005453-4057qib7	1859	19	-	-	HYPH
cord-005453-4057qib7	1859	20	related	relate	VBN
cord-005453-4057qib7	1859	21	mortality	mortality	NN
cord-005453-4057qib7	1859	22	is	be	VBZ
cord-005453-4057qib7	1859	23	considered	consider	VBN
cord-005453-4057qib7	1859	24	too	too	RB
cord-005453-4057qib7	1859	25	high	high	JJ
cord-005453-4057qib7	1859	26	to	to	TO
cord-005453-4057qib7	1859	27	justify	justify	VB
cord-005453-4057qib7	1859	28	allogeneic	allogeneic	IN
cord-005453-4057qib7	1859	29	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	1859	30	stem	stem	NN
cord-005453-4057qib7	1859	31	cell	cell	NN
cord-005453-4057qib7	1859	32	transplantation	transplantation	NN
cord-005453-4057qib7	1859	33	(	(	-LRB-
cord-005453-4057qib7	1859	34	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	1859	35	)	)	-RRB-
cord-005453-4057qib7	1859	36	as	as	IN
cord-005453-4057qib7	1859	37	first	first	JJ
cord-005453-4057qib7	1859	38	-	-	HYPH
cord-005453-4057qib7	1859	39	line	line	NN
cord-005453-4057qib7	1859	40	treatment	treatment	NN
cord-005453-4057qib7	1859	41	for	for	IN
cord-005453-4057qib7	1859	42	chronic	chronic	JJ
cord-005453-4057qib7	1859	43	myeloid	myeloid	NN
cord-005453-4057qib7	1859	44	leukemia	leukemia	NN
cord-005453-4057qib7	1859	45	(	(	-LRB-
cord-005453-4057qib7	1859	46	CML	CML	NNP
cord-005453-4057qib7	1859	47	)	)	-RRB-
cord-005453-4057qib7	1859	48	patients	patient	NNS
cord-005453-4057qib7	1859	49	in	in	IN
cord-005453-4057qib7	1859	50	chronic	chronic	JJ
cord-005453-4057qib7	1859	51	phase	phase	NN
cord-005453-4057qib7	1859	52	(	(	-LRB-
cord-005453-4057qib7	1859	53	CP	CP	NNP
cord-005453-4057qib7	1859	54	)	)	-RRB-
cord-005453-4057qib7	1859	55	.	.	.
cord-005453-4057qib7	1860	1	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	1860	2	is	be	VBZ
cord-005453-4057qib7	1860	3	currently	currently	RB
cord-005453-4057qib7	1860	4	considered	consider	VBN
cord-005453-4057qib7	1860	5	for	for	IN
cord-005453-4057qib7	1860	6	patients	patient	NNS
cord-005453-4057qib7	1860	7	failing	fail	VBG
cord-005453-4057qib7	1860	8	to	to	IN
cord-005453-4057qib7	1860	9	at	at	RB
cord-005453-4057qib7	1860	10	least	least	JJS
cord-005453-4057qib7	1860	11	2	2	CD
cord-005453-4057qib7	1860	12	TKIs	tki	NNS
cord-005453-4057qib7	1860	13	or	or	CC
cord-005453-4057qib7	1860	14	with	with	IN
cord-005453-4057qib7	1860	15	disease	disease	NN
cord-005453-4057qib7	1860	16	in	in	IN
cord-005453-4057qib7	1860	17	advanced	advanced	JJ
cord-005453-4057qib7	1860	18	phase	phase	NN
cord-005453-4057qib7	1860	19	.	.	.
cord-005453-4057qib7	1861	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	1861	2	,	,	,
cord-005453-4057qib7	1861	3	the	the	DT
cord-005453-4057qib7	1861	4	optimal	optimal	JJ
cord-005453-4057qib7	1861	5	timing	timing	NN
cord-005453-4057qib7	1861	6	for	for	IN
cord-005453-4057qib7	1861	7	transplant	transplant	NN
cord-005453-4057qib7	1861	8	referral	referral	NN
cord-005453-4057qib7	1861	9	is	be	VBZ
cord-005453-4057qib7	1861	10	still	still	RB
cord-005453-4057qib7	1861	11	not	not	RB
cord-005453-4057qib7	1861	12	well	well	RB
cord-005453-4057qib7	1861	13	defined	define	VBN
cord-005453-4057qib7	1861	14	.	.	.
cord-005453-4057qib7	1862	1	Methods	method	NNS
cord-005453-4057qib7	1862	2	:	:	:
cord-005453-4057qib7	1862	3	We	-PRON-	PRP
cord-005453-4057qib7	1862	4	performed	perform	VBD
cord-005453-4057qib7	1862	5	a	a	DT
cord-005453-4057qib7	1862	6	retrospective	retrospective	JJ
cord-005453-4057qib7	1862	7	analysis	analysis	NN
cord-005453-4057qib7	1862	8	on	on	IN
cord-005453-4057qib7	1862	9	23	23	CD
cord-005453-4057qib7	1862	10	consecutive	consecutive	JJ
cord-005453-4057qib7	1862	11	patients	patient	NNS
cord-005453-4057qib7	1862	12	with	with	IN
cord-005453-4057qib7	1862	13	CML	CML	NNP
cord-005453-4057qib7	1862	14	in	in	IN
cord-005453-4057qib7	1862	15	CP	cp	NN
cord-005453-4057qib7	1862	16	receiving	receive	VBG
cord-005453-4057qib7	1862	17	first	first	JJ
cord-005453-4057qib7	1862	18	transplants	transplant	NNS
cord-005453-4057qib7	1862	19	from	from	IN
cord-005453-4057qib7	1862	20	an	an	DT
cord-005453-4057qib7	1862	21	HLA	HLA	NNP
cord-005453-4057qib7	1862	22	-	-	HYPH
cord-005453-4057qib7	1862	23	identical	identical	JJ
cord-005453-4057qib7	1862	24	sibling	sibling	NN
cord-005453-4057qib7	1862	25	donor	donor	NN
cord-005453-4057qib7	1862	26	with	with	IN
cord-005453-4057qib7	1862	27	partially	partially	RB
cord-005453-4057qib7	1862	28	T	t	NN
cord-005453-4057qib7	1862	29	-	-	HYPH
cord-005453-4057qib7	1862	30	cell	cell	NN
cord-005453-4057qib7	1862	31	depleted	deplete	VBD
cord-005453-4057qib7	1862	32	grafts	graft	NNS
cord-005453-4057qib7	1862	33	from	from	IN
cord-005453-4057qib7	1862	34	1998	1998	CD
cord-005453-4057qib7	1862	35	to	to	IN
cord-005453-4057qib7	1862	36	2016	2016	CD
cord-005453-4057qib7	1862	37	at	at	IN
cord-005453-4057qib7	1862	38	our	-PRON-	PRP$
cord-005453-4057qib7	1862	39	center	center	NN
cord-005453-4057qib7	1862	40	.	.	.
cord-005453-4057qib7	1863	1	Partial	partial	JJ
cord-005453-4057qib7	1863	2	T	t	NN
cord-005453-4057qib7	1863	3	-	-	HYPH
cord-005453-4057qib7	1863	4	cell	cell	NN
cord-005453-4057qib7	1863	5	depletion	depletion	NN
cord-005453-4057qib7	1863	6	(	(	-LRB-
cord-005453-4057qib7	1863	7	pTD	pTD	NNP
cord-005453-4057qib7	1863	8	)	)	-RRB-
cord-005453-4057qib7	1863	9	consisted	consist	VBN
cord-005453-4057qib7	1863	10	of	of	IN
cord-005453-4057qib7	1863	11	in	in	FW
cord-005453-4057qib7	1863	12	vitro	vitro	FW
cord-005453-4057qib7	1863	13	alemtuzumab	alemtuzumab	JJ
cord-005453-4057qib7	1863	14	incubation	incubation	NN
cord-005453-4057qib7	1863	15	of	of	IN
cord-005453-4057qib7	1863	16	a	a	DT
cord-005453-4057qib7	1863	17	part	part	NN
cord-005453-4057qib7	1863	18	of	of	IN
cord-005453-4057qib7	1863	19	the	the	DT
cord-005453-4057qib7	1863	20	graft	graft	NN
cord-005453-4057qib7	1863	21	for	for	IN
cord-005453-4057qib7	1863	22	infusion	infusion	NN
cord-005453-4057qib7	1863	23	at	at	IN
cord-005453-4057qib7	1863	24	day	day	NN
cord-005453-4057qib7	1863	25	0	0	NFP
cord-005453-4057qib7	1863	26	while	while	IN
cord-005453-4057qib7	1863	27	the	the	DT
cord-005453-4057qib7	1863	28	rest	rest	NN
cord-005453-4057qib7	1863	29	,	,	,
cord-005453-4057qib7	1863	30	containing	contain	VBG
cord-005453-4057qib7	1863	31	100x10	100x10	CD
cord-005453-4057qib7	1863	32	6	6	CD
cord-005453-4057qib7	1863	33	CD3	cd3	NN
cord-005453-4057qib7	1864	1	+	+	CC
cord-005453-4057qib7	1865	1	cells/	cells/	CD
cord-005453-4057qib7	1866	1	kg	kg	NNP
cord-005453-4057qib7	1866	2	was	be	VBD
cord-005453-4057qib7	1866	3	given	give	VBN
cord-005453-4057qib7	1866	4	as	as	IN
cord-005453-4057qib7	1866	5	a	a	DT
cord-005453-4057qib7	1866	6	T	t	NN
cord-005453-4057qib7	1866	7	-	-	HYPH
cord-005453-4057qib7	1866	8	cell	cell	NN
cord-005453-4057qib7	1866	9	add	add	NN
cord-005453-4057qib7	1866	10	-	-	HYPH
cord-005453-4057qib7	1866	11	back	back	NN
cord-005453-4057qib7	1866	12	at	at	IN
cord-005453-4057qib7	1866	13	day	day	NN
cord-005453-4057qib7	1866	14	1	1	CD
cord-005453-4057qib7	1866	15	.	.	.
cord-005453-4057qib7	1867	1	Donor	donor	NN
cord-005453-4057qib7	1867	2	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	1867	3	infusions	infusion	NNS
cord-005453-4057qib7	1867	4	(	(	-LRB-
cord-005453-4057qib7	1867	5	DLIs	dli	NNS
cord-005453-4057qib7	1867	6	)	)	-RRB-
cord-005453-4057qib7	1867	7	were	be	VBD
cord-005453-4057qib7	1867	8	provided	provide	VBN
cord-005453-4057qib7	1867	9	,	,	,
cord-005453-4057qib7	1867	10	in	in	IN
cord-005453-4057qib7	1867	11	the	the	DT
cord-005453-4057qib7	1867	12	absence	absence	NN
cord-005453-4057qib7	1867	13	of	of	IN
cord-005453-4057qib7	1867	14	GvHD	GvHD	NNP
cord-005453-4057qib7	1867	15	,	,	,
cord-005453-4057qib7	1867	16	in	in	IN
cord-005453-4057qib7	1867	17	case	case	NN
cord-005453-4057qib7	1867	18	of	of	IN
cord-005453-4057qib7	1867	19	disease	disease	NN
cord-005453-4057qib7	1867	20	relapse	relapse	NN
cord-005453-4057qib7	1867	21	or	or	CC
cord-005453-4057qib7	1867	22	mixed	mixed	JJ
cord-005453-4057qib7	1867	23	chimerism	chimerism	NN
cord-005453-4057qib7	1867	24	.	.	.
cord-005453-4057qib7	1868	1	Molecular	molecular	JJ
cord-005453-4057qib7	1868	2	monitoring	monitoring	NN
cord-005453-4057qib7	1868	3	was	be	VBD
cord-005453-4057qib7	1868	4	performed	perform	VBN
cord-005453-4057qib7	1868	5	by	by	IN
cord-005453-4057qib7	1868	6	3-month	3-month	CD
cord-005453-4057qib7	1868	7	BCR	BCR	NNP
cord-005453-4057qib7	1868	8	-	-	HYPH
cord-005453-4057qib7	1868	9	ABL1	ABL1	NNP
cord-005453-4057qib7	1868	10	RT	RT	NNP
cord-005453-4057qib7	1868	11	-	-	HYPH
cord-005453-4057qib7	1868	12	qPCR	qpcr	NN
cord-005453-4057qib7	1868	13	testing	testing	NN
cord-005453-4057qib7	1868	14	in	in	IN
cord-005453-4057qib7	1868	15	peripheral	peripheral	JJ
cord-005453-4057qib7	1868	16	blood	blood	NN
cord-005453-4057qib7	1868	17	during	during	IN
cord-005453-4057qib7	1868	18	at	at	RB
cord-005453-4057qib7	1868	19	least	least	JJS
cord-005453-4057qib7	1868	20	a	a	DT
cord-005453-4057qib7	1868	21	5-year	5-year	CD
cord-005453-4057qib7	1868	22	period	period	NN
cord-005453-4057qib7	1868	23	after	after	IN
cord-005453-4057qib7	1868	24	HSCT	HSCT	NNP
cord-005453-4057qib7	1868	25	.	.	.
cord-005453-4057qib7	1869	1	Thereafter	thereafter	RB
cord-005453-4057qib7	1869	2	,	,	,
cord-005453-4057qib7	1869	3	3-month	3-month	CD
cord-005453-4057qib7	1869	4	testing	testing	NN
cord-005453-4057qib7	1869	5	schedule	schedule	NN
cord-005453-4057qib7	1869	6	was	be	VBD
cord-005453-4057qib7	1869	7	maintained	maintain	VBN
cord-005453-4057qib7	1869	8	where	where	WRB
cord-005453-4057qib7	1869	9	possible	possible	JJ
cord-005453-4057qib7	1869	10	,	,	,
cord-005453-4057qib7	1869	11	or	or	CC
cord-005453-4057qib7	1869	12	followed	follow	VBN
cord-005453-4057qib7	1869	13	by	by	IN
cord-005453-4057qib7	1869	14	a	a	DT
cord-005453-4057qib7	1869	15	6-month	6-month	CD
cord-005453-4057qib7	1869	16	one	one	CD
cord-005453-4057qib7	1869	17	.	.	.
cord-005453-4057qib7	1870	1	Kaplan	Kaplan	NNP
cord-005453-4057qib7	1870	2	-	-	HYPH
cord-005453-4057qib7	1870	3	Meier	Meier	NNP
cord-005453-4057qib7	1870	4	method	method	NN
cord-005453-4057qib7	1870	5	was	be	VBD
cord-005453-4057qib7	1870	6	employed	employ	VBN
cord-005453-4057qib7	1870	7	to	to	TO
cord-005453-4057qib7	1870	8	determine	determine	VB
cord-005453-4057qib7	1870	9	the	the	DT
cord-005453-4057qib7	1870	10	probability	probability	NN
cord-005453-4057qib7	1870	11	of	of	IN
cord-005453-4057qib7	1870	12	overall	overall	JJ
cord-005453-4057qib7	1870	13	survival	survival	NN
cord-005453-4057qib7	1870	14	(	(	-LRB-
cord-005453-4057qib7	1870	15	OS	OS	NNP
cord-005453-4057qib7	1870	16	)	)	-RRB-
cord-005453-4057qib7	1870	17	and	and	CC
cord-005453-4057qib7	1870	18	leukemia	leukemia	NN
cord-005453-4057qib7	1870	19	free	free	JJ
cord-005453-4057qib7	1870	20	survival	survival	NN
cord-005453-4057qib7	1870	21	(	(	-LRB-
cord-005453-4057qib7	1870	22	LFS	LFS	NNP
cord-005453-4057qib7	1870	23	)	)	-RRB-
cord-005453-4057qib7	1870	24	since	since	IN
cord-005453-4057qib7	1870	25	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	1870	26	.	.	.
cord-005453-4057qib7	1871	1	Results	result	NNS
cord-005453-4057qib7	1871	2	:	:	:
cord-005453-4057qib7	1872	1	Median	median	JJ
cord-005453-4057qib7	1872	2	age	age	NN
cord-005453-4057qib7	1872	3	at	at	IN
cord-005453-4057qib7	1872	4	HSCT	HSCT	NNP
cord-005453-4057qib7	1872	5	was	be	VBD
cord-005453-4057qib7	1872	6	36	36	CD
cord-005453-4057qib7	1872	7	years	year	NNS
cord-005453-4057qib7	1872	8	(	(	-LRB-
cord-005453-4057qib7	1872	9	range	range	NN
cord-005453-4057qib7	1872	10	,	,	,
cord-005453-4057qib7	1872	11	18	18	CD
cord-005453-4057qib7	1872	12	-	-	SYM
cord-005453-4057qib7	1872	13	58	58	CD
cord-005453-4057qib7	1872	14	)	)	-RRB-
cord-005453-4057qib7	1872	15	.	.	.
cord-005453-4057qib7	1873	1	All	all	DT
cord-005453-4057qib7	1873	2	patients	patient	NNS
cord-005453-4057qib7	1873	3	were	be	VBD
cord-005453-4057qib7	1873	4	in	in	IN
cord-005453-4057qib7	1873	5	first	first	JJ
cord-005453-4057qib7	1873	6	CP	cp	NN
cord-005453-4057qib7	1873	7	but	but	CC
cord-005453-4057qib7	1873	8	one	one	CD
cord-005453-4057qib7	1873	9	who	who	WP
cord-005453-4057qib7	1873	10	was	be	VBD
cord-005453-4057qib7	1873	11	in	in	IN
cord-005453-4057qib7	1873	12	second	second	JJ
cord-005453-4057qib7	1873	13	CP	cp	NN
cord-005453-4057qib7	1873	14	.	.	.
cord-005453-4057qib7	1874	1	Twelve	twelve	CD
cord-005453-4057qib7	1874	2	patients	patient	NNS
cord-005453-4057qib7	1874	3	were	be	VBD
cord-005453-4057qib7	1874	4	TKI	TKI	NNP
cord-005453-4057qib7	1874	5	-	-	HYPH
cord-005453-4057qib7	1874	6	naïve	naïve	JJ
cord-005453-4057qib7	1874	7	at	at	IN
cord-005453-4057qib7	1874	8	HSCT	HSCT	NNP
cord-005453-4057qib7	1874	9	(	(	-LRB-
cord-005453-4057qib7	1874	10	1998	1998	CD
cord-005453-4057qib7	1874	11	HSCT	HSCT	NNP
cord-005453-4057qib7	1874	12	(	(	-LRB-
cord-005453-4057qib7	1875	1	-2001	-2001	NNP
cord-005453-4057qib7	1875	2	,	,	,
cord-005453-4057qib7	1875	3	4	4	CD
cord-005453-4057qib7	1875	4	patients	patient	NNS
cord-005453-4057qib7	1875	5	had	have	VBD
cord-005453-4057qib7	1875	6	presented	present	VBN
cord-005453-4057qib7	1875	7	suboptimal	suboptimal	JJ
cord-005453-4057qib7	1875	8	response	response	NN
cord-005453-4057qib7	1875	9	or/	or/	NN
cord-005453-4057qib7	1875	10	and	and	CC
cord-005453-4057qib7	1875	11	intolerance	intolerance	NN
cord-005453-4057qib7	1875	12	to	to	IN
cord-005453-4057qib7	1875	13	imatinib	imatinib	NN
cord-005453-4057qib7	1875	14	(	(	-LRB-
cord-005453-4057qib7	1875	15	2002	2002	CD
cord-005453-4057qib7	1875	16	-	-	SYM
cord-005453-4057qib7	1875	17	2004	2004	CD
cord-005453-4057qib7	1875	18	period	period	NN
cord-005453-4057qib7	1875	19	)	)	-RRB-
cord-005453-4057qib7	1875	20	,	,	,
cord-005453-4057qib7	1875	21	while	while	IN
cord-005453-4057qib7	1875	22	the	the	DT
cord-005453-4057qib7	1875	23	last	last	JJ
cord-005453-4057qib7	1875	24	seven	seven	CD
cord-005453-4057qib7	1875	25	patients	patient	NNS
cord-005453-4057qib7	1875	26	had	have	VBD
cord-005453-4057qib7	1875	27	presented	present	VBN
cord-005453-4057qib7	1875	28	suboptimal	suboptimal	JJ
cord-005453-4057qib7	1875	29	response	response	NN
cord-005453-4057qib7	1875	30	or/	or/	NN
cord-005453-4057qib7	1875	31	and	and	CC
cord-005453-4057qib7	1875	32	intolerance	intolerance	NN
cord-005453-4057qib7	1875	33	to	to	IN
cord-005453-4057qib7	1875	34	imatinib	imatinib	NN
cord-005453-4057qib7	1875	35	,	,	,
cord-005453-4057qib7	1875	36	dasatinib	dasatinib	NN
cord-005453-4057qib7	1875	37	and	and	CC
cord-005453-4057qib7	1875	38	nilotinib	nilotinib	NN
cord-005453-4057qib7	1875	39	(	(	-LRB-
cord-005453-4057qib7	1875	40	2005	2005	CD
cord-005453-4057qib7	1875	41	-	-	SYM
cord-005453-4057qib7	1875	42	2016	2016	CD
cord-005453-4057qib7	1875	43	period	period	NN
cord-005453-4057qib7	1875	44	)	)	-RRB-
cord-005453-4057qib7	1875	45	.	.	.
cord-005453-4057qib7	1876	1	The	the	DT
cord-005453-4057qib7	1876	2	time	time	NN
cord-005453-4057qib7	1876	3	interval	interval	NN
cord-005453-4057qib7	1876	4	from	from	IN
cord-005453-4057qib7	1876	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	1876	6	to	to	IN
cord-005453-4057qib7	1876	7	transplant	transplant	NN
cord-005453-4057qib7	1876	8	was	be	VBD
cord-005453-4057qib7	1876	9	<	<	NNP
cord-005453-4057qib7	1876	10	12	12	CD
cord-005453-4057qib7	1876	11	months	month	NNS
cord-005453-4057qib7	1876	12	in	in	IN
cord-005453-4057qib7	1876	13	11/23	11/23	CD
cord-005453-4057qib7	1876	14	(	(	-LRB-
cord-005453-4057qib7	1876	15	48	48	CD
cord-005453-4057qib7	1876	16	%	%	NN
cord-005453-4057qib7	1876	17	)	)	-RRB-
cord-005453-4057qib7	1876	18	patients	patient	NNS
cord-005453-4057qib7	1876	19	.	.	.
cord-005453-4057qib7	1877	1	15	15	CD
cord-005453-4057qib7	1877	2	(	(	-LRB-
cord-005453-4057qib7	1877	3	65	65	CD
cord-005453-4057qib7	1877	4	%	%	NN
cord-005453-4057qib7	1877	5	)	)	-RRB-
cord-005453-4057qib7	1877	6	patients	patient	NNS
cord-005453-4057qib7	1877	7	had	have	VBD
cord-005453-4057qib7	1877	8	an	an	DT
cord-005453-4057qib7	1877	9	EBMT	EBMT	NNP
cord-005453-4057qib7	1877	10	risk	risk	NN
cord-005453-4057qib7	1877	11	score	score	NN
cord-005453-4057qib7	1877	12	of	of	IN
cord-005453-4057qib7	1877	13	0	0	CD
cord-005453-4057qib7	1877	14	-	-	SYM
cord-005453-4057qib7	1877	15	2	2	CD
cord-005453-4057qib7	1877	16	,	,	,
cord-005453-4057qib7	1877	17	while	while	IN
cord-005453-4057qib7	1877	18	8	8	CD
cord-005453-4057qib7	1877	19	(	(	-LRB-
cord-005453-4057qib7	1877	20	35	35	CD
cord-005453-4057qib7	1877	21	%	%	NN
cord-005453-4057qib7	1877	22	)	)	-RRB-
cord-005453-4057qib7	1877	23	patients	patient	NNS
cord-005453-4057qib7	1877	24	of	of	IN
cord-005453-4057qib7	1877	25	3	3	CD
cord-005453-4057qib7	1877	26	-	-	SYM
cord-005453-4057qib7	1877	27	4	4	CD
cord-005453-4057qib7	1877	28	.	.	.
cord-005453-4057qib7	1878	1	The	the	DT
cord-005453-4057qib7	1878	2	conditioning	conditioning	NN
cord-005453-4057qib7	1878	3	regimen	regimen	NN
cord-005453-4057qib7	1878	4	was	be	VBD
cord-005453-4057qib7	1878	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	1878	6	for	for	IN
cord-005453-4057qib7	1878	7	all	all	DT
cord-005453-4057qib7	1878	8	but	but	IN
cord-005453-4057qib7	1878	9	one	one	CD
cord-005453-4057qib7	1878	10	patients	patient	NNS
cord-005453-4057qib7	1878	11	.	.	.
cord-005453-4057qib7	1879	1	The	the	DT
cord-005453-4057qib7	1879	2	stem	stem	NN
cord-005453-4057qib7	1879	3	cell	cell	NN
cord-005453-4057qib7	1879	4	source	source	NN
cord-005453-4057qib7	1879	5	was	be	VBD
cord-005453-4057qib7	1879	6	PBSC	PBSC	NNP
cord-005453-4057qib7	1879	7	for	for	IN
cord-005453-4057qib7	1879	8	22	22	CD
cord-005453-4057qib7	1879	9	patients	patient	NNS
cord-005453-4057qib7	1879	10	and	and	CC
cord-005453-4057qib7	1879	11	bone	bone	NN
cord-005453-4057qib7	1879	12	marrow	marrow	NN
cord-005453-4057qib7	1879	13	for	for	IN
cord-005453-4057qib7	1879	14	one	one	CD
cord-005453-4057qib7	1879	15	.	.	.
cord-005453-4057qib7	1880	1	All	all	DT
cord-005453-4057qib7	1880	2	patients	patient	NNS
cord-005453-4057qib7	1880	3	engrafted	engraft	VBD
cord-005453-4057qib7	1880	4	.	.	.
cord-005453-4057qib7	1881	1	14	14	CD
cord-005453-4057qib7	1881	2	patients	patient	NNS
cord-005453-4057qib7	1881	3	presented	present	VBD
cord-005453-4057qib7	1881	4	molecular	molecular	JJ
cord-005453-4057qib7	1881	5	relapse	relapse	NN
cord-005453-4057qib7	1881	6	and	and	CC
cord-005453-4057qib7	1881	7	one	one	CD
cord-005453-4057qib7	1881	8	patient	patient	JJ
cord-005453-4057qib7	1881	9	hematological	hematological	JJ
cord-005453-4057qib7	1881	10	relapse	relapse	NN
cord-005453-4057qib7	1881	11	with	with	IN
cord-005453-4057qib7	1881	12	a	a	DT
cord-005453-4057qib7	1881	13	median	median	JJ
cord-005453-4057qib7	1881	14	interval	interval	NN
cord-005453-4057qib7	1881	15	from	from	IN
cord-005453-4057qib7	1881	16	transplant	transplant	NN
cord-005453-4057qib7	1881	17	to	to	IN
cord-005453-4057qib7	1881	18	relapse	relapse	VB
cord-005453-4057qib7	1881	19	of	of	IN
cord-005453-4057qib7	1881	20	9	9	CD
cord-005453-4057qib7	1881	21	months	month	NNS
cord-005453-4057qib7	1881	22	(	(	-LRB-
cord-005453-4057qib7	1881	23	range	range	NN
cord-005453-4057qib7	1881	24	,	,	,
cord-005453-4057qib7	1881	25	5	5	CD
cord-005453-4057qib7	1881	26	-	-	SYM
cord-005453-4057qib7	1881	27	70	70	CD
cord-005453-4057qib7	1881	28	)	)	-RRB-
cord-005453-4057qib7	1881	29	.	.	.
cord-005453-4057qib7	1882	1	17	17	CD
cord-005453-4057qib7	1882	2	patients	patient	NNS
cord-005453-4057qib7	1882	3	received	receive	VBD
cord-005453-4057qib7	1882	4	DLIs	dli	NNS
cord-005453-4057qib7	1882	5	(	(	-LRB-
cord-005453-4057qib7	1882	6	15	15	CD
cord-005453-4057qib7	1882	7	for	for	IN
cord-005453-4057qib7	1882	8	relapse	relapse	NN
cord-005453-4057qib7	1882	9	and	and	CC
cord-005453-4057qib7	1882	10	2	2	CD
cord-005453-4057qib7	1882	11	for	for	IN
cord-005453-4057qib7	1882	12	mixed	mixed	JJ
cord-005453-4057qib7	1882	13	chimerism	chimerism	NN
cord-005453-4057qib7	1882	14	)	)	-RRB-
cord-005453-4057qib7	1882	15	,	,	,
cord-005453-4057qib7	1882	16	while	while	IN
cord-005453-4057qib7	1882	17	3	3	CD
cord-005453-4057qib7	1882	18	patients	patient	NNS
cord-005453-4057qib7	1882	19	in	in	IN
cord-005453-4057qib7	1882	20	relapse	relapse	NN
cord-005453-4057qib7	1882	21	also	also	RB
cord-005453-4057qib7	1882	22	received	receive	VBD
cord-005453-4057qib7	1882	23	TKI	TKI	NNP
cord-005453-4057qib7	1882	24	.	.	.
cord-005453-4057qib7	1883	1	Without	without	IN
cord-005453-4057qib7	1883	2	prior	prior	JJ
cord-005453-4057qib7	1883	3	administration	administration	NN
cord-005453-4057qib7	1883	4	of	of	IN
cord-005453-4057qib7	1883	5	DLI	DLI	NNP
cord-005453-4057qib7	1883	6	,	,	,
cord-005453-4057qib7	1883	7	3(13	3(13	CD
cord-005453-4057qib7	1883	8	%	%	NN
cord-005453-4057qib7	1883	9	)	)	-RRB-
cord-005453-4057qib7	1883	10	patients	patient	NNS
cord-005453-4057qib7	1883	11	presented	present	VBD
cord-005453-4057qib7	1883	12	grade	grade	NN
cord-005453-4057qib7	1883	13	II	II	NNP
cord-005453-4057qib7	1883	14	aGvHD	agvhd	NN
cord-005453-4057qib7	1883	15	and	and	CC
cord-005453-4057qib7	1883	16	2	2	CD
cord-005453-4057qib7	1883	17	patients	patient	NNS
cord-005453-4057qib7	1883	18	moderate	moderate	JJ
cord-005453-4057qib7	1883	19	cGvHD	cgvhd	NN
cord-005453-4057qib7	1883	20	.	.	.
cord-005453-4057qib7	1884	1	After	after	IN
cord-005453-4057qib7	1884	2	DLI	DLI	NNP
cord-005453-4057qib7	1884	3	,	,	,
cord-005453-4057qib7	1884	4	aGvHD	agvhd	NN
cord-005453-4057qib7	1884	5	occurred	occur	VBD
cord-005453-4057qib7	1884	6	in	in	IN
cord-005453-4057qib7	1884	7	3	3	CD
cord-005453-4057qib7	1884	8	and	and	CC
cord-005453-4057qib7	1884	9	cGvHD	cgvhd	NN
cord-005453-4057qib7	1884	10	in	in	IN
cord-005453-4057qib7	1884	11	4	4	CD
cord-005453-4057qib7	1884	12	patients	patient	NNS
cord-005453-4057qib7	1884	13	.	.	.
cord-005453-4057qib7	1885	1	One	one	CD
cord-005453-4057qib7	1885	2	patient	patient	NN
cord-005453-4057qib7	1885	3	died	die	VBD
cord-005453-4057qib7	1885	4	of	of	IN
cord-005453-4057qib7	1885	5	disease	disease	NN
cord-005453-4057qib7	1885	6	progression	progression	NN
cord-005453-4057qib7	1885	7	3	3	CD
cord-005453-4057qib7	1885	8	years	year	NNS
cord-005453-4057qib7	1885	9	after	after	IN
cord-005453-4057qib7	1885	10	HSCT	HSCT	NNP
cord-005453-4057qib7	1885	11	and	and	CC
cord-005453-4057qib7	1885	12	one	one	CD
cord-005453-4057qib7	1885	13	of	of	IN
cord-005453-4057qib7	1885	14	myocardial	myocardial	JJ
cord-005453-4057qib7	1885	15	infarction	infarction	NN
cord-005453-4057qib7	1885	16	19	19	CD
cord-005453-4057qib7	1885	17	years	year	NNS
cord-005453-4057qib7	1885	18	after	after	IN
cord-005453-4057qib7	1885	19	HSCT	HSCT	NNP
cord-005453-4057qib7	1885	20	.	.	.
cord-005453-4057qib7	1886	1	With	with	IN
cord-005453-4057qib7	1886	2	a	a	DT
cord-005453-4057qib7	1886	3	median	median	JJ
cord-005453-4057qib7	1886	4	follow	follow	NN
cord-005453-4057qib7	1886	5	-	-	HYPH
cord-005453-4057qib7	1886	6	up	up	NN
cord-005453-4057qib7	1886	7	of	of	IN
cord-005453-4057qib7	1886	8	14.4	14.4	CD
cord-005453-4057qib7	1886	9	years	year	NNS
cord-005453-4057qib7	1886	10	(	(	-LRB-
cord-005453-4057qib7	1886	11	range	range	VBP
cord-005453-4057qib7	1886	12	2.3	2.3	CD
cord-005453-4057qib7	1886	13	-	-	HYPH
cord-005453-4057qib7	1886	14	20.6	20.6	CD
cord-005453-4057qib7	1886	15	)	)	-RRB-
cord-005453-4057qib7	1886	16	,	,	,
cord-005453-4057qib7	1886	17	15-year	15-year	JJ
cord-005453-4057qib7	1886	18	OS	OS	NNP
cord-005453-4057qib7	1886	19	and	and	CC
cord-005453-4057qib7	1886	20	LFS	LFS	NNP
cord-005453-4057qib7	1886	21	were	be	VBD
cord-005453-4057qib7	1886	22	95	95	CD
cord-005453-4057qib7	1886	23	%	%	NN
cord-005453-4057qib7	1886	24	.	.	.
cord-005453-4057qib7	1887	1	At	at	IN
cord-005453-4057qib7	1887	2	the	the	DT
cord-005453-4057qib7	1887	3	time	time	NN
cord-005453-4057qib7	1887	4	of	of	IN
cord-005453-4057qib7	1887	5	the	the	DT
cord-005453-4057qib7	1887	6	analysis	analysis	NN
cord-005453-4057qib7	1887	7	21/23	21/23	CD
cord-005453-4057qib7	1887	8	patients	patient	NNS
cord-005453-4057qib7	1887	9	were	be	VBD
cord-005453-4057qib7	1887	10	alive	alive	JJ
cord-005453-4057qib7	1887	11	and	and	CC
cord-005453-4057qib7	1887	12	in	in	IN
cord-005453-4057qib7	1887	13	major	major	JJ
cord-005453-4057qib7	1887	14	molecular	molecular	JJ
cord-005453-4057qib7	1887	15	response	response	NN
cord-005453-4057qib7	1887	16	.	.	.
cord-005453-4057qib7	1888	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1888	2	:	:	:
cord-005453-4057qib7	1889	1	These	these	DT
cord-005453-4057qib7	1889	2	results	result	NNS
cord-005453-4057qib7	1889	3	of	of	IN
cord-005453-4057qib7	1889	4	excellent	excellent	JJ
cord-005453-4057qib7	1889	5	long	long	JJ
cord-005453-4057qib7	1889	6	-	-	HYPH
cord-005453-4057qib7	1889	7	term	term	NN
cord-005453-4057qib7	1889	8	survival	survival	NN
cord-005453-4057qib7	1889	9	and	and	CC
cord-005453-4057qib7	1889	10	no	no	DT
cord-005453-4057qib7	1889	11	transplant	transplant	NN
cord-005453-4057qib7	1889	12	-	-	HYPH
cord-005453-4057qib7	1889	13	related	relate	VBN
cord-005453-4057qib7	1889	14	mortality	mortality	NN
cord-005453-4057qib7	1889	15	suggest	suggest	VBP
cord-005453-4057qib7	1889	16	that	that	IN
cord-005453-4057qib7	1889	17	pTCD	ptcd	NN
cord-005453-4057qib7	1889	18	improves	improve	VBZ
cord-005453-4057qib7	1889	19	the	the	DT
cord-005453-4057qib7	1889	20	outcome	outcome	NN
cord-005453-4057qib7	1889	21	of	of	IN
cord-005453-4057qib7	1889	22	CP	CP	NNP
cord-005453-4057qib7	1889	23	-	-	HYPH
cord-005453-4057qib7	1889	24	CML	CML	NNP
cord-005453-4057qib7	1889	25	patients	patient	NNS
cord-005453-4057qib7	1889	26	transplanted	transplant	VBN
cord-005453-4057qib7	1889	27	from	from	IN
cord-005453-4057qib7	1889	28	an	an	DT
cord-005453-4057qib7	1889	29	identical	identical	JJ
cord-005453-4057qib7	1889	30	sibling	sibling	NN
cord-005453-4057qib7	1889	31	donor	donor	NN
cord-005453-4057qib7	1889	32	and	and	CC
cord-005453-4057qib7	1889	33	they	-PRON-	PRP
cord-005453-4057qib7	1889	34	can	can	MD
cord-005453-4057qib7	1889	35	be	be	VB
cord-005453-4057qib7	1889	36	useful	useful	JJ
cord-005453-4057qib7	1889	37	for	for	IN
cord-005453-4057qib7	1889	38	deciding	decide	VBG
cord-005453-4057qib7	1889	39	risk	risk	NN
cord-005453-4057qib7	1889	40	-	-	HYPH
cord-005453-4057qib7	1889	41	adapted	adapt	VBN
cord-005453-4057qib7	1889	42	strategies	strategy	NNS
cord-005453-4057qib7	1889	43	.	.	.
cord-005453-4057qib7	1890	1	We	-PRON-	PRP
cord-005453-4057qib7	1890	2	believe	believe	VBP
cord-005453-4057qib7	1890	3	that	that	IN
cord-005453-4057qib7	1890	4	pTCD	ptcd	NN
cord-005453-4057qib7	1890	5	could	could	MD
cord-005453-4057qib7	1890	6	allow	allow	VB
cord-005453-4057qib7	1890	7	earlier	early	JJR
cord-005453-4057qib7	1890	8	transplant	transplant	NN
cord-005453-4057qib7	1890	9	referral	referral	NN
cord-005453-4057qib7	1890	10	of	of	IN
cord-005453-4057qib7	1890	11	patients	patient	NNS
cord-005453-4057qib7	1890	12	failing	fail	VBG
cord-005453-4057qib7	1890	13	TKIs	tki	NNS
cord-005453-4057qib7	1890	14	and	and	CC
cord-005453-4057qib7	1890	15	having	have	VBG
cord-005453-4057qib7	1890	16	an	an	DT
cord-005453-4057qib7	1890	17	identical	identical	JJ
cord-005453-4057qib7	1890	18	sibling	sibling	NN
cord-005453-4057qib7	1890	19	donor	donor	NN
cord-005453-4057qib7	1890	20	.	.	.
cord-005453-4057qib7	1891	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1891	2	:	:	:
cord-005453-4057qib7	1891	3	Nothing	nothing	NN
cord-005453-4057qib7	1891	4	to	to	TO
cord-005453-4057qib7	1891	5	declare	declare	VB
cord-005453-4057qib7	1891	6	Single	single	JJ
cord-005453-4057qib7	1891	7	tertiary	tertiary	JJ
cord-005453-4057qib7	1891	8	centre	centre	NN
cord-005453-4057qib7	1891	9	experience	experience	NN
cord-005453-4057qib7	1891	10	in	in	IN
cord-005453-4057qib7	1891	11	allogeneic	allogeneic	JJ
cord-005453-4057qib7	1891	12	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	1891	13	stem	stem	NN
cord-005453-4057qib7	1891	14	cell	cell	NN
cord-005453-4057qib7	1891	15	transplantation	transplantation	NN
cord-005453-4057qib7	1891	16	(	(	-LRB-
cord-005453-4057qib7	1891	17	allo	allo	NN
cord-005453-4057qib7	1891	18	-	-	HYPH
cord-005453-4057qib7	1891	19	HSCT	HSCT	NNP
cord-005453-4057qib7	1891	20	)	)	-RRB-
cord-005453-4057qib7	1891	21	for	for	IN
cord-005453-4057qib7	1891	22	primary	primary	JJ
cord-005453-4057qib7	1891	23	and	and	CC
cord-005453-4057qib7	1891	24	secondary	secondary	JJ
cord-005453-4057qib7	1891	25	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	1891	26	(	(	-LRB-
cord-005453-4057qib7	1891	27	MF	MF	NNP
cord-005453-4057qib7	1891	28	)	)	-RRB-
cord-005453-4057qib7	1892	1	The	the	DT
cord-005453-4057qib7	1892	2	only	only	JJ
cord-005453-4057qib7	1892	3	curative	curative	JJ
cord-005453-4057qib7	1892	4	option	option	NN
cord-005453-4057qib7	1892	5	for	for	IN
cord-005453-4057qib7	1892	6	fit	fit	JJ
cord-005453-4057qib7	1892	7	patients	patient	NNS
cord-005453-4057qib7	1892	8	is	be	VBZ
cord-005453-4057qib7	1892	9	allo	allo	NN
cord-005453-4057qib7	1892	10	-	-	HYPH
cord-005453-4057qib7	1892	11	HSCT	HSCT	NNP
cord-005453-4057qib7	1892	12	.	.	.
cord-005453-4057qib7	1893	1	Novel	novel	NN
cord-005453-4057qib7	1893	2	therapy	therapy	NN
cord-005453-4057qib7	1893	3	is	be	VBZ
cord-005453-4057qib7	1893	4	emerging	emerge	VBG
cord-005453-4057qib7	1893	5	but	but	CC
cord-005453-4057qib7	1893	6	current	current	JJ
cord-005453-4057qib7	1893	7	recommendation	recommendation	NN
cord-005453-4057qib7	1893	8	is	be	VBZ
cord-005453-4057qib7	1893	9	that	that	IN
cord-005453-4057qib7	1893	10	eligible	eligible	JJ
cord-005453-4057qib7	1893	11	patients	patient	NNS
cord-005453-4057qib7	1893	12	with	with	IN
cord-005453-4057qib7	1893	13	life	life	NN
cord-005453-4057qib7	1893	14	expectancy	expectancy	NN
cord-005453-4057qib7	1893	15	less	less	JJR
cord-005453-4057qib7	1893	16	than	than	IN
cord-005453-4057qib7	1893	17	5	5	CD
cord-005453-4057qib7	1893	18	years	year	NNS
cord-005453-4057qib7	1893	19	should	should	MD
cord-005453-4057qib7	1893	20	be	be	VB
cord-005453-4057qib7	1893	21	considered	consider	VBN
cord-005453-4057qib7	1893	22	for	for	IN
cord-005453-4057qib7	1893	23	allografting	allografte	VBG
cord-005453-4057qib7	1893	24	.	.	.
cord-005453-4057qib7	1894	1	Methods	method	NNS
cord-005453-4057qib7	1894	2	:	:	:
cord-005453-4057qib7	1894	3	We	-PRON-	PRP
cord-005453-4057qib7	1894	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	1894	5	looked	look	VBD
cord-005453-4057qib7	1894	6	at	at	IN
cord-005453-4057qib7	1894	7	the	the	DT
cord-005453-4057qib7	1894	8	clinical	clinical	JJ
cord-005453-4057qib7	1894	9	features	feature	NNS
cord-005453-4057qib7	1894	10	and	and	CC
cord-005453-4057qib7	1894	11	outcomes	outcome	NNS
cord-005453-4057qib7	1894	12	of	of	IN
cord-005453-4057qib7	1894	13	all	all	DT
cord-005453-4057qib7	1894	14	allo	allo	NN
cord-005453-4057qib7	1894	15	-	-	HYPH
cord-005453-4057qib7	1894	16	HSCT	HSCT	NNP
cord-005453-4057qib7	1894	17	for	for	IN
cord-005453-4057qib7	1894	18	MF	MF	NNP
cord-005453-4057qib7	1894	19	performed	perform	VBN
cord-005453-4057qib7	1894	20	in	in	IN
cord-005453-4057qib7	1894	21	our	-PRON-	PRP$
cord-005453-4057qib7	1894	22	centre	centre	NN
cord-005453-4057qib7	1894	23	since	since	IN
cord-005453-4057qib7	1894	24	2010	2010	CD
cord-005453-4057qib7	1894	25	.	.	.
cord-005453-4057qib7	1895	1	Results	result	NNS
cord-005453-4057qib7	1895	2	:	:	:
cord-005453-4057qib7	1895	3	12	12	CD
cord-005453-4057qib7	1895	4	patients	patient	NNS
cord-005453-4057qib7	1895	5	(	(	-LRB-
cord-005453-4057qib7	1895	6	10	10	CD
cord-005453-4057qib7	1895	7	male	male	NN
cord-005453-4057qib7	1895	8	,	,	,
cord-005453-4057qib7	1895	9	2	2	CD
cord-005453-4057qib7	1895	10	female	female	JJ
cord-005453-4057qib7	1895	11	)	)	-RRB-
cord-005453-4057qib7	1895	12	aged	age	VBN
cord-005453-4057qib7	1895	13	between	between	IN
cord-005453-4057qib7	1895	14	29	29	CD
cord-005453-4057qib7	1895	15	-	-	SYM
cord-005453-4057qib7	1895	16	68	68	CD
cord-005453-4057qib7	1895	17	years	year	NNS
cord-005453-4057qib7	1895	18	old	old	JJ
cord-005453-4057qib7	1895	19	(	(	-LRB-
cord-005453-4057qib7	1895	20	median	median	JJ
cord-005453-4057qib7	1895	21	age	age	NN
cord-005453-4057qib7	1895	22	60	60	CD
cord-005453-4057qib7	1895	23	)	)	-RRB-
cord-005453-4057qib7	1895	24	with	with	IN
cord-005453-4057qib7	1895	25	intermediate-2	intermediate-2	NNP
cord-005453-4057qib7	1895	26	or	or	CC
cord-005453-4057qib7	1895	27	high	high	JJ
cord-005453-4057qib7	1895	28	-	-	HYPH
cord-005453-4057qib7	1895	29	risk	risk	NN
cord-005453-4057qib7	1895	30	MF	mf	NN
cord-005453-4057qib7	1895	31	as	as	IN
cord-005453-4057qib7	1895	32	per	per	IN
cord-005453-4057qib7	1895	33	the	the	DT
cord-005453-4057qib7	1895	34	International	International	NNP
cord-005453-4057qib7	1895	35	Prognostic	Prognostic	NNP
cord-005453-4057qib7	1895	36	Scoring	Scoring	NNP
cord-005453-4057qib7	1895	37	System	System	NNP
cord-005453-4057qib7	1895	38	(	(	-LRB-
cord-005453-4057qib7	1895	39	IPSS	IPSS	NNP
cord-005453-4057qib7	1895	40	)	)	-RRB-
cord-005453-4057qib7	1895	41	or	or	CC
cord-005453-4057qib7	1895	42	Dynamic	dynamic	JJ
cord-005453-4057qib7	1895	43	IPPS	IPPS	NNPS
cord-005453-4057qib7	1895	44	(	(	-LRB-
cord-005453-4057qib7	1895	45	DIPPS	DIPPS	NNP
cord-005453-4057qib7	1895	46	)	)	-RRB-
cord-005453-4057qib7	1895	47	were	be	VBD
cord-005453-4057qib7	1895	48	transplanted	transplant	VBN
cord-005453-4057qib7	1895	49	in	in	IN
cord-005453-4057qib7	1895	50	our	-PRON-	PRP$
cord-005453-4057qib7	1895	51	centre	centre	NN
cord-005453-4057qib7	1895	52	since	since	IN
cord-005453-4057qib7	1895	53	2010	2010	CD
cord-005453-4057qib7	1895	54	.	.	.
cord-005453-4057qib7	1896	1	6	6	CD
cord-005453-4057qib7	1896	2	of	of	IN
cord-005453-4057qib7	1896	3	them	-PRON-	PRP
cord-005453-4057qib7	1896	4	(	(	-LRB-
cord-005453-4057qib7	1896	5	50	50	CD
cord-005453-4057qib7	1896	6	%	%	NN
cord-005453-4057qib7	1896	7	)	)	-RRB-
cord-005453-4057qib7	1896	8	were	be	VBD
cord-005453-4057qib7	1896	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	1896	10	with	with	IN
cord-005453-4057qib7	1896	11	PMF	PMF	NNP
cord-005453-4057qib7	1896	12	and	and	CC
cord-005453-4057qib7	1896	13	the	the	DT
cord-005453-4057qib7	1896	14	remaining	remain	VBG
cord-005453-4057qib7	1896	15	50	50	CD
cord-005453-4057qib7	1896	16	%	%	NN
cord-005453-4057qib7	1896	17	with	with	IN
cord-005453-4057qib7	1896	18	secondary	secondary	JJ
cord-005453-4057qib7	1896	19	MF	MF	NNP
cord-005453-4057qib7	1896	20	;	;	:
cord-005453-4057qib7	1896	21	4	4	CD
cord-005453-4057qib7	1896	22	post	post	VB
cord-005453-4057qib7	1896	23	-	-	NN
cord-005453-4057qib7	1896	24	ET	et	NN
cord-005453-4057qib7	1896	25	and	and	CC
cord-005453-4057qib7	1896	26	2	2	CD
cord-005453-4057qib7	1896	27	post	post	JJ
cord-005453-4057qib7	1896	28	-	-	JJ
cord-005453-4057qib7	1896	29	PV	PV	NNP
cord-005453-4057qib7	1896	30	MF	MF	NNP
cord-005453-4057qib7	1896	31	.	.	.
cord-005453-4057qib7	1897	1	2/12	2/12	CD
cord-005453-4057qib7	1897	2	of	of	IN
cord-005453-4057qib7	1897	3	our	-PRON-	PRP$
cord-005453-4057qib7	1897	4	patient	patient	NN
cord-005453-4057qib7	1897	5	group	group	NN
cord-005453-4057qib7	1897	6	received	receive	VBD
cord-005453-4057qib7	1897	7	a	a	DT
cord-005453-4057qib7	1897	8	sibling	sibling	NN
cord-005453-4057qib7	1897	9	allograft	allograft	NN
cord-005453-4057qib7	1897	10	and	and	CC
cord-005453-4057qib7	1897	11	10/12	10/12	CD
cord-005453-4057qib7	1897	12	a	a	DT
cord-005453-4057qib7	1897	13	matched	match	VBN
cord-005453-4057qib7	1897	14	unrelated	unrelated	JJ
cord-005453-4057qib7	1897	15	donor	donor	NN
cord-005453-4057qib7	1897	16	allograft	allograft	NN
cord-005453-4057qib7	1897	17	(	(	-LRB-
cord-005453-4057qib7	1897	18	70	70	CD
cord-005453-4057qib7	1897	19	%	%	NN
cord-005453-4057qib7	1897	20	received	receive	VBD
cord-005453-4057qib7	1897	21	a	a	DT
cord-005453-4057qib7	1897	22	10/10	10/10	CD
cord-005453-4057qib7	1897	23	Human	Human	NNP
cord-005453-4057qib7	1897	24	Leukocyte	Leukocyte	NNP
cord-005453-4057qib7	1897	25	Antigen	Antigen	NNP
cord-005453-4057qib7	1897	26	(	(	-LRB-
cord-005453-4057qib7	1897	27	HLA)-matched	hla)-matched	CD
cord-005453-4057qib7	1897	28	transplant	transplant	NN
cord-005453-4057qib7	1897	29	,	,	,
cord-005453-4057qib7	1897	30	20	20	CD
cord-005453-4057qib7	1897	31	%	%	NN
cord-005453-4057qib7	1897	32	a	a	DT
cord-005453-4057qib7	1897	33	9/10	9/10	CD
cord-005453-4057qib7	1897	34	HLAmatched	hlamatched	NN
cord-005453-4057qib7	1897	35	and	and	CC
cord-005453-4057qib7	1897	36	10	10	CD
cord-005453-4057qib7	1897	37	%	%	NN
cord-005453-4057qib7	1897	38	a	a	DT
cord-005453-4057qib7	1897	39	8/10	8/10	CD
cord-005453-4057qib7	1897	40	HLA	HLA	NNP
cord-005453-4057qib7	1897	41	-	-	HYPH
cord-005453-4057qib7	1897	42	matched	match	VBN
cord-005453-4057qib7	1897	43	graft	graft	NN
cord-005453-4057qib7	1897	44	)	)	-RRB-
cord-005453-4057qib7	1897	45	.	.	.
cord-005453-4057qib7	1898	1	All	all	DT
cord-005453-4057qib7	1898	2	patients	patient	NNS
cord-005453-4057qib7	1898	3	received	receive	VBD
cord-005453-4057qib7	1898	4	a	a	DT
cord-005453-4057qib7	1898	5	reduced	reduce	VBN
cord-005453-4057qib7	1898	6	intensity	intensity	NN
cord-005453-4057qib7	1898	7	conditioning	conditioning	NN
cord-005453-4057qib7	1898	8	(	(	-LRB-
cord-005453-4057qib7	1898	9	RIC	RIC	NNP
cord-005453-4057qib7	1898	10	)	)	-RRB-
cord-005453-4057qib7	1898	11	;	;	:
cord-005453-4057qib7	1898	12	3/12	3/12	CD
cord-005453-4057qib7	1898	13	patients	patient	NNS
cord-005453-4057qib7	1898	14	with	with	IN
cord-005453-4057qib7	1898	15	Fludarabine/	fludarabine/	CD
cord-005453-4057qib7	1898	16	Melphalan/	Melphalan/	NNP
cord-005453-4057qib7	1898	17	Campath	Campath	NNP
cord-005453-4057qib7	1898	18	(	(	-LRB-
cord-005453-4057qib7	1898	19	FMC	FMC	NNP
cord-005453-4057qib7	1898	20	)	)	-RRB-
cord-005453-4057qib7	1898	21	,	,	,
cord-005453-4057qib7	1898	22	8/	8/	CD
cord-005453-4057qib7	1898	23	12	12	CD
cord-005453-4057qib7	1898	24	Fludarabine/	fludarabine/	CD
cord-005453-4057qib7	1899	1	Busulphan/	busulphan/	IN
cord-005453-4057qib7	1899	2	ATG	ATG	NNP
cord-005453-4057qib7	1899	3	(	(	-LRB-
cord-005453-4057qib7	1899	4	FBATG	FBATG	NNP
cord-005453-4057qib7	1899	5	)	)	-RRB-
cord-005453-4057qib7	1899	6	and	and	CC
cord-005453-4057qib7	1899	7	1	1	CD
cord-005453-4057qib7	1899	8	Fludarabine/	Fludarabine/	NNP
cord-005453-4057qib7	1899	9	Ara	Ara	NNP
cord-005453-4057qib7	1899	10	-	-	HYPH
cord-005453-4057qib7	1899	11	C/	C/	NNP
cord-005453-4057qib7	1899	12	Campath	Campath	NNP
cord-005453-4057qib7	1899	13	(	(	-LRB-
cord-005453-4057qib7	1899	14	FLAG/	FLAG/	NNP
cord-005453-4057qib7	1899	15	Campath	Campath	NNP
cord-005453-4057qib7	1899	16	)	)	-RRB-
cord-005453-4057qib7	1900	1	;	;	:
cord-005453-4057qib7	1900	2	all	all	DT
cord-005453-4057qib7	1900	3	received	receive	VBD
cord-005453-4057qib7	1900	4	peripheral	peripheral	JJ
cord-005453-4057qib7	1900	5	blood	blood	NN
cord-005453-4057qib7	1900	6	as	as	IN
cord-005453-4057qib7	1900	7	source	source	NN
cord-005453-4057qib7	1900	8	of	of	IN
cord-005453-4057qib7	1900	9	HSC	HSC	NNP
cord-005453-4057qib7	1900	10	.	.	.
cord-005453-4057qib7	1901	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	1901	2	occurred	occur	VBD
cord-005453-4057qib7	1901	3	between	between	IN
cord-005453-4057qib7	1901	4	day	day	NN
cord-005453-4057qib7	1901	5	13	13	CD
cord-005453-4057qib7	1901	6	-	-	SYM
cord-005453-4057qib7	1901	7	48	48	CD
cord-005453-4057qib7	1901	8	,	,	,
cord-005453-4057qib7	1901	9	with	with	IN
cord-005453-4057qib7	1901	10	a	a	DT
cord-005453-4057qib7	1901	11	median	median	NN
cord-005453-4057qib7	1901	12	of	of	IN
cord-005453-4057qib7	1901	13	D+17	D+17	NNP
cord-005453-4057qib7	1901	14	.	.	.
cord-005453-4057qib7	1902	1	One	one	CD
cord-005453-4057qib7	1902	2	late	late	JJ
cord-005453-4057qib7	1902	3	graft	graft	NN
cord-005453-4057qib7	1902	4	rejection	rejection	NN
cord-005453-4057qib7	1902	5	occurred	occur	VBD
cord-005453-4057qib7	1902	6	.	.	.
cord-005453-4057qib7	1903	1	All	all	DT
cord-005453-4057qib7	1903	2	patients	patient	NNS
cord-005453-4057qib7	1903	3	were	be	VBD
cord-005453-4057qib7	1903	4	alive	alive	JJ
cord-005453-4057qib7	1903	5	at	at	IN
cord-005453-4057qib7	1903	6	D+100	D+100	NNS
cord-005453-4057qib7	1903	7	.	.	.
cord-005453-4057qib7	1904	1	9	9	CD
cord-005453-4057qib7	1904	2	patients	patient	NNS
cord-005453-4057qib7	1904	3	are	be	VBP
cord-005453-4057qib7	1904	4	currently	currently	RB
cord-005453-4057qib7	1904	5	alive	alive	JJ
cord-005453-4057qib7	1904	6	;	;	:
cord-005453-4057qib7	1904	7	Overall	overall	JJ
cord-005453-4057qib7	1904	8	survival	survival	NN
cord-005453-4057qib7	1904	9	(	(	-LRB-
cord-005453-4057qib7	1904	10	OS	OS	NNP
cord-005453-4057qib7	1904	11	)	)	-RRB-
cord-005453-4057qib7	1904	12	is	be	VBZ
cord-005453-4057qib7	1904	13	75	75	CD
cord-005453-4057qib7	1904	14	%	%	NN
cord-005453-4057qib7	1904	15	.	.	.
cord-005453-4057qib7	1905	1	Transplant	transplant	NN
cord-005453-4057qib7	1905	2	related	relate	VBN
cord-005453-4057qib7	1905	3	mortality	mortality	NN
cord-005453-4057qib7	1905	4	(	(	-LRB-
cord-005453-4057qib7	1905	5	TRM	TRM	NNP
cord-005453-4057qib7	1905	6	)	)	-RRB-
cord-005453-4057qib7	1905	7	was	be	VBD
cord-005453-4057qib7	1905	8	16.6	16.6	CD
cord-005453-4057qib7	1905	9	%	%	NN
cord-005453-4057qib7	1905	10	at	at	IN
cord-005453-4057qib7	1905	11	1	1	CD
cord-005453-4057qib7	1905	12	year	year	NN
cord-005453-4057qib7	1905	13	,	,	,
cord-005453-4057qib7	1905	14	25	25	CD
cord-005453-4057qib7	1905	15	%	%	NN
cord-005453-4057qib7	1905	16	at	at	IN
cord-005453-4057qib7	1905	17	3	3	CD
cord-005453-4057qib7	1905	18	years	year	NNS
cord-005453-4057qib7	1905	19	.	.	.
cord-005453-4057qib7	1906	1	1	1	CD
cord-005453-4057qib7	1906	2	patient	patient	NN
cord-005453-4057qib7	1906	3	died	die	VBD
cord-005453-4057qib7	1906	4	of	of	IN
cord-005453-4057qib7	1906	5	graft	graft	NN
cord-005453-4057qib7	1906	6	versus	versus	IN
cord-005453-4057qib7	1906	7	host	host	NN
cord-005453-4057qib7	1906	8	disease	disease	NN
cord-005453-4057qib7	1906	9	(	(	-LRB-
cord-005453-4057qib7	1906	10	GvHD	GvHD	NNP
cord-005453-4057qib7	1906	11	)	)	-RRB-
cord-005453-4057qib7	1906	12	and	and	CC
cord-005453-4057qib7	1906	13	2	2	CD
cord-005453-4057qib7	1906	14	patients	patient	NNS
cord-005453-4057qib7	1906	15	of	of	IN
cord-005453-4057qib7	1906	16	septicaemia	septicaemia	NN
cord-005453-4057qib7	1906	17	leading	lead	VBG
cord-005453-4057qib7	1906	18	to	to	IN
cord-005453-4057qib7	1906	19	multiorgan	multiorgan	NNP
cord-005453-4057qib7	1906	20	failure	failure	NN
cord-005453-4057qib7	1906	21	.	.	.
cord-005453-4057qib7	1907	1	Acute	acute	JJ
cord-005453-4057qib7	1907	2	GvHD	GvHD	NNP
cord-005453-4057qib7	1907	3	grade	grade	NN
cord-005453-4057qib7	1907	4	II	ii	CD
cord-005453-4057qib7	1907	5	skin	skin	NN
cord-005453-4057qib7	1907	6	occurred	occur	VBD
cord-005453-4057qib7	1907	7	in	in	IN
cord-005453-4057qib7	1907	8	5	5	CD
cord-005453-4057qib7	1907	9	patients	patient	NNS
cord-005453-4057qib7	1907	10	,	,	,
cord-005453-4057qib7	1907	11	grade	grade	NN
cord-005453-4057qib7	1907	12	III	III	NNP
cord-005453-4057qib7	1907	13	and	and	CC
cord-005453-4057qib7	1907	14	above	above	RB
cord-005453-4057qib7	1907	15	in	in	IN
cord-005453-4057qib7	1907	16	2	2	CD
cord-005453-4057qib7	1907	17	patients	patient	NNS
cord-005453-4057qib7	1907	18	.	.	.
cord-005453-4057qib7	1908	1	5	5	CD
cord-005453-4057qib7	1908	2	patients	patient	NNS
cord-005453-4057qib7	1908	3	have	have	VBP
cord-005453-4057qib7	1908	4	limited	limit	VBN
cord-005453-4057qib7	1908	5	chronic	chronic	JJ
cord-005453-4057qib7	1908	6	GvHD	GvHD	NNP
cord-005453-4057qib7	1908	7	.	.	.
cord-005453-4057qib7	1909	1	2/12	2/12	CD
cord-005453-4057qib7	1909	2	patients	patient	NNS
cord-005453-4057qib7	1909	3	received	receive	VBD
cord-005453-4057qib7	1909	4	Donor	Donor	NNP
cord-005453-4057qib7	1909	5	Lymphocyte	Lymphocyte	NNP
cord-005453-4057qib7	1909	6	Infusion	Infusion	NNP
cord-005453-4057qib7	1909	7	(	(	-LRB-
cord-005453-4057qib7	1909	8	DLI	DLI	NNP
cord-005453-4057qib7	1909	9	)	)	-RRB-
cord-005453-4057qib7	1909	10	for	for	IN
cord-005453-4057qib7	1909	11	mixed	mixed	JJ
cord-005453-4057qib7	1909	12	chimerism	chimerism	NN
cord-005453-4057qib7	1909	13	(	(	-LRB-
cord-005453-4057qib7	1909	14	one	one	CD
cord-005453-4057qib7	1909	15	of	of	IN
cord-005453-4057qib7	1909	16	which	which	WDT
cord-005453-4057qib7	1909	17	had	have	VBD
cord-005453-4057qib7	1909	18	2nd	2nd	JJ
cord-005453-4057qib7	1909	19	graft	graft	NN
cord-005453-4057qib7	1909	20	failure	failure	NN
cord-005453-4057qib7	1909	21	)	)	-RRB-
cord-005453-4057qib7	1909	22	.	.	.
cord-005453-4057qib7	1910	1	Out	out	IN
cord-005453-4057qib7	1910	2	of	of	IN
cord-005453-4057qib7	1910	3	these	these	DT
cord-005453-4057qib7	1910	4	2	2	CD
cord-005453-4057qib7	1910	5	patients	patient	NNS
cord-005453-4057qib7	1910	6	1	1	CD
cord-005453-4057qib7	1910	7	developed	develop	VBD
cord-005453-4057qib7	1910	8	acute	acute	JJ
cord-005453-4057qib7	1910	9	grade	grade	NN
cord-005453-4057qib7	1910	10	4	4	CD
cord-005453-4057qib7	1910	11	GvHD	gvhd	NN
cord-005453-4057qib7	1910	12	and	and	CC
cord-005453-4057qib7	1910	13	died	die	VBD
cord-005453-4057qib7	1910	14	.	.	.
cord-005453-4057qib7	1911	1	Response	response	NN
cord-005453-4057qib7	1911	2	rate	rate	NN
cord-005453-4057qib7	1911	3	:	:	:
cord-005453-4057qib7	1911	4	6/9	6/9	CD
cord-005453-4057qib7	1911	5	alive	alive	JJ
cord-005453-4057qib7	1911	6	patients	patient	NNS
cord-005453-4057qib7	1911	7	i.e	i.e	NNP
cord-005453-4057qib7	1911	8	66.6	66.6	CD
cord-005453-4057qib7	1911	9	%	%	NN
cord-005453-4057qib7	1911	10	exhibit	exhibit	NN
cord-005453-4057qib7	1911	11	no	no	DT
cord-005453-4057qib7	1911	12	fibrosis	fibrosis	NN
cord-005453-4057qib7	1911	13	in	in	IN
cord-005453-4057qib7	1911	14	trephine	trephine	JJ
cord-005453-4057qib7	1911	15	biopsies	biopsy	NNS
cord-005453-4057qib7	1911	16	,	,	.
cord-005453-4057qib7	1912	1	1/9	1/9	CD
cord-005453-4057qib7	1912	2	alive	alive	JJ
cord-005453-4057qib7	1912	3	patients	patient	NNS
cord-005453-4057qib7	1912	4	had	have	VBD
cord-005453-4057qib7	1912	5	residual	residual	JJ
cord-005453-4057qib7	1912	6	fibrosis	fibrosis	NN
cord-005453-4057qib7	1912	7	but	but	CC
cord-005453-4057qib7	1912	8	100	100	CD
cord-005453-4057qib7	1912	9	%	%	NN
cord-005453-4057qib7	1912	10	donor	donor	NN
cord-005453-4057qib7	1912	11	chimerism	chimerism	NN
cord-005453-4057qib7	1912	12	,	,	,
cord-005453-4057qib7	1912	13	1/9	1/9	CD
cord-005453-4057qib7	1912	14	alive	alive	JJ
cord-005453-4057qib7	1912	15	patients	patient	NNS
cord-005453-4057qib7	1912	16	had	have	VBD
cord-005453-4057qib7	1912	17	residual	residual	JJ
cord-005453-4057qib7	1912	18	fibrosis	fibrosis	NN
cord-005453-4057qib7	1912	19	with	with	IN
cord-005453-4057qib7	1912	20	mixed	mixed	JJ
cord-005453-4057qib7	1912	21	donor	donor	NN
cord-005453-4057qib7	1912	22	chimerism	chimerism	NN
cord-005453-4057qib7	1912	23	,	,	,
cord-005453-4057qib7	1912	24	other	other	JJ
cord-005453-4057qib7	1912	25	patient	patient	NN
cord-005453-4057qib7	1912	26	non	non	JJ
cord-005453-4057qib7	1912	27	-	-	JJ
cord-005453-4057qib7	1912	28	assessable	assessable	JJ
cord-005453-4057qib7	1912	29	.	.	.
cord-005453-4057qib7	1913	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1913	2	:	:	:
cord-005453-4057qib7	1914	1	Allo	Allo	NNP
cord-005453-4057qib7	1914	2	-	-	HYPH
cord-005453-4057qib7	1914	3	HSCT	HSCT	NNP
cord-005453-4057qib7	1914	4	remains	remain	VBZ
cord-005453-4057qib7	1914	5	the	the	DT
cord-005453-4057qib7	1914	6	only	only	JJ
cord-005453-4057qib7	1914	7	potentially	potentially	RB
cord-005453-4057qib7	1914	8	curable	curable	JJ
cord-005453-4057qib7	1914	9	option	option	NN
cord-005453-4057qib7	1914	10	for	for	IN
cord-005453-4057qib7	1914	11	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	1914	12	.	.	.
cord-005453-4057qib7	1915	1	In	in	IN
cord-005453-4057qib7	1915	2	our	-PRON-	PRP$
cord-005453-4057qib7	1915	3	centre	centre	NN
cord-005453-4057qib7	1915	4	which	which	WDT
cord-005453-4057qib7	1915	5	serves	serve	VBZ
cord-005453-4057qib7	1915	6	1.1	1.1	CD
cord-005453-4057qib7	1915	7	million	million	CD
cord-005453-4057qib7	1915	8	population	population	NN
cord-005453-4057qib7	1915	9	,	,	,
cord-005453-4057qib7	1915	10	with	with	IN
cord-005453-4057qib7	1915	11	12	12	CD
cord-005453-4057qib7	1915	12	new	new	JJ
cord-005453-4057qib7	1915	13	cases	case	NNS
cord-005453-4057qib7	1915	14	per	per	IN
cord-005453-4057qib7	1915	15	year	year	NN
cord-005453-4057qib7	1915	16	,	,	,
cord-005453-4057qib7	1915	17	12	12	CD
cord-005453-4057qib7	1915	18	patients	patient	NNS
cord-005453-4057qib7	1915	19	were	be	VBD
cord-005453-4057qib7	1915	20	transplanted	transplant	VBN
cord-005453-4057qib7	1915	21	since	since	IN
cord-005453-4057qib7	1915	22	2010	2010	CD
cord-005453-4057qib7	1915	23	.	.	.
cord-005453-4057qib7	1916	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1916	2	data	datum	NNS
cord-005453-4057qib7	1916	3	suggest	suggest	VBP
cord-005453-4057qib7	1916	4	that	that	IN
cord-005453-4057qib7	1916	5	close	close	JJ
cord-005453-4057qib7	1916	6	collaboration	collaboration	NN
cord-005453-4057qib7	1916	7	between	between	IN
cord-005453-4057qib7	1916	8	MPN	MPN	NNP
cord-005453-4057qib7	1916	9	-	-	HYPH
cord-005453-4057qib7	1916	10	treating	treat	VBG
cord-005453-4057qib7	1916	11	haematologists	haematologist	NNS
cord-005453-4057qib7	1916	12	and	and	CC
cord-005453-4057qib7	1916	13	transplant	transplant	NN
cord-005453-4057qib7	1916	14	physicians	physician	NNS
cord-005453-4057qib7	1916	15	is	be	VBZ
cord-005453-4057qib7	1916	16	required	require	VBN
cord-005453-4057qib7	1916	17	so	so	IN
cord-005453-4057qib7	1916	18	that	that	IN
cord-005453-4057qib7	1916	19	all	all	DT
cord-005453-4057qib7	1916	20	suitable	suitable	JJ
cord-005453-4057qib7	1916	21	patients	patient	NNS
cord-005453-4057qib7	1916	22	have	have	VBP
cord-005453-4057qib7	1916	23	a	a	DT
cord-005453-4057qib7	1916	24	transplant	transplant	NN
cord-005453-4057qib7	1916	25	assessment	assessment	NN
cord-005453-4057qib7	1916	26	early	early	RB
cord-005453-4057qib7	1916	27	in	in	IN
cord-005453-4057qib7	1916	28	their	-PRON-	PRP$
cord-005453-4057qib7	1916	29	disease	disease	NN
cord-005453-4057qib7	1916	30	course	course	NN
cord-005453-4057qib7	1916	31	.	.	.
cord-005453-4057qib7	1917	1	Novel	novel	JJ
cord-005453-4057qib7	1917	2	molecular	molecular	JJ
cord-005453-4057qib7	1917	3	prognostic	prognostic	JJ
cord-005453-4057qib7	1917	4	systems	system	NNS
cord-005453-4057qib7	1917	5	are	be	VBP
cord-005453-4057qib7	1917	6	likely	likely	JJ
cord-005453-4057qib7	1917	7	to	to	TO
cord-005453-4057qib7	1917	8	identify	identify	VB
cord-005453-4057qib7	1917	9	those	those	DT
cord-005453-4057qib7	1917	10	best	well	RBS
cord-005453-4057qib7	1917	11	placed	place	VBN
cord-005453-4057qib7	1917	12	to	to	TO
cord-005453-4057qib7	1917	13	benefit	benefit	VB
cord-005453-4057qib7	1917	14	in	in	IN
cord-005453-4057qib7	1917	15	future	future	NN
cord-005453-4057qib7	1917	16	but	but	CC
cord-005453-4057qib7	1917	17	this	this	DT
cord-005453-4057qib7	1917	18	series	series	NN
cord-005453-4057qib7	1917	19	currently	currently	RB
cord-005453-4057qib7	1917	20	supports	support	VBZ
cord-005453-4057qib7	1917	21	allo	allo	NN
cord-005453-4057qib7	1917	22	-	-	HYPH
cord-005453-4057qib7	1917	23	HSCT	HSCT	NNP
cord-005453-4057qib7	1917	24	survival	survival	NN
cord-005453-4057qib7	1917	25	and	and	CC
cord-005453-4057qib7	1917	26	cure	cure	NN
cord-005453-4057qib7	1917	27	.	.	.
cord-005453-4057qib7	1918	1	(	(	-LRB-
cord-005453-4057qib7	1918	2	range	range	NN
cord-005453-4057qib7	1918	3	,	,	,
cord-005453-4057qib7	1918	4	105	105	CD
cord-005453-4057qib7	1918	5	-	-	SYM
cord-005453-4057qib7	1918	6	4624	4624	CD
cord-005453-4057qib7	1918	7	)	)	-RRB-
cord-005453-4057qib7	1918	8	.	.	.
cord-005453-4057qib7	1919	1	Dynamic	dynamic	JJ
cord-005453-4057qib7	1919	2	international	international	JJ
cord-005453-4057qib7	1919	3	prognostic	prognostic	JJ
cord-005453-4057qib7	1919	4	scoring	scoring	NN
cord-005453-4057qib7	1919	5	system	system	NN
cord-005453-4057qib7	1919	6	(	(	-LRB-
cord-005453-4057qib7	1919	7	DIPSS	DIPSS	NNP
cord-005453-4057qib7	1919	8	)	)	-RRB-
cord-005453-4057qib7	1919	9	score	score	NN
cord-005453-4057qib7	1919	10	at	at	IN
cord-005453-4057qib7	1919	11	the	the	DT
cord-005453-4057qib7	1919	12	time	time	NN
cord-005453-4057qib7	1919	13	of	of	IN
cord-005453-4057qib7	1919	14	HCT	HCT	NNP
cord-005453-4057qib7	1919	15	was	be	VBD
cord-005453-4057qib7	1919	16	intermediate-2	intermediate-2	NNP
cord-005453-4057qib7	1919	17	or	or	CC
cord-005453-4057qib7	1919	18	high	high	JJ
cord-005453-4057qib7	1919	19	risk	risk	NN
cord-005453-4057qib7	1919	20	in	in	IN
cord-005453-4057qib7	1919	21	20	20	CD
cord-005453-4057qib7	1919	22	patients	patient	NNS
cord-005453-4057qib7	1919	23	(	(	-LRB-
cord-005453-4057qib7	1919	24	95	95	CD
cord-005453-4057qib7	1919	25	%	%	NN
cord-005453-4057qib7	1919	26	)	)	-RRB-
cord-005453-4057qib7	1919	27	,	,	,
cord-005453-4057qib7	1919	28	intermedate-1	intermedate-1	NNP
cord-005453-4057qib7	1919	29	in	in	IN
cord-005453-4057qib7	1919	30	1	1	CD
cord-005453-4057qib7	1919	31	patient	patient	NN
cord-005453-4057qib7	1919	32	.	.	.
cord-005453-4057qib7	1920	1	Molecular	molecular	JJ
cord-005453-4057qib7	1920	2	evaluation	evaluation	NN
cord-005453-4057qib7	1920	3	was	be	VBD
cord-005453-4057qib7	1920	4	available	available	JJ
cord-005453-4057qib7	1920	5	in	in	IN
cord-005453-4057qib7	1920	6	14	14	CD
cord-005453-4057qib7	1920	7	out	out	IN
cord-005453-4057qib7	1920	8	of	of	IN
cord-005453-4057qib7	1920	9	21	21	CD
cord-005453-4057qib7	1920	10	:	:	:
cord-005453-4057qib7	1921	1	JAK2	JAK2	NNP
cord-005453-4057qib7	1921	2	V617F	v617f	NN
cord-005453-4057qib7	1921	3	mutation	mutation	NN
cord-005453-4057qib7	1921	4	was	be	VBD
cord-005453-4057qib7	1921	5	detectable	detectable	JJ
cord-005453-4057qib7	1921	6	in	in	IN
cord-005453-4057qib7	1921	7	8	8	CD
cord-005453-4057qib7	1921	8	patients	patient	NNS
cord-005453-4057qib7	1921	9	,	,	,
cord-005453-4057qib7	1921	10	MPL	MPL	NNP
cord-005453-4057qib7	1921	11	-	-	:
cord-005453-4057qib7	1921	12	W515	W515	NNPS
cord-005453-4057qib7	1921	13	K	K	NNP
cord-005453-4057qib7	1921	14	in	in	IN
cord-005453-4057qib7	1921	15	1	1	CD
cord-005453-4057qib7	1921	16	patient	patient	NN
cord-005453-4057qib7	1921	17	,	,	,
cord-005453-4057qib7	1921	18	CARL	CARL	NNP
cord-005453-4057qib7	1921	19	in	in	IN
cord-005453-4057qib7	1921	20	1	1	CD
cord-005453-4057qib7	1921	21	patient	patient	NN
cord-005453-4057qib7	1921	22	.	.	.
cord-005453-4057qib7	1922	1	4	4	CD
cord-005453-4057qib7	1922	2	patients	patient	NNS
cord-005453-4057qib7	1922	3	were	be	VBD
cord-005453-4057qib7	1922	4	"	"	``
cord-005453-4057qib7	1922	5	triple	triple	JJ
cord-005453-4057qib7	1922	6	negative	negative	JJ
cord-005453-4057qib7	1922	7	"	"	''
cord-005453-4057qib7	1922	8	for	for	IN
cord-005453-4057qib7	1922	9	driver	driver	NN
cord-005453-4057qib7	1922	10	mutations	mutation	NNS
cord-005453-4057qib7	1922	11	.	.	.
cord-005453-4057qib7	1923	1	Cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	1923	2	information	information	NN
cord-005453-4057qib7	1923	3	was	be	VBD
cord-005453-4057qib7	1923	4	available	available	JJ
cord-005453-4057qib7	1923	5	for	for	IN
cord-005453-4057qib7	1923	6	6	6	CD
cord-005453-4057qib7	1923	7	out	out	IN
cord-005453-4057qib7	1923	8	of	of	IN
cord-005453-4057qib7	1923	9	21	21	CD
cord-005453-4057qib7	1923	10	;	;	:
cord-005453-4057qib7	1923	11	among	among	IN
cord-005453-4057qib7	1923	12	which	which	WDT
cord-005453-4057qib7	1923	13	3	3	CD
cord-005453-4057qib7	1923	14	patients	patient	NNS
cord-005453-4057qib7	1923	15	had	have	VBD
cord-005453-4057qib7	1923	16	complex	complex	JJ
cord-005453-4057qib7	1923	17	karyotype	karyotype	NN
cord-005453-4057qib7	1923	18	,	,	,
cord-005453-4057qib7	1923	19	1	1	CD
cord-005453-4057qib7	1923	20	trisomy	trisomy	NN
cord-005453-4057qib7	1923	21	8	8	CD
cord-005453-4057qib7	1923	22	and	and	CC
cord-005453-4057qib7	1923	23	1	1	CD
cord-005453-4057qib7	1923	24	trisomy	trisomy	NN
cord-005453-4057qib7	1923	25	9	9	CD
cord-005453-4057qib7	1923	26	.	.	.
cord-005453-4057qib7	1924	1	3	3	CD
cord-005453-4057qib7	1924	2	patients	patient	NNS
cord-005453-4057qib7	1924	3	underwent	undergo	VBD
cord-005453-4057qib7	1924	4	splenectomy	splenectomy	NN
cord-005453-4057qib7	1924	5	before	before	IN
cord-005453-4057qib7	1924	6	HCT	HCT	NNP
cord-005453-4057qib7	1924	7	.	.	.
cord-005453-4057qib7	1925	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	1925	2	was	be	VBD
cord-005453-4057qib7	1925	3	administered	administer	VBN
cord-005453-4057qib7	1925	4	in	in	IN
cord-005453-4057qib7	1925	5	4	4	CD
cord-005453-4057qib7	1925	6	patients	patient	NNS
cord-005453-4057qib7	1925	7	before	before	IN
cord-005453-4057qib7	1925	8	HCT	HCT	NNP
cord-005453-4057qib7	1925	9	.	.	.
cord-005453-4057qib7	1926	1	10	10	CD
cord-005453-4057qib7	1926	2	(	(	-LRB-
cord-005453-4057qib7	1926	3	48	48	CD
cord-005453-4057qib7	1926	4	%	%	NN
cord-005453-4057qib7	1926	5	)	)	-RRB-
cord-005453-4057qib7	1926	6	patients	patient	NNS
cord-005453-4057qib7	1926	7	received	receive	VBD
cord-005453-4057qib7	1926	8	stem	stem	NN
cord-005453-4057qib7	1926	9	cells	cell	NNS
cord-005453-4057qib7	1926	10	from	from	IN
cord-005453-4057qib7	1926	11	an	an	DT
cord-005453-4057qib7	1926	12	HLA	HLA	NNP
cord-005453-4057qib7	1926	13	identical	identical	JJ
cord-005453-4057qib7	1926	14	sibling	sibling	NN
cord-005453-4057qib7	1926	15	,	,	,
cord-005453-4057qib7	1926	16	9	9	CD
cord-005453-4057qib7	1926	17	(	(	-LRB-
cord-005453-4057qib7	1926	18	42	42	CD
cord-005453-4057qib7	1926	19	%	%	NN
cord-005453-4057qib7	1926	20	)	)	-RRB-
cord-005453-4057qib7	1926	21	from	from	IN
cord-005453-4057qib7	1926	22	a	a	DT
cord-005453-4057qib7	1926	23	matched	match	VBN
cord-005453-4057qib7	1926	24	unrelated	unrelated	JJ
cord-005453-4057qib7	1926	25	donor	donor	NN
cord-005453-4057qib7	1926	26	and	and	CC
cord-005453-4057qib7	1926	27	2	2	CD
cord-005453-4057qib7	1926	28	(	(	-LRB-
cord-005453-4057qib7	1926	29	10	10	CD
cord-005453-4057qib7	1926	30	%	%	NN
cord-005453-4057qib7	1926	31	)	)	-RRB-
cord-005453-4057qib7	1926	32	from	from	IN
cord-005453-4057qib7	1926	33	an	an	DT
cord-005453-4057qib7	1926	34	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1926	35	sibling	sibling	NN
cord-005453-4057qib7	1926	36	.	.	.
cord-005453-4057qib7	1927	1	Graft	graft	NN
cord-005453-4057qib7	1927	2	source	source	NN
cord-005453-4057qib7	1927	3	was	be	VBD
cord-005453-4057qib7	1927	4	bone	bone	NN
cord-005453-4057qib7	1927	5	marrow	marrow	NN
cord-005453-4057qib7	1927	6	in	in	IN
cord-005453-4057qib7	1927	7	7	7	CD
cord-005453-4057qib7	1927	8	patients	patient	NNS
cord-005453-4057qib7	1927	9	(	(	-LRB-
cord-005453-4057qib7	1927	10	34	34	CD
cord-005453-4057qib7	1927	11	%	%	NN
cord-005453-4057qib7	1927	12	)	)	-RRB-
cord-005453-4057qib7	1927	13	and	and	CC
cord-005453-4057qib7	1927	14	peripheral	peripheral	JJ
cord-005453-4057qib7	1927	15	blood	blood	NN
cord-005453-4057qib7	1927	16	in	in	IN
cord-005453-4057qib7	1927	17	14	14	CD
cord-005453-4057qib7	1927	18	(	(	-LRB-
cord-005453-4057qib7	1927	19	66	66	CD
cord-005453-4057qib7	1927	20	%	%	NN
cord-005453-4057qib7	1927	21	)	)	-RRB-
cord-005453-4057qib7	1927	22	.	.	.
cord-005453-4057qib7	1928	1	Conditioning	conditioning	NN
cord-005453-4057qib7	1928	2	was	be	VBD
cord-005453-4057qib7	1928	3	myeloablative	myeloablative	JJ
cord-005453-4057qib7	1928	4	in	in	IN
cord-005453-4057qib7	1928	5	16	16	CD
cord-005453-4057qib7	1928	6	patients	patient	NNS
cord-005453-4057qib7	1928	7	(	(	-LRB-
cord-005453-4057qib7	1928	8	76	76	CD
cord-005453-4057qib7	1928	9	%	%	NN
cord-005453-4057qib7	1928	10	)	)	-RRB-
cord-005453-4057qib7	1928	11	,	,	,
cord-005453-4057qib7	1928	12	reduced	reduce	VBN
cord-005453-4057qib7	1928	13	intensity	intensity	NN
cord-005453-4057qib7	1928	14	in	in	IN
cord-005453-4057qib7	1928	15	5	5	CD
cord-005453-4057qib7	1928	16	(	(	-LRB-
cord-005453-4057qib7	1928	17	24	24	CD
cord-005453-4057qib7	1928	18	%	%	NN
cord-005453-4057qib7	1928	19	)	)	-RRB-
cord-005453-4057qib7	1928	20	.	.	.
cord-005453-4057qib7	1929	1	All	all	DT
cord-005453-4057qib7	1929	2	patients	patient	NNS
cord-005453-4057qib7	1929	3	engrafted	engraft	VBD
cord-005453-4057qib7	1929	4	.	.	.
cord-005453-4057qib7	1930	1	Acute	acute	JJ
cord-005453-4057qib7	1930	2	graft	graft	NN
cord-005453-4057qib7	1930	3	versus	versus	IN
cord-005453-4057qib7	1930	4	host	host	NN
cord-005453-4057qib7	1930	5	disease	disease	NN
cord-005453-4057qib7	1930	6	was	be	VBD
cord-005453-4057qib7	1930	7	absent	absent	JJ
cord-005453-4057qib7	1930	8	in	in	IN
cord-005453-4057qib7	1930	9	12	12	CD
cord-005453-4057qib7	1930	10	patients	patient	NNS
cord-005453-4057qib7	1930	11	(	(	-LRB-
cord-005453-4057qib7	1930	12	57	57	CD
cord-005453-4057qib7	1930	13	%	%	NN
cord-005453-4057qib7	1930	14	)	)	-RRB-
cord-005453-4057qib7	1930	15	,	,	,
cord-005453-4057qib7	1930	16	grade	grade	NN
cord-005453-4057qib7	1930	17	I	I	NNP
cord-005453-4057qib7	1930	18	-	-	HYPH
cord-005453-4057qib7	1930	19	II	II	NNP
cord-005453-4057qib7	1930	20	in	in	IN
cord-005453-4057qib7	1930	21	7	7	CD
cord-005453-4057qib7	1930	22	(	(	-LRB-
cord-005453-4057qib7	1930	23	34	34	CD
cord-005453-4057qib7	1930	24	%	%	NN
cord-005453-4057qib7	1930	25	)	)	-RRB-
cord-005453-4057qib7	1930	26	,	,	,
cord-005453-4057qib7	1930	27	grade	grade	NN
cord-005453-4057qib7	1930	28	III	III	NNP
cord-005453-4057qib7	1930	29	-	-	HYPH
cord-005453-4057qib7	1930	30	IV	IV	NNP
cord-005453-4057qib7	1930	31	in	in	IN
cord-005453-4057qib7	1930	32	2	2	CD
cord-005453-4057qib7	1930	33	(	(	-LRB-
cord-005453-4057qib7	1930	34	9	9	CD
cord-005453-4057qib7	1930	35	%	%	NN
cord-005453-4057qib7	1930	36	)	)	-RRB-
cord-005453-4057qib7	1930	37	.	.	.
cord-005453-4057qib7	1931	1	In	in	IN
cord-005453-4057qib7	1931	2	18	18	CD
cord-005453-4057qib7	1931	3	evaluable	evaluable	JJ
cord-005453-4057qib7	1931	4	patients	patient	NNS
cord-005453-4057qib7	1931	5	chronic	chronic	JJ
cord-005453-4057qib7	1931	6	graft	graft	NN
cord-005453-4057qib7	1931	7	versus	versus	IN
cord-005453-4057qib7	1931	8	host	host	NN
cord-005453-4057qib7	1931	9	disease	disease	NN
cord-005453-4057qib7	1931	10	was	be	VBD
cord-005453-4057qib7	1931	11	limited	limit	VBN
cord-005453-4057qib7	1931	12	in	in	IN
cord-005453-4057qib7	1931	13	3	3	CD
cord-005453-4057qib7	1931	14	(	(	-LRB-
cord-005453-4057qib7	1931	15	17	17	CD
cord-005453-4057qib7	1931	16	%	%	NN
cord-005453-4057qib7	1931	17	)	)	-RRB-
cord-005453-4057qib7	1931	18	,	,	,
cord-005453-4057qib7	1931	19	extensive	extensive	JJ
cord-005453-4057qib7	1931	20	in	in	IN
cord-005453-4057qib7	1931	21	4	4	CD
cord-005453-4057qib7	1931	22	(	(	-LRB-
cord-005453-4057qib7	1931	23	22	22	CD
cord-005453-4057qib7	1931	24	%	%	NN
cord-005453-4057qib7	1931	25	)	)	-RRB-
cord-005453-4057qib7	1931	26	and	and	CC
cord-005453-4057qib7	1931	27	absent	absent	JJ
cord-005453-4057qib7	1931	28	in	in	IN
cord-005453-4057qib7	1931	29	11	11	CD
cord-005453-4057qib7	1931	30	(	(	-LRB-
cord-005453-4057qib7	1931	31	61	61	CD
cord-005453-4057qib7	1931	32	%	%	NN
cord-005453-4057qib7	1931	33	)	)	-RRB-
cord-005453-4057qib7	1931	34	.	.	.
cord-005453-4057qib7	1932	1	Transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	1932	2	mortality	mortality	NN
cord-005453-4057qib7	1932	3	at	at	IN
cord-005453-4057qib7	1932	4	180	180	CD
cord-005453-4057qib7	1932	5	days	day	NNS
cord-005453-4057qib7	1932	6	was	be	VBD
cord-005453-4057qib7	1932	7	24	24	CD
cord-005453-4057qib7	1932	8	%	%	NN
cord-005453-4057qib7	1932	9	.	.	.
cord-005453-4057qib7	1933	1	Main	main	JJ
cord-005453-4057qib7	1933	2	causes	cause	NNS
cord-005453-4057qib7	1933	3	of	of	IN
cord-005453-4057qib7	1933	4	death	death	NN
cord-005453-4057qib7	1933	5	were	be	VBD
cord-005453-4057qib7	1933	6	:	:	:
cord-005453-4057qib7	1933	7	acute	acute	JJ
cord-005453-4057qib7	1933	8	GvHD	gvhd	NN
cord-005453-4057qib7	1933	9	in	in	IN
cord-005453-4057qib7	1933	10	2	2	CD
cord-005453-4057qib7	1933	11	patients	patient	NNS
cord-005453-4057qib7	1933	12	,	,	,
cord-005453-4057qib7	1933	13	chronic	chronic	JJ
cord-005453-4057qib7	1933	14	GvHD	gvhd	NN
cord-005453-4057qib7	1933	15	in	in	IN
cord-005453-4057qib7	1933	16	1	1	CD
cord-005453-4057qib7	1933	17	,	,	,
cord-005453-4057qib7	1933	18	pancreatitis	pancreatitis	NN
cord-005453-4057qib7	1933	19	in	in	IN
cord-005453-4057qib7	1933	20	1	1	CD
cord-005453-4057qib7	1933	21	,	,	,
cord-005453-4057qib7	1933	22	pulmonary	pulmonary	JJ
cord-005453-4057qib7	1933	23	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	1933	24	in	in	IN
cord-005453-4057qib7	1933	25	1	1	CD
cord-005453-4057qib7	1933	26	.	.	.
cord-005453-4057qib7	1934	1	Relapse	relapse	NN
cord-005453-4057qib7	1934	2	occurred	occur	VBD
cord-005453-4057qib7	1934	3	in	in	IN
cord-005453-4057qib7	1934	4	7	7	CD
cord-005453-4057qib7	1934	5	patients	patient	NNS
cord-005453-4057qib7	1934	6	and	and	CC
cord-005453-4057qib7	1934	7	was	be	VBD
cord-005453-4057qib7	1934	8	the	the	DT
cord-005453-4057qib7	1934	9	main	main	JJ
cord-005453-4057qib7	1934	10	cause	cause	NN
cord-005453-4057qib7	1934	11	of	of	IN
cord-005453-4057qib7	1934	12	death	death	NN
cord-005453-4057qib7	1934	13	in	in	IN
cord-005453-4057qib7	1934	14	4	4	CD
cord-005453-4057qib7	1934	15	of	of	IN
cord-005453-4057qib7	1934	16	them	-PRON-	PRP
cord-005453-4057qib7	1934	17	.	.	.
cord-005453-4057qib7	1935	1	Notably	notably	RB
cord-005453-4057qib7	1935	2	,	,	,
cord-005453-4057qib7	1935	3	2	2	CD
cord-005453-4057qib7	1935	4	patients	patient	NNS
cord-005453-4057qib7	1935	5	experienced	experience	VBN
cord-005453-4057qib7	1935	6	late	late	JJ
cord-005453-4057qib7	1935	7	relapse	relapse	NN
cord-005453-4057qib7	1935	8	after	after	IN
cord-005453-4057qib7	1935	9	6.6	6.6	CD
cord-005453-4057qib7	1935	10	and	and	CC
cord-005453-4057qib7	1935	11	17.6	17.6	CD
cord-005453-4057qib7	1935	12	years	year	NNS
cord-005453-4057qib7	1935	13	after	after	IN
cord-005453-4057qib7	1935	14	HCT	HCT	NNP
cord-005453-4057qib7	1935	15	.	.	.
cord-005453-4057qib7	1936	1	Both	both	DT
cord-005453-4057qib7	1936	2	of	of	IN
cord-005453-4057qib7	1936	3	them	-PRON-	PRP
cord-005453-4057qib7	1936	4	are	be	VBP
cord-005453-4057qib7	1936	5	living	live	VBG
cord-005453-4057qib7	1936	6	while	while	IN
cord-005453-4057qib7	1936	7	receiving	receive	VBG
cord-005453-4057qib7	1936	8	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	1936	9	therapy	therapy	NN
cord-005453-4057qib7	1936	10	.	.	.
cord-005453-4057qib7	1937	1	After	after	IN
cord-005453-4057qib7	1937	2	a	a	DT
cord-005453-4057qib7	1937	3	median	median	NN
cord-005453-4057qib7	1937	4	follow	follow	NN
cord-005453-4057qib7	1937	5	up	up	IN
cord-005453-4057qib7	1937	6	of	of	IN
cord-005453-4057qib7	1937	7	581	581	CD
cord-005453-4057qib7	1937	8	days	day	NNS
cord-005453-4057qib7	1937	9	(	(	-LRB-
cord-005453-4057qib7	1937	10	range	range	NN
cord-005453-4057qib7	1937	11	,	,	,
cord-005453-4057qib7	1937	12	38	38	CD
cord-005453-4057qib7	1937	13	-	-	HYPH
cord-005453-4057qib7	1937	14	11660	11660	CD
cord-005453-4057qib7	1937	15	)	)	-RRB-
cord-005453-4057qib7	1937	16	,	,	,
cord-005453-4057qib7	1937	17	10	10	CD
cord-005453-4057qib7	1937	18	out	out	IN
cord-005453-4057qib7	1937	19	of	of	IN
cord-005453-4057qib7	1937	20	21	21	CD
cord-005453-4057qib7	1937	21	patients	patient	NNS
cord-005453-4057qib7	1937	22	are	be	VBP
cord-005453-4057qib7	1937	23	alive	alive	JJ
cord-005453-4057qib7	1937	24	.	.	.
cord-005453-4057qib7	1938	1	7	7	CD
cord-005453-4057qib7	1938	2	of	of	IN
cord-005453-4057qib7	1938	3	them	-PRON-	PRP
cord-005453-4057qib7	1938	4	(	(	-LRB-
cord-005453-4057qib7	1938	5	33	33	CD
cord-005453-4057qib7	1938	6	%	%	NN
cord-005453-4057qib7	1938	7	)	)	-RRB-
cord-005453-4057qib7	1938	8	are	be	VBP
cord-005453-4057qib7	1938	9	disease	disease	NN
cord-005453-4057qib7	1938	10	-	-	HYPH
cord-005453-4057qib7	1938	11	free	free	JJ
cord-005453-4057qib7	1938	12	and	and	CC
cord-005453-4057qib7	1938	13	3	3	CD
cord-005453-4057qib7	1938	14	are	be	VBP
cord-005453-4057qib7	1938	15	living	live	VBG
cord-005453-4057qib7	1938	16	.	.	.
cord-005453-4057qib7	1939	1	The	the	DT
cord-005453-4057qib7	1939	2	Kaplan	Kaplan	NNP
cord-005453-4057qib7	1939	3	-	-	HYPH
cord-005453-4057qib7	1939	4	Meyer	Meyer	NNP
cord-005453-4057qib7	1939	5	overall	overall	JJ
cord-005453-4057qib7	1939	6	survival	survival	NN
cord-005453-4057qib7	1939	7	and	and	CC
cord-005453-4057qib7	1939	8	disease	disease	NN
cord-005453-4057qib7	1939	9	-	-	HYPH
cord-005453-4057qib7	1939	10	free	free	JJ
cord-005453-4057qib7	1939	11	survival	survival	NN
cord-005453-4057qib7	1939	12	at	at	IN
cord-005453-4057qib7	1939	13	10	10	CD
cord-005453-4057qib7	1939	14	years	year	NNS
cord-005453-4057qib7	1939	15	was	be	VBD
cord-005453-4057qib7	1939	16	40	40	CD
cord-005453-4057qib7	1939	17	%	%	NN
cord-005453-4057qib7	1939	18	and	and	CC
cord-005453-4057qib7	1939	19	35	35	CD
cord-005453-4057qib7	1939	20	%	%	NN
cord-005453-4057qib7	1939	21	,	,	,
cord-005453-4057qib7	1939	22	respectively	respectively	RB
cord-005453-4057qib7	1939	23	.	.	.
cord-005453-4057qib7	1940	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1940	2	:	:	:
cord-005453-4057qib7	1941	1	Our	-PRON-	PRP$
cord-005453-4057qib7	1941	2	experience	experience	NN
cord-005453-4057qib7	1941	3	confirms	confirm	VBZ
cord-005453-4057qib7	1941	4	that	that	IN
cord-005453-4057qib7	1941	5	HCT	HCT	NNP
cord-005453-4057qib7	1941	6	is	be	VBZ
cord-005453-4057qib7	1941	7	a	a	DT
cord-005453-4057qib7	1941	8	valid	valid	JJ
cord-005453-4057qib7	1941	9	option	option	NN
cord-005453-4057qib7	1941	10	to	to	TO
cord-005453-4057qib7	1941	11	achieve	achieve	VB
cord-005453-4057qib7	1941	12	cure	cure	NN
cord-005453-4057qib7	1941	13	in	in	IN
cord-005453-4057qib7	1941	14	one	one	CD
cord-005453-4057qib7	1941	15	third	third	NN
cord-005453-4057qib7	1941	16	of	of	IN
cord-005453-4057qib7	1941	17	MF	MF	NNP
cord-005453-4057qib7	1941	18	patients	patient	NNS
cord-005453-4057qib7	1941	19	.	.	.
cord-005453-4057qib7	1942	1	Two	two	CD
cord-005453-4057qib7	1942	2	patients	patient	NNS
cord-005453-4057qib7	1942	3	experienced	experience	VBD
cord-005453-4057qib7	1942	4	very	very	RB
cord-005453-4057qib7	1942	5	late	late	RB
cord-005453-4057qib7	1942	6	(	(	-LRB-
cord-005453-4057qib7	1942	7	>	>	NFP
cord-005453-4057qib7	1942	8	5	5	CD
cord-005453-4057qib7	1942	9	years	year	NNS
cord-005453-4057qib7	1942	10	)	)	-RRB-
cord-005453-4057qib7	1942	11	recurrence	recurrence	NN
cord-005453-4057qib7	1942	12	of	of	IN
cord-005453-4057qib7	1942	13	MF	MF	NNP
cord-005453-4057qib7	1942	14	.	.	.
cord-005453-4057qib7	1943	1	The	the	DT
cord-005453-4057qib7	1943	2	rarity	rarity	NN
cord-005453-4057qib7	1943	3	of	of	IN
cord-005453-4057qib7	1943	4	this	this	DT
cord-005453-4057qib7	1943	5	condition	condition	NN
cord-005453-4057qib7	1943	6	limits	limit	VBZ
cord-005453-4057qib7	1943	7	the	the	DT
cord-005453-4057qib7	1943	8	amount	amount	NN
cord-005453-4057qib7	1943	9	of	of	IN
cord-005453-4057qib7	1943	10	data	datum	NNS
cord-005453-4057qib7	1943	11	and	and	CC
cord-005453-4057qib7	1943	12	cases	case	NNS
cord-005453-4057qib7	1943	13	available	available	JJ
cord-005453-4057qib7	1943	14	for	for	IN
cord-005453-4057qib7	1943	15	evaluation	evaluation	NN
cord-005453-4057qib7	1943	16	and	and	CC
cord-005453-4057qib7	1943	17	study	study	NN
cord-005453-4057qib7	1943	18	.	.	.
cord-005453-4057qib7	1944	1	Life	life	NN
cord-005453-4057qib7	1944	2	-	-	HYPH
cord-005453-4057qib7	1944	3	long	long	JJ
cord-005453-4057qib7	1944	4	follow	follow	NN
cord-005453-4057qib7	1944	5	-	-	HYPH
cord-005453-4057qib7	1944	6	up	up	NN
cord-005453-4057qib7	1944	7	of	of	IN
cord-005453-4057qib7	1944	8	all	all	DT
cord-005453-4057qib7	1944	9	MF	MF	NNP
cord-005453-4057qib7	1944	10	transplanted	transplant	VBN
cord-005453-4057qib7	1944	11	patients	patient	NNS
cord-005453-4057qib7	1944	12	is	be	VBZ
cord-005453-4057qib7	1944	13	warranted	warrant	VBN
cord-005453-4057qib7	1944	14	to	to	TO
cord-005453-4057qib7	1944	15	better	well	RBR
cord-005453-4057qib7	1944	16	understand	understand	VB
cord-005453-4057qib7	1944	17	this	this	DT
cord-005453-4057qib7	1944	18	rare	rare	JJ
cord-005453-4057qib7	1944	19	event	event	NN
cord-005453-4057qib7	1944	20	.	.	.
cord-005453-4057qib7	1945	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1945	2	:	:	:
cord-005453-4057qib7	1945	3	Nothing	nothing	NN
cord-005453-4057qib7	1945	4	to	to	TO
cord-005453-4057qib7	1945	5	declare	declare	VB
cord-005453-4057qib7	1945	6	Methods	method	NNS
cord-005453-4057qib7	1945	7	:	:	:
cord-005453-4057qib7	1945	8	А	а	JJ
cord-005453-4057qib7	1945	9	37-years	37-years	CD
cord-005453-4057qib7	1945	10	old	old	JJ
cord-005453-4057qib7	1945	11	female	female	NN
cord-005453-4057qib7	1945	12	was	be	VBD
cord-005453-4057qib7	1945	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	1945	14	with	with	IN
cord-005453-4057qib7	1945	15	JAK2V617F	jak2v617f	JJ
cord-005453-4057qib7	1945	16	-	-	HYPH
cord-005453-4057qib7	1945	17	positive	positive	JJ
cord-005453-4057qib7	1945	18	PMF	PMF	NNP
cord-005453-4057qib7	1945	19	,	,	,
cord-005453-4057qib7	1945	20	46XX	46xx	CD
cord-005453-4057qib7	1945	21	,	,	,
cord-005453-4057qib7	1945	22	IPSS	IPSS	NNP
cord-005453-4057qib7	1945	23	low	low	JJ
cord-005453-4057qib7	1945	24	risk	risk	NN
cord-005453-4057qib7	1945	25	,	,	,
cord-005453-4057qib7	1945	26	DIPSSplus	dipssplus	NN
cord-005453-4057qib7	1945	27	intermediate	intermediate	JJ
cord-005453-4057qib7	1945	28	-2	-2	CD
cord-005453-4057qib7	1945	29	risk	risk	NN
cord-005453-4057qib7	1945	30	,	,	,
cord-005453-4057qib7	1945	31	subacute	subacute	JJ
cord-005453-4057qib7	1945	32	Budd	Budd	NNP
cord-005453-4057qib7	1945	33	-	-	HYPH
cord-005453-4057qib7	1945	34	Chiari	Chiari	NNP
cord-005453-4057qib7	1945	35	syndrome	syndrome	NN
cord-005453-4057qib7	1945	36	and	and	CC
cord-005453-4057qib7	1945	37	portal	portal	JJ
cord-005453-4057qib7	1945	38	vein	vein	NN
cord-005453-4057qib7	1945	39	thrombosis	thrombosis	NN
cord-005453-4057qib7	1945	40	four	four	CD
cord-005453-4057qib7	1945	41	years	year	NNS
cord-005453-4057qib7	1945	42	before	before	IN
cord-005453-4057qib7	1945	43	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	1945	44	.	.	.
cord-005453-4057qib7	1946	1	To	to	TO
cord-005453-4057qib7	1946	2	reduce	reduce	VB
cord-005453-4057qib7	1946	3	the	the	DT
cord-005453-4057qib7	1946	4	splenomegaly	splenomegaly	JJ
cord-005453-4057qib7	1946	5	and	and	CC
cord-005453-4057qib7	1946	6	constitutional	constitutional	JJ
cord-005453-4057qib7	1946	7	symptoms	symptom	NNS
cord-005453-4057qib7	1946	8	we	-PRON-	PRP
cord-005453-4057qib7	1946	9	performed	perform	VBD
cord-005453-4057qib7	1946	10	pre	pre	JJ
cord-005453-4057qib7	1946	11	-	-	JJ
cord-005453-4057qib7	1946	12	transplant	transplant	JJ
cord-005453-4057qib7	1946	13	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	1946	14	therapy	therapy	NNP
cord-005453-4057qib7	1946	15	30	30	CD
cord-005453-4057qib7	1946	16	mg	mg	NNP
cord-005453-4057qib7	1946	17	daily	daily	RB
cord-005453-4057qib7	1946	18	.	.	.
cord-005453-4057qib7	1947	1	After	after	IN
cord-005453-4057qib7	1947	2	three	three	CD
cord-005453-4057qib7	1947	3	months	month	NNS
cord-005453-4057qib7	1947	4	of	of	IN
cord-005453-4057qib7	1947	5	therapy	therapy	NN
cord-005453-4057qib7	1947	6	the	the	DT
cord-005453-4057qib7	1947	7	patient	patient	NN
cord-005453-4057qib7	1947	8	achieved	achieve	VBD
cord-005453-4057qib7	1947	9	clinical	clinical	JJ
cord-005453-4057qib7	1947	10	improvement	improvement	NN
cord-005453-4057qib7	1947	11	(	(	-LRB-
cord-005453-4057qib7	1947	12	ELN	ELN	NNP
cord-005453-4057qib7	1947	13	criteria	criterion	NNS
cord-005453-4057qib7	1947	14	)	)	-RRB-
cord-005453-4057qib7	1947	15	.	.	.
cord-005453-4057qib7	1948	1	Contrast	contrast	NN
cord-005453-4057qib7	1948	2	-	-	HYPH
cord-005453-4057qib7	1948	3	enhanced	enhance	VBN
cord-005453-4057qib7	1948	4	computer	computer	NN
cord-005453-4057qib7	1948	5	tomography	tomography	NN
cord-005453-4057qib7	1948	6	and	and	CC
cord-005453-4057qib7	1948	7	magnetic	magnetic	JJ
cord-005453-4057qib7	1948	8	resonance	resonance	NN
cord-005453-4057qib7	1948	9	imaging	imaging	NN
cord-005453-4057qib7	1948	10	showed	show	VBD
cord-005453-4057qib7	1948	11	enlarged	enlarge	VBN
cord-005453-4057qib7	1948	12	intrahepatic	intrahepatic	JJ
cord-005453-4057qib7	1948	13	collateral	collateral	JJ
cord-005453-4057qib7	1948	14	vessels	vessel	NNS
cord-005453-4057qib7	1948	15	and	and	CC
cord-005453-4057qib7	1948	16	signs	sign	NNS
cord-005453-4057qib7	1948	17	of	of	IN
cord-005453-4057qib7	1948	18	portal	portal	JJ
cord-005453-4057qib7	1948	19	vein	vein	NN
cord-005453-4057qib7	1948	20	thrombosis	thrombosis	NN
cord-005453-4057qib7	1948	21	with	with	IN
cord-005453-4057qib7	1948	22	cavernous	cavernous	JJ
cord-005453-4057qib7	1948	23	transformation	transformation	NN
cord-005453-4057qib7	1948	24	and	and	CC
cord-005453-4057qib7	1948	25	multiple	multiple	JJ
cord-005453-4057qib7	1948	26	dilated	dilated	JJ
cord-005453-4057qib7	1948	27	collateral	collateral	JJ
cord-005453-4057qib7	1948	28	veins	vein	NNS
cord-005453-4057qib7	1948	29	.	.	.
cord-005453-4057qib7	1949	1	Gastroscopy	Gastroscopy	NNP
cord-005453-4057qib7	1949	2	documented	document	VBD
cord-005453-4057qib7	1949	3	enlarged	enlarged	JJ
cord-005453-4057qib7	1949	4	esophageal	esophageal	JJ
cord-005453-4057qib7	1949	5	veins	vein	NNS
cord-005453-4057qib7	1949	6	.	.	.
cord-005453-4057qib7	1950	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	1950	2	stem	stem	VBP
cord-005453-4057qib7	1950	3	cell	cell	NN
cord-005453-4057qib7	1950	4	transplantation	transplantation	NN
cord-005453-4057qib7	1950	5	was	be	VBD
cord-005453-4057qib7	1950	6	performed	perform	VBN
cord-005453-4057qib7	1950	7	from	from	IN
cord-005453-4057qib7	1950	8	10/10	10/10	CD
cord-005453-4057qib7	1950	9	-HLA	-HLA	HYPH
cord-005453-4057qib7	1950	10	matched	match	VBN
cord-005453-4057qib7	1950	11	unrelated	unrelated	JJ
cord-005453-4057qib7	1950	12	donor	donor	NN
cord-005453-4057qib7	1950	13	with	with	IN
cord-005453-4057qib7	1950	14	peripheral	peripheral	JJ
cord-005453-4057qib7	1950	15	stem	stem	NN
cord-005453-4057qib7	1950	16	cells	cell	NNS
cord-005453-4057qib7	1950	17	(	(	-LRB-
cord-005453-4057qib7	1950	18	6.1	6.1	CD
cord-005453-4057qib7	1950	19	x	x	SYM
cord-005453-4057qib7	1950	20	10	10	CD
cord-005453-4057qib7	1950	21	9	9	CD
cord-005453-4057qib7	1950	22	СD34	СD34	NNP
cord-005453-4057qib7	1950	23	+	+	CC
cord-005453-4057qib7	1950	24	cells	cell	NNS
cord-005453-4057qib7	1950	25	/	/	SYM
cord-005453-4057qib7	1950	26	kg	kg	NN
cord-005453-4057qib7	1950	27	)	)	-RRB-
cord-005453-4057qib7	1950	28	.	.	.
cord-005453-4057qib7	1951	1	Conditioning	conditioning	NN
cord-005453-4057qib7	1951	2	regimen	regimen	NN
cord-005453-4057qib7	1951	3	consisted	consist	VBD
cord-005453-4057qib7	1951	4	of	of	IN
cord-005453-4057qib7	1951	5	fludarabine	fludarabine	NN
cord-005453-4057qib7	1951	6	(	(	-LRB-
cord-005453-4057qib7	1951	7	180	180	CD
cord-005453-4057qib7	1951	8	mg/	mg/	NN
cord-005453-4057qib7	1951	9	m	m	CD
cord-005453-4057qib7	1951	10	2	2	CD
cord-005453-4057qib7	1951	11	)	)	-RRB-
cord-005453-4057qib7	1951	12	,	,	,
cord-005453-4057qib7	1951	13	busulfan	busulfan	NNP
cord-005453-4057qib7	1951	14	(	(	-LRB-
cord-005453-4057qib7	1951	15	10	10	CD
cord-005453-4057qib7	1951	16	mg	mg	NNP
cord-005453-4057qib7	1951	17	/	/	SYM
cord-005453-4057qib7	1951	18	kg	kg	NNP
cord-005453-4057qib7	1951	19	p.o	p.o	NNP
cord-005453-4057qib7	1951	20	.	.	NNP
cord-005453-4057qib7	1951	21	)	)	-RRB-
cord-005453-4057qib7	1951	22	.	.	.
cord-005453-4057qib7	1952	1	Post	post	JJ
cord-005453-4057qib7	1952	2	-	-	JJ
cord-005453-4057qib7	1952	3	transplant	transplant	NN
cord-005453-4057qib7	1952	4	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	1952	5	was	be	VBD
cord-005453-4057qib7	1952	6	administered	administer	VBN
cord-005453-4057qib7	1952	7	at	at	IN
cord-005453-4057qib7	1952	8	100	100	CD
cord-005453-4057qib7	1952	9	mg	mg	NNP
cord-005453-4057qib7	1952	10	/	/	SYM
cord-005453-4057qib7	1952	11	kg	kg	NN
cord-005453-4057qib7	1952	12	at	at	IN
cord-005453-4057qib7	1952	13	day	day	NN
cord-005453-4057qib7	1952	14	+3	+3	NNP
cord-005453-4057qib7	1952	15	,	,	,
cord-005453-4057qib7	1952	16	+4	+4	NNP
cord-005453-4057qib7	1952	17	,	,	,
cord-005453-4057qib7	1952	18	and	and	CC
cord-005453-4057qib7	1952	19	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	1952	20	15	15	CD
cord-005453-4057qib7	1952	21	mg	mg	NNP
cord-005453-4057qib7	1952	22	was	be	VBD
cord-005453-4057qib7	1952	23	used	use	VBN
cord-005453-4057qib7	1952	24	from	from	IN
cord-005453-4057qib7	1952	25	D+5	D+5	NNP
cord-005453-4057qib7	1952	26	till	till	IN
cord-005453-4057qib7	1952	27	D+100	D+100	NNS
cord-005453-4057qib7	1952	28	as	as	IN
cord-005453-4057qib7	1952	29	graft	graft	NN
cord-005453-4057qib7	1952	30	versus	versus	IN
cord-005453-4057qib7	1952	31	host	host	NN
cord-005453-4057qib7	1952	32	disease	disease	NN
cord-005453-4057qib7	1952	33	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1952	34	.	.	.
cord-005453-4057qib7	1953	1	Results	result	NNS
cord-005453-4057qib7	1953	2	:	:	:
cord-005453-4057qib7	1954	1	Starting	start	VBG
cord-005453-4057qib7	1954	2	D+1	d+1	NN
cord-005453-4057qib7	1955	1	the	the	DT
cord-005453-4057qib7	1955	2	patient	patient	NN
cord-005453-4057qib7	1955	3	experienced	experience	VBD
cord-005453-4057qib7	1955	4	eight	eight	CD
cord-005453-4057qib7	1955	5	episodes	episode	NNS
cord-005453-4057qib7	1955	6	of	of	IN
cord-005453-4057qib7	1955	7	EBV	EBV	NNP
cord-005453-4057qib7	1955	8	some	some	DT
cord-005453-4057qib7	1955	9	of	of	IN
cord-005453-4057qib7	1955	10	them	-PRON-	PRP
cord-005453-4057qib7	1955	11	with	with	IN
cord-005453-4057qib7	1955	12	severe	severe	JJ
cord-005453-4057qib7	1955	13	blood	blood	NN
cord-005453-4057qib7	1955	14	loss	loss	NN
cord-005453-4057qib7	1955	15	.	.	.
cord-005453-4057qib7	1956	1	To	to	TO
cord-005453-4057qib7	1956	2	treat	treat	VB
cord-005453-4057qib7	1956	3	the	the	DT
cord-005453-4057qib7	1956	4	bleeding	bleed	VBG
cord-005453-4057qib7	1956	5	episodes	episode	NNS
cord-005453-4057qib7	1956	6	Blackmore	Blackmore	NNP
cord-005453-4057qib7	1956	7	tube	tube	NN
cord-005453-4057qib7	1956	8	was	be	VBD
cord-005453-4057qib7	1956	9	placed	place	VBN
cord-005453-4057qib7	1956	10	six	six	CD
cord-005453-4057qib7	1956	11	times	time	NNS
cord-005453-4057qib7	1956	12	with	with	IN
cord-005453-4057qib7	1956	13	temporary	temporary	JJ
cord-005453-4057qib7	1956	14	effect	effect	NN
cord-005453-4057qib7	1956	15	.	.	.
cord-005453-4057qib7	1957	1	To	to	TO
cord-005453-4057qib7	1957	2	place	place	VB
cord-005453-4057qib7	1957	3	Blackmore	Blackmore	NNP
cord-005453-4057qib7	1957	4	tube	tube	VB
cord-005453-4057qib7	1957	5	the	the	DT
cord-005453-4057qib7	1957	6	patient	patient	NN
cord-005453-4057qib7	1957	7	was	be	VBD
cord-005453-4057qib7	1957	8	two	two	CD
cord-005453-4057qib7	1957	9	times	time	NNS
cord-005453-4057qib7	1957	10	intubated	intubate	VBN
cord-005453-4057qib7	1957	11	and	and	CC
cord-005453-4057qib7	1957	12	required	require	VBN
cord-005453-4057qib7	1957	13	mechanical	mechanical	JJ
cord-005453-4057qib7	1957	14	ventilation	ventilation	NN
cord-005453-4057qib7	1957	15	.	.	.
cord-005453-4057qib7	1958	1	At	at	IN
cord-005453-4057qib7	1958	2	D+18	D+18	NNP
cord-005453-4057qib7	1958	3	leukocyte	leukocyte	NN
cord-005453-4057qib7	1958	4	and	and	CC
cord-005453-4057qib7	1958	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	1958	6	engraftment	engraftment	NN
cord-005453-4057qib7	1958	7	,	,	,
cord-005453-4057qib7	1958	8	full	full	JJ
cord-005453-4057qib7	1958	9	donor	donor	NN
cord-005453-4057qib7	1958	10	chimerism	chimerism	NN
cord-005453-4057qib7	1958	11	and	and	CC
cord-005453-4057qib7	1958	12	molecular	molecular	JJ
cord-005453-4057qib7	1958	13	remission	remission	NN
cord-005453-4057qib7	1958	14	were	be	VBD
cord-005453-4057qib7	1958	15	achieved	achieve	VBN
cord-005453-4057qib7	1958	16	.	.	.
cord-005453-4057qib7	1959	1	Platelet	platelet	NN
cord-005453-4057qib7	1959	2	engraftment	engraftment	NN
cord-005453-4057qib7	1959	3	was	be	VBD
cord-005453-4057qib7	1959	4	documented	document	VBN
cord-005453-4057qib7	1959	5	only	only	RB
cord-005453-4057qib7	1959	6	at	at	IN
cord-005453-4057qib7	1959	7	D	D	NNP
cord-005453-4057qib7	1959	8	+42	+42	NNP
cord-005453-4057qib7	1959	9	and	and	CC
cord-005453-4057qib7	1959	10	poor	poor	JJ
cord-005453-4057qib7	1959	11	graft	graft	NN
cord-005453-4057qib7	1959	12	function	function	NN
cord-005453-4057qib7	1959	13	was	be	VBD
cord-005453-4057qib7	1959	14	present	present	JJ
cord-005453-4057qib7	1959	15	due	due	IN
cord-005453-4057qib7	1959	16	to	to	IN
cord-005453-4057qib7	1959	17	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	1959	18	reactivation	reactivation	NN
cord-005453-4057qib7	1959	19	(	(	-LRB-
cord-005453-4057qib7	1959	20	D+41	D+41	NNP
cord-005453-4057qib7	1959	21	)	)	-RRB-
cord-005453-4057qib7	1959	22	and	and	CC
cord-005453-4057qib7	1959	23	parvovirus	parvovirus	NN
cord-005453-4057qib7	1959	24	B19	B19	NNP
cord-005453-4057qib7	1959	25	reactivation	reactivation	NN
cord-005453-4057qib7	1959	26	(	(	-LRB-
cord-005453-4057qib7	1959	27	D+62	D+62	NNS
cord-005453-4057qib7	1959	28	)	)	-RRB-
cord-005453-4057qib7	1959	29	.	.	.
cord-005453-4057qib7	1960	1	EVB	EVB	NNP
cord-005453-4057qib7	1960	2	was	be	VBD
cord-005453-4057qib7	1960	3	stopped	stop	VBN
cord-005453-4057qib7	1960	4	at	at	IN
cord-005453-4057qib7	1960	5	D+95	D+95	NNP
cord-005453-4057qib7	1960	6	only	only	RB
cord-005453-4057qib7	1960	7	after	after	IN
cord-005453-4057qib7	1960	8	two	two	CD
cord-005453-4057qib7	1960	9	esophageal	esophageal	JJ
cord-005453-4057qib7	1960	10	veins	vein	NNS
cord-005453-4057qib7	1960	11	ligations	ligation	NNS
cord-005453-4057qib7	1960	12	,	,	,
cord-005453-4057qib7	1960	13	and	and	CC
cord-005453-4057qib7	1960	14	two	two	CD
cord-005453-4057qib7	1960	15	procedures	procedure	NNS
cord-005453-4057qib7	1960	16	of	of	IN
cord-005453-4057qib7	1960	17	gastric	gastric	JJ
cord-005453-4057qib7	1960	18	veins	vein	NNS
cord-005453-4057qib7	1960	19	sclerotherapy	sclerotherapy	NN
cord-005453-4057qib7	1960	20	.	.	.
cord-005453-4057qib7	1961	1	Soon	soon	RB
cord-005453-4057qib7	1961	2	(	(	-LRB-
cord-005453-4057qib7	1961	3	D+111	D+111	NNS
cord-005453-4057qib7	1961	4	)	)	-RRB-
cord-005453-4057qib7	1962	1	the	the	DT
cord-005453-4057qib7	1962	2	patient	patient	NN
cord-005453-4057qib7	1962	3	achieved	achieve	VBD
cord-005453-4057qib7	1962	4	complete	complete	JJ
cord-005453-4057qib7	1962	5	platelet	platelet	NN
cord-005453-4057qib7	1962	6	recovery	recovery	NN
cord-005453-4057qib7	1962	7	(	(	-LRB-
cord-005453-4057qib7	1962	8	more	more	JJR
cord-005453-4057qib7	1962	9	than	than	IN
cord-005453-4057qib7	1962	10	50x10	50x10	CD
cord-005453-4057qib7	1962	11	9	9	CD
cord-005453-4057qib7	1962	12	/l	/l	NN
cord-005453-4057qib7	1962	13	)	)	-RRB-
cord-005453-4057qib7	1962	14	and	and	CC
cord-005453-4057qib7	1962	15	became	become	VBD
cord-005453-4057qib7	1962	16	red	red	JJ
cord-005453-4057qib7	1962	17	blood	blood	NN
cord-005453-4057qib7	1962	18	cells	cell	NNS
cord-005453-4057qib7	1962	19	transfusion	transfusion	NN
cord-005453-4057qib7	1962	20	independent	independent	JJ
cord-005453-4057qib7	1962	21	.	.	.
cord-005453-4057qib7	1963	1	At	at	IN
cord-005453-4057qib7	1963	2	day	day	NN
cord-005453-4057qib7	1963	3	+	+	SYM
cord-005453-4057qib7	1963	4	180	180	CD
cord-005453-4057qib7	1963	5	complete	complete	JJ
cord-005453-4057qib7	1963	6	remission	remission	NN
cord-005453-4057qib7	1963	7	was	be	VBD
cord-005453-4057qib7	1963	8	confirmed	confirm	VBN
cord-005453-4057qib7	1963	9	by	by	IN
cord-005453-4057qib7	1963	10	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	1963	11	resolution	resolution	NN
cord-005453-4057qib7	1963	12	,	,	,
cord-005453-4057qib7	1963	13	regression	regression	NN
cord-005453-4057qib7	1963	14	of	of	IN
cord-005453-4057qib7	1963	15	bone	bone	NN
cord-005453-4057qib7	1963	16	marrow	marrow	NN
cord-005453-4057qib7	1963	17	fibrosis	fibrosis	NN
cord-005453-4057qib7	1963	18	,	,	,
cord-005453-4057qib7	1963	19	full	full	JJ
cord-005453-4057qib7	1963	20	donor	donor	NN
cord-005453-4057qib7	1963	21	chimerism	chimerism	NN
cord-005453-4057qib7	1963	22	,	,	,
cord-005453-4057qib7	1963	23	JAK2V617F	jak2v617f	JJ
cord-005453-4057qib7	1963	24	-	-	HYPH
cord-005453-4057qib7	1963	25	negative	negative	JJ
cord-005453-4057qib7	1963	26	molecular	molecular	JJ
cord-005453-4057qib7	1963	27	status	status	NN
cord-005453-4057qib7	1963	28	.	.	.
cord-005453-4057qib7	1964	1	CBC	CBC	NNP
cord-005453-4057qib7	1964	2	showed	show	VBD
cord-005453-4057qib7	1964	3	Hb	Hb	NNP
cord-005453-4057qib7	1964	4	130	130	CD
cord-005453-4057qib7	1964	5	g	g	NN
cord-005453-4057qib7	1964	6	/	/	SYM
cord-005453-4057qib7	1964	7	l	l	NN
cord-005453-4057qib7	1964	8	,	,	,
cord-005453-4057qib7	1964	9	platelets	platelet	NNS
cord-005453-4057qib7	1964	10	73x10	73x10	CD
cord-005453-4057qib7	1964	11	9	9	CD
cord-005453-4057qib7	1964	12	/l	/l	NNP
cord-005453-4057qib7	1964	13	,	,	,
cord-005453-4057qib7	1964	14	leucocytes	leucocytes	NNP
cord-005453-4057qib7	1964	15	3,8x10	3,8x10	NNP
cord-005453-4057qib7	1964	16	9	9	CD
cord-005453-4057qib7	1964	17	/l	/l	NNP
cord-005453-4057qib7	1964	18	.	.	.
cord-005453-4057qib7	1965	1	Ultrasound	ultrasound	NN
cord-005453-4057qib7	1965	2	examination	examination	NN
cord-005453-4057qib7	1965	3	after	after	IN
cord-005453-4057qib7	1965	4	transplant	transplant	NN
cord-005453-4057qib7	1965	5	documented	document	VBD
cord-005453-4057qib7	1965	6	portal	portal	JJ
cord-005453-4057qib7	1965	7	vein	vein	NN
cord-005453-4057qib7	1965	8	thrombosis	thrombosis	NN
cord-005453-4057qib7	1965	9	recanalization	recanalization	NN
cord-005453-4057qib7	1965	10	.	.	.
cord-005453-4057qib7	1966	1	At	at	IN
cord-005453-4057qib7	1966	2	day	day	NN
cord-005453-4057qib7	1966	3	+	+	CC
cord-005453-4057qib7	1966	4	180	180	CD
cord-005453-4057qib7	1966	5	she	-PRON-	PRP
cord-005453-4057qib7	1966	6	developed	develop	VBD
cord-005453-4057qib7	1966	7	mild	mild	JJ
cord-005453-4057qib7	1966	8	(	(	-LRB-
cord-005453-4057qib7	1966	9	NIH	NIH	NNP
cord-005453-4057qib7	1966	10	)	)	-RRB-
cord-005453-4057qib7	1966	11	chronic	chronic	JJ
cord-005453-4057qib7	1966	12	graft	graft	NN
cord-005453-4057qib7	1966	13	versus	versus	IN
cord-005453-4057qib7	1966	14	host	host	NN
cord-005453-4057qib7	1966	15	disease	disease	NN
cord-005453-4057qib7	1966	16	with	with	IN
cord-005453-4057qib7	1966	17	eyes	eye	NNS
cord-005453-4057qib7	1966	18	and	and	CC
cord-005453-4057qib7	1966	19	mouth	mouth	NN
cord-005453-4057qib7	1966	20	involvement	involvement	NN
cord-005453-4057qib7	1966	21	,	,	,
cord-005453-4057qib7	1966	22	which	which	WDT
cord-005453-4057qib7	1966	23	was	be	VBD
cord-005453-4057qib7	1966	24	managed	manage	VBN
cord-005453-4057qib7	1966	25	with	with	IN
cord-005453-4057qib7	1966	26	topical	topical	JJ
cord-005453-4057qib7	1966	27	steroids	steroid	NNS
cord-005453-4057qib7	1966	28	.	.	.
cord-005453-4057qib7	1967	1	At	at	IN
cord-005453-4057qib7	1967	2	D+958	d+958	NN
cord-005453-4057qib7	1967	3	after	after	IN
cord-005453-4057qib7	1967	4	transplant	transplant	NN
cord-005453-4057qib7	1967	5	the	the	DT
cord-005453-4057qib7	1967	6	patient	patient	NN
cord-005453-4057qib7	1967	7	is	be	VBZ
cord-005453-4057qib7	1967	8	alive	alive	JJ
cord-005453-4057qib7	1967	9	in	in	IN
cord-005453-4057qib7	1967	10	complete	complete	JJ
cord-005453-4057qib7	1967	11	remission	remission	NN
cord-005453-4057qib7	1967	12	and	and	CC
cord-005453-4057qib7	1967	13	has	have	VBZ
cord-005453-4057qib7	1967	14	no	no	DT
cord-005453-4057qib7	1967	15	recurrent	recurrent	JJ
cord-005453-4057qib7	1967	16	bleedings	bleeding	NNS
cord-005453-4057qib7	1967	17	.	.	.
cord-005453-4057qib7	1968	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1968	2	:	:	:
cord-005453-4057qib7	1969	1	Splanchnic	splanchnic	JJ
cord-005453-4057qib7	1969	2	vein	vein	NN
cord-005453-4057qib7	1969	3	thrombosis	thrombosis	NN
cord-005453-4057qib7	1969	4	can	can	MD
cord-005453-4057qib7	1969	5	significantly	significantly	RB
cord-005453-4057qib7	1969	6	complicate	complicate	VB
cord-005453-4057qib7	1969	7	the	the	DT
cord-005453-4057qib7	1969	8	course	course	NN
cord-005453-4057qib7	1969	9	of	of	IN
cord-005453-4057qib7	1969	10	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	1969	11	in	in	IN
cord-005453-4057qib7	1969	12	PMF	PMF	NNP
cord-005453-4057qib7	1969	13	.	.	.
cord-005453-4057qib7	1970	1	Easy	easy	JJ
cord-005453-4057qib7	1970	2	access	access	NN
cord-005453-4057qib7	1970	3	to	to	IN
cord-005453-4057qib7	1970	4	surgical	surgical	JJ
cord-005453-4057qib7	1970	5	,	,	,
cord-005453-4057qib7	1970	6	intensive	intensive	JJ
cord-005453-4057qib7	1970	7	care	care	NN
cord-005453-4057qib7	1970	8	unit	unit	NN
cord-005453-4057qib7	1970	9	and	and	CC
cord-005453-4057qib7	1970	10	endoscopic	endoscopic	NN
cord-005453-4057qib7	1970	11	teams	team	NNS
cord-005453-4057qib7	1970	12	is	be	VBZ
cord-005453-4057qib7	1970	13	required	require	VBN
cord-005453-4057qib7	1970	14	to	to	TO
cord-005453-4057qib7	1970	15	make	make	VB
cord-005453-4057qib7	1970	16	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	1970	17	more	more	RBR
cord-005453-4057qib7	1970	18	feasible	feasible	JJ
cord-005453-4057qib7	1970	19	in	in	IN
cord-005453-4057qib7	1970	20	this	this	DT
cord-005453-4057qib7	1970	21	group	group	NN
cord-005453-4057qib7	1970	22	of	of	IN
cord-005453-4057qib7	1970	23	patients	patient	NNS
cord-005453-4057qib7	1970	24	.	.	.
cord-005453-4057qib7	1971	1	Disclosure	disclosure	NN
cord-005453-4057qib7	1971	2	All	all	DT
cord-005453-4057qib7	1971	3	patients	patient	NNS
cord-005453-4057qib7	1971	4	received	receive	VBD
cord-005453-4057qib7	1971	5	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	1971	6	-	-	HYPH
cord-005453-4057qib7	1971	7	based	base	VBN
cord-005453-4057qib7	1971	8	MAC	MAC	NNP
cord-005453-4057qib7	1971	9	regimens	regimen	NNS
cord-005453-4057qib7	1971	10	,	,	,
cord-005453-4057qib7	1971	11	Treosulfan(Total	Treosulfan(Total	NNP
cord-005453-4057qib7	1971	12	dose	dose	NN
cord-005453-4057qib7	1971	13	,	,	,
cord-005453-4057qib7	1971	14	36	36	CD
cord-005453-4057qib7	1971	15	-	-	SYM
cord-005453-4057qib7	1971	16	42gms	42gms	CD
cord-005453-4057qib7	1971	17	/	/	SYM
cord-005453-4057qib7	1971	18	m2	m2	NNP
cord-005453-4057qib7	1971	19	)	)	-RRB-
cord-005453-4057qib7	1971	20	was	be	VBD
cord-005453-4057qib7	1971	21	given	give	VBN
cord-005453-4057qib7	1971	22	in	in	IN
cord-005453-4057qib7	1971	23	combination	combination	NN
cord-005453-4057qib7	1971	24	with	with	IN
cord-005453-4057qib7	1971	25	different	different	JJ
cord-005453-4057qib7	1971	26	conditioning	conditioning	NN
cord-005453-4057qib7	1971	27	drugs	drug	NNS
cord-005453-4057qib7	1971	28	.	.	.
cord-005453-4057qib7	1972	1	The	the	DT
cord-005453-4057qib7	1972	2	most	most	RBS
cord-005453-4057qib7	1972	3	commonly	commonly	RB
cord-005453-4057qib7	1972	4	used	use	VBN
cord-005453-4057qib7	1972	5	regimen	regimen	NN
cord-005453-4057qib7	1972	6	was	be	VBD
cord-005453-4057qib7	1972	7	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	1972	8	,	,	,
cord-005453-4057qib7	1972	9	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	1972	10	(	(	-LRB-
cord-005453-4057qib7	1972	11	150mgs	150mgs	CD
cord-005453-4057qib7	1972	12	/	/	SYM
cord-005453-4057qib7	1972	13	m2	m2	NNP
cord-005453-4057qib7	1972	14	)	)	-RRB-
cord-005453-4057qib7	1972	15	and	and	CC
cord-005453-4057qib7	1972	16	Thiotepa(10mgs	Thiotepa(10mgs	NNP
cord-005453-4057qib7	1972	17	/	/	SYM
cord-005453-4057qib7	1972	18	kg	kg	NN
cord-005453-4057qib7	1972	19	)	)	-RRB-
cord-005453-4057qib7	1972	20	referred	refer	VBD
cord-005453-4057qib7	1972	21	to	to	IN
cord-005453-4057qib7	1972	22	as	as	IN
cord-005453-4057qib7	1972	23	FTT	FTT	NNP
cord-005453-4057qib7	1972	24	that	that	WDT
cord-005453-4057qib7	1972	25	was	be	VBD
cord-005453-4057qib7	1972	26	used	use	VBN
cord-005453-4057qib7	1972	27	in	in	IN
cord-005453-4057qib7	1972	28	59%(n=55	59%(n=55	CD
cord-005453-4057qib7	1972	29	)	)	-RRB-
cord-005453-4057qib7	1972	30	.	.	.
cord-005453-4057qib7	1973	1	Serotherapy	Serotherapy	NNP
cord-005453-4057qib7	1973	2	was	be	VBD
cord-005453-4057qib7	1973	3	given	give	VBN
cord-005453-4057qib7	1973	4	in	in	IN
cord-005453-4057qib7	1973	5	93	93	CD
cord-005453-4057qib7	1973	6	%	%	NN
cord-005453-4057qib7	1973	7	of	of	IN
cord-005453-4057qib7	1973	8	patients(n=87	patients(n=87	NN
cord-005453-4057qib7	1973	9	)	)	-RRB-
cord-005453-4057qib7	1973	10	,	,	,
cord-005453-4057qib7	1973	11	as	as	IN
cord-005453-4057qib7	1973	12	either	either	CC
cord-005453-4057qib7	1973	13	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	1973	14	or	or	CC
cord-005453-4057qib7	1973	15	Antithymocyte	Antithymocyte	NNP
cord-005453-4057qib7	1973	16	globulin	globulin	NN
cord-005453-4057qib7	1973	17	in	in	IN
cord-005453-4057qib7	1973	18	82%(n=77	82%(n=77	CD
cord-005453-4057qib7	1973	19	)	)	-RRB-
cord-005453-4057qib7	1973	20	and	and	CC
cord-005453-4057qib7	1973	21	11%(n=10	11%(n=10	CD
cord-005453-4057qib7	1973	22	)	)	-RRB-
cord-005453-4057qib7	1973	23	,	,	,
cord-005453-4057qib7	1973	24	respectively	respectively	RB
cord-005453-4057qib7	1973	25	.	.	.
cord-005453-4057qib7	1974	1	post	post	JJ
cord-005453-4057qib7	1974	2	-	-	JJ
cord-005453-4057qib7	1974	3	transplant	transplant	JJ
cord-005453-4057qib7	1974	4	Graft	graft	NN
cord-005453-4057qib7	1974	5	-	-	HYPH
cord-005453-4057qib7	1974	6	versus	versus	IN
cord-005453-4057qib7	1974	7	-	-	HYPH
cord-005453-4057qib7	1974	8	Host	host	NN
cord-005453-4057qib7	1974	9	disease	disease	NN
cord-005453-4057qib7	1974	10	(	(	-LRB-
cord-005453-4057qib7	1974	11	GVHD	GVHD	NNP
cord-005453-4057qib7	1974	12	)	)	-RRB-
cord-005453-4057qib7	1974	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	1974	14	was	be	VBD
cord-005453-4057qib7	1974	15	given	give	VBN
cord-005453-4057qib7	1974	16	in	in	IN
cord-005453-4057qib7	1974	17	all	all	DT
cord-005453-4057qib7	1974	18	patients	patient	NNS
cord-005453-4057qib7	1974	19	,	,	,
cord-005453-4057qib7	1974	20	based	base	VBN
cord-005453-4057qib7	1974	21	mostly	mostly	RB
cord-005453-4057qib7	1974	22	on	on	IN
cord-005453-4057qib7	1974	23	ciclosporin	ciclosporin	NN
cord-005453-4057qib7	1974	24	.	.	.
cord-005453-4057qib7	1975	1	46	46	CD
cord-005453-4057qib7	1975	2	patients(49	patients(49	NNP
cord-005453-4057qib7	1975	3	%	%	NN
cord-005453-4057qib7	1975	4	)	)	-RRB-
cord-005453-4057qib7	1975	5	received	receive	VBD
cord-005453-4057qib7	1975	6	the	the	DT
cord-005453-4057qib7	1975	7	transplant	transplant	NN
cord-005453-4057qib7	1975	8	from	from	IN
cord-005453-4057qib7	1975	9	identicalrelated	identicalrelate	VBN
cord-005453-4057qib7	1975	10	donors	donor	NNS
cord-005453-4057qib7	1975	11	,	,	,
cord-005453-4057qib7	1975	12	46	46	CD
cord-005453-4057qib7	1975	13	patients(49	patients(49	NNP
cord-005453-4057qib7	1975	14	%	%	NN
cord-005453-4057qib7	1975	15	)	)	-RRB-
cord-005453-4057qib7	1975	16	received	receive	VBD
cord-005453-4057qib7	1975	17	the	the	DT
cord-005453-4057qib7	1975	18	transplant	transplant	NN
cord-005453-4057qib7	1975	19	from	from	IN
cord-005453-4057qib7	1975	20	matched	match	VBN
cord-005453-4057qib7	1975	21	-	-	HYPH
cord-005453-4057qib7	1975	22	unrelated	unrelated	JJ
cord-005453-4057qib7	1975	23	donors	donor	NNS
cord-005453-4057qib7	1975	24	,	,	,
cord-005453-4057qib7	1975	25	and	and	CC
cord-005453-4057qib7	1975	26	two	two	CD
cord-005453-4057qib7	1975	27	patients(2	patients(2	NN
cord-005453-4057qib7	1975	28	%	%	NN
cord-005453-4057qib7	1975	29	)	)	-RRB-
cord-005453-4057qib7	1975	30	had	have	VBD
cord-005453-4057qib7	1975	31	haploidentical	haploidentical	JJ
cord-005453-4057qib7	1975	32	transplants	transplant	NNS
cord-005453-4057qib7	1975	33	.	.	.
cord-005453-4057qib7	1976	1	90	90	CD
cord-005453-4057qib7	1976	2	%	%	NN
cord-005453-4057qib7	1976	3	of	of	IN
cord-005453-4057qib7	1976	4	the	the	DT
cord-005453-4057qib7	1976	5	patients(n=85	patients(n=85	NNS
cord-005453-4057qib7	1976	6	)	)	-RRB-
cord-005453-4057qib7	1976	7	were	be	VBD
cord-005453-4057qib7	1976	8	fully	fully	RB
cord-005453-4057qib7	1976	9	HLA	HLA	NNP
cord-005453-4057qib7	1976	10	-	-	HYPH
cord-005453-4057qib7	1976	11	matched	match	VBN
cord-005453-4057qib7	1976	12	.	.	.
cord-005453-4057qib7	1977	1	All	all	DT
cord-005453-4057qib7	1977	2	stem	stem	VBP
cord-005453-4057qib7	1977	3	cell	cell	NN
cord-005453-4057qib7	1977	4	sources	source	NNS
cord-005453-4057qib7	1977	5	were	be	VBD
cord-005453-4057qib7	1977	6	used	use	VBN
cord-005453-4057qib7	1977	7	as	as	IN
cord-005453-4057qib7	1977	8	bone	bone	NN
cord-005453-4057qib7	1977	9	marrow	marrow	NN
cord-005453-4057qib7	1977	10	in	in	IN
cord-005453-4057qib7	1977	11	59%(n=55	59%(n=55	CD
cord-005453-4057qib7	1977	12	)	)	-RRB-
cord-005453-4057qib7	1977	13	,	,	,
cord-005453-4057qib7	1977	14	peripheral	peripheral	JJ
cord-005453-4057qib7	1977	15	blood	blood	NN
cord-005453-4057qib7	1977	16	stem	stem	NN
cord-005453-4057qib7	1977	17	cells	cell	NNS
cord-005453-4057qib7	1977	18	in	in	IN
cord-005453-4057qib7	1977	19	33%(n=31	33%(n=31	CD
cord-005453-4057qib7	1977	20	)	)	-RRB-
cord-005453-4057qib7	1977	21	,	,	,
cord-005453-4057qib7	1977	22	and	and	CC
cord-005453-4057qib7	1977	23	umbilical	umbilical	JJ
cord-005453-4057qib7	1977	24	cord	cord	NN
cord-005453-4057qib7	1977	25	blood	blood	NN
cord-005453-4057qib7	1977	26	in	in	IN
cord-005453-4057qib7	1977	27	8%(n=8	8%(n=8	CD
cord-005453-4057qib7	1977	28	)	)	-RRB-
cord-005453-4057qib7	1977	29	.	.	.
cord-005453-4057qib7	1978	1	This	this	DT
cord-005453-4057qib7	1978	2	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	1978	3	-	-	HYPH
cord-005453-4057qib7	1978	4	based	base	VBN
cord-005453-4057qib7	1978	5	conditioning	conditioning	NN
cord-005453-4057qib7	1978	6	was	be	VBD
cord-005453-4057qib7	1978	7	given	give	VBN
cord-005453-4057qib7	1978	8	as	as	IN
cord-005453-4057qib7	1978	9	the	the	DT
cord-005453-4057qib7	1978	10	1	1	CD
cord-005453-4057qib7	1978	11	st	st	NNP
cord-005453-4057qib7	1978	12	transplant	transplant	NN
cord-005453-4057qib7	1978	13	in	in	IN
cord-005453-4057qib7	1978	14	92%(n=85	92%(n=85	CD
cord-005453-4057qib7	1978	15	)	)	-RRB-
cord-005453-4057qib7	1978	16	,	,	,
cord-005453-4057qib7	1978	17	and	and	CC
cord-005453-4057qib7	1978	18	as	as	IN
cord-005453-4057qib7	1978	19	the	the	DT
cord-005453-4057qib7	1978	20	2	2	CD
cord-005453-4057qib7	1978	21	nd	nd	NNP
cord-005453-4057qib7	1978	22	transplant	transplant	NN
cord-005453-4057qib7	1978	23	after	after	IN
cord-005453-4057qib7	1978	24	the	the	DT
cord-005453-4057qib7	1978	25	failure	failure	NN
cord-005453-4057qib7	1978	26	of	of	IN
cord-005453-4057qib7	1978	27	a	a	DT
cord-005453-4057qib7	1978	28	first	first	JJ
cord-005453-4057qib7	1978	29	procedure	procedure	NN
cord-005453-4057qib7	1978	30	in	in	IN
cord-005453-4057qib7	1978	31	8%(n=9	8%(n=9	CD
cord-005453-4057qib7	1978	32	)	)	-RRB-
cord-005453-4057qib7	1978	33	.	.	.
cord-005453-4057qib7	1979	1	Two	two	CD
cord-005453-4057qib7	1979	2	patients	patient	NNS
cord-005453-4057qib7	1979	3	received	receive	VBD
cord-005453-4057qib7	1979	4	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	1979	5	-	-	HYPH
cord-005453-4057qib7	1979	6	based	base	VBN
cord-005453-4057qib7	1979	7	conditioned	conditioned	JJ
cord-005453-4057qib7	1979	8	transplant	transplant	NN
cord-005453-4057qib7	1979	9	twice	twice	RB
cord-005453-4057qib7	1979	10	.	.	.
cord-005453-4057qib7	1980	1	Results	result	NNS
cord-005453-4057qib7	1980	2	:	:	:
cord-005453-4057qib7	1981	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	1981	2	engraftment	engraftment	NN
cord-005453-4057qib7	1981	3	and	and	CC
cord-005453-4057qib7	1981	4	platelet	platelet	NN
cord-005453-4057qib7	1981	5	engraftment	engraftment	NN
cord-005453-4057qib7	1981	6	occurred	occur	VBD
cord-005453-4057qib7	1981	7	at	at	IN
cord-005453-4057qib7	1981	8	a	a	DT
cord-005453-4057qib7	1981	9	median	median	NN
cord-005453-4057qib7	1981	10	of	of	IN
cord-005453-4057qib7	1981	11	13	13	CD
cord-005453-4057qib7	1981	12	days	day	NNS
cord-005453-4057qib7	1981	13	and	and	CC
cord-005453-4057qib7	1981	14	18	18	CD
cord-005453-4057qib7	1981	15	days	day	NNS
cord-005453-4057qib7	1981	16	respectively	respectively	RB
cord-005453-4057qib7	1981	17	.	.	.
cord-005453-4057qib7	1982	1	Chimerism	chimerism	NN
cord-005453-4057qib7	1982	2	was	be	VBD
cord-005453-4057qib7	1982	3	full	full	JJ
cord-005453-4057qib7	1982	4	donor	donor	NN
cord-005453-4057qib7	1982	5	in	in	IN
cord-005453-4057qib7	1982	6	55%(n=52	55%(n=52	CD
cord-005453-4057qib7	1982	7	)	)	-RRB-
cord-005453-4057qib7	1982	8	,	,	,
cord-005453-4057qib7	1982	9	high	high	JJ
cord-005453-4057qib7	1982	10	donor	donor	NN
cord-005453-4057qib7	1982	11	in	in	IN
cord-005453-4057qib7	1982	12	18%(n=17	18%(n=17	CD
cord-005453-4057qib7	1982	13	)	)	-RRB-
cord-005453-4057qib7	1982	14	,	,	,
cord-005453-4057qib7	1982	15	and	and	CC
cord-005453-4057qib7	1982	16	mixed	mixed	JJ
cord-005453-4057qib7	1982	17	donor	donor	NN
cord-005453-4057qib7	1982	18	in	in	IN
cord-005453-4057qib7	1982	19	9%(n=8	9%(n=8	CD
cord-005453-4057qib7	1982	20	)	)	-RRB-
cord-005453-4057qib7	1982	21	.	.	.
cord-005453-4057qib7	1983	1	GVHD	GVHD	NNP
cord-005453-4057qib7	1983	2	developed	develop	VBD
cord-005453-4057qib7	1983	3	in	in	IN
cord-005453-4057qib7	1983	4	43	43	CD
cord-005453-4057qib7	1983	5	%	%	NN
cord-005453-4057qib7	1983	6	of	of	IN
cord-005453-4057qib7	1983	7	patients(n=40	patients(n=40	NNP
cord-005453-4057qib7	1983	8	)	)	-RRB-
cord-005453-4057qib7	1983	9	,	,	,
cord-005453-4057qib7	1983	10	with	with	IN
cord-005453-4057qib7	1983	11	acute	acute	JJ
cord-005453-4057qib7	1983	12	GVHD	GVHD	NNP
cord-005453-4057qib7	1983	13	grade	grade	NN
cord-005453-4057qib7	1983	14	I	I	NNP
cord-005453-4057qib7	1983	15	/	/	SYM
cord-005453-4057qib7	1983	16	II	II	NNP
cord-005453-4057qib7	1983	17	and	and	CC
cord-005453-4057qib7	1983	18	grade	grade	NN
cord-005453-4057qib7	1983	19	III	III	NNP
cord-005453-4057qib7	1983	20	/	/	SYM
cord-005453-4057qib7	1983	21	IV	IV	NNP
cord-005453-4057qib7	1983	22	developed	develop	VBD
cord-005453-4057qib7	1983	23	in	in	IN
cord-005453-4057qib7	1983	24	29%(n=27	29%(n=27	CD
cord-005453-4057qib7	1983	25	)	)	-RRB-
cord-005453-4057qib7	1983	26	and	and	CC
cord-005453-4057qib7	1983	27	2%(n=2	2%(n=2	CD
cord-005453-4057qib7	1983	28	)	)	-RRB-
cord-005453-4057qib7	1983	29	,	,	,
cord-005453-4057qib7	1983	30	respectively	respectively	RB
cord-005453-4057qib7	1983	31	.	.	.
cord-005453-4057qib7	1984	1	Chronic	chronic	JJ
cord-005453-4057qib7	1984	2	GVHD	GVHD	NNP
cord-005453-4057qib7	1984	3	grade	grade	NN
cord-005453-4057qib7	1984	4	I	I	NNP
cord-005453-4057qib7	1984	5	/	/	SYM
cord-005453-4057qib7	1984	6	II	II	NNP
cord-005453-4057qib7	1984	7	and	and	CC
cord-005453-4057qib7	1984	8	grade	grade	NN
cord-005453-4057qib7	1984	9	III	III	NNP
cord-005453-4057qib7	1984	10	/	/	SYM
cord-005453-4057qib7	1984	11	IV	IV	NNP
cord-005453-4057qib7	1984	12	developed	develop	VBD
cord-005453-4057qib7	1984	13	in	in	IN
cord-005453-4057qib7	1984	14	13%(n=12	13%(n=12	CD
cord-005453-4057qib7	1984	15	)	)	-RRB-
cord-005453-4057qib7	1984	16	and	and	CC
cord-005453-4057qib7	1984	17	2%(n=2	2%(n=2	CD
cord-005453-4057qib7	1984	18	)	)	-RRB-
cord-005453-4057qib7	1984	19	,	,	,
cord-005453-4057qib7	1984	20	respectively	respectively	RB
cord-005453-4057qib7	1984	21	.	.	.
cord-005453-4057qib7	1985	1	All	all	DT
cord-005453-4057qib7	1985	2	chronic	chronic	JJ
cord-005453-4057qib7	1985	3	GVHD	GVHD	NNP
cord-005453-4057qib7	1985	4	were	be	VBD
cord-005453-4057qib7	1985	5	mild	mild	JJ
cord-005453-4057qib7	1985	6	,	,	,
cord-005453-4057qib7	1985	7	limited	limited	JJ
cord-005453-4057qib7	1985	8	,	,	,
cord-005453-4057qib7	1985	9	non	non	JJ
cord-005453-4057qib7	1985	10	-	-	JJ
cord-005453-4057qib7	1985	11	extensive	extensive	JJ
cord-005453-4057qib7	1985	12	,	,	,
cord-005453-4057qib7	1985	13	and	and	CC
cord-005453-4057qib7	1985	14	resolved	resolve	VBD
cord-005453-4057qib7	1985	15	completely	completely	RB
cord-005453-4057qib7	1985	16	.	.	.
cord-005453-4057qib7	1986	1	None	none	NN
cord-005453-4057qib7	1986	2	of	of	IN
cord-005453-4057qib7	1986	3	our	-PRON-	PRP$
cord-005453-4057qib7	1986	4	patients	patient	NNS
cord-005453-4057qib7	1986	5	had	have	VBD
cord-005453-4057qib7	1986	6	persistent	persistent	JJ
cord-005453-4057qib7	1986	7	GVHD	GVHD	NNP
cord-005453-4057qib7	1986	8	necessitating	necessitate	VBG
cord-005453-4057qib7	1986	9	long	long	JJ
cord-005453-4057qib7	1986	10	-	-	HYPH
cord-005453-4057qib7	1986	11	term	term	NN
cord-005453-4057qib7	1986	12	systemic	systemic	JJ
cord-005453-4057qib7	1986	13	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	1986	14	.	.	.
cord-005453-4057qib7	1987	1	Mild	mild	JJ
cord-005453-4057qib7	1987	2	VOD	VOD	NNP
cord-005453-4057qib7	1987	3	occurred	occur	VBD
cord-005453-4057qib7	1987	4	in	in	IN
cord-005453-4057qib7	1987	5	13%(n=12	13%(n=12	CD
cord-005453-4057qib7	1987	6	)	)	-RRB-
cord-005453-4057qib7	1987	7	,	,	,
cord-005453-4057qib7	1987	8	and	and	CC
cord-005453-4057qib7	1987	9	severe	severe	JJ
cord-005453-4057qib7	1987	10	VOD	vod	NN
cord-005453-4057qib7	1987	11	occurred	occur	VBD
cord-005453-4057qib7	1987	12	in	in	IN
cord-005453-4057qib7	1987	13	2%(n=2	2%(n=2	CD
cord-005453-4057qib7	1987	14	)	)	-RRB-
cord-005453-4057qib7	1987	15	.	.	.
cord-005453-4057qib7	1988	1	One	one	CD
cord-005453-4057qib7	1988	2	of	of	IN
cord-005453-4057qib7	1988	3	them	-PRON-	PRP
cord-005453-4057qib7	1988	4	died	die	VBD
cord-005453-4057qib7	1988	5	but	but	CC
cord-005453-4057qib7	1988	6	was	be	VBD
cord-005453-4057qib7	1988	7	believed	believe	VBN
cord-005453-4057qib7	1988	8	to	to	TO
cord-005453-4057qib7	1988	9	be	be	VB
cord-005453-4057qib7	1988	10	related	relate	VBN
cord-005453-4057qib7	1988	11	to	to	IN
cord-005453-4057qib7	1988	12	the	the	DT
cord-005453-4057qib7	1988	13	underlying	underlie	VBG
cord-005453-4057qib7	1988	14	disease	disease	NN
cord-005453-4057qib7	1988	15	(	(	-LRB-
cord-005453-4057qib7	1988	16	Wolman	Wolman	NNP
cord-005453-4057qib7	1988	17	Syndrome	Syndrome	NNP
cord-005453-4057qib7	1988	18	)	)	-RRB-
cord-005453-4057qib7	1988	19	.	.	.
cord-005453-4057qib7	1989	1	Viral	viral	JJ
cord-005453-4057qib7	1989	2	reactivation	reactivation	NN
cord-005453-4057qib7	1989	3	occurred	occur	VBD
cord-005453-4057qib7	1989	4	in	in	IN
cord-005453-4057qib7	1989	5	55	55	CD
cord-005453-4057qib7	1989	6	%	%	NN
cord-005453-4057qib7	1989	7	of	of	IN
cord-005453-4057qib7	1989	8	patients(n=52	patients(n=52	NN
cord-005453-4057qib7	1989	9	)	)	-RRB-
cord-005453-4057qib7	1989	10	,	,	,
cord-005453-4057qib7	1989	11	with	with	IN
cord-005453-4057qib7	1989	12	CMV	CMV	NNP
cord-005453-4057qib7	1989	13	,	,	,
cord-005453-4057qib7	1989	14	EBV	EBV	NNP
cord-005453-4057qib7	1989	15	,	,	,
cord-005453-4057qib7	1989	16	and	and	CC
cord-005453-4057qib7	1989	17	Adenovirus	Adenovirus	NNP
cord-005453-4057qib7	1989	18	reactivation	reactivation	NN
cord-005453-4057qib7	1989	19	was	be	VBD
cord-005453-4057qib7	1989	20	found	find	VBN
cord-005453-4057qib7	1989	21	in	in	IN
cord-005453-4057qib7	1989	22	34	34	CD
cord-005453-4057qib7	1989	23	%	%	NN
cord-005453-4057qib7	1989	24	,	,	,
cord-005453-4057qib7	1989	25	21	21	CD
cord-005453-4057qib7	1989	26	%	%	NN
cord-005453-4057qib7	1989	27	,	,	,
cord-005453-4057qib7	1989	28	and	and	CC
cord-005453-4057qib7	1989	29	14	14	CD
cord-005453-4057qib7	1989	30	%	%	NN
cord-005453-4057qib7	1989	31	,	,	,
cord-005453-4057qib7	1989	32	respectively	respectively	RB
cord-005453-4057qib7	1989	33	.	.	.
cord-005453-4057qib7	1990	1	Five	five	CD
cord-005453-4057qib7	1990	2	patients	patient	NNS
cord-005453-4057qib7	1990	3	had	have	VBD
cord-005453-4057qib7	1990	4	invasive	invasive	JJ
cord-005453-4057qib7	1990	5	adenoviraemia	adenoviraemia	NN
cord-005453-4057qib7	1990	6	that	that	WDT
cord-005453-4057qib7	1990	7	contributed	contribute	VBD
cord-005453-4057qib7	1990	8	to	to	IN
cord-005453-4057qib7	1990	9	death	death	NN
cord-005453-4057qib7	1990	10	in	in	IN
cord-005453-4057qib7	1990	11	two	two	CD
cord-005453-4057qib7	1990	12	of	of	IN
cord-005453-4057qib7	1990	13	them	-PRON-	PRP
cord-005453-4057qib7	1990	14	.	.	.
cord-005453-4057qib7	1991	1	Primary	primary	JJ
cord-005453-4057qib7	1991	2	graft	graft	NN
cord-005453-4057qib7	1991	3	failure	failure	NN
cord-005453-4057qib7	1991	4	happened	happen	VBD
cord-005453-4057qib7	1991	5	in	in	IN
cord-005453-4057qib7	1991	6	two	two	CD
cord-005453-4057qib7	1991	7	patients(2	patients(2	NN
cord-005453-4057qib7	1991	8	%	%	NN
cord-005453-4057qib7	1991	9	)	)	-RRB-
cord-005453-4057qib7	1991	10	due	due	IN
cord-005453-4057qib7	1991	11	to	to	IN
cord-005453-4057qib7	1991	12	adenoviraemia	adenoviraemia	NNP
cord-005453-4057qib7	1991	13	.	.	.
cord-005453-4057qib7	1992	1	Seven	seven	CD
cord-005453-4057qib7	1992	2	patients(7	patients(7	JJ
cord-005453-4057qib7	1992	3	%	%	NN
cord-005453-4057qib7	1992	4	)	)	-RRB-
cord-005453-4057qib7	1992	5	had	have	VBD
cord-005453-4057qib7	1992	6	secondary	secondary	JJ
cord-005453-4057qib7	1992	7	graft	graft	NN
cord-005453-4057qib7	1992	8	failure	failure	NN
cord-005453-4057qib7	1992	9	with	with	IN
cord-005453-4057qib7	1992	10	autologous	autologous	JJ
cord-005453-4057qib7	1992	11	reconstitution	reconstitution	NN
cord-005453-4057qib7	1992	12	.	.	.
cord-005453-4057qib7	1993	1	Graft	graft	NN
cord-005453-4057qib7	1993	2	failure	failure	NN
cord-005453-4057qib7	1993	3	was	be	VBD
cord-005453-4057qib7	1993	4	significantly	significantly	RB
cord-005453-4057qib7	1993	5	lower	low	JJR
cord-005453-4057qib7	1993	6	(	(	-LRB-
cord-005453-4057qib7	1993	7	P0.045	p0.045	NN
cord-005453-4057qib7	1993	8	)	)	-RRB-
cord-005453-4057qib7	1993	9	in	in	IN
cord-005453-4057qib7	1993	10	the	the	DT
cord-005453-4057qib7	1993	11	FTT	FTT	NNP
cord-005453-4057qib7	1993	12	group	group	NN
cord-005453-4057qib7	1993	13	than	than	IN
cord-005453-4057qib7	1993	14	other	other	JJ
cord-005453-4057qib7	1993	15	conditioning	conditioning	NN
cord-005453-4057qib7	1993	16	groups	group	NNS
cord-005453-4057qib7	1993	17	.	.	.
cord-005453-4057qib7	1994	1	At	at	IN
cord-005453-4057qib7	1994	2	a	a	DT
cord-005453-4057qib7	1994	3	median	median	JJ
cord-005453-4057qib7	1994	4	follow	follow	NN
cord-005453-4057qib7	1994	5	-	-	HYPH
cord-005453-4057qib7	1994	6	up	up	NN
cord-005453-4057qib7	1994	7	of	of	IN
cord-005453-4057qib7	1994	8	35	35	CD
cord-005453-4057qib7	1994	9	months	month	NNS
cord-005453-4057qib7	1994	10	(	(	-LRB-
cord-005453-4057qib7	1994	11	Range	range	NN
cord-005453-4057qib7	1994	12	,	,	,
cord-005453-4057qib7	1994	13	two-174	two-174	NNP
cord-005453-4057qib7	1994	14	months	month	NNS
cord-005453-4057qib7	1994	15	)	)	-RRB-
cord-005453-4057qib7	1994	16	,	,	,
cord-005453-4057qib7	1994	17	eleven	eleven	CD
cord-005453-4057qib7	1994	18	patients(11.9	patients(11.9	NN
cord-005453-4057qib7	1994	19	%	%	NN
cord-005453-4057qib7	1994	20	)	)	-RRB-
cord-005453-4057qib7	1994	21	died	die	VBD
cord-005453-4057qib7	1994	22	,	,	,
cord-005453-4057qib7	1994	23	with	with	IN
cord-005453-4057qib7	1994	24	Overall	overall	JJ
cord-005453-4057qib7	1994	25	survival	survival	NN
cord-005453-4057qib7	1994	26	of	of	IN
cord-005453-4057qib7	1994	27	88.1	88.1	CD
cord-005453-4057qib7	1994	28	%	%	NN
cord-005453-4057qib7	1994	29	,	,	,
cord-005453-4057qib7	1994	30	and	and	CC
cord-005453-4057qib7	1994	31	event	event	NN
cord-005453-4057qib7	1994	32	-	-	HYPH
cord-005453-4057qib7	1994	33	free	free	JJ
cord-005453-4057qib7	1994	34	survival	survival	NN
cord-005453-4057qib7	1994	35	of	of	IN
cord-005453-4057qib7	1994	36	80.9	80.9	CD
cord-005453-4057qib7	1994	37	%	%	NN
cord-005453-4057qib7	1994	38	.	.	.
cord-005453-4057qib7	1995	1	Five	five	CD
cord-005453-4057qib7	1995	2	patients	patient	NNS
cord-005453-4057qib7	1995	3	died	die	VBD
cord-005453-4057qib7	1995	4	due	due	IN
cord-005453-4057qib7	1995	5	to	to	IN
cord-005453-4057qib7	1995	6	complications	complication	NNS
cord-005453-4057qib7	1995	7	related	relate	VBN
cord-005453-4057qib7	1995	8	to	to	IN
cord-005453-4057qib7	1995	9	their	-PRON-	PRP$
cord-005453-4057qib7	1995	10	original	original	JJ
cord-005453-4057qib7	1995	11	disease	disease	NN
cord-005453-4057qib7	1995	12	,	,	,
cord-005453-4057qib7	1995	13	while	while	IN
cord-005453-4057qib7	1995	14	six	six	CD
cord-005453-4057qib7	1995	15	patients	patient	NNS
cord-005453-4057qib7	1995	16	died	die	VBD
cord-005453-4057qib7	1995	17	due	due	JJ
cord-005453-4057qib7	1995	18	to	to	IN
cord-005453-4057qib7	1995	19	transplant	transplant	NN
cord-005453-4057qib7	1995	20	-	-	HYPH
cord-005453-4057qib7	1995	21	related	relate	VBN
cord-005453-4057qib7	1995	22	causes	cause	NNS
cord-005453-4057qib7	1995	23	(	(	-LRB-
cord-005453-4057qib7	1995	24	transplant	transplant	NN
cord-005453-4057qib7	1995	25	-	-	HYPH
cord-005453-4057qib7	1995	26	related	relate	VBN
cord-005453-4057qib7	1995	27	mortality	mortality	NN
cord-005453-4057qib7	1995	28	6.5	6.5	CD
cord-005453-4057qib7	1995	29	%	%	NN
cord-005453-4057qib7	1995	30	)	)	-RRB-
cord-005453-4057qib7	1995	31	.	.	.
cord-005453-4057qib7	1996	1	Immune	immune	JJ
cord-005453-4057qib7	1996	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	1996	3	in	in	IN
cord-005453-4057qib7	1996	4	alive	alive	JJ
cord-005453-4057qib7	1996	5	patients	patient	NNS
cord-005453-4057qib7	1996	6	was	be	VBD
cord-005453-4057qib7	1996	7	achieved	achieve	VBN
cord-005453-4057qib7	1996	8	at	at	IN
cord-005453-4057qib7	1996	9	a	a	DT
cord-005453-4057qib7	1996	10	median	median	NN
cord-005453-4057qib7	1996	11	of	of	IN
cord-005453-4057qib7	1996	12	eight	eight	CD
cord-005453-4057qib7	1996	13	months	month	NNS
cord-005453-4057qib7	1996	14	.	.	.
cord-005453-4057qib7	1997	1	This	this	DT
cord-005453-4057qib7	1997	2	time	time	NN
cord-005453-4057qib7	1997	3	was	be	VBD
cord-005453-4057qib7	1997	4	significantly	significantly	RB
cord-005453-4057qib7	1997	5	longer	long	JJR
cord-005453-4057qib7	1997	6	(	(	-LRB-
cord-005453-4057qib7	1997	7	P0.034	P0.034	NNP
cord-005453-4057qib7	1997	8	)	)	-RRB-
cord-005453-4057qib7	1997	9	in	in	IN
cord-005453-4057qib7	1997	10	FTT	FTT	NNP
cord-005453-4057qib7	1997	11	group	group	NN
cord-005453-4057qib7	1997	12	.	.	.
cord-005453-4057qib7	1998	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	1998	2	:	:	:
cord-005453-4057qib7	1999	1	This	this	DT
cord-005453-4057qib7	1999	2	study	study	NN
cord-005453-4057qib7	1999	3	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	1999	4	that	that	IN
cord-005453-4057qib7	1999	5	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	1999	6	is	be	VBZ
cord-005453-4057qib7	1999	7	a	a	DT
cord-005453-4057qib7	1999	8	safe	safe	JJ
cord-005453-4057qib7	1999	9	and	and	CC
cord-005453-4057qib7	1999	10	effective	effective	JJ
cord-005453-4057qib7	1999	11	conditioning	conditioning	NN
cord-005453-4057qib7	1999	12	drug	drug	NN
cord-005453-4057qib7	1999	13	that	that	WDT
cord-005453-4057qib7	1999	14	can	can	MD
cord-005453-4057qib7	1999	15	achieve	achieve	VB
cord-005453-4057qib7	1999	16	engraftment	engraftment	NN
cord-005453-4057qib7	1999	17	,	,	,
cord-005453-4057qib7	1999	18	with	with	IN
cord-005453-4057qib7	1999	19	low	low	JJ
cord-005453-4057qib7	1999	20	rates	rate	NNS
cord-005453-4057qib7	1999	21	of	of	IN
cord-005453-4057qib7	1999	22	graft	graft	NN
cord-005453-4057qib7	1999	23	failure	failure	NN
cord-005453-4057qib7	1999	24	,	,	,
cord-005453-4057qib7	1999	25	transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	1999	26	mortality	mortality	NN
cord-005453-4057qib7	1999	27	and	and	CC
cord-005453-4057qib7	1999	28	morbidity	morbidity	NN
cord-005453-4057qib7	1999	29	,	,	,
cord-005453-4057qib7	1999	30	even	even	RB
cord-005453-4057qib7	1999	31	if	if	IN
cord-005453-4057qib7	1999	32	it	-PRON-	PRP
cord-005453-4057qib7	1999	33	is	be	VBZ
cord-005453-4057qib7	1999	34	used	use	VBN
cord-005453-4057qib7	1999	35	twice	twice	RB
cord-005453-4057qib7	1999	36	in	in	IN
cord-005453-4057qib7	1999	37	the	the	DT
cord-005453-4057qib7	1999	38	same	same	JJ
cord-005453-4057qib7	1999	39	patient	patient	NN
cord-005453-4057qib7	1999	40	.	.	.
cord-005453-4057qib7	2000	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2000	2	:	:	:
cord-005453-4057qib7	2001	1	Nothing	nothing	NN
cord-005453-4057qib7	2001	2	to	to	TO
cord-005453-4057qib7	2001	3	declare	declare	VB
cord-005453-4057qib7	2001	4	Background	background	NN
cord-005453-4057qib7	2001	5	:	:	:
cord-005453-4057qib7	2001	6	High	high	JJ
cord-005453-4057qib7	2001	7	-	-	HYPH
cord-005453-4057qib7	2001	8	dose	dose	NN
cord-005453-4057qib7	2001	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2001	10	(	(	-LRB-
cord-005453-4057qib7	2001	11	HDC	HDC	NNP
cord-005453-4057qib7	2001	12	)	)	-RRB-
cord-005453-4057qib7	2001	13	followed	follow	VBN
cord-005453-4057qib7	2001	14	by	by	IN
cord-005453-4057qib7	2001	15	autologous	autologous	JJ
cord-005453-4057qib7	2001	16	stem	stem	NN
cord-005453-4057qib7	2001	17	cell	cell	NN
cord-005453-4057qib7	2001	18	transplantation	transplantation	NN
cord-005453-4057qib7	2001	19	(	(	-LRB-
cord-005453-4057qib7	2001	20	ASCT	ASCT	NNP
cord-005453-4057qib7	2001	21	)	)	-RRB-
cord-005453-4057qib7	2001	22	is	be	VBZ
cord-005453-4057qib7	2001	23	the	the	DT
cord-005453-4057qib7	2001	24	treatment	treatment	NN
cord-005453-4057qib7	2001	25	of	of	IN
cord-005453-4057qib7	2001	26	choice	choice	NN
cord-005453-4057qib7	2001	27	for	for	IN
cord-005453-4057qib7	2001	28	the	the	DT
cord-005453-4057qib7	2001	29	patients	patient	NNS
cord-005453-4057qib7	2001	30	with	with	IN
cord-005453-4057qib7	2001	31	relapsed	relapsed	JJ
cord-005453-4057qib7	2001	32	or	or	CC
cord-005453-4057qib7	2001	33	high	high	JJ
cord-005453-4057qib7	2001	34	risk	risk	NN
cord-005453-4057qib7	2001	35	NHL	NHL	NNP
cord-005453-4057qib7	2001	36	.	.	.
cord-005453-4057qib7	2002	1	Although	although	IN
cord-005453-4057qib7	2002	2	the	the	DT
cord-005453-4057qib7	2002	3	high	high	JJ
cord-005453-4057qib7	2002	4	-	-	HYPH
cord-005453-4057qib7	2002	5	dose	dose	NN
cord-005453-4057qib7	2002	6	conditioning	conditioning	NN
cord-005453-4057qib7	2002	7	regimens	regimen	NNS
cord-005453-4057qib7	2002	8	commonly	commonly	RB
cord-005453-4057qib7	2002	9	used	use	VBN
cord-005453-4057qib7	2002	10	in	in	IN
cord-005453-4057qib7	2002	11	patients	patient	NNS
cord-005453-4057qib7	2002	12	with	with	IN
cord-005453-4057qib7	2002	13	non	non	JJ
cord-005453-4057qib7	2002	14	-	-	JJ
cord-005453-4057qib7	2002	15	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	2002	16	lymphoma	lymphoma	NN
cord-005453-4057qib7	2002	17	(	(	-LRB-
cord-005453-4057qib7	2002	18	NHL	NHL	NNP
cord-005453-4057qib7	2002	19	)	)	-RRB-
cord-005453-4057qib7	2002	20	are	be	VBP
cord-005453-4057qib7	2002	21	BEAM	beam	NN
cord-005453-4057qib7	2002	22	(	(	-LRB-
cord-005453-4057qib7	2002	23	BCNU	BCNU	NNP
cord-005453-4057qib7	2002	24	,	,	,
cord-005453-4057qib7	2002	25	etoposide	etoposide	RB
cord-005453-4057qib7	2002	26	,	,	,
cord-005453-4057qib7	2002	27	cytarabine	cytarabine	NNP
cord-005453-4057qib7	2002	28	,	,	,
cord-005453-4057qib7	2002	29	and	and	CC
cord-005453-4057qib7	2002	30	melphalan	melphalan	NNP
cord-005453-4057qib7	2002	31	)	)	-RRB-
cord-005453-4057qib7	2002	32	,	,	,
cord-005453-4057qib7	2002	33	BEAC	BEAC	NNP
cord-005453-4057qib7	2002	34	(	(	-LRB-
cord-005453-4057qib7	2002	35	BCNU	BCNU	NNP
cord-005453-4057qib7	2002	36	,	,	,
cord-005453-4057qib7	2002	37	etoposide	etoposide	RB
cord-005453-4057qib7	2002	38	,	,	,
cord-005453-4057qib7	2002	39	cytarabine	cytarabine	NN
cord-005453-4057qib7	2002	40	,	,	,
cord-005453-4057qib7	2002	41	and	and	CC
cord-005453-4057qib7	2002	42	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2002	43	)	)	-RRB-
cord-005453-4057qib7	2002	44	,	,	,
cord-005453-4057qib7	2002	45	survival	survival	NN
cord-005453-4057qib7	2002	46	of	of	IN
cord-005453-4057qib7	2002	47	patients	patient	NNS
cord-005453-4057qib7	2002	48	with	with	IN
cord-005453-4057qib7	2002	49	NHL	NHL	NNP
cord-005453-4057qib7	2002	50	received	receive	VBN
cord-005453-4057qib7	2002	51	above	above	IN
cord-005453-4057qib7	2002	52	high	high	JJ
cord-005453-4057qib7	2002	53	-	-	HYPH
cord-005453-4057qib7	2002	54	dose	dose	NN
cord-005453-4057qib7	2002	55	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2002	56	followed	follow	VBN
cord-005453-4057qib7	2002	57	by	by	IN
cord-005453-4057qib7	2002	58	ASCT	ASCT	NNP
cord-005453-4057qib7	2002	59	was	be	VBD
cord-005453-4057qib7	2002	60	still	still	RB
cord-005453-4057qib7	2002	61	unsatisfactory	unsatisfactory	JJ
cord-005453-4057qib7	2002	62	.	.	.
cord-005453-4057qib7	2003	1	Methods	method	NNS
cord-005453-4057qib7	2003	2	:	:	:
cord-005453-4057qib7	2003	3	We	-PRON-	PRP
cord-005453-4057qib7	2003	4	prospectively	prospectively	RB
cord-005453-4057qib7	2003	5	evaluated	evaluate	VBD
cord-005453-4057qib7	2003	6	the	the	DT
cord-005453-4057qib7	2003	7	efficacy	efficacy	NN
cord-005453-4057qib7	2003	8	and	and	CC
cord-005453-4057qib7	2003	9	toxicity	toxicity	NN
cord-005453-4057qib7	2003	10	of	of	IN
cord-005453-4057qib7	2003	11	busulfan	busulfan	NN
cord-005453-4057qib7	2003	12	,	,	,
cord-005453-4057qib7	2003	13	etoposide	etoposide	RB
cord-005453-4057qib7	2003	14	,	,	,
cord-005453-4057qib7	2003	15	cytarabine	cytarabine	NNP
cord-005453-4057qib7	2003	16	and	and	CC
cord-005453-4057qib7	2003	17	melphalan	melphalan	NNP
cord-005453-4057qib7	2003	18	(	(	-LRB-
cord-005453-4057qib7	2003	19	BuEAM	bueam	RB
cord-005453-4057qib7	2003	20	)	)	-RRB-
cord-005453-4057qib7	2003	21	including	include	VBG
cord-005453-4057qib7	2003	22	iv	iv	NNP
cord-005453-4057qib7	2003	23	busulfan	busulfan	NNP
cord-005453-4057qib7	2003	24	instead	instead	RB
cord-005453-4057qib7	2003	25	of	of	IN
cord-005453-4057qib7	2003	26	BCNU	BCNU	NNP
cord-005453-4057qib7	2003	27	of	of	IN
cord-005453-4057qib7	2003	28	standard	standard	JJ
cord-005453-4057qib7	2003	29	BEAM	BEAM	NNP
cord-005453-4057qib7	2003	30	as	as	IN
cord-005453-4057qib7	2003	31	a	a	DT
cord-005453-4057qib7	2003	32	conditioning	conditioning	NN
cord-005453-4057qib7	2003	33	for	for	IN
cord-005453-4057qib7	2003	34	ASCT	ASCT	NNP
cord-005453-4057qib7	2003	35	in	in	IN
cord-005453-4057qib7	2003	36	patients	patient	NNS
cord-005453-4057qib7	2003	37	with	with	IN
cord-005453-4057qib7	2003	38	NHL	NHL	NNP
cord-005453-4057qib7	2003	39	.	.	.
cord-005453-4057qib7	2004	1	The	the	DT
cord-005453-4057qib7	2004	2	high	high	JJ
cord-005453-4057qib7	2004	3	-	-	HYPH
cord-005453-4057qib7	2004	4	dose	dose	NN
cord-005453-4057qib7	2004	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2004	6	consisted	consist	VBN
cord-005453-4057qib7	2004	7	of	of	IN
cord-005453-4057qib7	2004	8	Bu	Bu	NNP
cord-005453-4057qib7	2004	9	(	(	-LRB-
cord-005453-4057qib7	2004	10	3.2	3.2	CD
cord-005453-4057qib7	2004	11	mg	mg	NNP
cord-005453-4057qib7	2004	12	/	/	SYM
cord-005453-4057qib7	2004	13	kg	kg	NNP
cord-005453-4057qib7	2004	14	i.v	i.v	NNP
cord-005453-4057qib7	2004	15	.	.	NNP
cord-005453-4057qib7	2004	16	q.d	q.d	NNP
cord-005453-4057qib7	2004	17	.	.	NNP
cord-005453-4057qib7	2004	18	from	from	IN
cord-005453-4057qib7	2004	19	day	day	NN
cord-005453-4057qib7	2004	20	-6	-6	NNP
cord-005453-4057qib7	2004	21	to	to	IN
cord-005453-4057qib7	2004	22	day	day	NN
cord-005453-4057qib7	2004	23	-5	-5	NNP
cord-005453-4057qib7	2004	24	)	)	-RRB-
cord-005453-4057qib7	2004	25	,	,	,
cord-005453-4057qib7	2004	26	E	E	NNP
cord-005453-4057qib7	2004	27	(	(	-LRB-
cord-005453-4057qib7	2004	28	200	200	CD
cord-005453-4057qib7	2004	29	mg	mg	NNP
cord-005453-4057qib7	2004	30	/	/	SYM
cord-005453-4057qib7	2004	31	m	m	NNP
cord-005453-4057qib7	2004	32	2	2	CD
cord-005453-4057qib7	2004	33	i.v	i.v	NNP
cord-005453-4057qib7	2004	34	.	.	NNP
cord-005453-4057qib7	2004	35	b.i.d	b.i.d	NNP
cord-005453-4057qib7	2004	36	.	.	NNP
cord-005453-4057qib7	2004	37	on	on	IN
cord-005453-4057qib7	2004	38	day	day	NN
cord-005453-4057qib7	2004	39	-4	-4	NNP
cord-005453-4057qib7	2004	40	and	and	CC
cord-005453-4057qib7	2004	41	day	day	NN
cord-005453-4057qib7	2004	42	-3	-3	NNP
cord-005453-4057qib7	2004	43	)	)	-RRB-
cord-005453-4057qib7	2005	1	A	a	DT
cord-005453-4057qib7	2005	2	(	(	-LRB-
cord-005453-4057qib7	2005	3	1	1	CD
cord-005453-4057qib7	2005	4	g	g	NN
cord-005453-4057qib7	2005	5	/	/	SYM
cord-005453-4057qib7	2005	6	m	m	NNP
cord-005453-4057qib7	2005	7	2	2	CD
cord-005453-4057qib7	2005	8	i.v	i.v	NNP
cord-005453-4057qib7	2005	9	.	.	NNP
cord-005453-4057qib7	2005	10	q.d	q.d	NNP
cord-005453-4057qib7	2005	11	.	.	.
cord-005453-4057qib7	2006	1	on	on	IN
cord-005453-4057qib7	2006	2	day	day	NN
cord-005453-4057qib7	2006	3	-4	-4	NNP
cord-005453-4057qib7	2006	4	and	and	CC
cord-005453-4057qib7	2006	5	day	day	NN
cord-005453-4057qib7	2006	6	-3	-3	NNP
cord-005453-4057qib7	2006	7	)	)	-RRB-
cord-005453-4057qib7	2007	1	and	and	CC
cord-005453-4057qib7	2007	2	M	M	NNP
cord-005453-4057qib7	2007	3	(	(	-LRB-
cord-005453-4057qib7	2007	4	140	140	CD
cord-005453-4057qib7	2007	5	mg	mg	NNP
cord-005453-4057qib7	2007	6	/	/	SYM
cord-005453-4057qib7	2007	7	m	m	NNP
cord-005453-4057qib7	2007	8	2	2	CD
cord-005453-4057qib7	2007	9	i.v	i.v	NNP
cord-005453-4057qib7	2007	10	.	.	NNP
cord-005453-4057qib7	2007	11	q.d	q.d	NNP
cord-005453-4057qib7	2007	12	.	.	NNP
cord-005453-4057qib7	2007	13	on	on	IN
cord-005453-4057qib7	2007	14	day	day	NN
cord-005453-4057qib7	2007	15	-2	-2	CD
cord-005453-4057qib7	2007	16	)	)	-RRB-
cord-005453-4057qib7	2007	17	at	at	IN
cord-005453-4057qib7	2007	18	7	7	CD
cord-005453-4057qib7	2007	19	centers	center	NNS
cord-005453-4057qib7	2007	20	in	in	IN
cord-005453-4057qib7	2007	21	Korea	Korea	NNP
cord-005453-4057qib7	2007	22	.	.	.
cord-005453-4057qib7	2008	1	Results	result	NNS
cord-005453-4057qib7	2008	2	:	:	:
cord-005453-4057qib7	2009	1	Two	two	CD
cord-005453-4057qib7	2009	2	hundred	hundred	CD
cord-005453-4057qib7	2009	3	five	five	CD
cord-005453-4057qib7	2009	4	patients	patient	NNS
cord-005453-4057qib7	2009	5	were	be	VBD
cord-005453-4057qib7	2009	6	enrolled	enrol	VBN
cord-005453-4057qib7	2009	7	onto	onto	IN
cord-005453-4057qib7	2009	8	the	the	DT
cord-005453-4057qib7	2009	9	study	study	NN
cord-005453-4057qib7	2009	10	.	.	.
cord-005453-4057qib7	2010	1	Main	main	JJ
cord-005453-4057qib7	2010	2	subgroup	subgroup	NN
cord-005453-4057qib7	2010	3	was	be	VBD
cord-005453-4057qib7	2010	4	diffuse	diffuse	JJ
cord-005453-4057qib7	2010	5	large	large	JJ
cord-005453-4057qib7	2010	6	B	b	NN
cord-005453-4057qib7	2010	7	cell	cell	NN
cord-005453-4057qib7	2010	8	lymphoma	lymphoma	NN
cord-005453-4057qib7	2010	9	(	(	-LRB-
cord-005453-4057qib7	2010	10	n=104	n=104	NNP
cord-005453-4057qib7	2010	11	,	,	,
cord-005453-4057qib7	2010	12	50.7	50.7	CD
cord-005453-4057qib7	2010	13	%	%	NN
cord-005453-4057qib7	2010	14	)	)	-RRB-
cord-005453-4057qib7	2010	15	,	,	,
cord-005453-4057qib7	2010	16	T	t	NN
cord-005453-4057qib7	2010	17	cell	cell	NN
cord-005453-4057qib7	2010	18	lymphomas	lymphoma	NNS
cord-005453-4057qib7	2010	19	(	(	-LRB-
cord-005453-4057qib7	2010	20	n=59	n=59	FW
cord-005453-4057qib7	2010	21	,	,	,
cord-005453-4057qib7	2010	22	29.8	29.8	CD
cord-005453-4057qib7	2010	23	%	%	NN
cord-005453-4057qib7	2010	24	)	)	-RRB-
cord-005453-4057qib7	2010	25	,	,	,
cord-005453-4057qib7	2010	26	and	and	CC
cord-005453-4057qib7	2010	27	NK	NK	NNP
cord-005453-4057qib7	2010	28	/	/	SYM
cord-005453-4057qib7	2010	29	T	T	NNP
cord-005453-4057qib7	2010	30	cell	cell	NN
cord-005453-4057qib7	2010	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	2010	32	(	(	-LRB-
cord-005453-4057qib7	2010	33	n=22	n=22	NNP
cord-005453-4057qib7	2010	34	,	,	,
cord-005453-4057qib7	2010	35	10.7	10.7	CD
cord-005453-4057qib7	2010	36	%	%	NN
cord-005453-4057qib7	2010	37	)	)	-RRB-
cord-005453-4057qib7	2010	38	.	.	.
cord-005453-4057qib7	2011	1	Upfront	Upfront	NNP
cord-005453-4057qib7	2011	2	ASCT	ASCT	NNP
cord-005453-4057qib7	2011	3	was	be	VBD
cord-005453-4057qib7	2011	4	performed	perform	VBN
cord-005453-4057qib7	2011	5	in	in	IN
cord-005453-4057qib7	2011	6	160	160	CD
cord-005453-4057qib7	2011	7	patients	patient	NNS
cord-005453-4057qib7	2011	8	(	(	-LRB-
cord-005453-4057qib7	2011	9	78.0	78.0	CD
cord-005453-4057qib7	2011	10	%	%	NN
cord-005453-4057qib7	2011	11	)	)	-RRB-
cord-005453-4057qib7	2011	12	,	,	,
cord-005453-4057qib7	2011	13	and	and	CC
cord-005453-4057qib7	2011	14	salvage	salvage	VB
cord-005453-4057qib7	2011	15	ASCT	ASCT	NNP
cord-005453-4057qib7	2011	16	in	in	IN
cord-005453-4057qib7	2011	17	45	45	CD
cord-005453-4057qib7	2011	18	patients	patient	NNS
cord-005453-4057qib7	2011	19	(	(	-LRB-
cord-005453-4057qib7	2011	20	22.0	22.0	CD
cord-005453-4057qib7	2011	21	%	%	NN
cord-005453-4057qib7	2011	22	)	)	-RRB-
cord-005453-4057qib7	2011	23	.	.	.
cord-005453-4057qib7	2012	1	The	the	DT
cord-005453-4057qib7	2012	2	disease	disease	NN
cord-005453-4057qib7	2012	3	status	status	NN
cord-005453-4057qib7	2012	4	of	of	IN
cord-005453-4057qib7	2012	5	the	the	DT
cord-005453-4057qib7	2012	6	patients	patient	NNS
cord-005453-4057qib7	2012	7	before	before	IN
cord-005453-4057qib7	2012	8	HDT	HDT	NNP
cord-005453-4057qib7	2012	9	/	/	SYM
cord-005453-4057qib7	2012	10	ASCT	ASCT	NNP
cord-005453-4057qib7	2012	11	consisted	consist	VBD
cord-005453-4057qib7	2012	12	of	of	IN
cord-005453-4057qib7	2012	13	133	133	CD
cord-005453-4057qib7	2012	14	patients	patient	NNS
cord-005453-4057qib7	2012	15	(	(	-LRB-
cord-005453-4057qib7	2012	16	64.8	64.8	CD
cord-005453-4057qib7	2012	17	%	%	NN
cord-005453-4057qib7	2012	18	)	)	-RRB-
cord-005453-4057qib7	2012	19	with	with	IN
cord-005453-4057qib7	2012	20	complete	complete	JJ
cord-005453-4057qib7	2012	21	response	response	NN
cord-005453-4057qib7	2012	22	and	and	CC
cord-005453-4057qib7	2012	23	72	72	CD
cord-005453-4057qib7	2012	24	patients	patient	NNS
cord-005453-4057qib7	2012	25	(	(	-LRB-
cord-005453-4057qib7	2012	26	35.2	35.2	CD
cord-005453-4057qib7	2012	27	%	%	NN
cord-005453-4057qib7	2012	28	)	)	-RRB-
cord-005453-4057qib7	2012	29	with	with	IN
cord-005453-4057qib7	2012	30	partial	partial	JJ
cord-005453-4057qib7	2012	31	response	response	NN
cord-005453-4057qib7	2012	32	.	.	.
cord-005453-4057qib7	2013	1	Treatment	treatment	NN
cord-005453-4057qib7	2013	2	related	related	JJ
cord-005453-4057qib7	2013	3	toxicities	toxicity	NNS
cord-005453-4057qib7	2013	4	included	include	VBD
cord-005453-4057qib7	2013	5	nausea	nausea	NN
cord-005453-4057qib7	2013	6	in	in	IN
cord-005453-4057qib7	2013	7	149	149	CD
cord-005453-4057qib7	2013	8	patients	patient	NNS
cord-005453-4057qib7	2013	9	(	(	-LRB-
cord-005453-4057qib7	2013	10	72.7	72.7	CD
cord-005453-4057qib7	2013	11	%	%	NN
cord-005453-4057qib7	2013	12	)	)	-RRB-
cord-005453-4057qib7	2013	13	,	,	,
cord-005453-4057qib7	2013	14	diarrhea	diarrhea	NN
cord-005453-4057qib7	2013	15	in	in	IN
cord-005453-4057qib7	2013	16	127	127	CD
cord-005453-4057qib7	2013	17	patients	patient	NNS
cord-005453-4057qib7	2013	18	(	(	-LRB-
cord-005453-4057qib7	2013	19	62.0	62.0	CD
cord-005453-4057qib7	2013	20	%	%	NN
cord-005453-4057qib7	2013	21	)	)	-RRB-
cord-005453-4057qib7	2013	22	,	,	,
cord-005453-4057qib7	2013	23	anorexia	anorexia	VBN
cord-005453-4057qib7	2013	24	in	in	IN
cord-005453-4057qib7	2013	25	107	107	CD
cord-005453-4057qib7	2013	26	patients	patient	NNS
cord-005453-4057qib7	2013	27	(	(	-LRB-
cord-005453-4057qib7	2013	28	52.2	52.2	CD
cord-005453-4057qib7	2013	29	%	%	NN
cord-005453-4057qib7	2013	30	)	)	-RRB-
cord-005453-4057qib7	2013	31	and	and	CC
cord-005453-4057qib7	2013	32	stomatitis	stomatitis	NN
cord-005453-4057qib7	2013	33	in	in	IN
cord-005453-4057qib7	2013	34	97	97	CD
cord-005453-4057qib7	2013	35	patients	patient	NNS
cord-005453-4057qib7	2013	36	(	(	-LRB-
cord-005453-4057qib7	2013	37	47.3	47.3	CD
cord-005453-4057qib7	2013	38	%	%	NN
cord-005453-4057qib7	2013	39	)	)	-RRB-
cord-005453-4057qib7	2013	40	,	,	,
cord-005453-4057qib7	2013	41	which	which	WDT
cord-005453-4057qib7	2013	42	were	be	VBD
cord-005453-4057qib7	2013	43	grade	grade	NN
cord-005453-4057qib7	2013	44	I	-PRON-	PRP
cord-005453-4057qib7	2013	45	or	or	CC
cord-005453-4057qib7	2013	46	II	II	NNP
cord-005453-4057qib7	2013	47	in	in	IN
cord-005453-4057qib7	2013	48	the	the	DT
cord-005453-4057qib7	2013	49	majority	majority	NN
cord-005453-4057qib7	2013	50	of	of	IN
cord-005453-4057qib7	2013	51	cases	case	NNS
cord-005453-4057qib7	2013	52	.	.	.
cord-005453-4057qib7	2014	1	The	the	DT
cord-005453-4057qib7	2014	2	common	common	JJ
cord-005453-4057qib7	2014	3	grade	grade	NN
cord-005453-4057qib7	2014	4	III	iii	CD
cord-005453-4057qib7	2014	5	toxicities	toxicity	NNS
cord-005453-4057qib7	2014	6	were	be	VBD
cord-005453-4057qib7	2014	7	stomatitis	stomatitis	JJ
cord-005453-4057qib7	2014	8	(	(	-LRB-
cord-005453-4057qib7	2014	9	6.9	6.9	CD
cord-005453-4057qib7	2014	10	%	%	NN
cord-005453-4057qib7	2014	11	)	)	-RRB-
cord-005453-4057qib7	2014	12	,	,	,
cord-005453-4057qib7	2014	13	diarrhea	diarrhea	NN
cord-005453-4057qib7	2014	14	(	(	-LRB-
cord-005453-4057qib7	2014	15	5.9	5.9	CD
cord-005453-4057qib7	2014	16	%	%	NN
cord-005453-4057qib7	2014	17	)	)	-RRB-
cord-005453-4057qib7	2014	18	,	,	,
cord-005453-4057qib7	2014	19	and	and	CC
cord-005453-4057qib7	2014	20	anorexia	anorexia	NN
cord-005453-4057qib7	2014	21	(	(	-LRB-
cord-005453-4057qib7	2014	22	5.4	5.4	CD
cord-005453-4057qib7	2014	23	%	%	NN
cord-005453-4057qib7	2014	24	)	)	-RRB-
cord-005453-4057qib7	2014	25	.	.	.
cord-005453-4057qib7	2015	1	There	there	EX
cord-005453-4057qib7	2015	2	were	be	VBD
cord-005453-4057qib7	2015	3	no	no	DT
cord-005453-4057qib7	2015	4	VOD	vod	NN
cord-005453-4057qib7	2015	5	,	,	,
cord-005453-4057qib7	2015	6	and	and	CC
cord-005453-4057qib7	2015	7	transplant	transplant	NN
cord-005453-4057qib7	2015	8	-	-	HYPH
cord-005453-4057qib7	2015	9	related	relate	VBN
cord-005453-4057qib7	2015	10	mortality	mortality	NN
cord-005453-4057qib7	2015	11	occurred	occur	VBD
cord-005453-4057qib7	2015	12	in	in	IN
cord-005453-4057qib7	2015	13	4	4	CD
cord-005453-4057qib7	2015	14	patients	patient	NNS
cord-005453-4057qib7	2015	15	(	(	-LRB-
cord-005453-4057qib7	2015	16	1.95	1.95	CD
cord-005453-4057qib7	2015	17	%	%	NN
cord-005453-4057qib7	2015	18	)	)	-RRB-
cord-005453-4057qib7	2015	19	,	,	,
cord-005453-4057qib7	2015	20	due	due	IN
cord-005453-4057qib7	2015	21	to	to	IN
cord-005453-4057qib7	2015	22	infection	infection	NN
cord-005453-4057qib7	2015	23	.	.	.
cord-005453-4057qib7	2016	1	One	one	CD
cord-005453-4057qib7	2016	2	hundred	hundred	CD
cord-005453-4057qib7	2016	3	fifty	fifty	CD
cord-005453-4057qib7	2016	4	three	three	CD
cord-005453-4057qib7	2016	5	patients	patient	NNS
cord-005453-4057qib7	2016	6	(	(	-LRB-
cord-005453-4057qib7	2016	7	74.6	74.6	CD
cord-005453-4057qib7	2016	8	%	%	NN
cord-005453-4057qib7	2016	9	)	)	-RRB-
cord-005453-4057qib7	2016	10	achieved	achieve	VBD
cord-005453-4057qib7	2016	11	a	a	DT
cord-005453-4057qib7	2016	12	complete	complete	JJ
cord-005453-4057qib7	2016	13	response	response	NN
cord-005453-4057qib7	2016	14	and	and	CC
cord-005453-4057qib7	2016	15	13	13	CD
cord-005453-4057qib7	2016	16	patients	patient	NNS
cord-005453-4057qib7	2016	17	(	(	-LRB-
cord-005453-4057qib7	2016	18	6.3	6.3	CD
cord-005453-4057qib7	2016	19	%	%	NN
cord-005453-4057qib7	2016	20	)	)	-RRB-
cord-005453-4057qib7	2016	21	after	after	IN
cord-005453-4057qib7	2016	22	ASCT	ASCT	NNP
cord-005453-4057qib7	2016	23	,	,	,
cord-005453-4057qib7	2016	24	while	while	IN
cord-005453-4057qib7	2016	25	28	28	CD
cord-005453-4057qib7	2016	26	patients	patient	NNS
cord-005453-4057qib7	2016	27	(	(	-LRB-
cord-005453-4057qib7	2016	28	13.7	13.7	CD
cord-005453-4057qib7	2016	29	%	%	NN
cord-005453-4057qib7	2016	30	)	)	-RRB-
cord-005453-4057qib7	2016	31	showed	show	VBD
cord-005453-4057qib7	2016	32	progressive	progressive	JJ
cord-005453-4057qib7	2016	33	disease	disease	NN
cord-005453-4057qib7	2016	34	.	.	.
cord-005453-4057qib7	2017	1	At	at	IN
cord-005453-4057qib7	2017	2	a	a	DT
cord-005453-4057qib7	2017	3	median	median	JJ
cord-005453-4057qib7	2017	4	follow	follow	NN
cord-005453-4057qib7	2017	5	-	-	HYPH
cord-005453-4057qib7	2017	6	up	up	NN
cord-005453-4057qib7	2017	7	duration	duration	NN
cord-005453-4057qib7	2017	8	of	of	IN
cord-005453-4057qib7	2017	9	38.6	38.6	CD
cord-005453-4057qib7	2017	10	months	month	NNS
cord-005453-4057qib7	2017	11	,	,	,
cord-005453-4057qib7	2017	12	the	the	DT
cord-005453-4057qib7	2017	13	estimated	estimate	VBN
cord-005453-4057qib7	2017	14	3-year	3-year	CD
cord-005453-4057qib7	2017	15	overall	overall	JJ
cord-005453-4057qib7	2017	16	survival	survival	NN
cord-005453-4057qib7	2017	17	and	and	CC
cord-005453-4057qib7	2017	18	progression	progression	NN
cord-005453-4057qib7	2017	19	free	free	JJ
cord-005453-4057qib7	2017	20	survival	survival	NN
cord-005453-4057qib7	2017	21	for	for	IN
cord-005453-4057qib7	2017	22	all	all	DT
cord-005453-4057qib7	2017	23	patients	patient	NNS
cord-005453-4057qib7	2017	24	was	be	VBD
cord-005453-4057qib7	2017	25	74.5	74.5	CD
cord-005453-4057qib7	2017	26	%	%	NN
cord-005453-4057qib7	2017	27	and	and	CC
cord-005453-4057qib7	2017	28	56.6	56.6	CD
cord-005453-4057qib7	2017	29	%	%	NN
cord-005453-4057qib7	2017	30	,	,	,
cord-005453-4057qib7	2017	31	respectively	respectively	RB
cord-005453-4057qib7	2017	32	.	.	.
cord-005453-4057qib7	2018	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2018	2	:	:	:
cord-005453-4057qib7	2019	1	The	the	DT
cord-005453-4057qib7	2019	2	conditioning	conditioning	NN
cord-005453-4057qib7	2019	3	regimen	regimen	NN
cord-005453-4057qib7	2019	4	of	of	IN
cord-005453-4057qib7	2019	5	BuEAM	BuEAM	NNP
cord-005453-4057qib7	2019	6	for	for	IN
cord-005453-4057qib7	2019	7	ASCT	ASCT	NNP
cord-005453-4057qib7	2019	8	was	be	VBD
cord-005453-4057qib7	2019	9	well	well	RB
cord-005453-4057qib7	2019	10	tolerated	tolerate	VBN
cord-005453-4057qib7	2019	11	and	and	CC
cord-005453-4057qib7	2019	12	seemed	seem	VBD
cord-005453-4057qib7	2019	13	to	to	TO
cord-005453-4057qib7	2019	14	be	be	VB
cord-005453-4057qib7	2019	15	effective	effective	JJ
cord-005453-4057qib7	2019	16	in	in	IN
cord-005453-4057qib7	2019	17	patients	patient	NNS
cord-005453-4057qib7	2019	18	with	with	IN
cord-005453-4057qib7	2019	19	relapsed	relapsed	JJ
cord-005453-4057qib7	2019	20	or	or	CC
cord-005453-4057qib7	2019	21	high	high	JJ
cord-005453-4057qib7	2019	22	risk	risk	NN
cord-005453-4057qib7	2019	23	NHL	NHL	NNP
cord-005453-4057qib7	2019	24	.	.	.
cord-005453-4057qib7	2020	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2020	2	:	:	:
cord-005453-4057qib7	2021	1	None	none	NN
cord-005453-4057qib7	2021	2	of	of	IN
cord-005453-4057qib7	2021	3	declare	declare	VB
cord-005453-4057qib7	2021	4	Background	background	NN
cord-005453-4057qib7	2021	5	:	:	:
cord-005453-4057qib7	2021	6	Allogeneic	allogeneic	NN
cord-005453-4057qib7	2021	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2021	8	cell	cell	NN
cord-005453-4057qib7	2021	9	transplantation	transplantation	NN
cord-005453-4057qib7	2021	10	(	(	-LRB-
cord-005453-4057qib7	2021	11	HCT	HCT	NNP
cord-005453-4057qib7	2021	12	)	)	-RRB-
cord-005453-4057qib7	2021	13	is	be	VBZ
cord-005453-4057qib7	2021	14	potentially	potentially	RB
cord-005453-4057qib7	2021	15	curative	curative	JJ
cord-005453-4057qib7	2021	16	for	for	IN
cord-005453-4057qib7	2021	17	high	high	JJ
cord-005453-4057qib7	2021	18	risk	risk	NN
cord-005453-4057qib7	2021	19	acute	acute	JJ
cord-005453-4057qib7	2021	20	myeloid	myeloid	NN
cord-005453-4057qib7	2021	21	leukemia	leukemia	NN
cord-005453-4057qib7	2021	22	(	(	-LRB-
cord-005453-4057qib7	2021	23	AML	AML	NNP
cord-005453-4057qib7	2021	24	)	)	-RRB-
cord-005453-4057qib7	2021	25	and	and	CC
cord-005453-4057qib7	2021	26	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	2021	27	syndrome	syndrome	NN
cord-005453-4057qib7	2021	28	(	(	-LRB-
cord-005453-4057qib7	2021	29	MDS	MDS	NNP
cord-005453-4057qib7	2021	30	)	)	-RRB-
cord-005453-4057qib7	2021	31	,	,	,
cord-005453-4057qib7	2021	32	however	however	RB
cord-005453-4057qib7	2021	33	both	both	DT
cord-005453-4057qib7	2021	34	GvHD	gvhd	NN
cord-005453-4057qib7	2021	35	and	and	CC
cord-005453-4057qib7	2021	36	disease	disease	NN
cord-005453-4057qib7	2022	1	relapse	relapse	NN
cord-005453-4057qib7	2022	2	remain	remain	VBP
cord-005453-4057qib7	2022	3	major	major	JJ
cord-005453-4057qib7	2022	4	challenges	challenge	NNS
cord-005453-4057qib7	2022	5	.	.	.
cord-005453-4057qib7	2023	1	We	-PRON-	PRP
cord-005453-4057qib7	2023	2	recently	recently	RB
cord-005453-4057qib7	2023	3	introduced	introduce	VBD
cord-005453-4057qib7	2023	4	a	a	DT
cord-005453-4057qib7	2023	5	combination	combination	NN
cord-005453-4057qib7	2023	6	of	of	IN
cord-005453-4057qib7	2023	7	posttransplant	posttransplant	NN
cord-005453-4057qib7	2023	8	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2023	9	(	(	-LRB-
cord-005453-4057qib7	2023	10	PTCy	PTCy	NNP
cord-005453-4057qib7	2023	11	)	)	-RRB-
cord-005453-4057qib7	2023	12	and	and	CC
cord-005453-4057qib7	2023	13	ATG	ATG	NNP
cord-005453-4057qib7	2023	14	(	(	-LRB-
cord-005453-4057qib7	2023	15	4.5	4.5	CD
cord-005453-4057qib7	2023	16	mg	mg	NNP
cord-005453-4057qib7	2023	17	/	/	SYM
cord-005453-4057qib7	2023	18	kg	kg	NNP
cord-005453-4057qib7	2023	19	)	)	-RRB-
cord-005453-4057qib7	2023	20	as	as	IN
cord-005453-4057qib7	2023	21	graft	graft	NN
cord-005453-4057qib7	2023	22	-	-	HYPH
cord-005453-4057qib7	2023	23	versus	versus	IN
cord-005453-4057qib7	2023	24	-	-	HYPH
cord-005453-4057qib7	2023	25	host	host	NN
cord-005453-4057qib7	2023	26	disease	disease	NN
cord-005453-4057qib7	2023	27	(	(	-LRB-
cord-005453-4057qib7	2023	28	GvHD	GvHD	NNP
cord-005453-4057qib7	2023	29	)	)	-RRB-
cord-005453-4057qib7	2023	30	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2023	31	.	.	.
cord-005453-4057qib7	2024	1	The	the	DT
cord-005453-4057qib7	2024	2	purpose	purpose	NN
cord-005453-4057qib7	2024	3	of	of	IN
cord-005453-4057qib7	2024	4	our	-PRON-	PRP$
cord-005453-4057qib7	2024	5	study	study	NN
cord-005453-4057qib7	2024	6	was	be	VBD
cord-005453-4057qib7	2024	7	to	to	TO
cord-005453-4057qib7	2024	8	compare	compare	VB
cord-005453-4057qib7	2024	9	outcomes	outcome	NNS
cord-005453-4057qib7	2024	10	between	between	IN
cord-005453-4057qib7	2024	11	PTCy/	PTCy/	NNP
cord-005453-4057qib7	2024	12	ATG	ATG	NNP
cord-005453-4057qib7	2024	13	and	and	CC
cord-005453-4057qib7	2024	14	other	other	JJ
cord-005453-4057qib7	2024	15	GvHD	GvHD	NNP
cord-005453-4057qib7	2024	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2024	17	regimens	regimen	NNS
cord-005453-4057qib7	2024	18	for	for	IN
cord-005453-4057qib7	2024	19	high	high	JJ
cord-005453-4057qib7	2024	20	risk	risk	NN
cord-005453-4057qib7	2024	21	AML	AML	NNP
cord-005453-4057qib7	2024	22	and	and	CC
cord-005453-4057qib7	2024	23	MDS	MDS	NNP
cord-005453-4057qib7	2024	24	.	.	.
cord-005453-4057qib7	2025	1	Methods	method	NNS
cord-005453-4057qib7	2025	2	:	:	:
cord-005453-4057qib7	2026	1	We	-PRON-	PRP
cord-005453-4057qib7	2026	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	2026	3	investigated	investigate	VBD
cord-005453-4057qib7	2026	4	outcomes	outcome	NNS
cord-005453-4057qib7	2026	5	of	of	IN
cord-005453-4057qib7	2026	6	159	159	CD
cord-005453-4057qib7	2026	7	patients	patient	NNS
cord-005453-4057qib7	2026	8	that	that	WDT
cord-005453-4057qib7	2026	9	underwent	undergo	VBD
cord-005453-4057qib7	2026	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	2026	11	HCT	hct	NN
cord-005453-4057qib7	2026	12	between	between	IN
cord-005453-4057qib7	2026	13	January	January	NNP
cord-005453-4057qib7	2026	14	2014	2014	CD
cord-005453-4057qib7	2026	15	and	and	CC
cord-005453-4057qib7	2026	16	July	July	NNP
cord-005453-4057qib7	2026	17	2017	2017	CD
cord-005453-4057qib7	2026	18	for	for	IN
cord-005453-4057qib7	2026	19	high	high	JJ
cord-005453-4057qib7	2026	20	risk	risk	NN
cord-005453-4057qib7	2026	21	AML	AML	NNP
cord-005453-4057qib7	2026	22	(	(	-LRB-
cord-005453-4057qib7	2026	23	n=120	n=120	UH
cord-005453-4057qib7	2026	24	,	,	,
cord-005453-4057qib7	2026	25	75	75	CD
cord-005453-4057qib7	2026	26	%	%	NN
cord-005453-4057qib7	2026	27	)	)	-RRB-
cord-005453-4057qib7	2026	28	and	and	CC
cord-005453-4057qib7	2026	29	MDS	MDS	NNP
cord-005453-4057qib7	2026	30	(	(	-LRB-
cord-005453-4057qib7	2026	31	n=39	n=39	NNP
cord-005453-4057qib7	2026	32	,	,	,
cord-005453-4057qib7	2026	33	25	25	CD
cord-005453-4057qib7	2026	34	%	%	NN
cord-005453-4057qib7	2026	35	)	)	-RRB-
cord-005453-4057qib7	2026	36	.	.	.
cord-005453-4057qib7	2027	1	GvHD	GvHD	NNP
cord-005453-4057qib7	2027	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2027	3	regimens	regimen	NNS
cord-005453-4057qib7	2027	4	were	be	VBD
cord-005453-4057qib7	2027	5	compared	compare	VBN
cord-005453-4057qib7	2027	6	for	for	IN
cord-005453-4057qib7	2027	7	overall	overall	JJ
cord-005453-4057qib7	2027	8	survival	survival	NN
cord-005453-4057qib7	2027	9	(	(	-LRB-
cord-005453-4057qib7	2027	10	OS	OS	NNP
cord-005453-4057qib7	2027	11	)	)	-RRB-
cord-005453-4057qib7	2027	12	,	,	,
cord-005453-4057qib7	2027	13	cumulative	cumulative	JJ
cord-005453-4057qib7	2027	14	incidence	incidence	NN
cord-005453-4057qib7	2027	15	of	of	IN
cord-005453-4057qib7	2027	16	relapse	relapse	NN
cord-005453-4057qib7	2027	17	(	(	-LRB-
cord-005453-4057qib7	2027	18	CIR	CIR	NNP
cord-005453-4057qib7	2027	19	)	)	-RRB-
cord-005453-4057qib7	2027	20	and	and	CC
cord-005453-4057qib7	2027	21	non	non	JJ
cord-005453-4057qib7	2027	22	-	-	JJ
cord-005453-4057qib7	2027	23	relapse	relapse	JJ
cord-005453-4057qib7	2027	24	mortality	mortality	NN
cord-005453-4057qib7	2027	25	(	(	-LRB-
cord-005453-4057qib7	2027	26	NRM	NRM	NNP
cord-005453-4057qib7	2027	27	)	)	-RRB-
cord-005453-4057qib7	2027	28	in	in	IN
cord-005453-4057qib7	2027	29	univariate	univariate	JJ
cord-005453-4057qib7	2027	30	and	and	CC
cord-005453-4057qib7	2027	31	multivariable	multivariable	JJ
cord-005453-4057qib7	2027	32	analysis	analysis	NN
cord-005453-4057qib7	2027	33	.	.	.
cord-005453-4057qib7	2028	1	High	high	JJ
cord-005453-4057qib7	2028	2	risk	risk	NN
cord-005453-4057qib7	2028	3	AML	AML	NNP
cord-005453-4057qib7	2028	4	was	be	VBD
cord-005453-4057qib7	2028	5	defined	define	VBN
cord-005453-4057qib7	2028	6	as	as	IN
cord-005453-4057qib7	2028	7	secondary	secondary	JJ
cord-005453-4057qib7	2028	8	AML	AML	NNP
cord-005453-4057qib7	2028	9	,	,	,
cord-005453-4057qib7	2028	10	therapy	therapy	NN
cord-005453-4057qib7	2028	11	related	relate	VBD
cord-005453-4057qib7	2028	12	AML	AML	NNP
cord-005453-4057qib7	2028	13	,	,	,
cord-005453-4057qib7	2028	14	high	high	JJ
cord-005453-4057qib7	2028	15	risk	risk	NN
cord-005453-4057qib7	2028	16	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	2028	17	(	(	-LRB-
cord-005453-4057qib7	2028	18	ELN	ELN	NNP
cord-005453-4057qib7	2028	19	criteria	criterion	NNS
cord-005453-4057qib7	2028	20	)	)	-RRB-
cord-005453-4057qib7	2029	1	in	in	IN
cord-005453-4057qib7	2029	2	CR1	CR1	NNP
cord-005453-4057qib7	2029	3	,	,	,
cord-005453-4057qib7	2029	4	good/	good/	CD
cord-005453-4057qib7	2029	5	intermediate	intermediate	JJ
cord-005453-4057qib7	2029	6	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	2029	7	risk	risk	NN
cord-005453-4057qib7	2029	8	AML	AML	NNP
cord-005453-4057qib7	2029	9	in	in	IN
cord-005453-4057qib7	2029	10	CR2	CR2	NNP
cord-005453-4057qib7	2029	11	and	and	CC
cord-005453-4057qib7	2029	12	primary	primary	JJ
cord-005453-4057qib7	2029	13	induction	induction	NN
cord-005453-4057qib7	2029	14	failure	failure	NN
cord-005453-4057qib7	2029	15	;	;	:
cord-005453-4057qib7	2029	16	high	high	JJ
cord-005453-4057qib7	2029	17	risk	risk	NN
cord-005453-4057qib7	2029	18	MDS	MDS	NNP
cord-005453-4057qib7	2029	19	was	be	VBD
cord-005453-4057qib7	2029	20	defined	define	VBN
cord-005453-4057qib7	2029	21	as	as	IN
cord-005453-4057qib7	2029	22	high	high	JJ
cord-005453-4057qib7	2029	23	/	/	,
cord-005453-4057qib7	2029	24	very	very	RB
cord-005453-4057qib7	2029	25	high	high	JJ
cord-005453-4057qib7	2029	26	risk	risk	NN
cord-005453-4057qib7	2029	27	WPSS	WPSS	NNP
cord-005453-4057qib7	2029	28	score	score	NN
cord-005453-4057qib7	2029	29	.	.	.
cord-005453-4057qib7	2030	1	Results	result	NNS
cord-005453-4057qib7	2030	2	:	:	:
cord-005453-4057qib7	2031	1	Median	median	JJ
cord-005453-4057qib7	2031	2	age	age	NN
cord-005453-4057qib7	2031	3	of	of	IN
cord-005453-4057qib7	2031	4	patients	patient	NNS
cord-005453-4057qib7	2031	5	was	be	VBD
cord-005453-4057qib7	2031	6	56	56	CD
cord-005453-4057qib7	2031	7	years	year	NNS
cord-005453-4057qib7	2032	1	(	(	-LRB-
cord-005453-4057qib7	2032	2	range	range	NNP
cord-005453-4057qib7	2032	3	22	22	CD
cord-005453-4057qib7	2032	4	-	-	SYM
cord-005453-4057qib7	2032	5	73	73	CD
cord-005453-4057qib7	2032	6	years	year	NNS
cord-005453-4057qib7	2032	7	)	)	-RRB-
cord-005453-4057qib7	2032	8	.	.	.
cord-005453-4057qib7	2033	1	Donors	donor	NNS
cord-005453-4057qib7	2033	2	were	be	VBD
cord-005453-4057qib7	2033	3	matched	match	VBN
cord-005453-4057qib7	2033	4	related	relate	VBN
cord-005453-4057qib7	2033	5	in	in	IN
cord-005453-4057qib7	2033	6	52	52	CD
cord-005453-4057qib7	2033	7	(	(	-LRB-
cord-005453-4057qib7	2033	8	33	33	CD
cord-005453-4057qib7	2033	9	%	%	NN
cord-005453-4057qib7	2033	10	)	)	-RRB-
cord-005453-4057qib7	2033	11	patients	patient	NNS
cord-005453-4057qib7	2033	12	,	,	,
cord-005453-4057qib7	2033	13	matched	match	VBN
cord-005453-4057qib7	2033	14	unrelated	unrelated	JJ
cord-005453-4057qib7	2033	15	in	in	IN
cord-005453-4057qib7	2033	16	89	89	CD
cord-005453-4057qib7	2033	17	(	(	-LRB-
cord-005453-4057qib7	2033	18	56	56	CD
cord-005453-4057qib7	2033	19	%	%	NN
cord-005453-4057qib7	2033	20	)	)	-RRB-
cord-005453-4057qib7	2033	21	patients	patient	NNS
cord-005453-4057qib7	2033	22	and	and	CC
cord-005453-4057qib7	2033	23	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2033	24	in	in	IN
cord-005453-4057qib7	2033	25	18	18	CD
cord-005453-4057qib7	2033	26	(	(	-LRB-
cord-005453-4057qib7	2033	27	11	11	CD
cord-005453-4057qib7	2033	28	%	%	NN
cord-005453-4057qib7	2033	29	)	)	-RRB-
cord-005453-4057qib7	2033	30	patients	patient	NNS
cord-005453-4057qib7	2033	31	.	.	.
cord-005453-4057qib7	2034	1	Graft	graft	NN
cord-005453-4057qib7	2034	2	source	source	NN
cord-005453-4057qib7	2034	3	was	be	VBD
cord-005453-4057qib7	2034	4	peripheral	peripheral	JJ
cord-005453-4057qib7	2034	5	blood	blood	NN
cord-005453-4057qib7	2034	6	stem	stem	NN
cord-005453-4057qib7	2034	7	cells	cell	NNS
cord-005453-4057qib7	2034	8	in	in	IN
cord-005453-4057qib7	2034	9	158	158	CD
cord-005453-4057qib7	2034	10	patients	patient	NNS
cord-005453-4057qib7	2034	11	(	(	-LRB-
cord-005453-4057qib7	2034	12	99	99	CD
cord-005453-4057qib7	2034	13	%	%	NN
cord-005453-4057qib7	2034	14	)	)	-RRB-
cord-005453-4057qib7	2034	15	.	.	.
cord-005453-4057qib7	2035	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	2035	2	conditioning	conditioning	NN
cord-005453-4057qib7	2035	3	was	be	VBD
cord-005453-4057qib7	2035	4	used	use	VBN
cord-005453-4057qib7	2035	5	in	in	IN
cord-005453-4057qib7	2035	6	54	54	CD
cord-005453-4057qib7	2035	7	patients	patient	NNS
cord-005453-4057qib7	2035	8	(	(	-LRB-
cord-005453-4057qib7	2035	9	34	34	CD
cord-005453-4057qib7	2035	10	%	%	NN
cord-005453-4057qib7	2035	11	)	)	-RRB-
cord-005453-4057qib7	2035	12	,	,	,
cord-005453-4057qib7	2035	13	reduced	reduce	VBN
cord-005453-4057qib7	2035	14	intensity	intensity	NN
cord-005453-4057qib7	2035	15	regimens	regimen	NNS
cord-005453-4057qib7	2035	16	in	in	IN
cord-005453-4057qib7	2035	17	105	105	CD
cord-005453-4057qib7	2035	18	(	(	-LRB-
cord-005453-4057qib7	2035	19	66	66	CD
cord-005453-4057qib7	2035	20	%	%	NN
cord-005453-4057qib7	2035	21	)	)	-RRB-
cord-005453-4057qib7	2035	22	patients	patient	NNS
cord-005453-4057qib7	2035	23	.	.	.
cord-005453-4057qib7	2036	1	PTCy	PTCy	NNS
cord-005453-4057qib7	2036	2	combined	combine	VBN
cord-005453-4057qib7	2036	3	with	with	IN
cord-005453-4057qib7	2036	4	ATG	ATG	NNP
cord-005453-4057qib7	2036	5	was	be	VBD
cord-005453-4057qib7	2036	6	used	use	VBN
cord-005453-4057qib7	2036	7	in	in	IN
cord-005453-4057qib7	2036	8	69	69	CD
cord-005453-4057qib7	2036	9	(	(	-LRB-
cord-005453-4057qib7	2036	10	43	43	CD
cord-005453-4057qib7	2036	11	%	%	NN
cord-005453-4057qib7	2036	12	)	)	-RRB-
cord-005453-4057qib7	2036	13	patients	patient	NNS
cord-005453-4057qib7	2036	14	,	,	,
cord-005453-4057qib7	2037	1	other	other	JJ
cord-005453-4057qib7	2037	2	GvHD	GvHD	NNP
cord-005453-4057qib7	2037	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2037	4	regimens	regimen	NNS
cord-005453-4057qib7	2037	5	were	be	VBD
cord-005453-4057qib7	2037	6	used	use	VBN
cord-005453-4057qib7	2037	7	in	in	IN
cord-005453-4057qib7	2037	8	90	90	CD
cord-005453-4057qib7	2037	9	(	(	-LRB-
cord-005453-4057qib7	2037	10	57	57	CD
cord-005453-4057qib7	2037	11	%	%	NN
cord-005453-4057qib7	2037	12	)	)	-RRB-
cord-005453-4057qib7	2037	13	patients	patient	NNS
cord-005453-4057qib7	2037	14	.	.	.
cord-005453-4057qib7	2038	1	Both	both	DT
cord-005453-4057qib7	2038	2	donor	donor	NN
cord-005453-4057qib7	2038	3	and	and	CC
cord-005453-4057qib7	2038	4	recipient	recipient	NN
cord-005453-4057qib7	2038	5	were	be	VBD
cord-005453-4057qib7	2038	6	CMV	CMV	NNP
cord-005453-4057qib7	2038	7	negative	negative	JJ
cord-005453-4057qib7	2038	8	in	in	IN
cord-005453-4057qib7	2038	9	18	18	CD
cord-005453-4057qib7	2038	10	(	(	-LRB-
cord-005453-4057qib7	2038	11	11	11	CD
cord-005453-4057qib7	2038	12	%	%	NN
cord-005453-4057qib7	2038	13	)	)	-RRB-
cord-005453-4057qib7	2038	14	patients	patient	NNS
cord-005453-4057qib7	2038	15	.	.	.
cord-005453-4057qib7	2039	1	Median	median	JJ
cord-005453-4057qib7	2039	2	follow	follow	NN
cord-005453-4057qib7	2039	3	-	-	HYPH
cord-005453-4057qib7	2039	4	up	up	NN
cord-005453-4057qib7	2039	5	of	of	IN
cord-005453-4057qib7	2039	6	survivors	survivor	NNS
cord-005453-4057qib7	2039	7	was	be	VBD
cord-005453-4057qib7	2039	8	29	29	CD
cord-005453-4057qib7	2039	9	months	month	NNS
cord-005453-4057qib7	2040	1	(	(	-LRB-
cord-005453-4057qib7	2040	2	range	range	NNP
cord-005453-4057qib7	2040	3	14	14	CD
cord-005453-4057qib7	2040	4	-	-	SYM
cord-005453-4057qib7	2040	5	56	56	CD
cord-005453-4057qib7	2040	6	months	month	NNS
cord-005453-4057qib7	2040	7	)	)	-RRB-
cord-005453-4057qib7	2040	8	.	.	.
cord-005453-4057qib7	2041	1	Univariate	Univariate	NNP
cord-005453-4057qib7	2041	2	analysis	analysis	NN
cord-005453-4057qib7	2041	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	2041	4	OS	OS	NNP
cord-005453-4057qib7	2041	5	of	of	IN
cord-005453-4057qib7	2041	6	the	the	DT
cord-005453-4057qib7	2041	7	entire	entire	JJ
cord-005453-4057qib7	2041	8	cohort	cohort	NN
cord-005453-4057qib7	2041	9	at	at	IN
cord-005453-4057qib7	2041	10	2	2	CD
cord-005453-4057qib7	2041	11	years	year	NNS
cord-005453-4057qib7	2041	12	was	be	VBD
cord-005453-4057qib7	2041	13	49	49	CD
cord-005453-4057qib7	2041	14	%	%	NN
cord-005453-4057qib7	2041	15	(	(	-LRB-
cord-005453-4057qib7	2041	16	95%CI	95%ci	CD
cord-005453-4057qib7	2041	17	41	41	CD
cord-005453-4057qib7	2041	18	-	-	SYM
cord-005453-4057qib7	2041	19	57	57	CD
cord-005453-4057qib7	2041	20	%	%	NN
cord-005453-4057qib7	2041	21	)	)	-RRB-
cord-005453-4057qib7	2041	22	,	,	,
cord-005453-4057qib7	2041	23	CIR	CIR	NNP
cord-005453-4057qib7	2041	24	at	at	IN
cord-005453-4057qib7	2041	25	2	2	CD
cord-005453-4057qib7	2041	26	years	year	NNS
cord-005453-4057qib7	2041	27	was	be	VBD
cord-005453-4057qib7	2041	28	22	22	CD
cord-005453-4057qib7	2041	29	%	%	NN
cord-005453-4057qib7	2041	30	(	(	-LRB-
cord-005453-4057qib7	2041	31	95%CI	95%ci	CD
cord-005453-4057qib7	2041	32	16	16	CD
cord-005453-4057qib7	2041	33	-	-	SYM
cord-005453-4057qib7	2041	34	29	29	CD
cord-005453-4057qib7	2041	35	%	%	NN
cord-005453-4057qib7	2041	36	)	)	-RRB-
cord-005453-4057qib7	2041	37	and	and	CC
cord-005453-4057qib7	2041	38	NRM	NRM	NNP
cord-005453-4057qib7	2041	39	at	at	IN
cord-005453-4057qib7	2041	40	2	2	CD
cord-005453-4057qib7	2041	41	years	year	NNS
cord-005453-4057qib7	2041	42	was	be	VBD
cord-005453-4057qib7	2041	43	32	32	CD
cord-005453-4057qib7	2041	44	%	%	NN
cord-005453-4057qib7	2041	45	(	(	-LRB-
cord-005453-4057qib7	2041	46	95%CI	95%ci	CD
cord-005453-4057qib7	2041	47	25	25	CD
cord-005453-4057qib7	2041	48	-	-	SYM
cord-005453-4057qib7	2041	49	39	39	CD
cord-005453-4057qib7	2041	50	%	%	NN
cord-005453-4057qib7	2041	51	)	)	-RRB-
cord-005453-4057qib7	2041	52	.	.	.
cord-005453-4057qib7	2042	1	Concerning	concern	VBG
cord-005453-4057qib7	2042	2	GvHD	GvHD	NNP
cord-005453-4057qib7	2042	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2042	4	regimen	regimen	NN
cord-005453-4057qib7	2042	5	,	,	,
cord-005453-4057qib7	2042	6	2-year	2-year	JJ
cord-005453-4057qib7	2042	7	OS	os	NN
cord-005453-4057qib7	2042	8	for	for	IN
cord-005453-4057qib7	2042	9	PTCy	PTCy	NNS
cord-005453-4057qib7	2042	10	/	/	SYM
cord-005453-4057qib7	2042	11	ATG	ATG	NNP
cord-005453-4057qib7	2042	12	versus	versus	IN
cord-005453-4057qib7	2042	13	others	other	NNS
cord-005453-4057qib7	2042	14	was	be	VBD
cord-005453-4057qib7	2042	15	46	46	CD
cord-005453-4057qib7	2042	16	%	%	NN
cord-005453-4057qib7	2042	17	(	(	-LRB-
cord-005453-4057qib7	2042	18	95%CI	95%ci	CD
cord-005453-4057qib7	2042	19	33	33	CD
cord-005453-4057qib7	2042	20	-	-	SYM
cord-005453-4057qib7	2042	21	58	58	CD
cord-005453-4057qib7	2042	22	%	%	NN
cord-005453-4057qib7	2042	23	)	)	-RRB-
cord-005453-4057qib7	2042	24	versus	versus	IN
cord-005453-4057qib7	2042	25	51	51	CD
cord-005453-4057qib7	2042	26	%	%	NN
cord-005453-4057qib7	2042	27	(	(	-LRB-
cord-005453-4057qib7	2042	28	95%CI	95%ci	CD
cord-005453-4057qib7	2042	29	40	40	CD
cord-005453-4057qib7	2042	30	-	-	SYM
cord-005453-4057qib7	2042	31	61	61	CD
cord-005453-4057qib7	2042	32	%	%	NN
cord-005453-4057qib7	2042	33	)	)	-RRB-
cord-005453-4057qib7	2042	34	(	(	-LRB-
cord-005453-4057qib7	2042	35	p=0.87	p=0.87	NNP
cord-005453-4057qib7	2042	36	,	,	,
cord-005453-4057qib7	2042	37	Figure	figure	NN
cord-005453-4057qib7	2042	38	)	)	-RRB-
cord-005453-4057qib7	2042	39	,	,	,
cord-005453-4057qib7	2042	40	2-year	2-year	CD
cord-005453-4057qib7	2042	41	CIR	CIR	NNP
cord-005453-4057qib7	2042	42	for	for	IN
cord-005453-4057qib7	2042	43	PTCy	PTCy	NNPS
cord-005453-4057qib7	2042	44	/	/	SYM
cord-005453-4057qib7	2042	45	ATG	ATG	NNP
cord-005453-4057qib7	2042	46	versus	versus	IN
cord-005453-4057qib7	2042	47	other	other	JJ
cord-005453-4057qib7	2042	48	was	be	VBD
cord-005453-4057qib7	2042	49	31	31	CD
cord-005453-4057qib7	2042	50	%	%	NN
cord-005453-4057qib7	2042	51	(	(	-LRB-
cord-005453-4057qib7	2042	52	95%CI	95%ci	CD
cord-005453-4057qib7	2042	53	20	20	CD
cord-005453-4057qib7	2042	54	-	-	SYM
cord-005453-4057qib7	2042	55	43	43	CD
cord-005453-4057qib7	2042	56	%	%	NN
cord-005453-4057qib7	2042	57	)	)	-RRB-
cord-005453-4057qib7	2042	58	versus	versus	IN
cord-005453-4057qib7	2042	59	16	16	CD
cord-005453-4057qib7	2042	60	%	%	NN
cord-005453-4057qib7	2042	61	(	(	-LRB-
cord-005453-4057qib7	2042	62	95%CI	95%ci	CD
cord-005453-4057qib7	2042	63	9	9	CD
cord-005453-4057qib7	2042	64	-	-	SYM
cord-005453-4057qib7	2042	65	24	24	CD
cord-005453-4057qib7	2042	66	%	%	NN
cord-005453-4057qib7	2042	67	)	)	-RRB-
cord-005453-4057qib7	2043	1	(	(	-LRB-
cord-005453-4057qib7	2043	2	p=0.02	p=0.02	NNP
cord-005453-4057qib7	2043	3	)	)	-RRB-
cord-005453-4057qib7	2043	4	and	and	CC
cord-005453-4057qib7	2043	5	2-year	2-year	CD
cord-005453-4057qib7	2043	6	NRM	NRM	NNP
cord-005453-4057qib7	2043	7	for	for	IN
cord-005453-4057qib7	2043	8	PTCy	PTCy	NNPS
cord-005453-4057qib7	2043	9	versus	versus	IN
cord-005453-4057qib7	2043	10	other	other	JJ
cord-005453-4057qib7	2043	11	was	be	VBD
cord-005453-4057qib7	2043	12	28	28	CD
cord-005453-4057qib7	2043	13	%	%	NN
cord-005453-4057qib7	2043	14	(	(	-LRB-
cord-005453-4057qib7	2043	15	95%CI	95%ci	CD
cord-005453-4057qib7	2043	16	18	18	CD
cord-005453-4057qib7	2043	17	-	-	SYM
cord-005453-4057qib7	2043	18	39	39	CD
cord-005453-4057qib7	2043	19	%	%	NN
cord-005453-4057qib7	2043	20	)	)	-RRB-
cord-005453-4057qib7	2043	21	versus	versus	IN
cord-005453-4057qib7	2043	22	34	34	CD
cord-005453-4057qib7	2043	23	%	%	NN
cord-005453-4057qib7	2043	24	(	(	-LRB-
cord-005453-4057qib7	2043	25	95%CI	95%ci	CD
cord-005453-4057qib7	2043	26	25	25	CD
cord-005453-4057qib7	2043	27	-	-	SYM
cord-005453-4057qib7	2043	28	44	44	CD
cord-005453-4057qib7	2043	29	%	%	NN
cord-005453-4057qib7	2043	30	)	)	-RRB-
cord-005453-4057qib7	2044	1	(	(	-LRB-
cord-005453-4057qib7	2044	2	p=0.35	p=0.35	NNP
cord-005453-4057qib7	2044	3	)	)	-RRB-
cord-005453-4057qib7	2044	4	.	.	.
cord-005453-4057qib7	2045	1	Grade	Grade	NNP
cord-005453-4057qib7	2045	2	II	II	NNP
cord-005453-4057qib7	2045	3	-	-	HYPH
cord-005453-4057qib7	2045	4	IV	IV	NNP
cord-005453-4057qib7	2045	5	acute	acute	JJ
cord-005453-4057qib7	2045	6	GvHD	GvHD	NNP
cord-005453-4057qib7	2045	7	was	be	VBD
cord-005453-4057qib7	2045	8	seen	see	VBN
cord-005453-4057qib7	2045	9	in	in	IN
cord-005453-4057qib7	2045	10	23	23	CD
cord-005453-4057qib7	2045	11	%	%	NN
cord-005453-4057qib7	2045	12	of	of	IN
cord-005453-4057qib7	2045	13	PTCy	PTCy	NNS
cord-005453-4057qib7	2045	14	/	/	SYM
cord-005453-4057qib7	2045	15	ATG	ATG	NNP
cord-005453-4057qib7	2045	16	patients	patient	NNS
cord-005453-4057qib7	2045	17	versus	versus	IN
cord-005453-4057qib7	2045	18	59	59	CD
cord-005453-4057qib7	2045	19	%	%	NN
cord-005453-4057qib7	2045	20	using	use	VBG
cord-005453-4057qib7	2045	21	other	other	JJ
cord-005453-4057qib7	2045	22	regimens	regimen	NNS
cord-005453-4057qib7	2045	23	(	(	-LRB-
cord-005453-4057qib7	2045	24	p	p	NN
cord-005453-4057qib7	2045	25	<	<	XX
cord-005453-4057qib7	2045	26	0.0001	0.0001	CD
cord-005453-4057qib7	2045	27	)	)	-RRB-
cord-005453-4057qib7	2045	28	.	.	.
cord-005453-4057qib7	2046	1	Chronic	chronic	JJ
cord-005453-4057qib7	2046	2	GvHD	GvHD	NNP
cord-005453-4057qib7	2046	3	was	be	VBD
cord-005453-4057qib7	2046	4	observed	observe	VBN
cord-005453-4057qib7	2046	5	in	in	IN
cord-005453-4057qib7	2046	6	20	20	CD
cord-005453-4057qib7	2046	7	%	%	NN
cord-005453-4057qib7	2046	8	of	of	IN
cord-005453-4057qib7	2046	9	PTCy	PTCy	NNS
cord-005453-4057qib7	2046	10	/	/	SYM
cord-005453-4057qib7	2046	11	ATG	ATG	NNP
cord-005453-4057qib7	2046	12	patients	patient	NNS
cord-005453-4057qib7	2046	13	versus	versus	IN
cord-005453-4057qib7	2046	14	42	42	CD
cord-005453-4057qib7	2046	15	%	%	NN
cord-005453-4057qib7	2046	16	using	use	VBG
cord-005453-4057qib7	2046	17	other	other	JJ
cord-005453-4057qib7	2046	18	regimens	regimen	NNS
cord-005453-4057qib7	2046	19	(	(	-LRB-
cord-005453-4057qib7	2046	20	p=0.004	p=0.004	NNP
cord-005453-4057qib7	2046	21	)	)	-RRB-
cord-005453-4057qib7	2046	22	.	.	.
cord-005453-4057qib7	2047	1	Multivariable	multivariable	JJ
cord-005453-4057qib7	2047	2	analysis	analysis	NN
cord-005453-4057qib7	2047	3	for	for	IN
cord-005453-4057qib7	2047	4	OS	OS	NNP
cord-005453-4057qib7	2047	5	confirmed	confirm	VBD
cord-005453-4057qib7	2047	6	that	that	IN
cord-005453-4057qib7	2047	7	the	the	DT
cord-005453-4057qib7	2047	8	GvHD	GvHD	NNP
cord-005453-4057qib7	2047	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2047	10	regimen	regimen	NN
cord-005453-4057qib7	2047	11	has	have	VBZ
cord-005453-4057qib7	2047	12	no	no	DT
cord-005453-4057qib7	2047	13	influence	influence	NN
cord-005453-4057qib7	2047	14	(	(	-LRB-
cord-005453-4057qib7	2047	15	p=0.19	p=0.19	NNP
cord-005453-4057qib7	2047	16	)	)	-RRB-
cord-005453-4057qib7	2047	17	,	,	,
cord-005453-4057qib7	2047	18	while	while	IN
cord-005453-4057qib7	2047	19	the	the	DT
cord-005453-4057qib7	2047	20	predominant	predominant	JJ
cord-005453-4057qib7	2047	21	predictor	predictor	NN
cord-005453-4057qib7	2047	22	of	of	IN
cord-005453-4057qib7	2047	23	survival	survival	NN
cord-005453-4057qib7	2047	24	was	be	VBD
cord-005453-4057qib7	2047	25	age	age	NN
cord-005453-4057qib7	2047	26	at	at	IN
cord-005453-4057qib7	2047	27	HCT	HCT	NNP
cord-005453-4057qib7	2047	28	(	(	-LRB-
cord-005453-4057qib7	2047	29	HR	HR	NNP
cord-005453-4057qib7	2047	30	1.03	1.03	CD
cord-005453-4057qib7	2047	31	,	,	,
cord-005453-4057qib7	2047	32	95%CI	95%ci	CD
cord-005453-4057qib7	2047	33	1.01	1.01	CD
cord-005453-4057qib7	2047	34	-	-	SYM
cord-005453-4057qib7	2047	35	1.05	1.05	CD
cord-005453-4057qib7	2047	36	,	,	,
cord-005453-4057qib7	2047	37	p=0.01	p=0.01	NNP
cord-005453-4057qib7	2047	38	)	)	-RRB-
cord-005453-4057qib7	2047	39	.	.	.
cord-005453-4057qib7	2048	1	For	for	IN
cord-005453-4057qib7	2048	2	CIR	CIR	NNP
cord-005453-4057qib7	2048	3	,	,	,
cord-005453-4057qib7	2048	4	the	the	DT
cord-005453-4057qib7	2048	5	PTCy	PTCy	NNPS
cord-005453-4057qib7	2048	6	/	/	SYM
cord-005453-4057qib7	2048	7	ATG	ATG	NNP
cord-005453-4057qib7	2048	8	combination	combination	NN
cord-005453-4057qib7	2048	9	had	have	VBD
cord-005453-4057qib7	2048	10	no	no	DT
cord-005453-4057qib7	2048	11	influence	influence	NN
cord-005453-4057qib7	2048	12	compared	compare	VBN
cord-005453-4057qib7	2048	13	to	to	IN
cord-005453-4057qib7	2048	14	other	other	JJ
cord-005453-4057qib7	2048	15	GvHD	gvhd	NN
cord-005453-4057qib7	2048	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2048	17	regimens	regimen	NNS
cord-005453-4057qib7	2048	18	(	(	-LRB-
cord-005453-4057qib7	2048	19	p=0.6	p=0.6	NNP
cord-005453-4057qib7	2048	20	)	)	-RRB-
cord-005453-4057qib7	2048	21	,	,	,
cord-005453-4057qib7	2048	22	while	while	IN
cord-005453-4057qib7	2048	23	RIC	RIC	NNP
cord-005453-4057qib7	2048	24	conditioning	conditioning	NN
cord-005453-4057qib7	2048	25	was	be	VBD
cord-005453-4057qib7	2048	26	the	the	DT
cord-005453-4057qib7	2048	27	predominant	predominant	JJ
cord-005453-4057qib7	2048	28	predictor	predictor	NN
cord-005453-4057qib7	2048	29	of	of	IN
cord-005453-4057qib7	2048	30	relapse	relapse	NN
cord-005453-4057qib7	2048	31	(	(	-LRB-
cord-005453-4057qib7	2048	32	HR	HR	NNP
cord-005453-4057qib7	2048	33	3.05	3.05	CD
cord-005453-4057qib7	2048	34	for	for	IN
cord-005453-4057qib7	2048	35	RIC	RIC	NNP
cord-005453-4057qib7	2048	36	,	,	,
cord-005453-4057qib7	2048	37	95	95	CD
cord-005453-4057qib7	2048	38	%	%	NN
cord-005453-4057qib7	2048	39	p=0.01	p=0.01	NNP
cord-005453-4057qib7	2048	40	)	)	-RRB-
cord-005453-4057qib7	2048	41	.	.	.
cord-005453-4057qib7	2049	1	For	for	IN
cord-005453-4057qib7	2049	2	NRM	NRM	NNP
cord-005453-4057qib7	2049	3	,	,	,
cord-005453-4057qib7	2049	4	the	the	DT
cord-005453-4057qib7	2049	5	ATG	ATG	NNP
cord-005453-4057qib7	2049	6	with	with	IN
cord-005453-4057qib7	2049	7	PTCy	PTCy	NNP
cord-005453-4057qib7	2049	8	combination	combination	NN
cord-005453-4057qib7	2049	9	demonstrated	demonstrate	VBD
cord-005453-4057qib7	2049	10	no	no	DT
cord-005453-4057qib7	2049	11	significant	significant	JJ
cord-005453-4057qib7	2049	12	difference	difference	NN
cord-005453-4057qib7	2049	13	(	(	-LRB-
cord-005453-4057qib7	2049	14	p=0.12	p=0.12	NNP
cord-005453-4057qib7	2049	15	)	)	-RRB-
cord-005453-4057qib7	2049	16	,	,	,
cord-005453-4057qib7	2049	17	while	while	IN
cord-005453-4057qib7	2049	18	age	age	NN
cord-005453-4057qib7	2049	19	at	at	IN
cord-005453-4057qib7	2049	20	HCT	HCT	NNP
cord-005453-4057qib7	2049	21	was	be	VBD
cord-005453-4057qib7	2049	22	the	the	DT
cord-005453-4057qib7	2049	23	predominant	predominant	JJ
cord-005453-4057qib7	2049	24	predictor	predictor	NN
cord-005453-4057qib7	2049	25	(	(	-LRB-
cord-005453-4057qib7	2049	26	HR=1.04	HR=1.04	NNP
cord-005453-4057qib7	2049	27	,	,	,
cord-005453-4057qib7	2049	28	95%CI	95%ci	CD
cord-005453-4057qib7	2049	29	1.01	1.01	CD
cord-005453-4057qib7	2049	30	-	-	SYM
cord-005453-4057qib7	2049	31	1.07	1.07	CD
cord-005453-4057qib7	2049	32	,	,	,
cord-005453-4057qib7	2049	33	p=0.02	p=0.02	NNP
cord-005453-4057qib7	2049	34	)	)	-RRB-
cord-005453-4057qib7	2049	35	.	.	.
cord-005453-4057qib7	2050	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2050	2	:	:	:
cord-005453-4057qib7	2051	1	The	the	DT
cord-005453-4057qib7	2051	2	PTCy	PTCy	NNPS
cord-005453-4057qib7	2051	3	/	/	SYM
cord-005453-4057qib7	2051	4	ATG	ATG	NNP
cord-005453-4057qib7	2051	5	combination	combination	NN
cord-005453-4057qib7	2051	6	for	for	IN
cord-005453-4057qib7	2051	7	GvHD	GvHD	NNP
cord-005453-4057qib7	2051	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2051	9	has	have	VBZ
cord-005453-4057qib7	2051	10	demonstrated	demonstrate	VBN
cord-005453-4057qib7	2051	11	on	on	IN
cord-005453-4057qib7	2051	12	multivariable	multivariable	JJ
cord-005453-4057qib7	2051	13	analysis	analysis	NN
cord-005453-4057qib7	2051	14	similar	similar	JJ
cord-005453-4057qib7	2051	15	OS	OS	NNP
cord-005453-4057qib7	2051	16	,	,	,
cord-005453-4057qib7	2051	17	CIR	CIR	NNP
cord-005453-4057qib7	2051	18	and	and	CC
cord-005453-4057qib7	2051	19	NRM	NRM	NNP
cord-005453-4057qib7	2051	20	with	with	IN
cord-005453-4057qib7	2051	21	other	other	JJ
cord-005453-4057qib7	2051	22	previously	previously	RB
cord-005453-4057qib7	2051	23	used	use	VBN
cord-005453-4057qib7	2051	24	regimens	regimen	NNS
cord-005453-4057qib7	2051	25	at	at	IN
cord-005453-4057qib7	2051	26	our	-PRON-	PRP$
cord-005453-4057qib7	2051	27	center	center	NN
cord-005453-4057qib7	2051	28	.	.	.
cord-005453-4057qib7	2052	1	A	a	DT
cord-005453-4057qib7	2052	2	decrease	decrease	NN
cord-005453-4057qib7	2052	3	in	in	IN
cord-005453-4057qib7	2052	4	ATG	ATG	NNP
cord-005453-4057qib7	2052	5	dose	dose	NN
cord-005453-4057qib7	2052	6	may	may	MD
cord-005453-4057qib7	2052	7	potentially	potentially	RB
cord-005453-4057qib7	2052	8	decrease	decrease	VB
cord-005453-4057qib7	2052	9	the	the	DT
cord-005453-4057qib7	2052	10	relapse	relapse	NN
cord-005453-4057qib7	2052	11	rate	rate	NN
cord-005453-4057qib7	2052	12	while	while	IN
cord-005453-4057qib7	2052	13	retaining	retain	VBG
cord-005453-4057qib7	2052	14	the	the	DT
cord-005453-4057qib7	2052	15	advantage	advantage	NN
cord-005453-4057qib7	2052	16	of	of	IN
cord-005453-4057qib7	2052	17	decreased	decreased	JJ
cord-005453-4057qib7	2052	18	GvHD	GvHD	NNP
cord-005453-4057qib7	2052	19	.	.	.
cord-005453-4057qib7	2053	1	[	[	-LRB-
cord-005453-4057qib7	2053	2	 	 	_SP
cord-005453-4057qib7	2053	3	Background	Background	NNP
cord-005453-4057qib7	2053	4	:	:	:
cord-005453-4057qib7	2054	1	The	the	DT
cord-005453-4057qib7	2054	2	combination	combination	NN
cord-005453-4057qib7	2054	3	of	of	IN
cord-005453-4057qib7	2054	4	fludarabine	fludarabine	NN
cord-005453-4057qib7	2054	5	with	with	IN
cord-005453-4057qib7	2054	6	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2054	7	doses	dose	NNS
cord-005453-4057qib7	2054	8	of	of	IN
cord-005453-4057qib7	2054	9	busulfan	busulfan	NNP
cord-005453-4057qib7	2054	10	(	(	-LRB-
cord-005453-4057qib7	2054	11	FB4	FB4	NNP
cord-005453-4057qib7	2054	12	)	)	-RRB-
cord-005453-4057qib7	2054	13	represents	represent	VBZ
cord-005453-4057qib7	2054	14	a	a	DT
cord-005453-4057qib7	2054	15	standard	standard	NN
cord-005453-4057qib7	2054	16	of	of	IN
cord-005453-4057qib7	2054	17	care	care	NN
cord-005453-4057qib7	2054	18	conditioning	conditioning	NN
cord-005453-4057qib7	2054	19	regimen	regimen	NN
cord-005453-4057qib7	2054	20	before	before	IN
cord-005453-4057qib7	2054	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	2054	22	transplantation	transplantation	NN
cord-005453-4057qib7	2054	23	in	in	IN
cord-005453-4057qib7	2054	24	patients	patient	NNS
cord-005453-4057qib7	2054	25	with	with	IN
cord-005453-4057qib7	2054	26	myeloid	myeloid	JJ
cord-005453-4057qib7	2054	27	malignancies	malignancy	NNS
cord-005453-4057qib7	2054	28	(	(	-LRB-
cord-005453-4057qib7	2054	29	Giralt	Giralt	NNP
cord-005453-4057qib7	2054	30	,	,	,
cord-005453-4057qib7	2054	31	S.	S.	NNP
cord-005453-4057qib7	2054	32	:	:	:
cord-005453-4057qib7	2054	33	The	the	DT
cord-005453-4057qib7	2054	34	Lancet	Lancet	NNP
cord-005453-4057qib7	2054	35	Oncology	Oncology	NNP
cord-005453-4057qib7	2054	36	2015	2015	CD
cord-005453-4057qib7	2054	37	)	)	-RRB-
cord-005453-4057qib7	2054	38	.	.	.
cord-005453-4057qib7	2055	1	FB4	FB4	NNP
cord-005453-4057qib7	2055	2	has	have	VBZ
cord-005453-4057qib7	2055	3	potent	potent	JJ
cord-005453-4057qib7	2055	4	antileukemic	antileukemic	JJ
cord-005453-4057qib7	2055	5	activity	activity	NN
cord-005453-4057qib7	2055	6	and	and	CC
cord-005453-4057qib7	2055	7	is	be	VBZ
cord-005453-4057qib7	2055	8	associated	associate	VBN
cord-005453-4057qib7	2055	9	with	with	IN
cord-005453-4057qib7	2055	10	low	low	JJ
cord-005453-4057qib7	2055	11	transplantrelated	transplantrelated	JJ
cord-005453-4057qib7	2055	12	mortality	mortality	NN
cord-005453-4057qib7	2055	13	and	and	CC
cord-005453-4057qib7	2055	14	acute	acute	JJ
cord-005453-4057qib7	2055	15	GvHD	gvhd	NN
cord-005453-4057qib7	2055	16	.	.	.
cord-005453-4057qib7	2056	1	However	however	RB
cord-005453-4057qib7	2056	2	,	,	,
cord-005453-4057qib7	2056	3	early	early	RB
cord-005453-4057qib7	2056	4	after	after	IN
cord-005453-4057qib7	2056	5	transplantation	transplantation	NN
cord-005453-4057qib7	2056	6	(	(	-LRB-
cord-005453-4057qib7	2056	7	days	day	NNS
cord-005453-4057qib7	2056	8	30	30	CD
cord-005453-4057qib7	2056	9	-	-	SYM
cord-005453-4057qib7	2056	10	90	90	CD
cord-005453-4057qib7	2056	11	)	)	-RRB-
cord-005453-4057qib7	2056	12	,	,	,
cord-005453-4057qib7	2056	13	a	a	DT
cord-005453-4057qib7	2056	14	proportion	proportion	NN
cord-005453-4057qib7	2056	15	of	of	IN
cord-005453-4057qib7	2056	16	patients	patient	NNS
cord-005453-4057qib7	2056	17	may	may	MD
cord-005453-4057qib7	2056	18	not	not	RB
cord-005453-4057qib7	2056	19	convert	convert	VB
cord-005453-4057qib7	2056	20	to	to	IN
cord-005453-4057qib7	2056	21	a	a	DT
cord-005453-4057qib7	2056	22	full	full	JJ
cord-005453-4057qib7	2056	23	donor	donor	NN
cord-005453-4057qib7	2056	24	haemopoietic	haemopoietic	NN
cord-005453-4057qib7	2056	25	chimerism	chimerism	NN
cord-005453-4057qib7	2056	26	,	,	,
cord-005453-4057qib7	2056	27	particularly	particularly	RB
cord-005453-4057qib7	2056	28	if	if	IN
cord-005453-4057qib7	2056	29	anti	anti	JJ
cord-005453-4057qib7	2056	30	-	-	JJ
cord-005453-4057qib7	2056	31	T	t	JJ
cord-005453-4057qib7	2056	32	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	2056	33	globulin	globulin	NN
cord-005453-4057qib7	2056	34	(	(	-LRB-
cord-005453-4057qib7	2056	35	ATG	ATG	NNP
cord-005453-4057qib7	2056	36	)	)	-RRB-
cord-005453-4057qib7	2056	37	is	be	VBZ
cord-005453-4057qib7	2056	38	used	use	VBN
cord-005453-4057qib7	2056	39	as	as	IN
cord-005453-4057qib7	2056	40	GvHD	GvHD	NNP
cord-005453-4057qib7	2056	41	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2056	42	(	(	-LRB-
cord-005453-4057qib7	2056	43	Rambaldi	Rambaldi	NNP
cord-005453-4057qib7	2056	44	A	A	NNP
cord-005453-4057qib7	2056	45	,	,	,
cord-005453-4057qib7	2056	46	et	et	NNP
cord-005453-4057qib7	2056	47	al	al	NNP
cord-005453-4057qib7	2056	48	.	.	NNP
cord-005453-4057qib7	2056	49	:	:	:
cord-005453-4057qib7	2057	1	The	the	DT
cord-005453-4057qib7	2057	2	Lancet	Lancet	NNP
cord-005453-4057qib7	2057	3	Oncology	Oncology	NNP
cord-005453-4057qib7	2057	4	2015	2015	CD
cord-005453-4057qib7	2057	5	)	)	-RRB-
cord-005453-4057qib7	2058	1	Methods	method	NNS
cord-005453-4057qib7	2059	1	:	:	:
cord-005453-4057qib7	2059	2	We	-PRON-	PRP
cord-005453-4057qib7	2059	3	retrospective	retrospective	VBP
cord-005453-4057qib7	2059	4	analyzed	analyze	VBD
cord-005453-4057qib7	2059	5	104	104	CD
cord-005453-4057qib7	2059	6	patients	patient	NNS
cord-005453-4057qib7	2059	7	who	who	WP
cord-005453-4057qib7	2059	8	underwent	undergo	VBD
cord-005453-4057qib7	2059	9	an	an	DT
cord-005453-4057qib7	2059	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	2059	11	stem	stem	NN
cord-005453-4057qib7	2059	12	cell	cell	NN
cord-005453-4057qib7	2059	13	transplantation	transplantation	NN
cord-005453-4057qib7	2059	14	after	after	IN
cord-005453-4057qib7	2059	15	FB4	FB4	NNP
cord-005453-4057qib7	2059	16	conditioning	conditioning	NN
cord-005453-4057qib7	2059	17	regimen	regimen	NN
cord-005453-4057qib7	2059	18	at	at	IN
cord-005453-4057qib7	2059	19	our	-PRON-	PRP$
cord-005453-4057qib7	2059	20	hospital	hospital	NN
cord-005453-4057qib7	2059	21	,	,	,
cord-005453-4057qib7	2059	22	from	from	IN
cord-005453-4057qib7	2059	23	November	November	NNP
cord-005453-4057qib7	2059	24	2007	2007	CD
cord-005453-4057qib7	2059	25	to	to	IN
cord-005453-4057qib7	2059	26	August	August	NNP
cord-005453-4057qib7	2059	27	2018	2018	CD
cord-005453-4057qib7	2059	28	.	.	.
cord-005453-4057qib7	2060	1	The	the	DT
cord-005453-4057qib7	2060	2	median	median	JJ
cord-005453-4057qib7	2060	3	age	age	NN
cord-005453-4057qib7	2060	4	was	be	VBD
cord-005453-4057qib7	2060	5	51	51	CD
cord-005453-4057qib7	2060	6	years	year	NNS
cord-005453-4057qib7	2061	1	(	(	-LRB-
cord-005453-4057qib7	2061	2	range	range	NNP
cord-005453-4057qib7	2061	3	22	22	CD
cord-005453-4057qib7	2061	4	-	-	SYM
cord-005453-4057qib7	2061	5	67	67	CD
cord-005453-4057qib7	2061	6	)	)	-RRB-
cord-005453-4057qib7	2061	7	and	and	CC
cord-005453-4057qib7	2061	8	diagnoses	diagnosis	NNS
cord-005453-4057qib7	2061	9	were	be	VBD
cord-005453-4057qib7	2061	10	AML	AML	NNP
cord-005453-4057qib7	2061	11	76	76	CD
cord-005453-4057qib7	2061	12	%	%	NN
cord-005453-4057qib7	2061	13	,	,	,
cord-005453-4057qib7	2061	14	MDS	MDS	NNP
cord-005453-4057qib7	2061	15	18	18	CD
cord-005453-4057qib7	2061	16	%	%	NN
cord-005453-4057qib7	2061	17	CML	CML	NNP
cord-005453-4057qib7	2061	18	5	5	CD
cord-005453-4057qib7	2061	19	%	%	NN
cord-005453-4057qib7	2061	20	MFI	MFI	NNP
cord-005453-4057qib7	2061	21	1	1	CD
cord-005453-4057qib7	2061	22	%	%	NN
cord-005453-4057qib7	2061	23	)	)	-RRB-
cord-005453-4057qib7	2061	24	.	.	.
cord-005453-4057qib7	2062	1	The	the	DT
cord-005453-4057qib7	2062	2	disease	disease	NN
cord-005453-4057qib7	2062	3	status	status	NN
cord-005453-4057qib7	2062	4	at	at	IN
cord-005453-4057qib7	2062	5	transplantation	transplantation	NN
cord-005453-4057qib7	2062	6	was	be	VBD
cord-005453-4057qib7	2062	7	:	:	:
cord-005453-4057qib7	2062	8	CR1	CR1	NNP
cord-005453-4057qib7	2062	9	in	in	IN
cord-005453-4057qib7	2062	10	59	59	CD
cord-005453-4057qib7	2062	11	%	%	NN
cord-005453-4057qib7	2062	12	,	,	,
cord-005453-4057qib7	2062	13	CR2	CR2	NNP
cord-005453-4057qib7	2062	14	in	in	IN
cord-005453-4057qib7	2062	15	5	5	CD
cord-005453-4057qib7	2062	16	%	%	NN
cord-005453-4057qib7	2062	17	and	and	CC
cord-005453-4057qib7	2062	18	active	active	JJ
cord-005453-4057qib7	2062	19	disease	disease	NN
cord-005453-4057qib7	2062	20	in	in	IN
cord-005453-4057qib7	2062	21	36	36	CD
cord-005453-4057qib7	2062	22	%	%	NN
cord-005453-4057qib7	2062	23	of	of	IN
cord-005453-4057qib7	2062	24	patients	patient	NNS
cord-005453-4057qib7	2062	25	.	.	.
cord-005453-4057qib7	2063	1	The	the	DT
cord-005453-4057qib7	2063	2	stem	stem	NN
cord-005453-4057qib7	2063	3	cell	cell	NN
cord-005453-4057qib7	2063	4	source	source	NN
cord-005453-4057qib7	2063	5	was	be	VBD
cord-005453-4057qib7	2063	6	represented	represent	VBN
cord-005453-4057qib7	2063	7	by	by	IN
cord-005453-4057qib7	2063	8	PBSC	PBSC	NNP
cord-005453-4057qib7	2063	9	in	in	IN
cord-005453-4057qib7	2063	10	more	more	JJR
cord-005453-4057qib7	2063	11	than	than	IN
cord-005453-4057qib7	2063	12	95	95	CD
cord-005453-4057qib7	2063	13	%	%	NN
cord-005453-4057qib7	2063	14	of	of	IN
cord-005453-4057qib7	2063	15	cases	case	NNS
cord-005453-4057qib7	2063	16	and	and	CC
cord-005453-4057qib7	2063	17	anti	anti	JJ
cord-005453-4057qib7	2063	18	-	-	JJ
cord-005453-4057qib7	2063	19	T	t	JJ
cord-005453-4057qib7	2063	20	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	2063	21	globulin	globulin	NN
cord-005453-4057qib7	2063	22	(	(	-LRB-
cord-005453-4057qib7	2063	23	ATG	ATG	NNP
cord-005453-4057qib7	2063	24	)	)	-RRB-
cord-005453-4057qib7	2064	1	was	be	VBD
cord-005453-4057qib7	2064	2	part	part	NN
cord-005453-4057qib7	2064	3	of	of	IN
cord-005453-4057qib7	2064	4	the	the	DT
cord-005453-4057qib7	2064	5	conditioning	conditioning	NN
cord-005453-4057qib7	2064	6	regimen	regimen	NN
cord-005453-4057qib7	2064	7	in	in	IN
cord-005453-4057qib7	2064	8	more	more	JJR
cord-005453-4057qib7	2064	9	than	than	IN
cord-005453-4057qib7	2064	10	95	95	CD
cord-005453-4057qib7	2064	11	%	%	NN
cord-005453-4057qib7	2064	12	of	of	IN
cord-005453-4057qib7	2064	13	cases	case	NNS
cord-005453-4057qib7	2064	14	at	at	IN
cord-005453-4057qib7	2064	15	a	a	DT
cord-005453-4057qib7	2064	16	dose	dose	NN
cord-005453-4057qib7	2064	17	of	of	IN
cord-005453-4057qib7	2064	18	5	5	CD
cord-005453-4057qib7	2064	19	mg	mg	NNP
cord-005453-4057qib7	2064	20	/	/	SYM
cord-005453-4057qib7	2064	21	Kg	Kg	NNP
cord-005453-4057qib7	2064	22	.	.	.
cord-005453-4057qib7	2065	1	The	the	DT
cord-005453-4057qib7	2065	2	donor	donor	NN
cord-005453-4057qib7	2065	3	was	be	VBD
cord-005453-4057qib7	2065	4	a	a	DT
cord-005453-4057qib7	2065	5	HLA	HLA	NNP
cord-005453-4057qib7	2065	6	identical	identical	JJ
cord-005453-4057qib7	2065	7	sibling	sibling	NN
cord-005453-4057qib7	2065	8	(	(	-LRB-
cord-005453-4057qib7	2065	9	26	26	CD
cord-005453-4057qib7	2065	10	%	%	NN
cord-005453-4057qib7	2065	11	)	)	-RRB-
cord-005453-4057qib7	2065	12	,	,	,
cord-005453-4057qib7	2065	13	a	a	DT
cord-005453-4057qib7	2065	14	matched	match	VBN
cord-005453-4057qib7	2065	15	unrelated	unrelated	JJ
cord-005453-4057qib7	2065	16	(	(	-LRB-
cord-005453-4057qib7	2065	17	65	65	CD
cord-005453-4057qib7	2065	18	%	%	NN
cord-005453-4057qib7	2065	19	)	)	-RRB-
cord-005453-4057qib7	2065	20	or	or	CC
cord-005453-4057qib7	2065	21	mismatched	mismatch	VBN
cord-005453-4057qib7	2065	22	(	(	-LRB-
cord-005453-4057qib7	2065	23	one	one	CD
cord-005453-4057qib7	2065	24	allele	allele	NN
cord-005453-4057qib7	2065	25	or	or	CC
cord-005453-4057qib7	2065	26	one	one	CD
cord-005453-4057qib7	2065	27	antigen	antigen	NN
cord-005453-4057qib7	2065	28	mismatched	mismatch	VBN
cord-005453-4057qib7	2065	29	)	)	-RRB-
cord-005453-4057qib7	2065	30	unrelated	unrelated	JJ
cord-005453-4057qib7	2065	31	,	,	,
cord-005453-4057qib7	2065	32	9	9	CD
cord-005453-4057qib7	2065	33	%	%	NN
cord-005453-4057qib7	2065	34	.	.	.
cord-005453-4057qib7	2066	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2066	2	chimerism	chimerism	NN
cord-005453-4057qib7	2066	3	was	be	VBD
cord-005453-4057qib7	2066	4	molecularly	molecularly	RB
cord-005453-4057qib7	2066	5	evaluated	evaluate	VBN
cord-005453-4057qib7	2066	6	by	by	IN
cord-005453-4057qib7	2066	7	Variable	Variable	NNP
cord-005453-4057qib7	2066	8	Number	Number	NNP
cord-005453-4057qib7	2066	9	of	of	IN
cord-005453-4057qib7	2066	10	Tandem	Tandem	NNP
cord-005453-4057qib7	2066	11	Repeats	repeat	VBZ
cord-005453-4057qib7	2066	12	(	(	-LRB-
cord-005453-4057qib7	2066	13	VNTR	VNTR	NNP
cord-005453-4057qib7	2066	14	)	)	-RRB-
cord-005453-4057qib7	2066	15	on	on	IN
cord-005453-4057qib7	2066	16	bone	bone	NN
cord-005453-4057qib7	2066	17	marrow	marrow	NN
cord-005453-4057qib7	2066	18	(	(	-LRB-
cord-005453-4057qib7	2066	19	BM	BM	NNP
cord-005453-4057qib7	2066	20	)	)	-RRB-
cord-005453-4057qib7	2066	21	mononuclear	mononuclear	NN
cord-005453-4057qib7	2066	22	cells	cell	NNS
cord-005453-4057qib7	2066	23	or	or	CC
cord-005453-4057qib7	2066	24	peripheral	peripheral	JJ
cord-005453-4057qib7	2066	25	blood	blood	NN
cord-005453-4057qib7	2066	26	(	(	-LRB-
cord-005453-4057qib7	2066	27	PB	PB	NNP
cord-005453-4057qib7	2066	28	)	)	-RRB-
cord-005453-4057qib7	2066	29	T	t	NN
cord-005453-4057qib7	2066	30	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	2066	31	,	,	,
cord-005453-4057qib7	2066	32	purified	purify	VBN
cord-005453-4057qib7	2066	33	by	by	IN
cord-005453-4057qib7	2066	34	immunomagnetic	immunomagnetic	JJ
cord-005453-4057qib7	2066	35	positive	positive	JJ
cord-005453-4057qib7	2066	36	selection	selection	NN
cord-005453-4057qib7	2066	37	(	(	-LRB-
cord-005453-4057qib7	2066	38	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	2066	39	,	,	,
cord-005453-4057qib7	2066	40	Biotec	Biotec	NNP
cord-005453-4057qib7	2066	41	)	)	-RRB-
cord-005453-4057qib7	2066	42	.	.	.
cord-005453-4057qib7	2067	1	The	the	DT
cord-005453-4057qib7	2067	2	analysis	analysis	NN
cord-005453-4057qib7	2067	3	was	be	VBD
cord-005453-4057qib7	2067	4	performed	perform	VBN
cord-005453-4057qib7	2067	5	at	at	IN
cord-005453-4057qib7	2067	6	day	day	NN
cord-005453-4057qib7	2067	7	30	30	CD
cord-005453-4057qib7	2067	8	,	,	,
cord-005453-4057qib7	2067	9	60	60	CD
cord-005453-4057qib7	2067	10	,	,	,
cord-005453-4057qib7	2067	11	90	90	CD
cord-005453-4057qib7	2067	12	,	,	,
cord-005453-4057qib7	2067	13	180	180	CD
cord-005453-4057qib7	2067	14	and	and	CC
cord-005453-4057qib7	2067	15	360	360	CD
cord-005453-4057qib7	2067	16	after	after	IN
cord-005453-4057qib7	2067	17	transplantation	transplantation	NN
cord-005453-4057qib7	2067	18	Results	result	NNS
cord-005453-4057qib7	2067	19	:	:	:
cord-005453-4057qib7	2068	1	After	after	IN
cord-005453-4057qib7	2068	2	30	30	CD
cord-005453-4057qib7	2068	3	,	,	,
cord-005453-4057qib7	2068	4	60	60	CD
cord-005453-4057qib7	2068	5	and	and	CC
cord-005453-4057qib7	2068	6	90	90	CD
cord-005453-4057qib7	2068	7	days	day	NNS
cord-005453-4057qib7	2068	8	from	from	IN
cord-005453-4057qib7	2068	9	transplantation	transplantation	NN
cord-005453-4057qib7	2068	10	,	,	,
cord-005453-4057qib7	2068	11	the	the	DT
cord-005453-4057qib7	2068	12	proportion	proportion	NN
cord-005453-4057qib7	2068	13	of	of	IN
cord-005453-4057qib7	2068	14	patients	patient	NNS
cord-005453-4057qib7	2068	15	with	with	IN
cord-005453-4057qib7	2068	16	a	a	DT
cord-005453-4057qib7	2068	17	full	full	JJ
cord-005453-4057qib7	2068	18	BM	bm	NN
cord-005453-4057qib7	2068	19	chimerism	chimerism	NN
cord-005453-4057qib7	2068	20	was	be	VBD
cord-005453-4057qib7	2068	21	94	94	CD
cord-005453-4057qib7	2068	22	%	%	NN
cord-005453-4057qib7	2068	23	,	,	,
cord-005453-4057qib7	2068	24	87	87	CD
cord-005453-4057qib7	2068	25	%	%	NN
cord-005453-4057qib7	2068	26	and	and	CC
cord-005453-4057qib7	2068	27	83	83	CD
cord-005453-4057qib7	2068	28	%	%	NN
cord-005453-4057qib7	2068	29	,	,	,
cord-005453-4057qib7	2068	30	respectively	respectively	RB
cord-005453-4057qib7	2068	31	.	.	.
cord-005453-4057qib7	2069	1	At	at	IN
cord-005453-4057qib7	2069	2	the	the	DT
cord-005453-4057qib7	2069	3	same	same	JJ
cord-005453-4057qib7	2069	4	time	time	NN
cord-005453-4057qib7	2069	5	points	point	NNS
cord-005453-4057qib7	2069	6	,	,	,
cord-005453-4057qib7	2069	7	the	the	DT
cord-005453-4057qib7	2069	8	PB	PB	NNP
cord-005453-4057qib7	2069	9	T	T	NNP
cord-005453-4057qib7	2069	10	cell	cell	NN
cord-005453-4057qib7	2069	11	chimerism	chimerism	NN
cord-005453-4057qib7	2069	12	was	be	VBD
cord-005453-4057qib7	2069	13	47	47	CD
cord-005453-4057qib7	2069	14	%	%	NN
cord-005453-4057qib7	2069	15	,	,	,
cord-005453-4057qib7	2069	16	65	65	CD
cord-005453-4057qib7	2069	17	%	%	NN
cord-005453-4057qib7	2069	18	and	and	CC
cord-005453-4057qib7	2069	19	69	69	CD
cord-005453-4057qib7	2069	20	%	%	NN
cord-005453-4057qib7	2069	21	.	.	.
cord-005453-4057qib7	2070	1	Before	before	IN
cord-005453-4057qib7	2070	2	day	day	NN
cord-005453-4057qib7	2070	3	100	100	CD
cord-005453-4057qib7	2070	4	,	,	,
cord-005453-4057qib7	2070	5	10	10	CD
cord-005453-4057qib7	2070	6	patients	patient	NNS
cord-005453-4057qib7	2070	7	required	require	VBD
cord-005453-4057qib7	2070	8	the	the	DT
cord-005453-4057qib7	2070	9	infusion	infusion	NN
cord-005453-4057qib7	2070	10	of	of	IN
cord-005453-4057qib7	2070	11	DLI	DLI	NNP
cord-005453-4057qib7	2070	12	to	to	TO
cord-005453-4057qib7	2070	13	treat	treat	VB
cord-005453-4057qib7	2070	14	a	a	DT
cord-005453-4057qib7	2070	15	pending	pende	VBG
cord-005453-4057qib7	2070	16	or	or	CC
cord-005453-4057qib7	2070	17	overt	overt	JJ
cord-005453-4057qib7	2070	18	hematologic	hematologic	JJ
cord-005453-4057qib7	2070	19	relapse	relapse	NN
cord-005453-4057qib7	2070	20	and	and	CC
cord-005453-4057qib7	2070	21	12	12	CD
cord-005453-4057qib7	2070	22	patients	patient	NNS
cord-005453-4057qib7	2070	23	to	to	TO
cord-005453-4057qib7	2070	24	convert	convert	VB
cord-005453-4057qib7	2070	25	the	the	DT
cord-005453-4057qib7	2070	26	lymphoid	lymphoid	JJ
cord-005453-4057qib7	2070	27	chimerism	chimerism	NN
cord-005453-4057qib7	2070	28	from	from	IN
cord-005453-4057qib7	2070	29	mixed	mixed	JJ
cord-005453-4057qib7	2070	30	(	(	-LRB-
cord-005453-4057qib7	2070	31	median	median	NN
cord-005453-4057qib7	2070	32	44	44	CD
cord-005453-4057qib7	2070	33	%	%	NN
cord-005453-4057qib7	2070	34	,	,	,
cord-005453-4057qib7	2070	35	range	range	VBP
cord-005453-4057qib7	2070	36	0	0	CD
cord-005453-4057qib7	2070	37	-	-	HYPH
cord-005453-4057qib7	2070	38	76	76	CD
cord-005453-4057qib7	2070	39	)	)	-RRB-
cord-005453-4057qib7	2070	40	,	,	,
cord-005453-4057qib7	2070	41	to	to	TO
cord-005453-4057qib7	2070	42	complete	complete	VB
cord-005453-4057qib7	2070	43	(	(	-LRB-
cord-005453-4057qib7	2070	44	successfully	successfully	RB
cord-005453-4057qib7	2070	45	in	in	IN
cord-005453-4057qib7	2070	46	7	7	CD
cord-005453-4057qib7	2070	47	cases	case	NNS
cord-005453-4057qib7	2070	48	)	)	-RRB-
cord-005453-4057qib7	2070	49	.	.	.
cord-005453-4057qib7	2071	1	After	after	IN
cord-005453-4057qib7	2071	2	day	day	NN
cord-005453-4057qib7	2071	3	100	100	CD
cord-005453-4057qib7	2071	4	,	,	,
cord-005453-4057qib7	2071	5	13	13	CD
cord-005453-4057qib7	2071	6	additional	additional	JJ
cord-005453-4057qib7	2071	7	patients	patient	NNS
cord-005453-4057qib7	2071	8	required	require	VBD
cord-005453-4057qib7	2071	9	DLI	DLI	NNP
cord-005453-4057qib7	2071	10	to	to	TO
cord-005453-4057qib7	2071	11	treat	treat	VB
cord-005453-4057qib7	2071	12	disease	disease	NN
cord-005453-4057qib7	2071	13	relapse	relapse	NN
cord-005453-4057qib7	2071	14	or	or	CC
cord-005453-4057qib7	2071	15	progression	progression	NN
cord-005453-4057qib7	2071	16	and	and	CC
cord-005453-4057qib7	2071	17	8	8	CD
cord-005453-4057qib7	2071	18	patients	patient	NNS
cord-005453-4057qib7	2071	19	to	to	TO
cord-005453-4057qib7	2071	20	improve	improve	VB
cord-005453-4057qib7	2071	21	the	the	DT
cord-005453-4057qib7	2071	22	chimeric	chimeric	JJ
cord-005453-4057qib7	2071	23	status	status	NN
cord-005453-4057qib7	2071	24	or	or	CC
cord-005453-4057qib7	2071	25	the	the	DT
cord-005453-4057qib7	2071	26	immune	immune	JJ
cord-005453-4057qib7	2071	27	reconstitution	reconstitution	NN
cord-005453-4057qib7	2071	28	.	.	.
cord-005453-4057qib7	2072	1	At	at	IN
cord-005453-4057qib7	2072	2	5	5	CD
cord-005453-4057qib7	2072	3	years	year	NNS
cord-005453-4057qib7	2072	4	,	,	,
cord-005453-4057qib7	2072	5	the	the	DT
cord-005453-4057qib7	2072	6	Overall	Overall	NNP
cord-005453-4057qib7	2072	7	Survival	Survival	NNP
cord-005453-4057qib7	2072	8	is	be	VBZ
cord-005453-4057qib7	2072	9	64	64	CD
cord-005453-4057qib7	2072	10	%	%	NN
cord-005453-4057qib7	2072	11	,	,	,
cord-005453-4057qib7	2072	12	with	with	IN
cord-005453-4057qib7	2072	13	a	a	DT
cord-005453-4057qib7	2072	14	relapse	relapse	NN
cord-005453-4057qib7	2072	15	and	and	CC
cord-005453-4057qib7	2072	16	non	non	JJ
cord-005453-4057qib7	2072	17	-	-	JJ
cord-005453-4057qib7	2072	18	relapse	relapse	JJ
cord-005453-4057qib7	2072	19	mortality	mortality	NN
cord-005453-4057qib7	2072	20	of	of	IN
cord-005453-4057qib7	2072	21	21	21	CD
cord-005453-4057qib7	2072	22	%	%	NN
cord-005453-4057qib7	2072	23	and	and	CC
cord-005453-4057qib7	2072	24	11	11	CD
cord-005453-4057qib7	2072	25	%	%	NN
cord-005453-4057qib7	2072	26	,	,	,
cord-005453-4057qib7	2072	27	respectively	respectively	RB
cord-005453-4057qib7	2072	28	(	(	-LRB-
cord-005453-4057qib7	2072	29	Figure	figure	NN
cord-005453-4057qib7	2072	30	1	1	CD
cord-005453-4057qib7	2072	31	)	)	-RRB-
cord-005453-4057qib7	2072	32	.	.	.
cord-005453-4057qib7	2073	1	By	by	IN
cord-005453-4057qib7	2073	2	uni	uni	NNP
cord-005453-4057qib7	2073	3	and	and	CC
cord-005453-4057qib7	2073	4	multivariable	multivariable	JJ
cord-005453-4057qib7	2073	5	analysis	analysis	NN
cord-005453-4057qib7	2073	6	,	,	,
cord-005453-4057qib7	2073	7	AML	AML	NNP
cord-005453-4057qib7	2073	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	2073	9	and	and	CC
cord-005453-4057qib7	2073	10	a	a	DT
cord-005453-4057qib7	2073	11	mixed	mixed	JJ
cord-005453-4057qib7	2073	12	BM	bm	NN
cord-005453-4057qib7	2073	13	chimerism	chimerism	NN
cord-005453-4057qib7	2073	14	before	before	IN
cord-005453-4057qib7	2073	15	day	day	NN
cord-005453-4057qib7	2073	16	100	100	CD
cord-005453-4057qib7	2073	17	were	be	VBD
cord-005453-4057qib7	2073	18	associated	associate	VBN
cord-005453-4057qib7	2073	19	with	with	IN
cord-005453-4057qib7	2073	20	Relapse	Relapse	NNP
cord-005453-4057qib7	2073	21	and	and	CC
cord-005453-4057qib7	2073	22	Overall	Overall	NNP
cord-005453-4057qib7	2073	23	Survival	Survival	NNP
cord-005453-4057qib7	2073	24	while	while	IN
cord-005453-4057qib7	2073	25	age	age	NN
cord-005453-4057qib7	2073	26	>	>	XX
cord-005453-4057qib7	2073	27	50	50	CD
cord-005453-4057qib7	2073	28	was	be	VBD
cord-005453-4057qib7	2073	29	the	the	DT
cord-005453-4057qib7	2073	30	only	only	JJ
cord-005453-4057qib7	2073	31	factor	factor	NN
cord-005453-4057qib7	2073	32	significantly	significantly	RB
cord-005453-4057qib7	2073	33	associated	associate	VBN
cord-005453-4057qib7	2073	34	with	with	IN
cord-005453-4057qib7	2073	35	NRM	NRM	NNP
cord-005453-4057qib7	2073	36	.	.	.
cord-005453-4057qib7	2074	1	A	a	DT
cord-005453-4057qib7	2074	2	mixed	mixed	JJ
cord-005453-4057qib7	2074	3	PB	PB	NNP
cord-005453-4057qib7	2074	4	T	T	NNP
cord-005453-4057qib7	2074	5	-	-	HYPH
cord-005453-4057qib7	2074	6	lymphoid	lymphoid	JJ
cord-005453-4057qib7	2074	7	chimerism	chimerism	NN
cord-005453-4057qib7	2074	8	before	before	IN
cord-005453-4057qib7	2074	9	day	day	NN
cord-005453-4057qib7	2074	10	100	100	CD
cord-005453-4057qib7	2074	11	does	do	VBZ
cord-005453-4057qib7	2074	12	not	not	RB
cord-005453-4057qib7	2074	13	adversely	adversely	RB
cord-005453-4057qib7	2074	14	impact	impact	VB
cord-005453-4057qib7	2074	15	on	on	IN
cord-005453-4057qib7	2074	16	non	non	JJ
cord-005453-4057qib7	2074	17	-	-	JJ
cord-005453-4057qib7	2074	18	relapse	relapse	JJ
cord-005453-4057qib7	2074	19	mortality	mortality	NN
cord-005453-4057qib7	2074	20	,	,	,
cord-005453-4057qib7	2074	21	cumulative	cumulative	JJ
cord-005453-4057qib7	2074	22	incidence	incidence	NN
cord-005453-4057qib7	2074	23	of	of	IN
cord-005453-4057qib7	2074	24	relapse	relapse	NN
cord-005453-4057qib7	2074	25	,	,	,
cord-005453-4057qib7	2074	26	leukemia	leukemia	NN
cord-005453-4057qib7	2074	27	-	-	HYPH
cord-005453-4057qib7	2074	28	free	free	JJ
cord-005453-4057qib7	2074	29	and	and	CC
cord-005453-4057qib7	2074	30	overall	overall	JJ
cord-005453-4057qib7	2074	31	survival	survival	NN
cord-005453-4057qib7	2074	32	.	.	.
cord-005453-4057qib7	2075	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2075	2	:	:	:
cord-005453-4057qib7	2076	1	After	after	IN
cord-005453-4057qib7	2076	2	FB4	FB4	NNP
cord-005453-4057qib7	2076	3	and	and	CC
cord-005453-4057qib7	2076	4	ATG	ATG	NNP
cord-005453-4057qib7	2076	5	,	,	,
cord-005453-4057qib7	2076	6	a	a	DT
cord-005453-4057qib7	2076	7	progressive	progressive	JJ
cord-005453-4057qib7	2076	8	increase	increase	NN
cord-005453-4057qib7	2076	9	of	of	IN
cord-005453-4057qib7	2076	10	PB	PB	NNP
cord-005453-4057qib7	2076	11	lymphoid	lymphoid	JJ
cord-005453-4057qib7	2076	12	donor	donor	NN
cord-005453-4057qib7	2076	13	chimerism	chimerism	NN
cord-005453-4057qib7	2076	14	develops	develop	VBZ
cord-005453-4057qib7	2076	15	gradually	gradually	RB
cord-005453-4057qib7	2076	16	after	after	IN
cord-005453-4057qib7	2076	17	transplantation	transplantation	NN
cord-005453-4057qib7	2076	18	,	,	,
cord-005453-4057qib7	2076	19	in	in	IN
cord-005453-4057qib7	2076	20	most	most	JJS
cord-005453-4057qib7	2076	21	of	of	IN
cord-005453-4057qib7	2076	22	cases	case	NNS
cord-005453-4057qib7	2076	23	without	without	IN
cord-005453-4057qib7	2076	24	the	the	DT
cord-005453-4057qib7	2076	25	need	need	NN
cord-005453-4057qib7	2076	26	of	of	IN
cord-005453-4057qib7	2076	27	DLI	DLI	NNP
cord-005453-4057qib7	2076	28	.	.	.
cord-005453-4057qib7	2077	1	Early	early	JJ
cord-005453-4057qib7	2077	2	mixed	mixed	JJ
cord-005453-4057qib7	2077	3	lymphoid	lymphoid	JJ
cord-005453-4057qib7	2077	4	chimerism	chimerism	NN
cord-005453-4057qib7	2077	5	does	do	VBZ
cord-005453-4057qib7	2077	6	not	not	RB
cord-005453-4057qib7	2077	7	compromise	compromise	VB
cord-005453-4057qib7	2077	8	the	the	DT
cord-005453-4057qib7	2077	9	main	main	JJ
cord-005453-4057qib7	2077	10	long	long	JJ
cord-005453-4057qib7	2077	11	-	-	HYPH
cord-005453-4057qib7	2077	12	term	term	NN
cord-005453-4057qib7	2077	13	clinical	clinical	JJ
cord-005453-4057qib7	2077	14	outcomes	outcome	NNS
cord-005453-4057qib7	2077	15	and	and	CC
cord-005453-4057qib7	2077	16	may	may	MD
cord-005453-4057qib7	2077	17	at	at	IN
cord-005453-4057qib7	2077	18	least	least	RBS
cord-005453-4057qib7	2077	19	partially	partially	RB
cord-005453-4057qib7	2077	20	explain	explain	VB
cord-005453-4057qib7	2077	21	the	the	DT
cord-005453-4057qib7	2077	22	low	low	JJ
cord-005453-4057qib7	2077	23	non	non	JJ
cord-005453-4057qib7	2077	24	-	-	JJ
cord-005453-4057qib7	2077	25	relapse	relapse	JJ
cord-005453-4057qib7	2077	26	mortality	mortality	NN
cord-005453-4057qib7	2077	27	.	.	.
cord-005453-4057qib7	2078	1	An	an	DT
cord-005453-4057qib7	2078	2	incomplete	incomplete	JJ
cord-005453-4057qib7	2078	3	BM	bm	NN
cord-005453-4057qib7	2078	4	chimerism	chimerism	NN
cord-005453-4057qib7	2078	5	within	within	IN
cord-005453-4057qib7	2078	6	the	the	DT
cord-005453-4057qib7	2078	7	first	first	JJ
cord-005453-4057qib7	2078	8	3	3	CD
cord-005453-4057qib7	2078	9	months	month	NNS
cord-005453-4057qib7	2078	10	strongly	strongly	RB
cord-005453-4057qib7	2078	11	correlates	correlate	VBZ
cord-005453-4057qib7	2078	12	with	with	IN
cord-005453-4057qib7	2078	13	early	early	JJ
cord-005453-4057qib7	2078	14	disease	disease	NN
cord-005453-4057qib7	2078	15	progression	progression	NN
cord-005453-4057qib7	2078	16	or	or	CC
cord-005453-4057qib7	2078	17	relapse	relapse	NN
cord-005453-4057qib7	2078	18	.	.	.
cord-005453-4057qib7	2079	1	Background	background	NN
cord-005453-4057qib7	2079	2	:	:	:
cord-005453-4057qib7	2080	1	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2080	2	(	(	-LRB-
cord-005453-4057qib7	2080	3	Bu	Bu	NNP
cord-005453-4057qib7	2080	4	)	)	-RRB-
cord-005453-4057qib7	2080	5	is	be	VBZ
cord-005453-4057qib7	2080	6	widely	widely	RB
cord-005453-4057qib7	2080	7	used	use	VBN
cord-005453-4057qib7	2080	8	as	as	IN
cord-005453-4057qib7	2080	9	a	a	DT
cord-005453-4057qib7	2080	10	component	component	NN
cord-005453-4057qib7	2080	11	of	of	IN
cord-005453-4057qib7	2080	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2080	13	conditioning	conditioning	NN
cord-005453-4057qib7	2080	14	regimen	regimen	NN
cord-005453-4057qib7	2080	15	before	before	IN
cord-005453-4057qib7	2080	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2080	17	stem	stem	NN
cord-005453-4057qib7	2080	18	cell	cell	NN
cord-005453-4057qib7	2080	19	transplantation	transplantation	NN
cord-005453-4057qib7	2080	20	(	(	-LRB-
cord-005453-4057qib7	2080	21	HSCT	HSCT	NNP
cord-005453-4057qib7	2080	22	)	)	-RRB-
cord-005453-4057qib7	2080	23	in	in	IN
cord-005453-4057qib7	2080	24	children	child	NNS
cord-005453-4057qib7	2080	25	.	.	.
cord-005453-4057qib7	2081	1	Bu	Bu	NNP
cord-005453-4057qib7	2081	2	has	have	VBZ
cord-005453-4057qib7	2081	3	a	a	DT
cord-005453-4057qib7	2081	4	narrow	narrow	JJ
cord-005453-4057qib7	2081	5	cumulative	cumulative	JJ
cord-005453-4057qib7	2081	6	exposure	exposure	NN
cord-005453-4057qib7	2081	7	window	window	NN
cord-005453-4057qib7	2081	8	.	.	.
cord-005453-4057qib7	2082	1	The	the	DT
cord-005453-4057qib7	2082	2	relation	relation	NN
cord-005453-4057qib7	2082	3	of	of	IN
cord-005453-4057qib7	2082	4	Bu	Bu	NNP
cord-005453-4057qib7	2082	5	exposure	exposure	NN
cord-005453-4057qib7	2082	6	with	with	IN
cord-005453-4057qib7	2082	7	toxicity	toxicity	NN
cord-005453-4057qib7	2082	8	is	be	VBZ
cord-005453-4057qib7	2082	9	well	well	RB
cord-005453-4057qib7	2082	10	established	establish	VBN
cord-005453-4057qib7	2082	11	,	,	,
cord-005453-4057qib7	2082	12	but	but	CC
cord-005453-4057qib7	2082	13	the	the	DT
cord-005453-4057qib7	2082	14	link	link	NN
cord-005453-4057qib7	2082	15	between	between	IN
cord-005453-4057qib7	2082	16	the	the	DT
cord-005453-4057qib7	2082	17	exposure	exposure	NN
cord-005453-4057qib7	2082	18	and	and	CC
cord-005453-4057qib7	2082	19	EFS	efs	NN
cord-005453-4057qib7	2082	20	is	be	VBZ
cord-005453-4057qib7	2082	21	not	not	RB
cord-005453-4057qib7	2082	22	clear	clear	JJ
cord-005453-4057qib7	2082	23	due	due	IN
cord-005453-4057qib7	2082	24	to	to	IN
cord-005453-4057qib7	2082	25	conflicting	conflicting	JJ
cord-005453-4057qib7	2082	26	reports	report	NNS
cord-005453-4057qib7	2082	27	especially	especially	RB
cord-005453-4057qib7	2082	28	in	in	IN
cord-005453-4057qib7	2082	29	pediatric	pediatric	JJ
cord-005453-4057qib7	2082	30	patients	patient	NNS
cord-005453-4057qib7	2082	31	.	.	.
cord-005453-4057qib7	2083	1	Obtaining	obtain	VBG
cord-005453-4057qib7	2083	2	the	the	DT
cord-005453-4057qib7	2083	3	ratio	ratio	NN
cord-005453-4057qib7	2083	4	of	of	IN
cord-005453-4057qib7	2083	5	Bu	Bu	NNP
cord-005453-4057qib7	2083	6	to	to	IN
cord-005453-4057qib7	2083	7	its	-PRON-	PRP$
cord-005453-4057qib7	2083	8	metabolite	metabolite	JJ
cord-005453-4057qib7	2083	9	i.e.	i.e.	FW
cord-005453-4057qib7	2083	10	metabolic	metabolic	JJ
cord-005453-4057qib7	2083	11	ratio	ratio	NN
cord-005453-4057qib7	2083	12	(	(	-LRB-
cord-005453-4057qib7	2083	13	MR	MR	NNP
cord-005453-4057qib7	2083	14	)	)	-RRB-
cord-005453-4057qib7	2083	15	may	may	MD
cord-005453-4057qib7	2083	16	serve	serve	VB
cord-005453-4057qib7	2083	17	as	as	IN
cord-005453-4057qib7	2083	18	an	an	DT
cord-005453-4057qib7	2083	19	indicator	indicator	NN
cord-005453-4057qib7	2083	20	of	of	IN
cord-005453-4057qib7	2083	21	Bu	Bu	NNP
cord-005453-4057qib7	2083	22	GSH	GSH	NNP
cord-005453-4057qib7	2083	23	conjugating	conjugate	VBG
cord-005453-4057qib7	2083	24	capacity	capacity	NN
cord-005453-4057qib7	2083	25	of	of	IN
cord-005453-4057qib7	2083	26	an	an	DT
cord-005453-4057qib7	2083	27	individual	individual	NN
cord-005453-4057qib7	2083	28	,	,	,
cord-005453-4057qib7	2083	29	thus	thus	RB
cord-005453-4057qib7	2083	30	cumulative	cumulative	JJ
cord-005453-4057qib7	2083	31	exposure	exposure	NN
cord-005453-4057qib7	2083	32	of	of	IN
cord-005453-4057qib7	2083	33	Bu	Bu	NNP
cord-005453-4057qib7	2083	34	for	for	IN
cord-005453-4057qib7	2083	35	a	a	DT
cord-005453-4057qib7	2083	36	particular	particular	JJ
cord-005453-4057qib7	2083	37	day	day	NN
cord-005453-4057qib7	2083	38	that	that	WDT
cord-005453-4057qib7	2083	39	could	could	MD
cord-005453-4057qib7	2083	40	be	be	VB
cord-005453-4057qib7	2083	41	used	use	VBN
cord-005453-4057qib7	2083	42	along	along	IN
cord-005453-4057qib7	2083	43	with	with	IN
cord-005453-4057qib7	2083	44	AUC	AUC	NNP
cord-005453-4057qib7	2083	45	as	as	IN
cord-005453-4057qib7	2083	46	a	a	DT
cord-005453-4057qib7	2083	47	marker	marker	NN
cord-005453-4057qib7	2083	48	to	to	TO
cord-005453-4057qib7	2083	49	predict	predict	VB
cord-005453-4057qib7	2083	50	EFS	EFS	NNP
cord-005453-4057qib7	2083	51	.	.	.
cord-005453-4057qib7	2084	1	The	the	DT
cord-005453-4057qib7	2084	2	present	present	JJ
cord-005453-4057qib7	2084	3	investigation	investigation	NN
cord-005453-4057qib7	2084	4	is	be	VBZ
cord-005453-4057qib7	2084	5	aimed	aim	VBN
cord-005453-4057qib7	2084	6	at	at	IN
cord-005453-4057qib7	2084	7	evaluating	evaluate	VBG
cord-005453-4057qib7	2084	8	the	the	DT
cord-005453-4057qib7	2084	9	utility	utility	NN
cord-005453-4057qib7	2084	10	of	of	IN
cord-005453-4057qib7	2084	11	Bu	Bu	NNP
cord-005453-4057qib7	2084	12	MR	MR	NNP
cord-005453-4057qib7	2084	13	to	to	TO
cord-005453-4057qib7	2084	14	predict	predict	VB
cord-005453-4057qib7	2084	15	EFS	efs	NN
cord-005453-4057qib7	2084	16	in	in	IN
cord-005453-4057qib7	2084	17	children	child	NNS
cord-005453-4057qib7	2084	18	undergoing	undergo	VBG
cord-005453-4057qib7	2084	19	allogeneic	allogeneic	IN
cord-005453-4057qib7	2084	20	HSCT	HSCT	NNP
cord-005453-4057qib7	2084	21	.	.	.
cord-005453-4057qib7	2085	1	Methods	method	NNS
cord-005453-4057qib7	2085	2	:	:	:
cord-005453-4057qib7	2086	1	Two	two	CD
cord-005453-4057qib7	2086	2	different	different	JJ
cord-005453-4057qib7	2086	3	cohorts	cohort	NNS
cord-005453-4057qib7	2086	4	with	with	IN
cord-005453-4057qib7	2086	5	children	child	NNS
cord-005453-4057qib7	2086	6	receiving	receive	VBG
cord-005453-4057qib7	2086	7	Bu	Bu	NNP
cord-005453-4057qib7	2086	8	in	in	IN
cord-005453-4057qib7	2086	9	four	four	CD
cord-005453-4057qib7	2086	10	times	time	NNS
cord-005453-4057qib7	2086	11	daily	daily	JJ
cord-005453-4057qib7	2086	12	(	(	-LRB-
cord-005453-4057qib7	2086	13	QID	QID	NNP
cord-005453-4057qib7	2086	14	,	,	,
cord-005453-4057qib7	2086	15	n=44	n=44	NNP
cord-005453-4057qib7	2086	16	)	)	-RRB-
cord-005453-4057qib7	2086	17	and	and	CC
cord-005453-4057qib7	2086	18	once	once	IN
cord-005453-4057qib7	2086	19	daily	daily	JJ
cord-005453-4057qib7	2086	20	doses	dose	NNS
cord-005453-4057qib7	2086	21	(	(	-LRB-
cord-005453-4057qib7	2086	22	QD	QD	NNP
cord-005453-4057qib7	2086	23	,	,	,
cord-005453-4057qib7	2086	24	n=13	n=13	NNP
cord-005453-4057qib7	2086	25	)	)	-RRB-
cord-005453-4057qib7	2086	26	at	at	IN
cord-005453-4057qib7	2086	27	St.	St.	NNP
cord-005453-4057qib7	2086	28	Justine	Justine	NNP
cord-005453-4057qib7	2086	29	's	's	POS
cord-005453-4057qib7	2086	30	Hospital	Hospital	NNP
cord-005453-4057qib7	2086	31	,	,	,
cord-005453-4057qib7	2086	32	Montreal	Montreal	NNP
cord-005453-4057qib7	2086	33	were	be	VBD
cord-005453-4057qib7	2086	34	studied	study	VBN
cord-005453-4057qib7	2086	35	.	.	.
cord-005453-4057qib7	2087	1	Bu	Bu	NNP
cord-005453-4057qib7	2087	2	and	and	CC
cord-005453-4057qib7	2087	3	Su	Su	NNP
cord-005453-4057qib7	2087	4	levels	level	NNS
cord-005453-4057qib7	2087	5	were	be	VBD
cord-005453-4057qib7	2087	6	measured	measure	VBN
cord-005453-4057qib7	2087	7	on	on	IN
cord-005453-4057qib7	2087	8	day	day	NN
cord-005453-4057qib7	2087	9	3	3	CD
cord-005453-4057qib7	2087	10	of	of	IN
cord-005453-4057qib7	2087	11	the	the	DT
cord-005453-4057qib7	2087	12	conditioning	conditioning	NN
cord-005453-4057qib7	2087	13	regimen	regimen	NN
cord-005453-4057qib7	2087	14	at	at	IN
cord-005453-4057qib7	2087	15	the	the	DT
cord-005453-4057qib7	2087	16	end	end	NN
cord-005453-4057qib7	2087	17	of	of	IN
cord-005453-4057qib7	2087	18	infusion	infusion	NN
cord-005453-4057qib7	2087	19	(	(	-LRB-
cord-005453-4057qib7	2087	20	dose	dose	NN
cord-005453-4057qib7	2087	21	9	9	CD
cord-005453-4057qib7	2087	22	in	in	IN
cord-005453-4057qib7	2087	23	QID	QID	NNP
cord-005453-4057qib7	2087	24	or	or	CC
cord-005453-4057qib7	2087	25	dose	dose	NN
cord-005453-4057qib7	2087	26	3	3	CD
cord-005453-4057qib7	2087	27	in	in	IN
cord-005453-4057qib7	2087	28	QD	QD	NNP
cord-005453-4057qib7	2087	29	dosing	dose	VBG
cord-005453-4057qib7	2087	30	)	)	-RRB-
cord-005453-4057qib7	2087	31	.	.	.
cord-005453-4057qib7	2088	1	EFS	EFS	NNP
cord-005453-4057qib7	2088	2	was	be	VBD
cord-005453-4057qib7	2088	3	defined	define	VBN
cord-005453-4057qib7	2088	4	from	from	IN
cord-005453-4057qib7	2088	5	the	the	DT
cord-005453-4057qib7	2088	6	time	time	NN
cord-005453-4057qib7	2088	7	of	of	IN
cord-005453-4057qib7	2088	8	transplant	transplant	NN
cord-005453-4057qib7	2088	9	until	until	IN
cord-005453-4057qib7	2088	10	death	death	NN
cord-005453-4057qib7	2088	11	,	,	,
cord-005453-4057qib7	2088	12	relapse	relapse	NN
cord-005453-4057qib7	2088	13	,	,	,
cord-005453-4057qib7	2088	14	or	or	CC
cord-005453-4057qib7	2088	15	rejection	rejection	NN
cord-005453-4057qib7	2088	16	,	,	,
cord-005453-4057qib7	2088	17	whichever	whichever	WDT
cord-005453-4057qib7	2088	18	occurred	occur	VBD
cord-005453-4057qib7	2088	19	first	first	RB
cord-005453-4057qib7	2088	20	.	.	.
cord-005453-4057qib7	2089	1	A	a	DT
cord-005453-4057qib7	2089	2	receiver	receiver	NN
cord-005453-4057qib7	2089	3	-	-	HYPH
cord-005453-4057qib7	2089	4	operator	operator	NN
cord-005453-4057qib7	2089	5	characteristic	characteristic	JJ
cord-005453-4057qib7	2089	6	curve	curve	NN
cord-005453-4057qib7	2089	7	(	(	-LRB-
cord-005453-4057qib7	2089	8	ROC	ROC	NNP
cord-005453-4057qib7	2089	9	)	)	-RRB-
cord-005453-4057qib7	2089	10	for	for	IN
cord-005453-4057qib7	2089	11	Bu	Bu	NNP
cord-005453-4057qib7	2089	12	MRs	MRs	NNP
cord-005453-4057qib7	2089	13	measured	measured	NNP
cord-005453-4057qib7	2089	14	was	be	VBD
cord-005453-4057qib7	2089	15	plotted	plot	VBN
cord-005453-4057qib7	2089	16	to	to	TO
cord-005453-4057qib7	2089	17	show	show	VB
cord-005453-4057qib7	2089	18	the	the	DT
cord-005453-4057qib7	2089	19	trade	trade	NN
cord-005453-4057qib7	2089	20	-	-	HYPH
cord-005453-4057qib7	2089	21	off	off	NN
cord-005453-4057qib7	2089	22	in	in	IN
cord-005453-4057qib7	2089	23	sensitivity	sensitivity	NN
cord-005453-4057qib7	2089	24	vs.	vs.	IN
cord-005453-4057qib7	2089	25	1-specificity	1-specificity	CD
cord-005453-4057qib7	2089	26	rates	rate	NNS
cord-005453-4057qib7	2089	27	for	for	IN
cord-005453-4057qib7	2089	28	EFS	efs	NN
cord-005453-4057qib7	2089	29	,	,	,
cord-005453-4057qib7	2089	30	as	as	IN
cord-005453-4057qib7	2089	31	the	the	DT
cord-005453-4057qib7	2089	32	cut	cut	NN
cord-005453-4057qib7	2089	33	-	-	HYPH
cord-005453-4057qib7	2089	34	off	off	NN
cord-005453-4057qib7	2089	35	of	of	IN
cord-005453-4057qib7	2089	36	the	the	DT
cord-005453-4057qib7	2089	37	test	test	NN
cord-005453-4057qib7	2089	38	was	be	VBD
cord-005453-4057qib7	2089	39	shifted	shift	VBN
cord-005453-4057qib7	2089	40	from	from	IN
cord-005453-4057qib7	2089	41	low	low	JJ
cord-005453-4057qib7	2089	42	to	to	IN
cord-005453-4057qib7	2089	43	high	high	JJ
cord-005453-4057qib7	2089	44	.	.	.
cord-005453-4057qib7	2090	1	Cutoff	cutoff	NN
cord-005453-4057qib7	2090	2	values	value	NNS
cord-005453-4057qib7	2090	3	were	be	VBD
cord-005453-4057qib7	2090	4	defined	define	VBN
cord-005453-4057qib7	2090	5	based	base	VBN
cord-005453-4057qib7	2090	6	on	on	IN
cord-005453-4057qib7	2090	7	the	the	DT
cord-005453-4057qib7	2090	8	Youden´s	Youden´s	NNPS
cord-005453-4057qib7	2090	9	J	J	NNP
cord-005453-4057qib7	2090	10	statistic	statistic	NN
cord-005453-4057qib7	2090	11	(	(	-LRB-
cord-005453-4057qib7	2090	12	i.e.	i.e.	FW
cord-005453-4057qib7	2090	13	sensitivity+specificty-1	sensitivity+specificty-1	NN
cord-005453-4057qib7	2090	14	)	)	-RRB-
cord-005453-4057qib7	2090	15	.	.	.
cord-005453-4057qib7	2091	1	Results	result	NNS
cord-005453-4057qib7	2091	2	:	:	:
cord-005453-4057qib7	2092	1	Twenty	twenty	CD
cord-005453-4057qib7	2092	2	-	-	HYPH
cord-005453-4057qib7	2092	3	two	two	CD
cord-005453-4057qib7	2092	4	males	male	NNS
cord-005453-4057qib7	2092	5	and	and	CC
cord-005453-4057qib7	2092	6	22	22	CD
cord-005453-4057qib7	2092	7	females	female	NNS
cord-005453-4057qib7	2092	8	aged	age	VBN
cord-005453-4057qib7	2092	9	from	from	IN
cord-005453-4057qib7	2092	10	0.1	0.1	CD
cord-005453-4057qib7	2092	11	to	to	TO
cord-005453-4057qib7	2092	12	19.9	19.9	CD
cord-005453-4057qib7	2092	13	years	year	NNS
cord-005453-4057qib7	2093	1	(	(	-LRB-
cord-005453-4057qib7	2093	2	mean±SD	mean±SD	NNP
cord-005453-4057qib7	2093	3	:	:	:
cord-005453-4057qib7	2093	4	7.2	7.2	CD
cord-005453-4057qib7	2093	5	±	±	NNP
cord-005453-4057qib7	2093	6	5.7	5.7	CD
cord-005453-4057qib7	2093	7	)	)	-RRB-
cord-005453-4057qib7	2093	8	from	from	IN
cord-005453-4057qib7	2093	9	Bu	Bu	NNP
cord-005453-4057qib7	2093	10	QID	QID	NNP
cord-005453-4057qib7	2093	11	cohort	cohort	NN
cord-005453-4057qib7	2093	12	had	have	VBD
cord-005453-4057qib7	2093	13	the	the	DT
cord-005453-4057qib7	2093	14	mean	mean	JJ
cord-005453-4057qib7	2093	15	MR	MR	NNP
cord-005453-4057qib7	2093	16	of	of	IN
cord-005453-4057qib7	2093	17	5.9	5.9	CD
cord-005453-4057qib7	2093	18	(	(	-LRB-
cord-005453-4057qib7	2093	19	SD	sd	NN
cord-005453-4057qib7	2093	20	:	:	:
cord-005453-4057qib7	2093	21	3.2	3.2	CD
cord-005453-4057qib7	2093	22	)	)	-RRB-
cord-005453-4057qib7	2093	23	.	.	.
cord-005453-4057qib7	2094	1	A	a	DT
cord-005453-4057qib7	2094	2	cut	cut	NN
cord-005453-4057qib7	2094	3	off	off	RP
cord-005453-4057qib7	2094	4	value	value	NN
cord-005453-4057qib7	2094	5	of	of	IN
cord-005453-4057qib7	2094	6	4.9	4.9	CD
cord-005453-4057qib7	2094	7	in	in	IN
cord-005453-4057qib7	2094	8	MR	MR	NNP
cord-005453-4057qib7	2094	9	was	be	VBD
cord-005453-4057qib7	2094	10	chosen	choose	VBN
cord-005453-4057qib7	2094	11	in	in	IN
cord-005453-4057qib7	2094	12	ROC	ROC	NNP
cord-005453-4057qib7	2094	13	analysis	analysis	NN
cord-005453-4057qib7	2094	14	in	in	IN
cord-005453-4057qib7	2094	15	this	this	DT
cord-005453-4057qib7	2094	16	cohort	cohort	NN
cord-005453-4057qib7	2094	17	,	,	,
cord-005453-4057qib7	2094	18	with	with	IN
cord-005453-4057qib7	2094	19	better	well	JJR
cord-005453-4057qib7	2094	20	sensitivity	sensitivity	NN
cord-005453-4057qib7	2094	21	(	(	-LRB-
cord-005453-4057qib7	2094	22	71	71	CD
cord-005453-4057qib7	2094	23	%	%	NN
cord-005453-4057qib7	2094	24	)	)	-RRB-
cord-005453-4057qib7	2094	25	and	and	CC
cord-005453-4057qib7	2094	26	specificity	specificity	NN
cord-005453-4057qib7	2094	27	(	(	-LRB-
cord-005453-4057qib7	2094	28	70	70	CD
cord-005453-4057qib7	2094	29	%	%	NN
cord-005453-4057qib7	2094	30	)	)	-RRB-
cord-005453-4057qib7	2094	31	for	for	IN
cord-005453-4057qib7	2094	32	EFS	efs	NN
cord-005453-4057qib7	2094	33	prediction	prediction	NN
cord-005453-4057qib7	2094	34	(	(	-LRB-
cord-005453-4057qib7	2094	35	p=0.01	p=0.01	NNP
cord-005453-4057qib7	2094	36	,	,	,
cord-005453-4057qib7	2094	37	AUC=	auc=	CD
cord-005453-4057qib7	2094	38	0.7	0.7	CD
cord-005453-4057qib7	2094	39	(	(	-LRB-
cord-005453-4057qib7	2094	40	95	95	CD
cord-005453-4057qib7	2094	41	%	%	NN
cord-005453-4057qib7	2094	42	CI=	ci=	CD
cord-005453-4057qib7	2094	43	0.6	0.6	CD
cord-005453-4057qib7	2094	44	-	-	SYM
cord-005453-4057qib7	2094	45	0.8	0.8	CD
cord-005453-4057qib7	2094	46	)	)	-RRB-
cord-005453-4057qib7	2094	47	.	.	.
cord-005453-4057qib7	2095	1	In	in	IN
cord-005453-4057qib7	2095	2	QD	QD	NNP
cord-005453-4057qib7	2095	3	cohort	cohort	NN
cord-005453-4057qib7	2095	4	nine	nine	CD
cord-005453-4057qib7	2095	5	females	female	NNS
cord-005453-4057qib7	2095	6	,	,	,
cord-005453-4057qib7	2095	7	and	and	CC
cord-005453-4057qib7	2095	8	four	four	CD
cord-005453-4057qib7	2095	9	males	male	NNS
cord-005453-4057qib7	2095	10	aged	age	VBN
cord-005453-4057qib7	2095	11	between	between	IN
cord-005453-4057qib7	2095	12	0.4	0.4	CD
cord-005453-4057qib7	2095	13	and	and	CC
cord-005453-4057qib7	2095	14	15.8	15.8	CD
cord-005453-4057qib7	2095	15	years	year	NNS
cord-005453-4057qib7	2095	16	(	(	-LRB-
cord-005453-4057qib7	2095	17	6.7±5.1	6.7±5.1	NNP
cord-005453-4057qib7	2095	18	)	)	-RRB-
cord-005453-4057qib7	2095	19	had	have	VBD
cord-005453-4057qib7	2095	20	the	the	DT
cord-005453-4057qib7	2095	21	mean	mean	JJ
cord-005453-4057qib7	2095	22	MR	MR	NNP
cord-005453-4057qib7	2095	23	of	of	IN
cord-005453-4057qib7	2095	24	29.3	29.3	CD
cord-005453-4057qib7	2095	25	(	(	-LRB-
cord-005453-4057qib7	2095	26	SD	sd	NN
cord-005453-4057qib7	2095	27	:	:	:
cord-005453-4057qib7	2095	28	16.6	16.6	CD
cord-005453-4057qib7	2095	29	)	)	-RRB-
cord-005453-4057qib7	2095	30	.	.	.
cord-005453-4057qib7	2096	1	In	in	IN
cord-005453-4057qib7	2096	2	ROC	ROC	NNP
cord-005453-4057qib7	2096	3	analysis	analysis	NN
cord-005453-4057qib7	2096	4	,	,	,
cord-005453-4057qib7	2096	5	a	a	DT
cord-005453-4057qib7	2096	6	cut	cut	NN
cord-005453-4057qib7	2096	7	off	off	RP
cord-005453-4057qib7	2096	8	value	value	NN
cord-005453-4057qib7	2096	9	of	of	IN
cord-005453-4057qib7	2096	10	25.06	25.06	CD
cord-005453-4057qib7	2096	11	was	be	VBD
cord-005453-4057qib7	2096	12	chosen	choose	VBN
cord-005453-4057qib7	2096	13	with	with	IN
cord-005453-4057qib7	2096	14	better	well	JJR
cord-005453-4057qib7	2096	15	sensitivity	sensitivity	NN
cord-005453-4057qib7	2096	16	(	(	-LRB-
cord-005453-4057qib7	2096	17	100	100	CD
cord-005453-4057qib7	2096	18	%	%	NN
cord-005453-4057qib7	2096	19	)	)	-RRB-
cord-005453-4057qib7	2096	20	and	and	CC
cord-005453-4057qib7	2096	21	specificity	specificity	NN
cord-005453-4057qib7	2096	22	(	(	-LRB-
cord-005453-4057qib7	2096	23	100	100	CD
cord-005453-4057qib7	2096	24	%	%	NN
cord-005453-4057qib7	2096	25	)	)	-RRB-
cord-005453-4057qib7	2096	26	for	for	IN
cord-005453-4057qib7	2096	27	EFS	efs	NN
cord-005453-4057qib7	2096	28	prediction	prediction	NN
cord-005453-4057qib7	2096	29	(	(	-LRB-
cord-005453-4057qib7	2096	30	p=0.003	p=0.003	NNP
cord-005453-4057qib7	2096	31	;	;	:
cord-005453-4057qib7	2096	32	AUC=1.0	AUC=1.0	NNP
cord-005453-4057qib7	2096	33	)	)	-RRB-
cord-005453-4057qib7	2096	34	.	.	.
cord-005453-4057qib7	2097	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2097	2	Background	Background	NNP
cord-005453-4057qib7	2097	3	:	:	:
cord-005453-4057qib7	2098	1	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2098	2	is	be	VBZ
cord-005453-4057qib7	2098	3	an	an	DT
cord-005453-4057qib7	2098	4	alkylating	alkylating	JJ
cord-005453-4057qib7	2098	5	agent	agent	NN
cord-005453-4057qib7	2098	6	increasingly	increasingly	RB
cord-005453-4057qib7	2098	7	used	use	VBN
cord-005453-4057qib7	2098	8	prior	prior	RB
cord-005453-4057qib7	2098	9	to	to	IN
cord-005453-4057qib7	2098	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2098	11	stem	stem	NN
cord-005453-4057qib7	2098	12	cell	cell	NN
cord-005453-4057qib7	2098	13	transplantation	transplantation	NN
cord-005453-4057qib7	2098	14	(	(	-LRB-
cord-005453-4057qib7	2098	15	HSCT	HSCT	NNP
cord-005453-4057qib7	2098	16	)	)	-RRB-
cord-005453-4057qib7	2098	17	.	.	.
cord-005453-4057qib7	2099	1	The	the	DT
cord-005453-4057qib7	2099	2	main	main	JJ
cord-005453-4057qib7	2099	3	objective	objective	NN
cord-005453-4057qib7	2099	4	of	of	IN
cord-005453-4057qib7	2099	5	this	this	DT
cord-005453-4057qib7	2099	6	study	study	NN
cord-005453-4057qib7	2099	7	was	be	VBD
cord-005453-4057qib7	2099	8	to	to	TO
cord-005453-4057qib7	2099	9	develop	develop	VB
cord-005453-4057qib7	2099	10	a	a	DT
cord-005453-4057qib7	2099	11	population	population	NN
cord-005453-4057qib7	2099	12	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	2099	13	model	model	NN
cord-005453-4057qib7	2099	14	of	of	IN
cord-005453-4057qib7	2099	15	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2099	16	in	in	IN
cord-005453-4057qib7	2099	17	pediatric	pediatric	JJ
cord-005453-4057qib7	2099	18	HSCT	HSCT	NNP
cord-005453-4057qib7	2099	19	recipients	recipient	NNS
cord-005453-4057qib7	2099	20	and	and	CC
cord-005453-4057qib7	2099	21	to	to	TO
cord-005453-4057qib7	2099	22	explore	explore	VB
cord-005453-4057qib7	2099	23	the	the	DT
cord-005453-4057qib7	2099	24	effect	effect	NN
cord-005453-4057qib7	2099	25	of	of	IN
cord-005453-4057qib7	2099	26	different	different	JJ
cord-005453-4057qib7	2099	27	covariates	covariate	NNS
cord-005453-4057qib7	2099	28	on	on	IN
cord-005453-4057qib7	2099	29	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2099	30	pharmacokinetics	pharmacokinetics	NNP
cord-005453-4057qib7	2099	31	(	(	-LRB-
cord-005453-4057qib7	2099	32	PK	PK	NNP
cord-005453-4057qib7	2099	33	)	)	-RRB-
cord-005453-4057qib7	2099	34	.	.	.
cord-005453-4057qib7	2100	1	Also	also	RB
cord-005453-4057qib7	2100	2	,	,	,
cord-005453-4057qib7	2100	3	a	a	DT
cord-005453-4057qib7	2100	4	limited	limited	JJ
cord-005453-4057qib7	2100	5	sampling	sampling	NN
cord-005453-4057qib7	2100	6	model	model	NN
cord-005453-4057qib7	2100	7	(	(	-LRB-
cord-005453-4057qib7	2100	8	LSM	LSM	NNP
cord-005453-4057qib7	2100	9	)	)	-RRB-
cord-005453-4057qib7	2100	10	was	be	VBD
cord-005453-4057qib7	2100	11	developed	develop	VBN
cord-005453-4057qib7	2100	12	.	.	.
cord-005453-4057qib7	2101	1	Methods	method	NNS
cord-005453-4057qib7	2101	2	:	:	:
cord-005453-4057qib7	2101	3	In	in	IN
cord-005453-4057qib7	2101	4	this	this	DT
cord-005453-4057qib7	2101	5	multicentre	multicentre	NNP
cord-005453-4057qib7	2101	6	study	study	NN
cord-005453-4057qib7	2101	7	,	,	,
cord-005453-4057qib7	2101	8	91	91	CD
cord-005453-4057qib7	2101	9	patients	patient	NNS
cord-005453-4057qib7	2101	10	,	,	,
cord-005453-4057qib7	2101	11	receiving	receive	VBG
cord-005453-4057qib7	2101	12	a	a	DT
cord-005453-4057qib7	2101	13	dose	dose	NN
cord-005453-4057qib7	2101	14	of	of	IN
cord-005453-4057qib7	2101	15	10	10	CD
cord-005453-4057qib7	2101	16	,	,	,
cord-005453-4057qib7	2101	17	12	12	CD
cord-005453-4057qib7	2101	18	or	or	CC
cord-005453-4057qib7	2101	19	14	14	CD
cord-005453-4057qib7	2101	20	g	g	NN
cord-005453-4057qib7	2101	21	/	/	SYM
cord-005453-4057qib7	2101	22	m	m	NN
cord-005453-4057qib7	2101	23	2	2	CD
cord-005453-4057qib7	2101	24	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2101	25	a	a	DT
cord-005453-4057qib7	2101	26	day	day	NN
cord-005453-4057qib7	2101	27	,	,	,
cord-005453-4057qib7	2101	28	administered	administer	VBN
cord-005453-4057qib7	2101	29	during	during	IN
cord-005453-4057qib7	2101	30	3	3	CD
cord-005453-4057qib7	2101	31	consecutive	consecutive	JJ
cord-005453-4057qib7	2101	32	days	day	NNS
cord-005453-4057qib7	2101	33	,	,	,
cord-005453-4057qib7	2101	34	were	be	VBD
cord-005453-4057qib7	2101	35	enrolled	enrol	VBN
cord-005453-4057qib7	2101	36	.	.	.
cord-005453-4057qib7	2102	1	A	a	DT
cord-005453-4057qib7	2102	2	population	population	NN
cord-005453-4057qib7	2102	3	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	2102	4	model	model	NN
cord-005453-4057qib7	2102	5	was	be	VBD
cord-005453-4057qib7	2102	6	developed	develop	VBN
cord-005453-4057qib7	2102	7	using	use	VBG
cord-005453-4057qib7	2102	8	nonlinear	nonlinear	JJ
cord-005453-4057qib7	2102	9	mixed	mixed	JJ
cord-005453-4057qib7	2102	10	effect	effect	NN
cord-005453-4057qib7	2102	11	modelling	modelling	NN
cord-005453-4057qib7	2102	12	(	(	-LRB-
cord-005453-4057qib7	2102	13	NONMEM	NONMEM	NNP
cord-005453-4057qib7	2102	14	version	version	NN
cord-005453-4057qib7	2102	15	7.3.0	7.3.0	NNP
cord-005453-4057qib7	2102	16	,	,	,
cord-005453-4057qib7	2102	17	using	use	VBG
cord-005453-4057qib7	2102	18	PsN	PsN	NNP
cord-005453-4057qib7	2102	19	toolkit	toolkit	NN
cord-005453-4057qib7	2102	20	4.7.0	4.7.0	NNP
cord-005453-4057qib7	2102	21	and	and	CC
cord-005453-4057qib7	2102	22	Piraña	Piraña	NNP
cord-005453-4057qib7	2102	23	version	version	NN
cord-005453-4057qib7	2102	24	2.9.7	2.9.7	CD
cord-005453-4057qib7	2102	25	as	as	IN
cord-005453-4057qib7	2102	26	modelling	modelling	NN
cord-005453-4057qib7	2102	27	environment	environment	NN
cord-005453-4057qib7	2102	28	)	)	-RRB-
cord-005453-4057qib7	2102	29	.	.	.
cord-005453-4057qib7	2103	1	Demographic	demographic	JJ
cord-005453-4057qib7	2103	2	factors	factor	NNS
cord-005453-4057qib7	2103	3	,	,	,
cord-005453-4057qib7	2103	4	as	as	RB
cord-005453-4057qib7	2103	5	well	well	RB
cord-005453-4057qib7	2103	6	as	as	IN
cord-005453-4057qib7	2103	7	laboratory	laboratory	NN
cord-005453-4057qib7	2103	8	parameters	parameter	NNS
cord-005453-4057qib7	2103	9	,	,	,
cord-005453-4057qib7	2103	10	were	be	VBD
cord-005453-4057qib7	2103	11	included	include	VBN
cord-005453-4057qib7	2103	12	as	as	IN
cord-005453-4057qib7	2103	13	covariates	covariate	NNS
cord-005453-4057qib7	2103	14	.	.	.
cord-005453-4057qib7	2104	1	Results	result	NNS
cord-005453-4057qib7	2104	2	:	:	:
cord-005453-4057qib7	2105	1	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2105	2	PK	PK	NNP
cord-005453-4057qib7	2105	3	was	be	VBD
cord-005453-4057qib7	2105	4	best	well	RBS
cord-005453-4057qib7	2105	5	described	describe	VBN
cord-005453-4057qib7	2105	6	by	by	IN
cord-005453-4057qib7	2105	7	a	a	DT
cord-005453-4057qib7	2105	8	twocompartment	twocompartment	JJ
cord-005453-4057qib7	2105	9	model	model	NN
cord-005453-4057qib7	2105	10	.	.	.
cord-005453-4057qib7	2106	1	A	a	DT
cord-005453-4057qib7	2106	2	bodyweight	bodyweight	NN
cord-005453-4057qib7	2106	3	-	-	HYPH
cord-005453-4057qib7	2106	4	based	base	VBN
cord-005453-4057qib7	2106	5	allometric	allometric	JJ
cord-005453-4057qib7	2106	6	model	model	NN
cord-005453-4057qib7	2106	7	improved	improve	VBD
cord-005453-4057qib7	2106	8	the	the	DT
cord-005453-4057qib7	2106	9	model	model	NN
cord-005453-4057qib7	2106	10	more	more	JJR
cord-005453-4057qib7	2106	11	than	than	IN
cord-005453-4057qib7	2106	12	a	a	DT
cord-005453-4057qib7	2106	13	model	model	NN
cord-005453-4057qib7	2106	14	incorporating	incorporate	VBG
cord-005453-4057qib7	2106	15	body	body	NN
cord-005453-4057qib7	2106	16	surface	surface	NN
cord-005453-4057qib7	2106	17	area	area	NN
cord-005453-4057qib7	2106	18	(	(	-LRB-
cord-005453-4057qib7	2106	19	BSA	BSA	NNP
cord-005453-4057qib7	2106	20	)	)	-RRB-
cord-005453-4057qib7	2106	21	.	.	.
cord-005453-4057qib7	2107	1	Clearance	clearance	NN
cord-005453-4057qib7	2107	2	(	(	-LRB-
cord-005453-4057qib7	2107	3	CL	CL	NNP
cord-005453-4057qib7	2107	4	)	)	-RRB-
cord-005453-4057qib7	2107	5	and	and	CC
cord-005453-4057qib7	2107	6	intercompartmental	intercompartmental	JJ
cord-005453-4057qib7	2107	7	clearance	clearance	NN
cord-005453-4057qib7	2107	8	parameters	parameter	NNS
cord-005453-4057qib7	2107	9	were	be	VBD
cord-005453-4057qib7	2107	10	6.07	6.07	CD
cord-005453-4057qib7	2107	11	L	L	NNP
cord-005453-4057qib7	2107	12	/	/	SYM
cord-005453-4057qib7	2107	13	h/15.6	h/15.6	NNP
cord-005453-4057qib7	2107	14	kg	kg	NNS
cord-005453-4057qib7	2107	15	(	(	-LRB-
cord-005453-4057qib7	2107	16	95%CI	95%ci	CD
cord-005453-4057qib7	2107	17	5.46	5.46	CD
cord-005453-4057qib7	2107	18	-	-	HYPH
cord-005453-4057qib7	2107	19	6.68	6.68	CD
cord-005453-4057qib7	2107	20	)	)	-RRB-
cord-005453-4057qib7	2107	21	and	and	CC
cord-005453-4057qib7	2107	22	2.15	2.15	CD
cord-005453-4057qib7	2107	23	L	l	NN
cord-005453-4057qib7	2107	24	/	/	SYM
cord-005453-4057qib7	2107	25	h	h	NN
cord-005453-4057qib7	2107	26	(	(	-LRB-
cord-005453-4057qib7	2107	27	95%CI	95%ci	CD
cord-005453-4057qib7	2107	28	1.39	1.39	CD
cord-005453-4057qib7	2107	29	-	-	HYPH
cord-005453-4057qib7	2107	30	2.91	2.91	CD
cord-005453-4057qib7	2107	31	)	)	-RRB-
cord-005453-4057qib7	2107	32	.	.	.
cord-005453-4057qib7	2108	1	Typical	typical	JJ
cord-005453-4057qib7	2108	2	volumes	volume	NNS
cord-005453-4057qib7	2108	3	of	of	IN
cord-005453-4057qib7	2108	4	distribution	distribution	NN
cord-005453-4057qib7	2108	5	of	of	IN
cord-005453-4057qib7	2108	6	the	the	DT
cord-005453-4057qib7	2108	7	central	central	JJ
cord-005453-4057qib7	2108	8	and	and	CC
cord-005453-4057qib7	2108	9	peripheral	peripheral	JJ
cord-005453-4057qib7	2108	10	compartments	compartment	NNS
cord-005453-4057qib7	2108	11	were	be	VBD
cord-005453-4057qib7	2108	12	8.00	8.00	CD
cord-005453-4057qib7	2108	13	L/15.6	L/15.6	NNP
cord-005453-4057qib7	2108	14	kg	kg	NNP
cord-005453-4057qib7	2108	15	(	(	-LRB-
cord-005453-4057qib7	2108	16	95%CI	95%ci	CD
cord-005453-4057qib7	2108	17	6.88	6.88	CD
cord-005453-4057qib7	2108	18	-	-	HYPH
cord-005453-4057qib7	2108	19	9.12	9.12	CD
cord-005453-4057qib7	2108	20	)	)	-RRB-
cord-005453-4057qib7	2108	21	and	and	CC
cord-005453-4057qib7	2108	22	2.05	2.05	CD
cord-005453-4057qib7	2108	23	L	l	NN
cord-005453-4057qib7	2108	24	(	(	-LRB-
cord-005453-4057qib7	2108	25	95%CI	95%ci	CD
cord-005453-4057qib7	2108	26	1.52	1.52	CD
cord-005453-4057qib7	2108	27	-	-	HYPH
cord-005453-4057qib7	2108	28	2.58	2.58	CD
cord-005453-4057qib7	2108	29	)	)	-RRB-
cord-005453-4057qib7	2108	30	.	.	.
cord-005453-4057qib7	2109	1	A	a	DT
cord-005453-4057qib7	2109	2	model	model	NN
cord-005453-4057qib7	2109	3	-	-	HYPH
cord-005453-4057qib7	2109	4	based	base	VBN
cord-005453-4057qib7	2109	5	dosing	dosing	NN
cord-005453-4057qib7	2109	6	table	table	NN
cord-005453-4057qib7	2109	7	based	base	VBN
cord-005453-4057qib7	2109	8	on	on	IN
cord-005453-4057qib7	2109	9	bodyweight	bodyweight	NN
cord-005453-4057qib7	2109	10	is	be	VBZ
cord-005453-4057qib7	2109	11	created	create	VBN
cord-005453-4057qib7	2109	12	to	to	TO
cord-005453-4057qib7	2109	13	achieve	achieve	VB
cord-005453-4057qib7	2109	14	a	a	DT
cord-005453-4057qib7	2109	15	target	target	NN
cord-005453-4057qib7	2109	16	exposure	exposure	NN
cord-005453-4057qib7	2109	17	of	of	IN
cord-005453-4057qib7	2109	18	1540	1540	CD
cord-005453-4057qib7	2109	19	mg*hr	mg*hr	NNP
cord-005453-4057qib7	2109	20	/	/	SYM
cord-005453-4057qib7	2109	21	L	L	NNP
cord-005453-4057qib7	2109	22	(	(	-LRB-
cord-005453-4057qib7	2109	23	Table	Table	NNP
cord-005453-4057qib7	2109	24	1	1	CD
cord-005453-4057qib7	2109	25	)	)	-RRB-
cord-005453-4057qib7	2109	26	,	,	,
cord-005453-4057qib7	2109	27	which	which	WDT
cord-005453-4057qib7	2109	28	was	be	VBD
cord-005453-4057qib7	2109	29	the	the	DT
cord-005453-4057qib7	2109	30	median	median	JJ
cord-005453-4057qib7	2109	31	exposure	exposure	NN
cord-005453-4057qib7	2109	32	of	of	IN
cord-005453-4057qib7	2109	33	our	-PRON-	PRP$
cord-005453-4057qib7	2109	34	population	population	NN
cord-005453-4057qib7	2109	35	.	.	.
cord-005453-4057qib7	2110	1	Estimated	estimate	VBN
cord-005453-4057qib7	2110	2	glomerular	glomerular	JJ
cord-005453-4057qib7	2110	3	filtration	filtration	NN
cord-005453-4057qib7	2110	4	rate	rate	NN
cord-005453-4057qib7	2110	5	(	(	-LRB-
cord-005453-4057qib7	2110	6	eGFR	egfr	NN
cord-005453-4057qib7	2110	7	)	)	-RRB-
cord-005453-4057qib7	2110	8	was	be	VBD
cord-005453-4057qib7	2110	9	shown	show	VBN
cord-005453-4057qib7	2110	10	to	to	TO
cord-005453-4057qib7	2110	11	be	be	VB
cord-005453-4057qib7	2110	12	the	the	DT
cord-005453-4057qib7	2110	13	only	only	JJ
cord-005453-4057qib7	2110	14	parameter	parameter	NN
cord-005453-4057qib7	2110	15	that	that	WDT
cord-005453-4057qib7	2110	16	significantly	significantly	RB
cord-005453-4057qib7	2110	17	reduced	reduce	VBN
cord-005453-4057qib7	2110	18	interpatient	interpatient	NN
cord-005453-4057qib7	2110	19	variability	variability	NN
cord-005453-4057qib7	2110	20	in	in	IN
cord-005453-4057qib7	2110	21	CL	CL	NNP
cord-005453-4057qib7	2110	22	from	from	IN
cord-005453-4057qib7	2110	23	36.5	36.5	CD
cord-005453-4057qib7	2110	24	%	%	NN
cord-005453-4057qib7	2110	25	to	to	IN
cord-005453-4057qib7	2110	26	34.8	34.8	CD
cord-005453-4057qib7	2110	27	%	%	NN
cord-005453-4057qib7	2110	28	.	.	.
cord-005453-4057qib7	2111	1	A	a	DT
cord-005453-4057qib7	2111	2	limited	limited	JJ
cord-005453-4057qib7	2111	3	sampling	sampling	NN
cord-005453-4057qib7	2111	4	model	model	NN
cord-005453-4057qib7	2111	5	with	with	IN
cord-005453-4057qib7	2111	6	3	3	CD
cord-005453-4057qib7	2111	7	samples	sample	NNS
cord-005453-4057qib7	2111	8	(	(	-LRB-
cord-005453-4057qib7	2111	9	taken	take	VBN
cord-005453-4057qib7	2111	10	at	at	IN
cord-005453-4057qib7	2111	11	1.5	1.5	CD
cord-005453-4057qib7	2111	12	,	,	,
cord-005453-4057qib7	2111	13	4	4	CD
cord-005453-4057qib7	2111	14	and	and	CC
cord-005453-4057qib7	2111	15	7	7	CD
cord-005453-4057qib7	2111	16	hours	hour	NNS
cord-005453-4057qib7	2111	17	after	after	IN
cord-005453-4057qib7	2111	18	start	start	NN
cord-005453-4057qib7	2111	19	of	of	IN
cord-005453-4057qib7	2111	20	infusion	infusion	NN
cord-005453-4057qib7	2111	21	)	)	-RRB-
cord-005453-4057qib7	2111	22	accurately	accurately	RB
cord-005453-4057qib7	2111	23	estimated	estimate	VBN
cord-005453-4057qib7	2111	24	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	2111	25	parameters	parameter	NNS
cord-005453-4057qib7	2111	26	of	of	IN
cord-005453-4057qib7	2111	27	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2111	28	.	.	.
cord-005453-4057qib7	2112	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2112	2	:	:	:
cord-005453-4057qib7	2113	1	To	to	IN
cord-005453-4057qib7	2113	2	the	the	DT
cord-005453-4057qib7	2113	3	best	good	JJS
cord-005453-4057qib7	2113	4	of	of	IN
cord-005453-4057qib7	2113	5	our	-PRON-	PRP$
cord-005453-4057qib7	2113	6	knowledge	knowledge	NN
cord-005453-4057qib7	2113	7	,	,	,
cord-005453-4057qib7	2113	8	this	this	DT
cord-005453-4057qib7	2113	9	is	be	VBZ
cord-005453-4057qib7	2113	10	the	the	DT
cord-005453-4057qib7	2113	11	largest	large	JJS
cord-005453-4057qib7	2113	12	cohort	cohort	NN
cord-005453-4057qib7	2113	13	of	of	IN
cord-005453-4057qib7	2113	14	pediatric	pediatric	JJ
cord-005453-4057qib7	2113	15	patients	patient	NNS
cord-005453-4057qib7	2113	16	treated	treat	VBN
cord-005453-4057qib7	2113	17	with	with	IN
cord-005453-4057qib7	2113	18	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2113	19	used	use	VBN
cord-005453-4057qib7	2113	20	for	for	IN
cord-005453-4057qib7	2113	21	a	a	DT
cord-005453-4057qib7	2113	22	population	population	NN
cord-005453-4057qib7	2113	23	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	2113	24	study	study	NN
cord-005453-4057qib7	2113	25	.	.	.
cord-005453-4057qib7	2114	1	We	-PRON-	PRP
cord-005453-4057qib7	2114	2	developed	develop	VBD
cord-005453-4057qib7	2114	3	a	a	DT
cord-005453-4057qib7	2114	4	two	two	CD
cord-005453-4057qib7	2114	5	-	-	HYPH
cord-005453-4057qib7	2114	6	compartment	compartment	NN
cord-005453-4057qib7	2114	7	model	model	NN
cord-005453-4057qib7	2114	8	with	with	IN
cord-005453-4057qib7	2114	9	weight	weight	NN
cord-005453-4057qib7	2114	10	and	and	CC
cord-005453-4057qib7	2114	11	eGFR	egfr	NN
cord-005453-4057qib7	2114	12	as	as	IN
cord-005453-4057qib7	2114	13	covariates	covariate	NNS
cord-005453-4057qib7	2114	14	influencing	influence	VBG
cord-005453-4057qib7	2114	15	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2114	16	PK	PK	NNP
cord-005453-4057qib7	2114	17	.	.	.
cord-005453-4057qib7	2115	1	Recently	recently	RB
cord-005453-4057qib7	2115	2	we	-PRON-	PRP
cord-005453-4057qib7	2115	3	showed	show	VBD
cord-005453-4057qib7	2115	4	a	a	DT
cord-005453-4057qib7	2115	5	relationship	relationship	NN
cord-005453-4057qib7	2115	6	between	between	IN
cord-005453-4057qib7	2115	7	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2115	8	exposure	exposure	NN
cord-005453-4057qib7	2115	9	and	and	CC
cord-005453-4057qib7	2115	10	early	early	JJ
cord-005453-4057qib7	2115	11	toxicity	toxicity	NN
cord-005453-4057qib7	2115	12	.	.	.
cord-005453-4057qib7	2116	1	Patients	patient	NNS
cord-005453-4057qib7	2116	2	with	with	IN
cord-005453-4057qib7	2116	3	an	an	DT
cord-005453-4057qib7	2116	4	exposure	exposure	NN
cord-005453-4057qib7	2116	5	>	>	XX
cord-005453-4057qib7	2117	1	1650	1650	CD
cord-005453-4057qib7	2117	2	mg*hr	mg*hr	NNP
cord-005453-4057qib7	2117	3	/	/	SYM
cord-005453-4057qib7	2117	4	L	L	NNP
cord-005453-4057qib7	2117	5	have	have	VBP
cord-005453-4057qib7	2117	6	an	an	DT
cord-005453-4057qib7	2117	7	increased	increase	VBN
cord-005453-4057qib7	2117	8	risk	risk	NN
cord-005453-4057qib7	2117	9	of	of	IN
cord-005453-4057qib7	2117	10	developing	develop	VBG
cord-005453-4057qib7	2117	11	grade	grade	NN
cord-005453-4057qib7	2117	12	2	2	CD
cord-005453-4057qib7	2117	13	or	or	CC
cord-005453-4057qib7	2117	14	higher	high	JJR
cord-005453-4057qib7	2117	15	mucositis	mucositis	NN
cord-005453-4057qib7	2117	16	and	and	CC
cord-005453-4057qib7	2117	17	skin	skin	NN
cord-005453-4057qib7	2117	18	toxicity	toxicity	NN
cord-005453-4057qib7	2117	19	.	.	.
cord-005453-4057qib7	2118	1	Another	another	DT
cord-005453-4057qib7	2118	2	study	study	NN
cord-005453-4057qib7	2118	3	in	in	IN
cord-005453-4057qib7	2118	4	87	87	CD
cord-005453-4057qib7	2118	5	pediatric	pediatric	JJ
cord-005453-4057qib7	2118	6	patients	patient	NNS
cord-005453-4057qib7	2118	7	with	with	IN
cord-005453-4057qib7	2118	8	thalassemia	thalassemia	NN
cord-005453-4057qib7	2118	9	major	major	NN
cord-005453-4057qib7	2118	10	reported	report	VBD
cord-005453-4057qib7	2118	11	an	an	DT
cord-005453-4057qib7	2118	12	association	association	NN
cord-005453-4057qib7	2118	13	between	between	IN
cord-005453-4057qib7	2118	14	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2118	15	clearance	clearance	NN
cord-005453-4057qib7	2118	16	(	(	-LRB-
cord-005453-4057qib7	2118	17	<	<	NNP
cord-005453-4057qib7	2118	18	7.97	7.97	CD
cord-005453-4057qib7	2118	19	L	L	NNP
cord-005453-4057qib7	2118	20	/	/	SYM
cord-005453-4057qib7	2118	21	h	h	NN
cord-005453-4057qib7	2118	22	/	/	SYM
cord-005453-4057qib7	2118	23	m	m	NNP
cord-005453-4057qib7	2118	24	2	2	CD
cord-005453-4057qib7	2118	25	)	)	-RRB-
cord-005453-4057qib7	2118	26	and	and	CC
cord-005453-4057qib7	2118	27	poor	poor	JJ
cord-005453-4057qib7	2118	28	overall	overall	JJ
cord-005453-4057qib7	2118	29	survival	survival	NN
cord-005453-4057qib7	2118	30	.	.	.
cord-005453-4057qib7	2119	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2119	2	model	model	NN
cord-005453-4057qib7	2119	3	,	,	,
cord-005453-4057qib7	2119	4	together	together	RB
cord-005453-4057qib7	2119	5	with	with	IN
cord-005453-4057qib7	2119	6	the	the	DT
cord-005453-4057qib7	2119	7	limited	limited	JJ
cord-005453-4057qib7	2119	8	sampling	sampling	NN
cord-005453-4057qib7	2119	9	strategy	strategy	NN
cord-005453-4057qib7	2119	10	,	,	,
cord-005453-4057qib7	2119	11	can	can	MD
cord-005453-4057qib7	2119	12	be	be	VB
cord-005453-4057qib7	2119	13	used	use	VBN
cord-005453-4057qib7	2119	14	to	to	TO
cord-005453-4057qib7	2119	15	adjust	adjust	VB
cord-005453-4057qib7	2119	16	the	the	DT
cord-005453-4057qib7	2119	17	dose	dose	NN
cord-005453-4057qib7	2119	18	,	,	,
cord-005453-4057qib7	2119	19	prior	prior	RB
cord-005453-4057qib7	2119	20	to	to	IN
cord-005453-4057qib7	2119	21	or	or	CC
cord-005453-4057qib7	2119	22	during	during	IN
cord-005453-4057qib7	2119	23	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2119	24	administration	administration	NN
cord-005453-4057qib7	2119	25	.	.	.
cord-005453-4057qib7	2120	1	Ongoing	ongoing	JJ
cord-005453-4057qib7	2120	2	studies	study	NNS
cord-005453-4057qib7	2120	3	conducted	conduct	VBN
cord-005453-4057qib7	2120	4	in	in	IN
cord-005453-4057qib7	2120	5	different	different	JJ
cord-005453-4057qib7	2120	6	disease	disease	NN
cord-005453-4057qib7	2120	7	settings	setting	NNS
cord-005453-4057qib7	2120	8	will	will	MD
cord-005453-4057qib7	2120	9	determine	determine	VB
cord-005453-4057qib7	2120	10	if	if	IN
cord-005453-4057qib7	2120	11	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2120	12	exposure	exposure	NN
cord-005453-4057qib7	2120	13	can	can	MD
cord-005453-4057qib7	2120	14	influence	influence	VB
cord-005453-4057qib7	2120	15	patient	patient	NN
cord-005453-4057qib7	2120	16	outcome	outcome	NN
cord-005453-4057qib7	2120	17	.	.	.
cord-005453-4057qib7	2121	1	Subsequently	subsequently	RB
cord-005453-4057qib7	2121	2	,	,	,
cord-005453-4057qib7	2121	3	the	the	DT
cord-005453-4057qib7	2121	4	optimal	optimal	JJ
cord-005453-4057qib7	2121	5	target	target	NN
cord-005453-4057qib7	2121	6	exposure	exposure	NN
cord-005453-4057qib7	2121	7	can	can	MD
cord-005453-4057qib7	2121	8	then	then	RB
cord-005453-4057qib7	2121	9	be	be	VB
cord-005453-4057qib7	2121	10	established	establish	VBN
cord-005453-4057qib7	2121	11	.	.	.
cord-005453-4057qib7	2122	1	Background	background	NN
cord-005453-4057qib7	2122	2	:	:	:
cord-005453-4057qib7	2123	1	Autologous	autologous	JJ
cord-005453-4057qib7	2123	2	stem	stem	NN
cord-005453-4057qib7	2123	3	cell	cell	NN
cord-005453-4057qib7	2123	4	transplant	transplant	NN
cord-005453-4057qib7	2123	5	(	(	-LRB-
cord-005453-4057qib7	2123	6	ASCT	ASCT	NNP
cord-005453-4057qib7	2123	7	)	)	-RRB-
cord-005453-4057qib7	2123	8	is	be	VBZ
cord-005453-4057qib7	2123	9	an	an	DT
cord-005453-4057qib7	2123	10	effective	effective	JJ
cord-005453-4057qib7	2123	11	treatment	treatment	NN
cord-005453-4057qib7	2123	12	method	method	NN
cord-005453-4057qib7	2123	13	for	for	IN
cord-005453-4057qib7	2123	14	non	non	JJ
cord-005453-4057qib7	2123	15	-	-	JJ
cord-005453-4057qib7	2123	16	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	2123	17	lymphoma	lymphoma	NN
cord-005453-4057qib7	2123	18	(	(	-LRB-
cord-005453-4057qib7	2123	19	NHL	NHL	NNP
cord-005453-4057qib7	2123	20	)	)	-RRB-
cord-005453-4057qib7	2123	21	.	.	.
cord-005453-4057qib7	2124	1	Until	until	IN
cord-005453-4057qib7	2124	2	recently	recently	RB
cord-005453-4057qib7	2124	3	,	,	,
cord-005453-4057qib7	2124	4	carmustine	carmustine	NNP
cord-005453-4057qib7	2124	5	,	,	,
cord-005453-4057qib7	2124	6	etoposide	etoposide	RB
cord-005453-4057qib7	2124	7	,	,	,
cord-005453-4057qib7	2124	8	cytarabine	cytarabine	NNP
cord-005453-4057qib7	2124	9	and	and	CC
cord-005453-4057qib7	2124	10	melphalan	melphalan	NNP
cord-005453-4057qib7	2124	11	(	(	-LRB-
cord-005453-4057qib7	2124	12	BEAM	BEAM	NNP
cord-005453-4057qib7	2124	13	)	)	-RRB-
cord-005453-4057qib7	2124	14	was	be	VBD
cord-005453-4057qib7	2124	15	the	the	DT
cord-005453-4057qib7	2124	16	most	most	RBS
cord-005453-4057qib7	2124	17	commonly	commonly	RB
cord-005453-4057qib7	2124	18	used	use	VBN
cord-005453-4057qib7	2124	19	conditioning	conditioning	NN
cord-005453-4057qib7	2124	20	regimen	regimen	NN
cord-005453-4057qib7	2124	21	.	.	.
cord-005453-4057qib7	2125	1	Despite	despite	IN
cord-005453-4057qib7	2125	2	acceptable	acceptable	JJ
cord-005453-4057qib7	2125	3	efficacy	efficacy	NN
cord-005453-4057qib7	2125	4	with	with	IN
cord-005453-4057qib7	2125	5	BEAM	BEAM	NNP
cord-005453-4057qib7	2125	6	,	,	,
cord-005453-4057qib7	2125	7	carmustine	carmustine	NNP
cord-005453-4057qib7	2125	8	is	be	VBZ
cord-005453-4057qib7	2125	9	associated	associate	VBN
cord-005453-4057qib7	2125	10	with	with	IN
cord-005453-4057qib7	2125	11	major	major	JJ
cord-005453-4057qib7	2125	12	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2125	13	toxicity	toxicity	NN
cord-005453-4057qib7	2125	14	.	.	.
cord-005453-4057qib7	2126	1	For	for	IN
cord-005453-4057qib7	2126	2	this	this	DT
cord-005453-4057qib7	2126	3	reason	reason	NN
cord-005453-4057qib7	2126	4	,	,	,
cord-005453-4057qib7	2126	5	the	the	DT
cord-005453-4057qib7	2126	6	aim	aim	NN
cord-005453-4057qib7	2126	7	of	of	IN
cord-005453-4057qib7	2126	8	this	this	DT
cord-005453-4057qib7	2126	9	study	study	NN
cord-005453-4057qib7	2126	10	was	be	VBD
cord-005453-4057qib7	2126	11	to	to	TO
cord-005453-4057qib7	2126	12	investigate	investigate	VB
cord-005453-4057qib7	2126	13	the	the	DT
cord-005453-4057qib7	2126	14	safety	safety	NN
cord-005453-4057qib7	2126	15	and	and	CC
cord-005453-4057qib7	2126	16	efficacy	efficacy	NN
cord-005453-4057qib7	2126	17	of	of	IN
cord-005453-4057qib7	2126	18	BEB	BEB	NNP
cord-005453-4057qib7	2126	19	conditioning	condition	VBG
cord-005453-4057qib7	2126	20	regimen	regimen	NN
cord-005453-4057qib7	2126	21	for	for	IN
cord-005453-4057qib7	2126	22	ASCT	ASCT	NNP
cord-005453-4057qib7	2126	23	in	in	IN
cord-005453-4057qib7	2126	24	NHL	NHL	NNP
cord-005453-4057qib7	2126	25	.	.	.
cord-005453-4057qib7	2127	1	Methods	method	NNS
cord-005453-4057qib7	2127	2	:	:	:
cord-005453-4057qib7	2128	1	We	-PRON-	PRP
cord-005453-4057qib7	2128	2	conducted	conduct	VBD
cord-005453-4057qib7	2128	3	a	a	DT
cord-005453-4057qib7	2128	4	prospective	prospective	JJ
cord-005453-4057qib7	2128	5	,	,	,
cord-005453-4057qib7	2128	6	multicenter	multicenter	JJ
cord-005453-4057qib7	2128	7	,	,	,
cord-005453-4057qib7	2128	8	phase	phase	NN
cord-005453-4057qib7	2128	9	II	ii	CD
cord-005453-4057qib7	2128	10	study	study	NN
cord-005453-4057qib7	2128	11	for	for	IN
cord-005453-4057qib7	2128	12	BEB	BEB	NNP
cord-005453-4057qib7	2128	13	conditioning	condition	VBG
cord-005453-4057qib7	2128	14	regimen	regimen	NN
cord-005453-4057qib7	2128	15	for	for	IN
cord-005453-4057qib7	2128	16	ASCT	ASCT	NNP
cord-005453-4057qib7	2128	17	in	in	IN
cord-005453-4057qib7	2128	18	NHL	NHL	NNP
cord-005453-4057qib7	2128	19	patients	patient	NNS
cord-005453-4057qib7	2128	20	.	.	.
cord-005453-4057qib7	2129	1	A	a	DT
cord-005453-4057qib7	2129	2	total	total	NN
cord-005453-4057qib7	2129	3	of	of	IN
cord-005453-4057qib7	2129	4	33	33	CD
cord-005453-4057qib7	2129	5	patients	patient	NNS
cord-005453-4057qib7	2129	6	were	be	VBD
cord-005453-4057qib7	2129	7	enrolled	enrol	VBN
cord-005453-4057qib7	2129	8	from	from	IN
cord-005453-4057qib7	2129	9	3	3	CD
cord-005453-4057qib7	2129	10	centers	center	NNS
cord-005453-4057qib7	2129	11	.	.	.
cord-005453-4057qib7	2130	1	They	-PRON-	PRP
cord-005453-4057qib7	2130	2	underwent	undergo	VBD
cord-005453-4057qib7	2130	3	ASCT	ASCT	NNP
cord-005453-4057qib7	2130	4	with	with	IN
cord-005453-4057qib7	2130	5	BEB	BEB	NNP
cord-005453-4057qib7	2130	6	conditioning	conditioning	NN
cord-005453-4057qib7	2130	7	regimen	regimen	NN
cord-005453-4057qib7	2130	8	(	(	-LRB-
cord-005453-4057qib7	2130	9	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2130	10	3.2mg	3.2mg	NNP
cord-005453-4057qib7	2130	11	/	/	SYM
cord-005453-4057qib7	2130	12	kg	kg	NN
cord-005453-4057qib7	2130	13	for	for	IN
cord-005453-4057qib7	2130	14	3days	3days	CD
cord-005453-4057qib7	2130	15	,	,	,
cord-005453-4057qib7	2130	16	Etoposide	etoposide	JJ
cord-005453-4057qib7	2130	17	400mg/	400mg/	CD
cord-005453-4057qib7	2130	18	m	m	CD
cord-005453-4057qib7	2130	19	2	2	CD
cord-005453-4057qib7	2130	20	for	for	IN
cord-005453-4057qib7	2130	21	2days	2days	CD
cord-005453-4057qib7	2130	22	,	,	,
cord-005453-4057qib7	2130	23	Bendamustine	Bendamustine	NNP
cord-005453-4057qib7	2130	24	200mg	200mg	NNP
cord-005453-4057qib7	2130	25	/	/	SYM
cord-005453-4057qib7	2130	26	m	m	NN
cord-005453-4057qib7	2130	27	2	2	CD
cord-005453-4057qib7	2130	28	for	for	IN
cord-005453-4057qib7	2130	29	2days	2days	CD
cord-005453-4057qib7	2130	30	)	)	-RRB-
cord-005453-4057qib7	2130	31	between	between	IN
cord-005453-4057qib7	2130	32	2016	2016	CD
cord-005453-4057qib7	2130	33	and	and	CC
cord-005453-4057qib7	2130	34	2018	2018	CD
cord-005453-4057qib7	2130	35	.	.	.
cord-005453-4057qib7	2131	1	[	[	-LRB-
cord-005453-4057qib7	2131	2	[	[	-LRB-
cord-005453-4057qib7	2131	3	P111	p111	JJ
cord-005453-4057qib7	2131	4	Image	image	NN
cord-005453-4057qib7	2131	5	]	]	-RRB-
cord-005453-4057qib7	2131	6	1	1	CD
cord-005453-4057qib7	2131	7	.	.	.
cord-005453-4057qib7	2132	1	Two	two	CD
cord-005453-4057qib7	2132	2	year	year	NN
cord-005453-4057qib7	2132	3	progression	progression	NN
cord-005453-4057qib7	2132	4	-	-	HYPH
cord-005453-4057qib7	2132	5	free	free	JJ
cord-005453-4057qib7	2132	6	survival	survival	NN
cord-005453-4057qib7	2132	7	and	and	CC
cord-005453-4057qib7	2132	8	overall	overall	JJ
cord-005453-4057qib7	2132	9	survival	survival	NN
cord-005453-4057qib7	2132	10	.	.	.
cord-005453-4057qib7	2132	11	]	]	-RRB-
cord-005453-4057qib7	2133	1	Results	result	NNS
cord-005453-4057qib7	2133	2	:	:	:
cord-005453-4057qib7	2133	3	The	the	DT
cord-005453-4057qib7	2133	4	median	median	JJ
cord-005453-4057qib7	2133	5	age	age	NN
cord-005453-4057qib7	2133	6	was	be	VBD
cord-005453-4057qib7	2133	7	52	52	CD
cord-005453-4057qib7	2133	8	years	year	NNS
cord-005453-4057qib7	2134	1	(	(	-LRB-
cord-005453-4057qib7	2134	2	range	range	NNP
cord-005453-4057qib7	2134	3	21	21	CD
cord-005453-4057qib7	2134	4	-	-	SYM
cord-005453-4057qib7	2134	5	66	66	CD
cord-005453-4057qib7	2134	6	)	)	-RRB-
cord-005453-4057qib7	2134	7	and	and	CC
cord-005453-4057qib7	2134	8	16	16	CD
cord-005453-4057qib7	2134	9	patients	patient	NNS
cord-005453-4057qib7	2134	10	(	(	-LRB-
cord-005453-4057qib7	2134	11	48.5	48.5	CD
cord-005453-4057qib7	2134	12	%	%	NN
cord-005453-4057qib7	2134	13	)	)	-RRB-
cord-005453-4057qib7	2134	14	were	be	VBD
cord-005453-4057qib7	2134	15	men	man	NNS
cord-005453-4057qib7	2134	16	.	.	.
cord-005453-4057qib7	2135	1	The	the	DT
cord-005453-4057qib7	2135	2	most	most	RBS
cord-005453-4057qib7	2135	3	common	common	JJ
cord-005453-4057qib7	2135	4	type	type	NN
cord-005453-4057qib7	2135	5	was	be	VBD
cord-005453-4057qib7	2135	6	diffuse	diffuse	JJ
cord-005453-4057qib7	2135	7	large	large	JJ
cord-005453-4057qib7	2135	8	B	b	NN
cord-005453-4057qib7	2135	9	cell	cell	NN
cord-005453-4057qib7	2135	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	2135	11	(	(	-LRB-
cord-005453-4057qib7	2135	12	n=23	n=23	NNP
cord-005453-4057qib7	2135	13	,	,	,
cord-005453-4057qib7	2135	14	69.7	69.7	CD
cord-005453-4057qib7	2135	15	%	%	NN
cord-005453-4057qib7	2135	16	)	)	-RRB-
cord-005453-4057qib7	2135	17	and	and	CC
cord-005453-4057qib7	2135	18	more	more	JJR
cord-005453-4057qib7	2135	19	than	than	IN
cord-005453-4057qib7	2135	20	half	half	NN
cord-005453-4057qib7	2135	21	of	of	IN
cord-005453-4057qib7	2135	22	patients	patient	NNS
cord-005453-4057qib7	2135	23	(	(	-LRB-
cord-005453-4057qib7	2135	24	n=19	n=19	JJ
cord-005453-4057qib7	2135	25	,	,	,
cord-005453-4057qib7	2135	26	57.6	57.6	CD
cord-005453-4057qib7	2135	27	%	%	NN
cord-005453-4057qib7	2135	28	)	)	-RRB-
cord-005453-4057qib7	2135	29	were	be	VBD
cord-005453-4057qib7	2135	30	classified	classify	VBN
cord-005453-4057qib7	2135	31	as	as	IN
cord-005453-4057qib7	2135	32	IPI	IPI	NNP
cord-005453-4057qib7	2135	33	score	score	NN
cord-005453-4057qib7	2135	34	3	3	CD
cord-005453-4057qib7	2135	35	or	or	CC
cord-005453-4057qib7	2135	36	4	4	CD
cord-005453-4057qib7	2135	37	.	.	.
cord-005453-4057qib7	2136	1	Eight	eight	CD
cord-005453-4057qib7	2136	2	patients	patient	NNS
cord-005453-4057qib7	2136	3	(	(	-LRB-
cord-005453-4057qib7	2136	4	27.3	27.3	CD
cord-005453-4057qib7	2136	5	%	%	NN
cord-005453-4057qib7	2136	6	)	)	-RRB-
cord-005453-4057qib7	2136	7	had	have	VBD
cord-005453-4057qib7	2136	8	a	a	DT
cord-005453-4057qib7	2136	9	history	history	NN
cord-005453-4057qib7	2136	10	of	of	IN
cord-005453-4057qib7	2136	11	relapse	relapse	NN
cord-005453-4057qib7	2136	12	and	and	CC
cord-005453-4057qib7	2136	13	19	19	CD
cord-005453-4057qib7	2136	14	patients	patient	NNS
cord-005453-4057qib7	2136	15	(	(	-LRB-
cord-005453-4057qib7	2136	16	57.6	57.6	CD
cord-005453-4057qib7	2136	17	%	%	NN
cord-005453-4057qib7	2136	18	)	)	-RRB-
cord-005453-4057qib7	2136	19	received	receive	VBD
cord-005453-4057qib7	2136	20	more	more	JJR
cord-005453-4057qib7	2136	21	than	than	IN
cord-005453-4057qib7	2136	22	2	2	CD
cord-005453-4057qib7	2136	23	lines	line	NNS
cord-005453-4057qib7	2136	24	of	of	IN
cord-005453-4057qib7	2136	25	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2136	26	before	before	IN
cord-005453-4057qib7	2136	27	ASCT	ASCT	NNP
cord-005453-4057qib7	2136	28	.	.	.
cord-005453-4057qib7	2137	1	Most	Most	JJS
cord-005453-4057qib7	2137	2	patients	patient	NNS
cord-005453-4057qib7	2137	3	(	(	-LRB-
cord-005453-4057qib7	2137	4	n=27	n=27	FW
cord-005453-4057qib7	2137	5	,	,	,
cord-005453-4057qib7	2137	6	81.8	81.8	CD
cord-005453-4057qib7	2137	7	%	%	NN
cord-005453-4057qib7	2137	8	)	)	-RRB-
cord-005453-4057qib7	2137	9	were	be	VBD
cord-005453-4057qib7	2137	10	complete	complete	JJ
cord-005453-4057qib7	2137	11	remission	remission	NN
cord-005453-4057qib7	2137	12	(	(	-LRB-
cord-005453-4057qib7	2137	13	CR	cr	NN
cord-005453-4057qib7	2137	14	)	)	-RRB-
cord-005453-4057qib7	2137	15	state	state	NN
cord-005453-4057qib7	2137	16	at	at	IN
cord-005453-4057qib7	2137	17	ASCT	ASCT	NNP
cord-005453-4057qib7	2137	18	.	.	.
cord-005453-4057qib7	2138	1	A	a	DT
cord-005453-4057qib7	2138	2	median	median	JJ
cord-005453-4057qib7	2138	3	number	number	NN
cord-005453-4057qib7	2138	4	of	of	IN
cord-005453-4057qib7	2138	5	5.85x10	5.85x10	CD
cord-005453-4057qib7	2138	6	6	6	CD
cord-005453-4057qib7	2138	7	/kg	/kg	.
cord-005453-4057qib7	2139	1	CD34	CD34	NNP
cord-005453-4057qib7	2139	2	cells	cell	NNS
cord-005453-4057qib7	2139	3	were	be	VBD
cord-005453-4057qib7	2139	4	infused	infuse	VBN
cord-005453-4057qib7	2139	5	(	(	-LRB-
cord-005453-4057qib7	2139	6	range	range	NNP
cord-005453-4057qib7	2139	7	2.0	2.0	CD
cord-005453-4057qib7	2139	8	-	-	HYPH
cord-005453-4057qib7	2139	9	18.6	18.6	CD
cord-005453-4057qib7	2139	10	)	)	-RRB-
cord-005453-4057qib7	2139	11	.	.	.
cord-005453-4057qib7	2140	1	All	all	DT
cord-005453-4057qib7	2140	2	patients	patient	NNS
cord-005453-4057qib7	2140	3	engrafted	engraft	VBN
cord-005453-4057qib7	2140	4	after	after	IN
cord-005453-4057qib7	2140	5	a	a	DT
cord-005453-4057qib7	2140	6	median	median	JJ
cord-005453-4057qib7	2140	7	time	time	NN
cord-005453-4057qib7	2140	8	of	of	IN
cord-005453-4057qib7	2140	9	11	11	CD
cord-005453-4057qib7	2140	10	days	day	NNS
cord-005453-4057qib7	2140	11	(	(	-LRB-
cord-005453-4057qib7	2140	12	range	range	VBP
cord-005453-4057qib7	2140	13	10	10	CD
cord-005453-4057qib7	2140	14	-	-	SYM
cord-005453-4057qib7	2140	15	14	14	CD
cord-005453-4057qib7	2140	16	)	)	-RRB-
cord-005453-4057qib7	2140	17	.	.	.
cord-005453-4057qib7	2141	1	Twelve	twelve	CD
cord-005453-4057qib7	2141	2	patients	patient	NNS
cord-005453-4057qib7	2141	3	(	(	-LRB-
cord-005453-4057qib7	2141	4	36.4	36.4	CD
cord-005453-4057qib7	2141	5	%	%	NN
cord-005453-4057qib7	2141	6	)	)	-RRB-
cord-005453-4057qib7	2141	7	experienced	experience	VBD
cord-005453-4057qib7	2141	8	neutropenic	neutropenic	JJ
cord-005453-4057qib7	2141	9	fever	fever	NN
cord-005453-4057qib7	2141	10	and	and	CC
cord-005453-4057qib7	2141	11	16	16	CD
cord-005453-4057qib7	2141	12	patients	patient	NNS
cord-005453-4057qib7	2141	13	(	(	-LRB-
cord-005453-4057qib7	2141	14	48.5	48.5	CD
cord-005453-4057qib7	2141	15	%	%	NN
cord-005453-4057qib7	2141	16	)	)	-RRB-
cord-005453-4057qib7	2141	17	had	have	VBD
cord-005453-4057qib7	2141	18	grade	grade	NN
cord-005453-4057qib7	2141	19	3	3	CD
cord-005453-4057qib7	2141	20	toxicities	toxicity	NNS
cord-005453-4057qib7	2141	21	during	during	IN
cord-005453-4057qib7	2141	22	ASCT	ASCT	NNP
cord-005453-4057qib7	2141	23	.	.	.
cord-005453-4057qib7	2142	1	However	however	RB
cord-005453-4057qib7	2142	2	,	,	,
cord-005453-4057qib7	2142	3	no	no	DT
cord-005453-4057qib7	2142	4	one	one	NN
cord-005453-4057qib7	2142	5	had	have	VBD
cord-005453-4057qib7	2142	6	a	a	DT
cord-005453-4057qib7	2142	7	documented	document	VBN
cord-005453-4057qib7	2142	8	infection	infection	NN
cord-005453-4057qib7	2142	9	,	,	,
cord-005453-4057qib7	2142	10	veno	veno	NNP
cord-005453-4057qib7	2142	11	-	-	HYPH
cord-005453-4057qib7	2142	12	occlusive	occlusive	JJ
cord-005453-4057qib7	2142	13	disease	disease	NN
cord-005453-4057qib7	2142	14	,	,	,
cord-005453-4057qib7	2142	15	or	or	CC
cord-005453-4057qib7	2142	16	treatment	treatment	NN
cord-005453-4057qib7	2142	17	-	-	HYPH
cord-005453-4057qib7	2142	18	related	relate	VBN
cord-005453-4057qib7	2142	19	death	death	NN
cord-005453-4057qib7	2142	20	.	.	.
cord-005453-4057qib7	2143	1	Three	three	CD
cord-005453-4057qib7	2143	2	months	month	NNS
cord-005453-4057qib7	2143	3	CR	cr	NN
cord-005453-4057qib7	2143	4	rate	rate	NN
cord-005453-4057qib7	2143	5	was	be	VBD
cord-005453-4057qib7	2143	6	81.8	81.8	CD
cord-005453-4057qib7	2143	7	%	%	NN
cord-005453-4057qib7	2143	8	.	.	.
cord-005453-4057qib7	2144	1	During	during	IN
cord-005453-4057qib7	2144	2	a	a	DT
cord-005453-4057qib7	2144	3	median	median	JJ
cord-005453-4057qib7	2144	4	follow	follow	NN
cord-005453-4057qib7	2144	5	-	-	HYPH
cord-005453-4057qib7	2144	6	up	up	NN
cord-005453-4057qib7	2144	7	period	period	NN
cord-005453-4057qib7	2144	8	of	of	IN
cord-005453-4057qib7	2144	9	10.2	10.2	CD
cord-005453-4057qib7	2144	10	month	month	NN
cord-005453-4057qib7	2144	11	,	,	,
cord-005453-4057qib7	2144	12	7	7	CD
cord-005453-4057qib7	2144	13	patients	patient	NNS
cord-005453-4057qib7	2144	14	(	(	-LRB-
cord-005453-4057qib7	2144	15	21.2	21.2	CD
cord-005453-4057qib7	2144	16	%	%	NN
cord-005453-4057qib7	2144	17	)	)	-RRB-
cord-005453-4057qib7	2144	18	exhibited	exhibit	VBN
cord-005453-4057qib7	2144	19	relapse	relapse	NN
cord-005453-4057qib7	2144	20	or	or	CC
cord-005453-4057qib7	2144	21	progression	progression	NN
cord-005453-4057qib7	2144	22	,	,	,
cord-005453-4057qib7	2144	23	while	while	IN
cord-005453-4057qib7	2144	24	1	1	CD
cord-005453-4057qib7	2144	25	patient	patient	NN
cord-005453-4057qib7	2144	26	(	(	-LRB-
cord-005453-4057qib7	2144	27	3.0	3.0	CD
cord-005453-4057qib7	2144	28	%	%	NN
cord-005453-4057qib7	2144	29	)	)	-RRB-
cord-005453-4057qib7	2144	30	died	die	VBD
cord-005453-4057qib7	2144	31	of	of	IN
cord-005453-4057qib7	2144	32	the	the	DT
cord-005453-4057qib7	2144	33	disease	disease	NN
cord-005453-4057qib7	2144	34	.	.	.
cord-005453-4057qib7	2145	1	The	the	DT
cord-005453-4057qib7	2145	2	estimated	estimate	VBN
cord-005453-4057qib7	2145	3	2-year	2-year	CD
cord-005453-4057qib7	2145	4	PFS	PFS	NNP
cord-005453-4057qib7	2145	5	and	and	CC
cord-005453-4057qib7	2145	6	OS	OS	NNP
cord-005453-4057qib7	2145	7	rate	rate	NN
cord-005453-4057qib7	2145	8	were	be	VBD
cord-005453-4057qib7	2145	9	73.0	73.0	CD
cord-005453-4057qib7	2145	10	%	%	NN
cord-005453-4057qib7	2145	11	and	and	CC
cord-005453-4057qib7	2145	12	89.8	89.8	CD
cord-005453-4057qib7	2145	13	%	%	NN
cord-005453-4057qib7	2145	14	,	,	,
cord-005453-4057qib7	2145	15	respectively	respectively	RB
cord-005453-4057qib7	2146	1	(	(	-LRB-
cord-005453-4057qib7	2146	2	Figure	figure	NN
cord-005453-4057qib7	2146	3	1	1	CD
cord-005453-4057qib7	2146	4	)	)	-RRB-
cord-005453-4057qib7	2146	5	.	.	.
cord-005453-4057qib7	2147	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2147	2	:	:	:
cord-005453-4057qib7	2148	1	The	the	DT
cord-005453-4057qib7	2148	2	BEB	BEB	NNP
cord-005453-4057qib7	2148	3	conditioning	condition	VBG
cord-005453-4057qib7	2148	4	regimens	regimen	NNS
cord-005453-4057qib7	2148	5	for	for	IN
cord-005453-4057qib7	2148	6	ASCT	ASCT	NNP
cord-005453-4057qib7	2148	7	is	be	VBZ
cord-005453-4057qib7	2148	8	a	a	DT
cord-005453-4057qib7	2148	9	feasible	feasible	JJ
cord-005453-4057qib7	2148	10	with	with	IN
cord-005453-4057qib7	2148	11	tolerable	tolerable	JJ
cord-005453-4057qib7	2148	12	toxicity	toxicity	NN
cord-005453-4057qib7	2148	13	in	in	IN
cord-005453-4057qib7	2148	14	patients	patient	NNS
cord-005453-4057qib7	2148	15	with	with	IN
cord-005453-4057qib7	2148	16	NHL	NHL	NNP
cord-005453-4057qib7	2148	17	.	.	.
cord-005453-4057qib7	2149	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2149	2	:	:	:
cord-005453-4057qib7	2149	3	Nothing	nothing	NN
cord-005453-4057qib7	2149	4	to	to	TO
cord-005453-4057qib7	2149	5	declare	declare	VB
cord-005453-4057qib7	2149	6	Long	long	JJ
cord-005453-4057qib7	2149	7	-	-	HYPH
cord-005453-4057qib7	2149	8	term	term	NN
cord-005453-4057qib7	2149	9	report	report	NN
cord-005453-4057qib7	2149	10	of	of	IN
cord-005453-4057qib7	2149	11	total	total	JJ
cord-005453-4057qib7	2149	12	marrow	marrow	NN
cord-005453-4057qib7	2149	13	or	or	CC
cord-005453-4057qib7	2149	14	total	total	JJ
cord-005453-4057qib7	2149	15	lymphoid	lymphoid	JJ
cord-005453-4057qib7	2149	16	IMRT	IMRT	NNP
cord-005453-4057qib7	2149	17	in	in	IN
cord-005453-4057qib7	2149	18	advanced	advanced	JJ
cord-005453-4057qib7	2149	19	leukemia	leukemia	NN
cord-005453-4057qib7	2149	20	,	,	,
cord-005453-4057qib7	2149	21	myeloma	myeloma	NN
cord-005453-4057qib7	2149	22	and	and	CC
cord-005453-4057qib7	2149	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	2149	24	Background	background	NN
cord-005453-4057qib7	2149	25	:	:	:
cord-005453-4057qib7	2149	26	During	during	IN
cord-005453-4057qib7	2149	27	the	the	DT
cord-005453-4057qib7	2149	28	last	last	JJ
cord-005453-4057qib7	2149	29	three	three	CD
cord-005453-4057qib7	2149	30	decades	decade	NNS
cord-005453-4057qib7	2149	31	,	,	,
cord-005453-4057qib7	2149	32	total	total	JJ
cord-005453-4057qib7	2149	33	body	body	NN
cord-005453-4057qib7	2149	34	irradiation	irradiation	NN
cord-005453-4057qib7	2149	35	(	(	-LRB-
cord-005453-4057qib7	2149	36	TBI	TBI	NNP
cord-005453-4057qib7	2149	37	)	)	-RRB-
cord-005453-4057qib7	2149	38	continues	continue	VBZ
cord-005453-4057qib7	2149	39	to	to	TO
cord-005453-4057qib7	2149	40	play	play	VB
cord-005453-4057qib7	2149	41	an	an	DT
cord-005453-4057qib7	2149	42	important	important	JJ
cord-005453-4057qib7	2149	43	role	role	NN
cord-005453-4057qib7	2149	44	in	in	IN
cord-005453-4057qib7	2149	45	the	the	DT
cord-005453-4057qib7	2149	46	conditioning	conditioning	NN
cord-005453-4057qib7	2149	47	regimens	regimen	NNS
cord-005453-4057qib7	2149	48	for	for	IN
cord-005453-4057qib7	2149	49	patients	patient	NNS
cord-005453-4057qib7	2149	50	undergoing	undergo	VBG
cord-005453-4057qib7	2149	51	stem	stem	NN
cord-005453-4057qib7	2149	52	-	-	HYPH
cord-005453-4057qib7	2149	53	cell	cell	NN
cord-005453-4057qib7	2149	54	transplant	transplant	NN
cord-005453-4057qib7	2149	55	(	(	-LRB-
cord-005453-4057qib7	2149	56	SCT	SCT	NNP
cord-005453-4057qib7	2149	57	)	)	-RRB-
cord-005453-4057qib7	2149	58	for	for	IN
cord-005453-4057qib7	2149	59	a	a	DT
cord-005453-4057qib7	2149	60	wide	wide	JJ
cord-005453-4057qib7	2149	61	variety	variety	NN
cord-005453-4057qib7	2149	62	of	of	IN
cord-005453-4057qib7	2149	63	advanced	advanced	JJ
cord-005453-4057qib7	2149	64	hematological	hematological	JJ
cord-005453-4057qib7	2149	65	malignancies	malignancy	NNS
cord-005453-4057qib7	2149	66	.	.	.
cord-005453-4057qib7	2150	1	However	however	RB
cord-005453-4057qib7	2150	2	,	,	,
cord-005453-4057qib7	2150	3	TBI	TBI	NNP
cord-005453-4057qib7	2150	4	showed	show	VBD
cord-005453-4057qib7	2150	5	boundaries	boundary	NNS
cord-005453-4057qib7	2150	6	in	in	IN
cord-005453-4057qib7	2150	7	dose	dose	NN
cord-005453-4057qib7	2150	8	limits	limit	NNS
cord-005453-4057qib7	2150	9	for	for	IN
cord-005453-4057qib7	2150	10	toxicity	toxicity	NN
cord-005453-4057qib7	2150	11	in	in	IN
cord-005453-4057qib7	2150	12	allogenic	allogenic	NN
cord-005453-4057qib7	2150	13	and	and	CC
cord-005453-4057qib7	2150	14	moreover	moreover	RB
cord-005453-4057qib7	2150	15	in	in	IN
cord-005453-4057qib7	2150	16	autologous	autologous	JJ
cord-005453-4057qib7	2150	17	stem	stem	NN
cord-005453-4057qib7	2150	18	cell	cell	NN
cord-005453-4057qib7	2150	19	transplantation	transplantation	NN
cord-005453-4057qib7	2150	20	.	.	.
cord-005453-4057qib7	2151	1	Currently	currently	RB
cord-005453-4057qib7	2151	2	,	,	,
cord-005453-4057qib7	2151	3	the	the	DT
cord-005453-4057qib7	2151	4	choice	choice	NN
cord-005453-4057qib7	2151	5	of	of	IN
cord-005453-4057qib7	2151	6	conditioning	conditioning	NN
cord-005453-4057qib7	2151	7	regimen	regimen	NN
cord-005453-4057qib7	2151	8	is	be	VBZ
cord-005453-4057qib7	2151	9	based	base	VBN
cord-005453-4057qib7	2151	10	on	on	IN
cord-005453-4057qib7	2151	11	the	the	DT
cord-005453-4057qib7	2151	12	use	use	NN
cord-005453-4057qib7	2151	13	of	of	IN
cord-005453-4057qib7	2151	14	the	the	DT
cord-005453-4057qib7	2151	15	least	least	JJS
cord-005453-4057qib7	2151	16	-	-	HYPH
cord-005453-4057qib7	2151	17	toxic	toxic	JJ
cord-005453-4057qib7	2151	18	regimen	regimen	NN
cord-005453-4057qib7	2151	19	to	to	TO
cord-005453-4057qib7	2151	20	achieve	achieve	VB
cord-005453-4057qib7	2151	21	the	the	DT
cord-005453-4057qib7	2151	22	optimal	optimal	JJ
cord-005453-4057qib7	2151	23	therapeutic	therapeutic	JJ
cord-005453-4057qib7	2151	24	result	result	NN
cord-005453-4057qib7	2151	25	.	.	.
cord-005453-4057qib7	2152	1	This	this	DT
cord-005453-4057qib7	2152	2	report	report	NN
cord-005453-4057qib7	2152	3	aims	aim	VBZ
cord-005453-4057qib7	2152	4	to	to	TO
cord-005453-4057qib7	2152	5	assess	assess	VB
cord-005453-4057qib7	2152	6	the	the	DT
cord-005453-4057qib7	2152	7	feasibility	feasibility	NN
cord-005453-4057qib7	2152	8	of	of	IN
cord-005453-4057qib7	2152	9	a	a	DT
cord-005453-4057qib7	2152	10	conditioning	conditioning	NN
cord-005453-4057qib7	2152	11	strategy	strategy	NN
cord-005453-4057qib7	2152	12	based	base	VBN
cord-005453-4057qib7	2152	13	on	on	IN
cord-005453-4057qib7	2152	14	high	high	JJ
cord-005453-4057qib7	2152	15	dose	dose	NN
cord-005453-4057qib7	2152	16	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2152	17	and	and	CC
cord-005453-4057qib7	2152	18	whole	whole	JJ
cord-005453-4057qib7	2152	19	-	-	HYPH
cord-005453-4057qib7	2152	20	body	body	NN
cord-005453-4057qib7	2152	21	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	2152	22	focused	focus	VBD
cord-005453-4057qib7	2152	23	on	on	IN
cord-005453-4057qib7	2152	24	selective	selective	JJ
cord-005453-4057qib7	2152	25	extensive	extensive	JJ
cord-005453-4057qib7	2152	26	tumor	tumor	NN
cord-005453-4057qib7	2152	27	burden	burden	NN
cord-005453-4057qib7	2152	28	irradiation	irradiation	NN
cord-005453-4057qib7	2152	29	,	,	,
cord-005453-4057qib7	2152	30	both	both	CC
cord-005453-4057qib7	2152	31	in	in	IN
cord-005453-4057qib7	2152	32	allogeneic	allogeneic	NN
cord-005453-4057qib7	2152	33	and	and	CC
cord-005453-4057qib7	2152	34	autologous	autologous	JJ
cord-005453-4057qib7	2152	35	stem	stem	NN
cord-005453-4057qib7	2152	36	cell	cell	NN
cord-005453-4057qib7	2152	37	transplantation	transplantation	NN
cord-005453-4057qib7	2152	38	.	.	.
cord-005453-4057qib7	2153	1	Methods	method	NNS
cord-005453-4057qib7	2153	2	:	:	:
cord-005453-4057qib7	2153	3	Since	since	IN
cord-005453-4057qib7	2153	4	December	December	NNP
cord-005453-4057qib7	2153	5	2009	2009	CD
cord-005453-4057qib7	2153	6	,	,	,
cord-005453-4057qib7	2153	7	sixty	sixty	CD
cord-005453-4057qib7	2153	8	-	-	HYPH
cord-005453-4057qib7	2153	9	two	two	CD
cord-005453-4057qib7	2153	10	patients	patient	NNS
cord-005453-4057qib7	2153	11	(	(	-LRB-
cord-005453-4057qib7	2153	12	pts	pt	NNS
cord-005453-4057qib7	2153	13	)	)	-RRB-
cord-005453-4057qib7	2153	14	have	have	VBP
cord-005453-4057qib7	2153	15	been	be	VBN
cord-005453-4057qib7	2153	16	irradiated	irradiate	VBN
cord-005453-4057qib7	2153	17	by	by	IN
cord-005453-4057qib7	2153	18	helical	helical	JJ
cord-005453-4057qib7	2153	19	tomotherapy	tomotherapy	NN
cord-005453-4057qib7	2153	20	(	(	-LRB-
cord-005453-4057qib7	2153	21	HT	HT	NNP
cord-005453-4057qib7	2153	22	)	)	-RRB-
cord-005453-4057qib7	2153	23	to	to	TO
cord-005453-4057qib7	2153	24	extensive	extensive	JJ
cord-005453-4057qib7	2153	25	target	target	NN
cord-005453-4057qib7	2153	26	before	before	IN
cord-005453-4057qib7	2153	27	allogeneic	allogeneic	NN
cord-005453-4057qib7	2153	28	or	or	CC
cord-005453-4057qib7	2153	29	autologous	autologous	JJ
cord-005453-4057qib7	2153	30	transplantation	transplantation	NN
cord-005453-4057qib7	2153	31	.	.	.
cord-005453-4057qib7	2154	1	Selected	select	VBN
cord-005453-4057qib7	2154	2	total	total	JJ
cord-005453-4057qib7	2154	3	marrow	marrow	NN
cord-005453-4057qib7	2154	4	irradiation	irradiation	NN
cord-005453-4057qib7	2154	5	(	(	-LRB-
cord-005453-4057qib7	2154	6	TMI	TMI	NNP
cord-005453-4057qib7	2154	7	)	)	-RRB-
cord-005453-4057qib7	2154	8	schedules	schedule	NNS
cord-005453-4057qib7	2154	9	were	be	VBD
cord-005453-4057qib7	2154	10	planned	plan	VBN
cord-005453-4057qib7	2154	11	to	to	TO
cord-005453-4057qib7	2154	12	treat	treat	VB
cord-005453-4057qib7	2154	13	patients	patient	NNS
cord-005453-4057qib7	2154	14	with	with	IN
cord-005453-4057qib7	2154	15	high	high	JJ
cord-005453-4057qib7	2154	16	risk	risk	NN
cord-005453-4057qib7	2154	17	acute	acute	JJ
cord-005453-4057qib7	2154	18	leukemia	leukemia	NN
cord-005453-4057qib7	2154	19	(	(	-LRB-
cord-005453-4057qib7	2154	20	ALL	all	DT
cord-005453-4057qib7	2154	21	or	or	CC
cord-005453-4057qib7	2154	22	AML	AML	NNP
cord-005453-4057qib7	2154	23	)	)	-RRB-
cord-005453-4057qib7	2154	24	or	or	CC
cord-005453-4057qib7	2154	25	multiple	multiple	JJ
cord-005453-4057qib7	2154	26	myeloma	myeloma	NN
cord-005453-4057qib7	2154	27	(	(	-LRB-
cord-005453-4057qib7	2154	28	MM	MM	NNP
cord-005453-4057qib7	2154	29	)	)	-RRB-
cord-005453-4057qib7	2154	30	as	as	IN
cord-005453-4057qib7	2154	31	a	a	DT
cord-005453-4057qib7	2154	32	part	part	NN
cord-005453-4057qib7	2154	33	of	of	IN
cord-005453-4057qib7	2154	34	conditioning	conditioning	NN
cord-005453-4057qib7	2154	35	regimen	regimen	NN
cord-005453-4057qib7	2154	36	.	.	.
cord-005453-4057qib7	2155	1	Total	total	JJ
cord-005453-4057qib7	2155	2	lymphoid	lymphoid	JJ
cord-005453-4057qib7	2155	3	irradiation	irradiation	NN
cord-005453-4057qib7	2155	4	(	(	-LRB-
cord-005453-4057qib7	2155	5	TLI	TLI	NNP
cord-005453-4057qib7	2155	6	)	)	-RRB-
cord-005453-4057qib7	2155	7	was	be	VBD
cord-005453-4057qib7	2155	8	planned	plan	VBN
cord-005453-4057qib7	2155	9	for	for	IN
cord-005453-4057qib7	2155	10	patients	patient	NNS
cord-005453-4057qib7	2155	11	with	with	IN
cord-005453-4057qib7	2155	12	refractory	refractory	JJ
cord-005453-4057qib7	2155	13	or	or	CC
cord-005453-4057qib7	2155	14	relapsed	relapsed	JJ
cord-005453-4057qib7	2155	15	(	(	-LRB-
cord-005453-4057qib7	2155	16	R	r	NN
cord-005453-4057qib7	2155	17	/	/	SYM
cord-005453-4057qib7	2155	18	R	r	NN
cord-005453-4057qib7	2155	19	)	)	-RRB-
cord-005453-4057qib7	2155	20	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	2155	21	(	(	-LRB-
cord-005453-4057qib7	2155	22	HD	HD	NNP
cord-005453-4057qib7	2155	23	)	)	-RRB-
cord-005453-4057qib7	2155	24	or	or	CC
cord-005453-4057qib7	2155	25	Non	Non	NNP
cord-005453-4057qib7	2155	26	-	-	JJ
cord-005453-4057qib7	2155	27	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	2155	28	lymphomas	lymphoma	NNS
cord-005453-4057qib7	2155	29	(	(	-LRB-
cord-005453-4057qib7	2155	30	NHL	NHL	NNP
cord-005453-4057qib7	2155	31	)	)	-RRB-
cord-005453-4057qib7	2155	32	.	.	.
cord-005453-4057qib7	2156	1	Results	result	NNS
cord-005453-4057qib7	2156	2	:	:	:
cord-005453-4057qib7	2157	1	TMI	TMI	NNP
cord-005453-4057qib7	2157	2	and	and	CC
cord-005453-4057qib7	2157	3	TLI	TLI	NNP
cord-005453-4057qib7	2157	4	allowed	allow	VBD
cord-005453-4057qib7	2157	5	delivering	deliver	VBG
cord-005453-4057qib7	2157	6	therapeutic	therapeutic	JJ
cord-005453-4057qib7	2157	7	dose	dose	NN
cord-005453-4057qib7	2157	8	over	over	IN
cord-005453-4057qib7	2157	9	extensive	extensive	JJ
cord-005453-4057qib7	2157	10	selected	select	VBN
cord-005453-4057qib7	2157	11	targets	target	NNS
cord-005453-4057qib7	2157	12	with	with	IN
cord-005453-4057qib7	2157	13	wide	wide	JJ
cord-005453-4057qib7	2157	14	reduction	reduction	NN
cord-005453-4057qib7	2157	15	of	of	IN
cord-005453-4057qib7	2157	16	toxicity	toxicity	NN
cord-005453-4057qib7	2157	17	to	to	IN
cord-005453-4057qib7	2157	18	all	all	PDT
cord-005453-4057qib7	2157	19	the	the	DT
cord-005453-4057qib7	2157	20	organs	organ	NNS
cord-005453-4057qib7	2157	21	at	at	IN
cord-005453-4057qib7	2157	22	risk	risk	NN
cord-005453-4057qib7	2157	23	(	(	-LRB-
cord-005453-4057qib7	2157	24	OARs	OARs	NNP
cord-005453-4057qib7	2157	25	)	)	-RRB-
cord-005453-4057qib7	2157	26	.	.	.
cord-005453-4057qib7	2158	1	The	the	DT
cord-005453-4057qib7	2158	2	higher	high	JJR
cord-005453-4057qib7	2158	3	radiation	radiation	NN
cord-005453-4057qib7	2158	4	doses	dose	NNS
cord-005453-4057qib7	2158	5	rate	rate	NN
cord-005453-4057qib7	2158	6	to	to	IN
cord-005453-4057qib7	2158	7	the	the	DT
cord-005453-4057qib7	2158	8	OARs	oars	NN
cord-005453-4057qib7	2158	9	is	be	VBZ
cord-005453-4057qib7	2158	10	reduced	reduce	VBN
cord-005453-4057qib7	2158	11	from	from	IN
cord-005453-4057qib7	2158	12	30	30	CD
cord-005453-4057qib7	2158	13	%	%	NN
cord-005453-4057qib7	2158	14	to	to	TO
cord-005453-4057qib7	2158	15	70	70	CD
cord-005453-4057qib7	2158	16	%	%	NN
cord-005453-4057qib7	2158	17	.	.	.
cord-005453-4057qib7	2159	1	Allogenic	allogenic	JJ
cord-005453-4057qib7	2159	2	conditioning	conditioning	NN
cord-005453-4057qib7	2159	3	regimen	regimen	NN
cord-005453-4057qib7	2159	4	was	be	VBD
cord-005453-4057qib7	2159	5	TLI	TLI	NNP
cord-005453-4057qib7	2159	6	(	(	-LRB-
cord-005453-4057qib7	2159	7	4Gy	4gy	JJ
cord-005453-4057qib7	2159	8	x	x	SYM
cord-005453-4057qib7	2159	9	3fx	3fx	NNS
cord-005453-4057qib7	2159	10	)	)	-RRB-
cord-005453-4057qib7	2159	11	than	than	IN
cord-005453-4057qib7	2159	12	fludarabine	fludarabine	NNP
cord-005453-4057qib7	2159	13	+	+	CC
cord-005453-4057qib7	2159	14	endoxan	endoxan	NN
cord-005453-4057qib7	2159	15	for	for	IN
cord-005453-4057qib7	2159	16	patients	patient	NNS
cord-005453-4057qib7	2159	17	with	with	IN
cord-005453-4057qib7	2159	18	HD	HD	NNP
cord-005453-4057qib7	2159	19	(	(	-LRB-
cord-005453-4057qib7	2159	20	4	4	CD
cord-005453-4057qib7	2159	21	pts	pts	CD
cord-005453-4057qib7	2159	22	)	)	-RRB-
cord-005453-4057qib7	2159	23	.	.	.
cord-005453-4057qib7	2160	1	TMI	TMI	NNP
cord-005453-4057qib7	2160	2	(	(	-LRB-
cord-005453-4057qib7	2160	3	4Gy	4gy	JJ
cord-005453-4057qib7	2160	4	x	x	SYM
cord-005453-4057qib7	2160	5	3fx	3fx	NNS
cord-005453-4057qib7	2160	6	)	)	-RRB-
cord-005453-4057qib7	2160	7	+	+	CC
cord-005453-4057qib7	2160	8	fludarabine	fludarabine	NN
cord-005453-4057qib7	2160	9	+	+	CC
cord-005453-4057qib7	2160	10	melphalan	melphalan	NN
cord-005453-4057qib7	2160	11	for	for	IN
cord-005453-4057qib7	2160	12	patients	patient	NNS
cord-005453-4057qib7	2160	13	with	with	IN
cord-005453-4057qib7	2160	14	MM	MM	NNP
cord-005453-4057qib7	2160	15	(	(	-LRB-
cord-005453-4057qib7	2160	16	4	4	CD
cord-005453-4057qib7	2160	17	pts	pts	CD
cord-005453-4057qib7	2160	18	)	)	-RRB-
cord-005453-4057qib7	2160	19	.	.	.
cord-005453-4057qib7	2161	1	TMI	TMI	NNP
cord-005453-4057qib7	2161	2	(	(	-LRB-
cord-005453-4057qib7	2161	3	4Gy	4gy	NN
cord-005453-4057qib7	2161	4	x	x	SYM
cord-005453-4057qib7	2161	5	2	2	CD
cord-005453-4057qib7	2161	6	fx	fx	NNP
cord-005453-4057qib7	2161	7	)	)	-RRB-
cord-005453-4057qib7	2161	8	+	+	SYM
cord-005453-4057qib7	2161	9	thiotepa	thiotepa	JJ
cord-005453-4057qib7	2161	10	+	+	CC
cord-005453-4057qib7	2161	11	fludarabine	fludarabine	NN
cord-005453-4057qib7	2161	12	+	+	CC
cord-005453-4057qib7	2161	13	busulfan	busulfan	NN
cord-005453-4057qib7	2161	14	for	for	IN
cord-005453-4057qib7	2161	15	advanced	advanced	JJ
cord-005453-4057qib7	2161	16	LAM	LAM	NNP
cord-005453-4057qib7	2161	17	patients	patient	NNS
cord-005453-4057qib7	2161	18	(	(	-LRB-
cord-005453-4057qib7	2161	19	4	4	CD
cord-005453-4057qib7	2161	20	pts	pts	CD
cord-005453-4057qib7	2161	21	)	)	-RRB-
cord-005453-4057qib7	2161	22	.	.	.
cord-005453-4057qib7	2162	1	TMI	TMI	NNP
cord-005453-4057qib7	2162	2	as	as	IN
cord-005453-4057qib7	2162	3	the	the	DT
cord-005453-4057qib7	2162	4	boost	boost	NN
cord-005453-4057qib7	2162	5	(	(	-LRB-
cord-005453-4057qib7	2162	6	2	2	CD
cord-005453-4057qib7	2162	7	-	-	HYPH
cord-005453-4057qib7	2162	8	3Gy	3gy	NN
cord-005453-4057qib7	2162	9	)	)	-RRB-
cord-005453-4057qib7	2163	1	after	after	IN
cord-005453-4057qib7	2163	2	conventional	conventional	JJ
cord-005453-4057qib7	2163	3	TBI	TBI	NNP
cord-005453-4057qib7	2163	4	was	be	VBD
cord-005453-4057qib7	2163	5	(	(	-LRB-
cord-005453-4057qib7	2163	6	12	12	CD
cord-005453-4057qib7	2163	7	Gy	Gy	NNP
cord-005453-4057qib7	2163	8	in	in	IN
cord-005453-4057qib7	2163	9	6	6	CD
cord-005453-4057qib7	2163	10	bi	bi	JJ
cord-005453-4057qib7	2163	11	-	-	HYPH
cord-005453-4057qib7	2163	12	fractionated	fractionate	VBN
cord-005453-4057qib7	2163	13	doses	dose	NNS
cord-005453-4057qib7	2163	14	)	)	-RRB-
cord-005453-4057qib7	2163	15	by	by	IN
cord-005453-4057qib7	2163	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2163	17	(	(	-LRB-
cord-005453-4057qib7	2163	18	18	18	CD
cord-005453-4057qib7	2163	19	pts	pt	NNS
cord-005453-4057qib7	2163	20	)	)	-RRB-
cord-005453-4057qib7	2163	21	.	.	.
cord-005453-4057qib7	2164	1	Autologous	autologous	JJ
cord-005453-4057qib7	2164	2	preparation	preparation	NN
cord-005453-4057qib7	2164	3	to	to	IN
cord-005453-4057qib7	2164	4	SCT	SCT	NNP
cord-005453-4057qib7	2164	5	consisted	consist	VBD
cord-005453-4057qib7	2164	6	of	of	IN
cord-005453-4057qib7	2164	7	TLI	TLI	NNP
cord-005453-4057qib7	2164	8	(	(	-LRB-
cord-005453-4057qib7	2164	9	4Gyx	4gyx	CD
cord-005453-4057qib7	2164	10	3fx	3fx	NNS
cord-005453-4057qib7	2164	11	)	)	-RRB-
cord-005453-4057qib7	2164	12	followed	follow	VBN
cord-005453-4057qib7	2164	13	by	by	IN
cord-005453-4057qib7	2164	14	high	high	JJ
cord-005453-4057qib7	2164	15	-	-	HYPH
cord-005453-4057qib7	2164	16	dose	dose	NN
cord-005453-4057qib7	2164	17	bendamustine	bendamustine	NN
cord-005453-4057qib7	2164	18	and	and	CC
cord-005453-4057qib7	2164	19	melphalan	melphalan	NNP
cord-005453-4057qib7	2164	20	for	for	IN
cord-005453-4057qib7	2164	21	patients	patient	NNS
cord-005453-4057qib7	2164	22	older	old	JJR
cord-005453-4057qib7	2164	23	than	than	IN
cord-005453-4057qib7	2164	24	40	40	CD
cord-005453-4057qib7	2164	25	years	year	NNS
cord-005453-4057qib7	2164	26	and	and	CC
cord-005453-4057qib7	2164	27	conventional	conventional	JJ
cord-005453-4057qib7	2164	28	FEAM	FEAM	NNP
cord-005453-4057qib7	2164	29	(	(	-LRB-
cord-005453-4057qib7	2164	30	Fotemustine	Fotemustine	NNP
cord-005453-4057qib7	2164	31	,	,	,
cord-005453-4057qib7	2164	32	Etoposide	Etoposide	NNP
cord-005453-4057qib7	2164	33	,	,	,
cord-005453-4057qib7	2164	34	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	2164	35	,	,	,
cord-005453-4057qib7	2164	36	and	and	CC
cord-005453-4057qib7	2164	37	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2164	38	)	)	-RRB-
cord-005453-4057qib7	2164	39	for	for	IN
cord-005453-4057qib7	2164	40	younger	young	JJR
cord-005453-4057qib7	2164	41	patients	patient	NNS
cord-005453-4057qib7	2164	42	,	,	,
cord-005453-4057qib7	2164	43	in	in	IN
cord-005453-4057qib7	2164	44	HD	HD	NNP
cord-005453-4057qib7	2164	45	e	e	NN
cord-005453-4057qib7	2164	46	NHL	NHL	NNP
cord-005453-4057qib7	2164	47	(	(	-LRB-
cord-005453-4057qib7	2164	48	20	20	CD
cord-005453-4057qib7	2164	49	pts	pt	NNS
cord-005453-4057qib7	2164	50	)	)	-RRB-
cord-005453-4057qib7	2164	51	.	.	.
cord-005453-4057qib7	2165	1	While	while	IN
cord-005453-4057qib7	2165	2	TMI	TMI	NNP
cord-005453-4057qib7	2165	3	(	(	-LRB-
cord-005453-4057qib7	2165	4	4Gy	4gy	NN
cord-005453-4057qib7	2165	5	x	x	SYM
cord-005453-4057qib7	2165	6	3	3	CD
cord-005453-4057qib7	2165	7	fx	fx	NNP
cord-005453-4057qib7	2165	8	)	)	-RRB-
cord-005453-4057qib7	2165	9	plus	plus	CC
cord-005453-4057qib7	2165	10	melphalan	melphalan	NNP
cord-005453-4057qib7	2165	11	was	be	VBD
cord-005453-4057qib7	2165	12	delivered	deliver	VBN
cord-005453-4057qib7	2165	13	for	for	IN
cord-005453-4057qib7	2165	14	autologous	autologous	JJ
cord-005453-4057qib7	2165	15	SCT	SCT	NNP
cord-005453-4057qib7	2165	16	in	in	IN
cord-005453-4057qib7	2165	17	MM	MM	NNP
cord-005453-4057qib7	2165	18	and	and	CC
cord-005453-4057qib7	2165	19	LAM	LAM	NNP
cord-005453-4057qib7	2165	20	(	(	-LRB-
cord-005453-4057qib7	2165	21	12	12	CD
cord-005453-4057qib7	2165	22	pts	pt	NNS
cord-005453-4057qib7	2165	23	)	)	-RRB-
cord-005453-4057qib7	2165	24	.	.	.
cord-005453-4057qib7	2166	1	No	no	DT
cord-005453-4057qib7	2166	2	unexpected	unexpected	JJ
cord-005453-4057qib7	2166	3	acute	acute	JJ
cord-005453-4057qib7	2166	4	toxicity	toxicity	NN
cord-005453-4057qib7	2166	5	was	be	VBD
cord-005453-4057qib7	2166	6	found	find	VBN
cord-005453-4057qib7	2166	7	.	.	.
cord-005453-4057qib7	2167	1	In	in	IN
cord-005453-4057qib7	2167	2	the	the	DT
cord-005453-4057qib7	2167	3	allogenic	allogenic	NN
cord-005453-4057qib7	2167	4	setting	setting	NN
cord-005453-4057qib7	2167	5	,	,	,
cord-005453-4057qib7	2167	6	all	all	PDT
cord-005453-4057qib7	2167	7	the	the	DT
cord-005453-4057qib7	2167	8	patients	patient	NNS
cord-005453-4057qib7	2167	9	'	'	POS
cord-005453-4057qib7	2167	10	engraftment	engraftment	NN
cord-005453-4057qib7	2167	11	was	be	VBD
cord-005453-4057qib7	2167	12	achieved	achieve	VBN
cord-005453-4057qib7	2167	13	in	in	IN
cord-005453-4057qib7	2167	14	all	all	DT
cord-005453-4057qib7	2167	15	patients	patient	NNS
cord-005453-4057qib7	2167	16	.	.	.
cord-005453-4057qib7	2168	1	No	no	DT
cord-005453-4057qib7	2168	2	acute	acute	JJ
cord-005453-4057qib7	2168	3	graft	graft	NN
cord-005453-4057qib7	2168	4	versus	versus	IN
cord-005453-4057qib7	2168	5	host	host	NN
cord-005453-4057qib7	2168	6	disease	disease	NN
cord-005453-4057qib7	2168	7	increasing	increase	VBG
cord-005453-4057qib7	2168	8	was	be	VBD
cord-005453-4057qib7	2168	9	detected	detect	VBN
cord-005453-4057qib7	2168	10	.	.	.
cord-005453-4057qib7	2169	1	Within	within	IN
cord-005453-4057qib7	2169	2	the	the	DT
cord-005453-4057qib7	2169	3	autologous	autologous	JJ
cord-005453-4057qib7	2169	4	setting	setting	NN
cord-005453-4057qib7	2169	5	,	,	,
cord-005453-4057qib7	2169	6	only	only	RB
cord-005453-4057qib7	2169	7	33	33	CD
cord-005453-4057qib7	2169	8	%	%	NN
cord-005453-4057qib7	2169	9	developed	develop	VBN
cord-005453-4057qib7	2169	10	grade	grade	NN
cord-005453-4057qib7	2169	11	3/4	3/4	CD
cord-005453-4057qib7	2169	12	mucositis	mucositis	NNP
cord-005453-4057qib7	2169	13	.	.	.
cord-005453-4057qib7	2170	1	None	none	NN
cord-005453-4057qib7	2170	2	experienced	experience	VBD
cord-005453-4057qib7	2170	3	grade	grade	NN
cord-005453-4057qib7	2170	4	3/4	3/4	CD
cord-005453-4057qib7	2170	5	extra	extra	JJ
cord-005453-4057qib7	2170	6	-	-	HYPH
cord-005453-4057qib7	2170	7	hematological	hematological	JJ
cord-005453-4057qib7	2170	8	toxicity	toxicity	NN
cord-005453-4057qib7	2170	9	.	.	.
cord-005453-4057qib7	2171	1	Outcomes	outcome	NNS
cord-005453-4057qib7	2171	2	of	of	IN
cord-005453-4057qib7	2171	3	the	the	DT
cord-005453-4057qib7	2171	4	specific	specific	JJ
cord-005453-4057qib7	2171	5	disease	disease	NN
cord-005453-4057qib7	2171	6	will	will	MD
cord-005453-4057qib7	2171	7	be	be	VB
cord-005453-4057qib7	2171	8	reported	report	VBN
cord-005453-4057qib7	2171	9	.	.	.
cord-005453-4057qib7	2172	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2172	2	:	:	:
cord-005453-4057qib7	2173	1	The	the	DT
cord-005453-4057qib7	2173	2	current	current	JJ
cord-005453-4057qib7	2173	3	report	report	NN
cord-005453-4057qib7	2173	4	describes	describe	VBZ
cord-005453-4057qib7	2173	5	the	the	DT
cord-005453-4057qib7	2173	6	clinical	clinical	JJ
cord-005453-4057qib7	2173	7	feasibility	feasibility	NN
cord-005453-4057qib7	2173	8	of	of	IN
cord-005453-4057qib7	2173	9	using	use	VBG
cord-005453-4057qib7	2173	10	HT	HT	NNP
cord-005453-4057qib7	2173	11	to	to	TO
cord-005453-4057qib7	2173	12	deliver	deliver	VB
cord-005453-4057qib7	2173	13	TMI	TMI	NNP
cord-005453-4057qib7	2173	14	or	or	CC
cord-005453-4057qib7	2173	15	TLI	TLI	NNP
cord-005453-4057qib7	2173	16	in	in	IN
cord-005453-4057qib7	2173	17	the	the	DT
cord-005453-4057qib7	2173	18	setting	setting	NN
cord-005453-4057qib7	2173	19	of	of	IN
cord-005453-4057qib7	2173	20	autologous	autologous	JJ
cord-005453-4057qib7	2173	21	transplantation	transplantation	NN
cord-005453-4057qib7	2173	22	or	or	CC
cord-005453-4057qib7	2173	23	during	during	IN
cord-005453-4057qib7	2173	24	allogenic	allogenic	JJ
cord-005453-4057qib7	2173	25	stem	stem	NN
cord-005453-4057qib7	2173	26	cell	cell	NN
cord-005453-4057qib7	2173	27	conditioning	conditioning	NN
cord-005453-4057qib7	2173	28	regimen	regimen	NN
cord-005453-4057qib7	2173	29	,	,	,
cord-005453-4057qib7	2173	30	to	to	TO
cord-005453-4057qib7	2173	31	allow	allow	VB
cord-005453-4057qib7	2173	32	all	all	DT
cord-005453-4057qib7	2173	33	patients	patient	NNS
cord-005453-4057qib7	2173	34	(	(	-LRB-
cord-005453-4057qib7	2173	35	old	old	JJ
cord-005453-4057qib7	2173	36	,	,	,
cord-005453-4057qib7	2173	37	fragile	fragile	JJ
cord-005453-4057qib7	2173	38	or	or	CC
cord-005453-4057qib7	2173	39	with	with	IN
cord-005453-4057qib7	2173	40	high	high	JJ
cord-005453-4057qib7	2173	41	tumor	tumor	NN
cord-005453-4057qib7	2173	42	burden	burden	NN
cord-005453-4057qib7	2173	43	)	)	-RRB-
cord-005453-4057qib7	2173	44	to	to	TO
cord-005453-4057qib7	2173	45	achieve	achieve	VB
cord-005453-4057qib7	2173	46	an	an	DT
cord-005453-4057qib7	2173	47	ablative	ablative	JJ
cord-005453-4057qib7	2173	48	regimen	regimen	NN
cord-005453-4057qib7	2173	49	before	before	IN
cord-005453-4057qib7	2173	50	SCT	SCT	NNP
cord-005453-4057qib7	2173	51	.	.	.
cord-005453-4057qib7	2174	1	To	to	IN
cord-005453-4057qib7	2174	2	our	-PRON-	PRP$
cord-005453-4057qib7	2174	3	knowledge	knowledge	NN
cord-005453-4057qib7	2174	4	,	,	,
cord-005453-4057qib7	2174	5	this	this	DT
cord-005453-4057qib7	2174	6	single	single	JJ
cord-005453-4057qib7	2174	7	institution	institution	NN
cord-005453-4057qib7	2174	8	experience	experience	NN
cord-005453-4057qib7	2174	9	describes	describe	VBZ
cord-005453-4057qib7	2174	10	data	datum	NNS
cord-005453-4057qib7	2174	11	from	from	IN
cord-005453-4057qib7	2174	12	one	one	CD
cord-005453-4057qib7	2174	13	of	of	IN
cord-005453-4057qib7	2174	14	the	the	DT
cord-005453-4057qib7	2174	15	largest	large	JJS
cord-005453-4057qib7	2174	16	cohort	cohort	NN
cord-005453-4057qib7	2174	17	of	of	IN
cord-005453-4057qib7	2174	18	patients	patient	NNS
cord-005453-4057qib7	2174	19	treated	treat	VBN
cord-005453-4057qib7	2174	20	in	in	IN
cord-005453-4057qib7	2174	21	Europe	Europe	NNP
cord-005453-4057qib7	2174	22	since	since	IN
cord-005453-4057qib7	2174	23	the	the	DT
cord-005453-4057qib7	2174	24	development	development	NN
cord-005453-4057qib7	2174	25	of	of	IN
cord-005453-4057qib7	2174	26	this	this	DT
cord-005453-4057qib7	2174	27	irradiation	irradiation	NN
cord-005453-4057qib7	2174	28	techniques	technique	NNS
cord-005453-4057qib7	2174	29	.	.	.
cord-005453-4057qib7	2175	1	Disclosure	Disclosure	NNP
cord-005453-4057qib7	2175	2	Induction	Induction	NNP
cord-005453-4057qib7	2175	3	therapy	therapy	NN
cord-005453-4057qib7	2175	4	in	in	IN
cord-005453-4057qib7	2175	5	both	both	DT
cord-005453-4057qib7	2175	6	groups	group	NNS
cord-005453-4057qib7	2175	7	of	of	IN
cord-005453-4057qib7	2175	8	patients	patient	NNS
cord-005453-4057qib7	2175	9	was	be	VBD
cord-005453-4057qib7	2175	10	based	base	VBN
cord-005453-4057qib7	2175	11	in	in	IN
cord-005453-4057qib7	2175	12	polychemotherapy	polychemotherapy	NNP
cord-005453-4057qib7	2175	13	without	without	IN
cord-005453-4057qib7	2175	14	the	the	DT
cord-005453-4057qib7	2175	15	use	use	NN
cord-005453-4057qib7	2175	16	of	of	IN
cord-005453-4057qib7	2175	17	new	new	JJ
cord-005453-4057qib7	2175	18	drugs	drug	NNS
cord-005453-4057qib7	2175	19	.	.	.
cord-005453-4057qib7	2176	1	Case	case	NN
cord-005453-4057qib7	2176	2	matching	matching	NN
cord-005453-4057qib7	2176	3	was	be	VBD
cord-005453-4057qib7	2176	4	performed	perform	VBN
cord-005453-4057qib7	2176	5	according	accord	VBG
cord-005453-4057qib7	2176	6	to	to	IN
cord-005453-4057qib7	2176	7	age	age	NN
cord-005453-4057qib7	2176	8	,	,	,
cord-005453-4057qib7	2176	9	clinical	clinical	JJ
cord-005453-4057qib7	2176	10	stage	stage	NN
cord-005453-4057qib7	2176	11	at	at	IN
cord-005453-4057qib7	2176	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	2176	13	,	,	,
cord-005453-4057qib7	2176	14	and	and	CC
cord-005453-4057qib7	2176	15	response	response	NN
cord-005453-4057qib7	2176	16	to	to	IN
cord-005453-4057qib7	2176	17	induction	induction	NN
cord-005453-4057qib7	2176	18	therapy	therapy	NN
cord-005453-4057qib7	2176	19	.	.	.
cord-005453-4057qib7	2177	1	Conditioning	conditioning	NN
cord-005453-4057qib7	2177	2	regimen	regimen	NN
cord-005453-4057qib7	2177	3	consisted	consist	VBD
cord-005453-4057qib7	2177	4	of	of	IN
cord-005453-4057qib7	2177	5	iv	iv	NNP
cord-005453-4057qib7	2177	6	BU	BU	NNP
cord-005453-4057qib7	2177	7	at	at	IN
cord-005453-4057qib7	2177	8	a	a	DT
cord-005453-4057qib7	2177	9	dose	dose	NN
cord-005453-4057qib7	2177	10	of	of	IN
cord-005453-4057qib7	2177	11	3.2	3.2	CD
cord-005453-4057qib7	2177	12	mg/	mg/	NN
cord-005453-4057qib7	2177	13	kg	kg	NNP
cord-005453-4057qib7	2177	14	once	once	RB
cord-005453-4057qib7	2177	15	a	a	DT
cord-005453-4057qib7	2177	16	day	day	NN
cord-005453-4057qib7	2177	17	on	on	IN
cord-005453-4057qib7	2177	18	days	day	NNS
cord-005453-4057qib7	2177	19	-5	-5	JJ
cord-005453-4057qib7	2177	20	to	to	IN
cord-005453-4057qib7	2177	21	-3	-3	NNP
cord-005453-4057qib7	2177	22	followed	follow	VBN
cord-005453-4057qib7	2177	23	by	by	IN
cord-005453-4057qib7	2177	24	MEL	MEL	NNP
cord-005453-4057qib7	2177	25	at	at	IN
cord-005453-4057qib7	2177	26	a	a	DT
cord-005453-4057qib7	2177	27	dose	dose	NN
cord-005453-4057qib7	2177	28	of	of	IN
cord-005453-4057qib7	2177	29	-140	-140	NN
cord-005453-4057qib7	2178	1	mg	mg	NNP
cord-005453-4057qib7	2178	2	/	/	SYM
cord-005453-4057qib7	2178	3	m	m	NNP
cord-005453-4057qib7	2178	4	2	2	CD
cord-005453-4057qib7	2178	5	on	on	IN
cord-005453-4057qib7	2178	6	day	day	NN
cord-005453-4057qib7	2178	7	-2	-2	CD
cord-005453-4057qib7	2179	1	in	in	IN
cord-005453-4057qib7	2179	2	the	the	DT
cord-005453-4057qib7	2179	3	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2179	4	group	group	NN
cord-005453-4057qib7	2179	5	versus	versus	IN
cord-005453-4057qib7	2179	6	MEL200	MEL200	NNP
cord-005453-4057qib7	2179	7	in	in	IN
cord-005453-4057qib7	2179	8	the	the	DT
cord-005453-4057qib7	2179	9	control	control	NN
cord-005453-4057qib7	2179	10	group	group	NN
cord-005453-4057qib7	2179	11	.	.	.
cord-005453-4057qib7	2180	1	Maintenance	maintenance	NN
cord-005453-4057qib7	2180	2	therapy	therapy	NN
cord-005453-4057qib7	2180	3	after	after	IN
cord-005453-4057qib7	2180	4	transplant	transplant	NN
cord-005453-4057qib7	2180	5	consisted	consist	VBD
cord-005453-4057qib7	2180	6	of	of	IN
cord-005453-4057qib7	2180	7	interferon	interferon	NN
cord-005453-4057qib7	2180	8	and	and	CC
cord-005453-4057qib7	2180	9	steroids	steroid	NNS
cord-005453-4057qib7	2180	10	in	in	IN
cord-005453-4057qib7	2180	11	the	the	DT
cord-005453-4057qib7	2180	12	majority	majority	NN
cord-005453-4057qib7	2180	13	of	of	IN
cord-005453-4057qib7	2180	14	patients	patient	NNS
cord-005453-4057qib7	2180	15	.	.	.
cord-005453-4057qib7	2181	1	Results	result	NNS
cord-005453-4057qib7	2181	2	:	:	:
cord-005453-4057qib7	2182	1	The	the	DT
cord-005453-4057qib7	2182	2	cut	cut	VB
cord-005453-4057qib7	2182	3	-	-	HYPH
cord-005453-4057qib7	2182	4	off	off	RP
cord-005453-4057qib7	2182	5	date	date	NN
cord-005453-4057qib7	2182	6	for	for	IN
cord-005453-4057qib7	2182	7	this	this	DT
cord-005453-4057qib7	2182	8	update	update	NN
cord-005453-4057qib7	2182	9	was	be	VBD
cord-005453-4057qib7	2182	10	June	June	NNP
cord-005453-4057qib7	2182	11	30	30	CD
cord-005453-4057qib7	2182	12	,	,	,
cord-005453-4057qib7	2182	13	2018	2018	CD
cord-005453-4057qib7	2182	14	.	.	.
cord-005453-4057qib7	2183	1	After	after	IN
cord-005453-4057qib7	2183	2	a	a	DT
cord-005453-4057qib7	2183	3	median	median	JJ
cord-005453-4057qib7	2183	4	follow	follow	NN
cord-005453-4057qib7	2183	5	-	-	HYPH
cord-005453-4057qib7	2183	6	up	up	NN
cord-005453-4057qib7	2183	7	of	of	IN
cord-005453-4057qib7	2183	8	56	56	CD
cord-005453-4057qib7	2183	9	and	and	CC
cord-005453-4057qib7	2183	10	63	63	CD
cord-005453-4057qib7	2183	11	months	month	NNS
cord-005453-4057qib7	2183	12	in	in	IN
cord-005453-4057qib7	2183	13	the	the	DT
cord-005453-4057qib7	2183	14	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2183	15	and	and	CC
cord-005453-4057qib7	2183	16	MEL200	MEL200	NNP
cord-005453-4057qib7	2183	17	groups	group	NNS
cord-005453-4057qib7	2183	18	respectively	respectively	RB
cord-005453-4057qib7	2183	19	,	,	,
cord-005453-4057qib7	2183	20	35	35	CD
cord-005453-4057qib7	2183	21	patients	patient	NNS
cord-005453-4057qib7	2183	22	had	have	VBD
cord-005453-4057qib7	2183	23	relapsed	relapse	VBN
cord-005453-4057qib7	2183	24	in	in	IN
cord-005453-4057qib7	2183	25	the	the	DT
cord-005453-4057qib7	2183	26	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2183	27	group	group	NN
cord-005453-4057qib7	2183	28	and	and	CC
cord-005453-4057qib7	2183	29	82	82	CD
cord-005453-4057qib7	2183	30	patients	patient	NNS
cord-005453-4057qib7	2183	31	in	in	IN
cord-005453-4057qib7	2183	32	the	the	DT
cord-005453-4057qib7	2183	33	control	control	NN
cord-005453-4057qib7	2183	34	group	group	NN
cord-005453-4057qib7	2183	35	.	.	.
cord-005453-4057qib7	2184	1	Median	median	JJ
cord-005453-4057qib7	2184	2	PFS	PFS	NNP
cord-005453-4057qib7	2184	3	was	be	VBD
cord-005453-4057qib7	2184	4	33	33	CD
cord-005453-4057qib7	2185	1	(	(	-LRB-
cord-005453-4057qib7	2185	2	95	95	CD
cord-005453-4057qib7	2185	3	%	%	NN
cord-005453-4057qib7	2185	4	CI	CI	NNP
cord-005453-4057qib7	2185	5	,	,	,
cord-005453-4057qib7	2185	6	25.4	25.4	CD
cord-005453-4057qib7	2185	7	-	-	SYM
cord-005453-4057qib7	2185	8	48.3	48.3	CD
cord-005453-4057qib7	2185	9	)	)	-RRB-
cord-005453-4057qib7	2185	10	months	month	NNS
cord-005453-4057qib7	2185	11	in	in	IN
cord-005453-4057qib7	2185	12	the	the	DT
cord-005453-4057qib7	2185	13	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2185	14	and	and	CC
cord-005453-4057qib7	2185	15	24	24	CD
cord-005453-4057qib7	2185	16	(	(	-LRB-
cord-005453-4057qib7	2185	17	95	95	CD
cord-005453-4057qib7	2185	18	%	%	NN
cord-005453-4057qib7	2185	19	CI	CI	NNP
cord-005453-4057qib7	2185	20	,	,	,
cord-005453-4057qib7	2185	21	20.1	20.1	CD
cord-005453-4057qib7	2185	22	-	-	HYPH
cord-005453-4057qib7	2185	23	32.7	32.7	CD
cord-005453-4057qib7	2185	24	)	)	-RRB-
cord-005453-4057qib7	2185	25	months	month	NNS
cord-005453-4057qib7	2185	26	in	in	IN
cord-005453-4057qib7	2185	27	the	the	DT
cord-005453-4057qib7	2185	28	MEL200	MEL200	NNP
cord-005453-4057qib7	2185	29	group	group	NN
cord-005453-4057qib7	2185	30	(	(	-LRB-
cord-005453-4057qib7	2185	31	P	p	NN
cord-005453-4057qib7	2185	32	=	=	SYM
cord-005453-4057qib7	2185	33	0.04	0.04	CD
cord-005453-4057qib7	2185	34	)	)	-RRB-
cord-005453-4057qib7	2186	1	(	(	-LRB-
cord-005453-4057qib7	2186	2	Figure	figure	NN
cord-005453-4057qib7	2186	3	1	1	CD
cord-005453-4057qib7	2186	4	)	)	-RRB-
cord-005453-4057qib7	2186	5	.	.	.
cord-005453-4057qib7	2187	1	In	in	IN
cord-005453-4057qib7	2187	2	this	this	DT
cord-005453-4057qib7	2187	3	update	update	NN
cord-005453-4057qib7	2187	4	,	,	,
cord-005453-4057qib7	2187	5	12	12	CD
cord-005453-4057qib7	2187	6	patients	patient	NNS
cord-005453-4057qib7	2187	7	in	in	IN
cord-005453-4057qib7	2187	8	the	the	DT
cord-005453-4057qib7	2187	9	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2187	10	group	group	NN
cord-005453-4057qib7	2187	11	are	be	VBP
cord-005453-4057qib7	2187	12	in	in	IN
cord-005453-4057qib7	2187	13	maintained	maintain	VBN
cord-005453-4057qib7	2187	14	response	response	NN
cord-005453-4057qib7	2187	15	and	and	CC
cord-005453-4057qib7	2187	16	7	7	CD
cord-005453-4057qib7	2187	17	of	of	IN
cord-005453-4057qib7	2187	18	them	-PRON-	PRP
cord-005453-4057qib7	2187	19	are	be	VBP
cord-005453-4057qib7	2187	20	in	in	IN
cord-005453-4057qib7	2187	21	continuous	continuous	JJ
cord-005453-4057qib7	2187	22	CR	cr	NN
cord-005453-4057qib7	2187	23	(	(	-LRB-
cord-005453-4057qib7	2187	24	two	two	CD
cord-005453-4057qib7	2187	25	with	with	IN
cord-005453-4057qib7	2187	26	negative	negative	JJ
cord-005453-4057qib7	2187	27	status	status	NN
cord-005453-4057qib7	2187	28	for	for	IN
cord-005453-4057qib7	2187	29	minimal	minimal	JJ
cord-005453-4057qib7	2187	30	residual	residual	JJ
cord-005453-4057qib7	2187	31	disease	disease	NN
cord-005453-4057qib7	2187	32	)	)	-RRB-
cord-005453-4057qib7	2187	33	between	between	IN
cord-005453-4057qib7	2187	34	9	9	CD
cord-005453-4057qib7	2187	35	and	and	CC
cord-005453-4057qib7	2187	36	12	12	CD
cord-005453-4057qib7	2187	37	years	year	NNS
cord-005453-4057qib7	2187	38	after	after	IN
cord-005453-4057qib7	2187	39	transplantation	transplantation	NN
cord-005453-4057qib7	2187	40	.	.	.
cord-005453-4057qib7	2188	1	Ten	ten	CD
cord-005453-4057qib7	2188	2	-	-	HYPH
cord-005453-4057qib7	2188	3	year	year	NN
cord-005453-4057qib7	2188	4	OS	OS	NNP
cord-005453-4057qib7	2188	5	was	be	VBD
cord-005453-4057qib7	2188	6	not	not	RB
cord-005453-4057qib7	2188	7	significantly	significantly	RB
cord-005453-4057qib7	2188	8	different	different	JJ
cord-005453-4057qib7	2188	9	between	between	IN
cord-005453-4057qib7	2188	10	both	both	DT
cord-005453-4057qib7	2188	11	groups	group	NNS
cord-005453-4057qib7	2188	12	,	,	,
cord-005453-4057qib7	2188	13	being	be	VBG
cord-005453-4057qib7	2188	14	41	41	CD
cord-005453-4057qib7	2189	1	(	(	-LRB-
cord-005453-4057qib7	2189	2	95	95	CD
cord-005453-4057qib7	2189	3	%	%	NN
cord-005453-4057qib7	2189	4	CI	CI	NNP
cord-005453-4057qib7	2189	5	30	30	CD
cord-005453-4057qib7	2189	6	-	-	SYM
cord-005453-4057qib7	2189	7	58	58	CD
cord-005453-4057qib7	2189	8	)	)	-RRB-
cord-005453-4057qib7	2189	9	months	month	NNS
cord-005453-4057qib7	2189	10	in	in	IN
cord-005453-4057qib7	2189	11	the	the	DT
cord-005453-4057qib7	2189	12	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2189	13	and	and	CC
cord-005453-4057qib7	2189	14	29	29	CD
cord-005453-4057qib7	2190	1	(	(	-LRB-
cord-005453-4057qib7	2190	2	95	95	CD
cord-005453-4057qib7	2190	3	%	%	NN
cord-005453-4057qib7	2190	4	CI	CI	NNP
cord-005453-4057qib7	2190	5	18	18	CD
cord-005453-4057qib7	2190	6	-	-	SYM
cord-005453-4057qib7	2190	7	47	47	CD
cord-005453-4057qib7	2190	8	)	)	-RRB-
cord-005453-4057qib7	2190	9	months	month	NNS
cord-005453-4057qib7	2190	10	in	in	IN
cord-005453-4057qib7	2190	11	the	the	DT
cord-005453-4057qib7	2190	12	control	control	NN
cord-005453-4057qib7	2190	13	group	group	NN
cord-005453-4057qib7	2190	14	.	.	.
cord-005453-4057qib7	2191	1	Transplant	transplant	NN
cord-005453-4057qib7	2191	2	-	-	HYPH
cord-005453-4057qib7	2191	3	related	relate	VBN
cord-005453-4057qib7	2191	4	mortality	mortality	NN
cord-005453-4057qib7	2191	5	was	be	VBD
cord-005453-4057qib7	2191	6	similar	similar	JJ
cord-005453-4057qib7	2191	7	in	in	IN
cord-005453-4057qib7	2191	8	both	both	DT
cord-005453-4057qib7	2191	9	groups	group	NNS
cord-005453-4057qib7	2191	10	of	of	IN
cord-005453-4057qib7	2191	11	patients	patient	NNS
cord-005453-4057qib7	2191	12	(	(	-LRB-
cord-005453-4057qib7	2191	13	4	4	CD
cord-005453-4057qib7	2191	14	%	%	NN
cord-005453-4057qib7	2191	15	in	in	IN
cord-005453-4057qib7	2191	16	the	the	DT
cord-005453-4057qib7	2191	17	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2191	18	and	and	CC
cord-005453-4057qib7	2191	19	2	2	CD
cord-005453-4057qib7	2191	20	%	%	NN
cord-005453-4057qib7	2191	21	in	in	IN
cord-005453-4057qib7	2191	22	the	the	DT
cord-005453-4057qib7	2191	23	MEL200	MEL200	NNP
cord-005453-4057qib7	2191	24	group	group	NN
cord-005453-4057qib7	2191	25	)	)	-RRB-
cord-005453-4057qib7	2191	26	.	.	.
cord-005453-4057qib7	2192	1	Regarding	regard	VBG
cord-005453-4057qib7	2192	2	toxicity	toxicity	NN
cord-005453-4057qib7	2192	3	,	,	,
cord-005453-4057qib7	2192	4	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2192	5	was	be	VBD
cord-005453-4057qib7	2192	6	associated	associate	VBN
cord-005453-4057qib7	2192	7	with	with	IN
cord-005453-4057qib7	2192	8	a	a	DT
cord-005453-4057qib7	2192	9	higher	high	JJR
cord-005453-4057qib7	2192	10	incidence	incidence	NN
cord-005453-4057qib7	2192	11	of	of	IN
cord-005453-4057qib7	2192	12	mucositis	mucositis	NN
cord-005453-4057qib7	2192	13	and	and	CC
cord-005453-4057qib7	2192	14	liver	liver	NN
cord-005453-4057qib7	2192	15	toxicity	toxicity	NN
cord-005453-4057qib7	2192	16	than	than	IN
cord-005453-4057qib7	2192	17	the	the	DT
cord-005453-4057qib7	2192	18	melphalan	melphalan	NN
cord-005453-4057qib7	2192	19	-	-	HYPH
cord-005453-4057qib7	2192	20	only	only	JJ
cord-005453-4057qib7	2192	21	approach	approach	NN
cord-005453-4057qib7	2192	22	but	but	CC
cord-005453-4057qib7	2192	23	no	no	DT
cord-005453-4057qib7	2192	24	patient	patient	NN
cord-005453-4057qib7	2192	25	in	in	IN
cord-005453-4057qib7	2192	26	our	-PRON-	PRP$
cord-005453-4057qib7	2192	27	series	series	NN
cord-005453-4057qib7	2192	28	developed	develop	VBD
cord-005453-4057qib7	2192	29	sinusoidal	sinusoidal	DT
cord-005453-4057qib7	2192	30	occlusive	occlusive	JJ
cord-005453-4057qib7	2192	31	syndrome	syndrome	NN
cord-005453-4057qib7	2192	32	and	and	CC
cord-005453-4057qib7	2192	33	the	the	DT
cord-005453-4057qib7	2192	34	hepatic	hepatic	JJ
cord-005453-4057qib7	2192	35	toxicity	toxicity	NN
cord-005453-4057qib7	2192	36	observed	observe	VBD
cord-005453-4057qib7	2192	37	was	be	VBD
cord-005453-4057qib7	2192	38	only	only	RB
cord-005453-4057qib7	2192	39	grade	grade	NN
cord-005453-4057qib7	2192	40	I	I	NNP
cord-005453-4057qib7	2192	41	/	/	SYM
cord-005453-4057qib7	2192	42	II	II	NNP
cord-005453-4057qib7	2192	43	.	.	.
cord-005453-4057qib7	2193	1	Finally	finally	RB
cord-005453-4057qib7	2193	2	,	,	,
cord-005453-4057qib7	2193	3	no	no	DT
cord-005453-4057qib7	2193	4	long	long	JJ
cord-005453-4057qib7	2193	5	-	-	HYPH
cord-005453-4057qib7	2193	6	term	term	NN
cord-005453-4057qib7	2193	7	side	side	NN
cord-005453-4057qib7	2193	8	effects	effect	NNS
cord-005453-4057qib7	2193	9	have	have	VBP
cord-005453-4057qib7	2193	10	been	be	VBN
cord-005453-4057qib7	2193	11	reported	report	VBN
cord-005453-4057qib7	2193	12	among	among	IN
cord-005453-4057qib7	2193	13	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2193	14	recipients	recipient	NNS
cord-005453-4057qib7	2193	15	.	.	.
cord-005453-4057qib7	2194	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2194	2	:	:	:
cord-005453-4057qib7	2195	1	This	this	DT
cord-005453-4057qib7	2195	2	long	long	JJ
cord-005453-4057qib7	2195	3	-	-	HYPH
cord-005453-4057qib7	2195	4	term	term	NN
cord-005453-4057qib7	2195	5	follow	follow	NN
cord-005453-4057qib7	2195	6	-	-	HYPH
cord-005453-4057qib7	2195	7	up	up	RP
cord-005453-4057qib7	2195	8	analysis	analysis	NN
cord-005453-4057qib7	2195	9	confirms	confirm	VBZ
cord-005453-4057qib7	2195	10	that	that	IN
cord-005453-4057qib7	2195	11	a	a	DT
cord-005453-4057qib7	2195	12	therapeutic	therapeutic	JJ
cord-005453-4057qib7	2195	13	strategy	strategy	NN
cord-005453-4057qib7	2195	14	including	include	VBG
cord-005453-4057qib7	2195	15	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2195	16	as	as	IN
cord-005453-4057qib7	2195	17	conditioning	conditioning	NN
cord-005453-4057qib7	2195	18	regimen	regimen	NN
cord-005453-4057qib7	2195	19	beforeASCT	beforeasct	NN
cord-005453-4057qib7	2195	20	in	in	IN
cord-005453-4057qib7	2195	21	patients	patient	NNS
cord-005453-4057qib7	2195	22	with	with	IN
cord-005453-4057qib7	2195	23	newly	newly	RB
cord-005453-4057qib7	2195	24	diagnosed	diagnose	VBN
cord-005453-4057qib7	2195	25	MM	MM	NNP
cord-005453-4057qib7	2195	26	is	be	VBZ
cord-005453-4057qib7	2195	27	highly	highly	RB
cord-005453-4057qib7	2195	28	active	active	JJ
cord-005453-4057qib7	2195	29	and	and	CC
cord-005453-4057qib7	2195	30	safe	safe	JJ
cord-005453-4057qib7	2195	31	in	in	IN
cord-005453-4057qib7	2195	32	these	these	DT
cord-005453-4057qib7	2195	33	patients	patient	NNS
cord-005453-4057qib7	2195	34	.	.	.
cord-005453-4057qib7	2196	1	[	[	-LRB-
cord-005453-4057qib7	2196	2	[	[	-LRB-
cord-005453-4057qib7	2196	3	P113	P113	NNP
cord-005453-4057qib7	2196	4	Image	Image	NNP
cord-005453-4057qib7	2196	5	]	]	-RRB-
cord-005453-4057qib7	2196	6	1	1	CD
cord-005453-4057qib7	2196	7	.	.	.
cord-005453-4057qib7	2197	1	Figure	figure	NN
cord-005453-4057qib7	2197	2	1	1	CD
cord-005453-4057qib7	2197	3	.	.	.
cord-005453-4057qib7	2198	1	Progression	progression	NN
cord-005453-4057qib7	2198	2	free	free	JJ
cord-005453-4057qib7	2198	3	survival	survival	NN
cord-005453-4057qib7	2198	4	in	in	IN
cord-005453-4057qib7	2198	5	the	the	DT
cord-005453-4057qib7	2198	6	BUMEL	BUMEL	NNP
cord-005453-4057qib7	2199	1	(	(	-LRB-
cord-005453-4057qib7	2199	2	_	_	NN
cord-005453-4057qib7	2200	1	_	_	NNP
cord-005453-4057qib7	2200	2	_	_	NNP
cord-005453-4057qib7	2200	3	_	_	NNP
cord-005453-4057qib7	2200	4	)	)	-RRB-
cord-005453-4057qib7	2200	5	and	and	CC
cord-005453-4057qib7	2200	6	control	control	NN
cord-005453-4057qib7	2200	7	group	group	NN
cord-005453-4057qib7	2200	8	(	(	-LRB-
cord-005453-4057qib7	2200	9	……	……	``
cord-005453-4057qib7	2200	10	Frequency	frequency	NN
cord-005453-4057qib7	2200	11	of	of	IN
cord-005453-4057qib7	2200	12	acute	acute	JJ
cord-005453-4057qib7	2200	13	GvHD	GvHD	NNP
cord-005453-4057qib7	2200	14	 	 	_SP
cord-005453-4057qib7	2200	15	grade	grade	NN
cord-005453-4057qib7	2200	16	III	III	NNP
cord-005453-4057qib7	2200	17	-	-	HYPH
cord-005453-4057qib7	2200	18	IV	IV	NNP
cord-005453-4057qib7	2201	1	[	[	-LRB-
cord-005453-4057qib7	2201	2	CC	cc	NN
cord-005453-4057qib7	2201	3	:	:	:
cord-005453-4057qib7	2201	4	11	11	CD
cord-005453-4057qib7	2201	5	%	%	NN
cord-005453-4057qib7	2201	6	;	;	:
cord-005453-4057qib7	2201	7	CT	CT	NNP
cord-005453-4057qib7	2201	8	:	:	:
cord-005453-4057qib7	2201	9	17	17	CD
cord-005453-4057qib7	2201	10	%	%	NN
cord-005453-4057qib7	2201	11	;	;	:
cord-005453-4057qib7	2201	12	TT	tt	NN
cord-005453-4057qib7	2201	13	:	:	:
cord-005453-4057qib7	2201	14	24	24	CD
cord-005453-4057qib7	2201	15	%	%	NN
cord-005453-4057qib7	2201	16	,	,	,
cord-005453-4057qib7	2201	17	p=0.057	p=0.057	NNP
cord-005453-4057qib7	2201	18	]	]	-RRB-
cord-005453-4057qib7	2201	19	,	,	,
cord-005453-4057qib7	2201	20	and	and	CC
cord-005453-4057qib7	2201	21	 	 	_SP
cord-005453-4057qib7	2201	22	transplant	transplant	NN
cord-005453-4057qib7	2201	23	-	-	HYPH
cord-005453-4057qib7	2201	24	related	relate	VBN
cord-005453-4057qib7	2201	25	mortality	mortality	NN
cord-005453-4057qib7	2201	26	was	be	VBD
cord-005453-4057qib7	2201	27	higher	high	JJR
cord-005453-4057qib7	2201	28	in	in	IN
cord-005453-4057qib7	2201	29	TT	TT	NNP
cord-005453-4057qib7	2201	30	-	-	HYPH
cord-005453-4057qib7	2201	31	carriers	carrier	NNS
cord-005453-4057qib7	2201	32	 	 	_SP
cord-005453-4057qib7	2201	33	(	(	-LRB-
cord-005453-4057qib7	2201	34	CC:26	cc:26	CD
cord-005453-4057qib7	2201	35	%	%	NN
cord-005453-4057qib7	2201	36	;	;	:
cord-005453-4057qib7	2201	37	CT:28	CT:28	NNP
cord-005453-4057qib7	2201	38	%	%	NN
cord-005453-4057qib7	2201	39	;	;	:
cord-005453-4057qib7	2201	40	TT:46	tt:46	CD
cord-005453-4057qib7	2201	41	%	%	NN
cord-005453-4057qib7	2201	42	,	,	,
cord-005453-4057qib7	2201	43	p=0.02	p=0.02	NNP
cord-005453-4057qib7	2201	44	CC&CT	CC&CT	NNP
cord-005453-4057qib7	2201	45	vs	vs	IN
cord-005453-4057qib7	2201	46	TT	TT	NNP
cord-005453-4057qib7	2201	47	)	)	-RRB-
cord-005453-4057qib7	2201	48	.	.	.
cord-005453-4057qib7	2202	1	TA	TA	NNP
cord-005453-4057qib7	2202	2	-	-	HYPH
cord-005453-4057qib7	2202	3	TMA	TMA	NNP
cord-005453-4057qib7	2202	4	,	,	,
cord-005453-4057qib7	2202	5	CMV	CMV	NNP
cord-005453-4057qib7	2202	6	infection	infection	NN
cord-005453-4057qib7	2202	7	/	/	SYM
cord-005453-4057qib7	2202	8	reactivation	reactivation	NN
cord-005453-4057qib7	2202	9	and	and	CC
cord-005453-4057qib7	2202	10	cGvHD	cgvhd	NN
cord-005453-4057qib7	2202	11	were	be	VBD
cord-005453-4057qib7	2202	12	also	also	RB
cord-005453-4057qib7	2202	13	not	not	RB
cord-005453-4057qib7	2202	14	different	different	JJ
cord-005453-4057qib7	2202	15	according	accord	VBG
cord-005453-4057qib7	2202	16	to	to	IN
cord-005453-4057qib7	2202	17	donor	donor	NN
cord-005453-4057qib7	2202	18	genotypes	genotype	NNS
cord-005453-4057qib7	2202	19	.	.	.
cord-005453-4057qib7	2203	1	Fungal	fungal	JJ
cord-005453-4057qib7	2203	2	infections	infection	NNS
cord-005453-4057qib7	2203	3	occurred	occur	VBD
cord-005453-4057qib7	2203	4	more	more	RBR
cord-005453-4057qib7	2203	5	frequently	frequently	RB
cord-005453-4057qib7	2203	6	as	as	IN
cord-005453-4057qib7	2203	7	causes	cause	NNS
cord-005453-4057qib7	2203	8	of	of	IN
cord-005453-4057qib7	2203	9	death	death	NN
cord-005453-4057qib7	2203	10	in	in	IN
cord-005453-4057qib7	2203	11	carriers	carrier	NNS
cord-005453-4057qib7	2203	12	(	(	-LRB-
cord-005453-4057qib7	2203	13	CC	cc	NN
cord-005453-4057qib7	2203	14	:	:	:
cord-005453-4057qib7	2203	15	9.7	9.7	CD
cord-005453-4057qib7	2203	16	%	%	NN
cord-005453-4057qib7	2203	17	vs.	vs.	IN
cord-005453-4057qib7	2203	18	CT	CT	NNP
cord-005453-4057qib7	2203	19	:	:	:
cord-005453-4057qib7	2203	20	38.1	38.1	CD
cord-005453-4057qib7	2203	21	%	%	NN
cord-005453-4057qib7	2203	22	vs	vs	IN
cord-005453-4057qib7	2203	23	TT	TT	NNP
cord-005453-4057qib7	2203	24	:	:	:
cord-005453-4057qib7	2203	25	33.3	33.3	CD
cord-005453-4057qib7	2203	26	%	%	NN
cord-005453-4057qib7	2203	27	,	,	,
cord-005453-4057qib7	2203	28	p=0.022	p=0.022	NNP
cord-005453-4057qib7	2203	29	)	)	-RRB-
cord-005453-4057qib7	2203	30	.	.	.
cord-005453-4057qib7	2204	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2204	2	:	:	:
cord-005453-4057qib7	2205	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2205	2	results	result	NNS
cord-005453-4057qib7	2205	3	suggest	suggest	VBP
cord-005453-4057qib7	2205	4	that	that	IN
cord-005453-4057qib7	2205	5	donor	donor	NN
cord-005453-4057qib7	2205	6	TGFB1	TGFB1	NNP
cord-005453-4057qib7	2205	7	-1347C	-1347c	CD
cord-005453-4057qib7	2206	1	>	>	XX
cord-005453-4057qib7	2207	1	T	T	NNP
cord-005453-4057qib7	2207	2	may	may	MD
cord-005453-4057qib7	2207	3	exert	exert	VB
cord-005453-4057qib7	2207	4	an	an	DT
cord-005453-4057qib7	2207	5	adverse	adverse	JJ
cord-005453-4057qib7	2207	6	influence	influence	NN
cord-005453-4057qib7	2207	7	on	on	IN
cord-005453-4057qib7	2207	8	the	the	DT
cord-005453-4057qib7	2207	9	outcome	outcome	NN
cord-005453-4057qib7	2207	10	of	of	IN
cord-005453-4057qib7	2207	11	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2207	12	conditioning	conditioning	NN
cord-005453-4057qib7	2207	13	.	.	.
cord-005453-4057qib7	2208	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2208	2	finding	finding	NN
cord-005453-4057qib7	2208	3	might	may	MD
cord-005453-4057qib7	2208	4	be	be	VB
cord-005453-4057qib7	2208	5	explained	explain	VBN
cord-005453-4057qib7	2208	6	by	by	IN
cord-005453-4057qib7	2208	7	the	the	DT
cord-005453-4057qib7	2208	8	combination	combination	NN
cord-005453-4057qib7	2208	9	therapy	therapy	NN
cord-005453-4057qib7	2208	10	of	of	IN
cord-005453-4057qib7	2208	11	calcineurin	calcineurin	NNP
cord-005453-4057qib7	2208	12	and	and	CC
cord-005453-4057qib7	2208	13	mTOR	mTOR	NNP
cord-005453-4057qib7	2208	14	inhibition	inhibition	NN
cord-005453-4057qib7	2208	15	in	in	IN
cord-005453-4057qib7	2208	16	GvHD	GvHD	NNP
cord-005453-4057qib7	2208	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2208	18	in	in	IN
cord-005453-4057qib7	2208	19	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2208	20	conditioning	conditioning	NN
cord-005453-4057qib7	2208	21	.	.	.
cord-005453-4057qib7	2209	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2209	2	:	:	:
cord-005453-4057qib7	2209	3	Nothing	nothing	NN
cord-005453-4057qib7	2209	4	to	to	TO
cord-005453-4057qib7	2209	5	declare	declare	VB
cord-005453-4057qib7	2209	6	.	.	.
cord-005453-4057qib7	2210	1	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2210	2	-	-	HYPH
cord-005453-4057qib7	2210	3	based	base	VBN
cord-005453-4057qib7	2210	4	reduced	reduced	JJ
cord-005453-4057qib7	2210	5	intensity	intensity	NN
cord-005453-4057qib7	2210	6	conditioning	conditioning	NN
cord-005453-4057qib7	2210	7	in	in	IN
cord-005453-4057qib7	2210	8	HLA	HLA	NNP
cord-005453-4057qib7	2210	9	-	-	HYPH
cord-005453-4057qib7	2210	10	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2210	11	transplantation	transplantation	NN
cord-005453-4057qib7	2210	12	using	use	VBG
cord-005453-4057qib7	2210	13	PTCY	PTCY	NNP
cord-005453-4057qib7	2210	14	as	as	IN
cord-005453-4057qib7	2210	15	GVHD	GVHD	NNP
cord-005453-4057qib7	2210	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2210	17	in	in	IN
cord-005453-4057qib7	2210	18	high	high	JJ
cord-005453-4057qib7	2210	19	-	-	HYPH
cord-005453-4057qib7	2210	20	risk	risk	NN
cord-005453-4057qib7	2210	21	MDS	MDS	NNP
cord-005453-4057qib7	2210	22	/AML	/AML	.
cord-005453-4057qib7	2210	23	of	of	IN
cord-005453-4057qib7	2210	24	the	the	DT
cord-005453-4057qib7	2210	25	elderly	elderly	JJ
cord-005453-4057qib7	2210	26	Background	background	NN
cord-005453-4057qib7	2210	27	:	:	:
cord-005453-4057qib7	2211	1	Standard	standard	JJ
cord-005453-4057qib7	2211	2	conditioning	conditioning	NN
cord-005453-4057qib7	2211	3	regimens	regimen	NNS
cord-005453-4057qib7	2211	4	prior	prior	RB
cord-005453-4057qib7	2211	5	to	to	IN
cord-005453-4057qib7	2211	6	allogeneic	allogeneic	JJ
cord-005453-4057qib7	2211	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2211	8	stem	stem	NN
cord-005453-4057qib7	2211	9	cell	cell	NN
cord-005453-4057qib7	2211	10	transplantation	transplantation	NN
cord-005453-4057qib7	2211	11	(	(	-LRB-
cord-005453-4057qib7	2211	12	allo	allo	NN
cord-005453-4057qib7	2211	13	-	-	HYPH
cord-005453-4057qib7	2211	14	HSCT	HSCT	NNP
cord-005453-4057qib7	2211	15	)	)	-RRB-
cord-005453-4057qib7	2211	16	are	be	VBP
cord-005453-4057qib7	2211	17	often	often	RB
cord-005453-4057qib7	2211	18	associated	associate	VBN
cord-005453-4057qib7	2211	19	with	with	IN
cord-005453-4057qib7	2211	20	a	a	DT
cord-005453-4057qib7	2211	21	considerable	considerable	JJ
cord-005453-4057qib7	2211	22	risk	risk	NN
cord-005453-4057qib7	2211	23	of	of	IN
cord-005453-4057qib7	2211	24	severe	severe	JJ
cord-005453-4057qib7	2211	25	adverse	adverse	JJ
cord-005453-4057qib7	2211	26	events	event	NNS
cord-005453-4057qib7	2211	27	,	,	,
cord-005453-4057qib7	2211	28	especially	especially	RB
cord-005453-4057qib7	2211	29	in	in	IN
cord-005453-4057qib7	2211	30	elderly	elderly	JJ
cord-005453-4057qib7	2211	31	patients	patient	NNS
cord-005453-4057qib7	2211	32	suffering	suffer	VBG
cord-005453-4057qib7	2211	33	from	from	IN
cord-005453-4057qib7	2211	34	high	high	JJ
cord-005453-4057qib7	2211	35	-	-	HYPH
cord-005453-4057qib7	2211	36	risk	risk	NN
cord-005453-4057qib7	2211	37	(	(	-LRB-
cord-005453-4057qib7	2211	38	HR	hr	NN
cord-005453-4057qib7	2211	39	)	)	-RRB-
cord-005453-4057qib7	2211	40	MDS	MDS	NNP
cord-005453-4057qib7	2211	41	/	/	SYM
cord-005453-4057qib7	2211	42	AML	AML	NNP
cord-005453-4057qib7	2211	43	.	.	.
cord-005453-4057qib7	2212	1	Previous	previous	JJ
cord-005453-4057qib7	2212	2	clinical	clinical	JJ
cord-005453-4057qib7	2212	3	studies	study	NNS
cord-005453-4057qib7	2212	4	have	have	VBP
cord-005453-4057qib7	2212	5	demonstrated	demonstrate	VBN
cord-005453-4057qib7	2212	6	feasibility	feasibility	NN
cord-005453-4057qib7	2212	7	of	of	IN
cord-005453-4057qib7	2212	8	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2212	9	-	-	HYPH
cord-005453-4057qib7	2212	10	based	base	VBN
cord-005453-4057qib7	2212	11	reduced	reduce	VBN
cord-005453-4057qib7	2212	12	-	-	HYPH
cord-005453-4057qib7	2212	13	intensity	intensity	NN
cord-005453-4057qib7	2212	14	conditioning	conditioning	NN
cord-005453-4057qib7	2212	15	(	(	-LRB-
cord-005453-4057qib7	2212	16	RIC	RIC	NNP
cord-005453-4057qib7	2212	17	)	)	-RRB-
cord-005453-4057qib7	2212	18	by	by	IN
cord-005453-4057qib7	2212	19	stable	stable	JJ
cord-005453-4057qib7	2212	20	engraftment	engraftment	NN
cord-005453-4057qib7	2212	21	,	,	,
cord-005453-4057qib7	2212	22	low	low	JJ
cord-005453-4057qib7	2212	23	non	non	JJ
cord-005453-4057qib7	2212	24	-	-	JJ
cord-005453-4057qib7	2212	25	relapse	relapse	JJ
cord-005453-4057qib7	2212	26	mortality	mortality	NN
cord-005453-4057qib7	2212	27	(	(	-LRB-
cord-005453-4057qib7	2212	28	NRM	NRM	NNP
cord-005453-4057qib7	2212	29	)	)	-RRB-
cord-005453-4057qib7	2212	30	,	,	,
cord-005453-4057qib7	2212	31	and	and	CC
cord-005453-4057qib7	2212	32	favorable	favorable	JJ
cord-005453-4057qib7	2212	33	survival	survival	NN
cord-005453-4057qib7	2212	34	in	in	IN
cord-005453-4057qib7	2212	35	elderly	elderly	JJ
cord-005453-4057qib7	2212	36	patients	patient	NNS
cord-005453-4057qib7	2212	37	undergoing	undergo	VBG
cord-005453-4057qib7	2212	38	HLA	HLA	NNP
cord-005453-4057qib7	2212	39	-	-	HYPH
cord-005453-4057qib7	2212	40	matched	match	VBN
cord-005453-4057qib7	2212	41	related	related	JJ
cord-005453-4057qib7	2212	42	or	or	CC
cord-005453-4057qib7	2212	43	unrelated	unrelated	JJ
cord-005453-4057qib7	2212	44	allo	allo	NN
cord-005453-4057qib7	2212	45	-	-	HYPH
cord-005453-4057qib7	2212	46	HSCT	HSCT	NNP
cord-005453-4057qib7	2212	47	(	(	-LRB-
cord-005453-4057qib7	2212	48	Beelen	Beelen	NNP
cord-005453-4057qib7	2212	49	et	et	NNP
cord-005453-4057qib7	2212	50	al	al	NNP
cord-005453-4057qib7	2212	51	,	,	,
cord-005453-4057qib7	2212	52	ASH	ASH	NNP
cord-005453-4057qib7	2212	53	2017	2017	CD
cord-005453-4057qib7	2212	54	#	#	$
cord-005453-4057qib7	2212	55	0521	0521	CD
cord-005453-4057qib7	2212	56	)	)	-RRB-
cord-005453-4057qib7	2212	57	.	.	.
cord-005453-4057qib7	2213	1	However	however	RB
cord-005453-4057qib7	2213	2	,	,	,
cord-005453-4057qib7	2213	3	data	datum	NNS
cord-005453-4057qib7	2213	4	for	for	IN
cord-005453-4057qib7	2213	5	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2213	6	-	-	HYPH
cord-005453-4057qib7	2213	7	based	base	VBN
cord-005453-4057qib7	2213	8	conditioning	conditioning	NN
cord-005453-4057qib7	2213	9	in	in	IN
cord-005453-4057qib7	2213	10	the	the	DT
cord-005453-4057qib7	2213	11	T	t	NN
cord-005453-4057qib7	2213	12	-	-	HYPH
cord-005453-4057qib7	2213	13	cell	cell	NN
cord-005453-4057qib7	2213	14	-	-	HYPH
cord-005453-4057qib7	2213	15	replete	replete	JJ
cord-005453-4057qib7	2213	16	HLAhaploidentical	HLAhaploidentical	NNP
cord-005453-4057qib7	2213	17	(	(	-LRB-
cord-005453-4057qib7	2213	18	haplo	haplo	NNP
cord-005453-4057qib7	2213	19	-	-	HYPH
cord-005453-4057qib7	2213	20	HSCT	HSCT	NNP
cord-005453-4057qib7	2213	21	)	)	-RRB-
cord-005453-4057qib7	2213	22	setting	set	VBG
cord-005453-4057qib7	2213	23	in	in	IN
cord-005453-4057qib7	2213	24	high	high	JJ
cord-005453-4057qib7	2213	25	-	-	HYPH
cord-005453-4057qib7	2213	26	risk	risk	NN
cord-005453-4057qib7	2213	27	AML	AML	NNP
cord-005453-4057qib7	2213	28	/	/	SYM
cord-005453-4057qib7	2213	29	MDS	MDS	NNP
cord-005453-4057qib7	2213	30	patients	patient	NNS
cord-005453-4057qib7	2213	31	are	be	VBP
cord-005453-4057qib7	2213	32	rare	rare	JJ
cord-005453-4057qib7	2213	33	.	.	.
cord-005453-4057qib7	2214	1	Here	here	RB
cord-005453-4057qib7	2214	2	we	-PRON-	PRP
cord-005453-4057qib7	2214	3	report	report	VBP
cord-005453-4057qib7	2214	4	on	on	IN
cord-005453-4057qib7	2214	5	the	the	DT
cord-005453-4057qib7	2214	6	outcome	outcome	NN
cord-005453-4057qib7	2214	7	of	of	IN
cord-005453-4057qib7	2214	8	eleven	eleven	CD
cord-005453-4057qib7	2214	9	patients	patient	NNS
cord-005453-4057qib7	2214	10	treated	treat	VBN
cord-005453-4057qib7	2214	11	with	with	IN
cord-005453-4057qib7	2214	12	a	a	DT
cord-005453-4057qib7	2214	13	treosulfan	treosulfan	NN
cord-005453-4057qib7	2214	14	-	-	HYPH
cord-005453-4057qib7	2214	15	based	base	VBN
cord-005453-4057qib7	2214	16	conditioning	conditioning	NN
cord-005453-4057qib7	2214	17	undergoing	undergo	VBG
cord-005453-4057qib7	2214	18	haplo	haplo	NNP
cord-005453-4057qib7	2214	19	-	-	HYPH
cord-005453-4057qib7	2214	20	HSCT	HSCT	NNP
cord-005453-4057qib7	2214	21	using	use	VBG
cord-005453-4057qib7	2214	22	exclusively	exclusively	RB
cord-005453-4057qib7	2214	23	post	post	JJ
cord-005453-4057qib7	2214	24	-	-	NN
cord-005453-4057qib7	2214	25	transplantation	transplantation	JJ
cord-005453-4057qib7	2214	26	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2214	27	(	(	-LRB-
cord-005453-4057qib7	2214	28	PTCY	PTCY	NNP
cord-005453-4057qib7	2214	29	)	)	-RRB-
cord-005453-4057qib7	2214	30	as	as	IN
cord-005453-4057qib7	2214	31	GvHD	GvHD	NNP
cord-005453-4057qib7	2214	32	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2214	33	.	.	.
cord-005453-4057qib7	2215	1	Methods	method	NNS
cord-005453-4057qib7	2215	2	:	:	:
cord-005453-4057qib7	2215	3	Eleven	eleven	CD
cord-005453-4057qib7	2215	4	patients	patient	NNS
cord-005453-4057qib7	2215	5	with	with	IN
cord-005453-4057qib7	2215	6	high	high	JJ
cord-005453-4057qib7	2215	7	-	-	HYPH
cord-005453-4057qib7	2215	8	risk	risk	NN
cord-005453-4057qib7	2215	9	(	(	-LRB-
cord-005453-4057qib7	2215	10	HR	HR	NNP
cord-005453-4057qib7	2215	11	)	)	-RRB-
cord-005453-4057qib7	2215	12	AML	AML	NNP
cord-005453-4057qib7	2215	13	(	(	-LRB-
cord-005453-4057qib7	2215	14	n=9)/MDS	n=9)/MDS	NNP
cord-005453-4057qib7	2215	15	(	(	-LRB-
cord-005453-4057qib7	2215	16	n=2	n=2	NNS
cord-005453-4057qib7	2215	17	)	)	-RRB-
cord-005453-4057qib7	2215	18	who	who	WP
cord-005453-4057qib7	2215	19	underwent	undergo	VBD
cord-005453-4057qib7	2215	20	haplo	haplo	NN
cord-005453-4057qib7	2215	21	-	-	HYPH
cord-005453-4057qib7	2215	22	HSCT	HSCT	NNP
cord-005453-4057qib7	2215	23	using	use	VBG
cord-005453-4057qib7	2215	24	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2215	25	for	for	IN
cord-005453-4057qib7	2215	26	reduced	reduced	JJ
cord-005453-4057qib7	2215	27	intensity	intensity	NN
cord-005453-4057qib7	2215	28	conditioning	conditioning	NN
cord-005453-4057qib7	2215	29	(	(	-LRB-
cord-005453-4057qib7	2215	30	RIC	RIC	NNP
cord-005453-4057qib7	2215	31	)	)	-RRB-
cord-005453-4057qib7	2215	32	and	and	CC
cord-005453-4057qib7	2215	33	PTCY	PTCY	NNP
cord-005453-4057qib7	2215	34	as	as	IN
cord-005453-4057qib7	2215	35	GvHD	GvHD	NNP
cord-005453-4057qib7	2215	36	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2215	37	were	be	VBD
cord-005453-4057qib7	2215	38	retrospectively	retrospectively	RB
cord-005453-4057qib7	2215	39	analyzed	analyze	VBN
cord-005453-4057qib7	2215	40	with	with	IN
cord-005453-4057qib7	2215	41	respect	respect	NN
cord-005453-4057qib7	2215	42	to	to	IN
cord-005453-4057qib7	2215	43	outcome	outcome	NN
cord-005453-4057qib7	2215	44	and	and	CC
cord-005453-4057qib7	2215	45	toxicity	toxicity	NN
cord-005453-4057qib7	2215	46	.	.	.
cord-005453-4057qib7	2216	1	All	all	DT
cord-005453-4057qib7	2216	2	patients	patient	NNS
cord-005453-4057qib7	2216	3	were	be	VBD
cord-005453-4057qib7	2216	4	>	>	$
cord-005453-4057qib7	2216	5	55	55	CD
cord-005453-4057qib7	2216	6	years	year	NNS
cord-005453-4057qib7	2216	7	old	old	JJ
cord-005453-4057qib7	2216	8	and	and	CC
cord-005453-4057qib7	2216	9	transplanted	transplant	VBN
cord-005453-4057qib7	2216	10	between	between	IN
cord-005453-4057qib7	2216	11	January	January	NNP
cord-005453-4057qib7	2216	12	2016	2016	CD
cord-005453-4057qib7	2216	13	and	and	CC
cord-005453-4057qib7	2216	14	February	February	NNP
cord-005453-4057qib7	2216	15	2018	2018	CD
cord-005453-4057qib7	2216	16	at	at	IN
cord-005453-4057qib7	2216	17	our	-PRON-	PRP$
cord-005453-4057qib7	2216	18	institution	institution	NN
cord-005453-4057qib7	2216	19	.	.	.
cord-005453-4057qib7	2217	1	The	the	DT
cord-005453-4057qib7	2217	2	majority	majority	NN
cord-005453-4057qib7	2217	3	of	of	IN
cord-005453-4057qib7	2217	4	the	the	DT
cord-005453-4057qib7	2217	5	patients	patient	NNS
cord-005453-4057qib7	2217	6	(	(	-LRB-
cord-005453-4057qib7	2217	7	9/11	9/11	CD
cord-005453-4057qib7	2217	8	)	)	-RRB-
cord-005453-4057qib7	2217	9	suffered	suffer	VBD
cord-005453-4057qib7	2217	10	from	from	IN
cord-005453-4057qib7	2217	11	active	active	JJ
cord-005453-4057qib7	2217	12	disease	disease	NN
cord-005453-4057qib7	2217	13	at	at	IN
cord-005453-4057qib7	2217	14	time	time	NN
cord-005453-4057qib7	2217	15	of	of	IN
cord-005453-4057qib7	2217	16	treatment	treatment	NN
cord-005453-4057qib7	2217	17	initiation	initiation	NN
cord-005453-4057qib7	2217	18	,	,	,
cord-005453-4057qib7	2217	19	only	only	RB
cord-005453-4057qib7	2217	20	two	two	CD
cord-005453-4057qib7	2217	21	patients	patient	NNS
cord-005453-4057qib7	2217	22	presented	present	VBN
cord-005453-4057qib7	2217	23	in	in	IN
cord-005453-4057qib7	2217	24	CR	CR	NNP
cord-005453-4057qib7	2217	25	.	.	.
cord-005453-4057qib7	2218	1	All	all	DT
cord-005453-4057qib7	2218	2	but	but	IN
cord-005453-4057qib7	2218	3	one	one	CD
cord-005453-4057qib7	2218	4	received	receive	VBD
cord-005453-4057qib7	2218	5	sequential	sequential	JJ
cord-005453-4057qib7	2218	6	conditioning	conditioning	NN
cord-005453-4057qib7	2218	7	with	with	IN
cord-005453-4057qib7	2218	8	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	2218	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2218	10	using	use	VBG
cord-005453-4057qib7	2218	11	FLAMSA	FLAMSA	NNP
cord-005453-4057qib7	2218	12	applied	apply	VBD
cord-005453-4057qib7	2218	13	shortly	shortly	RB
cord-005453-4057qib7	2218	14	prior	prior	RB
cord-005453-4057qib7	2218	15	to	to	IN
cord-005453-4057qib7	2218	16	treosulfan	treosulfan	NNP
cord-005453-4057qib7	2218	17	-	-	HYPH
cord-005453-4057qib7	2218	18	based	base	VBN
cord-005453-4057qib7	2218	19	RIC	RIC	NNP
cord-005453-4057qib7	2218	20	(	(	-LRB-
cord-005453-4057qib7	2218	21	10g	10g	NNS
cord-005453-4057qib7	2218	22	/	/	SYM
cord-005453-4057qib7	2218	23	m	m	NN
cord-005453-4057qib7	2218	24	2	2	CD
cord-005453-4057qib7	2218	25	over	over	IN
cord-005453-4057qib7	2218	26	3	3	CD
cord-005453-4057qib7	2218	27	days	day	NNS
cord-005453-4057qib7	2218	28	)	)	-RRB-
cord-005453-4057qib7	2218	29	.	.	.
cord-005453-4057qib7	2219	1	A	a	DT
cord-005453-4057qib7	2219	2	bone	bone	NN
cord-005453-4057qib7	2219	3	marrow	marrow	NN
cord-005453-4057qib7	2219	4	graft	graft	NN
cord-005453-4057qib7	2219	5	was	be	VBD
cord-005453-4057qib7	2219	6	used	use	VBN
cord-005453-4057qib7	2219	7	in	in	IN
cord-005453-4057qib7	2219	8	9/11	9/11	CD
cord-005453-4057qib7	2219	9	patients	patient	NNS
cord-005453-4057qib7	2219	10	.	.	.
cord-005453-4057qib7	2220	1	Post	post	JJ
cord-005453-4057qib7	2220	2	-	-	JJ
cord-005453-4057qib7	2220	3	grafting	graft	VBG
cord-005453-4057qib7	2220	4	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	2220	5	consisted	consist	VBD
cord-005453-4057qib7	2220	6	of	of	IN
cord-005453-4057qib7	2220	7	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2220	8	,	,	,
cord-005453-4057qib7	2220	9	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	2220	10	and	and	CC
cord-005453-4057qib7	2220	11	MMF	mmf	NN
cord-005453-4057qib7	2220	12	.	.	.
cord-005453-4057qib7	2221	1	National	National	NNP
cord-005453-4057qib7	2221	2	Cancer	Cancer	NNP
cord-005453-4057qib7	2221	3	Institute	Institute	NNP
cord-005453-4057qib7	2222	1	Common	common	JJ
cord-005453-4057qib7	2222	2	Terminology	terminology	NN
cord-005453-4057qib7	2222	3	Criteria	Criteria	NNP
cord-005453-4057qib7	2222	4	for	for	IN
cord-005453-4057qib7	2222	5	Adverse	adverse	JJ
cord-005453-4057qib7	2222	6	Events	Events	NNPS
cord-005453-4057qib7	2222	7	version	version	NN
cord-005453-4057qib7	2222	8	3.0	3.0	CD
cord-005453-4057qib7	2222	9	were	be	VBD
cord-005453-4057qib7	2222	10	used	use	VBN
cord-005453-4057qib7	2222	11	for	for	IN
cord-005453-4057qib7	2222	12	nonhematologic	nonhematologic	JJ
cord-005453-4057qib7	2222	13	toxicity	toxicity	NN
cord-005453-4057qib7	2222	14	assessment	assessment	NN
cord-005453-4057qib7	2222	15	starting	start	VBG
cord-005453-4057qib7	2222	16	from	from	IN
cord-005453-4057qib7	2222	17	sequential	sequential	JJ
cord-005453-4057qib7	2222	18	therapy	therapy	NN
cord-005453-4057qib7	2222	19	initiation	initiation	NN
cord-005453-4057qib7	2222	20	or	or	CC
cord-005453-4057qib7	2222	21	conditioning	conditioning	NN
cord-005453-4057qib7	2222	22	until	until	IN
cord-005453-4057qib7	2222	23	day	day	NN
cord-005453-4057qib7	2222	24	+30	+30	CD
cord-005453-4057qib7	2222	25	.	.	.
cord-005453-4057qib7	2223	1	Results	result	NNS
cord-005453-4057qib7	2223	2	:	:	:
cord-005453-4057qib7	2224	1	Median	median	JJ
cord-005453-4057qib7	2224	2	age	age	NN
cord-005453-4057qib7	2224	3	of	of	IN
cord-005453-4057qib7	2224	4	the	the	DT
cord-005453-4057qib7	2224	5	entire	entire	JJ
cord-005453-4057qib7	2224	6	cohort	cohort	NN
cord-005453-4057qib7	2224	7	was	be	VBD
cord-005453-4057qib7	2224	8	63	63	CD
cord-005453-4057qib7	2224	9	years	year	NNS
cord-005453-4057qib7	2225	1	(	(	-LRB-
cord-005453-4057qib7	2225	2	range	range	NN
cord-005453-4057qib7	2225	3	:	:	:
cord-005453-4057qib7	2225	4	58	58	CD
cord-005453-4057qib7	2225	5	-	-	SYM
cord-005453-4057qib7	2225	6	71	71	CD
cord-005453-4057qib7	2225	7	)	)	-RRB-
cord-005453-4057qib7	2225	8	.	.	.
cord-005453-4057qib7	2226	1	The	the	DT
cord-005453-4057qib7	2226	2	HCT	HCT	NNP
cord-005453-4057qib7	2226	3	-	-	HYPH
cord-005453-4057qib7	2226	4	CI	CI	NNP
cord-005453-4057qib7	2226	5	was	be	VBD
cord-005453-4057qib7	2226	6	≥2	≥2	NNP
cord-005453-4057qib7	2226	7	in	in	IN
cord-005453-4057qib7	2226	8	eight	eight	CD
cord-005453-4057qib7	2226	9	pts	pt	NNS
cord-005453-4057qib7	2226	10	(	(	-LRB-
cord-005453-4057qib7	2226	11	median	median	JJ
cord-005453-4057qib7	2226	12	HCT	HCT	NNP
cord-005453-4057qib7	2226	13	-	-	HYPH
cord-005453-4057qib7	2226	14	CI=2	CI=2	NNP
cord-005453-4057qib7	2226	15	,	,	,
cord-005453-4057qib7	2226	16	range	range	NN
cord-005453-4057qib7	2226	17	:	:	:
cord-005453-4057qib7	2226	18	0	0	CD
cord-005453-4057qib7	2226	19	-	-	SYM
cord-005453-4057qib7	2226	20	5	5	CD
cord-005453-4057qib7	2226	21	)	)	-RRB-
cord-005453-4057qib7	2226	22	.	.	.
cord-005453-4057qib7	2227	1	No	no	DT
cord-005453-4057qib7	2227	2	graft	graft	NN
cord-005453-4057qib7	2227	3	rejection	rejection	NN
cord-005453-4057qib7	2227	4	occurred	occur	VBD
cord-005453-4057qib7	2227	5	.	.	.
cord-005453-4057qib7	2228	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	2228	2	and	and	CC
cord-005453-4057qib7	2228	3	platelet	platelet	NN
cord-005453-4057qib7	2228	4	engraftment	engraftment	NN
cord-005453-4057qib7	2228	5	were	be	VBD
cord-005453-4057qib7	2228	6	achieved	achieve	VBN
cord-005453-4057qib7	2228	7	in	in	IN
cord-005453-4057qib7	2228	8	100	100	CD
cord-005453-4057qib7	2228	9	%	%	NN
cord-005453-4057qib7	2228	10	and	and	CC
cord-005453-4057qib7	2228	11	91	91	CD
cord-005453-4057qib7	2228	12	%	%	NN
cord-005453-4057qib7	2228	13	of	of	IN
cord-005453-4057qib7	2228	14	the	the	DT
cord-005453-4057qib7	2228	15	patients	patient	NNS
cord-005453-4057qib7	2228	16	at	at	IN
cord-005453-4057qib7	2228	17	a	a	DT
cord-005453-4057qib7	2228	18	median	median	NN
cord-005453-4057qib7	2228	19	of	of	IN
cord-005453-4057qib7	2228	20	20	20	CD
cord-005453-4057qib7	2228	21	(	(	-LRB-
cord-005453-4057qib7	2228	22	16	16	CD
cord-005453-4057qib7	2228	23	-	-	SYM
cord-005453-4057qib7	2228	24	23	23	CD
cord-005453-4057qib7	2228	25	)	)	-RRB-
cord-005453-4057qib7	2228	26	and	and	CC
cord-005453-4057qib7	2228	27	26.5	26.5	CD
cord-005453-4057qib7	2228	28	(	(	-LRB-
cord-005453-4057qib7	2228	29	13	13	CD
cord-005453-4057qib7	2228	30	-	-	SYM
cord-005453-4057qib7	2228	31	30	30	CD
cord-005453-4057qib7	2228	32	)	)	-RRB-
cord-005453-4057qib7	2228	33	days	day	NNS
cord-005453-4057qib7	2228	34	,	,	,
cord-005453-4057qib7	2228	35	respectively	respectively	RB
cord-005453-4057qib7	2228	36	.	.	.
cord-005453-4057qib7	2229	1	Acute	acute	JJ
cord-005453-4057qib7	2229	2	GvHD	GvHD	NNP
cord-005453-4057qib7	2229	3	grade	grade	NN
cord-005453-4057qib7	2229	4	II	II	NNP
cord-005453-4057qib7	2229	5	-	-	HYPH
cord-005453-4057qib7	2229	6	IV	IV	NNP
cord-005453-4057qib7	2229	7	occurred	occur	VBD
cord-005453-4057qib7	2229	8	in	in	IN
cord-005453-4057qib7	2229	9	18	18	CD
cord-005453-4057qib7	2229	10	%	%	NN
cord-005453-4057qib7	2229	11	of	of	IN
cord-005453-4057qib7	2229	12	the	the	DT
cord-005453-4057qib7	2229	13	patients	patient	NNS
cord-005453-4057qib7	2229	14	,	,	,
cord-005453-4057qib7	2229	15	exclusively	exclusively	RB
cord-005453-4057qib7	2229	16	involving	involve	VBG
cord-005453-4057qib7	2229	17	the	the	DT
cord-005453-4057qib7	2229	18	skin	skin	NN
cord-005453-4057qib7	2229	19	.	.	.
cord-005453-4057qib7	2230	1	No	no	DT
cord-005453-4057qib7	2230	2	one	one	NN
cord-005453-4057qib7	2230	3	developed	develop	VBD
cord-005453-4057qib7	2230	4	severe	severe	JJ
cord-005453-4057qib7	2230	5	(	(	-LRB-
cord-005453-4057qib7	2230	6	°	°	JJ
cord-005453-4057qib7	2230	7	III	III	NNP
cord-005453-4057qib7	2230	8	-	-	HYPH
cord-005453-4057qib7	2230	9	IV	IV	NNP
cord-005453-4057qib7	2230	10	)	)	-RRB-
cord-005453-4057qib7	2230	11	acute	acute	JJ
cord-005453-4057qib7	2230	12	GvHD	GvHD	NNP
cord-005453-4057qib7	2230	13	.	.	.
cord-005453-4057qib7	2231	1	No	no	DT
cord-005453-4057qib7	2231	2	patient	patient	NN
cord-005453-4057qib7	2231	3	died	die	VBD
cord-005453-4057qib7	2231	4	prior	prior	RB
cord-005453-4057qib7	2231	5	to	to	IN
cord-005453-4057qib7	2231	6	haplo	haplo	NNP
cord-005453-4057qib7	2231	7	-	-	HYPH
cord-005453-4057qib7	2231	8	HSCT	HSCT	NNP
cord-005453-4057qib7	2231	9	.	.	.
cord-005453-4057qib7	2232	1	Severe	severe	JJ
cord-005453-4057qib7	2232	2	nonhematologic	nonhematologic	JJ
cord-005453-4057qib7	2232	3	regimen	regimen	NN
cord-005453-4057qib7	2232	4	-	-	HYPH
cord-005453-4057qib7	2232	5	related	relate	VBN
cord-005453-4057qib7	2232	6	toxicities	toxicity	NNS
cord-005453-4057qib7	2232	7	(	(	-LRB-
cord-005453-4057qib7	2232	8	°	°	JJ
cord-005453-4057qib7	2232	9	III	III	NNP
cord-005453-4057qib7	2232	10	-	-	HYPH
cord-005453-4057qib7	2232	11	IV	IV	NNP
cord-005453-4057qib7	2232	12	)	)	-RRB-
cord-005453-4057qib7	2232	13	occurred	occur	VBD
cord-005453-4057qib7	2232	14	in	in	IN
cord-005453-4057qib7	2232	15	2/11	2/11	CD
cord-005453-4057qib7	2232	16	patients	patient	NNS
cord-005453-4057qib7	2232	17	,	,	,
cord-005453-4057qib7	2232	18	predominately	predominately	RB
cord-005453-4057qib7	2232	19	affecting	affect	VBG
cord-005453-4057qib7	2232	20	the	the	DT
cord-005453-4057qib7	2232	21	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	2232	22	tract	tract	NN
cord-005453-4057qib7	2232	23	.	.	.
cord-005453-4057qib7	2233	1	No	no	DT
cord-005453-4057qib7	2233	2	patient	patient	NN
cord-005453-4057qib7	2233	3	suffered	suffer	VBD
cord-005453-4057qib7	2233	4	from	from	IN
cord-005453-4057qib7	2233	5	≥two	≥two	CD
cord-005453-4057qib7	2233	6	III	III	NNP
cord-005453-4057qib7	2233	7	-	-	HYPH
cord-005453-4057qib7	2233	8	IV	IV	NNP
cord-005453-4057qib7	2233	9	°	°	NNS
cord-005453-4057qib7	2233	10	toxicities	toxicity	NNS
cord-005453-4057qib7	2233	11	.	.	.
cord-005453-4057qib7	2234	1	All	all	DT
cord-005453-4057qib7	2234	2	patients	patient	NNS
cord-005453-4057qib7	2234	3	developed	develop	VBD
cord-005453-4057qib7	2234	4	fever	fever	NN
cord-005453-4057qib7	2234	5	during	during	IN
cord-005453-4057qib7	2234	6	treatment	treatment	NN
cord-005453-4057qib7	2234	7	course	course	NN
cord-005453-4057qib7	2234	8	,	,	,
cord-005453-4057qib7	2234	9	four	four	CD
cord-005453-4057qib7	2234	10	with	with	IN
cord-005453-4057qib7	2234	11	positive	positive	JJ
cord-005453-4057qib7	2234	12	blood	blood	NN
cord-005453-4057qib7	2234	13	cultures	culture	NNS
cord-005453-4057qib7	2234	14	.	.	.
cord-005453-4057qib7	2235	1	CMV	CMV	NNP
cord-005453-4057qib7	2235	2	reactivated	reactivate	VBD
cord-005453-4057qib7	2235	3	in	in	IN
cord-005453-4057qib7	2235	4	6/7	6/7	CD
cord-005453-4057qib7	2235	5	patients	patient	NNS
cord-005453-4057qib7	2235	6	at	at	IN
cord-005453-4057qib7	2235	7	risk	risk	NN
cord-005453-4057qib7	2235	8	.	.	.
cord-005453-4057qib7	2236	1	No	no	DT
cord-005453-4057qib7	2236	2	EBV	EBV	NNP
cord-005453-4057qib7	2236	3	reactivation	reactivation	NN
cord-005453-4057qib7	2236	4	or	or	CC
cord-005453-4057qib7	2236	5	PTLD	PTLD	NNP
cord-005453-4057qib7	2236	6	occurred	occur	VBD
cord-005453-4057qib7	2236	7	.	.	.
cord-005453-4057qib7	2237	1	Six	six	CD
cord-005453-4057qib7	2237	2	patients	patient	NNS
cord-005453-4057qib7	2237	3	had	have	VBD
cord-005453-4057qib7	2237	4	clinical	clinical	JJ
cord-005453-4057qib7	2237	5	and	and	CC
cord-005453-4057qib7	2237	6	radiological	radiological	JJ
cord-005453-4057qib7	2237	7	signs	sign	NNS
cord-005453-4057qib7	2237	8	of	of	IN
cord-005453-4057qib7	2237	9	pneumonia	pneumonia	NN
cord-005453-4057qib7	2237	10	(	(	-LRB-
cord-005453-4057qib7	2237	11	probable	probable	JJ
cord-005453-4057qib7	2237	12	invasive	invasive	JJ
cord-005453-4057qib7	2237	13	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	2237	14	)	)	-RRB-
cord-005453-4057qib7	2237	15	without	without	IN
cord-005453-4057qib7	2237	16	detection	detection	NN
cord-005453-4057qib7	2237	17	of	of	IN
cord-005453-4057qib7	2237	18	aspergillus	aspergillus	NN
cord-005453-4057qib7	2237	19	/	/	SYM
cord-005453-4057qib7	2237	20	antigen	antigen	NN
cord-005453-4057qib7	2237	21	in	in	IN
cord-005453-4057qib7	2237	22	the	the	DT
cord-005453-4057qib7	2237	23	bronchoalveolar	bronchoalveolar	NNP
cord-005453-4057qib7	2237	24	lavage	lavage	NN
cord-005453-4057qib7	2237	25	.	.	.
cord-005453-4057qib7	2238	1	CI	CI	NNP
cord-005453-4057qib7	2238	2	of	of	IN
cord-005453-4057qib7	2238	3	NRM	NRM	NNP
cord-005453-4057qib7	2238	4	at	at	IN
cord-005453-4057qib7	2238	5	day	day	NN
cord-005453-4057qib7	2238	6	+180	+180	NNP
cord-005453-4057qib7	2238	7	was	be	VBD
cord-005453-4057qib7	2238	8	0	0	CD
cord-005453-4057qib7	2238	9	%	%	NN
cord-005453-4057qib7	2238	10	.	.	.
cord-005453-4057qib7	2239	1	Four	four	CD
cord-005453-4057qib7	2239	2	patients	patient	NNS
cord-005453-4057qib7	2239	3	relapsed	relapse	VBD
cord-005453-4057qib7	2239	4	within	within	IN
cord-005453-4057qib7	2239	5	the	the	DT
cord-005453-4057qib7	2239	6	first	first	JJ
cord-005453-4057qib7	2239	7	year	year	NN
cord-005453-4057qib7	2239	8	after	after	IN
cord-005453-4057qib7	2239	9	haplo	haplo	NNP
cord-005453-4057qib7	2239	10	-	-	HYPH
cord-005453-4057qib7	2239	11	HSCT	HSCT	NNP
cord-005453-4057qib7	2239	12	,	,	,
cord-005453-4057qib7	2239	13	with	with	IN
cord-005453-4057qib7	2239	14	two	two	CD
cord-005453-4057qib7	2239	15	of	of	IN
cord-005453-4057qib7	2239	16	them	-PRON-	PRP
cord-005453-4057qib7	2239	17	dying	die	VBG
cord-005453-4057qib7	2239	18	due	due	IN
cord-005453-4057qib7	2239	19	to	to	IN
cord-005453-4057qib7	2239	20	relapse	relapse	NN
cord-005453-4057qib7	2239	21	.	.	.
cord-005453-4057qib7	2240	1	At	at	IN
cord-005453-4057qib7	2240	2	last	last	JJ
cord-005453-4057qib7	2240	3	follow	follow	NN
cord-005453-4057qib7	2240	4	-	-	HYPH
cord-005453-4057qib7	2240	5	up	up	NN
cord-005453-4057qib7	2240	6	(	(	-LRB-
cord-005453-4057qib7	2240	7	Dec	Dec	NNP
cord-005453-4057qib7	2240	8	2018	2018	CD
cord-005453-4057qib7	2240	9	)	)	-RRB-
cord-005453-4057qib7	2240	10	9/11	9/11	CD
cord-005453-4057qib7	2240	11	patients	patient	NNS
cord-005453-4057qib7	2240	12	were	be	VBD
cord-005453-4057qib7	2240	13	alive	alive	JJ
cord-005453-4057qib7	2240	14	.	.	.
cord-005453-4057qib7	2241	1	With	with	IN
cord-005453-4057qib7	2241	2	a	a	DT
cord-005453-4057qib7	2241	3	median	median	JJ
cord-005453-4057qib7	2241	4	follow	follow	NN
cord-005453-4057qib7	2241	5	-	-	HYPH
cord-005453-4057qib7	2241	6	up	up	NN
cord-005453-4057qib7	2241	7	of	of	IN
cord-005453-4057qib7	2241	8	5	5	CD
cord-005453-4057qib7	2241	9	months	month	NNS
cord-005453-4057qib7	2241	10	(	(	-LRB-
cord-005453-4057qib7	2241	11	2	2	CD
cord-005453-4057qib7	2241	12	-	-	SYM
cord-005453-4057qib7	2241	13	31	31	CD
cord-005453-4057qib7	2241	14	)	)	-RRB-
cord-005453-4057qib7	2241	15	estimated	estimate	VBD
cord-005453-4057qib7	2241	16	1-year	1-year	CD
cord-005453-4057qib7	2241	17	OS	OS	NNP
cord-005453-4057qib7	2241	18	and	and	CC
cord-005453-4057qib7	2241	19	DFS	DFS	NNP
cord-005453-4057qib7	2241	20	were	be	VBD
cord-005453-4057qib7	2241	21	80	80	CD
cord-005453-4057qib7	2241	22	%	%	NN
cord-005453-4057qib7	2241	23	and	and	CC
cord-005453-4057qib7	2241	24	59	59	CD
cord-005453-4057qib7	2241	25	%	%	NN
cord-005453-4057qib7	2241	26	,	,	,
cord-005453-4057qib7	2241	27	respectively	respectively	RB
cord-005453-4057qib7	2241	28	.	.	.
cord-005453-4057qib7	2242	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2242	2	:	:	:
cord-005453-4057qib7	2243	1	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2243	2	-	-	HYPH
cord-005453-4057qib7	2243	3	based	base	VBN
cord-005453-4057qib7	2243	4	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	2243	5	HLAhaploidentical	hlahaploidentical	JJ
cord-005453-4057qib7	2243	6	allo	allo	NN
cord-005453-4057qib7	2243	7	-	-	HYPH
cord-005453-4057qib7	2243	8	grafting	grafting	NN
cord-005453-4057qib7	2243	9	using	use	VBG
cord-005453-4057qib7	2243	10	PTCY	PTCY	NNP
cord-005453-4057qib7	2243	11	as	as	IN
cord-005453-4057qib7	2243	12	GvHD	GvHD	NNP
cord-005453-4057qib7	2243	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2243	14	in	in	IN
cord-005453-4057qib7	2243	15	HR	HR	NNP
cord-005453-4057qib7	2243	16	MDS	MDS	NNP
cord-005453-4057qib7	2243	17	and	and	CC
cord-005453-4057qib7	2243	18	AML	AML	NNP
cord-005453-4057qib7	2243	19	patients	patient	NNS
cord-005453-4057qib7	2243	20	aged	age	VBN
cord-005453-4057qib7	2243	21	over	over	IN
cord-005453-4057qib7	2243	22	55	55	CD
cord-005453-4057qib7	2243	23	years	year	NNS
cord-005453-4057qib7	2243	24	is	be	VBZ
cord-005453-4057qib7	2243	25	safe	safe	JJ
cord-005453-4057qib7	2243	26	and	and	CC
cord-005453-4057qib7	2243	27	well	well	RB
cord-005453-4057qib7	2243	28	tolerated	tolerate	VBN
cord-005453-4057qib7	2243	29	resulting	result	VBG
cord-005453-4057qib7	2243	30	in	in	IN
cord-005453-4057qib7	2243	31	stable	stable	JJ
cord-005453-4057qib7	2243	32	engraftment	engraftment	NN
cord-005453-4057qib7	2243	33	and	and	CC
cord-005453-4057qib7	2243	34	a	a	DT
cord-005453-4057qib7	2243	35	favorable	favorable	JJ
cord-005453-4057qib7	2243	36	toxicity	toxicity	NN
cord-005453-4057qib7	2243	37	profile	profile	NN
cord-005453-4057qib7	2243	38	.	.	.
cord-005453-4057qib7	2244	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2244	2	preliminary	preliminary	JJ
cord-005453-4057qib7	2244	3	data	datum	NNS
cord-005453-4057qib7	2244	4	further	far	RBR
cord-005453-4057qib7	2244	5	show	show	VBP
cord-005453-4057qib7	2244	6	promising	promising	JJ
cord-005453-4057qib7	2244	7	outcome	outcome	NN
cord-005453-4057qib7	2244	8	with	with	IN
cord-005453-4057qib7	2244	9	low	low	JJ
cord-005453-4057qib7	2244	10	NRM	NRM	NNP
cord-005453-4057qib7	2244	11	,	,	,
cord-005453-4057qib7	2244	12	no	no	DT
cord-005453-4057qib7	2244	13	severe	severe	JJ
cord-005453-4057qib7	2244	14	acute	acute	JJ
cord-005453-4057qib7	2244	15	GvHD	gvhd	NN
cord-005453-4057qib7	2244	16	and	and	CC
cord-005453-4057qib7	2244	17	favorable	favorable	JJ
cord-005453-4057qib7	2244	18	survival	survival	NN
cord-005453-4057qib7	2244	19	offering	offer	VBG
cord-005453-4057qib7	2244	20	an	an	DT
cord-005453-4057qib7	2244	21	attractive	attractive	JJ
cord-005453-4057qib7	2244	22	alternative	alternative	NN
cord-005453-4057qib7	2244	23	in	in	IN
cord-005453-4057qib7	2244	24	RIC	RIC	NNP
cord-005453-4057qib7	2244	25	for	for	IN
cord-005453-4057qib7	2244	26	haplo	haplo	NNP
cord-005453-4057qib7	2244	27	-	-	HYPH
cord-005453-4057qib7	2244	28	HSCT	HSCT	NNP
cord-005453-4057qib7	2244	29	of	of	IN
cord-005453-4057qib7	2244	30	the	the	DT
cord-005453-4057qib7	2244	31	elderly	elderly	JJ
cord-005453-4057qib7	2244	32	.	.	.
cord-005453-4057qib7	2245	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2245	2	:	:	:
cord-005453-4057qib7	2245	3	nothing	nothing	NN
cord-005453-4057qib7	2245	4	to	to	TO
cord-005453-4057qib7	2245	5	declare	declare	VB
cord-005453-4057qib7	2245	6	Comparison	comparison	NN
cord-005453-4057qib7	2245	7	of	of	IN
cord-005453-4057qib7	2245	8	outcomes	outcome	NNS
cord-005453-4057qib7	2245	9	of	of	IN
cord-005453-4057qib7	2245	10	total	total	JJ
cord-005453-4057qib7	2245	11	body	body	NN
cord-005453-4057qib7	2245	12	irradiation	irradiation	NN
cord-005453-4057qib7	2245	13	(	(	-LRB-
cord-005453-4057qib7	2245	14	TBI	TBI	NNP
cord-005453-4057qib7	2245	15	)	)	-RRB-
cord-005453-4057qib7	2245	16	vs	vs	IN
cord-005453-4057qib7	2245	17	non	non	JJ
cord-005453-4057qib7	2245	18	-	-	JJ
cord-005453-4057qib7	2245	19	TBI	tbi	JJ
cord-005453-4057qib7	2245	20	conditioning	conditioning	NN
cord-005453-4057qib7	2245	21	regimens	regimen	NNS
cord-005453-4057qib7	2245	22	in	in	IN
cord-005453-4057qib7	2245	23	acute	acute	JJ
cord-005453-4057qib7	2245	24	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	2245	25	leukemia	leukemia	NN
cord-005453-4057qib7	2245	26	for	for	IN
cord-005453-4057qib7	2245	27	allogeneic	allogeneic	NN
cord-005453-4057qib7	2245	28	transplantation	transplantation	NN
cord-005453-4057qib7	2245	29	Background	background	NN
cord-005453-4057qib7	2245	30	:	:	:
cord-005453-4057qib7	2246	1	In	in	IN
cord-005453-4057qib7	2246	2	adult	adult	NN
cord-005453-4057qib7	2246	3	patients	patient	NNS
cord-005453-4057qib7	2246	4	diagnosed	diagnose	VBD
cord-005453-4057qib7	2246	5	acute	acute	JJ
cord-005453-4057qib7	2246	6	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	2246	7	leukemia	leukemia	NN
cord-005453-4057qib7	2246	8	(	(	-LRB-
cord-005453-4057qib7	2246	9	ALL	all	DT
cord-005453-4057qib7	2246	10	)	)	-RRB-
cord-005453-4057qib7	2246	11	long	long	JJ
cord-005453-4057qib7	2246	12	-	-	HYPH
cord-005453-4057qib7	2246	13	term	term	NN
cord-005453-4057qib7	2246	14	results	result	NNS
cord-005453-4057qib7	2246	15	are	be	VBP
cord-005453-4057qib7	2246	16	poor	poor	JJ
cord-005453-4057qib7	2246	17	with	with	IN
cord-005453-4057qib7	2246	18	intensive	intensive	JJ
cord-005453-4057qib7	2246	19	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2246	20	.	.	.
cord-005453-4057qib7	2247	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	2247	2	stem	stem	VB
cord-005453-4057qib7	2247	3	stem	stem	NN
cord-005453-4057qib7	2247	4	cell	cell	NN
cord-005453-4057qib7	2247	5	transplantation	transplantation	NN
cord-005453-4057qib7	2247	6	is	be	VBZ
cord-005453-4057qib7	2247	7	the	the	DT
cord-005453-4057qib7	2247	8	potential	potential	JJ
cord-005453-4057qib7	2247	9	treatment	treatment	NN
cord-005453-4057qib7	2247	10	that	that	WDT
cord-005453-4057qib7	2247	11	provides	provide	VBZ
cord-005453-4057qib7	2247	12	cure	cure	NN
cord-005453-4057qib7	2247	13	for	for	IN
cord-005453-4057qib7	2247	14	these	these	DT
cord-005453-4057qib7	2247	15	patients	patient	NNS
cord-005453-4057qib7	2247	16	.	.	.
cord-005453-4057qib7	2248	1	Myeloablative	myeloablative	JJ
cord-005453-4057qib7	2248	2	preparation	preparation	NN
cord-005453-4057qib7	2248	3	regimens	regimen	NNS
cord-005453-4057qib7	2248	4	include	include	VBP
cord-005453-4057qib7	2248	5	total	total	JJ
cord-005453-4057qib7	2248	6	body	body	NN
cord-005453-4057qib7	2248	7	irradiation	irradiation	NN
cord-005453-4057qib7	2248	8	(	(	-LRB-
cord-005453-4057qib7	2248	9	TBİ)+	TBİ)+	NNP
cord-005453-4057qib7	2248	10	cyclophosphamide(Cy	cyclophosphamide(Cy	NNP
cord-005453-4057qib7	2248	11	)	)	-RRB-
cord-005453-4057qib7	2248	12	and	and	CC
cord-005453-4057qib7	2248	13	busulfan	busulfan	NN
cord-005453-4057qib7	2248	14	+	+	CC
cord-005453-4057qib7	2248	15	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	2248	16	.	.	.
cord-005453-4057qib7	2249	1	In	in	IN
cord-005453-4057qib7	2249	2	adult	adult	NN
cord-005453-4057qib7	2249	3	ALL	all	DT
cord-005453-4057qib7	2249	4	patients	patient	NNS
cord-005453-4057qib7	2249	5	WBI	WBI	NNP
cord-005453-4057qib7	2249	6	/	/	SYM
cord-005453-4057qib7	2249	7	Cy	Cy	NNP
cord-005453-4057qib7	2249	8	widely	widely	RB
cord-005453-4057qib7	2249	9	used	use	VBD
cord-005453-4057qib7	2249	10	,	,	,
cord-005453-4057qib7	2249	11	but	but	CC
cord-005453-4057qib7	2249	12	the	the	DT
cord-005453-4057qib7	2249	13	toxicity	toxicity	NN
cord-005453-4057qib7	2249	14	rate	rate	NN
cord-005453-4057qib7	2249	15	is	be	VBZ
cord-005453-4057qib7	2249	16	higher	high	JJR
cord-005453-4057qib7	2249	17	.	.	.
cord-005453-4057qib7	2250	1	The	the	DT
cord-005453-4057qib7	2250	2	aim	aim	NN
cord-005453-4057qib7	2250	3	of	of	IN
cord-005453-4057qib7	2250	4	this	this	DT
cord-005453-4057qib7	2250	5	study	study	NN
cord-005453-4057qib7	2250	6	is	be	VBZ
cord-005453-4057qib7	2250	7	to	to	TO
cord-005453-4057qib7	2250	8	compare	compare	VB
cord-005453-4057qib7	2250	9	the	the	DT
cord-005453-4057qib7	2250	10	result	result	NN
cord-005453-4057qib7	2250	11	and	and	CC
cord-005453-4057qib7	2250	12	effect	effect	NN
cord-005453-4057qib7	2250	13	of	of	IN
cord-005453-4057qib7	2250	14	the	the	DT
cord-005453-4057qib7	2250	15	TBI	TBI	NNP
cord-005453-4057qib7	2250	16	/	/	SYM
cord-005453-4057qib7	2250	17	Cy	Cy	NNP
cord-005453-4057qib7	2250	18	and	and	CC
cord-005453-4057qib7	2250	19	busulfan	busulfan	NNP
cord-005453-4057qib7	2250	20	/	/	SYM
cord-005453-4057qib7	2250	21	Cy	Cy	NNP
cord-005453-4057qib7	2250	22	regimens	regimen	NNS
cord-005453-4057qib7	2250	23	in	in	IN
cord-005453-4057qib7	2250	24	Allogenic	Allogenic	NNP
cord-005453-4057qib7	2250	25	bone	bone	NN
cord-005453-4057qib7	2250	26	marrow	marrow	NN
cord-005453-4057qib7	2250	27	transplantation	transplantation	NN
cord-005453-4057qib7	2250	28	in	in	IN
cord-005453-4057qib7	2250	29	ALL	all	DT
cord-005453-4057qib7	2250	30	patients	patient	NNS
cord-005453-4057qib7	2250	31	.	.	.
cord-005453-4057qib7	2251	1	Methods	method	NNS
cord-005453-4057qib7	2251	2	:	:	:
cord-005453-4057qib7	2252	1	Between	between	IN
cord-005453-4057qib7	2252	2	1993	1993	CD
cord-005453-4057qib7	2252	3	-2018	-2018	NNS
cord-005453-4057qib7	2252	4	there	there	EX
cord-005453-4057qib7	2252	5	were	be	VBD
cord-005453-4057qib7	2252	6	137	137	CD
cord-005453-4057qib7	2252	7	ALL	all	DT
cord-005453-4057qib7	2252	8	patients	patient	NNS
cord-005453-4057qib7	2252	9	who	who	WP
cord-005453-4057qib7	2252	10	underwent	undergo	VBD
cord-005453-4057qib7	2252	11	transplantation	transplantation	NN
cord-005453-4057qib7	2252	12	using	use	VBG
cord-005453-4057qib7	2252	13	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2252	14	preparation	preparation	NN
cord-005453-4057qib7	2252	15	regimen	regimen	NN
cord-005453-4057qib7	2252	16	with	with	IN
cord-005453-4057qib7	2252	17	or	or	CC
cord-005453-4057qib7	2252	18	without	without	IN
cord-005453-4057qib7	2252	19	addition	addition	NN
cord-005453-4057qib7	2252	20	TBI	TBI	NNP
cord-005453-4057qib7	2252	21	in	in	IN
cord-005453-4057qib7	2252	22	the	the	DT
cord-005453-4057qib7	2252	23	adult	adult	NN
cord-005453-4057qib7	2252	24	bone	bone	NN
cord-005453-4057qib7	2252	25	marrow	marrow	NN
cord-005453-4057qib7	2252	26	transplantation	transplantation	NN
cord-005453-4057qib7	2252	27	units	unit	NNS
cord-005453-4057qib7	2252	28	of	of	IN
cord-005453-4057qib7	2252	29	Medipol	Medipol	NNP
cord-005453-4057qib7	2252	30	Medical	Medical	NNP
cord-005453-4057qib7	2252	31	Faculty	Faculty	NNP
cord-005453-4057qib7	2252	32	,	,	,
cord-005453-4057qib7	2252	33	Istanbul	Istanbul	NNP
cord-005453-4057qib7	2252	34	University	University	NNP
cord-005453-4057qib7	2252	35	Istanbul	Istanbul	NNP
cord-005453-4057qib7	2252	36	Medical	Medical	NNP
cord-005453-4057qib7	2252	37	Faculty	Faculty	NNP
cord-005453-4057qib7	2252	38	,	,	,
cord-005453-4057qib7	2252	39	Sisli	Sisli	NNP
cord-005453-4057qib7	2252	40	Florence	Florence	NNP
cord-005453-4057qib7	2252	41	Nightingale	Nightingale	NNP
cord-005453-4057qib7	2252	42	Hospital	Hospital	NNP
cord-005453-4057qib7	2252	43	,	,	,
cord-005453-4057qib7	2252	44	Atakent	Atakent	NNP
cord-005453-4057qib7	2252	45	Acıbadem	Acıbadem	NNP
cord-005453-4057qib7	2252	46	Hospital	Hospital	NNP
cord-005453-4057qib7	2252	47	adult	adult	NN
cord-005453-4057qib7	2252	48	bone	bone	NN
cord-005453-4057qib7	2252	49	marrow	marrow	NN
cord-005453-4057qib7	2252	50	units	unit	NNS
cord-005453-4057qib7	2252	51	.	.	.
cord-005453-4057qib7	2253	1	We	-PRON-	PRP
cord-005453-4057qib7	2253	2	analyzed	analyze	VBD
cord-005453-4057qib7	2253	3	overall	overall	JJ
cord-005453-4057qib7	2253	4	survival	survival	NN
cord-005453-4057qib7	2253	5	(	(	-LRB-
cord-005453-4057qib7	2253	6	OS	OS	NNP
cord-005453-4057qib7	2253	7	)	)	-RRB-
cord-005453-4057qib7	2253	8	,	,	,
cord-005453-4057qib7	2253	9	progression	progression	NN
cord-005453-4057qib7	2253	10	free	free	JJ
cord-005453-4057qib7	2253	11	survival	survival	NN
cord-005453-4057qib7	2253	12	(	(	-LRB-
cord-005453-4057qib7	2253	13	PFS	PFS	NNP
cord-005453-4057qib7	2253	14	)	)	-RRB-
cord-005453-4057qib7	2253	15	,	,	,
cord-005453-4057qib7	2253	16	veno	veno	NNP
cord-005453-4057qib7	2253	17	occlusive	occlusive	NNP
cord-005453-4057qib7	2253	18	disease	disease	NN
cord-005453-4057qib7	2253	19	,	,	,
cord-005453-4057qib7	2253	20	acute	acute	JJ
cord-005453-4057qib7	2253	21	and	and	CC
cord-005453-4057qib7	2253	22	chronic	chronic	JJ
cord-005453-4057qib7	2253	23	graft	graft	NN
cord-005453-4057qib7	2253	24	versus	versus	IN
cord-005453-4057qib7	2253	25	disease	disease	NN
cord-005453-4057qib7	2253	26	development	development	NN
cord-005453-4057qib7	2253	27	rates	rate	NNS
cord-005453-4057qib7	2253	28	in	in	IN
cord-005453-4057qib7	2253	29	these	these	DT
cord-005453-4057qib7	2253	30	patients	patient	NNS
cord-005453-4057qib7	2253	31	.	.	.
cord-005453-4057qib7	2254	1	Results	result	NNS
cord-005453-4057qib7	2254	2	:	:	:
cord-005453-4057qib7	2255	1	Demographic	demographic	JJ
cord-005453-4057qib7	2255	2	characteristics	characteristic	NNS
cord-005453-4057qib7	2255	3	of	of	IN
cord-005453-4057qib7	2255	4	patients	patient	NNS
cord-005453-4057qib7	2255	5	summarized	summarize	VBN
cord-005453-4057qib7	2255	6	in	in	IN
cord-005453-4057qib7	2255	7	table	table	NN
cord-005453-4057qib7	2255	8	-1	-1	.
cord-005453-4057qib7	2256	1	There	there	EX
cord-005453-4057qib7	2256	2	was	be	VBD
cord-005453-4057qib7	2256	3	no	no	DT
cord-005453-4057qib7	2256	4	significant	significant	JJ
cord-005453-4057qib7	2256	5	difference	difference	NN
cord-005453-4057qib7	2256	6	between	between	IN
cord-005453-4057qib7	2256	7	groups	group	NNS
cord-005453-4057qib7	2256	8	in	in	IN
cord-005453-4057qib7	2256	9	donor	donor	NN
cord-005453-4057qib7	2256	10	age	age	NN
cord-005453-4057qib7	2256	11	,	,	,
cord-005453-4057qib7	2256	12	gender	gender	NN
cord-005453-4057qib7	2256	13	,	,	,
cord-005453-4057qib7	2256	14	stem	stem	NN
cord-005453-4057qib7	2256	15	cell	cell	NN
cord-005453-4057qib7	2256	16	source	source	NN
cord-005453-4057qib7	2256	17	.	.	.
cord-005453-4057qib7	2257	1	It	-PRON-	PRP
cord-005453-4057qib7	2257	2	was	be	VBD
cord-005453-4057qib7	2257	3	observed	observe	VBN
cord-005453-4057qib7	2257	4	that	that	IN
cord-005453-4057qib7	2257	5	the	the	DT
cord-005453-4057qib7	2257	6	relapse	relapse	NN
cord-005453-4057qib7	2257	7	rate	rate	NN
cord-005453-4057qib7	2257	8	was	be	VBD
cord-005453-4057qib7	2257	9	not	not	RB
cord-005453-4057qib7	2257	10	statistically	statistically	RB
cord-005453-4057qib7	2257	11	significant	significant	JJ
cord-005453-4057qib7	2257	12	in	in	IN
cord-005453-4057qib7	2257	13	both	both	DT
cord-005453-4057qib7	2257	14	group	group	NN
cord-005453-4057qib7	2257	15	.	.	.
cord-005453-4057qib7	2258	1	There	there	EX
cord-005453-4057qib7	2258	2	was	be	VBD
cord-005453-4057qib7	2258	3	no	no	DT
cord-005453-4057qib7	2258	4	statistically	statistically	RB
cord-005453-4057qib7	2258	5	significant	significant	JJ
cord-005453-4057qib7	2258	6	difference	difference	NN
cord-005453-4057qib7	2258	7	between	between	IN
cord-005453-4057qib7	2258	8	the	the	DT
cord-005453-4057qib7	2258	9	patients	patient	NNS
cord-005453-4057qib7	2258	10	who	who	WP
cord-005453-4057qib7	2258	11	underwent	undergo	VBD
cord-005453-4057qib7	2258	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2258	13	regimen	regimen	NN
cord-005453-4057qib7	2258	14	and	and	CC
cord-005453-4057qib7	2258	15	myeloablative	myeloablative	NNP
cord-005453-4057qib7	2258	16	regimen	regimen	NN
cord-005453-4057qib7	2258	17	with	with	IN
cord-005453-4057qib7	2258	18	TBI	TBI	NNP
cord-005453-4057qib7	2258	19	in	in	IN
cord-005453-4057qib7	2258	20	relaps	relap	NNS
cord-005453-4057qib7	2258	21	,	,	,
cord-005453-4057qib7	2258	22	death	death	NN
cord-005453-4057qib7	2258	23	,	,	,
cord-005453-4057qib7	2258	24	OS	OS	NNP
cord-005453-4057qib7	2258	25	,	,	,
cord-005453-4057qib7	2258	26	PFS	PFS	NNP
cord-005453-4057qib7	2258	27	.	.	.
cord-005453-4057qib7	2259	1	(	(	-LRB-
cord-005453-4057qib7	2259	2	figure-1	figure-1	NNP
cord-005453-4057qib7	2259	3	)	)	-RRB-
cord-005453-4057qib7	2260	1	[	[	-LRB-
cord-005453-4057qib7	2260	2	[	[	-LRB-
cord-005453-4057qib7	2260	3	P117	P117	NNP
cord-005453-4057qib7	2260	4	Image	image	NN
cord-005453-4057qib7	2260	5	]	]	-RRB-
cord-005453-4057qib7	2260	6	1	1	CD
cord-005453-4057qib7	2260	7	.	.	.
cord-005453-4057qib7	2261	1	Figure	figure	NN
cord-005453-4057qib7	2261	2	1	1	CD
cord-005453-4057qib7	2261	3	]	]	-RRB-
cord-005453-4057qib7	2262	1	In	in	IN
cord-005453-4057qib7	2262	2	terms	term	NNS
cord-005453-4057qib7	2262	3	of	of	IN
cord-005453-4057qib7	2262	4	transplant	transplant	NN
cord-005453-4057qib7	2262	5	complications	complication	NNS
cord-005453-4057qib7	2262	6	there	there	EX
cord-005453-4057qib7	2262	7	was	be	VBD
cord-005453-4057qib7	2262	8	also	also	RB
cord-005453-4057qib7	2262	9	no	no	DT
cord-005453-4057qib7	2262	10	respectable	respectable	JJ
cord-005453-4057qib7	2262	11	difference	difference	NN
cord-005453-4057qib7	2262	12	in	in	IN
cord-005453-4057qib7	2262	13	development	development	NN
cord-005453-4057qib7	2262	14	of	of	IN
cord-005453-4057qib7	2262	15	VOD	VOD	NNP
cord-005453-4057qib7	2262	16	and	and	CC
cord-005453-4057qib7	2262	17	acute	acute	JJ
cord-005453-4057qib7	2262	18	and	and	CC
cord-005453-4057qib7	2262	19	chronic	chronic	JJ
cord-005453-4057qib7	2262	20	graft	graft	NN
cord-005453-4057qib7	2262	21	versus	versus	IN
cord-005453-4057qib7	2262	22	disease	disease	NN
cord-005453-4057qib7	2262	23	but	but	CC
cord-005453-4057qib7	2262	24	VOD	VOD	NNP
cord-005453-4057qib7	2262	25	was	be	VBD
cord-005453-4057qib7	2262	26	more	more	RBR
cord-005453-4057qib7	2262	27	common	common	JJ
cord-005453-4057qib7	2262	28	in	in	IN
cord-005453-4057qib7	2262	29	the	the	DT
cord-005453-4057qib7	2262	30	group	group	NN
cord-005453-4057qib7	2262	31	that	that	WDT
cord-005453-4057qib7	2262	32	did	do	VBD
cord-005453-4057qib7	2262	33	not	not	RB
cord-005453-4057qib7	2262	34	use	use	VB
cord-005453-4057qib7	2262	35	TBI	TBI	NNP
cord-005453-4057qib7	2262	36	(	(	-LRB-
cord-005453-4057qib7	2262	37	P	p	NN
cord-005453-4057qib7	2262	38	:	:	:
cord-005453-4057qib7	2262	39	0.068	0.068	CD
cord-005453-4057qib7	2262	40	)	)	-RRB-
cord-005453-4057qib7	2263	1	(	(	-LRB-
cord-005453-4057qib7	2263	2	Conclusions	conclusion	NNS
cord-005453-4057qib7	2263	3	:	:	:
cord-005453-4057qib7	2264	1	Although	although	IN
cord-005453-4057qib7	2264	2	there	there	EX
cord-005453-4057qib7	2264	3	are	be	VBP
cord-005453-4057qib7	2264	4	contradictory	contradictory	JJ
cord-005453-4057qib7	2264	5	data	datum	NNS
cord-005453-4057qib7	2264	6	in	in	IN
cord-005453-4057qib7	2264	7	the	the	DT
cord-005453-4057qib7	2264	8	literature	literature	NN
cord-005453-4057qib7	2264	9	,	,	,
cord-005453-4057qib7	2264	10	in	in	IN
cord-005453-4057qib7	2264	11	our	-PRON-	PRP$
cord-005453-4057qib7	2264	12	multicentre	multicentre	NNP
cord-005453-4057qib7	2264	13	study	study	NN
cord-005453-4057qib7	2264	14	,	,	,
cord-005453-4057qib7	2264	15	it	-PRON-	PRP
cord-005453-4057qib7	2264	16	was	be	VBD
cord-005453-4057qib7	2264	17	revealed	reveal	VBN
cord-005453-4057qib7	2264	18	that	that	IN
cord-005453-4057qib7	2264	19	the	the	DT
cord-005453-4057qib7	2264	20	addition	addition	NN
cord-005453-4057qib7	2264	21	of	of	IN
cord-005453-4057qib7	2264	22	TBI	TBI	NNP
cord-005453-4057qib7	2264	23	in	in	IN
cord-005453-4057qib7	2264	24	the	the	DT
cord-005453-4057qib7	2264	25	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2264	26	preparation	preparation	NN
cord-005453-4057qib7	2264	27	regimen	regimen	NN
cord-005453-4057qib7	2264	28	compared	compare	VBN
cord-005453-4057qib7	2264	29	with	with	IN
cord-005453-4057qib7	2264	30	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2264	31	preparation	preparation	NN
cord-005453-4057qib7	2264	32	regimen	regimen	NN
cord-005453-4057qib7	2264	33	alone	alone	RB
cord-005453-4057qib7	2264	34	did	do	VBD
cord-005453-4057qib7	2264	35	not	not	RB
cord-005453-4057qib7	2264	36	have	have	VB
cord-005453-4057qib7	2264	37	a	a	DT
cord-005453-4057qib7	2264	38	positive	positive	JJ
cord-005453-4057qib7	2264	39	or	or	CC
cord-005453-4057qib7	2264	40	negative	negative	JJ
cord-005453-4057qib7	2264	41	effect	effect	NN
cord-005453-4057qib7	2264	42	on	on	IN
cord-005453-4057qib7	2264	43	overall	overall	JJ
cord-005453-4057qib7	2264	44	survival	survival	NN
cord-005453-4057qib7	2264	45	.	.	.
cord-005453-4057qib7	2265	1	We	-PRON-	PRP
cord-005453-4057qib7	2265	2	think	think	VBP
cord-005453-4057qib7	2265	3	that	that	IN
cord-005453-4057qib7	2265	4	if	if	IN
cord-005453-4057qib7	2265	5	we	-PRON-	PRP
cord-005453-4057qib7	2265	6	can	can	MD
cord-005453-4057qib7	2265	7	prepare	prepare	VB
cord-005453-4057qib7	2265	8	a	a	DT
cord-005453-4057qib7	2265	9	good	good	JJ
cord-005453-4057qib7	2265	10	VOD	VOD	NNP
cord-005453-4057qib7	2265	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2265	12	approches	approches	NN
cord-005453-4057qib7	2265	13	,	,	,
cord-005453-4057qib7	2265	14	we	-PRON-	PRP
cord-005453-4057qib7	2265	15	can	can	MD
cord-005453-4057qib7	2265	16	give	give	VB
cord-005453-4057qib7	2265	17	up	up	RP
cord-005453-4057qib7	2265	18	TBI	TBI	NNP
cord-005453-4057qib7	2265	19	in	in	IN
cord-005453-4057qib7	2265	20	future	future	NN
cord-005453-4057qib7	2265	21	.	.	.
cord-005453-4057qib7	2266	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2266	2	(	(	-LRB-
cord-005453-4057qib7	2266	3	n=3	n=3	NN
cord-005453-4057qib7	2266	4	)	)	-RRB-
cord-005453-4057qib7	2266	5	.	.	.
cord-005453-4057qib7	2267	1	For	for	IN
cord-005453-4057qib7	2267	2	GVHD	GVHD	NNP
cord-005453-4057qib7	2267	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2267	4	,	,	,
cord-005453-4057qib7	2267	5	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	2267	6	A	A	NNP
cord-005453-4057qib7	2267	7	was	be	VBD
cord-005453-4057qib7	2267	8	given	give	VBN
cord-005453-4057qib7	2267	9	either	either	CC
cord-005453-4057qib7	2267	10	alone	alone	JJ
cord-005453-4057qib7	2267	11	(	(	-LRB-
cord-005453-4057qib7	2267	12	n=21	n=21	NNP
cord-005453-4057qib7	2267	13	)	)	-RRB-
cord-005453-4057qib7	2267	14	,	,	,
cord-005453-4057qib7	2267	15	with	with	IN
cord-005453-4057qib7	2267	16	MMF	MMF	NNP
cord-005453-4057qib7	2267	17	(	(	-LRB-
cord-005453-4057qib7	2267	18	n=13	n=13	NNP
cord-005453-4057qib7	2267	19	)	)	-RRB-
cord-005453-4057qib7	2267	20	or	or	CC
cord-005453-4057qib7	2267	21	with	with	IN
cord-005453-4057qib7	2267	22	methotrexate	methotrexate	NNP
cord-005453-4057qib7	2267	23	(	(	-LRB-
cord-005453-4057qib7	2267	24	n=1	n=1	NNP
cord-005453-4057qib7	2267	25	)	)	-RRB-
cord-005453-4057qib7	2267	26	.	.	.
cord-005453-4057qib7	2268	1	The	the	DT
cord-005453-4057qib7	2268	2	graft	graft	NN
cord-005453-4057qib7	2268	3	source	source	NN
cord-005453-4057qib7	2268	4	was	be	VBD
cord-005453-4057qib7	2268	5	bone	bone	NN
cord-005453-4057qib7	2268	6	marrow	marrow	NN
cord-005453-4057qib7	2268	7	(	(	-LRB-
cord-005453-4057qib7	2268	8	BM	BM	NNP
cord-005453-4057qib7	2268	9	)	)	-RRB-
cord-005453-4057qib7	2268	10	in	in	IN
cord-005453-4057qib7	2268	11	most	most	JJS
cord-005453-4057qib7	2268	12	cases	case	NNS
cord-005453-4057qib7	2268	13	(	(	-LRB-
cord-005453-4057qib7	2268	14	n=31	n=31	NNP
cord-005453-4057qib7	2268	15	)	)	-RRB-
cord-005453-4057qib7	2268	16	,	,	,
cord-005453-4057qib7	2268	17	PBSC	PBSC	NNP
cord-005453-4057qib7	2268	18	in	in	IN
cord-005453-4057qib7	2268	19	seven	seven	CD
cord-005453-4057qib7	2268	20	cases	case	NNS
cord-005453-4057qib7	2268	21	,	,	,
cord-005453-4057qib7	2268	22	matched	match	VBN
cord-005453-4057qib7	2268	23	sibling	sibling	NN
cord-005453-4057qib7	2268	24	cord	cord	NN
cord-005453-4057qib7	2268	25	+	+	CC
cord-005453-4057qib7	2268	26	BM	bm	NN
cord-005453-4057qib7	2268	27	in	in	IN
cord-005453-4057qib7	2268	28	two	two	CD
cord-005453-4057qib7	2268	29	cases	case	NNS
cord-005453-4057qib7	2268	30	and	and	CC
cord-005453-4057qib7	2268	31	one	one	CD
cord-005453-4057qib7	2268	32	matched	match	VBN
cord-005453-4057qib7	2268	33	related	related	JJ
cord-005453-4057qib7	2268	34	cord	cord	NN
cord-005453-4057qib7	2268	35	.	.	.
cord-005453-4057qib7	2269	1	Twentyfive	Twentyfive	NNP
cord-005453-4057qib7	2269	2	of	of	IN
cord-005453-4057qib7	2269	3	the	the	DT
cord-005453-4057qib7	2269	4	donors	donor	NNS
cord-005453-4057qib7	2269	5	were	be	VBD
cord-005453-4057qib7	2269	6	family	family	NN
cord-005453-4057qib7	2269	7	donors	donor	NNS
cord-005453-4057qib7	2269	8	and	and	CC
cord-005453-4057qib7	2269	9	ten	ten	CD
cord-005453-4057qib7	2269	10	were	be	VBD
cord-005453-4057qib7	2269	11	unrelated	unrelated	JJ
cord-005453-4057qib7	2269	12	.	.	.
cord-005453-4057qib7	2270	1	Twenty	twenty	CD
cord-005453-4057qib7	2270	2	-	-	HYPH
cord-005453-4057qib7	2270	3	nine	nine	CD
cord-005453-4057qib7	2270	4	of	of	IN
cord-005453-4057qib7	2270	5	the	the	DT
cord-005453-4057qib7	2270	6	donors	donor	NNS
cord-005453-4057qib7	2270	7	were	be	VBD
cord-005453-4057qib7	2270	8	10/10	10/10	CD
cord-005453-4057qib7	2270	9	HLA	HLA	NNP
cord-005453-4057qib7	2270	10	matched	match	VBN
cord-005453-4057qib7	2270	11	,	,	,
cord-005453-4057qib7	2270	12	six	six	CD
cord-005453-4057qib7	2270	13	were	be	VBD
cord-005453-4057qib7	2270	14	9/10	9/10	CD
cord-005453-4057qib7	2270	15	mismatched	mismatched	JJ
cord-005453-4057qib7	2270	16	and	and	CC
cord-005453-4057qib7	2270	17	one	one	CD
cord-005453-4057qib7	2270	18	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2270	19	.	.	.
cord-005453-4057qib7	2271	1	Four	four	CD
cord-005453-4057qib7	2271	2	patients	patient	NNS
cord-005453-4057qib7	2271	3	had	have	VBD
cord-005453-4057qib7	2271	4	engraftment	engraftment	NN
cord-005453-4057qib7	2271	5	failure	failure	NN
cord-005453-4057qib7	2271	6	and	and	CC
cord-005453-4057qib7	2271	7	required	require	VBD
cord-005453-4057qib7	2271	8	a	a	DT
cord-005453-4057qib7	2271	9	second	second	JJ
cord-005453-4057qib7	2271	10	transplant	transplant	NN
cord-005453-4057qib7	2271	11	,	,	,
cord-005453-4057qib7	2271	12	two	two	CD
cord-005453-4057qib7	2271	13	of	of	IN
cord-005453-4057qib7	2271	14	them	-PRON-	PRP
cord-005453-4057qib7	2271	15	were	be	VBD
cord-005453-4057qib7	2271	16	re	re	VBN
cord-005453-4057qib7	2271	17	-	-	VBN
cord-005453-4057qib7	2271	18	transplanted	transplant	VBN
cord-005453-4057qib7	2271	19	with	with	IN
cord-005453-4057qib7	2271	20	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2271	21	and	and	CC
cord-005453-4057qib7	2271	22	TBI	TBI	NNP
cord-005453-4057qib7	2271	23	,	,	,
cord-005453-4057qib7	2271	24	one	one	CD
cord-005453-4057qib7	2271	25	with	with	IN
cord-005453-4057qib7	2271	26	fludarabine	fludarabine	NN
cord-005453-4057qib7	2271	27	,	,	,
cord-005453-4057qib7	2271	28	busulfan	busulfan	NN
cord-005453-4057qib7	2271	29	and	and	CC
cord-005453-4057qib7	2271	30	campath	campath	NN
cord-005453-4057qib7	2271	31	,	,	,
cord-005453-4057qib7	2271	32	and	and	CC
cord-005453-4057qib7	2271	33	one	one	CD
cord-005453-4057qib7	2271	34	with	with	IN
cord-005453-4057qib7	2271	35	no	no	DT
cord-005453-4057qib7	2271	36	conditioning	conditioning	NN
cord-005453-4057qib7	2271	37	.	.	.
cord-005453-4057qib7	2272	1	Thirty	thirty	CD
cord-005453-4057qib7	2272	2	of	of	IN
cord-005453-4057qib7	2272	3	the	the	DT
cord-005453-4057qib7	2272	4	35	35	CD
cord-005453-4057qib7	2272	5	patients	patient	NNS
cord-005453-4057qib7	2272	6	are	be	VBP
cord-005453-4057qib7	2272	7	alive	alive	JJ
cord-005453-4057qib7	2272	8	(	(	-LRB-
cord-005453-4057qib7	2272	9	86	86	CD
cord-005453-4057qib7	2272	10	%	%	NN
cord-005453-4057qib7	2272	11	)	)	-RRB-
cord-005453-4057qib7	2272	12	.	.	.
cord-005453-4057qib7	2273	1	Four	four	CD
cord-005453-4057qib7	2273	2	patients	patient	NNS
cord-005453-4057qib7	2273	3	died	die	VBD
cord-005453-4057qib7	2273	4	of	of	IN
cord-005453-4057qib7	2273	5	transplant	transplant	NN
cord-005453-4057qib7	2273	6	complications	complication	NNS
cord-005453-4057qib7	2273	7	and	and	CC
cord-005453-4057qib7	2273	8	one	one	CD
cord-005453-4057qib7	2273	9	died	die	VBD
cord-005453-4057qib7	2273	10	of	of	IN
cord-005453-4057qib7	2273	11	metastatic	metastatic	JJ
cord-005453-4057qib7	2273	12	squamous	squamous	JJ
cord-005453-4057qib7	2273	13	cell	cell	NN
cord-005453-4057qib7	2273	14	carcinoma	carcinoma	NN
cord-005453-4057qib7	2273	15	.	.	.
cord-005453-4057qib7	2274	1	Eight	eight	CD
cord-005453-4057qib7	2274	2	survivors	survivor	NNS
cord-005453-4057qib7	2274	3	are	be	VBP
cord-005453-4057qib7	2274	4	mixed	mixed	JJ
cord-005453-4057qib7	2274	5	chimeras	chimera	NNS
cord-005453-4057qib7	2274	6	(	(	-LRB-
cord-005453-4057qib7	2274	7	81%-94	81%-94	CD
cord-005453-4057qib7	2274	8	%	%	NN
cord-005453-4057qib7	2274	9	donor	donor	NN
cord-005453-4057qib7	2274	10	)	)	-RRB-
cord-005453-4057qib7	2274	11	and	and	CC
cord-005453-4057qib7	2274	12	are	be	VBP
cord-005453-4057qib7	2274	13	all	all	DT
cord-005453-4057qib7	2274	14	doing	do	VBG
cord-005453-4057qib7	2274	15	well	well	RB
cord-005453-4057qib7	2274	16	,	,	,
cord-005453-4057qib7	2274	17	none	none	NN
cord-005453-4057qib7	2274	18	of	of	IN
cord-005453-4057qib7	2274	19	them	-PRON-	PRP
cord-005453-4057qib7	2274	20	developed	develop	VBD
cord-005453-4057qib7	2274	21	any	any	DT
cord-005453-4057qib7	2274	22	GVHD	GVHD	NNP
cord-005453-4057qib7	2274	23	.	.	.
cord-005453-4057qib7	2275	1	Nine	nine	CD
cord-005453-4057qib7	2275	2	patients	patient	NNS
cord-005453-4057qib7	2275	3	developed	develop	VBD
cord-005453-4057qib7	2275	4	acute	acute	JJ
cord-005453-4057qib7	2275	5	GVHD	GVHD	NNP
cord-005453-4057qib7	2275	6	,	,	,
cord-005453-4057qib7	2275	7	four	four	CD
cord-005453-4057qib7	2275	8	of	of	IN
cord-005453-4057qib7	2275	9	them	-PRON-	PRP
cord-005453-4057qib7	2275	10	with	with	IN
cord-005453-4057qib7	2275	11	grade	grade	NN
cord-005453-4057qib7	2275	12	3	3	CD
cord-005453-4057qib7	2275	13	-	-	SYM
cord-005453-4057qib7	2275	14	4	4	CD
cord-005453-4057qib7	2275	15	.	.	.
cord-005453-4057qib7	2276	1	Seven	seven	CD
cord-005453-4057qib7	2276	2	of	of	IN
cord-005453-4057qib7	2276	3	these	these	DT
cord-005453-4057qib7	2276	4	patients	patient	NNS
cord-005453-4057qib7	2276	5	later	later	RB
cord-005453-4057qib7	2276	6	developed	develop	VBD
cord-005453-4057qib7	2276	7	chronic	chronic	JJ
cord-005453-4057qib7	2276	8	GVHD	GVHD	NNP
cord-005453-4057qib7	2276	9	,	,	,
cord-005453-4057qib7	2276	10	two	two	CD
cord-005453-4057qib7	2276	11	of	of	IN
cord-005453-4057qib7	2276	12	them	-PRON-	PRP
cord-005453-4057qib7	2276	13	have	have	VBP
cord-005453-4057qib7	2276	14	extensive	extensive	JJ
cord-005453-4057qib7	2276	15	disease	disease	NN
cord-005453-4057qib7	2276	16	.	.	.
cord-005453-4057qib7	2277	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2277	2	:	:	:
cord-005453-4057qib7	2278	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2278	2	results	result	NNS
cord-005453-4057qib7	2278	3	show	show	VBP
cord-005453-4057qib7	2278	4	a	a	DT
cord-005453-4057qib7	2278	5	high	high	JJ
cord-005453-4057qib7	2278	6	survival	survival	NN
cord-005453-4057qib7	2278	7	rate	rate	NN
cord-005453-4057qib7	2278	8	of	of	IN
cord-005453-4057qib7	2278	9	86	86	CD
cord-005453-4057qib7	2278	10	%	%	NN
cord-005453-4057qib7	2278	11	,	,	,
cord-005453-4057qib7	2278	12	with	with	IN
cord-005453-4057qib7	2278	13	a	a	DT
cord-005453-4057qib7	2278	14	low	low	JJ
cord-005453-4057qib7	2278	15	rate	rate	NN
cord-005453-4057qib7	2278	16	of	of	IN
cord-005453-4057qib7	2278	17	engraftment	engraftment	NN
cord-005453-4057qib7	2278	18	failure	failure	NN
cord-005453-4057qib7	2278	19	and	and	CC
cord-005453-4057qib7	2278	20	reasonable	reasonable	JJ
cord-005453-4057qib7	2278	21	rates	rate	NNS
cord-005453-4057qib7	2278	22	of	of	IN
cord-005453-4057qib7	2278	23	GVHD	GVHD	NNP
cord-005453-4057qib7	2278	24	.	.	.
cord-005453-4057qib7	2279	1	Only	only	RB
cord-005453-4057qib7	2279	2	one	one	CD
cord-005453-4057qib7	2279	3	of	of	IN
cord-005453-4057qib7	2279	4	our	-PRON-	PRP$
cord-005453-4057qib7	2279	5	patients	patient	NNS
cord-005453-4057qib7	2279	6	died	die	VBD
cord-005453-4057qib7	2279	7	of	of	IN
cord-005453-4057qib7	2279	8	late	late	JJ
cord-005453-4057qib7	2279	9	effects	effect	NNS
cord-005453-4057qib7	2279	10	of	of	IN
cord-005453-4057qib7	2279	11	HSCT	HSCT	NNP
cord-005453-4057qib7	2279	12	for	for	IN
cord-005453-4057qib7	2279	13	FA	FA	NNP
cord-005453-4057qib7	2279	14	.	.	.
cord-005453-4057qib7	2280	1	Mixed	mixed	JJ
cord-005453-4057qib7	2280	2	chimerism	chimerism	NN
cord-005453-4057qib7	2280	3	does	do	VBZ
cord-005453-4057qib7	2280	4	not	not	RB
cord-005453-4057qib7	2280	5	seem	seem	VB
cord-005453-4057qib7	2280	6	to	to	TO
cord-005453-4057qib7	2280	7	present	present	VB
cord-005453-4057qib7	2280	8	a	a	DT
cord-005453-4057qib7	2280	9	problem	problem	NN
cord-005453-4057qib7	2280	10	.	.	.
cord-005453-4057qib7	2281	1	We	-PRON-	PRP
cord-005453-4057qib7	2281	2	conclude	conclude	VBP
cord-005453-4057qib7	2281	3	that	that	IN
cord-005453-4057qib7	2281	4	reduced	reduce	VBN
cord-005453-4057qib7	2281	5	intensity	intensity	NN
cord-005453-4057qib7	2281	6	fludarabine	fludarabine	NN
cord-005453-4057qib7	2281	7	based	base	VBN
cord-005453-4057qib7	2281	8	conditioning	conditioning	NN
cord-005453-4057qib7	2281	9	regimens	regimen	NNS
cord-005453-4057qib7	2281	10	are	be	VBP
cord-005453-4057qib7	2281	11	a	a	DT
cord-005453-4057qib7	2281	12	good	good	JJ
cord-005453-4057qib7	2281	13	treatment	treatment	NN
cord-005453-4057qib7	2281	14	option	option	NN
cord-005453-4057qib7	2281	15	for	for	IN
cord-005453-4057qib7	2281	16	patients	patient	NNS
cord-005453-4057qib7	2281	17	with	with	IN
cord-005453-4057qib7	2281	18	Fanconi	Fanconi	NNP
cord-005453-4057qib7	2281	19	anemia	anemia	NN
cord-005453-4057qib7	2281	20	undergoing	undergo	VBG
cord-005453-4057qib7	2281	21	HSCT	HSCT	NNP
cord-005453-4057qib7	2281	22	.	.	.
cord-005453-4057qib7	2282	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2282	2	:	:	:
cord-005453-4057qib7	2282	3	Nothing	nothing	NN
cord-005453-4057qib7	2282	4	to	to	TO
cord-005453-4057qib7	2282	5	declare	declare	VB
cord-005453-4057qib7	2282	6	Total	total	JJ
cord-005453-4057qib7	2282	7	marrow	marrow	NN
cord-005453-4057qib7	2282	8	irradiation	irradiation	NN
cord-005453-4057qib7	2282	9	+	+	CC
cord-005453-4057qib7	2282	10	bendamustine	bendamustine	NN
cord-005453-4057qib7	2282	11	as	as	IN
cord-005453-4057qib7	2282	12	reducedtoxicity	reducedtoxicity	NNP
cord-005453-4057qib7	2282	13	myeloablative	myeloablative	NNP
cord-005453-4057qib7	2282	14	conditioning	conditioning	NN
cord-005453-4057qib7	2282	15	prior	prior	RB
cord-005453-4057qib7	2282	16	to	to	IN
cord-005453-4057qib7	2282	17	allohsct	allohsct	NNP
cord-005453-4057qib7	2282	18	for	for	IN
cord-005453-4057qib7	2282	19	younger	young	JJR
cord-005453-4057qib7	2282	20	patients	patient	NNS
cord-005453-4057qib7	2282	21	with	with	IN
cord-005453-4057qib7	2282	22	multiple	multiple	JJ
cord-005453-4057qib7	2282	23	myeloma	myeloma	NN
cord-005453-4057qib7	2282	24	Background	background	NN
cord-005453-4057qib7	2282	25	:	:	:
cord-005453-4057qib7	2283	1	The	the	DT
cord-005453-4057qib7	2283	2	prognosis	prognosis	NN
cord-005453-4057qib7	2283	3	of	of	IN
cord-005453-4057qib7	2283	4	patients	patient	NNS
cord-005453-4057qib7	2283	5	with	with	IN
cord-005453-4057qib7	2283	6	multiple	multiple	JJ
cord-005453-4057qib7	2283	7	myeloma	myeloma	NN
cord-005453-4057qib7	2283	8	(	(	-LRB-
cord-005453-4057qib7	2283	9	MM	MM	NNP
cord-005453-4057qib7	2283	10	)	)	-RRB-
cord-005453-4057qib7	2283	11	has	have	VBZ
cord-005453-4057qib7	2283	12	improved	improve	VBN
cord-005453-4057qib7	2283	13	markedly	markedly	RB
cord-005453-4057qib7	2283	14	over	over	IN
cord-005453-4057qib7	2283	15	the	the	DT
cord-005453-4057qib7	2283	16	last	last	JJ
cord-005453-4057qib7	2283	17	two	two	CD
cord-005453-4057qib7	2283	18	decades	decade	NNS
cord-005453-4057qib7	2283	19	.	.	.
cord-005453-4057qib7	2284	1	Despite	despite	IN
cord-005453-4057qib7	2284	2	that	that	DT
cord-005453-4057qib7	2284	3	,	,	,
cord-005453-4057qib7	2284	4	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2284	5	remains	remain	VBZ
cord-005453-4057qib7	2284	6	the	the	DT
cord-005453-4057qib7	2284	7	only	only	JJ
cord-005453-4057qib7	2284	8	treatment	treatment	NN
cord-005453-4057qib7	2284	9	option	option	NN
cord-005453-4057qib7	2284	10	with	with	IN
cord-005453-4057qib7	2284	11	curative	curative	JJ
cord-005453-4057qib7	2284	12	potential	potential	NN
cord-005453-4057qib7	2284	13	.	.	.
cord-005453-4057qib7	2285	1	However	however	RB
cord-005453-4057qib7	2285	2	,	,	,
cord-005453-4057qib7	2285	3	its	-PRON-	PRP$
cord-005453-4057qib7	2285	4	use	use	NN
cord-005453-4057qib7	2285	5	is	be	VBZ
cord-005453-4057qib7	2285	6	limited	limit	VBN
cord-005453-4057qib7	2285	7	due	due	IN
cord-005453-4057qib7	2285	8	to	to	IN
cord-005453-4057qib7	2285	9	high	high	JJ
cord-005453-4057qib7	2285	10	incidence	incidence	NN
cord-005453-4057qib7	2285	11	of	of	IN
cord-005453-4057qib7	2285	12	non	non	JJ
cord-005453-4057qib7	2285	13	-	-	JJ
cord-005453-4057qib7	2285	14	relapse	relapse	JJ
cord-005453-4057qib7	2285	15	mortality	mortality	NN
cord-005453-4057qib7	2285	16	(	(	-LRB-
cord-005453-4057qib7	2285	17	NRM	NRM	NNP
cord-005453-4057qib7	2285	18	)	)	-RRB-
cord-005453-4057qib7	2285	19	after	after	IN
cord-005453-4057qib7	2285	20	myeloablative	myeloablative	NNP
cord-005453-4057qib7	2285	21	conditioning	conditioning	NN
cord-005453-4057qib7	2285	22	while	while	IN
cord-005453-4057qib7	2285	23	insufficient	insufficient	JJ
cord-005453-4057qib7	2285	24	efficacy	efficacy	NN
cord-005453-4057qib7	2285	25	of	of	IN
cord-005453-4057qib7	2285	26	reduced	reduce	VBN
cord-005453-4057qib7	2285	27	-	-	HYPH
cord-005453-4057qib7	2285	28	intensity	intensity	NN
cord-005453-4057qib7	2285	29	regimens	regimen	NNS
cord-005453-4057qib7	2285	30	.	.	.
cord-005453-4057qib7	2286	1	We	-PRON-	PRP
cord-005453-4057qib7	2286	2	developed	develop	VBD
cord-005453-4057qib7	2286	3	a	a	DT
cord-005453-4057qib7	2286	4	new	new	JJ
cord-005453-4057qib7	2286	5	protocol	protocol	NN
cord-005453-4057qib7	2286	6	characterized	characterize	VBN
cord-005453-4057qib7	2286	7	by	by	IN
cord-005453-4057qib7	2286	8	reduced	reduce	VBN
cord-005453-4057qib7	2286	9	toxicity	toxicity	NN
cord-005453-4057qib7	2286	10	while	while	IN
cord-005453-4057qib7	2286	11	preserved	preserve	VBD
cord-005453-4057qib7	2286	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2286	13	potential	potential	NN
cord-005453-4057qib7	2286	14	,	,	,
cord-005453-4057qib7	2286	15	based	base	VBN
cord-005453-4057qib7	2286	16	on	on	IN
cord-005453-4057qib7	2286	17	the	the	DT
cord-005453-4057qib7	2286	18	use	use	NN
cord-005453-4057qib7	2286	19	of	of	IN
cord-005453-4057qib7	2286	20	total	total	JJ
cord-005453-4057qib7	2286	21	marrow	marrow	NN
cord-005453-4057qib7	2286	22	irradiation	irradiation	NN
cord-005453-4057qib7	2286	23	(	(	-LRB-
cord-005453-4057qib7	2286	24	TMI	TMI	NNP
cord-005453-4057qib7	2286	25	)	)	-RRB-
cord-005453-4057qib7	2286	26	in	in	IN
cord-005453-4057qib7	2286	27	combination	combination	NN
cord-005453-4057qib7	2286	28	with	with	IN
cord-005453-4057qib7	2286	29	bendamustine	bendamustine	NNP
cord-005453-4057qib7	2286	30	.	.	.
cord-005453-4057qib7	2287	1	The	the	DT
cord-005453-4057qib7	2287	2	aim	aim	NN
cord-005453-4057qib7	2287	3	of	of	IN
cord-005453-4057qib7	2287	4	this	this	DT
cord-005453-4057qib7	2287	5	study	study	NN
cord-005453-4057qib7	2287	6	was	be	VBD
cord-005453-4057qib7	2287	7	to	to	TO
cord-005453-4057qib7	2287	8	evaluate	evaluate	VB
cord-005453-4057qib7	2287	9	its	-PRON-	PRP$
cord-005453-4057qib7	2287	10	safety	safety	NN
cord-005453-4057qib7	2287	11	and	and	CC
cord-005453-4057qib7	2287	12	efficacy	efficacy	NN
cord-005453-4057qib7	2287	13	in	in	IN
cord-005453-4057qib7	2287	14	a	a	DT
cord-005453-4057qib7	2287	15	singlecenter	singlecenter	JJ
cord-005453-4057qib7	2287	16	experience	experience	NN
cord-005453-4057qib7	2287	17	.	.	.
cord-005453-4057qib7	2288	1	Methods	method	NNS
cord-005453-4057qib7	2288	2	:	:	:
cord-005453-4057qib7	2288	3	Between	between	IN
cord-005453-4057qib7	2288	4	years	year	NNS
cord-005453-4057qib7	2288	5	2013	2013	CD
cord-005453-4057qib7	2288	6	-	-	SYM
cord-005453-4057qib7	2288	7	2018	2018	CD
cord-005453-4057qib7	2288	8	,	,	,
cord-005453-4057qib7	2288	9	MM	MM	NNP
cord-005453-4057qib7	2288	10	patients	patient	NNS
cord-005453-4057qib7	2288	11	below	below	IN
cord-005453-4057qib7	2288	12	55	55	CD
cord-005453-4057qib7	2288	13	years	year	NNS
cord-005453-4057qib7	2288	14	old	old	JJ
cord-005453-4057qib7	2288	15	were	be	VBD
cord-005453-4057qib7	2288	16	offered	offer	VBN
cord-005453-4057qib7	2288	17	tandem	tandem	JJ
cord-005453-4057qib7	2288	18	auto	auto	NN
cord-005453-4057qib7	2288	19	-	-	HYPH
cord-005453-4057qib7	2288	20	alloHSCT	allohsct	NN
cord-005453-4057qib7	2288	21	as	as	IN
cord-005453-4057qib7	2288	22	part	part	NN
cord-005453-4057qib7	2288	23	of	of	IN
cord-005453-4057qib7	2288	24	first	first	JJ
cord-005453-4057qib7	2288	25	-	-	HYPH
cord-005453-4057qib7	2288	26	line	line	NN
cord-005453-4057qib7	2288	27	therapy	therapy	NN
cord-005453-4057qib7	2288	28	.	.	.
cord-005453-4057qib7	2289	1	The	the	DT
cord-005453-4057qib7	2289	2	decision	decision	NN
cord-005453-4057qib7	2289	3	was	be	VBD
cord-005453-4057qib7	2289	4	based	base	VBN
cord-005453-4057qib7	2289	5	on	on	IN
cord-005453-4057qib7	2289	6	individual	individual	JJ
cord-005453-4057qib7	2289	7	patient	patient	NN
cord-005453-4057qib7	2289	8	preferences	preference	NNS
cord-005453-4057qib7	2289	9	after	after	IN
cord-005453-4057qib7	2289	10	detailed	detailed	JJ
cord-005453-4057qib7	2289	11	description	description	NN
cord-005453-4057qib7	2289	12	of	of	IN
cord-005453-4057qib7	2289	13	potential	potential	JJ
cord-005453-4057qib7	2289	14	risks	risk	NNS
cord-005453-4057qib7	2289	15	.	.	.
cord-005453-4057qib7	2290	1	AutoHSCT	AutoHSCT	NNP
cord-005453-4057qib7	2290	2	was	be	VBD
cord-005453-4057qib7	2290	3	preceded	precede	VBN
cord-005453-4057qib7	2290	4	by	by	IN
cord-005453-4057qib7	2290	5	melphalan	melphalan	NNP
cord-005453-4057qib7	2291	1	200	200	CD
cord-005453-4057qib7	2291	2	mg	mg	NNP
cord-005453-4057qib7	2291	3	/	/	SYM
cord-005453-4057qib7	2291	4	m	m	NNP
cord-005453-4057qib7	2291	5	2	2	CD
cord-005453-4057qib7	2291	6	iv	iv	CD
cord-005453-4057qib7	2291	7	.	.	.
cord-005453-4057qib7	2292	1	The	the	DT
cord-005453-4057qib7	2292	2	conditioning	conditioning	NN
cord-005453-4057qib7	2292	3	prior	prior	RB
cord-005453-4057qib7	2292	4	to	to	IN
cord-005453-4057qib7	2292	5	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2292	6	consisted	consisted	NNP
cord-005453-4057qib7	2292	7	of	of	IN
cord-005453-4057qib7	2292	8	TMI	TMI	NNP
cord-005453-4057qib7	2292	9	performed	perform	VBN
cord-005453-4057qib7	2292	10	using	use	VBG
cord-005453-4057qib7	2292	11	helical	helical	JJ
cord-005453-4057qib7	2292	12	tomotherapy	tomotherapy	NN
cord-005453-4057qib7	2292	13	at	at	IN
cord-005453-4057qib7	2292	14	the	the	DT
cord-005453-4057qib7	2292	15	dose	dose	NN
cord-005453-4057qib7	2292	16	of	of	IN
cord-005453-4057qib7	2292	17	4	4	CD
cord-005453-4057qib7	2292	18	Gy	Gy	NNP
cord-005453-4057qib7	2292	19	/	/	SYM
cord-005453-4057qib7	2292	20	d	d	NN
cord-005453-4057qib7	2292	21	on	on	IN
cord-005453-4057qib7	2292	22	days	day	NNS
cord-005453-4057qib7	2292	23	-3	-3	NNP
cord-005453-4057qib7	2292	24	,	,	,
cord-005453-4057qib7	2292	25	-2	-2	NNP
cord-005453-4057qib7	2292	26	,	,	,
cord-005453-4057qib7	2292	27	-1	-1	NNP
cord-005453-4057qib7	2292	28	(	(	-LRB-
cord-005453-4057qib7	2292	29	total	total	JJ
cord-005453-4057qib7	2292	30	12	12	CD
cord-005453-4057qib7	2292	31	Gy	Gy	NNP
cord-005453-4057qib7	2292	32	)	)	-RRB-
cord-005453-4057qib7	2292	33	and	and	CC
cord-005453-4057qib7	2292	34	bendamustine	bendamustine	NNP
cord-005453-4057qib7	2292	35	140	140	CD
cord-005453-4057qib7	2292	36	-	-	SYM
cord-005453-4057qib7	2292	37	220	220	CD
cord-005453-4057qib7	2292	38	mg	mg	NNP
cord-005453-4057qib7	2292	39	/	/	SYM
cord-005453-4057qib7	2292	40	m2	m2	NNP
cord-005453-4057qib7	2292	41	/	/	SYM
cord-005453-4057qib7	2292	42	d	d	NNP
cord-005453-4057qib7	2293	1	iv	iv	LS
cord-005453-4057qib7	2293	2	.	.	.
cord-005453-4057qib7	2294	1	on	on	IN
cord-005453-4057qib7	2294	2	days	day	NNS
cord-005453-4057qib7	2294	3	-5	-5	NNP
cord-005453-4057qib7	2294	4	,	,	,
cord-005453-4057qib7	2294	5	-4	-4	NNP
cord-005453-4057qib7	2294	6	(	(	-LRB-
cord-005453-4057qib7	2294	7	total	total	JJ
cord-005453-4057qib7	2294	8	280	280	CD
cord-005453-4057qib7	2294	9	-	-	SYM
cord-005453-4057qib7	2294	10	440	440	CD
cord-005453-4057qib7	2294	11	mg	mg	NNP
cord-005453-4057qib7	2294	12	/	/	SYM
cord-005453-4057qib7	2294	13	m2	m2	NNP
cord-005453-4057qib7	2294	14	)	)	-RRB-
cord-005453-4057qib7	2294	15	.	.	.
cord-005453-4057qib7	2295	1	The	the	DT
cord-005453-4057qib7	2295	2	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	2295	3	therapy	therapy	NN
cord-005453-4057qib7	2295	4	consisted	consist	VBD
cord-005453-4057qib7	2295	5	of	of	IN
cord-005453-4057qib7	2295	6	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	2295	7	+	+	CC
cord-005453-4057qib7	2295	8	methotrexate	methotrexate	NN
cord-005453-4057qib7	2295	9	+	+	.
cord-005453-4057qib7	2296	1	/-ATG	/-ATG	NNP
cord-005453-4057qib7	2296	2	.	.	.
cord-005453-4057qib7	2297	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	2297	2	blood	blood	NN
cord-005453-4057qib7	2297	3	was	be	VBD
cord-005453-4057qib7	2297	4	used	use	VBN
cord-005453-4057qib7	2297	5	as	as	IN
cord-005453-4057qib7	2297	6	a	a	DT
cord-005453-4057qib7	2297	7	source	source	NN
cord-005453-4057qib7	2297	8	of	of	IN
cord-005453-4057qib7	2297	9	stem	stem	NN
cord-005453-4057qib7	2297	10	cells	cell	NNS
cord-005453-4057qib7	2297	11	.	.	.
cord-005453-4057qib7	2298	1	Results	result	NNS
cord-005453-4057qib7	2298	2	:	:	:
cord-005453-4057qib7	2299	1	The	the	DT
cord-005453-4057qib7	2299	2	analysis	analysis	NN
cord-005453-4057qib7	2299	3	included	include	VBD
cord-005453-4057qib7	2299	4	18	18	CD
cord-005453-4057qib7	2299	5	patients	patient	NNS
cord-005453-4057qib7	2299	6	(	(	-LRB-
cord-005453-4057qib7	2299	7	women	woman	NNS
cord-005453-4057qib7	2299	8	-9	-9	ADD
cord-005453-4057qib7	2299	9	,	,	,
cord-005453-4057qib7	2299	10	men	man	NNS
cord-005453-4057qib7	2299	11	-9	-9	ADD
cord-005453-4057qib7	2299	12	)	)	-RRB-
cord-005453-4057qib7	2299	13	.	.	.
cord-005453-4057qib7	2300	1	The	the	DT
cord-005453-4057qib7	2300	2	median	median	JJ
cord-005453-4057qib7	2300	3	follow	follow	NN
cord-005453-4057qib7	2300	4	-	-	HYPH
cord-005453-4057qib7	2300	5	up	up	NN
cord-005453-4057qib7	2300	6	was	be	VBD
cord-005453-4057qib7	2300	7	28	28	CD
cord-005453-4057qib7	2300	8	(	(	-LRB-
cord-005453-4057qib7	2300	9	4	4	CD
cord-005453-4057qib7	2300	10	-	-	SYM
cord-005453-4057qib7	2300	11	68	68	CD
cord-005453-4057qib7	2300	12	)	)	-RRB-
cord-005453-4057qib7	2300	13	months	month	NNS
cord-005453-4057qib7	2300	14	.	.	.
cord-005453-4057qib7	2301	1	The	the	DT
cord-005453-4057qib7	2301	2	median	median	JJ
cord-005453-4057qib7	2301	3	age	age	NN
cord-005453-4057qib7	2301	4	at	at	IN
cord-005453-4057qib7	2301	5	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2301	6	was	be	VBD
cord-005453-4057qib7	2301	7	44	44	CD
cord-005453-4057qib7	2301	8	(	(	-LRB-
cord-005453-4057qib7	2301	9	26	26	CD
cord-005453-4057qib7	2301	10	-53	-53	NNP
cord-005453-4057qib7	2301	11	)	)	-RRB-
cord-005453-4057qib7	2301	12	years	year	NNS
cord-005453-4057qib7	2301	13	.	.	.
cord-005453-4057qib7	2302	1	The	the	DT
cord-005453-4057qib7	2302	2	disease	disease	NN
cord-005453-4057qib7	2302	3	stage	stage	NN
cord-005453-4057qib7	2302	4	before	before	IN
cord-005453-4057qib7	2302	5	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2302	6	was	be	VBD
cord-005453-4057qib7	2302	7	as	as	IN
cord-005453-4057qib7	2302	8	follows	follow	VBZ
cord-005453-4057qib7	2302	9	:	:	:
cord-005453-4057qib7	2303	1	CR-6	CR-6	NNP
cord-005453-4057qib7	2303	2	,	,	,
cord-005453-4057qib7	2303	3	VGPR-4	VGPR-4	NNP
cord-005453-4057qib7	2303	4	,	,	,
cord-005453-4057qib7	2303	5	PR-6	PR-6	NNP
cord-005453-4057qib7	2303	6	.	.	.
cord-005453-4057qib7	2304	1	Patients	patient	NNS
cord-005453-4057qib7	2304	2	were	be	VBD
cord-005453-4057qib7	2304	3	treated	treat	VBN
cord-005453-4057qib7	2304	4	with	with	IN
cord-005453-4057qib7	2304	5	HSCT	HSCT	NNP
cord-005453-4057qib7	2304	6	from	from	IN
cord-005453-4057qib7	2304	7	either	either	CC
cord-005453-4057qib7	2304	8	HLAmatched	hlamatche	VBN
cord-005453-4057qib7	2304	9	siblings	sibling	NNS
cord-005453-4057qib7	2304	10	(	(	-LRB-
cord-005453-4057qib7	2304	11	n=7	n=7	NNS
cord-005453-4057qib7	2304	12	)	)	-RRB-
cord-005453-4057qib7	2304	13	or	or	CC
cord-005453-4057qib7	2304	14	unrelated	unrelated	JJ
cord-005453-4057qib7	2304	15	donors	donor	NNS
cord-005453-4057qib7	2304	16	(	(	-LRB-
cord-005453-4057qib7	2304	17	n=11	n=11	NNP
cord-005453-4057qib7	2304	18	)	)	-RRB-
cord-005453-4057qib7	2304	19	.	.	.
cord-005453-4057qib7	2305	1	The	the	DT
cord-005453-4057qib7	2305	2	interval	interval	NN
cord-005453-4057qib7	2305	3	between	between	IN
cord-005453-4057qib7	2305	4	autoHSCT	autohsct	NN
cord-005453-4057qib7	2305	5	and	and	CC
cord-005453-4057qib7	2305	6	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2305	7	was	be	VBD
cord-005453-4057qib7	2305	8	5	5	CD
cord-005453-4057qib7	2305	9	(	(	-LRB-
cord-005453-4057qib7	2305	10	4	4	CD
cord-005453-4057qib7	2305	11	-	-	SYM
cord-005453-4057qib7	2305	12	23	23	CD
cord-005453-4057qib7	2305	13	)	)	-RRB-
cord-005453-4057qib7	2305	14	months	month	NNS
cord-005453-4057qib7	2305	15	.	.	.
cord-005453-4057qib7	2306	1	All	all	DT
cord-005453-4057qib7	2306	2	patients	patient	NNS
cord-005453-4057qib7	2306	3	engrafted	engraft	VBN
cord-005453-4057qib7	2306	4	after	after	IN
cord-005453-4057qib7	2306	5	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2306	6	with	with	IN
cord-005453-4057qib7	2306	7	median	median	JJ
cord-005453-4057qib7	2306	8	time	time	NN
cord-005453-4057qib7	2306	9	of	of	IN
cord-005453-4057qib7	2306	10	neutrophil	neutrophil	NN
cord-005453-4057qib7	2306	11	and	and	CC
cord-005453-4057qib7	2306	12	platelet	platelet	NN
cord-005453-4057qib7	2306	13	recovery	recovery	NN
cord-005453-4057qib7	2306	14	of	of	IN
cord-005453-4057qib7	2306	15	14	14	CD
cord-005453-4057qib7	2306	16	and	and	CC
cord-005453-4057qib7	2306	17	12	12	CD
cord-005453-4057qib7	2306	18	days	day	NNS
cord-005453-4057qib7	2306	19	,	,	,
cord-005453-4057qib7	2306	20	respectively	respectively	RB
cord-005453-4057qib7	2306	21	.	.	.
cord-005453-4057qib7	2307	1	One	one	CD
cord-005453-4057qib7	2307	2	patient	patient	NN
cord-005453-4057qib7	2307	3	(	(	-LRB-
cord-005453-4057qib7	2307	4	6	6	CD
cord-005453-4057qib7	2307	5	%	%	NN
cord-005453-4057qib7	2307	6	)	)	-RRB-
cord-005453-4057qib7	2307	7	experienced	experienced	JJ
cord-005453-4057qib7	2307	8	grade	grade	NN
cord-005453-4057qib7	2307	9	2	2	CD
cord-005453-4057qib7	2307	10	acute	acute	JJ
cord-005453-4057qib7	2307	11	GvHD	gvhd	NN
cord-005453-4057qib7	2307	12	,	,	,
cord-005453-4057qib7	2307	13	while	while	IN
cord-005453-4057qib7	2307	14	there	there	EX
cord-005453-4057qib7	2307	15	were	be	VBD
cord-005453-4057qib7	2307	16	no	no	DT
cord-005453-4057qib7	2307	17	cases	case	NNS
cord-005453-4057qib7	2307	18	of	of	IN
cord-005453-4057qib7	2307	19	grade	grade	NN
cord-005453-4057qib7	2307	20	3	3	CD
cord-005453-4057qib7	2307	21	-	-	SYM
cord-005453-4057qib7	2307	22	4	4	CD
cord-005453-4057qib7	2307	23	acute	acute	JJ
cord-005453-4057qib7	2307	24	GvHD	GvHD	NNP
cord-005453-4057qib7	2307	25	.	.	.
cord-005453-4057qib7	2308	1	The	the	DT
cord-005453-4057qib7	2308	2	incidence	incidence	NN
cord-005453-4057qib7	2308	3	of	of	IN
cord-005453-4057qib7	2308	4	mild	mild	JJ
cord-005453-4057qib7	2308	5	,	,	,
cord-005453-4057qib7	2308	6	moderate	moderate	JJ
cord-005453-4057qib7	2308	7	and	and	CC
cord-005453-4057qib7	2308	8	severe	severe	JJ
cord-005453-4057qib7	2308	9	chronic	chronic	JJ
cord-005453-4057qib7	2308	10	GvHD	gvhd	NN
cord-005453-4057qib7	2308	11	was	be	VBD
cord-005453-4057qib7	2308	12	17	17	CD
cord-005453-4057qib7	2308	13	%	%	NN
cord-005453-4057qib7	2308	14	,	,	,
cord-005453-4057qib7	2308	15	0	0	CD
cord-005453-4057qib7	2308	16	%	%	NN
cord-005453-4057qib7	2308	17	and	and	CC
cord-005453-4057qib7	2308	18	6	6	CD
cord-005453-4057qib7	2308	19	%	%	NN
cord-005453-4057qib7	2308	20	,	,	,
cord-005453-4057qib7	2308	21	respectively	respectively	RB
cord-005453-4057qib7	2308	22	.	.	.
cord-005453-4057qib7	2309	1	The	the	DT
cord-005453-4057qib7	2309	2	rate	rate	NN
cord-005453-4057qib7	2309	3	of	of	IN
cord-005453-4057qib7	2309	4	grade	grade	NN
cord-005453-4057qib7	2309	5	3	3	CD
cord-005453-4057qib7	2309	6	non	non	JJ
cord-005453-4057qib7	2309	7	-	-	JJ
cord-005453-4057qib7	2309	8	hematological	hematological	JJ
cord-005453-4057qib7	2309	9	toxicities	toxicity	NNS
cord-005453-4057qib7	2309	10	was	be	VBD
cord-005453-4057qib7	2309	11	11	11	CD
cord-005453-4057qib7	2309	12	%	%	NN
cord-005453-4057qib7	2309	13	.	.	.
cord-005453-4057qib7	2310	1	One	one	CD
cord-005453-4057qib7	2310	2	patient	patient	NN
cord-005453-4057qib7	2310	3	died	die	VBD
cord-005453-4057qib7	2310	4	of	of	IN
cord-005453-4057qib7	2310	5	late	late	JJ
cord-005453-4057qib7	2310	6	bacterial	bacterial	JJ
cord-005453-4057qib7	2310	7	infection	infection	NN
cord-005453-4057qib7	2310	8	.	.	.
cord-005453-4057qib7	2311	1	The	the	DT
cord-005453-4057qib7	2311	2	incidence	incidence	NN
cord-005453-4057qib7	2311	3	of	of	IN
cord-005453-4057qib7	2311	4	TRM	TRM	NNP
cord-005453-4057qib7	2311	5	was	be	VBD
cord-005453-4057qib7	2311	6	5	5	CD
cord-005453-4057qib7	2311	7	%	%	NN
cord-005453-4057qib7	2311	8	.	.	.
cord-005453-4057qib7	2312	1	Grade	grade	NN
cord-005453-4057qib7	2312	2	4	4	CD
cord-005453-4057qib7	2312	3	adverse	adverse	JJ
cord-005453-4057qib7	2312	4	events	event	NNS
cord-005453-4057qib7	2312	5	were	be	VBD
cord-005453-4057qib7	2312	6	not	not	RB
cord-005453-4057qib7	2312	7	reported	report	VBN
cord-005453-4057qib7	2312	8	.	.	.
cord-005453-4057qib7	2313	1	Disease	disease	NN
cord-005453-4057qib7	2313	2	status	status	NN
cord-005453-4057qib7	2313	3	3	3	CD
cord-005453-4057qib7	2313	4	months	month	NNS
cord-005453-4057qib7	2313	5	after	after	IN
cord-005453-4057qib7	2313	6	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2313	7	was	be	VBD
cord-005453-4057qib7	2313	8	:	:	:
cord-005453-4057qib7	2314	1	CR-10	CR-10	NNP
cord-005453-4057qib7	2314	2	,	,	,
cord-005453-4057qib7	2314	3	VGPR-5	VGPR-5	NNP
cord-005453-4057qib7	2314	4	,	,	,
cord-005453-4057qib7	2314	5	PR-3	PR-3	NNP
cord-005453-4057qib7	2314	6	.	.	.
cord-005453-4057qib7	2315	1	The	the	DT
cord-005453-4057qib7	2315	2	probability	probability	NN
cord-005453-4057qib7	2315	3	of	of	IN
cord-005453-4057qib7	2315	4	OS	OS	NNP
cord-005453-4057qib7	2315	5	and	and	CC
cord-005453-4057qib7	2315	6	PFS	PFS	NNP
cord-005453-4057qib7	2315	7	after	after	IN
cord-005453-4057qib7	2315	8	30	30	CD
cord-005453-4057qib7	2315	9	months	month	NNS
cord-005453-4057qib7	2315	10	was	be	VBD
cord-005453-4057qib7	2315	11	94	94	CD
cord-005453-4057qib7	2315	12	%	%	NN
cord-005453-4057qib7	2315	13	(	(	-LRB-
cord-005453-4057qib7	2315	14	+	+	CC
cord-005453-4057qib7	2315	15	/-6	/-6	CD
cord-005453-4057qib7	2315	16	%	%	NN
cord-005453-4057qib7	2315	17	)	)	-RRB-
cord-005453-4057qib7	2315	18	and	and	CC
cord-005453-4057qib7	2315	19	77	77	CD
cord-005453-4057qib7	2315	20	%	%	NN
cord-005453-4057qib7	2315	21	(	(	-LRB-
cord-005453-4057qib7	2315	22	+	+	CC
cord-005453-4057qib7	2315	23	/-12	/-12	.
cord-005453-4057qib7	2315	24	%	%	NN
cord-005453-4057qib7	2315	25	)	)	-RRB-
cord-005453-4057qib7	2315	26	,	,	,
cord-005453-4057qib7	2315	27	respectively	respectively	RB
cord-005453-4057qib7	2315	28	.	.	.
cord-005453-4057qib7	2316	1	The	the	DT
cord-005453-4057qib7	2316	2	incidence	incidence	NN
cord-005453-4057qib7	2316	3	of	of	IN
cord-005453-4057qib7	2316	4	progression	progression	NN
cord-005453-4057qib7	2316	5	and	and	CC
cord-005453-4057qib7	2316	6	TRM	TRM	NNP
cord-005453-4057qib7	2316	7	was	be	VBD
cord-005453-4057qib7	2316	8	17	17	CD
cord-005453-4057qib7	2316	9	%	%	NN
cord-005453-4057qib7	2316	10	and	and	CC
cord-005453-4057qib7	2316	11	6	6	CD
cord-005453-4057qib7	2316	12	%	%	NN
cord-005453-4057qib7	2316	13	,	,	,
cord-005453-4057qib7	2316	14	respectively	respectively	RB
cord-005453-4057qib7	2316	15	.	.	.
cord-005453-4057qib7	2317	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2317	2	:	:	:
cord-005453-4057qib7	2318	1	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	2319	1	using	use	VBG
cord-005453-4057qib7	2319	2	TMI	TMI	NNP
cord-005453-4057qib7	2319	3	12Gy	12gy	CD
cord-005453-4057qib7	2319	4	+	+	CC
cord-005453-4057qib7	2319	5	bendamustine	bendamustine	NNP
cord-005453-4057qib7	2319	6	conditioning	conditioning	NN
cord-005453-4057qib7	2319	7	protocol	protocol	NN
cord-005453-4057qib7	2319	8	is	be	VBZ
cord-005453-4057qib7	2319	9	characterized	characterize	VBN
cord-005453-4057qib7	2319	10	by	by	IN
cord-005453-4057qib7	2319	11	good	good	JJ
cord-005453-4057qib7	2319	12	tolerance	tolerance	NN
cord-005453-4057qib7	2319	13	and	and	CC
cord-005453-4057qib7	2319	14	low	low	JJ
cord-005453-4057qib7	2319	15	risk	risk	NN
cord-005453-4057qib7	2319	16	of	of	IN
cord-005453-4057qib7	2319	17	GvHD	GvHD	NNP
cord-005453-4057qib7	2319	18	.	.	.
cord-005453-4057qib7	2320	1	It	-PRON-	PRP
cord-005453-4057qib7	2320	2	may	may	MD
cord-005453-4057qib7	2320	3	be	be	VB
cord-005453-4057qib7	2320	4	used	use	VBN
cord-005453-4057qib7	2320	5	for	for	IN
cord-005453-4057qib7	2320	6	younger	young	JJR
cord-005453-4057qib7	2320	7	patients	patient	NNS
cord-005453-4057qib7	2320	8	with	with	IN
cord-005453-4057qib7	2320	9	MM	MM	NNP
cord-005453-4057qib7	2320	10	as	as	IN
cord-005453-4057qib7	2320	11	part	part	NN
cord-005453-4057qib7	2320	12	of	of	IN
cord-005453-4057qib7	2320	13	tandem	tandem	JJ
cord-005453-4057qib7	2320	14	auto	auto	NN
cord-005453-4057qib7	2320	15	-	-	HYPH
cord-005453-4057qib7	2320	16	alloHSCT	allohsct	NN
cord-005453-4057qib7	2320	17	strategy	strategy	NN
cord-005453-4057qib7	2320	18	.	.	.
cord-005453-4057qib7	2321	1	Encouraging	encourage	VBG
cord-005453-4057qib7	2321	2	results	result	NNS
cord-005453-4057qib7	2321	3	reported	report	VBN
cord-005453-4057qib7	2321	4	in	in	IN
cord-005453-4057qib7	2321	5	this	this	DT
cord-005453-4057qib7	2321	6	study	study	NN
cord-005453-4057qib7	2321	7	should	should	MD
cord-005453-4057qib7	2321	8	be	be	VB
cord-005453-4057qib7	2321	9	confirmed	confirm	VBN
cord-005453-4057qib7	2321	10	in	in	IN
cord-005453-4057qib7	2321	11	prospective	prospective	JJ
cord-005453-4057qib7	2321	12	clinical	clinical	JJ
cord-005453-4057qib7	2321	13	trials	trial	NNS
cord-005453-4057qib7	2321	14	.	.	.
cord-005453-4057qib7	2322	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2322	2	:	:	:
cord-005453-4057qib7	2322	3	Nothing	nothing	NN
cord-005453-4057qib7	2322	4	to	to	TO
cord-005453-4057qib7	2322	5	declare	declare	VB
cord-005453-4057qib7	2322	6	P120	P120	NNP
cord-005453-4057qib7	2322	7	Comparison	comparison	NN
cord-005453-4057qib7	2322	8	between	between	IN
cord-005453-4057qib7	2322	9	two	two	CD
cord-005453-4057qib7	2322	10	reduced	reduce	VBN
cord-005453-4057qib7	2322	11	intensity	intensity	NN
cord-005453-4057qib7	2322	12	conditioning	condition	VBG
cord-005453-4057qib7	2322	13	regimens	regimen	NNS
cord-005453-4057qib7	2322	14	in	in	IN
cord-005453-4057qib7	2322	15	patients	patient	NNS
cord-005453-4057qib7	2322	16	with	with	IN
cord-005453-4057qib7	2322	17	a	a	DT
cord-005453-4057qib7	2322	18	myeloid	myeloid	JJ
cord-005453-4057qib7	2322	19	malignancy	malignancy	NN
cord-005453-4057qib7	2322	20	:	:	:
cord-005453-4057qib7	2322	21	A	a	DT
cord-005453-4057qib7	2322	22	single	single	JJ
cord-005453-4057qib7	2322	23	center	center	NN
cord-005453-4057qib7	2322	24	experience	experience	NN
cord-005453-4057qib7	2322	25	comparing	compare	VBG
cord-005453-4057qib7	2322	26	FB2	FB2	NNP
cord-005453-4057qib7	2322	27	with	with	IN
cord-005453-4057qib7	2322	28	flumel	flumel	JJ
cord-005453-4057qib7	2322	29	Background	Background	NNP
cord-005453-4057qib7	2322	30	:	:	:
cord-005453-4057qib7	2322	31	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	2322	32	Stem	Stem	NNP
cord-005453-4057qib7	2322	33	cell	cell	NN
cord-005453-4057qib7	2322	34	transplantation	transplantation	NN
cord-005453-4057qib7	2322	35	(	(	-LRB-
cord-005453-4057qib7	2322	36	HSCT	HSCT	NNP
cord-005453-4057qib7	2322	37	)	)	-RRB-
cord-005453-4057qib7	2322	38	remains	remain	VBZ
cord-005453-4057qib7	2322	39	the	the	DT
cord-005453-4057qib7	2322	40	only	only	JJ
cord-005453-4057qib7	2322	41	curative	curative	JJ
cord-005453-4057qib7	2322	42	option	option	NN
cord-005453-4057qib7	2322	43	for	for	IN
cord-005453-4057qib7	2322	44	high	high	JJ
cord-005453-4057qib7	2322	45	-	-	HYPH
cord-005453-4057qib7	2322	46	risk	risk	NN
cord-005453-4057qib7	2322	47	myeloid	myeloid	JJ
cord-005453-4057qib7	2322	48	neoplasms	neoplasm	NNS
cord-005453-4057qib7	2322	49	.	.	.
cord-005453-4057qib7	2323	1	The	the	DT
cord-005453-4057qib7	2323	2	optimal	optimal	JJ
cord-005453-4057qib7	2323	3	reduced	reduce	VBN
cord-005453-4057qib7	2323	4	-	-	HYPH
cord-005453-4057qib7	2323	5	intensity	intensity	NN
cord-005453-4057qib7	2323	6	conditioning	conditioning	NN
cord-005453-4057qib7	2323	7	(	(	-LRB-
cord-005453-4057qib7	2323	8	RIC	RIC	NNP
cord-005453-4057qib7	2323	9	)	)	-RRB-
cord-005453-4057qib7	2323	10	is	be	VBZ
cord-005453-4057qib7	2323	11	still	still	RB
cord-005453-4057qib7	2323	12	debated	debate	VBN
cord-005453-4057qib7	2323	13	.	.	.
cord-005453-4057qib7	2324	1	Methods	method	NNS
cord-005453-4057qib7	2324	2	:	:	:
cord-005453-4057qib7	2325	1	A	a	DT
cord-005453-4057qib7	2325	2	single	single	JJ
cord-005453-4057qib7	2325	3	-	-	HYPH
cord-005453-4057qib7	2325	4	center	center	NN
cord-005453-4057qib7	2325	5	retrospective	retrospective	JJ
cord-005453-4057qib7	2325	6	analysis	analysis	NN
cord-005453-4057qib7	2325	7	was	be	VBD
cord-005453-4057qib7	2325	8	conducted	conduct	VBN
cord-005453-4057qib7	2325	9	at	at	IN
cord-005453-4057qib7	2325	10	our	-PRON-	PRP$
cord-005453-4057qib7	2325	11	institution	institution	NN
cord-005453-4057qib7	2325	12	to	to	TO
cord-005453-4057qib7	2325	13	compare	compare	VB
cord-005453-4057qib7	2325	14	two	two	CD
cord-005453-4057qib7	2325	15	different	different	JJ
cord-005453-4057qib7	2325	16	RIC	RIC	NNP
cord-005453-4057qib7	2325	17	regimens	regimen	NNS
cord-005453-4057qib7	2325	18	in	in	IN
cord-005453-4057qib7	2325	19	adult	adult	NN
cord-005453-4057qib7	2325	20	patients	patient	NNS
cord-005453-4057qib7	2325	21	transplanted	transplant	VBN
cord-005453-4057qib7	2325	22	for	for	IN
cord-005453-4057qib7	2325	23	myeloid	myeloid	JJ
cord-005453-4057qib7	2325	24	malignancy	malignancy	NN
cord-005453-4057qib7	2325	25	from	from	IN
cord-005453-4057qib7	2325	26	2001	2001	CD
cord-005453-4057qib7	2325	27	to	to	IN
cord-005453-4057qib7	2325	28	2018	2018	CD
cord-005453-4057qib7	2325	29	.	.	.
cord-005453-4057qib7	2326	1	A	a	DT
cord-005453-4057qib7	2326	2	total	total	NN
cord-005453-4057qib7	2326	3	of	of	IN
cord-005453-4057qib7	2326	4	137	137	CD
cord-005453-4057qib7	2326	5	patients	patient	NNS
cord-005453-4057qib7	2326	6	were	be	VBD
cord-005453-4057qib7	2326	7	analysed	analyse	VBN
cord-005453-4057qib7	2326	8	,	,	,
cord-005453-4057qib7	2326	9	74	74	CD
cord-005453-4057qib7	2326	10	of	of	IN
cord-005453-4057qib7	2326	11	them	-PRON-	PRP
cord-005453-4057qib7	2326	12	treated	treat	VBN
cord-005453-4057qib7	2326	13	with	with	IN
cord-005453-4057qib7	2326	14	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2326	15	-	-	HYPH
cord-005453-4057qib7	2326	16	based	base	VBN
cord-005453-4057qib7	2326	17	(	(	-LRB-
cord-005453-4057qib7	2326	18	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2326	19	150	150	CD
cord-005453-4057qib7	2326	20	mg	mg	NNP
cord-005453-4057qib7	2326	21	/	/	SYM
cord-005453-4057qib7	2326	22	m	m	NNP
cord-005453-4057qib7	2326	23	2	2	CD
cord-005453-4057qib7	2326	24	,	,	,
cord-005453-4057qib7	2326	25	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2326	26	6.4	6.4	CD
cord-005453-4057qib7	2326	27	mg	mg	NNP
cord-005453-4057qib7	2326	28	/	/	SYM
cord-005453-4057qib7	2326	29	kg	kg	NNP
cord-005453-4057qib7	2326	30	,	,	,
cord-005453-4057qib7	2326	31	FB2	FB2	NNP
cord-005453-4057qib7	2326	32	)	)	-RRB-
cord-005453-4057qib7	2326	33	and	and	CC
cord-005453-4057qib7	2326	34	63	63	CD
cord-005453-4057qib7	2326	35	with	with	IN
cord-005453-4057qib7	2326	36	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2326	37	-	-	HYPH
cord-005453-4057qib7	2326	38	based	base	VBN
cord-005453-4057qib7	2326	39	conditioning	conditioning	NN
cord-005453-4057qib7	2326	40	regimen	regimen	NN
cord-005453-4057qib7	2326	41	(	(	-LRB-
cord-005453-4057qib7	2326	42	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2326	43	150	150	CD
cord-005453-4057qib7	2326	44	mg	mg	NNP
cord-005453-4057qib7	2326	45	/	/	SYM
cord-005453-4057qib7	2326	46	m	m	NNP
cord-005453-4057qib7	2326	47	2	2	CD
cord-005453-4057qib7	2326	48	,	,	,
cord-005453-4057qib7	2326	49	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2326	50	140	140	CD
cord-005453-4057qib7	2327	1	mg	mg	NNP
cord-005453-4057qib7	2327	2	/	/	SYM
cord-005453-4057qib7	2327	3	m	m	NNP
cord-005453-4057qib7	2327	4	2	2	CD
cord-005453-4057qib7	2327	5	,	,	,
cord-005453-4057qib7	2327	6	FluMel	FluMel	NNP
cord-005453-4057qib7	2327	7	)	)	-RRB-
cord-005453-4057qib7	2327	8	.	.	.
cord-005453-4057qib7	2328	1	Antithymocyte	Antithymocyte	NNP
cord-005453-4057qib7	2328	2	globulin	globulin	NN
cord-005453-4057qib7	2328	3	(	(	-LRB-
cord-005453-4057qib7	2328	4	ATG	ATG	NNP
cord-005453-4057qib7	2328	5	)	)	-RRB-
cord-005453-4057qib7	2328	6	was	be	VBD
cord-005453-4057qib7	2328	7	administered	administer	VBN
cord-005453-4057qib7	2328	8	in	in	IN
cord-005453-4057qib7	2328	9	all	all	DT
cord-005453-4057qib7	2328	10	patients	patient	NNS
cord-005453-4057qib7	2328	11	while	while	IN
cord-005453-4057qib7	2328	12	no	no	DT
cord-005453-4057qib7	2328	13	one	one	NN
cord-005453-4057qib7	2328	14	received	receive	VBD
cord-005453-4057qib7	2328	15	TBI	TBI	NNP
cord-005453-4057qib7	2328	16	.	.	.
cord-005453-4057qib7	2329	1	Partial	partial	JJ
cord-005453-4057qib7	2329	2	in	in	IN
cord-005453-4057qib7	2329	3	vitro	vitro	FW
cord-005453-4057qib7	2329	4	T	t	NN
cord-005453-4057qib7	2329	5	-	-	HYPH
cord-005453-4057qib7	2329	6	cell	cell	NN
cord-005453-4057qib7	2329	7	depletion	depletion	NN
cord-005453-4057qib7	2329	8	was	be	VBD
cord-005453-4057qib7	2329	9	performed	perform	VBN
cord-005453-4057qib7	2329	10	using	use	VBG
cord-005453-4057qib7	2329	11	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	2329	12	for	for	IN
cord-005453-4057qib7	2329	13	low	low	JJ
cord-005453-4057qib7	2329	14	risk	risk	NN
cord-005453-4057qib7	2329	15	patients	patient	NNS
cord-005453-4057qib7	2329	16	.	.	.
cord-005453-4057qib7	2330	1	Results	result	NNS
cord-005453-4057qib7	2330	2	:	:	:
cord-005453-4057qib7	2331	1	The	the	DT
cord-005453-4057qib7	2331	2	two	two	CD
cord-005453-4057qib7	2331	3	groups	group	NNS
cord-005453-4057qib7	2331	4	were	be	VBD
cord-005453-4057qib7	2331	5	well	well	RB
cord-005453-4057qib7	2331	6	balanced	balanced	JJ
cord-005453-4057qib7	2331	7	with	with	IN
cord-005453-4057qib7	2331	8	a	a	DT
cord-005453-4057qib7	2331	9	median	median	JJ
cord-005453-4057qib7	2331	10	age	age	NN
cord-005453-4057qib7	2331	11	of	of	IN
cord-005453-4057qib7	2331	12	61	61	CD
cord-005453-4057qib7	2331	13	and	and	CC
cord-005453-4057qib7	2331	14	62	62	CD
cord-005453-4057qib7	2331	15	years	year	NNS
cord-005453-4057qib7	2331	16	in	in	IN
cord-005453-4057qib7	2331	17	the	the	DT
cord-005453-4057qib7	2331	18	FB2	FB2	NNP
cord-005453-4057qib7	2331	19	and	and	CC
cord-005453-4057qib7	2331	20	FluMel	FluMel	NNP
cord-005453-4057qib7	2331	21	group	group	NN
cord-005453-4057qib7	2331	22	,	,	,
cord-005453-4057qib7	2331	23	respectively	respectively	RB
cord-005453-4057qib7	2331	24	,	,	,
cord-005453-4057qib7	2331	25	and	and	CC
cord-005453-4057qib7	2331	26	a	a	DT
cord-005453-4057qib7	2331	27	median	median	NN
cord-005453-4057qib7	2331	28	follow	follow	NN
cord-005453-4057qib7	2331	29	up	up	IN
cord-005453-4057qib7	2331	30	of	of	IN
cord-005453-4057qib7	2331	31	46	46	CD
cord-005453-4057qib7	2331	32	months	month	NNS
cord-005453-4057qib7	2331	33	.	.	.
cord-005453-4057qib7	2332	1	The	the	DT
cord-005453-4057qib7	2332	2	most	most	RBS
cord-005453-4057qib7	2332	3	frequent	frequent	JJ
cord-005453-4057qib7	2332	4	indication	indication	NN
cord-005453-4057qib7	2332	5	for	for	IN
cord-005453-4057qib7	2332	6	transplant	transplant	NN
cord-005453-4057qib7	2332	7	in	in	IN
cord-005453-4057qib7	2332	8	both	both	DT
cord-005453-4057qib7	2332	9	groups	group	NNS
cord-005453-4057qib7	2332	10	was	be	VBD
cord-005453-4057qib7	2332	11	AML	AML	NNP
cord-005453-4057qib7	2332	12	(	(	-LRB-
cord-005453-4057qib7	2332	13	59.5	59.5	CD
cord-005453-4057qib7	2332	14	and	and	CC
cord-005453-4057qib7	2332	15	69.8	69.8	CD
cord-005453-4057qib7	2332	16	%	%	NN
cord-005453-4057qib7	2332	17	for	for	IN
cord-005453-4057qib7	2332	18	FB2	FB2	NNP
cord-005453-4057qib7	2332	19	group	group	NN
cord-005453-4057qib7	2332	20	and	and	CC
cord-005453-4057qib7	2332	21	FluMel	FluMel	NNP
cord-005453-4057qib7	2332	22	group	group	NN
cord-005453-4057qib7	2332	23	,	,	,
cord-005453-4057qib7	2332	24	respectively	respectively	RB
cord-005453-4057qib7	2332	25	)	)	-RRB-
cord-005453-4057qib7	2332	26	and	and	CC
cord-005453-4057qib7	2332	27	the	the	DT
cord-005453-4057qib7	2332	28	stem	stem	NN
cord-005453-4057qib7	2332	29	cell	cell	NN
cord-005453-4057qib7	2332	30	source	source	NN
cord-005453-4057qib7	2332	31	was	be	VBD
cord-005453-4057qib7	2332	32	peripheral	peripheral	JJ
cord-005453-4057qib7	2332	33	blood	blood	NN
cord-005453-4057qib7	2332	34	in	in	IN
cord-005453-4057qib7	2332	35	94.6	94.6	CD
cord-005453-4057qib7	2332	36	and	and	CC
cord-005453-4057qib7	2332	37	96.8	96.8	CD
cord-005453-4057qib7	2332	38	%	%	NN
cord-005453-4057qib7	2332	39	of	of	IN
cord-005453-4057qib7	2332	40	patients	patient	NNS
cord-005453-4057qib7	2332	41	.	.	.
cord-005453-4057qib7	2333	1	More	More	JJR
cord-005453-4057qib7	2333	2	patients	patient	NNS
cord-005453-4057qib7	2333	3	in	in	IN
cord-005453-4057qib7	2333	4	the	the	DT
cord-005453-4057qib7	2333	5	first	first	JJ
cord-005453-4057qib7	2333	6	group	group	NN
cord-005453-4057qib7	2333	7	had	have	VBD
cord-005453-4057qib7	2333	8	near	near	JJ
cord-005453-4057qib7	2333	9	to	to	IN
cord-005453-4057qib7	2333	10	significant	significant	JJ
cord-005453-4057qib7	2333	11	worst	bad	JJS
cord-005453-4057qib7	2333	12	Karnosfky	Karnosfky	NNP
cord-005453-4057qib7	2333	13	status	status	NN
cord-005453-4057qib7	2333	14	(	(	-LRB-
cord-005453-4057qib7	2333	15	<	<	XX
cord-005453-4057qib7	2333	16	90	90	CD
cord-005453-4057qib7	2333	17	)	)	-RRB-
cord-005453-4057qib7	2333	18	at	at	IN
cord-005453-4057qib7	2333	19	transplant	transplant	NN
cord-005453-4057qib7	2333	20	compared	compare	VBN
cord-005453-4057qib7	2333	21	to	to	IN
cord-005453-4057qib7	2333	22	second	second	JJ
cord-005453-4057qib7	2333	23	(	(	-LRB-
cord-005453-4057qib7	2333	24	35	35	CD
cord-005453-4057qib7	2333	25	.	.	NN
cord-005453-4057qib7	2333	26	1	1	CD
cord-005453-4057qib7	2333	27	vs	vs	IN
cord-005453-4057qib7	2333	28	19	19	CD
cord-005453-4057qib7	2333	29	%	%	NN
cord-005453-4057qib7	2333	30	,	,	,
cord-005453-4057qib7	2333	31	p=0	p=0	NNP
cord-005453-4057qib7	2333	32	.057	.057	CD
cord-005453-4057qib7	2333	33	)	)	-RRB-
cord-005453-4057qib7	2333	34	and	and	CC
cord-005453-4057qib7	2333	35	more	more	JJR
cord-005453-4057qib7	2333	36	patients	patient	NNS
cord-005453-4057qib7	2333	37	received	receive	VBD
cord-005453-4057qib7	2333	38	a	a	DT
cord-005453-4057qib7	2333	39	T	t	NN
cord-005453-4057qib7	2333	40	-	-	HYPH
cord-005453-4057qib7	2333	41	partial	partial	JJ
cord-005453-4057qib7	2333	42	depleted	deplete	VBN
cord-005453-4057qib7	2333	43	graft	graft	NN
cord-005453-4057qib7	2333	44	(	(	-LRB-
cord-005453-4057qib7	2333	45	54.1	54.1	CD
cord-005453-4057qib7	2333	46	vs	vs	IN
cord-005453-4057qib7	2333	47	33.3	33.3	CD
cord-005453-4057qib7	2333	48	%	%	NN
cord-005453-4057qib7	2333	49	,	,	,
cord-005453-4057qib7	2333	50	p=	p=	NNP
cord-005453-4057qib7	2333	51	.028	.028	CD
cord-005453-4057qib7	2333	52	)	)	-RRB-
cord-005453-4057qib7	2333	53	.	.	.
cord-005453-4057qib7	2334	1	The	the	DT
cord-005453-4057qib7	2334	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	2334	3	engraftment	engraftment	NN
cord-005453-4057qib7	2334	4	was	be	VBD
cord-005453-4057qib7	2334	5	significantly	significantly	RB
cord-005453-4057qib7	2334	6	shorter	short	JJR
cord-005453-4057qib7	2334	7	after	after	IN
cord-005453-4057qib7	2334	8	FluMel	FluMel	NNP
cord-005453-4057qib7	2334	9	(	(	-LRB-
cord-005453-4057qib7	2334	10	15	15	CD
cord-005453-4057qib7	2334	11	vs	vs	IN
cord-005453-4057qib7	2334	12	18	18	CD
cord-005453-4057qib7	2334	13	days	day	NNS
cord-005453-4057qib7	2334	14	,	,	,
cord-005453-4057qib7	2334	15	p	p	NN
cord-005453-4057qib7	2334	16	<	<	XX
cord-005453-4057qib7	2334	17	.01	.01	NFP
cord-005453-4057qib7	2334	18	)	)	-RRB-
cord-005453-4057qib7	2334	19	.	.	.
cord-005453-4057qib7	2335	1	The	the	DT
cord-005453-4057qib7	2335	2	3-year	3-year	CD
cord-005453-4057qib7	2335	3	overall	overall	JJ
cord-005453-4057qib7	2335	4	survival	survival	NN
cord-005453-4057qib7	2335	5	(	(	-LRB-
cord-005453-4057qib7	2335	6	OS	OS	NNP
cord-005453-4057qib7	2335	7	)	)	-RRB-
cord-005453-4057qib7	2335	8	and	and	CC
cord-005453-4057qib7	2335	9	disease	disease	NN
cord-005453-4057qib7	2335	10	-	-	HYPH
cord-005453-4057qib7	2335	11	free	free	JJ
cord-005453-4057qib7	2335	12	survival	survival	NN
cord-005453-4057qib7	2335	13	(	(	-LRB-
cord-005453-4057qib7	2335	14	DFS	DFS	NNP
cord-005453-4057qib7	2335	15	)	)	-RRB-
cord-005453-4057qib7	2335	16	were	be	VBD
cord-005453-4057qib7	2335	17	of	of	IN
cord-005453-4057qib7	2335	18	43.0	43.0	CD
cord-005453-4057qib7	2335	19	and	and	CC
cord-005453-4057qib7	2335	20	36.5	36.5	CD
cord-005453-4057qib7	2335	21	%	%	NN
cord-005453-4057qib7	2335	22	,	,	,
cord-005453-4057qib7	2335	23	respectively	respectively	RB
cord-005453-4057qib7	2335	24	,	,	,
cord-005453-4057qib7	2335	25	after	after	IN
cord-005453-4057qib7	2335	26	FB2	FB2	NNP
cord-005453-4057qib7	2335	27	and	and	CC
cord-005453-4057qib7	2335	28	54.9	54.9	CD
cord-005453-4057qib7	2335	29	and	and	CC
cord-005453-4057qib7	2335	30	52.0	52.0	CD
cord-005453-4057qib7	2335	31	%	%	NN
cord-005453-4057qib7	2335	32	after	after	IN
cord-005453-4057qib7	2335	33	FluMel	FluMel	NNP
cord-005453-4057qib7	2335	34	,	,	,
cord-005453-4057qib7	2335	35	respectively	respectively	RB
cord-005453-4057qib7	2335	36	,	,	,
cord-005453-4057qib7	2335	37	and	and	CC
cord-005453-4057qib7	2335	38	were	be	VBD
cord-005453-4057qib7	2335	39	not	not	RB
cord-005453-4057qib7	2335	40	significantly	significantly	RB
cord-005453-4057qib7	2335	41	different	different	JJ
cord-005453-4057qib7	2335	42	(	(	-LRB-
cord-005453-4057qib7	2335	43	p=.41	p=.41	NN
cord-005453-4057qib7	2335	44	for	for	IN
cord-005453-4057qib7	2335	45	OS	OS	NNP
cord-005453-4057qib7	2335	46	and	and	CC
cord-005453-4057qib7	2335	47	.15	.15	CD
cord-005453-4057qib7	2335	48	for	for	IN
cord-005453-4057qib7	2335	49	DFS	DFS	NNP
cord-005453-4057qib7	2335	50	)	)	-RRB-
cord-005453-4057qib7	2335	51	,	,	,
cord-005453-4057qib7	2335	52	with	with	IN
cord-005453-4057qib7	2335	53	a	a	DT
cord-005453-4057qib7	2335	54	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	2336	1	>	>	XX
cord-005453-4057qib7	2337	1	=	=	SYM
cord-005453-4057qib7	2337	2	90	90	CD
cord-005453-4057qib7	2338	1	being	be	VBG
cord-005453-4057qib7	2338	2	the	the	DT
cord-005453-4057qib7	2338	3	only	only	JJ
cord-005453-4057qib7	2338	4	factor	factor	NN
cord-005453-4057qib7	2338	5	significantly	significantly	RB
cord-005453-4057qib7	2338	6	associated	associate	VBN
cord-005453-4057qib7	2338	7	in	in	IN
cord-005453-4057qib7	2338	8	univariate	univariate	JJ
cord-005453-4057qib7	2338	9	analysis	analysis	NN
cord-005453-4057qib7	2338	10	with	with	IN
cord-005453-4057qib7	2338	11	better	well	JJR
cord-005453-4057qib7	2338	12	OS	OS	NNP
cord-005453-4057qib7	2338	13	and	and	CC
cord-005453-4057qib7	2338	14	DFS	DFS	NNP
cord-005453-4057qib7	2338	15	(	(	-LRB-
cord-005453-4057qib7	2338	16	p=.02	p=.02	CD
cord-005453-4057qib7	2338	17	for	for	IN
cord-005453-4057qib7	2338	18	both	both	DT
cord-005453-4057qib7	2338	19	)	)	-RRB-
cord-005453-4057qib7	2338	20	.	.	.
cord-005453-4057qib7	2339	1	The	the	DT
cord-005453-4057qib7	2339	2	cumulative	cumulative	JJ
cord-005453-4057qib7	2339	3	incidence	incidence	NN
cord-005453-4057qib7	2339	4	(	(	-LRB-
cord-005453-4057qib7	2339	5	CI	CI	NNP
cord-005453-4057qib7	2339	6	)	)	-RRB-
cord-005453-4057qib7	2339	7	of	of	IN
cord-005453-4057qib7	2339	8	grade	grade	NN
cord-005453-4057qib7	2339	9	2	2	CD
cord-005453-4057qib7	2339	10	to	to	TO
cord-005453-4057qib7	2339	11	4	4	CD
cord-005453-4057qib7	2339	12	acute	acute	JJ
cord-005453-4057qib7	2339	13	graft	graft	NN
cord-005453-4057qib7	2339	14	-	-	HYPH
cord-005453-4057qib7	2339	15	versus	versus	IN
cord-005453-4057qib7	2339	16	-	-	HYPH
cord-005453-4057qib7	2339	17	host	host	NN
cord-005453-4057qib7	2339	18	disease	disease	NN
cord-005453-4057qib7	2339	19	(	(	-LRB-
cord-005453-4057qib7	2339	20	aGVHD	aGVHD	NNP
cord-005453-4057qib7	2339	21	)	)	-RRB-
cord-005453-4057qib7	2339	22	was	be	VBD
cord-005453-4057qib7	2339	23	16.2	16.2	CD
cord-005453-4057qib7	2339	24	%	%	NN
cord-005453-4057qib7	2339	25	after	after	IN
cord-005453-4057qib7	2339	26	FB2	FB2	NNP
cord-005453-4057qib7	2339	27	and	and	CC
cord-005453-4057qib7	2339	28	38.3	38.3	CD
cord-005453-4057qib7	2339	29	%	%	NN
cord-005453-4057qib7	2339	30	after	after	IN
cord-005453-4057qib7	2339	31	FluMel	FluMel	NNP
cord-005453-4057qib7	2340	1	(	(	-LRB-
cord-005453-4057qib7	2340	2	p	p	NN
cord-005453-4057qib7	2340	3	<	<	XX
cord-005453-4057qib7	2340	4	.001	.001	CD
cord-005453-4057qib7	2340	5	)	)	-RRB-
cord-005453-4057qib7	2341	1	and	and	CC
cord-005453-4057qib7	2341	2	was	be	VBD
cord-005453-4057qib7	2341	3	associated	associate	VBN
cord-005453-4057qib7	2341	4	in	in	IN
cord-005453-4057qib7	2341	5	multivariate	multivariate	JJ
cord-005453-4057qib7	2341	6	analysis	analysis	NN
cord-005453-4057qib7	2341	7	with	with	IN
cord-005453-4057qib7	2341	8	both	both	CC
cord-005453-4057qib7	2341	9	T	T	NNP
cord-005453-4057qib7	2341	10	depletion	depletion	NN
cord-005453-4057qib7	2341	11	and	and	CC
cord-005453-4057qib7	2341	12	RIC	RIC	NNP
cord-005453-4057qib7	2341	13	type	type	NN
cord-005453-4057qib7	2341	14	(	(	-LRB-
cord-005453-4057qib7	2341	15	p	p	XX
cord-005453-4057qib7	2341	16	<	<	XX
cord-005453-4057qib7	2341	17	.001	.001	CD
cord-005453-4057qib7	2341	18	and	and	CC
cord-005453-4057qib7	2341	19	.005	.005	CD
cord-005453-4057qib7	2341	20	,	,	,
cord-005453-4057qib7	2341	21	respectively	respectively	RB
cord-005453-4057qib7	2341	22	)	)	-RRB-
cord-005453-4057qib7	2341	23	.	.	.
cord-005453-4057qib7	2342	1	The	the	DT
cord-005453-4057qib7	2342	2	CI	CI	NNP
cord-005453-4057qib7	2342	3	of	of	IN
cord-005453-4057qib7	2342	4	chronic	chronic	JJ
cord-005453-4057qib7	2342	5	GVHD	GVHD	NNP
cord-005453-4057qib7	2342	6	at	at	IN
cord-005453-4057qib7	2342	7	3	3	CD
cord-005453-4057qib7	2342	8	years	year	NNS
cord-005453-4057qib7	2342	9	was	be	VBD
cord-005453-4057qib7	2342	10	13.9	13.9	CD
cord-005453-4057qib7	2342	11	%	%	NN
cord-005453-4057qib7	2342	12	in	in	IN
cord-005453-4057qib7	2342	13	FB2	FB2	NNP
cord-005453-4057qib7	2342	14	and	and	CC
cord-005453-4057qib7	2342	15	22.1	22.1	CD
cord-005453-4057qib7	2342	16	%	%	NN
cord-005453-4057qib7	2342	17	in	in	IN
cord-005453-4057qib7	2342	18	FluMel	FluMel	NNP
cord-005453-4057qib7	2342	19	group	group	NN
cord-005453-4057qib7	2342	20	(	(	-LRB-
cord-005453-4057qib7	2342	21	p=.24	p=.24	NNP
cord-005453-4057qib7	2342	22	)	)	-RRB-
cord-005453-4057qib7	2342	23	.	.	.
cord-005453-4057qib7	2343	1	The	the	DT
cord-005453-4057qib7	2343	2	CI	CI	NNP
cord-005453-4057qib7	2343	3	of	of	IN
cord-005453-4057qib7	2343	4	Non	non	JJ
cord-005453-4057qib7	2343	5	-	-	JJ
cord-005453-4057qib7	2343	6	relapse	relapse	JJ
cord-005453-4057qib7	2343	7	mortality	mortality	NN
cord-005453-4057qib7	2343	8	at	at	IN
cord-005453-4057qib7	2343	9	3	3	CD
cord-005453-4057qib7	2343	10	years	year	NNS
cord-005453-4057qib7	2343	11	was	be	VBD
cord-005453-4057qib7	2343	12	18.7	18.7	CD
cord-005453-4057qib7	2343	13	%	%	NN
cord-005453-4057qib7	2343	14	after	after	IN
cord-005453-4057qib7	2343	15	FB2	FB2	NNP
cord-005453-4057qib7	2343	16	and	and	CC
cord-005453-4057qib7	2343	17	29.6	29.6	CD
cord-005453-4057qib7	2343	18	%	%	NN
cord-005453-4057qib7	2343	19	after	after	IN
cord-005453-4057qib7	2343	20	FluMel	FluMel	NNP
cord-005453-4057qib7	2343	21	(	(	-LRB-
cord-005453-4057qib7	2343	22	p=.11	p=.11	NNP
cord-005453-4057qib7	2343	23	)	)	-RRB-
cord-005453-4057qib7	2343	24	.	.	.
cord-005453-4057qib7	2344	1	The	the	DT
cord-005453-4057qib7	2344	2	CI	CI	NNP
cord-005453-4057qib7	2344	3	of	of	IN
cord-005453-4057qib7	2344	4	relapse	relapse	NN
cord-005453-4057qib7	2344	5	at	at	IN
cord-005453-4057qib7	2344	6	3	3	CD
cord-005453-4057qib7	2344	7	years	year	NNS
cord-005453-4057qib7	2344	8	was	be	VBD
cord-005453-4057qib7	2344	9	44.8	44.8	CD
cord-005453-4057qib7	2344	10	%	%	NN
cord-005453-4057qib7	2344	11	for	for	IN
cord-005453-4057qib7	2344	12	the	the	DT
cord-005453-4057qib7	2344	13	first	first	JJ
cord-005453-4057qib7	2344	14	and	and	CC
cord-005453-4057qib7	2344	15	18.4	18.4	CD
cord-005453-4057qib7	2344	16	%	%	NN
cord-005453-4057qib7	2344	17	for	for	IN
cord-005453-4057qib7	2344	18	the	the	DT
cord-005453-4057qib7	2344	19	second	second	JJ
cord-005453-4057qib7	2344	20	group	group	NN
cord-005453-4057qib7	2344	21	(	(	-LRB-
cord-005453-4057qib7	2344	22	p	p	NN
cord-005453-4057qib7	2344	23	<	<	XX
cord-005453-4057qib7	2344	24	.001	.001	CD
cord-005453-4057qib7	2344	25	)	)	-RRB-
cord-005453-4057qib7	2344	26	and	and	CC
cord-005453-4057qib7	2344	27	was	be	VBD
cord-005453-4057qib7	2344	28	associated	associate	VBN
cord-005453-4057qib7	2344	29	with	with	IN
cord-005453-4057qib7	2344	30	conditioning	conditioning	NN
cord-005453-4057qib7	2344	31	regimen	regimen	NN
cord-005453-4057qib7	2344	32	in	in	IN
cord-005453-4057qib7	2344	33	multivariate	multivariate	JJ
cord-005453-4057qib7	2344	34	analysis	analysis	NN
cord-005453-4057qib7	2344	35	(	(	-LRB-
cord-005453-4057qib7	2344	36	p=.02	p=.02	CD
cord-005453-4057qib7	2344	37	)	)	-RRB-
cord-005453-4057qib7	2344	38	.	.	.
cord-005453-4057qib7	2345	1	No	no	DT
cord-005453-4057qib7	2345	2	difference	difference	NN
cord-005453-4057qib7	2345	3	in	in	IN
cord-005453-4057qib7	2345	4	3-years	3-years	JJ
cord-005453-4057qib7	2345	5	GVHD	GVHD	NNP
cord-005453-4057qib7	2345	6	-	-	HYPH
cord-005453-4057qib7	2345	7	free/	free/	CD
cord-005453-4057qib7	2345	8	relapse	relapse	NN
cord-005453-4057qib7	2345	9	-	-	HYPH
cord-005453-4057qib7	2345	10	free	free	JJ
cord-005453-4057qib7	2345	11	survival	survival	NN
cord-005453-4057qib7	2345	12	(	(	-LRB-
cord-005453-4057qib7	2345	13	GRFS	GRFS	NNP
cord-005453-4057qib7	2345	14	)	)	-RRB-
cord-005453-4057qib7	2345	15	was	be	VBD
cord-005453-4057qib7	2345	16	observed	observe	VBN
cord-005453-4057qib7	2345	17	between	between	IN
cord-005453-4057qib7	2345	18	the	the	DT
cord-005453-4057qib7	2345	19	two	two	CD
cord-005453-4057qib7	2345	20	group	group	NN
cord-005453-4057qib7	2345	21	(	(	-LRB-
cord-005453-4057qib7	2345	22	25.5	25.5	CD
cord-005453-4057qib7	2345	23	%	%	NN
cord-005453-4057qib7	2345	24	for	for	IN
cord-005453-4057qib7	2345	25	FB2	FB2	NNP
cord-005453-4057qib7	2345	26	and	and	CC
cord-005453-4057qib7	2345	27	37.6	37.6	CD
cord-005453-4057qib7	2345	28	%	%	NN
cord-005453-4057qib7	2345	29	for	for	IN
cord-005453-4057qib7	2345	30	FluMel	FluMel	NNP
cord-005453-4057qib7	2345	31	,	,	,
cord-005453-4057qib7	2345	32	p=.48	p=.48	NNP
cord-005453-4057qib7	2345	33	)	)	-RRB-
cord-005453-4057qib7	2345	34	.	.	.
cord-005453-4057qib7	2346	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2346	2	:	:	:
cord-005453-4057qib7	2347	1	When	when	WRB
cord-005453-4057qib7	2347	2	comparing	compare	VBG
cord-005453-4057qib7	2347	3	two	two	CD
cord-005453-4057qib7	2347	4	RIC	RIC	NNP
cord-005453-4057qib7	2347	5	regimens	regimen	NNS
cord-005453-4057qib7	2347	6	for	for	IN
cord-005453-4057qib7	2347	7	myeloid	myeloid	JJ
cord-005453-4057qib7	2347	8	neoplasms	neoplasm	NNS
cord-005453-4057qib7	2347	9	,	,	,
cord-005453-4057qib7	2347	10	we	-PRON-	PRP
cord-005453-4057qib7	2347	11	observed	observe	VBD
cord-005453-4057qib7	2347	12	a	a	DT
cord-005453-4057qib7	2347	13	higher	high	JJR
cord-005453-4057qib7	2347	14	incidence	incidence	NN
cord-005453-4057qib7	2347	15	of	of	IN
cord-005453-4057qib7	2347	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	2347	17	after	after	IN
cord-005453-4057qib7	2347	18	FluMel	FluMel	NNP
cord-005453-4057qib7	2347	19	whereas	whereas	IN
cord-005453-4057qib7	2347	20	no	no	DT
cord-005453-4057qib7	2347	21	statistical	statistical	JJ
cord-005453-4057qib7	2347	22	difference	difference	NN
cord-005453-4057qib7	2347	23	was	be	VBD
cord-005453-4057qib7	2347	24	noted	note	VBN
cord-005453-4057qib7	2347	25	for	for	IN
cord-005453-4057qib7	2347	26	the	the	DT
cord-005453-4057qib7	2347	27	cGVHD	cGVHD	NNP
cord-005453-4057qib7	2347	28	occurrence	occurrence	NN
cord-005453-4057qib7	2347	29	.	.	.
cord-005453-4057qib7	2348	1	While	while	IN
cord-005453-4057qib7	2348	2	the	the	DT
cord-005453-4057qib7	2348	3	toxicity	toxicity	NN
cord-005453-4057qib7	2348	4	appears	appear	VBZ
cord-005453-4057qib7	2348	5	to	to	TO
cord-005453-4057qib7	2348	6	be	be	VB
cord-005453-4057qib7	2348	7	higher	high	JJR
cord-005453-4057qib7	2348	8	after	after	IN
cord-005453-4057qib7	2348	9	FluMel	FluMel	NNP
cord-005453-4057qib7	2348	10	,	,	,
cord-005453-4057qib7	2348	11	this	this	DT
cord-005453-4057qib7	2348	12	result	result	NN
cord-005453-4057qib7	2348	13	is	be	VBZ
cord-005453-4057qib7	2348	14	counterbalanced	counterbalance	VBN
cord-005453-4057qib7	2348	15	by	by	IN
cord-005453-4057qib7	2348	16	a	a	DT
cord-005453-4057qib7	2348	17	higher	high	JJR
cord-005453-4057qib7	2348	18	proportion	proportion	NN
cord-005453-4057qib7	2348	19	of	of	IN
cord-005453-4057qib7	2348	20	relapse	relapse	NN
cord-005453-4057qib7	2348	21	after	after	IN
cord-005453-4057qib7	2348	22	FB2	FB2	NNP
cord-005453-4057qib7	2348	23	,	,	,
cord-005453-4057qib7	2348	24	accounting	account	VBG
cord-005453-4057qib7	2348	25	for	for	IN
cord-005453-4057qib7	2348	26	no	no	DT
cord-005453-4057qib7	2348	27	difference	difference	NN
cord-005453-4057qib7	2348	28	in	in	IN
cord-005453-4057qib7	2348	29	OS	OS	NNP
cord-005453-4057qib7	2348	30	,	,	,
cord-005453-4057qib7	2348	31	DFS	DFS	NNP
cord-005453-4057qib7	2348	32	and	and	CC
cord-005453-4057qib7	2348	33	GRFS	GRFS	NNP
cord-005453-4057qib7	2348	34	between	between	IN
cord-005453-4057qib7	2348	35	the	the	DT
cord-005453-4057qib7	2348	36	two	two	CD
cord-005453-4057qib7	2348	37	groups	group	NNS
cord-005453-4057qib7	2348	38	.	.	.
cord-005453-4057qib7	2349	1	These	these	DT
cord-005453-4057qib7	2349	2	findings	finding	NNS
cord-005453-4057qib7	2349	3	could	could	MD
cord-005453-4057qib7	2349	4	be	be	VB
cord-005453-4057qib7	2349	5	partially	partially	RB
cord-005453-4057qib7	2349	6	explained	explain	VBN
cord-005453-4057qib7	2349	7	by	by	IN
cord-005453-4057qib7	2349	8	a	a	DT
cord-005453-4057qib7	2349	9	larger	large	JJR
cord-005453-4057qib7	2349	10	proportion	proportion	NN
cord-005453-4057qib7	2349	11	of	of	IN
cord-005453-4057qib7	2349	12	patients	patient	NNS
cord-005453-4057qib7	2349	13	receiving	receive	VBG
cord-005453-4057qib7	2349	14	a	a	DT
cord-005453-4057qib7	2349	15	partial	partial	JJ
cord-005453-4057qib7	2349	16	T	t	NN
cord-005453-4057qib7	2349	17	-	-	HYPH
cord-005453-4057qib7	2349	18	depletion	depletion	NN
cord-005453-4057qib7	2349	19	after	after	IN
cord-005453-4057qib7	2349	20	FB2	FB2	NNP
cord-005453-4057qib7	2349	21	RIC	RIC	NNP
cord-005453-4057qib7	2349	22	,	,	,
cord-005453-4057qib7	2349	23	but	but	CC
cord-005453-4057qib7	2349	24	a	a	DT
cord-005453-4057qib7	2349	25	larger	large	JJR
cord-005453-4057qib7	2349	26	trial	trial	NN
cord-005453-4057qib7	2349	27	is	be	VBZ
cord-005453-4057qib7	2349	28	needed	need	VBN
cord-005453-4057qib7	2349	29	to	to	TO
cord-005453-4057qib7	2349	30	clarify	clarify	VB
cord-005453-4057qib7	2349	31	this	this	DT
cord-005453-4057qib7	2349	32	issue	issue	NN
cord-005453-4057qib7	2349	33	.	.	.
cord-005453-4057qib7	2350	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2350	2	:	:	:
cord-005453-4057qib7	2350	3	Nothing	nothing	NN
cord-005453-4057qib7	2350	4	to	to	TO
cord-005453-4057qib7	2350	5	declare	declare	VB
cord-005453-4057qib7	2350	6	.	.	.
cord-005453-4057qib7	2351	1	Once	once	RB
cord-005453-4057qib7	2351	2	-	-	HYPH
cord-005453-4057qib7	2351	3	daily	daily	NN
cord-005453-4057qib7	2351	4	vs	vs	IN
cord-005453-4057qib7	2351	5	4-times	4-times	CD
cord-005453-4057qib7	2351	6	daily	daily	JJ
cord-005453-4057qib7	2351	7	intravenous	intravenous	JJ
cord-005453-4057qib7	2351	8	busilvex	busilvex	NNS
cord-005453-4057qib7	2351	9	in	in	IN
cord-005453-4057qib7	2351	10	conditioning	conditioning	NN
cord-005453-4057qib7	2351	11	regimen	regimen	NN
cord-005453-4057qib7	2351	12	before	before	IN
cord-005453-4057qib7	2351	13	allogeneic	allogeneic	NN
cord-005453-4057qib7	2351	14	stem	stem	NN
cord-005453-4057qib7	2351	15	cell	cell	NN
cord-005453-4057qib7	2351	16	transplantation	transplantation	NN
cord-005453-4057qib7	2351	17	for	for	IN
cord-005453-4057qib7	2351	18	patients	patient	NNS
cord-005453-4057qib7	2351	19	with	with	IN
cord-005453-4057qib7	2351	20	myeloid	myeloid	JJ
cord-005453-4057qib7	2351	21	malignancies	malignancy	NNS
cord-005453-4057qib7	2351	22	:	:	:
cord-005453-4057qib7	2352	1	Safety	safety	NN
cord-005453-4057qib7	2352	2	and	and	CC
cord-005453-4057qib7	2352	3	efficacy	efficacy	NN
cord-005453-4057qib7	2352	4	Background	background	NN
cord-005453-4057qib7	2352	5	:	:	:
cord-005453-4057qib7	2353	1	Busilvex	Busilvex	NNP
cord-005453-4057qib7	2353	2	(	(	-LRB-
cord-005453-4057qib7	2353	3	Bu	Bu	NNP
cord-005453-4057qib7	2353	4	)	)	-RRB-
cord-005453-4057qib7	2353	5	is	be	VBZ
cord-005453-4057qib7	2353	6	part	part	NN
cord-005453-4057qib7	2353	7	of	of	IN
cord-005453-4057qib7	2353	8	standard	standard	JJ
cord-005453-4057qib7	2353	9	conditioning	conditioning	NN
cord-005453-4057qib7	2353	10	regimen	regimen	NN
cord-005453-4057qib7	2353	11	before	before	IN
cord-005453-4057qib7	2353	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	2353	13	stem	stem	NN
cord-005453-4057qib7	2353	14	cell	cell	NN
cord-005453-4057qib7	2353	15	transplantation	transplantation	NN
cord-005453-4057qib7	2353	16	(	(	-LRB-
cord-005453-4057qib7	2353	17	ASCT	ASCT	NNP
cord-005453-4057qib7	2353	18	)	)	-RRB-
cord-005453-4057qib7	2353	19	for	for	IN
cord-005453-4057qib7	2353	20	patients	patient	NNS
cord-005453-4057qib7	2353	21	with	with	IN
cord-005453-4057qib7	2353	22	myeloid	myeloid	JJ
cord-005453-4057qib7	2353	23	malignancies	malignancy	NNS
cord-005453-4057qib7	2353	24	and	and	CC
cord-005453-4057qib7	2353	25	usually	usually	RB
cord-005453-4057qib7	2353	26	administered	administer	VBN
cord-005453-4057qib7	2353	27	as	as	IN
cord-005453-4057qib7	2353	28	an	an	DT
cord-005453-4057qib7	2353	29	intravenous	intravenous	JJ
cord-005453-4057qib7	2353	30	(	(	-LRB-
cord-005453-4057qib7	2353	31	iv	iv	LS
cord-005453-4057qib7	2353	32	)	)	-RRB-
cord-005453-4057qib7	2353	33	infusion	infusion	NN
cord-005453-4057qib7	2353	34	4-times	4-times	CD
cord-005453-4057qib7	2353	35	daily	daily	RB
cord-005453-4057qib7	2353	36	.	.	.
cord-005453-4057qib7	2354	1	This	this	DT
cord-005453-4057qib7	2354	2	study	study	NN
cord-005453-4057qib7	2354	3	aimed	aim	VBD
cord-005453-4057qib7	2354	4	to	to	TO
cord-005453-4057qib7	2354	5	compare	compare	VB
cord-005453-4057qib7	2354	6	the	the	DT
cord-005453-4057qib7	2354	7	saftey	saftey	NN
cord-005453-4057qib7	2354	8	and	and	CC
cord-005453-4057qib7	2354	9	efficacy	efficacy	NN
cord-005453-4057qib7	2354	10	of	of	IN
cord-005453-4057qib7	2354	11	this	this	DT
cord-005453-4057qib7	2354	12	schedule	schedule	NN
cord-005453-4057qib7	2354	13	to	to	IN
cord-005453-4057qib7	2354	14	a	a	DT
cord-005453-4057qib7	2354	15	once	once	RB
cord-005453-4057qib7	2354	16	-	-	HYPH
cord-005453-4057qib7	2354	17	daily	daily	NN
cord-005453-4057qib7	2354	18	iv	iv	NNP
cord-005453-4057qib7	2354	19	Bu	Bu	NNP
cord-005453-4057qib7	2354	20	.	.	.
cord-005453-4057qib7	2355	1	We	-PRON-	PRP
cord-005453-4057qib7	2355	2	conducted	conduct	VBD
cord-005453-4057qib7	2355	3	a	a	DT
cord-005453-4057qib7	2355	4	retrospective	retrospective	JJ
cord-005453-4057qib7	2355	5	study	study	NN
cord-005453-4057qib7	2355	6	in	in	IN
cord-005453-4057qib7	2355	7	adult	adult	NN
cord-005453-4057qib7	2355	8	patients	patient	NNS
cord-005453-4057qib7	2355	9	(	(	-LRB-
cord-005453-4057qib7	2355	10	≥18	≥18	IN
cord-005453-4057qib7	2355	11	years	year	NNS
cord-005453-4057qib7	2355	12	)	)	-RRB-
cord-005453-4057qib7	2355	13	with	with	IN
cord-005453-4057qib7	2355	14	myeloid	myeloid	JJ
cord-005453-4057qib7	2355	15	malignancies	malignancy	NNS
cord-005453-4057qib7	2355	16	who	who	WP
cord-005453-4057qib7	2355	17	received	receive	VBD
cord-005453-4057qib7	2355	18	ASCT	ASCT	NNP
cord-005453-4057qib7	2355	19	from	from	IN
cord-005453-4057qib7	2355	20	HLA	HLA	NNP
cord-005453-4057qib7	2355	21	-	-	HYPH
cord-005453-4057qib7	2355	22	identical	identical	JJ
cord-005453-4057qib7	2355	23	sibling	sibling	NN
cord-005453-4057qib7	2355	24	donors	donor	NNS
cord-005453-4057qib7	2355	25	between	between	IN
cord-005453-4057qib7	2355	26	January	January	NNP
cord-005453-4057qib7	2355	27	2011	2011	CD
cord-005453-4057qib7	2355	28	and	and	CC
cord-005453-4057qib7	2355	29	June	June	NNP
cord-005453-4057qib7	2355	30	2018	2018	CD
cord-005453-4057qib7	2355	31	following	follow	VBG
cord-005453-4057qib7	2355	32	iv	iv	NNP
cord-005453-4057qib7	2355	33	Bu	Bu	NNP
cord-005453-4057qib7	2355	34	-	-	HYPH
cord-005453-4057qib7	2355	35	based	base	VBN
cord-005453-4057qib7	2355	36	preparative	preparative	JJ
cord-005453-4057qib7	2355	37	regimens	regimen	NNS
cord-005453-4057qib7	2355	38	.	.	.
cord-005453-4057qib7	2356	1	Graft	graft	NN
cord-005453-4057qib7	2356	2	-	-	HYPH
cord-005453-4057qib7	2356	3	versus	versus	NN
cord-005453-4057qib7	2356	4	host	host	NN
cord-005453-4057qib7	2356	5	disease	disease	NN
cord-005453-4057qib7	2356	6	(	(	-LRB-
cord-005453-4057qib7	2356	7	GVHD	GVHD	NNP
cord-005453-4057qib7	2356	8	)	)	-RRB-
cord-005453-4057qib7	2356	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2356	10	consited	consite	VBN
cord-005453-4057qib7	2356	11	of	of	IN
cord-005453-4057qib7	2356	12	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	2356	13	and	and	CC
cord-005453-4057qib7	2356	14	short	short	JJ
cord-005453-4057qib7	2356	15	course	course	NN
cord-005453-4057qib7	2356	16	of	of	IN
cord-005453-4057qib7	2356	17	methotrexate	methotrexate	NNP
cord-005453-4057qib7	2356	18	.	.	.
cord-005453-4057qib7	2357	1	Intravenous	Intravenous	NNP
cord-005453-4057qib7	2357	2	Bu	Bu	NNP
cord-005453-4057qib7	2357	3	was	be	VBD
cord-005453-4057qib7	2357	4	administered	administer	VBN
cord-005453-4057qib7	2357	5	4-times	4-times	CD
cord-005453-4057qib7	2357	6	daily	daily	NN
cord-005453-4057qib7	2357	7	(	(	-LRB-
cord-005453-4057qib7	2357	8	0.8	0.8	CD
cord-005453-4057qib7	2357	9	mg	mg	NNP
cord-005453-4057qib7	2357	10	/	/	SYM
cord-005453-4057qib7	2357	11	kg	kg	NNP
cord-005453-4057qib7	2358	1	every	every	DT
cord-005453-4057qib7	2358	2	6	6	CD
cord-005453-4057qib7	2358	3	hours	hour	NNS
cord-005453-4057qib7	2358	4	x12	x12	CD
cord-005453-4057qib7	2358	5	to	to	IN
cord-005453-4057qib7	2358	6	16	16	CD
cord-005453-4057qib7	2358	7	doses	dose	NNS
cord-005453-4057qib7	2358	8	)	)	-RRB-
cord-005453-4057qib7	2358	9	or	or	CC
cord-005453-4057qib7	2358	10	oncedaily	oncedaily	RB
cord-005453-4057qib7	2358	11	in	in	IN
cord-005453-4057qib7	2358	12	a	a	DT
cord-005453-4057qib7	2358	13	3-hour	3-hour	CD
cord-005453-4057qib7	2358	14	infusion	infusion	NN
cord-005453-4057qib7	2358	15	(	(	-LRB-
cord-005453-4057qib7	2358	16	3.2	3.2	CD
cord-005453-4057qib7	2358	17	mg	mg	NNP
cord-005453-4057qib7	2358	18	/	/	SYM
cord-005453-4057qib7	2358	19	kg	kg	NNP
cord-005453-4057qib7	2358	20	x	x	SYM
cord-005453-4057qib7	2358	21	3	3	CD
cord-005453-4057qib7	2358	22	to	to	TO
cord-005453-4057qib7	2358	23	4	4	CD
cord-005453-4057qib7	2358	24	days	day	NNS
cord-005453-4057qib7	2358	25	)	)	-RRB-
cord-005453-4057qib7	2358	26	since	since	IN
cord-005453-4057qib7	2358	27	June	June	NNP
cord-005453-4057qib7	2358	28	2015	2015	CD
cord-005453-4057qib7	2358	29	.	.	.
cord-005453-4057qib7	2359	1	Results	result	NNS
cord-005453-4057qib7	2359	2	:	:	:
cord-005453-4057qib7	2360	1	Ninty	ninty	CD
cord-005453-4057qib7	2360	2	-	-	HYPH
cord-005453-4057qib7	2360	3	nine	nine	CD
cord-005453-4057qib7	2360	4	patients	patient	NNS
cord-005453-4057qib7	2360	5	were	be	VBD
cord-005453-4057qib7	2360	6	enrolled	enrol	VBN
cord-005453-4057qib7	2360	7	(	(	-LRB-
cord-005453-4057qib7	2360	8	54	54	CD
cord-005453-4057qib7	2360	9	men	man	NNS
cord-005453-4057qib7	2360	10	and	and	CC
cord-005453-4057qib7	2360	11	45	45	CD
cord-005453-4057qib7	2360	12	women	woman	NNS
cord-005453-4057qib7	2360	13	)	)	-RRB-
cord-005453-4057qib7	2360	14	.	.	.
cord-005453-4057qib7	2361	1	Median	median	JJ
cord-005453-4057qib7	2361	2	age	age	NN
cord-005453-4057qib7	2361	3	was	be	VBD
cord-005453-4057qib7	2361	4	35	35	CD
cord-005453-4057qib7	2361	5	years	year	NNS
cord-005453-4057qib7	2362	1	(	(	-LRB-
cord-005453-4057qib7	2362	2	range	range	NN
cord-005453-4057qib7	2362	3	,	,	,
cord-005453-4057qib7	2362	4	18	18	CD
cord-005453-4057qib7	2362	5	-	-	SYM
cord-005453-4057qib7	2362	6	50	50	CD
cord-005453-4057qib7	2362	7	y	y	NN
cord-005453-4057qib7	2362	8	)	)	-RRB-
cord-005453-4057qib7	2362	9	.	.	.
cord-005453-4057qib7	2363	1	The	the	DT
cord-005453-4057qib7	2363	2	median	median	JJ
cord-005453-4057qib7	2363	3	time	time	NN
cord-005453-4057qib7	2363	4	from	from	IN
cord-005453-4057qib7	2363	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	2363	6	to	to	IN
cord-005453-4057qib7	2363	7	ASCT	ASCT	NNP
cord-005453-4057qib7	2363	8	was	be	VBD
cord-005453-4057qib7	2363	9	5	5	CD
cord-005453-4057qib7	2363	10	months	month	NNS
cord-005453-4057qib7	2363	11	(	(	-LRB-
cord-005453-4057qib7	2363	12	range	range	NN
cord-005453-4057qib7	2363	13	,	,	,
cord-005453-4057qib7	2363	14	51days	51days	CD
cord-005453-4057qib7	2363	15	-7	-7	CD
cord-005453-4057qib7	2363	16	years	year	NNS
cord-005453-4057qib7	2363	17	)	)	-RRB-
cord-005453-4057qib7	2363	18	.	.	.
cord-005453-4057qib7	2364	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	2364	2	were	be	VBD
cord-005453-4057qib7	2364	3	acute	acute	JJ
cord-005453-4057qib7	2364	4	myeloid	myeloid	JJ
cord-005453-4057qib7	2364	5	leukemia	leukemia	NN
cord-005453-4057qib7	2364	6	(	(	-LRB-
cord-005453-4057qib7	2364	7	n=79	n=79	NN
cord-005453-4057qib7	2364	8	,	,	,
cord-005453-4057qib7	2364	9	80	80	CD
cord-005453-4057qib7	2364	10	%	%	NN
cord-005453-4057qib7	2364	11	)	)	-RRB-
cord-005453-4057qib7	2364	12	,	,	,
cord-005453-4057qib7	2364	13	chronic	chronic	JJ
cord-005453-4057qib7	2364	14	myeloid	myeloid	NN
cord-005453-4057qib7	2364	15	leukemia	leukemia	NN
cord-005453-4057qib7	2364	16	(	(	-LRB-
cord-005453-4057qib7	2364	17	n=8	n=8	NN
cord-005453-4057qib7	2364	18	,	,	,
cord-005453-4057qib7	2364	19	8	8	CD
cord-005453-4057qib7	2364	20	%	%	NN
cord-005453-4057qib7	2364	21	)	)	-RRB-
cord-005453-4057qib7	2364	22	,	,	,
cord-005453-4057qib7	2364	23	myelodysplasic	myelodysplasic	NNP
cord-005453-4057qib7	2364	24	syndrome	syndrome	NNP
cord-005453-4057qib7	2364	25	(	(	-LRB-
cord-005453-4057qib7	2364	26	n=6	n=6	NNP
cord-005453-4057qib7	2364	27	,	,	,
cord-005453-4057qib7	2364	28	6	6	CD
cord-005453-4057qib7	2364	29	%	%	NN
cord-005453-4057qib7	2364	30	)	)	-RRB-
cord-005453-4057qib7	2364	31	,	,	,
cord-005453-4057qib7	2364	32	primitive	primitive	JJ
cord-005453-4057qib7	2364	33	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	2364	34	(	(	-LRB-
cord-005453-4057qib7	2364	35	n=4	n=4	NNP
cord-005453-4057qib7	2364	36	,	,	,
cord-005453-4057qib7	2364	37	4	4	CD
cord-005453-4057qib7	2364	38	%	%	NN
cord-005453-4057qib7	2364	39	)	)	-RRB-
cord-005453-4057qib7	2364	40	and	and	CC
cord-005453-4057qib7	2364	41	chronic	chronic	JJ
cord-005453-4057qib7	2364	42	myelomonocytic	myelomonocytic	JJ
cord-005453-4057qib7	2364	43	leukemia	leukemia	NN
cord-005453-4057qib7	2364	44	(	(	-LRB-
cord-005453-4057qib7	2364	45	n=2	n=2	NNS
cord-005453-4057qib7	2364	46	,	,	,
cord-005453-4057qib7	2364	47	2	2	CD
cord-005453-4057qib7	2364	48	%	%	NN
cord-005453-4057qib7	2364	49	)	)	-RRB-
cord-005453-4057qib7	2364	50	.	.	.
cord-005453-4057qib7	2365	1	Thirty	thirty	CD
cord-005453-4057qib7	2365	2	-	-	HYPH
cord-005453-4057qib7	2365	3	seven	seven	CD
cord-005453-4057qib7	2365	4	(	(	-LRB-
cord-005453-4057qib7	2365	5	37.3	37.3	CD
cord-005453-4057qib7	2365	6	%	%	NN
cord-005453-4057qib7	2365	7	)	)	-RRB-
cord-005453-4057qib7	2365	8	patients	patient	NNS
cord-005453-4057qib7	2365	9	had	have	VBD
cord-005453-4057qib7	2365	10	EBMT	EBMT	NNP
cord-005453-4057qib7	2365	11	-	-	HYPH
cord-005453-4057qib7	2365	12	score	score	NN
cord-005453-4057qib7	2365	13	≥2	≥2	NNP
cord-005453-4057qib7	2365	14	.	.	.
cord-005453-4057qib7	2366	1	Sixty	sixty	CD
cord-005453-4057qib7	2366	2	-	-	HYPH
cord-005453-4057qib7	2366	3	five	five	CD
cord-005453-4057qib7	2366	4	(	(	-LRB-
cord-005453-4057qib7	2366	5	65.6	65.6	CD
cord-005453-4057qib7	2366	6	%	%	NN
cord-005453-4057qib7	2366	7	)	)	-RRB-
cord-005453-4057qib7	2366	8	patients	patient	NNS
cord-005453-4057qib7	2366	9	were	be	VBD
cord-005453-4057qib7	2366	10	transplanted	transplant	VBN
cord-005453-4057qib7	2366	11	in	in	IN
cord-005453-4057qib7	2366	12	CR1	CR1	NNP
cord-005453-4057qib7	2366	13	,	,	,
cord-005453-4057qib7	2366	14	5	5	CD
cord-005453-4057qib7	2366	15	(	(	-LRB-
cord-005453-4057qib7	2366	16	5	5	CD
cord-005453-4057qib7	2366	17	%	%	NN
cord-005453-4057qib7	2366	18	)	)	-RRB-
cord-005453-4057qib7	2366	19	beyond	beyond	IN
cord-005453-4057qib7	2366	20	CR1	CR1	NNP
cord-005453-4057qib7	2366	21	and	and	CC
cord-005453-4057qib7	2366	22	24	24	CD
cord-005453-4057qib7	2366	23	(	(	-LRB-
cord-005453-4057qib7	2366	24	24.2	24.2	CD
cord-005453-4057qib7	2366	25	%	%	NN
cord-005453-4057qib7	2366	26	)	)	-RRB-
cord-005453-4057qib7	2366	27	had	have	VBD
cord-005453-4057qib7	2366	28	active	active	JJ
cord-005453-4057qib7	2366	29	disease	disease	NN
cord-005453-4057qib7	2366	30	.	.	.
cord-005453-4057qib7	2367	1	Conditioning	conditioning	NN
cord-005453-4057qib7	2367	2	regimens	regimen	NNS
cord-005453-4057qib7	2367	3	consisted	consist	VBN
cord-005453-4057qib7	2367	4	of	of	IN
cord-005453-4057qib7	2367	5	Bu	Bu	NNP
cord-005453-4057qib7	2367	6	/	/	,
cord-005453-4057qib7	2367	7	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	2367	8	in	in	IN
cord-005453-4057qib7	2367	9	86	86	CD
cord-005453-4057qib7	2367	10	patients	patient	NNS
cord-005453-4057qib7	2367	11	(	(	-LRB-
cord-005453-4057qib7	2367	12	86.8	86.8	CD
cord-005453-4057qib7	2367	13	%	%	NN
cord-005453-4057qib7	2367	14	)	)	-RRB-
cord-005453-4057qib7	2368	1	,	,	,
cord-005453-4057qib7	2368	2	Bu	Bu	NNP
cord-005453-4057qib7	2368	3	/	/	SYM
cord-005453-4057qib7	2368	4	fludarabine	fludarabine	NN
cord-005453-4057qib7	2368	5	in	in	IN
cord-005453-4057qib7	2368	6	13	13	CD
cord-005453-4057qib7	2368	7	patients	patient	NNS
cord-005453-4057qib7	2368	8	(	(	-LRB-
cord-005453-4057qib7	2368	9	13.1	13.1	CD
cord-005453-4057qib7	2368	10	%	%	NN
cord-005453-4057qib7	2368	11	)	)	-RRB-
cord-005453-4057qib7	2368	12	.	.	.
cord-005453-4057qib7	2369	1	Four	four	CD
cord-005453-4057qib7	2369	2	-	-	HYPH
cord-005453-4057qib7	2369	3	times	time	NNS
cord-005453-4057qib7	2369	4	daily	daily	JJ
cord-005453-4057qib7	2369	5	Bu	Bu	NNP
cord-005453-4057qib7	2369	6	was	be	VBD
cord-005453-4057qib7	2369	7	given	give	VBN
cord-005453-4057qib7	2369	8	to	to	IN
cord-005453-4057qib7	2369	9	58	58	CD
cord-005453-4057qib7	2369	10	patients	patient	NNS
cord-005453-4057qib7	2369	11	(	(	-LRB-
cord-005453-4057qib7	2369	12	58.5	58.5	CD
cord-005453-4057qib7	2369	13	%	%	NN
cord-005453-4057qib7	2369	14	,	,	,
cord-005453-4057qib7	2369	15	groupe1	groupe1	NN
cord-005453-4057qib7	2369	16	)	)	-RRB-
cord-005453-4057qib7	2369	17	and	and	CC
cord-005453-4057qib7	2369	18	once	once	RB
cord-005453-4057qib7	2369	19	-	-	HYPH
cord-005453-4057qib7	2369	20	daily	daily	NN
cord-005453-4057qib7	2369	21	Bu	Bu	NNP
cord-005453-4057qib7	2369	22	to	to	IN
cord-005453-4057qib7	2369	23	41	41	CD
cord-005453-4057qib7	2369	24	patients	patient	NNS
cord-005453-4057qib7	2369	25	(	(	-LRB-
cord-005453-4057qib7	2369	26	41.5	41.5	CD
cord-005453-4057qib7	2369	27	%	%	NN
cord-005453-4057qib7	2369	28	,	,	,
cord-005453-4057qib7	2369	29	groupe	groupe	NNP
cord-005453-4057qib7	2369	30	2	2	CD
cord-005453-4057qib7	2369	31	)	)	-RRB-
cord-005453-4057qib7	2369	32	.	.	.
cord-005453-4057qib7	2370	1	Stem	stem	JJ
cord-005453-4057qib7	2370	2	cell	cell	NN
cord-005453-4057qib7	2370	3	source	source	NN
cord-005453-4057qib7	2370	4	were	be	VBD
cord-005453-4057qib7	2370	5	BM	BM	NNP
cord-005453-4057qib7	2370	6	in	in	IN
cord-005453-4057qib7	2370	7	46	46	CD
cord-005453-4057qib7	2370	8	patients	patient	NNS
cord-005453-4057qib7	2370	9	(	(	-LRB-
cord-005453-4057qib7	2370	10	46.5	46.5	CD
cord-005453-4057qib7	2370	11	%	%	NN
cord-005453-4057qib7	2370	12	)	)	-RRB-
cord-005453-4057qib7	2370	13	and	and	CC
cord-005453-4057qib7	2370	14	PBSC	PBSC	NNP
cord-005453-4057qib7	2370	15	in	in	IN
cord-005453-4057qib7	2370	16	53	53	CD
cord-005453-4057qib7	2370	17	patients	patient	NNS
cord-005453-4057qib7	2370	18	(	(	-LRB-
cord-005453-4057qib7	2370	19	53.5	53.5	CD
cord-005453-4057qib7	2370	20	%	%	NN
cord-005453-4057qib7	2370	21	)	)	-RRB-
cord-005453-4057qib7	2370	22	.	.	.
cord-005453-4057qib7	2371	1	Globally	globally	RB
cord-005453-4057qib7	2371	2	,	,	,
cord-005453-4057qib7	2371	3	patients	patient	NNS
cord-005453-4057qib7	2371	4	characteristics	characteristic	NNS
cord-005453-4057qib7	2371	5	were	be	VBD
cord-005453-4057qib7	2371	6	well	well	RB
cord-005453-4057qib7	2371	7	balanced	balanced	JJ
cord-005453-4057qib7	2371	8	between	between	IN
cord-005453-4057qib7	2371	9	the	the	DT
cord-005453-4057qib7	2371	10	two	two	CD
cord-005453-4057qib7	2371	11	groups	group	NNS
cord-005453-4057qib7	2371	12	.	.	.
cord-005453-4057qib7	2372	1	The	the	DT
cord-005453-4057qib7	2372	2	rates	rate	NNS
cord-005453-4057qib7	2372	3	of	of	IN
cord-005453-4057qib7	2372	4	severe	severe	JJ
cord-005453-4057qib7	2372	5	complications	complication	NNS
cord-005453-4057qib7	2372	6	were	be	VBD
cord-005453-4057qib7	2372	7	similar	similar	JJ
cord-005453-4057qib7	2372	8	between	between	IN
cord-005453-4057qib7	2372	9	the	the	DT
cord-005453-4057qib7	2372	10	two	two	CD
cord-005453-4057qib7	2372	11	groups	group	NNS
cord-005453-4057qib7	2372	12	with	with	IN
cord-005453-4057qib7	2372	13	no	no	DT
cord-005453-4057qib7	2372	14	statistically	statistically	RB
cord-005453-4057qib7	2372	15	significant	significant	JJ
cord-005453-4057qib7	2372	16	differences	difference	NNS
cord-005453-4057qib7	2372	17	except	except	IN
cord-005453-4057qib7	2372	18	oral	oral	JJ
cord-005453-4057qib7	2372	19	mucositis	mucositis	NN
cord-005453-4057qib7	2372	20	(	(	-LRB-
cord-005453-4057qib7	2372	21	table1	table1	NN
cord-005453-4057qib7	2372	22	)	)	-RRB-
cord-005453-4057qib7	2372	23	.	.	.
cord-005453-4057qib7	2373	1	Non	non	JJ
cord-005453-4057qib7	2373	2	-	-	JJ
cord-005453-4057qib7	2373	3	relapse	relapse	JJ
cord-005453-4057qib7	2373	4	mortality	mortality	NN
cord-005453-4057qib7	2373	5	(	(	-LRB-
cord-005453-4057qib7	2373	6	NRM	NRM	NNP
cord-005453-4057qib7	2373	7	)	)	-RRB-
cord-005453-4057qib7	2373	8	was	be	VBD
cord-005453-4057qib7	2373	9	comparable	comparable	JJ
cord-005453-4057qib7	2373	10	in	in	IN
cord-005453-4057qib7	2373	11	the	the	DT
cord-005453-4057qib7	2373	12	two	two	CD
cord-005453-4057qib7	2373	13	groups	group	NNS
cord-005453-4057qib7	2373	14	(	(	-LRB-
cord-005453-4057qib7	2373	15	21	21	CD
cord-005453-4057qib7	2373	16	%	%	NN
cord-005453-4057qib7	2373	17	and	and	CC
cord-005453-4057qib7	2373	18	17	17	CD
cord-005453-4057qib7	2373	19	%	%	NN
cord-005453-4057qib7	2373	20	in	in	IN
cord-005453-4057qib7	2373	21	groups	group	NNS
cord-005453-4057qib7	2373	22	1	1	CD
cord-005453-4057qib7	2373	23	and	and	CC
cord-005453-4057qib7	2373	24	2	2	CD
cord-005453-4057qib7	2373	25	,	,	,
cord-005453-4057qib7	2373	26	respectively	respectively	RB
cord-005453-4057qib7	2373	27	,	,	,
cord-005453-4057qib7	2373	28	p=0.65	p=0.65	NNP
cord-005453-4057qib7	2373	29	)	)	-RRB-
cord-005453-4057qib7	2373	30	.	.	.
cord-005453-4057qib7	2374	1	The	the	DT
cord-005453-4057qib7	2374	2	relapse	relapse	NN
cord-005453-4057qib7	2374	3	rate	rate	NN
cord-005453-4057qib7	2374	4	was	be	VBD
cord-005453-4057qib7	2374	5	24	24	CD
cord-005453-4057qib7	2374	6	%	%	NN
cord-005453-4057qib7	2374	7	and	and	CC
cord-005453-4057qib7	2374	8	32	32	CD
cord-005453-4057qib7	2374	9	%	%	NN
cord-005453-4057qib7	2374	10	,	,	,
cord-005453-4057qib7	2374	11	respectively	respectively	RB
cord-005453-4057qib7	2374	12	(	(	-LRB-
cord-005453-4057qib7	2374	13	p=0.4	p=0.4	NNP
cord-005453-4057qib7	2374	14	)	)	-RRB-
cord-005453-4057qib7	2374	15	.	.	.
cord-005453-4057qib7	2375	1	After	after	IN
cord-005453-4057qib7	2375	2	a	a	DT
cord-005453-4057qib7	2375	3	median	median	JJ
cord-005453-4057qib7	2375	4	follow	follow	NN
cord-005453-4057qib7	2375	5	-	-	HYPH
cord-005453-4057qib7	2375	6	up	up	NN
cord-005453-4057qib7	2375	7	of	of	IN
cord-005453-4057qib7	2375	8	2	2	CD
cord-005453-4057qib7	2375	9	years	year	NNS
cord-005453-4057qib7	2375	10	(	(	-LRB-
cord-005453-4057qib7	2375	11	range	range	NN
cord-005453-4057qib7	2375	12	,	,	,
cord-005453-4057qib7	2375	13	5days	5days	CD
cord-005453-4057qib7	2375	14	-7years	-7year	NNS
cord-005453-4057qib7	2375	15	)	)	-RRB-
cord-005453-4057qib7	2375	16	,	,	,
cord-005453-4057qib7	2375	17	the	the	DT
cord-005453-4057qib7	2375	18	OS	OS	NNP
cord-005453-4057qib7	2375	19	was	be	VBD
cord-005453-4057qib7	2375	20	not	not	RB
cord-005453-4057qib7	2375	21	significantly	significantly	RB
cord-005453-4057qib7	2375	22	different	different	JJ
cord-005453-4057qib7	2375	23	between	between	IN
cord-005453-4057qib7	2375	24	groups	group	NNS
cord-005453-4057qib7	2375	25	1	1	CD
cord-005453-4057qib7	2375	26	and	and	CC
cord-005453-4057qib7	2375	27	2	2	CD
cord-005453-4057qib7	2375	28	:	:	:
cord-005453-4057qib7	2375	29	64	64	CD
cord-005453-4057qib7	2375	30	%	%	NN
cord-005453-4057qib7	2375	31	vs	vs	IN
cord-005453-4057qib7	2375	32	56	56	CD
cord-005453-4057qib7	2375	33	%	%	NN
cord-005453-4057qib7	2375	34	(	(	-LRB-
cord-005453-4057qib7	2375	35	p=0.09	p=0.09	NN
cord-005453-4057qib7	2375	36	)	)	-RRB-
cord-005453-4057qib7	2375	37	.	.	.
cord-005453-4057qib7	2376	1	However	however	RB
cord-005453-4057qib7	2376	2	,	,	,
cord-005453-4057qib7	2376	3	the	the	DT
cord-005453-4057qib7	2376	4	RFS	RFS	NNP
cord-005453-4057qib7	2376	5	was	be	VBD
cord-005453-4057qib7	2376	6	significantly	significantly	RB
cord-005453-4057qib7	2376	7	better	well	JJR
cord-005453-4057qib7	2376	8	in	in	IN
cord-005453-4057qib7	2376	9	the	the	DT
cord-005453-4057qib7	2376	10	groupe	groupe	NNP
cord-005453-4057qib7	2376	11	1	1	CD
cord-005453-4057qib7	2376	12	:	:	:
cord-005453-4057qib7	2376	13	62	62	CD
cord-005453-4057qib7	2376	14	%	%	NN
cord-005453-4057qib7	2376	15	vs	vs	IN
cord-005453-4057qib7	2376	16	56	56	CD
cord-005453-4057qib7	2376	17	%	%	NN
cord-005453-4057qib7	2376	18	(	(	-LRB-
cord-005453-4057qib7	2376	19	p=0.03	p=0.03	NN
cord-005453-4057qib7	2376	20	)	)	-RRB-
cord-005453-4057qib7	2376	21	.	.	.
cord-005453-4057qib7	2377	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2377	2	:	:	:
cord-005453-4057qib7	2378	1	Once	once	RB
cord-005453-4057qib7	2378	2	-	-	HYPH
cord-005453-4057qib7	2378	3	daily	daily	NN
cord-005453-4057qib7	2378	4	iv	iv	.
cord-005453-4057qib7	2378	5	Bu	Bu	NNP
cord-005453-4057qib7	2378	6	regimen	regimen	NN
cord-005453-4057qib7	2378	7	seems	seem	VBZ
cord-005453-4057qib7	2378	8	to	to	TO
cord-005453-4057qib7	2378	9	be	be	VB
cord-005453-4057qib7	2378	10	an	an	DT
cord-005453-4057qib7	2378	11	efficient	efficient	JJ
cord-005453-4057qib7	2378	12	and	and	CC
cord-005453-4057qib7	2378	13	safe	safe	JJ
cord-005453-4057qib7	2378	14	alternative	alternative	NN
cord-005453-4057qib7	2378	15	to	to	IN
cord-005453-4057qib7	2378	16	the	the	DT
cord-005453-4057qib7	2378	17	4-times	4-times	CD
cord-005453-4057qib7	2378	18	daily	daily	JJ
cord-005453-4057qib7	2378	19	protocol	protocol	NN
cord-005453-4057qib7	2378	20	.	.	.
cord-005453-4057qib7	2379	1	However	however	RB
cord-005453-4057qib7	2379	2	,	,	,
cord-005453-4057qib7	2379	3	results	result	NNS
cord-005453-4057qib7	2379	4	should	should	MD
cord-005453-4057qib7	2379	5	be	be	VB
cord-005453-4057qib7	2379	6	interpreted	interpret	VBN
cord-005453-4057qib7	2379	7	with	with	IN
cord-005453-4057qib7	2379	8	caution	caution	NN
cord-005453-4057qib7	2379	9	because	because	IN
cord-005453-4057qib7	2379	10	the	the	DT
cord-005453-4057qib7	2379	11	historical	historical	JJ
cord-005453-4057qib7	2379	12	comparison	comparison	NN
cord-005453-4057qib7	2379	13	and	and	CC
cord-005453-4057qib7	2379	14	lack	lack	NN
cord-005453-4057qib7	2379	15	of	of	IN
cord-005453-4057qib7	2379	16	Bu	Bu	NNP
cord-005453-4057qib7	2379	17	pharmacokinetics	pharmacokinetics	NNP
cord-005453-4057qib7	2379	18	studies	study	NNS
cord-005453-4057qib7	2379	19	.	.	.
cord-005453-4057qib7	2380	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2380	2	Background	background	NN
cord-005453-4057qib7	2380	3	:	:	:
cord-005453-4057qib7	2381	1	Standard	standard	JJ
cord-005453-4057qib7	2381	2	therapy	therapy	NN
cord-005453-4057qib7	2381	3	of	of	IN
cord-005453-4057qib7	2381	4	the	the	DT
cord-005453-4057qib7	2381	5	most	most	JJS
cord-005453-4057qib7	2381	6	patients	patient	NNS
cord-005453-4057qib7	2381	7	with	with	IN
cord-005453-4057qib7	2381	8	juvenile	juvenile	JJ
cord-005453-4057qib7	2381	9	myelomonocytic	myelomonocytic	NN
cord-005453-4057qib7	2381	10	leukemia	leukemia	NN
cord-005453-4057qib7	2381	11	(	(	-LRB-
cord-005453-4057qib7	2381	12	JMML	JMML	NNP
cord-005453-4057qib7	2381	13	)	)	-RRB-
cord-005453-4057qib7	2381	14	is	be	VBZ
cord-005453-4057qib7	2381	15	allogeneic	allogeneic	VBG
cord-005453-4057qib7	2381	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2381	17	stem	stem	NN
cord-005453-4057qib7	2381	18	cell	cell	NN
cord-005453-4057qib7	2381	19	transplantation	transplantation	NN
cord-005453-4057qib7	2381	20	(	(	-LRB-
cord-005453-4057qib7	2381	21	aHSCT	aHSCT	NNP
cord-005453-4057qib7	2381	22	)	)	-RRB-
cord-005453-4057qib7	2381	23	.	.	.
cord-005453-4057qib7	2382	1	The	the	DT
cord-005453-4057qib7	2382	2	choice	choice	NN
cord-005453-4057qib7	2382	3	of	of	IN
cord-005453-4057qib7	2382	4	optimal	optimal	JJ
cord-005453-4057qib7	2382	5	conditioning	conditioning	NN
cord-005453-4057qib7	2382	6	regimen	regimen	NN
cord-005453-4057qib7	2382	7	for	for	IN
cord-005453-4057qib7	2382	8	patients	patient	NNS
cord-005453-4057qib7	2382	9	with	with	IN
cord-005453-4057qib7	2382	10	JMML	JMML	NNP
cord-005453-4057qib7	2382	11	is	be	VBZ
cord-005453-4057qib7	2382	12	crucial	crucial	JJ
cord-005453-4057qib7	2382	13	as	as	RB
cord-005453-4057qib7	2382	14	well	well	RB
cord-005453-4057qib7	2382	15	as	as	IN
cord-005453-4057qib7	2382	16	long	long	JJ
cord-005453-4057qib7	2382	17	-	-	HYPH
cord-005453-4057qib7	2382	18	term	term	NN
cord-005453-4057qib7	2382	19	observation	observation	NN
cord-005453-4057qib7	2382	20	.	.	.
cord-005453-4057qib7	2383	1	We	-PRON-	PRP
cord-005453-4057qib7	2383	2	aimed	aim	VBD
cord-005453-4057qib7	2383	3	to	to	TO
cord-005453-4057qib7	2383	4	estimate	estimate	VB
cord-005453-4057qib7	2383	5	the	the	DT
cord-005453-4057qib7	2383	6	long	long	JJ
cord-005453-4057qib7	2383	7	-	-	HYPH
cord-005453-4057qib7	2383	8	term	term	NN
cord-005453-4057qib7	2383	9	follow	follow	NN
cord-005453-4057qib7	2383	10	-	-	HYPH
cord-005453-4057qib7	2383	11	up	up	NN
cord-005453-4057qib7	2383	12	and	and	CC
cord-005453-4057qib7	2383	13	survival	survival	NN
cord-005453-4057qib7	2383	14	rates	rate	NNS
cord-005453-4057qib7	2383	15	of	of	IN
cord-005453-4057qib7	2383	16	patients	patient	NNS
cord-005453-4057qib7	2383	17	with	with	IN
cord-005453-4057qib7	2383	18	JMML	JMML	NNP
cord-005453-4057qib7	2383	19	after	after	IN
cord-005453-4057qib7	2383	20	aHSCT	ahsct	NN
cord-005453-4057qib7	2383	21	with	with	IN
cord-005453-4057qib7	2383	22	the	the	DT
cord-005453-4057qib7	2383	23	help	help	NN
cord-005453-4057qib7	2383	24	of	of	IN
cord-005453-4057qib7	2383	25	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2383	26	or	or	CC
cord-005453-4057qib7	2383	27	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2383	28	-	-	HYPH
cord-005453-4057qib7	2383	29	based	base	VBN
cord-005453-4057qib7	2383	30	conditioning	conditioning	NN
cord-005453-4057qib7	2383	31	regimens	regimen	NNS
cord-005453-4057qib7	2383	32	.	.	.
cord-005453-4057qib7	2384	1	Methods	method	NNS
cord-005453-4057qib7	2384	2	:	:	:
cord-005453-4057qib7	2385	1	Thirty	thirty	CD
cord-005453-4057qib7	2385	2	eight	eight	CD
cord-005453-4057qib7	2385	3	patients	patient	NNS
cord-005453-4057qib7	2385	4	with	with	IN
cord-005453-4057qib7	2385	5	JMML	JMML	NNP
cord-005453-4057qib7	2385	6	underwent	undergo	VBD
cord-005453-4057qib7	2385	7	aHSCT	ahsct	NN
cord-005453-4057qib7	2385	8	in	in	IN
cord-005453-4057qib7	2385	9	2002	2002	CD
cord-005453-4057qib7	2385	10	-	-	SYM
cord-005453-4057qib7	2385	11	2018	2018	CD
cord-005453-4057qib7	2385	12	.	.	.
cord-005453-4057qib7	2386	1	We	-PRON-	PRP
cord-005453-4057qib7	2386	2	compared	compare	VBD
cord-005453-4057qib7	2386	3	equal	equal	JJ
cord-005453-4057qib7	2386	4	groups	group	NNS
cord-005453-4057qib7	2386	5	of	of	IN
cord-005453-4057qib7	2386	6	patients	patient	NNS
cord-005453-4057qib7	2386	7	received	receive	VBD
cord-005453-4057qib7	2386	8	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2386	9	(	(	-LRB-
cord-005453-4057qib7	2386	10	n=19	n=19	NN
cord-005453-4057qib7	2386	11	)	)	-RRB-
cord-005453-4057qib7	2386	12	and	and	CC
cord-005453-4057qib7	2386	13	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2386	14	-	-	HYPH
cord-005453-4057qib7	2386	15	based	base	VBN
cord-005453-4057qib7	2386	16	(	(	-LRB-
cord-005453-4057qib7	2386	17	n=19	n=19	JJ
cord-005453-4057qib7	2386	18	)	)	-RRB-
cord-005453-4057qib7	2386	19	conditioning	conditioning	NN
cord-005453-4057qib7	2386	20	regimen	regimen	NN
cord-005453-4057qib7	2386	21	.	.	.
cord-005453-4057qib7	2387	1	M	M	NNP
cord-005453-4057qib7	2387	2	:	:	:
cord-005453-4057qib7	2388	1	F=28:11	F=28:11	NNP
cord-005453-4057qib7	2388	2	.	.	.
cord-005453-4057qib7	2389	1	Median	median	NN
cord-005453-4057qib7	2389	2	of	of	IN
cord-005453-4057qib7	2389	3	age	age	NN
cord-005453-4057qib7	2389	4	at	at	IN
cord-005453-4057qib7	2389	5	HSCT	HSCT	NNP
cord-005453-4057qib7	2389	6	was	be	VBD
cord-005453-4057qib7	2389	7	2.5	2.5	CD
cord-005453-4057qib7	2389	8	(	(	-LRB-
cord-005453-4057qib7	2389	9	0.6	0.6	CD
cord-005453-4057qib7	2389	10	-	-	SYM
cord-005453-4057qib7	2389	11	5	5	CD
cord-005453-4057qib7	2389	12	)	)	-RRB-
cord-005453-4057qib7	2389	13	.	.	.
cord-005453-4057qib7	2390	1	Donor	donor	NN
cord-005453-4057qib7	2390	2	type	type	NN
cord-005453-4057qib7	2390	3	:	:	:
cord-005453-4057qib7	2390	4	HLA	HLA	NNP
cord-005453-4057qib7	2390	5	-	-	HYPH
cord-005453-4057qib7	2390	6	related	relate	VBN
cord-005453-4057qib7	2390	7	10/10	10/10	CD
cord-005453-4057qib7	2390	8	-29	-29	CD
cord-005453-4057qib7	2390	9	%	%	NN
cord-005453-4057qib7	2390	10	(	(	-LRB-
cord-005453-4057qib7	2390	11	n=11	n=11	NNP
cord-005453-4057qib7	2390	12	)	)	-RRB-
cord-005453-4057qib7	2390	13	,	,	,
cord-005453-4057qib7	2390	14	HLA	HLA	NNP
cord-005453-4057qib7	2390	15	-	-	HYPH
cord-005453-4057qib7	2390	16	related	relate	VBN
cord-005453-4057qib7	2390	17	9/10	9/10	CD
cord-005453-4057qib7	2390	18	-2.6	-2.6	CD
cord-005453-4057qib7	2390	19	%	%	NN
cord-005453-4057qib7	2390	20	(	(	-LRB-
cord-005453-4057qib7	2390	21	n=1	n=1	CD
cord-005453-4057qib7	2390	22	)	)	-RRB-
cord-005453-4057qib7	2390	23	,	,	,
cord-005453-4057qib7	2390	24	HLAunrelated	HLAunrelated	NNP
cord-005453-4057qib7	2390	25	10/10	10/10	CD
cord-005453-4057qib7	2390	26	-39.4	-39.4	CD
cord-005453-4057qib7	2390	27	%	%	NN
cord-005453-4057qib7	2390	28	(	(	-LRB-
cord-005453-4057qib7	2390	29	n=15	n=15	NNP
cord-005453-4057qib7	2390	30	)	)	-RRB-
cord-005453-4057qib7	2390	31	,	,	,
cord-005453-4057qib7	2390	32	HLA	HLA	NNP
cord-005453-4057qib7	2390	33	-	-	HYPH
cord-005453-4057qib7	2390	34	unrelated	unrelated	JJ
cord-005453-4057qib7	2390	35	9/10	9/10	CD
cord-005453-4057qib7	2390	36	-15.8	-15.8	CD
cord-005453-4057qib7	2390	37	%	%	NN
cord-005453-4057qib7	2390	38	(	(	-LRB-
cord-005453-4057qib7	2390	39	n=6	n=6	NNP
cord-005453-4057qib7	2390	40	)	)	-RRB-
cord-005453-4057qib7	2390	41	,	,	,
cord-005453-4057qib7	2390	42	and	and	CC
cord-005453-4057qib7	2390	43	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2390	44	-13.2	-13.2	CD
cord-005453-4057qib7	2390	45	%	%	NN
cord-005453-4057qib7	2390	46	(	(	-LRB-
cord-005453-4057qib7	2390	47	n=5	n=5	NNP
cord-005453-4057qib7	2390	48	)	)	-RRB-
cord-005453-4057qib7	2390	49	.	.	.
cord-005453-4057qib7	2391	1	Stem	stem	JJ
cord-005453-4057qib7	2391	2	cell	cell	NN
cord-005453-4057qib7	2391	3	source	source	NN
cord-005453-4057qib7	2391	4	:	:	:
cord-005453-4057qib7	2391	5	BM	BM	NNP
cord-005453-4057qib7	2391	6	-55.3	-55.3	CD
cord-005453-4057qib7	2391	7	%	%	NN
cord-005453-4057qib7	2391	8	(	(	-LRB-
cord-005453-4057qib7	2391	9	n=21	n=21	NNP
cord-005453-4057qib7	2391	10	)	)	-RRB-
cord-005453-4057qib7	2391	11	,	,	,
cord-005453-4057qib7	2391	12	PBSC	PBSC	NNP
cord-005453-4057qib7	2391	13	-26.3	-26.3	DT
cord-005453-4057qib7	2391	14	%	%	NN
cord-005453-4057qib7	2391	15	(	(	-LRB-
cord-005453-4057qib7	2391	16	n=10	n=10	NNP
cord-005453-4057qib7	2391	17	)	)	-RRB-
cord-005453-4057qib7	2391	18	,	,	,
cord-005453-4057qib7	2391	19	UCB	UCB	NNP
cord-005453-4057qib7	2391	20	-10,5	-10,5	NNP
cord-005453-4057qib7	2391	21	%	%	NN
cord-005453-4057qib7	2391	22	(	(	-LRB-
cord-005453-4057qib7	2391	23	n=4	n=4	NNP
cord-005453-4057qib7	2391	24	)	)	-RRB-
cord-005453-4057qib7	2391	25	,	,	,
cord-005453-4057qib7	2391	26	and	and	CC
cord-005453-4057qib7	2391	27	UCB+BM	UCB+BM	NNP
cord-005453-4057qib7	2391	28	-7.9	-7.9	HYPH
cord-005453-4057qib7	2391	29	%	%	NN
cord-005453-4057qib7	2391	30	(	(	-LRB-
cord-005453-4057qib7	2391	31	n=3	n=3	NN
cord-005453-4057qib7	2391	32	)	)	-RRB-
cord-005453-4057qib7	2391	33	.	.	.
cord-005453-4057qib7	2392	1	Disease	disease	NN
cord-005453-4057qib7	2392	2	status	status	NN
cord-005453-4057qib7	2392	3	on	on	IN
cord-005453-4057qib7	2392	4	HSCT	HSCT	NNP
cord-005453-4057qib7	2392	5	:	:	:
cord-005453-4057qib7	2393	1	CR	CR	NNP
cord-005453-4057qib7	2393	2	-73.7	-73.7	CD
cord-005453-4057qib7	2393	3	%	%	NN
cord-005453-4057qib7	2393	4	(	(	-LRB-
cord-005453-4057qib7	2393	5	n=28	n=28	RB
cord-005453-4057qib7	2393	6	)	)	-RRB-
cord-005453-4057qib7	2393	7	,	,	,
cord-005453-4057qib7	2393	8	Refractory	Refractory	NNP
cord-005453-4057qib7	2393	9	-26.3	-26.3	NNP
cord-005453-4057qib7	2393	10	%	%	NN
cord-005453-4057qib7	2393	11	(	(	-LRB-
cord-005453-4057qib7	2393	12	n=10	n=10	NNP
cord-005453-4057qib7	2393	13	)	)	-RRB-
cord-005453-4057qib7	2393	14	.	.	.
cord-005453-4057qib7	2394	1	Results	result	NNS
cord-005453-4057qib7	2394	2	:	:	:
cord-005453-4057qib7	2395	1	Median	median	JJ
cord-005453-4057qib7	2395	2	follow	follow	NN
cord-005453-4057qib7	2395	3	-	-	HYPH
cord-005453-4057qib7	2395	4	up	up	NN
cord-005453-4057qib7	2395	5	15.5	15.5	CD
cord-005453-4057qib7	2395	6	months	month	NNS
cord-005453-4057qib7	2395	7	(	(	-LRB-
cord-005453-4057qib7	2395	8	1	1	CD
cord-005453-4057qib7	2395	9	-	-	SYM
cord-005453-4057qib7	2395	10	129	129	CD
cord-005453-4057qib7	2395	11	months	month	NNS
cord-005453-4057qib7	2395	12	)	)	-RRB-
cord-005453-4057qib7	2395	13	.	.	.
cord-005453-4057qib7	2396	1	The	the	DT
cord-005453-4057qib7	2396	2	estimated	estimate	VBN
cord-005453-4057qib7	2396	3	10-year	10-year	CD
cord-005453-4057qib7	2396	4	overall	overall	JJ
cord-005453-4057qib7	2396	5	survival	survival	NN
cord-005453-4057qib7	2396	6	(	(	-LRB-
cord-005453-4057qib7	2396	7	OS	os	NN
cord-005453-4057qib7	2396	8	)	)	-RRB-
cord-005453-4057qib7	2396	9	probability	probability	NN
cord-005453-4057qib7	2396	10	in	in	IN
cord-005453-4057qib7	2396	11	patients	patient	NNS
cord-005453-4057qib7	2396	12	received	receive	VBD
cord-005453-4057qib7	2396	13	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2396	14	-	-	HYPH
cord-005453-4057qib7	2396	15	based	base	VBN
cord-005453-4057qib7	2396	16	conditioning	conditioning	NN
cord-005453-4057qib7	2396	17	was	be	VBD
cord-005453-4057qib7	2396	18	48,8	48,8	CD
cord-005453-4057qib7	2396	19	±13,4	±13,4	ADD
cord-005453-4057qib7	2396	20	%	%	NN
cord-005453-4057qib7	2396	21	in	in	IN
cord-005453-4057qib7	2396	22	comparison	comparison	NN
cord-005453-4057qib7	2396	23	with	with	IN
cord-005453-4057qib7	2396	24	68,0±10,8	68,0±10,8	CD
cord-005453-4057qib7	2396	25	%	%	NN
cord-005453-4057qib7	2396	26	in	in	IN
cord-005453-4057qib7	2396	27	patients	patient	NNS
cord-005453-4057qib7	2396	28	with	with	IN
cord-005453-4057qib7	2396	29	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	2396	30	-	-	HYPH
cord-005453-4057qib7	2396	31	based	base	VBN
cord-005453-4057qib7	2396	32	regimen	regimen	NN
cord-005453-4057qib7	2396	33	(	(	-LRB-
cord-005453-4057qib7	2396	34	р=0,458	р=0,458	NNP
cord-005453-4057qib7	2396	35	)	)	-RRB-
cord-005453-4057qib7	2396	36	.	.	.
cord-005453-4057qib7	2397	1	Event	event	NN
cord-005453-4057qib7	2397	2	-	-	HYPH
cord-005453-4057qib7	2397	3	free	free	JJ
cord-005453-4057qib7	2397	4	survival	survival	NN
cord-005453-4057qib7	2397	5	(	(	-LRB-
cord-005453-4057qib7	2397	6	EFS	EFS	NNP
cord-005453-4057qib7	2397	7	)	)	-RRB-
cord-005453-4057qib7	2397	8	was	be	VBD
cord-005453-4057qib7	2397	9	42,1±11,3	42,1±11,3	CD
cord-005453-4057qib7	2397	10	%	%	NN
cord-005453-4057qib7	2397	11	in	in	IN
cord-005453-4057qib7	2397	12	group	group	NN
cord-005453-4057qib7	2397	13	with	with	IN
cord-005453-4057qib7	2397	14	Busulfan	Busulfan	NNP
cord-005453-4057qib7	2397	15	-	-	HYPH
cord-005453-4057qib7	2397	16	based	base	VBN
cord-005453-4057qib7	2397	17	regimen	regimen	NN
cord-005453-4057qib7	2397	18	and	and	CC
cord-005453-4057qib7	2397	19	57,0±11,5	57,0±11,5	CD
cord-005453-4057qib7	2397	20	%	%	NN
cord-005453-4057qib7	2397	21	in	in	IN
cord-005453-4057qib7	2397	22	patients	patient	NNS
cord-005453-4057qib7	2397	23	with	with	IN
cord-005453-4057qib7	2397	24	Treosulfanbased	Treosulfanbased	NNP
cord-005453-4057qib7	2397	25	conditioning	conditioning	NN
cord-005453-4057qib7	2397	26	(	(	-LRB-
cord-005453-4057qib7	2397	27	р=0,224	р=0,224	NNP
cord-005453-4057qib7	2397	28	)	)	-RRB-
cord-005453-4057qib7	2397	29	.	.	.
cord-005453-4057qib7	2398	1	Background	background	NN
cord-005453-4057qib7	2398	2	:	:	:
cord-005453-4057qib7	2399	1	Post	post	JJ
cord-005453-4057qib7	2399	2	-	-	JJ
cord-005453-4057qib7	2399	3	transplant	transplant	JJ
cord-005453-4057qib7	2399	4	relapse	relapse	NN
cord-005453-4057qib7	2399	5	remains	remain	VBZ
cord-005453-4057qib7	2399	6	the	the	DT
cord-005453-4057qib7	2399	7	leading	leading	JJ
cord-005453-4057qib7	2399	8	cause	cause	NN
cord-005453-4057qib7	2399	9	of	of	IN
cord-005453-4057qib7	2399	10	treatment	treatment	NN
cord-005453-4057qib7	2399	11	failure	failure	NN
cord-005453-4057qib7	2399	12	in	in	IN
cord-005453-4057qib7	2399	13	high	high	JJ
cord-005453-4057qib7	2399	14	risk	risk	NN
cord-005453-4057qib7	2399	15	(	(	-LRB-
cord-005453-4057qib7	2399	16	HR	HR	NNP
cord-005453-4057qib7	2399	17	)	)	-RRB-
cord-005453-4057qib7	2399	18	acute	acute	JJ
cord-005453-4057qib7	2399	19	myeloid	myeloid	NN
cord-005453-4057qib7	2399	20	leukemia	leukemia	NN
cord-005453-4057qib7	2399	21	(	(	-LRB-
cord-005453-4057qib7	2399	22	AML	AML	NNP
cord-005453-4057qib7	2399	23	)	)	-RRB-
cord-005453-4057qib7	2399	24	,	,	,
cord-005453-4057qib7	2399	25	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	2399	26	syndrome	syndrome	NN
cord-005453-4057qib7	2399	27	(	(	-LRB-
cord-005453-4057qib7	2399	28	MDS	MDS	NNP
cord-005453-4057qib7	2399	29	)	)	-RRB-
cord-005453-4057qib7	2399	30	,	,	.
cord-005453-4057qib7	2400	1	myeloproliferative	myeloproliferative	NNP
cord-005453-4057qib7	2400	2	neoplasia	neoplasia	NNP
cord-005453-4057qib7	2400	3	(	(	-LRB-
cord-005453-4057qib7	2400	4	MPNs	mpn	NNS
cord-005453-4057qib7	2400	5	)	)	-RRB-
cord-005453-4057qib7	2400	6	receiving	receive	VBG
cord-005453-4057qib7	2400	7	allogeneic	allogeneic	JJ
cord-005453-4057qib7	2400	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2400	9	cell	cell	NN
cord-005453-4057qib7	2400	10	transplantation	transplantation	NN
cord-005453-4057qib7	2400	11	(	(	-LRB-
cord-005453-4057qib7	2400	12	allo	allo	NN
cord-005453-4057qib7	2400	13	-	-	HYPH
cord-005453-4057qib7	2400	14	HCT	HCT	NNP
cord-005453-4057qib7	2400	15	)	)	-RRB-
cord-005453-4057qib7	2400	16	,	,	,
cord-005453-4057qib7	2400	17	especially	especially	RB
cord-005453-4057qib7	2400	18	for	for	IN
cord-005453-4057qib7	2400	19	patients	patient	NNS
cord-005453-4057qib7	2400	20	with	with	IN
cord-005453-4057qib7	2400	21	relapsed	relapsed	JJ
cord-005453-4057qib7	2400	22	or	or	CC
cord-005453-4057qib7	2400	23	refractory	refractory	JJ
cord-005453-4057qib7	2400	24	AML	AML	NNP
cord-005453-4057qib7	2400	25	.	.	.
cord-005453-4057qib7	2401	1	Recently	recently	RB
cord-005453-4057qib7	2401	2	,	,	,
cord-005453-4057qib7	2401	3	a	a	DT
cord-005453-4057qib7	2401	4	sequential	sequential	JJ
cord-005453-4057qib7	2401	5	transplant	transplant	NN
cord-005453-4057qib7	2401	6	approach	approach	NN
cord-005453-4057qib7	2401	7	,	,	,
cord-005453-4057qib7	2401	8	as	as	IN
cord-005453-4057qib7	2401	9	developed	develop	VBN
cord-005453-4057qib7	2401	10	by	by	IN
cord-005453-4057qib7	2401	11	the	the	DT
cord-005453-4057qib7	2401	12	Munich	Munich	NNP
cord-005453-4057qib7	2401	13	group	group	NN
cord-005453-4057qib7	2401	14	,	,	,
cord-005453-4057qib7	2401	15	comprising	comprise	VBG
cord-005453-4057qib7	2401	16	of	of	IN
cord-005453-4057qib7	2401	17	intensive	intensive	JJ
cord-005453-4057qib7	2401	18	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	2401	19	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2401	20	FLAMSA	FLAMSA	NNP
cord-005453-4057qib7	2401	21	(	(	-LRB-
cord-005453-4057qib7	2401	22	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2401	23	/	/	SYM
cord-005453-4057qib7	2401	24	Amsacrine	Amsacrine	NNP
cord-005453-4057qib7	2401	25	/	/	SYM
cord-005453-4057qib7	2401	26	cytarabine	cytarabine	NNP
cord-005453-4057qib7	2401	27	)	)	-RRB-
cord-005453-4057qib7	2401	28	to	to	TO
cord-005453-4057qib7	2401	29	decrease	decrease	VB
cord-005453-4057qib7	2401	30	leukemia	leukemia	NN
cord-005453-4057qib7	2401	31	cell	cell	NN
cord-005453-4057qib7	2401	32	burden	burden	NN
cord-005453-4057qib7	2401	33	shortly	shortly	RB
cord-005453-4057qib7	2401	34	prior	prior	RB
cord-005453-4057qib7	2401	35	to	to	IN
cord-005453-4057qib7	2401	36	conditioning	conditioning	NN
cord-005453-4057qib7	2401	37	regimen	regimen	NN
cord-005453-4057qib7	2401	38	,	,	,
cord-005453-4057qib7	2401	39	has	have	VBZ
cord-005453-4057qib7	2401	40	been	be	VBN
cord-005453-4057qib7	2401	41	successfully	successfully	RB
cord-005453-4057qib7	2401	42	used	use	VBN
cord-005453-4057qib7	2401	43	for	for	IN
cord-005453-4057qib7	2401	44	high	high	JJ
cord-005453-4057qib7	2401	45	-	-	HYPH
cord-005453-4057qib7	2401	46	risk	risk	NN
cord-005453-4057qib7	2401	47	(	(	-LRB-
cord-005453-4057qib7	2401	48	HR	HR	NNP
cord-005453-4057qib7	2401	49	)	)	-RRB-
cord-005453-4057qib7	2401	50	AML	AML	NNP
cord-005453-4057qib7	2401	51	/	/	SYM
cord-005453-4057qib7	2401	52	MDS	MDS	NNP
cord-005453-4057qib7	2401	53	with	with	IN
cord-005453-4057qib7	2401	54	promising	promising	JJ
cord-005453-4057qib7	2401	55	results	result	NNS
cord-005453-4057qib7	2401	56	.	.	.
cord-005453-4057qib7	2402	1	Methods	method	NNS
cord-005453-4057qib7	2402	2	:	:	:
cord-005453-4057qib7	2402	3	We	-PRON-	PRP
cord-005453-4057qib7	2402	4	studied	study	VBD
cord-005453-4057qib7	2402	5	48	48	CD
cord-005453-4057qib7	2402	6	patients	patient	NNS
cord-005453-4057qib7	2402	7	(	(	-LRB-
cord-005453-4057qib7	2402	8	median	median	JJ
cord-005453-4057qib7	2402	9	age	age	NN
cord-005453-4057qib7	2402	10	53	53	CD
cord-005453-4057qib7	2402	11	years	year	NNS
cord-005453-4057qib7	2402	12	,	,	,
cord-005453-4057qib7	2402	13	range	range	VBP
cord-005453-4057qib7	2402	14	26	26	CD
cord-005453-4057qib7	2402	15	-68	-68	NNP
cord-005453-4057qib7	2402	16	)	)	-RRB-
cord-005453-4057qib7	2402	17	with	with	IN
cord-005453-4057qib7	2402	18	HR	HR	NNP
cord-005453-4057qib7	2402	19	AML	AML	NNP
cord-005453-4057qib7	2402	20	(	(	-LRB-
cord-005453-4057qib7	2402	21	n=38	n=38	NNP
cord-005453-4057qib7	2402	22	)	)	-RRB-
cord-005453-4057qib7	2402	23	,	,	,
cord-005453-4057qib7	2402	24	as	as	IN
cord-005453-4057qib7	2402	25	defined	define	VBN
cord-005453-4057qib7	2402	26	by	by	IN
cord-005453-4057qib7	2402	27	refractory	refractory	JJ
cord-005453-4057qib7	2402	28	,	,	,
cord-005453-4057qib7	2402	29	relapsed	relapsed	JJ
cord-005453-4057qib7	2402	30	disease	disease	NN
cord-005453-4057qib7	2402	31	,	,	,
cord-005453-4057qib7	2402	32	secondary	secondary	JJ
cord-005453-4057qib7	2402	33	leukemia	leukemia	NN
cord-005453-4057qib7	2402	34	,	,	,
cord-005453-4057qib7	2402	35	or	or	CC
cord-005453-4057qib7	2402	36	high/	high/	ADD
cord-005453-4057qib7	2402	37	very	very	JJ
cord-005453-4057qib7	2402	38	risk	risk	NN
cord-005453-4057qib7	2402	39	disease	disease	NN
cord-005453-4057qib7	2402	40	risk	risk	NN
cord-005453-4057qib7	2402	41	index	index	NN
cord-005453-4057qib7	2402	42	risk	risk	NN
cord-005453-4057qib7	2402	43	,	,	,
cord-005453-4057qib7	2402	44	and	and	CC
cord-005453-4057qib7	2402	45	HR	HR	NNP
cord-005453-4057qib7	2402	46	MDS	MDS	NNP
cord-005453-4057qib7	2402	47	(	(	-LRB-
cord-005453-4057qib7	2402	48	n=10	n=10	NNP
cord-005453-4057qib7	2402	49	)	)	-RRB-
cord-005453-4057qib7	2402	50	according	accord	VBG
cord-005453-4057qib7	2402	51	to	to	IN
cord-005453-4057qib7	2402	52	IPSS	IPSS	NNP
cord-005453-4057qib7	2402	53	-	-	HYPH
cord-005453-4057qib7	2402	54	R	R	NNP
cord-005453-4057qib7	2402	55	,	,	,
cord-005453-4057qib7	2402	56	undergoing	undergo	VBG
cord-005453-4057qib7	2402	57	allo	allo	NN
cord-005453-4057qib7	2402	58	-	-	HYPH
cord-005453-4057qib7	2402	59	HCT	hct	NN
cord-005453-4057qib7	2402	60	using	use	VBG
cord-005453-4057qib7	2402	61	the	the	DT
cord-005453-4057qib7	2402	62	sequential	sequential	JJ
cord-005453-4057qib7	2402	63	transplant	transplant	NN
cord-005453-4057qib7	2402	64	approach	approach	NN
cord-005453-4057qib7	2402	65	in	in	IN
cord-005453-4057qib7	2402	66	2	2	CD
cord-005453-4057qib7	2402	67	institutions	institution	NNS
cord-005453-4057qib7	2402	68	between	between	IN
cord-005453-4057qib7	2402	69	January	January	NNP
cord-005453-4057qib7	2402	70	2009	2009	CD
cord-005453-4057qib7	2402	71	and	and	CC
cord-005453-4057qib7	2402	72	October	October	NNP
cord-005453-4057qib7	2402	73	2018	2018	CD
cord-005453-4057qib7	2402	74	.	.	.
cord-005453-4057qib7	2403	1	The	the	DT
cord-005453-4057qib7	2403	2	sequential	sequential	JJ
cord-005453-4057qib7	2403	3	transplant	transplant	NN
cord-005453-4057qib7	2403	4	approach	approach	NN
cord-005453-4057qib7	2403	5	combined	combine	VBD
cord-005453-4057qib7	2403	6	a	a	DT
cord-005453-4057qib7	2403	7	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	2403	8	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2403	9	,	,	,
cord-005453-4057qib7	2403	10	which	which	WDT
cord-005453-4057qib7	2403	11	consisted	consist	VBD
cord-005453-4057qib7	2403	12	of	of	IN
cord-005453-4057qib7	2403	13	either	either	DT
cord-005453-4057qib7	2403	14	FLAMSA	FLAMSA	NNP
cord-005453-4057qib7	2403	15	(	(	-LRB-
cord-005453-4057qib7	2403	16	n=17	n=17	NNP
cord-005453-4057qib7	2403	17	)	)	-RRB-
cord-005453-4057qib7	2403	18	,	,	,
cord-005453-4057qib7	2403	19	FLAG	flag	NN
cord-005453-4057qib7	2403	20	+	+	CC
cord-005453-4057qib7	2403	21	/-Ida	/-Ida	.
cord-005453-4057qib7	2403	22	(	(	-LRB-
cord-005453-4057qib7	2403	23	fludarabine	fludarabine	NNP
cord-005453-4057qib7	2403	24	/	/	SYM
cord-005453-4057qib7	2403	25	cytarabine	cytarabine	NNP
cord-005453-4057qib7	2403	26	/	/	SYM
cord-005453-4057qib7	2403	27	Granulocyte	Granulocyte	NNP
cord-005453-4057qib7	2403	28	colony	colony	NN
cord-005453-4057qib7	2403	29	stimulating	stimulate	VBG
cord-005453-4057qib7	2403	30	factor	factor	NN
cord-005453-4057qib7	2403	31	/Idarubicin	/Idarubicin	.
cord-005453-4057qib7	2403	32	)	)	-RRB-
cord-005453-4057qib7	2403	33	(	(	-LRB-
cord-005453-4057qib7	2403	34	n=23	n=23	NNP
cord-005453-4057qib7	2403	35	)	)	-RRB-
cord-005453-4057qib7	2403	36	,	,	,
cord-005453-4057qib7	2403	37	or	or	CC
cord-005453-4057qib7	2403	38	Clo	Clo	NNP
cord-005453-4057qib7	2403	39	-	-	HYPH
cord-005453-4057qib7	2403	40	AraC	AraC	NNP
cord-005453-4057qib7	2404	1	(	(	-LRB-
cord-005453-4057qib7	2404	2	Clofarabine	Clofarabine	NNP
cord-005453-4057qib7	2404	3	/	/	SYM
cord-005453-4057qib7	2404	4	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	2404	5	)	)	-RRB-
cord-005453-4057qib7	2404	6	(	(	-LRB-
cord-005453-4057qib7	2404	7	n=8	n=8	NN
cord-005453-4057qib7	2404	8	)	)	-RRB-
cord-005453-4057qib7	2404	9	,	,	,
cord-005453-4057qib7	2404	10	followed	follow	VBN
cord-005453-4057qib7	2404	11	by	by	IN
cord-005453-4057qib7	2404	12	reduced	reduce	VBN
cord-005453-4057qib7	2404	13	(	(	-LRB-
cord-005453-4057qib7	2404	14	RIC	RIC	NNP
cord-005453-4057qib7	2404	15	)	)	-RRB-
cord-005453-4057qib7	2404	16	(	(	-LRB-
cord-005453-4057qib7	2404	17	N=43	N=43	NNP
cord-005453-4057qib7	2404	18	)	)	-RRB-
cord-005453-4057qib7	2404	19	or	or	CC
cord-005453-4057qib7	2404	20	myeloablative	myeloablative	NNP
cord-005453-4057qib7	2404	21	(	(	-LRB-
cord-005453-4057qib7	2404	22	MAC	MAC	NNP
cord-005453-4057qib7	2404	23	)	)	-RRB-
cord-005453-4057qib7	2405	1	(	(	-LRB-
cord-005453-4057qib7	2405	2	N=5	N=5	NNP
cord-005453-4057qib7	2405	3	)	)	-RRB-
cord-005453-4057qib7	2405	4	conditioning	conditioning	NN
cord-005453-4057qib7	2405	5	regimen	regimen	NN
cord-005453-4057qib7	2405	6	.	.	.
cord-005453-4057qib7	2406	1	All	all	DT
cord-005453-4057qib7	2406	2	patients	patient	NNS
cord-005453-4057qib7	2406	3	received	receive	VBD
cord-005453-4057qib7	2406	4	peripheral	peripheral	JJ
cord-005453-4057qib7	2406	5	blood	blood	NN
cord-005453-4057qib7	2406	6	stem	stem	NN
cord-005453-4057qib7	2406	7	cell	cell	NN
cord-005453-4057qib7	2406	8	from	from	IN
cord-005453-4057qib7	2406	9	matched	match	VBN
cord-005453-4057qib7	2406	10	related	related	JJ
cord-005453-4057qib7	2406	11	donors	donor	NNS
cord-005453-4057qib7	2406	12	(	(	-LRB-
cord-005453-4057qib7	2406	13	N=27	N=27	NNP
cord-005453-4057qib7	2406	14	)	)	-RRB-
cord-005453-4057qib7	2406	15	matched	match	VBD
cord-005453-4057qib7	2406	16	unrelated	unrelated	JJ
cord-005453-4057qib7	2406	17	donors	donor	NNS
cord-005453-4057qib7	2406	18	(	(	-LRB-
cord-005453-4057qib7	2406	19	N=14	N=14	NNP
cord-005453-4057qib7	2406	20	)	)	-RRB-
cord-005453-4057qib7	2406	21	,	,	,
cord-005453-4057qib7	2406	22	or	or	CC
cord-005453-4057qib7	2406	23	mismatched	mismatch	VBN
cord-005453-4057qib7	2406	24	unrelated	unrelated	JJ
cord-005453-4057qib7	2406	25	donors	donor	NNS
cord-005453-4057qib7	2406	26	(	(	-LRB-
cord-005453-4057qib7	2406	27	N=7	N=7	NNP
cord-005453-4057qib7	2406	28	)	)	-RRB-
cord-005453-4057qib7	2406	29	.	.	.
cord-005453-4057qib7	2407	1	Post	post	JJ
cord-005453-4057qib7	2407	2	-	-	JJ
cord-005453-4057qib7	2407	3	grafting	graft	VBG
cord-005453-4057qib7	2407	4	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	2407	5	consisted	consist	VBD
cord-005453-4057qib7	2407	6	of	of	IN
cord-005453-4057qib7	2407	7	calcineurin	calcineurin	NNP
cord-005453-4057qib7	2407	8	inhibitor	inhibitor	NN
cord-005453-4057qib7	2407	9	and	and	CC
cord-005453-4057qib7	2407	10	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	2407	11	mofetil	mofetil	NNP
cord-005453-4057qib7	2407	12	in	in	IN
cord-005453-4057qib7	2407	13	all	all	DT
cord-005453-4057qib7	2407	14	patients	patient	NNS
cord-005453-4057qib7	2407	15	.	.	.
cord-005453-4057qib7	2408	1	Thymoglobulin	Thymoglobulin	NNP
cord-005453-4057qib7	2408	2	was	be	VBD
cord-005453-4057qib7	2408	3	added	add	VBN
cord-005453-4057qib7	2408	4	for	for	IN
cord-005453-4057qib7	2408	5	GVHD	GVHD	NNP
cord-005453-4057qib7	2408	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2408	7	for	for	IN
cord-005453-4057qib7	2408	8	unrelated	unrelated	JJ
cord-005453-4057qib7	2408	9	donor	donor	NN
cord-005453-4057qib7	2408	10	transplant	transplant	NN
cord-005453-4057qib7	2408	11	.	.	.
cord-005453-4057qib7	2409	1	Results	result	NNS
cord-005453-4057qib7	2409	2	:	:	:
cord-005453-4057qib7	2410	1	The	the	DT
cord-005453-4057qib7	2410	2	median	median	JJ
cord-005453-4057qib7	2410	3	time	time	NN
cord-005453-4057qib7	2410	4	to	to	IN
cord-005453-4057qib7	2410	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	2410	6	>	>	XX
cord-005453-4057qib7	2411	1	1000	1000	CD
cord-005453-4057qib7	2412	1	/μL	/μL	:
cord-005453-4057qib7	2412	2	was	be	VBD
cord-005453-4057qib7	2412	3	10	10	CD
cord-005453-4057qib7	2412	4	days	day	NNS
cord-005453-4057qib7	2412	5	(	(	-LRB-
cord-005453-4057qib7	2412	6	range	range	NN
cord-005453-4057qib7	2412	7	,	,	,
cord-005453-4057qib7	2412	8	9	9	CD
cord-005453-4057qib7	2412	9	-	-	SYM
cord-005453-4057qib7	2412	10	25	25	CD
cord-005453-4057qib7	2412	11	)	)	-RRB-
cord-005453-4057qib7	2412	12	.	.	.
cord-005453-4057qib7	2413	1	With	with	IN
cord-005453-4057qib7	2413	2	a	a	DT
cord-005453-4057qib7	2413	3	median	median	JJ
cord-005453-4057qib7	2413	4	follow	follow	NN
cord-005453-4057qib7	2413	5	-	-	HYPH
cord-005453-4057qib7	2413	6	up	up	NN
cord-005453-4057qib7	2413	7	of	of	IN
cord-005453-4057qib7	2413	8	28.2	28.2	CD
cord-005453-4057qib7	2413	9	months	month	NNS
cord-005453-4057qib7	2413	10	(	(	-LRB-
cord-005453-4057qib7	2413	11	range	range	NN
cord-005453-4057qib7	2413	12	,	,	,
cord-005453-4057qib7	2413	13	1.4	1.4	CD
cord-005453-4057qib7	2413	14	to	to	IN
cord-005453-4057qib7	2413	15	103.1	103.1	CD
cord-005453-4057qib7	2413	16	months	month	NNS
cord-005453-4057qib7	2413	17	)	)	-RRB-
cord-005453-4057qib7	2413	18	,	,	,
cord-005453-4057qib7	2413	19	the	the	DT
cord-005453-4057qib7	2413	20	Kaplan	Kaplan	NNP
cord-005453-4057qib7	2413	21	-	-	HYPH
cord-005453-4057qib7	2413	22	Meier	Meier	NNP
cord-005453-4057qib7	2413	23	estimate	estimate	NN
cord-005453-4057qib7	2413	24	of	of	IN
cord-005453-4057qib7	2413	25	leukemia	leukemia	NN
cord-005453-4057qib7	2413	26	-	-	HYPH
cord-005453-4057qib7	2413	27	free	free	JJ
cord-005453-4057qib7	2413	28	(	(	-LRB-
cord-005453-4057qib7	2413	29	LFS	lfs	NN
cord-005453-4057qib7	2413	30	)	)	-RRB-
cord-005453-4057qib7	2413	31	and	and	CC
cord-005453-4057qib7	2413	32	overall	overall	JJ
cord-005453-4057qib7	2413	33	survival	survival	NN
cord-005453-4057qib7	2413	34	(	(	-LRB-
cord-005453-4057qib7	2413	35	OS	OS	NNP
cord-005453-4057qib7	2413	36	)	)	-RRB-
cord-005453-4057qib7	2413	37	at	at	IN
cord-005453-4057qib7	2413	38	5	5	CD
cord-005453-4057qib7	2413	39	years	year	NNS
cord-005453-4057qib7	2413	40	were	be	VBD
cord-005453-4057qib7	2413	41	45	45	CD
cord-005453-4057qib7	2413	42	%	%	NN
cord-005453-4057qib7	2413	43	(	(	-LRB-
cord-005453-4057qib7	2413	44	95	95	CD
cord-005453-4057qib7	2413	45	%	%	NN
cord-005453-4057qib7	2413	46	CI	ci	NN
cord-005453-4057qib7	2413	47	,	,	,
cord-005453-4057qib7	2413	48	8	8	CD
cord-005453-4057qib7	2413	49	-	-	SYM
cord-005453-4057qib7	2413	50	30	30	CD
cord-005453-4057qib7	2413	51	)	)	-RRB-
cord-005453-4057qib7	2413	52	,	,	,
cord-005453-4057qib7	2413	53	46	46	CD
cord-005453-4057qib7	2413	54	%	%	NN
cord-005453-4057qib7	2413	55	(	(	-LRB-
cord-005453-4057qib7	2413	56	95	95	CD
cord-005453-4057qib7	2413	57	%	%	NN
cord-005453-4057qib7	2413	58	CI	ci	NN
cord-005453-4057qib7	2413	59	,	,	,
cord-005453-4057qib7	2413	60	8	8	CD
cord-005453-4057qib7	2413	61	-	-	SYM
cord-005453-4057qib7	2413	62	30	30	CD
cord-005453-4057qib7	2413	63	)	)	-RRB-
cord-005453-4057qib7	2413	64	,	,	,
cord-005453-4057qib7	2413	65	respectively	respectively	RB
cord-005453-4057qib7	2413	66	.	.	.
cord-005453-4057qib7	2414	1	Patients	patient	NNS
cord-005453-4057qib7	2414	2	receiving	receive	VBG
cord-005453-4057qib7	2414	3	FLAG	flag	NN
cord-005453-4057qib7	2414	4	or	or	CC
cord-005453-4057qib7	2414	5	Clo	Clo	NNP
cord-005453-4057qib7	2414	6	-	-	HYPH
cord-005453-4057qib7	2414	7	AraC	AraC	NNP
cord-005453-4057qib7	2414	8	based	base	VBD
cord-005453-4057qib7	2414	9	sequential	sequential	JJ
cord-005453-4057qib7	2414	10	regimen	regimen	NN
cord-005453-4057qib7	2414	11	showed	show	VBD
cord-005453-4057qib7	2414	12	a	a	DT
cord-005453-4057qib7	2414	13	trend	trend	NN
cord-005453-4057qib7	2414	14	towards	towards	IN
cord-005453-4057qib7	2414	15	more	more	RBR
cord-005453-4057qib7	2414	16	favourable	favourable	JJ
cord-005453-4057qib7	2414	17	overall	overall	JJ
cord-005453-4057qib7	2414	18	survival	survival	NN
cord-005453-4057qib7	2414	19	(	(	-LRB-
cord-005453-4057qib7	2414	20	OS	OS	NNP
cord-005453-4057qib7	2414	21	)	)	-RRB-
cord-005453-4057qib7	2414	22	as	as	IN
cord-005453-4057qib7	2414	23	compared	compare	VBN
cord-005453-4057qib7	2414	24	to	to	IN
cord-005453-4057qib7	2414	25	patients	patient	NNS
cord-005453-4057qib7	2414	26	given	give	VBN
cord-005453-4057qib7	2414	27	FLAMSA	FLAMSA	NNP
cord-005453-4057qib7	2414	28	(	(	-LRB-
cord-005453-4057qib7	2414	29	5	5	CD
cord-005453-4057qib7	2414	30	year	year	NN
cord-005453-4057qib7	2414	31	OS	os	NN
cord-005453-4057qib7	2414	32	:	:	:
cord-005453-4057qib7	2414	33	53	53	CD
cord-005453-4057qib7	2414	34	%	%	NN
cord-005453-4057qib7	2414	35	vs	vs	IN
cord-005453-4057qib7	2414	36	31	31	CD
cord-005453-4057qib7	2414	37	%	%	NN
cord-005453-4057qib7	2414	38	;	;	:
cord-005453-4057qib7	2414	39	p=0.236	p=0.236	NNP
cord-005453-4057qib7	2414	40	)	)	-RRB-
cord-005453-4057qib7	2414	41	.	.	.
cord-005453-4057qib7	2415	1	At	at	IN
cord-005453-4057qib7	2415	2	2	2	CD
cord-005453-4057qib7	2415	3	years	year	NNS
cord-005453-4057qib7	2415	4	,	,	,
cord-005453-4057qib7	2415	5	the	the	DT
cord-005453-4057qib7	2415	6	cumulative	cumulative	JJ
cord-005453-4057qib7	2415	7	incidences	incidence	NNS
cord-005453-4057qib7	2415	8	of	of	IN
cord-005453-4057qib7	2415	9	relapse	relapse	NN
cord-005453-4057qib7	2415	10	and	and	CC
cord-005453-4057qib7	2415	11	non	non	JJ
cord-005453-4057qib7	2415	12	-	-	JJ
cord-005453-4057qib7	2415	13	relapse	relapse	JJ
cord-005453-4057qib7	2415	14	mortality	mortality	NN
cord-005453-4057qib7	2415	15	(	(	-LRB-
cord-005453-4057qib7	2415	16	NRM	NRM	NNP
cord-005453-4057qib7	2415	17	)	)	-RRB-
cord-005453-4057qib7	2415	18	were	be	VBD
cord-005453-4057qib7	2415	19	46	46	CD
cord-005453-4057qib7	2415	20	%	%	NN
cord-005453-4057qib7	2415	21	(	(	-LRB-
cord-005453-4057qib7	2415	22	95	95	CD
cord-005453-4057qib7	2415	23	%	%	NN
cord-005453-4057qib7	2415	24	CI	CI	NNP
cord-005453-4057qib7	2415	25	,	,	,
cord-005453-4057qib7	2415	26	31	31	CD
cord-005453-4057qib7	2415	27	-	-	SYM
cord-005453-4057qib7	2415	28	60	60	CD
cord-005453-4057qib7	2415	29	%	%	NN
cord-005453-4057qib7	2415	30	)	)	-RRB-
cord-005453-4057qib7	2415	31	and	and	CC
cord-005453-4057qib7	2415	32	15	15	CD
cord-005453-4057qib7	2415	33	%	%	NN
cord-005453-4057qib7	2415	34	(	(	-LRB-
cord-005453-4057qib7	2415	35	95	95	CD
cord-005453-4057qib7	2415	36	%	%	NN
cord-005453-4057qib7	2415	37	CI	CI	NNP
cord-005453-4057qib7	2415	38	,	,	,
cord-005453-4057qib7	2415	39	7	7	CD
cord-005453-4057qib7	2415	40	-	-	SYM
cord-005453-4057qib7	2415	41	21	21	CD
cord-005453-4057qib7	2415	42	%	%	NN
cord-005453-4057qib7	2415	43	)	)	-RRB-
cord-005453-4057qib7	2415	44	,	,	,
cord-005453-4057qib7	2415	45	respectively	respectively	RB
cord-005453-4057qib7	2415	46	.	.	.
cord-005453-4057qib7	2416	1	In	in	IN
cord-005453-4057qib7	2416	2	multivariate	multivariate	JJ
cord-005453-4057qib7	2416	3	analysis	analysis	NN
cord-005453-4057qib7	2416	4	,	,	,
cord-005453-4057qib7	2416	5	the	the	DT
cord-005453-4057qib7	2416	6	type	type	NN
cord-005453-4057qib7	2416	7	of	of	IN
cord-005453-4057qib7	2416	8	sequential	sequential	JJ
cord-005453-4057qib7	2416	9	conditioning	conditioning	NN
cord-005453-4057qib7	2416	10	regimen	regimen	NN
cord-005453-4057qib7	2416	11	did	do	VBD
cord-005453-4057qib7	2416	12	not	not	RB
cord-005453-4057qib7	2416	13	show	show	VB
cord-005453-4057qib7	2416	14	any	any	DT
cord-005453-4057qib7	2416	15	significant	significant	JJ
cord-005453-4057qib7	2416	16	impact	impact	NN
cord-005453-4057qib7	2416	17	on	on	IN
cord-005453-4057qib7	2416	18	LFS	lfs	NN
cord-005453-4057qib7	2416	19	,	,	,
cord-005453-4057qib7	2416	20	OS	OS	NNP
cord-005453-4057qib7	2416	21	,	,	,
cord-005453-4057qib7	2416	22	NRM	NRM	NNP
cord-005453-4057qib7	2416	23	or	or	CC
cord-005453-4057qib7	2416	24	relapse	relapse	NN
cord-005453-4057qib7	2416	25	.	.	.
cord-005453-4057qib7	2417	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2417	2	:	:	:
cord-005453-4057qib7	2418	1	Sequential	sequential	JJ
cord-005453-4057qib7	2418	2	transplant	transplant	NN
cord-005453-4057qib7	2418	3	conditioning	conditioning	NN
cord-005453-4057qib7	2418	4	with	with	IN
cord-005453-4057qib7	2418	5	FLAMSA	FLAMSA	NNP
cord-005453-4057qib7	2418	6	,	,	,
cord-005453-4057qib7	2418	7	FLAG	flag	NN
cord-005453-4057qib7	2418	8	or	or	CC
cord-005453-4057qib7	2418	9	Clo	Clo	NNP
cord-005453-4057qib7	2418	10	-	-	HYPH
cord-005453-4057qib7	2418	11	AraC	AraC	NNP
cord-005453-4057qib7	2418	12	followed	follow	VBD
cord-005453-4057qib7	2418	13	by	by	IN
cord-005453-4057qib7	2418	14	allo	allo	NN
cord-005453-4057qib7	2418	15	-	-	HYPH
cord-005453-4057qib7	2418	16	HCT	HCT	NNP
cord-005453-4057qib7	2418	17	is	be	VBZ
cord-005453-4057qib7	2418	18	an	an	DT
cord-005453-4057qib7	2418	19	effective	effective	JJ
cord-005453-4057qib7	2418	20	strategy	strategy	NN
cord-005453-4057qib7	2418	21	in	in	IN
cord-005453-4057qib7	2418	22	overcoming	overcome	VBG
cord-005453-4057qib7	2418	23	the	the	DT
cord-005453-4057qib7	2418	24	dismal	dismal	JJ
cord-005453-4057qib7	2418	25	prognosis	prognosis	NN
cord-005453-4057qib7	2418	26	of	of	IN
cord-005453-4057qib7	2418	27	HR	HR	NNP
cord-005453-4057qib7	2418	28	AML	AML	NNP
cord-005453-4057qib7	2418	29	and	and	CC
cord-005453-4057qib7	2418	30	MDS	MDS	NNP
cord-005453-4057qib7	2418	31	,	,	,
cord-005453-4057qib7	2418	32	and	and	CC
cord-005453-4057qib7	2418	33	enabling	enable	VBG
cord-005453-4057qib7	2418	34	long	long	JJ
cord-005453-4057qib7	2418	35	-	-	HYPH
cord-005453-4057qib7	2418	36	term	term	NN
cord-005453-4057qib7	2418	37	disease	disease	NN
cord-005453-4057qib7	2418	38	free	free	JJ
cord-005453-4057qib7	2418	39	survival	survival	NN
cord-005453-4057qib7	2418	40	.	.	.
cord-005453-4057qib7	2419	1	More	More	JJR
cord-005453-4057qib7	2419	2	studies	study	NNS
cord-005453-4057qib7	2419	3	on	on	IN
cord-005453-4057qib7	2419	4	effective	effective	JJ
cord-005453-4057qib7	2419	5	strategies	strategy	NNS
cord-005453-4057qib7	2419	6	such	such	JJ
cord-005453-4057qib7	2419	7	as	as	IN
cord-005453-4057qib7	2419	8	posttransplant	posttransplant	NN
cord-005453-4057qib7	2419	9	maintenance	maintenance	NN
cord-005453-4057qib7	2419	10	therapy	therapy	NN
cord-005453-4057qib7	2419	11	of	of	IN
cord-005453-4057qib7	2419	12	prophylactic	prophylactic	JJ
cord-005453-4057qib7	2419	13	donor	donor	NN
cord-005453-4057qib7	2419	14	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	2419	15	infusion	infusion	NN
cord-005453-4057qib7	2419	16	,	,	,
cord-005453-4057qib7	2419	17	are	be	VBP
cord-005453-4057qib7	2419	18	needed	need	VBN
cord-005453-4057qib7	2419	19	to	to	TO
cord-005453-4057qib7	2419	20	further	further	RB
cord-005453-4057qib7	2419	21	eliminate	eliminate	VB
cord-005453-4057qib7	2419	22	the	the	DT
cord-005453-4057qib7	2419	23	risk	risk	NN
cord-005453-4057qib7	2419	24	of	of	IN
cord-005453-4057qib7	2419	25	relapse	relapse	NN
cord-005453-4057qib7	2419	26	,	,	,
cord-005453-4057qib7	2419	27	without	without	IN
cord-005453-4057qib7	2419	28	increasing	increase	VBG
cord-005453-4057qib7	2419	29	risk	risk	NN
cord-005453-4057qib7	2419	30	of	of	IN
cord-005453-4057qib7	2419	31	treatment	treatment	NN
cord-005453-4057qib7	2419	32	related	relate	VBN
cord-005453-4057qib7	2419	33	toxicity	toxicity	NN
cord-005453-4057qib7	2419	34	.	.	.
cord-005453-4057qib7	2420	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2420	2	:	:	:
cord-005453-4057qib7	2420	3	Nothing	nothing	NN
cord-005453-4057qib7	2420	4	to	to	TO
cord-005453-4057qib7	2420	5	declare	declare	VB
cord-005453-4057qib7	2420	6	Optimization	optimization	NN
cord-005453-4057qib7	2420	7	of	of	IN
cord-005453-4057qib7	2420	8	the	the	DT
cord-005453-4057qib7	2420	9	blood	blood	NN
cord-005453-4057qib7	2420	10	sampling	sampling	NN
cord-005453-4057qib7	2420	11	procedure	procedure	NN
cord-005453-4057qib7	2420	12	for	for	IN
cord-005453-4057qib7	2420	13	busulfan	busulfan	NN
cord-005453-4057qib7	2420	14	therapeutic	therapeutic	JJ
cord-005453-4057qib7	2420	15	drug	drug	NN
cord-005453-4057qib7	2420	16	monitoring	monitoring	NN
cord-005453-4057qib7	2420	17	(	(	-LRB-
cord-005453-4057qib7	2420	18	TDM	tdm	NN
cord-005453-4057qib7	2420	19	)	)	-RRB-
cord-005453-4057qib7	2420	20	To	to	TO
cord-005453-4057qib7	2420	21	optimize	optimize	VB
cord-005453-4057qib7	2420	22	our	-PRON-	PRP$
cord-005453-4057qib7	2420	23	sampling	sampling	NN
cord-005453-4057qib7	2420	24	scheme	scheme	NN
cord-005453-4057qib7	2420	25	(	(	-LRB-
cord-005453-4057qib7	2420	26	15	15	CD
cord-005453-4057qib7	2420	27	minutes	minute	NNS
cord-005453-4057qib7	2420	28	,	,	,
cord-005453-4057qib7	2420	29	1	1	CD
cord-005453-4057qib7	2420	30	,	,	,
cord-005453-4057qib7	2420	31	2	2	CD
cord-005453-4057qib7	2420	32	,	,	,
cord-005453-4057qib7	2420	33	3	3	CD
cord-005453-4057qib7	2420	34	,	,	,
cord-005453-4057qib7	2420	35	4	4	CD
cord-005453-4057qib7	2420	36	,	,	,
cord-005453-4057qib7	2420	37	6	6	CD
cord-005453-4057qib7	2420	38	,	,	,
cord-005453-4057qib7	2420	39	8	8	CD
cord-005453-4057qib7	2420	40	and	and	CC
cord-005453-4057qib7	2420	41	10	10	CD
cord-005453-4057qib7	2420	42	hours	hour	NNS
cord-005453-4057qib7	2420	43	after	after	IN
cord-005453-4057qib7	2420	44	the	the	DT
cord-005453-4057qib7	2420	45	end	end	NN
cord-005453-4057qib7	2420	46	of	of	IN
cord-005453-4057qib7	2420	47	a	a	DT
cord-005453-4057qib7	2420	48	3-hour	3-hour	CD
cord-005453-4057qib7	2420	49	infusion	infusion	NN
cord-005453-4057qib7	2420	50	)	)	-RRB-
cord-005453-4057qib7	2421	1	,	,	,
cord-005453-4057qib7	2421	2	we	-PRON-	PRP
cord-005453-4057qib7	2421	3	reduced	reduce	VBD
cord-005453-4057qib7	2421	4	the	the	DT
cord-005453-4057qib7	2421	5	number	number	NN
cord-005453-4057qib7	2421	6	of	of	IN
cord-005453-4057qib7	2421	7	blood	blood	NN
cord-005453-4057qib7	2421	8	samples	sample	NNS
cord-005453-4057qib7	2421	9	collected	collect	VBN
cord-005453-4057qib7	2421	10	,	,	,
cord-005453-4057qib7	2421	11	reducing	reduce	VBG
cord-005453-4057qib7	2421	12	nursing	nursing	NN
cord-005453-4057qib7	2421	13	and	and	CC
cord-005453-4057qib7	2421	14	laboratory	laboratory	NN
cord-005453-4057qib7	2421	15	staff	staff	NN
cord-005453-4057qib7	2421	16	time	time	NN
cord-005453-4057qib7	2421	17	and	and	CC
cord-005453-4057qib7	2421	18	increasing	increase	VBG
cord-005453-4057qib7	2421	19	patient	patient	JJ
cord-005453-4057qib7	2421	20	convenience	convenience	NN
cord-005453-4057qib7	2421	21	.	.	.
cord-005453-4057qib7	2422	1	This	this	DT
cord-005453-4057qib7	2422	2	study	study	NN
cord-005453-4057qib7	2422	3	aims	aim	VBZ
cord-005453-4057qib7	2422	4	to	to	TO
cord-005453-4057qib7	2422	5	show	show	VB
cord-005453-4057qib7	2422	6	the	the	DT
cord-005453-4057qib7	2422	7	performance	performance	NN
cord-005453-4057qib7	2422	8	of	of	IN
cord-005453-4057qib7	2422	9	a	a	DT
cord-005453-4057qib7	2422	10	simplified	simplified	JJ
cord-005453-4057qib7	2422	11	sampling	sampling	NN
cord-005453-4057qib7	2422	12	protocol	protocol	NN
cord-005453-4057qib7	2422	13	which	which	WDT
cord-005453-4057qib7	2422	14	includes	include	VBZ
cord-005453-4057qib7	2422	15	the	the	DT
cord-005453-4057qib7	2422	16	first	first	JJ
cord-005453-4057qib7	2422	17	5	5	CD
cord-005453-4057qib7	2422	18	samples	sample	NNS
cord-005453-4057qib7	2422	19	from	from	IN
cord-005453-4057qib7	2422	20	the	the	DT
cord-005453-4057qib7	2422	21	original	original	JJ
cord-005453-4057qib7	2422	22	protocol	protocol	NN
cord-005453-4057qib7	2422	23	.	.	.
cord-005453-4057qib7	2423	1	Methods	method	NNS
cord-005453-4057qib7	2423	2	:	:	:
cord-005453-4057qib7	2424	1	Individual	individual	JJ
cord-005453-4057qib7	2424	2	PK	PK	NNP
cord-005453-4057qib7	2424	3	parameters	parameter	NNS
cord-005453-4057qib7	2424	4	were	be	VBD
cord-005453-4057qib7	2424	5	retrospectively	retrospectively	RB
cord-005453-4057qib7	2424	6	estimated	estimate	VBN
cord-005453-4057qib7	2424	7	using	use	VBG
cord-005453-4057qib7	2424	8	5	5	CD
cord-005453-4057qib7	2424	9	samples	sample	NNS
cord-005453-4057qib7	2424	10	(	(	-LRB-
cord-005453-4057qib7	2424	11	simplified	simplified	JJ
cord-005453-4057qib7	2424	12	protocol	protocol	NN
cord-005453-4057qib7	2424	13	)	)	-RRB-
cord-005453-4057qib7	2424	14	and	and	CC
cord-005453-4057qib7	2424	15	were	be	VBD
cord-005453-4057qib7	2424	16	compared	compare	VBN
cord-005453-4057qib7	2424	17	with	with	IN
cord-005453-4057qib7	2424	18	those	those	DT
cord-005453-4057qib7	2424	19	obtained	obtain	VBN
cord-005453-4057qib7	2424	20	after	after	IN
cord-005453-4057qib7	2424	21	8	8	CD
cord-005453-4057qib7	2424	22	samples	sample	NNS
cord-005453-4057qib7	2424	23	(	(	-LRB-
cord-005453-4057qib7	2424	24	original	original	JJ
cord-005453-4057qib7	2424	25	protocol	protocol	NN
cord-005453-4057qib7	2424	26	)	)	-RRB-
cord-005453-4057qib7	2424	27	.	.	.
cord-005453-4057qib7	2425	1	Individual	individual	JJ
cord-005453-4057qib7	2425	2	PK	PK	NNP
cord-005453-4057qib7	2425	3	parameter	parameter	NN
cord-005453-4057qib7	2425	4	values	value	NNS
cord-005453-4057qib7	2425	5	for	for	IN
cord-005453-4057qib7	2425	6	a	a	DT
cord-005453-4057qib7	2425	7	one	one	CD
cord-005453-4057qib7	2425	8	compartment	compartment	NN
cord-005453-4057qib7	2425	9	model	model	NN
cord-005453-4057qib7	2425	10	were	be	VBD
cord-005453-4057qib7	2425	11	estimated	estimate	VBN
cord-005453-4057qib7	2425	12	using	use	VBG
cord-005453-4057qib7	2425	13	a	a	DT
cord-005453-4057qib7	2425	14	maximum	maximum	JJ
cord-005453-4057qib7	2425	15	likelihood	likelihood	NN
cord-005453-4057qib7	2425	16	estimation	estimation	NN
cord-005453-4057qib7	2425	17	modelling	modelling	NN
cord-005453-4057qib7	2425	18	algorithm	algorithm	NN
cord-005453-4057qib7	2425	19	(	(	-LRB-
cord-005453-4057qib7	2425	20	ADAPT	adapt	VB
cord-005453-4057qib7	2425	21	5.0	5.0	CD
cord-005453-4057qib7	2425	22	)	)	-RRB-
cord-005453-4057qib7	2425	23	and	and	CC
cord-005453-4057qib7	2425	24	the	the	DT
cord-005453-4057qib7	2425	25	statistical	statistical	JJ
cord-005453-4057qib7	2425	26	analysis	analysis	NN
cord-005453-4057qib7	2425	27	of	of	IN
cord-005453-4057qib7	2425	28	the	the	DT
cord-005453-4057qib7	2425	29	results	result	NNS
cord-005453-4057qib7	2425	30	was	be	VBD
cord-005453-4057qib7	2425	31	performed	perform	VBN
cord-005453-4057qib7	2425	32	(	(	-LRB-
cord-005453-4057qib7	2425	33	Statgraphics	Statgraphics	NNP
cord-005453-4057qib7	2425	34	Centurion	Centurion	NNP
cord-005453-4057qib7	2425	35	XV	XV	NNP
cord-005453-4057qib7	2425	36	)	)	-RRB-
cord-005453-4057qib7	2425	37	.	.	.
cord-005453-4057qib7	2426	1	Results	result	NNS
cord-005453-4057qib7	2426	2	Based	base	VBN
cord-005453-4057qib7	2426	3	on	on	IN
cord-005453-4057qib7	2426	4	the	the	DT
cord-005453-4057qib7	2426	5	approved	approve	VBN
cord-005453-4057qib7	2426	6	dosage	dosage	NN
cord-005453-4057qib7	2426	7	recommendations	recommendation	NNS
cord-005453-4057qib7	2426	8	,	,	,
cord-005453-4057qib7	2426	9	mean	mean	JJ
cord-005453-4057qib7	2426	10	(	(	-LRB-
cord-005453-4057qib7	2426	11	SD	sd	NN
cord-005453-4057qib7	2426	12	)	)	-RRB-
cord-005453-4057qib7	2426	13	initial	initial	JJ
cord-005453-4057qib7	2426	14	dose	dose	NN
cord-005453-4057qib7	2426	15	was	be	VBD
cord-005453-4057qib7	2426	16	171.1(69.3	171.1(69.3	CD
cord-005453-4057qib7	2426	17	)	)	-RRB-
cord-005453-4057qib7	2427	1	mg	mg	NNP
cord-005453-4057qib7	2427	2	.	.	.
cord-005453-4057qib7	2428	1	After	after	IN
cord-005453-4057qib7	2428	2	TDM	TDM	NNP
cord-005453-4057qib7	2428	3	,	,	,
cord-005453-4057qib7	2428	4	mean	mean	JJ
cord-005453-4057qib7	2428	5	(	(	-LRB-
cord-005453-4057qib7	2428	6	SD	sd	NN
cord-005453-4057qib7	2428	7	)	)	-RRB-
cord-005453-4057qib7	2428	8	calculated	calculate	VBN
cord-005453-4057qib7	2428	9	dose	dose	NN
cord-005453-4057qib7	2428	10	at	at	IN
cord-005453-4057qib7	2428	11	day	day	NN
cord-005453-4057qib7	2428	12	1	1	CD
cord-005453-4057qib7	2428	13	for	for	IN
cord-005453-4057qib7	2428	14	the	the	DT
cord-005453-4057qib7	2428	15	remaining	remain	VBG
cord-005453-4057qib7	2428	16	days	day	NNS
cord-005453-4057qib7	2428	17	(	(	-LRB-
cord-005453-4057qib7	2428	18	to	to	TO
cord-005453-4057qib7	2428	19	achieve	achieve	VB
cord-005453-4057qib7	2428	20	the	the	DT
cord-005453-4057qib7	2428	21	defined	define	VBN
cord-005453-4057qib7	2428	22	target	target	NN
cord-005453-4057qib7	2428	23	cumulative	cumulative	JJ
cord-005453-4057qib7	2428	24	AUC	AUC	NNP
cord-005453-4057qib7	2428	25	)	)	-RRB-
cord-005453-4057qib7	2428	26	was	be	VBD
cord-005453-4057qib7	2428	27	158,5	158,5	CD
cord-005453-4057qib7	2429	1	(	(	-LRB-
cord-005453-4057qib7	2429	2	72,6	72,6	LS
cord-005453-4057qib7	2429	3	)	)	-RRB-
cord-005453-4057qib7	2430	1	mg	mg	PRP
cord-005453-4057qib7	2430	2	obtained	obtain	VBD
cord-005453-4057qib7	2430	3	from	from	IN
cord-005453-4057qib7	2430	4	the	the	DT
cord-005453-4057qib7	2430	5	original	original	JJ
cord-005453-4057qib7	2430	6	protocol	protocol	NN
cord-005453-4057qib7	2430	7	.	.	.
cord-005453-4057qib7	2431	1	According	accord	VBG
cord-005453-4057qib7	2431	2	to	to	IN
cord-005453-4057qib7	2431	3	the	the	DT
cord-005453-4057qib7	2431	4	simplified	simplified	JJ
cord-005453-4057qib7	2431	5	protocol	protocol	NN
cord-005453-4057qib7	2431	6	the	the	DT
cord-005453-4057qib7	2431	7	result	result	NN
cord-005453-4057qib7	2431	8	would	would	MD
cord-005453-4057qib7	2431	9	be	be	VB
cord-005453-4057qib7	2431	10	159,8(73,7	159,8(73,7	CD
cord-005453-4057qib7	2431	11	)	)	-RRB-
cord-005453-4057qib7	2431	12	mg	mg	NN
cord-005453-4057qib7	2431	13	.	.	.
cord-005453-4057qib7	2432	1	The	the	DT
cord-005453-4057qib7	2432	2	median	median	NN
cord-005453-4057qib7	2432	3	and	and	CC
cord-005453-4057qib7	2432	4	the	the	DT
cord-005453-4057qib7	2432	5	mean	mean	JJ
cord-005453-4057qib7	2432	6	variation	variation	NN
cord-005453-4057qib7	2432	7	of	of	IN
cord-005453-4057qib7	2432	8	the	the	DT
cord-005453-4057qib7	2432	9	calculated	calculated	JJ
cord-005453-4057qib7	2432	10	dose	dose	NN
cord-005453-4057qib7	2432	11	were	be	VBD
cord-005453-4057qib7	2432	12	0	0	CD
cord-005453-4057qib7	2432	13	%	%	NN
cord-005453-4057qib7	2432	14	and	and	CC
cord-005453-4057qib7	2432	15	1	1	CD
cord-005453-4057qib7	2432	16	%	%	NN
cord-005453-4057qib7	2432	17	(	(	-LRB-
cord-005453-4057qib7	2432	18	0	0	CD
cord-005453-4057qib7	2432	19	-	-	SYM
cord-005453-4057qib7	2432	20	8	8	CD
cord-005453-4057qib7	2432	21	%	%	NN
cord-005453-4057qib7	2432	22	)	)	-RRB-
cord-005453-4057qib7	2432	23	between	between	IN
cord-005453-4057qib7	2432	24	protocols	protocol	NNS
cord-005453-4057qib7	2432	25	.	.	.
cord-005453-4057qib7	2433	1	A	a	DT
cord-005453-4057qib7	2433	2	strong	strong	JJ
cord-005453-4057qib7	2433	3	relationship	relationship	NN
cord-005453-4057qib7	2433	4	between	between	IN
cord-005453-4057qib7	2433	5	the	the	DT
cord-005453-4057qib7	2433	6	CL	CL	NNP
cord-005453-4057qib7	2433	7	of	of	IN
cord-005453-4057qib7	2433	8	the	the	DT
cord-005453-4057qib7	2433	9	day	day	NN
cord-005453-4057qib7	2433	10	1	1	CD
cord-005453-4057qib7	2433	11	-	-	SYM
cord-005453-4057qib7	2433	12	3	3	CD
cord-005453-4057qib7	2433	13	obtained	obtain	VBD
cord-005453-4057qib7	2433	14	from	from	IN
cord-005453-4057qib7	2433	15	the	the	DT
cord-005453-4057qib7	2433	16	original	original	JJ
cord-005453-4057qib7	2433	17	protocol	protocol	NN
cord-005453-4057qib7	2433	18	and	and	CC
cord-005453-4057qib7	2433	19	the	the	DT
cord-005453-4057qib7	2433	20	simplified	simplified	JJ
cord-005453-4057qib7	2433	21	protocol	protocol	NN
cord-005453-4057qib7	2433	22	is	be	VBZ
cord-005453-4057qib7	2433	23	observed	observe	VBN
cord-005453-4057qib7	2433	24	(	(	-LRB-
cord-005453-4057qib7	2433	25	R	r	NN
cord-005453-4057qib7	2433	26	2	2	CD
cord-005453-4057qib7	2433	27	=	=	SYM
cord-005453-4057qib7	2433	28	0.9985	0.9985	CD
cord-005453-4057qib7	2433	29	)	)	-RRB-
cord-005453-4057qib7	2433	30	.	.	.
cord-005453-4057qib7	2434	1	This	this	DT
cord-005453-4057qib7	2434	2	high	high	JJ
cord-005453-4057qib7	2434	3	correlation	correlation	NN
cord-005453-4057qib7	2434	4	is	be	VBZ
cord-005453-4057qib7	2434	5	also	also	RB
cord-005453-4057qib7	2434	6	observed	observe	VBN
cord-005453-4057qib7	2434	7	for	for	IN
cord-005453-4057qib7	2434	8	patients	patient	NNS
cord-005453-4057qib7	2434	9	with	with	IN
cord-005453-4057qib7	2434	10	busulfan	busulfan	NNP
cord-005453-4057qib7	2434	11	t	t	NNP
cord-005453-4057qib7	2434	12	1/2	1/2	CD
cord-005453-4057qib7	2435	1	>	>	XX
cord-005453-4057qib7	2436	1	3h	3h	NNP
cord-005453-4057qib7	2436	2	(	(	-LRB-
cord-005453-4057qib7	2436	3	R	r	NN
cord-005453-4057qib7	2436	4	2	2	CD
cord-005453-4057qib7	2436	5	=	=	SYM
cord-005453-4057qib7	2436	6	0.9936	0.9936	CD
cord-005453-4057qib7	2436	7	)	)	-RRB-
cord-005453-4057qib7	2437	1	,	,	,
cord-005453-4057qib7	2437	2	a	a	DT
cord-005453-4057qib7	2437	3	population	population	NN
cord-005453-4057qib7	2437	4	were	be	VBD
cord-005453-4057qib7	2437	5	the	the	DT
cord-005453-4057qib7	2437	6	reduction	reduction	NN
cord-005453-4057qib7	2437	7	of	of	IN
cord-005453-4057qib7	2437	8	sampling	sampling	NN
cord-005453-4057qib7	2437	9	could	could	MD
cord-005453-4057qib7	2437	10	be	be	VB
cord-005453-4057qib7	2437	11	more	more	RBR
cord-005453-4057qib7	2437	12	problematic	problematic	JJ
cord-005453-4057qib7	2437	13	.	.	.
cord-005453-4057qib7	2438	1	ANOVA	ANOVA	NNP
cord-005453-4057qib7	2438	2	test	test	NN
cord-005453-4057qib7	2438	3	for	for	IN
cord-005453-4057qib7	2438	4	the	the	DT
cord-005453-4057qib7	2438	5	log	log	NN
cord-005453-4057qib7	2438	6	CL	CL	NNP
cord-005453-4057qib7	2438	7	with	with	IN
cord-005453-4057qib7	2438	8	the	the	DT
cord-005453-4057qib7	2438	9	factors	factor	NNS
cord-005453-4057qib7	2438	10	:	:	:
cord-005453-4057qib7	2438	11	patient	patient	JJ
cord-005453-4057qib7	2438	12	,	,	,
cord-005453-4057qib7	2438	13	day	day	NN
cord-005453-4057qib7	2438	14	of	of	IN
cord-005453-4057qib7	2438	15	busulfan	busulfan	NN
cord-005453-4057qib7	2438	16	and	and	CC
cord-005453-4057qib7	2438	17	type	type	NN
cord-005453-4057qib7	2438	18	of	of	IN
cord-005453-4057qib7	2438	19	sampling	sampling	NN
cord-005453-4057qib7	2438	20	protocol	protocol	NN
cord-005453-4057qib7	2438	21	was	be	VBD
cord-005453-4057qib7	2438	22	performed	perform	VBN
cord-005453-4057qib7	2438	23	.	.	.
cord-005453-4057qib7	2439	1	Sampling	sampling	NN
cord-005453-4057qib7	2439	2	protocol	protocol	NN
cord-005453-4057qib7	2439	3	was	be	VBD
cord-005453-4057qib7	2439	4	determined	determine	VBN
cord-005453-4057qib7	2439	5	as	as	IN
cord-005453-4057qib7	2439	6	non	non	JJ
cord-005453-4057qib7	2439	7	-	-	JJ
cord-005453-4057qib7	2439	8	statistically	statistically	RB
cord-005453-4057qib7	2439	9	significant	significant	JJ
cord-005453-4057qib7	2439	10	(	(	-LRB-
cord-005453-4057qib7	2439	11	p	p	NN
cord-005453-4057qib7	2439	12	=	=	SYM
cord-005453-4057qib7	2439	13	0.7248	0.7248	CD
cord-005453-4057qib7	2439	14	)	)	-RRB-
cord-005453-4057qib7	2439	15	.	.	.
cord-005453-4057qib7	2440	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2440	2	:	:	:
cord-005453-4057qib7	2441	1	Results	result	NNS
cord-005453-4057qib7	2441	2	suggest	suggest	VBP
cord-005453-4057qib7	2441	3	that	that	IN
cord-005453-4057qib7	2441	4	both	both	DT
cord-005453-4057qib7	2441	5	protocols	protocol	NNS
cord-005453-4057qib7	2441	6	are	be	VBP
cord-005453-4057qib7	2441	7	equivalent	equivalent	JJ
cord-005453-4057qib7	2441	8	concerning	concern	VBG
cord-005453-4057qib7	2441	9	to	to	IN
cord-005453-4057qib7	2441	10	the	the	DT
cord-005453-4057qib7	2441	11	busulfan	busulfan	NN
cord-005453-4057qib7	2441	12	CL	CL	NNP
cord-005453-4057qib7	2441	13	estimation	estimation	NN
cord-005453-4057qib7	2441	14	and	and	CC
cord-005453-4057qib7	2441	15	calculated	calculate	VBD
cord-005453-4057qib7	2441	16	AUC	AUC	NNP
cord-005453-4057qib7	2441	17	.	.	.
cord-005453-4057qib7	2442	1	Variation	variation	NN
cord-005453-4057qib7	2442	2	between	between	IN
cord-005453-4057qib7	2442	3	protocols	protocol	NNS
cord-005453-4057qib7	2442	4	regarding	regard	VBG
cord-005453-4057qib7	2442	5	the	the	DT
cord-005453-4057qib7	2442	6	calculated	calculated	JJ
cord-005453-4057qib7	2442	7	dose	dose	NN
cord-005453-4057qib7	2442	8	at	at	IN
cord-005453-4057qib7	2442	9	day	day	NN
cord-005453-4057qib7	2442	10	1	1	CD
cord-005453-4057qib7	2442	11	for	for	IN
cord-005453-4057qib7	2442	12	the	the	DT
cord-005453-4057qib7	2442	13	remaining	remain	VBG
cord-005453-4057qib7	2442	14	days	day	NNS
cord-005453-4057qib7	2442	15	to	to	TO
cord-005453-4057qib7	2442	16	achieve	achieve	VB
cord-005453-4057qib7	2442	17	the	the	DT
cord-005453-4057qib7	2442	18	defined	define	VBN
cord-005453-4057qib7	2442	19	target	target	NN
cord-005453-4057qib7	2442	20	cumulative	cumulative	JJ
cord-005453-4057qib7	2442	21	AUC	AUC	NNP
cord-005453-4057qib7	2442	22	is	be	VBZ
cord-005453-4057qib7	2442	23	considered	consider	VBN
cord-005453-4057qib7	2442	24	acceptable	acceptable	JJ
cord-005453-4057qib7	2442	25	.	.	.
cord-005453-4057qib7	2443	1	We	-PRON-	PRP
cord-005453-4057qib7	2443	2	verified	verify	VBD
cord-005453-4057qib7	2443	3	a	a	DT
cord-005453-4057qib7	2443	4	strong	strong	JJ
cord-005453-4057qib7	2443	5	relationship	relationship	NN
cord-005453-4057qib7	2443	6	between	between	IN
cord-005453-4057qib7	2443	7	busulfan	busulfan	NN
cord-005453-4057qib7	2443	8	CL	CL	NNP
cord-005453-4057qib7	2443	9	obtained	obtain	VBD
cord-005453-4057qib7	2443	10	from	from	IN
cord-005453-4057qib7	2443	11	both	both	DT
cord-005453-4057qib7	2443	12	protocols	protocol	NNS
cord-005453-4057qib7	2443	13	and	and	CC
cord-005453-4057qib7	2443	14	sampling	sampling	NN
cord-005453-4057qib7	2443	15	protocol	protocol	NN
cord-005453-4057qib7	2443	16	does	do	VBZ
cord-005453-4057qib7	2443	17	n't	not	RB
cord-005453-4057qib7	2443	18	influence	influence	VB
cord-005453-4057qib7	2443	19	CL	CL	NNP
cord-005453-4057qib7	2443	20	statistically	statistically	RB
cord-005453-4057qib7	2443	21	.	.	.
cord-005453-4057qib7	2444	1	A	a	DT
cord-005453-4057qib7	2444	2	reduced	reduce	VBN
cord-005453-4057qib7	2444	3	sampling	sampling	NN
cord-005453-4057qib7	2444	4	collection	collection	NN
cord-005453-4057qib7	2444	5	of	of	IN
cord-005453-4057qib7	2444	6	5	5	CD
cord-005453-4057qib7	2444	7	determinations	determination	NNS
cord-005453-4057qib7	2444	8	until	until	IN
cord-005453-4057qib7	2444	9	4	4	CD
cord-005453-4057qib7	2444	10	h	h	NN
cord-005453-4057qib7	2444	11	after	after	IN
cord-005453-4057qib7	2444	12	the	the	DT
cord-005453-4057qib7	2444	13	end	end	NN
cord-005453-4057qib7	2444	14	of	of	IN
cord-005453-4057qib7	2444	15	the	the	DT
cord-005453-4057qib7	2444	16	infusion	infusion	NN
cord-005453-4057qib7	2444	17	is	be	VBZ
cord-005453-4057qib7	2444	18	shown	show	VBN
cord-005453-4057qib7	2444	19	to	to	TO
cord-005453-4057qib7	2444	20	be	be	VB
cord-005453-4057qib7	2444	21	sufficient	sufficient	JJ
cord-005453-4057qib7	2444	22	for	for	IN
cord-005453-4057qib7	2444	23	the	the	DT
cord-005453-4057qib7	2444	24	TDM	tdm	NN
cord-005453-4057qib7	2444	25	of	of	IN
cord-005453-4057qib7	2444	26	busulfan	busulfan	NN
cord-005453-4057qib7	2444	27	,	,	,
cord-005453-4057qib7	2444	28	so	so	CC
cord-005453-4057qib7	2444	29	this	this	DT
cord-005453-4057qib7	2444	30	was	be	VBD
cord-005453-4057qib7	2444	31	implemented	implement	VBN
cord-005453-4057qib7	2444	32	in	in	IN
cord-005453-4057qib7	2444	33	our	-PRON-	PRP$
cord-005453-4057qib7	2444	34	centre	centre	NN
cord-005453-4057qib7	2444	35	in	in	IN
cord-005453-4057qib7	2444	36	line	line	NN
cord-005453-4057qib7	2444	37	with	with	IN
cord-005453-4057qib7	2444	38	published	publish	VBN
cord-005453-4057qib7	2444	39	data	datum	NNS
cord-005453-4057qib7	2444	40	.	.	.
cord-005453-4057qib7	2445	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2445	2	:	:	:
cord-005453-4057qib7	2445	3	Nothing	nothing	NN
cord-005453-4057qib7	2445	4	to	to	TO
cord-005453-4057qib7	2445	5	declare	declare	VB
cord-005453-4057qib7	2445	6	P125	P125	NNP
cord-005453-4057qib7	2445	7	Impact	Impact	NNP
cord-005453-4057qib7	2445	8	of	of	IN
cord-005453-4057qib7	2445	9	anti	anti	JJ
cord-005453-4057qib7	2445	10	-	-	JJ
cord-005453-4057qib7	2445	11	thymocyte	thymocyte	JJ
cord-005453-4057qib7	2445	12	globulin	globulin	NN
cord-005453-4057qib7	2445	13	doses	dose	NNS
cord-005453-4057qib7	2445	14	in	in	IN
cord-005453-4057qib7	2445	15	unrelated	unrelated	JJ
cord-005453-4057qib7	2445	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2445	17	stem	stem	NN
cord-005453-4057qib7	2445	18	cell	cell	NN
cord-005453-4057qib7	2445	19	transplantation	transplantation	NN
cord-005453-4057qib7	2445	20	for	for	IN
cord-005453-4057qib7	2445	21	patients	patient	NNS
cord-005453-4057qib7	2445	22	with	with	IN
cord-005453-4057qib7	2445	23	myeloid	myeloid	NN
cord-005453-4057qib7	2445	24	neoplasm	neoplasm	NN
cord-005453-4057qib7	2445	25	Background	background	NN
cord-005453-4057qib7	2445	26	:	:	:
cord-005453-4057qib7	2445	27	Anti	anti	JJ
cord-005453-4057qib7	2445	28	-	-	JJ
cord-005453-4057qib7	2445	29	thymocyte	thymocyte	JJ
cord-005453-4057qib7	2445	30	globulin	globulin	NN
cord-005453-4057qib7	2445	31	(	(	-LRB-
cord-005453-4057qib7	2445	32	ATG	ATG	NNP
cord-005453-4057qib7	2445	33	)	)	-RRB-
cord-005453-4057qib7	2445	34	is	be	VBZ
cord-005453-4057qib7	2445	35	widely	widely	RB
cord-005453-4057qib7	2445	36	used	use	VBN
cord-005453-4057qib7	2445	37	for	for	IN
cord-005453-4057qib7	2445	38	the	the	DT
cord-005453-4057qib7	2445	39	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2445	40	of	of	IN
cord-005453-4057qib7	2445	41	graft	graft	NN
cord-005453-4057qib7	2445	42	-	-	HYPH
cord-005453-4057qib7	2445	43	versus	versus	IN
cord-005453-4057qib7	2445	44	-	-	HYPH
cord-005453-4057qib7	2445	45	host	host	NN
cord-005453-4057qib7	2445	46	disease	disease	NN
cord-005453-4057qib7	2445	47	(	(	-LRB-
cord-005453-4057qib7	2445	48	GVHD	GVHD	NNP
cord-005453-4057qib7	2445	49	)	)	-RRB-
cord-005453-4057qib7	2445	50	in	in	IN
cord-005453-4057qib7	2445	51	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2445	52	stem	stem	NN
cord-005453-4057qib7	2445	53	cell	cell	NN
cord-005453-4057qib7	2445	54	transplantation	transplantation	NN
cord-005453-4057qib7	2445	55	(	(	-LRB-
cord-005453-4057qib7	2445	56	HSCT	HSCT	NNP
cord-005453-4057qib7	2445	57	)	)	-RRB-
cord-005453-4057qib7	2445	58	.	.	.
cord-005453-4057qib7	2446	1	However	however	RB
cord-005453-4057qib7	2446	2	,	,	,
cord-005453-4057qib7	2446	3	there	there	EX
cord-005453-4057qib7	2446	4	is	be	VBZ
cord-005453-4057qib7	2446	5	still	still	RB
cord-005453-4057qib7	2446	6	controversy	controversy	NN
cord-005453-4057qib7	2446	7	regarding	regard	VBG
cord-005453-4057qib7	2446	8	the	the	DT
cord-005453-4057qib7	2446	9	optimal	optimal	JJ
cord-005453-4057qib7	2446	10	dose	dose	NN
cord-005453-4057qib7	2446	11	of	of	IN
cord-005453-4057qib7	2446	12	ATG	ATG	NNP
cord-005453-4057qib7	2446	13	.	.	.
cord-005453-4057qib7	2447	1	Therefore	therefore	RB
cord-005453-4057qib7	2447	2	,	,	,
cord-005453-4057qib7	2447	3	we	-PRON-	PRP
cord-005453-4057qib7	2447	4	analyzed	analyze	VBD
cord-005453-4057qib7	2447	5	the	the	DT
cord-005453-4057qib7	2447	6	impact	impact	NN
cord-005453-4057qib7	2447	7	of	of	IN
cord-005453-4057qib7	2447	8	ATG	ATG	NNP
cord-005453-4057qib7	2447	9	doses	dose	NNS
cord-005453-4057qib7	2447	10	in	in	IN
cord-005453-4057qib7	2447	11	unrelated	unrelated	JJ
cord-005453-4057qib7	2447	12	HSCT	HSCT	NNP
cord-005453-4057qib7	2447	13	for	for	IN
cord-005453-4057qib7	2447	14	patients	patient	NNS
cord-005453-4057qib7	2447	15	with	with	IN
cord-005453-4057qib7	2447	16	myeloid	myeloid	JJ
cord-005453-4057qib7	2447	17	neoplasm	neoplasm	NN
cord-005453-4057qib7	2447	18	.	.	.
cord-005453-4057qib7	2448	1	Methods	method	NNS
cord-005453-4057qib7	2448	2	:	:	:
cord-005453-4057qib7	2448	3	This	this	DT
cord-005453-4057qib7	2448	4	was	be	VBD
cord-005453-4057qib7	2448	5	a	a	DT
cord-005453-4057qib7	2448	6	retrospective	retrospective	JJ
cord-005453-4057qib7	2448	7	multi	multi	JJ
cord-005453-4057qib7	2448	8	-	-	JJ
cord-005453-4057qib7	2448	9	center	center	JJ
cord-005453-4057qib7	2448	10	study	study	NN
cord-005453-4057qib7	2448	11	that	that	WDT
cord-005453-4057qib7	2448	12	assessed	assess	VBD
cord-005453-4057qib7	2448	13	the	the	DT
cord-005453-4057qib7	2448	14	impact	impact	NN
cord-005453-4057qib7	2448	15	of	of	IN
cord-005453-4057qib7	2448	16	ATG	ATG	NNP
cord-005453-4057qib7	2448	17	doses	dose	NNS
cord-005453-4057qib7	2448	18	on	on	IN
cord-005453-4057qib7	2448	19	clinical	clinical	JJ
cord-005453-4057qib7	2448	20	outcomes	outcome	NNS
cord-005453-4057qib7	2448	21	in	in	IN
cord-005453-4057qib7	2448	22	patients	patient	NNS
cord-005453-4057qib7	2448	23	with	with	IN
cord-005453-4057qib7	2448	24	acute	acute	JJ
cord-005453-4057qib7	2448	25	myeloid	myeloid	NN
cord-005453-4057qib7	2448	26	leukemia	leukemia	NN
cord-005453-4057qib7	2448	27	(	(	-LRB-
cord-005453-4057qib7	2448	28	AML	AML	NNP
cord-005453-4057qib7	2448	29	)	)	-RRB-
cord-005453-4057qib7	2448	30	or	or	CC
cord-005453-4057qib7	2448	31	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	2448	32	syndrome	syndrome	NN
cord-005453-4057qib7	2448	33	(	(	-LRB-
cord-005453-4057qib7	2448	34	MDS	MDS	NNP
cord-005453-4057qib7	2448	35	)	)	-RRB-
cord-005453-4057qib7	2448	36	undergoing	undergo	VBG
cord-005453-4057qib7	2448	37	an	an	DT
cord-005453-4057qib7	2448	38	unrelated	unrelated	JJ
cord-005453-4057qib7	2448	39	HSCT	HSCT	NNP
cord-005453-4057qib7	2448	40	.	.	.
cord-005453-4057qib7	2449	1	The	the	DT
cord-005453-4057qib7	2449	2	patients	patient	NNS
cord-005453-4057qib7	2449	3	who	who	WP
cord-005453-4057qib7	2449	4	received	receive	VBD
cord-005453-4057qib7	2449	5	peripheral	peripheral	JJ
cord-005453-4057qib7	2449	6	blood	blood	NN
cord-005453-4057qib7	2449	7	stem	stem	NN
cord-005453-4057qib7	2449	8	cells	cell	NNS
cord-005453-4057qib7	2449	9	(	(	-LRB-
cord-005453-4057qib7	2449	10	PBSC	PBSC	NNP
cord-005453-4057qib7	2449	11	)	)	-RRB-
cord-005453-4057qib7	2449	12	transplantation	transplantation	NN
cord-005453-4057qib7	2449	13	after	after	IN
cord-005453-4057qib7	2449	14	conditioning	conditioning	NN
cord-005453-4057qib7	2449	15	regimens	regimen	NNS
cord-005453-4057qib7	2449	16	containing	contain	VBG
cord-005453-4057qib7	2449	17	i.v	i.v	NNP
cord-005453-4057qib7	2449	18	.	.	.
cord-005453-4057qib7	2449	19	busulfan	busulfan	NNP
cord-005453-4057qib7	2449	20	(	(	-LRB-
cord-005453-4057qib7	2449	21	BU	BU	NNP
cord-005453-4057qib7	2449	22	)	)	-RRB-
cord-005453-4057qib7	2449	23	,	,	,
cord-005453-4057qib7	2449	24	fludarabine	fludarabine	NN
cord-005453-4057qib7	2449	25	and	and	CC
cord-005453-4057qib7	2449	26	rabbit	rabbit	NN
cord-005453-4057qib7	2449	27	ATG	ATG	NNP
cord-005453-4057qib7	2449	28	between	between	IN
cord-005453-4057qib7	2449	29	2010	2010	CD
cord-005453-4057qib7	2449	30	and	and	CC
cord-005453-4057qib7	2449	31	2017	2017	CD
cord-005453-4057qib7	2449	32	were	be	VBD
cord-005453-4057qib7	2449	33	included	include	VBN
cord-005453-4057qib7	2449	34	in	in	IN
cord-005453-4057qib7	2449	35	this	this	DT
cord-005453-4057qib7	2449	36	study	study	NN
cord-005453-4057qib7	2449	37	.	.	.
cord-005453-4057qib7	2450	1	Results	result	NNS
cord-005453-4057qib7	2450	2	:	:	:
cord-005453-4057qib7	2451	1	A	a	DT
cord-005453-4057qib7	2451	2	total	total	NN
cord-005453-4057qib7	2451	3	of	of	IN
cord-005453-4057qib7	2451	4	96	96	CD
cord-005453-4057qib7	2451	5	patents	patent	NNS
cord-005453-4057qib7	2451	6	,	,	,
cord-005453-4057qib7	2451	7	median	median	JJ
cord-005453-4057qib7	2451	8	age	age	NN
cord-005453-4057qib7	2451	9	45	45	CD
cord-005453-4057qib7	2451	10	years	year	NNS
cord-005453-4057qib7	2451	11	,	,	,
cord-005453-4057qib7	2451	12	with	with	IN
cord-005453-4057qib7	2451	13	AML	AML	NNP
cord-005453-4057qib7	2451	14	(	(	-LRB-
cord-005453-4057qib7	2451	15	n=74	n=74	NNP
cord-005453-4057qib7	2451	16	)	)	-RRB-
cord-005453-4057qib7	2451	17	or	or	CC
cord-005453-4057qib7	2451	18	MDS	MDS	NNP
cord-005453-4057qib7	2451	19	(	(	-LRB-
cord-005453-4057qib7	2451	20	n=22	n=22	NNP
cord-005453-4057qib7	2451	21	)	)	-RRB-
cord-005453-4057qib7	2451	22	were	be	VBD
cord-005453-4057qib7	2451	23	included	include	VBN
cord-005453-4057qib7	2451	24	in	in	IN
cord-005453-4057qib7	2451	25	our	-PRON-	PRP$
cord-005453-4057qib7	2451	26	analyses	analysis	NNS
cord-005453-4057qib7	2451	27	.	.	.
cord-005453-4057qib7	2452	1	66	66	CD
cord-005453-4057qib7	2452	2	patients	patient	NNS
cord-005453-4057qib7	2452	3	(	(	-LRB-
cord-005453-4057qib7	2452	4	69	69	CD
cord-005453-4057qib7	2452	5	%	%	NN
cord-005453-4057qib7	2452	6	)	)	-RRB-
cord-005453-4057qib7	2452	7	received	receive	VBD
cord-005453-4057qib7	2452	8	a	a	DT
cord-005453-4057qib7	2452	9	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2452	10	regimen	regimen	NN
cord-005453-4057qib7	2452	11	(	(	-LRB-
cord-005453-4057qib7	2452	12	i.v	i.v	NNP
cord-005453-4057qib7	2452	13	.	.	.
cord-005453-4057qib7	2452	14	BU>6.4	BU>6.4	NNP
cord-005453-4057qib7	2452	15	mg	mg	NNP
cord-005453-4057qib7	2452	16	/	/	SYM
cord-005453-4057qib7	2452	17	kg	kg	NNP
cord-005453-4057qib7	2452	18	)	)	-RRB-
cord-005453-4057qib7	2452	19	.	.	.
cord-005453-4057qib7	2453	1	High	High	NNP
cord-005453-4057qib7	2453	2	-	-	HYPH
cord-005453-4057qib7	2453	3	ATG	ATG	NNP
cord-005453-4057qib7	2453	4	(	(	-LRB-
cord-005453-4057qib7	2453	5	ATG	ATG	NNP
cord-005453-4057qib7	2453	6	9	9	CD
cord-005453-4057qib7	2453	7	mg	mg	NNP
cord-005453-4057qib7	2453	8	/	/	SYM
cord-005453-4057qib7	2453	9	kg	kg	NNP
cord-005453-4057qib7	2453	10	)	)	-RRB-
cord-005453-4057qib7	2453	11	,	,	,
cord-005453-4057qib7	2453	12	intermediate	intermediate	JJ
cord-005453-4057qib7	2453	13	-	-	HYPH
cord-005453-4057qib7	2453	14	ATG	ATG	NNP
cord-005453-4057qib7	2453	15	(	(	-LRB-
cord-005453-4057qib7	2453	16	ATG	ATG	NNP
cord-005453-4057qib7	2453	17	4.5	4.5	CD
cord-005453-4057qib7	2453	18	-	-	SYM
cord-005453-4057qib7	2453	19	5	5	CD
cord-005453-4057qib7	2453	20	mg	mg	NNP
cord-005453-4057qib7	2453	21	/	/	SYM
cord-005453-4057qib7	2453	22	kg	kg	NNP
cord-005453-4057qib7	2453	23	)	)	-RRB-
cord-005453-4057qib7	2453	24	and	and	CC
cord-005453-4057qib7	2453	25	low	low	JJ
cord-005453-4057qib7	2453	26	-	-	HYPH
cord-005453-4057qib7	2453	27	ATG	ATG	NNP
cord-005453-4057qib7	2453	28	(	(	-LRB-
cord-005453-4057qib7	2453	29	ATG	ATG	NNP
cord-005453-4057qib7	2453	30	3	3	CD
cord-005453-4057qib7	2453	31	mg	mg	NNP
cord-005453-4057qib7	2453	32	/	/	SYM
cord-005453-4057qib7	2453	33	kg	kg	NNP
cord-005453-4057qib7	2453	34	)	)	-RRB-
cord-005453-4057qib7	2453	35	were	be	VBD
cord-005453-4057qib7	2453	36	given	give	VBN
cord-005453-4057qib7	2453	37	in	in	IN
cord-005453-4057qib7	2453	38	11	11	CD
cord-005453-4057qib7	2453	39	,	,	,
cord-005453-4057qib7	2453	40	49	49	CD
cord-005453-4057qib7	2453	41	and	and	CC
cord-005453-4057qib7	2453	42	36	36	CD
cord-005453-4057qib7	2453	43	patients	patient	NNS
cord-005453-4057qib7	2453	44	,	,	,
cord-005453-4057qib7	2453	45	respectively	respectively	RB
cord-005453-4057qib7	2453	46	.	.	.
cord-005453-4057qib7	2454	1	After	after	IN
cord-005453-4057qib7	2454	2	a	a	DT
cord-005453-4057qib7	2454	3	median	median	JJ
cord-005453-4057qib7	2454	4	follow	follow	NN
cord-005453-4057qib7	2454	5	-	-	HYPH
cord-005453-4057qib7	2454	6	up	up	NN
cord-005453-4057qib7	2454	7	of	of	IN
cord-005453-4057qib7	2454	8	23	23	CD
cord-005453-4057qib7	2454	9	months	month	NNS
cord-005453-4057qib7	2454	10	,	,	,
cord-005453-4057qib7	2454	11	the	the	DT
cord-005453-4057qib7	2454	12	cumulative	cumulative	JJ
cord-005453-4057qib7	2454	13	incidence	incidence	NN
cord-005453-4057qib7	2454	14	of	of	IN
cord-005453-4057qib7	2454	15	extensive	extensive	JJ
cord-005453-4057qib7	2454	16	chronic	chronic	JJ
cord-005453-4057qib7	2454	17	GVHD	GVHD	NNP
cord-005453-4057qib7	2454	18	was	be	VBD
cord-005453-4057qib7	2454	19	9.1	9.1	CD
cord-005453-4057qib7	2454	20	%	%	NN
cord-005453-4057qib7	2454	21	in	in	IN
cord-005453-4057qib7	2454	22	the	the	DT
cord-005453-4057qib7	2454	23	high	high	JJ
cord-005453-4057qib7	2454	24	-	-	HYPH
cord-005453-4057qib7	2454	25	ATG	ATG	NNP
cord-005453-4057qib7	2454	26	group	group	NN
cord-005453-4057qib7	2454	27	,	,	,
cord-005453-4057qib7	2454	28	13.8	13.8	CD
cord-005453-4057qib7	2454	29	%	%	NN
cord-005453-4057qib7	2454	30	in	in	IN
cord-005453-4057qib7	2454	31	the	the	DT
cord-005453-4057qib7	2454	32	intermediate	intermediate	JJ
cord-005453-4057qib7	2454	33	-	-	HYPH
cord-005453-4057qib7	2454	34	ATG	ATG	NNP
cord-005453-4057qib7	2454	35	group	group	NN
cord-005453-4057qib7	2454	36	and	and	CC
cord-005453-4057qib7	2454	37	29.7	29.7	CD
cord-005453-4057qib7	2454	38	%	%	NN
cord-005453-4057qib7	2454	39	in	in	IN
cord-005453-4057qib7	2454	40	the	the	DT
cord-005453-4057qib7	2454	41	low	low	JJ
cord-005453-4057qib7	2454	42	-	-	HYPH
cord-005453-4057qib7	2454	43	ATG	atg	NN
cord-005453-4057qib7	2454	44	group	group	NN
cord-005453-4057qib7	2454	45	(	(	-LRB-
cord-005453-4057qib7	2454	46	p=0.31	p=0.31	NNP
cord-005453-4057qib7	2454	47	)	)	-RRB-
cord-005453-4057qib7	2454	48	.	.	.
cord-005453-4057qib7	2455	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2455	2	:	:	:
cord-005453-4057qib7	2456	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2456	2	study	study	NN
cord-005453-4057qib7	2456	3	shows	show	VBZ
cord-005453-4057qib7	2456	4	that	that	IN
cord-005453-4057qib7	2456	5	the	the	DT
cord-005453-4057qib7	2456	6	incidence	incidence	NN
cord-005453-4057qib7	2456	7	of	of	IN
cord-005453-4057qib7	2456	8	extensive	extensive	JJ
cord-005453-4057qib7	2456	9	chronic	chronic	JJ
cord-005453-4057qib7	2456	10	GVHD	GVHD	NNP
cord-005453-4057qib7	2456	11	was	be	VBD
cord-005453-4057qib7	2456	12	similar	similar	JJ
cord-005453-4057qib7	2456	13	regardless	regardless	RB
cord-005453-4057qib7	2456	14	of	of	IN
cord-005453-4057qib7	2456	15	the	the	DT
cord-005453-4057qib7	2456	16	doses	dose	NNS
cord-005453-4057qib7	2456	17	of	of	IN
cord-005453-4057qib7	2456	18	ATG	ATG	NNP
cord-005453-4057qib7	2456	19	after	after	IN
cord-005453-4057qib7	2456	20	transplantation	transplantation	NN
cord-005453-4057qib7	2456	21	of	of	IN
cord-005453-4057qib7	2456	22	PBSC	PBSC	NNP
cord-005453-4057qib7	2456	23	from	from	IN
cord-005453-4057qib7	2456	24	unrelated	unrelated	JJ
cord-005453-4057qib7	2456	25	donor	donor	NN
cord-005453-4057qib7	2456	26	for	for	IN
cord-005453-4057qib7	2456	27	patients	patient	NNS
cord-005453-4057qib7	2456	28	with	with	IN
cord-005453-4057qib7	2456	29	AML	AML	NNP
cord-005453-4057qib7	2456	30	or	or	CC
cord-005453-4057qib7	2456	31	MDS	MDS	NNP
cord-005453-4057qib7	2456	32	.	.	.
cord-005453-4057qib7	2457	1	However	however	RB
cord-005453-4057qib7	2457	2	,	,	,
cord-005453-4057qib7	2457	3	the	the	DT
cord-005453-4057qib7	2457	4	rate	rate	NN
cord-005453-4057qib7	2457	5	of	of	IN
cord-005453-4057qib7	2457	6	relapsefree	relapsefree	NNP
cord-005453-4057qib7	2457	7	survival	survival	NN
cord-005453-4057qib7	2457	8	and	and	CC
cord-005453-4057qib7	2457	9	the	the	DT
cord-005453-4057qib7	2457	10	rate	rate	NN
cord-005453-4057qib7	2457	11	of	of	IN
cord-005453-4057qib7	2457	12	a	a	DT
cord-005453-4057qib7	2457	13	composite	composite	JJ
cord-005453-4057qib7	2457	14	end	end	NN
cord-005453-4057qib7	2457	15	point	point	NN
cord-005453-4057qib7	2457	16	chronic	chronic	JJ
cord-005453-4057qib7	2457	17	GVHD	GVHD	NNP
cord-005453-4057qib7	2457	18	-	-	HYPH
cord-005453-4057qib7	2457	19	free	free	JJ
cord-005453-4057qib7	2457	20	and	and	CC
cord-005453-4057qib7	2457	21	relapse	relapse	NN
cord-005453-4057qib7	2457	22	-	-	HYPH
cord-005453-4057qib7	2457	23	free	free	JJ
cord-005453-4057qib7	2457	24	survival	survival	NN
cord-005453-4057qib7	2457	25	were	be	VBD
cord-005453-4057qib7	2457	26	significantly	significantly	RB
cord-005453-4057qib7	2457	27	higher	high	JJR
cord-005453-4057qib7	2457	28	in	in	IN
cord-005453-4057qib7	2457	29	the	the	DT
cord-005453-4057qib7	2457	30	intermediate	intermediate	JJ
cord-005453-4057qib7	2457	31	dose	dose	NN
cord-005453-4057qib7	2457	32	(	(	-LRB-
cord-005453-4057qib7	2457	33	Methods	method	NNS
cord-005453-4057qib7	2457	34	:	:	:
cord-005453-4057qib7	2458	1	We	-PRON-	PRP
cord-005453-4057qib7	2458	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	2458	3	retrieved	retrieve	VBD
cord-005453-4057qib7	2458	4	data	datum	NNS
cord-005453-4057qib7	2458	5	from	from	IN
cord-005453-4057qib7	2458	6	the	the	DT
cord-005453-4057qib7	2458	7	electronic	electronic	JJ
cord-005453-4057qib7	2458	8	medical	medical	JJ
cord-005453-4057qib7	2458	9	records	record	NNS
cord-005453-4057qib7	2458	10	for	for	IN
cord-005453-4057qib7	2458	11	consecutive	consecutive	JJ
cord-005453-4057qib7	2458	12	patients	patient	NNS
cord-005453-4057qib7	2458	13	aged	age	VBN
cord-005453-4057qib7	2458	14	65	65	CD
cord-005453-4057qib7	2458	15	and	and	CC
cord-005453-4057qib7	2458	16	older	old	JJR
cord-005453-4057qib7	2458	17	,	,	,
cord-005453-4057qib7	2458	18	who	who	WP
cord-005453-4057qib7	2458	19	underwent	undergo	VBD
cord-005453-4057qib7	2458	20	an	an	DT
cord-005453-4057qib7	2458	21	ASCT	ASCT	NNP
cord-005453-4057qib7	2458	22	for	for	IN
cord-005453-4057qib7	2458	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	2458	24	over	over	IN
cord-005453-4057qib7	2458	25	the	the	DT
cord-005453-4057qib7	2458	26	last	last	JJ
cord-005453-4057qib7	2458	27	10	10	CD
cord-005453-4057qib7	2458	28	years	year	NNS
cord-005453-4057qib7	2458	29	at	at	IN
cord-005453-4057qib7	2458	30	our	-PRON-	PRP$
cord-005453-4057qib7	2458	31	institution	institution	NN
cord-005453-4057qib7	2458	32	.	.	.
cord-005453-4057qib7	2459	1	Results	result	NNS
cord-005453-4057qib7	2459	2	:	:	:
cord-005453-4057qib7	2460	1	Forty	forty	CD
cord-005453-4057qib7	2460	2	four	four	CD
cord-005453-4057qib7	2460	3	patients	patient	NNS
cord-005453-4057qib7	2460	4	≥	≥	CD
cord-005453-4057qib7	2460	5	65	65	CD
cord-005453-4057qib7	2460	6	years	year	NNS
cord-005453-4057qib7	2460	7	old	old	JJ
cord-005453-4057qib7	2460	8	underwent	undergo	VBD
cord-005453-4057qib7	2460	9	ASCT	ASCT	NNP
cord-005453-4057qib7	2460	10	between	between	IN
cord-005453-4057qib7	2460	11	1	1	CD
cord-005453-4057qib7	2460	12	Aug	Aug	NNP
cord-005453-4057qib7	2460	13	2008	2008	CD
cord-005453-4057qib7	2460	14	and	and	CC
cord-005453-4057qib7	2460	15	31	31	CD
cord-005453-4057qib7	2460	16	Aug	Aug	NNP
cord-005453-4057qib7	2460	17	2018	2018	CD
cord-005453-4057qib7	2460	18	.	.	.
cord-005453-4057qib7	2461	1	Twenty	twenty	CD
cord-005453-4057qib7	2461	2	eight	eight	CD
cord-005453-4057qib7	2461	3	of	of	IN
cord-005453-4057qib7	2461	4	them	-PRON-	PRP
cord-005453-4057qib7	2461	5	received	receive	VBD
cord-005453-4057qib7	2461	6	a	a	DT
cord-005453-4057qib7	2461	7	reduced	reduce	VBN
cord-005453-4057qib7	2461	8	-	-	HYPH
cord-005453-4057qib7	2461	9	dose	dose	NN
cord-005453-4057qib7	2461	10	conditioning	conditioning	NN
cord-005453-4057qib7	2461	11	(	(	-LRB-
cord-005453-4057qib7	2461	12	median	median	NN
cord-005453-4057qib7	2461	13	25	25	CD
cord-005453-4057qib7	2461	14	%	%	NN
cord-005453-4057qib7	2461	15	,	,	,
cord-005453-4057qib7	2461	16	range	range	VBP
cord-005453-4057qib7	2461	17	20%-33	20%-33	CD
cord-005453-4057qib7	2461	18	%	%	NN
cord-005453-4057qib7	2461	19	dose	dose	NN
cord-005453-4057qib7	2461	20	reduction	reduction	NN
cord-005453-4057qib7	2461	21	)	)	-RRB-
cord-005453-4057qib7	2461	22	.	.	.
cord-005453-4057qib7	2462	1	The	the	DT
cord-005453-4057qib7	2462	2	dose	dose	NN
cord-005453-4057qib7	2462	3	was	be	VBD
cord-005453-4057qib7	2462	4	reduced	reduce	VBN
cord-005453-4057qib7	2462	5	for	for	IN
cord-005453-4057qib7	2462	6	92	92	CD
cord-005453-4057qib7	2462	7	%	%	NN
cord-005453-4057qib7	2462	8	of	of	IN
cord-005453-4057qib7	2462	9	patients	patient	NNS
cord-005453-4057qib7	2462	10	≥	≥	CD
cord-005453-4057qib7	2462	11	70	70	CD
cord-005453-4057qib7	2462	12	years	year	NNS
cord-005453-4057qib7	2462	13	old	old	JJ
cord-005453-4057qib7	2462	14	and	and	CC
cord-005453-4057qib7	2462	15	for	for	IN
cord-005453-4057qib7	2462	16	53	53	CD
cord-005453-4057qib7	2462	17	%	%	NN
cord-005453-4057qib7	2462	18	of	of	IN
cord-005453-4057qib7	2462	19	patients	patient	NNS
cord-005453-4057qib7	2462	20	aged	age	VBN
cord-005453-4057qib7	2462	21	65	65	CD
cord-005453-4057qib7	2462	22	-	-	SYM
cord-005453-4057qib7	2462	23	69	69	CD
cord-005453-4057qib7	2462	24	.	.	.
cord-005453-4057qib7	2463	1	The	the	DT
cord-005453-4057qib7	2463	2	outcomes	outcome	NNS
cord-005453-4057qib7	2463	3	of	of	IN
cord-005453-4057qib7	2463	4	the	the	DT
cord-005453-4057qib7	2463	5	following	following	JJ
cord-005453-4057qib7	2463	6	three	three	CD
cord-005453-4057qib7	2463	7	groups	group	NNS
cord-005453-4057qib7	2463	8	of	of	IN
cord-005453-4057qib7	2463	9	patients	patient	NNS
cord-005453-4057qib7	2463	10	were	be	VBD
cord-005453-4057qib7	2463	11	compared	compare	VBN
cord-005453-4057qib7	2463	12	:	:	:
cord-005453-4057qib7	2463	13	A	a	LS
cord-005453-4057qib7	2463	14	)	)	-RRB-
cord-005453-4057qib7	2463	15	age	age	NN
cord-005453-4057qib7	2463	16	≥	≥	CD
cord-005453-4057qib7	2463	17	65	65	CD
cord-005453-4057qib7	2463	18	;	;	:
cord-005453-4057qib7	2463	19	without	without	IN
cord-005453-4057qib7	2463	20	dose	dose	NN
cord-005453-4057qib7	2463	21	reduction	reduction	NN
cord-005453-4057qib7	2463	22	,	,	,
cord-005453-4057qib7	2463	23	B	b	NN
cord-005453-4057qib7	2463	24	)	)	-RRB-
cord-005453-4057qib7	2463	25	age	age	NN
cord-005453-4057qib7	2463	26	65	65	CD
cord-005453-4057qib7	2463	27	-	-	SYM
cord-005453-4057qib7	2463	28	69	69	CD
cord-005453-4057qib7	2463	29	;	;	:
cord-005453-4057qib7	2463	30	with	with	IN
cord-005453-4057qib7	2463	31	dose	dose	JJ
cord-005453-4057qib7	2463	32	reduction	reduction	NN
cord-005453-4057qib7	2463	33	and	and	CC
cord-005453-4057qib7	2463	34	C	c	NN
cord-005453-4057qib7	2463	35	)	)	-RRB-
cord-005453-4057qib7	2463	36	age	age	NN
cord-005453-4057qib7	2463	37	≥	≥	CD
cord-005453-4057qib7	2463	38	70	70	CD
cord-005453-4057qib7	2463	39	;	;	:
cord-005453-4057qib7	2463	40	with	with	IN
cord-005453-4057qib7	2463	41	dose	dose	JJ
cord-005453-4057qib7	2463	42	reduction	reduction	NN
cord-005453-4057qib7	2463	43	(	(	-LRB-
cord-005453-4057qib7	2463	44	table	table	NN
cord-005453-4057qib7	2463	45	1	1	CD
cord-005453-4057qib7	2463	46	)	)	-RRB-
cord-005453-4057qib7	2463	47	.	.	.
cord-005453-4057qib7	2464	1	Only	only	RB
cord-005453-4057qib7	2464	2	one	one	CD
cord-005453-4057qib7	2464	3	patient	patient	NN
cord-005453-4057qib7	2464	4	aged	age	VBD
cord-005453-4057qib7	2464	5	70	70	CD
cord-005453-4057qib7	2464	6	received	receive	VBN
cord-005453-4057qib7	2464	7	full	full	JJ
cord-005453-4057qib7	2464	8	-	-	HYPH
cord-005453-4057qib7	2464	9	dose	dose	NN
cord-005453-4057qib7	2464	10	conditioning	conditioning	NN
cord-005453-4057qib7	2464	11	.	.	.
cord-005453-4057qib7	2465	1	There	there	EX
cord-005453-4057qib7	2465	2	was	be	VBD
cord-005453-4057qib7	2465	3	no	no	DT
cord-005453-4057qib7	2465	4	significant	significant	JJ
cord-005453-4057qib7	2465	5	difference	difference	NN
cord-005453-4057qib7	2465	6	between	between	IN
cord-005453-4057qib7	2465	7	the	the	DT
cord-005453-4057qib7	2465	8	groups	group	NNS
cord-005453-4057qib7	2465	9	in	in	IN
cord-005453-4057qib7	2465	10	the	the	DT
cord-005453-4057qib7	2465	11	number	number	NN
cord-005453-4057qib7	2465	12	of	of	IN
cord-005453-4057qib7	2465	13	previous	previous	JJ
cord-005453-4057qib7	2465	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2465	15	cycles	cycle	NNS
cord-005453-4057qib7	2465	16	(	(	-LRB-
cord-005453-4057qib7	2465	17	median	median	JJ
cord-005453-4057qib7	2465	18	2	2	CD
cord-005453-4057qib7	2465	19	,	,	,
cord-005453-4057qib7	2465	20	range	range	NN
cord-005453-4057qib7	2465	21	1	1	CD
cord-005453-4057qib7	2465	22	-	-	SYM
cord-005453-4057qib7	2465	23	3	3	CD
cord-005453-4057qib7	2465	24	)	)	-RRB-
cord-005453-4057qib7	2465	25	.	.	.
cord-005453-4057qib7	2466	1	However	however	RB
cord-005453-4057qib7	2466	2	,	,	,
cord-005453-4057qib7	2466	3	significantly	significantly	RB
cord-005453-4057qib7	2466	4	more	more	JJR
cord-005453-4057qib7	2466	5	patients	patient	NNS
cord-005453-4057qib7	2466	6	at	at	IN
cord-005453-4057qib7	2466	7	the	the	DT
cord-005453-4057qib7	2466	8	age	age	NN
cord-005453-4057qib7	2466	9	of	of	IN
cord-005453-4057qib7	2466	10	65	65	CD
cord-005453-4057qib7	2466	11	-	-	SYM
cord-005453-4057qib7	2466	12	69	69	CD
cord-005453-4057qib7	2466	13	were	be	VBD
cord-005453-4057qib7	2466	14	in	in	IN
cord-005453-4057qib7	2466	15	complete	complete	JJ
cord-005453-4057qib7	2466	16	remission	remission	NN
cord-005453-4057qib7	2467	1	(	(	-LRB-
cord-005453-4057qib7	2467	2	CR	CR	NNP
cord-005453-4057qib7	2467	3	)	)	-RRB-
cord-005453-4057qib7	2467	4	pre	pre	JJ
cord-005453-4057qib7	2467	5	-	-	NN
cord-005453-4057qib7	2467	6	transplant	transplant	NN
cord-005453-4057qib7	2467	7	in	in	IN
cord-005453-4057qib7	2467	8	both	both	CC
cord-005453-4057qib7	2467	9	full	full	JJ
cord-005453-4057qib7	2467	10	and	and	CC
cord-005453-4057qib7	2467	11	reduced	reduce	VBN
cord-005453-4057qib7	2467	12	-	-	HYPH
cord-005453-4057qib7	2467	13	dose	dose	NN
cord-005453-4057qib7	2467	14	conditioning	conditioning	NN
cord-005453-4057qib7	2467	15	groups	group	NNS
cord-005453-4057qib7	2467	16	(	(	-LRB-
cord-005453-4057qib7	2467	17	A	a	NN
cord-005453-4057qib7	2467	18	and	and	CC
cord-005453-4057qib7	2467	19	B	b	NN
cord-005453-4057qib7	2467	20	)	)	-RRB-
cord-005453-4057qib7	2467	21	.	.	.
cord-005453-4057qib7	2468	1	No	no	DT
cord-005453-4057qib7	2468	2	significant	significant	JJ
cord-005453-4057qib7	2468	3	intergroup	intergroup	NN
cord-005453-4057qib7	2468	4	differences	difference	NNS
cord-005453-4057qib7	2468	5	were	be	VBD
cord-005453-4057qib7	2468	6	observed	observe	VBN
cord-005453-4057qib7	2468	7	in	in	IN
cord-005453-4057qib7	2468	8	the	the	DT
cord-005453-4057qib7	2468	9	occurrence	occurrence	NN
cord-005453-4057qib7	2468	10	of	of	IN
cord-005453-4057qib7	2468	11	complications	complication	NNS
cord-005453-4057qib7	2468	12	(	(	-LRB-
cord-005453-4057qib7	2468	13	mucositis	mucositis	NNP
cord-005453-4057qib7	2468	14	and	and	CC
cord-005453-4057qib7	2468	15	infections	infection	NNS
cord-005453-4057qib7	2468	16	)	)	-RRB-
cord-005453-4057qib7	2468	17	,	,	,
cord-005453-4057qib7	2468	18	day	day	NN
cord-005453-4057qib7	2468	19	30	30	CD
cord-005453-4057qib7	2468	20	transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	2468	21	mortality	mortality	NN
cord-005453-4057qib7	2468	22	(	(	-LRB-
cord-005453-4057qib7	2468	23	TRM	TRM	NNP
cord-005453-4057qib7	2468	24	)	)	-RRB-
cord-005453-4057qib7	2468	25	or	or	CC
cord-005453-4057qib7	2468	26	engraftment	engraftment	NNP
cord-005453-4057qib7	2468	27	day	day	NNP
cord-005453-4057qib7	2468	28	.	.	.
cord-005453-4057qib7	2469	1	Similarly	similarly	RB
cord-005453-4057qib7	2469	2	,	,	,
cord-005453-4057qib7	2469	3	no	no	DT
cord-005453-4057qib7	2469	4	significant	significant	JJ
cord-005453-4057qib7	2469	5	differences	difference	NNS
cord-005453-4057qib7	2469	6	were	be	VBD
cord-005453-4057qib7	2469	7	found	find	VBN
cord-005453-4057qib7	2469	8	either	either	CC
cord-005453-4057qib7	2469	9	in	in	IN
cord-005453-4057qib7	2469	10	the	the	DT
cord-005453-4057qib7	2469	11	1-year	1-year	CD
cord-005453-4057qib7	2469	12	progression	progression	NN
cord-005453-4057qib7	2469	13	-	-	HYPH
cord-005453-4057qib7	2469	14	free	free	JJ
cord-005453-4057qib7	2469	15	survival	survival	NN
cord-005453-4057qib7	2469	16	(	(	-LRB-
cord-005453-4057qib7	2469	17	PFS	PFS	NNP
cord-005453-4057qib7	2469	18	)	)	-RRB-
cord-005453-4057qib7	2469	19	,	,	,
cord-005453-4057qib7	2469	20	which	which	WDT
cord-005453-4057qib7	2469	21	was	be	VBD
cord-005453-4057qib7	2469	22	50	50	CD
cord-005453-4057qib7	2469	23	%	%	NN
cord-005453-4057qib7	2469	24	,	,	,
cord-005453-4057qib7	2469	25	64	64	CD
cord-005453-4057qib7	2469	26	%	%	NN
cord-005453-4057qib7	2469	27	and	and	CC
cord-005453-4057qib7	2469	28	50	50	CD
cord-005453-4057qib7	2469	29	%	%	NN
cord-005453-4057qib7	2469	30	,	,	,
cord-005453-4057qib7	2469	31	or	or	CC
cord-005453-4057qib7	2469	32	1-year	1-year	CD
cord-005453-4057qib7	2469	33	non	non	JJ
cord-005453-4057qib7	2469	34	-	-	JJ
cord-005453-4057qib7	2469	35	relapse	relapse	JJ
cord-005453-4057qib7	2469	36	mortality	mortality	NN
cord-005453-4057qib7	2469	37	(	(	-LRB-
cord-005453-4057qib7	2469	38	NRM	NRM	NNP
cord-005453-4057qib7	2469	39	)	)	-RRB-
cord-005453-4057qib7	2469	40	,	,	,
cord-005453-4057qib7	2469	41	which	which	WDT
cord-005453-4057qib7	2469	42	was	be	VBD
cord-005453-4057qib7	2469	43	17	17	CD
cord-005453-4057qib7	2469	44	%	%	NN
cord-005453-4057qib7	2469	45	,	,	,
cord-005453-4057qib7	2469	46	7	7	CD
cord-005453-4057qib7	2469	47	%	%	NN
cord-005453-4057qib7	2469	48	and	and	CC
cord-005453-4057qib7	2469	49	10	10	CD
cord-005453-4057qib7	2469	50	%	%	NN
cord-005453-4057qib7	2469	51	,	,	,
cord-005453-4057qib7	2469	52	respectively	respectively	RB
cord-005453-4057qib7	2469	53	for	for	IN
cord-005453-4057qib7	2469	54	groups	group	NNS
cord-005453-4057qib7	2469	55	A	A	NNP
cord-005453-4057qib7	2469	56	,	,	,
cord-005453-4057qib7	2469	57	B	B	NNP
cord-005453-4057qib7	2469	58	and	and	CC
cord-005453-4057qib7	2469	59	C.	c.	NN
cord-005453-4057qib7	2470	1	The	the	DT
cord-005453-4057qib7	2470	2	1-year	1-year	CD
cord-005453-4057qib7	2470	3	overall	overall	JJ
cord-005453-4057qib7	2470	4	survival	survival	NN
cord-005453-4057qib7	2470	5	(	(	-LRB-
cord-005453-4057qib7	2470	6	OS	OS	NNP
cord-005453-4057qib7	2470	7	)	)	-RRB-
cord-005453-4057qib7	2470	8	tended	tend	VBD
cord-005453-4057qib7	2470	9	to	to	TO
cord-005453-4057qib7	2470	10	be	be	VB
cord-005453-4057qib7	2470	11	higher	high	JJR
cord-005453-4057qib7	2470	12	in	in	IN
cord-005453-4057qib7	2470	13	group	group	NN
cord-005453-4057qib7	2470	14	B	b	NN
cord-005453-4057qib7	2470	15	(	(	-LRB-
cord-005453-4057qib7	2470	16	85	85	CD
cord-005453-4057qib7	2470	17	%	%	NN
cord-005453-4057qib7	2470	18	)	)	-RRB-
cord-005453-4057qib7	2470	19	,	,	,
cord-005453-4057qib7	2470	20	compared	compare	VBN
cord-005453-4057qib7	2470	21	to	to	IN
cord-005453-4057qib7	2470	22	groups	group	NNS
cord-005453-4057qib7	2470	23	A	A	NNP
cord-005453-4057qib7	2470	24	(	(	-LRB-
cord-005453-4057qib7	2470	25	66	66	CD
cord-005453-4057qib7	2470	26	%	%	NN
cord-005453-4057qib7	2470	27	)	)	-RRB-
cord-005453-4057qib7	2470	28	and	and	CC
cord-005453-4057qib7	2470	29	C	C	NNP
cord-005453-4057qib7	2470	30	(	(	-LRB-
cord-005453-4057qib7	2470	31	70	70	CD
cord-005453-4057qib7	2470	32	%	%	NN
cord-005453-4057qib7	2470	33	)	)	-RRB-
cord-005453-4057qib7	2470	34	.	.	.
cord-005453-4057qib7	2471	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2471	2	:	:	:
cord-005453-4057qib7	2472	1	BEAM	BEAM	NNP
cord-005453-4057qib7	2472	2	/	/	SYM
cord-005453-4057qib7	2472	3	BEAC	BEAC	NNP
cord-005453-4057qib7	2472	4	conditioning	conditioning	NN
cord-005453-4057qib7	2472	5	dose	dose	NN
cord-005453-4057qib7	2472	6	reduction	reduction	NN
cord-005453-4057qib7	2472	7	was	be	VBD
cord-005453-4057qib7	2472	8	not	not	RB
cord-005453-4057qib7	2472	9	found	find	VBN
cord-005453-4057qib7	2472	10	to	to	TO
cord-005453-4057qib7	2472	11	adversely	adversely	RB
cord-005453-4057qib7	2472	12	affect	affect	VB
cord-005453-4057qib7	2472	13	1-year	1-year	CD
cord-005453-4057qib7	2472	14	PFS	PFS	NNP
cord-005453-4057qib7	2472	15	and	and	CC
cord-005453-4057qib7	2472	16	OS	OS	NNP
cord-005453-4057qib7	2472	17	rates	rate	NNS
cord-005453-4057qib7	2472	18	.	.	.
cord-005453-4057qib7	2473	1	Despite	despite	IN
cord-005453-4057qib7	2473	2	the	the	DT
cord-005453-4057qib7	2473	3	fact	fact	NN
cord-005453-4057qib7	2473	4	that	that	IN
cord-005453-4057qib7	2473	5	2/3	2/3	CD
cord-005453-4057qib7	2473	6	of	of	IN
cord-005453-4057qib7	2473	7	the	the	DT
cord-005453-4057qib7	2473	8	patients	patient	NNS
cord-005453-4057qib7	2473	9	in	in	IN
cord-005453-4057qib7	2473	10	the	the	DT
cord-005453-4057qib7	2473	11	age	age	NN
cord-005453-4057qib7	2473	12	group	group	NN
cord-005453-4057qib7	2473	13	≥	≥	CD
cord-005453-4057qib7	2473	14	70	70	CD
cord-005453-4057qib7	2473	15	underwent	undergo	VBD
cord-005453-4057qib7	2473	16	ASCT	ASCT	NNP
cord-005453-4057qib7	2473	17	in	in	IN
cord-005453-4057qib7	2473	18	partial	partial	JJ
cord-005453-4057qib7	2473	19	remission	remission	NN
cord-005453-4057qib7	2473	20	and	and	CC
cord-005453-4057qib7	2473	21	had	have	VBD
cord-005453-4057qib7	2473	22	dose	dose	JJ
cord-005453-4057qib7	2473	23	reduction	reduction	NN
cord-005453-4057qib7	2473	24	,	,	,
cord-005453-4057qib7	2473	25	theier	theier	NNPS
cord-005453-4057qib7	2473	26	achieved	achieve	VBD
cord-005453-4057qib7	2473	27	TRM	TRM	NNP
cord-005453-4057qib7	2473	28	,	,	,
cord-005453-4057qib7	2473	29	PFS	PFS	NNP
cord-005453-4057qib7	2473	30	and	and	CC
cord-005453-4057qib7	2473	31	OS	OS	NNP
cord-005453-4057qib7	2473	32	rates	rate	NNS
cord-005453-4057qib7	2473	33	were	be	VBD
cord-005453-4057qib7	2473	34	similar	similar	JJ
cord-005453-4057qib7	2473	35	to	to	IN
cord-005453-4057qib7	2473	36	those	those	DT
cord-005453-4057qib7	2473	37	of	of	IN
cord-005453-4057qib7	2473	38	patients	patient	NNS
cord-005453-4057qib7	2473	39	aged	age	VBN
cord-005453-4057qib7	2473	40	65	65	CD
cord-005453-4057qib7	2473	41	-	-	SYM
cord-005453-4057qib7	2473	42	69	69	CD
cord-005453-4057qib7	2473	43	.	.	.
cord-005453-4057qib7	2474	1	BEAM	BEAM	NNP
cord-005453-4057qib7	2474	2	/	/	SYM
cord-005453-4057qib7	2474	3	BEAC	BEAC	NNP
cord-005453-4057qib7	2474	4	conditioning	conditioning	NN
cord-005453-4057qib7	2474	5	at	at	IN
cord-005453-4057qib7	2474	6	a	a	DT
cord-005453-4057qib7	2474	7	75%dose	75%dose	CD
cord-005453-4057qib7	2474	8	may	may	MD
cord-005453-4057qib7	2474	9	be	be	VB
cord-005453-4057qib7	2474	10	a	a	DT
cord-005453-4057qib7	2474	11	suitable	suitable	JJ
cord-005453-4057qib7	2474	12	option	option	NN
cord-005453-4057qib7	2474	13	for	for	IN
cord-005453-4057qib7	2474	14	patients	patient	NNS
cord-005453-4057qib7	2474	15	in	in	IN
cord-005453-4057qib7	2474	16	their	-PRON-	PRP$
cord-005453-4057qib7	2474	17	seventh	seventh	JJ
cord-005453-4057qib7	2474	18	decade	decade	NN
cord-005453-4057qib7	2474	19	requiring	require	VBG
cord-005453-4057qib7	2474	20	ASCT	ASCT	NNP
cord-005453-4057qib7	2474	21	.	.	.
cord-005453-4057qib7	2475	1	This	this	DT
cord-005453-4057qib7	2475	2	strategy	strategy	NN
cord-005453-4057qib7	2475	3	should	should	MD
cord-005453-4057qib7	2475	4	be	be	VB
cord-005453-4057qib7	2475	5	further	further	RB
cord-005453-4057qib7	2475	6	evaluated	evaluate	VBN
cord-005453-4057qib7	2475	7	in	in	IN
cord-005453-4057qib7	2475	8	prospective	prospective	JJ
cord-005453-4057qib7	2475	9	clinical	clinical	JJ
cord-005453-4057qib7	2475	10	trials	trial	NNS
cord-005453-4057qib7	2475	11	.	.	.
cord-005453-4057qib7	2476	1	Background	background	NN
cord-005453-4057qib7	2476	2	:	:	:
cord-005453-4057qib7	2477	1	The	the	DT
cord-005453-4057qib7	2477	2	transplant	transplant	NN
cord-005453-4057qib7	2477	3	related	relate	VBN
cord-005453-4057qib7	2477	4	mortality	mortality	NN
cord-005453-4057qib7	2477	5	in	in	IN
cord-005453-4057qib7	2477	6	autologous	autologous	JJ
cord-005453-4057qib7	2477	7	transplants	transplant	NNS
cord-005453-4057qib7	2477	8	for	for	IN
cord-005453-4057qib7	2477	9	lymphoma	lymphoma	NN
cord-005453-4057qib7	2477	10	and	and	CC
cord-005453-4057qib7	2477	11	multiple	multiple	JJ
cord-005453-4057qib7	2477	12	myeloma	myeloma	NN
cord-005453-4057qib7	2477	13	,	,	,
cord-005453-4057qib7	2477	14	reported	report	VBD
cord-005453-4057qib7	2477	15	worldwide	worldwide	RB
cord-005453-4057qib7	2477	16	ranges	range	VBZ
cord-005453-4057qib7	2477	17	from	from	IN
cord-005453-4057qib7	2477	18	0	0	CD
cord-005453-4057qib7	2477	19	-	-	SYM
cord-005453-4057qib7	2477	20	5	5	CD
cord-005453-4057qib7	2477	21	%	%	NN
cord-005453-4057qib7	2477	22	.	.	.
cord-005453-4057qib7	2478	1	From	from	IN
cord-005453-4057qib7	2478	2	2004	2004	CD
cord-005453-4057qib7	2478	3	-	-	SYM
cord-005453-4057qib7	2478	4	2015	2015	CD
cord-005453-4057qib7	2478	5	,	,	,
cord-005453-4057qib7	2478	6	the	the	DT
cord-005453-4057qib7	2478	7	TRM	TRM	NNP
cord-005453-4057qib7	2478	8	at	at	IN
cord-005453-4057qib7	2478	9	our	-PRON-	PRP$
cord-005453-4057qib7	2478	10	center	center	NN
cord-005453-4057qib7	2478	11	for	for	IN
cord-005453-4057qib7	2478	12	these	these	DT
cord-005453-4057qib7	2478	13	two	two	CD
cord-005453-4057qib7	2478	14	diseases	disease	NNS
cord-005453-4057qib7	2478	15	was	be	VBD
cord-005453-4057qib7	2478	16	approximately	approximately	RB
cord-005453-4057qib7	2478	17	20	20	CD
cord-005453-4057qib7	2478	18	%	%	NN
cord-005453-4057qib7	2478	19	.	.	.
cord-005453-4057qib7	2479	1	We	-PRON-	PRP
cord-005453-4057qib7	2479	2	introduced	introduce	VBD
cord-005453-4057qib7	2479	3	changes	change	NNS
cord-005453-4057qib7	2479	4	in	in	IN
cord-005453-4057qib7	2479	5	mobilization	mobilization	NN
cord-005453-4057qib7	2479	6	schedule	schedule	NN
cord-005453-4057qib7	2479	7	,	,	,
cord-005453-4057qib7	2479	8	conditioning	conditioning	NN
cord-005453-4057qib7	2479	9	regimens	regimen	NNS
cord-005453-4057qib7	2479	10	and	and	CC
cord-005453-4057qib7	2479	11	drug	drug	NN
cord-005453-4057qib7	2479	12	dosages	dosage	NNS
cord-005453-4057qib7	2479	13	to	to	TO
cord-005453-4057qib7	2479	14	determine	determine	VB
cord-005453-4057qib7	2479	15	whether	whether	IN
cord-005453-4057qib7	2479	16	these	these	DT
cord-005453-4057qib7	2479	17	changes	change	NNS
cord-005453-4057qib7	2479	18	affected	affect	VBD
cord-005453-4057qib7	2479	19	the	the	DT
cord-005453-4057qib7	2479	20	transplant	transplant	NN
cord-005453-4057qib7	2479	21	related	relate	VBN
cord-005453-4057qib7	2479	22	mortality	mortality	NN
cord-005453-4057qib7	2479	23	and	and	CC
cord-005453-4057qib7	2479	24	overall	overall	JJ
cord-005453-4057qib7	2479	25	survival	survival	NN
cord-005453-4057qib7	2479	26	.	.	.
cord-005453-4057qib7	2480	1	Methods	method	NNS
cord-005453-4057qib7	2480	2	:	:	:
cord-005453-4057qib7	2481	1	From	from	IN
cord-005453-4057qib7	2481	2	April	April	NNP
cord-005453-4057qib7	2481	3	2004-December	2004-december	CD
cord-005453-4057qib7	2481	4	2015	2015	CD
cord-005453-4057qib7	2481	5	,	,	,
cord-005453-4057qib7	2481	6	we	-PRON-	PRP
cord-005453-4057qib7	2481	7	used	use	VBD
cord-005453-4057qib7	2481	8	BEAM	BEAM	NNP
cord-005453-4057qib7	2482	1	(	(	-LRB-
cord-005453-4057qib7	2482	2	BCNU	BCNU	NNP
cord-005453-4057qib7	2482	3	:	:	:
cord-005453-4057qib7	2483	1	300	300	CD
cord-005453-4057qib7	2483	2	mg	mg	NNP
cord-005453-4057qib7	2483	3	/	/	SYM
cord-005453-4057qib7	2483	4	m	m	NNP
cord-005453-4057qib7	2483	5	2	2	CD
cord-005453-4057qib7	2483	6	on	on	IN
cord-005453-4057qib7	2483	7	day	day	NN
cord-005453-4057qib7	2483	8	-6	-6	NNP
cord-005453-4057qib7	2483	9	;	;	.
cord-005453-4057qib7	2484	1	Etoposide	etoposide	RB
cord-005453-4057qib7	2484	2	200	200	CD
cord-005453-4057qib7	2484	3	mg/	mg/	NN
cord-005453-4057qib7	2484	4	m	m	CD
cord-005453-4057qib7	2484	5	2	2	CD
cord-005453-4057qib7	2484	6	on	on	IN
cord-005453-4057qib7	2484	7	days	day	NNS
cord-005453-4057qib7	2484	8	-5	-5	JJ
cord-005453-4057qib7	2484	9	to	to	IN
cord-005453-4057qib7	2485	1	-2	-2	NNP
cord-005453-4057qib7	2485	2	,	,	,
cord-005453-4057qib7	2485	3	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	2485	4	200	200	CD
cord-005453-4057qib7	2485	5	mg	mg	NNP
cord-005453-4057qib7	2485	6	/	/	SYM
cord-005453-4057qib7	2485	7	m	m	NNP
cord-005453-4057qib7	2485	8	2	2	CD
cord-005453-4057qib7	2485	9	on	on	IN
cord-005453-4057qib7	2485	10	days	day	NNS
cord-005453-4057qib7	2485	11	-5	-5	NNP
cord-005453-4057qib7	2486	1	to	to	IN
cord-005453-4057qib7	2486	2	-2	-2	CD
cord-005453-4057qib7	2486	3	and	and	CC
cord-005453-4057qib7	2486	4	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2487	1	140mg	140mg	NNP
cord-005453-4057qib7	2487	2	/	/	SYM
cord-005453-4057qib7	2487	3	m	m	NNP
cord-005453-4057qib7	2487	4	2	2	CD
cord-005453-4057qib7	2487	5	on	on	IN
cord-005453-4057qib7	2487	6	day	day	NN
cord-005453-4057qib7	2487	7	-1	-1	.
cord-005453-4057qib7	2488	1	as	as	IN
cord-005453-4057qib7	2488	2	conditioning	conditioning	NN
cord-005453-4057qib7	2488	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2488	4	for	for	IN
cord-005453-4057qib7	2488	5	patients	patient	NNS
cord-005453-4057qib7	2488	6	admitted	admit	VBN
cord-005453-4057qib7	2488	7	in	in	IN
cord-005453-4057qib7	2488	8	transplant	transplant	NN
cord-005453-4057qib7	2488	9	unit	unit	NN
cord-005453-4057qib7	2488	10	for	for	IN
cord-005453-4057qib7	2488	11	autologous	autologous	JJ
cord-005453-4057qib7	2488	12	transplants	transplant	NNS
cord-005453-4057qib7	2488	13	in	in	IN
cord-005453-4057qib7	2488	14	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	2488	15	's	's	POS
cord-005453-4057qib7	2488	16	and	and	CC
cord-005453-4057qib7	2488	17	Non	Non	NNP
cord-005453-4057qib7	2488	18	-	-	NNP
cord-005453-4057qib7	2488	19	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	2488	20	's	's	POS
cord-005453-4057qib7	2488	21	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	2488	22	.	.	.
cord-005453-4057qib7	2489	1	In	in	IN
cord-005453-4057qib7	2489	2	patients	patient	NNS
cord-005453-4057qib7	2489	3	with	with	IN
cord-005453-4057qib7	2489	4	multiple	multiple	JJ
cord-005453-4057qib7	2489	5	myeloma	myeloma	NN
cord-005453-4057qib7	2489	6	high	high	JJ
cord-005453-4057qib7	2489	7	dose	dose	NN
cord-005453-4057qib7	2489	8	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2489	9	(	(	-LRB-
cord-005453-4057qib7	2489	10	200mg	200mg	NNP
cord-005453-4057qib7	2489	11	/	/	SYM
cord-005453-4057qib7	2489	12	m	m	NNP
cord-005453-4057qib7	2489	13	2	2	CD
cord-005453-4057qib7	2489	14	)	)	-RRB-
cord-005453-4057qib7	2489	15	was	be	VBD
cord-005453-4057qib7	2489	16	used	use	VBN
cord-005453-4057qib7	2489	17	.	.	.
cord-005453-4057qib7	2490	1	The	the	DT
cord-005453-4057qib7	2490	2	mobilization	mobilization	NN
cord-005453-4057qib7	2490	3	protocol	protocol	NN
cord-005453-4057qib7	2490	4	consisted	consist	VBD
cord-005453-4057qib7	2490	5	of	of	IN
cord-005453-4057qib7	2490	6	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	2490	7	1.5gm	1.5gm	NNP
cord-005453-4057qib7	2490	8	/	/	SYM
cord-005453-4057qib7	2490	9	m	m	NN
cord-005453-4057qib7	2490	10	2	2	CD
cord-005453-4057qib7	2490	11	followed	follow	VBN
cord-005453-4057qib7	2490	12	by	by	IN
cord-005453-4057qib7	2490	13	GCSF	GCSF	NNP
cord-005453-4057qib7	2490	14	5μgm	5μgm	CD
cord-005453-4057qib7	2491	1	/kg	/kg	NFP
cord-005453-4057qib7	2491	2	twice	twice	RB
cord-005453-4057qib7	2491	3	daily	daily	RB
cord-005453-4057qib7	2491	4	till	till	IN
cord-005453-4057qib7	2491	5	stem	stem	NN
cord-005453-4057qib7	2491	6	cell	cell	NN
cord-005453-4057qib7	2491	7	collection	collection	NN
cord-005453-4057qib7	2491	8	was	be	VBD
cord-005453-4057qib7	2491	9	completed	complete	VBN
cord-005453-4057qib7	2491	10	.	.	.
cord-005453-4057qib7	2492	1	From	from	IN
cord-005453-4057qib7	2492	2	January	January	NNP
cord-005453-4057qib7	2492	3	2016	2016	CD
cord-005453-4057qib7	2492	4	,	,	,
cord-005453-4057qib7	2492	5	we	-PRON-	PRP
cord-005453-4057qib7	2492	6	changed	change	VBD
cord-005453-4057qib7	2492	7	the	the	DT
cord-005453-4057qib7	2492	8	BEAM	BEAM	NNP
cord-005453-4057qib7	2492	9	protocol	protocol	NN
cord-005453-4057qib7	2492	10	to	to	IN
cord-005453-4057qib7	2492	11	BendaEAM	BendaEAM	NNP
cord-005453-4057qib7	2492	12	with	with	IN
cord-005453-4057qib7	2492	13	dose	dose	NN
cord-005453-4057qib7	2492	14	modifications	modification	NNS
cord-005453-4057qib7	2492	15	that	that	WDT
cord-005453-4057qib7	2492	16	included	include	VBD
cord-005453-4057qib7	2492	17	:	:	:
cord-005453-4057qib7	2492	18	bendamustine	bendamustine	NNP
cord-005453-4057qib7	2492	19	150mg	150mg	NNP
cord-005453-4057qib7	2492	20	/	/	SYM
cord-005453-4057qib7	2492	21	m	m	NNP
cord-005453-4057qib7	2492	22	2	2	CD
cord-005453-4057qib7	2492	23	on	on	IN
cord-005453-4057qib7	2492	24	days	day	NNS
cord-005453-4057qib7	2492	25	-5	-5	NNP
cord-005453-4057qib7	2492	26	and	and	CC
cord-005453-4057qib7	2492	27	-4	-4	NNP
cord-005453-4057qib7	2492	28	,	,	,
cord-005453-4057qib7	2492	29	cytarabine	cytarabine	NNP
cord-005453-4057qib7	2492	30	150mg	150mg	NNP
cord-005453-4057qib7	2492	31	/	/	SYM
cord-005453-4057qib7	2492	32	m	m	NN
cord-005453-4057qib7	2492	33	2	2	CD
cord-005453-4057qib7	2492	34	on	on	IN
cord-005453-4057qib7	2492	35	days	day	NNS
cord-005453-4057qib7	2492	36	-5	-5	JJ
cord-005453-4057qib7	2492	37	to	to	IN
cord-005453-4057qib7	2492	38	-2	-2	CD
cord-005453-4057qib7	2492	39	,	,	,
cord-005453-4057qib7	2492	40	etoposide	etoposide	JJ
cord-005453-4057qib7	2492	41	150mg	150mg	NNP
cord-005453-4057qib7	2492	42	/	/	SYM
cord-005453-4057qib7	2492	43	m	m	NN
cord-005453-4057qib7	2492	44	2	2	CD
cord-005453-4057qib7	2492	45	on	on	IN
cord-005453-4057qib7	2492	46	days	day	NNS
cord-005453-4057qib7	2492	47	-5	-5	JJ
cord-005453-4057qib7	2492	48	to	to	IN
cord-005453-4057qib7	2492	49	-2	-2	CD
cord-005453-4057qib7	2492	50	and	and	CC
cord-005453-4057qib7	2492	51	melphalan	melphalan	NNP
cord-005453-4057qib7	2492	52	100mg	100mg	NNP
cord-005453-4057qib7	2492	53	/	/	SYM
cord-005453-4057qib7	2492	54	m	m	NNP
cord-005453-4057qib7	2492	55	2	2	CD
cord-005453-4057qib7	2492	56	on	on	IN
cord-005453-4057qib7	2492	57	day	day	NN
cord-005453-4057qib7	2492	58	-1	-1	CD
cord-005453-4057qib7	2492	59	.	.	.
cord-005453-4057qib7	2493	1	For	for	IN
cord-005453-4057qib7	2493	2	multiple	multiple	JJ
cord-005453-4057qib7	2493	3	myeloma	myeloma	NN
cord-005453-4057qib7	2493	4	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2493	5	was	be	VBD
cord-005453-4057qib7	2493	6	reduced	reduce	VBN
cord-005453-4057qib7	2493	7	to	to	IN
cord-005453-4057qib7	2493	8	150mg	150mg	NNP
cord-005453-4057qib7	2493	9	/	/	SYM
cord-005453-4057qib7	2493	10	m	m	NN
cord-005453-4057qib7	2493	11	2	2	CD
cord-005453-4057qib7	2493	12	.	.	.
cord-005453-4057qib7	2494	1	We	-PRON-	PRP
cord-005453-4057qib7	2494	2	used	use	VBD
cord-005453-4057qib7	2494	3	only	only	RB
cord-005453-4057qib7	2494	4	GCSF	GCSF	NNP
cord-005453-4057qib7	2494	5	for	for	IN
cord-005453-4057qib7	2494	6	mobilization	mobilization	NN
cord-005453-4057qib7	2494	7	of	of	IN
cord-005453-4057qib7	2494	8	stem	stem	NN
cord-005453-4057qib7	2494	9	cells	cell	NNS
cord-005453-4057qib7	2494	10	,	,	,
cord-005453-4057qib7	2494	11	which	which	WDT
cord-005453-4057qib7	2494	12	was	be	VBD
cord-005453-4057qib7	2494	13	continued	continue	VBN
cord-005453-4057qib7	2494	14	till	till	IN
cord-005453-4057qib7	2494	15	stem	stem	NN
cord-005453-4057qib7	2494	16	cell	cell	NN
cord-005453-4057qib7	2494	17	harvest	harvest	NN
cord-005453-4057qib7	2494	18	was	be	VBD
cord-005453-4057qib7	2494	19	complete	complete	JJ
cord-005453-4057qib7	2494	20	.	.	.
cord-005453-4057qib7	2495	1	Response	response	NN
cord-005453-4057qib7	2495	2	to	to	IN
cord-005453-4057qib7	2495	3	treatment	treatment	NN
cord-005453-4057qib7	2495	4	was	be	VBD
cord-005453-4057qib7	2495	5	evaluated	evaluate	VBN
cord-005453-4057qib7	2495	6	by	by	IN
cord-005453-4057qib7	2495	7	comparing	compare	VBG
cord-005453-4057qib7	2495	8	TRM	TRM	NNP
cord-005453-4057qib7	2495	9	and	and	CC
cord-005453-4057qib7	2495	10	overall	overall	JJ
cord-005453-4057qib7	2495	11	survival	survival	NN
cord-005453-4057qib7	2495	12	for	for	IN
cord-005453-4057qib7	2495	13	two	two	CD
cord-005453-4057qib7	2495	14	time	time	NN
cord-005453-4057qib7	2495	15	periods	period	NNS
cord-005453-4057qib7	2495	16	:	:	:
cord-005453-4057qib7	2495	17	2004	2004	CD
cord-005453-4057qib7	2495	18	-	-	SYM
cord-005453-4057qib7	2495	19	2015	2015	CD
cord-005453-4057qib7	2495	20	and	and	CC
cord-005453-4057qib7	2495	21	from	from	IN
cord-005453-4057qib7	2495	22	2016	2016	CD
cord-005453-4057qib7	2495	23	till	till	IN
cord-005453-4057qib7	2495	24	date	date	NN
cord-005453-4057qib7	2495	25	.	.	.
cord-005453-4057qib7	2496	1	Results	result	NNS
cord-005453-4057qib7	2496	2	:	:	:
cord-005453-4057qib7	2497	1	From	from	IN
cord-005453-4057qib7	2497	2	April	April	NNP
cord-005453-4057qib7	2497	3	2004	2004	CD
cord-005453-4057qib7	2497	4	till	till	IN
cord-005453-4057qib7	2497	5	December	December	NNP
cord-005453-4057qib7	2497	6	2015	2015	CD
cord-005453-4057qib7	2497	7	,	,	,
cord-005453-4057qib7	2497	8	n=78	n=78	IN
cord-005453-4057qib7	2497	9	autologous	autologous	JJ
cord-005453-4057qib7	2497	10	transplants	transplant	NNS
cord-005453-4057qib7	2497	11	were	be	VBD
cord-005453-4057qib7	2497	12	performed	perform	VBN
cord-005453-4057qib7	2497	13	.	.	.
cord-005453-4057qib7	2498	1	The	the	DT
cord-005453-4057qib7	2498	2	male	male	JJ
cord-005453-4057qib7	2498	3	:	:	:
cord-005453-4057qib7	2498	4	female	female	JJ
cord-005453-4057qib7	2498	5	ratio	ratio	NN
cord-005453-4057qib7	2498	6	was	be	VBD
cord-005453-4057qib7	2498	7	2.4:1	2.4:1	CD
cord-005453-4057qib7	2498	8	.	.	.
cord-005453-4057qib7	2499	1	Fifty	fifty	CD
cord-005453-4057qib7	2499	2	seven	seven	CD
cord-005453-4057qib7	2499	3	patients	patient	NNS
cord-005453-4057qib7	2499	4	underwent	undergo	VBD
cord-005453-4057qib7	2499	5	transplant	transplant	NN
cord-005453-4057qib7	2499	6	for	for	IN
cord-005453-4057qib7	2499	7	lymphomas	lymphoma	NNS
cord-005453-4057qib7	2499	8	,	,	,
cord-005453-4057qib7	2499	9	n=16	n=16	NNP
cord-005453-4057qib7	2499	10	for	for	IN
cord-005453-4057qib7	2499	11	multiple	multiple	JJ
cord-005453-4057qib7	2499	12	myeloma	myeloma	NN
cord-005453-4057qib7	2499	13	and	and	CC
cord-005453-4057qib7	2499	14	n=5	n=5	JJ
cord-005453-4057qib7	2499	15	for	for	IN
cord-005453-4057qib7	2499	16	other	other	JJ
cord-005453-4057qib7	2499	17	diagnosis	diagnosis	NN
cord-005453-4057qib7	2499	18	.	.	.
cord-005453-4057qib7	2500	1	Median	median	JJ
cord-005453-4057qib7	2500	2	age	age	NN
cord-005453-4057qib7	2500	3	was	be	VBD
cord-005453-4057qib7	2500	4	23±14.6	23±14.6	CD
cord-005453-4057qib7	2500	5	(	(	-LRB-
cord-005453-4057qib7	2500	6	2	2	CD
cord-005453-4057qib7	2500	7	-	-	SYM
cord-005453-4057qib7	2500	8	64	64	CD
cord-005453-4057qib7	2500	9	years	year	NNS
cord-005453-4057qib7	2500	10	)	)	-RRB-
cord-005453-4057qib7	2500	11	.	.	.
cord-005453-4057qib7	2501	1	The	the	DT
cord-005453-4057qib7	2501	2	mean	mean	JJ
cord-005453-4057qib7	2501	3	MNC	MNC	NNP
cord-005453-4057qib7	2501	4	was	be	VBD
cord-005453-4057qib7	2501	5	4.7	4.7	CD
cord-005453-4057qib7	2501	6	×	×	NN
cord-005453-4057qib7	2501	7	10	10	CD
cord-005453-4057qib7	2501	8	8	8	CD
cord-005453-4057qib7	2501	9	±	±	CD
cord-005453-4057qib7	2501	10	1.7	1.7	CD
cord-005453-4057qib7	2501	11	/	/	SYM
cord-005453-4057qib7	2501	12	kg	kg	NN
cord-005453-4057qib7	2501	13	.	.	.
cord-005453-4057qib7	2502	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	2502	2	was	be	VBD
cord-005453-4057qib7	2502	3	achieved	achieve	VBN
cord-005453-4057qib7	2502	4	in	in	IN
cord-005453-4057qib7	2502	5	80	80	CD
cord-005453-4057qib7	2502	6	%	%	NN
cord-005453-4057qib7	2502	7	of	of	IN
cord-005453-4057qib7	2502	8	patients	patient	NNS
cord-005453-4057qib7	2502	9	.	.	.
cord-005453-4057qib7	2503	1	The	the	DT
cord-005453-4057qib7	2503	2	transplant	transplant	NN
cord-005453-4057qib7	2503	3	related	relate	VBN
cord-005453-4057qib7	2503	4	mortality	mortality	NN
cord-005453-4057qib7	2503	5	was	be	VBD
cord-005453-4057qib7	2503	6	19.5	19.5	CD
cord-005453-4057qib7	2503	7	%	%	NN
cord-005453-4057qib7	2503	8	and	and	CC
cord-005453-4057qib7	2503	9	overall	overall	JJ
cord-005453-4057qib7	2503	10	survival	survival	NN
cord-005453-4057qib7	2503	11	was	be	VBD
cord-005453-4057qib7	2503	12	72	72	CD
cord-005453-4057qib7	2503	13	%	%	NN
cord-005453-4057qib7	2503	14	(	(	-LRB-
cord-005453-4057qib7	2503	15	follow	follow	VB
cord-005453-4057qib7	2503	16	up	up	RB
cord-005453-4057qib7	2503	17	:	:	:
cord-005453-4057qib7	2503	18	104	104	CD
cord-005453-4057qib7	2503	19	months	month	NNS
cord-005453-4057qib7	2503	20	)	)	-RRB-
cord-005453-4057qib7	2503	21	.	.	.
cord-005453-4057qib7	2504	1	Since	since	IN
cord-005453-4057qib7	2504	2	January	January	NNP
cord-005453-4057qib7	2504	3	2016	2016	CD
cord-005453-4057qib7	2504	4	till	till	IN
cord-005453-4057qib7	2504	5	March	March	NNP
cord-005453-4057qib7	2504	6	2018	2018	CD
cord-005453-4057qib7	2504	7	we	-PRON-	PRP
cord-005453-4057qib7	2504	8	have	have	VBP
cord-005453-4057qib7	2504	9	performed	perform	VBN
cord-005453-4057qib7	2504	10	n=18	n=18	JJ
cord-005453-4057qib7	2504	11	autologous	autologous	JJ
cord-005453-4057qib7	2504	12	transplants	transplant	NNS
cord-005453-4057qib7	2504	13	of	of	IN
cord-005453-4057qib7	2504	14	which	which	WDT
cord-005453-4057qib7	2504	15	n=17	n=17	NNP
cord-005453-4057qib7	2504	16	were	be	VBD
cord-005453-4057qib7	2504	17	males	male	NNS
cord-005453-4057qib7	2504	18	.	.	.
cord-005453-4057qib7	2505	1	Fifteen	fifteen	CD
cord-005453-4057qib7	2505	2	transplants	transplant	NNS
cord-005453-4057qib7	2505	3	were	be	VBD
cord-005453-4057qib7	2505	4	performed	perform	VBN
cord-005453-4057qib7	2505	5	for	for	IN
cord-005453-4057qib7	2505	6	lymphomas	lymphoma	NNS
cord-005453-4057qib7	2505	7	(	(	-LRB-
cord-005453-4057qib7	2505	8	NHL:8	nhl:8	XX
cord-005453-4057qib7	2505	9	,	,	,
cord-005453-4057qib7	2505	10	HD:7	hd:7	LS
cord-005453-4057qib7	2505	11	)	)	-RRB-
cord-005453-4057qib7	2505	12	and	and	CC
cord-005453-4057qib7	2505	13	n=3	n=3	NN
cord-005453-4057qib7	2505	14	for	for	IN
cord-005453-4057qib7	2505	15	multiple	multiple	JJ
cord-005453-4057qib7	2505	16	myeloma	myeloma	NN
cord-005453-4057qib7	2505	17	.	.	.
cord-005453-4057qib7	2506	1	Median	median	JJ
cord-005453-4057qib7	2506	2	age	age	NN
cord-005453-4057qib7	2506	3	was	be	VBD
cord-005453-4057qib7	2506	4	24±15	24±15	NNP
cord-005453-4057qib7	2506	5	(	(	-LRB-
cord-005453-4057qib7	2506	6	20	20	CD
cord-005453-4057qib7	2506	7	-64	-64	NN
cord-005453-4057qib7	2506	8	years	year	NNS
cord-005453-4057qib7	2506	9	)	)	-RRB-
cord-005453-4057qib7	2506	10	.	.	.
cord-005453-4057qib7	2507	1	The	the	DT
cord-005453-4057qib7	2507	2	mean	mean	JJ
cord-005453-4057qib7	2507	3	mononuclear	mononuclear	JJ
cord-005453-4057qib7	2507	4	cell	cell	NN
cord-005453-4057qib7	2507	5	count	count	NN
cord-005453-4057qib7	2507	6	was	be	VBD
cord-005453-4057qib7	2507	7	5.8	5.8	CD
cord-005453-4057qib7	2507	8	x	x	SYM
cord-005453-4057qib7	2507	9	10	10	CD
cord-005453-4057qib7	2507	10	8	8	CD
cord-005453-4057qib7	2507	11	/kg	/kg	.
cord-005453-4057qib7	2507	12	and	and	CC
cord-005453-4057qib7	2507	13	the	the	DT
cord-005453-4057qib7	2507	14	mean	mean	JJ
cord-005453-4057qib7	2507	15	CD34	CD34	NNP
cord-005453-4057qib7	2507	16	count	count	NN
cord-005453-4057qib7	2507	17	was	be	VBD
cord-005453-4057qib7	2507	18	3.7	3.7	CD
cord-005453-4057qib7	2507	19	x	x	SYM
cord-005453-4057qib7	2507	20	10	10	CD
cord-005453-4057qib7	2507	21	6	6	CD
cord-005453-4057qib7	2507	22	/kg	/kg	.
cord-005453-4057qib7	2507	23	.	.	.
cord-005453-4057qib7	2508	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	2508	2	was	be	VBD
cord-005453-4057qib7	2508	3	achieved	achieve	VBN
cord-005453-4057qib7	2508	4	in	in	IN
cord-005453-4057qib7	2508	5	all	all	DT
cord-005453-4057qib7	2508	6	patients	patient	NNS
cord-005453-4057qib7	2508	7	.	.	.
cord-005453-4057qib7	2509	1	The	the	DT
cord-005453-4057qib7	2509	2	transplant	transplant	NN
cord-005453-4057qib7	2509	3	related	relate	VBN
cord-005453-4057qib7	2509	4	mortality	mortality	NN
cord-005453-4057qib7	2509	5	was	be	VBD
cord-005453-4057qib7	2509	6	0	0	CD
cord-005453-4057qib7	2509	7	%	%	NN
cord-005453-4057qib7	2509	8	and	and	CC
cord-005453-4057qib7	2509	9	the	the	DT
cord-005453-4057qib7	2509	10	overall	overall	JJ
cord-005453-4057qib7	2509	11	survival	survival	NN
cord-005453-4057qib7	2509	12	was	be	VBD
cord-005453-4057qib7	2509	13	83	83	CD
cord-005453-4057qib7	2509	14	%	%	NN
cord-005453-4057qib7	2509	15	(	(	-LRB-
cord-005453-4057qib7	2509	16	follow	follow	VB
cord-005453-4057qib7	2509	17	up	up	RB
cord-005453-4057qib7	2509	18	22	22	CD
cord-005453-4057qib7	2509	19	months	month	NNS
cord-005453-4057qib7	2509	20	)	)	-RRB-
cord-005453-4057qib7	2509	21	.	.	.
cord-005453-4057qib7	2510	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2510	2	:	:	:
cord-005453-4057qib7	2511	1	We	-PRON-	PRP
cord-005453-4057qib7	2511	2	were	be	VBD
cord-005453-4057qib7	2511	3	able	able	JJ
cord-005453-4057qib7	2511	4	to	to	TO
cord-005453-4057qib7	2511	5	reduce	reduce	VB
cord-005453-4057qib7	2511	6	the	the	DT
cord-005453-4057qib7	2511	7	autologous	autologous	JJ
cord-005453-4057qib7	2511	8	transplant	transplant	NN
cord-005453-4057qib7	2511	9	related	relate	VBN
cord-005453-4057qib7	2511	10	mortality	mortality	NN
cord-005453-4057qib7	2511	11	to	to	IN
cord-005453-4057qib7	2511	12	0	0	CD
cord-005453-4057qib7	2511	13	%	%	NN
cord-005453-4057qib7	2511	14	by	by	IN
cord-005453-4057qib7	2511	15	decreasing	decrease	VBG
cord-005453-4057qib7	2511	16	dosages	dosage	NNS
cord-005453-4057qib7	2511	17	of	of	IN
cord-005453-4057qib7	2511	18	conditioning	conditioning	NN
cord-005453-4057qib7	2511	19	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2511	20	and	and	CC
cord-005453-4057qib7	2511	21	changing	change	VBG
cord-005453-4057qib7	2511	22	the	the	DT
cord-005453-4057qib7	2511	23	mobilization	mobilization	NN
cord-005453-4057qib7	2511	24	protocol	protocol	NN
cord-005453-4057qib7	2511	25	.	.	.
cord-005453-4057qib7	2512	1	Long	long	RB
cord-005453-4057qib7	2512	2	follow	follow	NN
cord-005453-4057qib7	2512	3	-	-	HYPH
cord-005453-4057qib7	2512	4	up	up	NN
cord-005453-4057qib7	2512	5	is	be	VBZ
cord-005453-4057qib7	2512	6	needed	need	VBN
cord-005453-4057qib7	2512	7	to	to	TO
cord-005453-4057qib7	2512	8	determine	determine	VB
cord-005453-4057qib7	2512	9	late	late	JJ
cord-005453-4057qib7	2512	10	mortality	mortality	NN
cord-005453-4057qib7	2512	11	and	and	CC
cord-005453-4057qib7	2512	12	late	late	JJ
cord-005453-4057qib7	2512	13	relapse	relapse	NN
cord-005453-4057qib7	2512	14	in	in	IN
cord-005453-4057qib7	2512	15	comparison	comparison	NN
cord-005453-4057qib7	2512	16	to	to	IN
cord-005453-4057qib7	2512	17	standard	standard	JJ
cord-005453-4057qib7	2512	18	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2512	19	dosages	dosage	NNS
cord-005453-4057qib7	2512	20	Disclosure	Disclosure	NNP
cord-005453-4057qib7	2512	21	:	:	:
cord-005453-4057qib7	2512	22	Nothing	nothing	NN
cord-005453-4057qib7	2512	23	to	to	TO
cord-005453-4057qib7	2512	24	declare	declare	VB
cord-005453-4057qib7	2512	25	Risk	risk	NN
cord-005453-4057qib7	2512	26	and	and	CC
cord-005453-4057qib7	2512	27	benefit	benefit	NN
cord-005453-4057qib7	2512	28	of	of	IN
cord-005453-4057qib7	2512	29	thiotepa	thiotepa	JJ
cord-005453-4057qib7	2512	30	based	base	VBN
cord-005453-4057qib7	2512	31	conditioning	conditioning	NN
cord-005453-4057qib7	2512	32	followed	follow	VBN
cord-005453-4057qib7	2512	33	by	by	IN
cord-005453-4057qib7	2512	34	autologous	autologous	JJ
cord-005453-4057qib7	2512	35	stem	stem	NN
cord-005453-4057qib7	2512	36	cell	cell	NN
cord-005453-4057qib7	2512	37	transplantation	transplantation	NN
cord-005453-4057qib7	2512	38	in	in	IN
cord-005453-4057qib7	2512	39	high	high	JJ
cord-005453-4057qib7	2512	40	risk	risk	NN
cord-005453-4057qib7	2512	41	lymphomas	lymphoma	NNS
cord-005453-4057qib7	2512	42	36	36	CD
cord-005453-4057qib7	2512	43	years	year	NNS
cord-005453-4057qib7	2512	44	(	(	-LRB-
cord-005453-4057qib7	2512	45	16	16	CD
cord-005453-4057qib7	2512	46	-	-	SYM
cord-005453-4057qib7	2512	47	62	62	CD
cord-005453-4057qib7	2512	48	)	)	-RRB-
cord-005453-4057qib7	2512	49	.	.	.
cord-005453-4057qib7	2513	1	Stage	stage	NN
cord-005453-4057qib7	2514	1	(	(	-LRB-
cord-005453-4057qib7	2514	2	Ann	Ann	NNP
cord-005453-4057qib7	2514	3	-	-	HYPH
cord-005453-4057qib7	2514	4	Arbor	Arbor	NNP
cord-005453-4057qib7	2514	5	)	)	-RRB-
cord-005453-4057qib7	2515	1	at	at	IN
cord-005453-4057qib7	2515	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	2515	3	of	of	IN
cord-005453-4057qib7	2515	4	HD	HD	NNP
cord-005453-4057qib7	2515	5	/	/	SYM
cord-005453-4057qib7	2515	6	DLBCL	DLBCL	NNP
cord-005453-4057qib7	2515	7	/	/	SYM
cord-005453-4057qib7	2515	8	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2515	9	:	:	:
cord-005453-4057qib7	2515	10	stage	stage	NN
cord-005453-4057qib7	2515	11	IE	IE	NNP
cord-005453-4057qib7	2515	12	n=0/	n=0/	NNP
cord-005453-4057qib7	2515	13	0/10	0/10	NN
cord-005453-4057qib7	2515	14	(	(	-LRB-
cord-005453-4057qib7	2515	15	0/0/91	0/0/91	CD
cord-005453-4057qib7	2515	16	%	%	NN
cord-005453-4057qib7	2515	17	)	)	-RRB-
cord-005453-4057qib7	2515	18	,	,	,
cord-005453-4057qib7	2515	19	stage	stage	NN
cord-005453-4057qib7	2515	20	II	II	NNP
cord-005453-4057qib7	2515	21	n=7/2/0	n=7/2/0	NNP
cord-005453-4057qib7	2515	22	(	(	-LRB-
cord-005453-4057qib7	2515	23	47/18/0	47/18/0	CD
cord-005453-4057qib7	2515	24	%	%	NN
cord-005453-4057qib7	2515	25	)	)	-RRB-
cord-005453-4057qib7	2515	26	,	,	.
cord-005453-4057qib7	2516	1	stage	stage	NN
cord-005453-4057qib7	2516	2	III	III	NNP
cord-005453-4057qib7	2516	3	n=2/	n=2/	JJ
cord-005453-4057qib7	2516	4	0/1	0/1	CD
cord-005453-4057qib7	2516	5	(	(	-LRB-
cord-005453-4057qib7	2516	6	13/0/9	13/0/9	CD
cord-005453-4057qib7	2516	7	%	%	NN
cord-005453-4057qib7	2516	8	)	)	-RRB-
cord-005453-4057qib7	2516	9	,	,	.
cord-005453-4057qib7	2517	1	stage	stage	NN
cord-005453-4057qib7	2517	2	IV	IV	NNP
cord-005453-4057qib7	2517	3	n=6/9/0	n=6/9/0	NNPS
cord-005453-4057qib7	2517	4	(	(	-LRB-
cord-005453-4057qib7	2517	5	40/82/0	40/82/0	CD
cord-005453-4057qib7	2517	6	%	%	NN
cord-005453-4057qib7	2517	7	)	)	-RRB-
cord-005453-4057qib7	2517	8	.	.	.
cord-005453-4057qib7	2518	1	Median	median	JJ
cord-005453-4057qib7	2518	2	time	time	NN
cord-005453-4057qib7	2518	3	from	from	IN
cord-005453-4057qib7	2518	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	2518	5	to	to	IN
cord-005453-4057qib7	2518	6	ASCT	ASCT	NNP
cord-005453-4057qib7	2518	7	HD	HD	NNP
cord-005453-4057qib7	2518	8	/	/	SYM
cord-005453-4057qib7	2518	9	DLBCL	DLBCL	NNP
cord-005453-4057qib7	2518	10	/	/	SYM
cord-005453-4057qib7	2518	11	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2518	12	:	:	:
cord-005453-4057qib7	2519	1	25/11/	25/11/	CD
cord-005453-4057qib7	2519	2	6	6	CD
cord-005453-4057qib7	2519	3	month	month	NN
cord-005453-4057qib7	2519	4	(	(	-LRB-
cord-005453-4057qib7	2519	5	4	4	CD
cord-005453-4057qib7	2519	6	-	-	SYM
cord-005453-4057qib7	2519	7	72	72	CD
cord-005453-4057qib7	2519	8	)	)	-RRB-
cord-005453-4057qib7	2519	9	.	.	.
cord-005453-4057qib7	2520	1	Induction	induction	NN
cord-005453-4057qib7	2520	2	treatment	treatment	NN
cord-005453-4057qib7	2520	3	in	in	IN
cord-005453-4057qib7	2520	4	HD	hd	NN
cord-005453-4057qib7	2520	5	patients	patient	NNS
cord-005453-4057qib7	2520	6	was	be	VBD
cord-005453-4057qib7	2520	7	ABVD	ABVD	NNP
cord-005453-4057qib7	2520	8	,	,	,
cord-005453-4057qib7	2520	9	in	in	IN
cord-005453-4057qib7	2520	10	most	most	JJS
cord-005453-4057qib7	2520	11	DLBCL	DLBCL	NNP
cord-005453-4057qib7	2520	12	patients	patient	NNS
cord-005453-4057qib7	2520	13	R	r	NN
cord-005453-4057qib7	2520	14	-	-	HYPH
cord-005453-4057qib7	2520	15	CHOP	chop	NN
cord-005453-4057qib7	2520	16	and	and	CC
cord-005453-4057qib7	2520	17	in	in	IN
cord-005453-4057qib7	2520	18	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2520	19	patients	patient	NNS
cord-005453-4057qib7	2520	20	high	high	JJ
cord-005453-4057qib7	2520	21	dose	dose	NN
cord-005453-4057qib7	2520	22	methotrexate	methotrexate	NNP
cord-005453-4057qib7	2520	23	and	and	CC
cord-005453-4057qib7	2520	24	cytosin	cytosin	NNP
cord-005453-4057qib7	2520	25	arabinoside	arabinoside	NNP
cord-005453-4057qib7	2520	26	.	.	.
cord-005453-4057qib7	2521	1	Tumor	tumor	NN
cord-005453-4057qib7	2521	2	status	status	NN
cord-005453-4057qib7	2521	3	at	at	IN
cord-005453-4057qib7	2521	4	ASCT	ASCT	NNP
cord-005453-4057qib7	2521	5	HD	HD	NNP
cord-005453-4057qib7	2521	6	/	/	SYM
cord-005453-4057qib7	2521	7	DLBCL	DLBCL	NNP
cord-005453-4057qib7	2521	8	/	/	SYM
cord-005453-4057qib7	2521	9	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2521	10	:	:	:
cord-005453-4057qib7	2521	11	complete	complete	JJ
cord-005453-4057qib7	2521	12	metabolic	metabolic	JJ
cord-005453-4057qib7	2521	13	remission	remission	NN
cord-005453-4057qib7	2522	1	(	(	-LRB-
cord-005453-4057qib7	2522	2	CMR	CMR	NNP
cord-005453-4057qib7	2522	3	)	)	-RRB-
cord-005453-4057qib7	2522	4	n=4/1/11	n=4/1/11	VBZ
cord-005453-4057qib7	2522	5	(	(	-LRB-
cord-005453-4057qib7	2522	6	27/9/91	27/9/91	CD
cord-005453-4057qib7	2522	7	%	%	NN
cord-005453-4057qib7	2522	8	)	)	-RRB-
cord-005453-4057qib7	2523	1	and	and	CC
cord-005453-4057qib7	2523	2	from	from	IN
cord-005453-4057qib7	2523	3	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2523	4	patient	patient	NNP
cord-005453-4057qib7	2523	5	's	's	POS
cord-005453-4057qib7	2523	6	n=8	n=8	NN
cord-005453-4057qib7	2523	7	(	(	-LRB-
cord-005453-4057qib7	2523	8	73	73	CD
cord-005453-4057qib7	2523	9	%	%	NN
cord-005453-4057qib7	2523	10	)	)	-RRB-
cord-005453-4057qib7	2523	11	were	be	VBD
cord-005453-4057qib7	2523	12	in	in	IN
cord-005453-4057qib7	2523	13	first	first	JJ
cord-005453-4057qib7	2523	14	complete	complete	JJ
cord-005453-4057qib7	2523	15	remission	remission	NN
cord-005453-4057qib7	2523	16	(	(	-LRB-
cord-005453-4057qib7	2523	17	CR1	CR1	NNP
cord-005453-4057qib7	2523	18	)	)	-RRB-
cord-005453-4057qib7	2523	19	.	.	.
cord-005453-4057qib7	2524	1	Type	type	NN
cord-005453-4057qib7	2524	2	of	of	IN
cord-005453-4057qib7	2524	3	stem	stem	NN
cord-005453-4057qib7	2524	4	cell	cell	NN
cord-005453-4057qib7	2524	5	graft	graft	NN
cord-005453-4057qib7	2524	6	was	be	VBD
cord-005453-4057qib7	2524	7	periferial	periferial	JJ
cord-005453-4057qib7	2524	8	blood	blood	NN
cord-005453-4057qib7	2524	9	stem	stem	NN
cord-005453-4057qib7	2524	10	cell	cell	NN
cord-005453-4057qib7	2524	11	in	in	IN
cord-005453-4057qib7	2524	12	all	all	DT
cord-005453-4057qib7	2524	13	case	case	NN
cord-005453-4057qib7	2524	14	.	.	.
cord-005453-4057qib7	2525	1	Conditioning	conditioning	NN
cord-005453-4057qib7	2525	2	:	:	:
cord-005453-4057qib7	2525	3	thiotepa	thiotepa	NNP
cord-005453-4057qib7	2525	4	(	(	-LRB-
cord-005453-4057qib7	2525	5	250mg/	250mg/	CD
cord-005453-4057qib7	2525	6	m2	m2	NNP
cord-005453-4057qib7	2525	7	on	on	IN
cord-005453-4057qib7	2525	8	days	day	NNS
cord-005453-4057qib7	2525	9	-9	-9	ADD
cord-005453-4057qib7	2525	10	to	to	IN
cord-005453-4057qib7	2525	11	-7	-7	NNP
cord-005453-4057qib7	2525	12	,	,	,
cord-005453-4057qib7	2525	13	busulphan	busulphan	NNP
cord-005453-4057qib7	2525	14	3,2mg	3,2mg	CD
cord-005453-4057qib7	2525	15	/	/	SYM
cord-005453-4057qib7	2525	16	kg	kg	NNS
cord-005453-4057qib7	2525	17	on	on	IN
cord-005453-4057qib7	2525	18	days	day	NNS
cord-005453-4057qib7	2525	19	-6	-6	JJ
cord-005453-4057qib7	2525	20	to	to	IN
cord-005453-4057qib7	2525	21	-4	-4	CD
cord-005453-4057qib7	2525	22	and	and	CC
cord-005453-4057qib7	2525	23	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	2525	24	60mg	60mg	NN
cord-005453-4057qib7	2525	25	/	/	SYM
cord-005453-4057qib7	2525	26	kg	kg	NNS
cord-005453-4057qib7	2525	27	on	on	IN
cord-005453-4057qib7	2525	28	days	day	NNS
cord-005453-4057qib7	2525	29	-3	-3	NNP
cord-005453-4057qib7	2525	30	to	to	IN
cord-005453-4057qib7	2525	31	-2	-2	NNP
cord-005453-4057qib7	2525	32	plus	plus	CC
cord-005453-4057qib7	2525	33	rituximab	rituximab	NNP
cord-005453-4057qib7	2525	34	500mg	500mg	NNP
cord-005453-4057qib7	2525	35	/	/	SYM
cord-005453-4057qib7	2525	36	m2	m2	NNP
cord-005453-4057qib7	2525	37	on	on	IN
cord-005453-4057qib7	2525	38	day	day	NN
cord-005453-4057qib7	2525	39	-10	-10	NN
cord-005453-4057qib7	2525	40	in	in	IN
cord-005453-4057qib7	2525	41	DLBCL	DLBCL	NNP
cord-005453-4057qib7	2525	42	and	and	CC
cord-005453-4057qib7	2525	43	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2525	44	.	.	.
cord-005453-4057qib7	2526	1	Median	median	JJ
cord-005453-4057qib7	2526	2	follow	follow	VBP
cord-005453-4057qib7	2526	3	up	up	RP
cord-005453-4057qib7	2526	4	from	from	IN
cord-005453-4057qib7	2526	5	ASCT	ASCT	NNP
cord-005453-4057qib7	2526	6	711	711	CD
cord-005453-4057qib7	2526	7	days	day	NNS
cord-005453-4057qib7	2526	8	.	.	.
cord-005453-4057qib7	2527	1	Tumor	tumor	NN
cord-005453-4057qib7	2527	2	stage	stage	NN
cord-005453-4057qib7	2527	3	at	at	IN
cord-005453-4057qib7	2527	4	ASCT	ASCT	NNP
cord-005453-4057qib7	2527	5	was	be	VBD
cord-005453-4057qib7	2527	6	defined	define	VBN
cord-005453-4057qib7	2527	7	with	with	IN
cord-005453-4057qib7	2527	8	computer	computer	NN
cord-005453-4057qib7	2527	9	tomography	tomography	NN
cord-005453-4057qib7	2527	10	with	with	IN
cord-005453-4057qib7	2527	11	positron	positron	NN
cord-005453-4057qib7	2527	12	emission	emission	NN
cord-005453-4057qib7	2527	13	tomography	tomography	NN
cord-005453-4057qib7	2527	14	(	(	-LRB-
cord-005453-4057qib7	2527	15	PET	PET	NNP
cord-005453-4057qib7	2527	16	-	-	HYPH
cord-005453-4057qib7	2527	17	CT	CT	NNP
cord-005453-4057qib7	2527	18	)	)	-RRB-
cord-005453-4057qib7	2527	19	.	.	.
cord-005453-4057qib7	2528	1	Results	result	NNS
cord-005453-4057qib7	2528	2	:	:	:
cord-005453-4057qib7	2529	1	Median	median	JJ
cord-005453-4057qib7	2529	2	time	time	NN
cord-005453-4057qib7	2529	3	of	of	IN
cord-005453-4057qib7	2529	4	engraftment	engraftment	NN
cord-005453-4057qib7	2529	5	was	be	VBD
cord-005453-4057qib7	2529	6	10	10	CD
cord-005453-4057qib7	2529	7	days	day	NNS
cord-005453-4057qib7	2529	8	(	(	-LRB-
cord-005453-4057qib7	2529	9	9	9	CD
cord-005453-4057qib7	2529	10	-	-	SYM
cord-005453-4057qib7	2529	11	14	14	CD
cord-005453-4057qib7	2529	12	)	)	-RRB-
cord-005453-4057qib7	2529	13	.	.	.
cord-005453-4057qib7	2530	1	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	2530	2	caused	cause	VBD
cord-005453-4057qib7	2530	3	toxicoderma	toxicoderma	NNS
cord-005453-4057qib7	2530	4	appeared	appear	VBD
cord-005453-4057qib7	2530	5	at	at	IN
cord-005453-4057qib7	2530	6	9	9	CD
cord-005453-4057qib7	2530	7	(	(	-LRB-
cord-005453-4057qib7	2530	8	24	24	CD
cord-005453-4057qib7	2530	9	%	%	NN
cord-005453-4057qib7	2530	10	)	)	-RRB-
cord-005453-4057qib7	2530	11	patients	patient	NNS
cord-005453-4057qib7	2530	12	.	.	.
cord-005453-4057qib7	2531	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	2531	2	(	(	-LRB-
cord-005453-4057qib7	2531	3	CMV	CMV	NNP
cord-005453-4057qib7	2531	4	)	)	-RRB-
cord-005453-4057qib7	2531	5	reactivation	reactivation	NN
cord-005453-4057qib7	2531	6	was	be	VBD
cord-005453-4057qib7	2531	7	seen	see	VBN
cord-005453-4057qib7	2531	8	in	in	IN
cord-005453-4057qib7	2531	9	3	3	CD
cord-005453-4057qib7	2531	10	(	(	-LRB-
cord-005453-4057qib7	2531	11	8	8	CD
cord-005453-4057qib7	2531	12	%	%	NN
cord-005453-4057qib7	2531	13	)	)	-RRB-
cord-005453-4057qib7	2531	14	cases	case	NNS
cord-005453-4057qib7	2531	15	with	with	IN
cord-005453-4057qib7	2531	16	low	low	JJ
cord-005453-4057qib7	2531	17	DNA	dna	NN
cord-005453-4057qib7	2531	18	content	content	NN
cord-005453-4057qib7	2531	19	(	(	-LRB-
cord-005453-4057qib7	2531	20	284,454,5500	284,454,5500	CD
cord-005453-4057qib7	2531	21	copies	copy	NNS
cord-005453-4057qib7	2531	22	/	/	SYM
cord-005453-4057qib7	2531	23	ml	ml	NN
cord-005453-4057qib7	2531	24	)	)	-RRB-
cord-005453-4057qib7	2531	25	and	and	CC
cord-005453-4057qib7	2531	26	responded	respond	VBD
cord-005453-4057qib7	2531	27	completely	completely	RB
cord-005453-4057qib7	2531	28	to	to	IN
cord-005453-4057qib7	2531	29	oral	oral	JJ
cord-005453-4057qib7	2531	30	valgancyclovir	valgancyclovir	NNS
cord-005453-4057qib7	2531	31	therapy	therapy	NN
cord-005453-4057qib7	2531	32	.	.	.
cord-005453-4057qib7	2532	1	Transplantation	transplantation	NN
cord-005453-4057qib7	2532	2	related	relate	VBN
cord-005453-4057qib7	2532	3	mortality	mortality	NN
cord-005453-4057qib7	2533	1	HD	HD	NNP
cord-005453-4057qib7	2533	2	/	/	SYM
cord-005453-4057qib7	2533	3	DLBCL/	DLBCL/	NNP
cord-005453-4057qib7	2534	1	PCNSL	PCNSL	NNP
cord-005453-4057qib7	2534	2	n=	n=	NNP
cord-005453-4057qib7	2535	1	2/3/1	2/3/1	LS
cord-005453-4057qib7	2535	2	(	(	-LRB-
cord-005453-4057qib7	2535	3	9/27/13	9/27/13	CD
cord-005453-4057qib7	2535	4	%	%	NN
cord-005453-4057qib7	2535	5	)	)	-RRB-
cord-005453-4057qib7	2535	6	,	,	,
cord-005453-4057qib7	2535	7	in	in	IN
cord-005453-4057qib7	2535	8	4	4	CD
cord-005453-4057qib7	2535	9	cases	case	NNS
cord-005453-4057qib7	2535	10	bacterial	bacterial	JJ
cord-005453-4057qib7	2535	11	sepsis	sepsis	NN
cord-005453-4057qib7	2535	12	and	and	CC
cord-005453-4057qib7	2535	13	one	one	CD
cord-005453-4057qib7	2535	14	systemic	systemic	JJ
cord-005453-4057qib7	2535	15	mycoses	mycose	NNS
cord-005453-4057qib7	2535	16	and	and	CC
cord-005453-4057qib7	2535	17	one	one	CD
cord-005453-4057qib7	2535	18	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2535	19	fibrosis	fibrosis	NN
cord-005453-4057qib7	2535	20	.	.	.
cord-005453-4057qib7	2536	1	Incidence	incidence	NN
cord-005453-4057qib7	2536	2	of	of	IN
cord-005453-4057qib7	2536	3	long	long	RB
cord-005453-4057qib7	2536	4	-	-	HYPH
cord-005453-4057qib7	2536	5	lasting	last	VBG
cord-005453-4057qib7	2536	6	grade	grade	NN
cord-005453-4057qib7	2536	7	III	III	NNP
cord-005453-4057qib7	2536	8	-	-	HYPH
cord-005453-4057qib7	2536	9	IV	IV	NNP
cord-005453-4057qib7	2536	10	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2536	11	and	and	CC
cord-005453-4057qib7	2536	12	anaemia	anaemia	NN
cord-005453-4057qib7	2536	13	:	:	:
cord-005453-4057qib7	2536	14	n=15	n=15	NNP
cord-005453-4057qib7	2536	15	(	(	-LRB-
cord-005453-4057qib7	2536	16	40,5	40,5	CD
cord-005453-4057qib7	2536	17	%	%	NN
cord-005453-4057qib7	2536	18	)	)	-RRB-
cord-005453-4057qib7	2536	19	and	and	CC
cord-005453-4057qib7	2536	20	n=3	n=3	NN
cord-005453-4057qib7	2536	21	(	(	-LRB-
cord-005453-4057qib7	2536	22	8	8	CD
cord-005453-4057qib7	2536	23	%	%	NN
cord-005453-4057qib7	2536	24	)	)	-RRB-
cord-005453-4057qib7	2536	25	,	,	,
cord-005453-4057qib7	2536	26	median	median	JJ
cord-005453-4057qib7	2536	27	time	time	NN
cord-005453-4057qib7	2536	28	of	of	IN
cord-005453-4057qib7	2536	29	duration	duration	NN
cord-005453-4057qib7	2536	30	from	from	IN
cord-005453-4057qib7	2536	31	transplantation	transplantation	NN
cord-005453-4057qib7	2536	32	71	71	CD
cord-005453-4057qib7	2536	33	days	day	NNS
cord-005453-4057qib7	2536	34	(	(	-LRB-
cord-005453-4057qib7	2536	35	31	31	CD
cord-005453-4057qib7	2536	36	-	-	SYM
cord-005453-4057qib7	2536	37	720	720	CD
cord-005453-4057qib7	2536	38	)	)	-RRB-
cord-005453-4057qib7	2536	39	and	and	CC
cord-005453-4057qib7	2536	40	35	35	CD
cord-005453-4057qib7	2536	41	days	day	NNS
cord-005453-4057qib7	2537	1	(	(	-LRB-
cord-005453-4057qib7	2537	2	Background	background	NN
cord-005453-4057qib7	2537	3	:	:	:
cord-005453-4057qib7	2538	1	This	this	DT
cord-005453-4057qib7	2538	2	study	study	NN
cord-005453-4057qib7	2538	3	evaluated	evaluate	VBD
cord-005453-4057qib7	2538	4	the	the	DT
cord-005453-4057qib7	2538	5	efficacy	efficacy	NN
cord-005453-4057qib7	2538	6	and	and	CC
cord-005453-4057qib7	2538	7	toxicity	toxicity	NN
cord-005453-4057qib7	2538	8	of	of	IN
cord-005453-4057qib7	2538	9	intravenous	intravenous	JJ
cord-005453-4057qib7	2538	10	busulfan	busulfan	NN
cord-005453-4057qib7	2538	11	and	and	CC
cord-005453-4057qib7	2538	12	thiotepa	thiotepa	NNP
cord-005453-4057qib7	2538	13	as	as	IN
cord-005453-4057qib7	2538	14	a	a	DT
cord-005453-4057qib7	2538	15	conditioning	conditioning	NN
cord-005453-4057qib7	2538	16	regimen	regimen	NN
cord-005453-4057qib7	2538	17	for	for	IN
cord-005453-4057qib7	2538	18	autologous	autologous	JJ
cord-005453-4057qib7	2538	19	stem	stem	NN
cord-005453-4057qib7	2538	20	cell	cell	NN
cord-005453-4057qib7	2538	21	transplantation	transplantation	NN
cord-005453-4057qib7	2538	22	(	(	-LRB-
cord-005453-4057qib7	2538	23	ASCT	ASCT	NNP
cord-005453-4057qib7	2538	24	)	)	-RRB-
cord-005453-4057qib7	2538	25	in	in	IN
cord-005453-4057qib7	2538	26	patients	patient	NNS
cord-005453-4057qib7	2538	27	with	with	IN
cord-005453-4057qib7	2538	28	multiple	multiple	JJ
cord-005453-4057qib7	2538	29	myeloma	myeloma	NN
cord-005453-4057qib7	2538	30	(	(	-LRB-
cord-005453-4057qib7	2538	31	MM	MM	NNP
cord-005453-4057qib7	2538	32	)	)	-RRB-
cord-005453-4057qib7	2538	33	.	.	.
cord-005453-4057qib7	2539	1	Methods	method	NNS
cord-005453-4057qib7	2539	2	:	:	:
cord-005453-4057qib7	2539	3	We	-PRON-	PRP
cord-005453-4057qib7	2539	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	2539	5	analyzed	analyze	VBD
cord-005453-4057qib7	2539	6	the	the	DT
cord-005453-4057qib7	2539	7	data	datum	NNS
cord-005453-4057qib7	2539	8	of	of	IN
cord-005453-4057qib7	2539	9	68	68	CD
cord-005453-4057qib7	2539	10	patients	patient	NNS
cord-005453-4057qib7	2539	11	with	with	IN
cord-005453-4057qib7	2539	12	MM	MM	NNP
cord-005453-4057qib7	2539	13	who	who	WP
cord-005453-4057qib7	2539	14	received	receive	VBD
cord-005453-4057qib7	2539	15	the	the	DT
cord-005453-4057qib7	2539	16	intravenous	intravenous	JJ
cord-005453-4057qib7	2539	17	busulfan	busulfan	NN
cord-005453-4057qib7	2539	18	and	and	CC
cord-005453-4057qib7	2539	19	thiotepa	thiotepa	JJ
cord-005453-4057qib7	2539	20	conditioning	conditioning	NN
cord-005453-4057qib7	2539	21	for	for	IN
cord-005453-4057qib7	2539	22	ASCT	ASCT	NNP
cord-005453-4057qib7	2539	23	between	between	IN
cord-005453-4057qib7	2539	24	November	November	NNP
cord-005453-4057qib7	2539	25	2016	2016	CD
cord-005453-4057qib7	2539	26	and	and	CC
cord-005453-4057qib7	2539	27	April	April	NNP
cord-005453-4057qib7	2539	28	2018	2018	CD
cord-005453-4057qib7	2539	29	in	in	IN
cord-005453-4057qib7	2539	30	Korea	Korea	NNP
cord-005453-4057qib7	2539	31	.	.	.
cord-005453-4057qib7	2540	1	Results	result	NNS
cord-005453-4057qib7	2540	2	:	:	:
cord-005453-4057qib7	2541	1	The	the	DT
cord-005453-4057qib7	2541	2	median	median	JJ
cord-005453-4057qib7	2541	3	time	time	NN
cord-005453-4057qib7	2541	4	to	to	IN
cord-005453-4057qib7	2541	5	transplant	transplant	NN
cord-005453-4057qib7	2541	6	was	be	VBD
cord-005453-4057qib7	2541	7	5.4	5.4	CD
cord-005453-4057qib7	2541	8	months	month	NNS
cord-005453-4057qib7	2541	9	,	,	,
cord-005453-4057qib7	2541	10	and	and	CC
cord-005453-4057qib7	2541	11	66	66	CD
cord-005453-4057qib7	2541	12	patients	patient	NNS
cord-005453-4057qib7	2541	13	(	(	-LRB-
cord-005453-4057qib7	2541	14	97.1	97.1	CD
cord-005453-4057qib7	2541	15	%	%	NN
cord-005453-4057qib7	2541	16	)	)	-RRB-
cord-005453-4057qib7	2541	17	underwent	undergo	VBD
cord-005453-4057qib7	2541	18	ASCT	ASCT	NNP
cord-005453-4057qib7	2541	19	within	within	IN
cord-005453-4057qib7	2541	20	12	12	CD
cord-005453-4057qib7	2541	21	months	month	NNS
cord-005453-4057qib7	2541	22	of	of	IN
cord-005453-4057qib7	2541	23	the	the	DT
cord-005453-4057qib7	2541	24	diagnosis	diagnosis	NN
cord-005453-4057qib7	2541	25	.	.	.
cord-005453-4057qib7	2542	1	The	the	DT
cord-005453-4057qib7	2542	2	overall	overall	JJ
cord-005453-4057qib7	2542	3	response	response	NN
cord-005453-4057qib7	2542	4	rate	rate	NN
cord-005453-4057qib7	2542	5	after	after	IN
cord-005453-4057qib7	2542	6	ASCT	ASCT	NNP
cord-005453-4057qib7	2542	7	was	be	VBD
cord-005453-4057qib7	2542	8	95.6	95.6	CD
cord-005453-4057qib7	2542	9	%	%	NN
cord-005453-4057qib7	2542	10	,	,	,
cord-005453-4057qib7	2542	11	including	include	VBG
cord-005453-4057qib7	2542	12	55.9	55.9	CD
cord-005453-4057qib7	2542	13	%	%	NN
cord-005453-4057qib7	2542	14	with	with	IN
cord-005453-4057qib7	2542	15	complete	complete	JJ
cord-005453-4057qib7	2542	16	response	response	NN
cord-005453-4057qib7	2542	17	,	,	,
cord-005453-4057qib7	2542	18	22.1	22.1	CD
cord-005453-4057qib7	2542	19	%	%	NN
cord-005453-4057qib7	2542	20	with	with	IN
cord-005453-4057qib7	2542	21	very	very	RB
cord-005453-4057qib7	2542	22	good	good	JJ
cord-005453-4057qib7	2542	23	partial	partial	JJ
cord-005453-4057qib7	2542	24	response	response	NN
cord-005453-4057qib7	2542	25	,	,	,
cord-005453-4057qib7	2542	26	and	and	CC
cord-005453-4057qib7	2542	27	17.6	17.6	CD
cord-005453-4057qib7	2542	28	%	%	NN
cord-005453-4057qib7	2542	29	with	with	IN
cord-005453-4057qib7	2542	30	partial	partial	JJ
cord-005453-4057qib7	2542	31	response	response	NN
cord-005453-4057qib7	2542	32	.	.	.
cord-005453-4057qib7	2543	1	The	the	DT
cord-005453-4057qib7	2543	2	most	most	RBS
cord-005453-4057qib7	2543	3	common	common	JJ
cord-005453-4057qib7	2543	4	severe	severe	JJ
cord-005453-4057qib7	2543	5	non	non	JJ
cord-005453-4057qib7	2543	6	-	-	JJ
cord-005453-4057qib7	2543	7	hematologic	hematologic	JJ
cord-005453-4057qib7	2543	8	toxicity	toxicity	NN
cord-005453-4057qib7	2543	9	(	(	-LRB-
cord-005453-4057qib7	2543	10	grade	grade	NN
cord-005453-4057qib7	2543	11	3	3	CD
cord-005453-4057qib7	2543	12	-	-	SYM
cord-005453-4057qib7	2543	13	4	4	CD
cord-005453-4057qib7	2543	14	)	)	-RRB-
cord-005453-4057qib7	2543	15	was	be	VBD
cord-005453-4057qib7	2543	16	infection	infection	NN
cord-005453-4057qib7	2543	17	(	(	-LRB-
cord-005453-4057qib7	2543	18	44.1	44.1	CD
cord-005453-4057qib7	2543	19	%	%	NN
cord-005453-4057qib7	2543	20	)	)	-RRB-
cord-005453-4057qib7	2543	21	.	.	.
cord-005453-4057qib7	2544	1	Three	three	CD
cord-005453-4057qib7	2544	2	patients	patient	NNS
cord-005453-4057qib7	2544	3	(	(	-LRB-
cord-005453-4057qib7	2544	4	4.4	4.4	CD
cord-005453-4057qib7	2544	5	%	%	NN
cord-005453-4057qib7	2544	6	)	)	-RRB-
cord-005453-4057qib7	2544	7	developed	develop	VBN
cord-005453-4057qib7	2544	8	venous	venous	JJ
cord-005453-4057qib7	2544	9	-	-	HYPH
cord-005453-4057qib7	2544	10	occlusive	occlusive	JJ
cord-005453-4057qib7	2544	11	disease	disease	NN
cord-005453-4057qib7	2544	12	.	.	.
cord-005453-4057qib7	2545	1	One	one	CD
cord-005453-4057qib7	2545	2	patient	patient	NN
cord-005453-4057qib7	2545	3	(	(	-LRB-
cord-005453-4057qib7	2545	4	1.5	1.5	CD
cord-005453-4057qib7	2545	5	%	%	NN
cord-005453-4057qib7	2545	6	)	)	-RRB-
cord-005453-4057qib7	2545	7	died	die	VBD
cord-005453-4057qib7	2545	8	due	due	JJ
cord-005453-4057qib7	2545	9	to	to	IN
cord-005453-4057qib7	2545	10	severe	severe	JJ
cord-005453-4057qib7	2545	11	pneumonia	pneumonia	NN
cord-005453-4057qib7	2545	12	after	after	IN
cord-005453-4057qib7	2545	13	ASCT	ASCT	NNP
cord-005453-4057qib7	2545	14	.	.	.
cord-005453-4057qib7	2546	1	After	after	IN
cord-005453-4057qib7	2546	2	a	a	DT
cord-005453-4057qib7	2546	3	median	median	JJ
cord-005453-4057qib7	2546	4	follow	follow	NN
cord-005453-4057qib7	2546	5	-	-	HYPH
cord-005453-4057qib7	2546	6	up	up	NN
cord-005453-4057qib7	2546	7	of	of	IN
cord-005453-4057qib7	2546	8	13.0	13.0	CD
cord-005453-4057qib7	2546	9	months	month	NNS
cord-005453-4057qib7	2546	10	,	,	,
cord-005453-4057qib7	2546	11	the	the	DT
cord-005453-4057qib7	2546	12	median	median	JJ
cord-005453-4057qib7	2546	13	progression	progression	NN
cord-005453-4057qib7	2546	14	-	-	HYPH
cord-005453-4057qib7	2546	15	free	free	JJ
cord-005453-4057qib7	2546	16	survival	survival	NN
cord-005453-4057qib7	2546	17	(	(	-LRB-
cord-005453-4057qib7	2546	18	PFS	PFS	NNP
cord-005453-4057qib7	2546	19	)	)	-RRB-
cord-005453-4057qib7	2546	20	and	and	CC
cord-005453-4057qib7	2546	21	overall	overall	JJ
cord-005453-4057qib7	2546	22	survival	survival	NN
cord-005453-4057qib7	2546	23	(	(	-LRB-
cord-005453-4057qib7	2546	24	OS	OS	NNP
cord-005453-4057qib7	2546	25	)	)	-RRB-
cord-005453-4057qib7	2546	26	were	be	VBD
cord-005453-4057qib7	2546	27	not	not	RB
cord-005453-4057qib7	2546	28	reached	reach	VBN
cord-005453-4057qib7	2546	29	.	.	.
cord-005453-4057qib7	2547	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2547	2	:	:	:
cord-005453-4057qib7	2548	1	In	in	IN
cord-005453-4057qib7	2548	2	conclusion	conclusion	NN
cord-005453-4057qib7	2548	3	,	,	,
cord-005453-4057qib7	2548	4	a	a	DT
cord-005453-4057qib7	2548	5	conditioning	conditioning	NN
cord-005453-4057qib7	2548	6	regimen	regimen	NN
cord-005453-4057qib7	2548	7	of	of	IN
cord-005453-4057qib7	2548	8	intravenous	intravenous	JJ
cord-005453-4057qib7	2548	9	busulfan	busulfan	NN
cord-005453-4057qib7	2548	10	and	and	CC
cord-005453-4057qib7	2548	11	thiotepa	thiotepa	NNP
cord-005453-4057qib7	2548	12	was	be	VBD
cord-005453-4057qib7	2548	13	effective	effective	JJ
cord-005453-4057qib7	2548	14	and	and	CC
cord-005453-4057qib7	2548	15	tolerable	tolerable	JJ
cord-005453-4057qib7	2548	16	.	.	.
cord-005453-4057qib7	2549	1	Clinical	clinical	JJ
cord-005453-4057qib7	2549	2	Trial	Trial	NNP
cord-005453-4057qib7	2549	3	Registry	Registry	NNP
cord-005453-4057qib7	2549	4	:	:	:
cord-005453-4057qib7	2550	1	Not	not	RB
cord-005453-4057qib7	2550	2	applicable	applicable	JJ
cord-005453-4057qib7	2550	3	Disclosure	disclosure	NN
cord-005453-4057qib7	2550	4	:	:	:
cord-005453-4057qib7	2550	5	The	the	DT
cord-005453-4057qib7	2550	6	authors	author	NNS
cord-005453-4057qib7	2550	7	have	have	VBP
cord-005453-4057qib7	2550	8	declared	declare	VBN
cord-005453-4057qib7	2550	9	no	no	DT
cord-005453-4057qib7	2550	10	conflicts	conflict	NNS
cord-005453-4057qib7	2550	11	of	of	IN
cord-005453-4057qib7	2550	12	interest	interest	NN
cord-005453-4057qib7	2550	13	.	.	.
cord-005453-4057qib7	2551	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	2551	2	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2551	3	bone	bone	NN
cord-005453-4057qib7	2551	4	marrow	marrow	NN
cord-005453-4057qib7	2551	5	transplantation	transplantation	NN
cord-005453-4057qib7	2551	6	with	with	IN
cord-005453-4057qib7	2551	7	post	post	JJ
cord-005453-4057qib7	2551	8	-	-	JJ
cord-005453-4057qib7	2551	9	transplant	transplant	JJ
cord-005453-4057qib7	2551	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	2551	11	in	in	IN
cord-005453-4057qib7	2551	12	paediatric	paediatric	JJ
cord-005453-4057qib7	2551	13	patients	patient	NNS
cord-005453-4057qib7	2551	14	with	with	IN
cord-005453-4057qib7	2551	15	haematological	haematological	JJ
cord-005453-4057qib7	2551	16	malignancies	malignancy	NNS
cord-005453-4057qib7	2552	1	Santanu	Santanu	NNP
cord-005453-4057qib7	2552	2	Sen	Sen	NNP
cord-005453-4057qib7	2552	3	1	1	CD
cord-005453-4057qib7	2553	1	,	,	,
cord-005453-4057qib7	2553	2	Sameer	Sameer	NNP
cord-005453-4057qib7	2553	3	Tulpule	Tulpule	NNP
cord-005453-4057qib7	2553	4	1	1	CD
cord-005453-4057qib7	2553	5	Background	Background	NNP
cord-005453-4057qib7	2553	6	:	:	:
cord-005453-4057qib7	2553	7	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	2553	8	transplants	transplant	NNS
cord-005453-4057qib7	2553	9	have	have	VBP
cord-005453-4057qib7	2553	10	been	be	VBN
cord-005453-4057qib7	2553	11	shown	show	VBN
cord-005453-4057qib7	2553	12	to	to	TO
cord-005453-4057qib7	2553	13	be	be	VB
cord-005453-4057qib7	2553	14	safe	safe	JJ
cord-005453-4057qib7	2553	15	and	and	CC
cord-005453-4057qib7	2553	16	effective	effective	JJ
cord-005453-4057qib7	2553	17	in	in	IN
cord-005453-4057qib7	2553	18	treating	treat	VBG
cord-005453-4057qib7	2553	19	haematological	haematological	JJ
cord-005453-4057qib7	2553	20	malignancies	malignancy	NNS
cord-005453-4057qib7	2553	21	in	in	IN
cord-005453-4057qib7	2553	22	the	the	DT
cord-005453-4057qib7	2553	23	paediatric	paediatric	JJ
cord-005453-4057qib7	2553	24	population	population	NN
cord-005453-4057qib7	2553	25	.	.	.
cord-005453-4057qib7	2554	1	We	-PRON-	PRP
cord-005453-4057qib7	2554	2	have	have	VBP
cord-005453-4057qib7	2554	3	previously	previously	RB
cord-005453-4057qib7	2554	4	reported	report	VBN
cord-005453-4057qib7	2554	5	on	on	IN
cord-005453-4057qib7	2554	6	our	-PRON-	PRP$
cord-005453-4057qib7	2554	7	experience	experience	NN
cord-005453-4057qib7	2554	8	of	of	IN
cord-005453-4057qib7	2554	9	using	use	VBG
cord-005453-4057qib7	2554	10	reduced	reduce	VBN
cord-005453-4057qib7	2554	11	intensity	intensity	NN
cord-005453-4057qib7	2554	12	conditioning	conditioning	NN
cord-005453-4057qib7	2554	13	with	with	IN
cord-005453-4057qib7	2554	14	post	post	NN
cord-005453-4057qib7	2554	15	Transplant	Transplant	NNP
cord-005453-4057qib7	2554	16	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	2554	17	in	in	IN
cord-005453-4057qib7	2554	18	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	2554	19	patients	patient	NNS
cord-005453-4057qib7	2554	20	.	.	.
cord-005453-4057qib7	2555	1	We	-PRON-	PRP
cord-005453-4057qib7	2555	2	herein	herein	RB
cord-005453-4057qib7	2555	3	report	report	VBP
cord-005453-4057qib7	2555	4	our	-PRON-	PRP$
cord-005453-4057qib7	2555	5	experience	experience	NN
cord-005453-4057qib7	2555	6	of	of	IN
cord-005453-4057qib7	2555	7	using	use	VBG
cord-005453-4057qib7	2555	8	a	a	DT
cord-005453-4057qib7	2555	9	TBI	TBI	NNP
cord-005453-4057qib7	2555	10	based	base	VBN
cord-005453-4057qib7	2555	11	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	2555	12	conditioning	conditioning	NN
cord-005453-4057qib7	2555	13	to	to	TO
cord-005453-4057qib7	2555	14	treat	treat	VB
cord-005453-4057qib7	2555	15	our	-PRON-	PRP$
cord-005453-4057qib7	2555	16	first	first	JJ
cord-005453-4057qib7	2555	17	8	8	CD
cord-005453-4057qib7	2555	18	patients	patient	NNS
cord-005453-4057qib7	2555	19	with	with	IN
cord-005453-4057qib7	2555	20	haematological	haematological	JJ
cord-005453-4057qib7	2555	21	malignancies	malignancy	NNS
cord-005453-4057qib7	2555	22	.	.	.
cord-005453-4057qib7	2556	1	Methods	method	NNS
cord-005453-4057qib7	2556	2	:	:	:
cord-005453-4057qib7	2556	3	8	8	CD
cord-005453-4057qib7	2556	4	patients	patient	NNS
cord-005453-4057qib7	2556	5	were	be	VBD
cord-005453-4057qib7	2556	6	enrolled	enrol	VBN
cord-005453-4057qib7	2556	7	in	in	IN
cord-005453-4057qib7	2556	8	the	the	DT
cord-005453-4057qib7	2556	9	study	study	NN
cord-005453-4057qib7	2556	10	,	,	,
cord-005453-4057qib7	2556	11	5	5	CD
cord-005453-4057qib7	2556	12	with	with	IN
cord-005453-4057qib7	2556	13	relapsed	relapse	VBN
cord-005453-4057qib7	2556	14	Acute	Acute	NNP
cord-005453-4057qib7	2556	15	Lymphoblastic	Lymphoblastic	NNP
cord-005453-4057qib7	2556	16	Leukemia	Leukemia	NNP
cord-005453-4057qib7	2556	17	(	(	-LRB-
cord-005453-4057qib7	2556	18	ALL	all	DT
cord-005453-4057qib7	2556	19	)	)	-RRB-
cord-005453-4057qib7	2556	20	and	and	CC
cord-005453-4057qib7	2556	21	3	3	CD
cord-005453-4057qib7	2556	22	with	with	IN
cord-005453-4057qib7	2556	23	relapsed	relapse	VBN
cord-005453-4057qib7	2556	24	/	/	SYM
cord-005453-4057qib7	2556	25	resistant	resistant	JJ
cord-005453-4057qib7	2556	26	Acute	Acute	NNP
cord-005453-4057qib7	2556	27	Myeloid	Myeloid	NNP
cord-005453-4057qib7	2556	28	Leukemia	Leukemia	NNP
cord-005453-4057qib7	2556	29	(	(	-LRB-
cord-005453-4057qib7	2556	30	AML	AML	NNP
cord-005453-4057qib7	2556	31	)	)	-RRB-
cord-005453-4057qib7	2556	32	.	.	.
cord-005453-4057qib7	2557	1	All	all	DT
cord-005453-4057qib7	2557	2	AML	AML	NNP
cord-005453-4057qib7	2557	3	patients	patient	NNS
cord-005453-4057qib7	2557	4	had	have	VBD
cord-005453-4057qib7	2557	5	genetic	genetic	JJ
cord-005453-4057qib7	2557	6	markers	marker	NNS
cord-005453-4057qib7	2557	7	of	of	IN
cord-005453-4057qib7	2557	8	high	high	JJ
cord-005453-4057qib7	2557	9	risk	risk	NN
cord-005453-4057qib7	2557	10	disease	disease	NN
cord-005453-4057qib7	2557	11	and	and	CC
cord-005453-4057qib7	2557	12	all	all	PDT
cord-005453-4057qib7	2557	13	ALL	all	DT
cord-005453-4057qib7	2557	14	patients	patient	NNS
cord-005453-4057qib7	2557	15	had	have	VBD
cord-005453-4057qib7	2557	16	very	very	RB
cord-005453-4057qib7	2557	17	early	early	JJ
cord-005453-4057qib7	2557	18	relapses	relapse	NNS
cord-005453-4057qib7	2557	19	(	(	-LRB-
cord-005453-4057qib7	2557	20	either	either	CC
cord-005453-4057qib7	2557	21	on	on	IN
cord-005453-4057qib7	2557	22	therapy	therapy	NN
cord-005453-4057qib7	2557	23	or	or	CC
cord-005453-4057qib7	2557	24	within	within	IN
cord-005453-4057qib7	2557	25	6	6	CD
cord-005453-4057qib7	2557	26	months	month	NNS
cord-005453-4057qib7	2557	27	of	of	IN
cord-005453-4057qib7	2557	28	stopping	stop	VBG
cord-005453-4057qib7	2557	29	therapy	therapy	NN
cord-005453-4057qib7	2557	30	)	)	-RRB-
cord-005453-4057qib7	2557	31	.	.	.
cord-005453-4057qib7	2558	1	All	all	DT
cord-005453-4057qib7	2558	2	patients	patient	NNS
cord-005453-4057qib7	2558	3	were	be	VBD
cord-005453-4057qib7	2558	4	conditioned	condition	VBN
cord-005453-4057qib7	2558	5	with	with	IN
cord-005453-4057qib7	2558	6	an	an	DT
cord-005453-4057qib7	2558	7	identical	identical	JJ
cord-005453-4057qib7	2558	8	protocol	protocol	NN
cord-005453-4057qib7	2558	9	using	use	VBG
cord-005453-4057qib7	2558	10	TBI	TBI	NNP
cord-005453-4057qib7	2558	11	-	-	HYPH
cord-005453-4057qib7	2558	12	based	base	VBN
cord-005453-4057qib7	2558	13	myeloablative	myeloablative	NNP
cord-005453-4057qib7	2558	14	preparative	preparative	JJ
cord-005453-4057qib7	2558	15	regimen	regimen	NN
cord-005453-4057qib7	2558	16	(	(	-LRB-
cord-005453-4057qib7	2558	17	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2559	1	30	30	CD
cord-005453-4057qib7	2559	2	mg	mg	NN
cord-005453-4057qib7	2559	3	/	/	SYM
cord-005453-4057qib7	2559	4	m	m	NN
cord-005453-4057qib7	2559	5	2	2	CD
cord-005453-4057qib7	2560	1	/d	/d	NNP
cord-005453-4057qib7	2560	2	×	×	NNP
cord-005453-4057qib7	2561	1	4	4	LS
cord-005453-4057qib7	2561	2	d	d	NN
cord-005453-4057qib7	2562	1	and	and	CC
cord-005453-4057qib7	2562	2	TBI	TBI	NNP
cord-005453-4057qib7	2562	3	150	150	CD
cord-005453-4057qib7	2562	4	cGy	cGy	NNS
cord-005453-4057qib7	2562	5	bid	bid	VBN
cord-005453-4057qib7	2562	6	on	on	IN
cord-005453-4057qib7	2562	7	d	d	XX
cord-005453-4057qib7	2562	8	−4	−4	CD
cord-005453-4057qib7	2562	9	to	to	IN
cord-005453-4057qib7	2562	10	−1	−1	NNP
cord-005453-4057qib7	2562	11	[	[	-LRB-
cord-005453-4057qib7	2562	12	total	total	JJ
cord-005453-4057qib7	2562	13	dose	dose	NN
cord-005453-4057qib7	2562	14	1200	1200	CD
cord-005453-4057qib7	2562	15	cGy	cGy	NNS
cord-005453-4057qib7	2562	16	]	]	-RRB-
cord-005453-4057qib7	2562	17	)	)	-RRB-
cord-005453-4057qib7	2562	18	followed	follow	VBD
cord-005453-4057qib7	2562	19	by	by	IN
cord-005453-4057qib7	2562	20	an	an	DT
cord-005453-4057qib7	2562	21	infusion	infusion	NN
cord-005453-4057qib7	2562	22	of	of	IN
cord-005453-4057qib7	2562	23	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	2562	24	peripheral	peripheral	JJ
cord-005453-4057qib7	2562	25	blood	blood	NN
cord-005453-4057qib7	2562	26	stem	stem	NN
cord-005453-4057qib7	2562	27	cells	cell	NNS
cord-005453-4057qib7	2562	28	from	from	IN
cord-005453-4057qib7	2562	29	a	a	DT
cord-005453-4057qib7	2562	30	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	2562	31	family	family	NN
cord-005453-4057qib7	2562	32	donor	donor	NN
cord-005453-4057qib7	2562	33	.	.	.
cord-005453-4057qib7	2563	1	Postgraft	postgraft	NN
cord-005453-4057qib7	2563	2	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	2563	3	consisted	consist	VBD
cord-005453-4057qib7	2563	4	of	of	IN
cord-005453-4057qib7	2563	5	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	2563	6	50	50	CD
cord-005453-4057qib7	2563	7	mg	mg	NNP
cord-005453-4057qib7	2563	8	/	/	SYM
cord-005453-4057qib7	2563	9	kg	kg	NNP
cord-005453-4057qib7	2563	10	/	/	SYM
cord-005453-4057qib7	2563	11	day	day	NN
cord-005453-4057qib7	2563	12	on	on	IN
cord-005453-4057qib7	2563	13	days	day	NNS
cord-005453-4057qib7	2563	14	3	3	CD
cord-005453-4057qib7	2563	15	and	and	CC
cord-005453-4057qib7	2563	16	4	4	CD
cord-005453-4057qib7	2563	17	,	,	,
cord-005453-4057qib7	2563	18	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	2563	19	Mofetil	Mofetil	NNP
cord-005453-4057qib7	2563	20	through	through	IN
cord-005453-4057qib7	2563	21	day	day	NN
cord-005453-4057qib7	2563	22	35	35	CD
cord-005453-4057qib7	2563	23	,	,	,
cord-005453-4057qib7	2563	24	and	and	CC
cord-005453-4057qib7	2563	25	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	2563	26	through	through	IN
cord-005453-4057qib7	2563	27	day	day	NN
cord-005453-4057qib7	2563	28	180	180	CD
cord-005453-4057qib7	2563	29	.	.	.
cord-005453-4057qib7	2564	1	Results	result	NNS
cord-005453-4057qib7	2564	2	:	:	:
cord-005453-4057qib7	2565	1	Median	median	JJ
cord-005453-4057qib7	2565	2	time	time	NN
cord-005453-4057qib7	2565	3	of	of	IN
cord-005453-4057qib7	2565	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	2565	5	and	and	CC
cord-005453-4057qib7	2565	6	platelet	platelet	NN
cord-005453-4057qib7	2565	7	engraftment	engraftment	NN
cord-005453-4057qib7	2565	8	was	be	VBD
cord-005453-4057qib7	2565	9	11	11	CD
cord-005453-4057qib7	2565	10	and	and	CC
cord-005453-4057qib7	2565	11	19	19	CD
cord-005453-4057qib7	2565	12	days	day	NNS
cord-005453-4057qib7	2565	13	,	,	,
cord-005453-4057qib7	2565	14	respectively	respectively	RB
cord-005453-4057qib7	2565	15	.	.	.
cord-005453-4057qib7	2566	1	All	all	DT
cord-005453-4057qib7	2566	2	patients	patient	NNS
cord-005453-4057qib7	2566	3	achieved	achieve	VBD
cord-005453-4057qib7	2566	4	sustained	sustained	JJ
cord-005453-4057qib7	2566	5	complete	complete	JJ
cord-005453-4057qib7	2566	6	donor	donor	NN
cord-005453-4057qib7	2566	7	chimerism	chimerism	NN
cord-005453-4057qib7	2566	8	by	by	IN
cord-005453-4057qib7	2566	9	day	day	NN
cord-005453-4057qib7	2566	10	+28	+28	NNS
cord-005453-4057qib7	2566	11	.	.	.
cord-005453-4057qib7	2567	1	Acute	acute	JJ
cord-005453-4057qib7	2567	2	GVHD	GVHD	NNP
cord-005453-4057qib7	2567	3	,	,	,
cord-005453-4057qib7	2567	4	grades	grade	NNS
cord-005453-4057qib7	2567	5	II	II	NNP
cord-005453-4057qib7	2567	6	-	-	HYPH
cord-005453-4057qib7	2567	7	IV	IV	NNP
cord-005453-4057qib7	2567	8	and	and	CC
cord-005453-4057qib7	2567	9	III	III	NNP
cord-005453-4057qib7	2567	10	-	-	HYPH
cord-005453-4057qib7	2567	11	IV	IV	NNP
cord-005453-4057qib7	2567	12	,	,	,
cord-005453-4057qib7	2567	13	was	be	VBD
cord-005453-4057qib7	2567	14	seen	see	VBN
cord-005453-4057qib7	2567	15	in	in	IN
cord-005453-4057qib7	2567	16	75	75	CD
cord-005453-4057qib7	2567	17	%	%	NN
cord-005453-4057qib7	2567	18	and	and	CC
cord-005453-4057qib7	2567	19	25	25	CD
cord-005453-4057qib7	2567	20	%	%	NN
cord-005453-4057qib7	2567	21	,	,	,
cord-005453-4057qib7	2567	22	respectively	respectively	RB
cord-005453-4057qib7	2567	23	.	.	.
cord-005453-4057qib7	2568	1	Disease	disease	NN
cord-005453-4057qib7	2568	2	progression	progression	NN
cord-005453-4057qib7	2568	3	occurred	occur	VBD
cord-005453-4057qib7	2568	4	in	in	IN
cord-005453-4057qib7	2568	5	2	2	CD
cord-005453-4057qib7	2568	6	patients	patient	NNS
cord-005453-4057qib7	2568	7	:	:	:
cord-005453-4057qib7	2568	8	8	8	CD
cord-005453-4057qib7	2568	9	&	&	CC
cord-005453-4057qib7	2568	10	10	10	CD
cord-005453-4057qib7	2568	11	months	month	NNS
cord-005453-4057qib7	2568	12	after	after	IN
cord-005453-4057qib7	2568	13	transplant	transplant	NN
cord-005453-4057qib7	2569	1	and	and	CC
cord-005453-4057qib7	2569	2	there	there	EX
cord-005453-4057qib7	2569	3	was	be	VBD
cord-005453-4057qib7	2569	4	one	one	CD
cord-005453-4057qib7	2569	5	death	death	NN
cord-005453-4057qib7	2569	6	due	due	IN
cord-005453-4057qib7	2569	7	to	to	IN
cord-005453-4057qib7	2569	8	severe	severe	JJ
cord-005453-4057qib7	2569	9	fungal	fungal	JJ
cord-005453-4057qib7	2569	10	infection	infection	NN
cord-005453-4057qib7	2569	11	.	.	.
cord-005453-4057qib7	2570	1	Estimated	estimate	VBN
cord-005453-4057qib7	2570	2	twoyear	twoyear	JJ
cord-005453-4057qib7	2570	3	survival	survival	NN
cord-005453-4057qib7	2570	4	and	and	CC
cord-005453-4057qib7	2570	5	relapse	relapse	NN
cord-005453-4057qib7	2570	6	were	be	VBD
cord-005453-4057qib7	2570	7	75	75	CD
cord-005453-4057qib7	2570	8	%	%	NN
cord-005453-4057qib7	2570	9	and	and	CC
cord-005453-4057qib7	2570	10	24	24	CD
cord-005453-4057qib7	2570	11	%	%	NN
cord-005453-4057qib7	2570	12	,	,	,
cord-005453-4057qib7	2570	13	respectively	respectively	RB
cord-005453-4057qib7	2570	14	.	.	.
cord-005453-4057qib7	2571	1	2	2	CD
cord-005453-4057qib7	2571	2	patients	patient	NNS
cord-005453-4057qib7	2571	3	had	have	VBD
cord-005453-4057qib7	2571	4	severe	severe	JJ
cord-005453-4057qib7	2571	5	BK	BK	NNP
cord-005453-4057qib7	2571	6	viremia	viremia	NN
cord-005453-4057qib7	2571	7	and	and	CC
cord-005453-4057qib7	2571	8	CMV	CMV	NNP
cord-005453-4057qib7	2571	9	reactivation	reactivation	NN
cord-005453-4057qib7	2571	10	occurred	occur	VBD
cord-005453-4057qib7	2571	11	in	in	IN
cord-005453-4057qib7	2571	12	4	4	CD
cord-005453-4057qib7	2571	13	patients	patient	NNS
cord-005453-4057qib7	2571	14	.	.	.
cord-005453-4057qib7	2572	1	All	all	DT
cord-005453-4057qib7	2572	2	patients	patient	NNS
cord-005453-4057qib7	2572	3	were	be	VBD
cord-005453-4057qib7	2572	4	successfully	successfully	RB
cord-005453-4057qib7	2572	5	managed	manage	VBN
cord-005453-4057qib7	2572	6	with	with	IN
cord-005453-4057qib7	2572	7	appropriate	appropriate	JJ
cord-005453-4057qib7	2572	8	supportive	supportive	JJ
cord-005453-4057qib7	2572	9	and	and	CC
cord-005453-4057qib7	2572	10	antiviral	antiviral	JJ
cord-005453-4057qib7	2572	11	therapy	therapy	NN
cord-005453-4057qib7	2572	12	.	.	.
cord-005453-4057qib7	2573	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2573	2	:	:	:
cord-005453-4057qib7	2574	1	We	-PRON-	PRP
cord-005453-4057qib7	2574	2	report	report	VBP
cord-005453-4057qib7	2574	3	good	good	JJ
cord-005453-4057qib7	2574	4	outcome	outcome	NN
cord-005453-4057qib7	2574	5	with	with	IN
cord-005453-4057qib7	2574	6	a	a	DT
cord-005453-4057qib7	2574	7	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2574	8	conditioning	conditioning	NN
cord-005453-4057qib7	2574	9	in	in	IN
cord-005453-4057qib7	2574	10	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2574	11	transplants	transplant	NNS
cord-005453-4057qib7	2574	12	with	with	IN
cord-005453-4057qib7	2574	13	excellent	excellent	JJ
cord-005453-4057qib7	2574	14	engraftment	engraftment	NN
cord-005453-4057qib7	2574	15	and	and	CC
cord-005453-4057qib7	2574	16	hopefully	hopefully	RB
cord-005453-4057qib7	2574	17	a	a	DT
cord-005453-4057qib7	2574	18	longer	long	JJR
cord-005453-4057qib7	2574	19	life	life	NN
cord-005453-4057qib7	2574	20	expectancy	expectancy	NN
cord-005453-4057qib7	2574	21	.	.	.
cord-005453-4057qib7	2575	1	With	with	IN
cord-005453-4057qib7	2575	2	small	small	JJ
cord-005453-4057qib7	2575	3	number	number	NN
cord-005453-4057qib7	2575	4	of	of	IN
cord-005453-4057qib7	2575	5	patients	patient	NNS
cord-005453-4057qib7	2575	6	,	,	,
cord-005453-4057qib7	2575	7	it	-PRON-	PRP
cord-005453-4057qib7	2575	8	is	be	VBZ
cord-005453-4057qib7	2575	9	difficult	difficult	JJ
cord-005453-4057qib7	2575	10	to	to	TO
cord-005453-4057qib7	2575	11	state	state	VB
cord-005453-4057qib7	2575	12	whether	whether	IN
cord-005453-4057qib7	2575	13	using	use	VBG
cord-005453-4057qib7	2575	14	a	a	DT
cord-005453-4057qib7	2575	15	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2575	16	conditioning	conditioning	NN
cord-005453-4057qib7	2575	17	would	would	MD
cord-005453-4057qib7	2575	18	lead	lead	VB
cord-005453-4057qib7	2575	19	to	to	IN
cord-005453-4057qib7	2575	20	better	well	JJR
cord-005453-4057qib7	2575	21	long	long	JJ
cord-005453-4057qib7	2575	22	term	term	NN
cord-005453-4057qib7	2575	23	outcomes	outcome	NNS
cord-005453-4057qib7	2575	24	in	in	IN
cord-005453-4057qib7	2575	25	this	this	DT
cord-005453-4057qib7	2575	26	cohort	cohort	NN
cord-005453-4057qib7	2575	27	of	of	IN
cord-005453-4057qib7	2575	28	patients	patient	NNS
cord-005453-4057qib7	2575	29	with	with	IN
cord-005453-4057qib7	2575	30	very	very	RB
cord-005453-4057qib7	2575	31	haematological	haematological	JJ
cord-005453-4057qib7	2575	32	malignancies	malignancy	NNS
cord-005453-4057qib7	2575	33	,	,	,
cord-005453-4057qib7	2575	34	but	but	CC
cord-005453-4057qib7	2575	35	we	-PRON-	PRP
cord-005453-4057qib7	2575	36	certainly	certainly	RB
cord-005453-4057qib7	2575	37	showed	show	VBD
cord-005453-4057qib7	2575	38	that	that	IN
cord-005453-4057qib7	2575	39	it	-PRON-	PRP
cord-005453-4057qib7	2575	40	is	be	VBZ
cord-005453-4057qib7	2575	41	possible	possible	JJ
cord-005453-4057qib7	2575	42	to	to	TO
cord-005453-4057qib7	2575	43	achieve	achieve	VB
cord-005453-4057qib7	2575	44	excellent	excellent	JJ
cord-005453-4057qib7	2575	45	early	early	JJ
cord-005453-4057qib7	2575	46	results	result	NNS
cord-005453-4057qib7	2575	47	.	.	.
cord-005453-4057qib7	2576	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2576	2	:	:	:
cord-005453-4057qib7	2576	3	Nothing	nothing	NN
cord-005453-4057qib7	2576	4	to	to	TO
cord-005453-4057qib7	2576	5	declare	declare	VB
cord-005453-4057qib7	2576	6	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2576	7	in	in	IN
cord-005453-4057qib7	2576	8	combination	combination	NN
cord-005453-4057qib7	2576	9	with	with	IN
cord-005453-4057qib7	2576	10	melphalan	melphalan	NNP
cord-005453-4057qib7	2576	11	and	and	CC
cord-005453-4057qib7	2576	12	ATG	ATG	NNP
cord-005453-4057qib7	2576	13	can	can	MD
cord-005453-4057qib7	2576	14	be	be	VB
cord-005453-4057qib7	2576	15	the	the	DT
cord-005453-4057qib7	2576	16	best	good	JJS
cord-005453-4057qib7	2576	17	conditioning	conditioning	NN
cord-005453-4057qib7	2576	18	for	for	IN
cord-005453-4057qib7	2576	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2576	20	stem	stem	NN
cord-005453-4057qib7	2576	21	cell	cell	NN
cord-005453-4057qib7	2576	22	transplant	transplant	NN
cord-005453-4057qib7	2576	23	of	of	IN
cord-005453-4057qib7	2576	24	children	child	NNS
cord-005453-4057qib7	2576	25	with	with	IN
cord-005453-4057qib7	2576	26	hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	2576	27	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	2576	28	Methods	method	NNS
cord-005453-4057qib7	2577	1	:	:	:
cord-005453-4057qib7	2577	2	In	in	IN
cord-005453-4057qib7	2577	3	this	this	DT
cord-005453-4057qib7	2577	4	prospective	prospective	JJ
cord-005453-4057qib7	2577	5	study	study	NN
cord-005453-4057qib7	2577	6	,	,	,
cord-005453-4057qib7	2577	7	we	-PRON-	PRP
cord-005453-4057qib7	2577	8	analyzed	analyze	VBD
cord-005453-4057qib7	2577	9	the	the	DT
cord-005453-4057qib7	2577	10	outcome	outcome	NN
cord-005453-4057qib7	2577	11	of	of	IN
cord-005453-4057qib7	2577	12	two	two	CD
cord-005453-4057qib7	2577	13	pediatric	pediatric	JJ
cord-005453-4057qib7	2577	14	patients	patient	NNS
cord-005453-4057qib7	2577	15	with	with	IN
cord-005453-4057qib7	2577	16	HLH	HLH	NNP
cord-005453-4057qib7	2577	17	who	who	WP
cord-005453-4057qib7	2577	18	had	have	VBD
cord-005453-4057qib7	2577	19	received	receive	VBN
cord-005453-4057qib7	2577	20	HSCT	HSCT	NNP
cord-005453-4057qib7	2577	21	,	,	,
cord-005453-4057qib7	2577	22	using	use	VBG
cord-005453-4057qib7	2577	23	reduced	reduce	VBN
cord-005453-4057qib7	2577	24	-	-	HYPH
cord-005453-4057qib7	2577	25	intensity	intensity	NN
cord-005453-4057qib7	2577	26	conditioning	conditioning	NN
cord-005453-4057qib7	2577	27	(	(	-LRB-
cord-005453-4057qib7	2577	28	RIC	RIC	NNP
cord-005453-4057qib7	2577	29	)	)	-RRB-
cord-005453-4057qib7	2577	30	regimen	regimen	NN
cord-005453-4057qib7	2577	31	.	.	.
cord-005453-4057qib7	2578	1	They	-PRON-	PRP
cord-005453-4057qib7	2578	2	received	receive	VBD
cord-005453-4057qib7	2578	3	the	the	DT
cord-005453-4057qib7	2578	4	same	same	JJ
cord-005453-4057qib7	2578	5	RIC	RIC	NNP
cord-005453-4057qib7	2578	6	regimen	regimen	NN
cord-005453-4057qib7	2578	7	based	base	VBN
cord-005453-4057qib7	2578	8	on	on	IN
cord-005453-4057qib7	2578	9	the	the	DT
cord-005453-4057qib7	2578	10	use	use	NN
cord-005453-4057qib7	2578	11	of	of	IN
cord-005453-4057qib7	2578	12	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2578	13	(	(	-LRB-
cord-005453-4057qib7	2578	14	30	30	CD
cord-005453-4057qib7	2578	15	mg	mg	NN
cord-005453-4057qib7	2578	16	/	/	SYM
cord-005453-4057qib7	2578	17	m	m	NN
cord-005453-4057qib7	2578	18	2	2	CD
cord-005453-4057qib7	2578	19	/day	/day	.
cord-005453-4057qib7	2578	20	for	for	IN
cord-005453-4057qib7	2578	21	5	5	CD
cord-005453-4057qib7	2578	22	days	day	NNS
cord-005453-4057qib7	2578	23	)	)	-RRB-
cord-005453-4057qib7	2578	24	in	in	IN
cord-005453-4057qib7	2578	25	combination	combination	NN
cord-005453-4057qib7	2578	26	with	with	IN
cord-005453-4057qib7	2578	27	melphalan	melphalan	NNP
cord-005453-4057qib7	2578	28	(	(	-LRB-
cord-005453-4057qib7	2578	29	70	70	CD
cord-005453-4057qib7	2578	30	mg	mg	NNP
cord-005453-4057qib7	2578	31	/	/	SYM
cord-005453-4057qib7	2578	32	m	m	NN
cord-005453-4057qib7	2578	33	2	2	CD
cord-005453-4057qib7	2578	34	/day	/day	.
cord-005453-4057qib7	2578	35	for	for	IN
cord-005453-4057qib7	2578	36	2	2	CD
cord-005453-4057qib7	2578	37	days	day	NNS
cord-005453-4057qib7	2578	38	)	)	-RRB-
cord-005453-4057qib7	2578	39	and	and	CC
cord-005453-4057qib7	2578	40	horse	horse	NN
cord-005453-4057qib7	2578	41	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	2578	42	globulin	globulin	NN
cord-005453-4057qib7	2578	43	(	(	-LRB-
cord-005453-4057qib7	2579	1	ATG	ATG	NNP
cord-005453-4057qib7	2579	2	10	10	CD
cord-005453-4057qib7	2579	3	mg	mg	NNP
cord-005453-4057qib7	2579	4	/	/	SYM
cord-005453-4057qib7	2579	5	kg	kg	NNP
cord-005453-4057qib7	2579	6	/	/	SYM
cord-005453-4057qib7	2579	7	d	d	NN
cord-005453-4057qib7	2579	8	for	for	IN
cord-005453-4057qib7	2579	9	4	4	CD
cord-005453-4057qib7	2579	10	days	day	NNS
cord-005453-4057qib7	2579	11	)	)	-RRB-
cord-005453-4057qib7	2579	12	.	.	.
cord-005453-4057qib7	2580	1	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	2580	2	and	and	CC
cord-005453-4057qib7	2580	3	Methotrexate	Methotrexate	NNP
cord-005453-4057qib7	2580	4	were	be	VBD
cord-005453-4057qib7	2580	5	used	use	VBN
cord-005453-4057qib7	2580	6	as	as	IN
cord-005453-4057qib7	2580	7	graft	graft	NN
cord-005453-4057qib7	2580	8	-	-	HYPH
cord-005453-4057qib7	2580	9	vs.-host	vs.-host	NN
cord-005453-4057qib7	2580	10	disease	disease	NN
cord-005453-4057qib7	2580	11	(	(	-LRB-
cord-005453-4057qib7	2580	12	GvHD	GvHD	NNP
cord-005453-4057qib7	2580	13	)	)	-RRB-
cord-005453-4057qib7	2580	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2580	15	.	.	.
cord-005453-4057qib7	2581	1	Results	result	NNS
cord-005453-4057qib7	2581	2	:	:	:
cord-005453-4057qib7	2582	1	A	a	DT
cord-005453-4057qib7	2582	2	2	2	CD
cord-005453-4057qib7	2582	3	months	month	NNS
cord-005453-4057qib7	2582	4	boy	boy	NN
cord-005453-4057qib7	2582	5	with	with	IN
cord-005453-4057qib7	2582	6	primary	primary	JJ
cord-005453-4057qib7	2582	7	HLH	HLH	NNP
cord-005453-4057qib7	2582	8	(	(	-LRB-
cord-005453-4057qib7	2582	9	FHL2	FHL2	NNP
cord-005453-4057qib7	2582	10	)	)	-RRB-
cord-005453-4057qib7	2582	11	was	be	VBD
cord-005453-4057qib7	2582	12	transplanted	transplant	VBN
cord-005453-4057qib7	2582	13	from	from	IN
cord-005453-4057qib7	2582	14	his	-PRON-	PRP$
cord-005453-4057qib7	2582	15	mother	mother	NN
cord-005453-4057qib7	2582	16	and	and	CC
cord-005453-4057qib7	2582	17	a	a	DT
cord-005453-4057qib7	2582	18	4	4	CD
cord-005453-4057qib7	2582	19	years	year	NNS
cord-005453-4057qib7	2582	20	girl	girl	NN
cord-005453-4057qib7	2582	21	with	with	IN
cord-005453-4057qib7	2582	22	secondary	secondary	JJ
cord-005453-4057qib7	2582	23	HLH	HLH	NNP
cord-005453-4057qib7	2582	24	was	be	VBD
cord-005453-4057qib7	2582	25	transplanted	transplant	VBN
cord-005453-4057qib7	2582	26	from	from	IN
cord-005453-4057qib7	2582	27	her	-PRON-	PRP$
cord-005453-4057qib7	2582	28	brother	brother	NN
cord-005453-4057qib7	2582	29	.	.	.
cord-005453-4057qib7	2583	1	Both	both	DT
cord-005453-4057qib7	2583	2	of	of	IN
cord-005453-4057qib7	2583	3	donors	donor	NNS
cord-005453-4057qib7	2583	4	were	be	VBD
cord-005453-4057qib7	2583	5	HLA	HLA	NNP
cord-005453-4057qib7	2583	6	match	match	NN
cord-005453-4057qib7	2583	7	with	with	IN
cord-005453-4057qib7	2583	8	their	-PRON-	PRP$
cord-005453-4057qib7	2583	9	recipients	recipient	NNS
cord-005453-4057qib7	2583	10	.	.	.
cord-005453-4057qib7	2584	1	They	-PRON-	PRP
cord-005453-4057qib7	2584	2	were	be	VBD
cord-005453-4057qib7	2584	3	received	receive	VBN
cord-005453-4057qib7	2584	4	6	6	CD
cord-005453-4057qib7	2584	5	x	x	SYM
cord-005453-4057qib7	2584	6	10	10	CD
cord-005453-4057qib7	2584	7	6	6	CD
cord-005453-4057qib7	2584	8	/kg	/kg	CD
cord-005453-4057qib7	2584	9	and	and	CC
cord-005453-4057qib7	2584	10	10	10	CD
cord-005453-4057qib7	2584	11	x	x	SYM
cord-005453-4057qib7	2584	12	10	10	CD
cord-005453-4057qib7	2584	13	6	6	CD
cord-005453-4057qib7	2584	14	/kg	/kg	.
cord-005453-4057qib7	2584	15	CD34	CD34	NNP
cord-005453-4057qib7	2584	16	+	+	CC
cord-005453-4057qib7	2584	17	cells	cell	NNS
cord-005453-4057qib7	2584	18	from	from	IN
cord-005453-4057qib7	2584	19	the	the	DT
cord-005453-4057qib7	2584	20	harvested	harvest	VBN
cord-005453-4057qib7	2584	21	peripheral	peripheral	JJ
cord-005453-4057qib7	2584	22	blood	blood	NN
cord-005453-4057qib7	2584	23	stem	stem	NN
cord-005453-4057qib7	2584	24	cells	cell	NNS
cord-005453-4057qib7	2584	25	,	,	,
cord-005453-4057qib7	2584	26	respectively	respectively	RB
cord-005453-4057qib7	2584	27	.	.	.
cord-005453-4057qib7	2585	1	They	-PRON-	PRP
cord-005453-4057qib7	2585	2	achieved	achieve	VBD
cord-005453-4057qib7	2585	3	full	full	JJ
cord-005453-4057qib7	2585	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	2585	5	and	and	CC
cord-005453-4057qib7	2585	6	platelet	platelet	NN
cord-005453-4057qib7	2585	7	recovery	recovery	NN
cord-005453-4057qib7	2585	8	.	.	.
cord-005453-4057qib7	2586	1	The	the	DT
cord-005453-4057qib7	2586	2	time	time	NN
cord-005453-4057qib7	2586	3	to	to	IN
cord-005453-4057qib7	2586	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	2586	5	recovery	recovery	NN
cord-005453-4057qib7	2586	6	was	be	VBD
cord-005453-4057qib7	2586	7	13	13	CD
cord-005453-4057qib7	2586	8	and	and	CC
cord-005453-4057qib7	2586	9	11	11	CD
cord-005453-4057qib7	2586	10	days	day	NNS
cord-005453-4057qib7	2586	11	,	,	,
cord-005453-4057qib7	2586	12	respectively	respectively	RB
cord-005453-4057qib7	2586	13	.	.	.
cord-005453-4057qib7	2587	1	Full	full	JJ
cord-005453-4057qib7	2587	2	chimerism	chimerism	NN
cord-005453-4057qib7	2587	3	was	be	VBD
cord-005453-4057qib7	2587	4	achieved	achieve	VBN
cord-005453-4057qib7	2587	5	for	for	IN
cord-005453-4057qib7	2587	6	both	both	DT
cord-005453-4057qib7	2587	7	of	of	IN
cord-005453-4057qib7	2587	8	them	-PRON-	PRP
cord-005453-4057qib7	2587	9	.	.	.
cord-005453-4057qib7	2588	1	In	in	IN
cord-005453-4057qib7	2588	2	addition	addition	NN
cord-005453-4057qib7	2588	3	,	,	,
cord-005453-4057qib7	2588	4	they	-PRON-	PRP
cord-005453-4057qib7	2588	5	was	be	VBD
cord-005453-4057qib7	2588	6	developed	develop	VBN
cord-005453-4057qib7	2588	7	grade	grade	NN
cord-005453-4057qib7	2588	8	3	3	CD
cord-005453-4057qib7	2588	9	and	and	CC
cord-005453-4057qib7	2588	10	2	2	CD
cord-005453-4057qib7	2588	11	of	of	IN
cord-005453-4057qib7	2588	12	acute	acute	JJ
cord-005453-4057qib7	2588	13	GvHD	gvhd	NN
cord-005453-4057qib7	2588	14	,	,	,
cord-005453-4057qib7	2588	15	respectively	respectively	RB
cord-005453-4057qib7	2588	16	.	.	.
cord-005453-4057qib7	2589	1	GvHD	GvHD	NNP
cord-005453-4057qib7	2589	2	was	be	VBD
cord-005453-4057qib7	2589	3	completely	completely	RB
cord-005453-4057qib7	2589	4	controlled	control	VBN
cord-005453-4057qib7	2589	5	with	with	IN
cord-005453-4057qib7	2589	6	prednisolone	prednisolone	NN
cord-005453-4057qib7	2589	7	.	.	.
cord-005453-4057qib7	2590	1	They	-PRON-	PRP
cord-005453-4057qib7	2590	2	are	be	VBP
cord-005453-4057qib7	2590	3	alive	alive	JJ
cord-005453-4057qib7	2590	4	and	and	CC
cord-005453-4057qib7	2590	5	in	in	IN
cord-005453-4057qib7	2590	6	complete	complete	JJ
cord-005453-4057qib7	2590	7	remission	remission	NN
cord-005453-4057qib7	2590	8	without	without	IN
cord-005453-4057qib7	2590	9	any	any	DT
cord-005453-4057qib7	2590	10	significant	significant	JJ
cord-005453-4057qib7	2590	11	complications	complication	NNS
cord-005453-4057qib7	2590	12	after	after	IN
cord-005453-4057qib7	2590	13	36	36	CD
cord-005453-4057qib7	2590	14	and	and	CC
cord-005453-4057qib7	2590	15	14	14	CD
cord-005453-4057qib7	2590	16	months	month	NNS
cord-005453-4057qib7	2590	17	,	,	,
cord-005453-4057qib7	2590	18	respectively	respectively	RB
cord-005453-4057qib7	2590	19	.	.	.
cord-005453-4057qib7	2591	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2591	2	:	:	:
cord-005453-4057qib7	2592	1	It	-PRON-	PRP
cord-005453-4057qib7	2592	2	appears	appear	VBZ
cord-005453-4057qib7	2592	3	that	that	IN
cord-005453-4057qib7	2592	4	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	2592	5	in	in	IN
cord-005453-4057qib7	2592	6	combination	combination	NN
cord-005453-4057qib7	2592	7	with	with	IN
cord-005453-4057qib7	2592	8	Melphalan	Melphalan	NNP
cord-005453-4057qib7	2592	9	and	and	CC
cord-005453-4057qib7	2592	10	ATG	ATG	NNP
cord-005453-4057qib7	2592	11	may	may	MD
cord-005453-4057qib7	2592	12	be	be	VB
cord-005453-4057qib7	2592	13	the	the	DT
cord-005453-4057qib7	2592	14	best	good	JJS
cord-005453-4057qib7	2592	15	conditioning	conditioning	NN
cord-005453-4057qib7	2592	16	regimen	regimen	NN
cord-005453-4057qib7	2592	17	for	for	IN
cord-005453-4057qib7	2592	18	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2592	19	stem	stem	NN
cord-005453-4057qib7	2592	20	cell	cell	NN
cord-005453-4057qib7	2592	21	transplant	transplant	NN
cord-005453-4057qib7	2592	22	of	of	IN
cord-005453-4057qib7	2592	23	children	child	NNS
cord-005453-4057qib7	2592	24	with	with	IN
cord-005453-4057qib7	2592	25	HLH	HLH	NNP
cord-005453-4057qib7	2592	26	.	.	.
cord-005453-4057qib7	2593	1	Due	due	IN
cord-005453-4057qib7	2593	2	to	to	IN
cord-005453-4057qib7	2593	3	a	a	DT
cord-005453-4057qib7	2593	4	few	few	JJ
cord-005453-4057qib7	2593	5	number	number	NN
cord-005453-4057qib7	2593	6	cases	case	NNS
cord-005453-4057qib7	2593	7	of	of	IN
cord-005453-4057qib7	2593	8	this	this	DT
cord-005453-4057qib7	2593	9	study	study	NN
cord-005453-4057qib7	2593	10	,	,	,
cord-005453-4057qib7	2593	11	a	a	DT
cord-005453-4057qib7	2593	12	study	study	NN
cord-005453-4057qib7	2593	13	with	with	IN
cord-005453-4057qib7	2593	14	sufficient	sufficient	JJ
cord-005453-4057qib7	2593	15	sample	sample	NN
cord-005453-4057qib7	2593	16	size	size	NN
cord-005453-4057qib7	2593	17	is	be	VBZ
cord-005453-4057qib7	2593	18	required	require	VBN
cord-005453-4057qib7	2593	19	.	.	.
cord-005453-4057qib7	2594	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2594	2	Background	background	NN
cord-005453-4057qib7	2594	3	:	:	:
cord-005453-4057qib7	2594	4	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2594	5	cell	cell	NN
cord-005453-4057qib7	2594	6	transplant	transplant	NN
cord-005453-4057qib7	2594	7	(	(	-LRB-
cord-005453-4057qib7	2594	8	HCT	HCT	NNP
cord-005453-4057qib7	2594	9	)	)	-RRB-
cord-005453-4057qib7	2594	10	recipients	recipient	NNS
cord-005453-4057qib7	2594	11	often	often	RB
cord-005453-4057qib7	2594	12	report	report	VBP
cord-005453-4057qib7	2594	13	depression	depression	NN
cord-005453-4057qib7	2594	14	and	and	CC
cord-005453-4057qib7	2594	15	impaired	impaired	JJ
cord-005453-4057qib7	2594	16	quality	quality	NN
cord-005453-4057qib7	2594	17	of	of	IN
cord-005453-4057qib7	2594	18	life	life	NN
cord-005453-4057qib7	2594	19	(	(	-LRB-
cord-005453-4057qib7	2594	20	QOL	QOL	NNP
cord-005453-4057qib7	2594	21	)	)	-RRB-
cord-005453-4057qib7	2594	22	before	before	IN
cord-005453-4057qib7	2594	23	transplant	transplant	NN
cord-005453-4057qib7	2594	24	.	.	.
cord-005453-4057qib7	2595	1	Mixed	mixed	JJ
cord-005453-4057qib7	2595	2	evidence	evidence	NN
cord-005453-4057qib7	2595	3	suggests	suggest	VBZ
cord-005453-4057qib7	2595	4	depression	depression	NN
cord-005453-4057qib7	2595	5	may	may	MD
cord-005453-4057qib7	2595	6	be	be	VB
cord-005453-4057qib7	2595	7	a	a	DT
cord-005453-4057qib7	2595	8	risk	risk	NN
cord-005453-4057qib7	2595	9	factor	factor	NN
cord-005453-4057qib7	2595	10	for	for	IN
cord-005453-4057qib7	2595	11	greater	great	JJR
cord-005453-4057qib7	2595	12	mortality	mortality	NN
cord-005453-4057qib7	2595	13	and	and	CC
cord-005453-4057qib7	2595	14	worse	bad	JJR
cord-005453-4057qib7	2595	15	QoL.	QoL.	NNP
cord-005453-4057qib7	2595	16	Inconsistent	inconsistent	JJ
cord-005453-4057qib7	2595	17	findings	finding	NNS
cord-005453-4057qib7	2595	18	may	may	MD
cord-005453-4057qib7	2595	19	be	be	VB
cord-005453-4057qib7	2595	20	due	due	JJ
cord-005453-4057qib7	2595	21	to	to	IN
cord-005453-4057qib7	2595	22	the	the	DT
cord-005453-4057qib7	2595	23	fact	fact	NN
cord-005453-4057qib7	2595	24	that	that	IN
cord-005453-4057qib7	2595	25	previous	previous	JJ
cord-005453-4057qib7	2595	26	studies	study	NNS
cord-005453-4057qib7	2595	27	have	have	VBP
cord-005453-4057qib7	2595	28	not	not	RB
cord-005453-4057qib7	2595	29	evaluated	evaluate	VBN
cord-005453-4057qib7	2595	30	antidepressant	antidepressant	JJ
cord-005453-4057qib7	2595	31	use	use	NN
cord-005453-4057qib7	2595	32	.	.	.
cord-005453-4057qib7	2596	1	The	the	DT
cord-005453-4057qib7	2596	2	aim	aim	NN
cord-005453-4057qib7	2596	3	of	of	IN
cord-005453-4057qib7	2596	4	the	the	DT
cord-005453-4057qib7	2596	5	study	study	NN
cord-005453-4057qib7	2596	6	was	be	VBD
cord-005453-4057qib7	2596	7	to	to	TO
cord-005453-4057qib7	2596	8	compare	compare	VB
cord-005453-4057qib7	2596	9	pre	pre	JJ
cord-005453-4057qib7	2596	10	-	-	JJ
cord-005453-4057qib7	2596	11	transplant	transplant	JJ
cord-005453-4057qib7	2596	12	patientreported	patientreporte	VBN
cord-005453-4057qib7	2596	13	physical	physical	JJ
cord-005453-4057qib7	2596	14	functioning	functioning	NN
cord-005453-4057qib7	2596	15	and	and	CC
cord-005453-4057qib7	2596	16	post	post	JJ
cord-005453-4057qib7	2596	17	-	-	JJ
cord-005453-4057qib7	2596	18	transplant	transplant	JJ
cord-005453-4057qib7	2596	19	overall	overall	JJ
cord-005453-4057qib7	2596	20	survival	survival	NN
cord-005453-4057qib7	2596	21	(	(	-LRB-
cord-005453-4057qib7	2596	22	OS	OS	NNP
cord-005453-4057qib7	2596	23	)	)	-RRB-
cord-005453-4057qib7	2596	24	between	between	IN
cord-005453-4057qib7	2596	25	four	four	CD
cord-005453-4057qib7	2596	26	groups	group	NNS
cord-005453-4057qib7	2596	27	of	of	IN
cord-005453-4057qib7	2596	28	HCT	HCT	NNP
cord-005453-4057qib7	2596	29	recipients	recipient	NNS
cord-005453-4057qib7	2596	30	:	:	:
cord-005453-4057qib7	2596	31	1	1	LS
cord-005453-4057qib7	2596	32	)	)	-RRB-
cord-005453-4057qib7	2596	33	non	non	JJ
cord-005453-4057qib7	2596	34	-	-	JJ
cord-005453-4057qib7	2596	35	depressed	depressed	JJ
cord-005453-4057qib7	2596	36	/	/	SYM
cord-005453-4057qib7	2596	37	taking	take	VBG
cord-005453-4057qib7	2596	38	antidepressant	antidepressant	JJ
cord-005453-4057qib7	2596	39	(	(	-LRB-
cord-005453-4057qib7	2596	40	treated	treat	VBN
cord-005453-4057qib7	2596	41	depression	depression	NN
cord-005453-4057qib7	2596	42	)	)	-RRB-
cord-005453-4057qib7	2596	43	,	,	,
cord-005453-4057qib7	2596	44	2	2	CD
cord-005453-4057qib7	2596	45	)	)	-RRB-
cord-005453-4057qib7	2597	1	depressed	depressed	JJ
cord-005453-4057qib7	2597	2	/	/	SYM
cord-005453-4057qib7	2597	3	taking	take	VBG
cord-005453-4057qib7	2597	4	antidepressant	antidepressant	JJ
cord-005453-4057qib7	2597	5	(	(	-LRB-
cord-005453-4057qib7	2597	6	undertreated	undertreated	JJ
cord-005453-4057qib7	2597	7	depression	depression	NN
cord-005453-4057qib7	2597	8	)	)	-RRB-
cord-005453-4057qib7	2597	9	,	,	.
cord-005453-4057qib7	2598	1	3	3	LS
cord-005453-4057qib7	2598	2	)	)	-RRB-
cord-005453-4057qib7	2598	3	depressed	depressed	JJ
cord-005453-4057qib7	2598	4	/	/	,
cord-005453-4057qib7	2598	5	not	not	RB
cord-005453-4057qib7	2598	6	taking	take	VBG
cord-005453-4057qib7	2598	7	an	an	DT
cord-005453-4057qib7	2598	8	antidepressant	antidepressant	NN
cord-005453-4057qib7	2598	9	(	(	-LRB-
cord-005453-4057qib7	2598	10	untreated	untreated	JJ
cord-005453-4057qib7	2598	11	depression	depression	NN
cord-005453-4057qib7	2598	12	)	)	-RRB-
cord-005453-4057qib7	2598	13	,	,	,
cord-005453-4057qib7	2598	14	and	and	CC
cord-005453-4057qib7	2598	15	4	4	LS
cord-005453-4057qib7	2598	16	)	)	-RRB-
cord-005453-4057qib7	2598	17	not	not	RB
cord-005453-4057qib7	2598	18	depressed	depressed	JJ
cord-005453-4057qib7	2598	19	/	/	SYM
cord-005453-4057qib7	2598	20	not	not	RB
cord-005453-4057qib7	2598	21	taking	take	VBG
cord-005453-4057qib7	2598	22	an	an	DT
cord-005453-4057qib7	2598	23	antidepressant	antidepressant	NN
cord-005453-4057qib7	2598	24	(	(	-LRB-
cord-005453-4057qib7	2598	25	control	control	NN
cord-005453-4057qib7	2598	26	)	)	-RRB-
cord-005453-4057qib7	2598	27	.	.	.
cord-005453-4057qib7	2599	1	It	-PRON-	PRP
cord-005453-4057qib7	2599	2	was	be	VBD
cord-005453-4057qib7	2599	3	hypothesized	hypothesize	VBN
cord-005453-4057qib7	2599	4	that	that	IN
cord-005453-4057qib7	2599	5	physical	physical	JJ
cord-005453-4057qib7	2599	6	functioning	functioning	NN
cord-005453-4057qib7	2599	7	and	and	CC
cord-005453-4057qib7	2599	8	OS	OS	NNP
cord-005453-4057qib7	2599	9	would	would	MD
cord-005453-4057qib7	2599	10	be	be	VB
cord-005453-4057qib7	2599	11	worse	bad	JJR
cord-005453-4057qib7	2599	12	among	among	IN
cord-005453-4057qib7	2599	13	patients	patient	NNS
cord-005453-4057qib7	2599	14	with	with	IN
cord-005453-4057qib7	2599	15	untreated	untreated	JJ
cord-005453-4057qib7	2599	16	and	and	CC
cord-005453-4057qib7	2599	17	undertreated	undertreated	JJ
cord-005453-4057qib7	2599	18	depression	depression	NN
cord-005453-4057qib7	2599	19	relative	relative	JJ
cord-005453-4057qib7	2599	20	to	to	IN
cord-005453-4057qib7	2599	21	those	those	DT
cord-005453-4057qib7	2599	22	with	with	IN
cord-005453-4057qib7	2599	23	treated	treat	VBN
cord-005453-4057qib7	2599	24	depression	depression	NN
cord-005453-4057qib7	2599	25	and	and	CC
cord-005453-4057qib7	2599	26	controls	control	NNS
cord-005453-4057qib7	2599	27	.	.	.
cord-005453-4057qib7	2600	1	Methods	method	NNS
cord-005453-4057qib7	2600	2	:	:	:
cord-005453-4057qib7	2601	1	This	this	DT
cord-005453-4057qib7	2601	2	retrospective	retrospective	JJ
cord-005453-4057qib7	2601	3	case	case	NN
cord-005453-4057qib7	2601	4	-	-	HYPH
cord-005453-4057qib7	2601	5	control	control	NN
cord-005453-4057qib7	2601	6	study	study	NN
cord-005453-4057qib7	2601	7	included	include	VBD
cord-005453-4057qib7	2601	8	patients	patient	NNS
cord-005453-4057qib7	2601	9	completing	complete	VBG
cord-005453-4057qib7	2601	10	depression	depression	NN
cord-005453-4057qib7	2601	11	(	(	-LRB-
cord-005453-4057qib7	2601	12	PHQ-8	PHQ-8	NNP
cord-005453-4057qib7	2601	13	)	)	-RRB-
cord-005453-4057qib7	2601	14	and	and	CC
cord-005453-4057qib7	2601	15	quality	quality	NN
cord-005453-4057qib7	2601	16	of	of	IN
cord-005453-4057qib7	2601	17	life	life	NN
cord-005453-4057qib7	2601	18	(	(	-LRB-
cord-005453-4057qib7	2601	19	SF-12	SF-12	NNP
cord-005453-4057qib7	2601	20	)	)	-RRB-
cord-005453-4057qib7	2601	21	questionnaires	questionnaire	VBZ
cord-005453-4057qib7	2601	22	at	at	IN
cord-005453-4057qib7	2601	23	pre	pre	NN
cord-005453-4057qib7	2601	24	-	-	NN
cord-005453-4057qib7	2601	25	transplant	transplant	NN
cord-005453-4057qib7	2601	26	.	.	.
cord-005453-4057qib7	2602	1	Analyses	analysis	NNS
cord-005453-4057qib7	2602	2	were	be	VBD
cord-005453-4057qib7	2602	3	conducted	conduct	VBN
cord-005453-4057qib7	2602	4	separately	separately	RB
cord-005453-4057qib7	2602	5	for	for	IN
cord-005453-4057qib7	2602	6	allogeneic	allogeneic	NN
cord-005453-4057qib7	2602	7	and	and	CC
cord-005453-4057qib7	2602	8	autologous	autologous	JJ
cord-005453-4057qib7	2602	9	recipients	recipient	NNS
cord-005453-4057qib7	2602	10	.	.	.
cord-005453-4057qib7	2603	1	Results	result	NNS
cord-005453-4057qib7	2603	2	:	:	:
cord-005453-4057qib7	2604	1	Participants	participant	NNS
cord-005453-4057qib7	2604	2	(	(	-LRB-
cord-005453-4057qib7	2604	3	N=1,797	N=1,797	NNP
cord-005453-4057qib7	2604	4	)	)	-RRB-
cord-005453-4057qib7	2604	5	were	be	VBD
cord-005453-4057qib7	2604	6	58	58	CD
cord-005453-4057qib7	2604	7	%	%	NN
cord-005453-4057qib7	2604	8	men	man	NNS
cord-005453-4057qib7	2604	9	,	,	,
cord-005453-4057qib7	2604	10	mean	mean	VB
cord-005453-4057qib7	2604	11	age	age	NN
cord-005453-4057qib7	2604	12	57	57	CD
cord-005453-4057qib7	2604	13	years	year	NNS
cord-005453-4057qib7	2604	14	(	(	-LRB-
cord-005453-4057qib7	2604	15	19	19	CD
cord-005453-4057qib7	2604	16	-	-	SYM
cord-005453-4057qib7	2604	17	79	79	CD
cord-005453-4057qib7	2604	18	)	)	-RRB-
cord-005453-4057qib7	2604	19	,	,	,
cord-005453-4057qib7	2604	20	39	39	CD
cord-005453-4057qib7	2604	21	%	%	NN
cord-005453-4057qib7	2604	22	allogeneic	allogeneic	IN
cord-005453-4057qib7	2604	23	recipients	recipient	NNS
cord-005453-4057qib7	2604	24	.	.	.
cord-005453-4057qib7	2605	1	Regarding	regard	VBG
cord-005453-4057qib7	2605	2	depression	depression	NN
cord-005453-4057qib7	2605	3	and	and	CC
cord-005453-4057qib7	2605	4	antidepressant	antidepressant	JJ
cord-005453-4057qib7	2605	5	use	use	NN
cord-005453-4057qib7	2605	6	,	,	,
cord-005453-4057qib7	2605	7	146	146	CD
cord-005453-4057qib7	2605	8	(	(	-LRB-
cord-005453-4057qib7	2605	9	21	21	CD
cord-005453-4057qib7	2605	10	%	%	NN
cord-005453-4057qib7	2605	11	)	)	-RRB-
cord-005453-4057qib7	2605	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	2605	13	patients	patient	NNS
cord-005453-4057qib7	2605	14	were	be	VBD
cord-005453-4057qib7	2605	15	characterized	characterize	VBN
cord-005453-4057qib7	2605	16	as	as	IN
cord-005453-4057qib7	2605	17	having	have	VBG
cord-005453-4057qib7	2605	18	treated	treat	VBN
cord-005453-4057qib7	2605	19	depression	depression	NN
cord-005453-4057qib7	2605	20	,	,	,
cord-005453-4057qib7	2605	21	47	47	CD
cord-005453-4057qib7	2605	22	(	(	-LRB-
cord-005453-4057qib7	2605	23	7	7	CD
cord-005453-4057qib7	2605	24	%	%	NN
cord-005453-4057qib7	2605	25	)	)	-RRB-
cord-005453-4057qib7	2605	26	as	as	IN
cord-005453-4057qib7	2605	27	untreated	untreated	JJ
cord-005453-4057qib7	2605	28	depression	depression	NN
cord-005453-4057qib7	2605	29	,	,	,
cord-005453-4057qib7	2605	30	49	49	CD
cord-005453-4057qib7	2605	31	(	(	-LRB-
cord-005453-4057qib7	2605	32	7	7	CD
cord-005453-4057qib7	2605	33	%	%	NN
cord-005453-4057qib7	2605	34	)	)	-RRB-
cord-005453-4057qib7	2605	35	as	as	IN
cord-005453-4057qib7	2605	36	undertreated	undertreated	JJ
cord-005453-4057qib7	2605	37	depression	depression	NN
cord-005453-4057qib7	2605	38	,	,	,
cord-005453-4057qib7	2605	39	and	and	CC
cord-005453-4057qib7	2605	40	461	461	CD
cord-005453-4057qib7	2605	41	(	(	-LRB-
cord-005453-4057qib7	2605	42	65	65	CD
cord-005453-4057qib7	2605	43	%	%	NN
cord-005453-4057qib7	2605	44	)	)	-RRB-
cord-005453-4057qib7	2605	45	as	as	IN
cord-005453-4057qib7	2605	46	controls	control	NNS
cord-005453-4057qib7	2605	47	.	.	.
cord-005453-4057qib7	2606	1	Hierarchical	hierarchical	JJ
cord-005453-4057qib7	2606	2	linear	linear	JJ
cord-005453-4057qib7	2606	3	regression	regression	NN
cord-005453-4057qib7	2606	4	models	model	NNS
cord-005453-4057qib7	2606	5	indicated	indicate	VBD
cord-005453-4057qib7	2606	6	that	that	IN
cord-005453-4057qib7	2606	7	after	after	IN
cord-005453-4057qib7	2606	8	adjusting	adjust	VBG
cord-005453-4057qib7	2606	9	for	for	IN
cord-005453-4057qib7	2606	10	significant	significant	JJ
cord-005453-4057qib7	2606	11	univariate	univariate	JJ
cord-005453-4057qib7	2606	12	factors	factor	NNS
cord-005453-4057qib7	2606	13	(	(	-LRB-
cord-005453-4057qib7	2606	14	performance	performance	NN
cord-005453-4057qib7	2606	15	status	status	NN
cord-005453-4057qib7	2606	16	,	,	,
cord-005453-4057qib7	2606	17	disease	disease	NN
cord-005453-4057qib7	2606	18	status	status	NN
cord-005453-4057qib7	2606	19	,	,	,
cord-005453-4057qib7	2606	20	and	and	CC
cord-005453-4057qib7	2606	21	regimen	regimen	NN
cord-005453-4057qib7	2606	22	intensity	intensity	NN
cord-005453-4057qib7	2606	23	)	)	-RRB-
cord-005453-4057qib7	2606	24	,	,	,
cord-005453-4057qib7	2606	25	allogeneic	allogeneic	IN
cord-005453-4057qib7	2606	26	patients	patient	NNS
cord-005453-4057qib7	2606	27	with	with	IN
cord-005453-4057qib7	2606	28	treated	treat	VBN
cord-005453-4057qib7	2606	29	depression	depression	NN
cord-005453-4057qib7	2606	30	(	(	-LRB-
cord-005453-4057qib7	2606	31	B=-2.58	B=-2.58	NNP
cord-005453-4057qib7	2606	32	,	,	,
cord-005453-4057qib7	2606	33	95	95	CD
cord-005453-4057qib7	2606	34	%	%	NN
cord-005453-4057qib7	2606	35	CI=-4.63	ci=-4.63	NN
cord-005453-4057qib7	2606	36	,	,	,
cord-005453-4057qib7	2606	37	-0.54	-0.54	CD
cord-005453-4057qib7	2606	38	)	)	-RRB-
cord-005453-4057qib7	2606	39	reported	report	VBD
cord-005453-4057qib7	2606	40	better	well	JJR
cord-005453-4057qib7	2606	41	physical	physical	JJ
cord-005453-4057qib7	2606	42	functioning	functioning	NN
cord-005453-4057qib7	2606	43	than	than	IN
cord-005453-4057qib7	2606	44	patients	patient	NNS
cord-005453-4057qib7	2606	45	with	with	IN
cord-005453-4057qib7	2606	46	undertreated	undertreated	JJ
cord-005453-4057qib7	2606	47	depression	depression	NN
cord-005453-4057qib7	2606	48	(	(	-LRB-
cord-005453-4057qib7	2606	49	B=-6.06	B=-6.06	NNP
cord-005453-4057qib7	2606	50	,	,	,
cord-005453-4057qib7	2606	51	95	95	CD
cord-005453-4057qib7	2606	52	%	%	NN
cord-005453-4057qib7	2606	53	CI=-9.43	CI=-9.43	NNS
cord-005453-4057qib7	2606	54	,	,	,
cord-005453-4057qib7	2606	55	-2.70	-2.70	CD
cord-005453-4057qib7	2606	56	)	)	-RRB-
cord-005453-4057qib7	2606	57	and	and	CC
cord-005453-4057qib7	2606	58	untreated	untreated	JJ
cord-005453-4057qib7	2606	59	depression	depression	NN
cord-005453-4057qib7	2606	60	)	)	-RRB-
cord-005453-4057qib7	2606	61	but	but	CC
cord-005453-4057qib7	2606	62	worse	bad	JJR
cord-005453-4057qib7	2606	63	physical	physical	JJ
cord-005453-4057qib7	2606	64	functioning	functioning	NN
cord-005453-4057qib7	2606	65	than	than	IN
cord-005453-4057qib7	2606	66	controls	control	NNS
cord-005453-4057qib7	2606	67	(	(	-LRB-
cord-005453-4057qib7	2606	68	p	p	IN
cord-005453-4057qib7	2606	69	values	value	VBZ
cord-005453-4057qib7	2606	70	<	<	XX
cord-005453-4057qib7	2606	71	0.05	0.05	CD
cord-005453-4057qib7	2606	72	)	)	-RRB-
cord-005453-4057qib7	2606	73	.	.	.
cord-005453-4057qib7	2607	1	Cox	Cox	NNP
cord-005453-4057qib7	2607	2	regression	regression	NN
cord-005453-4057qib7	2607	3	models	model	NNS
cord-005453-4057qib7	2607	4	indicated	indicate	VBD
cord-005453-4057qib7	2607	5	depression	depression	NN
cord-005453-4057qib7	2607	6	/	/	SYM
cord-005453-4057qib7	2607	7	antidepressant	antidepressant	NN
cord-005453-4057qib7	2607	8	usage	usage	NN
cord-005453-4057qib7	2607	9	was	be	VBD
cord-005453-4057qib7	2607	10	not	not	RB
cord-005453-4057qib7	2607	11	associated	associate	VBN
cord-005453-4057qib7	2607	12	with	with	IN
cord-005453-4057qib7	2607	13	OS	OS	NNP
cord-005453-4057qib7	2607	14	among	among	IN
cord-005453-4057qib7	2607	15	allogeneic	allogeneic	NN
cord-005453-4057qib7	2607	16	patients	patient	NNS
cord-005453-4057qib7	2607	17	(	(	-LRB-
cord-005453-4057qib7	2608	1	p	p	LS
cord-005453-4057qib7	2608	2	values>0.10).Among	values>0.10).among	NN
cord-005453-4057qib7	2608	3	autologous	autologous	JJ
cord-005453-4057qib7	2608	4	patients	patient	NNS
cord-005453-4057qib7	2608	5	,	,	,
cord-005453-4057qib7	2608	6	195	195	CD
cord-005453-4057qib7	2608	7	(	(	-LRB-
cord-005453-4057qib7	2608	8	17.82	17.82	CD
cord-005453-4057qib7	2608	9	%	%	NN
cord-005453-4057qib7	2608	10	)	)	-RRB-
cord-005453-4057qib7	2608	11	were	be	VBD
cord-005453-4057qib7	2608	12	characterized	characterize	VBN
cord-005453-4057qib7	2608	13	as	as	IN
cord-005453-4057qib7	2608	14	having	have	VBG
cord-005453-4057qib7	2608	15	treated	treat	VBN
cord-005453-4057qib7	2608	16	depression	depression	NN
cord-005453-4057qib7	2608	17	,	,	,
cord-005453-4057qib7	2608	18	83	83	CD
cord-005453-4057qib7	2608	19	(	(	-LRB-
cord-005453-4057qib7	2608	20	7.59	7.59	CD
cord-005453-4057qib7	2608	21	%	%	NN
cord-005453-4057qib7	2608	22	)	)	-RRB-
cord-005453-4057qib7	2608	23	as	as	IN
cord-005453-4057qib7	2608	24	untreated	untreated	JJ
cord-005453-4057qib7	2608	25	depression	depression	NN
cord-005453-4057qib7	2608	26	,	,	,
cord-005453-4057qib7	2608	27	77	77	CD
cord-005453-4057qib7	2608	28	(	(	-LRB-
cord-005453-4057qib7	2608	29	7.04	7.04	CD
cord-005453-4057qib7	2608	30	%	%	NN
cord-005453-4057qib7	2608	31	)	)	-RRB-
cord-005453-4057qib7	2608	32	as	as	IN
cord-005453-4057qib7	2608	33	undertreated	undertreated	JJ
cord-005453-4057qib7	2608	34	depression	depression	NN
cord-005453-4057qib7	2608	35	,	,	,
cord-005453-4057qib7	2608	36	and	and	CC
cord-005453-4057qib7	2608	37	739	739	CD
cord-005453-4057qib7	2608	38	(	(	-LRB-
cord-005453-4057qib7	2608	39	67.55	67.55	CD
cord-005453-4057qib7	2608	40	%	%	NN
cord-005453-4057qib7	2608	41	)	)	-RRB-
cord-005453-4057qib7	2608	42	as	as	IN
cord-005453-4057qib7	2608	43	controls	control	NNS
cord-005453-4057qib7	2608	44	.	.	.
cord-005453-4057qib7	2609	1	Hierarchical	hierarchical	JJ
cord-005453-4057qib7	2609	2	linear	linear	JJ
cord-005453-4057qib7	2609	3	regression	regression	NN
cord-005453-4057qib7	2609	4	models	model	NNS
cord-005453-4057qib7	2609	5	indicated	indicate	VBD
cord-005453-4057qib7	2609	6	that	that	IN
cord-005453-4057qib7	2609	7	after	after	IN
cord-005453-4057qib7	2609	8	controlling	control	VBG
cord-005453-4057qib7	2609	9	for	for	IN
cord-005453-4057qib7	2609	10	significant	significant	JJ
cord-005453-4057qib7	2609	11	univariate	univariate	JJ
cord-005453-4057qib7	2609	12	factors	factor	NNS
cord-005453-4057qib7	2609	13	(	(	-LRB-
cord-005453-4057qib7	2609	14	gender	gender	NN
cord-005453-4057qib7	2609	15	,	,	,
cord-005453-4057qib7	2609	16	performance	performance	NN
cord-005453-4057qib7	2609	17	status	status	NN
cord-005453-4057qib7	2609	18	,	,	,
cord-005453-4057qib7	2609	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	2609	20	,	,	,
cord-005453-4057qib7	2609	21	and	and	CC
cord-005453-4057qib7	2609	22	disease	disease	NN
cord-005453-4057qib7	2609	23	status	status	NN
cord-005453-4057qib7	2609	24	)	)	-RRB-
cord-005453-4057qib7	2609	25	,	,	,
cord-005453-4057qib7	2609	26	autologous	autologous	JJ
cord-005453-4057qib7	2609	27	patients	patient	NNS
cord-005453-4057qib7	2609	28	with	with	IN
cord-005453-4057qib7	2609	29	treated	treat	VBN
cord-005453-4057qib7	2609	30	depression	depression	NN
cord-005453-4057qib7	2609	31	(	(	-LRB-
cord-005453-4057qib7	2609	32	B=-2.97	B=-2.97	NNP
cord-005453-4057qib7	2609	33	,	,	,
cord-005453-4057qib7	2609	34	95	95	CD
cord-005453-4057qib7	2609	35	%	%	NN
cord-005453-4057qib7	2609	36	CI=-4.71	CI=-4.71	NNS
cord-005453-4057qib7	2609	37	,	,	,
cord-005453-4057qib7	2609	38	-1.23	-1.23	CD
cord-005453-4057qib7	2609	39	)	)	-RRB-
cord-005453-4057qib7	2609	40	reported	report	VBD
cord-005453-4057qib7	2609	41	better	well	JJR
cord-005453-4057qib7	2609	42	physical	physical	JJ
cord-005453-4057qib7	2609	43	functioning	functioning	NN
cord-005453-4057qib7	2609	44	than	than	IN
cord-005453-4057qib7	2609	45	patients	patient	NNS
cord-005453-4057qib7	2609	46	with	with	IN
cord-005453-4057qib7	2609	47	undertreated	undertreated	JJ
cord-005453-4057qib7	2609	48	depression	depression	NN
cord-005453-4057qib7	2609	49	(	(	-LRB-
cord-005453-4057qib7	2609	50	B=-8.63	B=-8.63	NNP
cord-005453-4057qib7	2609	51	,	,	,
cord-005453-4057qib7	2609	52	95	95	CD
cord-005453-4057qib7	2609	53	%	%	NN
cord-005453-4057qib7	2609	54	CI=-11.23	CI=-11.23	NNP
cord-005453-4057qib7	2609	55	,	,	,
cord-005453-4057qib7	2609	56	-6.03	-6.03	CD
cord-005453-4057qib7	2609	57	)	)	-RRB-
cord-005453-4057qib7	2609	58	and	and	CC
cord-005453-4057qib7	2609	59	untreated	untreated	JJ
cord-005453-4057qib7	2609	60	depression	depression	NN
cord-005453-4057qib7	2609	61	(	(	-LRB-
cord-005453-4057qib7	2609	62	B=-8.62	B=-8.62	NNP
cord-005453-4057qib7	2609	63	,	,	,
cord-005453-4057qib7	2609	64	95	95	CD
cord-005453-4057qib7	2609	65	%	%	NN
cord-005453-4057qib7	2609	66	CI=11.15	CI=11.15	NNP
cord-005453-4057qib7	2609	67	,	,	,
cord-005453-4057qib7	2609	68	-6.08	-6.08	CD
cord-005453-4057qib7	2609	69	)	)	-RRB-
cord-005453-4057qib7	2609	70	,	,	,
cord-005453-4057qib7	2609	71	but	but	CC
cord-005453-4057qib7	2609	72	worse	bad	JJR
cord-005453-4057qib7	2609	73	physical	physical	JJ
cord-005453-4057qib7	2609	74	functioning	functioning	NN
cord-005453-4057qib7	2609	75	than	than	IN
cord-005453-4057qib7	2609	76	controls	control	NNS
cord-005453-4057qib7	2609	77	(	(	-LRB-
cord-005453-4057qib7	2609	78	p	p	IN
cord-005453-4057qib7	2609	79	values	value	VBZ
cord-005453-4057qib7	2609	80	<	<	XX
cord-005453-4057qib7	2609	81	0.05	0.05	CD
cord-005453-4057qib7	2609	82	)	)	-RRB-
cord-005453-4057qib7	2609	83	.	.	.
cord-005453-4057qib7	2610	1	Cox	Cox	NNP
cord-005453-4057qib7	2610	2	regression	regression	NN
cord-005453-4057qib7	2610	3	models	model	NNS
cord-005453-4057qib7	2610	4	showed	show	VBD
cord-005453-4057qib7	2610	5	depression	depression	NN
cord-005453-4057qib7	2610	6	/	/	SYM
cord-005453-4057qib7	2610	7	antidepressant	antidepressant	NN
cord-005453-4057qib7	2610	8	usage	usage	NN
cord-005453-4057qib7	2610	9	was	be	VBD
cord-005453-4057qib7	2610	10	associated	associate	VBN
cord-005453-4057qib7	2610	11	with	with	IN
cord-005453-4057qib7	2610	12	OS	OS	NNP
cord-005453-4057qib7	2610	13	(	(	-LRB-
cord-005453-4057qib7	2610	14	p	p	IN
cord-005453-4057qib7	2610	15	values	value	NNS
cord-005453-4057qib7	2610	16	<	<	XX
cord-005453-4057qib7	2610	17	0.05	0.05	CD
cord-005453-4057qib7	2610	18	)	)	-RRB-
cord-005453-4057qib7	2610	19	,	,	,
cord-005453-4057qib7	2610	20	with	with	IN
cord-005453-4057qib7	2610	21	patients	patient	NNS
cord-005453-4057qib7	2610	22	with	with	IN
cord-005453-4057qib7	2610	23	treated	treat	VBN
cord-005453-4057qib7	2610	24	depression	depression	NN
cord-005453-4057qib7	2610	25	demonstrating	demonstrate	VBG
cord-005453-4057qib7	2610	26	significantly	significantly	RB
cord-005453-4057qib7	2610	27	worse	bad	JJR
cord-005453-4057qib7	2610	28	OS	os	NN
cord-005453-4057qib7	2610	29	than	than	IN
cord-005453-4057qib7	2610	30	other	other	JJ
cord-005453-4057qib7	2610	31	groups	group	NNS
cord-005453-4057qib7	2610	32	(	(	-LRB-
cord-005453-4057qib7	2610	33	p=0.05	p=0.05	JJ
cord-005453-4057qib7	2610	34	)	)	-RRB-
cord-005453-4057qib7	2610	35	,	,	,
cord-005453-4057qib7	2610	36	but	but	CC
cord-005453-4057qib7	2610	37	this	this	DT
cord-005453-4057qib7	2610	38	association	association	NN
cord-005453-4057qib7	2610	39	was	be	VBD
cord-005453-4057qib7	2610	40	no	no	RB
cord-005453-4057qib7	2610	41	longer	long	RBR
cord-005453-4057qib7	2610	42	significant	significant	JJ
cord-005453-4057qib7	2610	43	in	in	IN
cord-005453-4057qib7	2610	44	multivariate	multivariate	JJ
cord-005453-4057qib7	2610	45	analyses	analysis	NNS
cord-005453-4057qib7	2610	46	controlling	control	VBG
cord-005453-4057qib7	2610	47	for	for	IN
cord-005453-4057qib7	2610	48	diagnosis	diagnosis	NN
cord-005453-4057qib7	2610	49	and	and	CC
cord-005453-4057qib7	2610	50	disease	disease	NN
cord-005453-4057qib7	2610	51	status	status	NN
cord-005453-4057qib7	2610	52	(	(	-LRB-
cord-005453-4057qib7	2610	53	p=0.09	p=0.09	NN
cord-005453-4057qib7	2610	54	)	)	-RRB-
cord-005453-4057qib7	2610	55	.	.	.
cord-005453-4057qib7	2611	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2611	2	:	:	:
cord-005453-4057qib7	2612	1	Patients	patient	NNS
cord-005453-4057qib7	2612	2	with	with	IN
cord-005453-4057qib7	2612	3	untreated	untreated	JJ
cord-005453-4057qib7	2612	4	or	or	CC
cord-005453-4057qib7	2612	5	undertreated	undertreated	JJ
cord-005453-4057qib7	2612	6	depression	depression	NN
cord-005453-4057qib7	2612	7	pre	pre	JJ
cord-005453-4057qib7	2612	8	-	-	NN
cord-005453-4057qib7	2612	9	transplant	transplant	NN
cord-005453-4057qib7	2612	10	may	may	MD
cord-005453-4057qib7	2612	11	benefit	benefit	VB
cord-005453-4057qib7	2612	12	from	from	IN
cord-005453-4057qib7	2612	13	depression	depression	NN
cord-005453-4057qib7	2612	14	screening	screening	NN
cord-005453-4057qib7	2612	15	and	and	CC
cord-005453-4057qib7	2612	16	treatment	treatment	NN
cord-005453-4057qib7	2612	17	to	to	TO
cord-005453-4057qib7	2612	18	improve	improve	VB
cord-005453-4057qib7	2612	19	physical	physical	JJ
cord-005453-4057qib7	2612	20	functioning	functioning	NN
cord-005453-4057qib7	2612	21	.	.	.
cord-005453-4057qib7	2613	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2613	2	:	:	:
cord-005453-4057qib7	2613	3	HSLJ	HSLJ	NNP
cord-005453-4057qib7	2613	4	:	:	:
cord-005453-4057qib7	2614	1	Consultant	consultant	NN
cord-005453-4057qib7	2614	2	for	for	IN
cord-005453-4057qib7	2614	3	RedHill	RedHill	NNP
cord-005453-4057qib7	2614	4	Biopharma	Biopharma	NNP
cord-005453-4057qib7	2614	5	and	and	CC
cord-005453-4057qib7	2614	6	Janssen	Janssen	NNP
cord-005453-4057qib7	2614	7	Scientific	Scientific	NNP
cord-005453-4057qib7	2614	8	Affairs	Affairs	NNPS
cord-005453-4057qib7	2614	9	P133	P133	NNP
cord-005453-4057qib7	2614	10	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	2614	11	(	(	-LRB-
cord-005453-4057qib7	2614	12	EPAG	EPAG	NNP
cord-005453-4057qib7	2614	13	)	)	-RRB-
cord-005453-4057qib7	2614	14	induces	induce	VBZ
cord-005453-4057qib7	2614	15	a	a	DT
cord-005453-4057qib7	2614	16	high	high	JJ
cord-005453-4057qib7	2614	17	percentage	percentage	NN
cord-005453-4057qib7	2614	18	of	of	IN
cord-005453-4057qib7	2614	19	responses	response	NNS
cord-005453-4057qib7	2614	20	in	in	IN
cord-005453-4057qib7	2614	21	patients	patient	NNS
cord-005453-4057qib7	2614	22	WITH	with	IN
cord-005453-4057qib7	2614	23	post	post	FW
cord-005453-4057qib7	2614	24	allo	allo	FW
cord-005453-4057qib7	2614	25	-	-	HYPH
cord-005453-4057qib7	2614	26	HSCT	HSCT	NNP
cord-005453-4057qib7	2614	27	poor	poor	JJ
cord-005453-4057qib7	2614	28	graft	graft	NN
cord-005453-4057qib7	2614	29	function	function	NN
cord-005453-4057qib7	2614	30	(	(	-LRB-
cord-005453-4057qib7	2614	31	PGF	PGF	NNP
cord-005453-4057qib7	2614	32	)	)	-RRB-
cord-005453-4057qib7	2614	33	and	and	CC
cord-005453-4057qib7	2614	34	no	no	DT
cord-005453-4057qib7	2614	35	active	active	JJ
cord-005453-4057qib7	2614	36	GVHD	GVHD	NNP
cord-005453-4057qib7	2614	37	Lourdes	Lourdes	NNP
cord-005453-4057qib7	2614	38	Aguirre	Aguirre	NNP
cord-005453-4057qib7	2614	39	1	1	CD
cord-005453-4057qib7	2614	40	,	,	,
cord-005453-4057qib7	2614	41	Aitziber	Aitziber	NNP
cord-005453-4057qib7	2614	42	Lizardi	Lizardi	NNP
cord-005453-4057qib7	2614	43	1	1	CD
cord-005453-4057qib7	2614	44	,	,	,
cord-005453-4057qib7	2614	45	Pilar	Pilar	NNP
cord-005453-4057qib7	2614	46	Bachiller	Bachiller	NNP
cord-005453-4057qib7	2614	47	1	1	CD
cord-005453-4057qib7	2614	48	,	,	,
cord-005453-4057qib7	2614	49	Brigida	Brigida	NNP
cord-005453-4057qib7	2614	50	Esteban	Esteban	NNP
cord-005453-4057qib7	2614	51	1	1	CD
cord-005453-4057qib7	2614	52	,	,	,
cord-005453-4057qib7	2614	53	Carmen	Carmen	NNP
cord-005453-4057qib7	2614	54	González	González	NNP
cord-005453-4057qib7	2614	55	1	1	CD
cord-005453-4057qib7	2614	56	,	,	,
cord-005453-4057qib7	2614	57	Nagore	Nagore	NNP
cord-005453-4057qib7	2614	58	Argoitia	Argoitia	NNP
cord-005453-4057qib7	2614	59	1	1	CD
cord-005453-4057qib7	2614	60	,	,	,
cord-005453-4057qib7	2614	61	María	María	NNP
cord-005453-4057qib7	2614	62	Araiz	Araiz	NNP
cord-005453-4057qib7	2614	63	1	1	CD
cord-005453-4057qib7	2614	64	,	,	,
cord-005453-4057qib7	2614	65	Aranzazu	Aranzazu	NNP
cord-005453-4057qib7	2614	66	Aguirre	Aguirre	NNP
cord-005453-4057qib7	2614	67	1	1	CD
cord-005453-4057qib7	2614	68	,	,	,
cord-005453-4057qib7	2614	69	Anunciación	Anunciación	NNP
cord-005453-4057qib7	2614	70	Urquía	Urquía	NNP
cord-005453-4057qib7	2614	71	1	1	CD
cord-005453-4057qib7	2614	72	,	,	,
cord-005453-4057qib7	2614	73	Carlos	Carlos	NNP
cord-005453-4057qib7	2614	74	Vallejo	Vallejo	NNP
cord-005453-4057qib7	2614	75	1	1	CD
cord-005453-4057qib7	2614	76	Background	Background	NNP
cord-005453-4057qib7	2614	77	:	:	:
cord-005453-4057qib7	2615	1	Persistent	persistent	JJ
cord-005453-4057qib7	2615	2	cytopenia	cytopenia	NNP
cord-005453-4057qib7	2615	3	is	be	VBZ
cord-005453-4057qib7	2615	4	a	a	DT
cord-005453-4057qib7	2615	5	life	life	NN
cord-005453-4057qib7	2615	6	-	-	HYPH
cord-005453-4057qib7	2615	7	threating	threate	VBG
cord-005453-4057qib7	2615	8	complication	complication	NN
cord-005453-4057qib7	2615	9	after	after	IN
cord-005453-4057qib7	2615	10	HSCT	HSCT	NNP
cord-005453-4057qib7	2615	11	.	.	.
cord-005453-4057qib7	2616	1	Several	several	JJ
cord-005453-4057qib7	2616	2	causes	cause	NNS
cord-005453-4057qib7	2616	3	can	can	MD
cord-005453-4057qib7	2616	4	lead	lead	VB
cord-005453-4057qib7	2616	5	to	to	IN
cord-005453-4057qib7	2616	6	this	this	DT
cord-005453-4057qib7	2616	7	situation	situation	NN
cord-005453-4057qib7	2616	8	(	(	-LRB-
cord-005453-4057qib7	2616	9	viruses	virus	NNS
cord-005453-4057qib7	2616	10	,	,	,
cord-005453-4057qib7	2616	11	GVHD	GVHD	NNP
cord-005453-4057qib7	2616	12	,	,	,
cord-005453-4057qib7	2616	13	drugs	drug	NNS
cord-005453-4057qib7	2616	14	,	,	,
cord-005453-4057qib7	2616	15	etc	etc	FW
cord-005453-4057qib7	2616	16	)	)	-RRB-
cord-005453-4057qib7	2616	17	.	.	.
cord-005453-4057qib7	2617	1	A	a	DT
cord-005453-4057qib7	2617	2	specific	specific	JJ
cord-005453-4057qib7	2617	3	entity	entity	NN
cord-005453-4057qib7	2617	4	is	be	VBZ
cord-005453-4057qib7	2617	5	the	the	DT
cord-005453-4057qib7	2617	6	one	one	NN
cord-005453-4057qib7	2617	7	called	call	VBN
cord-005453-4057qib7	2617	8	"	"	``
cord-005453-4057qib7	2617	9	poor	poor	JJ
cord-005453-4057qib7	2617	10	graft	graft	NN
cord-005453-4057qib7	2617	11	function	function	NN
cord-005453-4057qib7	2617	12	(	(	-LRB-
cord-005453-4057qib7	2617	13	PGF	PGF	NNP
cord-005453-4057qib7	2617	14	)	)	-RRB-
cord-005453-4057qib7	2617	15	"	"	``
cord-005453-4057qib7	2617	16	,	,	,
cord-005453-4057qib7	2617	17	which	which	WDT
cord-005453-4057qib7	2617	18	is	be	VBZ
cord-005453-4057qib7	2617	19	diagnosed	diagnose	VBN
cord-005453-4057qib7	2617	20	in	in	IN
cord-005453-4057qib7	2617	21	pts	pts	NN
cord-005453-4057qib7	2617	22	with	with	IN
cord-005453-4057qib7	2617	23	≥2	≥2	NNP
cord-005453-4057qib7	2617	24	cytopenias	cytopenias	NNP
cord-005453-4057qib7	2617	25	after	after	IN
cord-005453-4057qib7	2617	26	day	day	NN
cord-005453-4057qib7	2617	27	+30	+30	CD
cord-005453-4057qib7	2617	28	,	,	,
cord-005453-4057qib7	2617	29	in	in	IN
cord-005453-4057qib7	2617	30	the	the	DT
cord-005453-4057qib7	2617	31	presence	presence	NN
cord-005453-4057qib7	2617	32	of	of	IN
cord-005453-4057qib7	2617	33	donor	donor	NN
cord-005453-4057qib7	2617	34	chimerism	chimerism	NN
cord-005453-4057qib7	2617	35	and	and	CC
cord-005453-4057qib7	2617	36	the	the	DT
cord-005453-4057qib7	2617	37	absence	absence	NN
cord-005453-4057qib7	2617	38	of	of	IN
cord-005453-4057qib7	2617	39	GVHD	GVHD	NNP
cord-005453-4057qib7	2617	40	or	or	CC
cord-005453-4057qib7	2617	41	relapse	relapse	NN
cord-005453-4057qib7	2617	42	.	.	.
cord-005453-4057qib7	2618	1	PGF	PGF	NNP
cord-005453-4057qib7	2618	2	is	be	VBZ
cord-005453-4057qib7	2618	3	more	more	RBR
cord-005453-4057qib7	2618	4	frequent	frequent	JJ
cord-005453-4057qib7	2618	5	after	after	IN
cord-005453-4057qib7	2618	6	alternative	alternative	JJ
cord-005453-4057qib7	2618	7	allo	allo	NN
cord-005453-4057qib7	2618	8	-	-	HYPH
cord-005453-4057qib7	2618	9	HSCTs	hsct	NNS
cord-005453-4057qib7	2618	10	,	,	,
cord-005453-4057qib7	2618	11	such	such	PDT
cord-005453-4057qib7	2618	12	a	a	DT
cord-005453-4057qib7	2618	13	haplo	haplo	NN
cord-005453-4057qib7	2618	14	-	-	HYPH
cord-005453-4057qib7	2618	15	identical	identical	JJ
cord-005453-4057qib7	2618	16	,	,	,
cord-005453-4057qib7	2618	17	mismatched	mismatched	JJ
cord-005453-4057qib7	2618	18	,	,	,
cord-005453-4057qib7	2618	19	or	or	CC
cord-005453-4057qib7	2618	20	UCB	UCB	NNP
cord-005453-4057qib7	2618	21	.	.	.
cord-005453-4057qib7	2619	1	Several	several	JJ
cord-005453-4057qib7	2619	2	therapeutic	therapeutic	JJ
cord-005453-4057qib7	2619	3	approaches	approach	NNS
cord-005453-4057qib7	2619	4	for	for	IN
cord-005453-4057qib7	2619	5	PGF	PGF	NNP
cord-005453-4057qib7	2619	6	,	,	,
cord-005453-4057qib7	2619	7	with	with	IN
cord-005453-4057qib7	2619	8	poor	poor	JJ
cord-005453-4057qib7	2619	9	results	result	NNS
cord-005453-4057qib7	2619	10	,	,	,
cord-005453-4057qib7	2619	11	have	have	VBP
cord-005453-4057qib7	2619	12	been	be	VBN
cord-005453-4057qib7	2619	13	tested	test	VBN
cord-005453-4057qib7	2619	14	.	.	.
cord-005453-4057qib7	2620	1	Recently	recently	RB
cord-005453-4057qib7	2620	2	,	,	,
cord-005453-4057qib7	2620	3	EPAG	EPAG	NNP
cord-005453-4057qib7	2620	4	has	have	VBZ
cord-005453-4057qib7	2620	5	been	be	VBN
cord-005453-4057qib7	2620	6	shown	show	VBN
cord-005453-4057qib7	2620	7	to	to	TO
cord-005453-4057qib7	2620	8	improve	improve	VB
cord-005453-4057qib7	2620	9	platelet	platelet	NN
cord-005453-4057qib7	2620	10	counts	count	NNS
cord-005453-4057qib7	2620	11	in	in	IN
cord-005453-4057qib7	2620	12	the	the	DT
cord-005453-4057qib7	2620	13	post	post	JJ
cord-005453-4057qib7	2620	14	-	-	JJ
cord-005453-4057qib7	2620	15	allo	allo	JJ
cord-005453-4057qib7	2620	16	-	-	HYPH
cord-005453-4057qib7	2620	17	HSCT	HSCT	NNP
cord-005453-4057qib7	2620	18	setting	setting	NN
cord-005453-4057qib7	2620	19	.	.	.
cord-005453-4057qib7	2621	1	In	in	IN
cord-005453-4057qib7	2621	2	this	this	DT
cord-005453-4057qib7	2621	3	study	study	NN
cord-005453-4057qib7	2621	4	,	,	,
cord-005453-4057qib7	2621	5	we	-PRON-	PRP
cord-005453-4057qib7	2621	6	analysed	analyse	VBD
cord-005453-4057qib7	2621	7	the	the	DT
cord-005453-4057qib7	2621	8	efficacy	efficacy	NN
cord-005453-4057qib7	2621	9	of	of	IN
cord-005453-4057qib7	2621	10	EPAG	EPAG	NNP
cord-005453-4057qib7	2621	11	in	in	IN
cord-005453-4057qib7	2621	12	pts	pts	NN
cord-005453-4057qib7	2621	13	with	with	IN
cord-005453-4057qib7	2621	14	post	post	JJ
cord-005453-4057qib7	2621	15	-	-	JJ
cord-005453-4057qib7	2621	16	transplant	transplant	JJ
cord-005453-4057qib7	2621	17	persistent	persistent	JJ
cord-005453-4057qib7	2621	18	cytopenias	cytopenia	NNS
cord-005453-4057qib7	2621	19	.	.	.
cord-005453-4057qib7	2622	1	Methods	method	NNS
cord-005453-4057qib7	2622	2	:	:	:
cord-005453-4057qib7	2623	1	The	the	DT
cord-005453-4057qib7	2623	2	population	population	NN
cord-005453-4057qib7	2623	3	analyzed	analyze	VBD
cord-005453-4057qib7	2623	4	includes	include	VBZ
cord-005453-4057qib7	2623	5	all	all	DT
cord-005453-4057qib7	2623	6	175	175	CD
cord-005453-4057qib7	2623	7	pts	pt	NNS
cord-005453-4057qib7	2623	8	who	who	WP
cord-005453-4057qib7	2623	9	underwent	undergo	VBD
cord-005453-4057qib7	2623	10	allo	allo	NN
cord-005453-4057qib7	2623	11	-	-	HYPH
cord-005453-4057qib7	2623	12	HSCT	HSCT	NNP
cord-005453-4057qib7	2623	13	from	from	IN
cord-005453-4057qib7	2623	14	June	June	NNP
cord-005453-4057qib7	2623	15	2015	2015	CD
cord-005453-4057qib7	2623	16	through	through	IN
cord-005453-4057qib7	2623	17	May	May	NNP
cord-005453-4057qib7	2623	18	2018	2018	CD
cord-005453-4057qib7	2623	19	in	in	IN
cord-005453-4057qib7	2623	20	our	-PRON-	PRP$
cord-005453-4057qib7	2623	21	Unit	unit	NN
cord-005453-4057qib7	2623	22	.	.	.
cord-005453-4057qib7	2624	1	Median	median	JJ
cord-005453-4057qib7	2624	2	age	age	NN
cord-005453-4057qib7	2624	3	was	be	VBD
cord-005453-4057qib7	2624	4	52	52	CD
cord-005453-4057qib7	2624	5	years	year	NNS
cord-005453-4057qib7	2624	6	(	(	-LRB-
cord-005453-4057qib7	2624	7	12	12	CD
cord-005453-4057qib7	2624	8	-	-	SYM
cord-005453-4057qib7	2624	9	69	69	CD
cord-005453-4057qib7	2624	10	)	)	-RRB-
cord-005453-4057qib7	2624	11	.	.	.
cord-005453-4057qib7	2625	1	102	102	CD
cord-005453-4057qib7	2625	2	were	be	VBD
cord-005453-4057qib7	2625	3	male	male	JJ
cord-005453-4057qib7	2625	4	(	(	-LRB-
cord-005453-4057qib7	2625	5	58.3	58.3	CD
cord-005453-4057qib7	2625	6	%	%	NN
cord-005453-4057qib7	2625	7	)	)	-RRB-
cord-005453-4057qib7	2625	8	and	and	CC
cord-005453-4057qib7	2625	9	73	73	CD
cord-005453-4057qib7	2625	10	female	female	JJ
cord-005453-4057qib7	2625	11	(	(	-LRB-
cord-005453-4057qib7	2625	12	41.7	41.7	CD
cord-005453-4057qib7	2625	13	%	%	NN
cord-005453-4057qib7	2625	14	)	)	-RRB-
cord-005453-4057qib7	2625	15	.	.	.
cord-005453-4057qib7	2626	1	Baseline	baseline	JJ
cord-005453-4057qib7	2626	2	diseases	disease	NNS
cord-005453-4057qib7	2626	3	were	be	VBD
cord-005453-4057qib7	2626	4	:	:	:
cord-005453-4057qib7	2626	5	69	69	CD
cord-005453-4057qib7	2626	6	AML	AML	NNP
cord-005453-4057qib7	2626	7	,	,	,
cord-005453-4057qib7	2626	8	39	39	CD
cord-005453-4057qib7	2626	9	LPD	LPD	NNP
cord-005453-4057qib7	2626	10	,	,	,
cord-005453-4057qib7	2626	11	20	20	CD
cord-005453-4057qib7	2626	12	ALL	all	DT
cord-005453-4057qib7	2626	13	,	,	,
cord-005453-4057qib7	2626	14	18	18	CD
cord-005453-4057qib7	2626	15	MDS	MDS	NNP
cord-005453-4057qib7	2626	16	,	,	,
cord-005453-4057qib7	2626	17	15	15	CD
cord-005453-4057qib7	2626	18	MPD	MPD	NNP
cord-005453-4057qib7	2626	19	,	,	,
cord-005453-4057qib7	2626	20	9	9	CD
cord-005453-4057qib7	2626	21	MM	mm	NN
cord-005453-4057qib7	2626	22	,	,	,
cord-005453-4057qib7	2626	23	and	and	CC
cord-005453-4057qib7	2626	24	5	5	CD
cord-005453-4057qib7	2626	25	BMF	BMF	NNS
cord-005453-4057qib7	2626	26	.	.	.
cord-005453-4057qib7	2627	1	Donor	donor	NN
cord-005453-4057qib7	2627	2	was	be	VBD
cord-005453-4057qib7	2627	3	unrelated	unrelated	JJ
cord-005453-4057qib7	2627	4	in	in	IN
cord-005453-4057qib7	2627	5	101	101	CD
cord-005453-4057qib7	2627	6	(	(	-LRB-
cord-005453-4057qib7	2627	7	54.3	54.3	CD
cord-005453-4057qib7	2627	8	%	%	NN
cord-005453-4057qib7	2627	9	)	)	-RRB-
cord-005453-4057qib7	2627	10	and	and	CC
cord-005453-4057qib7	2627	11	was	be	VBD
cord-005453-4057qib7	2627	12	family	family	NN
cord-005453-4057qib7	2627	13	in	in	IN
cord-005453-4057qib7	2627	14	74	74	CD
cord-005453-4057qib7	2627	15	(	(	-LRB-
cord-005453-4057qib7	2627	16	42.3	42.3	CD
cord-005453-4057qib7	2627	17	%	%	NN
cord-005453-4057qib7	2627	18	)	)	-RRB-
cord-005453-4057qib7	2627	19	(	(	-LRB-
cord-005453-4057qib7	2627	20	including	include	VBG
cord-005453-4057qib7	2627	21	25	25	CD
cord-005453-4057qib7	2627	22	haplo	haplo	NN
cord-005453-4057qib7	2627	23	-	-	HYPH
cord-005453-4057qib7	2627	24	identical	identical	JJ
cord-005453-4057qib7	2627	25	)	)	-RRB-
cord-005453-4057qib7	2627	26	.	.	.
cord-005453-4057qib7	2628	1	Conditioning	conditioning	NN
cord-005453-4057qib7	2628	2	was	be	VBD
cord-005453-4057qib7	2628	3	RIC	RIC	NNP
cord-005453-4057qib7	2628	4	in	in	IN
cord-005453-4057qib7	2628	5	95	95	CD
cord-005453-4057qib7	2628	6	(	(	-LRB-
cord-005453-4057qib7	2628	7	54.3	54.3	CD
cord-005453-4057qib7	2628	8	%	%	NN
cord-005453-4057qib7	2628	9	)	)	-RRB-
cord-005453-4057qib7	2628	10	and	and	CC
cord-005453-4057qib7	2628	11	intensive	intensive	JJ
cord-005453-4057qib7	2628	12	in	in	IN
cord-005453-4057qib7	2628	13	80	80	CD
cord-005453-4057qib7	2628	14	(	(	-LRB-
cord-005453-4057qib7	2628	15	45.7	45.7	CD
cord-005453-4057qib7	2628	16	%	%	NN
cord-005453-4057qib7	2628	17	)	)	-RRB-
cord-005453-4057qib7	2628	18	.	.	.
cord-005453-4057qib7	2629	1	SC	SC	NNP
cord-005453-4057qib7	2629	2	source	source	NN
cord-005453-4057qib7	2629	3	was	be	VBD
cord-005453-4057qib7	2629	4	PB	PB	NNP
cord-005453-4057qib7	2629	5	in	in	IN
cord-005453-4057qib7	2629	6	164	164	CD
cord-005453-4057qib7	2629	7	(	(	-LRB-
cord-005453-4057qib7	2629	8	93.7	93.7	CD
cord-005453-4057qib7	2629	9	%	%	NN
cord-005453-4057qib7	2629	10	)	)	-RRB-
cord-005453-4057qib7	2629	11	and	and	CC
cord-005453-4057qib7	2629	12	BM	BM	NNP
cord-005453-4057qib7	2629	13	in	in	IN
cord-005453-4057qib7	2629	14	11	11	CD
cord-005453-4057qib7	2629	15	(	(	-LRB-
cord-005453-4057qib7	2629	16	6.3	6.3	CD
cord-005453-4057qib7	2629	17	%	%	NN
cord-005453-4057qib7	2629	18	)	)	-RRB-
cord-005453-4057qib7	2629	19	.	.	.
cord-005453-4057qib7	2630	1	Median	median	JJ
cord-005453-4057qib7	2630	2	followup	followup	NN
cord-005453-4057qib7	2630	3	was	be	VBD
cord-005453-4057qib7	2630	4	24	24	CD
cord-005453-4057qib7	2630	5	months	month	NNS
cord-005453-4057qib7	2630	6	(	(	-LRB-
cord-005453-4057qib7	2630	7	6	6	CD
cord-005453-4057qib7	2630	8	-	-	SYM
cord-005453-4057qib7	2630	9	41	41	CD
cord-005453-4057qib7	2630	10	)	)	-RRB-
cord-005453-4057qib7	2630	11	.	.	.
cord-005453-4057qib7	2631	1	EPAG	EPAG	NNP
cord-005453-4057qib7	2631	2	was	be	VBD
cord-005453-4057qib7	2631	3	initiated	initiate	VBN
cord-005453-4057qib7	2631	4	at	at	IN
cord-005453-4057qib7	2631	5	some	some	DT
cord-005453-4057qib7	2631	6	point	point	NN
cord-005453-4057qib7	2631	7	during	during	IN
cord-005453-4057qib7	2631	8	the	the	DT
cord-005453-4057qib7	2631	9	first	first	JJ
cord-005453-4057qib7	2631	10	6-month	6-month	CD
cord-005453-4057qib7	2631	11	post	post	JJ
cord-005453-4057qib7	2631	12	-	-	JJ
cord-005453-4057qib7	2631	13	HSCT	hsct	JJ
cord-005453-4057qib7	2631	14	period	period	NN
cord-005453-4057qib7	2631	15	in	in	IN
cord-005453-4057qib7	2631	16	12	12	CD
cord-005453-4057qib7	2631	17	pts	pt	NNS
cord-005453-4057qib7	2631	18	(	(	-LRB-
cord-005453-4057qib7	2631	19	6.9	6.9	CD
cord-005453-4057qib7	2631	20	%	%	NN
cord-005453-4057qib7	2631	21	of	of	IN
cord-005453-4057qib7	2631	22	the	the	DT
cord-005453-4057qib7	2631	23	series	series	NN
cord-005453-4057qib7	2631	24	)	)	-RRB-
cord-005453-4057qib7	2631	25	due	due	JJ
cord-005453-4057qib7	2631	26	to	to	IN
cord-005453-4057qib7	2631	27	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2631	28	(	(	-LRB-
cord-005453-4057qib7	2631	29	<	<	XX
cord-005453-4057qib7	2631	30	20000	20000	CD
cord-005453-4057qib7	2631	31	/	/	SYM
cord-005453-4057qib7	2631	32	mcL	mcl	NN
cord-005453-4057qib7	2631	33	)	)	-RRB-
cord-005453-4057qib7	2631	34	plus	plus	CC
cord-005453-4057qib7	2631	35	,	,	,
cord-005453-4057qib7	2631	36	at	at	IN
cord-005453-4057qib7	2631	37	least	least	JJS
cord-005453-4057qib7	2631	38	,	,	,
cord-005453-4057qib7	2631	39	one	one	CD
cord-005453-4057qib7	2631	40	other	other	JJ
cord-005453-4057qib7	2631	41	cytopenia	cytopenia	NNS
cord-005453-4057qib7	2631	42	.	.	.
cord-005453-4057qib7	2632	1	Patients	patient	NNS
cord-005453-4057qib7	2632	2	characteristics	characteristic	NNS
cord-005453-4057qib7	2632	3	shown	show	VBN
cord-005453-4057qib7	2632	4	in	in	IN
cord-005453-4057qib7	2632	5	table	table	NN
cord-005453-4057qib7	2632	6	1	1	CD
cord-005453-4057qib7	2632	7	.	.	.
cord-005453-4057qib7	2633	1	EPAG	EPAG	NNP
cord-005453-4057qib7	2633	2	was	be	VBD
cord-005453-4057qib7	2633	3	started	start	VBN
cord-005453-4057qib7	2633	4	at	at	IN
cord-005453-4057qib7	2633	5	50	50	CD
cord-005453-4057qib7	2633	6	mg	mg	NNP
cord-005453-4057qib7	2633	7	/	/	SYM
cord-005453-4057qib7	2633	8	day	day	NN
cord-005453-4057qib7	2633	9	and	and	CC
cord-005453-4057qib7	2633	10	escalated	escalate	VBD
cord-005453-4057qib7	2633	11	each	each	DT
cord-005453-4057qib7	2633	12	2	2	CD
cord-005453-4057qib7	2633	13	weeks	week	NNS
cord-005453-4057qib7	2633	14	to	to	IN
cord-005453-4057qib7	2633	15	75	75	CD
cord-005453-4057qib7	2633	16	,	,	,
cord-005453-4057qib7	2633	17	125	125	CD
cord-005453-4057qib7	2633	18	and	and	CC
cord-005453-4057qib7	2633	19	150	150	CD
cord-005453-4057qib7	2633	20	mg	mg	NNP
cord-005453-4057qib7	2633	21	/	/	SYM
cord-005453-4057qib7	2633	22	day	day	NN
cord-005453-4057qib7	2633	23	if	if	IN
cord-005453-4057qib7	2633	24	platelet	platelet	NN
cord-005453-4057qib7	2633	25	count	count	NN
cord-005453-4057qib7	2633	26	was	be	VBD
cord-005453-4057qib7	2633	27	<	<	XX
cord-005453-4057qib7	2633	28	20000	20000	CD
cord-005453-4057qib7	2633	29	/	/	SYM
cord-005453-4057qib7	2633	30	mcL.	mcl.	NN
cord-005453-4057qib7	2633	31	Global	global	JJ
cord-005453-4057qib7	2633	32	response	response	NN
cord-005453-4057qib7	2633	33	was	be	VBD
cord-005453-4057qib7	2633	34	considered	consider	VBN
cord-005453-4057qib7	2633	35	when	when	WRB
cord-005453-4057qib7	2633	36	,	,	,
cord-005453-4057qib7	2633	37	after	after	IN
cord-005453-4057qib7	2633	38	EPAG	EPAG	NNP
cord-005453-4057qib7	2633	39	,	,	,
cord-005453-4057qib7	2633	40	the	the	DT
cord-005453-4057qib7	2633	41	patient	patient	NN
cord-005453-4057qib7	2633	42	needed	need	VBD
cord-005453-4057qib7	2633	43	no	no	DT
cord-005453-4057qib7	2633	44	transfusions	transfusion	NNS
cord-005453-4057qib7	2633	45	and	and	CC
cord-005453-4057qib7	2633	46	reached	reach	VBD
cord-005453-4057qib7	2633	47	the	the	DT
cord-005453-4057qib7	2633	48	three	three	CD
cord-005453-4057qib7	2633	49	of	of	IN
cord-005453-4057qib7	2633	50	the	the	DT
cord-005453-4057qib7	2633	51	following	follow	VBG
cord-005453-4057qib7	2633	52	:	:	:
cord-005453-4057qib7	2633	53	platelets	platelet	NNS
cord-005453-4057qib7	2633	54	>	>	NFP
cord-005453-4057qib7	2633	55	50000	50000	CD
cord-005453-4057qib7	2633	56	/	/	SYM
cord-005453-4057qib7	2633	57	mcL	mcl	NN
cord-005453-4057qib7	2633	58	,	,	,
cord-005453-4057qib7	2633	59	Hgb	Hgb	NNP
cord-005453-4057qib7	2634	1	>	>	XX
cord-005453-4057qib7	2635	1	10	10	CD
cord-005453-4057qib7	2635	2	g	g	NN
cord-005453-4057qib7	2635	3	/	/	SYM
cord-005453-4057qib7	2635	4	dL	dl	NN
cord-005453-4057qib7	2635	5	,	,	,
cord-005453-4057qib7	2635	6	and	and	CC
cord-005453-4057qib7	2635	7	ANC	ANC	NNP
cord-005453-4057qib7	2635	8	>	>	XX
cord-005453-4057qib7	2636	1	1000	1000	CD
cord-005453-4057qib7	2636	2	/	/	SYM
cord-005453-4057qib7	2636	3	mcL.	mcl.	NN
cord-005453-4057qib7	2636	4	EPAG	EPAG	NNP
cord-005453-4057qib7	2636	5	was	be	VBD
cord-005453-4057qib7	2636	6	tapered	taper	VBN
cord-005453-4057qib7	2636	7	off	off	RP
cord-005453-4057qib7	2636	8	in	in	IN
cord-005453-4057qib7	2636	9	responders	responder	NNS
cord-005453-4057qib7	2636	10	and	and	CC
cord-005453-4057qib7	2636	11	discontinued	discontinue	VBD
cord-005453-4057qib7	2636	12	if	if	IN
cord-005453-4057qib7	2636	13	no	no	DT
cord-005453-4057qib7	2636	14	response	response	NN
cord-005453-4057qib7	2636	15	was	be	VBD
cord-005453-4057qib7	2636	16	reached	reach	VBN
cord-005453-4057qib7	2636	17	after	after	IN
cord-005453-4057qib7	2636	18	16	16	CD
cord-005453-4057qib7	2636	19	weeks	week	NNS
cord-005453-4057qib7	2636	20	.	.	.
cord-005453-4057qib7	2637	1	Results	result	NNS
cord-005453-4057qib7	2637	2	:	:	:
cord-005453-4057qib7	2638	1	At	at	IN
cord-005453-4057qib7	2638	2	EPAG	EPAG	NNP
cord-005453-4057qib7	2638	3	initiation	initiation	NN
cord-005453-4057qib7	2638	4	,	,	,
cord-005453-4057qib7	2638	5	all	all	PDT
cord-005453-4057qib7	2638	6	the	the	DT
cord-005453-4057qib7	2638	7	12	12	CD
cord-005453-4057qib7	2638	8	pts	pt	NNS
cord-005453-4057qib7	2638	9	had	have	VBD
cord-005453-4057qib7	2638	10	thrombocytopenia	thrombocytopenia	VBN
cord-005453-4057qib7	2638	11	(	(	-LRB-
cord-005453-4057qib7	2638	12	<	<	XX
cord-005453-4057qib7	2638	13	20000	20000	CD
cord-005453-4057qib7	2638	14	/	/	SYM
cord-005453-4057qib7	2638	15	mcL	mcl	NN
cord-005453-4057qib7	2638	16	)	)	-RRB-
cord-005453-4057qib7	2638	17	,	,	,
cord-005453-4057qib7	2638	18	10	10	CD
cord-005453-4057qib7	2638	19	had	have	VBD
cord-005453-4057qib7	2638	20	anemia	anemia	NN
cord-005453-4057qib7	2638	21	(	(	-LRB-
cord-005453-4057qib7	2638	22	Hgb	Hgb	NNP
cord-005453-4057qib7	2638	23	<	<	XX
cord-005453-4057qib7	2638	24	10	10	CD
cord-005453-4057qib7	2638	25	g	g	NN
cord-005453-4057qib7	2638	26	/	/	SYM
cord-005453-4057qib7	2638	27	dL	dl	NN
cord-005453-4057qib7	2638	28	)	)	-RRB-
cord-005453-4057qib7	2638	29	,	,	,
cord-005453-4057qib7	2638	30	and	and	CC
cord-005453-4057qib7	2638	31	5	5	CD
cord-005453-4057qib7	2638	32	had	have	VBD
cord-005453-4057qib7	2638	33	neutropenia	neutropenia	VBN
cord-005453-4057qib7	2639	1	(	(	-LRB-
cord-005453-4057qib7	2639	2	ANC	ANC	NNP
cord-005453-4057qib7	2639	3	<	<	XX
cord-005453-4057qib7	2639	4	1000	1000	CD
cord-005453-4057qib7	2639	5	/	/	SYM
cord-005453-4057qib7	2639	6	mcL	mcl	NN
cord-005453-4057qib7	2639	7	)	)	-RRB-
cord-005453-4057qib7	2639	8	.	.	.
cord-005453-4057qib7	2640	1	Counts	count	NNS
cord-005453-4057qib7	2640	2	pre	pre	VBP
cord-005453-4057qib7	2640	3	and	and	CC
cord-005453-4057qib7	2640	4	post	post	VB
cord-005453-4057qib7	2640	5	and	and	CC
cord-005453-4057qib7	2640	6	response	response	NN
cord-005453-4057qib7	2640	7	to	to	IN
cord-005453-4057qib7	2640	8	EPAG	EPAG	NNP
cord-005453-4057qib7	2640	9	are	be	VBP
cord-005453-4057qib7	2640	10	shown	show	VBN
cord-005453-4057qib7	2640	11	in	in	IN
cord-005453-4057qib7	2640	12	table	table	NN
cord-005453-4057qib7	2640	13	2	2	CD
cord-005453-4057qib7	2640	14	.	.	.
cord-005453-4057qib7	2641	1	Among	among	IN
cord-005453-4057qib7	2641	2	the	the	DT
cord-005453-4057qib7	2641	3	8	8	CD
cord-005453-4057qib7	2641	4	responders	responder	NNS
cord-005453-4057qib7	2641	5	,	,	,
cord-005453-4057qib7	2641	6	all	all	DT
cord-005453-4057qib7	2641	7	but	but	IN
cord-005453-4057qib7	2641	8	one	one	NN
cord-005453-4057qib7	2641	9	(	(	-LRB-
cord-005453-4057qib7	2641	10	who	who	WP
cord-005453-4057qib7	2641	11	relapsed	relapse	VBD
cord-005453-4057qib7	2641	12	from	from	IN
cord-005453-4057qib7	2641	13	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2641	14	and	and	CC
cord-005453-4057qib7	2641	15	died	die	VBD
cord-005453-4057qib7	2641	16	from	from	IN
cord-005453-4057qib7	2641	17	bleeding	bleed	VBG
cord-005453-4057qib7	2641	18	)	)	-RRB-
cord-005453-4057qib7	2641	19	were	be	VBD
cord-005453-4057qib7	2641	20	alive	alive	JJ
cord-005453-4057qib7	2641	21	at	at	IN
cord-005453-4057qib7	2641	22	analysis	analysis	NN
cord-005453-4057qib7	2641	23	close	close	NN
cord-005453-4057qib7	2641	24	(	(	-LRB-
cord-005453-4057qib7	2641	25	87.5	87.5	CD
cord-005453-4057qib7	2641	26	%	%	NN
cord-005453-4057qib7	2641	27	)	)	-RRB-
cord-005453-4057qib7	2641	28	.	.	.
cord-005453-4057qib7	2642	1	Among	among	IN
cord-005453-4057qib7	2642	2	the	the	DT
cord-005453-4057qib7	2642	3	4	4	CD
cord-005453-4057qib7	2642	4	non	non	NNS
cord-005453-4057qib7	2642	5	-	-	NNS
cord-005453-4057qib7	2642	6	responders	responder	NNS
cord-005453-4057qib7	2642	7	,	,	,
cord-005453-4057qib7	2642	8	three	three	CD
cord-005453-4057qib7	2642	9	pts	pt	NNS
cord-005453-4057qib7	2642	10	had	have	VBD
cord-005453-4057qib7	2642	11	GVHD	GVHD	NNP
cord-005453-4057qib7	2642	12	-	-	HYPH
cord-005453-4057qib7	2642	13	associated	associate	VBN
cord-005453-4057qib7	2642	14	cytopenias	cytopenia	NNS
cord-005453-4057qib7	2642	15	,	,	,
cord-005453-4057qib7	2642	16	and	and	CC
cord-005453-4057qib7	2642	17	finally	finally	RB
cord-005453-4057qib7	2642	18	died	die	VBD
cord-005453-4057qib7	2642	19	from	from	IN
cord-005453-4057qib7	2642	20	infectious	infectious	JJ
cord-005453-4057qib7	2642	21	complications	complication	NNS
cord-005453-4057qib7	2642	22	;	;	:
cord-005453-4057qib7	2642	23	the	the	DT
cord-005453-4057qib7	2642	24	other	other	JJ
cord-005453-4057qib7	2642	25	patient	patient	NN
cord-005453-4057qib7	2642	26	relapsed	relapse	VBD
cord-005453-4057qib7	2642	27	from	from	IN
cord-005453-4057qib7	2642	28	her	-PRON-	PRP$
cord-005453-4057qib7	2642	29	AML	AML	NNP
cord-005453-4057qib7	2642	30	,	,	,
cord-005453-4057qib7	2642	31	reached	reach	VBD
cord-005453-4057qib7	2642	32	a	a	DT
cord-005453-4057qib7	2642	33	new	new	JJ
cord-005453-4057qib7	2642	34	CR	cr	NN
cord-005453-4057qib7	2642	35	after	after	IN
cord-005453-4057qib7	2642	36	treatment	treatment	NN
cord-005453-4057qib7	2642	37	,	,	,
cord-005453-4057qib7	2642	38	and	and	CC
cord-005453-4057qib7	2642	39	is	be	VBZ
cord-005453-4057qib7	2642	40	alive	alive	JJ
cord-005453-4057qib7	2642	41	and	and	CC
cord-005453-4057qib7	2642	42	well	well	RB
cord-005453-4057qib7	2642	43	27	27	CD
cord-005453-4057qib7	2642	44	months	month	NNS
cord-005453-4057qib7	2642	45	afterwards	afterwards	RB
cord-005453-4057qib7	2642	46	.	.	.
cord-005453-4057qib7	2643	1	EPAG	EPAG	NNP
cord-005453-4057qib7	2643	2	was	be	VBD
cord-005453-4057qib7	2643	3	tapered	taper	VBN
cord-005453-4057qib7	2643	4	off	off	RP
cord-005453-4057qib7	2643	5	and	and	CC
cord-005453-4057qib7	2643	6	discontinued	discontinue	VBD
cord-005453-4057qib7	2643	7	in	in	IN
cord-005453-4057qib7	2643	8	6/8	6/8	CD
cord-005453-4057qib7	2643	9	pts	pt	NNS
cord-005453-4057qib7	2643	10	who	who	WP
cord-005453-4057qib7	2643	11	responded	respond	VBD
cord-005453-4057qib7	2643	12	;	;	:
cord-005453-4057qib7	2643	13	2/8	2/8	CD
cord-005453-4057qib7	2643	14	responders	responder	NNS
cord-005453-4057qib7	2643	15	are	be	VBP
cord-005453-4057qib7	2643	16	still	still	RB
cord-005453-4057qib7	2643	17	on	on	IN
cord-005453-4057qib7	2643	18	EPAG	EPAG	NNP
cord-005453-4057qib7	2643	19	.	.	.
cord-005453-4057qib7	2644	1	EPAG	EPAG	NNP
cord-005453-4057qib7	2644	2	was	be	VBD
cord-005453-4057qib7	2644	3	discontinued	discontinue	VBN
cord-005453-4057qib7	2644	4	in	in	IN
cord-005453-4057qib7	2644	5	the	the	DT
cord-005453-4057qib7	2644	6	4/4	4/4	CD
cord-005453-4057qib7	2644	7	pts	pts	NN
cord-005453-4057qib7	2644	8	who	who	WP
cord-005453-4057qib7	2644	9	did	do	VBD
cord-005453-4057qib7	2644	10	not	not	RB
cord-005453-4057qib7	2644	11	respond	respond	VB
cord-005453-4057qib7	2644	12	.	.	.
cord-005453-4057qib7	2645	1	Rest	rest	NN
cord-005453-4057qib7	2645	2	of	of	IN
cord-005453-4057qib7	2645	3	treatment	treatment	NN
cord-005453-4057qib7	2645	4	details	detail	NNS
cord-005453-4057qib7	2645	5	shown	show	VBN
cord-005453-4057qib7	2645	6	in	in	IN
cord-005453-4057qib7	2645	7	table	table	NN
cord-005453-4057qib7	2645	8	2	2	CD
cord-005453-4057qib7	2645	9	.	.	.
cord-005453-4057qib7	2646	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2646	2	:	:	:
cord-005453-4057qib7	2646	3	1	1	LS
cord-005453-4057qib7	2646	4	)	)	-RRB-
cord-005453-4057qib7	2647	1	EPAG	EPAG	NNP
cord-005453-4057qib7	2647	2	worked	work	VBD
cord-005453-4057qib7	2647	3	striking	strike	VBG
cord-005453-4057qib7	2647	4	well	well	RB
cord-005453-4057qib7	2647	5	in	in	IN
cord-005453-4057qib7	2647	6	subjects	subject	NNS
cord-005453-4057qib7	2647	7	with	with	IN
cord-005453-4057qib7	2647	8	PGF	PGF	NNP
cord-005453-4057qib7	2647	9	,	,	,
cord-005453-4057qib7	2647	10	an	an	DT
cord-005453-4057qib7	2647	11	otherwise	otherwise	RB
cord-005453-4057qib7	2647	12	a	a	DT
cord-005453-4057qib7	2647	13	life	life	NN
cord-005453-4057qib7	2647	14	-	-	HYPH
cord-005453-4057qib7	2647	15	threatening	threaten	VBG
cord-005453-4057qib7	2647	16	situation	situation	NN
cord-005453-4057qib7	2647	17	for	for	IN
cord-005453-4057qib7	2647	18	patients	patient	NNS
cord-005453-4057qib7	2647	19	.	.	.
cord-005453-4057qib7	2648	1	2	2	LS
cord-005453-4057qib7	2648	2	)	)	-RRB-
cord-005453-4057qib7	2648	3	EPAG	EPAG	NNP
cord-005453-4057qib7	2648	4	induced	induce	VBD
cord-005453-4057qib7	2648	5	impressive	impressive	JJ
cord-005453-4057qib7	2648	6	responses	response	NNS
cord-005453-4057qib7	2648	7	in	in	IN
cord-005453-4057qib7	2648	8	platelets	platelet	NNS
cord-005453-4057qib7	2648	9	,	,	,
cord-005453-4057qib7	2648	10	but	but	CC
cord-005453-4057qib7	2648	11	strong	strong	JJ
cord-005453-4057qib7	2648	12	bilinear	bilinear	JJ
cord-005453-4057qib7	2648	13	and	and	CC
cord-005453-4057qib7	2648	14	trilinear	trilinear	JJ
cord-005453-4057qib7	2648	15	responses	response	NNS
cord-005453-4057qib7	2648	16	were	be	VBD
cord-005453-4057qib7	2648	17	also	also	RB
cord-005453-4057qib7	2648	18	seen	see	VBN
cord-005453-4057qib7	2648	19	.	.	.
cord-005453-4057qib7	2649	1	3	3	LS
cord-005453-4057qib7	2649	2	)	)	-RRB-
cord-005453-4057qib7	2649	3	EPAG	EPAG	NNP
cord-005453-4057qib7	2649	4	did	do	VBD
cord-005453-4057qib7	2649	5	not	not	RB
cord-005453-4057qib7	2649	6	improve	improve	VB
cord-005453-4057qib7	2649	7	GVHD	GVHD	NNP
cord-005453-4057qib7	2649	8	-	-	HYPH
cord-005453-4057qib7	2649	9	associated	associate	VBN
cord-005453-4057qib7	2649	10	cytopenias	cytopenia	NNS
cord-005453-4057qib7	2649	11	.	.	.
cord-005453-4057qib7	2650	1	4	4	LS
cord-005453-4057qib7	2650	2	)	)	-RRB-
cord-005453-4057qib7	2651	1	To	to	TO
cord-005453-4057qib7	2651	2	confirm	confirm	VB
cord-005453-4057qib7	2651	3	these	these	DT
cord-005453-4057qib7	2651	4	innovative	innovative	JJ
cord-005453-4057qib7	2651	5	and	and	CC
cord-005453-4057qib7	2651	6	transcendent	transcendent	JJ
cord-005453-4057qib7	2651	7	results	result	NNS
cord-005453-4057qib7	2651	8	,	,	,
cord-005453-4057qib7	2651	9	we	-PRON-	PRP
cord-005453-4057qib7	2651	10	have	have	VBP
cord-005453-4057qib7	2651	11	just	just	RB
cord-005453-4057qib7	2651	12	initiated	initiate	VBN
cord-005453-4057qib7	2651	13	a	a	DT
cord-005453-4057qib7	2651	14	multicenter	multicenter	JJ
cord-005453-4057qib7	2651	15	prospective	prospective	JJ
cord-005453-4057qib7	2651	16	study	study	NN
cord-005453-4057qib7	2651	17	on	on	IN
cord-005453-4057qib7	2651	18	the	the	DT
cord-005453-4057qib7	2651	19	role	role	NN
cord-005453-4057qib7	2651	20	of	of	IN
cord-005453-4057qib7	2651	21	EPAG	EPAG	NNP
cord-005453-4057qib7	2651	22	for	for	IN
cord-005453-4057qib7	2651	23	treatment	treatment	NN
cord-005453-4057qib7	2651	24	of	of	IN
cord-005453-4057qib7	2651	25	post	post	JJ
cord-005453-4057qib7	2651	26	-	-	JJ
cord-005453-4057qib7	2651	27	HSCT	HSCT	NNP
cord-005453-4057qib7	2651	28	PGF	PGF	NNP
cord-005453-4057qib7	2651	29	.	.	.
cord-005453-4057qib7	2652	1	1232	1232	CD
cord-005453-4057qib7	2653	1	*	*	NFP
cord-005453-4057qib7	2653	2	Five	five	CD
cord-005453-4057qib7	2653	3	out	out	IN
cord-005453-4057qib7	2653	4	of	of	IN
cord-005453-4057qib7	2653	5	the	the	DT
cord-005453-4057qib7	2653	6	six	six	CD
cord-005453-4057qib7	2653	7	URDT	URDT	NNP
cord-005453-4057qib7	2653	8	were	be	VBD
cord-005453-4057qib7	2653	9	mismatched	mismatch	VBN
cord-005453-4057qib7	2654	1	*	*	NFP
cord-005453-4057qib7	2654	2	*	*	NFP
cord-005453-4057qib7	2654	3	The	the	DT
cord-005453-4057qib7	2654	4	donor	donor	NN
cord-005453-4057qib7	2654	5	was	be	VBD
cord-005453-4057qib7	2654	6	a	a	DT
cord-005453-4057qib7	2654	7	woman	woman	NN
cord-005453-4057qib7	2654	8	in	in	IN
cord-005453-4057qib7	2654	9	the	the	DT
cord-005453-4057qib7	2654	10	six	six	CD
cord-005453-4057qib7	2654	11	cases	case	NNS
cord-005453-4057qib7	2654	12	:	:	:
cord-005453-4057qib7	2654	13	three	three	CD
cord-005453-4057qib7	2654	14	sisters	sister	NNS
cord-005453-4057qib7	2654	15	and	and	CC
cord-005453-4057qib7	2654	16	three	three	CD
cord-005453-4057qib7	2654	17	daughters	daughter	NNS
cord-005453-4057qib7	2655	1	Background	background	NN
cord-005453-4057qib7	2655	2	:	:	:
cord-005453-4057qib7	2655	3	Hepatic	hepatic	JJ
cord-005453-4057qib7	2655	4	VOD	VOD	NNP
cord-005453-4057qib7	2655	5	/	/	SYM
cord-005453-4057qib7	2655	6	SOS	SOS	NNP
cord-005453-4057qib7	2655	7	with	with	IN
cord-005453-4057qib7	2655	8	multi	multi	JJ
cord-005453-4057qib7	2655	9	-	-	JJ
cord-005453-4057qib7	2655	10	organ	organ	JJ
cord-005453-4057qib7	2655	11	dysfunction	dysfunction	NN
cord-005453-4057qib7	2655	12	(	(	-LRB-
cord-005453-4057qib7	2655	13	MOD	mod	NN
cord-005453-4057qib7	2655	14	;	;	:
cord-005453-4057qib7	2655	15	typically	typically	RB
cord-005453-4057qib7	2655	16	,	,	,
cord-005453-4057qib7	2655	17	renal	renal	JJ
cord-005453-4057qib7	2655	18	or	or	CC
cord-005453-4057qib7	2655	19	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2655	20	)	)	-RRB-
cord-005453-4057qib7	2655	21	may	may	MD
cord-005453-4057qib7	2655	22	be	be	VB
cord-005453-4057qib7	2655	23	associated	associate	VBN
cord-005453-4057qib7	2655	24	with	with	IN
cord-005453-4057qib7	2655	25	>	>	XX
cord-005453-4057qib7	2655	26	80	80	CD
cord-005453-4057qib7	2655	27	%	%	NN
cord-005453-4057qib7	2655	28	mortality	mortality	NN
cord-005453-4057qib7	2655	29	.	.	.
cord-005453-4057qib7	2656	1	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	2656	2	is	be	VBZ
cord-005453-4057qib7	2656	3	approved	approve	VBN
cord-005453-4057qib7	2656	4	for	for	IN
cord-005453-4057qib7	2656	5	treating	treat	VBG
cord-005453-4057qib7	2656	6	severe	severe	JJ
cord-005453-4057qib7	2656	7	hepatic	hepatic	JJ
cord-005453-4057qib7	2656	8	VOD	VOD	NNP
cord-005453-4057qib7	2656	9	/	/	SYM
cord-005453-4057qib7	2656	10	SOS	SOS	NNP
cord-005453-4057qib7	2656	11	post	post	NNP
cord-005453-4057qib7	2656	12	-	-	JJ
cord-005453-4057qib7	2656	13	HSCT	HSCT	NNP
cord-005453-4057qib7	2656	14	in	in	IN
cord-005453-4057qib7	2656	15	patients	patient	NNS
cord-005453-4057qib7	2656	16	aged	age	VBN
cord-005453-4057qib7	2656	17	>	>	SYM
cord-005453-4057qib7	2656	18	1	1	CD
cord-005453-4057qib7	2656	19	month	month	NN
cord-005453-4057qib7	2656	20	in	in	IN
cord-005453-4057qib7	2656	21	the	the	DT
cord-005453-4057qib7	2656	22	EU	EU	NNP
cord-005453-4057qib7	2656	23	,	,	,
cord-005453-4057qib7	2656	24	and	and	CC
cord-005453-4057qib7	2656	25	for	for	IN
cord-005453-4057qib7	2656	26	hepatic	hepatic	JJ
cord-005453-4057qib7	2656	27	VOD	VOD	NNP
cord-005453-4057qib7	2656	28	/	/	SYM
cord-005453-4057qib7	2656	29	SOS	SOS	NNP
cord-005453-4057qib7	2656	30	with	with	IN
cord-005453-4057qib7	2656	31	renal	renal	JJ
cord-005453-4057qib7	2656	32	or	or	CC
cord-005453-4057qib7	2656	33	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2656	34	dysfunction	dysfunction	NN
cord-005453-4057qib7	2656	35	post	post	NN
cord-005453-4057qib7	2656	36	-	-	JJ
cord-005453-4057qib7	2656	37	HSCT	HSCT	NNP
cord-005453-4057qib7	2656	38	in	in	IN
cord-005453-4057qib7	2656	39	the	the	DT
cord-005453-4057qib7	2656	40	US	US	NNP
cord-005453-4057qib7	2656	41	.	.	.
cord-005453-4057qib7	2657	1	This	this	DT
cord-005453-4057qib7	2657	2	analysis	analysis	NN
cord-005453-4057qib7	2657	3	provides	provide	VBZ
cord-005453-4057qib7	2657	4	an	an	DT
cord-005453-4057qib7	2657	5	overview	overview	NN
cord-005453-4057qib7	2657	6	of	of	IN
cord-005453-4057qib7	2657	7	the	the	DT
cord-005453-4057qib7	2657	8	safety	safety	NN
cord-005453-4057qib7	2657	9	results	result	NNS
cord-005453-4057qib7	2657	10	from	from	IN
cord-005453-4057qib7	2657	11	3	3	CD
cord-005453-4057qib7	2657	12	studies	study	NNS
cord-005453-4057qib7	2657	13	of	of	IN
cord-005453-4057qib7	2657	14	patients	patient	NNS
cord-005453-4057qib7	2657	15	with	with	IN
cord-005453-4057qib7	2657	16	VOD	VOD	NNP
cord-005453-4057qib7	2657	17	/	/	SYM
cord-005453-4057qib7	2657	18	SOS	SOS	NNP
cord-005453-4057qib7	2657	19	,	,	,
cord-005453-4057qib7	2657	20	with	with	IN
cord-005453-4057qib7	2657	21	or	or	CC
cord-005453-4057qib7	2657	22	without	without	IN
cord-005453-4057qib7	2657	23	MOD	mod	NN
cord-005453-4057qib7	2657	24	,	,	,
cord-005453-4057qib7	2657	25	who	who	WP
cord-005453-4057qib7	2657	26	received	receive	VBD
cord-005453-4057qib7	2657	27	defibrotide	defibrotide	NNP
cord-005453-4057qib7	2657	28	25	25	CD
cord-005453-4057qib7	2657	29	mg	mg	NNP
cord-005453-4057qib7	2657	30	/	/	SYM
cord-005453-4057qib7	2657	31	kg	kg	NNP
cord-005453-4057qib7	2657	32	/	/	SYM
cord-005453-4057qib7	2657	33	day	day	NN
cord-005453-4057qib7	2657	34	.	.	.
cord-005453-4057qib7	2658	1	Methods	method	NNS
cord-005453-4057qib7	2658	2	:	:	:
cord-005453-4057qib7	2658	3	Safety	safety	NN
cord-005453-4057qib7	2658	4	data	datum	NNS
cord-005453-4057qib7	2658	5	were	be	VBD
cord-005453-4057qib7	2658	6	pooled	pool	VBN
cord-005453-4057qib7	2658	7	from	from	IN
cord-005453-4057qib7	2658	8	patients	patient	NNS
cord-005453-4057qib7	2658	9	with	with	IN
cord-005453-4057qib7	2658	10	VOD	VOD	NNP
cord-005453-4057qib7	2658	11	/	/	SYM
cord-005453-4057qib7	2658	12	SOS	SOS	NNP
cord-005453-4057qib7	2658	13	post	post	NNP
cord-005453-4057qib7	2658	14	-	-	JJ
cord-005453-4057qib7	2658	15	HSCT	HSCT	NNP
cord-005453-4057qib7	2658	16	treated	treat	VBN
cord-005453-4057qib7	2658	17	with	with	IN
cord-005453-4057qib7	2658	18	defibrotide	defibrotide	NN
cord-005453-4057qib7	2658	19	in	in	IN
cord-005453-4057qib7	2658	20	a	a	DT
cord-005453-4057qib7	2658	21	phase	phase	NN
cord-005453-4057qib7	2658	22	3	3	CD
cord-005453-4057qib7	2658	23	trial	trial	NN
cord-005453-4057qib7	2658	24	(	(	-LRB-
cord-005453-4057qib7	2658	25	n=102	n=102	NNP
cord-005453-4057qib7	2658	26	)	)	-RRB-
cord-005453-4057qib7	2658	27	and	and	CC
cord-005453-4057qib7	2658	28	a	a	DT
cord-005453-4057qib7	2658	29	phase	phase	NN
cord-005453-4057qib7	2658	30	2	2	CD
cord-005453-4057qib7	2658	31	,	,	,
cord-005453-4057qib7	2658	32	randomized	randomized	JJ
cord-005453-4057qib7	2658	33	dose	dose	NN
cord-005453-4057qib7	2658	34	-	-	HYPH
cord-005453-4057qib7	2658	35	finding	find	VBG
cord-005453-4057qib7	2658	36	trial	trial	NN
cord-005453-4057qib7	2658	37	(	(	-LRB-
cord-005453-4057qib7	2658	38	n=74	n=74	NNP
cord-005453-4057qib7	2658	39	receiving	receive	VBG
cord-005453-4057qib7	2658	40	25	25	CD
cord-005453-4057qib7	2658	41	mg	mg	NNP
cord-005453-4057qib7	2658	42	/	/	SYM
cord-005453-4057qib7	2658	43	kg	kg	NNP
cord-005453-4057qib7	2658	44	/	/	SYM
cord-005453-4057qib7	2658	45	day	day	NN
cord-005453-4057qib7	2658	46	)	)	-RRB-
cord-005453-4057qib7	2658	47	.	.	.
cord-005453-4057qib7	2659	1	Safety	safety	NN
cord-005453-4057qib7	2659	2	data	datum	NNS
cord-005453-4057qib7	2659	3	for	for	IN
cord-005453-4057qib7	2659	4	historical	historical	JJ
cord-005453-4057qib7	2659	5	controls	control	NNS
cord-005453-4057qib7	2659	6	(	(	-LRB-
cord-005453-4057qib7	2659	7	HC	HC	NNP
cord-005453-4057qib7	2659	8	)	)	-RRB-
cord-005453-4057qib7	2659	9	from	from	IN
cord-005453-4057qib7	2659	10	the	the	DT
cord-005453-4057qib7	2659	11	phase	phase	NN
cord-005453-4057qib7	2659	12	3	3	CD
cord-005453-4057qib7	2659	13	study	study	NN
cord-005453-4057qib7	2659	14	(	(	-LRB-
cord-005453-4057qib7	2659	15	n=32	n=32	NNP
cord-005453-4057qib7	2659	16	)	)	-RRB-
cord-005453-4057qib7	2659	17	also	also	RB
cord-005453-4057qib7	2659	18	are	be	VBP
cord-005453-4057qib7	2659	19	provided	provide	VBN
cord-005453-4057qib7	2659	20	.	.	.
cord-005453-4057qib7	2660	1	Reported	report	VBN
cord-005453-4057qib7	2660	2	separately	separately	RB
cord-005453-4057qib7	2660	3	,	,	,
cord-005453-4057qib7	2660	4	due	due	IN
cord-005453-4057qib7	2660	5	to	to	IN
cord-005453-4057qib7	2660	6	differences	difference	NNS
cord-005453-4057qib7	2660	7	in	in	IN
cord-005453-4057qib7	2660	8	patient	patient	JJ
cord-005453-4057qib7	2660	9	population	population	NN
cord-005453-4057qib7	2660	10	and	and	CC
cord-005453-4057qib7	2660	11	data	datum	NNS
cord-005453-4057qib7	2660	12	monitoring	monitoring	NN
cord-005453-4057qib7	2660	13	protocol	protocol	NN
cord-005453-4057qib7	2660	14	,	,	,
cord-005453-4057qib7	2660	15	are	be	VBP
cord-005453-4057qib7	2660	16	AEs	ae	NNS
cord-005453-4057qib7	2660	17	from	from	IN
cord-005453-4057qib7	2660	18	the	the	DT
cord-005453-4057qib7	2660	19	expanded	expand	VBN
cord-005453-4057qib7	2660	20	-	-	HYPH
cord-005453-4057qib7	2660	21	access	access	NN
cord-005453-4057qib7	2660	22	program	program	NN
cord-005453-4057qib7	2661	1	(	(	-LRB-
cord-005453-4057qib7	2661	2	T	T	NNP
cord-005453-4057qib7	2661	3	-	-	HYPH
cord-005453-4057qib7	2661	4	IND	IND	NNP
cord-005453-4057qib7	2661	5	)	)	-RRB-
cord-005453-4057qib7	2661	6	in	in	IN
cord-005453-4057qib7	2661	7	patients	patient	NNS
cord-005453-4057qib7	2661	8	with	with	IN
cord-005453-4057qib7	2661	9	VOD/	VOD/	NNP
cord-005453-4057qib7	2661	10	SOS	SOS	NNP
cord-005453-4057qib7	2661	11	with	with	IN
cord-005453-4057qib7	2661	12	and	and	CC
cord-005453-4057qib7	2661	13	without	without	IN
cord-005453-4057qib7	2661	14	MOD	mod	NN
cord-005453-4057qib7	2661	15	(	(	-LRB-
cord-005453-4057qib7	2661	16	n=1000	n=1000	CD
cord-005453-4057qib7	2661	17	post	post	JJ
cord-005453-4057qib7	2661	18	-	-	JJ
cord-005453-4057qib7	2661	19	HSCT	HSCT	NNP
cord-005453-4057qib7	2661	20	)	)	-RRB-
cord-005453-4057qib7	2661	21	.	.	.
cord-005453-4057qib7	2662	1	VOD/	VOD/	NNP
cord-005453-4057qib7	2662	2	SOS	SOS	NNP
cord-005453-4057qib7	2662	3	was	be	VBD
cord-005453-4057qib7	2662	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	2662	5	by	by	IN
cord-005453-4057qib7	2662	6	Baltimore	Baltimore	NNP
cord-005453-4057qib7	2662	7	criteria	criterion	NNS
cord-005453-4057qib7	2662	8	/	/	SYM
cord-005453-4057qib7	2662	9	biopsy	biopsy	NN
cord-005453-4057qib7	2662	10	for	for	IN
cord-005453-4057qib7	2662	11	the	the	DT
cord-005453-4057qib7	2662	12	phase	phase	NN
cord-005453-4057qib7	2662	13	2/3	2/3	CD
cord-005453-4057qib7	2662	14	studies	study	NNS
cord-005453-4057qib7	2662	15	;	;	:
cord-005453-4057qib7	2662	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	2662	17	by	by	IN
cord-005453-4057qib7	2662	18	Baltimore	Baltimore	NNP
cord-005453-4057qib7	2662	19	or	or	CC
cord-005453-4057qib7	2662	20	modified	modify	VBN
cord-005453-4057qib7	2662	21	Seattle	Seattle	NNP
cord-005453-4057qib7	2662	22	criteria	criterion	NNS
cord-005453-4057qib7	2662	23	was	be	VBD
cord-005453-4057qib7	2662	24	permitted	permit	VBN
cord-005453-4057qib7	2662	25	in	in	IN
cord-005453-4057qib7	2662	26	the	the	DT
cord-005453-4057qib7	2662	27	T	T	NNP
cord-005453-4057qib7	2662	28	-	-	HYPH
cord-005453-4057qib7	2662	29	IND	IND	NNP
cord-005453-4057qib7	2662	30	.	.	.
cord-005453-4057qib7	2663	1	Results	result	NNS
cord-005453-4057qib7	2663	2	:	:	:
cord-005453-4057qib7	2664	1	Median	median	JJ
cord-005453-4057qib7	2664	2	patient	patient	JJ
cord-005453-4057qib7	2664	3	age	age	NN
cord-005453-4057qib7	2664	4	at	at	IN
cord-005453-4057qib7	2664	5	HSCT	HSCT	NNP
cord-005453-4057qib7	2664	6	for	for	IN
cord-005453-4057qib7	2664	7	the	the	DT
cord-005453-4057qib7	2664	8	phase	phase	NN
cord-005453-4057qib7	2664	9	2/	2/	CD
cord-005453-4057qib7	2664	10	3	3	CD
cord-005453-4057qib7	2664	11	studies	study	NNS
cord-005453-4057qib7	2664	12	was	be	VBD
cord-005453-4057qib7	2664	13	24.0	24.0	CD
cord-005453-4057qib7	2664	14	years	year	NNS
cord-005453-4057qib7	2664	15	,	,	,
cord-005453-4057qib7	2664	16	18.0	18.0	CD
cord-005453-4057qib7	2664	17	years	year	NNS
cord-005453-4057qib7	2664	18	for	for	IN
cord-005453-4057qib7	2664	19	the	the	DT
cord-005453-4057qib7	2664	20	HC	HC	NNP
cord-005453-4057qib7	2664	21	,	,	,
cord-005453-4057qib7	2664	22	and	and	CC
cord-005453-4057qib7	2664	23	14.0	14.0	CD
cord-005453-4057qib7	2664	24	years	year	NNS
cord-005453-4057qib7	2664	25	for	for	IN
cord-005453-4057qib7	2664	26	the	the	DT
cord-005453-4057qib7	2664	27	T	T	NNP
cord-005453-4057qib7	2664	28	-	-	HYPH
cord-005453-4057qib7	2664	29	IND	IND	NNP
cord-005453-4057qib7	2664	30	.	.	.
cord-005453-4057qib7	2665	1	In	in	IN
cord-005453-4057qib7	2665	2	the	the	DT
cord-005453-4057qib7	2665	3	phase	phase	NN
cord-005453-4057qib7	2665	4	2/3	2/3	CD
cord-005453-4057qib7	2665	5	studies	study	NNS
cord-005453-4057qib7	2665	6	defibrotide	defibrotide	RB
cord-005453-4057qib7	2665	7	-	-	HYPH
cord-005453-4057qib7	2665	8	treated	treat	VBN
cord-005453-4057qib7	2665	9	group	group	NN
cord-005453-4057qib7	2665	10	(	(	-LRB-
cord-005453-4057qib7	2665	11	n=176	n=176	NNP
cord-005453-4057qib7	2665	12	)	)	-RRB-
cord-005453-4057qib7	2665	13	,	,	,
cord-005453-4057qib7	2665	14	169	169	CD
cord-005453-4057qib7	2665	15	(	(	-LRB-
cord-005453-4057qib7	2665	16	96.0	96.0	CD
cord-005453-4057qib7	2665	17	%	%	NN
cord-005453-4057qib7	2665	18	)	)	-RRB-
cord-005453-4057qib7	2665	19	experienced	experience	VBD
cord-005453-4057qib7	2665	20	AEs	AEs	NNPS
cord-005453-4057qib7	2665	21	;	;	:
cord-005453-4057qib7	2665	22	most	most	RBS
cord-005453-4057qib7	2665	23	common	common	JJ
cord-005453-4057qib7	2665	24	(	(	-LRB-
cord-005453-4057qib7	2665	25	>	>	NFP
cord-005453-4057qib7	2665	26	10	10	CD
cord-005453-4057qib7	2665	27	%	%	NN
cord-005453-4057qib7	2665	28	)	)	-RRB-
cord-005453-4057qib7	2665	29	were	be	VBD
cord-005453-4057qib7	2665	30	hypotension	hypotension	NN
cord-005453-4057qib7	2665	31	(	(	-LRB-
cord-005453-4057qib7	2665	32	36.9	36.9	CD
cord-005453-4057qib7	2665	33	%	%	NN
cord-005453-4057qib7	2665	34	)	)	-RRB-
cord-005453-4057qib7	2665	35	,	,	,
cord-005453-4057qib7	2665	36	diarrhea	diarrhea	NN
cord-005453-4057qib7	2665	37	(	(	-LRB-
cord-005453-4057qib7	2665	38	24.4	24.4	CD
cord-005453-4057qib7	2665	39	%	%	NN
cord-005453-4057qib7	2665	40	)	)	-RRB-
cord-005453-4057qib7	2665	41	,	,	,
cord-005453-4057qib7	2665	42	and	and	CC
cord-005453-4057qib7	2665	43	multi	multi	JJ
cord-005453-4057qib7	2665	44	-	-	JJ
cord-005453-4057qib7	2665	45	organ	organ	JJ
cord-005453-4057qib7	2665	46	failure	failure	NN
cord-005453-4057qib7	2665	47	(	(	-LRB-
cord-005453-4057qib7	2665	48	21.6	21.6	CD
cord-005453-4057qib7	2665	49	%	%	NN
cord-005453-4057qib7	2665	50	)	)	-RRB-
cord-005453-4057qib7	2665	51	.	.	.
cord-005453-4057qib7	2666	1	Treatment	treatment	NN
cord-005453-4057qib7	2666	2	-	-	HYPH
cord-005453-4057qib7	2666	3	related	relate	VBN
cord-005453-4057qib7	2666	4	AEs	ae	NNS
cord-005453-4057qib7	2666	5	were	be	VBD
cord-005453-4057qib7	2666	6	at	at	IN
cord-005453-4057qib7	2666	7	least	least	JJS
cord-005453-4057qib7	2666	8	possibly	possibly	RB
cord-005453-4057qib7	2666	9	related	relate	VBN
cord-005453-4057qib7	2666	10	to	to	IN
cord-005453-4057qib7	2666	11	defibrotide	defibrotide	NNP
cord-005453-4057qib7	2666	12	(	(	-LRB-
cord-005453-4057qib7	2666	13	Table	table	NN
cord-005453-4057qib7	2666	14	)	)	-RRB-
cord-005453-4057qib7	2666	15	.	.	.
cord-005453-4057qib7	2667	1	Any	any	DT
cord-005453-4057qib7	2667	2	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2667	3	(	(	-LRB-
cord-005453-4057qib7	2667	4	an	an	DT
cord-005453-4057qib7	2667	5	AE	ae	NN
cord-005453-4057qib7	2667	6	of	of	IN
cord-005453-4057qib7	2667	7	special	special	JJ
cord-005453-4057qib7	2667	8	interest	interest	NN
cord-005453-4057qib7	2667	9	)	)	-RRB-
cord-005453-4057qib7	2667	10	occurred	occur	VBD
cord-005453-4057qib7	2667	11	in	in	IN
cord-005453-4057qib7	2667	12	101	101	CD
cord-005453-4057qib7	2667	13	patients	patient	NNS
cord-005453-4057qib7	2667	14	(	(	-LRB-
cord-005453-4057qib7	2667	15	57.4	57.4	CD
cord-005453-4057qib7	2667	16	%	%	NN
cord-005453-4057qib7	2667	17	)	)	-RRB-
cord-005453-4057qib7	2667	18	;	;	:
cord-005453-4057qib7	2667	19	most	most	RBS
cord-005453-4057qib7	2667	20	commonly	commonly	RB
cord-005453-4057qib7	2667	21	epistaxis	epistaxis	NN
cord-005453-4057qib7	2667	22	(	(	-LRB-
cord-005453-4057qib7	2667	23	13.6	13.6	CD
cord-005453-4057qib7	2667	24	%	%	NN
cord-005453-4057qib7	2667	25	)	)	-RRB-
cord-005453-4057qib7	2667	26	,	,	,
cord-005453-4057qib7	2667	27	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	2667	28	and	and	CC
cord-005453-4057qib7	2667	29	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2667	30	alveolar	alveolar	NN
cord-005453-4057qib7	2667	31	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2667	32	and	and	CC
cord-005453-4057qib7	2667	33	hematuria	hematuria	NN
cord-005453-4057qib7	2667	34	(	(	-LRB-
cord-005453-4057qib7	2667	35	8.5	8.5	CD
cord-005453-4057qib7	2667	36	%	%	NN
cord-005453-4057qib7	2667	37	each	each	DT
cord-005453-4057qib7	2667	38	)	)	-RRB-
cord-005453-4057qib7	2667	39	,	,	,
cord-005453-4057qib7	2667	40	and	and	CC
cord-005453-4057qib7	2667	41	conjunctival	conjunctival	NN
cord-005453-4057qib7	2667	42	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2667	43	(	(	-LRB-
cord-005453-4057qib7	2667	44	6.3	6.3	CD
cord-005453-4057qib7	2667	45	%	%	NN
cord-005453-4057qib7	2667	46	)	)	-RRB-
cord-005453-4057qib7	2667	47	.	.	.
cord-005453-4057qib7	2668	1	All	all	DT
cord-005453-4057qib7	2668	2	32	32	CD
cord-005453-4057qib7	2668	3	HC	HC	NNP
cord-005453-4057qib7	2668	4	experienced	experience	VBD
cord-005453-4057qib7	2668	5	an	an	DT
cord-005453-4057qib7	2668	6	AE	ae	NN
cord-005453-4057qib7	2668	7	;	;	:
cord-005453-4057qib7	2668	8	most	most	RBS
cord-005453-4057qib7	2668	9	common	common	JJ
cord-005453-4057qib7	2668	10	(	(	-LRB-
cord-005453-4057qib7	2668	11	>	>	NFP
cord-005453-4057qib7	2668	12	25	25	CD
cord-005453-4057qib7	2668	13	%	%	NN
cord-005453-4057qib7	2668	14	)	)	-RRB-
cord-005453-4057qib7	2668	15	were	be	VBD
cord-005453-4057qib7	2668	16	hypotension	hypotension	NN
cord-005453-4057qib7	2668	17	(	(	-LRB-
cord-005453-4057qib7	2668	18	50.0	50.0	CD
cord-005453-4057qib7	2668	19	%	%	NN
cord-005453-4057qib7	2668	20	)	)	-RRB-
cord-005453-4057qib7	2668	21	,	,	,
cord-005453-4057qib7	2668	22	tachycardia	tachycardia	NN
cord-005453-4057qib7	2668	23	(	(	-LRB-
cord-005453-4057qib7	2668	24	43.8	43.8	CD
cord-005453-4057qib7	2668	25	%	%	NN
cord-005453-4057qib7	2668	26	)	)	-RRB-
cord-005453-4057qib7	2668	27	,	,	,
cord-005453-4057qib7	2668	28	diarrhea	diarrhea	NN
cord-005453-4057qib7	2668	29	(	(	-LRB-
cord-005453-4057qib7	2668	30	37.5	37.5	CD
cord-005453-4057qib7	2668	31	%	%	NN
cord-005453-4057qib7	2668	32	)	)	-RRB-
cord-005453-4057qib7	2668	33	,	,	,
cord-005453-4057qib7	2668	34	nausea	nausea	NN
cord-005453-4057qib7	2668	35	(	(	-LRB-
cord-005453-4057qib7	2668	36	31.3	31.3	CD
cord-005453-4057qib7	2668	37	%	%	NN
cord-005453-4057qib7	2668	38	)	)	-RRB-
cord-005453-4057qib7	2668	39	,	,	,
cord-005453-4057qib7	2668	40	and	and	CC
cord-005453-4057qib7	2668	41	pyrexia	pyrexia	NN
cord-005453-4057qib7	2668	42	,	,	,
cord-005453-4057qib7	2668	43	agitation	agitation	NN
cord-005453-4057qib7	2668	44	,	,	,
cord-005453-4057qib7	2668	45	and	and	CC
cord-005453-4057qib7	2668	46	petechiae	petechia	NNS
cord-005453-4057qib7	2668	47	(	(	-LRB-
cord-005453-4057qib7	2668	48	28.1	28.1	CD
cord-005453-4057qib7	2668	49	%	%	NN
cord-005453-4057qib7	2668	50	each	each	DT
cord-005453-4057qib7	2668	51	)	)	-RRB-
cord-005453-4057qib7	2668	52	.	.	.
cord-005453-4057qib7	2669	1	Any	any	DT
cord-005453-4057qib7	2669	2	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2669	3	occurred	occur	VBD
cord-005453-4057qib7	2669	4	in	in	IN
cord-005453-4057qib7	2669	5	24	24	CD
cord-005453-4057qib7	2669	6	patients	patient	NNS
cord-005453-4057qib7	2669	7	(	(	-LRB-
cord-005453-4057qib7	2669	8	75.0	75.0	CD
cord-005453-4057qib7	2669	9	%	%	NN
cord-005453-4057qib7	2669	10	)	)	-RRB-
cord-005453-4057qib7	2669	11	:	:	:
cord-005453-4057qib7	2669	12	most	most	RBS
cord-005453-4057qib7	2669	13	common	common	JJ
cord-005453-4057qib7	2669	14	(	(	-LRB-
cord-005453-4057qib7	2669	15	>	>	NFP
cord-005453-4057qib7	2669	16	10	10	CD
cord-005453-4057qib7	2669	17	%	%	NN
cord-005453-4057qib7	2669	18	)	)	-RRB-
cord-005453-4057qib7	2669	19	were	be	VBD
cord-005453-4057qib7	2669	20	petechiae	petechia	NNS
cord-005453-4057qib7	2669	21	(	(	-LRB-
cord-005453-4057qib7	2669	22	28.1	28.1	CD
cord-005453-4057qib7	2669	23	%	%	NN
cord-005453-4057qib7	2669	24	)	)	-RRB-
cord-005453-4057qib7	2669	25	;	;	:
cord-005453-4057qib7	2669	26	hematuria	hematuria	NN
cord-005453-4057qib7	2669	27	,	,	,
cord-005453-4057qib7	2669	28	epistaxis	epistaxis	NN
cord-005453-4057qib7	2669	29	,	,	,
cord-005453-4057qib7	2669	30	and	and	CC
cord-005453-4057qib7	2669	31	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2669	32	alveolar	alveolar	NN
cord-005453-4057qib7	2669	33	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2669	34	(	(	-LRB-
cord-005453-4057qib7	2669	35	15.6	15.6	CD
cord-005453-4057qib7	2669	36	%	%	NN
cord-005453-4057qib7	2669	37	each	each	DT
cord-005453-4057qib7	2669	38	)	)	-RRB-
cord-005453-4057qib7	2669	39	;	;	:
cord-005453-4057qib7	2669	40	and	and	CC
cord-005453-4057qib7	2669	41	lip	lip	NN
cord-005453-4057qib7	2669	42	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2669	43	(	(	-LRB-
cord-005453-4057qib7	2669	44	12.5	12.5	CD
cord-005453-4057qib7	2669	45	%	%	NN
cord-005453-4057qib7	2669	46	)	)	-RRB-
cord-005453-4057qib7	2669	47	.	.	.
cord-005453-4057qib7	2670	1	In	in	IN
cord-005453-4057qib7	2670	2	the	the	DT
cord-005453-4057qib7	2670	3	T	T	NNP
cord-005453-4057qib7	2670	4	-	-	HYPH
cord-005453-4057qib7	2670	5	IND	IND	NNP
cord-005453-4057qib7	2670	6	(	(	-LRB-
cord-005453-4057qib7	2670	7	n=1000	n=1000	CD
cord-005453-4057qib7	2670	8	)	)	-RRB-
cord-005453-4057qib7	2670	9	,	,	,
cord-005453-4057qib7	2670	10	385/512	385/512	CD
cord-005453-4057qib7	2670	11	patients	patient	NNS
cord-005453-4057qib7	2670	12	with	with	IN
cord-005453-4057qib7	2670	13	MOD	mod	NN
cord-005453-4057qib7	2670	14	(	(	-LRB-
cord-005453-4057qib7	2670	15	75.2	75.2	CD
cord-005453-4057qib7	2670	16	%	%	NN
cord-005453-4057qib7	2670	17	)	)	-RRB-
cord-005453-4057qib7	2670	18	and	and	CC
cord-005453-4057qib7	2670	19	324/488	324/488	CD
cord-005453-4057qib7	2670	20	patients	patient	NNS
cord-005453-4057qib7	2670	21	without	without	IN
cord-005453-4057qib7	2670	22	MOD	mod	NN
cord-005453-4057qib7	2670	23	(	(	-LRB-
cord-005453-4057qib7	2670	24	66.4	66.4	CD
cord-005453-4057qib7	2670	25	%	%	NN
cord-005453-4057qib7	2670	26	)	)	-RRB-
cord-005453-4057qib7	2670	27	had	have	VBD
cord-005453-4057qib7	2670	28	an	an	DT
cord-005453-4057qib7	2670	29	AE	ae	NN
cord-005453-4057qib7	2670	30	;	;	:
cord-005453-4057qib7	2670	31	other	other	JJ
cord-005453-4057qib7	2670	32	than	than	IN
cord-005453-4057qib7	2670	33	VOD	VOD	NNP
cord-005453-4057qib7	2670	34	/	/	SYM
cord-005453-4057qib7	2670	35	SOS	SOS	NNP
cord-005453-4057qib7	2670	36	and	and	CC
cord-005453-4057qib7	2670	37	MOD	MOD	NNP
cord-005453-4057qib7	2670	38	,	,	,
cord-005453-4057qib7	2670	39	most	most	RBS
cord-005453-4057qib7	2670	40	commonly	commonly	RB
cord-005453-4057qib7	2670	41	(	(	-LRB-
cord-005453-4057qib7	2670	42	>	>	NFP
cord-005453-4057qib7	2670	43	10	10	CD
cord-005453-4057qib7	2670	44	%	%	NN
cord-005453-4057qib7	2670	45	in	in	IN
cord-005453-4057qib7	2670	46	either	either	DT
cord-005453-4057qib7	2670	47	subgroup	subgroup	NN
cord-005453-4057qib7	2670	48	)	)	-RRB-
cord-005453-4057qib7	2671	1	hypotension	hypotension	NN
cord-005453-4057qib7	2671	2	(	(	-LRB-
cord-005453-4057qib7	2671	3	15.2	15.2	CD
cord-005453-4057qib7	2671	4	%	%	NN
cord-005453-4057qib7	2671	5	and	and	CC
cord-005453-4057qib7	2671	6	8.4	8.4	CD
cord-005453-4057qib7	2671	7	%	%	NN
cord-005453-4057qib7	2671	8	,	,	,
cord-005453-4057qib7	2671	9	respectively	respectively	RB
cord-005453-4057qib7	2671	10	)	)	-RRB-
cord-005453-4057qib7	2671	11	.	.	.
cord-005453-4057qib7	2672	1	TRAEs	trae	NNS
cord-005453-4057qib7	2672	2	occurred	occur	VBD
cord-005453-4057qib7	2672	3	in	in	IN
cord-005453-4057qib7	2672	4	210	210	CD
cord-005453-4057qib7	2672	5	patients	patient	NNS
cord-005453-4057qib7	2672	6	(	(	-LRB-
cord-005453-4057qib7	2672	7	21.0	21.0	CD
cord-005453-4057qib7	2672	8	%	%	NN
cord-005453-4057qib7	2672	9	)	)	-RRB-
cord-005453-4057qib7	2672	10	(	(	-LRB-
cord-005453-4057qib7	2672	11	Table	table	NN
cord-005453-4057qib7	2672	12	)	)	-RRB-
cord-005453-4057qib7	2672	13	.	.	.
cord-005453-4057qib7	2673	1	Any	any	DT
cord-005453-4057qib7	2673	2	treatment	treatment	NN
cord-005453-4057qib7	2673	3	-	-	HYPH
cord-005453-4057qib7	2673	4	emergent	emergent	JJ
cord-005453-4057qib7	2673	5	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2673	6	occurred	occur	VBD
cord-005453-4057qib7	2673	7	in	in	IN
cord-005453-4057qib7	2673	8	166	166	CD
cord-005453-4057qib7	2673	9	patients	patient	NNS
cord-005453-4057qib7	2673	10	with	with	IN
cord-005453-4057qib7	2673	11	MOD	mod	NN
cord-005453-4057qib7	2673	12	(	(	-LRB-
cord-005453-4057qib7	2673	13	32.4	32.4	CD
cord-005453-4057qib7	2673	14	%	%	NN
cord-005453-4057qib7	2673	15	)	)	-RRB-
cord-005453-4057qib7	2673	16	and	and	CC
cord-005453-4057qib7	2673	17	124	124	CD
cord-005453-4057qib7	2673	18	patients	patient	NNS
cord-005453-4057qib7	2673	19	without	without	IN
cord-005453-4057qib7	2673	20	MOD	mod	NN
cord-005453-4057qib7	2673	21	(	(	-LRB-
cord-005453-4057qib7	2673	22	25.4	25.4	CD
cord-005453-4057qib7	2673	23	%	%	NN
cord-005453-4057qib7	2673	24	)	)	-RRB-
cord-005453-4057qib7	2673	25	;	;	:
cord-005453-4057qib7	2673	26	most	most	RBS
cord-005453-4057qib7	2673	27	commonly	commonly	RB
cord-005453-4057qib7	2673	28	(	(	-LRB-
cord-005453-4057qib7	2673	29	>	>	NFP
cord-005453-4057qib7	2673	30	5	5	CD
cord-005453-4057qib7	2673	31	%	%	NN
cord-005453-4057qib7	2673	32	in	in	IN
cord-005453-4057qib7	2673	33	either	either	DT
cord-005453-4057qib7	2673	34	subgroup	subgroup	NN
cord-005453-4057qib7	2673	35	)	)	-RRB-
cord-005453-4057qib7	2673	36	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2673	37	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2673	38	(	(	-LRB-
cord-005453-4057qib7	2673	39	8.2	8.2	CD
cord-005453-4057qib7	2673	40	%	%	NN
cord-005453-4057qib7	2673	41	and	and	CC
cord-005453-4057qib7	2673	42	4.7	4.7	CD
cord-005453-4057qib7	2673	43	%	%	NN
cord-005453-4057qib7	2673	44	,	,	,
cord-005453-4057qib7	2673	45	respectively	respectively	RB
cord-005453-4057qib7	2673	46	)	)	-RRB-
cord-005453-4057qib7	2673	47	and	and	CC
cord-005453-4057qib7	2673	48	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	2673	49	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2673	50	(	(	-LRB-
cord-005453-4057qib7	2673	51	5.5	5.5	CD
cord-005453-4057qib7	2673	52	%	%	NN
cord-005453-4057qib7	2673	53	and	and	CC
cord-005453-4057qib7	2673	54	4.3	4.3	CD
cord-005453-4057qib7	2673	55	%	%	NN
cord-005453-4057qib7	2673	56	,	,	,
cord-005453-4057qib7	2673	57	respectively	respectively	RB
cord-005453-4057qib7	2673	58	)	)	-RRB-
cord-005453-4057qib7	2673	59	.	.	.
cord-005453-4057qib7	2674	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2674	2	:	:	:
cord-005453-4057qib7	2675	1	The	the	DT
cord-005453-4057qib7	2675	2	incidence	incidence	NN
cord-005453-4057qib7	2675	3	and	and	CC
cord-005453-4057qib7	2675	4	type	type	NN
cord-005453-4057qib7	2675	5	of	of	IN
cord-005453-4057qib7	2675	6	AEs	ae	NNS
cord-005453-4057qib7	2675	7	were	be	VBD
cord-005453-4057qib7	2675	8	as	as	IN
cord-005453-4057qib7	2675	9	expected	expect	VBN
cord-005453-4057qib7	2675	10	in	in	IN
cord-005453-4057qib7	2675	11	these	these	DT
cord-005453-4057qib7	2675	12	critically	critically	RB
cord-005453-4057qib7	2675	13	ill	ill	JJ
cord-005453-4057qib7	2675	14	patients	patient	NNS
cord-005453-4057qib7	2675	15	.	.	.
cord-005453-4057qib7	2676	1	Of	of	IN
cord-005453-4057qib7	2676	2	the	the	DT
cord-005453-4057qib7	2676	3	pooled	pool	VBN
cord-005453-4057qib7	2676	4	patients	patient	NNS
cord-005453-4057qib7	2676	5	,	,	,
cord-005453-4057qib7	2676	6	96	96	CD
cord-005453-4057qib7	2676	7	%	%	NN
cord-005453-4057qib7	2676	8	had	have	VBD
cord-005453-4057qib7	2676	9	AEs	ae	NNS
cord-005453-4057qib7	2676	10	;	;	:
cord-005453-4057qib7	2676	11	57.4	57.4	CD
cord-005453-4057qib7	2676	12	%	%	NN
cord-005453-4057qib7	2676	13	had	have	VBD
cord-005453-4057qib7	2676	14	a	a	DT
cord-005453-4057qib7	2676	15	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2676	16	.	.	.
cord-005453-4057qib7	2677	1	All	all	DT
cord-005453-4057qib7	2677	2	HCs	hc	NNS
cord-005453-4057qib7	2677	3	had	have	VBD
cord-005453-4057qib7	2677	4	an	an	DT
cord-005453-4057qib7	2677	5	AE	AE	NNP
cord-005453-4057qib7	2677	6	,	,	,
cord-005453-4057qib7	2677	7	with	with	IN
cord-005453-4057qib7	2677	8	75.0	75.0	CD
cord-005453-4057qib7	2677	9	%	%	NN
cord-005453-4057qib7	2677	10	having	have	VBG
cord-005453-4057qib7	2677	11	a	a	DT
cord-005453-4057qib7	2677	12	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2677	13	.	.	.
cord-005453-4057qib7	2678	1	In	in	IN
cord-005453-4057qib7	2678	2	the	the	DT
cord-005453-4057qib7	2678	3	T	T	NNP
cord-005453-4057qib7	2678	4	-	-	HYPH
cord-005453-4057qib7	2678	5	IND	IND	NNP
cord-005453-4057qib7	2678	6	,	,	,
cord-005453-4057qib7	2678	7	patients	patient	NNS
cord-005453-4057qib7	2678	8	with	with	IN
cord-005453-4057qib7	2678	9	MOD	MOD	NNP
cord-005453-4057qib7	2678	10	had	have	VBD
cord-005453-4057qib7	2678	11	higher	high	JJR
cord-005453-4057qib7	2678	12	rates	rate	NNS
cord-005453-4057qib7	2678	13	of	of	IN
cord-005453-4057qib7	2678	14	AEs	ae	NNS
cord-005453-4057qib7	2678	15	.	.	.
cord-005453-4057qib7	2679	1	Support	support	NN
cord-005453-4057qib7	2679	2	:	:	:
cord-005453-4057qib7	2679	3	Jazz	Jazz	NNP
cord-005453-4057qib7	2679	4	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	2679	5	Event	Event	NNP
cord-005453-4057qib7	2679	6	,	,	,
cord-005453-4057qib7	2679	7	n(%	n(%	-RRB-
cord-005453-4057qib7	2679	8	)	)	-RRB-
cord-005453-4057qib7	2680	1	Phase	phase	NN
cord-005453-4057qib7	2680	2	2/3	2/3	CD
cord-005453-4057qib7	2680	3	studies	study	NNS
cord-005453-4057qib7	2680	4	(	(	-LRB-
cord-005453-4057qib7	2680	5	n=176	n=176	CD
cord-005453-4057qib7	2680	6	)	)	-RRB-
cord-005453-4057qib7	2681	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2681	2	:	:	:
cord-005453-4057qib7	2682	1	Paul	Paul	NNP
cord-005453-4057qib7	2682	2	G.	G.	NNP
cord-005453-4057qib7	2682	3	Richardson	Richardson	NNP
cord-005453-4057qib7	2682	4	has	have	VBZ
cord-005453-4057qib7	2682	5	served	serve	VBN
cord-005453-4057qib7	2682	6	on	on	IN
cord-005453-4057qib7	2682	7	advisory	advisory	JJ
cord-005453-4057qib7	2682	8	committees	committee	NNS
cord-005453-4057qib7	2682	9	and	and	CC
cord-005453-4057qib7	2682	10	as	as	IN
cord-005453-4057qib7	2682	11	a	a	DT
cord-005453-4057qib7	2682	12	consultant	consultant	NN
cord-005453-4057qib7	2682	13	,	,	,
cord-005453-4057qib7	2682	14	and	and	CC
cord-005453-4057qib7	2682	15	has	have	VBZ
cord-005453-4057qib7	2682	16	received	receive	VBN
cord-005453-4057qib7	2682	17	research	research	NN
cord-005453-4057qib7	2682	18	funding	funding	NN
cord-005453-4057qib7	2682	19	from	from	IN
cord-005453-4057qib7	2682	20	Jazz	Jazz	NNP
cord-005453-4057qib7	2682	21	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2682	22	.	.	.
cord-005453-4057qib7	2683	1	Angela	Angela	NNP
cord-005453-4057qib7	2683	2	R.	R.	NNP
cord-005453-4057qib7	2683	3	Smith	Smith	NNP
cord-005453-4057qib7	2683	4	and	and	CC
cord-005453-4057qib7	2683	5	Leslie	Leslie	NNP
cord-005453-4057qib7	2683	6	Lehmann	Lehmann	NNP
cord-005453-4057qib7	2683	7	have	have	VBP
cord-005453-4057qib7	2683	8	nothing	nothing	NN
cord-005453-4057qib7	2683	9	to	to	TO
cord-005453-4057qib7	2683	10	disclose	disclose	VB
cord-005453-4057qib7	2683	11	.	.	.
cord-005453-4057qib7	2684	1	Nancy	Nancy	NNP
cord-005453-4057qib7	2684	2	A.	A.	NNP
cord-005453-4057qib7	2684	3	Kernan	Kernan	NNP
cord-005453-4057qib7	2684	4	received	receive	VBD
cord-005453-4057qib7	2684	5	grants	grant	NNS
cord-005453-4057qib7	2684	6	from	from	IN
cord-005453-4057qib7	2684	7	Gentium	Gentium	NNP
cord-005453-4057qib7	2684	8	during	during	IN
cord-005453-4057qib7	2684	9	the	the	DT
cord-005453-4057qib7	2684	10	conduct	conduct	NN
cord-005453-4057qib7	2684	11	of	of	IN
cord-005453-4057qib7	2684	12	the	the	DT
cord-005453-4057qib7	2684	13	study	study	NN
cord-005453-4057qib7	2684	14	,	,	,
cord-005453-4057qib7	2684	15	and	and	CC
cord-005453-4057qib7	2684	16	her	-PRON-	PRP$
cord-005453-4057qib7	2684	17	research	research	NN
cord-005453-4057qib7	2684	18	was	be	VBD
cord-005453-4057qib7	2684	19	supported	support	VBN
cord-005453-4057qib7	2684	20	by	by	IN
cord-005453-4057qib7	2684	21	The	the	DT
cord-005453-4057qib7	2684	22	National	National	NNP
cord-005453-4057qib7	2684	23	Cancer	Cancer	NNP
cord-005453-4057qib7	2684	24	Institute	Institute	NNP
cord-005453-4057qib7	2684	25	of	of	IN
cord-005453-4057qib7	2684	26	the	the	DT
cord-005453-4057qib7	2684	27	National	National	NNP
cord-005453-4057qib7	2684	28	Institutes	Institutes	NNPS
cord-005453-4057qib7	2684	29	of	of	IN
cord-005453-4057qib7	2684	30	Health	Health	NNP
cord-005453-4057qib7	2684	31	under	under	IN
cord-005453-4057qib7	2684	32	award	award	NN
cord-005453-4057qib7	2684	33	number	number	NN
cord-005453-4057qib7	2684	34	P30	P30	NNP
cord-005453-4057qib7	2684	35	CA008748	CA008748	NNP
cord-005453-4057qib7	2684	36	;	;	:
cord-005453-4057qib7	2684	37	the	the	DT
cord-005453-4057qib7	2684	38	content	content	NN
cord-005453-4057qib7	2684	39	is	be	VBZ
cord-005453-4057qib7	2684	40	solely	solely	RB
cord-005453-4057qib7	2684	41	the	the	DT
cord-005453-4057qib7	2684	42	responsibility	responsibility	NN
cord-005453-4057qib7	2684	43	of	of	IN
cord-005453-4057qib7	2684	44	the	the	DT
cord-005453-4057qib7	2684	45	author	author	NN
cord-005453-4057qib7	2684	46	and	and	CC
cord-005453-4057qib7	2684	47	does	do	VBZ
cord-005453-4057qib7	2684	48	not	not	RB
cord-005453-4057qib7	2684	49	necessarily	necessarily	RB
cord-005453-4057qib7	2684	50	represent	represent	VB
cord-005453-4057qib7	2684	51	the	the	DT
cord-005453-4057qib7	2684	52	official	official	JJ
cord-005453-4057qib7	2684	53	views	view	NNS
cord-005453-4057qib7	2684	54	of	of	IN
cord-005453-4057qib7	2684	55	the	the	DT
cord-005453-4057qib7	2684	56	National	National	NNP
cord-005453-4057qib7	2684	57	Institutes	Institutes	NNPS
cord-005453-4057qib7	2684	58	of	of	IN
cord-005453-4057qib7	2684	59	Health	Health	NNP
cord-005453-4057qib7	2684	60	.	.	.
cord-005453-4057qib7	2685	1	She	-PRON-	PRP
cord-005453-4057qib7	2685	2	has	have	VBZ
cord-005453-4057qib7	2685	3	a	a	DT
cord-005453-4057qib7	2685	4	research	research	NN
cord-005453-4057qib7	2685	5	grant	grant	NN
cord-005453-4057qib7	2685	6	from	from	IN
cord-005453-4057qib7	2685	7	Jazz	Jazz	NNP
cord-005453-4057qib7	2685	8	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2685	9	.	.	.
cord-005453-4057qib7	2686	1	Robert	Robert	NNP
cord-005453-4057qib7	2686	2	Ryan	Ryan	NNP
cord-005453-4057qib7	2686	3	and	and	CC
cord-005453-4057qib7	2686	4	William	William	NNP
cord-005453-4057qib7	2686	5	Tappe	Tappe	NNP
cord-005453-4057qib7	2686	6	are	be	VBP
cord-005453-4057qib7	2686	7	employees	employee	NNS
cord-005453-4057qib7	2686	8	of	of	IN
cord-005453-4057qib7	2686	9	Jazz	Jazz	NNP
cord-005453-4057qib7	2686	10	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2686	11	and	and	CC
cord-005453-4057qib7	2686	12	hold	hold	VB
cord-005453-4057qib7	2686	13	stock	stock	NN
cord-005453-4057qib7	2686	14	and/or	and/or	CC
cord-005453-4057qib7	2686	15	stock	stock	NN
cord-005453-4057qib7	2686	16	options	option	NNS
cord-005453-4057qib7	2686	17	in	in	IN
cord-005453-4057qib7	2686	18	Jazz	Jazz	NNP
cord-005453-4057qib7	2686	19	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	2686	20	plc	plc	NNP
cord-005453-4057qib7	2686	21	.	.	.
cord-005453-4057qib7	2687	1	Stephan	Stephan	NNP
cord-005453-4057qib7	2687	2	A.	A.	NNP
cord-005453-4057qib7	2687	3	Grupp	Grupp	NNP
cord-005453-4057qib7	2687	4	has	have	VBZ
cord-005453-4057qib7	2687	5	served	serve	VBN
cord-005453-4057qib7	2687	6	on	on	IN
cord-005453-4057qib7	2687	7	a	a	DT
cord-005453-4057qib7	2687	8	steering	steering	NN
cord-005453-4057qib7	2687	9	committee	committee	NN
cord-005453-4057qib7	2687	10	and	and	CC
cord-005453-4057qib7	2687	11	as	as	IN
cord-005453-4057qib7	2687	12	a	a	DT
cord-005453-4057qib7	2687	13	consultant	consultant	NN
cord-005453-4057qib7	2687	14	to	to	IN
cord-005453-4057qib7	2687	15	Jazz	Jazz	NNP
cord-005453-4057qib7	2687	16	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2687	17	.	.	.
cord-005453-4057qib7	2688	1	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	2688	2	for	for	IN
cord-005453-4057qib7	2688	3	treatment	treatment	NN
cord-005453-4057qib7	2688	4	of	of	IN
cord-005453-4057qib7	2688	5	adults	adult	NNS
cord-005453-4057qib7	2688	6	with	with	IN
cord-005453-4057qib7	2688	7	hepatic	hepatic	JJ
cord-005453-4057qib7	2688	8	VOD/	VOD/	NNP
cord-005453-4057qib7	2688	9	SOS	SOS	NNP
cord-005453-4057qib7	2688	10	with	with	IN
cord-005453-4057qib7	2688	11	or	or	CC
cord-005453-4057qib7	2688	12	without	without	IN
cord-005453-4057qib7	2688	13	multiorgan	multiorgan	NN
cord-005453-4057qib7	2688	14	failure	failure	NN
cord-005453-4057qib7	2688	15	after	after	IN
cord-005453-4057qib7	2688	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2688	17	cell	cell	NN
cord-005453-4057qib7	2688	18	transplantation	transplantation	NN
cord-005453-4057qib7	2688	19	:	:	:
cord-005453-4057qib7	2688	20	Results	result	NNS
cord-005453-4057qib7	2688	21	of	of	IN
cord-005453-4057qib7	2688	22	a	a	DT
cord-005453-4057qib7	2688	23	systematic	systematic	JJ
cord-005453-4057qib7	2688	24	review	review	NN
cord-005453-4057qib7	2688	25	/	/	SYM
cord-005453-4057qib7	2688	26	meta	meta	NN
cord-005453-4057qib7	2688	27	-	-	HYPH
cord-005453-4057qib7	2688	28	analysis	analysis	NN
cord-005453-4057qib7	2688	29	Background	background	NN
cord-005453-4057qib7	2688	30	:	:	:
cord-005453-4057qib7	2688	31	Although	although	IN
cord-005453-4057qib7	2688	32	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2688	33	cell	cell	NN
cord-005453-4057qib7	2688	34	transplantation	transplantation	NN
cord-005453-4057qib7	2688	35	(	(	-LRB-
cord-005453-4057qib7	2688	36	HCT	HCT	NNP
cord-005453-4057qib7	2688	37	)	)	-RRB-
cord-005453-4057qib7	2688	38	,	,	,
cord-005453-4057qib7	2688	39	autologous	autologous	JJ
cord-005453-4057qib7	2688	40	or	or	CC
cord-005453-4057qib7	2688	41	allogeneic	allogeneic	NN
cord-005453-4057qib7	2688	42	,	,	,
cord-005453-4057qib7	2688	43	is	be	VBZ
cord-005453-4057qib7	2688	44	potentially	potentially	RB
cord-005453-4057qib7	2688	45	curable	curable	JJ
cord-005453-4057qib7	2688	46	in	in	IN
cord-005453-4057qib7	2688	47	various	various	JJ
cord-005453-4057qib7	2688	48	hematologic	hematologic	JJ
cord-005453-4057qib7	2688	49	malignancies	malignancy	NNS
cord-005453-4057qib7	2688	50	,	,	,
cord-005453-4057qib7	2688	51	the	the	DT
cord-005453-4057qib7	2688	52	procedure	procedure	NN
cord-005453-4057qib7	2688	53	is	be	VBZ
cord-005453-4057qib7	2688	54	associated	associate	VBN
cord-005453-4057qib7	2688	55	with	with	IN
cord-005453-4057qib7	2688	56	serious	serious	JJ
cord-005453-4057qib7	2688	57	and	and	CC
cord-005453-4057qib7	2688	58	potentially	potentially	RB
cord-005453-4057qib7	2688	59	life	life	NN
cord-005453-4057qib7	2688	60	-	-	HYPH
cord-005453-4057qib7	2688	61	threatening	threaten	VBG
cord-005453-4057qib7	2688	62	complications	complication	NNS
cord-005453-4057qib7	2688	63	,	,	,
cord-005453-4057qib7	2688	64	among	among	IN
cord-005453-4057qib7	2688	65	them	-PRON-	PRP
cord-005453-4057qib7	2688	66	veno	veno	NNP
cord-005453-4057qib7	2688	67	-	-	HYPH
cord-005453-4057qib7	2688	68	occlusive	occlusive	JJ
cord-005453-4057qib7	2688	69	disease	disease	NN
cord-005453-4057qib7	2688	70	/	/	,
cord-005453-4057qib7	2688	71	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	2688	72	obstructive	obstructive	JJ
cord-005453-4057qib7	2688	73	syndrome	syndrome	NN
cord-005453-4057qib7	2688	74	(	(	-LRB-
cord-005453-4057qib7	2688	75	VOD	VOD	NNP
cord-005453-4057qib7	2688	76	/	/	SYM
cord-005453-4057qib7	2688	77	SOS	SOS	NNP
cord-005453-4057qib7	2688	78	)	)	-RRB-
cord-005453-4057qib7	2688	79	of	of	IN
cord-005453-4057qib7	2688	80	the	the	DT
cord-005453-4057qib7	2688	81	liver	liver	NN
cord-005453-4057qib7	2688	82	.	.	.
cord-005453-4057qib7	2689	1	Several	several	JJ
cord-005453-4057qib7	2689	2	studies	study	NNS
cord-005453-4057qib7	2689	3	,	,	,
cord-005453-4057qib7	2689	4	prospective	prospective	JJ
cord-005453-4057qib7	2689	5	or	or	CC
cord-005453-4057qib7	2689	6	retrospective	retrospective	JJ
cord-005453-4057qib7	2689	7	,	,	,
cord-005453-4057qib7	2689	8	have	have	VBP
cord-005453-4057qib7	2689	9	reported	report	VBN
cord-005453-4057qib7	2689	10	outcomes	outcome	NNS
cord-005453-4057qib7	2689	11	of	of	IN
cord-005453-4057qib7	2689	12	defibrotide	defibrotide	NN
cord-005453-4057qib7	2689	13	,	,	,
cord-005453-4057qib7	2689	14	when	when	WRB
cord-005453-4057qib7	2689	15	used	use	VBN
cord-005453-4057qib7	2689	16	as	as	IN
cord-005453-4057qib7	2689	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2689	18	or	or	CC
cord-005453-4057qib7	2689	19	treatment	treatment	NN
cord-005453-4057qib7	2689	20	,	,	,
cord-005453-4057qib7	2689	21	in	in	IN
cord-005453-4057qib7	2689	22	a	a	DT
cord-005453-4057qib7	2689	23	mixed	mixed	JJ
cord-005453-4057qib7	2689	24	population	population	NN
cord-005453-4057qib7	2689	25	of	of	IN
cord-005453-4057qib7	2689	26	adult	adult	NN
cord-005453-4057qib7	2689	27	and	and	CC
cord-005453-4057qib7	2689	28	pediatric	pediatric	JJ
cord-005453-4057qib7	2689	29	patients	patient	NNS
cord-005453-4057qib7	2689	30	.	.	.
cord-005453-4057qib7	2690	1	In	in	IN
cord-005453-4057qib7	2690	2	this	this	DT
cord-005453-4057qib7	2690	3	systematic	systematic	JJ
cord-005453-4057qib7	2690	4	review	review	NN
cord-005453-4057qib7	2690	5	/	/	SYM
cord-005453-4057qib7	2690	6	meta	meta	NN
cord-005453-4057qib7	2690	7	-	-	HYPH
cord-005453-4057qib7	2690	8	analysis	analysis	NN
cord-005453-4057qib7	2690	9	,	,	,
cord-005453-4057qib7	2690	10	we	-PRON-	PRP
cord-005453-4057qib7	2690	11	analyze	analyze	VBP
cord-005453-4057qib7	2690	12	outcomes	outcome	NNS
cord-005453-4057qib7	2690	13	of	of	IN
cord-005453-4057qib7	2690	14	defibrotide	defibrotide	NN
cord-005453-4057qib7	2690	15	when	when	WRB
cord-005453-4057qib7	2690	16	specifically	specifically	RB
cord-005453-4057qib7	2690	17	used	use	VBN
cord-005453-4057qib7	2690	18	for	for	IN
cord-005453-4057qib7	2690	19	treatment	treatment	NN
cord-005453-4057qib7	2690	20	of	of	IN
cord-005453-4057qib7	2690	21	adult	adult	NN
cord-005453-4057qib7	2690	22	patients	patient	NNS
cord-005453-4057qib7	2690	23	with	with	IN
cord-005453-4057qib7	2690	24	hepatic	hepatic	JJ
cord-005453-4057qib7	2690	25	VOD	VOD	NNP
cord-005453-4057qib7	2690	26	/	/	SYM
cord-005453-4057qib7	2690	27	SOS	SOS	NNP
cord-005453-4057qib7	2690	28	with	with	IN
cord-005453-4057qib7	2690	29	or	or	CC
cord-005453-4057qib7	2690	30	without	without	IN
cord-005453-4057qib7	2690	31	multiorgan	multiorgan	NN
cord-005453-4057qib7	2690	32	failure	failure	NN
cord-005453-4057qib7	2690	33	.	.	.
cord-005453-4057qib7	2691	1	Methods	method	NNS
cord-005453-4057qib7	2691	2	:	:	:
cord-005453-4057qib7	2692	1	A	a	DT
cord-005453-4057qib7	2692	2	comprehensive	comprehensive	JJ
cord-005453-4057qib7	2692	3	search	search	NN
cord-005453-4057qib7	2692	4	of	of	IN
cord-005453-4057qib7	2692	5	3	3	CD
cord-005453-4057qib7	2692	6	large	large	JJ
cord-005453-4057qib7	2692	7	databases	database	NNS
cord-005453-4057qib7	2692	8	(	(	-LRB-
cord-005453-4057qib7	2692	9	Medline	Medline	NNP
cord-005453-4057qib7	2692	10	/	/	SYM
cord-005453-4057qib7	2692	11	Pubmed	Pubmed	NNP
cord-005453-4057qib7	2692	12	,	,	,
cord-005453-4057qib7	2692	13	Cochrane	Cochrane	NNP
cord-005453-4057qib7	2692	14	and	and	CC
cord-005453-4057qib7	2692	15	EMBASE	EMBASE	NNP
cord-005453-4057qib7	2692	16	)	)	-RRB-
cord-005453-4057qib7	2692	17	on	on	IN
cord-005453-4057qib7	2692	18	November	November	NNP
cord-005453-4057qib7	2692	19	2	2	CD
cord-005453-4057qib7	2692	20	,	,	,
cord-005453-4057qib7	2692	21	2018	2018	CD
cord-005453-4057qib7	2692	22	identified	identify	VBD
cord-005453-4057qib7	2692	23	642	642	CD
cord-005453-4057qib7	2692	24	publications	publication	NNS
cord-005453-4057qib7	2692	25	.	.	.
cord-005453-4057qib7	2693	1	Analysis	analysis	NN
cord-005453-4057qib7	2693	2	was	be	VBD
cord-005453-4057qib7	2693	3	restricted	restrict	VBN
cord-005453-4057qib7	2693	4	only	only	RB
cord-005453-4057qib7	2693	5	to	to	IN
cord-005453-4057qib7	2693	6	adult	adult	NN
cord-005453-4057qib7	2693	7	patients	patient	NNS
cord-005453-4057qib7	2693	8	(	(	-LRB-
cord-005453-4057qib7	2693	9	defined	define	VBN
cord-005453-4057qib7	2693	10	as	as	IN
cord-005453-4057qib7	2693	11	median	median	JJ
cord-005453-4057qib7	2693	12	age	age	NN
cord-005453-4057qib7	2693	13	older	old	JJR
cord-005453-4057qib7	2693	14	than	than	IN
cord-005453-4057qib7	2693	15	16	16	CD
cord-005453-4057qib7	2693	16	years	year	NNS
cord-005453-4057qib7	2693	17	)	)	-RRB-
cord-005453-4057qib7	2693	18	who	who	WP
cord-005453-4057qib7	2693	19	received	receive	VBD
cord-005453-4057qib7	2693	20	defibrotide	defibrotide	NN
cord-005453-4057qib7	2693	21	for	for	IN
cord-005453-4057qib7	2693	22	treatment	treatment	NN
cord-005453-4057qib7	2693	23	of	of	IN
cord-005453-4057qib7	2693	24	VOD	VOD	NNP
cord-005453-4057qib7	2693	25	/	/	SYM
cord-005453-4057qib7	2693	26	SOS	SOS	NNP
cord-005453-4057qib7	2693	27	and	and	CC
cord-005453-4057qib7	2693	28	were	be	VBD
cord-005453-4057qib7	2693	29	reported	report	VBN
cord-005453-4057qib7	2693	30	in	in	IN
cord-005453-4057qib7	2693	31	prospective	prospective	JJ
cord-005453-4057qib7	2693	32	or	or	CC
cord-005453-4057qib7	2693	33	retrospective	retrospective	JJ
cord-005453-4057qib7	2693	34	(	(	-LRB-
cord-005453-4057qib7	2693	35	which	which	WDT
cord-005453-4057qib7	2693	36	included	include	VBD
cord-005453-4057qib7	2693	37	≥	≥	CD
cord-005453-4057qib7	2693	38	5	5	CD
cord-005453-4057qib7	2693	39	patients	patient	NNS
cord-005453-4057qib7	2693	40	)	)	-RRB-
cord-005453-4057qib7	2693	41	studies	study	NNS
cord-005453-4057qib7	2693	42	published	publish	VBN
cord-005453-4057qib7	2693	43	in	in	IN
cord-005453-4057qib7	2693	44	full	full	JJ
cord-005453-4057qib7	2693	45	manuscript	manuscript	NN
cord-005453-4057qib7	2693	46	form	form	NN
cord-005453-4057qib7	2693	47	.	.	.
cord-005453-4057qib7	2694	1	There	there	EX
cord-005453-4057qib7	2694	2	were	be	VBD
cord-005453-4057qib7	2694	3	no	no	DT
cord-005453-4057qib7	2694	4	limitations	limitation	NNS
cord-005453-4057qib7	2694	5	based	base	VBN
cord-005453-4057qib7	2694	6	on	on	IN
cord-005453-4057qib7	2694	7	language	language	NN
cord-005453-4057qib7	2694	8	.	.	.
cord-005453-4057qib7	2695	1	Data	datum	NNS
cord-005453-4057qib7	2695	2	were	be	VBD
cord-005453-4057qib7	2695	3	extracted	extract	VBN
cord-005453-4057qib7	2695	4	in	in	IN
cord-005453-4057qib7	2695	5	relation	relation	NN
cord-005453-4057qib7	2695	6	to	to	IN
cord-005453-4057qib7	2695	7	benefits	benefit	NNS
cord-005453-4057qib7	2695	8	[	[	-LRB-
cord-005453-4057qib7	2695	9	complete	complete	JJ
cord-005453-4057qib7	2695	10	remission	remission	NN
cord-005453-4057qib7	2695	11	(	(	-LRB-
cord-005453-4057qib7	2695	12	CR	cr	NN
cord-005453-4057qib7	2695	13	)	)	-RRB-
cord-005453-4057qib7	2695	14	rate	rate	NN
cord-005453-4057qib7	2695	15	and	and	CC
cord-005453-4057qib7	2695	16	overall	overall	JJ
cord-005453-4057qib7	2695	17	survival	survival	NN
cord-005453-4057qib7	2695	18	(	(	-LRB-
cord-005453-4057qib7	2695	19	OS	OS	NNP
cord-005453-4057qib7	2695	20	)	)	-RRB-
cord-005453-4057qib7	2695	21	]	]	-RRB-
cord-005453-4057qib7	2695	22	and	and	CC
cord-005453-4057qib7	2695	23	harms	harm	NNS
cord-005453-4057qib7	2695	24	(	(	-LRB-
cord-005453-4057qib7	2695	25	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2695	26	,	,	,
cord-005453-4057qib7	2695	27	any	any	DT
cord-005453-4057qib7	2695	28	site	site	NN
cord-005453-4057qib7	2695	29	or	or	CC
cord-005453-4057qib7	2695	30	organ	organ	NN
cord-005453-4057qib7	2695	31	-	-	HYPH
cord-005453-4057qib7	2695	32	specific	specific	JJ
cord-005453-4057qib7	2695	33	)	)	-RRB-
cord-005453-4057qib7	2695	34	.	.	.
cord-005453-4057qib7	2696	1	A	a	DT
cord-005453-4057qib7	2696	2	total	total	NN
cord-005453-4057qib7	2696	3	of	of	IN
cord-005453-4057qib7	2696	4	15	15	CD
cord-005453-4057qib7	2696	5	studies	study	NNS
cord-005453-4057qib7	2696	6	(	(	-LRB-
cord-005453-4057qib7	2696	7	prospective=6	prospective=6	NN
cord-005453-4057qib7	2696	8	;	;	:
cord-005453-4057qib7	2696	9	retrospective=9	retrospective=9	LS
cord-005453-4057qib7	2696	10	)	)	-RRB-
cord-005453-4057qib7	2697	1	with	with	IN
cord-005453-4057qib7	2697	2	1437	1437	CD
cord-005453-4057qib7	2697	3	patients	patient	NNS
cord-005453-4057qib7	2697	4	met	meet	VBD
cord-005453-4057qib7	2697	5	inclusion	inclusion	NN
cord-005453-4057qib7	2697	6	criteria	criterion	NNS
cord-005453-4057qib7	2697	7	.	.	.
cord-005453-4057qib7	2698	1	Results	result	NNS
cord-005453-4057qib7	2698	2	:	:	:
cord-005453-4057qib7	2699	1	The	the	DT
cord-005453-4057qib7	2699	2	median	median	JJ
cord-005453-4057qib7	2699	3	year	year	NN
cord-005453-4057qib7	2699	4	of	of	IN
cord-005453-4057qib7	2699	5	publication	publication	NN
cord-005453-4057qib7	2699	6	of	of	IN
cord-005453-4057qib7	2699	7	prospective	prospective	JJ
cord-005453-4057qib7	2699	8	studies	study	NNS
cord-005453-4057qib7	2699	9	was	be	VBD
cord-005453-4057qib7	2699	10	2013	2013	CD
cord-005453-4057qib7	2699	11	(	(	-LRB-
cord-005453-4057qib7	2699	12	2002	2002	CD
cord-005453-4057qib7	2699	13	)	)	-RRB-
cord-005453-4057qib7	2700	1	(	(	-LRB-
cord-005453-4057qib7	2700	2	2003	2003	CD
cord-005453-4057qib7	2700	3	)	)	-RRB-
cord-005453-4057qib7	2701	1	(	(	-LRB-
cord-005453-4057qib7	2701	2	2004	2004	CD
cord-005453-4057qib7	2701	3	)	)	-RRB-
cord-005453-4057qib7	2702	1	(	(	-LRB-
cord-005453-4057qib7	2702	2	2005	2005	CD
cord-005453-4057qib7	2702	3	)	)	-RRB-
cord-005453-4057qib7	2703	1	(	(	-LRB-
cord-005453-4057qib7	2703	2	2006	2006	CD
cord-005453-4057qib7	2703	3	)	)	-RRB-
cord-005453-4057qib7	2704	1	(	(	-LRB-
cord-005453-4057qib7	2704	2	2007	2007	CD
cord-005453-4057qib7	2704	3	)	)	-RRB-
cord-005453-4057qib7	2705	1	(	(	-LRB-
cord-005453-4057qib7	2705	2	2008	2008	CD
cord-005453-4057qib7	2705	3	)	)	-RRB-
cord-005453-4057qib7	2706	1	(	(	-LRB-
cord-005453-4057qib7	2706	2	2009	2009	CD
cord-005453-4057qib7	2706	3	)	)	-RRB-
cord-005453-4057qib7	2707	1	(	(	-LRB-
cord-005453-4057qib7	2707	2	2010	2010	CD
cord-005453-4057qib7	2707	3	)	)	-RRB-
cord-005453-4057qib7	2708	1	(	(	-LRB-
cord-005453-4057qib7	2708	2	2011	2011	CD
cord-005453-4057qib7	2708	3	)	)	-RRB-
cord-005453-4057qib7	2709	1	(	(	-LRB-
cord-005453-4057qib7	2709	2	2012	2012	CD
cord-005453-4057qib7	2709	3	)	)	-RRB-
cord-005453-4057qib7	2710	1	(	(	-LRB-
cord-005453-4057qib7	2710	2	2013	2013	CD
cord-005453-4057qib7	2710	3	)	)	-RRB-
cord-005453-4057qib7	2711	1	(	(	-LRB-
cord-005453-4057qib7	2711	2	2014	2014	CD
cord-005453-4057qib7	2711	3	)	)	-RRB-
cord-005453-4057qib7	2711	4	(	(	-LRB-
cord-005453-4057qib7	2711	5	2015	2015	CD
cord-005453-4057qib7	2711	6	)	)	-RRB-
cord-005453-4057qib7	2711	7	(	(	-LRB-
cord-005453-4057qib7	2711	8	2016	2016	CD
cord-005453-4057qib7	2711	9	)	)	-RRB-
cord-005453-4057qib7	2711	10	(	(	-LRB-
cord-005453-4057qib7	2711	11	2017	2017	CD
cord-005453-4057qib7	2711	12	)	)	-RRB-
cord-005453-4057qib7	2711	13	(	(	-LRB-
cord-005453-4057qib7	2711	14	2018	2018	CD
cord-005453-4057qib7	2711	15	)	)	-RRB-
cord-005453-4057qib7	2712	1	and	and	CC
cord-005453-4057qib7	2712	2	for	for	IN
cord-005453-4057qib7	2712	3	retrospective	retrospective	JJ
cord-005453-4057qib7	2712	4	ones	one	NNS
cord-005453-4057qib7	2712	5	2016	2016	CD
cord-005453-4057qib7	2712	6	(	(	-LRB-
cord-005453-4057qib7	2712	7	2000	2000	CD
cord-005453-4057qib7	2712	8	)	)	-RRB-
cord-005453-4057qib7	2712	9	(	(	-LRB-
cord-005453-4057qib7	2712	10	2001	2001	CD
cord-005453-4057qib7	2712	11	)	)	-RRB-
cord-005453-4057qib7	2712	12	(	(	-LRB-
cord-005453-4057qib7	2712	13	2002	2002	CD
cord-005453-4057qib7	2712	14	)	)	-RRB-
cord-005453-4057qib7	2712	15	(	(	-LRB-
cord-005453-4057qib7	2712	16	2003	2003	CD
cord-005453-4057qib7	2712	17	)	)	-RRB-
cord-005453-4057qib7	2712	18	(	(	-LRB-
cord-005453-4057qib7	2712	19	2004	2004	CD
cord-005453-4057qib7	2712	20	)	)	-RRB-
cord-005453-4057qib7	2712	21	(	(	-LRB-
cord-005453-4057qib7	2712	22	2005	2005	CD
cord-005453-4057qib7	2712	23	)	)	-RRB-
cord-005453-4057qib7	2712	24	(	(	-LRB-
cord-005453-4057qib7	2712	25	2006	2006	CD
cord-005453-4057qib7	2712	26	)	)	-RRB-
cord-005453-4057qib7	2712	27	(	(	-LRB-
cord-005453-4057qib7	2712	28	2007	2007	CD
cord-005453-4057qib7	2712	29	)	)	-RRB-
cord-005453-4057qib7	2712	30	(	(	-LRB-
cord-005453-4057qib7	2712	31	2008	2008	CD
cord-005453-4057qib7	2712	32	)	)	-RRB-
cord-005453-4057qib7	2712	33	(	(	-LRB-
cord-005453-4057qib7	2712	34	2009	2009	CD
cord-005453-4057qib7	2712	35	)	)	-RRB-
cord-005453-4057qib7	2712	36	(	(	-LRB-
cord-005453-4057qib7	2712	37	2010	2010	CD
cord-005453-4057qib7	2712	38	)	)	-RRB-
cord-005453-4057qib7	2712	39	(	(	-LRB-
cord-005453-4057qib7	2712	40	2011	2011	CD
cord-005453-4057qib7	2712	41	)	)	-RRB-
cord-005453-4057qib7	2712	42	(	(	-LRB-
cord-005453-4057qib7	2712	43	2012	2012	CD
cord-005453-4057qib7	2712	44	)	)	-RRB-
cord-005453-4057qib7	2712	45	(	(	-LRB-
cord-005453-4057qib7	2712	46	2013	2013	CD
cord-005453-4057qib7	2712	47	)	)	-RRB-
cord-005453-4057qib7	2713	1	(	(	-LRB-
cord-005453-4057qib7	2713	2	2014	2014	CD
cord-005453-4057qib7	2713	3	)	)	-RRB-
cord-005453-4057qib7	2713	4	(	(	-LRB-
cord-005453-4057qib7	2713	5	2015	2015	CD
cord-005453-4057qib7	2713	6	)	)	-RRB-
cord-005453-4057qib7	2713	7	(	(	-LRB-
cord-005453-4057qib7	2713	8	2016	2016	CD
cord-005453-4057qib7	2713	9	)	)	-RRB-
cord-005453-4057qib7	2713	10	(	(	-LRB-
cord-005453-4057qib7	2713	11	2017	2017	CD
cord-005453-4057qib7	2713	12	)	)	-RRB-
cord-005453-4057qib7	2713	13	(	(	-LRB-
cord-005453-4057qib7	2713	14	2018	2018	CD
cord-005453-4057qib7	2713	15	)	)	-RRB-
cord-005453-4057qib7	2713	16	.	.	.
cord-005453-4057qib7	2714	1	The	the	DT
cord-005453-4057qib7	2714	2	prescribed	prescribed	JJ
cord-005453-4057qib7	2714	3	starting	starting	NN
cord-005453-4057qib7	2714	4	dose	dose	NN
cord-005453-4057qib7	2714	5	of	of	IN
cord-005453-4057qib7	2714	6	defibrotide	defibrotide	NN
cord-005453-4057qib7	2714	7	varied	varied	JJ
cord-005453-4057qib7	2714	8	among	among	IN
cord-005453-4057qib7	2714	9	studies	study	NNS
cord-005453-4057qib7	2714	10	ranging	range	VBG
cord-005453-4057qib7	2714	11	from	from	IN
cord-005453-4057qib7	2714	12	6.25	6.25	CD
cord-005453-4057qib7	2714	13	mg	mg	NNP
cord-005453-4057qib7	2714	14	/	/	SYM
cord-005453-4057qib7	2714	15	kg	kg	NNP
cord-005453-4057qib7	2714	16	/	/	SYM
cord-005453-4057qib7	2714	17	day	day	NN
cord-005453-4057qib7	2714	18	to	to	IN
cord-005453-4057qib7	2714	19	80	80	CD
cord-005453-4057qib7	2714	20	mg	mg	NNP
cord-005453-4057qib7	2714	21	/	/	SYM
cord-005453-4057qib7	2714	22	kg	kg	NNP
cord-005453-4057qib7	2714	23	/	/	SYM
cord-005453-4057qib7	2714	24	day	day	NN
cord-005453-4057qib7	2714	25	,	,	,
cord-005453-4057qib7	2714	26	mostly	mostly	RB
cord-005453-4057qib7	2714	27	for	for	IN
cord-005453-4057qib7	2714	28	a	a	DT
cord-005453-4057qib7	2714	29	21-day	21-day	CD
cord-005453-4057qib7	2714	30	course	course	NN
cord-005453-4057qib7	2714	31	.	.	.
cord-005453-4057qib7	2715	1	The	the	DT
cord-005453-4057qib7	2715	2	pooled	pool	VBN
cord-005453-4057qib7	2715	3	CR	cr	NN
cord-005453-4057qib7	2715	4	rate	rate	NN
cord-005453-4057qib7	2715	5	was	be	VBD
cord-005453-4057qib7	2715	6	39	39	CD
cord-005453-4057qib7	2715	7	%	%	NN
cord-005453-4057qib7	2715	8	(	(	-LRB-
cord-005453-4057qib7	2715	9	95%CI=28	95%CI=28	NNP
cord-005453-4057qib7	2715	10	-	-	SYM
cord-005453-4057qib7	2715	11	49	49	CD
cord-005453-4057qib7	2715	12	%	%	NN
cord-005453-4057qib7	2715	13	)	)	-RRB-
cord-005453-4057qib7	2715	14	for	for	IN
cord-005453-4057qib7	2715	15	prospective	prospective	JJ
cord-005453-4057qib7	2715	16	and	and	CC
cord-005453-4057qib7	2715	17	54	54	CD
cord-005453-4057qib7	2715	18	%	%	NN
cord-005453-4057qib7	2715	19	(	(	-LRB-
cord-005453-4057qib7	2715	20	95%CI=39	95%CI=39	NNP
cord-005453-4057qib7	2715	21	-	-	SYM
cord-005453-4057qib7	2715	22	69	69	CD
cord-005453-4057qib7	2715	23	%	%	NN
cord-005453-4057qib7	2715	24	)	)	-RRB-
cord-005453-4057qib7	2715	25	for	for	IN
cord-005453-4057qib7	2715	26	retrospective	retrospective	JJ
cord-005453-4057qib7	2715	27	studies	study	NNS
cord-005453-4057qib7	2715	28	.	.	.
cord-005453-4057qib7	2716	1	The	the	DT
cord-005453-4057qib7	2716	2	pooled	pooled	JJ
cord-005453-4057qib7	2716	3	day	day	NN
cord-005453-4057qib7	2716	4	+100	+100	NN
cord-005453-4057qib7	2716	5	OS	os	NN
cord-005453-4057qib7	2716	6	rates	rate	NNS
cord-005453-4057qib7	2716	7	were	be	VBD
cord-005453-4057qib7	2716	8	43	43	CD
cord-005453-4057qib7	2716	9	%	%	NN
cord-005453-4057qib7	2716	10	(	(	-LRB-
cord-005453-4057qib7	2716	11	95%CI=37	95%CI=37	NNP
cord-005453-4057qib7	2716	12	-	-	SYM
cord-005453-4057qib7	2716	13	48	48	CD
cord-005453-4057qib7	2716	14	%	%	NN
cord-005453-4057qib7	2716	15	)	)	-RRB-
cord-005453-4057qib7	2716	16	and	and	CC
cord-005453-4057qib7	2716	17	65	65	CD
cord-005453-4057qib7	2716	18	%	%	NN
cord-005453-4057qib7	2716	19	(	(	-LRB-
cord-005453-4057qib7	2716	20	95	95	CD
cord-005453-4057qib7	2716	21	%	%	NN
cord-005453-4057qib7	2716	22	CI=53	CI=53	NNP
cord-005453-4057qib7	2716	23	-	-	HYPH
cord-005453-4057qib7	2716	24	75	75	CD
cord-005453-4057qib7	2716	25	%	%	NN
cord-005453-4057qib7	2716	26	)	)	-RRB-
cord-005453-4057qib7	2716	27	for	for	IN
cord-005453-4057qib7	2716	28	prospective	prospective	JJ
cord-005453-4057qib7	2716	29	and	and	CC
cord-005453-4057qib7	2716	30	retrospective	retrospective	JJ
cord-005453-4057qib7	2716	31	studies	study	NNS
cord-005453-4057qib7	2716	32	,	,	,
cord-005453-4057qib7	2716	33	respectively	respectively	RB
cord-005453-4057qib7	2716	34	.	.	.
cord-005453-4057qib7	2717	1	The	the	DT
cord-005453-4057qib7	2717	2	pooled	pool	VBN
cord-005453-4057qib7	2717	3	rates	rate	NNS
cord-005453-4057qib7	2717	4	of	of	IN
cord-005453-4057qib7	2717	5	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2717	6	(	(	-LRB-
cord-005453-4057qib7	2717	7	any	any	DT
cord-005453-4057qib7	2717	8	site	site	NN
cord-005453-4057qib7	2717	9	)	)	-RRB-
cord-005453-4057qib7	2717	10	were	be	VBD
cord-005453-4057qib7	2717	11	15	15	CD
cord-005453-4057qib7	2717	12	%	%	NN
cord-005453-4057qib7	2717	13	(	(	-LRB-
cord-005453-4057qib7	2717	14	95%CI=2	95%ci=2	CD
cord-005453-4057qib7	2717	15	-	-	SYM
cord-005453-4057qib7	2717	16	35	35	CD
cord-005453-4057qib7	2717	17	%	%	NN
cord-005453-4057qib7	2717	18	)	)	-RRB-
cord-005453-4057qib7	2717	19	for	for	IN
cord-005453-4057qib7	2717	20	prospective	prospective	JJ
cord-005453-4057qib7	2717	21	and	and	CC
cord-005453-4057qib7	2717	22	21	21	CD
cord-005453-4057qib7	2717	23	%	%	NN
cord-005453-4057qib7	2717	24	(	(	-LRB-
cord-005453-4057qib7	2717	25	95	95	CD
cord-005453-4057qib7	2717	26	%	%	NN
cord-005453-4057qib7	2717	27	CI=4	CI=4	NNPS
cord-005453-4057qib7	2717	28	-	-	SYM
cord-005453-4057qib7	2717	29	43	43	CD
cord-005453-4057qib7	2717	30	%	%	NN
cord-005453-4057qib7	2717	31	)	)	-RRB-
cord-005453-4057qib7	2717	32	for	for	IN
cord-005453-4057qib7	2717	33	retrospective	retrospective	JJ
cord-005453-4057qib7	2717	34	studies	study	NNS
cord-005453-4057qib7	2717	35	.	.	.
cord-005453-4057qib7	2718	1	When	when	WRB
cord-005453-4057qib7	2718	2	analyzing	analyze	VBG
cord-005453-4057qib7	2718	3	organ	organ	NN
cord-005453-4057qib7	2718	4	-	-	HYPH
cord-005453-4057qib7	2718	5	specific	specific	JJ
cord-005453-4057qib7	2718	6	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2718	7	,	,	,
cord-005453-4057qib7	2718	8	3	3	CD
cord-005453-4057qib7	2718	9	prospective	prospective	JJ
cord-005453-4057qib7	2718	10	studies	study	NNS
cord-005453-4057qib7	2718	11	(	(	-LRB-
cord-005453-4057qib7	2718	12	n=1091	n=1091	CD
cord-005453-4057qib7	2718	13	patients	patient	NNS
cord-005453-4057qib7	2718	14	)	)	-RRB-
cord-005453-4057qib7	2718	15	reported	report	VBD
cord-005453-4057qib7	2718	16	pooled	pool	VBN
cord-005453-4057qib7	2718	17	rates	rate	NNS
cord-005453-4057qib7	2718	18	of	of	IN
cord-005453-4057qib7	2718	19	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2718	20	alveolar	alveolar	NN
cord-005453-4057qib7	2718	21	(	(	-LRB-
cord-005453-4057qib7	2718	22	PA	PA	NNP
cord-005453-4057qib7	2718	23	)	)	-RRB-
cord-005453-4057qib7	2718	24	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2718	25	of	of	IN
cord-005453-4057qib7	2718	26	2	2	CD
cord-005453-4057qib7	2718	27	%	%	NN
cord-005453-4057qib7	2718	28	(	(	-LRB-
cord-005453-4057qib7	2718	29	95%CI=1	95%ci=1	CD
cord-005453-4057qib7	2718	30	-	-	SYM
cord-005453-4057qib7	2718	31	3	3	CD
cord-005453-4057qib7	2718	32	%	%	NN
cord-005453-4057qib7	2718	33	)	)	-RRB-
cord-005453-4057qib7	2718	34	and	and	CC
cord-005453-4057qib7	2718	35	of	of	IN
cord-005453-4057qib7	2718	36	5	5	CD
cord-005453-4057qib7	2718	37	%	%	NN
cord-005453-4057qib7	2718	38	(	(	-LRB-
cord-005453-4057qib7	2718	39	95%CI=3	95%ci=3	CD
cord-005453-4057qib7	2718	40	-	-	SYM
cord-005453-4057qib7	2718	41	7	7	CD
cord-005453-4057qib7	2718	42	%	%	NN
cord-005453-4057qib7	2718	43	)	)	-RRB-
cord-005453-4057qib7	2718	44	for	for	IN
cord-005453-4057qib7	2718	45	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	2718	46	(	(	-LRB-
cord-005453-4057qib7	2718	47	GI	gi	NN
cord-005453-4057qib7	2718	48	)	)	-RRB-
cord-005453-4057qib7	2718	49	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2718	50	.	.	.
cord-005453-4057qib7	2719	1	Only	only	RB
cord-005453-4057qib7	2719	2	one	one	CD
cord-005453-4057qib7	2719	3	retrospective	retrospective	JJ
cord-005453-4057qib7	2719	4	study	study	NN
cord-005453-4057qib7	2719	5	(	(	-LRB-
cord-005453-4057qib7	2719	6	n=14	n=14	JJ
cord-005453-4057qib7	2719	7	patients	patient	NNS
cord-005453-4057qib7	2719	8	)	)	-RRB-
cord-005453-4057qib7	2719	9	reported	report	VBD
cord-005453-4057qib7	2719	10	an	an	DT
cord-005453-4057qib7	2719	11	incidence	incidence	NN
cord-005453-4057qib7	2719	12	of	of	IN
cord-005453-4057qib7	2719	13	PA	PA	NNP
cord-005453-4057qib7	2719	14	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2719	15	of	of	IN
cord-005453-4057qib7	2719	16	7	7	CD
cord-005453-4057qib7	2719	17	%	%	NN
cord-005453-4057qib7	2719	18	(	(	-LRB-
cord-005453-4057qib7	2719	19	95%CI=0	95%ci=0	CD
cord-005453-4057qib7	2719	20	-	-	SYM
cord-005453-4057qib7	2719	21	34	34	CD
cord-005453-4057qib7	2719	22	%	%	NN
cord-005453-4057qib7	2719	23	)	)	-RRB-
cord-005453-4057qib7	2719	24	and	and	CC
cord-005453-4057qib7	2719	25	a	a	DT
cord-005453-4057qib7	2719	26	different	different	JJ
cord-005453-4057qib7	2719	27	study	study	NN
cord-005453-4057qib7	2719	28	(	(	-LRB-
cord-005453-4057qib7	2719	29	n=14	n=14	JJ
cord-005453-4057qib7	2719	30	patients	patient	NNS
cord-005453-4057qib7	2719	31	)	)	-RRB-
cord-005453-4057qib7	2719	32	reported	report	VBD
cord-005453-4057qib7	2719	33	an	an	DT
cord-005453-4057qib7	2719	34	incidence	incidence	NN
cord-005453-4057qib7	2719	35	of	of	IN
cord-005453-4057qib7	2719	36	GI	GI	NNP
cord-005453-4057qib7	2719	37	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2719	38	of	of	IN
cord-005453-4057qib7	2719	39	14	14	CD
cord-005453-4057qib7	2719	40	%	%	NN
cord-005453-4057qib7	2719	41	(	(	-LRB-
cord-005453-4057qib7	2719	42	95%CI=2	95%ci=2	CD
cord-005453-4057qib7	2719	43	-	-	SYM
cord-005453-4057qib7	2719	44	43	43	CD
cord-005453-4057qib7	2719	45	%	%	NN
cord-005453-4057qib7	2719	46	)	)	-RRB-
cord-005453-4057qib7	2719	47	.	.	.
cord-005453-4057qib7	2720	1	None	none	NN
cord-005453-4057qib7	2720	2	of	of	IN
cord-005453-4057qib7	2720	3	the	the	DT
cord-005453-4057qib7	2720	4	15	15	CD
cord-005453-4057qib7	2720	5	studies	study	NNS
cord-005453-4057qib7	2720	6	reported	report	VBD
cord-005453-4057qib7	2720	7	cerebral	cerebral	JJ
cord-005453-4057qib7	2720	8	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2720	9	as	as	IN
cord-005453-4057qib7	2720	10	a	a	DT
cord-005453-4057qib7	2720	11	complication	complication	NN
cord-005453-4057qib7	2720	12	of	of	IN
cord-005453-4057qib7	2720	13	defibrotide	defibrotide	NN
cord-005453-4057qib7	2720	14	therapy	therapy	NN
cord-005453-4057qib7	2720	15	.	.	.
cord-005453-4057qib7	2721	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2721	2	:	:	:
cord-005453-4057qib7	2722	1	This	this	DT
cord-005453-4057qib7	2722	2	systematic	systematic	JJ
cord-005453-4057qib7	2722	3	review	review	NN
cord-005453-4057qib7	2722	4	/	/	SYM
cord-005453-4057qib7	2722	5	meta	meta	NNP
cord-005453-4057qib7	2722	6	-	-	HYPH
cord-005453-4057qib7	2722	7	analysis	analysis	NNP
cord-005453-4057qib7	2722	8	confirms	confirm	VBZ
cord-005453-4057qib7	2722	9	the	the	DT
cord-005453-4057qib7	2722	10	efficacy	efficacy	NN
cord-005453-4057qib7	2722	11	of	of	IN
cord-005453-4057qib7	2722	12	defibrotide	defibrotide	NN
cord-005453-4057qib7	2722	13	for	for	IN
cord-005453-4057qib7	2722	14	treatment	treatment	NN
cord-005453-4057qib7	2722	15	of	of	IN
cord-005453-4057qib7	2722	16	VOD	VOD	NNP
cord-005453-4057qib7	2722	17	/	/	SYM
cord-005453-4057qib7	2722	18	SOS	SOS	NNP
cord-005453-4057qib7	2722	19	with	with	IN
cord-005453-4057qib7	2722	20	or	or	CC
cord-005453-4057qib7	2722	21	without	without	IN
cord-005453-4057qib7	2722	22	multiorgan	multiorgan	NNP
cord-005453-4057qib7	2722	23	failure	failure	NN
cord-005453-4057qib7	2722	24	,	,	,
cord-005453-4057qib7	2722	25	yielding	yield	VBG
cord-005453-4057qib7	2722	26	CR	cr	NN
cord-005453-4057qib7	2722	27	rates	rate	NNS
cord-005453-4057qib7	2722	28	of	of	IN
cord-005453-4057qib7	2722	29	39	39	CD
cord-005453-4057qib7	2722	30	-	-	SYM
cord-005453-4057qib7	2722	31	54	54	CD
cord-005453-4057qib7	2722	32	%	%	NN
cord-005453-4057qib7	2722	33	and	and	CC
cord-005453-4057qib7	2722	34	day	day	NN
cord-005453-4057qib7	2722	35	+100	+100	NNS
cord-005453-4057qib7	2722	36	OS	os	NN
cord-005453-4057qib7	2722	37	rates	rate	NNS
cord-005453-4057qib7	2722	38	of	of	IN
cord-005453-4057qib7	2722	39	43	43	CD
cord-005453-4057qib7	2722	40	-	-	SYM
cord-005453-4057qib7	2722	41	65	65	CD
cord-005453-4057qib7	2722	42	%	%	NN
cord-005453-4057qib7	2722	43	.	.	.
cord-005453-4057qib7	2723	1	The	the	DT
cord-005453-4057qib7	2723	2	purportedly	purportedly	RB
cord-005453-4057qib7	2723	3	higher	high	JJR
cord-005453-4057qib7	2723	4	pooled	pool	VBN
cord-005453-4057qib7	2723	5	CR	CR	NNP
cord-005453-4057qib7	2723	6	and	and	CC
cord-005453-4057qib7	2723	7	OS	OS	NNP
cord-005453-4057qib7	2723	8	rates	rate	NNS
cord-005453-4057qib7	2723	9	observed	observe	VBN
cord-005453-4057qib7	2723	10	with	with	IN
cord-005453-4057qib7	2723	11	retrospective	retrospective	JJ
cord-005453-4057qib7	2723	12	(	(	-LRB-
cord-005453-4057qib7	2723	13	vs.	vs.	FW
cord-005453-4057qib7	2723	14	prospective	prospective	JJ
cord-005453-4057qib7	2723	15	)	)	-RRB-
cord-005453-4057qib7	2723	16	studies	study	NNS
cord-005453-4057qib7	2723	17	are	be	VBP
cord-005453-4057qib7	2723	18	likely	likely	JJ
cord-005453-4057qib7	2723	19	due	due	IN
cord-005453-4057qib7	2723	20	to	to	IN
cord-005453-4057qib7	2723	21	assignment	assignment	NN
cord-005453-4057qib7	2723	22	-	-	HYPH
cord-005453-4057qib7	2723	23	bias	bias	NN
cord-005453-4057qib7	2723	24	inherent	inherent	JJ
cord-005453-4057qib7	2723	25	to	to	IN
cord-005453-4057qib7	2723	26	observational	observational	JJ
cord-005453-4057qib7	2723	27	studies	study	NNS
cord-005453-4057qib7	2723	28	.	.	.
cord-005453-4057qib7	2724	1	Moreover	moreover	RB
cord-005453-4057qib7	2724	2	,	,	,
cord-005453-4057qib7	2724	3	although	although	IN
cord-005453-4057qib7	2724	4	the	the	DT
cord-005453-4057qib7	2724	5	pooled	pool	VBN
cord-005453-4057qib7	2724	6	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2724	7	(	(	-LRB-
cord-005453-4057qib7	2724	8	any	any	DT
cord-005453-4057qib7	2724	9	site	site	NN
cord-005453-4057qib7	2724	10	)	)	-RRB-
cord-005453-4057qib7	2724	11	rates	rate	NNS
cord-005453-4057qib7	2724	12	of	of	IN
cord-005453-4057qib7	2724	13	15	15	CD
cord-005453-4057qib7	2724	14	-	-	SYM
cord-005453-4057qib7	2724	15	21	21	CD
cord-005453-4057qib7	2724	16	%	%	NN
cord-005453-4057qib7	2724	17	is	be	VBZ
cord-005453-4057qib7	2724	18	considered	consider	VBN
cord-005453-4057qib7	2724	19	proportionally	proportionally	RB
cord-005453-4057qib7	2724	20	significant	significant	JJ
cord-005453-4057qib7	2724	21	,	,	,
cord-005453-4057qib7	2724	22	the	the	DT
cord-005453-4057qib7	2724	23	pooled	pool	VBN
cord-005453-4057qib7	2724	24	rates	rate	NNS
cord-005453-4057qib7	2724	25	of	of	IN
cord-005453-4057qib7	2724	26	PA	PA	NNP
cord-005453-4057qib7	2724	27	and	and	CC
cord-005453-4057qib7	2724	28	GI	GI	NNP
cord-005453-4057qib7	2724	29	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	2724	30	were	be	VBD
cord-005453-4057qib7	2724	31	≤	≤	NNS
cord-005453-4057qib7	2724	32	5	5	CD
cord-005453-4057qib7	2724	33	%	%	NN
cord-005453-4057qib7	2724	34	,	,	,
cord-005453-4057qib7	2724	35	in	in	IN
cord-005453-4057qib7	2724	36	prospective	prospective	JJ
cord-005453-4057qib7	2724	37	studies	study	NNS
cord-005453-4057qib7	2724	38	.	.	.
cord-005453-4057qib7	2725	1	Clinical	clinical	JJ
cord-005453-4057qib7	2725	2	Trial	Trial	NNP
cord-005453-4057qib7	2725	3	Registry	Registry	NNP
cord-005453-4057qib7	2725	4	:	:	:
cord-005453-4057qib7	2726	1	Not	not	RB
cord-005453-4057qib7	2726	2	applicable	applicable	JJ
cord-005453-4057qib7	2726	3	Disclosure	disclosure	NN
cord-005453-4057qib7	2726	4	:	:	:
cord-005453-4057qib7	2726	5	M.A.K	M.A.K	NNP
cord-005453-4057qib7	2726	6	-	-	HYPH
cord-005453-4057qib7	2726	7	D	D	NNP
cord-005453-4057qib7	2726	8	:	:	:
cord-005453-4057qib7	2726	9	Consultancy	consultancy	NN
cord-005453-4057qib7	2726	10	for	for	IN
cord-005453-4057qib7	2726	11	Pharmacyclics	Pharmacyclics	NNP
cord-005453-4057qib7	2726	12	M.M	M.M	NNP
cord-005453-4057qib7	2726	13	:	:	:
cord-005453-4057qib7	2726	14	received	receive	VBN
cord-005453-4057qib7	2726	15	lectures	lecture	NNS
cord-005453-4057qib7	2726	16	honoraria	honorarium	NNS
cord-005453-4057qib7	2726	17	and	and	CC
cord-005453-4057qib7	2726	18	research	research	NN
cord-005453-4057qib7	2726	19	support	support	NN
cord-005453-4057qib7	2726	20	from	from	IN
cord-005453-4057qib7	2726	21	Jazz	Jazz	NNP
cord-005453-4057qib7	2726	22	Pharma	Pharma	NNP
cord-005453-4057qib7	2726	23	Efficacy	Efficacy	NNP
cord-005453-4057qib7	2726	24	and	and	CC
cord-005453-4057qib7	2726	25	safety	safety	NN
cord-005453-4057qib7	2726	26	of	of	IN
cord-005453-4057qib7	2726	27	defibrotide	defibrotide	NN
cord-005453-4057qib7	2726	28	in	in	IN
cord-005453-4057qib7	2726	29	the	the	DT
cord-005453-4057qib7	2726	30	treatment	treatment	NN
cord-005453-4057qib7	2726	31	of	of	IN
cord-005453-4057qib7	2726	32	hepatic	hepatic	JJ
cord-005453-4057qib7	2726	33	veno	veno	NN
cord-005453-4057qib7	2726	34	-	-	HYPH
cord-005453-4057qib7	2726	35	occlusive	occlusive	JJ
cord-005453-4057qib7	2726	36	disease	disease	NN
cord-005453-4057qib7	2726	37	/	/	,
cord-005453-4057qib7	2726	38	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	2726	39	obstruction	obstruction	NN
cord-005453-4057qib7	2726	40	syndrome	syndrome	NN
cord-005453-4057qib7	2726	41	following	follow	VBG
cord-005453-4057qib7	2726	42	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2726	43	stem	stem	NN
cord-005453-4057qib7	2726	44	cell	cell	NN
cord-005453-4057qib7	2726	45	transplantation	transplantation	NN
cord-005453-4057qib7	2726	46	:	:	:
cord-005453-4057qib7	2727	1	Interim	interim	JJ
cord-005453-4057qib7	2727	2	results	result	NNS
cord-005453-4057qib7	2727	3	from	from	IN
cord-005453-4057qib7	2727	4	the	the	DT
cord-005453-4057qib7	2727	5	defifrance	defifrance	NN
cord-005453-4057qib7	2727	6	study	study	NN
cord-005453-4057qib7	2727	7	Background	Background	NNP
cord-005453-4057qib7	2727	8	:	:	:
cord-005453-4057qib7	2728	1	Hepatic	hepatic	JJ
cord-005453-4057qib7	2728	2	veno	veno	NN
cord-005453-4057qib7	2728	3	-	-	HYPH
cord-005453-4057qib7	2728	4	occlusive	occlusive	JJ
cord-005453-4057qib7	2728	5	disease	disease	NN
cord-005453-4057qib7	2728	6	/	/	,
cord-005453-4057qib7	2728	7	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	2728	8	obstruction	obstruction	NN
cord-005453-4057qib7	2728	9	syndrome	syndrome	NN
cord-005453-4057qib7	2728	10	(	(	-LRB-
cord-005453-4057qib7	2728	11	VOD	VOD	NNP
cord-005453-4057qib7	2728	12	/	/	SYM
cord-005453-4057qib7	2728	13	SOS	SOS	NNP
cord-005453-4057qib7	2728	14	)	)	-RRB-
cord-005453-4057qib7	2728	15	is	be	VBZ
cord-005453-4057qib7	2728	16	a	a	DT
cord-005453-4057qib7	2728	17	potentially	potentially	RB
cord-005453-4057qib7	2728	18	lifethreatening	lifethreatening	JJ
cord-005453-4057qib7	2728	19	complication	complication	NN
cord-005453-4057qib7	2728	20	of	of	IN
cord-005453-4057qib7	2728	21	conditioning	conditioning	NN
cord-005453-4057qib7	2728	22	for	for	IN
cord-005453-4057qib7	2728	23	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2728	24	stem	stem	NN
cord-005453-4057qib7	2728	25	cell	cell	NN
cord-005453-4057qib7	2728	26	transplant	transplant	NN
cord-005453-4057qib7	2728	27	(	(	-LRB-
cord-005453-4057qib7	2728	28	HSCT	HSCT	NNP
cord-005453-4057qib7	2728	29	)	)	-RRB-
cord-005453-4057qib7	2728	30	but	but	CC
cord-005453-4057qib7	2728	31	may	may	MD
cord-005453-4057qib7	2728	32	occur	occur	VB
cord-005453-4057qib7	2728	33	after	after	IN
cord-005453-4057qib7	2728	34	nontransplant	nontransplant	JJ
cord-005453-4057qib7	2728	35	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2728	36	alone	alone	RB
cord-005453-4057qib7	2728	37	.	.	.
cord-005453-4057qib7	2729	1	VOD	VOD	NNP
cord-005453-4057qib7	2729	2	/	/	SYM
cord-005453-4057qib7	2729	3	SOS	SOS	NNP
cord-005453-4057qib7	2729	4	with	with	IN
cord-005453-4057qib7	2729	5	multi	multi	JJ
cord-005453-4057qib7	2729	6	-	-	JJ
cord-005453-4057qib7	2729	7	organ	organ	JJ
cord-005453-4057qib7	2729	8	dysfunction	dysfunction	NN
cord-005453-4057qib7	2729	9	(	(	-LRB-
cord-005453-4057qib7	2729	10	MOD	mod	NN
cord-005453-4057qib7	2729	11	)	)	-RRB-
cord-005453-4057qib7	2729	12	may	may	MD
cord-005453-4057qib7	2729	13	be	be	VB
cord-005453-4057qib7	2729	14	associated	associate	VBN
cord-005453-4057qib7	2729	15	with	with	IN
cord-005453-4057qib7	2729	16	>	>	XX
cord-005453-4057qib7	2729	17	80	80	CD
cord-005453-4057qib7	2729	18	%	%	NN
cord-005453-4057qib7	2729	19	mortality	mortality	NN
cord-005453-4057qib7	2729	20	with	with	IN
cord-005453-4057qib7	2729	21	supportive	supportive	JJ
cord-005453-4057qib7	2729	22	care	care	NN
cord-005453-4057qib7	2729	23	alone	alone	RB
cord-005453-4057qib7	2729	24	.	.	.
cord-005453-4057qib7	2730	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	2730	2	of	of	IN
cord-005453-4057qib7	2730	3	VOD	VOD	NNP
cord-005453-4057qib7	2730	4	/	/	SYM
cord-005453-4057qib7	2730	5	SOS	SOS	NNP
cord-005453-4057qib7	2730	6	was	be	VBD
cord-005453-4057qib7	2730	7	traditionally	traditionally	RB
cord-005453-4057qib7	2730	8	based	base	VBN
cord-005453-4057qib7	2730	9	on	on	IN
cord-005453-4057qib7	2730	10	Baltimore	Baltimore	NNP
cord-005453-4057qib7	2730	11	or	or	CC
cord-005453-4057qib7	2730	12	modified	modify	VBN
cord-005453-4057qib7	2730	13	Seattle	Seattle	NNP
cord-005453-4057qib7	2730	14	criteria	criterion	NNS
cord-005453-4057qib7	2730	15	;	;	:
cord-005453-4057qib7	2730	16	however	however	RB
cord-005453-4057qib7	2730	17	,	,	,
cord-005453-4057qib7	2730	18	the	the	DT
cord-005453-4057qib7	2730	19	EBMT	EBMT	NNP
cord-005453-4057qib7	2730	20	recently	recently	RB
cord-005453-4057qib7	2730	21	published	publish	VBD
cord-005453-4057qib7	2730	22	separate	separate	JJ
cord-005453-4057qib7	2730	23	diagnostic	diagnostic	JJ
cord-005453-4057qib7	2730	24	criteria	criterion	NNS
cord-005453-4057qib7	2730	25	for	for	IN
cord-005453-4057qib7	2730	26	adults	adult	NNS
cord-005453-4057qib7	2730	27	and	and	CC
cord-005453-4057qib7	2730	28	children	child	NNS
cord-005453-4057qib7	2730	29	.	.	.
cord-005453-4057qib7	2731	1	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	2731	2	is	be	VBZ
cord-005453-4057qib7	2731	3	approved	approve	VBN
cord-005453-4057qib7	2731	4	for	for	IN
cord-005453-4057qib7	2731	5	treating	treat	VBG
cord-005453-4057qib7	2731	6	severe	severe	JJ
cord-005453-4057qib7	2731	7	hepatic	hepatic	JJ
cord-005453-4057qib7	2731	8	VOD	VOD	NNP
cord-005453-4057qib7	2731	9	/	/	SYM
cord-005453-4057qib7	2731	10	SOS	SOS	NNP
cord-005453-4057qib7	2731	11	post	post	NNP
cord-005453-4057qib7	2731	12	-	-	JJ
cord-005453-4057qib7	2731	13	HSCT	HSCT	NNP
cord-005453-4057qib7	2731	14	in	in	IN
cord-005453-4057qib7	2731	15	patients	patient	NNS
cord-005453-4057qib7	2731	16	aged	age	VBN
cord-005453-4057qib7	2731	17	>	>	SYM
cord-005453-4057qib7	2731	18	1	1	CD
cord-005453-4057qib7	2731	19	month	month	NN
cord-005453-4057qib7	2731	20	in	in	IN
cord-005453-4057qib7	2731	21	the	the	DT
cord-005453-4057qib7	2731	22	EU	EU	NNP
cord-005453-4057qib7	2731	23	,	,	,
cord-005453-4057qib7	2731	24	and	and	CC
cord-005453-4057qib7	2731	25	for	for	IN
cord-005453-4057qib7	2731	26	hepatic	hepatic	JJ
cord-005453-4057qib7	2731	27	VOD	VOD	NNP
cord-005453-4057qib7	2731	28	/	/	SYM
cord-005453-4057qib7	2731	29	SOS	SOS	NNP
cord-005453-4057qib7	2731	30	with	with	IN
cord-005453-4057qib7	2731	31	renal	renal	JJ
cord-005453-4057qib7	2731	32	or	or	CC
cord-005453-4057qib7	2731	33	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2731	34	dysfunction	dysfunction	NN
cord-005453-4057qib7	2731	35	post	post	NN
cord-005453-4057qib7	2731	36	-	-	JJ
cord-005453-4057qib7	2731	37	HSCT	HSCT	NNP
cord-005453-4057qib7	2731	38	in	in	IN
cord-005453-4057qib7	2731	39	the	the	DT
cord-005453-4057qib7	2731	40	USA	USA	NNP
cord-005453-4057qib7	2731	41	.	.	.
cord-005453-4057qib7	2732	1	The	the	DT
cord-005453-4057qib7	2732	2	goal	goal	NN
cord-005453-4057qib7	2732	3	of	of	IN
cord-005453-4057qib7	2732	4	the	the	DT
cord-005453-4057qib7	2732	5	DEFIFRANCE	DEFIFRANCE	NNP
cord-005453-4057qib7	2732	6	study	study	NN
cord-005453-4057qib7	2732	7	,	,	,
cord-005453-4057qib7	2732	8	requested	request	VBN
cord-005453-4057qib7	2732	9	by	by	IN
cord-005453-4057qib7	2732	10	the	the	DT
cord-005453-4057qib7	2732	11	French	french	JJ
cord-005453-4057qib7	2732	12	health	health	NN
cord-005453-4057qib7	2732	13	authorities	authority	NNS
cord-005453-4057qib7	2732	14	,	,	,
cord-005453-4057qib7	2732	15	is	be	VBZ
cord-005453-4057qib7	2732	16	to	to	TO
cord-005453-4057qib7	2732	17	collect	collect	VB
cord-005453-4057qib7	2732	18	real	real	JJ
cord-005453-4057qib7	2732	19	-	-	HYPH
cord-005453-4057qib7	2732	20	world	world	NN
cord-005453-4057qib7	2732	21	data	datum	NNS
cord-005453-4057qib7	2732	22	on	on	IN
cord-005453-4057qib7	2732	23	safety	safety	NN
cord-005453-4057qib7	2732	24	and	and	CC
cord-005453-4057qib7	2732	25	efficacy	efficacy	NN
cord-005453-4057qib7	2732	26	in	in	IN
cord-005453-4057qib7	2732	27	a	a	DT
cord-005453-4057qib7	2732	28	broader	broad	JJR
cord-005453-4057qib7	2732	29	patient	patient	JJ
cord-005453-4057qib7	2732	30	population	population	NN
cord-005453-4057qib7	2732	31	in	in	IN
cord-005453-4057qib7	2732	32	France	France	NNP
cord-005453-4057qib7	2732	33	,	,	,
cord-005453-4057qib7	2732	34	including	include	VBG
cord-005453-4057qib7	2732	35	all	all	DT
cord-005453-4057qib7	2732	36	indications	indication	NNS
cord-005453-4057qib7	2732	37	.	.	.
cord-005453-4057qib7	2733	1	This	this	DT
cord-005453-4057qib7	2733	2	is	be	VBZ
cord-005453-4057qib7	2733	3	the	the	DT
cord-005453-4057qib7	2733	4	first	first	JJ
cord-005453-4057qib7	2733	5	interim	interim	JJ
cord-005453-4057qib7	2733	6	analysis	analysis	NN
cord-005453-4057qib7	2733	7	of	of	IN
cord-005453-4057qib7	2733	8	the	the	DT
cord-005453-4057qib7	2733	9	largest	large	JJS
cord-005453-4057qib7	2733	10	current	current	JJ
cord-005453-4057qib7	2733	11	evaluation	evaluation	NN
cord-005453-4057qib7	2733	12	of	of	IN
cord-005453-4057qib7	2733	13	defibrotide	defibrotide	NN
cord-005453-4057qib7	2733	14	for	for	IN
cord-005453-4057qib7	2733	15	the	the	DT
cord-005453-4057qib7	2733	16	treatment	treatment	NN
cord-005453-4057qib7	2733	17	of	of	IN
cord-005453-4057qib7	2733	18	VOD	VOD	NNP
cord-005453-4057qib7	2733	19	/	/	SYM
cord-005453-4057qib7	2733	20	SOS	SOS	NNP
cord-005453-4057qib7	2733	21	in	in	IN
cord-005453-4057qib7	2733	22	Europe	Europe	NNP
cord-005453-4057qib7	2733	23	.	.	.
cord-005453-4057qib7	2734	1	Methods	method	NNS
cord-005453-4057qib7	2734	2	:	:	:
cord-005453-4057qib7	2734	3	DEFIFRANCE	DEFIFRANCE	NNP
cord-005453-4057qib7	2734	4	is	be	VBZ
cord-005453-4057qib7	2734	5	an	an	DT
cord-005453-4057qib7	2734	6	observational	observational	JJ
cord-005453-4057qib7	2734	7	,	,	,
cord-005453-4057qib7	2734	8	multicenter	multicenter	JJ
cord-005453-4057qib7	2734	9	,	,	,
cord-005453-4057qib7	2734	10	post	post	JJ
cord-005453-4057qib7	2734	11	-	-	JJ
cord-005453-4057qib7	2734	12	marketing	marketing	JJ
cord-005453-4057qib7	2734	13	study	study	NN
cord-005453-4057qib7	2734	14	that	that	WDT
cord-005453-4057qib7	2734	15	includes	include	VBZ
cord-005453-4057qib7	2734	16	any	any	DT
cord-005453-4057qib7	2734	17	patient	patient	NN
cord-005453-4057qib7	2734	18	treated	treat	VBN
cord-005453-4057qib7	2734	19	with	with	IN
cord-005453-4057qib7	2734	20	defibrotide	defibrotide	NN
cord-005453-4057qib7	2734	21	from	from	IN
cord-005453-4057qib7	2734	22	HSCT	HSCT	NNP
cord-005453-4057qib7	2734	23	centers	center	NNS
cord-005453-4057qib7	2734	24	in	in	IN
cord-005453-4057qib7	2734	25	France	France	NNP
cord-005453-4057qib7	2734	26	.	.	.
cord-005453-4057qib7	2735	1	This	this	DT
cord-005453-4057qib7	2735	2	interim	interim	JJ
cord-005453-4057qib7	2735	3	analysis	analysis	NN
cord-005453-4057qib7	2735	4	is	be	VBZ
cord-005453-4057qib7	2735	5	based	base	VBN
cord-005453-4057qib7	2735	6	on	on	IN
cord-005453-4057qib7	2735	7	all	all	DT
cord-005453-4057qib7	2735	8	patients	patient	NNS
cord-005453-4057qib7	2735	9	treated	treat	VBN
cord-005453-4057qib7	2735	10	with	with	IN
cord-005453-4057qib7	2735	11	defibrotide	defibrotide	NN
cord-005453-4057qib7	2735	12	,	,	,
cord-005453-4057qib7	2735	13	including	include	VBG
cord-005453-4057qib7	2735	14	those	those	DT
cord-005453-4057qib7	2735	15	with	with	IN
cord-005453-4057qib7	2735	16	severe	severe	JJ
cord-005453-4057qib7	2735	17	and	and	CC
cord-005453-4057qib7	2735	18	very	very	RB
cord-005453-4057qib7	2735	19	severe	severe	JJ
cord-005453-4057qib7	2735	20	post	post	JJ
cord-005453-4057qib7	2735	21	-	-	JJ
cord-005453-4057qib7	2735	22	HSCT	hsct	JJ
cord-005453-4057qib7	2735	23	VOD	VOD	NNP
cord-005453-4057qib7	2735	24	/	/	SYM
cord-005453-4057qib7	2735	25	SOS	SOS	NNP
cord-005453-4057qib7	2735	26	.	.	.
cord-005453-4057qib7	2736	1	VOD	VOD	NNP
cord-005453-4057qib7	2736	2	/	/	SYM
cord-005453-4057qib7	2736	3	SOS	SOS	NNP
cord-005453-4057qib7	2736	4	was	be	VBD
cord-005453-4057qib7	2736	5	diagnosed	diagnose	VBN
cord-005453-4057qib7	2736	6	using	use	VBG
cord-005453-4057qib7	2736	7	traditional	traditional	JJ
cord-005453-4057qib7	2736	8	criteria	criterion	NNS
cord-005453-4057qib7	2736	9	.	.	.
cord-005453-4057qib7	2737	1	Day+100	Day+100	NNP
cord-005453-4057qib7	2738	1	survival	survival	NN
cord-005453-4057qib7	2738	2	,	,	,
cord-005453-4057qib7	2738	3	complete	complete	JJ
cord-005453-4057qib7	2738	4	remission	remission	NN
cord-005453-4057qib7	2738	5	(	(	-LRB-
cord-005453-4057qib7	2738	6	CR	cr	NN
cord-005453-4057qib7	2738	7	;	;	:
cord-005453-4057qib7	2738	8	total	total	JJ
cord-005453-4057qib7	2738	9	serum	serum	NN
cord-005453-4057qib7	2738	10	bilirubin	bilirubin	NN
cord-005453-4057qib7	2738	11	<	<	XX
cord-005453-4057qib7	2738	12	2	2	CD
cord-005453-4057qib7	2738	13	mg	mg	NNP
cord-005453-4057qib7	2738	14	/	/	SYM
cord-005453-4057qib7	2738	15	dL	dl	NN
cord-005453-4057qib7	2738	16	and	and	CC
cord-005453-4057qib7	2738	17	resolution	resolution	NN
cord-005453-4057qib7	2738	18	of	of	IN
cord-005453-4057qib7	2738	19	MOD	mod	NN
cord-005453-4057qib7	2738	20	)	)	-RRB-
cord-005453-4057qib7	2738	21	,	,	,
cord-005453-4057qib7	2738	22	and	and	CC
cord-005453-4057qib7	2738	23	safety	safety	NN
cord-005453-4057qib7	2738	24	profile	profile	NN
cord-005453-4057qib7	2738	25	are	be	VBP
cord-005453-4057qib7	2738	26	reported	report	VBN
cord-005453-4057qib7	2738	27	.	.	.
cord-005453-4057qib7	2739	1	Results	result	NNS
cord-005453-4057qib7	2739	2	:	:	:
cord-005453-4057qib7	2740	1	A	a	DT
cord-005453-4057qib7	2740	2	total	total	NN
cord-005453-4057qib7	2740	3	of	of	IN
cord-005453-4057qib7	2740	4	324	324	CD
cord-005453-4057qib7	2740	5	patients	patient	NNS
cord-005453-4057qib7	2740	6	treated	treat	VBN
cord-005453-4057qib7	2740	7	with	with	IN
cord-005453-4057qib7	2740	8	defibrotide	defibrotide	NNP
cord-005453-4057qib7	2740	9	were	be	VBD
cord-005453-4057qib7	2740	10	included	include	VBN
cord-005453-4057qib7	2740	11	retrospectively	retrospectively	RB
cord-005453-4057qib7	2740	12	and	and	CC
cord-005453-4057qib7	2740	13	prospectively	prospectively	RB
cord-005453-4057qib7	2740	14	between	between	IN
cord-005453-4057qib7	2740	15	July	July	NNP
cord-005453-4057qib7	2740	16	2014	2014	CD
cord-005453-4057qib7	2740	17	and	and	CC
cord-005453-4057qib7	2740	18	October	October	NNP
cord-005453-4057qib7	2740	19	2018	2018	CD
cord-005453-4057qib7	2740	20	from	from	IN
cord-005453-4057qib7	2740	21	36	36	CD
cord-005453-4057qib7	2740	22	Table	table	NN
cord-005453-4057qib7	2740	23	]	]	-RRB-
cord-005453-4057qib7	2741	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2741	2	:	:	:
cord-005453-4057qib7	2742	1	Mohamad	Mohamad	NNP
cord-005453-4057qib7	2742	2	Mohty	Mohty	NNP
cord-005453-4057qib7	2742	3	:	:	:
cord-005453-4057qib7	2742	4	has	have	VBZ
cord-005453-4057qib7	2742	5	received	receive	VBN
cord-005453-4057qib7	2742	6	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	7	and	and	CC
cord-005453-4057qib7	2742	8	research	research	NN
cord-005453-4057qib7	2742	9	funding	funding	NN
cord-005453-4057qib7	2742	10	from	from	IN
cord-005453-4057qib7	2742	11	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	12	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	13	,	,	,
cord-005453-4057qib7	2742	14	Delphine	Delphine	NNP
cord-005453-4057qib7	2742	15	Lebon	Lebon	NNP
cord-005453-4057qib7	2742	16	:	:	:
cord-005453-4057qib7	2742	17	nothing	nothing	NN
cord-005453-4057qib7	2742	18	to	to	TO
cord-005453-4057qib7	2742	19	disclose	disclose	VB
cord-005453-4057qib7	2742	20	,	,	,
cord-005453-4057qib7	2742	21	Ann	Ann	NNP
cord-005453-4057qib7	2742	22	Berceanu	Berceanu	NNP
cord-005453-4057qib7	2742	23	:	:	:
cord-005453-4057qib7	2742	24	none	none	NN
cord-005453-4057qib7	2742	25	,	,	,
cord-005453-4057qib7	2742	26	Charlotte	Charlotte	NNP
cord-005453-4057qib7	2742	27	Jubert	Jubert	NNP
cord-005453-4057qib7	2742	28	:	:	:
cord-005453-4057qib7	2742	29	has	have	VBZ
cord-005453-4057qib7	2742	30	received	receive	VBN
cord-005453-4057qib7	2742	31	funding	funding	NN
cord-005453-4057qib7	2742	32	from	from	IN
cord-005453-4057qib7	2742	33	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	34	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	35	,	,	,
cord-005453-4057qib7	2742	36	Ibrahim	Ibrahim	NNP
cord-005453-4057qib7	2742	37	Yakoub	Yakoub	NNP
cord-005453-4057qib7	2742	38	-	-	HYPH
cord-005453-4057qib7	2742	39	Agha	Agha	NNP
cord-005453-4057qib7	2742	40	:	:	:
cord-005453-4057qib7	2742	41	has	have	VBZ
cord-005453-4057qib7	2742	42	received	receive	VBN
cord-005453-4057qib7	2742	43	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	44	from	from	IN
cord-005453-4057qib7	2742	45	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	46	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	47	,	,	,
cord-005453-4057qib7	2742	48	Stéphane	Stéphane	NNP
cord-005453-4057qib7	2742	49	Girault	Girault	NNP
cord-005453-4057qib7	2742	50	:	:	:
cord-005453-4057qib7	2742	51	none	none	NN
cord-005453-4057qib7	2742	52	,	,	,
cord-005453-4057qib7	2742	53	Marie	Marie	NNP
cord-005453-4057qib7	2742	54	Detrait	Detrait	NNP
cord-005453-4057qib7	2742	55	:	:	:
cord-005453-4057qib7	2742	56	has	have	VBZ
cord-005453-4057qib7	2742	57	received	receive	VBN
cord-005453-4057qib7	2742	58	research	research	NN
cord-005453-4057qib7	2742	59	funding	funding	NN
cord-005453-4057qib7	2742	60	from	from	IN
cord-005453-4057qib7	2742	61	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	62	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	63	,	,	,
cord-005453-4057qib7	2742	64	Cécile	Cécile	NNP
cord-005453-4057qib7	2742	65	Pochon	Pochon	NNP
cord-005453-4057qib7	2742	66	:	:	:
cord-005453-4057qib7	2742	67	none	none	NN
cord-005453-4057qib7	2742	68	,	,	,
cord-005453-4057qib7	2742	69	Fanny	Fanny	NNP
cord-005453-4057qib7	2742	70	Rialland	Rialland	NNP
cord-005453-4057qib7	2742	71	:	:	:
cord-005453-4057qib7	2742	72	none	none	NN
cord-005453-4057qib7	2742	73	,	,	,
cord-005453-4057qib7	2742	74	Virginie	Virginie	NNP
cord-005453-4057qib7	2742	75	Gandemer	Gandemer	NNP
cord-005453-4057qib7	2742	76	:	:	:
cord-005453-4057qib7	2742	77	none	none	NN
cord-005453-4057qib7	2742	78	,	,	,
cord-005453-4057qib7	2742	79	Jean	Jean	NNP
cord-005453-4057qib7	2742	80	-	-	HYPH
cord-005453-4057qib7	2742	81	Hugues	Hugues	NNP
cord-005453-4057qib7	2742	82	Dalle	Dalle	NNP
cord-005453-4057qib7	2742	83	:	:	:
cord-005453-4057qib7	2742	84	has	have	VBZ
cord-005453-4057qib7	2742	85	received	receive	VBN
cord-005453-4057qib7	2742	86	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	87	from	from	IN
cord-005453-4057qib7	2742	88	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	89	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	90	,	,	,
cord-005453-4057qib7	2742	91	Régis	Régis	NNP
cord-005453-4057qib7	2742	92	Peffault	Peffault	NNP
cord-005453-4057qib7	2742	93	de	de	NNP
cord-005453-4057qib7	2742	94	Latour	Latour	NNP
cord-005453-4057qib7	2742	95	:	:	:
cord-005453-4057qib7	2742	96	has	have	VBZ
cord-005453-4057qib7	2742	97	received	receive	VBN
cord-005453-4057qib7	2742	98	research	research	NN
cord-005453-4057qib7	2742	99	grant	grant	NN
cord-005453-4057qib7	2742	100	/	/	SYM
cord-005453-4057qib7	2742	101	honoraria	honoraria	NNP
cord-005453-4057qib7	2742	102	/	/	SYM
cord-005453-4057qib7	2742	103	board	board	NN
cord-005453-4057qib7	2742	104	from	from	IN
cord-005453-4057qib7	2742	105	Pfizer	Pfizer	NNP
cord-005453-4057qib7	2742	106	,	,	,
cord-005453-4057qib7	2742	107	Novartis	Novartis	NNP
cord-005453-4057qib7	2742	108	,	,	,
cord-005453-4057qib7	2742	109	Alexion	Alexion	NNP
cord-005453-4057qib7	2742	110	;	;	:
cord-005453-4057qib7	2742	111	research	research	NN
cord-005453-4057qib7	2742	112	grant	grant	VBP
cord-005453-4057qib7	2742	113	Amgen	Amgen	NNP
cord-005453-4057qib7	2742	114	;	;	:
cord-005453-4057qib7	2742	115	and	and	CC
cord-005453-4057qib7	2742	116	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	117	from	from	IN
cord-005453-4057qib7	2742	118	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	119	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	120	,	,	,
cord-005453-4057qib7	2742	121	David	David	NNP
cord-005453-4057qib7	2742	122	Michonneau	Michonneau	NNP
cord-005453-4057qib7	2742	123	:	:	:
cord-005453-4057qib7	2742	124	has	have	VBZ
cord-005453-4057qib7	2742	125	received	receive	VBN
cord-005453-4057qib7	2742	126	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	127	from	from	IN
cord-005453-4057qib7	2742	128	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	129	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	130	,	,	,
cord-005453-4057qib7	2742	131	Myriam	Myriam	NNP
cord-005453-4057qib7	2742	132	Labopin	Labopin	NNP
cord-005453-4057qib7	2742	133	:	:	:
cord-005453-4057qib7	2742	134	has	have	VBZ
cord-005453-4057qib7	2742	135	received	receive	VBN
cord-005453-4057qib7	2742	136	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	137	from	from	IN
cord-005453-4057qib7	2742	138	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	139	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	140	,	,	,
cord-005453-4057qib7	2742	141	Floriane	Floriane	NNP
cord-005453-4057qib7	2742	142	Delaval	Delaval	NNP
cord-005453-4057qib7	2742	143	:	:	:
cord-005453-4057qib7	2742	144	employee	employee	NN
cord-005453-4057qib7	2742	145	of	of	IN
cord-005453-4057qib7	2742	146	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	147	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	148	and	and	CC
cord-005453-4057qib7	2742	149	holds	hold	VBZ
cord-005453-4057qib7	2742	150	stock	stock	NN
cord-005453-4057qib7	2742	151	and/or	and/or	CC
cord-005453-4057qib7	2742	152	stock	stock	NN
cord-005453-4057qib7	2742	153	options	option	NNS
cord-005453-4057qib7	2742	154	in	in	IN
cord-005453-4057qib7	2742	155	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	156	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	2742	157	plc	plc	NNP
cord-005453-4057qib7	2742	158	,	,	,
cord-005453-4057qib7	2742	159	Gerard	Gerard	NNP
cord-005453-4057qib7	2742	160	Michel	Michel	NNP
cord-005453-4057qib7	2742	161	:	:	:
cord-005453-4057qib7	2742	162	none	none	NN
cord-005453-4057qib7	2742	163	,	,	,
cord-005453-4057qib7	2742	164	Anne	Anne	NNP
cord-005453-4057qib7	2742	165	Sirvent	Sirvent	NNP
cord-005453-4057qib7	2742	166	:	:	:
cord-005453-4057qib7	2742	167	none	none	NN
cord-005453-4057qib7	2742	168	,	,	,
cord-005453-4057qib7	2742	169	Laurence	Laurence	NNP
cord-005453-4057qib7	2742	170	Clement	Clement	NNP
cord-005453-4057qib7	2742	171	:	:	:
cord-005453-4057qib7	2742	172	none	none	NN
cord-005453-4057qib7	2742	173	Anne	Anne	NNP
cord-005453-4057qib7	2742	174	-	-	HYPH
cord-005453-4057qib7	2742	175	Lise	Lise	NNP
cord-005453-4057qib7	2742	176	Menard	Menard	NNP
cord-005453-4057qib7	2742	177	:	:	:
cord-005453-4057qib7	2742	178	none	none	NN
cord-005453-4057qib7	2742	179	,	,	,
cord-005453-4057qib7	2742	180	Anne	Anne	NNP
cord-005453-4057qib7	2742	181	Huynh	Huynh	NNP
cord-005453-4057qib7	2742	182	:	:	:
cord-005453-4057qib7	2742	183	has	have	VBZ
cord-005453-4057qib7	2742	184	received	receive	VBN
cord-005453-4057qib7	2742	185	honoraria	honorarium	NNS
cord-005453-4057qib7	2742	186	from	from	IN
cord-005453-4057qib7	2742	187	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	188	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	189	,	,	,
cord-005453-4057qib7	2742	190	Virginie	Virginie	NNP
cord-005453-4057qib7	2742	191	Bouvatier	Bouvatier	NNP
cord-005453-4057qib7	2742	192	:	:	:
cord-005453-4057qib7	2742	193	employee	employee	NN
cord-005453-4057qib7	2742	194	of	of	IN
cord-005453-4057qib7	2742	195	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	196	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	197	and	and	CC
cord-005453-4057qib7	2742	198	holds	hold	VBZ
cord-005453-4057qib7	2742	199	stock	stock	NN
cord-005453-4057qib7	2742	200	and/or	and/or	CC
cord-005453-4057qib7	2742	201	stock	stock	NN
cord-005453-4057qib7	2742	202	options	option	NNS
cord-005453-4057qib7	2742	203	in	in	IN
cord-005453-4057qib7	2742	204	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	205	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	2742	206	plc	plc	NNP
cord-005453-4057qib7	2742	207	,	,	,
cord-005453-4057qib7	2742	208	Raj	Raj	NNP
cord-005453-4057qib7	2742	209	Hanvesakul	Hanvesakul	NNP
cord-005453-4057qib7	2742	210	:	:	:
cord-005453-4057qib7	2742	211	employee	employee	NN
cord-005453-4057qib7	2742	212	of	of	IN
cord-005453-4057qib7	2742	213	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	214	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	215	and	and	CC
cord-005453-4057qib7	2742	216	holds	hold	VBZ
cord-005453-4057qib7	2742	217	stock	stock	NN
cord-005453-4057qib7	2742	218	and/	and/	CD
cord-005453-4057qib7	2742	219	or	or	CC
cord-005453-4057qib7	2742	220	stock	stock	NN
cord-005453-4057qib7	2742	221	options	option	NNS
cord-005453-4057qib7	2742	222	in	in	IN
cord-005453-4057qib7	2742	223	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	224	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	2742	225	plc	plc	NNP
cord-005453-4057qib7	2742	226	,	,	,
cord-005453-4057qib7	2742	227	Zakaria	Zakaria	NNP
cord-005453-4057qib7	2742	228	Medeghri	Medeghri	NNP
cord-005453-4057qib7	2742	229	:	:	:
cord-005453-4057qib7	2742	230	employee	employee	NN
cord-005453-4057qib7	2742	231	of	of	IN
cord-005453-4057qib7	2742	232	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	233	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2742	234	and	and	CC
cord-005453-4057qib7	2742	235	holds	hold	VBZ
cord-005453-4057qib7	2742	236	stock	stock	NN
cord-005453-4057qib7	2742	237	and/or	and/or	CC
cord-005453-4057qib7	2742	238	stock	stock	NN
cord-005453-4057qib7	2742	239	options	option	NNS
cord-005453-4057qib7	2742	240	in	in	IN
cord-005453-4057qib7	2742	241	Jazz	Jazz	NNP
cord-005453-4057qib7	2742	242	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	2742	243	plc	plc	NNP
cord-005453-4057qib7	2742	244	P137	p137	CD
cord-005453-4057qib7	2742	245	Incidence	Incidence	NNP
cord-005453-4057qib7	2742	246	and	and	CC
cord-005453-4057qib7	2742	247	predictors	predictor	NNS
cord-005453-4057qib7	2742	248	of	of	IN
cord-005453-4057qib7	2742	249	severe	severe	JJ
cord-005453-4057qib7	2742	250	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2742	251	in	in	IN
cord-005453-4057qib7	2742	252	patients	patient	NNS
cord-005453-4057qib7	2742	253	with	with	IN
cord-005453-4057qib7	2742	254	severe	severe	JJ
cord-005453-4057qib7	2742	255	aplastic	aplastic	JJ
cord-005453-4057qib7	2742	256	anemia	anemia	NN
cord-005453-4057qib7	2742	257	after	after	IN
cord-005453-4057qib7	2742	258	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2742	259	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2742	260	stem	stem	NN
cord-005453-4057qib7	2742	261	cell	cell	NN
cord-005453-4057qib7	2742	262	transplantation	transplantation	NN
cord-005453-4057qib7	2742	263	Zheng	Zheng	NNP
cord-005453-4057qib7	2742	264	-	-	HYPH
cord-005453-4057qib7	2742	265	Li	Li	NNP
cord-005453-4057qib7	2742	266	Xu	Xu	NNP
cord-005453-4057qib7	2742	267	1	1	CD
cord-005453-4057qib7	2742	268	,	,	,
cord-005453-4057qib7	2742	269	Lan	Lan	NNP
cord-005453-4057qib7	2742	270	-	-	HYPH
cord-005453-4057qib7	2742	271	Ping	Ping	NNP
cord-005453-4057qib7	2742	272	Xu	Xu	NNP
cord-005453-4057qib7	2742	273	1	1	CD
cord-005453-4057qib7	2742	274	,	,	,
cord-005453-4057qib7	2742	275	Yuan	Yuan	NNP
cord-005453-4057qib7	2742	276	-	-	HYPH
cord-005453-4057qib7	2742	277	Yuan	Yuan	NNP
cord-005453-4057qib7	2742	278	Zhang	Zhang	NNP
cord-005453-4057qib7	2742	279	1	1	CD
cord-005453-4057qib7	2742	280	,	,	,
cord-005453-4057qib7	2742	281	Yi	Yi	NNP
cord-005453-4057qib7	2742	282	-	-	HYPH
cord-005453-4057qib7	2742	283	Fei	Fei	NNP
cord-005453-4057qib7	2742	284	Cheng	Cheng	NNP
cord-005453-4057qib7	2742	285	1	1	CD
cord-005453-4057qib7	2742	286	,	,	,
cord-005453-4057qib7	2742	287	Xiao	Xiao	NNP
cord-005453-4057qib7	2742	288	-	-	HYPH
cord-005453-4057qib7	2742	289	Dong	Dong	NNP
cord-005453-4057qib7	2742	290	Mo	Mo	NNP
cord-005453-4057qib7	2742	291	1	1	CD
cord-005453-4057qib7	2742	292	,	,	,
cord-005453-4057qib7	2742	293	Feng	Feng	NNP
cord-005453-4057qib7	2742	294	-	-	HYPH
cord-005453-4057qib7	2742	295	Rong	Rong	NNP
cord-005453-4057qib7	2742	296	Wang	Wang	NNP
cord-005453-4057qib7	2742	297	1	1	CD
cord-005453-4057qib7	2742	298	,	,	,
cord-005453-4057qib7	2742	299	Yu	Yu	NNP
cord-005453-4057qib7	2742	300	-	-	HYPH
cord-005453-4057qib7	2742	301	Hong	Hong	NNP
cord-005453-4057qib7	2742	302	Chen	Chen	NNP
cord-005453-4057qib7	2742	303	1	1	CD
cord-005453-4057qib7	2742	304	,	,	,
cord-005453-4057qib7	2742	305	Wei	Wei	NNP
cord-005453-4057qib7	2742	306	Han	Han	NNP
cord-005453-4057qib7	2742	307	1	1	CD
cord-005453-4057qib7	2742	308	,	,	,
cord-005453-4057qib7	2742	309	Chen	Chen	NNP
cord-005453-4057qib7	2742	310	-	-	HYPH
cord-005453-4057qib7	2742	311	Hua	Hua	NNP
cord-005453-4057qib7	2742	312	Yan	Yan	NNP
cord-005453-4057qib7	2742	313	1	1	CD
cord-005453-4057qib7	2742	314	,	,	,
cord-005453-4057qib7	2743	1	Yu	Yu	NNP
cord-005453-4057qib7	2743	2	-	-	HYPH
cord-005453-4057qib7	2743	3	Qian	Qian	NNP
cord-005453-4057qib7	2743	4	Sun	Sun	NNP
cord-005453-4057qib7	2743	5	1	1	CD
cord-005453-4057qib7	2743	6	,	,	,
cord-005453-4057qib7	2743	7	Ting	Ting	NNP
cord-005453-4057qib7	2743	8	-	-	HYPH
cord-005453-4057qib7	2743	9	Ting	Ting	NNP
cord-005453-4057qib7	2743	10	Han	Han	NNP
cord-005453-4057qib7	2743	11	1	1	CD
cord-005453-4057qib7	2743	12	,	,	,
cord-005453-4057qib7	2743	13	Yu	Yu	NNP
cord-005453-4057qib7	2743	14	Wang	Wang	NNP
cord-005453-4057qib7	2743	15	1	1	CD
cord-005453-4057qib7	2743	16	,	,	,
cord-005453-4057qib7	2743	17	Xiao	Xiao	NNP
cord-005453-4057qib7	2743	18	-	-	HYPH
cord-005453-4057qib7	2743	19	Hui	Hui	NNP
cord-005453-4057qib7	2743	20	Zhang	Zhang	NNP
cord-005453-4057qib7	2743	21	1	1	CD
cord-005453-4057qib7	2743	22	,	,	,
cord-005453-4057qib7	2743	23	Xiao	Xiao	NNP
cord-005453-4057qib7	2743	24	-	-	HYPH
cord-005453-4057qib7	2743	25	Jun	Jun	NNP
cord-005453-4057qib7	2743	26	Huang	Huang	NNP
cord-005453-4057qib7	2743	27	1	1	CD
cord-005453-4057qib7	2743	28	1	1	CD
cord-005453-4057qib7	2743	29	Peking	Peking	NNP
cord-005453-4057qib7	2743	30	University	University	NNP
cord-005453-4057qib7	2743	31	Institute	Institute	NNP
cord-005453-4057qib7	2743	32	of	of	IN
cord-005453-4057qib7	2743	33	Hematology	Hematology	NNP
cord-005453-4057qib7	2743	34	,	,	,
cord-005453-4057qib7	2743	35	Peking	Peking	NNP
cord-005453-4057qib7	2743	36	University	University	NNP
cord-005453-4057qib7	2743	37	People	People	NNPS
cord-005453-4057qib7	2743	38	's	's	POS
cord-005453-4057qib7	2743	39	Hospital	Hospital	NNP
cord-005453-4057qib7	2743	40	,	,	,
cord-005453-4057qib7	2743	41	Beijing	Beijing	NNP
cord-005453-4057qib7	2743	42	,	,	,
cord-005453-4057qib7	2744	1	China	China	NNP
cord-005453-4057qib7	2744	2	Background	Background	NNP
cord-005453-4057qib7	2744	3	:	:	:
cord-005453-4057qib7	2745	1	Severe	severe	JJ
cord-005453-4057qib7	2745	2	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2745	3	after	after	IN
cord-005453-4057qib7	2745	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2745	5	stem	stem	NN
cord-005453-4057qib7	2745	6	cell	cell	NN
cord-005453-4057qib7	2745	7	transplantation	transplantation	NN
cord-005453-4057qib7	2745	8	(	(	-LRB-
cord-005453-4057qib7	2745	9	HSCT	HSCT	NNP
cord-005453-4057qib7	2745	10	)	)	-RRB-
cord-005453-4057qib7	2745	11	is	be	VBZ
cord-005453-4057qib7	2745	12	a	a	DT
cord-005453-4057qib7	2745	13	rare	rare	JJ
cord-005453-4057qib7	2745	14	but	but	CC
cord-005453-4057qib7	2745	15	fatal	fatal	JJ
cord-005453-4057qib7	2745	16	complication	complication	NN
cord-005453-4057qib7	2745	17	.	.	.
cord-005453-4057qib7	2746	1	The	the	DT
cord-005453-4057qib7	2746	2	aim	aim	NN
cord-005453-4057qib7	2746	3	of	of	IN
cord-005453-4057qib7	2746	4	this	this	DT
cord-005453-4057qib7	2746	5	study	study	NN
cord-005453-4057qib7	2746	6	was	be	VBD
cord-005453-4057qib7	2746	7	to	to	TO
cord-005453-4057qib7	2746	8	evaluate	evaluate	VB
cord-005453-4057qib7	2746	9	the	the	DT
cord-005453-4057qib7	2746	10	frequency	frequency	NN
cord-005453-4057qib7	2746	11	of	of	IN
cord-005453-4057qib7	2746	12	severe	severe	JJ
cord-005453-4057qib7	2746	13	cardiac	cardiac	JJ
cord-005453-4057qib7	2746	14	complications	complication	NNS
cord-005453-4057qib7	2746	15	and	and	CC
cord-005453-4057qib7	2746	16	to	to	TO
cord-005453-4057qib7	2746	17	assess	assess	VB
cord-005453-4057qib7	2746	18	the	the	DT
cord-005453-4057qib7	2746	19	ability	ability	NN
cord-005453-4057qib7	2746	20	of	of	IN
cord-005453-4057qib7	2746	21	various	various	JJ
cord-005453-4057qib7	2746	22	factors	factor	NNS
cord-005453-4057qib7	2746	23	to	to	TO
cord-005453-4057qib7	2746	24	predict	predict	VB
cord-005453-4057qib7	2746	25	these	these	DT
cord-005453-4057qib7	2746	26	complications	complication	NNS
cord-005453-4057qib7	2746	27	in	in	IN
cord-005453-4057qib7	2746	28	patients	patient	NNS
cord-005453-4057qib7	2746	29	with	with	IN
cord-005453-4057qib7	2746	30	aplastic	aplastic	JJ
cord-005453-4057qib7	2746	31	anemia	anemia	NN
cord-005453-4057qib7	2746	32	after	after	IN
cord-005453-4057qib7	2746	33	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2746	34	transplantation	transplantation	NN
cord-005453-4057qib7	2746	35	.	.	.
cord-005453-4057qib7	2747	1	,	,	,
cord-005453-4057qib7	2747	2	this	this	DT
cord-005453-4057qib7	2747	3	is	be	VBZ
cord-005453-4057qib7	2747	4	the	the	DT
cord-005453-4057qib7	2747	5	first	first	JJ
cord-005453-4057qib7	2747	6	study	study	NN
cord-005453-4057qib7	2747	7	evaluating	evaluate	VBG
cord-005453-4057qib7	2747	8	the	the	DT
cord-005453-4057qib7	2747	9	values	value	NNS
cord-005453-4057qib7	2747	10	of	of	IN
cord-005453-4057qib7	2747	11	both	both	CC
cord-005453-4057qib7	2747	12	clinical	clinical	JJ
cord-005453-4057qib7	2747	13	and	and	CC
cord-005453-4057qib7	2747	14	imaging	imaging	NN
cord-005453-4057qib7	2747	15	factors	factor	NNS
cord-005453-4057qib7	2747	16	in	in	IN
cord-005453-4057qib7	2747	17	the	the	DT
cord-005453-4057qib7	2747	18	prediction	prediction	NN
cord-005453-4057qib7	2747	19	of	of	IN
cord-005453-4057qib7	2747	20	severe	severe	JJ
cord-005453-4057qib7	2747	21	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2747	22	among	among	IN
cord-005453-4057qib7	2747	23	SAA	SAA	NNP
cord-005453-4057qib7	2747	24	patients	patient	NNS
cord-005453-4057qib7	2747	25	after	after	IN
cord-005453-4057qib7	2747	26	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2747	27	transplantation	transplantation	NN
cord-005453-4057qib7	2747	28	.	.	.
cord-005453-4057qib7	2748	1	Methods	method	NNS
cord-005453-4057qib7	2748	2	:	:	:
cord-005453-4057qib7	2748	3	A	a	DT
cord-005453-4057qib7	2748	4	retrospective	retrospective	JJ
cord-005453-4057qib7	2748	5	study	study	NN
cord-005453-4057qib7	2748	6	was	be	VBD
cord-005453-4057qib7	2748	7	conducted	conduct	VBN
cord-005453-4057qib7	2748	8	in	in	IN
cord-005453-4057qib7	2748	9	216	216	CD
cord-005453-4057qib7	2748	10	consecutive	consecutive	JJ
cord-005453-4057qib7	2748	11	aplastic	aplastic	JJ
cord-005453-4057qib7	2748	12	anemia	anemia	NN
cord-005453-4057qib7	2748	13	patients	patient	NNS
cord-005453-4057qib7	2748	14	who	who	WP
cord-005453-4057qib7	2748	15	received	receive	VBD
cord-005453-4057qib7	2748	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2748	17	transplantation	transplantation	NN
cord-005453-4057qib7	2748	18	from	from	IN
cord-005453-4057qib7	2748	19	2006	2006	CD
cord-005453-4057qib7	2748	20	to	to	IN
cord-005453-4057qib7	2748	21	2017	2017	CD
cord-005453-4057qib7	2748	22	.	.	.
cord-005453-4057qib7	2749	1	All	all	DT
cord-005453-4057qib7	2749	2	patients	patient	NNS
cord-005453-4057qib7	2749	3	received	receive	VBD
cord-005453-4057qib7	2749	4	a	a	DT
cord-005453-4057qib7	2749	5	unified	unified	JJ
cord-005453-4057qib7	2749	6	regimen	regimen	NN
cord-005453-4057qib7	2749	7	including	include	VBG
cord-005453-4057qib7	2749	8	busulfan	busulfan	NN
cord-005453-4057qib7	2749	9	,	,	,
cord-005453-4057qib7	2749	10	cyclophosphamide	cyclophosphamide	FW
cord-005453-4057qib7	2749	11	(	(	-LRB-
cord-005453-4057qib7	2749	12	CTX	CTX	NNP
cord-005453-4057qib7	2749	13	)	)	-RRB-
cord-005453-4057qib7	2749	14	and	and	CC
cord-005453-4057qib7	2749	15	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	2749	16	globulin	globulin	NN
cord-005453-4057qib7	2749	17	at	at	IN
cord-005453-4057qib7	2749	18	our	-PRON-	PRP$
cord-005453-4057qib7	2749	19	single	single	JJ
cord-005453-4057qib7	2749	20	center	center	NN
cord-005453-4057qib7	2749	21	.	.	.
cord-005453-4057qib7	2750	1	Results	result	NNS
cord-005453-4057qib7	2750	2	:	:	:
cord-005453-4057qib7	2751	1	A	a	DT
cord-005453-4057qib7	2751	2	total	total	NN
cord-005453-4057qib7	2751	3	of	of	IN
cord-005453-4057qib7	2751	4	12	12	CD
cord-005453-4057qib7	2751	5	(	(	-LRB-
cord-005453-4057qib7	2751	6	5.6	5.6	CD
cord-005453-4057qib7	2751	7	%	%	NN
cord-005453-4057qib7	2751	8	)	)	-RRB-
cord-005453-4057qib7	2751	9	patients	patient	NNS
cord-005453-4057qib7	2751	10	developed	develop	VBD
cord-005453-4057qib7	2751	11	grade	grade	NN
cord-005453-4057qib7	2751	12	III	III	NNP
cord-005453-4057qib7	2751	13	or	or	CC
cord-005453-4057qib7	2751	14	IV	IV	NNP
cord-005453-4057qib7	2751	15	cardiac	cardiac	JJ
cord-005453-4057qib7	2751	16	toxicity	toxicity	NN
cord-005453-4057qib7	2751	17	.	.	.
cord-005453-4057qib7	2752	1	Patients	patient	NNS
cord-005453-4057qib7	2752	2	with	with	IN
cord-005453-4057qib7	2752	3	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2752	4	had	have	VBD
cord-005453-4057qib7	2752	5	significantly	significantly	RB
cord-005453-4057qib7	2752	6	poorer	poor	JJR
cord-005453-4057qib7	2752	7	overall	overall	JJ
cord-005453-4057qib7	2752	8	survival	survival	NN
cord-005453-4057qib7	2752	9	(	(	-LRB-
cord-005453-4057qib7	2752	10	OS	OS	NNP
cord-005453-4057qib7	2752	11	)	)	-RRB-
cord-005453-4057qib7	2752	12	than	than	IN
cord-005453-4057qib7	2752	13	those	those	DT
cord-005453-4057qib7	2752	14	without	without	IN
cord-005453-4057qib7	2752	15	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2752	16	(	(	-LRB-
cord-005453-4057qib7	2752	17	12.5	12.5	CD
cord-005453-4057qib7	2752	18	%	%	NN
cord-005453-4057qib7	2752	19	vs.	vs.	CC
cord-005453-4057qib7	2752	20	89.6	89.6	CD
cord-005453-4057qib7	2752	21	%	%	NN
cord-005453-4057qib7	2752	22	,	,	,
cord-005453-4057qib7	2752	23	P	p	NN
cord-005453-4057qib7	2752	24	<	<	XX
cord-005453-4057qib7	2752	25	0.001	0.001	CD
cord-005453-4057qib7	2752	26	)	)	-RRB-
cord-005453-4057qib7	2752	27	.	.	.
cord-005453-4057qib7	2753	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2753	2	multivariable	multivariable	JJ
cord-005453-4057qib7	2753	3	model	model	NN
cord-005453-4057qib7	2753	4	identified	identify	VBD
cord-005453-4057qib7	2753	5	four	four	CD
cord-005453-4057qib7	2753	6	independent	independent	JJ
cord-005453-4057qib7	2753	7	adverse	adverse	JJ
cord-005453-4057qib7	2753	8	predictors	predictor	NNS
cord-005453-4057qib7	2753	9	of	of	IN
cord-005453-4057qib7	2753	10	severe	severe	JJ
cord-005453-4057qib7	2753	11	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2753	12	,	,	,
cord-005453-4057qib7	2753	13	including	include	VBG
cord-005453-4057qib7	2753	14	pre	pre	JJ
cord-005453-4057qib7	2753	15	-	-	JJ
cord-005453-4057qib7	2753	16	transplant	transplant	JJ
cord-005453-4057qib7	2753	17	ECOG	ECOG	NNP
cord-005453-4057qib7	2753	18	score	score	NN
cord-005453-4057qib7	2753	19	(	(	-LRB-
cord-005453-4057qib7	2753	20	≥2	≥2	NNP
cord-005453-4057qib7	2753	21	)	)	-RRB-
cord-005453-4057qib7	2753	22	,	,	,
cord-005453-4057qib7	2753	23	abnormal	abnormal	JJ
cord-005453-4057qib7	2753	24	ST	ST	NNP
cord-005453-4057qib7	2753	25	-	-	HYPH
cord-005453-4057qib7	2753	26	T	T	NNP
cord-005453-4057qib7	2753	27	wave	wave	NN
cord-005453-4057qib7	2753	28	on	on	IN
cord-005453-4057qib7	2753	29	12-lead	12-lead	JJ
cord-005453-4057qib7	2753	30	electrocardiogram	electrocardiogram	NN
cord-005453-4057qib7	2753	31	(	(	-LRB-
cord-005453-4057qib7	2753	32	ECG	ECG	NNP
cord-005453-4057qib7	2753	33	)	)	-RRB-
cord-005453-4057qib7	2753	34	,	,	,
cord-005453-4057qib7	2753	35	hyperlipemia	hyperlipemia	NNP
cord-005453-4057qib7	2753	36	and	and	CC
cord-005453-4057qib7	2753	37	recalculated	recalculate	VBD
cord-005453-4057qib7	2753	38	CTX	CTX	NNP
cord-005453-4057qib7	2753	39	dose	dose	NN
cord-005453-4057qib7	2753	40	(	(	-LRB-
cord-005453-4057qib7	2753	41	≥1.8	≥1.8	NNP
cord-005453-4057qib7	2753	42	g	g	NNP
cord-005453-4057qib7	2753	43	/	/	SYM
cord-005453-4057qib7	2753	44	m2	m2	NNP
cord-005453-4057qib7	2753	45	/	/	SYM
cord-005453-4057qib7	2753	46	d	d	NN
cord-005453-4057qib7	2753	47	)	)	-RRB-
cord-005453-4057qib7	2753	48	.	.	.
cord-005453-4057qib7	2754	1	A	a	DT
cord-005453-4057qib7	2754	2	predictive	predictive	JJ
cord-005453-4057qib7	2754	3	risk	risk	NN
cord-005453-4057qib7	2754	4	model	model	NN
cord-005453-4057qib7	2754	5	was	be	VBD
cord-005453-4057qib7	2754	6	refined	refine	VBN
cord-005453-4057qib7	2754	7	as	as	IN
cord-005453-4057qib7	2754	8	low	low	JJ
cord-005453-4057qib7	2754	9	risk	risk	NN
cord-005453-4057qib7	2754	10	(	(	-LRB-
cord-005453-4057qib7	2754	11	0	0	CD
cord-005453-4057qib7	2754	12	-	-	SYM
cord-005453-4057qib7	2754	13	1	1	CD
cord-005453-4057qib7	2754	14	factor	factor	NN
cord-005453-4057qib7	2754	15	)	)	-RRB-
cord-005453-4057qib7	2754	16	,	,	,
cord-005453-4057qib7	2754	17	intermediate	intermediate	JJ
cord-005453-4057qib7	2754	18	risk	risk	NN
cord-005453-4057qib7	2754	19	(	(	-LRB-
cord-005453-4057qib7	2754	20	2	2	CD
cord-005453-4057qib7	2754	21	factors	factor	NNS
cord-005453-4057qib7	2754	22	)	)	-RRB-
cord-005453-4057qib7	2754	23	and	and	CC
cord-005453-4057qib7	2754	24	high	high	JJ
cord-005453-4057qib7	2754	25	risk	risk	NN
cord-005453-4057qib7	2754	26	(	(	-LRB-
cord-005453-4057qib7	2754	27	3	3	CD
cord-005453-4057qib7	2754	28	-	-	SYM
cord-005453-4057qib7	2754	29	4	4	CD
cord-005453-4057qib7	2754	30	factors	factor	NNS
cord-005453-4057qib7	2754	31	)	)	-RRB-
cord-005453-4057qib7	2754	32	.	.	.
cord-005453-4057qib7	2755	1	The	the	DT
cord-005453-4057qib7	2755	2	respective	respective	JJ
cord-005453-4057qib7	2755	3	incidences	incidence	NNS
cord-005453-4057qib7	2755	4	of	of	IN
cord-005453-4057qib7	2755	5	severe	severe	JJ
cord-005453-4057qib7	2755	6	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	2755	7	were	be	VBD
cord-005453-4057qib7	2755	8	50.0	50.0	CD
cord-005453-4057qib7	2755	9	%	%	NN
cord-005453-4057qib7	2755	10	,	,	,
cord-005453-4057qib7	2755	11	6.0	6.0	CD
cord-005453-4057qib7	2755	12	%	%	NN
cord-005453-4057qib7	2755	13	,	,	,
cord-005453-4057qib7	2755	14	and	and	CC
cord-005453-4057qib7	2755	15	1.3	1.3	CD
cord-005453-4057qib7	2755	16	%	%	NN
cord-005453-4057qib7	2755	17	in	in	IN
cord-005453-4057qib7	2755	18	the	the	DT
cord-005453-4057qib7	2755	19	high-	high-	JJ
cord-005453-4057qib7	2755	20	,	,	,
cord-005453-4057qib7	2755	21	intermediate	intermediate	JJ
cord-005453-4057qib7	2755	22	-	-	HYPH
cord-005453-4057qib7	2755	23	and	and	CC
cord-005453-4057qib7	2755	24	low	low	JJ
cord-005453-4057qib7	2755	25	-	-	HYPH
cord-005453-4057qib7	2755	26	risk	risk	NN
cord-005453-4057qib7	2755	27	groups	group	NNS
cord-005453-4057qib7	2755	28	(	(	-LRB-
cord-005453-4057qib7	2755	29	P	p	NN
cord-005453-4057qib7	2755	30	<	<	XX
cord-005453-4057qib7	2755	31	0.001	0.001	CD
cord-005453-4057qib7	2755	32	)	)	-RRB-
cord-005453-4057qib7	2755	33	.	.	.
cord-005453-4057qib7	2756	1	The	the	DT
cord-005453-4057qib7	2756	2	corresponding	corresponding	JJ
cord-005453-4057qib7	2756	3	OS	os	NN
cord-005453-4057qib7	2756	4	rates	rate	NNS
cord-005453-4057qib7	2756	5	were	be	VBD
cord-005453-4057qib7	2756	6	49.0	49.0	CD
cord-005453-4057qib7	2756	7	%	%	NN
cord-005453-4057qib7	2756	8	,	,	,
cord-005453-4057qib7	2756	9	80.4	80.4	CD
cord-005453-4057qib7	2756	10	%	%	NN
cord-005453-4057qib7	2756	11	,	,	,
cord-005453-4057qib7	2756	12	and	and	CC
cord-005453-4057qib7	2756	13	90.3	90.3	CD
cord-005453-4057qib7	2756	14	%	%	NN
cord-005453-4057qib7	2756	15	in	in	IN
cord-005453-4057qib7	2756	16	the	the	DT
cord-005453-4057qib7	2756	17	three	three	CD
cord-005453-4057qib7	2756	18	groups	group	NNS
cord-005453-4057qib7	2756	19	(	(	-LRB-
cord-005453-4057qib7	2756	20	P	p	NN
cord-005453-4057qib7	2756	21	<	<	XX
cord-005453-4057qib7	2756	22	0.001	0.001	CD
cord-005453-4057qib7	2756	23	)	)	-RRB-
cord-005453-4057qib7	2756	24	at	at	IN
cord-005453-4057qib7	2756	25	the	the	DT
cord-005453-4057qib7	2756	26	last	last	JJ
cord-005453-4057qib7	2756	27	follow	follow	NN
cord-005453-4057qib7	2756	28	-	-	HYPH
cord-005453-4057qib7	2756	29	up	up	NN
cord-005453-4057qib7	2756	30	.	.	.
cord-005453-4057qib7	2757	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2757	2	:	:	:
cord-005453-4057qib7	2758	1	Patients	patient	NNS
cord-005453-4057qib7	2758	2	with	with	IN
cord-005453-4057qib7	2758	3	high	high	JJ
cord-005453-4057qib7	2758	4	risk	risk	NN
cord-005453-4057qib7	2758	5	scores	score	NNS
cord-005453-4057qib7	2758	6	had	have	VBD
cord-005453-4057qib7	2758	7	the	the	DT
cord-005453-4057qib7	2758	8	poorest	poor	JJS
cord-005453-4057qib7	2758	9	outcomes	outcome	NNS
cord-005453-4057qib7	2758	10	and	and	CC
cord-005453-4057qib7	2758	11	should	should	MD
cord-005453-4057qib7	2758	12	be	be	VB
cord-005453-4057qib7	2758	13	monitored	monitor	VBN
cord-005453-4057qib7	2758	14	closely	closely	RB
cord-005453-4057qib7	2758	15	.	.	.
cord-005453-4057qib7	2759	1	A	a	DT
cord-005453-4057qib7	2759	2	reduced	reduce	VBN
cord-005453-4057qib7	2759	3	intensity	intensity	NN
cord-005453-4057qib7	2759	4	conditioning	conditioning	NN
cord-005453-4057qib7	2759	5	might	may	MD
cord-005453-4057qib7	2759	6	be	be	VB
cord-005453-4057qib7	2759	7	recommended	recommend	VBN
cord-005453-4057qib7	2759	8	for	for	IN
cord-005453-4057qib7	2759	9	these	these	DT
cord-005453-4057qib7	2759	10	patients	patient	NNS
cord-005453-4057qib7	2759	11	.	.	.
cord-005453-4057qib7	2760	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2760	2	:	:	:
cord-005453-4057qib7	2760	3	There	there	EX
cord-005453-4057qib7	2760	4	are	be	VBP
cord-005453-4057qib7	2760	5	no	no	DT
cord-005453-4057qib7	2760	6	conflicts	conflict	NNS
cord-005453-4057qib7	2760	7	of	of	IN
cord-005453-4057qib7	2760	8	interest	interest	NN
cord-005453-4057qib7	2760	9	to	to	TO
cord-005453-4057qib7	2760	10	declare	declare	VB
cord-005453-4057qib7	2760	11	.	.	.
cord-005453-4057qib7	2761	1	Background	background	NN
cord-005453-4057qib7	2761	2	:	:	:
cord-005453-4057qib7	2762	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	2762	2	stem	stem	NN
cord-005453-4057qib7	2762	3	-	-	HYPH
cord-005453-4057qib7	2762	4	cell	cell	NN
cord-005453-4057qib7	2762	5	transplantation	transplantation	NN
cord-005453-4057qib7	2762	6	(	(	-LRB-
cord-005453-4057qib7	2762	7	allo	allo	FW
cord-005453-4057qib7	2762	8	-	-	HYPH
cord-005453-4057qib7	2762	9	SCT	SCT	NNP
cord-005453-4057qib7	2762	10	)	)	-RRB-
cord-005453-4057qib7	2762	11	is	be	VBZ
cord-005453-4057qib7	2762	12	associated	associate	VBN
cord-005453-4057qib7	2762	13	with	with	IN
cord-005453-4057qib7	2762	14	significant	significant	JJ
cord-005453-4057qib7	2762	15	transplant	transplant	NN
cord-005453-4057qib7	2762	16	-	-	HYPH
cord-005453-4057qib7	2762	17	related	relate	VBN
cord-005453-4057qib7	2762	18	mortality	mortality	NN
cord-005453-4057qib7	2762	19	(	(	-LRB-
cord-005453-4057qib7	2762	20	TRM	TRM	NNP
cord-005453-4057qib7	2762	21	)	)	-RRB-
cord-005453-4057qib7	2762	22	.	.	.
cord-005453-4057qib7	2763	1	Acute	acute	JJ
cord-005453-4057qib7	2763	2	renal	renal	JJ
cord-005453-4057qib7	2763	3	failure	failure	NN
cord-005453-4057qib7	2763	4	(	(	-LRB-
cord-005453-4057qib7	2763	5	ARF	ARF	NNP
cord-005453-4057qib7	2763	6	)	)	-RRB-
cord-005453-4057qib7	2763	7	is	be	VBZ
cord-005453-4057qib7	2763	8	a	a	DT
cord-005453-4057qib7	2763	9	frequent	frequent	JJ
cord-005453-4057qib7	2763	10	complication	complication	NN
cord-005453-4057qib7	2763	11	and	and	CC
cord-005453-4057qib7	2763	12	usually	usually	RB
cord-005453-4057qib7	2763	13	presents	present	VBZ
cord-005453-4057qib7	2763	14	early	early	RB
cord-005453-4057qib7	2763	15	after	after	IN
cord-005453-4057qib7	2763	16	the	the	DT
cord-005453-4057qib7	2763	17	procedure	procedure	NN
cord-005453-4057qib7	2763	18	,	,	,
cord-005453-4057qib7	2763	19	compromising	compromise	VBG
cord-005453-4057qib7	2763	20	its	-PRON-	PRP$
cord-005453-4057qib7	2763	21	feasibility	feasibility	NN
cord-005453-4057qib7	2763	22	.	.	.
cord-005453-4057qib7	2764	1	The	the	DT
cord-005453-4057qib7	2764	2	aim	aim	NN
cord-005453-4057qib7	2764	3	of	of	IN
cord-005453-4057qib7	2764	4	this	this	DT
cord-005453-4057qib7	2764	5	study	study	NN
cord-005453-4057qib7	2764	6	is	be	VBZ
cord-005453-4057qib7	2764	7	to	to	TO
cord-005453-4057qib7	2764	8	analyse	analyse	VB
cord-005453-4057qib7	2764	9	the	the	DT
cord-005453-4057qib7	2764	10	incidence	incidence	NN
cord-005453-4057qib7	2764	11	of	of	IN
cord-005453-4057qib7	2764	12	ARF	ARF	NNP
cord-005453-4057qib7	2764	13	,	,	,
cord-005453-4057qib7	2764	14	its	-PRON-	PRP$
cord-005453-4057qib7	2764	15	risk	risk	NN
cord-005453-4057qib7	2764	16	factors	factor	NNS
cord-005453-4057qib7	2764	17	and	and	CC
cord-005453-4057qib7	2764	18	its	-PRON-	PRP$
cord-005453-4057qib7	2764	19	potential	potential	JJ
cord-005453-4057qib7	2764	20	impact	impact	NN
cord-005453-4057qib7	2764	21	on	on	IN
cord-005453-4057qib7	2764	22	TRM	TRM	NNP
cord-005453-4057qib7	2764	23	after	after	IN
cord-005453-4057qib7	2764	24	allo	allo	NN
cord-005453-4057qib7	2764	25	-	-	HYPH
cord-005453-4057qib7	2764	26	SCT	SCT	NNP
cord-005453-4057qib7	2764	27	.	.	.
cord-005453-4057qib7	2765	1	Methods	method	NNS
cord-005453-4057qib7	2765	2	:	:	:
cord-005453-4057qib7	2765	3	422	422	CD
cord-005453-4057qib7	2765	4	patients	patient	NNS
cord-005453-4057qib7	2765	5	were	be	VBD
cord-005453-4057qib7	2765	6	included	include	VBN
cord-005453-4057qib7	2765	7	(	(	-LRB-
cord-005453-4057qib7	2765	8	244	244	CD
cord-005453-4057qib7	2765	9	males	male	NNS
cord-005453-4057qib7	2765	10	[	[	-LRB-
cord-005453-4057qib7	2765	11	58	58	CD
cord-005453-4057qib7	2765	12	%	%	NN
cord-005453-4057qib7	2765	13	]	]	-RRB-
cord-005453-4057qib7	2766	1	;	;	:
cord-005453-4057qib7	2766	2	median	median	NN
cord-005453-4057qib7	2766	3	age	age	NN
cord-005453-4057qib7	2766	4	43	43	CD
cord-005453-4057qib7	2766	5	years	year	NNS
cord-005453-4057qib7	2766	6	,	,	,
cord-005453-4057qib7	2766	7	range	range	VBP
cord-005453-4057qib7	2766	8	16	16	CD
cord-005453-4057qib7	2766	9	-	-	SYM
cord-005453-4057qib7	2766	10	67	67	CD
cord-005453-4057qib7	2766	11	)	)	-RRB-
cord-005453-4057qib7	2766	12	treated	treat	VBN
cord-005453-4057qib7	2766	13	with	with	IN
cord-005453-4057qib7	2766	14	Allo	Allo	NNP
cord-005453-4057qib7	2766	15	-	-	HYPH
cord-005453-4057qib7	2766	16	SCT	SCT	NNP
cord-005453-4057qib7	2766	17	consecutively	consecutively	RB
cord-005453-4057qib7	2766	18	between	between	IN
cord-005453-4057qib7	2766	19	January	January	NNP
cord-005453-4057qib7	2766	20	2001	2001	CD
cord-005453-4057qib7	2766	21	and	and	CC
cord-005453-4057qib7	2766	22	April	April	NNP
cord-005453-4057qib7	2766	23	2012	2012	CD
cord-005453-4057qib7	2766	24	in	in	IN
cord-005453-4057qib7	2766	25	a	a	DT
cord-005453-4057qib7	2766	26	single	single	JJ
cord-005453-4057qib7	2766	27	institution	institution	NN
cord-005453-4057qib7	2766	28	.	.	.
cord-005453-4057qib7	2767	1	Patient	patient	JJ
cord-005453-4057qib7	2767	2	characteristics	characteristic	NNS
cord-005453-4057qib7	2767	3	are	be	VBP
cord-005453-4057qib7	2767	4	detailed	detail	VBN
cord-005453-4057qib7	2767	5	in	in	IN
cord-005453-4057qib7	2767	6	table	table	NN
cord-005453-4057qib7	2767	7	1	1	CD
cord-005453-4057qib7	2767	8	.	.	.
cord-005453-4057qib7	2768	1	Median	median	JJ
cord-005453-4057qib7	2768	2	follow	follow	NN
cord-005453-4057qib7	2768	3	-	-	HYPH
cord-005453-4057qib7	2768	4	up	up	NN
cord-005453-4057qib7	2768	5	was	be	VBD
cord-005453-4057qib7	2768	6	1.8	1.8	CD
cord-005453-4057qib7	2768	7	years	year	NNS
cord-005453-4057qib7	2768	8	(	(	-LRB-
cord-005453-4057qib7	2768	9	range	range	NN
cord-005453-4057qib7	2768	10	,	,	,
cord-005453-4057qib7	2768	11	1.0	1.0	CD
cord-005453-4057qib7	2768	12	-	-	SYM
cord-005453-4057qib7	2768	13	2.7	2.7	CD
cord-005453-4057qib7	2768	14	)	)	-RRB-
cord-005453-4057qib7	2768	15	.	.	.
cord-005453-4057qib7	2769	1	Renal	renal	JJ
cord-005453-4057qib7	2769	2	function	function	NN
cord-005453-4057qib7	2769	3	was	be	VBD
cord-005453-4057qib7	2769	4	evaluated	evaluate	VBN
cord-005453-4057qib7	2769	5	using	use	VBG
cord-005453-4057qib7	2769	6	creatinine	creatinine	NN
cord-005453-4057qib7	2769	7	and	and	CC
cord-005453-4057qib7	2769	8	data	datum	NNS
cord-005453-4057qib7	2769	9	was	be	VBD
cord-005453-4057qib7	2769	10	collected	collect	VBN
cord-005453-4057qib7	2769	11	pre	pre	JJ
cord-005453-4057qib7	2769	12	-	-	NN
cord-005453-4057qib7	2769	13	transplant	transplant	JJ
cord-005453-4057qib7	2769	14	(	(	-LRB-
cord-005453-4057qib7	2769	15	baseline	baseline	NN
cord-005453-4057qib7	2769	16	)	)	-RRB-
cord-005453-4057qib7	2769	17	and	and	CC
cord-005453-4057qib7	2769	18	at	at	IN
cord-005453-4057qib7	2769	19	the	the	DT
cord-005453-4057qib7	2769	20	point	point	NN
cord-005453-4057qib7	2769	21	when	when	WRB
cord-005453-4057qib7	2769	22	ARF	ARF	NNP
cord-005453-4057qib7	2769	23	was	be	VBD
cord-005453-4057qib7	2769	24	developed	develop	VBN
cord-005453-4057qib7	2769	25	after	after	IN
cord-005453-4057qib7	2769	26	allo	allo	NN
cord-005453-4057qib7	2769	27	-	-	HYPH
cord-005453-4057qib7	2769	28	SCT	SCT	NNP
cord-005453-4057qib7	2769	29	.	.	.
cord-005453-4057qib7	2770	1	ARF	ARF	NNP
cord-005453-4057qib7	2770	2	was	be	VBD
cord-005453-4057qib7	2770	3	evaluated	evaluate	VBN
cord-005453-4057qib7	2770	4	using	use	VBG
cord-005453-4057qib7	2770	5	AKIN	akin	NN
cord-005453-4057qib7	2770	6	criteria	criterion	NNS
cord-005453-4057qib7	2770	7	,	,	,
cord-005453-4057qib7	2770	8	being	be	VBG
cord-005453-4057qib7	2770	9	AKIN-1	akin-1	WP
cord-005453-4057qib7	2770	10	an	an	DT
cord-005453-4057qib7	2770	11	increase	increase	NN
cord-005453-4057qib7	2770	12	1.5-to	1.5-to	CD
cord-005453-4057qib7	2770	13	1.9-fold	1.9-fold	CD
cord-005453-4057qib7	2770	14	from	from	IN
cord-005453-4057qib7	2770	15	baseline	baseline	NN
cord-005453-4057qib7	2770	16	,	,	,
cord-005453-4057qib7	2770	17	AKIN-2	AKIN-2	NNP
cord-005453-4057qib7	2770	18	an	an	DT
cord-005453-4057qib7	2770	19	increase	increase	NN
cord-005453-4057qib7	2771	1	2.0-to	2.0-to	CD
cord-005453-4057qib7	2771	2	2.0-fold	2.0-fold	CD
cord-005453-4057qib7	2771	3	and	and	CC
cord-005453-4057qib7	2771	4	AKIN-3	AKIN-3	NNP
cord-005453-4057qib7	2771	5	an	an	DT
cord-005453-4057qib7	2771	6	increase	increase	NN
cord-005453-4057qib7	2771	7	≥3-fold	≥3-fold	NN
cord-005453-4057qib7	2771	8	.	.	.
cord-005453-4057qib7	2772	1	Chronic	chronic	JJ
cord-005453-4057qib7	2772	2	renal	renal	JJ
cord-005453-4057qib7	2772	3	disease	disease	NN
cord-005453-4057qib7	2772	4	was	be	VBD
cord-005453-4057qib7	2772	5	evaluated	evaluate	VBN
cord-005453-4057qib7	2772	6	one	one	CD
cord-005453-4057qib7	2772	7	year	year	NN
cord-005453-4057qib7	2772	8	after	after	IN
cord-005453-4057qib7	2772	9	the	the	DT
cord-005453-4057qib7	2772	10	date	date	NN
cord-005453-4057qib7	2772	11	of	of	IN
cord-005453-4057qib7	2772	12	ARF	ARF	NNP
cord-005453-4057qib7	2772	13	using	use	VBG
cord-005453-4057qib7	2772	14	KDIGO	KDIGO	NNP
cord-005453-4057qib7	2772	15	criteria	criterion	NNS
cord-005453-4057qib7	2772	16	.	.	.
cord-005453-4057qib7	2773	1	Results	result	NNS
cord-005453-4057qib7	2773	2	:	:	:
cord-005453-4057qib7	2774	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	2774	2	incidence	incidence	NN
cord-005453-4057qib7	2774	3	of	of	IN
cord-005453-4057qib7	2774	4	ARF	arf	NN
cord-005453-4057qib7	2774	5	at	at	IN
cord-005453-4057qib7	2774	6	1	1	CD
cord-005453-4057qib7	2774	7	year	year	NN
cord-005453-4057qib7	2774	8	was	be	VBD
cord-005453-4057qib7	2774	9	63	63	CD
cord-005453-4057qib7	2774	10	%	%	NN
cord-005453-4057qib7	2774	11	(	(	-LRB-
cord-005453-4057qib7	2774	12	AKIN-1	AKIN-1	NNP
cord-005453-4057qib7	2774	13	,	,	,
cord-005453-4057qib7	2774	14	25	25	CD
cord-005453-4057qib7	2774	15	%	%	NN
cord-005453-4057qib7	2774	16	;	;	:
cord-005453-4057qib7	2774	17	AKIN-2	AKIN-2	NNP
cord-005453-4057qib7	2774	18	,	,	,
cord-005453-4057qib7	2774	19	27	27	CD
cord-005453-4057qib7	2774	20	%	%	NN
cord-005453-4057qib7	2774	21	;	;	:
cord-005453-4057qib7	2774	22	AKIN-3	AKIN-3	NNP
cord-005453-4057qib7	2774	23	,	,	,
cord-005453-4057qib7	2774	24	15	15	CD
cord-005453-4057qib7	2774	25	%	%	NN
cord-005453-4057qib7	2774	26	)	)	-RRB-
cord-005453-4057qib7	2774	27	.	.	.
cord-005453-4057qib7	2775	1	In	in	IN
cord-005453-4057qib7	2775	2	the	the	DT
cord-005453-4057qib7	2775	3	multivariate	multivariate	JJ
cord-005453-4057qib7	2775	4	analysis	analysis	NN
cord-005453-4057qib7	2775	5	,	,	,
cord-005453-4057qib7	2775	6	ARF	ARF	NNP
cord-005453-4057qib7	2775	7	(	(	-LRB-
cord-005453-4057qib7	2775	8	AKIN-1/2	AKIN-1/2	NNP
cord-005453-4057qib7	2775	9	)	)	-RRB-
cord-005453-4057qib7	2775	10	was	be	VBD
cord-005453-4057qib7	2775	11	associated	associate	VBN
cord-005453-4057qib7	2775	12	with	with	IN
cord-005453-4057qib7	2775	13	:	:	:
cord-005453-4057qib7	2775	14	non	non	JJ
cord-005453-4057qib7	2775	15	-	-	JJ
cord-005453-4057qib7	2775	16	use	use	NN
cord-005453-4057qib7	2775	17	of	of	IN
cord-005453-4057qib7	2775	18	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	2775	19	globulin	globulin	NN
cord-005453-4057qib7	2775	20	in	in	IN
cord-005453-4057qib7	2775	21	conditioning	conditioning	NN
cord-005453-4057qib7	2775	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	2775	23	,	,	,
cord-005453-4057qib7	2775	24	p=0.02	p=0.02	NNP
cord-005453-4057qib7	2775	25	(	(	-LRB-
cord-005453-4057qib7	2775	26	HR	HR	NNP
cord-005453-4057qib7	2775	27	2.3	2.3	CD
cord-005453-4057qib7	2775	28	,	,	,
cord-005453-4057qib7	2775	29	0.2	0.2	CD
cord-005453-4057qib7	2775	30	to	to	TO
cord-005453-4057qib7	2775	31	0.9	0.9	CD
cord-005453-4057qib7	2775	32	)	)	-RRB-
cord-005453-4057qib7	2775	33	and	and	CC
cord-005453-4057qib7	2775	34	development	development	NN
cord-005453-4057qib7	2775	35	of	of	IN
cord-005453-4057qib7	2775	36	severe	severe	JJ
cord-005453-4057qib7	2775	37	aGvHD	agvhd	NN
cord-005453-4057qib7	2775	38	,	,	,
cord-005453-4057qib7	2775	39	p=0.04	p=0.04	NNP
cord-005453-4057qib7	2775	40	(	(	-LRB-
cord-005453-4057qib7	2775	41	HR=	HR=	NNP
cord-005453-4057qib7	2775	42	1.5	1.5	CD
cord-005453-4057qib7	2775	43	,	,	,
cord-005453-4057qib7	2775	44	1	1	CD
cord-005453-4057qib7	2775	45	to	to	IN
cord-005453-4057qib7	2775	46	2.3	2.3	CD
cord-005453-4057qib7	2775	47	)	)	-RRB-
cord-005453-4057qib7	2775	48	.	.	.
cord-005453-4057qib7	2776	1	In	in	IN
cord-005453-4057qib7	2776	2	patients	patient	NNS
cord-005453-4057qib7	2776	3	with	with	IN
cord-005453-4057qib7	2776	4	ARF	ARF	NNP
cord-005453-4057qib7	2776	5	AKIN-3	AKIN-3	NNP
cord-005453-4057qib7	2776	6	,	,	,
cord-005453-4057qib7	2776	7	the	the	DT
cord-005453-4057qib7	2776	8	most	most	RBS
cord-005453-4057qib7	2776	9	important	important	JJ
cord-005453-4057qib7	2776	10	variables	variable	NNS
cord-005453-4057qib7	2776	11	in	in	IN
cord-005453-4057qib7	2776	12	the	the	DT
cord-005453-4057qib7	2776	13	multivariate	multivariate	JJ
cord-005453-4057qib7	2776	14	analysis	analysis	NN
cord-005453-4057qib7	2776	15	were	be	VBD
cord-005453-4057qib7	2776	16	:	:	:
cord-005453-4057qib7	2776	17	use	use	NN
cord-005453-4057qib7	2776	18	of	of	IN
cord-005453-4057qib7	2776	19	methotrexate	methotrexate	NNP
cord-005453-4057qib7	2776	20	(	(	-LRB-
cord-005453-4057qib7	2776	21	MTX	MTX	NNP
cord-005453-4057qib7	2776	22	)	)	-RRB-
cord-005453-4057qib7	2776	23	plus	plus	CC
cord-005453-4057qib7	2776	24	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	2776	25	vs	vs	IN
cord-005453-4057qib7	2776	26	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	2776	27	mofetil	mofetil	NNP
cord-005453-4057qib7	2776	28	plus	plus	CC
cord-005453-4057qib7	2776	29	cyclosporine	cyclosporine	NNP
cord-005453-4057qib7	2776	30	as	as	IN
cord-005453-4057qib7	2776	31	GvHD	GvHD	NNP
cord-005453-4057qib7	2776	32	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2776	33	,	,	,
cord-005453-4057qib7	2776	34	p=0.009	p=0.009	NN
cord-005453-4057qib7	2777	1	(	(	-LRB-
cord-005453-4057qib7	2777	2	HR=1.9	HR=1.9	NNP
cord-005453-4057qib7	2777	3	,	,	,
cord-005453-4057qib7	2777	4	1.2	1.2	CD
cord-005453-4057qib7	2777	5	to	to	IN
cord-005453-4057qib7	2777	6	3.1	3.1	CD
cord-005453-4057qib7	2777	7	)	)	-RRB-
cord-005453-4057qib7	2777	8	;	;	:
cord-005453-4057qib7	2777	9	myeloablative	myeloablative	NNP
cord-005453-4057qib7	2777	10	conditioning	conditioning	NN
cord-005453-4057qib7	2777	11	vs	vs	IN
cord-005453-4057qib7	2777	12	reduced	reduce	VBN
cord-005453-4057qib7	2777	13	intensity	intensity	NN
cord-005453-4057qib7	2777	14	,	,	,
cord-005453-4057qib7	2777	15	p=0.03	p=0.03	NN
cord-005453-4057qib7	2777	16	(	(	-LRB-
cord-005453-4057qib7	2777	17	HR=1.7	hr=1.7	NN
cord-005453-4057qib7	2777	18	,	,	,
cord-005453-4057qib7	2777	19	1	1	CD
cord-005453-4057qib7	2777	20	to	to	IN
cord-005453-4057qib7	2777	21	2.8	2.8	CD
cord-005453-4057qib7	2777	22	)	)	-RRB-
cord-005453-4057qib7	2777	23	and	and	CC
cord-005453-4057qib7	2777	24	use	use	NN
cord-005453-4057qib7	2777	25	of	of	IN
cord-005453-4057qib7	2777	26	total	total	JJ
cord-005453-4057qib7	2777	27	irradiation	irradiation	NN
cord-005453-4057qib7	2777	28	therapy	therapy	NN
cord-005453-4057qib7	2777	29	in	in	IN
cord-005453-4057qib7	2777	30	conditioning	conditioning	NN
cord-005453-4057qib7	2777	31	,	,	,
cord-005453-4057qib7	2777	32	p=0.02	p=0.02	JJ
cord-005453-4057qib7	2777	33	(	(	-LRB-
cord-005453-4057qib7	2777	34	HR=1.7	hr=1.7	NN
cord-005453-4057qib7	2777	35	,	,	,
cord-005453-4057qib7	2777	36	1.1	1.1	CD
cord-005453-4057qib7	2777	37	to	to	IN
cord-005453-4057qib7	2777	38	2.8	2.8	CD
cord-005453-4057qib7	2777	39	)	)	-RRB-
cord-005453-4057qib7	2777	40	.	.	.
cord-005453-4057qib7	2778	1	TRM	TRM	NNP
cord-005453-4057qib7	2778	2	at	at	IN
cord-005453-4057qib7	2778	3	1	1	CD
cord-005453-4057qib7	2778	4	year	year	NN
cord-005453-4057qib7	2778	5	increased	increase	VBD
cord-005453-4057qib7	2778	6	significantly	significantly	RB
cord-005453-4057qib7	2778	7	according	accord	VBG
cord-005453-4057qib7	2778	8	to	to	IN
cord-005453-4057qib7	2778	9	AKIN	akin	NN
cord-005453-4057qib7	2778	10	:	:	:
cord-005453-4057qib7	2779	1	AKIN-1	AKIN-1	NNP
cord-005453-4057qib7	2779	2	,	,	,
cord-005453-4057qib7	2779	3	25	25	CD
cord-005453-4057qib7	2779	4	%	%	NN
cord-005453-4057qib7	2779	5	;	;	:
cord-005453-4057qib7	2779	6	AKIN	akin	NN
cord-005453-4057qib7	2779	7	2	2	CD
cord-005453-4057qib7	2779	8	,	,	,
cord-005453-4057qib7	2779	9	35	35	CD
cord-005453-4057qib7	2779	10	%	%	NN
cord-005453-4057qib7	2779	11	;	;	:
cord-005453-4057qib7	2779	12	AKIN	AKIN	NNP
cord-005453-4057qib7	2779	13	3	3	CD
cord-005453-4057qib7	2779	14	,	,	,
cord-005453-4057qib7	2779	15	51	51	CD
cord-005453-4057qib7	2779	16	%	%	NN
cord-005453-4057qib7	2779	17	;	;	:
cord-005453-4057qib7	2779	18	p=0,003	p=0,003	NN
cord-005453-4057qib7	2779	19	;	;	:
cord-005453-4057qib7	2779	20	HR=11.2	hr=11.2	ADD
cord-005453-4057qib7	2779	21	.	.	.
cord-005453-4057qib7	2780	1	Overall	overall	JJ
cord-005453-4057qib7	2780	2	survival	survival	NN
cord-005453-4057qib7	2780	3	at	at	IN
cord-005453-4057qib7	2780	4	3	3	CD
cord-005453-4057qib7	2780	5	years	year	NNS
cord-005453-4057qib7	2780	6	according	accord	VBG
cord-005453-4057qib7	2780	7	to	to	IN
cord-005453-4057qib7	2780	8	AKIN	AKIN	NNP
cord-005453-4057qib7	2780	9	was	be	VBD
cord-005453-4057qib7	2780	10	:	:	:
cord-005453-4057qib7	2780	11	AKIN	akin	NN
cord-005453-4057qib7	2780	12	1	1	CD
cord-005453-4057qib7	2780	13	,	,	,
cord-005453-4057qib7	2780	14	52	52	CD
cord-005453-4057qib7	2780	15	%	%	NN
cord-005453-4057qib7	2780	16	,	,	,
cord-005453-4057qib7	2780	17	AKIN	akin	NN
cord-005453-4057qib7	2780	18	2	2	CD
cord-005453-4057qib7	2780	19	,	,	,
cord-005453-4057qib7	2780	20	45	45	CD
cord-005453-4057qib7	2780	21	%	%	NN
cord-005453-4057qib7	2780	22	and	and	CC
cord-005453-4057qib7	2780	23	AKIN	akin	NN
cord-005453-4057qib7	2780	24	3	3	CD
cord-005453-4057qib7	2780	25	,	,	,
cord-005453-4057qib7	2780	26	29	29	CD
cord-005453-4057qib7	2780	27	%	%	NN
cord-005453-4057qib7	2780	28	;	;	:
cord-005453-4057qib7	2780	29	p=0,004	p=0,004	NNP
cord-005453-4057qib7	2780	30	(	(	-LRB-
cord-005453-4057qib7	2780	31	figure	figure	NN
cord-005453-4057qib7	2780	32	1	1	CD
cord-005453-4057qib7	2780	33	)	)	-RRB-
cord-005453-4057qib7	2780	34	.	.	.
cord-005453-4057qib7	2781	1	The	the	DT
cord-005453-4057qib7	2781	2	incidence	incidence	NN
cord-005453-4057qib7	2781	3	of	of	IN
cord-005453-4057qib7	2781	4	chronic	chronic	JJ
cord-005453-4057qib7	2781	5	renal	renal	JJ
cord-005453-4057qib7	2781	6	disease	disease	NN
cord-005453-4057qib7	2781	7	at	at	IN
cord-005453-4057qib7	2781	8	1	1	CD
cord-005453-4057qib7	2781	9	year	year	NN
cord-005453-4057qib7	2781	10	after	after	IN
cord-005453-4057qib7	2781	11	allo	allo	NNP
cord-005453-4057qib7	2781	12	-	-	HYPH
cord-005453-4057qib7	2781	13	SCT	SCT	NNP
cord-005453-4057qib7	2781	14	according	accord	VBG
cord-005453-4057qib7	2781	15	to	to	IN
cord-005453-4057qib7	2781	16	ARF	ARF	NNP
cord-005453-4057qib7	2781	17	was	be	VBD
cord-005453-4057qib7	2781	18	:	:	:
cord-005453-4057qib7	2781	19	no	no	DT
cord-005453-4057qib7	2781	20	ARF	arf	NN
cord-005453-4057qib7	2781	21	(	(	-LRB-
cord-005453-4057qib7	2781	22	8	8	CD
cord-005453-4057qib7	2781	23	%	%	NN
cord-005453-4057qib7	2781	24	)	)	-RRB-
cord-005453-4057qib7	2781	25	,	,	,
cord-005453-4057qib7	2781	26	AKIN-1	AKIN-1	NNP
cord-005453-4057qib7	2781	27	(	(	-LRB-
cord-005453-4057qib7	2781	28	11	11	CD
cord-005453-4057qib7	2781	29	%	%	NN
cord-005453-4057qib7	2781	30	)	)	-RRB-
cord-005453-4057qib7	2781	31	,	,	,
cord-005453-4057qib7	2781	32	AKIN-2	AKIN-2	NNP
cord-005453-4057qib7	2781	33	(	(	-LRB-
cord-005453-4057qib7	2781	34	15	15	CD
cord-005453-4057qib7	2781	35	%	%	NN
cord-005453-4057qib7	2781	36	)	)	-RRB-
cord-005453-4057qib7	2781	37	and	and	CC
cord-005453-4057qib7	2781	38	AKIN-3	AKIN-3	NNP
cord-005453-4057qib7	2781	39	(	(	-LRB-
cord-005453-4057qib7	2781	40	16	16	CD
cord-005453-4057qib7	2781	41	%	%	NN
cord-005453-4057qib7	2781	42	)	)	-RRB-
cord-005453-4057qib7	2781	43	;	;	:
cord-005453-4057qib7	2782	1	p=0.006	p=0.006	NNS
cord-005453-4057qib7	2782	2	.	.	.
cord-005453-4057qib7	2783	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2783	2	:	:	:
cord-005453-4057qib7	2784	1	ARF	ARF	NNP
cord-005453-4057qib7	2784	2	is	be	VBZ
cord-005453-4057qib7	2784	3	a	a	DT
cord-005453-4057qib7	2784	4	frequent	frequent	JJ
cord-005453-4057qib7	2784	5	complication	complication	NN
cord-005453-4057qib7	2784	6	during	during	IN
cord-005453-4057qib7	2784	7	the	the	DT
cord-005453-4057qib7	2784	8	first	first	JJ
cord-005453-4057qib7	2784	9	year	year	NN
cord-005453-4057qib7	2784	10	after	after	IN
cord-005453-4057qib7	2784	11	allo	allo	NNP
cord-005453-4057qib7	2784	12	-	-	HYPH
cord-005453-4057qib7	2784	13	SCT	SCT	NNP
cord-005453-4057qib7	2784	14	and	and	CC
cord-005453-4057qib7	2784	15	is	be	VBZ
cord-005453-4057qib7	2784	16	associated	associate	VBN
cord-005453-4057qib7	2784	17	with	with	IN
cord-005453-4057qib7	2784	18	several	several	JJ
cord-005453-4057qib7	2784	19	factors	factor	NNS
cord-005453-4057qib7	2784	20	.	.	.
cord-005453-4057qib7	2785	1	ARF	ARF	NNP
cord-005453-4057qib7	2785	2	AKIN-3	AKIN-3	NNP
cord-005453-4057qib7	2785	3	was	be	VBD
cord-005453-4057qib7	2785	4	associated	associate	VBN
cord-005453-4057qib7	2785	5	with	with	IN
cord-005453-4057qib7	2785	6	more	more	RBR
cord-005453-4057qib7	2785	7	intensive	intensive	JJ
cord-005453-4057qib7	2785	8	strategies	strategy	NNS
cord-005453-4057qib7	2785	9	received	receive	VBN
cord-005453-4057qib7	2785	10	during	during	IN
cord-005453-4057qib7	2785	11	conditioning	conditioning	NN
cord-005453-4057qib7	2785	12	,	,	,
cord-005453-4057qib7	2785	13	meanwhile	meanwhile	RB
cord-005453-4057qib7	2785	14	AKIN-1/2	AKIN-1/2	NNP
cord-005453-4057qib7	2785	15	were	be	VBD
cord-005453-4057qib7	2785	16	related	relate	VBN
cord-005453-4057qib7	2785	17	to	to	IN
cord-005453-4057qib7	2785	18	development	development	NN
cord-005453-4057qib7	2785	19	of	of	IN
cord-005453-4057qib7	2785	20	GvHD	GvHD	NNP
cord-005453-4057qib7	2785	21	.	.	.
cord-005453-4057qib7	2786	1	There	there	EX
cord-005453-4057qib7	2786	2	is	be	VBZ
cord-005453-4057qib7	2786	3	an	an	DT
cord-005453-4057qib7	2786	4	association	association	NN
cord-005453-4057qib7	2786	5	of	of	IN
cord-005453-4057qib7	2786	6	ARF	ARF	NNP
cord-005453-4057qib7	2786	7	(	(	-LRB-
cord-005453-4057qib7	2786	8	AKIN-1	AKIN-1	NNP
cord-005453-4057qib7	2786	9	,	,	,
cord-005453-4057qib7	2786	10	2	2	CD
cord-005453-4057qib7	2786	11	or	or	CC
cord-005453-4057qib7	2786	12	3	3	CD
cord-005453-4057qib7	2786	13	)	)	-RRB-
cord-005453-4057qib7	2786	14	with	with	IN
cord-005453-4057qib7	2786	15	development	development	NN
cord-005453-4057qib7	2786	16	of	of	IN
cord-005453-4057qib7	2786	17	chronic	chronic	JJ
cord-005453-4057qib7	2786	18	renal	renal	JJ
cord-005453-4057qib7	2786	19	disease	disease	NN
cord-005453-4057qib7	2786	20	.	.	.
cord-005453-4057qib7	2787	1	Background	background	NN
cord-005453-4057qib7	2787	2	:	:	:
cord-005453-4057qib7	2788	1	The	the	DT
cord-005453-4057qib7	2788	2	introduction	introduction	NN
cord-005453-4057qib7	2788	3	of	of	IN
cord-005453-4057qib7	2788	4	cellular	cellular	JJ
cord-005453-4057qib7	2788	5	therapies	therapy	NNS
cord-005453-4057qib7	2788	6	such	such	JJ
cord-005453-4057qib7	2788	7	as	as	IN
cord-005453-4057qib7	2788	8	CAR	car	NN
cord-005453-4057qib7	2788	9	-	-	HYPH
cord-005453-4057qib7	2788	10	T	T	NNP
cord-005453-4057qib7	2788	11	and	and	CC
cord-005453-4057qib7	2788	12	modalities	modality	NNS
cord-005453-4057qib7	2788	13	of	of	IN
cord-005453-4057qib7	2788	14	GvHD	gvhd	NN
cord-005453-4057qib7	2788	15	-	-	HYPH
cord-005453-4057qib7	2788	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2788	17	with	with	IN
cord-005453-4057qib7	2788	18	posttransplant	posttransplant	NN
cord-005453-4057qib7	2788	19	/	/	,
cord-005453-4057qib7	2788	20	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	2788	21	(	(	-LRB-
cord-005453-4057qib7	2788	22	PtCy	ptcy	RB
cord-005453-4057qib7	2788	23	)	)	-RRB-
cord-005453-4057qib7	2788	24	that	that	WDT
cord-005453-4057qib7	2788	25	increase	increase	VBP
cord-005453-4057qib7	2788	26	the	the	DT
cord-005453-4057qib7	2788	27	number	number	NN
cord-005453-4057qib7	2788	28	of	of	IN
cord-005453-4057qib7	2788	29	admission	admission	NN
cord-005453-4057qib7	2788	30	days	day	NNS
cord-005453-4057qib7	2788	31	have	have	VBP
cord-005453-4057qib7	2788	32	boosted	boost	VBN
cord-005453-4057qib7	2788	33	the	the	DT
cord-005453-4057qib7	2788	34	pressure	pressure	NN
cord-005453-4057qib7	2788	35	of	of	IN
cord-005453-4057qib7	2788	36	available	available	JJ
cord-005453-4057qib7	2788	37	beds	bed	NNS
cord-005453-4057qib7	2788	38	in	in	IN
cord-005453-4057qib7	2788	39	the	the	DT
cord-005453-4057qib7	2788	40	BM	bm	NN
cord-005453-4057qib7	2788	41	-	-	HYPH
cord-005453-4057qib7	2788	42	units	unit	NNS
cord-005453-4057qib7	2788	43	.	.	.
cord-005453-4057qib7	2789	1	In	in	IN
cord-005453-4057qib7	2789	2	this	this	DT
cord-005453-4057qib7	2789	3	sense	sense	NN
cord-005453-4057qib7	2789	4	,	,	,
cord-005453-4057qib7	2789	5	our	-PRON-	PRP$
cord-005453-4057qib7	2789	6	centre	centre	NN
cord-005453-4057qib7	2789	7	started	start	VBD
cord-005453-4057qib7	2789	8	an	an	DT
cord-005453-4057qib7	2789	9	at	at	IN
cord-005453-4057qib7	2789	10	-	-	HYPH
cord-005453-4057qib7	2789	11	home	home	NN
cord-005453-4057qib7	2789	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	2789	13	stem	stem	NN
cord-005453-4057qib7	2789	14	cell	cell	NN
cord-005453-4057qib7	2789	15	transplantation	transplantation	NN
cord-005453-4057qib7	2789	16	(	(	-LRB-
cord-005453-4057qib7	2789	17	allo	allo	FW
cord-005453-4057qib7	2789	18	-	-	HYPH
cord-005453-4057qib7	2789	19	SCT	SCT	NNP
cord-005453-4057qib7	2789	20	)	)	-RRB-
cord-005453-4057qib7	2789	21	program	program	NN
cord-005453-4057qib7	2789	22	to	to	TO
cord-005453-4057qib7	2789	23	follow	follow	VB
cord-005453-4057qib7	2789	24	aplasia	aplasia	NNP
cord-005453-4057qib7	2789	25	from	from	IN
cord-005453-4057qib7	2789	26	the	the	DT
cord-005453-4057qib7	2789	27	D+1	D+1	NNP
cord-005453-4057qib7	2789	28	until	until	IN
cord-005453-4057qib7	2789	29	independent	independent	JJ
cord-005453-4057qib7	2789	30	ambulatory	ambulatory	JJ
cord-005453-4057qib7	2789	31	patient	patient	NN
cord-005453-4057qib7	2789	32	.	.	.
cord-005453-4057qib7	2790	1	To	to	TO
cord-005453-4057qib7	2790	2	evaluate	evaluate	VB
cord-005453-4057qib7	2790	3	the	the	DT
cord-005453-4057qib7	2790	4	feasibility	feasibility	NN
cord-005453-4057qib7	2790	5	and	and	CC
cord-005453-4057qib7	2790	6	safety	safety	NN
cord-005453-4057qib7	2790	7	of	of	IN
cord-005453-4057qib7	2790	8	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2790	9	,	,	,
cord-005453-4057qib7	2790	10	we	-PRON-	PRP
cord-005453-4057qib7	2790	11	compared	compare	VBD
cord-005453-4057qib7	2790	12	two	two	CD
cord-005453-4057qib7	2790	13	groups	group	NNS
cord-005453-4057qib7	2790	14	:	:	:
cord-005453-4057qib7	2790	15	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2790	16	/	/	SYM
cord-005453-4057qib7	2790	17	athome	athome	NNP
cord-005453-4057qib7	2790	18	(	(	-LRB-
cord-005453-4057qib7	2790	19	AH	AH	NNP
cord-005453-4057qib7	2790	20	-	-	HYPH
cord-005453-4057qib7	2790	21	Group	Group	NNP
cord-005453-4057qib7	2790	22	)	)	-RRB-
cord-005453-4057qib7	2790	23	vs.	vs.	FW
cord-005453-4057qib7	2790	24	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	2790	25	/	/	SYM
cord-005453-4057qib7	2790	26	in	in	IN
cord-005453-4057qib7	2790	27	-	-	HYPH
cord-005453-4057qib7	2790	28	patient	patient	NN
cord-005453-4057qib7	2790	29	(	(	-LRB-
cord-005453-4057qib7	2790	30	IP	IP	NNP
cord-005453-4057qib7	2790	31	-	-	HYPH
cord-005453-4057qib7	2790	32	Group	Group	NNP
cord-005453-4057qib7	2790	33	)	)	-RRB-
cord-005453-4057qib7	2790	34	.	.	.
cord-005453-4057qib7	2791	1	Methods	method	NNS
cord-005453-4057qib7	2791	2	:	:	:
cord-005453-4057qib7	2792	1	We	-PRON-	PRP
cord-005453-4057qib7	2792	2	included	include	VBD
cord-005453-4057qib7	2792	3	78	78	CD
cord-005453-4057qib7	2792	4	patients	patient	NNS
cord-005453-4057qib7	2792	5	receiving	receive	VBG
cord-005453-4057qib7	2792	6	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2792	7	(	(	-LRB-
cord-005453-4057qib7	2792	8	January	January	NNP
cord-005453-4057qib7	2792	9	2014-November	2014-november	CD
cord-005453-4057qib7	2792	10	2018	2018	CD
cord-005453-4057qib7	2792	11	)	)	-RRB-
cord-005453-4057qib7	2792	12	in	in	IN
cord-005453-4057qib7	2792	13	a	a	DT
cord-005453-4057qib7	2792	14	single	single	JJ
cord-005453-4057qib7	2792	15	centre	centre	NN
cord-005453-4057qib7	2792	16	:	:	:
cord-005453-4057qib7	2792	17	39	39	CD
cord-005453-4057qib7	2792	18	patients	patient	NNS
cord-005453-4057qib7	2792	19	,	,	,
cord-005453-4057qib7	2792	20	AH	AH	NNP
cord-005453-4057qib7	2792	21	-	-	HYPH
cord-005453-4057qib7	2792	22	Group	Group	NNP
cord-005453-4057qib7	2792	23	and	and	CC
cord-005453-4057qib7	2792	24	39	39	CD
cord-005453-4057qib7	2792	25	,	,	,
cord-005453-4057qib7	2792	26	IP	IP	NNP
cord-005453-4057qib7	2792	27	-	-	HYPH
cord-005453-4057qib7	2792	28	Group	Group	NNP
cord-005453-4057qib7	2792	29	.	.	.
cord-005453-4057qib7	2793	1	All	all	DT
cord-005453-4057qib7	2793	2	patients	patient	NNS
cord-005453-4057qib7	2793	3	received	receive	VBD
cord-005453-4057qib7	2793	4	conditioning	conditioning	NN
cord-005453-4057qib7	2793	5	at	at	IN
cord-005453-4057qib7	2793	6	the	the	DT
cord-005453-4057qib7	2793	7	hospital	hospital	NN
cord-005453-4057qib7	2793	8	.	.	.
cord-005453-4057qib7	2794	1	GvHD	gvhd	NN
cord-005453-4057qib7	2794	2	-	-	HYPH
cord-005453-4057qib7	2794	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2794	4	consisted	consist	VBN
cord-005453-4057qib7	2794	5	in	in	IN
cord-005453-4057qib7	2794	6	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	2794	7	(	(	-LRB-
cord-005453-4057qib7	2794	8	TK	TK	NNP
cord-005453-4057qib7	2794	9	)	)	-RRB-
cord-005453-4057qib7	2794	10	plus	plus	CC
cord-005453-4057qib7	2794	11	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	2794	12	(	(	-LRB-
cord-005453-4057qib7	2794	13	MPM	MPM	NNP
cord-005453-4057qib7	2794	14	)	)	-RRB-
cord-005453-4057qib7	2794	15	or	or	CC
cord-005453-4057qib7	2794	16	methotrexate	methotrexate	NNP
cord-005453-4057qib7	2794	17	,	,	,
cord-005453-4057qib7	2794	18	or	or	CC
cord-005453-4057qib7	2794	19	PtCy	ptcy	NN
cord-005453-4057qib7	2795	1	(	(	-LRB-
cord-005453-4057qib7	2795	2	D+3	D+3	NNP
cord-005453-4057qib7	2795	3	,	,	,
cord-005453-4057qib7	2795	4	D+4	D+4	NNP
cord-005453-4057qib7	2795	5	)	)	-RRB-
cord-005453-4057qib7	2795	6	plus	plus	CC
cord-005453-4057qib7	2795	7	TK	TK	NNP
cord-005453-4057qib7	2795	8	(	(	-LRB-
cord-005453-4057qib7	2795	9	D+5	D+5	NNP
cord-005453-4057qib7	2795	10	)	)	-RRB-
cord-005453-4057qib7	2795	11	.	.	.
cord-005453-4057qib7	2796	1	All	all	DT
cord-005453-4057qib7	2796	2	patients	patient	NNS
cord-005453-4057qib7	2796	3	received	receive	VBD
cord-005453-4057qib7	2796	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2796	5	with	with	IN
cord-005453-4057qib7	2796	6	levofloxacin	levofloxacin	NNS
cord-005453-4057qib7	2796	7	,	,	,
cord-005453-4057qib7	2796	8	fluconazole	fluconazole	NN
cord-005453-4057qib7	2796	9	and	and	CC
cord-005453-4057qib7	2796	10	acyclovir	acyclovir	NN
cord-005453-4057qib7	2796	11	.	.	.
cord-005453-4057qib7	2797	1	Besides	besides	IN
cord-005453-4057qib7	2797	2	that	that	DT
cord-005453-4057qib7	2797	3	,	,	,
cord-005453-4057qib7	2797	4	AH	AH	NNP
cord-005453-4057qib7	2797	5	-	-	HYPH
cord-005453-4057qib7	2797	6	Group	Group	NNP
cord-005453-4057qib7	2797	7	patients	patient	NNS
cord-005453-4057qib7	2797	8	received	receive	VBD
cord-005453-4057qib7	2797	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2797	10	with	with	IN
cord-005453-4057qib7	2797	11	ceftriaxone	ceftriaxone	NN
cord-005453-4057qib7	2797	12	1g/24h	1g/24h	CD
cord-005453-4057qib7	2797	13	IV	IV	NNP
cord-005453-4057qib7	2797	14	or	or	CC
cord-005453-4057qib7	2797	15	ertapenem	ertapenem	NNP
cord-005453-4057qib7	2797	16	1g/	1g/	CD
cord-005453-4057qib7	2797	17	24h	24h	CD
cord-005453-4057qib7	2797	18	IV	IV	NNP
cord-005453-4057qib7	2797	19	,	,	,
cord-005453-4057qib7	2797	20	and	and	CC
cord-005453-4057qib7	2797	21	Aspergillus	aspergillus	NN
cord-005453-4057qib7	2797	22	-	-	HYPH
cord-005453-4057qib7	2797	23	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2797	24	with	with	IN
cord-005453-4057qib7	2797	25	inhaled	inhale	VBN
cord-005453-4057qib7	2797	26	liposomal	liposomal	JJ
cord-005453-4057qib7	2797	27	amphotericin	amphotericin	NN
cord-005453-4057qib7	2797	28	-	-	HYPH
cord-005453-4057qib7	2797	29	B	B	NNP
cord-005453-4057qib7	2797	30	or	or	CC
cord-005453-4057qib7	2797	31	posaconazole	posaconazole	NN
cord-005453-4057qib7	2797	32	during	during	IN
cord-005453-4057qib7	2797	33	neutropenia	neutropenia	NN
cord-005453-4057qib7	2797	34	.	.	.
cord-005453-4057qib7	2798	1	Patients	patient	NNS
cord-005453-4057qib7	2798	2	of	of	IN
cord-005453-4057qib7	2798	3	AH	AH	NNP
cord-005453-4057qib7	2798	4	-	-	HYPH
cord-005453-4057qib7	2798	5	Group	Group	NNP
cord-005453-4057qib7	2798	6	since	since	IN
cord-005453-4057qib7	2798	7	D+1	D+1	NNP
cord-005453-4057qib7	2798	8	or	or	CC
cord-005453-4057qib7	2798	9	D+6	D+6	NNP
cord-005453-4057qib7	2798	10	(	(	-LRB-
cord-005453-4057qib7	2798	11	in	in	IN
cord-005453-4057qib7	2798	12	PtCyprophylaxis	PtCyprophylaxis	NNP
cord-005453-4057qib7	2798	13	)	)	-RRB-
cord-005453-4057qib7	2798	14	received	receive	VBD
cord-005453-4057qib7	2798	15	a	a	DT
cord-005453-4057qib7	2798	16	nurse	nurse	NN
cord-005453-4057qib7	2798	17	visit	visit	NN
cord-005453-4057qib7	2798	18	at	at	IN
cord-005453-4057qib7	2798	19	-	-	HYPH
cord-005453-4057qib7	2798	20	home	home	NN
cord-005453-4057qib7	2798	21	once	once	RB
cord-005453-4057qib7	2798	22	daily	daily	RB
cord-005453-4057qib7	2798	23	.	.	.
cord-005453-4057qib7	2799	1	The	the	DT
cord-005453-4057qib7	2799	2	visits	visit	NNS
cord-005453-4057qib7	2799	3	by	by	IN
cord-005453-4057qib7	2799	4	the	the	DT
cord-005453-4057qib7	2799	5	physician	physician	NN
cord-005453-4057qib7	2799	6	were	be	VBD
cord-005453-4057qib7	2799	7	performed	perform	VBN
cord-005453-4057qib7	2799	8	at	at	IN
cord-005453-4057qib7	2799	9	the	the	DT
cord-005453-4057qib7	2799	10	hospital	hospital	NN
cord-005453-4057qib7	2799	11	and	and	CC
cord-005453-4057qib7	2799	12	only	only	RB
cord-005453-4057qib7	2799	13	during	during	IN
cord-005453-4057qib7	2799	14	complication	complication	NN
cord-005453-4057qib7	2799	15	events	event	NNS
cord-005453-4057qib7	2799	16	.	.	.
cord-005453-4057qib7	2800	1	First	first	JJ
cord-005453-4057qib7	2800	2	-	-	HYPH
cord-005453-4057qib7	2800	3	line	line	NN
cord-005453-4057qib7	2800	4	therapy	therapy	NN
cord-005453-4057qib7	2800	5	of	of	IN
cord-005453-4057qib7	2800	6	neutropenic	neutropenic	JJ
cord-005453-4057qib7	2800	7	fever	fever	NN
cord-005453-4057qib7	2800	8	was	be	VBD
cord-005453-4057qib7	2800	9	meropenem	meropenem	NNP
cord-005453-4057qib7	2800	10	1	1	CD
cord-005453-4057qib7	2800	11	g/8h	g/8h	NNP
cord-005453-4057qib7	2800	12	in	in	IN
cord-005453-4057qib7	2800	13	both	both	DT
cord-005453-4057qib7	2800	14	groups	group	NNS
cord-005453-4057qib7	2800	15	,	,	,
cord-005453-4057qib7	2800	16	using	use	VBG
cord-005453-4057qib7	2800	17	a	a	DT
cord-005453-4057qib7	2800	18	portable	portable	JJ
cord-005453-4057qib7	2800	19	infusion	infusion	NN
cord-005453-4057qib7	2800	20	pump	pump	NN
cord-005453-4057qib7	2800	21	in	in	IN
cord-005453-4057qib7	2800	22	AH	AH	NNP
cord-005453-4057qib7	2800	23	-	-	HYPH
cord-005453-4057qib7	2800	24	Group	Group	NNP
cord-005453-4057qib7	2800	25	.	.	.
cord-005453-4057qib7	2801	1	In	in	IN
cord-005453-4057qib7	2801	2	this	this	DT
cord-005453-4057qib7	2801	3	group	group	NN
cord-005453-4057qib7	2801	4	,	,	,
cord-005453-4057qib7	2801	5	the	the	DT
cord-005453-4057qib7	2801	6	absence	absence	NN
cord-005453-4057qib7	2801	7	of	of	IN
cord-005453-4057qib7	2801	8	focal	focal	JJ
cord-005453-4057qib7	2801	9	infection	infection	NN
cord-005453-4057qib7	2801	10	or	or	CC
cord-005453-4057qib7	2801	11	signs	sign	NNS
cord-005453-4057qib7	2801	12	of	of	IN
cord-005453-4057qib7	2801	13	severe	severe	JJ
cord-005453-4057qib7	2801	14	sepsis	sepsis	NN
cord-005453-4057qib7	2801	15	allowed	allow	VBD
cord-005453-4057qib7	2801	16	returning	return	VBG
cord-005453-4057qib7	2801	17	home	home	RB
cord-005453-4057qib7	2801	18	after	after	IN
cord-005453-4057qib7	2801	19	the	the	DT
cord-005453-4057qib7	2801	20	initiation	initiation	NN
cord-005453-4057qib7	2801	21	of	of	IN
cord-005453-4057qib7	2801	22	antibiotics	antibiotic	NNS
cord-005453-4057qib7	2801	23	.	.	.
cord-005453-4057qib7	2802	1	The	the	DT
cord-005453-4057qib7	2802	2	platelets	platelet	NNS
cord-005453-4057qib7	2802	3	support	support	NN
cord-005453-4057qib7	2802	4	was	be	VBD
cord-005453-4057qib7	2802	5	performed	perform	VBN
cord-005453-4057qib7	2802	6	at	at	IN
cord-005453-4057qib7	2802	7	-	-	HYPH
cord-005453-4057qib7	2802	8	home	home	NN
cord-005453-4057qib7	2802	9	and	and	CC
cord-005453-4057qib7	2802	10	the	the	DT
cord-005453-4057qib7	2802	11	red	red	JJ
cord-005453-4057qib7	2802	12	blood	blood	NN
cord-005453-4057qib7	2802	13	support	support	NN
cord-005453-4057qib7	2802	14	at	at	IN
cord-005453-4057qib7	2802	15	hospital	hospital	NN
cord-005453-4057qib7	2802	16	.	.	.
cord-005453-4057qib7	2803	1	Results	result	NNS
cord-005453-4057qib7	2803	2	:	:	:
cord-005453-4057qib7	2804	1	The	the	DT
cord-005453-4057qib7	2804	2	median	median	NN
cord-005453-4057qib7	2804	3	(	(	-LRB-
cord-005453-4057qib7	2804	4	range	range	NN
cord-005453-4057qib7	2804	5	)	)	-RRB-
cord-005453-4057qib7	2804	6	age	age	NN
cord-005453-4057qib7	2804	7	(	(	-LRB-
cord-005453-4057qib7	2804	8	years	year	NNS
cord-005453-4057qib7	2804	9	)	)	-RRB-
cord-005453-4057qib7	2804	10	of	of	IN
cord-005453-4057qib7	2804	11	the	the	DT
cord-005453-4057qib7	2804	12	series	series	NN
cord-005453-4057qib7	2804	13	was	be	VBD
cord-005453-4057qib7	2804	14	54	54	CD
cord-005453-4057qib7	2804	15	.	.	.
cord-005453-4057qib7	2805	1	The	the	DT
cord-005453-4057qib7	2805	2	median	median	JJ
cord-005453-4057qib7	2805	3	follow	follow	NN
cord-005453-4057qib7	2805	4	-	-	HYPH
cord-005453-4057qib7	2805	5	up	up	NN
cord-005453-4057qib7	2805	6	of	of	IN
cord-005453-4057qib7	2805	7	the	the	DT
cord-005453-4057qib7	2805	8	series	series	NN
cord-005453-4057qib7	2805	9	has	have	VBZ
cord-005453-4057qib7	2805	10	been	be	VBN
cord-005453-4057qib7	2805	11	not	not	RB
cord-005453-4057qib7	2805	12	achieved	achieve	VBN
cord-005453-4057qib7	2805	13	.	.	.
cord-005453-4057qib7	2806	1	The	the	DT
cord-005453-4057qib7	2806	2	source	source	NN
cord-005453-4057qib7	2806	3	of	of	IN
cord-005453-4057qib7	2806	4	the	the	DT
cord-005453-4057qib7	2806	5	SCT	SCT	NNP
cord-005453-4057qib7	2806	6	was	be	VBD
cord-005453-4057qib7	2806	7	peripheral	peripheral	JJ
cord-005453-4057qib7	2806	8	blood	blood	NN
cord-005453-4057qib7	2806	9	in	in	IN
cord-005453-4057qib7	2806	10	all	all	DT
cord-005453-4057qib7	2806	11	cases	case	NNS
cord-005453-4057qib7	2806	12	.	.	.
cord-005453-4057qib7	2807	1	We	-PRON-	PRP
cord-005453-4057qib7	2807	2	did	do	VBD
cord-005453-4057qib7	2807	3	n't	not	RB
cord-005453-4057qib7	2807	4	find	find	VB
cord-005453-4057qib7	2807	5	statistical	statistical	JJ
cord-005453-4057qib7	2807	6	differences	difference	NNS
cord-005453-4057qib7	2807	7	between	between	IN
cord-005453-4057qib7	2807	8	two	two	CD
cord-005453-4057qib7	2807	9	groups	group	NNS
cord-005453-4057qib7	2807	10	(	(	-LRB-
cord-005453-4057qib7	2807	11	AH	ah	NN
cord-005453-4057qib7	2807	12	vs	vs	IN
cord-005453-4057qib7	2807	13	IP	IP	NNP
cord-005453-4057qib7	2807	14	)	)	-RRB-
cord-005453-4057qib7	2807	15	in	in	IN
cord-005453-4057qib7	2807	16	terms	term	NNS
cord-005453-4057qib7	2807	17	of	of	IN
cord-005453-4057qib7	2807	18	age	age	NN
cord-005453-4057qib7	2807	19	,	,	,
cord-005453-4057qib7	2807	20	diagnosis	diagnosis	NN
cord-005453-4057qib7	2807	21	,	,	,
cord-005453-4057qib7	2807	22	type	type	NN
cord-005453-4057qib7	2807	23	of	of	IN
cord-005453-4057qib7	2807	24	donor	donor	NN
cord-005453-4057qib7	2807	25	,	,	,
cord-005453-4057qib7	2807	26	intensity	intensity	NN
cord-005453-4057qib7	2807	27	of	of	IN
cord-005453-4057qib7	2807	28	conditioning	conditioning	NN
cord-005453-4057qib7	2807	29	,	,	,
cord-005453-4057qib7	2807	30	GvHD	gvhd	NN
cord-005453-4057qib7	2807	31	-	-	HYPH
cord-005453-4057qib7	2807	32	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2807	33	,	,	,
cord-005453-4057qib7	2807	34	toxicity	toxicity	NN
cord-005453-4057qib7	2807	35	(	(	-LRB-
cord-005453-4057qib7	2807	36	mucositis	mucositis	NNP
cord-005453-4057qib7	2807	37	,	,	,
cord-005453-4057qib7	2807	38	acute	acute	JJ
cord-005453-4057qib7	2807	39	renal	renal	JJ
cord-005453-4057qib7	2807	40	injury	injury	NN
cord-005453-4057qib7	2807	41	,	,	,
cord-005453-4057qib7	2807	42	neutropenia	neutropenia	NN
cord-005453-4057qib7	2807	43	and	and	CC
cord-005453-4057qib7	2807	44	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2807	45	)	)	-RRB-
cord-005453-4057qib7	2807	46	,	,	,
cord-005453-4057qib7	2807	47	aGvHD	aGvHD	NNP
cord-005453-4057qib7	2807	48	,	,	,
cord-005453-4057qib7	2807	49	Aspergilosis	Aspergilosis	NNP
cord-005453-4057qib7	2807	50	and	and	CC
cord-005453-4057qib7	2807	51	TRM	TRM	NNP
cord-005453-4057qib7	2807	52	.	.	.
cord-005453-4057qib7	2808	1	Interestingly	interestingly	RB
cord-005453-4057qib7	2808	2	,	,	,
cord-005453-4057qib7	2808	3	a	a	DT
cord-005453-4057qib7	2808	4	significant	significant	JJ
cord-005453-4057qib7	2808	5	reduction	reduction	NN
cord-005453-4057qib7	2808	6	of	of	IN
cord-005453-4057qib7	2808	7	neutropenic	neutropenic	JJ
cord-005453-4057qib7	2808	8	fever	fever	NN
cord-005453-4057qib7	2808	9	was	be	VBD
cord-005453-4057qib7	2808	10	observed	observe	VBN
cord-005453-4057qib7	2808	11	resulting	result	VBG
cord-005453-4057qib7	2808	12	the	the	DT
cord-005453-4057qib7	2808	13	lower	low	JJR
cord-005453-4057qib7	2808	14	use	use	NN
cord-005453-4057qib7	2808	15	of	of	IN
cord-005453-4057qib7	2808	16	meropenem	meropenem	NN
cord-005453-4057qib7	2808	17	in	in	IN
cord-005453-4057qib7	2808	18	the	the	DT
cord-005453-4057qib7	2808	19	AH	AH	NNP
cord-005453-4057qib7	2808	20	-	-	HYPH
cord-005453-4057qib7	2808	21	group	group	NN
cord-005453-4057qib7	2808	22	than	than	IN
cord-005453-4057qib7	2808	23	IP	ip	NN
cord-005453-4057qib7	2808	24	-	-	HYPH
cord-005453-4057qib7	2808	25	group	group	NN
cord-005453-4057qib7	2808	26	.	.	.
cord-005453-4057qib7	2809	1	The	the	DT
cord-005453-4057qib7	2809	2	admission	admission	NN
cord-005453-4057qib7	2809	3	median	median	JJ
cord-005453-4057qib7	2809	4	days	day	NNS
cord-005453-4057qib7	2809	5	were	be	VBD
cord-005453-4057qib7	2809	6	similar	similar	JJ
cord-005453-4057qib7	2809	7	in	in	IN
cord-005453-4057qib7	2809	8	the	the	DT
cord-005453-4057qib7	2809	9	both	both	DT
cord-005453-4057qib7	2809	10	groups	group	NNS
cord-005453-4057qib7	2809	11	and	and	CC
cord-005453-4057qib7	2809	12	it	-PRON-	PRP
cord-005453-4057qib7	2809	13	represented	represent	VBD
cord-005453-4057qib7	2809	14	21	21	CD
cord-005453-4057qib7	2809	15	-	-	SYM
cord-005453-4057qib7	2809	16	23	23	CD
cord-005453-4057qib7	2809	17	days	day	NNS
cord-005453-4057qib7	2809	18	the	the	DT
cord-005453-4057qib7	2809	19	reduction	reduction	NN
cord-005453-4057qib7	2809	20	in	in	IN
cord-005453-4057qib7	2809	21	the	the	DT
cord-005453-4057qib7	2809	22	total	total	JJ
cord-005453-4057qib7	2809	23	economic	economic	JJ
cord-005453-4057qib7	2809	24	cost	cost	NN
cord-005453-4057qib7	2809	25	of	of	IN
cord-005453-4057qib7	2809	26	the	the	DT
cord-005453-4057qib7	2809	27	AH	ah	NN
cord-005453-4057qib7	2809	28	-	-	HYPH
cord-005453-4057qib7	2809	29	group	group	NN
cord-005453-4057qib7	2809	30	.	.	.
cord-005453-4057qib7	2810	1	The	the	DT
cord-005453-4057qib7	2810	2	whole	whole	JJ
cord-005453-4057qib7	2810	3	analysis	analysis	NN
cord-005453-4057qib7	2810	4	of	of	IN
cord-005453-4057qib7	2810	5	the	the	DT
cord-005453-4057qib7	2810	6	results	result	NNS
cord-005453-4057qib7	2810	7	are	be	VBP
cord-005453-4057qib7	2810	8	detailed	detail	VBN
cord-005453-4057qib7	2810	9	in	in	IN
cord-005453-4057qib7	2810	10	table	table	NN
cord-005453-4057qib7	2810	11	:	:	:
cord-005453-4057qib7	2810	12	In	in	IN
cord-005453-4057qib7	2810	13	-	-	HYPH
cord-005453-4057qib7	2810	14	Patient	Patient	NNP
cord-005453-4057qib7	2810	15	Group	Group	NNP
cord-005453-4057qib7	2810	16	,	,	,
cord-005453-4057qib7	2810	17	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	2810	18	:	:	:
cord-005453-4057qib7	2810	19	In	in	IN
cord-005453-4057qib7	2810	20	our	-PRON-	PRP$
cord-005453-4057qib7	2810	21	experience	experience	NN
cord-005453-4057qib7	2810	22	,	,	,
cord-005453-4057qib7	2810	23	at	at	IN
cord-005453-4057qib7	2810	24	home	home	NN
cord-005453-4057qib7	2810	25	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2810	26	,	,	,
cord-005453-4057qib7	2810	27	including	include	VBG
cord-005453-4057qib7	2810	28	PtCy	ptcy	RB
cord-005453-4057qib7	2810	29	-	-	HYPH
cord-005453-4057qib7	2810	30	GvHD	GvHD	VBG
cord-005453-4057qib7	2810	31	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2810	32	,	,	,
cord-005453-4057qib7	2810	33	is	be	VBZ
cord-005453-4057qib7	2810	34	a	a	DT
cord-005453-4057qib7	2810	35	feasible	feasible	JJ
cord-005453-4057qib7	2810	36	and	and	CC
cord-005453-4057qib7	2810	37	safe	safe	JJ
cord-005453-4057qib7	2810	38	procedure	procedure	NN
cord-005453-4057qib7	2810	39	reflected	reflect	VBN
cord-005453-4057qib7	2810	40	in	in	IN
cord-005453-4057qib7	2810	41	similar	similar	JJ
cord-005453-4057qib7	2810	42	TRM	TRM	NNP
cord-005453-4057qib7	2810	43	and	and	CC
cord-005453-4057qib7	2810	44	Aspergillosis	Aspergillosis	NNP
cord-005453-4057qib7	2810	45	incidence	incidence	NN
cord-005453-4057qib7	2810	46	.	.	.
cord-005453-4057qib7	2811	1	At	at	IN
cord-005453-4057qib7	2811	2	-	-	HYPH
cord-005453-4057qib7	2811	3	home	home	NN
cord-005453-4057qib7	2811	4	allo	allo	NN
cord-005453-4057qib7	2811	5	-	-	HYPH
cord-005453-4057qib7	2811	6	SCT	SCT	NNP
cord-005453-4057qib7	2811	7	is	be	VBZ
cord-005453-4057qib7	2811	8	associated	associate	VBN
cord-005453-4057qib7	2811	9	with	with	IN
cord-005453-4057qib7	2811	10	a	a	DT
cord-005453-4057qib7	2811	11	significant	significant	JJ
cord-005453-4057qib7	2811	12	lower	low	JJR
cord-005453-4057qib7	2811	13	risk	risk	NN
cord-005453-4057qib7	2811	14	of	of	IN
cord-005453-4057qib7	2811	15	neutropenic	neutropenic	JJ
cord-005453-4057qib7	2811	16	fever	fever	NN
cord-005453-4057qib7	2811	17	than	than	IN
cord-005453-4057qib7	2811	18	in	in	IN
cord-005453-4057qib7	2811	19	-	-	HYPH
cord-005453-4057qib7	2811	20	patient	patient	NN
cord-005453-4057qib7	2811	21	group	group	NN
cord-005453-4057qib7	2811	22	,	,	,
cord-005453-4057qib7	2811	23	as	as	RB
cord-005453-4057qib7	2811	24	well	well	RB
cord-005453-4057qib7	2811	25	as	as	IN
cord-005453-4057qib7	2811	26	a	a	DT
cord-005453-4057qib7	2811	27	very	very	RB
cord-005453-4057qib7	2811	28	low	low	JJ
cord-005453-4057qib7	2811	29	readmission	readmission	NN
cord-005453-4057qib7	2811	30	rate	rate	NN
cord-005453-4057qib7	2811	31	.	.	.
cord-005453-4057qib7	2812	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2812	2	:	:	:
cord-005453-4057qib7	2812	3	Gonzalo	Gonzalo	NNP
cord-005453-4057qib7	2812	4	Gutiérrez	Gutiérrez	NNP
cord-005453-4057qib7	2812	5	-	-	HYPH
cord-005453-4057qib7	2812	6	García	García	NNP
cord-005453-4057qib7	2812	7	:	:	:
cord-005453-4057qib7	2812	8	honoraria	honorarium	NNS
cord-005453-4057qib7	2812	9	from	from	IN
cord-005453-4057qib7	2812	10	Gilead	Gilead	NNP
cord-005453-4057qib7	2812	11	.	.	.
cord-005453-4057qib7	2813	1	Grant	grant	VB
cord-005453-4057qib7	2813	2	from	from	IN
cord-005453-4057qib7	2813	3	Jazz	Jazz	NNP
cord-005453-4057qib7	2813	4	Pharmaceutical	Pharmaceutical	NNP
cord-005453-4057qib7	2813	5	and	and	CC
cord-005453-4057qib7	2813	6	Janssen	Janssen	NNP
cord-005453-4057qib7	2813	7	.	.	.
cord-005453-4057qib7	2814	1	Laura	Laura	NNP
cord-005453-4057qib7	2814	2	Rosiñol	Rosiñol	NNP
cord-005453-4057qib7	2814	3	:	:	:
cord-005453-4057qib7	2814	4	honoraria	honorarium	NNS
cord-005453-4057qib7	2814	5	from	from	IN
cord-005453-4057qib7	2814	6	Takeda	Takeda	NNP
cord-005453-4057qib7	2814	7	,	,	,
cord-005453-4057qib7	2814	8	Janssen	Janssen	NNP
cord-005453-4057qib7	2814	9	,	,	,
cord-005453-4057qib7	2814	10	Amgen	Amgen	NNP
cord-005453-4057qib7	2814	11	and	and	CC
cord-005453-4057qib7	2814	12	Celgene	Celgene	NNP
cord-005453-4057qib7	2814	13	.	.	.
cord-005453-4057qib7	2815	1	The	the	DT
cord-005453-4057qib7	2815	2	others	other	NNS
cord-005453-4057qib7	2815	3	author	author	NN
cord-005453-4057qib7	2815	4	do	do	VBP
cord-005453-4057qib7	2815	5	not	not	RB
cord-005453-4057qib7	2815	6	have	have	VB
cord-005453-4057qib7	2815	7	any	any	DT
cord-005453-4057qib7	2815	8	disclosures	disclosure	NNS
cord-005453-4057qib7	2815	9	to	to	TO
cord-005453-4057qib7	2815	10	declare	declare	VB
cord-005453-4057qib7	2815	11	.	.	.
cord-005453-4057qib7	2816	1	Background	background	NN
cord-005453-4057qib7	2816	2	:	:	:
cord-005453-4057qib7	2817	1	Renal	renal	JJ
cord-005453-4057qib7	2817	2	complications	complication	NNS
cord-005453-4057qib7	2817	3	in	in	IN
cord-005453-4057qib7	2817	4	sickle	sickle	NN
cord-005453-4057qib7	2817	5	cell	cell	NN
cord-005453-4057qib7	2817	6	disease	disease	NN
cord-005453-4057qib7	2817	7	(	(	-LRB-
cord-005453-4057qib7	2817	8	SCD	SCD	NNP
cord-005453-4057qib7	2817	9	)	)	-RRB-
cord-005453-4057qib7	2817	10	include	include	VBP
cord-005453-4057qib7	2817	11	episodes	episode	NNS
cord-005453-4057qib7	2817	12	of	of	IN
cord-005453-4057qib7	2817	13	acute	acute	JJ
cord-005453-4057qib7	2817	14	kidney	kidney	NN
cord-005453-4057qib7	2817	15	injury	injury	NN
cord-005453-4057qib7	2817	16	(	(	-LRB-
cord-005453-4057qib7	2817	17	AKI	AKI	NNP
cord-005453-4057qib7	2817	18	)	)	-RRB-
cord-005453-4057qib7	2817	19	,	,	,
cord-005453-4057qib7	2817	20	progressive	progressive	JJ
cord-005453-4057qib7	2817	21	chronic	chronic	JJ
cord-005453-4057qib7	2817	22	kidney	kidney	NN
cord-005453-4057qib7	2817	23	disease	disease	NN
cord-005453-4057qib7	2817	24	(	(	-LRB-
cord-005453-4057qib7	2817	25	CKD	CKD	NNP
cord-005453-4057qib7	2817	26	)	)	-RRB-
cord-005453-4057qib7	2817	27	and	and	CC
cord-005453-4057qib7	2817	28	hyperfiltration	hyperfiltration	NN
cord-005453-4057qib7	2817	29	,	,	,
cord-005453-4057qib7	2817	30	defined	define	VBN
cord-005453-4057qib7	2817	31	by	by	IN
cord-005453-4057qib7	2817	32	abnormally	abnormally	RB
cord-005453-4057qib7	2817	33	high	high	JJ
cord-005453-4057qib7	2817	34	glomerular	glomerular	JJ
cord-005453-4057qib7	2817	35	filtration	filtration	NN
cord-005453-4057qib7	2817	36	rates	rate	NNS
cord-005453-4057qib7	2817	37	(	(	-LRB-
cord-005453-4057qib7	2817	38	GFRs	gfr	NNS
cord-005453-4057qib7	2817	39	)	)	-RRB-
cord-005453-4057qib7	2817	40	.	.	.
cord-005453-4057qib7	2818	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2818	2	stem	stem	NN
cord-005453-4057qib7	2818	3	cell	cell	NN
cord-005453-4057qib7	2818	4	transplant	transplant	NN
cord-005453-4057qib7	2818	5	(	(	-LRB-
cord-005453-4057qib7	2818	6	HSCT	HSCT	NNP
cord-005453-4057qib7	2818	7	)	)	-RRB-
cord-005453-4057qib7	2818	8	from	from	IN
cord-005453-4057qib7	2818	9	an	an	DT
cord-005453-4057qib7	2818	10	HLA	HLA	NNP
cord-005453-4057qib7	2818	11	identical	identical	JJ
cord-005453-4057qib7	2818	12	sibling	sibling	NN
cord-005453-4057qib7	2818	13	donor	donor	NN
cord-005453-4057qib7	2818	14	is	be	VBZ
cord-005453-4057qib7	2818	15	a	a	DT
cord-005453-4057qib7	2818	16	well	well	RB
cord-005453-4057qib7	2818	17	-	-	HYPH
cord-005453-4057qib7	2818	18	established	establish	VBN
cord-005453-4057qib7	2818	19	curative	curative	JJ
cord-005453-4057qib7	2818	20	treatment	treatment	NN
cord-005453-4057qib7	2818	21	for	for	IN
cord-005453-4057qib7	2818	22	SCD	SCD	NNP
cord-005453-4057qib7	2818	23	,	,	,
cord-005453-4057qib7	2818	24	but	but	CC
cord-005453-4057qib7	2818	25	traditional	traditional	JJ
cord-005453-4057qib7	2818	26	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2818	27	conditioning	conditioning	NN
cord-005453-4057qib7	2818	28	(	(	-LRB-
cord-005453-4057qib7	2818	29	MAC	MAC	NNP
cord-005453-4057qib7	2818	30	)	)	-RRB-
cord-005453-4057qib7	2818	31	regimens	regimen	NNS
cord-005453-4057qib7	2818	32	pose	pose	VBP
cord-005453-4057qib7	2818	33	risks	risk	NNS
cord-005453-4057qib7	2818	34	of	of	IN
cord-005453-4057qib7	2818	35	kidney	kidney	NN
cord-005453-4057qib7	2818	36	injury	injury	NN
cord-005453-4057qib7	2818	37	due	due	IN
cord-005453-4057qib7	2818	38	to	to	IN
cord-005453-4057qib7	2818	39	intensive	intensive	JJ
cord-005453-4057qib7	2818	40	use	use	NN
cord-005453-4057qib7	2818	41	of	of	IN
cord-005453-4057qib7	2818	42	chemotherapeutic	chemotherapeutic	JJ
cord-005453-4057qib7	2818	43	agents	agent	NNS
cord-005453-4057qib7	2818	44	,	,	,
cord-005453-4057qib7	2818	45	infectious	infectious	JJ
cord-005453-4057qib7	2818	46	risks	risk	NNS
cord-005453-4057qib7	2818	47	,	,	,
cord-005453-4057qib7	2818	48	and	and	CC
cord-005453-4057qib7	2818	49	use	use	NN
cord-005453-4057qib7	2818	50	of	of	IN
cord-005453-4057qib7	2818	51	calcineurin	calcineurin	NNP
cord-005453-4057qib7	2818	52	inhibitors	inhibitor	NNS
cord-005453-4057qib7	2818	53	(	(	-LRB-
cord-005453-4057qib7	2818	54	CNIs	CNIs	NNP
cord-005453-4057qib7	2818	55	)	)	-RRB-
cord-005453-4057qib7	2818	56	.	.	.
cord-005453-4057qib7	2819	1	AKI	AKI	NNP
cord-005453-4057qib7	2819	2	and	and	CC
cord-005453-4057qib7	2819	3	subsequent	subsequent	JJ
cord-005453-4057qib7	2819	4	fluid	fluid	JJ
cord-005453-4057qib7	2819	5	overload	overload	NN
cord-005453-4057qib7	2819	6	(	(	-LRB-
cord-005453-4057qib7	2819	7	FO	FO	NNP
cord-005453-4057qib7	2819	8	)	)	-RRB-
cord-005453-4057qib7	2819	9	are	be	VBP
cord-005453-4057qib7	2819	10	common	common	JJ
cord-005453-4057qib7	2819	11	in	in	IN
cord-005453-4057qib7	2819	12	pediatric	pediatric	JJ
cord-005453-4057qib7	2819	13	HSCT	HSCT	NNP
cord-005453-4057qib7	2819	14	with	with	IN
cord-005453-4057qib7	2819	15	reported	report	VBN
cord-005453-4057qib7	2819	16	AKI	AKI	NNP
cord-005453-4057qib7	2819	17	incidence	incidence	NN
cord-005453-4057qib7	2819	18	of	of	IN
cord-005453-4057qib7	2819	19	21%-50	21%-50	CD
cord-005453-4057qib7	2819	20	%	%	NN
cord-005453-4057qib7	2819	21	(	(	-LRB-
cord-005453-4057qib7	2819	22	Kyung	Kyung	NNP
cord-005453-4057qib7	2819	23	-	-	HYPH
cord-005453-4057qib7	2819	24	Nam	Nam	NNP
cord-005453-4057qib7	2819	25	Koh	Koh	NNP
cord-005453-4057qib7	2819	26	et	et	NNP
cord-005453-4057qib7	2819	27	.	.	.
cord-005453-4057qib7	2820	1	Al	Al	NNP
cord-005453-4057qib7	2820	2	.	.	NNP
cord-005453-4057qib7	2820	3	,	,	,
cord-005453-4057qib7	2820	4	2017	2017	CD
cord-005453-4057qib7	2820	5	)	)	-RRB-
cord-005453-4057qib7	2820	6	.	.	.
cord-005453-4057qib7	2821	1	We	-PRON-	PRP
cord-005453-4057qib7	2821	2	report	report	VBP
cord-005453-4057qib7	2821	3	renal	renal	JJ
cord-005453-4057qib7	2821	4	outcomes	outcome	NNS
cord-005453-4057qib7	2821	5	in	in	IN
cord-005453-4057qib7	2821	6	pediatric	pediatric	JJ
cord-005453-4057qib7	2821	7	patients	patient	NNS
cord-005453-4057qib7	2821	8	with	with	IN
cord-005453-4057qib7	2821	9	SCD	SCD	NNP
cord-005453-4057qib7	2821	10	who	who	WP
cord-005453-4057qib7	2821	11	received	receive	VBD
cord-005453-4057qib7	2821	12	HSCT	HSCT	NNP
cord-005453-4057qib7	2821	13	following	follow	VBG
cord-005453-4057qib7	2821	14	a	a	DT
cord-005453-4057qib7	2821	15	non	non	JJ
cord-005453-4057qib7	2821	16	-	-	JJ
cord-005453-4057qib7	2821	17	myeloablative	myeloablative	JJ
cord-005453-4057qib7	2821	18	conditioning	conditioning	NN
cord-005453-4057qib7	2821	19	(	(	-LRB-
cord-005453-4057qib7	2821	20	NMA	NMA	NNP
cord-005453-4057qib7	2821	21	)	)	-RRB-
cord-005453-4057qib7	2821	22	regimen	regimen	NN
cord-005453-4057qib7	2821	23	without	without	IN
cord-005453-4057qib7	2821	24	CNI	CNI	NNP
cord-005453-4057qib7	2821	25	exposure	exposure	NN
cord-005453-4057qib7	2821	26	.	.	.
cord-005453-4057qib7	2822	1	Methods	method	NNS
cord-005453-4057qib7	2822	2	:	:	:
cord-005453-4057qib7	2823	1	Retrospective	retrospective	JJ
cord-005453-4057qib7	2823	2	chart	chart	NN
cord-005453-4057qib7	2823	3	review	review	NN
cord-005453-4057qib7	2823	4	describing	describe	VBG
cord-005453-4057qib7	2823	5	renal	renal	JJ
cord-005453-4057qib7	2823	6	outcomes	outcome	NNS
cord-005453-4057qib7	2823	7	in	in	IN
cord-005453-4057qib7	2823	8	pediatric	pediatric	JJ
cord-005453-4057qib7	2823	9	patients	patient	NNS
cord-005453-4057qib7	2823	10	(	(	-LRB-
cord-005453-4057qib7	2823	11	18	18	CD
cord-005453-4057qib7	2823	12	years	year	NNS
cord-005453-4057qib7	2823	13	of	of	IN
cord-005453-4057qib7	2823	14	age	age	NN
cord-005453-4057qib7	2823	15	or	or	CC
cord-005453-4057qib7	2823	16	younger	young	JJR
cord-005453-4057qib7	2823	17	)	)	-RRB-
cord-005453-4057qib7	2823	18	with	with	IN
cord-005453-4057qib7	2823	19	SCD	SCD	NNP
cord-005453-4057qib7	2823	20	(	(	-LRB-
cord-005453-4057qib7	2823	21	HbSS	HbSS	NNP
cord-005453-4057qib7	2823	22	)	)	-RRB-
cord-005453-4057qib7	2823	23	who	who	WP
cord-005453-4057qib7	2823	24	underwent	undergo	VBD
cord-005453-4057qib7	2823	25	NMA	NMA	NNP
cord-005453-4057qib7	2823	26	HSCT	HSCT	NNP
cord-005453-4057qib7	2823	27	in	in	IN
cord-005453-4057qib7	2823	28	Alberta	Alberta	NNP
cord-005453-4057qib7	2823	29	,	,	,
cord-005453-4057qib7	2823	30	Canada	Canada	NNP
cord-005453-4057qib7	2823	31	from	from	IN
cord-005453-4057qib7	2823	32	July	July	NNP
cord-005453-4057qib7	2823	33	2013	2013	CD
cord-005453-4057qib7	2823	34	to	to	IN
cord-005453-4057qib7	2823	35	February	February	NNP
cord-005453-4057qib7	2823	36	2018	2018	CD
cord-005453-4057qib7	2823	37	.	.	.
cord-005453-4057qib7	2824	1	The	the	DT
cord-005453-4057qib7	2824	2	NMA	NMA	NNP
cord-005453-4057qib7	2824	3	regimen	regimen	NN
cord-005453-4057qib7	2824	4	is	be	VBZ
cord-005453-4057qib7	2824	5	illustrated	illustrate	VBN
cord-005453-4057qib7	2824	6	in	in	IN
cord-005453-4057qib7	2824	7	Figure	Figure	NNP
cord-005453-4057qib7	2824	8	1	1	CD
cord-005453-4057qib7	2824	9	.	.	.
cord-005453-4057qib7	2825	1	Reported	reported	JJ
cord-005453-4057qib7	2825	2	renal	renal	JJ
cord-005453-4057qib7	2825	3	outcomes	outcome	NNS
cord-005453-4057qib7	2825	4	:	:	:
cord-005453-4057qib7	2825	5	1	1	LS
cord-005453-4057qib7	2825	6	)	)	-RRB-
cord-005453-4057qib7	2825	7	measured	measure	VBN
cord-005453-4057qib7	2825	8	GFR	GFR	NNP
cord-005453-4057qib7	2825	9	(	(	-LRB-
cord-005453-4057qib7	2825	10	DTPA	DTPA	NNP
cord-005453-4057qib7	2825	11	)	)	-RRB-
cord-005453-4057qib7	2825	12	pre	pre	JJ
cord-005453-4057qib7	2825	13	-	-	JJ
cord-005453-4057qib7	2825	14	HSCT	HSCT	NNP
cord-005453-4057qib7	2825	15	,	,	,
cord-005453-4057qib7	2825	16	2	2	CD
cord-005453-4057qib7	2825	17	)	)	-RRB-
cord-005453-4057qib7	2825	18	AKI	AKI	NNP
cord-005453-4057qib7	2825	19	(	(	-LRB-
cord-005453-4057qib7	2825	20	KDIGO	KDIGO	NNP
cord-005453-4057qib7	2825	21	definition	definition	NN
cord-005453-4057qib7	2825	22	)	)	-RRB-
cord-005453-4057qib7	2825	23	post	post	JJ
cord-005453-4057qib7	2825	24	-	-	JJ
cord-005453-4057qib7	2825	25	HSCT	HSCT	NNP
cord-005453-4057qib7	2825	26	by	by	IN
cord-005453-4057qib7	2825	27	reviewing	review	VBG
cord-005453-4057qib7	2825	28	all	all	DT
cord-005453-4057qib7	2825	29	serum	serum	NN
cord-005453-4057qib7	2825	30	creatinine	creatinine	NN
cord-005453-4057qib7	2825	31	levels	level	NNS
cord-005453-4057qib7	2825	32	from	from	IN
cord-005453-4057qib7	2825	33	pre	pre	JJ
cord-005453-4057qib7	2825	34	-	-	JJ
cord-005453-4057qib7	2825	35	HSCT	HSCT	NNP
cord-005453-4057qib7	2825	36	to	to	IN
cord-005453-4057qib7	2825	37	one	one	CD
cord-005453-4057qib7	2825	38	month	month	NN
cord-005453-4057qib7	2825	39	post	post	NN
cord-005453-4057qib7	2825	40	-	-	JJ
cord-005453-4057qib7	2825	41	HSCT	HSCT	NNP
cord-005453-4057qib7	2825	42	,	,	,
cord-005453-4057qib7	2826	1	3	3	LS
cord-005453-4057qib7	2826	2	)	)	-RRB-
cord-005453-4057qib7	2826	3	%	%	NN
cord-005453-4057qib7	2826	4	FO	FO	NNP
cord-005453-4057qib7	2826	5	calculated	calculate	VBN
cord-005453-4057qib7	2826	6	:	:	:
cord-005453-4057qib7	2826	7	(	(	-LRB-
cord-005453-4057qib7	2826	8	max	max	NNP
cord-005453-4057qib7	2826	9	post	post	NN
cord-005453-4057qib7	2826	10	HSCT	HSCT	NNP
cord-005453-4057qib7	2826	11	weight	weight	NN
cord-005453-4057qib7	2827	1	-baseline	-baseline	:
cord-005453-4057qib7	2828	1	weight)/	weight)/	NFP
cord-005453-4057qib7	2829	1	baseline	baseline	JJ
cord-005453-4057qib7	2829	2	weight	weight	NN
cord-005453-4057qib7	2830	1	x	x	LS
cord-005453-4057qib7	2830	2	100	100	CD
cord-005453-4057qib7	2830	3	for	for	IN
cord-005453-4057qib7	2830	4	the	the	DT
cord-005453-4057qib7	2830	5	two	two	CD
cord-005453-4057qib7	2830	6	first	first	JJ
cord-005453-4057qib7	2830	7	weeks	week	NNS
cord-005453-4057qib7	2830	8	post	post	JJ
cord-005453-4057qib7	2830	9	-	-	JJ
cord-005453-4057qib7	2830	10	HSCT	HSCT	NNP
cord-005453-4057qib7	2830	11	,	,	,
cord-005453-4057qib7	2830	12	and	and	CC
cord-005453-4057qib7	2830	13	4	4	LS
cord-005453-4057qib7	2830	14	)	)	-RRB-
cord-005453-4057qib7	2830	15	estimated	estimate	VBN
cord-005453-4057qib7	2830	16	GFR	GFR	NNP
cord-005453-4057qib7	2830	17	(	(	-LRB-
cord-005453-4057qib7	2830	18	eGFR	egfr	NN
cord-005453-4057qib7	2830	19	)	)	-RRB-
cord-005453-4057qib7	2830	20	using	use	VBG
cord-005453-4057qib7	2830	21	the	the	DT
cord-005453-4057qib7	2830	22	pediatric	pediatric	JJ
cord-005453-4057qib7	2830	23	Schwartz	Schwartz	NNP
cord-005453-4057qib7	2830	24	formula	formula	NN
cord-005453-4057qib7	2830	25	at	at	IN
cord-005453-4057qib7	2830	26	last	last	JJ
cord-005453-4057qib7	2830	27	follow	follow	NN
cord-005453-4057qib7	2830	28	-	-	HYPH
cord-005453-4057qib7	2830	29	up	up	NN
cord-005453-4057qib7	2830	30	post	post	JJ
cord-005453-4057qib7	2830	31	-	-	JJ
cord-005453-4057qib7	2830	32	HSCT	HSCT	NNP
cord-005453-4057qib7	2830	33	,	,	,
cord-005453-4057qib7	2830	34	CKD	CKD	NNP
cord-005453-4057qib7	2830	35	defined	define	VBD
cord-005453-4057qib7	2830	36	as	as	IN
cord-005453-4057qib7	2830	37	eGFR	egfr	NN
cord-005453-4057qib7	2830	38	<	<	XX
cord-005453-4057qib7	2830	39	60	60	CD
cord-005453-4057qib7	2830	40	mL/	mL/	NNS
cord-005453-4057qib7	2831	1	min/1.73	min/1.73	NNP
cord-005453-4057qib7	2831	2	m	m	CD
cord-005453-4057qib7	2831	3	2	2	CD
cord-005453-4057qib7	2831	4	,	,	,
cord-005453-4057qib7	2831	5	mildly	mildly	RB
cord-005453-4057qib7	2831	6	reduced	reduce	VBN
cord-005453-4057qib7	2831	7	GFR	gfr	NN
cord-005453-4057qib7	2831	8	:	:	:
cord-005453-4057qib7	2832	1	60	60	CD
cord-005453-4057qib7	2832	2	-	-	HYPH
cord-005453-4057qib7	2832	3	90mL	90ml	CD
cord-005453-4057qib7	2833	1	/min/1.73	/min/1.73	NFP
cord-005453-4057qib7	2833	2	m	m	NNP
cord-005453-4057qib7	2833	3	2	2	CD
cord-005453-4057qib7	2833	4	,	,	,
cord-005453-4057qib7	2833	5	and	and	CC
cord-005453-4057qib7	2833	6	hyperfiltration	hyperfiltration	NN
cord-005453-4057qib7	2833	7	:	:	:
cord-005453-4057qib7	2833	8	GFR	GFR	NNP
cord-005453-4057qib7	2833	9	≥	≥	CD
cord-005453-4057qib7	2833	10	150	150	CD
cord-005453-4057qib7	2834	1	mL/	mL/	NNP
cord-005453-4057qib7	2834	2	min/1.73	min/1.73	NNP
cord-005453-4057qib7	2834	3	m	m	CD
cord-005453-4057qib7	2834	4	2	2	CD
cord-005453-4057qib7	2834	5	.	.	.
cord-005453-4057qib7	2835	1	[	[	-LRB-
cord-005453-4057qib7	2835	2	[	[	-LRB-
cord-005453-4057qib7	2835	3	P140	P140	NNP
cord-005453-4057qib7	2835	4	Image	image	NN
cord-005453-4057qib7	2835	5	]	]	-RRB-
cord-005453-4057qib7	2835	6	1	1	CD
cord-005453-4057qib7	2835	7	.	.	.
cord-005453-4057qib7	2836	1	Results	result	NNS
cord-005453-4057qib7	2836	2	:	:	:
cord-005453-4057qib7	2837	1	Eighteen	eighteen	CD
cord-005453-4057qib7	2837	2	patients	patient	NNS
cord-005453-4057qib7	2837	3	(	(	-LRB-
cord-005453-4057qib7	2837	4	33	33	CD
cord-005453-4057qib7	2837	5	%	%	NN
cord-005453-4057qib7	2837	6	male	male	NN
cord-005453-4057qib7	2837	7	,	,	,
cord-005453-4057qib7	2837	8	3	3	CD
cord-005453-4057qib7	2837	9	-	-	SYM
cord-005453-4057qib7	2837	10	18	18	CD
cord-005453-4057qib7	2837	11	years	year	NNS
cord-005453-4057qib7	2837	12	old	old	JJ
cord-005453-4057qib7	2837	13	at	at	IN
cord-005453-4057qib7	2837	14	transplant	transplant	NN
cord-005453-4057qib7	2837	15	)	)	-RRB-
cord-005453-4057qib7	2837	16	were	be	VBD
cord-005453-4057qib7	2837	17	included	include	VBN
cord-005453-4057qib7	2837	18	.	.	.
cord-005453-4057qib7	2838	1	Most	Most	JJS
cord-005453-4057qib7	2838	2	common	common	JJ
cord-005453-4057qib7	2838	3	pre	pre	JJ
cord-005453-4057qib7	2838	4	-	-	JJ
cord-005453-4057qib7	2838	5	morbid	morbid	JJ
cord-005453-4057qib7	2838	6	events	event	NNS
cord-005453-4057qib7	2838	7	:	:	:
cord-005453-4057qib7	2838	8	vaso	vaso	JJ
cord-005453-4057qib7	2838	9	-	-	HYPH
cord-005453-4057qib7	2838	10	occlusive	occlusive	JJ
cord-005453-4057qib7	2838	11	crisis	crisis	NN
cord-005453-4057qib7	2838	12	(	(	-LRB-
cord-005453-4057qib7	2838	13	n=17	n=17	NNP
cord-005453-4057qib7	2838	14	)	)	-RRB-
cord-005453-4057qib7	2838	15	,	,	,
cord-005453-4057qib7	2838	16	acute	acute	JJ
cord-005453-4057qib7	2838	17	chest	chest	NN
cord-005453-4057qib7	2838	18	syndrome	syndrome	NN
cord-005453-4057qib7	2838	19	(	(	-LRB-
cord-005453-4057qib7	2838	20	n=8	n=8	NNP
cord-005453-4057qib7	2838	21	)	)	-RRB-
cord-005453-4057qib7	2838	22	,	,	,
cord-005453-4057qib7	2838	23	splenic	splenic	JJ
cord-005453-4057qib7	2838	24	sequestration	sequestration	NN
cord-005453-4057qib7	2838	25	(	(	-LRB-
cord-005453-4057qib7	2838	26	n=6	n=6	NNP
cord-005453-4057qib7	2838	27	)	)	-RRB-
cord-005453-4057qib7	2838	28	,	,	,
cord-005453-4057qib7	2838	29	and	and	CC
cord-005453-4057qib7	2838	30	cholelithiasis	cholelithiasis	NNP
cord-005453-4057qib7	2838	31	(	(	-LRB-
cord-005453-4057qib7	2838	32	n=4	n=4	NNP
cord-005453-4057qib7	2838	33	)	)	-RRB-
cord-005453-4057qib7	2838	34	.	.	.
cord-005453-4057qib7	2839	1	Median	median	JJ
cord-005453-4057qib7	2839	2	follow	follow	NN
cord-005453-4057qib7	2839	3	-	-	HYPH
cord-005453-4057qib7	2839	4	up	up	NN
cord-005453-4057qib7	2839	5	time	time	NN
cord-005453-4057qib7	2839	6	:	:	:
cord-005453-4057qib7	2839	7	27	27	CD
cord-005453-4057qib7	2839	8	months	month	NNS
cord-005453-4057qib7	2839	9	(	(	-LRB-
cord-005453-4057qib7	2839	10	range	range	NN
cord-005453-4057qib7	2839	11	:	:	:
cord-005453-4057qib7	2839	12	7	7	CD
cord-005453-4057qib7	2839	13	-62	-62	NN
cord-005453-4057qib7	2839	14	months	month	NNS
cord-005453-4057qib7	2839	15	)	)	-RRB-
cord-005453-4057qib7	2839	16	.	.	.
cord-005453-4057qib7	2840	1	All	all	DT
cord-005453-4057qib7	2840	2	patients	patient	NNS
cord-005453-4057qib7	2840	3	engrafted	engraft	VBD
cord-005453-4057qib7	2840	4	successfully	successfully	RB
cord-005453-4057qib7	2840	5	with	with	IN
cord-005453-4057qib7	2840	6	no	no	DT
cord-005453-4057qib7	2840	7	acute	acute	JJ
cord-005453-4057qib7	2840	8	or	or	CC
cord-005453-4057qib7	2840	9	chronic	chronic	JJ
cord-005453-4057qib7	2840	10	GVHD	GVHD	NNP
cord-005453-4057qib7	2840	11	.	.	.
cord-005453-4057qib7	2841	1	Baseline	baseline	JJ
cord-005453-4057qib7	2841	2	measured	measure	VBN
cord-005453-4057qib7	2841	3	GFRs	gfr	NNS
cord-005453-4057qib7	2841	4	were	be	VBD
cord-005453-4057qib7	2841	5	all	all	DT
cord-005453-4057qib7	2841	6	>	>	XX
cord-005453-4057qib7	2842	1	60	60	CD
cord-005453-4057qib7	2842	2	mL	ml	NN
cord-005453-4057qib7	2842	3	/	/	SYM
cord-005453-4057qib7	2842	4	min/1.73	min/1.73	JJ
cord-005453-4057qib7	2842	5	m	m	CD
cord-005453-4057qib7	2842	6	2	2	CD
cord-005453-4057qib7	2843	1	(	(	-LRB-
cord-005453-4057qib7	2843	2	range	range	NN
cord-005453-4057qib7	2843	3	:	:	:
cord-005453-4057qib7	2843	4	79	79	CD
cord-005453-4057qib7	2843	5	-	-	SYM
cord-005453-4057qib7	2843	6	227	227	CD
cord-005453-4057qib7	2843	7	)	)	-RRB-
cord-005453-4057qib7	2843	8	with	with	IN
cord-005453-4057qib7	2843	9	mildly	mildly	RB
cord-005453-4057qib7	2843	10	reduced	reduce	VBN
cord-005453-4057qib7	2843	11	GFR	GFR	NNP
cord-005453-4057qib7	2843	12	and	and	CC
cord-005453-4057qib7	2843	13	hyperfiltration	hyperfiltration	NN
cord-005453-4057qib7	2843	14	seen	see	VBN
cord-005453-4057qib7	2843	15	in	in	IN
cord-005453-4057qib7	2843	16	one	one	CD
cord-005453-4057qib7	2843	17	(	(	-LRB-
cord-005453-4057qib7	2843	18	5.6	5.6	CD
cord-005453-4057qib7	2843	19	%	%	NN
cord-005453-4057qib7	2843	20	)	)	-RRB-
cord-005453-4057qib7	2843	21	and	and	CC
cord-005453-4057qib7	2843	22	12	12	CD
cord-005453-4057qib7	2843	23	(	(	-LRB-
cord-005453-4057qib7	2843	24	66.7	66.7	CD
cord-005453-4057qib7	2843	25	%	%	NN
cord-005453-4057qib7	2843	26	)	)	-RRB-
cord-005453-4057qib7	2843	27	patients	patient	NNS
cord-005453-4057qib7	2843	28	respectively	respectively	RB
cord-005453-4057qib7	2843	29	.	.	.
cord-005453-4057qib7	2844	1	At	at	IN
cord-005453-4057qib7	2844	2	baseline	baseline	JJ
cord-005453-4057qib7	2844	3	(	(	-LRB-
cord-005453-4057qib7	2844	4	pre	pre	JJ
cord-005453-4057qib7	2844	5	-	-	JJ
cord-005453-4057qib7	2844	6	HSCT	HSCT	NNP
cord-005453-4057qib7	2844	7	)	)	-RRB-
cord-005453-4057qib7	2844	8	,	,	,
cord-005453-4057qib7	2844	9	the	the	DT
cord-005453-4057qib7	2844	10	only	only	JJ
cord-005453-4057qib7	2844	11	AKI	AKI	NNP
cord-005453-4057qib7	2844	12	event	event	NN
cord-005453-4057qib7	2844	13	was	be	VBD
cord-005453-4057qib7	2844	14	one	one	CD
cord-005453-4057qib7	2844	15	transplant	transplant	NN
cord-005453-4057qib7	2844	16	related	relate	VBN
cord-005453-4057qib7	2844	17	AKI	AKI	NNP
cord-005453-4057qib7	2844	18	secondary	secondary	JJ
cord-005453-4057qib7	2844	19	to	to	IN
cord-005453-4057qib7	2844	20	delayed	delayed	JJ
cord-005453-4057qib7	2844	21	hemolytic	hemolytic	JJ
cord-005453-4057qib7	2844	22	reaction	reaction	NN
cord-005453-4057qib7	2844	23	after	after	IN
cord-005453-4057qib7	2844	24	exchange	exchange	NN
cord-005453-4057qib7	2844	25	transfusion	transfusion	NN
cord-005453-4057qib7	2844	26	in	in	IN
cord-005453-4057qib7	2844	27	preparation	preparation	NN
cord-005453-4057qib7	2844	28	for	for	IN
cord-005453-4057qib7	2844	29	transplant	transplant	NN
cord-005453-4057qib7	2844	30	.	.	.
cord-005453-4057qib7	2845	1	Post	post	JJ
cord-005453-4057qib7	2845	2	-	-	JJ
cord-005453-4057qib7	2845	3	HSCT	HSCT	NNP
cord-005453-4057qib7	2845	4	,	,	,
cord-005453-4057qib7	2845	5	there	there	EX
cord-005453-4057qib7	2845	6	were	be	VBD
cord-005453-4057qib7	2845	7	no	no	DT
cord-005453-4057qib7	2845	8	AKI	AKI	NNP
cord-005453-4057qib7	2845	9	events	event	NNS
cord-005453-4057qib7	2845	10	.	.	.
cord-005453-4057qib7	2846	1	Additionally	additionally	RB
cord-005453-4057qib7	2846	2	,	,	,
cord-005453-4057qib7	2846	3	no	no	DT
cord-005453-4057qib7	2846	4	substantial	substantial	JJ
cord-005453-4057qib7	2846	5	%	%	NN
cord-005453-4057qib7	2846	6	FO	fo	IN
cord-005453-4057qib7	2846	7	post	post	NN
cord-005453-4057qib7	2846	8	-	-	JJ
cord-005453-4057qib7	2846	9	HSCT	HSCT	NNP
cord-005453-4057qib7	2846	10	was	be	VBD
cord-005453-4057qib7	2846	11	observed	observe	VBN
cord-005453-4057qib7	2846	12	.	.	.
cord-005453-4057qib7	2847	1	Average	average	JJ
cord-005453-4057qib7	2847	2	%	%	NN
cord-005453-4057qib7	2847	3	FO	FO	NNP
cord-005453-4057qib7	2847	4	week	week	NN
cord-005453-4057qib7	2847	5	one	one	CD
cord-005453-4057qib7	2847	6	post	post	JJ
cord-005453-4057qib7	2847	7	-	-	JJ
cord-005453-4057qib7	2847	8	HSCT	hsct	JJ
cord-005453-4057qib7	2847	9	:	:	:
cord-005453-4057qib7	2847	10	+0.01	+0.01	JJR
cord-005453-4057qib7	2847	11	%	%	NN
cord-005453-4057qib7	2847	12	(	(	-LRB-
cord-005453-4057qib7	2847	13	Range	range	NN
cord-005453-4057qib7	2847	14	:	:	:
cord-005453-4057qib7	2847	15	-4.2	-4.2	CD
cord-005453-4057qib7	2847	16	%	%	NN
cord-005453-4057qib7	2847	17	-+1.0	-+1.0	NNP
cord-005453-4057qib7	2847	18	%	%	NN
cord-005453-4057qib7	2847	19	)	)	-RRB-
cord-005453-4057qib7	2847	20	and	and	CC
cord-005453-4057qib7	2847	21	week	week	NN
cord-005453-4057qib7	2847	22	two	two	CD
cord-005453-4057qib7	2847	23	post	post	JJ
cord-005453-4057qib7	2847	24	-	-	JJ
cord-005453-4057qib7	2847	25	HSCT	HSCT	NNP
cord-005453-4057qib7	2847	26	:	:	:
cord-005453-4057qib7	2848	1	+0.04	+0.04	NNP
cord-005453-4057qib7	2848	2	%	%	NN
cord-005453-4057qib7	2849	1	(	(	-LRB-
cord-005453-4057qib7	2849	2	Range	range	NN
cord-005453-4057qib7	2849	3	:	:	:
cord-005453-4057qib7	2849	4	-4.24	-4.24	CD
cord-005453-4057qib7	2849	5	%	%	NN
cord-005453-4057qib7	2850	1	-+1.5	-+1.5	NNP
cord-005453-4057qib7	2850	2	%	%	NN
cord-005453-4057qib7	2850	3	)	)	-RRB-
cord-005453-4057qib7	2850	4	.	.	.
cord-005453-4057qib7	2851	1	Post	post	JJ
cord-005453-4057qib7	2851	2	-	-	JJ
cord-005453-4057qib7	2851	3	HSCT	HSCT	NNP
cord-005453-4057qib7	2851	4	eGFR	egfr	NN
cord-005453-4057qib7	2851	5	remained	remain	VBD
cord-005453-4057qib7	2851	6	>	>	XX
cord-005453-4057qib7	2852	1	90	90	CD
cord-005453-4057qib7	2852	2	mL	ml	NN
cord-005453-4057qib7	2852	3	/	/	SYM
cord-005453-4057qib7	2852	4	min/1.73	min/1.73	JJ
cord-005453-4057qib7	2852	5	m	m	CD
cord-005453-4057qib7	2852	6	2	2	CD
cord-005453-4057qib7	2852	7	at	at	IN
cord-005453-4057qib7	2852	8	last	last	JJ
cord-005453-4057qib7	2852	9	follow	follow	NN
cord-005453-4057qib7	2852	10	-	-	HYPH
cord-005453-4057qib7	2852	11	up	up	NN
cord-005453-4057qib7	2852	12	in	in	IN
cord-005453-4057qib7	2852	13	all	all	DT
cord-005453-4057qib7	2852	14	patients	patient	NNS
cord-005453-4057qib7	2852	15	.	.	.
cord-005453-4057qib7	2853	1	Hyperfiltration	hyperfiltration	NN
cord-005453-4057qib7	2853	2	was	be	VBD
cord-005453-4057qib7	2853	3	present	present	JJ
cord-005453-4057qib7	2853	4	in	in	IN
cord-005453-4057qib7	2853	5	5	5	CD
cord-005453-4057qib7	2853	6	(	(	-LRB-
cord-005453-4057qib7	2853	7	27.8	27.8	CD
cord-005453-4057qib7	2853	8	%	%	NN
cord-005453-4057qib7	2853	9	)	)	-RRB-
cord-005453-4057qib7	2853	10	of	of	IN
cord-005453-4057qib7	2853	11	the	the	DT
cord-005453-4057qib7	2853	12	patients	patient	NNS
cord-005453-4057qib7	2853	13	.	.	.
cord-005453-4057qib7	2854	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2854	2	:	:	:
cord-005453-4057qib7	2855	1	This	this	DT
cord-005453-4057qib7	2855	2	is	be	VBZ
cord-005453-4057qib7	2855	3	the	the	DT
cord-005453-4057qib7	2855	4	first	first	JJ
cord-005453-4057qib7	2855	5	study	study	NN
cord-005453-4057qib7	2855	6	describing	describe	VBG
cord-005453-4057qib7	2855	7	stable	stable	JJ
cord-005453-4057qib7	2855	8	kidney	kidney	NN
cord-005453-4057qib7	2855	9	function	function	NN
cord-005453-4057qib7	2855	10	in	in	IN
cord-005453-4057qib7	2855	11	children	child	NNS
cord-005453-4057qib7	2855	12	with	with	IN
cord-005453-4057qib7	2855	13	SCD	SCD	NNP
cord-005453-4057qib7	2855	14	after	after	IN
cord-005453-4057qib7	2855	15	the	the	DT
cord-005453-4057qib7	2855	16	present	present	JJ
cord-005453-4057qib7	2855	17	NMA	NMA	NNP
cord-005453-4057qib7	2855	18	HSCT	HSCT	NNP
cord-005453-4057qib7	2855	19	regimen	regimen	NN
cord-005453-4057qib7	2855	20	with	with	IN
cord-005453-4057qib7	2855	21	alemtuzumab/300	alemtuzumab/300	NNP
cord-005453-4057qib7	2855	22	cGy	cGy	NNP
cord-005453-4057qib7	2855	23	total	total	JJ
cord-005453-4057qib7	2855	24	body	body	NN
cord-005453-4057qib7	2855	25	irradiation	irradiation	NN
cord-005453-4057qib7	2855	26	(	(	-LRB-
cord-005453-4057qib7	2855	27	TBI	TBI	NNP
cord-005453-4057qib7	2855	28	)	)	-RRB-
cord-005453-4057qib7	2855	29	with	with	IN
cord-005453-4057qib7	2855	30	prolonged	prolong	VBN
cord-005453-4057qib7	2855	31	post	post	JJ
cord-005453-4057qib7	2855	32	-	-	JJ
cord-005453-4057qib7	2855	33	HSCT	HSCT	NNP
cord-005453-4057qib7	2855	34	Sirolimus	Sirolimus	NNP
cord-005453-4057qib7	2855	35	.	.	.
cord-005453-4057qib7	2856	1	No	no	DT
cord-005453-4057qib7	2856	2	episodes	episode	NNS
cord-005453-4057qib7	2856	3	of	of	IN
cord-005453-4057qib7	2856	4	AKI	AKI	NNP
cord-005453-4057qib7	2856	5	or	or	CC
cord-005453-4057qib7	2856	6	significant	significant	JJ
cord-005453-4057qib7	2856	7	fluid	fluid	JJ
cord-005453-4057qib7	2856	8	overload	overload	NN
cord-005453-4057qib7	2856	9	were	be	VBD
cord-005453-4057qib7	2856	10	observed	observe	VBN
cord-005453-4057qib7	2856	11	during	during	IN
cord-005453-4057qib7	2856	12	the	the	DT
cord-005453-4057qib7	2856	13	first	first	JJ
cord-005453-4057qib7	2856	14	month	month	NN
cord-005453-4057qib7	2856	15	post	post	NN
cord-005453-4057qib7	2856	16	-	-	JJ
cord-005453-4057qib7	2856	17	HSCT	HSCT	NNP
cord-005453-4057qib7	2856	18	,	,	,
cord-005453-4057qib7	2856	19	and	and	CC
cord-005453-4057qib7	2856	20	no	no	DT
cord-005453-4057qib7	2856	21	patient	patient	NN
cord-005453-4057qib7	2856	22	developed	develop	VBD
cord-005453-4057qib7	2856	23	CKD	CKD	NNP
cord-005453-4057qib7	2856	24	during	during	IN
cord-005453-4057qib7	2856	25	follow	follow	NN
cord-005453-4057qib7	2856	26	-	-	HYPH
cord-005453-4057qib7	2856	27	up	up	NN
cord-005453-4057qib7	2856	28	.	.	.
cord-005453-4057qib7	2857	1	Further	further	JJ
cord-005453-4057qib7	2857	2	prospective	prospective	JJ
cord-005453-4057qib7	2857	3	studies	study	NNS
cord-005453-4057qib7	2857	4	are	be	VBP
cord-005453-4057qib7	2857	5	needed	need	VBN
cord-005453-4057qib7	2857	6	to	to	TO
cord-005453-4057qib7	2857	7	confirm	confirm	VB
cord-005453-4057qib7	2857	8	our	-PRON-	PRP$
cord-005453-4057qib7	2857	9	findings	finding	NNS
cord-005453-4057qib7	2857	10	and	and	CC
cord-005453-4057qib7	2857	11	to	to	TO
cord-005453-4057qib7	2857	12	determine	determine	VB
cord-005453-4057qib7	2857	13	if	if	IN
cord-005453-4057qib7	2857	14	stable	stable	JJ
cord-005453-4057qib7	2857	15	renal	renal	JJ
cord-005453-4057qib7	2857	16	function	function	NN
cord-005453-4057qib7	2857	17	persists	persist	VBZ
cord-005453-4057qib7	2857	18	during	during	IN
cord-005453-4057qib7	2857	19	longer	long	JJR
cord-005453-4057qib7	2857	20	-	-	HYPH
cord-005453-4057qib7	2857	21	term	term	NN
cord-005453-4057qib7	2857	22	followup	followup	NN
cord-005453-4057qib7	2857	23	.	.	.
cord-005453-4057qib7	2858	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2858	2	:	:	:
cord-005453-4057qib7	2858	3	Nothing	nothing	NN
cord-005453-4057qib7	2858	4	to	to	TO
cord-005453-4057qib7	2858	5	declare	declare	VB
cord-005453-4057qib7	2858	6	.	.	.
cord-005453-4057qib7	2859	1	Lung	lung	NN
cord-005453-4057qib7	2859	2	microbiota	microbiota	NN
cord-005453-4057qib7	2859	3	in	in	IN
cord-005453-4057qib7	2859	4	patients	patient	NNS
cord-005453-4057qib7	2859	5	with	with	IN
cord-005453-4057qib7	2859	6	idiopathic	idiopathic	JJ
cord-005453-4057qib7	2859	7	pneumonia	pneumonia	NN
cord-005453-4057qib7	2859	8	syndrome	syndrome	NN
cord-005453-4057qib7	2859	9	(	(	-LRB-
cord-005453-4057qib7	2859	10	IPS	IPS	NNP
cord-005453-4057qib7	2859	11	)	)	-RRB-
cord-005453-4057qib7	2859	12	after	after	IN
cord-005453-4057qib7	2859	13	HCT	HCT	NNP
cord-005453-4057qib7	2859	14	Background	Background	NNP
cord-005453-4057qib7	2859	15	:	:	:
cord-005453-4057qib7	2860	1	Idiopathic	idiopathic	JJ
cord-005453-4057qib7	2860	2	pneumonia	pneumonia	NN
cord-005453-4057qib7	2860	3	syndrome	syndrome	NN
cord-005453-4057qib7	2860	4	(	(	-LRB-
cord-005453-4057qib7	2860	5	IPS	IPS	NNP
cord-005453-4057qib7	2860	6	)	)	-RRB-
cord-005453-4057qib7	2860	7	is	be	VBZ
cord-005453-4057qib7	2860	8	a	a	DT
cord-005453-4057qib7	2860	9	non	non	JJ
cord-005453-4057qib7	2860	10	-	-	JJ
cord-005453-4057qib7	2860	11	infectious	infectious	JJ
cord-005453-4057qib7	2860	12	pulmonary	pulmonary	JJ
cord-005453-4057qib7	2860	13	complication	complication	NN
cord-005453-4057qib7	2860	14	after	after	IN
cord-005453-4057qib7	2860	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2860	16	cell	cell	NN
cord-005453-4057qib7	2860	17	transplantation	transplantation	NN
cord-005453-4057qib7	2860	18	(	(	-LRB-
cord-005453-4057qib7	2860	19	HCT	HCT	NNP
cord-005453-4057qib7	2860	20	)	)	-RRB-
cord-005453-4057qib7	2860	21	and	and	CC
cord-005453-4057qib7	2860	22	the	the	DT
cord-005453-4057qib7	2860	23	etiology	etiology	NN
cord-005453-4057qib7	2860	24	remains	remain	VBZ
cord-005453-4057qib7	2860	25	unknown	unknown	JJ
cord-005453-4057qib7	2860	26	.	.	.
cord-005453-4057qib7	2861	1	Recent	recent	JJ
cord-005453-4057qib7	2861	2	studies	study	NNS
cord-005453-4057qib7	2861	3	have	have	VBP
cord-005453-4057qib7	2861	4	reported	report	VBN
cord-005453-4057qib7	2861	5	that	that	IN
cord-005453-4057qib7	2861	6	various	various	JJ
cord-005453-4057qib7	2861	7	diseases	disease	NNS
cord-005453-4057qib7	2861	8	are	be	VBP
cord-005453-4057qib7	2861	9	associated	associate	VBN
cord-005453-4057qib7	2861	10	with	with	IN
cord-005453-4057qib7	2861	11	changes	change	NNS
cord-005453-4057qib7	2861	12	of	of	IN
cord-005453-4057qib7	2861	13	microbiota	microbiota	NN
cord-005453-4057qib7	2861	14	.	.	.
cord-005453-4057qib7	2862	1	The	the	DT
cord-005453-4057qib7	2862	2	aim	aim	NN
cord-005453-4057qib7	2862	3	of	of	IN
cord-005453-4057qib7	2862	4	this	this	DT
cord-005453-4057qib7	2862	5	study	study	NN
cord-005453-4057qib7	2862	6	was	be	VBD
cord-005453-4057qib7	2862	7	to	to	TO
cord-005453-4057qib7	2862	8	evaluate	evaluate	VB
cord-005453-4057qib7	2862	9	the	the	DT
cord-005453-4057qib7	2862	10	lung	lung	NN
cord-005453-4057qib7	2862	11	microbiota	microbiota	NN
cord-005453-4057qib7	2862	12	in	in	IN
cord-005453-4057qib7	2862	13	HCT	HCT	NNP
cord-005453-4057qib7	2862	14	recipients	recipient	NNS
cord-005453-4057qib7	2862	15	with	with	IN
cord-005453-4057qib7	2862	16	IPS	IPS	NNP
cord-005453-4057qib7	2862	17	and	and	CC
cord-005453-4057qib7	2862	18	identify	identify	VB
cord-005453-4057qib7	2862	19	microorganisms	microorganism	NNS
cord-005453-4057qib7	2862	20	potentially	potentially	RB
cord-005453-4057qib7	2862	21	associated	associate	VBN
cord-005453-4057qib7	2862	22	with	with	IN
cord-005453-4057qib7	2862	23	IPS	IPS	NNP
cord-005453-4057qib7	2862	24	.	.	.
cord-005453-4057qib7	2863	1	Methods	method	NNS
cord-005453-4057qib7	2863	2	:	:	:
cord-005453-4057qib7	2864	1	Frozen	frozen	JJ
cord-005453-4057qib7	2864	2	bronchoalveolar	bronchoalveolar	JJ
cord-005453-4057qib7	2864	3	lavage	lavage	NN
cord-005453-4057qib7	2864	4	(	(	-LRB-
cord-005453-4057qib7	2864	5	BAL	BAL	NNP
cord-005453-4057qib7	2864	6	)	)	-RRB-
cord-005453-4057qib7	2864	7	samples	sample	NNS
cord-005453-4057qib7	2864	8	from	from	IN
cord-005453-4057qib7	2864	9	HCT	HCT	NNP
cord-005453-4057qib7	2864	10	recipients	recipient	NNS
cord-005453-4057qib7	2864	11	with	with	IN
cord-005453-4057qib7	2864	12	IPS	IPS	NNP
cord-005453-4057qib7	2864	13	(	(	-LRB-
cord-005453-4057qib7	2864	14	N=18	N=18	NNP
cord-005453-4057qib7	2864	15	)	)	-RRB-
cord-005453-4057qib7	2864	16	and	and	CC
cord-005453-4057qib7	2864	17	research	research	NN
cord-005453-4057qib7	2864	18	BAL	bal	NN
cord-005453-4057qib7	2864	19	samples	sample	NNS
cord-005453-4057qib7	2864	20	from	from	IN
cord-005453-4057qib7	2864	21	asymptomatic	asymptomatic	JJ
cord-005453-4057qib7	2864	22	HCT	HCT	NNP
cord-005453-4057qib7	2864	23	recipients	recipient	NNS
cord-005453-4057qib7	2864	24	as	as	IN
cord-005453-4057qib7	2864	25	controls	control	NNS
cord-005453-4057qib7	2864	26	(	(	-LRB-
cord-005453-4057qib7	2864	27	N=12	N=12	NNP
cord-005453-4057qib7	2864	28	)	)	-RRB-
cord-005453-4057qib7	2864	29	were	be	VBD
cord-005453-4057qib7	2864	30	retrospectively	retrospectively	RB
cord-005453-4057qib7	2864	31	analyzed	analyze	VBN
cord-005453-4057qib7	2864	32	.	.	.
cord-005453-4057qib7	2865	1	All	all	DT
cord-005453-4057qib7	2865	2	samples	sample	NNS
cord-005453-4057qib7	2865	3	were	be	VBD
cord-005453-4057qib7	2865	4	negative	negative	JJ
cord-005453-4057qib7	2865	5	for	for	IN
cord-005453-4057qib7	2865	6	common	common	JJ
cord-005453-4057qib7	2865	7	viruses	virus	NNS
cord-005453-4057qib7	2865	8	by	by	IN
cord-005453-4057qib7	2865	9	quantitative	quantitative	JJ
cord-005453-4057qib7	2865	10	PCR	PCR	NNP
cord-005453-4057qib7	2865	11	.	.	.
cord-005453-4057qib7	2866	1	Sequencing	sequencing	NN
cord-005453-4057qib7	2866	2	libraries	library	NNS
cord-005453-4057qib7	2866	3	were	be	VBD
cord-005453-4057qib7	2866	4	made	make	VBN
cord-005453-4057qib7	2866	5	with	with	IN
cord-005453-4057qib7	2866	6	1ng	1ng	CD
cord-005453-4057qib7	2866	7	of	of	IN
cord-005453-4057qib7	2866	8	input	input	NN
cord-005453-4057qib7	2866	9	DNA	dna	NN
cord-005453-4057qib7	2866	10	per	per	IN
cord-005453-4057qib7	2866	11	sample	sample	NN
cord-005453-4057qib7	2866	12	(	(	-LRB-
cord-005453-4057qib7	2866	13	Nextera	Nextera	NNP
cord-005453-4057qib7	2866	14	XT	XT	NNP
cord-005453-4057qib7	2866	15	,	,	,
cord-005453-4057qib7	2866	16	Illumina	Illumina	NNP
cord-005453-4057qib7	2866	17	)	)	-RRB-
cord-005453-4057qib7	2866	18	.	.	.
cord-005453-4057qib7	2867	1	Samples	sample	NNS
cord-005453-4057qib7	2867	2	were	be	VBD
cord-005453-4057qib7	2867	3	pooled	pool	VBN
cord-005453-4057qib7	2867	4	and	and	CC
cord-005453-4057qib7	2867	5	sequenced	sequence	VBN
cord-005453-4057qib7	2867	6	by	by	IN
cord-005453-4057qib7	2867	7	HiSeq	HiSeq	NNP
cord-005453-4057qib7	2867	8	2000	2000	CD
cord-005453-4057qib7	2867	9	to	to	TO
cord-005453-4057qib7	2867	10	obtain	obtain	VB
cord-005453-4057qib7	2867	11	100-bp	100-bp	CD
cord-005453-4057qib7	2867	12	paired	pair	VBN
cord-005453-4057qib7	2867	13	end	end	NN
cord-005453-4057qib7	2867	14	data	datum	NNS
cord-005453-4057qib7	2867	15	.	.	.
cord-005453-4057qib7	2868	1	Sequence	sequence	NN
cord-005453-4057qib7	2868	2	data	datum	NNS
cord-005453-4057qib7	2868	3	analysis	analysis	NN
cord-005453-4057qib7	2868	4	and	and	CC
cord-005453-4057qib7	2868	5	read	read	VB
cord-005453-4057qib7	2868	6	classification	classification	NN
cord-005453-4057qib7	2868	7	were	be	VBD
cord-005453-4057qib7	2868	8	performed	perform	VBN
cord-005453-4057qib7	2868	9	with	with	IN
cord-005453-4057qib7	2868	10	Sunbeam	Sunbeam	NNP
cord-005453-4057qib7	2868	11	and	and	CC
cord-005453-4057qib7	2868	12	the	the	DT
cord-005453-4057qib7	2868	13	quality	quality	NN
cord-005453-4057qib7	2868	14	control	control	NN
cord-005453-4057qib7	2868	15	and	and	CC
cord-005453-4057qib7	2868	16	read	read	VB
cord-005453-4057qib7	2868	17	classification	classification	NN
cord-005453-4057qib7	2868	18	were	be	VBD
cord-005453-4057qib7	2868	19	performed	perform	VBN
cord-005453-4057qib7	2868	20	using	use	VBG
cord-005453-4057qib7	2868	21	Komplexity	Komplexity	NNP
cord-005453-4057qib7	2868	22	and	and	CC
cord-005453-4057qib7	2868	23	Kraken	Kraken	NNP
cord-005453-4057qib7	2868	24	,	,	,
cord-005453-4057qib7	2868	25	which	which	WDT
cord-005453-4057qib7	2868	26	classifies	classify	VBZ
cord-005453-4057qib7	2868	27	bacterial	bacterial	JJ
cord-005453-4057qib7	2868	28	,	,	,
cord-005453-4057qib7	2868	29	archeal	archeal	NN
cord-005453-4057qib7	2868	30	,	,	,
cord-005453-4057qib7	2868	31	and	and	CC
cord-005453-4057qib7	2868	32	viral	viral	JJ
cord-005453-4057qib7	2868	33	genomes	genome	NNS
cord-005453-4057qib7	2868	34	.	.	.
cord-005453-4057qib7	2869	1	We	-PRON-	PRP
cord-005453-4057qib7	2869	2	used	use	VBD
cord-005453-4057qib7	2869	3	sequence	sequence	NN
cord-005453-4057qib7	2869	4	data	datum	NNS
cord-005453-4057qib7	2869	5	of	of	IN
cord-005453-4057qib7	2869	6	bronchoscope	bronchoscope	NN
cord-005453-4057qib7	2869	7	prewashes	prewashe	NNS
cord-005453-4057qib7	2869	8	from	from	IN
cord-005453-4057qib7	2869	9	a	a	DT
cord-005453-4057qib7	2869	10	separate	separate	JJ
cord-005453-4057qib7	2869	11	cohort	cohort	NN
cord-005453-4057qib7	2869	12	as	as	IN
cord-005453-4057qib7	2869	13	controls	control	NNS
cord-005453-4057qib7	2869	14	for	for	IN
cord-005453-4057qib7	2869	15	environmental	environmental	JJ
cord-005453-4057qib7	2869	16	sources	source	NNS
cord-005453-4057qib7	2869	17	(	(	-LRB-
cord-005453-4057qib7	2869	18	N=24	N=24	NNP
cord-005453-4057qib7	2869	19	)	)	-RRB-
cord-005453-4057qib7	2869	20	.	.	.
cord-005453-4057qib7	2870	1	Bray	Bray	NNP
cord-005453-4057qib7	2870	2	-	-	HYPH
cord-005453-4057qib7	2870	3	Curtiss	Curtiss	NNP
cord-005453-4057qib7	2870	4	dissimilarity	dissimilarity	NN
cord-005453-4057qib7	2870	5	among	among	IN
cord-005453-4057qib7	2870	6	samples	sample	NNS
cord-005453-4057qib7	2870	7	was	be	VBD
cord-005453-4057qib7	2870	8	calculated	calculate	VBN
cord-005453-4057qib7	2870	9	using	use	VBG
cord-005453-4057qib7	2870	10	the	the	DT
cord-005453-4057qib7	2870	11	Vegan	Vegan	NNP
cord-005453-4057qib7	2870	12	R	r	NN
cord-005453-4057qib7	2870	13	packages	package	NNS
cord-005453-4057qib7	2870	14	.	.	.
cord-005453-4057qib7	2871	1	PERMANOVA	PERMANOVA	NNP
cord-005453-4057qib7	2871	2	and	and	CC
cord-005453-4057qib7	2871	3	a	a	DT
cord-005453-4057qib7	2871	4	two	two	CD
cord-005453-4057qib7	2871	5	-	-	HYPH
cord-005453-4057qib7	2871	6	sided	sided	JJ
cord-005453-4057qib7	2871	7	Wilcoxon	Wilcoxon	NNP
cord-005453-4057qib7	2871	8	rank	rank	NN
cord-005453-4057qib7	2871	9	sum	sum	NN
cord-005453-4057qib7	2871	10	test	test	NN
cord-005453-4057qib7	2871	11	were	be	VBD
cord-005453-4057qib7	2871	12	used	use	VBN
cord-005453-4057qib7	2871	13	to	to	TO
cord-005453-4057qib7	2871	14	compare	compare	VB
cord-005453-4057qib7	2871	15	between	between	IN
cord-005453-4057qib7	2871	16	the	the	DT
cord-005453-4057qib7	2871	17	study	study	NN
cord-005453-4057qib7	2871	18	groups	group	NNS
cord-005453-4057qib7	2871	19	.	.	.
cord-005453-4057qib7	2872	1	Results	result	NNS
cord-005453-4057qib7	2872	2	:	:	:
cord-005453-4057qib7	2873	1	BAL	bal	NN
cord-005453-4057qib7	2873	2	samples	sample	NNS
cord-005453-4057qib7	2873	3	started	start	VBD
cord-005453-4057qib7	2873	4	at	at	IN
cord-005453-4057qib7	2873	5	a	a	DT
cord-005453-4057qib7	2873	6	median	median	NN
cord-005453-4057qib7	2873	7	of	of	IN
cord-005453-4057qib7	2873	8	22x10	22x10	CD
cord-005453-4057qib7	2873	9	6	6	CD
cord-005453-4057qib7	2873	10	raw	raw	JJ
cord-005453-4057qib7	2873	11	read	read	NN
cord-005453-4057qib7	2873	12	pairs	pair	NNS
cord-005453-4057qib7	2873	13	per	per	IN
cord-005453-4057qib7	2873	14	sample	sample	NN
cord-005453-4057qib7	2873	15	and	and	CC
cord-005453-4057qib7	2873	16	reduced	reduce	VBN
cord-005453-4057qib7	2873	17	to	to	IN
cord-005453-4057qib7	2873	18	21x10	21x10	CD
cord-005453-4057qib7	2873	19	3	3	CD
cord-005453-4057qib7	2873	20	reads	read	VBZ
cord-005453-4057qib7	2873	21	assignable	assignable	JJ
cord-005453-4057qib7	2873	22	to	to	IN
cord-005453-4057qib7	2873	23	microbial	microbial	JJ
cord-005453-4057qib7	2873	24	taxa	taxon	NNS
cord-005453-4057qib7	2873	25	following	follow	VBG
cord-005453-4057qib7	2873	26	quality	quality	NN
cord-005453-4057qib7	2873	27	control	control	NN
cord-005453-4057qib7	2873	28	.	.	.
cord-005453-4057qib7	2874	1	The	the	DT
cord-005453-4057qib7	2874	2	bacterial	bacterial	JJ
cord-005453-4057qib7	2874	3	phyla	phylum	NNS
cord-005453-4057qib7	2875	1	Proteobacteria	Proteobacteria	NNP
cord-005453-4057qib7	2875	2	and	and	CC
cord-005453-4057qib7	2875	3	Firmicutes	Firmicutes	NNPS
cord-005453-4057qib7	2875	4	were	be	VBD
cord-005453-4057qib7	2875	5	most	most	RBS
cord-005453-4057qib7	2875	6	abundant	abundant	JJ
cord-005453-4057qib7	2875	7	followed	follow	VBN
cord-005453-4057qib7	2875	8	by	by	IN
cord-005453-4057qib7	2875	9	Bacteroidetes	Bacteroidetes	NNPS
cord-005453-4057qib7	2875	10	and	and	CC
cord-005453-4057qib7	2875	11	Actinobacteria	Actinobacteria	NNP
cord-005453-4057qib7	2875	12	in	in	IN
cord-005453-4057qib7	2875	13	both	both	DT
cord-005453-4057qib7	2875	14	BAL	bal	NN
cord-005453-4057qib7	2875	15	and	and	CC
cord-005453-4057qib7	2875	16	bronchoscope	bronchoscope	NN
cord-005453-4057qib7	2875	17	prewash	prewash	NN
cord-005453-4057qib7	2875	18	samples	sample	NNS
cord-005453-4057qib7	2875	19	.	.	.
cord-005453-4057qib7	2876	1	Separation	separation	NN
cord-005453-4057qib7	2876	2	of	of	IN
cord-005453-4057qib7	2876	3	BAL	bal	NN
cord-005453-4057qib7	2876	4	and	and	CC
cord-005453-4057qib7	2876	5	prewash	prewash	NN
cord-005453-4057qib7	2876	6	microbiota	microbiota	NN
cord-005453-4057qib7	2876	7	using	use	VBG
cord-005453-4057qib7	2876	8	Bray	Bray	NNP
cord-005453-4057qib7	2876	9	-	-	HYPH
cord-005453-4057qib7	2876	10	Curtiss	Curtiss	NNP
cord-005453-4057qib7	2876	11	dissimilarity	dissimilarity	NN
cord-005453-4057qib7	2876	12	plots	plot	NNS
cord-005453-4057qib7	2876	13	showed	show	VBD
cord-005453-4057qib7	2876	14	that	that	IN
cord-005453-4057qib7	2876	15	BAL	bal	NN
cord-005453-4057qib7	2876	16	samples	sample	NNS
cord-005453-4057qib7	2876	17	were	be	VBD
cord-005453-4057qib7	2876	18	distinguished	distinguish	VBN
cord-005453-4057qib7	2876	19	by	by	IN
cord-005453-4057qib7	2876	20	sequences	sequence	NNS
cord-005453-4057qib7	2876	21	assigned	assign	VBN
cord-005453-4057qib7	2876	22	to	to	IN
cord-005453-4057qib7	2876	23	Staphylococcus	Staphylococcus	NNP
cord-005453-4057qib7	2876	24	,	,	,
cord-005453-4057qib7	2876	25	Acidovorax	Acidovorax	NNP
cord-005453-4057qib7	2876	26	,	,	,
cord-005453-4057qib7	2876	27	and	and	CC
cord-005453-4057qib7	2876	28	Bradyrhizobium	Bradyrhizobium	NNP
cord-005453-4057qib7	2876	29	species	specie	NNS
cord-005453-4057qib7	2876	30	,	,	,
cord-005453-4057qib7	2876	31	while	while	IN
cord-005453-4057qib7	2876	32	prewash	prewash	NN
cord-005453-4057qib7	2876	33	samples	sample	NNS
cord-005453-4057qib7	2876	34	were	be	VBD
cord-005453-4057qib7	2876	35	distinguished	distinguish	VBN
cord-005453-4057qib7	2876	36	mostly	mostly	RB
cord-005453-4057qib7	2876	37	by	by	IN
cord-005453-4057qib7	2876	38	Pseudomonas	Pseudomonas	NNP
cord-005453-4057qib7	2876	39	and	and	CC
cord-005453-4057qib7	2876	40	Elizabethkingia	Elizabethkingia	NNP
cord-005453-4057qib7	2876	41	species	specie	NNS
cord-005453-4057qib7	2876	42	,	,	,
cord-005453-4057qib7	2876	43	consistent	consistent	JJ
cord-005453-4057qib7	2876	44	with	with	IN
cord-005453-4057qib7	2876	45	environmental	environmental	JJ
cord-005453-4057qib7	2876	46	sources	source	NNS
cord-005453-4057qib7	2876	47	(	(	-LRB-
cord-005453-4057qib7	2876	48	Figure	figure	NN
cord-005453-4057qib7	2876	49	)	)	-RRB-
cord-005453-4057qib7	2876	50	.	.	.
cord-005453-4057qib7	2877	1	Within	within	IN
cord-005453-4057qib7	2877	2	BAL	bal	NN
cord-005453-4057qib7	2877	3	samples	sample	NNS
cord-005453-4057qib7	2877	4	,	,	,
cord-005453-4057qib7	2877	5	Staphylococcus	Staphylococcus	NNP
cord-005453-4057qib7	2877	6	species	specie	NNS
cord-005453-4057qib7	2877	7	were	be	VBD
cord-005453-4057qib7	2877	8	the	the	DT
cord-005453-4057qib7	2877	9	main	main	JJ
cord-005453-4057qib7	2877	10	drivers	driver	NNS
cord-005453-4057qib7	2877	11	of	of	IN
cord-005453-4057qib7	2877	12	separation	separation	NN
cord-005453-4057qib7	2877	13	between	between	IN
cord-005453-4057qib7	2877	14	IPS	IPS	NNP
cord-005453-4057qib7	2877	15	cases	case	NNS
cord-005453-4057qib7	2877	16	and	and	CC
cord-005453-4057qib7	2877	17	the	the	DT
cord-005453-4057qib7	2877	18	controls	control	NNS
cord-005453-4057qib7	2877	19	(	(	-LRB-
cord-005453-4057qib7	2877	20	p=0.002	p=0.002	NNP
cord-005453-4057qib7	2877	21	,	,	,
cord-005453-4057qib7	2877	22	PERMANOVA	PERMANOVA	NNP
cord-005453-4057qib7	2877	23	,	,	,
cord-005453-4057qib7	2877	24	Figure	figure	NN
cord-005453-4057qib7	2877	25	)	)	-RRB-
cord-005453-4057qib7	2877	26	.	.	.
cord-005453-4057qib7	2878	1	Consistent	consistent	JJ
cord-005453-4057qib7	2878	2	with	with	IN
cord-005453-4057qib7	2878	3	this	this	DT
cord-005453-4057qib7	2878	4	,	,	,
cord-005453-4057qib7	2878	5	a	a	DT
cord-005453-4057qib7	2878	6	linear	linear	JJ
cord-005453-4057qib7	2878	7	discriminant	discriminant	JJ
cord-005453-4057qib7	2878	8	analysis	analysis	NN
cord-005453-4057qib7	2878	9	to	to	TO
cord-005453-4057qib7	2878	10	identify	identify	VB
cord-005453-4057qib7	2878	11	taxa	taxon	NNS
cord-005453-4057qib7	2878	12	best	well	RBS
cord-005453-4057qib7	2878	13	distinguishing	distinguishing	JJ
cord-005453-4057qib7	2878	14	cases	case	NNS
cord-005453-4057qib7	2878	15	and	and	CC
cord-005453-4057qib7	2878	16	controls	control	NNS
cord-005453-4057qib7	2878	17	identified	identify	VBD
cord-005453-4057qib7	2878	18	Staphylococcus	Staphylococcus	NNP
cord-005453-4057qib7	2878	19	,	,	,
cord-005453-4057qib7	2878	20	especially	especially	RB
cord-005453-4057qib7	2878	21	S.	S.	NNP
cord-005453-4057qib7	2878	22	epidermidis	epidermidi	NNS
cord-005453-4057qib7	2878	23	,	,	,
cord-005453-4057qib7	2878	24	in	in	IN
cord-005453-4057qib7	2878	25	IPS	IPS	NNP
cord-005453-4057qib7	2878	26	cases	case	NNS
cord-005453-4057qib7	2878	27	with	with	IN
cord-005453-4057qib7	2878	28	Lactobacillus	lactobacillus	NN
cord-005453-4057qib7	2878	29	and	and	CC
cord-005453-4057qib7	2878	30	Streptococcus	Streptococcus	NNP
cord-005453-4057qib7	2878	31	species	specie	NNS
cord-005453-4057qib7	2878	32	in	in	IN
cord-005453-4057qib7	2878	33	controls	control	NNS
cord-005453-4057qib7	2878	34	.	.	.
cord-005453-4057qib7	2879	1	We	-PRON-	PRP
cord-005453-4057qib7	2879	2	then	then	RB
cord-005453-4057qib7	2879	3	compared	compare	VBD
cord-005453-4057qib7	2879	4	relative	relative	JJ
cord-005453-4057qib7	2879	5	abundances	abundance	NNS
cord-005453-4057qib7	2879	6	of	of	IN
cord-005453-4057qib7	2879	7	S.	S.	NNP
cord-005453-4057qib7	2879	8	epidermidis	epidermidi	NNS
cord-005453-4057qib7	2879	9	between	between	IN
cord-005453-4057qib7	2879	10	all	all	DT
cord-005453-4057qib7	2879	11	study	study	NN
cord-005453-4057qib7	2879	12	groups	group	NNS
cord-005453-4057qib7	2879	13	.	.	.
cord-005453-4057qib7	2880	1	IPS	IPS	NNP
cord-005453-4057qib7	2880	2	case	case	NN
cord-005453-4057qib7	2880	3	samples	sample	NNS
cord-005453-4057qib7	2880	4	were	be	VBD
cord-005453-4057qib7	2880	5	significantly	significantly	RB
cord-005453-4057qib7	2880	6	enriched	enrich	VBN
cord-005453-4057qib7	2880	7	in	in	IN
cord-005453-4057qib7	2880	8	S.	S.	NNP
cord-005453-4057qib7	2880	9	epidermidis	epidermidi	NNS
cord-005453-4057qib7	2880	10	compared	compare	VBN
cord-005453-4057qib7	2880	11	to	to	TO
cord-005453-4057qib7	2880	12	control	control	NN
cord-005453-4057qib7	2880	13	(	(	-LRB-
cord-005453-4057qib7	2880	14	p	p	NN
cord-005453-4057qib7	2880	15	<	<	XX
cord-005453-4057qib7	2880	16	0.001	0.001	CD
cord-005453-4057qib7	2880	17	,	,	,
cord-005453-4057qib7	2880	18	two	two	CD
cord-005453-4057qib7	2880	19	-	-	HYPH
cord-005453-4057qib7	2880	20	sided	sided	JJ
cord-005453-4057qib7	2880	21	Wilcoxon	Wilcoxon	NNP
cord-005453-4057qib7	2880	22	rank	rank	NN
cord-005453-4057qib7	2880	23	sum	sum	NN
cord-005453-4057qib7	2880	24	test	test	NN
cord-005453-4057qib7	2880	25	)	)	-RRB-
cord-005453-4057qib7	2880	26	and	and	CC
cord-005453-4057qib7	2880	27	prewash	prewash	VB
cord-005453-4057qib7	2880	28	samples	sample	NNS
cord-005453-4057qib7	2880	29	(	(	-LRB-
cord-005453-4057qib7	2880	30	p	p	NN
cord-005453-4057qib7	2880	31	<	<	XX
cord-005453-4057qib7	2880	32	0.001	0.001	CD
cord-005453-4057qib7	2880	33	)	)	-RRB-
cord-005453-4057qib7	2880	34	.	.	.
cord-005453-4057qib7	2881	1	Viruses	virus	NNS
cord-005453-4057qib7	2881	2	were	be	VBD
cord-005453-4057qib7	2881	3	classified	classify	VBN
cord-005453-4057qib7	2881	4	by	by	IN
cord-005453-4057qib7	2881	5	category	category	NN
cord-005453-4057qib7	2881	6	as	as	IN
cord-005453-4057qib7	2881	7	human	human	JJ
cord-005453-4057qib7	2881	8	pathogens	pathogen	NNS
cord-005453-4057qib7	2881	9	,	,	,
cord-005453-4057qib7	2881	10	non	non	JJ
cord-005453-4057qib7	2881	11	-	-	JJ
cord-005453-4057qib7	2881	12	human	human	JJ
cord-005453-4057qib7	2881	13	pathogens	pathogen	NNS
cord-005453-4057qib7	2881	14	,	,	,
cord-005453-4057qib7	2881	15	and	and	CC
cord-005453-4057qib7	2881	16	bacteriophages	bacteriophage	NNS
cord-005453-4057qib7	2881	17	.	.	.
cord-005453-4057qib7	2882	1	Torque	Torque	NNP
cord-005453-4057qib7	2882	2	teno	teno	NNP
cord-005453-4057qib7	2882	3	viruses	virus	NNS
cord-005453-4057qib7	2882	4	(	(	-LRB-
cord-005453-4057qib7	2882	5	TTV	TTV	NNP
cord-005453-4057qib7	2882	6	)	)	-RRB-
cord-005453-4057qib7	2882	7	was	be	VBD
cord-005453-4057qib7	2882	8	the	the	DT
cord-005453-4057qib7	2882	9	most	most	RBS
cord-005453-4057qib7	2882	10	commonly	commonly	RB
cord-005453-4057qib7	2882	11	detected	detect	VBN
cord-005453-4057qib7	2882	12	virus	virus	NN
cord-005453-4057qib7	2882	13	among	among	IN
cord-005453-4057qib7	2882	14	viruses	virus	NNS
cord-005453-4057qib7	2882	15	that	that	WDT
cord-005453-4057qib7	2882	16	replicate	replicate	VBP
cord-005453-4057qib7	2882	17	on	on	IN
cord-005453-4057qib7	2882	18	human	human	JJ
cord-005453-4057qib7	2882	19	cells	cell	NNS
cord-005453-4057qib7	2882	20	,	,	,
cord-005453-4057qib7	2882	21	and	and	CC
cord-005453-4057qib7	2882	22	there	there	EX
cord-005453-4057qib7	2882	23	was	be	VBD
cord-005453-4057qib7	2882	24	a	a	DT
cord-005453-4057qib7	2882	25	trend	trend	NN
cord-005453-4057qib7	2882	26	towards	towards	IN
cord-005453-4057qib7	2882	27	higher	high	JJR
cord-005453-4057qib7	2882	28	abundance	abundance	NN
cord-005453-4057qib7	2882	29	in	in	IN
cord-005453-4057qib7	2882	30	IPS	ips	NN
cord-005453-4057qib7	2882	31	case	case	NN
cord-005453-4057qib7	2882	32	samples	sample	NNS
cord-005453-4057qib7	2882	33	than	than	IN
cord-005453-4057qib7	2882	34	controls	control	NNS
cord-005453-4057qib7	2882	35	.	.	.
cord-005453-4057qib7	2883	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2883	2	:	:	:
cord-005453-4057qib7	2884	1	Lung	lung	NN
cord-005453-4057qib7	2884	2	microbial	microbial	JJ
cord-005453-4057qib7	2884	3	sequences	sequence	NNS
cord-005453-4057qib7	2884	4	in	in	IN
cord-005453-4057qib7	2884	5	HCT	HCT	NNP
cord-005453-4057qib7	2884	6	recipients	recipient	NNS
cord-005453-4057qib7	2884	7	predominantly	predominantly	RB
cord-005453-4057qib7	2884	8	consisted	consist	VBD
cord-005453-4057qib7	2884	9	of	of	IN
cord-005453-4057qib7	2884	10	Proteobacteria	Proteobacteria	NNP
cord-005453-4057qib7	2884	11	and	and	CC
cord-005453-4057qib7	2884	12	Firmicutes	Firmicutes	NNPS
cord-005453-4057qib7	2884	13	,	,	,
cord-005453-4057qib7	2884	14	and	and	CC
cord-005453-4057qib7	2884	15	had	have	VBD
cord-005453-4057qib7	2884	16	considerable	considerable	JJ
cord-005453-4057qib7	2884	17	overlap	overlap	NN
cord-005453-4057qib7	2884	18	with	with	IN
cord-005453-4057qib7	2884	19	environmental	environmental	JJ
cord-005453-4057qib7	2884	20	background	background	NN
cord-005453-4057qib7	2884	21	.	.	.
cord-005453-4057qib7	2885	1	Patients	patient	NNS
cord-005453-4057qib7	2885	2	with	with	IN
cord-005453-4057qib7	2885	3	IPS	IPS	NNP
cord-005453-4057qib7	2885	4	had	have	VBD
cord-005453-4057qib7	2885	5	significantly	significantly	RB
cord-005453-4057qib7	2885	6	more	more	JJR
cord-005453-4057qib7	2885	7	Staphylococcus	staphylococcus	NN
cord-005453-4057qib7	2885	8	sequences	sequence	NNS
cord-005453-4057qib7	2885	9	detected	detect	VBD
cord-005453-4057qib7	2885	10	than	than	IN
cord-005453-4057qib7	2885	11	asymptomatic	asymptomatic	JJ
cord-005453-4057qib7	2885	12	HCT	HCT	NNP
cord-005453-4057qib7	2885	13	patients	patient	NNS
cord-005453-4057qib7	2885	14	.	.	.
cord-005453-4057qib7	2886	1	These	these	DT
cord-005453-4057qib7	2886	2	results	result	NNS
cord-005453-4057qib7	2886	3	suggest	suggest	VBP
cord-005453-4057qib7	2886	4	that	that	IN
cord-005453-4057qib7	2886	5	patients	patient	NNS
cord-005453-4057qib7	2886	6	with	with	IN
cord-005453-4057qib7	2886	7	acute	acute	JJ
cord-005453-4057qib7	2886	8	lung	lung	NN
cord-005453-4057qib7	2886	9	injury	injury	NN
cord-005453-4057qib7	2886	10	post	post	JJ
cord-005453-4057qib7	2886	11	-	-	JJ
cord-005453-4057qib7	2886	12	HCT	HCT	NNP
cord-005453-4057qib7	2886	13	show	show	VBP
cord-005453-4057qib7	2886	14	distinct	distinct	JJ
cord-005453-4057qib7	2886	15	patterns	pattern	NNS
cord-005453-4057qib7	2886	16	of	of	IN
cord-005453-4057qib7	2886	17	lung	lung	NN
cord-005453-4057qib7	2886	18	microbiota	microbiota	NN
cord-005453-4057qib7	2886	19	,	,	,
cord-005453-4057qib7	2886	20	although	although	IN
cord-005453-4057qib7	2886	21	heterogeneity	heterogeneity	NN
cord-005453-4057qib7	2886	22	of	of	IN
cord-005453-4057qib7	2886	23	sample	sample	NN
cord-005453-4057qib7	2886	24	collection	collection	NN
cord-005453-4057qib7	2886	25	and	and	CC
cord-005453-4057qib7	2886	26	processing	processing	NN
cord-005453-4057qib7	2886	27	can	can	MD
cord-005453-4057qib7	2886	28	not	not	RB
cord-005453-4057qib7	2886	29	be	be	VB
cord-005453-4057qib7	2886	30	excluded	exclude	VBN
cord-005453-4057qib7	2886	31	and	and	CC
cord-005453-4057qib7	2886	32	no	no	DT
cord-005453-4057qib7	2886	33	singular	singular	JJ
cord-005453-4057qib7	2886	34	organism	organism	NN
cord-005453-4057qib7	2886	35	was	be	VBD
cord-005453-4057qib7	2886	36	uniquely	uniquely	RB
cord-005453-4057qib7	2886	37	associated	associate	VBN
cord-005453-4057qib7	2886	38	with	with	IN
cord-005453-4057qib7	2886	39	IPS	IPS	NNP
cord-005453-4057qib7	2886	40	.	.	.
cord-005453-4057qib7	2887	1	A	a	DT
cord-005453-4057qib7	2887	2	prospective	prospective	JJ
cord-005453-4057qib7	2887	3	study	study	NN
cord-005453-4057qib7	2887	4	is	be	VBZ
cord-005453-4057qib7	2887	5	required	require	VBN
cord-005453-4057qib7	2887	6	to	to	TO
cord-005453-4057qib7	2887	7	confirm	confirm	VB
cord-005453-4057qib7	2887	8	these	these	DT
cord-005453-4057qib7	2887	9	findings	finding	NNS
cord-005453-4057qib7	2887	10	and	and	CC
cord-005453-4057qib7	2887	11	define	define	VB
cord-005453-4057qib7	2887	12	the	the	DT
cord-005453-4057qib7	2887	13	clinical	clinical	JJ
cord-005453-4057qib7	2887	14	significance	significance	NN
cord-005453-4057qib7	2887	15	of	of	IN
cord-005453-4057qib7	2887	16	differences	difference	NNS
cord-005453-4057qib7	2887	17	in	in	IN
cord-005453-4057qib7	2887	18	abundance	abundance	NN
cord-005453-4057qib7	2887	19	patterns	pattern	NNS
cord-005453-4057qib7	2887	20	.	.	.
cord-005453-4057qib7	2888	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2888	2	:	:	:
cord-005453-4057qib7	2888	3	Nothing	nothing	NN
cord-005453-4057qib7	2888	4	to	to	TO
cord-005453-4057qib7	2888	5	declare	declare	VB
cord-005453-4057qib7	2888	6	P142	P142	NNP
cord-005453-4057qib7	2888	7	Abstract	Abstract	NNP
cord-005453-4057qib7	2888	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	2888	9	.	.	.
cord-005453-4057qib7	2889	1	Romiplostim	Romiplostim	NNP
cord-005453-4057qib7	2889	2	for	for	IN
cord-005453-4057qib7	2889	3	the	the	DT
cord-005453-4057qib7	2889	4	treatment	treatment	NN
cord-005453-4057qib7	2889	5	of	of	IN
cord-005453-4057qib7	2889	6	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2889	7	after	after	IN
cord-005453-4057qib7	2889	8	allogeneic	allogeneic	NN
cord-005453-4057qib7	2889	9	stem	stem	NN
cord-005453-4057qib7	2889	10	cell	cell	NN
cord-005453-4057qib7	2889	11	transplantation	transplantation	NN
cord-005453-4057qib7	2889	12	Background	background	NN
cord-005453-4057qib7	2889	13	:	:	:
cord-005453-4057qib7	2890	1	Thrombocytopenia	Thrombocytopenia	NNP
cord-005453-4057qib7	2890	2	is	be	VBZ
cord-005453-4057qib7	2890	3	a	a	DT
cord-005453-4057qib7	2890	4	common	common	JJ
cord-005453-4057qib7	2890	5	complication	complication	NN
cord-005453-4057qib7	2890	6	after	after	IN
cord-005453-4057qib7	2890	7	allogeneic	allogeneic	NN
cord-005453-4057qib7	2890	8	stem	stem	NN
cord-005453-4057qib7	2890	9	cell	cell	NN
cord-005453-4057qib7	2890	10	transplantation	transplantation	NN
cord-005453-4057qib7	2890	11	(	(	-LRB-
cord-005453-4057qib7	2890	12	allo	allo	NN
cord-005453-4057qib7	2890	13	-	-	HYPH
cord-005453-4057qib7	2890	14	HCT	HCT	NNP
cord-005453-4057qib7	2890	15	)	)	-RRB-
cord-005453-4057qib7	2890	16	.	.	.
cord-005453-4057qib7	2891	1	with	with	IN
cord-005453-4057qib7	2891	2	variable	variable	JJ
cord-005453-4057qib7	2891	3	possible	possible	JJ
cord-005453-4057qib7	2891	4	causes	cause	NNS
cord-005453-4057qib7	2891	5	,	,	,
cord-005453-4057qib7	2891	6	such	such	JJ
cord-005453-4057qib7	2891	7	as	as	IN
cord-005453-4057qib7	2891	8	drug	drug	NN
cord-005453-4057qib7	2891	9	side	side	NN
cord-005453-4057qib7	2891	10	effects	effect	NNS
cord-005453-4057qib7	2891	11	,	,	,
cord-005453-4057qib7	2891	12	infections	infection	NNS
cord-005453-4057qib7	2891	13	,	,	,
cord-005453-4057qib7	2891	14	poor	poor	JJ
cord-005453-4057qib7	2891	15	graft	graft	NN
cord-005453-4057qib7	2891	16	function	function	NN
cord-005453-4057qib7	2891	17	,	,	,
cord-005453-4057qib7	2891	18	Graft	Graft	NNP
cord-005453-4057qib7	2891	19	vs	vs	IN
cord-005453-4057qib7	2891	20	Host	Host	NNP
cord-005453-4057qib7	2891	21	disease	disease	NN
cord-005453-4057qib7	2891	22	(	(	-LRB-
cord-005453-4057qib7	2891	23	GvHD	GvHD	NNP
cord-005453-4057qib7	2891	24	)	)	-RRB-
cord-005453-4057qib7	2891	25	and	and	CC
cord-005453-4057qib7	2891	26	immune	immune	JJ
cord-005453-4057qib7	2891	27	mediated	mediate	VBN
cord-005453-4057qib7	2891	28	.	.	.
cord-005453-4057qib7	2892	1	The	the	DT
cord-005453-4057qib7	2892	2	purpose	purpose	NN
cord-005453-4057qib7	2892	3	of	of	IN
cord-005453-4057qib7	2892	4	this	this	DT
cord-005453-4057qib7	2892	5	study	study	NN
cord-005453-4057qib7	2892	6	was	be	VBD
cord-005453-4057qib7	2892	7	to	to	TO
cord-005453-4057qib7	2892	8	evaluate	evaluate	VB
cord-005453-4057qib7	2892	9	the	the	DT
cord-005453-4057qib7	2892	10	efficacy	efficacy	NN
cord-005453-4057qib7	2892	11	of	of	IN
cord-005453-4057qib7	2892	12	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2892	13	,	,	,
cord-005453-4057qib7	2892	14	a	a	DT
cord-005453-4057qib7	2892	15	thrombopoietin	thrombopoietin	NNP
cord-005453-4057qib7	2892	16	receptor	receptor	NN
cord-005453-4057qib7	2892	17	agonist	agonist	NN
cord-005453-4057qib7	2892	18	,	,	,
cord-005453-4057qib7	2892	19	in	in	IN
cord-005453-4057qib7	2892	20	patients	patient	NNS
cord-005453-4057qib7	2892	21	with	with	IN
cord-005453-4057qib7	2892	22	prolonged	prolonged	JJ
cord-005453-4057qib7	2892	23	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2892	24	with	with	IN
cord-005453-4057qib7	2892	25	no	no	DT
cord-005453-4057qib7	2892	26	obvious	obvious	JJ
cord-005453-4057qib7	2892	27	cause	cause	NN
cord-005453-4057qib7	2892	28	after	after	IN
cord-005453-4057qib7	2892	29	allogeneic	allogeneic	NN
cord-005453-4057qib7	2892	30	transplantation	transplantation	NN
cord-005453-4057qib7	2892	31	.	.	.
cord-005453-4057qib7	2893	1	Methods	method	NNS
cord-005453-4057qib7	2893	2	:	:	:
cord-005453-4057qib7	2893	3	Retrospective	retrospective	JJ
cord-005453-4057qib7	2893	4	analysis	analysis	NN
cord-005453-4057qib7	2893	5	of	of	IN
cord-005453-4057qib7	2893	6	allo	allo	NN
cord-005453-4057qib7	2893	7	-	-	HYPH
cord-005453-4057qib7	2893	8	HCT	hct	NN
cord-005453-4057qib7	2893	9	patients	patient	NNS
cord-005453-4057qib7	2893	10	who	who	WP
cord-005453-4057qib7	2893	11	received	receive	VBD
cord-005453-4057qib7	2893	12	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2893	13	at	at	IN
cord-005453-4057qib7	2893	14	a	a	DT
cord-005453-4057qib7	2893	15	single	single	JJ
cord-005453-4057qib7	2893	16	BMT	BMT	NNP
cord-005453-4057qib7	2893	17	Unit	Unit	NNP
cord-005453-4057qib7	2893	18	between	between	IN
cord-005453-4057qib7	2893	19	November	November	NNP
cord-005453-4057qib7	2893	20	2015	2015	CD
cord-005453-4057qib7	2893	21	and	and	CC
cord-005453-4057qib7	2893	22	November	November	NNP
cord-005453-4057qib7	2893	23	2018	2018	CD
cord-005453-4057qib7	2893	24	.	.	.
cord-005453-4057qib7	2894	1	Romiplostim	Romiplostim	NNP
cord-005453-4057qib7	2894	2	was	be	VBD
cord-005453-4057qib7	2894	3	given	give	VBN
cord-005453-4057qib7	2894	4	because	because	IN
cord-005453-4057qib7	2894	5	of	of	IN
cord-005453-4057qib7	2894	6	prolonged	prolong	VBN
cord-005453-4057qib7	2894	7	(	(	-LRB-
cord-005453-4057qib7	2894	8	>	>	NFP
cord-005453-4057qib7	2894	9	3	3	CD
cord-005453-4057qib7	2894	10	weeks	week	NNS
cord-005453-4057qib7	2894	11	)	)	-RRB-
cord-005453-4057qib7	2894	12	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2894	13	(	(	-LRB-
cord-005453-4057qib7	2895	1	<	<	XX
cord-005453-4057qib7	2895	2	60,000	60,000	CD
cord-005453-4057qib7	2895	3	μL	μL	.
cord-005453-4057qib7	2895	4	)	)	-RRB-
cord-005453-4057qib7	2896	1	that	that	DT
cord-005453-4057qib7	2896	2	could	could	MD
cord-005453-4057qib7	2896	3	n't	not	RB
cord-005453-4057qib7	2896	4	be	be	VB
cord-005453-4057qib7	2896	5	explained	explain	VBN
cord-005453-4057qib7	2896	6	by	by	IN
cord-005453-4057qib7	2896	7	obvious	obvious	JJ
cord-005453-4057qib7	2896	8	causes	cause	NNS
cord-005453-4057qib7	2896	9	such	such	JJ
cord-005453-4057qib7	2896	10	as	as	IN
cord-005453-4057qib7	2896	11	administration	administration	NN
cord-005453-4057qib7	2896	12	of	of	IN
cord-005453-4057qib7	2896	13	drugs	drug	NNS
cord-005453-4057qib7	2896	14	(	(	-LRB-
cord-005453-4057qib7	2896	15	antibiotics	antibiotic	NNS
cord-005453-4057qib7	2896	16	/	/	SYM
cord-005453-4057qib7	2896	17	antivirals	antiviral	NNS
cord-005453-4057qib7	2896	18	)	)	-RRB-
cord-005453-4057qib7	2896	19	,	,	,
cord-005453-4057qib7	2896	20	infection	infection	NN
cord-005453-4057qib7	2896	21	or	or	CC
cord-005453-4057qib7	2896	22	GvHD	gvhd	NN
cord-005453-4057qib7	2896	23	.	.	.
cord-005453-4057qib7	2897	1	All	all	DT
cord-005453-4057qib7	2897	2	patients	patient	NNS
cord-005453-4057qib7	2897	3	were	be	VBD
cord-005453-4057qib7	2897	4	in	in	IN
cord-005453-4057qib7	2897	5	complete	complete	JJ
cord-005453-4057qib7	2897	6	remission	remission	NN
cord-005453-4057qib7	2897	7	and	and	CC
cord-005453-4057qib7	2897	8	had	have	VBD
cord-005453-4057qib7	2897	9	complete	complete	JJ
cord-005453-4057qib7	2897	10	chimerism	chimerism	NN
cord-005453-4057qib7	2897	11	.	.	.
cord-005453-4057qib7	2898	1	Response	response	NN
cord-005453-4057qib7	2898	2	to	to	IN
cord-005453-4057qib7	2898	3	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2898	4	treatment	treatment	NN
cord-005453-4057qib7	2898	5	was	be	VBD
cord-005453-4057qib7	2898	6	considered	consider	VBN
cord-005453-4057qib7	2898	7	transfusion	transfusion	NN
cord-005453-4057qib7	2898	8	independence	independence	NN
cord-005453-4057qib7	2898	9	or	or	CC
cord-005453-4057qib7	2899	1	PLT>80.000	PLT>80.000	NNP
cord-005453-4057qib7	2899	2	/	/	SYM
cord-005453-4057qib7	2899	3	μL.	μl.	JJ
cord-005453-4057qib7	2899	4	Results	result	NNS
cord-005453-4057qib7	2899	5	:	:	:
cord-005453-4057qib7	2900	1	In	in	IN
cord-005453-4057qib7	2900	2	total	total	JJ
cord-005453-4057qib7	2900	3	,	,	,
cord-005453-4057qib7	2900	4	19	19	CD
cord-005453-4057qib7	2900	5	patients	patient	NNS
cord-005453-4057qib7	2900	6	(	(	-LRB-
cord-005453-4057qib7	2900	7	median	median	NN
cord-005453-4057qib7	2900	8	45	45	CD
cord-005453-4057qib7	2900	9	years	year	NNS
cord-005453-4057qib7	2900	10	,	,	,
cord-005453-4057qib7	2900	11	19	19	CD
cord-005453-4057qib7	2900	12	-	-	SYM
cord-005453-4057qib7	2900	13	67	67	CD
cord-005453-4057qib7	2900	14	)	)	-RRB-
cord-005453-4057qib7	2900	15	received	receive	VBD
cord-005453-4057qib7	2900	16	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2900	17	.	.	.
cord-005453-4057qib7	2901	1	Patients	patient	NNS
cord-005453-4057qib7	2901	2	(	(	-LRB-
cord-005453-4057qib7	2901	3	10	10	CD
cord-005453-4057qib7	2901	4	male	male	NN
cord-005453-4057qib7	2901	5	,	,	,
cord-005453-4057qib7	2901	6	9	9	CD
cord-005453-4057qib7	2901	7	females	female	NNS
cord-005453-4057qib7	2901	8	)	)	-RRB-
cord-005453-4057qib7	2901	9	had	have	VBD
cord-005453-4057qib7	2901	10	AML	AML	NNP
cord-005453-4057qib7	2901	11	(	(	-LRB-
cord-005453-4057qib7	2901	12	10	10	CD
cord-005453-4057qib7	2901	13	pts	pt	NNS
cord-005453-4057qib7	2901	14	)	)	-RRB-
cord-005453-4057qib7	2901	15	,	,	,
cord-005453-4057qib7	2901	16	ALL	all	DT
cord-005453-4057qib7	2901	17	(	(	-LRB-
cord-005453-4057qib7	2901	18	8)	8)	NN
cord-005453-4057qib7	2901	19	,	,	,
cord-005453-4057qib7	2901	20	MDS	MDS	NNP
cord-005453-4057qib7	2901	21	(	(	-LRB-
cord-005453-4057qib7	2901	22	2	2	CD
cord-005453-4057qib7	2901	23	)	)	-RRB-
cord-005453-4057qib7	2901	24	or	or	CC
cord-005453-4057qib7	2901	25	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	2901	26	(	(	-LRB-
cord-005453-4057qib7	2901	27	1	1	CD
cord-005453-4057qib7	2901	28	)	)	-RRB-
cord-005453-4057qib7	2901	29	,	,	,
cord-005453-4057qib7	2901	30	received	receive	VBD
cord-005453-4057qib7	2901	31	a	a	DT
cord-005453-4057qib7	2901	32	myeloblative	myeloblative	NN
cord-005453-4057qib7	2901	33	(	(	-LRB-
cord-005453-4057qib7	2901	34	busiphex	busiphex	NN
cord-005453-4057qib7	2901	35	-	-	HYPH
cord-005453-4057qib7	2901	36	based	base	VBN
cord-005453-4057qib7	2901	37	:	:	:
cord-005453-4057qib7	2901	38	16	16	CD
cord-005453-4057qib7	2901	39	,	,	,
cord-005453-4057qib7	2901	40	TBI	TBI	NNP
cord-005453-4057qib7	2901	41	-	-	HYPH
cord-005453-4057qib7	2901	42	based:1	based:1	NNP
cord-005453-4057qib7	2901	43	)	)	-RRB-
cord-005453-4057qib7	2901	44	or	or	CC
cord-005453-4057qib7	2901	45	RIC	RIC	NNP
cord-005453-4057qib7	2901	46	(	(	-LRB-
cord-005453-4057qib7	2901	47	2	2	CD
cord-005453-4057qib7	2901	48	)	)	-RRB-
cord-005453-4057qib7	2901	49	conditioning	conditioning	NN
cord-005453-4057qib7	2901	50	and	and	CC
cord-005453-4057qib7	2901	51	were	be	VBD
cord-005453-4057qib7	2901	52	transplanted	transplant	VBN
cord-005453-4057qib7	2901	53	from	from	IN
cord-005453-4057qib7	2901	54	a	a	DT
cord-005453-4057qib7	2901	55	sibling	sibling	NN
cord-005453-4057qib7	2901	56	(	(	-LRB-
cord-005453-4057qib7	2901	57	5	5	CD
cord-005453-4057qib7	2901	58	)	)	-RRB-
cord-005453-4057qib7	2901	59	,	,	,
cord-005453-4057qib7	2901	60	VUD	VUD	NNP
cord-005453-4057qib7	2901	61	(	(	-LRB-
cord-005453-4057qib7	2901	62	11	11	CD
cord-005453-4057qib7	2901	63	)	)	-RRB-
cord-005453-4057qib7	2901	64	or	or	CC
cord-005453-4057qib7	2901	65	haploidentical	haploidentical	JJ
cord-005453-4057qib7	2901	66	(	(	-LRB-
cord-005453-4057qib7	2901	67	3	3	CD
cord-005453-4057qib7	2901	68	)	)	-RRB-
cord-005453-4057qib7	2901	69	donor	donor	NN
cord-005453-4057qib7	2901	70	with	with	IN
cord-005453-4057qib7	2901	71	PBSC	PBSC	NNP
cord-005453-4057qib7	2901	72	(	(	-LRB-
cord-005453-4057qib7	2901	73	16	16	CD
cord-005453-4057qib7	2901	74	)	)	-RRB-
cord-005453-4057qib7	2901	75	or	or	CC
cord-005453-4057qib7	2901	76	BM	BM	NNP
cord-005453-4057qib7	2901	77	(	(	-LRB-
cord-005453-4057qib7	2901	78	3	3	CD
cord-005453-4057qib7	2901	79	)	)	-RRB-
cord-005453-4057qib7	2901	80	.	.	.
cord-005453-4057qib7	2902	1	All	all	DT
cord-005453-4057qib7	2902	2	patients	patient	NNS
cord-005453-4057qib7	2902	3	revealed	reveal	VBD
cord-005453-4057qib7	2902	4	primary	primary	JJ
cord-005453-4057qib7	2902	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	2902	6	(	(	-LRB-
cord-005453-4057qib7	2902	7	median	median	NN
cord-005453-4057qib7	2902	8	14	14	CD
cord-005453-4057qib7	2902	9	days	day	NNS
cord-005453-4057qib7	2902	10	,	,	,
cord-005453-4057qib7	2902	11	range	range	VBP
cord-005453-4057qib7	2902	12	10	10	CD
cord-005453-4057qib7	2902	13	-	-	SYM
cord-005453-4057qib7	2902	14	19	19	CD
cord-005453-4057qib7	2902	15	)	)	-RRB-
cord-005453-4057qib7	2902	16	and	and	CC
cord-005453-4057qib7	2902	17	>	>	XX
cord-005453-4057qib7	2903	1	20.000	20.000	CD
cord-005453-4057qib7	2903	2	/	/	SYM
cord-005453-4057qib7	2903	3	μL	μL	NNP
cord-005453-4057qib7	2903	4	platelet	platelet	NN
cord-005453-4057qib7	2903	5	(	(	-LRB-
cord-005453-4057qib7	2903	6	13	13	CD
cord-005453-4057qib7	2903	7	days	day	NNS
cord-005453-4057qib7	2903	8	,	,	,
cord-005453-4057qib7	2903	9	7	7	CD
cord-005453-4057qib7	2903	10	-	-	SYM
cord-005453-4057qib7	2903	11	31	31	CD
cord-005453-4057qib7	2903	12	)	)	-RRB-
cord-005453-4057qib7	2903	13	engraftment	engraftment	NN
cord-005453-4057qib7	2903	14	.	.	.
cord-005453-4057qib7	2904	1	Romiplostim	Romiplostim	NNP
cord-005453-4057qib7	2904	2	was	be	VBD
cord-005453-4057qib7	2904	3	started	start	VBN
cord-005453-4057qib7	2904	4	at	at	IN
cord-005453-4057qib7	2904	5	median	median	JJ
cord-005453-4057qib7	2904	6	day	day	NN
cord-005453-4057qib7	2904	7	+104	+104	NNP
cord-005453-4057qib7	2904	8	(	(	-LRB-
cord-005453-4057qib7	2904	9	range	range	NN
cord-005453-4057qib7	2904	10	58	58	CD
cord-005453-4057qib7	2904	11	-	-	SYM
cord-005453-4057qib7	2904	12	419	419	CD
cord-005453-4057qib7	2904	13	)	)	-RRB-
cord-005453-4057qib7	2904	14	with	with	IN
cord-005453-4057qib7	2904	15	a	a	DT
cord-005453-4057qib7	2904	16	median	median	NN
cord-005453-4057qib7	2904	17	dose	dose	NN
cord-005453-4057qib7	2904	18	5	5	CD
cord-005453-4057qib7	2904	19	μg	μg	NN
cord-005453-4057qib7	2904	20	/	/	SYM
cord-005453-4057qib7	2904	21	kg	kg	NNP
cord-005453-4057qib7	2904	22	(	(	-LRB-
cord-005453-4057qib7	2904	23	1	1	CD
cord-005453-4057qib7	2904	24	)	)	-RRB-
cord-005453-4057qib7	2904	25	(	(	-LRB-
cord-005453-4057qib7	2904	26	2	2	LS
cord-005453-4057qib7	2904	27	)	)	-RRB-
cord-005453-4057qib7	2904	28	(	(	-LRB-
cord-005453-4057qib7	2904	29	3	3	LS
cord-005453-4057qib7	2904	30	)	)	-RRB-
cord-005453-4057qib7	2904	31	(	(	-LRB-
cord-005453-4057qib7	2904	32	4	4	LS
cord-005453-4057qib7	2904	33	)	)	-RRB-
cord-005453-4057qib7	2904	34	(	(	-LRB-
cord-005453-4057qib7	2904	35	5	5	CD
cord-005453-4057qib7	2904	36	)	)	-RRB-
cord-005453-4057qib7	2904	37	.	.	.
cord-005453-4057qib7	2905	1	The	the	DT
cord-005453-4057qib7	2905	2	median	median	JJ
cord-005453-4057qib7	2905	3	platelet	platelet	NN
cord-005453-4057qib7	2905	4	count	count	NN
cord-005453-4057qib7	2905	5	before	before	IN
cord-005453-4057qib7	2905	6	commencement	commencement	NN
cord-005453-4057qib7	2905	7	of	of	IN
cord-005453-4057qib7	2905	8	treatment	treatment	NN
cord-005453-4057qib7	2905	9	with	with	IN
cord-005453-4057qib7	2905	10	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2905	11	was	be	VBD
cord-005453-4057qib7	2905	12	24.000/	24.000/	CD
cord-005453-4057qib7	2906	1	μL	μL	.
cord-005453-4057qib7	2907	1	(	(	-LRB-
cord-005453-4057qib7	2907	2	range	range	NNP
cord-005453-4057qib7	2907	3	12.000	12.000	CD
cord-005453-4057qib7	2907	4	-	-	SYM
cord-005453-4057qib7	2907	5	57.000	57.000	CD
cord-005453-4057qib7	2907	6	)	)	-RRB-
cord-005453-4057qib7	2907	7	and	and	CC
cord-005453-4057qib7	2907	8	10	10	CD
cord-005453-4057qib7	2907	9	them	-PRON-	PRP
cord-005453-4057qib7	2907	10	(	(	-LRB-
cord-005453-4057qib7	2907	11	59	59	CD
cord-005453-4057qib7	2907	12	%	%	NN
cord-005453-4057qib7	2907	13	)	)	-RRB-
cord-005453-4057qib7	2907	14	were	be	VBD
cord-005453-4057qib7	2907	15	transfusion	transfusion	NN
cord-005453-4057qib7	2907	16	-	-	HYPH
cord-005453-4057qib7	2907	17	dependent	dependent	JJ
cord-005453-4057qib7	2907	18	.	.	.
cord-005453-4057qib7	2908	1	In	in	IN
cord-005453-4057qib7	2908	2	total	total	JJ
cord-005453-4057qib7	2908	3	14/17	14/17	CD
cord-005453-4057qib7	2908	4	(	(	-LRB-
cord-005453-4057qib7	2908	5	82	82	CD
cord-005453-4057qib7	2908	6	%	%	NN
cord-005453-4057qib7	2908	7	)	)	-RRB-
cord-005453-4057qib7	2908	8	patients	patient	NNS
cord-005453-4057qib7	2908	9	responded	respond	VBD
cord-005453-4057qib7	2908	10	to	to	IN
cord-005453-4057qib7	2908	11	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2908	12	treatment	treatment	NN
cord-005453-4057qib7	2908	13	.	.	.
cord-005453-4057qib7	2909	1	Eight	eight	CD
cord-005453-4057qib7	2909	2	out	out	IN
cord-005453-4057qib7	2909	3	of	of	IN
cord-005453-4057qib7	2909	4	the	the	DT
cord-005453-4057qib7	2909	5	10	10	CD
cord-005453-4057qib7	2909	6	(	(	-LRB-
cord-005453-4057qib7	2909	7	80	80	CD
cord-005453-4057qib7	2909	8	%	%	NN
cord-005453-4057qib7	2909	9	)	)	-RRB-
cord-005453-4057qib7	2909	10	transfusion	transfusion	NN
cord-005453-4057qib7	2909	11	dependent	dependent	JJ
cord-005453-4057qib7	2909	12	patients	patient	NNS
cord-005453-4057qib7	2909	13	responded	respond	VBD
cord-005453-4057qib7	2909	14	to	to	IN
cord-005453-4057qib7	2909	15	the	the	DT
cord-005453-4057qib7	2909	16	administration	administration	NN
cord-005453-4057qib7	2909	17	of	of	IN
cord-005453-4057qib7	2909	18	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2909	19	.	.	.
cord-005453-4057qib7	2910	1	Six	six	CD
cord-005453-4057qib7	2910	2	out	out	IN
cord-005453-4057qib7	2910	3	of	of	IN
cord-005453-4057qib7	2910	4	the	the	DT
cord-005453-4057qib7	2910	5	7	7	CD
cord-005453-4057qib7	2910	6	patients	patient	NNS
cord-005453-4057qib7	2910	7	(	(	-LRB-
cord-005453-4057qib7	2910	8	86	86	CD
cord-005453-4057qib7	2910	9	%	%	NN
cord-005453-4057qib7	2910	10	)	)	-RRB-
cord-005453-4057qib7	2910	11	who	who	WP
cord-005453-4057qib7	2910	12	were	be	VBD
cord-005453-4057qib7	2910	13	transfusion	transfusion	NN
cord-005453-4057qib7	2910	14	independent	independent	JJ
cord-005453-4057qib7	2910	15	at	at	IN
cord-005453-4057qib7	2910	16	romiplostin	romiplostin	NNP
cord-005453-4057qib7	2910	17	initiation	initiation	NNP
cord-005453-4057qib7	2910	18	(	(	-LRB-
cord-005453-4057qib7	2910	19	PLT	PLT	NNP
cord-005453-4057qib7	2910	20	median	median	NN
cord-005453-4057qib7	2910	21	28.000	28.000	CD
cord-005453-4057qib7	2911	1	/μL	/μL	NFP
cord-005453-4057qib7	2911	2	,	,	,
cord-005453-4057qib7	2911	3	range	range	VBP
cord-005453-4057qib7	2911	4	19.000	19.000	CD
cord-005453-4057qib7	2911	5	-	-	HYPH
cord-005453-4057qib7	2911	6	56.000	56.000	CD
cord-005453-4057qib7	2911	7	)	)	-RRB-
cord-005453-4057qib7	2911	8	responded	respond	VBD
cord-005453-4057qib7	2911	9	.	.	.
cord-005453-4057qib7	2912	1	The	the	DT
cord-005453-4057qib7	2912	2	median	median	JJ
cord-005453-4057qib7	2912	3	duration	duration	NN
cord-005453-4057qib7	2912	4	of	of	IN
cord-005453-4057qib7	2912	5	treatment	treatment	NN
cord-005453-4057qib7	2912	6	was	be	VBD
cord-005453-4057qib7	2912	7	74	74	CD
cord-005453-4057qib7	2912	8	days	day	NNS
cord-005453-4057qib7	2912	9	(	(	-LRB-
cord-005453-4057qib7	2912	10	15	15	CD
cord-005453-4057qib7	2912	11	-	-	SYM
cord-005453-4057qib7	2912	12	253	253	CD
cord-005453-4057qib7	2912	13	)	)	-RRB-
cord-005453-4057qib7	2912	14	and	and	CC
cord-005453-4057qib7	2912	15	the	the	DT
cord-005453-4057qib7	2912	16	median	median	NN
cord-005453-4057qib7	2912	17	follow	follow	VBP
cord-005453-4057qib7	2912	18	up	up	RP
cord-005453-4057qib7	2912	19	from	from	IN
cord-005453-4057qib7	2912	20	the	the	DT
cord-005453-4057qib7	2912	21	commencement	commencement	NN
cord-005453-4057qib7	2912	22	of	of	IN
cord-005453-4057qib7	2912	23	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2912	24	was	be	VBD
cord-005453-4057qib7	2912	25	177	177	CD
cord-005453-4057qib7	2912	26	days	day	NNS
cord-005453-4057qib7	2912	27	(	(	-LRB-
cord-005453-4057qib7	2912	28	15	15	CD
cord-005453-4057qib7	2912	29	-	-	SYM
cord-005453-4057qib7	2912	30	1080	1080	CD
cord-005453-4057qib7	2912	31	)	)	-RRB-
cord-005453-4057qib7	2912	32	.	.	.
cord-005453-4057qib7	2913	1	Three	three	CD
cord-005453-4057qib7	2913	2	out	out	IN
cord-005453-4057qib7	2913	3	of	of	IN
cord-005453-4057qib7	2913	4	17	17	CD
cord-005453-4057qib7	2913	5	(	(	-LRB-
cord-005453-4057qib7	2913	6	18	18	CD
cord-005453-4057qib7	2913	7	%	%	NN
cord-005453-4057qib7	2913	8	)	)	-RRB-
cord-005453-4057qib7	2913	9	patients	patient	NNS
cord-005453-4057qib7	2913	10	experienced	experience	VBD
cord-005453-4057qib7	2913	11	relapse	relapse	NN
cord-005453-4057qib7	2913	12	of	of	IN
cord-005453-4057qib7	2913	13	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2913	14	after	after	IN
cord-005453-4057qib7	2913	15	discontinuation	discontinuation	NN
cord-005453-4057qib7	2913	16	of	of	IN
cord-005453-4057qib7	2913	17	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2913	18	and	and	CC
cord-005453-4057qib7	2913	19	re	re	NN
cord-005453-4057qib7	2913	20	-	-	NN
cord-005453-4057qib7	2913	21	initiation	initiation	NN
cord-005453-4057qib7	2913	22	of	of	IN
cord-005453-4057qib7	2913	23	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2913	24	was	be	VBD
cord-005453-4057qib7	2913	25	commenced	commence	VBN
cord-005453-4057qib7	2913	26	in	in	IN
cord-005453-4057qib7	2913	27	all	all	DT
cord-005453-4057qib7	2913	28	of	of	IN
cord-005453-4057qib7	2913	29	them	-PRON-	PRP
cord-005453-4057qib7	2913	30	,	,	,
cord-005453-4057qib7	2913	31	of	of	IN
cord-005453-4057qib7	2913	32	which	which	WDT
cord-005453-4057qib7	2913	33	2	2	CD
cord-005453-4057qib7	2913	34	responded	respond	VBD
cord-005453-4057qib7	2913	35	and	and	CC
cord-005453-4057qib7	2913	36	1	1	CD
cord-005453-4057qib7	2913	37	did	do	VBD
cord-005453-4057qib7	2913	38	n't	not	RB
cord-005453-4057qib7	2913	39	.	.	.
cord-005453-4057qib7	2914	1	The	the	DT
cord-005453-4057qib7	2914	2	administration	administration	NN
cord-005453-4057qib7	2914	3	of	of	IN
cord-005453-4057qib7	2914	4	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2914	5	was	be	VBD
cord-005453-4057qib7	2914	6	done	do	VBN
cord-005453-4057qib7	2914	7	on	on	IN
cord-005453-4057qib7	2914	8	an	an	DT
cord-005453-4057qib7	2914	9	external	external	JJ
cord-005453-4057qib7	2914	10	basis	basis	NN
cord-005453-4057qib7	2914	11	and	and	CC
cord-005453-4057qib7	2914	12	was	be	VBD
cord-005453-4057qib7	2914	13	well	well	RB
cord-005453-4057qib7	2914	14	tolerated	tolerate	VBN
cord-005453-4057qib7	2914	15	by	by	IN
cord-005453-4057qib7	2914	16	the	the	DT
cord-005453-4057qib7	2914	17	patients	patient	NNS
cord-005453-4057qib7	2914	18	.	.	.
cord-005453-4057qib7	2915	1	Two	two	CD
cord-005453-4057qib7	2915	2	patients	patient	NNS
cord-005453-4057qib7	2915	3	experienced	experience	VBD
cord-005453-4057qib7	2915	4	GvHD	GvHD	NNP
cord-005453-4057qib7	2915	5	during	during	IN
cord-005453-4057qib7	2915	6	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2915	7	treatment	treatment	NN
cord-005453-4057qib7	2915	8	(	(	-LRB-
cord-005453-4057qib7	2915	9	both	both	DT
cord-005453-4057qib7	2915	10	patients	patient	NNS
cord-005453-4057qib7	2915	11	transplanted	transplant	VBD
cord-005453-4057qib7	2915	12	from	from	IN
cord-005453-4057qib7	2915	13	7/8	7/8	CD
cord-005453-4057qib7	2915	14	unrelated	unrelated	JJ
cord-005453-4057qib7	2915	15	donor	donor	NN
cord-005453-4057qib7	2915	16	,	,	,
cord-005453-4057qib7	2915	17	25	25	CD
cord-005453-4057qib7	2915	18	and	and	CC
cord-005453-4057qib7	2915	19	42	42	CD
cord-005453-4057qib7	2915	20	days	day	NNS
cord-005453-4057qib7	2915	21	after	after	IN
cord-005453-4057qib7	2915	22	initiation	initiation	NN
cord-005453-4057qib7	2915	23	treatment	treatment	NN
cord-005453-4057qib7	2915	24	with	with	IN
cord-005453-4057qib7	2915	25	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2915	26	)	)	-RRB-
cord-005453-4057qib7	2915	27	.	.	.
cord-005453-4057qib7	2916	1	3/19	3/19	CD
cord-005453-4057qib7	2916	2	patients	patient	NNS
cord-005453-4057qib7	2916	3	interrupted	interrupt	VBD
cord-005453-4057qib7	2916	4	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2916	5	due	due	IN
cord-005453-4057qib7	2916	6	to	to	IN
cord-005453-4057qib7	2916	7	disease	disease	NN
cord-005453-4057qib7	2916	8	relapse	relapse	VB
cord-005453-4057qib7	2916	9	.	.	.
cord-005453-4057qib7	2917	1	11/19	11/19	CD
cord-005453-4057qib7	2917	2	patients	patient	NNS
cord-005453-4057qib7	2917	3	receiving	receive	VBG
cord-005453-4057qib7	2917	4	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2917	5	are	be	VBP
cord-005453-4057qib7	2917	6	alive	alive	JJ
cord-005453-4057qib7	2917	7	in	in	IN
cord-005453-4057qib7	2917	8	complete	complete	JJ
cord-005453-4057qib7	2917	9	remission	remission	NN
cord-005453-4057qib7	2917	10	and	and	CC
cord-005453-4057qib7	2917	11	8	8	CD
cord-005453-4057qib7	2917	12	died	die	VBD
cord-005453-4057qib7	2917	13	(	(	-LRB-
cord-005453-4057qib7	2917	14	3	3	CD
cord-005453-4057qib7	2917	15	due	due	JJ
cord-005453-4057qib7	2917	16	to	to	IN
cord-005453-4057qib7	2917	17	relapse	relapse	NN
cord-005453-4057qib7	2917	18	,	,	,
cord-005453-4057qib7	2917	19	and	and	CC
cord-005453-4057qib7	2917	20	5	5	CD
cord-005453-4057qib7	2917	21	due	due	IN
cord-005453-4057qib7	2917	22	to	to	IN
cord-005453-4057qib7	2917	23	TRM	TRM	NNP
cord-005453-4057qib7	2917	24	)	)	-RRB-
cord-005453-4057qib7	2917	25	.	.	.
cord-005453-4057qib7	2918	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2918	2	:	:	:
cord-005453-4057qib7	2919	1	We	-PRON-	PRP
cord-005453-4057qib7	2919	2	present	present	VBP
cord-005453-4057qib7	2919	3	high	high	JJ
cord-005453-4057qib7	2919	4	response	response	NN
cord-005453-4057qib7	2919	5	rates	rate	NNS
cord-005453-4057qib7	2919	6	to	to	IN
cord-005453-4057qib7	2919	7	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2919	8	in	in	IN
cord-005453-4057qib7	2919	9	patients	patient	NNS
cord-005453-4057qib7	2919	10	with	with	IN
cord-005453-4057qib7	2919	11	prolonged	prolonged	JJ
cord-005453-4057qib7	2919	12	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	2919	13	after	after	IN
cord-005453-4057qib7	2919	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	2919	15	transplantation	transplantation	NN
cord-005453-4057qib7	2919	16	.	.	.
cord-005453-4057qib7	2920	1	In	in	IN
cord-005453-4057qib7	2920	2	this	this	DT
cord-005453-4057qib7	2920	3	retrospective	retrospective	JJ
cord-005453-4057qib7	2920	4	study	study	NN
cord-005453-4057qib7	2920	5	there	there	EX
cord-005453-4057qib7	2920	6	were	be	VBD
cord-005453-4057qib7	2920	7	no	no	DT
cord-005453-4057qib7	2920	8	side	side	NN
cord-005453-4057qib7	2920	9	effects	effect	NNS
cord-005453-4057qib7	2920	10	from	from	IN
cord-005453-4057qib7	2920	11	the	the	DT
cord-005453-4057qib7	2920	12	administration	administration	NN
cord-005453-4057qib7	2920	13	of	of	IN
cord-005453-4057qib7	2920	14	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2920	15	.	.	.
cord-005453-4057qib7	2921	1	However	however	RB
cord-005453-4057qib7	2921	2	,	,	,
cord-005453-4057qib7	2921	3	the	the	DT
cord-005453-4057qib7	2921	4	administration	administration	NN
cord-005453-4057qib7	2921	5	of	of	IN
cord-005453-4057qib7	2921	6	romiplostim	romiplostim	NNP
cord-005453-4057qib7	2921	7	after	after	IN
cord-005453-4057qib7	2921	8	allo	allo	NN
cord-005453-4057qib7	2921	9	-	-	HYPH
cord-005453-4057qib7	2921	10	HCT	hct	NN
cord-005453-4057qib7	2921	11	should	should	MD
cord-005453-4057qib7	2921	12	be	be	VB
cord-005453-4057qib7	2921	13	controlled	control	VBN
cord-005453-4057qib7	2921	14	in	in	IN
cord-005453-4057qib7	2921	15	prospective	prospective	JJ
cord-005453-4057qib7	2921	16	trials	trial	NNS
cord-005453-4057qib7	2921	17	.	.	.
cord-005453-4057qib7	2922	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2923	1	We	-PRON-	PRP
cord-005453-4057qib7	2923	2	report	report	VBP
cord-005453-4057qib7	2923	3	a	a	DT
cord-005453-4057qib7	2923	4	single	single	JJ
cord-005453-4057qib7	2923	5	-	-	HYPH
cord-005453-4057qib7	2923	6	center	center	NN
cord-005453-4057qib7	2923	7	analysis	analysis	NN
cord-005453-4057qib7	2923	8	of	of	IN
cord-005453-4057qib7	2923	9	29	29	CD
cord-005453-4057qib7	2923	10	adult	adult	NN
cord-005453-4057qib7	2923	11	patients	patient	NNS
cord-005453-4057qib7	2923	12	(	(	-LRB-
cord-005453-4057qib7	2923	13	median	median	JJ
cord-005453-4057qib7	2923	14	age	age	NN
cord-005453-4057qib7	2923	15	22	22	CD
cord-005453-4057qib7	2923	16	years	year	NNS
cord-005453-4057qib7	2923	17	,	,	,
cord-005453-4057qib7	2923	18	range	range	VBP
cord-005453-4057qib7	2923	19	18	18	CD
cord-005453-4057qib7	2923	20	-	-	SYM
cord-005453-4057qib7	2923	21	57	57	CD
cord-005453-4057qib7	2923	22	,	,	,
cord-005453-4057qib7	2923	23	M	M	NNP
cord-005453-4057qib7	2923	24	/	/	SYM
cord-005453-4057qib7	2923	25	F	F	NNP
cord-005453-4057qib7	2923	26	13/16	13/16	CD
cord-005453-4057qib7	2923	27	)	)	-RRB-
cord-005453-4057qib7	2923	28	,	,	,
cord-005453-4057qib7	2923	29	receiving	receive	VBG
cord-005453-4057qib7	2923	30	TPO	TPO	NNP
cord-005453-4057qib7	2923	31	agonists	agonist	NNS
cord-005453-4057qib7	2923	32	for	for	IN
cord-005453-4057qib7	2923	33	isolated	isolate	VBN
cord-005453-4057qib7	2923	34	severe	severe	JJ
cord-005453-4057qib7	2923	35	thrombocytopenia	thrombocytopenia	NNS
cord-005453-4057qib7	2923	36	(	(	-LRB-
cord-005453-4057qib7	2923	37	n=7	n=7	NNS
cord-005453-4057qib7	2923	38	)	)	-RRB-
cord-005453-4057qib7	2923	39	and	and	CC
cord-005453-4057qib7	2924	1	sPGF	sPGF	NNP
cord-005453-4057qib7	2924	2	(	(	-LRB-
cord-005453-4057qib7	2924	3	n=22	n=22	NNP
cord-005453-4057qib7	2924	4	)	)	-RRB-
cord-005453-4057qib7	2924	5	after	after	IN
cord-005453-4057qib7	2924	6	allo	allo	NN
cord-005453-4057qib7	2924	7	-	-	HYPH
cord-005453-4057qib7	2924	8	HSCT	HSCT	NNP
cord-005453-4057qib7	2924	9	.	.	.
cord-005453-4057qib7	2925	1	Primary	primary	JJ
cord-005453-4057qib7	2925	2	diagnoses	diagnosis	NNS
cord-005453-4057qib7	2925	3	were	be	VBD
cord-005453-4057qib7	2925	4	AML	AML	NNP
cord-005453-4057qib7	2925	5	(	(	-LRB-
cord-005453-4057qib7	2925	6	10	10	CD
cord-005453-4057qib7	2925	7	)	)	-RRB-
cord-005453-4057qib7	2925	8	,	,	,
cord-005453-4057qib7	2925	9	ALL	all	DT
cord-005453-4057qib7	2925	10	(	(	-LRB-
cord-005453-4057qib7	2925	11	6	6	CD
cord-005453-4057qib7	2925	12	)	)	-RRB-
cord-005453-4057qib7	2925	13	,	,	,
cord-005453-4057qib7	2925	14	MDS	MDS	NNP
cord-005453-4057qib7	2925	15	(	(	-LRB-
cord-005453-4057qib7	2925	16	7	7	CD
cord-005453-4057qib7	2925	17	)	)	-RRB-
cord-005453-4057qib7	2925	18	,	,	,
cord-005453-4057qib7	2925	19	PMF	PMF	NNP
cord-005453-4057qib7	2925	20	(	(	-LRB-
cord-005453-4057qib7	2925	21	4	4	CD
cord-005453-4057qib7	2925	22	)	)	-RRB-
cord-005453-4057qib7	2925	23	,	,	,
cord-005453-4057qib7	2925	24	MDS	MDS	NNP
cord-005453-4057qib7	2925	25	/	/	SYM
cord-005453-4057qib7	2925	26	MPN	MPN	NNP
cord-005453-4057qib7	2925	27	(	(	-LRB-
cord-005453-4057qib7	2925	28	4	4	CD
cord-005453-4057qib7	2925	29	)	)	-RRB-
cord-005453-4057qib7	2925	30	,	,	.
cord-005453-4057qib7	2926	1	SAA	SAA	NNP
cord-005453-4057qib7	2926	2	(	(	-LRB-
cord-005453-4057qib7	2926	3	4	4	CD
cord-005453-4057qib7	2926	4	)	)	-RRB-
cord-005453-4057qib7	2926	5	,	,	,
cord-005453-4057qib7	2926	6	CML	CML	NNP
cord-005453-4057qib7	2926	7	(	(	-LRB-
cord-005453-4057qib7	2926	8	1	1	CD
cord-005453-4057qib7	2926	9	)	)	-RRB-
cord-005453-4057qib7	2926	10	,	,	,
cord-005453-4057qib7	2926	11	NHL	NHL	NNP
cord-005453-4057qib7	2926	12	(	(	-LRB-
cord-005453-4057qib7	2926	13	1	1	CD
cord-005453-4057qib7	2926	14	)	)	-RRB-
cord-005453-4057qib7	2926	15	.	.	.
cord-005453-4057qib7	2927	1	Severe	severe	JJ
cord-005453-4057qib7	2927	2	PGF	PGF	NNP
cord-005453-4057qib7	2927	3	was	be	VBD
cord-005453-4057qib7	2927	4	defined	define	VBN
cord-005453-4057qib7	2927	5	as	as	IN
cord-005453-4057qib7	2927	6	cytopenia	cytopenia	NNP
cord-005453-4057qib7	2927	7	in	in	IN
cord-005453-4057qib7	2927	8	≥	≥	CD
cord-005453-4057qib7	2927	9	2	2	CD
cord-005453-4057qib7	2927	10	lineages	lineage	NNS
cord-005453-4057qib7	2927	11	(	(	-LRB-
cord-005453-4057qib7	2927	12	platelet	platelet	NN
cord-005453-4057qib7	2927	13	<	<	XX
cord-005453-4057qib7	2927	14	20	20	CD
cord-005453-4057qib7	2927	15	×	×	NN
cord-005453-4057qib7	2927	16	10	10	CD
cord-005453-4057qib7	2927	17	9	9	CD
cord-005453-4057qib7	2927	18	/L	/l	CD
cord-005453-4057qib7	2927	19	,	,	,
cord-005453-4057qib7	2927	20	ANC	ANC	NNP
cord-005453-4057qib7	2927	21	<	<	XX
cord-005453-4057qib7	2927	22	0.5	0.5	CD
cord-005453-4057qib7	2927	23	×	×	CD
cord-005453-4057qib7	2927	24	10	10	CD
cord-005453-4057qib7	2927	25	9	9	CD
cord-005453-4057qib7	2927	26	/L	/l	CD
cord-005453-4057qib7	2927	27	,	,	,
cord-005453-4057qib7	2927	28	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	2927	29	<	<	XX
cord-005453-4057qib7	2927	30	70	70	CD
cord-005453-4057qib7	2927	31	g	g	NN
cord-005453-4057qib7	2927	32	/	/	SYM
cord-005453-4057qib7	2927	33	L	l	NN
cord-005453-4057qib7	2927	34	any	any	DT
cord-005453-4057qib7	2927	35	time	time	NN
cord-005453-4057qib7	2927	36	after	after	IN
cord-005453-4057qib7	2927	37	sustained	sustained	JJ
cord-005453-4057qib7	2927	38	engraftment	engraftment	NN
cord-005453-4057qib7	2927	39	)	)	-RRB-
cord-005453-4057qib7	2927	40	,	,	,
cord-005453-4057qib7	2927	41	full	full	JJ
cord-005453-4057qib7	2927	42	or	or	CC
cord-005453-4057qib7	2927	43	stable	stable	JJ
cord-005453-4057qib7	2927	44	mixed	mixed	JJ
cord-005453-4057qib7	2927	45	donor	donor	NN
cord-005453-4057qib7	2927	46	chimerism	chimerism	NN
cord-005453-4057qib7	2927	47	>	>	XX
cord-005453-4057qib7	2927	48	90	90	CD
cord-005453-4057qib7	2927	49	%	%	NN
cord-005453-4057qib7	2927	50	and	and	CC
cord-005453-4057qib7	2927	51	no	no	DT
cord-005453-4057qib7	2927	52	signs	sign	NNS
cord-005453-4057qib7	2927	53	of	of	IN
cord-005453-4057qib7	2927	54	relapse	relapse	NN
cord-005453-4057qib7	2927	55	.	.	.
cord-005453-4057qib7	2928	1	Median	median	JJ
cord-005453-4057qib7	2928	2	dose	dose	NN
cord-005453-4057qib7	2928	3	of	of	IN
cord-005453-4057qib7	2928	4	romiplostim	romiplostim	NNS
cord-005453-4057qib7	2928	5	was	be	VBD
cord-005453-4057qib7	2928	6	5	5	CD
cord-005453-4057qib7	2929	1	(	(	-LRB-
cord-005453-4057qib7	2929	2	range	range	NN
cord-005453-4057qib7	2929	3	,	,	,
cord-005453-4057qib7	2929	4	3	3	CD
cord-005453-4057qib7	2929	5	-	-	SYM
cord-005453-4057qib7	2929	6	5	5	CD
cord-005453-4057qib7	2929	7	)	)	-RRB-
cord-005453-4057qib7	2929	8	mcg	mcg	NN
cord-005453-4057qib7	2929	9	/	/	SYM
cord-005453-4057qib7	2929	10	kg	kg	NNP
cord-005453-4057qib7	2929	11	weekly	weekly	NNP
cord-005453-4057qib7	2929	12	,	,	,
cord-005453-4057qib7	2929	13	eltrombopag	eltrombopag	NNP
cord-005453-4057qib7	2929	14	-50	-50	NNP
cord-005453-4057qib7	2930	1	(	(	-LRB-
cord-005453-4057qib7	2930	2	range	range	NN
cord-005453-4057qib7	2930	3	,	,	,
cord-005453-4057qib7	2930	4	50	50	CD
cord-005453-4057qib7	2930	5	-	-	SYM
cord-005453-4057qib7	2930	6	150	150	CD
cord-005453-4057qib7	2930	7	)	)	-RRB-
cord-005453-4057qib7	2931	1	mg	mg	NNP
cord-005453-4057qib7	2931	2	/	/	SYM
cord-005453-4057qib7	2931	3	day	day	NN
cord-005453-4057qib7	2931	4	.	.	.
cord-005453-4057qib7	2932	1	Overall	overall	JJ
cord-005453-4057qib7	2932	2	response	response	NN
cord-005453-4057qib7	2932	3	(	(	-LRB-
cord-005453-4057qib7	2932	4	OR	or	NN
cord-005453-4057qib7	2932	5	)	)	-RRB-
cord-005453-4057qib7	2932	6	included	include	VBD
cord-005453-4057qib7	2932	7	CR	CR	NNP
cord-005453-4057qib7	2932	8	(	(	-LRB-
cord-005453-4057qib7	2932	9	platelet	platelet	NN
cord-005453-4057qib7	2932	10	≥	≥	CD
cord-005453-4057qib7	2932	11	100	100	CD
cord-005453-4057qib7	2932	12	×	×	NN
cord-005453-4057qib7	2932	13	10	10	CD
cord-005453-4057qib7	2932	14	9	9	CD
cord-005453-4057qib7	2932	15	/L	/l	CD
cord-005453-4057qib7	2932	16	,	,	,
cord-005453-4057qib7	2932	17	ANC	ANC	NNP
cord-005453-4057qib7	2932	18	≥	≥	CD
cord-005453-4057qib7	2932	19	1.5	1.5	CD
cord-005453-4057qib7	2932	20	×	×	NN
cord-005453-4057qib7	2932	21	10	10	CD
cord-005453-4057qib7	2932	22	9	9	CD
cord-005453-4057qib7	2932	23	/L	/l	CD
cord-005453-4057qib7	2932	24	,	,	,
cord-005453-4057qib7	2932	25	and	and	CC
cord-005453-4057qib7	2932	26	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	2932	27	≥	≥	CD
cord-005453-4057qib7	2932	28	100	100	CD
cord-005453-4057qib7	2932	29	g	g	NN
cord-005453-4057qib7	2932	30	/	/	SYM
cord-005453-4057qib7	2932	31	l	l	NN
cord-005453-4057qib7	2932	32	)	)	-RRB-
cord-005453-4057qib7	2932	33	and	and	CC
cord-005453-4057qib7	2932	34	PR	PR	NNP
cord-005453-4057qib7	2932	35	(	(	-LRB-
cord-005453-4057qib7	2932	36	platelet	platelet	NN
cord-005453-4057qib7	2932	37	>	>	XX
cord-005453-4057qib7	2933	1	20×	20×	CD
cord-005453-4057qib7	2933	2	10	10	CD
cord-005453-4057qib7	2933	3	9	9	CD
cord-005453-4057qib7	2933	4	/L	/l	CD
cord-005453-4057qib7	2933	5	,	,	,
cord-005453-4057qib7	2933	6	ANC	ANC	NNP
cord-005453-4057qib7	2933	7	≥	≥	CD
cord-005453-4057qib7	2933	8	0,5	0,5	NN
cord-005453-4057qib7	2933	9	×	×	NN
cord-005453-4057qib7	2933	10	10	10	CD
cord-005453-4057qib7	2933	11	9	9	CD
cord-005453-4057qib7	2933	12	/L	/l	CD
cord-005453-4057qib7	2933	13	,	,	,
cord-005453-4057qib7	2933	14	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	2933	15	>	>	XX
cord-005453-4057qib7	2933	16	70	70	CD
cord-005453-4057qib7	2933	17	g	g	NN
cord-005453-4057qib7	2933	18	/	/	SYM
cord-005453-4057qib7	2933	19	l	l	NN
cord-005453-4057qib7	2933	20	)	)	-RRB-
cord-005453-4057qib7	2933	21	.	.	.
cord-005453-4057qib7	2934	1	Results	result	NNS
cord-005453-4057qib7	2934	2	:	:	:
cord-005453-4057qib7	2935	1	Median	median	JJ
cord-005453-4057qib7	2935	2	time	time	NN
cord-005453-4057qib7	2935	3	from	from	IN
cord-005453-4057qib7	2935	4	PGF	PGF	NNP
cord-005453-4057qib7	2935	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	2935	6	to	to	IN
cord-005453-4057qib7	2935	7	treatment	treatment	NN
cord-005453-4057qib7	2935	8	with	with	IN
cord-005453-4057qib7	2935	9	TPO	TPO	NNP
cord-005453-4057qib7	2935	10	agonists	agonist	NNS
cord-005453-4057qib7	2935	11	was	be	VBD
cord-005453-4057qib7	2935	12	14	14	CD
cord-005453-4057qib7	2935	13	days	day	NNS
cord-005453-4057qib7	2935	14	(	(	-LRB-
cord-005453-4057qib7	2935	15	0	0	CD
cord-005453-4057qib7	2935	16	-	-	SYM
cord-005453-4057qib7	2935	17	119	119	CD
cord-005453-4057qib7	2935	18	)	)	-RRB-
cord-005453-4057qib7	2935	19	,	,	,
cord-005453-4057qib7	2935	20	median	median	JJ
cord-005453-4057qib7	2935	21	treatment	treatment	NN
cord-005453-4057qib7	2935	22	duration	duration	NN
cord-005453-4057qib7	2935	23	was	be	VBD
cord-005453-4057qib7	2935	24	3	3	CD
cord-005453-4057qib7	2935	25	weeks	week	NNS
cord-005453-4057qib7	2935	26	(	(	-LRB-
cord-005453-4057qib7	2935	27	1	1	CD
cord-005453-4057qib7	2935	28	-	-	SYM
cord-005453-4057qib7	2935	29	43	43	CD
cord-005453-4057qib7	2935	30	)	)	-RRB-
cord-005453-4057qib7	2935	31	.	.	.
cord-005453-4057qib7	2936	1	TPO	TPO	NNP
cord-005453-4057qib7	2936	2	agonists	agonist	NNS
cord-005453-4057qib7	2936	3	were	be	VBD
cord-005453-4057qib7	2936	4	well	well	RB
cord-005453-4057qib7	2936	5	tolerated	tolerate	VBN
cord-005453-4057qib7	2936	6	with	with	IN
cord-005453-4057qib7	2936	7	no	no	DT
cord-005453-4057qib7	2936	8	cases	case	NNS
cord-005453-4057qib7	2936	9	of	of	IN
cord-005453-4057qib7	2936	10	grade	grade	NN
cord-005453-4057qib7	2936	11	III	III	NNP
cord-005453-4057qib7	2936	12	-	-	HYPH
cord-005453-4057qib7	2936	13	IV	IV	NNP
cord-005453-4057qib7	2936	14	toxicity	toxicity	NN
cord-005453-4057qib7	2936	15	.	.	.
cord-005453-4057qib7	2937	1	TPO	TPO	NNP
cord-005453-4057qib7	2937	2	agonists	agonist	NNS
cord-005453-4057qib7	2937	3	were	be	VBD
cord-005453-4057qib7	2937	4	combined	combine	VBN
cord-005453-4057qib7	2937	5	with	with	IN
cord-005453-4057qib7	2937	6	rituximab	rituximab	NN
cord-005453-4057qib7	2937	7	(	(	-LRB-
cord-005453-4057qib7	2937	8	n=4	n=4	NNP
cord-005453-4057qib7	2937	9	)	)	-RRB-
cord-005453-4057qib7	2937	10	,	,	,
cord-005453-4057qib7	2937	11	rituximab	rituximab	NN
cord-005453-4057qib7	2937	12	and	and	CC
cord-005453-4057qib7	2937	13	DLI	DLI	NNP
cord-005453-4057qib7	2937	14	(	(	-LRB-
cord-005453-4057qib7	2937	15	n=3	n=3	NN
cord-005453-4057qib7	2937	16	)	)	-RRB-
cord-005453-4057qib7	2937	17	and	and	CC
cord-005453-4057qib7	2937	18	HSC	HSC	NNP
cord-005453-4057qib7	2937	19	boost	boost	NN
cord-005453-4057qib7	2937	20	(	(	-LRB-
cord-005453-4057qib7	2937	21	n=1	n=1	FW
cord-005453-4057qib7	2937	22	)	)	-RRB-
cord-005453-4057qib7	2937	23	in	in	IN
cord-005453-4057qib7	2937	24	8	8	CD
cord-005453-4057qib7	2937	25	(	(	-LRB-
cord-005453-4057qib7	2937	26	28	28	CD
cord-005453-4057qib7	2937	27	%	%	NN
cord-005453-4057qib7	2937	28	)	)	-RRB-
cord-005453-4057qib7	2937	29	patients	patient	NNS
cord-005453-4057qib7	2937	30	.	.	.
cord-005453-4057qib7	2938	1	A	a	DT
cord-005453-4057qib7	2938	2	total	total	NN
cord-005453-4057qib7	2938	3	of	of	IN
cord-005453-4057qib7	2938	4	14	14	CD
cord-005453-4057qib7	2938	5	(	(	-LRB-
cord-005453-4057qib7	2938	6	48	48	CD
cord-005453-4057qib7	2938	7	%	%	NN
cord-005453-4057qib7	2938	8	)	)	-RRB-
cord-005453-4057qib7	2938	9	patients	patient	NNS
cord-005453-4057qib7	2938	10	met	meet	VBD
cord-005453-4057qib7	2938	11	criteria	criterion	NNS
cord-005453-4057qib7	2938	12	of	of	IN
cord-005453-4057qib7	2938	13	response	response	NN
cord-005453-4057qib7	2938	14	(	(	-LRB-
cord-005453-4057qib7	2938	15	CR	cr	NN
cord-005453-4057qib7	2938	16	:	:	:
cord-005453-4057qib7	2938	17	n=4	n=4	JJ
cord-005453-4057qib7	2938	18	,	,	,
cord-005453-4057qib7	2938	19	14	14	CD
cord-005453-4057qib7	2938	20	%	%	NN
cord-005453-4057qib7	2938	21	;	;	:
cord-005453-4057qib7	2938	22	PR	pr	NN
cord-005453-4057qib7	2938	23	:	:	:
cord-005453-4057qib7	2938	24	n=10	n=10	NNP
cord-005453-4057qib7	2938	25	,	,	,
cord-005453-4057qib7	2938	26	34	34	CD
cord-005453-4057qib7	2938	27	%	%	NN
cord-005453-4057qib7	2938	28	)	)	-RRB-
cord-005453-4057qib7	2938	29	.	.	.
cord-005453-4057qib7	2939	1	Combination	combination	NN
cord-005453-4057qib7	2939	2	therapy	therapy	NN
cord-005453-4057qib7	2939	3	showed	show	VBD
cord-005453-4057qib7	2939	4	no	no	DT
cord-005453-4057qib7	2939	5	difference	difference	NN
cord-005453-4057qib7	2939	6	in	in	IN
cord-005453-4057qib7	2939	7	OR	or	CC
cord-005453-4057qib7	2939	8	compared	compare	VBN
cord-005453-4057qib7	2939	9	to	to	IN
cord-005453-4057qib7	2939	10	TPO	TPO	NNP
cord-005453-4057qib7	2939	11	agonists	agonist	NNS
cord-005453-4057qib7	2939	12	alone	alone	RB
cord-005453-4057qib7	2939	13	.	.	.
cord-005453-4057qib7	2940	1	OR	or	CC
cord-005453-4057qib7	2940	2	was	be	VBD
cord-005453-4057qib7	2940	3	not	not	RB
cord-005453-4057qib7	2940	4	depended	depend	VBN
cord-005453-4057qib7	2940	5	on	on	IN
cord-005453-4057qib7	2940	6	the	the	DT
cord-005453-4057qib7	2940	7	TPO	TPO	NNP
cord-005453-4057qib7	2940	8	agonist	agonist	NN
cord-005453-4057qib7	2940	9	used	use	VBD
cord-005453-4057qib7	2940	10	nor	nor	CC
cord-005453-4057qib7	2940	11	the	the	DT
cord-005453-4057qib7	2940	12	time	time	NN
cord-005453-4057qib7	2940	13	to	to	IN
cord-005453-4057qib7	2940	14	therapy	therapy	NN
cord-005453-4057qib7	2940	15	initiation	initiation	NN
cord-005453-4057qib7	2940	16	.	.	.
cord-005453-4057qib7	2941	1	Median	median	JJ
cord-005453-4057qib7	2941	2	increase	increase	NN
cord-005453-4057qib7	2941	3	in	in	IN
cord-005453-4057qib7	2941	4	ANC	ANC	NNP
cord-005453-4057qib7	2941	5	in	in	IN
cord-005453-4057qib7	2941	6	responders	responder	NNS
cord-005453-4057qib7	2941	7	was	be	VBD
cord-005453-4057qib7	2941	8	3.4	3.4	CD
cord-005453-4057qib7	2941	9	×	×	NN
cord-005453-4057qib7	2941	10	10	10	CD
cord-005453-4057qib7	2941	11	9	9	CD
cord-005453-4057qib7	2941	12	/L	/L	.
cord-005453-4057qib7	2941	13	(	(	-LRB-
cord-005453-4057qib7	2941	14	0.8	0.8	CD
cord-005453-4057qib7	2941	15	-	-	SYM
cord-005453-4057qib7	2941	16	6.0	6.0	CD
cord-005453-4057qib7	2941	17	)	)	-RRB-
cord-005453-4057qib7	2941	18	,	,	,
cord-005453-4057qib7	2941	19	in	in	IN
cord-005453-4057qib7	2941	20	platelet	platelet	NN
cord-005453-4057qib7	2941	21	count	count	NN
cord-005453-4057qib7	2941	22	-48×10	-48×10	NNP
cord-005453-4057qib7	2941	23	9	9	CD
cord-005453-4057qib7	2941	24	/L	/L	.
cord-005453-4057qib7	2941	25	(	(	-LRB-
cord-005453-4057qib7	2941	26	21	21	CD
cord-005453-4057qib7	2941	27	-	-	SYM
cord-005453-4057qib7	2941	28	205	205	CD
cord-005453-4057qib7	2941	29	)	)	-RRB-
cord-005453-4057qib7	2941	30	.	.	.
cord-005453-4057qib7	2942	1	A	a	DT
cord-005453-4057qib7	2942	2	total	total	NN
cord-005453-4057qib7	2942	3	of	of	IN
cord-005453-4057qib7	2942	4	15	15	CD
cord-005453-4057qib7	2942	5	patients	patient	NNS
cord-005453-4057qib7	2942	6	died	die	VBD
cord-005453-4057qib7	2942	7	due	due	IN
cord-005453-4057qib7	2942	8	to	to	IN
cord-005453-4057qib7	2942	9	relapse	relapse	NN
cord-005453-4057qib7	2942	10	(	(	-LRB-
cord-005453-4057qib7	2942	11	n=2	n=2	NNS
cord-005453-4057qib7	2942	12	)	)	-RRB-
cord-005453-4057qib7	2942	13	,	,	,
cord-005453-4057qib7	2942	14	GVHD	GVHD	NNP
cord-005453-4057qib7	2942	15	III	III	NNP
cord-005453-4057qib7	2942	16	-	-	HYPH
cord-005453-4057qib7	2942	17	IV	IV	NNP
cord-005453-4057qib7	2942	18	grade	grade	NN
cord-005453-4057qib7	2942	19	(	(	-LRB-
cord-005453-4057qib7	2942	20	n=3	n=3	NN
cord-005453-4057qib7	2942	21	)	)	-RRB-
cord-005453-4057qib7	2942	22	and	and	CC
cord-005453-4057qib7	2942	23	infection	infection	NN
cord-005453-4057qib7	2942	24	(	(	-LRB-
cord-005453-4057qib7	2942	25	n=10	n=10	NNP
cord-005453-4057qib7	2942	26	)	)	-RRB-
cord-005453-4057qib7	2942	27	.	.	.
cord-005453-4057qib7	2943	1	Two	two	CD
cord-005453-4057qib7	2943	2	-	-	HYPH
cord-005453-4057qib7	2943	3	year	year	NN
cord-005453-4057qib7	2943	4	OS	os	NN
cord-005453-4057qib7	2943	5	from	from	IN
cord-005453-4057qib7	2943	6	the	the	DT
cord-005453-4057qib7	2943	7	start	start	NN
cord-005453-4057qib7	2943	8	of	of	IN
cord-005453-4057qib7	2943	9	TPO	TPO	NNP
cord-005453-4057qib7	2943	10	agonist	agonist	NN
cord-005453-4057qib7	2943	11	therapy	therapy	NN
cord-005453-4057qib7	2943	12	was	be	VBD
cord-005453-4057qib7	2943	13	44	44	CD
cord-005453-4057qib7	2943	14	%	%	NN
cord-005453-4057qib7	2943	15	(	(	-LRB-
cord-005453-4057qib7	2943	16	95	95	CD
cord-005453-4057qib7	2943	17	%	%	NN
cord-005453-4057qib7	2943	18	CI	CI	NNP
cord-005453-4057qib7	2943	19	,	,	,
cord-005453-4057qib7	2943	20	25	25	CD
cord-005453-4057qib7	2943	21	-	-	SYM
cord-005453-4057qib7	2943	22	62	62	CD
cord-005453-4057qib7	2943	23	)	)	-RRB-
cord-005453-4057qib7	2943	24	with	with	IN
cord-005453-4057qib7	2943	25	a	a	DT
cord-005453-4057qib7	2943	26	significant	significant	JJ
cord-005453-4057qib7	2943	27	difference	difference	NN
cord-005453-4057qib7	2943	28	between	between	IN
cord-005453-4057qib7	2943	29	responders	responder	NNS
cord-005453-4057qib7	2943	30	and	and	CC
cord-005453-4057qib7	2943	31	non	non	NNS
cord-005453-4057qib7	2943	32	-	-	NNS
cord-005453-4057qib7	2943	33	responders	responder	NNS
cord-005453-4057qib7	2943	34	:	:	:
cord-005453-4057qib7	2943	35	71	71	CD
cord-005453-4057qib7	2943	36	%	%	NN
cord-005453-4057qib7	2943	37	(	(	-LRB-
cord-005453-4057qib7	2943	38	95	95	CD
cord-005453-4057qib7	2943	39	%	%	NN
cord-005453-4057qib7	2943	40	CI	CI	NNP
cord-005453-4057qib7	2943	41	,	,	,
cord-005453-4057qib7	2943	42	33	33	CD
cord-005453-4057qib7	2943	43	-	-	SYM
cord-005453-4057qib7	2943	44	90	90	CD
cord-005453-4057qib7	2943	45	)	)	-RRB-
cord-005453-4057qib7	2943	46	vs.	vs.	IN
cord-005453-4057qib7	2943	47	18	18	CD
cord-005453-4057qib7	2943	48	%	%	NN
cord-005453-4057qib7	2943	49	(	(	-LRB-
cord-005453-4057qib7	2943	50	95	95	CD
cord-005453-4057qib7	2943	51	%	%	NN
cord-005453-4057qib7	2943	52	CI	ci	NN
cord-005453-4057qib7	2943	53	,	,	,
cord-005453-4057qib7	2943	54	3	3	CD
cord-005453-4057qib7	2943	55	-	-	SYM
cord-005453-4057qib7	2943	56	40	40	CD
cord-005453-4057qib7	2943	57	)	)	-RRB-
cord-005453-4057qib7	2943	58	(	(	-LRB-
cord-005453-4057qib7	2943	59	p=0,002	p=0,002	NNP
cord-005453-4057qib7	2943	60	)	)	-RRB-
cord-005453-4057qib7	2943	61	.	.	.
cord-005453-4057qib7	2944	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2944	2	:	:	:
cord-005453-4057qib7	2945	1	This	this	DT
cord-005453-4057qib7	2945	2	study	study	NN
cord-005453-4057qib7	2945	3	showed	show	VBD
cord-005453-4057qib7	2945	4	promising	promising	JJ
cord-005453-4057qib7	2945	5	results	result	NNS
cord-005453-4057qib7	2945	6	of	of	IN
cord-005453-4057qib7	2945	7	TPO	TPO	NNP
cord-005453-4057qib7	2945	8	agonists	agonist	NNS
cord-005453-4057qib7	2945	9	for	for	IN
cord-005453-4057qib7	2945	10	management	management	NN
cord-005453-4057qib7	2945	11	of	of	IN
cord-005453-4057qib7	2945	12	sPGF	sPGF	NNP
cord-005453-4057qib7	2945	13	.	.	.
cord-005453-4057qib7	2946	1	Further	further	JJ
cord-005453-4057qib7	2946	2	studies	study	NNS
cord-005453-4057qib7	2946	3	are	be	VBP
cord-005453-4057qib7	2946	4	warranted	warrant	VBN
cord-005453-4057qib7	2946	5	to	to	TO
cord-005453-4057qib7	2946	6	specify	specify	VB
cord-005453-4057qib7	2946	7	optimal	optimal	JJ
cord-005453-4057qib7	2946	8	timing	timing	NN
cord-005453-4057qib7	2946	9	and	and	CC
cord-005453-4057qib7	2946	10	dosing	dose	VBG
cord-005453-4057qib7	2946	11	regimen	regimen	NN
cord-005453-4057qib7	2946	12	,	,	,
cord-005453-4057qib7	2946	13	predictors	predictor	NNS
cord-005453-4057qib7	2946	14	of	of	IN
cord-005453-4057qib7	2946	15	response	response	NN
cord-005453-4057qib7	2946	16	.	.	.
cord-005453-4057qib7	2947	1	[	[	-LRB-
cord-005453-4057qib7	2947	2	[	[	-LRB-
cord-005453-4057qib7	2947	3	P144	P144	NNP
cord-005453-4057qib7	2947	4	Image	image	NN
cord-005453-4057qib7	2947	5	]	]	-RRB-
cord-005453-4057qib7	2947	6	1	1	CD
cord-005453-4057qib7	2947	7	.	.	.
cord-005453-4057qib7	2948	1	Two	two	CD
cord-005453-4057qib7	2948	2	-	-	HYPH
cord-005453-4057qib7	2948	3	year	year	NN
cord-005453-4057qib7	2948	4	OS	os	NN
cord-005453-4057qib7	2948	5	in	in	IN
cord-005453-4057qib7	2948	6	responders	responder	NNS
cord-005453-4057qib7	2948	7	and	and	CC
cord-005453-4057qib7	2948	8	nonresponders	nonresponder	NNS
cord-005453-4057qib7	2948	9	to	to	IN
cord-005453-4057qib7	2948	10	TPO	tpo	VB
cord-005453-4057qib7	2948	11	agonist	agonist	NN
cord-005453-4057qib7	2948	12	therapy	therapy	NN
cord-005453-4057qib7	2948	13	]	]	-RRB-
cord-005453-4057qib7	2949	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2949	2	:	:	:
cord-005453-4057qib7	2949	3	There	there	EX
cord-005453-4057qib7	2949	4	are	be	VBP
cord-005453-4057qib7	2949	5	conflicts	conflict	NNS
cord-005453-4057qib7	2949	6	of	of	IN
cord-005453-4057qib7	2949	7	interest	interest	NN
cord-005453-4057qib7	2949	8	to	to	TO
cord-005453-4057qib7	2949	9	disclose	disclose	VB
cord-005453-4057qib7	2949	10	P145	p145	$
cord-005453-4057qib7	2949	11	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	2949	12	reactivation	reactivation	NN
cord-005453-4057qib7	2949	13	kinetics	kinetic	NNS
cord-005453-4057qib7	2949	14	and	and	CC
cord-005453-4057qib7	2949	15	peak	peak	NN
cord-005453-4057qib7	2949	16	titers	titer	NNS
cord-005453-4057qib7	2949	17	as	as	IN
cord-005453-4057qib7	2949	18	novel	novel	JJ
cord-005453-4057qib7	2949	19	predictors	predictor	NNS
cord-005453-4057qib7	2949	20	of	of	IN
cord-005453-4057qib7	2949	21	survival	survival	NN
cord-005453-4057qib7	2949	22	and	and	CC
cord-005453-4057qib7	2949	23	relapse	relapse	NN
cord-005453-4057qib7	2949	24	after	after	IN
cord-005453-4057qib7	2949	25	allogeneic	allogeneic	NN
cord-005453-4057qib7	2949	26	cell	cell	NN
cord-005453-4057qib7	2949	27	transplantation	transplantation	NN
cord-005453-4057qib7	2949	28	for	for	IN
cord-005453-4057qib7	2949	29	hematologic	hematologic	JJ
cord-005453-4057qib7	2949	30	malignancies	malignancy	NNS
cord-005453-4057qib7	2949	31	Saskia	Saskia	NNP
cord-005453-4057qib7	2949	32	Leserer	Leserer	NNP
cord-005453-4057qib7	2949	33	1	1	CD
cord-005453-4057qib7	2949	34	,	,	,
cord-005453-4057qib7	2949	35	Evren	Evren	NNP
cord-005453-4057qib7	2949	36	Bayraktar	Bayraktar	NNP
cord-005453-4057qib7	2949	37	1	1	CD
cord-005453-4057qib7	2949	38	,	,	,
cord-005453-4057qib7	2949	39	Nikolaos	Nikolaos	NNP
cord-005453-4057qib7	2949	40	Tsachakis	Tsachakis	NNP
cord-005453-4057qib7	2949	41	-	-	HYPH
cord-005453-4057qib7	2949	42	Mück	Mück	NNP
cord-005453-4057qib7	2949	43	1	1	CD
cord-005453-4057qib7	2949	44	,	,	,
cord-005453-4057qib7	2949	45	Michael	Michael	NNP
cord-005453-4057qib7	2949	46	Koldehoff	Koldehoff	NNP
cord-005453-4057qib7	2949	47	1	1	CD
cord-005453-4057qib7	2949	48	,	,	,
cord-005453-4057qib7	2949	49	Lara	Lara	NNP
cord-005453-4057qib7	2949	50	Kasperidus	Kasperidus	NNP
cord-005453-4057qib7	2949	51	1	1	CD
cord-005453-4057qib7	2949	52	,	,	,
cord-005453-4057qib7	2949	53	Esteban	Esteban	NNP
cord-005453-4057qib7	2949	54	Arrieta	Arrieta	NNP
cord-005453-4057qib7	2949	55	-	-	HYPH
cord-005453-4057qib7	2949	56	Bolanos	Bolanos	NNP
cord-005453-4057qib7	2949	57	1	1	CD
cord-005453-4057qib7	2949	58	,	,	,
cord-005453-4057qib7	2949	59	Mirko	Mirko	NNP
cord-005453-4057qib7	2949	60	Trilling	Trilling	NNP
cord-005453-4057qib7	2949	61	1	1	CD
cord-005453-4057qib7	2949	62	,	,	,
cord-005453-4057qib7	2949	63	Katharina	Katharina	NNP
cord-005453-4057qib7	2949	64	Fleischhauer	Fleischhauer	NNP
cord-005453-4057qib7	2949	65	1	1	CD
cord-005453-4057qib7	2949	66	,	,	,
cord-005453-4057qib7	2949	67	Dietrich	Dietrich	NNP
cord-005453-4057qib7	2949	68	W.	W.	NNP
cord-005453-4057qib7	2949	69	Beelen	Beelen	NNP
cord-005453-4057qib7	2949	70	1	1	CD
cord-005453-4057qib7	2949	71	,	,	,
cord-005453-4057qib7	2949	72	Amin	Amin	NNP
cord-005453-4057qib7	2949	73	T.	T.	NNP
cord-005453-4057qib7	2949	74	Turki	Turki	NNP
cord-005453-4057qib7	2949	75	1	1	CD
cord-005453-4057qib7	2949	76	1	1	CD
cord-005453-4057qib7	2949	77	University	University	NNP
cord-005453-4057qib7	2949	78	Hospital	Hospital	NNP
cord-005453-4057qib7	2949	79	Essen	Essen	NNP
cord-005453-4057qib7	2949	80	,	,	,
cord-005453-4057qib7	2949	81	Essen	Essen	NNP
cord-005453-4057qib7	2949	82	,	,	,
cord-005453-4057qib7	2949	83	Germany	Germany	NNP
cord-005453-4057qib7	2949	84	,	,	,
cord-005453-4057qib7	2950	1	Background	background	NN
cord-005453-4057qib7	2950	2	:	:	:
cord-005453-4057qib7	2951	1	After	after	IN
cord-005453-4057qib7	2951	2	allogeneic	allogeneic	JJ
cord-005453-4057qib7	2951	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	2951	4	cell	cell	NN
cord-005453-4057qib7	2951	5	transplantation	transplantation	NN
cord-005453-4057qib7	2951	6	(	(	-LRB-
cord-005453-4057qib7	2951	7	HCT	HCT	NNP
cord-005453-4057qib7	2951	8	)	)	-RRB-
cord-005453-4057qib7	2951	9	,	,	,
cord-005453-4057qib7	2951	10	human	human	JJ
cord-005453-4057qib7	2951	11	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	2951	12	(	(	-LRB-
cord-005453-4057qib7	2951	13	CMV	CMV	NNP
cord-005453-4057qib7	2951	14	)	)	-RRB-
cord-005453-4057qib7	2951	15	reactivation	reactivation	NN
cord-005453-4057qib7	2951	16	associates	associate	NNS
cord-005453-4057qib7	2951	17	with	with	IN
cord-005453-4057qib7	2951	18	non	non	JJ
cord-005453-4057qib7	2951	19	-	-	JJ
cord-005453-4057qib7	2951	20	relapse	relapse	JJ
cord-005453-4057qib7	2951	21	mortality	mortality	NN
cord-005453-4057qib7	2951	22	(	(	-LRB-
cord-005453-4057qib7	2951	23	NRM	NRM	NNP
cord-005453-4057qib7	2951	24	)	)	-RRB-
cord-005453-4057qib7	2951	25	but	but	CC
cord-005453-4057qib7	2951	26	also	also	RB
cord-005453-4057qib7	2951	27	with	with	IN
cord-005453-4057qib7	2951	28	reduced	reduce	VBN
cord-005453-4057qib7	2951	29	relapse	relapse	NN
cord-005453-4057qib7	2951	30	in	in	IN
cord-005453-4057qib7	2951	31	patients	patient	NNS
cord-005453-4057qib7	2951	32	with	with	IN
cord-005453-4057qib7	2951	33	leukemia	leukemia	NN
cord-005453-4057qib7	2951	34	,	,	,
cord-005453-4057qib7	2951	35	as	as	IN
cord-005453-4057qib7	2951	36	shown	show	VBN
cord-005453-4057qib7	2951	37	by	by	IN
cord-005453-4057qib7	2951	38	numerous	numerous	JJ
cord-005453-4057qib7	2951	39	studies	study	NNS
cord-005453-4057qib7	2951	40	that	that	WDT
cord-005453-4057qib7	2951	41	evaluated	evaluate	VBD
cord-005453-4057qib7	2951	42	CMV	CMV	NNP
cord-005453-4057qib7	2951	43	reactivation	reactivation	NN
cord-005453-4057qib7	2951	44	as	as	IN
cord-005453-4057qib7	2951	45	a	a	DT
cord-005453-4057qib7	2951	46	qualitative	qualitative	JJ
cord-005453-4057qib7	2951	47	yes	yes	UH
cord-005453-4057qib7	2951	48	/	/	SYM
cord-005453-4057qib7	2951	49	no	no	DT
cord-005453-4057qib7	2951	50	parameter	parameter	NN
cord-005453-4057qib7	2951	51	in	in	IN
cord-005453-4057qib7	2951	52	the	the	DT
cord-005453-4057qib7	2951	53	first	first	JJ
cord-005453-4057qib7	2951	54	months	month	NNS
cord-005453-4057qib7	2951	55	posttransplant	posttransplant	NNP
cord-005453-4057qib7	2951	56	.	.	.
cord-005453-4057qib7	2952	1	We	-PRON-	PRP
cord-005453-4057qib7	2952	2	hypothesized	hypothesize	VBD
cord-005453-4057qib7	2952	3	that	that	IN
cord-005453-4057qib7	2952	4	longitudinal	longitudinal	JJ
cord-005453-4057qib7	2952	5	quantitative	quantitative	JJ
cord-005453-4057qib7	2952	6	assessment	assessment	NN
cord-005453-4057qib7	2952	7	of	of	IN
cord-005453-4057qib7	2952	8	CMV	CMV	NNP
cord-005453-4057qib7	2952	9	reactivation	reactivation	NN
cord-005453-4057qib7	2952	10	kinetics	kinetic	NNS
cord-005453-4057qib7	2952	11	and	and	CC
cord-005453-4057qib7	2952	12	virus	virus	NN
cord-005453-4057qib7	2952	13	loads	load	NNS
cord-005453-4057qib7	2952	14	might	may	MD
cord-005453-4057qib7	2952	15	improve	improve	VB
cord-005453-4057qib7	2952	16	patient	patient	NN
cord-005453-4057qib7	2952	17	-	-	HYPH
cord-005453-4057qib7	2952	18	specific	specific	JJ
cord-005453-4057qib7	2952	19	clinical	clinical	JJ
cord-005453-4057qib7	2952	20	outcome	outcome	NN
cord-005453-4057qib7	2952	21	associations	association	NNS
cord-005453-4057qib7	2952	22	.	.	.
cord-005453-4057qib7	2953	1	Methods	method	NNS
cord-005453-4057qib7	2953	2	:	:	:
cord-005453-4057qib7	2954	1	This	this	DT
cord-005453-4057qib7	2954	2	retrospective	retrospective	JJ
cord-005453-4057qib7	2954	3	study	study	NN
cord-005453-4057qib7	2954	4	included	include	VBD
cord-005453-4057qib7	2954	5	705	705	CD
cord-005453-4057qib7	2954	6	patients	patient	NNS
cord-005453-4057qib7	2954	7	with	with	IN
cord-005453-4057qib7	2954	8	HCT	hct	NN
cord-005453-4057qib7	2954	9	for	for	IN
cord-005453-4057qib7	2954	10	hematologic	hematologic	JJ
cord-005453-4057qib7	2954	11	malignancies	malignancy	NNS
cord-005453-4057qib7	2954	12	treated	treat	VBN
cord-005453-4057qib7	2954	13	between	between	IN
cord-005453-4057qib7	2954	14	01/2012	01/2012	CD
cord-005453-4057qib7	2954	15	and	and	CC
cord-005453-4057qib7	2954	16	12/2017	12/2017	CD
cord-005453-4057qib7	2954	17	at	at	IN
cord-005453-4057qib7	2954	18	University	University	NNP
cord-005453-4057qib7	2954	19	Hospital	Hospital	NNP
cord-005453-4057qib7	2954	20	Essen	Essen	NNP
cord-005453-4057qib7	2954	21	,	,	,
cord-005453-4057qib7	2954	22	Germany	Germany	NNP
cord-005453-4057qib7	2954	23	.	.	.
cord-005453-4057qib7	2955	1	CMV	CMV	NNP
cord-005453-4057qib7	2955	2	titers	titer	NNS
cord-005453-4057qib7	2955	3	were	be	VBD
cord-005453-4057qib7	2955	4	monitored	monitor	VBN
cord-005453-4057qib7	2955	5	weekly	weekly	RB
cord-005453-4057qib7	2955	6	by	by	IN
cord-005453-4057qib7	2955	7	quantitative	quantitative	JJ
cord-005453-4057qib7	2955	8	PCR	PCR	NNP
cord-005453-4057qib7	2955	9	(	(	-LRB-
cord-005453-4057qib7	2955	10	qPCR	qPCR	NNP
cord-005453-4057qib7	2955	11	)	)	-RRB-
cord-005453-4057qib7	2955	12	;	;	:
cord-005453-4057qib7	2955	13	CMV	CMV	NNP
cord-005453-4057qib7	2955	14	reactivation	reactivation	NN
cord-005453-4057qib7	2955	15	was	be	VBD
cord-005453-4057qib7	2955	16	defined	define	VBN
cord-005453-4057qib7	2955	17	by	by	IN
cord-005453-4057qib7	2955	18	a	a	DT
cord-005453-4057qib7	2955	19	cutoff	cutoff	NN
cord-005453-4057qib7	2955	20	of	of	IN
cord-005453-4057qib7	2955	21	>	>	$
cord-005453-4057qib7	2955	22	500	500	CD
cord-005453-4057qib7	2955	23	genome	genome	NN
cord-005453-4057qib7	2955	24	copies	copy	NNS
cord-005453-4057qib7	2955	25	per	per	IN
cord-005453-4057qib7	2955	26	ml	ml	NN
cord-005453-4057qib7	2955	27	.	.	.
cord-005453-4057qib7	2956	1	Patients	patient	NNS
cord-005453-4057qib7	2956	2	were	be	VBD
cord-005453-4057qib7	2956	3	included	include	VBN
cord-005453-4057qib7	2956	4	for	for	IN
cord-005453-4057qib7	2956	5	analysis	analysis	NN
cord-005453-4057qib7	2956	6	,	,	,
cord-005453-4057qib7	2956	7	if	if	IN
cord-005453-4057qib7	2956	8	at	at	RB
cord-005453-4057qib7	2956	9	least	least	JJS
cord-005453-4057qib7	2956	10	5	5	CD
cord-005453-4057qib7	2956	11	measurements	measurement	NNS
cord-005453-4057qib7	2956	12	were	be	VBD
cord-005453-4057qib7	2956	13	available	available	JJ
cord-005453-4057qib7	2956	14	during	during	IN
cord-005453-4057qib7	2956	15	the	the	DT
cord-005453-4057qib7	2956	16	first	first	JJ
cord-005453-4057qib7	2956	17	200	200	CD
cord-005453-4057qib7	2956	18	days	day	NNS
cord-005453-4057qib7	2956	19	after	after	IN
cord-005453-4057qib7	2956	20	HCT	HCT	NNP
cord-005453-4057qib7	2956	21	.	.	.
cord-005453-4057qib7	2957	1	In	in	IN
cord-005453-4057qib7	2957	2	total	total	JJ
cord-005453-4057qib7	2957	3	,	,	,
cord-005453-4057qib7	2957	4	11,508	11,508	CD
cord-005453-4057qib7	2957	5	samples	sample	NNS
cord-005453-4057qib7	2957	6	were	be	VBD
cord-005453-4057qib7	2957	7	analyzed	analyze	VBN
cord-005453-4057qib7	2957	8	.	.	.
cord-005453-4057qib7	2958	1	Subgroup	subgroup	NN
cord-005453-4057qib7	2958	2	analyses	analysis	NNS
cord-005453-4057qib7	2958	3	were	be	VBD
cord-005453-4057qib7	2958	4	performed	perform	VBN
cord-005453-4057qib7	2958	5	according	accord	VBG
cord-005453-4057qib7	2958	6	to	to	IN
cord-005453-4057qib7	2958	7	the	the	DT
cord-005453-4057qib7	2958	8	time	time	NN
cord-005453-4057qib7	2958	9	of	of	IN
cord-005453-4057qib7	2958	10	CMV	CMV	NNP
cord-005453-4057qib7	2958	11	reactivation	reactivation	NN
cord-005453-4057qib7	2958	12	(	(	-LRB-
cord-005453-4057qib7	2958	13	before	before	IN
cord-005453-4057qib7	2958	14	/	/	SYM
cord-005453-4057qib7	2958	15	after	after	IN
cord-005453-4057qib7	2958	16	+30d	+30d	NN
cord-005453-4057qib7	2958	17	)	)	-RRB-
cord-005453-4057qib7	2958	18	or	or	CC
cord-005453-4057qib7	2958	19	the	the	DT
cord-005453-4057qib7	2958	20	CMV	CMV	NNP
cord-005453-4057qib7	2958	21	viremia	viremia	NN
cord-005453-4057qib7	2958	22	titer	titer	NN
cord-005453-4057qib7	2958	23	(	(	-LRB-
cord-005453-4057qib7	2958	24	>	>	NFP
cord-005453-4057qib7	2958	25	100,000	100,000	CD
cord-005453-4057qib7	2958	26	,	,	,
cord-005453-4057qib7	2958	27	20,000	20,000	CD
cord-005453-4057qib7	2958	28	-100,000	-100,000	NNS
cord-005453-4057qib7	2958	29	and	and	CC
cord-005453-4057qib7	2958	30	500	500	CD
cord-005453-4057qib7	2958	31	-20,000	-20,000	XX
cord-005453-4057qib7	2959	1	copies	copy	NNS
cord-005453-4057qib7	2959	2	/	/	SYM
cord-005453-4057qib7	2959	3	ml	ml	NN
cord-005453-4057qib7	2959	4	)	)	-RRB-
cord-005453-4057qib7	2959	5	.	.	.
cord-005453-4057qib7	2960	1	Results	result	NNS
cord-005453-4057qib7	2960	2	:	:	:
cord-005453-4057qib7	2961	1	CMV	CMV	NNP
cord-005453-4057qib7	2961	2	reactivation	reactivation	NN
cord-005453-4057qib7	2961	3	was	be	VBD
cord-005453-4057qib7	2961	4	detected	detect	VBN
cord-005453-4057qib7	2961	5	in	in	IN
cord-005453-4057qib7	2961	6	350	350	CD
cord-005453-4057qib7	2961	7	(	(	-LRB-
cord-005453-4057qib7	2961	8	median	median	NN
cord-005453-4057qib7	2961	9	age	age	NN
cord-005453-4057qib7	2961	10	58	58	CD
cord-005453-4057qib7	2961	11	years	year	NNS
cord-005453-4057qib7	2961	12	;	;	:
cord-005453-4057qib7	2961	13	range	range	VBP
cord-005453-4057qib7	2961	14	17	17	CD
cord-005453-4057qib7	2961	15	-	-	SYM
cord-005453-4057qib7	2961	16	76	76	CD
cord-005453-4057qib7	2961	17	years	year	NNS
cord-005453-4057qib7	2961	18	)	)	-RRB-
cord-005453-4057qib7	2961	19	out	out	IN
cord-005453-4057qib7	2961	20	of	of	IN
cord-005453-4057qib7	2961	21	705	705	CD
cord-005453-4057qib7	2961	22	patients	patient	NNS
cord-005453-4057qib7	2961	23	.	.	.
cord-005453-4057qib7	2962	1	Baseline	baseline	JJ
cord-005453-4057qib7	2962	2	characteristics	characteristic	NNS
cord-005453-4057qib7	2962	3	(	(	-LRB-
cord-005453-4057qib7	2962	4	age	age	NN
cord-005453-4057qib7	2962	5	,	,	,
cord-005453-4057qib7	2962	6	gender	gender	NN
cord-005453-4057qib7	2962	7	,	,	,
cord-005453-4057qib7	2962	8	underlying	underlie	VBG
cord-005453-4057qib7	2962	9	disease	disease	NN
cord-005453-4057qib7	2962	10	,	,	,
cord-005453-4057qib7	2962	11	transplant	transplant	NN
cord-005453-4057qib7	2962	12	)	)	-RRB-
cord-005453-4057qib7	2962	13	of	of	IN
cord-005453-4057qib7	2962	14	patients	patient	NNS
cord-005453-4057qib7	2962	15	without	without	IN
cord-005453-4057qib7	2962	16	CMV	CMV	NNP
cord-005453-4057qib7	2962	17	reactivation	reactivation	NN
cord-005453-4057qib7	2962	18	were	be	VBD
cord-005453-4057qib7	2962	19	comparable	comparable	JJ
cord-005453-4057qib7	2962	20	.	.	.
cord-005453-4057qib7	2963	1	CMV	CMV	NNP
cord-005453-4057qib7	2963	2	reactivation	reactivation	NN
cord-005453-4057qib7	2963	3	kinetics	kinetic	NNS
cord-005453-4057qib7	2963	4	followed	follow	VBD
cord-005453-4057qib7	2963	5	a	a	DT
cord-005453-4057qib7	2963	6	Gaussian	gaussian	JJ
cord-005453-4057qib7	2963	7	normal	normal	JJ
cord-005453-4057qib7	2963	8	distribution	distribution	NN
cord-005453-4057qib7	2963	9	with	with	IN
cord-005453-4057qib7	2963	10	a	a	DT
cord-005453-4057qib7	2963	11	median	median	JJ
cord-005453-4057qib7	2963	12	first	first	JJ
cord-005453-4057qib7	2963	13	reactivation	reactivation	NN
cord-005453-4057qib7	2963	14	at	at	IN
cord-005453-4057qib7	2963	15	+33d	+33d	RB
cord-005453-4057qib7	2963	16	and	and	CC
cord-005453-4057qib7	2963	17	peak	peak	VB
cord-005453-4057qib7	2963	18	titers	titer	NNS
cord-005453-4057qib7	2963	19	at	at	IN
cord-005453-4057qib7	2963	20	+47d	+47d	NNPS
cord-005453-4057qib7	2963	21	.	.	.
cord-005453-4057qib7	2964	1	All	all	DT
cord-005453-4057qib7	2964	2	except	except	IN
cord-005453-4057qib7	2964	3	1	1	CD
cord-005453-4057qib7	2964	4	patient	patient	NN
cord-005453-4057qib7	2964	5	reactivated	reactivate	VBN
cord-005453-4057qib7	2964	6	before	before	IN
cord-005453-4057qib7	2964	7	100d	100d	CD
cord-005453-4057qib7	2964	8	,	,	,
cord-005453-4057qib7	2964	9	40	40	CD
cord-005453-4057qib7	2964	10	%	%	NN
cord-005453-4057qib7	2964	11	before	before	RB
cord-005453-4057qib7	2964	12	+30d	+30d	NN
cord-005453-4057qib7	2964	13	.	.	.
cord-005453-4057qib7	2965	1	Overall	overall	JJ
cord-005453-4057qib7	2965	2	survival	survival	NN
cord-005453-4057qib7	2965	3	(	(	-LRB-
cord-005453-4057qib7	2965	4	OS	OS	NNP
cord-005453-4057qib7	2965	5	)	)	-RRB-
cord-005453-4057qib7	2965	6	of	of	IN
cord-005453-4057qib7	2965	7	the	the	DT
cord-005453-4057qib7	2965	8	CMV	CMV	NNP
cord-005453-4057qib7	2965	9	reactivation	reactivation	NN
cord-005453-4057qib7	2965	10	group	group	NN
cord-005453-4057qib7	2965	11	as	as	IN
cord-005453-4057qib7	2965	12	a	a	DT
cord-005453-4057qib7	2965	13	whole	whole	NN
cord-005453-4057qib7	2965	14	did	do	VBD
cord-005453-4057qib7	2965	15	not	not	RB
cord-005453-4057qib7	2965	16	significantly	significantly	RB
cord-005453-4057qib7	2965	17	differ	differ	VB
cord-005453-4057qib7	2965	18	from	from	IN
cord-005453-4057qib7	2965	19	the	the	DT
cord-005453-4057qib7	2965	20	non	non	JJ
cord-005453-4057qib7	2965	21	-	-	JJ
cord-005453-4057qib7	2965	22	reactivation	reactivation	JJ
cord-005453-4057qib7	2965	23	group	group	NN
cord-005453-4057qib7	2965	24	(	(	-LRB-
cord-005453-4057qib7	2965	25	34	34	CD
cord-005453-4057qib7	2965	26	vs.	vs.	NN
cord-005453-4057qib7	2965	27	38	38	CD
cord-005453-4057qib7	2965	28	months	month	NNS
cord-005453-4057qib7	2965	29	)	)	-RRB-
cord-005453-4057qib7	2965	30	.	.	.
cord-005453-4057qib7	2966	1	However	however	RB
cord-005453-4057qib7	2966	2	,	,	,
cord-005453-4057qib7	2966	3	in	in	IN
cord-005453-4057qib7	2966	4	subgroup	subgroup	NN
cord-005453-4057qib7	2966	5	analyses	analysis	NNS
cord-005453-4057qib7	2966	6	OS	OS	NNP
cord-005453-4057qib7	2966	7	was	be	VBD
cord-005453-4057qib7	2966	8	significantly	significantly	RB
cord-005453-4057qib7	2966	9	reduced	reduce	VBN
cord-005453-4057qib7	2966	10	in	in	IN
cord-005453-4057qib7	2966	11	patients	patient	NNS
cord-005453-4057qib7	2966	12	with	with	IN
cord-005453-4057qib7	2966	13	very	very	RB
cord-005453-4057qib7	2966	14	early	early	JJ
cord-005453-4057qib7	2966	15	(	(	-LRB-
cord-005453-4057qib7	2966	16	<	<	XX
cord-005453-4057qib7	2966	17	+30d	+30d	-RRB-
cord-005453-4057qib7	2966	18	)	)	-RRB-
cord-005453-4057qib7	2966	19	compared	compare	VBN
cord-005453-4057qib7	2966	20	to	to	IN
cord-005453-4057qib7	2966	21	later	later	JJ
cord-005453-4057qib7	2966	22	reactivation	reactivation	NN
cord-005453-4057qib7	2966	23	(	(	-LRB-
cord-005453-4057qib7	2966	24	17	17	CD
cord-005453-4057qib7	2966	25	vs.	vs.	NN
cord-005453-4057qib7	2966	26	59	59	CD
cord-005453-4057qib7	2966	27	months	month	NNS
cord-005453-4057qib7	2966	28	,	,	,
cord-005453-4057qib7	2966	29	p=0.040	p=0.040	NNP
cord-005453-4057qib7	2966	30	)	)	-RRB-
cord-005453-4057qib7	2966	31	.	.	.
cord-005453-4057qib7	2967	1	Moreover	moreover	RB
cord-005453-4057qib7	2967	2	and	and	CC
cord-005453-4057qib7	2967	3	importantly	importantly	RB
cord-005453-4057qib7	2967	4	,	,	,
cord-005453-4057qib7	2967	5	OS	OS	NNP
cord-005453-4057qib7	2967	6	was	be	VBD
cord-005453-4057qib7	2967	7	significantly	significantly	RB
cord-005453-4057qib7	2967	8	reduced	reduce	VBN
cord-005453-4057qib7	2967	9	in	in	IN
cord-005453-4057qib7	2967	10	patients	patient	NNS
cord-005453-4057qib7	2967	11	with	with	IN
cord-005453-4057qib7	2967	12	CMV	CMV	NNP
cord-005453-4057qib7	2967	13	reactivation	reactivation	NN
cord-005453-4057qib7	2967	14	at	at	IN
cord-005453-4057qib7	2967	15	high	high	JJ
cord-005453-4057qib7	2967	16	titers	titer	NNS
cord-005453-4057qib7	2967	17	of	of	IN
cord-005453-4057qib7	2967	18	>	>	$
cord-005453-4057qib7	2967	19	100,000	100,000	CD
cord-005453-4057qib7	2967	20	copies	copy	NNS
cord-005453-4057qib7	2967	21	/	/	SYM
cord-005453-4057qib7	2967	22	ml	ml	NNS
cord-005453-4057qib7	2967	23	compared	compare	VBN
cord-005453-4057qib7	2967	24	to	to	IN
cord-005453-4057qib7	2967	25	those	those	DT
cord-005453-4057qib7	2967	26	with	with	IN
cord-005453-4057qib7	2967	27	lower	low	JJR
cord-005453-4057qib7	2967	28	titers	titer	NNS
cord-005453-4057qib7	2967	29	(	(	-LRB-
cord-005453-4057qib7	2967	30	(	(	-LRB-
cord-005453-4057qib7	2967	31	10	10	CD
cord-005453-4057qib7	2967	32	vs.	vs.	NN
cord-005453-4057qib7	2967	33	45	45	CD
cord-005453-4057qib7	2967	34	months	month	NNS
cord-005453-4057qib7	2967	35	)	)	-RRB-
cord-005453-4057qib7	2968	1	p	p	LS
cord-005453-4057qib7	2968	2	<	<	XX
cord-005453-4057qib7	2969	1	0.0001).Cox	0.0001).cox	LS
cord-005453-4057qib7	2969	2	regression	regression	NN
cord-005453-4057qib7	2969	3	analyses	analysis	NNS
cord-005453-4057qib7	2969	4	confirmed	confirm	VBD
cord-005453-4057qib7	2969	5	significantly	significantly	RB
cord-005453-4057qib7	2969	6	reduced	reduce	VBN
cord-005453-4057qib7	2969	7	OS	os	NN
cord-005453-4057qib7	2969	8	for	for	IN
cord-005453-4057qib7	2969	9	patients	patient	NNS
cord-005453-4057qib7	2969	10	with	with	IN
cord-005453-4057qib7	2969	11	CMV	CMV	NNP
cord-005453-4057qib7	2969	12	reactivation	reactivation	NN
cord-005453-4057qib7	2969	13	>	>	XX
cord-005453-4057qib7	2969	14	100,000	100,000	CD
cord-005453-4057qib7	2969	15	copies	copy	NNS
cord-005453-4057qib7	2969	16	/	/	SYM
cord-005453-4057qib7	2969	17	ml	ml	NN
cord-005453-4057qib7	2969	18	and	and	CC
cord-005453-4057qib7	2969	19	<	<	NNP
cord-005453-4057qib7	2969	20	day	day	NN
cord-005453-4057qib7	2969	21	+30	+30	CD
cord-005453-4057qib7	2969	22	as	as	IN
cord-005453-4057qib7	2969	23	compared	compare	VBN
cord-005453-4057qib7	2969	24	to	to	IN
cord-005453-4057qib7	2969	25	the	the	DT
cord-005453-4057qib7	2969	26	other	other	JJ
cord-005453-4057qib7	2969	27	cohorts	cohort	NNS
cord-005453-4057qib7	2969	28	(	(	-LRB-
cord-005453-4057qib7	2969	29	HR	HR	NNP
cord-005453-4057qib7	2969	30	2.03	2.03	CD
cord-005453-4057qib7	2969	31	,	,	,
cord-005453-4057qib7	2969	32	95%CI	95%ci	CD
cord-005453-4057qib7	2969	33	1.45	1.45	CD
cord-005453-4057qib7	2969	34	-	-	SYM
cord-005453-4057qib7	2969	35	2.86	2.86	CD
cord-005453-4057qib7	2969	36	,	,	,
cord-005453-4057qib7	2969	37	p	p	NN
cord-005453-4057qib7	2969	38	<	<	XX
cord-005453-4057qib7	2969	39	0.0001	0.0001	CD
cord-005453-4057qib7	2969	40	and	and	CC
cord-005453-4057qib7	2969	41	HR	HR	NNP
cord-005453-4057qib7	2969	42	1.36	1.36	CD
cord-005453-4057qib7	2969	43	,	,	,
cord-005453-4057qib7	2969	44	95	95	CD
cord-005453-4057qib7	2969	45	%	%	NN
cord-005453-4057qib7	2969	46	CI	CI	NNP
cord-005453-4057qib7	2969	47	1.01	1.01	CD
cord-005453-4057qib7	2969	48	-	-	SYM
cord-005453-4057qib7	2969	49	1.83	1.83	CD
cord-005453-4057qib7	2969	50	,	,	,
cord-005453-4057qib7	2969	51	p=0.041	p=0.041	NNP
cord-005453-4057qib7	2969	52	)	)	-RRB-
cord-005453-4057qib7	2969	53	respectively	respectively	RB
cord-005453-4057qib7	2969	54	)	)	-RRB-
cord-005453-4057qib7	2969	55	.	.	.
cord-005453-4057qib7	2970	1	The	the	DT
cord-005453-4057qib7	2970	2	NRM	NRM	NNP
cord-005453-4057qib7	2970	3	was	be	VBD
cord-005453-4057qib7	2970	4	consistently	consistently	RB
cord-005453-4057qib7	2970	5	higher	high	JJR
cord-005453-4057qib7	2970	6	(	(	-LRB-
cord-005453-4057qib7	2970	7	HR	HR	NNP
cord-005453-4057qib7	2970	8	2.59	2.59	CD
cord-005453-4057qib7	2970	9	;	;	:
cord-005453-4057qib7	2970	10	95%CI	95%ci	CD
cord-005453-4057qib7	2970	11	,	,	,
cord-005453-4057qib7	2970	12	1.69	1.69	CD
cord-005453-4057qib7	2970	13	-	-	SYM
cord-005453-4057qib7	2970	14	3.97	3.97	CD
cord-005453-4057qib7	2970	15	,	,	,
cord-005453-4057qib7	2970	16	p	p	NN
cord-005453-4057qib7	2970	17	<	<	XX
cord-005453-4057qib7	2970	18	0.0001	0.0001	CD
cord-005453-4057qib7	2970	19	)	)	-RRB-
cord-005453-4057qib7	2970	20	for	for	IN
cord-005453-4057qib7	2970	21	patients	patient	NNS
cord-005453-4057qib7	2970	22	with	with	IN
cord-005453-4057qib7	2970	23	CMV	CMV	NNP
cord-005453-4057qib7	2970	24	copies	copy	NNS
cord-005453-4057qib7	2970	25	>	>	NFP
cord-005453-4057qib7	2970	26	100,000	100,000	CD
cord-005453-4057qib7	2970	27	/	/	SYM
cord-005453-4057qib7	2970	28	ml	ml	NN
cord-005453-4057qib7	2970	29	.	.	.
cord-005453-4057qib7	2971	1	The	the	DT
cord-005453-4057qib7	2971	2	risk	risk	NN
cord-005453-4057qib7	2971	3	of	of	IN
cord-005453-4057qib7	2971	4	hematologic	hematologic	JJ
cord-005453-4057qib7	2971	5	relapse	relapse	NN
cord-005453-4057qib7	2971	6	was	be	VBD
cord-005453-4057qib7	2971	7	exclusively	exclusively	RB
cord-005453-4057qib7	2971	8	reduced	reduce	VBN
cord-005453-4057qib7	2971	9	in	in	IN
cord-005453-4057qib7	2971	10	patients	patient	NNS
cord-005453-4057qib7	2971	11	with	with	IN
cord-005453-4057qib7	2971	12	a	a	DT
cord-005453-4057qib7	2971	13	peak	peak	JJ
cord-005453-4057qib7	2971	14	CMV	CMV	NNP
cord-005453-4057qib7	2971	15	viremia	viremia	NN
cord-005453-4057qib7	2971	16	between	between	IN
cord-005453-4057qib7	2971	17	20,000	20,000	CD
cord-005453-4057qib7	2971	18	and	and	CC
cord-005453-4057qib7	2971	19	100,000	100,000	CD
cord-005453-4057qib7	2971	20	copies	copy	NNS
cord-005453-4057qib7	2971	21	/	/	SYM
cord-005453-4057qib7	2971	22	ml	ml	NN
cord-005453-4057qib7	2971	23	(	(	-LRB-
cord-005453-4057qib7	2971	24	HR	HR	NNP
cord-005453-4057qib7	2971	25	0.55	0.55	CD
cord-005453-4057qib7	2971	26	,	,	,
cord-005453-4057qib7	2971	27	95	95	CD
cord-005453-4057qib7	2971	28	%	%	NN
cord-005453-4057qib7	2971	29	CI	CI	NNP
cord-005453-4057qib7	2971	30	0.32	0.32	CD
cord-005453-4057qib7	2971	31	-	-	HYPH
cord-005453-4057qib7	2971	32	0.95	0.95	CD
cord-005453-4057qib7	2971	33	;	;	:
cord-005453-4057qib7	2971	34	p=0.033	p=0.033	NNP
cord-005453-4057qib7	2971	35	)	)	-RRB-
cord-005453-4057qib7	2971	36	as	as	IN
cord-005453-4057qib7	2971	37	compared	compare	VBN
cord-005453-4057qib7	2971	38	to	to	IN
cord-005453-4057qib7	2971	39	patients	patient	NNS
cord-005453-4057qib7	2971	40	without	without	IN
cord-005453-4057qib7	2971	41	CMV	CMV	NNP
cord-005453-4057qib7	2971	42	reactivation	reactivation	NN
cord-005453-4057qib7	2971	43	.	.	.
cord-005453-4057qib7	2972	1	For	for	IN
cord-005453-4057qib7	2972	2	other	other	JJ
cord-005453-4057qib7	2972	3	levels	level	NNS
cord-005453-4057qib7	2972	4	of	of	IN
cord-005453-4057qib7	2972	5	CMV	CMV	NNP
cord-005453-4057qib7	2972	6	reactivation	reactivation	NN
cord-005453-4057qib7	2972	7	this	this	DT
cord-005453-4057qib7	2972	8	effect	effect	NN
cord-005453-4057qib7	2972	9	was	be	VBD
cord-005453-4057qib7	2972	10	not	not	RB
cord-005453-4057qib7	2972	11	observed	observe	VBN
cord-005453-4057qib7	2972	12	.	.	.
cord-005453-4057qib7	2973	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2973	2	:	:	:
cord-005453-4057qib7	2974	1	Our	-PRON-	PRP$
cord-005453-4057qib7	2974	2	data	datum	NNS
cord-005453-4057qib7	2974	3	showed	show	VBD
cord-005453-4057qib7	2974	4	that	that	IN
cord-005453-4057qib7	2974	5	CMV	CMV	NNP
cord-005453-4057qib7	2974	6	reactivations	reactivation	NNS
cord-005453-4057qib7	2974	7	before	before	IN
cord-005453-4057qib7	2974	8	+30d	+30d	NN
cord-005453-4057qib7	2974	9	or	or	CC
cord-005453-4057qib7	2974	10	with	with	IN
cord-005453-4057qib7	2974	11	high	high	JJ
cord-005453-4057qib7	2974	12	titers	titer	NNS
cord-005453-4057qib7	2974	13	of	of	IN
cord-005453-4057qib7	2974	14	>	>	$
cord-005453-4057qib7	2974	15	100,000	100,000	CD
cord-005453-4057qib7	2974	16	copies	copy	NNS
cord-005453-4057qib7	2974	17	/	/	SYM
cord-005453-4057qib7	2974	18	ml	ml	NN
cord-005453-4057qib7	2974	19	associated	associate	VBN
cord-005453-4057qib7	2974	20	with	with	IN
cord-005453-4057qib7	2974	21	significantly	significantly	RB
cord-005453-4057qib7	2974	22	reduced	reduce	VBN
cord-005453-4057qib7	2974	23	OS	os	NN
cord-005453-4057qib7	2974	24	,	,	,
cord-005453-4057qib7	2974	25	while	while	IN
cord-005453-4057qib7	2974	26	CMV	CMV	NNP
cord-005453-4057qib7	2974	27	reactivations	reactivation	NNS
cord-005453-4057qib7	2974	28	at	at	IN
cord-005453-4057qib7	2974	29	intermediate	intermediate	JJ
cord-005453-4057qib7	2974	30	titers	titer	NNS
cord-005453-4057qib7	2974	31	between	between	IN
cord-005453-4057qib7	2974	32	20,000	20,000	CD
cord-005453-4057qib7	2974	33	and	and	CC
cord-005453-4057qib7	2974	34	100,000	100,000	CD
cord-005453-4057qib7	2974	35	copies	copy	NNS
cord-005453-4057qib7	2974	36	/	/	SYM
cord-005453-4057qib7	2974	37	ml	ml	NNS
cord-005453-4057qib7	2974	38	had	have	VBD
cord-005453-4057qib7	2974	39	a	a	DT
cord-005453-4057qib7	2974	40	positive	positive	JJ
cord-005453-4057qib7	2974	41	impact	impact	NN
cord-005453-4057qib7	2974	42	on	on	IN
cord-005453-4057qib7	2974	43	relapse	relapse	NN
cord-005453-4057qib7	2974	44	incidence	incidence	NN
cord-005453-4057qib7	2974	45	.	.	.
cord-005453-4057qib7	2975	1	These	these	DT
cord-005453-4057qib7	2975	2	findings	finding	NNS
cord-005453-4057qib7	2975	3	underline	underline	VBP
cord-005453-4057qib7	2975	4	the	the	DT
cord-005453-4057qib7	2975	5	complexity	complexity	NN
cord-005453-4057qib7	2975	6	of	of	IN
cord-005453-4057qib7	2975	7	CMV	CMV	NNP
cord-005453-4057qib7	2975	8	reactivations	reactivation	NNS
cord-005453-4057qib7	2975	9	after	after	IN
cord-005453-4057qib7	2975	10	HCT	hct	NN
cord-005453-4057qib7	2975	11	outcome	outcome	NN
cord-005453-4057qib7	2975	12	,	,	,
cord-005453-4057qib7	2975	13	and	and	CC
cord-005453-4057qib7	2975	14	support	support	VB
cord-005453-4057qib7	2975	15	longitudinal	longitudinal	JJ
cord-005453-4057qib7	2975	16	evaluation	evaluation	NN
cord-005453-4057qib7	2975	17	of	of	IN
cord-005453-4057qib7	2975	18	CMV	CMV	NNP
cord-005453-4057qib7	2975	19	titers	titer	NNS
cord-005453-4057qib7	2975	20	and	and	CC
cord-005453-4057qib7	2975	21	individualized	individualized	JJ
cord-005453-4057qib7	2975	22	quantitative	quantitative	JJ
cord-005453-4057qib7	2975	23	kinetics	kinetics	NN
cord-005453-4057qib7	2975	24	models	model	NNS
cord-005453-4057qib7	2975	25	for	for	IN
cord-005453-4057qib7	2975	26	risk	risk	NN
cord-005453-4057qib7	2975	27	assessment	assessment	NN
cord-005453-4057qib7	2975	28	after	after	IN
cord-005453-4057qib7	2975	29	HCT	HCT	NNP
cord-005453-4057qib7	2975	30	to	to	TO
cord-005453-4057qib7	2975	31	distinguish	distinguish	VB
cord-005453-4057qib7	2975	32	the	the	DT
cord-005453-4057qib7	2975	33	advantageous	advantageous	JJ
cord-005453-4057qib7	2975	34	from	from	IN
cord-005453-4057qib7	2975	35	the	the	DT
cord-005453-4057qib7	2975	36	detrimental	detrimental	JJ
cord-005453-4057qib7	2975	37	aspects	aspect	NNS
cord-005453-4057qib7	2975	38	of	of	IN
cord-005453-4057qib7	2975	39	CMV	CMV	NNP
cord-005453-4057qib7	2975	40	reactivation	reactivation	NN
cord-005453-4057qib7	2975	41	.	.	.
cord-005453-4057qib7	2976	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2976	2	:	:	:
cord-005453-4057qib7	2977	1	ATT	ATT	NNP
cord-005453-4057qib7	2977	2	has	have	VBZ
cord-005453-4057qib7	2977	3	received	receive	VBN
cord-005453-4057qib7	2977	4	lecture	lecture	NN
cord-005453-4057qib7	2977	5	fees	fee	NNS
cord-005453-4057qib7	2977	6	from	from	IN
cord-005453-4057qib7	2977	7	Jazz	Jazz	NNP
cord-005453-4057qib7	2977	8	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	2977	9	and	and	CC
cord-005453-4057qib7	2977	10	travel	travel	NN
cord-005453-4057qib7	2977	11	subsidies	subsidy	NNS
cord-005453-4057qib7	2977	12	from	from	IN
cord-005453-4057qib7	2977	13	Neovii	Neovii	NNP
cord-005453-4057qib7	2977	14	Biotech	Biotech	NNP
cord-005453-4057qib7	2977	15	outside	outside	IN
cord-005453-4057qib7	2977	16	the	the	DT
cord-005453-4057qib7	2977	17	submitted	submit	VBN
cord-005453-4057qib7	2977	18	work	work	NN
cord-005453-4057qib7	2977	19	.	.	.
cord-005453-4057qib7	2978	1	The	the	DT
cord-005453-4057qib7	2978	2	other	other	JJ
cord-005453-4057qib7	2978	3	authors	author	NNS
cord-005453-4057qib7	2978	4	declare	declare	VBP
cord-005453-4057qib7	2978	5	no	no	DT
cord-005453-4057qib7	2978	6	competing	compete	VBG
cord-005453-4057qib7	2978	7	financial	financial	JJ
cord-005453-4057qib7	2978	8	interests	interest	NNS
cord-005453-4057qib7	2978	9	within	within	IN
cord-005453-4057qib7	2978	10	the	the	DT
cord-005453-4057qib7	2978	11	submitted	submit	VBN
cord-005453-4057qib7	2978	12	work	work	NN
cord-005453-4057qib7	2978	13	.	.	.
cord-005453-4057qib7	2979	1	Association	Association	NNP
cord-005453-4057qib7	2979	2	of	of	IN
cord-005453-4057qib7	2979	3	serum	serum	NN
cord-005453-4057qib7	2979	4	ferritin	ferritin	NN
cord-005453-4057qib7	2979	5	levels	level	NNS
cord-005453-4057qib7	2979	6	before	before	IN
cord-005453-4057qib7	2979	7	start	start	NN
cord-005453-4057qib7	2979	8	of	of	IN
cord-005453-4057qib7	2979	9	conditioning	conditioning	NN
cord-005453-4057qib7	2979	10	with	with	IN
cord-005453-4057qib7	2979	11	mortality	mortality	NN
cord-005453-4057qib7	2979	12	after	after	IN
cord-005453-4057qib7	2979	13	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2979	14	-a	-a	HYPH
cord-005453-4057qib7	2979	15	prospective	prospective	JJ
cord-005453-4057qib7	2979	16	,	,	,
cord-005453-4057qib7	2979	17	non	non	JJ
cord-005453-4057qib7	2979	18	-	-	JJ
cord-005453-4057qib7	2979	19	interventional	interventional	JJ
cord-005453-4057qib7	2979	20	study	study	NN
cord-005453-4057qib7	2979	21	of	of	IN
cord-005453-4057qib7	2979	22	the	the	DT
cord-005453-4057qib7	2979	23	EBMT	EBMT	NNP
cord-005453-4057qib7	2979	24	transplant	transplant	NN
cord-005453-4057qib7	2979	25	complication	complication	NN
cord-005453-4057qib7	2979	26	working	work	VBG
cord-005453-4057qib7	2979	27	party	party	NN
cord-005453-4057qib7	2979	28	Background	Background	NNP
cord-005453-4057qib7	2979	29	:	:	:
cord-005453-4057qib7	2980	1	Elevated	elevated	JJ
cord-005453-4057qib7	2980	2	serum	serum	NN
cord-005453-4057qib7	2980	3	ferritin	ferritin	NN
cord-005453-4057qib7	2980	4	levels	level	NNS
cord-005453-4057qib7	2980	5	occur	occur	VBP
cord-005453-4057qib7	2980	6	due	due	JJ
cord-005453-4057qib7	2980	7	to	to	IN
cord-005453-4057qib7	2980	8	iron	iron	NN
cord-005453-4057qib7	2980	9	overload	overload	NN
cord-005453-4057qib7	2980	10	or	or	CC
cord-005453-4057qib7	2980	11	during	during	IN
cord-005453-4057qib7	2980	12	inflammation	inflammation	NN
cord-005453-4057qib7	2980	13	and	and	CC
cord-005453-4057qib7	2980	14	macrophage	macrophage	NN
cord-005453-4057qib7	2980	15	activation	activation	NN
cord-005453-4057qib7	2980	16	.	.	.
cord-005453-4057qib7	2981	1	A	a	DT
cord-005453-4057qib7	2981	2	correlation	correlation	NN
cord-005453-4057qib7	2981	3	of	of	IN
cord-005453-4057qib7	2981	4	high	high	JJ
cord-005453-4057qib7	2981	5	serum	serum	NN
cord-005453-4057qib7	2981	6	ferritin	ferritin	NN
cord-005453-4057qib7	2981	7	levels	level	NNS
cord-005453-4057qib7	2981	8	with	with	IN
cord-005453-4057qib7	2981	9	increased	increase	VBN
cord-005453-4057qib7	2981	10	mortality	mortality	NN
cord-005453-4057qib7	2981	11	after	after	IN
cord-005453-4057qib7	2981	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2981	13	has	have	VBZ
cord-005453-4057qib7	2981	14	been	be	VBN
cord-005453-4057qib7	2981	15	suggested	suggest	VBN
cord-005453-4057qib7	2981	16	by	by	IN
cord-005453-4057qib7	2981	17	several	several	JJ
cord-005453-4057qib7	2981	18	retrospective	retrospective	JJ
cord-005453-4057qib7	2981	19	analyses	analysis	NNS
cord-005453-4057qib7	2981	20	as	as	RB
cord-005453-4057qib7	2981	21	well	well	RB
cord-005453-4057qib7	2981	22	as	as	IN
cord-005453-4057qib7	2981	23	by	by	IN
cord-005453-4057qib7	2981	24	two	two	CD
cord-005453-4057qib7	2981	25	smaller	small	JJR
cord-005453-4057qib7	2981	26	prospective	prospective	JJ
cord-005453-4057qib7	2981	27	studies	study	NNS
cord-005453-4057qib7	2981	28	.	.	.
cord-005453-4057qib7	2982	1	Methods	method	NNS
cord-005453-4057qib7	2982	2	:	:	:
cord-005453-4057qib7	2983	1	This	this	DT
cord-005453-4057qib7	2983	2	international	international	JJ
cord-005453-4057qib7	2983	3	multicentric	multicentric	NNP
cord-005453-4057qib7	2983	4	study	study	NN
cord-005453-4057qib7	2983	5	aimed	aim	VBN
cord-005453-4057qib7	2983	6	to	to	TO
cord-005453-4057qib7	2983	7	study	study	VB
cord-005453-4057qib7	2983	8	the	the	DT
cord-005453-4057qib7	2983	9	association	association	NNP
cord-005453-4057qib7	2983	10	of	of	IN
cord-005453-4057qib7	2983	11	ferritin	ferritin	NNP
cord-005453-4057qib7	2983	12	serum	serum	NN
cord-005453-4057qib7	2983	13	levels	level	NNS
cord-005453-4057qib7	2983	14	before	before	IN
cord-005453-4057qib7	2983	15	start	start	NN
cord-005453-4057qib7	2983	16	of	of	IN
cord-005453-4057qib7	2983	17	conditioning	conditioning	NN
cord-005453-4057qib7	2983	18	with	with	IN
cord-005453-4057qib7	2983	19	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2983	20	outcome	outcome	NN
cord-005453-4057qib7	2983	21	.	.	.
cord-005453-4057qib7	2984	1	Patients	patient	NNS
cord-005453-4057qib7	2984	2	with	with	IN
cord-005453-4057qib7	2984	3	acute	acute	JJ
cord-005453-4057qib7	2984	4	leukemia	leukemia	NN
cord-005453-4057qib7	2984	5	,	,	,
cord-005453-4057qib7	2984	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	2984	7	or	or	CC
cord-005453-4057qib7	2984	8	MDS	MDS	NNP
cord-005453-4057qib7	2984	9	receiving	receive	VBG
cord-005453-4057qib7	2984	10	a	a	DT
cord-005453-4057qib7	2984	11	matched	match	VBN
cord-005453-4057qib7	2984	12	sibling	sibling	NN
cord-005453-4057qib7	2984	13	alloSCT	allosct	NN
cord-005453-4057qib7	2984	14	for	for	IN
cord-005453-4057qib7	2984	15	the	the	DT
cord-005453-4057qib7	2984	16	first	first	JJ
cord-005453-4057qib7	2984	17	time	time	NN
cord-005453-4057qib7	2984	18	were	be	VBD
cord-005453-4057qib7	2984	19	considered	consider	VBN
cord-005453-4057qib7	2984	20	for	for	IN
cord-005453-4057qib7	2984	21	inclusion	inclusion	NN
cord-005453-4057qib7	2984	22	,	,	,
cord-005453-4057qib7	2984	23	regardless	regardless	RB
cord-005453-4057qib7	2984	24	of	of	IN
cord-005453-4057qib7	2984	25	conditioning	conditioning	NN
cord-005453-4057qib7	2984	26	.	.	.
cord-005453-4057qib7	2985	1	Data	datum	NNS
cord-005453-4057qib7	2985	2	were	be	VBD
cord-005453-4057qib7	2985	3	prospectively	prospectively	RB
cord-005453-4057qib7	2985	4	collected	collect	VBN
cord-005453-4057qib7	2985	5	between	between	IN
cord-005453-4057qib7	2985	6	8/2014	8/2014	NNS
cord-005453-4057qib7	2985	7	and	and	CC
cord-005453-4057qib7	2985	8	2/2018	2/2018	CD
cord-005453-4057qib7	2985	9	.	.	.
cord-005453-4057qib7	2986	1	A	a	DT
cord-005453-4057qib7	2986	2	comparison	comparison	NN
cord-005453-4057qib7	2986	3	of	of	IN
cord-005453-4057qib7	2986	4	outcomes	outcome	NNS
cord-005453-4057qib7	2986	5	between	between	IN
cord-005453-4057qib7	2986	6	patients	patient	NNS
cord-005453-4057qib7	2986	7	with	with	IN
cord-005453-4057qib7	2986	8	high	high	JJ
cord-005453-4057qib7	2986	9	and	and	CC
cord-005453-4057qib7	2986	10	low	low	JJ
cord-005453-4057qib7	2986	11	ferritin	ferritin	NN
cord-005453-4057qib7	2986	12	level	level	NN
cord-005453-4057qib7	2986	13	was	be	VBD
cord-005453-4057qib7	2986	14	performed	perform	VBN
cord-005453-4057qib7	2986	15	using	use	VBG
cord-005453-4057qib7	2986	16	univariate	univariate	JJ
cord-005453-4057qib7	2986	17	analysis	analysis	NN
cord-005453-4057qib7	2986	18	and	and	CC
cord-005453-4057qib7	2986	19	multivariate	multivariate	JJ
cord-005453-4057qib7	2986	20	analysis	analysis	NN
cord-005453-4057qib7	2986	21	using	use	VBG
cord-005453-4057qib7	2986	22	cause	cause	NN
cord-005453-4057qib7	2986	23	-	-	HYPH
cord-005453-4057qib7	2986	24	specific	specific	JJ
cord-005453-4057qib7	2986	25	Cox	Cox	NNP
cord-005453-4057qib7	2986	26	model	model	NN
cord-005453-4057qib7	2986	27	.	.	.
cord-005453-4057qib7	2987	1	Variables	variable	NNS
cord-005453-4057qib7	2987	2	included	include	VBN
cord-005453-4057qib7	2987	3	in	in	IN
cord-005453-4057qib7	2987	4	the	the	DT
cord-005453-4057qib7	2987	5	multivariate	multivariate	JJ
cord-005453-4057qib7	2987	6	analyses	analysis	NNS
cord-005453-4057qib7	2987	7	were	be	VBD
cord-005453-4057qib7	2987	8	age	age	NN
cord-005453-4057qib7	2987	9	,	,	,
cord-005453-4057qib7	2987	10	sex	sex	NN
cord-005453-4057qib7	2987	11	mismatch	mismatch	NN
cord-005453-4057qib7	2987	12	,	,	,
cord-005453-4057qib7	2987	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	2987	14	,	,	,
cord-005453-4057qib7	2987	15	disease	disease	NN
cord-005453-4057qib7	2987	16	status	status	NN
cord-005453-4057qib7	2987	17	,	,	,
cord-005453-4057qib7	2987	18	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	2987	19	score	score	NN
cord-005453-4057qib7	2987	20	,	,	,
cord-005453-4057qib7	2987	21	number	number	NN
cord-005453-4057qib7	2987	22	of	of	IN
cord-005453-4057qib7	2987	23	CD34	CD34	NNP
cord-005453-4057qib7	2987	24	cells	cell	NNS
cord-005453-4057qib7	2987	25	given	give	VBN
cord-005453-4057qib7	2987	26	,	,	,
cord-005453-4057qib7	2987	27	intensity	intensity	NN
cord-005453-4057qib7	2987	28	of	of	IN
cord-005453-4057qib7	2987	29	conditioning	conditioning	NN
cord-005453-4057qib7	2987	30	,	,	,
cord-005453-4057qib7	2987	31	type	type	NN
cord-005453-4057qib7	2987	32	of	of	IN
cord-005453-4057qib7	2987	33	GVHD	GVHD	NNP
cord-005453-4057qib7	2987	34	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	2987	35	,	,	,
cord-005453-4057qib7	2987	36	ATG	ATG	NNP
cord-005453-4057qib7	2987	37	use	use	NN
cord-005453-4057qib7	2987	38	,	,	,
cord-005453-4057qib7	2987	39	time	time	NN
cord-005453-4057qib7	2987	40	from	from	IN
cord-005453-4057qib7	2987	41	diagnosis	diagnosis	NN
cord-005453-4057qib7	2987	42	to	to	IN
cord-005453-4057qib7	2987	43	transplant	transplant	NN
cord-005453-4057qib7	2987	44	,	,	,
cord-005453-4057qib7	2987	45	year	year	NN
cord-005453-4057qib7	2987	46	of	of	IN
cord-005453-4057qib7	2987	47	transplant	transplant	NN
cord-005453-4057qib7	2987	48	and	and	CC
cord-005453-4057qib7	2987	49	CMV	CMV	NNP
cord-005453-4057qib7	2987	50	status	status	NN
cord-005453-4057qib7	2987	51	.	.	.
cord-005453-4057qib7	2988	1	Results	result	NNS
cord-005453-4057qib7	2988	2	:	:	:
cord-005453-4057qib7	2989	1	Twenty	twenty	CD
cord-005453-4057qib7	2989	2	centers	center	NNS
cord-005453-4057qib7	2989	3	from	from	IN
cord-005453-4057qib7	2989	4	10	10	CD
cord-005453-4057qib7	2989	5	European	european	JJ
cord-005453-4057qib7	2989	6	countries	country	NNS
cord-005453-4057qib7	2989	7	reported	report	VBD
cord-005453-4057qib7	2989	8	data	datum	NNS
cord-005453-4057qib7	2989	9	on	on	IN
cord-005453-4057qib7	2989	10	385	385	CD
cord-005453-4057qib7	2989	11	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2989	12	recipients	recipient	NNS
cord-005453-4057qib7	2989	13	.	.	.
cord-005453-4057qib7	2990	1	Patient	patient	JJ
cord-005453-4057qib7	2990	2	characteristics	characteristic	NNS
cord-005453-4057qib7	2990	3	are	be	VBP
cord-005453-4057qib7	2990	4	given	give	VBN
cord-005453-4057qib7	2990	5	in	in	IN
cord-005453-4057qib7	2990	6	Table	Table	NNP
cord-005453-4057qib7	2990	7	1	1	CD
cord-005453-4057qib7	2990	8	.	.	.
cord-005453-4057qib7	2991	1	The	the	DT
cord-005453-4057qib7	2991	2	ferritin	ferritin	NN
cord-005453-4057qib7	2991	3	cut	cut	VBD
cord-005453-4057qib7	2991	4	off	off	RP
cord-005453-4057qib7	2991	5	point	point	NN
cord-005453-4057qib7	2991	6	was	be	VBD
cord-005453-4057qib7	2991	7	determined	determine	VBN
cord-005453-4057qib7	2991	8	at	at	IN
cord-005453-4057qib7	2991	9	1500μg	1500μg	CD
cord-005453-4057qib7	2991	10	/	/	SYM
cord-005453-4057qib7	2991	11	l	l	NN
cord-005453-4057qib7	2991	12	(	(	-LRB-
cord-005453-4057qib7	2991	13	median	median	NN
cord-005453-4057qib7	2991	14	of	of	IN
cord-005453-4057qib7	2991	15	measured	measured	JJ
cord-005453-4057qib7	2991	16	ferritin	ferritin	NN
cord-005453-4057qib7	2991	17	levels	level	NNS
cord-005453-4057qib7	2991	18	)	)	-RRB-
cord-005453-4057qib7	2991	19	.	.	.
cord-005453-4057qib7	2992	1	Overall	overall	JJ
cord-005453-4057qib7	2992	2	survival	survival	NN
cord-005453-4057qib7	2992	3	of	of	IN
cord-005453-4057qib7	2992	4	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2992	5	recipients	recipient	NNS
cord-005453-4057qib7	2992	6	with	with	IN
cord-005453-4057qib7	2992	7	ferritin	ferritin	NN
cord-005453-4057qib7	2992	8	levels	level	NNS
cord-005453-4057qib7	2992	9	above	above	IN
cord-005453-4057qib7	2992	10	cut	cut	VBD
cord-005453-4057qib7	2992	11	off	off	RP
cord-005453-4057qib7	2992	12	measured	measure	VBN
cord-005453-4057qib7	2992	13	before	before	IN
cord-005453-4057qib7	2992	14	start	start	NN
cord-005453-4057qib7	2992	15	of	of	IN
cord-005453-4057qib7	2992	16	conditioning	conditioning	NN
cord-005453-4057qib7	2992	17	was	be	VBD
cord-005453-4057qib7	2992	18	significantly	significantly	RB
cord-005453-4057qib7	2992	19	shorter	short	JJR
cord-005453-4057qib7	2992	20	(	(	-LRB-
cord-005453-4057qib7	2992	21	Figure	figure	NN
cord-005453-4057qib7	2992	22	1A	1a	NN
cord-005453-4057qib7	2992	23	,	,	,
cord-005453-4057qib7	2992	24	univariate	univariate	JJ
cord-005453-4057qib7	2992	25	HR=2.3	HR=2.3	NNP
cord-005453-4057qib7	2992	26	CI=1.4	CI=1.4	NNP
cord-005453-4057qib7	2992	27	-	-	HYPH
cord-005453-4057qib7	2992	28	3.6	3.6	CD
cord-005453-4057qib7	2992	29	p=0.00041	p=0.00041	NNP
cord-005453-4057qib7	2992	30	;	;	:
cord-005453-4057qib7	2992	31	multivariate	multivariate	JJ
cord-005453-4057qib7	2992	32	HR=2.5	HR=2.5	NNP
cord-005453-4057qib7	2992	33	,	,	,
cord-005453-4057qib7	2992	34	CI=1.5	CI=1.5	NNP
cord-005453-4057qib7	2992	35	-	-	HYPH
cord-005453-4057qib7	2992	36	4.1	4.1	CD
cord-005453-4057qib7	2992	37	,	,	,
cord-005453-4057qib7	2992	38	p=0.0005	p=0.0005	NNP
cord-005453-4057qib7	2992	39	)	)	-RRB-
cord-005453-4057qib7	2992	40	.	.	.
cord-005453-4057qib7	2993	1	Progression	progression	NN
cord-005453-4057qib7	2993	2	-	-	HYPH
cord-005453-4057qib7	2993	3	free	free	JJ
cord-005453-4057qib7	2993	4	survival	survival	NN
cord-005453-4057qib7	2993	5	was	be	VBD
cord-005453-4057qib7	2993	6	also	also	RB
cord-005453-4057qib7	2993	7	shorter	short	JJR
cord-005453-4057qib7	2993	8	(	(	-LRB-
cord-005453-4057qib7	2993	9	Figure	figure	NN
cord-005453-4057qib7	2993	10	1B	1b	NN
cord-005453-4057qib7	2993	11	,	,	,
cord-005453-4057qib7	2993	12	univariate	univariate	JJ
cord-005453-4057qib7	2993	13	HR=2.1	HR=2.1	NNP
cord-005453-4057qib7	2993	14	CI=1.4	CI=1.4	NNP
cord-005453-4057qib7	2993	15	-	-	HYPH
cord-005453-4057qib7	2993	16	3.2	3.2	CD
cord-005453-4057qib7	2993	17	p=0.00014	p=0.00014	NNS
cord-005453-4057qib7	2993	18	;	;	:
cord-005453-4057qib7	2993	19	multivariate	multivariate	JJ
cord-005453-4057qib7	2993	20	HR=2.4	HR=2.4	NNP
cord-005453-4057qib7	2993	21	,	,	,
cord-005453-4057qib7	2993	22	CI=1.6	CI=1.6	NNP
cord-005453-4057qib7	2993	23	-	-	HYPH
cord-005453-4057qib7	2993	24	3.8	3.8	CD
cord-005453-4057qib7	2993	25	,	,	,
cord-005453-4057qib7	2993	26	p	p	NN
cord-005453-4057qib7	2993	27	<	<	XX
cord-005453-4057qib7	2993	28	0.0001	0.0001	CD
cord-005453-4057qib7	2993	29	)	)	-RRB-
cord-005453-4057qib7	2993	30	.	.	.
cord-005453-4057qib7	2994	1	Excess	excess	JJ
cord-005453-4057qib7	2994	2	mortality	mortality	NN
cord-005453-4057qib7	2994	3	in	in	IN
cord-005453-4057qib7	2994	4	the	the	DT
cord-005453-4057qib7	2994	5	high	high	JJ
cord-005453-4057qib7	2994	6	ferritin	ferritin	NN
cord-005453-4057qib7	2994	7	group	group	NN
cord-005453-4057qib7	2994	8	was	be	VBD
cord-005453-4057qib7	2994	9	due	due	JJ
cord-005453-4057qib7	2994	10	to	to	IN
cord-005453-4057qib7	2994	11	both	both	DT
cord-005453-4057qib7	2994	12	higher	high	JJR
cord-005453-4057qib7	2994	13	relapse	relapse	NN
cord-005453-4057qib7	2994	14	incidence	incidence	NN
cord-005453-4057qib7	2994	15	(	(	-LRB-
cord-005453-4057qib7	2994	16	univariate	univariate	JJ
cord-005453-4057qib7	2994	17	HR=1.7	HR=1.7	NNP
cord-005453-4057qib7	2994	18	CI=1	CI=1	NNP
cord-005453-4057qib7	2994	19	-	-	HYPH
cord-005453-4057qib7	2994	20	2.8	2.8	CD
cord-005453-4057qib7	2994	21	p=0.03	p=0.03	NNP
cord-005453-4057qib7	2994	22	;	;	,
cord-005453-4057qib7	2994	23	multivariate	multivariate	JJ
cord-005453-4057qib7	2994	24	HR=2.2	HR=2.2	NNP
cord-005453-4057qib7	2994	25	,	,	,
cord-005453-4057qib7	2994	26	CI=1.2	CI=1.2	NNP
cord-005453-4057qib7	2994	27	-	-	HYPH
cord-005453-4057qib7	2994	28	3.8	3.8	CD
cord-005453-4057qib7	2994	29	,	,	,
cord-005453-4057qib7	2994	30	p=0.007	p=0.007	NNP
cord-005453-4057qib7	2994	31	)	)	-RRB-
cord-005453-4057qib7	2994	32	and	and	CC
cord-005453-4057qib7	2994	33	increased	increase	VBN
cord-005453-4057qib7	2994	34	non	non	JJ
cord-005453-4057qib7	2994	35	-	-	JJ
cord-005453-4057qib7	2994	36	relapse	relapse	JJ
cord-005453-4057qib7	2994	37	mortality	mortality	NN
cord-005453-4057qib7	2994	38	(	(	-LRB-
cord-005453-4057qib7	2994	39	univariate	univariate	JJ
cord-005453-4057qib7	2994	40	HR=3.1	HR=3.1	NNP
cord-005453-4057qib7	2994	41	CI=1.5	CI=1.5	NNP
cord-005453-4057qib7	2994	42	-	-	HYPH
cord-005453-4057qib7	2994	43	6.3	6.3	CD
cord-005453-4057qib7	2994	44	p=0.002	p=0.002	NNS
cord-005453-4057qib7	2994	45	;	;	,
cord-005453-4057qib7	2994	46	multivariate	multivariate	JJ
cord-005453-4057qib7	2994	47	HR=3.1	HR=3.1	NNP
cord-005453-4057qib7	2994	48	,	,	,
cord-005453-4057qib7	2994	49	CI=1.5	CI=1.5	NNP
cord-005453-4057qib7	2994	50	-	-	HYPH
cord-005453-4057qib7	2994	51	6.4	6.4	CD
cord-005453-4057qib7	2994	52	,	,	,
cord-005453-4057qib7	2994	53	p=0.002	p=0.002	NNP
cord-005453-4057qib7	2994	54	)	)	-RRB-
cord-005453-4057qib7	2994	55	.	.	.
cord-005453-4057qib7	2995	1	Non	non	JJ
cord-005453-4057qib7	2995	2	-	-	JJ
cord-005453-4057qib7	2995	3	relapse	relapse	JJ
cord-005453-4057qib7	2995	4	mortality	mortality	NN
cord-005453-4057qib7	2995	5	was	be	VBD
cord-005453-4057qib7	2995	6	driven	drive	VBN
cord-005453-4057qib7	2995	7	by	by	IN
cord-005453-4057qib7	2995	8	significantly	significantly	RB
cord-005453-4057qib7	2995	9	higher	high	JJR
cord-005453-4057qib7	2995	10	infection	infection	NN
cord-005453-4057qib7	2995	11	-	-	HYPH
cord-005453-4057qib7	2995	12	related	relate	VBN
cord-005453-4057qib7	2995	13	mortality	mortality	NN
cord-005453-4057qib7	2995	14	in	in	IN
cord-005453-4057qib7	2995	15	the	the	DT
cord-005453-4057qib7	2995	16	high	high	JJ
cord-005453-4057qib7	2995	17	ferritin	ferritin	NN
cord-005453-4057qib7	2995	18	group	group	NN
cord-005453-4057qib7	2995	19	(	(	-LRB-
cord-005453-4057qib7	2995	20	univariate	univariate	JJ
cord-005453-4057qib7	2995	21	HR=3.9	HR=3.9	NNP
cord-005453-4057qib7	2995	22	CI=1.6	CI=1.6	NNP
cord-005453-4057qib7	2995	23	-	-	:
cord-005453-4057qib7	2995	24	9.7	9.7	CD
cord-005453-4057qib7	2995	25	p	p	NN
cord-005453-4057qib7	2995	26	=	=	SYM
cord-005453-4057qib7	2995	27	0.003	0.003	CD
cord-005453-4057qib7	2995	28	;	;	,
cord-005453-4057qib7	2995	29	multivariate	multivariate	JJ
cord-005453-4057qib7	2995	30	HR	hr	NN
cord-005453-4057qib7	2995	31	=	=	SYM
cord-005453-4057qib7	2995	32	3.9	3.9	CD
cord-005453-4057qib7	2995	33	,	,	,
cord-005453-4057qib7	2995	34	CI	CI	NNP
cord-005453-4057qib7	2995	35	=	=	SYM
cord-005453-4057qib7	2995	36	1.6	1.6	CD
cord-005453-4057qib7	2995	37	-	-	SYM
cord-005453-4057qib7	2995	38	9.7	9.7	CD
cord-005453-4057qib7	2995	39	p	p	NN
cord-005453-4057qib7	2995	40	=	=	SYM
cord-005453-4057qib7	2995	41	0.003	0.003	CD
cord-005453-4057qib7	2995	42	)	)	-RRB-
cord-005453-4057qib7	2995	43	.	.	.
cord-005453-4057qib7	2996	1	Acute	acute	JJ
cord-005453-4057qib7	2996	2	and	and	CC
cord-005453-4057qib7	2996	3	chronic	chronic	JJ
cord-005453-4057qib7	2996	4	GVHD	GVHD	NNP
cord-005453-4057qib7	2996	5	incidence	incidence	NN
cord-005453-4057qib7	2996	6	or	or	CC
cord-005453-4057qib7	2996	7	severity	severity	NN
cord-005453-4057qib7	2996	8	were	be	VBD
cord-005453-4057qib7	2996	9	not	not	RB
cord-005453-4057qib7	2996	10	associated	associate	VBN
cord-005453-4057qib7	2996	11	to	to	IN
cord-005453-4057qib7	2996	12	serum	serum	NN
cord-005453-4057qib7	2996	13	ferritin	ferritin	NN
cord-005453-4057qib7	2996	14	levels	level	NNS
cord-005453-4057qib7	2996	15	.	.	.
cord-005453-4057qib7	2997	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	2997	2	:	:	:
cord-005453-4057qib7	2998	1	Ferritin	ferritin	NN
cord-005453-4057qib7	2998	2	levels	level	NNS
cord-005453-4057qib7	2998	3	before	before	IN
cord-005453-4057qib7	2998	4	start	start	NN
cord-005453-4057qib7	2998	5	of	of	IN
cord-005453-4057qib7	2998	6	conditioning	conditioning	NN
cord-005453-4057qib7	2998	7	can	can	MD
cord-005453-4057qib7	2998	8	serve	serve	VB
cord-005453-4057qib7	2998	9	as	as	IN
cord-005453-4057qib7	2998	10	routine	routine	JJ
cord-005453-4057qib7	2998	11	laboratory	laboratory	NN
cord-005453-4057qib7	2998	12	biomarker	biomarker	NN
cord-005453-4057qib7	2998	13	to	to	TO
cord-005453-4057qib7	2998	14	predict	predict	VB
cord-005453-4057qib7	2998	15	mortality	mortality	NN
cord-005453-4057qib7	2998	16	after	after	IN
cord-005453-4057qib7	2998	17	alloSCT	alloSCT	NNP
cord-005453-4057qib7	2998	18	.	.	.
cord-005453-4057qib7	2999	1	Disclosure	disclosure	NN
cord-005453-4057qib7	2999	2	:	:	:
cord-005453-4057qib7	3000	1	The	the	DT
cord-005453-4057qib7	3000	2	authors	author	NNS
cord-005453-4057qib7	3000	3	declare	declare	VBP
cord-005453-4057qib7	3000	4	no	no	DT
cord-005453-4057qib7	3000	5	confict	confict	NN
cord-005453-4057qib7	3000	6	of	of	IN
cord-005453-4057qib7	3000	7	interest	interest	NN
cord-005453-4057qib7	3000	8	related	relate	VBN
cord-005453-4057qib7	3000	9	to	to	IN
cord-005453-4057qib7	3000	10	this	this	DT
cord-005453-4057qib7	3000	11	study	study	NN
cord-005453-4057qib7	3000	12	P147	P147	NNP
cord-005453-4057qib7	3000	13	Prediction	Prediction	NNP
cord-005453-4057qib7	3000	14	of	of	IN
cord-005453-4057qib7	3000	15	reduced	reduce	VBN
cord-005453-4057qib7	3000	16	lung	lung	NN
cord-005453-4057qib7	3000	17	function	function	NN
cord-005453-4057qib7	3000	18	and	and	CC
cord-005453-4057qib7	3000	19	acute	acute	JJ
cord-005453-4057qib7	3000	20	GVHD	GVHD	NNP
cord-005453-4057qib7	3000	21	by	by	IN
cord-005453-4057qib7	3000	22	surfactant	surfactant	NN
cord-005453-4057qib7	3000	23	protein	protein	NN
cord-005453-4057qib7	3000	24	D	d	NN
cord-005453-4057qib7	3000	25	in	in	IN
cord-005453-4057qib7	3000	26	allogeneic	allogeneic	NN
cord-005453-4057qib7	3000	27	stem	stem	NN
cord-005453-4057qib7	3000	28	cell	cell	NN
cord-005453-4057qib7	3000	29	transplantation	transplantation	NN
cord-005453-4057qib7	3000	30	transplantation	transplantation	NN
cord-005453-4057qib7	3000	31	(	(	-LRB-
cord-005453-4057qib7	3000	32	HSCT	HSCT	NNP
cord-005453-4057qib7	3000	33	)	)	-RRB-
cord-005453-4057qib7	3000	34	and	and	CC
cord-005453-4057qib7	3000	35	may	may	MD
cord-005453-4057qib7	3000	36	progress	progress	VB
cord-005453-4057qib7	3000	37	to	to	IN
cord-005453-4057qib7	3000	38	bronchiolitis	bronchiolitis	NNP
cord-005453-4057qib7	3000	39	obliterans	obliterans	NNP
cord-005453-4057qib7	3000	40	that	that	WDT
cord-005453-4057qib7	3000	41	has	have	VBZ
cord-005453-4057qib7	3000	42	a	a	DT
cord-005453-4057qib7	3000	43	high	high	JJ
cord-005453-4057qib7	3000	44	mortality	mortality	NN
cord-005453-4057qib7	3000	45	rate	rate	NN
cord-005453-4057qib7	3000	46	.	.	.
cord-005453-4057qib7	3001	1	Surfactant	surfactant	NN
cord-005453-4057qib7	3001	2	protein	protein	NN
cord-005453-4057qib7	3001	3	D	d	NN
cord-005453-4057qib7	3001	4	(	(	-LRB-
cord-005453-4057qib7	3001	5	SP	SP	NNP
cord-005453-4057qib7	3001	6	-	-	HYPH
cord-005453-4057qib7	3001	7	D	D	NNP
cord-005453-4057qib7	3001	8	)	)	-RRB-
cord-005453-4057qib7	3001	9	is	be	VBZ
cord-005453-4057qib7	3001	10	an	an	DT
cord-005453-4057qib7	3001	11	innate	innate	JJ
cord-005453-4057qib7	3001	12	defense	defense	NN
cord-005453-4057qib7	3001	13	molecule	molecule	NN
cord-005453-4057qib7	3001	14	involved	involve	VBN
cord-005453-4057qib7	3001	15	in	in	IN
cord-005453-4057qib7	3001	16	immune	immune	JJ
cord-005453-4057qib7	3001	17	regulation	regulation	NN
cord-005453-4057qib7	3001	18	at	at	IN
cord-005453-4057qib7	3001	19	the	the	DT
cord-005453-4057qib7	3001	20	epithelial	epithelial	JJ
cord-005453-4057qib7	3001	21	surfaces	surface	NNS
cord-005453-4057qib7	3001	22	,	,	,
cord-005453-4057qib7	3001	23	particularly	particularly	RB
cord-005453-4057qib7	3001	24	in	in	IN
cord-005453-4057qib7	3001	25	the	the	DT
cord-005453-4057qib7	3001	26	lungs	lung	NNS
cord-005453-4057qib7	3001	27	,	,	,
cord-005453-4057qib7	3001	28	and	and	CC
cord-005453-4057qib7	3001	29	elevated	elevated	JJ
cord-005453-4057qib7	3001	30	levels	level	NNS
cord-005453-4057qib7	3001	31	have	have	VBP
cord-005453-4057qib7	3001	32	been	be	VBN
cord-005453-4057qib7	3001	33	associated	associate	VBN
cord-005453-4057qib7	3001	34	with	with	IN
cord-005453-4057qib7	3001	35	exacerbation	exacerbation	NN
cord-005453-4057qib7	3001	36	of	of	IN
cord-005453-4057qib7	3001	37	chronic	chronic	JJ
cord-005453-4057qib7	3001	38	obstructive	obstructive	JJ
cord-005453-4057qib7	3001	39	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3001	40	disease	disease	NN
cord-005453-4057qib7	3001	41	(	(	-LRB-
cord-005453-4057qib7	3001	42	COPD	COPD	NNP
cord-005453-4057qib7	3001	43	)	)	-RRB-
cord-005453-4057qib7	3001	44	.	.	.
cord-005453-4057qib7	3002	1	The	the	DT
cord-005453-4057qib7	3002	2	aim	aim	NN
cord-005453-4057qib7	3002	3	of	of	IN
cord-005453-4057qib7	3002	4	this	this	DT
cord-005453-4057qib7	3002	5	study	study	NN
cord-005453-4057qib7	3002	6	was	be	VBD
cord-005453-4057qib7	3002	7	to	to	TO
cord-005453-4057qib7	3002	8	investigate	investigate	VB
cord-005453-4057qib7	3002	9	,	,	,
cord-005453-4057qib7	3002	10	whether	whether	IN
cord-005453-4057qib7	3002	11	SP	SP	NNP
cord-005453-4057qib7	3002	12	-	-	HYPH
cord-005453-4057qib7	3002	13	D	d	NN
cord-005453-4057qib7	3002	14	plasma	plasma	NN
cord-005453-4057qib7	3002	15	levels	level	NNS
cord-005453-4057qib7	3002	16	and	and	CC
cord-005453-4057qib7	3002	17	variants	variant	NNS
cord-005453-4057qib7	3002	18	in	in	IN
cord-005453-4057qib7	3002	19	the	the	DT
cord-005453-4057qib7	3002	20	gene	gene	NN
cord-005453-4057qib7	3002	21	encoding	encode	VBG
cord-005453-4057qib7	3002	22	SP	SP	NNP
cord-005453-4057qib7	3002	23	-	-	HYPH
cord-005453-4057qib7	3002	24	D	D	NNP
cord-005453-4057qib7	3002	25	may	may	MD
cord-005453-4057qib7	3002	26	predict	predict	VB
cord-005453-4057qib7	3002	27	the	the	DT
cord-005453-4057qib7	3002	28	development	development	NN
cord-005453-4057qib7	3002	29	of	of	IN
cord-005453-4057qib7	3002	30	reduced	reduce	VBN
cord-005453-4057qib7	3002	31	lung	lung	NN
cord-005453-4057qib7	3002	32	function	function	NN
cord-005453-4057qib7	3002	33	after	after	IN
cord-005453-4057qib7	3002	34	allogenic	allogenic	JJ
cord-005453-4057qib7	3002	35	HSCT	HSCT	NNP
cord-005453-4057qib7	3002	36	.	.	.
cord-005453-4057qib7	3003	1	Methods	method	NNS
cord-005453-4057qib7	3003	2	:	:	:
cord-005453-4057qib7	3003	3	We	-PRON-	PRP
cord-005453-4057qib7	3003	4	performed	perform	VBD
cord-005453-4057qib7	3003	5	a	a	DT
cord-005453-4057qib7	3003	6	population	population	NN
cord-005453-4057qib7	3003	7	-	-	HYPH
cord-005453-4057qib7	3003	8	based	base	VBN
cord-005453-4057qib7	3003	9	,	,	,
cord-005453-4057qib7	3003	10	singlecenter	singlecenter	JJ
cord-005453-4057qib7	3003	11	study	study	NN
cord-005453-4057qib7	3003	12	of	of	IN
cord-005453-4057qib7	3003	13	children	child	NNS
cord-005453-4057qib7	3003	14	(	(	-LRB-
cord-005453-4057qib7	3003	15	aged	aged	JJ
cord-005453-4057qib7	3003	16	6	6	CD
cord-005453-4057qib7	3003	17	-	-	SYM
cord-005453-4057qib7	3003	18	18	18	CD
cord-005453-4057qib7	3003	19	years	year	NNS
cord-005453-4057qib7	3003	20	)	)	-RRB-
cord-005453-4057qib7	3003	21	treated	treat	VBN
cord-005453-4057qib7	3003	22	with	with	IN
cord-005453-4057qib7	3003	23	allogeneic	allogeneic	IN
cord-005453-4057qib7	3003	24	HSCT	HSCT	NNP
cord-005453-4057qib7	3003	25	.	.	.
cord-005453-4057qib7	3004	1	The	the	DT
cord-005453-4057qib7	3004	2	study	study	NN
cord-005453-4057qib7	3004	3	consisted	consist	VBD
cord-005453-4057qib7	3004	4	of	of	IN
cord-005453-4057qib7	3004	5	1	1	CD
cord-005453-4057qib7	3004	6	)	)	-RRB-
cord-005453-4057qib7	3004	7	a	a	DT
cord-005453-4057qib7	3004	8	prospective	prospective	JJ
cord-005453-4057qib7	3004	9	study	study	NN
cord-005453-4057qib7	3004	10	of	of	IN
cord-005453-4057qib7	3004	11	serial	serial	JJ
cord-005453-4057qib7	3004	12	plasma	plasma	NN
cord-005453-4057qib7	3004	13	SP	sp	NN
cord-005453-4057qib7	3004	14	-	-	HYPH
cord-005453-4057qib7	3004	15	D	d	JJ
cord-005453-4057qib7	3004	16	levels	level	NNS
cord-005453-4057qib7	3004	17	and	and	CC
cord-005453-4057qib7	3004	18	rs721917	rs721917	NNP
cord-005453-4057qib7	3004	19	genotypes	genotype	NNS
cord-005453-4057qib7	3004	20	in	in	IN
cord-005453-4057qib7	3004	21	55	55	CD
cord-005453-4057qib7	3004	22	patients	patient	NNS
cord-005453-4057qib7	3004	23	during	during	IN
cord-005453-4057qib7	3004	24	the	the	DT
cord-005453-4057qib7	3004	25	first	first	JJ
cord-005453-4057qib7	3004	26	6	6	CD
cord-005453-4057qib7	3004	27	months	month	NNS
cord-005453-4057qib7	3004	28	after	after	IN
cord-005453-4057qib7	3004	29	HSCT	HSCT	NNP
cord-005453-4057qib7	3004	30	,	,	,
cord-005453-4057qib7	3004	31	and	and	CC
cord-005453-4057qib7	3004	32	2	2	LS
cord-005453-4057qib7	3004	33	)	)	-RRB-
cord-005453-4057qib7	3004	34	a	a	DT
cord-005453-4057qib7	3004	35	retrospective	retrospective	JJ
cord-005453-4057qib7	3004	36	study	study	NN
cord-005453-4057qib7	3004	37	of	of	IN
cord-005453-4057qib7	3004	38	rs721917	rs721917	NNP
cord-005453-4057qib7	3004	39	genotypes	genotype	NNS
cord-005453-4057qib7	3004	40	within	within	IN
cord-005453-4057qib7	3004	41	the	the	DT
cord-005453-4057qib7	3004	42	SP	SP	NNP
cord-005453-4057qib7	3004	43	-	-	HYPH
cord-005453-4057qib7	3004	44	D	d	JJ
cord-005453-4057qib7	3004	45	gene	gene	NN
cord-005453-4057qib7	3004	46	in	in	IN
cord-005453-4057qib7	3004	47	247	247	CD
cord-005453-4057qib7	3004	48	patients	patient	NNS
cord-005453-4057qib7	3004	49	transplanted	transplant	VBN
cord-005453-4057qib7	3004	50	between	between	IN
cord-005453-4057qib7	3004	51	1990	1990	CD
cord-005453-4057qib7	3004	52	-	-	SYM
cord-005453-4057qib7	3004	53	2017	2017	CD
cord-005453-4057qib7	3004	54	.	.	.
cord-005453-4057qib7	3005	1	Pulmonary	pulmonary	JJ
cord-005453-4057qib7	3005	2	function	function	NN
cord-005453-4057qib7	3005	3	tests	test	NNS
cord-005453-4057qib7	3005	4	were	be	VBD
cord-005453-4057qib7	3005	5	performed	perform	VBN
cord-005453-4057qib7	3005	6	regularly	regularly	RB
cord-005453-4057qib7	3005	7	as	as	IN
cord-005453-4057qib7	3005	8	part	part	NN
cord-005453-4057qib7	3005	9	of	of	IN
cord-005453-4057qib7	3005	10	the	the	DT
cord-005453-4057qib7	3005	11	clinical	clinical	JJ
cord-005453-4057qib7	3005	12	monitoring	monitoring	NN
cord-005453-4057qib7	3005	13	.	.	.
cord-005453-4057qib7	3006	1	Results	result	NNS
cord-005453-4057qib7	3006	2	:	:	:
cord-005453-4057qib7	3007	1	At	at	IN
cord-005453-4057qib7	3007	2	the	the	DT
cord-005453-4057qib7	3007	3	day	day	NN
cord-005453-4057qib7	3007	4	of	of	IN
cord-005453-4057qib7	3007	5	graft	graft	NN
cord-005453-4057qib7	3007	6	infusion	infusion	NN
cord-005453-4057qib7	3007	7	(	(	-LRB-
cord-005453-4057qib7	3007	8	day	day	NN
cord-005453-4057qib7	3007	9	0	0	CD
cord-005453-4057qib7	3007	10	)	)	-RRB-
cord-005453-4057qib7	3007	11	SP	SP	NNP
cord-005453-4057qib7	3007	12	-	-	HYPH
cord-005453-4057qib7	3007	13	D	d	JJ
cord-005453-4057qib7	3007	14	levels	level	NNS
cord-005453-4057qib7	3007	15	were	be	VBD
cord-005453-4057qib7	3007	16	reduced	reduce	VBN
cord-005453-4057qib7	3007	17	compared	compare	VBN
cord-005453-4057qib7	3007	18	to	to	IN
cord-005453-4057qib7	3007	19	levels	level	NNS
cord-005453-4057qib7	3007	20	before	before	IN
cord-005453-4057qib7	3007	21	start	start	NN
cord-005453-4057qib7	3007	22	of	of	IN
cord-005453-4057qib7	3007	23	treatment	treatment	NN
cord-005453-4057qib7	3007	24	with	with	IN
cord-005453-4057qib7	3007	25	conditioning	conditioning	NN
cord-005453-4057qib7	3007	26	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3007	27	,	,	,
cord-005453-4057qib7	3007	28	defined	define	VBN
cord-005453-4057qib7	3007	29	as	as	IN
cord-005453-4057qib7	3007	30	baseline	baseline	NN
cord-005453-4057qib7	3007	31	(	(	-LRB-
cord-005453-4057qib7	3007	32	615	615	CD
cord-005453-4057qib7	3007	33	ng	ng	NN
cord-005453-4057qib7	3007	34	/	/	SYM
cord-005453-4057qib7	3007	35	ml	ml	NN
cord-005453-4057qib7	3008	1	(	(	-LRB-
cord-005453-4057qib7	3008	2	quartiles	quartiles	NNP
cord-005453-4057qib7	3008	3	441	441	CD
cord-005453-4057qib7	3008	4	-	-	HYPH
cord-005453-4057qib7	3008	5	1132	1132	CD
cord-005453-4057qib7	3008	6	)	)	-RRB-
cord-005453-4057qib7	3008	7	at	at	IN
cord-005453-4057qib7	3008	8	day	day	NN
cord-005453-4057qib7	3008	9	0	0	CD
cord-005453-4057qib7	3008	10	vs	vs	IN
cord-005453-4057qib7	3008	11	771	771	CD
cord-005453-4057qib7	3008	12	ng	ng	NNP
cord-005453-4057qib7	3008	13	/	/	SYM
cord-005453-4057qib7	3008	14	ml	ml	NN
cord-005453-4057qib7	3008	15	(	(	-LRB-
cord-005453-4057qib7	3008	16	542	542	CD
cord-005453-4057qib7	3008	17	-	-	HYPH
cord-005453-4057qib7	3008	18	1348	1348	CD
cord-005453-4057qib7	3008	19	)	)	-RRB-
cord-005453-4057qib7	3008	20	at	at	IN
cord-005453-4057qib7	3008	21	baseline	baseline	NN
cord-005453-4057qib7	3008	22	,	,	,
cord-005453-4057qib7	3008	23	p	p	NN
cord-005453-4057qib7	3008	24	<	<	XX
cord-005453-4057qib7	3008	25	0.01	0.01	CD
cord-005453-4057qib7	3008	26	)	)	-RRB-
cord-005453-4057qib7	3008	27	.	.	.
cord-005453-4057qib7	3009	1	From	from	IN
cord-005453-4057qib7	3009	2	day	day	NN
cord-005453-4057qib7	3009	3	+7	+7	CD
cord-005453-4057qib7	3009	4	SP	sp	NN
cord-005453-4057qib7	3009	5	-	-	HYPH
cord-005453-4057qib7	3009	6	D	d	JJ
cord-005453-4057qib7	3009	7	levels	level	NNS
cord-005453-4057qib7	3009	8	increased	increase	VBD
cord-005453-4057qib7	3009	9	and	and	CC
cord-005453-4057qib7	3009	10	remained	remain	VBD
cord-005453-4057qib7	3009	11	increased	increase	VBN
cord-005453-4057qib7	3009	12	during	during	IN
cord-005453-4057qib7	3009	13	the	the	DT
cord-005453-4057qib7	3009	14	whole	whole	JJ
cord-005453-4057qib7	3009	15	study	study	NN
cord-005453-4057qib7	3009	16	period	period	NN
cord-005453-4057qib7	3009	17	(	(	-LRB-
cord-005453-4057qib7	3009	18	771	771	CD
cord-005453-4057qib7	3009	19	ng	ng	NN
cord-005453-4057qib7	3009	20	/	/	SYM
cord-005453-4057qib7	3009	21	ml	ml	NN
cord-005453-4057qib7	3009	22	(	(	-LRB-
cord-005453-4057qib7	3009	23	542	542	CD
cord-005453-4057qib7	3009	24	-	-	HYPH
cord-005453-4057qib7	3009	25	1348	1348	CD
cord-005453-4057qib7	3009	26	)	)	-RRB-
cord-005453-4057qib7	3009	27	at	at	IN
cord-005453-4057qib7	3009	28	baseline	baseline	NN
cord-005453-4057qib7	3009	29	vs	vs	IN
cord-005453-4057qib7	3009	30	1287	1287	CD
cord-005453-4057qib7	3009	31	ng	ng	NNP
cord-005453-4057qib7	3009	32	/	/	SYM
cord-005453-4057qib7	3009	33	ml	ml	NN
cord-005453-4057qib7	3009	34	(	(	-LRB-
cord-005453-4057qib7	3009	35	713	713	CD
cord-005453-4057qib7	3009	36	-	-	HYPH
cord-005453-4057qib7	3009	37	2549	2549	CD
cord-005453-4057qib7	3009	38	)	)	-RRB-
cord-005453-4057qib7	3009	39	at	at	IN
cord-005453-4057qib7	3009	40	6	6	CD
cord-005453-4057qib7	3009	41	months	month	NNS
cord-005453-4057qib7	3009	42	,	,	,
cord-005453-4057qib7	3009	43	p	p	NN
cord-005453-4057qib7	3009	44	<	<	XX
cord-005453-4057qib7	3009	45	0.01	0.01	CD
cord-005453-4057qib7	3009	46	)	)	-RRB-
cord-005453-4057qib7	3009	47	.	.	.
cord-005453-4057qib7	3010	1	Acute	acute	JJ
cord-005453-4057qib7	3010	2	GvHD	GvHD	NNP
cord-005453-4057qib7	3010	3	(	(	-LRB-
cord-005453-4057qib7	3010	4	aGvHD	agvhd	NN
cord-005453-4057qib7	3010	5	)	)	-RRB-
cord-005453-4057qib7	3010	6	occurred	occur	VBD
cord-005453-4057qib7	3010	7	in	in	IN
cord-005453-4057qib7	3010	8	25	25	CD
cord-005453-4057qib7	3010	9	patients	patient	NNS
cord-005453-4057qib7	3010	10	,	,	,
cord-005453-4057qib7	3010	11	of	of	IN
cord-005453-4057qib7	3010	12	those	those	DT
cord-005453-4057qib7	3010	13	17	17	CD
cord-005453-4057qib7	3010	14	patients	patient	NNS
cord-005453-4057qib7	3010	15	with	with	IN
cord-005453-4057qib7	3010	16	grade	grade	NN
cord-005453-4057qib7	3010	17	2	2	CD
cord-005453-4057qib7	3010	18	-	-	SYM
cord-005453-4057qib7	3010	19	4	4	CD
cord-005453-4057qib7	3010	20	.	.	.
cord-005453-4057qib7	3011	1	High	high	JJ
cord-005453-4057qib7	3011	2	SP	sp	NN
cord-005453-4057qib7	3011	3	-	-	HYPH
cord-005453-4057qib7	3011	4	D	d	JJ
cord-005453-4057qib7	3011	5	levels	level	NNS
cord-005453-4057qib7	3011	6	at	at	IN
cord-005453-4057qib7	3011	7	day	day	NN
cord-005453-4057qib7	3011	8	+14	+14	CD
cord-005453-4057qib7	3011	9	were	be	VBD
cord-005453-4057qib7	3011	10	associated	associate	VBN
cord-005453-4057qib7	3011	11	with	with	IN
cord-005453-4057qib7	3011	12	the	the	DT
cord-005453-4057qib7	3011	13	development	development	NN
cord-005453-4057qib7	3011	14	of	of	IN
cord-005453-4057qib7	3011	15	aGvHD	agvhd	NN
cord-005453-4057qib7	3011	16	(	(	-LRB-
cord-005453-4057qib7	3011	17	1402	1402	CD
cord-005453-4057qib7	3011	18	ng	ng	NN
cord-005453-4057qib7	3011	19	/	/	SYM
cord-005453-4057qib7	3011	20	ml	ml	NN
cord-005453-4057qib7	3011	21	(	(	-LRB-
cord-005453-4057qib7	3011	22	1244	1244	CD
cord-005453-4057qib7	3011	23	-	-	SYM
cord-005453-4057qib7	3011	24	2023	2023	CD
cord-005453-4057qib7	3011	25	)	)	-RRB-
cord-005453-4057qib7	3011	26	vs	vs	IN
cord-005453-4057qib7	3011	27	839	839	CD
cord-005453-4057qib7	3011	28	ng	ng	NN
cord-005453-4057qib7	3011	29	/	/	SYM
cord-005453-4057qib7	3011	30	ml	ml	NN
cord-005453-4057qib7	3011	31	(	(	-LRB-
cord-005453-4057qib7	3011	32	523	523	CD
cord-005453-4057qib7	3011	33	-	-	SYM
cord-005453-4057qib7	3011	34	1630	1630	CD
cord-005453-4057qib7	3011	35	)	)	-RRB-
cord-005453-4057qib7	3011	36	,	,	,
cord-005453-4057qib7	3011	37	p	p	NN
cord-005453-4057qib7	3011	38	<	<	XX
cord-005453-4057qib7	3011	39	0.01	0.01	CD
cord-005453-4057qib7	3011	40	)	)	-RRB-
cord-005453-4057qib7	3011	41	(	(	-LRB-
cord-005453-4057qib7	3011	42	fig	fig	NN
cord-005453-4057qib7	3011	43	.	.	NNP
cord-005453-4057qib7	3011	44	1	1	CD
cord-005453-4057qib7	3011	45	)	)	-RRB-
cord-005453-4057qib7	3011	46	.	.	.
cord-005453-4057qib7	3012	1	The	the	DT
cord-005453-4057qib7	3012	2	C	C	NNP
cord-005453-4057qib7	3012	3	/	/	SYM
cord-005453-4057qib7	3012	4	C	c	NN
cord-005453-4057qib7	3012	5	genotype	genotype	NN
cord-005453-4057qib7	3012	6	was	be	VBD
cord-005453-4057qib7	3012	7	associated	associate	VBN
cord-005453-4057qib7	3012	8	with	with	IN
cord-005453-4057qib7	3012	9	generally	generally	RB
cord-005453-4057qib7	3012	10	low	low	JJ
cord-005453-4057qib7	3012	11	SP	sp	NN
cord-005453-4057qib7	3012	12	-	-	HYPH
cord-005453-4057qib7	3012	13	D	d	JJ
cord-005453-4057qib7	3012	14	levels	level	NNS
cord-005453-4057qib7	3012	15	and	and	CC
cord-005453-4057qib7	3012	16	low	low	JJ
cord-005453-4057qib7	3012	17	FEV1	FEV1	NNP
cord-005453-4057qib7	3012	18	/	/	SYM
cord-005453-4057qib7	3012	19	FVC	FVC	NNP
cord-005453-4057qib7	3012	20	at	at	RB
cord-005453-4057qib7	3012	21	all	all	DT
cord-005453-4057qib7	3012	22	time	time	NN
cord-005453-4057qib7	3012	23	intervals	interval	NNS
cord-005453-4057qib7	3012	24	compared	compare	VBN
cord-005453-4057qib7	3012	25	to	to	IN
cord-005453-4057qib7	3012	26	the	the	DT
cord-005453-4057qib7	3012	27	other	other	JJ
cord-005453-4057qib7	3012	28	genotypes	genotype	NNS
cord-005453-4057qib7	3012	29	,	,	,
cord-005453-4057qib7	3012	30	significantly	significantly	RB
cord-005453-4057qib7	3012	31	24	24	CD
cord-005453-4057qib7	3012	32	-	-	SYM
cord-005453-4057qib7	3012	33	36	36	CD
cord-005453-4057qib7	3012	34	months	month	NNS
cord-005453-4057qib7	3012	35	post	post	NN
cord-005453-4057qib7	3012	36	-	-	JJ
cord-005453-4057qib7	3012	37	HSCT	hsct	JJ
cord-005453-4057qib7	3012	38	(	(	-LRB-
cord-005453-4057qib7	3012	39	p=0.02	p=0.02	NNP
cord-005453-4057qib7	3012	40	)	)	-RRB-
cord-005453-4057qib7	3012	41	.	.	.
cord-005453-4057qib7	3013	1	There	there	EX
cord-005453-4057qib7	3013	2	was	be	VBD
cord-005453-4057qib7	3013	3	no	no	DT
cord-005453-4057qib7	3013	4	overall	overall	JJ
cord-005453-4057qib7	3013	5	correlation	correlation	NN
cord-005453-4057qib7	3013	6	between	between	IN
cord-005453-4057qib7	3013	7	SP	SP	NNP
cord-005453-4057qib7	3013	8	-	-	HYPH
cord-005453-4057qib7	3013	9	D	d	JJ
cord-005453-4057qib7	3013	10	levels	level	NNS
cord-005453-4057qib7	3013	11	and	and	CC
cord-005453-4057qib7	3013	12	lung	lung	NN
cord-005453-4057qib7	3013	13	function	function	NN
cord-005453-4057qib7	3013	14	,	,	,
cord-005453-4057qib7	3013	15	but	but	CC
cord-005453-4057qib7	3013	16	stratifying	stratify	VBG
cord-005453-4057qib7	3013	17	for	for	IN
cord-005453-4057qib7	3013	18	genotype	genotype	NN
cord-005453-4057qib7	3013	19	,	,	,
cord-005453-4057qib7	3013	20	high	high	JJ
cord-005453-4057qib7	3013	21	baseline	baseline	JJ
cord-005453-4057qib7	3013	22	SP	sp	NN
cord-005453-4057qib7	3013	23	-	-	HYPH
cord-005453-4057qib7	3013	24	D	d	JJ
cord-005453-4057qib7	3013	25	levels	level	NNS
cord-005453-4057qib7	3013	26	were	be	VBD
cord-005453-4057qib7	3013	27	predictive	predictive	JJ
cord-005453-4057qib7	3013	28	for	for	IN
cord-005453-4057qib7	3013	29	reduced	reduced	JJ
cord-005453-4057qib7	3013	30	FEV1	FEV1	NNP
cord-005453-4057qib7	3013	31	/	/	SYM
cord-005453-4057qib7	3013	32	FVC	FVC	NNP
cord-005453-4057qib7	3013	33	at	at	IN
cord-005453-4057qib7	3013	34	8	8	CD
cord-005453-4057qib7	3013	35	-	-	SYM
cord-005453-4057qib7	3013	36	24	24	CD
cord-005453-4057qib7	3013	37	months	month	NNS
cord-005453-4057qib7	3013	38	in	in	IN
cord-005453-4057qib7	3013	39	CC	CC	NNP
cord-005453-4057qib7	3013	40	and	and	CC
cord-005453-4057qib7	3013	41	TT	TT	NNP
cord-005453-4057qib7	3013	42	homozygous	homozygous	JJ
cord-005453-4057qib7	3013	43	individuals	individual	NNS
cord-005453-4057qib7	3013	44	.	.	.
cord-005453-4057qib7	3014	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3014	2	:	:	:
cord-005453-4057qib7	3015	1	Patients	patient	NNS
cord-005453-4057qib7	3015	2	with	with	IN
cord-005453-4057qib7	3015	3	a	a	DT
cord-005453-4057qib7	3015	4	genotype	genotype	NN
cord-005453-4057qib7	3015	5	causing	cause	VBG
cord-005453-4057qib7	3015	6	low	low	JJ
cord-005453-4057qib7	3015	7	capacity	capacity	NN
cord-005453-4057qib7	3015	8	for	for	IN
cord-005453-4057qib7	3015	9	SP	SP	NNP
cord-005453-4057qib7	3015	10	-	-	HYPH
cord-005453-4057qib7	3015	11	D	d	JJ
cord-005453-4057qib7	3015	12	production	production	NN
cord-005453-4057qib7	3015	13	are	be	VBP
cord-005453-4057qib7	3015	14	at	at	IN
cord-005453-4057qib7	3015	15	increased	increase	VBN
cord-005453-4057qib7	3015	16	risk	risk	NN
cord-005453-4057qib7	3015	17	of	of	IN
cord-005453-4057qib7	3015	18	developing	develop	VBG
cord-005453-4057qib7	3015	19	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3015	20	impairment	impairment	NN
cord-005453-4057qib7	3015	21	after	after	IN
cord-005453-4057qib7	3015	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3015	23	.	.	.
cord-005453-4057qib7	3016	1	In	in	IN
cord-005453-4057qib7	3016	2	addition	addition	NN
cord-005453-4057qib7	3016	3	,	,	,
cord-005453-4057qib7	3016	4	our	-PRON-	PRP$
cord-005453-4057qib7	3016	5	data	datum	NNS
cord-005453-4057qib7	3016	6	lend	lend	VBP
cord-005453-4057qib7	3016	7	support	support	NN
cord-005453-4057qib7	3016	8	to	to	IN
cord-005453-4057qib7	3016	9	other	other	JJ
cord-005453-4057qib7	3016	10	studies	study	NNS
cord-005453-4057qib7	3016	11	indicating	indicate	VBG
cord-005453-4057qib7	3016	12	that	that	IN
cord-005453-4057qib7	3016	13	SPD	SPD	NNP
cord-005453-4057qib7	3016	14	production	production	NN
cord-005453-4057qib7	3016	15	may	may	MD
cord-005453-4057qib7	3016	16	increase	increase	VB
cord-005453-4057qib7	3016	17	during	during	IN
cord-005453-4057qib7	3016	18	inflammatory	inflammatory	JJ
cord-005453-4057qib7	3016	19	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3016	20	disease	disease	NN
cord-005453-4057qib7	3016	21	,	,	,
cord-005453-4057qib7	3016	22	acting	act	VBG
cord-005453-4057qib7	3016	23	as	as	IN
cord-005453-4057qib7	3016	24	a	a	DT
cord-005453-4057qib7	3016	25	reactive	reactive	JJ
cord-005453-4057qib7	3016	26	,	,	,
cord-005453-4057qib7	3016	27	protective	protective	JJ
cord-005453-4057qib7	3016	28	mechanism	mechanism	NN
cord-005453-4057qib7	3016	29	.	.	.
cord-005453-4057qib7	3017	1	Further	further	JJ
cord-005453-4057qib7	3017	2	research	research	NN
cord-005453-4057qib7	3017	3	is	be	VBZ
cord-005453-4057qib7	3017	4	warranted	warrant	VBN
cord-005453-4057qib7	3017	5	to	to	TO
cord-005453-4057qib7	3017	6	define	define	VB
cord-005453-4057qib7	3017	7	the	the	DT
cord-005453-4057qib7	3017	8	role	role	NN
cord-005453-4057qib7	3017	9	of	of	IN
cord-005453-4057qib7	3017	10	SP	SP	NNP
cord-005453-4057qib7	3017	11	-	-	HYPH
cord-005453-4057qib7	3017	12	D	d	JJ
cord-005453-4057qib7	3017	13	levels	level	NNS
cord-005453-4057qib7	3017	14	and	and	CC
cord-005453-4057qib7	3017	15	genotypes	genotype	NNS
cord-005453-4057qib7	3017	16	as	as	IN
cord-005453-4057qib7	3017	17	a	a	DT
cord-005453-4057qib7	3017	18	prognostic	prognostic	JJ
cord-005453-4057qib7	3017	19	tool	tool	NN
cord-005453-4057qib7	3017	20	for	for	IN
cord-005453-4057qib7	3017	21	lung	lung	NN
cord-005453-4057qib7	3017	22	function	function	NN
cord-005453-4057qib7	3017	23	and	and	CC
cord-005453-4057qib7	3017	24	aGvHD	agvhd	NN
cord-005453-4057qib7	3017	25	.	.	.
cord-005453-4057qib7	3018	1	[	[	-LRB-
cord-005453-4057qib7	3018	2	[	[	-LRB-
cord-005453-4057qib7	3018	3	P147	P147	NNP
cord-005453-4057qib7	3018	4	Image	image	NN
cord-005453-4057qib7	3018	5	]	]	-RRB-
cord-005453-4057qib7	3018	6	1	1	CD
cord-005453-4057qib7	3018	7	.	.	.
cord-005453-4057qib7	3019	1	Background	background	NN
cord-005453-4057qib7	3019	2	:	:	:
cord-005453-4057qib7	3020	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	3020	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3020	3	cell	cell	NN
cord-005453-4057qib7	3020	4	transplantation	transplantation	NN
cord-005453-4057qib7	3020	5	(	(	-LRB-
cord-005453-4057qib7	3020	6	alloHCT	alloHCT	NNP
cord-005453-4057qib7	3020	7	)	)	-RRB-
cord-005453-4057qib7	3020	8	means	mean	VBZ
cord-005453-4057qib7	3020	9	a	a	DT
cord-005453-4057qib7	3020	10	long	long	JJ
cord-005453-4057qib7	3020	11	period	period	NN
cord-005453-4057qib7	3020	12	of	of	IN
cord-005453-4057qib7	3020	13	restricted	restricted	JJ
cord-005453-4057qib7	3020	14	mobility	mobility	NN
cord-005453-4057qib7	3020	15	and	and	CC
cord-005453-4057qib7	3020	16	a	a	DT
cord-005453-4057qib7	3020	17	range	range	NN
cord-005453-4057qib7	3020	18	of	of	IN
cord-005453-4057qib7	3020	19	therapy	therapy	NN
cord-005453-4057qib7	3020	20	related	relate	VBN
cord-005453-4057qib7	3020	21	side	side	NN
cord-005453-4057qib7	3020	22	effects	effect	NNS
cord-005453-4057qib7	3020	23	on	on	IN
cord-005453-4057qib7	3020	24	muscle	muscle	NN
cord-005453-4057qib7	3020	25	function	function	NN
cord-005453-4057qib7	3020	26	.	.	.
cord-005453-4057qib7	3021	1	In	in	IN
cord-005453-4057qib7	3021	2	this	this	DT
cord-005453-4057qib7	3021	3	context	context	NN
cord-005453-4057qib7	3021	4	patients	patient	NNS
cord-005453-4057qib7	3021	5	demonstrated	demonstrate	VBD
cord-005453-4057qib7	3021	6	a	a	DT
cord-005453-4057qib7	3021	7	huge	huge	JJ
cord-005453-4057qib7	3021	8	decline	decline	NN
cord-005453-4057qib7	3021	9	of	of	IN
cord-005453-4057qib7	3021	10	physical	physical	JJ
cord-005453-4057qib7	3021	11	capacity	capacity	NN
cord-005453-4057qib7	3021	12	and	and	CC
cord-005453-4057qib7	3021	13	muscle	muscle	NN
cord-005453-4057qib7	3021	14	mass	mass	NN
cord-005453-4057qib7	3021	15	in	in	IN
cord-005453-4057qib7	3021	16	particular	particular	JJ
cord-005453-4057qib7	3021	17	,	,	,
cord-005453-4057qib7	3021	18	accompanied	accompany	VBN
cord-005453-4057qib7	3021	19	with	with	IN
cord-005453-4057qib7	3021	20	a	a	DT
cord-005453-4057qib7	3021	21	decrease	decrease	NN
cord-005453-4057qib7	3021	22	of	of	IN
cord-005453-4057qib7	3021	23	quality	quality	NN
cord-005453-4057qib7	3021	24	of	of	IN
cord-005453-4057qib7	3021	25	life	life	NN
cord-005453-4057qib7	3021	26	(	(	-LRB-
cord-005453-4057qib7	3021	27	QoL	qol	NN
cord-005453-4057qib7	3021	28	)	)	-RRB-
cord-005453-4057qib7	3021	29	.	.	.
cord-005453-4057qib7	3022	1	Resistance	resistance	NN
cord-005453-4057qib7	3022	2	training	training	NN
cord-005453-4057qib7	3022	3	could	could	MD
cord-005453-4057qib7	3022	4	maintain	maintain	VB
cord-005453-4057qib7	3022	5	muscle	muscle	NN
cord-005453-4057qib7	3022	6	mass	mass	NN
cord-005453-4057qib7	3022	7	but	but	CC
cord-005453-4057qib7	3022	8	is	be	VBZ
cord-005453-4057qib7	3022	9	limited	limit	VBN
cord-005453-4057qib7	3022	10	by	by	IN
cord-005453-4057qib7	3022	11	patientsb	patientsb	NNP
cord-005453-4057qib7	3022	12	lood	lood	NNP
cord-005453-4057qib7	3022	13	values	value	NNS
cord-005453-4057qib7	3022	14	(	(	-LRB-
cord-005453-4057qib7	3022	15	platelet	platelet	NN
cord-005453-4057qib7	3022	16	-	-	HYPH
cord-005453-4057qib7	3022	17	count	count	NN
cord-005453-4057qib7	3022	18	)	)	-RRB-
cord-005453-4057qib7	3022	19	and	and	CC
cord-005453-4057qib7	3022	20	well	well	RB
cord-005453-4057qib7	3022	21	-	-	HYPH
cord-005453-4057qib7	3022	22	being	being	NN
cord-005453-4057qib7	3022	23	.	.	.
cord-005453-4057qib7	3023	1	Whole	whole	JJ
cord-005453-4057qib7	3023	2	body	body	NN
cord-005453-4057qib7	3023	3	vibration	vibration	NN
cord-005453-4057qib7	3023	4	(	(	-LRB-
cord-005453-4057qib7	3023	5	WBV	wbv	NN
cord-005453-4057qib7	3023	6	)	)	-RRB-
cord-005453-4057qib7	3023	7	was	be	VBD
cord-005453-4057qib7	3023	8	shown	show	VBN
cord-005453-4057qib7	3023	9	to	to	TO
cord-005453-4057qib7	3023	10	maintain	maintain	VB
cord-005453-4057qib7	3023	11	muscle	muscle	NN
cord-005453-4057qib7	3023	12	mass	mass	NN
cord-005453-4057qib7	3023	13	during	during	IN
cord-005453-4057qib7	3023	14	bed	bed	NN
cord-005453-4057qib7	3023	15	rest	rest	NN
cord-005453-4057qib7	3023	16	and	and	CC
cord-005453-4057qib7	3023	17	has	have	VBZ
cord-005453-4057qib7	3023	18	less	less	JJR
cord-005453-4057qib7	3023	19	impact	impact	NN
cord-005453-4057qib7	3023	20	on	on	IN
cord-005453-4057qib7	3023	21	blood	blood	NN
cord-005453-4057qib7	3023	22	pressure	pressure	NN
cord-005453-4057qib7	3023	23	than	than	IN
cord-005453-4057qib7	3023	24	conventional	conventional	JJ
cord-005453-4057qib7	3023	25	resistance	resistance	NN
cord-005453-4057qib7	3023	26	exercises	exercise	NNS
cord-005453-4057qib7	3023	27	.	.	.
cord-005453-4057qib7	3024	1	Furthermore	furthermore	RB
cord-005453-4057qib7	3024	2	it	-PRON-	PRP
cord-005453-4057qib7	3024	3	was	be	VBD
cord-005453-4057qib7	3024	4	also	also	RB
cord-005453-4057qib7	3024	5	shown	show	VBN
cord-005453-4057qib7	3024	6	to	to	TO
cord-005453-4057qib7	3024	7	be	be	VB
cord-005453-4057qib7	3024	8	feasible	feasible	JJ
cord-005453-4057qib7	3024	9	in	in	IN
cord-005453-4057qib7	3024	10	patients	patient	NNS
cord-005453-4057qib7	3024	11	during	during	IN
cord-005453-4057qib7	3024	12	high	high	JJ
cord-005453-4057qib7	3024	13	dose	dose	NN
cord-005453-4057qib7	3024	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3024	15	.	.	.
cord-005453-4057qib7	3025	1	Therefore	therefore	RB
cord-005453-4057qib7	3025	2	the	the	DT
cord-005453-4057qib7	3025	3	aim	aim	NN
cord-005453-4057qib7	3025	4	of	of	IN
cord-005453-4057qib7	3025	5	our	-PRON-	PRP$
cord-005453-4057qib7	3025	6	study	study	NN
cord-005453-4057qib7	3025	7	was	be	VBD
cord-005453-4057qib7	3025	8	to	to	TO
cord-005453-4057qib7	3025	9	examine	examine	VB
cord-005453-4057qib7	3025	10	the	the	DT
cord-005453-4057qib7	3025	11	effects	effect	NNS
cord-005453-4057qib7	3025	12	of	of	IN
cord-005453-4057qib7	3025	13	WBV	WBV	NNP
cord-005453-4057qib7	3025	14	during	during	IN
cord-005453-4057qib7	3025	15	alloHCT	alloHCT	NNP
cord-005453-4057qib7	3025	16	on	on	IN
cord-005453-4057qib7	3025	17	patients	patient	NNS
cord-005453-4057qib7	3025	18	physical	physical	JJ
cord-005453-4057qib7	3025	19	and	and	CC
cord-005453-4057qib7	3025	20	functional	functional	JJ
cord-005453-4057qib7	3025	21	performance	performance	NN
cord-005453-4057qib7	3025	22	as	as	RB
cord-005453-4057qib7	3025	23	well	well	RB
cord-005453-4057qib7	3025	24	as	as	IN
cord-005453-4057qib7	3025	25	QoL.	QoL.	NNP
cord-005453-4057qib7	3025	26	Methods	Methods	NNPS
cord-005453-4057qib7	3025	27	:	:	:
cord-005453-4057qib7	3025	28	43	43	CD
cord-005453-4057qib7	3025	29	patients	patient	NNS
cord-005453-4057qib7	3025	30	receiving	receive	VBG
cord-005453-4057qib7	3025	31	alloHCT	alloHCT	NNP
cord-005453-4057qib7	3025	32	were	be	VBD
cord-005453-4057qib7	3025	33	randomly	randomly	RB
cord-005453-4057qib7	3025	34	allocated	allocate	VBN
cord-005453-4057qib7	3025	35	to	to	IN
cord-005453-4057qib7	3025	36	either	either	CC
cord-005453-4057qib7	3025	37	a	a	DT
cord-005453-4057qib7	3025	38	WBV	WBV	NNP
cord-005453-4057qib7	3025	39	exercise	exercise	NN
cord-005453-4057qib7	3025	40	group	group	NN
cord-005453-4057qib7	3025	41	(	(	-LRB-
cord-005453-4057qib7	3025	42	IG	IG	NNP
cord-005453-4057qib7	3025	43	)	)	-RRB-
cord-005453-4057qib7	3025	44	or	or	CC
cord-005453-4057qib7	3025	45	an	an	DT
cord-005453-4057qib7	3025	46	active	active	JJ
cord-005453-4057qib7	3025	47	control	control	NN
cord-005453-4057qib7	3025	48	group	group	NN
cord-005453-4057qib7	3025	49	(	(	-LRB-
cord-005453-4057qib7	3025	50	CG	CG	NNP
cord-005453-4057qib7	3025	51	)	)	-RRB-
cord-005453-4057qib7	3025	52	doing	do	VBG
cord-005453-4057qib7	3025	53	stretching	stretching	NN
cord-005453-4057qib7	3025	54	and	and	CC
cord-005453-4057qib7	3025	55	mobilization	mobilization	NN
cord-005453-4057qib7	3025	56	.	.	.
cord-005453-4057qib7	3026	1	Both	both	DT
cord-005453-4057qib7	3026	2	groups	group	NNS
cord-005453-4057qib7	3026	3	exercised	exercise	VBD
cord-005453-4057qib7	3026	4	during	during	IN
cord-005453-4057qib7	3026	5	the	the	DT
cord-005453-4057qib7	3026	6	whole	whole	JJ
cord-005453-4057qib7	3026	7	time	time	NN
cord-005453-4057qib7	3026	8	of	of	IN
cord-005453-4057qib7	3026	9	hospitalization	hospitalization	NN
cord-005453-4057qib7	3026	10	for	for	IN
cord-005453-4057qib7	3026	11	5	5	CD
cord-005453-4057qib7	3026	12	times	time	NNS
cord-005453-4057qib7	3026	13	per	per	IN
cord-005453-4057qib7	3026	14	week	week	NN
cord-005453-4057qib7	3026	15	and	and	CC
cord-005453-4057qib7	3026	16	underwent	undergo	VBD
cord-005453-4057qib7	3026	17	pre-	pre-	JJ
cord-005453-4057qib7	3026	18	,	,	,
cord-005453-4057qib7	3026	19	post	post	JJ
cord-005453-4057qib7	3026	20	-	-	JJ
cord-005453-4057qib7	3026	21	and	and	CC
cord-005453-4057qib7	3026	22	followup	followup	JJ
cord-005453-4057qib7	3026	23	-	-	HYPH
cord-005453-4057qib7	3026	24	assessment	assessment	NN
cord-005453-4057qib7	3026	25	.	.	.
cord-005453-4057qib7	3027	1	Physical	physical	JJ
cord-005453-4057qib7	3027	2	capacity	capacity	NN
cord-005453-4057qib7	3027	3	was	be	VBD
cord-005453-4057qib7	3027	4	determined	determine	VBN
cord-005453-4057qib7	3027	5	by	by	IN
cord-005453-4057qib7	3027	6	maximum	maximum	JJ
cord-005453-4057qib7	3027	7	oxygen	oxygen	NN
cord-005453-4057qib7	3027	8	consumption	consumption	NN
cord-005453-4057qib7	3027	9	(	(	-LRB-
cord-005453-4057qib7	3027	10	VO	VO	NNP
cord-005453-4057qib7	3027	11	2peak	2peak	CD
cord-005453-4057qib7	3027	12	)	)	-RRB-
cord-005453-4057qib7	3027	13	and	and	CC
cord-005453-4057qib7	3027	14	maximum	maximum	JJ
cord-005453-4057qib7	3027	15	power	power	NN
cord-005453-4057qib7	3027	16	(	(	-LRB-
cord-005453-4057qib7	3027	17	P	p	NN
cord-005453-4057qib7	3027	18	max	max	NN
cord-005453-4057qib7	3027	19	)	)	-RRB-
cord-005453-4057qib7	3027	20	during	during	IN
cord-005453-4057qib7	3027	21	cardiorespiratory	cardiorespiratory	JJ
cord-005453-4057qib7	3027	22	exercise	exercise	NN
cord-005453-4057qib7	3027	23	test	test	NN
cord-005453-4057qib7	3027	24	and	and	CC
cord-005453-4057qib7	3027	25	by	by	IN
cord-005453-4057qib7	3027	26	maximum	maximum	JJ
cord-005453-4057qib7	3027	27	strength	strength	NN
cord-005453-4057qib7	3027	28	of	of	IN
cord-005453-4057qib7	3027	29	the	the	DT
cord-005453-4057qib7	3027	30	knee	knee	NN
cord-005453-4057qib7	3027	31	extensors	extensor	NNS
cord-005453-4057qib7	3027	32	and	and	CC
cord-005453-4057qib7	3027	33	flexors	flexor	NNS
cord-005453-4057qib7	3027	34	(	(	-LRB-
cord-005453-4057qib7	3027	35	EX	EX	NNP
cord-005453-4057qib7	3027	36	max	max	NN
cord-005453-4057qib7	3027	37	,	,	,
cord-005453-4057qib7	3027	38	FLEX	FLEX	NNP
cord-005453-4057qib7	3027	39	max	max	NNP
cord-005453-4057qib7	3027	40	)	)	-RRB-
cord-005453-4057qib7	3027	41	during	during	IN
cord-005453-4057qib7	3027	42	isokinetic	isokinetic	JJ
cord-005453-4057qib7	3027	43	strength	strength	NN
cord-005453-4057qib7	3027	44	test	test	NN
cord-005453-4057qib7	3027	45	.	.	.
cord-005453-4057qib7	3028	1	Functional	functional	JJ
cord-005453-4057qib7	3028	2	performance	performance	NN
cord-005453-4057qib7	3028	3	was	be	VBD
cord-005453-4057qib7	3028	4	assessed	assess	VBN
cord-005453-4057qib7	3028	5	by	by	IN
cord-005453-4057qib7	3028	6	jumping	jump	VBG
cord-005453-4057qib7	3028	7	height	height	NN
cord-005453-4057qib7	3028	8	during	during	IN
cord-005453-4057qib7	3028	9	counter	counter	JJ
cord-005453-4057qib7	3028	10	movement	movement	NN
cord-005453-4057qib7	3028	11	jump	jump	NN
cord-005453-4057qib7	3028	12	(	(	-LRB-
cord-005453-4057qib7	3028	13	CMJ	CMJ	NNP
cord-005453-4057qib7	3028	14	)	)	-RRB-
cord-005453-4057qib7	3028	15	and	and	CC
cord-005453-4057qib7	3028	16	time	time	NN
cord-005453-4057qib7	3028	17	of	of	IN
cord-005453-4057qib7	3028	18	chair	chair	NN
cord-005453-4057qib7	3028	19	rising	rise	VBG
cord-005453-4057qib7	3028	20	test	test	NN
cord-005453-4057qib7	3028	21	(	(	-LRB-
cord-005453-4057qib7	3028	22	CRT	CRT	NNP
cord-005453-4057qib7	3028	23	)	)	-RRB-
cord-005453-4057qib7	3028	24	as	as	RB
cord-005453-4057qib7	3028	25	well	well	RB
cord-005453-4057qib7	3028	26	as	as	IN
cord-005453-4057qib7	3028	27	power	power	NN
cord-005453-4057qib7	3028	28	output	output	NN
cord-005453-4057qib7	3028	29	during	during	IN
cord-005453-4057qib7	3028	30	both	both	DT
cord-005453-4057qib7	3028	31	tests	test	NNS
cord-005453-4057qib7	3028	32	.	.	.
cord-005453-4057qib7	3029	1	QoL	QoL	NNP
cord-005453-4057qib7	3029	2	was	be	VBD
cord-005453-4057qib7	3029	3	assessed	assess	VBN
cord-005453-4057qib7	3029	4	by	by	IN
cord-005453-4057qib7	3029	5	questionnaires	questionnaire	NNS
cord-005453-4057qib7	3029	6	of	of	IN
cord-005453-4057qib7	3029	7	the	the	DT
cord-005453-4057qib7	3029	8	EORTC	EORTC	NNP
cord-005453-4057qib7	3029	9	.	.	.
cord-005453-4057qib7	3030	1	Results	result	NNS
cord-005453-4057qib7	3030	2	:	:	:
cord-005453-4057qib7	3031	1	During	during	IN
cord-005453-4057qib7	3031	2	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	3031	3	VO	VO	NNP
cord-005453-4057qib7	3031	4	2peak	2peak	CD
cord-005453-4057qib7	3031	5	and	and	CC
cord-005453-4057qib7	3031	6	P	P	NNP
cord-005453-4057qib7	3031	7	max	max	NN
cord-005453-4057qib7	3031	8	decreased	decrease	VBD
cord-005453-4057qib7	3031	9	in	in	IN
cord-005453-4057qib7	3031	10	both	both	DT
cord-005453-4057qib7	3031	11	groups	group	NNS
cord-005453-4057qib7	3031	12	but	but	CC
cord-005453-4057qib7	3031	13	till	till	IN
cord-005453-4057qib7	3031	14	follow	follow	NN
cord-005453-4057qib7	3031	15	-	-	HYPH
cord-005453-4057qib7	3031	16	up	up	RP
cord-005453-4057qib7	3031	17	an	an	DT
cord-005453-4057qib7	3031	18	increase	increase	NN
cord-005453-4057qib7	3031	19	is	be	VBZ
cord-005453-4057qib7	3031	20	seen	see	VBN
cord-005453-4057qib7	3031	21	in	in	IN
cord-005453-4057qib7	3031	22	the	the	DT
cord-005453-4057qib7	3031	23	IG	ig	NN
cord-005453-4057qib7	3031	24	(	(	-LRB-
cord-005453-4057qib7	3031	25	P=0.035	p=0.035	NN
cord-005453-4057qib7	3031	26	;	;	:
cord-005453-4057qib7	3031	27	P=0.011	P=0.011	NNP
cord-005453-4057qib7	3031	28	)	)	-RRB-
cord-005453-4057qib7	3031	29	.	.	.
cord-005453-4057qib7	3032	1	At	at	IN
cord-005453-4057qib7	3032	2	day	day	NN
cord-005453-4057qib7	3032	3	+180	+180	NNP
cord-005453-4057qib7	3032	4	/	/	CC
cord-005453-4057qib7	3032	5	follow	follow	NN
cord-005453-4057qib7	3032	6	-	-	HYPH
cord-005453-4057qib7	3032	7	up	up	NN
cord-005453-4057qib7	3032	8	a	a	DT
cord-005453-4057qib7	3032	9	VO	VO	NNP
cord-005453-4057qib7	3032	10	2peak	2peak	CD
cord-005453-4057qib7	3032	11	group	group	NN
cord-005453-4057qib7	3032	12	difference	difference	NN
cord-005453-4057qib7	3032	13	is	be	VBZ
cord-005453-4057qib7	3032	14	seen	see	VBN
cord-005453-4057qib7	3032	15	(	(	-LRB-
cord-005453-4057qib7	3032	16	P=0.034	P=0.034	NNP
cord-005453-4057qib7	3032	17	)	)	-RRB-
cord-005453-4057qib7	3032	18	.	.	.
cord-005453-4057qib7	3033	1	EX	EX	NNP
cord-005453-4057qib7	3033	2	max	max	NNP
cord-005453-4057qib7	3033	3	(	(	-LRB-
cord-005453-4057qib7	3033	4	P=0.003	P=0.003	NNP
cord-005453-4057qib7	3033	5	)	)	-RRB-
cord-005453-4057qib7	3033	6	and	and	CC
cord-005453-4057qib7	3033	7	FLEX	FLEX	NNP
cord-005453-4057qib7	3033	8	max	max	NNP
cord-005453-4057qib7	3033	9	(	(	-LRB-
cord-005453-4057qib7	3033	10	P=0.044	P=0.044	NNP
cord-005453-4057qib7	3033	11	)	)	-RRB-
cord-005453-4057qib7	3033	12	were	be	VBD
cord-005453-4057qib7	3033	13	only	only	RB
cord-005453-4057qib7	3033	14	reduced	reduce	VBN
cord-005453-4057qib7	3033	15	in	in	IN
cord-005453-4057qib7	3033	16	the	the	DT
cord-005453-4057qib7	3033	17	CG	CG	NNP
cord-005453-4057qib7	3033	18	during	during	IN
cord-005453-4057qib7	3033	19	hospitalization	hospitalization	NN
cord-005453-4057qib7	3033	20	.	.	.
cord-005453-4057qib7	3034	1	Jumping	jump	VBG
cord-005453-4057qib7	3034	2	height	height	NN
cord-005453-4057qib7	3034	3	and	and	CC
cord-005453-4057qib7	3034	4	power	power	NN
cord-005453-4057qib7	3034	5	output	output	NN
cord-005453-4057qib7	3034	6	decreased	decrease	VBD
cord-005453-4057qib7	3034	7	in	in	IN
cord-005453-4057qib7	3034	8	the	the	DT
cord-005453-4057qib7	3034	9	CG	CG	NNP
cord-005453-4057qib7	3034	10	during	during	IN
cord-005453-4057qib7	3034	11	hospitalization	hospitalization	NN
cord-005453-4057qib7	3034	12	(	(	-LRB-
cord-005453-4057qib7	3034	13	P=0.005	P=0.005	NNP
cord-005453-4057qib7	3034	14	,	,	,
cord-005453-4057qib7	3034	15	P=0.039	P=0.039	NNP
cord-005453-4057qib7	3034	16	)	)	-RRB-
cord-005453-4057qib7	3034	17	and	and	CC
cord-005453-4057qib7	3034	18	a	a	DT
cord-005453-4057qib7	3034	19	difference	difference	NN
cord-005453-4057qib7	3034	20	between	between	IN
cord-005453-4057qib7	3034	21	groups	group	NNS
cord-005453-4057qib7	3034	22	were	be	VBD
cord-005453-4057qib7	3034	23	seen	see	VBN
cord-005453-4057qib7	3034	24	in	in	IN
cord-005453-4057qib7	3034	25	changes	change	NNS
cord-005453-4057qib7	3034	26	of	of	IN
cord-005453-4057qib7	3034	27	jumping	jump	VBG
cord-005453-4057qib7	3034	28	height	height	NN
cord-005453-4057qib7	3034	29	from	from	IN
cord-005453-4057qib7	3034	30	pre	pre	NN
cord-005453-4057qib7	3034	31	-	-	NN
cord-005453-4057qib7	3034	32	to	to	TO
cord-005453-4057qib7	3034	33	follow	follow	VB
cord-005453-4057qib7	3034	34	-	-	HYPH
cord-005453-4057qib7	3034	35	up	up	NN
cord-005453-4057qib7	3034	36	-	-	HYPH
cord-005453-4057qib7	3034	37	assessment	assessment	NN
cord-005453-4057qib7	3034	38	(	(	-LRB-
cord-005453-4057qib7	3034	39	P=0.033	P=0.033	NNP
cord-005453-4057qib7	3034	40	)	)	-RRB-
cord-005453-4057qib7	3034	41	:	:	:
cord-005453-4057qib7	3034	42	increase	increase	VB
cord-005453-4057qib7	3034	43	in	in	IN
cord-005453-4057qib7	3034	44	the	the	DT
cord-005453-4057qib7	3034	45	IG	ig	NN
cord-005453-4057qib7	3034	46	and	and	CC
cord-005453-4057qib7	3034	47	decrease	decrease	NN
cord-005453-4057qib7	3034	48	in	in	IN
cord-005453-4057qib7	3034	49	the	the	DT
cord-005453-4057qib7	3034	50	CG	CG	NNP
cord-005453-4057qib7	3034	51	.	.	.
cord-005453-4057qib7	3035	1	The	the	DT
cord-005453-4057qib7	3035	2	IG	IG	NNP
cord-005453-4057qib7	3035	3	showed	show	VBD
cord-005453-4057qib7	3035	4	a	a	DT
cord-005453-4057qib7	3035	5	decrease	decrease	NN
cord-005453-4057qib7	3035	6	in	in	IN
cord-005453-4057qib7	3035	7	time	time	NN
cord-005453-4057qib7	3035	8	from	from	IN
cord-005453-4057qib7	3035	9	baseline	baseline	NN
cord-005453-4057qib7	3035	10	to	to	IN
cord-005453-4057qib7	3035	11	follow	follow	VB
cord-005453-4057qib7	3035	12	-	-	HYPH
cord-005453-4057qib7	3035	13	up	up	NN
cord-005453-4057qib7	3035	14	(	(	-LRB-
cord-005453-4057qib7	3035	15	P=0.022	p=0.022	NN
cord-005453-4057qib7	3035	16	)	)	-RRB-
cord-005453-4057qib7	3035	17	in	in	IN
cord-005453-4057qib7	3035	18	the	the	DT
cord-005453-4057qib7	3035	19	CRT	CRT	NNP
cord-005453-4057qib7	3035	20	and	and	CC
cord-005453-4057qib7	3035	21	an	an	DT
cord-005453-4057qib7	3035	22	increase	increase	NN
cord-005453-4057qib7	3035	23	of	of	IN
cord-005453-4057qib7	3035	24	power	power	NN
cord-005453-4057qib7	3035	25	output	output	NN
cord-005453-4057qib7	3035	26	(	(	-LRB-
cord-005453-4057qib7	3035	27	P=0.009	p=0.009	NN
cord-005453-4057qib7	3035	28	)	)	-RRB-
cord-005453-4057qib7	3035	29	.	.	.
cord-005453-4057qib7	3036	1	QoL	QoL	NNP
cord-005453-4057qib7	3036	2	decreased	decrease	VBD
cord-005453-4057qib7	3036	3	only	only	RB
cord-005453-4057qib7	3036	4	in	in	IN
cord-005453-4057qib7	3036	5	the	the	DT
cord-005453-4057qib7	3036	6	CG	CG	NNP
cord-005453-4057qib7	3036	7	during	during	IN
cord-005453-4057qib7	3036	8	hospitalization	hospitalization	NN
cord-005453-4057qib7	3036	9	(	(	-LRB-
cord-005453-4057qib7	3036	10	P=0.015	P=0.015	NNP
cord-005453-4057qib7	3036	11	)	)	-RRB-
cord-005453-4057qib7	3036	12	while	while	IN
cord-005453-4057qib7	3036	13	during	during	IN
cord-005453-4057qib7	3036	14	follow	follow	NN
cord-005453-4057qib7	3036	15	-	-	HYPH
cord-005453-4057qib7	3036	16	up	up	NN
cord-005453-4057qib7	3036	17	QoL	qol	NN
cord-005453-4057qib7	3036	18	increased	increase	VBD
cord-005453-4057qib7	3036	19	in	in	IN
cord-005453-4057qib7	3036	20	both	both	DT
cord-005453-4057qib7	3036	21	groups	group	NNS
cord-005453-4057qib7	3036	22	(	(	-LRB-
cord-005453-4057qib7	3036	23	IG	IG	NNP
cord-005453-4057qib7	3036	24	:	:	:
cord-005453-4057qib7	3036	25	P=0.013	p=0.013	NN
cord-005453-4057qib7	3036	26	;	;	:
cord-005453-4057qib7	3036	27	CG	cg	NN
cord-005453-4057qib7	3036	28	:	:	:
cord-005453-4057qib7	3036	29	P=0.037	P=0.037	NNP
cord-005453-4057qib7	3036	30	)	)	-RRB-
cord-005453-4057qib7	3036	31	.	.	.
cord-005453-4057qib7	3037	1	In	in	IN
cord-005453-4057qib7	3037	2	the	the	DT
cord-005453-4057qib7	3037	3	CG	CG	NNP
cord-005453-4057qib7	3037	4	physical	physical	JJ
cord-005453-4057qib7	3037	5	functioning	functioning	NN
cord-005453-4057qib7	3037	6	decreased	decrease	VBD
cord-005453-4057qib7	3037	7	during	during	IN
cord-005453-4057qib7	3037	8	intervention	intervention	NN
cord-005453-4057qib7	3037	9	(	(	-LRB-
cord-005453-4057qib7	3037	10	P=0.001	P=0.001	NNP
cord-005453-4057qib7	3037	11	)	)	-RRB-
cord-005453-4057qib7	3037	12	whereas	whereas	IN
cord-005453-4057qib7	3037	13	an	an	DT
cord-005453-4057qib7	3037	14	increase	increase	NN
cord-005453-4057qib7	3037	15	was	be	VBD
cord-005453-4057qib7	3037	16	seen	see	VBN
cord-005453-4057qib7	3037	17	in	in	IN
cord-005453-4057qib7	3037	18	the	the	DT
cord-005453-4057qib7	3037	19	IG	ig	NN
cord-005453-4057qib7	3037	20	from	from	IN
cord-005453-4057qib7	3037	21	pre	pre	NN
cord-005453-4057qib7	3037	22	-	-	VB
cord-005453-4057qib7	3037	23	to	to	TO
cord-005453-4057qib7	3037	24	follow	follow	VB
cord-005453-4057qib7	3037	25	-	-	HYPH
cord-005453-4057qib7	3037	26	upassessment	upassessment	NN
cord-005453-4057qib7	3037	27	(	(	-LRB-
cord-005453-4057qib7	3037	28	P=0.035	p=0.035	NN
cord-005453-4057qib7	3037	29	)	)	-RRB-
cord-005453-4057qib7	3037	30	.	.	.
cord-005453-4057qib7	3038	1	Body	body	NN
cord-005453-4057qib7	3038	2	image	image	NN
cord-005453-4057qib7	3038	3	was	be	VBD
cord-005453-4057qib7	3038	4	significant	significant	JJ
cord-005453-4057qib7	3038	5	worse	bad	JJR
cord-005453-4057qib7	3038	6	in	in	IN
cord-005453-4057qib7	3038	7	the	the	DT
cord-005453-4057qib7	3038	8	CG	CG	NNP
cord-005453-4057qib7	3038	9	compared	compare	VBN
cord-005453-4057qib7	3038	10	to	to	IN
cord-005453-4057qib7	3038	11	the	the	DT
cord-005453-4057qib7	3038	12	IG	IG	NNP
cord-005453-4057qib7	3038	13	at	at	IN
cord-005453-4057qib7	3038	14	hospital	hospital	NN
cord-005453-4057qib7	3038	15	discharge	discharge	NN
cord-005453-4057qib7	3038	16	(	(	-LRB-
cord-005453-4057qib7	3038	17	P=0.007	p=0.007	NN
cord-005453-4057qib7	3038	18	)	)	-RRB-
cord-005453-4057qib7	3038	19	as	as	RB
cord-005453-4057qib7	3038	20	well	well	RB
cord-005453-4057qib7	3038	21	as	as	IN
cord-005453-4057qib7	3038	22	at	at	IN
cord-005453-4057qib7	3038	23	follow	follow	NN
cord-005453-4057qib7	3038	24	-	-	HYPH
cord-005453-4057qib7	3038	25	up	up	NN
cord-005453-4057qib7	3038	26	measurement	measurement	NN
cord-005453-4057qib7	3038	27	(	(	-LRB-
cord-005453-4057qib7	3038	28	P=0.030	p=0.030	NN
cord-005453-4057qib7	3038	29	)	)	-RRB-
cord-005453-4057qib7	3038	30	where	where	WRB
cord-005453-4057qib7	3038	31	it	-PRON-	PRP
cord-005453-4057qib7	3038	32	got	get	VBD
cord-005453-4057qib7	3038	33	worse	bad	JJR
cord-005453-4057qib7	3038	34	over	over	IN
cord-005453-4057qib7	3038	35	time	time	NN
cord-005453-4057qib7	3038	36	(	(	-LRB-
cord-005453-4057qib7	3038	37	P=0.036	p=0.036	NN
cord-005453-4057qib7	3038	38	)	)	-RRB-
cord-005453-4057qib7	3038	39	.	.	.
cord-005453-4057qib7	3039	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3039	2	:	:	:
cord-005453-4057qib7	3040	1	WBV	wbv	NN
cord-005453-4057qib7	3040	2	was	be	VBD
cord-005453-4057qib7	3040	3	shown	show	VBN
cord-005453-4057qib7	3040	4	to	to	TO
cord-005453-4057qib7	3040	5	maintain	maintain	VB
cord-005453-4057qib7	3040	6	maximum	maximum	JJ
cord-005453-4057qib7	3040	7	strength	strength	NN
cord-005453-4057qib7	3040	8	,	,	,
cord-005453-4057qib7	3040	9	jumping	jump	VBG
cord-005453-4057qib7	3040	10	performance	performance	NN
cord-005453-4057qib7	3040	11	and	and	CC
cord-005453-4057qib7	3040	12	QoL	qol	NN
cord-005453-4057qib7	3040	13	during	during	IN
cord-005453-4057qib7	3040	14	alloHCT	alloHCT	NNP
cord-005453-4057qib7	3040	15	.	.	.
cord-005453-4057qib7	3041	1	Although	although	IN
cord-005453-4057qib7	3041	2	cardiorespiratory	cardiorespiratory	JJ
cord-005453-4057qib7	3041	3	fitness	fitness	NN
cord-005453-4057qib7	3041	4	could	could	MD
cord-005453-4057qib7	3041	5	not	not	RB
cord-005453-4057qib7	3041	6	be	be	VB
cord-005453-4057qib7	3041	7	maintained	maintain	VBN
cord-005453-4057qib7	3041	8	by	by	IN
cord-005453-4057qib7	3041	9	WBV	WBV	NNP
cord-005453-4057qib7	3041	10	during	during	IN
cord-005453-4057qib7	3041	11	hospitalization	hospitalization	NN
cord-005453-4057qib7	3041	12	,	,	,
cord-005453-4057qib7	3041	13	it	-PRON-	PRP
cord-005453-4057qib7	3041	14	seems	seem	VBZ
cord-005453-4057qib7	3041	15	in	in	IN
cord-005453-4057qib7	3041	16	the	the	DT
cord-005453-4057qib7	3041	17	follow	follow	NN
cord-005453-4057qib7	3041	18	up	up	RP
cord-005453-4057qib7	3041	19	period	period	NN
cord-005453-4057qib7	3041	20	till	till	IN
cord-005453-4057qib7	3041	21	day	day	NN
cord-005453-4057qib7	3041	22	+	+	SYM
cord-005453-4057qib7	3041	23	180	180	CD
cord-005453-4057qib7	3041	24	that	that	DT
cord-005453-4057qib7	3041	25	recovery	recovery	NN
cord-005453-4057qib7	3041	26	of	of	IN
cord-005453-4057qib7	3041	27	the	the	DT
cord-005453-4057qib7	3041	28	cardiorespiratory	cardiorespiratory	JJ
cord-005453-4057qib7	3041	29	system	system	NN
cord-005453-4057qib7	3041	30	is	be	VBZ
cord-005453-4057qib7	3041	31	enhanced	enhance	VBN
cord-005453-4057qib7	3041	32	by	by	IN
cord-005453-4057qib7	3041	33	WBV	WBV	NNP
cord-005453-4057qib7	3041	34	carried	carry	VBD
cord-005453-4057qib7	3041	35	out	out	RP
cord-005453-4057qib7	3041	36	during	during	IN
cord-005453-4057qib7	3041	37	alloHST	alloHST	NNP
cord-005453-4057qib7	3041	38	.	.	.
cord-005453-4057qib7	3042	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	3042	2	reasons	reason	NNS
cord-005453-4057qib7	3042	3	for	for	IN
cord-005453-4057qib7	3042	4	this	this	DT
cord-005453-4057qib7	3042	5	changes	change	NNS
cord-005453-4057qib7	3042	6	in	in	IN
cord-005453-4057qib7	3042	7	recovery	recovery	NN
cord-005453-4057qib7	3042	8	have	have	VBP
cord-005453-4057qib7	3042	9	to	to	TO
cord-005453-4057qib7	3042	10	be	be	VB
cord-005453-4057qib7	3042	11	analyzed	analyze	VBN
cord-005453-4057qib7	3042	12	in	in	IN
cord-005453-4057qib7	3042	13	further	further	JJ
cord-005453-4057qib7	3042	14	studies	study	NNS
cord-005453-4057qib7	3042	15	as	as	RB
cord-005453-4057qib7	3042	16	well	well	RB
cord-005453-4057qib7	3042	17	as	as	IN
cord-005453-4057qib7	3042	18	treatment	treatment	NN
cord-005453-4057qib7	3042	19	effects	effect	NNS
cord-005453-4057qib7	3042	20	of	of	IN
cord-005453-4057qib7	3042	21	WBV	wbv	NN
cord-005453-4057qib7	3042	22	compared	compare	VBN
cord-005453-4057qib7	3042	23	to	to	IN
cord-005453-4057qib7	3042	24	conventional	conventional	JJ
cord-005453-4057qib7	3042	25	resistance	resistance	NN
cord-005453-4057qib7	3042	26	training	training	NN
cord-005453-4057qib7	3042	27	.	.	.
cord-005453-4057qib7	3043	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3043	2	:	:	:
cord-005453-4057qib7	3043	3	Supported	support	VBN
cord-005453-4057qib7	3043	4	by	by	IN
cord-005453-4057qib7	3043	5	a	a	DT
cord-005453-4057qib7	3043	6	grant	grant	NN
cord-005453-4057qib7	3043	7	of	of	IN
cord-005453-4057qib7	3043	8	the	the	DT
cord-005453-4057qib7	3043	9	faculty	faculty	NN
cord-005453-4057qib7	3043	10	of	of	IN
cord-005453-4057qib7	3043	11	medicine	medicine	NN
cord-005453-4057qib7	3043	12	and	and	CC
cord-005453-4057qib7	3043	13	Comprehensive	Comprehensive	NNP
cord-005453-4057qib7	3043	14	Cancer	Cancer	NNP
cord-005453-4057qib7	3043	15	Center	Center	NNP
cord-005453-4057qib7	3043	16	Freiburg	Freiburg	NNP
cord-005453-4057qib7	3043	17	Respiratory	respiratory	JJ
cord-005453-4057qib7	3043	18	virus	virus	NN
cord-005453-4057qib7	3043	19	infection	infection	NN
cord-005453-4057qib7	3043	20	within	within	IN
cord-005453-4057qib7	3043	21	1	1	CD
cord-005453-4057qib7	3043	22	year	year	NN
cord-005453-4057qib7	3043	23	after	after	IN
cord-005453-4057qib7	3043	24	of	of	IN
cord-005453-4057qib7	3043	25	Allo	Allo	NNP
cord-005453-4057qib7	3043	26	-	-	HYPH
cord-005453-4057qib7	3043	27	SCT	SCT	NNP
cord-005453-4057qib7	3043	28	is	be	VBZ
cord-005453-4057qib7	3043	29	the	the	DT
cord-005453-4057qib7	3043	30	significant	significant	JJ
cord-005453-4057qib7	3043	31	risk	risk	NN
cord-005453-4057qib7	3043	32	factor	factor	NN
cord-005453-4057qib7	3043	33	of	of	IN
cord-005453-4057qib7	3043	34	obstructive	obstructive	JJ
cord-005453-4057qib7	3043	35	ventilatory	ventilatory	NN
cord-005453-4057qib7	3043	36	disturbance	disturbance	NN
cord-005453-4057qib7	3043	37	Kosei	Kosei	NNP
cord-005453-4057qib7	3043	38	Kageyama	Kageyama	NNP
cord-005453-4057qib7	3043	39	1	1	CD
cord-005453-4057qib7	3043	40	,	,	,
cord-005453-4057qib7	3043	41	Michiho	Michiho	NNP
cord-005453-4057qib7	3043	42	Ebihara	Ebihara	NNP
cord-005453-4057qib7	3043	43	1	1	CD
cord-005453-4057qib7	3043	44	,	,	,
cord-005453-4057qib7	3043	45	Mitsuhiro	Mitsuhiro	NNP
cord-005453-4057qib7	3043	46	Yuasa	Yuasa	NNP
cord-005453-4057qib7	3043	47	1	1	CD
cord-005453-4057qib7	3043	48	,	,	,
cord-005453-4057qib7	3043	49	Daisuke	Daisuke	NNP
cord-005453-4057qib7	3043	50	Kaji	Kaji	NNP
cord-005453-4057qib7	3043	51	1	1	CD
cord-005453-4057qib7	3043	52	,	,	,
cord-005453-4057qib7	3043	53	Aya	Aya	NNP
cord-005453-4057qib7	3043	54	Nishida	Nishida	NNP
cord-005453-4057qib7	3043	55	1	1	CD
cord-005453-4057qib7	3043	56	,	,	,
cord-005453-4057qib7	3043	57	Shinsuke	Shinsuke	NNP
cord-005453-4057qib7	3043	58	Takagi	Takagi	NNP
cord-005453-4057qib7	3043	59	1	1	CD
cord-005453-4057qib7	3043	60	,	,	,
cord-005453-4057qib7	3043	61	Hisashi	Hisashi	NNP
cord-005453-4057qib7	3043	62	Yamamoto	Yamamoto	NNP
cord-005453-4057qib7	3043	63	1	1	CD
cord-005453-4057qib7	3043	64	,	,	,
cord-005453-4057qib7	3043	65	Go	go	VB
cord-005453-4057qib7	3043	66	Yamamoto	Yamamoto	NNP
cord-005453-4057qib7	3043	67	1	1	CD
cord-005453-4057qib7	3043	68	,	,	,
cord-005453-4057qib7	3043	69	Yuki	Yuki	NNP
cord-005453-4057qib7	3043	70	Asano	Asano	NNP
cord-005453-4057qib7	3043	71	-	-	HYPH
cord-005453-4057qib7	3043	72	Mori	Mori	NNP
cord-005453-4057qib7	3043	73	1	1	CD
cord-005453-4057qib7	3043	74	,	,	,
cord-005453-4057qib7	3043	75	Naoyuki	Naoyuki	NNP
cord-005453-4057qib7	3043	76	Uchida	Uchida	NNP
cord-005453-4057qib7	3043	77	1	1	CD
cord-005453-4057qib7	3043	78	,	,	,
cord-005453-4057qib7	3044	1	Atsushi	Atsushi	NNP
cord-005453-4057qib7	3044	2	Wake	Wake	NNP
cord-005453-4057qib7	3044	3	1	1	CD
cord-005453-4057qib7	3044	4	,	,	,
cord-005453-4057qib7	3044	5	Akiko	Akiko	NNP
cord-005453-4057qib7	3044	6	Yoneyama	Yoneyama	NNP
cord-005453-4057qib7	3044	7	1	1	CD
cord-005453-4057qib7	3044	8	,	,	,
cord-005453-4057qib7	3044	9	Shigeyoshi	Shigeyoshi	NNP
cord-005453-4057qib7	3044	10	Makino	Makino	NNP
cord-005453-4057qib7	3044	11	1	1	CD
cord-005453-4057qib7	3044	12	,	,	,
cord-005453-4057qib7	3044	13	Shuichi	Shuichi	NNP
cord-005453-4057qib7	3044	14	Taniguchi	Taniguchi	NNP
cord-005453-4057qib7	3044	15	1	1	CD
cord-005453-4057qib7	3044	16	1	1	CD
cord-005453-4057qib7	3044	17	Toranomon	Toranomon	NNP
cord-005453-4057qib7	3044	18	Hospital	Hospital	NNP
cord-005453-4057qib7	3044	19	,	,	,
cord-005453-4057qib7	3044	20	Hematology	Hematology	NNP
cord-005453-4057qib7	3044	21	,	,	,
cord-005453-4057qib7	3044	22	Tokyo	Tokyo	NNP
cord-005453-4057qib7	3044	23	,	,	,
cord-005453-4057qib7	3044	24	Japan	Japan	NNP
cord-005453-4057qib7	3044	25	,	,	,
cord-005453-4057qib7	3045	1	Background	background	NN
cord-005453-4057qib7	3045	2	:	:	:
cord-005453-4057qib7	3046	1	Obstructive	obstructive	JJ
cord-005453-4057qib7	3046	2	ventilatory	ventilatory	JJ
cord-005453-4057qib7	3046	3	disturbance	disturbance	NN
cord-005453-4057qib7	3046	4	(	(	-LRB-
cord-005453-4057qib7	3046	5	OVD	OVD	NNP
cord-005453-4057qib7	3046	6	)	)	-RRB-
cord-005453-4057qib7	3046	7	is	be	VBZ
cord-005453-4057qib7	3046	8	one	one	CD
cord-005453-4057qib7	3046	9	of	of	IN
cord-005453-4057qib7	3046	10	the	the	DT
cord-005453-4057qib7	3046	11	major	major	JJ
cord-005453-4057qib7	3046	12	life	life	NN
cord-005453-4057qib7	3046	13	-	-	HYPH
cord-005453-4057qib7	3046	14	threading	thread	VBG
cord-005453-4057qib7	3046	15	complication	complication	NN
cord-005453-4057qib7	3046	16	at	at	IN
cord-005453-4057qib7	3046	17	the	the	DT
cord-005453-4057qib7	3046	18	chronic	chronic	JJ
cord-005453-4057qib7	3046	19	phase	phase	NN
cord-005453-4057qib7	3046	20	of	of	IN
cord-005453-4057qib7	3046	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	3046	22	stem	stem	NN
cord-005453-4057qib7	3046	23	cell	cell	NN
cord-005453-4057qib7	3046	24	transplantation	transplantation	NN
cord-005453-4057qib7	3046	25	(	(	-LRB-
cord-005453-4057qib7	3046	26	Allo	Allo	NNP
cord-005453-4057qib7	3046	27	-	-	HYPH
cord-005453-4057qib7	3046	28	SCT	SCT	NNP
cord-005453-4057qib7	3046	29	)	)	-RRB-
cord-005453-4057qib7	3046	30	.	.	.
cord-005453-4057qib7	3047	1	Bronchiolitis	Bronchiolitis	NNP
cord-005453-4057qib7	3047	2	obliterans	obliterans	NNP
cord-005453-4057qib7	3047	3	has	have	VBZ
cord-005453-4057qib7	3047	4	been	be	VBN
cord-005453-4057qib7	3047	5	the	the	DT
cord-005453-4057qib7	3047	6	most	most	RBS
cord-005453-4057qib7	3047	7	established	established	JJ
cord-005453-4057qib7	3047	8	etiology	etiology	NN
cord-005453-4057qib7	3047	9	as	as	IN
cord-005453-4057qib7	3047	10	a	a	DT
cord-005453-4057qib7	3047	11	part	part	NN
cord-005453-4057qib7	3047	12	of	of	IN
cord-005453-4057qib7	3047	13	chronic	chronic	JJ
cord-005453-4057qib7	3047	14	graft	graft	NN
cord-005453-4057qib7	3047	15	-	-	HYPH
cord-005453-4057qib7	3047	16	versus	versus	IN
cord-005453-4057qib7	3047	17	-	-	HYPH
cord-005453-4057qib7	3047	18	host	host	NN
cord-005453-4057qib7	3047	19	disease	disease	NN
cord-005453-4057qib7	3047	20	and	and	CC
cord-005453-4057qib7	3047	21	major	major	JJ
cord-005453-4057qib7	3047	22	cause	cause	NN
cord-005453-4057qib7	3047	23	of	of	IN
cord-005453-4057qib7	3047	24	late	late	JJ
cord-005453-4057qib7	3047	25	non	non	JJ
cord-005453-4057qib7	3047	26	-	-	JJ
cord-005453-4057qib7	3047	27	relapse	relapse	JJ
cord-005453-4057qib7	3047	28	mortality	mortality	NN
cord-005453-4057qib7	3047	29	of	of	IN
cord-005453-4057qib7	3047	30	Allo	Allo	NNP
cord-005453-4057qib7	3047	31	-	-	HYPH
cord-005453-4057qib7	3047	32	SCT	SCT	NNP
cord-005453-4057qib7	3047	33	.	.	.
cord-005453-4057qib7	3048	1	But	but	CC
cord-005453-4057qib7	3048	2	other	other	JJ
cord-005453-4057qib7	3048	3	etiologies	etiology	NNS
cord-005453-4057qib7	3048	4	impact	impact	VBP
cord-005453-4057qib7	3048	5	on	on	IN
cord-005453-4057qib7	3048	6	respiratory	respiratory	JJ
cord-005453-4057qib7	3048	7	function	function	NN
cord-005453-4057qib7	3048	8	after	after	IN
cord-005453-4057qib7	3048	9	Allo	Allo	NNP
cord-005453-4057qib7	3048	10	-	-	HYPH
cord-005453-4057qib7	3048	11	SCT	sct	NN
cord-005453-4057qib7	3048	12	and	and	CC
cord-005453-4057qib7	3048	13	risk	risk	NN
cord-005453-4057qib7	3048	14	factor	factor	NN
cord-005453-4057qib7	3048	15	of	of	IN
cord-005453-4057qib7	3048	16	OVD	OVD	NNP
cord-005453-4057qib7	3048	17	have	have	VBP
cord-005453-4057qib7	3048	18	not	not	RB
cord-005453-4057qib7	3048	19	been	be	VBN
cord-005453-4057qib7	3048	20	well	well	RB
cord-005453-4057qib7	3048	21	understood	understand	VBN
cord-005453-4057qib7	3048	22	.	.	.
cord-005453-4057qib7	3049	1	Methods	method	NNS
cord-005453-4057qib7	3049	2	:	:	:
cord-005453-4057qib7	3049	3	To	to	TO
cord-005453-4057qib7	3049	4	address	address	VB
cord-005453-4057qib7	3049	5	these	these	DT
cord-005453-4057qib7	3049	6	issues	issue	NNS
cord-005453-4057qib7	3049	7	,	,	,
cord-005453-4057qib7	3049	8	we	-PRON-	PRP
cord-005453-4057qib7	3049	9	retrospectively	retrospectively	RB
cord-005453-4057qib7	3049	10	reviewed	review	VBD
cord-005453-4057qib7	3049	11	the	the	DT
cord-005453-4057qib7	3049	12	medical	medical	JJ
cord-005453-4057qib7	3049	13	record	record	NN
cord-005453-4057qib7	3049	14	of	of	IN
cord-005453-4057qib7	3049	15	747	747	CD
cord-005453-4057qib7	3049	16	consecutive	consecutive	JJ
cord-005453-4057qib7	3049	17	patients	patient	NNS
cord-005453-4057qib7	3049	18	who	who	WP
cord-005453-4057qib7	3049	19	first	first	RB
cord-005453-4057qib7	3049	20	Allo	Allo	NNP
cord-005453-4057qib7	3049	21	-	-	HYPH
cord-005453-4057qib7	3049	22	SCT	SCT	NNP
cord-005453-4057qib7	3049	23	at	at	IN
cord-005453-4057qib7	3049	24	Toranomon	Toranomon	NNP
cord-005453-4057qib7	3049	25	Hospital	Hospital	NNP
cord-005453-4057qib7	3049	26	between	between	IN
cord-005453-4057qib7	3049	27	2009	2009	CD
cord-005453-4057qib7	3049	28	and	and	CC
cord-005453-4057qib7	3049	29	2017	2017	CD
cord-005453-4057qib7	3049	30	.	.	.
cord-005453-4057qib7	3050	1	To	to	TO
cord-005453-4057qib7	3050	2	detect	detect	VB
cord-005453-4057qib7	3050	3	OVD	OVD	NNP
cord-005453-4057qib7	3050	4	,	,	,
cord-005453-4057qib7	3050	5	forced	force	VBN
cord-005453-4057qib7	3050	6	expiratory	expiratory	JJ
cord-005453-4057qib7	3050	7	volume	volume	NN
cord-005453-4057qib7	3050	8	in	in	IN
cord-005453-4057qib7	3050	9	1	1	CD
cord-005453-4057qib7	3050	10	second	second	NN
cord-005453-4057qib7	3050	11	(	(	-LRB-
cord-005453-4057qib7	3050	12	FEV1.0	FEV1.0	NNP
cord-005453-4057qib7	3050	13	)	)	-RRB-
cord-005453-4057qib7	3050	14	showed	show	VBD
cord-005453-4057qib7	3050	15	less	less	JJR
cord-005453-4057qib7	3050	16	than	than	IN
cord-005453-4057qib7	3050	17	80	80	CD
cord-005453-4057qib7	3050	18	%	%	NN
cord-005453-4057qib7	3050	19	of	of	IN
cord-005453-4057qib7	3050	20	predicted	predict	VBN
cord-005453-4057qib7	3050	21	in	in	IN
cord-005453-4057qib7	3050	22	spirometry	spirometry	NN
cord-005453-4057qib7	3050	23	test	test	NN
cord-005453-4057qib7	3050	24	was	be	VBD
cord-005453-4057qib7	3050	25	defined	define	VBN
cord-005453-4057qib7	3050	26	as	as	IN
cord-005453-4057qib7	3050	27	positive	positive	JJ
cord-005453-4057qib7	3050	28	.	.	.
cord-005453-4057qib7	3051	1	In	in	IN
cord-005453-4057qib7	3051	2	the	the	DT
cord-005453-4057qib7	3051	3	recipients	recipient	NNS
cord-005453-4057qib7	3051	4	who	who	WP
cord-005453-4057qib7	3051	5	showed	show	VBD
cord-005453-4057qib7	3051	6	FEV1.0	FEV1.0	NNP
cord-005453-4057qib7	3051	7	less	less	JJR
cord-005453-4057qib7	3051	8	than	than	IN
cord-005453-4057qib7	3051	9	80	80	CD
cord-005453-4057qib7	3051	10	%	%	NN
cord-005453-4057qib7	3051	11	in	in	IN
cord-005453-4057qib7	3051	12	pre	pre	JJ
cord-005453-4057qib7	3051	13	-	-	JJ
cord-005453-4057qib7	3051	14	transplant	transplant	JJ
cord-005453-4057qib7	3051	15	test	test	NN
cord-005453-4057qib7	3051	16	,	,	,
cord-005453-4057qib7	3051	17	more	more	JJR
cord-005453-4057qib7	3051	18	than	than	IN
cord-005453-4057qib7	3051	19	20	20	CD
cord-005453-4057qib7	3051	20	%	%	NN
cord-005453-4057qib7	3051	21	reduction	reduction	NN
cord-005453-4057qib7	3051	22	of	of	IN
cord-005453-4057qib7	3051	23	FEV1.0	FEV1.0	NNP
cord-005453-4057qib7	3051	24	was	be	VBD
cord-005453-4057qib7	3051	25	regarded	regard	VBN
cord-005453-4057qib7	3051	26	as	as	IN
cord-005453-4057qib7	3051	27	positive	positive	JJ
cord-005453-4057qib7	3051	28	.	.	.
cord-005453-4057qib7	3052	1	Nasopharyngeal	nasopharyngeal	JJ
cord-005453-4057qib7	3052	2	swab	swab	NN
cord-005453-4057qib7	3052	3	of	of	IN
cord-005453-4057qib7	3052	4	those	those	DT
cord-005453-4057qib7	3052	5	who	who	WP
cord-005453-4057qib7	3052	6	had	have	VBD
cord-005453-4057qib7	3052	7	upper	upper	JJ
cord-005453-4057qib7	3052	8	respiratory	respiratory	JJ
cord-005453-4057qib7	3052	9	tract	tract	NN
cord-005453-4057qib7	3052	10	symptoms	symptom	NNS
cord-005453-4057qib7	3052	11	were	be	VBD
cord-005453-4057qib7	3052	12	tested	test	VBN
cord-005453-4057qib7	3052	13	for	for	IN
cord-005453-4057qib7	3052	14	the	the	DT
cord-005453-4057qib7	3052	15	presence	presence	NN
cord-005453-4057qib7	3052	16	of	of	IN
cord-005453-4057qib7	3052	17	respiratory	respiratory	JJ
cord-005453-4057qib7	3052	18	viral	viral	JJ
cord-005453-4057qib7	3052	19	antigens	antigen	NNS
cord-005453-4057qib7	3052	20	(	(	-LRB-
cord-005453-4057qib7	3052	21	ADV	ADV	NNP
cord-005453-4057qib7	3052	22	,	,	,
cord-005453-4057qib7	3052	23	PIV	PIV	NNP
cord-005453-4057qib7	3052	24	,	,	,
cord-005453-4057qib7	3052	25	and	and	CC
cord-005453-4057qib7	3052	26	RSV	RSV	NNP
cord-005453-4057qib7	3052	27	)	)	-RRB-
cord-005453-4057qib7	3052	28	.	.	.
cord-005453-4057qib7	3053	1	Patients	patient	NNS
cord-005453-4057qib7	3053	2	with	with	IN
cord-005453-4057qib7	3053	3	ECOG	ECOG	NNP
cord-005453-4057qib7	3053	4	performance	performance	NN
cord-005453-4057qib7	3053	5	status	status	NN
cord-005453-4057qib7	3053	6	of	of	IN
cord-005453-4057qib7	3053	7	4	4	CD
cord-005453-4057qib7	3053	8	,	,	,
cord-005453-4057qib7	3053	9	had	have	VBD
cord-005453-4057qib7	3053	10	active	active	JJ
cord-005453-4057qib7	3053	11	infection	infection	NN
cord-005453-4057qib7	3053	12	at	at	IN
cord-005453-4057qib7	3053	13	transplant	transplant	NN
cord-005453-4057qib7	3053	14	were	be	VBD
cord-005453-4057qib7	3053	15	excluded	exclude	VBN
cord-005453-4057qib7	3053	16	from	from	IN
cord-005453-4057qib7	3053	17	this	this	DT
cord-005453-4057qib7	3053	18	analysis	analysis	NN
cord-005453-4057qib7	3053	19	.	.	.
cord-005453-4057qib7	3054	1	The	the	DT
cord-005453-4057qib7	3054	2	cases	case	NNS
cord-005453-4057qib7	3054	3	of	of	IN
cord-005453-4057qib7	3054	4	early	early	JJ
cord-005453-4057qib7	3054	5	death	death	NN
cord-005453-4057qib7	3054	6	or	or	CC
cord-005453-4057qib7	3054	7	relapse	relapse	NN
cord-005453-4057qib7	3054	8	before	before	IN
cord-005453-4057qib7	3054	9	30	30	CD
cord-005453-4057qib7	3054	10	days	day	NNS
cord-005453-4057qib7	3054	11	post	post	NN
cord-005453-4057qib7	3054	12	-	-	NN
cord-005453-4057qib7	3054	13	transplant	transplant	NN
cord-005453-4057qib7	3054	14	,	,	,
cord-005453-4057qib7	3054	15	and	and	CC
cord-005453-4057qib7	3054	16	the	the	DT
cord-005453-4057qib7	3054	17	cases	case	NNS
cord-005453-4057qib7	3054	18	of	of	IN
cord-005453-4057qib7	3054	19	graft	graft	NN
cord-005453-4057qib7	3054	20	failure	failure	NN
cord-005453-4057qib7	3054	21	were	be	VBD
cord-005453-4057qib7	3054	22	also	also	RB
cord-005453-4057qib7	3054	23	excluded	exclude	VBN
cord-005453-4057qib7	3054	24	.	.	.
cord-005453-4057qib7	3055	1	Results	result	NNS
cord-005453-4057qib7	3055	2	:	:	:
cord-005453-4057qib7	3056	1	The	the	DT
cord-005453-4057qib7	3056	2	median	median	JJ
cord-005453-4057qib7	3056	3	age	age	NN
cord-005453-4057qib7	3056	4	was	be	VBD
cord-005453-4057qib7	3056	5	55	55	CD
cord-005453-4057qib7	3056	6	years	year	NNS
cord-005453-4057qib7	3057	1	(	(	-LRB-
cord-005453-4057qib7	3057	2	range	range	NN
cord-005453-4057qib7	3057	3	,	,	,
cord-005453-4057qib7	3057	4	16	16	CD
cord-005453-4057qib7	3057	5	-	-	SYM
cord-005453-4057qib7	3057	6	74	74	CD
cord-005453-4057qib7	3057	7	)	)	-RRB-
cord-005453-4057qib7	3057	8	.	.	.
cord-005453-4057qib7	3058	1	Underlying	underlie	VBG
cord-005453-4057qib7	3058	2	diseases	disease	NNS
cord-005453-4057qib7	3058	3	were	be	VBD
cord-005453-4057qib7	3058	4	AML	AML	NNP
cord-005453-4057qib7	3058	5	in	in	IN
cord-005453-4057qib7	3058	6	403	403	CD
cord-005453-4057qib7	3058	7	,	,	,
cord-005453-4057qib7	3058	8	MDS	MDS	NNP
cord-005453-4057qib7	3058	9	/	/	SYM
cord-005453-4057qib7	3058	10	MPD	MPD	NNP
cord-005453-4057qib7	3058	11	in	in	IN
cord-005453-4057qib7	3058	12	73	73	CD
cord-005453-4057qib7	3058	13	,	,	,
cord-005453-4057qib7	3058	14	CML	CML	NNP
cord-005453-4057qib7	3058	15	in	in	IN
cord-005453-4057qib7	3058	16	26	26	CD
cord-005453-4057qib7	3058	17	,	,	,
cord-005453-4057qib7	3058	18	ALL	all	DT
cord-005453-4057qib7	3058	19	in	in	IN
cord-005453-4057qib7	3058	20	82	82	CD
cord-005453-4057qib7	3058	21	,	,	,
cord-005453-4057qib7	3058	22	ATL	ATL	NNP
cord-005453-4057qib7	3058	23	in	in	IN
cord-005453-4057qib7	3058	24	19	19	CD
cord-005453-4057qib7	3058	25	,	,	,
cord-005453-4057qib7	3058	26	HL	HL	NNP
cord-005453-4057qib7	3058	27	in	in	IN
cord-005453-4057qib7	3058	28	12	12	CD
cord-005453-4057qib7	3058	29	,	,	,
cord-005453-4057qib7	3058	30	NHL	NHL	NNP
cord-005453-4057qib7	3058	31	in	in	IN
cord-005453-4057qib7	3058	32	104	104	CD
cord-005453-4057qib7	3058	33	,	,	,
cord-005453-4057qib7	3058	34	and	and	CC
cord-005453-4057qib7	3058	35	others	other	NNS
cord-005453-4057qib7	3058	36	in	in	IN
cord-005453-4057qib7	3058	37	28	28	CD
cord-005453-4057qib7	3058	38	.	.	.
cord-005453-4057qib7	3059	1	Five	five	CD
cord-005453-4057qib7	3059	2	hundred	hundred	CD
cord-005453-4057qib7	3059	3	twenty	twenty	CD
cord-005453-4057qib7	3059	4	-	-	HYPH
cord-005453-4057qib7	3059	5	nine	nine	CD
cord-005453-4057qib7	3059	6	(	(	-LRB-
cord-005453-4057qib7	3059	7	71	71	CD
cord-005453-4057qib7	3059	8	%	%	NN
cord-005453-4057qib7	3059	9	)	)	-RRB-
cord-005453-4057qib7	3059	10	were	be	VBD
cord-005453-4057qib7	3059	11	not	not	RB
cord-005453-4057qib7	3059	12	in	in	IN
cord-005453-4057qib7	3059	13	remission	remission	NN
cord-005453-4057qib7	3059	14	at	at	IN
cord-005453-4057qib7	3059	15	the	the	DT
cord-005453-4057qib7	3059	16	time	time	NN
cord-005453-4057qib7	3059	17	of	of	IN
cord-005453-4057qib7	3059	18	transplant	transplant	NN
cord-005453-4057qib7	3059	19	.	.	.
cord-005453-4057qib7	3060	1	Five	five	CD
cord-005453-4057qib7	3060	2	hundred	hundred	CD
cord-005453-4057qib7	3060	3	eightythree	eightythree	NNP
cord-005453-4057qib7	3060	4	patients	patient	NNS
cord-005453-4057qib7	3060	5	(	(	-LRB-
cord-005453-4057qib7	3060	6	78	78	CD
cord-005453-4057qib7	3060	7	%	%	NN
cord-005453-4057qib7	3060	8	)	)	-RRB-
cord-005453-4057qib7	3060	9	were	be	VBD
cord-005453-4057qib7	3060	10	conditioned	condition	VBN
cord-005453-4057qib7	3060	11	with	with	IN
cord-005453-4057qib7	3060	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	3060	13	regimens	regimen	NNS
cord-005453-4057qib7	3060	14	,	,	,
cord-005453-4057qib7	3060	15	whereas	whereas	IN
cord-005453-4057qib7	3060	16	164	164	CD
cord-005453-4057qib7	3060	17	patients	patient	NNS
cord-005453-4057qib7	3060	18	received	receive	VBD
cord-005453-4057qib7	3060	19	reduced	reduce	VBN
cord-005453-4057qib7	3060	20	-	-	HYPH
cord-005453-4057qib7	3060	21	intensity	intensity	NN
cord-005453-4057qib7	3060	22	regimens	regimen	NNS
cord-005453-4057qib7	3060	23	.	.	.
cord-005453-4057qib7	3061	1	Donor	donor	NN
cord-005453-4057qib7	3061	2	sources	source	NNS
cord-005453-4057qib7	3061	3	consisted	consist	VBD
cord-005453-4057qib7	3061	4	of	of	IN
cord-005453-4057qib7	3061	5	related	related	JJ
cord-005453-4057qib7	3061	6	peripheral	peripheral	JJ
cord-005453-4057qib7	3061	7	blood	blood	NN
cord-005453-4057qib7	3061	8	/bone	/bone	.
cord-005453-4057qib7	3061	9	marrow	marrow	NN
cord-005453-4057qib7	3061	10	(	(	-LRB-
cord-005453-4057qib7	3061	11	BM	BM	NNP
cord-005453-4057qib7	3061	12	)	)	-RRB-
cord-005453-4057qib7	3061	13	(	(	-LRB-
cord-005453-4057qib7	3061	14	n=85	n=85	NNP
cord-005453-4057qib7	3061	15	)	)	-RRB-
cord-005453-4057qib7	3061	16	,	,	,
cord-005453-4057qib7	3061	17	unrelated	unrelated	JJ
cord-005453-4057qib7	3061	18	BM	BM	NNP
cord-005453-4057qib7	3061	19	(	(	-LRB-
cord-005453-4057qib7	3061	20	153	153	CD
cord-005453-4057qib7	3061	21	)	)	-RRB-
cord-005453-4057qib7	3061	22	Forty	forty	CD
cord-005453-4057qib7	3061	23	-	-	HYPH
cord-005453-4057qib7	3061	24	six	six	CD
cord-005453-4057qib7	3061	25	developed	develop	VBD
cord-005453-4057qib7	3061	26	OVD	OVD	NNP
cord-005453-4057qib7	3061	27	on	on	IN
cord-005453-4057qib7	3061	28	median	median	NN
cord-005453-4057qib7	3061	29	of	of	IN
cord-005453-4057qib7	3061	30	198	198	CD
cord-005453-4057qib7	3062	1	(	(	-LRB-
cord-005453-4057qib7	3062	2	60	60	CD
cord-005453-4057qib7	3062	3	-	-	SYM
cord-005453-4057qib7	3062	4	804	804	CD
cord-005453-4057qib7	3062	5	)	)	-RRB-
cord-005453-4057qib7	3062	6	days	day	NNS
cord-005453-4057qib7	3062	7	post	post	NN
cord-005453-4057qib7	3062	8	-	-	NN
cord-005453-4057qib7	3062	9	transplant	transplant	NN
cord-005453-4057qib7	3062	10	.	.	.
cord-005453-4057qib7	3063	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	3063	2	incidence	incidence	NN
cord-005453-4057qib7	3063	3	of	of	IN
cord-005453-4057qib7	3063	4	OVD	OVD	NNP
cord-005453-4057qib7	3063	5	was	be	VBD
cord-005453-4057qib7	3063	6	6.4	6.4	CD
cord-005453-4057qib7	3063	7	%	%	NN
cord-005453-4057qib7	3063	8	in	in	IN
cord-005453-4057qib7	3063	9	total	total	JJ
cord-005453-4057qib7	3063	10	population	population	NN
cord-005453-4057qib7	3063	11	.	.	.
cord-005453-4057qib7	3064	1	In	in	IN
cord-005453-4057qib7	3064	2	490	490	CD
cord-005453-4057qib7	3064	3	recipients	recipient	NNS
cord-005453-4057qib7	3064	4	those	those	DT
cord-005453-4057qib7	3064	5	who	who	WP
cord-005453-4057qib7	3064	6	could	could	MD
cord-005453-4057qib7	3064	7	spirometry	spirometry	VB
cord-005453-4057qib7	3064	8	,	,	,
cord-005453-4057qib7	3064	9	overall	overall	JJ
cord-005453-4057qib7	3064	10	survival	survival	NN
cord-005453-4057qib7	3064	11	at	at	IN
cord-005453-4057qib7	3064	12	5	5	CD
cord-005453-4057qib7	3064	13	years	year	NNS
cord-005453-4057qib7	3064	14	was	be	VBD
cord-005453-4057qib7	3064	15	73.2	73.2	CD
cord-005453-4057qib7	3064	16	%	%	NN
cord-005453-4057qib7	3064	17	in	in	IN
cord-005453-4057qib7	3064	18	patients	patient	NNS
cord-005453-4057qib7	3064	19	who	who	WP
cord-005453-4057qib7	3064	20	developed	develop	VBD
cord-005453-4057qib7	3064	21	OVD	OVD	NNP
cord-005453-4057qib7	3064	22	and	and	CC
cord-005453-4057qib7	3064	23	was	be	VBD
cord-005453-4057qib7	3064	24	comparable	comparable	JJ
cord-005453-4057qib7	3064	25	with	with	IN
cord-005453-4057qib7	3064	26	those	those	DT
cord-005453-4057qib7	3064	27	who	who	WP
cord-005453-4057qib7	3064	28	did	do	VBD
cord-005453-4057qib7	3064	29	not	not	RB
cord-005453-4057qib7	3064	30	develop	develop	VB
cord-005453-4057qib7	3064	31	it	-PRON-	PRP
cord-005453-4057qib7	3064	32	(	(	-LRB-
cord-005453-4057qib7	3064	33	64.3	64.3	CD
cord-005453-4057qib7	3064	34	%	%	NN
cord-005453-4057qib7	3064	35	,	,	,
cord-005453-4057qib7	3064	36	p=0.486	p=0.486	NN
cord-005453-4057qib7	3064	37	)	)	-RRB-
cord-005453-4057qib7	3064	38	.	.	.
cord-005453-4057qib7	3065	1	In	in	IN
cord-005453-4057qib7	3065	2	univariate	univariate	JJ
cord-005453-4057qib7	3065	3	analysis	analysis	NN
cord-005453-4057qib7	3065	4	,	,	,
cord-005453-4057qib7	3065	5	disease	disease	NN
cord-005453-4057qib7	3065	6	status	status	NN
cord-005453-4057qib7	3065	7	(	(	-LRB-
cord-005453-4057qib7	3065	8	CR	CR	NNP
cord-005453-4057qib7	3065	9	/	/	SYM
cord-005453-4057qib7	3065	10	AA	AA	NNP
cord-005453-4057qib7	3065	11	or	or	CC
cord-005453-4057qib7	3065	12	nonCR	nonCR	NNP
cord-005453-4057qib7	3065	13	)	)	-RRB-
cord-005453-4057qib7	3065	14	,	,	,
cord-005453-4057qib7	3065	15	recipient	recipient	NN
cord-005453-4057qib7	3065	16	age	age	NN
cord-005453-4057qib7	3065	17	(	(	-LRB-
cord-005453-4057qib7	3065	18	age	age	NN
cord-005453-4057qib7	3065	19	<	<	XX
cord-005453-4057qib7	3065	20	55	55	CD
cord-005453-4057qib7	3065	21	or	or	CC
cord-005453-4057qib7	3065	22	≥55	≥55	NNP
cord-005453-4057qib7	3065	23	)	)	-RRB-
cord-005453-4057qib7	3065	24	,	,	,
cord-005453-4057qib7	3065	25	prior	prior	JJ
cord-005453-4057qib7	3065	26	autologous	autologous	JJ
cord-005453-4057qib7	3065	27	stem	stem	NN
cord-005453-4057qib7	3065	28	cell	cell	NN
cord-005453-4057qib7	3065	29	transplantation	transplantation	NN
cord-005453-4057qib7	3065	30	(	(	-LRB-
cord-005453-4057qib7	3065	31	yes	yes	UH
cord-005453-4057qib7	3065	32	or	or	CC
cord-005453-4057qib7	3065	33	no	no	UH
cord-005453-4057qib7	3065	34	)	)	-RRB-
cord-005453-4057qib7	3065	35	,	,	,
cord-005453-4057qib7	3065	36	intensity	intensity	NN
cord-005453-4057qib7	3065	37	of	of	IN
cord-005453-4057qib7	3065	38	conditioning	conditioning	NN
cord-005453-4057qib7	3065	39	regimen	regimen	NN
cord-005453-4057qib7	3065	40	(	(	-LRB-
cord-005453-4057qib7	3065	41	MAC	MAC	NNP
cord-005453-4057qib7	3065	42	or	or	CC
cord-005453-4057qib7	3065	43	RIC	RIC	NNP
cord-005453-4057qib7	3065	44	)	)	-RRB-
cord-005453-4057qib7	3065	45	,	,	,
cord-005453-4057qib7	3065	46	TBI	TBI	NNP
cord-005453-4057qib7	3065	47	dose	dose	NN
cord-005453-4057qib7	3065	48	(	(	-LRB-
cord-005453-4057qib7	3065	49	<	<	NNP
cord-005453-4057qib7	3065	50	8	8	CD
cord-005453-4057qib7	3065	51	Gy	Gy	NNP
cord-005453-4057qib7	3065	52	or	or	CC
cord-005453-4057qib7	3065	53	≥8	≥8	NNP
cord-005453-4057qib7	3065	54	Gy	Gy	NNP
cord-005453-4057qib7	3065	55	)	)	-RRB-
cord-005453-4057qib7	3065	56	,	,	,
cord-005453-4057qib7	3065	57	busulfan	busulfan	NN
cord-005453-4057qib7	3065	58	dose	dose	NN
cord-005453-4057qib7	3065	59	(	(	-LRB-
cord-005453-4057qib7	3065	60	<	<	XX
cord-005453-4057qib7	3065	61	9.6mg	9.6mg	CD
cord-005453-4057qib7	3065	62	/	/	SYM
cord-005453-4057qib7	3065	63	kg	kg	NN
cord-005453-4057qib7	3065	64	or	or	CC
cord-005453-4057qib7	3065	65	≥9.6mg	≥9.6mg	NNS
cord-005453-4057qib7	3065	66	/	/	SYM
cord-005453-4057qib7	3065	67	kg	kg	NNP
cord-005453-4057qib7	3065	68	)	)	-RRB-
cord-005453-4057qib7	3065	69	,	,	,
cord-005453-4057qib7	3065	70	donor	donor	NN
cord-005453-4057qib7	3065	71	source	source	NN
cord-005453-4057qib7	3065	72	(	(	-LRB-
cord-005453-4057qib7	3065	73	cord	cord	NN
cord-005453-4057qib7	3065	74	blood	blood	NN
cord-005453-4057qib7	3065	75	or	or	CC
cord-005453-4057qib7	3065	76	non	non	JJ
cord-005453-4057qib7	3065	77	-	-	JJ
cord-005453-4057qib7	3065	78	cord	cord	JJ
cord-005453-4057qib7	3065	79	)	)	-RRB-
cord-005453-4057qib7	3065	80	had	have	VBD
cord-005453-4057qib7	3065	81	no	no	DT
cord-005453-4057qib7	3065	82	impact	impact	NN
cord-005453-4057qib7	3065	83	on	on	IN
cord-005453-4057qib7	3065	84	the	the	DT
cord-005453-4057qib7	3065	85	incidence	incidence	NN
cord-005453-4057qib7	3065	86	of	of	IN
cord-005453-4057qib7	3065	87	OVD	OVD	NNP
cord-005453-4057qib7	3065	88	.	.	.
cord-005453-4057qib7	3066	1	Patients	patient	NNS
cord-005453-4057qib7	3066	2	who	who	WP
cord-005453-4057qib7	3066	3	developed	develop	VBD
cord-005453-4057qib7	3066	4	respiratory	respiratory	JJ
cord-005453-4057qib7	3066	5	virus	virus	NN
cord-005453-4057qib7	3066	6	infection	infection	NN
cord-005453-4057qib7	3066	7	showed	show	VBD
cord-005453-4057qib7	3066	8	significantly	significantly	RB
cord-005453-4057qib7	3066	9	higher	high	JJR
cord-005453-4057qib7	3066	10	incidence	incidence	NN
cord-005453-4057qib7	3066	11	of	of	IN
cord-005453-4057qib7	3066	12	OVD	OVD	NNP
cord-005453-4057qib7	3066	13	compared	compare	VBN
cord-005453-4057qib7	3066	14	to	to	IN
cord-005453-4057qib7	3066	15	those	those	DT
cord-005453-4057qib7	3066	16	who	who	WP
cord-005453-4057qib7	3066	17	did	do	VBD
cord-005453-4057qib7	3066	18	not	not	RB
cord-005453-4057qib7	3066	19	developed	develop	VBN
cord-005453-4057qib7	3066	20	it	-PRON-	PRP
cord-005453-4057qib7	3066	21	(	(	-LRB-
cord-005453-4057qib7	3066	22	12.4	12.4	CD
cord-005453-4057qib7	3066	23	%	%	NN
cord-005453-4057qib7	3066	24	vs	vs	IN
cord-005453-4057qib7	3066	25	5.3	5.3	CD
cord-005453-4057qib7	3066	26	%	%	NN
cord-005453-4057qib7	3066	27	,	,	,
cord-005453-4057qib7	3066	28	p	p	NN
cord-005453-4057qib7	3066	29	<	<	XX
cord-005453-4057qib7	3066	30	0.01	0.01	CD
cord-005453-4057qib7	3066	31	)	)	-RRB-
cord-005453-4057qib7	3066	32	.	.	.
cord-005453-4057qib7	3067	1	In	in	IN
cord-005453-4057qib7	3067	2	multivariate	multivariate	JJ
cord-005453-4057qib7	3067	3	analysis	analysis	NN
cord-005453-4057qib7	3067	4	,	,	,
cord-005453-4057qib7	3067	5	respiratory	respiratory	JJ
cord-005453-4057qib7	3067	6	virus	virus	NN
cord-005453-4057qib7	3067	7	infection	infection	NN
cord-005453-4057qib7	3067	8	was	be	VBD
cord-005453-4057qib7	3067	9	the	the	DT
cord-005453-4057qib7	3067	10	only	only	JJ
cord-005453-4057qib7	3067	11	significant	significant	JJ
cord-005453-4057qib7	3067	12	risk	risk	NN
cord-005453-4057qib7	3067	13	factor	factor	NN
cord-005453-4057qib7	3067	14	for	for	IN
cord-005453-4057qib7	3067	15	the	the	DT
cord-005453-4057qib7	3067	16	development	development	NN
cord-005453-4057qib7	3067	17	of	of	IN
cord-005453-4057qib7	3067	18	OVD	OVD	NNP
cord-005453-4057qib7	3067	19	(	(	-LRB-
cord-005453-4057qib7	3067	20	HR=2.43	hr=2.43	XX
cord-005453-4057qib7	3068	1	,	,	,
cord-005453-4057qib7	3068	2	95	95	CD
cord-005453-4057qib7	3068	3	%	%	NN
cord-005453-4057qib7	3068	4	CI	CI	NNP
cord-005453-4057qib7	3068	5	1.30	1.30	CD
cord-005453-4057qib7	3068	6	-	-	HYPH
cord-005453-4057qib7	3068	7	4.57	4.57	CD
cord-005453-4057qib7	3068	8	,	,	,
cord-005453-4057qib7	3068	9	p	p	NN
cord-005453-4057qib7	3068	10	<	<	XX
cord-005453-4057qib7	3068	11	0.01	0.01	CD
cord-005453-4057qib7	3068	12	)	)	-RRB-
cord-005453-4057qib7	3068	13	.	.	.
cord-005453-4057qib7	3069	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3069	2	:	:	:
cord-005453-4057qib7	3070	1	Respiratory	respiratory	JJ
cord-005453-4057qib7	3070	2	virus	virus	NN
cord-005453-4057qib7	3070	3	infection	infection	NN
cord-005453-4057qib7	3070	4	within	within	IN
cord-005453-4057qib7	3070	5	1	1	CD
cord-005453-4057qib7	3070	6	year	year	NN
cord-005453-4057qib7	3070	7	after	after	IN
cord-005453-4057qib7	3070	8	Allo	Allo	NNP
cord-005453-4057qib7	3070	9	-	-	HYPH
cord-005453-4057qib7	3070	10	SCT	SCT	NNP
cord-005453-4057qib7	3070	11	is	be	VBZ
cord-005453-4057qib7	3070	12	the	the	DT
cord-005453-4057qib7	3070	13	significant	significant	JJ
cord-005453-4057qib7	3070	14	risk	risk	NN
cord-005453-4057qib7	3070	15	factor	factor	NN
cord-005453-4057qib7	3070	16	of	of	IN
cord-005453-4057qib7	3070	17	OVD	OVD	NNP
cord-005453-4057qib7	3070	18	.	.	.
cord-005453-4057qib7	3071	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3071	2	:	:	:
cord-005453-4057qib7	3071	3	Nothing	nothing	NN
cord-005453-4057qib7	3071	4	to	to	TO
cord-005453-4057qib7	3071	5	declare	declare	VB
cord-005453-4057qib7	3071	6	.	.	.
cord-005453-4057qib7	3072	1	Background	background	NN
cord-005453-4057qib7	3072	2	:	:	:
cord-005453-4057qib7	3073	1	Metabolic	Metabolic	NNP
cord-005453-4057qib7	3073	2	Syndrome	Syndrome	NNP
cord-005453-4057qib7	3073	3	(	(	-LRB-
cord-005453-4057qib7	3073	4	MetS	MetS	NNP
cord-005453-4057qib7	3073	5	)	)	-RRB-
cord-005453-4057qib7	3073	6	is	be	VBZ
cord-005453-4057qib7	3073	7	related	relate	VBN
cord-005453-4057qib7	3073	8	to	to	IN
cord-005453-4057qib7	3073	9	increased	increase	VBN
cord-005453-4057qib7	3073	10	risk	risk	NN
cord-005453-4057qib7	3073	11	of	of	IN
cord-005453-4057qib7	3073	12	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	3073	13	disease	disease	NN
cord-005453-4057qib7	3073	14	and	and	CC
cord-005453-4057qib7	3073	15	type-2	type-2	NN
cord-005453-4057qib7	3073	16	diabetes	diabete	NNS
cord-005453-4057qib7	3073	17	(	(	-LRB-
cord-005453-4057qib7	3073	18	DM-2	DM-2	NNP
cord-005453-4057qib7	3073	19	)	)	-RRB-
cord-005453-4057qib7	3073	20	and	and	CC
cord-005453-4057qib7	3073	21	usually	usually	RB
cord-005453-4057qib7	3073	22	seen	see	VBN
cord-005453-4057qib7	3073	23	in	in	IN
cord-005453-4057qib7	3073	24	overweight	overweight	JJ
cord-005453-4057qib7	3073	25	individuals	individual	NNS
cord-005453-4057qib7	3073	26	in	in	IN
cord-005453-4057qib7	3073	27	the	the	DT
cord-005453-4057qib7	3073	28	general	general	JJ
cord-005453-4057qib7	3073	29	population	population	NN
cord-005453-4057qib7	3073	30	.	.	.
cord-005453-4057qib7	3074	1	We	-PRON-	PRP
cord-005453-4057qib7	3074	2	investigated	investigate	VBD
cord-005453-4057qib7	3074	3	MetS	MetS	NNP
cord-005453-4057qib7	3074	4	and	and	CC
cord-005453-4057qib7	3074	5	clinical	clinical	JJ
cord-005453-4057qib7	3074	6	risk	risk	NN
cord-005453-4057qib7	3074	7	factors	factor	NNS
cord-005453-4057qib7	3074	8	two	two	CD
cord-005453-4057qib7	3074	9	decades	decade	NNS
cord-005453-4057qib7	3074	10	after	after	IN
cord-005453-4057qib7	3074	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3074	12	.	.	.
cord-005453-4057qib7	3075	1	Methods	method	NNS
cord-005453-4057qib7	3075	2	:	:	:
cord-005453-4057qib7	3076	1	All	all	DT
cord-005453-4057qib7	3076	2	male	male	JJ
cord-005453-4057qib7	3076	3	survivors	survivor	NNS
cord-005453-4057qib7	3076	4	treated	treat	VBN
cord-005453-4057qib7	3076	5	with	with	IN
cord-005453-4057qib7	3076	6	myeloablative	myeloablative	NNP
cord-005453-4057qib7	3076	7	allo	allo	NNP
cord-005453-4057qib7	3076	8	-	-	HYPH
cord-005453-4057qib7	3076	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3076	10	during	during	IN
cord-005453-4057qib7	3076	11	childhood	childhood	NN
cord-005453-4057qib7	3076	12	(	(	-LRB-
cord-005453-4057qib7	3076	13	<	<	NNP
cord-005453-4057qib7	3076	14	17	17	CD
cord-005453-4057qib7	3076	15	years	year	NNS
cord-005453-4057qib7	3076	16	)	)	-RRB-
cord-005453-4057qib7	3076	17	between	between	IN
cord-005453-4057qib7	3076	18	1980	1980	CD
cord-005453-4057qib7	3076	19	-	-	SYM
cord-005453-4057qib7	3076	20	2010	2010	CD
cord-005453-4057qib7	3076	21	in	in	IN
cord-005453-4057qib7	3076	22	Denmark	Denmark	NNP
cord-005453-4057qib7	3076	23	were	be	VBD
cord-005453-4057qib7	3076	24	invited	invite	VBN
cord-005453-4057qib7	3076	25	to	to	IN
cord-005453-4057qib7	3076	26	a	a	DT
cord-005453-4057qib7	3076	27	follow	follow	VB
cord-005453-4057qib7	3076	28	-	-	HYPH
cord-005453-4057qib7	3076	29	up	up	NN
cord-005453-4057qib7	3076	30	study	study	NN
cord-005453-4057qib7	3076	31	.	.	.
cord-005453-4057qib7	3077	1	MetS	MetS	NNP
cord-005453-4057qib7	3077	2	was	be	VBD
cord-005453-4057qib7	3077	3	defined	define	VBN
cord-005453-4057qib7	3077	4	as	as	IN
cord-005453-4057qib7	3077	5	the	the	DT
cord-005453-4057qib7	3077	6	presence	presence	NN
cord-005453-4057qib7	3077	7	of	of	IN
cord-005453-4057qib7	3077	8	at	at	RB
cord-005453-4057qib7	3077	9	least	least	RBS
cord-005453-4057qib7	3077	10	three	three	CD
cord-005453-4057qib7	3077	11	NCEP	NCEP	NNP
cord-005453-4057qib7	3077	12	ATP	ATP	NNP
cord-005453-4057qib7	3077	13	III	III	NNP
cord-005453-4057qib7	3077	14	criteria	criterion	NNS
cord-005453-4057qib7	3077	15	:	:	:
cord-005453-4057qib7	3077	16	fasting	fast	VBG
cord-005453-4057qib7	3077	17	plasma	plasma	NN
cord-005453-4057qib7	3077	18	triglyceride	triglyceride	NN
cord-005453-4057qib7	3077	19	(	(	-LRB-
cord-005453-4057qib7	3077	20	TG	TG	NNP
cord-005453-4057qib7	3077	21	)	)	-RRB-
cord-005453-4057qib7	3077	22	≥1.7	≥1.7	NNP
cord-005453-4057qib7	3077	23	mmol	mmol	NNP
cord-005453-4057qib7	3077	24	/	/	SYM
cord-005453-4057qib7	3077	25	L	l	NN
cord-005453-4057qib7	3077	26	,	,	,
cord-005453-4057qib7	3077	27	high	high	JJ
cord-005453-4057qib7	3077	28	density	density	NN
cord-005453-4057qib7	3077	29	lipoprotein	lipoprotein	NN
cord-005453-4057qib7	3077	30	(	(	-LRB-
cord-005453-4057qib7	3077	31	HDL	HDL	NNP
cord-005453-4057qib7	3077	32	)	)	-RRB-
cord-005453-4057qib7	3078	1	<	<	XX
cord-005453-4057qib7	3078	2	1.03	1.03	CD
cord-005453-4057qib7	3078	3	mmol	mmol	NNP
cord-005453-4057qib7	3078	4	/	/	SYM
cord-005453-4057qib7	3078	5	L	L	NNP
cord-005453-4057qib7	3078	6	or	or	CC
cord-005453-4057qib7	3078	7	medical	medical	JJ
cord-005453-4057qib7	3078	8	treatment	treatment	NN
cord-005453-4057qib7	3078	9	of	of	IN
cord-005453-4057qib7	3078	10	hyperlipidemia	hyperlipidemia	NN
cord-005453-4057qib7	3078	11	;	;	:
cord-005453-4057qib7	3078	12	fasting	fast	VBG
cord-005453-4057qib7	3078	13	plasma	plasma	NN
cord-005453-4057qib7	3078	14	glucose	glucose	NN
cord-005453-4057qib7	3078	15	(	(	-LRB-
cord-005453-4057qib7	3078	16	FPG	FPG	NNP
cord-005453-4057qib7	3078	17	)	)	-RRB-
cord-005453-4057qib7	3078	18	≥5.6	≥5.6	NNP
cord-005453-4057qib7	3078	19	mmol	mmol	NNP
cord-005453-4057qib7	3078	20	/	/	SYM
cord-005453-4057qib7	3078	21	L	l	NN
cord-005453-4057qib7	3078	22	;	;	:
cord-005453-4057qib7	3078	23	abdominal	abdominal	JJ
cord-005453-4057qib7	3078	24	circumference	circumference	NN
cord-005453-4057qib7	3078	25	(	(	-LRB-
cord-005453-4057qib7	3078	26	AC	ac	NN
cord-005453-4057qib7	3078	27	)	)	-RRB-
cord-005453-4057qib7	3078	28	>	>	NFP
cord-005453-4057qib7	3078	29	102	102	CD
cord-005453-4057qib7	3078	30	cm	cm	NN
cord-005453-4057qib7	3079	1	;	;	:
cord-005453-4057qib7	3079	2	BP	BP	NNP
cord-005453-4057qib7	3079	3	≥130	≥130	``
cord-005453-4057qib7	3079	4	mmHg	mmHg	NNP
cord-005453-4057qib7	3079	5	(	(	-LRB-
cord-005453-4057qib7	3079	6	systolic	systolic	JJ
cord-005453-4057qib7	3079	7	)	)	-RRB-
cord-005453-4057qib7	3079	8	/	/	SYM
cord-005453-4057qib7	3079	9	≥85	≥85	NNP
cord-005453-4057qib7	3079	10	mmHg	mmHg	NNP
cord-005453-4057qib7	3079	11	(	(	-LRB-
cord-005453-4057qib7	3079	12	diastolic	diastolic	JJ
cord-005453-4057qib7	3079	13	)	)	-RRB-
cord-005453-4057qib7	3079	14	or	or	CC
cord-005453-4057qib7	3079	15	medical	medical	JJ
cord-005453-4057qib7	3079	16	treatment	treatment	NN
cord-005453-4057qib7	3079	17	for	for	IN
cord-005453-4057qib7	3079	18	hypertension	hypertension	NN
cord-005453-4057qib7	3079	19	.	.	.
cord-005453-4057qib7	3080	1	Patients	patient	NNS
cord-005453-4057qib7	3080	2	with	with	IN
cord-005453-4057qib7	3081	1	overt	overt	JJ
cord-005453-4057qib7	3081	2	DM-2	DM-2	NNP
cord-005453-4057qib7	3081	3	were	be	VBD
cord-005453-4057qib7	3081	4	included	include	VBN
cord-005453-4057qib7	3081	5	into	into	IN
cord-005453-4057qib7	3081	6	the	the	DT
cord-005453-4057qib7	3081	7	MetS	MetS	NNP
cord-005453-4057qib7	3081	8	group	group	NN
cord-005453-4057qib7	3081	9	.	.	.
cord-005453-4057qib7	3082	1	Furthermore	furthermore	RB
cord-005453-4057qib7	3082	2	,	,	,
cord-005453-4057qib7	3082	3	patients	patient	NNS
cord-005453-4057qib7	3082	4	were	be	VBD
cord-005453-4057qib7	3082	5	examined	examine	VBN
cord-005453-4057qib7	3082	6	for	for	IN
cord-005453-4057qib7	3082	7	chronic	chronic	JJ
cord-005453-4057qib7	3082	8	graft	graft	NN
cord-005453-4057qib7	3082	9	-	-	HYPH
cord-005453-4057qib7	3082	10	versus	versus	IN
cord-005453-4057qib7	3082	11	-	-	HYPH
cord-005453-4057qib7	3082	12	host	host	NN
cord-005453-4057qib7	3082	13	disease	disease	NN
cord-005453-4057qib7	3082	14	(	(	-LRB-
cord-005453-4057qib7	3082	15	cGvHD	cGvHD	NNP
cord-005453-4057qib7	3082	16	)	)	-RRB-
cord-005453-4057qib7	3082	17	by	by	IN
cord-005453-4057qib7	3082	18	the	the	DT
cord-005453-4057qib7	3082	19	NIH	NIH	NNP
cord-005453-4057qib7	3082	20	-	-	HYPH
cord-005453-4057qib7	3082	21	criteria	criterion	NNS
cord-005453-4057qib7	3082	22	at	at	IN
cord-005453-4057qib7	3082	23	the	the	DT
cord-005453-4057qib7	3082	24	time	time	NN
cord-005453-4057qib7	3082	25	of	of	IN
cord-005453-4057qib7	3082	26	follow	follow	NN
cord-005453-4057qib7	3082	27	-	-	HYPH
cord-005453-4057qib7	3082	28	up	up	NN
cord-005453-4057qib7	3082	29	and	and	CC
cord-005453-4057qib7	3082	30	high	high	JJ
cord-005453-4057qib7	3082	31	sensitivity	sensitivity	NN
cord-005453-4057qib7	3082	32	C	c	NN
cord-005453-4057qib7	3082	33	-	-	HYPH
cord-005453-4057qib7	3082	34	reactive	reactive	JJ
cord-005453-4057qib7	3082	35	protein	protein	NN
cord-005453-4057qib7	3082	36	(	(	-LRB-
cord-005453-4057qib7	3082	37	hsCRP	hscrp	NN
cord-005453-4057qib7	3082	38	)	)	-RRB-
cord-005453-4057qib7	3082	39	was	be	VBD
cord-005453-4057qib7	3082	40	measured	measure	VBN
cord-005453-4057qib7	3082	41	.	.	.
cord-005453-4057qib7	3083	1	The	the	DT
cord-005453-4057qib7	3083	2	prevalence	prevalence	NN
cord-005453-4057qib7	3083	3	of	of	IN
cord-005453-4057qib7	3083	4	MetS	MetS	NNP
cord-005453-4057qib7	3083	5	was	be	VBD
cord-005453-4057qib7	3083	6	compared	compare	VBN
cord-005453-4057qib7	3083	7	to	to	IN
cord-005453-4057qib7	3083	8	a	a	DT
cord-005453-4057qib7	3083	9	Nordic	nordic	JJ
cord-005453-4057qib7	3083	10	reference	reference	NN
cord-005453-4057qib7	3083	11	group	group	NN
cord-005453-4057qib7	3083	12	(	(	-LRB-
cord-005453-4057qib7	3083	13	Hildrum	Hildrum	NNP
cord-005453-4057qib7	3083	14	et	et	NNP
cord-005453-4057qib7	3083	15	al	al	NNP
cord-005453-4057qib7	3083	16	.	.	NNP
cord-005453-4057qib7	3083	17	2009	2009	CD
cord-005453-4057qib7	3083	18	)	)	-RRB-
cord-005453-4057qib7	3083	19	.	.	.
cord-005453-4057qib7	3084	1	Results	result	NNS
cord-005453-4057qib7	3084	2	:	:	:
cord-005453-4057qib7	3085	1	We	-PRON-	PRP
cord-005453-4057qib7	3085	2	included	include	VBD
cord-005453-4057qib7	3085	3	49	49	CD
cord-005453-4057qib7	3085	4	out	out	IN
cord-005453-4057qib7	3085	5	of	of	IN
cord-005453-4057qib7	3085	6	97	97	CD
cord-005453-4057qib7	3085	7	eligible	eligible	JJ
cord-005453-4057qib7	3085	8	males	male	NNS
cord-005453-4057qib7	3085	9	(	(	-LRB-
cord-005453-4057qib7	3085	10	participation	participation	NN
cord-005453-4057qib7	3085	11	rate	rate	NN
cord-005453-4057qib7	3085	12	51	51	CD
cord-005453-4057qib7	3085	13	%	%	NN
cord-005453-4057qib7	3085	14	)	)	-RRB-
cord-005453-4057qib7	3086	1	aged	aged	JJ
cord-005453-4057qib7	3086	2	18	18	CD
cord-005453-4057qib7	3086	3	-	-	SYM
cord-005453-4057qib7	3086	4	44	44	CD
cord-005453-4057qib7	3086	5	years	year	NNS
cord-005453-4057qib7	3086	6	,	,	,
cord-005453-4057qib7	3086	7	median	median	NN
cord-005453-4057qib7	3086	8	29	29	CD
cord-005453-4057qib7	3086	9	years	year	NNS
cord-005453-4057qib7	3086	10	.	.	.
cord-005453-4057qib7	3087	1	Median	median	JJ
cord-005453-4057qib7	3087	2	(	(	-LRB-
cord-005453-4057qib7	3087	3	range	range	NN
cord-005453-4057qib7	3087	4	)	)	-RRB-
cord-005453-4057qib7	3087	5	follow	follow	NN
cord-005453-4057qib7	3087	6	-	-	HYPH
cord-005453-4057qib7	3087	7	up	up	NN
cord-005453-4057qib7	3087	8	was	be	VBD
cord-005453-4057qib7	3087	9	21	21	CD
cord-005453-4057qib7	3087	10	(	(	-LRB-
cord-005453-4057qib7	3087	11	8	8	CD
cord-005453-4057qib7	3087	12	-	-	SYM
cord-005453-4057qib7	3087	13	32	32	CD
cord-005453-4057qib7	3087	14	)	)	-RRB-
cord-005453-4057qib7	3087	15	years	year	NNS
cord-005453-4057qib7	3087	16	.	.	.
cord-005453-4057qib7	3088	1	Of	of	IN
cord-005453-4057qib7	3088	2	these	these	DT
cord-005453-4057qib7	3088	3	49	49	CD
cord-005453-4057qib7	3088	4	males	male	NNS
cord-005453-4057qib7	3088	5	,	,	,
cord-005453-4057qib7	3088	6	74	74	CD
cord-005453-4057qib7	3088	7	%	%	NN
cord-005453-4057qib7	3088	8	had	have	VBD
cord-005453-4057qib7	3088	9	a	a	DT
cord-005453-4057qib7	3088	10	malignant	malignant	JJ
cord-005453-4057qib7	3088	11	diagnosis	diagnosis	NN
cord-005453-4057qib7	3088	12	and	and	CC
cord-005453-4057qib7	3088	13	65	65	CD
cord-005453-4057qib7	3088	14	%	%	NN
cord-005453-4057qib7	3088	15	were	be	VBD
cord-005453-4057qib7	3088	16	treated	treat	VBN
cord-005453-4057qib7	3088	17	with	with	IN
cord-005453-4057qib7	3088	18	TBI	TBI	NNP
cord-005453-4057qib7	3088	19	-	-	HYPH
cord-005453-4057qib7	3088	20	based	base	VBN
cord-005453-4057qib7	3088	21	conditioning	conditioning	NN
cord-005453-4057qib7	3088	22	.	.	.
cord-005453-4057qib7	3089	1	Donors	donor	NNS
cord-005453-4057qib7	3089	2	were	be	VBD
cord-005453-4057qib7	3089	3	matched	match	VBN
cord-005453-4057qib7	3089	4	siblings	sibling	NNS
cord-005453-4057qib7	3089	5	(	(	-LRB-
cord-005453-4057qib7	3089	6	n=21	n=21	NNP
cord-005453-4057qib7	3089	7	)	)	-RRB-
cord-005453-4057qib7	3089	8	,	,	,
cord-005453-4057qib7	3089	9	matched	match	VBN
cord-005453-4057qib7	3089	10	relatives	relative	NNS
cord-005453-4057qib7	3089	11	(	(	-LRB-
cord-005453-4057qib7	3089	12	n=3	n=3	NN
cord-005453-4057qib7	3089	13	)	)	-RRB-
cord-005453-4057qib7	3089	14	or	or	CC
cord-005453-4057qib7	3089	15	matched	match	VBD
cord-005453-4057qib7	3089	16	unrelated	unrelated	JJ
cord-005453-4057qib7	3089	17	donors	donor	NNS
cord-005453-4057qib7	3089	18	(	(	-LRB-
cord-005453-4057qib7	3089	19	n=25	n=25	NNP
cord-005453-4057qib7	3089	20	)	)	-RRB-
cord-005453-4057qib7	3089	21	.	.	.
cord-005453-4057qib7	3090	1	MetS	MetS	NNP
cord-005453-4057qib7	3090	2	was	be	VBD
cord-005453-4057qib7	3090	3	more	more	RBR
cord-005453-4057qib7	3090	4	prevalent	prevalent	JJ
cord-005453-4057qib7	3090	5	(	(	-LRB-
cord-005453-4057qib7	3090	6	33	33	CD
cord-005453-4057qib7	3090	7	%	%	NN
cord-005453-4057qib7	3090	8	)	)	-RRB-
cord-005453-4057qib7	3090	9	in	in	IN
cord-005453-4057qib7	3090	10	the	the	DT
cord-005453-4057qib7	3090	11	young	young	JJ
cord-005453-4057qib7	3090	12	adult	adult	NN
cord-005453-4057qib7	3090	13	survivors	survivor	NNS
cord-005453-4057qib7	3090	14	compared	compare	VBN
cord-005453-4057qib7	3090	15	to	to	IN
cord-005453-4057qib7	3090	16	the	the	DT
cord-005453-4057qib7	3090	17	prevalence	prevalence	NN
cord-005453-4057qib7	3090	18	reported	report	VBN
cord-005453-4057qib7	3090	19	for	for	IN
cord-005453-4057qib7	3090	20	20	20	CD
cord-005453-4057qib7	3090	21	-	-	HYPH
cord-005453-4057qib7	3090	22	39year	39year	CD
cord-005453-4057qib7	3090	23	-	-	HYPH
cord-005453-4057qib7	3090	24	olds	old	NNS
cord-005453-4057qib7	3090	25	in	in	IN
cord-005453-4057qib7	3090	26	the	the	DT
cord-005453-4057qib7	3090	27	Nordic	nordic	JJ
cord-005453-4057qib7	3090	28	reference	reference	NN
cord-005453-4057qib7	3090	29	(	(	-LRB-
cord-005453-4057qib7	3090	30	16	16	CD
cord-005453-4057qib7	3090	31	%	%	NN
cord-005453-4057qib7	3090	32	)	)	-RRB-
cord-005453-4057qib7	3090	33	.	.	.
cord-005453-4057qib7	3091	1	Instead	instead	RB
cord-005453-4057qib7	3091	2	the	the	DT
cord-005453-4057qib7	3091	3	prevalence	prevalence	NN
cord-005453-4057qib7	3091	4	was	be	VBD
cord-005453-4057qib7	3091	5	comparable	comparable	JJ
cord-005453-4057qib7	3091	6	to	to	IN
cord-005453-4057qib7	3091	7	that	that	DT
cord-005453-4057qib7	3091	8	reported	report	VBN
cord-005453-4057qib7	3091	9	for	for	IN
cord-005453-4057qib7	3091	10	the	the	DT
cord-005453-4057qib7	3091	11	50	50	CD
cord-005453-4057qib7	3091	12	-	-	HYPH
cord-005453-4057qib7	3091	13	69year	69year	CD
cord-005453-4057qib7	3091	14	-	-	HYPH
cord-005453-4057qib7	3091	15	olds	old	NNS
cord-005453-4057qib7	3091	16	(	(	-LRB-
cord-005453-4057qib7	3091	17	32	32	CD
cord-005453-4057qib7	3091	18	%	%	NN
cord-005453-4057qib7	3091	19	)	)	-RRB-
cord-005453-4057qib7	3091	20	.	.	.
cord-005453-4057qib7	3092	1	Of	of	IN
cord-005453-4057qib7	3092	2	the	the	DT
cord-005453-4057qib7	3092	3	components	component	NNS
cord-005453-4057qib7	3092	4	of	of	IN
cord-005453-4057qib7	3092	5	Mets	Mets	NNPS
cord-005453-4057qib7	3092	6	,	,	,
cord-005453-4057qib7	3092	7	elevated	elevated	JJ
cord-005453-4057qib7	3092	8	TG	TG	NNP
cord-005453-4057qib7	3092	9	(	(	-LRB-
cord-005453-4057qib7	3092	10	51	51	CD
cord-005453-4057qib7	3092	11	%	%	NN
cord-005453-4057qib7	3092	12	)	)	-RRB-
cord-005453-4057qib7	3092	13	,	,	,
cord-005453-4057qib7	3092	14	hypertension	hypertension	NN
cord-005453-4057qib7	3092	15	(	(	-LRB-
cord-005453-4057qib7	3092	16	47	47	CD
cord-005453-4057qib7	3092	17	%	%	NN
cord-005453-4057qib7	3092	18	)	)	-RRB-
cord-005453-4057qib7	3092	19	,	,	,
cord-005453-4057qib7	3092	20	and	and	CC
cord-005453-4057qib7	3092	21	decreased	decrease	VBD
cord-005453-4057qib7	3092	22	HDL	HDL	NNP
cord-005453-4057qib7	3092	23	(	(	-LRB-
cord-005453-4057qib7	3092	24	40	40	CD
cord-005453-4057qib7	3092	25	%	%	NN
cord-005453-4057qib7	3092	26	)	)	-RRB-
cord-005453-4057qib7	3092	27	were	be	VBD
cord-005453-4057qib7	3092	28	frequent	frequent	JJ
cord-005453-4057qib7	3092	29	,	,	,
cord-005453-4057qib7	3092	30	while	while	IN
cord-005453-4057qib7	3092	31	FPG	FPG	NNP
cord-005453-4057qib7	3092	32	was	be	VBD
cord-005453-4057qib7	3092	33	elevated	elevate	VBN
cord-005453-4057qib7	3092	34	in	in	IN
cord-005453-4057qib7	3092	35	16	16	CD
cord-005453-4057qib7	3092	36	%	%	NN
cord-005453-4057qib7	3092	37	.	.	.
cord-005453-4057qib7	3093	1	Importantly	importantly	RB
cord-005453-4057qib7	3093	2	,	,	,
cord-005453-4057qib7	3093	3	only	only	RB
cord-005453-4057qib7	3093	4	4	4	CD
cord-005453-4057qib7	3093	5	%	%	NN
cord-005453-4057qib7	3093	6	of	of	IN
cord-005453-4057qib7	3093	7	those	those	DT
cord-005453-4057qib7	3093	8	with	with	IN
cord-005453-4057qib7	3093	9	MetS	MetS	NNP
cord-005453-4057qib7	3093	10	had	have	VBD
cord-005453-4057qib7	3093	11	increased	increase	VBN
cord-005453-4057qib7	3093	12	AC	ac	NN
cord-005453-4057qib7	3093	13	and	and	CC
cord-005453-4057qib7	3093	14	mean	mean	VB
cord-005453-4057qib7	3093	15	BMI	BMI	NNP
cord-005453-4057qib7	3093	16	(	(	-LRB-
cord-005453-4057qib7	3093	17	23.8	23.8	CD
cord-005453-4057qib7	3093	18	kg	kg	NNS
cord-005453-4057qib7	3093	19	/	/	SYM
cord-005453-4057qib7	3093	20	m	m	NN
cord-005453-4057qib7	3093	21	2	2	CD
cord-005453-4057qib7	3093	22	)	)	-RRB-
cord-005453-4057qib7	3093	23	of	of	IN
cord-005453-4057qib7	3093	24	the	the	DT
cord-005453-4057qib7	3093	25	HSCT	HSCT	NNP
cord-005453-4057qib7	3093	26	survivors	survivor	NNS
cord-005453-4057qib7	3093	27	was	be	VBD
cord-005453-4057qib7	3093	28	within	within	IN
cord-005453-4057qib7	3093	29	normal	normal	JJ
cord-005453-4057qib7	3093	30	range	range	NN
cord-005453-4057qib7	3093	31	in	in	IN
cord-005453-4057qib7	3093	32	contrast	contrast	NN
cord-005453-4057qib7	3093	33	to	to	IN
cord-005453-4057qib7	3093	34	features	feature	NNS
cord-005453-4057qib7	3093	35	of	of	IN
cord-005453-4057qib7	3093	36	MetS	met	NNS
cord-005453-4057qib7	3093	37	observed	observe	VBN
cord-005453-4057qib7	3093	38	in	in	IN
cord-005453-4057qib7	3093	39	the	the	DT
cord-005453-4057qib7	3093	40	background	background	NN
cord-005453-4057qib7	3093	41	population	population	NN
cord-005453-4057qib7	3093	42	.	.	.
cord-005453-4057qib7	3094	1	Having	have	VBG
cord-005453-4057qib7	3094	2	MetS	MetS	NNP
cord-005453-4057qib7	3094	3	was	be	VBD
cord-005453-4057qib7	3094	4	significantly	significantly	RB
cord-005453-4057qib7	3094	5	associated	associate	VBN
cord-005453-4057qib7	3094	6	with	with	IN
cord-005453-4057qib7	3094	7	TBI	TBI	NNP
cord-005453-4057qib7	3094	8	(	(	-LRB-
cord-005453-4057qib7	3094	9	RR	rr	NN
cord-005453-4057qib7	3094	10	=	=	SYM
cord-005453-4057qib7	3094	11	7.9	7.9	CD
cord-005453-4057qib7	3094	12	,	,	,
cord-005453-4057qib7	3094	13	95%CI	95%ci	CD
cord-005453-4057qib7	3094	14	(	(	-LRB-
cord-005453-4057qib7	3094	15	1.1	1.1	CD
cord-005453-4057qib7	3094	16	-	-	SYM
cord-005453-4057qib7	3094	17	55.3	55.3	CD
cord-005453-4057qib7	3094	18	)	)	-RRB-
cord-005453-4057qib7	3094	19	,	,	,
cord-005453-4057qib7	3094	20	p=0.004	p=0.004	NNP
cord-005453-4057qib7	3094	21	)	)	-RRB-
cord-005453-4057qib7	3094	22	as	as	IN
cord-005453-4057qib7	3094	23	was	be	VBD
cord-005453-4057qib7	3094	24	the	the	DT
cord-005453-4057qib7	3094	25	following	follow	VBG
cord-005453-4057qib7	3094	26	single	single	JJ
cord-005453-4057qib7	3094	27	components	component	NNS
cord-005453-4057qib7	3094	28	of	of	IN
cord-005453-4057qib7	3094	29	MetS	met	NNS
cord-005453-4057qib7	3094	30	(	(	-LRB-
cord-005453-4057qib7	3094	31	mean	mean	VB
cord-005453-4057qib7	3094	32	in	in	IN
cord-005453-4057qib7	3094	33	TBI	TBI	NNP
cord-005453-4057qib7	3094	34	group	group	NN
cord-005453-4057qib7	3094	35	vs.	vs.	FW
cord-005453-4057qib7	3094	36	mean	mean	JJ
cord-005453-4057qib7	3094	37	in	in	IN
cord-005453-4057qib7	3094	38	non	non	JJ
cord-005453-4057qib7	3094	39	-	-	JJ
cord-005453-4057qib7	3094	40	TBI	tbi	JJ
cord-005453-4057qib7	3094	41	group	group	NN
cord-005453-4057qib7	3094	42	)	)	-RRB-
cord-005453-4057qib7	3094	43	:	:	:
cord-005453-4057qib7	3094	44	elevated	elevate	VBN
cord-005453-4057qib7	3094	45	TG	TG	NNP
cord-005453-4057qib7	3094	46	(	(	-LRB-
cord-005453-4057qib7	3094	47	2.34	2.34	CD
cord-005453-4057qib7	3094	48	mmol	mmol	NNP
cord-005453-4057qib7	3094	49	/	/	SYM
cord-005453-4057qib7	3094	50	L	l	NN
cord-005453-4057qib7	3094	51	vs.	vs.	NN
cord-005453-4057qib7	3095	1	0.93	0.93	CD
cord-005453-4057qib7	3095	2	mmol/	mmol/	NNP
cord-005453-4057qib7	3095	3	L	L	NNP
cord-005453-4057qib7	3095	4	,	,	,
cord-005453-4057qib7	3095	5	p=	p=	NNP
cord-005453-4057qib7	3095	6	0.006	0.006	CD
cord-005453-4057qib7	3095	7	)	)	-RRB-
cord-005453-4057qib7	3095	8	,	,	,
cord-005453-4057qib7	3095	9	lower	low	JJR
cord-005453-4057qib7	3095	10	HDL	HDL	NNP
cord-005453-4057qib7	3095	11	(	(	-LRB-
cord-005453-4057qib7	3095	12	1.04	1.04	CD
cord-005453-4057qib7	3095	13	mmol	mmol	NNP
cord-005453-4057qib7	3095	14	/	/	SYM
cord-005453-4057qib7	3095	15	L	l	NN
cord-005453-4057qib7	3095	16	vs.	vs.	NN
cord-005453-4057qib7	3095	17	1.38	1.38	CD
cord-005453-4057qib7	3095	18	mmol	mmol	NNP
cord-005453-4057qib7	3095	19	/	/	SYM
cord-005453-4057qib7	3095	20	L	L	NNP
cord-005453-4057qib7	3095	21	,	,	,
cord-005453-4057qib7	3095	22	p=0.001	p=0.001	NNP
cord-005453-4057qib7	3095	23	)	)	-RRB-
cord-005453-4057qib7	3095	24	and	and	CC
cord-005453-4057qib7	3095	25	higher	high	JJR
cord-005453-4057qib7	3095	26	diastolic	diastolic	JJ
cord-005453-4057qib7	3095	27	BP	BP	NNP
cord-005453-4057qib7	3095	28	(	(	-LRB-
cord-005453-4057qib7	3095	29	80	80	CD
cord-005453-4057qib7	3095	30	mmHg	mmHg	NNS
cord-005453-4057qib7	3095	31	vs.	vs.	NN
cord-005453-4057qib7	3095	32	72	72	CD
cord-005453-4057qib7	3095	33	mmHg	mmHg	NNS
cord-005453-4057qib7	3095	34	,	,	,
cord-005453-4057qib7	3095	35	p=0.03	p=0.03	NNP
cord-005453-4057qib7	3095	36	)	)	-RRB-
cord-005453-4057qib7	3095	37	.	.	.
cord-005453-4057qib7	3096	1	MetS	MetS	NNP
cord-005453-4057qib7	3096	2	was	be	VBD
cord-005453-4057qib7	3096	3	only	only	RB
cord-005453-4057qib7	3096	4	demonstrated	demonstrate	VBN
cord-005453-4057qib7	3096	5	in	in	IN
cord-005453-4057qib7	3096	6	one	one	CD
cord-005453-4057qib7	3096	7	patient	patient	NN
cord-005453-4057qib7	3096	8	who	who	WP
cord-005453-4057qib7	3096	9	received	receive	VBD
cord-005453-4057qib7	3096	10	non	non	JJ
cord-005453-4057qib7	3096	11	-	-	JJ
cord-005453-4057qib7	3096	12	TBI	TBI	NNP
cord-005453-4057qib7	3096	13	based	base	VBN
cord-005453-4057qib7	3096	14	conditioning	conditioning	NN
cord-005453-4057qib7	3096	15	.	.	.
cord-005453-4057qib7	3097	1	Sixteen	sixteen	CD
cord-005453-4057qib7	3097	2	of	of	IN
cord-005453-4057qib7	3097	3	49	49	CD
cord-005453-4057qib7	3097	4	patients	patient	NNS
cord-005453-4057qib7	3097	5	had	have	VBD
cord-005453-4057qib7	3097	6	cGvHD	cgvhd	NN
cord-005453-4057qib7	3097	7	of	of	IN
cord-005453-4057qib7	3097	8	which	which	WDT
cord-005453-4057qib7	3097	9	nine	nine	CD
cord-005453-4057qib7	3097	10	were	be	VBD
cord-005453-4057qib7	3097	11	moderate	moderate	JJ
cord-005453-4057qib7	3097	12	to	to	IN
cord-005453-4057qib7	3097	13	severe	severe	JJ
cord-005453-4057qib7	3097	14	cases	case	NNS
cord-005453-4057qib7	3097	15	,	,	,
cord-005453-4057qib7	3097	16	but	but	CC
cord-005453-4057qib7	3097	17	cGvHD	cGvHD	NNP
cord-005453-4057qib7	3097	18	was	be	VBD
cord-005453-4057qib7	3097	19	not	not	RB
cord-005453-4057qib7	3097	20	associated	associate	VBN
cord-005453-4057qib7	3097	21	with	with	IN
cord-005453-4057qib7	3097	22	MetS.	MetS.	NNP
cord-005453-4057qib7	3098	1	However	however	RB
cord-005453-4057qib7	3098	2	,	,	,
cord-005453-4057qib7	3098	3	low	low	JJ
cord-005453-4057qib7	3098	4	-	-	HYPH
cord-005453-4057qib7	3098	5	grade	grade	NN
cord-005453-4057qib7	3098	6	inflammation	inflammation	NN
cord-005453-4057qib7	3098	7	measured	measure	VBN
cord-005453-4057qib7	3098	8	by	by	IN
cord-005453-4057qib7	3098	9	hsCRP	hscrp	NN
cord-005453-4057qib7	3098	10	was	be	VBD
cord-005453-4057qib7	3098	11	related	relate	VBN
cord-005453-4057qib7	3098	12	to	to	IN
cord-005453-4057qib7	3098	13	increased	increase	VBN
cord-005453-4057qib7	3098	14	AC	ac	NN
cord-005453-4057qib7	3098	15	(	(	-LRB-
cord-005453-4057qib7	3098	16	rho=0.41	rho=0.41	ADD
cord-005453-4057qib7	3098	17	,	,	,
cord-005453-4057qib7	3098	18	p=0.004	p=0.004	NNP
cord-005453-4057qib7	3098	19	)	)	-RRB-
cord-005453-4057qib7	3098	20	and	and	CC
cord-005453-4057qib7	3098	21	TG	TG	NNP
cord-005453-4057qib7	3098	22	(	(	-LRB-
cord-005453-4057qib7	3098	23	rho=0.34	rho=0.34	''
cord-005453-4057qib7	3098	24	,	,	,
cord-005453-4057qib7	3098	25	p=0.028	p=0.028	NN
cord-005453-4057qib7	3098	26	)	)	-RRB-
cord-005453-4057qib7	3098	27	.	.	.
cord-005453-4057qib7	3099	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3099	2	:	:	:
cord-005453-4057qib7	3100	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3100	2	results	result	NNS
cord-005453-4057qib7	3100	3	indicate	indicate	VBP
cord-005453-4057qib7	3100	4	that	that	IN
cord-005453-4057qib7	3100	5	male	male	JJ
cord-005453-4057qib7	3100	6	long	long	JJ
cord-005453-4057qib7	3100	7	-	-	HYPH
cord-005453-4057qib7	3100	8	term	term	NN
cord-005453-4057qib7	3100	9	survivors	survivor	NNS
cord-005453-4057qib7	3100	10	of	of	IN
cord-005453-4057qib7	3100	11	allo	allo	NN
cord-005453-4057qib7	3100	12	-	-	HYPH
cord-005453-4057qib7	3100	13	HSCT	HSCT	NNP
cord-005453-4057qib7	3100	14	during	during	IN
cord-005453-4057qib7	3100	15	childhood	childhood	NN
cord-005453-4057qib7	3100	16	have	have	VBP
cord-005453-4057qib7	3100	17	a	a	DT
cord-005453-4057qib7	3100	18	high	high	JJ
cord-005453-4057qib7	3100	19	risk	risk	NN
cord-005453-4057qib7	3100	20	of	of	IN
cord-005453-4057qib7	3100	21	MetS	MetS	NNP
cord-005453-4057qib7	3100	22	at	at	IN
cord-005453-4057qib7	3100	23	an	an	DT
cord-005453-4057qib7	3100	24	earlier	early	JJR
cord-005453-4057qib7	3100	25	age	age	NN
cord-005453-4057qib7	3100	26	than	than	IN
cord-005453-4057qib7	3100	27	the	the	DT
cord-005453-4057qib7	3100	28	general	general	JJ
cord-005453-4057qib7	3100	29	population	population	NN
cord-005453-4057qib7	3100	30	.	.	.
cord-005453-4057qib7	3101	1	The	the	DT
cord-005453-4057qib7	3101	2	presence	presence	NN
cord-005453-4057qib7	3101	3	of	of	IN
cord-005453-4057qib7	3101	4	MetS	MetS	NNP
cord-005453-4057qib7	3101	5	despite	despite	IN
cord-005453-4057qib7	3101	6	normal	normal	JJ
cord-005453-4057qib7	3101	7	BMI	bmi	NN
cord-005453-4057qib7	3101	8	in	in	IN
cord-005453-4057qib7	3101	9	several	several	JJ
cord-005453-4057qib7	3101	10	patients	patient	NNS
cord-005453-4057qib7	3101	11	suggests	suggest	VBZ
cord-005453-4057qib7	3101	12	unconventional	unconventional	JJ
cord-005453-4057qib7	3101	13	etiologies	etiology	NNS
cord-005453-4057qib7	3101	14	like	like	IN
cord-005453-4057qib7	3101	15	the	the	DT
cord-005453-4057qib7	3101	16	effect	effect	NN
cord-005453-4057qib7	3101	17	of	of	IN
cord-005453-4057qib7	3101	18	TBI	TBI	NNP
cord-005453-4057qib7	3101	19	and	and	CC
cord-005453-4057qib7	3101	20	low	low	JJ
cord-005453-4057qib7	3101	21	-	-	HYPH
cord-005453-4057qib7	3101	22	grade	grade	NN
cord-005453-4057qib7	3101	23	inflammation	inflammation	NN
cord-005453-4057qib7	3101	24	.	.	.
cord-005453-4057qib7	3102	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3102	2	:	:	:
cord-005453-4057qib7	3102	3	Nothing	nothing	NN
cord-005453-4057qib7	3102	4	to	to	TO
cord-005453-4057qib7	3102	5	declare	declare	VB
cord-005453-4057qib7	3102	6	.	.	.
cord-005453-4057qib7	3103	1	Results	result	NNS
cord-005453-4057qib7	3103	2	:	:	:
cord-005453-4057qib7	3104	1	This	this	DT
cord-005453-4057qib7	3104	2	survey	survey	NN
cord-005453-4057qib7	3104	3	was	be	VBD
cord-005453-4057qib7	3104	4	completed	complete	VBN
cord-005453-4057qib7	3104	5	by	by	IN
cord-005453-4057qib7	3104	6	transplant	transplant	NN
cord-005453-4057qib7	3104	7	directors	director	NNS
cord-005453-4057qib7	3104	8	(	(	-LRB-
cord-005453-4057qib7	3104	9	46	46	CD
cord-005453-4057qib7	3104	10	%	%	NN
cord-005453-4057qib7	3104	11	)	)	-RRB-
cord-005453-4057qib7	3104	12	,	,	,
cord-005453-4057qib7	3104	13	transplant	transplant	NN
cord-005453-4057qib7	3104	14	consultants	consultant	NNS
cord-005453-4057qib7	3104	15	(	(	-LRB-
cord-005453-4057qib7	3104	16	41	41	CD
cord-005453-4057qib7	3104	17	%	%	NN
cord-005453-4057qib7	3104	18	)	)	-RRB-
cord-005453-4057qib7	3104	19	,	,	,
cord-005453-4057qib7	3104	20	nonconsultant	nonconsultant	JJ
cord-005453-4057qib7	3104	21	grade	grade	NN
cord-005453-4057qib7	3104	22	physicians	physician	NNS
cord-005453-4057qib7	3104	23	(	(	-LRB-
cord-005453-4057qib7	3104	24	8	8	CD
cord-005453-4057qib7	3104	25	%	%	NN
cord-005453-4057qib7	3104	26	)	)	-RRB-
cord-005453-4057qib7	3104	27	,	,	,
cord-005453-4057qib7	3104	28	HSCT	HSCT	NNP
cord-005453-4057qib7	3104	29	clinical	clinical	JJ
cord-005453-4057qib7	3104	30	nurses	nurse	NNS
cord-005453-4057qib7	3104	31	specialists	specialist	NNS
cord-005453-4057qib7	3104	32	(	(	-LRB-
cord-005453-4057qib7	3104	33	CNS	CNS	NNP
cord-005453-4057qib7	3104	34	)	)	-RRB-
cord-005453-4057qib7	3104	35	(	(	-LRB-
cord-005453-4057qib7	3104	36	3	3	CD
cord-005453-4057qib7	3104	37	%	%	NN
cord-005453-4057qib7	3104	38	)	)	-RRB-
cord-005453-4057qib7	3104	39	and	and	CC
cord-005453-4057qib7	3104	40	other	other	JJ
cord-005453-4057qib7	3104	41	(	(	-LRB-
cord-005453-4057qib7	3104	42	2	2	CD
cord-005453-4057qib7	3104	43	%	%	NN
cord-005453-4057qib7	3104	44	)	)	-RRB-
cord-005453-4057qib7	3104	45	from	from	IN
cord-005453-4057qib7	3104	46	114	114	CD
cord-005453-4057qib7	3104	47	centres	centre	NNS
cord-005453-4057qib7	3104	48	in	in	IN
cord-005453-4057qib7	3104	49	24	24	CD
cord-005453-4057qib7	3104	50	countries	country	NNS
cord-005453-4057qib7	3104	51	.	.	.
cord-005453-4057qib7	3105	1	58	58	CD
cord-005453-4057qib7	3105	2	%	%	NN
cord-005453-4057qib7	3105	3	of	of	IN
cord-005453-4057qib7	3105	4	the	the	DT
cord-005453-4057qib7	3105	5	centres	centre	NNS
cord-005453-4057qib7	3105	6	are	be	VBP
cord-005453-4057qib7	3105	7	adult	adult	NN
cord-005453-4057qib7	3105	8	-	-	HYPH
cord-005453-4057qib7	3105	9	only	only	RB
cord-005453-4057qib7	3105	10	,	,	,
cord-005453-4057qib7	3105	11	21	21	CD
cord-005453-4057qib7	3105	12	%	%	NN
cord-005453-4057qib7	3105	13	paediatric	paediatric	JJ
cord-005453-4057qib7	3105	14	-	-	HYPH
cord-005453-4057qib7	3105	15	only	only	RB
cord-005453-4057qib7	3105	16	and	and	CC
cord-005453-4057qib7	3105	17	21	21	CD
cord-005453-4057qib7	3105	18	%	%	NN
cord-005453-4057qib7	3105	19	treat	treat	NN
cord-005453-4057qib7	3105	20	adult	adult	NN
cord-005453-4057qib7	3105	21	and	and	CC
cord-005453-4057qib7	3105	22	paediatric	paediatric	JJ
cord-005453-4057qib7	3105	23	patients	patient	NNS
cord-005453-4057qib7	3105	24	(	(	-LRB-
cord-005453-4057qib7	3105	25	mixed	mixed	JJ
cord-005453-4057qib7	3105	26	centres	centre	NNS
cord-005453-4057qib7	3105	27	)	)	-RRB-
cord-005453-4057qib7	3105	28	.	.	.
cord-005453-4057qib7	3106	1	46	46	CD
cord-005453-4057qib7	3106	2	%	%	NN
cord-005453-4057qib7	3106	3	are	be	VBP
cord-005453-4057qib7	3106	4	located	locate	VBN
cord-005453-4057qib7	3106	5	higher	high	JJR
cord-005453-4057qib7	3106	6	than	than	IN
cord-005453-4057qib7	3106	7	50	50	CD
cord-005453-4057qib7	3106	8	degrees	degree	NNS
cord-005453-4057qib7	3106	9	latitude	latitude	NN
cord-005453-4057qib7	3106	10	(	(	-LRB-
cord-005453-4057qib7	3106	11	northern	northern	JJ
cord-005453-4057qib7	3106	12	countries	country	NNS
cord-005453-4057qib7	3106	13	)	)	-RRB-
cord-005453-4057qib7	3106	14	and	and	CC
cord-005453-4057qib7	3106	15	54	54	CD
cord-005453-4057qib7	3106	16	%	%	NN
cord-005453-4057qib7	3106	17	lower	low	JJR
cord-005453-4057qib7	3106	18	than	than	IN
cord-005453-4057qib7	3106	19	this	this	DT
cord-005453-4057qib7	3106	20	latitude	latitude	NN
cord-005453-4057qib7	3106	21	(	(	-LRB-
cord-005453-4057qib7	3106	22	southern	southern	JJ
cord-005453-4057qib7	3106	23	countries	country	NNS
cord-005453-4057qib7	3106	24	)	)	-RRB-
cord-005453-4057qib7	3106	25	.	.	.
cord-005453-4057qib7	3107	1	At	at	IN
cord-005453-4057qib7	3107	2	the	the	DT
cord-005453-4057qib7	3107	3	time	time	NN
cord-005453-4057qib7	3107	4	of	of	IN
cord-005453-4057qib7	3107	5	the	the	DT
cord-005453-4057qib7	3107	6	survey	survey	NN
cord-005453-4057qib7	3107	7	84	84	CD
cord-005453-4057qib7	3107	8	%	%	NN
cord-005453-4057qib7	3107	9	were	be	VBD
cord-005453-4057qib7	3107	10	members	member	NNS
cord-005453-4057qib7	3107	11	of	of	IN
cord-005453-4057qib7	3107	12	the	the	DT
cord-005453-4057qib7	3107	13	European	European	NNP
cord-005453-4057qib7	3107	14	Union	Union	NNP
cord-005453-4057qib7	3107	15	(	(	-LRB-
cord-005453-4057qib7	3107	16	EU	EU	NNP
cord-005453-4057qib7	3107	17	)	)	-RRB-
cord-005453-4057qib7	3107	18	.	.	.
cord-005453-4057qib7	3108	1	Measurement	measurement	NN
cord-005453-4057qib7	3108	2	of	of	IN
cord-005453-4057qib7	3108	3	serum	serum	NN
cord-005453-4057qib7	3108	4	VD	vd	NN
cord-005453-4057qib7	3108	5	is	be	VBZ
cord-005453-4057qib7	3108	6	routinely	routinely	RB
cord-005453-4057qib7	3108	7	performed	perform	VBN
cord-005453-4057qib7	3108	8	in	in	IN
cord-005453-4057qib7	3108	9	47	47	CD
cord-005453-4057qib7	3108	10	%	%	NN
cord-005453-4057qib7	3108	11	of	of	IN
cord-005453-4057qib7	3108	12	the	the	DT
cord-005453-4057qib7	3108	13	centres	centre	NNS
cord-005453-4057qib7	3108	14	prior	prior	RB
cord-005453-4057qib7	3108	15	and	and	CC
cord-005453-4057qib7	3108	16	in	in	IN
cord-005453-4057qib7	3108	17	70	70	CD
cord-005453-4057qib7	3108	18	%	%	NN
cord-005453-4057qib7	3108	19	after	after	IN
cord-005453-4057qib7	3108	20	allogeneic	allogeneic	NN
cord-005453-4057qib7	3108	21	HSCT	HSCT	NNP
cord-005453-4057qib7	3108	22	.	.	.
cord-005453-4057qib7	3109	1	The	the	DT
cord-005453-4057qib7	3109	2	main	main	JJ
cord-005453-4057qib7	3109	3	clinical	clinical	JJ
cord-005453-4057qib7	3109	4	indications	indication	NNS
cord-005453-4057qib7	3109	5	are	be	VBP
cord-005453-4057qib7	3109	6	known	know	VBN
cord-005453-4057qib7	3109	7	osteopaenia	osteopaenia	NNP
cord-005453-4057qib7	3109	8	/	/	SYM
cord-005453-4057qib7	3109	9	osteoporosis	osteoporosis	NN
cord-005453-4057qib7	3109	10	(	(	-LRB-
cord-005453-4057qib7	3109	11	86	86	CD
cord-005453-4057qib7	3109	12	%	%	NN
cord-005453-4057qib7	3109	13	)	)	-RRB-
cord-005453-4057qib7	3109	14	,	,	,
cord-005453-4057qib7	3109	15	previous	previous	JJ
cord-005453-4057qib7	3109	16	fracture	fracture	NN
cord-005453-4057qib7	3109	17	(	(	-LRB-
cord-005453-4057qib7	3109	18	71	71	CD
cord-005453-4057qib7	3109	19	%	%	NN
cord-005453-4057qib7	3109	20	)	)	-RRB-
cord-005453-4057qib7	3109	21	,	,	,
cord-005453-4057qib7	3109	22	treatment	treatment	NN
cord-005453-4057qib7	3109	23	with	with	IN
cord-005453-4057qib7	3109	24	steroids	steroid	NNS
cord-005453-4057qib7	3109	25	(	(	-LRB-
cord-005453-4057qib7	3109	26	68	68	CD
cord-005453-4057qib7	3109	27	%	%	NN
cord-005453-4057qib7	3109	28	)	)	-RRB-
cord-005453-4057qib7	3109	29	,	,	,
cord-005453-4057qib7	3109	30	premature	premature	JJ
cord-005453-4057qib7	3109	31	menopause	menopause	NN
cord-005453-4057qib7	3109	32	(	(	-LRB-
cord-005453-4057qib7	3109	33	46	46	CD
cord-005453-4057qib7	3109	34	%	%	NN
cord-005453-4057qib7	3109	35	)	)	-RRB-
cord-005453-4057qib7	3109	36	and	and	CC
cord-005453-4057qib7	3109	37	established	establish	VBD
cord-005453-4057qib7	3109	38	menopause	menopause	NN
cord-005453-4057qib7	3109	39	(	(	-LRB-
cord-005453-4057qib7	3109	40	32	32	CD
cord-005453-4057qib7	3109	41	%	%	NN
cord-005453-4057qib7	3109	42	)	)	-RRB-
cord-005453-4057qib7	3109	43	.	.	.
cord-005453-4057qib7	3110	1	Monitoring	monitoring	NN
cord-005453-4057qib7	3110	2	occurs	occur	VBZ
cord-005453-4057qib7	3110	3	every	every	DT
cord-005453-4057qib7	3110	4	3	3	CD
cord-005453-4057qib7	3110	5	months	month	NNS
cord-005453-4057qib7	3110	6	(	(	-LRB-
cord-005453-4057qib7	3110	7	39	39	CD
cord-005453-4057qib7	3110	8	%	%	NN
cord-005453-4057qib7	3110	9	)	)	-RRB-
cord-005453-4057qib7	3110	10	,	,	,
cord-005453-4057qib7	3110	11	every	every	DT
cord-005453-4057qib7	3110	12	6	6	CD
cord-005453-4057qib7	3110	13	months	month	NNS
cord-005453-4057qib7	3110	14	(	(	-LRB-
cord-005453-4057qib7	3110	15	24	24	CD
cord-005453-4057qib7	3110	16	%	%	NN
cord-005453-4057qib7	3110	17	)	)	-RRB-
cord-005453-4057qib7	3110	18	,	,	,
cord-005453-4057qib7	3110	19	once	once	RB
cord-005453-4057qib7	3110	20	a	a	DT
cord-005453-4057qib7	3110	21	year	year	NN
cord-005453-4057qib7	3110	22	(	(	-LRB-
cord-005453-4057qib7	3110	23	18	18	CD
cord-005453-4057qib7	3110	24	%	%	NN
cord-005453-4057qib7	3110	25	)	)	-RRB-
cord-005453-4057qib7	3110	26	or	or	CC
cord-005453-4057qib7	3110	27	at	at	IN
cord-005453-4057qib7	3110	28	other	other	JJ
cord-005453-4057qib7	3110	29	time	time	NN
cord-005453-4057qib7	3110	30	-	-	HYPH
cord-005453-4057qib7	3110	31	points	point	NNS
cord-005453-4057qib7	3110	32	(	(	-LRB-
cord-005453-4057qib7	3110	33	19	19	CD
cord-005453-4057qib7	3110	34	%	%	NN
cord-005453-4057qib7	3110	35	)	)	-RRB-
cord-005453-4057qib7	3110	36	.	.	.
cord-005453-4057qib7	3111	1	In	in	IN
cord-005453-4057qib7	3111	2	this	this	DT
cord-005453-4057qib7	3111	3	regard	regard	NN
cord-005453-4057qib7	3111	4	,	,	,
cord-005453-4057qib7	3111	5	seasonality	seasonality	NN
cord-005453-4057qib7	3111	6	is	be	VBZ
cord-005453-4057qib7	3111	7	not	not	RB
cord-005453-4057qib7	3111	8	taken	take	VBN
cord-005453-4057qib7	3111	9	into	into	IN
cord-005453-4057qib7	3111	10	account	account	NN
cord-005453-4057qib7	3111	11	in	in	IN
cord-005453-4057qib7	3111	12	the	the	DT
cord-005453-4057qib7	3111	13	majority	majority	NN
cord-005453-4057qib7	3111	14	of	of	IN
cord-005453-4057qib7	3111	15	the	the	DT
cord-005453-4057qib7	3111	16	centres	centre	NNS
cord-005453-4057qib7	3111	17	(	(	-LRB-
cord-005453-4057qib7	3111	18	94	94	CD
cord-005453-4057qib7	3111	19	%	%	NN
cord-005453-4057qib7	3111	20	)	)	-RRB-
cord-005453-4057qib7	3111	21	.	.	.
cord-005453-4057qib7	3112	1	Local	local	JJ
cord-005453-4057qib7	3112	2	and	and	CC
cord-005453-4057qib7	3112	3	national	national	JJ
cord-005453-4057qib7	3112	4	/	/	SYM
cord-005453-4057qib7	3112	5	international	international	JJ
cord-005453-4057qib7	3112	6	guidelines	guideline	NNS
cord-005453-4057qib7	3112	7	(	(	-LRB-
cord-005453-4057qib7	3112	8	NICE	NICE	NNP
cord-005453-4057qib7	3112	9	)	)	-RRB-
cord-005453-4057qib7	3112	10	are	be	VBP
cord-005453-4057qib7	3112	11	only	only	RB
cord-005453-4057qib7	3112	12	followed	follow	VBN
cord-005453-4057qib7	3112	13	by	by	IN
cord-005453-4057qib7	3112	14	19	19	CD
cord-005453-4057qib7	3112	15	%	%	NN
cord-005453-4057qib7	3112	16	and	and	CC
cord-005453-4057qib7	3112	17	18	18	CD
cord-005453-4057qib7	3112	18	%	%	NN
cord-005453-4057qib7	3112	19	of	of	IN
cord-005453-4057qib7	3112	20	the	the	DT
cord-005453-4057qib7	3112	21	centres	centre	NNS
cord-005453-4057qib7	3112	22	,	,	,
cord-005453-4057qib7	3112	23	respectively	respectively	RB
cord-005453-4057qib7	3112	24	.	.	.
cord-005453-4057qib7	3113	1	The	the	DT
cord-005453-4057qib7	3113	2	most	most	RBS
cord-005453-4057qib7	3113	3	common	common	JJ
cord-005453-4057qib7	3113	4	cut	cut	VBN
cord-005453-4057qib7	3113	5	-	-	HYPH
cord-005453-4057qib7	3113	6	off	off	RP
cord-005453-4057qib7	3113	7	value	value	NN
cord-005453-4057qib7	3113	8	of	of	IN
cord-005453-4057qib7	3113	9	serum	serum	NN
cord-005453-4057qib7	3113	10	VD	vd	NN
cord-005453-4057qib7	3113	11	for	for	IN
cord-005453-4057qib7	3113	12	commencing	commence	VBG
cord-005453-4057qib7	3113	13	on	on	IN
cord-005453-4057qib7	3113	14	replacement	replacement	NN
cord-005453-4057qib7	3113	15	is	be	VBZ
cord-005453-4057qib7	3113	16	50	50	CD
cord-005453-4057qib7	3113	17	nmol	nmol	JJ
cord-005453-4057qib7	3113	18	/	/	SYM
cord-005453-4057qib7	3113	19	L	l	NN
cord-005453-4057qib7	3113	20	(	(	-LRB-
cord-005453-4057qib7	3113	21	32	32	CD
cord-005453-4057qib7	3113	22	%	%	NN
cord-005453-4057qib7	3113	23	)	)	-RRB-
cord-005453-4057qib7	3113	24	.	.	.
cord-005453-4057qib7	3114	1	Northern	northern	JJ
cord-005453-4057qib7	3114	2	countries	country	NNS
cord-005453-4057qib7	3114	3	tend	tend	VBP
cord-005453-4057qib7	3114	4	to	to	TO
cord-005453-4057qib7	3114	5	use	use	VB
cord-005453-4057qib7	3114	6	values	value	NNS
cord-005453-4057qib7	3114	7	of	of	IN
cord-005453-4057qib7	3114	8	≥75	≥75	NNP
cord-005453-4057qib7	3114	9	nmol	nmol	NNP
cord-005453-4057qib7	3114	10	/	/	SYM
cord-005453-4057qib7	3114	11	L	L	NNP
cord-005453-4057qib7	3114	12	whereas	whereas	IN
cord-005453-4057qib7	3114	13	southern	southern	JJ
cord-005453-4057qib7	3114	14	countries	country	NNS
cord-005453-4057qib7	3114	15	≤50	≤50	NNP
cord-005453-4057qib7	3115	1	nmol	nmol	NNP
cord-005453-4057qib7	3115	2	/	/	SYM
cord-005453-4057qib7	3115	3	L.	L.	NNP
cord-005453-4057qib7	3116	1	15	15	CD
cord-005453-4057qib7	3116	2	%	%	NN
cord-005453-4057qib7	3116	3	do	do	VBP
cord-005453-4057qib7	3116	4	not	not	RB
cord-005453-4057qib7	3116	5	use	use	VB
cord-005453-4057qib7	3116	6	cut	cut	VB
cord-005453-4057qib7	3116	7	-	-	HYPH
cord-005453-4057qib7	3116	8	off	off	RP
cord-005453-4057qib7	3116	9	values	value	NNS
cord-005453-4057qib7	3116	10	.	.	.
cord-005453-4057qib7	3117	1	Following	follow	VBG
cord-005453-4057qib7	3117	2	HSCT	HSCT	NNP
cord-005453-4057qib7	3117	3	,	,	,
cord-005453-4057qib7	3117	4	83	83	CD
cord-005453-4057qib7	3117	5	%	%	NN
cord-005453-4057qib7	3117	6	of	of	IN
cord-005453-4057qib7	3117	7	centres	centre	NNS
cord-005453-4057qib7	3117	8	prescribe	prescribe	VBP
cord-005453-4057qib7	3117	9	VD	vd	NN
cord-005453-4057qib7	3117	10	supplements	supplement	NNS
cord-005453-4057qib7	3117	11	to	to	TO
cord-005453-4057qib7	3117	12	maintain	maintain	VB
cord-005453-4057qib7	3117	13	calcium	calcium	NN
cord-005453-4057qib7	3117	14	metabolism	metabolism	NN
cord-005453-4057qib7	3117	15	and	and	CC
cord-005453-4057qib7	3117	16	bone	bone	NN
cord-005453-4057qib7	3117	17	health	health	NN
cord-005453-4057qib7	3117	18	(	(	-LRB-
cord-005453-4057qib7	3117	19	92	92	CD
cord-005453-4057qib7	3117	20	%	%	NN
cord-005453-4057qib7	3117	21	)	)	-RRB-
cord-005453-4057qib7	3117	22	,	,	,
cord-005453-4057qib7	3117	23	enhance	enhance	VB
cord-005453-4057qib7	3117	24	immune	immune	JJ
cord-005453-4057qib7	3117	25	reconstitution	reconstitution	NN
cord-005453-4057qib7	3117	26	post	post	NN
cord-005453-4057qib7	3117	27	-	-	JJ
cord-005453-4057qib7	3117	28	HSCT	HSCT	NNP
cord-005453-4057qib7	3117	29	(	(	-LRB-
cord-005453-4057qib7	3117	30	24	24	CD
cord-005453-4057qib7	3117	31	%	%	NN
cord-005453-4057qib7	3117	32	)	)	-RRB-
cord-005453-4057qib7	3117	33	,	,	,
cord-005453-4057qib7	3117	34	GvHD	GvHD	NNP
cord-005453-4057qib7	3117	35	prevention	prevention	NN
cord-005453-4057qib7	3117	36	(	(	-LRB-
cord-005453-4057qib7	3117	37	17	17	CD
cord-005453-4057qib7	3117	38	%	%	NN
cord-005453-4057qib7	3117	39	)	)	-RRB-
cord-005453-4057qib7	3117	40	,	,	,
cord-005453-4057qib7	3117	41	enhance	enhance	VB
cord-005453-4057qib7	3117	42	immune	immune	JJ
cord-005453-4057qib7	3117	43	-	-	HYPH
cord-005453-4057qib7	3117	44	suppression	suppression	NN
cord-005453-4057qib7	3117	45	to	to	TO
cord-005453-4057qib7	3117	46	treat	treat	VB
cord-005453-4057qib7	3117	47	GvHD	GvHD	NNP
cord-005453-4057qib7	3117	48	(	(	-LRB-
cord-005453-4057qib7	3117	49	10	10	CD
cord-005453-4057qib7	3117	50	%	%	NN
cord-005453-4057qib7	3117	51	)	)	-RRB-
cord-005453-4057qib7	3117	52	,	,	,
cord-005453-4057qib7	3117	53	treat	treat	VB
cord-005453-4057qib7	3117	54	depression	depression	NN
cord-005453-4057qib7	3117	55	/	/	SYM
cord-005453-4057qib7	3117	56	fatigue	fatigue	NN
cord-005453-4057qib7	3117	57	(	(	-LRB-
cord-005453-4057qib7	3117	58	3	3	CD
cord-005453-4057qib7	3117	59	%	%	NN
cord-005453-4057qib7	3117	60	)	)	-RRB-
cord-005453-4057qib7	3117	61	and	and	CC
cord-005453-4057qib7	3117	62	reduce	reduce	VB
cord-005453-4057qib7	3117	63	relapse	relapse	NN
cord-005453-4057qib7	3117	64	risk	risk	NN
cord-005453-4057qib7	3117	65	2	2	CD
cord-005453-4057qib7	3117	66	%	%	NN
cord-005453-4057qib7	3117	67	.	.	.
cord-005453-4057qib7	3118	1	A	a	DT
cord-005453-4057qib7	3118	2	"	"	``
cord-005453-4057qib7	3118	3	loading	loading	NN
cord-005453-4057qib7	3118	4	"	"	''
cord-005453-4057qib7	3118	5	dose	dose	NN
cord-005453-4057qib7	3118	6	is	be	VBZ
cord-005453-4057qib7	3118	7	administrated	administrate	VBN
cord-005453-4057qib7	3118	8	in	in	IN
cord-005453-4057qib7	3118	9	30	30	CD
cord-005453-4057qib7	3118	10	%	%	NN
cord-005453-4057qib7	3118	11	(	(	-LRB-
cord-005453-4057qib7	3118	12	54	54	CD
cord-005453-4057qib7	3118	13	%	%	NN
cord-005453-4057qib7	3118	14	adult	adult	NN
cord-005453-4057qib7	3118	15	,	,	,
cord-005453-4057qib7	3118	16	25	25	CD
cord-005453-4057qib7	3118	17	%	%	NN
cord-005453-4057qib7	3118	18	mixed	mixed	JJ
cord-005453-4057qib7	3118	19	and	and	CC
cord-005453-4057qib7	3118	20	22	22	CD
cord-005453-4057qib7	3118	21	%	%	NN
cord-005453-4057qib7	3118	22	paediatric	paediatric	JJ
cord-005453-4057qib7	3118	23	)	)	-RRB-
cord-005453-4057qib7	3118	24	,	,	,
cord-005453-4057qib7	3118	25	with	with	IN
cord-005453-4057qib7	3118	26	a	a	DT
cord-005453-4057qib7	3118	27	mean	mean	JJ
cord-005453-4057qib7	3118	28	duration	duration	NN
cord-005453-4057qib7	3118	29	of	of	IN
cord-005453-4057qib7	3118	30	4	4	CD
cord-005453-4057qib7	3118	31	weeks	week	NNS
cord-005453-4057qib7	3118	32	.	.	.
cord-005453-4057qib7	3119	1	The	the	DT
cord-005453-4057qib7	3119	2	median	median	JJ
cord-005453-4057qib7	3119	3	daily	daily	JJ
cord-005453-4057qib7	3119	4	loading	loading	NN
cord-005453-4057qib7	3119	5	dose	dose	NN
cord-005453-4057qib7	3119	6	is	be	VBZ
cord-005453-4057qib7	3119	7	2,000	2,000	CD
cord-005453-4057qib7	3119	8	IU	IU	NNP
cord-005453-4057qib7	3119	9	(	(	-LRB-
cord-005453-4057qib7	3119	10	286	286	CD
cord-005453-4057qib7	3119	11	-	-	SYM
cord-005453-4057qib7	3119	12	20,000	20,000	CD
cord-005453-4057qib7	3119	13	)	)	-RRB-
cord-005453-4057qib7	3119	14	.	.	.
cord-005453-4057qib7	3120	1	The	the	DT
cord-005453-4057qib7	3120	2	median	median	JJ
cord-005453-4057qib7	3120	3	"	"	``
cord-005453-4057qib7	3120	4	maintenance	maintenance	NN
cord-005453-4057qib7	3120	5	"	"	''
cord-005453-4057qib7	3120	6	daily	daily	JJ
cord-005453-4057qib7	3120	7	dose	dose	NN
cord-005453-4057qib7	3120	8	is	be	VBZ
cord-005453-4057qib7	3120	9	800	800	CD
cord-005453-4057qib7	3120	10	IU	IU	NNP
cord-005453-4057qib7	3120	11	(	(	-LRB-
cord-005453-4057qib7	3120	12	67	67	CD
cord-005453-4057qib7	3120	13	-	-	SYM
cord-005453-4057qib7	3120	14	10,000	10,000	CD
cord-005453-4057qib7	3120	15	)	)	-RRB-
cord-005453-4057qib7	3120	16	.	.	.
cord-005453-4057qib7	3121	1	There	there	EX
cord-005453-4057qib7	3121	2	are	be	VBP
cord-005453-4057qib7	3121	3	not	not	RB
cord-005453-4057qib7	3121	4	remarkable	remarkable	JJ
cord-005453-4057qib7	3121	5	differences	difference	NNS
cord-005453-4057qib7	3121	6	between	between	IN
cord-005453-4057qib7	3121	7	adult	adult	NN
cord-005453-4057qib7	3121	8	and	and	CC
cord-005453-4057qib7	3121	9	paediatric	paediatric	JJ
cord-005453-4057qib7	3121	10	centres	centre	NNS
cord-005453-4057qib7	3121	11	or	or	CC
cord-005453-4057qib7	3121	12	northern	northern	JJ
cord-005453-4057qib7	3121	13	and	and	CC
cord-005453-4057qib7	3121	14	southern	southern	JJ
cord-005453-4057qib7	3121	15	countries	country	NNS
cord-005453-4057qib7	3121	16	.	.	.
cord-005453-4057qib7	3122	1	VD	VD	NNP
cord-005453-4057qib7	3122	2	replacement	replacement	NN
cord-005453-4057qib7	3122	3	is	be	VBZ
cord-005453-4057qib7	3122	4	prescribed	prescribe	VBN
cord-005453-4057qib7	3122	5	by	by	IN
cord-005453-4057qib7	3122	6	transplant	transplant	NN
cord-005453-4057qib7	3122	7	physicians	physician	NNS
cord-005453-4057qib7	3122	8	(	(	-LRB-
cord-005453-4057qib7	3122	9	75	75	CD
cord-005453-4057qib7	3122	10	%	%	NN
cord-005453-4057qib7	3122	11	)	)	-RRB-
cord-005453-4057qib7	3122	12	,	,	,
cord-005453-4057qib7	3122	13	family	family	NN
cord-005453-4057qib7	3122	14	physicians	physician	NNS
cord-005453-4057qib7	3122	15	(	(	-LRB-
cord-005453-4057qib7	3122	16	10	10	CD
cord-005453-4057qib7	3122	17	%	%	NN
cord-005453-4057qib7	3122	18	)	)	-RRB-
cord-005453-4057qib7	3122	19	,	,	,
cord-005453-4057qib7	3122	20	endocrinologists	endocrinologist	NNS
cord-005453-4057qib7	3122	21	(	(	-LRB-
cord-005453-4057qib7	3122	22	3	3	CD
cord-005453-4057qib7	3122	23	%	%	NN
cord-005453-4057qib7	3122	24	)	)	-RRB-
cord-005453-4057qib7	3122	25	,	,	,
cord-005453-4057qib7	3122	26	CNS	CNS	NNP
cord-005453-4057qib7	3122	27	(	(	-LRB-
cord-005453-4057qib7	3122	28	3	3	CD
cord-005453-4057qib7	3122	29	%	%	NN
cord-005453-4057qib7	3122	30	)	)	-RRB-
cord-005453-4057qib7	3122	31	,	,	,
cord-005453-4057qib7	3122	32	others	other	NNS
cord-005453-4057qib7	3122	33	(	(	-LRB-
cord-005453-4057qib7	3122	34	4	4	CD
cord-005453-4057qib7	3122	35	%	%	NN
cord-005453-4057qib7	3122	36	)	)	-RRB-
cord-005453-4057qib7	3122	37	and	and	CC
cord-005453-4057qib7	3122	38	in	in	IN
cord-005453-4057qib7	3122	39	5	5	CD
cord-005453-4057qib7	3122	40	%	%	NN
cord-005453-4057qib7	3122	41	of	of	IN
cord-005453-4057qib7	3122	42	the	the	DT
cord-005453-4057qib7	3122	43	centres	centre	NNS
cord-005453-4057qib7	3122	44	,	,	,
cord-005453-4057qib7	3122	45	patients	patient	NNS
cord-005453-4057qib7	3122	46	are	be	VBP
cord-005453-4057qib7	3122	47	advised	advise	VBN
cord-005453-4057qib7	3122	48	to	to	TO
cord-005453-4057qib7	3122	49	buy	buy	VB
cord-005453-4057qib7	3122	50	it	-PRON-	PRP
cord-005453-4057qib7	3122	51	over	over	IN
cord-005453-4057qib7	3122	52	-	-	HYPH
cord-005453-4057qib7	3122	53	the	the	DT
cord-005453-4057qib7	3122	54	-	-	HYPH
cord-005453-4057qib7	3122	55	counter	counter	NN
cord-005453-4057qib7	3122	56	.	.	.
cord-005453-4057qib7	3123	1	VD	VD	NNP
cord-005453-4057qib7	3123	2	is	be	VBZ
cord-005453-4057qib7	3123	3	prescribed	prescribe	VBN
cord-005453-4057qib7	3123	4	combined	combine	VBN
cord-005453-4057qib7	3123	5	with	with	IN
cord-005453-4057qib7	3123	6	calcium	calcium	NN
cord-005453-4057qib7	3123	7	carbonate	carbonate	NN
cord-005453-4057qib7	3123	8	in	in	IN
cord-005453-4057qib7	3123	9	52	52	CD
cord-005453-4057qib7	3123	10	%	%	NN
cord-005453-4057qib7	3123	11	and	and	CC
cord-005453-4057qib7	3123	12	alone	alone	RB
cord-005453-4057qib7	3123	13	in	in	IN
cord-005453-4057qib7	3123	14	48	48	CD
cord-005453-4057qib7	3123	15	%	%	NN
cord-005453-4057qib7	3123	16	of	of	IN
cord-005453-4057qib7	3123	17	the	the	DT
cord-005453-4057qib7	3123	18	centres	centre	NNS
cord-005453-4057qib7	3123	19	.	.	.
cord-005453-4057qib7	3124	1	It	-PRON-	PRP
cord-005453-4057qib7	3124	2	is	be	VBZ
cord-005453-4057qib7	3124	3	eventually	eventually	RB
cord-005453-4057qib7	3124	4	discontinued	discontinue	VBN
cord-005453-4057qib7	3124	5	by	by	IN
cord-005453-4057qib7	3124	6	69	69	CD
cord-005453-4057qib7	3124	7	%	%	NN
cord-005453-4057qib7	3124	8	of	of	IN
cord-005453-4057qib7	3124	9	the	the	DT
cord-005453-4057qib7	3124	10	centres	centre	NNS
cord-005453-4057qib7	3124	11	when	when	WRB
cord-005453-4057qib7	3124	12	therapeutical	therapeutical	JJ
cord-005453-4057qib7	3124	13	levels	level	NNS
cord-005453-4057qib7	3124	14	of	of	IN
cord-005453-4057qib7	3124	15	VD	VD	NNP
cord-005453-4057qib7	3124	16	are	be	VBP
cord-005453-4057qib7	3124	17	reached	reach	VBN
cord-005453-4057qib7	3124	18	(	(	-LRB-
cord-005453-4057qib7	3124	19	69	69	CD
cord-005453-4057qib7	3124	20	%	%	NN
cord-005453-4057qib7	3124	21	)	)	-RRB-
cord-005453-4057qib7	3124	22	,	,	,
cord-005453-4057qib7	3124	23	DEXA	DEXA	NNP
cord-005453-4057qib7	3124	24	scan	scan	JJ
cord-005453-4057qib7	3124	25	returns	return	NNS
cord-005453-4057qib7	3124	26	to	to	IN
cord-005453-4057qib7	3124	27	normal	normal	JJ
cord-005453-4057qib7	3124	28	(	(	-LRB-
cord-005453-4057qib7	3124	29	12	12	CD
cord-005453-4057qib7	3124	30	%	%	NN
cord-005453-4057qib7	3124	31	)	)	-RRB-
cord-005453-4057qib7	3124	32	and	and	CC
cord-005453-4057qib7	3124	33	symptomatic	symptomatic	JJ
cord-005453-4057qib7	3124	34	improvement	improvement	NN
cord-005453-4057qib7	3124	35	(	(	-LRB-
cord-005453-4057qib7	3124	36	9	9	CD
cord-005453-4057qib7	3124	37	%	%	NN
cord-005453-4057qib7	3124	38	)	)	-RRB-
cord-005453-4057qib7	3124	39	.	.	.
cord-005453-4057qib7	3125	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3125	2	:	:	:
cord-005453-4057qib7	3126	1	This	this	DT
cord-005453-4057qib7	3126	2	survey	survey	NN
cord-005453-4057qib7	3126	3	has	have	VBZ
cord-005453-4057qib7	3126	4	demonstrated	demonstrate	VBN
cord-005453-4057qib7	3126	5	discrepancies	discrepancy	NNS
cord-005453-4057qib7	3126	6	in	in	IN
cord-005453-4057qib7	3126	7	monitoring	monitoring	NN
cord-005453-4057qib7	3126	8	and	and	CC
cord-005453-4057qib7	3126	9	replacement	replacement	NN
cord-005453-4057qib7	3126	10	of	of	IN
cord-005453-4057qib7	3126	11	VD	VD	NNP
cord-005453-4057qib7	3126	12	across	across	IN
cord-005453-4057qib7	3126	13	EBMT	EBMT	NNP
cord-005453-4057qib7	3126	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	3126	15	HSCT	HSCT	NNP
cord-005453-4057qib7	3126	16	Programmes	Programmes	NNP
cord-005453-4057qib7	3126	17	.	.	.
cord-005453-4057qib7	3127	1	Although	although	IN
cord-005453-4057qib7	3127	2	awareness	awareness	NN
cord-005453-4057qib7	3127	3	has	have	VBZ
cord-005453-4057qib7	3127	4	arisen	arise	VBN
cord-005453-4057qib7	3127	5	over	over	IN
cord-005453-4057qib7	3127	6	the	the	DT
cord-005453-4057qib7	3127	7	last	last	JJ
cord-005453-4057qib7	3127	8	decade	decade	NN
cord-005453-4057qib7	3127	9	,	,	,
cord-005453-4057qib7	3127	10	there	there	EX
cord-005453-4057qib7	3127	11	is	be	VBZ
cord-005453-4057qib7	3127	12	still	still	RB
cord-005453-4057qib7	3127	13	lack	lack	NN
cord-005453-4057qib7	3127	14	of	of	IN
cord-005453-4057qib7	3127	15	evidence	evidence	NN
cord-005453-4057qib7	3127	16	about	about	IN
cord-005453-4057qib7	3127	17	the	the	DT
cord-005453-4057qib7	3127	18	optimal	optimal	JJ
cord-005453-4057qib7	3127	19	levels	level	NNS
cord-005453-4057qib7	3127	20	of	of	IN
cord-005453-4057qib7	3127	21	VD	VD	NNP
cord-005453-4057qib7	3127	22	required	require	VBN
cord-005453-4057qib7	3127	23	for	for	IN
cord-005453-4057qib7	3127	24	immunemodulation	immunemodulation	NN
cord-005453-4057qib7	3127	25	post	post	JJ
cord-005453-4057qib7	3127	26	-	-	JJ
cord-005453-4057qib7	3127	27	HSCT	HSCT	NNP
cord-005453-4057qib7	3127	28	.	.	.
cord-005453-4057qib7	3128	1	This	this	DT
cord-005453-4057qib7	3128	2	survey	survey	NN
cord-005453-4057qib7	3128	3	emphasises	emphasise	VBZ
cord-005453-4057qib7	3128	4	the	the	DT
cord-005453-4057qib7	3128	5	need	need	NN
cord-005453-4057qib7	3128	6	for	for	IN
cord-005453-4057qib7	3128	7	specific	specific	JJ
cord-005453-4057qib7	3128	8	guidelines	guideline	NNS
cord-005453-4057qib7	3128	9	to	to	TO
cord-005453-4057qib7	3128	10	harmonise	harmonise	VB
cord-005453-4057qib7	3128	11	the	the	DT
cord-005453-4057qib7	3128	12	current	current	JJ
cord-005453-4057qib7	3128	13	management	management	NN
cord-005453-4057qib7	3128	14	of	of	IN
cord-005453-4057qib7	3128	15	VD	VD	NNP
cord-005453-4057qib7	3128	16	deficiency	deficiency	NN
cord-005453-4057qib7	3128	17	in	in	IN
cord-005453-4057qib7	3128	18	adult	adult	NN
cord-005453-4057qib7	3128	19	and	and	CC
cord-005453-4057qib7	3128	20	paediatric	paediatric	JJ
cord-005453-4057qib7	3128	21	HSCT	HSCT	NNP
cord-005453-4057qib7	3128	22	setting	setting	NN
cord-005453-4057qib7	3128	23	.	.	.
cord-005453-4057qib7	3129	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3129	2	Background	background	NN
cord-005453-4057qib7	3129	3	:	:	:
cord-005453-4057qib7	3130	1	The	the	DT
cord-005453-4057qib7	3130	2	use	use	NN
cord-005453-4057qib7	3130	3	of	of	IN
cord-005453-4057qib7	3130	4	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	3130	5	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	3130	6	SCT	SCT	NNP
cord-005453-4057qib7	3130	7	(	(	-LRB-
cord-005453-4057qib7	3130	8	Haplo	Haplo	NNP
cord-005453-4057qib7	3130	9	-	-	HYPH
cord-005453-4057qib7	3130	10	SCT	SCT	NNP
cord-005453-4057qib7	3130	11	)	)	-RRB-
cord-005453-4057qib7	3130	12	with	with	IN
cord-005453-4057qib7	3130	13	post	post	JJ
cord-005453-4057qib7	3130	14	-	-	JJ
cord-005453-4057qib7	3130	15	transplant	transplant	NN
cord-005453-4057qib7	3130	16	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	3130	17	(	(	-LRB-
cord-005453-4057qib7	3130	18	PT	PT	NNP
cord-005453-4057qib7	3130	19	-	-	HYPH
cord-005453-4057qib7	3130	20	Cy	Cy	NNP
cord-005453-4057qib7	3130	21	)	)	-RRB-
cord-005453-4057qib7	3130	22	as	as	IN
cord-005453-4057qib7	3130	23	GVHD	GVHD	NNP
cord-005453-4057qib7	3130	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3130	25	has	have	VBZ
cord-005453-4057qib7	3130	26	widely	widely	RB
cord-005453-4057qib7	3130	27	extended	extend	VBN
cord-005453-4057qib7	3130	28	.	.	.
cord-005453-4057qib7	3131	1	Primary	primary	JJ
cord-005453-4057qib7	3131	2	and	and	CC
cord-005453-4057qib7	3131	3	secondary	secondary	JJ
cord-005453-4057qib7	3131	4	graft	graft	NN
cord-005453-4057qib7	3131	5	failure	failure	NN
cord-005453-4057qib7	3131	6	are	be	VBP
cord-005453-4057qib7	3131	7	relatively	relatively	RB
cord-005453-4057qib7	3131	8	uncommon	uncommon	JJ
cord-005453-4057qib7	3131	9	complications	complication	NNS
cord-005453-4057qib7	3131	10	.	.	.
cord-005453-4057qib7	3132	1	However	however	RB
cord-005453-4057qib7	3132	2	,	,	,
cord-005453-4057qib7	3132	3	poor	poor	JJ
cord-005453-4057qib7	3132	4	graft	graft	NN
cord-005453-4057qib7	3132	5	function	function	NN
cord-005453-4057qib7	3132	6	(	(	-LRB-
cord-005453-4057qib7	3132	7	PGF	PGF	NNP
cord-005453-4057qib7	3132	8	)	)	-RRB-
cord-005453-4057qib7	3132	9	after	after	IN
cord-005453-4057qib7	3132	10	Haplo	Haplo	NNP
cord-005453-4057qib7	3132	11	-	-	HYPH
cord-005453-4057qib7	3132	12	SCT	SCT	NNP
cord-005453-4057qib7	3132	13	with	with	IN
cord-005453-4057qib7	3132	14	PT	PT	NNP
cord-005453-4057qib7	3132	15	-	-	HYPH
cord-005453-4057qib7	3132	16	Cy	Cy	NNP
cord-005453-4057qib7	3132	17	has	have	VBZ
cord-005453-4057qib7	3132	18	not	not	RB
cord-005453-4057qib7	3132	19	been	be	VBN
cord-005453-4057qib7	3132	20	described	describe	VBN
cord-005453-4057qib7	3132	21	thoroughly	thoroughly	RB
cord-005453-4057qib7	3132	22	.	.	.
cord-005453-4057qib7	3133	1	The	the	DT
cord-005453-4057qib7	3133	2	objective	objective	NN
cord-005453-4057qib7	3133	3	of	of	IN
cord-005453-4057qib7	3133	4	this	this	DT
cord-005453-4057qib7	3133	5	study	study	NN
cord-005453-4057qib7	3133	6	is	be	VBZ
cord-005453-4057qib7	3133	7	to	to	TO
cord-005453-4057qib7	3133	8	describe	describe	VB
cord-005453-4057qib7	3133	9	characteristics	characteristic	NNS
cord-005453-4057qib7	3133	10	,	,	,
cord-005453-4057qib7	3133	11	treatments	treatment	NNS
cord-005453-4057qib7	3133	12	and	and	CC
cord-005453-4057qib7	3133	13	outcomes	outcome	NNS
cord-005453-4057qib7	3133	14	of	of	IN
cord-005453-4057qib7	3133	15	patients	patient	NNS
cord-005453-4057qib7	3133	16	with	with	IN
cord-005453-4057qib7	3133	17	PGF	PGF	NNP
cord-005453-4057qib7	3133	18	after	after	IN
cord-005453-4057qib7	3133	19	Haplo	Haplo	NNP
cord-005453-4057qib7	3133	20	-	-	HYPH
cord-005453-4057qib7	3133	21	SCT	SCT	NNP
cord-005453-4057qib7	3133	22	with	with	IN
cord-005453-4057qib7	3133	23	PT	PT	NNP
cord-005453-4057qib7	3133	24	-	-	HYPH
cord-005453-4057qib7	3133	25	Cy	Cy	NNP
cord-005453-4057qib7	3133	26	.	.	.
cord-005453-4057qib7	3134	1	Methods	method	NNS
cord-005453-4057qib7	3134	2	:	:	:
cord-005453-4057qib7	3134	3	We	-PRON-	PRP
cord-005453-4057qib7	3134	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	3134	5	analyzed	analyze	VBD
cord-005453-4057qib7	3134	6	132	132	CD
cord-005453-4057qib7	3134	7	Haplo	Haplo	NNP
cord-005453-4057qib7	3134	8	-	-	HYPH
cord-005453-4057qib7	3134	9	SCT	SCT	NNP
cord-005453-4057qib7	3134	10	with	with	IN
cord-005453-4057qib7	3134	11	PT	PT	NNP
cord-005453-4057qib7	3134	12	-	-	HYPH
cord-005453-4057qib7	3134	13	Cy	Cy	NNP
cord-005453-4057qib7	3134	14	consecutively	consecutively	RB
cord-005453-4057qib7	3134	15	performed	perform	VBD
cord-005453-4057qib7	3134	16	between	between	IN
cord-005453-4057qib7	3134	17	2011	2011	CD
cord-005453-4057qib7	3134	18	and	and	CC
cord-005453-4057qib7	3134	19	2017	2017	CD
cord-005453-4057qib7	3134	20	in	in	IN
cord-005453-4057qib7	3134	21	our	-PRON-	PRP$
cord-005453-4057qib7	3134	22	centre	centre	NN
cord-005453-4057qib7	3134	23	.	.	.
cord-005453-4057qib7	3135	1	PGF	PGF	NNP
cord-005453-4057qib7	3135	2	was	be	VBD
cord-005453-4057qib7	3135	3	defined	define	VBN
cord-005453-4057qib7	3135	4	as	as	IN
cord-005453-4057qib7	3135	5	either	either	DT
cord-005453-4057qib7	3135	6	occurring	occur	VBG
cord-005453-4057qib7	3135	7	after	after	IN
cord-005453-4057qib7	3135	8	initial	initial	JJ
cord-005453-4057qib7	3135	9	engraftment	engraftment	NN
cord-005453-4057qib7	3135	10	:	:	:
cord-005453-4057qib7	3135	11	persistent	persistent	JJ
cord-005453-4057qib7	3135	12	neutropenia	neutropenia	NN
cord-005453-4057qib7	3135	13	(	(	-LRB-
cord-005453-4057qib7	3135	14	ANC	ANC	NNP
cord-005453-4057qib7	3135	15	<	<	XX
cord-005453-4057qib7	3135	16	500	500	CD
cord-005453-4057qib7	3135	17	/	/	SYM
cord-005453-4057qib7	3135	18	uL	uL	NNP
cord-005453-4057qib7	3135	19	)	)	-RRB-
cord-005453-4057qib7	3135	20	with	with	IN
cord-005453-4057qib7	3135	21	the	the	DT
cord-005453-4057qib7	3135	22	need	need	NN
cord-005453-4057qib7	3135	23	of	of	IN
cord-005453-4057qib7	3135	24	at	at	RB
cord-005453-4057qib7	3135	25	least	least	JJS
cord-005453-4057qib7	3135	26	3	3	CD
cord-005453-4057qib7	3135	27	doses	dose	NNS
cord-005453-4057qib7	3135	28	of	of	IN
cord-005453-4057qib7	3135	29	G	G	NNP
cord-005453-4057qib7	3135	30	-	-	HYPH
cord-005453-4057qib7	3135	31	CSF	CSF	NNP
cord-005453-4057qib7	3135	32	and/or	and/or	CC
cord-005453-4057qib7	3135	33	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	3136	1	(	(	-LRB-
cord-005453-4057qib7	3136	2	platelets	platelet	NNS
cord-005453-4057qib7	3137	1	<	<	NNP
cord-005453-4057qib7	3137	2	20.000	20.000	CD
cord-005453-4057qib7	3137	3	/	/	SYM
cord-005453-4057qib7	3137	4	uL	ul	NN
cord-005453-4057qib7	3137	5	)	)	-RRB-
cord-005453-4057qib7	3138	1	with	with	IN
cord-005453-4057qib7	3138	2	platelet	platelet	NN
cord-005453-4057qib7	3138	3	transfusion	transfusion	NN
cord-005453-4057qib7	3138	4	dependence	dependence	NN
cord-005453-4057qib7	3138	5	,	,	,
cord-005453-4057qib7	3138	6	with	with	IN
cord-005453-4057qib7	3138	7	complete	complete	JJ
cord-005453-4057qib7	3138	8	donor	donor	NN
cord-005453-4057qib7	3138	9	chimerism	chimerism	NN
cord-005453-4057qib7	3138	10	and	and	CC
cord-005453-4057qib7	3138	11	without	without	IN
cord-005453-4057qib7	3138	12	concurrent	concurrent	JJ
cord-005453-4057qib7	3138	13	severe	severe	JJ
cord-005453-4057qib7	3138	14	GVHD	gvhd	NN
cord-005453-4057qib7	3138	15	or	or	CC
cord-005453-4057qib7	3138	16	disease	disease	NN
cord-005453-4057qib7	3138	17	relapse	relapse	NN
cord-005453-4057qib7	3138	18	.	.	.
cord-005453-4057qib7	3139	1	Results	result	NNS
cord-005453-4057qib7	3139	2	:	:	:
cord-005453-4057qib7	3140	1	Nineteen	nineteen	CD
cord-005453-4057qib7	3140	2	patients	patient	NNS
cord-005453-4057qib7	3140	3	were	be	VBD
cord-005453-4057qib7	3140	4	excluded	exclude	VBN
cord-005453-4057qib7	3140	5	from	from	IN
cord-005453-4057qib7	3140	6	the	the	DT
cord-005453-4057qib7	3140	7	analysis	analysis	NN
cord-005453-4057qib7	3140	8	due	due	IN
cord-005453-4057qib7	3140	9	to	to	IN
cord-005453-4057qib7	3140	10	early	early	JJ
cord-005453-4057qib7	3140	11	mortality	mortality	NN
cord-005453-4057qib7	3140	12	(	(	-LRB-
cord-005453-4057qib7	3140	13	death	death	NN
cord-005453-4057qib7	3140	14	before	before	IN
cord-005453-4057qib7	3140	15	day	day	NN
cord-005453-4057qib7	3140	16	+30	+30	CD
cord-005453-4057qib7	3140	17	)	)	-RRB-
cord-005453-4057qib7	3140	18	,	,	,
cord-005453-4057qib7	3140	19	primary	primary	JJ
cord-005453-4057qib7	3140	20	graft	graft	NN
cord-005453-4057qib7	3140	21	failure	failure	NN
cord-005453-4057qib7	3140	22	(	(	-LRB-
cord-005453-4057qib7	3140	23	absence	absence	NN
cord-005453-4057qib7	3140	24	of	of	IN
cord-005453-4057qib7	3140	25	neutrophil	neutrophil	NN
cord-005453-4057qib7	3140	26	engraftment	engraftment	NN
cord-005453-4057qib7	3140	27	by	by	IN
cord-005453-4057qib7	3140	28	day	day	NN
cord-005453-4057qib7	3140	29	+28	+28	NNP
cord-005453-4057qib7	3140	30	,	,	,
cord-005453-4057qib7	3140	31	with	with	IN
cord-005453-4057qib7	3140	32	mixed	mixed	JJ
cord-005453-4057qib7	3140	33	chimerism	chimerism	NN
cord-005453-4057qib7	3140	34	)	)	-RRB-
cord-005453-4057qib7	3140	35	or	or	CC
cord-005453-4057qib7	3140	36	secondary	secondary	JJ
cord-005453-4057qib7	3140	37	graft	graft	NN
cord-005453-4057qib7	3140	38	failure	failure	NN
cord-005453-4057qib7	3140	39	(	(	-LRB-
cord-005453-4057qib7	3140	40	development	development	NN
cord-005453-4057qib7	3140	41	of	of	IN
cord-005453-4057qib7	3140	42	severe	severe	JJ
cord-005453-4057qib7	3140	43	cytopenias	cytopenia	NNS
cord-005453-4057qib7	3140	44	and	and	CC
cord-005453-4057qib7	3140	45	mixed	mixed	JJ
cord-005453-4057qib7	3140	46	chimerism	chimerism	NN
cord-005453-4057qib7	3140	47	after	after	IN
cord-005453-4057qib7	3140	48	initial	initial	JJ
cord-005453-4057qib7	3140	49	achievement	achievement	NN
cord-005453-4057qib7	3140	50	of	of	IN
cord-005453-4057qib7	3140	51	neutrophil	neutrophil	NN
cord-005453-4057qib7	3140	52	engraftment	engraftment	NN
cord-005453-4057qib7	3140	53	)	)	-RRB-
cord-005453-4057qib7	3140	54	.	.	.
cord-005453-4057qib7	3141	1	Thirty	thirty	CD
cord-005453-4057qib7	3141	2	one	one	CD
cord-005453-4057qib7	3141	3	patients	patient	NNS
cord-005453-4057qib7	3141	4	(	(	-LRB-
cord-005453-4057qib7	3141	5	27,5	27,5	CD
cord-005453-4057qib7	3141	6	%	%	NN
cord-005453-4057qib7	3141	7	)	)	-RRB-
cord-005453-4057qib7	3141	8	were	be	VBD
cord-005453-4057qib7	3141	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	3141	10	with	with	IN
cord-005453-4057qib7	3141	11	PGF	PGF	NNP
cord-005453-4057qib7	3141	12	.	.	.
cord-005453-4057qib7	3142	1	Main	main	JJ
cord-005453-4057qib7	3142	2	characteristics	characteristic	NNS
cord-005453-4057qib7	3142	3	of	of	IN
cord-005453-4057qib7	3142	4	these	these	DT
cord-005453-4057qib7	3142	5	patients	patient	NNS
cord-005453-4057qib7	3142	6	are	be	VBP
cord-005453-4057qib7	3142	7	summarized	summarize	VBN
cord-005453-4057qib7	3142	8	in	in	IN
cord-005453-4057qib7	3142	9	Table	Table	NNP
cord-005453-4057qib7	3142	10	1	1	CD
cord-005453-4057qib7	3142	11	.	.	.
cord-005453-4057qib7	3143	1	Twenty	twenty	CD
cord-005453-4057qib7	3143	2	six	six	CD
cord-005453-4057qib7	3143	3	patients	patient	NNS
cord-005453-4057qib7	3143	4	(	(	-LRB-
cord-005453-4057qib7	3143	5	84	84	CD
cord-005453-4057qib7	3143	6	%	%	NN
cord-005453-4057qib7	3143	7	)	)	-RRB-
cord-005453-4057qib7	3143	8	presented	present	VBN
cord-005453-4057qib7	3143	9	with	with	IN
cord-005453-4057qib7	3143	10	neutropenia	neutropenia	NN
cord-005453-4057qib7	3143	11	and	and	CC
cord-005453-4057qib7	3143	12	were	be	VBD
cord-005453-4057qib7	3143	13	treated	treat	VBN
cord-005453-4057qib7	3143	14	with	with	IN
cord-005453-4057qib7	3143	15	G	G	NNP
cord-005453-4057qib7	3143	16	-	-	HYPH
cord-005453-4057qib7	3143	17	CSF	CSF	NNP
cord-005453-4057qib7	3143	18	,	,	,
cord-005453-4057qib7	3143	19	while	while	IN
cord-005453-4057qib7	3143	20	5	5	CD
cord-005453-4057qib7	3143	21	patients	patient	NNS
cord-005453-4057qib7	3143	22	(	(	-LRB-
cord-005453-4057qib7	3143	23	16	16	CD
cord-005453-4057qib7	3143	24	%	%	NN
cord-005453-4057qib7	3143	25	)	)	-RRB-
cord-005453-4057qib7	3143	26	only	only	RB
cord-005453-4057qib7	3143	27	developed	develop	VBD
cord-005453-4057qib7	3143	28	severe	severe	JJ
cord-005453-4057qib7	3143	29	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	3143	30	without	without	IN
cord-005453-4057qib7	3143	31	neutropenia	neutropenia	NN
cord-005453-4057qib7	3143	32	,	,	,
cord-005453-4057qib7	3143	33	and	and	CC
cord-005453-4057qib7	3143	34	were	be	VBD
cord-005453-4057qib7	3143	35	treated	treat	VBN
cord-005453-4057qib7	3143	36	only	only	RB
cord-005453-4057qib7	3143	37	with	with	IN
cord-005453-4057qib7	3143	38	platelet	platelet	NN
cord-005453-4057qib7	3143	39	transfusion	transfusion	NN
cord-005453-4057qib7	3143	40	.	.	.
cord-005453-4057qib7	3144	1	Twenty	twenty	CD
cord-005453-4057qib7	3144	2	four	four	CD
cord-005453-4057qib7	3144	3	patients	patient	NNS
cord-005453-4057qib7	3144	4	(	(	-LRB-
cord-005453-4057qib7	3144	5	77,5	77,5	CD
cord-005453-4057qib7	3144	6	%	%	NN
cord-005453-4057qib7	3144	7	)	)	-RRB-
cord-005453-4057qib7	3144	8	had	have	VBD
cord-005453-4057qib7	3144	9	at	at	RB
cord-005453-4057qib7	3144	10	least	least	JJS
cord-005453-4057qib7	3144	11	1	1	CD
cord-005453-4057qib7	3144	12	CMV	CMV	NNP
cord-005453-4057qib7	3144	13	reactivation	reactivation	NN
cord-005453-4057qib7	3144	14	,	,	,
cord-005453-4057qib7	3144	15	15	15	CD
cord-005453-4057qib7	3144	16	patients	patient	NNS
cord-005453-4057qib7	3144	17	(	(	-LRB-
cord-005453-4057qib7	3144	18	48	48	CD
cord-005453-4057qib7	3144	19	%	%	NN
cord-005453-4057qib7	3144	20	)	)	-RRB-
cord-005453-4057qib7	3144	21	had	have	VBD
cord-005453-4057qib7	3145	1	2	2	CD
cord-005453-4057qib7	3145	2	or	or	CC
cord-005453-4057qib7	3145	3	more	more	JJR
cord-005453-4057qib7	3145	4	CMV	CMV	NNP
cord-005453-4057qib7	3145	5	reactivations	reactivation	NNS
cord-005453-4057qib7	3145	6	and	and	CC
cord-005453-4057qib7	3145	7	21	21	CD
cord-005453-4057qib7	3145	8	patients	patient	NNS
cord-005453-4057qib7	3145	9	(	(	-LRB-
cord-005453-4057qib7	3145	10	67	67	CD
cord-005453-4057qib7	3145	11	%	%	NN
cord-005453-4057qib7	3145	12	)	)	-RRB-
cord-005453-4057qib7	3145	13	received	receive	VBD
cord-005453-4057qib7	3145	14	valganciclovir	valganciclovir	NN
cord-005453-4057qib7	3145	15	for	for	IN
cord-005453-4057qib7	3145	16	CMV	CMV	NNP
cord-005453-4057qib7	3145	17	reactivation	reactivation	NN
cord-005453-4057qib7	3145	18	treatment	treatment	NN
cord-005453-4057qib7	3145	19	.	.	.
cord-005453-4057qib7	3146	1	Although	although	IN
cord-005453-4057qib7	3146	2	most	most	JJS
cord-005453-4057qib7	3146	3	patients	patient	NNS
cord-005453-4057qib7	3146	4	achieved	achieve	VBD
cord-005453-4057qib7	3146	5	adequate	adequate	JJ
cord-005453-4057qib7	3146	6	peripheral	peripheral	JJ
cord-005453-4057qib7	3146	7	blood	blood	NN
cord-005453-4057qib7	3146	8	counts	count	NNS
cord-005453-4057qib7	3146	9	(	(	-LRB-
cord-005453-4057qib7	3146	10	PBC	PBC	NNP
cord-005453-4057qib7	3146	11	)	)	-RRB-
cord-005453-4057qib7	3146	12	with	with	IN
cord-005453-4057qib7	3146	13	initial	initial	JJ
cord-005453-4057qib7	3146	14	salvage	salvage	NN
cord-005453-4057qib7	3146	15	therapy	therapy	NN
cord-005453-4057qib7	3146	16	,	,	,
cord-005453-4057qib7	3146	17	6	6	CD
cord-005453-4057qib7	3146	18	patients	patient	NNS
cord-005453-4057qib7	3146	19	(	(	-LRB-
cord-005453-4057qib7	3146	20	19	19	CD
cord-005453-4057qib7	3146	21	%	%	NN
cord-005453-4057qib7	3146	22	)	)	-RRB-
cord-005453-4057qib7	3146	23	had	have	VBD
cord-005453-4057qib7	3146	24	persistent	persistent	JJ
cord-005453-4057qib7	3146	25	cytopenias	cytopenia	NNS
cord-005453-4057qib7	3146	26	in	in	IN
cord-005453-4057qib7	3146	27	spite	spite	NN
cord-005453-4057qib7	3146	28	of	of	IN
cord-005453-4057qib7	3146	29	G	G	NNP
cord-005453-4057qib7	3146	30	-	-	HYPH
cord-005453-4057qib7	3146	31	CSF	CSF	NNP
cord-005453-4057qib7	3146	32	,	,	,
cord-005453-4057qib7	3146	33	platelet	platelet	NN
cord-005453-4057qib7	3146	34	transfusion	transfusion	NN
cord-005453-4057qib7	3146	35	,	,	,
cord-005453-4057qib7	3146	36	CMV	CMV	NNP
cord-005453-4057qib7	3146	37	reactivation	reactivation	NN
cord-005453-4057qib7	3146	38	resolution	resolution	NN
cord-005453-4057qib7	3146	39	and	and	CC
cord-005453-4057qib7	3146	40	myelotoxic	myelotoxic	JJ
cord-005453-4057qib7	3146	41	drugs	drug	NNS
cord-005453-4057qib7	3146	42	withdrawal	withdrawal	NN
cord-005453-4057qib7	3146	43	.	.	.
cord-005453-4057qib7	3147	1	Four	four	CD
cord-005453-4057qib7	3147	2	of	of	IN
cord-005453-4057qib7	3147	3	them	-PRON-	PRP
cord-005453-4057qib7	3147	4	were	be	VBD
cord-005453-4057qib7	3147	5	treated	treat	VBN
cord-005453-4057qib7	3147	6	with	with	IN
cord-005453-4057qib7	3147	7	a	a	DT
cord-005453-4057qib7	3147	8	boost	boost	NN
cord-005453-4057qib7	3147	9	of	of	IN
cord-005453-4057qib7	3147	10	CD34	CD34	NNP
cord-005453-4057qib7	3147	11	+	+	SYM
cord-005453-4057qib7	3147	12	selected	select	VBN
cord-005453-4057qib7	3147	13	peripheral	peripheral	JJ
cord-005453-4057qib7	3147	14	blood	blood	NN
cord-005453-4057qib7	3147	15	donor	donor	NN
cord-005453-4057qib7	3147	16	cells	cell	NNS
cord-005453-4057qib7	3147	17	at	at	IN
cord-005453-4057qib7	3147	18	a	a	DT
cord-005453-4057qib7	3147	19	median	median	NN
cord-005453-4057qib7	3147	20	of	of	IN
cord-005453-4057qib7	3147	21	170	170	CD
cord-005453-4057qib7	3147	22	days	day	NNS
cord-005453-4057qib7	3147	23	after	after	RB
cord-005453-4057qib7	3147	24	.	.	.
cord-005453-4057qib7	3148	1	Median	median	JJ
cord-005453-4057qib7	3148	2	CD34	CD34	NNP
cord-005453-4057qib7	3149	1	+	+	CC
cord-005453-4057qib7	3149	2	cells	cell	NNS
cord-005453-4057qib7	3149	3	infused	infuse	VBN
cord-005453-4057qib7	3149	4	was	be	VBD
cord-005453-4057qib7	3149	5	3,42	3,42	CD
cord-005453-4057qib7	3149	6	x10	x10	CD
cord-005453-4057qib7	3149	7	6	6	CD
cord-005453-4057qib7	3150	1	/kg	/kg	NFP
cord-005453-4057qib7	3150	2	.	.	.
cord-005453-4057qib7	3151	1	These	these	DT
cord-005453-4057qib7	3151	2	4	4	CD
cord-005453-4057qib7	3151	3	patients	patient	NNS
cord-005453-4057qib7	3151	4	achieved	achieve	VBD
cord-005453-4057qib7	3151	5	adequate	adequate	JJ
cord-005453-4057qib7	3151	6	PBC	PBC	NNP
cord-005453-4057qib7	3151	7	after	after	IN
cord-005453-4057qib7	3151	8	salvage	salvage	NN
cord-005453-4057qib7	3151	9	therapy	therapy	NN
cord-005453-4057qib7	3151	10	and	and	CC
cord-005453-4057qib7	3151	11	two	two	CD
cord-005453-4057qib7	3151	12	developed	develop	VBN
cord-005453-4057qib7	3151	13	GVHD	GVHD	NNP
cord-005453-4057qib7	3151	14	.	.	.
cord-005453-4057qib7	3152	1	The	the	DT
cord-005453-4057qib7	3152	2	other	other	JJ
cord-005453-4057qib7	3152	3	2	2	CD
cord-005453-4057qib7	3152	4	patients	patient	NNS
cord-005453-4057qib7	3152	5	were	be	VBD
cord-005453-4057qib7	3152	6	treated	treat	VBN
cord-005453-4057qib7	3152	7	with	with	IN
cord-005453-4057qib7	3152	8	increasing	increase	VBG
cord-005453-4057qib7	3152	9	doses	dose	NNS
cord-005453-4057qib7	3152	10	of	of	IN
cord-005453-4057qib7	3152	11	thrombopoietin	thrombopoietin	NNP
cord-005453-4057qib7	3152	12	(	(	-LRB-
cord-005453-4057qib7	3152	13	TPO	TPO	NNP
cord-005453-4057qib7	3152	14	)	)	-RRB-
cord-005453-4057qib7	3152	15	receptor	receptor	NN
cord-005453-4057qib7	3152	16	agonist	agonist	NN
cord-005453-4057qib7	3152	17	(	(	-LRB-
cord-005453-4057qib7	3152	18	TRA	TRA	NNP
cord-005453-4057qib7	3152	19	)	)	-RRB-
cord-005453-4057qib7	3152	20	eltrombopag	eltrombopag	NNP
cord-005453-4057qib7	3152	21	.	.	.
cord-005453-4057qib7	3153	1	One	one	CD
cord-005453-4057qib7	3153	2	patient	patient	NN
cord-005453-4057qib7	3153	3	started	start	VBD
cord-005453-4057qib7	3153	4	treatment	treatment	NN
cord-005453-4057qib7	3153	5	160	160	CD
cord-005453-4057qib7	3153	6	days	day	NNS
cord-005453-4057qib7	3153	7	after	after	IN
cord-005453-4057qib7	3153	8	HSCT	HSCT	NNP
cord-005453-4057qib7	3153	9	with	with	IN
cord-005453-4057qib7	3153	10	25	25	CD
cord-005453-4057qib7	3153	11	mg	mg	NNP
cord-005453-4057qib7	3153	12	daily	daily	RB
cord-005453-4057qib7	3153	13	and	and	CC
cord-005453-4057qib7	3153	14	increased	increase	VBD
cord-005453-4057qib7	3153	15	dose	dose	NN
cord-005453-4057qib7	3153	16	to	to	IN
cord-005453-4057qib7	3153	17	125	125	CD
cord-005453-4057qib7	3153	18	mg	mg	NNP
cord-005453-4057qib7	3153	19	daily	daily	RB
cord-005453-4057qib7	3153	20	,	,	,
cord-005453-4057qib7	3153	21	with	with	IN
cord-005453-4057qib7	3153	22	complete	complete	JJ
cord-005453-4057qib7	3153	23	recovery	recovery	NN
cord-005453-4057qib7	3153	24	of	of	IN
cord-005453-4057qib7	3153	25	PBC	PBC	NNP
cord-005453-4057qib7	3153	26	6	6	CD
cord-005453-4057qib7	3153	27	months	month	NNS
cord-005453-4057qib7	3153	28	after	after	IN
cord-005453-4057qib7	3153	29	initiating	initiate	VBG
cord-005453-4057qib7	3153	30	TRA	TRA	NNP
cord-005453-4057qib7	3153	31	.	.	.
cord-005453-4057qib7	3154	1	The	the	DT
cord-005453-4057qib7	3154	2	second	second	JJ
cord-005453-4057qib7	3154	3	patient	patient	NN
cord-005453-4057qib7	3154	4	started	start	VBD
cord-005453-4057qib7	3154	5	treatment	treatment	NN
cord-005453-4057qib7	3154	6	110	110	CD
cord-005453-4057qib7	3154	7	days	day	NNS
cord-005453-4057qib7	3154	8	after	after	IN
cord-005453-4057qib7	3154	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3154	10	with	with	IN
cord-005453-4057qib7	3154	11	25	25	CD
cord-005453-4057qib7	3154	12	mg	mg	NNP
cord-005453-4057qib7	3154	13	daily	daily	RB
cord-005453-4057qib7	3154	14	and	and	CC
cord-005453-4057qib7	3154	15	increased	increase	VBD
cord-005453-4057qib7	3154	16	dose	dose	NN
cord-005453-4057qib7	3154	17	to	to	IN
cord-005453-4057qib7	3154	18	100	100	CD
cord-005453-4057qib7	3154	19	mg	mg	NNP
cord-005453-4057qib7	3154	20	daily	daily	RB
cord-005453-4057qib7	3154	21	,	,	,
cord-005453-4057qib7	3154	22	with	with	IN
cord-005453-4057qib7	3154	23	complete	complete	JJ
cord-005453-4057qib7	3154	24	recovery	recovery	NN
cord-005453-4057qib7	3154	25	of	of	IN
cord-005453-4057qib7	3154	26	PBC	PBC	NNP
cord-005453-4057qib7	3154	27	2	2	CD
cord-005453-4057qib7	3154	28	months	month	NNS
cord-005453-4057qib7	3154	29	after	after	IN
cord-005453-4057qib7	3154	30	initiating	initiate	VBG
cord-005453-4057qib7	3154	31	TRA	TRA	NNP
cord-005453-4057qib7	3154	32	.	.	.
cord-005453-4057qib7	3155	1	Twenty	twenty	CD
cord-005453-4057qib7	3155	2	one	one	CD
cord-005453-4057qib7	3155	3	patients	patient	NNS
cord-005453-4057qib7	3155	4	(	(	-LRB-
cord-005453-4057qib7	3155	5	67	67	CD
cord-005453-4057qib7	3155	6	%	%	NN
cord-005453-4057qib7	3155	7	)	)	-RRB-
cord-005453-4057qib7	3155	8	with	with	IN
cord-005453-4057qib7	3155	9	PGF	PGF	NNP
cord-005453-4057qib7	3155	10	diagnosis	diagnosis	NN
cord-005453-4057qib7	3155	11	had	have	VBD
cord-005453-4057qib7	3155	12	long	long	JJ
cord-005453-4057qib7	3155	13	term	term	NN
cord-005453-4057qib7	3155	14	survival	survival	NN
cord-005453-4057qib7	3155	15	.	.	.
cord-005453-4057qib7	3156	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3156	2	:	:	:
cord-005453-4057qib7	3157	1	Poor	poor	JJ
cord-005453-4057qib7	3157	2	graft	graft	NN
cord-005453-4057qib7	3157	3	function	function	NN
cord-005453-4057qib7	3157	4	is	be	VBZ
cord-005453-4057qib7	3157	5	a	a	DT
cord-005453-4057qib7	3157	6	frequent	frequent	JJ
cord-005453-4057qib7	3157	7	complication	complication	NN
cord-005453-4057qib7	3157	8	after	after	IN
cord-005453-4057qib7	3157	9	Haplo	Haplo	NNP
cord-005453-4057qib7	3157	10	-	-	HYPH
cord-005453-4057qib7	3157	11	SCT	SCT	NNP
cord-005453-4057qib7	3157	12	with	with	IN
cord-005453-4057qib7	3157	13	Cy	Cy	NNP
cord-005453-4057qib7	3157	14	-	-	HYPH
cord-005453-4057qib7	3157	15	post	post	NNP
cord-005453-4057qib7	3157	16	.	.	.
cord-005453-4057qib7	3158	1	CMV	CMV	NNP
cord-005453-4057qib7	3158	2	reactivation	reactivation	NN
cord-005453-4057qib7	3158	3	and	and	CC
cord-005453-4057qib7	3158	4	myelotoxic	myelotoxic	JJ
cord-005453-4057qib7	3158	5	drugs	drug	NNS
cord-005453-4057qib7	3158	6	could	could	MD
cord-005453-4057qib7	3158	7	be	be	VB
cord-005453-4057qib7	3158	8	the	the	DT
cord-005453-4057qib7	3158	9	most	most	RBS
cord-005453-4057qib7	3158	10	relevant	relevant	JJ
cord-005453-4057qib7	3158	11	factors	factor	NNS
cord-005453-4057qib7	3158	12	associated	associate	VBN
cord-005453-4057qib7	3158	13	with	with	IN
cord-005453-4057qib7	3158	14	development	development	NN
cord-005453-4057qib7	3158	15	of	of	IN
cord-005453-4057qib7	3158	16	this	this	DT
cord-005453-4057qib7	3158	17	entity	entity	NN
cord-005453-4057qib7	3158	18	.	.	.
cord-005453-4057qib7	3159	1	Although	although	IN
cord-005453-4057qib7	3159	2	most	most	JJS
cord-005453-4057qib7	3159	3	patients	patient	NNS
cord-005453-4057qib7	3159	4	recover	recover	VBP
cord-005453-4057qib7	3159	5	PBC	PBC	NNP
cord-005453-4057qib7	3159	6	without	without	IN
cord-005453-4057qib7	3159	7	specific	specific	JJ
cord-005453-4057qib7	3159	8	therapies	therapy	NNS
cord-005453-4057qib7	3159	9	beyond	beyond	IN
cord-005453-4057qib7	3159	10	G	G	NNP
cord-005453-4057qib7	3159	11	-	-	HYPH
cord-005453-4057qib7	3159	12	CSF	csf	NN
cord-005453-4057qib7	3159	13	and	and	CC
cord-005453-4057qib7	3159	14	platelets	platelet	NNS
cord-005453-4057qib7	3159	15	transfusion	transfusion	NN
cord-005453-4057qib7	3159	16	,	,	,
cord-005453-4057qib7	3159	17	there	there	EX
cord-005453-4057qib7	3159	18	is	be	VBZ
cord-005453-4057qib7	3159	19	a	a	DT
cord-005453-4057qib7	3159	20	small	small	JJ
cord-005453-4057qib7	3159	21	group	group	NN
cord-005453-4057qib7	3159	22	of	of	IN
cord-005453-4057qib7	3159	23	patients	patient	NNS
cord-005453-4057qib7	3159	24	with	with	IN
cord-005453-4057qib7	3159	25	persistent	persistent	JJ
cord-005453-4057qib7	3159	26	cytopenias	cytopenia	NNS
cord-005453-4057qib7	3159	27	.	.	.
cord-005453-4057qib7	3160	1	Boost	boost	NN
cord-005453-4057qib7	3160	2	of	of	IN
cord-005453-4057qib7	3160	3	CD34	CD34	NNP
cord-005453-4057qib7	3160	4	+	+	SYM
cord-005453-4057qib7	3160	5	selected	select	VBN
cord-005453-4057qib7	3160	6	cells	cell	NNS
cord-005453-4057qib7	3160	7	is	be	VBZ
cord-005453-4057qib7	3160	8	effective	effective	JJ
cord-005453-4057qib7	3160	9	in	in	IN
cord-005453-4057qib7	3160	10	reverting	revert	VBG
cord-005453-4057qib7	3160	11	this	this	DT
cord-005453-4057qib7	3160	12	condition	condition	NN
cord-005453-4057qib7	3160	13	,	,	,
cord-005453-4057qib7	3160	14	with	with	IN
cord-005453-4057qib7	3160	15	GVHD	GVHD	NNP
cord-005453-4057qib7	3160	16	as	as	IN
cord-005453-4057qib7	3160	17	main	main	JJ
cord-005453-4057qib7	3160	18	complication	complication	NN
cord-005453-4057qib7	3160	19	of	of	IN
cord-005453-4057qib7	3160	20	this	this	DT
cord-005453-4057qib7	3160	21	procedure	procedure	NN
cord-005453-4057qib7	3160	22	.	.	.
cord-005453-4057qib7	3161	1	Use	Use	NNP
cord-005453-4057qib7	3161	2	of	of	IN
cord-005453-4057qib7	3161	3	TRA	TRA	NNP
cord-005453-4057qib7	3161	4	seems	seem	VBZ
cord-005453-4057qib7	3161	5	to	to	TO
cord-005453-4057qib7	3161	6	be	be	VB
cord-005453-4057qib7	3161	7	an	an	DT
cord-005453-4057qib7	3161	8	interesting	interesting	JJ
cord-005453-4057qib7	3161	9	option	option	NN
cord-005453-4057qib7	3161	10	for	for	IN
cord-005453-4057qib7	3161	11	these	these	DT
cord-005453-4057qib7	3161	12	patients	patient	NNS
cord-005453-4057qib7	3161	13	,	,	,
cord-005453-4057qib7	3161	14	although	although	IN
cord-005453-4057qib7	3161	15	more	more	JJR
cord-005453-4057qib7	3161	16	experience	experience	NN
cord-005453-4057qib7	3161	17	is	be	VBZ
cord-005453-4057qib7	3161	18	needed	need	VBN
cord-005453-4057qib7	3161	19	to	to	TO
cord-005453-4057qib7	3161	20	draw	draw	VB
cord-005453-4057qib7	3161	21	definitive	definitive	JJ
cord-005453-4057qib7	3161	22	conclusions	conclusion	NNS
cord-005453-4057qib7	3161	23	.	.	.
cord-005453-4057qib7	3162	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3162	2	:	:	:
cord-005453-4057qib7	3162	3	Nothing	nothing	NN
cord-005453-4057qib7	3162	4	to	to	TO
cord-005453-4057qib7	3162	5	declare	declare	VB
cord-005453-4057qib7	3162	6	.	.	.
cord-005453-4057qib7	3163	1	were	be	VBD
cord-005453-4057qib7	3163	2	also	also	RB
cord-005453-4057qib7	3163	3	frequently	frequently	RB
cord-005453-4057qib7	3163	4	observed	observe	VBN
cord-005453-4057qib7	3163	5	.	.	.
cord-005453-4057qib7	3164	1	The	the	DT
cord-005453-4057qib7	3164	2	high	high	JJ
cord-005453-4057qib7	3164	3	risk	risk	NN
cord-005453-4057qib7	3164	4	patients	patient	NNS
cord-005453-4057qib7	3164	5	for	for	IN
cord-005453-4057qib7	3164	6	anxiety	anxiety	NN
cord-005453-4057qib7	3164	7	(	(	-LRB-
cord-005453-4057qib7	3164	8	HADS	HADS	NNP
cord-005453-4057qib7	3164	9	-	-	HYPH
cord-005453-4057qib7	3164	10	A	a	DT
cord-005453-4057qib7	3164	11	score	score	NN
cord-005453-4057qib7	3164	12	≥	≥	CD
cord-005453-4057qib7	3164	13	8)	8)	NN
cord-005453-4057qib7	3164	14	and	and	CC
cord-005453-4057qib7	3164	15	depression	depression	NN
cord-005453-4057qib7	3164	16	(	(	-LRB-
cord-005453-4057qib7	3164	17	HADS	HADS	NNP
cord-005453-4057qib7	3164	18	-	-	HYPH
cord-005453-4057qib7	3164	19	D	d	JJ
cord-005453-4057qib7	3164	20	score	score	NN
cord-005453-4057qib7	3164	21	≥	≥	CD
cord-005453-4057qib7	3164	22	8)	8)	NN
cord-005453-4057qib7	3164	23	was	be	VBD
cord-005453-4057qib7	3164	24	found	find	VBN
cord-005453-4057qib7	3164	25	in	in	IN
cord-005453-4057qib7	3164	26	14.9	14.9	CD
cord-005453-4057qib7	3164	27	%	%	NN
cord-005453-4057qib7	3164	28	and	and	CC
cord-005453-4057qib7	3164	29	13.6	13.6	CD
cord-005453-4057qib7	3164	30	%	%	NN
cord-005453-4057qib7	3164	31	,	,	,
cord-005453-4057qib7	3164	32	respectively	respectively	RB
cord-005453-4057qib7	3164	33	.	.	.
cord-005453-4057qib7	3165	1	10.4	10.4	CD
cord-005453-4057qib7	3165	2	%	%	NN
cord-005453-4057qib7	3165	3	of	of	IN
cord-005453-4057qib7	3165	4	patients	patient	NNS
cord-005453-4057qib7	3165	5	was	be	VBD
cord-005453-4057qib7	3165	6	in	in	IN
cord-005453-4057qib7	3165	7	high	high	JJ
cord-005453-4057qib7	3165	8	distress	distress	NN
cord-005453-4057qib7	3165	9	status	status	NN
cord-005453-4057qib7	3165	10	(	(	-LRB-
cord-005453-4057qib7	3165	11	NCCN	NCCN	NNP
cord-005453-4057qib7	3165	12	DT	DT	NNP
cord-005453-4057qib7	3165	13	score	score	NN
cord-005453-4057qib7	3165	14	≥	≥	CD
cord-005453-4057qib7	3165	15	4	4	CD
cord-005453-4057qib7	3165	16	)	)	-RRB-
cord-005453-4057qib7	3165	17	.	.	.
cord-005453-4057qib7	3166	1	We	-PRON-	PRP
cord-005453-4057qib7	3166	2	found	find	VBD
cord-005453-4057qib7	3166	3	that	that	IN
cord-005453-4057qib7	3166	4	younger	young	JJR
cord-005453-4057qib7	3166	5	age	age	NN
cord-005453-4057qib7	3166	6	(	(	-LRB-
cord-005453-4057qib7	3166	7	<	<	XX
cord-005453-4057qib7	3166	8	60	60	CD
cord-005453-4057qib7	3166	9	years	year	NNS
cord-005453-4057qib7	3166	10	)	)	-RRB-
cord-005453-4057qib7	3166	11	was	be	VBD
cord-005453-4057qib7	3166	12	significantly	significantly	RB
cord-005453-4057qib7	3166	13	associated	associate	VBN
cord-005453-4057qib7	3166	14	with	with	IN
cord-005453-4057qib7	3166	15	poor	poor	JJ
cord-005453-4057qib7	3166	16	quality	quality	NN
cord-005453-4057qib7	3166	17	of	of	IN
cord-005453-4057qib7	3166	18	life	life	NN
cord-005453-4057qib7	3166	19	score	score	NN
cord-005453-4057qib7	3166	20	(	(	-LRB-
cord-005453-4057qib7	3166	21	FACT	fact	NN
cord-005453-4057qib7	3166	22	-	-	HYPH
cord-005453-4057qib7	3166	23	BMT	BMT	NNP
cord-005453-4057qib7	3166	24	)	)	-RRB-
cord-005453-4057qib7	3167	1	(	(	-LRB-
cord-005453-4057qib7	3167	2	P=0.001	P=0.001	NNP
cord-005453-4057qib7	3167	3	)	)	-RRB-
cord-005453-4057qib7	3167	4	and	and	CC
cord-005453-4057qib7	3167	5	high	high	JJ
cord-005453-4057qib7	3167	6	risk	risk	NN
cord-005453-4057qib7	3167	7	of	of	IN
cord-005453-4057qib7	3167	8	fatigue	fatigue	NN
cord-005453-4057qib7	3167	9	(	(	-LRB-
cord-005453-4057qib7	3167	10	P=0.008	P=0.008	NNP
cord-005453-4057qib7	3167	11	)	)	-RRB-
cord-005453-4057qib7	3167	12	,	,	,
cord-005453-4057qib7	3167	13	anxiety	anxiety	NN
cord-005453-4057qib7	3167	14	(	(	-LRB-
cord-005453-4057qib7	3167	15	HADS	HADS	NNP
cord-005453-4057qib7	3167	16	-	-	HYPH
cord-005453-4057qib7	3167	17	A	A	NNP
cord-005453-4057qib7	3167	18	)	)	-RRB-
cord-005453-4057qib7	3167	19	(	(	-LRB-
cord-005453-4057qib7	3167	20	P=0.001	P=0.001	NNP
cord-005453-4057qib7	3167	21	)	)	-RRB-
cord-005453-4057qib7	3167	22	,	,	,
cord-005453-4057qib7	3167	23	and	and	CC
cord-005453-4057qib7	3167	24	depression	depression	NN
cord-005453-4057qib7	3167	25	(	(	-LRB-
cord-005453-4057qib7	3167	26	HADS	HADS	NNP
cord-005453-4057qib7	3167	27	-	-	HYPH
cord-005453-4057qib7	3167	28	D	D	NNP
cord-005453-4057qib7	3167	29	)	)	-RRB-
cord-005453-4057qib7	3167	30	(	(	-LRB-
cord-005453-4057qib7	3167	31	P=0.025	P=0.025	NNP
cord-005453-4057qib7	3167	32	)	)	-RRB-
cord-005453-4057qib7	3167	33	.	.	.
cord-005453-4057qib7	3168	1	Female	female	JJ
cord-005453-4057qib7	3168	2	sex	sex	NN
cord-005453-4057qib7	3168	3	was	be	VBD
cord-005453-4057qib7	3168	4	significantly	significantly	RB
cord-005453-4057qib7	3168	5	related	relate	VBN
cord-005453-4057qib7	3168	6	to	to	IN
cord-005453-4057qib7	3168	7	lower	low	JJR
cord-005453-4057qib7	3168	8	physical	physical	JJ
cord-005453-4057qib7	3168	9	well	well	RB
cord-005453-4057qib7	3168	10	-	-	HYPH
cord-005453-4057qib7	3168	11	being	be	VBG
cord-005453-4057qib7	3168	12	score	score	NN
cord-005453-4057qib7	3168	13	and	and	CC
cord-005453-4057qib7	3168	14	higher	high	JJR
cord-005453-4057qib7	3168	15	distress	distress	NN
cord-005453-4057qib7	3168	16	score	score	NN
cord-005453-4057qib7	3168	17	(	(	-LRB-
cord-005453-4057qib7	3168	18	P=	p=	NN
cord-005453-4057qib7	3168	19	0.046	0.046	CD
cord-005453-4057qib7	3168	20	and	and	CC
cord-005453-4057qib7	3168	21	P=0.05	P=0.05	NNS
cord-005453-4057qib7	3168	22	,	,	,
cord-005453-4057qib7	3168	23	respectively	respectively	RB
cord-005453-4057qib7	3168	24	)	)	-RRB-
cord-005453-4057qib7	3168	25	.	.	.
cord-005453-4057qib7	3169	1	Acute	acute	JJ
cord-005453-4057qib7	3169	2	lymphoblast	lymphoblast	NN
cord-005453-4057qib7	3169	3	leukemia	leukemia	NN
cord-005453-4057qib7	3169	4	(	(	-LRB-
cord-005453-4057qib7	3169	5	ALL	all	DT
cord-005453-4057qib7	3169	6	)	)	-RRB-
cord-005453-4057qib7	3169	7	survivors	survivor	NNS
cord-005453-4057qib7	3169	8	after	after	IN
cord-005453-4057qib7	3169	9	allo	allo	NN
cord-005453-4057qib7	3169	10	-	-	HYPH
cord-005453-4057qib7	3169	11	HCT	HCT	NNP
cord-005453-4057qib7	3169	12	showed	show	VBD
cord-005453-4057qib7	3169	13	significantly	significantly	RB
cord-005453-4057qib7	3169	14	worse	bad	JJR
cord-005453-4057qib7	3169	15	quality	quality	NN
cord-005453-4057qib7	3169	16	of	of	IN
cord-005453-4057qib7	3169	17	life	life	NN
cord-005453-4057qib7	3169	18	score	score	NN
cord-005453-4057qib7	3169	19	(	(	-LRB-
cord-005453-4057qib7	3169	20	FACT	fact	NN
cord-005453-4057qib7	3169	21	-	-	HYPH
cord-005453-4057qib7	3169	22	BMT	BMT	NNP
cord-005453-4057qib7	3169	23	)	)	-RRB-
cord-005453-4057qib7	3170	1	(	(	-LRB-
cord-005453-4057qib7	3170	2	P=0.006	P=0.006	NNP
cord-005453-4057qib7	3170	3	)	)	-RRB-
cord-005453-4057qib7	3170	4	and	and	CC
cord-005453-4057qib7	3170	5	higher	high	JJR
cord-005453-4057qib7	3170	6	depression	depression	NN
cord-005453-4057qib7	3170	7	score	score	NN
cord-005453-4057qib7	3170	8	(	(	-LRB-
cord-005453-4057qib7	3170	9	HADS	HADS	NNP
cord-005453-4057qib7	3170	10	-	-	HYPH
cord-005453-4057qib7	3170	11	D	D	NNP
cord-005453-4057qib7	3170	12	)	)	-RRB-
cord-005453-4057qib7	3170	13	(	(	-LRB-
cord-005453-4057qib7	3170	14	P=0.028	p=0.028	NN
cord-005453-4057qib7	3170	15	)	)	-RRB-
cord-005453-4057qib7	3170	16	compared	compare	VBN
cord-005453-4057qib7	3170	17	to	to	IN
cord-005453-4057qib7	3170	18	those	those	DT
cord-005453-4057qib7	3170	19	with	with	IN
cord-005453-4057qib7	3170	20	other	other	JJ
cord-005453-4057qib7	3170	21	disease	disease	NN
cord-005453-4057qib7	3170	22	.	.	.
cord-005453-4057qib7	3171	1	Chronic	chronic	JJ
cord-005453-4057qib7	3171	2	graft	graft	NN
cord-005453-4057qib7	3171	3	versus	versus	IN
cord-005453-4057qib7	3171	4	host	host	NN
cord-005453-4057qib7	3171	5	disease	disease	NN
cord-005453-4057qib7	3171	6	(	(	-LRB-
cord-005453-4057qib7	3171	7	GVHD	GVHD	NNP
cord-005453-4057qib7	3171	8	)	)	-RRB-
cord-005453-4057qib7	3171	9	and	and	CC
cord-005453-4057qib7	3171	10	continuous	continuous	JJ
cord-005453-4057qib7	3171	11	immunosuppressant	immunosuppressant	JJ
cord-005453-4057qib7	3171	12	usage	usage	NN
cord-005453-4057qib7	3171	13	also	also	RB
cord-005453-4057qib7	3171	14	have	have	VBP
cord-005453-4057qib7	3171	15	significant	significant	JJ
cord-005453-4057qib7	3171	16	adverse	adverse	JJ
cord-005453-4057qib7	3171	17	impact	impact	NN
cord-005453-4057qib7	3171	18	on	on	IN
cord-005453-4057qib7	3171	19	lower	low	JJR
cord-005453-4057qib7	3171	20	FACT	fact	NN
cord-005453-4057qib7	3171	21	-	-	HYPH
cord-005453-4057qib7	3171	22	BMT	BMT	NNP
cord-005453-4057qib7	3171	23	score	score	NN
cord-005453-4057qib7	3171	24	(	(	-LRB-
cord-005453-4057qib7	3171	25	P=0.024	P=0.024	NNP
cord-005453-4057qib7	3171	26	and	and	CC
cord-005453-4057qib7	3171	27	P=0.033	P=0.033	NNP
cord-005453-4057qib7	3171	28	,	,	,
cord-005453-4057qib7	3171	29	respectively	respectively	RB
cord-005453-4057qib7	3171	30	)	)	-RRB-
cord-005453-4057qib7	3171	31	and	and	CC
cord-005453-4057qib7	3171	32	higher	high	JJR
cord-005453-4057qib7	3171	33	HADS	HADS	NNP
cord-005453-4057qib7	3171	34	-	-	HYPH
cord-005453-4057qib7	3171	35	D	d	JJ
cord-005453-4057qib7	3171	36	score	score	NN
cord-005453-4057qib7	3171	37	(	(	-LRB-
cord-005453-4057qib7	3171	38	P=0.015	P=0.015	NNP
cord-005453-4057qib7	3171	39	and	and	CC
cord-005453-4057qib7	3171	40	P=0.019	P=0.019	NNP
cord-005453-4057qib7	3171	41	,	,	,
cord-005453-4057qib7	3171	42	respectively	respectively	RB
cord-005453-4057qib7	3171	43	)	)	-RRB-
cord-005453-4057qib7	3171	44	.	.	.
cord-005453-4057qib7	3172	1	But	but	CC
cord-005453-4057qib7	3172	2	there	there	EX
cord-005453-4057qib7	3172	3	was	be	VBD
cord-005453-4057qib7	3172	4	no	no	DT
cord-005453-4057qib7	3172	5	significant	significant	JJ
cord-005453-4057qib7	3172	6	difference	difference	NN
cord-005453-4057qib7	3172	7	in	in	IN
cord-005453-4057qib7	3172	8	FACT	fact	NN
cord-005453-4057qib7	3173	1	BMT	BMT	NNP
cord-005453-4057qib7	3173	2	,	,	,
cord-005453-4057qib7	3173	3	HADS	HADS	NNP
cord-005453-4057qib7	3173	4	-	-	HYPH
cord-005453-4057qib7	3173	5	A	A	NNP
cord-005453-4057qib7	3173	6	,	,	,
cord-005453-4057qib7	3173	7	HADS	HADS	NNP
cord-005453-4057qib7	3173	8	-	-	HYPH
cord-005453-4057qib7	3173	9	D	D	NNP
cord-005453-4057qib7	3173	10	,	,	,
cord-005453-4057qib7	3173	11	NCCN	NCCN	NNP
cord-005453-4057qib7	3173	12	DT	DT	NNP
cord-005453-4057qib7	3173	13	according	accord	VBG
cord-005453-4057qib7	3173	14	to	to	IN
cord-005453-4057qib7	3173	15	donor	donor	NN
cord-005453-4057qib7	3173	16	type	type	NN
cord-005453-4057qib7	3173	17	,	,	,
cord-005453-4057qib7	3173	18	conditioning	conditioning	NN
cord-005453-4057qib7	3173	19	intensity	intensity	NN
cord-005453-4057qib7	3173	20	,	,	,
cord-005453-4057qib7	3173	21	anti	anti	JJ
cord-005453-4057qib7	3173	22	-	-	JJ
cord-005453-4057qib7	3173	23	thymocyte	thymocyte	JJ
cord-005453-4057qib7	3173	24	globulin	globulin	NN
cord-005453-4057qib7	3173	25	use	use	NN
cord-005453-4057qib7	3173	26	,	,	,
cord-005453-4057qib7	3173	27	acute	acute	JJ
cord-005453-4057qib7	3173	28	GVHD	GVHD	NNP
cord-005453-4057qib7	3173	29	.	.	.
cord-005453-4057qib7	3174	1	Smoking	smoking	NN
cord-005453-4057qib7	3174	2	and	and	CC
cord-005453-4057qib7	3174	3	alcohol	alcohol	NN
cord-005453-4057qib7	3174	4	drinking	drinking	NN
cord-005453-4057qib7	3174	5	was	be	VBD
cord-005453-4057qib7	3174	6	continued	continue	VBN
cord-005453-4057qib7	3174	7	in	in	IN
cord-005453-4057qib7	3174	8	7.5	7.5	CD
cord-005453-4057qib7	3174	9	%	%	NN
cord-005453-4057qib7	3174	10	and	and	CC
cord-005453-4057qib7	3174	11	17.9	17.9	CD
cord-005453-4057qib7	3174	12	%	%	NN
cord-005453-4057qib7	3174	13	of	of	IN
cord-005453-4057qib7	3174	14	allo	allo	NN
cord-005453-4057qib7	3174	15	-	-	HYPH
cord-005453-4057qib7	3174	16	HCT	hct	NN
cord-005453-4057qib7	3174	17	survivors	survivor	NNS
cord-005453-4057qib7	3174	18	.	.	.
cord-005453-4057qib7	3175	1	20.9	20.9	CD
cord-005453-4057qib7	3175	2	%	%	NN
cord-005453-4057qib7	3175	3	of	of	IN
cord-005453-4057qib7	3175	4	survivors	survivor	NNS
cord-005453-4057qib7	3175	5	did	do	VBD
cord-005453-4057qib7	3175	6	not	not	RB
cord-005453-4057qib7	3175	7	exercise	exercise	VB
cord-005453-4057qib7	3175	8	regularly	regularly	RB
cord-005453-4057qib7	3175	9	.	.	.
cord-005453-4057qib7	3176	1	Regular	regular	JJ
cord-005453-4057qib7	3176	2	health	health	NN
cord-005453-4057qib7	3176	3	screening	screening	NN
cord-005453-4057qib7	3176	4	tests	test	NNS
cord-005453-4057qib7	3176	5	have	have	VBP
cord-005453-4057qib7	3176	6	been	be	VBN
cord-005453-4057qib7	3176	7	done	do	VBN
cord-005453-4057qib7	3176	8	only	only	RB
cord-005453-4057qib7	3176	9	in	in	IN
cord-005453-4057qib7	3176	10	40	40	CD
cord-005453-4057qib7	3176	11	patients	patient	NNS
cord-005453-4057qib7	3176	12	(	(	-LRB-
cord-005453-4057qib7	3176	13	59.7	59.7	CD
cord-005453-4057qib7	3176	14	%	%	NN
cord-005453-4057qib7	3176	15	)	)	-RRB-
cord-005453-4057qib7	3176	16	.	.	.
cord-005453-4057qib7	3177	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3177	2	:	:	:
cord-005453-4057qib7	3178	1	Allo	Allo	NNP
cord-005453-4057qib7	3178	2	-	-	HYPH
cord-005453-4057qib7	3178	3	HCT	hct	NN
cord-005453-4057qib7	3178	4	survivors	survivor	NNS
cord-005453-4057qib7	3178	5	over	over	IN
cord-005453-4057qib7	3178	6	2	2	CD
cord-005453-4057qib7	3178	7	years	year	NNS
cord-005453-4057qib7	3178	8	following	follow	VBG
cord-005453-4057qib7	3178	9	allo	allo	NN
cord-005453-4057qib7	3178	10	-	-	HYPH
cord-005453-4057qib7	3178	11	HCT	hct	NN
cord-005453-4057qib7	3178	12	still	still	RB
cord-005453-4057qib7	3178	13	have	have	VBP
cord-005453-4057qib7	3178	14	many	many	JJ
cord-005453-4057qib7	3178	15	physical	physical	JJ
cord-005453-4057qib7	3178	16	and	and	CC
cord-005453-4057qib7	3178	17	psychological	psychological	JJ
cord-005453-4057qib7	3178	18	symptoms	symptom	NNS
cord-005453-4057qib7	3178	19	.	.	.
cord-005453-4057qib7	3179	1	Younger	young	JJR
cord-005453-4057qib7	3179	2	patients	patient	NNS
cord-005453-4057qib7	3179	3	(	(	-LRB-
cord-005453-4057qib7	3179	4	<	<	XX
cord-005453-4057qib7	3179	5	60	60	CD
cord-005453-4057qib7	3179	6	years	year	NNS
cord-005453-4057qib7	3179	7	)	)	-RRB-
cord-005453-4057qib7	3179	8	,	,	,
cord-005453-4057qib7	3179	9	female	female	JJ
cord-005453-4057qib7	3179	10	,	,	,
cord-005453-4057qib7	3179	11	ALL	all	DT
cord-005453-4057qib7	3179	12	,	,	,
cord-005453-4057qib7	3179	13	chronic	chronic	JJ
cord-005453-4057qib7	3179	14	GVHD	GVHD	NNP
cord-005453-4057qib7	3179	15	,	,	,
cord-005453-4057qib7	3179	16	and	and	CC
cord-005453-4057qib7	3179	17	sustained	sustain	VBN
cord-005453-4057qib7	3179	18	use	use	NN
cord-005453-4057qib7	3179	19	of	of	IN
cord-005453-4057qib7	3179	20	immunosuppressant	immunosuppressant	JJ
cord-005453-4057qib7	3179	21	were	be	VBD
cord-005453-4057qib7	3179	22	significant	significant	JJ
cord-005453-4057qib7	3179	23	risk	risk	NN
cord-005453-4057qib7	3179	24	factors	factor	NNS
cord-005453-4057qib7	3179	25	for	for	IN
cord-005453-4057qib7	3179	26	poor	poor	JJ
cord-005453-4057qib7	3179	27	quality	quality	NN
cord-005453-4057qib7	3179	28	of	of	IN
cord-005453-4057qib7	3179	29	life	life	NN
cord-005453-4057qib7	3179	30	and	and	CC
cord-005453-4057qib7	3179	31	anxiety	anxiety	NN
cord-005453-4057qib7	3179	32	.	.	.
cord-005453-4057qib7	3180	1	We	-PRON-	PRP
cord-005453-4057qib7	3180	2	need	need	VBP
cord-005453-4057qib7	3180	3	to	to	TO
cord-005453-4057qib7	3180	4	build	build	VB
cord-005453-4057qib7	3180	5	more	more	RBR
cord-005453-4057qib7	3180	6	active	active	JJ
cord-005453-4057qib7	3180	7	survivorship	survivorship	NN
cord-005453-4057qib7	3180	8	care	care	NN
cord-005453-4057qib7	3180	9	plan	plan	NN
cord-005453-4057qib7	3180	10	after	after	IN
cord-005453-4057qib7	3180	11	allo	allo	NN
cord-005453-4057qib7	3180	12	-	-	HYPH
cord-005453-4057qib7	3180	13	HCT	HCT	NNP
cord-005453-4057qib7	3180	14	especially	especially	RB
cord-005453-4057qib7	3180	15	for	for	IN
cord-005453-4057qib7	3180	16	those	those	DT
cord-005453-4057qib7	3180	17	patients	patient	NNS
cord-005453-4057qib7	3180	18	.	.	.
cord-005453-4057qib7	3181	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3181	2	:	:	:
cord-005453-4057qib7	3182	1	All	all	DT
cord-005453-4057qib7	3182	2	authors	author	NNS
cord-005453-4057qib7	3182	3	have	have	VBP
cord-005453-4057qib7	3182	4	nothing	nothing	NN
cord-005453-4057qib7	3182	5	to	to	TO
cord-005453-4057qib7	3182	6	declare	declare	VB
cord-005453-4057qib7	3182	7	.	.	.
cord-005453-4057qib7	3183	1	Evaluation	evaluation	NN
cord-005453-4057qib7	3183	2	of	of	IN
cord-005453-4057qib7	3183	3	the	the	DT
cord-005453-4057qib7	3183	4	new	new	JJ
cord-005453-4057qib7	3183	5	EBMT	EBMT	NNP
cord-005453-4057qib7	3183	6	criteria	criterion	NNS
cord-005453-4057qib7	3183	7	for	for	IN
cord-005453-4057qib7	3183	8	the	the	DT
cord-005453-4057qib7	3183	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	3183	10	of	of	IN
cord-005453-4057qib7	3183	11	VOD	VOD	NNP
cord-005453-4057qib7	3183	12	/	/	SYM
cord-005453-4057qib7	3183	13	SOS	SOS	NNP
cord-005453-4057qib7	3183	14	in	in	IN
cord-005453-4057qib7	3183	15	693	693	CD
cord-005453-4057qib7	3183	16	consecutive	consecutive	JJ
cord-005453-4057qib7	3183	17	transplant	transplant	NN
cord-005453-4057qib7	3183	18	patients	patient	NNS
cord-005453-4057qib7	3183	19	using	use	VBG
cord-005453-4057qib7	3183	20	an	an	DT
cord-005453-4057qib7	3183	21	electronic	electronic	JJ
cord-005453-4057qib7	3183	22	patient	patient	NN
cord-005453-4057qib7	3183	23	record	record	NN
cord-005453-4057qib7	3183	24	analysis	analysis	NN
cord-005453-4057qib7	3183	25	system	system	NN
cord-005453-4057qib7	3183	26	Asha	Asha	NNP
cord-005453-4057qib7	3183	27	Aggarwal	Aggarwal	NNP
cord-005453-4057qib7	3183	28	1	1	CD
cord-005453-4057qib7	3183	29	,	,	,
cord-005453-4057qib7	3183	30	Nicola	Nicola	NNP
cord-005453-4057qib7	3183	31	Gray	Gray	NNP
cord-005453-4057qib7	3183	32	1	1	CD
cord-005453-4057qib7	3183	33	,	,	,
cord-005453-4057qib7	3183	34	Oliver	Oliver	NNP
cord-005453-4057qib7	3183	35	Lomas	Lomas	NNP
cord-005453-4057qib7	3183	36	1	1	CD
cord-005453-4057qib7	3183	37	,	,	,
cord-005453-4057qib7	3183	38	Katalin	Katalin	NNP
cord-005453-4057qib7	3183	39	Balassa	Balassa	NNP
cord-005453-4057qib7	3183	40	1	1	CD
cord-005453-4057qib7	3183	41	,	,	,
cord-005453-4057qib7	3183	42	Nadjoua	Nadjoua	NNP
cord-005453-4057qib7	3183	43	Maouche	Maouche	NNP
cord-005453-4057qib7	3183	44	1	1	CD
cord-005453-4057qib7	3183	45	,	,	,
cord-005453-4057qib7	3183	46	Robert	Robert	NNP
cord-005453-4057qib7	3183	47	Danby	Danby	NNP
cord-005453-4057qib7	3183	48	1,2	1,2	CD
cord-005453-4057qib7	3183	49	,	,	,
cord-005453-4057qib7	3183	50	Andy	Andy	NNP
cord-005453-4057qib7	3183	51	Peniket	Peniket	NNP
cord-005453-4057qib7	3183	52	1	1	CD
cord-005453-4057qib7	3183	53	,	,	,
cord-005453-4057qib7	3183	54	Grant	Grant	NNP
cord-005453-4057qib7	3183	55	Vallance	Vallance	NNP
cord-005453-4057qib7	3183	56	1	1	CD
cord-005453-4057qib7	3183	57	Background	Background	NNP
cord-005453-4057qib7	3183	58	:	:	:
cord-005453-4057qib7	3183	59	Veno	Veno	NNP
cord-005453-4057qib7	3183	60	-	-	HYPH
cord-005453-4057qib7	3183	61	Occlusive	Occlusive	NNP
cord-005453-4057qib7	3183	62	disease	disease	NN
cord-005453-4057qib7	3183	63	(	(	-LRB-
cord-005453-4057qib7	3183	64	VOD	VOD	NNP
cord-005453-4057qib7	3183	65	)	)	-RRB-
cord-005453-4057qib7	3183	66	,	,	,
cord-005453-4057qib7	3183	67	or	or	CC
cord-005453-4057qib7	3183	68	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	3183	69	obstruction	obstruction	NN
cord-005453-4057qib7	3183	70	syndrome	syndrome	NN
cord-005453-4057qib7	3183	71	(	(	-LRB-
cord-005453-4057qib7	3183	72	SOS	SOS	NNP
cord-005453-4057qib7	3183	73	)	)	-RRB-
cord-005453-4057qib7	3183	74	,	,	,
cord-005453-4057qib7	3183	75	is	be	VBZ
cord-005453-4057qib7	3183	76	a	a	DT
cord-005453-4057qib7	3183	77	recognised	recognise	VBN
cord-005453-4057qib7	3183	78	complication	complication	NN
cord-005453-4057qib7	3183	79	of	of	IN
cord-005453-4057qib7	3183	80	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	3183	81	stem	stem	NN
cord-005453-4057qib7	3183	82	cell	cell	NN
cord-005453-4057qib7	3183	83	transplantation	transplantation	NN
cord-005453-4057qib7	3183	84	.	.	.
cord-005453-4057qib7	3184	1	Hepatic	hepatic	JJ
cord-005453-4057qib7	3184	2	vasculature	vasculature	NN
cord-005453-4057qib7	3184	3	endothelial	endothelial	JJ
cord-005453-4057qib7	3184	4	cells	cell	NNS
cord-005453-4057qib7	3184	5	are	be	VBP
cord-005453-4057qib7	3184	6	damaged	damage	VBN
cord-005453-4057qib7	3184	7	by	by	IN
cord-005453-4057qib7	3184	8	conditioning	conditioning	NN
cord-005453-4057qib7	3184	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3184	10	,	,	,
cord-005453-4057qib7	3184	11	leading	lead	VBG
cord-005453-4057qib7	3184	12	to	to	IN
cord-005453-4057qib7	3184	13	venous	venous	JJ
cord-005453-4057qib7	3184	14	occlusion	occlusion	NN
cord-005453-4057qib7	3184	15	and	and	CC
cord-005453-4057qib7	3184	16	centrilobar	centrilobar	NN
cord-005453-4057qib7	3184	17	necrosis	necrosis	NN
cord-005453-4057qib7	3184	18	.	.	.
cord-005453-4057qib7	3185	1	The	the	DT
cord-005453-4057qib7	3185	2	EBMT	EBMT	NNP
cord-005453-4057qib7	3185	3	criteria	criterion	NNS
cord-005453-4057qib7	3185	4	for	for	IN
cord-005453-4057qib7	3185	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	3185	6	of	of	IN
cord-005453-4057qib7	3185	7	VOD	VOD	NNP
cord-005453-4057qib7	3185	8	are	be	VBP
cord-005453-4057qib7	3185	9	bilirubin	bilirubin	NN
cord-005453-4057qib7	3185	10	>	>	XX
cord-005453-4057qib7	3185	11	=	=	SYM
cord-005453-4057qib7	3185	12	34	34	CD
cord-005453-4057qib7	3185	13	with	with	IN
cord-005453-4057qib7	3185	14	two	two	CD
cord-005453-4057qib7	3185	15	of	of	IN
cord-005453-4057qib7	3185	16	painful	painful	JJ
cord-005453-4057qib7	3185	17	hepatomegaly	hepatomegaly	NNP
cord-005453-4057qib7	3185	18	,	,	.
cord-005453-4057qib7	3186	1	>	>	XX
cord-005453-4057qib7	3186	2	5	5	CD
cord-005453-4057qib7	3186	3	%	%	NN
cord-005453-4057qib7	3186	4	weight	weight	NN
cord-005453-4057qib7	3186	5	gain	gain	NN
cord-005453-4057qib7	3186	6	and	and	CC
cord-005453-4057qib7	3186	7	ascites	ascites	NN
cord-005453-4057qib7	3186	8	.	.	.
cord-005453-4057qib7	3187	1	VOD	VOD	NNP
cord-005453-4057qib7	3187	2	is	be	VBZ
cord-005453-4057qib7	3187	3	often	often	RB
cord-005453-4057qib7	3187	4	under	under	RB
cord-005453-4057qib7	3187	5	-	-	HYPH
cord-005453-4057qib7	3187	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	3187	7	,	,	,
cord-005453-4057qib7	3187	8	and	and	CC
cord-005453-4057qib7	3187	9	as	as	IN
cord-005453-4057qib7	3187	10	a	a	DT
cord-005453-4057qib7	3187	11	result	result	NN
cord-005453-4057qib7	3187	12	,	,	,
cord-005453-4057qib7	3187	13	treatment	treatment	NN
cord-005453-4057qib7	3187	14	may	may	MD
cord-005453-4057qib7	3187	15	be	be	VB
cord-005453-4057qib7	3187	16	delayed	delay	VBN
cord-005453-4057qib7	3187	17	.	.	.
cord-005453-4057qib7	3188	1	Integrated	integrate	VBN
cord-005453-4057qib7	3188	2	electronic	electronic	JJ
cord-005453-4057qib7	3188	3	patient	patient	NN
cord-005453-4057qib7	3188	4	record	record	NN
cord-005453-4057qib7	3188	5	(	(	-LRB-
cord-005453-4057qib7	3188	6	EPR	EPR	NNP
cord-005453-4057qib7	3188	7	)	)	-RRB-
cord-005453-4057qib7	3188	8	systems	system	NNS
cord-005453-4057qib7	3188	9	are	be	VBP
cord-005453-4057qib7	3188	10	now	now	RB
cord-005453-4057qib7	3188	11	widely	widely	RB
cord-005453-4057qib7	3188	12	used	use	VBN
cord-005453-4057qib7	3188	13	,	,	,
cord-005453-4057qib7	3188	14	and	and	CC
cord-005453-4057qib7	3188	15	provide	provide	VB
cord-005453-4057qib7	3188	16	an	an	DT
cord-005453-4057qib7	3188	17	opportunity	opportunity	NN
cord-005453-4057qib7	3188	18	to	to	TO
cord-005453-4057qib7	3188	19	retrospectively	retrospectively	RB
cord-005453-4057qib7	3188	20	audit	audit	VB
cord-005453-4057qib7	3188	21	practice	practice	NN
cord-005453-4057qib7	3188	22	to	to	TO
cord-005453-4057qib7	3188	23	identify	identify	VB
cord-005453-4057qib7	3188	24	patients	patient	NNS
cord-005453-4057qib7	3188	25	in	in	IN
cord-005453-4057qib7	3188	26	whom	whom	WP
cord-005453-4057qib7	3188	27	VOD	VOD	NNP
cord-005453-4057qib7	3188	28	may	may	MD
cord-005453-4057qib7	3188	29	have	have	VB
cord-005453-4057qib7	3188	30	been	be	VBN
cord-005453-4057qib7	3188	31	un	un	NNP
cord-005453-4057qib7	3188	32	-	-	JJ
cord-005453-4057qib7	3188	33	diagnosed	diagnose	VBN
cord-005453-4057qib7	3188	34	or	or	CC
cord-005453-4057qib7	3188	35	in	in	IN
cord-005453-4057qib7	3188	36	whom	whom	WP
cord-005453-4057qib7	3188	37	treatment	treatment	NN
cord-005453-4057qib7	3188	38	was	be	VBD
cord-005453-4057qib7	3188	39	delayed	delay	VBN
cord-005453-4057qib7	3188	40	.	.	.
cord-005453-4057qib7	3189	1	In	in	IN
cord-005453-4057qib7	3189	2	addition	addition	NN
cord-005453-4057qib7	3189	3	these	these	DT
cord-005453-4057qib7	3189	4	systems	system	NNS
cord-005453-4057qib7	3189	5	have	have	VBP
cord-005453-4057qib7	3189	6	potential	potential	NN
cord-005453-4057qib7	3189	7	for	for	IN
cord-005453-4057qib7	3189	8	alerting	alert	VBG
cord-005453-4057qib7	3189	9	clinicians	clinician	NNS
cord-005453-4057qib7	3189	10	to	to	IN
cord-005453-4057qib7	3189	11	the	the	DT
cord-005453-4057qib7	3189	12	potential	potential	JJ
cord-005453-4057qib7	3189	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	3189	14	of	of	IN
cord-005453-4057qib7	3189	15	VOD	VOD	NNP
cord-005453-4057qib7	3189	16	.	.	.
cord-005453-4057qib7	3190	1	Methods	method	NNS
cord-005453-4057qib7	3190	2	:	:	:
cord-005453-4057qib7	3191	1	We	-PRON-	PRP
cord-005453-4057qib7	3191	2	have	have	VBP
cord-005453-4057qib7	3191	3	developed	develop	VBN
cord-005453-4057qib7	3191	4	software	software	NN
cord-005453-4057qib7	3191	5	to	to	TO
cord-005453-4057qib7	3191	6	analyse	analyse	VB
cord-005453-4057qib7	3191	7	the	the	DT
cord-005453-4057qib7	3191	8	data	datum	NNS
cord-005453-4057qib7	3191	9	downloaded	download	VBN
cord-005453-4057qib7	3191	10	from	from	IN
cord-005453-4057qib7	3191	11	EPR	EPR	NNP
cord-005453-4057qib7	3191	12	to	to	TO
cord-005453-4057qib7	3191	13	identify	identify	VB
cord-005453-4057qib7	3191	14	patients	patient	NNS
cord-005453-4057qib7	3191	15	in	in	IN
cord-005453-4057qib7	3191	16	whom	whom	WP
cord-005453-4057qib7	3191	17	VOD	VOD	NNP
cord-005453-4057qib7	3191	18	was	be	VBD
cord-005453-4057qib7	3191	19	a	a	DT
cord-005453-4057qib7	3191	20	possible	possible	JJ
cord-005453-4057qib7	3191	21	diagnosis	diagnosis	NN
cord-005453-4057qib7	3191	22	according	accord	VBG
cord-005453-4057qib7	3191	23	to	to	IN
cord-005453-4057qib7	3191	24	the	the	DT
cord-005453-4057qib7	3191	25	new	new	JJ
cord-005453-4057qib7	3191	26	EBMT	EBMT	NNP
cord-005453-4057qib7	3191	27	criteria	criterion	NNS
cord-005453-4057qib7	3191	28	.	.	.
cord-005453-4057qib7	3192	1	In	in	IN
cord-005453-4057qib7	3192	2	order	order	NN
cord-005453-4057qib7	3192	3	to	to	TO
cord-005453-4057qib7	3192	4	identify	identify	VB
cord-005453-4057qib7	3192	5	patients	patient	NNS
cord-005453-4057qib7	3192	6	who	who	WP
cord-005453-4057qib7	3192	7	may	may	MD
cord-005453-4057qib7	3192	8	have	have	VB
cord-005453-4057qib7	3192	9	had	have	VBN
cord-005453-4057qib7	3192	10	VOD	VOD	NNP
cord-005453-4057qib7	3192	11	we	-PRON-	PRP
cord-005453-4057qib7	3192	12	first	first	RB
cord-005453-4057qib7	3192	13	screened	screen	VBD
cord-005453-4057qib7	3192	14	for	for	IN
cord-005453-4057qib7	3192	15	patients	patient	NNS
cord-005453-4057qib7	3192	16	with	with	IN
cord-005453-4057qib7	3192	17	a	a	DT
cord-005453-4057qib7	3192	18	bilirubin	bilirubin	NN
cord-005453-4057qib7	3192	19	of	of	IN
cord-005453-4057qib7	3192	20	>	>	XX
cord-005453-4057qib7	3192	21	=	=	SYM
cord-005453-4057qib7	3192	22	34	34	CD
cord-005453-4057qib7	3192	23	mmol	mmol	NNP
cord-005453-4057qib7	3192	24	/	/	SYM
cord-005453-4057qib7	3192	25	l	l	NN
cord-005453-4057qib7	3192	26	(	(	-LRB-
cord-005453-4057qib7	3192	27	which	which	WDT
cord-005453-4057qib7	3192	28	is	be	VBZ
cord-005453-4057qib7	3192	29	an	an	DT
cord-005453-4057qib7	3192	30	absolute	absolute	JJ
cord-005453-4057qib7	3192	31	requirement	requirement	NN
cord-005453-4057qib7	3192	32	for	for	IN
cord-005453-4057qib7	3192	33	the	the	DT
cord-005453-4057qib7	3192	34	clinical	clinical	JJ
cord-005453-4057qib7	3192	35	diagnosis	diagnosis	NN
cord-005453-4057qib7	3192	36	of	of	IN
cord-005453-4057qib7	3192	37	VOD	VOD	NNP
cord-005453-4057qib7	3192	38	)	)	-RRB-
cord-005453-4057qib7	3192	39	within	within	IN
cord-005453-4057qib7	3192	40	the	the	DT
cord-005453-4057qib7	3192	41	first	first	JJ
cord-005453-4057qib7	3192	42	50	50	CD
cord-005453-4057qib7	3192	43	days	day	NNS
cord-005453-4057qib7	3192	44	of	of	IN
cord-005453-4057qib7	3192	45	transplantation	transplantation	NN
cord-005453-4057qib7	3192	46	.	.	.
cord-005453-4057qib7	3193	1	EPR	EPR	NNP
cord-005453-4057qib7	3193	2	data	datum	NNS
cord-005453-4057qib7	3193	3	was	be	VBD
cord-005453-4057qib7	3193	4	then	then	RB
cord-005453-4057qib7	3193	5	used	use	VBN
cord-005453-4057qib7	3193	6	to	to	TO
cord-005453-4057qib7	3193	7	assess	assess	VB
cord-005453-4057qib7	3193	8	whether	whether	IN
cord-005453-4057qib7	3193	9	patients	patient	NNS
cord-005453-4057qib7	3193	10	had	have	VBD
cord-005453-4057qib7	3193	11	>	>	$
cord-005453-4057qib7	3193	12	5	5	CD
cord-005453-4057qib7	3193	13	%	%	NN
cord-005453-4057qib7	3193	14	weight	weight	NN
cord-005453-4057qib7	3193	15	gain	gain	NN
cord-005453-4057qib7	3193	16	.	.	.
cord-005453-4057qib7	3194	1	Radiology	radiology	NN
cord-005453-4057qib7	3194	2	reports	report	NNS
cord-005453-4057qib7	3194	3	were	be	VBD
cord-005453-4057qib7	3194	4	reviewed	review	VBN
cord-005453-4057qib7	3194	5	for	for	IN
cord-005453-4057qib7	3194	6	patients	patient	NNS
cord-005453-4057qib7	3194	7	who	who	WP
cord-005453-4057qib7	3194	8	had	have	VBD
cord-005453-4057qib7	3194	9	bilirubin	bilirubin	NN
cord-005453-4057qib7	3194	10	>	>	XX
cord-005453-4057qib7	3194	11	=	=	SYM
cord-005453-4057qib7	3194	12	34	34	CD
cord-005453-4057qib7	3194	13	mmol	mmol	NNP
cord-005453-4057qib7	3194	14	/	/	SYM
cord-005453-4057qib7	3194	15	L	L	NNP
cord-005453-4057qib7	3194	16	to	to	TO
cord-005453-4057qib7	3194	17	ascertain	ascertain	VB
cord-005453-4057qib7	3194	18	if	if	IN
cord-005453-4057qib7	3194	19	they	-PRON-	PRP
cord-005453-4057qib7	3194	20	revealed	reveal	VBD
cord-005453-4057qib7	3194	21	ascites	ascite	NNS
cord-005453-4057qib7	3194	22	or	or	CC
cord-005453-4057qib7	3194	23	painful	painful	JJ
cord-005453-4057qib7	3194	24	hepatomegaly	hepatomegaly	NNS
cord-005453-4057qib7	3194	25	.	.	.
cord-005453-4057qib7	3195	1	Results	result	NNS
cord-005453-4057qib7	3195	2	:	:	:
cord-005453-4057qib7	3196	1	652	652	CD
cord-005453-4057qib7	3196	2	patients	patient	NNS
cord-005453-4057qib7	3196	3	underwent	undergo	VBD
cord-005453-4057qib7	3196	4	693	693	CD
cord-005453-4057qib7	3196	5	transplant	transplant	NN
cord-005453-4057qib7	3196	6	procedures	procedure	NNS
cord-005453-4057qib7	3196	7	(	(	-LRB-
cord-005453-4057qib7	3196	8	January	January	NNP
cord-005453-4057qib7	3196	9	1st	1st	NN
cord-005453-4057qib7	3196	10	2013	2013	CD
cord-005453-4057qib7	3196	11	to	to	IN
cord-005453-4057qib7	3196	12	July	July	NNP
cord-005453-4057qib7	3196	13	31st	31st	NN
cord-005453-4057qib7	3196	14	2018	2018	CD
cord-005453-4057qib7	3196	15	)	)	-RRB-
cord-005453-4057qib7	3196	16	.	.	.
cord-005453-4057qib7	3197	1	162	162	CD
cord-005453-4057qib7	3197	2	of	of	IN
cord-005453-4057qib7	3197	3	all	all	DT
cord-005453-4057qib7	3197	4	transplant	transplant	NN
cord-005453-4057qib7	3197	5	patients	patient	NNS
cord-005453-4057qib7	3197	6	(	(	-LRB-
cord-005453-4057qib7	3197	7	23.4	23.4	CD
cord-005453-4057qib7	3197	8	%	%	NN
cord-005453-4057qib7	3197	9	)	)	-RRB-
cord-005453-4057qib7	3197	10	were	be	VBD
cord-005453-4057qib7	3197	11	found	find	VBN
cord-005453-4057qib7	3197	12	to	to	TO
cord-005453-4057qib7	3197	13	have	have	VB
cord-005453-4057qib7	3197	14	a	a	DT
cord-005453-4057qib7	3197	15	bilirubin	bilirubin	NN
cord-005453-4057qib7	3197	16	of	of	IN
cord-005453-4057qib7	3197	17	>	>	XX
cord-005453-4057qib7	3197	18	=	=	SYM
cord-005453-4057qib7	3197	19	34	34	CD
cord-005453-4057qib7	3197	20	mmol	mmol	NNP
cord-005453-4057qib7	3197	21	/	/	SYM
cord-005453-4057qib7	3197	22	l	l	NN
cord-005453-4057qib7	3197	23	.	.	NNP
cord-005453-4057qib7	3197	24	39	39	CD
cord-005453-4057qib7	3197	25	of	of	IN
cord-005453-4057qib7	3197	26	403	403	CD
cord-005453-4057qib7	3197	27	(	(	-LRB-
cord-005453-4057qib7	3197	28	9.6	9.6	CD
cord-005453-4057qib7	3197	29	%	%	NN
cord-005453-4057qib7	3197	30	)	)	-RRB-
cord-005453-4057qib7	3197	31	autograft	autograft	NN
cord-005453-4057qib7	3197	32	patients	patient	NNS
cord-005453-4057qib7	3197	33	and	and	CC
cord-005453-4057qib7	3197	34	123	123	CD
cord-005453-4057qib7	3197	35	of	of	IN
cord-005453-4057qib7	3197	36	249	249	CD
cord-005453-4057qib7	3197	37	(	(	-LRB-
cord-005453-4057qib7	3197	38	49.4	49.4	CD
cord-005453-4057qib7	3197	39	%	%	NN
cord-005453-4057qib7	3197	40	)	)	-RRB-
cord-005453-4057qib7	3197	41	allograft	allograft	NN
cord-005453-4057qib7	3197	42	patients	patient	NNS
cord-005453-4057qib7	3197	43	had	have	VBD
cord-005453-4057qib7	3197	44	an	an	DT
cord-005453-4057qib7	3197	45	elevated	elevated	JJ
cord-005453-4057qib7	3197	46	bilirubin	bilirubin	NN
cord-005453-4057qib7	3197	47	at	at	IN
cord-005453-4057qib7	3197	48	this	this	DT
cord-005453-4057qib7	3197	49	level	level	NN
cord-005453-4057qib7	3197	50	.	.	.
cord-005453-4057qib7	3198	1	These	these	DT
cord-005453-4057qib7	3198	2	162	162	CD
cord-005453-4057qib7	3198	3	patients	patient	NNS
cord-005453-4057qib7	3198	4	were	be	VBD
cord-005453-4057qib7	3198	5	assessed	assess	VBN
cord-005453-4057qib7	3198	6	for	for	IN
cord-005453-4057qib7	3198	7	evidence	evidence	NN
cord-005453-4057qib7	3198	8	of	of	IN
cord-005453-4057qib7	3198	9	5	5	CD
cord-005453-4057qib7	3198	10	%	%	NN
cord-005453-4057qib7	3198	11	weight	weight	NN
cord-005453-4057qib7	3198	12	gain	gain	NN
cord-005453-4057qib7	3198	13	.	.	.
cord-005453-4057qib7	3199	1	This	this	DT
cord-005453-4057qib7	3199	2	was	be	VBD
cord-005453-4057qib7	3199	3	the	the	DT
cord-005453-4057qib7	3199	4	case	case	NN
cord-005453-4057qib7	3199	5	in	in	IN
cord-005453-4057qib7	3199	6	30	30	CD
cord-005453-4057qib7	3199	7	patients	patient	NNS
cord-005453-4057qib7	3199	8	overall-1	overall-1	IN
cord-005453-4057qib7	3199	9	%	%	NN
cord-005453-4057qib7	3199	10	of	of	IN
cord-005453-4057qib7	3199	11	autograft	autograft	NN
cord-005453-4057qib7	3199	12	patients	patient	NNS
cord-005453-4057qib7	3199	13	,	,	,
cord-005453-4057qib7	3199	14	10.5	10.5	CD
cord-005453-4057qib7	3199	15	%	%	NN
cord-005453-4057qib7	3199	16	of	of	IN
cord-005453-4057qib7	3199	17	allograft	allograft	NN
cord-005453-4057qib7	3199	18	patients	patient	NNS
cord-005453-4057qib7	3199	19	.	.	.
cord-005453-4057qib7	3200	1	Seven	seven	CD
cord-005453-4057qib7	3200	2	patients	patient	NNS
cord-005453-4057qib7	3200	3	(	(	-LRB-
cord-005453-4057qib7	3200	4	2	2	CD
cord-005453-4057qib7	3200	5	autograft	autograft	NN
cord-005453-4057qib7	3200	6	and	and	CC
cord-005453-4057qib7	3200	7	5	5	CD
cord-005453-4057qib7	3200	8	allograft	allograft	NN
cord-005453-4057qib7	3200	9	)	)	-RRB-
cord-005453-4057qib7	3200	10	had	have	VBD
cord-005453-4057qib7	3200	11	radiological	radiological	JJ
cord-005453-4057qib7	3200	12	evidence	evidence	NN
cord-005453-4057qib7	3200	13	of	of	IN
cord-005453-4057qib7	3200	14	ascites	ascite	NNS
cord-005453-4057qib7	3200	15	.	.	.
cord-005453-4057qib7	3201	1	Two	two	CD
cord-005453-4057qib7	3201	2	patients	patient	NNS
cord-005453-4057qib7	3201	3	had	have	VBD
cord-005453-4057qib7	3201	4	a	a	DT
cord-005453-4057qib7	3201	5	recording	recording	NN
cord-005453-4057qib7	3201	6	of	of	IN
cord-005453-4057qib7	3201	7	painful	painful	JJ
cord-005453-4057qib7	3201	8	hepatomegaly	hepatomegaly	NNP
cord-005453-4057qib7	3201	9	(	(	-LRB-
cord-005453-4057qib7	3201	10	both	both	DT
cord-005453-4057qib7	3201	11	post	post	NN
cord-005453-4057qib7	3201	12	allograft	allograft	NN
cord-005453-4057qib7	3201	13	)	)	-RRB-
cord-005453-4057qib7	3201	14	.	.	.
cord-005453-4057qib7	3202	1	Overall	overall	JJ
cord-005453-4057qib7	3202	2	our	-PRON-	PRP$
cord-005453-4057qib7	3202	3	analysis	analysis	NN
cord-005453-4057qib7	3202	4	identified	identify	VBD
cord-005453-4057qib7	3202	5	5	5	CD
cord-005453-4057qib7	3202	6	patients	patient	NNS
cord-005453-4057qib7	3202	7	(	(	-LRB-
cord-005453-4057qib7	3202	8	0.7	0.7	CD
cord-005453-4057qib7	3202	9	%	%	NN
cord-005453-4057qib7	3202	10	overall	overall	NN
cord-005453-4057qib7	3202	11	)	)	-RRB-
cord-005453-4057qib7	3202	12	fulfilling	fulfil	VBG
cord-005453-4057qib7	3202	13	the	the	DT
cord-005453-4057qib7	3202	14	EBMT	EBMT	NNP
cord-005453-4057qib7	3202	15	diagnostic	diagnostic	JJ
cord-005453-4057qib7	3202	16	criteria	criterion	NNS
cord-005453-4057qib7	3202	17	for	for	IN
cord-005453-4057qib7	3202	18	classic	classic	JJ
cord-005453-4057qib7	3202	19	early	early	JJ
cord-005453-4057qib7	3202	20	VOD	VOD	NNP
cord-005453-4057qib7	3202	21	all	all	DT
cord-005453-4057qib7	3202	22	of	of	IN
cord-005453-4057qib7	3202	23	whom	whom	WP
cord-005453-4057qib7	3202	24	received	receive	VBD
cord-005453-4057qib7	3202	25	defibrotide	defibrotide	NN
cord-005453-4057qib7	3202	26	.	.	.
cord-005453-4057qib7	3203	1	All	all	DT
cord-005453-4057qib7	3203	2	patients	patient	NNS
cord-005453-4057qib7	3203	3	had	have	VBD
cord-005453-4057qib7	3203	4	received	receive	VBN
cord-005453-4057qib7	3203	5	allogeneic	allogeneic	IN
cord-005453-4057qib7	3203	6	transplants	transplant	NNS
cord-005453-4057qib7	3203	7	.	.	.
cord-005453-4057qib7	3204	1	We	-PRON-	PRP
cord-005453-4057qib7	3204	2	failed	fail	VBD
cord-005453-4057qib7	3204	3	to	to	TO
cord-005453-4057qib7	3204	4	identify	identify	VB
cord-005453-4057qib7	3204	5	any	any	DT
cord-005453-4057qib7	3204	6	cases	case	NNS
cord-005453-4057qib7	3204	7	of	of	IN
cord-005453-4057qib7	3204	8	late	late	JJ
cord-005453-4057qib7	3204	9	onset	onset	NN
cord-005453-4057qib7	3204	10	VOD	vod	NN
cord-005453-4057qib7	3204	11	or	or	CC
cord-005453-4057qib7	3204	12	any	any	DT
cord-005453-4057qib7	3204	13	undiagnosed	undiagnosed	JJ
cord-005453-4057qib7	3204	14	patients	patient	NNS
cord-005453-4057qib7	3204	15	over	over	IN
cord-005453-4057qib7	3204	16	this	this	DT
cord-005453-4057qib7	3204	17	period	period	NN
cord-005453-4057qib7	3204	18	.	.	.
cord-005453-4057qib7	3205	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3205	2	:	:	:
cord-005453-4057qib7	3206	1	This	this	DT
cord-005453-4057qib7	3206	2	analysis	analysis	NN
cord-005453-4057qib7	3206	3	enabled	enable	VBD
cord-005453-4057qib7	3206	4	us	-PRON-	PRP
cord-005453-4057qib7	3206	5	to	to	TO
cord-005453-4057qib7	3206	6	efficiently	efficiently	RB
cord-005453-4057qib7	3206	7	perform	perform	VB
cord-005453-4057qib7	3206	8	a	a	DT
cord-005453-4057qib7	3206	9	complete	complete	JJ
cord-005453-4057qib7	3206	10	audit	audit	NN
cord-005453-4057qib7	3206	11	of	of	IN
cord-005453-4057qib7	3206	12	our	-PRON-	PRP$
cord-005453-4057qib7	3206	13	practice	practice	NN
cord-005453-4057qib7	3206	14	to	to	TO
cord-005453-4057qib7	3206	15	identify	identify	VB
cord-005453-4057qib7	3206	16	patients	patient	NNS
cord-005453-4057qib7	3206	17	with	with	IN
cord-005453-4057qib7	3206	18	VOD	VOD	NNP
cord-005453-4057qib7	3206	19	.	.	.
cord-005453-4057qib7	3207	1	We	-PRON-	PRP
cord-005453-4057qib7	3207	2	would	would	MD
cord-005453-4057qib7	3207	3	recommend	recommend	VB
cord-005453-4057qib7	3207	4	using	use	VBG
cord-005453-4057qib7	3207	5	electronic	electronic	JJ
cord-005453-4057qib7	3207	6	patient	patient	NN
cord-005453-4057qib7	3207	7	records	record	NNS
cord-005453-4057qib7	3207	8	to	to	TO
cord-005453-4057qib7	3207	9	retrospectively	retrospectively	RB
cord-005453-4057qib7	3207	10	audit	audit	VB
cord-005453-4057qib7	3207	11	practice	practice	NN
cord-005453-4057qib7	3207	12	in	in	IN
cord-005453-4057qib7	3207	13	this	this	DT
cord-005453-4057qib7	3207	14	way	way	NN
cord-005453-4057qib7	3207	15	.	.	.
cord-005453-4057qib7	3208	1	The	the	DT
cord-005453-4057qib7	3208	2	tool	tool	NN
cord-005453-4057qib7	3208	3	that	that	WDT
cord-005453-4057qib7	3208	4	we	-PRON-	PRP
cord-005453-4057qib7	3208	5	have	have	VBP
cord-005453-4057qib7	3208	6	created	create	VBN
cord-005453-4057qib7	3208	7	for	for	IN
cord-005453-4057qib7	3208	8	this	this	DT
cord-005453-4057qib7	3208	9	analysis	analysis	NN
cord-005453-4057qib7	3208	10	will	will	MD
cord-005453-4057qib7	3208	11	be	be	VB
cord-005453-4057qib7	3208	12	made	make	VBN
cord-005453-4057qib7	3208	13	freely	freely	RB
cord-005453-4057qib7	3208	14	available	available	JJ
cord-005453-4057qib7	3208	15	for	for	IN
cord-005453-4057qib7	3208	16	public	public	JJ
cord-005453-4057qib7	3208	17	use	use	NN
cord-005453-4057qib7	3208	18	and	and	CC
cord-005453-4057qib7	3208	19	the	the	DT
cord-005453-4057qib7	3208	20	details	detail	NNS
cord-005453-4057qib7	3208	21	will	will	MD
cord-005453-4057qib7	3208	22	be	be	VB
cord-005453-4057qib7	3208	23	presented	present	VBN
cord-005453-4057qib7	3208	24	at	at	IN
cord-005453-4057qib7	3208	25	the	the	DT
cord-005453-4057qib7	3208	26	EBMT	EBMT	NNP
cord-005453-4057qib7	3208	27	meeting	meeting	NN
cord-005453-4057qib7	3208	28	.	.	.
cord-005453-4057qib7	3209	1	We	-PRON-	PRP
cord-005453-4057qib7	3209	2	now	now	RB
cord-005453-4057qib7	3209	3	plan	plan	VBP
cord-005453-4057qib7	3209	4	to	to	TO
cord-005453-4057qib7	3209	5	extend	extend	VB
cord-005453-4057qib7	3209	6	the	the	DT
cord-005453-4057qib7	3209	7	function	function	NN
cord-005453-4057qib7	3209	8	of	of	IN
cord-005453-4057qib7	3209	9	our	-PRON-	PRP$
cord-005453-4057qib7	3209	10	EPR	EPR	NNP
cord-005453-4057qib7	3209	11	system	system	NN
cord-005453-4057qib7	3209	12	to	to	TO
cord-005453-4057qib7	3209	13	provide	provide	VB
cord-005453-4057qib7	3209	14	alerts	alert	NNS
cord-005453-4057qib7	3209	15	to	to	IN
cord-005453-4057qib7	3209	16	clinicians	clinician	NNS
cord-005453-4057qib7	3209	17	when	when	WRB
cord-005453-4057qib7	3209	18	VOD	VOD	NNP
cord-005453-4057qib7	3209	19	is	be	VBZ
cord-005453-4057qib7	3209	20	a	a	DT
cord-005453-4057qib7	3209	21	possible	possible	JJ
cord-005453-4057qib7	3209	22	diagnosis	diagnosis	NN
cord-005453-4057qib7	3209	23	and	and	CC
cord-005453-4057qib7	3209	24	may	may	MD
cord-005453-4057qib7	3209	25	lead	lead	VB
cord-005453-4057qib7	3209	26	to	to	IN
cord-005453-4057qib7	3209	27	more	more	RBR
cord-005453-4057qib7	3209	28	rapid	rapid	JJ
cord-005453-4057qib7	3209	29	treatment	treatment	NN
cord-005453-4057qib7	3209	30	of	of	IN
cord-005453-4057qib7	3209	31	these	these	DT
cord-005453-4057qib7	3209	32	patients	patient	NNS
cord-005453-4057qib7	3209	33	.	.	.
cord-005453-4057qib7	3210	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3210	2	data	data	NN
cord-005453-4057qib7	3210	3	suggests	suggest	VBZ
cord-005453-4057qib7	3210	4	that	that	IN
cord-005453-4057qib7	3210	5	elevation	elevation	NN
cord-005453-4057qib7	3210	6	of	of	IN
cord-005453-4057qib7	3210	7	bilirubin	bilirubin	NN
cord-005453-4057qib7	3210	8	and	and	CC
cord-005453-4057qib7	3210	9	weight	weight	NN
cord-005453-4057qib7	3210	10	gain	gain	NN
cord-005453-4057qib7	3210	11	of	of	IN
cord-005453-4057qib7	3210	12	>	>	$
cord-005453-4057qib7	3210	13	5	5	CD
cord-005453-4057qib7	3210	14	%	%	NN
cord-005453-4057qib7	3210	15	will	will	MD
cord-005453-4057qib7	3210	16	be	be	VB
cord-005453-4057qib7	3210	17	the	the	DT
cord-005453-4057qib7	3210	18	most	most	RBS
cord-005453-4057qib7	3210	19	frequently	frequently	RB
cord-005453-4057qib7	3210	20	occurring	occur	VBG
cord-005453-4057qib7	3210	21	criteria	criterion	NNS
cord-005453-4057qib7	3210	22	on	on	IN
cord-005453-4057qib7	3210	23	which	which	WDT
cord-005453-4057qib7	3210	24	to	to	TO
cord-005453-4057qib7	3210	25	base	base	VB
cord-005453-4057qib7	3210	26	these	these	DT
cord-005453-4057qib7	3210	27	alerts	alert	NNS
cord-005453-4057qib7	3210	28	.	.	.
cord-005453-4057qib7	3211	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3211	2	:	:	:
cord-005453-4057qib7	3211	3	G.Vallance	G.Vallance	NNP
cord-005453-4057qib7	3211	4	has	have	VBZ
cord-005453-4057qib7	3211	5	performed	perform	VBN
cord-005453-4057qib7	3211	6	consultancy	consultancy	NN
cord-005453-4057qib7	3211	7	work	work	NN
cord-005453-4057qib7	3211	8	for	for	IN
cord-005453-4057qib7	3211	9	Jazz	jazz	NN
cord-005453-4057qib7	3211	10	pharmaceuticals	pharmaceutical	NNS
cord-005453-4057qib7	3211	11	.	.	.
cord-005453-4057qib7	3212	1	Endothelial	endothelial	JJ
cord-005453-4057qib7	3212	2	activation	activation	NN
cord-005453-4057qib7	3212	3	and	and	CC
cord-005453-4057qib7	3212	4	stress	stress	NN
cord-005453-4057qib7	3212	5	index	index	NN
cord-005453-4057qib7	3212	6	in	in	IN
cord-005453-4057qib7	3212	7	predicting	predict	VBG
cord-005453-4057qib7	3212	8	outcome	outcome	NN
cord-005453-4057qib7	3212	9	of	of	IN
cord-005453-4057qib7	3212	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	3212	11	stem	stem	NN
cord-005453-4057qib7	3212	12	cell	cell	NN
cord-005453-4057qib7	3212	13	transplantation	transplantation	NN
cord-005453-4057qib7	3213	1	-A	-A	:
cord-005453-4057qib7	3213	2	retrospective	retrospective	JJ
cord-005453-4057qib7	3213	3	cohort	cohort	NN
cord-005453-4057qib7	3213	4	analysis	analysis	NN
cord-005453-4057qib7	3213	5	Zinaida	Zinaida	NNP
cord-005453-4057qib7	3213	6	Peric	Peric	NNP
cord-005453-4057qib7	3213	7	1	1	CD
cord-005453-4057qib7	3213	8	,	,	,
cord-005453-4057qib7	3213	9	Tomislav	Tomislav	NNP
cord-005453-4057qib7	3213	10	Taborsak	Taborsak	NNP
cord-005453-4057qib7	3213	11	1	1	CD
cord-005453-4057qib7	3213	12	,	,	,
cord-005453-4057qib7	3213	13	Nadira	Nadira	NNP
cord-005453-4057qib7	3213	14	Durakovic	Durakovic	NNP
cord-005453-4057qib7	3213	15	1	1	CD
cord-005453-4057qib7	3213	16	,	,	,
cord-005453-4057qib7	3213	17	Lana	Lana	NNP
cord-005453-4057qib7	3213	18	Desnica	Desnica	NNP
cord-005453-4057qib7	3213	19	1	1	CD
cord-005453-4057qib7	3213	20	,	,	,
cord-005453-4057qib7	3213	21	Alen	Alen	NNP
cord-005453-4057qib7	3213	22	Ostojic	Ostojic	NNP
cord-005453-4057qib7	3213	23	1	1	CD
cord-005453-4057qib7	3213	24	,	,	,
cord-005453-4057qib7	3213	25	Ranka	Ranka	NNP
cord-005453-4057qib7	3213	26	Serventi	Serventi	NNP
cord-005453-4057qib7	3213	27	-	-	HYPH
cord-005453-4057qib7	3213	28	Seiwerth	Seiwerth	NNP
cord-005453-4057qib7	3213	29	1	1	CD
cord-005453-4057qib7	3213	30	,	,	,
cord-005453-4057qib7	3213	31	Radovan	Radovan	NNP
cord-005453-4057qib7	3213	32	Vrhovac	Vrhovac	NNP
cord-005453-4057qib7	3213	33	1	1	CD
cord-005453-4057qib7	3213	34	1	1	CD
cord-005453-4057qib7	3213	35	University	University	NNP
cord-005453-4057qib7	3213	36	Hospital	Hospital	NNP
cord-005453-4057qib7	3213	37	Centre	Centre	NNP
cord-005453-4057qib7	3213	38	Zagreb	Zagreb	NNP
cord-005453-4057qib7	3213	39	,	,	,
cord-005453-4057qib7	3213	40	Zagreb	Zagreb	NNP
cord-005453-4057qib7	3213	41	,	,	,
cord-005453-4057qib7	3213	42	Croatia	Croatia	NNP
cord-005453-4057qib7	3213	43	Background	Background	NNP
cord-005453-4057qib7	3213	44	:	:	:
cord-005453-4057qib7	3214	1	Endothelial	endothelial	JJ
cord-005453-4057qib7	3214	2	dysfunction	dysfunction	NN
cord-005453-4057qib7	3214	3	is	be	VBZ
cord-005453-4057qib7	3214	4	a	a	DT
cord-005453-4057qib7	3214	5	common	common	JJ
cord-005453-4057qib7	3214	6	pathophysiology	pathophysiology	NN
cord-005453-4057qib7	3214	7	of	of	IN
cord-005453-4057qib7	3214	8	major	major	JJ
cord-005453-4057qib7	3214	9	complications	complication	NNS
cord-005453-4057qib7	3214	10	after	after	IN
cord-005453-4057qib7	3214	11	allo	allo	NN
cord-005453-4057qib7	3214	12	-	-	HYPH
cord-005453-4057qib7	3214	13	SCT	SCT	NNP
cord-005453-4057qib7	3214	14	,	,	,
cord-005453-4057qib7	3214	15	such	such	JJ
cord-005453-4057qib7	3214	16	as	as	IN
cord-005453-4057qib7	3214	17	graft	graft	NN
cord-005453-4057qib7	3214	18	-	-	HYPH
cord-005453-4057qib7	3214	19	versus	versus	IN
cord-005453-4057qib7	3214	20	-	-	HYPH
cord-005453-4057qib7	3214	21	host	host	NN
cord-005453-4057qib7	3214	22	disease	disease	NN
cord-005453-4057qib7	3214	23	,	,	,
cord-005453-4057qib7	3214	24	veno	veno	NNP
cord-005453-4057qib7	3214	25	-	-	HYPH
cord-005453-4057qib7	3214	26	occlusive	occlusive	JJ
cord-005453-4057qib7	3214	27	disease	disease	NN
cord-005453-4057qib7	3214	28	,	,	,
cord-005453-4057qib7	3214	29	thrombotic	thrombotic	JJ
cord-005453-4057qib7	3214	30	microangiopathy	microangiopathy	NN
cord-005453-4057qib7	3214	31	and	and	CC
cord-005453-4057qib7	3214	32	sepsis	sepsis	NN
cord-005453-4057qib7	3214	33	.	.	.
cord-005453-4057qib7	3215	1	Endothelial	Endothelial	NNP
cord-005453-4057qib7	3215	2	Activation	Activation	NNP
cord-005453-4057qib7	3215	3	and	and	CC
cord-005453-4057qib7	3215	4	Stress	Stress	NNP
cord-005453-4057qib7	3215	5	Index	Index	NNP
cord-005453-4057qib7	3215	6	(	(	-LRB-
cord-005453-4057qib7	3215	7	EASIX	EASIX	NNP
cord-005453-4057qib7	3215	8	)	)	-RRB-
cord-005453-4057qib7	3215	9	is	be	VBZ
cord-005453-4057qib7	3215	10	a	a	DT
cord-005453-4057qib7	3215	11	simple	simple	JJ
cord-005453-4057qib7	3215	12	score	score	NN
cord-005453-4057qib7	3215	13	comprised	comprise	VBN
cord-005453-4057qib7	3215	14	of	of	IN
cord-005453-4057qib7	3215	15	standard	standard	JJ
cord-005453-4057qib7	3215	16	laboratory	laboratory	NN
cord-005453-4057qib7	3215	17	parameters	parameter	NNS
cord-005453-4057qib7	3215	18	(	(	-LRB-
cord-005453-4057qib7	3215	19	creatinine	creatinine	NN
cord-005453-4057qib7	3215	20	,	,	,
cord-005453-4057qib7	3215	21	LDH	LDH	NNP
cord-005453-4057qib7	3215	22	and	and	CC
cord-005453-4057qib7	3215	23	thrombocytes	thrombocytes	NNP
cord-005453-4057qib7	3215	24	)	)	-RRB-
cord-005453-4057qib7	3215	25	developed	develop	VBD
cord-005453-4057qib7	3215	26	as	as	IN
cord-005453-4057qib7	3215	27	a	a	DT
cord-005453-4057qib7	3215	28	potential	potential	JJ
cord-005453-4057qib7	3215	29	tool	tool	NN
cord-005453-4057qib7	3215	30	to	to	TO
cord-005453-4057qib7	3215	31	predict	predict	VB
cord-005453-4057qib7	3215	32	allo	allo	NNP
cord-005453-4057qib7	3215	33	-	-	HYPH
cord-005453-4057qib7	3215	34	SCT	SCT	NNP
cord-005453-4057qib7	3215	35	mortality	mortality	NN
cord-005453-4057qib7	3215	36	by	by	IN
cord-005453-4057qib7	3215	37	Luft	Luft	NNP
cord-005453-4057qib7	3215	38	and	and	CC
cord-005453-4057qib7	3215	39	colleagues	colleague	NNS
cord-005453-4057qib7	3215	40	.	.	.
cord-005453-4057qib7	3216	1	A	a	DT
cord-005453-4057qib7	3216	2	recent	recent	JJ
cord-005453-4057qib7	3216	3	validation	validation	NN
cord-005453-4057qib7	3216	4	of	of	IN
cord-005453-4057qib7	3216	5	EASIX	EASIX	NNP
cord-005453-4057qib7	3216	6	included	include	VBD
cord-005453-4057qib7	3216	7	three	three	CD
cord-005453-4057qib7	3216	8	retrospective	retrospective	JJ
cord-005453-4057qib7	3216	9	cohorts	cohort	NNS
cord-005453-4057qib7	3216	10	and	and	CC
cord-005453-4057qib7	3216	11	showed	show	VBD
cord-005453-4057qib7	3216	12	that	that	IN
cord-005453-4057qib7	3216	13	EASIX	EASIX	NNP
cord-005453-4057qib7	3216	14	taken	take	VBN
cord-005453-4057qib7	3216	15	before	before	IN
cord-005453-4057qib7	3216	16	start	start	NN
cord-005453-4057qib7	3216	17	of	of	IN
cord-005453-4057qib7	3216	18	conditioning	conditioning	NN
cord-005453-4057qib7	3216	19	can	can	MD
cord-005453-4057qib7	3216	20	be	be	VB
cord-005453-4057qib7	3216	21	used	use	VBN
cord-005453-4057qib7	3216	22	as	as	IN
cord-005453-4057qib7	3216	23	an	an	DT
cord-005453-4057qib7	3216	24	independent	independent	JJ
cord-005453-4057qib7	3216	25	predictor	predictor	NN
cord-005453-4057qib7	3216	26	of	of	IN
cord-005453-4057qib7	3216	27	survival	survival	NN
cord-005453-4057qib7	3216	28	after	after	IN
cord-005453-4057qib7	3216	29	allo	allo	NN
cord-005453-4057qib7	3216	30	-	-	HYPH
cord-005453-4057qib7	3216	31	SCT	SCT	NNP
cord-005453-4057qib7	3216	32	.	.	.
cord-005453-4057qib7	3217	1	Methods	method	NNS
cord-005453-4057qib7	3217	2	:	:	:
cord-005453-4057qib7	3218	1	The	the	DT
cord-005453-4057qib7	3218	2	aim	aim	NN
cord-005453-4057qib7	3218	3	of	of	IN
cord-005453-4057qib7	3218	4	our	-PRON-	PRP$
cord-005453-4057qib7	3218	5	study	study	NN
cord-005453-4057qib7	3218	6	was	be	VBD
cord-005453-4057qib7	3218	7	to	to	TO
cord-005453-4057qib7	3218	8	retrospectively	retrospectively	RB
cord-005453-4057qib7	3218	9	evaluate	evaluate	VB
cord-005453-4057qib7	3218	10	pre	pre	JJ
cord-005453-4057qib7	3218	11	-	-	JJ
cord-005453-4057qib7	3218	12	transplant	transplant	JJ
cord-005453-4057qib7	3218	13	EASIX	EASIX	NNP
cord-005453-4057qib7	3218	14	in	in	IN
cord-005453-4057qib7	3218	15	our	-PRON-	PRP$
cord-005453-4057qib7	3218	16	cohort	cohort	NN
cord-005453-4057qib7	3218	17	of	of	IN
cord-005453-4057qib7	3218	18	consecutive	consecutive	JJ
cord-005453-4057qib7	3218	19	patients	patient	NNS
cord-005453-4057qib7	3218	20	who	who	WP
cord-005453-4057qib7	3218	21	underwent	undergo	VBD
cord-005453-4057qib7	3218	22	allo	allo	NN
cord-005453-4057qib7	3218	23	-	-	HYPH
cord-005453-4057qib7	3218	24	SCT	SCT	NNP
cord-005453-4057qib7	3218	25	in	in	IN
cord-005453-4057qib7	3218	26	the	the	DT
cord-005453-4057qib7	3218	27	University	University	NNP
cord-005453-4057qib7	3218	28	Hospital	Hospital	NNP
cord-005453-4057qib7	3218	29	Centre	Centre	NNP
cord-005453-4057qib7	3218	30	Zagreb	Zagreb	NNP
cord-005453-4057qib7	3218	31	between	between	IN
cord-005453-4057qib7	3218	32	2012	2012	CD
cord-005453-4057qib7	3218	33	and	and	CC
cord-005453-4057qib7	3218	34	2017	2017	CD
cord-005453-4057qib7	3218	35	.	.	.
cord-005453-4057qib7	3219	1	With	with	IN
cord-005453-4057qib7	3219	2	the	the	DT
cord-005453-4057qib7	3219	3	use	use	NN
cord-005453-4057qib7	3219	4	of	of	IN
cord-005453-4057qib7	3219	5	a	a	DT
cord-005453-4057qib7	3219	6	cut	cut	VBN
cord-005453-4057qib7	3219	7	-	-	HYPH
cord-005453-4057qib7	3219	8	off	off	NN
cord-005453-4057qib7	3219	9	used	use	VBN
cord-005453-4057qib7	3219	10	in	in	IN
cord-005453-4057qib7	3219	11	the	the	DT
cord-005453-4057qib7	3219	12	validation	validation	NN
cord-005453-4057qib7	3219	13	cohorts	cohort	NNS
cord-005453-4057qib7	3219	14	,	,	,
cord-005453-4057qib7	3219	15	we	-PRON-	PRP
cord-005453-4057qib7	3219	16	compared	compare	VBD
cord-005453-4057qib7	3219	17	two	two	CD
cord-005453-4057qib7	3219	18	groups	group	NNS
cord-005453-4057qib7	3219	19	of	of	IN
cord-005453-4057qib7	3219	20	patients	patient	NNS
cord-005453-4057qib7	3219	21	for	for	IN
cord-005453-4057qib7	3219	22	overall	overall	JJ
cord-005453-4057qib7	3219	23	survival	survival	NN
cord-005453-4057qib7	3219	24	(	(	-LRB-
cord-005453-4057qib7	3219	25	OS	OS	NNP
cord-005453-4057qib7	3219	26	)	)	-RRB-
cord-005453-4057qib7	3219	27	and	and	CC
cord-005453-4057qib7	3219	28	transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	3219	29	mortality	mortality	NN
cord-005453-4057qib7	3219	30	(	(	-LRB-
cord-005453-4057qib7	3219	31	TRM	TRM	NNP
cord-005453-4057qib7	3219	32	)	)	-RRB-
cord-005453-4057qib7	3219	33	.	.	.
cord-005453-4057qib7	3220	1	Group	group	NN
cord-005453-4057qib7	3220	2	comparisons	comparison	NNS
cord-005453-4057qib7	3220	3	were	be	VBD
cord-005453-4057qib7	3220	4	done	do	VBN
cord-005453-4057qib7	3220	5	using	use	VBG
cord-005453-4057qib7	3220	6	the	the	DT
cord-005453-4057qib7	3220	7	log	log	NN
cord-005453-4057qib7	3220	8	-	-	HYPH
cord-005453-4057qib7	3220	9	rank	rank	NN
cord-005453-4057qib7	3220	10	test	test	NN
cord-005453-4057qib7	3220	11	or	or	CC
cord-005453-4057qib7	3220	12	Gray	gray	JJ
cord-005453-4057qib7	3220	13	test	test	NN
cord-005453-4057qib7	3220	14	for	for	IN
cord-005453-4057qib7	3220	15	competing	compete	VBG
cord-005453-4057qib7	3220	16	risks	risk	NNS
cord-005453-4057qib7	3220	17	outcomes	outcome	NNS
cord-005453-4057qib7	3220	18	.	.	.
cord-005453-4057qib7	3221	1	A	a	DT
cord-005453-4057qib7	3221	2	multivariate	multivariate	JJ
cord-005453-4057qib7	3221	3	analysis	analysis	NN
cord-005453-4057qib7	3221	4	evaluated	evaluate	VBD
cord-005453-4057qib7	3221	5	the	the	DT
cord-005453-4057qib7	3221	6	association	association	NN
cord-005453-4057qib7	3221	7	of	of	IN
cord-005453-4057qib7	3221	8	OS	OS	NNP
cord-005453-4057qib7	3221	9	with	with	IN
cord-005453-4057qib7	3221	10	relevant	relevant	JJ
cord-005453-4057qib7	3221	11	variables	variable	NNS
cord-005453-4057qib7	3221	12	by	by	IN
cord-005453-4057qib7	3221	13	using	use	VBG
cord-005453-4057qib7	3221	14	a	a	DT
cord-005453-4057qib7	3221	15	Cox	Cox	NNP
cord-005453-4057qib7	3221	16	's	's	POS
cord-005453-4057qib7	3221	17	proportionalhazard	proportionalhazard	JJ
cord-005453-4057qib7	3221	18	regression	regression	NN
cord-005453-4057qib7	3221	19	model	model	NN
cord-005453-4057qib7	3221	20	.	.	.
cord-005453-4057qib7	3222	1	Results	result	NNS
cord-005453-4057qib7	3222	2	:	:	:
cord-005453-4057qib7	3223	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3223	2	study	study	NN
cord-005453-4057qib7	3223	3	group	group	NN
cord-005453-4057qib7	3223	4	included	include	VBD
cord-005453-4057qib7	3223	5	313	313	CD
cord-005453-4057qib7	3223	6	patients	patient	NNS
cord-005453-4057qib7	3223	7	and	and	CC
cord-005453-4057qib7	3223	8	comprised	comprise	VBD
cord-005453-4057qib7	3223	9	180	180	CD
cord-005453-4057qib7	3223	10	males	male	NNS
cord-005453-4057qib7	3223	11	(	(	-LRB-
cord-005453-4057qib7	3223	12	57	57	CD
cord-005453-4057qib7	3223	13	%	%	NN
cord-005453-4057qib7	3223	14	)	)	-RRB-
cord-005453-4057qib7	3223	15	and	and	CC
cord-005453-4057qib7	3223	16	133	133	CD
cord-005453-4057qib7	3223	17	females	female	NNS
cord-005453-4057qib7	3223	18	(	(	-LRB-
cord-005453-4057qib7	3223	19	43	43	CD
cord-005453-4057qib7	3223	20	%	%	NN
cord-005453-4057qib7	3223	21	,	,	,
cord-005453-4057qib7	3223	22	with	with	IN
cord-005453-4057qib7	3223	23	a	a	DT
cord-005453-4057qib7	3223	24	median	median	JJ
cord-005453-4057qib7	3223	25	age	age	NN
cord-005453-4057qib7	3223	26	of	of	IN
cord-005453-4057qib7	3223	27	48	48	CD
cord-005453-4057qib7	3223	28	years	year	NNS
cord-005453-4057qib7	3223	29	(	(	-LRB-
cord-005453-4057qib7	3223	30	range	range	NN
cord-005453-4057qib7	3223	31	,	,	,
cord-005453-4057qib7	3223	32	18	18	CD
cord-005453-4057qib7	3223	33	to	to	TO
cord-005453-4057qib7	3223	34	67	67	CD
cord-005453-4057qib7	3223	35	years	year	NNS
cord-005453-4057qib7	3223	36	)	)	-RRB-
cord-005453-4057qib7	3223	37	at	at	IN
cord-005453-4057qib7	3223	38	the	the	DT
cord-005453-4057qib7	3223	39	time	time	NN
cord-005453-4057qib7	3223	40	of	of	IN
cord-005453-4057qib7	3223	41	transplantation	transplantation	NN
cord-005453-4057qib7	3223	42	.	.	.
cord-005453-4057qib7	3224	1	The	the	DT
cord-005453-4057qib7	3224	2	most	most	RBS
cord-005453-4057qib7	3224	3	frequent	frequent	JJ
cord-005453-4057qib7	3224	4	malignancies	malignancy	NNS
cord-005453-4057qib7	3224	5	in	in	IN
cord-005453-4057qib7	3224	6	our	-PRON-	PRP$
cord-005453-4057qib7	3224	7	population	population	NN
cord-005453-4057qib7	3224	8	were	be	VBD
cord-005453-4057qib7	3224	9	acute	acute	JJ
cord-005453-4057qib7	3224	10	leukemia	leukemia	NN
cord-005453-4057qib7	3224	11	(	(	-LRB-
cord-005453-4057qib7	3224	12	196	196	CD
cord-005453-4057qib7	3224	13	patients	patient	NNS
cord-005453-4057qib7	3224	14	,	,	,
cord-005453-4057qib7	3224	15	63	63	CD
cord-005453-4057qib7	3224	16	%	%	NN
cord-005453-4057qib7	3224	17	)	)	-RRB-
cord-005453-4057qib7	3224	18	and	and	CC
cord-005453-4057qib7	3224	19	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	3224	20	/	/	SYM
cord-005453-4057qib7	3224	21	myeloproliferative	myeloproliferative	JJ
cord-005453-4057qib7	3224	22	neoplasm	neoplasm	NN
cord-005453-4057qib7	3224	23	(	(	-LRB-
cord-005453-4057qib7	3224	24	451	451	CD
cord-005453-4057qib7	3224	25	patients	patient	NNS
cord-005453-4057qib7	3224	26	;	;	:
cord-005453-4057qib7	3224	27	16	16	CD
cord-005453-4057qib7	3224	28	%	%	NN
cord-005453-4057qib7	3224	29	)	)	-RRB-
cord-005453-4057qib7	3224	30	.	.	.
cord-005453-4057qib7	3225	1	The	the	DT
cord-005453-4057qib7	3225	2	donor	donor	NN
cord-005453-4057qib7	3225	3	was	be	VBD
cord-005453-4057qib7	3225	4	an	an	DT
cord-005453-4057qib7	3225	5	identical	identical	JJ
cord-005453-4057qib7	3225	6	sibling	sibling	NN
cord-005453-4057qib7	3225	7	for	for	IN
cord-005453-4057qib7	3225	8	106	106	CD
cord-005453-4057qib7	3225	9	patients	patient	NNS
cord-005453-4057qib7	3225	10	(	(	-LRB-
cord-005453-4057qib7	3225	11	34	34	CD
cord-005453-4057qib7	3225	12	%	%	NN
cord-005453-4057qib7	3225	13	)	)	-RRB-
cord-005453-4057qib7	3225	14	,	,	,
cord-005453-4057qib7	3225	15	matched	match	VBD
cord-005453-4057qib7	3225	16	unrelated	unrelated	JJ
cord-005453-4057qib7	3225	17	donor	donor	NN
cord-005453-4057qib7	3225	18	for	for	IN
cord-005453-4057qib7	3225	19	176	176	CD
cord-005453-4057qib7	3225	20	patients	patient	NNS
cord-005453-4057qib7	3225	21	(	(	-LRB-
cord-005453-4057qib7	3225	22	56	56	CD
cord-005453-4057qib7	3225	23	%	%	NN
cord-005453-4057qib7	3225	24	)	)	-RRB-
cord-005453-4057qib7	3225	25	and	and	CC
cord-005453-4057qib7	3225	26	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3225	27	for	for	IN
cord-005453-4057qib7	3225	28	31	31	CD
cord-005453-4057qib7	3225	29	patients	patient	NNS
cord-005453-4057qib7	3225	30	(	(	-LRB-
cord-005453-4057qib7	3225	31	10	10	CD
cord-005453-4057qib7	3225	32	%	%	NN
cord-005453-4057qib7	3225	33	)	)	-RRB-
cord-005453-4057qib7	3225	34	.	.	.
cord-005453-4057qib7	3226	1	104	104	CD
cord-005453-4057qib7	3226	2	patients	patient	NNS
cord-005453-4057qib7	3226	3	(	(	-LRB-
cord-005453-4057qib7	3226	4	33	33	CD
cord-005453-4057qib7	3226	5	%	%	NN
cord-005453-4057qib7	3226	6	)	)	-RRB-
cord-005453-4057qib7	3226	7	received	receive	VBD
cord-005453-4057qib7	3226	8	a	a	DT
cord-005453-4057qib7	3226	9	myeloablative	myeloablative	JJ
cord-005453-4057qib7	3226	10	conditioning	conditioning	NN
cord-005453-4057qib7	3226	11	regimen	regimen	NN
cord-005453-4057qib7	3226	12	while	while	IN
cord-005453-4057qib7	3226	13	209	209	CD
cord-005453-4057qib7	3226	14	patients	patient	NNS
cord-005453-4057qib7	3226	15	(	(	-LRB-
cord-005453-4057qib7	3226	16	67	67	CD
cord-005453-4057qib7	3226	17	%	%	NN
cord-005453-4057qib7	3226	18	)	)	-RRB-
cord-005453-4057qib7	3226	19	received	receive	VBD
cord-005453-4057qib7	3226	20	a	a	DT
cord-005453-4057qib7	3226	21	reduced	reduce	VBN
cord-005453-4057qib7	3226	22	-	-	HYPH
cord-005453-4057qib7	3226	23	intensity	intensity	NN
cord-005453-4057qib7	3226	24	conditioning	conditioning	NN
cord-005453-4057qib7	3226	25	regimen	regimen	NN
cord-005453-4057qib7	3226	26	.	.	.
cord-005453-4057qib7	3227	1	With	with	IN
cord-005453-4057qib7	3227	2	a	a	DT
cord-005453-4057qib7	3227	3	median	median	JJ
cord-005453-4057qib7	3227	4	follow	follow	NN
cord-005453-4057qib7	3227	5	-	-	HYPH
cord-005453-4057qib7	3227	6	up	up	NN
cord-005453-4057qib7	3227	7	of	of	IN
cord-005453-4057qib7	3227	8	16	16	CD
cord-005453-4057qib7	3227	9	months	month	NNS
cord-005453-4057qib7	3227	10	(	(	-LRB-
cord-005453-4057qib7	3227	11	range	range	NN
cord-005453-4057qib7	3227	12	,	,	,
cord-005453-4057qib7	3227	13	12	12	CD
cord-005453-4057qib7	3227	14	-	-	SYM
cord-005453-4057qib7	3227	15	60	60	CD
cord-005453-4057qib7	3227	16	)	)	-RRB-
cord-005453-4057qib7	3227	17	for	for	IN
cord-005453-4057qib7	3227	18	the	the	DT
cord-005453-4057qib7	3227	19	whole	whole	JJ
cord-005453-4057qib7	3227	20	study	study	NN
cord-005453-4057qib7	3227	21	group	group	NN
cord-005453-4057qib7	3227	22	,	,	,
cord-005453-4057qib7	3227	23	the	the	DT
cord-005453-4057qib7	3227	24	OS	OS	NNP
cord-005453-4057qib7	3227	25	at	at	IN
cord-005453-4057qib7	3227	26	24	24	CD
cord-005453-4057qib7	3227	27	months	month	NNS
cord-005453-4057qib7	3227	28	was	be	VBD
cord-005453-4057qib7	3227	29	60	60	CD
cord-005453-4057qib7	3227	30	%	%	NN
cord-005453-4057qib7	3227	31	,	,	,
cord-005453-4057qib7	3227	32	(	(	-LRB-
cord-005453-4057qib7	3227	33	95%CI	95%ci	CD
cord-005453-4057qib7	3227	34	54	54	CD
cord-005453-4057qib7	3227	35	-	-	SYM
cord-005453-4057qib7	3227	36	68	68	CD
cord-005453-4057qib7	3227	37	)	)	-RRB-
cord-005453-4057qib7	3227	38	in	in	IN
cord-005453-4057qib7	3227	39	the	the	DT
cord-005453-4057qib7	3227	40	group	group	NN
cord-005453-4057qib7	3227	41	of	of	IN
cord-005453-4057qib7	3227	42	patients	patient	NNS
cord-005453-4057qib7	3227	43	with	with	IN
cord-005453-4057qib7	3227	44	low	low	JJ
cord-005453-4057qib7	3227	45	EASIX	EASIX	NNP
cord-005453-4057qib7	3227	46	score	score	NN
cord-005453-4057qib7	3227	47	and	and	CC
cord-005453-4057qib7	3227	48	43	43	CD
cord-005453-4057qib7	3227	49	%	%	NN
cord-005453-4057qib7	3227	50	(	(	-LRB-
cord-005453-4057qib7	3227	51	95	95	CD
cord-005453-4057qib7	3227	52	%	%	NN
cord-005453-4057qib7	3227	53	CI	CI	NNP
cord-005453-4057qib7	3227	54	33	33	CD
cord-005453-4057qib7	3227	55	-	-	SYM
cord-005453-4057qib7	3227	56	56	56	CD
cord-005453-4057qib7	3227	57	)	)	-RRB-
cord-005453-4057qib7	3227	58	in	in	IN
cord-005453-4057qib7	3227	59	the	the	DT
cord-005453-4057qib7	3227	60	group	group	NN
cord-005453-4057qib7	3227	61	of	of	IN
cord-005453-4057qib7	3227	62	patients	patient	NNS
cord-005453-4057qib7	3227	63	with	with	IN
cord-005453-4057qib7	3227	64	high	high	JJ
cord-005453-4057qib7	3227	65	EASIX	EASIX	NNP
cord-005453-4057qib7	3227	66	score	score	NN
cord-005453-4057qib7	3227	67	(	(	-LRB-
cord-005453-4057qib7	3227	68	p=0.004	p=0.004	NNP
cord-005453-4057qib7	3227	69	)	)	-RRB-
cord-005453-4057qib7	3227	70	.	.	.
cord-005453-4057qib7	3228	1	This	this	DT
cord-005453-4057qib7	3228	2	difference	difference	NN
cord-005453-4057qib7	3228	3	was	be	VBD
cord-005453-4057qib7	3228	4	mainly	mainly	RB
cord-005453-4057qib7	3228	5	attributed	attribute	VBN
cord-005453-4057qib7	3228	6	to	to	IN
cord-005453-4057qib7	3228	7	higher	high	JJR
cord-005453-4057qib7	3228	8	TRM	TRM	NNP
cord-005453-4057qib7	3228	9	in	in	IN
cord-005453-4057qib7	3228	10	the	the	DT
cord-005453-4057qib7	3228	11	group	group	NN
cord-005453-4057qib7	3228	12	with	with	IN
cord-005453-4057qib7	3228	13	high	high	JJ
cord-005453-4057qib7	3228	14	EASIX	EASIX	NNP
cord-005453-4057qib7	3228	15	score	score	NN
cord-005453-4057qib7	3228	16	(	(	-LRB-
cord-005453-4057qib7	3228	17	32	32	CD
cord-005453-4057qib7	3228	18	%	%	NN
cord-005453-4057qib7	3228	19	,	,	,
cord-005453-4057qib7	3228	20	95%CI	95%ci	CD
cord-005453-4057qib7	3228	21	22	22	CD
cord-005453-4057qib7	3228	22	-	-	SYM
cord-005453-4057qib7	3228	23	45	45	CD
cord-005453-4057qib7	3228	24	at	at	IN
cord-005453-4057qib7	3228	25	12	12	CD
cord-005453-4057qib7	3228	26	months	month	NNS
cord-005453-4057qib7	3228	27	)	)	-RRB-
cord-005453-4057qib7	3228	28	compared	compare	VBN
cord-005453-4057qib7	3228	29	to	to	IN
cord-005453-4057qib7	3228	30	the	the	DT
cord-005453-4057qib7	3228	31	group	group	NN
cord-005453-4057qib7	3228	32	with	with	IN
cord-005453-4057qib7	3228	33	low	low	JJ
cord-005453-4057qib7	3228	34	EASIX	EASIX	NNP
cord-005453-4057qib7	3228	35	score	score	NN
cord-005453-4057qib7	3228	36	(	(	-LRB-
cord-005453-4057qib7	3228	37	18	18	CD
cord-005453-4057qib7	3228	38	%	%	NN
cord-005453-4057qib7	3228	39	,	,	,
cord-005453-4057qib7	3228	40	95%CI	95%ci	CD
cord-005453-4057qib7	3228	41	13	13	CD
cord-005453-4057qib7	3228	42	-	-	SYM
cord-005453-4057qib7	3228	43	23	23	CD
cord-005453-4057qib7	3228	44	at	at	IN
cord-005453-4057qib7	3228	45	12	12	CD
cord-005453-4057qib7	3228	46	months	month	NNS
cord-005453-4057qib7	3228	47	)	)	-RRB-
cord-005453-4057qib7	3228	48	(	(	-LRB-
cord-005453-4057qib7	3228	49	p=0.009	p=0.009	NN
cord-005453-4057qib7	3228	50	)	)	-RRB-
cord-005453-4057qib7	3228	51	.	.	.
cord-005453-4057qib7	3229	1	In	in	IN
cord-005453-4057qib7	3229	2	the	the	DT
cord-005453-4057qib7	3229	3	multivariate	multivariate	JJ
cord-005453-4057qib7	3229	4	analysis	analysis	NN
cord-005453-4057qib7	3229	5	which	which	WDT
cord-005453-4057qib7	3229	6	included	include	VBD
cord-005453-4057qib7	3229	7	EASIX	EASIX	NNP
cord-005453-4057qib7	3229	8	,	,	,
cord-005453-4057qib7	3229	9	patients	patient	NNS
cord-005453-4057qib7	3229	10	'	'	POS
cord-005453-4057qib7	3229	11	age	age	NN
cord-005453-4057qib7	3229	12	,	,	,
cord-005453-4057qib7	3229	13	intensity	intensity	NN
cord-005453-4057qib7	3229	14	of	of	IN
cord-005453-4057qib7	3229	15	conditioning	conditioning	NN
cord-005453-4057qib7	3229	16	,	,	,
cord-005453-4057qib7	3229	17	diagnosis	diagnosis	NN
cord-005453-4057qib7	3229	18	(	(	-LRB-
cord-005453-4057qib7	3229	19	lymphoid	lymphoid	NN
cord-005453-4057qib7	3229	20	vs	vs	IN
cord-005453-4057qib7	3229	21	myeloid	myeloid	NN
cord-005453-4057qib7	3229	22	)	)	-RRB-
cord-005453-4057qib7	3229	23	,	,	,
cord-005453-4057qib7	3229	24	status	status	NN
cord-005453-4057qib7	3229	25	of	of	IN
cord-005453-4057qib7	3229	26	the	the	DT
cord-005453-4057qib7	3229	27	disease	disease	NN
cord-005453-4057qib7	3229	28	at	at	IN
cord-005453-4057qib7	3229	29	transplant	transplant	NN
cord-005453-4057qib7	3229	30	and	and	CC
cord-005453-4057qib7	3229	31	type	type	NN
cord-005453-4057qib7	3229	32	of	of	IN
cord-005453-4057qib7	3229	33	the	the	DT
cord-005453-4057qib7	3229	34	donor	donor	NN
cord-005453-4057qib7	3229	35	,	,	,
cord-005453-4057qib7	3229	36	worse	bad	JJR
cord-005453-4057qib7	3229	37	OS	OS	NNP
cord-005453-4057qib7	3229	38	was	be	VBD
cord-005453-4057qib7	3229	39	independently	independently	RB
cord-005453-4057qib7	3229	40	associated	associate	VBN
cord-005453-4057qib7	3229	41	only	only	RB
cord-005453-4057qib7	3229	42	with	with	IN
cord-005453-4057qib7	3229	43	older	old	JJR
cord-005453-4057qib7	3229	44	age	age	NN
cord-005453-4057qib7	3229	45	of	of	IN
cord-005453-4057qib7	3229	46	patients	patient	NNS
cord-005453-4057qib7	3229	47	(	(	-LRB-
cord-005453-4057qib7	3229	48	HR	HR	NNP
cord-005453-4057qib7	3229	49	1.66	1.66	CD
cord-005453-4057qib7	3229	50	;	;	:
cord-005453-4057qib7	3229	51	95	95	CD
cord-005453-4057qib7	3229	52	%	%	NN
cord-005453-4057qib7	3229	53	CI	ci	NN
cord-005453-4057qib7	3229	54	,	,	,
cord-005453-4057qib7	3229	55	1.07	1.07	CD
cord-005453-4057qib7	3229	56	-	-	SYM
cord-005453-4057qib7	3229	57	2.59	2.59	CD
cord-005453-4057qib7	3229	58	,	,	,
cord-005453-4057qib7	3229	59	p=0.02	p=0.02	NN
cord-005453-4057qib7	3229	60	)	)	-RRB-
cord-005453-4057qib7	3229	61	and	and	CC
cord-005453-4057qib7	3229	62	high	high	JJ
cord-005453-4057qib7	3229	63	EASIX	EASIX	NNP
cord-005453-4057qib7	3229	64	score	score	NN
cord-005453-4057qib7	3229	65	(	(	-LRB-
cord-005453-4057qib7	3229	66	HR	HR	NNP
cord-005453-4057qib7	3229	67	1.51	1.51	CD
cord-005453-4057qib7	3229	68	;	;	:
cord-005453-4057qib7	3229	69	95	95	CD
cord-005453-4057qib7	3229	70	%	%	NN
cord-005453-4057qib7	3229	71	CI	CI	NNP
cord-005453-4057qib7	3229	72	,	,	,
cord-005453-4057qib7	3229	73	1.01	1.01	CD
cord-005453-4057qib7	3229	74	-	-	SYM
cord-005453-4057qib7	3229	75	2.24	2.24	CD
cord-005453-4057qib7	3229	76	,	,	,
cord-005453-4057qib7	3229	77	p=0.04	p=0.04	NNP
cord-005453-4057qib7	3229	78	)	)	-RRB-
cord-005453-4057qib7	3229	79	.	.	.
cord-005453-4057qib7	3230	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3230	2	:	:	:
cord-005453-4057qib7	3231	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3231	2	retrospective	retrospective	JJ
cord-005453-4057qib7	3231	3	data	datum	NNS
cord-005453-4057qib7	3231	4	support	support	VBP
cord-005453-4057qib7	3231	5	previous	previous	JJ
cord-005453-4057qib7	3231	6	data	datum	NNS
cord-005453-4057qib7	3231	7	and	and	CC
cord-005453-4057qib7	3231	8	suggest	suggest	VBP
cord-005453-4057qib7	3231	9	that	that	IN
cord-005453-4057qib7	3231	10	EASIX	EASIX	NNP
cord-005453-4057qib7	3231	11	could	could	MD
cord-005453-4057qib7	3231	12	potentially	potentially	RB
cord-005453-4057qib7	3231	13	serve	serve	VB
cord-005453-4057qib7	3231	14	as	as	IN
cord-005453-4057qib7	3231	15	a	a	DT
cord-005453-4057qib7	3231	16	valid	valid	JJ
cord-005453-4057qib7	3231	17	tool	tool	NN
cord-005453-4057qib7	3231	18	for	for	IN
cord-005453-4057qib7	3231	19	prediction	prediction	NN
cord-005453-4057qib7	3231	20	of	of	IN
cord-005453-4057qib7	3231	21	allo	allo	NNP
cord-005453-4057qib7	3231	22	-	-	HYPH
cord-005453-4057qib7	3231	23	SCT	SCT	NNP
cord-005453-4057qib7	3231	24	outcomes	outcome	NNS
cord-005453-4057qib7	3231	25	.	.	.
cord-005453-4057qib7	3232	1	As	as	IN
cord-005453-4057qib7	3232	2	a	a	DT
cord-005453-4057qib7	3232	3	simple	simple	JJ
cord-005453-4057qib7	3232	4	biomarker	biomarker	NN
cord-005453-4057qib7	3232	5	panel	panel	NN
cord-005453-4057qib7	3232	6	,	,	,
cord-005453-4057qib7	3232	7	EASIX	EASIX	NNP
cord-005453-4057qib7	3232	8	could	could	MD
cord-005453-4057qib7	3232	9	easily	easily	RB
cord-005453-4057qib7	3232	10	be	be	VB
cord-005453-4057qib7	3232	11	implemented	implement	VBN
cord-005453-4057qib7	3232	12	in	in	IN
cord-005453-4057qib7	3232	13	clinical	clinical	JJ
cord-005453-4057qib7	3232	14	decision	decision	NN
cord-005453-4057qib7	3232	15	making	make	VBG
cord-005453-4057qib7	3232	16	in	in	IN
cord-005453-4057qib7	3232	17	the	the	DT
cord-005453-4057qib7	3232	18	field	field	NN
cord-005453-4057qib7	3232	19	of	of	IN
cord-005453-4057qib7	3232	20	allo	allo	NN
cord-005453-4057qib7	3232	21	-	-	HYPH
cord-005453-4057qib7	3232	22	SCT	SCT	NNP
cord-005453-4057qib7	3232	23	.	.	.
cord-005453-4057qib7	3233	1	These	these	DT
cord-005453-4057qib7	3233	2	retrospective	retrospective	JJ
cord-005453-4057qib7	3233	3	data	datum	NNS
cord-005453-4057qib7	3233	4	need	need	VBP
cord-005453-4057qib7	3233	5	validation	validation	NN
cord-005453-4057qib7	3233	6	in	in	IN
cord-005453-4057qib7	3233	7	a	a	DT
cord-005453-4057qib7	3233	8	prospective	prospective	JJ
cord-005453-4057qib7	3233	9	study	study	NN
cord-005453-4057qib7	3233	10	which	which	WDT
cord-005453-4057qib7	3233	11	is	be	VBZ
cord-005453-4057qib7	3233	12	currently	currently	RB
cord-005453-4057qib7	3233	13	being	be	VBG
cord-005453-4057qib7	3233	14	conducted	conduct	VBN
cord-005453-4057qib7	3233	15	.	.	.
cord-005453-4057qib7	3234	1	Clinical	clinical	JJ
cord-005453-4057qib7	3234	2	Background	background	NN
cord-005453-4057qib7	3234	3	:	:	:
cord-005453-4057qib7	3234	4	Veno	Veno	NNP
cord-005453-4057qib7	3234	5	-	-	HYPH
cord-005453-4057qib7	3234	6	occlusive	occlusive	JJ
cord-005453-4057qib7	3234	7	disease	disease	NN
cord-005453-4057qib7	3235	1	(	(	-LRB-
cord-005453-4057qib7	3235	2	VOD	VOD	NNP
cord-005453-4057qib7	3235	3	)	)	-RRB-
cord-005453-4057qib7	3235	4	is	be	VBZ
cord-005453-4057qib7	3235	5	a	a	DT
cord-005453-4057qib7	3235	6	potentially	potentially	RB
cord-005453-4057qib7	3235	7	devastating	devastating	JJ
cord-005453-4057qib7	3235	8	complication	complication	NN
cord-005453-4057qib7	3235	9	that	that	WDT
cord-005453-4057qib7	3235	10	can	can	MD
cord-005453-4057qib7	3235	11	occur	occur	VB
cord-005453-4057qib7	3235	12	after	after	IN
cord-005453-4057qib7	3235	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3235	14	stem	stem	NN
cord-005453-4057qib7	3235	15	cell	cell	NN
cord-005453-4057qib7	3235	16	transplant	transplant	NN
cord-005453-4057qib7	3235	17	(	(	-LRB-
cord-005453-4057qib7	3235	18	HSCT	HSCT	NNP
cord-005453-4057qib7	3235	19	)	)	-RRB-
cord-005453-4057qib7	3235	20	and	and	CC
cord-005453-4057qib7	3235	21	in	in	IN
cord-005453-4057qib7	3235	22	severe	severe	JJ
cord-005453-4057qib7	3235	23	cases	case	NNS
cord-005453-4057qib7	3235	24	can	can	MD
cord-005453-4057qib7	3235	25	lead	lead	VB
cord-005453-4057qib7	3235	26	to	to	IN
cord-005453-4057qib7	3235	27	multi	multi	JJ
cord-005453-4057qib7	3235	28	-	-	JJ
cord-005453-4057qib7	3235	29	organ	organ	JJ
cord-005453-4057qib7	3235	30	failure	failure	NN
cord-005453-4057qib7	3235	31	.	.	.
cord-005453-4057qib7	3236	1	(	(	-LRB-
cord-005453-4057qib7	3236	2	Mohty	Mohty	NNP
cord-005453-4057qib7	3236	3	2016	2016	CD
cord-005453-4057qib7	3236	4	)	)	-RRB-
cord-005453-4057qib7	3236	5	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	3236	6	has	have	VBZ
cord-005453-4057qib7	3236	7	been	be	VBN
cord-005453-4057qib7	3236	8	proven	prove	VBN
cord-005453-4057qib7	3236	9	to	to	TO
cord-005453-4057qib7	3236	10	be	be	VB
cord-005453-4057qib7	3236	11	effective	effective	JJ
cord-005453-4057qib7	3236	12	to	to	TO
cord-005453-4057qib7	3236	13	prevent	prevent	VB
cord-005453-4057qib7	3236	14	and	and	CC
cord-005453-4057qib7	3236	15	treat	treat	VB
cord-005453-4057qib7	3236	16	VOD	VOD	NNP
cord-005453-4057qib7	3236	17	,	,	,
cord-005453-4057qib7	3236	18	and	and	CC
cord-005453-4057qib7	3236	19	it	-PRON-	PRP
cord-005453-4057qib7	3236	20	is	be	VBZ
cord-005453-4057qib7	3236	21	critical	critical	JJ
cord-005453-4057qib7	3236	22	that	that	IN
cord-005453-4057qib7	3236	23	clinicians	clinician	NNS
cord-005453-4057qib7	3236	24	are	be	VBP
cord-005453-4057qib7	3236	25	aware	aware	JJ
cord-005453-4057qib7	3236	26	of	of	IN
cord-005453-4057qib7	3236	27	how	how	WRB
cord-005453-4057qib7	3236	28	to	to	TO
cord-005453-4057qib7	3236	29	diagnose	diagnose	VB
cord-005453-4057qib7	3236	30	and	and	CC
cord-005453-4057qib7	3236	31	treat	treat	VB
cord-005453-4057qib7	3236	32	this	this	DT
cord-005453-4057qib7	3236	33	serious	serious	JJ
cord-005453-4057qib7	3236	34	complication	complication	NN
cord-005453-4057qib7	3236	35	of	of	IN
cord-005453-4057qib7	3236	36	HSCT	HSCT	NNP
cord-005453-4057qib7	3236	37	.	.	.
cord-005453-4057qib7	3237	1	This	this	DT
cord-005453-4057qib7	3237	2	study	study	NN
cord-005453-4057qib7	3237	3	was	be	VBD
cord-005453-4057qib7	3237	4	conducted	conduct	VBN
cord-005453-4057qib7	3237	5	to	to	TO
cord-005453-4057qib7	3237	6	determine	determine	VB
cord-005453-4057qib7	3237	7	if	if	IN
cord-005453-4057qib7	3237	8	an	an	DT
cord-005453-4057qib7	3237	9	online	online	NN
cord-005453-4057qib7	3237	10	,	,	,
cord-005453-4057qib7	3237	11	simulation	simulation	NN
cord-005453-4057qib7	3237	12	-	-	HYPH
cord-005453-4057qib7	3237	13	based	base	VBN
cord-005453-4057qib7	3237	14	continuing	continue	VBG
cord-005453-4057qib7	3237	15	medical	medical	JJ
cord-005453-4057qib7	3237	16	education	education	NN
cord-005453-4057qib7	3237	17	(	(	-LRB-
cord-005453-4057qib7	3237	18	CME	CME	NNP
cord-005453-4057qib7	3237	19	)	)	-RRB-
cord-005453-4057qib7	3237	20	intervention	intervention	NN
cord-005453-4057qib7	3237	21	could	could	MD
cord-005453-4057qib7	3237	22	improve	improve	VB
cord-005453-4057qib7	3237	23	performance	performance	NN
cord-005453-4057qib7	3237	24	of	of	IN
cord-005453-4057qib7	3237	25	hematologists	hematologist	NNS
cord-005453-4057qib7	3237	26	/	/	SYM
cord-005453-4057qib7	3237	27	oncologists	oncologist	NNS
cord-005453-4057qib7	3237	28	(	(	-LRB-
cord-005453-4057qib7	3237	29	hem/	hem/	NNP
cord-005453-4057qib7	3237	30	onc	onc	NNP
cord-005453-4057qib7	3237	31	)	)	-RRB-
cord-005453-4057qib7	3237	32	and	and	CC
cord-005453-4057qib7	3237	33	advanced	advanced	JJ
cord-005453-4057qib7	3237	34	practice	practice	NN
cord-005453-4057qib7	3237	35	providers	provider	NNS
cord-005453-4057qib7	3237	36	(	(	-LRB-
cord-005453-4057qib7	3237	37	nurse	nurse	NN
cord-005453-4057qib7	3237	38	practitioners	practitioner	NNS
cord-005453-4057qib7	3237	39	and	and	CC
cord-005453-4057qib7	3237	40	physician	physician	NN
cord-005453-4057qib7	3237	41	assistants	assistant	NNS
cord-005453-4057qib7	3237	42	,	,	,
cord-005453-4057qib7	3237	43	APPs	app	NNS
cord-005453-4057qib7	3237	44	)	)	-RRB-
cord-005453-4057qib7	3237	45	in	in	IN
cord-005453-4057qib7	3237	46	the	the	DT
cord-005453-4057qib7	3237	47	diagnosis	diagnosis	NN
cord-005453-4057qib7	3237	48	and	and	CC
cord-005453-4057qib7	3237	49	treatment	treatment	NN
cord-005453-4057qib7	3237	50	of	of	IN
cord-005453-4057qib7	3237	51	patients	patient	NNS
cord-005453-4057qib7	3237	52	with	with	IN
cord-005453-4057qib7	3237	53	VOD	VOD	NNP
cord-005453-4057qib7	3237	54	.	.	.
cord-005453-4057qib7	3238	1	(	(	-LRB-
cord-005453-4057qib7	3238	2	Methods	method	NNS
cord-005453-4057qib7	3238	3	:	:	:
cord-005453-4057qib7	3238	4	A	a	DT
cord-005453-4057qib7	3238	5	CME	CME	NNP
cord-005453-4057qib7	3238	6	certified	certify	VBN
cord-005453-4057qib7	3238	7	virtual	virtual	JJ
cord-005453-4057qib7	3238	8	patient	patient	NN
cord-005453-4057qib7	3238	9	simulation	simulation	NN
cord-005453-4057qib7	3238	10	(	(	-LRB-
cord-005453-4057qib7	3238	11	VPS	VPS	NNP
cord-005453-4057qib7	3238	12	)	)	-RRB-
cord-005453-4057qib7	3238	13	was	be	VBD
cord-005453-4057qib7	3238	14	made	make	VBN
cord-005453-4057qib7	3238	15	available	available	JJ
cord-005453-4057qib7	3238	16	via	via	IN
cord-005453-4057qib7	3238	17	a	a	DT
cord-005453-4057qib7	3238	18	website	website	NN
cord-005453-4057qib7	3238	19	dedicated	dedicate	VBN
cord-005453-4057qib7	3238	20	to	to	IN
cord-005453-4057qib7	3238	21	continuous	continuous	JJ
cord-005453-4057qib7	3238	22	professional	professional	JJ
cord-005453-4057qib7	3238	23	development	development	NN
cord-005453-4057qib7	3238	24	.	.	.
cord-005453-4057qib7	3239	1	The	the	DT
cord-005453-4057qib7	3239	2	VPS	VPS	NNP
cord-005453-4057qib7	3239	3	consisted	consist	VBD
cord-005453-4057qib7	3239	4	of	of	IN
cord-005453-4057qib7	3239	5	2	2	CD
cord-005453-4057qib7	3239	6	cases	case	NNS
cord-005453-4057qib7	3239	7	presented	present	VBN
cord-005453-4057qib7	3239	8	in	in	IN
cord-005453-4057qib7	3239	9	a	a	DT
cord-005453-4057qib7	3239	10	platform	platform	NN
cord-005453-4057qib7	3239	11	that	that	WDT
cord-005453-4057qib7	3239	12	allows	allow	VBZ
cord-005453-4057qib7	3239	13	clinicians	clinician	NNS
cord-005453-4057qib7	3239	14	to	to	TO
cord-005453-4057qib7	3239	15	assess	assess	VB
cord-005453-4057qib7	3239	16	the	the	DT
cord-005453-4057qib7	3239	17	patients	patient	NNS
cord-005453-4057qib7	3239	18	and	and	CC
cord-005453-4057qib7	3239	19	make	make	VB
cord-005453-4057qib7	3239	20	diagnostic	diagnostic	JJ
cord-005453-4057qib7	3239	21	and	and	CC
cord-005453-4057qib7	3239	22	therapeutic	therapeutic	JJ
cord-005453-4057qib7	3239	23	decisions	decision	NNS
cord-005453-4057qib7	3239	24	supported	support	VBN
cord-005453-4057qib7	3239	25	by	by	IN
cord-005453-4057qib7	3239	26	an	an	DT
cord-005453-4057qib7	3239	27	extensive	extensive	JJ
cord-005453-4057qib7	3239	28	database	database	NN
cord-005453-4057qib7	3239	29	of	of	IN
cord-005453-4057qib7	3239	30	diagnostic	diagnostic	JJ
cord-005453-4057qib7	3239	31	and	and	CC
cord-005453-4057qib7	3239	32	treatment	treatment	NN
cord-005453-4057qib7	3239	33	possibilities	possibility	NNS
cord-005453-4057qib7	3239	34	,	,	,
cord-005453-4057qib7	3239	35	matching	match	VBG
cord-005453-4057qib7	3239	36	the	the	DT
cord-005453-4057qib7	3239	37	scope	scope	NN
cord-005453-4057qib7	3239	38	and	and	CC
cord-005453-4057qib7	3239	39	depth	depth	NN
cord-005453-4057qib7	3239	40	of	of	IN
cord-005453-4057qib7	3239	41	actual	actual	JJ
cord-005453-4057qib7	3239	42	practice	practice	NN
cord-005453-4057qib7	3239	43	.	.	.
cord-005453-4057qib7	3240	1	Clinical	clinical	JJ
cord-005453-4057qib7	3240	2	decisions	decision	NNS
cord-005453-4057qib7	3240	3	were	be	VBD
cord-005453-4057qib7	3240	4	analyzed	analyze	VBN
cord-005453-4057qib7	3240	5	using	use	VBG
cord-005453-4057qib7	3240	6	a	a	DT
cord-005453-4057qib7	3240	7	sophisticated	sophisticated	JJ
cord-005453-4057qib7	3240	8	decision	decision	NN
cord-005453-4057qib7	3240	9	engine	engine	NN
cord-005453-4057qib7	3240	10	,	,	,
cord-005453-4057qib7	3240	11	and	and	CC
cord-005453-4057qib7	3240	12	tailored	tailor	VBN
cord-005453-4057qib7	3240	13	clinical	clinical	JJ
cord-005453-4057qib7	3240	14	guidance	guidance	NN
cord-005453-4057qib7	3240	15	(	(	-LRB-
cord-005453-4057qib7	3240	16	CG	CG	NNP
cord-005453-4057qib7	3240	17	)	)	-RRB-
cord-005453-4057qib7	3240	18	employing	employ	VBG
cord-005453-4057qib7	3241	1	up	up	IN
cord-005453-4057qib7	3241	2	-	-	HYPH
cord-005453-4057qib7	3241	3	to	to	IN
cord-005453-4057qib7	3241	4	-	-	HYPH
cord-005453-4057qib7	3241	5	date	date	NN
cord-005453-4057qib7	3241	6	evidence	evidence	NN
cord-005453-4057qib7	3241	7	-	-	HYPH
cord-005453-4057qib7	3241	8	based	base	VBN
cord-005453-4057qib7	3241	9	and	and	CC
cord-005453-4057qib7	3241	10	faculty	faculty	NN
cord-005453-4057qib7	3241	11	recommendations	recommendation	NNS
cord-005453-4057qib7	3241	12	was	be	VBD
cord-005453-4057qib7	3241	13	provided	provide	VBN
cord-005453-4057qib7	3241	14	after	after	IN
cord-005453-4057qib7	3241	15	each	each	DT
cord-005453-4057qib7	3241	16	decision	decision	NN
cord-005453-4057qib7	3241	17	.	.	.
cord-005453-4057qib7	3242	1	One	one	CD
cord-005453-4057qib7	3242	2	case	case	NN
cord-005453-4057qib7	3242	3	was	be	VBD
cord-005453-4057qib7	3242	4	about	about	IN
cord-005453-4057qib7	3242	5	VOD	VOD	NNP
cord-005453-4057qib7	3242	6	and	and	CC
cord-005453-4057qib7	3242	7	the	the	DT
cord-005453-4057qib7	3242	8	other	other	JJ
cord-005453-4057qib7	3242	9	case	case	NN
cord-005453-4057qib7	3242	10	was	be	VBD
cord-005453-4057qib7	3242	11	about	about	IN
cord-005453-4057qib7	3242	12	acute	acute	JJ
cord-005453-4057qib7	3242	13	myeloid	myeloid	NN
cord-005453-4057qib7	3242	14	leukemia	leukemia	NN
cord-005453-4057qib7	3242	15	(	(	-LRB-
cord-005453-4057qib7	3242	16	AML	AML	NNP
cord-005453-4057qib7	3242	17	)	)	-RRB-
cord-005453-4057qib7	3242	18	.	.	.
cord-005453-4057qib7	3243	1	Decisions	decision	NNS
cord-005453-4057qib7	3243	2	were	be	VBD
cord-005453-4057qib7	3243	3	collected	collect	VBN
cord-005453-4057qib7	3243	4	post	post	JJ
cord-005453-4057qib7	3243	5	-	-	JJ
cord-005453-4057qib7	3243	6	CG	cg	JJ
cord-005453-4057qib7	3243	7	and	and	CC
cord-005453-4057qib7	3243	8	compared	compare	VBN
cord-005453-4057qib7	3243	9	with	with	IN
cord-005453-4057qib7	3243	10	each	each	DT
cord-005453-4057qib7	3243	11	user	user	NN
cord-005453-4057qib7	3243	12	's	's	POS
cord-005453-4057qib7	3243	13	baseline	baseline	JJ
cord-005453-4057qib7	3243	14	(	(	-LRB-
cord-005453-4057qib7	3243	15	pre	pre	JJ
cord-005453-4057qib7	3243	16	-	-	JJ
cord-005453-4057qib7	3243	17	CG	cg	JJ
cord-005453-4057qib7	3243	18	)	)	-RRB-
cord-005453-4057qib7	3243	19	decisions	decision	NNS
cord-005453-4057qib7	3243	20	using	use	VBG
cord-005453-4057qib7	3243	21	a	a	DT
cord-005453-4057qib7	3243	22	2-tailed	2-tailed	CD
cord-005453-4057qib7	3243	23	paired	paired	JJ
cord-005453-4057qib7	3243	24	t	t	NN
cord-005453-4057qib7	3243	25	-	-	HYPH
cord-005453-4057qib7	3243	26	test	test	NN
cord-005453-4057qib7	3243	27	to	to	TO
cord-005453-4057qib7	3243	28	determine	determine	VB
cord-005453-4057qib7	3243	29	p	p	NN
cord-005453-4057qib7	3243	30	-	-	HYPH
cord-005453-4057qib7	3243	31	values	value	NNS
cord-005453-4057qib7	3243	32	(	(	-LRB-
cord-005453-4057qib7	3243	33	P	p	NN
cord-005453-4057qib7	3243	34	<	<	XX
cord-005453-4057qib7	3243	35	.05	.05	NFP
cord-005453-4057qib7	3243	36	indicates	indicate	VBZ
cord-005453-4057qib7	3243	37	significance	significance	NN
cord-005453-4057qib7	3243	38	)	)	-RRB-
cord-005453-4057qib7	3243	39	.	.	.
cord-005453-4057qib7	3244	1	Data	datum	NNS
cord-005453-4057qib7	3244	2	were	be	VBD
cord-005453-4057qib7	3244	3	collected	collect	VBN
cord-005453-4057qib7	3244	4	between	between	IN
cord-005453-4057qib7	3244	5	9/21/2017	9/21/2017	CD
cord-005453-4057qib7	3244	6	and	and	CC
cord-005453-4057qib7	3244	7	11/7/2018	11/7/2018	CD
cord-005453-4057qib7	3244	8	.	.	.
cord-005453-4057qib7	3245	1	Results	result	NNS
cord-005453-4057qib7	3245	2	:	:	:
cord-005453-4057qib7	3246	1	At	at	IN
cord-005453-4057qib7	3246	2	the	the	DT
cord-005453-4057qib7	3246	3	time	time	NN
cord-005453-4057qib7	3246	4	of	of	IN
cord-005453-4057qib7	3246	5	assessment	assessment	NN
cord-005453-4057qib7	3246	6	,	,	,
cord-005453-4057qib7	3246	7	115	115	CD
cord-005453-4057qib7	3246	8	hem	hem	NNP
cord-005453-4057qib7	3246	9	/	/	SYM
cord-005453-4057qib7	3246	10	oncs	oncs	NN
cord-005453-4057qib7	3246	11	and	and	CC
cord-005453-4057qib7	3246	12	409	409	CD
cord-005453-4057qib7	3246	13	APPs	app	NNS
cord-005453-4057qib7	3246	14	had	have	VBD
cord-005453-4057qib7	3246	15	fulfilled	fulfil	VBN
cord-005453-4057qib7	3246	16	the	the	DT
cord-005453-4057qib7	3246	17	participation	participation	NN
cord-005453-4057qib7	3246	18	criteria	criterion	NNS
cord-005453-4057qib7	3246	19	for	for	IN
cord-005453-4057qib7	3246	20	completing	complete	VBG
cord-005453-4057qib7	3246	21	the	the	DT
cord-005453-4057qib7	3246	22	VOD	VOD	NNP
cord-005453-4057qib7	3246	23	case	case	NN
cord-005453-4057qib7	3246	24	simulation	simulation	NN
cord-005453-4057qib7	3246	25	.	.	.
cord-005453-4057qib7	3247	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3247	2	:	:	:
cord-005453-4057qib7	3248	1	This	this	DT
cord-005453-4057qib7	3248	2	study	study	NN
cord-005453-4057qib7	3248	3	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	3248	4	that	that	IN
cord-005453-4057qib7	3248	5	VPS	VPS	NNP
cord-005453-4057qib7	3248	6	that	that	WDT
cord-005453-4057qib7	3248	7	immersed	immerse	VBD
cord-005453-4057qib7	3248	8	and	and	CC
cord-005453-4057qib7	3248	9	engaged	engage	VBD
cord-005453-4057qib7	3248	10	clinicians	clinician	NNS
cord-005453-4057qib7	3248	11	in	in	IN
cord-005453-4057qib7	3248	12	an	an	DT
cord-005453-4057qib7	3248	13	authentic	authentic	JJ
cord-005453-4057qib7	3248	14	and	and	CC
cord-005453-4057qib7	3248	15	practical	practical	JJ
cord-005453-4057qib7	3248	16	learning	learning	NN
cord-005453-4057qib7	3248	17	experience	experience	NN
cord-005453-4057qib7	3248	18	improved	improve	VBD
cord-005453-4057qib7	3248	19	evidence	evidence	NN
cord-005453-4057qib7	3248	20	-	-	HYPH
cord-005453-4057qib7	3248	21	based	base	VBN
cord-005453-4057qib7	3248	22	clinical	clinical	JJ
cord-005453-4057qib7	3248	23	decisions	decision	NNS
cord-005453-4057qib7	3248	24	related	relate	VBN
cord-005453-4057qib7	3248	25	to	to	IN
cord-005453-4057qib7	3248	26	the	the	DT
cord-005453-4057qib7	3248	27	management	management	NN
cord-005453-4057qib7	3248	28	of	of	IN
cord-005453-4057qib7	3248	29	VOD	VOD	NNP
cord-005453-4057qib7	3248	30	.	.	.
cord-005453-4057qib7	3249	1	This	this	DT
cord-005453-4057qib7	3249	2	VPS	VPS	NNP
cord-005453-4057qib7	3249	3	increased	increase	VBD
cord-005453-4057qib7	3249	4	the	the	DT
cord-005453-4057qib7	3249	5	percentage	percentage	NN
cord-005453-4057qib7	3249	6	of	of	IN
cord-005453-4057qib7	3249	7	clinicians	clinician	NNS
cord-005453-4057qib7	3249	8	who	who	WP
cord-005453-4057qib7	3249	9	utilized	utilize	VBD
cord-005453-4057qib7	3249	10	standardized	standardized	JJ
cord-005453-4057qib7	3249	11	criteria	criterion	NNS
cord-005453-4057qib7	3249	12	to	to	TO
cord-005453-4057qib7	3249	13	diagnose	diagnose	VB
cord-005453-4057qib7	3249	14	VOD	VOD	NNP
cord-005453-4057qib7	3249	15	and	and	CC
cord-005453-4057qib7	3249	16	who	who	WP
cord-005453-4057qib7	3249	17	ordered	order	VBD
cord-005453-4057qib7	3249	18	defibrotide	defibrotide	NN
cord-005453-4057qib7	3249	19	and	and	CC
cord-005453-4057qib7	3249	20	IV	IV	NNP
cord-005453-4057qib7	3249	21	fluids	fluid	NNS
cord-005453-4057qib7	3249	22	for	for	IN
cord-005453-4057qib7	3249	23	VOD	VOD	NNP
cord-005453-4057qib7	3249	24	management	management	NN
cord-005453-4057qib7	3249	25	.	.	.
cord-005453-4057qib7	3250	1	However	however	RB
cord-005453-4057qib7	3250	2	,	,	,
cord-005453-4057qib7	3250	3	further	further	JJ
cord-005453-4057qib7	3250	4	education	education	NN
cord-005453-4057qib7	3250	5	is	be	VBZ
cord-005453-4057qib7	3250	6	needed	need	VBN
cord-005453-4057qib7	3250	7	to	to	TO
cord-005453-4057qib7	3250	8	increase	increase	VB
cord-005453-4057qib7	3250	9	the	the	DT
cord-005453-4057qib7	3250	10	competence	competence	NN
cord-005453-4057qib7	3250	11	and	and	CC
cord-005453-4057qib7	3250	12	performance	performance	NN
cord-005453-4057qib7	3250	13	of	of	IN
cord-005453-4057qib7	3250	14	clinicians	clinician	NNS
cord-005453-4057qib7	3250	15	,	,	,
cord-005453-4057qib7	3250	16	particularly	particularly	RB
cord-005453-4057qib7	3250	17	APPs	app	NNS
cord-005453-4057qib7	3250	18	,	,	,
cord-005453-4057qib7	3250	19	in	in	IN
cord-005453-4057qib7	3250	20	these	these	DT
cord-005453-4057qib7	3250	21	areas	area	NNS
cord-005453-4057qib7	3250	22	in	in	IN
cord-005453-4057qib7	3250	23	order	order	NN
cord-005453-4057qib7	3250	24	to	to	TO
cord-005453-4057qib7	3250	25	positively	positively	RB
cord-005453-4057qib7	3250	26	impact	impact	VB
cord-005453-4057qib7	3250	27	patients	patient	NNS
cord-005453-4057qib7	3250	28	.	.	.
cord-005453-4057qib7	3251	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3251	2	:	:	:
cord-005453-4057qib7	3251	3	Nothing	nothing	NN
cord-005453-4057qib7	3251	4	to	to	TO
cord-005453-4057qib7	3251	5	declare	declare	VB
cord-005453-4057qib7	3251	6	.	.	.
cord-005453-4057qib7	3252	1	A	a	DT
cord-005453-4057qib7	3252	2	nationwide	nationwide	JJ
cord-005453-4057qib7	3252	3	retrospective	retrospective	JJ
cord-005453-4057qib7	3252	4	study	study	NN
cord-005453-4057qib7	3252	5	of	of	IN
cord-005453-4057qib7	3252	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3252	7	stem	stem	NN
cord-005453-4057qib7	3252	8	cell	cell	NN
cord-005453-4057qib7	3252	9	transplantation	transplantation	NN
cord-005453-4057qib7	3252	10	in	in	IN
cord-005453-4057qib7	3252	11	solid	solid	JJ
cord-005453-4057qib7	3252	12	organ	organ	NN
cord-005453-4057qib7	3252	13	transplant	transplant	NN
cord-005453-4057qib7	3252	14	recipients	recipient	NNS
cord-005453-4057qib7	3252	15	:	:	:
cord-005453-4057qib7	3252	16	On	on	IN
cord-005453-4057qib7	3252	17	behalf	behalf	NN
cord-005453-4057qib7	3252	18	of	of	IN
cord-005453-4057qib7	3252	19	JSHCT	JSHCT	NNP
cord-005453-4057qib7	3252	20	,	,	,
cord-005453-4057qib7	3252	21	transplant	transplant	NN
cord-005453-4057qib7	3252	22	complications	complication	NNS
cord-005453-4057qib7	3252	23	working	work	VBG
cord-005453-4057qib7	3252	24	group	group	NN
cord-005453-4057qib7	3252	25	Background	Background	NNP
cord-005453-4057qib7	3252	26	:	:	:
cord-005453-4057qib7	3252	27	The	the	DT
cord-005453-4057qib7	3252	28	outcome	outcome	NN
cord-005453-4057qib7	3252	29	of	of	IN
cord-005453-4057qib7	3252	30	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3252	31	stem	stem	NN
cord-005453-4057qib7	3252	32	cell	cell	NN
cord-005453-4057qib7	3252	33	transplantation	transplantation	NN
cord-005453-4057qib7	3252	34	(	(	-LRB-
cord-005453-4057qib7	3252	35	HSCT	HSCT	NNP
cord-005453-4057qib7	3252	36	)	)	-RRB-
cord-005453-4057qib7	3252	37	in	in	IN
cord-005453-4057qib7	3252	38	solid	solid	JJ
cord-005453-4057qib7	3252	39	organ	organ	NN
cord-005453-4057qib7	3252	40	transplant	transplant	NN
cord-005453-4057qib7	3252	41	remain	remain	VBP
cord-005453-4057qib7	3252	42	unclear	unclear	JJ
cord-005453-4057qib7	3252	43	.	.	.
cord-005453-4057qib7	3253	1	To	to	TO
cord-005453-4057qib7	3253	2	address	address	VB
cord-005453-4057qib7	3253	3	this	this	DT
cord-005453-4057qib7	3253	4	issue	issue	NN
cord-005453-4057qib7	3253	5	,	,	,
cord-005453-4057qib7	3253	6	we	-PRON-	PRP
cord-005453-4057qib7	3253	7	conducted	conduct	VBD
cord-005453-4057qib7	3253	8	a	a	DT
cord-005453-4057qib7	3253	9	retrospective	retrospective	JJ
cord-005453-4057qib7	3253	10	survey	survey	NN
cord-005453-4057qib7	3253	11	of	of	IN
cord-005453-4057qib7	3253	12	the	the	DT
cord-005453-4057qib7	3253	13	404	404	CD
cord-005453-4057qib7	3253	14	Japan	Japan	NNP
cord-005453-4057qib7	3253	15	Society	Society	NNP
cord-005453-4057qib7	3253	16	for	for	IN
cord-005453-4057qib7	3253	17	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	3253	18	Stem	Stem	NNP
cord-005453-4057qib7	3253	19	Cell	Cell	NNP
cord-005453-4057qib7	3253	20	Transplantation	transplantation	NN
cord-005453-4057qib7	3253	21	centers	center	NNS
cord-005453-4057qib7	3253	22	.	.	.
cord-005453-4057qib7	3254	1	Methods	method	NNS
cord-005453-4057qib7	3254	2	:	:	:
cord-005453-4057qib7	3254	3	To	to	TO
cord-005453-4057qib7	3254	4	address	address	VB
cord-005453-4057qib7	3254	5	this	this	DT
cord-005453-4057qib7	3254	6	issue	issue	NN
cord-005453-4057qib7	3254	7	,	,	,
cord-005453-4057qib7	3254	8	we	-PRON-	PRP
cord-005453-4057qib7	3254	9	conducted	conduct	VBD
cord-005453-4057qib7	3254	10	a	a	DT
cord-005453-4057qib7	3254	11	nationwide	nationwide	JJ
cord-005453-4057qib7	3254	12	retrospective	retrospective	JJ
cord-005453-4057qib7	3254	13	survey	survey	NN
cord-005453-4057qib7	3254	14	of	of	IN
cord-005453-4057qib7	3254	15	the	the	DT
cord-005453-4057qib7	3254	16	Japan	Japan	NNP
cord-005453-4057qib7	3254	17	Society	Society	NNP
cord-005453-4057qib7	3254	18	for	for	IN
cord-005453-4057qib7	3254	19	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	3254	20	Stem	Stem	NNP
cord-005453-4057qib7	3254	21	Cell	Cell	NNP
cord-005453-4057qib7	3254	22	Transplantation	transplantation	NN
cord-005453-4057qib7	3254	23	(	(	-LRB-
cord-005453-4057qib7	3254	24	JSHCT	JSHCT	NNP
cord-005453-4057qib7	3254	25	)	)	-RRB-
cord-005453-4057qib7	3254	26	centers	center	NNS
cord-005453-4057qib7	3254	27	.	.	.
cord-005453-4057qib7	3255	1	A	a	DT
cord-005453-4057qib7	3255	2	first	first	JJ
cord-005453-4057qib7	3255	3	questionnaire	questionnaire	NN
cord-005453-4057qib7	3255	4	was	be	VBD
cord-005453-4057qib7	3255	5	emailed	email	VBN
cord-005453-4057qib7	3255	6	to	to	IN
cord-005453-4057qib7	3255	7	JSHCT	JSHCT	NNP
cord-005453-4057qib7	3255	8	centers	center	NNS
cord-005453-4057qib7	3255	9	requesting	request	VBG
cord-005453-4057qib7	3255	10	information	information	NN
cord-005453-4057qib7	3255	11	on	on	IN
cord-005453-4057qib7	3255	12	cases	case	NNS
cord-005453-4057qib7	3255	13	of	of	IN
cord-005453-4057qib7	3255	14	HSCT	HSCT	NNP
cord-005453-4057qib7	3255	15	in	in	IN
cord-005453-4057qib7	3255	16	SOT	SOT	NNP
cord-005453-4057qib7	3255	17	recipient	recipient	NN
cord-005453-4057qib7	3255	18	.	.	.
cord-005453-4057qib7	3256	1	Patients	patient	NNS
cord-005453-4057qib7	3256	2	'	'	POS
cord-005453-4057qib7	3256	3	data	datum	NNS
cord-005453-4057qib7	3256	4	about	about	IN
cord-005453-4057qib7	3256	5	SOT	SOT	NNP
cord-005453-4057qib7	3256	6	were	be	VBD
cord-005453-4057qib7	3256	7	collected	collect	VBN
cord-005453-4057qib7	3256	8	by	by	IN
cord-005453-4057qib7	3256	9	sending	send	VBG
cord-005453-4057qib7	3256	10	a	a	DT
cord-005453-4057qib7	3256	11	second	second	JJ
cord-005453-4057qib7	3256	12	questionnaire	questionnaire	NN
cord-005453-4057qib7	3256	13	to	to	IN
cord-005453-4057qib7	3256	14	the	the	DT
cord-005453-4057qib7	3256	15	centers	center	NNS
cord-005453-4057qib7	3256	16	with	with	IN
cord-005453-4057qib7	3256	17	the	the	DT
cord-005453-4057qib7	3256	18	patient	patient	NN
cord-005453-4057qib7	3256	19	.	.	.
cord-005453-4057qib7	3257	1	Based	base	VBN
cord-005453-4057qib7	3257	2	on	on	IN
cord-005453-4057qib7	3257	3	these	these	DT
cord-005453-4057qib7	3257	4	reports	report	NNS
cord-005453-4057qib7	3257	5	,	,	,
cord-005453-4057qib7	3257	6	patients	patient	NNS
cord-005453-4057qib7	3257	7	'	'	POS
cord-005453-4057qib7	3257	8	data	datum	NNS
cord-005453-4057qib7	3257	9	about	about	IN
cord-005453-4057qib7	3257	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3257	11	was	be	VBD
cord-005453-4057qib7	3257	12	identified	identify	VBN
cord-005453-4057qib7	3257	13	in	in	IN
cord-005453-4057qib7	3257	14	the	the	DT
cord-005453-4057qib7	3257	15	Japan	Japan	NNP
cord-005453-4057qib7	3257	16	transplant	transplant	NN
cord-005453-4057qib7	3257	17	outcomes	outcome	NNS
cord-005453-4057qib7	3257	18	registry	registry	NN
cord-005453-4057qib7	3257	19	database	database	NN
cord-005453-4057qib7	3257	20	by	by	IN
cord-005453-4057qib7	3257	21	the	the	DT
cord-005453-4057qib7	3257	22	Transplant	Transplant	NNP
cord-005453-4057qib7	3257	23	Registry	Registry	NNP
cord-005453-4057qib7	3257	24	Unified	Unified	NNP
cord-005453-4057qib7	3257	25	Management	Management	NNP
cord-005453-4057qib7	3257	26	Program	Program	NNP
cord-005453-4057qib7	3257	27	(	(	-LRB-
cord-005453-4057qib7	3257	28	TRUMP	TRUMP	NNP
cord-005453-4057qib7	3257	29	)	)	-RRB-
cord-005453-4057qib7	3257	30	,	,	,
cord-005453-4057qib7	3257	31	confirmed	confirm	VBD
cord-005453-4057qib7	3257	32	in	in	IN
cord-005453-4057qib7	3257	33	2017	2017	CD
cord-005453-4057qib7	3257	34	.	.	.
cord-005453-4057qib7	3258	1	Results	result	NNS
cord-005453-4057qib7	3258	2	:	:	:
cord-005453-4057qib7	3259	1	Of	of	IN
cord-005453-4057qib7	3259	2	the	the	DT
cord-005453-4057qib7	3259	3	404	404	CD
cord-005453-4057qib7	3259	4	JSHCT	JSHCT	NNP
cord-005453-4057qib7	3259	5	centers	center	NNS
cord-005453-4057qib7	3259	6	,	,	,
cord-005453-4057qib7	3259	7	238	238	CD
cord-005453-4057qib7	3259	8	responded	respond	VBD
cord-005453-4057qib7	3259	9	to	to	IN
cord-005453-4057qib7	3259	10	the	the	DT
cord-005453-4057qib7	3259	11	survey	survey	NN
cord-005453-4057qib7	3259	12	(	(	-LRB-
cord-005453-4057qib7	3259	13	58.9	58.9	CD
cord-005453-4057qib7	3259	14	%	%	NN
cord-005453-4057qib7	3259	15	)	)	-RRB-
cord-005453-4057qib7	3259	16	.	.	.
cord-005453-4057qib7	3260	1	14	14	CD
cord-005453-4057qib7	3260	2	of	of	IN
cord-005453-4057qib7	3260	3	the	the	DT
cord-005453-4057qib7	3260	4	responding	respond	VBG
cord-005453-4057qib7	3260	5	centers	center	NNS
cord-005453-4057qib7	3260	6	reported	report	VBD
cord-005453-4057qib7	3260	7	a	a	DT
cord-005453-4057qib7	3260	8	total	total	NN
cord-005453-4057qib7	3260	9	of	of	IN
cord-005453-4057qib7	3260	10	19	19	CD
cord-005453-4057qib7	3260	11	patients	patient	NNS
cord-005453-4057qib7	3260	12	who	who	WP
cord-005453-4057qib7	3260	13	had	have	VBD
cord-005453-4057qib7	3260	14	undergone	undergo	VBN
cord-005453-4057qib7	3260	15	SOT	SOT	NNP
cord-005453-4057qib7	3260	16	from	from	IN
cord-005453-4057qib7	3260	17	living	live	VBG
cord-005453-4057qib7	3260	18	donor	donor	NN
cord-005453-4057qib7	3260	19	,	,	,
cord-005453-4057qib7	3260	20	and	and	CC
cord-005453-4057qib7	3260	21	subsequent	subsequent	JJ
cord-005453-4057qib7	3260	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3260	23	.	.	.
cord-005453-4057qib7	3261	1	They	-PRON-	PRP
cord-005453-4057qib7	3261	2	consist	consist	VBP
cord-005453-4057qib7	3261	3	of	of	IN
cord-005453-4057qib7	3261	4	three	three	CD
cord-005453-4057qib7	3261	5	autologous	autologous	JJ
cord-005453-4057qib7	3261	6	HSCT	HSCT	NNP
cord-005453-4057qib7	3261	7	(	(	-LRB-
cord-005453-4057qib7	3261	8	auto	auto	NN
cord-005453-4057qib7	3261	9	-	-	HYPH
cord-005453-4057qib7	3261	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3261	11	)	)	-RRB-
cord-005453-4057qib7	3261	12	and	and	CC
cord-005453-4057qib7	3261	13	13	13	CD
cord-005453-4057qib7	3261	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	3261	15	HSCT	HSCT	NNP
cord-005453-4057qib7	3261	16	(	(	-LRB-
cord-005453-4057qib7	3261	17	allo	allo	NN
cord-005453-4057qib7	3261	18	-	-	HYPH
cord-005453-4057qib7	3261	19	HSCT	HSCT	NNP
cord-005453-4057qib7	3261	20	)	)	-RRB-
cord-005453-4057qib7	3261	21	.	.	.
cord-005453-4057qib7	3262	1	In	in	IN
cord-005453-4057qib7	3262	2	auto	auto	NN
cord-005453-4057qib7	3262	3	-	-	HYPH
cord-005453-4057qib7	3262	4	HSCT	HSCT	NNP
cord-005453-4057qib7	3262	5	,	,	,
cord-005453-4057qib7	3262	6	all	all	DT
cord-005453-4057qib7	3262	7	patients	patient	NNS
cord-005453-4057qib7	3262	8	had	have	VBD
cord-005453-4057qib7	3262	9	received	receive	VBN
cord-005453-4057qib7	3262	10	liver	liver	NN
cord-005453-4057qib7	3262	11	transplant	transplant	NN
cord-005453-4057qib7	3262	12	for	for	IN
cord-005453-4057qib7	3262	13	hapatoblastoma	hapatoblastoma	NNP
cord-005453-4057qib7	3262	14	.	.	.
cord-005453-4057qib7	3263	1	They	-PRON-	PRP
cord-005453-4057qib7	3263	2	achieved	achieve	VBD
cord-005453-4057qib7	3263	3	neutrophil	neutrophil	NN
cord-005453-4057qib7	3263	4	engraftment	engraftment	NN
cord-005453-4057qib7	3263	5	at	at	IN
cord-005453-4057qib7	3263	6	30	30	CD
cord-005453-4057qib7	3263	7	days	day	NNS
cord-005453-4057qib7	3263	8	after	after	IN
cord-005453-4057qib7	3263	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3263	10	,	,	,
cord-005453-4057qib7	3263	11	and	and	CC
cord-005453-4057qib7	3263	12	two	two	CD
cord-005453-4057qib7	3263	13	of	of	IN
cord-005453-4057qib7	3263	14	three	three	CD
cord-005453-4057qib7	3263	15	patients	patient	NNS
cord-005453-4057qib7	3263	16	were	be	VBD
cord-005453-4057qib7	3263	17	alive	alive	JJ
cord-005453-4057qib7	3263	18	at	at	IN
cord-005453-4057qib7	3263	19	one	one	CD
cord-005453-4057qib7	3263	20	year	year	NN
cord-005453-4057qib7	3263	21	after	after	IN
cord-005453-4057qib7	3263	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3263	23	.	.	.
cord-005453-4057qib7	3264	1	In	in	IN
cord-005453-4057qib7	3264	2	allo	allo	NN
cord-005453-4057qib7	3264	3	-	-	HYPH
cord-005453-4057qib7	3264	4	HSCT	HSCT	NNP
cord-005453-4057qib7	3264	5	(	(	-LRB-
cord-005453-4057qib7	3264	6	n=16	n=16	NNP
cord-005453-4057qib7	3264	7	)	)	-RRB-
cord-005453-4057qib7	3264	8	,	,	,
cord-005453-4057qib7	3264	9	seven	seven	CD
cord-005453-4057qib7	3264	10	patients	patient	NNS
cord-005453-4057qib7	3264	11	had	have	VBD
cord-005453-4057qib7	3264	12	received	receive	VBN
cord-005453-4057qib7	3264	13	liver	liver	NN
cord-005453-4057qib7	3264	14	transplants	transplant	NNS
cord-005453-4057qib7	3264	15	,	,	,
cord-005453-4057qib7	3264	16	and	and	CC
cord-005453-4057qib7	3264	17	nine	nine	CD
cord-005453-4057qib7	3264	18	patients	patient	NNS
cord-005453-4057qib7	3264	19	had	have	VBD
cord-005453-4057qib7	3264	20	received	receive	VBN
cord-005453-4057qib7	3264	21	kidney	kidney	NN
cord-005453-4057qib7	3264	22	transplants	transplant	NNS
cord-005453-4057qib7	3264	23	.	.	.
cord-005453-4057qib7	3265	1	Five	five	CD
cord-005453-4057qib7	3265	2	patients	patient	NNS
cord-005453-4057qib7	3265	3	received	receive	VBD
cord-005453-4057qib7	3265	4	HSCT	HSCT	NNP
cord-005453-4057qib7	3265	5	from	from	IN
cord-005453-4057qib7	3265	6	unrelated	unrelated	JJ
cord-005453-4057qib7	3265	7	donor	donor	NN
cord-005453-4057qib7	3265	8	,	,	,
cord-005453-4057qib7	3265	9	and	and	CC
cord-005453-4057qib7	3265	10	11	11	CD
cord-005453-4057qib7	3265	11	patients	patient	NNS
cord-005453-4057qib7	3265	12	received	receive	VBD
cord-005453-4057qib7	3265	13	HSCT	HSCT	NNP
cord-005453-4057qib7	3265	14	from	from	IN
cord-005453-4057qib7	3265	15	related	related	JJ
cord-005453-4057qib7	3265	16	donor	donor	NN
cord-005453-4057qib7	3265	17	;	;	:
cord-005453-4057qib7	3265	18	two	two	CD
cord-005453-4057qib7	3265	19	donors	donor	NNS
cord-005453-4057qib7	3265	20	were	be	VBD
cord-005453-4057qib7	3265	21	identical	identical	JJ
cord-005453-4057qib7	3265	22	in	in	IN
cord-005453-4057qib7	3265	23	SOT	SOT	NNP
cord-005453-4057qib7	3265	24	.	.	.
cord-005453-4057qib7	3266	1	Their	-PRON-	PRP$
cord-005453-4057qib7	3266	2	stem	stem	NN
cord-005453-4057qib7	3266	3	cell	cell	NN
cord-005453-4057qib7	3266	4	sources	source	NNS
cord-005453-4057qib7	3266	5	were	be	VBD
cord-005453-4057qib7	3266	6	seven	seven	CD
cord-005453-4057qib7	3266	7	peripheral	peripheral	JJ
cord-005453-4057qib7	3266	8	blood	blood	NN
cord-005453-4057qib7	3266	9	stem	stem	NN
cord-005453-4057qib7	3266	10	cell	cell	NN
cord-005453-4057qib7	3266	11	,	,	,
cord-005453-4057qib7	3266	12	six	six	CD
cord-005453-4057qib7	3266	13	bone	bone	NN
cord-005453-4057qib7	3266	14	marrow	marrow	NN
cord-005453-4057qib7	3266	15	,	,	,
cord-005453-4057qib7	3266	16	and	and	CC
cord-005453-4057qib7	3266	17	three	three	CD
cord-005453-4057qib7	3266	18	cord	cord	NN
cord-005453-4057qib7	3266	19	blood	blood	NN
cord-005453-4057qib7	3266	20	.	.	.
cord-005453-4057qib7	3267	1	All	all	DT
cord-005453-4057qib7	3267	2	but	but	IN
cord-005453-4057qib7	3267	3	one	one	CD
cord-005453-4057qib7	3267	4	patients	patient	NNS
cord-005453-4057qib7	3267	5	achieved	achieve	VBD
cord-005453-4057qib7	3267	6	neutrophil	neutrophil	NN
cord-005453-4057qib7	3267	7	engraftment	engraftment	NN
cord-005453-4057qib7	3267	8	at	at	IN
cord-005453-4057qib7	3267	9	30	30	CD
cord-005453-4057qib7	3267	10	days	day	NNS
cord-005453-4057qib7	3267	11	after	after	IN
cord-005453-4057qib7	3267	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3267	13	.	.	.
cord-005453-4057qib7	3268	1	Five	five	CD
cord-005453-4057qib7	3268	2	-	-	HYPH
cord-005453-4057qib7	3268	3	year	year	NN
cord-005453-4057qib7	3268	4	overall	overall	JJ
cord-005453-4057qib7	3268	5	survival	survival	NN
cord-005453-4057qib7	3268	6	(	(	-LRB-
cord-005453-4057qib7	3268	7	5yOS	5yOS	NNP
cord-005453-4057qib7	3268	8	)	)	-RRB-
cord-005453-4057qib7	3268	9	was	be	VBD
cord-005453-4057qib7	3268	10	37.5	37.5	CD
cord-005453-4057qib7	3268	11	%	%	NN
cord-005453-4057qib7	3268	12	.	.	.
cord-005453-4057qib7	3269	1	While	while	IN
cord-005453-4057qib7	3269	2	5yOS	5yos	CD
cord-005453-4057qib7	3269	3	in	in	IN
cord-005453-4057qib7	3269	4	patients	patient	NNS
cord-005453-4057qib7	3269	5	with	with	IN
cord-005453-4057qib7	3269	6	bone	bone	NN
cord-005453-4057qib7	3269	7	marrow	marrow	NN
cord-005453-4057qib7	3269	8	failure	failure	NN
cord-005453-4057qib7	3269	9	(	(	-LRB-
cord-005453-4057qib7	3269	10	n=4	n=4	NNS
cord-005453-4057qib7	3269	11	)	)	-RRB-
cord-005453-4057qib7	3269	12	was	be	VBD
cord-005453-4057qib7	3269	13	100	100	CD
cord-005453-4057qib7	3269	14	%	%	NN
cord-005453-4057qib7	3269	15	,	,	,
cord-005453-4057qib7	3269	16	that	that	IN
cord-005453-4057qib7	3269	17	in	in	IN
cord-005453-4057qib7	3269	18	patients	patient	NNS
cord-005453-4057qib7	3269	19	with	with	IN
cord-005453-4057qib7	3269	20	malignant	malignant	JJ
cord-005453-4057qib7	3269	21	disease	disease	NN
cord-005453-4057qib7	3269	22	(	(	-LRB-
cord-005453-4057qib7	3269	23	n=12	n=12	NNP
cord-005453-4057qib7	3269	24	)	)	-RRB-
cord-005453-4057qib7	3269	25	was	be	VBD
cord-005453-4057qib7	3269	26	16.7	16.7	CD
cord-005453-4057qib7	3269	27	%	%	NN
cord-005453-4057qib7	3269	28	;	;	.
cord-005453-4057qib7	3270	1	all	all	DT
cord-005453-4057qib7	3270	2	but	but	IN
cord-005453-4057qib7	3270	3	one	one	CD
cord-005453-4057qib7	3270	4	patients	patient	NNS
cord-005453-4057qib7	3270	5	with	with	IN
cord-005453-4057qib7	3270	6	malignant	malignant	JJ
cord-005453-4057qib7	3270	7	disease	disease	NN
cord-005453-4057qib7	3270	8	received	receive	VBD
cord-005453-4057qib7	3270	9	allo	allo	NN
cord-005453-4057qib7	3270	10	-	-	HYPH
cord-005453-4057qib7	3270	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3270	12	in	in	IN
cord-005453-4057qib7	3270	13	non	non	JJ
cord-005453-4057qib7	3270	14	-	-	JJ
cord-005453-4057qib7	3270	15	remission	remission	NN
cord-005453-4057qib7	3270	16	.	.	.
cord-005453-4057qib7	3271	1	Seven	seven	CD
cord-005453-4057qib7	3271	2	of	of	IN
cord-005453-4057qib7	3271	3	nine	nine	CD
cord-005453-4057qib7	3271	4	kidney	kidney	NN
cord-005453-4057qib7	3271	5	-	-	HYPH
cord-005453-4057qib7	3271	6	transplant	transplant	NN
cord-005453-4057qib7	3271	7	recipients	recipient	NNS
cord-005453-4057qib7	3271	8	experienced	experience	VBD
cord-005453-4057qib7	3271	9	dialysis	dialysis	NN
cord-005453-4057qib7	3271	10	,	,	,
cord-005453-4057qib7	3271	11	and	and	CC
cord-005453-4057qib7	3271	12	three	three	CD
cord-005453-4057qib7	3271	13	patients	patient	NNS
cord-005453-4057qib7	3271	14	experienced	experience	VBD
cord-005453-4057qib7	3271	15	renal	renal	JJ
cord-005453-4057qib7	3271	16	rejection	rejection	NN
cord-005453-4057qib7	3271	17	after	after	IN
cord-005453-4057qib7	3271	18	HSCT	HSCT	NNP
cord-005453-4057qib7	3271	19	.	.	.
cord-005453-4057qib7	3272	1	On	on	IN
cord-005453-4057qib7	3272	2	the	the	DT
cord-005453-4057qib7	3272	3	contrary	contrary	NN
cord-005453-4057qib7	3272	4	,	,	,
cord-005453-4057qib7	3272	5	no	no	DT
cord-005453-4057qib7	3272	6	liver	liver	NN
cord-005453-4057qib7	3272	7	-	-	HYPH
cord-005453-4057qib7	3272	8	transplant	transplant	NN
cord-005453-4057qib7	3272	9	recipient	recipient	NN
cord-005453-4057qib7	3272	10	experienced	experience	VBD
cord-005453-4057qib7	3272	11	hepatic	hepatic	JJ
cord-005453-4057qib7	3272	12	rejection	rejection	NN
cord-005453-4057qib7	3272	13	.	.	.
cord-005453-4057qib7	3273	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3273	2	:	:	:
cord-005453-4057qib7	3274	1	In	in	IN
cord-005453-4057qib7	3274	2	SOT	SOT	NNP
cord-005453-4057qib7	3274	3	recipients	recipient	NNS
cord-005453-4057qib7	3274	4	,	,	,
cord-005453-4057qib7	3274	5	the	the	DT
cord-005453-4057qib7	3274	6	outcome	outcome	NN
cord-005453-4057qib7	3274	7	of	of	IN
cord-005453-4057qib7	3274	8	allo	allo	NN
cord-005453-4057qib7	3274	9	-	-	HYPH
cord-005453-4057qib7	3274	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3274	11	for	for	IN
cord-005453-4057qib7	3274	12	malignant	malignant	JJ
cord-005453-4057qib7	3274	13	disease	disease	NN
cord-005453-4057qib7	3274	14	was	be	VBD
cord-005453-4057qib7	3274	15	poor	poor	JJ
cord-005453-4057qib7	3274	16	,	,	,
cord-005453-4057qib7	3274	17	partly	partly	RB
cord-005453-4057qib7	3274	18	due	due	JJ
cord-005453-4057qib7	3274	19	to	to	IN
cord-005453-4057qib7	3274	20	disease	disease	NN
cord-005453-4057qib7	3274	21	status	status	NN
cord-005453-4057qib7	3274	22	before	before	IN
cord-005453-4057qib7	3274	23	allo	allo	NN
cord-005453-4057qib7	3274	24	-	-	HYPH
cord-005453-4057qib7	3274	25	HSCT	HSCT	NNP
cord-005453-4057qib7	3274	26	.	.	.
cord-005453-4057qib7	3275	1	Severe	severe	JJ
cord-005453-4057qib7	3275	2	renal	renal	JJ
cord-005453-4057qib7	3275	3	complications	complication	NNS
cord-005453-4057qib7	3275	4	were	be	VBD
cord-005453-4057qib7	3275	5	common	common	JJ
cord-005453-4057qib7	3275	6	in	in	IN
cord-005453-4057qib7	3275	7	kidney	kidney	NN
cord-005453-4057qib7	3275	8	-	-	HYPH
cord-005453-4057qib7	3275	9	transplant	transplant	NN
cord-005453-4057qib7	3275	10	recipients	recipient	NNS
cord-005453-4057qib7	3275	11	,	,	,
cord-005453-4057qib7	3275	12	suggesting	suggest	VBG
cord-005453-4057qib7	3275	13	renal	renal	JJ
cord-005453-4057qib7	3275	14	care	care	NN
cord-005453-4057qib7	3275	15	with	with	IN
cord-005453-4057qib7	3275	16	caution	caution	NN
cord-005453-4057qib7	3275	17	during	during	IN
cord-005453-4057qib7	3275	18	and	and	CC
cord-005453-4057qib7	3275	19	after	after	IN
cord-005453-4057qib7	3275	20	allo	allo	NN
cord-005453-4057qib7	3275	21	-	-	HYPH
cord-005453-4057qib7	3275	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3275	23	.	.	.
cord-005453-4057qib7	3276	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3276	2	:	:	:
cord-005453-4057qib7	3277	1	This	this	DT
cord-005453-4057qib7	3277	2	work	work	NN
cord-005453-4057qib7	3277	3	was	be	VBD
cord-005453-4057qib7	3277	4	supported	support	VBN
cord-005453-4057qib7	3277	5	in	in	IN
cord-005453-4057qib7	3277	6	part	part	NN
cord-005453-4057qib7	3277	7	by	by	IN
cord-005453-4057qib7	3277	8	the	the	DT
cord-005453-4057qib7	3277	9	Practical	Practical	NNP
cord-005453-4057qib7	3277	10	Research	Research	NNP
cord-005453-4057qib7	3277	11	Project	Project	NNP
cord-005453-4057qib7	3277	12	for	for	IN
cord-005453-4057qib7	3277	13	Allergic	Allergic	NNP
cord-005453-4057qib7	3277	14	Diseases	Diseases	NNPS
cord-005453-4057qib7	3277	15	and	and	CC
cord-005453-4057qib7	3277	16	Immunology	Immunology	NNP
cord-005453-4057qib7	3277	17	(	(	-LRB-
cord-005453-4057qib7	3277	18	Research	Research	NNP
cord-005453-4057qib7	3277	19	Technology	Technology	NNP
cord-005453-4057qib7	3277	20	of	of	IN
cord-005453-4057qib7	3277	21	Medical	Medical	NNP
cord-005453-4057qib7	3277	22	Transplantation	Transplantation	NNP
cord-005453-4057qib7	3277	23	)	)	-RRB-
cord-005453-4057qib7	3277	24	from	from	IN
cord-005453-4057qib7	3277	25	Japan	Japan	NNP
cord-005453-4057qib7	3277	26	Agency	Agency	NNP
cord-005453-4057qib7	3277	27	for	for	IN
cord-005453-4057qib7	3277	28	Medical	Medical	NNP
cord-005453-4057qib7	3277	29	Research	Research	NNP
cord-005453-4057qib7	3277	30	and	and	CC
cord-005453-4057qib7	3277	31	Development	Development	NNP
cord-005453-4057qib7	3277	32	,	,	,
cord-005453-4057qib7	3277	33	AMED	AMED	NNP
cord-005453-4057qib7	3277	34	.	.	.
cord-005453-4057qib7	3278	1	High	high	JJ
cord-005453-4057qib7	3278	2	incidence	incidence	NN
cord-005453-4057qib7	3278	3	but	but	CC
cord-005453-4057qib7	3278	4	low	low	JJ
cord-005453-4057qib7	3278	5	mortality	mortality	NN
cord-005453-4057qib7	3278	6	of	of	IN
cord-005453-4057qib7	3278	7	EBV	EBV	NNP
cord-005453-4057qib7	3278	8	related	relate	VBN
cord-005453-4057qib7	3278	9	PTLD	PTLD	NNP
cord-005453-4057qib7	3278	10	after	after	IN
cord-005453-4057qib7	3278	11	T	t	NN
cord-005453-4057qib7	3278	12	-	-	HYPH
cord-005453-4057qib7	3278	13	cell	cell	NN
cord-005453-4057qib7	3278	14	replete	replete	JJ
cord-005453-4057qib7	3278	15	allo	allo	NN
cord-005453-4057qib7	3278	16	-	-	HYPH
cord-005453-4057qib7	3278	17	peripheral	peripheral	JJ
cord-005453-4057qib7	3278	18	blood	blood	NN
cord-005453-4057qib7	3278	19	HCT	hct	NN
cord-005453-4057qib7	3278	20	with	with	IN
cord-005453-4057qib7	3278	21	aggressive	aggressive	JJ
cord-005453-4057qib7	3278	22	monitoring	monitoring	NN
cord-005453-4057qib7	3278	23	and	and	CC
cord-005453-4057qib7	3278	24	without	without	IN
cord-005453-4057qib7	3278	25	pre	pre	JJ
cord-005453-4057qib7	3278	26	-	-	JJ
cord-005453-4057qib7	3278	27	emptive	emptive	JJ
cord-005453-4057qib7	3278	28	rituximab	rituximab	NNP
cord-005453-4057qib7	3278	29	Background	Background	NNP
cord-005453-4057qib7	3278	30	:	:	:
cord-005453-4057qib7	3279	1	The	the	DT
cord-005453-4057qib7	3279	2	aim	aim	NN
cord-005453-4057qib7	3279	3	of	of	IN
cord-005453-4057qib7	3279	4	the	the	DT
cord-005453-4057qib7	3279	5	study	study	NN
cord-005453-4057qib7	3279	6	is	be	VBZ
cord-005453-4057qib7	3279	7	to	to	TO
cord-005453-4057qib7	3279	8	report	report	VB
cord-005453-4057qib7	3279	9	the	the	DT
cord-005453-4057qib7	3279	10	incidence	incidence	NN
cord-005453-4057qib7	3279	11	and	and	CC
cord-005453-4057qib7	3279	12	outcome	outcome	NN
cord-005453-4057qib7	3279	13	of	of	IN
cord-005453-4057qib7	3279	14	post	post	JJ
cord-005453-4057qib7	3279	15	-	-	JJ
cord-005453-4057qib7	3279	16	transplant	transplant	JJ
cord-005453-4057qib7	3279	17	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	3279	18	disorder	disorder	NN
cord-005453-4057qib7	3279	19	(	(	-LRB-
cord-005453-4057qib7	3279	20	PTLD	PTLD	NNP
cord-005453-4057qib7	3279	21	)	)	-RRB-
cord-005453-4057qib7	3279	22	in	in	IN
cord-005453-4057qib7	3279	23	the	the	DT
cord-005453-4057qib7	3279	24	setting	setting	NN
cord-005453-4057qib7	3279	25	of	of	IN
cord-005453-4057qib7	3279	26	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3279	27	peripheral	peripheral	JJ
cord-005453-4057qib7	3279	28	blood	blood	NN
cord-005453-4057qib7	3279	29	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3279	30	stem	stem	NN
cord-005453-4057qib7	3279	31	cell	cell	NN
cord-005453-4057qib7	3279	32	transplantation	transplantation	NN
cord-005453-4057qib7	3279	33	(	(	-LRB-
cord-005453-4057qib7	3279	34	allo	allo	NN
cord-005453-4057qib7	3279	35	-	-	HYPH
cord-005453-4057qib7	3279	36	HSCT	HSCT	NNP
cord-005453-4057qib7	3279	37	)	)	-RRB-
cord-005453-4057qib7	3280	1	combining	combine	VBG
cord-005453-4057qib7	3280	2	post	post	JJ
cord-005453-4057qib7	3280	3	-	-	JJ
cord-005453-4057qib7	3280	4	transplant	transplant	NN
cord-005453-4057qib7	3280	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	3280	6	(	(	-LRB-
cord-005453-4057qib7	3280	7	PTCy	PTCy	NNP
cord-005453-4057qib7	3280	8	)	)	-RRB-
cord-005453-4057qib7	3280	9	and	and	CC
cord-005453-4057qib7	3280	10	anti	anti	JJ
cord-005453-4057qib7	3280	11	-	-	JJ
cord-005453-4057qib7	3280	12	thymocyte	thymocyte	JJ
cord-005453-4057qib7	3280	13	globulin	globulin	NN
cord-005453-4057qib7	3280	14	(	(	-LRB-
cord-005453-4057qib7	3280	15	ATG	ATG	NNP
cord-005453-4057qib7	3280	16	)	)	-RRB-
cord-005453-4057qib7	3280	17	as	as	IN
cord-005453-4057qib7	3280	18	graft	graft	NN
cord-005453-4057qib7	3280	19	versus	versus	IN
cord-005453-4057qib7	3280	20	host	host	NN
cord-005453-4057qib7	3280	21	disease	disease	NN
cord-005453-4057qib7	3280	22	(	(	-LRB-
cord-005453-4057qib7	3280	23	GVHD	GVHD	NNP
cord-005453-4057qib7	3280	24	)	)	-RRB-
cord-005453-4057qib7	3280	25	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3280	26	.	.	.
cord-005453-4057qib7	3281	1	Methods	method	NNS
cord-005453-4057qib7	3281	2	:	:	:
cord-005453-4057qib7	3281	3	Between	between	IN
cord-005453-4057qib7	3281	4	October	October	NNP
cord-005453-4057qib7	3281	5	2015	2015	CD
cord-005453-4057qib7	3281	6	and	and	CC
cord-005453-4057qib7	3281	7	May	May	NNP
cord-005453-4057qib7	3281	8	2018	2018	CD
cord-005453-4057qib7	3281	9	,	,	,
cord-005453-4057qib7	3281	10	195	195	CD
cord-005453-4057qib7	3281	11	adult	adult	NN
cord-005453-4057qib7	3281	12	patients	patient	NNS
cord-005453-4057qib7	3281	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	3281	14	with	with	IN
cord-005453-4057qib7	3281	15	hematological	hematological	JJ
cord-005453-4057qib7	3281	16	malignancies	malignancy	NNS
cord-005453-4057qib7	3281	17	underwent	undergo	VBD
cord-005453-4057qib7	3281	18	a	a	DT
cord-005453-4057qib7	3281	19	first	first	JJ
cord-005453-4057qib7	3281	20	T	t	NN
cord-005453-4057qib7	3281	21	-	-	HYPH
cord-005453-4057qib7	3281	22	cell	cell	NN
cord-005453-4057qib7	3281	23	replete	replete	JJ
cord-005453-4057qib7	3281	24	allo	allo	NN
cord-005453-4057qib7	3281	25	-	-	HYPH
cord-005453-4057qib7	3281	26	HSCT	HSCT	NNP
cord-005453-4057qib7	3281	27	in	in	IN
cord-005453-4057qib7	3281	28	our	-PRON-	PRP$
cord-005453-4057qib7	3281	29	center	center	NN
cord-005453-4057qib7	3281	30	.	.	.
cord-005453-4057qib7	3282	1	All	all	DT
cord-005453-4057qib7	3282	2	patients	patient	NNS
cord-005453-4057qib7	3282	3	received	receive	VBD
cord-005453-4057qib7	3282	4	a	a	DT
cord-005453-4057qib7	3282	5	reduced	reduce	VBN
cord-005453-4057qib7	3282	6	intensity	intensity	NN
cord-005453-4057qib7	3282	7	conditioning	conditioning	NN
cord-005453-4057qib7	3282	8	regimen	regimen	NN
cord-005453-4057qib7	3282	9	with	with	IN
cord-005453-4057qib7	3282	10	fludarabine	fludarabine	NN
cord-005453-4057qib7	3282	11	,	,	,
cord-005453-4057qib7	3282	12	busulfan	busulfan	NN
cord-005453-4057qib7	3282	13	,	,	,
cord-005453-4057qib7	3282	14	and	and	CC
cord-005453-4057qib7	3282	15	200cGy	200cgy	CD
cord-005453-4057qib7	3282	16	of	of	IN
cord-005453-4057qib7	3282	17	total	total	JJ
cord-005453-4057qib7	3282	18	body	body	NN
cord-005453-4057qib7	3282	19	irradiation	irradiation	NN
cord-005453-4057qib7	3282	20	,	,	,
cord-005453-4057qib7	3282	21	combined	combine	VBN
cord-005453-4057qib7	3282	22	with	with	IN
cord-005453-4057qib7	3282	23	rabbit	rabbit	NN
cord-005453-4057qib7	3282	24	-	-	HYPH
cord-005453-4057qib7	3282	25	ATG	ATG	NNP
cord-005453-4057qib7	3282	26	,	,	,
cord-005453-4057qib7	3282	27	PTCy	PTCy	NNS
cord-005453-4057qib7	3282	28	and	and	CC
cord-005453-4057qib7	3282	29	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	3282	30	(	(	-LRB-
cord-005453-4057qib7	3282	31	CsA	CsA	NNP
cord-005453-4057qib7	3282	32	)	)	-RRB-
cord-005453-4057qib7	3282	33	.	.	.
cord-005453-4057qib7	3283	1	EBV	EBV	NNP
cord-005453-4057qib7	3283	2	titres	titre	NNS
cord-005453-4057qib7	3283	3	were	be	VBD
cord-005453-4057qib7	3283	4	monitored	monitor	VBN
cord-005453-4057qib7	3283	5	weekly	weekly	RB
cord-005453-4057qib7	3283	6	by	by	IN
cord-005453-4057qib7	3283	7	quantitative	quantitative	JJ
cord-005453-4057qib7	3283	8	PCR	PCR	NNP
cord-005453-4057qib7	3283	9	in	in	IN
cord-005453-4057qib7	3283	10	plasma	plasma	NN
cord-005453-4057qib7	3283	11	samples	sample	NNS
cord-005453-4057qib7	3283	12	.	.	.
cord-005453-4057qib7	3284	1	The	the	DT
cord-005453-4057qib7	3284	2	cut	cut	VB
cord-005453-4057qib7	3284	3	-	-	HYPH
cord-005453-4057qib7	3284	4	off	off	RP
cord-005453-4057qib7	3284	5	value	value	NN
cord-005453-4057qib7	3284	6	for	for	IN
cord-005453-4057qib7	3284	7	test	test	NN
cord-005453-4057qib7	3284	8	positivity	positivity	NN
cord-005453-4057qib7	3284	9	was	be	VBD
cord-005453-4057qib7	3284	10	>	>	XX
cord-005453-4057qib7	3284	11	600	600	CD
cord-005453-4057qib7	3284	12	copies	copy	NNS
cord-005453-4057qib7	3284	13	of	of	IN
cord-005453-4057qib7	3284	14	EBV	EBV	NNP
cord-005453-4057qib7	3284	15	DNA	DNA	NNP
cord-005453-4057qib7	3284	16	/	/	SYM
cord-005453-4057qib7	3284	17	ml	ml	NNS
cord-005453-4057qib7	3284	18	of	of	IN
cord-005453-4057qib7	3284	19	plasma	plasma	NN
cord-005453-4057qib7	3284	20	.	.	.
cord-005453-4057qib7	3285	1	Last	last	JJ
cord-005453-4057qib7	3285	2	follow	follow	NN
cord-005453-4057qib7	3285	3	up	up	RP
cord-005453-4057qib7	3285	4	was	be	VBD
cord-005453-4057qib7	3285	5	November	November	NNP
cord-005453-4057qib7	3285	6	2018	2018	CD
cord-005453-4057qib7	3285	7	.	.	.
cord-005453-4057qib7	3286	1	Median	median	JJ
cord-005453-4057qib7	3286	2	follow	follow	VBP
cord-005453-4057qib7	3286	3	up	up	RP
cord-005453-4057qib7	3286	4	for	for	IN
cord-005453-4057qib7	3286	5	patients	patient	NNS
cord-005453-4057qib7	3286	6	known	know	VBN
cord-005453-4057qib7	3286	7	to	to	TO
cord-005453-4057qib7	3286	8	be	be	VB
cord-005453-4057qib7	3286	9	alive	alive	JJ
cord-005453-4057qib7	3286	10	was	be	VBD
cord-005453-4057qib7	3286	11	19	19	CD
cord-005453-4057qib7	3286	12	months	month	NNS
cord-005453-4057qib7	3287	1	(	(	-LRB-
cord-005453-4057qib7	3287	2	range	range	NNP
cord-005453-4057qib7	3287	3	5	5	CD
cord-005453-4057qib7	3287	4	-	-	SYM
cord-005453-4057qib7	3287	5	35	35	CD
cord-005453-4057qib7	3287	6	)	)	-RRB-
cord-005453-4057qib7	3287	7	.	.	.
cord-005453-4057qib7	3288	1	Results	result	NNS
cord-005453-4057qib7	3288	2	:	:	:
cord-005453-4057qib7	3289	1	Patient	patient	JJ
cord-005453-4057qib7	3289	2	information	information	NN
cord-005453-4057qib7	3289	3	is	be	VBZ
cord-005453-4057qib7	3289	4	summarized	summarize	VBN
cord-005453-4057qib7	3289	5	in	in	IN
cord-005453-4057qib7	3289	6	Table	Table	NNP
cord-005453-4057qib7	3289	7	1	1	CD
cord-005453-4057qib7	3289	8	.	.	.
cord-005453-4057qib7	3290	1	EBV	EBV	NNP
cord-005453-4057qib7	3290	2	reactivation	reactivation	NN
cord-005453-4057qib7	3290	3	was	be	VBD
cord-005453-4057qib7	3290	4	documented	document	VBN
cord-005453-4057qib7	3290	5	in	in	IN
cord-005453-4057qib7	3290	6	117	117	CD
cord-005453-4057qib7	3290	7	(	(	-LRB-
cord-005453-4057qib7	3290	8	60	60	CD
cord-005453-4057qib7	3290	9	%	%	NN
cord-005453-4057qib7	3290	10	)	)	-RRB-
cord-005453-4057qib7	3290	11	patients	patient	NNS
cord-005453-4057qib7	3290	12	.	.	.
cord-005453-4057qib7	3291	1	Median	median	JJ
cord-005453-4057qib7	3291	2	time	time	NN
cord-005453-4057qib7	3291	3	to	to	IN
cord-005453-4057qib7	3291	4	EBV	EBV	NNP
cord-005453-4057qib7	3291	5	reactivation	reactivation	NN
cord-005453-4057qib7	3291	6	and	and	CC
cord-005453-4057qib7	3291	7	the	the	DT
cord-005453-4057qib7	3291	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	3291	9	of	of	IN
cord-005453-4057qib7	3291	10	presumed	presume	VBN
cord-005453-4057qib7	3291	11	/	/	SYM
cord-005453-4057qib7	3291	12	proven	prove	VBN
cord-005453-4057qib7	3292	1	(	(	-LRB-
cord-005453-4057qib7	3292	2	P	P	NNP
cord-005453-4057qib7	3292	3	/	/	SYM
cord-005453-4057qib7	3292	4	P)-PTLD	P)-PTLD	NNP
cord-005453-4057qib7	3292	5	were	be	VBD
cord-005453-4057qib7	3292	6	75	75	CD
cord-005453-4057qib7	3292	7	(	(	-LRB-
cord-005453-4057qib7	3292	8	16	16	CD
cord-005453-4057qib7	3292	9	-	-	SYM
cord-005453-4057qib7	3292	10	326	326	CD
cord-005453-4057qib7	3292	11	)	)	-RRB-
cord-005453-4057qib7	3292	12	days	day	NNS
cord-005453-4057qib7	3292	13	and	and	CC
cord-005453-4057qib7	3292	14	97	97	CD
cord-005453-4057qib7	3292	15	(	(	-LRB-
cord-005453-4057qib7	3292	16	54	54	CD
cord-005453-4057qib7	3292	17	-	-	SYM
cord-005453-4057qib7	3292	18	306	306	CD
cord-005453-4057qib7	3292	19	)	)	-RRB-
cord-005453-4057qib7	3292	20	days	day	NNS
cord-005453-4057qib7	3292	21	[	[	-LRB-
cord-005453-4057qib7	3292	22	3	3	CD
cord-005453-4057qib7	3292	23	(	(	-LRB-
cord-005453-4057qib7	3292	24	0	0	CD
cord-005453-4057qib7	3292	25	-	-	SYM
cord-005453-4057qib7	3292	26	10	10	CD
cord-005453-4057qib7	3292	27	)	)	-RRB-
cord-005453-4057qib7	3292	28	months	month	NNS
cord-005453-4057qib7	3292	29	]	]	-RRB-
cord-005453-4057qib7	3292	30	,	,	,
cord-005453-4057qib7	3292	31	respectively	respectively	RB
cord-005453-4057qib7	3292	32	.	.	.
cord-005453-4057qib7	3293	1	Median	median	JJ
cord-005453-4057qib7	3293	2	time	time	NN
cord-005453-4057qib7	3293	3	between	between	IN
cord-005453-4057qib7	3293	4	first	first	JJ
cord-005453-4057qib7	3293	5	EBV	EBV	NNP
cord-005453-4057qib7	3293	6	reactivation	reactivation	NN
cord-005453-4057qib7	3293	7	to	to	IN
cord-005453-4057qib7	3293	8	P	p	NN
cord-005453-4057qib7	3293	9	/	/	SYM
cord-005453-4057qib7	3293	10	P	p	NN
cord-005453-4057qib7	3293	11	-	-	HYPH
cord-005453-4057qib7	3293	12	PTLD	PTLD	NNP
cord-005453-4057qib7	3293	13	was	be	VBD
cord-005453-4057qib7	3293	14	21	21	CD
cord-005453-4057qib7	3293	15	(	(	-LRB-
cord-005453-4057qib7	3293	16	0	0	CD
cord-005453-4057qib7	3293	17	-	-	SYM
cord-005453-4057qib7	3293	18	175	175	CD
cord-005453-4057qib7	3293	19	)	)	-RRB-
cord-005453-4057qib7	3293	20	days	day	NNS
cord-005453-4057qib7	3293	21	.	.	.
cord-005453-4057qib7	3294	1	Seventeen	seventeen	CD
cord-005453-4057qib7	3294	2	(	(	-LRB-
cord-005453-4057qib7	3294	3	14	14	CD
cord-005453-4057qib7	3294	4	%	%	NN
cord-005453-4057qib7	3294	5	)	)	-RRB-
cord-005453-4057qib7	3294	6	of	of	IN
cord-005453-4057qib7	3294	7	the	the	DT
cord-005453-4057qib7	3294	8	117	117	CD
cord-005453-4057qib7	3294	9	patients	patient	NNS
cord-005453-4057qib7	3294	10	developed	develop	VBN
cord-005453-4057qib7	3294	11	P	p	NN
cord-005453-4057qib7	3294	12	/	/	SYM
cord-005453-4057qib7	3294	13	P	p	NN
cord-005453-4057qib7	3294	14	-	-	HYPH
cord-005453-4057qib7	3294	15	PTLD	PTLD	NNP
cord-005453-4057qib7	3294	16	.	.	.
cord-005453-4057qib7	3295	1	Median	median	JJ
cord-005453-4057qib7	3295	2	age	age	NN
cord-005453-4057qib7	3295	3	was	be	VBD
cord-005453-4057qib7	3295	4	55	55	CD
cord-005453-4057qib7	3295	5	years	year	NNS
cord-005453-4057qib7	3295	6	.	.	.
cord-005453-4057qib7	3296	1	Two	two	CD
cord-005453-4057qib7	3296	2	(	(	-LRB-
cord-005453-4057qib7	3296	3	12	12	CD
cord-005453-4057qib7	3296	4	%	%	NN
cord-005453-4057qib7	3296	5	)	)	-RRB-
cord-005453-4057qib7	3296	6	received	receive	VBD
cord-005453-4057qib7	3296	7	MRD	MRD	NNP
cord-005453-4057qib7	3296	8	,	,	,
cord-005453-4057qib7	3296	9	9	9	CD
cord-005453-4057qib7	3296	10	(	(	-LRB-
cord-005453-4057qib7	3296	11	53	53	CD
cord-005453-4057qib7	3296	12	%	%	NN
cord-005453-4057qib7	3296	13	)	)	-RRB-
cord-005453-4057qib7	3296	14	10/10	10/10	CD
cord-005453-4057qib7	3296	15	MUD	mud	NN
cord-005453-4057qib7	3296	16	,	,	,
cord-005453-4057qib7	3296	17	1	1	CD
cord-005453-4057qib7	3296	18	(	(	-LRB-
cord-005453-4057qib7	3296	19	6	6	CD
cord-005453-4057qib7	3296	20	%	%	NN
cord-005453-4057qib7	3296	21	)	)	-RRB-
cord-005453-4057qib7	3296	22	9/10	9/10	CD
cord-005453-4057qib7	3296	23	MUD	mud	NN
cord-005453-4057qib7	3296	24	,	,	,
cord-005453-4057qib7	3296	25	and	and	CC
cord-005453-4057qib7	3296	26	5	5	CD
cord-005453-4057qib7	3296	27	(	(	-LRB-
cord-005453-4057qib7	3296	28	29	29	CD
cord-005453-4057qib7	3296	29	%	%	NN
cord-005453-4057qib7	3296	30	)	)	-RRB-
cord-005453-4057qib7	3296	31	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3296	32	donor	donor	NN
cord-005453-4057qib7	3296	33	grafts	graft	NNS
cord-005453-4057qib7	3296	34	.	.	.
cord-005453-4057qib7	3297	1	Twelve	twelve	CD
cord-005453-4057qib7	3297	2	(	(	-LRB-
cord-005453-4057qib7	3297	3	71	71	CD
cord-005453-4057qib7	3297	4	%	%	NN
cord-005453-4057qib7	3297	5	)	)	-RRB-
cord-005453-4057qib7	3297	6	were	be	VBD
cord-005453-4057qib7	3297	7	on	on	IN
cord-005453-4057qib7	3297	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	3297	9	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	3297	10	at	at	IN
cord-005453-4057qib7	3297	11	diagnosis	diagnosis	NN
cord-005453-4057qib7	3297	12	.	.	.
cord-005453-4057qib7	3298	1	Pre	pre	JJ
cord-005453-4057qib7	3298	2	-	-	JJ
cord-005453-4057qib7	3298	3	Emptive	emptive	JJ
cord-005453-4057qib7	3298	4	therapy	therapy	NN
cord-005453-4057qib7	3298	5	was	be	VBD
cord-005453-4057qib7	3298	6	not	not	RB
cord-005453-4057qib7	3298	7	given	give	VBN
cord-005453-4057qib7	3298	8	to	to	IN
cord-005453-4057qib7	3298	9	any	any	DT
cord-005453-4057qib7	3298	10	case	case	NN
cord-005453-4057qib7	3298	11	and	and	CC
cord-005453-4057qib7	3298	12	only	only	RB
cord-005453-4057qib7	3298	13	Probable	probable	JJ
cord-005453-4057qib7	3298	14	or	or	CC
cord-005453-4057qib7	3298	15	Proven	Proven	NNP
cord-005453-4057qib7	3298	16	PTLD	PTLD	NNP
cord-005453-4057qib7	3298	17	were	be	VBD
cord-005453-4057qib7	3298	18	given	give	VBN
cord-005453-4057qib7	3298	19	rituximab	rituximab	JJ
cord-005453-4057qib7	3298	20	.	.	.
cord-005453-4057qib7	3299	1	Treatment	treatment	NN
cord-005453-4057qib7	3299	2	was	be	VBD
cord-005453-4057qib7	3299	3	based	base	VBN
cord-005453-4057qib7	3299	4	on	on	IN
cord-005453-4057qib7	3299	5	reduction	reduction	NN
cord-005453-4057qib7	3299	6	of	of	IN
cord-005453-4057qib7	3299	7	the	the	DT
cord-005453-4057qib7	3299	8	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	3299	9	in	in	IN
cord-005453-4057qib7	3299	10	3	3	CD
cord-005453-4057qib7	3299	11	patients	patient	NNS
cord-005453-4057qib7	3299	12	and	and	CC
cord-005453-4057qib7	3299	13	with	with	IN
cord-005453-4057qib7	3299	14	the	the	DT
cord-005453-4057qib7	3299	15	addition	addition	NN
cord-005453-4057qib7	3299	16	of	of	IN
cord-005453-4057qib7	3299	17	weekly	weekly	JJ
cord-005453-4057qib7	3299	18	Rituximab	Rituximab	NNP
cord-005453-4057qib7	3299	19	375	375	CD
cord-005453-4057qib7	3299	20	mg/	mg/	NN
cord-005453-4057qib7	3299	21	m	m	CD
cord-005453-4057qib7	3299	22	2	2	CD
cord-005453-4057qib7	3299	23	in	in	IN
cord-005453-4057qib7	3299	24	15	15	CD
cord-005453-4057qib7	3299	25	cases	case	NNS
cord-005453-4057qib7	3299	26	.	.	.
cord-005453-4057qib7	3300	1	Fifteen	fifteen	CD
cord-005453-4057qib7	3300	2	(	(	-LRB-
cord-005453-4057qib7	3300	3	88	88	CD
cord-005453-4057qib7	3300	4	%	%	NN
cord-005453-4057qib7	3300	5	)	)	-RRB-
cord-005453-4057qib7	3300	6	achieved	achieve	VBN
cord-005453-4057qib7	3300	7	complete	complete	JJ
cord-005453-4057qib7	3300	8	clinical	clinical	JJ
cord-005453-4057qib7	3300	9	responses	response	NNS
cord-005453-4057qib7	3300	10	with	with	IN
cord-005453-4057qib7	3300	11	PCR	PCR	NNP
cord-005453-4057qib7	3300	12	negativity	negativity	NN
cord-005453-4057qib7	3300	13	.	.	.
cord-005453-4057qib7	3301	1	Two	two	CD
cord-005453-4057qib7	3301	2	(	(	-LRB-
cord-005453-4057qib7	3301	3	12	12	CD
cord-005453-4057qib7	3301	4	%	%	NN
cord-005453-4057qib7	3301	5	)	)	-RRB-
cord-005453-4057qib7	3301	6	patients	patient	NNS
cord-005453-4057qib7	3301	7	died	die	VBD
cord-005453-4057qib7	3301	8	secondary	secondary	JJ
cord-005453-4057qib7	3301	9	to	to	IN
cord-005453-4057qib7	3301	10	PTLD	PTLD	NNP
cord-005453-4057qib7	3301	11	.	.	.
cord-005453-4057qib7	3302	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3302	2	:	:	:
cord-005453-4057qib7	3303	1	ATG	ATG	NNP
cord-005453-4057qib7	3303	2	based	base	VBN
cord-005453-4057qib7	3303	3	conditioning	conditioning	NN
cord-005453-4057qib7	3303	4	is	be	VBZ
cord-005453-4057qib7	3303	5	associated	associate	VBN
cord-005453-4057qib7	3303	6	with	with	IN
cord-005453-4057qib7	3303	7	increased	increase	VBN
cord-005453-4057qib7	3303	8	viral	viral	JJ
cord-005453-4057qib7	3303	9	reactivations	reactivation	NNS
cord-005453-4057qib7	3303	10	.	.	.
cord-005453-4057qib7	3304	1	Frequent	frequent	JJ
cord-005453-4057qib7	3304	2	EBV	EBV	NNP
cord-005453-4057qib7	3304	3	monitoring	monitoring	NN
cord-005453-4057qib7	3304	4	and	and	CC
cord-005453-4057qib7	3304	5	pre	pre	JJ
cord-005453-4057qib7	3304	6	-	-	JJ
cord-005453-4057qib7	3304	7	emptive	emptive	JJ
cord-005453-4057qib7	3304	8	treatment	treatment	NN
cord-005453-4057qib7	3304	9	may	may	MD
cord-005453-4057qib7	3304	10	lead	lead	VB
cord-005453-4057qib7	3304	11	to	to	IN
cord-005453-4057qib7	3304	12	rapid	rapid	JJ
cord-005453-4057qib7	3304	13	disease	disease	NN
cord-005453-4057qib7	3304	14	control	control	NN
cord-005453-4057qib7	3304	15	.	.	.
cord-005453-4057qib7	3305	1	Further	further	JJ
cord-005453-4057qib7	3305	2	research	research	NN
cord-005453-4057qib7	3305	3	is	be	VBZ
cord-005453-4057qib7	3305	4	required	require	VBN
cord-005453-4057qib7	3305	5	to	to	TO
cord-005453-4057qib7	3305	6	optimize	optimize	VB
cord-005453-4057qib7	3305	7	monitoring	monitoring	NN
cord-005453-4057qib7	3305	8	and	and	CC
cord-005453-4057qib7	3305	9	management	management	NN
cord-005453-4057qib7	3305	10	strategies	strategy	NNS
cord-005453-4057qib7	3305	11	in	in	IN
cord-005453-4057qib7	3305	12	allo	allo	NN
cord-005453-4057qib7	3305	13	-	-	HYPH
cord-005453-4057qib7	3305	14	HSCT	HSCT	NNP
cord-005453-4057qib7	3305	15	recipients	recipient	NNS
cord-005453-4057qib7	3305	16	.	.	.
cord-005453-4057qib7	3306	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3306	2	:	:	:
cord-005453-4057qib7	3306	3	Nothing	nothing	NN
cord-005453-4057qib7	3306	4	to	to	TO
cord-005453-4057qib7	3306	5	declare	declare	VB
cord-005453-4057qib7	3306	6	P160	P160	NNP
cord-005453-4057qib7	3306	7	Acoustically	acoustically	RB
cord-005453-4057qib7	3306	8	enriched	enrich	VBN
cord-005453-4057qib7	3306	9	extracellular	extracellular	JJ
cord-005453-4057qib7	3306	10	vesicles	vesicle	NNS
cord-005453-4057qib7	3306	11	as	as	IN
cord-005453-4057qib7	3306	12	potential	potential	JJ
cord-005453-4057qib7	3306	13	markers	marker	NNS
cord-005453-4057qib7	3306	14	for	for	IN
cord-005453-4057qib7	3306	15	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3306	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3306	17	stem	stem	NN
cord-005453-4057qib7	3306	18	cell	cell	NN
cord-005453-4057qib7	3306	19	transplantation	transplantation	NN
cord-005453-4057qib7	3306	20	complications	complication	NNS
cord-005453-4057qib7	3306	21	Hooi	Hooi	NNP
cord-005453-4057qib7	3306	22	-	-	HYPH
cord-005453-4057qib7	3306	23	Ching	Ching	NNP
cord-005453-4057qib7	3306	24	Lim	Lim	NNP
cord-005453-4057qib7	3306	25	1	1	CD
cord-005453-4057qib7	3306	26	,	,	,
cord-005453-4057qib7	3306	27	Robert	Robert	NNP
cord-005453-4057qib7	3306	28	Palmason	Palmason	NNP
cord-005453-4057qib7	3306	29	2	2	CD
cord-005453-4057qib7	3306	30	,	,	,
cord-005453-4057qib7	3306	31	Stig	Stig	NNP
cord-005453-4057qib7	3306	32	Lenhoff	Lenhoff	NNP
cord-005453-4057qib7	3306	33	2	2	CD
cord-005453-4057qib7	3306	34	,	,	,
cord-005453-4057qib7	3306	35	Thomas	Thomas	NNP
cord-005453-4057qib7	3306	36	Laurell	Laurell	NNP
cord-005453-4057qib7	3306	37	1	1	CD
cord-005453-4057qib7	3306	38	,	,	,
cord-005453-4057qib7	3306	39	Stefan	Stefan	NNP
cord-005453-4057qib7	3306	40	Scheding	Scheding	NNP
cord-005453-4057qib7	3307	1	1,2	1,2	LS
cord-005453-4057qib7	3307	2	Background	background	NN
cord-005453-4057qib7	3307	3	:	:	:
cord-005453-4057qib7	3308	1	Extracellular	Extracellular	NNP
cord-005453-4057qib7	3308	2	vesicles	vesicle	NNS
cord-005453-4057qib7	3308	3	(	(	-LRB-
cord-005453-4057qib7	3308	4	EVs	ev	NNS
cord-005453-4057qib7	3308	5	)	)	-RRB-
cord-005453-4057qib7	3308	6	contain	contain	VBP
cord-005453-4057qib7	3308	7	a	a	DT
cord-005453-4057qib7	3308	8	number	number	NN
cord-005453-4057qib7	3308	9	of	of	IN
cord-005453-4057qib7	3308	10	condition	condition	NN
cord-005453-4057qib7	3308	11	-	-	HYPH
cord-005453-4057qib7	3308	12	specific	specific	JJ
cord-005453-4057qib7	3308	13	proteins	protein	NNS
cord-005453-4057qib7	3308	14	,	,	,
cord-005453-4057qib7	3308	15	DNA	DNA	NNP
cord-005453-4057qib7	3308	16	and	and	CC
cord-005453-4057qib7	3308	17	RNA	RNA	NNP
cord-005453-4057qib7	3308	18	types	type	NNS
cord-005453-4057qib7	3308	19	and	and	CC
cord-005453-4057qib7	3308	20	might	may	MD
cord-005453-4057qib7	3308	21	therefore	therefore	RB
cord-005453-4057qib7	3308	22	be	be	VB
cord-005453-4057qib7	3308	23	used	use	VBN
cord-005453-4057qib7	3308	24	for	for	IN
cord-005453-4057qib7	3308	25	the	the	DT
cord-005453-4057qib7	3308	26	early	early	JJ
cord-005453-4057qib7	3308	27	detection	detection	NN
cord-005453-4057qib7	3308	28	of	of	IN
cord-005453-4057qib7	3308	29	posttransplant	posttransplant	NN
cord-005453-4057qib7	3308	30	complications	complication	NNS
cord-005453-4057qib7	3308	31	.	.	.
cord-005453-4057qib7	3309	1	However	however	RB
cord-005453-4057qib7	3309	2	,	,	,
cord-005453-4057qib7	3309	3	traditional	traditional	JJ
cord-005453-4057qib7	3309	4	EV	ev	NN
cord-005453-4057qib7	3309	5	isolation	isolation	NN
cord-005453-4057qib7	3309	6	(	(	-LRB-
cord-005453-4057qib7	3309	7	ultracentrifugation	ultracentrifugation	NN
cord-005453-4057qib7	3309	8	)	)	-RRB-
cord-005453-4057qib7	3309	9	is	be	VBZ
cord-005453-4057qib7	3309	10	time	time	NN
cord-005453-4057qib7	3309	11	consuming	consume	VBG
cord-005453-4057qib7	3309	12	and	and	CC
cord-005453-4057qib7	3309	13	requires	require	VBZ
cord-005453-4057qib7	3309	14	large	large	JJ
cord-005453-4057qib7	3309	15	sample	sample	NN
cord-005453-4057qib7	3309	16	volumes	volume	NNS
cord-005453-4057qib7	3309	17	thus	thus	RB
cord-005453-4057qib7	3309	18	making	make	VBG
cord-005453-4057qib7	3309	19	it	-PRON-	PRP
cord-005453-4057qib7	3309	20	difficult	difficult	JJ
cord-005453-4057qib7	3309	21	to	to	TO
cord-005453-4057qib7	3309	22	perform	perform	VB
cord-005453-4057qib7	3309	23	longitudinal	longitudinal	JJ
cord-005453-4057qib7	3309	24	studies	study	NNS
cord-005453-4057qib7	3309	25	on	on	IN
cord-005453-4057qib7	3309	26	larger	large	JJR
cord-005453-4057qib7	3309	27	patient	patient	JJ
cord-005453-4057qib7	3309	28	cohorts	cohort	NNS
cord-005453-4057qib7	3309	29	.	.	.
cord-005453-4057qib7	3310	1	We	-PRON-	PRP
cord-005453-4057qib7	3310	2	therefore	therefore	RB
cord-005453-4057qib7	3310	3	investigated	investigate	VBD
cord-005453-4057qib7	3310	4	whether	whether	IN
cord-005453-4057qib7	3310	5	recently	recently	RB
cord-005453-4057qib7	3310	6	-	-	HYPH
cord-005453-4057qib7	3310	7	developed	develop	VBN
cord-005453-4057qib7	3310	8	acoustic	acoustic	JJ
cord-005453-4057qib7	3310	9	trapping	trapping	NN
cord-005453-4057qib7	3310	10	could	could	MD
cord-005453-4057qib7	3310	11	be	be	VB
cord-005453-4057qib7	3310	12	applied	apply	VBN
cord-005453-4057qib7	3310	13	to	to	TO
cord-005453-4057qib7	3310	14	isolate	isolate	VB
cord-005453-4057qib7	3310	15	EVs	ev	NNS
cord-005453-4057qib7	3310	16	from	from	IN
cord-005453-4057qib7	3310	17	patient	patient	JJ
cord-005453-4057qib7	3310	18	plasma	plasma	NN
cord-005453-4057qib7	3310	19	for	for	IN
cord-005453-4057qib7	3310	20	biomarker	biomarker	NN
cord-005453-4057qib7	3310	21	development	development	NN
cord-005453-4057qib7	3310	22	.	.	.
cord-005453-4057qib7	3311	1	Methods	method	NNS
cord-005453-4057qib7	3311	2	:	:	:
cord-005453-4057qib7	3311	3	Plasma	plasma	NN
cord-005453-4057qib7	3311	4	samples	sample	NNS
cord-005453-4057qib7	3311	5	were	be	VBD
cord-005453-4057qib7	3311	6	collected	collect	VBN
cord-005453-4057qib7	3311	7	from	from	IN
cord-005453-4057qib7	3311	8	10	10	CD
cord-005453-4057qib7	3311	9	consecutive	consecutive	JJ
cord-005453-4057qib7	3311	10	patients	patient	NNS
cord-005453-4057qib7	3311	11	before	before	RB
cord-005453-4057qib7	3311	12	and	and	CC
cord-005453-4057qib7	3311	13	up	up	IN
cord-005453-4057qib7	3311	14	to	to	TO
cord-005453-4057qib7	3311	15	3	3	CD
cord-005453-4057qib7	3311	16	months	month	NNS
cord-005453-4057qib7	3311	17	after	after	IN
cord-005453-4057qib7	3311	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	3311	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3311	20	stem	stem	NN
cord-005453-4057qib7	3311	21	cell	cell	NN
cord-005453-4057qib7	3311	22	transplantation	transplantation	NN
cord-005453-4057qib7	3311	23	.	.	.
cord-005453-4057qib7	3312	1	Patients	patient	NNS
cord-005453-4057qib7	3312	2	(	(	-LRB-
cord-005453-4057qib7	3312	3	age	age	NN
cord-005453-4057qib7	3312	4	:	:	:
cord-005453-4057qib7	3312	5	22	22	CD
cord-005453-4057qib7	3312	6	-	-	SYM
cord-005453-4057qib7	3312	7	58	58	CD
cord-005453-4057qib7	3312	8	years	year	NNS
cord-005453-4057qib7	3312	9	)	)	-RRB-
cord-005453-4057qib7	3312	10	with	with	IN
cord-005453-4057qib7	3312	11	high	high	JJ
cord-005453-4057qib7	3312	12	-	-	HYPH
cord-005453-4057qib7	3312	13	risk	risk	NN
cord-005453-4057qib7	3312	14	or	or	CC
cord-005453-4057qib7	3312	15	refractory	refractory	JJ
cord-005453-4057qib7	3312	16	/	/	SYM
cord-005453-4057qib7	3312	17	relapsed	relapse	VBN
cord-005453-4057qib7	3312	18	diseases	disease	NNS
cord-005453-4057qib7	3312	19	were	be	VBD
cord-005453-4057qib7	3312	20	transplanted	transplant	VBN
cord-005453-4057qib7	3312	21	with	with	IN
cord-005453-4057qib7	3312	22	mobilized	mobilize	VBN
cord-005453-4057qib7	3312	23	PBSC	PBSC	NNP
cord-005453-4057qib7	3312	24	from	from	IN
cord-005453-4057qib7	3312	25	related	related	JJ
cord-005453-4057qib7	3312	26	(	(	-LRB-
cord-005453-4057qib7	3312	27	n=2	n=2	NNS
cord-005453-4057qib7	3312	28	)	)	-RRB-
cord-005453-4057qib7	3312	29	and	and	CC
cord-005453-4057qib7	3312	30	unrelated	unrelated	JJ
cord-005453-4057qib7	3312	31	donors	donor	NNS
cord-005453-4057qib7	3312	32	(	(	-LRB-
cord-005453-4057qib7	3312	33	n=8	n=8	NN
cord-005453-4057qib7	3312	34	)	)	-RRB-
cord-005453-4057qib7	3312	35	after	after	IN
cord-005453-4057qib7	3312	36	standard	standard	JJ
cord-005453-4057qib7	3312	37	conditioning	conditioning	NN
cord-005453-4057qib7	3312	38	.	.	.
cord-005453-4057qib7	3313	1	GvHD	GvHD	NNP
cord-005453-4057qib7	3313	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3313	3	was	be	VBD
cord-005453-4057qib7	3313	4	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	3313	5	and	and	CC
cord-005453-4057qib7	3313	6	methotrexate	methotrexate	NNP
cord-005453-4057qib7	3313	7	.	.	.
cord-005453-4057qib7	3314	1	Plasma	plasma	NN
cord-005453-4057qib7	3314	2	samples	sample	NNS
cord-005453-4057qib7	3314	3	were	be	VBD
cord-005453-4057qib7	3314	4	frozen	freeze	VBN
cord-005453-4057qib7	3314	5	and	and	CC
cord-005453-4057qib7	3314	6	thawed	thaw	VBN
cord-005453-4057qib7	3314	7	for	for	IN
cord-005453-4057qib7	3314	8	EV	ev	NN
cord-005453-4057qib7	3314	9	enrichment	enrichment	NN
cord-005453-4057qib7	3314	10	using	use	VBG
cord-005453-4057qib7	3314	11	a	a	DT
cord-005453-4057qib7	3314	12	novel	novel	JJ
cord-005453-4057qib7	3314	13	acoustofluidic	acoustofluidic	NN
cord-005453-4057qib7	3314	14	-	-	HYPH
cord-005453-4057qib7	3314	15	based	base	VBN
cord-005453-4057qib7	3314	16	technology	technology	NN
cord-005453-4057qib7	3314	17	(	(	-LRB-
cord-005453-4057qib7	3314	18	acoustic	acoustic	JJ
cord-005453-4057qib7	3314	19	trapping	trapping	NN
cord-005453-4057qib7	3314	20	)	)	-RRB-
cord-005453-4057qib7	3314	21	.	.	.
cord-005453-4057qib7	3315	1	Acoustic	acoustic	JJ
cord-005453-4057qib7	3315	2	trapping	trapping	NN
cord-005453-4057qib7	3315	3	uses	use	VBZ
cord-005453-4057qib7	3315	4	ultrasound	ultrasound	NN
cord-005453-4057qib7	3315	5	as	as	IN
cord-005453-4057qib7	3315	6	a	a	DT
cord-005453-4057qib7	3315	7	local	local	JJ
cord-005453-4057qib7	3315	8	λ/2	λ/2	NN
cord-005453-4057qib7	3315	9	acoustic	acoustic	JJ
cord-005453-4057qib7	3315	10	standing	standing	NN
cord-005453-4057qib7	3315	11	wave	wave	NN
cord-005453-4057qib7	3315	12	produced	produce	VBN
cord-005453-4057qib7	3315	13	by	by	IN
cord-005453-4057qib7	3315	14	a	a	DT
cord-005453-4057qib7	3315	15	piezoelectric	piezoelectric	JJ
cord-005453-4057qib7	3315	16	transducer	transducer	NN
cord-005453-4057qib7	3315	17	over	over	IN
cord-005453-4057qib7	3315	18	a	a	DT
cord-005453-4057qib7	3315	19	capillary	capillary	NN
cord-005453-4057qib7	3315	20	.	.	.
cord-005453-4057qib7	3316	1	First	first	RB
cord-005453-4057qib7	3316	2	,	,	,
cord-005453-4057qib7	3316	3	12	12	CD
cord-005453-4057qib7	3316	4	μm	μm	NN
cord-005453-4057qib7	3316	5	polystyrene	polystyrene	NN
cord-005453-4057qib7	3316	6	beads	bead	NNS
cord-005453-4057qib7	3316	7	are	be	VBP
cord-005453-4057qib7	3316	8	captured	capture	VBN
cord-005453-4057qib7	3316	9	which	which	WDT
cord-005453-4057qib7	3316	10	serve	serve	VBP
cord-005453-4057qib7	3316	11	as	as	IN
cord-005453-4057qib7	3316	12	seeding	seed	VBG
cord-005453-4057qib7	3316	13	particles	particle	NNS
cord-005453-4057qib7	3316	14	.	.	.
cord-005453-4057qib7	3317	1	After	after	IN
cord-005453-4057qib7	3317	2	washing	washing	NN
cord-005453-4057qib7	3317	3	,	,	,
cord-005453-4057qib7	3317	4	target	target	NN
cord-005453-4057qib7	3317	5	particles	particle	NNS
cord-005453-4057qib7	3317	6	(	(	-LRB-
cord-005453-4057qib7	3317	7	EVs	ev	NNS
cord-005453-4057qib7	3317	8	)	)	-RRB-
cord-005453-4057qib7	3317	9	are	be	VBP
cord-005453-4057qib7	3317	10	then	then	RB
cord-005453-4057qib7	3317	11	captured	capture	VBN
cord-005453-4057qib7	3317	12	(	(	-LRB-
cord-005453-4057qib7	3317	13	"	"	``
cord-005453-4057qib7	3317	14	trapped	trap	VBN
cord-005453-4057qib7	3317	15	"	"	''
cord-005453-4057qib7	3317	16	)	)	-RRB-
cord-005453-4057qib7	3317	17	in	in	IN
cord-005453-4057qib7	3317	18	the	the	DT
cord-005453-4057qib7	3317	19	acoustic	acoustic	JJ
cord-005453-4057qib7	3317	20	field	field	NN
cord-005453-4057qib7	3317	21	.	.	.
cord-005453-4057qib7	3318	1	A	a	DT
cord-005453-4057qib7	3318	2	semi	semi	JJ
cord-005453-4057qib7	3318	3	-	-	JJ
cord-005453-4057qib7	3318	4	automatic	automatic	JJ
cord-005453-4057qib7	3318	5	trapping	trapping	NN
cord-005453-4057qib7	3318	6	device	device	NN
cord-005453-4057qib7	3318	7	(	(	-LRB-
cord-005453-4057qib7	3318	8	AcouTrap	AcouTrap	NNP
cord-005453-4057qib7	3318	9	)	)	-RRB-
cord-005453-4057qib7	3318	10	was	be	VBD
cord-005453-4057qib7	3318	11	used	use	VBN
cord-005453-4057qib7	3318	12	to	to	TO
cord-005453-4057qib7	3318	13	isolate	isolate	VB
cord-005453-4057qib7	3318	14	EVs	ev	NNS
cord-005453-4057qib7	3318	15	from	from	IN
cord-005453-4057qib7	3318	16	diluted	diluted	JJ
cord-005453-4057qib7	3318	17	plasma	plasma	NN
cord-005453-4057qib7	3318	18	(	(	-LRB-
cord-005453-4057qib7	3318	19	1:2	1:2	CD
cord-005453-4057qib7	3318	20	in	in	IN
cord-005453-4057qib7	3318	21	PBS	PBS	NNP
cord-005453-4057qib7	3318	22	)	)	-RRB-
cord-005453-4057qib7	3318	23	.	.	.
cord-005453-4057qib7	3319	1	The	the	DT
cord-005453-4057qib7	3319	2	number	number	NN
cord-005453-4057qib7	3319	3	of	of	IN
cord-005453-4057qib7	3319	4	EVs	ev	NNS
cord-005453-4057qib7	3319	5	and	and	CC
cord-005453-4057qib7	3319	6	size	size	NN
cord-005453-4057qib7	3319	7	distribution	distribution	NN
cord-005453-4057qib7	3319	8	were	be	VBD
cord-005453-4057qib7	3319	9	analyzed	analyze	VBN
cord-005453-4057qib7	3319	10	by	by	IN
cord-005453-4057qib7	3319	11	nanoparticle	nanoparticle	NN
cord-005453-4057qib7	3319	12	tracking	tracking	NN
cord-005453-4057qib7	3319	13	analysis	analysis	NN
cord-005453-4057qib7	3319	14	.	.	.
cord-005453-4057qib7	3320	1	miRNA	miRNA	NNP
cord-005453-4057qib7	3320	2	analysis	analysis	NN
cord-005453-4057qib7	3320	3	was	be	VBD
cord-005453-4057qib7	3320	4	performed	perform	VBN
cord-005453-4057qib7	3320	5	by	by	IN
cord-005453-4057qib7	3320	6	qPCR.EVs	qpcr.ev	NNS
cord-005453-4057qib7	3320	7	were	be	VBD
cord-005453-4057qib7	3320	8	enriched	enrich	VBN
cord-005453-4057qib7	3320	9	in	in	IN
cord-005453-4057qib7	3320	10	duplicate	duplicate	NN
cord-005453-4057qib7	3320	11	from	from	IN
cord-005453-4057qib7	3320	12	50μl	50μl	NN
cord-005453-4057qib7	3320	13	and	and	CC
cord-005453-4057qib7	3320	14	300μl	300μl	NN
cord-005453-4057qib7	3320	15	of	of	IN
cord-005453-4057qib7	3320	16	diluted	diluted	JJ
cord-005453-4057qib7	3320	17	plasma	plasma	NN
cord-005453-4057qib7	3320	18	for	for	IN
cord-005453-4057qib7	3320	19	nanoparticle	nanoparticle	NN
cord-005453-4057qib7	3320	20	tracking	tracking	NN
cord-005453-4057qib7	3320	21	analysis	analysis	NN
cord-005453-4057qib7	3320	22	and	and	CC
cord-005453-4057qib7	3320	23	qPCR	qPCR	NNP
cord-005453-4057qib7	3320	24	analysis	analysis	NNP
cord-005453-4057qib7	3320	25	,	,	,
cord-005453-4057qib7	3320	26	respectively	respectively	RB
cord-005453-4057qib7	3320	27	.	.	.
cord-005453-4057qib7	3321	1	Results	result	NNS
cord-005453-4057qib7	3321	2	:	:	:
cord-005453-4057qib7	3322	1	EVs	ev	NNS
cord-005453-4057qib7	3322	2	were	be	VBD
cord-005453-4057qib7	3322	3	successfully	successfully	RB
cord-005453-4057qib7	3322	4	isolated	isolate	VBN
cord-005453-4057qib7	3322	5	from	from	IN
cord-005453-4057qib7	3322	6	all	all	DT
cord-005453-4057qib7	3322	7	plasma	plasma	NN
cord-005453-4057qib7	3322	8	samples	sample	NNS
cord-005453-4057qib7	3322	9	.	.	.
cord-005453-4057qib7	3323	1	A	a	DT
cord-005453-4057qib7	3323	2	total	total	NN
cord-005453-4057qib7	3323	3	of	of	IN
cord-005453-4057qib7	3323	4	89	89	CD
cord-005453-4057qib7	3323	5	plasma	plasma	NN
cord-005453-4057qib7	3323	6	samples	sample	NNS
cord-005453-4057qib7	3323	7	were	be	VBD
cord-005453-4057qib7	3323	8	processed	process	VBN
cord-005453-4057qib7	3323	9	.	.	.
cord-005453-4057qib7	3324	1	Numbers	number	NNS
cord-005453-4057qib7	3324	2	of	of	IN
cord-005453-4057qib7	3324	3	trapped	trap	VBN
cord-005453-4057qib7	3324	4	EVs	ev	NNS
cord-005453-4057qib7	3324	5	ranged	range	VBD
cord-005453-4057qib7	3324	6	from	from	IN
cord-005453-4057qib7	3324	7	3.7x10	3.7x10	CD
cord-005453-4057qib7	3324	8	8	8	CD
cord-005453-4057qib7	3324	9	-5.5x10	-5.5x10	NNP
cord-005453-4057qib7	3324	10	9	9	CD
cord-005453-4057qib7	3324	11	before	before	IN
cord-005453-4057qib7	3324	12	conditioning	conditioning	NN
cord-005453-4057qib7	3324	13	to	to	IN
cord-005453-4057qib7	3324	14	4.4x10	4.4x10	CD
cord-005453-4057qib7	3324	15	8	8	CD
cord-005453-4057qib7	3324	16	-1.5x10	-1.5x10	CD
cord-005453-4057qib7	3324	17	10	10	CD
cord-005453-4057qib7	3324	18	per	per	IN
cord-005453-4057qib7	3324	19	50μl	50μl	JJ
cord-005453-4057qib7	3324	20	diluted	diluted	JJ
cord-005453-4057qib7	3324	21	plasma	plasma	NN
cord-005453-4057qib7	3324	22	after	after	IN
cord-005453-4057qib7	3324	23	transplantation	transplantation	NN
cord-005453-4057qib7	3324	24	.	.	.
cord-005453-4057qib7	3325	1	The	the	DT
cord-005453-4057qib7	3325	2	maximum	maximum	JJ
cord-005453-4057qib7	3325	3	change	change	NN
cord-005453-4057qib7	3325	4	in	in	IN
cord-005453-4057qib7	3325	5	EV	EV	NNP
cord-005453-4057qib7	3325	6	numbers	number	NNS
cord-005453-4057qib7	3325	7	in	in	IN
cord-005453-4057qib7	3325	8	individual	individual	JJ
cord-005453-4057qib7	3325	9	patients	patient	NNS
cord-005453-4057qib7	3325	10	compared	compare	VBN
cord-005453-4057qib7	3325	11	to	to	IN
cord-005453-4057qib7	3325	12	pretransplantation	pretransplantation	NN
cord-005453-4057qib7	3325	13	values	value	NNS
cord-005453-4057qib7	3325	14	ranged	range	VBD
cord-005453-4057qib7	3325	15	from	from	IN
cord-005453-4057qib7	3325	16	2-fold	2-fold	CD
cord-005453-4057qib7	3325	17	to	to	IN
cord-005453-4057qib7	3325	18	7-fold	7-fold	CD
cord-005453-4057qib7	3325	19	.	.	.
cord-005453-4057qib7	3326	1	Most	Most	JJS
cord-005453-4057qib7	3326	2	patients	patient	NNS
cord-005453-4057qib7	3326	3	showed	show	VBD
cord-005453-4057qib7	3326	4	slight	slight	JJ
cord-005453-4057qib7	3326	5	increases	increase	NNS
cord-005453-4057qib7	3326	6	in	in	IN
cord-005453-4057qib7	3326	7	EV	ev	NN
cord-005453-4057qib7	3326	8	size	size	NN
cord-005453-4057qib7	3326	9	after	after	IN
cord-005453-4057qib7	3326	10	transplantation	transplantation	NN
cord-005453-4057qib7	3326	11	.	.	.
cord-005453-4057qib7	3327	1	Eight	eight	CD
cord-005453-4057qib7	3327	2	of	of	IN
cord-005453-4057qib7	3327	3	the	the	DT
cord-005453-4057qib7	3327	4	patients	patient	NNS
cord-005453-4057qib7	3327	5	showed	show	VBD
cord-005453-4057qib7	3327	6	signs	sign	NNS
cord-005453-4057qib7	3327	7	of	of	IN
cord-005453-4057qib7	3327	8	infection	infection	NN
cord-005453-4057qib7	3327	9	and	and	CC
cord-005453-4057qib7	3327	10	received	receive	VBD
cord-005453-4057qib7	3327	11	i.v	i.v	NNP
cord-005453-4057qib7	3327	12	.	.	.
cord-005453-4057qib7	3327	13	antibiotics	antibiotic	NNS
cord-005453-4057qib7	3327	14	.	.	.
cord-005453-4057qib7	3328	1	Increased	increase	VBN
cord-005453-4057qib7	3328	2	levels	level	NNS
cord-005453-4057qib7	3328	3	of	of	IN
cord-005453-4057qib7	3328	4	EVs	ev	NNS
cord-005453-4057qib7	3328	5	(	(	-LRB-
cord-005453-4057qib7	3328	6	>	>	XX
cord-005453-4057qib7	3328	7	2-fold	2-fold	CD
cord-005453-4057qib7	3328	8	)	)	-RRB-
cord-005453-4057qib7	3328	9	were	be	VBD
cord-005453-4057qib7	3328	10	recorded	record	VBN
cord-005453-4057qib7	3328	11	in	in	IN
cord-005453-4057qib7	3328	12	three	three	CD
cord-005453-4057qib7	3328	13	patients	patient	NNS
cord-005453-4057qib7	3328	14	during	during	IN
cord-005453-4057qib7	3328	15	these	these	DT
cord-005453-4057qib7	3328	16	episodes	episode	NNS
cord-005453-4057qib7	3328	17	.	.	.
cord-005453-4057qib7	3329	1	Furthermore	furthermore	RB
cord-005453-4057qib7	3329	2	,	,	,
cord-005453-4057qib7	3329	3	increased	increase	VBN
cord-005453-4057qib7	3329	4	EV	ev	NN
cord-005453-4057qib7	3329	5	numbers	number	NNS
cord-005453-4057qib7	3329	6	were	be	VBD
cord-005453-4057qib7	3329	7	observed	observe	VBN
cord-005453-4057qib7	3329	8	in	in	IN
cord-005453-4057qib7	3329	9	a	a	DT
cord-005453-4057qib7	3329	10	patient	patient	NN
cord-005453-4057qib7	3329	11	who	who	WP
cord-005453-4057qib7	3329	12	required	require	VBD
cord-005453-4057qib7	3329	13	i.v	i.v	NNP
cord-005453-4057qib7	3329	14	.	.	.
cord-005453-4057qib7	3329	15	antiviral	antiviral	JJ
cord-005453-4057qib7	3329	16	therapy	therapy	NN
cord-005453-4057qib7	3329	17	for	for	IN
cord-005453-4057qib7	3329	18	CMV	CMV	NNP
cord-005453-4057qib7	3329	19	reactivation	reactivation	NN
cord-005453-4057qib7	3329	20	.	.	.
cord-005453-4057qib7	3330	1	Acute	acute	JJ
cord-005453-4057qib7	3330	2	grade	grade	NN
cord-005453-4057qib7	3331	1	I	-PRON-	PRP
cord-005453-4057qib7	3331	2	GvHD	GvHD	NNP
cord-005453-4057qib7	3331	3	was	be	VBD
cord-005453-4057qib7	3331	4	observed	observe	VBN
cord-005453-4057qib7	3331	5	in	in	IN
cord-005453-4057qib7	3331	6	five	five	CD
cord-005453-4057qib7	3331	7	patients	patient	NNS
cord-005453-4057qib7	3331	8	of	of	IN
cord-005453-4057qib7	3331	9	which	which	WDT
cord-005453-4057qib7	3331	10	two	two	CD
cord-005453-4057qib7	3331	11	had	have	VBD
cord-005453-4057qib7	3331	12	increased	increase	VBN
cord-005453-4057qib7	3331	13	EV	ev	NN
cord-005453-4057qib7	3331	14	numbers	number	NNS
cord-005453-4057qib7	3331	15	(	(	-LRB-
cord-005453-4057qib7	3331	16	>	>	XX
cord-005453-4057qib7	3331	17	2-fold	2-fold	CD
cord-005453-4057qib7	3331	18	)	)	-RRB-
cord-005453-4057qib7	3331	19	.	.	.
cord-005453-4057qib7	3332	1	One	one	CD
cord-005453-4057qib7	3332	2	patient	patient	NN
cord-005453-4057qib7	3332	3	developed	develop	VBD
cord-005453-4057qib7	3332	4	grade	grade	NN
cord-005453-4057qib7	3332	5	IV	IV	NNP
cord-005453-4057qib7	3332	6	GvHD	GvHD	NNP
cord-005453-4057qib7	3332	7	which	which	WDT
cord-005453-4057qib7	3332	8	was	be	VBD
cord-005453-4057qib7	3332	9	accompanied	accompany	VBN
cord-005453-4057qib7	3332	10	by	by	IN
cord-005453-4057qib7	3332	11	a	a	DT
cord-005453-4057qib7	3332	12	4-fold	4-fold	CD
cord-005453-4057qib7	3332	13	increase	increase	NN
cord-005453-4057qib7	3332	14	in	in	IN
cord-005453-4057qib7	3332	15	EV	EV	NNP
cord-005453-4057qib7	3332	16	numbers	number	NNS
cord-005453-4057qib7	3332	17	.	.	.
cord-005453-4057qib7	3333	1	Interestingly	interestingly	RB
cord-005453-4057qib7	3333	2	,	,	,
cord-005453-4057qib7	3333	3	progressively	progressively	RB
cord-005453-4057qib7	3333	4	increasing	increase	VBG
cord-005453-4057qib7	3333	5	EV	EV	NNP
cord-005453-4057qib7	3333	6	numbers	number	NNS
cord-005453-4057qib7	3333	7	preceded	precede	VBD
cord-005453-4057qib7	3333	8	the	the	DT
cord-005453-4057qib7	3333	9	detection	detection	NN
cord-005453-4057qib7	3333	10	of	of	IN
cord-005453-4057qib7	3333	11	early	early	JJ
cord-005453-4057qib7	3333	12	relapse	relapse	NN
cord-005453-4057qib7	3333	13	in	in	IN
cord-005453-4057qib7	3333	14	a	a	DT
cord-005453-4057qib7	3333	15	pre	pre	NN
cord-005453-4057qib7	3333	16	-	-	NN
cord-005453-4057qib7	3333	17	B	b	NN
cord-005453-4057qib7	3333	18	ALL	all	DT
cord-005453-4057qib7	3333	19	patient	patient	NN
cord-005453-4057qib7	3333	20	by	by	IN
cord-005453-4057qib7	3333	21	three	three	CD
cord-005453-4057qib7	3333	22	weeks	week	NNS
cord-005453-4057qib7	3333	23	.	.	.
cord-005453-4057qib7	3334	1	RNA	rna	NN
cord-005453-4057qib7	3334	2	isolation	isolation	NN
cord-005453-4057qib7	3334	3	from	from	IN
cord-005453-4057qib7	3334	4	trapped	trap	VBN
cord-005453-4057qib7	3334	5	EVs	ev	NNS
cord-005453-4057qib7	3334	6	yielded	yield	VBD
cord-005453-4057qib7	3334	7	sufficient	sufficient	JJ
cord-005453-4057qib7	3334	8	material	material	NN
cord-005453-4057qib7	3334	9	for	for	IN
cord-005453-4057qib7	3334	10	miRNA	miRNA	NNP
cord-005453-4057qib7	3334	11	profiling	profiling	NN
cord-005453-4057qib7	3334	12	.	.	.
cord-005453-4057qib7	3335	1	Here	here	RB
cord-005453-4057qib7	3335	2	,	,	,
cord-005453-4057qib7	3335	3	first	first	RB
cord-005453-4057qib7	3335	4	miRNA	miRNA	NNP
cord-005453-4057qib7	3335	5	profiling	profiling	NN
cord-005453-4057qib7	3335	6	data	datum	NNS
cord-005453-4057qib7	3335	7	demonstrated	demonstrate	VBD
cord-005453-4057qib7	3335	8	that	that	IN
cord-005453-4057qib7	3335	9	miRNAs	miRNAs	NNP
cord-005453-4057qib7	3335	10	were	be	VBD
cord-005453-4057qib7	3335	11	detected	detect	VBN
cord-005453-4057qib7	3335	12	in	in	IN
cord-005453-4057qib7	3335	13	EV	EV	NNP
cord-005453-4057qib7	3335	14	samples	sample	NNS
cord-005453-4057qib7	3335	15	(	(	-LRB-
cord-005453-4057qib7	3335	16	miR-103a	mir-103a	CD
cord-005453-4057qib7	3335	17	,	,	,
cord-005453-4057qib7	3335	18	-23a	-23a	NNP
cord-005453-4057qib7	3335	19	,	,	,
cord-005453-4057qib7	3335	20	-30c	-30c	JJ
cord-005453-4057qib7	3335	21	,	,	,
cord-005453-4057qib7	3335	22	-142	-142	NNP
cord-005453-4057qib7	3335	23	and	and	CC
cord-005453-4057qib7	3335	24	-451a	-451a	NNP
cord-005453-4057qib7	3335	25	)	)	-RRB-
cord-005453-4057qib7	3335	26	,	,	,
cord-005453-4057qib7	3335	27	and	and	CC
cord-005453-4057qib7	3335	28	that	that	IN
cord-005453-4057qib7	3335	29	acoustically	acoustically	RB
cord-005453-4057qib7	3335	30	enriched	enrich	VBN
cord-005453-4057qib7	3335	31	EVs	ev	NNS
cord-005453-4057qib7	3335	32	were	be	VBD
cord-005453-4057qib7	3335	33	not	not	RB
cord-005453-4057qib7	3335	34	affected	affect	VBN
cord-005453-4057qib7	3335	35	by	by	IN
cord-005453-4057qib7	3335	36	hemolysis	hemolysis	NN
cord-005453-4057qib7	3335	37	in	in	IN
cord-005453-4057qib7	3335	38	contrast	contrast	NN
cord-005453-4057qib7	3335	39	to	to	IN
cord-005453-4057qib7	3335	40	the	the	DT
cord-005453-4057qib7	3335	41	corresponding	corresponding	JJ
cord-005453-4057qib7	3335	42	whole	whole	JJ
cord-005453-4057qib7	3335	43	plasma	plasma	NN
cord-005453-4057qib7	3335	44	samples	sample	NNS
cord-005453-4057qib7	3335	45	(	(	-LRB-
cord-005453-4057qib7	3335	46	dCq	dcq	NN
cord-005453-4057qib7	3335	47	of	of	IN
cord-005453-4057qib7	3335	48	miR-23a	miR-23a	NNP
cord-005453-4057qib7	3335	49	and	and	CC
cord-005453-4057qib7	3335	50	miR-451a	mir-451a	CD
cord-005453-4057qib7	3335	51	)	)	-RRB-
cord-005453-4057qib7	3335	52	.	.	.
cord-005453-4057qib7	3336	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3336	2	:	:	:
cord-005453-4057qib7	3337	1	Acoustic	acoustic	JJ
cord-005453-4057qib7	3337	2	trapping	trapping	NN
cord-005453-4057qib7	3337	3	allows	allow	VBZ
cord-005453-4057qib7	3337	4	for	for	IN
cord-005453-4057qib7	3337	5	efficient	efficient	JJ
cord-005453-4057qib7	3337	6	and	and	CC
cord-005453-4057qib7	3337	7	rapid	rapid	JJ
cord-005453-4057qib7	3337	8	enrichment	enrichment	NN
cord-005453-4057qib7	3337	9	of	of	IN
cord-005453-4057qib7	3337	10	EVs	ev	NNS
cord-005453-4057qib7	3337	11	from	from	IN
cord-005453-4057qib7	3337	12	small	small	JJ
cord-005453-4057qib7	3337	13	volume	volume	NN
cord-005453-4057qib7	3337	14	plasma	plasma	NN
cord-005453-4057qib7	3337	15	samples	sample	NNS
cord-005453-4057qib7	3337	16	.	.	.
cord-005453-4057qib7	3338	1	Trapped	trap	VBN
cord-005453-4057qib7	3338	2	EV	ev	NN
cord-005453-4057qib7	3338	3	samples	sample	NNS
cord-005453-4057qib7	3338	4	contain	contain	VBP
cord-005453-4057qib7	3338	5	sufficient	sufficient	JJ
cord-005453-4057qib7	3338	6	amounts	amount	NNS
cord-005453-4057qib7	3338	7	of	of	IN
cord-005453-4057qib7	3338	8	miRNA	miRNA	NNP
cord-005453-4057qib7	3338	9	for	for	IN
cord-005453-4057qib7	3338	10	downstream	downstream	JJ
cord-005453-4057qib7	3338	11	analysis	analysis	NN
cord-005453-4057qib7	3338	12	and	and	CC
cord-005453-4057qib7	3338	13	are	be	VBP
cord-005453-4057qib7	3338	14	thus	thus	RB
cord-005453-4057qib7	3338	15	promising	promising	JJ
cord-005453-4057qib7	3338	16	candidates	candidate	NNS
cord-005453-4057qib7	3338	17	for	for	IN
cord-005453-4057qib7	3338	18	biomarker	biomarker	NN
cord-005453-4057qib7	3338	19	development	development	NN
cord-005453-4057qib7	3338	20	in	in	IN
cord-005453-4057qib7	3338	21	transplantation	transplantation	NN
cord-005453-4057qib7	3338	22	.	.	.
cord-005453-4057qib7	3339	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3339	2	:	:	:
cord-005453-4057qib7	3339	3	Laurell	Laurell	NNP
cord-005453-4057qib7	3339	4	and	and	CC
cord-005453-4057qib7	3339	5	Scheding	Scheding	NNP
cord-005453-4057qib7	3339	6	are	be	VBP
cord-005453-4057qib7	3339	7	founders	founder	NNS
cord-005453-4057qib7	3339	8	and	and	CC
cord-005453-4057qib7	3339	9	board	board	NN
cord-005453-4057qib7	3339	10	members	member	NNS
cord-005453-4057qib7	3339	11	of	of	IN
cord-005453-4057qib7	3339	12	Acousort	Acousort	NNP
cord-005453-4057qib7	3339	13	AB	AB	NNP
cord-005453-4057qib7	3339	14	,	,	,
cord-005453-4057qib7	3339	15	a	a	DT
cord-005453-4057qib7	3339	16	Lund	Lund	NNP
cord-005453-4057qib7	3339	17	-	-	HYPH
cord-005453-4057qib7	3339	18	based	base	VBN
cord-005453-4057qib7	3339	19	biotech	biotech	JJ
cord-005453-4057qib7	3339	20	SME	SME	NNP
cord-005453-4057qib7	3339	21	that	that	WDT
cord-005453-4057qib7	3339	22	develops	develop	VBZ
cord-005453-4057qib7	3339	23	particle	particle	NN
cord-005453-4057qib7	3339	24	and	and	CC
cord-005453-4057qib7	3339	25	cell	cell	NN
cord-005453-4057qib7	3339	26	sorting	sorting	NN
cord-005453-4057qib7	3339	27	methods	method	NNS
cord-005453-4057qib7	3339	28	based	base	VBN
cord-005453-4057qib7	3339	29	on	on	IN
cord-005453-4057qib7	3339	30	ultrasound	ultrasound	NN
cord-005453-4057qib7	3339	31	.	.	.
cord-005453-4057qib7	3340	1	The	the	DT
cord-005453-4057qib7	3340	2	incidence	incidence	NN
cord-005453-4057qib7	3340	3	,	,	,
cord-005453-4057qib7	3340	4	risk	risk	NN
cord-005453-4057qib7	3340	5	factors	factor	NNS
cord-005453-4057qib7	3340	6	and	and	CC
cord-005453-4057qib7	3340	7	outcomes	outcome	NNS
cord-005453-4057qib7	3340	8	of	of	IN
cord-005453-4057qib7	3340	9	primary	primary	JJ
cord-005453-4057qib7	3340	10	poor	poor	JJ
cord-005453-4057qib7	3340	11	graft	graft	NN
cord-005453-4057qib7	3340	12	function	function	NN
cord-005453-4057qib7	3340	13	after	after	IN
cord-005453-4057qib7	3340	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	3340	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3340	16	stem	stem	NN
cord-005453-4057qib7	3340	17	cell	cell	NN
cord-005453-4057qib7	3340	18	transplantation	transplantation	NN
cord-005453-4057qib7	3340	19	Fei	Fei	NNP
cord-005453-4057qib7	3340	20	Gao	Gao	NNP
cord-005453-4057qib7	3340	21	1,2	1,2	CD
cord-005453-4057qib7	3340	22	,	,	,
cord-005453-4057qib7	3340	23	Jimin	Jimin	NNP
cord-005453-4057qib7	3340	24	Shi	Shi	NNP
cord-005453-4057qib7	3340	25	1,2	1,2	CD
cord-005453-4057qib7	3340	26	,	,	,
cord-005453-4057qib7	3340	27	Yi	Yi	NNP
cord-005453-4057qib7	3340	28	Luo	Luo	NNP
cord-005453-4057qib7	3340	29	1,2	1,2	CD
cord-005453-4057qib7	3340	30	,	,	,
cord-005453-4057qib7	3340	31	Yamin	Yamin	NNP
cord-005453-4057qib7	3340	32	Tan	Tan	NNP
cord-005453-4057qib7	3340	33	1,2	1,2	CD
cord-005453-4057qib7	3340	34	,	,	,
cord-005453-4057qib7	3340	35	Xiaoyu	Xiaoyu	NNP
cord-005453-4057qib7	3340	36	Lai	Lai	NNP
cord-005453-4057qib7	3340	37	1,2	1,2	CD
cord-005453-4057qib7	3340	38	,	,	,
cord-005453-4057qib7	3340	39	Jian	Jian	NNP
cord-005453-4057qib7	3340	40	Yu	Yu	NNP
cord-005453-4057qib7	3340	41	1,2	1,2	CD
cord-005453-4057qib7	3340	42	,	,	,
cord-005453-4057qib7	3340	43	He	-PRON-	PRP
cord-005453-4057qib7	3340	44	Huang	Huang	NNP
cord-005453-4057qib7	3340	45	1,2	1,2	CD
cord-005453-4057qib7	3340	46	,	,	,
cord-005453-4057qib7	3340	47	Yanmin	Yanmin	NNP
cord-005453-4057qib7	3340	48	Zhao	Zhao	NNP
cord-005453-4057qib7	3340	49	1	1	CD
cord-005453-4057qib7	3340	50	,	,	,
cord-005453-4057qib7	3340	51	2	2	CD
cord-005453-4057qib7	3340	52	Background	background	NN
cord-005453-4057qib7	3340	53	:	:	:
cord-005453-4057qib7	3341	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	3341	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3341	3	stem	stem	NN
cord-005453-4057qib7	3341	4	cell	cell	NN
cord-005453-4057qib7	3341	5	transplantation	transplantation	NN
cord-005453-4057qib7	3341	6	(	(	-LRB-
cord-005453-4057qib7	3341	7	allo	allo	NN
cord-005453-4057qib7	3341	8	-	-	HYPH
cord-005453-4057qib7	3341	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3341	10	)	)	-RRB-
cord-005453-4057qib7	3341	11	is	be	VBZ
cord-005453-4057qib7	3341	12	a	a	DT
cord-005453-4057qib7	3341	13	curative	curative	JJ
cord-005453-4057qib7	3341	14	therapy	therapy	NN
cord-005453-4057qib7	3341	15	for	for	IN
cord-005453-4057qib7	3341	16	both	both	DT
cord-005453-4057qib7	3341	17	hematologic	hematologic	JJ
cord-005453-4057qib7	3341	18	malignancy	malignancy	NN
cord-005453-4057qib7	3341	19	and	and	CC
cord-005453-4057qib7	3341	20	many	many	JJ
cord-005453-4057qib7	3341	21	other	other	JJ
cord-005453-4057qib7	3341	22	blood	blood	NN
cord-005453-4057qib7	3341	23	disease	disease	NN
cord-005453-4057qib7	3341	24	.	.	.
cord-005453-4057qib7	3342	1	While	while	IN
cord-005453-4057qib7	3342	2	,	,	,
cord-005453-4057qib7	3342	3	primary	primary	JJ
cord-005453-4057qib7	3342	4	poor	poor	JJ
cord-005453-4057qib7	3342	5	graft	graft	NN
cord-005453-4057qib7	3342	6	function	function	NN
cord-005453-4057qib7	3342	7	(	(	-LRB-
cord-005453-4057qib7	3342	8	PGF	PGF	NNP
cord-005453-4057qib7	3342	9	)	)	-RRB-
cord-005453-4057qib7	3342	10	is	be	VBZ
cord-005453-4057qib7	3342	11	still	still	RB
cord-005453-4057qib7	3342	12	a	a	DT
cord-005453-4057qib7	3342	13	severe	severe	JJ
cord-005453-4057qib7	3342	14	complication	complication	NN
cord-005453-4057qib7	3342	15	following	follow	VBG
cord-005453-4057qib7	3342	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3342	17	which	which	WDT
cord-005453-4057qib7	3342	18	lead	lead	VBP
cord-005453-4057qib7	3342	19	to	to	IN
cord-005453-4057qib7	3342	20	poor	poor	JJ
cord-005453-4057qib7	3342	21	prognosis	prognosis	NN
cord-005453-4057qib7	3342	22	.	.	.
cord-005453-4057qib7	3343	1	Up	up	IN
cord-005453-4057qib7	3343	2	to	to	IN
cord-005453-4057qib7	3343	3	now	now	RB
cord-005453-4057qib7	3343	4	,	,	,
cord-005453-4057qib7	3343	5	the	the	DT
cord-005453-4057qib7	3343	6	incidence	incidence	NN
cord-005453-4057qib7	3343	7	and	and	CC
cord-005453-4057qib7	3343	8	risk	risk	NN
cord-005453-4057qib7	3343	9	factors	factor	NNS
cord-005453-4057qib7	3343	10	of	of	IN
cord-005453-4057qib7	3343	11	PGF	PGF	NNP
cord-005453-4057qib7	3343	12	have	have	VBP
cord-005453-4057qib7	3343	13	not	not	RB
cord-005453-4057qib7	3343	14	been	be	VBN
cord-005453-4057qib7	3343	15	totally	totally	RB
cord-005453-4057qib7	3343	16	revealed	reveal	VBN
cord-005453-4057qib7	3343	17	.	.	.
cord-005453-4057qib7	3344	1	Methods	method	NNS
cord-005453-4057qib7	3344	2	:	:	:
cord-005453-4057qib7	3344	3	From	from	IN
cord-005453-4057qib7	3344	4	January	January	NNP
cord-005453-4057qib7	3344	5	2013	2013	CD
cord-005453-4057qib7	3344	6	to	to	IN
cord-005453-4057qib7	3344	7	December	December	NNP
cord-005453-4057qib7	3344	8	2017	2017	CD
cord-005453-4057qib7	3344	9	,	,	,
cord-005453-4057qib7	3344	10	a	a	DT
cord-005453-4057qib7	3344	11	total	total	NN
cord-005453-4057qib7	3344	12	of	of	IN
cord-005453-4057qib7	3344	13	647	647	CD
cord-005453-4057qib7	3344	14	patients	patient	NNS
cord-005453-4057qib7	3344	15	who	who	WP
cord-005453-4057qib7	3344	16	received	receive	VBD
cord-005453-4057qib7	3344	17	allo	allo	NN
cord-005453-4057qib7	3344	18	-	-	HYPH
cord-005453-4057qib7	3344	19	HSCT	HSCT	NNP
cord-005453-4057qib7	3344	20	in	in	IN
cord-005453-4057qib7	3344	21	our	-PRON-	PRP$
cord-005453-4057qib7	3344	22	center	center	NN
cord-005453-4057qib7	3344	23	were	be	VBD
cord-005453-4057qib7	3344	24	analyzed	analyze	VBN
cord-005453-4057qib7	3344	25	retrospectively	retrospectively	RB
cord-005453-4057qib7	3344	26	.	.	.
cord-005453-4057qib7	3345	1	There	there	EX
cord-005453-4057qib7	3345	2	were	be	VBD
cord-005453-4057qib7	3345	3	9	9	CD
cord-005453-4057qib7	3345	4	males	male	NNS
cord-005453-4057qib7	3345	5	(	(	-LRB-
cord-005453-4057qib7	3345	6	47.4	47.4	CD
cord-005453-4057qib7	3345	7	%	%	NN
cord-005453-4057qib7	3345	8	)	)	-RRB-
cord-005453-4057qib7	3345	9	and	and	CC
cord-005453-4057qib7	3345	10	10	10	CD
cord-005453-4057qib7	3345	11	females	female	NNS
cord-005453-4057qib7	3345	12	(	(	-LRB-
cord-005453-4057qib7	3345	13	52.6	52.6	CD
cord-005453-4057qib7	3345	14	%	%	NN
cord-005453-4057qib7	3345	15	)	)	-RRB-
cord-005453-4057qib7	3345	16	with	with	IN
cord-005453-4057qib7	3345	17	a	a	DT
cord-005453-4057qib7	3345	18	median	median	JJ
cord-005453-4057qib7	3345	19	age	age	NN
cord-005453-4057qib7	3345	20	of	of	IN
cord-005453-4057qib7	3345	21	36.21	36.21	CD
cord-005453-4057qib7	3345	22	years	year	NNS
cord-005453-4057qib7	3345	23	(	(	-LRB-
cord-005453-4057qib7	3345	24	21	21	CD
cord-005453-4057qib7	3345	25	-	-	SYM
cord-005453-4057qib7	3345	26	49	49	CD
cord-005453-4057qib7	3345	27	years	year	NNS
cord-005453-4057qib7	3345	28	)	)	-RRB-
cord-005453-4057qib7	3345	29	.	.	.
cord-005453-4057qib7	3346	1	PGF	PGF	NNP
cord-005453-4057qib7	3346	2	was	be	VBD
cord-005453-4057qib7	3346	3	defined	define	VBN
cord-005453-4057qib7	3346	4	as	as	IN
cord-005453-4057qib7	3346	5	persistent	persistent	JJ
cord-005453-4057qib7	3346	6	neutropenia	neutropenia	NN
cord-005453-4057qib7	3346	7	(	(	-LRB-
cord-005453-4057qib7	3346	8	≤0.5×10	≤0.5×10	NNP
cord-005453-4057qib7	3346	9	9	9	CD
cord-005453-4057qib7	3346	10	/L	/L	.
cord-005453-4057qib7	3346	11	)	)	-RRB-
cord-005453-4057qib7	3346	12	,	,	,
cord-005453-4057qib7	3346	13	thrombocytopenia	thrombocytopenia	NNP
cord-005453-4057qib7	3346	14	(	(	-LRB-
cord-005453-4057qib7	3346	15	platelets≤20×10	platelets≤20×10	NN
cord-005453-4057qib7	3346	16	9	9	CD
cord-005453-4057qib7	3346	17	/L	/L	.
cord-005453-4057qib7	3346	18	)	)	-RRB-
cord-005453-4057qib7	3346	19	,	,	,
cord-005453-4057qib7	3346	20	and/	and/	CD
cord-005453-4057qib7	3346	21	or	or	CC
cord-005453-4057qib7	3346	22	hemoglobin≤70	hemoglobin≤70	NNP
cord-005453-4057qib7	3346	23	g	g	NNP
cord-005453-4057qib7	3346	24	/	/	SYM
cord-005453-4057qib7	3346	25	L	l	NN
cord-005453-4057qib7	3346	26	after	after	IN
cord-005453-4057qib7	3346	27	engraftment	engraftment	NN
cord-005453-4057qib7	3346	28	with	with	IN
cord-005453-4057qib7	3346	29	hypocellular	hypocellular	NNP
cord-005453-4057qib7	3346	30	bone	bone	NN
cord-005453-4057qib7	3346	31	marrow	marrow	NN
cord-005453-4057qib7	3346	32	and	and	CC
cord-005453-4057qib7	3346	33	full	full	JJ
cord-005453-4057qib7	3346	34	donor	donor	NN
cord-005453-4057qib7	3346	35	chimerism	chimerism	NN
cord-005453-4057qib7	3346	36	,	,	,
cord-005453-4057qib7	3346	37	without	without	IN
cord-005453-4057qib7	3346	38	concurrent	concurrent	JJ
cord-005453-4057qib7	3346	39	graft	graft	NN
cord-005453-4057qib7	3346	40	-	-	HYPH
cord-005453-4057qib7	3346	41	versus	versus	IN
cord-005453-4057qib7	3346	42	-	-	HYPH
cord-005453-4057qib7	3346	43	host	host	NN
cord-005453-4057qib7	3346	44	disease	disease	NN
cord-005453-4057qib7	3346	45	or	or	CC
cord-005453-4057qib7	3346	46	disease	disease	NN
cord-005453-4057qib7	3346	47	relapse	relapse	NN
cord-005453-4057qib7	3346	48	.	.	.
cord-005453-4057qib7	3347	1	Incidence	incidence	NN
cord-005453-4057qib7	3347	2	was	be	VBD
cord-005453-4057qib7	3347	3	calculated	calculate	VBN
cord-005453-4057qib7	3347	4	from	from	IN
cord-005453-4057qib7	3347	5	all	all	DT
cord-005453-4057qib7	3347	6	patients	patient	NNS
cord-005453-4057qib7	3347	7	.	.	.
cord-005453-4057qib7	3348	1	Of	of	IN
cord-005453-4057qib7	3348	2	the	the	DT
cord-005453-4057qib7	3348	3	647	647	CD
cord-005453-4057qib7	3348	4	total	total	JJ
cord-005453-4057qib7	3348	5	patients	patient	NNS
cord-005453-4057qib7	3348	6	,	,	,
cord-005453-4057qib7	3348	7	nineteen	nineteen	CD
cord-005453-4057qib7	3348	8	(	(	-LRB-
cord-005453-4057qib7	3348	9	2.94	2.94	CD
cord-005453-4057qib7	3348	10	%	%	NN
cord-005453-4057qib7	3348	11	)	)	-RRB-
cord-005453-4057qib7	3348	12	developed	develop	VBN
cord-005453-4057qib7	3348	13	primary	primary	NN
cord-005453-4057qib7	3348	14	PGF	PGF	NNP
cord-005453-4057qib7	3348	15	.	.	.
cord-005453-4057qib7	3349	1	A	a	DT
cord-005453-4057qib7	3349	2	1:4	1:4	CD
cord-005453-4057qib7	3349	3	ratio	ratio	NN
cord-005453-4057qib7	3349	4	of	of	IN
cord-005453-4057qib7	3349	5	nested	nested	JJ
cord-005453-4057qib7	3349	6	case	case	NN
cord-005453-4057qib7	3349	7	control	control	NN
cord-005453-4057qib7	3349	8	study	study	NN
cord-005453-4057qib7	3349	9	using	use	VBG
cord-005453-4057qib7	3349	10	the	the	DT
cord-005453-4057qib7	3349	11	good	good	JJ
cord-005453-4057qib7	3349	12	graft	graft	NN
cord-005453-4057qib7	3349	13	function	function	NN
cord-005453-4057qib7	3349	14	(	(	-LRB-
cord-005453-4057qib7	3349	15	GGF	GGF	NNP
cord-005453-4057qib7	3349	16	)	)	-RRB-
cord-005453-4057qib7	3349	17	subjects	subject	NNS
cord-005453-4057qib7	3349	18	transplanted	transplant	VBN
cord-005453-4057qib7	3349	19	in	in	IN
cord-005453-4057qib7	3349	20	the	the	DT
cord-005453-4057qib7	3349	21	same	same	JJ
cord-005453-4057qib7	3349	22	year	year	NN
cord-005453-4057qib7	3349	23	with	with	IN
cord-005453-4057qib7	3349	24	the	the	DT
cord-005453-4057qib7	3349	25	same	same	JJ
cord-005453-4057qib7	3349	26	sex	sex	NN
cord-005453-4057qib7	3349	27	and	and	CC
cord-005453-4057qib7	3349	28	age	age	NN
cord-005453-4057qib7	3349	29	of	of	IN
cord-005453-4057qib7	3349	30	±5	±5	NNS
cord-005453-4057qib7	3349	31	years	year	NNS
cord-005453-4057qib7	3349	32	was	be	VBD
cord-005453-4057qib7	3349	33	carried	carry	VBN
cord-005453-4057qib7	3349	34	out	out	RP
cord-005453-4057qib7	3349	35	.	.	.
cord-005453-4057qib7	3350	1	Results	result	NNS
cord-005453-4057qib7	3350	2	:	:	:
cord-005453-4057qib7	3351	1	Data	datum	NNS
cord-005453-4057qib7	3351	2	was	be	VBD
cord-005453-4057qib7	3351	3	analyzed	analyze	VBN
cord-005453-4057qib7	3351	4	by	by	IN
cord-005453-4057qib7	3351	5	univariate	univariate	JJ
cord-005453-4057qib7	3351	6	and	and	CC
cord-005453-4057qib7	3351	7	multivariate	multivariate	JJ
cord-005453-4057qib7	3351	8	logistic	logistic	JJ
cord-005453-4057qib7	3351	9	regression	regression	NN
cord-005453-4057qib7	3351	10	,	,	,
cord-005453-4057qib7	3351	11	and	and	CC
cord-005453-4057qib7	3351	12	univariate	univariate	JJ
cord-005453-4057qib7	3351	13	analysis	analysis	NN
cord-005453-4057qib7	3351	14	identified	identify	VBD
cord-005453-4057qib7	3351	15	disease	disease	NN
cord-005453-4057qib7	3351	16	species	specie	NNS
cord-005453-4057qib7	3351	17	,	,	,
cord-005453-4057qib7	3351	18	the	the	DT
cord-005453-4057qib7	3351	19	time	time	NN
cord-005453-4057qib7	3351	20	from	from	IN
cord-005453-4057qib7	3351	21	diagnosis	diagnosis	NN
cord-005453-4057qib7	3351	22	to	to	IN
cord-005453-4057qib7	3351	23	transplantation	transplantation	NN
cord-005453-4057qib7	3351	24	,	,	,
cord-005453-4057qib7	3351	25	disease	disease	NN
cord-005453-4057qib7	3351	26	states	state	NNS
cord-005453-4057qib7	3351	27	,	,	,
cord-005453-4057qib7	3351	28	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	3351	29	,	,	,
cord-005453-4057qib7	3351	30	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	3351	31	,	,	,
cord-005453-4057qib7	3351	32	serum	serum	NN
cord-005453-4057qib7	3351	33	ferritin	ferritin	NN
cord-005453-4057qib7	3351	34	(	(	-LRB-
cord-005453-4057qib7	3351	35	SF	SF	NNP
cord-005453-4057qib7	3351	36	)	)	-RRB-
cord-005453-4057qib7	3351	37	level	level	NN
cord-005453-4057qib7	3351	38	,	,	,
cord-005453-4057qib7	3351	39	CMV	CMV	NNP
cord-005453-4057qib7	3351	40	infection	infection	NN
cord-005453-4057qib7	3351	41	,	,	,
cord-005453-4057qib7	3351	42	mononuclear	mononuclear	NN
cord-005453-4057qib7	3351	43	and	and	CC
cord-005453-4057qib7	3351	44	CD34	CD34	NNP
cord-005453-4057qib7	3351	45	+	+	CC
cord-005453-4057qib7	3351	46	cells	cell	NNS
cord-005453-4057qib7	3351	47	in	in	IN
cord-005453-4057qib7	3351	48	graft	graft	NN
cord-005453-4057qib7	3351	49	as	as	IN
cord-005453-4057qib7	3351	50	potential	potential	JJ
cord-005453-4057qib7	3351	51	risk	risk	NN
cord-005453-4057qib7	3351	52	factors	factor	NNS
cord-005453-4057qib7	3351	53	(	(	-LRB-
cord-005453-4057qib7	3351	54	P	p	NN
cord-005453-4057qib7	3351	55	<	<	XX
cord-005453-4057qib7	3351	56	0.1	0.1	CD
cord-005453-4057qib7	3351	57	)	)	-RRB-
cord-005453-4057qib7	3351	58	for	for	IN
cord-005453-4057qib7	3351	59	PGF	PGF	NNP
cord-005453-4057qib7	3351	60	.	.	.
cord-005453-4057qib7	3352	1	multivariate	multivariate	JJ
cord-005453-4057qib7	3352	2	analysis	analysis	NN
cord-005453-4057qib7	3352	3	identified	identify	VBD
cord-005453-4057qib7	3352	4	3	3	CD
cord-005453-4057qib7	3352	5	elements	element	NNS
cord-005453-4057qib7	3352	6	as	as	IN
cord-005453-4057qib7	3352	7	the	the	DT
cord-005453-4057qib7	3352	8	independent	independent	JJ
cord-005453-4057qib7	3352	9	risk	risk	NN
cord-005453-4057qib7	3352	10	factors	factor	NNS
cord-005453-4057qib7	3352	11	(	(	-LRB-
cord-005453-4057qib7	3352	12	P	p	NN
cord-005453-4057qib7	3352	13	<	<	XX
cord-005453-4057qib7	3352	14	0.05	0.05	CD
cord-005453-4057qib7	3352	15	)	)	-RRB-
cord-005453-4057qib7	3352	16	,	,	,
cord-005453-4057qib7	3352	17	including	include	VBG
cord-005453-4057qib7	3352	18	CD34	CD34	NNP
cord-005453-4057qib7	3352	19	+	+	CC
cord-005453-4057qib7	3352	20	cells	cell	NNS
cord-005453-4057qib7	3352	21	<	<	XX
cord-005453-4057qib7	3352	22	5×10	5×10	CD
cord-005453-4057qib7	3352	23	5	5	CD
cord-005453-4057qib7	3353	1	/	/	NFP
cord-005453-4057qib7	3353	2	Background	background	NN
cord-005453-4057qib7	3353	3	:	:	:
cord-005453-4057qib7	3354	1	Transplant	transplant	NN
cord-005453-4057qib7	3354	2	survivors	survivor	NNS
cord-005453-4057qib7	3354	3	affected	affect	VBN
cord-005453-4057qib7	3354	4	by	by	IN
cord-005453-4057qib7	3354	5	cGVHD	cGVHD	NNP
cord-005453-4057qib7	3354	6	usually	usually	RB
cord-005453-4057qib7	3354	7	take	take	VB
cord-005453-4057qib7	3354	8	one	one	CD
cord-005453-4057qib7	3354	9	or	or	CC
cord-005453-4057qib7	3354	10	more	more	JJR
cord-005453-4057qib7	3354	11	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	3354	12	,	,	,
cord-005453-4057qib7	3354	13	as	as	RB
cord-005453-4057qib7	3354	14	well	well	RB
cord-005453-4057qib7	3354	15	as	as	IN
cord-005453-4057qib7	3354	16	prophylactic	prophylactic	JJ
cord-005453-4057qib7	3354	17	antimicrobials	antimicrobial	NNS
cord-005453-4057qib7	3354	18	;	;	:
cord-005453-4057qib7	3354	19	use	use	NN
cord-005453-4057qib7	3354	20	of	of	IN
cord-005453-4057qib7	3354	21	multiple	multiple	JJ
cord-005453-4057qib7	3354	22	medication	medication	NN
cord-005453-4057qib7	3354	23	classes	class	NNS
cord-005453-4057qib7	3354	24	concurrently	concurrently	RB
cord-005453-4057qib7	3354	25	poses	pose	VBZ
cord-005453-4057qib7	3354	26	a	a	DT
cord-005453-4057qib7	3354	27	risk	risk	NN
cord-005453-4057qib7	3354	28	for	for	IN
cord-005453-4057qib7	3354	29	drug	drug	NN
cord-005453-4057qib7	3354	30	-	-	HYPH
cord-005453-4057qib7	3354	31	drug	drug	NN
cord-005453-4057qib7	3354	32	interactions	interaction	NNS
cord-005453-4057qib7	3354	33	or	or	CC
cord-005453-4057qib7	3354	34	amplified	amplify	VBN
cord-005453-4057qib7	3354	35	side	side	NN
cord-005453-4057qib7	3354	36	-	-	HYPH
cord-005453-4057qib7	3354	37	effects	effect	NNS
cord-005453-4057qib7	3354	38	.	.	.
cord-005453-4057qib7	3355	1	The	the	DT
cord-005453-4057qib7	3355	2	use	use	NN
cord-005453-4057qib7	3355	3	of	of	IN
cord-005453-4057qib7	3355	4	medications	medication	NNS
cord-005453-4057qib7	3355	5	other	other	JJ
cord-005453-4057qib7	3355	6	than	than	IN
cord-005453-4057qib7	3355	7	cGVHD	cgvhd	JJ
cord-005453-4057qib7	3355	8	-	-	HYPH
cord-005453-4057qib7	3355	9	direct	direct	JJ
cord-005453-4057qib7	3355	10	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	3355	11	therapies	therapy	NNS
cord-005453-4057qib7	3355	12	has	have	VBZ
cord-005453-4057qib7	3355	13	not	not	RB
cord-005453-4057qib7	3355	14	been	be	VBN
cord-005453-4057qib7	3355	15	well	well	RB
cord-005453-4057qib7	3355	16	-	-	HYPH
cord-005453-4057qib7	3355	17	characterized	characterize	VBN
cord-005453-4057qib7	3355	18	.	.	.
cord-005453-4057qib7	3356	1	This	this	DT
cord-005453-4057qib7	3356	2	study	study	NN
cord-005453-4057qib7	3356	3	aims	aim	VBZ
cord-005453-4057qib7	3356	4	to	to	TO
cord-005453-4057qib7	3356	5	evaluate	evaluate	VB
cord-005453-4057qib7	3356	6	patterns	pattern	NNS
cord-005453-4057qib7	3356	7	of	of	IN
cord-005453-4057qib7	3356	8	opioid	opioid	JJ
cord-005453-4057qib7	3356	9	analgesic	analgesic	JJ
cord-005453-4057qib7	3356	10	use	use	NN
cord-005453-4057qib7	3356	11	in	in	IN
cord-005453-4057qib7	3356	12	a	a	DT
cord-005453-4057qib7	3356	13	cohort	cohort	NN
cord-005453-4057qib7	3356	14	of	of	IN
cord-005453-4057qib7	3356	15	patients	patient	NNS
cord-005453-4057qib7	3356	16	severely	severely	RB
cord-005453-4057qib7	3356	17	affected	affect	VBN
cord-005453-4057qib7	3356	18	by	by	IN
cord-005453-4057qib7	3356	19	cGVHD	cGVHD	NNP
cord-005453-4057qib7	3356	20	.	.	.
cord-005453-4057qib7	3357	1	Methods	method	NNS
cord-005453-4057qib7	3357	2	:	:	:
cord-005453-4057qib7	3357	3	Patients	patient	NNS
cord-005453-4057qib7	3357	4	(	(	-LRB-
cord-005453-4057qib7	3357	5	n=335	n=335	NNP
cord-005453-4057qib7	3357	6	)	)	-RRB-
cord-005453-4057qib7	3357	7	with	with	IN
cord-005453-4057qib7	3357	8	cGVHD	cGVHD	NNP
cord-005453-4057qib7	3357	9	were	be	VBD
cord-005453-4057qib7	3357	10	consecutively	consecutively	RB
cord-005453-4057qib7	3357	11	enrolled	enrol	VBN
cord-005453-4057qib7	3357	12	in	in	IN
cord-005453-4057qib7	3357	13	a	a	DT
cord-005453-4057qib7	3357	14	cross	cross	JJ
cord-005453-4057qib7	3357	15	-	-	JJ
cord-005453-4057qib7	3357	16	sectional	sectional	JJ
cord-005453-4057qib7	3357	17	natural	natural	JJ
cord-005453-4057qib7	3357	18	history	history	NN
cord-005453-4057qib7	3357	19	study	study	NN
cord-005453-4057qib7	3357	20	(	(	-LRB-
cord-005453-4057qib7	3357	21	NCT00092235	NCT00092235	NNP
cord-005453-4057qib7	3357	22	)	)	-RRB-
cord-005453-4057qib7	3357	23	from	from	IN
cord-005453-4057qib7	3357	24	10/2004	10/2004	CD
cord-005453-4057qib7	3357	25	-	-	HYPH
cord-005453-4057qib7	3357	26	12/2016	12/2016	CD
cord-005453-4057qib7	3357	27	at	at	IN
cord-005453-4057qib7	3357	28	the	the	DT
cord-005453-4057qib7	3357	29	NIH	NIH	NNP
cord-005453-4057qib7	3357	30	.	.	.
cord-005453-4057qib7	3358	1	Participants	participant	NNS
cord-005453-4057qib7	3358	2	underwent	undergo	VBD
cord-005453-4057qib7	3358	3	a	a	DT
cord-005453-4057qib7	3358	4	comprehensive	comprehensive	JJ
cord-005453-4057qib7	3358	5	evaluation	evaluation	NN
cord-005453-4057qib7	3358	6	including	include	VBG
cord-005453-4057qib7	3358	7	a	a	DT
cord-005453-4057qib7	3358	8	detailed	detailed	JJ
cord-005453-4057qib7	3358	9	history	history	NN
cord-005453-4057qib7	3358	10	and	and	CC
cord-005453-4057qib7	3358	11	physical	physical	JJ
cord-005453-4057qib7	3358	12	examination	examination	NN
cord-005453-4057qib7	3358	13	(	(	-LRB-
cord-005453-4057qib7	3358	14	including	include	VBG
cord-005453-4057qib7	3358	15	current	current	JJ
cord-005453-4057qib7	3358	16	medications	medication	NNS
cord-005453-4057qib7	3358	17	)	)	-RRB-
cord-005453-4057qib7	3358	18	,	,	,
cord-005453-4057qib7	3358	19	multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	3358	20	evaluations	evaluation	NNS
cord-005453-4057qib7	3358	21	,	,	,
cord-005453-4057qib7	3358	22	and	and	CC
cord-005453-4057qib7	3358	23	laboratory	laboratory	NN
cord-005453-4057qib7	3358	24	and	and	CC
cord-005453-4057qib7	3358	25	diagnostic	diagnostic	JJ
cord-005453-4057qib7	3358	26	testing	testing	NN
cord-005453-4057qib7	3358	27	.	.	.
cord-005453-4057qib7	3359	1	For	for	IN
cord-005453-4057qib7	3359	2	this	this	DT
cord-005453-4057qib7	3359	3	analysis	analysis	NN
cord-005453-4057qib7	3359	4	,	,	,
cord-005453-4057qib7	3359	5	respondents	respondent	NNS
cord-005453-4057qib7	3359	6	were	be	VBD
cord-005453-4057qib7	3359	7	classified	classify	VBN
cord-005453-4057qib7	3359	8	as	as	IN
cord-005453-4057qib7	3359	9	receiving	receive	VBG
cord-005453-4057qib7	3359	10	or	or	CC
cord-005453-4057qib7	3359	11	not	not	RB
cord-005453-4057qib7	3359	12	receiving	receive	VBG
cord-005453-4057qib7	3359	13	an	an	DT
cord-005453-4057qib7	3359	14	opioid	opioid	JJ
cord-005453-4057qib7	3359	15	analgesic	analgesic	NN
cord-005453-4057qib7	3359	16	.	.	.
cord-005453-4057qib7	3360	1	Following	follow	VBG
cord-005453-4057qib7	3360	2	the	the	DT
cord-005453-4057qib7	3360	3	initial	initial	JJ
cord-005453-4057qib7	3360	4	screening	screening	NN
cord-005453-4057qib7	3360	5	by	by	IN
cord-005453-4057qib7	3360	6	univariate	univariate	JJ
cord-005453-4057qib7	3360	7	methods	method	NNS
cord-005453-4057qib7	3360	8	(	(	-LRB-
cord-005453-4057qib7	3360	9	n=335	n=335	NNP
cord-005453-4057qib7	3360	10	)	)	-RRB-
cord-005453-4057qib7	3360	11	,	,	,
cord-005453-4057qib7	3360	12	multivariable	multivariable	JJ
cord-005453-4057qib7	3360	13	logistic	logistic	JJ
cord-005453-4057qib7	3360	14	regression	regression	NN
cord-005453-4057qib7	3360	15	analysis	analysis	NN
cord-005453-4057qib7	3360	16	(	(	-LRB-
cord-005453-4057qib7	3360	17	MLR	MLR	NNP
cord-005453-4057qib7	3360	18	)	)	-RRB-
cord-005453-4057qib7	3360	19	was	be	VBD
cord-005453-4057qib7	3360	20	used	use	VBN
cord-005453-4057qib7	3360	21	to	to	TO
cord-005453-4057qib7	3360	22	identify	identify	VB
cord-005453-4057qib7	3360	23	a	a	DT
cord-005453-4057qib7	3360	24	set	set	NN
cord-005453-4057qib7	3360	25	of	of	IN
cord-005453-4057qib7	3360	26	factors	factor	NNS
cord-005453-4057qib7	3360	27	which	which	WDT
cord-005453-4057qib7	3360	28	could	could	MD
cord-005453-4057qib7	3360	29	jointly	jointly	RB
cord-005453-4057qib7	3360	30	impact	impact	VB
cord-005453-4057qib7	3360	31	opioid	opioid	NN
cord-005453-4057qib7	3360	32	use	use	NN
cord-005453-4057qib7	3360	33	.	.	.
cord-005453-4057qib7	3361	1	For	for	IN
cord-005453-4057qib7	3361	2	MLR	MLR	NNP
cord-005453-4057qib7	3361	3	data	datum	NNS
cord-005453-4057qib7	3361	4	were	be	VBD
cord-005453-4057qib7	3361	5	divided	divide	VBN
cord-005453-4057qib7	3361	6	into	into	IN
cord-005453-4057qib7	3361	7	a	a	DT
cord-005453-4057qib7	3361	8	training	training	NN
cord-005453-4057qib7	3361	9	(	(	-LRB-
cord-005453-4057qib7	3361	10	n=167	n=167	CD
cord-005453-4057qib7	3361	11	patients	patient	NNS
cord-005453-4057qib7	3361	12	)	)	-RRB-
cord-005453-4057qib7	3361	13	and	and	CC
cord-005453-4057qib7	3361	14	a	a	DT
cord-005453-4057qib7	3361	15	validation	validation	NN
cord-005453-4057qib7	3361	16	set	set	NN
cord-005453-4057qib7	3361	17	(	(	-LRB-
cord-005453-4057qib7	3361	18	n=168	n=168	NNP
cord-005453-4057qib7	3361	19	)	)	-RRB-
cord-005453-4057qib7	3361	20	.	.	.
cord-005453-4057qib7	3362	1	Results	result	NNS
cord-005453-4057qib7	3362	2	:	:	:
cord-005453-4057qib7	3363	1	Study	study	NN
cord-005453-4057qib7	3363	2	participants´median	participants´median	JJ
cord-005453-4057qib7	3363	3	age	age	NN
cord-005453-4057qib7	3363	4	was	be	VBD
cord-005453-4057qib7	3363	5	48.5	48.5	CD
cord-005453-4057qib7	3363	6	years	year	NNS
cord-005453-4057qib7	3363	7	(	(	-LRB-
cord-005453-4057qib7	3363	8	19	19	CD
cord-005453-4057qib7	3363	9	-	-	SYM
cord-005453-4057qib7	3363	10	75	75	CD
cord-005453-4057qib7	3363	11	)	)	-RRB-
cord-005453-4057qib7	3363	12	,	,	,
cord-005453-4057qib7	3363	13	44	44	CD
cord-005453-4057qib7	3363	14	%	%	NN
cord-005453-4057qib7	3363	15	were	be	VBD
cord-005453-4057qib7	3363	16	female	female	JJ
cord-005453-4057qib7	3363	17	,	,	,
cord-005453-4057qib7	3363	18	74	74	CD
cord-005453-4057qib7	3363	19	%	%	NN
cord-005453-4057qib7	3363	20	had	have	VBD
cord-005453-4057qib7	3363	21	severe	severe	JJ
cord-005453-4057qib7	3363	22	cGVHD	cgvhd	NN
cord-005453-4057qib7	3363	23	per	per	IN
cord-005453-4057qib7	3363	24	NIH	NIH	NNP
cord-005453-4057qib7	3363	25	scoring	scoring	NN
cord-005453-4057qib7	3363	26	criteria	criterion	NNS
cord-005453-4057qib7	3363	27	,	,	,
cord-005453-4057qib7	3363	28	and	and	CC
cord-005453-4057qib7	3363	29	77	77	CD
cord-005453-4057qib7	3363	30	%	%	NN
cord-005453-4057qib7	3363	31	were	be	VBD
cord-005453-4057qib7	3363	32	currently	currently	RB
cord-005453-4057qib7	3363	33	receiving	receive	VBG
cord-005453-4057qib7	3363	34	high	high	JJ
cord-005453-4057qib7	3363	35	or	or	CC
cord-005453-4057qib7	3363	36	moderate	moderate	JJ
cord-005453-4057qib7	3363	37	levels	level	NNS
cord-005453-4057qib7	3363	38	of	of	IN
cord-005453-4057qib7	3363	39	systemic	systemic	JJ
cord-005453-4057qib7	3363	40	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	3363	41	.	.	.
cord-005453-4057qib7	3364	1	Approximately	approximately	RB
cord-005453-4057qib7	3364	2	one	one	CD
cord-005453-4057qib7	3364	3	third	third	JJ
cord-005453-4057qib7	3364	4	(	(	-LRB-
cord-005453-4057qib7	3364	5	33	33	CD
cord-005453-4057qib7	3364	6	%	%	NN
cord-005453-4057qib7	3364	7	)	)	-RRB-
cord-005453-4057qib7	3364	8	were	be	VBD
cord-005453-4057qib7	3364	9	taking	take	VBG
cord-005453-4057qib7	3364	10	opioid	opioid	JJ
cord-005453-4057qib7	3364	11	analgesics	analgesic	NNS
cord-005453-4057qib7	3364	12	(	(	-LRB-
cord-005453-4057qib7	3364	13	OA	OA	NNP
cord-005453-4057qib7	3364	14	)	)	-RRB-
cord-005453-4057qib7	3364	15	.	.	.
cord-005453-4057qib7	3365	1	Based	base	VBN
cord-005453-4057qib7	3365	2	on	on	IN
cord-005453-4057qib7	3365	3	the	the	DT
cord-005453-4057qib7	3365	4	univariate	univariate	JJ
cord-005453-4057qib7	3365	5	screening	screening	NN
cord-005453-4057qib7	3365	6	results	result	NNS
cord-005453-4057qib7	3365	7	(	(	-LRB-
cord-005453-4057qib7	3365	8	p	p	NN
cord-005453-4057qib7	3365	9	<	<	XX
cord-005453-4057qib7	3365	10	=	=	SYM
cord-005453-4057qib7	3365	11	0.05	0.05	CD
cord-005453-4057qib7	3365	12	)	)	-RRB-
cord-005453-4057qib7	3365	13	,	,	,
cord-005453-4057qib7	3365	14	a	a	DT
cord-005453-4057qib7	3365	15	set	set	NN
cord-005453-4057qib7	3365	16	of	of	IN
cord-005453-4057qib7	3365	17	24	24	CD
cord-005453-4057qib7	3365	18	parameters	parameter	NNS
cord-005453-4057qib7	3365	19	was	be	VBD
cord-005453-4057qib7	3365	20	evaluated	evaluate	VBN
cord-005453-4057qib7	3365	21	by	by	IN
cord-005453-4057qib7	3365	22	univariate	univariate	JJ
cord-005453-4057qib7	3365	23	logistic	logistic	JJ
cord-005453-4057qib7	3365	24	regression	regression	NN
cord-005453-4057qib7	3365	25	in	in	IN
cord-005453-4057qib7	3365	26	the	the	DT
cord-005453-4057qib7	3365	27	167-patient	167-patient	CD
cord-005453-4057qib7	3365	28	training	training	NN
cord-005453-4057qib7	3365	29	set	set	NN
cord-005453-4057qib7	3365	30	,	,	,
cord-005453-4057qib7	3365	31	and	and	CC
cord-005453-4057qib7	3365	32	the	the	DT
cord-005453-4057qib7	3365	33	following	follow	VBG
cord-005453-4057qib7	3365	34	parameters	parameter	NNS
cord-005453-4057qib7	3365	35	retained	retain	VBD
cord-005453-4057qib7	3365	36	their	-PRON-	PRP$
cord-005453-4057qib7	3365	37	significance	significance	NN
cord-005453-4057qib7	3365	38	and	and	CC
cord-005453-4057qib7	3365	39	were	be	VBD
cord-005453-4057qib7	3365	40	included	include	VBN
cord-005453-4057qib7	3365	41	in	in	IN
cord-005453-4057qib7	3365	42	the	the	DT
cord-005453-4057qib7	3365	43	MLR	MLR	NNP
cord-005453-4057qib7	3365	44	model	model	NN
cord-005453-4057qib7	3365	45	:	:	:
cord-005453-4057qib7	3365	46	NIH	NIH	NNP
cord-005453-4057qib7	3365	47	average	average	JJ
cord-005453-4057qib7	3365	48	score	score	NN
cord-005453-4057qib7	3365	49	per	per	IN
cord-005453-4057qib7	3365	50	organ	organ	NN
cord-005453-4057qib7	3365	51	,	,	,
cord-005453-4057qib7	3365	52	total	total	JJ
cord-005453-4057qib7	3365	53	LSS	LSS	NNP
cord-005453-4057qib7	3365	54	,	,	,
cord-005453-4057qib7	3365	55	patient	patient	JJ
cord-005453-4057qib7	3365	56	impression	impression	NN
cord-005453-4057qib7	3365	57	of	of	IN
cord-005453-4057qib7	3365	58	severity	severity	NN
cord-005453-4057qib7	3365	59	,	,	,
cord-005453-4057qib7	3365	60	NIH	NIH	NNP
cord-005453-4057qib7	3365	61	cGVHD	cgvhd	NN
cord-005453-4057qib7	3365	62	severity	severity	NN
cord-005453-4057qib7	3365	63	,	,	,
cord-005453-4057qib7	3365	64	presence	presence	NN
cord-005453-4057qib7	3365	65	of	of	IN
cord-005453-4057qib7	3365	66	skin	skin	NN
cord-005453-4057qib7	3365	67	erythema	erythema	NN
cord-005453-4057qib7	3365	68	,	,	,
cord-005453-4057qib7	3365	69	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	3365	70	performance	performance	NN
cord-005453-4057qib7	3365	71	score	score	NN
cord-005453-4057qib7	3365	72	(	(	-LRB-
cord-005453-4057qib7	3365	73	KPS	KPS	NNP
cord-005453-4057qib7	3365	74	,	,	,
cord-005453-4057qib7	3365	75	)	)	-RRB-
cord-005453-4057qib7	3366	1	clinician	clinician	NN
cord-005453-4057qib7	3366	2	's	's	POS
cord-005453-4057qib7	3366	3	therapeutic	therapeutic	JJ
cord-005453-4057qib7	3366	4	intent	intent	NN
cord-005453-4057qib7	3366	5	,	,	,
cord-005453-4057qib7	3366	6	NIH	NIH	NNP
cord-005453-4057qib7	3366	7	joint	joint	JJ
cord-005453-4057qib7	3366	8	score	score	NN
cord-005453-4057qib7	3366	9	,	,	,
cord-005453-4057qib7	3366	10	and	and	CC
cord-005453-4057qib7	3366	11	with	with	IN
cord-005453-4057qib7	3366	12	the	the	DT
cord-005453-4057qib7	3366	13	presence	presence	NN
cord-005453-4057qib7	3366	14	of	of	IN
cord-005453-4057qib7	3366	15	several	several	JJ
cord-005453-4057qib7	3366	16	cGVHD	cgvhd	NN
cord-005453-4057qib7	3366	17	symptoms	symptom	NNS
cord-005453-4057qib7	3366	18	including	include	VBG
cord-005453-4057qib7	3366	19	rashes	rash	NNS
cord-005453-4057qib7	3366	20	,	,	,
cord-005453-4057qib7	3366	21	mouth	mouth	NN
cord-005453-4057qib7	3366	22	sores	sore	NNS
cord-005453-4057qib7	3366	23	,	,	,
cord-005453-4057qib7	3366	24	avoidance	avoidance	NN
cord-005453-4057qib7	3366	25	of	of	IN
cord-005453-4057qib7	3366	26	food	food	NN
cord-005453-4057qib7	3366	27	,	,	,
cord-005453-4057qib7	3366	28	vomiting	vomiting	NN
cord-005453-4057qib7	3366	29	,	,	,
cord-005453-4057qib7	3366	30	weight	weight	NN
cord-005453-4057qib7	3366	31	loss	loss	NN
cord-005453-4057qib7	3366	32	,	,	,
cord-005453-4057qib7	3366	33	joint	joint	NN
cord-005453-4057qib7	3366	34	and	and	CC
cord-005453-4057qib7	3366	35	muscle	muscle	NN
cord-005453-4057qib7	3366	36	aches	ache	NNS
cord-005453-4057qib7	3366	37	,	,	,
cord-005453-4057qib7	3366	38	joint	joint	JJ
cord-005453-4057qib7	3366	39	limitation	limitation	NN
cord-005453-4057qib7	3366	40	,	,	,
cord-005453-4057qib7	3366	41	energy	energy	NN
cord-005453-4057qib7	3366	42	loss	loss	NN
cord-005453-4057qib7	3366	43	,	,	,
cord-005453-4057qib7	3366	44	need	need	VBP
cord-005453-4057qib7	3366	45	for	for	IN
cord-005453-4057qib7	3366	46	naps	nap	NNS
cord-005453-4057qib7	3366	47	,	,	,
cord-005453-4057qib7	3366	48	fevers	fever	NNS
cord-005453-4057qib7	3366	49	,	,	,
cord-005453-4057qib7	3366	50	anxiety	anxiety	NN
cord-005453-4057qib7	3366	51	.	.	.
cord-005453-4057qib7	3367	1	Multivariable	multivariable	JJ
cord-005453-4057qib7	3367	2	logistic	logistic	JJ
cord-005453-4057qib7	3367	3	regression	regression	NN
cord-005453-4057qib7	3367	4	identified	identify	VBD
cord-005453-4057qib7	3367	5	KPS	KPS	NNP
cord-005453-4057qib7	3367	6	<	<	XX
cord-005453-4057qib7	3367	7	77	77	CD
cord-005453-4057qib7	3367	8	%	%	NN
cord-005453-4057qib7	3367	9	as	as	IN
cord-005453-4057qib7	3367	10	predictive	predictive	NN
cord-005453-4057qib7	3367	11	of	of	IN
cord-005453-4057qib7	3367	12	OA	OA	NNP
cord-005453-4057qib7	3367	13	use	use	NN
cord-005453-4057qib7	3367	14	,	,	,
cord-005453-4057qib7	3367	15	OR	or	CC
cord-005453-4057qib7	3367	16	0.92	0.92	CD
cord-005453-4057qib7	3367	17	,	,	,
cord-005453-4057qib7	3367	18	95	95	CD
cord-005453-4057qib7	3367	19	%	%	NN
cord-005453-4057qib7	3367	20	CI	CI	NNP
cord-005453-4057qib7	3367	21	0.89	0.89	CD
cord-005453-4057qib7	3367	22	-	-	HYPH
cord-005453-4057qib7	3367	23	0.95	0.95	CD
cord-005453-4057qib7	3367	24	.	.	.
cord-005453-4057qib7	3368	1	In	in	IN
cord-005453-4057qib7	3368	2	the	the	DT
cord-005453-4057qib7	3368	3	training	training	NN
cord-005453-4057qib7	3368	4	set	set	VBD
cord-005453-4057qib7	3368	5	56.4	56.4	CD
cord-005453-4057qib7	3368	6	%	%	NN
cord-005453-4057qib7	3368	7	of	of	IN
cord-005453-4057qib7	3368	8	pts	pt	NNS
cord-005453-4057qib7	3368	9	using	use	VBG
cord-005453-4057qib7	3368	10	opioids	opioid	NNS
cord-005453-4057qib7	3368	11	were	be	VBD
cord-005453-4057qib7	3368	12	correctly	correctly	RB
cord-005453-4057qib7	3368	13	identified	identify	VBN
cord-005453-4057qib7	3368	14	,	,	,
cord-005453-4057qib7	3368	15	78.2	78.2	CD
cord-005453-4057qib7	3368	16	%	%	NN
cord-005453-4057qib7	3368	17	of	of	IN
cord-005453-4057qib7	3368	18	those	those	DT
cord-005453-4057qib7	3368	19	not	not	RB
cord-005453-4057qib7	3368	20	taking	take	VBG
cord-005453-4057qib7	3368	21	opioids	opioid	NNS
cord-005453-4057qib7	3368	22	were	be	VBD
cord-005453-4057qib7	3368	23	identified	identify	VBN
cord-005453-4057qib7	3368	24	,	,	,
cord-005453-4057qib7	3368	25	an	an	DT
cord-005453-4057qib7	3368	26	overall	overall	JJ
cord-005453-4057qib7	3368	27	fraction	fraction	NN
cord-005453-4057qib7	3368	28	of	of	IN
cord-005453-4057qib7	3368	29	correctly	correctly	RB
cord-005453-4057qib7	3368	30	identified	identify	VBN
cord-005453-4057qib7	3368	31	pts	pts	NNP
cord-005453-4057qib7	3368	32	was	be	VBD
cord-005453-4057qib7	3368	33	70.9	70.9	CD
cord-005453-4057qib7	3368	34	%	%	NN
cord-005453-4057qib7	3368	35	(	(	-LRB-
cord-005453-4057qib7	3368	36	95	95	CD
cord-005453-4057qib7	3368	37	%	%	NN
cord-005453-4057qib7	3368	38	CI	CI	NNP
cord-005453-4057qib7	3368	39	63.3	63.3	CD
cord-005453-4057qib7	3368	40	-77.7	-77.7	CD
cord-005453-4057qib7	3368	41	%	%	NN
cord-005453-4057qib7	3368	42	)	)	-RRB-
cord-005453-4057qib7	3368	43	,	,	,
cord-005453-4057qib7	3368	44	while	while	IN
cord-005453-4057qib7	3368	45	in	in	IN
cord-005453-4057qib7	3368	46	the	the	DT
cord-005453-4057qib7	3368	47	testing	testing	NN
cord-005453-4057qib7	3368	48	set	set	VBN
cord-005453-4057qib7	3368	49	,	,	,
cord-005453-4057qib7	3368	50	45.5	45.5	CD
cord-005453-4057qib7	3368	51	%	%	NN
cord-005453-4057qib7	3368	52	of	of	IN
cord-005453-4057qib7	3368	53	those	those	DT
cord-005453-4057qib7	3368	54	using	use	VBG
cord-005453-4057qib7	3368	55	opioids	opioid	NNS
cord-005453-4057qib7	3368	56	were	be	VBD
cord-005453-4057qib7	3368	57	correctly	correctly	RB
cord-005453-4057qib7	3368	58	identified	identify	VBN
cord-005453-4057qib7	3368	59	,	,	,
cord-005453-4057qib7	3368	60	and	and	CC
cord-005453-4057qib7	3368	61	67.9	67.9	CD
cord-005453-4057qib7	3368	62	%	%	NN
cord-005453-4057qib7	3368	63	of	of	IN
cord-005453-4057qib7	3368	64	those	those	DT
cord-005453-4057qib7	3368	65	not	not	RB
cord-005453-4057qib7	3368	66	taking	take	VBG
cord-005453-4057qib7	3368	67	opioids	opioid	NNS
cord-005453-4057qib7	3368	68	were	be	VBD
cord-005453-4057qib7	3368	69	correctly	correctly	RB
cord-005453-4057qib7	3368	70	identified	identify	VBN
cord-005453-4057qib7	3368	71	,	,	,
cord-005453-4057qib7	3368	72	with	with	IN
cord-005453-4057qib7	3368	73	overall	overall	JJ
cord-005453-4057qib7	3368	74	60.5	60.5	CD
cord-005453-4057qib7	3368	75	%	%	NN
cord-005453-4057qib7	3368	76	(	(	-LRB-
cord-005453-4057qib7	3368	77	95	95	CD
cord-005453-4057qib7	3368	78	%	%	NN
cord-005453-4057qib7	3368	79	CI	ci	NN
cord-005453-4057qib7	3368	80	:	:	:
cord-005453-4057qib7	3368	81	52.6	52.6	CD
cord-005453-4057qib7	3368	82	-	-	HYPH
cord-005453-4057qib7	3368	83	68.0	68.0	CD
cord-005453-4057qib7	3368	84	%	%	NN
cord-005453-4057qib7	3368	85	)	)	-RRB-
cord-005453-4057qib7	3368	86	classification	classification	NN
cord-005453-4057qib7	3368	87	accuracy	accuracy	NN
cord-005453-4057qib7	3368	88	.	.	.
cord-005453-4057qib7	3369	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3369	2	:	:	:
cord-005453-4057qib7	3370	1	This	this	DT
cord-005453-4057qib7	3370	2	study	study	NN
cord-005453-4057qib7	3370	3	showed	show	VBD
cord-005453-4057qib7	3370	4	the	the	DT
cord-005453-4057qib7	3370	5	burden	burden	NN
cord-005453-4057qib7	3370	6	of	of	IN
cord-005453-4057qib7	3370	7	OA	OA	NNP
cord-005453-4057qib7	3370	8	in	in	IN
cord-005453-4057qib7	3370	9	this	this	DT
cord-005453-4057qib7	3370	10	cGVHD	cGVHD	NNP
cord-005453-4057qib7	3370	11	cohort	cohort	NN
cord-005453-4057qib7	3370	12	.	.	.
cord-005453-4057qib7	3371	1	Lower	low	JJR
cord-005453-4057qib7	3371	2	KPS	KPS	NNP
cord-005453-4057qib7	3371	3	was	be	VBD
cord-005453-4057qib7	3371	4	significantly	significantly	RB
cord-005453-4057qib7	3371	5	associated	associate	VBN
cord-005453-4057qib7	3371	6	with	with	IN
cord-005453-4057qib7	3371	7	OA	OA	NNP
cord-005453-4057qib7	3371	8	use	use	NN
cord-005453-4057qib7	3371	9	,	,	,
cord-005453-4057qib7	3371	10	as	as	RB
cord-005453-4057qib7	3371	11	well	well	RB
cord-005453-4057qib7	3371	12	as	as	IN
cord-005453-4057qib7	3371	13	self	self	NN
cord-005453-4057qib7	3371	14	-	-	HYPH
cord-005453-4057qib7	3371	15	reported	report	VBN
cord-005453-4057qib7	3371	16	symptoms	symptom	NNS
cord-005453-4057qib7	3371	17	and	and	CC
cord-005453-4057qib7	3371	18	a	a	DT
cord-005453-4057qib7	3371	19	more	more	RBR
cord-005453-4057qib7	3371	20	severe	severe	JJ
cord-005453-4057qib7	3371	21	cGVHD	cgvhd	NN
cord-005453-4057qib7	3371	22	disease	disease	NN
cord-005453-4057qib7	3371	23	,	,	,
cord-005453-4057qib7	3371	24	which	which	WDT
cord-005453-4057qib7	3371	25	could	could	MD
cord-005453-4057qib7	3371	26	be	be	VB
cord-005453-4057qib7	3371	27	of	of	IN
cord-005453-4057qib7	3371	28	interest	interest	NN
cord-005453-4057qib7	3371	29	in	in	IN
cord-005453-4057qib7	3371	30	the	the	DT
cord-005453-4057qib7	3371	31	development	development	NN
cord-005453-4057qib7	3371	32	of	of	IN
cord-005453-4057qib7	3371	33	non	non	JJ
cord-005453-4057qib7	3371	34	-	-	JJ
cord-005453-4057qib7	3371	35	pharmaceutical	pharmaceutical	JJ
cord-005453-4057qib7	3371	36	interventions	intervention	NNS
cord-005453-4057qib7	3371	37	in	in	IN
cord-005453-4057qib7	3371	38	this	this	DT
cord-005453-4057qib7	3371	39	patient	patient	JJ
cord-005453-4057qib7	3371	40	population	population	NN
cord-005453-4057qib7	3371	41	.	.	.
cord-005453-4057qib7	3372	1	Additional	additional	JJ
cord-005453-4057qib7	3372	2	,	,	,
cord-005453-4057qib7	3372	3	prospective	prospective	JJ
cord-005453-4057qib7	3372	4	studies	study	NNS
cord-005453-4057qib7	3372	5	are	be	VBP
cord-005453-4057qib7	3372	6	needed	need	VBN
cord-005453-4057qib7	3372	7	to	to	TO
cord-005453-4057qib7	3372	8	explore	explore	VB
cord-005453-4057qib7	3372	9	the	the	DT
cord-005453-4057qib7	3372	10	indications	indication	NNS
cord-005453-4057qib7	3372	11	for	for	IN
cord-005453-4057qib7	3372	12	and	and	CC
cord-005453-4057qib7	3372	13	effectiveness	effectiveness	NN
cord-005453-4057qib7	3372	14	of	of	IN
cord-005453-4057qib7	3372	15	OA	OA	NNP
cord-005453-4057qib7	3372	16	in	in	IN
cord-005453-4057qib7	3372	17	this	this	DT
cord-005453-4057qib7	3372	18	population	population	NN
cord-005453-4057qib7	3372	19	of	of	IN
cord-005453-4057qib7	3372	20	survivors	survivor	NNS
cord-005453-4057qib7	3372	21	.	.	.
cord-005453-4057qib7	3373	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3373	2	:	:	:
cord-005453-4057qib7	3374	1	No	no	DT
cord-005453-4057qib7	3374	2	conflict	conflict	NN
cord-005453-4057qib7	3374	3	of	of	IN
cord-005453-4057qib7	3374	4	interest	interest	NN
cord-005453-4057qib7	3374	5	to	to	TO
cord-005453-4057qib7	3374	6	declare	declare	VB
cord-005453-4057qib7	3374	7	.	.	.
cord-005453-4057qib7	3375	1	RCTs	RCTs	NNP
cord-005453-4057qib7	3375	2	that	that	WDT
cord-005453-4057qib7	3375	3	tested	test	VBD
cord-005453-4057qib7	3375	4	an	an	DT
cord-005453-4057qib7	3375	5	internet	internet	NN
cord-005453-4057qib7	3375	6	-	-	HYPH
cord-005453-4057qib7	3375	7	based	base	VBN
cord-005453-4057qib7	3375	8	program	program	NN
cord-005453-4057qib7	3375	9	and	and	CC
cord-005453-4057qib7	3375	10	patientcentered	patientcentered	JJ
cord-005453-4057qib7	3375	11	survivorship	survivorship	NN
cord-005453-4057qib7	3375	12	care	care	NN
cord-005453-4057qib7	3375	13	plans	plan	NNS
cord-005453-4057qib7	3375	14	for	for	IN
cord-005453-4057qib7	3375	15	HCT	hct	NN
cord-005453-4057qib7	3375	16	survivors	survivor	NNS
cord-005453-4057qib7	3375	17	.	.	.
cord-005453-4057qib7	3376	1	Patient	patient	JJ
cord-005453-4057qib7	3376	2	and	and	CC
cord-005453-4057qib7	3376	3	caregiver	caregiver	NN
cord-005453-4057qib7	3376	4	input	input	NN
cord-005453-4057qib7	3376	5	is	be	VBZ
cord-005453-4057qib7	3376	6	essential	essential	JJ
cord-005453-4057qib7	3376	7	to	to	TO
cord-005453-4057qib7	3376	8	inform	inform	VB
cord-005453-4057qib7	3376	9	the	the	DT
cord-005453-4057qib7	3376	10	design	design	NN
cord-005453-4057qib7	3376	11	and	and	CC
cord-005453-4057qib7	3376	12	features	feature	VBZ
cord-005453-4057qib7	3376	13	for	for	IN
cord-005453-4057qib7	3376	14	the	the	DT
cord-005453-4057qib7	3376	15	mobile	mobile	JJ
cord-005453-4057qib7	3376	16	app	app	NN
cord-005453-4057qib7	3376	17	platform	platform	NN
cord-005453-4057qib7	3376	18	so	so	IN
cord-005453-4057qib7	3376	19	that	that	IN
cord-005453-4057qib7	3376	20	it	-PRON-	PRP
cord-005453-4057qib7	3376	21	is	be	VBZ
cord-005453-4057qib7	3376	22	usable	usable	JJ
cord-005453-4057qib7	3376	23	and	and	CC
cord-005453-4057qib7	3376	24	engaging	engaging	JJ
cord-005453-4057qib7	3376	25	for	for	IN
cord-005453-4057qib7	3376	26	those	those	DT
cord-005453-4057qib7	3376	27	it	-PRON-	PRP
cord-005453-4057qib7	3376	28	targets	target	VBZ
cord-005453-4057qib7	3376	29	.	.	.
cord-005453-4057qib7	3377	1	Methods	method	NNS
cord-005453-4057qib7	3377	2	:	:	:
cord-005453-4057qib7	3377	3	Using	use	VBG
cord-005453-4057qib7	3377	4	a	a	DT
cord-005453-4057qib7	3377	5	qualitative	qualitative	JJ
cord-005453-4057qib7	3377	6	research	research	NN
cord-005453-4057qib7	3377	7	design	design	NN
cord-005453-4057qib7	3377	8	,	,	,
cord-005453-4057qib7	3377	9	we	-PRON-	PRP
cord-005453-4057qib7	3377	10	conducted	conduct	VBD
cord-005453-4057qib7	3377	11	telephone	telephone	NN
cord-005453-4057qib7	3377	12	focus	focus	NN
cord-005453-4057qib7	3377	13	groups	group	NNS
cord-005453-4057qib7	3377	14	of	of	IN
cord-005453-4057qib7	3377	15	adult	adult	NN
cord-005453-4057qib7	3377	16	patients	patient	NNS
cord-005453-4057qib7	3377	17	and	and	CC
cord-005453-4057qib7	3377	18	caregivers	caregiver	NNS
cord-005453-4057qib7	3377	19	in	in	IN
cord-005453-4057qib7	3377	20	the	the	DT
cord-005453-4057qib7	3377	21	United	United	NNP
cord-005453-4057qib7	3377	22	States	States	NNP
cord-005453-4057qib7	3377	23	.	.	.
cord-005453-4057qib7	3378	1	Adult	adult	NN
cord-005453-4057qib7	3378	2	(	(	-LRB-
cord-005453-4057qib7	3378	3	age	age	NN
cord-005453-4057qib7	3378	4	>	>	XX
cord-005453-4057qib7	3378	5	18	18	CD
cord-005453-4057qib7	3378	6	years	year	NNS
cord-005453-4057qib7	3378	7	at	at	IN
cord-005453-4057qib7	3378	8	the	the	DT
cord-005453-4057qib7	3378	9	time	time	NN
cord-005453-4057qib7	3378	10	of	of	IN
cord-005453-4057qib7	3378	11	study	study	NN
cord-005453-4057qib7	3378	12	entry	entry	NN
cord-005453-4057qib7	3378	13	)	)	-RRB-
cord-005453-4057qib7	3379	1	HCT	HCT	NNP
cord-005453-4057qib7	3379	2	recipients	recipient	NNS
cord-005453-4057qib7	3379	3	had	have	VBD
cord-005453-4057qib7	3379	4	to	to	TO
cord-005453-4057qib7	3379	5	be	be	VB
cord-005453-4057qib7	3379	6	at	at	IN
cord-005453-4057qib7	3379	7	least	least	JJS
cord-005453-4057qib7	3379	8	oneyear	oneyear	JJ
cord-005453-4057qib7	3379	9	post	post	NN
cord-005453-4057qib7	3379	10	-	-	JJ
cord-005453-4057qib7	3379	11	HCT	HCT	NNP
cord-005453-4057qib7	3379	12	to	to	TO
cord-005453-4057qib7	3379	13	participate	participate	VB
cord-005453-4057qib7	3379	14	.	.	.
cord-005453-4057qib7	3380	1	Participants	participant	NNS
cord-005453-4057qib7	3380	2	had	have	VBD
cord-005453-4057qib7	3380	3	to	to	TO
cord-005453-4057qib7	3380	4	be	be	VB
cord-005453-4057qib7	3380	5	able	able	JJ
cord-005453-4057qib7	3380	6	to	to	TO
cord-005453-4057qib7	3380	7	communicate	communicate	VB
cord-005453-4057qib7	3380	8	in	in	IN
cord-005453-4057qib7	3380	9	English	English	NNP
cord-005453-4057qib7	3380	10	,	,	,
cord-005453-4057qib7	3380	11	and	and	CC
cord-005453-4057qib7	3380	12	could	could	MD
cord-005453-4057qib7	3380	13	have	have	VB
cord-005453-4057qib7	3380	14	received	receive	VBN
cord-005453-4057qib7	3380	15	a	a	DT
cord-005453-4057qib7	3380	16	HCT	hct	NN
cord-005453-4057qib7	3380	17	for	for	IN
cord-005453-4057qib7	3380	18	any	any	DT
cord-005453-4057qib7	3380	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	3380	20	,	,	,
cord-005453-4057qib7	3380	21	and	and	CC
cord-005453-4057qib7	3380	22	from	from	IN
cord-005453-4057qib7	3380	23	any	any	DT
cord-005453-4057qib7	3380	24	donor	donor	NN
cord-005453-4057qib7	3380	25	source	source	NN
cord-005453-4057qib7	3380	26	or	or	CC
cord-005453-4057qib7	3380	27	stem	stem	NN
cord-005453-4057qib7	3380	28	cell	cell	NN
cord-005453-4057qib7	3380	29	type	type	NN
cord-005453-4057qib7	3380	30	.	.	.
cord-005453-4057qib7	3381	1	Those	those	DT
cord-005453-4057qib7	3381	2	who	who	WP
cord-005453-4057qib7	3381	3	had	have	VBD
cord-005453-4057qib7	3381	4	multiple	multiple	JJ
cord-005453-4057qib7	3381	5	transplants	transplant	NNS
cord-005453-4057qib7	3381	6	were	be	VBD
cord-005453-4057qib7	3381	7	included	include	VBN
cord-005453-4057qib7	3381	8	.	.	.
cord-005453-4057qib7	3382	1	Participants	participant	NNS
cord-005453-4057qib7	3382	2	were	be	VBD
cord-005453-4057qib7	3382	3	asked	ask	VBN
cord-005453-4057qib7	3382	4	to	to	TO
cord-005453-4057qib7	3382	5	review	review	VB
cord-005453-4057qib7	3382	6	printed	print	VBN
cord-005453-4057qib7	3382	7	and	and	CC
cord-005453-4057qib7	3382	8	online	online	JJ
cord-005453-4057qib7	3382	9	visual	visual	JJ
cord-005453-4057qib7	3382	10	presentations	presentation	NNS
cord-005453-4057qib7	3382	11	of	of	IN
cord-005453-4057qib7	3382	12	the	the	DT
cord-005453-4057qib7	3382	13	mobile	mobile	JJ
cord-005453-4057qib7	3382	14	app	app	NN
cord-005453-4057qib7	3382	15	before	before	IN
cord-005453-4057qib7	3382	16	the	the	DT
cord-005453-4057qib7	3382	17	focus	focus	NN
cord-005453-4057qib7	3382	18	groups	group	NNS
cord-005453-4057qib7	3383	1	so	so	RB
cord-005453-4057qib7	3383	2	they	-PRON-	PRP
cord-005453-4057qib7	3383	3	were	be	VBD
cord-005453-4057qib7	3383	4	prepared	prepared	JJ
cord-005453-4057qib7	3383	5	to	to	TO
cord-005453-4057qib7	3383	6	discuss	discuss	VB
cord-005453-4057qib7	3383	7	their	-PRON-	PRP$
cord-005453-4057qib7	3383	8	responses	response	NNS
cord-005453-4057qib7	3383	9	to	to	IN
cord-005453-4057qib7	3383	10	the	the	DT
cord-005453-4057qib7	3383	11	materials	material	NNS
cord-005453-4057qib7	3383	12	during	during	IN
cord-005453-4057qib7	3383	13	the	the	DT
cord-005453-4057qib7	3383	14	call	call	NN
cord-005453-4057qib7	3383	15	.	.	.
cord-005453-4057qib7	3384	1	Focus	focus	JJ
cord-005453-4057qib7	3384	2	groups	group	NNS
cord-005453-4057qib7	3384	3	were	be	VBD
cord-005453-4057qib7	3384	4	conducted	conduct	VBN
cord-005453-4057qib7	3384	5	to	to	IN
cord-005453-4057qib7	3384	6	saturation	saturation	NN
cord-005453-4057qib7	3384	7	,	,	,
cord-005453-4057qib7	3384	8	when	when	WRB
cord-005453-4057qib7	3384	9	no	no	DT
cord-005453-4057qib7	3384	10	new	new	JJ
cord-005453-4057qib7	3384	11	qualitative	qualitative	JJ
cord-005453-4057qib7	3384	12	content	content	NN
cord-005453-4057qib7	3384	13	was	be	VBD
cord-005453-4057qib7	3384	14	offered	offer	VBN
cord-005453-4057qib7	3384	15	.	.	.
cord-005453-4057qib7	3385	1	Results	result	NNS
cord-005453-4057qib7	3385	2	:	:	:
cord-005453-4057qib7	3386	1	Three	three	CD
cord-005453-4057qib7	3386	2	focus	focus	NN
cord-005453-4057qib7	3386	3	groups	group	NNS
cord-005453-4057qib7	3386	4	were	be	VBD
cord-005453-4057qib7	3386	5	conducted	conduct	VBN
cord-005453-4057qib7	3386	6	with	with	IN
cord-005453-4057qib7	3386	7	22	22	CD
cord-005453-4057qib7	3386	8	total	total	JJ
cord-005453-4057qib7	3386	9	participants	participant	NNS
cord-005453-4057qib7	3386	10	(	(	-LRB-
cord-005453-4057qib7	3386	11	20	20	CD
cord-005453-4057qib7	3386	12	patients	patient	NNS
cord-005453-4057qib7	3386	13	,	,	,
cord-005453-4057qib7	3386	14	two	two	CD
cord-005453-4057qib7	3386	15	caregivers	caregiver	NNS
cord-005453-4057qib7	3386	16	/	/	SYM
cord-005453-4057qib7	3386	17	patient	patient	NN
cord-005453-4057qib7	3386	18	advocates	advocate	NNS
cord-005453-4057qib7	3386	19	)	)	-RRB-
cord-005453-4057qib7	3386	20	.	.	.
cord-005453-4057qib7	3387	1	All	all	DT
cord-005453-4057qib7	3387	2	patients	patient	NNS
cord-005453-4057qib7	3387	3	received	receive	VBD
cord-005453-4057qib7	3387	4	an	an	DT
cord-005453-4057qib7	3387	5	allogeneic	allogeneic	NN
cord-005453-4057qib7	3387	6	HCT	hct	NN
cord-005453-4057qib7	3387	7	;	;	:
cord-005453-4057qib7	3387	8	average	average	JJ
cord-005453-4057qib7	3387	9	time	time	NN
cord-005453-4057qib7	3387	10	since	since	IN
cord-005453-4057qib7	3387	11	HCT	HCT	NNP
cord-005453-4057qib7	3387	12	was	be	VBD
cord-005453-4057qib7	3387	13	8	8	CD
cord-005453-4057qib7	3387	14	years	year	NNS
cord-005453-4057qib7	3387	15	(	(	-LRB-
cord-005453-4057qib7	3387	16	range	range	NN
cord-005453-4057qib7	3387	17	:	:	:
cord-005453-4057qib7	3387	18	2	2	CD
cord-005453-4057qib7	3387	19	-	-	SYM
cord-005453-4057qib7	3387	20	22	22	CD
cord-005453-4057qib7	3387	21	years).The	years).The	NNP
cord-005453-4057qib7	3387	22	majority	majority	NN
cord-005453-4057qib7	3387	23	of	of	IN
cord-005453-4057qib7	3387	24	participants	participant	NNS
cord-005453-4057qib7	3387	25	were	be	VBD
cord-005453-4057qib7	3387	26	female	female	JJ
cord-005453-4057qib7	3387	27	(	(	-LRB-
cord-005453-4057qib7	3387	28	77.3	77.3	CD
cord-005453-4057qib7	3387	29	%	%	NN
cord-005453-4057qib7	3387	30	)	)	-RRB-
cord-005453-4057qib7	3387	31	.	.	.
cord-005453-4057qib7	3388	1	Participants	participant	NNS
cord-005453-4057qib7	3388	2	had	have	VBD
cord-005453-4057qib7	3388	3	differing	differ	VBG
cord-005453-4057qib7	3388	4	perspectives	perspective	NNS
cord-005453-4057qib7	3388	5	on	on	IN
cord-005453-4057qib7	3388	6	the	the	DT
cord-005453-4057qib7	3388	7	usefulness	usefulness	NN
cord-005453-4057qib7	3388	8	of	of	IN
cord-005453-4057qib7	3388	9	the	the	DT
cord-005453-4057qib7	3388	10	app	app	NN
cord-005453-4057qib7	3388	11	to	to	TO
cord-005453-4057qib7	3388	12	track	track	VB
cord-005453-4057qib7	3388	13	follow	follow	VB
cord-005453-4057qib7	3388	14	-	-	HYPH
cord-005453-4057qib7	3388	15	up	up	RP
cord-005453-4057qib7	3388	16	appointments	appointment	NNS
cord-005453-4057qib7	3388	17	,	,	,
cord-005453-4057qib7	3388	18	lab	lab	NN
cord-005453-4057qib7	3388	19	values	value	NNS
cord-005453-4057qib7	3388	20	,	,	,
cord-005453-4057qib7	3388	21	and	and	CC
cord-005453-4057qib7	3388	22	other	other	JJ
cord-005453-4057qib7	3388	23	health	health	NN
cord-005453-4057qib7	3388	24	care	care	NN
cord-005453-4057qib7	3388	25	plans	plan	NNS
cord-005453-4057qib7	3388	26	.	.	.
cord-005453-4057qib7	3389	1	There	there	EX
cord-005453-4057qib7	3389	2	was	be	VBD
cord-005453-4057qib7	3389	3	high	high	JJ
cord-005453-4057qib7	3389	4	interest	interest	NN
cord-005453-4057qib7	3389	5	in	in	IN
cord-005453-4057qib7	3389	6	having	have	VBG
cord-005453-4057qib7	3389	7	the	the	DT
cord-005453-4057qib7	3389	8	app	app	NN
cord-005453-4057qib7	3389	9	tailored	tailor	VBN
cord-005453-4057qib7	3389	10	to	to	TO
cord-005453-4057qib7	3389	11	meet	meet	VB
cord-005453-4057qib7	3389	12	specific	specific	JJ
cord-005453-4057qib7	3389	13	needs	need	NNS
cord-005453-4057qib7	3389	14	of	of	IN
cord-005453-4057qib7	3389	15	patients	patient	NNS
cord-005453-4057qib7	3389	16	,	,	,
cord-005453-4057qib7	3389	17	including	include	VBG
cord-005453-4057qib7	3389	18	tracking	track	VBG
cord-005453-4057qib7	3389	19	information	information	NN
cord-005453-4057qib7	3389	20	over	over	IN
cord-005453-4057qib7	3389	21	time	time	NN
cord-005453-4057qib7	3389	22	(	(	-LRB-
cord-005453-4057qib7	3389	23	e.g.	e.g.	IN
cord-005453-4057qib7	3389	24	test	test	NN
cord-005453-4057qib7	3389	25	results	result	NNS
cord-005453-4057qib7	3389	26	,	,	,
cord-005453-4057qib7	3389	27	medications	medication	NNS
cord-005453-4057qib7	3389	28	)	)	-RRB-
cord-005453-4057qib7	3389	29	,	,	,
cord-005453-4057qib7	3389	30	and	and	CC
cord-005453-4057qib7	3389	31	having	have	VBG
cord-005453-4057qib7	3389	32	health	health	NN
cord-005453-4057qib7	3389	33	information	information	NN
cord-005453-4057qib7	3389	34	available	available	JJ
cord-005453-4057qib7	3389	35	specific	specific	JJ
cord-005453-4057qib7	3389	36	to	to	IN
cord-005453-4057qib7	3389	37	their	-PRON-	PRP$
cord-005453-4057qib7	3389	38	needs	need	NNS
cord-005453-4057qib7	3389	39	.	.	.
cord-005453-4057qib7	3390	1	To	to	TO
cord-005453-4057qib7	3390	2	minimize	minimize	VB
cord-005453-4057qib7	3390	3	duplication	duplication	NN
cord-005453-4057qib7	3390	4	of	of	IN
cord-005453-4057qib7	3390	5	information	information	NN
cord-005453-4057qib7	3390	6	and	and	CC
cord-005453-4057qib7	3390	7	data	datum	NNS
cord-005453-4057qib7	3390	8	entry	entry	NN
cord-005453-4057qib7	3390	9	,	,	,
cord-005453-4057qib7	3390	10	participants	participant	NNS
cord-005453-4057qib7	3390	11	recommended	recommend	VBD
cord-005453-4057qib7	3390	12	syncing	sync	VBG
cord-005453-4057qib7	3390	13	the	the	DT
cord-005453-4057qib7	3390	14	app	app	NN
cord-005453-4057qib7	3390	15	with	with	IN
cord-005453-4057qib7	3390	16	their	-PRON-	PRP$
cord-005453-4057qib7	3390	17	calendars	calendar	NNS
cord-005453-4057qib7	3390	18	and	and	CC
cord-005453-4057qib7	3390	19	online	online	JJ
cord-005453-4057qib7	3390	20	patient	patient	NN
cord-005453-4057qib7	3390	21	portals	portal	NNS
cord-005453-4057qib7	3390	22	they	-PRON-	PRP
cord-005453-4057qib7	3390	23	already	already	RB
cord-005453-4057qib7	3390	24	use	use	VBP
cord-005453-4057qib7	3390	25	.	.	.
cord-005453-4057qib7	3391	1	Reasons	reason	NNS
cord-005453-4057qib7	3391	2	provided	provide	VBN
cord-005453-4057qib7	3391	3	for	for	IN
cord-005453-4057qib7	3391	4	not	not	RB
cord-005453-4057qib7	3391	5	using	use	VBG
cord-005453-4057qib7	3391	6	the	the	DT
cord-005453-4057qib7	3391	7	app	app	NN
cord-005453-4057qib7	3391	8	included	include	VBD
cord-005453-4057qib7	3391	9	perception	perception	NN
cord-005453-4057qib7	3391	10	that	that	IN
cord-005453-4057qib7	3391	11	the	the	DT
cord-005453-4057qib7	3391	12	materials	material	NNS
cord-005453-4057qib7	3391	13	repeated	repeat	VBD
cord-005453-4057qib7	3391	14	information	information	NN
cord-005453-4057qib7	3391	15	already	already	RB
cord-005453-4057qib7	3391	16	received	receive	VBN
cord-005453-4057qib7	3391	17	,	,	,
cord-005453-4057qib7	3391	18	side	side	NN
cord-005453-4057qib7	3391	19	effects	effect	NNS
cord-005453-4057qib7	3391	20	such	such	JJ
cord-005453-4057qib7	3391	21	as	as	IN
cord-005453-4057qib7	3391	22	graft	graft	NN
cord-005453-4057qib7	3391	23	-	-	HYPH
cord-005453-4057qib7	3391	24	versus	versus	IN
cord-005453-4057qib7	3391	25	-	-	HYPH
cord-005453-4057qib7	3391	26	host	host	NN
cord-005453-4057qib7	3391	27	disease	disease	NN
cord-005453-4057qib7	3391	28	that	that	WDT
cord-005453-4057qib7	3391	29	restricted	restrict	VBD
cord-005453-4057qib7	3391	30	vision	vision	NN
cord-005453-4057qib7	3391	31	or	or	CC
cord-005453-4057qib7	3391	32	motor	motor	NN
cord-005453-4057qib7	3391	33	skills	skill	NNS
cord-005453-4057qib7	3391	34	,	,	,
cord-005453-4057qib7	3391	35	and	and	CC
cord-005453-4057qib7	3391	36	lack	lack	NN
cord-005453-4057qib7	3391	37	of	of	IN
cord-005453-4057qib7	3391	38	comfort	comfort	NN
cord-005453-4057qib7	3391	39	with	with	IN
cord-005453-4057qib7	3391	40	apps	app	NNS
cord-005453-4057qib7	3391	41	for	for	IN
cord-005453-4057qib7	3391	42	some	some	DT
cord-005453-4057qib7	3391	43	older	old	JJR
cord-005453-4057qib7	3391	44	participants	participant	NNS
cord-005453-4057qib7	3391	45	.	.	.
cord-005453-4057qib7	3392	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3392	2	:	:	:
cord-005453-4057qib7	3393	1	Many	many	JJ
cord-005453-4057qib7	3393	2	health	health	NN
cord-005453-4057qib7	3393	3	technology	technology	NN
cord-005453-4057qib7	3393	4	and	and	CC
cord-005453-4057qib7	3393	5	mobile	mobile	JJ
cord-005453-4057qib7	3393	6	apps	app	NNS
cord-005453-4057qib7	3393	7	are	be	VBP
cord-005453-4057qib7	3393	8	being	be	VBG
cord-005453-4057qib7	3393	9	created	create	VBN
cord-005453-4057qib7	3393	10	to	to	TO
cord-005453-4057qib7	3393	11	improve	improve	VB
cord-005453-4057qib7	3393	12	patients	patient	NNS
cord-005453-4057qib7	3393	13	'	'	POS
cord-005453-4057qib7	3393	14	health	health	NN
cord-005453-4057qib7	3393	15	and	and	CC
cord-005453-4057qib7	3393	16	survivorship	survivorship	NN
cord-005453-4057qib7	3393	17	care	care	NN
cord-005453-4057qib7	3393	18	.	.	.
cord-005453-4057qib7	3394	1	In	in	IN
cord-005453-4057qib7	3394	2	this	this	DT
cord-005453-4057qib7	3394	3	study	study	NN
cord-005453-4057qib7	3394	4	,	,	,
cord-005453-4057qib7	3394	5	HCT	HCT	NNP
cord-005453-4057qib7	3394	6	survivors	survivor	NNS
cord-005453-4057qib7	3394	7	and	and	CC
cord-005453-4057qib7	3394	8	caregivers	caregiver	NNS
cord-005453-4057qib7	3394	9	identified	identify	VBD
cord-005453-4057qib7	3394	10	a	a	DT
cord-005453-4057qib7	3394	11	variety	variety	NN
cord-005453-4057qib7	3394	12	of	of	IN
cord-005453-4057qib7	3394	13	features	feature	NNS
cord-005453-4057qib7	3394	14	that	that	WDT
cord-005453-4057qib7	3394	15	they	-PRON-	PRP
cord-005453-4057qib7	3394	16	would	would	MD
cord-005453-4057qib7	3394	17	want	want	VB
cord-005453-4057qib7	3394	18	in	in	IN
cord-005453-4057qib7	3394	19	an	an	DT
cord-005453-4057qib7	3394	20	app	app	NN
cord-005453-4057qib7	3394	21	or	or	CC
cord-005453-4057qib7	3394	22	website	website	NN
cord-005453-4057qib7	3394	23	,	,	,
cord-005453-4057qib7	3394	24	in	in	IN
cord-005453-4057qib7	3394	25	particular	particular	JJ
cord-005453-4057qib7	3394	26	,	,	,
cord-005453-4057qib7	3394	27	features	feature	VBZ
cord-005453-4057qib7	3394	28	tailored	tailor	VBN
cord-005453-4057qib7	3394	29	to	to	IN
cord-005453-4057qib7	3394	30	individual	individual	JJ
cord-005453-4057qib7	3394	31	needs	need	NNS
cord-005453-4057qib7	3394	32	.	.	.
cord-005453-4057qib7	3395	1	Health	health	NN
cord-005453-4057qib7	3395	2	technologies	technology	NNS
cord-005453-4057qib7	3395	3	provide	provide	VBP
cord-005453-4057qib7	3395	4	an	an	DT
cord-005453-4057qib7	3395	5	opportunity	opportunity	NN
cord-005453-4057qib7	3395	6	to	to	TO
cord-005453-4057qib7	3395	7	improve	improve	VB
cord-005453-4057qib7	3395	8	survivorship	survivorship	NN
cord-005453-4057qib7	3395	9	care	care	NN
cord-005453-4057qib7	3395	10	,	,	,
cord-005453-4057qib7	3395	11	but	but	CC
cord-005453-4057qib7	3395	12	patients	patient	NNS
cord-005453-4057qib7	3395	13	and	and	CC
cord-005453-4057qib7	3395	14	caregivers	caregiver	NNS
cord-005453-4057qib7	3395	15	should	should	MD
cord-005453-4057qib7	3395	16	be	be	VB
cord-005453-4057qib7	3395	17	engaged	engage	VBN
cord-005453-4057qib7	3395	18	in	in	IN
cord-005453-4057qib7	3395	19	the	the	DT
cord-005453-4057qib7	3395	20	process	process	NN
cord-005453-4057qib7	3395	21	of	of	IN
cord-005453-4057qib7	3395	22	developing	develop	VBG
cord-005453-4057qib7	3395	23	these	these	DT
cord-005453-4057qib7	3395	24	tools	tool	NNS
cord-005453-4057qib7	3395	25	to	to	TO
cord-005453-4057qib7	3395	26	assure	assure	VB
cord-005453-4057qib7	3395	27	the	the	DT
cord-005453-4057qib7	3395	28	technology	technology	NN
cord-005453-4057qib7	3395	29	fits	fit	VBZ
cord-005453-4057qib7	3395	30	their	-PRON-	PRP$
cord-005453-4057qib7	3395	31	needs	need	NNS
cord-005453-4057qib7	3395	32	and	and	CC
cord-005453-4057qib7	3395	33	will	will	MD
cord-005453-4057qib7	3395	34	be	be	VB
cord-005453-4057qib7	3395	35	used	use	VBN
cord-005453-4057qib7	3395	36	.	.	.
cord-005453-4057qib7	3396	1	Given	give	VBN
cord-005453-4057qib7	3396	2	the	the	DT
cord-005453-4057qib7	3396	3	effort	effort	NN
cord-005453-4057qib7	3396	4	required	require	VBN
cord-005453-4057qib7	3396	5	to	to	TO
cord-005453-4057qib7	3396	6	maintain	maintain	VB
cord-005453-4057qib7	3396	7	these	these	DT
cord-005453-4057qib7	3396	8	technologies	technology	NNS
cord-005453-4057qib7	3396	9	,	,	,
cord-005453-4057qib7	3396	10	they	-PRON-	PRP
cord-005453-4057qib7	3396	11	require	require	VBP
cord-005453-4057qib7	3396	12	testing	testing	NN
cord-005453-4057qib7	3396	13	for	for	IN
cord-005453-4057qib7	3396	14	health	health	NN
cord-005453-4057qib7	3396	15	benefits	benefit	NNS
cord-005453-4057qib7	3396	16	in	in	IN
cord-005453-4057qib7	3396	17	rigorous	rigorous	JJ
cord-005453-4057qib7	3396	18	clinical	clinical	JJ
cord-005453-4057qib7	3396	19	trials	trial	NNS
cord-005453-4057qib7	3396	20	.	.	.
cord-005453-4057qib7	3397	1	Clinical	clinical	JJ
cord-005453-4057qib7	3397	2	Background	background	NN
cord-005453-4057qib7	3397	3	:	:	:
cord-005453-4057qib7	3398	1	Thanks	thank	NNS
cord-005453-4057qib7	3398	2	to	to	IN
cord-005453-4057qib7	3399	1	allogeneic	allogeneic	IN
cord-005453-4057qib7	3399	2	stem	stem	NN
cord-005453-4057qib7	3399	3	cell	cell	NN
cord-005453-4057qib7	3399	4	transplantation	transplantation	NN
cord-005453-4057qib7	3399	5	(	(	-LRB-
cord-005453-4057qib7	3399	6	allo	allo	NN
cord-005453-4057qib7	3399	7	-	-	HYPH
cord-005453-4057qib7	3399	8	HSCT	HSCT	NNP
cord-005453-4057qib7	3399	9	)	)	-RRB-
cord-005453-4057qib7	3399	10	patients	patient	NNS
cord-005453-4057qib7	3399	11	suffering	suffer	VBG
cord-005453-4057qib7	3399	12	from	from	IN
cord-005453-4057qib7	3399	13	hematologic	hematologic	JJ
cord-005453-4057qib7	3399	14	malignancies	malignancy	NNS
cord-005453-4057qib7	3399	15	have	have	VBP
cord-005453-4057qib7	3399	16	seen	see	VBN
cord-005453-4057qib7	3399	17	an	an	DT
cord-005453-4057qib7	3399	18	increase	increase	NN
cord-005453-4057qib7	3399	19	in	in	IN
cord-005453-4057qib7	3399	20	there	there	RB
cord-005453-4057qib7	3399	21	life	life	NN
cord-005453-4057qib7	3399	22	duration	duration	NN
cord-005453-4057qib7	3399	23	expectancy	expectancy	NN
cord-005453-4057qib7	3399	24	,	,	,
cord-005453-4057qib7	3399	25	but	but	CC
cord-005453-4057qib7	3399	26	they	-PRON-	PRP
cord-005453-4057qib7	3399	27	are	be	VBP
cord-005453-4057qib7	3399	28	many	many	JJ
cord-005453-4057qib7	3399	29	side	side	NN
cord-005453-4057qib7	3399	30	effets	effet	NNS
cord-005453-4057qib7	3399	31	including	include	VBG
cord-005453-4057qib7	3399	32	decreasing	decrease	VBG
cord-005453-4057qib7	3399	33	in	in	IN
cord-005453-4057qib7	3399	34	physical	physical	JJ
cord-005453-4057qib7	3399	35	performance	performance	NN
cord-005453-4057qib7	3399	36	and	and	CC
cord-005453-4057qib7	3399	37	in	in	IN
cord-005453-4057qib7	3399	38	quality	quality	NN
cord-005453-4057qib7	3399	39	of	of	IN
cord-005453-4057qib7	3399	40	life	life	NN
cord-005453-4057qib7	3399	41	.	.	.
cord-005453-4057qib7	3400	1	The	the	DT
cord-005453-4057qib7	3400	2	intensity	intensity	NN
cord-005453-4057qib7	3400	3	of	of	IN
cord-005453-4057qib7	3400	4	physical	physical	JJ
cord-005453-4057qib7	3400	5	performance	performance	NN
cord-005453-4057qib7	3400	6	decrease	decrease	NN
cord-005453-4057qib7	3400	7	is	be	VBZ
cord-005453-4057qib7	3400	8	variable	variable	JJ
cord-005453-4057qib7	3400	9	between	between	IN
cord-005453-4057qib7	3400	10	patients	patient	NNS
cord-005453-4057qib7	3400	11	,	,	,
cord-005453-4057qib7	3400	12	and	and	CC
cord-005453-4057qib7	3400	13	today	today	NN
cord-005453-4057qib7	3400	14	we	-PRON-	PRP
cord-005453-4057qib7	3400	15	did	do	VBD
cord-005453-4057qib7	3400	16	not	not	RB
cord-005453-4057qib7	3400	17	know	know	VB
cord-005453-4057qib7	3400	18	why	why	WRB
cord-005453-4057qib7	3400	19	.	.	.
cord-005453-4057qib7	3401	1	The	the	DT
cord-005453-4057qib7	3401	2	aim	aim	NN
cord-005453-4057qib7	3401	3	of	of	IN
cord-005453-4057qib7	3401	4	our	-PRON-	PRP$
cord-005453-4057qib7	3401	5	study	study	NN
cord-005453-4057qib7	3401	6	was	be	VBD
cord-005453-4057qib7	3401	7	first	first	JJ
cord-005453-4057qib7	3401	8	to	to	TO
cord-005453-4057qib7	3401	9	characterize	characterize	VB
cord-005453-4057qib7	3401	10	the	the	DT
cord-005453-4057qib7	3401	11	physical	physical	JJ
cord-005453-4057qib7	3401	12	performance	performance	NN
cord-005453-4057qib7	3401	13	of	of	IN
cord-005453-4057qib7	3401	14	subjects	subject	NNS
cord-005453-4057qib7	3401	15	less	less	JJR
cord-005453-4057qib7	3401	16	than	than	IN
cord-005453-4057qib7	3401	17	1	1	CD
cord-005453-4057qib7	3401	18	year	year	NN
cord-005453-4057qib7	3401	19	following	follow	VBG
cord-005453-4057qib7	3401	20	allo	allo	NN
cord-005453-4057qib7	3401	21	-	-	HYPH
cord-005453-4057qib7	3401	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3401	23	by	by	IN
cord-005453-4057qib7	3401	24	the	the	DT
cord-005453-4057qib7	3401	25	use	use	NN
cord-005453-4057qib7	3401	26	of	of	IN
cord-005453-4057qib7	3401	27	a	a	DT
cord-005453-4057qib7	3401	28	cardiopulmonary	cardiopulmonary	JJ
cord-005453-4057qib7	3401	29	exercise	exercise	NN
cord-005453-4057qib7	3401	30	testing	testing	NN
cord-005453-4057qib7	3401	31	(	(	-LRB-
cord-005453-4057qib7	3401	32	CPET	CPET	NNP
cord-005453-4057qib7	3401	33	)	)	-RRB-
cord-005453-4057qib7	3401	34	,	,	,
cord-005453-4057qib7	3401	35	and	and	CC
cord-005453-4057qib7	3401	36	then	then	RB
cord-005453-4057qib7	3401	37	to	to	TO
cord-005453-4057qib7	3401	38	determine	determine	VB
cord-005453-4057qib7	3401	39	the	the	DT
cord-005453-4057qib7	3401	40	predictive	predictive	JJ
cord-005453-4057qib7	3401	41	factors	factor	NNS
cord-005453-4057qib7	3401	42	of	of	IN
cord-005453-4057qib7	3401	43	exercise	exercise	NN
cord-005453-4057qib7	3401	44	performance	performance	NN
cord-005453-4057qib7	3401	45	.	.	.
cord-005453-4057qib7	3402	1	Methods	method	NNS
cord-005453-4057qib7	3402	2	:	:	:
cord-005453-4057qib7	3402	3	We	-PRON-	PRP
cord-005453-4057qib7	3402	4	did	do	VBD
cord-005453-4057qib7	3402	5	a	a	DT
cord-005453-4057qib7	3402	6	retrospective	retrospective	JJ
cord-005453-4057qib7	3402	7	analysis	analysis	NN
cord-005453-4057qib7	3402	8	from	from	IN
cord-005453-4057qib7	3402	9	59	59	CD
cord-005453-4057qib7	3402	10	patients	patient	NNS
cord-005453-4057qib7	3402	11	who	who	WP
cord-005453-4057qib7	3402	12	had	have	VBD
cord-005453-4057qib7	3402	13	an	an	DT
cord-005453-4057qib7	3402	14	allo	allo	NN
cord-005453-4057qib7	3402	15	-	-	HYPH
cord-005453-4057qib7	3402	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3402	17	at	at	IN
cord-005453-4057qib7	3402	18	hematology	hematology	NN
cord-005453-4057qib7	3402	19	department	department	NN
cord-005453-4057qib7	3402	20	of	of	IN
cord-005453-4057qib7	3402	21	Toulouse	Toulouse	NNP
cord-005453-4057qib7	3402	22	-	-	HYPH
cord-005453-4057qib7	3402	23	Oncopole	Oncopole	NNP
cord-005453-4057qib7	3402	24	and	and	CC
cord-005453-4057qib7	3402	25	CPET	CPET	NNP
cord-005453-4057qib7	3402	26	from	from	IN
cord-005453-4057qib7	3402	27	01/2015	01/2015	CD
cord-005453-4057qib7	3402	28	to	to	IN
cord-005453-4057qib7	3402	29	09/2017	09/2017	CD
cord-005453-4057qib7	3402	30	.	.	.
cord-005453-4057qib7	3403	1	The	the	DT
cord-005453-4057qib7	3403	2	CPET	CPET	NNS
cord-005453-4057qib7	3403	3	was	be	VBD
cord-005453-4057qib7	3403	4	performed	perform	VBN
cord-005453-4057qib7	3403	5	using	use	VBG
cord-005453-4057qib7	3403	6	a	a	DT
cord-005453-4057qib7	3403	7	cycle	cycle	NN
cord-005453-4057qib7	3403	8	ergometer	ergometer	NN
cord-005453-4057qib7	3403	9	with	with	IN
cord-005453-4057qib7	3403	10	O2	O2	NNP
cord-005453-4057qib7	3403	11	and	and	CC
cord-005453-4057qib7	3403	12	CO2	CO2	NNP
cord-005453-4057qib7	3403	13	analyzer	analyzer	NN
cord-005453-4057qib7	3403	14	breath	breath	NN
cord-005453-4057qib7	3403	15	by	by	IN
cord-005453-4057qib7	3403	16	breath	breath	NN
cord-005453-4057qib7	3403	17	,	,	,
cord-005453-4057qib7	3403	18	(	(	-LRB-
cord-005453-4057qib7	3403	19	Masterscreen	Masterscreen	NNP
cord-005453-4057qib7	3403	20	CPX	CPX	NNP
cord-005453-4057qib7	3403	21	CareFusion	CareFusion	NNP
cord-005453-4057qib7	3403	22	,	,	,
cord-005453-4057qib7	3403	23	San	San	NNP
cord-005453-4057qib7	3403	24	Diego	Diego	NNP
cord-005453-4057qib7	3403	25	,	,	,
cord-005453-4057qib7	3403	26	USA	USA	NNP
cord-005453-4057qib7	3403	27	)	)	-RRB-
cord-005453-4057qib7	3403	28	,	,	,
cord-005453-4057qib7	3403	29	a	a	DT
cord-005453-4057qib7	3403	30	continuous	continuous	JJ
cord-005453-4057qib7	3403	31	12-lead	12-lead	JJ
cord-005453-4057qib7	3403	32	electrocardiogram	electrocardiogram	NN
cord-005453-4057qib7	3403	33	,	,	,
cord-005453-4057qib7	3403	34	and	and	CC
cord-005453-4057qib7	3403	35	a	a	DT
cord-005453-4057qib7	3403	36	blood	blood	NN
cord-005453-4057qib7	3403	37	pressure	pressure	NN
cord-005453-4057qib7	3403	38	monitoring	monitoring	NN
cord-005453-4057qib7	3403	39	.	.	.
cord-005453-4057qib7	3404	1	The	the	DT
cord-005453-4057qib7	3404	2	protocol	protocol	NN
cord-005453-4057qib7	3404	3	included	include	VBD
cord-005453-4057qib7	3404	4	a	a	DT
cord-005453-4057qib7	3404	5	2-min	2-min	JJ
cord-005453-4057qib7	3404	6	rest	rest	NN
cord-005453-4057qib7	3404	7	period	period	NN
cord-005453-4057qib7	3404	8	,	,	,
cord-005453-4057qib7	3404	9	a	a	DT
cord-005453-4057qib7	3404	10	2-min	2-min	JJ
cord-005453-4057qib7	3404	11	warm	warm	NN
cord-005453-4057qib7	3404	12	-	-	HYPH
cord-005453-4057qib7	3404	13	up	up	NN
cord-005453-4057qib7	3404	14	of	of	IN
cord-005453-4057qib7	3404	15	20W	20w	NN
cord-005453-4057qib7	3404	16	pedaling	pedaling	NN
cord-005453-4057qib7	3404	17	followed	follow	VBN
cord-005453-4057qib7	3404	18	by	by	IN
cord-005453-4057qib7	3404	19	a	a	DT
cord-005453-4057qib7	3404	20	10W	10W	NNP
cord-005453-4057qib7	3404	21	/	/	SYM
cord-005453-4057qib7	3404	22	min	min	NN
cord-005453-4057qib7	3404	23	incremental	incremental	JJ
cord-005453-4057qib7	3404	24	phase	phase	NN
cord-005453-4057qib7	3404	25	,	,	,
cord-005453-4057qib7	3404	26	up	up	IN
cord-005453-4057qib7	3404	27	to	to	IN
cord-005453-4057qib7	3404	28	exhaustion	exhaustion	NN
cord-005453-4057qib7	3404	29	,	,	,
cord-005453-4057qib7	3404	30	then	then	RB
cord-005453-4057qib7	3404	31	a	a	DT
cord-005453-4057qib7	3404	32	2-min	2-min	JJ
cord-005453-4057qib7	3404	33	active	active	JJ
cord-005453-4057qib7	3404	34	recovery	recovery	NN
cord-005453-4057qib7	3404	35	of	of	IN
cord-005453-4057qib7	3404	36	20W	20w	NN
cord-005453-4057qib7	3404	37	pedaling	pedaling	NN
cord-005453-4057qib7	3404	38	,	,	,
cord-005453-4057qib7	3404	39	then	then	RB
cord-005453-4057qib7	3404	40	a	a	DT
cord-005453-4057qib7	3404	41	2-min	2-min	JJ
cord-005453-4057qib7	3404	42	passive	passive	JJ
cord-005453-4057qib7	3404	43	recovery	recovery	NN
cord-005453-4057qib7	3404	44	.	.	.
cord-005453-4057qib7	3405	1	Three	three	CD
cord-005453-4057qib7	3405	2	exercise	exercise	NN
cord-005453-4057qib7	3405	3	markers	marker	NNS
cord-005453-4057qib7	3405	4	were	be	VBD
cord-005453-4057qib7	3405	5	analysed	analyse	VBN
cord-005453-4057qib7	3405	6	:	:	:
cord-005453-4057qib7	3405	7	the	the	DT
cord-005453-4057qib7	3405	8	peak	peak	NN
cord-005453-4057qib7	3405	9	of	of	IN
cord-005453-4057qib7	3405	10	oxygen	oxygen	NN
cord-005453-4057qib7	3405	11	uptake	uptake	NN
cord-005453-4057qib7	3405	12	(	(	-LRB-
cord-005453-4057qib7	3405	13	peak	peak	NNP
cord-005453-4057qib7	3405	14	VO	VO	NNP
cord-005453-4057qib7	3405	15	2	2	CD
cord-005453-4057qib7	3405	16	)	)	-RRB-
cord-005453-4057qib7	3405	17	,	,	,
cord-005453-4057qib7	3405	18	the	the	DT
cord-005453-4057qib7	3405	19	VE	VE	NNP
cord-005453-4057qib7	3405	20	/	/	SYM
cord-005453-4057qib7	3405	21	VCO	VCO	NNP
cord-005453-4057qib7	3405	22	2	2	CD
cord-005453-4057qib7	3405	23	slope	slope	NN
cord-005453-4057qib7	3405	24	and	and	CC
cord-005453-4057qib7	3405	25	the	the	DT
cord-005453-4057qib7	3405	26	first	first	JJ
cord-005453-4057qib7	3405	27	ventilatory	ventilatory	JJ
cord-005453-4057qib7	3405	28	threshold	threshold	NN
cord-005453-4057qib7	3405	29	(	(	-LRB-
cord-005453-4057qib7	3405	30	VT	VT	NNP
cord-005453-4057qib7	3405	31	1	1	CD
cord-005453-4057qib7	3405	32	)	)	-RRB-
cord-005453-4057qib7	3405	33	.	.	.
cord-005453-4057qib7	3406	1	Data	datum	NNS
cord-005453-4057qib7	3406	2	relative	relative	JJ
cord-005453-4057qib7	3406	3	to	to	IN
cord-005453-4057qib7	3406	4	conditioning	conditioning	NN
cord-005453-4057qib7	3406	5	regimen	regimen	NN
cord-005453-4057qib7	3406	6	,	,	,
cord-005453-4057qib7	3406	7	short	short	JJ
cord-005453-4057qib7	3406	8	-	-	HYPH
cord-005453-4057qib7	3406	9	term	term	NN
cord-005453-4057qib7	3406	10	complications	complication	NNS
cord-005453-4057qib7	3406	11	,	,	,
cord-005453-4057qib7	3406	12	impairment	impairment	NN
cord-005453-4057qib7	3406	13	at	at	IN
cord-005453-4057qib7	3406	14	CPET	CPET	NNP
cord-005453-4057qib7	3406	15	day	day	NN
cord-005453-4057qib7	3406	16	,	,	,
cord-005453-4057qib7	3406	17	and	and	CC
cord-005453-4057qib7	3406	18	physical	physical	JJ
cord-005453-4057qib7	3406	19	activity	activity	NN
cord-005453-4057qib7	3406	20	since	since	IN
cord-005453-4057qib7	3406	21	allo	allo	NN
cord-005453-4057qib7	3406	22	-	-	HYPH
cord-005453-4057qib7	3406	23	HSCT	HSCT	NNP
cord-005453-4057qib7	3406	24	were	be	VBD
cord-005453-4057qib7	3406	25	gathered	gather	VBN
cord-005453-4057qib7	3406	26	.	.	.
cord-005453-4057qib7	3407	1	Results	result	NNS
cord-005453-4057qib7	3407	2	:	:	:
cord-005453-4057qib7	3408	1	After	after	IN
cord-005453-4057qib7	3408	2	allo	allo	NN
cord-005453-4057qib7	3408	3	-	-	HYPH
cord-005453-4057qib7	3408	4	HSCT	HSCT	NNP
cord-005453-4057qib7	3408	5	,	,	,
cord-005453-4057qib7	3408	6	nearly	nearly	RB
cord-005453-4057qib7	3408	7	3	3	CD
cord-005453-4057qib7	3408	8	over	over	IN
cord-005453-4057qib7	3408	9	4	4	CD
cord-005453-4057qib7	3408	10	patients	patient	NNS
cord-005453-4057qib7	3408	11	reported	report	VBD
cord-005453-4057qib7	3408	12	fatigue	fatigue	NN
cord-005453-4057qib7	3408	13	,	,	,
cord-005453-4057qib7	3408	14	a	a	DT
cord-005453-4057qib7	3408	15	half	half	NN
cord-005453-4057qib7	3408	16	reported	report	VBN
cord-005453-4057qib7	3408	17	dyspnea	dyspnea	NN
cord-005453-4057qib7	3408	18	,	,	,
cord-005453-4057qib7	3408	19	and	and	CC
cord-005453-4057qib7	3408	20	1	1	CD
cord-005453-4057qib7	3408	21	over	over	IN
cord-005453-4057qib7	3408	22	4	4	CD
cord-005453-4057qib7	3408	23	or	or	CC
cord-005453-4057qib7	3408	24	more	more	RBR
cord-005453-4057qib7	3408	25	reported	report	VBN
cord-005453-4057qib7	3408	26	pain	pain	NN
cord-005453-4057qib7	3408	27	,	,	,
cord-005453-4057qib7	3408	28	muscular	muscular	JJ
cord-005453-4057qib7	3408	29	,	,	,
cord-005453-4057qib7	3408	30	neurological	neurological	JJ
cord-005453-4057qib7	3408	31	or	or	CC
cord-005453-4057qib7	3408	32	psychological	psychological	JJ
cord-005453-4057qib7	3408	33	impairment	impairment	NN
cord-005453-4057qib7	3408	34	.	.	.
cord-005453-4057qib7	3409	1	More	More	JJR
cord-005453-4057qib7	3409	2	than	than	IN
cord-005453-4057qib7	3409	3	60	60	CD
cord-005453-4057qib7	3409	4	%	%	NN
cord-005453-4057qib7	3409	5	of	of	IN
cord-005453-4057qib7	3409	6	patients	patient	NNS
cord-005453-4057qib7	3409	7	suffer	suffer	VBP
cord-005453-4057qib7	3409	8	from	from	IN
cord-005453-4057qib7	3409	9	moderate	moderate	JJ
cord-005453-4057qib7	3409	10	or	or	CC
cord-005453-4057qib7	3409	11	severe	severe	JJ
cord-005453-4057qib7	3409	12	physical	physical	JJ
cord-005453-4057qib7	3409	13	intolerance	intolerance	NN
cord-005453-4057qib7	3409	14	,	,	,
cord-005453-4057qib7	3409	15	particularly	particularly	RB
cord-005453-4057qib7	3409	16	when	when	WRB
cord-005453-4057qib7	3409	17	myeloablative	myeloablative	NNP
cord-005453-4057qib7	3409	18	conditioning	conditioning	NNP
cord-005453-4057qib7	3409	19	regimen	regimen	NN
cord-005453-4057qib7	3409	20	was	be	VBD
cord-005453-4057qib7	3409	21	used	use	VBN
cord-005453-4057qib7	3409	22	.	.	.
cord-005453-4057qib7	3410	1	Only	only	RB
cord-005453-4057qib7	3410	2	37	37	CD
cord-005453-4057qib7	3410	3	%	%	NN
cord-005453-4057qib7	3410	4	of	of	IN
cord-005453-4057qib7	3410	5	patients	patient	NNS
cord-005453-4057qib7	3410	6	followed	follow	VBD
cord-005453-4057qib7	3410	7	rehabilitation	rehabilitation	NN
cord-005453-4057qib7	3410	8	sessions	session	NNS
cord-005453-4057qib7	3410	9	supervised	supervise	VBN
cord-005453-4057qib7	3410	10	by	by	IN
cord-005453-4057qib7	3410	11	a	a	DT
cord-005453-4057qib7	3410	12	physiotherapist	physiotherapist	NN
cord-005453-4057qib7	3410	13	,	,	,
cord-005453-4057qib7	3410	14	and	and	CC
cord-005453-4057qib7	3410	15	non	non	JJ
cord-005453-4057qib7	3410	16	-	-	JJ
cord-005453-4057qib7	3410	17	supervised	supervised	JJ
cord-005453-4057qib7	3410	18	physical	physical	JJ
cord-005453-4057qib7	3410	19	activity	activity	NN
cord-005453-4057qib7	3410	20	has	have	VBZ
cord-005453-4057qib7	3410	21	been	be	VBN
cord-005453-4057qib7	3410	22	performed	perform	VBN
cord-005453-4057qib7	3410	23	by	by	IN
cord-005453-4057qib7	3410	24	87	87	CD
cord-005453-4057qib7	3410	25	%	%	NN
cord-005453-4057qib7	3410	26	of	of	IN
cord-005453-4057qib7	3410	27	patients	patient	NNS
cord-005453-4057qib7	3410	28	.	.	.
cord-005453-4057qib7	3411	1	Despite	despite	IN
cord-005453-4057qib7	3411	2	normal	normal	JJ
cord-005453-4057qib7	3411	3	lung	lung	NN
cord-005453-4057qib7	3411	4	function	function	NN
cord-005453-4057qib7	3411	5	tests	test	NNS
cord-005453-4057qib7	3411	6	and	and	CC
cord-005453-4057qib7	3411	7	echocardiography	echocardiography	NN
cord-005453-4057qib7	3411	8	findings	finding	NNS
cord-005453-4057qib7	3411	9	in	in	IN
cord-005453-4057qib7	3411	10	most	most	JJS
cord-005453-4057qib7	3411	11	patients	patient	NNS
cord-005453-4057qib7	3411	12	,	,	,
cord-005453-4057qib7	3411	13	80	80	CD
cord-005453-4057qib7	3411	14	%	%	NN
cord-005453-4057qib7	3411	15	had	have	VBD
cord-005453-4057qib7	3411	16	exercise	exercise	NN
cord-005453-4057qib7	3411	17	intolerance	intolerance	NN
cord-005453-4057qib7	3411	18	(	(	-LRB-
cord-005453-4057qib7	3411	19	EI	EI	NNP
cord-005453-4057qib7	3411	20	)	)	-RRB-
cord-005453-4057qib7	3411	21	,	,	,
cord-005453-4057qib7	3411	22	85	85	CD
cord-005453-4057qib7	3411	23	%	%	NN
cord-005453-4057qib7	3411	24	exercise	exercise	NN
cord-005453-4057qib7	3411	25	deconditioning	deconditioning	NN
cord-005453-4057qib7	3411	26	,	,	,
cord-005453-4057qib7	3411	27	and	and	CC
cord-005453-4057qib7	3411	28	55	55	CD
cord-005453-4057qib7	3411	29	%	%	NN
cord-005453-4057qib7	3411	30	had	have	VBD
cord-005453-4057qib7	3411	31	abnormal	abnormal	JJ
cord-005453-4057qib7	3411	32	ventilatory	ventilatory	JJ
cord-005453-4057qib7	3411	33	efficiency	efficiency	NN
cord-005453-4057qib7	3411	34	.	.	.
cord-005453-4057qib7	3412	1	Patients	patient	NNS
cord-005453-4057qib7	3412	2	with	with	IN
cord-005453-4057qib7	3412	3	moderate	moderate	JJ
cord-005453-4057qib7	3412	4	and	and	CC
cord-005453-4057qib7	3412	5	severe	severe	JJ
cord-005453-4057qib7	3412	6	impaired	impaired	JJ
cord-005453-4057qib7	3412	7	exercise	exercise	NN
cord-005453-4057qib7	3412	8	capacity	capacity	NN
cord-005453-4057qib7	3412	9	were	be	VBD
cord-005453-4057qib7	3412	10	significantly	significantly	RB
cord-005453-4057qib7	3412	11	younger	young	JJR
cord-005453-4057qib7	3412	12	at	at	IN
cord-005453-4057qib7	3412	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	3412	14	and	and	CC
cord-005453-4057qib7	3412	15	at	at	IN
cord-005453-4057qib7	3412	16	allo	allo	NN
cord-005453-4057qib7	3412	17	-	-	HYPH
cord-005453-4057qib7	3412	18	HSCT	HSCT	NNP
cord-005453-4057qib7	3412	19	,	,	,
cord-005453-4057qib7	3412	20	such	such	JJ
cord-005453-4057qib7	3412	21	as	as	IN
cord-005453-4057qib7	3412	22	patients	patient	NNS
cord-005453-4057qib7	3412	23	with	with	IN
cord-005453-4057qib7	3412	24	severe	severe	JJ
cord-005453-4057qib7	3412	25	deconditioning	deconditione	VBG
cord-005453-4057qib7	3412	26	Conclusions	conclusion	NNS
cord-005453-4057qib7	3412	27	:	:	:
cord-005453-4057qib7	3413	1	Based	base	VBN
cord-005453-4057qib7	3413	2	on	on	IN
cord-005453-4057qib7	3413	3	a	a	DT
cord-005453-4057qib7	3413	4	retrospective	retrospective	JJ
cord-005453-4057qib7	3413	5	study	study	NN
cord-005453-4057qib7	3413	6	,	,	,
cord-005453-4057qib7	3413	7	we	-PRON-	PRP
cord-005453-4057qib7	3413	8	reported	report	VBD
cord-005453-4057qib7	3413	9	for	for	IN
cord-005453-4057qib7	3413	10	the	the	DT
cord-005453-4057qib7	3413	11	first	first	JJ
cord-005453-4057qib7	3413	12	time	time	NN
cord-005453-4057qib7	3413	13	complete	complete	JJ
cord-005453-4057qib7	3413	14	results	result	NNS
cord-005453-4057qib7	3413	15	from	from	IN
cord-005453-4057qib7	3413	16	CPET	CPET	NNS
cord-005453-4057qib7	3413	17	and	and	CC
cord-005453-4057qib7	3413	18	detailed	detailed	JJ
cord-005453-4057qib7	3413	19	clinical	clinical	JJ
cord-005453-4057qib7	3413	20	evaluation	evaluation	NN
cord-005453-4057qib7	3413	21	concerning	concern	VBG
cord-005453-4057qib7	3413	22	deficiency	deficiency	NN
cord-005453-4057qib7	3413	23	and	and	CC
cord-005453-4057qib7	3413	24	disability	disability	NN
cord-005453-4057qib7	3413	25	following	follow	VBG
cord-005453-4057qib7	3413	26	first	first	JJ
cord-005453-4057qib7	3413	27	year	year	NN
cord-005453-4057qib7	3413	28	after	after	IN
cord-005453-4057qib7	3413	29	allo	allo	NN
cord-005453-4057qib7	3413	30	-	-	HYPH
cord-005453-4057qib7	3413	31	HSCT	HSCT	NNP
cord-005453-4057qib7	3413	32	.	.	.
cord-005453-4057qib7	3414	1	These	these	DT
cord-005453-4057qib7	3414	2	results	result	NNS
cord-005453-4057qib7	3414	3	confirm	confirm	VBP
cord-005453-4057qib7	3414	4	that	that	IN
cord-005453-4057qib7	3414	5	exercise	exercise	NN
cord-005453-4057qib7	3414	6	impairment	impairment	NN
cord-005453-4057qib7	3414	7	is	be	VBZ
cord-005453-4057qib7	3414	8	very	very	RB
cord-005453-4057qib7	3414	9	frequent	frequent	JJ
cord-005453-4057qib7	3414	10	with	with	IN
cord-005453-4057qib7	3414	11	more	more	JJR
cord-005453-4057qib7	3414	12	than	than	IN
cord-005453-4057qib7	3414	13	a	a	DT
cord-005453-4057qib7	3414	14	half	half	NN
cord-005453-4057qib7	3414	15	of	of	IN
cord-005453-4057qib7	3414	16	patients	patient	NNS
cord-005453-4057qib7	3414	17	suffering	suffer	VBG
cord-005453-4057qib7	3414	18	from	from	IN
cord-005453-4057qib7	3414	19	alterations	alteration	NNS
cord-005453-4057qib7	3414	20	of	of	IN
cord-005453-4057qib7	3414	21	one	one	CD
cord-005453-4057qib7	3414	22	or	or	CC
cord-005453-4057qib7	3414	23	more	more	JJR
cord-005453-4057qib7	3414	24	of	of	IN
cord-005453-4057qib7	3414	25	the	the	DT
cord-005453-4057qib7	3414	26	three	three	CD
cord-005453-4057qib7	3414	27	performance	performance	NN
cord-005453-4057qib7	3414	28	markers	marker	NNS
cord-005453-4057qib7	3414	29	,	,	,
cord-005453-4057qib7	3414	30	despite	despite	IN
cord-005453-4057qib7	3414	31	being	be	VBG
cord-005453-4057qib7	3414	32	active	active	JJ
cord-005453-4057qib7	3414	33	.	.	.
cord-005453-4057qib7	3415	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3415	2	:	:	:
cord-005453-4057qib7	3415	3	Nothing	nothing	NN
cord-005453-4057qib7	3415	4	to	to	TO
cord-005453-4057qib7	3415	5	declare	declare	VB
cord-005453-4057qib7	3415	6	Demyelinating	demyelinating	NN
cord-005453-4057qib7	3415	7	disorders	disorder	NNS
cord-005453-4057qib7	3415	8	:	:	:
cord-005453-4057qib7	3416	1	A	a	DT
cord-005453-4057qib7	3416	2	paradigm	paradigm	NN
cord-005453-4057qib7	3416	3	of	of	IN
cord-005453-4057qib7	3416	4	immunity	immunity	NN
cord-005453-4057qib7	3416	5	disorders	disorder	NNS
cord-005453-4057qib7	3416	6	after	after	IN
cord-005453-4057qib7	3416	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3416	8	stem	stem	NN
cord-005453-4057qib7	3416	9	cell	cell	NN
cord-005453-4057qib7	3416	10	transplantation	transplantation	NN
cord-005453-4057qib7	3416	11	Background	background	NN
cord-005453-4057qib7	3416	12	:	:	:
cord-005453-4057qib7	3417	1	Neurologic	neurologic	JJ
cord-005453-4057qib7	3417	2	complications	complication	NNS
cord-005453-4057qib7	3417	3	are	be	VBP
cord-005453-4057qib7	3417	4	a	a	DT
cord-005453-4057qib7	3417	5	major	major	JJ
cord-005453-4057qib7	3417	6	problem	problem	NN
cord-005453-4057qib7	3417	7	in	in	IN
cord-005453-4057qib7	3417	8	patients	patient	NNS
cord-005453-4057qib7	3417	9	who	who	WP
cord-005453-4057qib7	3417	10	undergone	undergo	VBD
cord-005453-4057qib7	3417	11	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	3417	12	Stem	Stem	NNP
cord-005453-4057qib7	3417	13	Cell	cell	NN
cord-005453-4057qib7	3417	14	Transplantation	transplantation	NN
cord-005453-4057qib7	3417	15	(	(	-LRB-
cord-005453-4057qib7	3417	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3417	17	)	)	-RRB-
cord-005453-4057qib7	3417	18	.	.	.
cord-005453-4057qib7	3418	1	Given	give	VBN
cord-005453-4057qib7	3418	2	the	the	DT
cord-005453-4057qib7	3418	3	higher	high	JJR
cord-005453-4057qib7	3418	4	survival	survival	NN
cord-005453-4057qib7	3418	5	of	of	IN
cord-005453-4057qib7	3418	6	transplanted	transplanted	JJ
cord-005453-4057qib7	3418	7	patients	patient	NNS
cord-005453-4057qib7	3418	8	,	,	,
cord-005453-4057qib7	3418	9	the	the	DT
cord-005453-4057qib7	3418	10	burden	burden	NN
cord-005453-4057qib7	3418	11	of	of	IN
cord-005453-4057qib7	3418	12	neurological	neurological	JJ
cord-005453-4057qib7	3418	13	complications	complication	NNS
cord-005453-4057qib7	3418	14	is	be	VBZ
cord-005453-4057qib7	3418	15	increasing	increase	VBG
cord-005453-4057qib7	3418	16	in	in	IN
cord-005453-4057qib7	3418	17	the	the	DT
cord-005453-4057qib7	3418	18	last	last	JJ
cord-005453-4057qib7	3418	19	years	year	NNS
cord-005453-4057qib7	3418	20	.	.	.
cord-005453-4057qib7	3419	1	A	a	DT
cord-005453-4057qib7	3419	2	significant	significant	JJ
cord-005453-4057qib7	3419	3	reduction	reduction	NN
cord-005453-4057qib7	3419	4	in	in	IN
cord-005453-4057qib7	3419	5	overall	overall	JJ
cord-005453-4057qib7	3419	6	survival	survival	NN
cord-005453-4057qib7	3419	7	was	be	VBD
cord-005453-4057qib7	3419	8	demonstrated	demonstrate	VBN
cord-005453-4057qib7	3419	9	in	in	IN
cord-005453-4057qib7	3419	10	patients	patient	NNS
cord-005453-4057qib7	3419	11	who	who	WP
cord-005453-4057qib7	3419	12	developed	develop	VBD
cord-005453-4057qib7	3419	13	neurological	neurological	JJ
cord-005453-4057qib7	3419	14	complication	complication	NN
cord-005453-4057qib7	3419	15	after	after	IN
cord-005453-4057qib7	3419	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3419	17	,	,	,
cord-005453-4057qib7	3419	18	irrespectively	irrespectively	RB
cord-005453-4057qib7	3419	19	of	of	IN
cord-005453-4057qib7	3419	20	the	the	DT
cord-005453-4057qib7	3419	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3419	22	stem	stem	NN
cord-005453-4057qib7	3419	23	cell	cell	NN
cord-005453-4057qib7	3419	24	(	(	-LRB-
cord-005453-4057qib7	3419	25	HSC	HSC	NNP
cord-005453-4057qib7	3419	26	)	)	-RRB-
cord-005453-4057qib7	3419	27	source	source	NN
cord-005453-4057qib7	3419	28	.	.	.
cord-005453-4057qib7	3420	1	Neurologic	neurologic	JJ
cord-005453-4057qib7	3420	2	disorders	disorder	NNS
cord-005453-4057qib7	3420	3	in	in	IN
cord-005453-4057qib7	3420	4	transplanting	transplant	VBG
cord-005453-4057qib7	3420	5	setting	set	VBG
cord-005453-4057qib7	3420	6	comprise	comprise	VBP
cord-005453-4057qib7	3420	7	a	a	DT
cord-005453-4057qib7	3420	8	wide	wide	JJ
cord-005453-4057qib7	3420	9	variety	variety	NN
cord-005453-4057qib7	3420	10	of	of	IN
cord-005453-4057qib7	3420	11	ethiologies	ethiologie	NNS
cord-005453-4057qib7	3420	12	including	include	VBG
cord-005453-4057qib7	3420	13	demyelinating	demyelinate	VBG
cord-005453-4057qib7	3420	14	disease	disease	NN
cord-005453-4057qib7	3420	15	,	,	,
cord-005453-4057qib7	3420	16	which	which	WDT
cord-005453-4057qib7	3420	17	are	be	VBP
cord-005453-4057qib7	3420	18	caused	cause	VBN
cord-005453-4057qib7	3420	19	by	by	IN
cord-005453-4057qib7	3420	20	immune	immune	JJ
cord-005453-4057qib7	3420	21	and	and	CC
cord-005453-4057qib7	3420	22	non	non	JJ
cord-005453-4057qib7	3420	23	-	-	JJ
cord-005453-4057qib7	3420	24	immune	immune	JJ
cord-005453-4057qib7	3420	25	mechanisms	mechanism	NNS
cord-005453-4057qib7	3420	26	.	.	.
cord-005453-4057qib7	3421	1	Here	here	RB
cord-005453-4057qib7	3421	2	,	,	,
cord-005453-4057qib7	3421	3	we	-PRON-	PRP
cord-005453-4057qib7	3421	4	analyzed	analyze	VBD
cord-005453-4057qib7	3421	5	the	the	DT
cord-005453-4057qib7	3421	6	clinical	clinical	JJ
cord-005453-4057qib7	3421	7	presentation	presentation	NN
cord-005453-4057qib7	3421	8	and	and	CC
cord-005453-4057qib7	3421	9	the	the	DT
cord-005453-4057qib7	3421	10	underlie	underlie	JJ
cord-005453-4057qib7	3421	11	ethiologies	ethiologie	NNS
cord-005453-4057qib7	3421	12	of	of	IN
cord-005453-4057qib7	3421	13	patients	patient	NNS
cord-005453-4057qib7	3421	14	developing	develop	VBG
cord-005453-4057qib7	3421	15	HSCT	HSCT	NNP
cord-005453-4057qib7	3421	16	-	-	HYPH
cord-005453-4057qib7	3421	17	related	relate	VBN
cord-005453-4057qib7	3421	18	demyelinating	demyelinating	JJ
cord-005453-4057qib7	3421	19	disorders	disorder	NNS
cord-005453-4057qib7	3421	20	in	in	IN
cord-005453-4057qib7	3421	21	order	order	NN
cord-005453-4057qib7	3421	22	to	to	TO
cord-005453-4057qib7	3421	23	give	give	VB
cord-005453-4057qib7	3421	24	diagnostic	diagnostic	JJ
cord-005453-4057qib7	3421	25	and	and	CC
cord-005453-4057qib7	3421	26	prognostic	prognostic	JJ
cord-005453-4057qib7	3421	27	clues	clue	NNS
cord-005453-4057qib7	3421	28	useful	useful	JJ
cord-005453-4057qib7	3421	29	to	to	TO
cord-005453-4057qib7	3421	30	manage	manage	VB
cord-005453-4057qib7	3421	31	these	these	DT
cord-005453-4057qib7	3421	32	severe	severe	JJ
cord-005453-4057qib7	3421	33	but	but	CC
cord-005453-4057qib7	3421	34	treatable	treatable	JJ
cord-005453-4057qib7	3421	35	complications	complication	NNS
cord-005453-4057qib7	3421	36	in	in	IN
cord-005453-4057qib7	3421	37	the	the	DT
cord-005453-4057qib7	3421	38	transplant	transplant	NN
cord-005453-4057qib7	3421	39	setting	setting	NN
cord-005453-4057qib7	3421	40	.	.	.
cord-005453-4057qib7	3422	1	Methods	method	NNS
cord-005453-4057qib7	3422	2	:	:	:
cord-005453-4057qib7	3422	3	A	a	DT
cord-005453-4057qib7	3422	4	total	total	NN
cord-005453-4057qib7	3422	5	of	of	IN
cord-005453-4057qib7	3422	6	45	45	CD
cord-005453-4057qib7	3422	7	patients	patient	NNS
cord-005453-4057qib7	3422	8	of	of	IN
cord-005453-4057qib7	3422	9	our	-PRON-	PRP$
cord-005453-4057qib7	3422	10	department	department	NN
cord-005453-4057qib7	3422	11	which	which	WDT
cord-005453-4057qib7	3422	12	developed	develop	VBD
cord-005453-4057qib7	3422	13	neurological	neurological	JJ
cord-005453-4057qib7	3422	14	complications	complication	NNS
cord-005453-4057qib7	3422	15	after	after	IN
cord-005453-4057qib7	3422	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3422	17	were	be	VBD
cord-005453-4057qib7	3422	18	consecutively	consecutively	RB
cord-005453-4057qib7	3422	19	collected	collect	VBN
cord-005453-4057qib7	3422	20	and	and	CC
cord-005453-4057qib7	3422	21	33	33	CD
cord-005453-4057qib7	3422	22	(	(	-LRB-
cord-005453-4057qib7	3422	23	73	73	CD
cord-005453-4057qib7	3422	24	%	%	NN
cord-005453-4057qib7	3422	25	)	)	-RRB-
cord-005453-4057qib7	3422	26	of	of	IN
cord-005453-4057qib7	3422	27	them	-PRON-	PRP
cord-005453-4057qib7	3422	28	,	,	,
cord-005453-4057qib7	3422	29	namely	namely	RB
cord-005453-4057qib7	3422	30	those	those	DT
cord-005453-4057qib7	3422	31	having	have	VBG
cord-005453-4057qib7	3422	32	a	a	DT
cord-005453-4057qib7	3422	33	diagnosis	diagnosis	NN
cord-005453-4057qib7	3422	34	of	of	IN
cord-005453-4057qib7	3422	35	a	a	DT
cord-005453-4057qib7	3422	36	demyelinating	demyelinating	JJ
cord-005453-4057qib7	3422	37	disorder	disorder	NN
cord-005453-4057qib7	3422	38	,	,	,
cord-005453-4057qib7	3422	39	were	be	VBD
cord-005453-4057qib7	3422	40	grouped	group	VBN
cord-005453-4057qib7	3422	41	and	and	CC
cord-005453-4057qib7	3422	42	described	describe	VBN
cord-005453-4057qib7	3422	43	according	accord	VBG
cord-005453-4057qib7	3422	44	to	to	IN
cord-005453-4057qib7	3422	45	the	the	DT
cord-005453-4057qib7	3422	46	ethiologies	ethiologie	NNS
cord-005453-4057qib7	3422	47	of	of	IN
cord-005453-4057qib7	3422	48	their	-PRON-	PRP$
cord-005453-4057qib7	3422	49	neurological	neurological	JJ
cord-005453-4057qib7	3422	50	disorder	disorder	NN
cord-005453-4057qib7	3422	51	.	.	.
cord-005453-4057qib7	3423	1	Results	result	NNS
cord-005453-4057qib7	3423	2	:	:	:
cord-005453-4057qib7	3424	1	In	in	IN
cord-005453-4057qib7	3424	2	14/33	14/33	CD
cord-005453-4057qib7	3424	3	(	(	-LRB-
cord-005453-4057qib7	3424	4	42	42	CD
cord-005453-4057qib7	3424	5	%	%	NN
cord-005453-4057qib7	3424	6	)	)	-RRB-
cord-005453-4057qib7	3424	7	patients	patient	NNS
cord-005453-4057qib7	3424	8	,	,	,
cord-005453-4057qib7	3424	9	an	an	DT
cord-005453-4057qib7	3424	10	immune	immune	NN
cord-005453-4057qib7	3424	11	-	-	HYPH
cord-005453-4057qib7	3424	12	mediated	mediate	VBN
cord-005453-4057qib7	3424	13	process	process	NN
cord-005453-4057qib7	3424	14	was	be	VBD
cord-005453-4057qib7	3424	15	found	find	VBN
cord-005453-4057qib7	3424	16	,	,	,
cord-005453-4057qib7	3424	17	while	while	IN
cord-005453-4057qib7	3424	18	10/33	10/33	CD
cord-005453-4057qib7	3424	19	(	(	-LRB-
cord-005453-4057qib7	3424	20	30	30	CD
cord-005453-4057qib7	3424	21	%	%	NN
cord-005453-4057qib7	3424	22	)	)	-RRB-
cord-005453-4057qib7	3424	23	were	be	VBD
cord-005453-4057qib7	3424	24	diagnosed	diagnose	VBN
cord-005453-4057qib7	3424	25	as	as	IN
cord-005453-4057qib7	3424	26	having	have	VBG
cord-005453-4057qib7	3424	27	an	an	DT
cord-005453-4057qib7	3424	28	infective	infective	JJ
cord-005453-4057qib7	3424	29	etiology	etiology	NN
cord-005453-4057qib7	3424	30	and	and	CC
cord-005453-4057qib7	3424	31	2/33	2/33	CD
cord-005453-4057qib7	3424	32	(	(	-LRB-
cord-005453-4057qib7	3424	33	6	6	CD
cord-005453-4057qib7	3424	34	%	%	NN
cord-005453-4057qib7	3424	35	)	)	-RRB-
cord-005453-4057qib7	3424	36	were	be	VBD
cord-005453-4057qib7	3424	37	supposed	suppose	VBN
cord-005453-4057qib7	3424	38	to	to	TO
cord-005453-4057qib7	3424	39	have	have	VB
cord-005453-4057qib7	3424	40	a	a	DT
cord-005453-4057qib7	3424	41	demyelinating	demyelinating	JJ
cord-005453-4057qib7	3424	42	disorder	disorder	NN
cord-005453-4057qib7	3424	43	caused	cause	VBN
cord-005453-4057qib7	3424	44	by	by	IN
cord-005453-4057qib7	3424	45	toxic	toxic	JJ
cord-005453-4057qib7	3424	46	exposition	exposition	NN
cord-005453-4057qib7	3424	47	.	.	.
cord-005453-4057qib7	3425	1	A	a	DT
cord-005453-4057qib7	3425	2	definitive	definitive	JJ
cord-005453-4057qib7	3425	3	etiologic	etiologic	JJ
cord-005453-4057qib7	3425	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	3425	5	was	be	VBD
cord-005453-4057qib7	3425	6	not	not	RB
cord-005453-4057qib7	3425	7	formulated	formulate	VBN
cord-005453-4057qib7	3425	8	in	in	IN
cord-005453-4057qib7	3425	9	the	the	DT
cord-005453-4057qib7	3425	10	remaining	remain	VBG
cord-005453-4057qib7	3425	11	7/33	7/33	CD
cord-005453-4057qib7	3425	12	(	(	-LRB-
cord-005453-4057qib7	3425	13	21	21	CD
cord-005453-4057qib7	3425	14	%	%	NN
cord-005453-4057qib7	3425	15	)	)	-RRB-
cord-005453-4057qib7	3425	16	patients	patient	NNS
cord-005453-4057qib7	3425	17	.	.	.
cord-005453-4057qib7	3426	1	When	when	WRB
cord-005453-4057qib7	3426	2	patients	patient	NNS
cord-005453-4057qib7	3426	3	who	who	WP
cord-005453-4057qib7	3426	4	developed	develop	VBD
cord-005453-4057qib7	3426	5	an	an	DT
cord-005453-4057qib7	3426	6	immune	immune	NN
cord-005453-4057qib7	3426	7	-	-	HYPH
cord-005453-4057qib7	3426	8	mediated	mediate	VBN
cord-005453-4057qib7	3426	9	demyelinating	demyelinating	NN
cord-005453-4057qib7	3426	10	disorder	disorder	NN
cord-005453-4057qib7	3426	11	(	(	-LRB-
cord-005453-4057qib7	3426	12	10/33	10/33	CD
cord-005453-4057qib7	3426	13	)	)	-RRB-
cord-005453-4057qib7	3426	14	were	be	VBD
cord-005453-4057qib7	3426	15	compared	compare	VBN
cord-005453-4057qib7	3426	16	to	to	IN
cord-005453-4057qib7	3426	17	those	those	DT
cord-005453-4057qib7	3426	18	in	in	IN
cord-005453-4057qib7	3426	19	which	which	WDT
cord-005453-4057qib7	3426	20	a	a	DT
cord-005453-4057qib7	3426	21	clear	clear	JJ
cord-005453-4057qib7	3426	22	immune	immune	JJ
cord-005453-4057qib7	3426	23	pathogenic	pathogenic	JJ
cord-005453-4057qib7	3426	24	mechanism	mechanism	NN
cord-005453-4057qib7	3426	25	was	be	VBD
cord-005453-4057qib7	3426	26	not	not	RB
cord-005453-4057qib7	3426	27	detected	detect	VBN
cord-005453-4057qib7	3426	28	(	(	-LRB-
cord-005453-4057qib7	3426	29	23/33	23/33	CD
cord-005453-4057qib7	3426	30	)	)	-RRB-
cord-005453-4057qib7	3426	31	,	,	,
cord-005453-4057qib7	3426	32	a	a	DT
cord-005453-4057qib7	3426	33	higher	high	JJR
cord-005453-4057qib7	3426	34	incidence	incidence	NN
cord-005453-4057qib7	3426	35	of	of	IN
cord-005453-4057qib7	3426	36	acute	acute	JJ
cord-005453-4057qib7	3426	37	graft	graft	NN
cord-005453-4057qib7	3426	38	-	-	HYPH
cord-005453-4057qib7	3426	39	versus	versus	IN
cord-005453-4057qib7	3426	40	-	-	HYPH
cord-005453-4057qib7	3426	41	host	host	NN
cord-005453-4057qib7	3426	42	disease	disease	NN
cord-005453-4057qib7	3426	43	(	(	-LRB-
cord-005453-4057qib7	3426	44	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3426	45	)	)	-RRB-
cord-005453-4057qib7	3426	46	was	be	VBD
cord-005453-4057qib7	3426	47	detected	detect	VBN
cord-005453-4057qib7	3426	48	in	in	IN
cord-005453-4057qib7	3426	49	the	the	DT
cord-005453-4057qib7	3426	50	former	former	JJ
cord-005453-4057qib7	3426	51	than	than	IN
cord-005453-4057qib7	3426	52	in	in	IN
cord-005453-4057qib7	3426	53	the	the	DT
cord-005453-4057qib7	3426	54	latter	latter	JJ
cord-005453-4057qib7	3426	55	(	(	-LRB-
cord-005453-4057qib7	3426	56	20	20	CD
cord-005453-4057qib7	3426	57	%	%	NN
cord-005453-4057qib7	3426	58	vs	vs	IN
cord-005453-4057qib7	3426	59	8	8	CD
cord-005453-4057qib7	3426	60	%	%	NN
cord-005453-4057qib7	3426	61	)	)	-RRB-
cord-005453-4057qib7	3426	62	.	.	.
cord-005453-4057qib7	3427	1	Moreover	moreover	RB
cord-005453-4057qib7	3427	2	,	,	,
cord-005453-4057qib7	3427	3	comparison	comparison	NN
cord-005453-4057qib7	3427	4	of	of	IN
cord-005453-4057qib7	3427	5	these	these	DT
cord-005453-4057qib7	3427	6	two	two	CD
cord-005453-4057qib7	3427	7	groups	group	NNS
cord-005453-4057qib7	3427	8	revealed	reveal	VBD
cord-005453-4057qib7	3427	9	that	that	IN
cord-005453-4057qib7	3427	10	those	those	DT
cord-005453-4057qib7	3427	11	with	with	IN
cord-005453-4057qib7	3427	12	no	no	DT
cord-005453-4057qib7	3427	13	evidence	evidence	NN
cord-005453-4057qib7	3427	14	of	of	IN
cord-005453-4057qib7	3427	15	immune	immune	NN
cord-005453-4057qib7	3427	16	-	-	HYPH
cord-005453-4057qib7	3427	17	mediated	mediate	VBN
cord-005453-4057qib7	3427	18	process	process	NN
cord-005453-4057qib7	3427	19	have	have	VBP
cord-005453-4057qib7	3427	20	a	a	DT
cord-005453-4057qib7	3427	21	slight	slight	JJ
cord-005453-4057qib7	3427	22	higher	high	JJR
cord-005453-4057qib7	3427	23	prevalence	prevalence	NN
cord-005453-4057qib7	3427	24	of	of	IN
cord-005453-4057qib7	3427	25	T	t	NN
cord-005453-4057qib7	3427	26	-	-	HYPH
cord-005453-4057qib7	3427	27	cell	cell	NN
cord-005453-4057qib7	3427	28	depleted	deplete	VBN
cord-005453-4057qib7	3427	29	HSCT	HSCT	NNP
cord-005453-4057qib7	3427	30	thanthose	thanthose	NN
cord-005453-4057qib7	3427	31	with	with	IN
cord-005453-4057qib7	3427	32	an	an	DT
cord-005453-4057qib7	3427	33	immune	immune	NN
cord-005453-4057qib7	3427	34	-	-	HYPH
cord-005453-4057qib7	3427	35	mediated	mediate	VBN
cord-005453-4057qib7	3427	36	demyelinating	demyelinating	NN
cord-005453-4057qib7	3427	37	disorder	disorder	NN
cord-005453-4057qib7	3427	38	(	(	-LRB-
cord-005453-4057qib7	3427	39	60	60	CD
cord-005453-4057qib7	3427	40	%	%	NN
cord-005453-4057qib7	3427	41	vs	vs	IN
cord-005453-4057qib7	3427	42	50	50	CD
cord-005453-4057qib7	3427	43	%	%	NN
cord-005453-4057qib7	3427	44	)	)	-RRB-
cord-005453-4057qib7	3427	45	.	.	.
cord-005453-4057qib7	3428	1	Finally	finally	RB
cord-005453-4057qib7	3428	2	,	,	,
cord-005453-4057qib7	3428	3	a	a	DT
cord-005453-4057qib7	3428	4	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	3428	5	disorder	disorder	NN
cord-005453-4057qib7	3428	6	pre	pre	VBN
cord-005453-4057qib7	3428	7	-	-	JJ
cord-005453-4057qib7	3428	8	existing	existing	JJ
cord-005453-4057qib7	3429	1	the	the	DT
cord-005453-4057qib7	3429	2	HSCT	HSCT	NNP
cord-005453-4057qib7	3429	3	was	be	VBD
cord-005453-4057qib7	3429	4	detected	detect	VBN
cord-005453-4057qib7	3429	5	in	in	IN
cord-005453-4057qib7	3429	6	5/14	5/14	CD
cord-005453-4057qib7	3429	7	(	(	-LRB-
cord-005453-4057qib7	3429	8	36	36	CD
cord-005453-4057qib7	3429	9	%	%	NN
cord-005453-4057qib7	3429	10	)	)	-RRB-
cord-005453-4057qib7	3429	11	patients	patient	NNS
cord-005453-4057qib7	3429	12	with	with	IN
cord-005453-4057qib7	3429	13	immune	immune	NN
cord-005453-4057qib7	3429	14	-	-	HYPH
cord-005453-4057qib7	3429	15	mediated	mediate	VBN
cord-005453-4057qib7	3429	16	demyelinating	demyelinating	JJ
cord-005453-4057qib7	3429	17	disorder	disorder	NN
cord-005453-4057qib7	3429	18	but	but	CC
cord-005453-4057qib7	3429	19	only	only	RB
cord-005453-4057qib7	3429	20	in	in	IN
cord-005453-4057qib7	3429	21	4/19	4/19	CD
cord-005453-4057qib7	3429	22	(	(	-LRB-
cord-005453-4057qib7	3429	23	21	21	CD
cord-005453-4057qib7	3429	24	%	%	NN
cord-005453-4057qib7	3429	25	)	)	-RRB-
cord-005453-4057qib7	3429	26	of	of	IN
cord-005453-4057qib7	3429	27	those	those	DT
cord-005453-4057qib7	3429	28	without	without	IN
cord-005453-4057qib7	3429	29	evidence	evidence	NN
cord-005453-4057qib7	3429	30	of	of	IN
cord-005453-4057qib7	3429	31	immune	immune	NN
cord-005453-4057qib7	3429	32	-	-	HYPH
cord-005453-4057qib7	3429	33	mediated	mediate	VBN
cord-005453-4057qib7	3429	34	processes	process	NNS
cord-005453-4057qib7	3429	35	.	.	.
cord-005453-4057qib7	3430	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3430	2	:	:	:
cord-005453-4057qib7	3431	1	Demyelinating	demyelinating	NN
cord-005453-4057qib7	3431	2	disorders	disorder	NNS
cord-005453-4057qib7	3431	3	may	may	MD
cord-005453-4057qib7	3431	4	be	be	VB
cord-005453-4057qib7	3431	5	responsible	responsible	JJ
cord-005453-4057qib7	3431	6	of	of	IN
cord-005453-4057qib7	3431	7	near	near	IN
cord-005453-4057qib7	3431	8	40	40	CD
cord-005453-4057qib7	3431	9	%	%	NN
cord-005453-4057qib7	3431	10	of	of	IN
cord-005453-4057qib7	3431	11	neurologic	neurologic	JJ
cord-005453-4057qib7	3431	12	complications	complication	NNS
cord-005453-4057qib7	3431	13	in	in	IN
cord-005453-4057qib7	3431	14	the	the	DT
cord-005453-4057qib7	3431	15	posttransplant	posttransplant	NN
cord-005453-4057qib7	3431	16	setting	setting	NN
cord-005453-4057qib7	3431	17	and	and	CC
cord-005453-4057qib7	3431	18	,	,	,
cord-005453-4057qib7	3431	19	among	among	IN
cord-005453-4057qib7	3431	20	them	-PRON-	PRP
cord-005453-4057qib7	3431	21	,	,	,
cord-005453-4057qib7	3431	22	an	an	DT
cord-005453-4057qib7	3431	23	immune	immune	NN
cord-005453-4057qib7	3431	24	-	-	HYPH
cord-005453-4057qib7	3431	25	mediated	mediate	VBN
cord-005453-4057qib7	3431	26	process	process	NN
cord-005453-4057qib7	3431	27	is	be	VBZ
cord-005453-4057qib7	3431	28	likely	likely	JJ
cord-005453-4057qib7	3431	29	to	to	TO
cord-005453-4057qib7	3431	30	be	be	VB
cord-005453-4057qib7	3431	31	involved	involve	VBN
cord-005453-4057qib7	3431	32	in	in	IN
cord-005453-4057qib7	3431	33	more	more	JJR
cord-005453-4057qib7	3431	34	than	than	IN
cord-005453-4057qib7	3431	35	40	40	CD
cord-005453-4057qib7	3431	36	%	%	NN
cord-005453-4057qib7	3431	37	of	of	IN
cord-005453-4057qib7	3431	38	cases	case	NNS
cord-005453-4057qib7	3431	39	.	.	.
cord-005453-4057qib7	3432	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3432	2	results	result	NNS
cord-005453-4057qib7	3432	3	suggest	suggest	VBP
cord-005453-4057qib7	3432	4	that	that	IN
cord-005453-4057qib7	3432	5	the	the	DT
cord-005453-4057qib7	3432	6	immune	immune	JJ
cord-005453-4057qib7	3432	7	mechanism	mechanism	NN
cord-005453-4057qib7	3432	8	that	that	WDT
cord-005453-4057qib7	3432	9	underliesthe	underliesthe	NNP
cord-005453-4057qib7	3432	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3432	11	may	may	MD
cord-005453-4057qib7	3432	12	also	also	RB
cord-005453-4057qib7	3432	13	be	be	VB
cord-005453-4057qib7	3432	14	involved	involve	VBN
cord-005453-4057qib7	3432	15	in	in	IN
cord-005453-4057qib7	3432	16	developing	develop	VBG
cord-005453-4057qib7	3432	17	demyelinating	demyelinate	VBG
cord-005453-4057qib7	3432	18	disease	disease	NN
cord-005453-4057qib7	3432	19	in	in	IN
cord-005453-4057qib7	3432	20	transplanted	transplanted	JJ
cord-005453-4057qib7	3432	21	patients	patient	NNS
cord-005453-4057qib7	3432	22	.	.	.
cord-005453-4057qib7	3433	1	It	-PRON-	PRP
cord-005453-4057qib7	3433	2	also	also	RB
cord-005453-4057qib7	3433	3	may	may	MD
cord-005453-4057qib7	3433	4	be	be	VB
cord-005453-4057qib7	3433	5	possible	possible	JJ
cord-005453-4057qib7	3433	6	that	that	IN
cord-005453-4057qib7	3433	7	the	the	DT
cord-005453-4057qib7	3433	8	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	3433	9	disorder	disorder	NN
cord-005453-4057qib7	3433	10	preexisting	preexist	VBG
cord-005453-4057qib7	3433	11	the	the	DT
cord-005453-4057qib7	3433	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3433	13	is	be	VBZ
cord-005453-4057qib7	3433	14	a	a	DT
cord-005453-4057qib7	3433	15	risk	risk	NN
cord-005453-4057qib7	3433	16	factor	factor	NN
cord-005453-4057qib7	3433	17	able	able	JJ
cord-005453-4057qib7	3433	18	to	to	TO
cord-005453-4057qib7	3433	19	increase	increase	VB
cord-005453-4057qib7	3433	20	the	the	DT
cord-005453-4057qib7	3433	21	risk	risk	NN
cord-005453-4057qib7	3433	22	to	to	TO
cord-005453-4057qib7	3433	23	develop	develop	VB
cord-005453-4057qib7	3433	24	an	an	DT
cord-005453-4057qib7	3433	25	immune	immune	NN
cord-005453-4057qib7	3433	26	-	-	HYPH
cord-005453-4057qib7	3433	27	mediated	mediate	VBN
cord-005453-4057qib7	3433	28	demyelinating	demyelinating	JJ
cord-005453-4057qib7	3433	29	disorder	disorder	NN
cord-005453-4057qib7	3433	30	in	in	IN
cord-005453-4057qib7	3433	31	the	the	DT
cord-005453-4057qib7	3433	32	post	post	NN
cord-005453-4057qib7	3433	33	-	-	JJ
cord-005453-4057qib7	3433	34	transplanting	transplanting	JJ
cord-005453-4057qib7	3433	35	setting	setting	NN
cord-005453-4057qib7	3433	36	.	.	.
cord-005453-4057qib7	3434	1	Using	use	VBG
cord-005453-4057qib7	3434	2	a	a	DT
cord-005453-4057qib7	3434	3	T	t	NN
cord-005453-4057qib7	3434	4	-	-	HYPH
cord-005453-4057qib7	3434	5	cell	cell	NN
cord-005453-4057qib7	3434	6	depleted	deplete	VBN
cord-005453-4057qib7	3434	7	HSCT	HSCT	NNP
cord-005453-4057qib7	3434	8	can	can	MD
cord-005453-4057qib7	3434	9	increase	increase	VB
cord-005453-4057qib7	3434	10	the	the	DT
cord-005453-4057qib7	3434	11	risk	risk	NN
cord-005453-4057qib7	3434	12	of	of	IN
cord-005453-4057qib7	3434	13	immune	immune	NN
cord-005453-4057qib7	3434	14	-	-	HYPH
cord-005453-4057qib7	3434	15	mediated	mediate	VBN
cord-005453-4057qib7	3434	16	disorders	disorder	NNS
cord-005453-4057qib7	3434	17	in	in	IN
cord-005453-4057qib7	3434	18	at	at	IN
cord-005453-4057qib7	3434	19	least	least	JJS
cord-005453-4057qib7	3434	20	a	a	DT
cord-005453-4057qib7	3434	21	small	small	JJ
cord-005453-4057qib7	3434	22	fraction	fraction	NN
cord-005453-4057qib7	3434	23	of	of	IN
cord-005453-4057qib7	3434	24	transplanted	transplanted	JJ
cord-005453-4057qib7	3434	25	patients	patient	NNS
cord-005453-4057qib7	3434	26	.	.	.
cord-005453-4057qib7	3435	1	Despite	despite	IN
cord-005453-4057qib7	3435	2	our	-PRON-	PRP$
cord-005453-4057qib7	3435	3	results	result	NNS
cord-005453-4057qib7	3435	4	should	should	MD
cord-005453-4057qib7	3435	5	be	be	VB
cord-005453-4057qib7	3435	6	validated	validate	VBN
cord-005453-4057qib7	3435	7	on	on	IN
cord-005453-4057qib7	3435	8	a	a	DT
cord-005453-4057qib7	3435	9	larger	large	JJR
cord-005453-4057qib7	3435	10	cohort	cohort	NN
cord-005453-4057qib7	3435	11	of	of	IN
cord-005453-4057qib7	3435	12	patients	patient	NNS
cord-005453-4057qib7	3435	13	,	,	,
cord-005453-4057qib7	3435	14	we	-PRON-	PRP
cord-005453-4057qib7	3435	15	can	can	MD
cord-005453-4057qib7	3435	16	speculate	speculate	VB
cord-005453-4057qib7	3435	17	on	on	IN
cord-005453-4057qib7	3435	18	the	the	DT
cord-005453-4057qib7	3435	19	possible	possible	JJ
cord-005453-4057qib7	3435	20	connections	connection	NNS
cord-005453-4057qib7	3435	21	between	between	IN
cord-005453-4057qib7	3435	22	the	the	DT
cord-005453-4057qib7	3435	23	wide	wide	JJ
cord-005453-4057qib7	3435	24	range	range	NN
cord-005453-4057qib7	3435	25	of	of	IN
cord-005453-4057qib7	3435	26	complex	complex	NN
cord-005453-4057qib7	3435	27	and	and	CC
cord-005453-4057qib7	3435	28	still	still	RB
cord-005453-4057qib7	3435	29	poorly	poorly	RB
cord-005453-4057qib7	3435	30	defined	define	VBN
cord-005453-4057qib7	3435	31	immunity	immunity	NN
cord-005453-4057qib7	3435	32	disorders	disorder	NNS
cord-005453-4057qib7	3435	33	which	which	WDT
cord-005453-4057qib7	3435	34	can	can	MD
cord-005453-4057qib7	3435	35	influence	influence	VB
cord-005453-4057qib7	3435	36	the	the	DT
cord-005453-4057qib7	3435	37	prognosis	prognosis	NN
cord-005453-4057qib7	3435	38	and	and	CC
cord-005453-4057qib7	3435	39	course	course	NN
cord-005453-4057qib7	3435	40	of	of	IN
cord-005453-4057qib7	3435	41	transplanted	transplanted	JJ
cord-005453-4057qib7	3435	42	patients	patient	NNS
cord-005453-4057qib7	3435	43	.	.	.
cord-005453-4057qib7	3436	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3436	2	Background	background	NN
cord-005453-4057qib7	3436	3	:	:	:
cord-005453-4057qib7	3437	1	Injury	injury	NN
cord-005453-4057qib7	3437	2	to	to	IN
cord-005453-4057qib7	3437	3	the	the	DT
cord-005453-4057qib7	3437	4	mucosal	mucosal	JJ
cord-005453-4057qib7	3437	5	barrier	barrier	NN
cord-005453-4057qib7	3437	6	and	and	CC
cord-005453-4057qib7	3437	7	subsequent	subsequent	JJ
cord-005453-4057qib7	3437	8	development	development	NN
cord-005453-4057qib7	3437	9	of	of	IN
cord-005453-4057qib7	3437	10	oral	oral	JJ
cord-005453-4057qib7	3437	11	mucositis	mucositis	NN
cord-005453-4057qib7	3437	12	(	(	-LRB-
cord-005453-4057qib7	3437	13	OM	OM	NNP
cord-005453-4057qib7	3437	14	)	)	-RRB-
cord-005453-4057qib7	3437	15	is	be	VBZ
cord-005453-4057qib7	3437	16	among	among	IN
cord-005453-4057qib7	3437	17	the	the	DT
cord-005453-4057qib7	3437	18	most	most	RBS
cord-005453-4057qib7	3437	19	common	common	JJ
cord-005453-4057qib7	3437	20	toxicities	toxicity	NNS
cord-005453-4057qib7	3437	21	of	of	IN
cord-005453-4057qib7	3437	22	allogeneic	allogeneic	NN
cord-005453-4057qib7	3437	23	stem	stem	NN
cord-005453-4057qib7	3437	24	cell	cell	NN
cord-005453-4057qib7	3437	25	transplantation	transplantation	NN
cord-005453-4057qib7	3437	26	(	(	-LRB-
cord-005453-4057qib7	3437	27	SCT	SCT	NNP
cord-005453-4057qib7	3437	28	)	)	-RRB-
cord-005453-4057qib7	3437	29	.	.	.
cord-005453-4057qib7	3438	1	Despite	despite	IN
cord-005453-4057qib7	3438	2	the	the	DT
cord-005453-4057qib7	3438	3	high	high	JJ
cord-005453-4057qib7	3438	4	prevalence	prevalence	NN
cord-005453-4057qib7	3438	5	of	of	IN
cord-005453-4057qib7	3438	6	OM	om	NN
cord-005453-4057qib7	3438	7	and	and	CC
cord-005453-4057qib7	3438	8	its	-PRON-	PRP$
cord-005453-4057qib7	3438	9	debilitating	debilitating	JJ
cord-005453-4057qib7	3438	10	nature	nature	NN
cord-005453-4057qib7	3438	11	,	,	,
cord-005453-4057qib7	3438	12	prospective	prospective	JJ
cord-005453-4057qib7	3438	13	studies	study	NNS
cord-005453-4057qib7	3438	14	evaluating	evaluate	VBG
cord-005453-4057qib7	3438	15	determinants	determinant	NNS
cord-005453-4057qib7	3438	16	of	of	IN
cord-005453-4057qib7	3438	17	OM	OM	NNP
cord-005453-4057qib7	3438	18	are	be	VBP
cord-005453-4057qib7	3438	19	scarce	scarce	JJ
cord-005453-4057qib7	3438	20	.	.	.
cord-005453-4057qib7	3439	1	We	-PRON-	PRP
cord-005453-4057qib7	3439	2	therefore	therefore	RB
cord-005453-4057qib7	3439	3	prospectively	prospectively	RB
cord-005453-4057qib7	3439	4	evaluated	evaluate	VBD
cord-005453-4057qib7	3439	5	the	the	DT
cord-005453-4057qib7	3439	6	occurrence	occurrence	NN
cord-005453-4057qib7	3439	7	of	of	IN
cord-005453-4057qib7	3439	8	OM	OM	NNP
cord-005453-4057qib7	3439	9	following	follow	VBG
cord-005453-4057qib7	3439	10	SCT	SCT	NNP
cord-005453-4057qib7	3439	11	.	.	.
cord-005453-4057qib7	3440	1	Risk	risk	NN
cord-005453-4057qib7	3440	2	factors	factor	NNS
cord-005453-4057qib7	3440	3	for	for	IN
cord-005453-4057qib7	3440	4	OM	om	NN
cord-005453-4057qib7	3440	5	and	and	CC
cord-005453-4057qib7	3440	6	its	-PRON-	PRP$
cord-005453-4057qib7	3440	7	implications	implication	NNS
cord-005453-4057qib7	3440	8	short	short	JJ
cord-005453-4057qib7	3440	9	and	and	CC
cord-005453-4057qib7	3440	10	long	long	JJ
cord-005453-4057qib7	3440	11	-	-	HYPH
cord-005453-4057qib7	3440	12	term	term	NN
cord-005453-4057qib7	3440	13	outcomes	outcome	NNS
cord-005453-4057qib7	3440	14	were	be	VBD
cord-005453-4057qib7	3440	15	assessed	assess	VBN
cord-005453-4057qib7	3440	16	.	.	.
cord-005453-4057qib7	3441	1	Methods	method	NNS
cord-005453-4057qib7	3441	2	:	:	:
cord-005453-4057qib7	3441	3	OM	OM	NNP
cord-005453-4057qib7	3441	4	was	be	VBD
cord-005453-4057qib7	3441	5	prospectively	prospectively	RB
cord-005453-4057qib7	3441	6	evaluated	evaluate	VBN
cord-005453-4057qib7	3441	7	on	on	IN
cord-005453-4057qib7	3441	8	a	a	DT
cord-005453-4057qib7	3441	9	weekly	weekly	JJ
cord-005453-4057qib7	3441	10	basis	basis	NN
cord-005453-4057qib7	3441	11	in	in	IN
cord-005453-4057qib7	3441	12	patients	patient	NNS
cord-005453-4057qib7	3441	13	undergoing	undergo	VBG
cord-005453-4057qib7	3441	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	3441	15	HSCT	HSCT	NNP
cord-005453-4057qib7	3441	16	.	.	.
cord-005453-4057qib7	3442	1	The	the	DT
cord-005453-4057qib7	3442	2	grade	grade	NN
cord-005453-4057qib7	3442	3	of	of	IN
cord-005453-4057qib7	3442	4	OM	OM	NNP
cord-005453-4057qib7	3442	5	was	be	VBD
cord-005453-4057qib7	3442	6	determined	determine	VBN
cord-005453-4057qib7	3442	7	based	base	VBN
cord-005453-4057qib7	3442	8	on	on	IN
cord-005453-4057qib7	3442	9	the	the	DT
cord-005453-4057qib7	3442	10	National	National	NNP
cord-005453-4057qib7	3442	11	Cancer	Cancer	NNP
cord-005453-4057qib7	3442	12	Institute	Institute	NNP
cord-005453-4057qib7	3442	13	Common	Common	NNP
cord-005453-4057qib7	3442	14	Toxicity	toxicity	NN
cord-005453-4057qib7	3442	15	Criteria	criterion	NNS
cord-005453-4057qib7	3442	16	for	for	IN
cord-005453-4057qib7	3442	17	Adverse	adverse	JJ
cord-005453-4057qib7	3442	18	Events	event	NNS
cord-005453-4057qib7	3442	19	(	(	-LRB-
cord-005453-4057qib7	3442	20	CTCAE	CTCAE	NNP
cord-005453-4057qib7	3442	21	)	)	-RRB-
cord-005453-4057qib7	3442	22	scale	scale	NN
cord-005453-4057qib7	3442	23	(	(	-LRB-
cord-005453-4057qib7	3442	24	v.	v.	IN
cord-005453-4057qib7	3442	25	4.0	4.0	CD
cord-005453-4057qib7	3442	26	)	)	-RRB-
cord-005453-4057qib7	3442	27	.	.	.
cord-005453-4057qib7	3443	1	Severe	severe	JJ
cord-005453-4057qib7	3443	2	OM	om	NN
cord-005453-4057qib7	3443	3	was	be	VBD
cord-005453-4057qib7	3443	4	defined	define	VBN
cord-005453-4057qib7	3443	5	as	as	IN
cord-005453-4057qib7	3443	6	grade	grade	NN
cord-005453-4057qib7	3443	7	II	II	NNP
cord-005453-4057qib7	3443	8	to	to	IN
cord-005453-4057qib7	3443	9	IV	IV	NNP
cord-005453-4057qib7	3443	10	.	.	.
cord-005453-4057qib7	3444	1	Conditioning	conditioning	NN
cord-005453-4057qib7	3444	2	regimens	regimen	NNS
cord-005453-4057qib7	3444	3	were	be	VBD
cord-005453-4057qib7	3444	4	evaluated	evaluate	VBN
cord-005453-4057qib7	3444	5	individually	individually	RB
cord-005453-4057qib7	3444	6	and	and	CC
cord-005453-4057qib7	3444	7	according	accord	VBG
cord-005453-4057qib7	3444	8	to	to	IN
cord-005453-4057qib7	3444	9	intensity	intensity	NN
cord-005453-4057qib7	3444	10	;	;	:
cord-005453-4057qib7	3444	11	myeloablative	myeloablative	NNP
cord-005453-4057qib7	3444	12	(	(	-LRB-
cord-005453-4057qib7	3444	13	MAC	MAC	NNP
cord-005453-4057qib7	3444	14	)	)	-RRB-
cord-005453-4057qib7	3444	15	,	,	,
cord-005453-4057qib7	3444	16	reduced	reduce	VBN
cord-005453-4057qib7	3444	17	intensity	intensity	NN
cord-005453-4057qib7	3444	18	(	(	-LRB-
cord-005453-4057qib7	3444	19	RIC	RIC	NNP
cord-005453-4057qib7	3444	20	)	)	-RRB-
cord-005453-4057qib7	3444	21	or	or	CC
cord-005453-4057qib7	3444	22	reduced	reduce	VBN
cord-005453-4057qib7	3444	23	toxicity	toxicity	NN
cord-005453-4057qib7	3444	24	(	(	-LRB-
cord-005453-4057qib7	3444	25	RTC	RTC	NNP
cord-005453-4057qib7	3444	26	)	)	-RRB-
cord-005453-4057qib7	3444	27	.	.	.
cord-005453-4057qib7	3445	1	The	the	DT
cord-005453-4057qib7	3445	2	latter	latter	JJ
cord-005453-4057qib7	3445	3	category	category	NN
cord-005453-4057qib7	3445	4	included	include	VBD
cord-005453-4057qib7	3445	5	only	only	RB
cord-005453-4057qib7	3445	6	patients	patient	NNS
cord-005453-4057qib7	3445	7	receiving	receive	VBG
cord-005453-4057qib7	3445	8	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	3445	9	and	and	CC
cord-005453-4057qib7	3445	10	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	3445	11	at	at	IN
cord-005453-4057qib7	3445	12	dose	dose	NN
cord-005453-4057qib7	3445	13	of	of	IN
cord-005453-4057qib7	3445	14	30	30	CD
cord-005453-4057qib7	3445	15	-	-	SYM
cord-005453-4057qib7	3445	16	42	42	CD
cord-005453-4057qib7	3445	17	g	g	NN
cord-005453-4057qib7	3445	18	/	/	SYM
cord-005453-4057qib7	3445	19	m2	m2	NNP
cord-005453-4057qib7	3445	20	(	(	-LRB-
cord-005453-4057qib7	3445	21	Flu	Flu	NNP
cord-005453-4057qib7	3445	22	/	/	SYM
cord-005453-4057qib7	3445	23	Treo	Treo	NNP
cord-005453-4057qib7	3445	24	)	)	-RRB-
cord-005453-4057qib7	3445	25	.	.	.
cord-005453-4057qib7	3446	1	Risk	risk	NN
cord-005453-4057qib7	3446	2	factors	factor	NNS
cord-005453-4057qib7	3446	3	for	for	IN
cord-005453-4057qib7	3446	4	the	the	DT
cord-005453-4057qib7	3446	5	development	development	NN
cord-005453-4057qib7	3446	6	of	of	IN
cord-005453-4057qib7	3446	7	severe	severe	JJ
cord-005453-4057qib7	3446	8	OM	om	NN
cord-005453-4057qib7	3446	9	were	be	VBD
cord-005453-4057qib7	3446	10	initially	initially	RB
cord-005453-4057qib7	3446	11	identified	identify	VBN
cord-005453-4057qib7	3446	12	by	by	IN
cord-005453-4057qib7	3446	13	a	a	DT
cord-005453-4057qib7	3446	14	univariate	univariate	JJ
cord-005453-4057qib7	3446	15	analysis	analysis	NN
cord-005453-4057qib7	3446	16	and	and	CC
cord-005453-4057qib7	3446	17	then	then	RB
cord-005453-4057qib7	3446	18	analyzed	analyze	VBD
cord-005453-4057qib7	3446	19	in	in	IN
cord-005453-4057qib7	3446	20	a	a	DT
cord-005453-4057qib7	3446	21	multivariate	multivariate	JJ
cord-005453-4057qib7	3446	22	logistic	logistic	JJ
cord-005453-4057qib7	3446	23	regression	regression	NN
cord-005453-4057qib7	3446	24	model	model	NN
cord-005453-4057qib7	3446	25	.	.	.
cord-005453-4057qib7	3447	1	Association	Association	NNP
cord-005453-4057qib7	3447	2	of	of	IN
cord-005453-4057qib7	3447	3	OM	OM	NNP
cord-005453-4057qib7	3447	4	with	with	IN
cord-005453-4057qib7	3447	5	peritransplant	peritransplant	JJ
cord-005453-4057qib7	3447	6	infectious	infectious	JJ
cord-005453-4057qib7	3447	7	complications	complication	NNS
cord-005453-4057qib7	3447	8	,	,	,
cord-005453-4057qib7	3447	9	IV	IV	NNP
cord-005453-4057qib7	3447	10	morphine	morphine	NN
cord-005453-4057qib7	3447	11	consumption	consumption	NN
cord-005453-4057qib7	3447	12	,	,	,
cord-005453-4057qib7	3447	13	hospitalization	hospitalization	NN
cord-005453-4057qib7	3447	14	length	length	NN
cord-005453-4057qib7	3447	15	,	,	,
cord-005453-4057qib7	3447	16	neutrophil	neutrophil	NN
cord-005453-4057qib7	3447	17	engraftment	engraftment	NN
cord-005453-4057qib7	3447	18	,	,	,
cord-005453-4057qib7	3447	19	acute	acute	JJ
cord-005453-4057qib7	3447	20	and	and	CC
cord-005453-4057qib7	3447	21	chronic	chronic	JJ
cord-005453-4057qib7	3447	22	graft	graft	NN
cord-005453-4057qib7	3447	23	-	-	HYPH
cord-005453-4057qib7	3447	24	versus	versus	IN
cord-005453-4057qib7	3447	25	-	-	HYPH
cord-005453-4057qib7	3447	26	host	host	NN
cord-005453-4057qib7	3447	27	disease	disease	NN
cord-005453-4057qib7	3447	28	(	(	-LRB-
cord-005453-4057qib7	3447	29	GVHD	GVHD	NNP
cord-005453-4057qib7	3447	30	)	)	-RRB-
cord-005453-4057qib7	3447	31	,	,	,
cord-005453-4057qib7	3447	32	non	non	JJ
cord-005453-4057qib7	3447	33	-	-	JJ
cord-005453-4057qib7	3447	34	relapse	relapse	JJ
cord-005453-4057qib7	3447	35	mortality	mortality	NN
cord-005453-4057qib7	3447	36	(	(	-LRB-
cord-005453-4057qib7	3447	37	NRM	NRM	NNP
cord-005453-4057qib7	3447	38	)	)	-RRB-
cord-005453-4057qib7	3447	39	and	and	CC
cord-005453-4057qib7	3447	40	overall	overall	JJ
cord-005453-4057qib7	3447	41	survival	survival	NN
cord-005453-4057qib7	3447	42	were	be	VBD
cord-005453-4057qib7	3447	43	assessed	assess	VBN
cord-005453-4057qib7	3447	44	in	in	IN
cord-005453-4057qib7	3447	45	a	a	DT
cord-005453-4057qib7	3447	46	univariate	univariate	JJ
cord-005453-4057qib7	3447	47	analysis	analysis	NN
cord-005453-4057qib7	3447	48	.	.	.
cord-005453-4057qib7	3448	1	Competing	compete	VBG
cord-005453-4057qib7	3448	2	events	event	NNS
cord-005453-4057qib7	3448	3	were	be	VBD
cord-005453-4057qib7	3448	4	considered	consider	VBN
cord-005453-4057qib7	3448	5	in	in	IN
cord-005453-4057qib7	3448	6	analyzing	analyze	VBG
cord-005453-4057qib7	3448	7	engraftment	engraftment	NN
cord-005453-4057qib7	3448	8	,	,	,
cord-005453-4057qib7	3448	9	GVHD	GVHD	NNP
cord-005453-4057qib7	3448	10	,	,	,
cord-005453-4057qib7	3448	11	and	and	CC
cord-005453-4057qib7	3448	12	NRM	NRM	NNP
cord-005453-4057qib7	3448	13	.	.	.
cord-005453-4057qib7	3449	1	Results	result	NNS
cord-005453-4057qib7	3449	2	:	:	:
cord-005453-4057qib7	3449	3	115	115	CD
cord-005453-4057qib7	3449	4	patients	patient	NNS
cord-005453-4057qib7	3449	5	who	who	WP
cord-005453-4057qib7	3449	6	underwent	undergo	VBD
cord-005453-4057qib7	3449	7	an	an	DT
cord-005453-4057qib7	3449	8	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3449	9	SCT	SCT	NNP
cord-005453-4057qib7	3449	10	between	between	IN
cord-005453-4057qib7	3449	11	2016	2016	CD
cord-005453-4057qib7	3449	12	and	and	CC
cord-005453-4057qib7	3449	13	2017	2017	CD
cord-005453-4057qib7	3449	14	were	be	VBD
cord-005453-4057qib7	3449	15	included	include	VBN
cord-005453-4057qib7	3449	16	.	.	.
cord-005453-4057qib7	3450	1	Median	median	JJ
cord-005453-4057qib7	3450	2	follow	follow	NN
cord-005453-4057qib7	3450	3	-	-	HYPH
cord-005453-4057qib7	3450	4	up	up	NN
cord-005453-4057qib7	3450	5	was	be	VBD
cord-005453-4057qib7	3450	6	316	316	CD
cord-005453-4057qib7	3450	7	days	day	NNS
cord-005453-4057qib7	3450	8	.	.	.
cord-005453-4057qib7	3451	1	Leading	lead	VBG
cord-005453-4057qib7	3451	2	indications	indication	NNS
cord-005453-4057qib7	3451	3	for	for	IN
cord-005453-4057qib7	3451	4	transplantation	transplantation	NN
cord-005453-4057qib7	3451	5	were	be	VBD
cord-005453-4057qib7	3451	6	acute	acute	JJ
cord-005453-4057qib7	3451	7	myeloid	myeloid	JJ
cord-005453-4057qib7	3451	8	leukemia	leukemia	NN
cord-005453-4057qib7	3451	9	(	(	-LRB-
cord-005453-4057qib7	3451	10	49	49	CD
cord-005453-4057qib7	3451	11	%	%	NN
cord-005453-4057qib7	3451	12	)	)	-RRB-
cord-005453-4057qib7	3451	13	,	,	,
cord-005453-4057qib7	3451	14	lymphoma	lymphoma	NN
cord-005453-4057qib7	3451	15	(	(	-LRB-
cord-005453-4057qib7	3451	16	16	16	CD
cord-005453-4057qib7	3451	17	%	%	NN
cord-005453-4057qib7	3451	18	)	)	-RRB-
cord-005453-4057qib7	3451	19	,	,	,
cord-005453-4057qib7	3451	20	and	and	CC
cord-005453-4057qib7	3451	21	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	3451	22	syndrome	syndrome	NN
cord-005453-4057qib7	3451	23	(	(	-LRB-
cord-005453-4057qib7	3451	24	15	15	CD
cord-005453-4057qib7	3451	25	%	%	NN
cord-005453-4057qib7	3451	26	)	)	-RRB-
cord-005453-4057qib7	3451	27	.	.	.
cord-005453-4057qib7	3452	1	The	the	DT
cord-005453-4057qib7	3452	2	majority	majority	NN
cord-005453-4057qib7	3452	3	of	of	IN
cord-005453-4057qib7	3452	4	patients	patient	NNS
cord-005453-4057qib7	3452	5	received	receive	VBD
cord-005453-4057qib7	3452	6	an	an	DT
cord-005453-4057qib7	3452	7	allograft	allograft	NN
cord-005453-4057qib7	3452	8	from	from	IN
cord-005453-4057qib7	3452	9	a	a	DT
cord-005453-4057qib7	3452	10	matched	match	VBN
cord-005453-4057qib7	3452	11	sibling	sibling	NN
cord-005453-4057qib7	3452	12	or	or	CC
cord-005453-4057qib7	3452	13	unrelated	unrelated	JJ
cord-005453-4057qib7	3452	14	donor	donor	NN
cord-005453-4057qib7	3452	15	(	(	-LRB-
cord-005453-4057qib7	3452	16	88	88	CD
cord-005453-4057qib7	3452	17	%	%	NN
cord-005453-4057qib7	3452	18	)	)	-RRB-
cord-005453-4057qib7	3452	19	and	and	CC
cord-005453-4057qib7	3452	20	methotrexate	methotrexate	NNP
cord-005453-4057qib7	3452	21	GVHD	GVHD	NNP
cord-005453-4057qib7	3452	22	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3452	23	(	(	-LRB-
cord-005453-4057qib7	3452	24	74	74	CD
cord-005453-4057qib7	3452	25	%	%	NN
cord-005453-4057qib7	3452	26	)	)	-RRB-
cord-005453-4057qib7	3452	27	.	.	.
cord-005453-4057qib7	3453	1	The	the	DT
cord-005453-4057qib7	3453	2	median	median	JJ
cord-005453-4057qib7	3453	3	time	time	NN
cord-005453-4057qib7	3453	4	to	to	IN
cord-005453-4057qib7	3453	5	OM	OM	NNP
cord-005453-4057qib7	3453	6	onset	onset	NN
cord-005453-4057qib7	3453	7	was	be	VBD
cord-005453-4057qib7	3453	8	7	7	CD
cord-005453-4057qib7	3453	9	(	(	-LRB-
cord-005453-4057qib7	3453	10	interquartile	interquartile	JJ
cord-005453-4057qib7	3453	11	range	range	NN
cord-005453-4057qib7	3453	12	[	[	-LRB-
cord-005453-4057qib7	3453	13	IQR	IQR	NNP
cord-005453-4057qib7	3453	14	]	]	-RRB-
cord-005453-4057qib7	3453	15	5	5	CD
cord-005453-4057qib7	3453	16	-	-	SYM
cord-005453-4057qib7	3453	17	9	9	CD
cord-005453-4057qib7	3453	18	)	)	-RRB-
cord-005453-4057qib7	3453	19	days	day	NNS
cord-005453-4057qib7	3453	20	.	.	.
cord-005453-4057qib7	3454	1	Prevalence	prevalence	NN
cord-005453-4057qib7	3454	2	of	of	IN
cord-005453-4057qib7	3454	3	grade	grade	NN
cord-005453-4057qib7	3454	4	II	II	NNP
cord-005453-4057qib7	3454	5	-	-	HYPH
cord-005453-4057qib7	3454	6	IV	IV	NNP
cord-005453-4057qib7	3454	7	OM	OM	NNP
cord-005453-4057qib7	3454	8	was	be	VBD
cord-005453-4057qib7	3454	9	60	60	CD
cord-005453-4057qib7	3454	10	%	%	NN
cord-005453-4057qib7	3454	11	.	.	.
cord-005453-4057qib7	3455	1	The	the	DT
cord-005453-4057qib7	3455	2	median	median	JJ
cord-005453-4057qib7	3455	3	duration	duration	NN
cord-005453-4057qib7	3455	4	OM	OM	NNP
cord-005453-4057qib7	3455	5	was	be	VBD
cord-005453-4057qib7	3455	6	10	10	CD
cord-005453-4057qib7	3455	7	[	[	-LRB-
cord-005453-4057qib7	3455	8	6	6	CD
cord-005453-4057qib7	3455	9	-	-	SYM
cord-005453-4057qib7	3455	10	13	13	CD
cord-005453-4057qib7	3455	11	]	]	-RRB-
cord-005453-4057qib7	3455	12	days	day	NNS
cord-005453-4057qib7	3455	13	,	,	,
cord-005453-4057qib7	3455	14	and	and	CC
cord-005453-4057qib7	3455	15	IV	IV	NNP
cord-005453-4057qib7	3455	16	morphine	morphine	NN
cord-005453-4057qib7	3455	17	was	be	VBD
cord-005453-4057qib7	3455	18	administrated	administrate	VBN
cord-005453-4057qib7	3455	19	for	for	IN
cord-005453-4057qib7	3455	20	a	a	DT
cord-005453-4057qib7	3455	21	median	median	NN
cord-005453-4057qib7	3455	22	of	of	IN
cord-005453-4057qib7	3455	23	5	5	CD
cord-005453-4057qib7	3455	24	[	[	-LRB-
cord-005453-4057qib7	3455	25	6	6	CD
cord-005453-4057qib7	3455	26	-	-	SYM
cord-005453-4057qib7	3455	27	12	12	CD
cord-005453-4057qib7	3455	28	]	]	-RRB-
cord-005453-4057qib7	3455	29	days	day	NNS
cord-005453-4057qib7	3455	30	for	for	IN
cord-005453-4057qib7	3455	31	patients	patient	NNS
cord-005453-4057qib7	3455	32	with	with	IN
cord-005453-4057qib7	3455	33	grades	grade	NNS
cord-005453-4057qib7	3455	34	III	III	NNP
cord-005453-4057qib7	3455	35	-	-	HYPH
cord-005453-4057qib7	3455	36	IV	IV	NNP
cord-005453-4057qib7	3455	37	OM	OM	NNP
cord-005453-4057qib7	3455	38	(	(	-LRB-
cord-005453-4057qib7	3455	39	45	45	CD
cord-005453-4057qib7	3455	40	%	%	NN
cord-005453-4057qib7	3455	41	)	)	-RRB-
cord-005453-4057qib7	3455	42	.	.	.
cord-005453-4057qib7	3456	1	In	in	IN
cord-005453-4057qib7	3456	2	a	a	DT
cord-005453-4057qib7	3456	3	univariate	univariate	JJ
cord-005453-4057qib7	3456	4	analysis	analysis	NN
cord-005453-4057qib7	3456	5	a	a	DT
cord-005453-4057qib7	3456	6	younger	young	JJR
cord-005453-4057qib7	3456	7	age	age	NN
cord-005453-4057qib7	3456	8	(	(	-LRB-
cord-005453-4057qib7	3456	9	p=0.023	p=0.023	NNS
cord-005453-4057qib7	3456	10	)	)	-RRB-
cord-005453-4057qib7	3456	11	,	,	,
cord-005453-4057qib7	3456	12	lower	low	JJR
cord-005453-4057qib7	3456	13	BMI	BMI	NNP
cord-005453-4057qib7	3456	14	(	(	-LRB-
cord-005453-4057qib7	3456	15	p=0.01	p=0.01	NNP
cord-005453-4057qib7	3456	16	)	)	-RRB-
cord-005453-4057qib7	3456	17	,	,	,
cord-005453-4057qib7	3456	18	recent	recent	JJ
cord-005453-4057qib7	3456	19	smoking	smoking	NN
cord-005453-4057qib7	3456	20	history	history	NN
cord-005453-4057qib7	3456	21	(	(	-LRB-
cord-005453-4057qib7	3456	22	p=0.08	p=0.08	NNP
cord-005453-4057qib7	3456	23	)	)	-RRB-
cord-005453-4057qib7	3456	24	,	,	,
cord-005453-4057qib7	3456	25	recent	recent	JJ
cord-005453-4057qib7	3456	26	antibiotics	antibiotic	NNS
cord-005453-4057qib7	3456	27	exposure	exposure	NN
cord-005453-4057qib7	3456	28	(	(	-LRB-
cord-005453-4057qib7	3456	29	p=0.018	p=0.018	NNP
cord-005453-4057qib7	3456	30	)	)	-RRB-
cord-005453-4057qib7	3456	31	,	,	,
cord-005453-4057qib7	3456	32	MAC	MAC	NNP
cord-005453-4057qib7	3456	33	(	(	-LRB-
cord-005453-4057qib7	3456	34	p	p	NN
cord-005453-4057qib7	3456	35	<	<	XX
cord-005453-4057qib7	3456	36	0.001	0.001	CD
cord-005453-4057qib7	3456	37	)	)	-RRB-
cord-005453-4057qib7	3456	38	,	,	,
cord-005453-4057qib7	3456	39	and	and	CC
cord-005453-4057qib7	3456	40	use	use	NN
cord-005453-4057qib7	3456	41	of	of	IN
cord-005453-4057qib7	3456	42	methotrexate	methotrexate	NNP
cord-005453-4057qib7	3456	43	(	(	-LRB-
cord-005453-4057qib7	3456	44	p=0.009	p=0.009	NN
cord-005453-4057qib7	3456	45	)	)	-RRB-
cord-005453-4057qib7	3456	46	were	be	VBD
cord-005453-4057qib7	3456	47	associated	associate	VBN
cord-005453-4057qib7	3456	48	with	with	IN
cord-005453-4057qib7	3456	49	an	an	DT
cord-005453-4057qib7	3456	50	increased	increase	VBN
cord-005453-4057qib7	3456	51	risk	risk	NN
cord-005453-4057qib7	3456	52	for	for	IN
cord-005453-4057qib7	3456	53	grade	grade	NN
cord-005453-4057qib7	3456	54	II	II	NNP
cord-005453-4057qib7	3456	55	-	-	HYPH
cord-005453-4057qib7	3456	56	IV	IV	NNP
cord-005453-4057qib7	3456	57	OM	om	NN
cord-005453-4057qib7	3456	58	.	.	.
cord-005453-4057qib7	3457	1	In	in	IN
cord-005453-4057qib7	3457	2	a	a	DT
cord-005453-4057qib7	3457	3	multivariable	multivariable	JJ
cord-005453-4057qib7	3457	4	model	model	NN
cord-005453-4057qib7	3457	5	the	the	DT
cord-005453-4057qib7	3457	6	risk	risk	NN
cord-005453-4057qib7	3457	7	for	for	IN
cord-005453-4057qib7	3457	8	grade	grade	NN
cord-005453-4057qib7	3457	9	II	II	NNP
cord-005453-4057qib7	3457	10	-	-	HYPH
cord-005453-4057qib7	3457	11	IV	IV	NNP
cord-005453-4057qib7	3457	12	OM	OM	NNP
cord-005453-4057qib7	3457	13	was	be	VBD
cord-005453-4057qib7	3457	14	lower	low	JJR
cord-005453-4057qib7	3457	15	with	with	IN
cord-005453-4057qib7	3457	16	RTC	RTC	NNP
cord-005453-4057qib7	3457	17	(	(	-LRB-
cord-005453-4057qib7	3457	18	i.e.	i.e.	FW
cord-005453-4057qib7	3457	19	,	,	,
cord-005453-4057qib7	3457	20	Flu	Flu	NNP
cord-005453-4057qib7	3457	21	/	/	SYM
cord-005453-4057qib7	3457	22	Treo	Treo	NNP
cord-005453-4057qib7	3457	23	)	)	-RRB-
cord-005453-4057qib7	3457	24	vs.	vs.	IN
cord-005453-4057qib7	3457	25	MAC	MAC	NNP
cord-005453-4057qib7	3457	26	(	(	-LRB-
cord-005453-4057qib7	3457	27	odds	odd	NNS
cord-005453-4057qib7	3457	28	ratio	ratio	NN
cord-005453-4057qib7	3457	29	[	[	-LRB-
cord-005453-4057qib7	3457	30	OR	or	CC
cord-005453-4057qib7	3457	31	]	]	-RRB-
cord-005453-4057qib7	3457	32	27.31	27.31	CD
cord-005453-4057qib7	3457	33	;	;	:
cord-005453-4057qib7	3457	34	p	p	NN
cord-005453-4057qib7	3457	35	<	<	XX
cord-005453-4057qib7	3457	36	0.001	0.001	CD
cord-005453-4057qib7	3457	37	)	)	-RRB-
cord-005453-4057qib7	3457	38	and	and	CC
cord-005453-4057qib7	3457	39	RTC	RTC	NNP
cord-005453-4057qib7	3457	40	vs	vs	IN
cord-005453-4057qib7	3457	41	RIC	RIC	NNP
cord-005453-4057qib7	3457	42	(	(	-LRB-
cord-005453-4057qib7	3457	43	OR	OR	NNP
cord-005453-4057qib7	3457	44	7.25	7.25	CD
cord-005453-4057qib7	3457	45	;	;	:
cord-005453-4057qib7	3457	46	p=0.001	p=0.001	NNP
cord-005453-4057qib7	3457	47	)	)	-RRB-
cord-005453-4057qib7	3457	48	,	,	,
cord-005453-4057qib7	3457	49	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	3457	50	mofetil	mofetil	NNP
cord-005453-4057qib7	3457	51	vs.	vs.	FW
cord-005453-4057qib7	3457	52	methotrexate	methotrexate	NNP
cord-005453-4057qib7	3457	53	(	(	-LRB-
cord-005453-4057qib7	3457	54	OR	or	CC
cord-005453-4057qib7	3457	55	3.43	3.43	CD
cord-005453-4057qib7	3457	56	;	;	:
cord-005453-4057qib7	3457	57	p=0.027	p=0.027	NNP
cord-005453-4057qib7	3457	58	)	)	-RRB-
cord-005453-4057qib7	3457	59	and	and	CC
cord-005453-4057qib7	3457	60	recent	recent	JJ
cord-005453-4057qib7	3457	61	smoking	smoking	NN
cord-005453-4057qib7	3457	62	(	(	-LRB-
cord-005453-4057qib7	3457	63	OR	OR	NNP
cord-005453-4057qib7	3457	64	4.7	4.7	CD
cord-005453-4057qib7	3457	65	;	;	:
cord-005453-4057qib7	3457	66	p=0.075	p=0.075	NNP
cord-005453-4057qib7	3457	67	)	)	-RRB-
cord-005453-4057qib7	3457	68	.	.	.
cord-005453-4057qib7	3458	1	Compared	compare	VBN
cord-005453-4057qib7	3458	2	to	to	IN
cord-005453-4057qib7	3458	3	lower	low	JJR
cord-005453-4057qib7	3458	4	grades	grade	NNS
cord-005453-4057qib7	3458	5	,	,	,
cord-005453-4057qib7	3458	6	grade	grade	NN
cord-005453-4057qib7	3458	7	II	II	NNP
cord-005453-4057qib7	3458	8	-	-	HYPH
cord-005453-4057qib7	3458	9	IV	IV	NNP
cord-005453-4057qib7	3458	10	OM	OM	NNP
cord-005453-4057qib7	3458	11	was	be	VBD
cord-005453-4057qib7	3458	12	associated	associate	VBN
cord-005453-4057qib7	3458	13	with	with	IN
cord-005453-4057qib7	3458	14	a	a	DT
cord-005453-4057qib7	3458	15	longer	long	JJR
cord-005453-4057qib7	3458	16	hospitalization	hospitalization	NN
cord-005453-4057qib7	3458	17	duration	duration	NN
cord-005453-4057qib7	3458	18	(	(	-LRB-
cord-005453-4057qib7	3458	19	median	median	JJ
cord-005453-4057qib7	3458	20	29	29	CD
cord-005453-4057qib7	3458	21	days	day	NNS
cord-005453-4057qib7	3458	22	vs.	vs.	IN
cord-005453-4057qib7	3458	23	27	27	CD
cord-005453-4057qib7	3458	24	days	day	NNS
cord-005453-4057qib7	3458	25	;	;	:
cord-005453-4057qib7	3458	26	p=0.006	p=0.006	NNS
cord-005453-4057qib7	3458	27	)	)	-RRB-
cord-005453-4057qib7	3458	28	,	,	,
cord-005453-4057qib7	3458	29	delayed	delay	VBN
cord-005453-4057qib7	3458	30	neutrophil	neutrophil	NN
cord-005453-4057qib7	3458	31	engraftment	engraftment	NN
cord-005453-4057qib7	3458	32	(	(	-LRB-
cord-005453-4057qib7	3458	33	median	median	NN
cord-005453-4057qib7	3458	34	14	14	CD
cord-005453-4057qib7	3458	35	vs.	vs.	NN
cord-005453-4057qib7	3458	36	12	12	CD
cord-005453-4057qib7	3458	37	days	day	NNS
cord-005453-4057qib7	3458	38	;	;	:
cord-005453-4057qib7	3458	39	p=-0.004	p=-0.004	NNP
cord-005453-4057qib7	3458	40	)	)	-RRB-
cord-005453-4057qib7	3458	41	,	,	,
cord-005453-4057qib7	3458	42	and	and	CC
cord-005453-4057qib7	3458	43	more	more	RBR
cord-005453-4057qib7	3458	44	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3458	45	related	relate	VBN
cord-005453-4057qib7	3458	46	infections	infection	NNS
cord-005453-4057qib7	3458	47	(	(	-LRB-
cord-005453-4057qib7	3458	48	10	10	CD
cord-005453-4057qib7	3458	49	%	%	NN
cord-005453-4057qib7	3458	50	vs.	vs.	CC
cord-005453-4057qib7	3458	51	0	0	CD
cord-005453-4057qib7	3458	52	%	%	NN
cord-005453-4057qib7	3458	53	;	;	:
cord-005453-4057qib7	3458	54	p=0.045	p=0.045	NNP
cord-005453-4057qib7	3458	55	)	)	-RRB-
cord-005453-4057qib7	3458	56	.	.	.
cord-005453-4057qib7	3459	1	Grade	Grade	NNP
cord-005453-4057qib7	3459	2	II	II	NNP
cord-005453-4057qib7	3459	3	-	-	HYPH
cord-005453-4057qib7	3459	4	IV	IV	NNP
cord-005453-4057qib7	3459	5	OM	OM	NNP
cord-005453-4057qib7	3459	6	was	be	VBD
cord-005453-4057qib7	3459	7	not	not	RB
cord-005453-4057qib7	3459	8	associated	associate	VBN
cord-005453-4057qib7	3459	9	with	with	IN
cord-005453-4057qib7	3459	10	increased	increase	VBN
cord-005453-4057qib7	3459	11	risk	risk	NN
cord-005453-4057qib7	3459	12	of	of	IN
cord-005453-4057qib7	3459	13	bloodstream	bloodstream	NN
cord-005453-4057qib7	3459	14	infections	infection	NNS
cord-005453-4057qib7	3459	15	,	,	,
cord-005453-4057qib7	3459	16	acute	acute	JJ
cord-005453-4057qib7	3459	17	or	or	CC
cord-005453-4057qib7	3459	18	chronic	chronic	JJ
cord-005453-4057qib7	3459	19	GVHD	GVHD	NNP
cord-005453-4057qib7	3459	20	,	,	,
cord-005453-4057qib7	3459	21	non	non	JJ
cord-005453-4057qib7	3459	22	-	-	JJ
cord-005453-4057qib7	3459	23	relapse	relapse	JJ
cord-005453-4057qib7	3459	24	mortality	mortality	NN
cord-005453-4057qib7	3459	25	,	,	,
cord-005453-4057qib7	3459	26	and	and	CC
cord-005453-4057qib7	3459	27	increased	increase	VBN
cord-005453-4057qib7	3459	28	mortality	mortality	NN
cord-005453-4057qib7	3459	29	.	.	.
cord-005453-4057qib7	3460	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3460	2	:	:	:
cord-005453-4057qib7	3461	1	Oral	oral	JJ
cord-005453-4057qib7	3461	2	mucositis	mucositis	NNP
cord-005453-4057qib7	3461	3	is	be	VBZ
cord-005453-4057qib7	3461	4	prevalent	prevalent	JJ
cord-005453-4057qib7	3461	5	among	among	IN
cord-005453-4057qib7	3461	6	allogeneic	allogeneic	NN
cord-005453-4057qib7	3461	7	-	-	HYPH
cord-005453-4057qib7	3461	8	SCT	SCT	NNP
cord-005453-4057qib7	3461	9	recipients	recipient	NNS
cord-005453-4057qib7	3461	10	.	.	.
cord-005453-4057qib7	3462	1	Importantly	importantly	RB
cord-005453-4057qib7	3462	2	,	,	,
cord-005453-4057qib7	3462	3	fludarabine	fludarabine	NN
cord-005453-4057qib7	3462	4	-	-	HYPH
cord-005453-4057qib7	3462	5	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3462	6	,	,	,
cord-005453-4057qib7	3462	7	which	which	WDT
cord-005453-4057qib7	3462	8	is	be	VBZ
cord-005453-4057qib7	3462	9	considered	consider	VBN
cord-005453-4057qib7	3462	10	a	a	DT
cord-005453-4057qib7	3462	11	myeloablative	myeloablative	NN
cord-005453-4057qib7	3462	12	is	be	VBZ
cord-005453-4057qib7	3462	13	associated	associate	VBN
cord-005453-4057qib7	3462	14	with	with	IN
cord-005453-4057qib7	3462	15	a	a	DT
cord-005453-4057qib7	3462	16	markedly	markedly	RB
cord-005453-4057qib7	3462	17	reduced	reduce	VBN
cord-005453-4057qib7	3462	18	risk	risk	NN
cord-005453-4057qib7	3462	19	for	for	IN
cord-005453-4057qib7	3462	20	OM	OM	NNP
cord-005453-4057qib7	3462	21	.	.	.
cord-005453-4057qib7	3463	1	Consequences	consequence	NNS
cord-005453-4057qib7	3463	2	of	of	IN
cord-005453-4057qib7	3463	3	OM	OM	NNP
cord-005453-4057qib7	3463	4	include	include	VBP
cord-005453-4057qib7	3463	5	prolongation	prolongation	NN
cord-005453-4057qib7	3463	6	of	of	IN
cord-005453-4057qib7	3463	7	hospitalization	hospitalization	NN
cord-005453-4057qib7	3463	8	,	,	,
cord-005453-4057qib7	3463	9	delay	delay	VBP
cord-005453-4057qib7	3463	10	in	in	IN
cord-005453-4057qib7	3463	11	neutrophil	neutrophil	NN
cord-005453-4057qib7	3463	12	engraftment	engraftment	NN
cord-005453-4057qib7	3463	13	,	,	,
cord-005453-4057qib7	3463	14	and	and	CC
cord-005453-4057qib7	3463	15	a	a	DT
cord-005453-4057qib7	3463	16	tendency	tendency	NN
cord-005453-4057qib7	3463	17	for	for	IN
cord-005453-4057qib7	3463	18	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3463	19	infections	infection	NNS
cord-005453-4057qib7	3463	20	,	,	,
cord-005453-4057qib7	3463	21	but	but	CC
cord-005453-4057qib7	3463	22	does	do	VBZ
cord-005453-4057qib7	3463	23	not	not	RB
cord-005453-4057qib7	3463	24	increase	increase	VB
cord-005453-4057qib7	3463	25	the	the	DT
cord-005453-4057qib7	3463	26	risk	risk	NN
cord-005453-4057qib7	3463	27	for	for	IN
cord-005453-4057qib7	3463	28	GVHD	GVHD	NNP
cord-005453-4057qib7	3463	29	and	and	CC
cord-005453-4057qib7	3463	30	mortality	mortality	NN
cord-005453-4057qib7	3463	31	.	.	.
cord-005453-4057qib7	3464	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3464	2	:	:	:
cord-005453-4057qib7	3464	3	Nothing	nothing	NN
cord-005453-4057qib7	3464	4	to	to	TO
cord-005453-4057qib7	3464	5	declare	declare	VB
cord-005453-4057qib7	3464	6	Background	background	NN
cord-005453-4057qib7	3464	7	:	:	:
cord-005453-4057qib7	3465	1	The	the	DT
cord-005453-4057qib7	3465	2	advent	advent	NN
cord-005453-4057qib7	3465	3	of	of	IN
cord-005453-4057qib7	3465	4	recent	recent	JJ
cord-005453-4057qib7	3465	5	diagnostic	diagnostic	JJ
cord-005453-4057qib7	3465	6	techniques	technique	NNS
cord-005453-4057qib7	3465	7	for	for	IN
cord-005453-4057qib7	3465	8	the	the	DT
cord-005453-4057qib7	3465	9	assessment	assessment	NN
cord-005453-4057qib7	3465	10	of	of	IN
cord-005453-4057qib7	3465	11	iron	iron	NN
cord-005453-4057qib7	3465	12	overload	overload	NN
cord-005453-4057qib7	3465	13	(	(	-LRB-
cord-005453-4057qib7	3465	14	T2	T2	NNP
cord-005453-4057qib7	3465	15	*	*	NFP
cord-005453-4057qib7	3465	16	-MRI	-MRI	NFP
cord-005453-4057qib7	3465	17	)	)	-RRB-
cord-005453-4057qib7	3465	18	and	and	CC
cord-005453-4057qib7	3465	19	their	-PRON-	PRP$
cord-005453-4057qib7	3465	20	systematic	systematic	JJ
cord-005453-4057qib7	3465	21	use	use	NN
cord-005453-4057qib7	3465	22	as	as	IN
cord-005453-4057qib7	3465	23	screening	screening	NN
cord-005453-4057qib7	3465	24	tools	tool	NNS
cord-005453-4057qib7	3465	25	in	in	IN
cord-005453-4057qib7	3465	26	the	the	DT
cord-005453-4057qib7	3465	27	setting	setting	NN
cord-005453-4057qib7	3465	28	of	of	IN
cord-005453-4057qib7	3465	29	secondary	secondary	JJ
cord-005453-4057qib7	3465	30	hemochromatosis	hemochromatosis	NN
cord-005453-4057qib7	3465	31	have	have	VBP
cord-005453-4057qib7	3465	32	led	lead	VBN
cord-005453-4057qib7	3465	33	to	to	IN
cord-005453-4057qib7	3465	34	an	an	DT
cord-005453-4057qib7	3465	35	increased	increase	VBN
cord-005453-4057qib7	3465	36	awareness	awareness	NN
cord-005453-4057qib7	3465	37	that	that	IN
cord-005453-4057qib7	3465	38	focal	focal	JJ
cord-005453-4057qib7	3465	39	nodular	nodular	JJ
cord-005453-4057qib7	3465	40	hyperplasia	hyperplasia	NN
cord-005453-4057qib7	3465	41	(	(	-LRB-
cord-005453-4057qib7	3465	42	FNH	FNH	NNP
cord-005453-4057qib7	3465	43	)	)	-RRB-
cord-005453-4057qib7	3465	44	represents	represent	VBZ
cord-005453-4057qib7	3465	45	a	a	DT
cord-005453-4057qib7	3465	46	possible	possible	JJ
cord-005453-4057qib7	3465	47	incidental	incidental	JJ
cord-005453-4057qib7	3465	48	finding	finding	NN
cord-005453-4057qib7	3465	49	after	after	IN
cord-005453-4057qib7	3465	50	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3465	51	stem	stem	NN
cord-005453-4057qib7	3465	52	cell	cell	NN
cord-005453-4057qib7	3465	53	transplantation	transplantation	NN
cord-005453-4057qib7	3465	54	(	(	-LRB-
cord-005453-4057qib7	3465	55	HSCT	HSCT	NNP
cord-005453-4057qib7	3465	56	)	)	-RRB-
cord-005453-4057qib7	3465	57	.	.	.
cord-005453-4057qib7	3466	1	Methods	method	NNS
cord-005453-4057qib7	3466	2	:	:	:
cord-005453-4057qib7	3466	3	Clinical	clinical	JJ
cord-005453-4057qib7	3466	4	and	and	CC
cord-005453-4057qib7	3466	5	radiological	radiological	JJ
cord-005453-4057qib7	3466	6	features	feature	NNS
cord-005453-4057qib7	3466	7	of	of	IN
cord-005453-4057qib7	3466	8	patients	patient	NNS
cord-005453-4057qib7	3466	9	undergoing	undergo	VBG
cord-005453-4057qib7	3466	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3466	11	in	in	IN
cord-005453-4057qib7	3466	12	a	a	DT
cord-005453-4057qib7	3466	13	single	single	JJ
cord-005453-4057qib7	3466	14	pediatric	pediatric	JJ
cord-005453-4057qib7	3466	15	institution	institution	NN
cord-005453-4057qib7	3466	16	have	have	VBP
cord-005453-4057qib7	3466	17	been	be	VBN
cord-005453-4057qib7	3466	18	retrospectively	retrospectively	RB
cord-005453-4057qib7	3466	19	reviewed	review	VBN
cord-005453-4057qib7	3466	20	for	for	IN
cord-005453-4057qib7	3466	21	FNH	FNH	NNP
cord-005453-4057qib7	3466	22	.	.	.
cord-005453-4057qib7	3467	1	In	in	IN
cord-005453-4057qib7	3467	2	order	order	NN
cord-005453-4057qib7	3467	3	to	to	TO
cord-005453-4057qib7	3467	4	provide	provide	VB
cord-005453-4057qib7	3467	5	an	an	DT
cord-005453-4057qib7	3467	6	estimate	estimate	NN
cord-005453-4057qib7	3467	7	of	of	IN
cord-005453-4057qib7	3467	8	the	the	DT
cord-005453-4057qib7	3467	9	prevalence	prevalence	NN
cord-005453-4057qib7	3467	10	of	of	IN
cord-005453-4057qib7	3467	11	FNH	FNH	NNP
cord-005453-4057qib7	3467	12	after	after	IN
cord-005453-4057qib7	3467	13	HSCT	HSCT	NNP
cord-005453-4057qib7	3467	14	,	,	,
cord-005453-4057qib7	3467	15	we	-PRON-	PRP
cord-005453-4057qib7	3467	16	analysed	analyse	VBD
cord-005453-4057qib7	3467	17	all	all	PDT
cord-005453-4057qib7	3467	18	the	the	DT
cord-005453-4057qib7	3467	19	T2	T2	NNP
cord-005453-4057qib7	3467	20	*	*	NFP
cord-005453-4057qib7	3467	21	-MRI	-mri	WDT
cord-005453-4057qib7	3467	22	scans	scan	NNS
cord-005453-4057qib7	3467	23	performed	perform	VBN
cord-005453-4057qib7	3467	24	during	during	IN
cord-005453-4057qib7	3467	25	the	the	DT
cord-005453-4057qib7	3467	26	last	last	JJ
cord-005453-4057qib7	3467	27	5	5	CD
cord-005453-4057qib7	3467	28	years	year	NNS
cord-005453-4057qib7	3467	29	in	in	IN
cord-005453-4057qib7	3467	30	our	-PRON-	PRP$
cord-005453-4057qib7	3467	31	Centre	Centre	NNP
cord-005453-4057qib7	3467	32	and	and	CC
cord-005453-4057qib7	3467	33	recorded	record	VBD
cord-005453-4057qib7	3467	34	the	the	DT
cord-005453-4057qib7	3467	35	number	number	NN
cord-005453-4057qib7	3467	36	of	of	IN
cord-005453-4057qib7	3467	37	patients	patient	NNS
cord-005453-4057qib7	3467	38	with	with	IN
cord-005453-4057qib7	3467	39	FNH	FNH	NNP
cord-005453-4057qib7	3467	40	(	(	-LRB-
cord-005453-4057qib7	3467	41	group	group	NN
cord-005453-4057qib7	3467	42	A	A	NNP
cord-005453-4057qib7	3467	43	)	)	-RRB-
cord-005453-4057qib7	3467	44	.	.	.
cord-005453-4057qib7	3468	1	In	in	IN
cord-005453-4057qib7	3468	2	addition	addition	NN
cord-005453-4057qib7	3468	3	,	,	,
cord-005453-4057qib7	3468	4	data	datum	NNS
cord-005453-4057qib7	3468	5	about	about	IN
cord-005453-4057qib7	3468	6	patients	patient	NNS
cord-005453-4057qib7	3468	7	incidentally	incidentally	RB
cord-005453-4057qib7	3468	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	3468	9	with	with	IN
cord-005453-4057qib7	3468	10	FNH	FNH	NNP
cord-005453-4057qib7	3468	11	at	at	IN
cord-005453-4057qib7	3468	12	abdominal	abdominal	JJ
cord-005453-4057qib7	3468	13	imaging	imaging	NN
cord-005453-4057qib7	3468	14	performed	perform	VBN
cord-005453-4057qib7	3468	15	for	for	IN
cord-005453-4057qib7	3468	16	different	different	JJ
cord-005453-4057qib7	3468	17	clinical	clinical	JJ
cord-005453-4057qib7	3468	18	indications	indication	NNS
cord-005453-4057qib7	3468	19	have	have	VBP
cord-005453-4057qib7	3468	20	been	be	VBN
cord-005453-4057qib7	3468	21	collected	collect	VBN
cord-005453-4057qib7	3468	22	(	(	-LRB-
cord-005453-4057qib7	3468	23	group	group	NN
cord-005453-4057qib7	3468	24	B	B	NNP
cord-005453-4057qib7	3468	25	)	)	-RRB-
cord-005453-4057qib7	3468	26	.	.	.
cord-005453-4057qib7	3469	1	Results	result	NNS
cord-005453-4057qib7	3469	2	:	:	:
cord-005453-4057qib7	3470	1	Eight	eight	CD
cord-005453-4057qib7	3470	2	out	out	IN
cord-005453-4057qib7	3470	3	of	of	IN
cord-005453-4057qib7	3470	4	118	118	CD
cord-005453-4057qib7	3470	5	(	(	-LRB-
cord-005453-4057qib7	3470	6	7	7	CD
cord-005453-4057qib7	3470	7	%	%	NN
cord-005453-4057qib7	3470	8	)	)	-RRB-
cord-005453-4057qib7	3470	9	transplanted	transplant	VBN
cord-005453-4057qib7	3470	10	patients	patient	NNS
cord-005453-4057qib7	3470	11	who	who	WP
cord-005453-4057qib7	3470	12	underwent	undergo	VBD
cord-005453-4057qib7	3470	13	at	at	RB
cord-005453-4057qib7	3470	14	least	least	RBS
cord-005453-4057qib7	3470	15	one	one	CD
cord-005453-4057qib7	3470	16	T2	t2	NN
cord-005453-4057qib7	3470	17	*	*	NFP
cord-005453-4057qib7	3470	18	-MRI	-MRI	-LRB-
cord-005453-4057qib7	3470	19	scan	scan	NN
cord-005453-4057qib7	3470	20	from	from	IN
cord-005453-4057qib7	3470	21	September	September	NNP
cord-005453-4057qib7	3470	22	2013	2013	CD
cord-005453-4057qib7	3470	23	to	to	IN
cord-005453-4057qib7	3470	24	September	September	NNP
cord-005453-4057qib7	3470	25	2018	2018	CD
cord-005453-4057qib7	3470	26	were	be	VBD
cord-005453-4057qib7	3470	27	incidentally	incidentally	RB
cord-005453-4057qib7	3470	28	diagnosed	diagnose	VBN
cord-005453-4057qib7	3470	29	with	with	IN
cord-005453-4057qib7	3470	30	FNH	FNH	NNP
cord-005453-4057qib7	3470	31	.	.	.
cord-005453-4057qib7	3471	1	Group	Group	NNP
cord-005453-4057qib7	3471	2	B	B	NNP
cord-005453-4057qib7	3471	3	included	include	VBD
cord-005453-4057qib7	3471	4	3	3	CD
cord-005453-4057qib7	3471	5	subjects	subject	NNS
cord-005453-4057qib7	3471	6	with	with	IN
cord-005453-4057qib7	3471	7	FNH	FNH	NNP
cord-005453-4057qib7	3471	8	incidentally	incidentally	RB
cord-005453-4057qib7	3471	9	found	find	VBD
cord-005453-4057qib7	3471	10	at	at	IN
cord-005453-4057qib7	3471	11	ultrasound	ultrasound	NN
cord-005453-4057qib7	3471	12	or	or	CC
cord-005453-4057qib7	3471	13	non	non	JJ
cord-005453-4057qib7	3471	14	-	-	JJ
cord-005453-4057qib7	3471	15	T2	t2	NN
cord-005453-4057qib7	3472	1	*	*	NFP
cord-005453-4057qib7	3472	2	MRI	MRI	NNP
cord-005453-4057qib7	3472	3	scans	scan	NNS
cord-005453-4057qib7	3472	4	performed	perform	VBN
cord-005453-4057qib7	3472	5	before	before	IN
cord-005453-4057qib7	3472	6	2013	2013	CD
cord-005453-4057qib7	3472	7	.	.	.
cord-005453-4057qib7	3473	1	Overall	overall	RB
cord-005453-4057qib7	3473	2	,	,	,
cord-005453-4057qib7	3473	3	11	11	CD
cord-005453-4057qib7	3473	4	transplanted	transplant	VBN
cord-005453-4057qib7	3473	5	patients	patient	NNS
cord-005453-4057qib7	3473	6	(	(	-LRB-
cord-005453-4057qib7	3473	7	5	5	CD
cord-005453-4057qib7	3473	8	males	male	NNS
cord-005453-4057qib7	3473	9	,	,	,
cord-005453-4057qib7	3473	10	45	45	CD
cord-005453-4057qib7	3473	11	%	%	NN
cord-005453-4057qib7	3473	12	)	)	-RRB-
cord-005453-4057qib7	3473	13	,	,	,
cord-005453-4057qib7	3473	14	transplanted	transplant	VBN
cord-005453-4057qib7	3473	15	for	for	IN
cord-005453-4057qib7	3473	16	AL	AL	NNP
cord-005453-4057qib7	3473	17	(	(	-LRB-
cord-005453-4057qib7	3473	18	9	9	CD
cord-005453-4057qib7	3473	19	cases	case	NNS
cord-005453-4057qib7	3473	20	)	)	-RRB-
cord-005453-4057qib7	3473	21	or	or	CC
cord-005453-4057qib7	3473	22	bone	bone	NN
cord-005453-4057qib7	3473	23	marrow	marrow	NN
cord-005453-4057qib7	3473	24	failure	failure	NN
cord-005453-4057qib7	3473	25	(	(	-LRB-
cord-005453-4057qib7	3473	26	2	2	CD
cord-005453-4057qib7	3473	27	cases	case	NNS
cord-005453-4057qib7	3473	28	)	)	-RRB-
cord-005453-4057qib7	3473	29	at	at	IN
cord-005453-4057qib7	3473	30	a	a	DT
cord-005453-4057qib7	3473	31	median	median	JJ
cord-005453-4057qib7	3473	32	age	age	NN
cord-005453-4057qib7	3473	33	of	of	IN
cord-005453-4057qib7	3473	34	13.1±3.6	13.1±3.6	CD
cord-005453-4057qib7	3473	35	years	year	NNS
cord-005453-4057qib7	3473	36	,	,	,
cord-005453-4057qib7	3473	37	were	be	VBD
cord-005453-4057qib7	3473	38	diagnosed	diagnose	VBN
cord-005453-4057qib7	3473	39	with	with	IN
cord-005453-4057qib7	3473	40	FNH	FNH	NNP
cord-005453-4057qib7	3473	41	between	between	IN
cord-005453-4057qib7	3473	42	0.6	0.6	CD
cord-005453-4057qib7	3473	43	and	and	CC
cord-005453-4057qib7	3473	44	12.8	12.8	CD
cord-005453-4057qib7	3473	45	years	year	NNS
cord-005453-4057qib7	3473	46	after	after	IN
cord-005453-4057qib7	3473	47	HSCT	HSCT	NNP
cord-005453-4057qib7	3473	48	,	,	,
cord-005453-4057qib7	3473	49	namely	namely	RB
cord-005453-4057qib7	3473	50	3.2±2.6	3.2±2.6	CD
cord-005453-4057qib7	3473	51	years	year	NNS
cord-005453-4057qib7	3473	52	in	in	IN
cord-005453-4057qib7	3473	53	Group	Group	NNP
cord-005453-4057qib7	3473	54	A	A	NNP
cord-005453-4057qib7	3473	55	and	and	CC
cord-005453-4057qib7	3473	56	7.0±4.1	7.0±4.1	CD
cord-005453-4057qib7	3473	57	years	year	NNS
cord-005453-4057qib7	3473	58	in	in	IN
cord-005453-4057qib7	3473	59	Group	Group	NNP
cord-005453-4057qib7	3473	60	B.	B.	NNP
cord-005453-4057qib7	3473	61	A	A	NNP
cord-005453-4057qib7	3474	1	variable	variable	JJ
cord-005453-4057qib7	3474	2	degree	degree	NN
cord-005453-4057qib7	3474	3	of	of	IN
cord-005453-4057qib7	3474	4	iron	iron	NN
cord-005453-4057qib7	3474	5	overload	overload	NN
cord-005453-4057qib7	3474	6	was	be	VBD
cord-005453-4057qib7	3474	7	demonstrated	demonstrate	VBN
cord-005453-4057qib7	3474	8	in	in	IN
cord-005453-4057qib7	3474	9	all	all	DT
cord-005453-4057qib7	3474	10	patient	patient	JJ
cord-005453-4057qib7	3474	11	(	(	-LRB-
cord-005453-4057qib7	3474	12	LIC	LIC	NNP
cord-005453-4057qib7	3474	13	:	:	:
cord-005453-4057qib7	3474	14	230	230	CD
cord-005453-4057qib7	3474	15	-	-	HYPH
cord-005453-4057qib7	3474	16	340±50	340±50	CD
cord-005453-4057qib7	3474	17	microg	microg	NNP
cord-005453-4057qib7	3474	18	/	/	SYM
cord-005453-4057qib7	3474	19	g	g	NN
cord-005453-4057qib7	3474	20	;	;	:
cord-005453-4057qib7	3474	21	baseline	baseline	JJ
cord-005453-4057qib7	3474	22	serum	serum	NN
cord-005453-4057qib7	3474	23	ferritin	ferritin	NN
cord-005453-4057qib7	3474	24	:	:	:
cord-005453-4057qib7	3474	25	685	685	CD
cord-005453-4057qib7	3474	26	-	-	HYPH
cord-005453-4057qib7	3474	27	3189	3189	CD
cord-005453-4057qib7	3474	28	ng	ng	NNP
cord-005453-4057qib7	3474	29	/	/	SYM
cord-005453-4057qib7	3474	30	mL	mL	NNP
cord-005453-4057qib7	3474	31	)	)	-RRB-
cord-005453-4057qib7	3474	32	.	.	.
cord-005453-4057qib7	3475	1	The	the	DT
cord-005453-4057qib7	3475	2	potential	potential	JJ
cord-005453-4057qib7	3475	3	risk	risk	NN
cord-005453-4057qib7	3475	4	factors	factor	NNS
cord-005453-4057qib7	3475	5	for	for	IN
cord-005453-4057qib7	3475	6	FNH	FNH	NNP
cord-005453-4057qib7	3475	7	are	be	VBP
cord-005453-4057qib7	3475	8	reported	report	VBN
cord-005453-4057qib7	3475	9	in	in	IN
cord-005453-4057qib7	3475	10	table	table	NN
cord-005453-4057qib7	3475	11	1	1	CD
cord-005453-4057qib7	3475	12	.	.	.
cord-005453-4057qib7	3476	1	In	in	IN
cord-005453-4057qib7	3476	2	8/11	8/11	CD
cord-005453-4057qib7	3476	3	patients	patient	NNS
cord-005453-4057qib7	3476	4	,	,	,
cord-005453-4057qib7	3476	5	the	the	DT
cord-005453-4057qib7	3476	6	radiological	radiological	JJ
cord-005453-4057qib7	3476	7	finding	finding	NN
cord-005453-4057qib7	3476	8	was	be	VBD
cord-005453-4057qib7	3476	9	pathognomonic	pathognomonic	JJ
cord-005453-4057qib7	3476	10	;	;	:
cord-005453-4057qib7	3476	11	in	in	IN
cord-005453-4057qib7	3476	12	1/11	1/11	CD
cord-005453-4057qib7	3476	13	the	the	DT
cord-005453-4057qib7	3476	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	3476	15	of	of	IN
cord-005453-4057qib7	3476	16	FNH	FNH	NNP
cord-005453-4057qib7	3476	17	was	be	VBD
cord-005453-4057qib7	3476	18	confirmed	confirm	VBN
cord-005453-4057qib7	3476	19	histologically	histologically	RB
cord-005453-4057qib7	3476	20	,	,	,
cord-005453-4057qib7	3476	21	while	while	IN
cord-005453-4057qib7	3476	22	2/11	2/11	CD
cord-005453-4057qib7	3476	23	subjects	subject	NNS
cord-005453-4057qib7	3476	24	were	be	VBD
cord-005453-4057qib7	3476	25	labelled	label	VBN
cord-005453-4057qib7	3476	26	as	as	IN
cord-005453-4057qib7	3476	27	"	"	``
cord-005453-4057qib7	3476	28	FNHlike	fnhlike	JJ
cord-005453-4057qib7	3476	29	"	"	''
cord-005453-4057qib7	3476	30	,	,	,
cord-005453-4057qib7	3476	31	although	although	IN
cord-005453-4057qib7	3476	32	a	a	DT
cord-005453-4057qib7	3476	33	potential	potential	JJ
cord-005453-4057qib7	3476	34	diagnosis	diagnosis	NN
cord-005453-4057qib7	3476	35	of	of	IN
cord-005453-4057qib7	3476	36	hepatic	hepatic	JJ
cord-005453-4057qib7	3476	37	adenoma	adenoma	NN
cord-005453-4057qib7	3476	38	could	could	MD
cord-005453-4057qib7	3476	39	not	not	RB
cord-005453-4057qib7	3476	40	be	be	VB
cord-005453-4057qib7	3476	41	ruled	rule	VBN
cord-005453-4057qib7	3476	42	out	out	RP
cord-005453-4057qib7	3476	43	.	.	.
cord-005453-4057qib7	3477	1	In	in	IN
cord-005453-4057qib7	3477	2	3/11	3/11	CD
cord-005453-4057qib7	3477	3	patients	patient	NNS
cord-005453-4057qib7	3477	4	,	,	,
cord-005453-4057qib7	3477	5	FNH	FNH	NNP
cord-005453-4057qib7	3477	6	presented	present	VBD
cord-005453-4057qib7	3477	7	with	with	IN
cord-005453-4057qib7	3477	8	an	an	DT
cord-005453-4057qib7	3477	9	isolated	isolated	JJ
cord-005453-4057qib7	3477	10	lesion	lesion	NN
cord-005453-4057qib7	3477	11	,	,	,
cord-005453-4057qib7	3477	12	while	while	IN
cord-005453-4057qib7	3477	13	8/11	8/11	CD
cord-005453-4057qib7	3477	14	had	have	VBD
cord-005453-4057qib7	3477	15	2	2	CD
cord-005453-4057qib7	3477	16	to	to	IN
cord-005453-4057qib7	3477	17	more	more	JJR
cord-005453-4057qib7	3477	18	than	than	IN
cord-005453-4057qib7	3477	19	10	10	CD
cord-005453-4057qib7	3477	20	hepatic	hepatic	JJ
cord-005453-4057qib7	3477	21	nodules	nodule	NNS
cord-005453-4057qib7	3477	22	at	at	IN
cord-005453-4057qib7	3477	23	diagnosis	diagnosis	NN
cord-005453-4057qib7	3477	24	.	.	.
cord-005453-4057qib7	3478	1	The	the	DT
cord-005453-4057qib7	3478	2	size	size	NN
cord-005453-4057qib7	3478	3	of	of	IN
cord-005453-4057qib7	3478	4	nodules	nodule	NNS
cord-005453-4057qib7	3478	5	at	at	IN
cord-005453-4057qib7	3478	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	3478	7	ranged	range	VBD
cord-005453-4057qib7	3478	8	from	from	IN
cord-005453-4057qib7	3478	9	3	3	CD
cord-005453-4057qib7	3478	10	to	to	IN
cord-005453-4057qib7	3478	11	41	41	CD
cord-005453-4057qib7	3478	12	mm	mm	NNS
cord-005453-4057qib7	3478	13	.	.	.
cord-005453-4057qib7	3479	1	In	in	IN
cord-005453-4057qib7	3479	2	unenhanced	unenhanced	JJ
cord-005453-4057qib7	3479	3	MRI	MRI	NNP
cord-005453-4057qib7	3479	4	scans	scan	NNS
cord-005453-4057qib7	3479	5	,	,	,
cord-005453-4057qib7	3479	6	lesions	lesion	NNS
cord-005453-4057qib7	3479	7	were	be	VBD
cord-005453-4057qib7	3479	8	predominantly	predominantly	RB
cord-005453-4057qib7	3479	9	hyperintense	hyperintense	NN
cord-005453-4057qib7	3479	10	on	on	IN
cord-005453-4057qib7	3479	11	both	both	CC
cord-005453-4057qib7	3479	12	T1-and	t1-and	XX
cord-005453-4057qib7	3479	13	T2weighted	t2weighted	JJ
cord-005453-4057qib7	3479	14	sequences	sequence	NNS
cord-005453-4057qib7	3479	15	.	.	.
cord-005453-4057qib7	3480	1	In	in	IN
cord-005453-4057qib7	3480	2	dynamic	dynamic	JJ
cord-005453-4057qib7	3480	3	studies	study	NNS
cord-005453-4057qib7	3480	4	with	with	IN
cord-005453-4057qib7	3480	5	contrast	contrast	NN
cord-005453-4057qib7	3480	6	medium	medium	NN
cord-005453-4057qib7	3480	7	,	,	,
cord-005453-4057qib7	3480	8	all	all	DT
cord-005453-4057qib7	3480	9	lesions	lesion	NNS
cord-005453-4057qib7	3480	10	strongly	strongly	RB
cord-005453-4057qib7	3480	11	enhanced	enhance	VBD
cord-005453-4057qib7	3480	12	during	during	IN
cord-005453-4057qib7	3480	13	the	the	DT
cord-005453-4057qib7	3480	14	arterial	arterial	JJ
cord-005453-4057qib7	3480	15	phase	phase	NN
cord-005453-4057qib7	3480	16	,	,	,
cord-005453-4057qib7	3480	17	with	with	IN
cord-005453-4057qib7	3480	18	a	a	DT
cord-005453-4057qib7	3480	19	variable	variable	JJ
cord-005453-4057qib7	3480	20	degree	degree	NN
cord-005453-4057qib7	3480	21	of	of	IN
cord-005453-4057qib7	3480	22	wash	wash	NN
cord-005453-4057qib7	3480	23	-	-	HYPH
cord-005453-4057qib7	3480	24	out	out	NN
cord-005453-4057qib7	3480	25	in	in	IN
cord-005453-4057qib7	3480	26	the	the	DT
cord-005453-4057qib7	3480	27	late	late	JJ
cord-005453-4057qib7	3480	28	venous	venous	JJ
cord-005453-4057qib7	3480	29	scans	scan	NNS
cord-005453-4057qib7	3480	30	.	.	.
cord-005453-4057qib7	3481	1	Hepatic	hepatic	JJ
cord-005453-4057qib7	3481	2	function	function	NN
cord-005453-4057qib7	3481	3	tests	test	NNS
cord-005453-4057qib7	3481	4	were	be	VBD
cord-005453-4057qib7	3481	5	normal	normal	JJ
cord-005453-4057qib7	3481	6	in	in	IN
cord-005453-4057qib7	3481	7	all	all	PDT
cord-005453-4057qib7	3481	8	the	the	DT
cord-005453-4057qib7	3481	9	enrolled	enrol	VBN
cord-005453-4057qib7	3481	10	patients	patient	NNS
cord-005453-4057qib7	3481	11	at	at	IN
cord-005453-4057qib7	3481	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	3481	13	of	of	IN
cord-005453-4057qib7	3481	14	FNH	FNH	NNP
cord-005453-4057qib7	3481	15	.	.	.
cord-005453-4057qib7	3482	1	Among	among	IN
cord-005453-4057qib7	3482	2	the	the	DT
cord-005453-4057qib7	3482	3	9/11	9/11	CD
cord-005453-4057qib7	3482	4	patients	patient	NNS
cord-005453-4057qib7	3482	5	for	for	IN
cord-005453-4057qib7	3482	6	whom	whom	WP
cord-005453-4057qib7	3482	7	at	at	IN
cord-005453-4057qib7	3482	8	least	least	JJS
cord-005453-4057qib7	3482	9	a	a	DT
cord-005453-4057qib7	3482	10	follow	follow	NN
cord-005453-4057qib7	3482	11	-	-	HYPH
cord-005453-4057qib7	3482	12	up	up	NN
cord-005453-4057qib7	3482	13	scan	scan	NN
cord-005453-4057qib7	3482	14	was	be	VBD
cord-005453-4057qib7	3482	15	available	available	JJ
cord-005453-4057qib7	3482	16	,	,	,
cord-005453-4057qib7	3482	17	1	1	CD
cord-005453-4057qib7	3482	18	presented	present	VBD
cord-005453-4057qib7	3482	19	a	a	DT
cord-005453-4057qib7	3482	20	complete	complete	JJ
cord-005453-4057qib7	3482	21	regression	regression	NN
cord-005453-4057qib7	3482	22	,	,	,
cord-005453-4057qib7	3482	23	3	3	CD
cord-005453-4057qib7	3482	24	a	a	DT
cord-005453-4057qib7	3482	25	reduction	reduction	NN
cord-005453-4057qib7	3482	26	and	and	CC
cord-005453-4057qib7	3482	27	3	3	CD
cord-005453-4057qib7	3482	28	an	an	DT
cord-005453-4057qib7	3482	29	increase	increase	NN
cord-005453-4057qib7	3482	30	in	in	IN
cord-005453-4057qib7	3482	31	the	the	DT
cord-005453-4057qib7	3482	32	size	size	NN
cord-005453-4057qib7	3482	33	and/or	and/or	CC
cord-005453-4057qib7	3482	34	number	number	NN
cord-005453-4057qib7	3482	35	of	of	IN
cord-005453-4057qib7	3482	36	lesions	lesion	NNS
cord-005453-4057qib7	3482	37	,	,	,
cord-005453-4057qib7	3482	38	while	while	IN
cord-005453-4057qib7	3482	39	in	in	IN
cord-005453-4057qib7	3482	40	2	2	CD
cord-005453-4057qib7	3482	41	patients	patient	NNS
cord-005453-4057qib7	3482	42	the	the	DT
cord-005453-4057qib7	3482	43	nodules	nodule	NNS
cord-005453-4057qib7	3482	44	remained	remain	VBD
cord-005453-4057qib7	3482	45	substantially	substantially	RB
cord-005453-4057qib7	3482	46	unchanged	unchanged	JJ
cord-005453-4057qib7	3482	47	after	after	IN
cord-005453-4057qib7	3482	48	a	a	DT
cord-005453-4057qib7	3482	49	mean	mean	JJ
cord-005453-4057qib7	3482	50	radiological	radiological	JJ
cord-005453-4057qib7	3482	51	follow	follow	NN
cord-005453-4057qib7	3482	52	-	-	HYPH
cord-005453-4057qib7	3482	53	up	up	NN
cord-005453-4057qib7	3482	54	of	of	IN
cord-005453-4057qib7	3482	55	4.5±3.3	4.5±3.3	CD
cord-005453-4057qib7	3482	56	years	year	NNS
cord-005453-4057qib7	3482	57	.	.	.
cord-005453-4057qib7	3483	1	No	no	DT
cord-005453-4057qib7	3483	2	malignant	malignant	JJ
cord-005453-4057qib7	3483	3	transformations	transformation	NNS
cord-005453-4057qib7	3483	4	were	be	VBD
cord-005453-4057qib7	3483	5	observed	observe	VBN
cord-005453-4057qib7	3483	6	.	.	.
cord-005453-4057qib7	3484	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3484	2	:	:	:
cord-005453-4057qib7	3485	1	FNH	FNH	NNP
cord-005453-4057qib7	3485	2	represents	represent	VBZ
cord-005453-4057qib7	3485	3	a	a	DT
cord-005453-4057qib7	3485	4	relatively	relatively	RB
cord-005453-4057qib7	3485	5	frequent	frequent	JJ
cord-005453-4057qib7	3485	6	incidental	incidental	JJ
cord-005453-4057qib7	3485	7	finding	finding	NN
cord-005453-4057qib7	3485	8	after	after	IN
cord-005453-4057qib7	3485	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3485	10	.	.	.
cord-005453-4057qib7	3486	1	Although	although	IN
cord-005453-4057qib7	3486	2	a	a	DT
cord-005453-4057qib7	3486	3	malignant	malignant	JJ
cord-005453-4057qib7	3486	4	transformation	transformation	NN
cord-005453-4057qib7	3486	5	is	be	VBZ
cord-005453-4057qib7	3486	6	rare	rare	JJ
cord-005453-4057qib7	3486	7	,	,	,
cord-005453-4057qib7	3486	8	given	give	VBN
cord-005453-4057qib7	3486	9	the	the	DT
cord-005453-4057qib7	3486	10	demonstrated	demonstrate	VBN
cord-005453-4057qib7	3486	11	variable	variable	JJ
cord-005453-4057qib7	3486	12	evolution	evolution	NN
cord-005453-4057qib7	3486	13	of	of	IN
cord-005453-4057qib7	3486	14	the	the	DT
cord-005453-4057qib7	3486	15	hepatic	hepatic	JJ
cord-005453-4057qib7	3486	16	nodules	nodule	NNS
cord-005453-4057qib7	3486	17	,	,	,
cord-005453-4057qib7	3486	18	a	a	DT
cord-005453-4057qib7	3486	19	radiological	radiological	JJ
cord-005453-4057qib7	3486	20	follow	follow	NN
cord-005453-4057qib7	3486	21	-	-	HYPH
cord-005453-4057qib7	3486	22	up	up	NN
cord-005453-4057qib7	3486	23	is	be	VBZ
cord-005453-4057qib7	3486	24	highly	highly	RB
cord-005453-4057qib7	3486	25	recommended	recommend	VBN
cord-005453-4057qib7	3486	26	.	.	.
cord-005453-4057qib7	3487	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3487	2	:	:	:
cord-005453-4057qib7	3487	3	Nothing	nothing	NN
cord-005453-4057qib7	3487	4	to	to	TO
cord-005453-4057qib7	3487	5	disclose	disclose	VB
cord-005453-4057qib7	3487	6	.	.	.
cord-005453-4057qib7	3488	1	Incidence	incidence	NN
cord-005453-4057qib7	3488	2	and	and	CC
cord-005453-4057qib7	3488	3	risk	risk	NN
cord-005453-4057qib7	3488	4	factors	factor	NNS
cord-005453-4057qib7	3488	5	for	for	IN
cord-005453-4057qib7	3488	6	hepatic	hepatic	JJ
cord-005453-4057qib7	3488	7	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	3488	8	obstruction	obstruction	NN
cord-005453-4057qib7	3488	9	syndrome	syndrome	NN
cord-005453-4057qib7	3488	10	after	after	IN
cord-005453-4057qib7	3488	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	3488	12	transplantation	transplantation	NN
cord-005453-4057qib7	3488	13	:	:	:
cord-005453-4057qib7	3488	14	Retrospective	retrospective	JJ
cord-005453-4057qib7	3488	15	multicenter	multicenter	JJ
cord-005453-4057qib7	3488	16	study	study	NN
cord-005453-4057qib7	3488	17	of	of	IN
cord-005453-4057qib7	3488	18	Turkish	turkish	JJ
cord-005453-4057qib7	3488	19	hematology	hematology	NN
cord-005453-4057qib7	3488	20	research	research	NN
cord-005453-4057qib7	3488	21	and	and	CC
cord-005453-4057qib7	3488	22	education	education	NN
cord-005453-4057qib7	3488	23	group	group	NN
cord-005453-4057qib7	3488	24	(	(	-LRB-
cord-005453-4057qib7	3488	25	THREG	THREG	NNP
cord-005453-4057qib7	3488	26	)	)	-RRB-
cord-005453-4057qib7	3488	27	,	,	,
cord-005453-4057qib7	3488	28	updated	update	VBN
cord-005453-4057qib7	3488	29	data	datum	NNS
cord-005453-4057qib7	3488	30	Methods	method	NNS
cord-005453-4057qib7	3488	31	:	:	:
cord-005453-4057qib7	3488	32	Ten	ten	CD
cord-005453-4057qib7	3488	33	centers	center	NNS
cord-005453-4057qib7	3488	34	from	from	IN
cord-005453-4057qib7	3488	35	Turkey	Turkey	NNP
cord-005453-4057qib7	3488	36	were	be	VBD
cord-005453-4057qib7	3488	37	enrolled	enrol	VBN
cord-005453-4057qib7	3488	38	in	in	IN
cord-005453-4057qib7	3488	39	the	the	DT
cord-005453-4057qib7	3488	40	study	study	NN
cord-005453-4057qib7	3488	41	.	.	.
cord-005453-4057qib7	3489	1	We	-PRON-	PRP
cord-005453-4057qib7	3489	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	3489	3	evaluated	evaluate	VBD
cord-005453-4057qib7	3489	4	the	the	DT
cord-005453-4057qib7	3489	5	medical	medical	JJ
cord-005453-4057qib7	3489	6	records	record	NNS
cord-005453-4057qib7	3489	7	of	of	IN
cord-005453-4057qib7	3489	8	patients	patient	NNS
cord-005453-4057qib7	3489	9	who	who	WP
cord-005453-4057qib7	3489	10	were	be	VBD
cord-005453-4057qib7	3489	11	treated	treat	VBN
cord-005453-4057qib7	3489	12	with	with	IN
cord-005453-4057qib7	3489	13	allo	allo	NNP
cord-005453-4057qib7	3489	14	-	-	HYPH
cord-005453-4057qib7	3489	15	SCT	SCT	NNP
cord-005453-4057qib7	3489	16	between	between	IN
cord-005453-4057qib7	3489	17	January	January	NNP
cord-005453-4057qib7	3489	18	2012	2012	CD
cord-005453-4057qib7	3489	19	and	and	CC
cord-005453-4057qib7	3489	20	December	December	NNP
cord-005453-4057qib7	3489	21	2015	2015	CD
cord-005453-4057qib7	3489	22	.	.	.
cord-005453-4057qib7	3490	1	A	a	DT
cord-005453-4057qib7	3490	2	Baltimore	Baltimore	NNP
cord-005453-4057qib7	3490	3	criterion	criterion	NN
cord-005453-4057qib7	3490	4	was	be	VBD
cord-005453-4057qib7	3490	5	used	use	VBN
cord-005453-4057qib7	3490	6	for	for	IN
cord-005453-4057qib7	3490	7	assessment	assessment	NN
cord-005453-4057qib7	3490	8	of	of	IN
cord-005453-4057qib7	3490	9	HSOS	HSOS	NNP
cord-005453-4057qib7	3490	10	.	.	.
cord-005453-4057qib7	3491	1	Four	four	CD
cord-005453-4057qib7	3491	2	hundred	hundred	CD
cord-005453-4057qib7	3491	3	twenty	twenty	CD
cord-005453-4057qib7	3491	4	six	six	CD
cord-005453-4057qib7	3491	5	(	(	-LRB-
cord-005453-4057qib7	3491	6	97.2	97.2	CD
cord-005453-4057qib7	3491	7	%	%	NN
cord-005453-4057qib7	3491	8	)	)	-RRB-
cord-005453-4057qib7	3491	9	of	of	IN
cord-005453-4057qib7	3491	10	438	438	CD
cord-005453-4057qib7	3491	11	patients	patient	NNS
cord-005453-4057qib7	3491	12	who	who	WP
cord-005453-4057qib7	3491	13	were	be	VBD
cord-005453-4057qib7	3491	14	treated	treat	VBN
cord-005453-4057qib7	3491	15	with	with	IN
cord-005453-4057qib7	3491	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3491	17	with	with	IN
cord-005453-4057qib7	3491	18	defibrotide	defibrotide	NN
cord-005453-4057qib7	3491	19	alone	alone	JJ
cord-005453-4057qib7	3491	20	or	or	CC
cord-005453-4057qib7	3491	21	one	one	CD
cord-005453-4057qib7	3491	22	or	or	CC
cord-005453-4057qib7	3491	23	more	more	JJR
cord-005453-4057qib7	3491	24	of	of	IN
cord-005453-4057qib7	3491	25	the	the	DT
cord-005453-4057qib7	3491	26	N	N	NNP
cord-005453-4057qib7	3491	27	-	-	HYPH
cord-005453-4057qib7	3491	28	Acetylcysteine	Acetylcysteine	NNP
cord-005453-4057qib7	3491	29	,	,	,
cord-005453-4057qib7	3491	30	diuretics	diuretic	NNS
cord-005453-4057qib7	3491	31	and	and	CC
cord-005453-4057qib7	3491	32	heparin	heparin	NN
cord-005453-4057qib7	3491	33	used	use	VBD
cord-005453-4057qib7	3491	34	defibrotide	defibrotide	NNP
cord-005453-4057qib7	3491	35	(	(	-LRB-
cord-005453-4057qib7	3491	36	10	10	CD
cord-005453-4057qib7	3491	37	-	-	SYM
cord-005453-4057qib7	3491	38	25	25	CD
cord-005453-4057qib7	3491	39	mg	mg	NNP
cord-005453-4057qib7	3491	40	/	/	SYM
cord-005453-4057qib7	3491	41	kg	kg	NNP
cord-005453-4057qib7	3491	42	/	/	SYM
cord-005453-4057qib7	3491	43	day	day	NN
cord-005453-4057qib7	3491	44	)	)	-RRB-
cord-005453-4057qib7	3491	45	.	.	.
cord-005453-4057qib7	3492	1	Results	result	NNS
cord-005453-4057qib7	3492	2	:	:	:
cord-005453-4057qib7	3493	1	The	the	DT
cord-005453-4057qib7	3493	2	study	study	NN
cord-005453-4057qib7	3493	3	included	include	VBD
cord-005453-4057qib7	3493	4	1153	1153	CD
cord-005453-4057qib7	3493	5	patients	patient	NNS
cord-005453-4057qib7	3493	6	(	(	-LRB-
cord-005453-4057qib7	3493	7	687	687	CD
cord-005453-4057qib7	3493	8	males/	males/	CD
cord-005453-4057qib7	3493	9	466	466	CD
cord-005453-4057qib7	3493	10	females	female	NNS
cord-005453-4057qib7	3493	11	)	)	-RRB-
cord-005453-4057qib7	3493	12	with	with	IN
cord-005453-4057qib7	3493	13	median	median	JJ
cord-005453-4057qib7	3493	14	age	age	NN
cord-005453-4057qib7	3493	15	of	of	IN
cord-005453-4057qib7	3493	16	38	38	CD
cord-005453-4057qib7	3493	17	(	(	-LRB-
cord-005453-4057qib7	3493	18	15	15	CD
cord-005453-4057qib7	3493	19	-	-	SYM
cord-005453-4057qib7	3493	20	71	71	CD
cord-005453-4057qib7	3493	21	)	)	-RRB-
cord-005453-4057qib7	3493	22	years	year	NNS
cord-005453-4057qib7	3493	23	.	.	.
cord-005453-4057qib7	3494	1	The	the	DT
cord-005453-4057qib7	3494	2	demographic	demographic	JJ
cord-005453-4057qib7	3494	3	and	and	CC
cord-005453-4057qib7	3494	4	clinical	clinical	JJ
cord-005453-4057qib7	3494	5	characteristics	characteristic	NNS
cord-005453-4057qib7	3494	6	of	of	IN
cord-005453-4057qib7	3494	7	patients	patient	NNS
cord-005453-4057qib7	3494	8	were	be	VBD
cord-005453-4057qib7	3494	9	summarized	summarize	VBN
cord-005453-4057qib7	3494	10	in	in	IN
cord-005453-4057qib7	3494	11	Table	Table	NNP
cord-005453-4057qib7	3494	12	1	1	CD
cord-005453-4057qib7	3494	13	Seventy	seventy	CD
cord-005453-4057qib7	3494	14	-	-	HYPH
cord-005453-4057qib7	3494	15	three	three	CD
cord-005453-4057qib7	3494	16	(	(	-LRB-
cord-005453-4057qib7	3494	17	84.9	84.9	CD
cord-005453-4057qib7	3494	18	%	%	NN
cord-005453-4057qib7	3494	19	)	)	-RRB-
cord-005453-4057qib7	3494	20	of	of	IN
cord-005453-4057qib7	3494	21	patients	patient	NNS
cord-005453-4057qib7	3494	22	with	with	IN
cord-005453-4057qib7	3494	23	HSOS	HSOS	NNP
cord-005453-4057qib7	3494	24	were	be	VBD
cord-005453-4057qib7	3494	25	treated	treat	VBN
cord-005453-4057qib7	3494	26	with	with	IN
cord-005453-4057qib7	3494	27	defibrotide	defibrotide	NN
cord-005453-4057qib7	3494	28	after	after	IN
cord-005453-4057qib7	3494	29	diagnosis	diagnosis	NN
cord-005453-4057qib7	3494	30	.	.	.
cord-005453-4057qib7	3495	1	The	the	DT
cord-005453-4057qib7	3495	2	median	median	JJ
cord-005453-4057qib7	3495	3	time	time	NN
cord-005453-4057qib7	3495	4	of	of	IN
cord-005453-4057qib7	3495	5	starting	start	VBG
cord-005453-4057qib7	3495	6	defibrotide	defibrotide	NN
cord-005453-4057qib7	3495	7	in	in	IN
cord-005453-4057qib7	3495	8	these	these	DT
cord-005453-4057qib7	3495	9	patients	patient	NNS
cord-005453-4057qib7	3495	10	was	be	VBD
cord-005453-4057qib7	3495	11	13.5	13.5	CD
cord-005453-4057qib7	3495	12	(	(	-LRB-
cord-005453-4057qib7	3495	13	2	2	CD
cord-005453-4057qib7	3495	14	-	-	SYM
cord-005453-4057qib7	3495	15	29	29	CD
cord-005453-4057qib7	3495	16	)	)	-RRB-
cord-005453-4057qib7	3495	17	days	day	NNS
cord-005453-4057qib7	3495	18	.	.	.
cord-005453-4057qib7	3496	1	Thirty	thirty	CD
cord-005453-4057qib7	3496	2	-	-	HYPH
cord-005453-4057qib7	3496	3	seven	seven	CD
cord-005453-4057qib7	3496	4	(	(	-LRB-
cord-005453-4057qib7	3496	5	43	43	CD
cord-005453-4057qib7	3496	6	%	%	NN
cord-005453-4057qib7	3496	7	)	)	-RRB-
cord-005453-4057qib7	3496	8	of	of	IN
cord-005453-4057qib7	3496	9	patients	patient	NNS
cord-005453-4057qib7	3496	10	with	with	IN
cord-005453-4057qib7	3496	11	HSOS	HSOS	NNP
cord-005453-4057qib7	3496	12	recovered	recover	VBD
cord-005453-4057qib7	3496	13	completely	completely	RB
cord-005453-4057qib7	3496	14	and	and	CC
cord-005453-4057qib7	3496	15	forty	forty	CD
cord-005453-4057qib7	3496	16	-	-	HYPH
cord-005453-4057qib7	3496	17	nine	nine	CD
cord-005453-4057qib7	3496	18	(	(	-LRB-
cord-005453-4057qib7	3496	19	57	57	CD
cord-005453-4057qib7	3496	20	%	%	NN
cord-005453-4057qib7	3496	21	)	)	-RRB-
cord-005453-4057qib7	3496	22	of	of	IN
cord-005453-4057qib7	3496	23	them	-PRON-	PRP
cord-005453-4057qib7	3496	24	died	die	VBD
cord-005453-4057qib7	3496	25	as	as	IN
cord-005453-4057qib7	3496	26	a	a	DT
cord-005453-4057qib7	3496	27	result	result	NN
cord-005453-4057qib7	3496	28	of	of	IN
cord-005453-4057qib7	3496	29	multi	multi	JJ
cord-005453-4057qib7	3496	30	organ	organ	NN
cord-005453-4057qib7	3496	31	failure	failure	NN
cord-005453-4057qib7	3496	32	.	.	.
cord-005453-4057qib7	3497	1	The	the	DT
cord-005453-4057qib7	3497	2	incidence	incidence	NN
cord-005453-4057qib7	3497	3	of	of	IN
cord-005453-4057qib7	3497	4	HSOS	HSOS	NNP
cord-005453-4057qib7	3497	5	-	-	HYPH
cord-005453-4057qib7	3497	6	related	relate	VBN
cord-005453-4057qib7	3497	7	mortality	mortality	NN
cord-005453-4057qib7	3497	8	in	in	IN
cord-005453-4057qib7	3497	9	allo	allo	NN
cord-005453-4057qib7	3497	10	-	-	HYPH
cord-005453-4057qib7	3497	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3497	12	cohort	cohort	NN
cord-005453-4057qib7	3497	13	was	be	VBD
cord-005453-4057qib7	3497	14	found	find	VBN
cord-005453-4057qib7	3497	15	to	to	TO
cord-005453-4057qib7	3497	16	be	be	VB
cord-005453-4057qib7	3497	17	4.2	4.2	CD
cord-005453-4057qib7	3497	18	%	%	NN
cord-005453-4057qib7	3497	19	.	.	.
cord-005453-4057qib7	3498	1	In	in	IN
cord-005453-4057qib7	3498	2	univariate	univariate	JJ
cord-005453-4057qib7	3498	3	analysis	analysis	NN
cord-005453-4057qib7	3498	4	,	,	,
cord-005453-4057qib7	3498	5	statistically	statistically	RB
cord-005453-4057qib7	3498	6	significant	significant	JJ
cord-005453-4057qib7	3498	7	associations	association	NNS
cord-005453-4057qib7	3498	8	were	be	VBD
cord-005453-4057qib7	3498	9	not	not	RB
cord-005453-4057qib7	3498	10	found	find	VBN
cord-005453-4057qib7	3498	11	between	between	IN
cord-005453-4057qib7	3498	12	HSOS	HSOS	NNP
cord-005453-4057qib7	3498	13	incidence	incidence	NN
cord-005453-4057qib7	3498	14	and	and	CC
cord-005453-4057qib7	3498	15	age	age	NN
cord-005453-4057qib7	3498	16	/	/	SYM
cord-005453-4057qib7	3498	17	sex	sex	NN
cord-005453-4057qib7	3498	18	of	of	IN
cord-005453-4057qib7	3498	19	recipient	recipient	NN
cord-005453-4057qib7	3498	20	,	,	,
cord-005453-4057qib7	3498	21	type	type	NN
cord-005453-4057qib7	3498	22	of	of	IN
cord-005453-4057qib7	3498	23	conditioning	conditioning	NN
cord-005453-4057qib7	3498	24	regimen	regimen	NN
cord-005453-4057qib7	3498	25	,	,	,
cord-005453-4057qib7	3498	26	stem	stem	NN
cord-005453-4057qib7	3498	27	cell	cell	NN
cord-005453-4057qib7	3498	28	source	source	NN
cord-005453-4057qib7	3498	29	and	and	CC
cord-005453-4057qib7	3498	30	type	type	NN
cord-005453-4057qib7	3498	31	of	of	IN
cord-005453-4057qib7	3498	32	GVHD	GVHD	NNP
cord-005453-4057qib7	3498	33	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3498	34	.	.	.
cord-005453-4057qib7	3499	1	On	on	IN
cord-005453-4057qib7	3499	2	the	the	DT
cord-005453-4057qib7	3499	3	other	other	JJ
cord-005453-4057qib7	3499	4	hand	hand	NN
cord-005453-4057qib7	3499	5	donor	donor	NN
cord-005453-4057qib7	3499	6	type	type	NN
cord-005453-4057qib7	3499	7	,	,	,
cord-005453-4057qib7	3499	8	engraftment	engraftment	NN
cord-005453-4057qib7	3499	9	status	status	NN
cord-005453-4057qib7	3499	10	and	and	CC
cord-005453-4057qib7	3499	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3499	12	for	for	IN
cord-005453-4057qib7	3499	13	HSOS	HSOS	NNP
cord-005453-4057qib7	3499	14	were	be	VBD
cord-005453-4057qib7	3499	15	significantly	significantly	RB
cord-005453-4057qib7	3499	16	associated	associate	VBN
cord-005453-4057qib7	3499	17	with	with	IN
cord-005453-4057qib7	3499	18	HSOS	HSOS	NNP
cord-005453-4057qib7	3499	19	development	development	NN
cord-005453-4057qib7	3499	20	.	.	.
cord-005453-4057qib7	3500	1	HSOS	HSOS	NNP
cord-005453-4057qib7	3500	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3500	3	was	be	VBD
cord-005453-4057qib7	3500	4	significantly	significantly	RB
cord-005453-4057qib7	3500	5	decreased	decrease	VBN
cord-005453-4057qib7	3500	6	HSOS	HSOS	NNP
cord-005453-4057qib7	3500	7	-	-	HYPH
cord-005453-4057qib7	3500	8	associated	associate	VBN
cord-005453-4057qib7	3500	9	mortality	mortality	NN
cord-005453-4057qib7	3500	10	(	(	-LRB-
cord-005453-4057qib7	3500	11	p=0.001	p=0.001	NNP
cord-005453-4057qib7	3500	12	)	)	-RRB-
cord-005453-4057qib7	3500	13	.	.	.
cord-005453-4057qib7	3501	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3501	2	:	:	:
cord-005453-4057qib7	3502	1	HSOS	HSOS	NNP
cord-005453-4057qib7	3502	2	still	still	RB
cord-005453-4057qib7	3502	3	remains	remain	VBZ
cord-005453-4057qib7	3502	4	a	a	DT
cord-005453-4057qib7	3502	5	serious	serious	JJ
cord-005453-4057qib7	3502	6	lifethreatening	lifethreatening	JJ
cord-005453-4057qib7	3502	7	complication	complication	NN
cord-005453-4057qib7	3502	8	of	of	IN
cord-005453-4057qib7	3502	9	allo	allo	NN
cord-005453-4057qib7	3502	10	-	-	HYPH
cord-005453-4057qib7	3502	11	SCT	SCT	NNP
cord-005453-4057qib7	3502	12	.	.	.
cord-005453-4057qib7	3503	1	Although	although	IN
cord-005453-4057qib7	3503	2	the	the	DT
cord-005453-4057qib7	3503	3	incidence	incidence	NN
cord-005453-4057qib7	3503	4	is	be	VBZ
cord-005453-4057qib7	3503	5	low	low	JJ
cord-005453-4057qib7	3503	6	,	,	,
cord-005453-4057qib7	3503	7	HSOS	HSOS	NNP
cord-005453-4057qib7	3503	8	is	be	VBZ
cord-005453-4057qib7	3503	9	associated	associate	VBN
cord-005453-4057qib7	3503	10	with	with	IN
cord-005453-4057qib7	3503	11	increased	increase	VBN
cord-005453-4057qib7	3503	12	100-day	100-day	JJ
cord-005453-4057qib7	3503	13	non	non	JJ
cord-005453-4057qib7	3503	14	-	-	JJ
cord-005453-4057qib7	3503	15	relapse	relapse	JJ
cord-005453-4057qib7	3503	16	mortality	mortality	NN
cord-005453-4057qib7	3503	17	.	.	.
cord-005453-4057qib7	3504	1	HSOS	HSOS	NNP
cord-005453-4057qib7	3504	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3504	3	especially	especially	RB
cord-005453-4057qib7	3504	4	with	with	IN
cord-005453-4057qib7	3504	5	defibrotide	defibrotide	NN
cord-005453-4057qib7	3504	6	,	,	,
cord-005453-4057qib7	3504	7	seems	seem	VBZ
cord-005453-4057qib7	3504	8	to	to	TO
cord-005453-4057qib7	3504	9	reduce	reduce	VB
cord-005453-4057qib7	3504	10	HSOS	HSOS	NNP
cord-005453-4057qib7	3504	11	associated	associate	VBN
cord-005453-4057qib7	3504	12	mortality	mortality	NN
cord-005453-4057qib7	3504	13	in	in	IN
cord-005453-4057qib7	3504	14	high	high	JJ
cord-005453-4057qib7	3504	15	risk	risk	NN
cord-005453-4057qib7	3504	16	patients	patient	NNS
cord-005453-4057qib7	3504	17	.	.	.
cord-005453-4057qib7	3505	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3505	2	:	:	:
cord-005453-4057qib7	3505	3	Nothing	nothing	NN
cord-005453-4057qib7	3505	4	to	to	TO
cord-005453-4057qib7	3505	5	declare	declare	VB
cord-005453-4057qib7	3505	6	Prophylaxis	Prophylaxis	NNP
cord-005453-4057qib7	3505	7	with	with	IN
cord-005453-4057qib7	3505	8	defibrotide	defibrotide	NN
cord-005453-4057qib7	3505	9	in	in	IN
cord-005453-4057qib7	3505	10	adults	adult	NNS
cord-005453-4057qib7	3505	11	at	at	IN
cord-005453-4057qib7	3505	12	very	very	RB
cord-005453-4057qib7	3505	13	high	high	JJ
cord-005453-4057qib7	3505	14	risk	risk	NN
cord-005453-4057qib7	3505	15	of	of	IN
cord-005453-4057qib7	3505	16	veno	veno	NNP
cord-005453-4057qib7	3505	17	-	-	HYPH
cord-005453-4057qib7	3505	18	occlusive	occlusive	JJ
cord-005453-4057qib7	3505	19	disease	disease	NN
cord-005453-4057qib7	3505	20	:	:	:
cord-005453-4057qib7	3505	21	Results	result	NNS
cord-005453-4057qib7	3505	22	in	in	IN
cord-005453-4057qib7	3505	23	11	11	CD
cord-005453-4057qib7	3505	24	patients	patient	NNS
cord-005453-4057qib7	3506	1	Background	background	NN
cord-005453-4057qib7	3506	2	:	:	:
cord-005453-4057qib7	3507	1	Hepatic	hepatic	JJ
cord-005453-4057qib7	3507	2	Sinusoidal	Sinusoidal	NNP
cord-005453-4057qib7	3507	3	Obstruction	obstruction	NN
cord-005453-4057qib7	3508	1	Syndrome/	Syndrome/	NNP
cord-005453-4057qib7	3508	2	Veno	Veno	NNP
cord-005453-4057qib7	3508	3	-	-	HYPH
cord-005453-4057qib7	3508	4	Occlusive	Occlusive	NNP
cord-005453-4057qib7	3508	5	Disease	Disease	NNP
cord-005453-4057qib7	3509	1	(	(	-LRB-
cord-005453-4057qib7	3509	2	SOS	SOS	NNP
cord-005453-4057qib7	3509	3	/	/	SYM
cord-005453-4057qib7	3509	4	VOD	VOD	NNP
cord-005453-4057qib7	3509	5	)	)	-RRB-
cord-005453-4057qib7	3509	6	is	be	VBZ
cord-005453-4057qib7	3509	7	a	a	DT
cord-005453-4057qib7	3509	8	life	life	NN
cord-005453-4057qib7	3509	9	threatening	threaten	VBG
cord-005453-4057qib7	3509	10	complication	complication	NN
cord-005453-4057qib7	3509	11	that	that	WDT
cord-005453-4057qib7	3509	12	can	can	MD
cord-005453-4057qib7	3509	13	occur	occur	VB
cord-005453-4057qib7	3509	14	after	after	IN
cord-005453-4057qib7	3509	15	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	3509	16	Stem	Stem	NNP
cord-005453-4057qib7	3509	17	Cell	Cell	NNP
cord-005453-4057qib7	3509	18	Transplantation	transplantation	NN
cord-005453-4057qib7	3509	19	(	(	-LRB-
cord-005453-4057qib7	3509	20	HSCT	HSCT	NNP
cord-005453-4057qib7	3509	21	)	)	-RRB-
cord-005453-4057qib7	3509	22	.	.	.
cord-005453-4057qib7	3510	1	Severe	severe	JJ
cord-005453-4057qib7	3510	2	SOS	SOS	NNP
cord-005453-4057qib7	3510	3	/	/	SYM
cord-005453-4057qib7	3510	4	VOD	VOD	NNP
cord-005453-4057qib7	3510	5	rapidly	rapidly	RB
cord-005453-4057qib7	3510	6	evolves	evolve	VBZ
cord-005453-4057qib7	3510	7	in	in	IN
cord-005453-4057qib7	3510	8	Multiple	Multiple	NNP
cord-005453-4057qib7	3510	9	Organ	Organ	NNP
cord-005453-4057qib7	3510	10	Dysfunction	Dysfunction	NNP
cord-005453-4057qib7	3510	11	Syndrome	Syndrome	NNP
cord-005453-4057qib7	3510	12	(	(	-LRB-
cord-005453-4057qib7	3510	13	MODS	MODS	NNP
cord-005453-4057qib7	3510	14	)	)	-RRB-
cord-005453-4057qib7	3510	15	,	,	,
cord-005453-4057qib7	3510	16	associated	associate	VBN
cord-005453-4057qib7	3510	17	with	with	IN
cord-005453-4057qib7	3510	18	a	a	DT
cord-005453-4057qib7	3510	19	mortality	mortality	NN
cord-005453-4057qib7	3510	20	rate	rate	NN
cord-005453-4057qib7	3510	21	exceding	excede	VBG
cord-005453-4057qib7	3510	22	80	80	CD
cord-005453-4057qib7	3510	23	%	%	NN
cord-005453-4057qib7	3510	24	.	.	.
cord-005453-4057qib7	3511	1	Precocity	precocity	NN
cord-005453-4057qib7	3511	2	of	of	IN
cord-005453-4057qib7	3511	3	defibrotide	defibrotide	NN
cord-005453-4057qib7	3511	4	(	(	-LRB-
cord-005453-4057qib7	3511	5	DF	DF	NNP
cord-005453-4057qib7	3511	6	)	)	-RRB-
cord-005453-4057qib7	3511	7	treatment	treatment	NN
cord-005453-4057qib7	3511	8	is	be	VBZ
cord-005453-4057qib7	3511	9	the	the	DT
cord-005453-4057qib7	3511	10	leading	leading	JJ
cord-005453-4057qib7	3511	11	factor	factor	NN
cord-005453-4057qib7	3511	12	for	for	IN
cord-005453-4057qib7	3511	13	efficacy	efficacy	NN
cord-005453-4057qib7	3511	14	.	.	.
cord-005453-4057qib7	3512	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	3512	2	use	use	NN
cord-005453-4057qib7	3512	3	of	of	IN
cord-005453-4057qib7	3512	4	DF	DF	NNP
cord-005453-4057qib7	3512	5	is	be	VBZ
cord-005453-4057qib7	3512	6	recommended	recommend	VBN
cord-005453-4057qib7	3512	7	in	in	IN
cord-005453-4057qib7	3512	8	children	child	NNS
cord-005453-4057qib7	3512	9	,	,	,
cord-005453-4057qib7	3512	10	but	but	CC
cord-005453-4057qib7	3512	11	its	-PRON-	PRP$
cord-005453-4057qib7	3512	12	value	value	NN
cord-005453-4057qib7	3512	13	has	have	VBZ
cord-005453-4057qib7	3512	14	not	not	RB
cord-005453-4057qib7	3512	15	been	be	VBN
cord-005453-4057qib7	3512	16	validated	validate	VBN
cord-005453-4057qib7	3512	17	in	in	IN
cord-005453-4057qib7	3512	18	the	the	DT
cord-005453-4057qib7	3512	19	adult	adult	NN
cord-005453-4057qib7	3512	20	population	population	NN
cord-005453-4057qib7	3512	21	,	,	,
cord-005453-4057qib7	3512	22	although	although	IN
cord-005453-4057qib7	3512	23	factors	factor	NNS
cord-005453-4057qib7	3512	24	for	for	IN
cord-005453-4057qib7	3512	25	individual	individual	JJ
cord-005453-4057qib7	3512	26	risk	risk	NN
cord-005453-4057qib7	3512	27	assessment	assessment	NN
cord-005453-4057qib7	3512	28	for	for	IN
cord-005453-4057qib7	3512	29	VOD	VOD	NNP
cord-005453-4057qib7	3512	30	are	be	VBP
cord-005453-4057qib7	3512	31	debated	debate	VBN
cord-005453-4057qib7	3512	32	.	.	.
cord-005453-4057qib7	3513	1	We	-PRON-	PRP
cord-005453-4057qib7	3513	2	here	here	RB
cord-005453-4057qib7	3513	3	present	present	VBP
cord-005453-4057qib7	3513	4	a	a	DT
cord-005453-4057qib7	3513	5	real	real	JJ
cord-005453-4057qib7	3513	6	-	-	HYPH
cord-005453-4057qib7	3513	7	world	world	NN
cord-005453-4057qib7	3513	8	experience	experience	NN
cord-005453-4057qib7	3513	9	of	of	IN
cord-005453-4057qib7	3513	10	DF	DF	NNP
cord-005453-4057qib7	3513	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3513	12	in	in	IN
cord-005453-4057qib7	3513	13	adult	adult	NN
cord-005453-4057qib7	3513	14	patients	patient	NNS
cord-005453-4057qib7	3513	15	at	at	IN
cord-005453-4057qib7	3513	16	very	very	RB
cord-005453-4057qib7	3513	17	high	high	JJ
cord-005453-4057qib7	3513	18	risk	risk	NN
cord-005453-4057qib7	3513	19	of	of	IN
cord-005453-4057qib7	3513	20	SOS	SOS	NNP
cord-005453-4057qib7	3513	21	/	/	SYM
cord-005453-4057qib7	3513	22	VOD	VOD	NNP
cord-005453-4057qib7	3513	23	receiving	receive	VBG
cord-005453-4057qib7	3513	24	allogeneic	allogeneic	IN
cord-005453-4057qib7	3513	25	HSCT	HSCT	NNP
cord-005453-4057qib7	3513	26	.	.	.
cord-005453-4057qib7	3514	1	Methods	method	NNS
cord-005453-4057qib7	3514	2	:	:	:
cord-005453-4057qib7	3515	1	From	from	IN
cord-005453-4057qib7	3515	2	2016	2016	CD
cord-005453-4057qib7	3515	3	to	to	IN
cord-005453-4057qib7	3515	4	2018	2018	CD
cord-005453-4057qib7	3515	5	we	-PRON-	PRP
cord-005453-4057qib7	3515	6	treated	treat	VBN
cord-005453-4057qib7	3515	7	with	with	IN
cord-005453-4057qib7	3515	8	prophylactic	prophylactic	JJ
cord-005453-4057qib7	3515	9	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	3515	10	and	and	CC
cord-005453-4057qib7	3515	11	Ursodeoxycholic	Ursodeoxycholic	NNP
cord-005453-4057qib7	3515	12	Acid	Acid	NNP
cord-005453-4057qib7	3515	13	(	(	-LRB-
cord-005453-4057qib7	3515	14	UDCA	UDCA	NNP
cord-005453-4057qib7	3515	15	)	)	-RRB-
cord-005453-4057qib7	3516	1	11	11	CD
cord-005453-4057qib7	3516	2	patients	patient	NNS
cord-005453-4057qib7	3516	3	,	,	,
cord-005453-4057qib7	3516	4	median	median	JJ
cord-005453-4057qib7	3516	5	age	age	NN
cord-005453-4057qib7	3516	6	30	30	CD
cord-005453-4057qib7	3516	7	years	year	NNS
cord-005453-4057qib7	3517	1	(	(	-LRB-
cord-005453-4057qib7	3517	2	range	range	NNP
cord-005453-4057qib7	3517	3	21	21	CD
cord-005453-4057qib7	3517	4	-	-	SYM
cord-005453-4057qib7	3517	5	59	59	CD
cord-005453-4057qib7	3517	6	)	)	-RRB-
cord-005453-4057qib7	3517	7	.	.	.
cord-005453-4057qib7	3518	1	Nine	nine	CD
cord-005453-4057qib7	3518	2	patients	patient	NNS
cord-005453-4057qib7	3518	3	received	receive	VBD
cord-005453-4057qib7	3518	4	allogeneic	allogeneic	IN
cord-005453-4057qib7	3518	5	HSCT	HSCT	NNP
cord-005453-4057qib7	3518	6	for	for	IN
cord-005453-4057qib7	3518	7	acute	acute	JJ
cord-005453-4057qib7	3518	8	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	3518	9	leukemia	leukemia	NN
cord-005453-4057qib7	3518	10	(	(	-LRB-
cord-005453-4057qib7	3518	11	8	8	CD
cord-005453-4057qib7	3518	12	B	b	NN
cord-005453-4057qib7	3518	13	-	-	:
cord-005453-4057qib7	3518	14	ALL	all	DT
cord-005453-4057qib7	3518	15	and	and	CC
cord-005453-4057qib7	3518	16	1	1	CD
cord-005453-4057qib7	3518	17	T	t	NN
cord-005453-4057qib7	3518	18	-	-	HYPH
cord-005453-4057qib7	3518	19	ALL	ALL	NNP
cord-005453-4057qib7	3518	20	)	)	-RRB-
cord-005453-4057qib7	3518	21	,	,	,
cord-005453-4057qib7	3518	22	one	one	CD
cord-005453-4057qib7	3518	23	patient	patient	NN
cord-005453-4057qib7	3518	24	for	for	IN
cord-005453-4057qib7	3518	25	Severe	severe	JJ
cord-005453-4057qib7	3518	26	Aplastic	Aplastic	NNP
cord-005453-4057qib7	3518	27	Anemia	anemia	NN
cord-005453-4057qib7	3518	28	,	,	,
cord-005453-4057qib7	3518	29	one	one	CD
cord-005453-4057qib7	3518	30	patient	patient	NN
cord-005453-4057qib7	3518	31	for	for	IN
cord-005453-4057qib7	3518	32	Primary	Primary	NNP
cord-005453-4057qib7	3518	33	Myelofibrosis	Myelofibrosis	NNP
cord-005453-4057qib7	3518	34	.	.	.
cord-005453-4057qib7	3519	1	They	-PRON-	PRP
cord-005453-4057qib7	3519	2	were	be	VBD
cord-005453-4057qib7	3519	3	all	all	RB
cord-005453-4057qib7	3519	4	at	at	IN
cord-005453-4057qib7	3519	5	high	high	JJ
cord-005453-4057qib7	3519	6	risk	risk	NN
cord-005453-4057qib7	3519	7	for	for	IN
cord-005453-4057qib7	3519	8	SOS	SOS	NNP
cord-005453-4057qib7	3519	9	/	/	SYM
cord-005453-4057qib7	3519	10	VOD	VOD	NNP
cord-005453-4057qib7	3519	11	because	because	IN
cord-005453-4057qib7	3519	12	of	of	IN
cord-005453-4057qib7	3519	13	previous	previous	JJ
cord-005453-4057qib7	3519	14	hepatotoxicity	hepatotoxicity	NN
cord-005453-4057qib7	3519	15	(	(	-LRB-
cord-005453-4057qib7	3519	16	3	3	CD
cord-005453-4057qib7	3519	17	patients	patient	NNS
cord-005453-4057qib7	3519	18	)	)	-RRB-
cord-005453-4057qib7	3519	19	,	,	,
cord-005453-4057qib7	3519	20	previous	previous	JJ
cord-005453-4057qib7	3519	21	HSCT	HSCT	NNP
cord-005453-4057qib7	3519	22	(	(	-LRB-
cord-005453-4057qib7	3519	23	6	6	CD
cord-005453-4057qib7	3519	24	patients	patient	NNS
cord-005453-4057qib7	3519	25	)	)	-RRB-
cord-005453-4057qib7	3519	26	,	,	,
cord-005453-4057qib7	3519	27	double	double	JJ
cord-005453-4057qib7	3519	28	alkylating	alkylating	JJ
cord-005453-4057qib7	3519	29	agent	agent	NN
cord-005453-4057qib7	3519	30	(	(	-LRB-
cord-005453-4057qib7	3519	31	5	5	CD
cord-005453-4057qib7	3519	32	patients	patient	NNS
cord-005453-4057qib7	3519	33	)	)	-RRB-
cord-005453-4057qib7	3519	34	or	or	CC
cord-005453-4057qib7	3519	35	previous	previous	JJ
cord-005453-4057qib7	3519	36	treatment	treatment	NN
cord-005453-4057qib7	3519	37	with	with	IN
cord-005453-4057qib7	3519	38	Inotuzomab	Inotuzomab	NNP
cord-005453-4057qib7	3519	39	Ozogamicin	Ozogamicin	NNP
cord-005453-4057qib7	3519	40	(	(	-LRB-
cord-005453-4057qib7	3519	41	IO	IO	NNP
cord-005453-4057qib7	3519	42	;	;	:
cord-005453-4057qib7	3519	43	7	7	CD
cord-005453-4057qib7	3519	44	patients	patient	NNS
cord-005453-4057qib7	3519	45	)	)	-RRB-
cord-005453-4057qib7	3519	46	.	.	.
cord-005453-4057qib7	3520	1	Of	of	IN
cord-005453-4057qib7	3520	2	the	the	DT
cord-005453-4057qib7	3520	3	7	7	CD
cord-005453-4057qib7	3520	4	patients	patient	NNS
cord-005453-4057qib7	3520	5	treated	treat	VBN
cord-005453-4057qib7	3520	6	with	with	IN
cord-005453-4057qib7	3520	7	IO	IO	NNP
cord-005453-4057qib7	3520	8	,	,	,
cord-005453-4057qib7	3520	9	6	6	CD
cord-005453-4057qib7	3520	10	received	receive	VBD
cord-005453-4057qib7	3520	11	2	2	CD
cord-005453-4057qib7	3520	12	cycles	cycle	NNS
cord-005453-4057qib7	3520	13	of	of	IN
cord-005453-4057qib7	3520	14	IO	IO	NNP
cord-005453-4057qib7	3520	15	,	,	,
cord-005453-4057qib7	3520	16	and	and	CC
cord-005453-4057qib7	3520	17	1	1	CD
cord-005453-4057qib7	3520	18	received	receive	VBD
cord-005453-4057qib7	3520	19	1	1	CD
cord-005453-4057qib7	3520	20	cycle	cycle	NN
cord-005453-4057qib7	3520	21	,	,	,
cord-005453-4057qib7	3520	22	with	with	IN
cord-005453-4057qib7	3520	23	the	the	DT
cord-005453-4057qib7	3520	24	last	last	JJ
cord-005453-4057qib7	3520	25	IO	IO	NNP
cord-005453-4057qib7	3520	26	dose	dose	NN
cord-005453-4057qib7	3520	27	administered	administer	VBD
cord-005453-4057qib7	3520	28	a	a	DT
cord-005453-4057qib7	3520	29	median	median	JJ
cord-005453-4057qib7	3520	30	41.5	41.5	CD
cord-005453-4057qib7	3520	31	days	day	NNS
cord-005453-4057qib7	3520	32	before	before	IN
cord-005453-4057qib7	3520	33	HSCT	HSCT	NNP
cord-005453-4057qib7	3520	34	(	(	-LRB-
cord-005453-4057qib7	3520	35	range	range	NNP
cord-005453-4057qib7	3520	36	34	34	CD
cord-005453-4057qib7	3520	37	-	-	SYM
cord-005453-4057qib7	3520	38	61	61	CD
cord-005453-4057qib7	3520	39	d	d	NN
cord-005453-4057qib7	3520	40	)	)	-RRB-
cord-005453-4057qib7	3520	41	.	.	.
cord-005453-4057qib7	3521	1	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	3521	2	was	be	VBD
cord-005453-4057qib7	3521	3	administered	administer	VBN
cord-005453-4057qib7	3521	4	in	in	IN
cord-005453-4057qib7	3521	5	4	4	CD
cord-005453-4057qib7	3521	6	daily	daily	JJ
cord-005453-4057qib7	3521	7	doses	dose	NNS
cord-005453-4057qib7	3521	8	for	for	IN
cord-005453-4057qib7	3521	9	a	a	DT
cord-005453-4057qib7	3521	10	total	total	JJ
cord-005453-4057qib7	3521	11	dose	dose	NN
cord-005453-4057qib7	3521	12	of	of	IN
cord-005453-4057qib7	3521	13	25	25	CD
cord-005453-4057qib7	3521	14	mg/	mg/	NN
cord-005453-4057qib7	3521	15	kg	kg	NN
cord-005453-4057qib7	3521	16	per	per	IN
cord-005453-4057qib7	3521	17	day	day	NN
cord-005453-4057qib7	3521	18	and	and	CC
cord-005453-4057qib7	3521	19	UDCA	UDCA	NNP
cord-005453-4057qib7	3521	20	at	at	IN
cord-005453-4057qib7	3521	21	the	the	DT
cord-005453-4057qib7	3521	22	dose	dose	NN
cord-005453-4057qib7	3521	23	of	of	IN
cord-005453-4057qib7	3521	24	300	300	CD
cord-005453-4057qib7	3521	25	mg	mg	NN
cord-005453-4057qib7	3521	26	twice	twice	RB
cord-005453-4057qib7	3521	27	per	per	IN
cord-005453-4057qib7	3521	28	day	day	NN
cord-005453-4057qib7	3521	29	,	,	,
cord-005453-4057qib7	3521	30	starting	start	VBG
cord-005453-4057qib7	3521	31	from	from	IN
cord-005453-4057qib7	3521	32	day	day	NN
cord-005453-4057qib7	3521	33	-6	-6	JJ
cord-005453-4057qib7	3521	34	prior	prior	JJ
cord-005453-4057qib7	3521	35	transplant	transplant	NN
cord-005453-4057qib7	3521	36	.	.	.
cord-005453-4057qib7	3522	1	All	all	DT
cord-005453-4057qib7	3522	2	patients	patient	NNS
cord-005453-4057qib7	3522	3	received	receive	VBD
cord-005453-4057qib7	3522	4	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	3522	5	-	-	HYPH
cord-005453-4057qib7	3522	6	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	3522	7	based	base	VBN
cord-005453-4057qib7	3522	8	conditioning	conditioning	NN
cord-005453-4057qib7	3522	9	.	.	.
cord-005453-4057qib7	3523	1	In	in	IN
cord-005453-4057qib7	3523	2	5	5	CD
cord-005453-4057qib7	3523	3	patients	patient	NNS
cord-005453-4057qib7	3523	4	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	3523	5	was	be	VBD
cord-005453-4057qib7	3523	6	added	add	VBN
cord-005453-4057qib7	3523	7	to	to	IN
cord-005453-4057qib7	3523	8	the	the	DT
cord-005453-4057qib7	3523	9	conditioning	conditioning	NN
cord-005453-4057qib7	3523	10	and	and	CC
cord-005453-4057qib7	3523	11	in	in	IN
cord-005453-4057qib7	3523	12	2	2	CD
cord-005453-4057qib7	3523	13	patients	patient	NNS
cord-005453-4057qib7	3523	14	a	a	DT
cord-005453-4057qib7	3523	15	low	low	JJ
cord-005453-4057qib7	3523	16	dose	dose	NN
cord-005453-4057qib7	3523	17	4Gy	4gy	JJ
cord-005453-4057qib7	3523	18	TBI	TBI	NNP
cord-005453-4057qib7	3523	19	.	.	.
cord-005453-4057qib7	3524	1	GvHD	GvHD	NNP
cord-005453-4057qib7	3524	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3524	3	included	include	VBD
cord-005453-4057qib7	3524	4	posttransplant	posttransplant	NNP
cord-005453-4057qib7	3524	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	3524	6	,	,	,
cord-005453-4057qib7	3524	7	rapamycin	rapamycin	NN
cord-005453-4057qib7	3524	8	and	and	CC
cord-005453-4057qib7	3524	9	mycophenolate	mycophenolate	VBP
cord-005453-4057qib7	3524	10	in	in	IN
cord-005453-4057qib7	3524	11	all	all	DT
cord-005453-4057qib7	3524	12	patients	patient	NNS
cord-005453-4057qib7	3524	13	,	,	,
cord-005453-4057qib7	3524	14	except	except	IN
cord-005453-4057qib7	3524	15	one	one	CD
cord-005453-4057qib7	3524	16	patient	patient	NN
cord-005453-4057qib7	3524	17	with	with	IN
cord-005453-4057qib7	3524	18	Aplastic	Aplastic	NNP
cord-005453-4057qib7	3524	19	Anemia	Anemia	NNP
cord-005453-4057qib7	3524	20	receiving	receive	VBG
cord-005453-4057qib7	3524	21	ATG	ATG	NNP
cord-005453-4057qib7	3524	22	,	,	,
cord-005453-4057qib7	3524	23	rapamycin	rapamycin	NN
cord-005453-4057qib7	3524	24	and	and	CC
cord-005453-4057qib7	3524	25	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	3524	26	.	.	.
cord-005453-4057qib7	3525	1	Donor	donor	NN
cord-005453-4057qib7	3525	2	source	source	NN
cord-005453-4057qib7	3525	3	was	be	VBD
cord-005453-4057qib7	3525	4	PBSC	PBSC	NNS
cord-005453-4057qib7	3525	5	in	in	IN
cord-005453-4057qib7	3525	6	all	all	DT
cord-005453-4057qib7	3525	7	cases	case	NNS
cord-005453-4057qib7	3525	8	.	.	.
cord-005453-4057qib7	3526	1	Seven	seven	CD
cord-005453-4057qib7	3526	2	patients	patient	NNS
cord-005453-4057qib7	3526	3	received	receive	VBD
cord-005453-4057qib7	3526	4	family	family	NN
cord-005453-4057qib7	3526	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3526	6	(	(	-LRB-
cord-005453-4057qib7	3526	7	MMRD	MMRD	NNP
cord-005453-4057qib7	3526	8	)	)	-RRB-
cord-005453-4057qib7	3526	9	transplant	transplant	NN
cord-005453-4057qib7	3526	10	,	,	,
cord-005453-4057qib7	3526	11	1	1	CD
cord-005453-4057qib7	3526	12	patient	patient	NN
cord-005453-4057qib7	3526	13	a	a	DT
cord-005453-4057qib7	3526	14	MRD	MRD	NNP
cord-005453-4057qib7	3526	15	transplant	transplant	NN
cord-005453-4057qib7	3526	16	and	and	CC
cord-005453-4057qib7	3526	17	3	3	CD
cord-005453-4057qib7	3526	18	patients	patient	NNS
cord-005453-4057qib7	3526	19	a	a	DT
cord-005453-4057qib7	3526	20	MUD	mud	NN
cord-005453-4057qib7	3526	21	transplant	transplant	NN
cord-005453-4057qib7	3526	22	.	.	.
cord-005453-4057qib7	3527	1	Results	result	NNS
cord-005453-4057qib7	3527	2	:	:	:
cord-005453-4057qib7	3528	1	The	the	DT
cord-005453-4057qib7	3528	2	median	median	JJ
cord-005453-4057qib7	3528	3	duration	duration	NN
cord-005453-4057qib7	3528	4	of	of	IN
cord-005453-4057qib7	3528	5	defibrotide	defibrotide	NN
cord-005453-4057qib7	3528	6	therapy	therapy	NN
cord-005453-4057qib7	3528	7	was	be	VBD
cord-005453-4057qib7	3528	8	34	34	CD
cord-005453-4057qib7	3528	9	days	day	NNS
cord-005453-4057qib7	3529	1	(	(	-LRB-
cord-005453-4057qib7	3529	2	range	range	NNP
cord-005453-4057qib7	3529	3	32	32	CD
cord-005453-4057qib7	3529	4	-	-	SYM
cord-005453-4057qib7	3529	5	64	64	CD
cord-005453-4057qib7	3529	6	days	day	NNS
cord-005453-4057qib7	3529	7	)	)	-RRB-
cord-005453-4057qib7	3529	8	.	.	.
cord-005453-4057qib7	3530	1	Documented	document	VBN
cord-005453-4057qib7	3530	2	non	non	JJ
cord-005453-4057qib7	3530	3	-	-	JJ
cord-005453-4057qib7	3530	4	severe	severe	JJ
cord-005453-4057qib7	3530	5	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3530	6	bleeding	bleeding	NN
cord-005453-4057qib7	3530	7	occurred	occur	VBD
cord-005453-4057qib7	3530	8	in	in	IN
cord-005453-4057qib7	3530	9	2	2	CD
cord-005453-4057qib7	3530	10	patients	patient	NNS
cord-005453-4057qib7	3530	11	requiring	require	VBG
cord-005453-4057qib7	3530	12	defibrotide	defibrotide	NN
cord-005453-4057qib7	3530	13	temporarily	temporarily	RB
cord-005453-4057qib7	3530	14	discontinuation	discontinuation	VB
cord-005453-4057qib7	3530	15	,	,	,
cord-005453-4057qib7	3530	16	no	no	DT
cord-005453-4057qib7	3530	17	other	other	JJ
cord-005453-4057qib7	3530	18	significant	significant	JJ
cord-005453-4057qib7	3530	19	bleedings	bleeding	NNS
cord-005453-4057qib7	3530	20	were	be	VBD
cord-005453-4057qib7	3530	21	experienced	experience	VBN
cord-005453-4057qib7	3530	22	.	.	.
cord-005453-4057qib7	3531	1	Four	four	CD
cord-005453-4057qib7	3531	2	patients	patient	NNS
cord-005453-4057qib7	3531	3	developed	develop	VBD
cord-005453-4057qib7	3531	4	grade	grade	NN
cord-005453-4057qib7	3531	5	II	II	NNP
cord-005453-4057qib7	3531	6	-	-	HYPH
cord-005453-4057qib7	3531	7	IV	IV	NNP
cord-005453-4057qib7	3531	8	acute	acute	JJ
cord-005453-4057qib7	3531	9	GVHD	GVHD	NNP
cord-005453-4057qib7	3531	10	and	and	CC
cord-005453-4057qib7	3531	11	no	no	DT
cord-005453-4057qib7	3531	12	transplant	transplant	NN
cord-005453-4057qib7	3531	13	-	-	HYPH
cord-005453-4057qib7	3531	14	associated	associate	VBN
cord-005453-4057qib7	3531	15	thrombotic	thrombotic	JJ
cord-005453-4057qib7	3531	16	microangiopathy	microangiopathy	NNP
cord-005453-4057qib7	3531	17	were	be	VBD
cord-005453-4057qib7	3531	18	diagnosed	diagnose	VBN
cord-005453-4057qib7	3531	19	.	.	.
cord-005453-4057qib7	3532	1	Overall	overall	RB
cord-005453-4057qib7	3532	2	,	,	,
cord-005453-4057qib7	3532	3	SOS	SOS	NNP
cord-005453-4057qib7	3532	4	/	/	SYM
cord-005453-4057qib7	3532	5	VOD	VOD	NNP
cord-005453-4057qib7	3532	6	occurred	occur	VBD
cord-005453-4057qib7	3532	7	in	in	IN
cord-005453-4057qib7	3532	8	3/11	3/11	CD
cord-005453-4057qib7	3532	9	cases	case	NNS
cord-005453-4057qib7	3532	10	within	within	IN
cord-005453-4057qib7	3532	11	21	21	CD
cord-005453-4057qib7	3532	12	days	day	NNS
cord-005453-4057qib7	3532	13	after	after	IN
cord-005453-4057qib7	3532	14	HSCT	HSCT	NNP
cord-005453-4057qib7	3532	15	(	(	-LRB-
cord-005453-4057qib7	3532	16	days	day	NNS
cord-005453-4057qib7	3532	17	9	9	CD
cord-005453-4057qib7	3532	18	,	,	,
cord-005453-4057qib7	3532	19	10	10	CD
cord-005453-4057qib7	3532	20	and	and	CC
cord-005453-4057qib7	3532	21	13	13	CD
cord-005453-4057qib7	3532	22	)	)	-RRB-
cord-005453-4057qib7	3532	23	and	and	CC
cord-005453-4057qib7	3532	24	no	no	DT
cord-005453-4057qib7	3532	25	late	late	JJ
cord-005453-4057qib7	3532	26	-	-	HYPH
cord-005453-4057qib7	3532	27	onset	onset	NN
cord-005453-4057qib7	3532	28	SOS	SOS	NNP
cord-005453-4057qib7	3532	29	/	/	SYM
cord-005453-4057qib7	3532	30	VOD	VOD	NNP
cord-005453-4057qib7	3532	31	were	be	VBD
cord-005453-4057qib7	3532	32	diagnosed	diagnose	VBN
cord-005453-4057qib7	3532	33	.	.	.
cord-005453-4057qib7	3533	1	SOS	SOS	NNP
cord-005453-4057qib7	3533	2	/	/	SYM
cord-005453-4057qib7	3533	3	VOD	VOD	NNP
cord-005453-4057qib7	3533	4	was	be	VBD
cord-005453-4057qib7	3533	5	very	very	RB
cord-005453-4057qib7	3533	6	severe	severe	JJ
cord-005453-4057qib7	3533	7	,	,	,
cord-005453-4057qib7	3533	8	causing	cause	VBG
cord-005453-4057qib7	3533	9	MODS	mod	NNS
cord-005453-4057qib7	3533	10	and	and	CC
cord-005453-4057qib7	3533	11	death	death	NN
cord-005453-4057qib7	3533	12	in	in	IN
cord-005453-4057qib7	3533	13	all	all	DT
cord-005453-4057qib7	3533	14	3	3	CD
cord-005453-4057qib7	3533	15	cases	case	NNS
cord-005453-4057qib7	3533	16	.	.	.
cord-005453-4057qib7	3534	1	All	all	DT
cord-005453-4057qib7	3534	2	3	3	CD
cord-005453-4057qib7	3534	3	patients	patient	NNS
cord-005453-4057qib7	3534	4	were	be	VBD
cord-005453-4057qib7	3534	5	characterized	characterize	VBN
cord-005453-4057qib7	3534	6	by	by	IN
cord-005453-4057qib7	3534	7	a	a	DT
cord-005453-4057qib7	3534	8	common	common	JJ
cord-005453-4057qib7	3534	9	pattern	pattern	NN
cord-005453-4057qib7	3534	10	of	of	IN
cord-005453-4057qib7	3534	11	very	very	RB
cord-005453-4057qib7	3534	12	high	high	JJ
cord-005453-4057qib7	3534	13	risk	risk	NN
cord-005453-4057qib7	3534	14	factors	factor	NNS
cord-005453-4057qib7	3534	15	for	for	IN
cord-005453-4057qib7	3534	16	SOS	SOS	NNP
cord-005453-4057qib7	3534	17	/	/	SYM
cord-005453-4057qib7	3534	18	VOD	VOD	NNP
cord-005453-4057qib7	3534	19	by	by	IN
cord-005453-4057qib7	3534	20	prior	prior	JJ
cord-005453-4057qib7	3534	21	HSCT	HSCT	NNP
cord-005453-4057qib7	3534	22	and	and	CC
cord-005453-4057qib7	3534	23	salvage	salvage	NN
cord-005453-4057qib7	3534	24	treatment	treatment	NN
cord-005453-4057qib7	3534	25	for	for	IN
cord-005453-4057qib7	3534	26	B	b	NN
cord-005453-4057qib7	3534	27	-	-	,
cord-005453-4057qib7	3534	28	ALL	all	NN
cord-005453-4057qib7	3534	29	with	with	IN
cord-005453-4057qib7	3534	30	2	2	CD
cord-005453-4057qib7	3534	31	cycles	cycle	NNS
cord-005453-4057qib7	3534	32	of	of	IN
cord-005453-4057qib7	3534	33	IO	IO	NNP
cord-005453-4057qib7	3534	34	close	close	NN
cord-005453-4057qib7	3534	35	to	to	IN
cord-005453-4057qib7	3534	36	HSCT	HSCT	NNP
cord-005453-4057qib7	3534	37	.	.	.
cord-005453-4057qib7	3535	1	Furthermore	furthermore	RB
cord-005453-4057qib7	3535	2	,	,	,
cord-005453-4057qib7	3535	3	they	-PRON-	PRP
cord-005453-4057qib7	3535	4	all	all	DT
cord-005453-4057qib7	3535	5	received	receive	VBD
cord-005453-4057qib7	3535	6	a	a	DT
cord-005453-4057qib7	3535	7	fully	fully	RB
cord-005453-4057qib7	3535	8	myeloablative	myeloablative	JJ
cord-005453-4057qib7	3535	9	conditioning	conditioning	NN
cord-005453-4057qib7	3535	10	regimen	regimen	NN
cord-005453-4057qib7	3535	11	with	with	IN
cord-005453-4057qib7	3535	12	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	3535	13	and	and	CC
cord-005453-4057qib7	3535	14	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	3535	15	and	and	CC
cord-005453-4057qib7	3535	16	a	a	DT
cord-005453-4057qib7	3535	17	MMRD	MMRD	NNP
cord-005453-4057qib7	3535	18	transplant	transplant	NN
cord-005453-4057qib7	3535	19	.	.	.
cord-005453-4057qib7	3536	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3536	2	:	:	:
cord-005453-4057qib7	3537	1	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	3537	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3537	3	was	be	VBD
cord-005453-4057qib7	3537	4	safe	safe	JJ
cord-005453-4057qib7	3537	5	and	and	CC
cord-005453-4057qib7	3537	6	well	well	RB
cord-005453-4057qib7	3537	7	tolerated	tolerate	VBN
cord-005453-4057qib7	3537	8	with	with	IN
cord-005453-4057qib7	3537	9	no	no	DT
cord-005453-4057qib7	3537	10	severe	severe	JJ
cord-005453-4057qib7	3537	11	related	related	JJ
cord-005453-4057qib7	3537	12	complications	complication	NNS
cord-005453-4057qib7	3537	13	.	.	.
cord-005453-4057qib7	3538	1	SOS	SOS	NNP
cord-005453-4057qib7	3538	2	/	/	SYM
cord-005453-4057qib7	3538	3	VOD	VOD	NNP
cord-005453-4057qib7	3538	4	occurred	occur	VBD
cord-005453-4057qib7	3538	5	despite	despite	IN
cord-005453-4057qib7	3538	6	continuous	continuous	JJ
cord-005453-4057qib7	3538	7	DF	DF	NNP
cord-005453-4057qib7	3538	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3538	9	in	in	IN
cord-005453-4057qib7	3538	10	3/7	3/7	CD
cord-005453-4057qib7	3538	11	patients	patient	NNS
cord-005453-4057qib7	3538	12	treated	treat	VBN
cord-005453-4057qib7	3538	13	with	with	IN
cord-005453-4057qib7	3538	14	Inotuzomab	Inotuzomab	NNP
cord-005453-4057qib7	3538	15	Ozogamicin	Ozogamicin	NNP
cord-005453-4057qib7	3538	16	close	close	RB
cord-005453-4057qib7	3538	17	before	before	IN
cord-005453-4057qib7	3538	18	undergoing	undergo	VBG
cord-005453-4057qib7	3538	19	2	2	CD
cord-005453-4057qib7	3538	20	nd	nd	NNP
cord-005453-4057qib7	3538	21	transplant	transplant	NN
cord-005453-4057qib7	3538	22	.	.	.
cord-005453-4057qib7	3539	1	To	to	TO
cord-005453-4057qib7	3539	2	reduce	reduce	VB
cord-005453-4057qib7	3539	3	the	the	DT
cord-005453-4057qib7	3539	4	incidence	incidence	NN
cord-005453-4057qib7	3539	5	of	of	IN
cord-005453-4057qib7	3539	6	severe	severe	JJ
cord-005453-4057qib7	3539	7	VOD	vod	NN
cord-005453-4057qib7	3539	8	,	,	,
cord-005453-4057qib7	3539	9	pre	pre	JJ
cord-005453-4057qib7	3539	10	allo	allo	NN
cord-005453-4057qib7	3539	11	-	-	HYPH
cord-005453-4057qib7	3539	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3539	13	treatment	treatment	NN
cord-005453-4057qib7	3539	14	with	with	IN
cord-005453-4057qib7	3539	15	Inotuzomab	Inotuzomab	NNP
cord-005453-4057qib7	3539	16	Ozogamicin	Ozogamicin	NNP
cord-005453-4057qib7	3539	17	should	should	MD
cord-005453-4057qib7	3539	18	prompt	prompt	VB
cord-005453-4057qib7	3539	19	avoidance	avoidance	NN
cord-005453-4057qib7	3539	20	of	of	IN
cord-005453-4057qib7	3539	21	other	other	JJ
cord-005453-4057qib7	3539	22	cumulative	cumulative	JJ
cord-005453-4057qib7	3539	23	risk	risk	NN
cord-005453-4057qib7	3539	24	factors	factor	NNS
cord-005453-4057qib7	3539	25	for	for	IN
cord-005453-4057qib7	3539	26	VOD	VOD	NNP
cord-005453-4057qib7	3539	27	,	,	,
cord-005453-4057qib7	3539	28	such	such	JJ
cord-005453-4057qib7	3539	29	as	as	IN
cord-005453-4057qib7	3539	30	use	use	NN
cord-005453-4057qib7	3539	31	of	of	IN
cord-005453-4057qib7	3539	32	double	double	JJ
cord-005453-4057qib7	3539	33	alkylating	alkylating	JJ
cord-005453-4057qib7	3539	34	agents	agent	NNS
cord-005453-4057qib7	3539	35	.	.	.
cord-005453-4057qib7	3540	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3540	2	Background	background	NN
cord-005453-4057qib7	3540	3	:	:	:
cord-005453-4057qib7	3540	4	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3540	5	is	be	VBZ
cord-005453-4057qib7	3540	6	the	the	DT
cord-005453-4057qib7	3540	7	backbone	backbone	NN
cord-005453-4057qib7	3540	8	of	of	IN
cord-005453-4057qib7	3540	9	many	many	JJ
cord-005453-4057qib7	3540	10	preparative	preparative	JJ
cord-005453-4057qib7	3540	11	regimens	regimen	NNS
cord-005453-4057qib7	3540	12	administered	administer	VBN
cord-005453-4057qib7	3540	13	to	to	IN
cord-005453-4057qib7	3540	14	children	child	NNS
cord-005453-4057qib7	3540	15	undergoing	undergo	VBG
cord-005453-4057qib7	3540	16	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3540	17	and	and	CC
cord-005453-4057qib7	3540	18	autologous	autologous	JJ
cord-005453-4057qib7	3540	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3540	20	stem	stem	NN
cord-005453-4057qib7	3540	21	cell	cell	NN
cord-005453-4057qib7	3540	22	transplantation	transplantation	NN
cord-005453-4057qib7	3540	23	(	(	-LRB-
cord-005453-4057qib7	3540	24	HSCT	HSCT	NNP
cord-005453-4057qib7	3540	25	)	)	-RRB-
cord-005453-4057qib7	3540	26	.	.	.
cord-005453-4057qib7	3541	1	Among	among	IN
cord-005453-4057qib7	3541	2	its	-PRON-	PRP$
cord-005453-4057qib7	3541	3	many	many	JJ
cord-005453-4057qib7	3541	4	long	long	JJ
cord-005453-4057qib7	3541	5	-	-	HYPH
cord-005453-4057qib7	3541	6	term	term	NN
cord-005453-4057qib7	3541	7	adverse	adverse	JJ
cord-005453-4057qib7	3541	8	effects	effect	NNS
cord-005453-4057qib7	3541	9	,	,	,
cord-005453-4057qib7	3541	10	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3541	11	can	can	MD
cord-005453-4057qib7	3541	12	cause	cause	VB
cord-005453-4057qib7	3541	13	various	various	JJ
cord-005453-4057qib7	3541	14	degrees	degree	NNS
cord-005453-4057qib7	3541	15	of	of	IN
cord-005453-4057qib7	3541	16	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3541	17	injury	injury	NN
cord-005453-4057qib7	3541	18	.	.	.
cord-005453-4057qib7	3542	1	Although	although	IN
cord-005453-4057qib7	3542	2	well	well	RB
cord-005453-4057qib7	3542	3	described	describe	VBN
cord-005453-4057qib7	3542	4	in	in	IN
cord-005453-4057qib7	3542	5	adults	adult	NNS
cord-005453-4057qib7	3542	6	,	,	,
cord-005453-4057qib7	3542	7	there	there	EX
cord-005453-4057qib7	3542	8	are	be	VBP
cord-005453-4057qib7	3542	9	few	few	JJ
cord-005453-4057qib7	3542	10	large	large	JJ
cord-005453-4057qib7	3542	11	series	series	NN
cord-005453-4057qib7	3542	12	exploring	explore	VBG
cord-005453-4057qib7	3542	13	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3542	14	toxicity	toxicity	NN
cord-005453-4057qib7	3542	15	of	of	IN
cord-005453-4057qib7	3542	16	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3542	17	in	in	IN
cord-005453-4057qib7	3542	18	children	child	NNS
cord-005453-4057qib7	3542	19	.	.	.
cord-005453-4057qib7	3543	1	We	-PRON-	PRP
cord-005453-4057qib7	3543	2	describe	describe	VBP
cord-005453-4057qib7	3543	3	long	long	JJ
cord-005453-4057qib7	3543	4	-	-	HYPH
cord-005453-4057qib7	3543	5	term	term	NN
cord-005453-4057qib7	3543	6	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3543	7	follow	follow	NN
cord-005453-4057qib7	3543	8	-	-	HYPH
cord-005453-4057qib7	3543	9	up	up	NN
cord-005453-4057qib7	3543	10	in	in	IN
cord-005453-4057qib7	3543	11	a	a	DT
cord-005453-4057qib7	3543	12	large	large	JJ
cord-005453-4057qib7	3543	13	group	group	NN
cord-005453-4057qib7	3543	14	of	of	IN
cord-005453-4057qib7	3543	15	children	child	NNS
cord-005453-4057qib7	3543	16	treated	treat	VBN
cord-005453-4057qib7	3543	17	at	at	IN
cord-005453-4057qib7	3543	18	a	a	DT
cord-005453-4057qib7	3543	19	single	single	JJ
cord-005453-4057qib7	3543	20	center	center	NN
cord-005453-4057qib7	3543	21	who	who	WP
cord-005453-4057qib7	3543	22	had	have	VBD
cord-005453-4057qib7	3543	23	received	receive	VBN
cord-005453-4057qib7	3543	24	high	high	JJ
cord-005453-4057qib7	3543	25	-	-	HYPH
cord-005453-4057qib7	3543	26	dose	dose	NN
cord-005453-4057qib7	3543	27	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3543	28	and	and	CC
cord-005453-4057qib7	3543	29	examine	examine	VB
cord-005453-4057qib7	3543	30	the	the	DT
cord-005453-4057qib7	3543	31	relationship	relationship	NN
cord-005453-4057qib7	3543	32	of	of	IN
cord-005453-4057qib7	3543	33	systemic	systemic	JJ
cord-005453-4057qib7	3543	34	drug	drug	NN
cord-005453-4057qib7	3543	35	exposure	exposure	NN
cord-005453-4057qib7	3543	36	and	and	CC
cord-005453-4057qib7	3543	37	lung	lung	NN
cord-005453-4057qib7	3543	38	function	function	NN
cord-005453-4057qib7	3543	39	over	over	IN
cord-005453-4057qib7	3543	40	time	time	NN
cord-005453-4057qib7	3543	41	.	.	.
cord-005453-4057qib7	3544	1	Methods	method	NNS
cord-005453-4057qib7	3544	2	:	:	:
cord-005453-4057qib7	3545	1	All	all	DT
cord-005453-4057qib7	3545	2	surviving	survive	VBG
cord-005453-4057qib7	3545	3	children	child	NNS
cord-005453-4057qib7	3545	4	who	who	WP
cord-005453-4057qib7	3545	5	had	have	VBD
cord-005453-4057qib7	3545	6	received	receive	VBN
cord-005453-4057qib7	3545	7	highdose	highdose	NN
cord-005453-4057qib7	3545	8	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3545	9	between	between	IN
cord-005453-4057qib7	3545	10	1993	1993	CD
cord-005453-4057qib7	3545	11	-	-	SYM
cord-005453-4057qib7	3545	12	2013	2013	CD
cord-005453-4057qib7	3545	13	in	in	IN
cord-005453-4057qib7	3545	14	the	the	DT
cord-005453-4057qib7	3545	15	context	context	NN
cord-005453-4057qib7	3545	16	of	of	IN
cord-005453-4057qib7	3545	17	HSCT	HSCT	NNP
cord-005453-4057qib7	3545	18	at	at	IN
cord-005453-4057qib7	3545	19	the	the	DT
cord-005453-4057qib7	3545	20	Schneider	Schneider	NNP
cord-005453-4057qib7	3545	21	Children´s	Children´s	NNP
cord-005453-4057qib7	3545	22	Medical	Medical	NNP
cord-005453-4057qib7	3545	23	Center	Center	NNP
cord-005453-4057qib7	3545	24	,	,	,
cord-005453-4057qib7	3545	25	were	be	VBD
cord-005453-4057qib7	3545	26	referred	refer	VBN
cord-005453-4057qib7	3545	27	for	for	IN
cord-005453-4057qib7	3545	28	serial	serial	JJ
cord-005453-4057qib7	3545	29	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3545	30	function	function	NN
cord-005453-4057qib7	3545	31	monitoring	monitoring	NN
cord-005453-4057qib7	3545	32	(	(	-LRB-
cord-005453-4057qib7	3545	33	including	include	VBG
cord-005453-4057qib7	3545	34	spirometry	spirometry	NN
cord-005453-4057qib7	3545	35	,	,	,
cord-005453-4057qib7	3545	36	plethysmography	plethysmography	NN
cord-005453-4057qib7	3545	37	and	and	CC
cord-005453-4057qib7	3545	38	diffusing	diffuse	VBG
cord-005453-4057qib7	3545	39	capacity	capacity	NN
cord-005453-4057qib7	3545	40	for	for	IN
cord-005453-4057qib7	3545	41	carbon	carbon	NN
cord-005453-4057qib7	3545	42	monoxide	monoxide	NN
cord-005453-4057qib7	3545	43	[	[	-LRB-
cord-005453-4057qib7	3545	44	DLCO	DLCO	NNP
cord-005453-4057qib7	3545	45	]	]	-RRB-
cord-005453-4057qib7	3545	46	.	.	.
cord-005453-4057qib7	3546	1	Pre	pre	JJ
cord-005453-4057qib7	3546	2	-	-	JJ
cord-005453-4057qib7	3546	3	transplant	transplant	JJ
cord-005453-4057qib7	3546	4	testing	testing	NN
cord-005453-4057qib7	3546	5	was	be	VBD
cord-005453-4057qib7	3546	6	available	available	JJ
cord-005453-4057qib7	3546	7	for	for	IN
cord-005453-4057qib7	3546	8	children	child	NNS
cord-005453-4057qib7	3546	9	who	who	WP
cord-005453-4057qib7	3546	10	were	be	VBD
cord-005453-4057qib7	3546	11	old	old	JJ
cord-005453-4057qib7	3546	12	enough	enough	RB
cord-005453-4057qib7	3546	13	to	to	TO
cord-005453-4057qib7	3546	14	perform	perform	VB
cord-005453-4057qib7	3546	15	the	the	DT
cord-005453-4057qib7	3546	16	procedure	procedure	NN
cord-005453-4057qib7	3546	17	.	.	.
cord-005453-4057qib7	3547	1	Spirometry	Spirometry	NNP
cord-005453-4057qib7	3547	2	results	result	NNS
cord-005453-4057qib7	3547	3	were	be	VBD
cord-005453-4057qib7	3547	4	adjusted	adjust	VBN
cord-005453-4057qib7	3547	5	according	accord	VBG
cord-005453-4057qib7	3547	6	to	to	IN
cord-005453-4057qib7	3547	7	the	the	DT
cord-005453-4057qib7	3547	8	revised	revise	VBN
cord-005453-4057qib7	3547	9	Global	Global	NNP
cord-005453-4057qib7	3547	10	Lung	Lung	NNP
cord-005453-4057qib7	3547	11	Initiative	Initiative	NNP
cord-005453-4057qib7	3547	12	formulas	formula	NNS
cord-005453-4057qib7	3547	13	for	for	IN
cord-005453-4057qib7	3547	14	age	age	NN
cord-005453-4057qib7	3547	15	,	,	,
cord-005453-4057qib7	3547	16	gender	gender	NN
cord-005453-4057qib7	3547	17	,	,	,
cord-005453-4057qib7	3547	18	and	and	CC
cord-005453-4057qib7	3547	19	height	height	NN
cord-005453-4057qib7	3547	20	.	.	.
cord-005453-4057qib7	3548	1	Pulmonary	pulmonary	JJ
cord-005453-4057qib7	3548	2	injury	injury	NN
cord-005453-4057qib7	3548	3	was	be	VBD
cord-005453-4057qib7	3548	4	defined	define	VBN
cord-005453-4057qib7	3548	5	as	as	IN
cord-005453-4057qib7	3548	6	a	a	DT
cord-005453-4057qib7	3548	7	Z	z	NN
cord-005453-4057qib7	3548	8	score	score	NN
cord-005453-4057qib7	3548	9	below	below	IN
cord-005453-4057qib7	3548	10	-1.96	-1.96	CD
cord-005453-4057qib7	3548	11	for	for	IN
cord-005453-4057qib7	3548	12	spirometry	spirometry	NN
cord-005453-4057qib7	3548	13	,	,	,
cord-005453-4057qib7	3548	14	or	or	CC
cord-005453-4057qib7	3548	15	<	<	XX
cord-005453-4057qib7	3548	16	80	80	CD
cord-005453-4057qib7	3548	17	%	%	NN
cord-005453-4057qib7	3548	18	of	of	IN
cord-005453-4057qib7	3548	19	predicted	predict	VBN
cord-005453-4057qib7	3548	20	for	for	IN
cord-005453-4057qib7	3548	21	the	the	DT
cord-005453-4057qib7	3548	22	other	other	JJ
cord-005453-4057qib7	3548	23	parameters	parameter	NNS
cord-005453-4057qib7	3548	24	.	.	.
cord-005453-4057qib7	3549	1	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3549	2	levels	level	NNS
cord-005453-4057qib7	3549	3	were	be	VBD
cord-005453-4057qib7	3549	4	monitored	monitor	VBN
cord-005453-4057qib7	3549	5	following	follow	VBG
cord-005453-4057qib7	3549	6	the	the	DT
cord-005453-4057qib7	3549	7	second	second	JJ
cord-005453-4057qib7	3549	8	drug	drug	NN
cord-005453-4057qib7	3549	9	dose	dose	NN
cord-005453-4057qib7	3549	10	.	.	.
cord-005453-4057qib7	3550	1	All	all	DT
cord-005453-4057qib7	3550	2	patients	patient	NNS
cord-005453-4057qib7	3550	3	received	receive	VBD
cord-005453-4057qib7	3550	4	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3550	5	in	in	IN
cord-005453-4057qib7	3550	6	four	four	CD
cord-005453-4057qib7	3550	7	daily	daily	JJ
cord-005453-4057qib7	3550	8	doses	dose	NNS
cord-005453-4057qib7	3550	9	.	.	.
cord-005453-4057qib7	3551	1	Area	area	NN
cord-005453-4057qib7	3551	2	Under	under	IN
cord-005453-4057qib7	3551	3	the	the	DT
cord-005453-4057qib7	3551	4	Curve	curve	NN
cord-005453-4057qib7	3551	5	(	(	-LRB-
cord-005453-4057qib7	3551	6	AUC	AUC	NNP
cord-005453-4057qib7	3551	7	)	)	-RRB-
cord-005453-4057qib7	3551	8	calculations	calculation	NNS
cord-005453-4057qib7	3551	9	were	be	VBD
cord-005453-4057qib7	3551	10	performed	perform	VBN
cord-005453-4057qib7	3551	11	by	by	IN
cord-005453-4057qib7	3551	12	Bayesian	bayesian	JJ
cord-005453-4057qib7	3551	13	calculations	calculation	NNS
cord-005453-4057qib7	3551	14	.	.	.
cord-005453-4057qib7	3552	1	Results	result	NNS
cord-005453-4057qib7	3552	2	:	:	:
cord-005453-4057qib7	3553	1	Between	between	IN
cord-005453-4057qib7	3553	2	1993	1993	CD
cord-005453-4057qib7	3553	3	-	-	SYM
cord-005453-4057qib7	3553	4	2013	2013	CD
cord-005453-4057qib7	3553	5	,	,	,
cord-005453-4057qib7	3553	6	263	263	CD
cord-005453-4057qib7	3553	7	patients	patient	NNS
cord-005453-4057qib7	3553	8	aged	aged	JJ
cord-005453-4057qib7	3553	9	0	0	CD
cord-005453-4057qib7	3553	10	-	-	SYM
cord-005453-4057qib7	3553	11	18	18	CD
cord-005453-4057qib7	3553	12	years	year	NNS
cord-005453-4057qib7	3553	13	were	be	VBD
cord-005453-4057qib7	3553	14	diagnosed	diagnose	VBN
cord-005453-4057qib7	3553	15	with	with	IN
cord-005453-4057qib7	3553	16	malignant	malignant	JJ
cord-005453-4057qib7	3553	17	or	or	CC
cord-005453-4057qib7	3553	18	non	non	JJ
cord-005453-4057qib7	3553	19	-	-	JJ
cord-005453-4057qib7	3553	20	malignant	malignant	JJ
cord-005453-4057qib7	3553	21	diseases	disease	NNS
cord-005453-4057qib7	3553	22	and	and	CC
cord-005453-4057qib7	3553	23	treated	treat	VBN
cord-005453-4057qib7	3553	24	with	with	IN
cord-005453-4057qib7	3553	25	high	high	JJ
cord-005453-4057qib7	3553	26	-	-	HYPH
cord-005453-4057qib7	3553	27	dose	dose	NN
cord-005453-4057qib7	3553	28	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3553	29	.	.	.
cord-005453-4057qib7	3554	1	Of	of	IN
cord-005453-4057qib7	3554	2	130	130	CD
cord-005453-4057qib7	3554	3	shortterm	shortterm	JJ
cord-005453-4057qib7	3554	4	survivors	survivor	NNS
cord-005453-4057qib7	3554	5	,	,	,
cord-005453-4057qib7	3554	6	75	75	CD
cord-005453-4057qib7	3554	7	had	have	VBD
cord-005453-4057qib7	3554	8	at	at	RB
cord-005453-4057qib7	3554	9	least	least	RBS
cord-005453-4057qib7	3554	10	one	one	CD
cord-005453-4057qib7	3554	11	post	post	JJ
cord-005453-4057qib7	3554	12	-	-	JJ
cord-005453-4057qib7	3554	13	transplant	transplant	JJ
cord-005453-4057qib7	3554	14	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3554	15	function	function	NN
cord-005453-4057qib7	3554	16	evaluation	evaluation	NN
cord-005453-4057qib7	3554	17	.	.	.
cord-005453-4057qib7	3555	1	The	the	DT
cord-005453-4057qib7	3555	2	mean	mean	JJ
cord-005453-4057qib7	3555	3	age	age	NN
cord-005453-4057qib7	3555	4	at	at	IN
cord-005453-4057qib7	3555	5	treatment	treatment	NN
cord-005453-4057qib7	3555	6	with	with	IN
cord-005453-4057qib7	3555	7	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3555	8	was	be	VBD
cord-005453-4057qib7	3555	9	7.9	7.9	CD
cord-005453-4057qib7	3555	10	years	year	NNS
cord-005453-4057qib7	3555	11	(	(	-LRB-
cord-005453-4057qib7	3555	12	range	range	NN
cord-005453-4057qib7	3555	13	,	,	,
cord-005453-4057qib7	3555	14	0.4	0.4	CD
cord-005453-4057qib7	3555	15	-	-	SYM
cord-005453-4057qib7	3555	16	27	27	CD
cord-005453-4057qib7	3555	17	years	year	NNS
cord-005453-4057qib7	3555	18	)	)	-RRB-
cord-005453-4057qib7	3555	19	.	.	.
cord-005453-4057qib7	3556	1	Of	of	IN
cord-005453-4057qib7	3556	2	these	these	DT
cord-005453-4057qib7	3556	3	75	75	CD
cord-005453-4057qib7	3556	4	children	child	NNS
cord-005453-4057qib7	3556	5	,	,	,
cord-005453-4057qib7	3556	6	22	22	CD
cord-005453-4057qib7	3556	7	children	child	NNS
cord-005453-4057qib7	3556	8	had	have	VBD
cord-005453-4057qib7	3556	9	undergone	undergo	VBN
cord-005453-4057qib7	3556	10	autologous	autologous	JJ
cord-005453-4057qib7	3556	11	transplantation	transplantation	NN
cord-005453-4057qib7	3556	12	and	and	CC
cord-005453-4057qib7	3556	13	53	53	CD
cord-005453-4057qib7	3556	14	children	child	NNS
cord-005453-4057qib7	3556	15	had	have	VBD
cord-005453-4057qib7	3556	16	an	an	DT
cord-005453-4057qib7	3556	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	3556	18	transplant	transplant	NN
cord-005453-4057qib7	3556	19	.	.	.
cord-005453-4057qib7	3557	1	7	7	CD
cord-005453-4057qib7	3557	2	of	of	IN
cord-005453-4057qib7	3557	3	these	these	DT
cord-005453-4057qib7	3557	4	patients	patient	NNS
cord-005453-4057qib7	3557	5	eventually	eventually	RB
cord-005453-4057qib7	3557	6	relapsed	relapse	VBD
cord-005453-4057qib7	3557	7	and	and	CC
cord-005453-4057qib7	3557	8	3	3	CD
cord-005453-4057qib7	3557	9	died	die	VBD
cord-005453-4057qib7	3557	10	.	.	.
cord-005453-4057qib7	3558	1	26	26	CD
cord-005453-4057qib7	3558	2	children	child	NNS
cord-005453-4057qib7	3558	3	had	have	VBD
cord-005453-4057qib7	3558	4	one	one	CD
cord-005453-4057qib7	3558	5	or	or	CC
cord-005453-4057qib7	3558	6	more	more	JJR
cord-005453-4057qib7	3558	7	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3558	8	risk	risk	NN
cord-005453-4057qib7	3558	9	factors	factor	NNS
cord-005453-4057qib7	3558	10	before	before	IN
cord-005453-4057qib7	3558	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3558	12	-chest	-chest	RBS
cord-005453-4057qib7	3558	13	or	or	CC
cord-005453-4057qib7	3558	14	upper	upper	JJ
cord-005453-4057qib7	3558	15	abdomen	abdomen	NN
cord-005453-4057qib7	3558	16	radiation	radiation	NN
cord-005453-4057qib7	3558	17	(	(	-LRB-
cord-005453-4057qib7	3558	18	13	13	CD
cord-005453-4057qib7	3558	19	)	)	-RRB-
cord-005453-4057qib7	3558	20	,	,	,
cord-005453-4057qib7	3558	21	chest	chest	NN
cord-005453-4057qib7	3558	22	wall	wall	NN
cord-005453-4057qib7	3558	23	tumors	tumor	NNS
cord-005453-4057qib7	3558	24	or	or	CC
cord-005453-4057qib7	3558	25	lung	lung	NN
cord-005453-4057qib7	3558	26	metastasis	metastasis	NN
cord-005453-4057qib7	3558	27	(	(	-LRB-
cord-005453-4057qib7	3558	28	8)	8)	NNP
cord-005453-4057qib7	3558	29	,	,	,
cord-005453-4057qib7	3558	30	chest	chest	NN
cord-005453-4057qib7	3558	31	surgery	surgery	NN
cord-005453-4057qib7	3558	32	(	(	-LRB-
cord-005453-4057qib7	3558	33	5	5	CD
cord-005453-4057qib7	3558	34	)	)	-RRB-
cord-005453-4057qib7	3558	35	,	,	,
cord-005453-4057qib7	3558	36	prior	prior	JJ
cord-005453-4057qib7	3558	37	administration	administration	NN
cord-005453-4057qib7	3558	38	of	of	IN
cord-005453-4057qib7	3558	39	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3558	40	-	-	HYPH
cord-005453-4057qib7	3558	41	toxic	toxic	JJ
cord-005453-4057qib7	3558	42	drug	drug	NN
cord-005453-4057qib7	3558	43	(	(	-LRB-
cord-005453-4057qib7	3558	44	3	3	CD
cord-005453-4057qib7	3558	45	)	)	-RRB-
cord-005453-4057qib7	3558	46	or	or	CC
cord-005453-4057qib7	3558	47	asthma	asthma	NN
cord-005453-4057qib7	3558	48	(	(	-LRB-
cord-005453-4057qib7	3558	49	2	2	CD
cord-005453-4057qib7	3558	50	)	)	-RRB-
cord-005453-4057qib7	3558	51	.	.	.
cord-005453-4057qib7	3559	1	During	during	IN
cord-005453-4057qib7	3559	2	follow	follow	NN
cord-005453-4057qib7	3559	3	-	-	HYPH
cord-005453-4057qib7	3559	4	up	up	NN
cord-005453-4057qib7	3559	5	(	(	-LRB-
cord-005453-4057qib7	3559	6	up	up	IN
cord-005453-4057qib7	3559	7	to	to	TO
cord-005453-4057qib7	3559	8	14	14	CD
cord-005453-4057qib7	3559	9	years	year	NNS
cord-005453-4057qib7	3559	10	,	,	,
cord-005453-4057qib7	3559	11	median	median	NN
cord-005453-4057qib7	3559	12	5.5	5.5	CD
cord-005453-4057qib7	3559	13	years	year	NNS
cord-005453-4057qib7	3559	14	)	)	-RRB-
cord-005453-4057qib7	3559	15	,	,	,
cord-005453-4057qib7	3559	16	FEV1	FEV1	NNP
cord-005453-4057qib7	3559	17	and	and	CC
cord-005453-4057qib7	3559	18	FVC	FVC	NNP
cord-005453-4057qib7	3559	19	spirometry	spirometry	NN
cord-005453-4057qib7	3559	20	tests	test	NNS
cord-005453-4057qib7	3559	21	both	both	CC
cord-005453-4057qib7	3559	22	decreased	decrease	VBD
cord-005453-4057qib7	3559	23	significantly	significantly	RB
cord-005453-4057qib7	3559	24	(	(	-LRB-
cord-005453-4057qib7	3559	25	p=0.002	p=0.002	NN
cord-005453-4057qib7	3559	26	and	and	CC
cord-005453-4057qib7	3559	27	0.001	0.001	CD
cord-005453-4057qib7	3559	28	,	,	,
cord-005453-4057qib7	3559	29	respectively	respectively	RB
cord-005453-4057qib7	3559	30	)	)	-RRB-
cord-005453-4057qib7	3559	31	,	,	,
cord-005453-4057qib7	3559	32	while	while	IN
cord-005453-4057qib7	3559	33	the	the	DT
cord-005453-4057qib7	3559	34	decrease	decrease	NN
cord-005453-4057qib7	3559	35	in	in	IN
cord-005453-4057qib7	3559	36	DLCO	DLCO	NNP
cord-005453-4057qib7	3559	37	was	be	VBD
cord-005453-4057qib7	3559	38	not	not	RB
cord-005453-4057qib7	3559	39	statistically	statistically	RB
cord-005453-4057qib7	3559	40	significant	significant	JJ
cord-005453-4057qib7	3559	41	.	.	.
cord-005453-4057qib7	3560	1	35	35	CD
cord-005453-4057qib7	3560	2	%	%	NN
cord-005453-4057qib7	3560	3	of	of	IN
cord-005453-4057qib7	3560	4	patients	patient	NNS
cord-005453-4057qib7	3560	5	had	have	VBD
cord-005453-4057qib7	3560	6	abnormal	abnormal	JJ
cord-005453-4057qib7	3560	7	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3560	8	function	function	NN
cord-005453-4057qib7	3560	9	tests	test	NNS
cord-005453-4057qib7	3560	10	and	and	CC
cord-005453-4057qib7	3560	11	seven	seven	CD
cord-005453-4057qib7	3560	12	children	child	NNS
cord-005453-4057qib7	3560	13	had	have	VBD
cord-005453-4057qib7	3560	14	symptomatic	symptomatic	JJ
cord-005453-4057qib7	3560	15	disease	disease	NN
cord-005453-4057qib7	3560	16	which	which	WDT
cord-005453-4057qib7	3560	17	in	in	IN
cord-005453-4057qib7	3560	18	two	two	CD
cord-005453-4057qib7	3560	19	may	may	MD
cord-005453-4057qib7	3560	20	have	have	VB
cord-005453-4057qib7	3560	21	been	be	VBN
cord-005453-4057qib7	3560	22	manifestations	manifestation	NNS
cord-005453-4057qib7	3560	23	of	of	IN
cord-005453-4057qib7	3560	24	GVHD	GVHD	NNP
cord-005453-4057qib7	3560	25	.	.	.
cord-005453-4057qib7	3561	1	Interestingly	interestingly	RB
cord-005453-4057qib7	3561	2	,	,	,
cord-005453-4057qib7	3561	3	no	no	DT
cord-005453-4057qib7	3561	4	correlation	correlation	NN
cord-005453-4057qib7	3561	5	was	be	VBD
cord-005453-4057qib7	3561	6	found	find	VBN
cord-005453-4057qib7	3561	7	between	between	IN
cord-005453-4057qib7	3561	8	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3561	9	AUC	AUC	NNP
cord-005453-4057qib7	3561	10	,	,	,
cord-005453-4057qib7	3561	11	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3561	12	peak	peak	NN
cord-005453-4057qib7	3561	13	levels	level	NNS
cord-005453-4057qib7	3561	14	,	,	,
cord-005453-4057qib7	3561	15	the	the	DT
cord-005453-4057qib7	3561	16	number	number	NN
cord-005453-4057qib7	3561	17	of	of	IN
cord-005453-4057qib7	3561	18	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3561	19	doses	dose	NNS
cord-005453-4057qib7	3561	20	administered	administer	VBN
cord-005453-4057qib7	3561	21	,	,	,
cord-005453-4057qib7	3561	22	the	the	DT
cord-005453-4057qib7	3561	23	type	type	NN
cord-005453-4057qib7	3561	24	of	of	IN
cord-005453-4057qib7	3561	25	transplantation	transplantation	NN
cord-005453-4057qib7	3561	26	(	(	-LRB-
cord-005453-4057qib7	3561	27	autologous	autologous	JJ
cord-005453-4057qib7	3561	28	vs.	vs.	FW
cord-005453-4057qib7	3561	29	allogeneic	allogeneic	NN
cord-005453-4057qib7	3561	30	)	)	-RRB-
cord-005453-4057qib7	3561	31	or	or	CC
cord-005453-4057qib7	3561	32	primary	primary	JJ
cord-005453-4057qib7	3561	33	disease	disease	NN
cord-005453-4057qib7	3561	34	to	to	IN
cord-005453-4057qib7	3561	35	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3561	36	injury	injury	NN
cord-005453-4057qib7	3561	37	.	.	.
cord-005453-4057qib7	3562	1	Even	even	RB
cord-005453-4057qib7	3562	2	after	after	IN
cord-005453-4057qib7	3562	3	censoring	censor	VBG
cord-005453-4057qib7	3562	4	of	of	IN
cord-005453-4057qib7	3562	5	children	child	NNS
cord-005453-4057qib7	3562	6	with	with	IN
cord-005453-4057qib7	3562	7	pre	pre	JJ
cord-005453-4057qib7	3562	8	-	-	JJ
cord-005453-4057qib7	3562	9	transplant	transplant	JJ
cord-005453-4057qib7	3562	10	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3562	11	risk	risk	NN
cord-005453-4057qib7	3562	12	factors	factor	NNS
cord-005453-4057qib7	3562	13	we	-PRON-	PRP
cord-005453-4057qib7	3562	14	noted	note	VBD
cord-005453-4057qib7	3562	15	a	a	DT
cord-005453-4057qib7	3562	16	decrease	decrease	NN
cord-005453-4057qib7	3562	17	of	of	IN
cord-005453-4057qib7	3562	18	FEV1	FEV1	NNP
cord-005453-4057qib7	3562	19	and	and	CC
cord-005453-4057qib7	3562	20	FVC	FVC	NNP
cord-005453-4057qib7	3562	21	.	.	.
cord-005453-4057qib7	3563	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3563	2	:	:	:
cord-005453-4057qib7	3564	1	As	as	IN
cord-005453-4057qib7	3564	2	in	in	IN
cord-005453-4057qib7	3564	3	adults	adult	NNS
cord-005453-4057qib7	3564	4	,	,	,
cord-005453-4057qib7	3564	5	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3564	6	injury	injury	NN
cord-005453-4057qib7	3564	7	is	be	VBZ
cord-005453-4057qib7	3564	8	observed	observe	VBN
cord-005453-4057qib7	3564	9	in	in	IN
cord-005453-4057qib7	3564	10	children	child	NNS
cord-005453-4057qib7	3564	11	treated	treat	VBN
cord-005453-4057qib7	3564	12	with	with	IN
cord-005453-4057qib7	3564	13	high	high	JJ
cord-005453-4057qib7	3564	14	-	-	HYPH
cord-005453-4057qib7	3564	15	dose	dose	NN
cord-005453-4057qib7	3564	16	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3564	17	prior	prior	RB
cord-005453-4057qib7	3564	18	to	to	IN
cord-005453-4057qib7	3564	19	HSCT	HSCT	NNP
cord-005453-4057qib7	3564	20	.	.	.
cord-005453-4057qib7	3565	1	No	no	DT
cord-005453-4057qib7	3565	2	correlation	correlation	NN
cord-005453-4057qib7	3565	3	was	be	VBD
cord-005453-4057qib7	3565	4	observed	observe	VBN
cord-005453-4057qib7	3565	5	between	between	IN
cord-005453-4057qib7	3565	6	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3565	7	AUC	AUC	NNP
cord-005453-4057qib7	3565	8	and	and	CC
cord-005453-4057qib7	3565	9	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3565	10	injury	injury	NN
cord-005453-4057qib7	3565	11	.	.	.
cord-005453-4057qib7	3566	1	Follow	follow	VB
cord-005453-4057qib7	3566	2	-	-	HYPH
cord-005453-4057qib7	3566	3	up	up	NN
cord-005453-4057qib7	3566	4	of	of	IN
cord-005453-4057qib7	3566	5	children	child	NNS
cord-005453-4057qib7	3566	6	who	who	WP
cord-005453-4057qib7	3566	7	receive	receive	VBP
cord-005453-4057qib7	3566	8	this	this	DT
cord-005453-4057qib7	3566	9	drug	drug	NN
cord-005453-4057qib7	3566	10	should	should	MD
cord-005453-4057qib7	3566	11	include	include	VB
cord-005453-4057qib7	3566	12	regular	regular	JJ
cord-005453-4057qib7	3566	13	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3566	14	monitoring	monitoring	NN
cord-005453-4057qib7	3566	15	,	,	,
cord-005453-4057qib7	3566	16	referral	referral	NN
cord-005453-4057qib7	3566	17	to	to	IN
cord-005453-4057qib7	3566	18	a	a	DT
cord-005453-4057qib7	3566	19	pulmonologist	pulmonologist	NN
cord-005453-4057qib7	3566	20	when	when	WRB
cord-005453-4057qib7	3566	21	subclinical	subclinical	JJ
cord-005453-4057qib7	3566	22	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3566	23	compromise	compromise	NN
cord-005453-4057qib7	3566	24	is	be	VBZ
cord-005453-4057qib7	3566	25	found	find	VBN
cord-005453-4057qib7	3566	26	,	,	,
cord-005453-4057qib7	3566	27	and	and	CC
cord-005453-4057qib7	3566	28	counseling	counsel	VBG
cord-005453-4057qib7	3566	29	regarding	regard	VBG
cord-005453-4057qib7	3566	30	measures	measure	NNS
cord-005453-4057qib7	3566	31	that	that	WDT
cord-005453-4057qib7	3566	32	might	may	MD
cord-005453-4057qib7	3566	33	prevent	prevent	VB
cord-005453-4057qib7	3566	34	or	or	CC
cord-005453-4057qib7	3566	35	ameliorate	ameliorate	VB
cord-005453-4057qib7	3566	36	pulmonary	pulmonary	JJ
cord-005453-4057qib7	3566	37	damage	damage	NN
cord-005453-4057qib7	3566	38	.	.	.
cord-005453-4057qib7	3567	1	Continued	continue	VBN
cord-005453-4057qib7	3567	2	follow	follow	NN
cord-005453-4057qib7	3567	3	-	-	HYPH
cord-005453-4057qib7	3567	4	up	up	NN
cord-005453-4057qib7	3567	5	of	of	IN
cord-005453-4057qib7	3567	6	this	this	DT
cord-005453-4057qib7	3567	7	cohort	cohort	NN
cord-005453-4057qib7	3567	8	of	of	IN
cord-005453-4057qib7	3567	9	patients	patient	NNS
cord-005453-4057qib7	3567	10	should	should	MD
cord-005453-4057qib7	3567	11	inform	inform	VB
cord-005453-4057qib7	3567	12	our	-PRON-	PRP$
cord-005453-4057qib7	3567	13	pretransplant	pretransplant	JJ
cord-005453-4057qib7	3567	14	patient	patient	NN
cord-005453-4057qib7	3567	15	information	information	NN
cord-005453-4057qib7	3567	16	sessions	session	NNS
cord-005453-4057qib7	3567	17	,	,	,
cord-005453-4057qib7	3567	18	and	and	CC
cord-005453-4057qib7	3567	19	the	the	DT
cord-005453-4057qib7	3567	20	future	future	JJ
cord-005453-4057qib7	3567	21	use	use	NN
cord-005453-4057qib7	3567	22	of	of	IN
cord-005453-4057qib7	3567	23	Busulfan	Busulfan	NNP
cord-005453-4057qib7	3567	24	in	in	IN
cord-005453-4057qib7	3567	25	children	child	NNS
cord-005453-4057qib7	3567	26	.	.	.
cord-005453-4057qib7	3568	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3568	2	:	:	:
cord-005453-4057qib7	3568	3	Nothing	nothing	NN
cord-005453-4057qib7	3568	4	to	to	TO
cord-005453-4057qib7	3568	5	declare	declare	VB
cord-005453-4057qib7	3568	6	Background	background	NN
cord-005453-4057qib7	3568	7	:	:	:
cord-005453-4057qib7	3568	8	Transplant	transplant	NN
cord-005453-4057qib7	3568	9	-	-	HYPH
cord-005453-4057qib7	3568	10	associated	associate	VBN
cord-005453-4057qib7	3568	11	thrombotic	thrombotic	JJ
cord-005453-4057qib7	3568	12	microangiopathy	microangiopathy	NNP
cord-005453-4057qib7	3568	13	(	(	-LRB-
cord-005453-4057qib7	3568	14	TA	TA	NNP
cord-005453-4057qib7	3568	15	-	-	HYPH
cord-005453-4057qib7	3568	16	TMA	TMA	NNP
cord-005453-4057qib7	3568	17	)	)	-RRB-
cord-005453-4057qib7	3568	18	is	be	VBZ
cord-005453-4057qib7	3568	19	a	a	DT
cord-005453-4057qib7	3568	20	specific	specific	JJ
cord-005453-4057qib7	3568	21	complication	complication	NN
cord-005453-4057qib7	3568	22	of	of	IN
cord-005453-4057qib7	3568	23	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3568	24	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3568	25	stem	stem	NN
cord-005453-4057qib7	3568	26	cell	cell	NN
cord-005453-4057qib7	3568	27	transplantation	transplantation	NN
cord-005453-4057qib7	3568	28	(	(	-LRB-
cord-005453-4057qib7	3568	29	HSCT	HSCT	NNP
cord-005453-4057qib7	3568	30	)	)	-RRB-
cord-005453-4057qib7	3568	31	.	.	.
cord-005453-4057qib7	3569	1	Post	post	JJ
cord-005453-4057qib7	3569	2	-	-	JJ
cord-005453-4057qib7	3569	3	HSCT	HSCT	NNP
cord-005453-4057qib7	3569	4	TMA	TMA	NNP
cord-005453-4057qib7	3569	5	has	have	VBZ
cord-005453-4057qib7	3569	6	been	be	VBN
cord-005453-4057qib7	3569	7	attributed	attribute	VBN
cord-005453-4057qib7	3569	8	to	to	IN
cord-005453-4057qib7	3569	9	the	the	DT
cord-005453-4057qib7	3569	10	vascular	vascular	JJ
cord-005453-4057qib7	3569	11	endothelial	endothelial	JJ
cord-005453-4057qib7	3569	12	damage	damage	NN
cord-005453-4057qib7	3569	13	caused	cause	VBN
cord-005453-4057qib7	3569	14	by	by	IN
cord-005453-4057qib7	3569	15	high	high	JJ
cord-005453-4057qib7	3569	16	-	-	HYPH
cord-005453-4057qib7	3569	17	dose	dose	NN
cord-005453-4057qib7	3569	18	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3569	19	,	,	,
cord-005453-4057qib7	3569	20	calcineurin	calcineurin	NN
cord-005453-4057qib7	3569	21	inhibitors	inhibitor	NNS
cord-005453-4057qib7	3569	22	(	(	-LRB-
cord-005453-4057qib7	3569	23	CNIs	CNIs	NNP
cord-005453-4057qib7	3569	24	)	)	-RRB-
cord-005453-4057qib7	3569	25	,	,	,
cord-005453-4057qib7	3569	26	graft	graft	NN
cord-005453-4057qib7	3569	27	-	-	HYPH
cord-005453-4057qib7	3569	28	versus	versus	IN
cord-005453-4057qib7	3569	29	-	-	HYPH
cord-005453-4057qib7	3569	30	host	host	NN
cord-005453-4057qib7	3569	31	disease	disease	NN
cord-005453-4057qib7	3569	32	(	(	-LRB-
cord-005453-4057qib7	3569	33	GVHD	GVHD	NNP
cord-005453-4057qib7	3569	34	)	)	-RRB-
cord-005453-4057qib7	3569	35	,	,	,
cord-005453-4057qib7	3569	36	infections	infection	NNS
cord-005453-4057qib7	3569	37	.	.	.
cord-005453-4057qib7	3570	1	There	there	EX
cord-005453-4057qib7	3570	2	is	be	VBZ
cord-005453-4057qib7	3570	3	a	a	DT
cord-005453-4057qib7	3570	4	little	little	JJ
cord-005453-4057qib7	3570	5	evidence	evidence	NN
cord-005453-4057qib7	3570	6	published	publish	VBN
cord-005453-4057qib7	3570	7	regarding	regard	VBG
cord-005453-4057qib7	3570	8	the	the	DT
cord-005453-4057qib7	3570	9	efficacy	efficacy	NN
cord-005453-4057qib7	3570	10	and	and	CC
cord-005453-4057qib7	3570	11	factors	factor	NNS
cord-005453-4057qib7	3570	12	influencing	influence	VBG
cord-005453-4057qib7	3570	13	the	the	DT
cord-005453-4057qib7	3570	14	outcome	outcome	NN
cord-005453-4057qib7	3570	15	of	of	IN
cord-005453-4057qib7	3570	16	withdrawal	withdrawal	NN
cord-005453-4057qib7	3570	17	of	of	IN
cord-005453-4057qib7	3570	18	CNIs	cni	NNS
cord-005453-4057qib7	3570	19	.	.	.
cord-005453-4057qib7	3571	1	Methods	method	NNS
cord-005453-4057qib7	3571	2	:	:	:
cord-005453-4057qib7	3572	1	The	the	DT
cord-005453-4057qib7	3572	2	analysis	analysis	NN
cord-005453-4057qib7	3572	3	comprised	comprise	VBD
cord-005453-4057qib7	3572	4	a	a	DT
cord-005453-4057qib7	3572	5	total	total	NN
cord-005453-4057qib7	3572	6	of	of	IN
cord-005453-4057qib7	3572	7	54	54	CD
cord-005453-4057qib7	3572	8	patients	patient	NNS
cord-005453-4057qib7	3572	9	,	,	,
cord-005453-4057qib7	3572	10	with	with	IN
cord-005453-4057qib7	3572	11	diagnosed	diagnosed	JJ
cord-005453-4057qib7	3572	12	hematologic	hematologic	JJ
cord-005453-4057qib7	3572	13	malignancy	malignancy	NN
cord-005453-4057qib7	3572	14	(	(	-LRB-
cord-005453-4057qib7	3572	15	AML	AML	NNP
cord-005453-4057qib7	3572	16	(	(	-LRB-
cord-005453-4057qib7	3572	17	16	16	CD
cord-005453-4057qib7	3572	18	)	)	-RRB-
cord-005453-4057qib7	3572	19	,	,	,
cord-005453-4057qib7	3572	20	ALL	all	DT
cord-005453-4057qib7	3572	21	(	(	-LRB-
cord-005453-4057qib7	3572	22	12	12	CD
cord-005453-4057qib7	3572	23	)	)	-RRB-
cord-005453-4057qib7	3572	24	,	,	,
cord-005453-4057qib7	3572	25	MDS	MDS	NNP
cord-005453-4057qib7	3572	26	(	(	-LRB-
cord-005453-4057qib7	3572	27	4	4	CD
cord-005453-4057qib7	3572	28	)	)	-RRB-
cord-005453-4057qib7	3572	29	,	,	,
cord-005453-4057qib7	3572	30	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	3572	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	3572	32	(	(	-LRB-
cord-005453-4057qib7	3572	33	5	5	CD
cord-005453-4057qib7	3572	34	)	)	-RRB-
cord-005453-4057qib7	3572	35	,	,	,
cord-005453-4057qib7	3572	36	CML	CML	NNP
cord-005453-4057qib7	3572	37	(	(	-LRB-
cord-005453-4057qib7	3572	38	3	3	CD
cord-005453-4057qib7	3572	39	)	)	-RRB-
cord-005453-4057qib7	3572	40	and	and	CC
cord-005453-4057qib7	3572	41	Neuroblastoma	Neuroblastoma	NNP
cord-005453-4057qib7	3572	42	(	(	-LRB-
cord-005453-4057qib7	3572	43	1	1	CD
cord-005453-4057qib7	3572	44	)	)	-RRB-
cord-005453-4057qib7	3572	45	received	receive	VBD
cord-005453-4057qib7	3572	46	allo	allo	NN
cord-005453-4057qib7	3572	47	-	-	HYPH
cord-005453-4057qib7	3572	48	SCT	SCT	NNP
cord-005453-4057qib7	3572	49	,	,	,
cord-005453-4057qib7	3572	50	from	from	IN
cord-005453-4057qib7	3572	51	a	a	DT
cord-005453-4057qib7	3572	52	matched	match	VBN
cord-005453-4057qib7	3572	53	related	relate	VBN
cord-005453-4057qib7	3572	54	,	,	,
cord-005453-4057qib7	3572	55	unrelated	unrelated	JJ
cord-005453-4057qib7	3572	56	or	or	CC
cord-005453-4057qib7	3572	57	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3572	58	donor	donor	NN
cord-005453-4057qib7	3572	59	between	between	IN
cord-005453-4057qib7	3572	60	2007	2007	CD
cord-005453-4057qib7	3572	61	and	and	CC
cord-005453-4057qib7	3572	62	2018	2018	CD
cord-005453-4057qib7	3572	63	.	.	.
cord-005453-4057qib7	3573	1	Patients	patient	NNS
cord-005453-4057qib7	3573	2	were	be	VBD
cord-005453-4057qib7	3573	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	3573	4	with	with	IN
cord-005453-4057qib7	3573	5	TA	TA	NNP
cord-005453-4057qib7	3573	6	-	-	HYPH
cord-005453-4057qib7	3573	7	TMA	TMA	NNP
cord-005453-4057qib7	3573	8	based	base	VBN
cord-005453-4057qib7	3573	9	on	on	IN
cord-005453-4057qib7	3573	10	Cho	Cho	NNP
cord-005453-4057qib7	3573	11	criteria	criterion	NNS
cord-005453-4057qib7	3573	12	.	.	.
cord-005453-4057qib7	3574	1	The	the	DT
cord-005453-4057qib7	3574	2	median	median	JJ
cord-005453-4057qib7	3574	3	age	age	NN
cord-005453-4057qib7	3574	4	of	of	IN
cord-005453-4057qib7	3574	5	patients	patient	NNS
cord-005453-4057qib7	3574	6	was	be	VBD
cord-005453-4057qib7	3574	7	23	23	CD
cord-005453-4057qib7	3574	8	(	(	-LRB-
cord-005453-4057qib7	3574	9	37	37	CD
cord-005453-4057qib7	3574	10	adults	adult	NNS
cord-005453-4057qib7	3574	11	,	,	,
cord-005453-4057qib7	3574	12	17	17	CD
cord-005453-4057qib7	3574	13	children	child	NNS
cord-005453-4057qib7	3574	14	)	)	-RRB-
cord-005453-4057qib7	3574	15	.	.	.
cord-005453-4057qib7	3575	1	GVHD	GVHD	NNP
cord-005453-4057qib7	3575	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3575	3	was	be	VBD
cord-005453-4057qib7	3575	4	performed	perform	VBN
cord-005453-4057qib7	3575	5	with	with	IN
cord-005453-4057qib7	3575	6	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	3575	7	(	(	-LRB-
cord-005453-4057qib7	3575	8	Tac	Tac	NNP
cord-005453-4057qib7	3575	9	)	)	-RRB-
cord-005453-4057qib7	3575	10	in	in	IN
cord-005453-4057qib7	3575	11	42	42	CD
cord-005453-4057qib7	3575	12	,	,	,
cord-005453-4057qib7	3575	13	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	3575	14	A(CsA	a(csa	CD
cord-005453-4057qib7	3575	15	)	)	-RRB-
cord-005453-4057qib7	3575	16	in	in	IN
cord-005453-4057qib7	3575	17	11	11	CD
cord-005453-4057qib7	3575	18	,	,	,
cord-005453-4057qib7	3575	19	combination	combination	NN
cord-005453-4057qib7	3575	20	tacrolimus+sirolimus	tacrolimus+sirolimus	NN
cord-005453-4057qib7	3575	21	(	(	-LRB-
cord-005453-4057qib7	3575	22	Sir	Sir	NNP
cord-005453-4057qib7	3575	23	)	)	-RRB-
cord-005453-4057qib7	3575	24	in	in	IN
cord-005453-4057qib7	3575	25	12	12	CD
cord-005453-4057qib7	3575	26	.	.	.
cord-005453-4057qib7	3576	1	24	24	CD
cord-005453-4057qib7	3576	2	patients	patient	NNS
cord-005453-4057qib7	3576	3	received	receive	VBD
cord-005453-4057qib7	3576	4	ATG	ATG	NNP
cord-005453-4057qib7	3576	5	and	and	CC
cord-005453-4057qib7	3576	6	26	26	CD
cord-005453-4057qib7	3576	7	PTCy	PTCy	NNS
cord-005453-4057qib7	3576	8	.	.	.
cord-005453-4057qib7	3577	1	Withdrawal	withdrawal	NN
cord-005453-4057qib7	3577	2	of	of	IN
cord-005453-4057qib7	3577	3	CNIs	cni	NNS
cord-005453-4057qib7	3577	4	was	be	VBD
cord-005453-4057qib7	3577	5	accompanied	accompany	VBN
cord-005453-4057qib7	3577	6	by	by	IN
cord-005453-4057qib7	3577	7	administration	administration	NN
cord-005453-4057qib7	3577	8	of	of	IN
cord-005453-4057qib7	3577	9	systemic	systemic	JJ
cord-005453-4057qib7	3577	10	steroids	steroid	NNS
cord-005453-4057qib7	3577	11	(	(	-LRB-
cord-005453-4057qib7	3577	12	21	21	CD
cord-005453-4057qib7	3577	13	patients	patient	NNS
cord-005453-4057qib7	3577	14	)	)	-RRB-
cord-005453-4057qib7	3577	15	or	or	CC
cord-005453-4057qib7	3577	16	substitution	substitution	NN
cord-005453-4057qib7	3577	17	with	with	IN
cord-005453-4057qib7	3577	18	Sir	Sir	NNP
cord-005453-4057qib7	3577	19	after	after	IN
cord-005453-4057qib7	3577	20	reaching	reach	VBG
cord-005453-4057qib7	3577	21	levels	level	NNS
cord-005453-4057qib7	3577	22	of	of	IN
cord-005453-4057qib7	3577	23	CsA	CsA	NNP
cord-005453-4057qib7	3577	24	<	<	XX
cord-005453-4057qib7	3577	25	100	100	CD
cord-005453-4057qib7	3577	26	ng	ng	NNP
cord-005453-4057qib7	3577	27	/	/	SYM
cord-005453-4057qib7	3577	28	ml	ml	NN
cord-005453-4057qib7	3577	29	or	or	CC
cord-005453-4057qib7	3577	30	Tac	Tac	NNP
cord-005453-4057qib7	3577	31	<	<	XX
cord-005453-4057qib7	3577	32	3	3	CD
cord-005453-4057qib7	3577	33	ng	ng	NNP
cord-005453-4057qib7	3577	34	/	/	SYM
cord-005453-4057qib7	3577	35	ml	ml	NN
cord-005453-4057qib7	3577	36	in	in	IN
cord-005453-4057qib7	3577	37	13	13	CD
cord-005453-4057qib7	3577	38	.	.	.
cord-005453-4057qib7	3578	1	The	the	DT
cord-005453-4057qib7	3578	2	target	target	NN
cord-005453-4057qib7	3578	3	concentration	concentration	NN
cord-005453-4057qib7	3578	4	of	of	IN
cord-005453-4057qib7	3578	5	Sir	Sir	NNP
cord-005453-4057qib7	3578	6	was	be	VBD
cord-005453-4057qib7	3578	7	3	3	CD
cord-005453-4057qib7	3578	8	-	-	SYM
cord-005453-4057qib7	3578	9	9	9	CD
cord-005453-4057qib7	3578	10	ng	ng	NN
cord-005453-4057qib7	3578	11	/	/	SYM
cord-005453-4057qib7	3578	12	ml	ml	NN
cord-005453-4057qib7	3578	13	.	.	.
cord-005453-4057qib7	3579	1	In	in	IN
cord-005453-4057qib7	3579	2	pediatric	pediatric	JJ
cord-005453-4057qib7	3579	3	patients	patient	NNS
cord-005453-4057qib7	3579	4	who	who	WP
cord-005453-4057qib7	3579	5	received	receive	VBD
cord-005453-4057qib7	3579	6	combination	combination	NN
cord-005453-4057qib7	3579	7	Tac+Sir	Tac+Sir	NNP
cord-005453-4057qib7	3579	8	,	,	,
cord-005453-4057qib7	3579	9	the	the	DT
cord-005453-4057qib7	3579	10	Tac	Tac	NNP
cord-005453-4057qib7	3579	11	was	be	VBD
cord-005453-4057qib7	3579	12	discontinued	discontinue	VBN
cord-005453-4057qib7	3579	13	in	in	IN
cord-005453-4057qib7	3579	14	one	one	CD
cord-005453-4057qib7	3579	15	step	step	NN
cord-005453-4057qib7	3579	16	while	while	IN
cord-005453-4057qib7	3579	17	Sir	Sir	NNP
cord-005453-4057qib7	3579	18	continued	continue	VBD
cord-005453-4057qib7	3579	19	.	.	.
cord-005453-4057qib7	3580	1	Median	median	JJ
cord-005453-4057qib7	3580	2	time	time	NN
cord-005453-4057qib7	3580	3	to	to	IN
cord-005453-4057qib7	3580	4	development	development	NN
cord-005453-4057qib7	3581	1	TMA	TMA	NNP
cord-005453-4057qib7	3581	2	was	be	VBD
cord-005453-4057qib7	3581	3	31,5	31,5	CD
cord-005453-4057qib7	3581	4	days	day	NNS
cord-005453-4057qib7	3581	5	after	after	IN
cord-005453-4057qib7	3581	6	allo	allo	NN
cord-005453-4057qib7	3581	7	-	-	HYPH
cord-005453-4057qib7	3581	8	SCT	SCT	NNP
cord-005453-4057qib7	3581	9	(	(	-LRB-
cord-005453-4057qib7	3581	10	range	range	NNP
cord-005453-4057qib7	3581	11	1	1	CD
cord-005453-4057qib7	3581	12	-	-	SYM
cord-005453-4057qib7	3581	13	408	408	CD
cord-005453-4057qib7	3581	14	)	)	-RRB-
cord-005453-4057qib7	3581	15	.	.	.
cord-005453-4057qib7	3582	1	Median	median	JJ
cord-005453-4057qib7	3582	2	follow	follow	NN
cord-005453-4057qib7	3582	3	-	-	HYPH
cord-005453-4057qib7	3582	4	up	up	NN
cord-005453-4057qib7	3582	5	of	of	IN
cord-005453-4057qib7	3582	6	surviving	survive	VBG
cord-005453-4057qib7	3582	7	patients	patient	NNS
cord-005453-4057qib7	3582	8	was	be	VBD
cord-005453-4057qib7	3582	9	395	395	CD
cord-005453-4057qib7	3582	10	days	day	NNS
cord-005453-4057qib7	3582	11	.	.	.
cord-005453-4057qib7	3583	1	The	the	DT
cord-005453-4057qib7	3583	2	primary	primary	JJ
cord-005453-4057qib7	3583	3	outcome	outcome	NN
cord-005453-4057qib7	3583	4	was	be	VBD
cord-005453-4057qib7	3583	5	overall	overall	JJ
cord-005453-4057qib7	3583	6	survival	survival	NN
cord-005453-4057qib7	3583	7	(	(	-LRB-
cord-005453-4057qib7	3583	8	OS	OS	NNP
cord-005453-4057qib7	3583	9	)	)	-RRB-
cord-005453-4057qib7	3583	10	up	up	IN
cord-005453-4057qib7	3583	11	to	to	TO
cord-005453-4057qib7	3583	12	2	2	CD
cord-005453-4057qib7	3583	13	years	year	NNS
cord-005453-4057qib7	3583	14	after	after	IN
cord-005453-4057qib7	3583	15	development	development	NN
cord-005453-4057qib7	3583	16	of	of	IN
cord-005453-4057qib7	3583	17	TA	TA	NNP
cord-005453-4057qib7	3583	18	-	-	HYPH
cord-005453-4057qib7	3583	19	TMA	TMA	NNP
cord-005453-4057qib7	3583	20	.	.	.
cord-005453-4057qib7	3584	1	Results	result	NNS
cord-005453-4057qib7	3584	2	:	:	:
cord-005453-4057qib7	3585	1	The	the	DT
cord-005453-4057qib7	3585	2	following	follow	VBG
cord-005453-4057qib7	3585	3	significant	significant	JJ
cord-005453-4057qib7	3585	4	predictors	predictor	NNS
cord-005453-4057qib7	3585	5	of	of	IN
cord-005453-4057qib7	3585	6	2-year	2-year	CD
cord-005453-4057qib7	3585	7	OS	OS	NNP
cord-005453-4057qib7	3585	8	were	be	VBD
cord-005453-4057qib7	3585	9	identified	identify	VBN
cord-005453-4057qib7	3585	10	:	:	:
cord-005453-4057qib7	3585	11	Tac	Tac	NNP
cord-005453-4057qib7	3585	12	replacement	replacement	NN
cord-005453-4057qib7	3585	13	with	with	IN
cord-005453-4057qib7	3585	14	Sir	Sir	NNP
cord-005453-4057qib7	3585	15	(	(	-LRB-
cord-005453-4057qib7	3585	16	p	p	NN
cord-005453-4057qib7	3585	17	<	<	XX
cord-005453-4057qib7	3585	18	0,001	0,001	CD
cord-005453-4057qib7	3585	19	)	)	-RRB-
cord-005453-4057qib7	3585	20	,	,	,
cord-005453-4057qib7	3585	21	PTCy	PTCy	NNS
cord-005453-4057qib7	3585	22	in	in	IN
cord-005453-4057qib7	3585	23	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3585	24	(	(	-LRB-
cord-005453-4057qib7	3585	25	p	p	NN
cord-005453-4057qib7	3585	26	<	<	XX
cord-005453-4057qib7	3585	27	0,001	0,001	CD
cord-005453-4057qib7	3585	28	)	)	-RRB-
cord-005453-4057qib7	3585	29	,	,	,
cord-005453-4057qib7	3585	30	acute	acute	JJ
cord-005453-4057qib7	3585	31	GVHD	GVHD	NNP
cord-005453-4057qib7	3585	32	(	(	-LRB-
cord-005453-4057qib7	3585	33	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3585	34	)	)	-RRB-
cord-005453-4057qib7	3585	35	grade	grade	NN
cord-005453-4057qib7	3585	36	2	2	CD
cord-005453-4057qib7	3585	37	-	-	SYM
cord-005453-4057qib7	3585	38	4	4	CD
cord-005453-4057qib7	3585	39	(	(	-LRB-
cord-005453-4057qib7	3585	40	p=0,029	p=0,029	NNP
cord-005453-4057qib7	3585	41	)	)	-RRB-
cord-005453-4057qib7	3585	42	,	,	,
cord-005453-4057qib7	3585	43	previous	previous	JJ
cord-005453-4057qib7	3585	44	sepsis	sepsis	NN
cord-005453-4057qib7	3585	45	(	(	-LRB-
cord-005453-4057qib7	3585	46	p=0,003	p=0,003	NNP
cord-005453-4057qib7	3585	47	)	)	-RRB-
cord-005453-4057qib7	3585	48	,	,	,
cord-005453-4057qib7	3585	49	level	level	NN
cord-005453-4057qib7	3585	50	of	of	IN
cord-005453-4057qib7	3585	51	LDH	LDH	NNP
cord-005453-4057qib7	3585	52	in	in	IN
cord-005453-4057qib7	3585	53	debut	debut	NN
cord-005453-4057qib7	3585	54	(	(	-LRB-
cord-005453-4057qib7	3585	55	p=0,001	p=0,001	NNP
cord-005453-4057qib7	3585	56	)	)	-RRB-
cord-005453-4057qib7	3585	57	,	,	,
cord-005453-4057qib7	3585	58	combination	combination	NN
cord-005453-4057qib7	3585	59	Sir+Tac	Sir+Tac	NNP
cord-005453-4057qib7	3585	60	in	in	IN
cord-005453-4057qib7	3585	61	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3585	62	(	(	-LRB-
cord-005453-4057qib7	3585	63	p=0,05	p=0,05	NNP
cord-005453-4057qib7	3585	64	)	)	-RRB-
cord-005453-4057qib7	3585	65	,	,	,
cord-005453-4057qib7	3585	66	major	major	JJ
cord-005453-4057qib7	3585	67	AB0-mismatch	ab0-mismatch	NN
cord-005453-4057qib7	3585	68	(	(	-LRB-
cord-005453-4057qib7	3585	69	p=0,022	p=0,022	NNP
cord-005453-4057qib7	3585	70	)	)	-RRB-
cord-005453-4057qib7	3585	71	,	,	.
cord-005453-4057qib7	3586	1	severity	severity	NN
cord-005453-4057qib7	3586	2	of	of	IN
cord-005453-4057qib7	3586	3	CNS	CNS	NNP
cord-005453-4057qib7	3586	4	symptoms	symptom	NNS
cord-005453-4057qib7	3586	5	(	(	-LRB-
cord-005453-4057qib7	3586	6	p	p	NN
cord-005453-4057qib7	3586	7	<	<	XX
cord-005453-4057qib7	3586	8	0,001	0,001	CD
cord-005453-4057qib7	3586	9	)	)	-RRB-
cord-005453-4057qib7	3586	10	.	.	.
cord-005453-4057qib7	3587	1	There	there	EX
cord-005453-4057qib7	3587	2	was	be	VBD
cord-005453-4057qib7	3587	3	no	no	DT
cord-005453-4057qib7	3587	4	significant	significant	JJ
cord-005453-4057qib7	3587	5	difference	difference	NN
cord-005453-4057qib7	3587	6	in	in	IN
cord-005453-4057qib7	3587	7	OS	OS	NNP
cord-005453-4057qib7	3587	8	according	accord	VBG
cord-005453-4057qib7	3587	9	to	to	IN
cord-005453-4057qib7	3587	10	patients	patient	NNS
cord-005453-4057qib7	3587	11	'	'	POS
cord-005453-4057qib7	3587	12	age	age	NN
cord-005453-4057qib7	3587	13	,	,	,
cord-005453-4057qib7	3587	14	sex	sex	NN
cord-005453-4057qib7	3587	15	,	,	,
cord-005453-4057qib7	3587	16	"	"	``
cord-005453-4057qib7	3587	17	salvage	salvage	NN
cord-005453-4057qib7	3587	18	"	"	''
cord-005453-4057qib7	3587	19	disease	disease	NN
cord-005453-4057qib7	3587	20	status	status	NN
cord-005453-4057qib7	3587	21	at	at	IN
cord-005453-4057qib7	3587	22	transplantation	transplantation	NN
cord-005453-4057qib7	3587	23	,	,	,
cord-005453-4057qib7	3587	24	previous	previous	JJ
cord-005453-4057qib7	3587	25	VOD	vod	NN
cord-005453-4057qib7	3587	26	,	,	,
cord-005453-4057qib7	3587	27	viral	viral	JJ
cord-005453-4057qib7	3587	28	(	(	-LRB-
cord-005453-4057qib7	3587	29	HHV	HHV	NNP
cord-005453-4057qib7	3587	30	1,2,6	1,2,6	CD
cord-005453-4057qib7	3587	31	,	,	,
cord-005453-4057qib7	3587	32	CMV	CMV	NNP
cord-005453-4057qib7	3587	33	,	,	,
cord-005453-4057qib7	3587	34	EBV	EBV	NNP
cord-005453-4057qib7	3587	35	)	)	-RRB-
cord-005453-4057qib7	3587	36	reactivations	reactivation	NNS
cord-005453-4057qib7	3587	37	,	,	,
cord-005453-4057qib7	3587	38	count	count	NN
cord-005453-4057qib7	3587	39	of	of	IN
cord-005453-4057qib7	3587	40	CD34	CD34	NNP
cord-005453-4057qib7	3587	41	+	+	CC
cord-005453-4057qib7	3587	42	cells	cell	NNS
cord-005453-4057qib7	3587	43	transfused	transfuse	VBN
cord-005453-4057qib7	3587	44	,	,	,
cord-005453-4057qib7	3587	45	LDH	LDH	NNP
cord-005453-4057qib7	3587	46	level	level	NN
cord-005453-4057qib7	3587	47	,	,	,
cord-005453-4057qib7	3587	48	shizocytes	shizocyte	NNS
cord-005453-4057qib7	3587	49	and	and	CC
cord-005453-4057qib7	3587	50	creatinine	creatinine	NN
cord-005453-4057qib7	3587	51	in	in	IN
cord-005453-4057qib7	3587	52	the	the	DT
cord-005453-4057qib7	3587	53	debut	debut	NN
cord-005453-4057qib7	3587	54	of	of	IN
cord-005453-4057qib7	3587	55	TA	TA	NNP
cord-005453-4057qib7	3587	56	-	-	HYPH
cord-005453-4057qib7	3587	57	TMA	TMA	NNP
cord-005453-4057qib7	3587	58	.	.	.
cord-005453-4057qib7	3588	1	In	in	IN
cord-005453-4057qib7	3588	2	the	the	DT
cord-005453-4057qib7	3588	3	multivariate	multivariate	JJ
cord-005453-4057qib7	3588	4	analysis	analysis	NN
cord-005453-4057qib7	3588	5	replacement	replacement	NN
cord-005453-4057qib7	3588	6	of	of	IN
cord-005453-4057qib7	3588	7	CNIs	cni	NNS
cord-005453-4057qib7	3588	8	with	with	IN
cord-005453-4057qib7	3588	9	Sir	Sir	NNP
cord-005453-4057qib7	3588	10	(	(	-LRB-
cord-005453-4057qib7	3588	11	HR	HR	NNP
cord-005453-4057qib7	3588	12	0.27	0.27	CD
cord-005453-4057qib7	3588	13	,	,	,
cord-005453-4057qib7	3588	14	95%CI	95%ci	CD
cord-005453-4057qib7	3588	15	0.08	0.08	CD
cord-005453-4057qib7	3588	16	-	-	HYPH
cord-005453-4057qib7	3588	17	0.96	0.96	CD
cord-005453-4057qib7	3588	18	,	,	,
cord-005453-4057qib7	3588	19	p=0.018	p=0.018	NNP
cord-005453-4057qib7	3588	20	)	)	-RRB-
cord-005453-4057qib7	3588	21	and	and	CC
cord-005453-4057qib7	3588	22	baseline	baseline	JJ
cord-005453-4057qib7	3588	23	LDH	LDH	NNP
cord-005453-4057qib7	3588	24	level	level	NN
cord-005453-4057qib7	3588	25	(	(	-LRB-
cord-005453-4057qib7	3588	26	HR	HR	NNP
cord-005453-4057qib7	3588	27	1.01	1.01	CD
cord-005453-4057qib7	3588	28	,	,	,
cord-005453-4057qib7	3588	29	95%HR	95%hr	CD
cord-005453-4057qib7	3588	30	1.00	1.00	CD
cord-005453-4057qib7	3588	31	-	-	SYM
cord-005453-4057qib7	3588	32	1.01	1.01	CD
cord-005453-4057qib7	3588	33	,	,	,
cord-005453-4057qib7	3588	34	p=0.029	p=0.029	NNP
cord-005453-4057qib7	3588	35	)	)	-RRB-
cord-005453-4057qib7	3588	36	were	be	VBD
cord-005453-4057qib7	3588	37	associated	associate	VBN
cord-005453-4057qib7	3588	38	with	with	IN
cord-005453-4057qib7	3588	39	survival	survival	NN
cord-005453-4057qib7	3588	40	differences	difference	NNS
cord-005453-4057qib7	3588	41	.	.	.
cord-005453-4057qib7	3589	1	The	the	DT
cord-005453-4057qib7	3589	2	cut	cut	NN
cord-005453-4057qib7	3589	3	off	off	RP
cord-005453-4057qib7	3589	4	for	for	IN
cord-005453-4057qib7	3589	5	LDH	LDH	NNP
cord-005453-4057qib7	3589	6	was	be	VBD
cord-005453-4057qib7	3589	7	4xUNL	4xunl	CD
cord-005453-4057qib7	3589	8	.	.	.
cord-005453-4057qib7	3590	1	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3590	2	grade	grade	NN
cord-005453-4057qib7	3590	3	2	2	CD
cord-005453-4057qib7	3590	4	-	-	SYM
cord-005453-4057qib7	3590	5	4	4	CD
cord-005453-4057qib7	3590	6	(	(	-LRB-
cord-005453-4057qib7	3590	7	HR	HR	NNP
cord-005453-4057qib7	3590	8	1.96	1.96	CD
cord-005453-4057qib7	3590	9	,	,	,
cord-005453-4057qib7	3590	10	p=0	p=0	NNP
cord-005453-4057qib7	3590	11	,	,	,
cord-005453-4057qib7	3590	12	081	081	CD
cord-005453-4057qib7	3590	13	)	)	-RRB-
cord-005453-4057qib7	3590	14	and	and	CC
cord-005453-4057qib7	3590	15	use	use	NN
cord-005453-4057qib7	3590	16	of	of	IN
cord-005453-4057qib7	3590	17	PTCy	PTCy	NNS
cord-005453-4057qib7	3590	18	(	(	-LRB-
cord-005453-4057qib7	3590	19	HR	hr	NN
cord-005453-4057qib7	3590	20	0.535	0.535	CD
cord-005453-4057qib7	3590	21	,	,	,
cord-005453-4057qib7	3590	22	p=0.317	p=0.317	NNP
cord-005453-4057qib7	3590	23	)	)	-RRB-
cord-005453-4057qib7	3590	24	were	be	VBD
cord-005453-4057qib7	3590	25	not	not	RB
cord-005453-4057qib7	3590	26	significant	significant	JJ
cord-005453-4057qib7	3590	27	in	in	IN
cord-005453-4057qib7	3590	28	the	the	DT
cord-005453-4057qib7	3590	29	multivariate	multivariate	JJ
cord-005453-4057qib7	3590	30	analysis	analysis	NN
cord-005453-4057qib7	3590	31	(	(	-LRB-
cord-005453-4057qib7	3590	32	figure	figure	NN
cord-005453-4057qib7	3590	33	1	1	CD
cord-005453-4057qib7	3590	34	)	)	-RRB-
cord-005453-4057qib7	3590	35	.	.	.
cord-005453-4057qib7	3591	1	TA	TA	NNP
cord-005453-4057qib7	3591	2	-	-	HYPH
cord-005453-4057qib7	3591	3	TMA	TMA	NNP
cord-005453-4057qib7	3591	4	cases	case	NNS
cord-005453-4057qib7	3591	5	after	after	IN
cord-005453-4057qib7	3591	6	PTCy	PTCy	NNS
cord-005453-4057qib7	3591	7	were	be	VBD
cord-005453-4057qib7	3591	8	significantly	significantly	RB
cord-005453-4057qib7	3591	9	less	less	RBR
cord-005453-4057qib7	3591	10	frequently	frequently	RB
cord-005453-4057qib7	3591	11	associated	associate	VBN
cord-005453-4057qib7	3591	12	with	with	IN
cord-005453-4057qib7	3591	13	clinically	clinically	RB
cord-005453-4057qib7	3591	14	significant	significant	JJ
cord-005453-4057qib7	3591	15	aGVHD	agvhd	NN
cord-005453-4057qib7	3591	16	(	(	-LRB-
cord-005453-4057qib7	3591	17	19	19	CD
cord-005453-4057qib7	3591	18	%	%	NN
cord-005453-4057qib7	3591	19	vs	vs	IN
cord-005453-4057qib7	3591	20	68	68	CD
cord-005453-4057qib7	3591	21	%	%	NN
cord-005453-4057qib7	3591	22	,	,	,
cord-005453-4057qib7	3591	23	p	p	NN
cord-005453-4057qib7	3591	24	<	<	XX
cord-005453-4057qib7	3591	25	0,001	0,001	CD
cord-005453-4057qib7	3591	26	)	)	-RRB-
cord-005453-4057qib7	3591	27	.	.	.
cord-005453-4057qib7	3592	1	The	the	DT
cord-005453-4057qib7	3592	2	survival	survival	NN
cord-005453-4057qib7	3592	3	was	be	VBD
cord-005453-4057qib7	3592	4	higher	high	JJR
cord-005453-4057qib7	3592	5	after	after	IN
cord-005453-4057qib7	3592	6	PTCy	PTCy	NNS
cord-005453-4057qib7	3592	7	(	(	-LRB-
cord-005453-4057qib7	3592	8	74	74	CD
cord-005453-4057qib7	3592	9	%	%	NN
cord-005453-4057qib7	3592	10	vs	vs	IN
cord-005453-4057qib7	3592	11	15	15	CD
cord-005453-4057qib7	3592	12	%	%	NN
cord-005453-4057qib7	3592	13	)	)	-RRB-
cord-005453-4057qib7	3592	14	,	,	,
cord-005453-4057qib7	3592	15	but	but	CC
cord-005453-4057qib7	3592	16	not	not	RB
cord-005453-4057qib7	3592	17	significant	significant	JJ
cord-005453-4057qib7	3592	18	due	due	IN
cord-005453-4057qib7	3592	19	to	to	IN
cord-005453-4057qib7	3592	20	sample	sample	NN
cord-005453-4057qib7	3592	21	size	size	NN
cord-005453-4057qib7	3592	22	and	and	CC
cord-005453-4057qib7	3592	23	other	other	JJ
cord-005453-4057qib7	3592	24	TA	TA	NNP
cord-005453-4057qib7	3592	25	-	-	HYPH
cord-005453-4057qib7	3592	26	TMA	TMA	NNP
cord-005453-4057qib7	3592	27	factors	factor	NNS
cord-005453-4057qib7	3592	28	.	.	.
cord-005453-4057qib7	3593	1	Leading	lead	VBG
cord-005453-4057qib7	3593	2	causes	cause	NNS
cord-005453-4057qib7	3593	3	of	of	IN
cord-005453-4057qib7	3593	4	death	death	NN
cord-005453-4057qib7	3593	5	were	be	VBD
cord-005453-4057qib7	3593	6	:	:	:
cord-005453-4057qib7	3593	7	GVHD	gvhd	JJ
cord-005453-4057qib7	3593	8	progression	progression	NN
cord-005453-4057qib7	3593	9	(	(	-LRB-
cord-005453-4057qib7	3593	10	11	11	CD
cord-005453-4057qib7	3593	11	%	%	NN
cord-005453-4057qib7	3593	12	)	)	-RRB-
cord-005453-4057qib7	3593	13	,	,	,
cord-005453-4057qib7	3593	14	bacterial	bacterial	JJ
cord-005453-4057qib7	3593	15	infection	infection	NN
cord-005453-4057qib7	3593	16	(	(	-LRB-
cord-005453-4057qib7	3593	17	11	11	CD
cord-005453-4057qib7	3593	18	%	%	NN
cord-005453-4057qib7	3593	19	)	)	-RRB-
cord-005453-4057qib7	3593	20	,	,	,
cord-005453-4057qib7	3593	21	TMA	TMA	NNP
cord-005453-4057qib7	3593	22	(	(	-LRB-
cord-005453-4057qib7	3593	23	17	17	CD
cord-005453-4057qib7	3593	24	%	%	NN
cord-005453-4057qib7	3593	25	)	)	-RRB-
cord-005453-4057qib7	3593	26	and	and	CC
cord-005453-4057qib7	3593	27	other	other	JJ
cord-005453-4057qib7	3593	28	(	(	-LRB-
cord-005453-4057qib7	3593	29	19	19	CD
cord-005453-4057qib7	3593	30	%	%	NN
cord-005453-4057qib7	3593	31	)	)	-RRB-
cord-005453-4057qib7	3593	32	.	.	.
cord-005453-4057qib7	3594	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3594	2	:	:	:
cord-005453-4057qib7	3595	1	Replacing	replace	VBG
cord-005453-4057qib7	3595	2	Tac	Tac	NNP
cord-005453-4057qib7	3595	3	by	by	IN
cord-005453-4057qib7	3595	4	Sir	Sir	NNP
cord-005453-4057qib7	3595	5	is	be	VBZ
cord-005453-4057qib7	3595	6	an	an	DT
cord-005453-4057qib7	3595	7	effective	effective	JJ
cord-005453-4057qib7	3595	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	3595	9	strategy	strategy	NN
cord-005453-4057qib7	3595	10	in	in	IN
cord-005453-4057qib7	3595	11	a	a	DT
cord-005453-4057qib7	3595	12	group	group	NN
cord-005453-4057qib7	3595	13	of	of	IN
cord-005453-4057qib7	3595	14	patients	patient	NNS
cord-005453-4057qib7	3595	15	with	with	IN
cord-005453-4057qib7	3595	16	debut	debut	NN
cord-005453-4057qib7	3595	17	of	of	IN
cord-005453-4057qib7	3595	18	TA	TA	NNP
cord-005453-4057qib7	3595	19	-	-	HYPH
cord-005453-4057qib7	3595	20	TMA	TMA	NNP
cord-005453-4057qib7	3595	21	at	at	IN
cord-005453-4057qib7	3595	22	least	least	JJS
cord-005453-4057qib7	3595	23	after	after	IN
cord-005453-4057qib7	3595	24	PTCy	PTCy	NNS
cord-005453-4057qib7	3595	25	,	,	,
cord-005453-4057qib7	3595	26	where	where	WRB
cord-005453-4057qib7	3595	27	it	-PRON-	PRP
cord-005453-4057qib7	3595	28	is	be	VBZ
cord-005453-4057qib7	3595	29	less	less	RBR
cord-005453-4057qib7	3595	30	likely	likely	JJ
cord-005453-4057qib7	3595	31	to	to	TO
cord-005453-4057qib7	3595	32	be	be	VB
cord-005453-4057qib7	3595	33	associated	associate	VBN
cord-005453-4057qib7	3595	34	with	with	IN
cord-005453-4057qib7	3595	35	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3595	36	.	.	.
cord-005453-4057qib7	3596	1	There	there	EX
cord-005453-4057qib7	3596	2	is	be	VBZ
cord-005453-4057qib7	3596	3	a	a	DT
cord-005453-4057qib7	3596	4	significant	significant	JJ
cord-005453-4057qib7	3596	5	overlap	overlap	NN
cord-005453-4057qib7	3596	6	of	of	IN
cord-005453-4057qib7	3596	7	populations	population	NNS
cord-005453-4057qib7	3596	8	with	with	IN
cord-005453-4057qib7	3596	9	PTCy	PTCy	NNS
cord-005453-4057qib7	3596	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3596	11	and	and	CC
cord-005453-4057qib7	3596	12	substitution	substitution	NN
cord-005453-4057qib7	3596	13	with	with	IN
cord-005453-4057qib7	3596	14	Sir	Sir	NNP
cord-005453-4057qib7	3596	15	,	,	,
cord-005453-4057qib7	3596	16	thus	thus	RB
cord-005453-4057qib7	3596	17	the	the	DT
cord-005453-4057qib7	3596	18	study	study	NN
cord-005453-4057qib7	3596	19	is	be	VBZ
cord-005453-4057qib7	3596	20	not	not	RB
cord-005453-4057qib7	3596	21	powered	power	VBN
cord-005453-4057qib7	3596	22	to	to	TO
cord-005453-4057qib7	3596	23	provide	provide	VB
cord-005453-4057qib7	3596	24	guidance	guidance	NN
cord-005453-4057qib7	3596	25	for	for	IN
cord-005453-4057qib7	3596	26	patients	patient	NNS
cord-005453-4057qib7	3596	27	on	on	IN
cord-005453-4057qib7	3596	28	conventional	conventional	JJ
cord-005453-4057qib7	3596	29	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3596	30	with	with	IN
cord-005453-4057qib7	3596	31	TA	TA	NNP
cord-005453-4057qib7	3596	32	-	-	HYPH
cord-005453-4057qib7	3596	33	TMA	TMA	NNP
cord-005453-4057qib7	3596	34	.	.	.
cord-005453-4057qib7	3597	1	[	[	-LRB-
cord-005453-4057qib7	3597	2	[	[	-LRB-
cord-005453-4057qib7	3597	3	P172	P172	NNP
cord-005453-4057qib7	3597	4	Image	image	NN
cord-005453-4057qib7	3597	5	]	]	-RRB-
cord-005453-4057qib7	3597	6	1	1	CD
cord-005453-4057qib7	3597	7	.	.	.
cord-005453-4057qib7	3598	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3598	2	:	:	:
cord-005453-4057qib7	3598	3	None	none	NN
cord-005453-4057qib7	3598	4	of	of	IN
cord-005453-4057qib7	3598	5	the	the	DT
cord-005453-4057qib7	3598	6	authors	author	NNS
cord-005453-4057qib7	3598	7	has	have	VBZ
cord-005453-4057qib7	3598	8	anything	anything	NN
cord-005453-4057qib7	3598	9	to	to	TO
cord-005453-4057qib7	3598	10	disclose	disclose	VB
cord-005453-4057qib7	3598	11	.	.	.
cord-005453-4057qib7	3599	1	Donor	donor	NN
cord-005453-4057qib7	3599	2	-	-	HYPH
cord-005453-4057qib7	3599	3	recipient	recipient	NN
cord-005453-4057qib7	3599	4	AB0	ab0	NN
cord-005453-4057qib7	3599	5	mismatch	mismatch	NN
cord-005453-4057qib7	3599	6	effect	effect	NN
cord-005453-4057qib7	3599	7	on	on	IN
cord-005453-4057qib7	3599	8	the	the	DT
cord-005453-4057qib7	3599	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	3599	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3599	11	stem	stem	NN
cord-005453-4057qib7	3599	12	cell	cell	NN
cord-005453-4057qib7	3599	13	transplantation	transplantation	NN
cord-005453-4057qib7	3599	14	outcome	outcome	NN
cord-005453-4057qib7	3599	15	:	:	:
cord-005453-4057qib7	3600	1	A	a	DT
cord-005453-4057qib7	3600	2	single	single	JJ
cord-005453-4057qib7	3600	3	-	-	HYPH
cord-005453-4057qib7	3600	4	center	center	NN
cord-005453-4057qib7	3600	5	retrospective	retrospective	JJ
cord-005453-4057qib7	3600	6	study	study	NN
cord-005453-4057qib7	3600	7	Background	background	NN
cord-005453-4057qib7	3600	8	:	:	:
cord-005453-4057qib7	3601	1	Because	because	IN
cord-005453-4057qib7	3601	2	transmission	transmission	NN
cord-005453-4057qib7	3601	3	of	of	IN
cord-005453-4057qib7	3601	4	major	major	JJ
cord-005453-4057qib7	3601	5	histocompatibility	histocompatibility	NN
cord-005453-4057qib7	3601	6	complex	complex	NN
cord-005453-4057qib7	3601	7	and	and	CC
cord-005453-4057qib7	3601	8	blood	blood	NN
cord-005453-4057qib7	3601	9	group	group	NN
cord-005453-4057qib7	3601	10	system	system	NN
cord-005453-4057qib7	3601	11	genes	gene	NNS
cord-005453-4057qib7	3601	12	is	be	VBZ
cord-005453-4057qib7	3601	13	independent	independent	JJ
cord-005453-4057qib7	3601	14	from	from	IN
cord-005453-4057qib7	3601	15	each	each	DT
cord-005453-4057qib7	3601	16	other	other	JJ
cord-005453-4057qib7	3601	17	,	,	,
cord-005453-4057qib7	3601	18	approximately	approximately	RB
cord-005453-4057qib7	3601	19	40	40	CD
cord-005453-4057qib7	3601	20	-	-	SYM
cord-005453-4057qib7	3601	21	50	50	CD
cord-005453-4057qib7	3601	22	%	%	NN
cord-005453-4057qib7	3601	23	of	of	IN
cord-005453-4057qib7	3601	24	all	all	DT
cord-005453-4057qib7	3601	25	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3601	26	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3601	27	stem	stem	NN
cord-005453-4057qib7	3601	28	cell	cell	NN
cord-005453-4057qib7	3601	29	transplantations	transplantation	NNS
cord-005453-4057qib7	3601	30	(	(	-LRB-
cord-005453-4057qib7	3601	31	allo	allo	NN
cord-005453-4057qib7	3601	32	-	-	HYPH
cord-005453-4057qib7	3601	33	HSCT	HSCT	NNP
cord-005453-4057qib7	3601	34	)	)	-RRB-
cord-005453-4057qib7	3601	35	are	be	VBP
cord-005453-4057qib7	3601	36	realized	realize	VBN
cord-005453-4057qib7	3601	37	crosswise	crosswise	IN
cord-005453-4057qib7	3601	38	the	the	DT
cord-005453-4057qib7	3601	39	AB0-blood	ab0-blood	NN
cord-005453-4057qib7	3601	40	group	group	NN
cord-005453-4057qib7	3601	41	boundary	boundary	NN
cord-005453-4057qib7	3601	42	.	.	.
cord-005453-4057qib7	3602	1	However	however	RB
cord-005453-4057qib7	3602	2	,	,	,
cord-005453-4057qib7	3602	3	due	due	IN
cord-005453-4057qib7	3602	4	to	to	IN
cord-005453-4057qib7	3602	5	the	the	DT
cord-005453-4057qib7	3602	6	widespread	widespread	JJ
cord-005453-4057qib7	3602	7	expression	expression	NN
cord-005453-4057qib7	3602	8	of	of	IN
cord-005453-4057qib7	3602	9	AB0	AB0	NNP
cord-005453-4057qib7	3602	10	antigens	antigen	NNS
cord-005453-4057qib7	3602	11	on	on	IN
cord-005453-4057qib7	3602	12	a	a	DT
cord-005453-4057qib7	3602	13	variety	variety	NN
cord-005453-4057qib7	3602	14	of	of	IN
cord-005453-4057qib7	3602	15	human	human	JJ
cord-005453-4057qib7	3602	16	tissues	tissue	NNS
cord-005453-4057qib7	3602	17	other	other	JJ
cord-005453-4057qib7	3602	18	than	than	IN
cord-005453-4057qib7	3602	19	erythrocytes	erythrocyte	NNS
cord-005453-4057qib7	3602	20	,	,	,
cord-005453-4057qib7	3602	21	AB0	ab0	NN
cord-005453-4057qib7	3602	22	incompatibility	incompatibility	NN
cord-005453-4057qib7	3602	23	may	may	MD
cord-005453-4057qib7	3602	24	have	have	VB
cord-005453-4057qib7	3602	25	an	an	DT
cord-005453-4057qib7	3602	26	impact	impact	NN
cord-005453-4057qib7	3602	27	on	on	IN
cord-005453-4057qib7	3602	28	the	the	DT
cord-005453-4057qib7	3602	29	outcome	outcome	NN
cord-005453-4057qib7	3602	30	of	of	IN
cord-005453-4057qib7	3602	31	allogeneic	allogeneic	NN
cord-005453-4057qib7	3602	32	HSCT	HSCT	NNP
cord-005453-4057qib7	3602	33	that	that	WDT
cord-005453-4057qib7	3602	34	goes	go	VBZ
cord-005453-4057qib7	3602	35	beyond	beyond	IN
cord-005453-4057qib7	3602	36	the	the	DT
cord-005453-4057qib7	3602	37	wellknown	wellknown	JJ
cord-005453-4057qib7	3602	38	immune	immune	JJ
cord-005453-4057qib7	3602	39	-	-	HYPH
cord-005453-4057qib7	3602	40	hematological	hematological	JJ
cord-005453-4057qib7	3602	41	complications	complication	NNS
cord-005453-4057qib7	3602	42	such	such	JJ
cord-005453-4057qib7	3602	43	as	as	IN
cord-005453-4057qib7	3602	44	immediate	immediate	JJ
cord-005453-4057qib7	3602	45	hemolysis	hemolysis	NN
cord-005453-4057qib7	3602	46	due	due	IN
cord-005453-4057qib7	3602	47	to	to	IN
cord-005453-4057qib7	3602	48	the	the	DT
cord-005453-4057qib7	3602	49	presence	presence	NN
cord-005453-4057qib7	3602	50	of	of	IN
cord-005453-4057qib7	3602	51	isoagglutinins	isoagglutinin	NNS
cord-005453-4057qib7	3602	52	and	and	CC
cord-005453-4057qib7	3602	53	delayed	delay	VBN
cord-005453-4057qib7	3602	54	hemolysis	hemolysis	NN
cord-005453-4057qib7	3602	55	due	due	IN
cord-005453-4057qib7	3602	56	to	to	IN
cord-005453-4057qib7	3602	57	passenger	passenger	NN
cord-005453-4057qib7	3602	58	B	b	NN
cord-005453-4057qib7	3602	59	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	3602	60	.	.	.
cord-005453-4057qib7	3603	1	Here	here	RB
cord-005453-4057qib7	3603	2	we	-PRON-	PRP
cord-005453-4057qib7	3603	3	aimed	aim	VBD
cord-005453-4057qib7	3603	4	to	to	TO
cord-005453-4057qib7	3603	5	assess	assess	VB
cord-005453-4057qib7	3603	6	the	the	DT
cord-005453-4057qib7	3603	7	donor	donor	NN
cord-005453-4057qib7	3603	8	-	-	HYPH
cord-005453-4057qib7	3603	9	recipient	recipient	NN
cord-005453-4057qib7	3603	10	AB0	ab0	NN
cord-005453-4057qib7	3603	11	mismatch	mismatch	NN
cord-005453-4057qib7	3603	12	effect	effect	NN
cord-005453-4057qib7	3603	13	on	on	IN
cord-005453-4057qib7	3603	14	the	the	DT
cord-005453-4057qib7	3603	15	allo	allo	NN
cord-005453-4057qib7	3603	16	-	-	HYPH
cord-005453-4057qib7	3603	17	HSCT	HSCT	NNP
cord-005453-4057qib7	3603	18	outcome	outcome	NN
cord-005453-4057qib7	3603	19	,	,	,
cord-005453-4057qib7	3603	20	comprising	comprise	VBG
cord-005453-4057qib7	3603	21	non	non	JJ
cord-005453-4057qib7	3603	22	-	-	JJ
cord-005453-4057qib7	3603	23	relapse	relapse	JJ
cord-005453-4057qib7	3603	24	mortality	mortality	NN
cord-005453-4057qib7	3603	25	(	(	-LRB-
cord-005453-4057qib7	3603	26	NRM	NRM	NNP
cord-005453-4057qib7	3603	27	)	)	-RRB-
cord-005453-4057qib7	3603	28	,	,	,
cord-005453-4057qib7	3603	29	overall	overall	JJ
cord-005453-4057qib7	3603	30	and	and	CC
cord-005453-4057qib7	3603	31	relapse	relapse	NN
cord-005453-4057qib7	3603	32	-	-	HYPH
cord-005453-4057qib7	3603	33	free	free	JJ
cord-005453-4057qib7	3603	34	survival	survival	NN
cord-005453-4057qib7	3603	35	,	,	,
cord-005453-4057qib7	3603	36	posttransplant	posttransplant	NN
cord-005453-4057qib7	3603	37	PRC	PRC	NNP
cord-005453-4057qib7	3603	38	transfusion	transfusion	NN
cord-005453-4057qib7	3603	39	requirement	requirement	NN
cord-005453-4057qib7	3603	40	,	,	,
cord-005453-4057qib7	3603	41	as	as	RB
cord-005453-4057qib7	3603	42	well	well	RB
cord-005453-4057qib7	3603	43	as	as	IN
cord-005453-4057qib7	3603	44	relapse	relapse	NN
cord-005453-4057qib7	3603	45	rate	rate	NN
cord-005453-4057qib7	3603	46	,	,	,
cord-005453-4057qib7	3603	47	incidence	incidence	NN
cord-005453-4057qib7	3603	48	of	of	IN
cord-005453-4057qib7	3603	49	graft	graft	NN
cord-005453-4057qib7	3603	50	-	-	HYPH
cord-005453-4057qib7	3603	51	failure	failure	NN
cord-005453-4057qib7	3603	52	and	and	CC
cord-005453-4057qib7	3603	53	acute	acute	JJ
cord-005453-4057qib7	3603	54	GvHD	gvhd	NN
cord-005453-4057qib7	3603	55	.	.	.
cord-005453-4057qib7	3604	1	Methods	method	NNS
cord-005453-4057qib7	3604	2	:	:	:
cord-005453-4057qib7	3605	1	Clinical	clinical	JJ
cord-005453-4057qib7	3605	2	and	and	CC
cord-005453-4057qib7	3605	3	laboratory	laboratory	NN
cord-005453-4057qib7	3605	4	data	datum	NNS
cord-005453-4057qib7	3605	5	from	from	IN
cord-005453-4057qib7	3605	6	180	180	CD
cord-005453-4057qib7	3605	7	consecutive	consecutive	JJ
cord-005453-4057qib7	3605	8	patients	patient	NNS
cord-005453-4057qib7	3605	9	undergoing	undergo	VBG
cord-005453-4057qib7	3605	10	allogeneic	allogeneic	IN
cord-005453-4057qib7	3605	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3605	12	between	between	IN
cord-005453-4057qib7	3605	13	01/2008	01/2008	CD
cord-005453-4057qib7	3605	14	and	and	CC
cord-005453-4057qib7	3605	15	06/2018	06/2018	CD
cord-005453-4057qib7	3605	16	at	at	IN
cord-005453-4057qib7	3605	17	the	the	DT
cord-005453-4057qib7	3605	18	Fondazione	Fondazione	NNP
cord-005453-4057qib7	3605	19	IRCCS	IRCCS	NNP
cord-005453-4057qib7	3606	1	Ca	ca	RB
cord-005453-4057qib7	3606	2	'	'	''
cord-005453-4057qib7	3606	3	Granda	Granda	NNP
cord-005453-4057qib7	3606	4	Maggiore	Maggiore	NNP
cord-005453-4057qib7	3606	5	Policlinico	Policlinico	NNP
cord-005453-4057qib7	3606	6	Hospital	Hospital	NNP
cord-005453-4057qib7	3606	7	in	in	IN
cord-005453-4057qib7	3606	8	Milan	Milan	NNP
cord-005453-4057qib7	3606	9	,	,	,
cord-005453-4057qib7	3606	10	Italy	Italy	NNP
cord-005453-4057qib7	3606	11	,	,	,
cord-005453-4057qib7	3606	12	were	be	VBD
cord-005453-4057qib7	3606	13	retrospectively	retrospectively	RB
cord-005453-4057qib7	3606	14	collected	collect	VBN
cord-005453-4057qib7	3606	15	.	.	.
cord-005453-4057qib7	3607	1	Kaplan	Kaplan	NNP
cord-005453-4057qib7	3607	2	Meier	Meier	NNP
cord-005453-4057qib7	3607	3	estimates	estimate	NNS
cord-005453-4057qib7	3607	4	were	be	VBD
cord-005453-4057qib7	3607	5	used	use	VBN
cord-005453-4057qib7	3607	6	for	for	IN
cord-005453-4057qib7	3607	7	the	the	DT
cord-005453-4057qib7	3607	8	analysis	analysis	NN
cord-005453-4057qib7	3607	9	of	of	IN
cord-005453-4057qib7	3607	10	survival	survival	NN
cord-005453-4057qib7	3607	11	outcomes	outcome	NNS
cord-005453-4057qib7	3607	12	while	while	IN
cord-005453-4057qib7	3607	13	NRM	NRM	NNP
cord-005453-4057qib7	3607	14	,	,	,
cord-005453-4057qib7	3607	15	relapse	relapse	NN
cord-005453-4057qib7	3607	16	and	and	CC
cord-005453-4057qib7	3607	17	acute	acute	JJ
cord-005453-4057qib7	3607	18	GvHD	GvHD	NNP
cord-005453-4057qib7	3607	19	cumulative	cumulative	JJ
cord-005453-4057qib7	3607	20	incidences	incidence	NNS
cord-005453-4057qib7	3607	21	were	be	VBD
cord-005453-4057qib7	3607	22	investigated	investigate	VBN
cord-005453-4057qib7	3607	23	by	by	IN
cord-005453-4057qib7	3607	24	competing	compete	VBG
cord-005453-4057qib7	3607	25	risk	risk	NN
cord-005453-4057qib7	3607	26	analysis	analysis	NN
cord-005453-4057qib7	3607	27	.	.	.
cord-005453-4057qib7	3608	1	Results	result	NNS
cord-005453-4057qib7	3608	2	:	:	:
cord-005453-4057qib7	3609	1	The	the	DT
cord-005453-4057qib7	3609	2	patient	patient	JJ
cord-005453-4057qib7	3609	3	series	series	NN
cord-005453-4057qib7	3609	4	included	include	VBD
cord-005453-4057qib7	3609	5	105	105	CD
cord-005453-4057qib7	3609	6	AB0-match	ab0-match	NN
cord-005453-4057qib7	3609	7	,	,	,
cord-005453-4057qib7	3609	8	31	31	CD
cord-005453-4057qib7	3609	9	major	major	JJ
cord-005453-4057qib7	3609	10	AB0-mismatch	ab0-mismatch	NN
cord-005453-4057qib7	3609	11	,	,	,
cord-005453-4057qib7	3609	12	34	34	CD
cord-005453-4057qib7	3609	13	minor	minor	JJ
cord-005453-4057qib7	3609	14	AB0-mismatched	ab0-mismatche	VBN
cord-005453-4057qib7	3609	15	and	and	CC
cord-005453-4057qib7	3609	16	10	10	CD
cord-005453-4057qib7	3609	17	bidirectionally	bidirectionally	RB
cord-005453-4057qib7	3609	18	AB0-mismatch	ab0-mismatch	JJ
cord-005453-4057qib7	3609	19	transplants	transplant	NNS
cord-005453-4057qib7	3609	20	.	.	.
cord-005453-4057qib7	3610	1	Indication	indication	NN
cord-005453-4057qib7	3610	2	for	for	IN
cord-005453-4057qib7	3610	3	allo	allo	NN
cord-005453-4057qib7	3610	4	-	-	HYPH
cord-005453-4057qib7	3610	5	HSCT	HSCT	NNP
cord-005453-4057qib7	3610	6	were	be	VBD
cord-005453-4057qib7	3610	7	mainly	mainly	RB
cord-005453-4057qib7	3610	8	AML	AML	NNP
cord-005453-4057qib7	3610	9	/	/	SYM
cord-005453-4057qib7	3610	10	MDS	MDS	NNP
cord-005453-4057qib7	3610	11	(	(	-LRB-
cord-005453-4057qib7	3610	12	77	77	CD
cord-005453-4057qib7	3610	13	pts	pts	CD
cord-005453-4057qib7	3610	14	)	)	-RRB-
cord-005453-4057qib7	3610	15	,	,	,
cord-005453-4057qib7	3610	16	ALL	all	DT
cord-005453-4057qib7	3610	17	(	(	-LRB-
cord-005453-4057qib7	3610	18	34	34	CD
cord-005453-4057qib7	3610	19	pts	pts	CD
cord-005453-4057qib7	3610	20	)	)	-RRB-
cord-005453-4057qib7	3610	21	and	and	CC
cord-005453-4057qib7	3610	22	T	T	NNP
cord-005453-4057qib7	3610	23	-	-	HYPH
cord-005453-4057qib7	3610	24	NHL	NHL	NNP
cord-005453-4057qib7	3610	25	/	/	SYM
cord-005453-4057qib7	3610	26	CTCL	CTCL	NNP
cord-005453-4057qib7	3610	27	(	(	-LRB-
cord-005453-4057qib7	3610	28	32	32	CD
cord-005453-4057qib7	3610	29	pts	pts	NN
cord-005453-4057qib7	3610	30	)	)	-RRB-
cord-005453-4057qib7	3610	31	.	.	.
cord-005453-4057qib7	3611	1	Mean	mean	JJ
cord-005453-4057qib7	3611	2	overall	overall	JJ
cord-005453-4057qib7	3611	3	survival	survival	NN
cord-005453-4057qib7	3611	4	for	for	IN
cord-005453-4057qib7	3611	5	groups	group	NNS
cord-005453-4057qib7	3611	6	of	of	IN
cord-005453-4057qib7	3611	7	patients	patient	NNS
cord-005453-4057qib7	3611	8	undergoing	undergo	VBG
cord-005453-4057qib7	3611	9	AB0-identical	ab0-identical	JJ
cord-005453-4057qib7	3611	10	,	,	,
cord-005453-4057qib7	3611	11	major	major	JJ
cord-005453-4057qib7	3611	12	AB0	ab0	NN
cord-005453-4057qib7	3611	13	mismatch	mismatch	NN
cord-005453-4057qib7	3611	14	and	and	CC
cord-005453-4057qib7	3611	15	minor	minor	JJ
cord-005453-4057qib7	3611	16	AB0	ab0	NN
cord-005453-4057qib7	3611	17	mismatch	mismatch	NN
cord-005453-4057qib7	3612	1	HSCT	HSCT	NNP
cord-005453-4057qib7	3612	2	were	be	VBD
cord-005453-4057qib7	3612	3	66	66	CD
cord-005453-4057qib7	3612	4	months	month	NNS
cord-005453-4057qib7	3613	1	(	(	-LRB-
cord-005453-4057qib7	3613	2	95	95	CD
cord-005453-4057qib7	3613	3	%	%	NN
cord-005453-4057qib7	3613	4	CI	CI	NNP
cord-005453-4057qib7	3613	5	[	[	-LRB-
cord-005453-4057qib7	3613	6	55	55	CD
cord-005453-4057qib7	3613	7	;	;	:
cord-005453-4057qib7	3613	8	77	77	CD
cord-005453-4057qib7	3613	9	]	]	-RRB-
cord-005453-4057qib7	3613	10	)	)	-RRB-
cord-005453-4057qib7	3613	11	,	,	,
cord-005453-4057qib7	3613	12	47	47	CD
cord-005453-4057qib7	3613	13	months	month	NNS
cord-005453-4057qib7	3613	14	(	(	-LRB-
cord-005453-4057qib7	3613	15	95	95	CD
cord-005453-4057qib7	3613	16	%	%	NN
cord-005453-4057qib7	3613	17	CI	CI	NNP
cord-005453-4057qib7	3613	18	[	[	-LRB-
cord-005453-4057qib7	3613	19	28	28	CD
cord-005453-4057qib7	3613	20	;	;	:
cord-005453-4057qib7	3613	21	65	65	CD
cord-005453-4057qib7	3613	22	)	)	-RRB-
cord-005453-4057qib7	3613	23	and	and	CC
cord-005453-4057qib7	3613	24	46	46	CD
cord-005453-4057qib7	3613	25	months	month	NNS
cord-005453-4057qib7	3614	1	(	(	-LRB-
cord-005453-4057qib7	3614	2	95	95	CD
cord-005453-4057qib7	3614	3	%	%	NN
cord-005453-4057qib7	3614	4	CI	CI	NNP
cord-005453-4057qib7	3614	5	[	[	-LRB-
cord-005453-4057qib7	3614	6	31	31	CD
cord-005453-4057qib7	3614	7	;	;	:
cord-005453-4057qib7	3614	8	61	61	CD
cord-005453-4057qib7	3614	9	]	]	-RRB-
cord-005453-4057qib7	3614	10	)	)	-RRB-
cord-005453-4057qib7	3614	11	,	,	,
cord-005453-4057qib7	3614	12	respectively	respectively	RB
cord-005453-4057qib7	3614	13	.	.	.
cord-005453-4057qib7	3615	1	NRM	NRM	NNP
cord-005453-4057qib7	3615	2	in	in	IN
cord-005453-4057qib7	3615	3	the	the	DT
cord-005453-4057qib7	3615	4	three	three	CD
cord-005453-4057qib7	3615	5	groups	group	NNS
cord-005453-4057qib7	3615	6	were	be	VBD
cord-005453-4057qib7	3615	7	significantly	significantly	RB
cord-005453-4057qib7	3615	8	different	different	JJ
cord-005453-4057qib7	3615	9	,	,	,
cord-005453-4057qib7	3615	10	with	with	IN
cord-005453-4057qib7	3615	11	point	point	NN
cord-005453-4057qib7	3615	12	estimates	estimate	NNS
cord-005453-4057qib7	3615	13	of	of	IN
cord-005453-4057qib7	3615	14	12	12	CD
cord-005453-4057qib7	3615	15	%	%	NN
cord-005453-4057qib7	3615	16	,	,	,
cord-005453-4057qib7	3615	17	29	29	CD
cord-005453-4057qib7	3615	18	%	%	NN
cord-005453-4057qib7	3615	19	and	and	CC
cord-005453-4057qib7	3615	20	26	26	CD
cord-005453-4057qib7	3615	21	%	%	NN
cord-005453-4057qib7	3615	22	at	at	IN
cord-005453-4057qib7	3615	23	5	5	CD
cord-005453-4057qib7	3615	24	years	year	NNS
cord-005453-4057qib7	3615	25	,	,	,
cord-005453-4057qib7	3615	26	respectively	respectively	RB
cord-005453-4057qib7	3615	27	,	,	,
cord-005453-4057qib7	3615	28	whereas	whereas	IN
cord-005453-4057qib7	3615	29	no	no	DT
cord-005453-4057qib7	3615	30	significant	significant	JJ
cord-005453-4057qib7	3615	31	differences	difference	NNS
cord-005453-4057qib7	3615	32	were	be	VBD
cord-005453-4057qib7	3615	33	observed	observe	VBN
cord-005453-4057qib7	3615	34	for	for	IN
cord-005453-4057qib7	3615	35	relapse	relapse	NN
cord-005453-4057qib7	3615	36	rate	rate	NN
cord-005453-4057qib7	3615	37	and	and	CC
cord-005453-4057qib7	3615	38	graft	graft	NN
cord-005453-4057qib7	3615	39	failure	failure	NN
cord-005453-4057qib7	3615	40	incidence	incidence	NN
cord-005453-4057qib7	3615	41	.	.	.
cord-005453-4057qib7	3616	1	Although	although	IN
cord-005453-4057qib7	3616	2	not	not	RB
cord-005453-4057qib7	3616	3	statistically	statistically	RB
cord-005453-4057qib7	3616	4	different	different	JJ
cord-005453-4057qib7	3616	5	,	,	,
cord-005453-4057qib7	3616	6	incidence	incidence	NN
cord-005453-4057qib7	3616	7	of	of	IN
cord-005453-4057qib7	3616	8	acute	acute	JJ
cord-005453-4057qib7	3616	9	grade	grade	NN
cord-005453-4057qib7	3616	10	III	III	NNP
cord-005453-4057qib7	3616	11	-	-	HYPH
cord-005453-4057qib7	3616	12	IV	IV	NNP
cord-005453-4057qib7	3616	13	GvHD	GvHD	NNP
cord-005453-4057qib7	3616	14	was	be	VBD
cord-005453-4057qib7	3616	15	twice	twice	RB
cord-005453-4057qib7	3616	16	as	as	RB
cord-005453-4057qib7	3616	17	high	high	JJ
cord-005453-4057qib7	3616	18	in	in	IN
cord-005453-4057qib7	3616	19	patients	patient	NNS
cord-005453-4057qib7	3616	20	transplanted	transplant	VBN
cord-005453-4057qib7	3616	21	from	from	IN
cord-005453-4057qib7	3616	22	minor	minor	JJ
cord-005453-4057qib7	3616	23	AB0mismatched	AB0mismatched	NNP
cord-005453-4057qib7	3616	24	donors	donor	NNS
cord-005453-4057qib7	3616	25	than	than	IN
cord-005453-4057qib7	3616	26	in	in	IN
cord-005453-4057qib7	3616	27	the	the	DT
cord-005453-4057qib7	3616	28	AB0	AB0	NNP
cord-005453-4057qib7	3616	29	identical	identical	JJ
cord-005453-4057qib7	3616	30	group	group	NN
cord-005453-4057qib7	3616	31	(	(	-LRB-
cord-005453-4057qib7	3616	32	16	16	CD
cord-005453-4057qib7	3616	33	%	%	NN
cord-005453-4057qib7	3616	34	vs	vs	IN
cord-005453-4057qib7	3616	35	8	8	CD
cord-005453-4057qib7	3616	36	%	%	NN
cord-005453-4057qib7	3616	37	)	)	-RRB-
cord-005453-4057qib7	3616	38	.	.	.
cord-005453-4057qib7	3617	1	Following	follow	VBG
cord-005453-4057qib7	3617	2	transplantation	transplantation	NN
cord-005453-4057qib7	3617	3	,	,	,
cord-005453-4057qib7	3617	4	PRC	PRC	NNP
cord-005453-4057qib7	3617	5	transfusion	transfusion	NN
cord-005453-4057qib7	3617	6	requirement	requirement	NN
cord-005453-4057qib7	3617	7	was	be	VBD
cord-005453-4057qib7	3617	8	significantly	significantly	RB
cord-005453-4057qib7	3617	9	higher	high	JJR
cord-005453-4057qib7	3617	10	in	in	IN
cord-005453-4057qib7	3617	11	the	the	DT
cord-005453-4057qib7	3617	12	major	major	JJ
cord-005453-4057qib7	3617	13	AB0	ab0	NN
cord-005453-4057qib7	3617	14	mismatch	mismatch	NN
cord-005453-4057qib7	3617	15	then	then	RB
cord-005453-4057qib7	3617	16	in	in	IN
cord-005453-4057qib7	3617	17	the	the	DT
cord-005453-4057qib7	3617	18	AB0-match	ab0-match	NN
cord-005453-4057qib7	3617	19	transplanted	transplant	VBN
cord-005453-4057qib7	3617	20	patients	patient	NNS
cord-005453-4057qib7	3617	21	(	(	-LRB-
cord-005453-4057qib7	3617	22	median	median	NN
cord-005453-4057qib7	3617	23	14	14	CD
cord-005453-4057qib7	3617	24	vs	vs	IN
cord-005453-4057qib7	3617	25	7	7	CD
cord-005453-4057qib7	3617	26	,	,	,
cord-005453-4057qib7	3617	27	p=0.01	p=0.01	NNP
cord-005453-4057qib7	3617	28	)	)	-RRB-
cord-005453-4057qib7	3617	29	,	,	,
cord-005453-4057qib7	3617	30	with	with	IN
cord-005453-4057qib7	3617	31	a	a	DT
cord-005453-4057qib7	3617	32	marginal	marginal	JJ
cord-005453-4057qib7	3617	33	positive	positive	JJ
cord-005453-4057qib7	3617	34	correlation	correlation	NN
cord-005453-4057qib7	3617	35	between	between	IN
cord-005453-4057qib7	3617	36	the	the	DT
cord-005453-4057qib7	3617	37	anti	anti	JJ
cord-005453-4057qib7	3617	38	-	-	JJ
cord-005453-4057qib7	3617	39	donor	donor	JJ
cord-005453-4057qib7	3617	40	A	a	NN
cord-005453-4057qib7	3617	41	/	/	SYM
cord-005453-4057qib7	3617	42	B	b	NN
cord-005453-4057qib7	3617	43	IgG	igg	NN
cord-005453-4057qib7	3617	44	titers	titer	NNS
cord-005453-4057qib7	3617	45	measured	measure	VBD
cord-005453-4057qib7	3617	46	prior	prior	JJ
cord-005453-4057qib7	3617	47	HSCT	HSCT	NNP
cord-005453-4057qib7	3617	48	and	and	CC
cord-005453-4057qib7	3617	49	the	the	DT
cord-005453-4057qib7	3617	50	total	total	JJ
cord-005453-4057qib7	3617	51	number	number	NN
cord-005453-4057qib7	3617	52	of	of	IN
cord-005453-4057qib7	3617	53	PRC	PRC	NNP
cord-005453-4057qib7	3617	54	transfused	transfuse	VBN
cord-005453-4057qib7	3617	55	during	during	IN
cord-005453-4057qib7	3617	56	the	the	DT
cord-005453-4057qib7	3617	57	first	first	JJ
cord-005453-4057qib7	3617	58	year	year	NN
cord-005453-4057qib7	3617	59	following	follow	VBG
cord-005453-4057qib7	3617	60	transplantation	transplantation	NN
cord-005453-4057qib7	3617	61	.	.	.
cord-005453-4057qib7	3618	1	We	-PRON-	PRP
cord-005453-4057qib7	3618	2	observed	observe	VBD
cord-005453-4057qib7	3618	3	only	only	RB
cord-005453-4057qib7	3618	4	one	one	CD
cord-005453-4057qib7	3618	5	case	case	NN
cord-005453-4057qib7	3618	6	of	of	IN
cord-005453-4057qib7	3618	7	PRCA	PRCA	NNP
cord-005453-4057qib7	3618	8	occurring	occur	VBG
cord-005453-4057qib7	3618	9	in	in	IN
cord-005453-4057qib7	3618	10	a	a	DT
cord-005453-4057qib7	3618	11	50year	50year	JJ
cord-005453-4057qib7	3618	12	-	-	HYPH
cord-005453-4057qib7	3618	13	old	old	JJ
cord-005453-4057qib7	3618	14	0	0	CD
cord-005453-4057qib7	3618	15	+	+	CC
cord-005453-4057qib7	3618	16	woman	woman	NN
cord-005453-4057qib7	3618	17	who	who	WP
cord-005453-4057qib7	3618	18	was	be	VBD
cord-005453-4057qib7	3618	19	transplanted	transplant	VBN
cord-005453-4057qib7	3618	20	from	from	IN
cord-005453-4057qib7	3618	21	a	a	DT
cord-005453-4057qib7	3618	22	32-yearold	32-yearold	CD
cord-005453-4057qib7	3618	23	male	male	JJ
cord-005453-4057qib7	3618	24	A+	a+	ADD
cord-005453-4057qib7	3618	25	HLA	HLA	NNP
cord-005453-4057qib7	3618	26	-	-	HYPH
cord-005453-4057qib7	3618	27	identical	identical	JJ
cord-005453-4057qib7	3618	28	sibling	sibling	NN
cord-005453-4057qib7	3618	29	using	use	VBG
cord-005453-4057qib7	3618	30	peripheral	peripheral	JJ
cord-005453-4057qib7	3618	31	blood	blood	NN
cord-005453-4057qib7	3618	32	as	as	IN
cord-005453-4057qib7	3618	33	the	the	DT
cord-005453-4057qib7	3618	34	stem	stem	NN
cord-005453-4057qib7	3618	35	cell	cell	NN
cord-005453-4057qib7	3618	36	source	source	NN
cord-005453-4057qib7	3618	37	following	follow	VBG
cord-005453-4057qib7	3618	38	a	a	DT
cord-005453-4057qib7	3618	39	myeloablative	myeloablative	JJ
cord-005453-4057qib7	3618	40	conditioning	conditioning	NN
cord-005453-4057qib7	3618	41	for	for	IN
cord-005453-4057qib7	3618	42	AML	AML	NNP
cord-005453-4057qib7	3618	43	in	in	IN
cord-005453-4057qib7	3618	44	first	first	JJ
cord-005453-4057qib7	3618	45	complete	complete	JJ
cord-005453-4057qib7	3618	46	remission	remission	NN
cord-005453-4057qib7	3618	47	.	.	.
cord-005453-4057qib7	3619	1	Anti	anti	JJ
cord-005453-4057qib7	3619	2	-	-	JJ
cord-005453-4057qib7	3619	3	A	a	DT
cord-005453-4057qib7	3619	4	IgG	igg	NN
cord-005453-4057qib7	3619	5	isoagglutinin	isoagglutinin	NNS
cord-005453-4057qib7	3619	6	titers	titer	NNS
cord-005453-4057qib7	3619	7	prior	prior	RB
cord-005453-4057qib7	3619	8	to	to	IN
cord-005453-4057qib7	3619	9	transplantation	transplantation	NN
cord-005453-4057qib7	3619	10	were	be	VBD
cord-005453-4057qib7	3619	11	1:256	1:256	CD
cord-005453-4057qib7	3619	12	.	.	.
cord-005453-4057qib7	3620	1	During	during	IN
cord-005453-4057qib7	3620	2	the	the	DT
cord-005453-4057qib7	3620	3	first	first	JJ
cord-005453-4057qib7	3620	4	year	year	NN
cord-005453-4057qib7	3620	5	post	post	NN
cord-005453-4057qib7	3620	6	transplantation	transplantation	NN
cord-005453-4057qib7	3620	7	,	,	,
cord-005453-4057qib7	3620	8	the	the	DT
cord-005453-4057qib7	3620	9	patient	patient	NN
cord-005453-4057qib7	3620	10	required	require	VBD
cord-005453-4057qib7	3620	11	a	a	DT
cord-005453-4057qib7	3620	12	total	total	NN
cord-005453-4057qib7	3620	13	of	of	IN
cord-005453-4057qib7	3620	14	46	46	CD
cord-005453-4057qib7	3620	15	PRC	PRC	NNP
cord-005453-4057qib7	3620	16	transfusions	transfusion	NNS
cord-005453-4057qib7	3620	17	,	,	,
cord-005453-4057qib7	3620	18	with	with	IN
cord-005453-4057qib7	3620	19	gradual	gradual	JJ
cord-005453-4057qib7	3620	20	resolution	resolution	NN
cord-005453-4057qib7	3620	21	occurring	occur	VBG
cord-005453-4057qib7	3620	22	only	only	RB
cord-005453-4057qib7	3620	23	after	after	IN
cord-005453-4057qib7	3620	24	introduction	introduction	NN
cord-005453-4057qib7	3620	25	of	of	IN
cord-005453-4057qib7	3620	26	danazole	danazole	NNP
cord-005453-4057qib7	3620	27	treatment	treatment	NN
cord-005453-4057qib7	3620	28	.	.	.
cord-005453-4057qib7	3621	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3621	2	:	:	:
cord-005453-4057qib7	3622	1	In	in	IN
cord-005453-4057qib7	3622	2	our	-PRON-	PRP$
cord-005453-4057qib7	3622	3	patient	patient	JJ
cord-005453-4057qib7	3622	4	cohort	cohort	NN
cord-005453-4057qib7	3622	5	,	,	,
cord-005453-4057qib7	3622	6	both	both	DT
cord-005453-4057qib7	3622	7	major	major	JJ
cord-005453-4057qib7	3622	8	and	and	CC
cord-005453-4057qib7	3622	9	minor	minor	JJ
cord-005453-4057qib7	3622	10	AB0	ab0	NN
cord-005453-4057qib7	3622	11	mismatch	mismatch	NN
cord-005453-4057qib7	3622	12	associated	associate	VBN
cord-005453-4057qib7	3622	13	to	to	IN
cord-005453-4057qib7	3622	14	a	a	DT
cord-005453-4057qib7	3622	15	significantly	significantly	RB
cord-005453-4057qib7	3622	16	higher	high	JJR
cord-005453-4057qib7	3622	17	NRM	NRM	NNP
cord-005453-4057qib7	3622	18	.	.	.
cord-005453-4057qib7	3623	1	Major	major	JJ
cord-005453-4057qib7	3623	2	AB0	ab0	NN
cord-005453-4057qib7	3623	3	mismatch	mismatch	NN
cord-005453-4057qib7	3623	4	associated	associate	VBN
cord-005453-4057qib7	3623	5	to	to	IN
cord-005453-4057qib7	3623	6	a	a	DT
cord-005453-4057qib7	3623	7	higher	high	JJR
cord-005453-4057qib7	3623	8	PRC	PRC	NNP
cord-005453-4057qib7	3623	9	transfusion	transfusion	NN
cord-005453-4057qib7	3623	10	requirement	requirement	NN
cord-005453-4057qib7	3623	11	.	.	.
cord-005453-4057qib7	3624	1	A	a	DT
cord-005453-4057qib7	3624	2	more	more	RBR
cord-005453-4057qib7	3624	3	frequently	frequently	RB
cord-005453-4057qib7	3624	4	occurring	occur	VBG
cord-005453-4057qib7	3624	5	severe	severe	JJ
cord-005453-4057qib7	3624	6	acute	acute	JJ
cord-005453-4057qib7	3624	7	GvHD	gvhd	NN
cord-005453-4057qib7	3624	8	was	be	VBD
cord-005453-4057qib7	3624	9	also	also	RB
cord-005453-4057qib7	3624	10	suggested	suggest	VBN
cord-005453-4057qib7	3624	11	in	in	IN
cord-005453-4057qib7	3624	12	minor	minor	JJ
cord-005453-4057qib7	3624	13	AB0-mismatch	ab0-mismatch	NN
cord-005453-4057qib7	3624	14	transplants	transplant	NNS
cord-005453-4057qib7	3624	15	.	.	.
cord-005453-4057qib7	3625	1	Altogether	altogether	RB
cord-005453-4057qib7	3625	2	,	,	,
cord-005453-4057qib7	3625	3	our	-PRON-	PRP$
cord-005453-4057qib7	3625	4	results	result	NNS
cord-005453-4057qib7	3625	5	suggest	suggest	VBP
cord-005453-4057qib7	3625	6	that	that	IN
cord-005453-4057qib7	3625	7	allo	allo	NN
cord-005453-4057qib7	3625	8	-	-	HYPH
cord-005453-4057qib7	3625	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3625	10	outcome	outcome	NN
cord-005453-4057qib7	3625	11	may	may	MD
cord-005453-4057qib7	3625	12	be	be	VB
cord-005453-4057qib7	3625	13	significantly	significantly	RB
cord-005453-4057qib7	3625	14	affected	affect	VBN
cord-005453-4057qib7	3625	15	by	by	IN
cord-005453-4057qib7	3625	16	AB0	AB0	NNP
cord-005453-4057qib7	3625	17	blood	blood	NN
cord-005453-4057qib7	3625	18	group	group	NN
cord-005453-4057qib7	3625	19	mismatch	mismatch	NN
cord-005453-4057qib7	3625	20	.	.	.
cord-005453-4057qib7	3626	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3626	2	:	:	:
cord-005453-4057qib7	3626	3	Nothing	nothing	NN
cord-005453-4057qib7	3626	4	to	to	TO
cord-005453-4057qib7	3626	5	declare	declare	VB
cord-005453-4057qib7	3626	6	Background	background	NN
cord-005453-4057qib7	3626	7	:	:	:
cord-005453-4057qib7	3627	1	AT	AT	NNP
cord-005453-4057qib7	3627	2	-	-	HYPH
cord-005453-4057qib7	3627	3	TMA	TMA	NNP
cord-005453-4057qib7	3627	4	is	be	VBZ
cord-005453-4057qib7	3627	5	a	a	DT
cord-005453-4057qib7	3627	6	severe	severe	JJ
cord-005453-4057qib7	3627	7	endothelial	endothelial	JJ
cord-005453-4057qib7	3627	8	injury	injury	NN
cord-005453-4057qib7	3627	9	complication	complication	NN
cord-005453-4057qib7	3627	10	and	and	CC
cord-005453-4057qib7	3627	11	it	-PRON-	PRP
cord-005453-4057qib7	3627	12	may	may	MD
cord-005453-4057qib7	3627	13	involve	involve	VB
cord-005453-4057qib7	3627	14	the	the	DT
cord-005453-4057qib7	3627	15	intestinal	intestinal	JJ
cord-005453-4057qib7	3627	16	vasculature	vasculature	NN
cord-005453-4057qib7	3627	17	.	.	.
cord-005453-4057qib7	3628	1	Intestinal	intestinal	JJ
cord-005453-4057qib7	3628	2	TMA	TMA	NNP
cord-005453-4057qib7	3628	3	could	could	MD
cord-005453-4057qib7	3628	4	be	be	VB
cord-005453-4057qib7	3628	5	fatal	fatal	JJ
cord-005453-4057qib7	3628	6	and	and	CC
cord-005453-4057qib7	3628	7	missdiagnosed	missdiagnosed	JJ
cord-005453-4057qib7	3628	8	.	.	.
cord-005453-4057qib7	3629	1	Clinical	clinical	JJ
cord-005453-4057qib7	3629	2	and	and	CC
cord-005453-4057qib7	3629	3	pathological	pathological	JJ
cord-005453-4057qib7	3629	4	criteria	criterion	NNS
cord-005453-4057qib7	3629	5	to	to	TO
cord-005453-4057qib7	3629	6	differentiate	differentiate	VB
cord-005453-4057qib7	3629	7	from	from	IN
cord-005453-4057qib7	3629	8	intestinal	intestinal	JJ
cord-005453-4057qib7	3629	9	GVHD	GVHD	NNP
cord-005453-4057qib7	3629	10	are	be	VBP
cord-005453-4057qib7	3629	11	needed	need	VBN
cord-005453-4057qib7	3629	12	.	.	.
cord-005453-4057qib7	3630	1	The	the	DT
cord-005453-4057qib7	3630	2	aim	aim	NN
cord-005453-4057qib7	3630	3	of	of	IN
cord-005453-4057qib7	3630	4	this	this	DT
cord-005453-4057qib7	3630	5	study	study	NN
cord-005453-4057qib7	3630	6	was	be	VBD
cord-005453-4057qib7	3630	7	to	to	TO
cord-005453-4057qib7	3630	8	analyze	analyze	VB
cord-005453-4057qib7	3630	9	the	the	DT
cord-005453-4057qib7	3630	10	incidence	incidence	NN
cord-005453-4057qib7	3630	11	and	and	CC
cord-005453-4057qib7	3630	12	histological	histological	JJ
cord-005453-4057qib7	3630	13	characteristics	characteristic	NNS
cord-005453-4057qib7	3630	14	of	of	IN
cord-005453-4057qib7	3630	15	intestinal	intestinal	JJ
cord-005453-4057qib7	3630	16	TMA	TMA	NNP
cord-005453-4057qib7	3630	17	in	in	IN
cord-005453-4057qib7	3630	18	patients	patient	NNS
cord-005453-4057qib7	3630	19	diagnosed	diagnose	VBN
cord-005453-4057qib7	3630	20	of	of	IN
cord-005453-4057qib7	3630	21	systemic	systemic	JJ
cord-005453-4057qib7	3630	22	TMA	TMA	NNP
cord-005453-4057qib7	3630	23	.	.	.
cord-005453-4057qib7	3631	1	Methods	method	NNS
cord-005453-4057qib7	3631	2	:	:	:
cord-005453-4057qib7	3631	3	We	-PRON-	PRP
cord-005453-4057qib7	3631	4	analyzed	analyze	VBD
cord-005453-4057qib7	3631	5	the	the	DT
cord-005453-4057qib7	3631	6	incidence	incidence	NN
cord-005453-4057qib7	3631	7	of	of	IN
cord-005453-4057qib7	3631	8	TMA	TMA	NNP
cord-005453-4057qib7	3631	9	in	in	IN
cord-005453-4057qib7	3631	10	555	555	CD
cord-005453-4057qib7	3631	11	patients	patient	NNS
cord-005453-4057qib7	3631	12	who	who	WP
cord-005453-4057qib7	3631	13	underwent	undergo	VBD
cord-005453-4057qib7	3631	14	allo	allo	NN
cord-005453-4057qib7	3631	15	-	-	HYPH
cord-005453-4057qib7	3631	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3631	17	in	in	IN
cord-005453-4057qib7	3631	18	our	-PRON-	PRP$
cord-005453-4057qib7	3631	19	institution	institution	NN
cord-005453-4057qib7	3631	20	between	between	IN
cord-005453-4057qib7	3631	21	january	january	NNP
cord-005453-4057qib7	3631	22	2010-august	2010-august	CD
cord-005453-4057qib7	3631	23	2018	2018	CD
cord-005453-4057qib7	3631	24	.	.	.
cord-005453-4057qib7	3632	1	TMA	TMA	NNP
cord-005453-4057qib7	3632	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	3632	3	was	be	VBD
cord-005453-4057qib7	3632	4	based	base	VBN
cord-005453-4057qib7	3632	5	on	on	IN
cord-005453-4057qib7	3632	6	Ho	Ho	NNP
cord-005453-4057qib7	3632	7	criteria	criterion	NNS
cord-005453-4057qib7	3632	8	.	.	.
cord-005453-4057qib7	3633	1	We	-PRON-	PRP
cord-005453-4057qib7	3633	2	do	do	VBP
cord-005453-4057qib7	3633	3	a	a	DT
cord-005453-4057qib7	3633	4	pathological	pathological	JJ
cord-005453-4057qib7	3633	5	review	review	NN
cord-005453-4057qib7	3633	6	in	in	IN
cord-005453-4057qib7	3633	7	103	103	CD
cord-005453-4057qib7	3633	8	biopsies	biopsy	NNS
cord-005453-4057qib7	3633	9	from	from	IN
cord-005453-4057qib7	3633	10	25	25	CD
cord-005453-4057qib7	3633	11	out	out	IN
cord-005453-4057qib7	3633	12	of	of	IN
cord-005453-4057qib7	3633	13	52	52	CD
cord-005453-4057qib7	3633	14	patients	patient	NNS
cord-005453-4057qib7	3633	15	in	in	IN
cord-005453-4057qib7	3633	16	whom	whom	WP
cord-005453-4057qib7	3633	17	an	an	DT
cord-005453-4057qib7	3633	18	endoscopy	endoscopy	NN
cord-005453-4057qib7	3633	19	have	have	VBP
cord-005453-4057qib7	3633	20	been	be	VBN
cord-005453-4057qib7	3633	21	performed	perform	VBN
cord-005453-4057qib7	3633	22	30	30	CD
cord-005453-4057qib7	3633	23	days	day	NNS
cord-005453-4057qib7	3633	24	before	before	RB
cord-005453-4057qib7	3633	25	and	and	CC
cord-005453-4057qib7	3633	26	60	60	CD
cord-005453-4057qib7	3633	27	days	day	NNS
cord-005453-4057qib7	3633	28	after	after	IN
cord-005453-4057qib7	3633	29	the	the	DT
cord-005453-4057qib7	3633	30	diagnosis	diagnosis	NN
cord-005453-4057qib7	3633	31	of	of	IN
cord-005453-4057qib7	3633	32	TMA	TMA	NNP
cord-005453-4057qib7	3633	33	for	for	IN
cord-005453-4057qib7	3633	34	suspicious	suspicious	JJ
cord-005453-4057qib7	3633	35	of	of	IN
cord-005453-4057qib7	3633	36	GVHD	GVHD	NNP
cord-005453-4057qib7	3633	37	.	.	.
cord-005453-4057qib7	3634	1	Review	Review	NNP
cord-005453-4057qib7	3634	2	was	be	VBD
cord-005453-4057qib7	3634	3	performed	perform	VBN
cord-005453-4057qib7	3634	4	by	by	IN
cord-005453-4057qib7	3634	5	a	a	DT
cord-005453-4057qib7	3634	6	pathologist	pathologist	NN
cord-005453-4057qib7	3634	7	expert	expert	NN
cord-005453-4057qib7	3634	8	in	in	IN
cord-005453-4057qib7	3634	9	GVHD	GVHD	NNP
cord-005453-4057qib7	3634	10	,	,	,
cord-005453-4057qib7	3634	11	who	who	WP
cord-005453-4057qib7	3634	12	examined	examine	VBD
cord-005453-4057qib7	3634	13	the	the	DT
cord-005453-4057qib7	3634	14	biopsies	biopsy	NNS
cord-005453-4057qib7	3634	15	in	in	IN
cord-005453-4057qib7	3634	16	search	search	NN
cord-005453-4057qib7	3634	17	of	of	IN
cord-005453-4057qib7	3634	18	hystopathological	hystopathological	JJ
cord-005453-4057qib7	3634	19	features	feature	NNS
cord-005453-4057qib7	3634	20	of	of	IN
cord-005453-4057qib7	3634	21	GVHD	GVHD	NNP
cord-005453-4057qib7	3634	22	,	,	,
cord-005453-4057qib7	3634	23	TMA	TMA	NNP
cord-005453-4057qib7	3634	24	or	or	CC
cord-005453-4057qib7	3634	25	viral	viral	JJ
cord-005453-4057qib7	3634	26	infection	infection	NN
cord-005453-4057qib7	3634	27	.	.	.
cord-005453-4057qib7	3635	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	3635	2	of	of	IN
cord-005453-4057qib7	3635	3	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3635	4	GVHD	GVHD	NNP
cord-005453-4057qib7	3635	5	was	be	VBD
cord-005453-4057qib7	3635	6	stablished	stablishe	VBN
cord-005453-4057qib7	3635	7	according	accord	VBG
cord-005453-4057qib7	3635	8	to	to	IN
cord-005453-4057qib7	3635	9	Mcdonald	Mcdonald	NNP
cord-005453-4057qib7	3635	10	and	and	CC
cord-005453-4057qib7	3635	11	Sales	Sales	NNP
cord-005453-4057qib7	3635	12	criteria	criterion	NNS
cord-005453-4057qib7	3635	13	,	,	,
cord-005453-4057qib7	3635	14	while	while	IN
cord-005453-4057qib7	3635	15	intestinal	intestinal	JJ
cord-005453-4057qib7	3635	16	TMA	TMA	NNP
cord-005453-4057qib7	3635	17	diagnosis	diagnosis	NN
cord-005453-4057qib7	3635	18	was	be	VBD
cord-005453-4057qib7	3635	19	stablished	stablishe	VBN
cord-005453-4057qib7	3635	20	by	by	IN
cord-005453-4057qib7	3635	21	Warren	Warren	NNP
cord-005453-4057qib7	3635	22	et	et	NNP
cord-005453-4057qib7	3635	23	al	al	NNP
cord-005453-4057qib7	3635	24	criteria	criterion	NNS
cord-005453-4057qib7	3635	25	.	.	.
cord-005453-4057qib7	3636	1	Results	result	NNS
cord-005453-4057qib7	3636	2	:	:	:
cord-005453-4057qib7	3636	3	52	52	CD
cord-005453-4057qib7	3636	4	out	out	IN
cord-005453-4057qib7	3636	5	of	of	IN
cord-005453-4057qib7	3636	6	555	555	CD
cord-005453-4057qib7	3636	7	patients	patient	NNS
cord-005453-4057qib7	3636	8	(	(	-LRB-
cord-005453-4057qib7	3636	9	9,4	9,4	CD
cord-005453-4057qib7	3636	10	%	%	NN
cord-005453-4057qib7	3636	11	)	)	-RRB-
cord-005453-4057qib7	3636	12	were	be	VBD
cord-005453-4057qib7	3636	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	3636	14	of	of	IN
cord-005453-4057qib7	3636	15	TMA	TMA	NNP
cord-005453-4057qib7	3636	16	.	.	.
cord-005453-4057qib7	3637	1	Transplant	transplant	NN
cord-005453-4057qib7	3637	2	characteristics	characteristic	NNS
cord-005453-4057qib7	3637	3	and	and	CC
cord-005453-4057qib7	3637	4	TMA	TMA	NNP
cord-005453-4057qib7	3637	5	data	datum	NNS
cord-005453-4057qib7	3637	6	of	of	IN
cord-005453-4057qib7	3637	7	patients	patient	NNS
cord-005453-4057qib7	3637	8	with	with	IN
cord-005453-4057qib7	3637	9	systemic	systemic	JJ
cord-005453-4057qib7	3637	10	TMA	TMA	NNP
cord-005453-4057qib7	3637	11	are	be	VBP
cord-005453-4057qib7	3637	12	shown	show	VBN
cord-005453-4057qib7	3637	13	in	in	IN
cord-005453-4057qib7	3637	14	image	image	NN
cord-005453-4057qib7	3637	15	.	.	.
cord-005453-4057qib7	3638	1	47	47	CD
cord-005453-4057qib7	3638	2	out	out	IN
cord-005453-4057qib7	3638	3	of	of	IN
cord-005453-4057qib7	3638	4	52	52	CD
cord-005453-4057qib7	3638	5	patients	patient	NNS
cord-005453-4057qib7	3638	6	with	with	IN
cord-005453-4057qib7	3638	7	TMA	TMA	NNP
cord-005453-4057qib7	3638	8	(	(	-LRB-
cord-005453-4057qib7	3638	9	90	90	CD
cord-005453-4057qib7	3638	10	%	%	NN
cord-005453-4057qib7	3638	11	)	)	-RRB-
cord-005453-4057qib7	3638	12	had	have	VBD
cord-005453-4057qib7	3638	13	been	be	VBN
cord-005453-4057qib7	3638	14	diagnosed	diagnose	VBN
cord-005453-4057qib7	3638	15	with	with	IN
cord-005453-4057qib7	3638	16	prior/	prior/	CD
cord-005453-4057qib7	3638	17	simultaneous	simultaneous	JJ
cord-005453-4057qib7	3638	18	acute	acute	JJ
cord-005453-4057qib7	3638	19	GVHD	GVHD	NNP
cord-005453-4057qib7	3638	20	,	,	,
cord-005453-4057qib7	3638	21	20	20	CD
cord-005453-4057qib7	3638	22	of	of	IN
cord-005453-4057qib7	3638	23	them	-PRON-	PRP
cord-005453-4057qib7	3638	24	grade	grade	NN
cord-005453-4057qib7	3638	25	III	III	NNP
cord-005453-4057qib7	3638	26	-	-	HYPH
cord-005453-4057qib7	3638	27	IV	IV	NNP
cord-005453-4057qib7	3638	28	,	,	,
cord-005453-4057qib7	3638	29	and	and	CC
cord-005453-4057qib7	3638	30	80	80	CD
cord-005453-4057qib7	3638	31	%	%	NN
cord-005453-4057qib7	3638	32	with	with	IN
cord-005453-4057qib7	3638	33	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3638	34	GVHD	GVHD	NNP
cord-005453-4057qib7	3638	35	.	.	.
cord-005453-4057qib7	3639	1	Intestinal	intestinal	JJ
cord-005453-4057qib7	3639	2	TMA	TMA	NNP
cord-005453-4057qib7	3639	3	have	have	VBP
cord-005453-4057qib7	3639	4	been	be	VBN
cord-005453-4057qib7	3639	5	reported	report	VBN
cord-005453-4057qib7	3639	6	only	only	RB
cord-005453-4057qib7	3639	7	in	in	IN
cord-005453-4057qib7	3639	8	7	7	CD
cord-005453-4057qib7	3639	9	out	out	IN
cord-005453-4057qib7	3639	10	of	of	IN
cord-005453-4057qib7	3639	11	25	25	CD
cord-005453-4057qib7	3639	12	patients	patient	NNS
cord-005453-4057qib7	3639	13	(	(	-LRB-
cord-005453-4057qib7	3639	14	28	28	CD
cord-005453-4057qib7	3639	15	%	%	NN
cord-005453-4057qib7	3639	16	)	)	-RRB-
cord-005453-4057qib7	3639	17	at	at	IN
cord-005453-4057qib7	3639	18	diagnosis	diagnosis	NN
cord-005453-4057qib7	3639	19	,	,	,
cord-005453-4057qib7	3639	20	whereas	whereas	IN
cord-005453-4057qib7	3639	21	when	when	WRB
cord-005453-4057qib7	3639	22	review	review	NN
cord-005453-4057qib7	3639	23	based	base	VBN
cord-005453-4057qib7	3639	24	on	on	IN
cord-005453-4057qib7	3639	25	Warren	Warren	NNP
cord-005453-4057qib7	3639	26	criteria	criterion	NNS
cord-005453-4057qib7	3639	27	was	be	VBD
cord-005453-4057qib7	3639	28	performed	perform	VBN
cord-005453-4057qib7	3639	29	,	,	,
cord-005453-4057qib7	3639	30	in	in	IN
cord-005453-4057qib7	3639	31	19	19	CD
cord-005453-4057qib7	3639	32	patients	patient	NNS
cord-005453-4057qib7	3639	33	(	(	-LRB-
cord-005453-4057qib7	3639	34	76	76	CD
cord-005453-4057qib7	3639	35	%	%	NN
cord-005453-4057qib7	3639	36	)	)	-RRB-
cord-005453-4057qib7	3640	1	the	the	DT
cord-005453-4057qib7	3640	2	pathologist	pathologist	NN
cord-005453-4057qib7	3640	3	found	find	VBD
cord-005453-4057qib7	3640	4	at	at	IN
cord-005453-4057qib7	3640	5	least	least	JJS
cord-005453-4057qib7	3640	6	1	1	CD
cord-005453-4057qib7	3640	7	of	of	IN
cord-005453-4057qib7	3640	8	the	the	DT
cord-005453-4057qib7	3640	9	criteria	criterion	NNS
cord-005453-4057qib7	3640	10	of	of	IN
cord-005453-4057qib7	3640	11	endothelial	endothelial	JJ
cord-005453-4057qib7	3640	12	damage	damage	NN
cord-005453-4057qib7	3640	13	and	and	CC
cord-005453-4057qib7	3640	14	48	48	CD
cord-005453-4057qib7	3640	15	%	%	NN
cord-005453-4057qib7	3640	16	of	of	IN
cord-005453-4057qib7	3640	17	the	the	DT
cord-005453-4057qib7	3640	18	patients	patient	NNS
cord-005453-4057qib7	3640	19	3	3	CD
cord-005453-4057qib7	3640	20	or	or	CC
cord-005453-4057qib7	3640	21	more	more	JJR
cord-005453-4057qib7	3640	22	Warren	Warren	NNP
cord-005453-4057qib7	3640	23	criteria	criterion	NNS
cord-005453-4057qib7	3640	24	were	be	VBD
cord-005453-4057qib7	3640	25	founded	found	VBN
cord-005453-4057qib7	3640	26	.	.	.
cord-005453-4057qib7	3641	1	The	the	DT
cord-005453-4057qib7	3641	2	most	most	RBS
cord-005453-4057qib7	3641	3	frequent	frequent	JJ
cord-005453-4057qib7	3641	4	features	feature	NNS
cord-005453-4057qib7	3641	5	were	be	VBD
cord-005453-4057qib7	3641	6	endothelial	endothelial	JJ
cord-005453-4057qib7	3641	7	cell	cell	NN
cord-005453-4057qib7	3641	8	swelling	swelling	NN
cord-005453-4057qib7	3641	9	(	(	-LRB-
cord-005453-4057qib7	3641	10	n=16	n=16	NNP
cord-005453-4057qib7	3641	11	,	,	,
cord-005453-4057qib7	3641	12	64	64	CD
cord-005453-4057qib7	3641	13	%	%	NN
cord-005453-4057qib7	3641	14	)	)	-RRB-
cord-005453-4057qib7	3641	15	and	and	CC
cord-005453-4057qib7	3641	16	perivascular	perivascular	JJ
cord-005453-4057qib7	3641	17	mucosal	mucosal	JJ
cord-005453-4057qib7	3641	18	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	3641	19	(	(	-LRB-
cord-005453-4057qib7	3641	20	n=15	n=15	NNP
cord-005453-4057qib7	3641	21	,	,	,
cord-005453-4057qib7	3641	22	60	60	CD
cord-005453-4057qib7	3641	23	%	%	NN
cord-005453-4057qib7	3641	24	)	)	-RRB-
cord-005453-4057qib7	3641	25	.	.	.
cord-005453-4057qib7	3642	1	Review	review	VB
cord-005453-4057qib7	3642	2	hystological	hystological	NN
cord-005453-4057qib7	3642	3	features	feature	NNS
cord-005453-4057qib7	3642	4	of	of	IN
cord-005453-4057qib7	3642	5	biopsies	biopsy	NNS
cord-005453-4057qib7	3642	6	are	be	VBP
cord-005453-4057qib7	3642	7	shown	show	VBN
cord-005453-4057qib7	3642	8	in	in	IN
cord-005453-4057qib7	3642	9	table	table	NN
cord-005453-4057qib7	3642	10	3	3	CD
cord-005453-4057qib7	3642	11	of	of	IN
cord-005453-4057qib7	3642	12	the	the	DT
cord-005453-4057qib7	3642	13	image	image	NN
cord-005453-4057qib7	3642	14	.	.	.
cord-005453-4057qib7	3643	1	Regarding	regard	VBG
cord-005453-4057qib7	3643	2	GVHD	GVHD	NNP
cord-005453-4057qib7	3643	3	,	,	,
cord-005453-4057qib7	3643	4	it	-PRON-	PRP
cord-005453-4057qib7	3643	5	was	be	VBD
cord-005453-4057qib7	3643	6	found	find	VBN
cord-005453-4057qib7	3643	7	in	in	IN
cord-005453-4057qib7	3643	8	21	21	CD
cord-005453-4057qib7	3643	9	patients	patient	NNS
cord-005453-4057qib7	3643	10	(	(	-LRB-
cord-005453-4057qib7	3643	11	84	84	CD
cord-005453-4057qib7	3643	12	%	%	NN
cord-005453-4057qib7	3643	13	)	)	-RRB-
cord-005453-4057qib7	3643	14	at	at	IN
cord-005453-4057qib7	3643	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	3643	16	and	and	CC
cord-005453-4057qib7	3643	17	in	in	IN
cord-005453-4057qib7	3643	18	23	23	CD
cord-005453-4057qib7	3643	19	(	(	-LRB-
cord-005453-4057qib7	3643	20	92	92	CD
cord-005453-4057qib7	3643	21	%	%	NN
cord-005453-4057qib7	3643	22	)	)	-RRB-
cord-005453-4057qib7	3643	23	at	at	IN
cord-005453-4057qib7	3643	24	pathological	pathological	JJ
cord-005453-4057qib7	3643	25	review	review	NN
cord-005453-4057qib7	3643	26	.	.	.
cord-005453-4057qib7	3644	1	With	with	IN
cord-005453-4057qib7	3644	2	a	a	DT
cord-005453-4057qib7	3644	3	median	median	JJ
cord-005453-4057qib7	3644	4	follow	follow	NN
cord-005453-4057qib7	3644	5	-	-	HYPH
cord-005453-4057qib7	3644	6	up	up	NN
cord-005453-4057qib7	3644	7	of	of	IN
cord-005453-4057qib7	3644	8	10	10	CD
cord-005453-4057qib7	3644	9	months	month	NNS
cord-005453-4057qib7	3644	10	(	(	-LRB-
cord-005453-4057qib7	3644	11	1	1	CD
cord-005453-4057qib7	3644	12	-	-	SYM
cord-005453-4057qib7	3644	13	73	73	CD
cord-005453-4057qib7	3644	14	)	)	-RRB-
cord-005453-4057qib7	3644	15	32	32	CD
cord-005453-4057qib7	3644	16	patients	patient	NNS
cord-005453-4057qib7	3644	17	of	of	IN
cord-005453-4057qib7	3644	18	the	the	DT
cord-005453-4057qib7	3644	19	52	52	CD
cord-005453-4057qib7	3644	20	with	with	IN
cord-005453-4057qib7	3644	21	systemic	systemic	JJ
cord-005453-4057qib7	3644	22	TMA	TMA	NNP
cord-005453-4057qib7	3644	23	(	(	-LRB-
cord-005453-4057qib7	3644	24	62	62	CD
cord-005453-4057qib7	3644	25	%	%	NN
cord-005453-4057qib7	3644	26	)	)	-RRB-
cord-005453-4057qib7	3644	27	are	be	VBP
cord-005453-4057qib7	3644	28	dead	dead	JJ
cord-005453-4057qib7	3644	29	.	.	.
cord-005453-4057qib7	3645	1	9	9	CD
cord-005453-4057qib7	3645	2	of	of	IN
cord-005453-4057qib7	3645	3	the	the	DT
cord-005453-4057qib7	3645	4	deaths	death	NNS
cord-005453-4057qib7	3645	5	(	(	-LRB-
cord-005453-4057qib7	3645	6	41	41	CD
cord-005453-4057qib7	3645	7	%	%	NN
cord-005453-4057qib7	3645	8	)	)	-RRB-
cord-005453-4057qib7	3645	9	were	be	VBD
cord-005453-4057qib7	3645	10	related	relate	VBN
cord-005453-4057qib7	3645	11	to	to	IN
cord-005453-4057qib7	3645	12	TMA	TMA	NNP
cord-005453-4057qib7	3645	13	(	(	-LRB-
cord-005453-4057qib7	3645	14	3	3	CD
cord-005453-4057qib7	3645	15	TMA	TMA	NNP
cord-005453-4057qib7	3645	16	,	,	,
cord-005453-4057qib7	3645	17	3	3	CD
cord-005453-4057qib7	3645	18	TMA	TMA	NNP
cord-005453-4057qib7	3645	19	+	+	CC
cord-005453-4057qib7	3645	20	GVHD	GVHD	NNP
cord-005453-4057qib7	3645	21	,	,	,
cord-005453-4057qib7	3645	22	and	and	CC
cord-005453-4057qib7	3645	23	3	3	CD
cord-005453-4057qib7	3645	24	TMA+infection	tma+infection	NN
cord-005453-4057qib7	3645	25	)	)	-RRB-
cord-005453-4057qib7	3645	26	.	.	.
cord-005453-4057qib7	3646	1	Patients	patient	NNS
cord-005453-4057qib7	3646	2	with	with	IN
cord-005453-4057qib7	3646	3	3	3	CD
cord-005453-4057qib7	3646	4	or	or	CC
cord-005453-4057qib7	3646	5	more	more	JJR
cord-005453-4057qib7	3646	6	Warren	Warren	NNP
cord-005453-4057qib7	3646	7	criteria	criterion	NNS
cord-005453-4057qib7	3646	8	in	in	IN
cord-005453-4057qib7	3646	9	pathological	pathological	JJ
cord-005453-4057qib7	3646	10	review	review	NN
cord-005453-4057qib7	3646	11	had	have	VBD
cord-005453-4057qib7	3646	12	poor	poor	JJ
cord-005453-4057qib7	3646	13	outcome	outcome	NN
cord-005453-4057qib7	3646	14	compared	compare	VBN
cord-005453-4057qib7	3646	15	with	with	IN
cord-005453-4057qib7	3646	16	patients	patient	NNS
cord-005453-4057qib7	3646	17	less	less	JJR
cord-005453-4057qib7	3646	18	than	than	IN
cord-005453-4057qib7	3646	19	3	3	CD
cord-005453-4057qib7	3646	20	criteria	criterion	NNS
cord-005453-4057qib7	3646	21	(	(	-LRB-
cord-005453-4057qib7	3646	22	30	30	CD
cord-005453-4057qib7	3646	23	%	%	NN
cord-005453-4057qib7	3646	24	alive	alive	JJ
cord-005453-4057qib7	3646	25	VS	VS	NNP
cord-005453-4057qib7	3646	26	51	51	CD
cord-005453-4057qib7	3646	27	%	%	NN
cord-005453-4057qib7	3646	28	at	at	IN
cord-005453-4057qib7	3646	29	12	12	CD
cord-005453-4057qib7	3646	30	months	month	NNS
cord-005453-4057qib7	3646	31	,	,	,
cord-005453-4057qib7	3646	32	p=0.9	p=0.9	NNP
cord-005453-4057qib7	3646	33	)	)	-RRB-
cord-005453-4057qib7	3646	34	.	.	.
cord-005453-4057qib7	3647	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3647	2	:	:	:
cord-005453-4057qib7	3648	1	Intestinal	intestinal	JJ
cord-005453-4057qib7	3648	2	TMA	TMA	NNP
cord-005453-4057qib7	3648	3	is	be	VBZ
cord-005453-4057qib7	3648	4	a	a	DT
cord-005453-4057qib7	3648	5	life	life	NN
cord-005453-4057qib7	3648	6	-	-	HYPH
cord-005453-4057qib7	3648	7	threatening	threaten	VBG
cord-005453-4057qib7	3648	8	underdiagnosed	underdiagnosed	JJ
cord-005453-4057qib7	3648	9	entity	entity	NN
cord-005453-4057qib7	3648	10	.	.	.
cord-005453-4057qib7	3649	1	Only	only	RB
cord-005453-4057qib7	3649	2	7	7	CD
cord-005453-4057qib7	3649	3	patients	patient	NNS
cord-005453-4057qib7	3649	4	of	of	IN
cord-005453-4057qib7	3649	5	25	25	CD
cord-005453-4057qib7	3649	6	patients	patient	NNS
cord-005453-4057qib7	3649	7	were	be	VBD
cord-005453-4057qib7	3649	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	3649	9	of	of	IN
cord-005453-4057qib7	3649	10	intestinal	intestinal	JJ
cord-005453-4057qib7	3649	11	TMA	TMA	NNP
cord-005453-4057qib7	3649	12	.	.	.
cord-005453-4057qib7	3650	1	We	-PRON-	PRP
cord-005453-4057qib7	3650	2	found	find	VBD
cord-005453-4057qib7	3650	3	that	that	IN
cord-005453-4057qib7	3650	4	most	most	JJS
cord-005453-4057qib7	3650	5	of	of	IN
cord-005453-4057qib7	3650	6	our	-PRON-	PRP$
cord-005453-4057qib7	3650	7	patients	patient	NNS
cord-005453-4057qib7	3650	8	had	have	VBD
cord-005453-4057qib7	3650	9	endothelial	endothelial	JJ
cord-005453-4057qib7	3650	10	damage	damage	NN
cord-005453-4057qib7	3650	11	in	in	IN
cord-005453-4057qib7	3650	12	the	the	DT
cord-005453-4057qib7	3650	13	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3650	14	biopsy	biopsy	JJ
cord-005453-4057qib7	3650	15	pathological	pathological	JJ
cord-005453-4057qib7	3650	16	reviews	review	NNS
cord-005453-4057qib7	3650	17	.	.	.
cord-005453-4057qib7	3651	1	GVHD	gvhd	JJ
cord-005453-4057qib7	3651	2	histological	histological	JJ
cord-005453-4057qib7	3651	3	criteria	criterion	NNS
cord-005453-4057qib7	3651	4	were	be	VBD
cord-005453-4057qib7	3651	5	present	present	JJ
cord-005453-4057qib7	3651	6	in	in	IN
cord-005453-4057qib7	3651	7	most	most	JJS
cord-005453-4057qib7	3651	8	of	of	IN
cord-005453-4057qib7	3651	9	the	the	DT
cord-005453-4057qib7	3651	10	patients	patient	NNS
cord-005453-4057qib7	3651	11	,	,	,
cord-005453-4057qib7	3651	12	mainly	mainly	RB
cord-005453-4057qib7	3651	13	histological	histological	JJ
cord-005453-4057qib7	3651	14	grade	grade	NN
cord-005453-4057qib7	3651	15	I	I	NNP
cord-005453-4057qib7	3651	16	-	-	HYPH
cord-005453-4057qib7	3651	17	II	II	NNP
cord-005453-4057qib7	3651	18	.	.	.
cord-005453-4057qib7	3652	1	Prognosis	prognosis	NN
cord-005453-4057qib7	3652	2	of	of	IN
cord-005453-4057qib7	3652	3	these	these	DT
cord-005453-4057qib7	3652	4	patients	patient	NNS
cord-005453-4057qib7	3652	5	is	be	VBZ
cord-005453-4057qib7	3652	6	poor	poor	JJ
cord-005453-4057qib7	3652	7	and	and	CC
cord-005453-4057qib7	3652	8	pathologist	pathologist	NN
cord-005453-4057qib7	3652	9	effords	efford	NNS
cord-005453-4057qib7	3652	10	in	in	IN
cord-005453-4057qib7	3652	11	diagnosed	diagnose	VBN
cord-005453-4057qib7	3653	1	the	the	DT
cord-005453-4057qib7	3653	2	entity	entity	NN
cord-005453-4057qib7	3653	3	is	be	VBZ
cord-005453-4057qib7	3653	4	guarranted	guarrante	VBN
cord-005453-4057qib7	3653	5	.	.	.
cord-005453-4057qib7	3654	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3654	2	:	:	:
cord-005453-4057qib7	3654	3	Nothing	nothing	NN
cord-005453-4057qib7	3654	4	to	to	IN
cord-005453-4057qib7	3654	5	disclosure	disclosure	NN
cord-005453-4057qib7	3654	6	P175	P175	``
cord-005453-4057qib7	3654	7	Strategies	strategy	NNS
cord-005453-4057qib7	3654	8	to	to	TO
cord-005453-4057qib7	3654	9	reduce	reduce	VB
cord-005453-4057qib7	3654	10	neutropenic	neutropenic	JJ
cord-005453-4057qib7	3654	11	fever	fever	NN
cord-005453-4057qib7	3654	12	and	and	CC
cord-005453-4057qib7	3654	13	hospital	hospital	NN
cord-005453-4057qib7	3654	14	readmission	readmission	NN
cord-005453-4057qib7	3654	15	in	in	IN
cord-005453-4057qib7	3654	16	multiple	multiple	JJ
cord-005453-4057qib7	3654	17	myeloma	myeloma	NN
cord-005453-4057qib7	3654	18	patients	patient	NNS
cord-005453-4057qib7	3654	19	managed	manage	VBD
cord-005453-4057qib7	3654	20	at	at	IN
cord-005453-4057qib7	3654	21	home	home	NN
cord-005453-4057qib7	3654	22	after	after	IN
cord-005453-4057qib7	3654	23	autologous	autologous	JJ
cord-005453-4057qib7	3654	24	stem	stem	NN
cord-005453-4057qib7	3654	25	cell	cell	NN
cord-005453-4057qib7	3654	26	transplantation	transplantation	NN
cord-005453-4057qib7	3654	27	Background	background	NN
cord-005453-4057qib7	3654	28	:	:	:
cord-005453-4057qib7	3655	1	Neutropenic	neutropenic	JJ
cord-005453-4057qib7	3655	2	fever	fever	NN
cord-005453-4057qib7	3655	3	(	(	-LRB-
cord-005453-4057qib7	3655	4	NF	NF	NNP
cord-005453-4057qib7	3655	5	)	)	-RRB-
cord-005453-4057qib7	3655	6	is	be	VBZ
cord-005453-4057qib7	3655	7	the	the	DT
cord-005453-4057qib7	3655	8	most	most	RBS
cord-005453-4057qib7	3655	9	frequent	frequent	JJ
cord-005453-4057qib7	3655	10	cause	cause	NN
cord-005453-4057qib7	3655	11	of	of	IN
cord-005453-4057qib7	3655	12	readmission	readmission	NN
cord-005453-4057qib7	3655	13	in	in	IN
cord-005453-4057qib7	3655	14	the	the	DT
cord-005453-4057qib7	3655	15	outpatient	outpatient	NN
cord-005453-4057qib7	3655	16	autologous	autologous	JJ
cord-005453-4057qib7	3655	17	stem	stem	NN
cord-005453-4057qib7	3655	18	cell	cell	NN
cord-005453-4057qib7	3655	19	transplantation	transplantation	NN
cord-005453-4057qib7	3655	20	(	(	-LRB-
cord-005453-4057qib7	3655	21	ASCT	ASCT	NNP
cord-005453-4057qib7	3655	22	)	)	-RRB-
cord-005453-4057qib7	3655	23	programs	program	NNS
cord-005453-4057qib7	3655	24	.	.	.
cord-005453-4057qib7	3656	1	In	in	IN
cord-005453-4057qib7	3656	2	our	-PRON-	PRP$
cord-005453-4057qib7	3656	3	at	at	IN
cord-005453-4057qib7	3656	4	home	home	NN
cord-005453-4057qib7	3656	5	model	model	NN
cord-005453-4057qib7	3656	6	for	for	IN
cord-005453-4057qib7	3656	7	multiple	multiple	JJ
cord-005453-4057qib7	3656	8	myeloma	myeloma	NN
cord-005453-4057qib7	3656	9	patients	patient	NNS
cord-005453-4057qib7	3656	10	,	,	,
cord-005453-4057qib7	3656	11	we	-PRON-	PRP
cord-005453-4057qib7	3656	12	added	add	VBD
cord-005453-4057qib7	3656	13	primary	primary	JJ
cord-005453-4057qib7	3656	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3656	15	with	with	IN
cord-005453-4057qib7	3656	16	ceftriaxone	ceftriaxone	NN
cord-005453-4057qib7	3656	17	,	,	,
cord-005453-4057qib7	3656	18	decreasing	decrease	VBG
cord-005453-4057qib7	3656	19	the	the	DT
cord-005453-4057qib7	3656	20	incidence	incidence	NN
cord-005453-4057qib7	3656	21	of	of	IN
cord-005453-4057qib7	3656	22	fever	fever	NN
cord-005453-4057qib7	3656	23	during	during	IN
cord-005453-4057qib7	3656	24	aplasia	aplasia	JJ
cord-005453-4057qib7	3656	25	phase	phase	NN
cord-005453-4057qib7	3656	26	from	from	IN
cord-005453-4057qib7	3656	27	85	85	CD
cord-005453-4057qib7	3656	28	%	%	NN
cord-005453-4057qib7	3656	29	to	to	IN
cord-005453-4057qib7	3656	30	57.6	57.6	CD
cord-005453-4057qib7	3656	31	%	%	NN
cord-005453-4057qib7	3656	32	.	.	.
cord-005453-4057qib7	3657	1	The	the	DT
cord-005453-4057qib7	3657	2	aim	aim	NN
cord-005453-4057qib7	3657	3	of	of	IN
cord-005453-4057qib7	3657	4	this	this	DT
cord-005453-4057qib7	3657	5	study	study	NN
cord-005453-4057qib7	3657	6	was	be	VBD
cord-005453-4057qib7	3657	7	to	to	TO
cord-005453-4057qib7	3657	8	analyze	analyze	VB
cord-005453-4057qib7	3657	9	the	the	DT
cord-005453-4057qib7	3657	10	addition	addition	NN
cord-005453-4057qib7	3657	11	of	of	IN
cord-005453-4057qib7	3657	12	two	two	CD
cord-005453-4057qib7	3657	13	strategies	strategy	NNS
cord-005453-4057qib7	3657	14	to	to	TO
cord-005453-4057qib7	3657	15	reduce	reduce	VB
cord-005453-4057qib7	3657	16	the	the	DT
cord-005453-4057qib7	3657	17	non	non	JJ
cord-005453-4057qib7	3657	18	-	-	JJ
cord-005453-4057qib7	3657	19	infectious	infectious	JJ
cord-005453-4057qib7	3657	20	NF	nf	NN
cord-005453-4057qib7	3657	21	:	:	:
cord-005453-4057qib7	3657	22	withdrawal	withdrawal	NN
cord-005453-4057qib7	3657	23	of	of	IN
cord-005453-4057qib7	3657	24	G	G	NNP
cord-005453-4057qib7	3657	25	-	-	HYPH
cord-005453-4057qib7	3657	26	CSF	CSF	NNP
cord-005453-4057qib7	3657	27	and	and	CC
cord-005453-4057qib7	3657	28	the	the	DT
cord-005453-4057qib7	3657	29	addition	addition	NN
cord-005453-4057qib7	3657	30	of	of	IN
cord-005453-4057qib7	3657	31	primary	primary	JJ
cord-005453-4057qib7	3657	32	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3657	33	for	for	IN
cord-005453-4057qib7	3657	34	engraftment	engraftment	NNP
cord-005453-4057qib7	3657	35	syndrome	syndrome	NN
cord-005453-4057qib7	3657	36	with	with	IN
cord-005453-4057qib7	3657	37	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	3657	38	after	after	IN
cord-005453-4057qib7	3657	39	ASCT	ASCT	NNP
cord-005453-4057qib7	3657	40	.	.	.
cord-005453-4057qib7	3658	1	Methods	method	NNS
cord-005453-4057qib7	3658	2	:	:	:
cord-005453-4057qib7	3658	3	Between	between	IN
cord-005453-4057qib7	3658	4	January	January	NNP
cord-005453-4057qib7	3658	5	2002	2002	CD
cord-005453-4057qib7	3658	6	and	and	CC
cord-005453-4057qib7	3658	7	August	August	NNP
cord-005453-4057qib7	3658	8	2018	2018	CD
cord-005453-4057qib7	3658	9	111	111	CD
cord-005453-4057qib7	3658	10	myeloma	myeloma	NN
cord-005453-4057qib7	3658	11	patients	patient	NNS
cord-005453-4057qib7	3658	12	were	be	VBD
cord-005453-4057qib7	3658	13	managed	manage	VBN
cord-005453-4057qib7	3658	14	at	at	IN
cord-005453-4057qib7	3658	15	-	-	HYPH
cord-005453-4057qib7	3658	16	home	home	NN
cord-005453-4057qib7	3658	17	since	since	IN
cord-005453-4057qib7	3658	18	day	day	NN
cord-005453-4057qib7	3658	19	+1	+1	NNS
cord-005453-4057qib7	3658	20	of	of	IN
cord-005453-4057qib7	3658	21	ASCT	ASCT	NNP
cord-005453-4057qib7	3658	22	.	.	.
cord-005453-4057qib7	3659	1	All	all	DT
cord-005453-4057qib7	3659	2	were	be	VBD
cord-005453-4057qib7	3659	3	conditioned	condition	VBN
cord-005453-4057qib7	3659	4	with	with	IN
cord-005453-4057qib7	3659	5	Mel200	mel200	NN
cord-005453-4057qib7	3659	6	.	.	.
cord-005453-4057qib7	3660	1	All	all	DT
cord-005453-4057qib7	3660	2	patients	patient	NNS
cord-005453-4057qib7	3660	3	received	receive	VBD
cord-005453-4057qib7	3660	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3660	5	with	with	IN
cord-005453-4057qib7	3660	6	quinolone	quinolone	NNP
cord-005453-4057qib7	3660	7	,	,	,
cord-005453-4057qib7	3660	8	fluconazole	fluconazole	NNP
cord-005453-4057qib7	3660	9	,	,	,
cord-005453-4057qib7	3660	10	aerolized	aerolize	VBN
cord-005453-4057qib7	3660	11	pentamidine	pentamidine	NNP
cord-005453-4057qib7	3660	12	,	,	,
cord-005453-4057qib7	3660	13	low	low	JJ
cord-005453-4057qib7	3660	14	-	-	HYPH
cord-005453-4057qib7	3660	15	dose	dose	NN
cord-005453-4057qib7	3660	16	acyclovir	acyclovir	NN
cord-005453-4057qib7	3660	17	(	(	-LRB-
cord-005453-4057qib7	3660	18	HVS+	HVS+	NNP
cord-005453-4057qib7	3660	19	)	)	-RRB-
cord-005453-4057qib7	3660	20	,	,	,
cord-005453-4057qib7	3660	21	and	and	CC
cord-005453-4057qib7	3660	22	ceftriaxone	ceftriaxone	NN
cord-005453-4057qib7	3660	23	(	(	-LRB-
cord-005453-4057qib7	3660	24	since	since	IN
cord-005453-4057qib7	3660	25	day	day	NN
cord-005453-4057qib7	3660	26	+4	+4	NN
cord-005453-4057qib7	3660	27	)	)	-RRB-
cord-005453-4057qib7	3660	28	.	.	.
cord-005453-4057qib7	3661	1	The	the	DT
cord-005453-4057qib7	3661	2	patients	patient	NNS
cord-005453-4057qib7	3661	3	were	be	VBD
cord-005453-4057qib7	3661	4	classified	classify	VBN
cord-005453-4057qib7	3661	5	into	into	IN
cord-005453-4057qib7	3661	6	3	3	CD
cord-005453-4057qib7	3661	7	groups	group	NNS
cord-005453-4057qib7	3661	8	:	:	:
cord-005453-4057qib7	3661	9	group	group	NN
cord-005453-4057qib7	3661	10	A	A	NNP
cord-005453-4057qib7	3661	11	(	(	-LRB-
cord-005453-4057qib7	3661	12	n=33	n=33	NN
cord-005453-4057qib7	3661	13	;	;	:
cord-005453-4057qib7	3661	14	G	G	NNP
cord-005453-4057qib7	3661	15	-	-	HYPH
cord-005453-4057qib7	3661	16	CSF	CSF	NNP
cord-005453-4057qib7	3661	17	since	since	IN
cord-005453-4057qib7	3661	18	day	day	NN
cord-005453-4057qib7	3661	19	+7	+7	.
cord-005453-4057qib7	3661	20	without	without	IN
cord-005453-4057qib7	3661	21	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	3661	22	)	)	-RRB-
cord-005453-4057qib7	3661	23	,	,	,
cord-005453-4057qib7	3661	24	group	group	NN
cord-005453-4057qib7	3661	25	B	B	NNP
cord-005453-4057qib7	3661	26	(	(	-LRB-
cord-005453-4057qib7	3661	27	n=32	n=32	NNP
cord-005453-4057qib7	3661	28	;	;	:
cord-005453-4057qib7	3661	29	no	no	DT
cord-005453-4057qib7	3661	30	G	G	NNP
cord-005453-4057qib7	3661	31	-	-	HYPH
cord-005453-4057qib7	3661	32	CSF	CSF	NNP
cord-005453-4057qib7	3661	33	and	and	CC
cord-005453-4057qib7	3661	34	no	no	DT
cord-005453-4057qib7	3661	35	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	3661	36	)	)	-RRB-
cord-005453-4057qib7	3661	37	,	,	,
cord-005453-4057qib7	3661	38	group	group	NN
cord-005453-4057qib7	3661	39	C	C	NNP
cord-005453-4057qib7	3661	40	(	(	-LRB-
cord-005453-4057qib7	3661	41	n=46	n=46	JJ
cord-005453-4057qib7	3661	42	;	;	:
cord-005453-4057qib7	3661	43	no	no	DT
cord-005453-4057qib7	3661	44	G	G	NNP
cord-005453-4057qib7	3661	45	-	-	HYPH
cord-005453-4057qib7	3661	46	CSF	CSF	NNP
cord-005453-4057qib7	3661	47	with	with	IN
cord-005453-4057qib7	3661	48	prednisone	prednisone	NNP
cord-005453-4057qib7	3661	49	0.5	0.5	CD
cord-005453-4057qib7	3662	1	mg	mg	NNP
cord-005453-4057qib7	3662	2	/	/	SYM
cord-005453-4057qib7	3662	3	kg	kg	NNP
cord-005453-4057qib7	3662	4	/	/	SYM
cord-005453-4057qib7	3662	5	day	day	NN
cord-005453-4057qib7	3662	6	since	since	IN
cord-005453-4057qib7	3662	7	day	day	NN
cord-005453-4057qib7	3662	8	+7	+7	.
cord-005453-4057qib7	3662	9	until	until	IN
cord-005453-4057qib7	3662	10	granulocyte	granulocyte	NN
cord-005453-4057qib7	3662	11	recovery	recovery	NN
cord-005453-4057qib7	3662	12	)	)	-RRB-
cord-005453-4057qib7	3662	13	.	.	.
cord-005453-4057qib7	3663	1	First	first	JJ
cord-005453-4057qib7	3663	2	-	-	HYPH
cord-005453-4057qib7	3663	3	line	line	NN
cord-005453-4057qib7	3663	4	therapy	therapy	NN
cord-005453-4057qib7	3663	5	at	at	IN
cord-005453-4057qib7	3663	6	home	home	NN
cord-005453-4057qib7	3663	7	of	of	IN
cord-005453-4057qib7	3663	8	NF	nf	NN
cord-005453-4057qib7	3663	9	was	be	VBD
cord-005453-4057qib7	3663	10	piperacillin	piperacillin	NN
cord-005453-4057qib7	3663	11	-	-	HYPH
cord-005453-4057qib7	3663	12	tazobactam	tazobactam	NNP
cord-005453-4057qib7	3664	1	4.5	4.5	CD
cord-005453-4057qib7	3664	2	g/6h	g/6h	POS
cord-005453-4057qib7	3664	3	i.v	i.v	NNP
cord-005453-4057qib7	3664	4	.	.	.
cord-005453-4057qib7	3665	1	using	use	VBG
cord-005453-4057qib7	3665	2	a	a	DT
cord-005453-4057qib7	3665	3	portable	portable	JJ
cord-005453-4057qib7	3665	4	intermittent	intermittent	JJ
cord-005453-4057qib7	3665	5	infusion	infusion	NN
cord-005453-4057qib7	3665	6	pump	pump	NN
cord-005453-4057qib7	3665	7	.	.	.
cord-005453-4057qib7	3666	1	Fever	fever	NN
cord-005453-4057qib7	3666	2	was	be	VBD
cord-005453-4057qib7	3666	3	an	an	DT
cord-005453-4057qib7	3666	4	indication	indication	NN
cord-005453-4057qib7	3666	5	of	of	IN
cord-005453-4057qib7	3666	6	immediate	immediate	JJ
cord-005453-4057qib7	3666	7	medical	medical	JJ
cord-005453-4057qib7	3666	8	consultation	consultation	NN
cord-005453-4057qib7	3666	9	and	and	CC
cord-005453-4057qib7	3666	10	those	those	DT
cord-005453-4057qib7	3666	11	patients	patient	NNS
cord-005453-4057qib7	3666	12	presenting	present	VBG
cord-005453-4057qib7	3666	13	signs	sign	NNS
cord-005453-4057qib7	3666	14	of	of	IN
cord-005453-4057qib7	3666	15	focal	focal	JJ
cord-005453-4057qib7	3666	16	infection	infection	NN
cord-005453-4057qib7	3666	17	or	or	CC
cord-005453-4057qib7	3666	18	severe	severe	JJ
cord-005453-4057qib7	3666	19	sepsis	sepsis	NN
cord-005453-4057qib7	3666	20	were	be	VBD
cord-005453-4057qib7	3666	21	admitted	admit	VBN
cord-005453-4057qib7	3666	22	.	.	.
cord-005453-4057qib7	3667	1	Other	other	JJ
cord-005453-4057qib7	3667	2	indications	indication	NNS
cord-005453-4057qib7	3667	3	for	for	IN
cord-005453-4057qib7	3667	4	readmission	readmission	NN
cord-005453-4057qib7	3667	5	were	be	VBD
cord-005453-4057qib7	3667	6	:	:	:
cord-005453-4057qib7	3667	7	willingness	willingness	NN
cord-005453-4057qib7	3667	8	of	of	IN
cord-005453-4057qib7	3667	9	the	the	DT
cord-005453-4057qib7	3667	10	patient	patient	NN
cord-005453-4057qib7	3667	11	or	or	CC
cord-005453-4057qib7	3667	12	caregiver	caregiver	NN
cord-005453-4057qib7	3667	13	,	,	,
cord-005453-4057qib7	3667	14	uncontrolled	uncontrolled	JJ
cord-005453-4057qib7	3667	15	nausea	nausea	NN
cord-005453-4057qib7	3667	16	,	,	,
cord-005453-4057qib7	3667	17	vomiting	vomiting	NN
cord-005453-4057qib7	3667	18	or	or	CC
cord-005453-4057qib7	3667	19	diarrhoea	diarrhoea	NN
cord-005453-4057qib7	3667	20	,	,	,
cord-005453-4057qib7	3667	21	and	and	CC
cord-005453-4057qib7	3667	22	mucositis	mucositis	NNP
cord-005453-4057qib7	3667	23	requiring	require	VBG
cord-005453-4057qib7	3667	24	total	total	JJ
cord-005453-4057qib7	3667	25	parenteral	parenteral	JJ
cord-005453-4057qib7	3667	26	nutrition	nutrition	NN
cord-005453-4057qib7	3667	27	or	or	CC
cord-005453-4057qib7	3667	28	i.v	i.v	NNP
cord-005453-4057qib7	3667	29	.	.	NNP
cord-005453-4057qib7	3667	30	morphics	morphic	NNS
cord-005453-4057qib7	3667	31	.	.	.
cord-005453-4057qib7	3668	1	Results	result	NNS
cord-005453-4057qib7	3668	2	:	:	:
cord-005453-4057qib7	3669	1	The	the	DT
cord-005453-4057qib7	3669	2	main	main	JJ
cord-005453-4057qib7	3669	3	characteristics	characteristic	NNS
cord-005453-4057qib7	3669	4	of	of	IN
cord-005453-4057qib7	3669	5	the	the	DT
cord-005453-4057qib7	3669	6	patients	patient	NNS
cord-005453-4057qib7	3669	7	and	and	CC
cord-005453-4057qib7	3669	8	outcomes	outcome	NNS
cord-005453-4057qib7	3669	9	are	be	VBP
cord-005453-4057qib7	3669	10	shown	show	VBN
cord-005453-4057qib7	3669	11	in	in	IN
cord-005453-4057qib7	3669	12	table	table	NN
cord-005453-4057qib7	3669	13	1	1	CD
cord-005453-4057qib7	3669	14	.	.	.
cord-005453-4057qib7	3670	1	There	there	EX
cord-005453-4057qib7	3670	2	were	be	VBD
cord-005453-4057qib7	3670	3	no	no	DT
cord-005453-4057qib7	3670	4	differences	difference	NNS
cord-005453-4057qib7	3670	5	between	between	IN
cord-005453-4057qib7	3670	6	groups	group	NNS
cord-005453-4057qib7	3670	7	regarding	regard	VBG
cord-005453-4057qib7	3670	8	age	age	NN
cord-005453-4057qib7	3670	9	,	,	,
cord-005453-4057qib7	3670	10	gender	gender	NN
cord-005453-4057qib7	3670	11	,	,	,
cord-005453-4057qib7	3670	12	immunological	immunological	JJ
cord-005453-4057qib7	3670	13	subtype	subtype	NN
cord-005453-4057qib7	3670	14	,	,	,
cord-005453-4057qib7	3670	15	response	response	NN
cord-005453-4057qib7	3670	16	before	before	IN
cord-005453-4057qib7	3670	17	ASCT	ASCT	NNP
cord-005453-4057qib7	3670	18	,	,	,
cord-005453-4057qib7	3670	19	HCT	HCT	NNP
cord-005453-4057qib7	3670	20	-	-	HYPH
cord-005453-4057qib7	3670	21	CI	CI	NNP
cord-005453-4057qib7	3670	22	,	,	,
cord-005453-4057qib7	3670	23	and	and	CC
cord-005453-4057qib7	3670	24	CD34	CD34	NNP
cord-005453-4057qib7	3670	25	cell	cell	NN
cord-005453-4057qib7	3670	26	dose	dose	NN
cord-005453-4057qib7	3670	27	infused	infuse	VBN
cord-005453-4057qib7	3670	28	.	.	.
cord-005453-4057qib7	3671	1	There	there	EX
cord-005453-4057qib7	3671	2	were	be	VBD
cord-005453-4057qib7	3671	3	more	more	JJR
cord-005453-4057qib7	3671	4	patients	patient	NNS
cord-005453-4057qib7	3671	5	with	with	IN
cord-005453-4057qib7	3671	6	advanced	advanced	JJ
cord-005453-4057qib7	3671	7	disease	disease	NN
cord-005453-4057qib7	3671	8	(	(	-LRB-
cord-005453-4057qib7	3671	9	ISS	ISS	NNP
cord-005453-4057qib7	3671	10	III	III	NNP
cord-005453-4057qib7	3671	11	)	)	-RRB-
cord-005453-4057qib7	3671	12	in	in	IN
cord-005453-4057qib7	3671	13	group	group	NN
cord-005453-4057qib7	3671	14	C	c	NN
cord-005453-4057qib7	3671	15	compared	compare	VBN
cord-005453-4057qib7	3671	16	to	to	IN
cord-005453-4057qib7	3671	17	group	group	NN
cord-005453-4057qib7	3671	18	A	a	NN
cord-005453-4057qib7	3671	19	(	(	-LRB-
cord-005453-4057qib7	3671	20	19.5	19.5	CD
cord-005453-4057qib7	3671	21	%	%	NN
cord-005453-4057qib7	3671	22	vs.	vs.	IN
cord-005453-4057qib7	3671	23	6.1	6.1	CD
cord-005453-4057qib7	3671	24	%	%	NN
cord-005453-4057qib7	3671	25	;	;	:
cord-005453-4057qib7	3671	26	P=0.003	P=0.003	NNP
cord-005453-4057qib7	3671	27	)	)	-RRB-
cord-005453-4057qib7	3671	28	.	.	.
cord-005453-4057qib7	3672	1	The	the	DT
cord-005453-4057qib7	3672	2	duration	duration	NN
cord-005453-4057qib7	3672	3	of	of	IN
cord-005453-4057qib7	3672	4	neutropenia	neutropenia	NN
cord-005453-4057qib7	3672	5	was	be	VBD
cord-005453-4057qib7	3672	6	longer	long	JJR
cord-005453-4057qib7	3672	7	in	in	IN
cord-005453-4057qib7	3672	8	those	those	DT
cord-005453-4057qib7	3672	9	groups	group	NNS
cord-005453-4057qib7	3672	10	that	that	WDT
cord-005453-4057qib7	3672	11	did	do	VBD
cord-005453-4057qib7	3672	12	not	not	RB
cord-005453-4057qib7	3672	13	receive	receive	VB
cord-005453-4057qib7	3672	14	G	G	NNP
cord-005453-4057qib7	3672	15	-	-	HYPH
cord-005453-4057qib7	3672	16	CSF	CSF	NNP
cord-005453-4057qib7	3672	17	(	(	-LRB-
cord-005453-4057qib7	3672	18	A	a	NN
cord-005453-4057qib7	3672	19	:	:	:
cord-005453-4057qib7	3672	20	8	8	CD
cord-005453-4057qib7	3672	21	days	day	NNS
cord-005453-4057qib7	3672	22	,	,	,
cord-005453-4057qib7	3672	23	B	b	NN
cord-005453-4057qib7	3672	24	:	:	:
cord-005453-4057qib7	3672	25	11	11	CD
cord-005453-4057qib7	3672	26	days	day	NNS
cord-005453-4057qib7	3672	27	,	,	,
cord-005453-4057qib7	3672	28	C	c	NN
cord-005453-4057qib7	3672	29	:	:	:
cord-005453-4057qib7	3672	30	10	10	CD
cord-005453-4057qib7	3672	31	days	day	NNS
cord-005453-4057qib7	3672	32	;	;	:
cord-005453-4057qib7	3672	33	P	p	NN
cord-005453-4057qib7	3672	34	<	<	XX
cord-005453-4057qib7	3672	35	0.01	0.01	CD
cord-005453-4057qib7	3672	36	)	)	-RRB-
cord-005453-4057qib7	3672	37	.	.	.
cord-005453-4057qib7	3673	1	Comparing	compare	VBG
cord-005453-4057qib7	3673	2	group	group	NN
cord-005453-4057qib7	3673	3	A	A	NNP
cord-005453-4057qib7	3673	4	with	with	IN
cord-005453-4057qib7	3673	5	group	group	NN
cord-005453-4057qib7	3673	6	C	C	NNP
cord-005453-4057qib7	3673	7	,	,	,
cord-005453-4057qib7	3673	8	we	-PRON-	PRP
cord-005453-4057qib7	3673	9	observed	observe	VBD
cord-005453-4057qib7	3673	10	that	that	IN
cord-005453-4057qib7	3673	11	the	the	DT
cord-005453-4057qib7	3673	12	incidence	incidence	NN
cord-005453-4057qib7	3673	13	of	of	IN
cord-005453-4057qib7	3673	14	NF	nf	NN
cord-005453-4057qib7	3673	15	and	and	CC
cord-005453-4057qib7	3673	16	the	the	DT
cord-005453-4057qib7	3673	17	readmissions	readmission	NNS
cord-005453-4057qib7	3673	18	rates	rate	NNS
cord-005453-4057qib7	3673	19	were	be	VBD
cord-005453-4057qib7	3673	20	lower	low	JJR
cord-005453-4057qib7	3673	21	in	in	IN
cord-005453-4057qib7	3673	22	group	group	NN
cord-005453-4057qib7	3673	23	C	C	NNP
cord-005453-4057qib7	3673	24	(	(	-LRB-
cord-005453-4057qib7	3673	25	NF	nf	NN
cord-005453-4057qib7	3673	26	:	:	:
cord-005453-4057qib7	3673	27	57.6	57.6	CD
cord-005453-4057qib7	3673	28	%	%	NN
cord-005453-4057qib7	3673	29	vs.	vs.	IN
cord-005453-4057qib7	3673	30	23.9	23.9	CD
cord-005453-4057qib7	3673	31	%	%	NN
cord-005453-4057qib7	3673	32	;	;	:
cord-005453-4057qib7	3673	33	P=0.002	p=0.002	NN
cord-005453-4057qib7	3673	34	;	;	,
cord-005453-4057qib7	3673	35	relative	relative	JJ
cord-005453-4057qib7	3673	36	risk	risk	NN
cord-005453-4057qib7	3673	37	reduction	reduction	NN
cord-005453-4057qib7	3673	38	:	:	:
cord-005453-4057qib7	3673	39	0.41	0.41	CD
cord-005453-4057qib7	3673	40	,	,	,
cord-005453-4057qib7	3673	41	and	and	CC
cord-005453-4057qib7	3673	42	number	number	NN
cord-005453-4057qib7	3673	43	needed	need	VBN
cord-005453-4057qib7	3673	44	to	to	TO
cord-005453-4057qib7	3673	45	treat	treat	VB
cord-005453-4057qib7	3673	46	2.97	2.97	CD
cord-005453-4057qib7	3673	47	;	;	:
cord-005453-4057qib7	3673	48	readmissions	readmission	NNS
cord-005453-4057qib7	3673	49	:	:	:
cord-005453-4057qib7	3673	50	12.1	12.1	CD
cord-005453-4057qib7	3673	51	%	%	NN
cord-005453-4057qib7	3673	52	vs.	vs.	IN
cord-005453-4057qib7	3673	53	2.2	2.2	CD
cord-005453-4057qib7	3673	54	%	%	NN
cord-005453-4057qib7	3673	55	;	;	:
cord-005453-4057qib7	3673	56	P=0.07	P=0.07	NNS
cord-005453-4057qib7	3673	57	,	,	,
cord-005453-4057qib7	3673	58	respectively	respectively	RB
cord-005453-4057qib7	3673	59	)	)	-RRB-
cord-005453-4057qib7	3673	60	.	.	.
cord-005453-4057qib7	3674	1	The	the	DT
cord-005453-4057qib7	3674	2	10-day	10-day	CD
cord-005453-4057qib7	3674	3	cumulative	cumulative	JJ
cord-005453-4057qib7	3674	4	incidence	incidence	NN
cord-005453-4057qib7	3674	5	of	of	IN
cord-005453-4057qib7	3674	6	NF	NF	NNP
cord-005453-4057qib7	3674	7	were	be	VBD
cord-005453-4057qib7	3674	8	54.5	54.5	CD
cord-005453-4057qib7	3674	9	%	%	NN
cord-005453-4057qib7	3674	10	in	in	IN
cord-005453-4057qib7	3674	11	group	group	NN
cord-005453-4057qib7	3674	12	A	A	NNP
cord-005453-4057qib7	3674	13	,	,	,
cord-005453-4057qib7	3674	14	40.6	40.6	CD
cord-005453-4057qib7	3674	15	%	%	NN
cord-005453-4057qib7	3674	16	in	in	IN
cord-005453-4057qib7	3674	17	group	group	NN
cord-005453-4057qib7	3674	18	B	B	NNP
cord-005453-4057qib7	3674	19	,	,	,
cord-005453-4057qib7	3674	20	and	and	CC
cord-005453-4057qib7	3674	21	23.9	23.9	CD
cord-005453-4057qib7	3674	22	%	%	NN
cord-005453-4057qib7	3674	23	in	in	IN
cord-005453-4057qib7	3674	24	group	group	NN
cord-005453-4057qib7	3674	25	C	c	NN
cord-005453-4057qib7	3674	26	;	;	:
cord-005453-4057qib7	3674	27	P=0.009	p=0.009	NN
cord-005453-4057qib7	3674	28	.	.	.
cord-005453-4057qib7	3675	1	The	the	DT
cord-005453-4057qib7	3675	2	non	non	JJ
cord-005453-4057qib7	3675	3	-	-	JJ
cord-005453-4057qib7	3675	4	administration	administration	JJ
cord-005453-4057qib7	3675	5	of	of	IN
cord-005453-4057qib7	3675	6	G	G	NNP
cord-005453-4057qib7	3675	7	-	-	HYPH
cord-005453-4057qib7	3675	8	CSF	CSF	NNP
cord-005453-4057qib7	3675	9	with	with	IN
cord-005453-4057qib7	3675	10	the	the	DT
cord-005453-4057qib7	3675	11	addition	addition	NN
cord-005453-4057qib7	3675	12	of	of	IN
cord-005453-4057qib7	3675	13	prophylactic	prophylactic	JJ
cord-005453-4057qib7	3675	14	corticosteroid	corticosteroid	NNP
cord-005453-4057qib7	3675	15	did	do	VBD
cord-005453-4057qib7	3675	16	not	not	RB
cord-005453-4057qib7	3675	17	modify	modify	VB
cord-005453-4057qib7	3675	18	the	the	DT
cord-005453-4057qib7	3675	19	incidence	incidence	NN
cord-005453-4057qib7	3675	20	and	and	CC
cord-005453-4057qib7	3675	21	grade	grade	NN
cord-005453-4057qib7	3675	22	of	of	IN
cord-005453-4057qib7	3675	23	mucositis	mucositis	NNP
cord-005453-4057qib7	3675	24	,	,	,
cord-005453-4057qib7	3675	25	the	the	DT
cord-005453-4057qib7	3675	26	first	first	JJ
cord-005453-4057qib7	3675	27	day	day	NN
cord-005453-4057qib7	3675	28	and	and	CC
cord-005453-4057qib7	3675	29	duration	duration	NN
cord-005453-4057qib7	3675	30	of	of	IN
cord-005453-4057qib7	3675	31	fever	fever	NN
cord-005453-4057qib7	3675	32	,	,	,
cord-005453-4057qib7	3675	33	nor	nor	CC
cord-005453-4057qib7	3675	34	the	the	DT
cord-005453-4057qib7	3675	35	number	number	NN
cord-005453-4057qib7	3675	36	of	of	IN
cord-005453-4057qib7	3675	37	bacterial	bacterial	JJ
cord-005453-4057qib7	3675	38	infections	infection	NNS
cord-005453-4057qib7	3675	39	documented	document	VBN
cord-005453-4057qib7	3675	40	.	.	.
cord-005453-4057qib7	3676	1	In	in	IN
cord-005453-4057qib7	3676	2	the	the	DT
cord-005453-4057qib7	3676	3	multivariate	multivariate	JJ
cord-005453-4057qib7	3676	4	analysis	analysis	NN
cord-005453-4057qib7	3676	5	,	,	,
cord-005453-4057qib7	3676	6	this	this	DT
cord-005453-4057qib7	3676	7	combination	combination	NN
cord-005453-4057qib7	3676	8	(	(	-LRB-
cord-005453-4057qib7	3676	9	no	no	DT
cord-005453-4057qib7	3676	10	G	G	NNP
cord-005453-4057qib7	3676	11	-	-	HYPH
cord-005453-4057qib7	3676	12	CSF	CSF	NNP
cord-005453-4057qib7	3676	13	with	with	IN
cord-005453-4057qib7	3676	14	corticosteroid	corticosteroid	NNP
cord-005453-4057qib7	3676	15	)	)	-RRB-
cord-005453-4057qib7	3676	16	maintained	maintain	VBD
cord-005453-4057qib7	3676	17	its	-PRON-	PRP$
cord-005453-4057qib7	3676	18	protective	protective	JJ
cord-005453-4057qib7	3676	19	effect	effect	NN
cord-005453-4057qib7	3676	20	for	for	IN
cord-005453-4057qib7	3676	21	the	the	DT
cord-005453-4057qib7	3676	22	development	development	NN
cord-005453-4057qib7	3676	23	of	of	IN
cord-005453-4057qib7	3676	24	NF	nf	NN
cord-005453-4057qib7	3676	25	and	and	CC
cord-005453-4057qib7	3676	26	hospital	hospital	NN
cord-005453-4057qib7	3676	27	readmission	readmission	NN
cord-005453-4057qib7	3676	28	(	(	-LRB-
cord-005453-4057qib7	3676	29	OR	or	CC
cord-005453-4057qib7	3676	30	0.07	0.07	CD
cord-005453-4057qib7	3676	31	;	;	:
cord-005453-4057qib7	3676	32	P=0.001	P=0.001	NNS
cord-005453-4057qib7	3676	33	and	and	CC
cord-005453-4057qib7	3676	34	OR	or	CC
cord-005453-4057qib7	3676	35	0.07	0.07	CD
cord-005453-4057qib7	3676	36	;	;	:
cord-005453-4057qib7	3676	37	P=0.05	p=0.05	JJ
cord-005453-4057qib7	3676	38	,	,	,
cord-005453-4057qib7	3676	39	respectively	respectively	RB
cord-005453-4057qib7	3676	40	)	)	-RRB-
cord-005453-4057qib7	3676	41	.	.	.
cord-005453-4057qib7	3677	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3677	2	:	:	:
cord-005453-4057qib7	3678	1	The	the	DT
cord-005453-4057qib7	3678	2	non	non	JJ
cord-005453-4057qib7	3678	3	-	-	JJ
cord-005453-4057qib7	3678	4	use	use	NN
cord-005453-4057qib7	3678	5	of	of	IN
cord-005453-4057qib7	3678	6	G	G	NNP
cord-005453-4057qib7	3678	7	-	-	HYPH
cord-005453-4057qib7	3678	8	CSF	CSF	NNP
cord-005453-4057qib7	3678	9	and	and	CC
cord-005453-4057qib7	3678	10	the	the	DT
cord-005453-4057qib7	3678	11	addition	addition	NN
cord-005453-4057qib7	3678	12	of	of	IN
cord-005453-4057qib7	3678	13	prophylactic	prophylactic	JJ
cord-005453-4057qib7	3678	14	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	3678	15	in	in	IN
cord-005453-4057qib7	3678	16	MM	MM	NNP
cord-005453-4057qib7	3678	17	patients	patient	NNS
cord-005453-4057qib7	3678	18	managed	manage	VBN
cord-005453-4057qib7	3678	19	at	at	IN
cord-005453-4057qib7	3678	20	home	home	NN
cord-005453-4057qib7	3678	21	after	after	IN
cord-005453-4057qib7	3678	22	ASCT	ASCT	NNP
cord-005453-4057qib7	3678	23	minimize	minimize	VB
cord-005453-4057qib7	3678	24	the	the	DT
cord-005453-4057qib7	3678	25	incidence	incidence	NN
cord-005453-4057qib7	3678	26	of	of	IN
cord-005453-4057qib7	3678	27	non	non	JJ
cord-005453-4057qib7	3678	28	-	-	JJ
cord-005453-4057qib7	3678	29	infectious	infectious	JJ
cord-005453-4057qib7	3678	30	fever	fever	NN
cord-005453-4057qib7	3678	31	and	and	CC
cord-005453-4057qib7	3678	32	optimize	optimize	VB
cord-005453-4057qib7	3678	33	hospital	hospital	NN
cord-005453-4057qib7	3678	34	resources	resource	NNS
cord-005453-4057qib7	3678	35	by	by	IN
cord-005453-4057qib7	3678	36	reducing	reduce	VBG
cord-005453-4057qib7	3678	37	hospital	hospital	NN
cord-005453-4057qib7	3678	38	readmissions	readmission	NNS
cord-005453-4057qib7	3678	39	.	.	.
cord-005453-4057qib7	3679	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3679	2	:	:	:
cord-005453-4057qib7	3679	3	Nothing	nothing	NN
cord-005453-4057qib7	3679	4	to	to	TO
cord-005453-4057qib7	3679	5	declare	declare	VB
cord-005453-4057qib7	3679	6	.	.	.
cord-005453-4057qib7	3680	1	Background	background	NN
cord-005453-4057qib7	3680	2	:	:	:
cord-005453-4057qib7	3681	1	Antibody	antibody	NN
cord-005453-4057qib7	3681	2	titers	titer	NNS
cord-005453-4057qib7	3681	3	to	to	IN
cord-005453-4057qib7	3681	4	vaccine	vaccine	NN
cord-005453-4057qib7	3681	5	-	-	HYPH
cord-005453-4057qib7	3681	6	preventable	preventable	JJ
cord-005453-4057qib7	3681	7	diseases	disease	NNS
cord-005453-4057qib7	3681	8	decline	decline	VBP
cord-005453-4057qib7	3681	9	during	during	IN
cord-005453-4057qib7	3681	10	the	the	DT
cord-005453-4057qib7	3681	11	1	1	CD
cord-005453-4057qib7	3681	12	-	-	SYM
cord-005453-4057qib7	3681	13	10	10	CD
cord-005453-4057qib7	3681	14	years	year	NNS
cord-005453-4057qib7	3681	15	after	after	IN
cord-005453-4057qib7	3681	16	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3681	17	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	3681	18	Stem	Stem	NNP
cord-005453-4057qib7	3681	19	Cell	cell	NN
cord-005453-4057qib7	3681	20	Transplantation	transplantation	NN
cord-005453-4057qib7	3681	21	(	(	-LRB-
cord-005453-4057qib7	3681	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3681	23	)	)	-RRB-
cord-005453-4057qib7	3681	24	if	if	IN
cord-005453-4057qib7	3681	25	the	the	DT
cord-005453-4057qib7	3681	26	recipient	recipient	NN
cord-005453-4057qib7	3681	27	is	be	VBZ
cord-005453-4057qib7	3681	28	not	not	RB
cord-005453-4057qib7	3681	29	revaccinated	revaccinate	VBN
cord-005453-4057qib7	3681	30	.	.	.
cord-005453-4057qib7	3682	1	It	-PRON-	PRP
cord-005453-4057qib7	3682	2	is	be	VBZ
cord-005453-4057qib7	3682	3	therefore	therefore	RB
cord-005453-4057qib7	3682	4	considered	consider	VBN
cord-005453-4057qib7	3682	5	best	good	JJS
cord-005453-4057qib7	3682	6	practice	practice	NN
cord-005453-4057qib7	3682	7	to	to	TO
cord-005453-4057qib7	3682	8	try	try	VB
cord-005453-4057qib7	3682	9	to	to	TO
cord-005453-4057qib7	3682	10	offer	offer	VB
cord-005453-4057qib7	3682	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3682	12	recipients	recipient	NNS
cord-005453-4057qib7	3682	13	the	the	DT
cord-005453-4057qib7	3682	14	same	same	JJ
cord-005453-4057qib7	3682	15	level	level	NN
cord-005453-4057qib7	3682	16	of	of	IN
cord-005453-4057qib7	3682	17	protection	protection	NN
cord-005453-4057qib7	3682	18	against	against	IN
cord-005453-4057qib7	3682	19	all	all	DT
cord-005453-4057qib7	3682	20	vaccine	vaccine	NN
cord-005453-4057qib7	3682	21	preventable	preventable	JJ
cord-005453-4057qib7	3682	22	diseases	disease	NNS
cord-005453-4057qib7	3682	23	as	as	IN
cord-005453-4057qib7	3682	24	the	the	DT
cord-005453-4057qib7	3682	25	general	general	JJ
cord-005453-4057qib7	3682	26	population	population	NN
cord-005453-4057qib7	3682	27	.	.	.
cord-005453-4057qib7	3683	1	Few	few	JJ
cord-005453-4057qib7	3683	2	data	datum	NNS
cord-005453-4057qib7	3683	3	in	in	IN
cord-005453-4057qib7	3683	4	the	the	DT
cord-005453-4057qib7	3683	5	literature	literature	NN
cord-005453-4057qib7	3683	6	are	be	VBP
cord-005453-4057qib7	3683	7	available	available	JJ
cord-005453-4057qib7	3683	8	concerning	concern	VBG
cord-005453-4057qib7	3683	9	vaccine	vaccine	NN
cord-005453-4057qib7	3683	10	-	-	HYPH
cord-005453-4057qib7	3683	11	related	relate	VBN
cord-005453-4057qib7	3683	12	problems	problem	NNS
cord-005453-4057qib7	3683	13	in	in	IN
cord-005453-4057qib7	3683	14	HSCT	HSCT	NNP
cord-005453-4057qib7	3683	15	recipients	recipient	NNS
cord-005453-4057qib7	3683	16	.	.	.
cord-005453-4057qib7	3684	1	We	-PRON-	PRP
cord-005453-4057qib7	3684	2	performed	perform	VBD
cord-005453-4057qib7	3684	3	a	a	DT
cord-005453-4057qib7	3684	4	farmacovigilance	farmacovigilance	NN
cord-005453-4057qib7	3684	5	evaluation	evaluation	NN
cord-005453-4057qib7	3684	6	in	in	IN
cord-005453-4057qib7	3684	7	a	a	DT
cord-005453-4057qib7	3684	8	cohort	cohort	NN
cord-005453-4057qib7	3684	9	of	of	IN
cord-005453-4057qib7	3684	10	allotransplanted	allotransplante	VBN
cord-005453-4057qib7	3684	11	patients	patient	NNS
cord-005453-4057qib7	3684	12	followed	follow	VBD
cord-005453-4057qib7	3684	13	in	in	IN
cord-005453-4057qib7	3684	14	our	-PRON-	PRP$
cord-005453-4057qib7	3684	15	clinic	clinic	NN
cord-005453-4057qib7	3684	16	during	during	IN
cord-005453-4057qib7	3684	17	a	a	DT
cord-005453-4057qib7	3684	18	1	1	CD
cord-005453-4057qib7	3684	19	year	year	NN
cord-005453-4057qib7	3684	20	period	period	NN
cord-005453-4057qib7	3684	21	.	.	.
cord-005453-4057qib7	3685	1	Methods	method	NNS
cord-005453-4057qib7	3685	2	:	:	:
cord-005453-4057qib7	3686	1	From	from	IN
cord-005453-4057qib7	3686	2	October	October	NNP
cord-005453-4057qib7	3686	3	2017	2017	CD
cord-005453-4057qib7	3686	4	to	to	IN
cord-005453-4057qib7	3686	5	November	November	NNP
cord-005453-4057qib7	3686	6	2018	2018	CD
cord-005453-4057qib7	3686	7	we	-PRON-	PRP
cord-005453-4057qib7	3686	8	administered	administer	VBD
cord-005453-4057qib7	3686	9	a	a	DT
cord-005453-4057qib7	3686	10	list	list	NN
cord-005453-4057qib7	3686	11	of	of	IN
cord-005453-4057qib7	3686	12	recommended	recommend	VBN
cord-005453-4057qib7	3686	13	vaccines	vaccine	NNS
cord-005453-4057qib7	3686	14	to	to	IN
cord-005453-4057qib7	3686	15	49	49	CD
cord-005453-4057qib7	3686	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3686	17	recipients	recipient	NNS
cord-005453-4057qib7	3686	18	attending	attend	VBG
cord-005453-4057qib7	3686	19	our	-PRON-	PRP$
cord-005453-4057qib7	3686	20	routine	routine	JJ
cord-005453-4057qib7	3686	21	out	out	RP
cord-005453-4057qib7	3686	22	patient	patient	JJ
cord-005453-4057qib7	3686	23	clinic	clinic	NN
cord-005453-4057qib7	3686	24	who	who	WP
cord-005453-4057qib7	3686	25	fulfilled	fulfil	VBD
cord-005453-4057qib7	3686	26	the	the	DT
cord-005453-4057qib7	3686	27	following	follow	VBG
cord-005453-4057qib7	3686	28	criteria	criterion	NNS
cord-005453-4057qib7	3686	29	:	:	:
cord-005453-4057qib7	3687	1	CD4	CD4	NNP
cord-005453-4057qib7	3687	2	T	T	NNP
cord-005453-4057qib7	3687	3	cells>200	cells>200	NNP
cord-005453-4057qib7	3687	4	/	/	SYM
cord-005453-4057qib7	3687	5	μl	μl	XX
cord-005453-4057qib7	3688	1	,	,	,
cord-005453-4057qib7	3688	2	CD19	CD19	NNP
cord-005453-4057qib7	3688	3	B	B	NNP
cord-005453-4057qib7	3688	4	cells>20/	cells>20/	NN
cord-005453-4057qib7	3689	1	μl	μl	IN
cord-005453-4057qib7	3690	1	,	,	,
cord-005453-4057qib7	3690	2	anti	anti	JJ
cord-005453-4057qib7	3690	3	-	-	JJ
cord-005453-4057qib7	3690	4	CD20	cd20	JJ
cord-005453-4057qib7	3690	5	antibody	antibody	NN
cord-005453-4057qib7	3691	1	infusion>6	infusion>6	JJ
cord-005453-4057qib7	3691	2	months	month	NNS
cord-005453-4057qib7	3691	3	,	,	,
cord-005453-4057qib7	3691	4	IVIG	IVIG	NNP
cord-005453-4057qib7	3691	5	therapy>2	therapy>2	NNP
cord-005453-4057qib7	3691	6	months	month	NNS
cord-005453-4057qib7	3691	7	,	,	,
cord-005453-4057qib7	3691	8	no	no	DT
cord-005453-4057qib7	3691	9	active	active	JJ
cord-005453-4057qib7	3691	10	and	and	CC
cord-005453-4057qib7	3691	11	severe	severe	JJ
cord-005453-4057qib7	3691	12	Graft	graft	NN
cord-005453-4057qib7	3691	13	-	-	HYPH
cord-005453-4057qib7	3691	14	versus	versus	IN
cord-005453-4057qib7	3691	15	-	-	HYPH
cord-005453-4057qib7	3691	16	Host	Host	NNP
cord-005453-4057qib7	3691	17	-	-	HYPH
cord-005453-4057qib7	3691	18	Disease	Disease	NNP
cord-005453-4057qib7	3691	19	(	(	-LRB-
cord-005453-4057qib7	3691	20	GvHD	GvHD	NNP
cord-005453-4057qib7	3691	21	)	)	-RRB-
cord-005453-4057qib7	3691	22	,	,	,
cord-005453-4057qib7	3691	23	no	no	DT
cord-005453-4057qib7	3691	24	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3691	25	or	or	CC
cord-005453-4057qib7	3691	26	biological	biological	JJ
cord-005453-4057qib7	3691	27	therapeutic	therapeutic	JJ
cord-005453-4057qib7	3691	28	agents	agent	NNS
cord-005453-4057qib7	3691	29	on	on	IN
cord-005453-4057qib7	3691	30	going	go	VBG
cord-005453-4057qib7	3691	31	.	.	.
cord-005453-4057qib7	3692	1	Vaccines	vaccine	NNS
cord-005453-4057qib7	3692	2	suggested	suggest	VBN
cord-005453-4057qib7	3692	3	were	be	VBD
cord-005453-4057qib7	3692	4	Influenza	Influenza	NNP
cord-005453-4057qib7	3692	5	,	,	,
cord-005453-4057qib7	3692	6	Pneumococcal	Pneumococcal	NNP
cord-005453-4057qib7	3692	7	conjugate	conjugate	NN
cord-005453-4057qib7	3692	8	(	(	-LRB-
cord-005453-4057qib7	3692	9	PCV13	PCV13	NNP
cord-005453-4057qib7	3692	10	)	)	-RRB-
cord-005453-4057qib7	3692	11	,	,	,
cord-005453-4057qib7	3692	12	Polio	Polio	NNP
cord-005453-4057qib7	3692	13	(	(	-LRB-
cord-005453-4057qib7	3692	14	inactivated	inactivate	VBN
cord-005453-4057qib7	3692	15	polio	polio	NN
cord-005453-4057qib7	3692	16	vaccine	vaccine	NN
cord-005453-4057qib7	3692	17	)	)	-RRB-
cord-005453-4057qib7	3692	18	,	,	,
cord-005453-4057qib7	3692	19	Diphteria	Diphteria	NNP
cord-005453-4057qib7	3692	20	,	,	,
cord-005453-4057qib7	3692	21	Tetanus	Tetanus	NNP
cord-005453-4057qib7	3692	22	,	,	,
cord-005453-4057qib7	3692	23	Acellular	Acellular	NNP
cord-005453-4057qib7	3692	24	pertussis	pertussis	NN
cord-005453-4057qib7	3692	25	,	,	,
cord-005453-4057qib7	3692	26	Hepatitis	Hepatitis	NNP
cord-005453-4057qib7	3692	27	B	B	NNP
cord-005453-4057qib7	3692	28	,	,	,
cord-005453-4057qib7	3692	29	Hepatitis	Hepatitis	NNP
cord-005453-4057qib7	3692	30	A	A	NNP
cord-005453-4057qib7	3692	31	,	,	,
cord-005453-4057qib7	3692	32	Haemophilus	haemophilus	JJ
cord-005453-4057qib7	3692	33	influenzae	influenzae	NN
cord-005453-4057qib7	3692	34	type	type	NN
cord-005453-4057qib7	3692	35	B	b	NN
cord-005453-4057qib7	3692	36	,	,	,
cord-005453-4057qib7	3692	37	Meningococcal	meningococcal	JJ
cord-005453-4057qib7	3692	38	quadrivalent	quadrivalent	NN
cord-005453-4057qib7	3692	39	(	(	-LRB-
cord-005453-4057qib7	3692	40	MCV4	MCV4	NNP
cord-005453-4057qib7	3692	41	)	)	-RRB-
cord-005453-4057qib7	3692	42	,	,	,
cord-005453-4057qib7	3692	43	Human	human	JJ
cord-005453-4057qib7	3692	44	papillomavirus	papillomavirus	NN
cord-005453-4057qib7	3692	45	,	,	,
cord-005453-4057qib7	3692	46	Meningococcal	Meningococcal	NNP
cord-005453-4057qib7	3692	47	B	B	NNP
cord-005453-4057qib7	3692	48	,	,	,
cord-005453-4057qib7	3692	49	Measles	Measles	NNP
cord-005453-4057qib7	3692	50	-	-	HYPH
cord-005453-4057qib7	3692	51	Mumps	Mumps	NNP
cord-005453-4057qib7	3692	52	-	-	HYPH
cord-005453-4057qib7	3692	53	Rubella	Rubella	NNP
cord-005453-4057qib7	3692	54	(	(	-LRB-
cord-005453-4057qib7	3692	55	MMR	MMR	NNP
cord-005453-4057qib7	3692	56	)	)	-RRB-
cord-005453-4057qib7	3692	57	,	,	,
cord-005453-4057qib7	3692	58	Varicella	Varicella	NNP
cord-005453-4057qib7	3692	59	.	.	.
cord-005453-4057qib7	3693	1	Live	live	JJ
cord-005453-4057qib7	3693	2	vaccines	vaccine	NNS
cord-005453-4057qib7	3693	3	(	(	-LRB-
cord-005453-4057qib7	3693	4	MMR	MMR	NNP
cord-005453-4057qib7	3693	5	and	and	CC
cord-005453-4057qib7	3693	6	Varicella	Varicella	NNP
cord-005453-4057qib7	3693	7	)	)	-RRB-
cord-005453-4057qib7	3693	8	were	be	VBD
cord-005453-4057qib7	3693	9	not	not	RB
cord-005453-4057qib7	3693	10	recommended	recommend	VBN
cord-005453-4057qib7	3693	11	before	before	IN
cord-005453-4057qib7	3693	12	2	2	CD
cord-005453-4057qib7	3693	13	years	year	NNS
cord-005453-4057qib7	3693	14	after	after	IN
cord-005453-4057qib7	3693	15	HSCT	HSCT	NNP
cord-005453-4057qib7	3693	16	and	and	CC
cord-005453-4057qib7	3693	17	in	in	IN
cord-005453-4057qib7	3693	18	patients	patient	NNS
cord-005453-4057qib7	3693	19	with	with	IN
cord-005453-4057qib7	3693	20	chronic	chronic	JJ
cord-005453-4057qib7	3693	21	GvHD	GvHD	NNP
cord-005453-4057qib7	3693	22	.	.	.
cord-005453-4057qib7	3694	1	All	all	PDT
cord-005453-4057qib7	3694	2	the	the	DT
cord-005453-4057qib7	3694	3	patients	patient	NNS
cord-005453-4057qib7	3694	4	were	be	VBD
cord-005453-4057qib7	3694	5	asked	ask	VBN
cord-005453-4057qib7	3694	6	to	to	TO
cord-005453-4057qib7	3694	7	take	take	VB
cord-005453-4057qib7	3694	8	the	the	DT
cord-005453-4057qib7	3694	9	list	list	NN
cord-005453-4057qib7	3694	10	to	to	IN
cord-005453-4057qib7	3694	11	the	the	DT
cord-005453-4057qib7	3694	12	local	local	JJ
cord-005453-4057qib7	3694	13	health	health	NN
cord-005453-4057qib7	3694	14	facilities	facility	NNS
cord-005453-4057qib7	3694	15	in	in	IN
cord-005453-4057qib7	3694	16	order	order	NN
cord-005453-4057qib7	3694	17	to	to	TO
cord-005453-4057qib7	3694	18	have	have	VB
cord-005453-4057qib7	3694	19	the	the	DT
cord-005453-4057qib7	3694	20	vaccines	vaccine	NNS
cord-005453-4057qib7	3694	21	injected	inject	VBN
cord-005453-4057qib7	3694	22	and	and	CC
cord-005453-4057qib7	3694	23	a	a	DT
cord-005453-4057qib7	3694	24	vaccination	vaccination	NN
cord-005453-4057qib7	3694	25	table	table	NN
cord-005453-4057qib7	3694	26	arranged	arrange	VBN
cord-005453-4057qib7	3694	27	with	with	IN
cord-005453-4057qib7	3694	28	the	the	DT
cord-005453-4057qib7	3694	29	doses	dose	NNS
cord-005453-4057qib7	3694	30	already	already	RB
cord-005453-4057qib7	3694	31	received	receive	VBN
cord-005453-4057qib7	3694	32	and	and	CC
cord-005453-4057qib7	3694	33	those	those	DT
cord-005453-4057qib7	3694	34	to	to	TO
cord-005453-4057qib7	3694	35	receive	receive	VB
cord-005453-4057qib7	3694	36	.	.	.
cord-005453-4057qib7	3695	1	We	-PRON-	PRP
cord-005453-4057qib7	3695	2	checked	check	VBD
cord-005453-4057qib7	3695	3	the	the	DT
cord-005453-4057qib7	3695	4	vaccination	vaccination	NN
cord-005453-4057qib7	3695	5	tables	table	NNS
cord-005453-4057qib7	3695	6	at	at	IN
cord-005453-4057qib7	3695	7	each	each	DT
cord-005453-4057qib7	3695	8	visit	visit	NN
cord-005453-4057qib7	3695	9	and	and	CC
cord-005453-4057qib7	3695	10	monitored	monitor	VBD
cord-005453-4057qib7	3695	11	potential	potential	JJ
cord-005453-4057qib7	3695	12	side	side	NN
cord-005453-4057qib7	3695	13	effects	effect	NNS
cord-005453-4057qib7	3695	14	and	and	CC
cord-005453-4057qib7	3695	15	GvHD	gvhd	NN
cord-005453-4057qib7	3695	16	status	status	NN
cord-005453-4057qib7	3695	17	at	at	IN
cord-005453-4057qib7	3695	18	3	3	CD
cord-005453-4057qib7	3695	19	,	,	,
cord-005453-4057qib7	3695	20	6	6	CD
cord-005453-4057qib7	3695	21	,	,	,
cord-005453-4057qib7	3695	22	and	and	CC
cord-005453-4057qib7	3695	23	12	12	CD
cord-005453-4057qib7	3695	24	months	month	NNS
cord-005453-4057qib7	3695	25	after	after	IN
cord-005453-4057qib7	3695	26	the	the	DT
cord-005453-4057qib7	3695	27	first	first	JJ
cord-005453-4057qib7	3695	28	vaccine	vaccine	NN
cord-005453-4057qib7	3695	29	injection	injection	NN
cord-005453-4057qib7	3695	30	.	.	.
cord-005453-4057qib7	3696	1	Results	result	NNS
cord-005453-4057qib7	3696	2	:	:	:
cord-005453-4057qib7	3697	1	Twenty	twenty	CD
cord-005453-4057qib7	3697	2	-	-	HYPH
cord-005453-4057qib7	3697	3	nine	nine	CD
cord-005453-4057qib7	3697	4	out	out	IN
cord-005453-4057qib7	3697	5	of	of	IN
cord-005453-4057qib7	3697	6	49	49	CD
cord-005453-4057qib7	3697	7	patients	patient	NNS
cord-005453-4057qib7	3697	8	were	be	VBD
cord-005453-4057qib7	3697	9	evaluable	evaluable	JJ
cord-005453-4057qib7	3697	10	(	(	-LRB-
cord-005453-4057qib7	3697	11	table	table	NN
cord-005453-4057qib7	3697	12	1	1	CD
cord-005453-4057qib7	3697	13	)	)	-RRB-
cord-005453-4057qib7	3697	14	,	,	,
cord-005453-4057qib7	3697	15	16	16	CD
cord-005453-4057qib7	3697	16	without	without	IN
cord-005453-4057qib7	3697	17	GvHD	GvHD	NNP
cord-005453-4057qib7	3697	18	and	and	CC
cord-005453-4057qib7	3697	19	13	13	CD
cord-005453-4057qib7	3697	20	with	with	IN
cord-005453-4057qib7	3697	21	chronic	chronic	JJ
cord-005453-4057qib7	3697	22	GvHD	GvHD	NNP
cord-005453-4057qib7	3697	23	(	(	-LRB-
cord-005453-4057qib7	3697	24	5	5	CD
cord-005453-4057qib7	3697	25	mild	mild	JJ
cord-005453-4057qib7	3697	26	,	,	,
cord-005453-4057qib7	3697	27	4	4	CD
cord-005453-4057qib7	3697	28	moderate	moderate	JJ
cord-005453-4057qib7	3697	29	,	,	,
cord-005453-4057qib7	3697	30	4	4	CD
cord-005453-4057qib7	3697	31	severe	severe	NN
cord-005453-4057qib7	3697	32	)	)	-RRB-
cord-005453-4057qib7	3697	33	.	.	.
cord-005453-4057qib7	3698	1	Median	median	JJ
cord-005453-4057qib7	3698	2	time	time	NN
cord-005453-4057qib7	3698	3	after	after	IN
cord-005453-4057qib7	3698	4	HSCT	HSCT	NNP
cord-005453-4057qib7	3698	5	was	be	VBD
cord-005453-4057qib7	3698	6	34	34	CD
cord-005453-4057qib7	3698	7	months	month	NNS
cord-005453-4057qib7	3698	8	(	(	-LRB-
cord-005453-4057qib7	3698	9	16	16	CD
cord-005453-4057qib7	3698	10	-	-	SYM
cord-005453-4057qib7	3698	11	240	240	CD
cord-005453-4057qib7	3698	12	)	)	-RRB-
cord-005453-4057qib7	3698	13	.	.	.
cord-005453-4057qib7	3699	1	Median	median	JJ
cord-005453-4057qib7	3699	2	number	number	NN
cord-005453-4057qib7	3699	3	of	of	IN
cord-005453-4057qib7	3699	4	vaccines	vaccine	NNS
cord-005453-4057qib7	3699	5	received	receive	VBN
cord-005453-4057qib7	3699	6	was	be	VBD
cord-005453-4057qib7	3699	7	8	8	CD
cord-005453-4057qib7	3699	8	(	(	-LRB-
cord-005453-4057qib7	3699	9	1	1	CD
cord-005453-4057qib7	3699	10	)	)	-RRB-
cord-005453-4057qib7	3699	11	(	(	-LRB-
cord-005453-4057qib7	3699	12	2	2	LS
cord-005453-4057qib7	3699	13	)	)	-RRB-
cord-005453-4057qib7	3699	14	(	(	-LRB-
cord-005453-4057qib7	3699	15	3	3	LS
cord-005453-4057qib7	3699	16	)	)	-RRB-
cord-005453-4057qib7	3699	17	(	(	-LRB-
cord-005453-4057qib7	3699	18	4	4	LS
cord-005453-4057qib7	3699	19	)	)	-RRB-
cord-005453-4057qib7	3699	20	(	(	-LRB-
cord-005453-4057qib7	3699	21	5	5	LS
cord-005453-4057qib7	3699	22	)	)	-RRB-
cord-005453-4057qib7	3699	23	(	(	-LRB-
cord-005453-4057qib7	3699	24	6	6	LS
cord-005453-4057qib7	3699	25	)	)	-RRB-
cord-005453-4057qib7	3699	26	(	(	-LRB-
cord-005453-4057qib7	3699	27	7	7	LS
cord-005453-4057qib7	3699	28	)	)	-RRB-
cord-005453-4057qib7	3699	29	(	(	-LRB-
cord-005453-4057qib7	3699	30	8)	8)	NNP
cord-005453-4057qib7	3699	31	(	(	-LRB-
cord-005453-4057qib7	3699	32	9	9	CD
cord-005453-4057qib7	3699	33	)	)	-RRB-
cord-005453-4057qib7	3699	34	(	(	-LRB-
cord-005453-4057qib7	3699	35	10	10	CD
cord-005453-4057qib7	3699	36	)	)	-RRB-
cord-005453-4057qib7	3699	37	(	(	-LRB-
cord-005453-4057qib7	3699	38	11	11	CD
cord-005453-4057qib7	3699	39	)	)	-RRB-
cord-005453-4057qib7	3699	40	(	(	-LRB-
cord-005453-4057qib7	3699	41	12	12	CD
cord-005453-4057qib7	3699	42	)	)	-RRB-
cord-005453-4057qib7	3699	43	(	(	-LRB-
cord-005453-4057qib7	3699	44	13	13	CD
cord-005453-4057qib7	3699	45	)	)	-RRB-
cord-005453-4057qib7	3699	46	(	(	-LRB-
cord-005453-4057qib7	3699	47	14	14	CD
cord-005453-4057qib7	3699	48	)	)	-RRB-
cord-005453-4057qib7	3699	49	.	.	.
cord-005453-4057qib7	3700	1	As	as	IN
cord-005453-4057qib7	3700	2	regards	regard	VBZ
cord-005453-4057qib7	3700	3	patients	patient	NNS
cord-005453-4057qib7	3700	4	without	without	IN
cord-005453-4057qib7	3700	5	chronic	chronic	JJ
cord-005453-4057qib7	3700	6	GvHD	gvhd	NN
cord-005453-4057qib7	3700	7	,	,	,
cord-005453-4057qib7	3700	8	2	2	CD
cord-005453-4057qib7	3700	9	out	out	IN
cord-005453-4057qib7	3700	10	of	of	IN
cord-005453-4057qib7	3700	11	16	16	CD
cord-005453-4057qib7	3700	12	experienced	experienced	JJ
cord-005453-4057qib7	3700	13	fever	fever	NN
cord-005453-4057qib7	3700	14	after	after	IN
cord-005453-4057qib7	3700	15	vaccine	vaccine	NN
cord-005453-4057qib7	3700	16	injections	injection	NNS
cord-005453-4057qib7	3700	17	;	;	:
cord-005453-4057qib7	3700	18	1	1	CD
cord-005453-4057qib7	3700	19	out	out	IN
cord-005453-4057qib7	3700	20	of	of	IN
cord-005453-4057qib7	3700	21	16	16	CD
cord-005453-4057qib7	3700	22	developed	develop	VBN
cord-005453-4057qib7	3700	23	transient	transient	JJ
cord-005453-4057qib7	3700	24	mild	mild	JJ
cord-005453-4057qib7	3700	25	reduction	reduction	NN
cord-005453-4057qib7	3700	26	of	of	IN
cord-005453-4057qib7	3700	27	platelet	platelet	NN
cord-005453-4057qib7	3700	28	count	count	NN
cord-005453-4057qib7	3700	29	;	;	:
cord-005453-4057qib7	3700	30	1	1	CD
cord-005453-4057qib7	3700	31	patient	patient	NN
cord-005453-4057qib7	3700	32	reported	report	VBD
cord-005453-4057qib7	3700	33	headache	headache	NN
cord-005453-4057qib7	3700	34	and	and	CC
cord-005453-4057qib7	3700	35	otalgia	otalgia	NNP
cord-005453-4057qib7	3700	36	after	after	IN
cord-005453-4057qib7	3700	37	vaccine	vaccine	NN
cord-005453-4057qib7	3700	38	injection	injection	NN
cord-005453-4057qib7	3700	39	,	,	,
cord-005453-4057qib7	3700	40	while	while	IN
cord-005453-4057qib7	3700	41	another	another	DT
cord-005453-4057qib7	3700	42	one	one	CD
cord-005453-4057qib7	3700	43	transient	transient	JJ
cord-005453-4057qib7	3700	44	joint	joint	JJ
cord-005453-4057qib7	3700	45	pain	pain	NN
cord-005453-4057qib7	3700	46	;	;	:
cord-005453-4057qib7	3700	47	1	1	CD
cord-005453-4057qib7	3700	48	out	out	IN
cord-005453-4057qib7	3700	49	of	of	IN
cord-005453-4057qib7	3700	50	16	16	CD
cord-005453-4057qib7	3700	51	patients	patient	NNS
cord-005453-4057qib7	3700	52	presented	present	VBD
cord-005453-4057qib7	3700	53	signs	sign	NNS
cord-005453-4057qib7	3700	54	of	of	IN
cord-005453-4057qib7	3700	55	mouth	mouth	NN
cord-005453-4057qib7	3700	56	chronic	chronic	JJ
cord-005453-4057qib7	3700	57	GvHD	GvHD	NNP
cord-005453-4057qib7	3700	58	(	(	-LRB-
cord-005453-4057qib7	3700	59	score	score	NN
cord-005453-4057qib7	3700	60	1	1	CD
cord-005453-4057qib7	3700	61	NIH	NIH	NNP
cord-005453-4057qib7	3700	62	)	)	-RRB-
cord-005453-4057qib7	3700	63	and	and	CC
cord-005453-4057qib7	3700	64	transaminase	transaminase	FW
cord-005453-4057qib7	3700	65	increase	increase	NN
cord-005453-4057qib7	3700	66	(	(	-LRB-
cord-005453-4057qib7	3700	67	grade	grade	NN
cord-005453-4057qib7	3700	68	1	1	CD
cord-005453-4057qib7	3700	69	according	accord	VBG
cord-005453-4057qib7	3700	70	to	to	IN
cord-005453-4057qib7	3700	71	World	World	NNP
cord-005453-4057qib7	3700	72	Health	Health	NNP
cord-005453-4057qib7	3700	73	Organization	Organization	NNP
cord-005453-4057qib7	3700	74	Toxicity	toxicity	NN
cord-005453-4057qib7	3700	75	Scale	Scale	NNP
cord-005453-4057qib7	3700	76	)	)	-RRB-
cord-005453-4057qib7	3700	77	3	3	CD
cord-005453-4057qib7	3700	78	months	month	NNS
cord-005453-4057qib7	3700	79	after	after	IN
cord-005453-4057qib7	3700	80	the	the	DT
cord-005453-4057qib7	3700	81	first	first	JJ
cord-005453-4057qib7	3700	82	vaccine	vaccine	NN
cord-005453-4057qib7	3700	83	dose	dose	NN
cord-005453-4057qib7	3700	84	,	,	,
cord-005453-4057qib7	3700	85	so	so	IN
cord-005453-4057qib7	3700	86	that	that	IN
cord-005453-4057qib7	3700	87	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	3700	88	dose	dose	NN
cord-005453-4057qib7	3700	89	had	have	VBD
cord-005453-4057qib7	3700	90	to	to	TO
cord-005453-4057qib7	3700	91	be	be	VB
cord-005453-4057qib7	3700	92	augmented	augment	VBN
cord-005453-4057qib7	3700	93	.	.	.
cord-005453-4057qib7	3701	1	As	as	IN
cord-005453-4057qib7	3701	2	regards	regard	VBZ
cord-005453-4057qib7	3701	3	patients	patient	NNS
cord-005453-4057qib7	3701	4	with	with	IN
cord-005453-4057qib7	3701	5	chronic	chronic	JJ
cord-005453-4057qib7	3701	6	GvHD	GvHD	NNP
cord-005453-4057qib7	3701	7	,	,	,
cord-005453-4057qib7	3701	8	4	4	CD
cord-005453-4057qib7	3701	9	out	out	IN
cord-005453-4057qib7	3701	10	of	of	IN
cord-005453-4057qib7	3701	11	13	13	CD
cord-005453-4057qib7	3701	12	experienced	experienced	JJ
cord-005453-4057qib7	3701	13	fever	fever	NN
cord-005453-4057qib7	3701	14	after	after	IN
cord-005453-4057qib7	3701	15	vaccine	vaccine	NN
cord-005453-4057qib7	3701	16	injections	injection	NNS
cord-005453-4057qib7	3701	17	;	;	:
cord-005453-4057qib7	3701	18	2	2	CD
cord-005453-4057qib7	3701	19	patients	patient	NNS
cord-005453-4057qib7	3701	20	with	with	IN
cord-005453-4057qib7	3701	21	mild	mild	JJ
cord-005453-4057qib7	3701	22	chronic	chronic	JJ
cord-005453-4057qib7	3701	23	GvHD	gvhd	NN
cord-005453-4057qib7	3701	24	of	of	IN
cord-005453-4057qib7	3701	25	the	the	DT
cord-005453-4057qib7	3701	26	mouth	mouth	NN
cord-005453-4057qib7	3701	27	presented	present	VBD
cord-005453-4057qib7	3701	28	hepatic	hepatic	JJ
cord-005453-4057qib7	3701	29	flare	flare	NN
cord-005453-4057qib7	3701	30	two	two	CD
cord-005453-4057qib7	3701	31	and	and	CC
cord-005453-4057qib7	3701	32	three	three	CD
cord-005453-4057qib7	3701	33	months	month	NNS
cord-005453-4057qib7	3701	34	after	after	IN
cord-005453-4057qib7	3701	35	the	the	DT
cord-005453-4057qib7	3701	36	first	first	JJ
cord-005453-4057qib7	3701	37	vaccine	vaccine	NN
cord-005453-4057qib7	3701	38	dose	dose	NN
cord-005453-4057qib7	3701	39	,	,	,
cord-005453-4057qib7	3701	40	respectively	respectively	RB
cord-005453-4057qib7	3701	41	.	.	.
cord-005453-4057qib7	3702	1	In	in	IN
cord-005453-4057qib7	3702	2	both	both	DT
cord-005453-4057qib7	3702	3	cases	case	NNS
cord-005453-4057qib7	3702	4	a	a	DT
cord-005453-4057qib7	3702	5	new	new	JJ
cord-005453-4057qib7	3702	6	increase	increase	NN
cord-005453-4057qib7	3702	7	of	of	IN
cord-005453-4057qib7	3702	8	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	3702	9	and	and	CC
cord-005453-4057qib7	3702	10	methylprednisolone	methylprednisolone	JJ
cord-005453-4057qib7	3702	11	doses	dose	NNS
cord-005453-4057qib7	3702	12	determined	determine	VBD
cord-005453-4057qib7	3702	13	progressive	progressive	JJ
cord-005453-4057qib7	3702	14	normalization	normalization	NN
cord-005453-4057qib7	3702	15	of	of	IN
cord-005453-4057qib7	3702	16	liver	liver	NN
cord-005453-4057qib7	3702	17	enzymes	enzyme	NNS
cord-005453-4057qib7	3702	18	.	.	.
cord-005453-4057qib7	3703	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3703	2	:	:	:
cord-005453-4057qib7	3704	1	These	these	DT
cord-005453-4057qib7	3704	2	data	datum	NNS
cord-005453-4057qib7	3704	3	show	show	VBP
cord-005453-4057qib7	3704	4	that	that	IN
cord-005453-4057qib7	3704	5	vaccines	vaccine	NNS
cord-005453-4057qib7	3704	6	were	be	VBD
cord-005453-4057qib7	3704	7	globally	globally	RB
cord-005453-4057qib7	3704	8	well	well	RB
cord-005453-4057qib7	3704	9	tolerated	tolerate	VBN
cord-005453-4057qib7	3704	10	in	in	IN
cord-005453-4057qib7	3704	11	HSCT	HSCT	NNP
cord-005453-4057qib7	3704	12	recipients	recipient	NNS
cord-005453-4057qib7	3704	13	,	,	,
cord-005453-4057qib7	3704	14	even	even	RB
cord-005453-4057qib7	3704	15	when	when	WRB
cord-005453-4057qib7	3704	16	they	-PRON-	PRP
cord-005453-4057qib7	3704	17	suffered	suffer	VBD
cord-005453-4057qib7	3704	18	from	from	IN
cord-005453-4057qib7	3704	19	chronic	chronic	JJ
cord-005453-4057qib7	3704	20	GvHD	GvHD	NNP
cord-005453-4057qib7	3704	21	.	.	.
cord-005453-4057qib7	3705	1	However	however	RB
cord-005453-4057qib7	3705	2	,	,	,
cord-005453-4057qib7	3705	3	close	close	JJ
cord-005453-4057qib7	3705	4	monitoring	monitoring	NN
cord-005453-4057qib7	3705	5	is	be	VBZ
cord-005453-4057qib7	3705	6	warranted	warrant	VBN
cord-005453-4057qib7	3705	7	in	in	IN
cord-005453-4057qib7	3705	8	order	order	NN
cord-005453-4057qib7	3705	9	to	to	TO
cord-005453-4057qib7	3705	10	better	better	RB
cord-005453-4057qib7	3705	11	evaluate	evaluate	VB
cord-005453-4057qib7	3705	12	possible	possible	JJ
cord-005453-4057qib7	3705	13	vaccine	vaccine	NN
cord-005453-4057qib7	3705	14	side	side	NN
cord-005453-4057qib7	3705	15	effects	effect	NNS
cord-005453-4057qib7	3705	16	in	in	IN
cord-005453-4057qib7	3705	17	this	this	DT
cord-005453-4057qib7	3705	18	setting	setting	NN
cord-005453-4057qib7	3705	19	of	of	IN
cord-005453-4057qib7	3705	20	patients	patient	NNS
cord-005453-4057qib7	3705	21	.	.	.
cord-005453-4057qib7	3706	1	Background	background	NN
cord-005453-4057qib7	3706	2	:	:	:
cord-005453-4057qib7	3707	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	3707	2	HSCT	HSCT	NNP
cord-005453-4057qib7	3707	3	improves	improve	VBZ
cord-005453-4057qib7	3707	4	survival	survival	NN
cord-005453-4057qib7	3707	5	for	for	IN
cord-005453-4057qib7	3707	6	AML	AML	NNP
cord-005453-4057qib7	3707	7	patients	patient	NNS
cord-005453-4057qib7	3707	8	over	over	IN
cord-005453-4057qib7	3707	9	the	the	DT
cord-005453-4057qib7	3707	10	age	age	NN
cord-005453-4057qib7	3707	11	of	of	IN
cord-005453-4057qib7	3707	12	60	60	CD
cord-005453-4057qib7	3707	13	years	year	NNS
cord-005453-4057qib7	3707	14	of	of	IN
cord-005453-4057qib7	3707	15	age	age	NN
cord-005453-4057qib7	3707	16	when	when	WRB
cord-005453-4057qib7	3707	17	compared	compare	VBN
cord-005453-4057qib7	3707	18	to	to	IN
cord-005453-4057qib7	3707	19	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3707	20	alone	alone	RB
cord-005453-4057qib7	3707	21	.	.	.
cord-005453-4057qib7	3708	1	The	the	DT
cord-005453-4057qib7	3708	2	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	3708	3	stem	stem	NN
cord-005453-4057qib7	3708	4	cell	cell	NN
cord-005453-4057qib7	3708	5	transplantation	transplantation	NN
cord-005453-4057qib7	3708	6	comorbidity	comorbidity	NN
cord-005453-4057qib7	3708	7	index	index	NN
cord-005453-4057qib7	3708	8	(	(	-LRB-
cord-005453-4057qib7	3708	9	HCT	HCT	NNP
cord-005453-4057qib7	3708	10	-	-	HYPH
cord-005453-4057qib7	3708	11	CI	CI	NNP
cord-005453-4057qib7	3708	12	)	)	-RRB-
cord-005453-4057qib7	3708	13	and	and	CC
cord-005453-4057qib7	3708	14	EBMT	EBMT	NNP
cord-005453-4057qib7	3708	15	score	score	NN
cord-005453-4057qib7	3708	16	predict	predict	VB
cord-005453-4057qib7	3708	17	for	for	IN
cord-005453-4057qib7	3708	18	non	non	JJ
cord-005453-4057qib7	3708	19	-	-	JJ
cord-005453-4057qib7	3708	20	relapse	relapse	JJ
cord-005453-4057qib7	3708	21	mortality	mortality	NN
cord-005453-4057qib7	3708	22	and	and	CC
cord-005453-4057qib7	3708	23	overall	overall	JJ
cord-005453-4057qib7	3708	24	survival	survival	NN
cord-005453-4057qib7	3708	25	,	,	,
cord-005453-4057qib7	3708	26	yet	yet	CC
cord-005453-4057qib7	3708	27	little	little	JJ
cord-005453-4057qib7	3708	28	is	be	VBZ
cord-005453-4057qib7	3708	29	known	know	VBN
cord-005453-4057qib7	3708	30	about	about	IN
cord-005453-4057qib7	3708	31	whether	whether	IN
cord-005453-4057qib7	3708	32	QoL	QoL	NNP
cord-005453-4057qib7	3708	33	is	be	VBZ
cord-005453-4057qib7	3708	34	preserved	preserve	VBN
cord-005453-4057qib7	3708	35	in	in	IN
cord-005453-4057qib7	3708	36	this	this	DT
cord-005453-4057qib7	3708	37	patient	patient	NN
cord-005453-4057qib7	3708	38	group	group	NN
cord-005453-4057qib7	3708	39	and	and	CC
cord-005453-4057qib7	3708	40	whether	whether	IN
cord-005453-4057qib7	3708	41	HCT	HCT	NNP
cord-005453-4057qib7	3708	42	-	-	HYPH
cord-005453-4057qib7	3708	43	CI	CI	NNP
cord-005453-4057qib7	3708	44	and	and	CC
cord-005453-4057qib7	3708	45	other	other	JJ
cord-005453-4057qib7	3708	46	performance	performance	NN
cord-005453-4057qib7	3708	47	scores	score	NNS
cord-005453-4057qib7	3708	48	pre	pre	JJ
cord-005453-4057qib7	3708	49	-	-	NNP
cord-005453-4057qib7	3708	50	BMT	BMT	NNP
cord-005453-4057qib7	3708	51	correlate	correlate	VB
cord-005453-4057qib7	3708	52	with	with	IN
cord-005453-4057qib7	3708	53	QoL	qol	FW
cord-005453-4057qib7	3708	54	post	post	AFX
cord-005453-4057qib7	3708	55	allo	allo	NN
cord-005453-4057qib7	3708	56	-	-	HYPH
cord-005453-4057qib7	3708	57	HSCT	HSCT	NNP
cord-005453-4057qib7	3708	58	.	.	.
cord-005453-4057qib7	3709	1	Methods	method	NNS
cord-005453-4057qib7	3709	2	:	:	:
cord-005453-4057qib7	3709	3	We	-PRON-	PRP
cord-005453-4057qib7	3709	4	conducted	conduct	VBD
cord-005453-4057qib7	3709	5	a	a	DT
cord-005453-4057qib7	3709	6	retrospective	retrospective	JJ
cord-005453-4057qib7	3709	7	analysis	analysis	NN
cord-005453-4057qib7	3709	8	of	of	IN
cord-005453-4057qib7	3709	9	patients	patient	NNS
cord-005453-4057qib7	3709	10	60	60	CD
cord-005453-4057qib7	3709	11	years	year	NNS
cord-005453-4057qib7	3709	12	and	and	CC
cord-005453-4057qib7	3709	13	older	old	JJR
cord-005453-4057qib7	3709	14	who	who	WP
cord-005453-4057qib7	3709	15	underwent	undergo	VBD
cord-005453-4057qib7	3709	16	RIC	RIC	NNP
cord-005453-4057qib7	3709	17	allo	allo	NNP
cord-005453-4057qib7	3709	18	-	-	HYPH
cord-005453-4057qib7	3709	19	HSCT	HSCT	NNP
cord-005453-4057qib7	3709	20	at	at	IN
cord-005453-4057qib7	3709	21	the	the	DT
cord-005453-4057qib7	3709	22	University	University	NNP
cord-005453-4057qib7	3709	23	Hospital	Hospital	NNP
cord-005453-4057qib7	3709	24	of	of	IN
cord-005453-4057qib7	3709	25	Wales	Wales	NNP
cord-005453-4057qib7	3709	26	,	,	,
cord-005453-4057qib7	3709	27	Cardiff	Cardiff	NNP
cord-005453-4057qib7	3709	28	between	between	IN
cord-005453-4057qib7	3709	29	September	September	NNP
cord-005453-4057qib7	3709	30	2011	2011	CD
cord-005453-4057qib7	3709	31	and	and	CC
cord-005453-4057qib7	3709	32	December	December	NNP
cord-005453-4057qib7	3709	33	2017	2017	CD
cord-005453-4057qib7	3710	1	(	(	-LRB-
cord-005453-4057qib7	3710	2	n=41	n=41	RB
cord-005453-4057qib7	3710	3	)	)	-RRB-
cord-005453-4057qib7	3710	4	.	.	.
cord-005453-4057qib7	3711	1	HCT	HCT	NNP
cord-005453-4057qib7	3711	2	-	-	HYPH
cord-005453-4057qib7	3711	3	CI	CI	NNP
cord-005453-4057qib7	3711	4	,	,	,
cord-005453-4057qib7	3711	5	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	3711	6	Performance	Performance	NNP
cord-005453-4057qib7	3711	7	Score	Score	NNP
cord-005453-4057qib7	3711	8	(	(	-LRB-
cord-005453-4057qib7	3711	9	KPS	KPS	NNP
cord-005453-4057qib7	3711	10	)	)	-RRB-
cord-005453-4057qib7	3711	11	and	and	CC
cord-005453-4057qib7	3711	12	EBMT	EBMT	NNP
cord-005453-4057qib7	3711	13	scores	score	NNS
cord-005453-4057qib7	3711	14	were	be	VBD
cord-005453-4057qib7	3711	15	calculated	calculate	VBN
cord-005453-4057qib7	3711	16	prior	prior	RB
cord-005453-4057qib7	3711	17	to	to	IN
cord-005453-4057qib7	3711	18	transplant	transplant	NN
cord-005453-4057qib7	3711	19	and	and	CC
cord-005453-4057qib7	3711	20	QoL	qol	NN
cord-005453-4057qib7	3711	21	measured	measure	VBN
cord-005453-4057qib7	3711	22	using	use	VBG
cord-005453-4057qib7	3711	23	the	the	DT
cord-005453-4057qib7	3711	24	FACT	FACT	NNP
cord-005453-4057qib7	3711	25	BMT	BMT	NNP
cord-005453-4057qib7	3711	26	(	(	-LRB-
cord-005453-4057qib7	3711	27	version	version	NN
cord-005453-4057qib7	3711	28	4	4	CD
cord-005453-4057qib7	3711	29	)	)	-RRB-
cord-005453-4057qib7	3711	30	questionnaire	questionnaire	NN
cord-005453-4057qib7	3711	31	,	,	,
cord-005453-4057qib7	3711	32	which	which	WDT
cord-005453-4057qib7	3711	33	was	be	VBD
cord-005453-4057qib7	3711	34	completed	complete	VBN
cord-005453-4057qib7	3711	35	at	at	IN
cord-005453-4057qib7	3711	36	3	3	CD
cord-005453-4057qib7	3711	37	,	,	,
cord-005453-4057qib7	3711	38	6	6	CD
cord-005453-4057qib7	3711	39	and	and	CC
cord-005453-4057qib7	3711	40	12	12	CD
cord-005453-4057qib7	3711	41	months	month	NNS
cord-005453-4057qib7	3711	42	post	post	NN
cord-005453-4057qib7	3711	43	transplant	transplant	NN
cord-005453-4057qib7	3711	44	.	.	.
cord-005453-4057qib7	3712	1	Patients	patient	NNS
cord-005453-4057qib7	3712	2	were	be	VBD
cord-005453-4057qib7	3712	3	grouped	group	VBN
cord-005453-4057qib7	3712	4	at	at	IN
cord-005453-4057qib7	3712	5	the	the	DT
cord-005453-4057qib7	3712	6	3-	3-	NNP
cord-005453-4057qib7	3712	7	,	,	,
cord-005453-4057qib7	3712	8	6-and	6-and	CD
cord-005453-4057qib7	3712	9	12-month	12-month	JJ
cord-005453-4057qib7	3712	10	time	time	NN
cord-005453-4057qib7	3712	11	points	point	NNS
cord-005453-4057qib7	3712	12	for	for	IN
cord-005453-4057qib7	3712	13	each	each	DT
cord-005453-4057qib7	3712	14	of	of	IN
cord-005453-4057qib7	3712	15	the	the	DT
cord-005453-4057qib7	3712	16	different	different	JJ
cord-005453-4057qib7	3712	17	performance	performance	NN
cord-005453-4057qib7	3712	18	indices	index	NNS
cord-005453-4057qib7	3712	19	,	,	,
cord-005453-4057qib7	3712	20	allowing	allow	VBG
cord-005453-4057qib7	3712	21	group	group	NN
cord-005453-4057qib7	3712	22	comparison	comparison	NN
cord-005453-4057qib7	3712	23	against	against	IN
cord-005453-4057qib7	3712	24	compound	compound	NN
cord-005453-4057qib7	3712	25	sub	sub	NN
cord-005453-4057qib7	3712	26	scores	score	NNS
cord-005453-4057qib7	3712	27	using	use	VBG
cord-005453-4057qib7	3712	28	the	the	DT
cord-005453-4057qib7	3712	29	Mann	Mann	NNP
cord-005453-4057qib7	3712	30	-	-	HYPH
cord-005453-4057qib7	3712	31	Whitney	Whitney	NNP
cord-005453-4057qib7	3712	32	U	U	NNP
cord-005453-4057qib7	3712	33	test	test	NN
cord-005453-4057qib7	3712	34	.	.	.
cord-005453-4057qib7	3713	1	Results	result	NNS
cord-005453-4057qib7	3713	2	:	:	:
cord-005453-4057qib7	3713	3	41	41	CD
cord-005453-4057qib7	3713	4	patients	patient	NNS
cord-005453-4057qib7	3713	5	were	be	VBD
cord-005453-4057qib7	3713	6	included	include	VBN
cord-005453-4057qib7	3713	7	in	in	IN
cord-005453-4057qib7	3713	8	this	this	DT
cord-005453-4057qib7	3713	9	study	study	NN
cord-005453-4057qib7	3713	10	,	,	,
cord-005453-4057qib7	3713	11	with	with	IN
cord-005453-4057qib7	3713	12	median	median	JJ
cord-005453-4057qib7	3713	13	age	age	NN
cord-005453-4057qib7	3713	14	65	65	CD
cord-005453-4057qib7	3713	15	years	year	NNS
cord-005453-4057qib7	3714	1	(	(	-LRB-
cord-005453-4057qib7	3714	2	range	range	NNP
cord-005453-4057qib7	3714	3	60	60	CD
cord-005453-4057qib7	3714	4	-	-	SYM
cord-005453-4057qib7	3714	5	74	74	CD
cord-005453-4057qib7	3714	6	)	)	-RRB-
cord-005453-4057qib7	3714	7	.	.	.
cord-005453-4057qib7	3715	1	Patient	patient	JJ
cord-005453-4057qib7	3715	2	characteristics	characteristic	NNS
cord-005453-4057qib7	3715	3	,	,	,
cord-005453-4057qib7	3715	4	including	include	VBG
cord-005453-4057qib7	3715	5	conditioning	conditioning	NN
cord-005453-4057qib7	3715	6	,	,	,
cord-005453-4057qib7	3715	7	donor	donor	NN
cord-005453-4057qib7	3715	8	type	type	NN
cord-005453-4057qib7	3715	9	,	,	,
cord-005453-4057qib7	3715	10	pre	pre	JJ
cord-005453-4057qib7	3715	11	-	-	JJ
cord-005453-4057qib7	3715	12	transplant	transplant	JJ
cord-005453-4057qib7	3715	13	HCT	HCT	NNP
cord-005453-4057qib7	3715	14	-	-	HYPH
cord-005453-4057qib7	3715	15	CI	CI	NNP
cord-005453-4057qib7	3715	16	and	and	CC
cord-005453-4057qib7	3715	17	KPS	KPS	NNP
cord-005453-4057qib7	3715	18	scores	score	NNS
cord-005453-4057qib7	3715	19	are	be	VBP
cord-005453-4057qib7	3715	20	summarised	summarise	VBN
cord-005453-4057qib7	3715	21	in	in	IN
cord-005453-4057qib7	3715	22	table	table	NN
cord-005453-4057qib7	3715	23	1	1	CD
cord-005453-4057qib7	3715	24	.	.	.
cord-005453-4057qib7	3716	1	The	the	DT
cord-005453-4057qib7	3716	2	2	2	CD
cord-005453-4057qib7	3716	3	year	year	NN
cord-005453-4057qib7	3716	4	and	and	CC
cord-005453-4057qib7	3716	5	5	5	CD
cord-005453-4057qib7	3716	6	year	year	NN
cord-005453-4057qib7	3716	7	overall	overall	JJ
cord-005453-4057qib7	3716	8	survival	survival	NN
cord-005453-4057qib7	3716	9	(	(	-LRB-
cord-005453-4057qib7	3716	10	OS	OS	NNP
cord-005453-4057qib7	3716	11	)	)	-RRB-
cord-005453-4057qib7	3716	12	for	for	IN
cord-005453-4057qib7	3716	13	the	the	DT
cord-005453-4057qib7	3716	14	patient	patient	JJ
cord-005453-4057qib7	3716	15	cohort	cohort	NN
cord-005453-4057qib7	3716	16	was	be	VBD
cord-005453-4057qib7	3716	17	65.4	65.4	CD
cord-005453-4057qib7	3716	18	%	%	NN
cord-005453-4057qib7	3716	19	and	and	CC
cord-005453-4057qib7	3716	20	48.7	48.7	CD
cord-005453-4057qib7	3716	21	%	%	NN
cord-005453-4057qib7	3716	22	respectively	respectively	RB
cord-005453-4057qib7	3716	23	.	.	.
cord-005453-4057qib7	3717	1	HCT	HCT	NNP
cord-005453-4057qib7	3717	2	-	-	HYPH
cord-005453-4057qib7	3717	3	CI	CI	NNP
cord-005453-4057qib7	3717	4	of	of	IN
cord-005453-4057qib7	3717	5	≥3	≥3	NNP
cord-005453-4057qib7	3717	6	vs	vs	IN
cord-005453-4057qib7	3717	7	0	0	CD
cord-005453-4057qib7	3717	8	was	be	VBD
cord-005453-4057qib7	3717	9	significantly	significantly	RB
cord-005453-4057qib7	3717	10	associated	associate	VBN
cord-005453-4057qib7	3717	11	with	with	IN
cord-005453-4057qib7	3717	12	poorer	poor	JJR
cord-005453-4057qib7	3717	13	BMT	BMT	NNP
cord-005453-4057qib7	3717	14	-	-	HYPH
cord-005453-4057qib7	3717	15	related	relate	VBN
cord-005453-4057qib7	3717	16	QoL	qol	NN
cord-005453-4057qib7	3717	17	domains	domain	NNS
cord-005453-4057qib7	3717	18	at	at	IN
cord-005453-4057qib7	3717	19	3	3	CD
cord-005453-4057qib7	3717	20	months	month	NNS
cord-005453-4057qib7	3717	21	(	(	-LRB-
cord-005453-4057qib7	3717	22	p=0.035	p=0.035	NNP
cord-005453-4057qib7	3717	23	)	)	-RRB-
cord-005453-4057qib7	3717	24	and	and	CC
cord-005453-4057qib7	3717	25	general	general	JJ
cord-005453-4057qib7	3717	26	QoL	qol	NN
cord-005453-4057qib7	3717	27	domains	domain	NNS
cord-005453-4057qib7	3717	28	at	at	IN
cord-005453-4057qib7	3717	29	6	6	CD
cord-005453-4057qib7	3717	30	months	month	NNS
cord-005453-4057qib7	3717	31	(	(	-LRB-
cord-005453-4057qib7	3717	32	p=0.025	p=0.025	NNP
cord-005453-4057qib7	3717	33	)	)	-RRB-
cord-005453-4057qib7	3717	34	post	post	JJ
cord-005453-4057qib7	3717	35	-	-	NN
cord-005453-4057qib7	3717	36	transplant	transplant	NN
cord-005453-4057qib7	3717	37	.	.	.
cord-005453-4057qib7	3718	1	While	while	IN
cord-005453-4057qib7	3718	2	EBMT	EBMT	NNP
cord-005453-4057qib7	3718	3	score	score	NN
cord-005453-4057qib7	3718	4	showed	show	VBD
cord-005453-4057qib7	3718	5	no	no	DT
cord-005453-4057qib7	3718	6	correlation	correlation	NN
cord-005453-4057qib7	3718	7	with	with	IN
cord-005453-4057qib7	3718	8	QoL	qol	NN
cord-005453-4057qib7	3718	9	parameters	parameter	NNS
cord-005453-4057qib7	3718	10	,	,	,
cord-005453-4057qib7	3718	11	patients	patient	NNS
cord-005453-4057qib7	3718	12	with	with	IN
cord-005453-4057qib7	3718	13	KPS	KPS	NNP
cord-005453-4057qib7	3718	14	of	of	IN
cord-005453-4057qib7	3718	15	100	100	CD
cord-005453-4057qib7	3718	16	vs	vs	IN
cord-005453-4057qib7	3718	17	≤90	≤90	NNP
cord-005453-4057qib7	3718	18	showed	show	VBD
cord-005453-4057qib7	3718	19	significant	significant	JJ
cord-005453-4057qib7	3718	20	differences	difference	NNS
cord-005453-4057qib7	3718	21	in	in	IN
cord-005453-4057qib7	3718	22	both	both	DT
cord-005453-4057qib7	3718	23	general	general	JJ
cord-005453-4057qib7	3718	24	(	(	-LRB-
cord-005453-4057qib7	3718	25	p=0.01	p=0.01	NNP
cord-005453-4057qib7	3718	26	)	)	-RRB-
cord-005453-4057qib7	3718	27	and	and	CC
cord-005453-4057qib7	3718	28	BMT	BMT	NNP
cord-005453-4057qib7	3718	29	-	-	HYPH
cord-005453-4057qib7	3718	30	related	relate	VBN
cord-005453-4057qib7	3718	31	QoL	qol	NN
cord-005453-4057qib7	3718	32	(	(	-LRB-
cord-005453-4057qib7	3718	33	p=0.04	p=0.04	NN
cord-005453-4057qib7	3718	34	)	)	-RRB-
cord-005453-4057qib7	3718	35	at	at	IN
cord-005453-4057qib7	3718	36	3	3	CD
cord-005453-4057qib7	3718	37	months	month	NNS
cord-005453-4057qib7	3718	38	and	and	CC
cord-005453-4057qib7	3718	39	in	in	IN
cord-005453-4057qib7	3718	40	all	all	DT
cord-005453-4057qib7	3718	41	QoL	qol	NN
cord-005453-4057qib7	3718	42	domains	domain	NNS
cord-005453-4057qib7	3718	43	at	at	IN
cord-005453-4057qib7	3718	44	6	6	CD
cord-005453-4057qib7	3718	45	months	month	NNS
cord-005453-4057qib7	3718	46	(	(	-LRB-
cord-005453-4057qib7	3718	47	symptomrelated	symptomrelate	VBN
cord-005453-4057qib7	3718	48	QoL	QoL	NNP
cord-005453-4057qib7	3718	49	p=0.05	p=0.05	NNP
cord-005453-4057qib7	3718	50	,	,	,
cord-005453-4057qib7	3718	51	general	general	JJ
cord-005453-4057qib7	3718	52	QoL	qol	NN
cord-005453-4057qib7	3718	53	p=0.01	p=0.01	NNP
cord-005453-4057qib7	3718	54	,	,	,
cord-005453-4057qib7	3718	55	BMT	BMT	NNP
cord-005453-4057qib7	3718	56	-	-	HYPH
cord-005453-4057qib7	3718	57	related	relate	VBN
cord-005453-4057qib7	3718	58	QoL	qol	NN
cord-005453-4057qib7	3718	59	p=0.01	p=0.01	NNP
cord-005453-4057qib7	3718	60	)	)	-RRB-
cord-005453-4057qib7	3718	61	.	.	.
cord-005453-4057qib7	3719	1	Importantly	importantly	RB
cord-005453-4057qib7	3719	2	neither	neither	CC
cord-005453-4057qib7	3719	3	the	the	DT
cord-005453-4057qib7	3719	4	HCT	HCT	NNP
cord-005453-4057qib7	3719	5	-	-	HYPH
cord-005453-4057qib7	3719	6	CI	CI	NNP
cord-005453-4057qib7	3719	7	nor	nor	CC
cord-005453-4057qib7	3719	8	the	the	DT
cord-005453-4057qib7	3719	9	KPS	KPS	NNP
cord-005453-4057qib7	3719	10	pre	pre	JJ
cord-005453-4057qib7	3719	11	-	-	JJ
cord-005453-4057qib7	3719	12	transplant	transplant	NN
cord-005453-4057qib7	3719	13	predicted	predict	VBN
cord-005453-4057qib7	3719	14	for	for	IN
cord-005453-4057qib7	3719	15	QoL	QoL	NNP
cord-005453-4057qib7	3719	16	at	at	IN
cord-005453-4057qib7	3719	17	12	12	CD
cord-005453-4057qib7	3719	18	months	month	NNS
cord-005453-4057qib7	3719	19	post	post	NN
cord-005453-4057qib7	3719	20	transplant	transplant	NN
cord-005453-4057qib7	3719	21	.	.	.
cord-005453-4057qib7	3720	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3720	2	:	:	:
cord-005453-4057qib7	3721	1	Patient	patient	JJ
cord-005453-4057qib7	3721	2	selection	selection	NN
cord-005453-4057qib7	3721	3	is	be	VBZ
cord-005453-4057qib7	3721	4	key	key	JJ
cord-005453-4057qib7	3721	5	to	to	IN
cord-005453-4057qib7	3721	6	ensuring	ensure	VBG
cord-005453-4057qib7	3721	7	maximum	maximum	JJ
cord-005453-4057qib7	3721	8	benefit	benefit	NN
cord-005453-4057qib7	3721	9	from	from	IN
cord-005453-4057qib7	3721	10	allo	allo	NN
cord-005453-4057qib7	3721	11	-	-	HYPH
cord-005453-4057qib7	3721	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3721	13	both	both	CC
cord-005453-4057qib7	3721	14	in	in	IN
cord-005453-4057qib7	3721	15	terms	term	NNS
cord-005453-4057qib7	3721	16	of	of	IN
cord-005453-4057qib7	3721	17	overall	overall	JJ
cord-005453-4057qib7	3721	18	survival	survival	NN
cord-005453-4057qib7	3721	19	but	but	CC
cord-005453-4057qib7	3721	20	also	also	RB
cord-005453-4057qib7	3721	21	with	with	IN
cord-005453-4057qib7	3721	22	regards	regard	NNS
cord-005453-4057qib7	3721	23	to	to	IN
cord-005453-4057qib7	3721	24	QoL	qol	NN
cord-005453-4057qib7	3721	25	and	and	CC
cord-005453-4057qib7	3721	26	survivorship	survivorship	NN
cord-005453-4057qib7	3721	27	.	.	.
cord-005453-4057qib7	3722	1	We	-PRON-	PRP
cord-005453-4057qib7	3722	2	note	note	VBP
cord-005453-4057qib7	3722	3	that	that	IN
cord-005453-4057qib7	3722	4	while	while	IN
cord-005453-4057qib7	3722	5	patients	patient	NNS
cord-005453-4057qib7	3722	6	with	with	IN
cord-005453-4057qib7	3722	7	HCT	HCT	NNP
cord-005453-4057qib7	3722	8	-	-	HYPH
cord-005453-4057qib7	3722	9	CI	CI	NNP
cord-005453-4057qib7	3722	10	³3	³3	NN
cord-005453-4057qib7	3722	11	or	or	CC
cord-005453-4057qib7	3722	12	KPS	KPS	NNP
cord-005453-4057qib7	3722	13	≤90	≤90	NNP
cord-005453-4057qib7	3722	14	had	have	VBD
cord-005453-4057qib7	3722	15	significantly	significantly	RB
cord-005453-4057qib7	3722	16	poorer	poor	JJR
cord-005453-4057qib7	3722	17	QoL	qol	NN
cord-005453-4057qib7	3722	18	at	at	IN
cord-005453-4057qib7	3722	19	6	6	CD
cord-005453-4057qib7	3722	20	months	month	NNS
cord-005453-4057qib7	3722	21	post	post	NN
cord-005453-4057qib7	3722	22	allo	allo	NN
cord-005453-4057qib7	3722	23	-	-	HYPH
cord-005453-4057qib7	3722	24	HSCT	HSCT	NNP
cord-005453-4057qib7	3722	25	,	,	,
cord-005453-4057qib7	3723	1	QoL	QoL	NNP
cord-005453-4057qib7	3723	2	was	be	VBD
cord-005453-4057qib7	3723	3	recovered	recover	VBN
cord-005453-4057qib7	3723	4	by	by	IN
cord-005453-4057qib7	3723	5	12	12	CD
cord-005453-4057qib7	3723	6	months	month	NNS
cord-005453-4057qib7	3723	7	post	post	NN
cord-005453-4057qib7	3723	8	transplant	transplant	NN
cord-005453-4057qib7	3723	9	,	,	,
cord-005453-4057qib7	3723	10	with	with	IN
cord-005453-4057qib7	3723	11	this	this	DT
cord-005453-4057qib7	3723	12	significant	significant	JJ
cord-005453-4057qib7	3723	13	difference	difference	NN
cord-005453-4057qib7	3723	14	no	no	RB
cord-005453-4057qib7	3723	15	longer	long	RBR
cord-005453-4057qib7	3723	16	seen	see	VBN
cord-005453-4057qib7	3723	17	.	.	.
cord-005453-4057qib7	3724	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3724	2	data	data	NN
cord-005453-4057qib7	3724	3	shows	show	VBZ
cord-005453-4057qib7	3724	4	that	that	IN
cord-005453-4057qib7	3724	5	in	in	IN
cord-005453-4057qib7	3724	6	selected	select	VBN
cord-005453-4057qib7	3724	7	AML	AML	NNP
cord-005453-4057qib7	3724	8	patients	patient	NNS
cord-005453-4057qib7	3724	9	over	over	IN
cord-005453-4057qib7	3724	10	the	the	DT
cord-005453-4057qib7	3724	11	age	age	NN
cord-005453-4057qib7	3724	12	of	of	IN
cord-005453-4057qib7	3724	13	60	60	CD
cord-005453-4057qib7	3724	14	years	year	NNS
cord-005453-4057qib7	3724	15	with	with	IN
cord-005453-4057qib7	3724	16	good	good	JJ
cord-005453-4057qib7	3724	17	performance	performance	NN
cord-005453-4057qib7	3724	18	status	status	NN
cord-005453-4057qib7	3724	19	and	and	CC
cord-005453-4057qib7	3724	20	low	low	JJ
cord-005453-4057qib7	3724	21	comorbidity	comorbidity	NN
cord-005453-4057qib7	3724	22	index	index	NN
cord-005453-4057qib7	3724	23	,	,	,
cord-005453-4057qib7	3724	24	a	a	DT
cord-005453-4057qib7	3724	25	favourable	favourable	JJ
cord-005453-4057qib7	3724	26	outcome	outcome	NN
cord-005453-4057qib7	3724	27	can	can	MD
cord-005453-4057qib7	3724	28	be	be	VB
cord-005453-4057qib7	3724	29	achieved	achieve	VBN
cord-005453-4057qib7	3724	30	with	with	IN
cord-005453-4057qib7	3724	31	good	good	JJ
cord-005453-4057qib7	3724	32	QoL	qol	NN
cord-005453-4057qib7	3724	33	maintained	maintain	VBN
cord-005453-4057qib7	3724	34	throughout	throughout	IN
cord-005453-4057qib7	3724	35	the	the	DT
cord-005453-4057qib7	3724	36	post	post	NN
cord-005453-4057qib7	3724	37	transplant	transplant	NN
cord-005453-4057qib7	3724	38	period	period	NN
cord-005453-4057qib7	3724	39	.	.	.
cord-005453-4057qib7	3725	1	Background	background	NN
cord-005453-4057qib7	3725	2	:	:	:
cord-005453-4057qib7	3726	1	Advances	advance	NNS
cord-005453-4057qib7	3726	2	in	in	IN
cord-005453-4057qib7	3726	3	alloSCT	alloSCT	NNP
cord-005453-4057qib7	3726	4	technology	technology	NN
cord-005453-4057qib7	3726	5	,	,	,
cord-005453-4057qib7	3726	6	supportive	supportive	JJ
cord-005453-4057qib7	3726	7	care	care	NN
cord-005453-4057qib7	3726	8	,	,	,
cord-005453-4057qib7	3726	9	and	and	CC
cord-005453-4057qib7	3726	10	use	use	NN
cord-005453-4057qib7	3726	11	of	of	IN
cord-005453-4057qib7	3726	12	reduced	reduced	JJ
cord-005453-4057qib7	3726	13	intensity	intensity	NN
cord-005453-4057qib7	3726	14	conditioning	conditioning	NN
cord-005453-4057qib7	3726	15	regimens	regimen	NNS
cord-005453-4057qib7	3726	16	for	for	IN
cord-005453-4057qib7	3726	17	older	old	JJR
cord-005453-4057qib7	3726	18	patients	patient	NNS
cord-005453-4057qib7	3726	19	have	have	VBP
cord-005453-4057qib7	3726	20	led	lead	VBN
cord-005453-4057qib7	3726	21	to	to	IN
cord-005453-4057qib7	3726	22	significant	significant	JJ
cord-005453-4057qib7	3726	23	improvements	improvement	NNS
cord-005453-4057qib7	3726	24	in	in	IN
cord-005453-4057qib7	3726	25	longterm	longterm	JJ
cord-005453-4057qib7	3726	26	survival	survival	NN
cord-005453-4057qib7	3726	27	after	after	IN
cord-005453-4057qib7	3726	28	transplant	transplant	NN
cord-005453-4057qib7	3726	29	.	.	.
cord-005453-4057qib7	3727	1	The	the	DT
cord-005453-4057qib7	3727	2	survivors	survivor	NNS
cord-005453-4057qib7	3727	3	have	have	VBP
cord-005453-4057qib7	3727	4	an	an	DT
cord-005453-4057qib7	3727	5	elevated	elevated	JJ
cord-005453-4057qib7	3727	6	probability	probability	NN
cord-005453-4057qib7	3727	7	of	of	IN
cord-005453-4057qib7	3727	8	late	late	JJ
cord-005453-4057qib7	3727	9	morbidity	morbidity	NN
cord-005453-4057qib7	3727	10	and	and	CC
cord-005453-4057qib7	3727	11	mortality	mortality	NN
cord-005453-4057qib7	3727	12	,	,	,
cord-005453-4057qib7	3727	13	including	include	VBG
cord-005453-4057qib7	3727	14	abnormalities	abnormality	NNS
cord-005453-4057qib7	3727	15	in	in	IN
cord-005453-4057qib7	3727	16	phosphocalcic	phosphocalcic	NN
cord-005453-4057qib7	3727	17	metabolism	metabolism	NN
cord-005453-4057qib7	3727	18	and	and	CC
cord-005453-4057qib7	3727	19	bone	bone	NN
cord-005453-4057qib7	3727	20	disease	disease	NN
cord-005453-4057qib7	3727	21	.	.	.
cord-005453-4057qib7	3728	1	Rapid	rapid	JJ
cord-005453-4057qib7	3728	2	and	and	CC
cord-005453-4057qib7	3728	3	progressive	progressive	JJ
cord-005453-4057qib7	3728	4	bone	bone	NN
cord-005453-4057qib7	3728	5	loss	loss	NN
cord-005453-4057qib7	3728	6	occurs	occur	VBZ
cord-005453-4057qib7	3728	7	within	within	IN
cord-005453-4057qib7	3728	8	the	the	DT
cord-005453-4057qib7	3728	9	first	first	JJ
cord-005453-4057qib7	3728	10	6	6	CD
cord-005453-4057qib7	3728	11	-	-	SYM
cord-005453-4057qib7	3728	12	12	12	CD
cord-005453-4057qib7	3728	13	months	month	NNS
cord-005453-4057qib7	3728	14	after	after	IN
cord-005453-4057qib7	3728	15	transplant	transplant	NN
cord-005453-4057qib7	3728	16	,	,	,
cord-005453-4057qib7	3728	17	and	and	CC
cord-005453-4057qib7	3728	18	this	this	DT
cord-005453-4057qib7	3728	19	is	be	VBZ
cord-005453-4057qib7	3728	20	followed	follow	VBN
cord-005453-4057qib7	3728	21	by	by	IN
cord-005453-4057qib7	3728	22	a	a	DT
cord-005453-4057qib7	3728	23	slow	slow	JJ
cord-005453-4057qib7	3728	24	process	process	NN
cord-005453-4057qib7	3728	25	of	of	IN
cord-005453-4057qib7	3728	26	recovery	recovery	NN
cord-005453-4057qib7	3728	27	,	,	,
cord-005453-4057qib7	3728	28	with	with	IN
cord-005453-4057qib7	3728	29	bone	bone	NN
cord-005453-4057qib7	3728	30	loss	loss	NN
cord-005453-4057qib7	3728	31	persisting	persist	VBG
cord-005453-4057qib7	3728	32	for	for	IN
cord-005453-4057qib7	3728	33	48	48	CD
cord-005453-4057qib7	3728	34	to	to	TO
cord-005453-4057qib7	3728	35	120	120	CD
cord-005453-4057qib7	3728	36	months	month	NNS
cord-005453-4057qib7	3728	37	.	.	.
cord-005453-4057qib7	3729	1	Bone	bone	NN
cord-005453-4057qib7	3729	2	fractures	fracture	NNS
cord-005453-4057qib7	3729	3	can	can	MD
cord-005453-4057qib7	3729	4	worsen	worsen	VB
cord-005453-4057qib7	3729	5	the	the	DT
cord-005453-4057qib7	3729	6	quality	quality	NN
cord-005453-4057qib7	3729	7	of	of	IN
cord-005453-4057qib7	3729	8	life	life	NN
cord-005453-4057qib7	3729	9	of	of	IN
cord-005453-4057qib7	3729	10	alloSCT	alloSCT	NNP
cord-005453-4057qib7	3729	11	survivors	survivor	NNS
cord-005453-4057qib7	3729	12	,	,	,
cord-005453-4057qib7	3729	13	but	but	CC
cord-005453-4057qib7	3729	14	the	the	DT
cord-005453-4057qib7	3729	15	real	real	JJ
cord-005453-4057qib7	3729	16	burden	burden	NN
cord-005453-4057qib7	3729	17	of	of	IN
cord-005453-4057qib7	3729	18	the	the	DT
cord-005453-4057qib7	3729	19	disease	disease	NN
cord-005453-4057qib7	3729	20	is	be	VBZ
cord-005453-4057qib7	3729	21	unknown	unknown	JJ
cord-005453-4057qib7	3729	22	.	.	.
cord-005453-4057qib7	3730	1	The	the	DT
cord-005453-4057qib7	3730	2	objective	objective	NN
cord-005453-4057qib7	3730	3	of	of	IN
cord-005453-4057qib7	3730	4	the	the	DT
cord-005453-4057qib7	3730	5	study	study	NN
cord-005453-4057qib7	3730	6	is	be	VBZ
cord-005453-4057qib7	3730	7	to	to	TO
cord-005453-4057qib7	3730	8	ascertain	ascertain	VB
cord-005453-4057qib7	3730	9	the	the	DT
cord-005453-4057qib7	3730	10	prevalence	prevalence	NN
cord-005453-4057qib7	3730	11	of	of	IN
cord-005453-4057qib7	3730	12	bone	bone	NN
cord-005453-4057qib7	3730	13	pathology	pathology	NN
cord-005453-4057qib7	3730	14	and	and	CC
cord-005453-4057qib7	3730	15	vertebral	vertebral	JJ
cord-005453-4057qib7	3730	16	fractures	fracture	NNS
cord-005453-4057qib7	3730	17	early	early	RB
cord-005453-4057qib7	3730	18	after	after	IN
cord-005453-4057qib7	3730	19	transplant	transplant	NN
cord-005453-4057qib7	3730	20	in	in	IN
cord-005453-4057qib7	3730	21	our	-PRON-	PRP$
cord-005453-4057qib7	3730	22	center	center	NN
cord-005453-4057qib7	3730	23	.	.	.
cord-005453-4057qib7	3731	1	Methods	method	NNS
cord-005453-4057qib7	3731	2	:	:	:
cord-005453-4057qib7	3731	3	This	this	DT
cord-005453-4057qib7	3731	4	is	be	VBZ
cord-005453-4057qib7	3731	5	a	a	DT
cord-005453-4057qib7	3731	6	retrospective	retrospective	JJ
cord-005453-4057qib7	3731	7	and	and	CC
cord-005453-4057qib7	3731	8	observational	observational	JJ
cord-005453-4057qib7	3731	9	study	study	NN
cord-005453-4057qib7	3731	10	.	.	.
cord-005453-4057qib7	3732	1	Forty	forty	CD
cord-005453-4057qib7	3732	2	-	-	HYPH
cord-005453-4057qib7	3732	3	nine	nine	CD
cord-005453-4057qib7	3732	4	patients	patient	NNS
cord-005453-4057qib7	3732	5	(	(	-LRB-
cord-005453-4057qib7	3732	6	25	25	CD
cord-005453-4057qib7	3732	7	male/24	male/24	NNP
cord-005453-4057qib7	3732	8	female	female	JJ
cord-005453-4057qib7	3732	9	,	,	,
cord-005453-4057qib7	3732	10	median	median	JJ
cord-005453-4057qib7	3732	11	age	age	NN
cord-005453-4057qib7	3732	12	54y	54y	NNS
cord-005453-4057qib7	3732	13	,	,	,
cord-005453-4057qib7	3732	14	range	range	VBP
cord-005453-4057qib7	3732	15	19	19	CD
cord-005453-4057qib7	3732	16	-	-	SYM
cord-005453-4057qib7	3732	17	69	69	CD
cord-005453-4057qib7	3732	18	)	)	-RRB-
cord-005453-4057qib7	3732	19	that	that	WDT
cord-005453-4057qib7	3732	20	underwent	undergo	VBD
cord-005453-4057qib7	3732	21	alloSCT	alloSCT	NNP
cord-005453-4057qib7	3732	22	were	be	VBD
cord-005453-4057qib7	3732	23	included	include	VBN
cord-005453-4057qib7	3732	24	in	in	IN
cord-005453-4057qib7	3732	25	the	the	DT
cord-005453-4057qib7	3732	26	study	study	NN
cord-005453-4057qib7	3732	27	in	in	IN
cord-005453-4057qib7	3732	28	the	the	DT
cord-005453-4057qib7	3732	29	period	period	NN
cord-005453-4057qib7	3732	30	of	of	IN
cord-005453-4057qib7	3732	31	6	6	CD
cord-005453-4057qib7	3732	32	to	to	TO
cord-005453-4057qib7	3732	33	24	24	CD
cord-005453-4057qib7	3732	34	months	month	NNS
cord-005453-4057qib7	3732	35	after	after	IN
cord-005453-4057qib7	3732	36	transplant	transplant	NN
cord-005453-4057qib7	3732	37	(	(	-LRB-
cord-005453-4057qib7	3732	38	May	May	NNP
cord-005453-4057qib7	3732	39	2016-December	2016-december	CD
cord-005453-4057qib7	3732	40	2017	2017	CD
cord-005453-4057qib7	3732	41	)	)	-RRB-
cord-005453-4057qib7	3732	42	.	.	.
cord-005453-4057qib7	3733	1	Pre	pre	JJ
cord-005453-4057qib7	3733	2	-	-	JJ
cord-005453-4057qib7	3733	3	and	and	CC
cord-005453-4057qib7	3733	4	post	post	JJ
cord-005453-4057qib7	3733	5	-	-	JJ
cord-005453-4057qib7	3733	6	transplant	transplant	JJ
cord-005453-4057qib7	3733	7	risk	risk	NN
cord-005453-4057qib7	3733	8	factors	factor	NNS
cord-005453-4057qib7	3733	9	associated	associate	VBN
cord-005453-4057qib7	3733	10	with	with	IN
cord-005453-4057qib7	3733	11	bone	bone	NN
cord-005453-4057qib7	3733	12	disease	disease	NN
cord-005453-4057qib7	3733	13	were	be	VBD
cord-005453-4057qib7	3733	14	recorded	record	VBN
cord-005453-4057qib7	3733	15	:	:	:
cord-005453-4057qib7	3734	1	age	age	NN
cord-005453-4057qib7	3734	2	>	>	XX
cord-005453-4057qib7	3734	3	65	65	CD
cord-005453-4057qib7	3734	4	years	year	NNS
cord-005453-4057qib7	3734	5	,	,	,
cord-005453-4057qib7	3734	6	female	female	JJ
cord-005453-4057qib7	3734	7	sex	sex	NN
cord-005453-4057qib7	3734	8	,	,	,
cord-005453-4057qib7	3734	9	menopause	menopause	NN
cord-005453-4057qib7	3734	10	,	,	,
cord-005453-4057qib7	3734	11	hormone	hormone	NN
cord-005453-4057qib7	3734	12	replacement	replacement	NN
cord-005453-4057qib7	3734	13	therapy	therapy	NN
cord-005453-4057qib7	3734	14	,	,	,
cord-005453-4057qib7	3734	15	previous	previous	JJ
cord-005453-4057qib7	3734	16	treatment	treatment	NN
cord-005453-4057qib7	3734	17	with	with	IN
cord-005453-4057qib7	3734	18	steroids	steroid	NNS
cord-005453-4057qib7	3734	19	,	,	,
cord-005453-4057qib7	3734	20	previous	previous	JJ
cord-005453-4057qib7	3734	21	fractures	fracture	NNS
cord-005453-4057qib7	3734	22	,	,	,
cord-005453-4057qib7	3734	23	weight	weight	NN
cord-005453-4057qib7	3734	24	<	<	XX
cord-005453-4057qib7	3734	25	40	40	CD
cord-005453-4057qib7	3734	26	kg	kg	NNS
cord-005453-4057qib7	3734	27	,	,	,
cord-005453-4057qib7	3734	28	BMI	BMI	NNP
cord-005453-4057qib7	3734	29	<	<	XX
cord-005453-4057qib7	3734	30	20	20	CD
cord-005453-4057qib7	3734	31	-	-	SYM
cord-005453-4057qib7	3734	32	25	25	CD
cord-005453-4057qib7	3734	33	,	,	,
cord-005453-4057qib7	3734	34	low	low	JJ
cord-005453-4057qib7	3734	35	physical	physical	JJ
cord-005453-4057qib7	3734	36	activity	activity	NN
cord-005453-4057qib7	3734	37	,	,	,
cord-005453-4057qib7	3734	38	low	low	JJ
cord-005453-4057qib7	3734	39	calcium	calcium	NN
cord-005453-4057qib7	3734	40	intake	intake	NN
cord-005453-4057qib7	3734	41	,	,	,
cord-005453-4057qib7	3734	42	smoking	smoking	NN
cord-005453-4057qib7	3734	43	,	,	,
cord-005453-4057qib7	3734	44	alcohol	alcohol	NN
cord-005453-4057qib7	3734	45	intake	intake	NN
cord-005453-4057qib7	3734	46	,	,	,
cord-005453-4057qib7	3734	47	and	and	CC
cord-005453-4057qib7	3734	48	history	history	NN
cord-005453-4057qib7	3734	49	of	of	IN
cord-005453-4057qib7	3734	50	femoral	femoral	JJ
cord-005453-4057qib7	3734	51	fractures	fracture	NNS
cord-005453-4057qib7	3734	52	in	in	IN
cord-005453-4057qib7	3734	53	parents	parent	NNS
cord-005453-4057qib7	3734	54	.	.	.
cord-005453-4057qib7	3735	1	In	in	IN
cord-005453-4057qib7	3735	2	all	all	DT
cord-005453-4057qib7	3735	3	patients	patient	NNS
cord-005453-4057qib7	3735	4	laboratory	laboratory	NN
cord-005453-4057qib7	3735	5	data	datum	NNS
cord-005453-4057qib7	3735	6	(	(	-LRB-
cord-005453-4057qib7	3735	7	including	include	VBG
cord-005453-4057qib7	3735	8	serum	serum	NN
cord-005453-4057qib7	3735	9	calcium	calcium	NN
cord-005453-4057qib7	3735	10	,	,	,
cord-005453-4057qib7	3735	11	25-hydroxyvitamin	25-hydroxyvitamin	CD
cord-005453-4057qib7	3735	12	D	d	NN
cord-005453-4057qib7	3735	13	,	,	,
cord-005453-4057qib7	3735	14	and	and	CC
cord-005453-4057qib7	3735	15	PTH	PTH	NNP
cord-005453-4057qib7	3735	16	)	)	-RRB-
cord-005453-4057qib7	3735	17	,	,	,
cord-005453-4057qib7	3735	18	lumbar	lumbar	NN
cord-005453-4057qib7	3735	19	and	and	CC
cord-005453-4057qib7	3735	20	femoral	femoral	JJ
cord-005453-4057qib7	3735	21	BMD	bmd	NN
cord-005453-4057qib7	3735	22	(	(	-LRB-
cord-005453-4057qib7	3735	23	DXA	DXA	NNP
cord-005453-4057qib7	3735	24	)	)	-RRB-
cord-005453-4057qib7	3735	25	,	,	,
cord-005453-4057qib7	3735	26	and	and	CC
cord-005453-4057qib7	3735	27	spinal	spinal	JJ
cord-005453-4057qib7	3735	28	x	x	NN
cord-005453-4057qib7	3735	29	-	-	NN
cord-005453-4057qib7	3735	30	ray	ray	NN
cord-005453-4057qib7	3735	31	were	be	VBD
cord-005453-4057qib7	3735	32	also	also	RB
cord-005453-4057qib7	3735	33	evaluated	evaluate	VBN
cord-005453-4057qib7	3735	34	.	.	.
cord-005453-4057qib7	3736	1	A	a	DT
cord-005453-4057qib7	3736	2	vertebral	vertebral	JJ
cord-005453-4057qib7	3736	3	fracture	fracture	NN
cord-005453-4057qib7	3736	4	was	be	VBD
cord-005453-4057qib7	3736	5	defined	define	VBN
cord-005453-4057qib7	3736	6	as	as	IN
cord-005453-4057qib7	3736	7	a	a	DT
cord-005453-4057qib7	3736	8	reduction	reduction	NN
cord-005453-4057qib7	3736	9	of	of	IN
cord-005453-4057qib7	3736	10	>	>	XX
cord-005453-4057qib7	3736	11	20	20	CD
cord-005453-4057qib7	3736	12	%	%	NN
cord-005453-4057qib7	3736	13	in	in	IN
cord-005453-4057qib7	3736	14	the	the	DT
cord-005453-4057qib7	3736	15	anterior	anterior	JJ
cord-005453-4057qib7	3736	16	,	,	,
cord-005453-4057qib7	3736	17	middle	middle	JJ
cord-005453-4057qib7	3736	18	or	or	CC
cord-005453-4057qib7	3736	19	posterior	posterior	JJ
cord-005453-4057qib7	3736	20	high	high	NN
cord-005453-4057qib7	3736	21	of	of	IN
cord-005453-4057qib7	3736	22	the	the	DT
cord-005453-4057qib7	3736	23	vertebral	vertebral	JJ
cord-005453-4057qib7	3736	24	body	body	NN
cord-005453-4057qib7	3736	25	.	.	.
cord-005453-4057qib7	3737	1	Results	result	NNS
cord-005453-4057qib7	3737	2	:	:	:
cord-005453-4057qib7	3738	1	We	-PRON-	PRP
cord-005453-4057qib7	3738	2	identified	identify	VBD
cord-005453-4057qib7	3738	3	vertebral	vertebral	JJ
cord-005453-4057qib7	3738	4	fractures	fracture	NNS
cord-005453-4057qib7	3738	5	in	in	IN
cord-005453-4057qib7	3738	6	12	12	CD
cord-005453-4057qib7	3738	7	(	(	-LRB-
cord-005453-4057qib7	3738	8	24	24	CD
cord-005453-4057qib7	3738	9	%	%	NN
cord-005453-4057qib7	3738	10	)	)	-RRB-
cord-005453-4057qib7	3738	11	patients	patient	NNS
cord-005453-4057qib7	3738	12	.	.	.
cord-005453-4057qib7	3739	1	Five	five	CD
cord-005453-4057qib7	3739	2	patients	patient	NNS
cord-005453-4057qib7	3739	3	had	have	VBD
cord-005453-4057qib7	3739	4	fractures	fracture	NNS
cord-005453-4057qib7	3739	5	prior	prior	RB
cord-005453-4057qib7	3739	6	to	to	IN
cord-005453-4057qib7	3739	7	transplantation	transplantation	NN
cord-005453-4057qib7	3739	8	,	,	,
cord-005453-4057qib7	3739	9	and	and	CC
cord-005453-4057qib7	3739	10	7	7	CD
cord-005453-4057qib7	3739	11	patients	patient	NNS
cord-005453-4057qib7	3739	12	presented	present	VBD
cord-005453-4057qib7	3739	13	"	"	``
cord-005453-4057qib7	3739	14	de	de	FW
cord-005453-4057qib7	3739	15	novo	novo	NNP
cord-005453-4057qib7	3739	16	"	"	''
cord-005453-4057qib7	3739	17	vertebral	vertebral	JJ
cord-005453-4057qib7	3739	18	fractures	fracture	NNS
cord-005453-4057qib7	3739	19	following	follow	VBG
cord-005453-4057qib7	3739	20	transplantation	transplantation	NN
cord-005453-4057qib7	3739	21	;	;	:
cord-005453-4057qib7	3739	22	therefore	therefore	RB
cord-005453-4057qib7	3739	23	,	,	,
cord-005453-4057qib7	3739	24	the	the	DT
cord-005453-4057qib7	3739	25	prevalence	prevalence	NN
cord-005453-4057qib7	3739	26	of	of	IN
cord-005453-4057qib7	3739	27	"	"	``
cord-005453-4057qib7	3739	28	de	de	FW
cord-005453-4057qib7	3739	29	novo	novo	NNP
cord-005453-4057qib7	3739	30	"	"	''
cord-005453-4057qib7	3739	31	postransplant	postransplant	NN
cord-005453-4057qib7	3739	32	fractures	fracture	NNS
cord-005453-4057qib7	3739	33	was	be	VBD
cord-005453-4057qib7	3739	34	7/49	7/49	CD
cord-005453-4057qib7	3739	35	(	(	-LRB-
cord-005453-4057qib7	3739	36	14	14	CD
cord-005453-4057qib7	3739	37	%	%	NN
cord-005453-4057qib7	3739	38	)	)	-RRB-
cord-005453-4057qib7	3739	39	.	.	.
cord-005453-4057qib7	3740	1	Most	Most	JJS
cord-005453-4057qib7	3740	2	(	(	-LRB-
cord-005453-4057qib7	3740	3	85	85	CD
cord-005453-4057qib7	3740	4	%	%	NN
cord-005453-4057qib7	3740	5	)	)	-RRB-
cord-005453-4057qib7	3740	6	of	of	IN
cord-005453-4057qib7	3740	7	these	these	DT
cord-005453-4057qib7	3740	8	fractures	fracture	NNS
cord-005453-4057qib7	3740	9	were	be	VBD
cord-005453-4057qib7	3740	10	asymptomatic	asymptomatic	JJ
cord-005453-4057qib7	3740	11	at	at	IN
cord-005453-4057qib7	3740	12	the	the	DT
cord-005453-4057qib7	3740	13	time	time	NN
cord-005453-4057qib7	3740	14	of	of	IN
cord-005453-4057qib7	3740	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	3740	16	.	.	.
cord-005453-4057qib7	3741	1	Most	Most	JJS
cord-005453-4057qib7	3741	2	patients	patient	NNS
cord-005453-4057qib7	3741	3	(	(	-LRB-
cord-005453-4057qib7	3741	4	64	64	CD
cord-005453-4057qib7	3741	5	%	%	NN
cord-005453-4057qib7	3741	6	)	)	-RRB-
cord-005453-4057qib7	3741	7	with	with	IN
cord-005453-4057qib7	3741	8	vertebral	vertebral	JJ
cord-005453-4057qib7	3741	9	fractures	fracture	NNS
cord-005453-4057qib7	3741	10	had	have	VBD
cord-005453-4057qib7	3741	11	>	>	XX
cord-005453-4057qib7	3741	12	3	3	CD
cord-005453-4057qib7	3741	13	pre	pre	JJ
cord-005453-4057qib7	3741	14	-	-	JJ
cord-005453-4057qib7	3741	15	SCT	sct	JJ
cord-005453-4057qib7	3741	16	risk	risk	NN
cord-005453-4057qib7	3741	17	factors	factor	NNS
cord-005453-4057qib7	3741	18	(	(	-LRB-
cord-005453-4057qib7	3741	19	median	median	JJ
cord-005453-4057qib7	3741	20	risk	risk	NN
cord-005453-4057qib7	3741	21	factors	factor	NNS
cord-005453-4057qib7	3741	22	pre	pre	VBP
cord-005453-4057qib7	3741	23	-	-	JJ
cord-005453-4057qib7	3741	24	SCT	SCT	NNP
cord-005453-4057qib7	3741	25	3	3	CD
cord-005453-4057qib7	3741	26	,	,	,
cord-005453-4057qib7	3741	27	range	range	NNP
cord-005453-4057qib7	3741	28	2	2	CD
cord-005453-4057qib7	3741	29	-	-	SYM
cord-005453-4057qib7	3741	30	6	6	CD
cord-005453-4057qib7	3741	31	)	)	-RRB-
cord-005453-4057qib7	3741	32	,	,	,
cord-005453-4057qib7	3741	33	the	the	DT
cord-005453-4057qib7	3741	34	most	most	RBS
cord-005453-4057qib7	3741	35	frequent	frequent	JJ
cord-005453-4057qib7	3741	36	being	be	VBG
cord-005453-4057qib7	3741	37	low	low	JJ
cord-005453-4057qib7	3741	38	calcium	calcium	NN
cord-005453-4057qib7	3741	39	intake	intake	NN
cord-005453-4057qib7	3741	40	,	,	,
cord-005453-4057qib7	3741	41	steroid	steroid	NN
cord-005453-4057qib7	3741	42	exposure	exposure	NN
cord-005453-4057qib7	3741	43	,	,	,
cord-005453-4057qib7	3741	44	presence	presence	NN
cord-005453-4057qib7	3741	45	of	of	IN
cord-005453-4057qib7	3741	46	previous	previous	JJ
cord-005453-4057qib7	3741	47	fractures	fracture	NNS
cord-005453-4057qib7	3741	48	,	,	,
cord-005453-4057qib7	3741	49	and	and	CC
cord-005453-4057qib7	3741	50	menopause	menopause	NN
cord-005453-4057qib7	3741	51	.	.	.
cord-005453-4057qib7	3742	1	Those	those	DT
cord-005453-4057qib7	3742	2	patients	patient	NNS
cord-005453-4057qib7	3742	3	with	with	IN
cord-005453-4057qib7	3742	4	fractures	fracture	NNS
cord-005453-4057qib7	3742	5	and	and	CC
cord-005453-4057qib7	3742	6	less	less	JJR
cord-005453-4057qib7	3742	7	than	than	IN
cord-005453-4057qib7	3742	8	3	3	CD
cord-005453-4057qib7	3742	9	risk	risk	NN
cord-005453-4057qib7	3742	10	factors	factor	NNS
cord-005453-4057qib7	3742	11	pre	pre	VBP
cord-005453-4057qib7	3742	12	-	-	NN
cord-005453-4057qib7	3742	13	TPH	TPH	NNP
cord-005453-4057qib7	3742	14	,	,	,
cord-005453-4057qib7	3742	15	added	add	VBD
cord-005453-4057qib7	3742	16	new	new	JJ
cord-005453-4057qib7	3742	17	risk	risk	NN
cord-005453-4057qib7	3742	18	factors	factor	NNS
cord-005453-4057qib7	3742	19	after	after	IN
cord-005453-4057qib7	3742	20	transplant	transplant	NN
cord-005453-4057qib7	3742	21	,	,	,
cord-005453-4057qib7	3742	22	mainly	mainly	RB
cord-005453-4057qib7	3742	23	steroid	steroid	JJ
cord-005453-4057qib7	3742	24	treatment	treatment	NN
cord-005453-4057qib7	3742	25	.	.	.
cord-005453-4057qib7	3743	1	Forty	forty	CD
cord-005453-4057qib7	3743	2	-	-	HYPH
cord-005453-4057qib7	3743	3	four	four	CD
cord-005453-4057qib7	3743	4	patients	patient	NNS
cord-005453-4057qib7	3743	5	(	(	-LRB-
cord-005453-4057qib7	3743	6	90	90	CD
cord-005453-4057qib7	3743	7	%	%	NN
cord-005453-4057qib7	3743	8	)	)	-RRB-
cord-005453-4057qib7	3743	9	had	have	VBD
cord-005453-4057qib7	3743	10	vitamin	vitamin	NN
cord-005453-4057qib7	3743	11	D	d	NN
cord-005453-4057qib7	3743	12	insufficiency	insufficiency	NN
cord-005453-4057qib7	3743	13	(	(	-LRB-
cord-005453-4057qib7	3743	14	<	<	NNP
cord-005453-4057qib7	3743	15	30ng	30ng	NNP
cord-005453-4057qib7	3743	16	/	/	SYM
cord-005453-4057qib7	3743	17	ml	ml	NNP
cord-005453-4057qib7	3743	18	)	)	-RRB-
cord-005453-4057qib7	3743	19	,	,	,
cord-005453-4057qib7	3743	20	15	15	CD
cord-005453-4057qib7	3743	21	(	(	-LRB-
cord-005453-4057qib7	3743	22	32	32	CD
cord-005453-4057qib7	3743	23	%	%	NN
cord-005453-4057qib7	3743	24	)	)	-RRB-
cord-005453-4057qib7	3743	25	had	have	VBD
cord-005453-4057qib7	3743	26	osteopenia	osteopenia	VBN
cord-005453-4057qib7	3743	27	and	and	CC
cord-005453-4057qib7	3743	28	9	9	CD
cord-005453-4057qib7	3743	29	(	(	-LRB-
cord-005453-4057qib7	3743	30	18	18	CD
cord-005453-4057qib7	3743	31	%	%	NN
cord-005453-4057qib7	3743	32	)	)	-RRB-
cord-005453-4057qib7	3743	33	had	have	VBD
cord-005453-4057qib7	3743	34	osteoporosis	osteoporosis	NN
cord-005453-4057qib7	3743	35	.	.	.
cord-005453-4057qib7	3744	1	Vitamin	vitamin	NN
cord-005453-4057qib7	3744	2	D	d	NN
cord-005453-4057qib7	3744	3	insufficiency	insufficiency	NN
cord-005453-4057qib7	3744	4	and	and	CC
cord-005453-4057qib7	3744	5	bone	bone	NN
cord-005453-4057qib7	3744	6	disease	disease	NN
cord-005453-4057qib7	3744	7	were	be	VBD
cord-005453-4057qib7	3744	8	more	more	RBR
cord-005453-4057qib7	3744	9	frequent	frequent	JJ
cord-005453-4057qib7	3744	10	in	in	IN
cord-005453-4057qib7	3744	11	women	woman	NNS
cord-005453-4057qib7	3744	12	than	than	IN
cord-005453-4057qib7	3744	13	in	in	IN
cord-005453-4057qib7	3744	14	men	man	NNS
cord-005453-4057qib7	3744	15	(	(	-LRB-
cord-005453-4057qib7	3744	16	98	98	CD
cord-005453-4057qib7	3744	17	%	%	NN
cord-005453-4057qib7	3744	18	vs.	vs.	IN
cord-005453-4057qib7	3744	19	84	84	CD
cord-005453-4057qib7	3744	20	%	%	NN
cord-005453-4057qib7	3744	21	for	for	IN
cord-005453-4057qib7	3744	22	vitamin	vitamin	NN
cord-005453-4057qib7	3744	23	D	d	NN
cord-005453-4057qib7	3744	24	,	,	,
cord-005453-4057qib7	3744	25	37	37	CD
cord-005453-4057qib7	3744	26	%	%	NN
cord-005453-4057qib7	3744	27	vs.	vs.	IN
cord-005453-4057qib7	3744	28	28	28	CD
cord-005453-4057qib7	3744	29	%	%	NN
cord-005453-4057qib7	3744	30	for	for	IN
cord-005453-4057qib7	3744	31	osteopenia	osteopenia	NN
cord-005453-4057qib7	3744	32	,	,	,
cord-005453-4057qib7	3744	33	29	29	CD
cord-005453-4057qib7	3744	34	%	%	NN
cord-005453-4057qib7	3744	35	vs.	vs.	IN
cord-005453-4057qib7	3744	36	8	8	CD
cord-005453-4057qib7	3744	37	%	%	NN
cord-005453-4057qib7	3744	38	for	for	IN
cord-005453-4057qib7	3744	39	osteoporosis	osteoporosis	NN
cord-005453-4057qib7	3744	40	,	,	,
cord-005453-4057qib7	3744	41	and	and	CC
cord-005453-4057qib7	3744	42	25	25	CD
cord-005453-4057qib7	3744	43	%	%	NN
cord-005453-4057qib7	3744	44	vs.	vs.	CC
cord-005453-4057qib7	3744	45	20	20	CD
cord-005453-4057qib7	3744	46	%	%	NN
cord-005453-4057qib7	3744	47	for	for	IN
cord-005453-4057qib7	3744	48	vertebral	vertebral	JJ
cord-005453-4057qib7	3744	49	fractures	fracture	NNS
cord-005453-4057qib7	3744	50	,	,	,
cord-005453-4057qib7	3744	51	respectively	respectively	RB
cord-005453-4057qib7	3744	52	)	)	-RRB-
cord-005453-4057qib7	3744	53	.	.	.
cord-005453-4057qib7	3745	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3745	2	:	:	:
cord-005453-4057qib7	3746	1	The	the	DT
cord-005453-4057qib7	3746	2	prevalence	prevalence	NN
cord-005453-4057qib7	3746	3	of	of	IN
cord-005453-4057qib7	3746	4	post	post	JJ
cord-005453-4057qib7	3746	5	-	-	JJ
cord-005453-4057qib7	3746	6	transplant	transplant	JJ
cord-005453-4057qib7	3746	7	bone	bone	NN
cord-005453-4057qib7	3746	8	disease	disease	NN
cord-005453-4057qib7	3746	9	and	and	CC
cord-005453-4057qib7	3746	10	vertebral	vertebral	JJ
cord-005453-4057qib7	3746	11	fractures	fracture	NNS
cord-005453-4057qib7	3746	12	in	in	IN
cord-005453-4057qib7	3746	13	our	-PRON-	PRP$
cord-005453-4057qib7	3746	14	series	series	NN
cord-005453-4057qib7	3746	15	is	be	VBZ
cord-005453-4057qib7	3746	16	high	high	JJ
cord-005453-4057qib7	3746	17	.	.	.
cord-005453-4057qib7	3747	1	Most	Most	JJS
cord-005453-4057qib7	3747	2	fractures	fracture	NNS
cord-005453-4057qib7	3747	3	appearing	appear	VBG
cord-005453-4057qib7	3747	4	"	"	``
cord-005453-4057qib7	3747	5	de	de	FW
cord-005453-4057qib7	3747	6	novo	novo	NNP
cord-005453-4057qib7	3747	7	"	"	''
cord-005453-4057qib7	3747	8	after	after	IN
cord-005453-4057qib7	3747	9	alloSCT	alloSCT	NNP
cord-005453-4057qib7	3747	10	were	be	VBD
cord-005453-4057qib7	3747	11	asymptomatic	asymptomatic	JJ
cord-005453-4057qib7	3747	12	and	and	CC
cord-005453-4057qib7	3747	13	were	be	VBD
cord-005453-4057qib7	3747	14	diagnosed	diagnose	VBN
cord-005453-4057qib7	3747	15	by	by	IN
cord-005453-4057qib7	3747	16	x	x	NN
cord-005453-4057qib7	3747	17	-	-	NN
cord-005453-4057qib7	3747	18	ray	ray	NN
cord-005453-4057qib7	3747	19	.	.	.
cord-005453-4057qib7	3748	1	Patients	patient	NNS
cord-005453-4057qib7	3748	2	who	who	WP
cord-005453-4057qib7	3748	3	presented	present	VBD
cord-005453-4057qib7	3748	4	vertebral	vertebral	JJ
cord-005453-4057qib7	3748	5	fractures	fracture	NNS
cord-005453-4057qib7	3748	6	frequently	frequently	RB
cord-005453-4057qib7	3748	7	had	have	VBD
cord-005453-4057qib7	3748	8	more	more	JJR
cord-005453-4057qib7	3748	9	than	than	IN
cord-005453-4057qib7	3748	10	3	3	CD
cord-005453-4057qib7	3748	11	risk	risk	NN
cord-005453-4057qib7	3748	12	factors	factor	NNS
cord-005453-4057qib7	3748	13	identified	identify	VBD
cord-005453-4057qib7	3748	14	pre	pre	JJ
cord-005453-4057qib7	3748	15	-	-	JJ
cord-005453-4057qib7	3748	16	SCT	SCT	NNP
cord-005453-4057qib7	3748	17	.	.	.
cord-005453-4057qib7	3749	1	Patients	patient	NNS
cord-005453-4057qib7	3749	2	undergoing	undergo	VBG
cord-005453-4057qib7	3749	3	alloSCT	alloSCT	NNP
cord-005453-4057qib7	3749	4	should	should	MD
cord-005453-4057qib7	3749	5	have	have	VB
cord-005453-4057qib7	3749	6	their	-PRON-	PRP$
cord-005453-4057qib7	3749	7	bone	bone	NN
cord-005453-4057qib7	3749	8	health	health	NN
cord-005453-4057qib7	3749	9	assessed	assess	VBN
cord-005453-4057qib7	3749	10	early	early	RB
cord-005453-4057qib7	3749	11	in	in	IN
cord-005453-4057qib7	3749	12	their	-PRON-	PRP$
cord-005453-4057qib7	3749	13	treatment	treatment	NN
cord-005453-4057qib7	3749	14	and	and	CC
cord-005453-4057qib7	3749	15	,	,	,
cord-005453-4057qib7	3749	16	if	if	IN
cord-005453-4057qib7	3749	17	indicated	indicate	VBN
cord-005453-4057qib7	3749	18	,	,	,
cord-005453-4057qib7	3749	19	should	should	MD
cord-005453-4057qib7	3749	20	start	start	VB
cord-005453-4057qib7	3749	21	preventative	preventative	JJ
cord-005453-4057qib7	3749	22	therapy	therapy	NN
cord-005453-4057qib7	3749	23	to	to	TO
cord-005453-4057qib7	3749	24	avoid	avoid	VB
cord-005453-4057qib7	3749	25	bone	bone	NN
cord-005453-4057qib7	3749	26	loss	loss	NN
cord-005453-4057qib7	3749	27	and	and	CC
cord-005453-4057qib7	3749	28	fractures	fracture	NNS
cord-005453-4057qib7	3749	29	.	.	.
cord-005453-4057qib7	3750	1	Other	other	JJ
cord-005453-4057qib7	3750	2	measures	measure	NNS
cord-005453-4057qib7	3750	3	such	such	JJ
cord-005453-4057qib7	3750	4	as	as	IN
cord-005453-4057qib7	3750	5	physical	physical	JJ
cord-005453-4057qib7	3750	6	exercise	exercise	NN
cord-005453-4057qib7	3750	7	,	,	,
cord-005453-4057qib7	3750	8	vitamin	vitamin	NN
cord-005453-4057qib7	3750	9	D	d	NN
cord-005453-4057qib7	3750	10	and	and	CC
cord-005453-4057qib7	3750	11	calcium	calcium	NN
cord-005453-4057qib7	3750	12	supplementation	supplementation	NN
cord-005453-4057qib7	3750	13	,	,	,
cord-005453-4057qib7	3750	14	and	and	CC
cord-005453-4057qib7	3750	15	DXA	DXA	NNP
cord-005453-4057qib7	3750	16	and	and	CC
cord-005453-4057qib7	3750	17	spinal	spinal	JJ
cord-005453-4057qib7	3750	18	x	x	NN
cord-005453-4057qib7	3750	19	-	-	NN
cord-005453-4057qib7	3750	20	ray	ray	NN
cord-005453-4057qib7	3750	21	at	at	IN
cord-005453-4057qib7	3750	22	baseline	baseline	NN
cord-005453-4057qib7	3750	23	and	and	CC
cord-005453-4057qib7	3750	24	following	follow	VBG
cord-005453-4057qib7	3750	25	transplantation	transplantation	NN
cord-005453-4057qib7	3750	26	are	be	VBP
cord-005453-4057qib7	3750	27	also	also	RB
cord-005453-4057qib7	3750	28	highly	highly	RB
cord-005453-4057qib7	3750	29	recommended	recommend	VBN
cord-005453-4057qib7	3750	30	.	.	.
cord-005453-4057qib7	3751	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3751	2	:	:	:
cord-005453-4057qib7	3752	1	María	María	NNP
cord-005453-4057qib7	3752	2	Suárez	Suárez	NNP
cord-005453-4057qib7	3752	3	-	-	HYPH
cord-005453-4057qib7	3752	4	Lledó	Lledó	NNP
cord-005453-4057qib7	3752	5	received	receive	VBD
cord-005453-4057qib7	3752	6	a	a	DT
cord-005453-4057qib7	3752	7	grant	grant	NN
cord-005453-4057qib7	3752	8	from	from	IN
cord-005453-4057qib7	3752	9	DKMS	DKMS	NNP
cord-005453-4057qib7	3752	10	-	-	HYPH
cord-005453-4057qib7	3752	11	Spain	Spain	NNP
cord-005453-4057qib7	3752	12	Foundation	Foundation	NNP
cord-005453-4057qib7	3752	13	.	.	.
cord-005453-4057qib7	3753	1	Other	other	JJ
cord-005453-4057qib7	3753	2	Authors	author	NNS
cord-005453-4057qib7	3753	3	have	have	VBP
cord-005453-4057qib7	3753	4	Nothing	nothing	NN
cord-005453-4057qib7	3753	5	to	to	TO
cord-005453-4057qib7	3753	6	declare	declare	VB
cord-005453-4057qib7	3753	7	The	the	DT
cord-005453-4057qib7	3753	8	use	use	NN
cord-005453-4057qib7	3753	9	of	of	IN
cord-005453-4057qib7	3753	10	G	G	NNP
cord-005453-4057qib7	3753	11	-	-	HYPH
cord-005453-4057qib7	3753	12	CSF	CSF	NNP
cord-005453-4057qib7	3753	13	in	in	IN
cord-005453-4057qib7	3753	14	selected	select	VBN
cord-005453-4057qib7	3753	15	patients	patient	NNS
cord-005453-4057qib7	3753	16	after	after	IN
cord-005453-4057qib7	3753	17	autologous	autologous	JJ
cord-005453-4057qib7	3753	18	stem	stem	NN
cord-005453-4057qib7	3753	19	cell	cell	NN
cord-005453-4057qib7	3753	20	transplantation	transplantation	NN
cord-005453-4057qib7	3753	21	is	be	VBZ
cord-005453-4057qib7	3753	22	associated	associate	VBN
cord-005453-4057qib7	3753	23	with	with	IN
cord-005453-4057qib7	3753	24	low	low	JJ
cord-005453-4057qib7	3753	25	incidence	incidence	NN
cord-005453-4057qib7	3753	26	of	of	IN
cord-005453-4057qib7	3753	27	engraftment	engraftment	NN
cord-005453-4057qib7	3753	28	syndrome	syndrome	NN
cord-005453-4057qib7	3753	29	Background	Background	NNP
cord-005453-4057qib7	3753	30	:	:	:
cord-005453-4057qib7	3754	1	The	the	DT
cord-005453-4057qib7	3754	2	use	use	NN
cord-005453-4057qib7	3754	3	of	of	IN
cord-005453-4057qib7	3754	4	G	G	NNP
cord-005453-4057qib7	3754	5	-	-	HYPH
cord-005453-4057qib7	3754	6	CSF	CSF	NNP
cord-005453-4057qib7	3754	7	after	after	IN
cord-005453-4057qib7	3754	8	autologous	autologous	JJ
cord-005453-4057qib7	3754	9	stem	stem	NN
cord-005453-4057qib7	3754	10	cell	cell	NN
cord-005453-4057qib7	3754	11	transplantation	transplantation	NN
cord-005453-4057qib7	3754	12	(	(	-LRB-
cord-005453-4057qib7	3754	13	ASCT	ASCT	NNP
cord-005453-4057qib7	3754	14	)	)	-RRB-
cord-005453-4057qib7	3754	15	accelerates	accelerate	VBZ
cord-005453-4057qib7	3754	16	neutrophil	neutrophil	NN
cord-005453-4057qib7	3754	17	recovery	recovery	NN
cord-005453-4057qib7	3754	18	,	,	,
cord-005453-4057qib7	3754	19	however	however	RB
cord-005453-4057qib7	3754	20	it	-PRON-	PRP
cord-005453-4057qib7	3754	21	has	have	VBZ
cord-005453-4057qib7	3754	22	been	be	VBN
cord-005453-4057qib7	3754	23	related	relate	VBN
cord-005453-4057qib7	3754	24	to	to	IN
cord-005453-4057qib7	3754	25	an	an	DT
cord-005453-4057qib7	3754	26	increased	increase	VBN
cord-005453-4057qib7	3754	27	risk	risk	NN
cord-005453-4057qib7	3754	28	of	of	IN
cord-005453-4057qib7	3754	29	engraftment	engraftment	NNP
cord-005453-4057qib7	3754	30	syndrome	syndrome	NN
cord-005453-4057qib7	3754	31	(	(	-LRB-
cord-005453-4057qib7	3754	32	ES	ES	NNP
cord-005453-4057qib7	3754	33	)	)	-RRB-
cord-005453-4057qib7	3754	34	development	development	NN
cord-005453-4057qib7	3754	35	in	in	IN
cord-005453-4057qib7	3754	36	some	some	DT
cord-005453-4057qib7	3754	37	studies	study	NNS
cord-005453-4057qib7	3754	38	.	.	.
cord-005453-4057qib7	3755	1	For	for	IN
cord-005453-4057qib7	3755	2	this	this	DT
cord-005453-4057qib7	3755	3	reason	reason	NN
cord-005453-4057qib7	3755	4	,	,	,
cord-005453-4057qib7	3755	5	we	-PRON-	PRP
cord-005453-4057qib7	3755	6	do	do	VBP
cord-005453-4057qib7	3755	7	not	not	RB
cord-005453-4057qib7	3755	8	routinely	routinely	RB
cord-005453-4057qib7	3755	9	prescribe	prescribe	VB
cord-005453-4057qib7	3755	10	G	G	NNP
cord-005453-4057qib7	3755	11	-	-	HYPH
cord-005453-4057qib7	3755	12	CSF	CSF	NNP
cord-005453-4057qib7	3755	13	after	after	IN
cord-005453-4057qib7	3755	14	ASCT	ASCT	NNP
cord-005453-4057qib7	3756	1	and	and	CC
cord-005453-4057qib7	3756	2	we	-PRON-	PRP
cord-005453-4057qib7	3756	3	only	only	RB
cord-005453-4057qib7	3756	4	use	use	VBP
cord-005453-4057qib7	3756	5	it	-PRON-	PRP
cord-005453-4057qib7	3756	6	in	in	IN
cord-005453-4057qib7	3756	7	patients	patient	NNS
cord-005453-4057qib7	3756	8	with	with	IN
cord-005453-4057qib7	3756	9	significant	significant	JJ
cord-005453-4057qib7	3756	10	complications	complication	NNS
cord-005453-4057qib7	3756	11	(	(	-LRB-
cord-005453-4057qib7	3756	12	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	3756	13	,	,	,
cord-005453-4057qib7	3756	14	severe	severe	JJ
cord-005453-4057qib7	3756	15	sepsis	sepsis	NN
cord-005453-4057qib7	3756	16	,	,	,
cord-005453-4057qib7	3756	17	atrial	atrial	JJ
cord-005453-4057qib7	3756	18	fibrillation	fibrillation	NN
cord-005453-4057qib7	3756	19	)	)	-RRB-
cord-005453-4057qib7	3756	20	after	after	IN
cord-005453-4057qib7	3756	21	stem	stem	NN
cord-005453-4057qib7	3756	22	cell	cell	NN
cord-005453-4057qib7	3756	23	infusion	infusion	NN
cord-005453-4057qib7	3756	24	.	.	.
cord-005453-4057qib7	3757	1	The	the	DT
cord-005453-4057qib7	3757	2	main	main	JJ
cord-005453-4057qib7	3757	3	objective	objective	NN
cord-005453-4057qib7	3757	4	of	of	IN
cord-005453-4057qib7	3757	5	this	this	DT
cord-005453-4057qib7	3757	6	study	study	NN
cord-005453-4057qib7	3757	7	is	be	VBZ
cord-005453-4057qib7	3757	8	to	to	TO
cord-005453-4057qib7	3757	9	evaluate	evaluate	VB
cord-005453-4057qib7	3757	10	the	the	DT
cord-005453-4057qib7	3757	11	incidence	incidence	NN
cord-005453-4057qib7	3757	12	of	of	IN
cord-005453-4057qib7	3757	13	ES	ES	NNP
cord-005453-4057qib7	3757	14	in	in	IN
cord-005453-4057qib7	3757	15	patients	patient	NNS
cord-005453-4057qib7	3757	16	who	who	WP
cord-005453-4057qib7	3757	17	receive	receive	VBP
cord-005453-4057qib7	3757	18	ASCT	ASCT	NNP
cord-005453-4057qib7	3757	19	for	for	IN
cord-005453-4057qib7	3757	20	monoclonal	monoclonal	JJ
cord-005453-4057qib7	3757	21	gammopathies	gammopathy	NNS
cord-005453-4057qib7	3757	22	(	(	-LRB-
cord-005453-4057qib7	3757	23	MG	MG	NNP
cord-005453-4057qib7	3757	24	)	)	-RRB-
cord-005453-4057qib7	3757	25	,	,	,
cord-005453-4057qib7	3757	26	non	non	JJ
cord-005453-4057qib7	3757	27	-	-	JJ
cord-005453-4057qib7	3757	28	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	3757	29	lymphoma	lymphoma	NN
cord-005453-4057qib7	3757	30	(	(	-LRB-
cord-005453-4057qib7	3757	31	NHL	NHL	NNP
cord-005453-4057qib7	3757	32	)	)	-RRB-
cord-005453-4057qib7	3757	33	and	and	CC
cord-005453-4057qib7	3757	34	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	3757	35	lymphoma	lymphoma	NN
cord-005453-4057qib7	3757	36	(	(	-LRB-
cord-005453-4057qib7	3757	37	HL	HL	NNP
cord-005453-4057qib7	3757	38	)	)	-RRB-
cord-005453-4057qib7	3757	39	and	and	CC
cord-005453-4057qib7	3757	40	receive	receive	VB
cord-005453-4057qib7	3757	41	G	G	NNP
cord-005453-4057qib7	3757	42	-	-	HYPH
cord-005453-4057qib7	3757	43	CSF	CSF	NNP
cord-005453-4057qib7	3757	44	only	only	RB
cord-005453-4057qib7	3757	45	if	if	IN
cord-005453-4057qib7	3757	46	needed	need	VBN
cord-005453-4057qib7	3757	47	.	.	.
cord-005453-4057qib7	3758	1	As	as	IN
cord-005453-4057qib7	3758	2	secondary	secondary	JJ
cord-005453-4057qib7	3758	3	objectives	objective	NNS
cord-005453-4057qib7	3758	4	we	-PRON-	PRP
cord-005453-4057qib7	3758	5	evaluate	evaluate	VBP
cord-005453-4057qib7	3758	6	differences	difference	NNS
cord-005453-4057qib7	3758	7	in	in	IN
cord-005453-4057qib7	3758	8	the	the	DT
cord-005453-4057qib7	3758	9	engraftment	engraftment	NNP
cord-005453-4057qib7	3758	10	day	day	NNP
cord-005453-4057qib7	3758	11	as	as	RB
cord-005453-4057qib7	3758	12	well	well	RB
cord-005453-4057qib7	3758	13	as	as	IN
cord-005453-4057qib7	3758	14	the	the	DT
cord-005453-4057qib7	3758	15	length	length	NN
cord-005453-4057qib7	3758	16	of	of	IN
cord-005453-4057qib7	3758	17	inpatient	inpatient	JJ
cord-005453-4057qib7	3758	18	stay	stay	NN
cord-005453-4057qib7	3758	19	.	.	.
cord-005453-4057qib7	3759	1	Methods	method	NNS
cord-005453-4057qib7	3759	2	:	:	:
cord-005453-4057qib7	3759	3	We	-PRON-	PRP
cord-005453-4057qib7	3759	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	3759	5	analyzed	analyze	VBD
cord-005453-4057qib7	3759	6	patients	patient	NNS
cord-005453-4057qib7	3759	7	with	with	IN
cord-005453-4057qib7	3759	8	MG	MG	NNP
cord-005453-4057qib7	3759	9	or	or	CC
cord-005453-4057qib7	3759	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	3759	11	,	,	,
cord-005453-4057qib7	3759	12	who	who	WP
cord-005453-4057qib7	3759	13	underwent	undergo	VBD
cord-005453-4057qib7	3759	14	ASCT	ASCT	NNP
cord-005453-4057qib7	3759	15	conditioned	condition	VBN
cord-005453-4057qib7	3759	16	with	with	IN
cord-005453-4057qib7	3759	17	high	high	JJ
cord-005453-4057qib7	3759	18	dose	dose	NN
cord-005453-4057qib7	3759	19	melphalan	melphalan	NN
cord-005453-4057qib7	3759	20	(	(	-LRB-
cord-005453-4057qib7	3759	21	140	140	CD
cord-005453-4057qib7	3759	22	-	-	SYM
cord-005453-4057qib7	3759	23	200	200	CD
cord-005453-4057qib7	3759	24	mg	mg	NNP
cord-005453-4057qib7	3759	25	/	/	SYM
cord-005453-4057qib7	3759	26	m	m	NNP
cord-005453-4057qib7	3759	27	2	2	CD
cord-005453-4057qib7	3759	28	)	)	-RRB-
cord-005453-4057qib7	3759	29	or	or	CC
cord-005453-4057qib7	3759	30	BEAM	beam	NN
cord-005453-4057qib7	3759	31	,	,	,
cord-005453-4057qib7	3759	32	respectively	respectively	RB
cord-005453-4057qib7	3759	33	,	,	,
cord-005453-4057qib7	3759	34	between	between	IN
cord-005453-4057qib7	3759	35	2015	2015	CD
cord-005453-4057qib7	3759	36	and	and	CC
cord-005453-4057qib7	3759	37	2017	2017	CD
cord-005453-4057qib7	3759	38	in	in	IN
cord-005453-4057qib7	3759	39	our	-PRON-	PRP$
cord-005453-4057qib7	3759	40	center	center	NN
cord-005453-4057qib7	3759	41	.	.	.
cord-005453-4057qib7	3760	1	Specific	specific	JJ
cord-005453-4057qib7	3760	2	clinical	clinical	JJ
cord-005453-4057qib7	3760	3	features	feature	NNS
cord-005453-4057qib7	3760	4	for	for	IN
cord-005453-4057qib7	3760	5	ES	ES	NNP
cord-005453-4057qib7	3760	6	according	accord	VBG
cord-005453-4057qib7	3760	7	to	to	IN
cord-005453-4057qib7	3760	8	Spitzer	Spitzer	NNP
cord-005453-4057qib7	3760	9	and	and	CC
cord-005453-4057qib7	3760	10	Maiolino	Maiolino	NNP
cord-005453-4057qib7	3760	11	criteria	criterion	NNS
cord-005453-4057qib7	3760	12	were	be	VBD
cord-005453-4057qib7	3760	13	evaluated	evaluate	VBN
cord-005453-4057qib7	3760	14	between	between	IN
cord-005453-4057qib7	3760	15	3	3	CD
cord-005453-4057qib7	3760	16	days	day	NNS
cord-005453-4057qib7	3760	17	before	before	RB
cord-005453-4057qib7	3760	18	and	and	CC
cord-005453-4057qib7	3760	19	7	7	CD
cord-005453-4057qib7	3760	20	days	day	NNS
cord-005453-4057qib7	3760	21	after	after	IN
cord-005453-4057qib7	3760	22	the	the	DT
cord-005453-4057qib7	3760	23	engraftment	engraftment	NN
cord-005453-4057qib7	3760	24	.	.	.
cord-005453-4057qib7	3761	1	Statistical	statistical	JJ
cord-005453-4057qib7	3761	2	analysis	analysis	NN
cord-005453-4057qib7	3761	3	was	be	VBD
cord-005453-4057qib7	3761	4	performed	perform	VBN
cord-005453-4057qib7	3761	5	with	with	IN
cord-005453-4057qib7	3761	6	SPSS	SPSS	NNP
cord-005453-4057qib7	3761	7	v.	v.	NNP
cord-005453-4057qib7	3761	8	15.0	15.0	CD
cord-005453-4057qib7	3761	9	.	.	.
cord-005453-4057qib7	3762	1	Results	result	NNS
cord-005453-4057qib7	3762	2	:	:	:
cord-005453-4057qib7	3763	1	Thirty	thirty	CD
cord-005453-4057qib7	3763	2	-	-	HYPH
cord-005453-4057qib7	3763	3	one	one	CD
cord-005453-4057qib7	3763	4	patients	patient	NNS
cord-005453-4057qib7	3763	5	with	with	IN
cord-005453-4057qib7	3763	6	MG	MG	NNP
cord-005453-4057qib7	3763	7	and	and	CC
cord-005453-4057qib7	3763	8	34	34	CD
cord-005453-4057qib7	3763	9	patients	patient	NNS
cord-005453-4057qib7	3763	10	with	with	IN
cord-005453-4057qib7	3763	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	3763	12	were	be	VBD
cord-005453-4057qib7	3763	13	analyzed	analyze	VBN
cord-005453-4057qib7	3763	14	.	.	.
cord-005453-4057qib7	3764	1	Median	median	JJ
cord-005453-4057qib7	3764	2	age	age	NN
cord-005453-4057qib7	3764	3	at	at	IN
cord-005453-4057qib7	3764	4	transplant	transplant	NN
cord-005453-4057qib7	3764	5	was	be	VBD
cord-005453-4057qib7	3764	6	56.8	56.8	CD
cord-005453-4057qib7	3764	7	years	year	NNS
cord-005453-4057qib7	3764	8	(	(	-LRB-
cord-005453-4057qib7	3764	9	48.7	48.7	CD
cord-005453-4057qib7	3764	10	-	-	HYPH
cord-005453-4057qib7	3764	11	65.4	65.4	CD
cord-005453-4057qib7	3764	12	)	)	-RRB-
cord-005453-4057qib7	3764	13	and	and	CC
cord-005453-4057qib7	3764	14	41	41	CD
cord-005453-4057qib7	3764	15	patients	patient	NNS
cord-005453-4057qib7	3764	16	(	(	-LRB-
cord-005453-4057qib7	3764	17	63.1	63.1	CD
cord-005453-4057qib7	3764	18	%	%	NN
cord-005453-4057qib7	3764	19	)	)	-RRB-
cord-005453-4057qib7	3764	20	were	be	VBD
cord-005453-4057qib7	3764	21	male	male	JJ
cord-005453-4057qib7	3764	22	.	.	.
cord-005453-4057qib7	3765	1	Median	median	JJ
cord-005453-4057qib7	3765	2	prior	prior	JJ
cord-005453-4057qib7	3765	3	lines	line	NNS
cord-005453-4057qib7	3765	4	of	of	IN
cord-005453-4057qib7	3765	5	treatment	treatment	NN
cord-005453-4057qib7	3765	6	in	in	IN
cord-005453-4057qib7	3765	7	patients	patient	NNS
cord-005453-4057qib7	3765	8	with	with	IN
cord-005453-4057qib7	3765	9	GM	GM	NNP
cord-005453-4057qib7	3765	10	or	or	CC
cord-005453-4057qib7	3765	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	3765	12	were	be	VBD
cord-005453-4057qib7	3765	13	1	1	CD
cord-005453-4057qib7	3765	14	(	(	-LRB-
cord-005453-4057qib7	3765	15	1	1	CD
cord-005453-4057qib7	3765	16	-	-	SYM
cord-005453-4057qib7	3765	17	3	3	CD
cord-005453-4057qib7	3765	18	)	)	-RRB-
cord-005453-4057qib7	3765	19	and	and	CC
cord-005453-4057qib7	3765	20	2	2	LS
cord-005453-4057qib7	3765	21	(	(	-LRB-
cord-005453-4057qib7	3765	22	1	1	CD
cord-005453-4057qib7	3765	23	-	-	SYM
cord-005453-4057qib7	3765	24	5	5	CD
cord-005453-4057qib7	3765	25	)	)	-RRB-
cord-005453-4057qib7	3765	26	,	,	,
cord-005453-4057qib7	3765	27	respectively	respectively	RB
cord-005453-4057qib7	3765	28	.	.	.
cord-005453-4057qib7	3766	1	Table	table	NN
cord-005453-4057qib7	3766	2	 	 	_SP
cord-005453-4057qib7	3766	3	1	1	CD
cord-005453-4057qib7	3766	4	shows	show	VBZ
cord-005453-4057qib7	3766	5	patients´characteristics	patients´characteristic	NNS
cord-005453-4057qib7	3766	6	.	.	.
cord-005453-4057qib7	3767	1	Mobilization	mobilization	NN
cord-005453-4057qib7	3767	2	with	with	IN
cord-005453-4057qib7	3767	3	G	G	NNP
cord-005453-4057qib7	3767	4	-	-	HYPH
cord-005453-4057qib7	3767	5	CSF	CSF	NNP
cord-005453-4057qib7	3767	6	±	±	NNP
cord-005453-4057qib7	3767	7	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	3767	8	was	be	VBD
cord-005453-4057qib7	3767	9	performed	perform	VBN
cord-005453-4057qib7	3767	10	in	in	IN
cord-005453-4057qib7	3767	11	27	27	CD
cord-005453-4057qib7	3767	12	patients	patient	NNS
cord-005453-4057qib7	3767	13	(	(	-LRB-
cord-005453-4057qib7	3767	14	36	36	CD
cord-005453-4057qib7	3767	15	%	%	NN
cord-005453-4057qib7	3767	16	)	)	-RRB-
cord-005453-4057qib7	3767	17	and	and	CC
cord-005453-4057qib7	3767	18	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3767	19	+	+	CC
cord-005453-4057qib7	3767	20	G	g	NN
cord-005453-4057qib7	3767	21	-	-	HYPH
cord-005453-4057qib7	3767	22	CSF	CSF	NNP
cord-005453-4057qib7	3767	23	±	±	NNP
cord-005453-4057qib7	3767	24	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	3767	25	in	in	IN
cord-005453-4057qib7	3767	26	38	38	CD
cord-005453-4057qib7	3767	27	patients	patient	NNS
cord-005453-4057qib7	3767	28	(	(	-LRB-
cord-005453-4057qib7	3767	29	64	64	CD
cord-005453-4057qib7	3767	30	%	%	NN
cord-005453-4057qib7	3767	31	)	)	-RRB-
cord-005453-4057qib7	3767	32	.	.	.
cord-005453-4057qib7	3768	1	Median	median	JJ
cord-005453-4057qib7	3768	2	CD34	CD34	NNP
cord-005453-4057qib7	3769	1	x	x	LS
cord-005453-4057qib7	3770	1	10	10	CD
cord-005453-4057qib7	3770	2	6	6	CD
cord-005453-4057qib7	3770	3	/Kg	/kg	NN
cord-005453-4057qib7	3770	4	cells	cell	NNS
cord-005453-4057qib7	3770	5	infused	infuse	VBN
cord-005453-4057qib7	3770	6	was	be	VBD
cord-005453-4057qib7	3770	7	3.6	3.6	CD
cord-005453-4057qib7	3770	8	(	(	-LRB-
cord-005453-4057qib7	3770	9	2.7	2.7	CD
cord-005453-4057qib7	3770	10	-	-	SYM
cord-005453-4057qib7	3770	11	5.3	5.3	CD
cord-005453-4057qib7	3770	12	)	)	-RRB-
cord-005453-4057qib7	3770	13	.	.	.
cord-005453-4057qib7	3771	1	Eleven	eleven	CD
cord-005453-4057qib7	3771	2	patients	patient	NNS
cord-005453-4057qib7	3771	3	(	(	-LRB-
cord-005453-4057qib7	3771	4	16.9	16.9	CD
cord-005453-4057qib7	3771	5	%	%	NN
cord-005453-4057qib7	3771	6	)	)	-RRB-
cord-005453-4057qib7	3771	7	received	receive	VBD
cord-005453-4057qib7	3771	8	G	G	NNP
cord-005453-4057qib7	3771	9	-	-	HYPH
cord-005453-4057qib7	3771	10	CSF	CSF	NNP
cord-005453-4057qib7	3771	11	,	,	,
cord-005453-4057qib7	3771	12	5	5	CD
cord-005453-4057qib7	3771	13	due	due	IN
cord-005453-4057qib7	3771	14	to	to	IN
cord-005453-4057qib7	3771	15	infection	infection	NN
cord-005453-4057qib7	3771	16	(	(	-LRB-
cord-005453-4057qib7	3771	17	2	2	CD
cord-005453-4057qib7	3771	18	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	3771	19	,	,	,
cord-005453-4057qib7	3771	20	1	1	CD
cord-005453-4057qib7	3771	21	listeriosis	listeriosis	NN
cord-005453-4057qib7	3771	22	,	,	,
cord-005453-4057qib7	3771	23	1	1	CD
cord-005453-4057qib7	3771	24	acute	acute	JJ
cord-005453-4057qib7	3771	25	hepatitis	hepatitis	NN
cord-005453-4057qib7	3771	26	,	,	,
cord-005453-4057qib7	3771	27	1	1	CD
cord-005453-4057qib7	3771	28	septic	septic	JJ
cord-005453-4057qib7	3771	29	shock	shock	NN
cord-005453-4057qib7	3771	30	)	)	-RRB-
cord-005453-4057qib7	3771	31	and	and	CC
cord-005453-4057qib7	3771	32	6	6	CD
cord-005453-4057qib7	3771	33	because	because	IN
cord-005453-4057qib7	3771	34	of	of	IN
cord-005453-4057qib7	3771	35	atrial	atrial	JJ
cord-005453-4057qib7	3771	36	fibrillation	fibrillation	NN
cord-005453-4057qib7	3771	37	or	or	CC
cord-005453-4057qib7	3771	38	fibrilloflutter	fibrilloflutter	NN
cord-005453-4057qib7	3771	39	.	.	.
cord-005453-4057qib7	3772	1	Median	median	JJ
cord-005453-4057qib7	3772	2	time	time	NN
cord-005453-4057qib7	3772	3	from	from	IN
cord-005453-4057qib7	3772	4	SCT	SCT	NNP
cord-005453-4057qib7	3772	5	to	to	IN
cord-005453-4057qib7	3772	6	first	first	JJ
cord-005453-4057qib7	3772	7	day	day	NN
cord-005453-4057qib7	3772	8	of	of	IN
cord-005453-4057qib7	3772	9	G	G	NNP
cord-005453-4057qib7	3772	10	-	-	HYPH
cord-005453-4057qib7	3772	11	CSF	CSF	NNP
cord-005453-4057qib7	3772	12	was	be	VBD
cord-005453-4057qib7	3772	13	5	5	CD
cord-005453-4057qib7	3772	14	days	day	NNS
cord-005453-4057qib7	3772	15	(	(	-LRB-
cord-005453-4057qib7	3772	16	5	5	CD
cord-005453-4057qib7	3772	17	-	-	SYM
cord-005453-4057qib7	3772	18	7	7	CD
cord-005453-4057qib7	3772	19	)	)	-RRB-
cord-005453-4057qib7	3772	20	and	and	CC
cord-005453-4057qib7	3772	21	median	median	JJ
cord-005453-4057qib7	3772	22	time	time	NN
cord-005453-4057qib7	3772	23	on	on	IN
cord-005453-4057qib7	3772	24	G	G	NNP
cord-005453-4057qib7	3772	25	-	-	HYPH
cord-005453-4057qib7	3772	26	CSF	CSF	NNP
cord-005453-4057qib7	3772	27	treatment	treatment	NN
cord-005453-4057qib7	3772	28	was	be	VBD
cord-005453-4057qib7	3772	29	5	5	CD
cord-005453-4057qib7	3772	30	days	day	NNS
cord-005453-4057qib7	3772	31	(	(	-LRB-
cord-005453-4057qib7	3772	32	4	4	CD
cord-005453-4057qib7	3772	33	-	-	SYM
cord-005453-4057qib7	3772	34	7	7	CD
cord-005453-4057qib7	3772	35	)	)	-RRB-
cord-005453-4057qib7	3772	36	.	.	.
cord-005453-4057qib7	3773	1	Patients	patient	NNS
cord-005453-4057qib7	3773	2	who	who	WP
cord-005453-4057qib7	3773	3	received	receive	VBD
cord-005453-4057qib7	3773	4	G	G	NNP
cord-005453-4057qib7	3773	5	-	-	HYPH
cord-005453-4057qib7	3773	6	CSF	CSF	NNP
cord-005453-4057qib7	3773	7	showed	show	VBD
cord-005453-4057qib7	3773	8	a	a	DT
cord-005453-4057qib7	3773	9	short	short	JJ
cord-005453-4057qib7	3773	10	time	time	NN
cord-005453-4057qib7	3773	11	to	to	IN
cord-005453-4057qib7	3773	12	neutrophil	neutrophil	NN
cord-005453-4057qib7	3773	13	engraftment	engraftment	NN
cord-005453-4057qib7	3773	14	(	(	-LRB-
cord-005453-4057qib7	3773	15	≥0.5x10	≥0.5x10	NNP
cord-005453-4057qib7	3773	16	6	6	CD
cord-005453-4057qib7	3773	17	/L	/L	.
cord-005453-4057qib7	3773	18	)	)	-RRB-
cord-005453-4057qib7	3773	19	,	,	,
cord-005453-4057qib7	3773	20	10	10	CD
cord-005453-4057qib7	3773	21	days	day	NNS
cord-005453-4057qib7	3773	22	vs.	vs.	IN
cord-005453-4057qib7	3773	23	13	13	CD
cord-005453-4057qib7	3773	24	days	day	NNS
cord-005453-4057qib7	3773	25	,	,	,
cord-005453-4057qib7	3773	26	p	p	NN
cord-005453-4057qib7	3773	27	<	<	XX
cord-005453-4057qib7	3773	28	0.001	0.001	CD
cord-005453-4057qib7	3773	29	but	but	CC
cord-005453-4057qib7	3773	30	longer	long	JJR
cord-005453-4057qib7	3773	31	duration	duration	NN
cord-005453-4057qib7	3773	32	of	of	IN
cord-005453-4057qib7	3773	33	hospitalization	hospitalization	NN
cord-005453-4057qib7	3773	34	,	,	,
cord-005453-4057qib7	3773	35	18	18	CD
cord-005453-4057qib7	3773	36	days	day	NNS
cord-005453-4057qib7	3773	37	vs.	vs.	IN
cord-005453-4057qib7	3773	38	15	15	CD
cord-005453-4057qib7	3773	39	days	day	NNS
cord-005453-4057qib7	3773	40	,	,	,
cord-005453-4057qib7	3773	41	p	p	NN
cord-005453-4057qib7	3773	42	=	=	SYM
cord-005453-4057qib7	3773	43	0.050	0.050	CD
cord-005453-4057qib7	3773	44	.	.	.
cord-005453-4057qib7	3774	1	Non	non	JJ
cord-005453-4057qib7	3774	2	-	-	JJ
cord-005453-4057qib7	3774	3	relapse	relapse	JJ
cord-005453-4057qib7	3774	4	mortality	mortality	NN
cord-005453-4057qib7	3774	5	at	at	IN
cord-005453-4057qib7	3774	6	day	day	NN
cord-005453-4057qib7	3774	7	+30	+30	CD
cord-005453-4057qib7	3774	8	,	,	,
cord-005453-4057qib7	3774	9	+100	+100	NNP
cord-005453-4057qib7	3774	10	and	and	CC
cord-005453-4057qib7	3774	11	+180	+180	NNP
cord-005453-4057qib7	3774	12	was	be	VBD
cord-005453-4057qib7	3774	13	0	0	CD
cord-005453-4057qib7	3774	14	%	%	NN
cord-005453-4057qib7	3774	15	.	.	.
cord-005453-4057qib7	3775	1	ES	ES	NNP
cord-005453-4057qib7	3775	2	was	be	VBD
cord-005453-4057qib7	3775	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	3775	4	in	in	IN
cord-005453-4057qib7	3775	5	4	4	CD
cord-005453-4057qib7	3775	6	(	(	-LRB-
cord-005453-4057qib7	3775	7	6.2	6.2	CD
cord-005453-4057qib7	3775	8	%	%	NN
cord-005453-4057qib7	3775	9	)	)	-RRB-
cord-005453-4057qib7	3775	10	patients	patient	NNS
cord-005453-4057qib7	3775	11	,	,	,
cord-005453-4057qib7	3775	12	1	1	CD
cord-005453-4057qib7	3775	13	amyloidosis	amyloidosis	NN
cord-005453-4057qib7	3775	14	,	,	,
cord-005453-4057qib7	3775	15	2	2	CD
cord-005453-4057qib7	3775	16	multiple	multiple	JJ
cord-005453-4057qib7	3775	17	myeloma	myeloma	NN
cord-005453-4057qib7	3775	18	and	and	CC
cord-005453-4057qib7	3775	19	1	1	CD
cord-005453-4057qib7	3775	20	plasmablastic	plasmablastic	JJ
cord-005453-4057qib7	3775	21	lymphoma	lymphoma	NN
cord-005453-4057qib7	3775	22	.	.	.
cord-005453-4057qib7	3776	1	There	there	EX
cord-005453-4057qib7	3776	2	was	be	VBD
cord-005453-4057qib7	3776	3	not	not	RB
cord-005453-4057qib7	3776	4	statistical	statistical	JJ
cord-005453-4057qib7	3776	5	difference	difference	NN
cord-005453-4057qib7	3776	6	in	in	IN
cord-005453-4057qib7	3776	7	the	the	DT
cord-005453-4057qib7	3776	8	incidence	incidence	NN
cord-005453-4057qib7	3776	9	of	of	IN
cord-005453-4057qib7	3776	10	ES	es	NN
cord-005453-4057qib7	3776	11	between	between	IN
cord-005453-4057qib7	3776	12	patients	patient	NNS
cord-005453-4057qib7	3776	13	who	who	WP
cord-005453-4057qib7	3776	14	received	receive	VBD
cord-005453-4057qib7	3776	15	G	G	NNP
cord-005453-4057qib7	3776	16	-	-	HYPH
cord-005453-4057qib7	3776	17	CSF	CSF	NNP
cord-005453-4057qib7	3776	18	(	(	-LRB-
cord-005453-4057qib7	3776	19	9.1	9.1	CD
cord-005453-4057qib7	3776	20	%	%	NN
cord-005453-4057qib7	3776	21	)	)	-RRB-
cord-005453-4057qib7	3776	22	and	and	CC
cord-005453-4057qib7	3776	23	patients	patient	NNS
cord-005453-4057qib7	3776	24	who	who	WP
cord-005453-4057qib7	3776	25	did	do	VBD
cord-005453-4057qib7	3776	26	not	not	RB
cord-005453-4057qib7	3776	27	(	(	-LRB-
cord-005453-4057qib7	3776	28	5.6	5.6	CD
cord-005453-4057qib7	3776	29	%	%	NN
cord-005453-4057qib7	3776	30	)	)	-RRB-
cord-005453-4057qib7	3776	31	,	,	,
cord-005453-4057qib7	3776	32	p=0.533	p=0.533	NNP
cord-005453-4057qib7	3776	33	.	.	.
cord-005453-4057qib7	3777	1	Analyzed	analyze	VBN
cord-005453-4057qib7	3777	2	by	by	IN
cord-005453-4057qib7	3777	3	disease	disease	NN
cord-005453-4057qib7	3777	4	,	,	,
cord-005453-4057qib7	3777	5	ES	ES	NNP
cord-005453-4057qib7	3777	6	appeared	appear	VBD
cord-005453-4057qib7	3777	7	in	in	IN
cord-005453-4057qib7	3777	8	1	1	CD
cord-005453-4057qib7	3777	9	of	of	IN
cord-005453-4057qib7	3777	10	6	6	CD
cord-005453-4057qib7	3777	11	patients	patient	NNS
cord-005453-4057qib7	3777	12	who	who	WP
cord-005453-4057qib7	3777	13	received	receive	VBD
cord-005453-4057qib7	3777	14	G	G	NNP
cord-005453-4057qib7	3777	15	-	-	HYPH
cord-005453-4057qib7	3777	16	CSF	CSF	NNP
cord-005453-4057qib7	3777	17	in	in	IN
cord-005453-4057qib7	3777	18	the	the	DT
cord-005453-4057qib7	3777	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	3777	20	group	group	NN
cord-005453-4057qib7	3777	21	(	(	-LRB-
cord-005453-4057qib7	3777	22	16.6	16.6	CD
cord-005453-4057qib7	3777	23	%	%	NN
cord-005453-4057qib7	3777	24	)	)	-RRB-
cord-005453-4057qib7	3777	25	but	but	CC
cord-005453-4057qib7	3777	26	none	none	NN
cord-005453-4057qib7	3777	27	of	of	IN
cord-005453-4057qib7	3777	28	the	the	DT
cord-005453-4057qib7	3777	29	7	7	CD
cord-005453-4057qib7	3777	30	patients	patient	NNS
cord-005453-4057qib7	3777	31	with	with	IN
cord-005453-4057qib7	3777	32	MG	MG	NNP
cord-005453-4057qib7	3777	33	that	that	WDT
cord-005453-4057qib7	3777	34	received	receive	VBD
cord-005453-4057qib7	3777	35	G	G	NNP
cord-005453-4057qib7	3777	36	-	-	HYPH
cord-005453-4057qib7	3777	37	CSF	CSF	NNP
cord-005453-4057qib7	3777	38	developed	develop	VBD
cord-005453-4057qib7	3777	39	it	-PRON-	PRP
cord-005453-4057qib7	3777	40	.	.	.
cord-005453-4057qib7	3778	1	We	-PRON-	PRP
cord-005453-4057qib7	3778	2	did	do	VBD
cord-005453-4057qib7	3778	3	not	not	RB
cord-005453-4057qib7	3778	4	find	find	VB
cord-005453-4057qib7	3778	5	statistical	statistical	JJ
cord-005453-4057qib7	3778	6	differences	difference	NNS
cord-005453-4057qib7	3778	7	between	between	IN
cord-005453-4057qib7	3778	8	patients	patient	NNS
cord-005453-4057qib7	3778	9	who	who	WP
cord-005453-4057qib7	3778	10	developed	develop	VBD
cord-005453-4057qib7	3778	11	ES	ES	NNP
cord-005453-4057qib7	3778	12	and	and	CC
cord-005453-4057qib7	3778	13	those	those	DT
cord-005453-4057qib7	3778	14	who	who	WP
cord-005453-4057qib7	3778	15	did	do	VBD
cord-005453-4057qib7	3778	16	not	not	RB
cord-005453-4057qib7	3778	17	in	in	IN
cord-005453-4057qib7	3778	18	age	age	NN
cord-005453-4057qib7	3778	19	(	(	-LRB-
cord-005453-4057qib7	3778	20	49	49	CD
cord-005453-4057qib7	3778	21	years	year	NNS
cord-005453-4057qib7	3778	22	vs.	vs.	IN
cord-005453-4057qib7	3778	23	56	56	CD
cord-005453-4057qib7	3778	24	years	year	NNS
cord-005453-4057qib7	3778	25	,	,	,
cord-005453-4057qib7	3778	26	p=0	p=0	NNP
cord-005453-4057qib7	3778	27	.	.	.
cord-005453-4057qib7	3779	1	314	314	LS
cord-005453-4057qib7	3779	2	)	)	-RRB-
cord-005453-4057qib7	3779	3	,	,	,
cord-005453-4057qib7	3779	4	length	length	NN
cord-005453-4057qib7	3779	5	of	of	IN
cord-005453-4057qib7	3779	6	hospitalization	hospitalization	NN
cord-005453-4057qib7	3779	7	(	(	-LRB-
cord-005453-4057qib7	3779	8	19	19	CD
cord-005453-4057qib7	3779	9	days	day	NNS
cord-005453-4057qib7	3779	10	vs.	vs.	IN
cord-005453-4057qib7	3779	11	15	15	CD
cord-005453-4057qib7	3779	12	days	day	NNS
cord-005453-4057qib7	3779	13	,	,	,
cord-005453-4057qib7	3779	14	p=0.185	p=0.185	LS
cord-005453-4057qib7	3779	15	)	)	-RRB-
cord-005453-4057qib7	3779	16	and	and	CC
cord-005453-4057qib7	3779	17	the	the	DT
cord-005453-4057qib7	3779	18	number	number	NN
cord-005453-4057qib7	3779	19	of	of	IN
cord-005453-4057qib7	3779	20	CD34	CD34	NNP
cord-005453-4057qib7	3780	1	x	x	SYM
cord-005453-4057qib7	3780	2	10	10	CD
cord-005453-4057qib7	3780	3	6	6	CD
cord-005453-4057qib7	3780	4	/Kg	/kg	NN
cord-005453-4057qib7	3780	5	cells	cell	NNS
cord-005453-4057qib7	3780	6	infused	infuse	VBN
cord-005453-4057qib7	3780	7	(	(	-LRB-
cord-005453-4057qib7	3780	8	3.65	3.65	CD
cord-005453-4057qib7	3780	9	vs.	vs.	IN
cord-005453-4057qib7	3780	10	4.62	4.62	CD
cord-005453-4057qib7	3780	11	,	,	,
cord-005453-4057qib7	3780	12	p=0.408	p=0.408	NN
cord-005453-4057qib7	3780	13	)	)	-RRB-
cord-005453-4057qib7	3780	14	.	.	.
cord-005453-4057qib7	3781	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3781	2	:	:	:
cord-005453-4057qib7	3782	1	The	the	DT
cord-005453-4057qib7	3782	2	use	use	NN
cord-005453-4057qib7	3782	3	of	of	IN
cord-005453-4057qib7	3782	4	G	G	NNP
cord-005453-4057qib7	3782	5	-	-	HYPH
cord-005453-4057qib7	3782	6	CSF	CSF	NNP
cord-005453-4057qib7	3782	7	in	in	IN
cord-005453-4057qib7	3782	8	selected	select	VBN
cord-005453-4057qib7	3782	9	patients	patient	NNS
cord-005453-4057qib7	3782	10	is	be	VBZ
cord-005453-4057qib7	3782	11	associated	associate	VBN
cord-005453-4057qib7	3782	12	with	with	IN
cord-005453-4057qib7	3782	13	low	low	JJ
cord-005453-4057qib7	3782	14	incidence	incidence	NN
cord-005453-4057qib7	3782	15	of	of	IN
cord-005453-4057qib7	3782	16	ES	ES	NNP
cord-005453-4057qib7	3782	17	.	.	.
cord-005453-4057qib7	3783	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3783	2	study	study	NN
cord-005453-4057qib7	3783	3	confirms	confirm	VBZ
cord-005453-4057qib7	3783	4	that	that	IN
cord-005453-4057qib7	3783	5	the	the	DT
cord-005453-4057qib7	3783	6	use	use	NN
cord-005453-4057qib7	3783	7	of	of	IN
cord-005453-4057qib7	3783	8	G	G	NNP
cord-005453-4057qib7	3783	9	-	-	HYPH
cord-005453-4057qib7	3783	10	CSF	CSF	NNP
cord-005453-4057qib7	3783	11	accelerates	accelerate	VBZ
cord-005453-4057qib7	3783	12	neutrophil	neutrophil	NN
cord-005453-4057qib7	3783	13	recovery	recovery	NN
cord-005453-4057qib7	3783	14	but	but	CC
cord-005453-4057qib7	3783	15	it	-PRON-	PRP
cord-005453-4057qib7	3783	16	is	be	VBZ
cord-005453-4057qib7	3783	17	unclear	unclear	JJ
cord-005453-4057qib7	3783	18	if	if	IN
cord-005453-4057qib7	3783	19	it	-PRON-	PRP
cord-005453-4057qib7	3783	20	can	can	MD
cord-005453-4057qib7	3783	21	increase	increase	VB
cord-005453-4057qib7	3783	22	the	the	DT
cord-005453-4057qib7	3783	23	incidence	incidence	NN
cord-005453-4057qib7	3783	24	of	of	IN
cord-005453-4057qib7	3783	25	ES	ES	NNP
cord-005453-4057qib7	3783	26	,	,	,
cord-005453-4057qib7	3783	27	especially	especially	RB
cord-005453-4057qib7	3783	28	in	in	IN
cord-005453-4057qib7	3783	29	patients	patient	NNS
cord-005453-4057qib7	3783	30	with	with	IN
cord-005453-4057qib7	3783	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	3783	32	.	.	.
cord-005453-4057qib7	3784	1	[	[	-LRB-
cord-005453-4057qib7	3784	2	[	[	-LRB-
cord-005453-4057qib7	3784	3	P180	P180	NNP
cord-005453-4057qib7	3784	4	Image	image	NN
cord-005453-4057qib7	3784	5	]	]	-RRB-
cord-005453-4057qib7	3784	6	1	1	CD
cord-005453-4057qib7	3784	7	.	.	.
cord-005453-4057qib7	3785	1	Background	background	NN
cord-005453-4057qib7	3785	2	:	:	:
cord-005453-4057qib7	3786	1	Graft	graft	NN
cord-005453-4057qib7	3786	2	failure	failure	NN
cord-005453-4057qib7	3786	3	is	be	VBZ
cord-005453-4057qib7	3786	4	one	one	CD
cord-005453-4057qib7	3786	5	of	of	IN
cord-005453-4057qib7	3786	6	the	the	DT
cord-005453-4057qib7	3786	7	TOP-3	TOP-3	NNP
cord-005453-4057qib7	3786	8	problems	problem	NNS
cord-005453-4057qib7	3786	9	of	of	IN
cord-005453-4057qib7	3786	10	allo	allo	NN
cord-005453-4057qib7	3786	11	-	-	HYPH
cord-005453-4057qib7	3786	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3786	13	(	(	-LRB-
cord-005453-4057qib7	3786	14	after	after	IN
cord-005453-4057qib7	3786	15	GVHD	GVHD	NNP
cord-005453-4057qib7	3786	16	and	and	CC
cord-005453-4057qib7	3786	17	relapse	relapse	NN
cord-005453-4057qib7	3786	18	)	)	-RRB-
cord-005453-4057qib7	3786	19	.	.	.
cord-005453-4057qib7	3787	1	The	the	DT
cord-005453-4057qib7	3787	2	problem	problem	NN
cord-005453-4057qib7	3787	3	of	of	IN
cord-005453-4057qib7	3787	4	graft	graft	NN
cord-005453-4057qib7	3787	5	failure	failure	NN
cord-005453-4057qib7	3787	6	becomes	become	VBZ
cord-005453-4057qib7	3787	7	more	more	RBR
cord-005453-4057qib7	3787	8	significant	significant	JJ
cord-005453-4057qib7	3787	9	due	due	IN
cord-005453-4057qib7	3787	10	to	to	IN
cord-005453-4057qib7	3787	11	increasing	increase	VBG
cord-005453-4057qib7	3787	12	number	number	NN
cord-005453-4057qib7	3787	13	of	of	IN
cord-005453-4057qib7	3787	14	allo	allo	NN
cord-005453-4057qib7	3787	15	-	-	HYPH
cord-005453-4057qib7	3787	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3787	17	with	with	IN
cord-005453-4057qib7	3787	18	RIC	RIC	NNP
cord-005453-4057qib7	3787	19	conditioning	conditioning	NN
cord-005453-4057qib7	3787	20	regimen	regimen	NN
cord-005453-4057qib7	3787	21	from	from	IN
cord-005453-4057qib7	3787	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3787	23	and	and	CC
cord-005453-4057qib7	3787	24	HLA	HLA	NNP
cord-005453-4057qib7	3787	25	-	-	HYPH
cord-005453-4057qib7	3787	26	mismatched	mismatch	VBN
cord-005453-4057qib7	3787	27	unrelated	unrelated	JJ
cord-005453-4057qib7	3787	28	donors	donor	NNS
cord-005453-4057qib7	3787	29	.	.	.
cord-005453-4057qib7	3788	1	Role	role	NN
cord-005453-4057qib7	3788	2	of	of	IN
cord-005453-4057qib7	3788	3	T	T	NNP
cord-005453-4057qib7	3788	4	cells	cell	NNS
cord-005453-4057qib7	3788	5	in	in	IN
cord-005453-4057qib7	3788	6	graft	graft	NN
cord-005453-4057qib7	3788	7	failure	failure	NN
cord-005453-4057qib7	3788	8	is	be	VBZ
cord-005453-4057qib7	3788	9	well	well	RB
cord-005453-4057qib7	3788	10	known	known	JJ
cord-005453-4057qib7	3788	11	.	.	.
cord-005453-4057qib7	3789	1	Here	here	RB
cord-005453-4057qib7	3789	2	we	-PRON-	PRP
cord-005453-4057qib7	3789	3	report	report	VBP
cord-005453-4057qib7	3789	4	an	an	DT
cord-005453-4057qib7	3789	5	impact	impact	NN
cord-005453-4057qib7	3789	6	of	of	IN
cord-005453-4057qib7	3789	7	T	t	NN
cord-005453-4057qib7	3789	8	-	-	HYPH
cord-005453-4057qib7	3789	9	memory	memory	NN
cord-005453-4057qib7	3789	10	cell	cell	NN
cord-005453-4057qib7	3789	11	subsets	subset	NNS
cord-005453-4057qib7	3789	12	count	count	VBP
cord-005453-4057qib7	3789	13	before	before	IN
cord-005453-4057qib7	3789	14	Antithymocyte	Antithymocyte	NNP
cord-005453-4057qib7	3789	15	globulin	globulin	NN
cord-005453-4057qib7	3789	16	(	(	-LRB-
cord-005453-4057qib7	3789	17	ATG	ATG	NNP
cord-005453-4057qib7	3789	18	)	)	-RRB-
cord-005453-4057qib7	3789	19	administration	administration	NN
cord-005453-4057qib7	3789	20	on	on	IN
cord-005453-4057qib7	3789	21	primary	primary	JJ
cord-005453-4057qib7	3789	22	graft	graft	NN
cord-005453-4057qib7	3789	23	failure	failure	NN
cord-005453-4057qib7	3789	24	after	after	IN
cord-005453-4057qib7	3789	25	allo	allo	NN
cord-005453-4057qib7	3789	26	-	-	HYPH
cord-005453-4057qib7	3789	27	HSCT	HSCT	NNP
cord-005453-4057qib7	3789	28	.	.	.
cord-005453-4057qib7	3790	1	Methods	method	NNS
cord-005453-4057qib7	3790	2	:	:	:
cord-005453-4057qib7	3791	1	Sixteen	sixteen	CD
cord-005453-4057qib7	3791	2	patients	patient	NNS
cord-005453-4057qib7	3791	3	with	with	IN
cord-005453-4057qib7	3791	4	acute	acute	JJ
cord-005453-4057qib7	3791	5	leukemia	leukemia	NN
cord-005453-4057qib7	3791	6	transplanted	transplant	VBN
cord-005453-4057qib7	3791	7	in	in	IN
cord-005453-4057qib7	3791	8	National	National	NNP
cord-005453-4057qib7	3791	9	Research	Research	NNP
cord-005453-4057qib7	3791	10	Center	Center	NNP
cord-005453-4057qib7	3791	11	for	for	IN
cord-005453-4057qib7	3791	12	Hematology	Hematology	NNP
cord-005453-4057qib7	3791	13	were	be	VBD
cord-005453-4057qib7	3791	14	included	include	VBN
cord-005453-4057qib7	3791	15	on	on	IN
cord-005453-4057qib7	3791	16	this	this	DT
cord-005453-4057qib7	3791	17	prospective	prospective	JJ
cord-005453-4057qib7	3791	18	study	study	NN
cord-005453-4057qib7	3791	19	.	.	.
cord-005453-4057qib7	3792	1	All	all	DT
cord-005453-4057qib7	3792	2	patients	patient	NNS
cord-005453-4057qib7	3792	3	received	receive	VBD
cord-005453-4057qib7	3792	4	horse	horse	NN
cord-005453-4057qib7	3792	5	ATG	ATG	NNP
cord-005453-4057qib7	3792	6	at	at	IN
cord-005453-4057qib7	3792	7	dose	dose	NN
cord-005453-4057qib7	3792	8	10	10	CD
cord-005453-4057qib7	3792	9	mg	mg	NNP
cord-005453-4057qib7	3792	10	/	/	SYM
cord-005453-4057qib7	3792	11	kg	kg	NNP
cord-005453-4057qib7	3792	12	/	/	SYM
cord-005453-4057qib7	3792	13	day	day	NN
cord-005453-4057qib7	3792	14	from	from	IN
cord-005453-4057qib7	3792	15	day	day	NN
cord-005453-4057qib7	3792	16	-4	-4	ADD
cord-005453-4057qib7	3792	17	to	to	IN
cord-005453-4057qib7	3792	18	-1	-1	NN
cord-005453-4057qib7	3792	19	before	before	IN
cord-005453-4057qib7	3792	20	allo	allo	NN
cord-005453-4057qib7	3792	21	-	-	HYPH
cord-005453-4057qib7	3792	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3792	23	as	as	IN
cord-005453-4057qib7	3792	24	GVHD	GVHD	NNP
cord-005453-4057qib7	3792	25	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3792	26	and	and	CC
cord-005453-4057qib7	3792	27	were	be	VBD
cord-005453-4057qib7	3792	28	balanced	balance	VBN
cord-005453-4057qib7	3792	29	by	by	IN
cord-005453-4057qib7	3792	30	other	other	JJ
cord-005453-4057qib7	3792	31	factors	factor	NNS
cord-005453-4057qib7	3792	32	that	that	WDT
cord-005453-4057qib7	3792	33	could	could	MD
cord-005453-4057qib7	3792	34	affect	affect	VB
cord-005453-4057qib7	3792	35	engraftment	engraftment	NN
cord-005453-4057qib7	3792	36	.	.	.
cord-005453-4057qib7	3793	1	Detailed	detailed	JJ
cord-005453-4057qib7	3793	2	patients	patient	NNS
cord-005453-4057qib7	3793	3	characteristics	characteristic	NNS
cord-005453-4057qib7	3793	4	are	be	VBP
cord-005453-4057qib7	3793	5	listed	list	VBN
cord-005453-4057qib7	3793	6	in	in	IN
cord-005453-4057qib7	3793	7	Table	Table	NNP
cord-005453-4057qib7	3793	8	1	1	CD
cord-005453-4057qib7	3793	9	.	.	.
cord-005453-4057qib7	3794	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	3794	2	blood	blood	NN
cord-005453-4057qib7	3794	3	samples	sample	NNS
cord-005453-4057qib7	3794	4	were	be	VBD
cord-005453-4057qib7	3794	5	collected	collect	VBN
cord-005453-4057qib7	3794	6	on	on	IN
cord-005453-4057qib7	3794	7	day	day	NN
cord-005453-4057qib7	3794	8	-4	-4	NFP
cord-005453-4057qib7	3794	9	before	before	IN
cord-005453-4057qib7	3794	10	allo	allo	NN
cord-005453-4057qib7	3794	11	-	-	HYPH
cord-005453-4057qib7	3794	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3794	13	(	(	-LRB-
cord-005453-4057qib7	3794	14	before	before	IN
cord-005453-4057qib7	3794	15	ATG	ATG	NNP
cord-005453-4057qib7	3794	16	injection	injection	NN
cord-005453-4057qib7	3794	17	)	)	-RRB-
cord-005453-4057qib7	3794	18	in	in	IN
cord-005453-4057qib7	3794	19	EDTA	EDTA	NNP
cord-005453-4057qib7	3794	20	-	-	HYPH
cord-005453-4057qib7	3794	21	tubes	tube	NNS
cord-005453-4057qib7	3794	22	.	.	.
cord-005453-4057qib7	3795	1	Flow	flow	NN
cord-005453-4057qib7	3795	2	cytometry	cytometry	NN
cord-005453-4057qib7	3795	3	analysis	analysis	NN
cord-005453-4057qib7	3795	4	was	be	VBD
cord-005453-4057qib7	3795	5	performed	perform	VBN
cord-005453-4057qib7	3795	6	on	on	IN
cord-005453-4057qib7	3795	7	BD	BD	NNP
cord-005453-4057qib7	3795	8	FACS	FACS	NNP
cord-005453-4057qib7	3795	9	Canto	Canto	NNP
cord-005453-4057qib7	3795	10	II	II	NNP
cord-005453-4057qib7	3796	1	(	(	-LRB-
cord-005453-4057qib7	3796	2	Becton	Becton	NNP
cord-005453-4057qib7	3796	3	Dickinson	Dickinson	NNP
cord-005453-4057qib7	3796	4	,	,	,
cord-005453-4057qib7	3796	5	USA	USA	NNP
cord-005453-4057qib7	3796	6	)	)	-RRB-
cord-005453-4057qib7	3796	7	to	to	TO
cord-005453-4057qib7	3796	8	define	define	VB
cord-005453-4057qib7	3796	9	T	t	NN
cord-005453-4057qib7	3796	10	-	-	HYPH
cord-005453-4057qib7	3796	11	memory	memory	NN
cord-005453-4057qib7	3796	12	subsets	subset	NNS
cord-005453-4057qib7	3796	13	:	:	:
cord-005453-4057qib7	3796	14	T	t	NN
cord-005453-4057qib7	3796	15	-	-	HYPH
cord-005453-4057qib7	3796	16	naive	naive	JJ
cord-005453-4057qib7	3796	17	and	and	CC
cord-005453-4057qib7	3796	18	T	t	NN
cord-005453-4057qib7	3796	19	-	-	HYPH
cord-005453-4057qib7	3796	20	stem	stem	NN
cord-005453-4057qib7	3796	21	cell	cell	NN
cord-005453-4057qib7	3796	22	memory	memory	NN
cord-005453-4057qib7	3796	23	(	(	-LRB-
cord-005453-4057qib7	3796	24	Tnv+scm	Tnv+scm	NNP
cord-005453-4057qib7	3796	25	)	)	-RRB-
cord-005453-4057qib7	3797	1	-CD45R0-CCR7+CD28	-cd45r0-ccr7+cd28	LS
cord-005453-4057qib7	3797	2	+	+	CC
cord-005453-4057qib7	3797	3	;	;	:
cord-005453-4057qib7	3797	4	T	t	JJ
cord-005453-4057qib7	3797	5	-	-	HYPH
cord-005453-4057qib7	3797	6	central	central	JJ
cord-005453-4057qib7	3797	7	memory	memory	NN
cord-005453-4057qib7	3797	8	(	(	-LRB-
cord-005453-4057qib7	3797	9	Tcm	Tcm	NNP
cord-005453-4057qib7	3797	10	)	)	-RRB-
cord-005453-4057qib7	3797	11	-CD45R0+CCR7+CD28	-CD45R0+CCR7+CD28	.
cord-005453-4057qib7	3798	1	+	+	CC
cord-005453-4057qib7	3798	2	;	;	:
cord-005453-4057qib7	3798	3	T	t	JJ
cord-005453-4057qib7	3798	4	-	-	HYPH
cord-005453-4057qib7	3798	5	transitional	transitional	JJ
cord-005453-4057qib7	3798	6	memory	memory	NN
cord-005453-4057qib7	3798	7	(	(	-LRB-
cord-005453-4057qib7	3798	8	Ttm	Ttm	NNP
cord-005453-4057qib7	3798	9	)	)	-RRB-
cord-005453-4057qib7	3798	10	-CD45R0+CCR7-CD28	-CD45R0+CCR7-CD28	.
cord-005453-4057qib7	3799	1	+	+	CC
cord-005453-4057qib7	3799	2	;	;	:
cord-005453-4057qib7	3799	3	T	t	NN
cord-005453-4057qib7	3799	4	-	-	HYPH
cord-005453-4057qib7	3799	5	effector	effector	NN
cord-005453-4057qib7	3799	6	memory	memory	NN
cord-005453-4057qib7	3799	7	(	(	-LRB-
cord-005453-4057qib7	3799	8	Tem	Tem	NNP
cord-005453-4057qib7	3799	9	)	)	-RRB-
cord-005453-4057qib7	3799	10	-CD45R0+CCR7-CD28-	-cd45r0+ccr7-cd28-	NN
cord-005453-4057qib7	3799	11	;	;	:
cord-005453-4057qib7	3799	12	T	t	NN
cord-005453-4057qib7	3799	13	-	-	HYPH
cord-005453-4057qib7	3799	14	terminal	terminal	NN
cord-005453-4057qib7	3799	15	effector	effector	NN
cord-005453-4057qib7	3799	16	(	(	-LRB-
cord-005453-4057qib7	3799	17	Tte	Tte	NNP
cord-005453-4057qib7	3799	18	)	)	-RRB-
cord-005453-4057qib7	3799	19	-CD45R0-CCR7-CD28-	-CD45R0-CCR7-CD28-	NNP
cord-005453-4057qib7	3799	20	,	,	,
cord-005453-4057qib7	3799	21	among	among	IN
cord-005453-4057qib7	3799	22	CD4	CD4	NNP
cord-005453-4057qib7	3799	23	+	+	CC
cord-005453-4057qib7	3799	24	and	and	CC
cord-005453-4057qib7	3799	25	CD8	CD8	NNP
cord-005453-4057qib7	3799	26	+	+	CC
cord-005453-4057qib7	3799	27	T	T	NNP
cord-005453-4057qib7	3799	28	-	-	HYPH
cord-005453-4057qib7	3799	29	cells	cell	NNS
cord-005453-4057qib7	3799	30	.	.	.
cord-005453-4057qib7	3800	1	Sysmex	Sysmex	NNP
cord-005453-4057qib7	3800	2	XE-2100	XE-2100	NNS
cord-005453-4057qib7	3800	3	was	be	VBD
cord-005453-4057qib7	3800	4	used	use	VBN
cord-005453-4057qib7	3800	5	to	to	TO
cord-005453-4057qib7	3800	6	calculate	calculate	VB
cord-005453-4057qib7	3800	7	absolute	absolute	JJ
cord-005453-4057qib7	3800	8	count	count	NN
cord-005453-4057qib7	3800	9	of	of	IN
cord-005453-4057qib7	3800	10	different	different	JJ
cord-005453-4057qib7	3800	11	T	t	NN
cord-005453-4057qib7	3800	12	-	-	HYPH
cord-005453-4057qib7	3800	13	cell	cell	NN
cord-005453-4057qib7	3800	14	subsets	subset	NNS
cord-005453-4057qib7	3800	15	.	.	.
cord-005453-4057qib7	3801	1	Mann	Mann	NNP
cord-005453-4057qib7	3801	2	-	-	HYPH
cord-005453-4057qib7	3801	3	Whitney	Whitney	NNP
cord-005453-4057qib7	3801	4	U	U	NNP
cord-005453-4057qib7	3801	5	test	test	NN
cord-005453-4057qib7	3801	6	was	be	VBD
cord-005453-4057qib7	3801	7	used	use	VBN
cord-005453-4057qib7	3801	8	for	for	IN
cord-005453-4057qib7	3801	9	nonparametric	nonparametric	JJ
cord-005453-4057qib7	3801	10	data	data	NN
cord-005453-4057qib7	3801	11	analysis	analysis	NN
cord-005453-4057qib7	3801	12	between	between	IN
cord-005453-4057qib7	3801	13	two	two	CD
cord-005453-4057qib7	3801	14	groups	group	NNS
cord-005453-4057qib7	3801	15	.	.	.
cord-005453-4057qib7	3802	1	Fisher	Fisher	NNP
cord-005453-4057qib7	3802	2	's	's	POS
cord-005453-4057qib7	3802	3	exact	exact	JJ
cord-005453-4057qib7	3802	4	test	test	NN
cord-005453-4057qib7	3802	5	was	be	VBD
cord-005453-4057qib7	3802	6	used	use	VBN
cord-005453-4057qib7	3802	7	for	for	IN
cord-005453-4057qib7	3802	8	2x2	2x2	CD
cord-005453-4057qib7	3802	9	tables	table	NNS
cord-005453-4057qib7	3802	10	.	.	.
cord-005453-4057qib7	3803	1	P	p	NN
cord-005453-4057qib7	3803	2	-	-	HYPH
cord-005453-4057qib7	3803	3	value	value	NN
cord-005453-4057qib7	3803	4	less	less	JJR
cord-005453-4057qib7	3803	5	than	than	IN
cord-005453-4057qib7	3803	6	0.05	0.05	CD
cord-005453-4057qib7	3803	7	was	be	VBD
cord-005453-4057qib7	3803	8	considered	consider	VBN
cord-005453-4057qib7	3803	9	statistically	statistically	RB
cord-005453-4057qib7	3803	10	significant	significant	JJ
cord-005453-4057qib7	3803	11	.	.	.
cord-005453-4057qib7	3804	1	Results	result	NNS
cord-005453-4057qib7	3804	2	:	:	:
cord-005453-4057qib7	3805	1	An	an	DT
cord-005453-4057qib7	3805	2	influence	influence	NN
cord-005453-4057qib7	3805	3	of	of	IN
cord-005453-4057qib7	3805	4	T	t	NN
cord-005453-4057qib7	3805	5	-	-	HYPH
cord-005453-4057qib7	3805	6	memory	memory	NN
cord-005453-4057qib7	3805	7	cell	cell	NN
cord-005453-4057qib7	3805	8	subsets	subset	NNS
cord-005453-4057qib7	3805	9	count	count	VBP
cord-005453-4057qib7	3805	10	before	before	IN
cord-005453-4057qib7	3805	11	ATG	ATG	NNP
cord-005453-4057qib7	3805	12	administration	administration	NN
cord-005453-4057qib7	3805	13	on	on	IN
cord-005453-4057qib7	3805	14	primary	primary	JJ
cord-005453-4057qib7	3805	15	graft	graft	NN
cord-005453-4057qib7	3805	16	failure	failure	NN
cord-005453-4057qib7	3805	17	is	be	VBZ
cord-005453-4057qib7	3805	18	shown	show	VBN
cord-005453-4057qib7	3805	19	in	in	IN
cord-005453-4057qib7	3805	20	Figure	figure	NN
cord-005453-4057qib7	3805	21	1	1	CD
cord-005453-4057qib7	3805	22	.	.	.
cord-005453-4057qib7	3806	1	According	accord	VBG
cord-005453-4057qib7	3806	2	to	to	IN
cord-005453-4057qib7	3806	3	our	-PRON-	PRP$
cord-005453-4057qib7	3806	4	data	data	NN
cord-005453-4057qib7	3806	5	high	high	JJ
cord-005453-4057qib7	3806	6	absolute	absolute	JJ
cord-005453-4057qib7	3806	7	number	number	NN
cord-005453-4057qib7	3806	8	of	of	IN
cord-005453-4057qib7	3806	9	CD4+Ttm	cd4+ttm	NN
cord-005453-4057qib7	3806	10	and	and	CC
cord-005453-4057qib7	3806	11	CD4+Tte	CD4+Tte	NNP
cord-005453-4057qib7	3806	12	is	be	VBZ
cord-005453-4057qib7	3806	13	associated	associate	VBN
cord-005453-4057qib7	3806	14	with	with	IN
cord-005453-4057qib7	3806	15	primary	primary	JJ
cord-005453-4057qib7	3806	16	graft	graft	NN
cord-005453-4057qib7	3806	17	failure	failure	NN
cord-005453-4057qib7	3806	18	.	.	.
cord-005453-4057qib7	3807	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3807	2	:	:	:
cord-005453-4057qib7	3808	1	Based	base	VBN
cord-005453-4057qib7	3808	2	on	on	IN
cord-005453-4057qib7	3808	3	these	these	DT
cord-005453-4057qib7	3808	4	findings	finding	NNS
cord-005453-4057qib7	3808	5	high	high	JJ
cord-005453-4057qib7	3808	6	absolute	absolute	JJ
cord-005453-4057qib7	3808	7	number	number	NN
cord-005453-4057qib7	3808	8	of	of	IN
cord-005453-4057qib7	3808	9	CD4+Ttm	cd4+ttm	NN
cord-005453-4057qib7	3808	10	and	and	CC
cord-005453-4057qib7	3808	11	CD4+Tte	CD4+Tte	NNP
cord-005453-4057qib7	3808	12	could	could	MD
cord-005453-4057qib7	3808	13	be	be	VB
cord-005453-4057qib7	3808	14	one	one	CD
cord-005453-4057qib7	3808	15	of	of	IN
cord-005453-4057qib7	3808	16	the	the	DT
cord-005453-4057qib7	3808	17	prognostic	prognostic	JJ
cord-005453-4057qib7	3808	18	factors	factor	NNS
cord-005453-4057qib7	3808	19	of	of	IN
cord-005453-4057qib7	3808	20	primary	primary	JJ
cord-005453-4057qib7	3808	21	graft	graft	NN
cord-005453-4057qib7	3808	22	failure	failure	NN
cord-005453-4057qib7	3808	23	after	after	IN
cord-005453-4057qib7	3808	24	allo	allo	NN
cord-005453-4057qib7	3808	25	-	-	HYPH
cord-005453-4057qib7	3808	26	HSCT	HSCT	NNP
cord-005453-4057qib7	3808	27	.	.	.
cord-005453-4057qib7	3809	1	Optimizing	optimize	VBG
cord-005453-4057qib7	3809	2	ATG	ATG	NNP
cord-005453-4057qib7	3809	3	dose	dose	NN
cord-005453-4057qib7	3809	4	due	due	IN
cord-005453-4057qib7	3809	5	to	to	IN
cord-005453-4057qib7	3809	6	recipient	recipient	NN
cord-005453-4057qib7	3810	1	absolute	absolute	NNP
cord-005453-4057qib7	3810	2	T	T	NNP
cord-005453-4057qib7	3810	3	-	-	HYPH
cord-005453-4057qib7	3810	4	memory	memory	NN
cord-005453-4057qib7	3810	5	cell	cell	NN
cord-005453-4057qib7	3810	6	subsets	subset	NNS
cord-005453-4057qib7	3810	7	count	count	VBP
cord-005453-4057qib7	3810	8	before	before	IN
cord-005453-4057qib7	3810	9	ATG	ATG	NNP
cord-005453-4057qib7	3810	10	administering	administer	VBG
cord-005453-4057qib7	3810	11	may	may	MD
cord-005453-4057qib7	3810	12	prevent	prevent	VB
cord-005453-4057qib7	3810	13	graft	graft	NN
cord-005453-4057qib7	3810	14	failure	failure	NN
cord-005453-4057qib7	3810	15	and	and	CC
cord-005453-4057qib7	3810	16	improve	improve	VB
cord-005453-4057qib7	3810	17	posttransplant	posttransplant	NN
cord-005453-4057qib7	3810	18	results	result	NNS
cord-005453-4057qib7	3810	19	.	.	.
cord-005453-4057qib7	3811	1	Background	background	NN
cord-005453-4057qib7	3811	2	:	:	:
cord-005453-4057qib7	3812	1	Upper	upper	JJ
cord-005453-4057qib7	3812	2	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	3812	3	graft	graft	NN
cord-005453-4057qib7	3812	4	-	-	HYPH
cord-005453-4057qib7	3812	5	versus	versus	IN
cord-005453-4057qib7	3812	6	-	-	HYPH
cord-005453-4057qib7	3812	7	host	host	NN
cord-005453-4057qib7	3812	8	disease	disease	NN
cord-005453-4057qib7	3812	9	(	(	-LRB-
cord-005453-4057qib7	3812	10	GI	GI	NNP
cord-005453-4057qib7	3812	11	GVHD	GVHD	NNP
cord-005453-4057qib7	3812	12	)	)	-RRB-
cord-005453-4057qib7	3812	13	has	have	VBZ
cord-005453-4057qib7	3812	14	been	be	VBN
cord-005453-4057qib7	3812	15	an	an	DT
cord-005453-4057qib7	3812	16	increasingly	increasingly	RB
cord-005453-4057qib7	3812	17	recognised	recognise	VBN
cord-005453-4057qib7	3812	18	entity	entity	NN
cord-005453-4057qib7	3812	19	following	follow	VBG
cord-005453-4057qib7	3812	20	allogeneic	allogeneic	IN
cord-005453-4057qib7	3812	21	stem	stem	NN
cord-005453-4057qib7	3812	22	cell	cell	NN
cord-005453-4057qib7	3812	23	transplantation	transplantation	NN
cord-005453-4057qib7	3812	24	(	(	-LRB-
cord-005453-4057qib7	3812	25	SCT	SCT	NNP
cord-005453-4057qib7	3812	26	)	)	-RRB-
cord-005453-4057qib7	3812	27	.	.	.
cord-005453-4057qib7	3813	1	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3813	2	,	,	,
cord-005453-4057qib7	3813	3	widely	widely	RB
cord-005453-4057qib7	3813	4	used	use	VBN
cord-005453-4057qib7	3813	5	in	in	IN
cord-005453-4057qib7	3813	6	inflammatory	inflammatory	JJ
cord-005453-4057qib7	3813	7	bowel	bowel	NN
cord-005453-4057qib7	3813	8	conditions	condition	NNS
cord-005453-4057qib7	3813	9	,	,	,
cord-005453-4057qib7	3813	10	has	have	VBZ
cord-005453-4057qib7	3813	11	also	also	RB
cord-005453-4057qib7	3813	12	been	be	VBN
cord-005453-4057qib7	3813	13	found	find	VBN
cord-005453-4057qib7	3813	14	beneficial	beneficial	JJ
cord-005453-4057qib7	3813	15	in	in	IN
cord-005453-4057qib7	3813	16	GI	GI	NNP
cord-005453-4057qib7	3813	17	GVHD	GVHD	NNP
cord-005453-4057qib7	3813	18	.	.	.
cord-005453-4057qib7	3814	1	The	the	DT
cord-005453-4057qib7	3814	2	major	major	JJ
cord-005453-4057qib7	3814	3	benefit	benefit	NN
cord-005453-4057qib7	3814	4	of	of	IN
cord-005453-4057qib7	3814	5	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3814	6	is	be	VBZ
cord-005453-4057qib7	3814	7	attributable	attributable	JJ
cord-005453-4057qib7	3814	8	to	to	IN
cord-005453-4057qib7	3814	9	its	-PRON-	PRP$
cord-005453-4057qib7	3814	10	poor	poor	JJ
cord-005453-4057qib7	3814	11	absorption	absorption	NN
cord-005453-4057qib7	3814	12	and	and	CC
cord-005453-4057qib7	3814	13	extensive	extensive	JJ
cord-005453-4057qib7	3814	14	first	first	JJ
cord-005453-4057qib7	3814	15	-	-	HYPH
cord-005453-4057qib7	3814	16	pass	pass	NN
cord-005453-4057qib7	3814	17	metabolism	metabolism	NN
cord-005453-4057qib7	3814	18	via	via	IN
cord-005453-4057qib7	3814	19	cytochrome	cytochrome	NN
cord-005453-4057qib7	3814	20	P450	p450	NN
cord-005453-4057qib7	3814	21	(	(	-LRB-
cord-005453-4057qib7	3814	22	CYP	CYP	NNP
cord-005453-4057qib7	3814	23	)	)	-RRB-
cord-005453-4057qib7	3814	24	3A4	3A4	NNP
cord-005453-4057qib7	3814	25	,	,	,
cord-005453-4057qib7	3814	26	which	which	WDT
cord-005453-4057qib7	3814	27	translates	translate	VBZ
cord-005453-4057qib7	3814	28	to	to	IN
cord-005453-4057qib7	3814	29	less	less	RBR
cord-005453-4057qib7	3814	30	systemic	systemic	JJ
cord-005453-4057qib7	3814	31	steroid	steroid	NN
cord-005453-4057qib7	3814	32	-	-	HYPH
cord-005453-4057qib7	3814	33	related	relate	VBN
cord-005453-4057qib7	3814	34	effects	effect	NNS
cord-005453-4057qib7	3814	35	.	.	.
cord-005453-4057qib7	3815	1	However	however	RB
cord-005453-4057qib7	3815	2	,	,	,
cord-005453-4057qib7	3815	3	transplant	transplant	NN
cord-005453-4057qib7	3815	4	patients	patient	NNS
cord-005453-4057qib7	3815	5	are	be	VBP
cord-005453-4057qib7	3815	6	often	often	RB
cord-005453-4057qib7	3815	7	exposed	expose	VBN
cord-005453-4057qib7	3815	8	to	to	IN
cord-005453-4057qib7	3815	9	multiple	multiple	JJ
cord-005453-4057qib7	3815	10	drugs	drug	NNS
cord-005453-4057qib7	3815	11	,	,	,
cord-005453-4057qib7	3815	12	among	among	IN
cord-005453-4057qib7	3815	13	which	which	WDT
cord-005453-4057qib7	3815	14	some	some	DT
cord-005453-4057qib7	3815	15	agents	agent	NNS
cord-005453-4057qib7	3815	16	act	act	VBP
cord-005453-4057qib7	3815	17	as	as	IN
cord-005453-4057qib7	3815	18	CYP3A4	cyp3a4	JJ
cord-005453-4057qib7	3815	19	inhibitors	inhibitor	NNS
cord-005453-4057qib7	3815	20	and	and	CC
cord-005453-4057qib7	3815	21	therefore	therefore	RB
cord-005453-4057qib7	3815	22	can	can	MD
cord-005453-4057qib7	3815	23	increase	increase	VB
cord-005453-4057qib7	3815	24	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3815	25	bioavailability	bioavailability	NN
cord-005453-4057qib7	3815	26	and	and	CC
cord-005453-4057qib7	3815	27	might	may	MD
cord-005453-4057qib7	3815	28	lead	lead	VB
cord-005453-4057qib7	3815	29	to	to	IN
cord-005453-4057qib7	3815	30	systemic	systemic	JJ
cord-005453-4057qib7	3815	31	toxicity	toxicity	NN
cord-005453-4057qib7	3815	32	.	.	.
cord-005453-4057qib7	3816	1	Azole	Azole	NNP
cord-005453-4057qib7	3816	2	antifungal	antifungal	JJ
cord-005453-4057qib7	3816	3	drugs	drug	NNS
cord-005453-4057qib7	3816	4	are	be	VBP
cord-005453-4057qib7	3816	5	probably	probably	RB
cord-005453-4057qib7	3816	6	the	the	DT
cord-005453-4057qib7	3816	7	most	most	RBS
cord-005453-4057qib7	3816	8	common	common	JJ
cord-005453-4057qib7	3816	9	concomitantly	concomitantly	RB
cord-005453-4057qib7	3816	10	used	use	VBN
cord-005453-4057qib7	3816	11	CYP3A4	cyp3a4	JJ
cord-005453-4057qib7	3816	12	inhibitors	inhibitor	NNS
cord-005453-4057qib7	3816	13	in	in	IN
cord-005453-4057qib7	3816	14	transplant	transplant	NN
cord-005453-4057qib7	3816	15	recipients	recipient	NNS
cord-005453-4057qib7	3816	16	.	.	.
cord-005453-4057qib7	3817	1	Methods	method	NNS
cord-005453-4057qib7	3817	2	:	:	:
cord-005453-4057qib7	3817	3	We	-PRON-	PRP
cord-005453-4057qib7	3817	4	reviewed	review	VBD
cord-005453-4057qib7	3817	5	allogeneic	allogeneic	JJ
cord-005453-4057qib7	3817	6	SCT	SCT	NNP
cord-005453-4057qib7	3817	7	records	record	NNS
cord-005453-4057qib7	3817	8	for	for	IN
cord-005453-4057qib7	3817	9	patients	patient	NNS
cord-005453-4057qib7	3817	10	treated	treat	VBN
cord-005453-4057qib7	3817	11	with	with	IN
cord-005453-4057qib7	3817	12	oral	oral	JJ
cord-005453-4057qib7	3817	13	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3817	14	for	for	IN
cord-005453-4057qib7	3817	15	GI	GI	NNP
cord-005453-4057qib7	3817	16	GVHD	GVHD	NNP
cord-005453-4057qib7	3817	17	at	at	IN
cord-005453-4057qib7	3817	18	our	-PRON-	PRP$
cord-005453-4057qib7	3817	19	transplant	transplant	NN
cord-005453-4057qib7	3817	20	centre	centre	NN
cord-005453-4057qib7	3817	21	between	between	IN
cord-005453-4057qib7	3817	22	2015	2015	CD
cord-005453-4057qib7	3817	23	and	and	CC
cord-005453-4057qib7	3817	24	2018	2018	CD
cord-005453-4057qib7	3817	25	retrospectively	retrospectively	RB
cord-005453-4057qib7	3817	26	.	.	.
cord-005453-4057qib7	3818	1	The	the	DT
cord-005453-4057qib7	3818	2	aim	aim	NN
cord-005453-4057qib7	3818	3	of	of	IN
cord-005453-4057qib7	3818	4	the	the	DT
cord-005453-4057qib7	3818	5	work	work	NN
cord-005453-4057qib7	3818	6	was	be	VBD
cord-005453-4057qib7	3818	7	to	to	TO
cord-005453-4057qib7	3818	8	assess	assess	VB
cord-005453-4057qib7	3818	9	the	the	DT
cord-005453-4057qib7	3818	10	development	development	NN
cord-005453-4057qib7	3818	11	of	of	IN
cord-005453-4057qib7	3818	12	adrenal	adrenal	JJ
cord-005453-4057qib7	3818	13	suppression	suppression	NN
cord-005453-4057qib7	3818	14	with	with	IN
cord-005453-4057qib7	3818	15	or	or	CC
cord-005453-4057qib7	3818	16	without	without	IN
cord-005453-4057qib7	3818	17	clinical	clinical	JJ
cord-005453-4057qib7	3818	18	features	feature	NNS
cord-005453-4057qib7	3818	19	of	of	IN
cord-005453-4057qib7	3818	20	iatrogenic	iatrogenic	JJ
cord-005453-4057qib7	3818	21	Cushing`s	cushing`s	NN
cord-005453-4057qib7	3818	22	syndrome	syndrome	NN
cord-005453-4057qib7	3818	23	.	.	.
cord-005453-4057qib7	3819	1	The	the	DT
cord-005453-4057qib7	3819	2	standard	standard	JJ
cord-005453-4057qib7	3819	3	dose	dose	NN
cord-005453-4057qib7	3819	4	of	of	IN
cord-005453-4057qib7	3819	5	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3819	6	was	be	VBD
cord-005453-4057qib7	3819	7	3	3	CD
cord-005453-4057qib7	3819	8	mg	mg	NNP
cord-005453-4057qib7	3819	9	three	three	CD
cord-005453-4057qib7	3819	10	times	time	NNS
cord-005453-4057qib7	3819	11	a	a	DT
cord-005453-4057qib7	3819	12	day	day	NN
cord-005453-4057qib7	3819	13	.	.	.
cord-005453-4057qib7	3820	1	Patients	patient	NNS
cord-005453-4057qib7	3820	2	receiving	receive	VBG
cord-005453-4057qib7	3820	3	Prednisolone	Prednisolone	NNP
cord-005453-4057qib7	3820	4	or	or	CC
cord-005453-4057qib7	3820	5	other	other	JJ
cord-005453-4057qib7	3820	6	glucocorticosteroids	glucocorticosteroid	NNS
cord-005453-4057qib7	3820	7	and	and	CC
cord-005453-4057qib7	3820	8	those	those	DT
cord-005453-4057qib7	3820	9	with	with	IN
cord-005453-4057qib7	3820	10	no	no	DT
cord-005453-4057qib7	3820	11	available	available	JJ
cord-005453-4057qib7	3820	12	serum	serum	NN
cord-005453-4057qib7	3820	13	cortisol	cortisol	NN
cord-005453-4057qib7	3820	14	level	level	NN
cord-005453-4057qib7	3820	15	measurements	measurement	NNS
cord-005453-4057qib7	3820	16	were	be	VBD
cord-005453-4057qib7	3820	17	excluded	exclude	VBN
cord-005453-4057qib7	3820	18	.	.	.
cord-005453-4057qib7	3821	1	Results	result	NNS
cord-005453-4057qib7	3821	2	:	:	:
cord-005453-4057qib7	3822	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3822	2	analyses	analysis	NNS
cord-005453-4057qib7	3822	3	identified	identify	VBD
cord-005453-4057qib7	3822	4	four	four	CD
cord-005453-4057qib7	3822	5	allogeneic	allogeneic	NN
cord-005453-4057qib7	3822	6	SCT	SCT	NNP
cord-005453-4057qib7	3822	7	patients	patient	NNS
cord-005453-4057qib7	3822	8	in	in	IN
cord-005453-4057qib7	3822	9	whom	whom	WP
cord-005453-4057qib7	3822	10	adrenal	adrenal	JJ
cord-005453-4057qib7	3822	11	suppression	suppression	NN
cord-005453-4057qib7	3822	12	was	be	VBD
cord-005453-4057qib7	3822	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	3822	14	with	with	IN
cord-005453-4057qib7	3822	15	undetectable	undetectable	JJ
cord-005453-4057qib7	3822	16	serum	serum	NN
cord-005453-4057qib7	3822	17	cortisol	cortisol	NN
cord-005453-4057qib7	3822	18	levels	level	NNS
cord-005453-4057qib7	3822	19	during	during	IN
cord-005453-4057qib7	3822	20	oral	oral	JJ
cord-005453-4057qib7	3822	21	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3822	22	treatment	treatment	NN
cord-005453-4057qib7	3822	23	.	.	.
cord-005453-4057qib7	3823	1	Of	of	IN
cord-005453-4057qib7	3823	2	these	these	DT
cord-005453-4057qib7	3823	3	patients	patient	NNS
cord-005453-4057qib7	3823	4	two	two	CD
cord-005453-4057qib7	3823	5	developed	develop	VBN
cord-005453-4057qib7	3823	6	iatrogenic	iatrogenic	JJ
cord-005453-4057qib7	3823	7	Cushing`s	cushing`s	NN
cord-005453-4057qib7	3823	8	syndrome	syndrome	NN
cord-005453-4057qib7	3823	9	and	and	CC
cord-005453-4057qib7	3823	10	both	both	DT
cord-005453-4057qib7	3823	11	patients	patient	NNS
cord-005453-4057qib7	3823	12	were	be	VBD
cord-005453-4057qib7	3823	13	treated	treat	VBN
cord-005453-4057qib7	3823	14	with	with	IN
cord-005453-4057qib7	3823	15	CYP3A4	cyp3a4	JJ
cord-005453-4057qib7	3823	16	inhibitors	inhibitor	NNS
cord-005453-4057qib7	3823	17	concomitantly	concomitantly	RB
cord-005453-4057qib7	3823	18	:	:	:
cord-005453-4057qib7	3823	19	1	1	CD
cord-005453-4057qib7	3823	20	.	.	.
cord-005453-4057qib7	3824	1	Clarithromycin	Clarithromycin	NNP
cord-005453-4057qib7	3824	2	and	and	CC
cord-005453-4057qib7	3824	3	Fluconazole	Fluconazole	NNP
cord-005453-4057qib7	3824	4	;	;	:
cord-005453-4057qib7	3824	5	2	2	CD
cord-005453-4057qib7	3824	6	.	.	.
cord-005453-4057qib7	3825	1	Clarithomycin	Clarithomycin	NNP
cord-005453-4057qib7	3825	2	and	and	CC
cord-005453-4057qib7	3825	3	Voriconazole	Voriconazole	NNP
cord-005453-4057qib7	3825	4	.	.	.
cord-005453-4057qib7	3826	1	The	the	DT
cord-005453-4057qib7	3826	2	development	development	NN
cord-005453-4057qib7	3826	3	was	be	VBD
cord-005453-4057qib7	3826	4	rapid	rapid	JJ
cord-005453-4057qib7	3826	5	(	(	-LRB-
cord-005453-4057qib7	3826	6	within	within	IN
cord-005453-4057qib7	3826	7	3	3	CD
cord-005453-4057qib7	3826	8	and	and	CC
cord-005453-4057qib7	3826	9	4	4	CD
cord-005453-4057qib7	3826	10	weeks	week	NNS
cord-005453-4057qib7	3826	11	)	)	-RRB-
cord-005453-4057qib7	3826	12	.	.	.
cord-005453-4057qib7	3827	1	Symptoms	symptom	NNS
cord-005453-4057qib7	3827	2	included	include	VBD
cord-005453-4057qib7	3827	3	morphological	morphological	JJ
cord-005453-4057qib7	3827	4	features	feature	NNS
cord-005453-4057qib7	3827	5	such	such	JJ
cord-005453-4057qib7	3827	6	as	as	IN
cord-005453-4057qib7	3827	7	moon	moon	NN
cord-005453-4057qib7	3827	8	face	face	NN
cord-005453-4057qib7	3827	9	,	,	,
cord-005453-4057qib7	3827	10	high	high	JJ
cord-005453-4057qib7	3827	11	blood	blood	NN
cord-005453-4057qib7	3827	12	pressure	pressure	NN
cord-005453-4057qib7	3827	13	,	,	,
cord-005453-4057qib7	3827	14	weight	weight	NN
cord-005453-4057qib7	3827	15	gain	gain	NN
cord-005453-4057qib7	3827	16	,	,	,
cord-005453-4057qib7	3827	17	peripheral	peripheral	JJ
cord-005453-4057qib7	3827	18	oedema	oedema	NN
cord-005453-4057qib7	3827	19	and	and	CC
cord-005453-4057qib7	3827	20	proximal	proximal	JJ
cord-005453-4057qib7	3827	21	myopathy	myopathy	NN
cord-005453-4057qib7	3827	22	.	.	.
cord-005453-4057qib7	3828	1	Symptoms	symptom	NNS
cord-005453-4057qib7	3828	2	resolved	resolve	VBD
cord-005453-4057qib7	3828	3	gradually	gradually	RB
cord-005453-4057qib7	3828	4	following	follow	VBG
cord-005453-4057qib7	3828	5	cessation	cessation	NN
cord-005453-4057qib7	3828	6	of	of	IN
cord-005453-4057qib7	3828	7	azole	azole	NNP
cord-005453-4057qib7	3828	8	antifungal	antifungal	JJ
cord-005453-4057qib7	3828	9	agents	agent	NNS
cord-005453-4057qib7	3828	10	and	and	CC
cord-005453-4057qib7	3828	11	on	on	IN
cord-005453-4057qib7	3828	12	gradual	gradual	JJ
cord-005453-4057qib7	3828	13	weaning	weaning	NN
cord-005453-4057qib7	3828	14	of	of	IN
cord-005453-4057qib7	3828	15	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3828	16	.	.	.
cord-005453-4057qib7	3829	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3829	2	:	:	:
cord-005453-4057qib7	3830	1	Although	although	IN
cord-005453-4057qib7	3830	2	single	single	JJ
cord-005453-4057qib7	3830	3	agent	agent	NN
cord-005453-4057qib7	3830	4	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3830	5	treatment	treatment	NN
cord-005453-4057qib7	3830	6	given	give	VBN
cord-005453-4057qib7	3830	7	for	for	IN
cord-005453-4057qib7	3830	8	GI	GI	NNP
cord-005453-4057qib7	3830	9	GVHD	GVHD	NNP
cord-005453-4057qib7	3830	10	is	be	VBZ
cord-005453-4057qib7	3830	11	rarely	rarely	RB
cord-005453-4057qib7	3830	12	associated	associate	VBN
cord-005453-4057qib7	3830	13	with	with	IN
cord-005453-4057qib7	3830	14	systemic	systemic	JJ
cord-005453-4057qib7	3830	15	side	side	NN
cord-005453-4057qib7	3830	16	effects	effect	NNS
cord-005453-4057qib7	3830	17	,	,	,
cord-005453-4057qib7	3830	18	patients	patient	NNS
cord-005453-4057qib7	3830	19	on	on	IN
cord-005453-4057qib7	3830	20	azole	azole	NNP
cord-005453-4057qib7	3830	21	antifungal	antifungal	JJ
cord-005453-4057qib7	3830	22	drugs	drug	NNS
cord-005453-4057qib7	3830	23	and	and	CC
cord-005453-4057qib7	3830	24	macrolide	macrolide	NN
cord-005453-4057qib7	3830	25	antibiotics	antibiotic	NNS
cord-005453-4057qib7	3830	26	are	be	VBP
cord-005453-4057qib7	3830	27	at	at	IN
cord-005453-4057qib7	3830	28	higher	high	JJR
cord-005453-4057qib7	3830	29	risk	risk	NN
cord-005453-4057qib7	3830	30	of	of	IN
cord-005453-4057qib7	3830	31	systemic	systemic	JJ
cord-005453-4057qib7	3830	32	toxicity	toxicity	NN
cord-005453-4057qib7	3830	33	due	due	IN
cord-005453-4057qib7	3830	34	to	to	IN
cord-005453-4057qib7	3830	35	drug	drug	NN
cord-005453-4057qib7	3830	36	interactions	interaction	NNS
cord-005453-4057qib7	3830	37	.	.	.
cord-005453-4057qib7	3831	1	Patients	patient	NNS
cord-005453-4057qib7	3831	2	who	who	WP
cord-005453-4057qib7	3831	3	are	be	VBP
cord-005453-4057qib7	3831	4	allergic	allergic	JJ
cord-005453-4057qib7	3831	5	to	to	IN
cord-005453-4057qib7	3831	6	Penicillin	Penicillin	NNP
cord-005453-4057qib7	3831	7	and	and	CC
cord-005453-4057qib7	3831	8	receive	receive	VB
cord-005453-4057qib7	3831	9	macrolide	macrolide	NN
cord-005453-4057qib7	3831	10	-	-	HYPH
cord-005453-4057qib7	3831	11	based	base	VBN
cord-005453-4057qib7	3831	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3831	13	can	can	MD
cord-005453-4057qib7	3831	14	be	be	VB
cord-005453-4057qib7	3831	15	especially	especially	RB
cord-005453-4057qib7	3831	16	vulnerable	vulnerable	JJ
cord-005453-4057qib7	3831	17	.	.	.
cord-005453-4057qib7	3832	1	To	to	IN
cord-005453-4057qib7	3832	2	our	-PRON-	PRP$
cord-005453-4057qib7	3832	3	knowledge	knowledge	NN
cord-005453-4057qib7	3832	4	the	the	DT
cord-005453-4057qib7	3832	5	number	number	NN
cord-005453-4057qib7	3832	6	of	of	IN
cord-005453-4057qib7	3832	7	cases	case	NNS
cord-005453-4057qib7	3832	8	reported	report	VBN
cord-005453-4057qib7	3832	9	in	in	IN
cord-005453-4057qib7	3832	10	literature	literature	NN
cord-005453-4057qib7	3832	11	about	about	IN
cord-005453-4057qib7	3832	12	systemic	systemic	JJ
cord-005453-4057qib7	3832	13	effects	effect	NNS
cord-005453-4057qib7	3832	14	of	of	IN
cord-005453-4057qib7	3832	15	oral	oral	JJ
cord-005453-4057qib7	3832	16	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3832	17	in	in	IN
cord-005453-4057qib7	3832	18	transplant	transplant	NN
cord-005453-4057qib7	3832	19	recipients	recipient	NNS
cord-005453-4057qib7	3832	20	is	be	VBZ
cord-005453-4057qib7	3832	21	less	less	JJR
cord-005453-4057qib7	3832	22	than	than	IN
cord-005453-4057qib7	3832	23	10	10	CD
cord-005453-4057qib7	3832	24	.	.	.
cord-005453-4057qib7	3833	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3833	2	observation	observation	NN
cord-005453-4057qib7	3833	3	supports	support	VBZ
cord-005453-4057qib7	3833	4	previous	previous	JJ
cord-005453-4057qib7	3833	5	reports	report	NNS
cord-005453-4057qib7	3833	6	on	on	IN
cord-005453-4057qib7	3833	7	the	the	DT
cord-005453-4057qib7	3833	8	potential	potential	NN
cord-005453-4057qib7	3833	9	of	of	IN
cord-005453-4057qib7	3833	10	oral	oral	JJ
cord-005453-4057qib7	3833	11	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3833	12	to	to	TO
cord-005453-4057qib7	3833	13	induce	induce	VB
cord-005453-4057qib7	3833	14	systemic	systemic	JJ
cord-005453-4057qib7	3833	15	effects	effect	NNS
cord-005453-4057qib7	3833	16	.	.	.
cord-005453-4057qib7	3834	1	We	-PRON-	PRP
cord-005453-4057qib7	3834	2	therefore	therefore	RB
cord-005453-4057qib7	3834	3	advise	advise	VBP
cord-005453-4057qib7	3834	4	careful	careful	JJ
cord-005453-4057qib7	3834	5	monitoring	monitoring	NN
cord-005453-4057qib7	3834	6	of	of	IN
cord-005453-4057qib7	3834	7	patients	patient	NNS
cord-005453-4057qib7	3834	8	treated	treat	VBN
cord-005453-4057qib7	3834	9	with	with	IN
cord-005453-4057qib7	3834	10	Budesonide	Budesonide	NNP
cord-005453-4057qib7	3834	11	in	in	IN
cord-005453-4057qib7	3834	12	combination	combination	NN
cord-005453-4057qib7	3834	13	with	with	IN
cord-005453-4057qib7	3834	14	CYP3A4	CYP3A4	NNP
cord-005453-4057qib7	3834	15	inhibitors	inhibitor	NNS
cord-005453-4057qib7	3834	16	,	,	,
cord-005453-4057qib7	3834	17	including	include	VBG
cord-005453-4057qib7	3834	18	antimicrobial	antimicrobial	JJ
cord-005453-4057qib7	3834	19	agents	agent	NNS
cord-005453-4057qib7	3834	20	routinely	routinely	RB
cord-005453-4057qib7	3834	21	used	use	VBN
cord-005453-4057qib7	3834	22	in	in	IN
cord-005453-4057qib7	3834	23	SCT	SCT	NNP
cord-005453-4057qib7	3834	24	.	.	.
cord-005453-4057qib7	3835	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3835	2	:	:	:
cord-005453-4057qib7	3836	1	None	none	NN
cord-005453-4057qib7	3836	2	Implemented	implement	VBD
cord-005453-4057qib7	3836	3	strategies	strategy	NNS
cord-005453-4057qib7	3836	4	to	to	TO
cord-005453-4057qib7	3836	5	overcome	overcome	VB
cord-005453-4057qib7	3836	6	barriers	barrier	NNS
cord-005453-4057qib7	3836	7	in	in	IN
cord-005453-4057qib7	3836	8	the	the	DT
cord-005453-4057qib7	3836	9	establishment	establishment	NN
cord-005453-4057qib7	3836	10	of	of	IN
cord-005453-4057qib7	3836	11	a	a	DT
cord-005453-4057qib7	3836	12	consolidated	consolidated	JJ
cord-005453-4057qib7	3836	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3836	14	stem	stem	NN
cord-005453-4057qib7	3836	15	cell	cell	NN
cord-005453-4057qib7	3836	16	transplantation	transplantation	NN
cord-005453-4057qib7	3836	17	program	program	NN
cord-005453-4057qib7	3836	18	in	in	IN
cord-005453-4057qib7	3836	19	a	a	DT
cord-005453-4057qib7	3836	20	developing	develop	VBG
cord-005453-4057qib7	3836	21	country	country	NN
cord-005453-4057qib7	3836	22	Background	background	NN
cord-005453-4057qib7	3836	23	:	:	:
cord-005453-4057qib7	3836	24	The	the	DT
cord-005453-4057qib7	3836	25	National	National	NNP
cord-005453-4057qib7	3836	26	Institute	Institute	NNP
cord-005453-4057qib7	3836	27	of	of	IN
cord-005453-4057qib7	3836	28	Medical	Medical	NNP
cord-005453-4057qib7	3836	29	Sciences	Sciences	NNPS
cord-005453-4057qib7	3836	30	and	and	CC
cord-005453-4057qib7	3836	31	Nutrition	Nutrition	NNP
cord-005453-4057qib7	3836	32	"	"	``
cord-005453-4057qib7	3836	33	Salvador	Salvador	NNP
cord-005453-4057qib7	3836	34	Zubiran	Zubiran	NNP
cord-005453-4057qib7	3836	35	"	"	''
cord-005453-4057qib7	3836	36	is	be	VBZ
cord-005453-4057qib7	3836	37	a	a	DT
cord-005453-4057qib7	3836	38	National	National	NNP
cord-005453-4057qib7	3836	39	Health	Health	NNP
cord-005453-4057qib7	3836	40	Institute	Institute	NNP
cord-005453-4057qib7	3836	41	located	locate	VBN
cord-005453-4057qib7	3836	42	in	in	IN
cord-005453-4057qib7	3836	43	Mexico	Mexico	NNP
cord-005453-4057qib7	3836	44	City	City	NNP
cord-005453-4057qib7	3836	45	.	.	.
cord-005453-4057qib7	3837	1	Although	although	IN
cord-005453-4057qib7	3837	2	Mexico	Mexico	NNP
cord-005453-4057qib7	3837	3	is	be	VBZ
cord-005453-4057qib7	3837	4	considered	consider	VBN
cord-005453-4057qib7	3837	5	an	an	DT
cord-005453-4057qib7	3837	6	upper	upper	JJ
cord-005453-4057qib7	3837	7	-	-	HYPH
cord-005453-4057qib7	3837	8	middle	middle	JJ
cord-005453-4057qib7	3837	9	income	income	NN
cord-005453-4057qib7	3837	10	country	country	NN
cord-005453-4057qib7	3837	11	,	,	,
cord-005453-4057qib7	3837	12	more	more	JJR
cord-005453-4057qib7	3837	13	than	than	IN
cord-005453-4057qib7	3837	14	50	50	CD
cord-005453-4057qib7	3837	15	%	%	NN
cord-005453-4057qib7	3837	16	of	of	IN
cord-005453-4057qib7	3837	17	the	the	DT
cord-005453-4057qib7	3837	18	population	population	NN
cord-005453-4057qib7	3837	19	lives	live	VBZ
cord-005453-4057qib7	3837	20	in	in	IN
cord-005453-4057qib7	3837	21	poverty	poverty	NN
cord-005453-4057qib7	3837	22	without	without	IN
cord-005453-4057qib7	3837	23	health	health	NN
cord-005453-4057qib7	3837	24	care	care	NN
cord-005453-4057qib7	3837	25	coverage	coverage	NN
cord-005453-4057qib7	3837	26	and	and	CC
cord-005453-4057qib7	3837	27	patients	patient	NNS
cord-005453-4057qib7	3837	28	within	within	IN
cord-005453-4057qib7	3837	29	this	this	DT
cord-005453-4057qib7	3837	30	social	social	JJ
cord-005453-4057qib7	3837	31	stratum	stratum	NN
cord-005453-4057qib7	3837	32	are	be	VBP
cord-005453-4057qib7	3837	33	referred	refer	VBN
cord-005453-4057qib7	3837	34	to	to	IN
cord-005453-4057qib7	3837	35	our	-PRON-	PRP$
cord-005453-4057qib7	3837	36	Institution	Institution	NNP
cord-005453-4057qib7	3837	37	.	.	.
cord-005453-4057qib7	3838	1	The	the	DT
cord-005453-4057qib7	3838	2	first	first	JJ
cord-005453-4057qib7	3838	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3838	4	stem	stem	NN
cord-005453-4057qib7	3838	5	cell	cell	NN
cord-005453-4057qib7	3838	6	transplantation	transplantation	NN
cord-005453-4057qib7	3838	7	(	(	-LRB-
cord-005453-4057qib7	3838	8	HSCT	HSCT	NNP
cord-005453-4057qib7	3838	9	)	)	-RRB-
cord-005453-4057qib7	3838	10	in	in	IN
cord-005453-4057qib7	3838	11	Mexico	Mexico	NNP
cord-005453-4057qib7	3838	12	was	be	VBD
cord-005453-4057qib7	3838	13	performed	perform	VBN
cord-005453-4057qib7	3838	14	at	at	IN
cord-005453-4057qib7	3838	15	our	-PRON-	PRP$
cord-005453-4057qib7	3838	16	Institution	Institution	NNP
cord-005453-4057qib7	3838	17	in	in	IN
cord-005453-4057qib7	3838	18	1980	1980	CD
cord-005453-4057qib7	3838	19	.	.	.
cord-005453-4057qib7	3839	1	From	from	IN
cord-005453-4057qib7	3839	2	this	this	DT
cord-005453-4057qib7	3839	3	year	year	NN
cord-005453-4057qib7	3839	4	until	until	IN
cord-005453-4057qib7	3839	5	1997	1997	CD
cord-005453-4057qib7	3839	6	,	,	,
cord-005453-4057qib7	3839	7	HSCT	HSCT	NNP
cord-005453-4057qib7	3839	8	were	be	VBD
cord-005453-4057qib7	3839	9	sporadically	sporadically	RB
cord-005453-4057qib7	3839	10	performed	perform	VBN
cord-005453-4057qib7	3839	11	(	(	-LRB-
cord-005453-4057qib7	3839	12	n=33	n=33	NNP
cord-005453-4057qib7	3839	13	)	)	-RRB-
cord-005453-4057qib7	3839	14	,	,	,
cord-005453-4057qib7	3839	15	showing	show	VBG
cord-005453-4057qib7	3839	16	a	a	DT
cord-005453-4057qib7	3839	17	poor	poor	JJ
cord-005453-4057qib7	3839	18	overall	overall	JJ
cord-005453-4057qib7	3839	19	survival	survival	NN
cord-005453-4057qib7	3839	20	(	(	-LRB-
cord-005453-4057qib7	3839	21	OS	OS	NNP
cord-005453-4057qib7	3839	22	)	)	-RRB-
cord-005453-4057qib7	3839	23	and	and	CC
cord-005453-4057qib7	3839	24	high	high	JJ
cord-005453-4057qib7	3839	25	non	non	JJ
cord-005453-4057qib7	3839	26	-	-	JJ
cord-005453-4057qib7	3839	27	relapse	relapse	JJ
cord-005453-4057qib7	3839	28	mortality	mortality	NN
cord-005453-4057qib7	3839	29	(	(	-LRB-
cord-005453-4057qib7	3839	30	NRM	NRM	NNP
cord-005453-4057qib7	3839	31	)	)	-RRB-
cord-005453-4057qib7	3839	32	.	.	.
cord-005453-4057qib7	3840	1	These	these	DT
cord-005453-4057qib7	3840	2	outcomes	outcome	NNS
cord-005453-4057qib7	3840	3	resulted	result	VBD
cord-005453-4057qib7	3840	4	from	from	IN
cord-005453-4057qib7	3840	5	an	an	DT
cord-005453-4057qib7	3840	6	unstructured	unstructured	JJ
cord-005453-4057qib7	3840	7	HSCT	HSCT	NNP
cord-005453-4057qib7	3840	8	Program	Program	NNP
cord-005453-4057qib7	3840	9	,	,	,
cord-005453-4057qib7	3840	10	limitedresources	limitedresource	NNS
cord-005453-4057qib7	3840	11	,	,	,
cord-005453-4057qib7	3840	12	patient	patient	JJ
cord-005453-4057qib7	3840	13	low	low	JJ
cord-005453-4057qib7	3840	14	socioeconomic	socioeconomic	JJ
cord-005453-4057qib7	3840	15	status	status	NN
cord-005453-4057qib7	3840	16	,	,	,
cord-005453-4057qib7	3840	17	and	and	CC
cord-005453-4057qib7	3840	18	paucity	paucity	NN
cord-005453-4057qib7	3840	19	of	of	IN
cord-005453-4057qib7	3840	20	population	population	NN
cord-005453-4057qib7	3840	21	-	-	HYPH
cord-005453-4057qib7	3840	22	adapted	adapt	VBN
cord-005453-4057qib7	3840	23	procedures	procedure	NNS
cord-005453-4057qib7	3840	24	.	.	.
cord-005453-4057qib7	3841	1	In	in	IN
cord-005453-4057qib7	3841	2	1998	1998	CD
cord-005453-4057qib7	3841	3	,	,	,
cord-005453-4057qib7	3841	4	according	accord	VBG
cord-005453-4057qib7	3841	5	to	to	IN
cord-005453-4057qib7	3841	6	these	these	DT
cord-005453-4057qib7	3841	7	results	result	NNS
cord-005453-4057qib7	3841	8	,	,	,
cord-005453-4057qib7	3841	9	a	a	DT
cord-005453-4057qib7	3841	10	decision	decision	NN
cord-005453-4057qib7	3841	11	to	to	TO
cord-005453-4057qib7	3841	12	establish	establish	VB
cord-005453-4057qib7	3841	13	a	a	DT
cord-005453-4057qib7	3841	14	HSCT	HSCT	NNP
cord-005453-4057qib7	3841	15	Program	Program	NNP
cord-005453-4057qib7	3841	16	was	be	VBD
cord-005453-4057qib7	3841	17	made	make	VBN
cord-005453-4057qib7	3841	18	.	.	.
cord-005453-4057qib7	3842	1	Therefore	therefore	RB
cord-005453-4057qib7	3842	2	,	,	,
cord-005453-4057qib7	3842	3	in	in	IN
cord-005453-4057qib7	3842	4	order	order	NN
cord-005453-4057qib7	3842	5	to	to	TO
cord-005453-4057qib7	3842	6	set	set	VB
cord-005453-4057qib7	3842	7	up	up	RP
cord-005453-4057qib7	3842	8	a	a	DT
cord-005453-4057qib7	3842	9	successful	successful	JJ
cord-005453-4057qib7	3842	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3842	11	Program	Program	NNP
cord-005453-4057qib7	3842	12	,	,	,
cord-005453-4057qib7	3842	13	implementation	implementation	NN
cord-005453-4057qib7	3842	14	of	of	IN
cord-005453-4057qib7	3842	15	financial	financial	JJ
cord-005453-4057qib7	3842	16	and	and	CC
cord-005453-4057qib7	3842	17	medical	medical	JJ
cord-005453-4057qib7	3842	18	strategies	strategy	NNS
cord-005453-4057qib7	3842	19	were	be	VBD
cord-005453-4057qib7	3842	20	necessary	necessary	JJ
cord-005453-4057qib7	3842	21	.	.	.
cord-005453-4057qib7	3843	1	The	the	DT
cord-005453-4057qib7	3843	2	objectives	objective	NNS
cord-005453-4057qib7	3843	3	of	of	IN
cord-005453-4057qib7	3843	4	this	this	DT
cord-005453-4057qib7	3843	5	study	study	NN
cord-005453-4057qib7	3843	6	were	be	VBD
cord-005453-4057qib7	3843	7	to	to	TO
cord-005453-4057qib7	3843	8	describe	describe	VB
cord-005453-4057qib7	3843	9	the	the	DT
cord-005453-4057qib7	3843	10	barriers	barrier	NNS
cord-005453-4057qib7	3843	11	and	and	CC
cord-005453-4057qib7	3843	12	implemented	implement	VBN
cord-005453-4057qib7	3843	13	strategies	strategy	NNS
cord-005453-4057qib7	3843	14	for	for	IN
cord-005453-4057qib7	3843	15	the	the	DT
cord-005453-4057qib7	3843	16	establishment	establishment	NN
cord-005453-4057qib7	3843	17	of	of	IN
cord-005453-4057qib7	3843	18	a	a	DT
cord-005453-4057qib7	3843	19	HSCT	HSCT	NNP
cord-005453-4057qib7	3843	20	Program	Program	NNP
cord-005453-4057qib7	3843	21	in	in	IN
cord-005453-4057qib7	3843	22	Mexico	Mexico	NNP
cord-005453-4057qib7	3843	23	along	along	IN
cord-005453-4057qib7	3843	24	with	with	IN
cord-005453-4057qib7	3843	25	the	the	DT
cord-005453-4057qib7	3843	26	outcomes	outcome	NNS
cord-005453-4057qib7	3843	27	of	of	IN
cord-005453-4057qib7	3843	28	patients	patient	NNS
cord-005453-4057qib7	3843	29	undergoing	undergo	VBG
cord-005453-4057qib7	3843	30	this	this	DT
cord-005453-4057qib7	3843	31	procedure	procedure	NN
cord-005453-4057qib7	3843	32	throughout	throughout	IN
cord-005453-4057qib7	3843	33	the	the	DT
cord-005453-4057qib7	3843	34	reorganization	reorganization	NN
cord-005453-4057qib7	3843	35	of	of	IN
cord-005453-4057qib7	3843	36	the	the	DT
cord-005453-4057qib7	3843	37	Program	Program	NNP
cord-005453-4057qib7	3843	38	.	.	.
cord-005453-4057qib7	3844	1	Methods	method	NNS
cord-005453-4057qib7	3844	2	:	:	:
cord-005453-4057qib7	3844	3	This	this	DT
cord-005453-4057qib7	3844	4	study	study	NN
cord-005453-4057qib7	3844	5	is	be	VBZ
cord-005453-4057qib7	3844	6	a	a	DT
cord-005453-4057qib7	3844	7	health	health	NN
cord-005453-4057qib7	3844	8	services	service	NNS
cord-005453-4057qib7	3844	9	research	research	NN
cord-005453-4057qib7	3844	10	.	.	.
cord-005453-4057qib7	3845	1	Barriers	barrier	NNS
cord-005453-4057qib7	3845	2	were	be	VBD
cord-005453-4057qib7	3845	3	detected	detect	VBN
cord-005453-4057qib7	3845	4	based	base	VBN
cord-005453-4057qib7	3845	5	on	on	IN
cord-005453-4057qib7	3845	6	the	the	DT
cord-005453-4057qib7	3845	7	results	result	NNS
cord-005453-4057qib7	3845	8	of	of	IN
cord-005453-4057qib7	3845	9	the	the	DT
cord-005453-4057qib7	3845	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3845	11	Program	Program	NNP
cord-005453-4057qib7	3845	12	from	from	IN
cord-005453-4057qib7	3845	13	1980	1980	CD
cord-005453-4057qib7	3845	14	-	-	SYM
cord-005453-4057qib7	3845	15	1997	1997	CD
cord-005453-4057qib7	3845	16	(	(	-LRB-
cord-005453-4057qib7	3845	17	not	not	RB
cord-005453-4057qib7	3845	18	shown	show	VBN
cord-005453-4057qib7	3845	19	)	)	-RRB-
cord-005453-4057qib7	3845	20	.	.	.
cord-005453-4057qib7	3846	1	Table	table	NN
cord-005453-4057qib7	3846	2	1	1	CD
cord-005453-4057qib7	3846	3	shows	show	VBZ
cord-005453-4057qib7	3846	4	the	the	DT
cord-005453-4057qib7	3846	5	financial	financial	JJ
cord-005453-4057qib7	3846	6	,	,	,
cord-005453-4057qib7	3846	7	medical	medical	JJ
cord-005453-4057qib7	3846	8	,	,	,
cord-005453-4057qib7	3846	9	and	and	CC
cord-005453-4057qib7	3846	10	research	research	NN
cord-005453-4057qib7	3846	11	strategies	strategy	NNS
cord-005453-4057qib7	3846	12	that	that	WDT
cord-005453-4057qib7	3846	13	were	be	VBD
cord-005453-4057qib7	3846	14	implemented	implement	VBN
cord-005453-4057qib7	3846	15	for	for	IN
cord-005453-4057qib7	3846	16	each	each	DT
cord-005453-4057qib7	3846	17	barrier	barrier	NN
cord-005453-4057qib7	3846	18	.	.	.
cord-005453-4057qib7	3847	1	Results	result	NNS
cord-005453-4057qib7	3847	2	:	:	:
cord-005453-4057qib7	3848	1	From	from	IN
cord-005453-4057qib7	3848	2	November	November	NNP
cord-005453-4057qib7	3848	3	1998	1998	CD
cord-005453-4057qib7	3848	4	to	to	IN
cord-005453-4057qib7	3848	5	November	November	NNP
cord-005453-4057qib7	3848	6	2018	2018	CD
cord-005453-4057qib7	3848	7	,	,	,
cord-005453-4057qib7	3848	8	363	363	CD
cord-005453-4057qib7	3848	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3848	10	have	have	VBP
cord-005453-4057qib7	3848	11	been	be	VBN
cord-005453-4057qib7	3848	12	performed	perform	VBN
cord-005453-4057qib7	3848	13	in	in	IN
cord-005453-4057qib7	3848	14	322	322	CD
cord-005453-4057qib7	3848	15	patients	patient	NNS
cord-005453-4057qib7	3848	16	at	at	IN
cord-005453-4057qib7	3848	17	our	-PRON-	PRP$
cord-005453-4057qib7	3848	18	Institution	Institution	NNP
cord-005453-4057qib7	3848	19	.	.	.
cord-005453-4057qib7	3849	1	Most	Most	JJS
cord-005453-4057qib7	3849	2	HSCT	HSCT	NNP
cord-005453-4057qib7	3849	3	were	be	VBD
cord-005453-4057qib7	3849	4	autologous	autologous	JJ
cord-005453-4057qib7	3849	5	(	(	-LRB-
cord-005453-4057qib7	3849	6	n=213	n=213	NNP
cord-005453-4057qib7	3849	7	,	,	,
cord-005453-4057qib7	3849	8	59	59	CD
cord-005453-4057qib7	3849	9	%	%	NN
cord-005453-4057qib7	3849	10	)	)	-RRB-
cord-005453-4057qib7	3849	11	.	.	.
cord-005453-4057qib7	3850	1	Forty	forty	CD
cord-005453-4057qib7	3850	2	one	one	CD
cord-005453-4057qib7	3850	3	patients	patient	NNS
cord-005453-4057qib7	3850	4	underwent	undergo	VBD
cord-005453-4057qib7	3850	5	2	2	CD
cord-005453-4057qib7	3850	6	HSCT	HSCT	NNP
cord-005453-4057qib7	3850	7	.	.	.
cord-005453-4057qib7	3851	1	From	from	IN
cord-005453-4057qib7	3851	2	the	the	DT
cord-005453-4057qib7	3851	3	322	322	CD
cord-005453-4057qib7	3851	4	patients	patient	NNS
cord-005453-4057qib7	3851	5	,	,	,
cord-005453-4057qib7	3851	6	most	most	JJS
cord-005453-4057qib7	3851	7	were	be	VBD
cord-005453-4057qib7	3851	8	males	male	NNS
cord-005453-4057qib7	3851	9	(	(	-LRB-
cord-005453-4057qib7	3851	10	n=196	n=196	ADD
cord-005453-4057qib7	3851	11	,	,	,
cord-005453-4057qib7	3851	12	61	61	CD
cord-005453-4057qib7	3851	13	%	%	NN
cord-005453-4057qib7	3851	14	)	)	-RRB-
cord-005453-4057qib7	3851	15	and	and	CC
cord-005453-4057qib7	3851	16	the	the	DT
cord-005453-4057qib7	3851	17	median	median	JJ
cord-005453-4057qib7	3851	18	age	age	NN
cord-005453-4057qib7	3851	19	was	be	VBD
cord-005453-4057qib7	3851	20	33.5	33.5	CD
cord-005453-4057qib7	3851	21	years	year	NNS
cord-005453-4057qib7	3851	22	(	(	-LRB-
cord-005453-4057qib7	3851	23	range	range	NN
cord-005453-4057qib7	3851	24	,	,	,
cord-005453-4057qib7	3851	25	15	15	CD
cord-005453-4057qib7	3851	26	-	-	SYM
cord-005453-4057qib7	3851	27	65	65	CD
cord-005453-4057qib7	3851	28	)	)	-RRB-
cord-005453-4057qib7	3851	29	.	.	.
cord-005453-4057qib7	3852	1	The	the	DT
cord-005453-4057qib7	3852	2	most	most	RBS
cord-005453-4057qib7	3852	3	frequent	frequent	JJ
cord-005453-4057qib7	3852	4	underlying	underlie	VBG
cord-005453-4057qib7	3852	5	diseases	disease	NNS
cord-005453-4057qib7	3852	6	for	for	IN
cord-005453-4057qib7	3852	7	auto	auto	NN
cord-005453-4057qib7	3852	8	-	-	HYPH
cord-005453-4057qib7	3852	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3852	10	were	be	VBD
cord-005453-4057qib7	3852	11	lymphomas	lymphoma	NNS
cord-005453-4057qib7	3852	12	(	(	-LRB-
cord-005453-4057qib7	3852	13	n=68	n=68	JJ
cord-005453-4057qib7	3852	14	,	,	,
cord-005453-4057qib7	3852	15	36	36	CD
cord-005453-4057qib7	3852	16	%	%	NN
cord-005453-4057qib7	3852	17	)	)	-RRB-
cord-005453-4057qib7	3852	18	,	,	,
cord-005453-4057qib7	3852	19	non	non	JJ
cord-005453-4057qib7	3852	20	-	-	JJ
cord-005453-4057qib7	3852	21	seminomatous	seminomatous	JJ
cord-005453-4057qib7	3852	22	germ	germ	NN
cord-005453-4057qib7	3852	23	cell	cell	NN
cord-005453-4057qib7	3852	24	tumors	tumor	NNS
cord-005453-4057qib7	3852	25	(	(	-LRB-
cord-005453-4057qib7	3852	26	n=42	n=42	NN
cord-005453-4057qib7	3852	27	,	,	,
cord-005453-4057qib7	3852	28	22	22	CD
cord-005453-4057qib7	3852	29	%	%	NN
cord-005453-4057qib7	3852	30	)	)	-RRB-
cord-005453-4057qib7	3852	31	,	,	,
cord-005453-4057qib7	3852	32	and	and	CC
cord-005453-4057qib7	3852	33	multiple	multiple	JJ
cord-005453-4057qib7	3852	34	myeloma	myeloma	NN
cord-005453-4057qib7	3852	35	(	(	-LRB-
cord-005453-4057qib7	3853	1	n=42	n=42	NNP
cord-005453-4057qib7	3853	2	,	,	,
cord-005453-4057qib7	3853	3	22	22	CD
cord-005453-4057qib7	3853	4	%	%	NN
cord-005453-4057qib7	3853	5	)	)	-RRB-
cord-005453-4057qib7	3853	6	.	.	.
cord-005453-4057qib7	3854	1	Acute	acute	JJ
cord-005453-4057qib7	3854	2	leukemias	leukemia	NNS
cord-005453-4057qib7	3854	3	(	(	-LRB-
cord-005453-4057qib7	3855	1	n=41	n=41	RB
cord-005453-4057qib7	3855	2	,	,	,
cord-005453-4057qib7	3855	3	34	34	CD
cord-005453-4057qib7	3855	4	%	%	NN
cord-005453-4057qib7	3855	5	)	)	-RRB-
cord-005453-4057qib7	3855	6	,	,	,
cord-005453-4057qib7	3855	7	aplastic	aplastic	JJ
cord-005453-4057qib7	3855	8	anemia	anemia	NN
cord-005453-4057qib7	3855	9	(	(	-LRB-
cord-005453-4057qib7	3855	10	n=25	n=25	NN
cord-005453-4057qib7	3855	11	,	,	,
cord-005453-4057qib7	3855	12	21	21	CD
cord-005453-4057qib7	3855	13	%	%	NN
cord-005453-4057qib7	3855	14	)	)	-RRB-
cord-005453-4057qib7	3855	15	,	,	,
cord-005453-4057qib7	3855	16	and	and	CC
cord-005453-4057qib7	3855	17	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	3855	18	syndromes	syndrome	NNS
cord-005453-4057qib7	3855	19	(	(	-LRB-
cord-005453-4057qib7	3855	20	n=20	n=20	NN
cord-005453-4057qib7	3855	21	,	,	,
cord-005453-4057qib7	3855	22	17	17	CD
cord-005453-4057qib7	3855	23	%	%	NN
cord-005453-4057qib7	3855	24	)	)	-RRB-
cord-005453-4057qib7	3855	25	were	be	VBD
cord-005453-4057qib7	3855	26	the	the	DT
cord-005453-4057qib7	3855	27	most	most	RBS
cord-005453-4057qib7	3855	28	frequent	frequent	JJ
cord-005453-4057qib7	3855	29	diagnosis	diagnosis	NN
cord-005453-4057qib7	3855	30	for	for	IN
cord-005453-4057qib7	3855	31	patients	patient	NNS
cord-005453-4057qib7	3855	32	undergoing	undergo	VBG
cord-005453-4057qib7	3855	33	allo	allo	NN
cord-005453-4057qib7	3855	34	-	-	HYPH
cord-005453-4057qib7	3855	35	HSCT	HSCT	NNP
cord-005453-4057qib7	3855	36	;	;	:
cord-005453-4057qib7	3855	37	and	and	CC
cord-005453-4057qib7	3855	38	acute	acute	JJ
cord-005453-4057qib7	3855	39	leukemia	leukemia	NN
cord-005453-4057qib7	3855	40	was	be	VBD
cord-005453-4057qib7	3855	41	the	the	DT
cord-005453-4057qib7	3855	42	most	most	RBS
cord-005453-4057qib7	3855	43	frequent	frequent	JJ
cord-005453-4057qib7	3855	44	diagnosis	diagnosis	NN
cord-005453-4057qib7	3855	45	for	for	IN
cord-005453-4057qib7	3855	46	patients	patient	NNS
cord-005453-4057qib7	3855	47	undergoing	undergo	VBG
cord-005453-4057qib7	3855	48	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3855	49	HSCT	HSCT	NNP
cord-005453-4057qib7	3855	50	(	(	-LRB-
cord-005453-4057qib7	3855	51	n=10	n=10	NNP
cord-005453-4057qib7	3855	52	,	,	,
cord-005453-4057qib7	3855	53	83	83	CD
cord-005453-4057qib7	3855	54	%	%	NN
cord-005453-4057qib7	3855	55	)	)	-RRB-
cord-005453-4057qib7	3855	56	.	.	.
cord-005453-4057qib7	3856	1	Acute	acute	JJ
cord-005453-4057qib7	3856	2	and	and	CC
cord-005453-4057qib7	3856	3	chronic	chronic	JJ
cord-005453-4057qib7	3856	4	GVHD	GVHD	NNP
cord-005453-4057qib7	3856	5	were	be	VBD
cord-005453-4057qib7	3856	6	present	present	JJ
cord-005453-4057qib7	3856	7	in	in	IN
cord-005453-4057qib7	3856	8	25	25	CD
cord-005453-4057qib7	3856	9	%	%	NN
cord-005453-4057qib7	3856	10	(	(	-LRB-
cord-005453-4057qib7	3856	11	Grades	grade	NNS
cord-005453-4057qib7	3856	12	I	I	NNP
cord-005453-4057qib7	3856	13	-	-	HYPH
cord-005453-4057qib7	3856	14	II	II	NNP
cord-005453-4057qib7	3856	15	89	89	CD
cord-005453-4057qib7	3856	16	%	%	NN
cord-005453-4057qib7	3856	17	)	)	-RRB-
cord-005453-4057qib7	3856	18	and	and	CC
cord-005453-4057qib7	3856	19	35	35	CD
cord-005453-4057qib7	3856	20	%	%	NN
cord-005453-4057qib7	3856	21	(	(	-LRB-
cord-005453-4057qib7	3856	22	limited	limited	JJ
cord-005453-4057qib7	3856	23	76	76	CD
cord-005453-4057qib7	3856	24	%	%	NN
cord-005453-4057qib7	3856	25	)	)	-RRB-
cord-005453-4057qib7	3856	26	,	,	,
cord-005453-4057qib7	3856	27	respectively	respectively	RB
cord-005453-4057qib7	3856	28	.	.	.
cord-005453-4057qib7	3857	1	For	for	IN
cord-005453-4057qib7	3857	2	allo	allo	NN
cord-005453-4057qib7	3857	3	-	-	HYPH
cord-005453-4057qib7	3857	4	HSCT	HSCT	NNP
cord-005453-4057qib7	3857	5	,	,	,
cord-005453-4057qib7	3857	6	30	30	CD
cord-005453-4057qib7	3857	7	,	,	,
cord-005453-4057qib7	3857	8	100day	100day	CD
cord-005453-4057qib7	3857	9	,	,	,
cord-005453-4057qib7	3857	10	and	and	CC
cord-005453-4057qib7	3857	11	1-year	1-year	CD
cord-005453-4057qib7	3857	12	NRM	NRM	NNP
cord-005453-4057qib7	3857	13	was	be	VBD
cord-005453-4057qib7	3857	14	2.5	2.5	CD
cord-005453-4057qib7	3857	15	%	%	NN
cord-005453-4057qib7	3857	16	,	,	,
cord-005453-4057qib7	3857	17	8	8	CD
cord-005453-4057qib7	3857	18	%	%	NN
cord-005453-4057qib7	3857	19	,	,	,
cord-005453-4057qib7	3857	20	and	and	CC
cord-005453-4057qib7	3857	21	12	12	CD
cord-005453-4057qib7	3857	22	%	%	NN
cord-005453-4057qib7	3857	23	,	,	,
cord-005453-4057qib7	3857	24	respectively	respectively	RB
cord-005453-4057qib7	3857	25	;	;	:
cord-005453-4057qib7	3857	26	30	30	CD
cord-005453-4057qib7	3857	27	and	and	CC
cord-005453-4057qib7	3857	28	100-day	100-day	JJ
cord-005453-4057qib7	3857	29	NRM	NRM	NNP
cord-005453-4057qib7	3857	30	in	in	IN
cord-005453-4057qib7	3857	31	auto	auto	NN
cord-005453-4057qib7	3857	32	-	-	HYPH
cord-005453-4057qib7	3857	33	HSCT	HSCT	NNP
cord-005453-4057qib7	3857	34	was	be	VBD
cord-005453-4057qib7	3857	35	1.5	1.5	CD
cord-005453-4057qib7	3857	36	%	%	NN
cord-005453-4057qib7	3857	37	;	;	,
cord-005453-4057qib7	3857	38	10year	10year	JJ
cord-005453-4057qib7	3857	39	OS	OS	NNP
cord-005453-4057qib7	3857	40	was	be	VBD
cord-005453-4057qib7	3857	41	63	63	CD
cord-005453-4057qib7	3857	42	%	%	NN
cord-005453-4057qib7	3857	43	and	and	CC
cord-005453-4057qib7	3857	44	56	56	CD
cord-005453-4057qib7	3857	45	%	%	NN
cord-005453-4057qib7	3857	46	for	for	IN
cord-005453-4057qib7	3857	47	auto	auto	NN
cord-005453-4057qib7	3857	48	and	and	CC
cord-005453-4057qib7	3857	49	allo	allo	NN
cord-005453-4057qib7	3857	50	-	-	HYPH
cord-005453-4057qib7	3857	51	HSCT	HSCT	NNP
cord-005453-4057qib7	3857	52	,	,	,
cord-005453-4057qib7	3857	53	respectively	respectively	RB
cord-005453-4057qib7	3857	54	.	.	.
cord-005453-4057qib7	3858	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3858	2	:	:	:
cord-005453-4057qib7	3859	1	Future	future	JJ
cord-005453-4057qib7	3859	2	perspectives	perspective	NNS
cord-005453-4057qib7	3859	3	of	of	IN
cord-005453-4057qib7	3859	4	the	the	DT
cord-005453-4057qib7	3859	5	HSCT	HSCT	NNP
cord-005453-4057qib7	3859	6	Program	Program	NNP
cord-005453-4057qib7	3859	7	include	include	VBP
cord-005453-4057qib7	3859	8	the	the	DT
cord-005453-4057qib7	3859	9	acquisition	acquisition	NN
cord-005453-4057qib7	3859	10	of	of	IN
cord-005453-4057qib7	3859	11	funds	fund	NNS
cord-005453-4057qib7	3859	12	for	for	IN
cord-005453-4057qib7	3859	13	unrelated	unrelated	JJ
cord-005453-4057qib7	3859	14	donors	donor	NNS
cord-005453-4057qib7	3859	15	;	;	:
cord-005453-4057qib7	3859	16	to	to	TO
cord-005453-4057qib7	3859	17	improve	improve	VB
cord-005453-4057qib7	3859	18	outcomes	outcome	NNS
cord-005453-4057qib7	3859	19	of	of	IN
cord-005453-4057qib7	3859	20	patients	patient	NNS
cord-005453-4057qib7	3859	21	undergoing	undergo	VBG
cord-005453-4057qib7	3859	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3859	23	HSCT	HSCT	NNP
cord-005453-4057qib7	3859	24	,	,	,
cord-005453-4057qib7	3859	25	and	and	CC
cord-005453-4057qib7	3859	26	to	to	TO
cord-005453-4057qib7	3859	27	increase	increase	VB
cord-005453-4057qib7	3859	28	the	the	DT
cord-005453-4057qib7	3859	29	number	number	NN
cord-005453-4057qib7	3859	30	of	of	IN
cord-005453-4057qib7	3859	31	in	in	IN
cord-005453-4057qib7	3859	32	-	-	HYPH
cord-005453-4057qib7	3859	33	patient	patient	NN
cord-005453-4057qib7	3859	34	rooms	room	NNS
cord-005453-4057qib7	3859	35	.	.	.
cord-005453-4057qib7	3860	1	We	-PRON-	PRP
cord-005453-4057qib7	3860	2	conclude	conclude	VBP
cord-005453-4057qib7	3860	3	that	that	IN
cord-005453-4057qib7	3860	4	despite	despite	IN
cord-005453-4057qib7	3860	5	paucity	paucity	NN
cord-005453-4057qib7	3860	6	of	of	IN
cord-005453-4057qib7	3860	7	resources	resource	NNS
cord-005453-4057qib7	3860	8	and	and	CC
cord-005453-4057qib7	3860	9	other	other	JJ
cord-005453-4057qib7	3860	10	limitations	limitation	NNS
cord-005453-4057qib7	3860	11	,	,	,
cord-005453-4057qib7	3860	12	the	the	DT
cord-005453-4057qib7	3860	13	implementation	implementation	NN
cord-005453-4057qib7	3860	14	of	of	IN
cord-005453-4057qib7	3860	15	financial	financial	JJ
cord-005453-4057qib7	3860	16	,	,	,
cord-005453-4057qib7	3860	17	medical	medical	JJ
cord-005453-4057qib7	3860	18	,	,	,
cord-005453-4057qib7	3860	19	and	and	CC
cord-005453-4057qib7	3860	20	research	research	NN
cord-005453-4057qib7	3860	21	strategies	strategy	NNS
cord-005453-4057qib7	3860	22	have	have	VBP
cord-005453-4057qib7	3860	23	shown	show	VBN
cord-005453-4057qib7	3860	24	that	that	IN
cord-005453-4057qib7	3860	25	barriers	barrier	NNS
cord-005453-4057qib7	3860	26	can	can	MD
cord-005453-4057qib7	3860	27	be	be	VB
cord-005453-4057qib7	3860	28	effectively	effectively	RB
cord-005453-4057qib7	3860	29	overcome	overcome	VBN
cord-005453-4057qib7	3860	30	in	in	IN
cord-005453-4057qib7	3860	31	a	a	DT
cord-005453-4057qib7	3860	32	developing	develop	VBG
cord-005453-4057qib7	3860	33	country	country	NN
cord-005453-4057qib7	3860	34	in	in	IN
cord-005453-4057qib7	3860	35	order	order	NN
cord-005453-4057qib7	3860	36	to	to	TO
cord-005453-4057qib7	3860	37	establish	establish	VB
cord-005453-4057qib7	3860	38	a	a	DT
cord-005453-4057qib7	3860	39	consolidated	consolidate	VBN
cord-005453-4057qib7	3860	40	and	and	CC
cord-005453-4057qib7	3860	41	nationally	nationally	RB
cord-005453-4057qib7	3860	42	renowned	renowned	JJ
cord-005453-4057qib7	3860	43	HSCT	HSCT	NNP
cord-005453-4057qib7	3860	44	Program	Program	NNP
cord-005453-4057qib7	3860	45	,	,	,
cord-005453-4057qib7	3860	46	providing	provide	VBG
cord-005453-4057qib7	3860	47	good	good	JJ
cord-005453-4057qib7	3860	48	outcomes	outcome	NNS
cord-005453-4057qib7	3860	49	for	for	IN
cord-005453-4057qib7	3860	50	patients	patient	NNS
cord-005453-4057qib7	3860	51	.	.	.
cord-005453-4057qib7	3861	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3861	2	:	:	:
cord-005453-4057qib7	3861	3	None	none	NN
cord-005453-4057qib7	3861	4	of	of	IN
cord-005453-4057qib7	3861	5	the	the	DT
cord-005453-4057qib7	3861	6	authors	author	NNS
cord-005453-4057qib7	3861	7	have	have	VBP
cord-005453-4057qib7	3861	8	any	any	DT
cord-005453-4057qib7	3861	9	conflict	conflict	NN
cord-005453-4057qib7	3861	10	of	of	IN
cord-005453-4057qib7	3861	11	interest	interest	NN
cord-005453-4057qib7	3861	12	to	to	TO
cord-005453-4057qib7	3861	13	disclose	disclose	VB
cord-005453-4057qib7	3861	14	.	.	.
cord-005453-4057qib7	3862	1	The	the	DT
cord-005453-4057qib7	3862	2	effect	effect	NN
cord-005453-4057qib7	3862	3	of	of	IN
cord-005453-4057qib7	3862	4	protective	protective	JJ
cord-005453-4057qib7	3862	5	buffering	buffering	NN
cord-005453-4057qib7	3862	6	on	on	IN
cord-005453-4057qib7	3862	7	daily	daily	JJ
cord-005453-4057qib7	3862	8	stress	stress	NN
cord-005453-4057qib7	3862	9	and	and	CC
cord-005453-4057qib7	3862	10	relationship	relationship	NN
cord-005453-4057qib7	3862	11	quality	quality	NN
cord-005453-4057qib7	3862	12	in	in	IN
cord-005453-4057qib7	3862	13	dyads	dyad	NNS
cord-005453-4057qib7	3862	14	following	follow	VBG
cord-005453-4057qib7	3862	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3862	16	stem	stem	NN
cord-005453-4057qib7	3862	17	cell	cell	NN
cord-005453-4057qib7	3862	18	transplantation	transplantation	NN
cord-005453-4057qib7	3862	19	:	:	:
cord-005453-4057qib7	3862	20	Results	result	NNS
cord-005453-4057qib7	3862	21	from	from	IN
cord-005453-4057qib7	3862	22	daily	daily	JJ
cord-005453-4057qib7	3862	23	process	process	NN
cord-005453-4057qib7	3862	24	methodology	methodology	NN
cord-005453-4057qib7	3863	1	Malgorzata	Malgorzata	NNP
cord-005453-4057qib7	3863	2	Sobczyk	Sobczyk	NNP
cord-005453-4057qib7	3863	3	-	-	HYPH
cord-005453-4057qib7	3863	4	Kruszelnicka	Kruszelnicka	NNP
cord-005453-4057qib7	3863	5	1	1	CD
cord-005453-4057qib7	3863	6	,	,	,
cord-005453-4057qib7	3863	7	Aleksandra	Aleksandra	NNP
cord-005453-4057qib7	3863	8	Kroemeke	Kroemeke	NNP
cord-005453-4057qib7	3863	9	2	2	CD
cord-005453-4057qib7	3863	10	,	,	,
cord-005453-4057qib7	3863	11	Zuzanna	Zuzanna	NNP
cord-005453-4057qib7	3863	12	Kwissa	Kwissa	NNP
cord-005453-4057qib7	3863	13	-	-	HYPH
cord-005453-4057qib7	3863	14	Gajewska	Gajewska	NNP
cord-005453-4057qib7	3863	15	2	2	CD
cord-005453-4057qib7	3863	16	,	,	,
cord-005453-4057qib7	3863	17	Sebastian	Sebastian	NNP
cord-005453-4057qib7	3863	18	Giebel	Giebel	NNP
cord-005453-4057qib7	3863	19	1	1	CD
cord-005453-4057qib7	3863	20	Background	Background	NNP
cord-005453-4057qib7	3863	21	:	:	:
cord-005453-4057qib7	3863	22	Cancer	cancer	NN
cord-005453-4057qib7	3863	23	-	-	HYPH
cord-005453-4057qib7	3863	24	related	relate	VBN
cord-005453-4057qib7	3863	25	support	support	NN
cord-005453-4057qib7	3863	26	communication	communication	NN
cord-005453-4057qib7	3863	27	(	(	-LRB-
cord-005453-4057qib7	3863	28	e.g.	e.g.	RB
cord-005453-4057qib7	3863	29	,	,	,
cord-005453-4057qib7	3863	30	protective	protective	JJ
cord-005453-4057qib7	3863	31	buffering	buffering	NN
cord-005453-4057qib7	3863	32	)	)	-RRB-
cord-005453-4057qib7	3863	33	may	may	MD
cord-005453-4057qib7	3863	34	impact	impact	VB
cord-005453-4057qib7	3863	35	the	the	DT
cord-005453-4057qib7	3863	36	risk	risk	NN
cord-005453-4057qib7	3863	37	for	for	IN
cord-005453-4057qib7	3863	38	psychological	psychological	JJ
cord-005453-4057qib7	3863	39	and	and	CC
cord-005453-4057qib7	3863	40	relationship	relationship	NN
cord-005453-4057qib7	3863	41	distress	distress	NN
cord-005453-4057qib7	3863	42	in	in	IN
cord-005453-4057qib7	3863	43	patients	patient	NNS
cord-005453-4057qib7	3863	44	following	follow	VBG
cord-005453-4057qib7	3863	45	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3863	46	stem	stem	NN
cord-005453-4057qib7	3863	47	cell	cell	NN
cord-005453-4057qib7	3863	48	transplantation	transplantation	NN
cord-005453-4057qib7	3863	49	(	(	-LRB-
cord-005453-4057qib7	3863	50	HSCT	HSCT	NNP
cord-005453-4057qib7	3863	51	)	)	-RRB-
cord-005453-4057qib7	3863	52	and	and	CC
cord-005453-4057qib7	3863	53	their	-PRON-	PRP$
cord-005453-4057qib7	3863	54	caregivers	caregiver	NNS
cord-005453-4057qib7	3863	55	.	.	.
cord-005453-4057qib7	3864	1	Previous	previous	JJ
cord-005453-4057qib7	3864	2	studies	study	NNS
cord-005453-4057qib7	3864	3	have	have	VBP
cord-005453-4057qib7	3864	4	revealed	reveal	VBN
cord-005453-4057qib7	3864	5	that	that	IN
cord-005453-4057qib7	3864	6	protective	protective	JJ
cord-005453-4057qib7	3864	7	buffering	buffering	NN
cord-005453-4057qib7	3864	8	(	(	-LRB-
cord-005453-4057qib7	3864	9	i.e.	i.e.	FW
cord-005453-4057qib7	3864	10	,	,	,
cord-005453-4057qib7	3864	11	hiding	hide	VBG
cord-005453-4057qib7	3864	12	one	one	PRP
cord-005453-4057qib7	3864	13	's	's	POS
cord-005453-4057qib7	3864	14	concerns	concern	NNS
cord-005453-4057qib7	3864	15	and	and	CC
cord-005453-4057qib7	3864	16	denying	deny	VBG
cord-005453-4057qib7	3864	17	one	one	PRP
cord-005453-4057qib7	3864	18	's	's	POS
cord-005453-4057qib7	3864	19	worries	worry	NNS
cord-005453-4057qib7	3864	20	)	)	-RRB-
cord-005453-4057qib7	3864	21	has	have	VBZ
cord-005453-4057qib7	3864	22	mixed	mix	VBN
cord-005453-4057qib7	3864	23	effects	effect	NNS
cord-005453-4057qib7	3864	24	:	:	:
cord-005453-4057qib7	3864	25	is	be	VBZ
cord-005453-4057qib7	3864	26	beneficial	beneficial	JJ
cord-005453-4057qib7	3864	27	(	(	-LRB-
cord-005453-4057qib7	3864	28	for	for	IN
cord-005453-4057qib7	3864	29	"	"	``
cord-005453-4057qib7	3864	30	protected	protect	VBN
cord-005453-4057qib7	3864	31	"	"	''
cord-005453-4057qib7	3864	32	person	person	NN
cord-005453-4057qib7	3864	33	)	)	-RRB-
cord-005453-4057qib7	3864	34	,	,	,
cord-005453-4057qib7	3864	35	costly	costly	JJ
cord-005453-4057qib7	3864	36	(	(	-LRB-
cord-005453-4057qib7	3864	37	especially	especially	RB
cord-005453-4057qib7	3864	38	for	for	IN
cord-005453-4057qib7	3864	39	the	the	DT
cord-005453-4057qib7	3864	40	person	person	NN
cord-005453-4057qib7	3864	41	using	use	VBG
cord-005453-4057qib7	3864	42	it	-PRON-	PRP
cord-005453-4057qib7	3864	43	)	)	-RRB-
cord-005453-4057qib7	3864	44	,	,	,
cord-005453-4057qib7	3864	45	or	or	CC
cord-005453-4057qib7	3864	46	unrelated	unrelated	JJ
cord-005453-4057qib7	3864	47	to	to	IN
cord-005453-4057qib7	3864	48	dyadic	dyadic	JJ
cord-005453-4057qib7	3864	49	wellbeing	wellbeing	NN
cord-005453-4057qib7	3864	50	.	.	.
cord-005453-4057qib7	3865	1	There	there	EX
cord-005453-4057qib7	3865	2	has	have	VBZ
cord-005453-4057qib7	3865	3	been	be	VBN
cord-005453-4057qib7	3865	4	,	,	,
cord-005453-4057qib7	3865	5	however	however	RB
cord-005453-4057qib7	3865	6	,	,	,
cord-005453-4057qib7	3865	7	little	little	JJ
cord-005453-4057qib7	3865	8	evidence	evidence	NN
cord-005453-4057qib7	3865	9	linking	link	VBG
cord-005453-4057qib7	3865	10	dyadic	dyadic	JJ
cord-005453-4057qib7	3865	11	protective	protective	JJ
cord-005453-4057qib7	3865	12	buffering	buffering	NN
cord-005453-4057qib7	3865	13	with	with	IN
cord-005453-4057qib7	3865	14	distress	distress	NN
cord-005453-4057qib7	3865	15	using	use	VBG
cord-005453-4057qib7	3865	16	daily	daily	JJ
cord-005453-4057qib7	3865	17	process	process	NN
cord-005453-4057qib7	3865	18	methodology	methodology	NN
cord-005453-4057qib7	3865	19	.	.	.
cord-005453-4057qib7	3866	1	We	-PRON-	PRP
cord-005453-4057qib7	3866	2	assessed	assess	VBD
cord-005453-4057qib7	3866	3	(	(	-LRB-
cord-005453-4057qib7	3866	4	1	1	CD
cord-005453-4057qib7	3866	5	)	)	-RRB-
cord-005453-4057qib7	3866	6	the	the	DT
cord-005453-4057qib7	3866	7	relationship	relationship	NN
cord-005453-4057qib7	3866	8	between	between	IN
cord-005453-4057qib7	3866	9	daily	daily	JJ
cord-005453-4057qib7	3866	10	protective	protective	JJ
cord-005453-4057qib7	3866	11	buffering	buffering	NN
cord-005453-4057qib7	3866	12	,	,	,
cord-005453-4057qib7	3866	13	and	and	CC
cord-005453-4057qib7	3866	14	same	same	JJ
cord-005453-4057qib7	3866	15	-	-	:
cord-005453-4057qib7	3866	16	and	and	CC
cord-005453-4057qib7	3866	17	next	next	JJ
cord-005453-4057qib7	3866	18	-	-	HYPH
cord-005453-4057qib7	3866	19	day	day	NN
cord-005453-4057qib7	3866	20	stress	stress	NN
cord-005453-4057qib7	3866	21	and	and	CC
cord-005453-4057qib7	3866	22	relationship	relationship	NN
cord-005453-4057qib7	3866	23	quality	quality	NN
cord-005453-4057qib7	3866	24	in	in	IN
cord-005453-4057qib7	3866	25	patient	patient	NN
cord-005453-4057qib7	3866	26	-	-	HYPH
cord-005453-4057qib7	3866	27	caregiver	caregiver	NN
cord-005453-4057qib7	3866	28	dyads	dyad	NNS
cord-005453-4057qib7	3866	29	following	follow	VBG
cord-005453-4057qib7	3866	30	HSCT	HSCT	NNP
cord-005453-4057qib7	3866	31	and	and	CC
cord-005453-4057qib7	3866	32	(	(	-LRB-
cord-005453-4057qib7	3866	33	2	2	LS
cord-005453-4057qib7	3866	34	)	)	-RRB-
cord-005453-4057qib7	3867	1	whether	whether	IN
cord-005453-4057qib7	3867	2	similarity	similarity	NN
cord-005453-4057qib7	3867	3	or	or	CC
cord-005453-4057qib7	3867	4	complementarity	complementarity	NN
cord-005453-4057qib7	3867	5	in	in	IN
cord-005453-4057qib7	3867	6	protective	protective	JJ
cord-005453-4057qib7	3867	7	buffering	buffering	NN
cord-005453-4057qib7	3867	8	between	between	IN
cord-005453-4057qib7	3867	9	dyads	dyad	NNS
cord-005453-4057qib7	3867	10	is	be	VBZ
cord-005453-4057qib7	3867	11	adaptive	adaptive	JJ
cord-005453-4057qib7	3867	12	.	.	.
cord-005453-4057qib7	3868	1	Methods	method	NNS
cord-005453-4057qib7	3868	2	:	:	:
cord-005453-4057qib7	3869	1	Two	two	CD
cord-005453-4057qib7	3869	2	hundred	hundred	CD
cord-005453-4057qib7	3869	3	patients	patient	NNS
cord-005453-4057qib7	3869	4	(	(	-LRB-
cord-005453-4057qib7	3869	5	after	after	IN
cord-005453-4057qib7	3869	6	first	first	JJ
cord-005453-4057qib7	3869	7	autologous	autologous	JJ
cord-005453-4057qib7	3869	8	or	or	CC
cord-005453-4057qib7	3869	9	allogeneic	allogeneic	IN
cord-005453-4057qib7	3869	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3869	11	)	)	-RRB-
cord-005453-4057qib7	3869	12	and	and	CC
cord-005453-4057qib7	3869	13	their	-PRON-	PRP$
cord-005453-4057qib7	3869	14	caregivers	caregiver	NNS
cord-005453-4057qib7	3869	15	(	(	-LRB-
cord-005453-4057qib7	3869	16	spouse	spouse	NN
cord-005453-4057qib7	3869	17	or	or	CC
cord-005453-4057qib7	3869	18	another	another	DT
cord-005453-4057qib7	3869	19	relative	relative	NN
cord-005453-4057qib7	3869	20	)	)	-RRB-
cord-005453-4057qib7	3869	21	independently	independently	RB
cord-005453-4057qib7	3869	22	completed	complete	VBN
cord-005453-4057qib7	3869	23	measures	measure	NNS
cord-005453-4057qib7	3869	24	of	of	IN
cord-005453-4057qib7	3869	25	daily	daily	JJ
cord-005453-4057qib7	3869	26	protective	protective	JJ
cord-005453-4057qib7	3869	27	buffering	buffering	NN
cord-005453-4057qib7	3869	28	,	,	,
cord-005453-4057qib7	3869	29	daily	daily	JJ
cord-005453-4057qib7	3869	30	relationship	relationship	NN
cord-005453-4057qib7	3869	31	quality	quality	NN
cord-005453-4057qib7	3869	32	,	,	,
cord-005453-4057qib7	3869	33	and	and	CC
cord-005453-4057qib7	3869	34	daily	daily	JJ
cord-005453-4057qib7	3869	35	stress	stress	NN
cord-005453-4057qib7	3869	36	for	for	IN
cord-005453-4057qib7	3869	37	28	28	CD
cord-005453-4057qib7	3869	38	consecutive	consecutive	JJ
cord-005453-4057qib7	3869	39	evenings	evening	NNS
cord-005453-4057qib7	3869	40	after	after	IN
cord-005453-4057qib7	3869	41	patients´hospital	patients´hospital	NNP
cord-005453-4057qib7	3869	42	discharge	discharge	NN
cord-005453-4057qib7	3869	43	.	.	.
cord-005453-4057qib7	3870	1	Actor	Actor	NNP
cord-005453-4057qib7	3870	2	-	-	HYPH
cord-005453-4057qib7	3870	3	Partner	Partner	NNP
cord-005453-4057qib7	3870	4	-	-	HYPH
cord-005453-4057qib7	3870	5	Interdependence	Interdependence	NNP
cord-005453-4057qib7	3870	6	Model	Model	NNP
cord-005453-4057qib7	3870	7	(	(	-LRB-
cord-005453-4057qib7	3870	8	i.e.	i.e.	FW
cord-005453-4057qib7	3870	9	,	,	,
cord-005453-4057qib7	3870	10	both	both	DT
cord-005453-4057qib7	3870	11	partners	partner	NNS
cord-005453-4057qib7	3870	12	'	'	POS
cord-005453-4057qib7	3870	13	and	and	CC
cord-005453-4057qib7	3870	14	caregivers	caregiver	NNS
cord-005453-4057qib7	3870	15	'	'	POS
cord-005453-4057qib7	3870	16	reports	report	NNS
cord-005453-4057qib7	3870	17	regarding	regard	VBG
cord-005453-4057qib7	3870	18	support	support	NN
cord-005453-4057qib7	3870	19	communication	communication	NN
cord-005453-4057qib7	3870	20	and	and	CC
cord-005453-4057qib7	3870	21	distress	distress	NN
cord-005453-4057qib7	3870	22	were	be	VBD
cord-005453-4057qib7	3870	23	studied	study	VBN
cord-005453-4057qib7	3870	24	)	)	-RRB-
cord-005453-4057qib7	3870	25	was	be	VBD
cord-005453-4057qib7	3870	26	used	use	VBN
cord-005453-4057qib7	3870	27	to	to	TO
cord-005453-4057qib7	3870	28	test	test	VB
cord-005453-4057qib7	3870	29	study	study	NN
cord-005453-4057qib7	3870	30	hypotheses	hypothesis	NNS
cord-005453-4057qib7	3870	31	.	.	.
cord-005453-4057qib7	3871	1	Results	result	NNS
cord-005453-4057qib7	3871	2	:	:	:
cord-005453-4057qib7	3872	1	For	for	IN
cord-005453-4057qib7	3872	2	both	both	DT
cord-005453-4057qib7	3872	3	patients	patient	NNS
cord-005453-4057qib7	3872	4	and	and	CC
cord-005453-4057qib7	3872	5	caregivers	caregiver	NNS
cord-005453-4057qib7	3872	6	,	,	,
cord-005453-4057qib7	3872	7	multilevel	multilevel	JJ
cord-005453-4057qib7	3872	8	structural	structural	JJ
cord-005453-4057qib7	3872	9	equation	equation	NN
cord-005453-4057qib7	3872	10	modeling	modeling	NN
cord-005453-4057qib7	3872	11	showed	show	VBD
cord-005453-4057qib7	3872	12	a	a	DT
cord-005453-4057qib7	3872	13	significant	significant	JJ
cord-005453-4057qib7	3872	14	positive	positive	JJ
cord-005453-4057qib7	3872	15	relationship	relationship	NN
cord-005453-4057qib7	3872	16	between	between	IN
cord-005453-4057qib7	3872	17	daily	daily	JJ
cord-005453-4057qib7	3872	18	protective	protective	JJ
cord-005453-4057qib7	3872	19	buffering	buffering	NN
cord-005453-4057qib7	3872	20	and	and	CC
cord-005453-4057qib7	3872	21	sameday	sameday	NN
cord-005453-4057qib7	3872	22	relationship	relationship	NN
cord-005453-4057qib7	3872	23	quality	quality	NN
cord-005453-4057qib7	3872	24	.	.	.
cord-005453-4057qib7	3873	1	Association	Association	NNP
cord-005453-4057qib7	3873	2	of	of	IN
cord-005453-4057qib7	3873	3	protective	protective	JJ
cord-005453-4057qib7	3873	4	buffering	buffering	NN
cord-005453-4057qib7	3873	5	with	with	IN
cord-005453-4057qib7	3873	6	same	same	JJ
cord-005453-4057qib7	3873	7	-	-	HYPH
cord-005453-4057qib7	3873	8	day	day	NN
cord-005453-4057qib7	3873	9	stress	stress	NN
cord-005453-4057qib7	3873	10	level	level	NN
cord-005453-4057qib7	3873	11	was	be	VBD
cord-005453-4057qib7	3873	12	negative	negative	JJ
cord-005453-4057qib7	3873	13	.	.	.
cord-005453-4057qib7	3874	1	In	in	IN
cord-005453-4057qib7	3874	2	next	next	JJ
cord-005453-4057qib7	3874	3	-	-	HYPH
cord-005453-4057qib7	3874	4	day	day	NN
cord-005453-4057qib7	3874	5	analyses	analysis	NNS
cord-005453-4057qib7	3874	6	,	,	,
cord-005453-4057qib7	3874	7	patient	patient	NN
cord-005453-4057qib7	3874	8	-	-	HYPH
cord-005453-4057qib7	3874	9	reported	report	VBN
cord-005453-4057qib7	3874	10	protective	protective	JJ
cord-005453-4057qib7	3874	11	buffering	buffering	NN
cord-005453-4057qib7	3874	12	was	be	VBD
cord-005453-4057qib7	3874	13	related	relate	VBN
cord-005453-4057qib7	3874	14	to	to	IN
cord-005453-4057qib7	3874	15	patient	patient	NN
cord-005453-4057qib7	3874	16	's	's	POS
cord-005453-4057qib7	3874	17	higher	high	JJR
cord-005453-4057qib7	3874	18	relationship	relationship	NN
cord-005453-4057qib7	3874	19	quality	quality	NN
cord-005453-4057qib7	3874	20	,	,	,
cord-005453-4057qib7	3874	21	whereas	whereas	IN
cord-005453-4057qib7	3874	22	caregiverreported	caregiverreported	JJ
cord-005453-4057qib7	3874	23	protective	protective	JJ
cord-005453-4057qib7	3874	24	buffering	buffering	NN
cord-005453-4057qib7	3874	25	increased	increase	VBN
cord-005453-4057qib7	3874	26	patient	patient	NN
cord-005453-4057qib7	3874	27	's	's	POS
cord-005453-4057qib7	3874	28	daily	daily	JJ
cord-005453-4057qib7	3874	29	stress	stress	NN
cord-005453-4057qib7	3874	30	.	.	.
cord-005453-4057qib7	3875	1	Complementarity	complementarity	NN
cord-005453-4057qib7	3875	2	in	in	IN
cord-005453-4057qib7	3875	3	protective	protective	JJ
cord-005453-4057qib7	3875	4	buffering	buffering	NN
cord-005453-4057qib7	3875	5	was	be	VBD
cord-005453-4057qib7	3875	6	related	relate	VBN
cord-005453-4057qib7	3875	7	to	to	IN
cord-005453-4057qib7	3875	8	higher	high	JJR
cord-005453-4057qib7	3875	9	immediate	immediate	JJ
cord-005453-4057qib7	3875	10	same	same	JJ
cord-005453-4057qib7	3875	11	-	-	HYPH
cord-005453-4057qib7	3875	12	day	day	NN
cord-005453-4057qib7	3875	13	relationship	relationship	NN
cord-005453-4057qib7	3875	14	quality	quality	NN
cord-005453-4057qib7	3875	15	for	for	IN
cord-005453-4057qib7	3875	16	both	both	DT
cord-005453-4057qib7	3875	17	patients	patient	NNS
cord-005453-4057qib7	3875	18	and	and	CC
cord-005453-4057qib7	3875	19	caregivers	caregiver	NNS
cord-005453-4057qib7	3875	20	,	,	,
cord-005453-4057qib7	3875	21	while	while	IN
cord-005453-4057qib7	3875	22	benefits	benefit	NNS
cord-005453-4057qib7	3875	23	from	from	IN
cord-005453-4057qib7	3875	24	similarity	similarity	NN
cord-005453-4057qib7	3875	25	have	have	VBP
cord-005453-4057qib7	3875	26	delayed	delay	VBN
cord-005453-4057qib7	3875	27	effects	effect	NNS
cord-005453-4057qib7	3875	28	,	,	,
cord-005453-4057qib7	3875	29	although	although	IN
cord-005453-4057qib7	3875	30	only	only	RB
cord-005453-4057qib7	3875	31	in	in	IN
cord-005453-4057qib7	3875	32	patients	patient	NNS
cord-005453-4057qib7	3875	33	.	.	.
cord-005453-4057qib7	3876	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3876	2	:	:	:
cord-005453-4057qib7	3877	1	Contrary	contrary	JJ
cord-005453-4057qib7	3877	2	to	to	IN
cord-005453-4057qib7	3877	3	previous	previous	JJ
cord-005453-4057qib7	3877	4	studies	study	NNS
cord-005453-4057qib7	3877	5	,	,	,
cord-005453-4057qib7	3877	6	protective	protective	JJ
cord-005453-4057qib7	3877	7	buffering	buffering	NN
cord-005453-4057qib7	3877	8	rather	rather	RB
cord-005453-4057qib7	3877	9	has	have	VBZ
cord-005453-4057qib7	3877	10	a	a	DT
cord-005453-4057qib7	3877	11	beneficial	beneficial	JJ
cord-005453-4057qib7	3877	12	effect	effect	NN
cord-005453-4057qib7	3877	13	in	in	IN
cord-005453-4057qib7	3877	14	dyads	dyad	NNS
cord-005453-4057qib7	3877	15	following	follow	VBG
cord-005453-4057qib7	3877	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3877	17	.	.	.
cord-005453-4057qib7	3878	1	Protection	protection	NN
cord-005453-4057qib7	3878	2	of	of	IN
cord-005453-4057qib7	3878	3	the	the	DT
cord-005453-4057qib7	3878	4	partner	partner	NN
cord-005453-4057qib7	3878	5	and	and	CC
cord-005453-4057qib7	3878	6	relationship	relationship	NN
cord-005453-4057qib7	3878	7	against	against	IN
cord-005453-4057qib7	3878	8	revealing	reveal	VBG
cord-005453-4057qib7	3878	9	negative	negative	JJ
cord-005453-4057qib7	3878	10	emotions	emotion	NNS
cord-005453-4057qib7	3878	11	and	and	CC
cord-005453-4057qib7	3878	12	powerlessness	powerlessness	NN
cord-005453-4057qib7	3878	13	was	be	VBD
cord-005453-4057qib7	3878	14	not	not	RB
cord-005453-4057qib7	3878	15	related	relate	VBN
cord-005453-4057qib7	3878	16	to	to	IN
cord-005453-4057qib7	3878	17	costs	cost	NNS
cord-005453-4057qib7	3878	18	in	in	IN
cord-005453-4057qib7	3878	19	both	both	DT
cord-005453-4057qib7	3878	20	parties	party	NNS
cord-005453-4057qib7	3878	21	.	.	.
cord-005453-4057qib7	3879	1	The	the	DT
cord-005453-4057qib7	3879	2	findings	finding	NNS
cord-005453-4057qib7	3879	3	suggest	suggest	VBP
cord-005453-4057qib7	3879	4	that	that	IN
cord-005453-4057qib7	3879	5	the	the	DT
cord-005453-4057qib7	3879	6	effect	effect	NN
cord-005453-4057qib7	3879	7	of	of	IN
cord-005453-4057qib7	3879	8	daily	daily	JJ
cord-005453-4057qib7	3879	9	protective	protective	JJ
cord-005453-4057qib7	3879	10	buffering	buffering	NN
cord-005453-4057qib7	3879	11	in	in	IN
cord-005453-4057qib7	3879	12	dyads	dyad	NNS
cord-005453-4057qib7	3879	13	following	follow	VBG
cord-005453-4057qib7	3879	14	HSCT	HSCT	NNP
cord-005453-4057qib7	3879	15	depends	depend	VBZ
cord-005453-4057qib7	3879	16	on	on	IN
cord-005453-4057qib7	3879	17	support	support	NN
cord-005453-4057qib7	3879	18	timing	timing	NN
cord-005453-4057qib7	3879	19	(	(	-LRB-
cord-005453-4057qib7	3879	20	same	same	JJ
cord-005453-4057qib7	3879	21	-	-	:
cord-005453-4057qib7	3879	22	or	or	CC
cord-005453-4057qib7	3879	23	next	next	JJ
cord-005453-4057qib7	3879	24	-	-	HYPH
cord-005453-4057qib7	3879	25	day	day	NN
cord-005453-4057qib7	3879	26	effect	effect	NN
cord-005453-4057qib7	3879	27	)	)	-RRB-
cord-005453-4057qib7	3879	28	and	and	CC
cord-005453-4057qib7	3879	29	differs	differ	VBZ
cord-005453-4057qib7	3879	30	for	for	IN
cord-005453-4057qib7	3879	31	both	both	DT
cord-005453-4057qib7	3879	32	parties	party	NNS
cord-005453-4057qib7	3879	33	.	.	.
cord-005453-4057qib7	3880	1	Patients	patient	NNS
cord-005453-4057qib7	3880	2	seem	seem	VBP
cord-005453-4057qib7	3880	3	to	to	TO
cord-005453-4057qib7	3880	4	benefit	benefit	VB
cord-005453-4057qib7	3880	5	the	the	DT
cord-005453-4057qib7	3880	6	most	most	JJS
cord-005453-4057qib7	3880	7	from	from	IN
cord-005453-4057qib7	3880	8	the	the	DT
cord-005453-4057qib7	3880	9	similarity	similarity	NN
cord-005453-4057qib7	3880	10	in	in	IN
cord-005453-4057qib7	3880	11	protective	protective	JJ
cord-005453-4057qib7	3880	12	buffering	buffering	NN
cord-005453-4057qib7	3880	13	,	,	,
cord-005453-4057qib7	3880	14	while	while	IN
cord-005453-4057qib7	3880	15	caregivers	caregiver	NNS
cord-005453-4057qib7	3880	16	from	from	IN
cord-005453-4057qib7	3880	17	complementarity	complementarity	NN
cord-005453-4057qib7	3880	18	.	.	.
cord-005453-4057qib7	3881	1	The	the	DT
cord-005453-4057qib7	3881	2	"	"	``
cord-005453-4057qib7	3881	3	fit	fit	JJ
cord-005453-4057qib7	3881	4	"	"	''
cord-005453-4057qib7	3881	5	between	between	IN
cord-005453-4057qib7	3881	6	patient	patient	NN
cord-005453-4057qib7	3881	7	and	and	CC
cord-005453-4057qib7	3881	8	caregiver	caregiver	NN
cord-005453-4057qib7	3881	9	in	in	IN
cord-005453-4057qib7	3881	10	support	support	NN
cord-005453-4057qib7	3881	11	communication	communication	NN
cord-005453-4057qib7	3881	12	ought	ought	MD
cord-005453-4057qib7	3881	13	to	to	TO
cord-005453-4057qib7	3881	14	be	be	VB
cord-005453-4057qib7	3881	15	taken	take	VBN
cord-005453-4057qib7	3881	16	into	into	IN
cord-005453-4057qib7	3881	17	consideration	consideration	NN
cord-005453-4057qib7	3881	18	in	in	IN
cord-005453-4057qib7	3881	19	the	the	DT
cord-005453-4057qib7	3881	20	practical	practical	JJ
cord-005453-4057qib7	3881	21	approach	approach	NN
cord-005453-4057qib7	3881	22	.	.	.
cord-005453-4057qib7	3882	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3882	2	:	:	:
cord-005453-4057qib7	3882	3	Nothing	nothing	NN
cord-005453-4057qib7	3882	4	to	to	TO
cord-005453-4057qib7	3882	5	declare	declare	VB
cord-005453-4057qib7	3882	6	.	.	.
cord-005453-4057qib7	3883	1	Virus	virus	NN
cord-005453-4057qib7	3883	2	reactivation	reactivation	NN
cord-005453-4057qib7	3883	3	and	and	CC
cord-005453-4057qib7	3883	4	low	low	JJ
cord-005453-4057qib7	3883	5	dose	dose	NN
cord-005453-4057qib7	3883	6	of	of	IN
cord-005453-4057qib7	3883	7	CD34	CD34	NNP
cord-005453-4057qib7	3883	8	+	+	CC
cord-005453-4057qib7	3883	9	cell	cell	NN
cord-005453-4057qib7	3883	10	were	be	VBD
cord-005453-4057qib7	3883	11	associatied	associatie	VBN
cord-005453-4057qib7	3883	12	with	with	IN
cord-005453-4057qib7	3883	13	secondary	secondary	JJ
cord-005453-4057qib7	3883	14	poor	poor	JJ
cord-005453-4057qib7	3883	15	graft	graft	NN
cord-005453-4057qib7	3883	16	function	function	NN
cord-005453-4057qib7	3883	17	within	within	IN
cord-005453-4057qib7	3883	18	the	the	DT
cord-005453-4057qib7	3883	19	first	first	JJ
cord-005453-4057qib7	3883	20	100	100	CD
cord-005453-4057qib7	3883	21	days	day	NNS
cord-005453-4057qib7	3883	22	after	after	IN
cord-005453-4057qib7	3883	23	allogeneic	allogeneic	NN
cord-005453-4057qib7	3883	24	stem	stem	NN
cord-005453-4057qib7	3883	25	cell	cell	NN
cord-005453-4057qib7	3883	26	transplantation	transplantation	NN
cord-005453-4057qib7	3884	1	Yuqian	Yuqian	NNP
cord-005453-4057qib7	3884	2	Sun	Sun	NNP
cord-005453-4057qib7	3884	3	1	1	CD
cord-005453-4057qib7	3884	4	,	,	,
cord-005453-4057qib7	3884	5	Xiao	Xiao	NNP
cord-005453-4057qib7	3884	6	-	-	HYPH
cord-005453-4057qib7	3884	7	Jun	Jun	NNP
cord-005453-4057qib7	3884	8	Huang	Huang	NNP
cord-005453-4057qib7	3884	9	1	1	CD
cord-005453-4057qib7	3884	10	Background	Background	NNP
cord-005453-4057qib7	3884	11	:	:	:
cord-005453-4057qib7	3884	12	Secondary	secondary	JJ
cord-005453-4057qib7	3884	13	poof	poof	NN
cord-005453-4057qib7	3884	14	graft	graft	NN
cord-005453-4057qib7	3884	15	function	function	NN
cord-005453-4057qib7	3884	16	(	(	-LRB-
cord-005453-4057qib7	3884	17	sPGF	spgf	FW
cord-005453-4057qib7	3884	18	)	)	-RRB-
cord-005453-4057qib7	3884	19	was	be	VBD
cord-005453-4057qib7	3884	20	defined	define	VBN
cord-005453-4057qib7	3884	21	as	as	IN
cord-005453-4057qib7	3884	22	the	the	DT
cord-005453-4057qib7	3884	23	secondary	secondary	JJ
cord-005453-4057qib7	3884	24	cytopenia	cytopenia	NNS
cord-005453-4057qib7	3884	25	after	after	IN
cord-005453-4057qib7	3884	26	initial	initial	JJ
cord-005453-4057qib7	3884	27	engraftment	engraftment	NN
cord-005453-4057qib7	3884	28	of	of	IN
cord-005453-4057qib7	3884	29	HSCT	HSCT	NNP
cord-005453-4057qib7	3884	30	.	.	.
cord-005453-4057qib7	3885	1	It	-PRON-	PRP
cord-005453-4057qib7	3885	2	was	be	VBD
cord-005453-4057qib7	3885	3	shown	show	VBN
cord-005453-4057qib7	3885	4	to	to	TO
cord-005453-4057qib7	3885	5	be	be	VB
cord-005453-4057qib7	3885	6	associated	associate	VBN
cord-005453-4057qib7	3885	7	with	with	IN
cord-005453-4057qib7	3885	8	poor	poor	JJ
cord-005453-4057qib7	3885	9	prognosis	prognosis	NN
cord-005453-4057qib7	3885	10	,	,	,
cord-005453-4057qib7	3885	11	however	however	RB
cord-005453-4057qib7	3885	12	there	there	EX
cord-005453-4057qib7	3885	13	are	be	VBP
cord-005453-4057qib7	3885	14	very	very	RB
cord-005453-4057qib7	3885	15	few	few	JJ
cord-005453-4057qib7	3885	16	reports	report	NNS
cord-005453-4057qib7	3885	17	on	on	IN
cord-005453-4057qib7	3885	18	the	the	DT
cord-005453-4057qib7	3885	19	incidence	incidence	NN
cord-005453-4057qib7	3885	20	,	,	,
cord-005453-4057qib7	3885	21	risk	risk	NN
cord-005453-4057qib7	3885	22	factors	factor	NNS
cord-005453-4057qib7	3885	23	and	and	CC
cord-005453-4057qib7	3885	24	outcomes	outcome	NNS
cord-005453-4057qib7	3885	25	of	of	IN
cord-005453-4057qib7	3885	26	sPGF	spgf	FW
cord-005453-4057qib7	3885	27	.	.	.
cord-005453-4057qib7	3886	1	Methods	method	NNS
cord-005453-4057qib7	3886	2	:	:	:
cord-005453-4057qib7	3887	1	Patients	patient	NNS
cord-005453-4057qib7	3887	2	who	who	WP
cord-005453-4057qib7	3887	3	received	receive	VBD
cord-005453-4057qib7	3887	4	transplantation	transplantation	NN
cord-005453-4057qib7	3887	5	from	from	IN
cord-005453-4057qib7	3887	6	Peking	Peking	NNP
cord-005453-4057qib7	3887	7	University	University	NNP
cord-005453-4057qib7	3887	8	People	People	NNPS
cord-005453-4057qib7	3887	9	's	's	POS
cord-005453-4057qib7	3887	10	Hospitial	Hospitial	NNP
cord-005453-4057qib7	3887	11	during	during	IN
cord-005453-4057qib7	3887	12	January	January	NNP
cord-005453-4057qib7	3887	13	,	,	,
cord-005453-4057qib7	3887	14	2015	2015	CD
cord-005453-4057qib7	3887	15	to	to	IN
cord-005453-4057qib7	3887	16	December	December	NNP
cord-005453-4057qib7	3887	17	,	,	,
cord-005453-4057qib7	3887	18	2015	2015	CD
cord-005453-4057qib7	3887	19	were	be	VBD
cord-005453-4057qib7	3887	20	retrospectively	retrospectively	RB
cord-005453-4057qib7	3887	21	reviewed	review	VBN
cord-005453-4057qib7	3887	22	if	if	IN
cord-005453-4057qib7	3887	23	they	-PRON-	PRP
cord-005453-4057qib7	3887	24	fulfilled	fulfil	VBD
cord-005453-4057qib7	3887	25	the	the	DT
cord-005453-4057qib7	3887	26	following	follow	VBG
cord-005453-4057qib7	3887	27	conditions	condition	NNS
cord-005453-4057qib7	3887	28	:	:	:
cord-005453-4057qib7	3887	29	(	(	-LRB-
cord-005453-4057qib7	3887	30	1	1	LS
cord-005453-4057qib7	3887	31	)	)	-RRB-
cord-005453-4057qib7	3887	32	diagnosed	diagnose	VBN
cord-005453-4057qib7	3887	33	with	with	IN
cord-005453-4057qib7	3887	34	acute	acute	JJ
cord-005453-4057qib7	3887	35	leukemia	leukemia	NN
cord-005453-4057qib7	3887	36	or	or	CC
cord-005453-4057qib7	3887	37	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	3887	38	syndrome	syndrome	NN
cord-005453-4057qib7	3887	39	;	;	:
cord-005453-4057qib7	3887	40	(	(	-LRB-
cord-005453-4057qib7	3887	41	2	2	LS
cord-005453-4057qib7	3887	42	)	)	-RRB-
cord-005453-4057qib7	3887	43	received	receive	VBD
cord-005453-4057qib7	3887	44	allo	allo	NN
cord-005453-4057qib7	3887	45	-	-	HYPH
cord-005453-4057qib7	3887	46	SCT	SCT	NNP
cord-005453-4057qib7	3887	47	from	from	IN
cord-005453-4057qib7	3887	48	either	either	CC
cord-005453-4057qib7	3887	49	matched	match	VBN
cord-005453-4057qib7	3887	50	sibling	sibling	NN
cord-005453-4057qib7	3887	51	donor	donor	NN
cord-005453-4057qib7	3887	52	(	(	-LRB-
cord-005453-4057qib7	3887	53	MSD	MSD	NNP
cord-005453-4057qib7	3887	54	)	)	-RRB-
cord-005453-4057qib7	3887	55	or	or	CC
cord-005453-4057qib7	3887	56	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3887	57	related	related	JJ
cord-005453-4057qib7	3887	58	donor	donor	NN
cord-005453-4057qib7	3887	59	(	(	-LRB-
cord-005453-4057qib7	3887	60	HID	HID	NNP
cord-005453-4057qib7	3887	61	)	)	-RRB-
cord-005453-4057qib7	3887	62	.	.	.
cord-005453-4057qib7	3888	1	PGF	PGF	NNP
cord-005453-4057qib7	3888	2	was	be	VBD
cord-005453-4057qib7	3888	3	defined	define	VBN
cord-005453-4057qib7	3888	4	as	as	IN
cord-005453-4057qib7	3888	5	persistent	persistent	JJ
cord-005453-4057qib7	3888	6	neutropenia	neutropenia	NN
cord-005453-4057qib7	3888	7	(	(	-LRB-
cord-005453-4057qib7	3888	8	≤0.5×10	≤0.5×10	NNP
cord-005453-4057qib7	3888	9	9	9	CD
cord-005453-4057qib7	3888	10	/L	/L	.
cord-005453-4057qib7	3888	11	)	)	-RRB-
cord-005453-4057qib7	3888	12	,	,	,
cord-005453-4057qib7	3888	13	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	3888	14	(	(	-LRB-
cord-005453-4057qib7	3888	15	platelets	platelet	NNS
cord-005453-4057qib7	3888	16	≤20×10	≤20×10	VBD
cord-005453-4057qib7	3888	17	9	9	CD
cord-005453-4057qib7	3888	18	/L	/L	.
cord-005453-4057qib7	3888	19	)	)	-RRB-
cord-005453-4057qib7	3888	20	,	,	,
cord-005453-4057qib7	3888	21	and/or	and/or	CC
cord-005453-4057qib7	3888	22	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	3888	23	≤70	≤70	:
cord-005453-4057qib7	3888	24	g	g	NN
cord-005453-4057qib7	3888	25	/	/	SYM
cord-005453-4057qib7	3888	26	L	l	NN
cord-005453-4057qib7	3888	27	for	for	IN
cord-005453-4057qib7	3888	28	at	at	RB
cord-005453-4057qib7	3888	29	least	least	JJS
cord-005453-4057qib7	3888	30	3	3	CD
cord-005453-4057qib7	3888	31	consecutive	consecutive	JJ
cord-005453-4057qib7	3888	32	days	day	NNS
cord-005453-4057qib7	3888	33	,	,	,
cord-005453-4057qib7	3888	34	transfusion	transfusion	NN
cord-005453-4057qib7	3888	35	-	-	HYPH
cord-005453-4057qib7	3888	36	dependence	dependence	NN
cord-005453-4057qib7	3888	37	,	,	,
cord-005453-4057qib7	3888	38	associated	associate	VBN
cord-005453-4057qib7	3888	39	with	with	IN
cord-005453-4057qib7	3888	40	hypoplastic	hypoplastic	JJ
cord-005453-4057qib7	3888	41	-	-	HYPH
cord-005453-4057qib7	3888	42	aplastic	aplastic	NN
cord-005453-4057qib7	3888	43	bone	bone	NN
cord-005453-4057qib7	3888	44	marrow	marrow	NN
cord-005453-4057qib7	3888	45	(	(	-LRB-
cord-005453-4057qib7	3888	46	BM	BM	NNP
cord-005453-4057qib7	3888	47	)	)	-RRB-
cord-005453-4057qib7	3888	48	,	,	,
cord-005453-4057qib7	3888	49	and	and	CC
cord-005453-4057qib7	3888	50	complete	complete	JJ
cord-005453-4057qib7	3888	51	donor	donor	NN
cord-005453-4057qib7	3888	52	chimerism	chimerism	NN
cord-005453-4057qib7	3888	53	without	without	IN
cord-005453-4057qib7	3888	54	concurrent	concurrent	JJ
cord-005453-4057qib7	3888	55	graftversus	graftversus	NN
cord-005453-4057qib7	3888	56	-	-	HYPH
cord-005453-4057qib7	3888	57	host	host	NN
cord-005453-4057qib7	3888	58	disease	disease	NN
cord-005453-4057qib7	3888	59	(	(	-LRB-
cord-005453-4057qib7	3888	60	GVHD	GVHD	NNP
cord-005453-4057qib7	3888	61	)	)	-RRB-
cord-005453-4057qib7	3888	62	or	or	CC
cord-005453-4057qib7	3888	63	disease	disease	NN
cord-005453-4057qib7	3888	64	relapse	relapse	NN
cord-005453-4057qib7	3888	65	.	.	.
cord-005453-4057qib7	3889	1	Primary	Primary	NNP
cord-005453-4057qib7	3889	2	PGF	PGF	NNP
cord-005453-4057qib7	3889	3	was	be	VBD
cord-005453-4057qib7	3889	4	defined	define	VBN
cord-005453-4057qib7	3889	5	as	as	IN
cord-005453-4057qib7	3889	6	the	the	DT
cord-005453-4057qib7	3889	7	failure	failure	NN
cord-005453-4057qib7	3889	8	to	to	TO
cord-005453-4057qib7	3889	9	achieve	achieve	VB
cord-005453-4057qib7	3889	10	initial	initial	JJ
cord-005453-4057qib7	3889	11	engraftment	engraftment	NN
cord-005453-4057qib7	3889	12	by	by	IN
cord-005453-4057qib7	3889	13	days	day	NNS
cord-005453-4057qib7	3889	14	28	28	CD
cord-005453-4057qib7	3889	15	after	after	IN
cord-005453-4057qib7	3889	16	transplantation	transplantation	NN
cord-005453-4057qib7	3889	17	,	,	,
cord-005453-4057qib7	3889	18	while	while	IN
cord-005453-4057qib7	3889	19	secondary	secondary	JJ
cord-005453-4057qib7	3889	20	PGF	PGF	NNP
cord-005453-4057qib7	3889	21	was	be	VBD
cord-005453-4057qib7	3889	22	defined	define	VBN
cord-005453-4057qib7	3889	23	as	as	IN
cord-005453-4057qib7	3889	24	the	the	DT
cord-005453-4057qib7	3889	25	fulfillment	fulfillment	NN
cord-005453-4057qib7	3889	26	of	of	IN
cord-005453-4057qib7	3889	27	the	the	DT
cord-005453-4057qib7	3889	28	criteria	criterion	NNS
cord-005453-4057qib7	3889	29	after	after	IN
cord-005453-4057qib7	3889	30	initial	initial	JJ
cord-005453-4057qib7	3889	31	engraftment	engraftment	NN
cord-005453-4057qib7	3889	32	HSCT	HSCT	NNP
cord-005453-4057qib7	3889	33	.	.	.
cord-005453-4057qib7	3890	1	Results	result	NNS
cord-005453-4057qib7	3890	2	:	:	:
cord-005453-4057qib7	3891	1	During	during	IN
cord-005453-4057qib7	3891	2	January	January	NNP
cord-005453-4057qib7	3891	3	,	,	,
cord-005453-4057qib7	3891	4	2015	2015	CD
cord-005453-4057qib7	3891	5	to	to	IN
cord-005453-4057qib7	3891	6	December	December	NNP
cord-005453-4057qib7	3891	7	,	,	,
cord-005453-4057qib7	3891	8	2015	2015	CD
cord-005453-4057qib7	3891	9	,	,	,
cord-005453-4057qib7	3891	10	564	564	CD
cord-005453-4057qib7	3891	11	patients	patient	NNS
cord-005453-4057qib7	3891	12	who	who	WP
cord-005453-4057qib7	3891	13	received	receive	VBD
cord-005453-4057qib7	3891	14	transplantation	transplantation	NN
cord-005453-4057qib7	3891	15	from	from	IN
cord-005453-4057qib7	3891	16	Peking	Peking	NNP
cord-005453-4057qib7	3891	17	University	University	NNP
cord-005453-4057qib7	3891	18	People	People	NNPS
cord-005453-4057qib7	3891	19	's	's	POS
cord-005453-4057qib7	3891	20	Hospitial	Hospitial	NNP
cord-005453-4057qib7	3891	21	were	be	VBD
cord-005453-4057qib7	3891	22	retrospectively	retrospectively	RB
cord-005453-4057qib7	3891	23	reviewed	review	VBN
cord-005453-4057qib7	3891	24	.	.	.
cord-005453-4057qib7	3892	1	Among	among	IN
cord-005453-4057qib7	3892	2	the	the	DT
cord-005453-4057qib7	3892	3	490	490	CD
cord-005453-4057qib7	3892	4	patients	patient	NNS
cord-005453-4057qib7	3892	5	who	who	WP
cord-005453-4057qib7	3892	6	achieved	achieve	VBD
cord-005453-4057qib7	3892	7	initial	initial	JJ
cord-005453-4057qib7	3892	8	engraftment	engraftment	NN
cord-005453-4057qib7	3892	9	,	,	,
cord-005453-4057qib7	3892	10	28	28	CD
cord-005453-4057qib7	3892	11	patients	patient	NNS
cord-005453-4057qib7	3892	12	developed	develop	VBD
cord-005453-4057qib7	3892	13	sPGF	spgf	FW
cord-005453-4057qib7	3892	14	.	.	.
cord-005453-4057qib7	3893	1	The	the	DT
cord-005453-4057qib7	3893	2	cumulative	cumulative	JJ
cord-005453-4057qib7	3893	3	incidence	incidence	NN
cord-005453-4057qib7	3893	4	of	of	IN
cord-005453-4057qib7	3893	5	sPGF	sPGF	NNP
cord-005453-4057qib7	3893	6	on	on	IN
cord-005453-4057qib7	3893	7	day	day	NN
cord-005453-4057qib7	3893	8	100	100	CD
cord-005453-4057qib7	3893	9	was	be	VBD
cord-005453-4057qib7	3893	10	5.7	5.7	CD
cord-005453-4057qib7	3893	11	%	%	NN
cord-005453-4057qib7	3893	12	.	.	.
cord-005453-4057qib7	3894	1	The	the	DT
cord-005453-4057qib7	3894	2	median	median	JJ
cord-005453-4057qib7	3894	3	time	time	NN
cord-005453-4057qib7	3894	4	of	of	IN
cord-005453-4057qib7	3894	5	secondary	secondary	JJ
cord-005453-4057qib7	3894	6	PGF	PGF	NNP
cord-005453-4057qib7	3894	7	was	be	VBD
cord-005453-4057qib7	3895	1	54.5	54.5	CD
cord-005453-4057qib7	3895	2	(	(	-LRB-
cord-005453-4057qib7	3895	3	34	34	CD
cord-005453-4057qib7	3895	4	-	-	SYM
cord-005453-4057qib7	3895	5	91	91	CD
cord-005453-4057qib7	3895	6	)	)	-RRB-
cord-005453-4057qib7	3895	7	days	day	NNS
cord-005453-4057qib7	3895	8	after	after	IN
cord-005453-4057qib7	3895	9	transplantation	transplantation	NN
cord-005453-4057qib7	3895	10	.	.	.
cord-005453-4057qib7	3896	1	Low	low	JJ
cord-005453-4057qib7	3896	2	(	(	-LRB-
cord-005453-4057qib7	3896	3	<	<	XX
cord-005453-4057qib7	3896	4	median	median	NN
cord-005453-4057qib7	3896	5	)	)	-RRB-
cord-005453-4057qib7	3897	1	CD34	CD34	NNP
cord-005453-4057qib7	3897	2	+	+	CC
cord-005453-4057qib7	3897	3	cell	cell	NN
cord-005453-4057qib7	3897	4	dose	dose	NN
cord-005453-4057qib7	3897	5	(	(	-LRB-
cord-005453-4057qib7	3897	6	p=0.019	p=0.019	NNP
cord-005453-4057qib7	3897	7	,	,	,
cord-005453-4057qib7	3897	8	HR	HR	NNP
cord-005453-4057qib7	3897	9	3.07(95%CI	3.07(95%ci	CD
cord-005453-4057qib7	3897	10	,	,	,
cord-005453-4057qib7	3897	11	1.207	1.207	CD
cord-005453-4057qib7	3897	12	-	-	SYM
cord-005453-4057qib7	3897	13	7.813	7.813	CD
cord-005453-4057qib7	3897	14	)	)	-RRB-
cord-005453-4057qib7	3897	15	)	)	-RRB-
cord-005453-4057qib7	3897	16	,	,	,
cord-005453-4057qib7	3897	17	EBV	EBV	NNP
cord-005453-4057qib7	3897	18	reactivation	reactivation	NN
cord-005453-4057qib7	3897	19	(	(	-LRB-
cord-005453-4057qib7	3897	20	p=0.009	p=0.009	NN
cord-005453-4057qib7	3897	21	,	,	,
cord-005453-4057qib7	3897	22	HR	HR	NNP
cord-005453-4057qib7	3897	23	3.648(95%CI	3.648(95%ci	CD
cord-005453-4057qib7	3897	24	,	,	,
cord-005453-4057qib7	3897	25	1.382	1.382	CD
cord-005453-4057qib7	3897	26	-	-	HYPH
cord-005453-4057qib7	3897	27	9.629	9.629	CD
cord-005453-4057qib7	3897	28	)	)	-RRB-
cord-005453-4057qib7	3897	29	)	)	-RRB-
cord-005453-4057qib7	3897	30	and	and	CC
cord-005453-4057qib7	3897	31	CMV	CMV	NNP
cord-005453-4057qib7	3897	32	reactivation	reactivation	NN
cord-005453-4057qib7	3897	33	(	(	-LRB-
cord-005453-4057qib7	3897	34	p=0.003	p=0.003	NNP
cord-005453-4057qib7	3897	35	,	,	,
cord-005453-4057qib7	3897	36	HR	HR	NNP
cord-005453-4057qib7	3897	37	7.827	7.827	CD
cord-005453-4057qib7	3897	38	(	(	-LRB-
cord-005453-4057qib7	3898	1	95%CI	95%ci	CD
cord-005453-4057qib7	3898	2	,	,	,
cord-005453-4057qib7	3898	3	2.002	2.002	CD
cord-005453-4057qib7	3898	4	-	-	HYPH
cord-005453-4057qib7	3898	5	30.602	30.602	CD
cord-005453-4057qib7	3898	6	)	)	-RRB-
cord-005453-4057qib7	3898	7	)	)	-RRB-
cord-005453-4057qib7	3898	8	were	be	VBD
cord-005453-4057qib7	3898	9	identified	identify	VBN
cord-005453-4057qib7	3898	10	as	as	IN
cord-005453-4057qib7	3898	11	independent	independent	JJ
cord-005453-4057qib7	3898	12	risk	risk	NN
cord-005453-4057qib7	3898	13	factors	factor	NNS
cord-005453-4057qib7	3898	14	with	with	IN
cord-005453-4057qib7	3898	15	sPGF	sPGF	NNP
cord-005453-4057qib7	3898	16	.	.	.
cord-005453-4057qib7	3899	1	There	there	EX
cord-005453-4057qib7	3899	2	is	be	VBZ
cord-005453-4057qib7	3899	3	no	no	DT
cord-005453-4057qib7	3899	4	significant	significant	JJ
cord-005453-4057qib7	3899	5	difference	difference	NN
cord-005453-4057qib7	3899	6	of	of	IN
cord-005453-4057qib7	3899	7	PGF	PGF	NNP
cord-005453-4057qib7	3899	8	incidence	incidence	NN
cord-005453-4057qib7	3899	9	in	in	IN
cord-005453-4057qib7	3899	10	MSD	MSD	NNP
cord-005453-4057qib7	3899	11	group	group	NN
cord-005453-4057qib7	3899	12	and	and	CC
cord-005453-4057qib7	3899	13	HID	HID	NNP
cord-005453-4057qib7	3899	14	patients	patient	NNS
cord-005453-4057qib7	3899	15	(	(	-LRB-
cord-005453-4057qib7	3899	16	p=0.44	p=0.44	NNS
cord-005453-4057qib7	3899	17	)	)	-RRB-
cord-005453-4057qib7	3899	18	.	.	.
cord-005453-4057qib7	3900	1	The	the	DT
cord-005453-4057qib7	3900	2	overall	overall	JJ
cord-005453-4057qib7	3900	3	survival	survival	NN
cord-005453-4057qib7	3900	4	of	of	IN
cord-005453-4057qib7	3900	5	patients	patient	NNS
cord-005453-4057qib7	3900	6	with	with	IN
cord-005453-4057qib7	3900	7	sPGF	sPGF	NNP
cord-005453-4057qib7	3900	8	at	at	IN
cord-005453-4057qib7	3900	9	1	1	CD
cord-005453-4057qib7	3900	10	year	year	NN
cord-005453-4057qib7	3900	11	after	after	IN
cord-005453-4057qib7	3900	12	transplantation	transplantation	NN
cord-005453-4057qib7	3900	13	was	be	VBD
cord-005453-4057qib7	3900	14	significantly	significantly	RB
cord-005453-4057qib7	3900	15	poor	poor	JJ
cord-005453-4057qib7	3900	16	than	than	IN
cord-005453-4057qib7	3900	17	patients	patient	NNS
cord-005453-4057qib7	3900	18	with	with	IN
cord-005453-4057qib7	3900	19	GGF	GGF	NNP
cord-005453-4057qib7	3900	20	(	(	-LRB-
cord-005453-4057qib7	3900	21	50.5	50.5	CD
cord-005453-4057qib7	3900	22	%	%	NN
cord-005453-4057qib7	3900	23	versus	versus	IN
cord-005453-4057qib7	3900	24	87.2	87.2	CD
cord-005453-4057qib7	3900	25	%	%	NN
cord-005453-4057qib7	3900	26	,	,	,
cord-005453-4057qib7	3900	27	p	p	NN
cord-005453-4057qib7	3900	28	<	<	XX
cord-005453-4057qib7	3900	29	0.001	0.001	CD
cord-005453-4057qib7	3900	30	)	)	-RRB-
cord-005453-4057qib7	3900	31	.	.	.
cord-005453-4057qib7	3901	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3901	2	:	:	:
cord-005453-4057qib7	3902	1	In	in	IN
cord-005453-4057qib7	3902	2	conclusion	conclusion	NN
cord-005453-4057qib7	3902	3	,	,	,
cord-005453-4057qib7	3902	4	sPGF	spgf	FW
cord-005453-4057qib7	3902	5	develop	develop	VBP
cord-005453-4057qib7	3902	6	in	in	IN
cord-005453-4057qib7	3902	7	5.7	5.7	CD
cord-005453-4057qib7	3902	8	%	%	NN
cord-005453-4057qib7	3902	9	patients	patient	NNS
cord-005453-4057qib7	3902	10	after	after	IN
cord-005453-4057qib7	3902	11	allo	allo	NN
cord-005453-4057qib7	3902	12	-	-	HYPH
cord-005453-4057qib7	3902	13	SCT	SCT	NNP
cord-005453-4057qib7	3902	14	,	,	,
cord-005453-4057qib7	3902	15	especially	especially	RB
cord-005453-4057qib7	3902	16	in	in	IN
cord-005453-4057qib7	3902	17	patients	patient	NNS
cord-005453-4057qib7	3902	18	with	with	IN
cord-005453-4057qib7	3902	19	CMV	CMV	NNP
cord-005453-4057qib7	3902	20	,	,	,
cord-005453-4057qib7	3902	21	EBV	EBV	NNP
cord-005453-4057qib7	3902	22	reactivation	reactivation	NN
cord-005453-4057qib7	3902	23	or	or	CC
cord-005453-4057qib7	3902	24	infused	infuse	VBN
cord-005453-4057qib7	3902	25	with	with	IN
cord-005453-4057qib7	3902	26	low	low	JJ
cord-005453-4057qib7	3902	27	dose	dose	NN
cord-005453-4057qib7	3902	28	of	of	IN
cord-005453-4057qib7	3902	29	CD34	CD34	NNP
cord-005453-4057qib7	3902	30	+	+	CC
cord-005453-4057qib7	3902	31	cell	cell	NN
cord-005453-4057qib7	3902	32	.	.	.
cord-005453-4057qib7	3903	1	The	the	DT
cord-005453-4057qib7	3903	2	prognosis	prognosis	NN
cord-005453-4057qib7	3903	3	of	of	IN
cord-005453-4057qib7	3903	4	sPGF	sPGF	NNP
cord-005453-4057qib7	3903	5	is	be	VBZ
cord-005453-4057qib7	3903	6	still	still	RB
cord-005453-4057qib7	3903	7	poor	poor	JJ
cord-005453-4057qib7	3903	8	due	due	IN
cord-005453-4057qib7	3903	9	to	to	IN
cord-005453-4057qib7	3903	10	lack	lack	NN
cord-005453-4057qib7	3903	11	of	of	IN
cord-005453-4057qib7	3903	12	standard	standard	JJ
cord-005453-4057qib7	3903	13	treatment	treatment	NN
cord-005453-4057qib7	3903	14	.	.	.
cord-005453-4057qib7	3904	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3904	2	:	:	:
cord-005453-4057qib7	3904	3	There	there	EX
cord-005453-4057qib7	3904	4	is	be	VBZ
cord-005453-4057qib7	3904	5	no	no	DT
cord-005453-4057qib7	3904	6	conflict	conflict	NN
cord-005453-4057qib7	3904	7	of	of	IN
cord-005453-4057qib7	3904	8	interet	interet	NN
cord-005453-4057qib7	3904	9	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	3904	10	with	with	IN
cord-005453-4057qib7	3904	11	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3904	12	and	and	CC
cord-005453-4057qib7	3904	13	busulfan	busulfan	NN
cord-005453-4057qib7	3904	14	based	base	VBN
cord-005453-4057qib7	3904	15	conditioning	conditioning	NN
cord-005453-4057qib7	3904	16	are	be	VBP
cord-005453-4057qib7	3904	17	significantly	significantly	RB
cord-005453-4057qib7	3904	18	more	more	RBR
cord-005453-4057qib7	3904	19	gonadotoxic	gonadotoxic	JJ
cord-005453-4057qib7	3904	20	than	than	IN
cord-005453-4057qib7	3904	21	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3905	1	Previous	previous	JJ
cord-005453-4057qib7	3905	2	studies	study	NNS
cord-005453-4057qib7	3905	3	suggest	suggest	VBP
cord-005453-4057qib7	3905	4	that	that	IN
cord-005453-4057qib7	3905	5	busulfan	busulfan	NN
cord-005453-4057qib7	3905	6	results	result	NNS
cord-005453-4057qib7	3905	7	in	in	IN
cord-005453-4057qib7	3905	8	long	long	JJ
cord-005453-4057qib7	3905	9	-	-	HYPH
cord-005453-4057qib7	3905	10	term	term	NN
cord-005453-4057qib7	3905	11	gonadal	gonadal	JJ
cord-005453-4057qib7	3905	12	toxicity	toxicity	NN
cord-005453-4057qib7	3905	13	.	.	.
cord-005453-4057qib7	3906	1	No	no	DT
cord-005453-4057qib7	3906	2	previous	previous	JJ
cord-005453-4057qib7	3906	3	studies	study	NNS
cord-005453-4057qib7	3906	4	have	have	VBP
cord-005453-4057qib7	3906	5	compared	compare	VBN
cord-005453-4057qib7	3906	6	gonadal	gonadal	JJ
cord-005453-4057qib7	3906	7	toxicity	toxicity	NN
cord-005453-4057qib7	3906	8	outcomes	outcome	NNS
cord-005453-4057qib7	3906	9	after	after	IN
cord-005453-4057qib7	3906	10	treatment	treatment	NN
cord-005453-4057qib7	3906	11	with	with	IN
cord-005453-4057qib7	3906	12	busulfan	busulfan	NNP
cord-005453-4057qib7	3906	13	with	with	IN
cord-005453-4057qib7	3906	14	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3906	15	,	,	,
cord-005453-4057qib7	3906	16	a	a	DT
cord-005453-4057qib7	3906	17	newer	new	JJR
cord-005453-4057qib7	3906	18	agent	agent	NN
cord-005453-4057qib7	3906	19	with	with	IN
cord-005453-4057qib7	3906	20	similar	similar	JJ
cord-005453-4057qib7	3906	21	marrow	marrow	NN
cord-005453-4057qib7	3906	22	toxicity	toxicity	NN
cord-005453-4057qib7	3906	23	to	to	IN
cord-005453-4057qib7	3906	24	busulfan	busulfan	NN
cord-005453-4057qib7	3906	25	but	but	CC
cord-005453-4057qib7	3906	26	with	with	IN
cord-005453-4057qib7	3906	27	reduced	reduce	VBN
cord-005453-4057qib7	3906	28	non	non	JJ
cord-005453-4057qib7	3906	29	-	-	JJ
cord-005453-4057qib7	3906	30	marrow	marrow	JJ
cord-005453-4057qib7	3906	31	toxcitiy	toxcitiy	NNS
cord-005453-4057qib7	3906	32	.	.	.
cord-005453-4057qib7	3907	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3907	2	aim	aim	NN
cord-005453-4057qib7	3907	3	was	be	VBD
cord-005453-4057qib7	3907	4	to	to	TO
cord-005453-4057qib7	3907	5	determine	determine	VB
cord-005453-4057qib7	3907	6	whether	whether	IN
cord-005453-4057qib7	3907	7	there	there	EX
cord-005453-4057qib7	3907	8	are	be	VBP
cord-005453-4057qib7	3907	9	differences	difference	NNS
cord-005453-4057qib7	3907	10	in	in	IN
cord-005453-4057qib7	3907	11	pubertal	pubertal	JJ
cord-005453-4057qib7	3907	12	and	and	CC
cord-005453-4057qib7	3907	13	fertility	fertility	NN
cord-005453-4057qib7	3907	14	outcomes	outcome	NNS
cord-005453-4057qib7	3907	15	in	in	IN
cord-005453-4057qib7	3907	16	paediatric	paediatric	JJ
cord-005453-4057qib7	3907	17	patients	patient	NNS
cord-005453-4057qib7	3907	18	treated	treat	VBN
cord-005453-4057qib7	3907	19	with	with	IN
cord-005453-4057qib7	3907	20	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3907	21	compared	compare	VBN
cord-005453-4057qib7	3907	22	with	with	IN
cord-005453-4057qib7	3907	23	busulfan	busulfan	NN
cord-005453-4057qib7	3907	24	.	.	.
cord-005453-4057qib7	3908	1	Methods	method	NNS
cord-005453-4057qib7	3908	2	:	:	:
cord-005453-4057qib7	3909	1	Inclusion	inclusion	NN
cord-005453-4057qib7	3909	2	criteria	criterion	NNS
cord-005453-4057qib7	3909	3	were	be	VBD
cord-005453-4057qib7	3909	4	patients	patient	NNS
cord-005453-4057qib7	3909	5	who	who	WP
cord-005453-4057qib7	3909	6	had	have	VBD
cord-005453-4057qib7	3909	7	received	receive	VBN
cord-005453-4057qib7	3909	8	either	either	CC
cord-005453-4057qib7	3909	9	busulfan	busulfan	NN
cord-005453-4057qib7	3909	10	or	or	CC
cord-005453-4057qib7	3909	11	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3909	12	or	or	CC
cord-005453-4057qib7	3909	13	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3909	14	with	with	IN
cord-005453-4057qib7	3909	15	thiotepa	thiotepa	NNP
cord-005453-4057qib7	3909	16	,	,	,
cord-005453-4057qib7	3909	17	only	only	RB
cord-005453-4057qib7	3909	18	one	one	CD
cord-005453-4057qib7	3909	19	HCT	hct	NN
cord-005453-4057qib7	3909	20	and	and	CC
cord-005453-4057qib7	3909	21	were	be	VBD
cord-005453-4057qib7	3909	22	aged	age	VBN
cord-005453-4057qib7	3909	23	14	14	CD
cord-005453-4057qib7	3909	24	years	year	NNS
cord-005453-4057qib7	3909	25	and	and	CC
cord-005453-4057qib7	3909	26	above	above	RB
cord-005453-4057qib7	3909	27	in	in	IN
cord-005453-4057qib7	3909	28	August	August	NNP
cord-005453-4057qib7	3909	29	2018	2018	CD
cord-005453-4057qib7	3909	30	.	.	.
cord-005453-4057qib7	3910	1	Eligible	eligible	JJ
cord-005453-4057qib7	3910	2	patients	patient	NNS
cord-005453-4057qib7	3910	3	were	be	VBD
cord-005453-4057qib7	3910	4	reviewed	review	VBN
cord-005453-4057qib7	3910	5	in	in	IN
cord-005453-4057qib7	3910	6	clinic	clinic	NN
cord-005453-4057qib7	3910	7	as	as	IN
cord-005453-4057qib7	3910	8	part	part	NN
cord-005453-4057qib7	3910	9	of	of	IN
cord-005453-4057qib7	3910	10	their	-PRON-	PRP$
cord-005453-4057qib7	3910	11	routine	routine	JJ
cord-005453-4057qib7	3910	12	follow	follow	NN
cord-005453-4057qib7	3910	13	-	-	HYPH
cord-005453-4057qib7	3910	14	up	up	NN
cord-005453-4057qib7	3910	15	,	,	,
cord-005453-4057qib7	3910	16	thus	thus	RB
cord-005453-4057qib7	3910	17	research	research	NN
cord-005453-4057qib7	3910	18	ethical	ethical	JJ
cord-005453-4057qib7	3910	19	approval	approval	NN
cord-005453-4057qib7	3910	20	was	be	VBD
cord-005453-4057qib7	3910	21	not	not	RB
cord-005453-4057qib7	3910	22	required	require	VBN
cord-005453-4057qib7	3910	23	.	.	.
cord-005453-4057qib7	3911	1	Follice	Follice	NNP
cord-005453-4057qib7	3911	2	Stimulating	Stimulating	NNP
cord-005453-4057qib7	3911	3	Hormone	Hormone	NNP
cord-005453-4057qib7	3911	4	,	,	,
cord-005453-4057qib7	3911	5	Luteinising	Luteinising	NNP
cord-005453-4057qib7	3911	6	Hormone	Hormone	NNP
cord-005453-4057qib7	3911	7	,	,	,
cord-005453-4057qib7	3911	8	oestradiol	oestradiol	NN
cord-005453-4057qib7	3911	9	,	,	,
cord-005453-4057qib7	3911	10	and	and	CC
cord-005453-4057qib7	3911	11	pubertal	pubertal	JJ
cord-005453-4057qib7	3911	12	history	history	NN
cord-005453-4057qib7	3911	13	were	be	VBD
cord-005453-4057qib7	3911	14	noted	note	VBN
cord-005453-4057qib7	3911	15	.	.	.
cord-005453-4057qib7	3912	1	Ovarian	Ovarian	NNP
cord-005453-4057qib7	3912	2	reserve	reserve	NN
cord-005453-4057qib7	3912	3	was	be	VBD
cord-005453-4057qib7	3912	4	estimated	estimate	VBN
cord-005453-4057qib7	3912	5	in	in	IN
cord-005453-4057qib7	3912	6	female	female	JJ
cord-005453-4057qib7	3912	7	patients	patient	NNS
cord-005453-4057qib7	3912	8	by	by	IN
cord-005453-4057qib7	3912	9	measuring	measure	VBG
cord-005453-4057qib7	3912	10	serum	serum	NN
cord-005453-4057qib7	3912	11	Anti	anti	JJ
cord-005453-4057qib7	3912	12	-	-	JJ
cord-005453-4057qib7	3912	13	Mullerian	mullerian	JJ
cord-005453-4057qib7	3912	14	Hormone	hormone	NN
cord-005453-4057qib7	3912	15	(	(	-LRB-
cord-005453-4057qib7	3912	16	AMH	AMH	NNP
cord-005453-4057qib7	3912	17	)	)	-RRB-
cord-005453-4057qib7	3912	18	.	.	.
cord-005453-4057qib7	3913	1	Male	male	JJ
cord-005453-4057qib7	3913	2	patients	patient	NNS
cord-005453-4057qib7	3913	3	had	have	VBD
cord-005453-4057qib7	3913	4	serum	serum	NN
cord-005453-4057qib7	3913	5	testosterone	testosterone	NN
cord-005453-4057qib7	3913	6	measured	measure	VBN
cord-005453-4057qib7	3913	7	and	and	CC
cord-005453-4057qib7	3913	8	were	be	VBD
cord-005453-4057qib7	3913	9	also	also	RB
cord-005453-4057qib7	3913	10	offered	offer	VBN
cord-005453-4057qib7	3913	11	semen	semen	NN
cord-005453-4057qib7	3913	12	analysis	analysis	NN
cord-005453-4057qib7	3913	13	.	.	.
cord-005453-4057qib7	3914	1	Results	result	NNS
cord-005453-4057qib7	3914	2	:	:	:
cord-005453-4057qib7	3915	1	Thirty	thirty	CD
cord-005453-4057qib7	3915	2	-	-	HYPH
cord-005453-4057qib7	3915	3	five	five	CD
cord-005453-4057qib7	3915	4	patients	patient	NNS
cord-005453-4057qib7	3915	5	met	meet	VBD
cord-005453-4057qib7	3915	6	the	the	DT
cord-005453-4057qib7	3915	7	inclusion	inclusion	NN
cord-005453-4057qib7	3915	8	criteria	criterion	NNS
cord-005453-4057qib7	3915	9	,	,	,
cord-005453-4057qib7	3915	10	of	of	IN
cord-005453-4057qib7	3915	11	which	which	WDT
cord-005453-4057qib7	3915	12	twenty	twenty	CD
cord-005453-4057qib7	3915	13	-	-	HYPH
cord-005453-4057qib7	3915	14	five	five	CD
cord-005453-4057qib7	3915	15	wanted	want	VBD
cord-005453-4057qib7	3915	16	to	to	TO
cord-005453-4057qib7	3915	17	be	be	VB
cord-005453-4057qib7	3915	18	reviewed	review	VBN
cord-005453-4057qib7	3915	19	(	(	-LRB-
cord-005453-4057qib7	3915	20	71	71	CD
cord-005453-4057qib7	3915	21	%	%	NN
cord-005453-4057qib7	3915	22	)	)	-RRB-
cord-005453-4057qib7	3915	23	;	;	:
cord-005453-4057qib7	3915	24	seventeen	seventeen	CD
cord-005453-4057qib7	3915	25	females	female	NNS
cord-005453-4057qib7	3915	26	and	and	CC
cord-005453-4057qib7	3915	27	eight	eight	CD
cord-005453-4057qib7	3915	28	males	male	NNS
cord-005453-4057qib7	3915	29	.	.	.
cord-005453-4057qib7	3916	1	Mean	mean	JJ
cord-005453-4057qib7	3916	2	age	age	NN
cord-005453-4057qib7	3916	3	at	at	IN
cord-005453-4057qib7	3916	4	HCT	HCT	NNP
cord-005453-4057qib7	3916	5	was	be	VBD
cord-005453-4057qib7	3916	6	13	13	CD
cord-005453-4057qib7	3916	7	years	year	NNS
cord-005453-4057qib7	3916	8	,	,	,
cord-005453-4057qib7	3916	9	mean	mean	VB
cord-005453-4057qib7	3916	10	age	age	NN
cord-005453-4057qib7	3916	11	at	at	IN
cord-005453-4057qib7	3916	12	review	review	NN
cord-005453-4057qib7	3916	13	was	be	VBD
cord-005453-4057qib7	3916	14	19	19	CD
cord-005453-4057qib7	3916	15	years	year	NNS
cord-005453-4057qib7	3916	16	and	and	CC
cord-005453-4057qib7	3916	17	mean	mean	VB
cord-005453-4057qib7	3916	18	years	year	NNS
cord-005453-4057qib7	3916	19	since	since	IN
cord-005453-4057qib7	3916	20	HCT	HCT	NNP
cord-005453-4057qib7	3916	21	was	be	VBD
cord-005453-4057qib7	3916	22	5	5	CD
cord-005453-4057qib7	3916	23	years	year	NNS
cord-005453-4057qib7	3916	24	.	.	.
cord-005453-4057qib7	3917	1	Female	female	JJ
cord-005453-4057qib7	3917	2	patients	patient	NNS
cord-005453-4057qib7	3917	3	treated	treat	VBN
cord-005453-4057qib7	3917	4	with	with	IN
cord-005453-4057qib7	3917	5	busulfan	busulfan	NN
cord-005453-4057qib7	3917	6	or	or	CC
cord-005453-4057qib7	3917	7	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3917	8	with	with	IN
cord-005453-4057qib7	3917	9	thiotepa	thiotepa	NNP
cord-005453-4057qib7	3917	10	(	(	-LRB-
cord-005453-4057qib7	3917	11	n=14	n=14	NNP
cord-005453-4057qib7	3917	12	)	)	-RRB-
cord-005453-4057qib7	3917	13	had	have	VBD
cord-005453-4057qib7	3917	14	minimal	minimal	JJ
cord-005453-4057qib7	3917	15	AMH	amh	NN
cord-005453-4057qib7	3917	16	and	and	CC
cord-005453-4057qib7	3917	17	none	none	NN
cord-005453-4057qib7	3917	18	of	of	IN
cord-005453-4057qib7	3917	19	these	these	DT
cord-005453-4057qib7	3917	20	patients	patient	NNS
cord-005453-4057qib7	3917	21	were	be	VBD
cord-005453-4057qib7	3917	22	having	have	VBG
cord-005453-4057qib7	3917	23	regular	regular	JJ
cord-005453-4057qib7	3917	24	periods	period	NNS
cord-005453-4057qib7	3917	25	.	.	.
cord-005453-4057qib7	3918	1	Females	female	NNS
cord-005453-4057qib7	3918	2	treated	treat	VBN
cord-005453-4057qib7	3918	3	with	with	IN
cord-005453-4057qib7	3918	4	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3918	5	(	(	-LRB-
cord-005453-4057qib7	3918	6	n=3	n=3	NN
cord-005453-4057qib7	3918	7	)	)	-RRB-
cord-005453-4057qib7	3918	8	had	have	VBD
cord-005453-4057qib7	3918	9	normal	normal	JJ
cord-005453-4057qib7	3918	10	AMH	amh	NN
cord-005453-4057qib7	3918	11	and	and	CC
cord-005453-4057qib7	3918	12	regular	regular	JJ
cord-005453-4057qib7	3918	13	periods	period	NNS
cord-005453-4057qib7	3918	14	without	without	IN
cord-005453-4057qib7	3918	15	needing	need	VBG
cord-005453-4057qib7	3918	16	hormone	hormone	NN
cord-005453-4057qib7	3918	17	replacement	replacement	NN
cord-005453-4057qib7	3918	18	.	.	.
cord-005453-4057qib7	3919	1	Only	only	RB
cord-005453-4057qib7	3919	2	four	four	CD
cord-005453-4057qib7	3919	3	male	male	JJ
cord-005453-4057qib7	3919	4	patients	patient	NNS
cord-005453-4057qib7	3919	5	opted	opt	VBD
cord-005453-4057qib7	3919	6	for	for	IN
cord-005453-4057qib7	3919	7	a	a	DT
cord-005453-4057qib7	3919	8	semen	semen	NN
cord-005453-4057qib7	3919	9	analysis	analysis	NN
cord-005453-4057qib7	3919	10	and	and	CC
cord-005453-4057qib7	3919	11	all	all	DT
cord-005453-4057qib7	3919	12	had	have	VBD
cord-005453-4057qib7	3919	13	significantly	significantly	RB
cord-005453-4057qib7	3919	14	reduced	reduce	VBN
cord-005453-4057qib7	3919	15	sperm	sperm	NN
cord-005453-4057qib7	3919	16	counts	count	NNS
cord-005453-4057qib7	3919	17	.	.	.
cord-005453-4057qib7	3920	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3920	2	:	:	:
cord-005453-4057qib7	3921	1	Our	-PRON-	PRP$
cord-005453-4057qib7	3921	2	results	result	NNS
cord-005453-4057qib7	3921	3	suggest	suggest	VBP
cord-005453-4057qib7	3921	4	that	that	IN
cord-005453-4057qib7	3921	5	females	female	NNS
cord-005453-4057qib7	3921	6	treated	treat	VBN
cord-005453-4057qib7	3921	7	with	with	IN
cord-005453-4057qib7	3921	8	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3921	9	have	have	VBP
cord-005453-4057qib7	3921	10	minimal	minimal	JJ
cord-005453-4057qib7	3921	11	(	(	-LRB-
cord-005453-4057qib7	3921	12	if	if	IN
cord-005453-4057qib7	3921	13	any	any	DT
cord-005453-4057qib7	3921	14	)	)	-RRB-
cord-005453-4057qib7	3921	15	reduction	reduction	NN
cord-005453-4057qib7	3921	16	in	in	IN
cord-005453-4057qib7	3921	17	ovarian	ovarian	JJ
cord-005453-4057qib7	3921	18	reserve	reserve	NN
cord-005453-4057qib7	3921	19	compared	compare	VBN
cord-005453-4057qib7	3921	20	to	to	IN
cord-005453-4057qib7	3921	21	other	other	JJ
cord-005453-4057qib7	3921	22	conditioning	conditioning	NN
cord-005453-4057qib7	3921	23	regimens	regimen	NNS
cord-005453-4057qib7	3921	24	which	which	WDT
cord-005453-4057qib7	3921	25	casue	casue	VBP
cord-005453-4057qib7	3921	26	significant	significant	JJ
cord-005453-4057qib7	3921	27	compromise	compromise	NN
cord-005453-4057qib7	3921	28	.	.	.
cord-005453-4057qib7	3922	1	Although	although	IN
cord-005453-4057qib7	3922	2	this	this	DT
cord-005453-4057qib7	3922	3	was	be	VBD
cord-005453-4057qib7	3922	4	a	a	DT
cord-005453-4057qib7	3922	5	small	small	JJ
cord-005453-4057qib7	3922	6	study	study	NN
cord-005453-4057qib7	3922	7	,	,	,
cord-005453-4057qib7	3922	8	and	and	CC
cord-005453-4057qib7	3922	9	thus	thus	RB
cord-005453-4057qib7	3922	10	not	not	RB
cord-005453-4057qib7	3922	11	suitable	suitable	JJ
cord-005453-4057qib7	3922	12	for	for	IN
cord-005453-4057qib7	3922	13	statistical	statistical	JJ
cord-005453-4057qib7	3922	14	analysis	analysis	NN
cord-005453-4057qib7	3922	15	,	,	,
cord-005453-4057qib7	3922	16	the	the	DT
cord-005453-4057qib7	3922	17	clinical	clinical	JJ
cord-005453-4057qib7	3922	18	findings	finding	NNS
cord-005453-4057qib7	3922	19	are	be	VBP
cord-005453-4057qib7	3922	20	marked	mark	VBN
cord-005453-4057qib7	3922	21	.	.	.
cord-005453-4057qib7	3923	1	Future	future	JJ
cord-005453-4057qib7	3923	2	studies	study	NNS
cord-005453-4057qib7	3923	3	should	should	MD
cord-005453-4057qib7	3923	4	further	further	RB
cord-005453-4057qib7	3923	5	investigate	investigate	VB
cord-005453-4057qib7	3923	6	optimal	optimal	JJ
cord-005453-4057qib7	3923	7	doses	dose	NNS
cord-005453-4057qib7	3923	8	of	of	IN
cord-005453-4057qib7	3923	9	treosulfan	treosulfan	NNP
cord-005453-4057qib7	3923	10	that	that	WDT
cord-005453-4057qib7	3923	11	could	could	MD
cord-005453-4057qib7	3923	12	be	be	VB
cord-005453-4057qib7	3923	13	used	use	VBN
cord-005453-4057qib7	3923	14	to	to	TO
cord-005453-4057qib7	3923	15	achieve	achieve	VB
cord-005453-4057qib7	3923	16	bone	bone	NN
cord-005453-4057qib7	3923	17	marrow	marrow	NN
cord-005453-4057qib7	3923	18	engraftment	engraftment	NN
cord-005453-4057qib7	3923	19	and	and	CC
cord-005453-4057qib7	3923	20	limit	limit	VB
cord-005453-4057qib7	3923	21	long	long	JJ
cord-005453-4057qib7	3923	22	-	-	HYPH
cord-005453-4057qib7	3923	23	term	term	NN
cord-005453-4057qib7	3923	24	effects	effect	NNS
cord-005453-4057qib7	3923	25	on	on	IN
cord-005453-4057qib7	3923	26	fertility	fertility	NN
cord-005453-4057qib7	3923	27	.	.	.
cord-005453-4057qib7	3924	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3924	2	Background	background	NN
cord-005453-4057qib7	3924	3	:	:	:
cord-005453-4057qib7	3925	1	Autologous	autologous	JJ
cord-005453-4057qib7	3925	2	and	and	CC
cord-005453-4057qib7	3925	3	allogenic	allogenic	JJ
cord-005453-4057qib7	3925	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3925	5	stem	stem	NN
cord-005453-4057qib7	3925	6	cell	cell	NN
cord-005453-4057qib7	3925	7	transplantation	transplantation	NN
cord-005453-4057qib7	3925	8	(	(	-LRB-
cord-005453-4057qib7	3925	9	HSCT	HSCT	NNP
cord-005453-4057qib7	3925	10	)	)	-RRB-
cord-005453-4057qib7	3925	11	are	be	VBP
cord-005453-4057qib7	3925	12	potentially	potentially	RB
cord-005453-4057qib7	3925	13	curative	curative	JJ
cord-005453-4057qib7	3925	14	treatments	treatment	NNS
cord-005453-4057qib7	3925	15	for	for	IN
cord-005453-4057qib7	3925	16	hematological	hematological	JJ
cord-005453-4057qib7	3925	17	malignancies	malignancy	NNS
cord-005453-4057qib7	3925	18	.	.	.
cord-005453-4057qib7	3926	1	Patients	patient	NNS
cord-005453-4057qib7	3926	2	with	with	IN
cord-005453-4057qib7	3926	3	related	related	JJ
cord-005453-4057qib7	3926	4	complications	complication	NNS
cord-005453-4057qib7	3926	5	may	may	MD
cord-005453-4057qib7	3926	6	need	need	VB
cord-005453-4057qib7	3926	7	admission	admission	NN
cord-005453-4057qib7	3926	8	to	to	IN
cord-005453-4057qib7	3926	9	the	the	DT
cord-005453-4057qib7	3926	10	intensive	intensive	JJ
cord-005453-4057qib7	3926	11	care	care	NN
cord-005453-4057qib7	3926	12	unit	unit	NN
cord-005453-4057qib7	3926	13	(	(	-LRB-
cord-005453-4057qib7	3926	14	ICU	ICU	NNP
cord-005453-4057qib7	3926	15	)	)	-RRB-
cord-005453-4057qib7	3926	16	for	for	IN
cord-005453-4057qib7	3926	17	specific	specific	JJ
cord-005453-4057qib7	3926	18	therapy	therapy	NN
cord-005453-4057qib7	3926	19	and	and	CC
cord-005453-4057qib7	3926	20	organ	organ	NN
cord-005453-4057qib7	3926	21	support	support	NN
cord-005453-4057qib7	3926	22	.	.	.
cord-005453-4057qib7	3927	1	Mortality	mortality	NN
cord-005453-4057qib7	3927	2	risk	risk	NN
cord-005453-4057qib7	3927	3	factors	factor	NNS
cord-005453-4057qib7	3927	4	,	,	,
cord-005453-4057qib7	3927	5	supportive	supportive	JJ
cord-005453-4057qib7	3927	6	care	care	NN
cord-005453-4057qib7	3927	7	and	and	CC
cord-005453-4057qib7	3927	8	principal	principal	JJ
cord-005453-4057qib7	3927	9	causes	cause	NNS
cord-005453-4057qib7	3927	10	of	of	IN
cord-005453-4057qib7	3927	11	admission	admission	NN
cord-005453-4057qib7	3927	12	in	in	IN
cord-005453-4057qib7	3927	13	ICU	ICU	NNP
cord-005453-4057qib7	3927	14	are	be	VBP
cord-005453-4057qib7	3927	15	described	describe	VBN
cord-005453-4057qib7	3927	16	in	in	IN
cord-005453-4057qib7	3927	17	our	-PRON-	PRP$
cord-005453-4057qib7	3927	18	cohort	cohort	NN
cord-005453-4057qib7	3927	19	of	of	IN
cord-005453-4057qib7	3927	20	patients	patient	NNS
cord-005453-4057qib7	3927	21	(	(	-LRB-
cord-005453-4057qib7	3927	22	pts	pts	NNP
cord-005453-4057qib7	3927	23	)	)	-RRB-
cord-005453-4057qib7	3927	24	.	.	.
cord-005453-4057qib7	3928	1	Methods	method	NNS
cord-005453-4057qib7	3928	2	:	:	:
cord-005453-4057qib7	3929	1	We	-PRON-	PRP
cord-005453-4057qib7	3929	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	3929	3	studied	study	VBD
cord-005453-4057qib7	3929	4	326	326	CD
cord-005453-4057qib7	3929	5	pts	pt	NNS
cord-005453-4057qib7	3929	6	,	,	,
cord-005453-4057qib7	3929	7	185	185	CD
cord-005453-4057qib7	3929	8	male	male	NN
cord-005453-4057qib7	3929	9	,	,	,
cord-005453-4057qib7	3929	10	with	with	IN
cord-005453-4057qib7	3929	11	a	a	DT
cord-005453-4057qib7	3929	12	median	median	JJ
cord-005453-4057qib7	3929	13	age	age	NN
cord-005453-4057qib7	3929	14	of	of	IN
cord-005453-4057qib7	3929	15	56,63	56,63	CD
cord-005453-4057qib7	3929	16	years	year	NNS
cord-005453-4057qib7	3929	17	(	(	-LRB-
cord-005453-4057qib7	3929	18	range	range	NN
cord-005453-4057qib7	3929	19	:	:	:
cord-005453-4057qib7	3929	20	18	18	CD
cord-005453-4057qib7	3929	21	-	-	SYM
cord-005453-4057qib7	3929	22	73	73	CD
cord-005453-4057qib7	3929	23	)	)	-RRB-
cord-005453-4057qib7	3929	24	who	who	WP
cord-005453-4057qib7	3929	25	underwent	undergo	VBD
cord-005453-4057qib7	3929	26	allo	allo	NN
cord-005453-4057qib7	3929	27	-	-	HYPH
cord-005453-4057qib7	3929	28	HSCT	HSCT	NNP
cord-005453-4057qib7	3929	29	in	in	IN
cord-005453-4057qib7	3929	30	our	-PRON-	PRP$
cord-005453-4057qib7	3929	31	center	center	NN
cord-005453-4057qib7	3929	32	between	between	IN
cord-005453-4057qib7	3929	33	July	July	NNP
cord-005453-4057qib7	3929	34	2014	2014	CD
cord-005453-4057qib7	3929	35	and	and	CC
cord-005453-4057qib7	3929	36	October	October	NNP
cord-005453-4057qib7	3929	37	2018	2018	CD
cord-005453-4057qib7	3929	38	.	.	.
cord-005453-4057qib7	3930	1	Two	two	CD
cord-005453-4057qib7	3930	2	hundred	hundred	CD
cord-005453-4057qib7	3930	3	and	and	CC
cord-005453-4057qib7	3930	4	twenty	twenty	CD
cord-005453-4057qib7	3930	5	-	-	HYPH
cord-005453-4057qib7	3930	6	seven(69,6	seven(69,6	NN
cord-005453-4057qib7	3930	7	%	%	NN
cord-005453-4057qib7	3930	8	)	)	-RRB-
cord-005453-4057qib7	3930	9	pts	pt	NNS
cord-005453-4057qib7	3930	10	received	receive	VBD
cord-005453-4057qib7	3930	11	autologous	autologous	JJ
cord-005453-4057qib7	3930	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3930	13	(	(	-LRB-
cord-005453-4057qib7	3930	14	auto	auto	NN
cord-005453-4057qib7	3930	15	-	-	HYPH
cord-005453-4057qib7	3930	16	HCT	hct	NN
cord-005453-4057qib7	3930	17	)	)	-RRB-
cord-005453-4057qib7	3931	1	and	and	CC
cord-005453-4057qib7	3931	2	99	99	CD
cord-005453-4057qib7	3931	3	(	(	-LRB-
cord-005453-4057qib7	3931	4	30,4	30,4	CD
cord-005453-4057qib7	3931	5	%	%	NN
cord-005453-4057qib7	3931	6	)	)	-RRB-
cord-005453-4057qib7	3931	7	allogenic	allogenic	JJ
cord-005453-4057qib7	3931	8	HSCT	HSCT	NNP
cord-005453-4057qib7	3931	9	(	(	-LRB-
cord-005453-4057qib7	3931	10	allo	allo	NN
cord-005453-4057qib7	3931	11	-	-	HYPH
cord-005453-4057qib7	3931	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3931	13	)	)	-RRB-
cord-005453-4057qib7	3931	14	;	;	:
cord-005453-4057qib7	3931	15	50	50	CD
cord-005453-4057qib7	3931	16	from	from	IN
cord-005453-4057qib7	3931	17	unrelated	unrelated	JJ
cord-005453-4057qib7	3931	18	donor	donor	NN
cord-005453-4057qib7	3931	19	,	,	,
cord-005453-4057qib7	3931	20	38	38	CD
cord-005453-4057qib7	3931	21	from	from	IN
cord-005453-4057qib7	3931	22	identical	identical	JJ
cord-005453-4057qib7	3931	23	sibling	sibling	NN
cord-005453-4057qib7	3931	24	,	,	,
cord-005453-4057qib7	3931	25	and	and	CC
cord-005453-4057qib7	3931	26	the	the	DT
cord-005453-4057qib7	3931	27	remainder	remainder	NN
cord-005453-4057qib7	3931	28	,	,	,
cord-005453-4057qib7	3931	29	mismatched	mismatch	VBN
cord-005453-4057qib7	3931	30	related	related	JJ
cord-005453-4057qib7	3931	31	donor	donor	NN
cord-005453-4057qib7	3931	32	11	11	CD
cord-005453-4057qib7	3931	33	.	.	.
cord-005453-4057qib7	3932	1	Twenty	twenty	CD
cord-005453-4057qib7	3932	2	-	-	HYPH
cord-005453-4057qib7	3932	3	three	three	CD
cord-005453-4057qib7	3932	4	(	(	-LRB-
cord-005453-4057qib7	3932	5	7,1	7,1	CD
cord-005453-4057qib7	3932	6	%	%	NN
cord-005453-4057qib7	3932	7	)	)	-RRB-
cord-005453-4057qib7	3933	1	out	out	IN
cord-005453-4057qib7	3933	2	of	of	IN
cord-005453-4057qib7	3933	3	326	326	CD
cord-005453-4057qib7	3933	4	pts	pt	NNS
cord-005453-4057qib7	3933	5	were	be	VBD
cord-005453-4057qib7	3933	6	admitted	admit	VBN
cord-005453-4057qib7	3933	7	in	in	IN
cord-005453-4057qib7	3933	8	the	the	DT
cord-005453-4057qib7	3933	9	ICU	ICU	NNP
cord-005453-4057qib7	3933	10	in	in	IN
cord-005453-4057qib7	3933	11	the	the	DT
cord-005453-4057qib7	3933	12	transplant	transplant	NN
cord-005453-4057qib7	3933	13	procedure	procedure	NN
cord-005453-4057qib7	3933	14	admission	admission	NN
cord-005453-4057qib7	3933	15	.	.	.
cord-005453-4057qib7	3934	1	Results	result	NNS
cord-005453-4057qib7	3934	2	:	:	:
cord-005453-4057qib7	3935	1	Fifteen	fifteen	CD
cord-005453-4057qib7	3935	2	(	(	-LRB-
cord-005453-4057qib7	3935	3	65,2	65,2	CD
cord-005453-4057qib7	3935	4	%	%	NN
cord-005453-4057qib7	3935	5	)	)	-RRB-
cord-005453-4057qib7	3936	1	out	out	IN
cord-005453-4057qib7	3936	2	of	of	IN
cord-005453-4057qib7	3936	3	23	23	CD
cord-005453-4057qib7	3936	4	pts	pt	NNS
cord-005453-4057qib7	3936	5	were	be	VBD
cord-005453-4057qib7	3936	6	male	male	JJ
cord-005453-4057qib7	3936	7	with	with	IN
cord-005453-4057qib7	3936	8	a	a	DT
cord-005453-4057qib7	3936	9	median	median	JJ
cord-005453-4057qib7	3936	10	age	age	NN
cord-005453-4057qib7	3936	11	of	of	IN
cord-005453-4057qib7	3936	12	55	55	CD
cord-005453-4057qib7	3936	13	years	year	NNS
cord-005453-4057qib7	3937	1	(	(	-LRB-
cord-005453-4057qib7	3937	2	range	range	NN
cord-005453-4057qib7	3937	3	:	:	:
cord-005453-4057qib7	3937	4	28	28	CD
cord-005453-4057qib7	3937	5	-	-	SYM
cord-005453-4057qib7	3937	6	69	69	CD
cord-005453-4057qib7	3937	7	)	)	-RRB-
cord-005453-4057qib7	3937	8	.	.	.
cord-005453-4057qib7	3938	1	Patients	patient	NNS
cord-005453-4057qib7	3938	2	'	'	POS
cord-005453-4057qib7	3938	3	baseline	baseline	JJ
cord-005453-4057qib7	3938	4	diseases	disease	NNS
cord-005453-4057qib7	3938	5	were	be	VBD
cord-005453-4057qib7	3938	6	:	:	:
cord-005453-4057qib7	3938	7	multiple	multiple	JJ
cord-005453-4057qib7	3938	8	myeloma	myeloma	NN
cord-005453-4057qib7	3938	9	(	(	-LRB-
cord-005453-4057qib7	3938	10	34,8	34,8	CD
cord-005453-4057qib7	3938	11	%	%	NN
cord-005453-4057qib7	3938	12	)	)	-RRB-
cord-005453-4057qib7	3938	13	,	,	,
cord-005453-4057qib7	3938	14	non	non	JJ
cord-005453-4057qib7	3938	15	-	-	JJ
cord-005453-4057qib7	3938	16	Hodgkin´s	hodgkin´s	JJ
cord-005453-4057qib7	3938	17	Lymphoma	lymphoma	NN
cord-005453-4057qib7	3938	18	(	(	-LRB-
cord-005453-4057qib7	3938	19	26,1	26,1	CD
cord-005453-4057qib7	3938	20	%	%	NN
cord-005453-4057qib7	3938	21	)	)	-RRB-
cord-005453-4057qib7	3938	22	,	,	,
cord-005453-4057qib7	3938	23	Hodgkin´s	Hodgkin´s	NNP
cord-005453-4057qib7	3938	24	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	3938	25	(	(	-LRB-
cord-005453-4057qib7	3938	26	8,7	8,7	CD
cord-005453-4057qib7	3938	27	%	%	NN
cord-005453-4057qib7	3938	28	)	)	-RRB-
cord-005453-4057qib7	3938	29	,	,	,
cord-005453-4057qib7	3938	30	acute	acute	JJ
cord-005453-4057qib7	3938	31	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	3938	32	leukemia	leukemia	NN
cord-005453-4057qib7	3938	33	(	(	-LRB-
cord-005453-4057qib7	3938	34	8,7	8,7	CD
cord-005453-4057qib7	3938	35	%	%	NN
cord-005453-4057qib7	3938	36	)	)	-RRB-
cord-005453-4057qib7	3938	37	,	,	,
cord-005453-4057qib7	3938	38	myelodisplasic	myelodisplasic	NNP
cord-005453-4057qib7	3938	39	syndrome	syndrome	NN
cord-005453-4057qib7	3938	40	(	(	-LRB-
cord-005453-4057qib7	3938	41	8,7	8,7	CD
cord-005453-4057qib7	3938	42	%	%	NN
cord-005453-4057qib7	3938	43	)	)	-RRB-
cord-005453-4057qib7	3938	44	,	,	,
cord-005453-4057qib7	3938	45	solid	solid	JJ
cord-005453-4057qib7	3938	46	tumor	tumor	NN
cord-005453-4057qib7	3938	47	(	(	-LRB-
cord-005453-4057qib7	3938	48	8,7	8,7	CD
cord-005453-4057qib7	3938	49	)	)	-RRB-
cord-005453-4057qib7	3938	50	and	and	CC
cord-005453-4057qib7	3938	51	acute	acute	JJ
cord-005453-4057qib7	3938	52	myeloblastic	myeloblastic	JJ
cord-005453-4057qib7	3938	53	leukemia	leukemia	NN
cord-005453-4057qib7	3938	54	(	(	-LRB-
cord-005453-4057qib7	3938	55	4,3	4,3	CD
cord-005453-4057qib7	3938	56	%	%	NN
cord-005453-4057qib7	3938	57	)	)	-RRB-
cord-005453-4057qib7	3938	58	.	.	.
cord-005453-4057qib7	3939	1	Fifteen	fifteen	CD
cord-005453-4057qib7	3939	2	(	(	-LRB-
cord-005453-4057qib7	3939	3	65,2	65,2	CD
cord-005453-4057qib7	3939	4	%	%	NN
cord-005453-4057qib7	3939	5	)	)	-RRB-
cord-005453-4057qib7	3939	6	pts	pt	NNS
cord-005453-4057qib7	3939	7	received	receive	VBD
cord-005453-4057qib7	3939	8	auto	auto	NN
cord-005453-4057qib7	3939	9	-	-	HYPH
cord-005453-4057qib7	3939	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3939	11	,	,	,
cord-005453-4057qib7	3939	12	5	5	CD
cord-005453-4057qib7	3939	13	(	(	-LRB-
cord-005453-4057qib7	3939	14	21,7	21,7	CD
cord-005453-4057qib7	3939	15	%	%	NN
cord-005453-4057qib7	3939	16	)	)	-RRB-
cord-005453-4057qib7	3939	17	allo	allo	NN
cord-005453-4057qib7	3939	18	-	-	HYPH
cord-005453-4057qib7	3939	19	HSCT	HSCT	NNP
cord-005453-4057qib7	3939	20	from	from	IN
cord-005453-4057qib7	3939	21	unrelated	unrelated	JJ
cord-005453-4057qib7	3939	22	donor	donor	NN
cord-005453-4057qib7	3939	23	,	,	,
cord-005453-4057qib7	3939	24	2	2	CD
cord-005453-4057qib7	3939	25	(	(	-LRB-
cord-005453-4057qib7	3939	26	8,7	8,7	CD
cord-005453-4057qib7	3939	27	%	%	NN
cord-005453-4057qib7	3939	28	)	)	-RRB-
cord-005453-4057qib7	3940	1	allo	allo	NN
cord-005453-4057qib7	3940	2	-	-	HYPH
cord-005453-4057qib7	3940	3	HSCT	HSCT	NNP
cord-005453-4057qib7	3940	4	from	from	IN
cord-005453-4057qib7	3940	5	identical	identical	JJ
cord-005453-4057qib7	3940	6	sibling	sibling	NN
cord-005453-4057qib7	3940	7	,	,	,
cord-005453-4057qib7	3940	8	and	and	CC
cord-005453-4057qib7	3940	9	the	the	DT
cord-005453-4057qib7	3940	10	remainder	remainder	NN
cord-005453-4057qib7	3940	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	3940	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3940	13	(	(	-LRB-
cord-005453-4057qib7	3940	14	1	1	CD
cord-005453-4057qib7	3940	15	)	)	-RRB-
cord-005453-4057qib7	3940	16	(	(	-LRB-
cord-005453-4057qib7	3940	17	4,3	4,3	CD
cord-005453-4057qib7	3940	18	%	%	NN
cord-005453-4057qib7	3940	19	)	)	-RRB-
cord-005453-4057qib7	3940	20	.	.	.
cord-005453-4057qib7	3941	1	So	so	RB
cord-005453-4057qib7	3941	2	,	,	,
cord-005453-4057qib7	3941	3	6,6	6,6	CD
cord-005453-4057qib7	3941	4	%	%	NN
cord-005453-4057qib7	3941	5	of	of	IN
cord-005453-4057qib7	3941	6	auto	auto	NN
cord-005453-4057qib7	3941	7	-	-	HYPH
cord-005453-4057qib7	3941	8	HSCT	HSCT	NNP
cord-005453-4057qib7	3941	9	pts	pts	NN
cord-005453-4057qib7	3941	10	and	and	CC
cord-005453-4057qib7	3941	11	8	8	CD
cord-005453-4057qib7	3941	12	%	%	NN
cord-005453-4057qib7	3941	13	of	of	IN
cord-005453-4057qib7	3941	14	allo	allo	NN
cord-005453-4057qib7	3941	15	-	-	HYPH
cord-005453-4057qib7	3941	16	HSCT	HSCT	NNP
cord-005453-4057qib7	3941	17	were	be	VBD
cord-005453-4057qib7	3941	18	admitted	admit	VBN
cord-005453-4057qib7	3941	19	in	in	IN
cord-005453-4057qib7	3941	20	the	the	DT
cord-005453-4057qib7	3941	21	ICU	ICU	NNP
cord-005453-4057qib7	3941	22	.	.	.
cord-005453-4057qib7	3942	1	The	the	DT
cord-005453-4057qib7	3942	2	median	median	NN
cord-005453-4057qib7	3942	3	stay	stay	NN
cord-005453-4057qib7	3942	4	in	in	IN
cord-005453-4057qib7	3942	5	the	the	DT
cord-005453-4057qib7	3942	6	ICU	ICU	NNP
cord-005453-4057qib7	3942	7	was	be	VBD
cord-005453-4057qib7	3942	8	5	5	CD
cord-005453-4057qib7	3942	9	days	day	NNS
cord-005453-4057qib7	3942	10	(	(	-LRB-
cord-005453-4057qib7	3942	11	range	range	NN
cord-005453-4057qib7	3942	12	:	:	:
cord-005453-4057qib7	3942	13	1	1	CD
cord-005453-4057qib7	3942	14	-	-	SYM
cord-005453-4057qib7	3942	15	30	30	CD
cord-005453-4057qib7	3942	16	)	)	-RRB-
cord-005453-4057qib7	3942	17	and	and	CC
cord-005453-4057qib7	3942	18	reasons	reason	NNS
cord-005453-4057qib7	3942	19	for	for	IN
cord-005453-4057qib7	3942	20	admission	admission	NN
cord-005453-4057qib7	3942	21	were	be	VBD
cord-005453-4057qib7	3942	22	:	:	:
cord-005453-4057qib7	3942	23	respiratory	respiratory	JJ
cord-005453-4057qib7	3942	24	insufficiency	insufficiency	NN
cord-005453-4057qib7	3942	25	(	(	-LRB-
cord-005453-4057qib7	3942	26	60,8	60,8	CD
cord-005453-4057qib7	3942	27	%	%	NN
cord-005453-4057qib7	3942	28	)	)	-RRB-
cord-005453-4057qib7	3942	29	,	,	,
cord-005453-4057qib7	3942	30	septic	septic	JJ
cord-005453-4057qib7	3942	31	shock	shock	NN
cord-005453-4057qib7	3942	32	(	(	-LRB-
cord-005453-4057qib7	3942	33	30,4	30,4	CD
cord-005453-4057qib7	3942	34	%	%	NN
cord-005453-4057qib7	3942	35	)	)	-RRB-
cord-005453-4057qib7	3942	36	,	,	,
cord-005453-4057qib7	3942	37	renal	renal	JJ
cord-005453-4057qib7	3942	38	insufficiency	insufficiency	NN
cord-005453-4057qib7	3942	39	(	(	-LRB-
cord-005453-4057qib7	3942	40	4,3	4,3	CD
cord-005453-4057qib7	3942	41	%	%	NN
cord-005453-4057qib7	3942	42	)	)	-RRB-
cord-005453-4057qib7	3942	43	and	and	CC
cord-005453-4057qib7	3942	44	multi	multi	JJ
cord-005453-4057qib7	3942	45	-	-	JJ
cord-005453-4057qib7	3942	46	organic	organic	JJ
cord-005453-4057qib7	3942	47	failure	failure	NN
cord-005453-4057qib7	3942	48	(	(	-LRB-
cord-005453-4057qib7	3942	49	4,3	4,3	CD
cord-005453-4057qib7	3942	50	%	%	NN
cord-005453-4057qib7	3942	51	)	)	-RRB-
cord-005453-4057qib7	3942	52	.	.	.
cord-005453-4057qib7	3943	1	Twenty	twenty	CD
cord-005453-4057qib7	3943	2	-	-	HYPH
cord-005453-4057qib7	3943	3	one	one	CD
cord-005453-4057qib7	3943	4	(	(	-LRB-
cord-005453-4057qib7	3943	5	91.3	91.3	CD
cord-005453-4057qib7	3943	6	%	%	NN
cord-005453-4057qib7	3943	7	)	)	-RRB-
cord-005453-4057qib7	3943	8	pts	pt	NNS
cord-005453-4057qib7	3943	9	required	require	VBN
cord-005453-4057qib7	3943	10	respiratory	respiratory	JJ
cord-005453-4057qib7	3943	11	support	support	NN
cord-005453-4057qib7	3943	12	with	with	IN
cord-005453-4057qib7	3943	13	:	:	:
cord-005453-4057qib7	3943	14	nasal	nasal	NN
cord-005453-4057qib7	3943	15	cannula	cannula	NN
cord-005453-4057qib7	3943	16	or	or	CC
cord-005453-4057qib7	3943	17	oxygen	oxygen	NN
cord-005453-4057qib7	3943	18	mask	mask	NN
cord-005453-4057qib7	3943	19	(	(	-LRB-
cord-005453-4057qib7	3943	20	C	C	NNP
cord-005453-4057qib7	3943	21	/	/	SYM
cord-005453-4057qib7	3943	22	M	M	NNP
cord-005453-4057qib7	3943	23	)	)	-RRB-
cord-005453-4057qib7	3943	24	(	(	-LRB-
cord-005453-4057qib7	3943	25	19	19	CD
cord-005453-4057qib7	3943	26	%	%	NN
cord-005453-4057qib7	3943	27	)	)	-RRB-
cord-005453-4057qib7	3943	28	,	,	,
cord-005453-4057qib7	3943	29	non	non	JJ
cord-005453-4057qib7	3943	30	-	-	JJ
cord-005453-4057qib7	3943	31	invasive	invasive	JJ
cord-005453-4057qib7	3943	32	mechanical	mechanical	JJ
cord-005453-4057qib7	3943	33	ventilation	ventilation	NN
cord-005453-4057qib7	3944	1	(	(	-LRB-
cord-005453-4057qib7	3944	2	NIMV	NIMV	NNP
cord-005453-4057qib7	3944	3	)	)	-RRB-
cord-005453-4057qib7	3945	1	(	(	-LRB-
cord-005453-4057qib7	3945	2	66,7	66,7	CD
cord-005453-4057qib7	3945	3	%	%	NN
cord-005453-4057qib7	3945	4	)	)	-RRB-
cord-005453-4057qib7	3945	5	and	and	CC
cord-005453-4057qib7	3945	6	invasive	invasive	JJ
cord-005453-4057qib7	3945	7	mechanical	mechanical	JJ
cord-005453-4057qib7	3945	8	ventilation	ventilation	NN
cord-005453-4057qib7	3945	9	(	(	-LRB-
cord-005453-4057qib7	3945	10	IMV	IMV	NNP
cord-005453-4057qib7	3945	11	)	)	-RRB-
cord-005453-4057qib7	3946	1	(	(	-LRB-
cord-005453-4057qib7	3946	2	14,3	14,3	CD
cord-005453-4057qib7	3946	3	%	%	NN
cord-005453-4057qib7	3946	4	)	)	-RRB-
cord-005453-4057qib7	3946	5	.	.	.
cord-005453-4057qib7	3947	1	Fourteen	fourteen	CD
cord-005453-4057qib7	3947	2	(	(	-LRB-
cord-005453-4057qib7	3947	3	60	60	CD
cord-005453-4057qib7	3947	4	%	%	NN
cord-005453-4057qib7	3947	5	)	)	-RRB-
cord-005453-4057qib7	3947	6	pts	pt	NNS
cord-005453-4057qib7	3947	7	needed	need	VBD
cord-005453-4057qib7	3947	8	inotropic	inotropic	NNP
cord-005453-4057qib7	3947	9	agents	agent	NNS
cord-005453-4057qib7	3947	10	for	for	IN
cord-005453-4057qib7	3947	11	shock	shock	NN
cord-005453-4057qib7	3947	12	treatment	treatment	NN
cord-005453-4057qib7	3947	13	.	.	.
cord-005453-4057qib7	3948	1	Finally	finally	RB
cord-005453-4057qib7	3948	2	,	,	,
cord-005453-4057qib7	3948	3	4	4	CD
cord-005453-4057qib7	3948	4	(	(	-LRB-
cord-005453-4057qib7	3948	5	4,5	4,5	CD
cord-005453-4057qib7	3948	6	%	%	NN
cord-005453-4057qib7	3948	7	)	)	-RRB-
cord-005453-4057qib7	3948	8	pts	pt	NNS
cord-005453-4057qib7	3948	9	required	require	VBD
cord-005453-4057qib7	3948	10	substitutive	substitutive	JJ
cord-005453-4057qib7	3948	11	renal	renal	JJ
cord-005453-4057qib7	3948	12	therapy	therapy	NN
cord-005453-4057qib7	3948	13	with	with	IN
cord-005453-4057qib7	3948	14	hemodialysis	hemodialysis	NN
cord-005453-4057qib7	3948	15	or	or	CC
cord-005453-4057qib7	3948	16	haemofiltration	haemofiltration	NN
cord-005453-4057qib7	3948	17	(	(	-LRB-
cord-005453-4057qib7	3948	18	HD	HD	NNP
cord-005453-4057qib7	3948	19	/	/	SYM
cord-005453-4057qib7	3948	20	HF	HF	NNP
cord-005453-4057qib7	3948	21	)	)	-RRB-
cord-005453-4057qib7	3948	22	.	.	.
cord-005453-4057qib7	3949	1	Eleven	eleven	CD
cord-005453-4057qib7	3949	2	(	(	-LRB-
cord-005453-4057qib7	3949	3	47,8	47,8	CD
cord-005453-4057qib7	3949	4	%	%	NN
cord-005453-4057qib7	3949	5	)	)	-RRB-
cord-005453-4057qib7	3950	1	out	out	IN
cord-005453-4057qib7	3950	2	of	of	IN
cord-005453-4057qib7	3950	3	23	23	CD
cord-005453-4057qib7	3950	4	pts	pt	NNS
cord-005453-4057qib7	3950	5	died	die	VBD
cord-005453-4057qib7	3950	6	,	,	,
cord-005453-4057qib7	3950	7	7	7	CD
cord-005453-4057qib7	3950	8	(	(	-LRB-
cord-005453-4057qib7	3950	9	63,6	63,6	CD
cord-005453-4057qib7	3950	10	%	%	NN
cord-005453-4057qib7	3950	11	)	)	-RRB-
cord-005453-4057qib7	3950	12	were	be	VBD
cord-005453-4057qib7	3950	13	male	male	JJ
cord-005453-4057qib7	3950	14	with	with	IN
cord-005453-4057qib7	3950	15	a	a	DT
cord-005453-4057qib7	3950	16	median	median	JJ
cord-005453-4057qib7	3950	17	age	age	NN
cord-005453-4057qib7	3950	18	of	of	IN
cord-005453-4057qib7	3950	19	55	55	CD
cord-005453-4057qib7	3950	20	years	year	NNS
cord-005453-4057qib7	3951	1	(	(	-LRB-
cord-005453-4057qib7	3951	2	range	range	NN
cord-005453-4057qib7	3951	3	:	:	:
cord-005453-4057qib7	3951	4	24	24	CD
cord-005453-4057qib7	3951	5	-	-	SYM
cord-005453-4057qib7	3951	6	64	64	CD
cord-005453-4057qib7	3951	7	)	)	-RRB-
cord-005453-4057qib7	3951	8	.	.	.
cord-005453-4057qib7	3952	1	Ten	ten	CD
cord-005453-4057qib7	3952	2	of	of	IN
cord-005453-4057qib7	3952	3	them	-PRON-	PRP
cord-005453-4057qib7	3952	4	(	(	-LRB-
cord-005453-4057qib7	3952	5	90,9	90,9	CD
cord-005453-4057qib7	3952	6	%	%	NN
cord-005453-4057qib7	3952	7	)	)	-RRB-
cord-005453-4057qib7	3952	8	needed	need	VBD
cord-005453-4057qib7	3952	9	IMV	IMV	NNP
cord-005453-4057qib7	3952	10	and	and	CC
cord-005453-4057qib7	3952	11	were	be	VBD
cord-005453-4057qib7	3952	12	treated	treat	VBN
cord-005453-4057qib7	3952	13	with	with	IN
cord-005453-4057qib7	3952	14	inotropic	inotropic	NNP
cord-005453-4057qib7	3952	15	agents	agent	NNS
cord-005453-4057qib7	3952	16	.	.	.
cord-005453-4057qib7	3953	1	All	all	DT
cord-005453-4057qib7	3953	2	patients	patient	NNS
cord-005453-4057qib7	3953	3	who	who	WP
cord-005453-4057qib7	3953	4	required	require	VBD
cord-005453-4057qib7	3953	5	HD	HD	NNP
cord-005453-4057qib7	3953	6	/	/	SYM
cord-005453-4057qib7	3953	7	HF	HF	NNP
cord-005453-4057qib7	3953	8	(	(	-LRB-
cord-005453-4057qib7	3953	9	n=4	n=4	NNP
cord-005453-4057qib7	3953	10	)	)	-RRB-
cord-005453-4057qib7	3953	11	died	die	VBD
cord-005453-4057qib7	3953	12	.	.	.
cord-005453-4057qib7	3954	1	IMV	IMV	NNP
cord-005453-4057qib7	3954	2	and	and	CC
cord-005453-4057qib7	3954	3	treatment	treatment	NN
cord-005453-4057qib7	3954	4	with	with	IN
cord-005453-4057qib7	3954	5	inotropic	inotropic	NNP
cord-005453-4057qib7	3954	6	agents	agent	NNS
cord-005453-4057qib7	3954	7	were	be	VBD
cord-005453-4057qib7	3954	8	associated	associate	VBN
cord-005453-4057qib7	3954	9	with	with	IN
cord-005453-4057qib7	3954	10	ICU	ICU	NNP
cord-005453-4057qib7	3954	11	mortality	mortality	NN
cord-005453-4057qib7	3954	12	(	(	-LRB-
cord-005453-4057qib7	3954	13	OR	or	CC
cord-005453-4057qib7	3954	14	6,5	6,5	CD
cord-005453-4057qib7	3954	15	;	;	:
cord-005453-4057qib7	3954	16	p=0,03	p=0,03	XX
cord-005453-4057qib7	3954	17	,	,	,
cord-005453-4057qib7	3954	18	OR	or	CC
cord-005453-4057qib7	3954	19	7	7	CD
cord-005453-4057qib7	3954	20	;	;	:
cord-005453-4057qib7	3954	21	p=0,008	p=0,008	NNP
cord-005453-4057qib7	3954	22	;	;	:
cord-005453-4057qib7	3954	23	respectively	respectively	RB
cord-005453-4057qib7	3954	24	)	)	-RRB-
cord-005453-4057qib7	3954	25	.	.	.
cord-005453-4057qib7	3955	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3955	2	:	:	:
cord-005453-4057qib7	3956	1	In	in	IN
cord-005453-4057qib7	3956	2	our	-PRON-	PRP$
cord-005453-4057qib7	3956	3	series	series	NN
cord-005453-4057qib7	3956	4	of	of	IN
cord-005453-4057qib7	3956	5	pts	pts	NNP
cord-005453-4057qib7	3956	6	,	,	,
cord-005453-4057qib7	3956	7	7,1	7,1	CD
cord-005453-4057qib7	3956	8	%	%	NN
cord-005453-4057qib7	3956	9	needed	need	VBN
cord-005453-4057qib7	3956	10	admission	admission	NN
cord-005453-4057qib7	3956	11	in	in	IN
cord-005453-4057qib7	3956	12	the	the	DT
cord-005453-4057qib7	3956	13	ICU	ICU	NNP
cord-005453-4057qib7	3956	14	,	,	,
cord-005453-4057qib7	3956	15	presenting	present	VBG
cord-005453-4057qib7	3956	16	a	a	DT
cord-005453-4057qib7	3956	17	mortality	mortality	NN
cord-005453-4057qib7	3956	18	rate	rate	NN
cord-005453-4057qib7	3956	19	of	of	IN
cord-005453-4057qib7	3956	20	48	48	CD
cord-005453-4057qib7	3956	21	%	%	NN
cord-005453-4057qib7	3956	22	approximately	approximately	RB
cord-005453-4057qib7	3956	23	.	.	.
cord-005453-4057qib7	3957	1	There	there	EX
cord-005453-4057qib7	3957	2	were	be	VBD
cord-005453-4057qib7	3957	3	no	no	DT
cord-005453-4057qib7	3957	4	differences	difference	NNS
cord-005453-4057qib7	3957	5	in	in	IN
cord-005453-4057qib7	3957	6	the	the	DT
cord-005453-4057qib7	3957	7	prevalence	prevalence	NN
cord-005453-4057qib7	3957	8	of	of	IN
cord-005453-4057qib7	3957	9	ICU	ICU	NNP
cord-005453-4057qib7	3957	10	admission	admission	NN
cord-005453-4057qib7	3957	11	regarding	regard	VBG
cord-005453-4057qib7	3957	12	HSCT	HSCT	NNP
cord-005453-4057qib7	3957	13	donor	donor	NN
cord-005453-4057qib7	3957	14	.	.	.
cord-005453-4057qib7	3958	1	Main	main	JJ
cord-005453-4057qib7	3958	2	reason	reason	NN
cord-005453-4057qib7	3958	3	for	for	IN
cord-005453-4057qib7	3958	4	admission	admission	NN
cord-005453-4057qib7	3958	5	was	be	VBD
cord-005453-4057qib7	3958	6	respiratory	respiratory	JJ
cord-005453-4057qib7	3958	7	failure	failure	NN
cord-005453-4057qib7	3958	8	with	with	IN
cord-005453-4057qib7	3958	9	IMV	IMV	NNP
cord-005453-4057qib7	3958	10	requirement	requirement	NN
cord-005453-4057qib7	3958	11	in	in	IN
cord-005453-4057qib7	3958	12	14,3	14,3	CD
cord-005453-4057qib7	3958	13	%	%	NN
cord-005453-4057qib7	3958	14	of	of	IN
cord-005453-4057qib7	3958	15	pts	pt	NNS
cord-005453-4057qib7	3958	16	.	.	.
cord-005453-4057qib7	3959	1	IMV	IMV	NNP
cord-005453-4057qib7	3959	2	and	and	CC
cord-005453-4057qib7	3959	3	treatment	treatment	NN
cord-005453-4057qib7	3959	4	with	with	IN
cord-005453-4057qib7	3959	5	inotropic	inotropic	NNP
cord-005453-4057qib7	3959	6	agents	agent	NNS
cord-005453-4057qib7	3959	7	were	be	VBD
cord-005453-4057qib7	3959	8	associated	associate	VBN
cord-005453-4057qib7	3959	9	with	with	IN
cord-005453-4057qib7	3959	10	ICU	ICU	NNP
cord-005453-4057qib7	3959	11	mortality	mortality	NN
cord-005453-4057qib7	3959	12	.	.	.
cord-005453-4057qib7	3960	1	An	an	DT
cord-005453-4057qib7	3960	2	early	early	JJ
cord-005453-4057qib7	3960	3	identification	identification	NN
cord-005453-4057qib7	3960	4	of	of	IN
cord-005453-4057qib7	3960	5	pts	pts	NN
cord-005453-4057qib7	3960	6	at	at	IN
cord-005453-4057qib7	3960	7	risk	risk	NN
cord-005453-4057qib7	3960	8	of	of	IN
cord-005453-4057qib7	3960	9	ICU	ICU	NNP
cord-005453-4057qib7	3960	10	admission	admission	NN
cord-005453-4057qib7	3960	11	could	could	MD
cord-005453-4057qib7	3960	12	have	have	VB
cord-005453-4057qib7	3960	13	a	a	DT
cord-005453-4057qib7	3960	14	beneficial	beneficial	JJ
cord-005453-4057qib7	3960	15	impact	impact	NN
cord-005453-4057qib7	3960	16	on	on	IN
cord-005453-4057qib7	3960	17	survival	survival	NN
cord-005453-4057qib7	3960	18	improvement	improvement	NN
cord-005453-4057qib7	3960	19	Disclosure	Disclosure	NNP
cord-005453-4057qib7	3960	20	:	:	:
cord-005453-4057qib7	3961	1	Nothing	nothing	NN
cord-005453-4057qib7	3961	2	to	to	TO
cord-005453-4057qib7	3961	3	declare	declare	VB
cord-005453-4057qib7	3961	4	Is	be	VBZ
cord-005453-4057qib7	3961	5	there	there	EX
cord-005453-4057qib7	3961	6	any	any	DT
cord-005453-4057qib7	3961	7	association	association	NN
cord-005453-4057qib7	3961	8	between	between	IN
cord-005453-4057qib7	3961	9	thrombotic	thrombotic	JJ
cord-005453-4057qib7	3961	10	risk	risk	NN
cord-005453-4057qib7	3961	11	factors	factor	NNS
cord-005453-4057qib7	3961	12	and	and	CC
cord-005453-4057qib7	3961	13	veno	veno	NNP
cord-005453-4057qib7	3961	14	-	-	HYPH
cord-005453-4057qib7	3961	15	oclusive	oclusive	JJ
cord-005453-4057qib7	3961	16	disease	disease	NN
cord-005453-4057qib7	3961	17	in	in	IN
cord-005453-4057qib7	3961	18	childhood	childhood	NN
cord-005453-4057qib7	3961	19	allogeneic	allogeneic	IN
cord-005453-4057qib7	3961	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3961	21	stem	stem	NN
cord-005453-4057qib7	3961	22	cell	cell	NN
cord-005453-4057qib7	3961	23	transplantation	transplantation	NN
cord-005453-4057qib7	3961	24	?	?	.
cord-005453-4057qib7	3962	1	Background	background	NN
cord-005453-4057qib7	3962	2	:	:	:
cord-005453-4057qib7	3963	1	Veno	Veno	NNP
cord-005453-4057qib7	3963	2	-	-	HYPH
cord-005453-4057qib7	3963	3	oclusive	oclusive	JJ
cord-005453-4057qib7	3963	4	disease	disease	NN
cord-005453-4057qib7	3963	5	(	(	-LRB-
cord-005453-4057qib7	3963	6	VOD	VOD	NNP
cord-005453-4057qib7	3963	7	)	)	-RRB-
cord-005453-4057qib7	3963	8	is	be	VBZ
cord-005453-4057qib7	3963	9	a	a	DT
cord-005453-4057qib7	3963	10	major	major	JJ
cord-005453-4057qib7	3963	11	complication	complication	NN
cord-005453-4057qib7	3963	12	of	of	IN
cord-005453-4057qib7	3963	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3963	14	stem	stem	NN
cord-005453-4057qib7	3963	15	cell	cell	NN
cord-005453-4057qib7	3963	16	transplantation	transplantation	NN
cord-005453-4057qib7	3963	17	(	(	-LRB-
cord-005453-4057qib7	3963	18	HSCT	HSCT	NNP
cord-005453-4057qib7	3963	19	)	)	-RRB-
cord-005453-4057qib7	3963	20	.	.	.
cord-005453-4057qib7	3964	1	In	in	IN
cord-005453-4057qib7	3964	2	some	some	DT
cord-005453-4057qib7	3964	3	studies	study	NNS
cord-005453-4057qib7	3964	4	levels	level	NNS
cord-005453-4057qib7	3964	5	of	of	IN
cord-005453-4057qib7	3964	6	fibrinolytic	fibrinolytic	JJ
cord-005453-4057qib7	3964	7	factors	factor	NNS
cord-005453-4057qib7	3964	8	especially	especially	RB
cord-005453-4057qib7	3964	9	plasminogen	plasminogen	NN
cord-005453-4057qib7	3964	10	activator	activator	NN
cord-005453-4057qib7	3964	11	inhibitor-1	inhibitor-1	NNP
cord-005453-4057qib7	3964	12	(	(	-LRB-
cord-005453-4057qib7	3964	13	PAI-1	PAI-1	NNP
cord-005453-4057qib7	3964	14	)	)	-RRB-
cord-005453-4057qib7	3964	15	level	level	NN
cord-005453-4057qib7	3964	16	were	be	VBD
cord-005453-4057qib7	3964	17	found	find	VBN
cord-005453-4057qib7	3964	18	associated	associate	VBN
cord-005453-4057qib7	3964	19	with	with	IN
cord-005453-4057qib7	3964	20	VOD	VOD	NNP
cord-005453-4057qib7	3964	21	.	.	.
cord-005453-4057qib7	3965	1	However	however	RB
cord-005453-4057qib7	3965	2	,	,	,
cord-005453-4057qib7	3965	3	little	little	JJ
cord-005453-4057qib7	3965	4	is	be	VBZ
cord-005453-4057qib7	3965	5	known	know	VBN
cord-005453-4057qib7	3965	6	about	about	IN
cord-005453-4057qib7	3965	7	the	the	DT
cord-005453-4057qib7	3965	8	relationship	relationship	NN
cord-005453-4057qib7	3965	9	between	between	IN
cord-005453-4057qib7	3965	10	thrombophilia	thrombophilia	NNP
cord-005453-4057qib7	3965	11	risk	risk	NN
cord-005453-4057qib7	3965	12	factors	factor	NNS
cord-005453-4057qib7	3965	13	and	and	CC
cord-005453-4057qib7	3965	14	VOD	vod	NN
cord-005453-4057qib7	3965	15	.	.	.
cord-005453-4057qib7	3966	1	In	in	IN
cord-005453-4057qib7	3966	2	this	this	DT
cord-005453-4057qib7	3966	3	study	study	NN
cord-005453-4057qib7	3966	4	we	-PRON-	PRP
cord-005453-4057qib7	3966	5	aimed	aim	VBD
cord-005453-4057qib7	3966	6	to	to	TO
cord-005453-4057qib7	3966	7	investigate	investigate	VB
cord-005453-4057qib7	3966	8	association	association	NNP
cord-005453-4057qib7	3966	9	of	of	IN
cord-005453-4057qib7	3966	10	major	major	NNP
cord-005453-4057qib7	3966	11	thrombophilic	thrombophilic	NNP
cord-005453-4057qib7	3966	12	gene	gene	NN
cord-005453-4057qib7	3966	13	mutations	mutation	NNS
cord-005453-4057qib7	3966	14	on	on	IN
cord-005453-4057qib7	3966	15	VOD	VOD	NNP
cord-005453-4057qib7	3966	16	in	in	IN
cord-005453-4057qib7	3966	17	pediatric	pediatric	JJ
cord-005453-4057qib7	3966	18	HSCT	HSCT	NNP
cord-005453-4057qib7	3966	19	patients	patient	NNS
cord-005453-4057qib7	3966	20	.	.	.
cord-005453-4057qib7	3967	1	Methods	method	NNS
cord-005453-4057qib7	3967	2	:	:	:
cord-005453-4057qib7	3968	1	We	-PRON-	PRP
cord-005453-4057qib7	3968	2	reviewed	review	VBD
cord-005453-4057qib7	3968	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	3968	4	35	35	CD
cord-005453-4057qib7	3968	5	patients	patient	NNS
cord-005453-4057qib7	3968	6	with	with	IN
cord-005453-4057qib7	3968	7	VOD	VOD	NNP
cord-005453-4057qib7	3968	8	who	who	WP
cord-005453-4057qib7	3968	9	underwent	undergo	VBD
cord-005453-4057qib7	3968	10	HSCT	HSCT	NNP
cord-005453-4057qib7	3968	11	between	between	IN
cord-005453-4057qib7	3968	12	2010	2010	CD
cord-005453-4057qib7	3968	13	-	-	SYM
cord-005453-4057qib7	3968	14	2018	2018	CD
cord-005453-4057qib7	3968	15	in	in	IN
cord-005453-4057qib7	3968	16	Ankara	Ankara	NNP
cord-005453-4057qib7	3968	17	Pediatrics	Pediatrics	NNP
cord-005453-4057qib7	3968	18	and	and	CC
cord-005453-4057qib7	3968	19	Pediatric	Pediatric	NNP
cord-005453-4057qib7	3968	20	Hematology	Hematology	NNP
cord-005453-4057qib7	3968	21	-	-	HYPH
cord-005453-4057qib7	3968	22	Oncology	Oncology	NNP
cord-005453-4057qib7	3968	23	Training	Training	NNP
cord-005453-4057qib7	3968	24	and	and	CC
cord-005453-4057qib7	3968	25	Education	Education	NNP
cord-005453-4057qib7	3968	26	Hospital	Hospital	NNP
cord-005453-4057qib7	3968	27	,	,	,
cord-005453-4057qib7	3968	28	Bone	Bone	NNP
cord-005453-4057qib7	3968	29	Marrow	Marrow	NNP
cord-005453-4057qib7	3968	30	Transplantation	Transplantation	NNP
cord-005453-4057qib7	3968	31	Unit	Unit	NNP
cord-005453-4057qib7	3968	32	,	,	,
cord-005453-4057qib7	3968	33	Turkey	Turkey	NNP
cord-005453-4057qib7	3968	34	.	.	.
cord-005453-4057qib7	3969	1	Fifty	fifty	CD
cord-005453-4057qib7	3969	2	-	-	HYPH
cord-005453-4057qib7	3969	3	one	one	CD
cord-005453-4057qib7	3969	4	patients	patient	NNS
cord-005453-4057qib7	3969	5	who	who	WP
cord-005453-4057qib7	3969	6	did	do	VBD
cord-005453-4057qib7	3969	7	not	not	RB
cord-005453-4057qib7	3969	8	develop	develop	VB
cord-005453-4057qib7	3969	9	VOD	VOD	NNP
cord-005453-4057qib7	3969	10	and	and	CC
cord-005453-4057qib7	3969	11	transplanted	transplant	VBN
cord-005453-4057qib7	3969	12	during	during	IN
cord-005453-4057qib7	3969	13	the	the	DT
cord-005453-4057qib7	3969	14	study	study	NN
cord-005453-4057qib7	3969	15	period	period	NN
cord-005453-4057qib7	3969	16	were	be	VBD
cord-005453-4057qib7	3969	17	accepted	accept	VBN
cord-005453-4057qib7	3969	18	as	as	IN
cord-005453-4057qib7	3969	19	control	control	NN
cord-005453-4057qib7	3969	20	group	group	NN
cord-005453-4057qib7	3969	21	.	.	.
cord-005453-4057qib7	3970	1	We	-PRON-	PRP
cord-005453-4057qib7	3970	2	evaluated	evaluate	VBD
cord-005453-4057qib7	3970	3	plasma	plasma	NN
cord-005453-4057qib7	3970	4	homocysteine	homocysteine	NN
cord-005453-4057qib7	3970	5	and	and	CC
cord-005453-4057qib7	3970	6	lipoprotein	lipoprotein	VB
cord-005453-4057qib7	3970	7	a	a	DT
cord-005453-4057qib7	3970	8	level	level	NN
cord-005453-4057qib7	3970	9	,	,	,
cord-005453-4057qib7	3970	10	protein	protein	NN
cord-005453-4057qib7	3970	11	S	S	NNP
cord-005453-4057qib7	3970	12	and	and	CC
cord-005453-4057qib7	3970	13	C	C	NNP
cord-005453-4057qib7	3970	14	activity	activity	NN
cord-005453-4057qib7	3970	15	and	and	CC
cord-005453-4057qib7	3970	16	antigen	antigen	NN
cord-005453-4057qib7	3970	17	levels	level	NNS
cord-005453-4057qib7	3970	18	and	and	CC
cord-005453-4057qib7	3970	19	factor	factor	NN
cord-005453-4057qib7	3970	20	V	V	NNP
cord-005453-4057qib7	3970	21	G1691A	G1691A	NNP
cord-005453-4057qib7	3970	22	mutation	mutation	NN
cord-005453-4057qib7	3970	23	,	,	,
cord-005453-4057qib7	3970	24	prothrombin	prothrombin	NN
cord-005453-4057qib7	3970	25	G20210A	G20210A	NNP
cord-005453-4057qib7	3970	26	mutation	mutation	NN
cord-005453-4057qib7	3970	27	,	,	,
cord-005453-4057qib7	3971	1	methylenetetrahydrofolatereductase	methylenetetrahydrofolatereductase	NNP
cord-005453-4057qib7	3971	2	(	(	-LRB-
cord-005453-4057qib7	3971	3	MTHFR	MTHFR	NNP
cord-005453-4057qib7	3971	4	)	)	-RRB-
cord-005453-4057qib7	3972	1	C677	C677	NNP
cord-005453-4057qib7	3972	2	T	T	NNP
cord-005453-4057qib7	3972	3	and	and	CC
cord-005453-4057qib7	3972	4	A1298C	A1298C	NNP
cord-005453-4057qib7	3972	5	mutations	mutation	NNS
cord-005453-4057qib7	3972	6	,	,	,
cord-005453-4057qib7	3972	7	plasminogen	plasminogen	NN
cord-005453-4057qib7	3972	8	activator	activator	NN
cord-005453-4057qib7	3972	9	inhibitor-1	inhibitor-1	NNP
cord-005453-4057qib7	3972	10	-675	-675	NN
cord-005453-4057qib7	3972	11	4G/5	4g/5	CD
cord-005453-4057qib7	3972	12	G	g	NN
cord-005453-4057qib7	3972	13	polymorphism	polymorphism	NN
cord-005453-4057qib7	3972	14	before	before	IN
cord-005453-4057qib7	3972	15	HSCT	HSCT	NNP
cord-005453-4057qib7	3972	16	.	.	.
cord-005453-4057qib7	3973	1	We	-PRON-	PRP
cord-005453-4057qib7	3973	2	also	also	RB
cord-005453-4057qib7	3973	3	evaluated	evaluate	VBD
cord-005453-4057qib7	3973	4	the	the	DT
cord-005453-4057qib7	3973	5	patients	patient	NNS
cord-005453-4057qib7	3973	6	'	'	POS
cord-005453-4057qib7	3973	7	hospital	hospital	NN
cord-005453-4057qib7	3973	8	files	file	NNS
cord-005453-4057qib7	3973	9	and	and	CC
cord-005453-4057qib7	3973	10	noted	note	VBD
cord-005453-4057qib7	3973	11	the	the	DT
cord-005453-4057qib7	3973	12	demographic	demographic	JJ
cord-005453-4057qib7	3973	13	values	value	NNS
cord-005453-4057qib7	3973	14	and	and	CC
cord-005453-4057qib7	3973	15	complications	complication	NNS
cord-005453-4057qib7	3973	16	of	of	IN
cord-005453-4057qib7	3973	17	HSCT	HSCT	NNP
cord-005453-4057qib7	3973	18	.	.	.
cord-005453-4057qib7	3974	1	Statistical	statistical	JJ
cord-005453-4057qib7	3974	2	investigations	investigation	NNS
cord-005453-4057qib7	3974	3	were	be	VBD
cord-005453-4057qib7	3974	4	done	do	VBN
cord-005453-4057qib7	3974	5	with	with	IN
cord-005453-4057qib7	3974	6	SPSS	SPSS	NNP
cord-005453-4057qib7	3974	7	statistics	statistic	NNS
cord-005453-4057qib7	3974	8	17.0	17.0	CD
cord-005453-4057qib7	3974	9	for	for	IN
cord-005453-4057qib7	3974	10	windows	window	NNS
cord-005453-4057qib7	3974	11	and	and	CC
cord-005453-4057qib7	3974	12	p	p	NN
cord-005453-4057qib7	3974	13	<	<	XX
cord-005453-4057qib7	3974	14	0.05	0.05	CD
cord-005453-4057qib7	3974	15	has	have	VBZ
cord-005453-4057qib7	3974	16	been	be	VBN
cord-005453-4057qib7	3974	17	accepted	accept	VBN
cord-005453-4057qib7	3974	18	as	as	IN
cord-005453-4057qib7	3974	19	significant	significant	JJ
cord-005453-4057qib7	3974	20	.	.	.
cord-005453-4057qib7	3975	1	Results	result	NNS
cord-005453-4057qib7	3975	2	:	:	:
cord-005453-4057qib7	3976	1	There	there	EX
cord-005453-4057qib7	3976	2	was	be	VBD
cord-005453-4057qib7	3976	3	no	no	DT
cord-005453-4057qib7	3976	4	difference	difference	NN
cord-005453-4057qib7	3976	5	between	between	IN
cord-005453-4057qib7	3976	6	control	control	NN
cord-005453-4057qib7	3976	7	and	and	CC
cord-005453-4057qib7	3976	8	VOD	VOD	NNP
cord-005453-4057qib7	3976	9	groups	group	NNS
cord-005453-4057qib7	3976	10	as	as	IN
cord-005453-4057qib7	3976	11	regard	regard	NN
cord-005453-4057qib7	3976	12	to	to	IN
cord-005453-4057qib7	3976	13	age	age	NN
cord-005453-4057qib7	3976	14	,	,	,
cord-005453-4057qib7	3976	15	sex	sex	NN
cord-005453-4057qib7	3976	16	,	,	,
cord-005453-4057qib7	3976	17	diagnosis	diagnosis	NN
cord-005453-4057qib7	3976	18	,	,	,
cord-005453-4057qib7	3976	19	donor	donor	NN
cord-005453-4057qib7	3976	20	type	type	NN
cord-005453-4057qib7	3976	21	,	,	,
cord-005453-4057qib7	3976	22	conditioning	conditioning	NN
cord-005453-4057qib7	3976	23	regimen	regimen	NN
cord-005453-4057qib7	3976	24	,	,	,
cord-005453-4057qib7	3976	25	HSC	HSC	NNP
cord-005453-4057qib7	3976	26	source	source	NN
cord-005453-4057qib7	3976	27	,	,	,
cord-005453-4057qib7	3976	28	and	and	CC
cord-005453-4057qib7	3976	29	HLA	HLA	NNP
cord-005453-4057qib7	3976	30	typing	typing	NN
cord-005453-4057qib7	3976	31	.	.	.
cord-005453-4057qib7	3977	1	There	there	EX
cord-005453-4057qib7	3977	2	was	be	VBD
cord-005453-4057qib7	3977	3	no	no	DT
cord-005453-4057qib7	3977	4	difference	difference	NN
cord-005453-4057qib7	3977	5	between	between	IN
cord-005453-4057qib7	3977	6	the	the	DT
cord-005453-4057qib7	3977	7	groups	group	NNS
cord-005453-4057qib7	3977	8	according	accord	VBG
cord-005453-4057qib7	3977	9	to	to	IN
cord-005453-4057qib7	3977	10	homocysteine	homocysteine	NN
cord-005453-4057qib7	3977	11	,	,	,
cord-005453-4057qib7	3977	12	lipoprotein	lipoprotein	VB
cord-005453-4057qib7	3977	13	a	a	DT
cord-005453-4057qib7	3977	14	,	,	,
cord-005453-4057qib7	3977	15	protein	protein	NN
cord-005453-4057qib7	3977	16	S	S	NNP
cord-005453-4057qib7	3977	17	and	and	CC
cord-005453-4057qib7	3977	18	C	C	NNP
cord-005453-4057qib7	3977	19	activity	activity	NN
cord-005453-4057qib7	3977	20	and	and	CC
cord-005453-4057qib7	3977	21	antigen	antigen	NN
cord-005453-4057qib7	3977	22	levels	level	NNS
cord-005453-4057qib7	3977	23	.	.	.
cord-005453-4057qib7	3978	1	We	-PRON-	PRP
cord-005453-4057qib7	3978	2	did	do	VBD
cord-005453-4057qib7	3978	3	not	not	RB
cord-005453-4057qib7	3978	4	find	find	VB
cord-005453-4057qib7	3978	5	any	any	DT
cord-005453-4057qib7	3978	6	relation	relation	NN
cord-005453-4057qib7	3978	7	between	between	IN
cord-005453-4057qib7	3978	8	the	the	DT
cord-005453-4057qib7	3978	9	genetic	genetic	JJ
cord-005453-4057qib7	3978	10	variations	variation	NNS
cord-005453-4057qib7	3978	11	of	of	IN
cord-005453-4057qib7	3978	12	thrombophilia	thrombophilia	NNP
cord-005453-4057qib7	3978	13	and	and	CC
cord-005453-4057qib7	3978	14	VOD	VOD	NNP
cord-005453-4057qib7	3978	15	(	(	-LRB-
cord-005453-4057qib7	3978	16	Table	Table	NNP
cord-005453-4057qib7	3978	17	1	1	CD
cord-005453-4057qib7	3978	18	)	)	-RRB-
cord-005453-4057qib7	3978	19	.	.	.
cord-005453-4057qib7	3979	1	In	in	IN
cord-005453-4057qib7	3979	2	VOD	VOD	NNP
cord-005453-4057qib7	3979	3	group	group	NN
cord-005453-4057qib7	3979	4	there	there	EX
cord-005453-4057qib7	3979	5	were	be	VBD
cord-005453-4057qib7	3979	6	6	6	CD
cord-005453-4057qib7	3979	7	patients	patient	NNS
cord-005453-4057qib7	3979	8	(	(	-LRB-
cord-005453-4057qib7	3979	9	17.1	17.1	CD
cord-005453-4057qib7	3979	10	%	%	NN
cord-005453-4057qib7	3979	11	)	)	-RRB-
cord-005453-4057qib7	3979	12	with	with	IN
cord-005453-4057qib7	3979	13	acute	acute	JJ
cord-005453-4057qib7	3979	14	graft	graft	NN
cord-005453-4057qib7	3979	15	versus	versus	IN
cord-005453-4057qib7	3979	16	host	host	NN
cord-005453-4057qib7	3979	17	disease	disease	NN
cord-005453-4057qib7	3979	18	(	(	-LRB-
cord-005453-4057qib7	3979	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3979	20	)	)	-RRB-
cord-005453-4057qib7	3979	21	and	and	CC
cord-005453-4057qib7	3979	22	in	in	IN
cord-005453-4057qib7	3979	23	control	control	NN
cord-005453-4057qib7	3979	24	group	group	NN
cord-005453-4057qib7	3979	25	there	there	EX
cord-005453-4057qib7	3979	26	were	be	VBD
cord-005453-4057qib7	3979	27	7	7	CD
cord-005453-4057qib7	3979	28	(	(	-LRB-
cord-005453-4057qib7	3979	29	15.9	15.9	CD
cord-005453-4057qib7	3979	30	%	%	NN
cord-005453-4057qib7	3979	31	)	)	-RRB-
cord-005453-4057qib7	3979	32	patients	patient	NNS
cord-005453-4057qib7	3979	33	with	with	IN
cord-005453-4057qib7	3979	34	aGVHD	aGVHD	NNP
cord-005453-4057qib7	3979	35	(	(	-LRB-
cord-005453-4057qib7	3979	36	p=0.046	p=0.046	NNP
cord-005453-4057qib7	3979	37	)	)	-RRB-
cord-005453-4057qib7	3979	38	.	.	.
cord-005453-4057qib7	3980	1	Febrile	febrile	JJ
cord-005453-4057qib7	3980	2	episodes	episode	NNS
cord-005453-4057qib7	3980	3	were	be	VBD
cord-005453-4057qib7	3980	4	more	more	RBR
cord-005453-4057qib7	3980	5	frequent	frequent	JJ
cord-005453-4057qib7	3980	6	in	in	IN
cord-005453-4057qib7	3980	7	VOD	VOD	NNP
cord-005453-4057qib7	3980	8	group	group	NN
cord-005453-4057qib7	3980	9	compared	compare	VBN
cord-005453-4057qib7	3980	10	to	to	IN
cord-005453-4057qib7	3980	11	the	the	DT
cord-005453-4057qib7	3980	12	controls	control	NNS
cord-005453-4057qib7	3980	13	(	(	-LRB-
cord-005453-4057qib7	3980	14	respectively	respectively	RB
cord-005453-4057qib7	3980	15	;	;	:
cord-005453-4057qib7	3980	16	n=30	n=30	NNP
cord-005453-4057qib7	3980	17	,	,	,
cord-005453-4057qib7	3980	18	85.7	85.7	CD
cord-005453-4057qib7	3980	19	%	%	NN
cord-005453-4057qib7	3980	20	vs.	vs.	IN
cord-005453-4057qib7	3980	21	n=23	n=23	NNP
cord-005453-4057qib7	3980	22	,	,	,
cord-005453-4057qib7	3980	23	54.8	54.8	CD
cord-005453-4057qib7	3980	24	%	%	NN
cord-005453-4057qib7	3980	25	,	,	,
cord-005453-4057qib7	3980	26	p=0.006	p=0.006	NNP
cord-005453-4057qib7	3980	27	)	)	-RRB-
cord-005453-4057qib7	3980	28	.	.	.
cord-005453-4057qib7	3981	1	8-year	8-year	JJ
cord-005453-4057qib7	3981	2	overall	overall	JJ
cord-005453-4057qib7	3981	3	survival	survival	NN
cord-005453-4057qib7	3981	4	was	be	VBD
cord-005453-4057qib7	3981	5	%	%	NN
cord-005453-4057qib7	3981	6	77.1	77.1	CD
cord-005453-4057qib7	3981	7	in	in	IN
cord-005453-4057qib7	3981	8	VOD	VOD	NNP
cord-005453-4057qib7	3981	9	group	group	NN
cord-005453-4057qib7	3981	10	and	and	CC
cord-005453-4057qib7	3981	11	100	100	CD
cord-005453-4057qib7	3981	12	%	%	NN
cord-005453-4057qib7	3981	13	in	in	IN
cord-005453-4057qib7	3981	14	control	control	NN
cord-005453-4057qib7	3981	15	group	group	NN
cord-005453-4057qib7	3981	16	(	(	-LRB-
cord-005453-4057qib7	3981	17	p=0.001	p=0.001	NNP
cord-005453-4057qib7	3981	18	)	)	-RRB-
cord-005453-4057qib7	3981	19	.	.	.
cord-005453-4057qib7	3982	1	Disease	Disease	NNP
cord-005453-4057qib7	3982	2	free	free	JJ
cord-005453-4057qib7	3982	3	survival	survival	NN
cord-005453-4057qib7	3982	4	was	be	VBD
cord-005453-4057qib7	3982	5	also	also	RB
cord-005453-4057qib7	3982	6	different	different	JJ
cord-005453-4057qib7	3982	7	between	between	IN
cord-005453-4057qib7	3982	8	VOD	vod	NN
cord-005453-4057qib7	3982	9	and	and	CC
cord-005453-4057qib7	3982	10	control	control	NN
cord-005453-4057qib7	3982	11	groups	group	NNS
cord-005453-4057qib7	3982	12	(	(	-LRB-
cord-005453-4057qib7	3982	13	respectively	respectively	RB
cord-005453-4057qib7	3982	14	;	;	:
cord-005453-4057qib7	3982	15	74.3	74.3	CD
cord-005453-4057qib7	3982	16	%	%	NN
cord-005453-4057qib7	3982	17	vs.	vs.	CC
cord-005453-4057qib7	3982	18	97.3	97.3	CD
cord-005453-4057qib7	3982	19	%	%	NN
cord-005453-4057qib7	3982	20	,	,	,
cord-005453-4057qib7	3982	21	p=0.001	p=0.001	NNP
cord-005453-4057qib7	3982	22	)	)	-RRB-
cord-005453-4057qib7	3982	23	.	.	.
cord-005453-4057qib7	3983	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	3983	2	:	:	:
cord-005453-4057qib7	3984	1	In	in	IN
cord-005453-4057qib7	3984	2	literature	literature	NN
cord-005453-4057qib7	3984	3	there	there	EX
cord-005453-4057qib7	3984	4	are	be	VBP
cord-005453-4057qib7	3984	5	recent	recent	JJ
cord-005453-4057qib7	3984	6	studies	study	NNS
cord-005453-4057qib7	3984	7	showing	show	VBG
cord-005453-4057qib7	3984	8	higher	high	JJR
cord-005453-4057qib7	3984	9	PAI-1	PAI-1	NNP
cord-005453-4057qib7	3984	10	levels	level	NNS
cord-005453-4057qib7	3984	11	in	in	IN
cord-005453-4057qib7	3984	12	patients	patient	NNS
cord-005453-4057qib7	3984	13	with	with	IN
cord-005453-4057qib7	3984	14	VOD	VOD	NNP
cord-005453-4057qib7	3984	15	.	.	.
cord-005453-4057qib7	3985	1	However	however	RB
cord-005453-4057qib7	3985	2	,	,	,
cord-005453-4057qib7	3985	3	in	in	IN
cord-005453-4057qib7	3985	4	our	-PRON-	PRP$
cord-005453-4057qib7	3985	5	study	study	NN
cord-005453-4057qib7	3985	6	we	-PRON-	PRP
cord-005453-4057qib7	3985	7	did	do	VBD
cord-005453-4057qib7	3985	8	not	not	RB
cord-005453-4057qib7	3985	9	find	find	VB
cord-005453-4057qib7	3985	10	any	any	DT
cord-005453-4057qib7	3985	11	relationship	relationship	NN
cord-005453-4057qib7	3985	12	between	between	IN
cord-005453-4057qib7	3985	13	congenital	congenital	JJ
cord-005453-4057qib7	3985	14	thrombophilia	thrombophilia	JJ
cord-005453-4057qib7	3985	15	factors	factor	NNS
cord-005453-4057qib7	3985	16	and	and	CC
cord-005453-4057qib7	3985	17	VOD	VOD	NNP
cord-005453-4057qib7	3985	18	.	.	.
cord-005453-4057qib7	3986	1	New	new	JJ
cord-005453-4057qib7	3986	2	studies	study	NNS
cord-005453-4057qib7	3986	3	with	with	IN
cord-005453-4057qib7	3986	4	larger	large	JJR
cord-005453-4057qib7	3986	5	sample	sample	NN
cord-005453-4057qib7	3986	6	groups	group	NNS
cord-005453-4057qib7	3986	7	is	be	VBZ
cord-005453-4057qib7	3986	8	necessary	necessary	JJ
cord-005453-4057qib7	3986	9	to	to	TO
cord-005453-4057qib7	3986	10	better	better	RB
cord-005453-4057qib7	3986	11	evaluate	evaluate	VB
cord-005453-4057qib7	3986	12	the	the	DT
cord-005453-4057qib7	3986	13	association	association	NN
cord-005453-4057qib7	3986	14	of	of	IN
cord-005453-4057qib7	3986	15	congenital	congenital	NNP
cord-005453-4057qib7	3986	16	thrombophilia	thrombophilia	NNP
cord-005453-4057qib7	3986	17	factors	factor	NNS
cord-005453-4057qib7	3986	18	and	and	CC
cord-005453-4057qib7	3986	19	VOD	VOD	NNP
cord-005453-4057qib7	3986	20	.	.	.
cord-005453-4057qib7	3987	1	Disclosure	disclosure	NN
cord-005453-4057qib7	3987	2	:	:	:
cord-005453-4057qib7	3987	3	Nothing	nothing	NN
cord-005453-4057qib7	3987	4	to	to	TO
cord-005453-4057qib7	3987	5	declare	declare	VB
cord-005453-4057qib7	3987	6	P189	p189	CD
cord-005453-4057qib7	3988	1	Different	different	JJ
cord-005453-4057qib7	3988	2	strategies	strategy	NNS
cord-005453-4057qib7	3988	3	of	of	IN
cord-005453-4057qib7	3988	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	3988	5	-	-	HYPH
cord-005453-4057qib7	3988	6	induced	induce	VBN
cord-005453-4057qib7	3988	7	nausea	nausea	NN
cord-005453-4057qib7	3988	8	and	and	CC
cord-005453-4057qib7	3988	9	vomiting	vomiting	NN
cord-005453-4057qib7	3988	10	(	(	-LRB-
cord-005453-4057qib7	3988	11	CINV	CINV	NNP
cord-005453-4057qib7	3988	12	)	)	-RRB-
cord-005453-4057qib7	3988	13	prevention	prevention	NN
cord-005453-4057qib7	3988	14	in	in	IN
cord-005453-4057qib7	3988	15	hematological	hematological	JJ
cord-005453-4057qib7	3988	16	patients	patient	NNS
cord-005453-4057qib7	3988	17	receiving	receive	VBG
cord-005453-4057qib7	3988	18	an	an	DT
cord-005453-4057qib7	3988	19	autologous	autologous	JJ
cord-005453-4057qib7	3988	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3988	21	stem	stem	NN
cord-005453-4057qib7	3988	22	cell	cell	NN
cord-005453-4057qib7	3988	23	transplantation	transplantation	NN
cord-005453-4057qib7	3989	1	:	:	:
cord-005453-4057qib7	3989	2	A	a	DT
cord-005453-4057qib7	3989	3	single	single	JJ
cord-005453-4057qib7	3989	4	center	center	NN
cord-005453-4057qib7	3989	5	experience	experience	NN
cord-005453-4057qib7	3990	1	Ilaria	Ilaria	NNP
cord-005453-4057qib7	3990	2	Cutini	Cutini	NNP
cord-005453-4057qib7	3990	3	1	1	CD
cord-005453-4057qib7	3990	4	,	,	,
cord-005453-4057qib7	3990	5	Riccardo	Riccardo	NNP
cord-005453-4057qib7	3990	6	Boncompagni	Boncompagni	NNP
cord-005453-4057qib7	3990	7	1	1	CD
cord-005453-4057qib7	3990	8	,	,	,
cord-005453-4057qib7	3990	9	Chiara	Chiara	NNP
cord-005453-4057qib7	3990	10	Nozzoli	Nozzoli	NNP
cord-005453-4057qib7	3990	11	1	1	CD
cord-005453-4057qib7	3990	12	,	,	,
cord-005453-4057qib7	3990	13	Antonella	Antonella	NNP
cord-005453-4057qib7	3990	14	Gozzini	Gozzini	NNP
cord-005453-4057qib7	3990	15	1	1	CD
cord-005453-4057qib7	3990	16	,	,	,
cord-005453-4057qib7	3990	17	Stefano	Stefano	NNP
cord-005453-4057qib7	3990	18	Guidi	Guidi	NNP
cord-005453-4057qib7	3990	19	1	1	CD
cord-005453-4057qib7	3990	20	,	,	,
cord-005453-4057qib7	3990	21	Chiara	Chiara	NNP
cord-005453-4057qib7	3990	22	Innocenti	Innocenti	NNP
cord-005453-4057qib7	3990	23	1	1	CD
cord-005453-4057qib7	3990	24	,	,	,
cord-005453-4057qib7	3990	25	Massimo	Massimo	NNP
cord-005453-4057qib7	3990	26	Di	Di	NNP
cord-005453-4057qib7	3990	27	Gioia	Gioia	NNP
cord-005453-4057qib7	3990	28	1	1	CD
cord-005453-4057qib7	3990	29	,	,	,
cord-005453-4057qib7	3990	30	Lorenzo	Lorenzo	NNP
cord-005453-4057qib7	3990	31	Tofani	Tofani	NNP
cord-005453-4057qib7	3990	32	1	1	CD
cord-005453-4057qib7	3990	33	,	,	,
cord-005453-4057qib7	3990	34	Riccardo	Riccardo	NNP
cord-005453-4057qib7	3990	35	Saccardi	Saccardi	NNP
cord-005453-4057qib7	3990	36	1	1	CD
cord-005453-4057qib7	3990	37	Background	Background	NNP
cord-005453-4057qib7	3990	38	:	:	:
cord-005453-4057qib7	3991	1	Despite	despite	IN
cord-005453-4057qib7	3991	2	the	the	DT
cord-005453-4057qib7	3991	3	improvements	improvement	NNS
cord-005453-4057qib7	3991	4	of	of	IN
cord-005453-4057qib7	3991	5	pharmacological	pharmacological	JJ
cord-005453-4057qib7	3991	6	control	control	NN
cord-005453-4057qib7	3991	7	,	,	,
cord-005453-4057qib7	3991	8	CINV	CINV	NNP
cord-005453-4057qib7	3991	9	still	still	RB
cord-005453-4057qib7	3991	10	represents	represent	VBZ
cord-005453-4057qib7	3991	11	a	a	DT
cord-005453-4057qib7	3991	12	major	major	JJ
cord-005453-4057qib7	3991	13	problem	problem	NN
cord-005453-4057qib7	3991	14	in	in	IN
cord-005453-4057qib7	3991	15	patient	patient	NN
cord-005453-4057qib7	3991	16	undergoing	undergo	VBG
cord-005453-4057qib7	3991	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	3991	18	stem	stem	NN
cord-005453-4057qib7	3991	19	cell	cell	NN
cord-005453-4057qib7	3991	20	transplantation	transplantation	NN
cord-005453-4057qib7	3991	21	(	(	-LRB-
cord-005453-4057qib7	3991	22	HSCT	HSCT	NNP
cord-005453-4057qib7	3991	23	)	)	-RRB-
cord-005453-4057qib7	3991	24	.	.	.
cord-005453-4057qib7	3992	1	We	-PRON-	PRP
cord-005453-4057qib7	3992	2	present	present	VBP
cord-005453-4057qib7	3992	3	here	here	RB
cord-005453-4057qib7	3992	4	a	a	DT
cord-005453-4057qib7	3992	5	comparison	comparison	NN
cord-005453-4057qib7	3992	6	of	of	IN
cord-005453-4057qib7	3992	7	two	two	CD
cord-005453-4057qib7	3992	8	pharmacological	pharmacological	JJ
cord-005453-4057qib7	3992	9	strategies	strategy	NNS
cord-005453-4057qib7	3992	10	for	for	IN
cord-005453-4057qib7	3992	11	preventing	prevent	VBG
cord-005453-4057qib7	3992	12	CINV	CINV	NNP
cord-005453-4057qib7	3992	13	in	in	IN
cord-005453-4057qib7	3992	14	Multiple	Multiple	NNP
cord-005453-4057qib7	3992	15	Myeloma	Myeloma	NNP
cord-005453-4057qib7	3992	16	(	(	-LRB-
cord-005453-4057qib7	3992	17	MM	MM	NNP
cord-005453-4057qib7	3992	18	)	)	-RRB-
cord-005453-4057qib7	3992	19	,	,	,
cord-005453-4057qib7	3992	20	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	3992	21	(	(	-LRB-
cord-005453-4057qib7	3992	22	HL	HL	NNP
cord-005453-4057qib7	3992	23	)	)	-RRB-
cord-005453-4057qib7	3992	24	,	,	,
cord-005453-4057qib7	3992	25	and	and	CC
cord-005453-4057qib7	3992	26	Non	Non	NNP
cord-005453-4057qib7	3992	27	-	-	NNP
cord-005453-4057qib7	3992	28	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	3992	29	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	3992	30	(	(	-LRB-
cord-005453-4057qib7	3992	31	NHL	NHL	NNP
cord-005453-4057qib7	3992	32	)	)	-RRB-
cord-005453-4057qib7	3992	33	patients	patient	NNS
cord-005453-4057qib7	3992	34	who	who	WP
cord-005453-4057qib7	3992	35	received	receive	VBD
cord-005453-4057qib7	3992	36	an	an	DT
cord-005453-4057qib7	3992	37	autologous	autologous	JJ
cord-005453-4057qib7	3992	38	HSCT	HSCT	NNP
cord-005453-4057qib7	3992	39	in	in	IN
cord-005453-4057qib7	3992	40	our	-PRON-	PRP$
cord-005453-4057qib7	3992	41	Institution	Institution	NNP
cord-005453-4057qib7	3992	42	.	.	.
cord-005453-4057qib7	3993	1	Methods	method	NNS
cord-005453-4057qib7	3993	2	:	:	:
cord-005453-4057qib7	3994	1	From	from	IN
cord-005453-4057qib7	3994	2	January	January	NNP
cord-005453-4057qib7	3994	3	2015	2015	CD
cord-005453-4057qib7	3994	4	to	to	IN
cord-005453-4057qib7	3994	5	July	July	NNP
cord-005453-4057qib7	3994	6	2018	2018	CD
cord-005453-4057qib7	3994	7	,	,	,
cord-005453-4057qib7	3994	8	we	-PRON-	PRP
cord-005453-4057qib7	3994	9	retrospectively	retrospectively	RB
cord-005453-4057qib7	3994	10	analyzed	analyze	VBD
cord-005453-4057qib7	3994	11	250	250	CD
cord-005453-4057qib7	3994	12	consecutive	consecutive	JJ
cord-005453-4057qib7	3994	13	patients	patient	NNS
cord-005453-4057qib7	3994	14	,	,	,
cord-005453-4057qib7	3994	15	median	median	JJ
cord-005453-4057qib7	3994	16	age	age	NN
cord-005453-4057qib7	3994	17	58	58	CD
cord-005453-4057qib7	3994	18	years	year	NNS
cord-005453-4057qib7	3994	19	(	(	-LRB-
cord-005453-4057qib7	3994	20	22	22	CD
cord-005453-4057qib7	3994	21	-	-	HYPH
cord-005453-4057qib7	3994	22	71yo	71yo	NN
cord-005453-4057qib7	3994	23	)	)	-RRB-
cord-005453-4057qib7	3994	24	,	,	,
cord-005453-4057qib7	3994	25	diagnosed	diagnose	VBN
cord-005453-4057qib7	3994	26	with	with	IN
cord-005453-4057qib7	3994	27	MM	MM	NNP
cord-005453-4057qib7	3994	28	,	,	,
cord-005453-4057qib7	3994	29	HL	HL	NNP
cord-005453-4057qib7	3994	30	,	,	,
cord-005453-4057qib7	3994	31	and	and	CC
cord-005453-4057qib7	3994	32	NHL	NHL	NNP
cord-005453-4057qib7	3994	33	,	,	,
cord-005453-4057qib7	3994	34	who	who	WP
cord-005453-4057qib7	3994	35	underwent	undergo	VBD
cord-005453-4057qib7	3994	36	an	an	DT
cord-005453-4057qib7	3994	37	autologous	autologous	JJ
cord-005453-4057qib7	3994	38	HSCT	HSCT	NNP
cord-005453-4057qib7	3994	39	following	follow	VBG
cord-005453-4057qib7	3994	40	a	a	DT
cord-005453-4057qib7	3994	41	Melphalan	Melphalan	NNP
cord-005453-4057qib7	3994	42	200	200	CD
cord-005453-4057qib7	3994	43	mg	mg	NNP
cord-005453-4057qib7	3994	44	/	/	SYM
cord-005453-4057qib7	3994	45	sqm	sqm	NN
cord-005453-4057qib7	3994	46	and	and	CC
cord-005453-4057qib7	3994	47	BEAM	BEAM	NNP
cord-005453-4057qib7	3994	48	/	/	SYM
cord-005453-4057qib7	3994	49	FEAM	feam	JJ
cord-005453-4057qib7	3994	50	condition	condition	NN
cord-005453-4057qib7	3994	51	regimens	regimen	NNS
cord-005453-4057qib7	3994	52	,	,	,
cord-005453-4057qib7	3994	53	respectively	respectively	RB
cord-005453-4057qib7	3994	54	.	.	.
cord-005453-4057qib7	3995	1	The	the	DT
cord-005453-4057qib7	3995	2	first	first	JJ
cord-005453-4057qib7	3995	3	122	122	CD
cord-005453-4057qib7	3995	4	patients	patient	NNS
cord-005453-4057qib7	3995	5	received	receive	VBD
cord-005453-4057qib7	3995	6	CINV	CINV	NNP
cord-005453-4057qib7	3995	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3995	8	with	with	IN
cord-005453-4057qib7	3995	9	palonosetron	palonosetron	NNP
cord-005453-4057qib7	3995	10	i.v	i.v	NNP
cord-005453-4057qib7	3995	11	and	and	CC
cord-005453-4057qib7	3995	12	dexamethasone	dexamethasone	NNP
cord-005453-4057qib7	3995	13	8	8	CD
cord-005453-4057qib7	3995	14	mg	mg	NNP
cord-005453-4057qib7	3995	15	die	die	VBP
cord-005453-4057qib7	3995	16	(	(	-LRB-
cord-005453-4057qib7	3995	17	Regimen	regimen	NN
cord-005453-4057qib7	3995	18	A	A	NNP
cord-005453-4057qib7	3995	19	)	)	-RRB-
cord-005453-4057qib7	3995	20	,	,	,
cord-005453-4057qib7	3995	21	whilst	whilst	IN
cord-005453-4057qib7	3995	22	the	the	DT
cord-005453-4057qib7	3995	23	following	follow	VBG
cord-005453-4057qib7	3995	24	128	128	CD
cord-005453-4057qib7	3995	25	were	be	VBD
cord-005453-4057qib7	3995	26	administered	administer	VBN
cord-005453-4057qib7	3995	27	with	with	IN
cord-005453-4057qib7	3995	28	fosaprepitant	fosaprepitant	JJ
cord-005453-4057qib7	3995	29	iv	iv	NNP
cord-005453-4057qib7	3995	30	,	,	,
cord-005453-4057qib7	3995	31	ondansetron	ondansetron	NNP
cord-005453-4057qib7	3995	32	iv	iv	CD
cord-005453-4057qib7	3995	33	and	and	CC
cord-005453-4057qib7	3995	34	dexamethasone	dexamethasone	NNP
cord-005453-4057qib7	3995	35	8	8	CD
cord-005453-4057qib7	3995	36	mg	mg	NNP
cord-005453-4057qib7	3995	37	die	die	VBP
cord-005453-4057qib7	3995	38	(	(	-LRB-
cord-005453-4057qib7	3995	39	Regimen	regimen	NN
cord-005453-4057qib7	3995	40	B	b	NN
cord-005453-4057qib7	3995	41	)	)	-RRB-
cord-005453-4057qib7	3996	1	Both	both	DT
cord-005453-4057qib7	3996	2	CINV	CINV	NNP
cord-005453-4057qib7	3996	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	3996	4	was	be	VBD
cord-005453-4057qib7	3996	5	administered	administer	VBN
cord-005453-4057qib7	3996	6	the	the	DT
cord-005453-4057qib7	3996	7	day	day	NN
cord-005453-4057qib7	3996	8	of	of	IN
cord-005453-4057qib7	3996	9	melphalan	melphalan	NNP
cord-005453-4057qib7	3996	10	infusion	infusion	NNP
cord-005453-4057qib7	3996	11	(	(	-LRB-
cord-005453-4057qib7	3996	12	day	day	NN
cord-005453-4057qib7	3996	13	-1	-1	CD
cord-005453-4057qib7	3996	14	form	form	NN
cord-005453-4057qib7	3996	15	transplant	transplant	NN
cord-005453-4057qib7	3996	16	)	)	-RRB-
cord-005453-4057qib7	3996	17	.	.	.
cord-005453-4057qib7	3997	1	Emesis	emesis	NN
cord-005453-4057qib7	3997	2	breakthroughs	breakthrough	NNS
cord-005453-4057qib7	3997	3	were	be	VBD
cord-005453-4057qib7	3997	4	treated	treat	VBN
cord-005453-4057qib7	3997	5	with	with	IN
cord-005453-4057qib7	3997	6	alizapride	alizapride	NN
cord-005453-4057qib7	3997	7	and	and	CC
cord-005453-4057qib7	3997	8	metoclopramide	metoclopramide	NN
cord-005453-4057qib7	3997	9	.	.	.
cord-005453-4057qib7	3998	1	Nausea	nausea	NN
cord-005453-4057qib7	3998	2	and	and	CC
cord-005453-4057qib7	3998	3	vomiting	vomiting	NN
cord-005453-4057qib7	3998	4	were	be	VBD
cord-005453-4057qib7	3998	5	assessed	assess	VBN
cord-005453-4057qib7	3998	6	through	through	IN
cord-005453-4057qib7	3998	7	the	the	DT
cord-005453-4057qib7	3998	8	CTCAE	CTCAE	NNP
cord-005453-4057qib7	3998	9	4.0	4.0	CD
cord-005453-4057qib7	3998	10	score	score	NN
cord-005453-4057qib7	3998	11	system	system	NN
cord-005453-4057qib7	3998	12	.	.	.
cord-005453-4057qib7	3999	1	Categorical	categorical	JJ
cord-005453-4057qib7	3999	2	variables	variable	NNS
cord-005453-4057qib7	3999	3	were	be	VBD
cord-005453-4057qib7	3999	4	compared	compare	VBN
cord-005453-4057qib7	3999	5	with	with	IN
cord-005453-4057qib7	3999	6	Pearson	Pearson	NNP
cord-005453-4057qib7	3999	7	Chi	Chi	NNP
cord-005453-4057qib7	3999	8	-	-	HYPH
cord-005453-4057qib7	3999	9	square	square	JJ
cord-005453-4057qib7	3999	10	test	test	NN
cord-005453-4057qib7	3999	11	.	.	.
cord-005453-4057qib7	4000	1	Results	result	NNS
cord-005453-4057qib7	4000	2	:	:	:
cord-005453-4057qib7	4001	1	The	the	DT
cord-005453-4057qib7	4001	2	overall	overall	JJ
cord-005453-4057qib7	4001	3	incidence	incidence	NN
cord-005453-4057qib7	4001	4	of	of	IN
cord-005453-4057qib7	4001	5	nausea	nausea	NN
cord-005453-4057qib7	4001	6	was	be	VBD
cord-005453-4057qib7	4001	7	78	78	CD
cord-005453-4057qib7	4001	8	%	%	NN
cord-005453-4057qib7	4001	9	,	,	,
cord-005453-4057qib7	4001	10	(	(	-LRB-
cord-005453-4057qib7	4001	11	55	55	CD
cord-005453-4057qib7	4001	12	%	%	NN
cord-005453-4057qib7	4001	13	grade	grade	NN
cord-005453-4057qib7	4001	14	1	1	CD
cord-005453-4057qib7	4001	15	,	,	,
cord-005453-4057qib7	4001	16	41	41	CD
cord-005453-4057qib7	4001	17	%	%	NN
cord-005453-4057qib7	4001	18	grade	grade	NN
cord-005453-4057qib7	4001	19	2	2	CD
cord-005453-4057qib7	4001	20	,	,	,
cord-005453-4057qib7	4001	21	and	and	CC
cord-005453-4057qib7	4001	22	4	4	CD
cord-005453-4057qib7	4001	23	%	%	NN
cord-005453-4057qib7	4001	24	grade	grade	NN
cord-005453-4057qib7	4001	25	3	3	CD
cord-005453-4057qib7	4001	26	,	,	,
cord-005453-4057qib7	4001	27	respectively	respectively	RB
cord-005453-4057qib7	4001	28	)	)	-RRB-
cord-005453-4057qib7	4001	29	.	.	.
cord-005453-4057qib7	4002	1	In	in	IN
cord-005453-4057qib7	4002	2	Regimen	Regimen	NNP
cord-005453-4057qib7	4002	3	A	A	NNP
cord-005453-4057qib7	4002	4	was	be	VBD
cord-005453-4057qib7	4002	5	shown	show	VBN
cord-005453-4057qib7	4002	6	to	to	TO
cord-005453-4057qib7	4002	7	be	be	VB
cord-005453-4057qib7	4002	8	80	80	CD
cord-005453-4057qib7	4002	9	%	%	NN
cord-005453-4057qib7	4002	10	,	,	,
cord-005453-4057qib7	4002	11	(	(	-LRB-
cord-005453-4057qib7	4002	12	56	56	CD
cord-005453-4057qib7	4002	13	%	%	NN
cord-005453-4057qib7	4002	14	grade1	grade1	NN
cord-005453-4057qib7	4002	15	,	,	,
cord-005453-4057qib7	4002	16	41	41	CD
cord-005453-4057qib7	4002	17	%	%	NN
cord-005453-4057qib7	4002	18	grade	grade	NN
cord-005453-4057qib7	4002	19	2	2	CD
cord-005453-4057qib7	4002	20	,	,	,
cord-005453-4057qib7	4002	21	and	and	CC
cord-005453-4057qib7	4002	22	3	3	CD
cord-005453-4057qib7	4002	23	%	%	NN
cord-005453-4057qib7	4002	24	grade	grade	NN
cord-005453-4057qib7	4002	25	3	3	CD
cord-005453-4057qib7	4002	26	,	,	,
cord-005453-4057qib7	4002	27	respectively	respectively	RB
cord-005453-4057qib7	4002	28	)	)	-RRB-
cord-005453-4057qib7	4002	29	while	while	IN
cord-005453-4057qib7	4002	30	in	in	IN
cord-005453-4057qib7	4002	31	Regimen	Regimen	NNP
cord-005453-4057qib7	4002	32	B	B	NNP
cord-005453-4057qib7	4002	33	was	be	VBD
cord-005453-4057qib7	4002	34	77	77	CD
cord-005453-4057qib7	4002	35	%	%	NN
cord-005453-4057qib7	4002	36	(	(	-LRB-
cord-005453-4057qib7	4002	37	54	54	CD
cord-005453-4057qib7	4002	38	%	%	NN
cord-005453-4057qib7	4002	39	grade	grade	NN
cord-005453-4057qib7	4002	40	1	1	CD
cord-005453-4057qib7	4002	41	,	,	,
cord-005453-4057qib7	4002	42	41	41	CD
cord-005453-4057qib7	4002	43	%	%	NN
cord-005453-4057qib7	4002	44	grade	grade	NN
cord-005453-4057qib7	4002	45	2	2	CD
cord-005453-4057qib7	4002	46	,	,	,
cord-005453-4057qib7	4002	47	and	and	CC
cord-005453-4057qib7	4002	48	5	5	CD
cord-005453-4057qib7	4002	49	%	%	NN
cord-005453-4057qib7	4002	50	grade	grade	NN
cord-005453-4057qib7	4002	51	3	3	CD
cord-005453-4057qib7	4002	52	,	,	,
cord-005453-4057qib7	4002	53	respectively	respectively	RB
cord-005453-4057qib7	4002	54	)	)	-RRB-
cord-005453-4057qib7	4002	55	.	.	.
cord-005453-4057qib7	4003	1	Pearson	Pearson	NNP
cord-005453-4057qib7	4003	2	Chi	Chi	NNP
cord-005453-4057qib7	4003	3	-	-	HYPH
cord-005453-4057qib7	4003	4	square	square	JJ
cord-005453-4057qib7	4003	5	test	test	NN
cord-005453-4057qib7	4003	6	did	do	VBD
cord-005453-4057qib7	4003	7	not	not	RB
cord-005453-4057qib7	4003	8	show	show	VB
cord-005453-4057qib7	4003	9	any	any	DT
cord-005453-4057qib7	4003	10	differences	difference	NNS
cord-005453-4057qib7	4003	11	between	between	IN
cord-005453-4057qib7	4003	12	the	the	DT
cord-005453-4057qib7	4003	13	2	2	CD
cord-005453-4057qib7	4003	14	groups	group	NNS
cord-005453-4057qib7	4003	15	(	(	-LRB-
cord-005453-4057qib7	4003	16	p=0.679	p=0.679	NN
cord-005453-4057qib7	4003	17	)	)	-RRB-
cord-005453-4057qib7	4003	18	.	.	.
cord-005453-4057qib7	4004	1	The	the	DT
cord-005453-4057qib7	4004	2	overall	overall	JJ
cord-005453-4057qib7	4004	3	observed	observed	JJ
cord-005453-4057qib7	4004	4	vomit	vomit	NN
cord-005453-4057qib7	4004	5	was	be	VBD
cord-005453-4057qib7	4004	6	32	32	CD
cord-005453-4057qib7	4004	7	%	%	NN
cord-005453-4057qib7	4004	8	(	(	-LRB-
cord-005453-4057qib7	4004	9	83	83	CD
cord-005453-4057qib7	4004	10	%	%	NN
cord-005453-4057qib7	4004	11	grade	grade	NN
cord-005453-4057qib7	4004	12	1	1	CD
cord-005453-4057qib7	4004	13	,	,	,
cord-005453-4057qib7	4004	14	16	16	CD
cord-005453-4057qib7	4004	15	%	%	NN
cord-005453-4057qib7	4004	16	grade	grade	NN
cord-005453-4057qib7	4004	17	2	2	CD
cord-005453-4057qib7	4004	18	,	,	,
cord-005453-4057qib7	4004	19	and	and	CC
cord-005453-4057qib7	4004	20	1	1	CD
cord-005453-4057qib7	4004	21	%	%	NN
cord-005453-4057qib7	4004	22	grade	grade	NN
cord-005453-4057qib7	4004	23	3	3	CD
cord-005453-4057qib7	4004	24	)	)	-RRB-
cord-005453-4057qib7	4004	25	.	.	.
cord-005453-4057qib7	4005	1	In	in	IN
cord-005453-4057qib7	4005	2	Regimen	regimen	NN
cord-005453-4057qib7	4005	3	A	A	NNP
cord-005453-4057qib7	4005	4	it	-PRON-	PRP
cord-005453-4057qib7	4005	5	was	be	VBD
cord-005453-4057qib7	4005	6	(	(	-LRB-
cord-005453-4057qib7	4005	7	47	47	CD
cord-005453-4057qib7	4005	8	%	%	NN
cord-005453-4057qib7	4005	9	(	(	-LRB-
cord-005453-4057qib7	4005	10	84	84	CD
cord-005453-4057qib7	4005	11	%	%	NN
cord-005453-4057qib7	4005	12	grade	grade	NN
cord-005453-4057qib7	4005	13	14	14	CD
cord-005453-4057qib7	4005	14	%	%	NN
cord-005453-4057qib7	4005	15	grade	grade	NN
cord-005453-4057qib7	4005	16	2	2	CD
cord-005453-4057qib7	4005	17	,	,	,
cord-005453-4057qib7	4005	18	and	and	CC
cord-005453-4057qib7	4005	19	2	2	CD
cord-005453-4057qib7	4005	20	%	%	NN
cord-005453-4057qib7	4005	21	grade	grade	NN
cord-005453-4057qib7	4005	22	3	3	CD
cord-005453-4057qib7	4005	23	)	)	-RRB-
cord-005453-4057qib7	4005	24	,	,	,
cord-005453-4057qib7	4005	25	and	and	CC
cord-005453-4057qib7	4005	26	17	17	CD
cord-005453-4057qib7	4005	27	%	%	NN
cord-005453-4057qib7	4005	28	in	in	IN
cord-005453-4057qib7	4005	29	Regimen	Regimen	NNP
cord-005453-4057qib7	4005	30	B	B	NNP
cord-005453-4057qib7	4005	31	(	(	-LRB-
cord-005453-4057qib7	4005	32	77	77	CD
cord-005453-4057qib7	4005	33	%	%	NN
cord-005453-4057qib7	4005	34	grade	grade	NN
cord-005453-4057qib7	4005	35	1	1	CD
cord-005453-4057qib7	4005	36	and	and	CC
cord-005453-4057qib7	4005	37	23	23	CD
cord-005453-4057qib7	4005	38	%	%	NN
cord-005453-4057qib7	4005	39	grade	grade	NN
cord-005453-4057qib7	4005	40	2	2	CD
cord-005453-4057qib7	4005	41	)	)	-RRB-
cord-005453-4057qib7	4005	42	.	.	.
cord-005453-4057qib7	4006	1	Conditioning	conditioning	NN
cord-005453-4057qib7	4006	2	regimens	regimen	NNS
cord-005453-4057qib7	4006	3	did	do	VBD
cord-005453-4057qib7	4006	4	n't	not	RB
cord-005453-4057qib7	4006	5	'	'	''
cord-005453-4057qib7	4006	6	have	have	VB
cord-005453-4057qib7	4006	7	any	any	DT
cord-005453-4057qib7	4006	8	significant	significant	JJ
cord-005453-4057qib7	4006	9	impact	impact	NN
cord-005453-4057qib7	4006	10	on	on	IN
cord-005453-4057qib7	4006	11	either	either	CC
cord-005453-4057qib7	4006	12	nausea	nausea	NN
cord-005453-4057qib7	4006	13	or	or	CC
cord-005453-4057qib7	4006	14	vomit	vomit	NN
cord-005453-4057qib7	4006	15	.	.	.
cord-005453-4057qib7	4007	1	Patientsyounger	Patientsyounger	NNP
cord-005453-4057qib7	4007	2	then	then	RB
cord-005453-4057qib7	4007	3	median	median	NN
cord-005453-4057qib7	4007	4	(	(	-LRB-
cord-005453-4057qib7	4007	5	58	58	CD
cord-005453-4057qib7	4007	6	yrs	yr	NNS
cord-005453-4057qib7	4007	7	)	)	-RRB-
cord-005453-4057qib7	4007	8	,	,	,
cord-005453-4057qib7	4007	9	were	be	VBD
cord-005453-4057qib7	4007	10	reported	report	VBN
cord-005453-4057qib7	4007	11	to	to	TO
cord-005453-4057qib7	4007	12	have	have	VB
cord-005453-4057qib7	4007	13	higher	high	JJR
cord-005453-4057qib7	4007	14	incidence	incidence	NN
cord-005453-4057qib7	4007	15	of	of	IN
cord-005453-4057qib7	4007	16	both	both	DT
cord-005453-4057qib7	4007	17	nausea	nausea	NN
cord-005453-4057qib7	4007	18	,	,	,
cord-005453-4057qib7	4007	19	(	(	-LRB-
cord-005453-4057qib7	4007	20	p=0.028	p=0.028	NN
cord-005453-4057qib7	4007	21	)	)	-RRB-
cord-005453-4057qib7	4008	1	not	not	RB
cord-005453-4057qib7	4008	2	related	relate	VBN
cord-005453-4057qib7	4008	3	to	to	IN
cord-005453-4057qib7	4008	4	CINV	CINV	NNP
cord-005453-4057qib7	4008	5	treatment	treatment	NN
cord-005453-4057qib7	4008	6	,	,	,
cord-005453-4057qib7	4008	7	and	and	CC
cord-005453-4057qib7	4008	8	vomit	vomit	NN
cord-005453-4057qib7	4008	9	(	(	-LRB-
cord-005453-4057qib7	4008	10	40	40	CD
cord-005453-4057qib7	4008	11	%	%	NN
cord-005453-4057qib7	4008	12	vs	vs	IN
cord-005453-4057qib7	4008	13	24	24	CD
cord-005453-4057qib7	4008	14	%	%	NN
cord-005453-4057qib7	4008	15	,	,	,
cord-005453-4057qib7	4008	16	p=0.012	p=0.012	NNP
cord-005453-4057qib7	4008	17	)	)	-RRB-
cord-005453-4057qib7	4008	18	.	.	.
cord-005453-4057qib7	4009	1	In	in	IN
cord-005453-4057qib7	4009	2	multivariate	multivariate	JJ
cord-005453-4057qib7	4009	3	analysis	analysis	NN
cord-005453-4057qib7	4009	4	the	the	DT
cord-005453-4057qib7	4009	5	overall	overall	JJ
cord-005453-4057qib7	4009	6	incidence	incidence	NN
cord-005453-4057qib7	4009	7	of	of	IN
cord-005453-4057qib7	4009	8	nausea	nausea	NN
cord-005453-4057qib7	4009	9	is	be	VBZ
cord-005453-4057qib7	4009	10	related	relate	VBN
cord-005453-4057qib7	4009	11	to	to	IN
cord-005453-4057qib7	4009	12	age	age	NN
cord-005453-4057qib7	4009	13	(	(	-LRB-
cord-005453-4057qib7	4009	14	younger	young	JJR
cord-005453-4057qib7	4009	15	patients	patient	NNS
cord-005453-4057qib7	4009	16	have	have	VBP
cord-005453-4057qib7	4009	17	higher	high	JJR
cord-005453-4057qib7	4009	18	probability	probability	NN
cord-005453-4057qib7	4009	19	to	to	TO
cord-005453-4057qib7	4009	20	develop	develop	VB
cord-005453-4057qib7	4009	21	nausea	nausea	NN
cord-005453-4057qib7	4009	22	(	(	-LRB-
cord-005453-4057qib7	4009	23	OR	or	CC
cord-005453-4057qib7	4009	24	2,282	2,282	CD
cord-005453-4057qib7	4009	25	;	;	:
cord-005453-4057qib7	4009	26	p=	p=	VB
cord-005453-4057qib7	4009	27	0,024	0,024	CD
cord-005453-4057qib7	4009	28	)	)	-RRB-
cord-005453-4057qib7	4010	1	whilst	whilst	IN
cord-005453-4057qib7	4010	2	the	the	DT
cord-005453-4057qib7	4010	3	higher	high	JJR
cord-005453-4057qib7	4010	4	incidence	incidence	NN
cord-005453-4057qib7	4010	5	of	of	IN
cord-005453-4057qib7	4010	6	vomit	vomit	NN
cord-005453-4057qib7	4010	7	is	be	VBZ
cord-005453-4057qib7	4010	8	related	relate	VBN
cord-005453-4057qib7	4010	9	to	to	IN
cord-005453-4057qib7	4010	10	:	:	:
cord-005453-4057qib7	4010	11	Regimen	regimen	NN
cord-005453-4057qib7	4010	12	A	a	NN
cord-005453-4057qib7	4010	13	(	(	-LRB-
cord-005453-4057qib7	4010	14	OR	or	NN
cord-005453-4057qib7	4010	15	3.958	3.958	CD
cord-005453-4057qib7	4010	16	;	;	:
cord-005453-4057qib7	4010	17	p	p	NN
cord-005453-4057qib7	4010	18	<	<	XX
cord-005453-4057qib7	4010	19	0,001	0,001	CD
cord-005453-4057qib7	4010	20	)	)	-RRB-
cord-005453-4057qib7	4010	21	,	,	,
cord-005453-4057qib7	4010	22	previously	previously	RB
cord-005453-4057qib7	4010	23	reported	report	VBD
cord-005453-4057qib7	4010	24	nausea	nausea	NN
cord-005453-4057qib7	4010	25	(	(	-LRB-
cord-005453-4057qib7	4010	26	OR	or	CC
cord-005453-4057qib7	4010	27	4,506	4,506	CD
cord-005453-4057qib7	4010	28	;	;	:
cord-005453-4057qib7	4010	29	p	p	NN
cord-005453-4057qib7	4010	30	<	<	XX
cord-005453-4057qib7	4010	31	0,001	0,001	CD
cord-005453-4057qib7	4010	32	)	)	-RRB-
cord-005453-4057qib7	4010	33	,	,	,
cord-005453-4057qib7	4010	34	and	and	CC
cord-005453-4057qib7	4010	35	no	no	DT
cord-005453-4057qib7	4010	36	smoking	smoking	NN
cord-005453-4057qib7	4010	37	habits	habit	NNS
cord-005453-4057qib7	4010	38	(	(	-LRB-
cord-005453-4057qib7	4010	39	OR	or	CC
cord-005453-4057qib7	4010	40	2,761	2,761	CD
cord-005453-4057qib7	4010	41	;	;	:
cord-005453-4057qib7	4010	42	p=0,02	p=0,02	ADD
cord-005453-4057qib7	4010	43	)	)	-RRB-
cord-005453-4057qib7	4010	44	.	.	.
cord-005453-4057qib7	4011	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4011	2	:	:	:
cord-005453-4057qib7	4012	1	Both	both	DT
cord-005453-4057qib7	4012	2	regimens	regimen	NNS
cord-005453-4057qib7	4012	3	are	be	VBP
cord-005453-4057qib7	4012	4	equally	equally	RB
cord-005453-4057qib7	4012	5	effective	effective	JJ
cord-005453-4057qib7	4012	6	for	for	IN
cord-005453-4057qib7	4012	7	nausea	nausea	NN
cord-005453-4057qib7	4012	8	control	control	NN
cord-005453-4057qib7	4013	1	however	however	RB
cord-005453-4057qib7	4013	2	Regimen	Regimen	NNP
cord-005453-4057qib7	4013	3	B	B	NNP
cord-005453-4057qib7	4013	4	evidenced	evidence	VBD
cord-005453-4057qib7	4013	5	a	a	DT
cord-005453-4057qib7	4013	6	better	well	JJR
cord-005453-4057qib7	4013	7	vomiting	vomiting	NN
cord-005453-4057qib7	4013	8	control	control	NN
cord-005453-4057qib7	4013	9	.	.	.
cord-005453-4057qib7	4014	1	This	this	DT
cord-005453-4057qib7	4014	2	finding	finding	NN
cord-005453-4057qib7	4014	3	is	be	VBZ
cord-005453-4057qib7	4014	4	particularly	particularly	RB
cord-005453-4057qib7	4014	5	relevant	relevant	JJ
cord-005453-4057qib7	4014	6	when	when	WRB
cord-005453-4057qib7	4014	7	the	the	DT
cord-005453-4057qib7	4014	8	Center	Center	NNP
cord-005453-4057qib7	4014	9	policies	policy	NNS
cord-005453-4057qib7	4014	10	include	include	VBP
cord-005453-4057qib7	4014	11	an	an	DT
cord-005453-4057qib7	4014	12	early	early	JJ
cord-005453-4057qib7	4014	13	discharge	discharge	NN
cord-005453-4057qib7	4014	14	program	program	NN
cord-005453-4057qib7	4014	15	,	,	,
cord-005453-4057qib7	4014	16	therefore	therefore	RB
cord-005453-4057qib7	4014	17	improving	improve	VBG
cord-005453-4057qib7	4014	18	both	both	DT
cord-005453-4057qib7	4014	19	patient	patient	NN
cord-005453-4057qib7	4014	20	's	's	POS
cord-005453-4057qib7	4014	21	Quality	Quality	NNP
cord-005453-4057qib7	4014	22	of	of	IN
cord-005453-4057qib7	4014	23	Life	Life	NNP
cord-005453-4057qib7	4014	24	and	and	CC
cord-005453-4057qib7	4014	25	procedure	procedure	NN
cord-005453-4057qib7	4014	26	cost	cost	NN
cord-005453-4057qib7	4014	27	-	-	HYPH
cord-005453-4057qib7	4014	28	effectiveness	effectiveness	NN
cord-005453-4057qib7	4014	29	.	.	.
cord-005453-4057qib7	4015	1	Clinical	clinical	JJ
cord-005453-4057qib7	4015	2	Background	background	NN
cord-005453-4057qib7	4015	3	:	:	:
cord-005453-4057qib7	4016	1	Patients	patient	NNS
cord-005453-4057qib7	4016	2	who	who	WP
cord-005453-4057qib7	4016	3	underwent	undergo	VBD
cord-005453-4057qib7	4016	4	an	an	DT
cord-005453-4057qib7	4016	5	allogeneic	allogeneic	JJ
cord-005453-4057qib7	4016	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4016	7	cell	cell	NN
cord-005453-4057qib7	4016	8	transplantation	transplantation	NN
cord-005453-4057qib7	4016	9	(	(	-LRB-
cord-005453-4057qib7	4016	10	HCT	HCT	NNP
cord-005453-4057qib7	4016	11	)	)	-RRB-
cord-005453-4057qib7	4016	12	are	be	VBP
cord-005453-4057qib7	4016	13	challenged	challenge	VBN
cord-005453-4057qib7	4016	14	by	by	IN
cord-005453-4057qib7	4016	15	medical	medical	JJ
cord-005453-4057qib7	4016	16	,	,	,
cord-005453-4057qib7	4016	17	psychological	psychological	JJ
cord-005453-4057qib7	4016	18	and	and	CC
cord-005453-4057qib7	4016	19	social	social	JJ
cord-005453-4057qib7	4016	20	complications	complication	NNS
cord-005453-4057qib7	4016	21	.	.	.
cord-005453-4057qib7	4017	1	Support	support	NN
cord-005453-4057qib7	4017	2	groups	group	NNS
cord-005453-4057qib7	4017	3	might	may	MD
cord-005453-4057qib7	4017	4	help	help	VB
cord-005453-4057qib7	4017	5	HCT	hct	NN
cord-005453-4057qib7	4017	6	-	-	HYPH
cord-005453-4057qib7	4017	7	survivors	survivor	NNS
cord-005453-4057qib7	4017	8	to	to	TO
cord-005453-4057qib7	4017	9	cope	cope	VB
cord-005453-4057qib7	4017	10	with	with	IN
cord-005453-4057qib7	4017	11	these	these	DT
cord-005453-4057qib7	4017	12	challenges	challenge	NNS
cord-005453-4057qib7	4017	13	.	.	.
cord-005453-4057qib7	4018	1	However	however	RB
cord-005453-4057qib7	4018	2	,	,	,
cord-005453-4057qib7	4018	3	the	the	DT
cord-005453-4057qib7	4018	4	existing	exist	VBG
cord-005453-4057qib7	4018	5	literature	literature	NN
cord-005453-4057qib7	4018	6	about	about	IN
cord-005453-4057qib7	4018	7	post	post	JJ
cord-005453-4057qib7	4018	8	-	-	JJ
cord-005453-4057qib7	4018	9	HCT	hct	JJ
cord-005453-4057qib7	4018	10	support	support	NN
cord-005453-4057qib7	4018	11	groups	group	NNS
cord-005453-4057qib7	4018	12	is	be	VBZ
cord-005453-4057qib7	4018	13	scarce	scarce	JJ
cord-005453-4057qib7	4018	14	.	.	.
cord-005453-4057qib7	4019	1	Moreover	moreover	RB
cord-005453-4057qib7	4019	2	,	,	,
cord-005453-4057qib7	4019	3	data	datum	NNS
cord-005453-4057qib7	4019	4	on	on	IN
cord-005453-4057qib7	4019	5	professionallyfacilitated	professionallyfacilitated	JJ
cord-005453-4057qib7	4019	6	support	support	NN
cord-005453-4057qib7	4019	7	groups	group	NNS
cord-005453-4057qib7	4019	8	do	do	VBP
cord-005453-4057qib7	4019	9	not	not	RB
cord-005453-4057qib7	4019	10	exist	exist	VB
cord-005453-4057qib7	4019	11	.	.	.
cord-005453-4057qib7	4020	1	The	the	DT
cord-005453-4057qib7	4020	2	aim	aim	NN
cord-005453-4057qib7	4020	3	of	of	IN
cord-005453-4057qib7	4020	4	this	this	DT
cord-005453-4057qib7	4020	5	project	project	NN
cord-005453-4057qib7	4020	6	was	be	VBD
cord-005453-4057qib7	4020	7	(	(	-LRB-
cord-005453-4057qib7	4020	8	1	1	CD
cord-005453-4057qib7	4020	9	)	)	-RRB-
cord-005453-4057qib7	4020	10	to	to	TO
cord-005453-4057qib7	4020	11	establish	establish	VB
cord-005453-4057qib7	4020	12	a	a	DT
cord-005453-4057qib7	4020	13	professionally	professionally	RB
cord-005453-4057qib7	4020	14	-	-	HYPH
cord-005453-4057qib7	4020	15	facilitated	facilitate	VBN
cord-005453-4057qib7	4020	16	support	support	NN
cord-005453-4057qib7	4020	17	group	group	NN
cord-005453-4057qib7	4020	18	and	and	CC
cord-005453-4057qib7	4020	19	(	(	-LRB-
cord-005453-4057qib7	4020	20	2	2	LS
cord-005453-4057qib7	4020	21	)	)	-RRB-
cord-005453-4057qib7	4020	22	to	to	TO
cord-005453-4057qib7	4020	23	assess	assess	VB
cord-005453-4057qib7	4020	24	the	the	DT
cord-005453-4057qib7	4020	25	discussed	discuss	VBN
cord-005453-4057qib7	4020	26	topics	topic	NNS
cord-005453-4057qib7	4020	27	.	.	.
cord-005453-4057qib7	4021	1	Methods	method	NNS
cord-005453-4057qib7	4021	2	:	:	:
cord-005453-4057qib7	4022	1	From	from	IN
cord-005453-4057qib7	4022	2	11/2013	11/2013	CD
cord-005453-4057qib7	4022	3	until	until	IN
cord-005453-4057qib7	4022	4	6/2017	6/2017	NNP
cord-005453-4057qib7	4022	5	all	all	DT
cord-005453-4057qib7	4022	6	patients	patient	NNS
cord-005453-4057qib7	4022	7	who	who	WP
cord-005453-4057qib7	4022	8	received	receive	VBD
cord-005453-4057qib7	4022	9	an	an	DT
cord-005453-4057qib7	4022	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	4022	11	HCT	hct	NN
cord-005453-4057qib7	4022	12	at	at	IN
cord-005453-4057qib7	4022	13	the	the	DT
cord-005453-4057qib7	4022	14	adult	adult	NN
cord-005453-4057qib7	4022	15	stem	stem	NN
cord-005453-4057qib7	4022	16	cell	cell	NN
cord-005453-4057qib7	4022	17	transplantation	transplantation	NN
cord-005453-4057qib7	4022	18	program	program	NN
cord-005453-4057qib7	4022	19	of	of	IN
cord-005453-4057qib7	4022	20	the	the	DT
cord-005453-4057qib7	4022	21	University	University	NNP
cord-005453-4057qib7	4022	22	clinic	clinic	NN
cord-005453-4057qib7	4022	23	Mannheim	Mannheim	NNP
cord-005453-4057qib7	4022	24	were	be	VBD
cord-005453-4057qib7	4022	25	invited	invite	VBN
cord-005453-4057qib7	4022	26	to	to	TO
cord-005453-4057qib7	4022	27	participate	participate	VB
cord-005453-4057qib7	4022	28	in	in	IN
cord-005453-4057qib7	4022	29	a	a	DT
cord-005453-4057qib7	4022	30	professionally	professionally	RB
cord-005453-4057qib7	4022	31	-	-	HYPH
cord-005453-4057qib7	4022	32	facilitated	facilitate	VBN
cord-005453-4057qib7	4022	33	support	support	NN
cord-005453-4057qib7	4022	34	group	group	NN
cord-005453-4057qib7	4022	35	.	.	.
cord-005453-4057qib7	4023	1	Additionally	additionally	RB
cord-005453-4057qib7	4023	2	,	,	,
cord-005453-4057qib7	4023	3	spouses	spouse	NNS
cord-005453-4057qib7	4023	4	and	and	CC
cord-005453-4057qib7	4023	5	life	life	NN
cord-005453-4057qib7	4023	6	partners	partner	NNS
cord-005453-4057qib7	4023	7	were	be	VBD
cord-005453-4057qib7	4023	8	invited	invite	VBN
cord-005453-4057qib7	4023	9	.	.	.
cord-005453-4057qib7	4024	1	A	a	DT
cord-005453-4057qib7	4024	2	theologian	theologian	NN
cord-005453-4057qib7	4024	3	who	who	WP
cord-005453-4057qib7	4024	4	is	be	VBZ
cord-005453-4057qib7	4024	5	also	also	RB
cord-005453-4057qib7	4024	6	a	a	DT
cord-005453-4057qib7	4024	7	physician	physician	NN
cord-005453-4057qib7	4024	8	served	serve	VBD
cord-005453-4057qib7	4024	9	as	as	IN
cord-005453-4057qib7	4024	10	facilitator	facilitator	NN
cord-005453-4057qib7	4024	11	.	.	.
cord-005453-4057qib7	4025	1	He	-PRON-	PRP
cord-005453-4057qib7	4025	2	had	have	VBD
cord-005453-4057qib7	4025	3	no	no	DT
cord-005453-4057qib7	4025	4	further	further	JJ
cord-005453-4057qib7	4025	5	function	function	NN
cord-005453-4057qib7	4025	6	within	within	IN
cord-005453-4057qib7	4025	7	the	the	DT
cord-005453-4057qib7	4025	8	transplant	transplant	NN
cord-005453-4057qib7	4025	9	team	team	NN
cord-005453-4057qib7	4025	10	.	.	.
cord-005453-4057qib7	4026	1	The	the	DT
cord-005453-4057qib7	4026	2	format	format	NN
cord-005453-4057qib7	4026	3	of	of	IN
cord-005453-4057qib7	4026	4	the	the	DT
cord-005453-4057qib7	4026	5	group	group	NN
cord-005453-4057qib7	4026	6	was	be	VBD
cord-005453-4057qib7	4026	7	unstructured	unstructured	JJ
cord-005453-4057qib7	4026	8	without	without	IN
cord-005453-4057qib7	4026	9	any	any	DT
cord-005453-4057qib7	4026	10	rules	rule	NNS
cord-005453-4057qib7	4026	11	regarding	regard	VBG
cord-005453-4057qib7	4026	12	regular	regular	JJ
cord-005453-4057qib7	4026	13	attendance	attendance	NN
cord-005453-4057qib7	4026	14	.	.	.
cord-005453-4057qib7	4027	1	The	the	DT
cord-005453-4057qib7	4027	2	facilitator	facilitator	NN
cord-005453-4057qib7	4027	3	did	do	VBD
cord-005453-4057qib7	4027	4	not	not	RB
cord-005453-4057qib7	4027	5	provide	provide	VB
cord-005453-4057qib7	4027	6	topics	topic	NNS
cord-005453-4057qib7	4027	7	or	or	CC
cord-005453-4057qib7	4027	8	a	a	DT
cord-005453-4057qib7	4027	9	curriculum	curriculum	NN
cord-005453-4057qib7	4027	10	.	.	.
cord-005453-4057qib7	4028	1	During	during	IN
cord-005453-4057qib7	4028	2	the	the	DT
cord-005453-4057qib7	4028	3	first	first	JJ
cord-005453-4057qib7	4028	4	year	year	NN
cord-005453-4057qib7	4028	5	the	the	DT
cord-005453-4057qib7	4028	6	group	group	NN
cord-005453-4057qib7	4028	7	met	meet	VBD
cord-005453-4057qib7	4028	8	every	every	DT
cord-005453-4057qib7	4028	9	14	14	CD
cord-005453-4057qib7	4028	10	days	day	NNS
cord-005453-4057qib7	4028	11	followed	follow	VBN
cord-005453-4057qib7	4028	12	by	by	IN
cord-005453-4057qib7	4028	13	a	a	DT
cord-005453-4057qib7	4028	14	monthly	monthly	JJ
cord-005453-4057qib7	4028	15	schedule	schedule	NN
cord-005453-4057qib7	4028	16	.	.	.
cord-005453-4057qib7	4029	1	From	from	IN
cord-005453-4057qib7	4029	2	the	the	DT
cord-005453-4057qib7	4029	3	fifth	fifth	NN
cord-005453-4057qib7	4029	4	until	until	IN
cord-005453-4057qib7	4029	5	the	the	DT
cord-005453-4057qib7	4029	6	39th	39th	JJ
cord-005453-4057qib7	4029	7	meeting	meeting	NN
cord-005453-4057qib7	4029	8	the	the	DT
cord-005453-4057qib7	4029	9	attendance	attendance	NN
cord-005453-4057qib7	4029	10	and	and	CC
cord-005453-4057qib7	4029	11	the	the	DT
cord-005453-4057qib7	4029	12	discussed	discuss	VBN
cord-005453-4057qib7	4029	13	topics	topic	NNS
cord-005453-4057qib7	4029	14	were	be	VBD
cord-005453-4057qib7	4029	15	minuted	minute	VBN
cord-005453-4057qib7	4029	16	by	by	IN
cord-005453-4057qib7	4029	17	the	the	DT
cord-005453-4057qib7	4029	18	facilitator	facilitator	NN
cord-005453-4057qib7	4029	19	.	.	.
cord-005453-4057qib7	4030	1	The	the	DT
cord-005453-4057qib7	4030	2	content	content	NN
cord-005453-4057qib7	4030	3	of	of	IN
cord-005453-4057qib7	4030	4	the	the	DT
cord-005453-4057qib7	4030	5	minutes	minute	NNS
cord-005453-4057qib7	4030	6	was	be	VBD
cord-005453-4057qib7	4030	7	analysed	analyse	VBN
cord-005453-4057qib7	4030	8	by	by	IN
cord-005453-4057qib7	4030	9	a	a	DT
cord-005453-4057qib7	4030	10	combination	combination	NN
cord-005453-4057qib7	4030	11	of	of	IN
cord-005453-4057qib7	4030	12	an	an	DT
cord-005453-4057qib7	4030	13	inductive	inductive	JJ
cord-005453-4057qib7	4030	14	and	and	CC
cord-005453-4057qib7	4030	15	a	a	DT
cord-005453-4057qib7	4030	16	deductive	deductive	JJ
cord-005453-4057qib7	4030	17	approach	approach	NN
cord-005453-4057qib7	4030	18	.	.	.
cord-005453-4057qib7	4031	1	All	all	DT
cord-005453-4057qib7	4031	2	participants	participant	NNS
cord-005453-4057qib7	4031	3	provided	provide	VBD
cord-005453-4057qib7	4031	4	their	-PRON-	PRP$
cord-005453-4057qib7	4031	5	informed	informed	JJ
cord-005453-4057qib7	4031	6	consent	consent	NN
cord-005453-4057qib7	4031	7	for	for	IN
cord-005453-4057qib7	4031	8	the	the	DT
cord-005453-4057qib7	4031	9	study	study	NN
cord-005453-4057qib7	4031	10	.	.	.
cord-005453-4057qib7	4032	1	Results	result	NNS
cord-005453-4057qib7	4032	2	:	:	:
cord-005453-4057qib7	4033	1	Altogether	altogether	RB
cord-005453-4057qib7	4033	2	23	23	CD
cord-005453-4057qib7	4033	3	patients	patient	NNS
cord-005453-4057qib7	4033	4	(	(	-LRB-
cord-005453-4057qib7	4033	5	female	female	NN
cord-005453-4057qib7	4033	6	:	:	:
cord-005453-4057qib7	4033	7	n=10	n=10	NNP
cord-005453-4057qib7	4033	8	;	;	:
cord-005453-4057qib7	4033	9	male	male	JJ
cord-005453-4057qib7	4033	10	:	:	:
cord-005453-4057qib7	4033	11	n=13	n=13	NNP
cord-005453-4057qib7	4033	12	)	)	-RRB-
cord-005453-4057qib7	4033	13	and	and	CC
cord-005453-4057qib7	4033	14	10	10	CD
cord-005453-4057qib7	4033	15	spouses	spouse	NNS
cord-005453-4057qib7	4033	16	/	/	SYM
cord-005453-4057qib7	4033	17	life	life	NN
cord-005453-4057qib7	4033	18	partners	partner	NNS
cord-005453-4057qib7	4033	19	(	(	-LRB-
cord-005453-4057qib7	4033	20	female	female	JJ
cord-005453-4057qib7	4033	21	:	:	:
cord-005453-4057qib7	4033	22	n=9	n=9	NN
cord-005453-4057qib7	4033	23	;	;	:
cord-005453-4057qib7	4033	24	male	male	JJ
cord-005453-4057qib7	4033	25	:	:	:
cord-005453-4057qib7	4033	26	n=1	n=1	CD
cord-005453-4057qib7	4033	27	)	)	-RRB-
cord-005453-4057qib7	4033	28	participated	participate	VBD
cord-005453-4057qib7	4033	29	.	.	.
cord-005453-4057qib7	4034	1	13	13	CD
cord-005453-4057qib7	4034	2	patients	patient	NNS
cord-005453-4057qib7	4034	3	(	(	-LRB-
cord-005453-4057qib7	4034	4	57	57	CD
cord-005453-4057qib7	4034	5	%	%	NN
cord-005453-4057qib7	4034	6	)	)	-RRB-
cord-005453-4057qib7	4034	7	and	and	CC
cord-005453-4057qib7	4034	8	6	6	CD
cord-005453-4057qib7	4034	9	spouses	spouse	NNS
cord-005453-4057qib7	4034	10	(	(	-LRB-
cord-005453-4057qib7	4034	11	60	60	CD
cord-005453-4057qib7	4034	12	%	%	NN
cord-005453-4057qib7	4034	13	)	)	-RRB-
cord-005453-4057qib7	4034	14	attended	attend	VBD
cord-005453-4057qib7	4034	15	more	more	JJR
cord-005453-4057qib7	4034	16	than	than	IN
cord-005453-4057qib7	4034	17	one	one	CD
cord-005453-4057qib7	4034	18	meeting	meeting	NN
cord-005453-4057qib7	4034	19	.	.	.
cord-005453-4057qib7	4035	1	Among	among	IN
cord-005453-4057qib7	4035	2	those	those	DT
cord-005453-4057qib7	4035	3	who	who	WP
cord-005453-4057qib7	4035	4	participated	participate	VBD
cord-005453-4057qib7	4035	5	in	in	IN
cord-005453-4057qib7	4035	6	≥2	≥2	NNP
cord-005453-4057qib7	4035	7	meetings	meeting	NNS
cord-005453-4057qib7	4035	8	the	the	DT
cord-005453-4057qib7	4035	9	median	median	JJ
cord-005453-4057qib7	4035	10	time	time	NN
cord-005453-4057qib7	4035	11	of	of	IN
cord-005453-4057qib7	4035	12	participation	participation	NN
cord-005453-4057qib7	4035	13	was	be	VBD
cord-005453-4057qib7	4035	14	16	16	CD
cord-005453-4057qib7	4035	15	months	month	NNS
cord-005453-4057qib7	4035	16	.	.	.
cord-005453-4057qib7	4036	1	The	the	DT
cord-005453-4057qib7	4036	2	median	median	JJ
cord-005453-4057qib7	4036	3	count	count	NN
cord-005453-4057qib7	4036	4	of	of	IN
cord-005453-4057qib7	4036	5	participations	participation	NNS
cord-005453-4057qib7	4036	6	was	be	VBD
cord-005453-4057qib7	4036	7	eight	eight	CD
cord-005453-4057qib7	4036	8	.	.	.
cord-005453-4057qib7	4037	1	30	30	CD
cord-005453-4057qib7	4037	2	%	%	NN
cord-005453-4057qib7	4037	3	of	of	IN
cord-005453-4057qib7	4037	4	the	the	DT
cord-005453-4057qib7	4037	5	participants	participant	NNS
cord-005453-4057qib7	4037	6	attended	attend	VBD
cord-005453-4057qib7	4037	7	the	the	DT
cord-005453-4057qib7	4037	8	meetings	meeting	NNS
cord-005453-4057qib7	4037	9	longer	long	RBR
cord-005453-4057qib7	4037	10	than	than	IN
cord-005453-4057qib7	4037	11	one	one	CD
cord-005453-4057qib7	4037	12	year	year	NN
cord-005453-4057qib7	4037	13	,	,	,
cord-005453-4057qib7	4037	14	9	9	CD
cord-005453-4057qib7	4037	15	%	%	NN
cord-005453-4057qib7	4037	16	longer	long	JJR
cord-005453-4057qib7	4037	17	than	than	IN
cord-005453-4057qib7	4037	18	three	three	CD
cord-005453-4057qib7	4037	19	years	year	NNS
cord-005453-4057qib7	4037	20	.	.	.
cord-005453-4057qib7	4038	1	There	there	EX
cord-005453-4057qib7	4038	2	was	be	VBD
cord-005453-4057qib7	4038	3	no	no	DT
cord-005453-4057qib7	4038	4	sex	sex	NN
cord-005453-4057qib7	4038	5	difference	difference	NN
cord-005453-4057qib7	4038	6	with	with	IN
cord-005453-4057qib7	4038	7	respect	respect	NN
cord-005453-4057qib7	4038	8	to	to	IN
cord-005453-4057qib7	4038	9	the	the	DT
cord-005453-4057qib7	4038	10	frequency	frequency	NN
cord-005453-4057qib7	4038	11	and	and	CC
cord-005453-4057qib7	4038	12	the	the	DT
cord-005453-4057qib7	4038	13	duration	duration	NN
cord-005453-4057qib7	4038	14	of	of	IN
cord-005453-4057qib7	4038	15	participation	participation	NN
cord-005453-4057qib7	4038	16	.	.	.
cord-005453-4057qib7	4039	1	However	however	RB
cord-005453-4057qib7	4039	2	,	,	,
cord-005453-4057qib7	4039	3	the	the	DT
cord-005453-4057qib7	4039	4	frequency	frequency	NN
cord-005453-4057qib7	4039	5	of	of	IN
cord-005453-4057qib7	4039	6	participation	participation	NN
cord-005453-4057qib7	4039	7	decreased	decrease	VBD
cord-005453-4057qib7	4039	8	significantly	significantly	RB
cord-005453-4057qib7	4039	9	the	the	DT
cord-005453-4057qib7	4039	10	longer	long	RBR
cord-005453-4057qib7	4039	11	a	a	DT
cord-005453-4057qib7	4039	12	participant	participant	NN
cord-005453-4057qib7	4039	13	was	be	VBD
cord-005453-4057qib7	4039	14	attending	attend	VBG
cord-005453-4057qib7	4039	15	the	the	DT
cord-005453-4057qib7	4039	16	meetings	meeting	NNS
cord-005453-4057qib7	4039	17	.	.	.
cord-005453-4057qib7	4040	1	During	during	IN
cord-005453-4057qib7	4040	2	35	35	CD
cord-005453-4057qib7	4040	3	group	group	NN
cord-005453-4057qib7	4040	4	meetings	meeting	NNS
cord-005453-4057qib7	4040	5	the	the	DT
cord-005453-4057qib7	4040	6	facilitator	facilitator	NN
cord-005453-4057qib7	4040	7	recorded	record	VBD
cord-005453-4057qib7	4040	8	5138	5138	CD
cord-005453-4057qib7	4040	9	thematically	thematically	RB
cord-005453-4057qib7	4040	10	different	different	JJ
cord-005453-4057qib7	4040	11	contributions	contribution	NNS
cord-005453-4057qib7	4040	12	to	to	IN
cord-005453-4057qib7	4040	13	the	the	DT
cord-005453-4057qib7	4040	14	discussions	discussion	NNS
cord-005453-4057qib7	4040	15	divided	divide	VBN
cord-005453-4057qib7	4040	16	in	in	IN
cord-005453-4057qib7	4040	17	37	37	CD
cord-005453-4057qib7	4040	18	distinct	distinct	JJ
cord-005453-4057qib7	4040	19	topics	topic	NNS
cord-005453-4057qib7	4040	20	.	.	.
cord-005453-4057qib7	4041	1	These	these	DT
cord-005453-4057qib7	4041	2	topics	topic	NNS
cord-005453-4057qib7	4041	3	were	be	VBD
cord-005453-4057qib7	4041	4	grouped	group	VBN
cord-005453-4057qib7	4041	5	into	into	IN
cord-005453-4057qib7	4041	6	5	5	CD
cord-005453-4057qib7	4041	7	main	main	JJ
cord-005453-4057qib7	4041	8	categories	category	NNS
cord-005453-4057qib7	4041	9	[	[	-LRB-
cord-005453-4057qib7	4041	10	(	(	-LRB-
cord-005453-4057qib7	4041	11	a	a	DT
cord-005453-4057qib7	4041	12	)	)	-RRB-
cord-005453-4057qib7	4041	13	medical	medical	JJ
cord-005453-4057qib7	4041	14	topics	topic	NNS
cord-005453-4057qib7	4041	15	,	,	,
cord-005453-4057qib7	4041	16	(	(	-LRB-
cord-005453-4057qib7	4041	17	b	b	LS
cord-005453-4057qib7	4041	18	)	)	-RRB-
cord-005453-4057qib7	4041	19	private	private	JJ
cord-005453-4057qib7	4041	20	life	life	NN
cord-005453-4057qib7	4041	21	and	and	CC
cord-005453-4057qib7	4041	22	environment	environment	NN
cord-005453-4057qib7	4041	23	,	,	,
cord-005453-4057qib7	4041	24	(	(	-LRB-
cord-005453-4057qib7	4041	25	c	c	NN
cord-005453-4057qib7	4041	26	)	)	-RRB-
cord-005453-4057qib7	4041	27	human	human	JJ
cord-005453-4057qib7	4041	28	relationships	relationship	NNS
cord-005453-4057qib7	4041	29	,	,	,
cord-005453-4057qib7	4041	30	(	(	-LRB-
cord-005453-4057qib7	4041	31	d	d	LS
cord-005453-4057qib7	4041	32	)	)	-RRB-
cord-005453-4057qib7	4041	33	physical	physical	JJ
cord-005453-4057qib7	4041	34	and	and	CC
cord-005453-4057qib7	4041	35	mental	mental	JJ
cord-005453-4057qib7	4041	36	condition	condition	NN
cord-005453-4057qib7	4041	37	and	and	CC
cord-005453-4057qib7	4041	38	(	(	-LRB-
cord-005453-4057qib7	4041	39	e	e	LS
cord-005453-4057qib7	4041	40	)	)	-RRB-
cord-005453-4057qib7	4041	41	the	the	DT
cord-005453-4057qib7	4041	42	support	support	NN
cord-005453-4057qib7	4041	43	group	group	NN
cord-005453-4057qib7	4041	44	itself	-PRON-	PRP
cord-005453-4057qib7	4041	45	]	]	-RRB-
cord-005453-4057qib7	4041	46	and	and	CC
cord-005453-4057qib7	4041	47	eight	eight	CD
cord-005453-4057qib7	4041	48	further	further	JJ
cord-005453-4057qib7	4041	49	categories	category	NNS
cord-005453-4057qib7	4041	50	[	[	-LRB-
cord-005453-4057qib7	4041	51	(	(	-LRB-
cord-005453-4057qib7	4041	52	1	1	CD
cord-005453-4057qib7	4041	53	)	)	-RRB-
cord-005453-4057qib7	4041	54	compliance	compliance	NN
cord-005453-4057qib7	4041	55	,	,	,
cord-005453-4057qib7	4041	56	(	(	-LRB-
cord-005453-4057qib7	4041	57	2	2	LS
cord-005453-4057qib7	4041	58	)	)	-RRB-
cord-005453-4057qib7	4041	59	economic	economic	JJ
cord-005453-4057qib7	4041	60	issues	issue	NNS
cord-005453-4057qib7	4041	61	,	,	,
cord-005453-4057qib7	4041	62	(	(	-LRB-
cord-005453-4057qib7	4041	63	3	3	LS
cord-005453-4057qib7	4041	64	)	)	-RRB-
cord-005453-4057qib7	4041	65	religion	religion	NN
cord-005453-4057qib7	4041	66	,	,	,
cord-005453-4057qib7	4041	67	(	(	-LRB-
cord-005453-4057qib7	4041	68	4	4	LS
cord-005453-4057qib7	4041	69	)	)	-RRB-
cord-005453-4057qib7	4041	70	sexuality	sexuality	NN
cord-005453-4057qib7	4041	71	,	,	,
cord-005453-4057qib7	4041	72	(	(	-LRB-
cord-005453-4057qib7	4041	73	5	5	LS
cord-005453-4057qib7	4041	74	)	)	-RRB-
cord-005453-4057qib7	4041	75	death	death	NN
cord-005453-4057qib7	4041	76	and	and	CC
cord-005453-4057qib7	4041	77	dying	dying	NN
cord-005453-4057qib7	4041	78	,	,	,
cord-005453-4057qib7	4041	79	(	(	-LRB-
cord-005453-4057qib7	4041	80	6	6	CD
cord-005453-4057qib7	4041	81	)	)	-RRB-
cord-005453-4057qib7	4041	82	support	support	NN
cord-005453-4057qib7	4041	83	and	and	CC
cord-005453-4057qib7	4041	84	coping	coping	NN
cord-005453-4057qib7	4041	85	,	,	,
cord-005453-4057qib7	4041	86	(	(	-LRB-
cord-005453-4057qib7	4041	87	7	7	CD
cord-005453-4057qib7	4041	88	)	)	-RRB-
cord-005453-4057qib7	4041	89	objectives	objective	NNS
cord-005453-4057qib7	4041	90	and	and	CC
cord-005453-4057qib7	4041	91	needs	need	NNS
cord-005453-4057qib7	4042	1	and	and	CC
cord-005453-4057qib7	4042	2	(	(	-LRB-
cord-005453-4057qib7	4042	3	8)	8)	MD
cord-005453-4057qib7	4042	4	not	not	RB
cord-005453-4057qib7	4042	5	otherwise	otherwise	RB
cord-005453-4057qib7	4042	6	specified	specify	VBN
cord-005453-4057qib7	4042	7	issues	issue	NNS
cord-005453-4057qib7	4042	8	]	]	-RRB-
cord-005453-4057qib7	4042	9	which	which	WDT
cord-005453-4057qib7	4042	10	could	could	MD
cord-005453-4057qib7	4042	11	not	not	RB
cord-005453-4057qib7	4042	12	be	be	VB
cord-005453-4057qib7	4042	13	grouped	group	VBN
cord-005453-4057qib7	4042	14	in	in	IN
cord-005453-4057qib7	4042	15	one	one	CD
cord-005453-4057qib7	4042	16	of	of	IN
cord-005453-4057qib7	4042	17	the	the	DT
cord-005453-4057qib7	4042	18	main	main	JJ
cord-005453-4057qib7	4042	19	categories	category	NNS
cord-005453-4057qib7	4042	20	.	.	.
cord-005453-4057qib7	4043	1	The	the	DT
cord-005453-4057qib7	4043	2	most	most	RBS
cord-005453-4057qib7	4043	3	frequent	frequent	JJ
cord-005453-4057qib7	4043	4	issues	issue	NNS
cord-005453-4057qib7	4043	5	were	be	VBD
cord-005453-4057qib7	4043	6	medical	medical	JJ
cord-005453-4057qib7	4043	7	topics	topic	NNS
cord-005453-4057qib7	4043	8	(	(	-LRB-
cord-005453-4057qib7	4043	9	34	34	CD
cord-005453-4057qib7	4043	10	%	%	NN
cord-005453-4057qib7	4043	11	)	)	-RRB-
cord-005453-4057qib7	4043	12	,	,	,
cord-005453-4057qib7	4043	13	human	human	JJ
cord-005453-4057qib7	4043	14	relationships	relationship	NNS
cord-005453-4057qib7	4043	15	(	(	-LRB-
cord-005453-4057qib7	4043	16	16	16	CD
cord-005453-4057qib7	4043	17	%	%	NN
cord-005453-4057qib7	4043	18	)	)	-RRB-
cord-005453-4057qib7	4043	19	,	,	,
cord-005453-4057qib7	4043	20	physical	physical	JJ
cord-005453-4057qib7	4043	21	and	and	CC
cord-005453-4057qib7	4043	22	mental	mental	JJ
cord-005453-4057qib7	4043	23	condition	condition	NN
cord-005453-4057qib7	4043	24	(	(	-LRB-
cord-005453-4057qib7	4043	25	15	15	CD
cord-005453-4057qib7	4043	26	%	%	NN
cord-005453-4057qib7	4043	27	)	)	-RRB-
cord-005453-4057qib7	4043	28	,	,	,
cord-005453-4057qib7	4043	29	private	private	JJ
cord-005453-4057qib7	4043	30	life	life	NN
cord-005453-4057qib7	4043	31	and	and	CC
cord-005453-4057qib7	4043	32	environment	environment	NN
cord-005453-4057qib7	4043	33	(	(	-LRB-
cord-005453-4057qib7	4043	34	14	14	CD
cord-005453-4057qib7	4043	35	%	%	NN
cord-005453-4057qib7	4043	36	)	)	-RRB-
cord-005453-4057qib7	4043	37	,	,	,
cord-005453-4057qib7	4043	38	financial	financial	JJ
cord-005453-4057qib7	4043	39	issues	issue	NNS
cord-005453-4057qib7	4043	40	(	(	-LRB-
cord-005453-4057qib7	4043	41	5	5	CD
cord-005453-4057qib7	4043	42	%	%	NN
cord-005453-4057qib7	4043	43	)	)	-RRB-
cord-005453-4057qib7	4043	44	,	,	,
cord-005453-4057qib7	4043	45	the	the	DT
cord-005453-4057qib7	4043	46	support	support	NN
cord-005453-4057qib7	4043	47	group	group	NN
cord-005453-4057qib7	4043	48	itself	-PRON-	PRP
cord-005453-4057qib7	4043	49	(	(	-LRB-
cord-005453-4057qib7	4043	50	4	4	CD
cord-005453-4057qib7	4043	51	%	%	NN
cord-005453-4057qib7	4043	52	)	)	-RRB-
cord-005453-4057qib7	4043	53	,	,	,
cord-005453-4057qib7	4043	54	support	support	NN
cord-005453-4057qib7	4043	55	and	and	CC
cord-005453-4057qib7	4043	56	coping	coping	NN
cord-005453-4057qib7	4043	57	(	(	-LRB-
cord-005453-4057qib7	4043	58	4	4	CD
cord-005453-4057qib7	4043	59	%	%	NN
cord-005453-4057qib7	4043	60	)	)	-RRB-
cord-005453-4057qib7	4043	61	and	and	CC
cord-005453-4057qib7	4043	62	objectives	objective	NNS
cord-005453-4057qib7	4043	63	and	and	CC
cord-005453-4057qib7	4043	64	needs	need	NNS
cord-005453-4057qib7	4043	65	(	(	-LRB-
cord-005453-4057qib7	4043	66	4	4	CD
cord-005453-4057qib7	4043	67	%	%	NN
cord-005453-4057qib7	4043	68	)	)	-RRB-
cord-005453-4057qib7	4043	69	.	.	.
cord-005453-4057qib7	4044	1	Noteworthy	noteworthy	JJ
cord-005453-4057qib7	4044	2	,	,	,
cord-005453-4057qib7	4044	3	death	death	NN
cord-005453-4057qib7	4044	4	and	and	CC
cord-005453-4057qib7	4044	5	dying	dying	NN
cord-005453-4057qib7	4044	6	(	(	-LRB-
cord-005453-4057qib7	4044	7	0.5	0.5	CD
cord-005453-4057qib7	4044	8	%	%	NN
cord-005453-4057qib7	4044	9	)	)	-RRB-
cord-005453-4057qib7	4044	10	were	be	VBD
cord-005453-4057qib7	4044	11	rare	rare	JJ
cord-005453-4057qib7	4044	12	topics	topic	NNS
cord-005453-4057qib7	4044	13	and	and	CC
cord-005453-4057qib7	4044	14	sexuality	sexuality	NN
cord-005453-4057qib7	4044	15	was	be	VBD
cord-005453-4057qib7	4044	16	never	never	RB
cord-005453-4057qib7	4044	17	mentioned	mention	VBN
cord-005453-4057qib7	4044	18	.	.	.
cord-005453-4057qib7	4045	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4045	2	:	:	:
cord-005453-4057qib7	4046	1	To	to	IN
cord-005453-4057qib7	4046	2	our	-PRON-	PRP$
cord-005453-4057qib7	4046	3	knowledge	knowledge	NN
cord-005453-4057qib7	4046	4	,	,	,
cord-005453-4057qib7	4046	5	this	this	DT
cord-005453-4057qib7	4046	6	is	be	VBZ
cord-005453-4057qib7	4046	7	the	the	DT
cord-005453-4057qib7	4046	8	first	first	JJ
cord-005453-4057qib7	4046	9	prospective	prospective	JJ
cord-005453-4057qib7	4046	10	and	and	CC
cord-005453-4057qib7	4046	11	systematic	systematic	JJ
cord-005453-4057qib7	4046	12	analysis	analysis	NN
cord-005453-4057qib7	4046	13	of	of	IN
cord-005453-4057qib7	4046	14	a	a	DT
cord-005453-4057qib7	4046	15	professionallyfacilitated	professionallyfacilitated	JJ
cord-005453-4057qib7	4046	16	support	support	NN
cord-005453-4057qib7	4046	17	group	group	NN
cord-005453-4057qib7	4046	18	for	for	IN
cord-005453-4057qib7	4046	19	HCT	hct	NN
cord-005453-4057qib7	4046	20	-	-	HYPH
cord-005453-4057qib7	4046	21	survivors	survivor	NNS
cord-005453-4057qib7	4046	22	.	.	.
cord-005453-4057qib7	4047	1	These	these	DT
cord-005453-4057qib7	4047	2	data	datum	NNS
cord-005453-4057qib7	4047	3	might	may	MD
cord-005453-4057qib7	4047	4	help	help	VB
cord-005453-4057qib7	4047	5	to	to	TO
cord-005453-4057qib7	4047	6	establish	establish	VB
cord-005453-4057qib7	4047	7	support	support	NN
cord-005453-4057qib7	4047	8	groups	group	NNS
cord-005453-4057qib7	4047	9	and	and	CC
cord-005453-4057qib7	4047	10	to	to	TO
cord-005453-4057qib7	4047	11	identify	identify	VB
cord-005453-4057qib7	4047	12	psychosocial	psychosocial	JJ
cord-005453-4057qib7	4047	13	needs	need	NNS
cord-005453-4057qib7	4047	14	of	of	IN
cord-005453-4057qib7	4047	15	patients	patient	NNS
cord-005453-4057qib7	4047	16	and	and	CC
cord-005453-4057qib7	4047	17	targets	target	NNS
cord-005453-4057qib7	4047	18	for	for	IN
cord-005453-4057qib7	4047	19	specific	specific	JJ
cord-005453-4057qib7	4047	20	support	support	NN
cord-005453-4057qib7	4047	21	.	.	.
cord-005453-4057qib7	4048	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4048	2	:	:	:
cord-005453-4057qib7	4048	3	Nothing	nothing	NN
cord-005453-4057qib7	4048	4	to	to	TO
cord-005453-4057qib7	4048	5	declare	declare	VB
cord-005453-4057qib7	4048	6	Background	background	NN
cord-005453-4057qib7	4048	7	:	:	:
cord-005453-4057qib7	4048	8	Endothelial	endothelial	JJ
cord-005453-4057qib7	4048	9	damage	damage	NN
cord-005453-4057qib7	4048	10	is	be	VBZ
cord-005453-4057qib7	4048	11	associated	associate	VBN
cord-005453-4057qib7	4048	12	with	with	IN
cord-005453-4057qib7	4048	13	inflammatory	inflammatory	JJ
cord-005453-4057qib7	4048	14	complications	complication	NNS
cord-005453-4057qib7	4048	15	that	that	WDT
cord-005453-4057qib7	4048	16	appear	appear	VBP
cord-005453-4057qib7	4048	17	early	early	RB
cord-005453-4057qib7	4048	18	after	after	IN
cord-005453-4057qib7	4048	19	HSCT	HSCT	NNP
cord-005453-4057qib7	4048	20	,	,	,
cord-005453-4057qib7	4048	21	such	such	JJ
cord-005453-4057qib7	4048	22	as	as	IN
cord-005453-4057qib7	4048	23	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	4048	24	obstruction	obstruction	NN
cord-005453-4057qib7	4048	25	syndrome	syndrome	NN
cord-005453-4057qib7	4048	26	or	or	CC
cord-005453-4057qib7	4048	27	acute	acute	JJ
cord-005453-4057qib7	4048	28	GVHD	GVHD	NNP
cord-005453-4057qib7	4048	29	.	.	.
cord-005453-4057qib7	4049	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	4049	2	syndrome	syndrome	NN
cord-005453-4057qib7	4049	3	(	(	-LRB-
cord-005453-4057qib7	4049	4	ES	ES	NNP
cord-005453-4057qib7	4049	5	)	)	-RRB-
cord-005453-4057qib7	4049	6	is	be	VBZ
cord-005453-4057qib7	4049	7	an	an	DT
cord-005453-4057qib7	4049	8	inflammatory	inflammatory	JJ
cord-005453-4057qib7	4049	9	condition	condition	NN
cord-005453-4057qib7	4049	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	4049	11	by	by	IN
cord-005453-4057qib7	4049	12	Maiolino	Maiolino	NNP
cord-005453-4057qib7	4049	13	clinical	clinical	JJ
cord-005453-4057qib7	4049	14	score	score	NN
cord-005453-4057qib7	4049	15	.	.	.
cord-005453-4057qib7	4050	1	Potentially	potentially	RB
cord-005453-4057qib7	4050	2	,	,	,
cord-005453-4057qib7	4050	3	ES	ES	NNP
cord-005453-4057qib7	4050	4	can	can	MD
cord-005453-4057qib7	4050	5	exhibit	exhibit	VB
cord-005453-4057qib7	4050	6	high	high	JJ
cord-005453-4057qib7	4050	7	morbidity	morbidity	NN
cord-005453-4057qib7	4050	8	and	and	CC
cord-005453-4057qib7	4050	9	mortality	mortality	NN
cord-005453-4057qib7	4050	10	,	,	,
cord-005453-4057qib7	4050	11	especially	especially	RB
cord-005453-4057qib7	4050	12	after	after	IN
cord-005453-4057qib7	4050	13	autologous	autologous	JJ
cord-005453-4057qib7	4050	14	-	-	HYPH
cord-005453-4057qib7	4050	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4050	16	in	in	IN
cord-005453-4057qib7	4050	17	multiple	multiple	JJ
cord-005453-4057qib7	4050	18	myeloma	myeloma	NN
cord-005453-4057qib7	4050	19	(	(	-LRB-
cord-005453-4057qib7	4050	20	MM	MM	NNP
cord-005453-4057qib7	4050	21	)	)	-RRB-
cord-005453-4057qib7	4050	22	patients	patient	NNS
cord-005453-4057qib7	4050	23	since	since	IN
cord-005453-4057qib7	4050	24	the	the	DT
cord-005453-4057qib7	4050	25	introduction	introduction	NN
cord-005453-4057qib7	4050	26	of	of	IN
cord-005453-4057qib7	4050	27	new	new	JJ
cord-005453-4057qib7	4050	28	drugs	drug	NNS
cord-005453-4057qib7	4050	29	such	such	JJ
cord-005453-4057qib7	4050	30	proteasome	proteasome	VBN
cord-005453-4057qib7	4050	31	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4050	32	and	and	CC
cord-005453-4057qib7	4050	33	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	4050	34	drugs	drug	NNS
cord-005453-4057qib7	4050	35	(	(	-LRB-
cord-005453-4057qib7	4050	36	IMiDs	IMiDs	NNP
cord-005453-4057qib7	4050	37	)	)	-RRB-
cord-005453-4057qib7	4050	38	.	.	.
cord-005453-4057qib7	4051	1	The	the	DT
cord-005453-4057qib7	4051	2	objective	objective	NN
cord-005453-4057qib7	4051	3	of	of	IN
cord-005453-4057qib7	4051	4	the	the	DT
cord-005453-4057qib7	4051	5	present	present	JJ
cord-005453-4057qib7	4051	6	study	study	NN
cord-005453-4057qib7	4051	7	was	be	VBD
cord-005453-4057qib7	4051	8	to	to	TO
cord-005453-4057qib7	4051	9	evaluate	evaluate	VB
cord-005453-4057qib7	4051	10	if	if	IN
cord-005453-4057qib7	4051	11	ES	ES	NNP
cord-005453-4057qib7	4051	12	is	be	VBZ
cord-005453-4057qib7	4051	13	associated	associate	VBN
cord-005453-4057qib7	4051	14	with	with	IN
cord-005453-4057qib7	4051	15	endothelial	endothelial	JJ
cord-005453-4057qib7	4051	16	dysfunction	dysfunction	NN
cord-005453-4057qib7	4051	17	in	in	IN
cord-005453-4057qib7	4051	18	patients	patient	NNS
cord-005453-4057qib7	4051	19	with	with	IN
cord-005453-4057qib7	4051	20	MM	MM	NNP
cord-005453-4057qib7	4051	21	who	who	WP
cord-005453-4057qib7	4051	22	underwent	undergo	VBD
cord-005453-4057qib7	4051	23	auto	auto	NN
cord-005453-4057qib7	4051	24	-	-	HYPH
cord-005453-4057qib7	4051	25	HSCT	HSCT	NNP
cord-005453-4057qib7	4051	26	.	.	.
cord-005453-4057qib7	4052	1	Methods	method	NNS
cord-005453-4057qib7	4053	1	:	:	:
cord-005453-4057qib7	4053	2	We	-PRON-	PRP
cord-005453-4057qib7	4053	3	included	include	VBD
cord-005453-4057qib7	4053	4	six	six	CD
cord-005453-4057qib7	4053	5	patients	patient	NNS
cord-005453-4057qib7	4053	6	with	with	IN
cord-005453-4057qib7	4053	7	MM	MM	NNP
cord-005453-4057qib7	4053	8	who	who	WP
cord-005453-4057qib7	4053	9	received	receive	VBD
cord-005453-4057qib7	4053	10	induction	induction	NN
cord-005453-4057qib7	4053	11	treatment	treatment	NN
cord-005453-4057qib7	4053	12	including	include	VBG
cord-005453-4057qib7	4053	13	new	new	JJ
cord-005453-4057qib7	4053	14	drugs	drug	NNS
cord-005453-4057qib7	4053	15	and	and	CC
cord-005453-4057qib7	4053	16	consolidated	consolidate	VBD
cord-005453-4057qib7	4053	17	their	-PRON-	PRP$
cord-005453-4057qib7	4053	18	response	response	NN
cord-005453-4057qib7	4053	19	with	with	IN
cord-005453-4057qib7	4053	20	an	an	DT
cord-005453-4057qib7	4053	21	autologous	autologous	JJ
cord-005453-4057qib7	4053	22	-	-	HYPH
cord-005453-4057qib7	4053	23	HSCT	HSCT	NNP
cord-005453-4057qib7	4053	24	.	.	.
cord-005453-4057qib7	4054	1	We	-PRON-	PRP
cord-005453-4057qib7	4054	2	analysed	analyse	VBD
cord-005453-4057qib7	4054	3	comparatively	comparatively	RB
cord-005453-4057qib7	4054	4	the	the	DT
cord-005453-4057qib7	4054	5	effect	effect	NN
cord-005453-4057qib7	4054	6	of	of	IN
cord-005453-4057qib7	4054	7	incubating	incubate	VBG
cord-005453-4057qib7	4054	8	endothelial	endothelial	JJ
cord-005453-4057qib7	4054	9	cells	cell	NNS
cord-005453-4057qib7	4054	10	in	in	IN
cord-005453-4057qib7	4054	11	vitro	vitro	FW
cord-005453-4057qib7	4054	12	with	with	IN
cord-005453-4057qib7	4054	13	serum	serum	NN
cord-005453-4057qib7	4054	14	samples	sample	NNS
cord-005453-4057qib7	4054	15	from	from	IN
cord-005453-4057qib7	4054	16	patients	patient	NNS
cord-005453-4057qib7	4054	17	with	with	IN
cord-005453-4057qib7	4054	18	ES	ES	NNP
cord-005453-4057qib7	4054	19	vs.	vs.	FW
cord-005453-4057qib7	4054	20	no	no	DT
cord-005453-4057qib7	4054	21	ES	es	NN
cord-005453-4057qib7	4054	22	.	.	.
cord-005453-4057qib7	4055	1	Serum	serum	NN
cord-005453-4057qib7	4055	2	samples	sample	NNS
cord-005453-4057qib7	4055	3	were	be	VBD
cord-005453-4057qib7	4055	4	collected	collect	VBN
cord-005453-4057qib7	4055	5	before	before	RB
cord-005453-4057qib7	4055	6	(	(	-LRB-
cord-005453-4057qib7	4055	7	PRE	PRE	NNP
cord-005453-4057qib7	4055	8	)	)	-RRB-
cord-005453-4057qib7	4055	9	,	,	,
cord-005453-4057qib7	4055	10	and	and	CC
cord-005453-4057qib7	4055	11	after	after	IN
cord-005453-4057qib7	4055	12	5	5	CD
cord-005453-4057qib7	4055	13	,	,	,
cord-005453-4057qib7	4055	14	7	7	CD
cord-005453-4057qib7	4055	15	,	,	,
cord-005453-4057qib7	4055	16	and	and	CC
cord-005453-4057qib7	4055	17	10	10	CD
cord-005453-4057qib7	4055	18	days	day	NNS
cord-005453-4057qib7	4055	19	from	from	IN
cord-005453-4057qib7	4055	20	the	the	DT
cord-005453-4057qib7	4055	21	transplant	transplant	NN
cord-005453-4057qib7	4055	22	.	.	.
cord-005453-4057qib7	4056	1	An	an	DT
cord-005453-4057qib7	4056	2	additional	additional	JJ
cord-005453-4057qib7	4056	3	sample	sample	NN
cord-005453-4057qib7	4056	4	was	be	VBD
cord-005453-4057qib7	4056	5	collected	collect	VBN
cord-005453-4057qib7	4056	6	at	at	IN
cord-005453-4057qib7	4056	7	the	the	DT
cord-005453-4057qib7	4056	8	ES	ES	NNP
cord-005453-4057qib7	4056	9	onset	onset	NN
cord-005453-4057qib7	4056	10	and	and	CC
cord-005453-4057qib7	4056	11	at	at	IN
cord-005453-4057qib7	4056	12	the	the	DT
cord-005453-4057qib7	4056	13	discharge	discharge	NN
cord-005453-4057qib7	4056	14	day	day	NNP
cord-005453-4057qib7	4056	15	(	(	-LRB-
cord-005453-4057qib7	4056	16	no	no	DT
cord-005453-4057qib7	4056	17	ES	ES	NNP
cord-005453-4057qib7	4056	18	group	group	NN
cord-005453-4057qib7	4056	19	)	)	-RRB-
cord-005453-4057qib7	4056	20	.	.	.
cord-005453-4057qib7	4057	1	Endothelial	endothelial	JJ
cord-005453-4057qib7	4057	2	cells	cell	NNS
cord-005453-4057qib7	4057	3	(	(	-LRB-
cord-005453-4057qib7	4057	4	HMEC	HMEC	NNP
cord-005453-4057qib7	4057	5	)	)	-RRB-
cord-005453-4057qib7	4057	6	in	in	IN
cord-005453-4057qib7	4057	7	culture	culture	NN
cord-005453-4057qib7	4057	8	were	be	VBD
cord-005453-4057qib7	4057	9	exposed	expose	VBN
cord-005453-4057qib7	4057	10	to	to	IN
cord-005453-4057qib7	4057	11	media	medium	NNS
cord-005453-4057qib7	4057	12	containing	contain	VBG
cord-005453-4057qib7	4057	13	20	20	CD
cord-005453-4057qib7	4057	14	%	%	NN
cord-005453-4057qib7	4057	15	of	of	IN
cord-005453-4057qib7	4057	16	serum	serum	NN
cord-005453-4057qib7	4057	17	from	from	IN
cord-005453-4057qib7	4057	18	each	each	DT
cord-005453-4057qib7	4057	19	patient	patient	NN
cord-005453-4057qib7	4057	20	for	for	IN
cord-005453-4057qib7	4057	21	24h	24h	NNS
cord-005453-4057qib7	4057	22	.	.	.
cord-005453-4057qib7	4058	1	Cell	cell	NN
cord-005453-4057qib7	4058	2	growth	growth	NN
cord-005453-4057qib7	4058	3	was	be	VBD
cord-005453-4057qib7	4058	4	controlled	control	VBN
cord-005453-4057qib7	4058	5	morphologically	morphologically	RB
cord-005453-4057qib7	4058	6	.	.	.
cord-005453-4057qib7	4059	1	Expression	expression	NN
cord-005453-4057qib7	4059	2	of	of	IN
cord-005453-4057qib7	4059	3	the	the	DT
cord-005453-4057qib7	4059	4	adhesion	adhesion	NN
cord-005453-4057qib7	4059	5	receptor	receptor	NN
cord-005453-4057qib7	4059	6	ICAM-1	icam-1	NN
cord-005453-4057qib7	4059	7	on	on	IN
cord-005453-4057qib7	4059	8	the	the	DT
cord-005453-4057qib7	4059	9	cell	cell	NN
cord-005453-4057qib7	4059	10	surface	surface	NN
cord-005453-4057qib7	4059	11	was	be	VBD
cord-005453-4057qib7	4059	12	analysed	analyse	VBN
cord-005453-4057qib7	4059	13	by	by	IN
cord-005453-4057qib7	4059	14	immunofluorescence	immunofluorescence	NN
cord-005453-4057qib7	4059	15	,	,	,
cord-005453-4057qib7	4059	16	and	and	CC
cord-005453-4057qib7	4059	17	activation	activation	NN
cord-005453-4057qib7	4059	18	of	of	IN
cord-005453-4057qib7	4059	19	the	the	DT
cord-005453-4057qib7	4059	20	inflammation	inflammation	NN
cord-005453-4057qib7	4059	21	related	relate	VBN
cord-005453-4057qib7	4059	22	p-38	p-38	NNP
cord-005453-4057qib7	4059	23	MAPK	MAPK	NNP
cord-005453-4057qib7	4059	24	signalling	signal	VBG
cord-005453-4057qib7	4059	25	pathway	pathway	NN
cord-005453-4057qib7	4059	26	was	be	VBD
cord-005453-4057qib7	4059	27	evaluated	evaluate	VBN
cord-005453-4057qib7	4059	28	by	by	IN
cord-005453-4057qib7	4059	29	SDS	SDS	NNP
cord-005453-4057qib7	4059	30	-	-	HYPH
cord-005453-4057qib7	4059	31	PAGE	PAGE	NNP
cord-005453-4057qib7	4059	32	and	and	CC
cord-005453-4057qib7	4059	33	western	western	JJ
cord-005453-4057qib7	4059	34	blot	blot	NN
cord-005453-4057qib7	4059	35	.	.	.
cord-005453-4057qib7	4060	1	Results	result	NNS
cord-005453-4057qib7	4060	2	:	:	:
cord-005453-4057qib7	4061	1	Exposure	exposure	NN
cord-005453-4057qib7	4061	2	of	of	IN
cord-005453-4057qib7	4061	3	HMEC	HMEC	NNP
cord-005453-4057qib7	4061	4	monolayers	monolayer	NNS
cord-005453-4057qib7	4061	5	to	to	IN
cord-005453-4057qib7	4061	6	sera	sera	NNP
cord-005453-4057qib7	4061	7	from	from	IN
cord-005453-4057qib7	4061	8	patients	patient	NNS
cord-005453-4057qib7	4061	9	who	who	WP
cord-005453-4057qib7	4061	10	developed	develop	VBD
cord-005453-4057qib7	4061	11	ES	ES	NNP
cord-005453-4057qib7	4062	1	(	(	-LRB-
cord-005453-4057qib7	4062	2	onset	onset	NNP
cord-005453-4057qib7	4062	3	day	day	NN
cord-005453-4057qib7	4062	4	,	,	,
cord-005453-4057qib7	4062	5	n=4	n=4	NNS
cord-005453-4057qib7	4062	6	)	)	-RRB-
cord-005453-4057qib7	4062	7	resulted	result	VBD
cord-005453-4057qib7	4062	8	in	in	IN
cord-005453-4057qib7	4062	9	an	an	DT
cord-005453-4057qib7	4062	10	increased	increase	VBN
cord-005453-4057qib7	4062	11	ICAM-1	icam-1	NN
cord-005453-4057qib7	4062	12	expression	expression	NN
cord-005453-4057qib7	4062	13	on	on	IN
cord-005453-4057qib7	4062	14	the	the	DT
cord-005453-4057qib7	4062	15	cell	cell	NN
cord-005453-4057qib7	4062	16	surface	surface	NN
cord-005453-4057qib7	4062	17	,	,	,
cord-005453-4057qib7	4062	18	higher	high	JJR
cord-005453-4057qib7	4062	19	that	that	IN
cord-005453-4057qib7	4062	20	the	the	DT
cord-005453-4057qib7	4062	21	observed	observe	VBN
cord-005453-4057qib7	4062	22	with	with	IN
cord-005453-4057qib7	4062	23	sera	sera	NNP
cord-005453-4057qib7	4062	24	from	from	IN
cord-005453-4057qib7	4062	25	patients	patient	NNS
cord-005453-4057qib7	4062	26	who	who	WP
cord-005453-4057qib7	4062	27	did	do	VBD
cord-005453-4057qib7	4062	28	not	not	RB
cord-005453-4057qib7	4062	29	develop	develop	VB
cord-005453-4057qib7	4062	30	ES	ES	NNP
cord-005453-4057qib7	4062	31	(	(	-LRB-
cord-005453-4057qib7	4062	32	discharge	discharge	NN
cord-005453-4057qib7	4062	33	day	day	NN
cord-005453-4057qib7	4062	34	,	,	,
cord-005453-4057qib7	4062	35	n=4	n=4	NNS
cord-005453-4057qib7	4062	36	)	)	-RRB-
cord-005453-4057qib7	4062	37	(	(	-LRB-
cord-005453-4057qib7	4062	38	26.4	26.4	CD
cord-005453-4057qib7	4062	39	%	%	NN
cord-005453-4057qib7	4062	40	of	of	IN
cord-005453-4057qib7	4062	41	labelled	labelled	JJ
cord-005453-4057qib7	4062	42	area	area	NN
cord-005453-4057qib7	4062	43	vs.	vs.	CC
cord-005453-4057qib7	4062	44	6.4	6.4	CD
cord-005453-4057qib7	4062	45	%	%	NN
cord-005453-4057qib7	4062	46	,	,	,
cord-005453-4057qib7	4062	47	respectively	respectively	RB
cord-005453-4057qib7	4062	48	)	)	-RRB-
cord-005453-4057qib7	4062	49	.	.	.
cord-005453-4057qib7	4063	1	In	in	IN
cord-005453-4057qib7	4063	2	addition	addition	NN
cord-005453-4057qib7	4063	3	,	,	,
cord-005453-4057qib7	4063	4	in	in	IN
cord-005453-4057qib7	4063	5	experiments	experiment	NNS
cord-005453-4057qib7	4063	6	with	with	IN
cord-005453-4057qib7	4063	7	sera	sera	NNP
cord-005453-4057qib7	4063	8	from	from	IN
cord-005453-4057qib7	4063	9	patients	patient	NNS
cord-005453-4057qib7	4063	10	not	not	RB
cord-005453-4057qib7	4063	11	developing	develop	VBG
cord-005453-4057qib7	4063	12	ES	ES	NNP
cord-005453-4057qib7	4063	13	,	,	,
cord-005453-4057qib7	4063	14	ICAM-1	icam-1	NN
cord-005453-4057qib7	4063	15	expression	expression	NN
cord-005453-4057qib7	4063	16	on	on	IN
cord-005453-4057qib7	4063	17	cells	cell	NNS
cord-005453-4057qib7	4063	18	exposed	expose	VBN
cord-005453-4057qib7	4063	19	to	to	IN
cord-005453-4057qib7	4063	20	sera	sera	NNP
cord-005453-4057qib7	4063	21	from	from	IN
cord-005453-4057qib7	4063	22	day	day	NN
cord-005453-4057qib7	4063	23	+10	+10	CD
cord-005453-4057qib7	4063	24	was	be	VBD
cord-005453-4057qib7	4063	25	reduced	reduce	VBN
cord-005453-4057qib7	4063	26	with	with	IN
cord-005453-4057qib7	4063	27	respect	respect	NN
cord-005453-4057qib7	4063	28	to	to	IN
cord-005453-4057qib7	4063	29	the	the	DT
cord-005453-4057qib7	4063	30	observed	observe	VBN
cord-005453-4057qib7	4063	31	with	with	IN
cord-005453-4057qib7	4063	32	sera	sera	NNP
cord-005453-4057qib7	4063	33	from	from	IN
cord-005453-4057qib7	4063	34	day	day	NN
cord-005453-4057qib7	4063	35	+5	+5	XX
cord-005453-4057qib7	4063	36	,	,	,
cord-005453-4057qib7	4063	37	probably	probably	RB
cord-005453-4057qib7	4063	38	due	due	IN
cord-005453-4057qib7	4063	39	to	to	IN
cord-005453-4057qib7	4063	40	the	the	DT
cord-005453-4057qib7	4063	41	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	4063	42	used	use	VBN
cord-005453-4057qib7	4063	43	as	as	IN
cord-005453-4057qib7	4063	44	a	a	DT
cord-005453-4057qib7	4063	45	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4063	46	in	in	IN
cord-005453-4057qib7	4063	47	our	-PRON-	PRP$
cord-005453-4057qib7	4063	48	centre	centre	NN
cord-005453-4057qib7	4063	49	.	.	.
cord-005453-4057qib7	4064	1	This	this	DT
cord-005453-4057qib7	4064	2	reduction	reduction	NN
cord-005453-4057qib7	4064	3	was	be	VBD
cord-005453-4057qib7	4064	4	not	not	RB
cord-005453-4057qib7	4064	5	observed	observe	VBN
cord-005453-4057qib7	4064	6	in	in	IN
cord-005453-4057qib7	4064	7	ES	ES	NNP
cord-005453-4057qib7	4064	8	patients	patient	NNS
cord-005453-4057qib7	4064	9	.	.	.
cord-005453-4057qib7	4065	1	Regarding	regard	VBG
cord-005453-4057qib7	4065	2	phosphorylation	phosphorylation	NN
cord-005453-4057qib7	4065	3	of	of	IN
cord-005453-4057qib7	4065	4	p-38	p-38	NNP
cord-005453-4057qib7	4065	5	,	,	,
cord-005453-4057qib7	4065	6	it	-PRON-	PRP
cord-005453-4057qib7	4065	7	was	be	VBD
cord-005453-4057qib7	4065	8	significantly	significantly	RB
cord-005453-4057qib7	4065	9	higher	high	JJR
cord-005453-4057qib7	4065	10	in	in	IN
cord-005453-4057qib7	4065	11	cells	cell	NNS
cord-005453-4057qib7	4065	12	exposed	expose	VBN
cord-005453-4057qib7	4065	13	to	to	IN
cord-005453-4057qib7	4065	14	sera	sera	NNP
cord-005453-4057qib7	4065	15	from	from	IN
cord-005453-4057qib7	4065	16	ES	ES	NNP
cord-005453-4057qib7	4065	17	patients	patient	NNS
cord-005453-4057qib7	4065	18	than	than	IN
cord-005453-4057qib7	4065	19	in	in	IN
cord-005453-4057qib7	4065	20	response	response	NN
cord-005453-4057qib7	4065	21	to	to	IN
cord-005453-4057qib7	4065	22	sera	sera	NNP
cord-005453-4057qib7	4065	23	from	from	IN
cord-005453-4057qib7	4065	24	patients	patient	NNS
cord-005453-4057qib7	4065	25	who	who	WP
cord-005453-4057qib7	4065	26	did	do	VBD
cord-005453-4057qib7	4065	27	not	not	RB
cord-005453-4057qib7	4065	28	develop	develop	VB
cord-005453-4057qib7	4065	29	ES	ES	NNP
cord-005453-4057qib7	4065	30	.	.	.
cord-005453-4057qib7	4066	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4066	2	:	:	:
cord-005453-4057qib7	4067	1	The	the	DT
cord-005453-4057qib7	4067	2	increase	increase	NN
cord-005453-4057qib7	4067	3	in	in	IN
cord-005453-4057qib7	4067	4	the	the	DT
cord-005453-4057qib7	4067	5	expression	expression	NN
cord-005453-4057qib7	4067	6	of	of	IN
cord-005453-4057qib7	4067	7	the	the	DT
cord-005453-4057qib7	4067	8	adhesion	adhesion	NN
cord-005453-4057qib7	4067	9	receptor	receptor	NN
cord-005453-4057qib7	4067	10	ICAM-1	icam-1	NN
cord-005453-4057qib7	4067	11	on	on	IN
cord-005453-4057qib7	4067	12	the	the	DT
cord-005453-4057qib7	4067	13	surface	surface	NN
cord-005453-4057qib7	4067	14	and	and	CC
cord-005453-4057qib7	4067	15	the	the	DT
cord-005453-4057qib7	4067	16	intracellular	intracellular	JJ
cord-005453-4057qib7	4067	17	activation	activation	NN
cord-005453-4057qib7	4067	18	of	of	IN
cord-005453-4057qib7	4067	19	p38MAPK	p38MAPK	NNPS
cord-005453-4057qib7	4067	20	in	in	IN
cord-005453-4057qib7	4067	21	endothelial	endothelial	JJ
cord-005453-4057qib7	4067	22	cells	cell	NNS
cord-005453-4057qib7	4067	23	exposed	expose	VBN
cord-005453-4057qib7	4067	24	to	to	IN
cord-005453-4057qib7	4067	25	sera	sera	NNP
cord-005453-4057qib7	4067	26	from	from	IN
cord-005453-4057qib7	4067	27	patients	patient	NNS
cord-005453-4057qib7	4067	28	developing	develop	VBG
cord-005453-4057qib7	4067	29	ES	ES	NNP
cord-005453-4057qib7	4067	30	indicates	indicate	VBZ
cord-005453-4057qib7	4067	31	the	the	DT
cord-005453-4057qib7	4067	32	existence	existence	NN
cord-005453-4057qib7	4067	33	of	of	IN
cord-005453-4057qib7	4067	34	endothelial	endothelial	JJ
cord-005453-4057qib7	4067	35	activation	activation	NN
cord-005453-4057qib7	4067	36	in	in	IN
cord-005453-4057qib7	4067	37	association	association	NN
cord-005453-4057qib7	4067	38	with	with	IN
cord-005453-4057qib7	4067	39	ES	ES	NNP
cord-005453-4057qib7	4067	40	.	.	.
cord-005453-4057qib7	4068	1	Interestingly	interestingly	RB
cord-005453-4057qib7	4068	2	,	,	,
cord-005453-4057qib7	4068	3	the	the	DT
cord-005453-4057qib7	4068	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4068	5	of	of	IN
cord-005453-4057qib7	4068	6	ES	ES	NNP
cord-005453-4057qib7	4068	7	with	with	IN
cord-005453-4057qib7	4068	8	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	4068	9	seems	seem	VBZ
cord-005453-4057qib7	4068	10	to	to	TO
cord-005453-4057qib7	4068	11	be	be	VB
cord-005453-4057qib7	4068	12	less	less	RBR
cord-005453-4057qib7	4068	13	effective	effective	JJ
cord-005453-4057qib7	4068	14	in	in	IN
cord-005453-4057qib7	4068	15	patients	patient	NNS
cord-005453-4057qib7	4068	16	who	who	WP
cord-005453-4057qib7	4068	17	developed	develop	VBD
cord-005453-4057qib7	4068	18	ES	ES	NNP
cord-005453-4057qib7	4068	19	than	than	IN
cord-005453-4057qib7	4068	20	in	in	IN
cord-005453-4057qib7	4068	21	patients	patient	NNS
cord-005453-4057qib7	4068	22	who	who	WP
cord-005453-4057qib7	4068	23	did	do	VBD
cord-005453-4057qib7	4068	24	not	not	RB
cord-005453-4057qib7	4068	25	develop	develop	VB
cord-005453-4057qib7	4068	26	this	this	DT
cord-005453-4057qib7	4068	27	complication	complication	NN
cord-005453-4057qib7	4068	28	.	.	.
cord-005453-4057qib7	4069	1	These	these	DT
cord-005453-4057qib7	4069	2	results	result	NNS
cord-005453-4057qib7	4069	3	need	need	VBP
cord-005453-4057qib7	4069	4	to	to	TO
cord-005453-4057qib7	4069	5	be	be	VB
cord-005453-4057qib7	4069	6	validated	validate	VBN
cord-005453-4057qib7	4069	7	in	in	IN
cord-005453-4057qib7	4069	8	a	a	DT
cord-005453-4057qib7	4069	9	higher	high	JJR
cord-005453-4057qib7	4069	10	number	number	NN
cord-005453-4057qib7	4069	11	of	of	IN
cord-005453-4057qib7	4069	12	patients	patient	NNS
cord-005453-4057qib7	4069	13	and	and	CC
cord-005453-4057qib7	4069	14	modifications	modification	NNS
cord-005453-4057qib7	4069	15	in	in	IN
cord-005453-4057qib7	4069	16	additional	additional	JJ
cord-005453-4057qib7	4069	17	markers	marker	NNS
cord-005453-4057qib7	4069	18	of	of	IN
cord-005453-4057qib7	4069	19	endothelial	endothelial	JJ
cord-005453-4057qib7	4069	20	dysfunction	dysfunction	NN
cord-005453-4057qib7	4069	21	should	should	MD
cord-005453-4057qib7	4069	22	be	be	VB
cord-005453-4057qib7	4069	23	investigated	investigate	VBN
cord-005453-4057qib7	4069	24	.	.	.
cord-005453-4057qib7	4070	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4070	2	:	:	:
cord-005453-4057qib7	4070	3	Gonzalo	Gonzalo	NNP
cord-005453-4057qib7	4070	4	Gutiérrez	Gutiérrez	NNP
cord-005453-4057qib7	4070	5	-	-	HYPH
cord-005453-4057qib7	4070	6	García	García	NNP
cord-005453-4057qib7	4071	1	:	:	:
cord-005453-4057qib7	4071	2	Honoraria	Honoraria	NNP
cord-005453-4057qib7	4071	3	from	from	IN
cord-005453-4057qib7	4071	4	Gilead	Gilead	NNP
cord-005453-4057qib7	4071	5	.	.	.
cord-005453-4057qib7	4072	1	Grant	grant	VB
cord-005453-4057qib7	4072	2	from	from	IN
cord-005453-4057qib7	4072	3	Jazz	jazz	NN
cord-005453-4057qib7	4072	4	Pharmaceutical	Pharmaceutical	NNP
cord-005453-4057qib7	4073	1	The	the	DT
cord-005453-4057qib7	4073	2	other	other	JJ
cord-005453-4057qib7	4073	3	authors	author	NNS
cord-005453-4057qib7	4073	4	do	do	VBP
cord-005453-4057qib7	4073	5	not	not	RB
cord-005453-4057qib7	4073	6	have	have	VB
cord-005453-4057qib7	4073	7	any	any	DT
cord-005453-4057qib7	4073	8	disclosure	disclosure	NN
cord-005453-4057qib7	4073	9	to	to	TO
cord-005453-4057qib7	4073	10	comment	comment	VB
cord-005453-4057qib7	4073	11	.	.	.
cord-005453-4057qib7	4074	1	P192	P192	NNP
cord-005453-4057qib7	4074	2	association	association	NN
cord-005453-4057qib7	4074	3	between	between	IN
cord-005453-4057qib7	4074	4	uric	uric	JJ
cord-005453-4057qib7	4074	5	acid	acid	NN
cord-005453-4057qib7	4074	6	levels	level	NNS
cord-005453-4057qib7	4074	7	before	before	IN
cord-005453-4057qib7	4074	8	and	and	CC
cord-005453-4057qib7	4074	9	after	after	IN
cord-005453-4057qib7	4074	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	4074	11	haematopoetic	haematopoetic	JJ
cord-005453-4057qib7	4074	12	stem	stem	NN
cord-005453-4057qib7	4074	13	cell	cell	NN
cord-005453-4057qib7	4074	14	transplant	transplant	NN
cord-005453-4057qib7	4074	15	and	and	CC
cord-005453-4057qib7	4074	16	transplant	transplant	NN
cord-005453-4057qib7	4074	17	outcomes	outcome	NNS
cord-005453-4057qib7	4074	18	:	:	:
cord-005453-4057qib7	4075	1	A	a	DT
cord-005453-4057qib7	4075	2	single	single	JJ
cord-005453-4057qib7	4075	3	centre	centre	NN
cord-005453-4057qib7	4075	4	experience	experience	NN
cord-005453-4057qib7	4076	1	Background	background	NN
cord-005453-4057qib7	4076	2	:	:	:
cord-005453-4057qib7	4076	3	Uric	uric	NN
cord-005453-4057qib7	4076	4	acid	acid	NN
cord-005453-4057qib7	4076	5	(	(	-LRB-
cord-005453-4057qib7	4076	6	UA	UA	NNP
cord-005453-4057qib7	4076	7	)	)	-RRB-
cord-005453-4057qib7	4076	8	is	be	VBZ
cord-005453-4057qib7	4076	9	a	a	DT
cord-005453-4057qib7	4076	10	known	know	VBN
cord-005453-4057qib7	4076	11	endogenous	endogenous	JJ
cord-005453-4057qib7	4076	12	danger	danger	NN
cord-005453-4057qib7	4076	13	signal	signal	NN
cord-005453-4057qib7	4076	14	which	which	WDT
cord-005453-4057qib7	4076	15	activates	activate	VBZ
cord-005453-4057qib7	4076	16	the	the	DT
cord-005453-4057qib7	4076	17	NOD	nod	JJ
cord-005453-4057qib7	4076	18	-	-	HYPH
cord-005453-4057qib7	4076	19	like	like	JJ
cord-005453-4057qib7	4076	20	receptor	receptor	NN
cord-005453-4057qib7	4076	21	protein	protein	NN
cord-005453-4057qib7	4076	22	(	(	-LRB-
cord-005453-4057qib7	4076	23	NLRP)3	NLRP)3	NNP
cord-005453-4057qib7	4076	24	inflasome	inflasome	NNP
cord-005453-4057qib7	4076	25	.	.	.
cord-005453-4057qib7	4077	1	UA	UA	NNP
cord-005453-4057qib7	4077	2	is	be	VBZ
cord-005453-4057qib7	4077	3	released	release	VBN
cord-005453-4057qib7	4077	4	from	from	IN
cord-005453-4057qib7	4077	5	injured	injured	JJ
cord-005453-4057qib7	4077	6	cells	cell	NNS
cord-005453-4057qib7	4077	7	during	during	IN
cord-005453-4057qib7	4077	8	conditioning	conditioning	NN
cord-005453-4057qib7	4077	9	in	in	IN
cord-005453-4057qib7	4077	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	4077	11	stem	stem	NN
cord-005453-4057qib7	4077	12	cell	cell	NN
cord-005453-4057qib7	4077	13	transplantation	transplantation	NN
cord-005453-4057qib7	4077	14	(	(	-LRB-
cord-005453-4057qib7	4077	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4077	16	)	)	-RRB-
cord-005453-4057qib7	4077	17	.	.	.
cord-005453-4057qib7	4078	1	A	a	DT
cord-005453-4057qib7	4078	2	pre	pre	JJ
cord-005453-4057qib7	4078	3	-	-	JJ
cord-005453-4057qib7	4078	4	clinical	clinical	JJ
cord-005453-4057qib7	4078	5	study	study	NN
cord-005453-4057qib7	4078	6	has	have	VBZ
cord-005453-4057qib7	4078	7	demonstrated	demonstrate	VBN
cord-005453-4057qib7	4078	8	that	that	IN
cord-005453-4057qib7	4078	9	NLRP3	NLRP3	NNP
cord-005453-4057qib7	4078	10	inflasome	inflasome	NN
cord-005453-4057qib7	4078	11	-	-	HYPH
cord-005453-4057qib7	4078	12	mediated	mediate	VBN
cord-005453-4057qib7	4078	13	IL-1	IL-1	NNP
cord-005453-4057qib7	4078	14	production	production	NN
cord-005453-4057qib7	4078	15	regulates	regulate	VBZ
cord-005453-4057qib7	4078	16	graft	graft	NN
cord-005453-4057qib7	4078	17	-	-	HYPH
cord-005453-4057qib7	4078	18	versushost	versushost	NN
cord-005453-4057qib7	4078	19	disease	disease	NN
cord-005453-4057qib7	4078	20	(	(	-LRB-
cord-005453-4057qib7	4078	21	GVHD	GVHD	NNP
cord-005453-4057qib7	4078	22	)	)	-RRB-
cord-005453-4057qib7	4078	23	.	.	.
cord-005453-4057qib7	4079	1	The	the	DT
cord-005453-4057qib7	4079	2	UA	UA	NNP
cord-005453-4057qib7	4079	3	role	role	NN
cord-005453-4057qib7	4079	4	in	in	IN
cord-005453-4057qib7	4079	5	inflammation	inflammation	NN
cord-005453-4057qib7	4079	6	and	and	CC
cord-005453-4057qib7	4079	7	GVHD	GVHD	NNP
cord-005453-4057qib7	4079	8	is	be	VBZ
cord-005453-4057qib7	4079	9	unclear	unclear	JJ
cord-005453-4057qib7	4079	10	.	.	.
cord-005453-4057qib7	4080	1	There	there	EX
cord-005453-4057qib7	4080	2	are	be	VBP
cord-005453-4057qib7	4080	3	discordant	discordant	JJ
cord-005453-4057qib7	4080	4	reports	report	NNS
cord-005453-4057qib7	4080	5	in	in	IN
cord-005453-4057qib7	4080	6	the	the	DT
cord-005453-4057qib7	4080	7	literature	literature	NN
cord-005453-4057qib7	4080	8	about	about	IN
cord-005453-4057qib7	4080	9	a	a	DT
cord-005453-4057qib7	4080	10	potential	potential	JJ
cord-005453-4057qib7	4080	11	protective	protective	JJ
cord-005453-4057qib7	4080	12	role	role	NN
cord-005453-4057qib7	4080	13	of	of	IN
cord-005453-4057qib7	4080	14	UA	UA	NNP
cord-005453-4057qib7	4080	15	on	on	IN
cord-005453-4057qib7	4080	16	GVHD	GVHD	NNP
cord-005453-4057qib7	4080	17	after	after	IN
cord-005453-4057qib7	4080	18	a	a	DT
cord-005453-4057qib7	4080	19	HSCT	HSCT	NNP
cord-005453-4057qib7	4080	20	.	.	.
cord-005453-4057qib7	4081	1	Methods	method	NNS
cord-005453-4057qib7	4081	2	:	:	:
cord-005453-4057qib7	4081	3	We	-PRON-	PRP
cord-005453-4057qib7	4081	4	performed	perform	VBD
cord-005453-4057qib7	4081	5	a	a	DT
cord-005453-4057qib7	4081	6	retrospective	retrospective	JJ
cord-005453-4057qib7	4081	7	study	study	NN
cord-005453-4057qib7	4081	8	to	to	TO
cord-005453-4057qib7	4081	9	assess	assess	VB
cord-005453-4057qib7	4081	10	the	the	DT
cord-005453-4057qib7	4081	11	association	association	NN
cord-005453-4057qib7	4081	12	between	between	IN
cord-005453-4057qib7	4081	13	serum	serum	NN
cord-005453-4057qib7	4081	14	UA	UA	NNP
cord-005453-4057qib7	4081	15	levels	level	NNS
cord-005453-4057qib7	4081	16	pre	pre	VBP
cord-005453-4057qib7	4081	17	-	-	JJ
cord-005453-4057qib7	4081	18	and	and	CC
cord-005453-4057qib7	4081	19	post-	post-	NN
cord-005453-4057qib7	4081	20	Table	table	NN
cord-005453-4057qib7	4081	21	]	]	-RRB-
cord-005453-4057qib7	4081	22	1	1	CD
cord-005453-4057qib7	4081	23	.	.	.
cord-005453-4057qib7	4082	1	Table	table	NN
cord-005453-4057qib7	4082	2	1	1	CD
cord-005453-4057qib7	4082	3	]	]	-RRB-
cord-005453-4057qib7	4082	4	Results	result	NNS
cord-005453-4057qib7	4082	5	:	:	:
cord-005453-4057qib7	4083	1	The	the	DT
cord-005453-4057qib7	4083	2	characteristics	characteristic	NNS
cord-005453-4057qib7	4083	3	of	of	IN
cord-005453-4057qib7	4083	4	the	the	DT
cord-005453-4057qib7	4083	5	142	142	CD
cord-005453-4057qib7	4083	6	patients	patient	NNS
cord-005453-4057qib7	4083	7	are	be	VBP
cord-005453-4057qib7	4083	8	shown	show	VBN
cord-005453-4057qib7	4083	9	in	in	IN
cord-005453-4057qib7	4083	10	Table	Table	NNP
cord-005453-4057qib7	4083	11	1	1	CD
cord-005453-4057qib7	4083	12	.	.	.
cord-005453-4057qib7	4084	1	Median	median	JJ
cord-005453-4057qib7	4084	2	age	age	NN
cord-005453-4057qib7	4084	3	was	be	VBD
cord-005453-4057qib7	4084	4	52	52	CD
cord-005453-4057qib7	4084	5	years	year	NNS
cord-005453-4057qib7	4085	1	(	(	-LRB-
cord-005453-4057qib7	4085	2	range	range	NNP
cord-005453-4057qib7	4085	3	15	15	CD
cord-005453-4057qib7	4085	4	-	-	SYM
cord-005453-4057qib7	4085	5	69	69	CD
cord-005453-4057qib7	4085	6	)	)	-RRB-
cord-005453-4057qib7	4085	7	,	,	,
cord-005453-4057qib7	4085	8	and	and	CC
cord-005453-4057qib7	4085	9	80	80	CD
cord-005453-4057qib7	4085	10	patients	patient	NNS
cord-005453-4057qib7	4085	11	(	(	-LRB-
cord-005453-4057qib7	4085	12	56	56	CD
cord-005453-4057qib7	4085	13	%	%	NN
cord-005453-4057qib7	4085	14	)	)	-RRB-
cord-005453-4057qib7	4085	15	were	be	VBD
cord-005453-4057qib7	4085	16	male	male	JJ
cord-005453-4057qib7	4085	17	.	.	.
cord-005453-4057qib7	4086	1	Twenty	twenty	CD
cord-005453-4057qib7	4086	2	-	-	HYPH
cord-005453-4057qib7	4086	3	seven	seven	CD
cord-005453-4057qib7	4086	4	patients	patient	NNS
cord-005453-4057qib7	4086	5	(	(	-LRB-
cord-005453-4057qib7	4086	6	19	19	CD
cord-005453-4057qib7	4086	7	%	%	NN
cord-005453-4057qib7	4086	8	)	)	-RRB-
cord-005453-4057qib7	4086	9	received	receive	VBD
cord-005453-4057qib7	4086	10	low	low	JJ
cord-005453-4057qib7	4086	11	doses	dose	NNS
cord-005453-4057qib7	4086	12	ATG	ATG	NNP
cord-005453-4057qib7	4086	13	as	as	IN
cord-005453-4057qib7	4086	14	part	part	NN
cord-005453-4057qib7	4086	15	of	of	IN
cord-005453-4057qib7	4086	16	GVHD	GVHD	NNP
cord-005453-4057qib7	4086	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4086	18	.	.	.
cord-005453-4057qib7	4087	1	Allopurinol	Allopurinol	NNP
cord-005453-4057qib7	4087	2	was	be	VBD
cord-005453-4057qib7	4087	3	from	from	IN
cord-005453-4057qib7	4087	4	the	the	DT
cord-005453-4057qib7	4087	5	day	day	NN
cord-005453-4057qib7	4087	6	before	before	IN
cord-005453-4057qib7	4087	7	start	start	NN
cord-005453-4057qib7	4087	8	of	of	IN
cord-005453-4057qib7	4087	9	conditioning	conditioning	NN
cord-005453-4057qib7	4087	10	therapy	therapy	NN
cord-005453-4057qib7	4087	11	until	until	IN
cord-005453-4057qib7	4087	12	day	day	NN
cord-005453-4057qib7	4087	13	0	0	CD
cord-005453-4057qib7	4087	14	.	.	.
cord-005453-4057qib7	4088	1	The	the	DT
cord-005453-4057qib7	4088	2	median	median	JJ
cord-005453-4057qib7	4088	3	levels	level	NNS
cord-005453-4057qib7	4088	4	of	of	IN
cord-005453-4057qib7	4088	5	UA	UA	NNP
cord-005453-4057qib7	4088	6	were	be	VBD
cord-005453-4057qib7	4088	7	4,8	4,8	CD
cord-005453-4057qib7	4088	8	mg/	mg/	NN
cord-005453-4057qib7	4088	9	dL	dl	NN
cord-005453-4057qib7	4088	10	before	before	IN
cord-005453-4057qib7	4088	11	conditioning	conditioning	NN
cord-005453-4057qib7	4088	12	,	,	,
cord-005453-4057qib7	4089	1	2,85	2,85	CD
cord-005453-4057qib7	4089	2	mg	mg	NNP
cord-005453-4057qib7	4089	3	/	/	SYM
cord-005453-4057qib7	4089	4	dL	dl	NN
cord-005453-4057qib7	4089	5	at	at	IN
cord-005453-4057qib7	4089	6	day	day	NN
cord-005453-4057qib7	4089	7	0	0	CD
cord-005453-4057qib7	4090	1	,	,	,
cord-005453-4057qib7	4090	2	3,1	3,1	CD
cord-005453-4057qib7	4090	3	mg	mg	NNP
cord-005453-4057qib7	4090	4	/	/	SYM
cord-005453-4057qib7	4090	5	dL	dl	NN
cord-005453-4057qib7	4090	6	at	at	IN
cord-005453-4057qib7	4090	7	day	day	NN
cord-005453-4057qib7	4090	8	+7	+7	CD
cord-005453-4057qib7	4090	9	and	and	CC
cord-005453-4057qib7	4090	10	3,2	3,2	CD
cord-005453-4057qib7	4090	11	mg	mg	NNP
cord-005453-4057qib7	4090	12	/	/	SYM
cord-005453-4057qib7	4090	13	dL	dl	NN
cord-005453-4057qib7	4090	14	at	at	IN
cord-005453-4057qib7	4090	15	day	day	NN
cord-005453-4057qib7	4090	16	+14	+14	CD
cord-005453-4057qib7	4090	17	.	.	.
cord-005453-4057qib7	4091	1	There	there	EX
cord-005453-4057qib7	4091	2	was	be	VBD
cord-005453-4057qib7	4091	3	no	no	DT
cord-005453-4057qib7	4091	4	impact	impact	NN
cord-005453-4057qib7	4091	5	between	between	IN
cord-005453-4057qib7	4091	6	the	the	DT
cord-005453-4057qib7	4091	7	UA	UA	NNP
cord-005453-4057qib7	4091	8	levels	level	NNS
cord-005453-4057qib7	4091	9	and	and	CC
cord-005453-4057qib7	4091	10	OS	os	NN
cord-005453-4057qib7	4091	11	at	at	IN
cord-005453-4057qib7	4091	12	any	any	DT
cord-005453-4057qib7	4091	13	time	time	NN
cord-005453-4057qib7	4091	14	of	of	IN
cord-005453-4057qib7	4091	15	the	the	DT
cord-005453-4057qib7	4091	16	HSCT	HSCT	NNP
cord-005453-4057qib7	4091	17	.	.	.
cord-005453-4057qib7	4092	1	UA	UA	NNP
cord-005453-4057qib7	4092	2	levels	level	NNS
cord-005453-4057qib7	4092	3	at	at	IN
cord-005453-4057qib7	4092	4	day	day	NN
cord-005453-4057qib7	4092	5	+7	+7	''
cord-005453-4057qib7	4092	6	were	be	VBD
cord-005453-4057qib7	4092	7	associated	associate	VBN
cord-005453-4057qib7	4092	8	with	with	IN
cord-005453-4057qib7	4092	9	a	a	DT
cord-005453-4057qib7	4092	10	higher	high	JJR
cord-005453-4057qib7	4092	11	CI	CI	NNP
cord-005453-4057qib7	4092	12	relapse	relapse	NN
cord-005453-4057qib7	4092	13	at	at	IN
cord-005453-4057qib7	4092	14	5	5	CD
cord-005453-4057qib7	4092	15	years	year	NNS
cord-005453-4057qib7	4092	16	(	(	-LRB-
cord-005453-4057qib7	4092	17	34	34	CD
cord-005453-4057qib7	4092	18	%	%	NN
cord-005453-4057qib7	4092	19	[	[	-LRB-
cord-005453-4057qib7	4092	20	95	95	CD
cord-005453-4057qib7	4092	21	%	%	NN
cord-005453-4057qib7	4092	22	CI	CI	NNP
cord-005453-4057qib7	4092	23	,	,	,
cord-005453-4057qib7	4092	24	20	20	CD
cord-005453-4057qib7	4092	25	-	-	SYM
cord-005453-4057qib7	4092	26	49	49	CD
cord-005453-4057qib7	4092	27	%	%	NN
cord-005453-4057qib7	4092	28	]	]	-RRB-
cord-005453-4057qib7	4092	29	for	for	IN
cord-005453-4057qib7	4092	30	UA	UA	NNP
cord-005453-4057qib7	4092	31	level	level	NN
cord-005453-4057qib7	4092	32	>	>	XX
cord-005453-4057qib7	4093	1	3,1	3,1	NFP
cord-005453-4057qib7	4094	1	mg	mg	NNP
cord-005453-4057qib7	4094	2	/	/	SYM
cord-005453-4057qib7	4094	3	dL	dL	NNP
cord-005453-4057qib7	4094	4	,	,	,
cord-005453-4057qib7	4094	5	and	and	CC
cord-005453-4057qib7	4094	6	17	17	CD
cord-005453-4057qib7	4094	7	%	%	NN
cord-005453-4057qib7	4094	8	[	[	-LRB-
cord-005453-4057qib7	4094	9	95	95	CD
cord-005453-4057qib7	4094	10	%	%	NN
cord-005453-4057qib7	4094	11	CI	CI	NNP
cord-005453-4057qib7	4094	12	,	,	,
cord-005453-4057qib7	4094	13	8%-30	8%-30	CD
cord-005453-4057qib7	4094	14	%	%	NN
cord-005453-4057qib7	4094	15	]	]	-RRB-
cord-005453-4057qib7	4095	1	for	for	IN
cord-005453-4057qib7	4095	2	UA	UA	NNP
cord-005453-4057qib7	4095	3	level	level	NN
cord-005453-4057qib7	4095	4	≤	≤	NNP
cord-005453-4057qib7	4095	5	3,1	3,1	CD
cord-005453-4057qib7	4095	6	mg	mg	NNP
cord-005453-4057qib7	4095	7	/	/	SYM
cord-005453-4057qib7	4095	8	dL	dl	NN
cord-005453-4057qib7	4096	1	[	[	-LRB-
cord-005453-4057qib7	4096	2	p=	p=	NNP
cord-005453-4057qib7	4096	3	0,046	0,046	CD
cord-005453-4057qib7	4096	4	]	]	-RRB-
cord-005453-4057qib7	4096	5	)	)	-RRB-
cord-005453-4057qib7	4096	6	.	.	.
cord-005453-4057qib7	4097	1	There	there	EX
cord-005453-4057qib7	4097	2	was	be	VBD
cord-005453-4057qib7	4097	3	a	a	DT
cord-005453-4057qib7	4097	4	trend	trend	NN
cord-005453-4057qib7	4097	5	for	for	IN
cord-005453-4057qib7	4097	6	a	a	DT
cord-005453-4057qib7	4097	7	higher	high	JJR
cord-005453-4057qib7	4097	8	CI	ci	NN
cord-005453-4057qib7	4097	9	of	of	IN
cord-005453-4057qib7	4097	10	grade	grade	NN
cord-005453-4057qib7	4097	11	II	II	NNP
cord-005453-4057qib7	4097	12	-	-	HYPH
cord-005453-4057qib7	4097	13	IV	IV	NNP
cord-005453-4057qib7	4097	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	4097	15	for	for	IN
cord-005453-4057qib7	4097	16	the	the	DT
cord-005453-4057qib7	4097	17	subgroup	subgroup	NN
cord-005453-4057qib7	4097	18	of	of	IN
cord-005453-4057qib7	4097	19	patients	patient	NNS
cord-005453-4057qib7	4097	20	not	not	RB
cord-005453-4057qib7	4097	21	treated	treat	VBN
cord-005453-4057qib7	4097	22	with	with	IN
cord-005453-4057qib7	4097	23	ATG	ATG	NNP
cord-005453-4057qib7	4097	24	with	with	IN
cord-005453-4057qib7	4097	25	UA	UA	NNP
cord-005453-4057qib7	4098	1	<	<	XX
cord-005453-4057qib7	4098	2	4,8	4,8	CD
cord-005453-4057qib7	4099	1	mg	mg	NNP
cord-005453-4057qib7	4099	2	/	/	SYM
cord-005453-4057qib7	4099	3	dL	dL	NNP
cord-005453-4057qib7	4099	4	(	(	-LRB-
cord-005453-4057qib7	4099	5	48	48	CD
cord-005453-4057qib7	4099	6	%	%	NN
cord-005453-4057qib7	4099	7	vs	vs	IN
cord-005453-4057qib7	4099	8	30	30	CD
cord-005453-4057qib7	4099	9	%	%	NN
cord-005453-4057qib7	4099	10	;	;	:
cord-005453-4057qib7	4099	11	p=	p=	JJ
cord-005453-4057qib7	4099	12	0,083	0,083	CD
cord-005453-4057qib7	4099	13	)	)	-RRB-
cord-005453-4057qib7	4099	14	on	on	IN
cord-005453-4057qib7	4099	15	day	day	NN
cord-005453-4057qib7	4099	16	-8	-8	NNPS
cord-005453-4057qib7	4099	17	and	and	CC
cord-005453-4057qib7	4099	18	a	a	DT
cord-005453-4057qib7	4099	19	higher	high	JJR
cord-005453-4057qib7	4099	20	NRM	NRM	NNP
cord-005453-4057qib7	4099	21	with	with	IN
cord-005453-4057qib7	4099	22	UA	UA	NNP
cord-005453-4057qib7	4100	1	<	<	XX
cord-005453-4057qib7	4100	2	2,85	2,85	CD
cord-005453-4057qib7	4100	3	on	on	IN
cord-005453-4057qib7	4100	4	day	day	NN
cord-005453-4057qib7	4100	5	0	0	CD
cord-005453-4057qib7	4100	6	(	(	-LRB-
cord-005453-4057qib7	4100	7	50	50	CD
cord-005453-4057qib7	4100	8	%	%	NN
cord-005453-4057qib7	4100	9	vs	vs	IN
cord-005453-4057qib7	4100	10	30	30	CD
cord-005453-4057qib7	4100	11	%	%	NN
cord-005453-4057qib7	4100	12	;	;	.
cord-005453-4057qib7	4101	1	p=0,080	p=0,080	LS
cord-005453-4057qib7	4101	2	)	)	-RRB-
cord-005453-4057qib7	4101	3	.	.	.
cord-005453-4057qib7	4102	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4102	2	:	:	:
cord-005453-4057qib7	4103	1	In	in	IN
cord-005453-4057qib7	4103	2	our	-PRON-	PRP$
cord-005453-4057qib7	4103	3	study	study	NN
cord-005453-4057qib7	4103	4	the	the	DT
cord-005453-4057qib7	4103	5	UA	UA	NNP
cord-005453-4057qib7	4103	6	levels	level	NNS
cord-005453-4057qib7	4103	7	showed	show	VBD
cord-005453-4057qib7	4103	8	no	no	DT
cord-005453-4057qib7	4103	9	impact	impact	NN
cord-005453-4057qib7	4103	10	on	on	IN
cord-005453-4057qib7	4103	11	OS	OS	NNP
cord-005453-4057qib7	4103	12	,	,	,
cord-005453-4057qib7	4103	13	and	and	CC
cord-005453-4057qib7	4103	14	only	only	RB
cord-005453-4057qib7	4103	15	a	a	DT
cord-005453-4057qib7	4103	16	tendency	tendency	NN
cord-005453-4057qib7	4103	17	for	for	IN
cord-005453-4057qib7	4103	18	CI	CI	NNP
cord-005453-4057qib7	4103	19	of	of	IN
cord-005453-4057qib7	4103	20	grades	grade	NNS
cord-005453-4057qib7	4103	21	II	II	NNP
cord-005453-4057qib7	4103	22	-	-	HYPH
cord-005453-4057qib7	4103	23	IV	IV	NNP
cord-005453-4057qib7	4103	24	aGVHD	aGVHD	NNP
cord-005453-4057qib7	4103	25	grades	grade	NNS
cord-005453-4057qib7	4103	26	II	II	NNP
cord-005453-4057qib7	4103	27	-	-	HYPH
cord-005453-4057qib7	4103	28	IV	IV	NNP
cord-005453-4057qib7	4103	29	and	and	CC
cord-005453-4057qib7	4103	30	NRM	NRM	NNP
cord-005453-4057qib7	4103	31	for	for	IN
cord-005453-4057qib7	4103	32	the	the	DT
cord-005453-4057qib7	4103	33	subgroup	subgroup	NN
cord-005453-4057qib7	4103	34	of	of	IN
cord-005453-4057qib7	4103	35	patients	patient	NNS
cord-005453-4057qib7	4103	36	not	not	RB
cord-005453-4057qib7	4103	37	treated	treat	VBN
cord-005453-4057qib7	4103	38	with	with	IN
cord-005453-4057qib7	4103	39	ATG	ATG	NNP
cord-005453-4057qib7	4103	40	.	.	.
cord-005453-4057qib7	4104	1	Surprisingly	surprisingly	RB
cord-005453-4057qib7	4104	2	,	,	,
cord-005453-4057qib7	4104	3	high	high	JJ
cord-005453-4057qib7	4104	4	levels	level	NNS
cord-005453-4057qib7	4104	5	of	of	IN
cord-005453-4057qib7	4104	6	UA	UA	NNP
cord-005453-4057qib7	4104	7	at	at	IN
cord-005453-4057qib7	4104	8	day	day	NN
cord-005453-4057qib7	4104	9	+7	+7	CD
cord-005453-4057qib7	4104	10	of	of	IN
cord-005453-4057qib7	4104	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4104	12	were	be	VBD
cord-005453-4057qib7	4104	13	associated	associate	VBN
cord-005453-4057qib7	4104	14	with	with	IN
cord-005453-4057qib7	4104	15	a	a	DT
cord-005453-4057qib7	4104	16	significant	significant	JJ
cord-005453-4057qib7	4104	17	higher	high	JJR
cord-005453-4057qib7	4104	18	incidence	incidence	NN
cord-005453-4057qib7	4104	19	of	of	IN
cord-005453-4057qib7	4104	20	relapse	relapse	NN
cord-005453-4057qib7	4104	21	.	.	.
cord-005453-4057qib7	4105	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4105	2	:	:	:
cord-005453-4057qib7	4105	3	DKMS	DKMS	NNP
cord-005453-4057qib7	4105	4	Foundation	Foundation	NNP
cord-005453-4057qib7	4105	5	,	,	,
cord-005453-4057qib7	4105	6	PI14/01971	PI14/01971	NNP
cord-005453-4057qib7	4106	1	(	(	-LRB-
cord-005453-4057qib7	4106	2	Instituto	Instituto	NNP
cord-005453-4057qib7	4106	3	Carlos	Carlos	NNP
cord-005453-4057qib7	4106	4	III	III	NNP
cord-005453-4057qib7	4106	5	)	)	-RRB-
cord-005453-4057qib7	4107	1	and	and	CC
cord-005453-4057qib7	4107	2	SGR288	SGR288	NNP
cord-005453-4057qib7	4107	3	(	(	-LRB-
cord-005453-4057qib7	4107	4	GRC	GRC	NNP
cord-005453-4057qib7	4107	5	)	)	-RRB-
cord-005453-4057qib7	4107	6	,	,	,
cord-005453-4057qib7	4107	7	Generalitat	Generalitat	NNP
cord-005453-4057qib7	4107	8	de	de	NNP
cord-005453-4057qib7	4107	9	Catalunya	Catalunya	NNP
cord-005453-4057qib7	4107	10	.	.	.
cord-005453-4057qib7	4108	1	Background	background	NN
cord-005453-4057qib7	4108	2	:	:	:
cord-005453-4057qib7	4109	1	Veno	Veno	NNP
cord-005453-4057qib7	4109	2	-	-	HYPH
cord-005453-4057qib7	4109	3	occlusive	occlusive	JJ
cord-005453-4057qib7	4109	4	disease	disease	NN
cord-005453-4057qib7	4109	5	(	(	-LRB-
cord-005453-4057qib7	4109	6	VOD	VOD	NNP
cord-005453-4057qib7	4109	7	)	)	-RRB-
cord-005453-4057qib7	4109	8	is	be	VBZ
cord-005453-4057qib7	4109	9	an	an	DT
cord-005453-4057qib7	4109	10	early	early	JJ
cord-005453-4057qib7	4109	11	,	,	,
cord-005453-4057qib7	4109	12	uncommon	uncommon	JJ
cord-005453-4057qib7	4109	13	but	but	CC
cord-005453-4057qib7	4109	14	serious	serious	JJ
cord-005453-4057qib7	4109	15	complication	complication	NN
cord-005453-4057qib7	4109	16	of	of	IN
cord-005453-4057qib7	4109	17	stem	stem	NN
cord-005453-4057qib7	4109	18	cell	cell	NN
cord-005453-4057qib7	4109	19	transplantation	transplantation	NN
cord-005453-4057qib7	4109	20	(	(	-LRB-
cord-005453-4057qib7	4109	21	SCT	SCT	NNP
cord-005453-4057qib7	4109	22	)	)	-RRB-
cord-005453-4057qib7	4109	23	that	that	WDT
cord-005453-4057qib7	4109	24	is	be	VBZ
cord-005453-4057qib7	4109	25	associated	associate	VBN
cord-005453-4057qib7	4109	26	with	with	IN
cord-005453-4057qib7	4109	27	high	high	JJ
cord-005453-4057qib7	4109	28	morbidity	morbidity	NN
cord-005453-4057qib7	4109	29	and	and	CC
cord-005453-4057qib7	4109	30	mortality	mortality	NN
cord-005453-4057qib7	4109	31	.	.	.
cord-005453-4057qib7	4110	1	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	4110	2	is	be	VBZ
cord-005453-4057qib7	4110	3	the	the	DT
cord-005453-4057qib7	4110	4	only	only	RB
cord-005453-4057qib7	4110	5	licensed	license	VBN
cord-005453-4057qib7	4110	6	treatment	treatment	NN
cord-005453-4057qib7	4110	7	for	for	IN
cord-005453-4057qib7	4110	8	VOD	VOD	NNP
cord-005453-4057qib7	4110	9	,	,	,
cord-005453-4057qib7	4110	10	and	and	CC
cord-005453-4057qib7	4110	11	time	time	NN
cord-005453-4057qib7	4110	12	to	to	TO
cord-005453-4057qib7	4110	13	start	start	VB
cord-005453-4057qib7	4110	14	of	of	IN
cord-005453-4057qib7	4110	15	treatment	treatment	NN
cord-005453-4057qib7	4110	16	(	(	-LRB-
cord-005453-4057qib7	4110	17	TsT	TsT	NNP
cord-005453-4057qib7	4110	18	)	)	-RRB-
cord-005453-4057qib7	4110	19	affects	affect	VBZ
cord-005453-4057qib7	4110	20	outcomes	outcome	NNS
cord-005453-4057qib7	4110	21	.	.	.
cord-005453-4057qib7	4111	1	Minor	minor	JJ
cord-005453-4057qib7	4111	2	differences	difference	NNS
cord-005453-4057qib7	4111	3	exist	exist	VBP
cord-005453-4057qib7	4111	4	between	between	IN
cord-005453-4057qib7	4111	5	the	the	DT
cord-005453-4057qib7	4111	6	Seattle	Seattle	NNP
cord-005453-4057qib7	4111	7	,	,	,
cord-005453-4057qib7	4111	8	Baltimore	Baltimore	NNP
cord-005453-4057qib7	4111	9	and	and	CC
cord-005453-4057qib7	4111	10	classical	classical	JJ
cord-005453-4057qib7	4111	11	EBMT	EBMT	NNP
cord-005453-4057qib7	4111	12	(	(	-LRB-
cord-005453-4057qib7	4111	13	2016	2016	CD
cord-005453-4057qib7	4111	14	)	)	-RRB-
cord-005453-4057qib7	4111	15	criteria	criterion	NNS
cord-005453-4057qib7	4111	16	,	,	,
cord-005453-4057qib7	4111	17	which	which	WDT
cord-005453-4057qib7	4111	18	may	may	MD
cord-005453-4057qib7	4111	19	trigger	trigger	VB
cord-005453-4057qib7	4111	20	different	different	JJ
cord-005453-4057qib7	4111	21	start	start	NN
cord-005453-4057qib7	4111	22	points	point	NNS
cord-005453-4057qib7	4111	23	for	for	IN
cord-005453-4057qib7	4111	24	treatment	treatment	NN
cord-005453-4057qib7	4111	25	.	.	.
cord-005453-4057qib7	4112	1	Late	late	JJ
cord-005453-4057qib7	4112	2	onset	onset	NN
cord-005453-4057qib7	4112	3	VOD	vod	NN
cord-005453-4057qib7	4112	4	(	(	-LRB-
cord-005453-4057qib7	4112	5	>	>	NFP
cord-005453-4057qib7	4112	6	21	21	CD
cord-005453-4057qib7	4112	7	days	day	NNS
cord-005453-4057qib7	4112	8	)	)	-RRB-
cord-005453-4057qib7	4112	9	is	be	VBZ
cord-005453-4057qib7	4112	10	less	less	RBR
cord-005453-4057qib7	4112	11	recognised	recognised	JJ
cord-005453-4057qib7	4112	12	and	and	CC
cord-005453-4057qib7	4112	13	we	-PRON-	PRP
cord-005453-4057qib7	4112	14	hypothesize	hypothesize	VBP
cord-005453-4057qib7	4112	15	,	,	,
cord-005453-4057qib7	4112	16	may	may	MD
cord-005453-4057qib7	4112	17	have	have	VB
cord-005453-4057qib7	4112	18	worse	bad	JJR
cord-005453-4057qib7	4112	19	outcomes	outcome	NNS
cord-005453-4057qib7	4112	20	with	with	IN
cord-005453-4057qib7	4112	21	longer	long	JJR
cord-005453-4057qib7	4112	22	time	time	NN
cord-005453-4057qib7	4112	23	to	to	IN
cord-005453-4057qib7	4112	24	diagnosis	diagnosis	NN
cord-005453-4057qib7	4112	25	,	,	,
cord-005453-4057qib7	4112	26	and	and	CC
cord-005453-4057qib7	4112	27	more	more	RBR
cord-005453-4057qib7	4112	28	limited	limited	JJ
cord-005453-4057qib7	4112	29	treatment	treatment	NN
cord-005453-4057qib7	4112	30	options	option	NNS
cord-005453-4057qib7	4112	31	across	across	IN
cord-005453-4057qib7	4112	32	different	different	JJ
cord-005453-4057qib7	4112	33	healthcare	healthcare	NN
cord-005453-4057qib7	4112	34	systems	system	NNS
cord-005453-4057qib7	4112	35	.	.	.
cord-005453-4057qib7	4113	1	Methods	method	NNS
cord-005453-4057qib7	4113	2	:	:	:
cord-005453-4057qib7	4113	3	Electronic	electronic	JJ
cord-005453-4057qib7	4113	4	patient	patient	NN
cord-005453-4057qib7	4113	5	records	record	NNS
cord-005453-4057qib7	4113	6	from	from	IN
cord-005453-4057qib7	4113	7	Sept.2013	Sept.2013	NNP
cord-005453-4057qib7	4114	1	-Oct.2018	-Oct.2018	NNP
cord-005453-4057qib7	4115	1	at	at	IN
cord-005453-4057qib7	4115	2	King´s	King´s	NNP
cord-005453-4057qib7	4115	3	BMT	BMT	NNP
cord-005453-4057qib7	4115	4	centre	centre	NN
cord-005453-4057qib7	4115	5	and	and	CC
cord-005453-4057qib7	4115	6	pharmacy	pharmacy	NN
cord-005453-4057qib7	4115	7	databases	database	NNS
cord-005453-4057qib7	4115	8	were	be	VBD
cord-005453-4057qib7	4115	9	reviewed	review	VBN
cord-005453-4057qib7	4115	10	,	,	,
cord-005453-4057qib7	4115	11	timepoint	timepoint	NN
cord-005453-4057qib7	4115	12	to	to	IN
cord-005453-4057qib7	4115	13	clinical	clinical	JJ
cord-005453-4057qib7	4115	14	and	and	CC
cord-005453-4057qib7	4115	15	bio	bio	JJ
cord-005453-4057qib7	4115	16	-	-	JJ
cord-005453-4057qib7	4115	17	chemical	chemical	JJ
cord-005453-4057qib7	4115	18	manifestation	manifestation	NN
cord-005453-4057qib7	4115	19	of	of	IN
cord-005453-4057qib7	4115	20	VOD	VOD	NNP
cord-005453-4057qib7	4115	21	,	,	,
cord-005453-4057qib7	4115	22	diagnosis	diagnosis	NN
cord-005453-4057qib7	4115	23	,	,	,
cord-005453-4057qib7	4115	24	TsT	tst	NN
cord-005453-4057qib7	4115	25	,	,	,
cord-005453-4057qib7	4115	26	survival	survival	NN
cord-005453-4057qib7	4115	27	and	and	CC
cord-005453-4057qib7	4115	28	longterm	longterm	JJ
cord-005453-4057qib7	4115	29	outcomes	outcome	NNS
cord-005453-4057qib7	4115	30	were	be	VBD
cord-005453-4057qib7	4115	31	analysed	analyse	VBN
cord-005453-4057qib7	4115	32	.	.	.
cord-005453-4057qib7	4116	1	Results	result	NNS
cord-005453-4057qib7	4116	2	:	:	:
cord-005453-4057qib7	4116	3	30	30	CD
cord-005453-4057qib7	4116	4	of	of	IN
cord-005453-4057qib7	4116	5	the	the	DT
cord-005453-4057qib7	4116	6	532	532	CD
cord-005453-4057qib7	4116	7	patients(5.6	patients(5.6	NNP
cord-005453-4057qib7	4116	8	%	%	NN
cord-005453-4057qib7	4116	9	)	)	-RRB-
cord-005453-4057qib7	4116	10	who	who	WP
cord-005453-4057qib7	4116	11	underwent	undergo	VBD
cord-005453-4057qib7	4116	12	an	an	DT
cord-005453-4057qib7	4116	13	allogeneic	allogeneic	JJ
cord-005453-4057qib7	4116	14	SCT	SCT	NNP
cord-005453-4057qib7	4116	15	,	,	,
cord-005453-4057qib7	4116	16	developed	develop	VBD
cord-005453-4057qib7	4116	17	VOD	VOD	NNP
cord-005453-4057qib7	4116	18	,	,	,
cord-005453-4057qib7	4116	19	including	include	VBG
cord-005453-4057qib7	4116	20	2	2	CD
cord-005453-4057qib7	4116	21	paediatric	paediatric	JJ
cord-005453-4057qib7	4116	22	cases	case	NNS
cord-005453-4057qib7	4116	23	.	.	.
cord-005453-4057qib7	4117	1	None	none	NN
cord-005453-4057qib7	4117	2	of	of	IN
cord-005453-4057qib7	4117	3	the	the	DT
cord-005453-4057qib7	4117	4	Autologous	autologous	JJ
cord-005453-4057qib7	4117	5	SCT	SCT	NNP
cord-005453-4057qib7	4117	6	patients	patient	NNS
cord-005453-4057qib7	4117	7	developed	develop	VBD
cord-005453-4057qib7	4117	8	VOD	VOD	NNP
cord-005453-4057qib7	4117	9	.	.	.
cord-005453-4057qib7	4118	1	The	the	DT
cord-005453-4057qib7	4118	2	paediatric	paediatric	JJ
cord-005453-4057qib7	4118	3	and	and	CC
cord-005453-4057qib7	4118	4	Autologous	autologous	JJ
cord-005453-4057qib7	4118	5	SCT	SCT	NNP
cord-005453-4057qib7	4118	6	patients	patient	NNS
cord-005453-4057qib7	4118	7	were	be	VBD
cord-005453-4057qib7	4118	8	not	not	RB
cord-005453-4057qib7	4118	9	analysed	analyse	VBN
cord-005453-4057qib7	4118	10	any	any	RB
cord-005453-4057qib7	4118	11	further	further	RB
cord-005453-4057qib7	4118	12	.	.	.
cord-005453-4057qib7	4119	1	28	28	CD
cord-005453-4057qib7	4119	2	adult	adult	NN
cord-005453-4057qib7	4119	3	patients	patient	NNS
cord-005453-4057qib7	4119	4	(	(	-LRB-
cord-005453-4057qib7	4119	5	Male=22;78.5	Male=22;78.5	NNP
cord-005453-4057qib7	4119	6	%	%	NN
cord-005453-4057qib7	4119	7	)	)	-RRB-
cord-005453-4057qib7	4119	8	developed	develop	VBD
cord-005453-4057qib7	4119	9	VOD	VOD	NNP
cord-005453-4057qib7	4119	10	at	at	IN
cord-005453-4057qib7	4119	11	a	a	DT
cord-005453-4057qib7	4119	12	median	median	JJ
cord-005453-4057qib7	4119	13	age	age	NN
cord-005453-4057qib7	4119	14	of	of	IN
cord-005453-4057qib7	4119	15	56	56	CD
cord-005453-4057qib7	4119	16	years(range	years(range	CD
cord-005453-4057qib7	4119	17	26	26	CD
cord-005453-4057qib7	4119	18	-	-	SYM
cord-005453-4057qib7	4119	19	72	72	CD
cord-005453-4057qib7	4119	20	)	)	-RRB-
cord-005453-4057qib7	4119	21	,	,	,
cord-005453-4057qib7	4119	22	of	of	IN
cord-005453-4057qib7	4119	23	whom	whom	WP
cord-005453-4057qib7	4119	24	21	21	CD
cord-005453-4057qib7	4119	25	developed	develop	VBD
cord-005453-4057qib7	4119	26	<	<	NNP
cord-005453-4057qib7	4119	27	21	21	CD
cord-005453-4057qib7	4119	28	days	day	NNS
cord-005453-4057qib7	4119	29	and	and	CC
cord-005453-4057qib7	4119	30	7	7	CD
cord-005453-4057qib7	4119	31	patients	patient	NNS
cord-005453-4057qib7	4119	32	had	have	VBD
cord-005453-4057qib7	4119	33	late	late	JJ
cord-005453-4057qib7	4119	34	-	-	HYPH
cord-005453-4057qib7	4119	35	onset	onset	NN
cord-005453-4057qib7	4119	36	VOD	vod	NN
cord-005453-4057qib7	4119	37	as	as	IN
cord-005453-4057qib7	4119	38	per	per	IN
cord-005453-4057qib7	4119	39	EBMT	EBMT	NNP
cord-005453-4057qib7	4120	1	criteria(range	criteria(range	PRP$
cord-005453-4057qib7	4120	2	22	22	CD
cord-005453-4057qib7	4120	3	-	-	SYM
cord-005453-4057qib7	4120	4	93	93	CD
cord-005453-4057qib7	4120	5	days	day	NNS
cord-005453-4057qib7	4120	6	)	)	-RRB-
cord-005453-4057qib7	4120	7	.	.	.
cord-005453-4057qib7	4121	1	24	24	CD
cord-005453-4057qib7	4121	2	cases	case	NNS
cord-005453-4057qib7	4121	3	classed	class	VBN
cord-005453-4057qib7	4121	4	as	as	IN
cord-005453-4057qib7	4121	5	severe	severe	JJ
cord-005453-4057qib7	4121	6	and	and	CC
cord-005453-4057qib7	4121	7	4	4	CD
cord-005453-4057qib7	4121	8	as	as	IN
cord-005453-4057qib7	4121	9	moderate	moderate	JJ
cord-005453-4057qib7	4121	10	VOD	VOD	NNP
cord-005453-4057qib7	4121	11	.	.	.
cord-005453-4057qib7	4122	1	10	10	CD
cord-005453-4057qib7	4122	2	patients	patient	NNS
cord-005453-4057qib7	4122	3	received	receive	VBD
cord-005453-4057qib7	4122	4	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	4122	5	at	at	IN
cord-005453-4057qib7	4122	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	4122	7	,	,	,
cord-005453-4057qib7	4122	8	7	7	CD
cord-005453-4057qib7	4122	9	patients	patient	NNS
cord-005453-4057qib7	4122	10	within	within	IN
cord-005453-4057qib7	4122	11	3	3	CD
cord-005453-4057qib7	4122	12	days	day	NNS
cord-005453-4057qib7	4122	13	,	,	,
cord-005453-4057qib7	4122	14	5	5	CD
cord-005453-4057qib7	4122	15	patients	patient	NNS
cord-005453-4057qib7	4122	16	between	between	IN
cord-005453-4057qib7	4122	17	4	4	CD
cord-005453-4057qib7	4122	18	-	-	SYM
cord-005453-4057qib7	4122	19	7	7	CD
cord-005453-4057qib7	4122	20	days	day	NNS
cord-005453-4057qib7	4122	21	,	,	,
cord-005453-4057qib7	4122	22	and	and	CC
cord-005453-4057qib7	4122	23	6	6	CD
cord-005453-4057qib7	4122	24	patients	patient	NNS
cord-005453-4057qib7	4122	25	received	receive	VBD
cord-005453-4057qib7	4122	26	treatment	treatment	NN
cord-005453-4057qib7	4122	27	after	after	IN
cord-005453-4057qib7	4122	28	7	7	CD
cord-005453-4057qib7	4122	29	days	day	NNS
cord-005453-4057qib7	4122	30	.	.	.
cord-005453-4057qib7	4123	1	Overall	overall	JJ
cord-005453-4057qib7	4123	2	mortality	mortality	NN
cord-005453-4057qib7	4123	3	for	for	IN
cord-005453-4057qib7	4123	4	this	this	DT
cord-005453-4057qib7	4123	5	cohort	cohort	NN
cord-005453-4057qib7	4123	6	was	be	VBD
cord-005453-4057qib7	4123	7	50%(14/28	50%(14/28	CD
cord-005453-4057qib7	4123	8	)	)	-RRB-
cord-005453-4057qib7	4123	9	.	.	.
cord-005453-4057qib7	4124	1	12/21	12/21	CD
cord-005453-4057qib7	4124	2	(	(	-LRB-
cord-005453-4057qib7	4124	3	57.1	57.1	CD
cord-005453-4057qib7	4124	4	%	%	NN
cord-005453-4057qib7	4124	5	)	)	-RRB-
cord-005453-4057qib7	4124	6	of	of	IN
cord-005453-4057qib7	4124	7	patients	patient	NNS
cord-005453-4057qib7	4124	8	with	with	IN
cord-005453-4057qib7	4124	9	early	early	JJ
cord-005453-4057qib7	4124	10	onset	onset	NN
cord-005453-4057qib7	4124	11	VOD	vod	NN
cord-005453-4057qib7	4124	12	and	and	CC
cord-005453-4057qib7	4124	13	2/7(28.5	2/7(28.5	CD
cord-005453-4057qib7	4124	14	%	%	NN
cord-005453-4057qib7	4124	15	)	)	-RRB-
cord-005453-4057qib7	4124	16	patients	patient	NNS
cord-005453-4057qib7	4124	17	with	with	IN
cord-005453-4057qib7	4124	18	late	late	JJ
cord-005453-4057qib7	4124	19	-	-	HYPH
cord-005453-4057qib7	4124	20	onset	onset	NN
cord-005453-4057qib7	4124	21	VOD	VOD	NNP
cord-005453-4057qib7	4124	22	died	die	VBD
cord-005453-4057qib7	4124	23	.	.	.
cord-005453-4057qib7	4125	1	Of	of	IN
cord-005453-4057qib7	4125	2	the	the	DT
cord-005453-4057qib7	4125	3	14	14	CD
cord-005453-4057qib7	4125	4	deaths	death	NNS
cord-005453-4057qib7	4125	5	,	,	,
cord-005453-4057qib7	4125	6	10	10	CD
cord-005453-4057qib7	4125	7	died	die	VBD
cord-005453-4057qib7	4125	8	of	of	IN
cord-005453-4057qib7	4125	9	liver	liver	NN
cord-005453-4057qib7	4125	10	failure	failure	NN
cord-005453-4057qib7	4125	11	and	and	CC
cord-005453-4057qib7	4125	12	a	a	DT
cord-005453-4057qib7	4125	13	further	further	JJ
cord-005453-4057qib7	4125	14	2	2	CD
cord-005453-4057qib7	4125	15	patients	patient	NNS
cord-005453-4057qib7	4125	16	had	have	VBD
cord-005453-4057qib7	4125	17	VOD	VOD	NNP
cord-005453-4057qib7	4125	18	as	as	IN
cord-005453-4057qib7	4125	19	a	a	DT
cord-005453-4057qib7	4125	20	likely	likely	JJ
cord-005453-4057qib7	4125	21	contributing	contribute	VBG
cord-005453-4057qib7	4125	22	factor	factor	NN
cord-005453-4057qib7	4125	23	in	in	IN
cord-005453-4057qib7	4125	24	their	-PRON-	PRP$
cord-005453-4057qib7	4125	25	deaths	death	NNS
cord-005453-4057qib7	4125	26	.	.	.
cord-005453-4057qib7	4126	1	1	1	CD
cord-005453-4057qib7	4126	2	patient	patient	NN
cord-005453-4057qib7	4126	3	died	die	VBD
cord-005453-4057qib7	4126	4	with	with	IN
cord-005453-4057qib7	4126	5	subarachnoid	subarachnoid	NN
cord-005453-4057qib7	4126	6	haemorrhage	haemorrhage	NN
cord-005453-4057qib7	4126	7	and	and	CC
cord-005453-4057qib7	4126	8	1	1	CD
cord-005453-4057qib7	4126	9	with	with	IN
cord-005453-4057qib7	4126	10	relapsed	relapsed	JJ
cord-005453-4057qib7	4126	11	disease	disease	NN
cord-005453-4057qib7	4126	12	.	.	.
cord-005453-4057qib7	4127	1	Patients	patient	NNS
cord-005453-4057qib7	4127	2	that	that	WDT
cord-005453-4057qib7	4127	3	received	receive	VBD
cord-005453-4057qib7	4127	4	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	4127	5	after	after	IN
cord-005453-4057qib7	4127	6	7	7	CD
cord-005453-4057qib7	4127	7	days	day	NNS
cord-005453-4057qib7	4127	8	,	,	,
cord-005453-4057qib7	4127	9	5/6	5/6	CD
cord-005453-4057qib7	4127	10	patients(83.3	patients(83.3	NNP
cord-005453-4057qib7	4127	11	%	%	NN
cord-005453-4057qib7	4127	12	)	)	-RRB-
cord-005453-4057qib7	4127	13	died	die	VBD
cord-005453-4057qib7	4127	14	,	,	,
cord-005453-4057qib7	4127	15	as	as	IN
cord-005453-4057qib7	4127	16	compared	compare	VBN
cord-005453-4057qib7	4127	17	to	to	IN
cord-005453-4057qib7	4127	18	3/5(60	3/5(60	CD
cord-005453-4057qib7	4127	19	%	%	NN
cord-005453-4057qib7	4127	20	)	)	-RRB-
cord-005453-4057qib7	4127	21	for	for	IN
cord-005453-4057qib7	4127	22	treatments	treatment	NNS
cord-005453-4057qib7	4127	23	between	between	IN
cord-005453-4057qib7	4127	24	4	4	CD
cord-005453-4057qib7	4127	25	-	-	SYM
cord-005453-4057qib7	4127	26	7	7	CD
cord-005453-4057qib7	4127	27	days	day	NNS
cord-005453-4057qib7	4127	28	,	,	,
cord-005453-4057qib7	4127	29	6/17(35.2	6/17(35.2	CD
cord-005453-4057qib7	4127	30	%	%	NN
cord-005453-4057qib7	4127	31	)	)	-RRB-
cord-005453-4057qib7	4127	32	for	for	IN
cord-005453-4057qib7	4127	33	treatments	treatment	NNS
cord-005453-4057qib7	4127	34	within	within	IN
cord-005453-4057qib7	4127	35	3	3	CD
cord-005453-4057qib7	4127	36	days	day	NNS
cord-005453-4057qib7	4127	37	.	.	.
cord-005453-4057qib7	4128	1	The	the	DT
cord-005453-4057qib7	4128	2	lone	lone	JJ
cord-005453-4057qib7	4128	3	surviving	survive	VBG
cord-005453-4057qib7	4128	4	patient	patient	NN
cord-005453-4057qib7	4128	5	who	who	WP
cord-005453-4057qib7	4128	6	received	receive	VBD
cord-005453-4057qib7	4128	7	treatment	treatment	NN
cord-005453-4057qib7	4128	8	after	after	IN
cord-005453-4057qib7	4128	9	7	7	CD
cord-005453-4057qib7	4128	10	days	day	NNS
cord-005453-4057qib7	4128	11	has	have	VBZ
cord-005453-4057qib7	4128	12	severe	severe	JJ
cord-005453-4057qib7	4128	13	chronic	chronic	JJ
cord-005453-4057qib7	4128	14	liver	liver	NN
cord-005453-4057qib7	4128	15	disease	disease	NN
cord-005453-4057qib7	4128	16	and	and	CC
cord-005453-4057qib7	4128	17	it	-PRON-	PRP
cord-005453-4057qib7	4128	18	's	be	VBZ
cord-005453-4057qib7	4128	19	complications	complication	NNS
cord-005453-4057qib7	4128	20	.	.	.
cord-005453-4057qib7	4129	1	Of	of	IN
cord-005453-4057qib7	4129	2	the	the	DT
cord-005453-4057qib7	4129	3	21	21	CD
cord-005453-4057qib7	4129	4	patients	patient	NNS
cord-005453-4057qib7	4129	5	who	who	WP
cord-005453-4057qib7	4129	6	fit	fit	VBP
cord-005453-4057qib7	4129	7	Seattle	Seattle	NNP
cord-005453-4057qib7	4129	8	criteria	criterion	NNS
cord-005453-4057qib7	4129	9	for	for	IN
cord-005453-4057qib7	4129	10	early	early	JJ
cord-005453-4057qib7	4129	11	-	-	HYPH
cord-005453-4057qib7	4129	12	onset	onset	NN
cord-005453-4057qib7	4129	13	VOD	vod	NN
cord-005453-4057qib7	4129	14	,	,	,
cord-005453-4057qib7	4129	15	only	only	RB
cord-005453-4057qib7	4129	16	6	6	CD
cord-005453-4057qib7	4129	17	fit	fit	VBP
cord-005453-4057qib7	4129	18	the	the	DT
cord-005453-4057qib7	4129	19	Baltimore	Baltimore	NNP
cord-005453-4057qib7	4129	20	or	or	CC
cord-005453-4057qib7	4129	21	EBMT	EBMT	NNP
cord-005453-4057qib7	4129	22	criteria	criterion	NNS
cord-005453-4057qib7	4129	23	for	for	IN
cord-005453-4057qib7	4129	24	classical	classical	JJ
cord-005453-4057qib7	4129	25	VOD	vod	NN
cord-005453-4057qib7	4129	26	.	.	.
cord-005453-4057qib7	4130	1	4	4	CD
cord-005453-4057qib7	4130	2	of	of	IN
cord-005453-4057qib7	4130	3	these	these	DT
cord-005453-4057qib7	4130	4	6	6	CD
cord-005453-4057qib7	4130	5	patients	patient	NNS
cord-005453-4057qib7	4130	6	met	meet	VBD
cord-005453-4057qib7	4130	7	the	the	DT
cord-005453-4057qib7	4130	8	Baltimore	Baltimore	NNP
cord-005453-4057qib7	4130	9	criteria	criterion	NNS
cord-005453-4057qib7	4130	10	later	later	RB
cord-005453-4057qib7	4130	11	than	than	IN
cord-005453-4057qib7	4130	12	the	the	DT
cord-005453-4057qib7	4130	13	Seattle	Seattle	NNP
cord-005453-4057qib7	4130	14	criteria	criterion	NNS
cord-005453-4057qib7	4130	15	were	be	VBD
cord-005453-4057qib7	4130	16	met(range	met(range	NN
cord-005453-4057qib7	4130	17	=	=	SYM
cord-005453-4057qib7	4130	18	2	2	CD
cord-005453-4057qib7	4130	19	-	-	SYM
cord-005453-4057qib7	4130	20	9	9	CD
cord-005453-4057qib7	4130	21	days	day	NNS
cord-005453-4057qib7	4130	22	)	)	-RRB-
cord-005453-4057qib7	4130	23	.	.	.
cord-005453-4057qib7	4131	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4131	2	:	:	:
cord-005453-4057qib7	4132	1	VOD	VOD	NNP
cord-005453-4057qib7	4132	2	carries	carry	VBZ
cord-005453-4057qib7	4132	3	high	high	JJ
cord-005453-4057qib7	4132	4	morbidity	morbidity	NN
cord-005453-4057qib7	4132	5	and	and	CC
cord-005453-4057qib7	4132	6	mortality	mortality	NN
cord-005453-4057qib7	4132	7	,	,	,
cord-005453-4057qib7	4132	8	and	and	CC
cord-005453-4057qib7	4132	9	beyond	beyond	IN
cord-005453-4057qib7	4132	10	the	the	DT
cord-005453-4057qib7	4132	11	known	know	VBN
cord-005453-4057qib7	4132	12	risk	risk	NN
cord-005453-4057qib7	4132	13	factors	factor	NNS
cord-005453-4057qib7	4132	14	and	and	CC
cord-005453-4057qib7	4132	15	with	with	IN
cord-005453-4057qib7	4132	16	the	the	DT
cord-005453-4057qib7	4132	17	caveat	caveat	NN
cord-005453-4057qib7	4132	18	of	of	IN
cord-005453-4057qib7	4132	19	limited	limited	JJ
cord-005453-4057qib7	4132	20	numbers	number	NNS
cord-005453-4057qib7	4132	21	in	in	IN
cord-005453-4057qib7	4132	22	this	this	DT
cord-005453-4057qib7	4132	23	study	study	NN
cord-005453-4057qib7	4132	24	,	,	,
cord-005453-4057qib7	4132	25	we	-PRON-	PRP
cord-005453-4057qib7	4132	26	strongly	strongly	RB
cord-005453-4057qib7	4132	27	suspect	suspect	VBP
cord-005453-4057qib7	4132	28	this	this	DT
cord-005453-4057qib7	4132	29	is	be	VBZ
cord-005453-4057qib7	4132	30	further	further	RB
cord-005453-4057qib7	4132	31	increased	increase	VBN
cord-005453-4057qib7	4132	32	when	when	WRB
cord-005453-4057qib7	4132	33	time	time	NN
cord-005453-4057qib7	4132	34	to	to	IN
cord-005453-4057qib7	4132	35	definitive	definitive	JJ
cord-005453-4057qib7	4132	36	treatment	treatment	NN
cord-005453-4057qib7	4132	37	with	with	IN
cord-005453-4057qib7	4132	38	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	4132	39	is	be	VBZ
cord-005453-4057qib7	4132	40	delayed	delay	VBN
cord-005453-4057qib7	4132	41	,	,	,
cord-005453-4057qib7	4132	42	particularly	particularly	RB
cord-005453-4057qib7	4132	43	beyond	beyond	IN
cord-005453-4057qib7	4132	44	7	7	CD
cord-005453-4057qib7	4132	45	days	day	NNS
cord-005453-4057qib7	4132	46	.	.	.
cord-005453-4057qib7	4133	1	Nearly	nearly	RB
cord-005453-4057qib7	4133	2	a	a	DT
cord-005453-4057qib7	4133	3	quarter	quarter	NN
cord-005453-4057qib7	4133	4	of	of	IN
cord-005453-4057qib7	4133	5	cases	case	NNS
cord-005453-4057qib7	4133	6	with	with	IN
cord-005453-4057qib7	4133	7	VOD	VOD	NNP
cord-005453-4057qib7	4133	8	are	be	VBP
cord-005453-4057qib7	4133	9	late	late	JJ
cord-005453-4057qib7	4133	10	-	-	HYPH
cord-005453-4057qib7	4133	11	onset	onset	NN
cord-005453-4057qib7	4133	12	as	as	IN
cord-005453-4057qib7	4133	13	per	per	IN
cord-005453-4057qib7	4133	14	classical	classical	JJ
cord-005453-4057qib7	4133	15	EBMT	EBMT	NNP
cord-005453-4057qib7	4133	16	criteria	criterion	NNS
cord-005453-4057qib7	4133	17	.	.	.
cord-005453-4057qib7	4134	1	However	however	RB
cord-005453-4057qib7	4134	2	contrary	contrary	JJ
cord-005453-4057qib7	4134	3	to	to	IN
cord-005453-4057qib7	4134	4	our	-PRON-	PRP$
cord-005453-4057qib7	4134	5	hypothesis	hypothesis	NN
cord-005453-4057qib7	4134	6	,	,	,
cord-005453-4057qib7	4134	7	their	-PRON-	PRP$
cord-005453-4057qib7	4134	8	overall	overall	JJ
cord-005453-4057qib7	4134	9	outcomes	outcome	NNS
cord-005453-4057qib7	4134	10	and	and	CC
cord-005453-4057qib7	4134	11	mortality	mortality	NN
cord-005453-4057qib7	4134	12	do	do	VBP
cord-005453-4057qib7	4134	13	not	not	RB
cord-005453-4057qib7	4134	14	appear	appear	VB
cord-005453-4057qib7	4134	15	worse	bad	JJR
cord-005453-4057qib7	4134	16	,	,	,
cord-005453-4057qib7	4134	17	with	with	IN
cord-005453-4057qib7	4134	18	time	time	NN
cord-005453-4057qib7	4134	19	to	to	IN
cord-005453-4057qib7	4134	20	treatment	treatment	NN
cord-005453-4057qib7	4134	21	again	again	RB
cord-005453-4057qib7	4134	22	emerging	emerge	VBG
cord-005453-4057qib7	4134	23	as	as	IN
cord-005453-4057qib7	4134	24	a	a	DT
cord-005453-4057qib7	4134	25	strong	strong	JJ
cord-005453-4057qib7	4134	26	predictive	predictive	JJ
cord-005453-4057qib7	4134	27	factor	factor	NN
cord-005453-4057qib7	4134	28	.	.	.
cord-005453-4057qib7	4135	1	Conditioning	conditioning	NN
cord-005453-4057qib7	4135	2	treatment	treatment	NN
cord-005453-4057qib7	4135	3	related	relate	VBN
cord-005453-4057qib7	4135	4	factors	factor	NNS
cord-005453-4057qib7	4135	5	,	,	,
cord-005453-4057qib7	4135	6	which	which	WDT
cord-005453-4057qib7	4135	7	play	play	VBP
cord-005453-4057qib7	4135	8	a	a	DT
cord-005453-4057qib7	4135	9	stronger	strong	JJR
cord-005453-4057qib7	4135	10	role	role	NN
cord-005453-4057qib7	4135	11	in	in	IN
cord-005453-4057qib7	4135	12	endothelial	endothelial	JJ
cord-005453-4057qib7	4135	13	dysfunction	dysfunction	NN
cord-005453-4057qib7	4135	14	in	in	IN
cord-005453-4057qib7	4135	15	the	the	DT
cord-005453-4057qib7	4135	16	hepato	hepato	NN
cord-005453-4057qib7	4135	17	-	-	HYPH
cord-005453-4057qib7	4135	18	portal	portal	JJ
cord-005453-4057qib7	4135	19	circulation	circulation	NN
cord-005453-4057qib7	4135	20	,	,	,
cord-005453-4057qib7	4135	21	may	may	MD
cord-005453-4057qib7	4135	22	not	not	RB
cord-005453-4057qib7	4135	23	be	be	VB
cord-005453-4057qib7	4135	24	as	as	RB
cord-005453-4057qib7	4135	25	much	much	JJ
cord-005453-4057qib7	4135	26	at	at	IN
cord-005453-4057qib7	4135	27	play	play	NN
cord-005453-4057qib7	4135	28	,	,	,
cord-005453-4057qib7	4135	29	perhaps	perhaps	RB
cord-005453-4057qib7	4135	30	for	for	IN
cord-005453-4057qib7	4135	31	late	late	JJ
cord-005453-4057qib7	4135	32	-	-	HYPH
cord-005453-4057qib7	4135	33	onset	onset	NN
cord-005453-4057qib7	4135	34	disease	disease	NN
cord-005453-4057qib7	4135	35	.	.	.
cord-005453-4057qib7	4136	1	Uniformity	uniformity	NN
cord-005453-4057qib7	4136	2	in	in	IN
cord-005453-4057qib7	4136	3	the	the	DT
cord-005453-4057qib7	4136	4	use	use	NN
cord-005453-4057qib7	4136	5	of	of	IN
cord-005453-4057qib7	4136	6	diagnostic	diagnostic	JJ
cord-005453-4057qib7	4136	7	criteria	criterion	NNS
cord-005453-4057qib7	4136	8	,	,	,
cord-005453-4057qib7	4136	9	and	and	CC
cord-005453-4057qib7	4136	10	high	high	JJ
cord-005453-4057qib7	4136	11	degree	degree	NN
cord-005453-4057qib7	4136	12	of	of	IN
cord-005453-4057qib7	4136	13	vigilance	vigilance	NN
cord-005453-4057qib7	4136	14	,	,	,
cord-005453-4057qib7	4136	15	even	even	RB
cord-005453-4057qib7	4136	16	beyond	beyond	IN
cord-005453-4057qib7	4136	17	21	21	CD
cord-005453-4057qib7	4136	18	days	day	NNS
cord-005453-4057qib7	4136	19	,	,	,
cord-005453-4057qib7	4136	20	leading	lead	VBG
cord-005453-4057qib7	4136	21	to	to	IN
cord-005453-4057qib7	4136	22	early	early	JJ
cord-005453-4057qib7	4136	23	treatments	treatment	NNS
cord-005453-4057qib7	4136	24	may	may	MD
cord-005453-4057qib7	4136	25	improve	improve	VB
cord-005453-4057qib7	4136	26	outcomes	outcome	NNS
cord-005453-4057qib7	4136	27	in	in	IN
cord-005453-4057qib7	4136	28	VOD	VOD	NNP
cord-005453-4057qib7	4136	29	.	.	.
cord-005453-4057qib7	4137	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4137	2	:	:	:
cord-005453-4057qib7	4137	3	Nothing	nothing	NN
cord-005453-4057qib7	4137	4	to	to	TO
cord-005453-4057qib7	4137	5	declare	declare	VB
cord-005453-4057qib7	4137	6	Background	background	NN
cord-005453-4057qib7	4137	7	:	:	:
cord-005453-4057qib7	4137	8	HSCT	HSCT	NNP
cord-005453-4057qib7	4137	9	-	-	HYPH
cord-005453-4057qib7	4137	10	associated	associate	VBN
cord-005453-4057qib7	4137	11	thrombotic	thrombotic	JJ
cord-005453-4057qib7	4137	12	microangiopathy	microangiopathy	NNP
cord-005453-4057qib7	4137	13	(	(	-LRB-
cord-005453-4057qib7	4137	14	TA	TA	NNP
cord-005453-4057qib7	4137	15	-	-	HYPH
cord-005453-4057qib7	4137	16	TMA	TMA	NNP
cord-005453-4057qib7	4137	17	)	)	-RRB-
cord-005453-4057qib7	4137	18	affects	affect	VBZ
cord-005453-4057qib7	4137	19	10	10	CD
cord-005453-4057qib7	4137	20	-	-	SYM
cord-005453-4057qib7	4137	21	30	30	CD
cord-005453-4057qib7	4137	22	%	%	NN
cord-005453-4057qib7	4137	23	of	of	IN
cord-005453-4057qib7	4137	24	patients	patient	NNS
cord-005453-4057qib7	4137	25	receiving	receive	VBG
cord-005453-4057qib7	4137	26	an	an	DT
cord-005453-4057qib7	4137	27	allogenic	allogenic	JJ
cord-005453-4057qib7	4137	28	SCT	sct	NN
cord-005453-4057qib7	4137	29	,	,	,
cord-005453-4057qib7	4137	30	with	with	IN
cord-005453-4057qib7	4137	31	a	a	DT
cord-005453-4057qib7	4137	32	high	high	JJ
cord-005453-4057qib7	4137	33	mortality	mortality	NN
cord-005453-4057qib7	4137	34	up	up	IN
cord-005453-4057qib7	4137	35	to	to	TO
cord-005453-4057qib7	4137	36	80	80	CD
cord-005453-4057qib7	4137	37	-	-	SYM
cord-005453-4057qib7	4137	38	90	90	CD
cord-005453-4057qib7	4137	39	%	%	NN
cord-005453-4057qib7	4137	40	in	in	IN
cord-005453-4057qib7	4137	41	severe	severe	JJ
cord-005453-4057qib7	4137	42	cases	case	NNS
cord-005453-4057qib7	4137	43	.	.	.
cord-005453-4057qib7	4138	1	Endothelial	endothelial	JJ
cord-005453-4057qib7	4138	2	injury	injury	NN
cord-005453-4057qib7	4138	3	mediated	mediate	VBN
cord-005453-4057qib7	4138	4	by	by	IN
cord-005453-4057qib7	4138	5	complement	complement	JJ
cord-005453-4057qib7	4138	6	activation	activation	NN
cord-005453-4057qib7	4138	7	has	have	VBZ
cord-005453-4057qib7	4138	8	been	be	VBN
cord-005453-4057qib7	4138	9	atribuited	atribuite	VBN
cord-005453-4057qib7	4138	10	a	a	DT
cord-005453-4057qib7	4138	11	major	major	JJ
cord-005453-4057qib7	4138	12	role	role	NN
cord-005453-4057qib7	4138	13	in	in	IN
cord-005453-4057qib7	4138	14	the	the	DT
cord-005453-4057qib7	4138	15	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	4138	16	,	,	,
cord-005453-4057qib7	4138	17	and	and	CC
cord-005453-4057qib7	4138	18	blockade	blockade	NN
cord-005453-4057qib7	4138	19	of	of	IN
cord-005453-4057qib7	4138	20	C5	C5	NNP
cord-005453-4057qib7	4138	21	with	with	IN
cord-005453-4057qib7	4138	22	Eculizumab	Eculizumab	NNP
cord-005453-4057qib7	4138	23	offers	offer	VBZ
cord-005453-4057qib7	4138	24	promising	promising	JJ
cord-005453-4057qib7	4138	25	results	result	NNS
cord-005453-4057qib7	4138	26	.	.	.
cord-005453-4057qib7	4139	1	Methods	method	NNS
cord-005453-4057qib7	4139	2	:	:	:
cord-005453-4057qib7	4139	3	We	-PRON-	PRP
cord-005453-4057qib7	4139	4	present	present	VBP
cord-005453-4057qib7	4139	5	our	-PRON-	PRP$
cord-005453-4057qib7	4139	6	experience	experience	NN
cord-005453-4057qib7	4139	7	with	with	IN
cord-005453-4057qib7	4139	8	6	6	CD
cord-005453-4057qib7	4139	9	pediatric	pediatric	JJ
cord-005453-4057qib7	4139	10	cases	case	NNS
cord-005453-4057qib7	4139	11	of	of	IN
cord-005453-4057qib7	4139	12	TA	TA	NNP
cord-005453-4057qib7	4139	13	-	-	HYPH
cord-005453-4057qib7	4139	14	TMA	TMA	NNP
cord-005453-4057qib7	4139	15	treated	treat	VBN
cord-005453-4057qib7	4139	16	with	with	IN
cord-005453-4057qib7	4139	17	Eculizumab	Eculizumab	NNP
cord-005453-4057qib7	4139	18	.	.	.
cord-005453-4057qib7	4140	1	The	the	DT
cord-005453-4057qib7	4140	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	4140	3	of	of	IN
cord-005453-4057qib7	4140	4	TA	TA	NNP
cord-005453-4057qib7	4140	5	-	-	HYPH
cord-005453-4057qib7	4140	6	TMA	TMA	NNP
cord-005453-4057qib7	4140	7	was	be	VBD
cord-005453-4057qib7	4140	8	stablished	stablishe	VBN
cord-005453-4057qib7	4140	9	attending	attend	VBG
cord-005453-4057qib7	4140	10	to	to	IN
cord-005453-4057qib7	4140	11	Jodele	Jodele	NNP
cord-005453-4057qib7	4140	12	et	et	NNP
cord-005453-4057qib7	4140	13	al	al	NNP
cord-005453-4057qib7	4140	14	criteria	criterion	NNS
cord-005453-4057qib7	4140	15	.	.	.
cord-005453-4057qib7	4141	1	Clinical	clinical	JJ
cord-005453-4057qib7	4141	2	data	datum	NNS
cord-005453-4057qib7	4141	3	were	be	VBD
cord-005453-4057qib7	4141	4	collected	collect	VBN
cord-005453-4057qib7	4141	5	retrospectively	retrospectively	RB
cord-005453-4057qib7	4141	6	from	from	IN
cord-005453-4057qib7	4141	7	medical	medical	JJ
cord-005453-4057qib7	4141	8	records	record	NNS
cord-005453-4057qib7	4141	9	.	.	.
cord-005453-4057qib7	4142	1	Results	result	NNS
cord-005453-4057qib7	4142	2	:	:	:
cord-005453-4057qib7	4143	1	All	all	DT
cord-005453-4057qib7	4143	2	cases	case	NNS
cord-005453-4057qib7	4143	3	were	be	VBD
cord-005453-4057qib7	4143	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	4143	5	between	between	IN
cord-005453-4057qib7	4143	6	August	August	NNP
cord-005453-4057qib7	4143	7	2016	2016	CD
cord-005453-4057qib7	4143	8	and	and	CC
cord-005453-4057qib7	4143	9	April	April	NNP
cord-005453-4057qib7	4143	10	2018	2018	CD
cord-005453-4057qib7	4143	11	,	,	,
cord-005453-4057qib7	4143	12	with	with	IN
cord-005453-4057qib7	4143	13	a	a	DT
cord-005453-4057qib7	4143	14	median	median	JJ
cord-005453-4057qib7	4143	15	age	age	NN
cord-005453-4057qib7	4143	16	of	of	IN
cord-005453-4057qib7	4143	17	11	11	CD
cord-005453-4057qib7	4143	18	years	year	NNS
cord-005453-4057qib7	4143	19	(	(	-LRB-
cord-005453-4057qib7	4143	20	2.5	2.5	CD
cord-005453-4057qib7	4143	21	-17	-17	CD
cord-005453-4057qib7	4143	22	)	)	-RRB-
cord-005453-4057qib7	4143	23	at	at	IN
cord-005453-4057qib7	4143	24	time	time	NN
cord-005453-4057qib7	4143	25	of	of	IN
cord-005453-4057qib7	4143	26	diagnosis	diagnosis	NN
cord-005453-4057qib7	4143	27	.	.	.
cord-005453-4057qib7	4144	1	Primary	primary	JJ
cord-005453-4057qib7	4144	2	disease	disease	NN
cord-005453-4057qib7	4144	3	was	be	VBD
cord-005453-4057qib7	4144	4	acute	acute	JJ
cord-005453-4057qib7	4144	5	leukemia	leukemia	NN
cord-005453-4057qib7	4144	6	in	in	IN
cord-005453-4057qib7	4144	7	2	2	CD
cord-005453-4057qib7	4144	8	cases	case	NNS
cord-005453-4057qib7	4144	9	(	(	-LRB-
cord-005453-4057qib7	4144	10	1	1	CD
cord-005453-4057qib7	4144	11	ALL	all	DT
cord-005453-4057qib7	4144	12	and	and	CC
cord-005453-4057qib7	4144	13	1	1	CD
cord-005453-4057qib7	4144	14	AML	AML	NNP
cord-005453-4057qib7	4144	15	)	)	-RRB-
cord-005453-4057qib7	4144	16	,	,	,
cord-005453-4057qib7	4144	17	severe	severe	JJ
cord-005453-4057qib7	4144	18	aplastic	aplastic	JJ
cord-005453-4057qib7	4144	19	anemia	anemia	NN
cord-005453-4057qib7	4144	20	in	in	IN
cord-005453-4057qib7	4144	21	3	3	CD
cord-005453-4057qib7	4144	22	,	,	,
cord-005453-4057qib7	4144	23	and	and	CC
cord-005453-4057qib7	4144	24	primary	primary	JJ
cord-005453-4057qib7	4144	25	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	4144	26	in	in	IN
cord-005453-4057qib7	4144	27	1	1	CD
cord-005453-4057qib7	4144	28	.	.	.
cord-005453-4057qib7	4145	1	They	-PRON-	PRP
cord-005453-4057qib7	4145	2	received	receive	VBD
cord-005453-4057qib7	4145	3	their	-PRON-	PRP$
cord-005453-4057qib7	4145	4	first	first	JJ
cord-005453-4057qib7	4145	5	SCT	SCT	NNP
cord-005453-4057qib7	4145	6	in	in	IN
cord-005453-4057qib7	4145	7	all	all	DT
cord-005453-4057qib7	4145	8	cases	case	NNS
cord-005453-4057qib7	4145	9	,	,	,
cord-005453-4057qib7	4145	10	3	3	CD
cord-005453-4057qib7	4145	11	from	from	IN
cord-005453-4057qib7	4145	12	MUD	mud	NN
cord-005453-4057qib7	4145	13	and	and	CC
cord-005453-4057qib7	4145	14	3	3	CD
cord-005453-4057qib7	4145	15	from	from	IN
cord-005453-4057qib7	4145	16	MMRD	MMRD	NNP
cord-005453-4057qib7	4146	1	(	(	-LRB-
cord-005453-4057qib7	4146	2	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	4146	3	depleted	deplete	VBD
cord-005453-4057qib7	4146	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4146	5	grafts	graft	NNS
cord-005453-4057qib7	4146	6	)	)	-RRB-
cord-005453-4057qib7	4146	7	,	,	,
cord-005453-4057qib7	4146	8	with	with	IN
cord-005453-4057qib7	4146	9	MAC	MAC	NNP
cord-005453-4057qib7	4146	10	regimen	regimen	NN
cord-005453-4057qib7	4146	11	in	in	IN
cord-005453-4057qib7	4146	12	2	2	CD
cord-005453-4057qib7	4146	13	cases	case	NNS
cord-005453-4057qib7	4146	14	,	,	,
cord-005453-4057qib7	4146	15	and	and	CC
cord-005453-4057qib7	4146	16	RIC	RIC	NNP
cord-005453-4057qib7	4146	17	in	in	IN
cord-005453-4057qib7	4146	18	4	4	CD
cord-005453-4057qib7	4146	19	cases	case	NNS
cord-005453-4057qib7	4146	20	.	.	.
cord-005453-4057qib7	4147	1	3	3	CD
cord-005453-4057qib7	4147	2	of	of	IN
cord-005453-4057qib7	4147	3	them	-PRON-	PRP
cord-005453-4057qib7	4147	4	received	receive	VBD
cord-005453-4057qib7	4147	5	calcineurin	calcineurin	NNP
cord-005453-4057qib7	4147	6	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4147	7	(	(	-LRB-
cord-005453-4057qib7	4147	8	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	4147	9	)	)	-RRB-
cord-005453-4057qib7	4147	10	as	as	IN
cord-005453-4057qib7	4147	11	GVHD	GVHD	NNP
cord-005453-4057qib7	4147	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4147	13	.	.	.
cord-005453-4057qib7	4148	1	All	all	DT
cord-005453-4057qib7	4148	2	patients	patient	NNS
cord-005453-4057qib7	4148	3	developed	develop	VBD
cord-005453-4057qib7	4148	4	aGVHD	aGVHD	NNP
cord-005453-4057qib7	4149	1	(	(	-LRB-
cord-005453-4057qib7	4149	2	grade	grade	NN
cord-005453-4057qib7	4149	3	2	2	CD
cord-005453-4057qib7	4149	4	or	or	CC
cord-005453-4057qib7	4149	5	higher	high	JJR
cord-005453-4057qib7	4149	6	in	in	IN
cord-005453-4057qib7	4149	7	3	3	CD
cord-005453-4057qib7	4149	8	cases	case	NNS
cord-005453-4057qib7	4149	9	)	)	-RRB-
cord-005453-4057qib7	4149	10	.	.	.
cord-005453-4057qib7	4150	1	and	and	CC
cord-005453-4057qib7	4150	2	5	5	CD
cord-005453-4057qib7	4150	3	patients	patient	NNS
cord-005453-4057qib7	4150	4	presented	present	VBD
cord-005453-4057qib7	4150	5	viral	viral	JJ
cord-005453-4057qib7	4150	6	reactivation	reactivation	NN
cord-005453-4057qib7	4150	7	.	.	.
cord-005453-4057qib7	4151	1	Hypertension	hypertension	NN
cord-005453-4057qib7	4151	2	was	be	VBD
cord-005453-4057qib7	4151	3	present	present	JJ
cord-005453-4057qib7	4151	4	in	in	IN
cord-005453-4057qib7	4151	5	4	4	CD
cord-005453-4057qib7	4151	6	cases	case	NNS
cord-005453-4057qib7	4151	7	at	at	IN
cord-005453-4057qib7	4151	8	TMA	TMA	NNP
cord-005453-4057qib7	4151	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	4151	10	,	,	,
cord-005453-4057qib7	4151	11	requiring	require	VBG
cord-005453-4057qib7	4151	12	2	2	CD
cord-005453-4057qib7	4151	13	or	or	CC
cord-005453-4057qib7	4151	14	more	more	JJR
cord-005453-4057qib7	4151	15	antihypertensive	antihypertensive	JJ
cord-005453-4057qib7	4151	16	drugs	drug	NNS
cord-005453-4057qib7	4151	17	in	in	IN
cord-005453-4057qib7	4151	18	3	3	CD
cord-005453-4057qib7	4151	19	of	of	IN
cord-005453-4057qib7	4151	20	them	-PRON-	PRP
cord-005453-4057qib7	4151	21	.	.	.
cord-005453-4057qib7	4152	1	All	all	DT
cord-005453-4057qib7	4152	2	patients	patient	NNS
cord-005453-4057qib7	4152	3	had	have	VBD
cord-005453-4057qib7	4152	4	renal	renal	JJ
cord-005453-4057qib7	4152	5	injury	injury	NN
cord-005453-4057qib7	4152	6	consisting	consist	VBG
cord-005453-4057qib7	4152	7	of	of	IN
cord-005453-4057qib7	4152	8	less	less	JJR
cord-005453-4057qib7	4152	9	-	-	HYPH
cord-005453-4057qib7	4152	10	than	than	IN
cord-005453-4057qib7	4152	11	-	-	HYPH
cord-005453-4057qib7	4152	12	normal	normal	JJ
cord-005453-4057qib7	4152	13	glomerular	glomerular	JJ
cord-005453-4057qib7	4152	14	filtration	filtration	NN
cord-005453-4057qib7	4152	15	rate	rate	NN
cord-005453-4057qib7	4152	16	(	(	-LRB-
cord-005453-4057qib7	4152	17	median	median	NN
cord-005453-4057qib7	4152	18	of	of	IN
cord-005453-4057qib7	4152	19	41	41	CD
cord-005453-4057qib7	4152	20	(	(	-LRB-
cord-005453-4057qib7	4152	21	20	20	CD
cord-005453-4057qib7	4152	22	-	-	SYM
cord-005453-4057qib7	4152	23	59	59	CD
cord-005453-4057qib7	4152	24	)	)	-RRB-
cord-005453-4057qib7	4152	25	)	)	-RRB-
cord-005453-4057qib7	4152	26	and	and	CC
cord-005453-4057qib7	4152	27	proteinuria	proteinuria	NN
cord-005453-4057qib7	4152	28	,	,	,
cord-005453-4057qib7	4152	29	with	with	IN
cord-005453-4057qib7	4152	30	urine	urine	NN
cord-005453-4057qib7	4152	31	protein	protein	NN
cord-005453-4057qib7	4152	32	-	-	HYPH
cord-005453-4057qib7	4152	33	to	to	IN
cord-005453-4057qib7	4152	34	-	-	HYPH
cord-005453-4057qib7	4152	35	creatinine	creatinine	NN
cord-005453-4057qib7	4152	36	ratio	ratio	NN
cord-005453-4057qib7	4152	37	higher	high	JJR
cord-005453-4057qib7	4152	38	tan	tan	NNP
cord-005453-4057qib7	4152	39	2	2	CD
cord-005453-4057qib7	4152	40	mg	mg	NNP
cord-005453-4057qib7	4152	41	/	/	SYM
cord-005453-4057qib7	4152	42	mg	mg	NN
cord-005453-4057qib7	4152	43	in	in	IN
cord-005453-4057qib7	4152	44	2	2	CD
cord-005453-4057qib7	4152	45	cases	case	NNS
cord-005453-4057qib7	4153	1	(	(	-LRB-
cord-005453-4057qib7	4153	2	data	datum	NNS
cord-005453-4057qib7	4153	3	not	not	RB
cord-005453-4057qib7	4153	4	available	available	JJ
cord-005453-4057qib7	4153	5	in	in	IN
cord-005453-4057qib7	4153	6	2	2	CD
cord-005453-4057qib7	4153	7	patients	patient	NNS
cord-005453-4057qib7	4153	8	)	)	-RRB-
cord-005453-4057qib7	4153	9	.	.	.
cord-005453-4057qib7	4154	1	Serum	serum	NN
cord-005453-4057qib7	4154	2	haptoglobin	haptoglobin	NN
cord-005453-4057qib7	4154	3	was	be	VBD
cord-005453-4057qib7	4154	4	decreased	decrease	VBN
cord-005453-4057qib7	4154	5	in	in	IN
cord-005453-4057qib7	4154	6	just	just	RB
cord-005453-4057qib7	4154	7	2	2	CD
cord-005453-4057qib7	4154	8	cases	case	NNS
cord-005453-4057qib7	4154	9	at	at	IN
cord-005453-4057qib7	4154	10	diagnosis	diagnosis	NN
cord-005453-4057qib7	4154	11	,	,	,
cord-005453-4057qib7	4154	12	and	and	CC
cord-005453-4057qib7	4154	13	schistocytes	schistocyte	NNS
cord-005453-4057qib7	4154	14	were	be	VBD
cord-005453-4057qib7	4154	15	detected	detect	VBN
cord-005453-4057qib7	4154	16	in	in	IN
cord-005453-4057qib7	4154	17	3	3	CD
cord-005453-4057qib7	4154	18	patients	patient	NNS
cord-005453-4057qib7	4154	19	.	.	.
cord-005453-4057qib7	4155	1	Cutaneos	cutaneos	JJ
cord-005453-4057qib7	4155	2	signs	sign	NNS
cord-005453-4057qib7	4155	3	were	be	VBD
cord-005453-4057qib7	4155	4	present	present	JJ
cord-005453-4057qib7	4155	5	in	in	IN
cord-005453-4057qib7	4155	6	all	all	DT
cord-005453-4057qib7	4155	7	cases	case	NNS
cord-005453-4057qib7	4155	8	,	,	,
cord-005453-4057qib7	4155	9	digestive	digestive	JJ
cord-005453-4057qib7	4155	10	symptoms	symptom	NNS
cord-005453-4057qib7	4155	11	in	in	IN
cord-005453-4057qib7	4155	12	2	2	CD
cord-005453-4057qib7	4155	13	,	,	,
cord-005453-4057qib7	4155	14	neurological	neurological	JJ
cord-005453-4057qib7	4155	15	affection	affection	NN
cord-005453-4057qib7	4155	16	in	in	IN
cord-005453-4057qib7	4155	17	2	2	CD
cord-005453-4057qib7	4155	18	,	,	,
cord-005453-4057qib7	4155	19	and	and	CC
cord-005453-4057qib7	4155	20	notoriously	notoriously	RB
cord-005453-4057qib7	4155	21	all	all	DT
cord-005453-4057qib7	4155	22	of	of	IN
cord-005453-4057qib7	4155	23	them	-PRON-	PRP
cord-005453-4057qib7	4155	24	developed	develop	VBD
cord-005453-4057qib7	4155	25	polyserositis	polyserositis	NN
cord-005453-4057qib7	4155	26	.	.	.
cord-005453-4057qib7	4156	1	C3	C3	NNP
cord-005453-4057qib7	4156	2	and	and	CC
cord-005453-4057qib7	4156	3	C4	C4	NNP
cord-005453-4057qib7	4156	4	were	be	VBD
cord-005453-4057qib7	4156	5	normal	normal	JJ
cord-005453-4057qib7	4156	6	in	in	IN
cord-005453-4057qib7	4156	7	all	all	DT
cord-005453-4057qib7	4156	8	cases	case	NNS
cord-005453-4057qib7	4156	9	,	,	,
cord-005453-4057qib7	4156	10	with	with	IN
cord-005453-4057qib7	4156	11	sC5b9	sC5b9	NNS
cord-005453-4057qib7	4156	12	higher	high	JJR
cord-005453-4057qib7	4156	13	than	than	IN
cord-005453-4057qib7	4156	14	244	244	CD
cord-005453-4057qib7	4156	15	ng	ng	NN
cord-005453-4057qib7	4156	16	/	/	SYM
cord-005453-4057qib7	4156	17	mL	ml	NN
cord-005453-4057qib7	4156	18	in	in	IN
cord-005453-4057qib7	4156	19	2	2	CD
cord-005453-4057qib7	4156	20	patients	patient	NNS
cord-005453-4057qib7	4156	21	and	and	CC
cord-005453-4057qib7	4156	22	lower	low	JJR
cord-005453-4057qib7	4156	23	in	in	IN
cord-005453-4057qib7	4156	24	1	1	CD
cord-005453-4057qib7	4156	25	(	(	-LRB-
cord-005453-4057qib7	4156	26	data	datum	NNS
cord-005453-4057qib7	4156	27	not	not	RB
cord-005453-4057qib7	4156	28	available	available	JJ
cord-005453-4057qib7	4156	29	in	in	IN
cord-005453-4057qib7	4156	30	3	3	CD
cord-005453-4057qib7	4156	31	cases	case	NNS
cord-005453-4057qib7	4156	32	)	)	-RRB-
cord-005453-4057qib7	4156	33	.	.	.
cord-005453-4057qib7	4157	1	All	all	DT
cord-005453-4057qib7	4157	2	patients	patient	NNS
cord-005453-4057qib7	4157	3	received	receive	VBD
cord-005453-4057qib7	4157	4	defibrotide	defibrotide	NN
cord-005453-4057qib7	4157	5	as	as	IN
cord-005453-4057qib7	4157	6	treatment	treatment	NN
cord-005453-4057qib7	4157	7	,	,	,
cord-005453-4057qib7	4157	8	and	and	CC
cord-005453-4057qib7	4157	9	4	4	CD
cord-005453-4057qib7	4157	10	cases	case	NNS
cord-005453-4057qib7	4157	11	received	receive	VBN
cord-005453-4057qib7	4157	12	also	also	RB
cord-005453-4057qib7	4157	13	rituximab	rituximab	VBN
cord-005453-4057qib7	4157	14	,	,	,
cord-005453-4057qib7	4157	15	associated	associate	VBN
cord-005453-4057qib7	4157	16	to	to	IN
cord-005453-4057qib7	4157	17	therapeutical	therapeutical	JJ
cord-005453-4057qib7	4157	18	plasma	plasma	NN
cord-005453-4057qib7	4157	19	exchange	exchange	NN
cord-005453-4057qib7	4157	20	in	in	IN
cord-005453-4057qib7	4157	21	3	3	CD
cord-005453-4057qib7	4157	22	.	.	.
cord-005453-4057qib7	4158	1	All	all	DT
cord-005453-4057qib7	4158	2	of	of	IN
cord-005453-4057qib7	4158	3	them	-PRON-	PRP
cord-005453-4057qib7	4158	4	received	receive	VBD
cord-005453-4057qib7	4158	5	Eculizumab	Eculizumab	NNP
cord-005453-4057qib7	4158	6	,	,	,
cord-005453-4057qib7	4158	7	as	as	IN
cord-005453-4057qib7	4158	8	first	first	JJ
cord-005453-4057qib7	4158	9	line	line	NN
cord-005453-4057qib7	4158	10	in	in	IN
cord-005453-4057qib7	4158	11	2	2	CD
cord-005453-4057qib7	4158	12	cases	case	NNS
cord-005453-4057qib7	4158	13	(	(	-LRB-
cord-005453-4057qib7	4158	14	median	median	NN
cord-005453-4057qib7	4158	15	of	of	IN
cord-005453-4057qib7	4158	16	40	40	CD
cord-005453-4057qib7	4158	17	days	day	NNS
cord-005453-4057qib7	4158	18	between	between	IN
cord-005453-4057qib7	4158	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	4158	20	and	and	CC
cord-005453-4057qib7	4158	21	Eculizumab	Eculizumab	NNP
cord-005453-4057qib7	4158	22	start	start	VBP
cord-005453-4057qib7	4158	23	)	)	-RRB-
cord-005453-4057qib7	4158	24	.	.	.
cord-005453-4057qib7	4159	1	Treatment	treatment	NN
cord-005453-4057qib7	4159	2	was	be	VBD
cord-005453-4057qib7	4159	3	correctly	correctly	RB
cord-005453-4057qib7	4159	4	monitorized	monitorize	VBN
cord-005453-4057qib7	4159	5	with	with	IN
cord-005453-4057qib7	4159	6	CH50	CH50	NNP
cord-005453-4057qib7	4159	7	levels	level	NNS
cord-005453-4057qib7	4159	8	in	in	IN
cord-005453-4057qib7	4159	9	3	3	CD
cord-005453-4057qib7	4159	10	cases	case	NNS
cord-005453-4057qib7	4159	11	(	(	-LRB-
cord-005453-4057qib7	4159	12	not	not	RB
cord-005453-4057qib7	4159	13	available	available	JJ
cord-005453-4057qib7	4159	14	quick	quick	JJ
cord-005453-4057qib7	4159	15	enough	enough	RB
cord-005453-4057qib7	4159	16	in	in	IN
cord-005453-4057qib7	4159	17	other	other	JJ
cord-005453-4057qib7	4159	18	3	3	CD
cord-005453-4057qib7	4159	19	)	)	-RRB-
cord-005453-4057qib7	4159	20	.	.	.
cord-005453-4057qib7	4160	1	Median	median	JJ
cord-005453-4057qib7	4160	2	number	number	NN
cord-005453-4057qib7	4160	3	of	of	IN
cord-005453-4057qib7	4160	4	doses	dose	NNS
cord-005453-4057qib7	4160	5	needed	need	VBN
cord-005453-4057qib7	4160	6	in	in	IN
cord-005453-4057qib7	4160	7	induction	induction	NN
cord-005453-4057qib7	4160	8	therapy	therapy	NN
cord-005453-4057qib7	4160	9	was	be	VBD
cord-005453-4057qib7	4160	10	8	8	CD
cord-005453-4057qib7	4160	11	,	,	,
cord-005453-4057qib7	4160	12	and	and	CC
cord-005453-4057qib7	4160	13	median	median	JJ
cord-005453-4057qib7	4160	14	interval	interval	NN
cord-005453-4057qib7	4160	15	between	between	IN
cord-005453-4057qib7	4160	16	doses	dose	NNS
cord-005453-4057qib7	4160	17	was	be	VBD
cord-005453-4057qib7	4160	18	7	7	CD
cord-005453-4057qib7	4160	19	days	day	NNS
cord-005453-4057qib7	4160	20	.	.	.
cord-005453-4057qib7	4161	1	2	2	CD
cord-005453-4057qib7	4161	2	patients	patient	NNS
cord-005453-4057qib7	4161	3	required	require	VBN
cord-005453-4057qib7	4161	4	reduced	reduced	JJ
cord-005453-4057qib7	4161	5	interval	interval	NN
cord-005453-4057qib7	4161	6	and	and	CC
cord-005453-4057qib7	4161	7	higher	high	JJR
cord-005453-4057qib7	4161	8	doses	dose	NNS
cord-005453-4057qib7	4161	9	to	to	TO
cord-005453-4057qib7	4161	10	maintain	maintain	VB
cord-005453-4057qib7	4161	11	CH50	CH50	NNP
cord-005453-4057qib7	4161	12	supressed	supresse	VBN
cord-005453-4057qib7	4161	13	.	.	.
cord-005453-4057qib7	4162	1	2	2	CD
cord-005453-4057qib7	4162	2	patients	patient	NNS
cord-005453-4057qib7	4162	3	did	do	VBD
cord-005453-4057qib7	4162	4	not	not	RB
cord-005453-4057qib7	4162	5	respond	respond	VB
cord-005453-4057qib7	4162	6	,	,	,
cord-005453-4057qib7	4162	7	and	and	CC
cord-005453-4057qib7	4162	8	died	die	VBD
cord-005453-4057qib7	4162	9	because	because	IN
cord-005453-4057qib7	4162	10	of	of	IN
cord-005453-4057qib7	4162	11	TMA	TMA	NNP
cord-005453-4057qib7	4162	12	.	.	.
cord-005453-4057qib7	4163	1	4	4	CD
cord-005453-4057qib7	4163	2	patients	patient	NNS
cord-005453-4057qib7	4163	3	had	have	VBD
cord-005453-4057qib7	4163	4	hematological	hematological	JJ
cord-005453-4057qib7	4163	5	response	response	NN
cord-005453-4057qib7	4163	6	,	,	,
cord-005453-4057qib7	4163	7	with	with	IN
cord-005453-4057qib7	4163	8	chronic	chronic	JJ
cord-005453-4057qib7	4163	9	renal	renal	JJ
cord-005453-4057qib7	4163	10	injury	injury	NN
cord-005453-4057qib7	4163	11	in	in	IN
cord-005453-4057qib7	4163	12	3	3	CD
cord-005453-4057qib7	4163	13	of	of	IN
cord-005453-4057qib7	4163	14	them	-PRON-	PRP
cord-005453-4057qib7	4163	15	and	and	CC
cord-005453-4057qib7	4163	16	resolution	resolution	NN
cord-005453-4057qib7	4163	17	of	of	IN
cord-005453-4057qib7	4163	18	acute	acute	JJ
cord-005453-4057qib7	4163	19	renal	renal	JJ
cord-005453-4057qib7	4163	20	failure	failure	NN
cord-005453-4057qib7	4163	21	in	in	IN
cord-005453-4057qib7	4163	22	1	1	CD
cord-005453-4057qib7	4163	23	case	case	NN
cord-005453-4057qib7	4163	24	.	.	.
cord-005453-4057qib7	4164	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	4164	2	1	1	CD
cord-005453-4057qib7	4164	3	patient	patient	NN
cord-005453-4057qib7	4164	4	responding	respond	VBG
cord-005453-4057qib7	4164	5	to	to	IN
cord-005453-4057qib7	4164	6	Eculizumab	Eculizumab	NNP
cord-005453-4057qib7	4164	7	died	die	VBD
cord-005453-4057qib7	4164	8	because	because	IN
cord-005453-4057qib7	4164	9	of	of	IN
cord-005453-4057qib7	4164	10	TMA	TMA	NNP
cord-005453-4057qib7	4164	11	related	relate	VBN
cord-005453-4057qib7	4164	12	complications	complication	NNS
cord-005453-4057qib7	4164	13	,	,	,
cord-005453-4057qib7	4164	14	and	and	CC
cord-005453-4057qib7	4164	15	1	1	CD
cord-005453-4057qib7	4164	16	because	because	IN
cord-005453-4057qib7	4164	17	of	of	IN
cord-005453-4057qib7	4164	18	an	an	DT
cord-005453-4057qib7	4164	19	invasive	invasive	JJ
cord-005453-4057qib7	4164	20	fungal	fungal	NN
cord-005453-4057qib7	4164	21	infection	infection	NN
cord-005453-4057qib7	4164	22	.	.	.
cord-005453-4057qib7	4165	1	2	2	CD
cord-005453-4057qib7	4165	2	patients	patient	NNS
cord-005453-4057qib7	4165	3	are	be	VBP
cord-005453-4057qib7	4165	4	alive	alive	JJ
cord-005453-4057qib7	4165	5	,	,	,
cord-005453-4057qib7	4165	6	with	with	IN
cord-005453-4057qib7	4165	7	a	a	DT
cord-005453-4057qib7	4165	8	median	median	NN
cord-005453-4057qib7	4165	9	follow	follow	NN
cord-005453-4057qib7	4165	10	up	up	IN
cord-005453-4057qib7	4165	11	of	of	IN
cord-005453-4057qib7	4165	12	6	6	CD
cord-005453-4057qib7	4165	13	months	month	NNS
cord-005453-4057qib7	4165	14	from	from	IN
cord-005453-4057qib7	4165	15	treatment	treatment	NN
cord-005453-4057qib7	4165	16	start	start	NN
cord-005453-4057qib7	4165	17	.	.	.
cord-005453-4057qib7	4166	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4166	2	:	:	:
cord-005453-4057qib7	4167	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4167	2	experience	experience	NN
cord-005453-4057qib7	4167	3	supports	support	VBZ
cord-005453-4057qib7	4167	4	promising	promising	JJ
cord-005453-4057qib7	4167	5	results	result	NNS
cord-005453-4057qib7	4167	6	of	of	IN
cord-005453-4057qib7	4167	7	Eculizumab	Eculizumab	NNP
cord-005453-4057qib7	4167	8	based	base	VBN
cord-005453-4057qib7	4167	9	treatment	treatment	NN
cord-005453-4057qib7	4167	10	for	for	IN
cord-005453-4057qib7	4167	11	TA	TA	NNP
cord-005453-4057qib7	4167	12	-	-	HYPH
cord-005453-4057qib7	4167	13	TMA	TMA	NNP
cord-005453-4057qib7	4167	14	,	,	,
cord-005453-4057qib7	4167	15	highlighting	highlight	VBG
cord-005453-4057qib7	4167	16	the	the	DT
cord-005453-4057qib7	4167	17	importance	importance	NN
cord-005453-4057qib7	4167	18	of	of	IN
cord-005453-4057qib7	4167	19	an	an	DT
cord-005453-4057qib7	4167	20	early	early	JJ
cord-005453-4057qib7	4167	21	treatment	treatment	NN
cord-005453-4057qib7	4167	22	and	and	CC
cord-005453-4057qib7	4167	23	a	a	DT
cord-005453-4057qib7	4167	24	careful	careful	JJ
cord-005453-4057qib7	4167	25	therapy	therapy	NN
cord-005453-4057qib7	4167	26	monitoring	monitoring	NN
cord-005453-4057qib7	4167	27	by	by	IN
cord-005453-4057qib7	4167	28	CH50	CH50	NNP
cord-005453-4057qib7	4167	29	supression	supression	NN
cord-005453-4057qib7	4167	30	.	.	.
cord-005453-4057qib7	4168	1	Prospective	prospective	JJ
cord-005453-4057qib7	4168	2	studies	study	NNS
cord-005453-4057qib7	4168	3	are	be	VBP
cord-005453-4057qib7	4168	4	needed	need	VBN
cord-005453-4057qib7	4168	5	to	to	TO
cord-005453-4057qib7	4168	6	achieve	achieve	VB
cord-005453-4057qib7	4168	7	a	a	DT
cord-005453-4057qib7	4168	8	better	well	JJR
cord-005453-4057qib7	4168	9	knowledge	knowledge	NN
cord-005453-4057qib7	4168	10	of	of	IN
cord-005453-4057qib7	4168	11	this	this	DT
cord-005453-4057qib7	4168	12	pathology	pathology	NN
cord-005453-4057qib7	4168	13	and	and	CC
cord-005453-4057qib7	4168	14	its	-PRON-	PRP$
cord-005453-4057qib7	4168	15	treatment	treatment	NN
cord-005453-4057qib7	4168	16	.	.	.
cord-005453-4057qib7	4169	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4169	2	:	:	:
cord-005453-4057qib7	4169	3	Nothing	nothing	NN
cord-005453-4057qib7	4169	4	to	to	TO
cord-005453-4057qib7	4169	5	declare	declare	VB
cord-005453-4057qib7	4169	6	Background	background	NN
cord-005453-4057qib7	4169	7	:	:	:
cord-005453-4057qib7	4170	1	Approximately	approximately	RB
cord-005453-4057qib7	4170	2	40	40	CD
cord-005453-4057qib7	4170	3	-	-	SYM
cord-005453-4057qib7	4170	4	50	50	CD
cord-005453-4057qib7	4170	5	%	%	NN
cord-005453-4057qib7	4170	6	of	of	IN
cord-005453-4057qib7	4170	7	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	4170	8	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	4170	9	Stem	Stem	NNP
cord-005453-4057qib7	4170	10	Cell	cell	NN
cord-005453-4057qib7	4170	11	Transplant	transplant	NN
cord-005453-4057qib7	4170	12	(	(	-LRB-
cord-005453-4057qib7	4170	13	Allo	Allo	NNP
cord-005453-4057qib7	4170	14	-	-	HYPH
cord-005453-4057qib7	4170	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4170	16	)	)	-RRB-
cord-005453-4057qib7	4170	17	are	be	VBP
cord-005453-4057qib7	4170	18	made	make	VBN
cord-005453-4057qib7	4170	19	with	with	IN
cord-005453-4057qib7	4170	20	some	some	DT
cord-005453-4057qib7	4170	21	sort	sort	NN
cord-005453-4057qib7	4170	22	of	of	IN
cord-005453-4057qib7	4170	23	ABO	ABO	NNP
cord-005453-4057qib7	4170	24	blood	blood	NN
cord-005453-4057qib7	4170	25	group	group	NN
cord-005453-4057qib7	4170	26	system	system	NN
cord-005453-4057qib7	4170	27	incompatibility	incompatibility	NN
cord-005453-4057qib7	4170	28	.	.	.
cord-005453-4057qib7	4171	1	An	an	DT
cord-005453-4057qib7	4171	2	HSCT	HSCT	NNP
cord-005453-4057qib7	4171	3	ABO	ABO	NNP
cord-005453-4057qib7	4171	4	donor	donor	NN
cord-005453-4057qib7	4171	5	-	-	HYPH
cord-005453-4057qib7	4171	6	recipient	recipient	NN
cord-005453-4057qib7	4171	7	incompatibility	incompatibility	NN
cord-005453-4057qib7	4171	8	implies	imply	VBZ
cord-005453-4057qib7	4171	9	risks	risk	NNS
cord-005453-4057qib7	4171	10	of	of	IN
cord-005453-4057qib7	4171	11	complications	complication	NNS
cord-005453-4057qib7	4171	12	during	during	IN
cord-005453-4057qib7	4171	13	the	the	DT
cord-005453-4057qib7	4171	14	process	process	NN
cord-005453-4057qib7	4171	15	of	of	IN
cord-005453-4057qib7	4171	16	infusion	infusion	NN
cord-005453-4057qib7	4171	17	as	as	IN
cord-005453-4057qib7	4171	18	acute	acute	JJ
cord-005453-4057qib7	4171	19	hemolytic	hemolytic	JJ
cord-005453-4057qib7	4171	20	anemia	anemia	NN
cord-005453-4057qib7	4171	21	(	(	-LRB-
cord-005453-4057qib7	4171	22	AH	AH	NNP
cord-005453-4057qib7	4171	23	)	)	-RRB-
cord-005453-4057qib7	4171	24	,	,	,
cord-005453-4057qib7	4171	25	delayed	delay	VBN
cord-005453-4057qib7	4171	26	graft	graft	NN
cord-005453-4057qib7	4171	27	and	and	CC
cord-005453-4057qib7	4171	28	other	other	JJ
cord-005453-4057qib7	4171	29	later	later	JJ
cord-005453-4057qib7	4171	30	complications	complication	NNS
cord-005453-4057qib7	4171	31	due	due	IN
cord-005453-4057qib7	4171	32	to	to	IN
cord-005453-4057qib7	4171	33	the	the	DT
cord-005453-4057qib7	4171	34	presence	presence	NN
cord-005453-4057qib7	4171	35	of	of	IN
cord-005453-4057qib7	4171	36	isohemaglutinins	isohemaglutinins	NNP
cord-005453-4057qib7	4172	1	(	(	-LRB-
cord-005453-4057qib7	4172	2	Pure	Pure	NNP
cord-005453-4057qib7	4172	3	Red	Red	NNP
cord-005453-4057qib7	4172	4	Cell	Cell	NNP
cord-005453-4057qib7	4172	5	Aplasia	Aplasia	NNP
cord-005453-4057qib7	4172	6	or	or	CC
cord-005453-4057qib7	4172	7	passenger	passenger	NN
cord-005453-4057qib7	4172	8	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4172	9	syndrome	syndrome	NN
cord-005453-4057qib7	4172	10	)	)	-RRB-
cord-005453-4057qib7	4172	11	.	.	.
cord-005453-4057qib7	4173	1	Also	also	RB
cord-005453-4057qib7	4173	2	,	,	,
cord-005453-4057qib7	4173	3	ABO	ABO	NNP
cord-005453-4057qib7	4173	4	incompatibility	incompatibility	NN
cord-005453-4057qib7	4173	5	could	could	MD
cord-005453-4057qib7	4173	6	impact	impact	VB
cord-005453-4057qib7	4173	7	on	on	IN
cord-005453-4057qib7	4173	8	graft	graft	NN
cord-005453-4057qib7	4173	9	versus	versus	IN
cord-005453-4057qib7	4173	10	host	host	NN
cord-005453-4057qib7	4173	11	disease	disease	NN
cord-005453-4057qib7	4173	12	(	(	-LRB-
cord-005453-4057qib7	4173	13	GVHD	GVHD	NNP
cord-005453-4057qib7	4173	14	)	)	-RRB-
cord-005453-4057qib7	4173	15	incidence	incidence	NN
cord-005453-4057qib7	4173	16	,	,	,
cord-005453-4057qib7	4173	17	and	and	CC
cord-005453-4057qib7	4173	18	could	could	MD
cord-005453-4057qib7	4173	19	be	be	VB
cord-005453-4057qib7	4173	20	associated	associate	VBN
cord-005453-4057qib7	4173	21	with	with	IN
cord-005453-4057qib7	4173	22	Not	not	RB
cord-005453-4057qib7	4173	23	Relapse	Relapse	NNP
cord-005453-4057qib7	4173	24	Mortality	mortality	NN
cord-005453-4057qib7	4173	25	(	(	-LRB-
cord-005453-4057qib7	4173	26	NRM	NRM	NNP
cord-005453-4057qib7	4173	27	)	)	-RRB-
cord-005453-4057qib7	4173	28	and	and	CC
cord-005453-4057qib7	4173	29	overall	overall	JJ
cord-005453-4057qib7	4173	30	survival	survival	NN
cord-005453-4057qib7	4173	31	(	(	-LRB-
cord-005453-4057qib7	4173	32	OS	OS	NNP
cord-005453-4057qib7	4173	33	)	)	-RRB-
cord-005453-4057qib7	4173	34	.	.	.
cord-005453-4057qib7	4174	1	There	there	EX
cord-005453-4057qib7	4174	2	are	be	VBP
cord-005453-4057qib7	4174	3	not	not	RB
cord-005453-4057qib7	4174	4	concluded	conclude	VBN
cord-005453-4057qib7	4174	5	evidence	evidence	NN
cord-005453-4057qib7	4174	6	about	about	IN
cord-005453-4057qib7	4174	7	the	the	DT
cord-005453-4057qib7	4174	8	ABO	ABO	NNP
cord-005453-4057qib7	4174	9	incompatibility	incompatibility	NN
cord-005453-4057qib7	4174	10	impact	impact	NN
cord-005453-4057qib7	4174	11	,	,	,
cord-005453-4057qib7	4174	12	so	so	CC
cord-005453-4057qib7	4174	13	the	the	DT
cord-005453-4057qib7	4174	14	aim	aim	NN
cord-005453-4057qib7	4174	15	of	of	IN
cord-005453-4057qib7	4174	16	this	this	DT
cord-005453-4057qib7	4174	17	study	study	NN
cord-005453-4057qib7	4174	18	was	be	VBD
cord-005453-4057qib7	4174	19	to	to	TO
cord-005453-4057qib7	4174	20	identify	identify	VB
cord-005453-4057qib7	4174	21	complications	complication	NNS
cord-005453-4057qib7	4174	22	and	and	CC
cord-005453-4057qib7	4174	23	response	response	NN
cord-005453-4057qib7	4174	24	associated	associate	VBN
cord-005453-4057qib7	4174	25	with	with	IN
cord-005453-4057qib7	4174	26	ABO	ABO	NNP
cord-005453-4057qib7	4174	27	incompatibility	incompatibility	NN
cord-005453-4057qib7	4174	28	in	in	IN
cord-005453-4057qib7	4174	29	patients	patient	NNS
cord-005453-4057qib7	4174	30	undergoing	undergo	VBG
cord-005453-4057qib7	4174	31	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	4174	32	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	4174	33	Stem	Stem	NNP
cord-005453-4057qib7	4174	34	Cell	Cell	NNP
cord-005453-4057qib7	4174	35	Transplantation	transplantation	NN
cord-005453-4057qib7	4174	36	.	.	.
cord-005453-4057qib7	4175	1	Methods	method	NNS
cord-005453-4057qib7	4175	2	:	:	:
cord-005453-4057qib7	4175	3	A	a	DT
cord-005453-4057qib7	4175	4	retrospective	retrospective	JJ
cord-005453-4057qib7	4175	5	study	study	NN
cord-005453-4057qib7	4175	6	was	be	VBD
cord-005453-4057qib7	4175	7	performed	perform	VBN
cord-005453-4057qib7	4175	8	on	on	IN
cord-005453-4057qib7	4175	9	patients	patient	NNS
cord-005453-4057qib7	4175	10	who	who	WP
cord-005453-4057qib7	4175	11	receive	receive	VBP
cord-005453-4057qib7	4175	12	an	an	DT
cord-005453-4057qib7	4175	13	allo	allo	NN
cord-005453-4057qib7	4175	14	-	-	HYPH
cord-005453-4057qib7	4175	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4175	16	between	between	IN
cord-005453-4057qib7	4175	17	January	January	NNP
cord-005453-4057qib7	4175	18	2014	2014	CD
cord-005453-4057qib7	4175	19	and	and	CC
cord-005453-4057qib7	4175	20	August	August	NNP
cord-005453-4057qib7	4175	21	2018	2018	CD
cord-005453-4057qib7	4175	22	.	.	.
cord-005453-4057qib7	4176	1	Two	two	CD
cord-005453-4057qib7	4176	2	groups	group	NNS
cord-005453-4057qib7	4176	3	were	be	VBD
cord-005453-4057qib7	4176	4	performed	perform	VBN
cord-005453-4057qib7	4176	5	according	accord	VBG
cord-005453-4057qib7	4176	6	to	to	IN
cord-005453-4057qib7	4176	7	the	the	DT
cord-005453-4057qib7	4176	8	presences	presence	NNS
cord-005453-4057qib7	4176	9	or	or	CC
cord-005453-4057qib7	4176	10	not	not	RB
cord-005453-4057qib7	4176	11	of	of	IN
cord-005453-4057qib7	4176	12	ABO	ABO	NNP
cord-005453-4057qib7	4176	13	incompatibility	incompatibility	NN
cord-005453-4057qib7	4176	14	.	.	.
cord-005453-4057qib7	4177	1	Demographic	demographic	JJ
cord-005453-4057qib7	4177	2	and	and	CC
cord-005453-4057qib7	4177	3	clinical	clinical	JJ
cord-005453-4057qib7	4177	4	information	information	NN
cord-005453-4057qib7	4177	5	was	be	VBD
cord-005453-4057qib7	4177	6	collected	collect	VBN
cord-005453-4057qib7	4177	7	from	from	IN
cord-005453-4057qib7	4177	8	physical	physical	JJ
cord-005453-4057qib7	4177	9	and	and	CC
cord-005453-4057qib7	4177	10	electronic	electronic	JJ
cord-005453-4057qib7	4177	11	medical	medical	JJ
cord-005453-4057qib7	4177	12	records	record	NNS
cord-005453-4057qib7	4177	13	,	,	,
cord-005453-4057qib7	4177	14	and	and	CC
cord-005453-4057qib7	4177	15	information	information	NN
cord-005453-4057qib7	4177	16	was	be	VBD
cord-005453-4057qib7	4177	17	analyzed	analyze	VBN
cord-005453-4057qib7	4177	18	in	in	IN
cord-005453-4057qib7	4177	19	SPSS	SPSS	NNP
cord-005453-4057qib7	4177	20	v21	v21	NNP
cord-005453-4057qib7	4177	21	Results	Results	NNPS
cord-005453-4057qib7	4177	22	:	:	:
cord-005453-4057qib7	4177	23	Sixty	sixty	CD
cord-005453-4057qib7	4177	24	-	-	HYPH
cord-005453-4057qib7	4177	25	eight	eight	CD
cord-005453-4057qib7	4177	26	patients	patient	NNS
cord-005453-4057qib7	4177	27	were	be	VBD
cord-005453-4057qib7	4177	28	enrolled	enrol	VBN
cord-005453-4057qib7	4177	29	in	in	IN
cord-005453-4057qib7	4177	30	the	the	DT
cord-005453-4057qib7	4177	31	study	study	NN
cord-005453-4057qib7	4177	32	,	,	,
cord-005453-4057qib7	4177	33	54	54	CD
cord-005453-4057qib7	4177	34	%	%	NN
cord-005453-4057qib7	4177	35	male	male	NN
cord-005453-4057qib7	4177	36	,	,	,
cord-005453-4057qib7	4177	37	the	the	DT
cord-005453-4057qib7	4177	38	median	median	JJ
cord-005453-4057qib7	4177	39	age	age	NN
cord-005453-4057qib7	4177	40	was	be	VBD
cord-005453-4057qib7	4177	41	34	34	CD
cord-005453-4057qib7	4177	42	years	year	NNS
cord-005453-4057qib7	4177	43	(	(	-LRB-
cord-005453-4057qib7	4177	44	19	19	CD
cord-005453-4057qib7	4177	45	-	-	SYM
cord-005453-4057qib7	4177	46	61	61	CD
cord-005453-4057qib7	4177	47	)	)	-RRB-
cord-005453-4057qib7	4177	48	with	with	IN
cord-005453-4057qib7	4177	49	the	the	DT
cord-005453-4057qib7	4177	50	following	follow	VBG
cord-005453-4057qib7	4177	51	diagnoses	diagnosis	NNS
cord-005453-4057qib7	4178	1	:	:	:
cord-005453-4057qib7	4178	2	acute	acute	JJ
cord-005453-4057qib7	4178	3	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	4178	4	leukemia	leukemia	NN
cord-005453-4057qib7	4178	5	44	44	CD
cord-005453-4057qib7	4178	6	%	%	NN
cord-005453-4057qib7	4178	7	,	,	,
cord-005453-4057qib7	4178	8	acute	acute	JJ
cord-005453-4057qib7	4178	9	myeloblastic	myeloblastic	JJ
cord-005453-4057qib7	4178	10	leukemia	leukemia	NN
cord-005453-4057qib7	4178	11	26.5	26.5	CD
cord-005453-4057qib7	4178	12	%	%	NN
cord-005453-4057qib7	4178	13	,	,	,
cord-005453-4057qib7	4178	14	granulocytic	granulocytic	JJ
cord-005453-4057qib7	4178	15	chronic	chronic	JJ
cord-005453-4057qib7	4178	16	leukemia	leukemia	NN
cord-005453-4057qib7	4178	17	17.6	17.6	CD
cord-005453-4057qib7	4178	18	%	%	NN
cord-005453-4057qib7	4178	19	,	,	,
cord-005453-4057qib7	4178	20	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	4178	21	syndrome	syndrome	NN
cord-005453-4057qib7	4178	22	4.4	4.4	CD
cord-005453-4057qib7	4178	23	%	%	NN
cord-005453-4057qib7	4178	24	,	,	,
cord-005453-4057qib7	4178	25	dendritic	dendritic	JJ
cord-005453-4057qib7	4178	26	cell	cell	NN
cord-005453-4057qib7	4178	27	neoplasm	neoplasm	NN
cord-005453-4057qib7	4178	28	4.4	4.4	CD
cord-005453-4057qib7	4178	29	%	%	NN
cord-005453-4057qib7	4178	30	,	,	,
cord-005453-4057qib7	4178	31	aplastic	aplastic	JJ
cord-005453-4057qib7	4178	32	anemia	anemia	NN
cord-005453-4057qib7	4178	33	2.9	2.9	CD
cord-005453-4057qib7	4178	34	%	%	NN
cord-005453-4057qib7	4178	35	.	.	.
cord-005453-4057qib7	4179	1	Ninety	ninety	CD
cord-005453-4057qib7	4179	2	-	-	HYPH
cord-005453-4057qib7	4179	3	one	one	CD
cord-005453-4057qib7	4179	4	percent	percent	NN
cord-005453-4057qib7	4179	5	of	of	IN
cord-005453-4057qib7	4179	6	the	the	DT
cord-005453-4057qib7	4179	7	patients	patient	NNS
cord-005453-4057qib7	4179	8	received	receive	VBD
cord-005453-4057qib7	4179	9	a	a	DT
cord-005453-4057qib7	4179	10	transplant	transplant	NN
cord-005453-4057qib7	4179	11	from	from	IN
cord-005453-4057qib7	4179	12	an	an	DT
cord-005453-4057qib7	4179	13	identical	identical	JJ
cord-005453-4057qib7	4179	14	HLA	HLA	NNP
cord-005453-4057qib7	4179	15	donor	donor	NN
cord-005453-4057qib7	4179	16	and	and	CC
cord-005453-4057qib7	4179	17	8.8	8.8	CD
cord-005453-4057qib7	4179	18	%	%	NN
cord-005453-4057qib7	4179	19	received	receive	VBD
cord-005453-4057qib7	4179	20	a	a	DT
cord-005453-4057qib7	4179	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4179	22	transplant	transplant	NN
cord-005453-4057qib7	4179	23	.	.	.
cord-005453-4057qib7	4180	1	Fifty	fifty	CD
cord-005453-4057qib7	4180	2	-	-	HYPH
cord-005453-4057qib7	4180	3	two	two	CD
cord-005453-4057qib7	4180	4	patients	patient	NNS
cord-005453-4057qib7	4180	5	(	(	-LRB-
cord-005453-4057qib7	4180	6	76	76	CD
cord-005453-4057qib7	4180	7	%	%	NN
cord-005453-4057qib7	4180	8	)	)	-RRB-
cord-005453-4057qib7	4180	9	were	be	VBD
cord-005453-4057qib7	4180	10	ABOcompatibility	ABOcompatibility	NNP
cord-005453-4057qib7	4180	11	(	(	-LRB-
cord-005453-4057qib7	4180	12	G1	G1	NNP
cord-005453-4057qib7	4180	13	)	)	-RRB-
cord-005453-4057qib7	4180	14	and	and	CC
cord-005453-4057qib7	4180	15	16	16	CD
cord-005453-4057qib7	4180	16	patients	patient	NNS
cord-005453-4057qib7	4180	17	(	(	-LRB-
cord-005453-4057qib7	4180	18	24	24	CD
cord-005453-4057qib7	4180	19	%	%	NN
cord-005453-4057qib7	4180	20	)	)	-RRB-
cord-005453-4057qib7	4180	21	had	have	VBD
cord-005453-4057qib7	4180	22	ABOincompatibility	aboincompatibility	NN
cord-005453-4057qib7	4180	23	(	(	-LRB-
cord-005453-4057qib7	4180	24	G2	G2	NNP
cord-005453-4057qib7	4180	25	)	)	-RRB-
cord-005453-4057qib7	4180	26	.	.	.
cord-005453-4057qib7	4181	1	None	none	NN
cord-005453-4057qib7	4181	2	patient	patient	JJ
cord-005453-4057qib7	4181	3	with	with	IN
cord-005453-4057qib7	4181	4	ABOincompatibility	aboincompatibility	NN
cord-005453-4057qib7	4181	5	received	receive	VBD
cord-005453-4057qib7	4181	6	a	a	DT
cord-005453-4057qib7	4181	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4181	8	transplant	transplant	NN
cord-005453-4057qib7	4181	9	.	.	.
cord-005453-4057qib7	4182	1	The	the	DT
cord-005453-4057qib7	4182	2	contrast	contrast	NN
cord-005453-4057qib7	4182	3	between	between	IN
cord-005453-4057qib7	4182	4	groups	group	NNS
cord-005453-4057qib7	4182	5	did	do	VBD
cord-005453-4057qib7	4182	6	n't	not	RB
cord-005453-4057qib7	4182	7	show	show	VB
cord-005453-4057qib7	4182	8	differences	difference	NNS
cord-005453-4057qib7	4182	9	in	in	IN
cord-005453-4057qib7	4182	10	fever	fever	NN
cord-005453-4057qib7	4182	11	,	,	,
cord-005453-4057qib7	4182	12	infections	infection	NNS
cord-005453-4057qib7	4182	13	,	,	,
cord-005453-4057qib7	4182	14	bacterial	bacterial	JJ
cord-005453-4057qib7	4182	15	isolation	isolation	NN
cord-005453-4057qib7	4182	16	,	,	,
cord-005453-4057qib7	4182	17	presence	presence	NN
cord-005453-4057qib7	4182	18	and	and	CC
cord-005453-4057qib7	4182	19	degree	degree	NN
cord-005453-4057qib7	4182	20	of	of	IN
cord-005453-4057qib7	4182	21	acute	acute	JJ
cord-005453-4057qib7	4182	22	or	or	CC
cord-005453-4057qib7	4182	23	chronic	chronic	JJ
cord-005453-4057qib7	4182	24	GVHD	GVHD	NNP
cord-005453-4057qib7	4182	25	and	and	CC
cord-005453-4057qib7	4182	26	relapse	relapse	NN
cord-005453-4057qib7	4182	27	of	of	IN
cord-005453-4057qib7	4182	28	the	the	DT
cord-005453-4057qib7	4182	29	disease	disease	NN
cord-005453-4057qib7	4182	30	.	.	.
cord-005453-4057qib7	4183	1	Graft	graft	NN
cord-005453-4057qib7	4183	2	failure	failure	NN
cord-005453-4057qib7	4183	3	was	be	VBD
cord-005453-4057qib7	4183	4	6%(G1	6%(G1	NNP
cord-005453-4057qib7	4183	5	)	)	-RRB-
cord-005453-4057qib7	4183	6	vs	vs	IN
cord-005453-4057qib7	4183	7	20%(G2	20%(g2	CD
cord-005453-4057qib7	4183	8	)	)	-RRB-
cord-005453-4057qib7	4184	1	(	(	-LRB-
cord-005453-4057qib7	4184	2	p=0.27	p=0.27	NNP
cord-005453-4057qib7	4184	3	)	)	-RRB-
cord-005453-4057qib7	4184	4	,	,	,
cord-005453-4057qib7	4184	5	intermediate	intermediate	JJ
cord-005453-4057qib7	4184	6	risk	risk	NN
cord-005453-4057qib7	4184	7	CMV	CMV	NNP
cord-005453-4057qib7	4184	8	serostatus	serostatus	NN
cord-005453-4057qib7	4184	9	79%(G1	79%(g1	CD
cord-005453-4057qib7	4184	10	)	)	-RRB-
cord-005453-4057qib7	4184	11	vs	vs	IN
cord-005453-4057qib7	4184	12	87(G2	87(g2	CD
cord-005453-4057qib7	4184	13	)	)	-RRB-
cord-005453-4057qib7	4185	1	(	(	-LRB-
cord-005453-4057qib7	4185	2	p=0.35	p=0.35	NNP
cord-005453-4057qib7	4185	3	)	)	-RRB-
cord-005453-4057qib7	4185	4	.	.	.
cord-005453-4057qib7	4186	1	The	the	DT
cord-005453-4057qib7	4186	2	most	most	RBS
cord-005453-4057qib7	4186	3	relevant	relevant	JJ
cord-005453-4057qib7	4186	4	characteristics	characteristic	NNS
cord-005453-4057qib7	4186	5	and	and	CC
cord-005453-4057qib7	4186	6	complications	complication	NNS
cord-005453-4057qib7	4186	7	are	be	VBP
cord-005453-4057qib7	4186	8	described	describe	VBN
cord-005453-4057qib7	4186	9	in	in	IN
cord-005453-4057qib7	4186	10	table	table	NN
cord-005453-4057qib7	4186	11	1	1	CD
cord-005453-4057qib7	4186	12	.	.	.
cord-005453-4057qib7	4187	1	Contrast	contrast	NN
cord-005453-4057qib7	4187	2	analysis	analysis	NN
cord-005453-4057qib7	4187	3	between	between	IN
cord-005453-4057qib7	4187	4	G1	G1	NNP
cord-005453-4057qib7	4187	5	vs	vs	IN
cord-005453-4057qib7	4187	6	G2	G2	NNP
cord-005453-4057qib7	4187	7	showed	show	VBD
cord-005453-4057qib7	4187	8	that	that	IN
cord-005453-4057qib7	4187	9	within	within	IN
cord-005453-4057qib7	4187	10	the	the	DT
cord-005453-4057qib7	4187	11	whole	whole	JJ
cord-005453-4057qib7	4187	12	group	group	NN
cord-005453-4057qib7	4187	13	there	there	EX
cord-005453-4057qib7	4187	14	were	be	VBD
cord-005453-4057qib7	4187	15	29	29	CD
cord-005453-4057qib7	4187	16	deaths	death	NNS
cord-005453-4057qib7	4187	17	(	(	-LRB-
cord-005453-4057qib7	4187	18	40	40	CD
cord-005453-4057qib7	4187	19	%	%	NN
cord-005453-4057qib7	4187	20	vs	vs	IN
cord-005453-4057qib7	4187	21	50	50	CD
cord-005453-4057qib7	4187	22	%	%	NN
cord-005453-4057qib7	4187	23	respectively	respectively	RB
cord-005453-4057qib7	4187	24	)	)	-RRB-
cord-005453-4057qib7	4187	25	(	(	-LRB-
cord-005453-4057qib7	4187	26	p=0.69	p=0.69	NNP
cord-005453-4057qib7	4187	27	)	)	-RRB-
cord-005453-4057qib7	4187	28	,	,	,
cord-005453-4057qib7	4187	29	the	the	DT
cord-005453-4057qib7	4187	30	overall	overall	JJ
cord-005453-4057qib7	4187	31	survival	survival	NN
cord-005453-4057qib7	4187	32	1-year	1-year	CD
cord-005453-4057qib7	4187	33	was	be	VBD
cord-005453-4057qib7	4187	34	74	74	CD
cord-005453-4057qib7	4187	35	%	%	NN
cord-005453-4057qib7	4187	36	vs	vs	IN
cord-005453-4057qib7	4187	37	66	66	CD
cord-005453-4057qib7	4187	38	%	%	NN
cord-005453-4057qib7	4188	1	(	(	-LRB-
cord-005453-4057qib7	4188	2	p=0.58	p=0.58	JJ
cord-005453-4057qib7	4188	3	)	)	-RRB-
cord-005453-4057qib7	4188	4	with	with	IN
cord-005453-4057qib7	4188	5	a	a	DT
cord-005453-4057qib7	4188	6	median	median	NN
cord-005453-4057qib7	4188	7	of	of	IN
cord-005453-4057qib7	4188	8	29	29	CD
cord-005453-4057qib7	4188	9	vs	vs	IN
cord-005453-4057qib7	4188	10	34	34	CD
cord-005453-4057qib7	4188	11	months	month	NNS
cord-005453-4057qib7	4188	12	respectively	respectively	RB
cord-005453-4057qib7	4188	13	;	;	:
cord-005453-4057qib7	4188	14	mortality	mortality	NN
cord-005453-4057qib7	4188	15	associated	associate	VBN
cord-005453-4057qib7	4188	16	with	with	IN
cord-005453-4057qib7	4188	17	relapse	relapse	NN
cord-005453-4057qib7	4188	18	was	be	VBD
cord-005453-4057qib7	4188	19	68	68	CD
cord-005453-4057qib7	4188	20	%	%	NN
cord-005453-4057qib7	4188	21	vs	vs	IN
cord-005453-4057qib7	4188	22	87	87	CD
cord-005453-4057qib7	4188	23	%	%	NN
cord-005453-4057qib7	4188	24	respectively	respectively	RB
cord-005453-4057qib7	4188	25	,	,	,
cord-005453-4057qib7	4188	26	and	and	CC
cord-005453-4057qib7	4188	27	mortality	mortality	NN
cord-005453-4057qib7	4188	28	related	relate	VBN
cord-005453-4057qib7	4188	29	with	with	IN
cord-005453-4057qib7	4188	30	transplantation	transplantation	NN
cord-005453-4057qib7	4188	31	was	be	VBD
cord-005453-4057qib7	4188	32	35	35	CD
cord-005453-4057qib7	4188	33	%	%	NN
cord-005453-4057qib7	4188	34	vs	vs	IN
cord-005453-4057qib7	4188	35	13	13	CD
cord-005453-4057qib7	4188	36	%	%	NN
cord-005453-4057qib7	4188	37	respectively	respectively	RB
cord-005453-4057qib7	4188	38	.	.	.
cord-005453-4057qib7	4189	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4189	2	:	:	:
cord-005453-4057qib7	4190	1	ABO	ABO	NNP
cord-005453-4057qib7	4190	2	incompatibility	incompatibility	NN
cord-005453-4057qib7	4190	3	did	do	VBD
cord-005453-4057qib7	4190	4	not	not	RB
cord-005453-4057qib7	4190	5	show	show	VB
cord-005453-4057qib7	4190	6	association	association	NN
cord-005453-4057qib7	4190	7	with	with	IN
cord-005453-4057qib7	4190	8	complications	complication	NNS
cord-005453-4057qib7	4190	9	related	relate	VBN
cord-005453-4057qib7	4190	10	with	with	IN
cord-005453-4057qib7	4190	11	the	the	DT
cord-005453-4057qib7	4190	12	infusion	infusion	NN
cord-005453-4057qib7	4190	13	,	,	,
cord-005453-4057qib7	4190	14	but	but	CC
cord-005453-4057qib7	4190	15	there	there	EX
cord-005453-4057qib7	4190	16	was	be	VBD
cord-005453-4057qib7	4190	17	a	a	DT
cord-005453-4057qib7	4190	18	higher	high	JJR
cord-005453-4057qib7	4190	19	tendency	tendency	NN
cord-005453-4057qib7	4190	20	of	of	IN
cord-005453-4057qib7	4190	21	graft	graft	NN
cord-005453-4057qib7	4190	22	failure	failure	NN
cord-005453-4057qib7	4190	23	in	in	IN
cord-005453-4057qib7	4190	24	the	the	DT
cord-005453-4057qib7	4190	25	ABO	ABO	NNP
cord-005453-4057qib7	4190	26	incompatibility	incompatibility	NN
cord-005453-4057qib7	4190	27	group	group	NN
cord-005453-4057qib7	4190	28	.	.	.
cord-005453-4057qib7	4191	1	It	-PRON-	PRP
cord-005453-4057qib7	4191	2	has	have	VBZ
cord-005453-4057qib7	4191	3	no	no	DT
cord-005453-4057qib7	4191	4	statistical	statistical	JJ
cord-005453-4057qib7	4191	5	significance	significance	NN
cord-005453-4057qib7	4191	6	,	,	,
cord-005453-4057qib7	4191	7	but	but	CC
cord-005453-4057qib7	4191	8	it	-PRON-	PRP
cord-005453-4057qib7	4191	9	is	be	VBZ
cord-005453-4057qib7	4191	10	important	important	JJ
cord-005453-4057qib7	4191	11	to	to	TO
cord-005453-4057qib7	4191	12	expand	expand	VB
cord-005453-4057qib7	4191	13	its	-PRON-	PRP$
cord-005453-4057qib7	4191	14	study	study	NN
cord-005453-4057qib7	4191	15	.	.	.
cord-005453-4057qib7	4192	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4192	2	:	:	:
cord-005453-4057qib7	4193	1	None	none	NN
cord-005453-4057qib7	4193	2	declared	declare	VBD
cord-005453-4057qib7	4193	3	Methods	method	NNS
cord-005453-4057qib7	4193	4	:	:	:
cord-005453-4057qib7	4193	5	Retrospective	retrospective	JJ
cord-005453-4057qib7	4193	6	data	datum	NNS
cord-005453-4057qib7	4193	7	for	for	IN
cord-005453-4057qib7	4193	8	142	142	CD
cord-005453-4057qib7	4193	9	NHL	NHL	NNP
cord-005453-4057qib7	4193	10	patients	patient	NNS
cord-005453-4057qib7	4193	11	who	who	WP
cord-005453-4057qib7	4193	12	underwent	undergo	VBD
cord-005453-4057qib7	4193	13	ASCT	ASCT	NNP
cord-005453-4057qib7	4193	14	between	between	IN
cord-005453-4057qib7	4193	15	1999	1999	CD
cord-005453-4057qib7	4193	16	and	and	CC
cord-005453-4057qib7	4193	17	2017	2017	CD
cord-005453-4057qib7	4193	18	was	be	VBD
cord-005453-4057qib7	4193	19	analysed	analyse	VBN
cord-005453-4057qib7	4193	20	.	.	.
cord-005453-4057qib7	4194	1	Patients	patient	NNS
cord-005453-4057qib7	4194	2	were	be	VBD
cord-005453-4057qib7	4194	3	identified	identify	VBN
cord-005453-4057qib7	4194	4	using	use	VBG
cord-005453-4057qib7	4194	5	the	the	DT
cord-005453-4057qib7	4194	6	SWBMT	SWBMT	NNP
cord-005453-4057qib7	4194	7	database	database	NN
cord-005453-4057qib7	4194	8	and	and	CC
cord-005453-4057qib7	4194	9	data	datum	NNS
cord-005453-4057qib7	4194	10	on	on	IN
cord-005453-4057qib7	4194	11	MetS	MetS	NNP
cord-005453-4057qib7	4194	12	was	be	VBD
cord-005453-4057qib7	4194	13	collected	collect	VBN
cord-005453-4057qib7	4194	14	using	use	VBG
cord-005453-4057qib7	4194	15	paper	paper	NN
cord-005453-4057qib7	4194	16	and	and	CC
cord-005453-4057qib7	4194	17	electronic	electronic	JJ
cord-005453-4057qib7	4194	18	hospital	hospital	NN
cord-005453-4057qib7	4194	19	records	record	NNS
cord-005453-4057qib7	4194	20	.	.	.
cord-005453-4057qib7	4195	1	Forty	forty	CD
cord-005453-4057qib7	4195	2	-	-	HYPH
cord-005453-4057qib7	4195	3	eight	eight	CD
cord-005453-4057qib7	4195	4	patients	patient	NNS
cord-005453-4057qib7	4195	5	were	be	VBD
cord-005453-4057qib7	4195	6	excluded	exclude	VBN
cord-005453-4057qib7	4195	7	due	due	IN
cord-005453-4057qib7	4195	8	to	to	IN
cord-005453-4057qib7	4195	9	loss	loss	NN
cord-005453-4057qib7	4195	10	of	of	IN
cord-005453-4057qib7	4195	11	follow	follow	NN
cord-005453-4057qib7	4195	12	-	-	HYPH
cord-005453-4057qib7	4195	13	up	up	NN
cord-005453-4057qib7	4195	14	,	,	,
cord-005453-4057qib7	4195	15	inaccessible	inaccessible	JJ
cord-005453-4057qib7	4195	16	/	/	SYM
cord-005453-4057qib7	4195	17	incomplete	incomplete	JJ
cord-005453-4057qib7	4195	18	records	record	NNS
cord-005453-4057qib7	4195	19	,	,	,
cord-005453-4057qib7	4195	20	or	or	CC
cord-005453-4057qib7	4195	21	death	death	NN
cord-005453-4057qib7	4195	22	.	.	.
cord-005453-4057qib7	4196	1	Cause	cause	NN
cord-005453-4057qib7	4196	2	of	of	IN
cord-005453-4057qib7	4196	3	death	death	NN
cord-005453-4057qib7	4196	4	was	be	VBD
cord-005453-4057qib7	4196	5	not	not	RB
cord-005453-4057qib7	4196	6	determined	determine	VBN
cord-005453-4057qib7	4196	7	.	.	.
cord-005453-4057qib7	4197	1	The	the	DT
cord-005453-4057qib7	4197	2	NCEP	NCEP	NNP
cord-005453-4057qib7	4197	3	-	-	HYPH
cord-005453-4057qib7	4197	4	ATPIII	ATPIII	NNP
cord-005453-4057qib7	4197	5	definition	definition	NN
cord-005453-4057qib7	4197	6	of	of	IN
cord-005453-4057qib7	4197	7	MetS	MetS	NNP
cord-005453-4057qib7	4197	8	was	be	VBD
cord-005453-4057qib7	4197	9	used	use	VBN
cord-005453-4057qib7	4197	10	.	.	.
cord-005453-4057qib7	4198	1	This	this	DT
cord-005453-4057qib7	4198	2	requires	require	VBZ
cord-005453-4057qib7	4198	3	≥3	≥3	NN
cord-005453-4057qib7	4198	4	of	of	IN
cord-005453-4057qib7	4198	5	5	5	CD
cord-005453-4057qib7	4198	6	criteria	criterion	NNS
cord-005453-4057qib7	4198	7	to	to	TO
cord-005453-4057qib7	4198	8	be	be	VB
cord-005453-4057qib7	4198	9	met	meet	VBN
cord-005453-4057qib7	4198	10	.	.	.
cord-005453-4057qib7	4199	1	A	a	DT
cord-005453-4057qib7	4199	2	BMI	bmi	NN
cord-005453-4057qib7	4199	3	of	of	IN
cord-005453-4057qib7	4199	4	≥30kg	≥30kg	NNP
cord-005453-4057qib7	4199	5	/	/	SYM
cord-005453-4057qib7	4199	6	m	m	NNP
cord-005453-4057qib7	4199	7	2	2	CD
cord-005453-4057qib7	4199	8	and	and	CC
cord-005453-4057qib7	4199	9	HbA1c	hba1c	NN
cord-005453-4057qib7	4199	10	of	of	IN
cord-005453-4057qib7	4199	11	≥42mmol	≥42mmol	NNP
cord-005453-4057qib7	4199	12	/	/	SYM
cord-005453-4057qib7	4199	13	L	L	NNP
cord-005453-4057qib7	4199	14	were	be	VBD
cord-005453-4057qib7	4199	15	used	use	VBN
cord-005453-4057qib7	4199	16	to	to	TO
cord-005453-4057qib7	4199	17	replace	replace	VB
cord-005453-4057qib7	4199	18	central	central	JJ
cord-005453-4057qib7	4199	19	obesity	obesity	NN
cord-005453-4057qib7	4199	20	and	and	CC
cord-005453-4057qib7	4199	21	impaired	impair	VBN
cord-005453-4057qib7	4199	22	fasting	fast	VBG
cord-005453-4057qib7	4199	23	glucose	glucose	NN
cord-005453-4057qib7	4199	24	,	,	,
cord-005453-4057qib7	4199	25	respectively	respectively	RB
cord-005453-4057qib7	4199	26	.	.	.
cord-005453-4057qib7	4200	1	Other	other	JJ
cord-005453-4057qib7	4200	2	criteria	criterion	NNS
cord-005453-4057qib7	4200	3	include	include	VBP
cord-005453-4057qib7	4200	4	triglycerides	triglyceride	NNS
cord-005453-4057qib7	4200	5	(	(	-LRB-
cord-005453-4057qib7	4200	6	TGs	tg	NNS
cord-005453-4057qib7	4200	7	)	)	-RRB-
cord-005453-4057qib7	4201	1	≥1.7mmol	≥1.7mmol	NNP
cord-005453-4057qib7	4201	2	/	/	SYM
cord-005453-4057qib7	4201	3	L	l	NN
cord-005453-4057qib7	4201	4	or	or	CC
cord-005453-4057qib7	4201	5	treatment	treatment	NN
cord-005453-4057qib7	4201	6	,	,	,
cord-005453-4057qib7	4201	7	high	high	JJ
cord-005453-4057qib7	4201	8	density	density	NN
cord-005453-4057qib7	4201	9	lipoprotein	lipoprotein	NN
cord-005453-4057qib7	4201	10	cholesterol	cholesterol	NN
cord-005453-4057qib7	4201	11	(	(	-LRB-
cord-005453-4057qib7	4201	12	HDL	HDL	NNP
cord-005453-4057qib7	4201	13	-	-	HYPH
cord-005453-4057qib7	4201	14	C	C	NNP
cord-005453-4057qib7	4201	15	)	)	-RRB-
cord-005453-4057qib7	4202	1	<	<	XX
cord-005453-4057qib7	4203	1	1.0mmol	1.0mmol	LS
cord-005453-4057qib7	4203	2	/	/	SYM
cord-005453-4057qib7	4203	3	L	L	NNP
cord-005453-4057qib7	4203	4	(	(	-LRB-
cord-005453-4057qib7	4203	5	male	male	NNP
cord-005453-4057qib7	4203	6	)	)	-RRB-
cord-005453-4057qib7	4203	7	,	,	,
cord-005453-4057qib7	4203	8	<	<	XX
cord-005453-4057qib7	4203	9	1.3mmol	1.3mmol	NNP
cord-005453-4057qib7	4203	10	/	/	SYM
cord-005453-4057qib7	4203	11	L	L	NNP
cord-005453-4057qib7	4203	12	(	(	-LRB-
cord-005453-4057qib7	4203	13	female	female	JJ
cord-005453-4057qib7	4203	14	)	)	-RRB-
cord-005453-4057qib7	4203	15	or	or	CC
cord-005453-4057qib7	4203	16	treatment	treatment	NN
cord-005453-4057qib7	4203	17	and	and	CC
cord-005453-4057qib7	4203	18	blood	blood	NN
cord-005453-4057qib7	4203	19	pressure	pressure	NN
cord-005453-4057qib7	4203	20	>	>	XX
cord-005453-4057qib7	4204	1	130mmHg	130mmhg	CD
cord-005453-4057qib7	4204	2	systolic	systolic	JJ
cord-005453-4057qib7	4204	3	or	or	CC
cord-005453-4057qib7	4204	4	>	>	XX
cord-005453-4057qib7	4204	5	85mmHg	85mmhg	CD
cord-005453-4057qib7	4204	6	diastolic	diastolic	JJ
cord-005453-4057qib7	4204	7	,	,	,
cord-005453-4057qib7	4204	8	or	or	CC
cord-005453-4057qib7	4204	9	treatment	treatment	NN
cord-005453-4057qib7	4204	10	.	.	.
cord-005453-4057qib7	4205	1	Results	result	NNS
cord-005453-4057qib7	4205	2	:	:	:
cord-005453-4057qib7	4206	1	The	the	DT
cord-005453-4057qib7	4206	2	prevalence	prevalence	NN
cord-005453-4057qib7	4206	3	of	of	IN
cord-005453-4057qib7	4206	4	MetS	met	NNS
cord-005453-4057qib7	4206	5	in	in	IN
cord-005453-4057qib7	4206	6	the	the	DT
cord-005453-4057qib7	4206	7	cohort	cohort	NN
cord-005453-4057qib7	4206	8	was	be	VBD
cord-005453-4057qib7	4206	9	33	33	CD
cord-005453-4057qib7	4206	10	%	%	NN
cord-005453-4057qib7	4206	11	(	(	-LRB-
cord-005453-4057qib7	4206	12	n=31	n=31	NNP
cord-005453-4057qib7	4206	13	)	)	-RRB-
cord-005453-4057qib7	4206	14	.	.	.
cord-005453-4057qib7	4207	1	Eighty	eighty	CD
cord-005453-4057qib7	4207	2	-	-	HYPH
cord-005453-4057qib7	4207	3	two	two	CD
cord-005453-4057qib7	4207	4	percent	percent	NN
cord-005453-4057qib7	4207	5	of	of	IN
cord-005453-4057qib7	4207	6	patients	patient	NNS
cord-005453-4057qib7	4207	7	(	(	-LRB-
cord-005453-4057qib7	4207	8	n=77	n=77	RB
cord-005453-4057qib7	4207	9	)	)	-RRB-
cord-005453-4057qib7	4207	10	met	meet	VBD
cord-005453-4057qib7	4207	11	one	one	CD
cord-005453-4057qib7	4207	12	or	or	CC
cord-005453-4057qib7	4207	13	more	more	JJR
cord-005453-4057qib7	4207	14	criterion	criterion	NN
cord-005453-4057qib7	4207	15	for	for	IN
cord-005453-4057qib7	4207	16	MetS.	MetS.	NNP
cord-005453-4057qib7	4208	1	Twenty	twenty	CD
cord-005453-4057qib7	4208	2	-	-	HYPH
cord-005453-4057qib7	4208	3	seven	seven	CD
cord-005453-4057qib7	4208	4	percent	percent	NN
cord-005453-4057qib7	4208	5	(	(	-LRB-
cord-005453-4057qib7	4208	6	n=25	n=25	NN
cord-005453-4057qib7	4208	7	)	)	-RRB-
cord-005453-4057qib7	4208	8	fulfilled	fulfil	VBD
cord-005453-4057qib7	4208	9	only	only	RB
cord-005453-4057qib7	4208	10	one	one	CD
cord-005453-4057qib7	4208	11	criterion	criterion	NN
cord-005453-4057qib7	4208	12	,	,	,
cord-005453-4057qib7	4208	13	23	23	CD
cord-005453-4057qib7	4208	14	%	%	NN
cord-005453-4057qib7	4208	15	(	(	-LRB-
cord-005453-4057qib7	4208	16	n=22	n=22	NNP
cord-005453-4057qib7	4208	17	)	)	-RRB-
cord-005453-4057qib7	4208	18	fulfilled	fulfil	VBD
cord-005453-4057qib7	4208	19	two	two	CD
cord-005453-4057qib7	4208	20	criteria	criterion	NNS
cord-005453-4057qib7	4208	21	,	,	,
cord-005453-4057qib7	4208	22	20	20	CD
cord-005453-4057qib7	4208	23	%	%	NN
cord-005453-4057qib7	4208	24	(	(	-LRB-
cord-005453-4057qib7	4208	25	n=19	n=19	NN
cord-005453-4057qib7	4208	26	)	)	-RRB-
cord-005453-4057qib7	4209	1	three	three	CD
cord-005453-4057qib7	4209	2	criteria	criterion	NNS
cord-005453-4057qib7	4209	3	,	,	,
cord-005453-4057qib7	4209	4	12	12	CD
cord-005453-4057qib7	4209	5	%	%	NN
cord-005453-4057qib7	4209	6	(	(	-LRB-
cord-005453-4057qib7	4209	7	n=11	n=11	NNP
cord-005453-4057qib7	4209	8	)	)	-RRB-
cord-005453-4057qib7	4209	9	four	four	CD
cord-005453-4057qib7	4209	10	criteria	criterion	NNS
cord-005453-4057qib7	4209	11	,	,	,
cord-005453-4057qib7	4209	12	and	and	CC
cord-005453-4057qib7	4209	13	1	1	CD
cord-005453-4057qib7	4209	14	%	%	NN
cord-005453-4057qib7	4209	15	(	(	-LRB-
cord-005453-4057qib7	4209	16	n=1	n=1	CD
cord-005453-4057qib7	4209	17	)	)	-RRB-
cord-005453-4057qib7	4209	18	five	five	CD
cord-005453-4057qib7	4209	19	criteria	criterion	NNS
cord-005453-4057qib7	4209	20	.	.	.
cord-005453-4057qib7	4210	1	The	the	DT
cord-005453-4057qib7	4210	2	greatest	great	JJS
cord-005453-4057qib7	4210	3	prevalence	prevalence	NN
cord-005453-4057qib7	4210	4	of	of	IN
cord-005453-4057qib7	4210	5	MetS	MetS	NNP
cord-005453-4057qib7	4210	6	was	be	VBD
cord-005453-4057qib7	4210	7	in	in	IN
cord-005453-4057qib7	4210	8	the	the	DT
cord-005453-4057qib7	4210	9	60	60	CD
cord-005453-4057qib7	4210	10	+	+	CC
cord-005453-4057qib7	4210	11	age	age	NN
cord-005453-4057qib7	4210	12	group	group	NN
cord-005453-4057qib7	4210	13	,	,	,
cord-005453-4057qib7	4210	14	accounting	account	VBG
cord-005453-4057qib7	4210	15	for	for	IN
cord-005453-4057qib7	4210	16	17	17	CD
cord-005453-4057qib7	4210	17	out	out	IN
cord-005453-4057qib7	4210	18	of	of	IN
cord-005453-4057qib7	4210	19	31	31	CD
cord-005453-4057qib7	4210	20	(	(	-LRB-
cord-005453-4057qib7	4210	21	55	55	CD
cord-005453-4057qib7	4210	22	%	%	NN
cord-005453-4057qib7	4210	23	)	)	-RRB-
cord-005453-4057qib7	4210	24	patients	patient	NNS
cord-005453-4057qib7	4210	25	with	with	IN
cord-005453-4057qib7	4210	26	MetS.	MetS.	NNP
cord-005453-4057qib7	4211	1	Overall	overall	JJ
cord-005453-4057qib7	4211	2	prevalence	prevalence	NN
cord-005453-4057qib7	4211	3	decreased	decrease	VBD
cord-005453-4057qib7	4211	4	with	with	IN
cord-005453-4057qib7	4211	5	declining	decline	VBG
cord-005453-4057qib7	4211	6	age	age	NN
cord-005453-4057qib7	4211	7	(	(	-LRB-
cord-005453-4057qib7	4211	8	Table	table	NN
cord-005453-4057qib7	4211	9	1	1	CD
cord-005453-4057qib7	4211	10	)	)	-RRB-
cord-005453-4057qib7	4211	11	.	.	.
cord-005453-4057qib7	4212	1	The	the	DT
cord-005453-4057qib7	4212	2	number	number	NN
cord-005453-4057qib7	4212	3	of	of	IN
cord-005453-4057qib7	4212	4	patients	patient	NNS
cord-005453-4057qib7	4212	5	aged	age	VBN
cord-005453-4057qib7	4212	6	<	<	XX
cord-005453-4057qib7	4212	7	20	20	CD
cord-005453-4057qib7	4212	8	years	year	NNS
cord-005453-4057qib7	4212	9	was	be	VBD
cord-005453-4057qib7	4212	10	too	too	RB
cord-005453-4057qib7	4212	11	small	small	JJ
cord-005453-4057qib7	4212	12	to	to	TO
cord-005453-4057qib7	4212	13	make	make	VB
cord-005453-4057qib7	4212	14	any	any	DT
cord-005453-4057qib7	4212	15	judgement	judgement	NN
cord-005453-4057qib7	4212	16	on	on	IN
cord-005453-4057qib7	4212	17	risk	risk	NN
cord-005453-4057qib7	4212	18	.	.	.
cord-005453-4057qib7	4213	1	Raised	raise	VBN
cord-005453-4057qib7	4213	2	triglycerides	triglyceride	NNS
cord-005453-4057qib7	4213	3	was	be	VBD
cord-005453-4057qib7	4213	4	the	the	DT
cord-005453-4057qib7	4213	5	criterion	criterion	NN
cord-005453-4057qib7	4213	6	most	most	RBS
cord-005453-4057qib7	4213	7	frequently	frequently	RB
cord-005453-4057qib7	4213	8	met	meet	VBD
cord-005453-4057qib7	4213	9	(	(	-LRB-
cord-005453-4057qib7	4213	10	61/94	61/94	CD
cord-005453-4057qib7	4213	11	patients	patient	NNS
cord-005453-4057qib7	4213	12	)	)	-RRB-
cord-005453-4057qib7	4213	13	,	,	,
cord-005453-4057qib7	4213	14	followed	follow	VBN
cord-005453-4057qib7	4213	15	by	by	IN
cord-005453-4057qib7	4213	16	hypertension	hypertension	NN
cord-005453-4057qib7	4213	17	(	(	-LRB-
cord-005453-4057qib7	4213	18	48	48	CD
cord-005453-4057qib7	4213	19	)	)	-RRB-
cord-005453-4057qib7	4213	20	,	,	,
cord-005453-4057qib7	4213	21	raised	raise	VBD
cord-005453-4057qib7	4213	22	BMI	BMI	NNP
cord-005453-4057qib7	4213	23	(	(	-LRB-
cord-005453-4057qib7	4213	24	26	26	CD
cord-005453-4057qib7	4213	25	)	)	-RRB-
cord-005453-4057qib7	4213	26	,	,	,
cord-005453-4057qib7	4213	27	low	low	JJ
cord-005453-4057qib7	4213	28	HDL	HDL	NNP
cord-005453-4057qib7	4213	29	-	-	HYPH
cord-005453-4057qib7	4213	30	C	C	NNP
cord-005453-4057qib7	4213	31	(	(	-LRB-
cord-005453-4057qib7	4213	32	23	23	CD
cord-005453-4057qib7	4213	33	)	)	-RRB-
cord-005453-4057qib7	4213	34	and	and	CC
cord-005453-4057qib7	4213	35	an	an	DT
cord-005453-4057qib7	4213	36	increased	increase	VBN
cord-005453-4057qib7	4213	37	HbA1c	hba1c	NN
cord-005453-4057qib7	4213	38	(	(	-LRB-
cord-005453-4057qib7	4213	39	15	15	CD
cord-005453-4057qib7	4213	40	)	)	-RRB-
cord-005453-4057qib7	4213	41	.	.	.
cord-005453-4057qib7	4214	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4214	2	:	:	:
cord-005453-4057qib7	4215	1	The	the	DT
cord-005453-4057qib7	4215	2	prevalence	prevalence	NN
cord-005453-4057qib7	4215	3	of	of	IN
cord-005453-4057qib7	4215	4	MetS	met	NNS
cord-005453-4057qib7	4215	5	in	in	IN
cord-005453-4057qib7	4215	6	our	-PRON-	PRP$
cord-005453-4057qib7	4215	7	cohort	cohort	NN
cord-005453-4057qib7	4215	8	(	(	-LRB-
cord-005453-4057qib7	4215	9	33	33	CD
cord-005453-4057qib7	4215	10	%	%	NN
cord-005453-4057qib7	4215	11	)	)	-RRB-
cord-005453-4057qib7	4215	12	was	be	VBD
cord-005453-4057qib7	4215	13	higher	high	JJR
cord-005453-4057qib7	4215	14	than	than	IN
cord-005453-4057qib7	4215	15	the	the	DT
cord-005453-4057qib7	4215	16	estimated	estimate	VBN
cord-005453-4057qib7	4215	17	worldwide	worldwide	JJ
cord-005453-4057qib7	4215	18	prevalence	prevalence	NN
cord-005453-4057qib7	4215	19	of	of	IN
cord-005453-4057qib7	4215	20	25	25	CD
cord-005453-4057qib7	4215	21	%	%	NN
cord-005453-4057qib7	4215	22	,	,	,
cord-005453-4057qib7	4215	23	with	with	IN
cord-005453-4057qib7	4215	24	the	the	DT
cord-005453-4057qib7	4215	25	majority	majority	NN
cord-005453-4057qib7	4215	26	in	in	IN
cord-005453-4057qib7	4215	27	the	the	DT
cord-005453-4057qib7	4215	28	60	60	CD
cord-005453-4057qib7	4215	29	+	+	CC
cord-005453-4057qib7	4215	30	age	age	NN
cord-005453-4057qib7	4215	31	category	category	NN
cord-005453-4057qib7	4215	32	.	.	.
cord-005453-4057qib7	4216	1	This	this	DT
cord-005453-4057qib7	4216	2	is	be	VBZ
cord-005453-4057qib7	4216	3	in	in	IN
cord-005453-4057qib7	4216	4	keeping	keep	VBG
cord-005453-4057qib7	4216	5	with	with	IN
cord-005453-4057qib7	4216	6	other	other	JJ
cord-005453-4057qib7	4216	7	post	post	JJ
cord-005453-4057qib7	4216	8	-	-	JJ
cord-005453-4057qib7	4216	9	transplant	transplant	JJ
cord-005453-4057qib7	4216	10	studies	study	NNS
cord-005453-4057qib7	4216	11	,	,	,
cord-005453-4057qib7	4216	12	which	which	WDT
cord-005453-4057qib7	4216	13	show	show	VBP
cord-005453-4057qib7	4216	14	an	an	DT
cord-005453-4057qib7	4216	15	increase	increase	NN
cord-005453-4057qib7	4216	16	in	in	IN
cord-005453-4057qib7	4216	17	prevalence	prevalence	NN
cord-005453-4057qib7	4216	18	of	of	IN
cord-005453-4057qib7	4216	19	MetS	mets	NN
cord-005453-4057qib7	4216	20	after	after	IN
cord-005453-4057qib7	4216	21	transplantation	transplantation	NN
cord-005453-4057qib7	4216	22	.	.	.
cord-005453-4057qib7	4217	1	Moreover	moreover	RB
cord-005453-4057qib7	4217	2	,	,	,
cord-005453-4057qib7	4217	3	the	the	DT
cord-005453-4057qib7	4217	4	overall	overall	JJ
cord-005453-4057qib7	4217	5	prevalence	prevalence	NN
cord-005453-4057qib7	4217	6	of	of	IN
cord-005453-4057qib7	4217	7	MetS	MetS	NNP
cord-005453-4057qib7	4217	8	was	be	VBD
cord-005453-4057qib7	4217	9	greater	great	JJR
cord-005453-4057qib7	4217	10	in	in	IN
cord-005453-4057qib7	4217	11	the	the	DT
cord-005453-4057qib7	4217	12	older	old	JJR
cord-005453-4057qib7	4217	13	population	population	NN
cord-005453-4057qib7	4217	14	,	,	,
cord-005453-4057qib7	4217	15	which	which	WDT
cord-005453-4057qib7	4217	16	could	could	MD
cord-005453-4057qib7	4217	17	be	be	VB
cord-005453-4057qib7	4217	18	associated	associate	VBN
cord-005453-4057qib7	4217	19	with	with	IN
cord-005453-4057qib7	4217	20	the	the	DT
cord-005453-4057qib7	4217	21	cumulative	cumulative	JJ
cord-005453-4057qib7	4217	22	effect	effect	NN
cord-005453-4057qib7	4217	23	of	of	IN
cord-005453-4057qib7	4217	24	ageing	age	VBG
cord-005453-4057qib7	4217	25	on	on	IN
cord-005453-4057qib7	4217	26	the	the	DT
cord-005453-4057qib7	4217	27	decline	decline	NN
cord-005453-4057qib7	4217	28	of	of	IN
cord-005453-4057qib7	4217	29	normal	normal	JJ
cord-005453-4057qib7	4217	30	metabolic	metabolic	JJ
cord-005453-4057qib7	4217	31	homeostatic	homeostatic	JJ
cord-005453-4057qib7	4217	32	mechanisms	mechanism	NNS
cord-005453-4057qib7	4217	33	.	.	.
cord-005453-4057qib7	4218	1	Background	background	NN
cord-005453-4057qib7	4218	2	:	:	:
cord-005453-4057qib7	4219	1	Acute	acute	JJ
cord-005453-4057qib7	4219	2	renal	renal	JJ
cord-005453-4057qib7	4219	3	failure	failure	NN
cord-005453-4057qib7	4219	4	(	(	-LRB-
cord-005453-4057qib7	4219	5	ARF	ARF	NNP
cord-005453-4057qib7	4219	6	)	)	-RRB-
cord-005453-4057qib7	4219	7	is	be	VBZ
cord-005453-4057qib7	4219	8	a	a	DT
cord-005453-4057qib7	4219	9	frequent	frequent	JJ
cord-005453-4057qib7	4219	10	complication	complication	NN
cord-005453-4057qib7	4219	11	in	in	IN
cord-005453-4057qib7	4219	12	the	the	DT
cord-005453-4057qib7	4219	13	early	early	JJ
cord-005453-4057qib7	4219	14	post	post	JJ
cord-005453-4057qib7	4219	15	-	-	JJ
cord-005453-4057qib7	4219	16	allogeneic	allogeneic	JJ
cord-005453-4057qib7	4219	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4219	18	stem	stem	NN
cord-005453-4057qib7	4219	19	cell	cell	NN
cord-005453-4057qib7	4219	20	transplant	transplant	NN
cord-005453-4057qib7	4219	21	(	(	-LRB-
cord-005453-4057qib7	4219	22	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	4219	23	)	)	-RRB-
cord-005453-4057qib7	4219	24	period	period	NN
cord-005453-4057qib7	4219	25	with	with	IN
cord-005453-4057qib7	4219	26	either	either	DT
cord-005453-4057qib7	4219	27	myeloablative	myeloablative	NNP
cord-005453-4057qib7	4219	28	(	(	-LRB-
cord-005453-4057qib7	4219	29	MA	MA	NNP
cord-005453-4057qib7	4219	30	)	)	-RRB-
cord-005453-4057qib7	4219	31	or	or	CC
cord-005453-4057qib7	4219	32	non	non	JJ
cord-005453-4057qib7	4219	33	-	-	JJ
cord-005453-4057qib7	4219	34	myeloablative	myeloablative	JJ
cord-005453-4057qib7	4219	35	(	(	-LRB-
cord-005453-4057qib7	4219	36	NMA	NMA	NNP
cord-005453-4057qib7	4219	37	)	)	-RRB-
cord-005453-4057qib7	4219	38	conditioning	conditioning	NN
cord-005453-4057qib7	4219	39	regimens	regimen	NNS
cord-005453-4057qib7	4219	40	.	.	.
cord-005453-4057qib7	4220	1	The	the	DT
cord-005453-4057qib7	4220	2	aim	aim	NN
cord-005453-4057qib7	4220	3	of	of	IN
cord-005453-4057qib7	4220	4	this	this	DT
cord-005453-4057qib7	4220	5	study	study	NN
cord-005453-4057qib7	4220	6	was	be	VBD
cord-005453-4057qib7	4220	7	to	to	TO
cord-005453-4057qib7	4220	8	compare	compare	VB
cord-005453-4057qib7	4220	9	the	the	DT
cord-005453-4057qib7	4220	10	incidence	incidence	NN
cord-005453-4057qib7	4220	11	of	of	IN
cord-005453-4057qib7	4220	12	ARF	arf	NN
cord-005453-4057qib7	4220	13	in	in	IN
cord-005453-4057qib7	4220	14	both	both	DT
cord-005453-4057qib7	4220	15	types	type	NNS
cord-005453-4057qib7	4220	16	of	of	IN
cord-005453-4057qib7	4220	17	HSCT	HSCT	NNP
cord-005453-4057qib7	4220	18	and	and	CC
cord-005453-4057qib7	4220	19	to	to	TO
cord-005453-4057qib7	4220	20	evaluate	evaluate	VB
cord-005453-4057qib7	4220	21	its	-PRON-	PRP$
cord-005453-4057qib7	4220	22	impact	impact	NN
cord-005453-4057qib7	4220	23	on	on	IN
cord-005453-4057qib7	4220	24	overall	overall	JJ
cord-005453-4057qib7	4220	25	survival	survival	NN
cord-005453-4057qib7	4220	26	(	(	-LRB-
cord-005453-4057qib7	4220	27	OS	OS	NNP
cord-005453-4057qib7	4220	28	)	)	-RRB-
cord-005453-4057qib7	4220	29	and	and	CC
cord-005453-4057qib7	4220	30	non	non	JJ
cord-005453-4057qib7	4220	31	-	-	JJ
cord-005453-4057qib7	4220	32	relapse	relapse	JJ
cord-005453-4057qib7	4220	33	mortality	mortality	NN
cord-005453-4057qib7	4220	34	(	(	-LRB-
cord-005453-4057qib7	4220	35	NRM	NRM	NNP
cord-005453-4057qib7	4220	36	)	)	-RRB-
cord-005453-4057qib7	4220	37	.	.	.
cord-005453-4057qib7	4221	1	Methods	method	NNS
cord-005453-4057qib7	4221	2	:	:	:
cord-005453-4057qib7	4221	3	All	all	DT
cord-005453-4057qib7	4221	4	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4221	5	performed	perform	VBN
cord-005453-4057qib7	4221	6	in	in	IN
cord-005453-4057qib7	4221	7	one	one	CD
cord-005453-4057qib7	4221	8	center	center	NN
cord-005453-4057qib7	4221	9	between	between	IN
cord-005453-4057qib7	4221	10	2010	2010	CD
cord-005453-4057qib7	4221	11	and	and	CC
cord-005453-4057qib7	4221	12	2018	2018	CD
cord-005453-4057qib7	4221	13	were	be	VBD
cord-005453-4057qib7	4221	14	included	include	VBN
cord-005453-4057qib7	4221	15	in	in	IN
cord-005453-4057qib7	4221	16	this	this	DT
cord-005453-4057qib7	4221	17	study	study	NN
cord-005453-4057qib7	4221	18	.	.	.
cord-005453-4057qib7	4222	1	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	4222	2	from	from	IN
cord-005453-4057qib7	4222	3	cord	cord	NN
cord-005453-4057qib7	4222	4	blood	blood	NN
cord-005453-4057qib7	4222	5	and	and	CC
cord-005453-4057qib7	4222	6	from	from	IN
cord-005453-4057qib7	4222	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4222	8	donors	donor	NNS
cord-005453-4057qib7	4222	9	were	be	VBD
cord-005453-4057qib7	4222	10	excluded	exclude	VBN
cord-005453-4057qib7	4222	11	.	.	.
cord-005453-4057qib7	4223	1	The	the	DT
cord-005453-4057qib7	4223	2	renal	renal	JJ
cord-005453-4057qib7	4223	3	function	function	NN
cord-005453-4057qib7	4223	4	and	and	CC
cord-005453-4057qib7	4223	5	the	the	DT
cord-005453-4057qib7	4223	6	incidence	incidence	NN
cord-005453-4057qib7	4223	7	of	of	IN
cord-005453-4057qib7	4223	8	the	the	DT
cord-005453-4057qib7	4223	9	main	main	JJ
cord-005453-4057qib7	4223	10	complications	complication	NNS
cord-005453-4057qib7	4223	11	after	after	IN
cord-005453-4057qib7	4223	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4223	13	from	from	IN
cord-005453-4057qib7	4223	14	day	day	NN
cord-005453-4057qib7	4223	15	0	0	CD
cord-005453-4057qib7	4223	16	to	to	IN
cord-005453-4057qib7	4223	17	day	day	NN
cord-005453-4057qib7	4223	18	+90	+90	CD
cord-005453-4057qib7	4223	19	were	be	VBD
cord-005453-4057qib7	4223	20	evaluated	evaluate	VBN
cord-005453-4057qib7	4223	21	.	.	.
cord-005453-4057qib7	4224	1	ARF	ARF	NNP
cord-005453-4057qib7	4224	2	was	be	VBD
cord-005453-4057qib7	4224	3	defined	define	VBN
cord-005453-4057qib7	4224	4	according	accord	VBG
cord-005453-4057qib7	4224	5	to	to	IN
cord-005453-4057qib7	4224	6	KDIGO	KDIGO	NNP
cord-005453-4057qib7	4224	7	(	(	-LRB-
cord-005453-4057qib7	4224	8	Kidney	Kidney	NNP
cord-005453-4057qib7	4224	9	Disease	Disease	NNP
cord-005453-4057qib7	4224	10	Improving	Improving	NNP
cord-005453-4057qib7	4224	11	Global	Global	NNP
cord-005453-4057qib7	4224	12	Outcomes	Outcomes	NNPS
cord-005453-4057qib7	4224	13	)	)	-RRB-
cord-005453-4057qib7	4224	14	classification	classification	NN
cord-005453-4057qib7	4224	15	;	;	:
cord-005453-4057qib7	4224	16	the	the	DT
cord-005453-4057qib7	4224	17	relative	relative	JJ
cord-005453-4057qib7	4224	18	increase	increase	NN
cord-005453-4057qib7	4224	19	of	of	IN
cord-005453-4057qib7	4224	20	serum	serum	NN
cord-005453-4057qib7	4224	21	creatinine	creatinine	NN
cord-005453-4057qib7	4224	22	levels	level	NNS
cord-005453-4057qib7	4224	23	was	be	VBD
cord-005453-4057qib7	4224	24	considered	consider	VBN
cord-005453-4057qib7	4224	25	a	a	DT
cord-005453-4057qib7	4224	26	marker	marker	NN
cord-005453-4057qib7	4224	27	of	of	IN
cord-005453-4057qib7	4224	28	kidney	kidney	NN
cord-005453-4057qib7	4224	29	damage	damage	NN
cord-005453-4057qib7	4224	30	.	.	.
cord-005453-4057qib7	4225	1	Results	result	NNS
cord-005453-4057qib7	4225	2	:	:	:
cord-005453-4057qib7	4226	1	Seventy	seventy	CD
cord-005453-4057qib7	4226	2	-	-	HYPH
cord-005453-4057qib7	4226	3	seven	seven	CD
cord-005453-4057qib7	4226	4	patients	patient	NNS
cord-005453-4057qib7	4226	5	received	receive	VBD
cord-005453-4057qib7	4226	6	a	a	DT
cord-005453-4057qib7	4226	7	MA	MA	NNP
cord-005453-4057qib7	4226	8	alloHSCT	allohsct	NN
cord-005453-4057qib7	4226	9	and	and	CC
cord-005453-4057qib7	4226	10	72	72	CD
cord-005453-4057qib7	4226	11	a	a	DT
cord-005453-4057qib7	4226	12	NMA	NMA	NNP
cord-005453-4057qib7	4226	13	alloHSCT	allohsct	NN
cord-005453-4057qib7	4226	14	.	.	.
cord-005453-4057qib7	4227	1	Recipients	recipient	NNS
cord-005453-4057qib7	4227	2	of	of	IN
cord-005453-4057qib7	4227	3	NMA	NMA	NNP
cord-005453-4057qib7	4227	4	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	4227	5	had	have	VBD
cord-005453-4057qib7	4227	6	a	a	DT
cord-005453-4057qib7	4227	7	higher	high	JJR
cord-005453-4057qib7	4227	8	median	median	NN
cord-005453-4057qib7	4227	9	age	age	NN
cord-005453-4057qib7	4227	10	(	(	-LRB-
cord-005453-4057qib7	4227	11	61	61	CD
cord-005453-4057qib7	4227	12	years	year	NNS
cord-005453-4057qib7	4228	1	[	[	-LRB-
cord-005453-4057qib7	4228	2	range	range	NN
cord-005453-4057qib7	4228	3	:	:	:
cord-005453-4057qib7	4228	4	18	18	CD
cord-005453-4057qib7	4228	5	-	-	SYM
cord-005453-4057qib7	4228	6	69	69	CD
cord-005453-4057qib7	4228	7	]	]	-RRB-
cord-005453-4057qib7	4228	8	vs.	vs.	NN
cord-005453-4057qib7	4228	9	41	41	CD
cord-005453-4057qib7	4228	10	years	year	NNS
cord-005453-4057qib7	4228	11	,	,	,
cord-005453-4057qib7	4228	12	p	p	NN
cord-005453-4057qib7	4228	13	<	<	XX
cord-005453-4057qib7	4228	14	0.001	0.001	CD
cord-005453-4057qib7	4228	15	)	)	-RRB-
cord-005453-4057qib7	4228	16	,	,	,
cord-005453-4057qib7	4228	17	higher	high	JJR
cord-005453-4057qib7	4228	18	frequency	frequency	NN
cord-005453-4057qib7	4228	19	of	of	IN
cord-005453-4057qib7	4228	20	arterial	arterial	JJ
cord-005453-4057qib7	4228	21	hypertension	hypertension	NN
cord-005453-4057qib7	4228	22	(	(	-LRB-
cord-005453-4057qib7	4228	23	29	29	CD
cord-005453-4057qib7	4228	24	%	%	NN
cord-005453-4057qib7	4228	25	vs.	vs.	CC
cord-005453-4057qib7	4228	26	6	6	CD
cord-005453-4057qib7	4228	27	%	%	NN
cord-005453-4057qib7	4228	28	,	,	,
cord-005453-4057qib7	4228	29	p	p	NN
cord-005453-4057qib7	4228	30	<	<	XX
cord-005453-4057qib7	4228	31	0.001	0.001	CD
cord-005453-4057qib7	4228	32	)	)	-RRB-
cord-005453-4057qib7	4228	33	and	and	CC
cord-005453-4057qib7	4228	34	showed	show	VBD
cord-005453-4057qib7	4228	35	most	most	RBS
cord-005453-4057qib7	4228	36	frequently	frequently	RB
cord-005453-4057qib7	4228	37	active	active	JJ
cord-005453-4057qib7	4228	38	disease	disease	NN
cord-005453-4057qib7	4228	39	at	at	IN
cord-005453-4057qib7	4228	40	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4228	41	(	(	-LRB-
cord-005453-4057qib7	4228	42	42	42	CD
cord-005453-4057qib7	4228	43	%	%	NN
cord-005453-4057qib7	4228	44	vs.	vs.	IN
cord-005453-4057qib7	4228	45	18	18	CD
cord-005453-4057qib7	4228	46	%	%	NN
cord-005453-4057qib7	4228	47	,	,	,
cord-005453-4057qib7	4228	48	p=0.002	p=0.002	NNP
cord-005453-4057qib7	4228	49	)	)	-RRB-
cord-005453-4057qib7	4228	50	.	.	.
cord-005453-4057qib7	4229	1	In	in	IN
cord-005453-4057qib7	4229	2	both	both	DT
cord-005453-4057qib7	4229	3	groups	group	NNS
cord-005453-4057qib7	4229	4	the	the	DT
cord-005453-4057qib7	4229	5	most	most	RBS
cord-005453-4057qib7	4229	6	frequent	frequent	JJ
cord-005453-4057qib7	4229	7	graft	graft	NN
cord-005453-4057qib7	4229	8	-	-	HYPH
cord-005453-4057qib7	4229	9	versushost	versushost	NN
cord-005453-4057qib7	4229	10	disease	disease	NN
cord-005453-4057qib7	4229	11	(	(	-LRB-
cord-005453-4057qib7	4229	12	GVHD	GVHD	NNP
cord-005453-4057qib7	4229	13	)	)	-RRB-
cord-005453-4057qib7	4229	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4229	15	regimen	regimen	NN
cord-005453-4057qib7	4229	16	was	be	VBD
cord-005453-4057qib7	4229	17	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	4229	18	A	A	NNP
cord-005453-4057qib7	4229	19	and	and	CC
cord-005453-4057qib7	4229	20	methotrexate	methotrexate	NNP
cord-005453-4057qib7	4229	21	.	.	.
cord-005453-4057qib7	4230	1	The	the	DT
cord-005453-4057qib7	4230	2	median	median	JJ
cord-005453-4057qib7	4230	3	follow	follow	NN
cord-005453-4057qib7	4230	4	-	-	HYPH
cord-005453-4057qib7	4230	5	up	up	RP
cord-005453-4057qib7	4230	6	time	time	NN
cord-005453-4057qib7	4230	7	was	be	VBD
cord-005453-4057qib7	4230	8	2.3	2.3	CD
cord-005453-4057qib7	4230	9	years	year	NNS
cord-005453-4057qib7	4230	10	for	for	IN
cord-005453-4057qib7	4230	11	the	the	DT
cord-005453-4057qib7	4230	12	NMA	NMA	NNP
cord-005453-4057qib7	4230	13	group	group	NN
cord-005453-4057qib7	4230	14	and	and	CC
cord-005453-4057qib7	4230	15	3.6	3.6	CD
cord-005453-4057qib7	4230	16	years	year	NNS
cord-005453-4057qib7	4230	17	for	for	IN
cord-005453-4057qib7	4230	18	the	the	DT
cord-005453-4057qib7	4230	19	MA	MA	NNP
cord-005453-4057qib7	4230	20	group	group	NN
cord-005453-4057qib7	4230	21	.	.	.
cord-005453-4057qib7	4231	1	Patients	patient	NNS
cord-005453-4057qib7	4231	2	from	from	IN
cord-005453-4057qib7	4231	3	the	the	DT
cord-005453-4057qib7	4231	4	MA	MA	NNP
cord-005453-4057qib7	4231	5	group	group	NN
cord-005453-4057qib7	4231	6	had	have	VBD
cord-005453-4057qib7	4231	7	higher	high	JJR
cord-005453-4057qib7	4231	8	incidence	incidence	NN
cord-005453-4057qib7	4231	9	of	of	IN
cord-005453-4057qib7	4231	10	grade	grade	NN
cord-005453-4057qib7	4231	11	3	3	CD
cord-005453-4057qib7	4231	12	-	-	SYM
cord-005453-4057qib7	4231	13	4	4	CD
cord-005453-4057qib7	4231	14	mucositis	mucositis	NNP
cord-005453-4057qib7	4231	15	(	(	-LRB-
cord-005453-4057qib7	4231	16	60	60	CD
cord-005453-4057qib7	4231	17	%	%	NN
cord-005453-4057qib7	4231	18	vs.	vs.	IN
cord-005453-4057qib7	4231	19	22	22	CD
cord-005453-4057qib7	4231	20	%	%	NN
cord-005453-4057qib7	4231	21	,	,	,
cord-005453-4057qib7	4231	22	p	p	NN
cord-005453-4057qib7	4231	23	<	<	XX
cord-005453-4057qib7	4231	24	0.001	0.001	CD
cord-005453-4057qib7	4231	25	)	)	-RRB-
cord-005453-4057qib7	4231	26	and	and	CC
cord-005453-4057qib7	4231	27	acute	acute	JJ
cord-005453-4057qib7	4231	28	GVHD	GVHD	NNP
cord-005453-4057qib7	4231	29	of	of	IN
cord-005453-4057qib7	4231	30	any	any	DT
cord-005453-4057qib7	4231	31	grade	grade	NN
cord-005453-4057qib7	4231	32	(	(	-LRB-
cord-005453-4057qib7	4231	33	70	70	CD
cord-005453-4057qib7	4231	34	%	%	NN
cord-005453-4057qib7	4231	35	vs.	vs.	IN
cord-005453-4057qib7	4231	36	53	53	CD
cord-005453-4057qib7	4231	37	%	%	NN
cord-005453-4057qib7	4231	38	,	,	,
cord-005453-4057qib7	4231	39	p=0.029	p=0.029	NNP
cord-005453-4057qib7	4231	40	)	)	-RRB-
cord-005453-4057qib7	4231	41	than	than	IN
cord-005453-4057qib7	4231	42	patients	patient	NNS
cord-005453-4057qib7	4231	43	from	from	IN
cord-005453-4057qib7	4231	44	the	the	DT
cord-005453-4057qib7	4231	45	NMA	NMA	NNP
cord-005453-4057qib7	4231	46	alloHSCT	allohsct	NN
cord-005453-4057qib7	4231	47	.	.	.
cord-005453-4057qib7	4232	1	The	the	DT
cord-005453-4057qib7	4232	2	incidence	incidence	NN
cord-005453-4057qib7	4232	3	of	of	IN
cord-005453-4057qib7	4232	4	ARF	ARF	NNP
cord-005453-4057qib7	4232	5	was	be	VBD
cord-005453-4057qib7	4232	6	similar	similar	JJ
cord-005453-4057qib7	4232	7	in	in	IN
cord-005453-4057qib7	4232	8	both	both	DT
cord-005453-4057qib7	4232	9	groups	group	NNS
cord-005453-4057qib7	4232	10	(	(	-LRB-
cord-005453-4057qib7	4232	11	72	72	CD
cord-005453-4057qib7	4232	12	%	%	NN
cord-005453-4057qib7	4232	13	in	in	IN
cord-005453-4057qib7	4232	14	NMA	NMA	NNP
cord-005453-4057qib7	4232	15	and	and	CC
cord-005453-4057qib7	4232	16	71	71	CD
cord-005453-4057qib7	4232	17	%	%	NN
cord-005453-4057qib7	4232	18	in	in	IN
cord-005453-4057qib7	4232	19	MA	MA	NNP
cord-005453-4057qib7	4232	20	)	)	-RRB-
cord-005453-4057qib7	4232	21	.	.	.
cord-005453-4057qib7	4233	1	In	in	IN
cord-005453-4057qib7	4233	2	the	the	DT
cord-005453-4057qib7	4233	3	NMA	NMA	NNP
cord-005453-4057qib7	4233	4	group	group	NN
cord-005453-4057qib7	4233	5	arterial	arterial	JJ
cord-005453-4057qib7	4233	6	hypertension	hypertension	NN
cord-005453-4057qib7	4233	7	(	(	-LRB-
cord-005453-4057qib7	4233	8	HR	HR	NNP
cord-005453-4057qib7	4233	9	2.05	2.05	CD
cord-005453-4057qib7	4233	10	,	,	,
cord-005453-4057qib7	4233	11	p=0.018	p=0.018	NNP
cord-005453-4057qib7	4233	12	)	)	-RRB-
cord-005453-4057qib7	4233	13	,	,	,
cord-005453-4057qib7	4233	14	obesity	obesity	NN
cord-005453-4057qib7	4233	15	(	(	-LRB-
cord-005453-4057qib7	4233	16	HR	HR	NNP
cord-005453-4057qib7	4233	17	4.16	4.16	CD
cord-005453-4057qib7	4233	18	,	,	,
cord-005453-4057qib7	4233	19	p	p	NN
cord-005453-4057qib7	4233	20	<	<	XX
cord-005453-4057qib7	4233	21	0.001	0.001	CD
cord-005453-4057qib7	4233	22	)	)	-RRB-
cord-005453-4057qib7	4233	23	and	and	CC
cord-005453-4057qib7	4233	24	prior	prior	JJ
cord-005453-4057qib7	4233	25	pneumonia	pneumonia	NN
cord-005453-4057qib7	4233	26	(	(	-LRB-
cord-005453-4057qib7	4233	27	HR	HR	NNP
cord-005453-4057qib7	4233	28	3.19	3.19	CD
cord-005453-4057qib7	4233	29	,	,	,
cord-005453-4057qib7	4233	30	<	<	XX
cord-005453-4057qib7	4233	31	0.001	0.001	CD
cord-005453-4057qib7	4233	32	)	)	-RRB-
cord-005453-4057qib7	4233	33	were	be	VBD
cord-005453-4057qib7	4233	34	predisposing	predispose	VBG
cord-005453-4057qib7	4233	35	factors	factor	NNS
cord-005453-4057qib7	4233	36	for	for	IN
cord-005453-4057qib7	4233	37	ARF	arf	NN
cord-005453-4057qib7	4233	38	by	by	IN
cord-005453-4057qib7	4233	39	multivariate	multivariate	JJ
cord-005453-4057qib7	4233	40	analysis	analysis	NN
cord-005453-4057qib7	4233	41	,	,	,
cord-005453-4057qib7	4233	42	whereas	whereas	IN
cord-005453-4057qib7	4233	43	any	any	DT
cord-005453-4057qib7	4233	44	factor	factor	NN
cord-005453-4057qib7	4233	45	was	be	VBD
cord-005453-4057qib7	4233	46	identified	identify	VBN
cord-005453-4057qib7	4233	47	in	in	IN
cord-005453-4057qib7	4233	48	the	the	DT
cord-005453-4057qib7	4233	49	MA	MA	NNP
cord-005453-4057qib7	4233	50	group	group	NN
cord-005453-4057qib7	4233	51	.	.	.
cord-005453-4057qib7	4234	1	ARF	ARF	NNP
cord-005453-4057qib7	4234	2	had	have	VBD
cord-005453-4057qib7	4234	3	no	no	DT
cord-005453-4057qib7	4234	4	impact	impact	NN
cord-005453-4057qib7	4234	5	on	on	IN
cord-005453-4057qib7	4234	6	2-year	2-year	CD
cord-005453-4057qib7	4234	7	OS	os	NN
cord-005453-4057qib7	4234	8	in	in	IN
cord-005453-4057qib7	4234	9	both	both	DT
cord-005453-4057qib7	4234	10	groups	group	NNS
cord-005453-4057qib7	4234	11	(	(	-LRB-
cord-005453-4057qib7	4234	12	28	28	CD
cord-005453-4057qib7	4234	13	%	%	NN
cord-005453-4057qib7	4234	14	vs.	vs.	CC
cord-005453-4057qib7	4234	15	35	35	CD
cord-005453-4057qib7	4234	16	%	%	NN
cord-005453-4057qib7	4234	17	p=0.406	p=0.406	XX
cord-005453-4057qib7	4235	1	for	for	IN
cord-005453-4057qib7	4235	2	the	the	DT
cord-005453-4057qib7	4235	3	NMA	NMA	NNP
cord-005453-4057qib7	4235	4	group	group	NN
cord-005453-4057qib7	4235	5	and	and	CC
cord-005453-4057qib7	4235	6	45	45	CD
cord-005453-4057qib7	4235	7	%	%	NN
cord-005453-4057qib7	4235	8	vs.	vs.	IN
cord-005453-4057qib7	4235	9	40	40	CD
cord-005453-4057qib7	4235	10	%	%	NN
cord-005453-4057qib7	4235	11	p=0.623	p=0.623	NNS
cord-005453-4057qib7	4235	12	for	for	IN
cord-005453-4057qib7	4235	13	the	the	DT
cord-005453-4057qib7	4235	14	MA	MA	NNP
cord-005453-4057qib7	4235	15	group	group	NN
cord-005453-4057qib7	4235	16	)	)	-RRB-
cord-005453-4057qib7	4235	17	.	.	.
cord-005453-4057qib7	4236	1	However	however	RB
cord-005453-4057qib7	4236	2	,	,	,
cord-005453-4057qib7	4236	3	worse	bad	JJR
cord-005453-4057qib7	4236	4	OS	OS	NNP
cord-005453-4057qib7	4236	5	were	be	VBD
cord-005453-4057qib7	4236	6	observed	observe	VBN
cord-005453-4057qib7	4236	7	in	in	IN
cord-005453-4057qib7	4236	8	patients	patient	NNS
cord-005453-4057qib7	4236	9	with	with	IN
cord-005453-4057qib7	4236	10	grade	grade	NN
cord-005453-4057qib7	4236	11	2	2	CD
cord-005453-4057qib7	4236	12	-	-	SYM
cord-005453-4057qib7	4236	13	3	3	CD
cord-005453-4057qib7	4236	14	ARF	arf	NN
cord-005453-4057qib7	4236	15	in	in	IN
cord-005453-4057qib7	4236	16	the	the	DT
cord-005453-4057qib7	4236	17	NMA	NMA	NNP
cord-005453-4057qib7	4236	18	group	group	NN
cord-005453-4057qib7	4236	19	(	(	-LRB-
cord-005453-4057qib7	4236	20	18	18	CD
cord-005453-4057qib7	4236	21	%	%	NN
cord-005453-4057qib7	4236	22	vs.	vs.	IN
cord-005453-4057qib7	4236	23	43	43	CD
cord-005453-4057qib7	4236	24	%	%	NN
cord-005453-4057qib7	4236	25	,	,	,
cord-005453-4057qib7	4236	26	p=0.048	p=0.048	NNP
cord-005453-4057qib7	4236	27	)	)	-RRB-
cord-005453-4057qib7	4236	28	and	and	CC
cord-005453-4057qib7	4236	29	in	in	IN
cord-005453-4057qib7	4236	30	patients	patient	NNS
cord-005453-4057qib7	4236	31	with	with	IN
cord-005453-4057qib7	4236	32	grade	grade	NN
cord-005453-4057qib7	4236	33	3	3	CD
cord-005453-4057qib7	4236	34	ARF	arf	NN
cord-005453-4057qib7	4236	35	in	in	IN
cord-005453-4057qib7	4236	36	the	the	DT
cord-005453-4057qib7	4236	37	MA	MA	NNP
cord-005453-4057qib7	4236	38	group	group	NN
cord-005453-4057qib7	4236	39	(	(	-LRB-
cord-005453-4057qib7	4236	40	25	25	CD
cord-005453-4057qib7	4236	41	%	%	NN
cord-005453-4057qib7	4236	42	vs.	vs.	IN
cord-005453-4057qib7	4236	43	59	59	CD
cord-005453-4057qib7	4236	44	%	%	NN
cord-005453-4057qib7	4236	45	,	,	,
cord-005453-4057qib7	4236	46	p=0.011	p=0.011	NNP
cord-005453-4057qib7	4236	47	)	)	-RRB-
cord-005453-4057qib7	4236	48	.	.	.
cord-005453-4057qib7	4237	1	In	in	IN
cord-005453-4057qib7	4237	2	turn	turn	NN
cord-005453-4057qib7	4237	3	,	,	,
cord-005453-4057qib7	4237	4	ARF	ARF	NNP
cord-005453-4057qib7	4237	5	had	have	VBD
cord-005453-4057qib7	4237	6	no	no	DT
cord-005453-4057qib7	4237	7	influence	influence	NN
cord-005453-4057qib7	4237	8	on	on	IN
cord-005453-4057qib7	4237	9	NRM	NRM	NNP
cord-005453-4057qib7	4237	10	in	in	IN
cord-005453-4057qib7	4237	11	the	the	DT
cord-005453-4057qib7	4237	12	MA	MA	NNP
cord-005453-4057qib7	4237	13	group	group	NN
cord-005453-4057qib7	4237	14	but	but	CC
cord-005453-4057qib7	4237	15	was	be	VBD
cord-005453-4057qib7	4237	16	associated	associate	VBN
cord-005453-4057qib7	4237	17	with	with	IN
cord-005453-4057qib7	4237	18	a	a	DT
cord-005453-4057qib7	4237	19	trend	trend	NN
cord-005453-4057qib7	4237	20	for	for	IN
cord-005453-4057qib7	4237	21	higher	high	JJR
cord-005453-4057qib7	4237	22	NRM	NRM	NNP
cord-005453-4057qib7	4237	23	in	in	IN
cord-005453-4057qib7	4237	24	the	the	DT
cord-005453-4057qib7	4237	25	NMA	NMA	NNP
cord-005453-4057qib7	4237	26	group	group	NN
cord-005453-4057qib7	4237	27	(	(	-LRB-
cord-005453-4057qib7	4237	28	59	59	CD
cord-005453-4057qib7	4237	29	%	%	NN
cord-005453-4057qib7	4237	30	vs.	vs.	CC
cord-005453-4057qib7	4237	31	35	35	CD
cord-005453-4057qib7	4237	32	%	%	NN
cord-005453-4057qib7	4237	33	,	,	,
cord-005453-4057qib7	4237	34	p=0.084	p=0.084	NNP
cord-005453-4057qib7	4237	35	)	)	-RRB-
cord-005453-4057qib7	4237	36	.	.	.
cord-005453-4057qib7	4238	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4238	2	:	:	:
cord-005453-4057qib7	4238	3	ARF	ARF	NNP
cord-005453-4057qib7	4238	4	is	be	VBZ
cord-005453-4057qib7	4238	5	a	a	DT
cord-005453-4057qib7	4238	6	frequent	frequent	JJ
cord-005453-4057qib7	4238	7	complication	complication	NN
cord-005453-4057qib7	4238	8	in	in	IN
cord-005453-4057qib7	4238	9	patients	patient	NNS
cord-005453-4057qib7	4238	10	receiving	receive	VBG
cord-005453-4057qib7	4238	11	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	4238	12	irrespective	irrespective	RB
cord-005453-4057qib7	4238	13	of	of	IN
cord-005453-4057qib7	4238	14	the	the	DT
cord-005453-4057qib7	4238	15	intensity	intensity	NN
cord-005453-4057qib7	4238	16	of	of	IN
cord-005453-4057qib7	4238	17	the	the	DT
cord-005453-4057qib7	4238	18	conditioning	conditioning	NN
cord-005453-4057qib7	4238	19	regimen	regimen	NN
cord-005453-4057qib7	4238	20	.	.	.
cord-005453-4057qib7	4239	1	Moderate	moderate	JJ
cord-005453-4057qib7	4239	2	and	and	CC
cord-005453-4057qib7	4239	3	severe	severe	JJ
cord-005453-4057qib7	4239	4	ARF	arf	NN
cord-005453-4057qib7	4239	5	had	have	VBD
cord-005453-4057qib7	4239	6	negative	negative	JJ
cord-005453-4057qib7	4239	7	impact	impact	NN
cord-005453-4057qib7	4239	8	on	on	IN
cord-005453-4057qib7	4239	9	OS	OS	NNP
cord-005453-4057qib7	4239	10	.	.	.
cord-005453-4057qib7	4240	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4240	2	:	:	:
cord-005453-4057qib7	4240	3	Supported	support	VBN
cord-005453-4057qib7	4240	4	by	by	IN
cord-005453-4057qib7	4240	5	grants	grant	NNS
cord-005453-4057qib7	4240	6	from	from	IN
cord-005453-4057qib7	4240	7	:	:	:
cord-005453-4057qib7	4240	8	Asociación	Asociación	NNP
cord-005453-4057qib7	4240	9	Española	Española	NNP
cord-005453-4057qib7	4240	10	Contra	Contra	NNP
cord-005453-4057qib7	4240	11	el	el	NNP
cord-005453-4057qib7	4240	12	Cáncer	Cáncer	NNP
cord-005453-4057qib7	4240	13	,	,	,
cord-005453-4057qib7	4240	14	AECC	AECC	NNP
cord-005453-4057qib7	4240	15	(	(	-LRB-
cord-005453-4057qib7	4240	16	GC16173697BIGA	GC16173697BIGA	NNP
cord-005453-4057qib7	4240	17	)	)	-RRB-
cord-005453-4057qib7	4240	18	,	,	,
cord-005453-4057qib7	4240	19	Instituto	Instituto	NNP
cord-005453-4057qib7	4240	20	Carlos	Carlos	NNP
cord-005453-4057qib7	4240	21	III	III	NNP
cord-005453-4057qib7	4240	22	(	(	-LRB-
cord-005453-4057qib7	4240	23	PI14/01971	PI14/01971	NNP
cord-005453-4057qib7	4240	24	FI	FI	NNP
cord-005453-4057qib7	4240	25	)	)	-RRB-
cord-005453-4057qib7	4240	26	,	,	,
cord-005453-4057qib7	4240	27	2017-SGR288	2017-sgr288	CD
cord-005453-4057qib7	4240	28	(	(	-LRB-
cord-005453-4057qib7	4240	29	GRC	GRC	NNP
cord-005453-4057qib7	4240	30	)	)	-RRB-
cord-005453-4057qib7	4240	31	,	,	.
cord-005453-4057qib7	4241	1	CERCA	CERCA	NNP
cord-005453-4057qib7	4241	2	Program	Program	NNP
cord-005453-4057qib7	4241	3	from	from	IN
cord-005453-4057qib7	4241	4	Generalitat	Generalitat	NNP
cord-005453-4057qib7	4241	5	de	de	NNP
cord-005453-4057qib7	4241	6	Catalunya	Catalunya	NNP
cord-005453-4057qib7	4241	7	,	,	,
cord-005453-4057qib7	4241	8	and	and	CC
cord-005453-4057qib7	4241	9	"	"	``
cord-005453-4057qib7	4241	10	La	La	NNP
cord-005453-4057qib7	4241	11	Caixa	Caixa	NNP
cord-005453-4057qib7	4241	12	"	"	''
cord-005453-4057qib7	4241	13	Foundation	Foundation	NNP
cord-005453-4057qib7	4241	14	.	.	.
cord-005453-4057qib7	4242	1	Treatment	treatment	NN
cord-005453-4057qib7	4242	2	and	and	CC
cord-005453-4057qib7	4242	3	risk	risk	NN
cord-005453-4057qib7	4242	4	factors	factor	NNS
cord-005453-4057qib7	4242	5	of	of	IN
cord-005453-4057qib7	4242	6	hepatic	hepatic	JJ
cord-005453-4057qib7	4242	7	veno	veno	NN
cord-005453-4057qib7	4242	8	-	-	HYPH
cord-005453-4057qib7	4242	9	occlusive	occlusive	JJ
cord-005453-4057qib7	4242	10	disease	disease	NN
cord-005453-4057qib7	4242	11	after	after	IN
cord-005453-4057qib7	4242	12	pediatric	pediatric	JJ
cord-005453-4057qib7	4242	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4242	14	stem	stem	NN
cord-005453-4057qib7	4242	15	cell	cell	NN
cord-005453-4057qib7	4242	16	transplantation	transplantation	NN
cord-005453-4057qib7	4242	17	:	:	:
cord-005453-4057qib7	4242	18	A	a	DT
cord-005453-4057qib7	4242	19	single	single	JJ
cord-005453-4057qib7	4242	20	-	-	HYPH
cord-005453-4057qib7	4242	21	center	center	NN
cord-005453-4057qib7	4242	22	experience	experience	NN
cord-005453-4057qib7	4242	23	Barbaros	Barbaros	NNP
cord-005453-4057qib7	4242	24	Sahin	Sahin	NNP
cord-005453-4057qib7	4242	25	Karagün	Karagün	NNP
cord-005453-4057qib7	4242	26	1	1	CD
cord-005453-4057qib7	4242	27	,	,	,
cord-005453-4057qib7	4242	28	Ilgen	Ilgen	NNP
cord-005453-4057qib7	4242	29	Sasmaz	Sasmaz	NNP
cord-005453-4057qib7	4242	30	2	2	CD
cord-005453-4057qib7	4242	31	,	,	,
cord-005453-4057qib7	4242	32	Ali	Ali	NNP
cord-005453-4057qib7	4242	33	Bülent	Bülent	NNP
cord-005453-4057qib7	4243	1	Antmen	Antmen	NNP
cord-005453-4057qib7	4243	2	1	1	CD
cord-005453-4057qib7	4243	3	Background	Background	NNP
cord-005453-4057qib7	4243	4	:	:	:
cord-005453-4057qib7	4243	5	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	4243	6	emerged	emerge	VBD
cord-005453-4057qib7	4243	7	as	as	IN
cord-005453-4057qib7	4243	8	a	a	DT
cord-005453-4057qib7	4243	9	promising	promising	JJ
cord-005453-4057qib7	4243	10	treatment	treatment	NN
cord-005453-4057qib7	4243	11	option	option	NN
cord-005453-4057qib7	4243	12	for	for	IN
cord-005453-4057qib7	4243	13	hepatic	hepatic	JJ
cord-005453-4057qib7	4243	14	veno	veno	NNP
cord-005453-4057qib7	4243	15	-	-	HYPH
cord-005453-4057qib7	4243	16	occlusive	occlusive	JJ
cord-005453-4057qib7	4243	17	disease	disease	NN
cord-005453-4057qib7	4243	18	,	,	,
cord-005453-4057qib7	4243	19	a	a	DT
cord-005453-4057qib7	4243	20	significant	significant	JJ
cord-005453-4057qib7	4243	21	cause	cause	NN
cord-005453-4057qib7	4243	22	of	of	IN
cord-005453-4057qib7	4243	23	mortality	mortality	NN
cord-005453-4057qib7	4243	24	in	in	IN
cord-005453-4057qib7	4243	25	recipients	recipient	NNS
cord-005453-4057qib7	4243	26	of	of	IN
cord-005453-4057qib7	4243	27	HSCT	HSCT	NNP
cord-005453-4057qib7	4243	28	.	.	.
cord-005453-4057qib7	4244	1	As	as	IN
cord-005453-4057qib7	4244	2	VOD	VOD	NNP
cord-005453-4057qib7	4244	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	4244	4	is	be	VBZ
cord-005453-4057qib7	4244	5	quite	quite	RB
cord-005453-4057qib7	4244	6	difficult	difficult	JJ
cord-005453-4057qib7	4244	7	even	even	RB
cord-005453-4057qib7	4244	8	with	with	IN
cord-005453-4057qib7	4244	9	the	the	DT
cord-005453-4057qib7	4244	10	recently	recently	RB
cord-005453-4057qib7	4244	11	introduced	introduce	VBN
cord-005453-4057qib7	4244	12	EBMT	EBMT	NNP
cord-005453-4057qib7	4244	13	2017	2017	CD
cord-005453-4057qib7	4244	14	criteria	criterion	NNS
cord-005453-4057qib7	4244	15	,	,	,
cord-005453-4057qib7	4244	16	studies	study	NNS
cord-005453-4057qib7	4244	17	which	which	WDT
cord-005453-4057qib7	4244	18	report	report	VBP
cord-005453-4057qib7	4244	19	treatment	treatment	NN
cord-005453-4057qib7	4244	20	outcomes	outcome	NNS
cord-005453-4057qib7	4244	21	and	and	CC
cord-005453-4057qib7	4244	22	response	response	NN
cord-005453-4057qib7	4244	23	to	to	IN
cord-005453-4057qib7	4244	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4244	25	are	be	VBP
cord-005453-4057qib7	4244	26	required	require	VBN
cord-005453-4057qib7	4244	27	.	.	.
cord-005453-4057qib7	4245	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4245	2	aim	aim	NN
cord-005453-4057qib7	4245	3	was	be	VBD
cord-005453-4057qib7	4245	4	to	to	TO
cord-005453-4057qib7	4245	5	evaluate	evaluate	VB
cord-005453-4057qib7	4245	6	the	the	DT
cord-005453-4057qib7	4245	7	efficacy	efficacy	NN
cord-005453-4057qib7	4245	8	of	of	IN
cord-005453-4057qib7	4245	9	defibrotide	defibrotide	NN
cord-005453-4057qib7	4245	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4245	11	in	in	IN
cord-005453-4057qib7	4245	12	HSCT	HSCT	NNP
cord-005453-4057qib7	4245	13	recipients	recipient	NNS
cord-005453-4057qib7	4245	14	at	at	IN
cord-005453-4057qib7	4245	15	our	-PRON-	PRP$
cord-005453-4057qib7	4245	16	center	center	NN
cord-005453-4057qib7	4245	17	.	.	.
cord-005453-4057qib7	4246	1	Methods	method	NNS
cord-005453-4057qib7	4246	2	:	:	:
cord-005453-4057qib7	4246	3	A	a	DT
cord-005453-4057qib7	4246	4	total	total	NN
cord-005453-4057qib7	4246	5	of	of	IN
cord-005453-4057qib7	4246	6	236	236	CD
cord-005453-4057qib7	4246	7	transplants	transplant	NNS
cord-005453-4057qib7	4246	8	in	in	IN
cord-005453-4057qib7	4246	9	210	210	CD
cord-005453-4057qib7	4246	10	patients	patient	NNS
cord-005453-4057qib7	4246	11	from	from	IN
cord-005453-4057qib7	4246	12	January	January	NNP
cord-005453-4057qib7	4246	13	2013	2013	CD
cord-005453-4057qib7	4246	14	to	to	IN
cord-005453-4057qib7	4246	15	July	July	NNP
cord-005453-4057qib7	4246	16	2018	2018	CD
cord-005453-4057qib7	4246	17	were	be	VBD
cord-005453-4057qib7	4246	18	included	include	VBN
cord-005453-4057qib7	4246	19	in	in	IN
cord-005453-4057qib7	4246	20	this	this	DT
cord-005453-4057qib7	4246	21	study	study	NN
cord-005453-4057qib7	4246	22	.	.	.
cord-005453-4057qib7	4247	1	All	all	DT
cord-005453-4057qib7	4247	2	patients	patient	NNS
cord-005453-4057qib7	4247	3	had	have	VBD
cord-005453-4057qib7	4247	4	factors	factor	NNS
cord-005453-4057qib7	4247	5	that	that	WDT
cord-005453-4057qib7	4247	6	increased	increase	VBD
cord-005453-4057qib7	4247	7	the	the	DT
cord-005453-4057qib7	4247	8	risk	risk	NN
cord-005453-4057qib7	4247	9	of	of	IN
cord-005453-4057qib7	4247	10	VOD	VOD	NNP
cord-005453-4057qib7	4247	11	and	and	CC
cord-005453-4057qib7	4247	12	all	all	DT
cord-005453-4057qib7	4247	13	received	receive	VBD
cord-005453-4057qib7	4247	14	25	25	CD
cord-005453-4057qib7	4247	15	mg	mg	NNP
cord-005453-4057qib7	4247	16	/	/	SYM
cord-005453-4057qib7	4247	17	kg	kg	NNP
cord-005453-4057qib7	4247	18	/	/	SYM
cord-005453-4057qib7	4247	19	day	day	NN
cord-005453-4057qib7	4247	20	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4247	21	.	.	.
cord-005453-4057qib7	4248	1	Patients	patient	NNS
cord-005453-4057qib7	4248	2	'	'	POS
cord-005453-4057qib7	4248	3	coagulation	coagulation	NN
cord-005453-4057qib7	4248	4	,	,	,
cord-005453-4057qib7	4248	5	renal	renal	JJ
cord-005453-4057qib7	4248	6	and	and	CC
cord-005453-4057qib7	4248	7	liver	liver	NN
cord-005453-4057qib7	4248	8	function	function	NN
cord-005453-4057qib7	4248	9	test	test	NN
cord-005453-4057qib7	4248	10	were	be	VBD
cord-005453-4057qib7	4248	11	monitored	monitor	VBN
cord-005453-4057qib7	4248	12	daily	daily	RB
cord-005453-4057qib7	4248	13	and	and	CC
cord-005453-4057qib7	4248	14	all	all	DT
cord-005453-4057qib7	4248	15	clinical	clinical	JJ
cord-005453-4057qib7	4248	16	findings	finding	NNS
cord-005453-4057qib7	4248	17	and	and	CC
cord-005453-4057qib7	4248	18	complaints	complaint	NNS
cord-005453-4057qib7	4248	19	were	be	VBD
cord-005453-4057qib7	4248	20	recorded	record	VBN
cord-005453-4057qib7	4248	21	.	.	.
cord-005453-4057qib7	4249	1	Diagnoses	diagnosis	NNS
cord-005453-4057qib7	4249	2	were	be	VBD
cord-005453-4057qib7	4249	3	made	make	VBN
cord-005453-4057qib7	4249	4	via	via	IN
cord-005453-4057qib7	4249	5	the	the	DT
cord-005453-4057qib7	4249	6	EBMT	EBMT	NNP
cord-005453-4057qib7	4249	7	2017	2017	CD
cord-005453-4057qib7	4249	8	VOD	VOD	NNP
cord-005453-4057qib7	4249	9	criteria	criterion	NNS
cord-005453-4057qib7	4249	10	and	and	CC
cord-005453-4057qib7	4249	11	patients	patient	NNS
cord-005453-4057qib7	4249	12	who	who	WP
cord-005453-4057qib7	4249	13	developed	develop	VBD
cord-005453-4057qib7	4249	14	VOD	VOD	NNP
cord-005453-4057qib7	4249	15	received	receive	VBD
cord-005453-4057qib7	4249	16	treatment	treatment	NN
cord-005453-4057qib7	4249	17	with	with	IN
cord-005453-4057qib7	4249	18	increased	increase	VBN
cord-005453-4057qib7	4249	19	DF	DF	NNP
cord-005453-4057qib7	4249	20	dose	dose	NN
cord-005453-4057qib7	4249	21	(	(	-LRB-
cord-005453-4057qib7	4249	22	40	40	CD
cord-005453-4057qib7	4249	23	mg	mg	NNP
cord-005453-4057qib7	4249	24	/	/	SYM
cord-005453-4057qib7	4249	25	kg	kg	NNP
cord-005453-4057qib7	4249	26	/	/	SYM
cord-005453-4057qib7	4249	27	day	day	NN
cord-005453-4057qib7	4249	28	)	)	-RRB-
cord-005453-4057qib7	4249	29	and	and	CC
cord-005453-4057qib7	4249	30	supportive	supportive	JJ
cord-005453-4057qib7	4249	31	interventions	intervention	NNS
cord-005453-4057qib7	4249	32	.	.	.
cord-005453-4057qib7	4250	1	After	after	IN
cord-005453-4057qib7	4250	2	complete	complete	JJ
cord-005453-4057qib7	4250	3	remission	remission	NN
cord-005453-4057qib7	4250	4	of	of	IN
cord-005453-4057qib7	4250	5	VOD	VOD	NNP
cord-005453-4057qib7	4250	6	findings	finding	NNS
cord-005453-4057qib7	4250	7	,	,	,
cord-005453-4057qib7	4250	8	patients	patient	NNS
cord-005453-4057qib7	4250	9	were	be	VBD
cord-005453-4057qib7	4250	10	returned	return	VBN
cord-005453-4057qib7	4250	11	to	to	IN
cord-005453-4057qib7	4250	12	the	the	DT
cord-005453-4057qib7	4250	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4250	14	dose	dose	NN
cord-005453-4057qib7	4250	15	.	.	.
cord-005453-4057qib7	4251	1	Close	close	JJ
cord-005453-4057qib7	4251	2	follow	follow	NN
cord-005453-4057qib7	4251	3	-	-	HYPH
cord-005453-4057qib7	4251	4	up	up	NN
cord-005453-4057qib7	4251	5	of	of	IN
cord-005453-4057qib7	4251	6	patients	patient	NNS
cord-005453-4057qib7	4251	7	was	be	VBD
cord-005453-4057qib7	4251	8	performed	perform	VBN
cord-005453-4057qib7	4251	9	until	until	IN
cord-005453-4057qib7	4251	10	100	100	CD
cord-005453-4057qib7	4251	11	days	day	NNS
cord-005453-4057qib7	4251	12	.	.	.
cord-005453-4057qib7	4252	1	Results	result	NNS
cord-005453-4057qib7	4252	2	:	:	:
cord-005453-4057qib7	4253	1	In	in	IN
cord-005453-4057qib7	4253	2	total	total	NN
cord-005453-4057qib7	4253	3	,	,	,
cord-005453-4057qib7	4253	4	17	17	CD
cord-005453-4057qib7	4253	5	patients	patient	NNS
cord-005453-4057qib7	4253	6	developed	develop	VBD
cord-005453-4057qib7	4253	7	VOD	VOD	NNP
cord-005453-4057qib7	4253	8	(	(	-LRB-
cord-005453-4057qib7	4253	9	7.2	7.2	CD
cord-005453-4057qib7	4253	10	%	%	NN
cord-005453-4057qib7	4253	11	)	)	-RRB-
cord-005453-4057qib7	4253	12	,	,	,
cord-005453-4057qib7	4253	13	none	none	NN
cord-005453-4057qib7	4253	14	of	of	IN
cord-005453-4057qib7	4253	15	the	the	DT
cord-005453-4057qib7	4253	16	cases	case	NNS
cord-005453-4057qib7	4253	17	were	be	VBD
cord-005453-4057qib7	4253	18	severe	severe	JJ
cord-005453-4057qib7	4253	19	(	(	-LRB-
cord-005453-4057qib7	4253	20	13	13	CD
cord-005453-4057qib7	4253	21	mild	mild	JJ
cord-005453-4057qib7	4253	22	,	,	,
cord-005453-4057qib7	4253	23	4	4	CD
cord-005453-4057qib7	4253	24	moderate	moderate	JJ
cord-005453-4057qib7	4253	25	)	)	-RRB-
cord-005453-4057qib7	4253	26	.	.	.
cord-005453-4057qib7	4254	1	Median	median	JJ
cord-005453-4057qib7	4254	2	age	age	NN
cord-005453-4057qib7	4254	3	was	be	VBD
cord-005453-4057qib7	4254	4	8.5	8.5	CD
cord-005453-4057qib7	4254	5	years	year	NNS
cord-005453-4057qib7	4254	6	and	and	CC
cord-005453-4057qib7	4254	7	the	the	DT
cord-005453-4057qib7	4254	8	most	most	RBS
cord-005453-4057qib7	4254	9	common	common	JJ
cord-005453-4057qib7	4254	10	clinical	clinical	JJ
cord-005453-4057qib7	4254	11	findings	finding	NNS
cord-005453-4057qib7	4254	12	were	be	VBD
cord-005453-4057qib7	4254	13	weight	weight	NN
cord-005453-4057qib7	4254	14	increase	increase	NN
cord-005453-4057qib7	4254	15	,	,	,
cord-005453-4057qib7	4254	16	hepatomegaly	hepatomegaly	NNP
cord-005453-4057qib7	4254	17	,	,	,
cord-005453-4057qib7	4254	18	right	right	JJ
cord-005453-4057qib7	4254	19	upper	upper	JJ
cord-005453-4057qib7	4254	20	quadrant	quadrant	JJ
cord-005453-4057qib7	4254	21	pain	pain	NN
cord-005453-4057qib7	4254	22	and	and	CC
cord-005453-4057qib7	4254	23	ascites	ascites	NN
cord-005453-4057qib7	4254	24	development	development	NN
cord-005453-4057qib7	4254	25	.	.	.
cord-005453-4057qib7	4255	1	In	in	IN
cord-005453-4057qib7	4255	2	those	those	DT
cord-005453-4057qib7	4255	3	with	with	IN
cord-005453-4057qib7	4255	4	VOD	VOD	NNP
cord-005453-4057qib7	4255	5	,	,	,
cord-005453-4057qib7	4255	6	treatment	treatment	NN
cord-005453-4057qib7	4255	7	with	with	IN
cord-005453-4057qib7	4255	8	40	40	CD
cord-005453-4057qib7	4255	9	mg	mg	NNP
cord-005453-4057qib7	4255	10	/	/	SYM
cord-005453-4057qib7	4255	11	kg	kg	NNP
cord-005453-4057qib7	4255	12	/	/	SYM
cord-005453-4057qib7	4255	13	day	day	NN
cord-005453-4057qib7	4255	14	DF	DF	NNP
cord-005453-4057qib7	4255	15	was	be	VBD
cord-005453-4057qib7	4255	16	initiated	initiate	VBN
cord-005453-4057qib7	4255	17	and	and	CC
cord-005453-4057qib7	4255	18	average	average	JJ
cord-005453-4057qib7	4255	19	duration	duration	NN
cord-005453-4057qib7	4255	20	of	of	IN
cord-005453-4057qib7	4255	21	treatment	treatment	NN
cord-005453-4057qib7	4255	22	with	with	IN
cord-005453-4057qib7	4255	23	this	this	DT
cord-005453-4057qib7	4255	24	dosage	dosage	NN
cord-005453-4057qib7	4255	25	was	be	VBD
cord-005453-4057qib7	4255	26	7.4	7.4	CD
cord-005453-4057qib7	4255	27	(	(	-LRB-
cord-005453-4057qib7	4255	28	5	5	CD
cord-005453-4057qib7	4255	29	-	-	SYM
cord-005453-4057qib7	4255	30	11	11	CD
cord-005453-4057qib7	4255	31	)	)	-RRB-
cord-005453-4057qib7	4255	32	days	day	NNS
cord-005453-4057qib7	4255	33	.	.	.
cord-005453-4057qib7	4256	1	No	no	DT
cord-005453-4057qib7	4256	2	adverse	adverse	JJ
cord-005453-4057qib7	4256	3	events	event	NNS
cord-005453-4057qib7	4256	4	were	be	VBD
cord-005453-4057qib7	4256	5	reported	report	VBN
cord-005453-4057qib7	4256	6	in	in	IN
cord-005453-4057qib7	4256	7	any	any	DT
cord-005453-4057qib7	4256	8	of	of	IN
cord-005453-4057qib7	4256	9	the	the	DT
cord-005453-4057qib7	4256	10	patients	patient	NNS
cord-005453-4057qib7	4256	11	.	.	.
cord-005453-4057qib7	4257	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4257	2	:	:	:
cord-005453-4057qib7	4258	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4258	2	findings	finding	NNS
cord-005453-4057qib7	4258	3	are	be	VBP
cord-005453-4057qib7	4258	4	consistent	consistent	JJ
cord-005453-4057qib7	4258	5	with	with	IN
cord-005453-4057qib7	4258	6	previous	previous	JJ
cord-005453-4057qib7	4258	7	studies	study	NNS
cord-005453-4057qib7	4258	8	on	on	IN
cord-005453-4057qib7	4258	9	this	this	DT
cord-005453-4057qib7	4258	10	topic	topic	NN
cord-005453-4057qib7	4258	11	,	,	,
cord-005453-4057qib7	4258	12	and	and	CC
cord-005453-4057qib7	4258	13	we	-PRON-	PRP
cord-005453-4057qib7	4258	14	believe	believe	VBP
cord-005453-4057qib7	4258	15	that	that	IN
cord-005453-4057qib7	4258	16	the	the	DT
cord-005453-4057qib7	4258	17	use	use	NN
cord-005453-4057qib7	4258	18	of	of	IN
cord-005453-4057qib7	4258	19	DF	DF	NNP
cord-005453-4057qib7	4258	20	as	as	IN
cord-005453-4057qib7	4258	21	a	a	DT
cord-005453-4057qib7	4258	22	prophylactic	prophylactic	JJ
cord-005453-4057qib7	4258	23	agent	agent	NN
cord-005453-4057qib7	4258	24	for	for	IN
cord-005453-4057qib7	4258	25	VOD	VOD	NNP
cord-005453-4057qib7	4258	26	is	be	VBZ
cord-005453-4057qib7	4258	27	beneficial	beneficial	JJ
cord-005453-4057qib7	4258	28	for	for	IN
cord-005453-4057qib7	4258	29	pediatric	pediatric	JJ
cord-005453-4057qib7	4258	30	patients	patient	NNS
cord-005453-4057qib7	4258	31	with	with	IN
cord-005453-4057qib7	4258	32	risk	risk	NN
cord-005453-4057qib7	4258	33	factors	factor	NNS
cord-005453-4057qib7	4258	34	.	.	.
cord-005453-4057qib7	4259	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4259	2	:	:	:
cord-005453-4057qib7	4260	1	The	the	DT
cord-005453-4057qib7	4260	2	authors	author	NNS
cord-005453-4057qib7	4260	3	report	report	VBP
cord-005453-4057qib7	4260	4	no	no	DT
cord-005453-4057qib7	4260	5	conflicts	conflict	NNS
cord-005453-4057qib7	4260	6	of	of	IN
cord-005453-4057qib7	4260	7	interest	interest	NN
cord-005453-4057qib7	4260	8	in	in	IN
cord-005453-4057qib7	4260	9	this	this	DT
cord-005453-4057qib7	4260	10	work	work	NN
cord-005453-4057qib7	4260	11	.	.	.
cord-005453-4057qib7	4261	1	Background	background	NN
cord-005453-4057qib7	4261	2	:	:	:
cord-005453-4057qib7	4262	1	Several	several	JJ
cord-005453-4057qib7	4262	2	factors	factor	NNS
cord-005453-4057qib7	4262	3	might	may	MD
cord-005453-4057qib7	4262	4	influence	influence	VB
cord-005453-4057qib7	4262	5	outcome	outcome	NN
cord-005453-4057qib7	4262	6	of	of	IN
cord-005453-4057qib7	4262	7	allo	allo	NN
cord-005453-4057qib7	4262	8	-	-	HYPH
cord-005453-4057qib7	4262	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4262	10	.	.	.
cord-005453-4057qib7	4263	1	Analysis	analysis	NN
cord-005453-4057qib7	4263	2	of	of	IN
cord-005453-4057qib7	4263	3	the	the	DT
cord-005453-4057qib7	4263	4	impact	impact	NN
cord-005453-4057qib7	4263	5	of	of	IN
cord-005453-4057qib7	4263	6	donor	donor	NN
cord-005453-4057qib7	4263	7	-	-	HYPH
cord-005453-4057qib7	4263	8	receptor	receptor	NN
cord-005453-4057qib7	4263	9	blood	blood	NN
cord-005453-4057qib7	4263	10	group	group	NN
cord-005453-4057qib7	4263	11	-	-	HYPH
cord-005453-4057qib7	4263	12	incompatibility	incompatibility	NN
cord-005453-4057qib7	4263	13	have	have	VBP
cord-005453-4057qib7	4263	14	been	be	VBN
cord-005453-4057qib7	4263	15	performed	perform	VBN
cord-005453-4057qib7	4263	16	in	in	IN
cord-005453-4057qib7	4263	17	different	different	JJ
cord-005453-4057qib7	4263	18	series	series	NN
cord-005453-4057qib7	4263	19	not	not	RB
cord-005453-4057qib7	4263	20	always	always	RB
cord-005453-4057qib7	4263	21	showing	show	VBG
cord-005453-4057qib7	4263	22	the	the	DT
cord-005453-4057qib7	4263	23	same	same	JJ
cord-005453-4057qib7	4263	24	results	result	NNS
cord-005453-4057qib7	4263	25	.	.	.
cord-005453-4057qib7	4264	1	As	as	IN
cord-005453-4057qib7	4264	2	a	a	DT
cord-005453-4057qib7	4264	3	consequence	consequence	NN
cord-005453-4057qib7	4264	4	,	,	,
cord-005453-4057qib7	4264	5	its	-PRON-	PRP$
cord-005453-4057qib7	4264	6	clinical	clinical	JJ
cord-005453-4057qib7	4264	7	impact	impact	NN
cord-005453-4057qib7	4264	8	remains	remain	VBZ
cord-005453-4057qib7	4264	9	controversial	controversial	JJ
cord-005453-4057qib7	4264	10	.	.	.
cord-005453-4057qib7	4265	1	Minormismatch	Minormismatch	NNP
cord-005453-4057qib7	4265	2	is	be	VBZ
cord-005453-4057qib7	4265	3	characterized	characterize	VBN
cord-005453-4057qib7	4265	4	by	by	IN
cord-005453-4057qib7	4265	5	the	the	DT
cord-005453-4057qib7	4265	6	ability	ability	NN
cord-005453-4057qib7	4265	7	of	of	IN
cord-005453-4057qib7	4265	8	donor	donor	NN
cord-005453-4057qib7	4265	9	B	b	NN
cord-005453-4057qib7	4265	10	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	4265	11	to	to	TO
cord-005453-4057qib7	4265	12	produce	produce	VB
cord-005453-4057qib7	4265	13	anti	anti	JJ
cord-005453-4057qib7	4265	14	-	-	JJ
cord-005453-4057qib7	4265	15	recipient	recipient	JJ
cord-005453-4057qib7	4265	16	antibodies	antibody	NNS
cord-005453-4057qib7	4265	17	.	.	.
cord-005453-4057qib7	4266	1	In	in	IN
cord-005453-4057qib7	4266	2	majormismatch	majormismatch	NN
cord-005453-4057qib7	4266	3	cases	case	NNS
cord-005453-4057qib7	4266	4	,	,	,
cord-005453-4057qib7	4266	5	antibodies	antibody	NNS
cord-005453-4057qib7	4266	6	against	against	IN
cord-005453-4057qib7	4266	7	donor	donor	NN
cord-005453-4057qib7	4266	8	antigens	antigen	NNS
cord-005453-4057qib7	4266	9	are	be	VBP
cord-005453-4057qib7	4266	10	present	present	JJ
cord-005453-4057qib7	4266	11	in	in	IN
cord-005453-4057qib7	4266	12	the	the	DT
cord-005453-4057qib7	4266	13	recipient	recipient	NN
cord-005453-4057qib7	4266	14	.	.	.
cord-005453-4057qib7	4267	1	Methods	method	NNS
cord-005453-4057qib7	4267	2	:	:	:
cord-005453-4057qib7	4268	1	343	343	CD
cord-005453-4057qib7	4268	2	pts	pt	NNS
cord-005453-4057qib7	4268	3	underwent	undergo	VBD
cord-005453-4057qib7	4268	4	allo	allo	NN
cord-005453-4057qib7	4268	5	-	-	HYPH
cord-005453-4057qib7	4268	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4268	7	between	between	IN
cord-005453-4057qib7	4268	8	May	May	NNP
cord-005453-4057qib7	4268	9	2011	2011	CD
cord-005453-4057qib7	4268	10	and	and	CC
cord-005453-4057qib7	4268	11	August	August	NNP
cord-005453-4057qib7	4268	12	2018	2018	CD
cord-005453-4057qib7	4268	13	in	in	IN
cord-005453-4057qib7	4268	14	our	-PRON-	PRP$
cord-005453-4057qib7	4268	15	center	center	NN
cord-005453-4057qib7	4268	16	.	.	.
cord-005453-4057qib7	4269	1	Median	median	JJ
cord-005453-4057qib7	4269	2	age	age	NN
cord-005453-4057qib7	4269	3	was	be	VBD
cord-005453-4057qib7	4269	4	52	52	CD
cord-005453-4057qib7	4269	5	years	year	NNS
cord-005453-4057qib7	4270	1	(	(	-LRB-
cord-005453-4057qib7	4270	2	range	range	NN
cord-005453-4057qib7	4270	3	:	:	:
cord-005453-4057qib7	4270	4	7	7	CD
cord-005453-4057qib7	4270	5	-	-	SYM
cord-005453-4057qib7	4270	6	69	69	CD
cord-005453-4057qib7	4270	7	)	)	-RRB-
cord-005453-4057qib7	4270	8	.	.	.
cord-005453-4057qib7	4271	1	193	193	CD
cord-005453-4057qib7	4271	2	pts	pt	NNS
cord-005453-4057qib7	4271	3	were	be	VBD
cord-005453-4057qib7	4271	4	male	male	JJ
cord-005453-4057qib7	4271	5	(	(	-LRB-
cord-005453-4057qib7	4271	6	56.3	56.3	CD
cord-005453-4057qib7	4271	7	%	%	NN
cord-005453-4057qib7	4271	8	)	)	-RRB-
cord-005453-4057qib7	4271	9	and	and	CC
cord-005453-4057qib7	4271	10	150	150	CD
cord-005453-4057qib7	4271	11	female	female	JJ
cord-005453-4057qib7	4271	12	(	(	-LRB-
cord-005453-4057qib7	4271	13	43.7	43.7	CD
cord-005453-4057qib7	4271	14	%	%	NN
cord-005453-4057qib7	4271	15	)	)	-RRB-
cord-005453-4057qib7	4271	16	.	.	.
cord-005453-4057qib7	4272	1	Baseline	baseline	JJ
cord-005453-4057qib7	4272	2	diseases	disease	NNS
cord-005453-4057qib7	4272	3	were	be	VBD
cord-005453-4057qib7	4272	4	:	:	:
cord-005453-4057qib7	4272	5	138	138	CD
cord-005453-4057qib7	4272	6	AML	AML	NNP
cord-005453-4057qib7	4272	7	,	,	,
cord-005453-4057qib7	4272	8	76	76	CD
cord-005453-4057qib7	4272	9	LPD	LPD	NNP
cord-005453-4057qib7	4272	10	,	,	,
cord-005453-4057qib7	4272	11	44	44	CD
cord-005453-4057qib7	4272	12	MDS	MDS	NNP
cord-005453-4057qib7	4272	13	,	,	,
cord-005453-4057qib7	4272	14	41	41	CD
cord-005453-4057qib7	4272	15	ALL	all	DT
cord-005453-4057qib7	4272	16	,	,	,
cord-005453-4057qib7	4272	17	21	21	CD
cord-005453-4057qib7	4272	18	MPD	MPD	NNP
cord-005453-4057qib7	4272	19	,	,	,
cord-005453-4057qib7	4272	20	16	16	CD
cord-005453-4057qib7	4272	21	MM	MM	NNP
cord-005453-4057qib7	4272	22	,	,	,
cord-005453-4057qib7	4272	23	and	and	CC
cord-005453-4057qib7	4272	24	7	7	CD
cord-005453-4057qib7	4272	25	BMF	bmf	NN
cord-005453-4057qib7	4272	26	.	.	.
cord-005453-4057qib7	4273	1	Donor	donor	NN
cord-005453-4057qib7	4273	2	was	be	VBD
cord-005453-4057qib7	4273	3	unrelated	unrelated	JJ
cord-005453-4057qib7	4273	4	in	in	IN
cord-005453-4057qib7	4273	5	191	191	CD
cord-005453-4057qib7	4273	6	,	,	,
cord-005453-4057qib7	4273	7	and	and	CC
cord-005453-4057qib7	4273	8	related	relate	VBN
cord-005453-4057qib7	4273	9	in	in	IN
cord-005453-4057qib7	4273	10	152	152	CD
cord-005453-4057qib7	4273	11	cases	case	NNS
cord-005453-4057qib7	4273	12	(	(	-LRB-
cord-005453-4057qib7	4273	13	including	include	VBG
cord-005453-4057qib7	4273	14	36	36	CD
cord-005453-4057qib7	4273	15	haplo	haplo	NN
cord-005453-4057qib7	4273	16	-	-	HYPH
cord-005453-4057qib7	4273	17	identical	identical	JJ
cord-005453-4057qib7	4273	18	)	)	-RRB-
cord-005453-4057qib7	4273	19	.	.	.
cord-005453-4057qib7	4274	1	Donor	donor	NN
cord-005453-4057qib7	4274	2	-	-	HYPH
cord-005453-4057qib7	4274	3	recipient	recipient	NN
cord-005453-4057qib7	4274	4	ABO	ABO	NNP
cord-005453-4057qib7	4274	5	compatibility	compatibility	NN
cord-005453-4057qib7	4274	6	was	be	VBD
cord-005453-4057qib7	4274	7	as	as	IN
cord-005453-4057qib7	4274	8	follows	follow	VBZ
cord-005453-4057qib7	4274	9	:	:	:
cord-005453-4057qib7	4274	10	69	69	CD
cord-005453-4057qib7	4274	11	(	(	-LRB-
cord-005453-4057qib7	4274	12	20.1	20.1	CD
cord-005453-4057qib7	4274	13	%	%	NN
cord-005453-4057qib7	4274	14	)	)	-RRB-
cord-005453-4057qib7	4274	15	majormismatched	majormismatched	NNP
cord-005453-4057qib7	4274	16	(	(	-LRB-
cord-005453-4057qib7	4274	17	including	include	VBG
cord-005453-4057qib7	4274	18	11	11	CD
cord-005453-4057qib7	4274	19	bidirectional	bidirectional	JJ
cord-005453-4057qib7	4274	20	)	)	-RRB-
cord-005453-4057qib7	4274	21	,	,	,
cord-005453-4057qib7	4274	22	and	and	CC
cord-005453-4057qib7	4274	23	274	274	CD
cord-005453-4057qib7	4274	24	(	(	-LRB-
cord-005453-4057qib7	4274	25	79.9	79.9	CD
cord-005453-4057qib7	4274	26	%	%	NN
cord-005453-4057qib7	4274	27	)	)	-RRB-
cord-005453-4057qib7	4274	28	nonmajor	nonmajor	NN
cord-005453-4057qib7	4274	29	-	-	HYPH
cord-005453-4057qib7	4274	30	mismatched	mismatched	JJ
cord-005453-4057qib7	4274	31	(	(	-LRB-
cord-005453-4057qib7	4274	32	including	include	VBG
cord-005453-4057qib7	4274	33	68	68	CD
cord-005453-4057qib7	4274	34	minormismatched	minormismatche	VBN
cord-005453-4057qib7	4274	35	and	and	CC
cord-005453-4057qib7	4274	36	206	206	CD
cord-005453-4057qib7	4274	37	matched	match	VBD
cord-005453-4057qib7	4274	38	)	)	-RRB-
cord-005453-4057qib7	4274	39	.	.	.
cord-005453-4057qib7	4275	1	Donor	donor	NN
cord-005453-4057qib7	4275	2	-	-	HYPH
cord-005453-4057qib7	4275	3	recipient	recipient	NN
cord-005453-4057qib7	4275	4	Rh	Rh	NNP
cord-005453-4057qib7	4275	5	compatibility	compatibility	NN
cord-005453-4057qib7	4275	6	was	be	VBD
cord-005453-4057qib7	4275	7	as	as	IN
cord-005453-4057qib7	4275	8	follows	follow	VBZ
cord-005453-4057qib7	4275	9	:	:	:
cord-005453-4057qib7	4275	10	50	50	CD
cord-005453-4057qib7	4275	11	(	(	-LRB-
cord-005453-4057qib7	4275	12	15.6	15.6	CD
cord-005453-4057qib7	4275	13	%	%	NN
cord-005453-4057qib7	4275	14	)	)	-RRB-
cord-005453-4057qib7	4275	15	major	major	JJ
cord-005453-4057qib7	4275	16	-	-	HYPH
cord-005453-4057qib7	4275	17	mismatched	mismatched	JJ
cord-005453-4057qib7	4275	18	,	,	,
cord-005453-4057qib7	4275	19	and	and	CC
cord-005453-4057qib7	4275	20	293	293	CD
cord-005453-4057qib7	4275	21	(	(	-LRB-
cord-005453-4057qib7	4275	22	84.4	84.4	CD
cord-005453-4057qib7	4275	23	%	%	NN
cord-005453-4057qib7	4275	24	)	)	-RRB-
cord-005453-4057qib7	4275	25	nonmajor	nonmajor	NN
cord-005453-4057qib7	4275	26	-	-	HYPH
cord-005453-4057qib7	4275	27	mismatched	mismatched	JJ
cord-005453-4057qib7	4275	28	(	(	-LRB-
cord-005453-4057qib7	4275	29	including	include	VBG
cord-005453-4057qib7	4275	30	34	34	CD
cord-005453-4057qib7	4275	31	minor	minor	JJ
cord-005453-4057qib7	4275	32	-	-	HYPH
cord-005453-4057qib7	4275	33	mismatched	mismatched	JJ
cord-005453-4057qib7	4275	34	and	and	CC
cord-005453-4057qib7	4275	35	259	259	CD
cord-005453-4057qib7	4275	36	matched	match	VBN
cord-005453-4057qib7	4275	37	)	)	-RRB-
cord-005453-4057qib7	4275	38	.	.	.
cord-005453-4057qib7	4276	1	The	the	DT
cord-005453-4057qib7	4276	2	impact	impact	NN
cord-005453-4057qib7	4276	3	of	of	IN
cord-005453-4057qib7	4276	4	donor	donor	NN
cord-005453-4057qib7	4276	5	-	-	HYPH
cord-005453-4057qib7	4276	6	recipient	recipient	NN
cord-005453-4057qib7	4276	7	ABO	ABO	NNP
cord-005453-4057qib7	4276	8	and	and	CC
cord-005453-4057qib7	4276	9	Rh	Rh	NNP
cord-005453-4057qib7	4276	10	compatibility	compatibility	NN
cord-005453-4057qib7	4276	11	on	on	IN
cord-005453-4057qib7	4276	12	transfusion	transfusion	NN
cord-005453-4057qib7	4276	13	needs	need	NNS
cord-005453-4057qib7	4276	14	(	(	-LRB-
cord-005453-4057qib7	4276	15	PRBC	PRBC	NNP
cord-005453-4057qib7	4276	16	and	and	CC
cord-005453-4057qib7	4276	17	platelet	platelet	NN
cord-005453-4057qib7	4276	18	concentrates	concentrate	NNS
cord-005453-4057qib7	4276	19	)	)	-RRB-
cord-005453-4057qib7	4276	20	and	and	CC
cord-005453-4057qib7	4276	21	survival	survival	NN
cord-005453-4057qib7	4276	22	by	by	IN
cord-005453-4057qib7	4276	23	day	day	NN
cord-005453-4057qib7	4276	24	+100	+100	NNP
cord-005453-4057qib7	4276	25	was	be	VBD
cord-005453-4057qib7	4276	26	analyzed	analyze	VBN
cord-005453-4057qib7	4276	27	.	.	.
cord-005453-4057qib7	4277	1	Results	result	NNS
cord-005453-4057qib7	4277	2	:	:	:
cord-005453-4057qib7	4278	1	For	for	IN
cord-005453-4057qib7	4278	2	the	the	DT
cord-005453-4057qib7	4278	3	global	global	JJ
cord-005453-4057qib7	4278	4	series	series	NN
cord-005453-4057qib7	4278	5	the	the	DT
cord-005453-4057qib7	4278	6	median	median	JJ
cord-005453-4057qib7	4278	7	number	number	NN
cord-005453-4057qib7	4278	8	transfusions	transfusion	NNS
cord-005453-4057qib7	4278	9	by	by	IN
cord-005453-4057qib7	4278	10	day	day	NN
cord-005453-4057qib7	4278	11	+100	+100	NNP
cord-005453-4057qib7	4278	12	was	be	VBD
cord-005453-4057qib7	4278	13	:	:	:
cord-005453-4057qib7	4278	14	4	4	LS
cord-005453-4057qib7	4278	15	(	(	-LRB-
cord-005453-4057qib7	4278	16	0	0	CD
cord-005453-4057qib7	4278	17	-	-	SYM
cord-005453-4057qib7	4278	18	81	81	CD
cord-005453-4057qib7	4278	19	)	)	-RRB-
cord-005453-4057qib7	4278	20	PRBC	PRBC	NNP
cord-005453-4057qib7	4278	21	and	and	CC
cord-005453-4057qib7	4278	22	4	4	CD
cord-005453-4057qib7	4278	23	(	(	-LRB-
cord-005453-4057qib7	4278	24	0	0	CD
cord-005453-4057qib7	4278	25	-	-	SYM
cord-005453-4057qib7	4278	26	92	92	CD
cord-005453-4057qib7	4278	27	)	)	-RRB-
cord-005453-4057qib7	4278	28	platelets	platelet	NNS
cord-005453-4057qib7	4278	29	concentrates	concentrate	VBZ
cord-005453-4057qib7	4278	30	.	.	.
cord-005453-4057qib7	4279	1	Day	day	NN
cord-005453-4057qib7	4279	2	+100	+100	NNS
cord-005453-4057qib7	4279	3	overall	overall	JJ
cord-005453-4057qib7	4279	4	mortality	mortality	NN
cord-005453-4057qib7	4279	5	was	be	VBD
cord-005453-4057qib7	4279	6	9.3	9.3	CD
cord-005453-4057qib7	4279	7	%	%	NN
cord-005453-4057qib7	4279	8	.	.	.
cord-005453-4057qib7	4280	1	Rh	rh	NN
cord-005453-4057qib7	4280	2	-	-	HYPH
cord-005453-4057qib7	4280	3	incompatible	incompatible	JJ
cord-005453-4057qib7	4280	4	and	and	CC
cord-005453-4057qib7	4280	5	nonmajor	nonmajor	JJ
cord-005453-4057qib7	4280	6	ABO	ABO	NNP
cord-005453-4057qib7	4280	7	incompatible	incompatible	JJ
cord-005453-4057qib7	4280	8	cases	case	NNS
cord-005453-4057qib7	4280	9	showed	show	VBD
cord-005453-4057qib7	4280	10	no	no	DT
cord-005453-4057qib7	4280	11	different	different	JJ
cord-005453-4057qib7	4280	12	results	result	NNS
cord-005453-4057qib7	4280	13	.	.	.
cord-005453-4057qib7	4281	1	However	however	RB
cord-005453-4057qib7	4281	2	,	,	,
cord-005453-4057qib7	4281	3	major	major	JJ
cord-005453-4057qib7	4281	4	ABOmismatched	abomismatched	JJ
cord-005453-4057qib7	4281	5	cases	case	NNS
cord-005453-4057qib7	4281	6	needed	need	VBD
cord-005453-4057qib7	4281	7	more	more	JJR
cord-005453-4057qib7	4281	8	PRBC	PRBC	NNP
cord-005453-4057qib7	4281	9	transfusions	transfusion	NNS
cord-005453-4057qib7	4281	10	(	(	-LRB-
cord-005453-4057qib7	4281	11	median	median	NN
cord-005453-4057qib7	4281	12	:	:	:
cord-005453-4057qib7	4281	13	6	6	CD
cord-005453-4057qib7	4281	14	;	;	:
cord-005453-4057qib7	4281	15	range	range	NN
cord-005453-4057qib7	4281	16	:	:	:
cord-005453-4057qib7	4281	17	0	0	CD
cord-005453-4057qib7	4281	18	-	-	SYM
cord-005453-4057qib7	4281	19	49	49	CD
cord-005453-4057qib7	4281	20	)	)	-RRB-
cord-005453-4057qib7	4281	21	and	and	CC
cord-005453-4057qib7	4281	22	more	more	JJR
cord-005453-4057qib7	4281	23	platelet	platelet	NN
cord-005453-4057qib7	4281	24	transfusions	transfusion	NNS
cord-005453-4057qib7	4281	25	(	(	-LRB-
cord-005453-4057qib7	4281	26	median	median	NN
cord-005453-4057qib7	4281	27	:	:	SYM
cord-005453-4057qib7	4281	28	7	7	CD
cord-005453-4057qib7	4281	29	;	;	:
cord-005453-4057qib7	4281	30	range	range	VB
cord-005453-4057qib7	4281	31	:	:	:
cord-005453-4057qib7	4281	32	0	0	CD
cord-005453-4057qib7	4281	33	-	-	SYM
cord-005453-4057qib7	4281	34	60	60	CD
cord-005453-4057qib7	4281	35	)	)	-RRB-
cord-005453-4057qib7	4281	36	,	,	,
cord-005453-4057qib7	4281	37	and	and	CC
cord-005453-4057qib7	4281	38	had	have	VBD
cord-005453-4057qib7	4281	39	higher	high	JJR
cord-005453-4057qib7	4281	40	day	day	NN
cord-005453-4057qib7	4281	41	+100	+100	NNS
cord-005453-4057qib7	4281	42	mortality	mortality	NN
cord-005453-4057qib7	4281	43	(	(	-LRB-
cord-005453-4057qib7	4281	44	18.8	18.8	CD
cord-005453-4057qib7	4281	45	%	%	NN
cord-005453-4057qib7	4281	46	)	)	-RRB-
cord-005453-4057qib7	4281	47	(	(	-LRB-
cord-005453-4057qib7	4281	48	p	p	NN
cord-005453-4057qib7	4281	49	<	<	XX
cord-005453-4057qib7	4281	50	0.05	0.05	CD
cord-005453-4057qib7	4281	51	)	)	-RRB-
cord-005453-4057qib7	4281	52	(	(	-LRB-
cord-005453-4057qib7	4281	53	see	see	VB
cord-005453-4057qib7	4281	54	table	table	NN
cord-005453-4057qib7	4281	55	)	)	-RRB-
cord-005453-4057qib7	4281	56	.	.	.
cord-005453-4057qib7	4282	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4282	2	:	:	:
cord-005453-4057qib7	4283	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4283	2	analysis	analysis	NN
cord-005453-4057qib7	4283	3	showed	show	VBD
cord-005453-4057qib7	4283	4	:	:	:
cord-005453-4057qib7	4283	5	1	1	LS
cord-005453-4057qib7	4283	6	)	)	-RRB-
cord-005453-4057qib7	4283	7	Donor	donor	NN
cord-005453-4057qib7	4283	8	-	-	HYPH
cord-005453-4057qib7	4283	9	recipient	recipient	NN
cord-005453-4057qib7	4283	10	Rh	Rh	NNP
cord-005453-4057qib7	4283	11	-	-	HYPH
cord-005453-4057qib7	4283	12	incompatibility	incompatibility	NN
cord-005453-4057qib7	4283	13	,	,	,
cord-005453-4057qib7	4283	14	as	as	RB
cord-005453-4057qib7	4283	15	well	well	RB
cord-005453-4057qib7	4283	16	as	as	IN
cord-005453-4057qib7	4283	17	minor	minor	JJ
cord-005453-4057qib7	4283	18	ABOincompatibility	aboincompatibility	NN
cord-005453-4057qib7	4283	19	had	have	VBD
cord-005453-4057qib7	4283	20	no	no	DT
cord-005453-4057qib7	4283	21	impact	impact	NN
cord-005453-4057qib7	4283	22	on	on	IN
cord-005453-4057qib7	4283	23	PRBC	PRBC	NNP
cord-005453-4057qib7	4283	24	and	and	CC
cord-005453-4057qib7	4283	25	platelet	platelet	NN
cord-005453-4057qib7	4283	26	concentrates	concentrate	VBZ
cord-005453-4057qib7	4283	27	transfusion	transfusion	NN
cord-005453-4057qib7	4283	28	needs	need	NNS
cord-005453-4057qib7	4283	29	nor	nor	CC
cord-005453-4057qib7	4283	30	on	on	IN
cord-005453-4057qib7	4283	31	100-day	100-day	CD
cord-005453-4057qib7	4283	32	mortality	mortality	NN
cord-005453-4057qib7	4283	33	;	;	:
cord-005453-4057qib7	4283	34	2	2	LS
cord-005453-4057qib7	4283	35	)	)	-RRB-
cord-005453-4057qib7	4284	1	Contrarily	contrarily	RB
cord-005453-4057qib7	4284	2	,	,	,
cord-005453-4057qib7	4284	3	donor	donor	NN
cord-005453-4057qib7	4284	4	-	-	HYPH
cord-005453-4057qib7	4284	5	recipient	recipient	NN
cord-005453-4057qib7	4284	6	major	major	JJ
cord-005453-4057qib7	4284	7	ABO	ABO	NNP
cord-005453-4057qib7	4284	8	-	-	HYPH
cord-005453-4057qib7	4284	9	incompatibility	incompatibility	NN
cord-005453-4057qib7	4284	10	had	have	VBD
cord-005453-4057qib7	4284	11	a	a	DT
cord-005453-4057qib7	4284	12	significant	significant	JJ
cord-005453-4057qib7	4284	13	adverse	adverse	JJ
cord-005453-4057qib7	4284	14	impact	impact	NN
cord-005453-4057qib7	4284	15	on	on	IN
cord-005453-4057qib7	4284	16	PRBC	PRBC	NNP
cord-005453-4057qib7	4284	17	and	and	CC
cord-005453-4057qib7	4284	18	platelet	platelet	NN
cord-005453-4057qib7	4284	19	concentrates	concentrate	VBZ
cord-005453-4057qib7	4284	20	transfusion	transfusion	NN
cord-005453-4057qib7	4284	21	needs	need	NNS
cord-005453-4057qib7	4284	22	and	and	CC
cord-005453-4057qib7	4284	23	100-day	100-day	JJ
cord-005453-4057qib7	4284	24	mortality	mortality	NN
cord-005453-4057qib7	4284	25	.	.	.
cord-005453-4057qib7	4285	1	3	3	LS
cord-005453-4057qib7	4285	2	)	)	-RRB-
cord-005453-4057qib7	4285	3	Donor	donor	NN
cord-005453-4057qib7	4285	4	-	-	HYPH
cord-005453-4057qib7	4285	5	recipient	recipient	NN
cord-005453-4057qib7	4285	6	Rh	Rh	NNP
cord-005453-4057qib7	4285	7	-	-	HYPH
cord-005453-4057qib7	4285	8	incompatibility	incompatibility	NN
cord-005453-4057qib7	4285	9	and	and	CC
cord-005453-4057qib7	4285	10	minor	minor	JJ
cord-005453-4057qib7	4285	11	ABOincompatibility.might	aboincompatibility.might	NN
cord-005453-4057qib7	4285	12	be	be	VB
cord-005453-4057qib7	4285	13	considered	consider	VBN
cord-005453-4057qib7	4285	14	of	of	IN
cord-005453-4057qib7	4285	15	marginal	marginal	JJ
cord-005453-4057qib7	4285	16	importance	importance	NN
cord-005453-4057qib7	4285	17	at	at	IN
cord-005453-4057qib7	4285	18	the	the	DT
cord-005453-4057qib7	4285	19	time	time	NN
cord-005453-4057qib7	4285	20	to	to	TO
cord-005453-4057qib7	4285	21	choose	choose	VB
cord-005453-4057qib7	4285	22	a	a	DT
cord-005453-4057qib7	4285	23	potential	potential	JJ
cord-005453-4057qib7	4285	24	donor	donor	NN
cord-005453-4057qib7	4285	25	.	.	.
cord-005453-4057qib7	4286	1	4	4	LS
cord-005453-4057qib7	4286	2	)	)	-RRB-
cord-005453-4057qib7	4287	1	Donorrecipient	donorrecipient	JJ
cord-005453-4057qib7	4287	2	major	major	JJ
cord-005453-4057qib7	4287	3	ABO	ABO	NNP
cord-005453-4057qib7	4287	4	-	-	HYPH
cord-005453-4057qib7	4287	5	incompatibility	incompatibility	NN
cord-005453-4057qib7	4287	6	should	should	MD
cord-005453-4057qib7	4287	7	probably	probably	RB
cord-005453-4057qib7	4287	8	be	be	VB
cord-005453-4057qib7	4287	9	a	a	DT
cord-005453-4057qib7	4287	10	factor	factor	NN
cord-005453-4057qib7	4287	11	to	to	TO
cord-005453-4057qib7	4287	12	be	be	VB
cord-005453-4057qib7	4287	13	considered	consider	VBN
cord-005453-4057qib7	4287	14	,	,	,
cord-005453-4057qib7	4287	15	along	along	IN
cord-005453-4057qib7	4287	16	with	with	IN
cord-005453-4057qib7	4287	17	other	other	JJ
cord-005453-4057qib7	4287	18	features	feature	NNS
cord-005453-4057qib7	4287	19	,	,	,
cord-005453-4057qib7	4287	20	to	to	TO
cord-005453-4057qib7	4287	21	choose	choose	VB
cord-005453-4057qib7	4287	22	the	the	DT
cord-005453-4057qib7	4287	23	best	good	JJS
cord-005453-4057qib7	4287	24	donor	donor	NN
cord-005453-4057qib7	4287	25	Background	background	NN
cord-005453-4057qib7	4287	26	:	:	:
cord-005453-4057qib7	4288	1	Survivors	survivor	NNS
cord-005453-4057qib7	4288	2	of	of	IN
cord-005453-4057qib7	4288	3	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	4288	4	stem	stem	NN
cord-005453-4057qib7	4288	5	cell	cell	NN
cord-005453-4057qib7	4288	6	transplantation	transplantation	NN
cord-005453-4057qib7	4288	7	(	(	-LRB-
cord-005453-4057qib7	4288	8	HSCT	HSCT	NNP
cord-005453-4057qib7	4288	9	)	)	-RRB-
cord-005453-4057qib7	4288	10	are	be	VBP
cord-005453-4057qib7	4288	11	at	at	IN
cord-005453-4057qib7	4288	12	significant	significant	JJ
cord-005453-4057qib7	4288	13	risk	risk	NN
cord-005453-4057qib7	4288	14	of	of	IN
cord-005453-4057qib7	4288	15	developing	develop	VBG
cord-005453-4057qib7	4288	16	treatment	treatment	NN
cord-005453-4057qib7	4288	17	-	-	HYPH
cord-005453-4057qib7	4288	18	related	relate	VBN
cord-005453-4057qib7	4288	19	complications	complication	NNS
cord-005453-4057qib7	4288	20	,	,	,
cord-005453-4057qib7	4288	21	including	include	VBG
cord-005453-4057qib7	4288	22	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	4288	23	risk	risk	NN
cord-005453-4057qib7	4288	24	factors	factor	NNS
cord-005453-4057qib7	4288	25	such	such	JJ
cord-005453-4057qib7	4288	26	as	as	IN
cord-005453-4057qib7	4288	27	arterial	arterial	JJ
cord-005453-4057qib7	4288	28	hypertension	hypertension	NN
cord-005453-4057qib7	4288	29	,	,	,
cord-005453-4057qib7	4288	30	that	that	WDT
cord-005453-4057qib7	4288	31	could	could	MD
cord-005453-4057qib7	4288	32	eventually	eventually	RB
cord-005453-4057qib7	4288	33	lead	lead	VB
cord-005453-4057qib7	4288	34	to	to	IN
cord-005453-4057qib7	4288	35	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	4288	36	disease	disease	NN
cord-005453-4057qib7	4288	37	.	.	.
cord-005453-4057qib7	4289	1	The	the	DT
cord-005453-4057qib7	4289	2	aim	aim	NN
cord-005453-4057qib7	4289	3	of	of	IN
cord-005453-4057qib7	4289	4	this	this	DT
cord-005453-4057qib7	4289	5	study	study	NN
cord-005453-4057qib7	4289	6	is	be	VBZ
cord-005453-4057qib7	4289	7	to	to	TO
cord-005453-4057qib7	4289	8	evaluate	evaluate	VB
cord-005453-4057qib7	4289	9	the	the	DT
cord-005453-4057qib7	4289	10	incidence	incidence	NN
cord-005453-4057qib7	4289	11	and	and	CC
cord-005453-4057qib7	4289	12	risk	risk	NN
cord-005453-4057qib7	4289	13	factors	factor	NNS
cord-005453-4057qib7	4289	14	of	of	IN
cord-005453-4057qib7	4289	15	hypertension	hypertension	NN
cord-005453-4057qib7	4289	16	following	follow	VBG
cord-005453-4057qib7	4289	17	HSCT	HSCT	NNP
cord-005453-4057qib7	4289	18	in	in	IN
cord-005453-4057qib7	4289	19	a	a	DT
cord-005453-4057qib7	4289	20	Colombian	colombian	JJ
cord-005453-4057qib7	4289	21	population	population	NN
cord-005453-4057qib7	4289	22	.	.	.
cord-005453-4057qib7	4290	1	Methods	method	NNS
cord-005453-4057qib7	4290	2	:	:	:
cord-005453-4057qib7	4291	1	A	a	DT
cord-005453-4057qib7	4291	2	retrospective	retrospective	JJ
cord-005453-4057qib7	4291	3	cohort	cohort	NN
cord-005453-4057qib7	4291	4	study	study	NN
cord-005453-4057qib7	4291	5	was	be	VBD
cord-005453-4057qib7	4291	6	conducted	conduct	VBN
cord-005453-4057qib7	4291	7	to	to	TO
cord-005453-4057qib7	4291	8	assess	assess	VB
cord-005453-4057qib7	4291	9	the	the	DT
cord-005453-4057qib7	4291	10	incidence	incidence	NN
cord-005453-4057qib7	4291	11	and	and	CC
cord-005453-4057qib7	4291	12	risk	risk	NN
cord-005453-4057qib7	4291	13	factors	factor	NNS
cord-005453-4057qib7	4291	14	of	of	IN
cord-005453-4057qib7	4291	15	hypertension	hypertension	NN
cord-005453-4057qib7	4291	16	in	in	IN
cord-005453-4057qib7	4291	17	220	220	CD
cord-005453-4057qib7	4291	18	consecutive	consecutive	JJ
cord-005453-4057qib7	4291	19	adult	adult	NN
cord-005453-4057qib7	4291	20	HSCT	HSCT	NNP
cord-005453-4057qib7	4291	21	recipients	recipient	NNS
cord-005453-4057qib7	4291	22	who	who	WP
cord-005453-4057qib7	4291	23	underwent	undergo	VBD
cord-005453-4057qib7	4291	24	transplantation	transplantation	NN
cord-005453-4057qib7	4291	25	between	between	IN
cord-005453-4057qib7	4291	26	2009	2009	CD
cord-005453-4057qib7	4291	27	and	and	CC
cord-005453-4057qib7	4291	28	2017	2017	CD
cord-005453-4057qib7	4291	29	at	at	IN
cord-005453-4057qib7	4291	30	a	a	DT
cord-005453-4057qib7	4291	31	tertiary	tertiary	JJ
cord-005453-4057qib7	4291	32	referral	referral	JJ
cord-005453-4057qib7	4291	33	center	center	NN
cord-005453-4057qib7	4291	34	in	in	IN
cord-005453-4057qib7	4291	35	Colombia	Colombia	NNP
cord-005453-4057qib7	4291	36	,	,	,
cord-005453-4057qib7	4291	37	South	South	NNP
cord-005453-4057qib7	4291	38	America	America	NNP
cord-005453-4057qib7	4291	39	.	.	.
cord-005453-4057qib7	4292	1	Blood	blood	NN
cord-005453-4057qib7	4292	2	pressure	pressure	NN
cord-005453-4057qib7	4292	3	data	datum	NNS
cord-005453-4057qib7	4292	4	,	,	,
cord-005453-4057qib7	4292	5	from	from	IN
cord-005453-4057qib7	4292	6	two	two	CD
cord-005453-4057qib7	4292	7	different	different	JJ
cord-005453-4057qib7	4292	8	measures	measure	NNS
cord-005453-4057qib7	4292	9	,	,	,
cord-005453-4057qib7	4292	10	were	be	VBD
cord-005453-4057qib7	4292	11	collected	collect	VBN
cord-005453-4057qib7	4292	12	at	at	IN
cord-005453-4057qib7	4292	13	7	7	CD
cord-005453-4057qib7	4292	14	time	time	NN
cord-005453-4057qib7	4292	15	points	point	NNS
cord-005453-4057qib7	4292	16	:	:	:
cord-005453-4057qib7	4292	17	day	day	NN
cord-005453-4057qib7	4292	18	of	of	IN
cord-005453-4057qib7	4292	19	mobilization	mobilization	NN
cord-005453-4057qib7	4292	20	for	for	IN
cord-005453-4057qib7	4292	21	autologous	autologous	JJ
cord-005453-4057qib7	4292	22	HSCT	HSCT	NNP
cord-005453-4057qib7	4292	23	and	and	CC
cord-005453-4057qib7	4292	24	day	day	NN
cord-005453-4057qib7	4292	25	0	0	CD
cord-005453-4057qib7	4292	26	before	before	IN
cord-005453-4057qib7	4292	27	infusion	infusion	NN
cord-005453-4057qib7	4292	28	for	for	IN
cord-005453-4057qib7	4292	29	allogeneic	allogeneic	NN
cord-005453-4057qib7	4292	30	transplantation	transplantation	NN
cord-005453-4057qib7	4292	31	,	,	,
cord-005453-4057qib7	4292	32	day	day	NN
cord-005453-4057qib7	4292	33	7	7	CD
cord-005453-4057qib7	4292	34	,	,	,
cord-005453-4057qib7	4292	35	and	and	CC
cord-005453-4057qib7	4292	36	months	month	NNS
cord-005453-4057qib7	4292	37	1	1	CD
cord-005453-4057qib7	4292	38	,	,	,
cord-005453-4057qib7	4292	39	3	3	CD
cord-005453-4057qib7	4292	40	,	,	,
cord-005453-4057qib7	4292	41	6	6	CD
cord-005453-4057qib7	4292	42	and	and	CC
cord-005453-4057qib7	4292	43	12	12	CD
cord-005453-4057qib7	4292	44	post	post	NN
cord-005453-4057qib7	4292	45	-	-	NN
cord-005453-4057qib7	4292	46	transplantation	transplantation	NN
cord-005453-4057qib7	4292	47	.	.	.
cord-005453-4057qib7	4293	1	Hypertension	hypertension	NN
cord-005453-4057qib7	4293	2	was	be	VBD
cord-005453-4057qib7	4293	3	defined	define	VBN
cord-005453-4057qib7	4293	4	as	as	IN
cord-005453-4057qib7	4293	5	having	have	VBG
cord-005453-4057qib7	4293	6	a	a	DT
cord-005453-4057qib7	4293	7	systolic	systolic	JJ
cord-005453-4057qib7	4293	8	blood	blood	NN
cord-005453-4057qib7	4293	9	pressure	pressure	NN
cord-005453-4057qib7	4293	10	>	>	XX
cord-005453-4057qib7	4294	1	=	=	SYM
cord-005453-4057qib7	4294	2	140mmHg	140mmHg	NNS
cord-005453-4057qib7	4294	3	and/or	and/or	CC
cord-005453-4057qib7	4295	1	a	a	DT
cord-005453-4057qib7	4295	2	diastolic	diastolic	JJ
cord-005453-4057qib7	4295	3	blood	blood	NN
cord-005453-4057qib7	4295	4	pressure	pressure	NN
cord-005453-4057qib7	4295	5	>	>	XX
cord-005453-4057qib7	4296	1	=	=	SYM
cord-005453-4057qib7	4296	2	90	90	CD
cord-005453-4057qib7	4296	3	mmHg	mmHg	NNS
cord-005453-4057qib7	4296	4	.	.	.
cord-005453-4057qib7	4296	5	Patients	patient	NNS
cord-005453-4057qib7	4296	6	with	with	IN
cord-005453-4057qib7	4296	7	history	history	NN
cord-005453-4057qib7	4296	8	of	of	IN
cord-005453-4057qib7	4296	9	arterial	arterial	JJ
cord-005453-4057qib7	4296	10	hypertension	hypertension	NN
cord-005453-4057qib7	4296	11	were	be	VBD
cord-005453-4057qib7	4296	12	excluded	exclude	VBN
cord-005453-4057qib7	4296	13	.	.	.
cord-005453-4057qib7	4297	1	Results	result	NNS
cord-005453-4057qib7	4297	2	:	:	:
cord-005453-4057qib7	4298	1	One	one	CD
cord-005453-4057qib7	4298	2	hundred	hundred	CD
cord-005453-4057qib7	4298	3	and	and	CC
cord-005453-4057qib7	4298	4	seventy	seventy	CD
cord-005453-4057qib7	4298	5	-	-	HYPH
cord-005453-4057qib7	4298	6	five	five	CD
cord-005453-4057qib7	4298	7	patients	patient	NNS
cord-005453-4057qib7	4298	8	were	be	VBD
cord-005453-4057qib7	4298	9	included	include	VBN
cord-005453-4057qib7	4298	10	,	,	,
cord-005453-4057qib7	4298	11	with	with	IN
cord-005453-4057qib7	4298	12	a	a	DT
cord-005453-4057qib7	4298	13	mean	mean	JJ
cord-005453-4057qib7	4298	14	age	age	NN
cord-005453-4057qib7	4298	15	of	of	IN
cord-005453-4057qib7	4298	16	44	44	CD
cord-005453-4057qib7	4298	17	years	year	NNS
cord-005453-4057qib7	4298	18	(	(	-LRB-
cord-005453-4057qib7	4298	19	range	range	VBP
cord-005453-4057qib7	4298	20	15	15	CD
cord-005453-4057qib7	4298	21	-	-	SYM
cord-005453-4057qib7	4298	22	67	67	CD
cord-005453-4057qib7	4298	23	)	)	-RRB-
cord-005453-4057qib7	4298	24	.	.	.
cord-005453-4057qib7	4299	1	Ninety	ninety	CD
cord-005453-4057qib7	4299	2	-	-	HYPH
cord-005453-4057qib7	4299	3	one	one	CD
cord-005453-4057qib7	4299	4	patients	patient	NNS
cord-005453-4057qib7	4299	5	(	(	-LRB-
cord-005453-4057qib7	4299	6	52	52	CD
cord-005453-4057qib7	4299	7	%	%	NN
cord-005453-4057qib7	4299	8	)	)	-RRB-
cord-005453-4057qib7	4299	9	were	be	VBD
cord-005453-4057qib7	4299	10	male	male	JJ
cord-005453-4057qib7	4299	11	.	.	.
cord-005453-4057qib7	4300	1	One	one	CD
cord-005453-4057qib7	4300	2	hundred	hundred	CD
cord-005453-4057qib7	4300	3	and	and	CC
cord-005453-4057qib7	4300	4	sixteen	sixteen	CD
cord-005453-4057qib7	4300	5	patients	patient	NNS
cord-005453-4057qib7	4300	6	(	(	-LRB-
cord-005453-4057qib7	4300	7	66.3	66.3	CD
cord-005453-4057qib7	4300	8	%	%	NN
cord-005453-4057qib7	4300	9	)	)	-RRB-
cord-005453-4057qib7	4300	10	underwent	undergo	VBD
cord-005453-4057qib7	4300	11	autologous	autologous	JJ
cord-005453-4057qib7	4300	12	HSCT	HSCT	NNP
cord-005453-4057qib7	4300	13	and	and	CC
cord-005453-4057qib7	4300	14	59	59	CD
cord-005453-4057qib7	4300	15	(	(	-LRB-
cord-005453-4057qib7	4300	16	33.7	33.7	CD
cord-005453-4057qib7	4300	17	%	%	NN
cord-005453-4057qib7	4300	18	)	)	-RRB-
cord-005453-4057qib7	4300	19	allogeneic	allogeneic	IN
cord-005453-4057qib7	4300	20	HSCT	HSCT	NNP
cord-005453-4057qib7	4300	21	.	.	.
cord-005453-4057qib7	4301	1	The	the	DT
cord-005453-4057qib7	4301	2	most	most	RBS
cord-005453-4057qib7	4301	3	common	common	JJ
cord-005453-4057qib7	4301	4	indication	indication	NN
cord-005453-4057qib7	4301	5	for	for	IN
cord-005453-4057qib7	4301	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4301	7	was	be	VBD
cord-005453-4057qib7	4301	8	acute	acute	JJ
cord-005453-4057qib7	4301	9	leukemia	leukemia	NN
cord-005453-4057qib7	4301	10	(	(	-LRB-
cord-005453-4057qib7	4301	11	26.3	26.3	CD
cord-005453-4057qib7	4301	12	%	%	NN
cord-005453-4057qib7	4301	13	)	)	-RRB-
cord-005453-4057qib7	4301	14	,	,	,
cord-005453-4057qib7	4301	15	followed	follow	VBN
cord-005453-4057qib7	4301	16	by	by	IN
cord-005453-4057qib7	4301	17	non	non	JJ
cord-005453-4057qib7	4301	18	-	-	JJ
cord-005453-4057qib7	4301	19	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	4301	20	lymphoma	lymphoma	NN
cord-005453-4057qib7	4301	21	(	(	-LRB-
cord-005453-4057qib7	4301	22	23.4	23.4	CD
cord-005453-4057qib7	4301	23	%	%	NN
cord-005453-4057qib7	4301	24	)	)	-RRB-
cord-005453-4057qib7	4301	25	and	and	CC
cord-005453-4057qib7	4301	26	multiple	multiple	JJ
cord-005453-4057qib7	4301	27	myeloma	myeloma	NN
cord-005453-4057qib7	4301	28	(	(	-LRB-
cord-005453-4057qib7	4301	29	22.9	22.9	CD
cord-005453-4057qib7	4301	30	%	%	NN
cord-005453-4057qib7	4301	31	)	)	-RRB-
cord-005453-4057qib7	4301	32	.	.	.
cord-005453-4057qib7	4302	1	Twelve	twelve	CD
cord-005453-4057qib7	4302	2	patients	patient	NNS
cord-005453-4057qib7	4302	3	(	(	-LRB-
cord-005453-4057qib7	4302	4	6.9	6.9	CD
cord-005453-4057qib7	4302	5	%	%	NN
cord-005453-4057qib7	4302	6	)	)	-RRB-
cord-005453-4057qib7	4302	7	had	have	VBD
cord-005453-4057qib7	4302	8	medical	medical	JJ
cord-005453-4057qib7	4302	9	history	history	NN
cord-005453-4057qib7	4302	10	of	of	IN
cord-005453-4057qib7	4302	11	type	type	NN
cord-005453-4057qib7	4302	12	2	2	CD
cord-005453-4057qib7	4302	13	diabetes	diabetes	NN
cord-005453-4057qib7	4302	14	mellitus	mellitus	NN
cord-005453-4057qib7	4302	15	(	(	-LRB-
cord-005453-4057qib7	4302	16	DM	DM	NNP
cord-005453-4057qib7	4302	17	)	)	-RRB-
cord-005453-4057qib7	4302	18	,	,	,
cord-005453-4057qib7	4302	19	11	11	CD
cord-005453-4057qib7	4302	20	(	(	-LRB-
cord-005453-4057qib7	4302	21	6.3	6.3	CD
cord-005453-4057qib7	4302	22	%	%	NN
cord-005453-4057qib7	4302	23	)	)	-RRB-
cord-005453-4057qib7	4302	24	dyslipidemia	dyslipidemia	NN
cord-005453-4057qib7	4302	25	,	,	,
cord-005453-4057qib7	4302	26	24	24	CD
cord-005453-4057qib7	4302	27	(	(	-LRB-
cord-005453-4057qib7	4302	28	13.7	13.7	CD
cord-005453-4057qib7	4302	29	%	%	NN
cord-005453-4057qib7	4302	30	)	)	-RRB-
cord-005453-4057qib7	4302	31	alcohol	alcohol	NN
cord-005453-4057qib7	4302	32	consumption	consumption	NN
cord-005453-4057qib7	4302	33	,	,	,
cord-005453-4057qib7	4302	34	and	and	CC
cord-005453-4057qib7	4302	35	25	25	CD
cord-005453-4057qib7	4302	36	(	(	-LRB-
cord-005453-4057qib7	4302	37	14.3	14.3	CD
cord-005453-4057qib7	4302	38	%	%	NN
cord-005453-4057qib7	4302	39	)	)	-RRB-
cord-005453-4057qib7	4302	40	tobacco	tobacco	NN
cord-005453-4057qib7	4302	41	smoking	smoking	NN
cord-005453-4057qib7	4302	42	.	.	.
cord-005453-4057qib7	4303	1	Only	only	RB
cord-005453-4057qib7	4303	2	two	two	CD
cord-005453-4057qib7	4303	3	of	of	IN
cord-005453-4057qib7	4303	4	the	the	DT
cord-005453-4057qib7	4303	5	patients	patient	NNS
cord-005453-4057qib7	4303	6	with	with	IN
cord-005453-4057qib7	4303	7	history	history	NN
cord-005453-4057qib7	4303	8	of	of	IN
cord-005453-4057qib7	4303	9	tobacco	tobacco	NN
cord-005453-4057qib7	4303	10	smoking	smoking	NN
cord-005453-4057qib7	4303	11	were	be	VBD
cord-005453-4057qib7	4303	12	active	active	JJ
cord-005453-4057qib7	4303	13	smokers	smoker	NNS
cord-005453-4057qib7	4303	14	at	at	IN
cord-005453-4057qib7	4303	15	time	time	NN
cord-005453-4057qib7	4303	16	of	of	IN
cord-005453-4057qib7	4303	17	transplantation	transplantation	NN
cord-005453-4057qib7	4303	18	.	.	.
cord-005453-4057qib7	4304	1	Twenty	twenty	CD
cord-005453-4057qib7	4304	2	-	-	HYPH
cord-005453-4057qib7	4304	3	four	four	CD
cord-005453-4057qib7	4304	4	patients	patient	NNS
cord-005453-4057qib7	4304	5	(	(	-LRB-
cord-005453-4057qib7	4304	6	13.7	13.7	CD
cord-005453-4057qib7	4304	7	%	%	NN
cord-005453-4057qib7	4304	8	)	)	-RRB-
cord-005453-4057qib7	4304	9	had	have	VBD
cord-005453-4057qib7	4304	10	developed	develop	VBN
cord-005453-4057qib7	4304	11	hypertension	hypertension	NN
cord-005453-4057qib7	4304	12	by	by	IN
cord-005453-4057qib7	4304	13	the	the	DT
cord-005453-4057qib7	4304	14	end	end	NN
cord-005453-4057qib7	4304	15	of	of	IN
cord-005453-4057qib7	4304	16	the	the	DT
cord-005453-4057qib7	4304	17	first	first	JJ
cord-005453-4057qib7	4304	18	year	year	NN
cord-005453-4057qib7	4304	19	post	post	NN
cord-005453-4057qib7	4304	20	-	-	JJ
cord-005453-4057qib7	4304	21	HSCT	hsct	JJ
cord-005453-4057qib7	4304	22	follow	follow	NN
cord-005453-4057qib7	4304	23	-	-	HYPH
cord-005453-4057qib7	4304	24	up	up	NN
cord-005453-4057qib7	4304	25	.	.	.
cord-005453-4057qib7	4305	1	Two	two	CD
cord-005453-4057qib7	4305	2	patients	patient	NNS
cord-005453-4057qib7	4305	3	(	(	-LRB-
cord-005453-4057qib7	4305	4	8.3	8.3	CD
cord-005453-4057qib7	4305	5	%	%	NN
cord-005453-4057qib7	4305	6	)	)	-RRB-
cord-005453-4057qib7	4305	7	had	have	VBD
cord-005453-4057qib7	4305	8	systolic	systolic	JJ
cord-005453-4057qib7	4305	9	and	and	CC
cord-005453-4057qib7	4305	10	diastolic	diastolic	JJ
cord-005453-4057qib7	4305	11	,	,	,
cord-005453-4057qib7	4305	12	12	12	CD
cord-005453-4057qib7	4305	13	(	(	-LRB-
cord-005453-4057qib7	4305	14	50	50	CD
cord-005453-4057qib7	4305	15	%	%	NN
cord-005453-4057qib7	4305	16	)	)	-RRB-
cord-005453-4057qib7	4305	17	had	have	VBD
cord-005453-4057qib7	4305	18	only	only	RB
cord-005453-4057qib7	4305	19	systolic	systolic	JJ
cord-005453-4057qib7	4305	20	,	,	,
cord-005453-4057qib7	4305	21	and	and	CC
cord-005453-4057qib7	4305	22	10	10	CD
cord-005453-4057qib7	4305	23	(	(	-LRB-
cord-005453-4057qib7	4305	24	41.7	41.7	CD
cord-005453-4057qib7	4305	25	%	%	NN
cord-005453-4057qib7	4305	26	)	)	-RRB-
cord-005453-4057qib7	4305	27	had	have	VBD
cord-005453-4057qib7	4305	28	only	only	RB
cord-005453-4057qib7	4305	29	diastolic	diastolic	JJ
cord-005453-4057qib7	4305	30	hypertension	hypertension	NN
cord-005453-4057qib7	4305	31	.	.	.
cord-005453-4057qib7	4306	1	Only	only	RB
cord-005453-4057qib7	4306	2	one	one	CD
cord-005453-4057qib7	4306	3	patient	patient	NN
cord-005453-4057qib7	4306	4	was	be	VBD
cord-005453-4057qib7	4306	5	hypertensive	hypertensive	JJ
cord-005453-4057qib7	4306	6	at	at	IN
cord-005453-4057qib7	4306	7	more	more	JJR
cord-005453-4057qib7	4306	8	than	than	IN
cord-005453-4057qib7	4306	9	two	two	CD
cord-005453-4057qib7	4306	10	time	time	NN
cord-005453-4057qib7	4306	11	points	point	NNS
cord-005453-4057qib7	4306	12	.	.	.
cord-005453-4057qib7	4307	1	The	the	DT
cord-005453-4057qib7	4307	2	incidences	incidence	NNS
cord-005453-4057qib7	4307	3	of	of	IN
cord-005453-4057qib7	4307	4	hypertension	hypertension	NN
cord-005453-4057qib7	4307	5	at	at	IN
cord-005453-4057qib7	4307	6	each	each	DT
cord-005453-4057qib7	4307	7	time	time	NN
cord-005453-4057qib7	4307	8	point	point	NN
cord-005453-4057qib7	4307	9	were	be	VBD
cord-005453-4057qib7	4307	10	2.3	2.3	CD
cord-005453-4057qib7	4307	11	%	%	NN
cord-005453-4057qib7	4307	12	on	on	IN
cord-005453-4057qib7	4307	13	day	day	NN
cord-005453-4057qib7	4307	14	7	7	CD
cord-005453-4057qib7	4307	15	post	post	JJ
cord-005453-4057qib7	4307	16	-	-	JJ
cord-005453-4057qib7	4307	17	HSCT	HSCT	NNP
cord-005453-4057qib7	4307	18	,	,	,
cord-005453-4057qib7	4307	19	6.9	6.9	CD
cord-005453-4057qib7	4307	20	%	%	NN
cord-005453-4057qib7	4307	21	at	at	IN
cord-005453-4057qib7	4307	22	first	first	JJ
cord-005453-4057qib7	4307	23	month	month	NN
cord-005453-4057qib7	4307	24	,	,	,
cord-005453-4057qib7	4307	25	9.8	9.8	CD
cord-005453-4057qib7	4307	26	%	%	NN
cord-005453-4057qib7	4307	27	at	at	IN
cord-005453-4057qib7	4307	28	three	three	CD
cord-005453-4057qib7	4307	29	months	month	NNS
cord-005453-4057qib7	4307	30	,	,	,
cord-005453-4057qib7	4307	31	12.1	12.1	CD
cord-005453-4057qib7	4307	32	%	%	NN
cord-005453-4057qib7	4307	33	at	at	IN
cord-005453-4057qib7	4307	34	6	6	CD
cord-005453-4057qib7	4307	35	months	month	NNS
cord-005453-4057qib7	4307	36	,	,	,
cord-005453-4057qib7	4307	37	and	and	CC
cord-005453-4057qib7	4307	38	13.8	13.8	CD
cord-005453-4057qib7	4307	39	%	%	NN
cord-005453-4057qib7	4307	40	at	at	IN
cord-005453-4057qib7	4307	41	one	one	CD
cord-005453-4057qib7	4307	42	-	-	HYPH
cord-005453-4057qib7	4307	43	year	year	NN
cord-005453-4057qib7	4307	44	post	post	NN
cord-005453-4057qib7	4307	45	-	-	NN
cord-005453-4057qib7	4307	46	transplantation	transplantation	NN
cord-005453-4057qib7	4307	47	.	.	.
cord-005453-4057qib7	4308	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	4308	2	HSCT	HSCT	NNP
cord-005453-4057qib7	4308	3	(	(	-LRB-
cord-005453-4057qib7	4308	4	P	p	NN
cord-005453-4057qib7	4308	5	<	<	XX
cord-005453-4057qib7	4308	6	0.01	0.01	CD
cord-005453-4057qib7	4308	7	)	)	-RRB-
cord-005453-4057qib7	4308	8	,	,	,
cord-005453-4057qib7	4308	9	therapy	therapy	NN
cord-005453-4057qib7	4308	10	with	with	IN
cord-005453-4057qib7	4308	11	calcineurin	calcineurin	NNP
cord-005453-4057qib7	4308	12	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4308	13	(	(	-LRB-
cord-005453-4057qib7	4308	14	P	p	NN
cord-005453-4057qib7	4308	15	<	<	XX
cord-005453-4057qib7	4308	16	0.01	0.01	CD
cord-005453-4057qib7	4308	17	)	)	-RRB-
cord-005453-4057qib7	4308	18	,	,	,
cord-005453-4057qib7	4308	19	pre	pre	VBN
cord-005453-4057qib7	4308	20	-	-	JJ
cord-005453-4057qib7	4308	21	HSCT	hsct	JJ
cord-005453-4057qib7	4308	22	fasting	fast	VBG
cord-005453-4057qib7	4308	23	glucose	glucose	NN
cord-005453-4057qib7	4308	24	levels	level	NNS
cord-005453-4057qib7	4308	25	(	(	-LRB-
cord-005453-4057qib7	4308	26	P	p	NN
cord-005453-4057qib7	4308	27	<	<	XX
cord-005453-4057qib7	4308	28	0.05	0.05	CD
cord-005453-4057qib7	4308	29	)	)	-RRB-
cord-005453-4057qib7	4308	30	,	,	,
cord-005453-4057qib7	4308	31	acute	acute	JJ
cord-005453-4057qib7	4308	32	GvHD	GvHD	NNP
cord-005453-4057qib7	4308	33	(	(	-LRB-
cord-005453-4057qib7	4308	34	P	p	NN
cord-005453-4057qib7	4308	35	<	<	XX
cord-005453-4057qib7	4308	36	0.05	0.05	CD
cord-005453-4057qib7	4308	37	)	)	-RRB-
cord-005453-4057qib7	4308	38	,	,	,
cord-005453-4057qib7	4308	39	chronic	chronic	JJ
cord-005453-4057qib7	4308	40	GvHD	GvHD	NNP
cord-005453-4057qib7	4308	41	(	(	-LRB-
cord-005453-4057qib7	4308	42	P	p	NN
cord-005453-4057qib7	4308	43	<	<	XX
cord-005453-4057qib7	4308	44	0.05	0.05	CD
cord-005453-4057qib7	4308	45	)	)	-RRB-
cord-005453-4057qib7	4308	46	,	,	,
cord-005453-4057qib7	4308	47	and	and	CC
cord-005453-4057qib7	4308	48	media	medium	NNS
cord-005453-4057qib7	4308	49	of	of	IN
cord-005453-4057qib7	4308	50	diastolic	diastolic	JJ
cord-005453-4057qib7	4308	51	blood	blood	NN
cord-005453-4057qib7	4308	52	pressure	pressure	NN
cord-005453-4057qib7	4308	53	(	(	-LRB-
cord-005453-4057qib7	4308	54	P	p	NN
cord-005453-4057qib7	4308	55	<	<	XX
cord-005453-4057qib7	4308	56	0.05	0.05	CD
cord-005453-4057qib7	4308	57	)	)	-RRB-
cord-005453-4057qib7	4308	58	were	be	VBD
cord-005453-4057qib7	4308	59	significantly	significantly	RB
cord-005453-4057qib7	4308	60	associated	associate	VBN
cord-005453-4057qib7	4308	61	with	with	IN
cord-005453-4057qib7	4308	62	the	the	DT
cord-005453-4057qib7	4308	63	development	development	NN
cord-005453-4057qib7	4308	64	of	of	IN
cord-005453-4057qib7	4308	65	arterial	arterial	JJ
cord-005453-4057qib7	4308	66	hypertension	hypertension	NN
cord-005453-4057qib7	4308	67	.	.	.
cord-005453-4057qib7	4309	1	However	however	RB
cord-005453-4057qib7	4309	2	,	,	,
cord-005453-4057qib7	4309	3	age	age	NN
cord-005453-4057qib7	4309	4	,	,	,
cord-005453-4057qib7	4309	5	history	history	NN
cord-005453-4057qib7	4309	6	of	of	IN
cord-005453-4057qib7	4309	7	type	type	NN
cord-005453-4057qib7	4309	8	2	2	CD
cord-005453-4057qib7	4309	9	DM	dm	NN
cord-005453-4057qib7	4309	10	,	,	,
cord-005453-4057qib7	4309	11	history	history	NN
cord-005453-4057qib7	4309	12	of	of	IN
cord-005453-4057qib7	4309	13	tobacco	tobacco	NN
cord-005453-4057qib7	4309	14	consumption	consumption	NN
cord-005453-4057qib7	4309	15	,	,	,
cord-005453-4057qib7	4309	16	volume	volume	NN
cord-005453-4057qib7	4309	17	of	of	IN
cord-005453-4057qib7	4309	18	infusion	infusion	NN
cord-005453-4057qib7	4309	19	,	,	,
cord-005453-4057qib7	4309	20	prophylactic	prophylactic	JJ
cord-005453-4057qib7	4309	21	treatment	treatment	NN
cord-005453-4057qib7	4309	22	for	for	IN
cord-005453-4057qib7	4309	23	GvHD	GvHD	NNP
cord-005453-4057qib7	4309	24	with	with	IN
cord-005453-4057qib7	4309	25	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	4309	26	,	,	,
cord-005453-4057qib7	4309	27	chronic	chronic	JJ
cord-005453-4057qib7	4309	28	GvHD	gvhd	NN
cord-005453-4057qib7	4309	29	,	,	,
cord-005453-4057qib7	4309	30	serum	serum	NN
cord-005453-4057qib7	4309	31	creatinine	creatinine	NN
cord-005453-4057qib7	4309	32	level	level	NN
cord-005453-4057qib7	4309	33	on	on	IN
cord-005453-4057qib7	4309	34	day	day	NN
cord-005453-4057qib7	4309	35	of	of	IN
cord-005453-4057qib7	4309	36	HSCT	HSCT	NNP
cord-005453-4057qib7	4309	37	,	,	,
cord-005453-4057qib7	4309	38	and	and	CC
cord-005453-4057qib7	4309	39	being	be	VBG
cord-005453-4057qib7	4309	40	overweight	overweight	JJ
cord-005453-4057qib7	4309	41	or	or	CC
cord-005453-4057qib7	4309	42	obese	obese	JJ
cord-005453-4057qib7	4309	43	at	at	IN
cord-005453-4057qib7	4309	44	time	time	NN
cord-005453-4057qib7	4309	45	of	of	IN
cord-005453-4057qib7	4309	46	transplantation	transplantation	NN
cord-005453-4057qib7	4309	47	were	be	VBD
cord-005453-4057qib7	4309	48	not	not	RB
cord-005453-4057qib7	4309	49	significantly	significantly	RB
cord-005453-4057qib7	4309	50	associated	associate	VBN
cord-005453-4057qib7	4309	51	with	with	IN
cord-005453-4057qib7	4309	52	the	the	DT
cord-005453-4057qib7	4309	53	development	development	NN
cord-005453-4057qib7	4309	54	of	of	IN
cord-005453-4057qib7	4309	55	hypertension	hypertension	NN
cord-005453-4057qib7	4309	56	.	.	.
cord-005453-4057qib7	4310	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4310	2	:	:	:
cord-005453-4057qib7	4311	1	Arterial	arterial	JJ
cord-005453-4057qib7	4311	2	hypertension	hypertension	NN
cord-005453-4057qib7	4311	3	is	be	VBZ
cord-005453-4057qib7	4311	4	a	a	DT
cord-005453-4057qib7	4311	5	fairly	fairly	RB
cord-005453-4057qib7	4311	6	common	common	JJ
cord-005453-4057qib7	4311	7	complication	complication	NN
cord-005453-4057qib7	4311	8	in	in	IN
cord-005453-4057qib7	4311	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4311	10	recipients	recipient	NNS
cord-005453-4057qib7	4311	11	.	.	.
cord-005453-4057qib7	4312	1	Similar	similar	JJ
cord-005453-4057qib7	4312	2	to	to	IN
cord-005453-4057qib7	4312	3	findings	finding	NNS
cord-005453-4057qib7	4312	4	reported	report	VBN
cord-005453-4057qib7	4312	5	in	in	IN
cord-005453-4057qib7	4312	6	previous	previous	JJ
cord-005453-4057qib7	4312	7	studies	study	NNS
cord-005453-4057qib7	4312	8	,	,	,
cord-005453-4057qib7	4312	9	association	association	NN
cord-005453-4057qib7	4312	10	between	between	IN
cord-005453-4057qib7	4312	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	4312	12	stem	stem	NN
cord-005453-4057qib7	4312	13	cell	cell	NN
cord-005453-4057qib7	4312	14	transplantation	transplantation	NN
cord-005453-4057qib7	4312	15	,	,	,
cord-005453-4057qib7	4312	16	therapy	therapy	NN
cord-005453-4057qib7	4312	17	with	with	IN
cord-005453-4057qib7	4312	18	calcineurin	calcineurin	NNP
cord-005453-4057qib7	4312	19	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4312	20	,	,	,
cord-005453-4057qib7	4312	21	and	and	CC
cord-005453-4057qib7	4312	22	acute	acute	JJ
cord-005453-4057qib7	4312	23	and	and	CC
cord-005453-4057qib7	4312	24	chronic	chronic	JJ
cord-005453-4057qib7	4312	25	GvHD	gvhd	NN
cord-005453-4057qib7	4312	26	,	,	,
cord-005453-4057qib7	4312	27	and	and	CC
cord-005453-4057qib7	4312	28	post	post	JJ
cord-005453-4057qib7	4312	29	-	-	JJ
cord-005453-4057qib7	4312	30	HSCT	hsct	JJ
cord-005453-4057qib7	4312	31	hypertension	hypertension	NN
cord-005453-4057qib7	4312	32	was	be	VBD
cord-005453-4057qib7	4312	33	found	find	VBN
cord-005453-4057qib7	4312	34	in	in	IN
cord-005453-4057qib7	4312	35	the	the	DT
cord-005453-4057qib7	4312	36	present	present	JJ
cord-005453-4057qib7	4312	37	cohort	cohort	NN
cord-005453-4057qib7	4312	38	.	.	.
cord-005453-4057qib7	4313	1	Further	further	JJ
cord-005453-4057qib7	4313	2	studies	study	NNS
cord-005453-4057qib7	4313	3	are	be	VBP
cord-005453-4057qib7	4313	4	needed	need	VBN
cord-005453-4057qib7	4313	5	to	to	TO
cord-005453-4057qib7	4313	6	assess	assess	VB
cord-005453-4057qib7	4313	7	the	the	DT
cord-005453-4057qib7	4313	8	link	link	NN
cord-005453-4057qib7	4313	9	between	between	IN
cord-005453-4057qib7	4313	10	HSCT	HSCT	NNP
cord-005453-4057qib7	4313	11	and	and	CC
cord-005453-4057qib7	4313	12	developing	develop	VBG
cord-005453-4057qib7	4313	13	long	long	JJ
cord-005453-4057qib7	4313	14	-	-	HYPH
cord-005453-4057qib7	4313	15	term	term	NN
cord-005453-4057qib7	4313	16	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	4313	17	complications	complication	NNS
cord-005453-4057qib7	4313	18	.	.	.
cord-005453-4057qib7	4314	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4314	2	:	:	:
cord-005453-4057qib7	4314	3	Nothing	nothing	NN
cord-005453-4057qib7	4314	4	to	to	TO
cord-005453-4057qib7	4314	5	declare	declare	VB
cord-005453-4057qib7	4314	6	Tramadol	Tramadol	NNP
cord-005453-4057qib7	4314	7	-	-	HYPH
cord-005453-4057qib7	4314	8	based	base	VBN
cord-005453-4057qib7	4314	9	pain	pain	NN
cord-005453-4057qib7	4314	10	management	management	NN
cord-005453-4057qib7	4314	11	of	of	IN
cord-005453-4057qib7	4314	12	oral	oral	JJ
cord-005453-4057qib7	4314	13	and	and	CC
cord-005453-4057qib7	4314	14	esophageal	esophageal	JJ
cord-005453-4057qib7	4314	15	mucositis	mucositis	NN
cord-005453-4057qib7	4314	16	in	in	IN
cord-005453-4057qib7	4314	17	pediatric	pediatric	JJ
cord-005453-4057qib7	4314	18	HSCT	HSCT	NNP
cord-005453-4057qib7	4314	19	recipients	recipient	NNS
cord-005453-4057qib7	4314	20	Background	Background	NNP
cord-005453-4057qib7	4314	21	:	:	:
cord-005453-4057qib7	4314	22	Mucositis	Mucositis	NNP
cord-005453-4057qib7	4314	23	is	be	VBZ
cord-005453-4057qib7	4314	24	one	one	CD
cord-005453-4057qib7	4314	25	of	of	IN
cord-005453-4057qib7	4314	26	the	the	DT
cord-005453-4057qib7	4314	27	most	most	RBS
cord-005453-4057qib7	4314	28	common	common	JJ
cord-005453-4057qib7	4314	29	early	early	JJ
cord-005453-4057qib7	4314	30	HSCT	HSCT	NNP
cord-005453-4057qib7	4314	31	complications	complication	NNS
cord-005453-4057qib7	4314	32	seen	see	VBN
cord-005453-4057qib7	4314	33	in	in	IN
cord-005453-4057qib7	4314	34	about	about	RB
cord-005453-4057qib7	4314	35	70	70	CD
cord-005453-4057qib7	4314	36	%	%	NN
cord-005453-4057qib7	4314	37	transplant	transplant	NN
cord-005453-4057qib7	4314	38	recipients	recipient	NNS
cord-005453-4057qib7	4314	39	with	with	IN
cord-005453-4057qib7	4314	40	20	20	CD
cord-005453-4057qib7	4314	41	%	%	NN
cord-005453-4057qib7	4314	42	of	of	IN
cord-005453-4057qib7	4314	43	patients	patient	NNS
cord-005453-4057qib7	4314	44	developing	develop	VBG
cord-005453-4057qib7	4314	45	Gr	Gr	NNP
cord-005453-4057qib7	4314	46	III	III	NNP
cord-005453-4057qib7	4314	47	-	-	HYPH
cord-005453-4057qib7	4314	48	IV	IV	NNP
cord-005453-4057qib7	4314	49	mucositis	mucositis	NNP
cord-005453-4057qib7	4314	50	.	.	.
cord-005453-4057qib7	4315	1	Mucositis	Mucositis	NNP
cord-005453-4057qib7	4315	2	is	be	VBZ
cord-005453-4057qib7	4315	3	characterized	characterize	VBN
cord-005453-4057qib7	4315	4	by	by	IN
cord-005453-4057qib7	4315	5	painful	painful	JJ
cord-005453-4057qib7	4315	6	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	4315	7	mucosa	mucosa	JJ
cord-005453-4057qib7	4315	8	lesions	lesion	NNS
cord-005453-4057qib7	4315	9	impairing	impair	VBG
cord-005453-4057qib7	4315	10	the	the	DT
cord-005453-4057qib7	4315	11	solid	solid	JJ
cord-005453-4057qib7	4315	12	and	and	CC
cord-005453-4057qib7	4315	13	liquid	liquid	JJ
cord-005453-4057qib7	4315	14	foods	food	NNS
cord-005453-4057qib7	4315	15	intake	intake	NN
cord-005453-4057qib7	4315	16	and	and	CC
cord-005453-4057qib7	4315	17	increased	increase	VBN
cord-005453-4057qib7	4315	18	risk	risk	NN
cord-005453-4057qib7	4315	19	of	of	IN
cord-005453-4057qib7	4315	20	infections	infection	NNS
cord-005453-4057qib7	4315	21	,	,	,
cord-005453-4057qib7	4315	22	bleeding	bleed	VBG
cord-005453-4057qib7	4315	23	,	,	,
cord-005453-4057qib7	4315	24	and	and	CC
cord-005453-4057qib7	4315	25	intestinal	intestinal	JJ
cord-005453-4057qib7	4315	26	paresis	paresis	NN
cord-005453-4057qib7	4315	27	.	.	.
cord-005453-4057qib7	4316	1	Thus	thus	RB
cord-005453-4057qib7	4316	2	,	,	,
cord-005453-4057qib7	4316	3	it	-PRON-	PRP
cord-005453-4057qib7	4316	4	greatly	greatly	RB
cord-005453-4057qib7	4316	5	decreases	decrease	VBZ
cord-005453-4057qib7	4316	6	the	the	DT
cord-005453-4057qib7	4316	7	quality	quality	NN
cord-005453-4057qib7	4316	8	of	of	IN
cord-005453-4057qib7	4316	9	life	life	NN
cord-005453-4057qib7	4316	10	of	of	IN
cord-005453-4057qib7	4316	11	a	a	DT
cord-005453-4057qib7	4316	12	transplant	transplant	NN
cord-005453-4057qib7	4316	13	recipient	recipient	NN
cord-005453-4057qib7	4316	14	.	.	.
cord-005453-4057qib7	4317	1	According	accord	VBG
cord-005453-4057qib7	4317	2	to	to	IN
cord-005453-4057qib7	4317	3	WHO	WHO	NNP
cord-005453-4057qib7	4317	4	recommendations	recommendation	NNS
cord-005453-4057qib7	4317	5	,	,	,
cord-005453-4057qib7	4317	6	the	the	DT
cord-005453-4057qib7	4317	7	moderate	moderate	JJ
cord-005453-4057qib7	4317	8	pain	pain	NN
cord-005453-4057qib7	4317	9	control	control	NN
cord-005453-4057qib7	4317	10	in	in	IN
cord-005453-4057qib7	4317	11	pediatric	pediatric	JJ
cord-005453-4057qib7	4317	12	patient	patient	NN
cord-005453-4057qib7	4317	13	is	be	VBZ
cord-005453-4057qib7	4317	14	based	base	VBN
cord-005453-4057qib7	4317	15	on	on	IN
cord-005453-4057qib7	4317	16	the	the	DT
cord-005453-4057qib7	4317	17	use	use	NN
cord-005453-4057qib7	4317	18	of	of	IN
cord-005453-4057qib7	4317	19	low	low	JJ
cord-005453-4057qib7	4317	20	-	-	HYPH
cord-005453-4057qib7	4317	21	dose	dose	NN
cord-005453-4057qib7	4317	22	morphine	morphine	NN
cord-005453-4057qib7	4317	23	.	.	.
cord-005453-4057qib7	4318	1	However	however	RB
cord-005453-4057qib7	4318	2	,	,	,
cord-005453-4057qib7	4318	3	there	there	EX
cord-005453-4057qib7	4318	4	are	be	VBP
cord-005453-4057qib7	4318	5	some	some	DT
cord-005453-4057qib7	4318	6	factors	factor	NNS
cord-005453-4057qib7	4318	7	such	such	JJ
cord-005453-4057qib7	4318	8	as	as	IN
cord-005453-4057qib7	4318	9	genetic	genetic	JJ
cord-005453-4057qib7	4318	10	polymorphisms	polymorphism	NNS
cord-005453-4057qib7	4318	11	causing	cause	VBG
cord-005453-4057qib7	4318	12	variable	variable	JJ
cord-005453-4057qib7	4318	13	morphine	morphine	NN
cord-005453-4057qib7	4318	14	pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	4318	15	in	in	IN
cord-005453-4057qib7	4318	16	children	child	NNS
cord-005453-4057qib7	4318	17	,	,	,
cord-005453-4057qib7	4318	18	side	side	NN
cord-005453-4057qib7	4318	19	effects	effect	NNS
cord-005453-4057qib7	4318	20	,	,	,
cord-005453-4057qib7	4318	21	and	and	CC
cord-005453-4057qib7	4318	22	social	social	JJ
cord-005453-4057qib7	4318	23	factors	factor	NNS
cord-005453-4057qib7	4318	24	(	(	-LRB-
cord-005453-4057qib7	4318	25	caregivers	caregiver	NNS
cord-005453-4057qib7	4318	26	'	'	POS
cord-005453-4057qib7	4318	27	general	general	JJ
cord-005453-4057qib7	4318	28	unwillingness	unwillingness	NN
cord-005453-4057qib7	4318	29	to	to	TO
cord-005453-4057qib7	4318	30	use	use	VB
cord-005453-4057qib7	4318	31	narcotic	narcotic	JJ
cord-005453-4057qib7	4318	32	analgesics	analgesic	NNS
cord-005453-4057qib7	4318	33	)	)	-RRB-
cord-005453-4057qib7	4318	34	,	,	,
cord-005453-4057qib7	4318	35	which	which	WDT
cord-005453-4057qib7	4318	36	cause	cause	VBP
cord-005453-4057qib7	4318	37	the	the	DT
cord-005453-4057qib7	4318	38	need	need	NN
cord-005453-4057qib7	4318	39	for	for	IN
cord-005453-4057qib7	4318	40	alternative	alternative	JJ
cord-005453-4057qib7	4318	41	pain	pain	NN
cord-005453-4057qib7	4318	42	relief	relief	NN
cord-005453-4057qib7	4318	43	options	option	NNS
cord-005453-4057qib7	4318	44	in	in	IN
cord-005453-4057qib7	4318	45	pediatric	pediatric	JJ
cord-005453-4057qib7	4318	46	practice	practice	NN
cord-005453-4057qib7	4318	47	.	.	.
cord-005453-4057qib7	4319	1	Tramadol	Tramadol	NNP
cord-005453-4057qib7	4319	2	,	,	,
cord-005453-4057qib7	4319	3	which	which	WDT
cord-005453-4057qib7	4319	4	has	have	VBZ
cord-005453-4057qib7	4319	5	both	both	DT
cord-005453-4057qib7	4319	6	opioid	opioid	JJ
cord-005453-4057qib7	4319	7	and	and	CC
cord-005453-4057qib7	4319	8	non	non	JJ
cord-005453-4057qib7	4319	9	-	-	JJ
cord-005453-4057qib7	4319	10	opioid	opioid	JJ
cord-005453-4057qib7	4319	11	mechanisms	mechanism	NNS
cord-005453-4057qib7	4319	12	of	of	IN
cord-005453-4057qib7	4319	13	action	action	NN
cord-005453-4057qib7	4319	14	,	,	,
cord-005453-4057qib7	4319	15	may	may	MD
cord-005453-4057qib7	4319	16	be	be	VB
cord-005453-4057qib7	4319	17	a	a	DT
cord-005453-4057qib7	4319	18	feasible	feasible	JJ
cord-005453-4057qib7	4319	19	option	option	NN
cord-005453-4057qib7	4319	20	in	in	IN
cord-005453-4057qib7	4319	21	mild	mild	JJ
cord-005453-4057qib7	4319	22	to	to	IN
cord-005453-4057qib7	4319	23	moderate	moderate	JJ
cord-005453-4057qib7	4319	24	pain	pain	NN
cord-005453-4057qib7	4319	25	.	.	.
cord-005453-4057qib7	4320	1	It	-PRON-	PRP
cord-005453-4057qib7	4320	2	may	may	MD
cord-005453-4057qib7	4320	3	be	be	VB
cord-005453-4057qib7	4320	4	delivered	deliver	VBN
cord-005453-4057qib7	4320	5	via	via	IN
cord-005453-4057qib7	4320	6	patient	patient	NN
cord-005453-4057qib7	4320	7	-	-	HYPH
cord-005453-4057qib7	4320	8	controlled	control	VBN
cord-005453-4057qib7	4320	9	analgesia	analgesia	NN
cord-005453-4057qib7	4320	10	(	(	-LRB-
cord-005453-4057qib7	4320	11	PCA	PCA	NNP
cord-005453-4057qib7	4320	12	)	)	-RRB-
cord-005453-4057qib7	4320	13	,	,	,
cord-005453-4057qib7	4320	14	although	although	IN
cord-005453-4057qib7	4320	15	there	there	EX
cord-005453-4057qib7	4320	16	is	be	VBZ
cord-005453-4057qib7	4320	17	no	no	DT
cord-005453-4057qib7	4320	18	consensus	consensus	NN
cord-005453-4057qib7	4320	19	on	on	IN
cord-005453-4057qib7	4320	20	its	-PRON-	PRP$
cord-005453-4057qib7	4320	21	optimal	optimal	JJ
cord-005453-4057qib7	4320	22	parameters	parameter	NNS
cord-005453-4057qib7	4320	23	in	in	IN
cord-005453-4057qib7	4320	24	pediatric	pediatric	JJ
cord-005453-4057qib7	4320	25	practice	practice	NN
cord-005453-4057qib7	4320	26	.	.	.
cord-005453-4057qib7	4321	1	Methods	method	NNS
cord-005453-4057qib7	4321	2	:	:	:
cord-005453-4057qib7	4321	3	A	a	DT
cord-005453-4057qib7	4321	4	total	total	NN
cord-005453-4057qib7	4321	5	of	of	IN
cord-005453-4057qib7	4321	6	69	69	CD
cord-005453-4057qib7	4321	7	pediatric	pediatric	JJ
cord-005453-4057qib7	4321	8	patients	patient	NNS
cord-005453-4057qib7	4321	9	with	with	IN
cord-005453-4057qib7	4321	10	a	a	DT
cord-005453-4057qib7	4321	11	median	median	JJ
cord-005453-4057qib7	4321	12	age	age	NN
cord-005453-4057qib7	4321	13	of	of	IN
cord-005453-4057qib7	4321	14	8	8	CD
cord-005453-4057qib7	4321	15	(	(	-LRB-
cord-005453-4057qib7	4321	16	range	range	NN
cord-005453-4057qib7	4321	17	2	2	CD
cord-005453-4057qib7	4321	18	to	to	IN
cord-005453-4057qib7	4321	19	18	18	CD
cord-005453-4057qib7	4321	20	)	)	-RRB-
cord-005453-4057qib7	4321	21	years	year	NNS
cord-005453-4057qib7	4321	22	receiving	receive	VBG
cord-005453-4057qib7	4321	23	an	an	DT
cord-005453-4057qib7	4321	24	autologous	autologous	JJ
cord-005453-4057qib7	4321	25	or	or	CC
cord-005453-4057qib7	4321	26	allogeneic	allogeneic	IN
cord-005453-4057qib7	4321	27	HSCT	HSCT	NNP
cord-005453-4057qib7	4321	28	in	in	IN
cord-005453-4057qib7	4321	29	our	-PRON-	PRP$
cord-005453-4057qib7	4321	30	clinic	clinic	NN
cord-005453-4057qib7	4321	31	as	as	IN
cord-005453-4057qib7	4321	32	part	part	NN
cord-005453-4057qib7	4321	33	of	of	IN
cord-005453-4057qib7	4321	34	the	the	DT
cord-005453-4057qib7	4321	35	treatment	treatment	NN
cord-005453-4057qib7	4321	36	regimen	regimen	NN
cord-005453-4057qib7	4321	37	for	for	IN
cord-005453-4057qib7	4321	38	solid	solid	JJ
cord-005453-4057qib7	4321	39	tumor	tumor	NN
cord-005453-4057qib7	4321	40	(	(	-LRB-
cord-005453-4057qib7	4321	41	n=40	n=40	NNP
cord-005453-4057qib7	4321	42	)	)	-RRB-
cord-005453-4057qib7	4321	43	,	,	,
cord-005453-4057qib7	4321	44	leukemia	leukemia	NN
cord-005453-4057qib7	4321	45	(	(	-LRB-
cord-005453-4057qib7	4321	46	n=24	n=24	NNP
cord-005453-4057qib7	4321	47	)	)	-RRB-
cord-005453-4057qib7	4321	48	,	,	,
cord-005453-4057qib7	4321	49	acquired	acquire	VBD
cord-005453-4057qib7	4321	50	aplastic	aplastic	JJ
cord-005453-4057qib7	4321	51	anemia	anemia	NN
cord-005453-4057qib7	4321	52	(	(	-LRB-
cord-005453-4057qib7	4321	53	n=3	n=3	NN
cord-005453-4057qib7	4321	54	)	)	-RRB-
cord-005453-4057qib7	4321	55	or	or	CC
cord-005453-4057qib7	4321	56	inherited	inherit	VBN
cord-005453-4057qib7	4321	57	condition	condition	NN
cord-005453-4057qib7	4321	58	(	(	-LRB-
cord-005453-4057qib7	4321	59	n=2	n=2	NNS
cord-005453-4057qib7	4321	60	)	)	-RRB-
cord-005453-4057qib7	4321	61	were	be	VBD
cord-005453-4057qib7	4321	62	included	include	VBN
cord-005453-4057qib7	4321	63	.	.	.
cord-005453-4057qib7	4322	1	Conditioning	conditioning	NN
cord-005453-4057qib7	4322	2	regimens	regimen	NNS
cord-005453-4057qib7	4322	3	were	be	VBD
cord-005453-4057qib7	4322	4	myeloablative	myeloablative	NNP
cord-005453-4057qib7	4322	5	(	(	-LRB-
cord-005453-4057qib7	4322	6	MAC	MAC	NNP
cord-005453-4057qib7	4322	7	)	)	-RRB-
cord-005453-4057qib7	4322	8	in	in	IN
cord-005453-4057qib7	4322	9	54	54	CD
cord-005453-4057qib7	4322	10	and	and	CC
cord-005453-4057qib7	4322	11	reduced	reduce	VBN
cord-005453-4057qib7	4322	12	-	-	HYPH
cord-005453-4057qib7	4322	13	intensity	intensity	NN
cord-005453-4057qib7	4322	14	(	(	-LRB-
cord-005453-4057qib7	4322	15	RIC	RIC	NNP
cord-005453-4057qib7	4322	16	)	)	-RRB-
cord-005453-4057qib7	4322	17	in	in	IN
cord-005453-4057qib7	4322	18	15	15	CD
cord-005453-4057qib7	4322	19	patients	patient	NNS
cord-005453-4057qib7	4322	20	.	.	.
cord-005453-4057qib7	4323	1	All	all	DT
cord-005453-4057qib7	4323	2	patients	patient	NNS
cord-005453-4057qib7	4323	3	had	have	VBD
cord-005453-4057qib7	4323	4	oral	oral	JJ
cord-005453-4057qib7	4323	5	and/or	and/or	CC
cord-005453-4057qib7	4323	6	esophageal	esophageal	JJ
cord-005453-4057qib7	4323	7	mucositis	mucositis	NN
cord-005453-4057qib7	4323	8	accompanied	accompany	VBN
cord-005453-4057qib7	4323	9	by	by	IN
cord-005453-4057qib7	4323	10	moderate	moderate	JJ
cord-005453-4057qib7	4323	11	pain	pain	NN
cord-005453-4057qib7	4323	12	.	.	.
cord-005453-4057qib7	4324	1	The	the	DT
cord-005453-4057qib7	4324	2	pain	pain	NN
cord-005453-4057qib7	4324	3	severity	severity	NN
cord-005453-4057qib7	4324	4	was	be	VBD
cord-005453-4057qib7	4324	5	assessed	assess	VBN
cord-005453-4057qib7	4324	6	using	use	VBG
cord-005453-4057qib7	4324	7	the	the	DT
cord-005453-4057qib7	4324	8	scales	scale	NNS
cord-005453-4057qib7	4324	9	corresponding	correspond	VBG
cord-005453-4057qib7	4324	10	to	to	IN
cord-005453-4057qib7	4324	11	patient	patient	NN
cord-005453-4057qib7	4324	12	's	's	POS
cord-005453-4057qib7	4324	13	age	age	NN
cord-005453-4057qib7	4324	14	and	and	CC
cord-005453-4057qib7	4324	15	varied	varied	JJ
cord-005453-4057qib7	4324	16	from	from	IN
cord-005453-4057qib7	4324	17	3	3	CD
cord-005453-4057qib7	4324	18	to	to	TO
cord-005453-4057qib7	4324	19	6	6	CD
cord-005453-4057qib7	4324	20	points	point	NNS
cord-005453-4057qib7	4324	21	.	.	.
cord-005453-4057qib7	4325	1	The	the	DT
cord-005453-4057qib7	4325	2	pain	pain	NN
cord-005453-4057qib7	4325	3	control	control	NN
cord-005453-4057qib7	4325	4	was	be	VBD
cord-005453-4057qib7	4325	5	based	base	VBN
cord-005453-4057qib7	4325	6	on	on	IN
cord-005453-4057qib7	4325	7	intravenous	intravenous	JJ
cord-005453-4057qib7	4325	8	tramadol	tramadol	NN
cord-005453-4057qib7	4325	9	administration	administration	NN
cord-005453-4057qib7	4325	10	using	use	VBG
cord-005453-4057qib7	4325	11	patientcontrolled	patientcontrolle	VBN
cord-005453-4057qib7	4325	12	analgesia	analgesia	NNP
cord-005453-4057qib7	4325	13	(	(	-LRB-
cord-005453-4057qib7	4325	14	PCA	PCA	NNP
cord-005453-4057qib7	4325	15	)	)	-RRB-
cord-005453-4057qib7	4325	16	approach	approach	NN
cord-005453-4057qib7	4325	17	.	.	.
cord-005453-4057qib7	4326	1	The	the	DT
cord-005453-4057qib7	4326	2	following	follow	VBG
cord-005453-4057qib7	4326	3	PCA	PCA	NNP
cord-005453-4057qib7	4326	4	parameters	parameter	NNS
cord-005453-4057qib7	4326	5	were	be	VBD
cord-005453-4057qib7	4326	6	used	use	VBN
cord-005453-4057qib7	4326	7	:	:	:
cord-005453-4057qib7	4326	8	loading	loading	NN
cord-005453-4057qib7	4326	9	dose	dose	NN
cord-005453-4057qib7	4326	10	of	of	IN
cord-005453-4057qib7	4326	11	0.5	0.5	CD
cord-005453-4057qib7	4326	12	mg	mg	NNP
cord-005453-4057qib7	4326	13	/	/	SYM
cord-005453-4057qib7	4326	14	kg	kg	NNP
cord-005453-4057qib7	4326	15	(	(	-LRB-
cord-005453-4057qib7	4326	16	not	not	RB
cord-005453-4057qib7	4326	17	exceeding	exceed	VBG
cord-005453-4057qib7	4326	18	25	25	CD
cord-005453-4057qib7	4326	19	mg	mg	CD
cord-005453-4057qib7	4326	20	)	)	-RRB-
cord-005453-4057qib7	4326	21	,	,	,
cord-005453-4057qib7	4326	22	basal	basal	NN
cord-005453-4057qib7	4326	23	infusion	infusion	NN
cord-005453-4057qib7	4326	24	rate	rate	NN
cord-005453-4057qib7	4326	25	of	of	IN
cord-005453-4057qib7	4326	26	0.25	0.25	CD
cord-005453-4057qib7	4326	27	mg	mg	NN
cord-005453-4057qib7	4326	28	/	/	SYM
cord-005453-4057qib7	4326	29	kg	kg	NNP
cord-005453-4057qib7	4326	30	(	(	-LRB-
cord-005453-4057qib7	4326	31	not	not	RB
cord-005453-4057qib7	4326	32	exceeding	exceed	VBG
cord-005453-4057qib7	4326	33	12.5	12.5	CD
cord-005453-4057qib7	4326	34	mg	mg	NNPS
cord-005453-4057qib7	4326	35	)	)	-RRB-
cord-005453-4057qib7	4326	36	,	,	,
cord-005453-4057qib7	4326	37	a	a	DT
cord-005453-4057qib7	4326	38	bolus	bolus	NN
cord-005453-4057qib7	4326	39	of	of	IN
cord-005453-4057qib7	4326	40	0.25	0.25	CD
cord-005453-4057qib7	4326	41	mg	mg	NNP
cord-005453-4057qib7	4326	42	/	/	SYM
cord-005453-4057qib7	4326	43	kg	kg	NNP
cord-005453-4057qib7	4326	44	(	(	-LRB-
cord-005453-4057qib7	4326	45	not	not	RB
cord-005453-4057qib7	4326	46	exceeding	exceed	VBG
cord-005453-4057qib7	4326	47	12.5	12.5	CD
cord-005453-4057qib7	4326	48	mg	mg	NNPS
cord-005453-4057qib7	4326	49	)	)	-RRB-
cord-005453-4057qib7	4326	50	,	,	,
cord-005453-4057qib7	4326	51	lockout	lockout	NN
cord-005453-4057qib7	4326	52	interval	interval	NN
cord-005453-4057qib7	4326	53	of	of	IN
cord-005453-4057qib7	4326	54	25	25	CD
cord-005453-4057qib7	4326	55	min	min	NN
cord-005453-4057qib7	4326	56	.	.	.
cord-005453-4057qib7	4327	1	The	the	DT
cord-005453-4057qib7	4327	2	maximal	maximal	JJ
cord-005453-4057qib7	4327	3	daily	daily	JJ
cord-005453-4057qib7	4327	4	dose	dose	NN
cord-005453-4057qib7	4327	5	was	be	VBD
cord-005453-4057qib7	4327	6	8	8	CD
cord-005453-4057qib7	4327	7	mg	mg	NN
cord-005453-4057qib7	4327	8	/	/	SYM
cord-005453-4057qib7	4327	9	kg	kg	NNP
cord-005453-4057qib7	4327	10	/	/	SYM
cord-005453-4057qib7	4327	11	day	day	NN
cord-005453-4057qib7	4327	12	.	.	.
cord-005453-4057qib7	4328	1	The	the	DT
cord-005453-4057qib7	4328	2	pain	pain	NN
cord-005453-4057qib7	4328	3	control	control	NN
cord-005453-4057qib7	4328	4	was	be	VBD
cord-005453-4057qib7	4328	5	considered	consider	VBN
cord-005453-4057qib7	4328	6	adequate	adequate	JJ
cord-005453-4057qib7	4328	7	if	if	IN
cord-005453-4057qib7	4328	8	a	a	DT
cord-005453-4057qib7	4328	9	patient	patient	NN
cord-005453-4057qib7	4328	10	was	be	VBD
cord-005453-4057qib7	4328	11	satisfied	satisfied	JJ
cord-005453-4057qib7	4328	12	or	or	CC
cord-005453-4057qib7	4328	13	the	the	DT
cord-005453-4057qib7	4328	14	basic	basic	JJ
cord-005453-4057qib7	4328	15	and	and	CC
cord-005453-4057qib7	4328	16	breakthrough	breakthrough	JJ
cord-005453-4057qib7	4328	17	pain	pain	NN
cord-005453-4057qib7	4328	18	score	score	NN
cord-005453-4057qib7	4328	19	values	value	NNS
cord-005453-4057qib7	4328	20	were	be	VBD
cord-005453-4057qib7	4328	21	not	not	RB
cord-005453-4057qib7	4328	22	higher	high	JJR
cord-005453-4057qib7	4328	23	than	than	IN
cord-005453-4057qib7	4328	24	3	3	CD
cord-005453-4057qib7	4328	25	and	and	CC
cord-005453-4057qib7	4328	26	,	,	,
cord-005453-4057qib7	4328	27	accordingly	accordingly	RB
cord-005453-4057qib7	4328	28	.	.	.
cord-005453-4057qib7	4329	1	In	in	IN
cord-005453-4057qib7	4329	2	case	case	NN
cord-005453-4057qib7	4329	3	of	of	IN
cord-005453-4057qib7	4329	4	inadequate	inadequate	JJ
cord-005453-4057qib7	4329	5	pain	pain	NN
cord-005453-4057qib7	4329	6	control	control	NN
cord-005453-4057qib7	4329	7	NSAIDs	NSAIDs	NNPS
cord-005453-4057qib7	4329	8	were	be	VBD
cord-005453-4057qib7	4329	9	added	add	VBN
cord-005453-4057qib7	4329	10	.	.	.
cord-005453-4057qib7	4330	1	Non	Non	NNS
cord-005453-4057qib7	4330	2	-	-	NNS
cord-005453-4057qib7	4330	3	responders	responder	NNS
cord-005453-4057qib7	4330	4	were	be	VBD
cord-005453-4057qib7	4330	5	switched	switch	VBN
cord-005453-4057qib7	4330	6	to	to	IN
cord-005453-4057qib7	4330	7	morphine	morphine	NN
cord-005453-4057qib7	4330	8	.	.	.
cord-005453-4057qib7	4331	1	All	all	DT
cord-005453-4057qib7	4331	2	patients	patient	NNS
cord-005453-4057qib7	4331	3	were	be	VBD
cord-005453-4057qib7	4331	4	divided	divide	VBN
cord-005453-4057qib7	4331	5	into	into	IN
cord-005453-4057qib7	4331	6	2	2	CD
cord-005453-4057qib7	4331	7	groups	group	NNS
cord-005453-4057qib7	4331	8	based	base	VBN
cord-005453-4057qib7	4331	9	on	on	IN
cord-005453-4057qib7	4331	10	conditioning	conditioning	NN
cord-005453-4057qib7	4331	11	regimen	regimen	NN
cord-005453-4057qib7	4331	12	intensity	intensity	NN
cord-005453-4057qib7	4331	13	.	.	.
cord-005453-4057qib7	4332	1	Results	result	NNS
cord-005453-4057qib7	4332	2	:	:	:
cord-005453-4057qib7	4333	1	As	as	IN
cord-005453-4057qib7	4333	2	a	a	DT
cord-005453-4057qib7	4333	3	whole	whole	NN
cord-005453-4057qib7	4333	4	,	,	,
cord-005453-4057qib7	4333	5	46	46	CD
cord-005453-4057qib7	4333	6	%	%	NN
cord-005453-4057qib7	4333	7	of	of	IN
cord-005453-4057qib7	4333	8	patients	patient	NNS
cord-005453-4057qib7	4333	9	did	do	VBD
cord-005453-4057qib7	4333	10	not	not	RB
cord-005453-4057qib7	4333	11	require	require	VB
cord-005453-4057qib7	4333	12	pain	pain	NN
cord-005453-4057qib7	4333	13	control	control	NN
cord-005453-4057qib7	4333	14	measures	measure	NNS
cord-005453-4057qib7	4333	15	escalation	escalation	NN
cord-005453-4057qib7	4333	16	.	.	.
cord-005453-4057qib7	4334	1	The	the	DT
cord-005453-4057qib7	4334	2	tramadol	tramadol	NN
cord-005453-4057qib7	4334	3	pain	pain	NN
cord-005453-4057qib7	4334	4	control	control	NN
cord-005453-4057qib7	4334	5	rate	rate	NN
cord-005453-4057qib7	4334	6	was	be	VBD
cord-005453-4057qib7	4334	7	slightly	slightly	RB
cord-005453-4057qib7	4334	8	higher	high	JJR
cord-005453-4057qib7	4334	9	for	for	IN
cord-005453-4057qib7	4334	10	RIC	RIC	NNP
cord-005453-4057qib7	4334	11	(	(	-LRB-
cord-005453-4057qib7	4334	12	n=9	n=9	NN
cord-005453-4057qib7	4334	13	,	,	,
cord-005453-4057qib7	4334	14	60	60	CD
cord-005453-4057qib7	4334	15	%	%	NN
cord-005453-4057qib7	4334	16	)	)	-RRB-
cord-005453-4057qib7	4334	17	compared	compare	VBN
cord-005453-4057qib7	4334	18	to	to	IN
cord-005453-4057qib7	4334	19	MAC	MAC	NNP
cord-005453-4057qib7	4334	20	(	(	-LRB-
cord-005453-4057qib7	4334	21	n=23	n=23	UH
cord-005453-4057qib7	4334	22	,	,	,
cord-005453-4057qib7	4334	23	47	47	CD
cord-005453-4057qib7	4334	24	%	%	NN
cord-005453-4057qib7	4334	25	)	)	-RRB-
cord-005453-4057qib7	4334	26	recipients	recipient	NNS
cord-005453-4057qib7	4334	27	.	.	.
cord-005453-4057qib7	4335	1	In	in	IN
cord-005453-4057qib7	4335	2	most	most	JJS
cord-005453-4057qib7	4335	3	cases	case	NNS
cord-005453-4057qib7	4335	4	the	the	DT
cord-005453-4057qib7	4335	5	inadequate	inadequate	JJ
cord-005453-4057qib7	4335	6	pain	pain	NN
cord-005453-4057qib7	4335	7	control	control	NN
cord-005453-4057qib7	4335	8	was	be	VBD
cord-005453-4057qib7	4335	9	due	due	JJ
cord-005453-4057qib7	4335	10	to	to	IN
cord-005453-4057qib7	4335	11	progressive	progressive	JJ
cord-005453-4057qib7	4335	12	mucosal	mucosal	JJ
cord-005453-4057qib7	4335	13	lesions	lesion	NNS
cord-005453-4057qib7	4335	14	.	.	.
cord-005453-4057qib7	4336	1	The	the	DT
cord-005453-4057qib7	4336	2	PCA	PCA	NNP
cord-005453-4057qib7	4336	3	regimen	regimen	NN
cord-005453-4057qib7	4336	4	used	use	VBN
cord-005453-4057qib7	4336	5	was	be	VBD
cord-005453-4057qib7	4336	6	characterized	characterize	VBN
cord-005453-4057qib7	4336	7	by	by	IN
cord-005453-4057qib7	4336	8	very	very	RB
cord-005453-4057qib7	4336	9	few	few	JJ
cord-005453-4057qib7	4336	10	complications	complication	NNS
cord-005453-4057qib7	4336	11	.	.	.
cord-005453-4057qib7	4337	1	Drowsiness	drowsiness	NN
cord-005453-4057qib7	4337	2	was	be	VBD
cord-005453-4057qib7	4337	3	observed	observe	VBN
cord-005453-4057qib7	4337	4	in	in	IN
cord-005453-4057qib7	4337	5	4	4	CD
cord-005453-4057qib7	4337	6	(	(	-LRB-
cord-005453-4057qib7	4337	7	7	7	CD
cord-005453-4057qib7	4337	8	%	%	NN
cord-005453-4057qib7	4337	9	)	)	-RRB-
cord-005453-4057qib7	4337	10	of	of	IN
cord-005453-4057qib7	4337	11	patients	patient	NNS
cord-005453-4057qib7	4337	12	,	,	,
cord-005453-4057qib7	4337	13	in	in	IN
cord-005453-4057qib7	4337	14	all	all	DT
cord-005453-4057qib7	4337	15	cases	case	NNS
cord-005453-4057qib7	4337	16	the	the	DT
cord-005453-4057qib7	4337	17	patients	patient	NNS
cord-005453-4057qib7	4337	18	also	also	RB
cord-005453-4057qib7	4337	19	had	have	VBD
cord-005453-4057qib7	4337	20	anemia	anemia	NN
cord-005453-4057qib7	4337	21	.	.	.
cord-005453-4057qib7	4338	1	There	there	EX
cord-005453-4057qib7	4338	2	was	be	VBD
cord-005453-4057qib7	4338	3	only	only	RB
cord-005453-4057qib7	4338	4	1	1	CD
cord-005453-4057qib7	4338	5	(	(	-LRB-
cord-005453-4057qib7	4338	6	7	7	CD
cord-005453-4057qib7	4338	7	%	%	NN
cord-005453-4057qib7	4338	8	)	)	-RRB-
cord-005453-4057qib7	4338	9	patients	patient	NNS
cord-005453-4057qib7	4338	10	with	with	IN
cord-005453-4057qib7	4338	11	severe	severe	JJ
cord-005453-4057qib7	4338	12	nausea	nausea	NN
cord-005453-4057qib7	4338	13	requiring	require	VBG
cord-005453-4057qib7	4338	14	switching	switch	VBG
cord-005453-4057qib7	4338	15	to	to	IN
cord-005453-4057qib7	4338	16	morphine	morphine	NN
cord-005453-4057qib7	4338	17	.	.	.
cord-005453-4057qib7	4339	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4339	2	:	:	:
cord-005453-4057qib7	4340	1	Tramadol	Tramadol	NNP
cord-005453-4057qib7	4340	2	is	be	VBZ
cord-005453-4057qib7	4340	3	an	an	DT
cord-005453-4057qib7	4340	4	effective	effective	JJ
cord-005453-4057qib7	4340	5	pain	pain	NN
cord-005453-4057qib7	4340	6	control	control	NN
cord-005453-4057qib7	4340	7	option	option	NN
cord-005453-4057qib7	4340	8	in	in	IN
cord-005453-4057qib7	4340	9	transplant	transplant	NN
cord-005453-4057qib7	4340	10	recipients	recipient	NNS
cord-005453-4057qib7	4340	11	with	with	IN
cord-005453-4057qib7	4340	12	mild	mild	JJ
cord-005453-4057qib7	4340	13	to	to	IN
cord-005453-4057qib7	4340	14	moderate	moderate	JJ
cord-005453-4057qib7	4340	15	pain	pain	NN
cord-005453-4057qib7	4340	16	due	due	IN
cord-005453-4057qib7	4340	17	to	to	IN
cord-005453-4057qib7	4340	18	oral	oral	JJ
cord-005453-4057qib7	4340	19	and	and	CC
cord-005453-4057qib7	4340	20	esophageal	esophageal	JJ
cord-005453-4057qib7	4340	21	mucositis	mucositis	NN
cord-005453-4057qib7	4340	22	without	without	IN
cord-005453-4057qib7	4340	23	progressive	progressive	JJ
cord-005453-4057qib7	4340	24	mucosal	mucosal	JJ
cord-005453-4057qib7	4340	25	lesions	lesion	NNS
cord-005453-4057qib7	4340	26	.	.	.
cord-005453-4057qib7	4341	1	The	the	DT
cord-005453-4057qib7	4341	2	PCA	PCA	NNP
cord-005453-4057qib7	4341	3	allows	allow	VBZ
cord-005453-4057qib7	4341	4	achieving	achieve	VBG
cord-005453-4057qib7	4341	5	a	a	DT
cord-005453-4057qib7	4341	6	very	very	RB
cord-005453-4057qib7	4341	7	low	low	JJ
cord-005453-4057qib7	4341	8	complication	complication	NN
cord-005453-4057qib7	4341	9	rate	rate	NN
cord-005453-4057qib7	4341	10	.	.	.
cord-005453-4057qib7	4342	1	Therefore	therefore	RB
cord-005453-4057qib7	4342	2	,	,	,
cord-005453-4057qib7	4342	3	this	this	DT
cord-005453-4057qib7	4342	4	option	option	NN
cord-005453-4057qib7	4342	5	may	may	MD
cord-005453-4057qib7	4342	6	be	be	VB
cord-005453-4057qib7	4342	7	considered	consider	VBN
cord-005453-4057qib7	4342	8	for	for	IN
cord-005453-4057qib7	4342	9	both	both	CC
cord-005453-4057qib7	4342	10	MAC	MAC	NNP
cord-005453-4057qib7	4342	11	and	and	CC
cord-005453-4057qib7	4342	12	RIC	RIC	NNP
cord-005453-4057qib7	4342	13	recipients	recipient	NNS
cord-005453-4057qib7	4342	14	.	.	.
cord-005453-4057qib7	4343	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4343	2	:	:	:
cord-005453-4057qib7	4343	3	No	no	DT
cord-005453-4057qib7	4343	4	Immune	Immune	NNP
cord-005453-4057qib7	4343	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	4343	6	of	of	IN
cord-005453-4057qib7	4343	7	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4343	8	subsets	subset	NNS
cord-005453-4057qib7	4343	9	after	after	IN
cord-005453-4057qib7	4343	10	allogenic	allogenic	JJ
cord-005453-4057qib7	4343	11	stem	stem	NN
cord-005453-4057qib7	4343	12	cell	cell	NN
cord-005453-4057qib7	4343	13	transplant	transplant	NN
cord-005453-4057qib7	4343	14	(	(	-LRB-
cord-005453-4057qib7	4343	15	SCT	SCT	NNP
cord-005453-4057qib7	4343	16	)	)	-RRB-
cord-005453-4057qib7	4343	17	and	and	CC
cord-005453-4057qib7	4343	18	vaccination	vaccination	NN
cord-005453-4057qib7	4343	19	Background	background	NN
cord-005453-4057qib7	4343	20	:	:	:
cord-005453-4057qib7	4344	1	Infectious	infectious	JJ
cord-005453-4057qib7	4344	2	diseases	disease	NNS
cord-005453-4057qib7	4344	3	are	be	VBP
cord-005453-4057qib7	4344	4	a	a	DT
cord-005453-4057qib7	4344	5	major	major	JJ
cord-005453-4057qib7	4344	6	cause	cause	NN
cord-005453-4057qib7	4344	7	of	of	IN
cord-005453-4057qib7	4344	8	morbidity	morbidity	NN
cord-005453-4057qib7	4344	9	and	and	CC
cord-005453-4057qib7	4344	10	mortality	mortality	NN
cord-005453-4057qib7	4344	11	after	after	IN
cord-005453-4057qib7	4344	12	allogenic	allogenic	JJ
cord-005453-4057qib7	4344	13	stem	stem	NN
cord-005453-4057qib7	4344	14	cell	cell	NN
cord-005453-4057qib7	4344	15	transplant	transplant	NN
cord-005453-4057qib7	4344	16	(	(	-LRB-
cord-005453-4057qib7	4344	17	SCT	SCT	NNP
cord-005453-4057qib7	4344	18	)	)	-RRB-
cord-005453-4057qib7	4344	19	.	.	.
cord-005453-4057qib7	4345	1	Vaccines	vaccine	NNS
cord-005453-4057qib7	4345	2	constitute	constitute	VBP
cord-005453-4057qib7	4345	3	an	an	DT
cord-005453-4057qib7	4345	4	effective	effective	JJ
cord-005453-4057qib7	4345	5	strategy	strategy	NN
cord-005453-4057qib7	4345	6	to	to	TO
cord-005453-4057qib7	4345	7	prevent	prevent	VB
cord-005453-4057qib7	4345	8	infections	infection	NNS
cord-005453-4057qib7	4345	9	but	but	CC
cord-005453-4057qib7	4345	10	the	the	DT
cord-005453-4057qib7	4345	11	optimal	optimal	JJ
cord-005453-4057qib7	4345	12	timing	timing	NN
cord-005453-4057qib7	4345	13	to	to	TO
cord-005453-4057qib7	4345	14	start	start	VB
cord-005453-4057qib7	4345	15	vaccinating	vaccinate	VBG
cord-005453-4057qib7	4345	16	is	be	VBZ
cord-005453-4057qib7	4345	17	not	not	RB
cord-005453-4057qib7	4345	18	well	well	RB
cord-005453-4057qib7	4345	19	stablished	stablishe	VBN
cord-005453-4057qib7	4345	20	.	.	.
cord-005453-4057qib7	4346	1	In	in	IN
cord-005453-4057qib7	4346	2	order	order	NN
cord-005453-4057qib7	4346	3	to	to	TO
cord-005453-4057qib7	4346	4	individualize	individualize	VB
cord-005453-4057qib7	4346	5	the	the	DT
cord-005453-4057qib7	4346	6	early	early	JJ
cord-005453-4057qib7	4346	7	vaccination	vaccination	NN
cord-005453-4057qib7	4346	8	schedule	schedule	NN
cord-005453-4057qib7	4346	9	,	,	,
cord-005453-4057qib7	4346	10	we	-PRON-	PRP
cord-005453-4057qib7	4346	11	studied	study	VBD
cord-005453-4057qib7	4346	12	the	the	DT
cord-005453-4057qib7	4346	13	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4346	14	subsets	subset	NNS
cord-005453-4057qib7	4346	15	involved	involve	VBN
cord-005453-4057qib7	4346	16	in	in	IN
cord-005453-4057qib7	4346	17	generating	generate	VBG
cord-005453-4057qib7	4346	18	enough	enough	JJ
cord-005453-4057qib7	4346	19	response	response	NN
cord-005453-4057qib7	4346	20	to	to	TO
cord-005453-4057qib7	4346	21	produce	produce	VB
cord-005453-4057qib7	4346	22	protective	protective	JJ
cord-005453-4057qib7	4346	23	serological	serological	JJ
cord-005453-4057qib7	4346	24	levels	level	NNS
cord-005453-4057qib7	4346	25	.	.	.
cord-005453-4057qib7	4347	1	Methods	method	NNS
cord-005453-4057qib7	4347	2	:	:	:
cord-005453-4057qib7	4347	3	We	-PRON-	PRP
cord-005453-4057qib7	4347	4	studied	study	VBD
cord-005453-4057qib7	4347	5	retrospectively	retrospectively	RB
cord-005453-4057qib7	4347	6	20	20	CD
cord-005453-4057qib7	4347	7	patients	patient	NNS
cord-005453-4057qib7	4347	8	that	that	WDT
cord-005453-4057qib7	4347	9	had	have	VBD
cord-005453-4057qib7	4347	10	undergone	undergo	VBN
cord-005453-4057qib7	4347	11	allogenic	allogenic	JJ
cord-005453-4057qib7	4347	12	SCT	SCT	NNP
cord-005453-4057qib7	4347	13	at	at	IN
cord-005453-4057qib7	4347	14	our	-PRON-	PRP$
cord-005453-4057qib7	4347	15	hospital	hospital	NN
cord-005453-4057qib7	4347	16	.	.	.
cord-005453-4057qib7	4348	1	Patient	patient	JJ
cord-005453-4057qib7	4348	2	distribution	distribution	NN
cord-005453-4057qib7	4348	3	-Age	-age	NN
cord-005453-4057qib7	4348	4	range	range	NN
cord-005453-4057qib7	4348	5	:	:	:
cord-005453-4057qib7	4348	6	21	21	CD
cord-005453-4057qib7	4348	7	-	-	SYM
cord-005453-4057qib7	4348	8	68	68	CD
cord-005453-4057qib7	4348	9	years	year	NNS
cord-005453-4057qib7	4348	10	-	-	HYPH
cord-005453-4057qib7	4348	11	old	old	JJ
cord-005453-4057qib7	4348	12	;	;	:
cord-005453-4057qib7	4348	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	4348	14	:	:	:
cord-005453-4057qib7	4348	15	acute	acute	JJ
cord-005453-4057qib7	4348	16	leukaemia	leukaemia	NN
cord-005453-4057qib7	4348	17	/	/	SYM
cord-005453-4057qib7	4348	18	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	4348	19	syndrome/	syndrome/	CD
cord-005453-4057qib7	4348	20	chronic	chronic	JJ
cord-005453-4057qib7	4348	21	myeloid	myeloid	NN
cord-005453-4057qib7	4348	22	leukemia	leukemia	NN
cord-005453-4057qib7	4348	23	(	(	-LRB-
cord-005453-4057qib7	4348	24	16	16	CD
cord-005453-4057qib7	4348	25	patients	patient	NNS
cord-005453-4057qib7	4348	26	)	)	-RRB-
cord-005453-4057qib7	4348	27	,	,	,
cord-005453-4057qib7	4348	28	lymphoma	lymphoma	NN
cord-005453-4057qib7	4348	29	(	(	-LRB-
cord-005453-4057qib7	4348	30	4	4	CD
cord-005453-4057qib7	4348	31	patients	patient	NNS
cord-005453-4057qib7	4348	32	)	)	-RRB-
cord-005453-4057qib7	4348	33	.	.	.
cord-005453-4057qib7	4349	1	Analytic	analytic	JJ
cord-005453-4057qib7	4349	2	parameters	parameter	NNS
cord-005453-4057qib7	4349	3	:	:	:
cord-005453-4057qib7	4349	4	TCD4	TCD4	NNP
cord-005453-4057qib7	4349	5	+	+	CC
cord-005453-4057qib7	4349	6	,	,	,
cord-005453-4057qib7	4349	7	TCD8	TCD8	NNP
cord-005453-4057qib7	4349	8	+	+	SYM
cord-005453-4057qib7	4349	9	,	,	,
cord-005453-4057qib7	4349	10	NK	NK	NNP
cord-005453-4057qib7	4349	11	,	,	,
cord-005453-4057qib7	4349	12	total	total	JJ
cord-005453-4057qib7	4349	13	B	b	NN
cord-005453-4057qib7	4349	14	and	and	CC
cord-005453-4057qib7	4349	15	functional	functional	JJ
cord-005453-4057qib7	4349	16	B	b	NN
cord-005453-4057qib7	4349	17	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4349	18	subsets	subset	NNS
cord-005453-4057qib7	4349	19	(	(	-LRB-
cord-005453-4057qib7	4349	20	naïve	naïve	JJ
cord-005453-4057qib7	4349	21	IgD+CD27-	IgD+CD27-	NNP
cord-005453-4057qib7	4349	22	,	,	,
cord-005453-4057qib7	4350	1	memory	memory	NN
cord-005453-4057qib7	4351	1	IgD+CD27	igd+cd27	NN
cord-005453-4057qib7	4352	1	+	+	CC
cord-005453-4057qib7	4353	1	and	and	CC
cord-005453-4057qib7	4353	2	IgD	IgD	NNP
cord-005453-4057qib7	4353	3	-	-	:
cord-005453-4057qib7	4353	4	CD27	CD27	NNP
cord-005453-4057qib7	4353	5	+	+	CC
cord-005453-4057qib7	4353	6	,	,	,
cord-005453-4057qib7	4353	7	and	and	CC
cord-005453-4057qib7	4353	8	effectors	effector	NNS
cord-005453-4057qib7	4353	9	CD27++CD38++	cd27++cd38++	JJ
cord-005453-4057qib7	4353	10	)	)	-RRB-
cord-005453-4057qib7	4353	11	.	.	.
cord-005453-4057qib7	4354	1	Immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	4354	2	levels	level	NNS
cord-005453-4057qib7	4354	3	(	(	-LRB-
cord-005453-4057qib7	4354	4	IgG	IgG	NNP
cord-005453-4057qib7	4354	5	,	,	,
cord-005453-4057qib7	4354	6	IgA	IgA	NNP
cord-005453-4057qib7	4354	7	,	,	,
cord-005453-4057qib7	4354	8	IgM	IgM	NNP
cord-005453-4057qib7	4354	9	)	)	-RRB-
cord-005453-4057qib7	4354	10	and	and	CC
cord-005453-4057qib7	4354	11	specific	specific	JJ
cord-005453-4057qib7	4354	12	IgG	igg	NN
cord-005453-4057qib7	4354	13	for	for	IN
cord-005453-4057qib7	4354	14	pneumococcus	pneumococcus	NNP
cord-005453-4057qib7	4354	15	,	,	,
cord-005453-4057qib7	4354	16	tetanus	tetanus	NN
cord-005453-4057qib7	4354	17	,	,	,
cord-005453-4057qib7	4354	18	HBV	HBV	NNP
cord-005453-4057qib7	4354	19	,	,	,
cord-005453-4057qib7	4354	20	chickenpox	chickenpox	NN
cord-005453-4057qib7	4354	21	,	,	,
cord-005453-4057qib7	4354	22	measles	measle	NNS
cord-005453-4057qib7	4354	23	,	,	,
cord-005453-4057qib7	4354	24	rubella	rubella	NN
cord-005453-4057qib7	4354	25	and	and	CC
cord-005453-4057qib7	4354	26	mumps	mump	NNS
cord-005453-4057qib7	4354	27	.	.	.
cord-005453-4057qib7	4355	1	Clinical	clinical	JJ
cord-005453-4057qib7	4355	2	parameters	parameter	NNS
cord-005453-4057qib7	4355	3	were	be	VBD
cord-005453-4057qib7	4355	4	collected	collect	VBN
cord-005453-4057qib7	4355	5	from	from	IN
cord-005453-4057qib7	4355	6	medical	medical	JJ
cord-005453-4057qib7	4355	7	records	record	NNS
cord-005453-4057qib7	4355	8	.	.	.
cord-005453-4057qib7	4356	1	Results	result	NNS
cord-005453-4057qib7	4356	2	:	:	:
cord-005453-4057qib7	4357	1	We	-PRON-	PRP
cord-005453-4057qib7	4357	2	distributed	distribute	VBD
cord-005453-4057qib7	4357	3	patients	patient	NNS
cord-005453-4057qib7	4357	4	in	in	IN
cord-005453-4057qib7	4357	5	two	two	CD
cord-005453-4057qib7	4357	6	groups	group	NNS
cord-005453-4057qib7	4357	7	,	,	,
cord-005453-4057qib7	4357	8	based	base	VBN
cord-005453-4057qib7	4357	9	on	on	IN
cord-005453-4057qib7	4357	10	the	the	DT
cord-005453-4057qib7	4357	11	timing	timing	NN
cord-005453-4057qib7	4357	12	of	of	IN
cord-005453-4057qib7	4357	13	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4357	14	analyses	analysis	NNS
cord-005453-4057qib7	4357	15	:	:	:
cord-005453-4057qib7	4357	16	-Less	-less	NN
cord-005453-4057qib7	4357	17	than	than	IN
cord-005453-4057qib7	4357	18	12	12	CD
cord-005453-4057qib7	4357	19	months	month	NNS
cord-005453-4057qib7	4357	20	since	since	IN
cord-005453-4057qib7	4357	21	SCT	SCT	NNP
cord-005453-4057qib7	4357	22	(	(	-LRB-
cord-005453-4057qib7	4357	23	5	5	CD
cord-005453-4057qib7	4357	24	patients	patient	NNS
cord-005453-4057qib7	4357	25	)	)	-RRB-
cord-005453-4057qib7	4358	1	No	no	DT
cord-005453-4057qib7	4358	2	patient	patient	NN
cord-005453-4057qib7	4358	3	showed	show	VBD
cord-005453-4057qib7	4358	4	complete	complete	JJ
cord-005453-4057qib7	4358	5	immune	immune	JJ
cord-005453-4057qib7	4358	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	4358	7	,	,	,
cord-005453-4057qib7	4358	8	although	although	IN
cord-005453-4057qib7	4358	9	2	2	CD
cord-005453-4057qib7	4358	10	had	have	VBD
cord-005453-4057qib7	4358	11	enough	enough	JJ
cord-005453-4057qib7	4358	12	T	t	NN
cord-005453-4057qib7	4358	13	and	and	CC
cord-005453-4057qib7	4358	14	functional	functional	JJ
cord-005453-4057qib7	4358	15	B	b	NN
cord-005453-4057qib7	4358	16	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	4358	17	to	to	TO
cord-005453-4057qib7	4358	18	generate	generate	VB
cord-005453-4057qib7	4358	19	response	response	NN
cord-005453-4057qib7	4358	20	to	to	IN
cord-005453-4057qib7	4358	21	vaccination	vaccination	NN
cord-005453-4057qib7	4358	22	.	.	.
cord-005453-4057qib7	4359	1	In	in	IN
cord-005453-4057qib7	4359	2	these	these	DT
cord-005453-4057qib7	4359	3	patients	patient	NNS
cord-005453-4057qib7	4359	4	,	,	,
cord-005453-4057qib7	4359	5	vaccination	vaccination	NN
cord-005453-4057qib7	4359	6	for	for	IN
cord-005453-4057qib7	4359	7	pneumococcus	pneumococcus	NNP
cord-005453-4057qib7	4359	8	was	be	VBD
cord-005453-4057qib7	4359	9	completed	complete	VBN
cord-005453-4057qib7	4359	10	and	and	CC
cord-005453-4057qib7	4359	11	they	-PRON-	PRP
cord-005453-4057qib7	4359	12	generated	generate	VBD
cord-005453-4057qib7	4359	13	sufficient	sufficient	JJ
cord-005453-4057qib7	4359	14	protection	protection	NN
cord-005453-4057qib7	4359	15	antibody	antibody	NN
cord-005453-4057qib7	4359	16	levels	level	NNS
cord-005453-4057qib7	4359	17	,	,	,
cord-005453-4057qib7	4359	18	despite	despite	IN
cord-005453-4057qib7	4359	19	being	be	VBG
cord-005453-4057qib7	4359	20	under	under	IN
cord-005453-4057qib7	4359	21	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4359	22	treatment	treatment	NN
cord-005453-4057qib7	4359	23	.	.	.
cord-005453-4057qib7	4360	1	-More	-More	.
cord-005453-4057qib7	4361	1	than	than	IN
cord-005453-4057qib7	4361	2	12	12	CD
cord-005453-4057qib7	4361	3	months	month	NNS
cord-005453-4057qib7	4361	4	since	since	IN
cord-005453-4057qib7	4361	5	SCT	SCT	NNP
cord-005453-4057qib7	4361	6	(	(	-LRB-
cord-005453-4057qib7	4361	7	15	15	CD
cord-005453-4057qib7	4361	8	patients	patient	NNS
cord-005453-4057qib7	4361	9	)	)	-RRB-
cord-005453-4057qib7	4361	10	Before	before	IN
cord-005453-4057qib7	4361	11	the	the	DT
cord-005453-4057qib7	4361	12	beginning	beginning	NN
cord-005453-4057qib7	4361	13	of	of	IN
cord-005453-4057qib7	4361	14	vaccination	vaccination	NN
cord-005453-4057qib7	4361	15	,	,	,
cord-005453-4057qib7	4361	16	we	-PRON-	PRP
cord-005453-4057qib7	4361	17	collected	collect	VBD
cord-005453-4057qib7	4361	18	specific	specific	JJ
cord-005453-4057qib7	4361	19	antibodies	antibody	NNS
cord-005453-4057qib7	4361	20	of	of	IN
cord-005453-4057qib7	4361	21	7	7	CD
cord-005453-4057qib7	4361	22	patients	patient	NNS
cord-005453-4057qib7	4361	23	.	.	.
cord-005453-4057qib7	4362	1	We	-PRON-	PRP
cord-005453-4057qib7	4362	2	compared	compare	VBD
cord-005453-4057qib7	4362	3	the	the	DT
cord-005453-4057qib7	4362	4	serological	serological	JJ
cord-005453-4057qib7	4362	5	status	status	NN
cord-005453-4057qib7	4362	6	before	before	IN
cord-005453-4057qib7	4362	7	and	and	CC
cord-005453-4057qib7	4362	8	after	after	IN
cord-005453-4057qib7	4362	9	SCT	SCT	NNP
cord-005453-4057qib7	4362	10	and	and	CC
cord-005453-4057qib7	4362	11	observed	observe	VBD
cord-005453-4057qib7	4362	12	that	that	IN
cord-005453-4057qib7	4362	13	protection	protection	NN
cord-005453-4057qib7	4362	14	against	against	IN
cord-005453-4057qib7	4362	15	tetanus	tetanus	NN
cord-005453-4057qib7	4362	16	was	be	VBD
cord-005453-4057qib7	4362	17	the	the	DT
cord-005453-4057qib7	4362	18	most	most	RBS
cord-005453-4057qib7	4362	19	frequently	frequently	RB
cord-005453-4057qib7	4362	20	preserved	preserve	VBN
cord-005453-4057qib7	4362	21	(	(	-LRB-
cord-005453-4057qib7	4362	22	6	6	CD
cord-005453-4057qib7	4362	23	patients	patient	NNS
cord-005453-4057qib7	4362	24	)	)	-RRB-
cord-005453-4057qib7	4362	25	and	and	CC
cord-005453-4057qib7	4362	26	HBV	HBV	NNP
cord-005453-4057qib7	4362	27	the	the	DT
cord-005453-4057qib7	4362	28	least	least	RBS
cord-005453-4057qib7	4362	29	frequent	frequent	JJ
cord-005453-4057qib7	4362	30	(	(	-LRB-
cord-005453-4057qib7	4362	31	2	2	CD
cord-005453-4057qib7	4362	32	patients	patient	NNS
cord-005453-4057qib7	4362	33	)	)	-RRB-
cord-005453-4057qib7	4362	34	.	.	.
cord-005453-4057qib7	4363	1	Other	other	JJ
cord-005453-4057qib7	4363	2	than	than	IN
cord-005453-4057qib7	4363	3	one	one	CD
cord-005453-4057qib7	4363	4	patient	patient	NN
cord-005453-4057qib7	4363	5	treated	treat	VBN
cord-005453-4057qib7	4363	6	with	with	IN
cord-005453-4057qib7	4363	7	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	4363	8	,	,	,
cord-005453-4057qib7	4363	9	all	all	DT
cord-005453-4057qib7	4363	10	patients	patient	NNS
cord-005453-4057qib7	4363	11	in	in	IN
cord-005453-4057qib7	4363	12	this	this	DT
cord-005453-4057qib7	4363	13	group	group	NN
cord-005453-4057qib7	4363	14	had	have	VBD
cord-005453-4057qib7	4363	15	minimum	minimum	JJ
cord-005453-4057qib7	4363	16	absolute	absolute	JJ
cord-005453-4057qib7	4363	17	count	count	NN
cord-005453-4057qib7	4363	18	of	of	IN
cord-005453-4057qib7	4363	19	TCD4	TCD4	NNP
cord-005453-4057qib7	4363	20	+	+	CC
cord-005453-4057qib7	4363	21	(	(	-LRB-
cord-005453-4057qib7	4363	22	>	>	NFP
cord-005453-4057qib7	4363	23	200	200	CD
cord-005453-4057qib7	4363	24	cells	cell	NNS
cord-005453-4057qib7	4363	25	/	/	SYM
cord-005453-4057qib7	4363	26	microl	microl	NNP
cord-005453-4057qib7	4363	27	)	)	-RRB-
cord-005453-4057qib7	4363	28	,	,	.
cord-005453-4057qib7	4364	1	TCD8	TCD8	NNP
cord-005453-4057qib7	4364	2	+	+	CC
cord-005453-4057qib7	4365	1	(	(	-LRB-
cord-005453-4057qib7	4365	2	>	>	NFP
cord-005453-4057qib7	4365	3	200	200	CD
cord-005453-4057qib7	4365	4	cells	cell	NNS
cord-005453-4057qib7	4365	5	/	/	SYM
cord-005453-4057qib7	4365	6	microl	microl	NNP
cord-005453-4057qib7	4365	7	)	)	-RRB-
cord-005453-4057qib7	4365	8	,	,	.
cord-005453-4057qib7	4366	1	NK	NK	NNP
cord-005453-4057qib7	4366	2	(	(	-LRB-
cord-005453-4057qib7	4366	3	>	>	NFP
cord-005453-4057qib7	4366	4	100	100	CD
cord-005453-4057qib7	4366	5	cells	cell	NNS
cord-005453-4057qib7	4366	6	/	/	SYM
cord-005453-4057qib7	4366	7	microl	microl	NNP
cord-005453-4057qib7	4366	8	)	)	-RRB-
cord-005453-4057qib7	4366	9	and	and	CC
cord-005453-4057qib7	4366	10	B	b	NN
cord-005453-4057qib7	4366	11	cells	cell	NNS
cord-005453-4057qib7	4366	12	(	(	-LRB-
cord-005453-4057qib7	4367	1	>	>	XX
cord-005453-4057qib7	4367	2	100	100	CD
cord-005453-4057qib7	4367	3	cells	cell	NNS
cord-005453-4057qib7	4367	4	/	/	SYM
cord-005453-4057qib7	4367	5	microl	microl	NNP
cord-005453-4057qib7	4367	6	)	)	-RRB-
cord-005453-4057qib7	4367	7	.	.	.
cord-005453-4057qib7	4368	1	We	-PRON-	PRP
cord-005453-4057qib7	4368	2	also	also	RB
cord-005453-4057qib7	4368	3	observed	observe	VBD
cord-005453-4057qib7	4368	4	presence	presence	NN
cord-005453-4057qib7	4368	5	of	of	IN
cord-005453-4057qib7	4368	6	B	B	NNP
cord-005453-4057qib7	4368	7	effector	effector	NN
cord-005453-4057qib7	4368	8	and	and	CC
cord-005453-4057qib7	4368	9	B	b	NN
cord-005453-4057qib7	4368	10	memory	memory	NN
cord-005453-4057qib7	4368	11	cells	cell	NNS
cord-005453-4057qib7	4368	12	,	,	,
cord-005453-4057qib7	4368	13	with	with	IN
cord-005453-4057qib7	4368	14	predominance	predominance	NN
cord-005453-4057qib7	4368	15	of	of	IN
cord-005453-4057qib7	4368	16	IgD	igd	NN
cord-005453-4057qib7	4368	17	-	-	:
cord-005453-4057qib7	4368	18	CD27	CD27	NNP
cord-005453-4057qib7	4368	19	+	+	CC
cord-005453-4057qib7	4368	20	memory	memory	NN
cord-005453-4057qib7	4368	21	cells	cell	NNS
cord-005453-4057qib7	4368	22	.	.	.
cord-005453-4057qib7	4369	1	Immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	4369	2	levels	level	NNS
cord-005453-4057qib7	4369	3	were	be	VBD
cord-005453-4057qib7	4369	4	within	within	IN
cord-005453-4057qib7	4369	5	the	the	DT
cord-005453-4057qib7	4369	6	normal	normal	JJ
cord-005453-4057qib7	4369	7	range	range	NN
cord-005453-4057qib7	4369	8	.	.	.
cord-005453-4057qib7	4370	1	In	in	IN
cord-005453-4057qib7	4370	2	this	this	DT
cord-005453-4057qib7	4370	3	group	group	NN
cord-005453-4057qib7	4370	4	,	,	,
cord-005453-4057qib7	4370	5	we	-PRON-	PRP
cord-005453-4057qib7	4370	6	registered	register	VBD
cord-005453-4057qib7	4370	7	vaccination	vaccination	NN
cord-005453-4057qib7	4370	8	in	in	IN
cord-005453-4057qib7	4370	9	13	13	CD
cord-005453-4057qib7	4370	10	patients	patient	NNS
cord-005453-4057qib7	4370	11	.	.	.
cord-005453-4057qib7	4371	1	All	all	DT
cord-005453-4057qib7	4371	2	of	of	IN
cord-005453-4057qib7	4371	3	them	-PRON-	PRP
cord-005453-4057qib7	4371	4	were	be	VBD
cord-005453-4057qib7	4371	5	vaccinated	vaccinate	VBN
cord-005453-4057qib7	4371	6	against	against	IN
cord-005453-4057qib7	4371	7	flu	flu	NN
cord-005453-4057qib7	4371	8	,	,	,
cord-005453-4057qib7	4371	9	and	and	CC
cord-005453-4057qib7	4371	10	11	11	CD
cord-005453-4057qib7	4371	11	against	against	IN
cord-005453-4057qib7	4371	12	pneumococcus	pneumococcus	NNP
cord-005453-4057qib7	4371	13	and	and	CC
cord-005453-4057qib7	4371	14	HBV	HBV	NNP
cord-005453-4057qib7	4371	15	.	.	.
cord-005453-4057qib7	4372	1	The	the	DT
cord-005453-4057qib7	4372	2	rest	rest	NN
cord-005453-4057qib7	4372	3	of	of	IN
cord-005453-4057qib7	4372	4	vaccines	vaccine	NNS
cord-005453-4057qib7	4372	5	administered	administer	VBN
cord-005453-4057qib7	4372	6	were	be	VBD
cord-005453-4057qib7	4372	7	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	4372	8	in	in	IN
cord-005453-4057qib7	4372	9	type	type	NN
cord-005453-4057qib7	4372	10	and	and	CC
cord-005453-4057qib7	4372	11	timing	timing	NN
cord-005453-4057qib7	4372	12	.	.	.
cord-005453-4057qib7	4373	1	6	6	CD
cord-005453-4057qib7	4373	2	patients	patient	NNS
cord-005453-4057qib7	4373	3	were	be	VBD
cord-005453-4057qib7	4373	4	under	under	IN
cord-005453-4057qib7	4373	5	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4373	6	treatment	treatment	NN
cord-005453-4057qib7	4373	7	at	at	IN
cord-005453-4057qib7	4373	8	the	the	DT
cord-005453-4057qib7	4373	9	time	time	NN
cord-005453-4057qib7	4373	10	of	of	IN
cord-005453-4057qib7	4373	11	vaccination	vaccination	NN
cord-005453-4057qib7	4373	12	and	and	CC
cord-005453-4057qib7	4373	13	were	be	VBD
cord-005453-4057qib7	4373	14	able	able	JJ
cord-005453-4057qib7	4373	15	to	to	TO
cord-005453-4057qib7	4373	16	generate	generate	VB
cord-005453-4057qib7	4373	17	enough	enough	JJ
cord-005453-4057qib7	4373	18	specific	specific	JJ
cord-005453-4057qib7	4373	19	antibodies	antibody	NNS
cord-005453-4057qib7	4373	20	for	for	IN
cord-005453-4057qib7	4373	21	pneumococcus	pneumococcus	NNP
cord-005453-4057qib7	4373	22	.	.	.
cord-005453-4057qib7	4374	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4374	2	:	:	:
cord-005453-4057qib7	4375	1	Immune	immune	JJ
cord-005453-4057qib7	4375	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	4375	3	was	be	VBD
cord-005453-4057qib7	4375	4	not	not	RB
cord-005453-4057qib7	4375	5	completed	complete	VBN
cord-005453-4057qib7	4375	6	12	12	CD
cord-005453-4057qib7	4375	7	months	month	NNS
cord-005453-4057qib7	4375	8	after	after	IN
cord-005453-4057qib7	4375	9	SCT	SCT	NNP
cord-005453-4057qib7	4375	10	,	,	,
cord-005453-4057qib7	4375	11	although	although	IN
cord-005453-4057qib7	4375	12	minimal	minimal	JJ
cord-005453-4057qib7	4375	13	immunological	immunological	JJ
cord-005453-4057qib7	4375	14	reconstitution	reconstitution	NN
cord-005453-4057qib7	4375	15	was	be	VBD
cord-005453-4057qib7	4375	16	observed	observe	VBN
cord-005453-4057qib7	4375	17	TCD4	TCD4	NNP
cord-005453-4057qib7	4375	18	+	+	CC
cord-005453-4057qib7	4375	19	and	and	CC
cord-005453-4057qib7	4376	1	no	no	DT
cord-005453-4057qib7	4376	2	-	-	HYPH
cord-005453-4057qib7	4376	3	switching	switch	VBG
cord-005453-4057qib7	4376	4	memory	memory	NN
cord-005453-4057qib7	4376	5	B	b	NN
cord-005453-4057qib7	4376	6	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	4376	7	were	be	VBD
cord-005453-4057qib7	4376	8	the	the	DT
cord-005453-4057qib7	4376	9	last	last	JJ
cord-005453-4057qib7	4376	10	ones	one	NNS
cord-005453-4057qib7	4376	11	to	to	TO
cord-005453-4057qib7	4376	12	reach	reach	VB
cord-005453-4057qib7	4376	13	minimum	minimum	JJ
cord-005453-4057qib7	4376	14	normal	normal	JJ
cord-005453-4057qib7	4376	15	values	value	NNS
cord-005453-4057qib7	4376	16	according	accord	VBG
cord-005453-4057qib7	4376	17	to	to	IN
cord-005453-4057qib7	4376	18	patient	patient	JJ
cord-005453-4057qib7	4376	19	age	age	NN
cord-005453-4057qib7	4376	20	.	.	.
cord-005453-4057qib7	4377	1	Some	some	DT
cord-005453-4057qib7	4377	2	patients	patient	NNS
cord-005453-4057qib7	4377	3	maintain	maintain	VBP
cord-005453-4057qib7	4377	4	serological	serological	JJ
cord-005453-4057qib7	4377	5	protection	protection	NN
cord-005453-4057qib7	4377	6	after	after	IN
cord-005453-4057qib7	4377	7	allogenic	allogenic	JJ
cord-005453-4057qib7	4377	8	SCT	SCT	NNP
cord-005453-4057qib7	4377	9	.	.	.
cord-005453-4057qib7	4378	1	Immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	4378	2	levels	level	NNS
cord-005453-4057qib7	4378	3	were	be	VBD
cord-005453-4057qib7	4378	4	normal	normal	JJ
cord-005453-4057qib7	4378	5	,	,	,
cord-005453-4057qib7	4378	6	suggesting	suggest	VBG
cord-005453-4057qib7	4378	7	no	no	DT
cord-005453-4057qib7	4378	8	need	need	NN
cord-005453-4057qib7	4378	9	for	for	IN
cord-005453-4057qib7	4378	10	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	4378	11	administration	administration	NN
cord-005453-4057qib7	4378	12	to	to	TO
cord-005453-4057qib7	4378	13	prevent	prevent	VB
cord-005453-4057qib7	4378	14	infections	infection	NNS
cord-005453-4057qib7	4378	15	.	.	.
cord-005453-4057qib7	4379	1	Flu	flu	NN
cord-005453-4057qib7	4379	2	,	,	,
cord-005453-4057qib7	4379	3	pneumococcus	pneumococcus	NN
cord-005453-4057qib7	4379	4	and	and	CC
cord-005453-4057qib7	4379	5	HBV	HBV	NNP
cord-005453-4057qib7	4379	6	vaccines	vaccine	NNS
cord-005453-4057qib7	4379	7	were	be	VBD
cord-005453-4057qib7	4379	8	the	the	DT
cord-005453-4057qib7	4379	9	most	most	RBS
cord-005453-4057qib7	4379	10	frequently	frequently	RB
cord-005453-4057qib7	4379	11	administered	administer	VBN
cord-005453-4057qib7	4379	12	.	.	.
cord-005453-4057qib7	4380	1	Pneumococcus	Pneumococcus	NNP
cord-005453-4057qib7	4380	2	vaccination	vaccination	NN
cord-005453-4057qib7	4380	3	generated	generate	VBD
cord-005453-4057qib7	4380	4	a	a	DT
cord-005453-4057qib7	4380	5	much	much	RB
cord-005453-4057qib7	4380	6	larger	large	JJR
cord-005453-4057qib7	4380	7	serological	serological	JJ
cord-005453-4057qib7	4380	8	response	response	NN
cord-005453-4057qib7	4380	9	than	than	IN
cord-005453-4057qib7	4380	10	HBV	HBV	NNP
cord-005453-4057qib7	4380	11	.	.	.
cord-005453-4057qib7	4381	1	This	this	DT
cord-005453-4057qib7	4381	2	seroconversion	seroconversion	NN
cord-005453-4057qib7	4381	3	occurred	occur	VBD
cord-005453-4057qib7	4381	4	in	in	IN
cord-005453-4057qib7	4381	5	patients	patient	NNS
cord-005453-4057qib7	4381	6	under	under	IN
cord-005453-4057qib7	4381	7	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4381	8	treatment	treatment	NN
cord-005453-4057qib7	4381	9	.	.	.
cord-005453-4057qib7	4382	1	The	the	DT
cord-005453-4057qib7	4382	2	analysis	analysis	NN
cord-005453-4057qib7	4382	3	of	of	IN
cord-005453-4057qib7	4382	4	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4382	5	T	T	NNP
cord-005453-4057qib7	4382	6	,	,	,
cord-005453-4057qib7	4382	7	NK	NK	NNP
cord-005453-4057qib7	4382	8	,	,	,
cord-005453-4057qib7	4382	9	B	B	NNP
cord-005453-4057qib7	4382	10	total	total	NN
cord-005453-4057qib7	4382	11	and	and	CC
cord-005453-4057qib7	4382	12	B	b	VB
cord-005453-4057qib7	4382	13	functional	functional	JJ
cord-005453-4057qib7	4382	14	subsets	subset	NNS
cord-005453-4057qib7	4382	15	could	could	MD
cord-005453-4057qib7	4382	16	be	be	VB
cord-005453-4057qib7	4382	17	useful	useful	JJ
cord-005453-4057qib7	4382	18	when	when	WRB
cord-005453-4057qib7	4382	19	programming	program	VBG
cord-005453-4057qib7	4382	20	an	an	DT
cord-005453-4057qib7	4382	21	early	early	JJ
cord-005453-4057qib7	4382	22	vaccination	vaccination	NN
cord-005453-4057qib7	4382	23	schedule	schedule	NN
cord-005453-4057qib7	4382	24	after	after	IN
cord-005453-4057qib7	4382	25	SCT	SCT	NNP
cord-005453-4057qib7	4382	26	.	.	.
cord-005453-4057qib7	4383	1	Completion	completion	NN
cord-005453-4057qib7	4383	2	of	of	IN
cord-005453-4057qib7	4383	3	the	the	DT
cord-005453-4057qib7	4383	4	vaccination	vaccination	NN
cord-005453-4057qib7	4383	5	schedule	schedule	NN
cord-005453-4057qib7	4383	6	was	be	VBD
cord-005453-4057qib7	4383	7	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	4383	8	despite	despite	IN
cord-005453-4057qib7	4383	9	giving	give	VBG
cord-005453-4057qib7	4383	10	specific	specific	JJ
cord-005453-4057qib7	4383	11	indications	indication	NNS
cord-005453-4057qib7	4383	12	.	.	.
cord-005453-4057qib7	4384	1	Therefore	therefore	RB
cord-005453-4057qib7	4384	2	a	a	DT
cord-005453-4057qib7	4384	3	more	more	RBR
cord-005453-4057qib7	4384	4	rigorous	rigorous	JJ
cord-005453-4057qib7	4384	5	supervision	supervision	NN
cord-005453-4057qib7	4384	6	of	of	IN
cord-005453-4057qib7	4384	7	the	the	DT
cord-005453-4057qib7	4384	8	process	process	NN
cord-005453-4057qib7	4384	9	may	may	MD
cord-005453-4057qib7	4384	10	be	be	VB
cord-005453-4057qib7	4384	11	required	require	VBN
cord-005453-4057qib7	4384	12	.	.	.
cord-005453-4057qib7	4385	1	Background	background	NN
cord-005453-4057qib7	4385	2	:	:	:
cord-005453-4057qib7	4386	1	The	the	DT
cord-005453-4057qib7	4386	2	significant	significant	JJ
cord-005453-4057qib7	4386	3	advances	advance	NNS
cord-005453-4057qib7	4386	4	that	that	WDT
cord-005453-4057qib7	4386	5	have	have	VBP
cord-005453-4057qib7	4386	6	been	be	VBN
cord-005453-4057qib7	4386	7	achieved	achieve	VBN
cord-005453-4057qib7	4386	8	in	in	IN
cord-005453-4057qib7	4386	9	the	the	DT
cord-005453-4057qib7	4386	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	4386	11	transplantation	transplantation	NN
cord-005453-4057qib7	4386	12	(	(	-LRB-
cord-005453-4057qib7	4386	13	alloHCT	alloHCT	NNP
cord-005453-4057qib7	4386	14	)	)	-RRB-
cord-005453-4057qib7	4386	15	field	field	NN
cord-005453-4057qib7	4386	16	,	,	,
cord-005453-4057qib7	4386	17	have	have	VBP
cord-005453-4057qib7	4386	18	resulted	result	VBN
cord-005453-4057qib7	4386	19	in	in	IN
cord-005453-4057qib7	4386	20	better	well	JJR
cord-005453-4057qib7	4386	21	post	post	JJ
cord-005453-4057qib7	4386	22	-	-	JJ
cord-005453-4057qib7	4386	23	transplant	transplant	JJ
cord-005453-4057qib7	4386	24	outcome	outcome	NN
cord-005453-4057qib7	4386	25	and	and	CC
cord-005453-4057qib7	4386	26	therefore	therefore	RB
cord-005453-4057qib7	4386	27	complications	complication	NNS
cord-005453-4057qib7	4386	28	other	other	JJ
cord-005453-4057qib7	4386	29	than	than	IN
cord-005453-4057qib7	4386	30	the	the	DT
cord-005453-4057qib7	4386	31	Graft	Graft	NNP
cord-005453-4057qib7	4386	32	vs.	vs.	IN
cord-005453-4057qib7	4386	33	Host	host	NN
cord-005453-4057qib7	4386	34	disease	disease	NN
cord-005453-4057qib7	4386	35	(	(	-LRB-
cord-005453-4057qib7	4386	36	GvHD	GvHD	NNP
cord-005453-4057qib7	4386	37	)	)	-RRB-
cord-005453-4057qib7	4386	38	or	or	CC
cord-005453-4057qib7	4386	39	disease	disease	NN
cord-005453-4057qib7	4386	40	recurrence	recurrence	NN
cord-005453-4057qib7	4386	41	become	become	VBP
cord-005453-4057qib7	4386	42	increasingly	increasingly	RB
cord-005453-4057qib7	4386	43	important	important	JJ
cord-005453-4057qib7	4386	44	.	.	.
cord-005453-4057qib7	4387	1	The	the	DT
cord-005453-4057qib7	4387	2	post	post	JJ
cord-005453-4057qib7	4387	3	transplant	transplant	NN
cord-005453-4057qib7	4387	4	metabolic	metabolic	JJ
cord-005453-4057qib7	4387	5	syndrome	syndrome	NN
cord-005453-4057qib7	4387	6	(	(	-LRB-
cord-005453-4057qib7	4387	7	PT	PT	NNP
cord-005453-4057qib7	4387	8	-	-	HYPH
cord-005453-4057qib7	4387	9	MS	MS	NNP
cord-005453-4057qib7	4387	10	)	)	-RRB-
cord-005453-4057qib7	4387	11	,	,	,
cord-005453-4057qib7	4387	12	which	which	WDT
cord-005453-4057qib7	4387	13	caused	cause	VBN
cord-005453-4057qib7	4387	14	by	by	IN
cord-005453-4057qib7	4387	15	several	several	JJ
cord-005453-4057qib7	4387	16	factors	factor	NNS
cord-005453-4057qib7	4387	17	(	(	-LRB-
cord-005453-4057qib7	4387	18	i.e.	i.e.	FW
cord-005453-4057qib7	4387	19	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4387	20	agents	agent	NNS
cord-005453-4057qib7	4387	21	,	,	,
cord-005453-4057qib7	4387	22	chemo	chemo	NN
cord-005453-4057qib7	4387	23	-	-	HYPH
cord-005453-4057qib7	4387	24	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	4387	25	,	,	,
cord-005453-4057qib7	4387	26	anti	anti	JJ
cord-005453-4057qib7	4387	27	-	-	JJ
cord-005453-4057qib7	4387	28	viral	viral	JJ
cord-005453-4057qib7	4387	29	,	,	,
cord-005453-4057qib7	4387	30	and	and	CC
cord-005453-4057qib7	4387	31	biologic	biologic	JJ
cord-005453-4057qib7	4387	32	therapies	therapy	NNS
cord-005453-4057qib7	4387	33	)	)	-RRB-
cord-005453-4057qib7	4387	34	is	be	VBZ
cord-005453-4057qib7	4387	35	a	a	DT
cord-005453-4057qib7	4387	36	well	well	RB
cord-005453-4057qib7	4387	37	known	know	VBN
cord-005453-4057qib7	4387	38	post	post	NN
cord-005453-4057qib7	4387	39	transplant	transplant	NN
cord-005453-4057qib7	4387	40	complication	complication	NN
cord-005453-4057qib7	4387	41	in	in	IN
cord-005453-4057qib7	4387	42	pediatric	pediatric	JJ
cord-005453-4057qib7	4387	43	allografted	allografte	VBN
cord-005453-4057qib7	4387	44	long	long	JJ
cord-005453-4057qib7	4387	45	-	-	HYPH
cord-005453-4057qib7	4387	46	term	term	NN
cord-005453-4057qib7	4387	47	survivors	survivor	NNS
cord-005453-4057qib7	4387	48	however	however	RB
cord-005453-4057qib7	4387	49	,	,	,
cord-005453-4057qib7	4387	50	only	only	RB
cord-005453-4057qib7	4387	51	few	few	JJ
cord-005453-4057qib7	4387	52	studies	study	NNS
cord-005453-4057qib7	4387	53	have	have	VBP
cord-005453-4057qib7	4387	54	evaluated	evaluate	VBN
cord-005453-4057qib7	4387	55	the	the	DT
cord-005453-4057qib7	4387	56	prevalence	prevalence	NN
cord-005453-4057qib7	4387	57	of	of	IN
cord-005453-4057qib7	4387	58	the	the	DT
cord-005453-4057qib7	4387	59	PT	PT	NNP
cord-005453-4057qib7	4387	60	-	-	HYPH
cord-005453-4057qib7	4387	61	MS	MS	NNP
cord-005453-4057qib7	4387	62	in	in	IN
cord-005453-4057qib7	4387	63	adults	adult	NNS
cord-005453-4057qib7	4387	64	.	.	.
cord-005453-4057qib7	4388	1	In	in	IN
cord-005453-4057qib7	4388	2	this	this	DT
cord-005453-4057qib7	4388	3	retrospective	retrospective	JJ
cord-005453-4057qib7	4388	4	study	study	NN
cord-005453-4057qib7	4388	5	,	,	,
cord-005453-4057qib7	4388	6	we	-PRON-	PRP
cord-005453-4057qib7	4388	7	sought	seek	VBD
cord-005453-4057qib7	4388	8	to	to	TO
cord-005453-4057qib7	4388	9	evaluate	evaluate	VB
cord-005453-4057qib7	4388	10	the	the	DT
cord-005453-4057qib7	4388	11	incidence	incidence	NN
cord-005453-4057qib7	4388	12	,	,	,
cord-005453-4057qib7	4388	13	the	the	DT
cord-005453-4057qib7	4388	14	risk	risk	NN
cord-005453-4057qib7	4388	15	factors	factor	NNS
cord-005453-4057qib7	4388	16	and	and	CC
cord-005453-4057qib7	4388	17	the	the	DT
cord-005453-4057qib7	4388	18	impact	impact	NN
cord-005453-4057qib7	4388	19	of	of	IN
cord-005453-4057qib7	4388	20	the	the	DT
cord-005453-4057qib7	4388	21	PT	PT	NNP
cord-005453-4057qib7	4388	22	-	-	HYPH
cord-005453-4057qib7	4388	23	MS	MS	NNP
cord-005453-4057qib7	4388	24	on	on	IN
cord-005453-4057qib7	4388	25	the	the	DT
cord-005453-4057qib7	4388	26	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4388	27	outcome	outcome	NN
cord-005453-4057qib7	4388	28	.	.	.
cord-005453-4057qib7	4389	1	Methods	method	NNS
cord-005453-4057qib7	4389	2	:	:	:
cord-005453-4057qib7	4389	3	Since	since	IN
cord-005453-4057qib7	4389	4	2011	2011	CD
cord-005453-4057qib7	4389	5	,	,	,
cord-005453-4057qib7	4389	6	42	42	CD
cord-005453-4057qib7	4389	7	patients	patient	NNS
cord-005453-4057qib7	4389	8	(	(	-LRB-
cord-005453-4057qib7	4389	9	25	25	CD
cord-005453-4057qib7	4389	10	males	male	NNS
cord-005453-4057qib7	4389	11	and	and	CC
cord-005453-4057qib7	4389	12	17	17	CD
cord-005453-4057qib7	4389	13	females	female	NNS
cord-005453-4057qib7	4389	14	)	)	-RRB-
cord-005453-4057qib7	4389	15	with	with	IN
cord-005453-4057qib7	4389	16	adequate	adequate	JJ
cord-005453-4057qib7	4389	17	clinical	clinical	JJ
cord-005453-4057qib7	4389	18	and	and	CC
cord-005453-4057qib7	4389	19	laboratory	laboratory	NN
cord-005453-4057qib7	4389	20	data	datum	NNS
cord-005453-4057qib7	4389	21	and	and	CC
cord-005453-4057qib7	4389	22	a	a	DT
cord-005453-4057qib7	4389	23	minimum	minimum	JJ
cord-005453-4057qib7	4389	24	follow	follow	NN
cord-005453-4057qib7	4389	25	-	-	HYPH
cord-005453-4057qib7	4389	26	up	up	NN
cord-005453-4057qib7	4389	27	of	of	IN
cord-005453-4057qib7	4389	28	6	6	CD
cord-005453-4057qib7	4389	29	months	month	NNS
cord-005453-4057qib7	4389	30	were	be	VBD
cord-005453-4057qib7	4389	31	included	include	VBN
cord-005453-4057qib7	4389	32	in	in	IN
cord-005453-4057qib7	4389	33	the	the	DT
cord-005453-4057qib7	4389	34	study	study	NN
cord-005453-4057qib7	4389	35	.	.	.
cord-005453-4057qib7	4390	1	Their	-PRON-	PRP$
cord-005453-4057qib7	4390	2	median	median	JJ
cord-005453-4057qib7	4390	3	age	age	NN
cord-005453-4057qib7	4390	4	was	be	VBD
cord-005453-4057qib7	4390	5	35.5	35.5	CD
cord-005453-4057qib7	4390	6	(	(	-LRB-
cord-005453-4057qib7	4390	7	17	17	CD
cord-005453-4057qib7	4390	8	-	-	SYM
cord-005453-4057qib7	4390	9	62	62	CD
cord-005453-4057qib7	4390	10	)	)	-RRB-
cord-005453-4057qib7	4390	11	years	year	NNS
cord-005453-4057qib7	4390	12	and	and	CC
cord-005453-4057qib7	4390	13	after	after	IN
cord-005453-4057qib7	4390	14	a	a	DT
cord-005453-4057qib7	4390	15	myeloablative	myeloablative	NNP
cord-005453-4057qib7	4390	16	(	(	-LRB-
cord-005453-4057qib7	4390	17	n=28	n=28	NN
cord-005453-4057qib7	4390	18	)	)	-RRB-
cord-005453-4057qib7	4390	19	or	or	CC
cord-005453-4057qib7	4390	20	a	a	DT
cord-005453-4057qib7	4390	21	reduced	reduce	VBN
cord-005453-4057qib7	4390	22	intensity	intensity	NN
cord-005453-4057qib7	4391	1	(	(	-LRB-
cord-005453-4057qib7	4391	2	n=14	n=14	NNP
cord-005453-4057qib7	4391	3	)	)	-RRB-
cord-005453-4057qib7	4391	4	regimen	regimen	NN
cord-005453-4057qib7	4391	5	they	-PRON-	PRP
cord-005453-4057qib7	4391	6	received	receive	VBD
cord-005453-4057qib7	4391	7	either	either	CC
cord-005453-4057qib7	4391	8	mobilized	mobilize	VBD
cord-005453-4057qib7	4391	9	peripheral	peripheral	JJ
cord-005453-4057qib7	4391	10	blood	blood	NN
cord-005453-4057qib7	4391	11	stem	stem	NN
cord-005453-4057qib7	4391	12	cells	cell	NNS
cord-005453-4057qib7	4391	13	(	(	-LRB-
cord-005453-4057qib7	4391	14	n=34	n=34	NNP
cord-005453-4057qib7	4391	15	)	)	-RRB-
cord-005453-4057qib7	4391	16	or	or	CC
cord-005453-4057qib7	4391	17	marrow	marrow	NN
cord-005453-4057qib7	4391	18	graft	graft	NN
cord-005453-4057qib7	4391	19	(	(	-LRB-
cord-005453-4057qib7	4391	20	n=8	n=8	NN
cord-005453-4057qib7	4391	21	)	)	-RRB-
cord-005453-4057qib7	4391	22	,	,	,
cord-005453-4057qib7	4391	23	originated	originate	VBD
cord-005453-4057qib7	4391	24	from	from	IN
cord-005453-4057qib7	4391	25	full	full	RB
cord-005453-4057qib7	4391	26	-	-	HYPH
cord-005453-4057qib7	4391	27	matched	match	VBN
cord-005453-4057qib7	4391	28	siblings	sibling	NNS
cord-005453-4057qib7	4391	29	(	(	-LRB-
cord-005453-4057qib7	4391	30	n=35	n=35	NNP
cord-005453-4057qib7	4391	31	)	)	-RRB-
cord-005453-4057qib7	4391	32	or	or	CC
cord-005453-4057qib7	4391	33	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4391	34	donors	donor	NNS
cord-005453-4057qib7	4391	35	(	(	-LRB-
cord-005453-4057qib7	4391	36	n=7	n=7	NNS
cord-005453-4057qib7	4391	37	)	)	-RRB-
cord-005453-4057qib7	4391	38	.	.	.
cord-005453-4057qib7	4392	1	Calcineurin	Calcineurin	NNP
cord-005453-4057qib7	4392	2	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4392	3	plus	plus	CC
cord-005453-4057qib7	4392	4	either	either	CC
cord-005453-4057qib7	4392	5	short	short	JJ
cord-005453-4057qib7	4392	6	-	-	HYPH
cord-005453-4057qib7	4392	7	term	term	NN
cord-005453-4057qib7	4392	8	Methotrexate	Methotrexate	NNP
cord-005453-4057qib7	4392	9	or	or	CC
cord-005453-4057qib7	4392	10	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	4392	11	Mofetil	Mofetil	NNP
cord-005453-4057qib7	4392	12	were	be	VBD
cord-005453-4057qib7	4392	13	given	give	VBN
cord-005453-4057qib7	4392	14	as	as	IN
cord-005453-4057qib7	4392	15	GvHD	GvHD	NNP
cord-005453-4057qib7	4392	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4392	17	.	.	.
cord-005453-4057qib7	4393	1	The	the	DT
cord-005453-4057qib7	4393	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	4393	3	of	of	IN
cord-005453-4057qib7	4393	4	PT	PT	NNP
cord-005453-4057qib7	4393	5	-	-	HYPH
cord-005453-4057qib7	4393	6	MS	MS	NNP
cord-005453-4057qib7	4393	7	was	be	VBD
cord-005453-4057qib7	4393	8	based	base	VBN
cord-005453-4057qib7	4393	9	on	on	IN
cord-005453-4057qib7	4393	10	the	the	DT
cord-005453-4057qib7	4393	11	NCEP	NCEP	NNP
cord-005453-4057qib7	4393	12	-	-	HYPH
cord-005453-4057qib7	4393	13	ATPIII	ATPIII	NNP
cord-005453-4057qib7	4393	14	criteria	criterion	NNS
cord-005453-4057qib7	4393	15	;	;	:
cord-005453-4057qib7	4393	16	for	for	IN
cord-005453-4057qib7	4393	17	patients	patient	NNS
cord-005453-4057qib7	4393	18	with	with	IN
cord-005453-4057qib7	4393	19	unknown	unknown	JJ
cord-005453-4057qib7	4393	20	data	datum	NNS
cord-005453-4057qib7	4393	21	for	for	IN
cord-005453-4057qib7	4393	22	abdominal	abdominal	JJ
cord-005453-4057qib7	4393	23	circumference	circumference	NN
cord-005453-4057qib7	4393	24	the	the	DT
cord-005453-4057qib7	4393	25	body	body	NN
cord-005453-4057qib7	4393	26	mass	mass	NN
cord-005453-4057qib7	4393	27	index	index	NN
cord-005453-4057qib7	4393	28	(	(	-LRB-
cord-005453-4057qib7	4393	29	BMI	BMI	NNP
cord-005453-4057qib7	4393	30	)	)	-RRB-
cord-005453-4057qib7	4393	31	≥25kg	≥25kg	NNP
cord-005453-4057qib7	4393	32	/	/	SYM
cord-005453-4057qib7	4393	33	m	m	NNP
cord-005453-4057qib7	4393	34	2	2	CD
cord-005453-4057qib7	4393	35	was	be	VBD
cord-005453-4057qib7	4393	36	consider	consider	JJ
cord-005453-4057qib7	4393	37	as	as	IN
cord-005453-4057qib7	4393	38	a	a	DT
cord-005453-4057qib7	4393	39	criterion	criterion	NN
cord-005453-4057qib7	4393	40	for	for	IN
cord-005453-4057qib7	4393	41	PT	PT	NNP
cord-005453-4057qib7	4393	42	-	-	HYPH
cord-005453-4057qib7	4393	43	MS	MS	NNP
cord-005453-4057qib7	4393	44	diagnosis	diagnosis	NN
cord-005453-4057qib7	4393	45	.	.	.
cord-005453-4057qib7	4394	1	The	the	DT
cord-005453-4057qib7	4394	2	independent	independent	JJ
cord-005453-4057qib7	4394	3	T	t	NN
cord-005453-4057qib7	4394	4	-	-	HYPH
cord-005453-4057qib7	4394	5	test	test	NN
cord-005453-4057qib7	4394	6	,	,	,
cord-005453-4057qib7	4394	7	logistic	logistic	JJ
cord-005453-4057qib7	4394	8	regression	regression	NN
cord-005453-4057qib7	4394	9	analysis	analysis	NN
cord-005453-4057qib7	4394	10	and	and	CC
cord-005453-4057qib7	4394	11	logrank	logrank	NN
cord-005453-4057qib7	4394	12	tests	test	NNS
cord-005453-4057qib7	4394	13	were	be	VBD
cord-005453-4057qib7	4394	14	used	use	VBN
cord-005453-4057qib7	4394	15	for	for	IN
cord-005453-4057qib7	4394	16	the	the	DT
cord-005453-4057qib7	4394	17	statistical	statistical	JJ
cord-005453-4057qib7	4394	18	analysis	analysis	NN
cord-005453-4057qib7	4394	19	.	.	.
cord-005453-4057qib7	4395	1	Results	result	NNS
cord-005453-4057qib7	4395	2	:	:	:
cord-005453-4057qib7	4396	1	Twenty	twenty	CD
cord-005453-4057qib7	4396	2	(	(	-LRB-
cord-005453-4057qib7	4396	3	47.6	47.6	CD
cord-005453-4057qib7	4396	4	%	%	NN
cord-005453-4057qib7	4396	5	)	)	-RRB-
cord-005453-4057qib7	4396	6	patients	patient	NNS
cord-005453-4057qib7	4396	7	(	(	-LRB-
cord-005453-4057qib7	4396	8	12	12	CD
cord-005453-4057qib7	4396	9	males	male	NNS
cord-005453-4057qib7	4396	10	,	,	,
cord-005453-4057qib7	4396	11	8	8	CD
cord-005453-4057qib7	4396	12	females	female	NNS
cord-005453-4057qib7	4396	13	)	)	-RRB-
cord-005453-4057qib7	4396	14	assessed	assess	VBN
cord-005453-4057qib7	4396	15	to	to	TO
cord-005453-4057qib7	4396	16	have	have	VB
cord-005453-4057qib7	4396	17	PT	PT	NNP
cord-005453-4057qib7	4396	18	-	-	HYPH
cord-005453-4057qib7	4396	19	MS	MS	NNP
cord-005453-4057qib7	4396	20	within	within	IN
cord-005453-4057qib7	4396	21	the	the	DT
cord-005453-4057qib7	4396	22	first	first	JJ
cord-005453-4057qib7	4396	23	6	6	CD
cord-005453-4057qib7	4396	24	months	month	NNS
cord-005453-4057qib7	4396	25	following	follow	VBG
cord-005453-4057qib7	4396	26	the	the	DT
cord-005453-4057qib7	4396	27	allograft	allograft	NN
cord-005453-4057qib7	4396	28	.	.	.
cord-005453-4057qib7	4397	1	Seventeen	seventeen	CD
cord-005453-4057qib7	4397	2	diagnosed	diagnose	VBN
cord-005453-4057qib7	4397	3	after	after	IN
cord-005453-4057qib7	4397	4	the	the	DT
cord-005453-4057qib7	4397	5	1	1	CD
cord-005453-4057qib7	4397	6	st	st	NNP
cord-005453-4057qib7	4397	7	trimester	trimester	NNP
cord-005453-4057qib7	4397	8	post	post	NNP
cord-005453-4057qib7	4398	1	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4398	2	and	and	CC
cord-005453-4057qib7	4398	3	additional	additional	JJ
cord-005453-4057qib7	4398	4	3	3	CD
cord-005453-4057qib7	4398	5	patients	patient	NNS
cord-005453-4057qib7	4398	6	after	after	IN
cord-005453-4057qib7	4398	7	2	2	CD
cord-005453-4057qib7	4398	8	nd	nd	NNP
cord-005453-4057qib7	4398	9	trimester	trimester	NN
cord-005453-4057qib7	4398	10	.	.	.
cord-005453-4057qib7	4399	1	Sixteen	sixteen	CD
cord-005453-4057qib7	4399	2	out	out	IN
cord-005453-4057qib7	4399	3	of	of	IN
cord-005453-4057qib7	4399	4	20	20	CD
cord-005453-4057qib7	4399	5	patients	patient	NNS
cord-005453-4057qib7	4399	6	had	have	VBD
cord-005453-4057qib7	4399	7	elevated	elevate	VBN
cord-005453-4057qib7	4399	8	glucose	glucose	NN
cord-005453-4057qib7	4399	9	and	and	CC
cord-005453-4057qib7	4399	10	BMI>25kg	BMI>25kg	NNP
cord-005453-4057qib7	4399	11	/	/	SYM
cord-005453-4057qib7	4399	12	m	m	NN
cord-005453-4057qib7	4399	13	2	2	CD
cord-005453-4057qib7	4399	14	,	,	,
cord-005453-4057qib7	4399	15	13/20	13/20	CD
cord-005453-4057qib7	4399	16	elevated	elevate	VBN
cord-005453-4057qib7	4399	17	triglycerides	triglyceride	NNS
cord-005453-4057qib7	4399	18	levels	level	NNS
cord-005453-4057qib7	4399	19	,	,	,
cord-005453-4057qib7	4399	20	12/20	12/20	CD
cord-005453-4057qib7	4399	21	low	low	JJ
cord-005453-4057qib7	4399	22	HDL	HDL	NNP
cord-005453-4057qib7	4399	23	levels	level	NNS
cord-005453-4057qib7	4399	24	and	and	CC
cord-005453-4057qib7	4399	25	10/20	10/20	CD
cord-005453-4057qib7	4399	26	hypertension	hypertension	NN
cord-005453-4057qib7	4399	27	.	.	.
cord-005453-4057qib7	4400	1	Four	four	CD
cord-005453-4057qib7	4400	2	(	(	-LRB-
cord-005453-4057qib7	4400	3	20	20	CD
cord-005453-4057qib7	4400	4	%	%	NN
cord-005453-4057qib7	4400	5	)	)	-RRB-
cord-005453-4057qib7	4400	6	had	have	VBD
cord-005453-4057qib7	4400	7	already	already	RB
cord-005453-4057qib7	4400	8	known	know	VBN
cord-005453-4057qib7	4400	9	history	history	NN
cord-005453-4057qib7	4400	10	of	of	IN
cord-005453-4057qib7	4400	11	MS	MS	NNP
cord-005453-4057qib7	4400	12	before	before	IN
cord-005453-4057qib7	4400	13	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4400	14	(	(	-LRB-
cord-005453-4057qib7	4400	15	for	for	IN
cord-005453-4057qib7	4400	16	10	10	CD
cord-005453-4057qib7	4400	17	patients	patient	NNS
cord-005453-4057qib7	4401	1	no	no	DT
cord-005453-4057qib7	4401	2	data	datum	NNS
cord-005453-4057qib7	4401	3	were	be	VBD
cord-005453-4057qib7	4401	4	available	available	JJ
cord-005453-4057qib7	4401	5	for	for	IN
cord-005453-4057qib7	4401	6	MS	MS	NNP
cord-005453-4057qib7	4401	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	4401	8	before	before	IN
cord-005453-4057qib7	4401	9	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4401	10	)	)	-RRB-
cord-005453-4057qib7	4401	11	.	.	.
cord-005453-4057qib7	4402	1	Interestingly	interestingly	RB
cord-005453-4057qib7	4402	2	,	,	,
cord-005453-4057qib7	4402	3	for	for	IN
cord-005453-4057qib7	4402	4	7/20(35	7/20(35	CD
cord-005453-4057qib7	4402	5	%	%	NN
cord-005453-4057qib7	4402	6	)	)	-RRB-
cord-005453-4057qib7	4402	7	patients	patient	NNS
cord-005453-4057qib7	4402	8	who	who	WP
cord-005453-4057qib7	4402	9	had	have	VBD
cord-005453-4057qib7	4402	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	4402	11	with	with	IN
cord-005453-4057qib7	4402	12	PT	PT	NNP
cord-005453-4057qib7	4402	13	-	-	HYPH
cord-005453-4057qib7	4402	14	MS	MS	NNP
cord-005453-4057qib7	4402	15	either	either	CC
cord-005453-4057qib7	4402	16	in	in	IN
cord-005453-4057qib7	4402	17	the	the	DT
cord-005453-4057qib7	4402	18	1	1	CD
cord-005453-4057qib7	4402	19	st	st	NNP
cord-005453-4057qib7	4402	20	or	or	CC
cord-005453-4057qib7	4402	21	in	in	IN
cord-005453-4057qib7	4402	22	the	the	DT
cord-005453-4057qib7	4402	23	2	2	CD
cord-005453-4057qib7	4402	24	nd	nd	NNP
cord-005453-4057qib7	4402	25	trimester	trimester	NNP
cord-005453-4057qib7	4402	26	the	the	DT
cord-005453-4057qib7	4402	27	syndrome	syndrome	NN
cord-005453-4057qib7	4402	28	was	be	VBD
cord-005453-4057qib7	4402	29	reversible	reversible	JJ
cord-005453-4057qib7	4402	30	and	and	CC
cord-005453-4057qib7	4402	31	did	do	VBD
cord-005453-4057qib7	4402	32	not	not	RB
cord-005453-4057qib7	4402	33	fulfill	fulfill	VB
cord-005453-4057qib7	4402	34	the	the	DT
cord-005453-4057qib7	4402	35	criteria	criterion	NNS
cord-005453-4057qib7	4402	36	for	for	IN
cord-005453-4057qib7	4402	37	PT	PT	NNP
cord-005453-4057qib7	4402	38	-	-	HYPH
cord-005453-4057qib7	4402	39	MS	MS	NNP
cord-005453-4057qib7	4402	40	beyond	beyond	IN
cord-005453-4057qib7	4402	41	6	6	CD
cord-005453-4057qib7	4402	42	months	month	NNS
cord-005453-4057qib7	4402	43	post	post	NN
cord-005453-4057qib7	4402	44	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4402	45	.	.	.
cord-005453-4057qib7	4403	1	Patients	patient	NNS
cord-005453-4057qib7	4403	2	'	'	POS
cord-005453-4057qib7	4403	3	gender	gender	NN
cord-005453-4057qib7	4403	4	,	,	,
cord-005453-4057qib7	4403	5	age	age	NN
cord-005453-4057qib7	4403	6	,	,	,
cord-005453-4057qib7	4403	7	BMI	BMI	NNP
cord-005453-4057qib7	4403	8	,	,	,
cord-005453-4057qib7	4403	9	the	the	DT
cord-005453-4057qib7	4403	10	type	type	NN
cord-005453-4057qib7	4403	11	of	of	IN
cord-005453-4057qib7	4403	12	conditioning	conditioning	NN
cord-005453-4057qib7	4403	13	regimen	regimen	NN
cord-005453-4057qib7	4403	14	and	and	CC
cord-005453-4057qib7	4403	15	GvHD	gvhd	NN
cord-005453-4057qib7	4403	16	co	co	NN
cord-005453-4057qib7	4403	17	-	-	NN
cord-005453-4057qib7	4403	18	existence	existence	NN
cord-005453-4057qib7	4403	19	evaluated	evaluate	VBN
cord-005453-4057qib7	4403	20	as	as	IN
cord-005453-4057qib7	4403	21	potential	potential	JJ
cord-005453-4057qib7	4403	22	predisposing	predispose	VBG
cord-005453-4057qib7	4403	23	factors	factor	NNS
cord-005453-4057qib7	4403	24	for	for	IN
cord-005453-4057qib7	4403	25	PT	PT	NNP
cord-005453-4057qib7	4403	26	-	-	HYPH
cord-005453-4057qib7	4403	27	MS	MS	NNP
cord-005453-4057qib7	4403	28	diagnosis	diagnosis	NN
cord-005453-4057qib7	4403	29	.	.	.
cord-005453-4057qib7	4404	1	In	in	IN
cord-005453-4057qib7	4404	2	univariate	univariate	JJ
cord-005453-4057qib7	4404	3	and	and	CC
cord-005453-4057qib7	4404	4	multivariate	multivariate	JJ
cord-005453-4057qib7	4404	5	analysis	analysis	NN
cord-005453-4057qib7	4404	6	only	only	RB
cord-005453-4057qib7	4404	7	the	the	DT
cord-005453-4057qib7	4404	8	:	:	:
cord-005453-4057qib7	4404	9	BMI>25kg	BMI>25kg	NNP
cord-005453-4057qib7	4404	10	/	/	SYM
cord-005453-4057qib7	4404	11	m	m	NN
cord-005453-4057qib7	4404	12	2	2	CD
cord-005453-4057qib7	4404	13	and	and	CC
cord-005453-4057qib7	4404	14	age>35	age>35	CD
cord-005453-4057qib7	4404	15	years	year	NNS
cord-005453-4057qib7	4404	16	were	be	VBD
cord-005453-4057qib7	4404	17	detected	detect	VBN
cord-005453-4057qib7	4404	18	as	as	IN
cord-005453-4057qib7	4404	19	significant	significant	JJ
cord-005453-4057qib7	4404	20	risk	risk	NN
cord-005453-4057qib7	4404	21	factors	factor	NNS
cord-005453-4057qib7	4404	22	(	(	-LRB-
cord-005453-4057qib7	4404	23	p	p	NN
cord-005453-4057qib7	4404	24	<	<	XX
cord-005453-4057qib7	4404	25	0.03	0.03	CD
cord-005453-4057qib7	4404	26	)	)	-RRB-
cord-005453-4057qib7	4404	27	.	.	.
cord-005453-4057qib7	4405	1	The	the	DT
cord-005453-4057qib7	4405	2	PT	PT	NNP
cord-005453-4057qib7	4405	3	-	-	HYPH
cord-005453-4057qib7	4405	4	MS	MS	NNP
cord-005453-4057qib7	4405	5	did	do	VBD
cord-005453-4057qib7	4405	6	not	not	RB
cord-005453-4057qib7	4405	7	affected	affect	VBN
cord-005453-4057qib7	4405	8	negatively	negatively	RB
cord-005453-4057qib7	4405	9	the	the	DT
cord-005453-4057qib7	4405	10	survival	survival	NN
cord-005453-4057qib7	4405	11	or	or	CC
cord-005453-4057qib7	4405	12	the	the	DT
cord-005453-4057qib7	4405	13	NRM	NRM	NNP
cord-005453-4057qib7	4406	1	incidence	incidence	NN
cord-005453-4057qib7	4406	2	post	post	NN
cord-005453-4057qib7	4406	3	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4406	4	Conclusions	conclusion	NNS
cord-005453-4057qib7	4406	5	:	:	:
cord-005453-4057qib7	4407	1	In	in	IN
cord-005453-4057qib7	4407	2	our	-PRON-	PRP$
cord-005453-4057qib7	4407	3	study	study	NN
cord-005453-4057qib7	4407	4	,	,	,
cord-005453-4057qib7	4407	5	in	in	IN
cord-005453-4057qib7	4407	6	agreement	agreement	NN
cord-005453-4057qib7	4407	7	with	with	IN
cord-005453-4057qib7	4407	8	other	other	JJ
cord-005453-4057qib7	4407	9	publications	publication	NNS
cord-005453-4057qib7	4407	10	,	,	,
cord-005453-4057qib7	4407	11	we	-PRON-	PRP
cord-005453-4057qib7	4407	12	demonstrated	demonstrate	VBD
cord-005453-4057qib7	4407	13	that	that	IN
cord-005453-4057qib7	4407	14	the	the	DT
cord-005453-4057qib7	4407	15	PT	PT	NNP
cord-005453-4057qib7	4407	16	-	-	HYPH
cord-005453-4057qib7	4407	17	MS	MS	NNP
cord-005453-4057qib7	4407	18	is	be	VBZ
cord-005453-4057qib7	4407	19	not	not	RB
cord-005453-4057qib7	4407	20	an	an	DT
cord-005453-4057qib7	4407	21	uncommon	uncommon	JJ
cord-005453-4057qib7	4407	22	complication	complication	NN
cord-005453-4057qib7	4407	23	post	post	NN
cord-005453-4057qib7	4407	24	in	in	IN
cord-005453-4057qib7	4407	25	the	the	DT
cord-005453-4057qib7	4407	26	early	early	JJ
cord-005453-4057qib7	4407	27	post	post	JJ
cord-005453-4057qib7	4407	28	transplant	transplant	NN
cord-005453-4057qib7	4407	29	period	period	NN
cord-005453-4057qib7	4407	30	however	however	RB
cord-005453-4057qib7	4407	31	,	,	,
cord-005453-4057qib7	4407	32	for	for	IN
cord-005453-4057qib7	4407	33	a	a	DT
cord-005453-4057qib7	4407	34	significant	significant	JJ
cord-005453-4057qib7	4407	35	number	number	NN
cord-005453-4057qib7	4407	36	of	of	IN
cord-005453-4057qib7	4407	37	patients	patient	NNS
cord-005453-4057qib7	4407	38	the	the	DT
cord-005453-4057qib7	4407	39	syndrome	syndrome	NN
cord-005453-4057qib7	4407	40	was	be	VBD
cord-005453-4057qib7	4407	41	a	a	DT
cord-005453-4057qib7	4407	42	reversible	reversible	JJ
cord-005453-4057qib7	4407	43	.	.	.
cord-005453-4057qib7	4408	1	For	for	IN
cord-005453-4057qib7	4408	2	patients	patient	NNS
cord-005453-4057qib7	4408	3	with	with	IN
cord-005453-4057qib7	4408	4	high	high	JJ
cord-005453-4057qib7	4408	5	risk	risk	NN
cord-005453-4057qib7	4408	6	features	feature	NNS
cord-005453-4057qib7	4408	7	(	(	-LRB-
cord-005453-4057qib7	4408	8	BMI>25kg	BMI>25kg	NNP
cord-005453-4057qib7	4408	9	/	/	SYM
cord-005453-4057qib7	4408	10	m	m	NN
cord-005453-4057qib7	4408	11	2	2	CD
cord-005453-4057qib7	4408	12	,	,	,
cord-005453-4057qib7	4408	13	age	age	NN
cord-005453-4057qib7	4408	14	>	>	XX
cord-005453-4057qib7	4408	15	35	35	CD
cord-005453-4057qib7	4408	16	years	year	NNS
cord-005453-4057qib7	4408	17	,	,	,
cord-005453-4057qib7	4408	18	known	know	VBN
cord-005453-4057qib7	4408	19	history	history	NN
cord-005453-4057qib7	4408	20	of	of	IN
cord-005453-4057qib7	4408	21	diabetes	diabetes	NN
cord-005453-4057qib7	4408	22	-	-	HYPH
cord-005453-4057qib7	4408	23	mellitus	mellitus	NN
cord-005453-4057qib7	4408	24	,	,	,
cord-005453-4057qib7	4408	25	dyslipidemia	dyslipidemia	NN
cord-005453-4057qib7	4408	26	,	,	,
cord-005453-4057qib7	4408	27	hypertension	hypertension	NN
cord-005453-4057qib7	4408	28	)	)	-RRB-
cord-005453-4057qib7	4408	29	apart	apart	RB
cord-005453-4057qib7	4408	30	of	of	IN
cord-005453-4057qib7	4408	31	close	close	JJ
cord-005453-4057qib7	4408	32	monitoring	monitoring	NN
cord-005453-4057qib7	4408	33	,	,	,
cord-005453-4057qib7	4408	34	specific	specific	JJ
cord-005453-4057qib7	4408	35	diet	diet	NN
cord-005453-4057qib7	4408	36	and	and	CC
cord-005453-4057qib7	4408	37	encouragement	encouragement	NN
cord-005453-4057qib7	4408	38	for	for	IN
cord-005453-4057qib7	4408	39	adequate	adequate	JJ
cord-005453-4057qib7	4408	40	exercise	exercise	NN
cord-005453-4057qib7	4408	41	might	may	MD
cord-005453-4057qib7	4408	42	help	help	VB
cord-005453-4057qib7	4408	43	to	to	TO
cord-005453-4057qib7	4408	44	reduce	reduce	VB
cord-005453-4057qib7	4408	45	the	the	DT
cord-005453-4057qib7	4408	46	incidence	incidence	NN
cord-005453-4057qib7	4408	47	and	and	CC
cord-005453-4057qib7	4408	48	the	the	DT
cord-005453-4057qib7	4408	49	severity	severity	NN
cord-005453-4057qib7	4408	50	of	of	IN
cord-005453-4057qib7	4408	51	PT	PT	NNP
cord-005453-4057qib7	4408	52	-	-	HYPH
cord-005453-4057qib7	4408	53	MS	MS	NNP
cord-005453-4057qib7	4408	54	.	.	.
cord-005453-4057qib7	4409	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	4409	2	,	,	,
cord-005453-4057qib7	4409	3	prospective	prospective	JJ
cord-005453-4057qib7	4409	4	and	and	CC
cord-005453-4057qib7	4409	5	well	well	JJ
cord-005453-4057qib7	4409	6	design	design	NN
cord-005453-4057qib7	4409	7	trials	trial	NNS
cord-005453-4057qib7	4409	8	are	be	VBP
cord-005453-4057qib7	4409	9	warranted	warrant	VBN
cord-005453-4057qib7	4409	10	to	to	TO
cord-005453-4057qib7	4409	11	determine	determine	VB
cord-005453-4057qib7	4409	12	the	the	DT
cord-005453-4057qib7	4409	13	accurate	accurate	JJ
cord-005453-4057qib7	4409	14	incidence	incidence	NN
cord-005453-4057qib7	4409	15	,	,	,
cord-005453-4057qib7	4409	16	severity	severity	NN
cord-005453-4057qib7	4409	17	and	and	CC
cord-005453-4057qib7	4409	18	the	the	DT
cord-005453-4057qib7	4409	19	impact	impact	NN
cord-005453-4057qib7	4409	20	of	of	IN
cord-005453-4057qib7	4409	21	PT	PT	NNP
cord-005453-4057qib7	4409	22	-	-	HYPH
cord-005453-4057qib7	4409	23	MS	MS	NNP
cord-005453-4057qib7	4409	24	on	on	IN
cord-005453-4057qib7	4409	25	the	the	DT
cord-005453-4057qib7	4409	26	alloSCT	alloSCT	NNP
cord-005453-4057qib7	4409	27	outcome	outcome	NN
cord-005453-4057qib7	4409	28	.	.	.
cord-005453-4057qib7	4410	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4410	2	:	:	:
cord-005453-4057qib7	4410	3	No	no	DT
cord-005453-4057qib7	4410	4	conflict	conflict	NN
cord-005453-4057qib7	4411	1	ofinterest	ofinterest	NNP
cord-005453-4057qib7	4411	2	Experience	experience	NN
cord-005453-4057qib7	4411	3	of	of	IN
cord-005453-4057qib7	4411	4	a	a	DT
cord-005453-4057qib7	4411	5	single	single	JJ
cord-005453-4057qib7	4411	6	center	center	NN
cord-005453-4057qib7	4411	7	in	in	IN
cord-005453-4057qib7	4411	8	the	the	DT
cord-005453-4057qib7	4411	9	humanization	humanization	NN
cord-005453-4057qib7	4411	10	of	of	IN
cord-005453-4057qib7	4411	11	the	the	DT
cord-005453-4057qib7	4411	12	hospitalization	hospitalization	NN
cord-005453-4057qib7	4411	13	process	process	NN
cord-005453-4057qib7	4411	14	:	:	:
cord-005453-4057qib7	4412	1	Technology	technology	NN
cord-005453-4057qib7	4412	2	and	and	CC
cord-005453-4057qib7	4412	3	team	team	NN
cord-005453-4057qib7	4412	4	training	training	NN
cord-005453-4057qib7	4412	5	impact	impact	NN
cord-005453-4057qib7	4412	6	on	on	IN
cord-005453-4057qib7	4412	7	the	the	DT
cord-005453-4057qib7	4412	8	QOL	QOL	NNP
cord-005453-4057qib7	4412	9	of	of	IN
cord-005453-4057qib7	4412	10	the	the	DT
cord-005453-4057qib7	4412	11	patient	patient	NN
cord-005453-4057qib7	4412	12	and	and	CC
cord-005453-4057qib7	4412	13	family	family	NN
cord-005453-4057qib7	4412	14	Maria	Maria	NNP
cord-005453-4057qib7	4412	15	Claudia	Claudia	NNP
cord-005453-4057qib7	4412	16	Moreira	Moreira	NNP
cord-005453-4057qib7	4412	17	1	1	CD
cord-005453-4057qib7	4412	18	,	,	,
cord-005453-4057qib7	4412	19	Marcia	Marcia	NNP
cord-005453-4057qib7	4412	20	Rejane	Rejane	NNP
cord-005453-4057qib7	4412	21	1	1	CD
cord-005453-4057qib7	4412	22	,	,	,
cord-005453-4057qib7	4412	23	Marcia	Marcia	NNP
cord-005453-4057qib7	4412	24	Garnica	Garnica	NNP
cord-005453-4057qib7	4412	25	1	1	CD
cord-005453-4057qib7	4412	26	,	,	,
cord-005453-4057qib7	4412	27	Andrea	Andrea	NNP
cord-005453-4057qib7	4412	28	Ribeiro	Ribeiro	NNP
cord-005453-4057qib7	4412	29	1	1	CD
cord-005453-4057qib7	4412	30	,	,	,
cord-005453-4057qib7	4412	31	Paulo	Paulo	NNP
cord-005453-4057qib7	4412	32	Cesar	Cesar	NNP
cord-005453-4057qib7	4412	33	Dias	Dias	NNP
cord-005453-4057qib7	4412	34	1	1	CD
cord-005453-4057qib7	4412	35	,	,	,
cord-005453-4057qib7	4412	36	Ilza	Ilza	NNP
cord-005453-4057qib7	4412	37	Fellows	Fellows	NNP
cord-005453-4057qib7	4413	1	1	1	CD
cord-005453-4057qib7	4413	2	Background	background	NN
cord-005453-4057qib7	4413	3	:	:	:
cord-005453-4057qib7	4414	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4414	2	stem	stem	NN
cord-005453-4057qib7	4414	3	cell	cell	NN
cord-005453-4057qib7	4414	4	transplantation	transplantation	NN
cord-005453-4057qib7	4414	5	(	(	-LRB-
cord-005453-4057qib7	4414	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4414	7	)	)	-RRB-
cord-005453-4057qib7	4414	8	is	be	VBZ
cord-005453-4057qib7	4414	9	one	one	CD
cord-005453-4057qib7	4414	10	of	of	IN
cord-005453-4057qib7	4414	11	the	the	DT
cord-005453-4057qib7	4414	12	most	most	RBS
cord-005453-4057qib7	4414	13	aggressive	aggressive	JJ
cord-005453-4057qib7	4414	14	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4414	15	modalities	modality	NNS
cord-005453-4057qib7	4414	16	of	of	IN
cord-005453-4057qib7	4414	17	internal	internal	JJ
cord-005453-4057qib7	4414	18	medicine	medicine	NN
cord-005453-4057qib7	4414	19	,	,	,
cord-005453-4057qib7	4414	20	making	make	VBG
cord-005453-4057qib7	4414	21	it	-PRON-	PRP
cord-005453-4057qib7	4414	22	a	a	DT
cord-005453-4057qib7	4414	23	highly	highly	RB
cord-005453-4057qib7	4414	24	stressful	stressful	JJ
cord-005453-4057qib7	4414	25	experience	experience	NN
cord-005453-4057qib7	4414	26	for	for	IN
cord-005453-4057qib7	4414	27	the	the	DT
cord-005453-4057qib7	4414	28	patient	patient	NN
cord-005453-4057qib7	4414	29	and	and	CC
cord-005453-4057qib7	4414	30	his	-PRON-	PRP$
cord-005453-4057qib7	4414	31	family	family	NN
cord-005453-4057qib7	4414	32	.	.	.
cord-005453-4057qib7	4415	1	The	the	DT
cord-005453-4057qib7	4415	2	duration	duration	NN
cord-005453-4057qib7	4415	3	of	of	IN
cord-005453-4057qib7	4415	4	hospitalization	hospitalization	NN
cord-005453-4057qib7	4415	5	can	can	MD
cord-005453-4057qib7	4415	6	be	be	VB
cord-005453-4057qib7	4415	7	prolonged	prolong	VBN
cord-005453-4057qib7	4415	8	by	by	IN
cord-005453-4057qib7	4415	9	several	several	JJ
cord-005453-4057qib7	4415	10	intercurrences	intercurrence	NNS
cord-005453-4057qib7	4415	11	,	,	,
cord-005453-4057qib7	4415	12	frequently	frequently	RB
cord-005453-4057qib7	4415	13	generating	generate	VBG
cord-005453-4057qib7	4415	14	anxiety	anxiety	NN
cord-005453-4057qib7	4415	15	in	in	IN
cord-005453-4057qib7	4415	16	the	the	DT
cord-005453-4057qib7	4415	17	patient	patient	NN
cord-005453-4057qib7	4415	18	and	and	CC
cord-005453-4057qib7	4415	19	their	-PRON-	PRP$
cord-005453-4057qib7	4415	20	caregiver	caregiver	NN
cord-005453-4057qib7	4415	21	,	,	,
cord-005453-4057qib7	4415	22	which	which	WDT
cord-005453-4057qib7	4415	23	may	may	MD
cord-005453-4057qib7	4415	24	lead	lead	VB
cord-005453-4057qib7	4415	25	to	to	IN
cord-005453-4057qib7	4415	26	confinement	confinement	NN
cord-005453-4057qib7	4415	27	and	and	CC
cord-005453-4057qib7	4415	28	reactive	reactive	JJ
cord-005453-4057qib7	4415	29	depression	depression	NN
cord-005453-4057qib7	4415	30	.	.	.
cord-005453-4057qib7	4416	1	Interventions	intervention	NNS
cord-005453-4057qib7	4416	2	in	in	IN
cord-005453-4057qib7	4416	3	the	the	DT
cord-005453-4057qib7	4416	4	hospital	hospital	NN
cord-005453-4057qib7	4416	5	environment	environment	NN
cord-005453-4057qib7	4416	6	,	,	,
cord-005453-4057qib7	4416	7	in	in	IN
cord-005453-4057qib7	4416	8	addition	addition	NN
cord-005453-4057qib7	4416	9	to	to	IN
cord-005453-4057qib7	4416	10	the	the	DT
cord-005453-4057qib7	4416	11	continuous	continuous	JJ
cord-005453-4057qib7	4416	12	training	training	NN
cord-005453-4057qib7	4416	13	of	of	IN
cord-005453-4057qib7	4416	14	the	the	DT
cord-005453-4057qib7	4416	15	multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	4416	16	team	team	NN
cord-005453-4057qib7	4416	17	,	,	,
cord-005453-4057qib7	4416	18	can	can	MD
cord-005453-4057qib7	4416	19	have	have	VB
cord-005453-4057qib7	4416	20	a	a	DT
cord-005453-4057qib7	4416	21	positive	positive	JJ
cord-005453-4057qib7	4416	22	impact	impact	NN
cord-005453-4057qib7	4416	23	in	in	IN
cord-005453-4057qib7	4416	24	this	this	DT
cord-005453-4057qib7	4416	25	process	process	NN
cord-005453-4057qib7	4416	26	with	with	IN
cord-005453-4057qib7	4416	27	improvement	improvement	NN
cord-005453-4057qib7	4416	28	in	in	IN
cord-005453-4057qib7	4416	29	the	the	DT
cord-005453-4057qib7	4416	30	process	process	NN
cord-005453-4057qib7	4416	31	of	of	IN
cord-005453-4057qib7	4416	32	discharge	discharge	NN
cord-005453-4057qib7	4416	33	and	and	CC
cord-005453-4057qib7	4416	34	quality	quality	NN
cord-005453-4057qib7	4416	35	of	of	IN
cord-005453-4057qib7	4416	36	life	life	NN
cord-005453-4057qib7	4416	37	of	of	IN
cord-005453-4057qib7	4416	38	the	the	DT
cord-005453-4057qib7	4416	39	patient	patient	NN
cord-005453-4057qib7	4416	40	and	and	CC
cord-005453-4057qib7	4416	41	his	-PRON-	PRP$
cord-005453-4057qib7	4416	42	/	/	SYM
cord-005453-4057qib7	4416	43	her	-PRON-	PRP$
cord-005453-4057qib7	4416	44	family	family	NN
cord-005453-4057qib7	4416	45	.	.	.
cord-005453-4057qib7	4417	1	Methods	method	NNS
cord-005453-4057qib7	4417	2	:	:	:
cord-005453-4057qib7	4418	1	The	the	DT
cord-005453-4057qib7	4418	2	objective	objective	NN
cord-005453-4057qib7	4418	3	of	of	IN
cord-005453-4057qib7	4418	4	this	this	DT
cord-005453-4057qib7	4418	5	research	research	NN
cord-005453-4057qib7	4418	6	was	be	VBD
cord-005453-4057qib7	4418	7	to	to	TO
cord-005453-4057qib7	4418	8	evaluate	evaluate	VB
cord-005453-4057qib7	4418	9	the	the	DT
cord-005453-4057qib7	4418	10	impact	impact	NN
cord-005453-4057qib7	4418	11	of	of	IN
cord-005453-4057qib7	4418	12	a	a	DT
cord-005453-4057qib7	4418	13	reformulation	reformulation	NN
cord-005453-4057qib7	4418	14	in	in	IN
cord-005453-4057qib7	4418	15	the	the	DT
cord-005453-4057qib7	4418	16	unit	unit	NN
cord-005453-4057qib7	4418	17	,	,	,
cord-005453-4057qib7	4418	18	completed	complete	VBN
cord-005453-4057qib7	4418	19	in	in	IN
cord-005453-4057qib7	4418	20	May	May	NNP
cord-005453-4057qib7	4418	21	2018	2018	CD
cord-005453-4057qib7	4418	22	,	,	,
cord-005453-4057qib7	4418	23	which	which	WDT
cord-005453-4057qib7	4418	24	modified	modify	VBD
cord-005453-4057qib7	4418	25	the	the	DT
cord-005453-4057qib7	4418	26	facilities	facility	NNS
cord-005453-4057qib7	4418	27	with	with	IN
cord-005453-4057qib7	4418	28	availability	availability	NN
cord-005453-4057qib7	4418	29	of	of	IN
cord-005453-4057qib7	4418	30	hermetic	hermetic	JJ
cord-005453-4057qib7	4418	31	balconies	balcony	NNS
cord-005453-4057qib7	4418	32	in	in	IN
cord-005453-4057qib7	4418	33	each	each	DT
cord-005453-4057qib7	4418	34	room	room	NN
cord-005453-4057qib7	4418	35	,	,	,
cord-005453-4057qib7	4418	36	with	with	IN
cord-005453-4057qib7	4418	37	a	a	DT
cord-005453-4057qib7	4418	38	view	view	NN
cord-005453-4057qib7	4418	39	of	of	IN
cord-005453-4057qib7	4418	40	an	an	DT
cord-005453-4057qib7	4418	41	internal	internal	JJ
cord-005453-4057qib7	4418	42	garden	garden	NN
cord-005453-4057qib7	4418	43	.	.	.
cord-005453-4057qib7	4419	1	There	there	EX
cord-005453-4057qib7	4419	2	was	be	VBD
cord-005453-4057qib7	4419	3	also	also	RB
cord-005453-4057qib7	4419	4	the	the	DT
cord-005453-4057qib7	4419	5	addition	addition	NN
cord-005453-4057qib7	4419	6	of	of	IN
cord-005453-4057qib7	4419	7	a	a	DT
cord-005453-4057qib7	4419	8	screen	screen	NN
cord-005453-4057qib7	4419	9	in	in	IN
cord-005453-4057qib7	4419	10	the	the	DT
cord-005453-4057qib7	4419	11	corridor	corridor	NN
cord-005453-4057qib7	4419	12	of	of	IN
cord-005453-4057qib7	4419	13	the	the	DT
cord-005453-4057qib7	4419	14	floor	floor	NN
cord-005453-4057qib7	4419	15	with	with	IN
cord-005453-4057qib7	4419	16	images	image	NNS
cord-005453-4057qib7	4419	17	-technology	-technology	WP
cord-005453-4057qib7	4419	18	known	know	VBN
cord-005453-4057qib7	4419	19	as	as	IN
cord-005453-4057qib7	4419	20	videoowall	videoowall	NNP
cord-005453-4057qib7	4419	21	,	,	,
cord-005453-4057qib7	4419	22	interconnected	interconnect	VBN
cord-005453-4057qib7	4419	23	to	to	IN
cord-005453-4057qib7	4419	24	motion	motion	NN
cord-005453-4057qib7	4419	25	sensors	sensor	NNS
cord-005453-4057qib7	4419	26	(	(	-LRB-
cord-005453-4057qib7	4419	27	kinects	kinect	NNS
cord-005453-4057qib7	4419	28	)	)	-RRB-
cord-005453-4057qib7	4419	29	that	that	WDT
cord-005453-4057qib7	4419	30	allow	allow	VBP
cord-005453-4057qib7	4419	31	interaction	interaction	NN
cord-005453-4057qib7	4419	32	between	between	IN
cord-005453-4057qib7	4419	33	patients	patient	NNS
cord-005453-4057qib7	4419	34	and	and	CC
cord-005453-4057qib7	4419	35	families	family	NNS
cord-005453-4057qib7	4419	36	,	,	,
cord-005453-4057qib7	4419	37	besides	besides	IN
cord-005453-4057qib7	4419	38	facilitating	facilitate	VBG
cord-005453-4057qib7	4419	39	physiotherapy	physiotherapy	NN
cord-005453-4057qib7	4419	40	and	and	CC
cord-005453-4057qib7	4419	41	physical	physical	JJ
cord-005453-4057qib7	4419	42	exercise	exercise	NN
cord-005453-4057qib7	4419	43	.	.	.
cord-005453-4057qib7	4420	1	There	there	EX
cord-005453-4057qib7	4420	2	was	be	VBD
cord-005453-4057qib7	4420	3	re	re	NN
cord-005453-4057qib7	4420	4	-	-	NN
cord-005453-4057qib7	4420	5	training	training	NN
cord-005453-4057qib7	4420	6	of	of	IN
cord-005453-4057qib7	4420	7	the	the	DT
cord-005453-4057qib7	4420	8	multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	4420	9	team	team	NN
cord-005453-4057qib7	4420	10	with	with	IN
cord-005453-4057qib7	4420	11	emphasis	emphasis	NN
cord-005453-4057qib7	4420	12	on	on	IN
cord-005453-4057qib7	4420	13	the	the	DT
cord-005453-4057qib7	4420	14	practice	practice	NN
cord-005453-4057qib7	4420	15	of	of	IN
cord-005453-4057qib7	4420	16	humanization	humanization	NN
cord-005453-4057qib7	4420	17	.	.	.
cord-005453-4057qib7	4421	1	The	the	DT
cord-005453-4057qib7	4421	2	methodology	methodology	NN
cord-005453-4057qib7	4421	3	consisted	consist	VBD
cord-005453-4057qib7	4421	4	in	in	IN
cord-005453-4057qib7	4421	5	the	the	DT
cord-005453-4057qib7	4421	6	application	application	NN
cord-005453-4057qib7	4421	7	of	of	IN
cord-005453-4057qib7	4421	8	questionnaires	questionnaire	NNS
cord-005453-4057qib7	4421	9	of	of	IN
cord-005453-4057qib7	4421	10	satisfaction	satisfaction	NN
cord-005453-4057qib7	4421	11	to	to	IN
cord-005453-4057qib7	4421	12	patients	patient	NNS
cord-005453-4057qib7	4421	13	and	and	CC
cord-005453-4057qib7	4421	14	their	-PRON-	PRP$
cord-005453-4057qib7	4421	15	families	family	NNS
cord-005453-4057qib7	4421	16	during	during	IN
cord-005453-4057qib7	4421	17	the	the	DT
cord-005453-4057qib7	4421	18	period	period	NN
cord-005453-4057qib7	4421	19	of	of	IN
cord-005453-4057qib7	4421	20	hospitalization	hospitalization	NN
cord-005453-4057qib7	4421	21	in	in	IN
cord-005453-4057qib7	4421	22	a	a	DT
cord-005453-4057qib7	4421	23	bone	bone	NN
cord-005453-4057qib7	4421	24	marrow	marrow	NN
cord-005453-4057qib7	4421	25	transplant	transplant	NN
cord-005453-4057qib7	4421	26	unit	unit	NN
cord-005453-4057qib7	4421	27	in	in	IN
cord-005453-4057qib7	4421	28	the	the	DT
cord-005453-4057qib7	4421	29	third	third	JJ
cord-005453-4057qib7	4421	30	quarter	quarter	NN
cord-005453-4057qib7	4421	31	of	of	IN
cord-005453-4057qib7	4421	32	2018	2018	CD
cord-005453-4057qib7	4421	33	.	.	.
cord-005453-4057qib7	4422	1	The	the	DT
cord-005453-4057qib7	4422	2	items	item	NNS
cord-005453-4057qib7	4422	3	evaluated	evaluate	VBD
cord-005453-4057qib7	4422	4	ranged	range	VBD
cord-005453-4057qib7	4422	5	from	from	IN
cord-005453-4057qib7	4422	6	the	the	DT
cord-005453-4057qib7	4422	7	quality	quality	NN
cord-005453-4057qib7	4422	8	of	of	IN
cord-005453-4057qib7	4422	9	the	the	DT
cord-005453-4057qib7	4422	10	information	information	NN
cord-005453-4057qib7	4422	11	provided	provide	VBN
cord-005453-4057qib7	4422	12	by	by	IN
cord-005453-4057qib7	4422	13	the	the	DT
cord-005453-4057qib7	4422	14	medical	medical	JJ
cord-005453-4057qib7	4422	15	team	team	NN
cord-005453-4057qib7	4422	16	and	and	CC
cord-005453-4057qib7	4422	17	nursing	nursing	NN
cord-005453-4057qib7	4422	18	,	,	,
cord-005453-4057qib7	4422	19	to	to	IN
cord-005453-4057qib7	4422	20	the	the	DT
cord-005453-4057qib7	4422	21	cordiality	cordiality	NN
cord-005453-4057qib7	4422	22	and	and	CC
cord-005453-4057qib7	4422	23	agility	agility	NN
cord-005453-4057qib7	4422	24	with	with	IN
cord-005453-4057qib7	4422	25	which	which	WDT
cord-005453-4057qib7	4422	26	the	the	DT
cord-005453-4057qib7	4422	27	patient	patient	NN
cord-005453-4057qib7	4422	28	and	and	CC
cord-005453-4057qib7	4422	29	his	-PRON-	PRP$
cord-005453-4057qib7	4422	30	patient	patient	NN
cord-005453-4057qib7	4422	31	were	be	VBD
cord-005453-4057qib7	4422	32	treated	treat	VBN
cord-005453-4057qib7	4422	33	by	by	IN
cord-005453-4057qib7	4422	34	the	the	DT
cord-005453-4057qib7	4422	35	global	global	JJ
cord-005453-4057qib7	4422	36	team	team	NN
cord-005453-4057qib7	4422	37	.	.	.
cord-005453-4057qib7	4423	1	The	the	DT
cord-005453-4057qib7	4423	2	results	result	NNS
cord-005453-4057qib7	4423	3	were	be	VBD
cord-005453-4057qib7	4423	4	compared	compare	VBN
cord-005453-4057qib7	4423	5	with	with	IN
cord-005453-4057qib7	4423	6	a	a	DT
cord-005453-4057qib7	4423	7	similar	similar	JJ
cord-005453-4057qib7	4423	8	period	period	NN
cord-005453-4057qib7	4423	9	of	of	IN
cord-005453-4057qib7	4423	10	the	the	DT
cord-005453-4057qib7	4423	11	same	same	JJ
cord-005453-4057qib7	4423	12	unit	unit	NN
cord-005453-4057qib7	4423	13	in	in	IN
cord-005453-4057qib7	4423	14	the	the	DT
cord-005453-4057qib7	4423	15	previous	previous	JJ
cord-005453-4057qib7	4423	16	year	year	NN
cord-005453-4057qib7	4423	17	and	and	CC
cord-005453-4057qib7	4423	18	with	with	IN
cord-005453-4057qib7	4423	19	the	the	DT
cord-005453-4057qib7	4423	20	indices	index	NNS
cord-005453-4057qib7	4423	21	collected	collect	VBN
cord-005453-4057qib7	4423	22	simultaneously	simultaneously	RB
cord-005453-4057qib7	4423	23	in	in	IN
cord-005453-4057qib7	4423	24	another	another	DT
cord-005453-4057qib7	4423	25	unit	unit	NN
cord-005453-4057qib7	4423	26	of	of	IN
cord-005453-4057qib7	4423	27	the	the	DT
cord-005453-4057qib7	4423	28	same	same	JJ
cord-005453-4057qib7	4423	29	hospital	hospital	NN
cord-005453-4057qib7	4423	30	(	(	-LRB-
cord-005453-4057qib7	4423	31	cardio	cardio	NN
cord-005453-4057qib7	4423	32	-	-	HYPH
cord-005453-4057qib7	4423	33	intensive	intensive	JJ
cord-005453-4057qib7	4423	34	)	)	-RRB-
cord-005453-4057qib7	4423	35	.	.	.
cord-005453-4057qib7	4424	1	Results	result	NNS
cord-005453-4057qib7	4424	2	:	:	:
cord-005453-4057qib7	4425	1	Overall	overall	JJ
cord-005453-4057qib7	4425	2	and	and	CC
cord-005453-4057qib7	4425	3	segmental	segmental	JJ
cord-005453-4057qib7	4425	4	satisfaction	satisfaction	NN
cord-005453-4057qib7	4425	5	scores	score	NNS
cord-005453-4057qib7	4425	6	in	in	IN
cord-005453-4057qib7	4425	7	the	the	DT
cord-005453-4057qib7	4425	8	various	various	JJ
cord-005453-4057qib7	4425	9	items	item	NNS
cord-005453-4057qib7	4425	10	surveyed	survey	VBN
cord-005453-4057qib7	4425	11	were	be	VBD
cord-005453-4057qib7	4425	12	higher	high	JJR
cord-005453-4057qib7	4425	13	when	when	WRB
cord-005453-4057qib7	4425	14	compared	compare	VBN
cord-005453-4057qib7	4425	15	to	to	IN
cord-005453-4057qib7	4425	16	the	the	DT
cord-005453-4057qib7	4425	17	previous	previous	JJ
cord-005453-4057qib7	4425	18	period	period	NN
cord-005453-4057qib7	4425	19	of	of	IN
cord-005453-4057qib7	4425	20	the	the	DT
cord-005453-4057qib7	4425	21	same	same	JJ
cord-005453-4057qib7	4425	22	unit	unit	NN
cord-005453-4057qib7	4425	23	and	and	CC
cord-005453-4057qib7	4425	24	were	be	VBD
cord-005453-4057qib7	4425	25	also	also	RB
cord-005453-4057qib7	4425	26	higher	high	JJR
cord-005453-4057qib7	4425	27	in	in	IN
cord-005453-4057qib7	4425	28	those	those	DT
cord-005453-4057qib7	4425	29	obtained	obtain	VBN
cord-005453-4057qib7	4425	30	in	in	IN
cord-005453-4057qib7	4425	31	a	a	DT
cord-005453-4057qib7	4425	32	high	high	JJ
cord-005453-4057qib7	4425	33	complexity	complexity	NN
cord-005453-4057qib7	4425	34	unit	unit	NN
cord-005453-4057qib7	4425	35	of	of	IN
cord-005453-4057qib7	4425	36	the	the	DT
cord-005453-4057qib7	4425	37	same	same	JJ
cord-005453-4057qib7	4425	38	hospital	hospital	NN
cord-005453-4057qib7	4425	39	,	,	,
cord-005453-4057qib7	4425	40	composed	compose	VBN
cord-005453-4057qib7	4425	41	of	of	IN
cord-005453-4057qib7	4425	42	patients	patient	NNS
cord-005453-4057qib7	4425	43	submitted	submit	VBN
cord-005453-4057qib7	4425	44	to	to	IN
cord-005453-4057qib7	4425	45	mental	mental	JJ
cord-005453-4057qib7	4425	46	and	and	CC
cord-005453-4057qib7	4425	47	psychological	psychological	JJ
cord-005453-4057qib7	4425	48	stress	stress	NN
cord-005453-4057qib7	4425	49	similar	similar	JJ
cord-005453-4057qib7	4425	50	to	to	IN
cord-005453-4057qib7	4425	51	onco	onco	NNP
cord-005453-4057qib7	4425	52	-	-	HYPH
cord-005453-4057qib7	4425	53	hematologicos	hematologicos	NNP
cord-005453-4057qib7	4425	54	.	.	.
cord-005453-4057qib7	4426	1	A	a	DT
cord-005453-4057qib7	4426	2	reports	report	NNS
cord-005453-4057qib7	4426	3	of	of	IN
cord-005453-4057qib7	4426	4	"	"	``
cord-005453-4057qib7	4426	5	free	free	JJ
cord-005453-4057qib7	4426	6	speech	speech	NN
cord-005453-4057qib7	4426	7	"	"	''
cord-005453-4057qib7	4426	8	were	be	VBD
cord-005453-4057qib7	4426	9	also	also	RB
cord-005453-4057qib7	4426	10	obtained	obtain	VBN
cord-005453-4057qib7	4426	11	anonymously	anonymously	RB
cord-005453-4057qib7	4426	12	,	,	,
cord-005453-4057qib7	4426	13	in	in	IN
cord-005453-4057qib7	4426	14	order	order	NN
cord-005453-4057qib7	4426	15	to	to	TO
cord-005453-4057qib7	4426	16	guarantee	guarantee	VB
cord-005453-4057qib7	4426	17	the	the	DT
cord-005453-4057qib7	4426	18	authenticity	authenticity	NN
cord-005453-4057qib7	4426	19	and	and	CC
cord-005453-4057qib7	4426	20	free	free	JJ
cord-005453-4057qib7	4426	21	expression	expression	NN
cord-005453-4057qib7	4426	22	of	of	IN
cord-005453-4057qib7	4426	23	the	the	DT
cord-005453-4057qib7	4426	24	subjects	subject	NNS
cord-005453-4057qib7	4426	25	analyzed	analyze	VBN
cord-005453-4057qib7	4426	26	.	.	.
cord-005453-4057qib7	4427	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4427	2	:	:	:
cord-005453-4057qib7	4428	1	The	the	DT
cord-005453-4057qib7	4428	2	results	result	NNS
cord-005453-4057qib7	4428	3	obtained	obtain	VBN
cord-005453-4057qib7	4428	4	allowed	allow	VBD
cord-005453-4057qib7	4428	5	the	the	DT
cord-005453-4057qib7	4428	6	validation	validation	NN
cord-005453-4057qib7	4428	7	of	of	IN
cord-005453-4057qib7	4428	8	the	the	DT
cord-005453-4057qib7	4428	9	technical	technical	JJ
cord-005453-4057qib7	4428	10	and	and	CC
cord-005453-4057qib7	4428	11	professional	professional	JJ
cord-005453-4057qib7	4428	12	team	team	NN
cord-005453-4057qib7	4428	13	initiatives	initiative	NNS
cord-005453-4057qib7	4428	14	,	,	,
cord-005453-4057qib7	4428	15	bringing	bring	VBG
cord-005453-4057qib7	4428	16	indicators	indicator	NNS
cord-005453-4057qib7	4428	17	that	that	WDT
cord-005453-4057qib7	4428	18	will	will	MD
cord-005453-4057qib7	4428	19	allow	allow	VB
cord-005453-4057qib7	4428	20	better	well	JJR
cord-005453-4057qib7	4428	21	monitoring	monitoring	NN
cord-005453-4057qib7	4428	22	and	and	CC
cord-005453-4057qib7	4428	23	support	support	NN
cord-005453-4057qib7	4428	24	of	of	IN
cord-005453-4057qib7	4428	25	these	these	DT
cord-005453-4057qib7	4428	26	patients	patient	NNS
cord-005453-4057qib7	4428	27	and	and	CC
cord-005453-4057qib7	4428	28	their	-PRON-	PRP$
cord-005453-4057qib7	4428	29	relatives	relative	NNS
cord-005453-4057qib7	4428	30	in	in	IN
cord-005453-4057qib7	4428	31	this	this	DT
cord-005453-4057qib7	4428	32	difficult	difficult	JJ
cord-005453-4057qib7	4428	33	time	time	NN
cord-005453-4057qib7	4428	34	of	of	IN
cord-005453-4057qib7	4428	35	treatment	treatment	NN
cord-005453-4057qib7	4428	36	.	.	.
cord-005453-4057qib7	4429	1	They	-PRON-	PRP
cord-005453-4057qib7	4429	2	served	serve	VBD
cord-005453-4057qib7	4429	3	as	as	IN
cord-005453-4057qib7	4429	4	an	an	DT
cord-005453-4057qib7	4429	5	initial	initial	JJ
cord-005453-4057qib7	4429	6	tool	tool	NN
cord-005453-4057qib7	4429	7	in	in	IN
cord-005453-4057qib7	4429	8	the	the	DT
cord-005453-4057qib7	4429	9	continuous	continuous	JJ
cord-005453-4057qib7	4429	10	process	process	NN
cord-005453-4057qib7	4429	11	of	of	IN
cord-005453-4057qib7	4429	12	humanization	humanization	NN
cord-005453-4057qib7	4429	13	and	and	CC
cord-005453-4057qib7	4429	14	stimulated	stimulate	VBD
cord-005453-4057qib7	4429	15	the	the	DT
cord-005453-4057qib7	4429	16	multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	4429	17	team	team	NN
cord-005453-4057qib7	4429	18	to	to	TO
cord-005453-4057qib7	4429	19	continuously	continuously	RB
cord-005453-4057qib7	4429	20	improve	improve	VB
cord-005453-4057qib7	4429	21	this	this	DT
cord-005453-4057qib7	4429	22	process	process	NN
cord-005453-4057qib7	4429	23	.	.	.
cord-005453-4057qib7	4430	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4430	2	Background	background	NN
cord-005453-4057qib7	4430	3	:	:	:
cord-005453-4057qib7	4430	4	Pure	pure	JJ
cord-005453-4057qib7	4430	5	red	red	JJ
cord-005453-4057qib7	4430	6	cell	cell	NN
cord-005453-4057qib7	4430	7	anemia	anemia	NN
cord-005453-4057qib7	4430	8	(	(	-LRB-
cord-005453-4057qib7	4430	9	PRCA	PRCA	NNP
cord-005453-4057qib7	4430	10	)	)	-RRB-
cord-005453-4057qib7	4430	11	is	be	VBZ
cord-005453-4057qib7	4430	12	a	a	DT
cord-005453-4057qib7	4430	13	rare	rare	JJ
cord-005453-4057qib7	4430	14	complication	complication	NN
cord-005453-4057qib7	4430	15	of	of	IN
cord-005453-4057qib7	4430	16	ABO	ABO	NNP
cord-005453-4057qib7	4430	17	-	-	HYPH
cord-005453-4057qib7	4430	18	incopatible	incopatible	JJ
cord-005453-4057qib7	4430	19	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	4430	20	stem	stem	NN
cord-005453-4057qib7	4430	21	cell	cell	NN
cord-005453-4057qib7	4430	22	transplantation	transplantation	NN
cord-005453-4057qib7	4430	23	characterized	characterize	VBN
cord-005453-4057qib7	4430	24	by	by	IN
cord-005453-4057qib7	4430	25	anemia	anemia	NN
cord-005453-4057qib7	4430	26	,	,	,
cord-005453-4057qib7	4430	27	reticulocytopenia	reticulocytopenia	NN
cord-005453-4057qib7	4430	28	and	and	CC
cord-005453-4057qib7	4430	29	absence	absence	NN
cord-005453-4057qib7	4430	30	of	of	IN
cord-005453-4057qib7	4430	31	erythroid	erythroid	NN
cord-005453-4057qib7	4430	32	precursors	precursor	NNS
cord-005453-4057qib7	4430	33	in	in	IN
cord-005453-4057qib7	4430	34	patient	patient	NN
cord-005453-4057qib7	4430	35	's	's	POS
cord-005453-4057qib7	4430	36	bone	bone	NN
cord-005453-4057qib7	4430	37	marrow	marrow	NN
cord-005453-4057qib7	4430	38	.	.	.
cord-005453-4057qib7	4431	1	Most	Most	JJS
cord-005453-4057qib7	4431	2	patients	patient	NNS
cord-005453-4057qib7	4431	3	with	with	IN
cord-005453-4057qib7	4431	4	PRCA	PRCA	NNP
cord-005453-4057qib7	4431	5	resolve	resolve	VB
cord-005453-4057qib7	4431	6	spontaneously	spontaneously	RB
cord-005453-4057qib7	4431	7	within	within	IN
cord-005453-4057qib7	4431	8	months	month	NNS
cord-005453-4057qib7	4431	9	,	,	,
cord-005453-4057qib7	4431	10	however	however	RB
cord-005453-4057qib7	4431	11	a	a	DT
cord-005453-4057qib7	4431	12	small	small	JJ
cord-005453-4057qib7	4431	13	number	number	NN
cord-005453-4057qib7	4431	14	of	of	IN
cord-005453-4057qib7	4431	15	patients	patient	NNS
cord-005453-4057qib7	4431	16	requires	require	VBZ
cord-005453-4057qib7	4431	17	continued	continued	JJ
cord-005453-4057qib7	4431	18	red	red	JJ
cord-005453-4057qib7	4431	19	blood	blood	NN
cord-005453-4057qib7	4431	20	cell	cell	NN
cord-005453-4057qib7	4431	21	(	(	-LRB-
cord-005453-4057qib7	4431	22	RBC	RBC	NNP
cord-005453-4057qib7	4431	23	)	)	-RRB-
cord-005453-4057qib7	4431	24	transfusions	transfusion	NNS
cord-005453-4057qib7	4431	25	.	.	.
cord-005453-4057qib7	4432	1	The	the	DT
cord-005453-4057qib7	4432	2	treatment	treatment	NN
cord-005453-4057qib7	4432	3	of	of	IN
cord-005453-4057qib7	4432	4	this	this	DT
cord-005453-4057qib7	4432	5	complication	complication	NN
cord-005453-4057qib7	4432	6	is	be	VBZ
cord-005453-4057qib7	4432	7	difficult	difficult	JJ
cord-005453-4057qib7	4432	8	and	and	CC
cord-005453-4057qib7	4432	9	not	not	RB
cord-005453-4057qib7	4432	10	standardized	standardized	JJ
cord-005453-4057qib7	4432	11	.	.	.
cord-005453-4057qib7	4433	1	Different	different	JJ
cord-005453-4057qib7	4433	2	approaches	approach	NNS
cord-005453-4057qib7	4433	3	has	have	VBZ
cord-005453-4057qib7	4433	4	been	be	VBN
cord-005453-4057qib7	4433	5	used	use	VBN
cord-005453-4057qib7	4433	6	such	such	JJ
cord-005453-4057qib7	4433	7	as	as	IN
cord-005453-4057qib7	4433	8	Rituximab	Rituximab	NNP
cord-005453-4057qib7	4433	9	,	,	,
cord-005453-4057qib7	4433	10	donor	donor	NN
cord-005453-4057qib7	4433	11	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	4433	12	,	,	,
cord-005453-4057qib7	4433	13	plasma	plasma	NN
cord-005453-4057qib7	4433	14	exchange	exchange	NN
cord-005453-4057qib7	4433	15	with	with	IN
cord-005453-4057qib7	4433	16	different	different	JJ
cord-005453-4057qib7	4433	17	outcome	outcome	NN
cord-005453-4057qib7	4433	18	.	.	.
cord-005453-4057qib7	4434	1	Recently	recently	RB
cord-005453-4057qib7	4434	2	,	,	,
cord-005453-4057qib7	4434	3	a	a	DT
cord-005453-4057qib7	4434	4	remarkable	remarkable	JJ
cord-005453-4057qib7	4434	5	response	response	NN
cord-005453-4057qib7	4434	6	to	to	IN
cord-005453-4057qib7	4434	7	treatment	treatment	NN
cord-005453-4057qib7	4434	8	with	with	IN
cord-005453-4057qib7	4434	9	bortezomib	bortezomib	NNP
cord-005453-4057qib7	4434	10	has	have	VBZ
cord-005453-4057qib7	4434	11	been	be	VBN
cord-005453-4057qib7	4434	12	described	describe	VBN
cord-005453-4057qib7	4434	13	in	in	IN
cord-005453-4057qib7	4434	14	a	a	DT
cord-005453-4057qib7	4434	15	case	case	NN
cord-005453-4057qib7	4434	16	of	of	IN
cord-005453-4057qib7	4434	17	PRCA	PRCA	NNP
cord-005453-4057qib7	4434	18	.	.	.
cord-005453-4057qib7	4435	1	Methods	method	NNS
cord-005453-4057qib7	4436	1	:	:	:
cord-005453-4057qib7	4436	2	We	-PRON-	PRP
cord-005453-4057qib7	4436	3	reviewed	review	VBD
cord-005453-4057qib7	4436	4	146	146	CD
cord-005453-4057qib7	4436	5	patients	patient	NNS
cord-005453-4057qib7	4436	6	who	who	WP
cord-005453-4057qib7	4436	7	received	receive	VBD
cord-005453-4057qib7	4436	8	an	an	DT
cord-005453-4057qib7	4436	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	4436	10	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	4436	11	stem	stem	NN
cord-005453-4057qib7	4436	12	cell	cell	NN
cord-005453-4057qib7	4436	13	transplant	transplant	NN
cord-005453-4057qib7	4436	14	(	(	-LRB-
cord-005453-4057qib7	4436	15	HCT	HCT	NNP
cord-005453-4057qib7	4436	16	)	)	-RRB-
cord-005453-4057qib7	4436	17	between	between	IN
cord-005453-4057qib7	4436	18	Januar	Januar	NNP
cord-005453-4057qib7	4436	19	2012	2012	CD
cord-005453-4057qib7	4436	20	and	and	CC
cord-005453-4057qib7	4436	21	August	August	NNP
cord-005453-4057qib7	4436	22	2018	2018	CD
cord-005453-4057qib7	4436	23	at	at	IN
cord-005453-4057qib7	4436	24	our	-PRON-	PRP$
cord-005453-4057qib7	4436	25	institution	institution	NN
cord-005453-4057qib7	4436	26	.	.	.
cord-005453-4057qib7	4437	1	Sixty	sixty	CD
cord-005453-4057qib7	4437	2	eight	eight	CD
cord-005453-4057qib7	4437	3	patients	patient	NNS
cord-005453-4057qib7	4437	4	received	receive	VBD
cord-005453-4057qib7	4437	5	a	a	DT
cord-005453-4057qib7	4437	6	major	major	JJ
cord-005453-4057qib7	4437	7	ABO	ABO	NNP
cord-005453-4057qib7	4437	8	-	-	HYPH
cord-005453-4057qib7	4437	9	mismached	mismache	VBN
cord-005453-4057qib7	4437	10	HCT	hct	NN
cord-005453-4057qib7	4437	11	.	.	.
cord-005453-4057qib7	4438	1	PRCA	PRCA	NNP
cord-005453-4057qib7	4438	2	was	be	VBD
cord-005453-4057qib7	4438	3	defined	define	VBN
cord-005453-4057qib7	4438	4	as	as	IN
cord-005453-4057qib7	4438	5	a	a	DT
cord-005453-4057qib7	4438	6	completely	completely	RB
cord-005453-4057qib7	4438	7	absence	absence	NN
cord-005453-4057qib7	4438	8	of	of	IN
cord-005453-4057qib7	4438	9	erythroid	erythroid	JJ
cord-005453-4057qib7	4438	10	precursors	precursor	NNS
cord-005453-4057qib7	4438	11	on	on	IN
cord-005453-4057qib7	4438	12	day	day	NN
cord-005453-4057qib7	4438	13	+30	+30	CD
cord-005453-4057qib7	4438	14	bone	bone	NN
cord-005453-4057qib7	4438	15	marrow	marrow	NN
cord-005453-4057qib7	4438	16	puncture	puncture	NN
cord-005453-4057qib7	4438	17	,	,	,
cord-005453-4057qib7	4438	18	with	with	IN
cord-005453-4057qib7	4438	19	absence	absence	NN
cord-005453-4057qib7	4438	20	of	of	IN
cord-005453-4057qib7	4438	21	donor	donor	NN
cord-005453-4057qib7	4438	22	red	red	JJ
cord-005453-4057qib7	4438	23	cells	cell	NNS
cord-005453-4057qib7	4438	24	and	and	CC
cord-005453-4057qib7	4438	25	the	the	DT
cord-005453-4057qib7	4438	26	recipient	recipient	NN
cord-005453-4057qib7	4438	27	requiring	require	VBG
cord-005453-4057qib7	4438	28	RBC	RBC	NNP
cord-005453-4057qib7	4438	29	transfusion	transfusion	NN
cord-005453-4057qib7	4438	30	.	.	.
cord-005453-4057qib7	4439	1	Results	result	NNS
cord-005453-4057qib7	4439	2	:	:	:
cord-005453-4057qib7	4440	1	Only	only	RB
cord-005453-4057qib7	4440	2	one	one	CD
cord-005453-4057qib7	4440	3	patient	patient	NN
cord-005453-4057qib7	4440	4	developed	develop	VBD
cord-005453-4057qib7	4440	5	PRCA	PRCA	NNP
cord-005453-4057qib7	4440	6	(	(	-LRB-
cord-005453-4057qib7	4440	7	1.5	1.5	CD
cord-005453-4057qib7	4440	8	%	%	NN
cord-005453-4057qib7	4440	9	)	)	-RRB-
cord-005453-4057qib7	4440	10	.	.	.
cord-005453-4057qib7	4441	1	A	a	DT
cord-005453-4057qib7	4441	2	18	18	CD
cord-005453-4057qib7	4441	3	years	year	NNS
cord-005453-4057qib7	4441	4	old	old	JJ
cord-005453-4057qib7	4441	5	male	male	NN
cord-005453-4057qib7	4441	6	received	receive	VBD
cord-005453-4057qib7	4441	7	a	a	DT
cord-005453-4057qib7	4441	8	myeloablative	myeloablative	JJ
cord-005453-4057qib7	4441	9	HLA	HLA	NNP
cord-005453-4057qib7	4441	10	-	-	HYPH
cord-005453-4057qib7	4441	11	matched	match	VBN
cord-005453-4057qib7	4441	12	ABOmismatched	abomismatched	JJ
cord-005453-4057qib7	4441	13	sibling	sibling	NN
cord-005453-4057qib7	4441	14	donor	donor	NN
cord-005453-4057qib7	4441	15	transplant	transplant	NN
cord-005453-4057qib7	4441	16	(	(	-LRB-
cord-005453-4057qib7	4441	17	brother	brother	NN
cord-005453-4057qib7	4441	18	,	,	,
cord-005453-4057qib7	4441	19	12	12	CD
cord-005453-4057qib7	4441	20	years	year	NNS
cord-005453-4057qib7	4441	21	)	)	-RRB-
cord-005453-4057qib7	4441	22	for	for	IN
cord-005453-4057qib7	4441	23	acute	acute	JJ
cord-005453-4057qib7	4441	24	myeloid	myeloid	JJ
cord-005453-4057qib7	4441	25	leukemia	leukemia	NN
cord-005453-4057qib7	4441	26	(	(	-LRB-
cord-005453-4057qib7	4441	27	AML	AML	NNP
cord-005453-4057qib7	4441	28	)	)	-RRB-
cord-005453-4057qib7	4441	29	,	,	,
cord-005453-4057qib7	4441	30	with	with	IN
cord-005453-4057qib7	4441	31	t(8;21	t(8;21	NNP
cord-005453-4057qib7	4441	32	)	)	-RRB-
cord-005453-4057qib7	4442	1	CR1,MRD	CR1,MRD	NNP
cord-005453-4057qib7	4442	2	positive	positive	JJ
cord-005453-4057qib7	4442	3	(	(	-LRB-
cord-005453-4057qib7	4442	4	RUNX1-RUNX1T1	runx1-runx1t1	NN
cord-005453-4057qib7	4442	5	)	)	-RRB-
cord-005453-4057qib7	4442	6	.	.	.
cord-005453-4057qib7	4443	1	The	the	DT
cord-005453-4057qib7	4443	2	donor	donor	NN
cord-005453-4057qib7	4443	3	was	be	VBD
cord-005453-4057qib7	4443	4	blood	blood	NN
cord-005453-4057qib7	4443	5	type	type	NN
cord-005453-4057qib7	4443	6	A	a	DT
cord-005453-4057qib7	4443	7	Rh	Rh	NNP
cord-005453-4057qib7	4443	8	positive	positive	JJ
cord-005453-4057qib7	4443	9	and	and	CC
cord-005453-4057qib7	4443	10	the	the	DT
cord-005453-4057qib7	4443	11	patient	patient	NN
cord-005453-4057qib7	4443	12	0	0	CD
cord-005453-4057qib7	4443	13	Rh	Rh	NNP
cord-005453-4057qib7	4443	14	positive	positive	JJ
cord-005453-4057qib7	4443	15	.	.	.
cord-005453-4057qib7	4444	1	The	the	DT
cord-005453-4057qib7	4444	2	patient	patient	NN
cord-005453-4057qib7	4444	3	had	have	VBD
cord-005453-4057qib7	4444	4	no	no	DT
cord-005453-4057qib7	4444	5	complication	complication	NN
cord-005453-4057qib7	4444	6	after	after	IN
cord-005453-4057qib7	4444	7	transplant	transplant	NN
cord-005453-4057qib7	4444	8	.	.	.
cord-005453-4057qib7	4445	1	The	the	DT
cord-005453-4057qib7	4445	2	day	day	NN
cord-005453-4057qib7	4445	3	+30	+30	CD
cord-005453-4057qib7	4445	4	bone	bone	NN
cord-005453-4057qib7	4445	5	marrow	marrow	NN
cord-005453-4057qib7	4445	6	puncture	puncture	NN
cord-005453-4057qib7	4445	7	has	have	VBZ
cord-005453-4057qib7	4445	8	shown	show	VBN
cord-005453-4057qib7	4445	9	only	only	RB
cord-005453-4057qib7	4445	10	few	few	JJ
cord-005453-4057qib7	4445	11	erythroid	erythroid	JJ
cord-005453-4057qib7	4445	12	precursors	precursor	NNS
cord-005453-4057qib7	4445	13	and	and	CC
cord-005453-4057qib7	4445	14	day	day	NN
cord-005453-4057qib7	4445	15	+100	+100	.
cord-005453-4057qib7	4446	1	puncture	puncture	NN
cord-005453-4057qib7	4446	2	and	and	CC
cord-005453-4057qib7	4446	3	biopsy	biopsy	JJ
cord-005453-4057qib7	4446	4	no	no	DT
cord-005453-4057qib7	4446	5	erythroid	erythroid	JJ
cord-005453-4057qib7	4446	6	precursors	precursor	NNS
cord-005453-4057qib7	4446	7	,	,	,
cord-005453-4057qib7	4446	8	he	-PRON-	PRP
cord-005453-4057qib7	4446	9	had	have	VBD
cord-005453-4057qib7	4446	10	transfusion	transfusion	NN
cord-005453-4057qib7	4446	11	dependent	dependent	JJ
cord-005453-4057qib7	4446	12	anemia	anemia	NN
cord-005453-4057qib7	4446	13	requiring	require	VBG
cord-005453-4057qib7	4446	14	a	a	DT
cord-005453-4057qib7	4446	15	RBC	RBC	NNP
cord-005453-4057qib7	4446	16	transfusion	transfusion	NN
cord-005453-4057qib7	4446	17	every	every	DT
cord-005453-4057qib7	4446	18	two	two	CD
cord-005453-4057qib7	4446	19	weeks	week	NNS
cord-005453-4057qib7	4446	20	and	and	CC
cord-005453-4057qib7	4446	21	retukulocytopenia	retukulocytopenia	NNP
cord-005453-4057qib7	4446	22	.	.	.
cord-005453-4057qib7	4447	1	Parvo	parvo	NN
cord-005453-4057qib7	4447	2	virus	virus	NN
cord-005453-4057qib7	4447	3	and	and	CC
cord-005453-4057qib7	4447	4	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	4447	5	were	be	VBD
cord-005453-4057qib7	4447	6	negative	negative	JJ
cord-005453-4057qib7	4447	7	.	.	.
cord-005453-4057qib7	4448	1	Due	due	IN
cord-005453-4057qib7	4448	2	to	to	IN
cord-005453-4057qib7	4448	3	very	very	RB
cord-005453-4057qib7	4448	4	high	high	JJ
cord-005453-4057qib7	4448	5	ferritin	ferritin	NN
cord-005453-4057qib7	4448	6	level	level	NN
cord-005453-4057qib7	4448	7	(	(	-LRB-
cord-005453-4057qib7	4448	8	>	>	NFP
cord-005453-4057qib7	4448	9	4.000u	4.000u	NNP
cord-005453-4057qib7	4448	10	/	/	SYM
cord-005453-4057qib7	4448	11	l	l	NN
cord-005453-4057qib7	4448	12	)	)	-RRB-
cord-005453-4057qib7	4448	13	and	and	CC
cord-005453-4057qib7	4448	14	increased	increase	VBN
cord-005453-4057qib7	4448	15	luiver	luiver	NNP
cord-005453-4057qib7	4448	16	enzymes	enzyme	NNS
cord-005453-4057qib7	4448	17	without	without	IN
cord-005453-4057qib7	4448	18	signs	sign	NNS
cord-005453-4057qib7	4448	19	of	of	IN
cord-005453-4057qib7	4448	20	GvHD	GvHD	NNP
cord-005453-4057qib7	4448	21	,	,	,
cord-005453-4057qib7	4448	22	the	the	DT
cord-005453-4057qib7	4448	23	treatment	treatment	NN
cord-005453-4057qib7	4448	24	with	with	IN
cord-005453-4057qib7	4448	25	deferasirox	deferasirox	NNP
cord-005453-4057qib7	4448	26	has	have	VBZ
cord-005453-4057qib7	4448	27	been	be	VBN
cord-005453-4057qib7	4448	28	started	start	VBN
cord-005453-4057qib7	4448	29	.	.	.
cord-005453-4057qib7	4449	1	The	the	DT
cord-005453-4057qib7	4449	2	patient	patient	NN
cord-005453-4057qib7	4449	3	has	have	VBZ
cord-005453-4057qib7	4449	4	achived	achive	VBN
cord-005453-4057qib7	4449	5	CR1	CR1	NNP
cord-005453-4057qib7	4449	6	,	,	,
cord-005453-4057qib7	4449	7	MRD	MRD	NNP
cord-005453-4057qib7	4449	8	negative	negative	JJ
cord-005453-4057qib7	4449	9	,	,	,
cord-005453-4057qib7	4449	10	and	and	CC
cord-005453-4057qib7	4449	11	has	have	VBZ
cord-005453-4057qib7	4449	12	evidence	evidence	NN
cord-005453-4057qib7	4449	13	of	of	IN
cord-005453-4057qib7	4449	14	complete	complete	JJ
cord-005453-4057qib7	4449	15	chimerism	chimerism	NN
cord-005453-4057qib7	4449	16	.	.	.
cord-005453-4057qib7	4450	1	High	high	JJ
cord-005453-4057qib7	4450	2	titers	titer	NNS
cord-005453-4057qib7	4450	3	of	of	IN
cord-005453-4057qib7	4450	4	anti	anti	JJ
cord-005453-4057qib7	4450	5	-	-	JJ
cord-005453-4057qib7	4450	6	A	a	JJ
cord-005453-4057qib7	4450	7	and	and	CC
cord-005453-4057qib7	4450	8	anti	anti	JJ
cord-005453-4057qib7	4450	9	-	-	JJ
cord-005453-4057qib7	4450	10	B	b	NN
cord-005453-4057qib7	4450	11	issohemagglutinin	issohemagglutinin	NN
cord-005453-4057qib7	4450	12	was	be	VBD
cord-005453-4057qib7	4450	13	present	present	JJ
cord-005453-4057qib7	4450	14	.	.	.
cord-005453-4057qib7	4451	1	We	-PRON-	PRP
cord-005453-4057qib7	4451	2	started	start	VBD
cord-005453-4057qib7	4451	3	the	the	DT
cord-005453-4057qib7	4451	4	treatment	treatment	NN
cord-005453-4057qib7	4451	5	with	with	IN
cord-005453-4057qib7	4451	6	Rituximab	Rituximab	NNP
cord-005453-4057qib7	4451	7	375mg	375mg	NNP
cord-005453-4057qib7	4451	8	/	/	SYM
cord-005453-4057qib7	4451	9	m2	m2	NNP
cord-005453-4057qib7	4451	10	weekly	weekly	NN
cord-005453-4057qib7	4451	11	,	,	,
cord-005453-4057qib7	4451	12	4	4	CD
cord-005453-4057qib7	4451	13	weeks	week	NNS
cord-005453-4057qib7	4451	14	,	,	,
cord-005453-4057qib7	4451	15	however	however	RB
cord-005453-4057qib7	4451	16	without	without	IN
cord-005453-4057qib7	4451	17	response	response	NN
cord-005453-4057qib7	4451	18	.	.	.
cord-005453-4057qib7	4452	1	The	the	DT
cord-005453-4057qib7	4452	2	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	4452	3	of	of	IN
cord-005453-4057qib7	4452	4	the	the	DT
cord-005453-4057qib7	4452	5	PRCA	PRCA	NNP
cord-005453-4057qib7	4452	6	is	be	VBZ
cord-005453-4057qib7	4452	7	thought	think	VBN
cord-005453-4057qib7	4452	8	to	to	TO
cord-005453-4057qib7	4452	9	be	be	VB
cord-005453-4057qib7	4452	10	due	due	JJ
cord-005453-4057qib7	4452	11	to	to	IN
cord-005453-4057qib7	4452	12	the	the	DT
cord-005453-4057qib7	4452	13	recipients	recipient	NNS
cord-005453-4057qib7	4452	14	plasma	plasma	NN
cord-005453-4057qib7	4452	15	cells	cell	NNS
cord-005453-4057qib7	4452	16	,	,	,
cord-005453-4057qib7	4452	17	bortezomib	bortezomib	NNP
cord-005453-4057qib7	4452	18	,	,	,
cord-005453-4057qib7	4452	19	a	a	DT
cord-005453-4057qib7	4452	20	proteasome	proteasome	VBN
cord-005453-4057qib7	4452	21	inhibitor	inhibitor	NN
cord-005453-4057qib7	4452	22	inducing	induce	VBG
cord-005453-4057qib7	4452	23	apoptosis	apoptosis	NN
cord-005453-4057qib7	4452	24	of	of	IN
cord-005453-4057qib7	4452	25	plasma	plasma	NN
cord-005453-4057qib7	4452	26	cells	cell	NNS
cord-005453-4057qib7	4452	27	has	have	VBZ
cord-005453-4057qib7	4452	28	been	be	VBN
cord-005453-4057qib7	4452	29	given	give	VBN
cord-005453-4057qib7	4452	30	s.	s.	NNP
cord-005453-4057qib7	4452	31	c.	c.	NNP
cord-005453-4057qib7	4452	32	1,3mg	1,3mg	NNP
cord-005453-4057qib7	4452	33	/	/	SYM
cord-005453-4057qib7	4452	34	m2	m2	NNP
cord-005453-4057qib7	4452	35	two	two	CD
cord-005453-4057qib7	4452	36	times	time	NNS
cord-005453-4057qib7	4452	37	weekly	weekly	RB
cord-005453-4057qib7	4452	38	,	,	,
cord-005453-4057qib7	4452	39	for	for	IN
cord-005453-4057qib7	4452	40	two	two	CD
cord-005453-4057qib7	4452	41	weeks	week	NNS
cord-005453-4057qib7	4452	42	.	.	.
cord-005453-4057qib7	4453	1	The	the	DT
cord-005453-4057qib7	4453	2	patient	patient	NN
cord-005453-4057qib7	4453	3	responded	respond	VBD
cord-005453-4057qib7	4453	4	to	to	IN
cord-005453-4057qib7	4453	5	the	the	DT
cord-005453-4057qib7	4453	6	treatment	treatment	NN
cord-005453-4057qib7	4453	7	two	two	CD
cord-005453-4057qib7	4453	8	weeks	week	NNS
cord-005453-4057qib7	4453	9	later	later	RB
cord-005453-4057qib7	4453	10	with	with	IN
cord-005453-4057qib7	4453	11	increase	increase	NN
cord-005453-4057qib7	4453	12	in	in	IN
cord-005453-4057qib7	4453	13	Hb	Hb	NNP
cord-005453-4057qib7	4453	14	,	,	,
cord-005453-4057qib7	4453	15	which	which	WDT
cord-005453-4057qib7	4453	16	was	be	VBD
cord-005453-4057qib7	4453	17	12,9	12,9	CD
cord-005453-4057qib7	4453	18	g	g	NNP
cord-005453-4057qib7	4453	19	/	/	SYM
cord-005453-4057qib7	4453	20	dl	dl	NN
cord-005453-4057qib7	4453	21	and	and	CC
cord-005453-4057qib7	4453	22	increase	increase	VB
cord-005453-4057qib7	4453	23	in	in	IN
cord-005453-4057qib7	4453	24	retikulocyte	retikulocyte	JJ
cord-005453-4057qib7	4453	25	number	number	NN
cord-005453-4057qib7	4453	26	.	.	.
cord-005453-4057qib7	4454	1	The	the	DT
cord-005453-4057qib7	4454	2	patient	patient	NN
cord-005453-4057qib7	4454	3	has	have	VBZ
cord-005453-4057qib7	4454	4	continued	continue	VBN
cord-005453-4057qib7	4454	5	to	to	TO
cord-005453-4057qib7	4454	6	be	be	VB
cord-005453-4057qib7	4454	7	well	well	RB
cord-005453-4057qib7	4454	8	at	at	IN
cord-005453-4057qib7	4454	9	the	the	DT
cord-005453-4057qib7	4454	10	last	last	JJ
cord-005453-4057qib7	4454	11	control	control	NN
cord-005453-4057qib7	4454	12	.	.	.
cord-005453-4057qib7	4455	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4455	2	:	:	:
cord-005453-4057qib7	4456	1	PRCA	PRCA	NNP
cord-005453-4057qib7	4456	2	aplasia	aplasia	NNP
cord-005453-4057qib7	4456	3	is	be	VBZ
cord-005453-4057qib7	4456	4	a	a	DT
cord-005453-4057qib7	4456	5	rare	rare	JJ
cord-005453-4057qib7	4456	6	but	but	CC
cord-005453-4057qib7	4456	7	serious	serious	JJ
cord-005453-4057qib7	4456	8	complication	complication	NN
cord-005453-4057qib7	4456	9	after	after	IN
cord-005453-4057qib7	4456	10	ABO	ABO	NNP
cord-005453-4057qib7	4456	11	-	-	HYPH
cord-005453-4057qib7	4456	12	incompatible	incompatible	JJ
cord-005453-4057qib7	4456	13	HCT	hct	NN
cord-005453-4057qib7	4456	14	.	.	.
cord-005453-4057qib7	4457	1	Bortezomib	Bortezomib	NNP
cord-005453-4057qib7	4457	2	is	be	VBZ
cord-005453-4057qib7	4457	3	an	an	DT
cord-005453-4057qib7	4457	4	effective	effective	JJ
cord-005453-4057qib7	4457	5	treatment	treatment	NN
cord-005453-4057qib7	4457	6	for	for	IN
cord-005453-4057qib7	4457	7	this	this	DT
cord-005453-4057qib7	4457	8	complication	complication	NN
cord-005453-4057qib7	4457	9	if	if	IN
cord-005453-4057qib7	4457	10	mediated	mediate	VBN
cord-005453-4057qib7	4457	11	by	by	IN
cord-005453-4057qib7	4457	12	residual	residual	JJ
cord-005453-4057qib7	4457	13	host	host	NN
cord-005453-4057qib7	4457	14	isohemeagglutinins	isohemeagglutinin	NNS
cord-005453-4057qib7	4457	15	after	after	IN
cord-005453-4057qib7	4457	16	HCT	HCT	NNP
cord-005453-4057qib7	4457	17	and	and	CC
cord-005453-4057qib7	4457	18	should	should	MD
cord-005453-4057qib7	4457	19	be	be	VB
cord-005453-4057qib7	4457	20	recommended	recommend	VBN
cord-005453-4057qib7	4457	21	as	as	IN
cord-005453-4057qib7	4457	22	standard	standard	NN
cord-005453-4057qib7	4457	23	of	of	IN
cord-005453-4057qib7	4457	24	care	care	NN
cord-005453-4057qib7	4457	25	.	.	.
cord-005453-4057qib7	4458	1	Clinical	clinical	JJ
cord-005453-4057qib7	4458	2	Methods	method	NNS
cord-005453-4057qib7	4459	1	:	:	:
cord-005453-4057qib7	4459	2	This	this	DT
cord-005453-4057qib7	4459	3	work	work	NN
cord-005453-4057qib7	4459	4	is	be	VBZ
cord-005453-4057qib7	4459	5	retrospective	retrospective	JJ
cord-005453-4057qib7	4459	6	,	,	,
cord-005453-4057qib7	4459	7	observational	observational	JJ
cord-005453-4057qib7	4459	8	,	,	,
cord-005453-4057qib7	4459	9	cross	cross	JJ
cord-005453-4057qib7	4459	10	-	-	JJ
cord-005453-4057qib7	4459	11	sectional	sectional	JJ
cord-005453-4057qib7	4459	12	and	and	CC
cord-005453-4057qib7	4459	13	analytical	analytical	JJ
cord-005453-4057qib7	4459	14	.	.	.
cord-005453-4057qib7	4460	1	It	-PRON-	PRP
cord-005453-4057qib7	4460	2	included	include	VBD
cord-005453-4057qib7	4460	3	all	all	DT
cord-005453-4057qib7	4460	4	patients	patient	NNS
cord-005453-4057qib7	4460	5	who	who	WP
cord-005453-4057qib7	4460	6	received	receive	VBD
cord-005453-4057qib7	4460	7	HSCT	HSCT	NNP
cord-005453-4057qib7	4460	8	at	at	IN
cord-005453-4057qib7	4460	9	Stem	Stem	NNP
cord-005453-4057qib7	4460	10	Cell	Cell	NNP
cord-005453-4057qib7	4460	11	Transplantation	Transplantation	NNP
cord-005453-4057qib7	4460	12	Unit	unit	NN
cord-005453-4057qib7	4460	13	(	(	-LRB-
cord-005453-4057qib7	4460	14	UTMO	UTMO	NNP
cord-005453-4057qib7	4460	15	,	,	,
cord-005453-4057qib7	4460	16	by	by	IN
cord-005453-4057qib7	4460	17	its	-PRON-	PRP$
cord-005453-4057qib7	4460	18	Spanish	spanish	JJ
cord-005453-4057qib7	4460	19	acronym	acronym	NN
cord-005453-4057qib7	4460	20	)	)	-RRB-
cord-005453-4057qib7	4460	21	at	at	IN
cord-005453-4057qib7	4460	22	SOLCA	SOLCA	NNP
cord-005453-4057qib7	4460	23	-	-	HYPH
cord-005453-4057qib7	4460	24	Guayaquil	Guayaquil	NNP
cord-005453-4057qib7	4460	25	,	,	,
cord-005453-4057qib7	4460	26	between	between	IN
cord-005453-4057qib7	4460	27	the	the	DT
cord-005453-4057qib7	4460	28	years	year	NNS
cord-005453-4057qib7	4460	29	2009	2009	CD
cord-005453-4057qib7	4460	30	-2016.We	-2016.We	JJS
cord-005453-4057qib7	4460	31	use	use	VBP
cord-005453-4057qib7	4460	32	the	the	DT
cord-005453-4057qib7	4460	33	Kaplan	Kaplan	NNP
cord-005453-4057qib7	4460	34	-	-	HYPH
cord-005453-4057qib7	4460	35	Meier	Meier	NNP
cord-005453-4057qib7	4460	36	method	method	NN
cord-005453-4057qib7	4460	37	to	to	TO
cord-005453-4057qib7	4460	38	analyze	analyze	VB
cord-005453-4057qib7	4460	39	the	the	DT
cord-005453-4057qib7	4460	40	survival	survival	NN
cord-005453-4057qib7	4460	41	rate	rate	NN
cord-005453-4057qib7	4460	42	between	between	IN
cord-005453-4057qib7	4460	43	the	the	DT
cord-005453-4057qib7	4460	44	autologous	autologous	JJ
cord-005453-4057qib7	4460	45	and	and	CC
cord-005453-4057qib7	4460	46	allogeneic	allogeneic	NN
cord-005453-4057qib7	4460	47	transplant	transplant	NN
cord-005453-4057qib7	4460	48	.	.	.
cord-005453-4057qib7	4461	1	The	the	DT
cord-005453-4057qib7	4461	2	information	information	NN
cord-005453-4057qib7	4461	3	collected	collect	VBN
cord-005453-4057qib7	4461	4	for	for	IN
cord-005453-4057qib7	4461	5	this	this	DT
cord-005453-4057qib7	4461	6	study	study	NN
cord-005453-4057qib7	4461	7	was	be	VBD
cord-005453-4057qib7	4461	8	obtained	obtain	VBN
cord-005453-4057qib7	4461	9	from	from	IN
cord-005453-4057qib7	4461	10	the	the	DT
cord-005453-4057qib7	4461	11	database	database	NN
cord-005453-4057qib7	4461	12	of	of	IN
cord-005453-4057qib7	4461	13	the	the	DT
cord-005453-4057qib7	4461	14	SOLCAy	SOLCAy	NNPS
cord-005453-4057qib7	4461	15	Institute	Institute	NNP
cord-005453-4057qib7	4461	16	and	and	CC
cord-005453-4057qib7	4461	17	the	the	DT
cord-005453-4057qib7	4461	18	review	review	NN
cord-005453-4057qib7	4461	19	of	of	IN
cord-005453-4057qib7	4461	20	the	the	DT
cord-005453-4057qib7	4461	21	files	file	NNS
cord-005453-4057qib7	4461	22	of	of	IN
cord-005453-4057qib7	4461	23	the	the	DT
cord-005453-4057qib7	4461	24	patients	patient	NNS
cord-005453-4057qib7	4461	25	included	include	VBN
cord-005453-4057qib7	4461	26	.	.	.
cord-005453-4057qib7	4462	1	Results	result	NNS
cord-005453-4057qib7	4462	2	:	:	:
cord-005453-4057qib7	4463	1	At	at	RB
cord-005453-4057qib7	4463	2	least	least	JJS
cord-005453-4057qib7	4463	3	,	,	,
cord-005453-4057qib7	4463	4	150	150	CD
cord-005453-4057qib7	4463	5	patients	patient	NNS
cord-005453-4057qib7	4463	6	have	have	VBP
cord-005453-4057qib7	4463	7	been	be	VBN
cord-005453-4057qib7	4463	8	undergoing	undergo	VBG
cord-005453-4057qib7	4463	9	to	to	IN
cord-005453-4057qib7	4463	10	HSCT	HSCT	NNP
cord-005453-4057qib7	4463	11	between	between	IN
cord-005453-4057qib7	4463	12	2009	2009	CD
cord-005453-4057qib7	4463	13	-	-	SYM
cord-005453-4057qib7	4463	14	2016	2016	CD
cord-005453-4057qib7	4463	15	years	year	NNS
cord-005453-4057qib7	4463	16	.	.	.
cord-005453-4057qib7	4464	1	According	accord	VBG
cord-005453-4057qib7	4464	2	to	to	IN
cord-005453-4057qib7	4464	3	the	the	DT
cord-005453-4057qib7	4464	4	type	type	NN
cord-005453-4057qib7	4464	5	of	of	IN
cord-005453-4057qib7	4464	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4464	7	,	,	,
cord-005453-4057qib7	4464	8	42.1	42.1	CD
cord-005453-4057qib7	4464	9	%	%	NN
cord-005453-4057qib7	4464	10	received	receive	VBD
cord-005453-4057qib7	4464	11	an	an	DT
cord-005453-4057qib7	4464	12	autologous	autologous	JJ
cord-005453-4057qib7	4464	13	transplant	transplant	NN
cord-005453-4057qib7	4464	14	and	and	CC
cord-005453-4057qib7	4464	15	57.9	57.9	CD
cord-005453-4057qib7	4464	16	%	%	NN
cord-005453-4057qib7	4464	17	received	receive	VBD
cord-005453-4057qib7	4464	18	an	an	DT
cord-005453-4057qib7	4464	19	allogeneic	allogeneic	NN
cord-005453-4057qib7	4464	20	transplant	transplant	NN
cord-005453-4057qib7	4464	21	,	,	,
cord-005453-4057qib7	4464	22	from	from	IN
cord-005453-4057qib7	4464	23	which	which	WDT
cord-005453-4057qib7	4464	24	79.3	79.3	CD
cord-005453-4057qib7	4464	25	%	%	NN
cord-005453-4057qib7	4464	26	were	be	VBD
cord-005453-4057qib7	4464	27	from	from	IN
cord-005453-4057qib7	4464	28	a	a	DT
cord-005453-4057qib7	4464	29	related	related	JJ
cord-005453-4057qib7	4464	30	donor	donor	NN
cord-005453-4057qib7	4464	31	.	.	.
cord-005453-4057qib7	4465	1	The	the	DT
cord-005453-4057qib7	4465	2	main	main	JJ
cord-005453-4057qib7	4465	3	source	source	NN
cord-005453-4057qib7	4465	4	of	of	IN
cord-005453-4057qib7	4465	5	transplant	transplant	NN
cord-005453-4057qib7	4465	6	was	be	VBD
cord-005453-4057qib7	4465	7	peripheral	peripheral	JJ
cord-005453-4057qib7	4465	8	blood	blood	NN
cord-005453-4057qib7	4465	9	in	in	IN
cord-005453-4057qib7	4465	10	86.67	86.67	CD
cord-005453-4057qib7	4465	11	%	%	NN
cord-005453-4057qib7	4465	12	,	,	,
cord-005453-4057qib7	4465	13	followed	follow	VBN
cord-005453-4057qib7	4465	14	by	by	IN
cord-005453-4057qib7	4465	15	12	12	CD
cord-005453-4057qib7	4465	16	%	%	NN
cord-005453-4057qib7	4465	17	obtained	obtain	VBN
cord-005453-4057qib7	4465	18	from	from	IN
cord-005453-4057qib7	4465	19	umbilical	umbilical	JJ
cord-005453-4057qib7	4465	20	cord	cord	NN
cord-005453-4057qib7	4465	21	blood	blood	NN
cord-005453-4057qib7	4465	22	and	and	CC
cord-005453-4057qib7	4465	23	1.33	1.33	CD
cord-005453-4057qib7	4465	24	%	%	NN
cord-005453-4057qib7	4465	25	by	by	IN
cord-005453-4057qib7	4465	26	bone	bone	NN
cord-005453-4057qib7	4465	27	marrow	marrow	NN
cord-005453-4057qib7	4465	28	aspiration	aspiration	NN
cord-005453-4057qib7	4465	29	.	.	.
cord-005453-4057qib7	4466	1	The	the	DT
cord-005453-4057qib7	4466	2	most	most	RBS
cord-005453-4057qib7	4466	3	frequently	frequently	RB
cord-005453-4057qib7	4466	4	reported	report	VBN
cord-005453-4057qib7	4466	5	pathologies	pathology	NNS
cord-005453-4057qib7	4466	6	were	be	VBD
cord-005453-4057qib7	4466	7	acute	acute	JJ
cord-005453-4057qib7	4466	8	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	4466	9	leukemia	leukemia	NN
cord-005453-4057qib7	4466	10	(	(	-LRB-
cord-005453-4057qib7	4466	11	ALL	all	DT
cord-005453-4057qib7	4466	12	)	)	-RRB-
cord-005453-4057qib7	4466	13	(	(	-LRB-
cord-005453-4057qib7	4466	14	34	34	CD
cord-005453-4057qib7	4466	15	%	%	NN
cord-005453-4057qib7	4466	16	)	)	-RRB-
cord-005453-4057qib7	4466	17	,	,	,
cord-005453-4057qib7	4466	18	multiple	multiple	JJ
cord-005453-4057qib7	4466	19	myeloma	myeloma	NN
cord-005453-4057qib7	4466	20	(	(	-LRB-
cord-005453-4057qib7	4466	21	MM	MM	NNP
cord-005453-4057qib7	4466	22	)	)	-RRB-
cord-005453-4057qib7	4466	23	(	(	-LRB-
cord-005453-4057qib7	4466	24	22	22	CD
cord-005453-4057qib7	4466	25	%	%	NN
cord-005453-4057qib7	4466	26	)	)	-RRB-
cord-005453-4057qib7	4466	27	and	and	CC
cord-005453-4057qib7	4466	28	acute	acute	JJ
cord-005453-4057qib7	4466	29	myeloid	myeloid	NN
cord-005453-4057qib7	4466	30	leukemia	leukemia	NN
cord-005453-4057qib7	4466	31	(	(	-LRB-
cord-005453-4057qib7	4466	32	AML	AML	NNP
cord-005453-4057qib7	4466	33	)	)	-RRB-
cord-005453-4057qib7	4466	34	(	(	-LRB-
cord-005453-4057qib7	4466	35	13.33	13.33	CD
cord-005453-4057qib7	4466	36	%	%	NN
cord-005453-4057qib7	4466	37	)	)	-RRB-
cord-005453-4057qib7	4466	38	.	.	.
cord-005453-4057qib7	4467	1	The	the	DT
cord-005453-4057qib7	4467	2	overall	overall	JJ
cord-005453-4057qib7	4467	3	survival	survival	NN
cord-005453-4057qib7	4467	4	was	be	VBD
cord-005453-4057qib7	4467	5	68	68	CD
cord-005453-4057qib7	4467	6	%	%	NN
cord-005453-4057qib7	4467	7	(	(	-LRB-
cord-005453-4057qib7	4467	8	IC	IC	NNP
cord-005453-4057qib7	4467	9	:	:	:
cord-005453-4057qib7	4467	10	95	95	CD
cord-005453-4057qib7	4467	11	%	%	NN
cord-005453-4057qib7	4467	12	)	)	-RRB-
cord-005453-4057qib7	4467	13	.	.	.
cord-005453-4057qib7	4468	1	The	the	DT
cord-005453-4057qib7	4468	2	82.53	82.53	CD
cord-005453-4057qib7	4468	3	%	%	NN
cord-005453-4057qib7	4468	4	of	of	IN
cord-005453-4057qib7	4468	5	patients	patient	NNS
cord-005453-4057qib7	4468	6	that	that	WDT
cord-005453-4057qib7	4468	7	were	be	VBD
cord-005453-4057qib7	4468	8	undergoing	undergo	VBG
cord-005453-4057qib7	4468	9	to	to	IN
cord-005453-4057qib7	4468	10	autologous	autologous	JJ
cord-005453-4057qib7	4468	11	transplant	transplant	NN
cord-005453-4057qib7	4468	12	have	have	VBP
cord-005453-4057qib7	4468	13	survive	survive	VB
cord-005453-4057qib7	4468	14	,	,	,
cord-005453-4057qib7	4468	15	meanwhile	meanwhile	RB
cord-005453-4057qib7	4468	16	the	the	DT
cord-005453-4057qib7	4468	17	patients	patient	NNS
cord-005453-4057qib7	4468	18	that	that	WDT
cord-005453-4057qib7	4468	19	were	be	VBD
cord-005453-4057qib7	4468	20	undergoing	undergo	VBG
cord-005453-4057qib7	4468	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	4468	22	transplant	transplant	NN
cord-005453-4057qib7	4468	23	only	only	RB
cord-005453-4057qib7	4468	24	the	the	DT
cord-005453-4057qib7	4468	25	57.47	57.47	CD
cord-005453-4057qib7	4468	26	%	%	NN
cord-005453-4057qib7	4468	27	have	have	VBP
cord-005453-4057qib7	4468	28	survived	survive	VBN
cord-005453-4057qib7	4468	29	(	(	-LRB-
cord-005453-4057qib7	4468	30	p	p	NN
cord-005453-4057qib7	4468	31	<	<	XX
cord-005453-4057qib7	4468	32	0.05	0.05	CD
cord-005453-4057qib7	4468	33	)	)	-RRB-
cord-005453-4057qib7	4468	34	.	.	.
cord-005453-4057qib7	4469	1	The	the	DT
cord-005453-4057qib7	4469	2	highest	high	JJS
cord-005453-4057qib7	4469	3	death	death	NN
cord-005453-4057qib7	4469	4	rate	rate	NN
cord-005453-4057qib7	4469	5	occurred	occur	VBD
cord-005453-4057qib7	4469	6	during	during	IN
cord-005453-4057qib7	4469	7	the	the	DT
cord-005453-4057qib7	4469	8	first	first	JJ
cord-005453-4057qib7	4469	9	year	year	NN
cord-005453-4057qib7	4469	10	after	after	IN
cord-005453-4057qib7	4469	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4469	12	,	,	,
cord-005453-4057qib7	4469	13	and	and	CC
cord-005453-4057qib7	4469	14	decreased	decrease	VBD
cord-005453-4057qib7	4469	15	considerably	considerably	RB
cord-005453-4057qib7	4469	16	after	after	IN
cord-005453-4057qib7	4469	17	that	that	DT
cord-005453-4057qib7	4469	18	period	period	NN
cord-005453-4057qib7	4469	19	.	.	.
cord-005453-4057qib7	4470	1	The	the	DT
cord-005453-4057qib7	4470	2	main	main	JJ
cord-005453-4057qib7	4470	3	cause	cause	NN
cord-005453-4057qib7	4470	4	of	of	IN
cord-005453-4057qib7	4470	5	mortality	mortality	NN
cord-005453-4057qib7	4470	6	related	relate	VBN
cord-005453-4057qib7	4470	7	to	to	IN
cord-005453-4057qib7	4470	8	transplant	transplant	NN
cord-005453-4057qib7	4470	9	(	(	-LRB-
cord-005453-4057qib7	4470	10	MRT	MRT	NNP
cord-005453-4057qib7	4470	11	)	)	-RRB-
cord-005453-4057qib7	4470	12	was	be	VBD
cord-005453-4057qib7	4470	13	the	the	DT
cord-005453-4057qib7	4470	14	graft	graft	NN
cord-005453-4057qib7	4470	15	-	-	HYPH
cord-005453-4057qib7	4470	16	versus	versus	IN
cord-005453-4057qib7	4470	17	-	-	HYPH
cord-005453-4057qib7	4470	18	host	host	NN
cord-005453-4057qib7	4470	19	disease	disease	NN
cord-005453-4057qib7	4470	20	(	(	-LRB-
cord-005453-4057qib7	4470	21	GVHD	GVHD	NNP
cord-005453-4057qib7	4470	22	)	)	-RRB-
cord-005453-4057qib7	4470	23	(	(	-LRB-
cord-005453-4057qib7	4470	24	8	8	CD
cord-005453-4057qib7	4470	25	%	%	NN
cord-005453-4057qib7	4470	26	)	)	-RRB-
cord-005453-4057qib7	4470	27	;	;	:
cord-005453-4057qib7	4470	28	however	however	RB
cord-005453-4057qib7	4470	29	,	,	,
cord-005453-4057qib7	4470	30	the	the	DT
cord-005453-4057qib7	4470	31	main	main	JJ
cord-005453-4057qib7	4470	32	cause	cause	NN
cord-005453-4057qib7	4470	33	of	of	IN
cord-005453-4057qib7	4470	34	mortality	mortality	NN
cord-005453-4057qib7	4470	35	in	in	IN
cord-005453-4057qib7	4470	36	the	the	DT
cord-005453-4057qib7	4470	37	study	study	NN
cord-005453-4057qib7	4470	38	population	population	NN
cord-005453-4057qib7	4470	39	(	(	-LRB-
cord-005453-4057qib7	4470	40	n=150	n=150	NNP
cord-005453-4057qib7	4470	41	)	)	-RRB-
cord-005453-4057qib7	4470	42	was	be	VBD
cord-005453-4057qib7	4470	43	relapse	relapse	NN
cord-005453-4057qib7	4470	44	in	in	IN
cord-005453-4057qib7	4470	45	12.66	12.66	CD
cord-005453-4057qib7	4470	46	%	%	NN
cord-005453-4057qib7	4470	47	of	of	IN
cord-005453-4057qib7	4470	48	the	the	DT
cord-005453-4057qib7	4470	49	patients	patient	NNS
cord-005453-4057qib7	4470	50	,	,	,
cord-005453-4057qib7	4470	51	presented	present	VBD
cord-005453-4057qib7	4470	52	more	more	RBR
cord-005453-4057qib7	4470	53	frequently	frequently	RB
cord-005453-4057qib7	4470	54	in	in	IN
cord-005453-4057qib7	4470	55	ALL	all	DT
cord-005453-4057qib7	4470	56	.	.	.
cord-005453-4057qib7	4471	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4471	2	:	:	:
cord-005453-4057qib7	4472	1	The	the	DT
cord-005453-4057qib7	4472	2	results	result	NNS
cord-005453-4057qib7	4472	3	showed	show	VBD
cord-005453-4057qib7	4472	4	that	that	IN
cord-005453-4057qib7	4472	5	68	68	CD
cord-005453-4057qib7	4472	6	%	%	NN
cord-005453-4057qib7	4472	7	of	of	IN
cord-005453-4057qib7	4472	8	patients	patient	NNS
cord-005453-4057qib7	4472	9	undergoing	undergo	VBG
cord-005453-4057qib7	4472	10	to	to	IN
cord-005453-4057qib7	4472	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4472	12	have	have	VBP
cord-005453-4057qib7	4472	13	survived	survive	VBN
cord-005453-4057qib7	4472	14	.	.	.
cord-005453-4057qib7	4473	1	A	a	DT
cord-005453-4057qib7	4473	2	high	high	JJ
cord-005453-4057qib7	4473	3	rate	rate	NN
cord-005453-4057qib7	4473	4	of	of	IN
cord-005453-4057qib7	4473	5	deceased	deceased	JJ
cord-005453-4057qib7	4473	6	patients	patient	NNS
cord-005453-4057qib7	4473	7	in	in	IN
cord-005453-4057qib7	4473	8	this	this	DT
cord-005453-4057qib7	4473	9	study	study	NN
cord-005453-4057qib7	4473	10	,	,	,
cord-005453-4057qib7	4473	11	have	have	VBP
cord-005453-4057qib7	4473	12	died	die	VBN
cord-005453-4057qib7	4473	13	in	in	IN
cord-005453-4057qib7	4473	14	the	the	DT
cord-005453-4057qib7	4473	15	first	first	JJ
cord-005453-4057qib7	4473	16	year	year	NN
cord-005453-4057qib7	4473	17	before	before	IN
cord-005453-4057qib7	4473	18	the	the	DT
cord-005453-4057qib7	4473	19	transplant	transplant	NN
cord-005453-4057qib7	4473	20	(	(	-LRB-
cord-005453-4057qib7	4473	21	26.6	26.6	CD
cord-005453-4057qib7	4473	22	%	%	NN
cord-005453-4057qib7	4473	23	%	%	NN
cord-005453-4057qib7	4473	24	)	)	-RRB-
cord-005453-4057qib7	4473	25	,	,	,
cord-005453-4057qib7	4473	26	due	due	IN
cord-005453-4057qib7	4473	27	to	to	IN
cord-005453-4057qib7	4473	28	relapse	relapse	NN
cord-005453-4057qib7	4473	29	.	.	.
cord-005453-4057qib7	4474	1	The	the	DT
cord-005453-4057qib7	4474	2	main	main	JJ
cord-005453-4057qib7	4474	3	cause	cause	NN
cord-005453-4057qib7	4474	4	of	of	IN
cord-005453-4057qib7	4474	5	deceased	deceased	JJ
cord-005453-4057qib7	4474	6	in	in	IN
cord-005453-4057qib7	4474	7	the	the	DT
cord-005453-4057qib7	4474	8	study	study	NN
cord-005453-4057qib7	4474	9	is	be	VBZ
cord-005453-4057qib7	4474	10	not	not	RB
cord-005453-4057qib7	4474	11	related	relate	VBN
cord-005453-4057qib7	4474	12	to	to	IN
cord-005453-4057qib7	4474	13	HSCT	HSCT	NNP
cord-005453-4057qib7	4474	14	,	,	,
cord-005453-4057qib7	4474	15	and	and	CC
cord-005453-4057qib7	4474	16	was	be	VBD
cord-005453-4057qib7	4474	17	the	the	DT
cord-005453-4057qib7	4474	18	relapse	relapse	NN
cord-005453-4057qib7	4474	19	in	in	IN
cord-005453-4057qib7	4474	20	12	12	CD
cord-005453-4057qib7	4474	21	%	%	NN
cord-005453-4057qib7	4474	22	of	of	IN
cord-005453-4057qib7	4474	23	patients	patient	NNS
cord-005453-4057qib7	4474	24	,	,	,
cord-005453-4057qib7	4474	25	in	in	IN
cord-005453-4057qib7	4474	26	compare	compare	VB
cord-005453-4057qib7	4474	27	the	the	DT
cord-005453-4057qib7	4474	28	GVHD	GVHD	NNP
cord-005453-4057qib7	4474	29	was	be	VBD
cord-005453-4057qib7	4474	30	the	the	DT
cord-005453-4057qib7	4474	31	main	main	JJ
cord-005453-4057qib7	4474	32	cause	cause	NN
cord-005453-4057qib7	4474	33	of	of	IN
cord-005453-4057qib7	4474	34	MRT	MRT	NNP
cord-005453-4057qib7	4474	35	(	(	-LRB-
cord-005453-4057qib7	4474	36	8	8	CD
cord-005453-4057qib7	4474	37	%	%	NN
cord-005453-4057qib7	4474	38	)	)	-RRB-
cord-005453-4057qib7	4474	39	.	.	.
cord-005453-4057qib7	4475	1	We	-PRON-	PRP
cord-005453-4057qib7	4475	2	consider	consider	VBP
cord-005453-4057qib7	4475	3	that	that	IN
cord-005453-4057qib7	4475	4	HSCT	HSCT	NNP
cord-005453-4057qib7	4475	5	is	be	VBZ
cord-005453-4057qib7	4475	6	a	a	DT
cord-005453-4057qib7	4475	7	technique	technique	NN
cord-005453-4057qib7	4475	8	that	that	WDT
cord-005453-4057qib7	4475	9	is	be	VBZ
cord-005453-4057qib7	4475	10	still	still	RB
cord-005453-4057qib7	4475	11	under	under	IN
cord-005453-4057qib7	4475	12	development	development	NN
cord-005453-4057qib7	4475	13	in	in	IN
cord-005453-4057qib7	4475	14	Ecuador	Ecuador	NNP
cord-005453-4057qib7	4475	15	,	,	,
cord-005453-4057qib7	4475	16	but	but	CC
cord-005453-4057qib7	4475	17	despite	despite	IN
cord-005453-4057qib7	4475	18	the	the	DT
cord-005453-4057qib7	4475	19	short	short	JJ
cord-005453-4057qib7	4475	20	time	time	NN
cord-005453-4057qib7	4475	21	it	-PRON-	PRP
cord-005453-4057qib7	4475	22	has	have	VBZ
cord-005453-4057qib7	4475	23	been	be	VBN
cord-005453-4057qib7	4475	24	taking	take	VBG
cord-005453-4057qib7	4475	25	and	and	CC
cord-005453-4057qib7	4475	26	the	the	DT
cord-005453-4057qib7	4475	27	institutional	institutional	JJ
cord-005453-4057qib7	4475	28	and	and	CC
cord-005453-4057qib7	4475	29	medical	medical	JJ
cord-005453-4057qib7	4475	30	limitations	limitation	NNS
cord-005453-4057qib7	4475	31	present	present	JJ
cord-005453-4057qib7	4475	32	in	in	IN
cord-005453-4057qib7	4475	33	the	the	DT
cord-005453-4057qib7	4475	34	health	health	NN
cord-005453-4057qib7	4475	35	field	field	NN
cord-005453-4057qib7	4475	36	,	,	,
cord-005453-4057qib7	4475	37	has	have	VBZ
cord-005453-4057qib7	4475	38	presented	present	VBN
cord-005453-4057qib7	4475	39	excellent	excellent	JJ
cord-005453-4057qib7	4475	40	results	result	NNS
cord-005453-4057qib7	4475	41	comparable	comparable	JJ
cord-005453-4057qib7	4475	42	to	to	IN
cord-005453-4057qib7	4475	43	studies	study	NNS
cord-005453-4057qib7	4475	44	conducted	conduct	VBN
cord-005453-4057qib7	4475	45	in	in	IN
cord-005453-4057qib7	4475	46	developed	develop	VBN
cord-005453-4057qib7	4475	47	countries	country	NNS
cord-005453-4057qib7	4475	48	.	.	.
cord-005453-4057qib7	4476	1	[	[	-LRB-
cord-005453-4057qib7	4476	2	Background	background	NN
cord-005453-4057qib7	4476	3	:	:	:
cord-005453-4057qib7	4476	4	Pigmented	pigmented	JJ
cord-005453-4057qib7	4476	5	epithelioid	epithelioid	NN
cord-005453-4057qib7	4476	6	melanocytoma	melanocytoma	NN
cord-005453-4057qib7	4476	7	(	(	-LRB-
cord-005453-4057qib7	4476	8	PEM	PEM	NNP
cord-005453-4057qib7	4476	9	,	,	,
cord-005453-4057qib7	4476	10	early	early	RB
cord-005453-4057qib7	4476	11	known	know	VBN
cord-005453-4057qib7	4476	12	as	as	IN
cord-005453-4057qib7	4476	13	'	'	``
cord-005453-4057qib7	4476	14	Аnimal	Аnimal	NNP
cord-005453-4057qib7	4476	15	type	type	NN
cord-005453-4057qib7	4476	16	'	'	''
cord-005453-4057qib7	4476	17	melanoma	melanoma	NN
cord-005453-4057qib7	4476	18	)	)	-RRB-
cord-005453-4057qib7	4476	19	is	be	VBZ
cord-005453-4057qib7	4476	20	a	a	DT
cord-005453-4057qib7	4476	21	rare	rare	JJ
cord-005453-4057qib7	4476	22	tumor	tumor	NN
cord-005453-4057qib7	4476	23	with	with	IN
cord-005453-4057qib7	4476	24	unpredictable	unpredictable	JJ
cord-005453-4057qib7	4476	25	clinical	clinical	JJ
cord-005453-4057qib7	4476	26	behavior	behavior	NN
cord-005453-4057qib7	4476	27	and	and	CC
cord-005453-4057qib7	4476	28	metastatic	metastatic	JJ
cord-005453-4057qib7	4476	29	potential	potential	NN
cord-005453-4057qib7	4476	30	.	.	.
cord-005453-4057qib7	4477	1	PEM	PEM	NNP
cord-005453-4057qib7	4477	2	generally	generally	RB
cord-005453-4057qib7	4477	3	has	have	VBZ
cord-005453-4057qib7	4477	4	favorable	favorable	JJ
cord-005453-4057qib7	4477	5	prognosis	prognosis	NN
cord-005453-4057qib7	4477	6	.	.	.
cord-005453-4057qib7	4478	1	Involvement	involvement	NN
cord-005453-4057qib7	4478	2	of	of	IN
cord-005453-4057qib7	4478	3	regional	regional	JJ
cord-005453-4057qib7	4478	4	lymph	lymph	NN
cord-005453-4057qib7	4478	5	nodes	node	NNS
cord-005453-4057qib7	4478	6	is	be	VBZ
cord-005453-4057qib7	4478	7	not	not	RB
cord-005453-4057qib7	4478	8	rare	rare	JJ
cord-005453-4057qib7	4478	9	.	.	.
cord-005453-4057qib7	4479	1	Extranodal	extranodal	JJ
cord-005453-4057qib7	4479	2	and	and	CC
cord-005453-4057qib7	4479	3	distant	distant	JJ
cord-005453-4057qib7	4479	4	nodal	nodal	JJ
cord-005453-4057qib7	4479	5	metastases	metastasis	NNS
cord-005453-4057qib7	4479	6	are	be	VBP
cord-005453-4057qib7	4479	7	extremely	extremely	RB
cord-005453-4057qib7	4479	8	rare	rare	JJ
cord-005453-4057qib7	4479	9	.	.	.
cord-005453-4057qib7	4480	1	We	-PRON-	PRP
cord-005453-4057qib7	4480	2	report	report	VBP
cord-005453-4057qib7	4480	3	about	about	IN
cord-005453-4057qib7	4480	4	patient	patient	NN
cord-005453-4057qib7	4480	5	with	with	IN
cord-005453-4057qib7	4480	6	Fanconi	Fanconi	NNP
cord-005453-4057qib7	4480	7	anemia	anemia	NN
cord-005453-4057qib7	4480	8	(	(	-LRB-
cord-005453-4057qib7	4480	9	FA	FA	NNP
cord-005453-4057qib7	4480	10	)	)	-RRB-
cord-005453-4057qib7	4480	11	and	and	CC
cord-005453-4057qib7	4480	12	PEM	PEM	NNP
cord-005453-4057qib7	4480	13	with	with	IN
cord-005453-4057qib7	4480	14	developed	develop	VBN
cord-005453-4057qib7	4480	15	distant	distant	JJ
cord-005453-4057qib7	4480	16	metastases	metastasis	NNS
cord-005453-4057qib7	4480	17	in	in	IN
cord-005453-4057qib7	4480	18	the	the	DT
cord-005453-4057qib7	4480	19	early	early	JJ
cord-005453-4057qib7	4480	20	term	term	NN
cord-005453-4057qib7	4480	21	after	after	IN
cord-005453-4057qib7	4480	22	allogeneic	allogeneic	JJ
cord-005453-4057qib7	4480	23	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4480	24	stem	stem	NN
cord-005453-4057qib7	4480	25	cell	cell	NN
cord-005453-4057qib7	4480	26	transplantation	transplantation	NN
cord-005453-4057qib7	4480	27	(	(	-LRB-
cord-005453-4057qib7	4480	28	HSCT	HSCT	NNP
cord-005453-4057qib7	4480	29	)	)	-RRB-
cord-005453-4057qib7	4480	30	.	.	.
cord-005453-4057qib7	4481	1	Methods	method	NNS
cord-005453-4057qib7	4481	2	:	:	:
cord-005453-4057qib7	4482	1	10-years	10-years	CD
cord-005453-4057qib7	4482	2	old	old	JJ
cord-005453-4057qib7	4482	3	boy	boy	NN
cord-005453-4057qib7	4482	4	with	with	IN
cord-005453-4057qib7	4482	5	FA	FA	NNP
cord-005453-4057qib7	4482	6	was	be	VBD
cord-005453-4057qib7	4482	7	hospitalized	hospitalize	VBN
cord-005453-4057qib7	4482	8	for	for	IN
cord-005453-4057qib7	4482	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4482	10	.	.	.
cord-005453-4057qib7	4483	1	The	the	DT
cord-005453-4057qib7	4483	2	blue	blue	JJ
cord-005453-4057qib7	4483	3	-	-	HYPH
cord-005453-4057qib7	4483	4	black	black	JJ
cord-005453-4057qib7	4483	5	painless	painless	JJ
cord-005453-4057qib7	4483	6	nodulus	nodulus	NNP
cord-005453-4057qib7	4483	7	15х15	15х15	CD
cord-005453-4057qib7	4483	8	mm	mm	NNP
cord-005453-4057qib7	4483	9	was	be	VBD
cord-005453-4057qib7	4483	10	noted	note	VBN
cord-005453-4057qib7	4483	11	on	on	IN
cord-005453-4057qib7	4483	12	the	the	DT
cord-005453-4057qib7	4483	13	left	left	JJ
cord-005453-4057qib7	4483	14	cheek	cheek	NN
cord-005453-4057qib7	4483	15	.	.	.
cord-005453-4057qib7	4484	1	This	this	DT
cord-005453-4057qib7	4484	2	lesion	lesion	NN
cord-005453-4057qib7	4484	3	was	be	VBD
cord-005453-4057qib7	4484	4	observed	observe	VBN
cord-005453-4057qib7	4484	5	from	from	IN
cord-005453-4057qib7	4484	6	early	early	JJ
cord-005453-4057qib7	4484	7	childhood	childhood	NN
cord-005453-4057qib7	4484	8	and	and	CC
cord-005453-4057qib7	4484	9	during	during	IN
cord-005453-4057qib7	4484	10	life	life	NN
cord-005453-4057qib7	4484	11	only	only	RB
cord-005453-4057qib7	4484	12	slightly	slightly	RB
cord-005453-4057qib7	4484	13	increased	increase	VBD
cord-005453-4057qib7	4484	14	in	in	IN
cord-005453-4057qib7	4484	15	size	size	NN
cord-005453-4057qib7	4484	16	.	.	.
cord-005453-4057qib7	4485	1	There	there	EX
cord-005453-4057qib7	4485	2	were	be	VBD
cord-005453-4057qib7	4485	3	no	no	DT
cord-005453-4057qib7	4485	4	distant	distant	JJ
cord-005453-4057qib7	4485	5	and	and	CC
cord-005453-4057qib7	4485	6	regional	regional	JJ
cord-005453-4057qib7	4485	7	metastases	metastasis	NNS
cord-005453-4057qib7	4485	8	on	on	IN
cord-005453-4057qib7	4485	9	computerized	computerized	NN
cord-005453-4057qib7	4485	10	tomography	tomography	NN
cord-005453-4057qib7	4485	11	(	(	-LRB-
cord-005453-4057qib7	4485	12	CT	CT	NNP
cord-005453-4057qib7	4485	13	)	)	-RRB-
cord-005453-4057qib7	4485	14	and	and	CC
cord-005453-4057qib7	4485	15	scintigraphy	scintigraphy	NN
cord-005453-4057qib7	4485	16	with	with	IN
cord-005453-4057qib7	4485	17	99	99	CD
cord-005453-4057qib7	4485	18	m	m	NN
cord-005453-4057qib7	4485	19	Tc	Tc	NNP
cord-005453-4057qib7	4485	20	.	.	.
cord-005453-4057qib7	4486	1	The	the	DT
cord-005453-4057qib7	4486	2	nodulus	nodulus	NN
cord-005453-4057qib7	4486	3	and	and	CC
cord-005453-4057qib7	4486	4	regional	regional	JJ
cord-005453-4057qib7	4486	5	lymph	lymph	NN
cord-005453-4057qib7	4486	6	nodes	node	NNS
cord-005453-4057qib7	4486	7	were	be	VBD
cord-005453-4057qib7	4486	8	radically	radically	RB
cord-005453-4057qib7	4486	9	removed	remove	VBN
cord-005453-4057qib7	4486	10	before	before	IN
cord-005453-4057qib7	4486	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4486	12	.	.	.
cord-005453-4057qib7	4487	1	The	the	DT
cord-005453-4057qib7	4487	2	resection	resection	NN
cord-005453-4057qib7	4487	3	margin	margin	NN
cord-005453-4057qib7	4487	4	was	be	VBD
cord-005453-4057qib7	4487	5	within	within	IN
cord-005453-4057qib7	4487	6	the	the	DT
cord-005453-4057qib7	4487	7	normal	normal	JJ
cord-005453-4057qib7	4487	8	tissue	tissue	NN
cord-005453-4057qib7	4487	9	.	.	.
cord-005453-4057qib7	4488	1	Microscopically	microscopically	RB
cord-005453-4057qib7	4488	2	the	the	DT
cord-005453-4057qib7	4488	3	derma	derma	NN
cord-005453-4057qib7	4488	4	and	and	CC
cord-005453-4057qib7	4488	5	subcutaneous	subcutaneous	JJ
cord-005453-4057qib7	4488	6	fat	fat	NN
cord-005453-4057qib7	4488	7	were	be	VBD
cord-005453-4057qib7	4488	8	infiltrated	infiltrate	VBN
cord-005453-4057qib7	4488	9	with	with	IN
cord-005453-4057qib7	4488	10	epithelioid	epithelioid	NN
cord-005453-4057qib7	4488	11	and	and	CC
cord-005453-4057qib7	4488	12	spindle	spindle	NN
cord-005453-4057qib7	4488	13	cells	cell	NNS
cord-005453-4057qib7	4488	14	with	with	IN
cord-005453-4057qib7	4488	15	total	total	JJ
cord-005453-4057qib7	4488	16	expression	expression	NN
cord-005453-4057qib7	4488	17	of	of	IN
cord-005453-4057qib7	4488	18	S100	S100	NNP
cord-005453-4057qib7	4488	19	,	,	,
cord-005453-4057qib7	4488	20	MelanA	melana	NN
cord-005453-4057qib7	4488	21	,	,	,
cord-005453-4057qib7	4488	22	MHB45	MHB45	NNP
cord-005453-4057qib7	4488	23	,	,	,
cord-005453-4057qib7	4488	24	CyclinD1	CyclinD1	NNP
cord-005453-4057qib7	4488	25	.	.	.
cord-005453-4057qib7	4489	1	Ki-67	Ki-67	.
cord-005453-4057qib7	4490	1	expression	expression	NN
cord-005453-4057qib7	4490	2	level	level	NN
cord-005453-4057qib7	4490	3	was	be	VBD
cord-005453-4057qib7	4490	4	15	15	CD
cord-005453-4057qib7	4490	5	-	-	SYM
cord-005453-4057qib7	4490	6	20	20	CD
cord-005453-4057qib7	4490	7	%	%	NN
cord-005453-4057qib7	4490	8	.	.	.
cord-005453-4057qib7	4491	1	Histological	histological	JJ
cord-005453-4057qib7	4491	2	structure	structure	NN
cord-005453-4057qib7	4491	3	was	be	VBD
cord-005453-4057qib7	4491	4	specific	specific	JJ
cord-005453-4057qib7	4491	5	for	for	IN
cord-005453-4057qib7	4491	6	PEM	PEM	NNP
cord-005453-4057qib7	4491	7	.	.	.
cord-005453-4057qib7	4492	1	HSCT	HSCT	NNP
cord-005453-4057qib7	4492	2	with	with	IN
cord-005453-4057qib7	4492	3	TCRαβ+/CD19	tcrαβ+/cd19	NN
cord-005453-4057qib7	4492	4	+	+	CC
cord-005453-4057qib7	4492	5	graft	graft	NN
cord-005453-4057qib7	4492	6	depletion	depletion	NN
cord-005453-4057qib7	4492	7	from	from	IN
cord-005453-4057qib7	4492	8	match	match	NN
cord-005453-4057qib7	4492	9	unrelated	unrelated	JJ
cord-005453-4057qib7	4492	10	donor	donor	NN
cord-005453-4057qib7	4492	11	was	be	VBD
cord-005453-4057qib7	4492	12	performed	perform	VBN
cord-005453-4057qib7	4492	13	.	.	.
cord-005453-4057qib7	4493	1	The	the	DT
cord-005453-4057qib7	4493	2	conditioning	conditioning	NN
cord-005453-4057qib7	4493	3	regimen	regimen	NN
cord-005453-4057qib7	4493	4	included	include	VBD
cord-005453-4057qib7	4493	5	total	total	JJ
cord-005453-4057qib7	4493	6	lymphoid	lymphoid	JJ
cord-005453-4057qib7	4493	7	irradiation	irradiation	NN
cord-005453-4057qib7	4493	8	2Gy	2gy	NN
cord-005453-4057qib7	4493	9	,	,	,
cord-005453-4057qib7	4493	10	fludarabin	fludarabin	NNP
cord-005453-4057qib7	4493	11	150	150	CD
cord-005453-4057qib7	4493	12	mg/	mg/	NN
cord-005453-4057qib7	4493	13	m	m	NN
cord-005453-4057qib7	4493	14	2	2	CD
cord-005453-4057qib7	4493	15	,	,	,
cord-005453-4057qib7	4493	16	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	4493	17	40	40	CD
cord-005453-4057qib7	4493	18	mg	mg	NNP
cord-005453-4057qib7	4493	19	/	/	SYM
cord-005453-4057qib7	4493	20	kg	kg	NNP
cord-005453-4057qib7	4493	21	,	,	,
cord-005453-4057qib7	4493	22	rabbit	rabbit	NN
cord-005453-4057qib7	4493	23	ATG	ATG	NNP
cord-005453-4057qib7	4493	24	5	5	CD
cord-005453-4057qib7	4493	25	mg	mg	NNP
cord-005453-4057qib7	4493	26	/	/	SYM
cord-005453-4057qib7	4493	27	kg	kg	NNS
cord-005453-4057qib7	4493	28	and	and	CC
cord-005453-4057qib7	4494	1	rituximab	rituximab	RB
cord-005453-4057qib7	4494	2	100	100	CD
cord-005453-4057qib7	4494	3	mg	mg	NNP
cord-005453-4057qib7	4494	4	/	/	SYM
cord-005453-4057qib7	4494	5	m	m	NNP
cord-005453-4057qib7	4494	6	2	2	CD
cord-005453-4057qib7	4494	7	.	.	.
cord-005453-4057qib7	4495	1	Results	result	NNS
cord-005453-4057qib7	4495	2	:	:	:
cord-005453-4057qib7	4496	1	At	at	IN
cord-005453-4057qib7	4496	2	+45	+45	NNP
cord-005453-4057qib7	4496	3	day	day	NN
cord-005453-4057qib7	4496	4	after	after	IN
cord-005453-4057qib7	4496	5	HSCT	HSCT	NNP
cord-005453-4057qib7	4496	6	was	be	VBD
cord-005453-4057qib7	4496	7	detected	detect	VBN
cord-005453-4057qib7	4496	8	the	the	DT
cord-005453-4057qib7	4496	9	tumor	tumor	NN
cord-005453-4057qib7	4496	10	on	on	IN
cord-005453-4057qib7	4496	11	the	the	DT
cord-005453-4057qib7	4496	12	left	left	JJ
cord-005453-4057qib7	4496	13	cheek	cheek	NN
cord-005453-4057qib7	4496	14	and	and	CC
cord-005453-4057qib7	4496	15	parotid	parotid	NN
cord-005453-4057qib7	4496	16	region	region	NN
cord-005453-4057qib7	4496	17	with	with	IN
cord-005453-4057qib7	4496	18	a	a	DT
cord-005453-4057qib7	4496	19	histological	histological	JJ
cord-005453-4057qib7	4496	20	structure	structure	NN
cord-005453-4057qib7	4496	21	identical	identical	JJ
cord-005453-4057qib7	4496	22	to	to	IN
cord-005453-4057qib7	4496	23	the	the	DT
cord-005453-4057qib7	4496	24	primary	primary	JJ
cord-005453-4057qib7	4496	25	lesion	lesion	NN
cord-005453-4057qib7	4496	26	.	.	.
cord-005453-4057qib7	4497	1	On	on	IN
cord-005453-4057qib7	4497	2	CT	CT	NNP
cord-005453-4057qib7	4497	3	in	in	IN
cord-005453-4057qib7	4497	4	S6	S6	NNP
cord-005453-4057qib7	4497	5	segment	segment	NN
cord-005453-4057qib7	4497	6	of	of	IN
cord-005453-4057qib7	4497	7	the	the	DT
cord-005453-4057qib7	4497	8	left	left	JJ
cord-005453-4057qib7	4497	9	lung	lung	NN
cord-005453-4057qib7	4497	10	was	be	VBD
cord-005453-4057qib7	4497	11	detected	detect	VBN
cord-005453-4057qib7	4497	12	focus	focus	VBP
cord-005453-4057qib7	4497	13	20x20	20x20	CD
cord-005453-4057qib7	4497	14	mm	mm	NN
cord-005453-4057qib7	4497	15	with	with	IN
cord-005453-4057qib7	4497	16	a	a	DT
cord-005453-4057qib7	4497	17	cavity	cavity	NN
cord-005453-4057qib7	4497	18	.	.	.
cord-005453-4057qib7	4498	1	Invasive	invasive	JJ
cord-005453-4057qib7	4498	2	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	4498	3	was	be	VBD
cord-005453-4057qib7	4498	4	suspected	suspect	VBN
cord-005453-4057qib7	4498	5	and	and	CC
cord-005453-4057qib7	4498	6	empirical	empirical	JJ
cord-005453-4057qib7	4498	7	antifungal	antifungal	JJ
cord-005453-4057qib7	4498	8	treatment	treatment	NN
cord-005453-4057qib7	4498	9	was	be	VBD
cord-005453-4057qib7	4498	10	started	start	VBN
cord-005453-4057qib7	4498	11	.	.	.
cord-005453-4057qib7	4499	1	But	but	CC
cord-005453-4057qib7	4499	2	in	in	IN
cord-005453-4057qib7	4499	3	15	15	CD
cord-005453-4057qib7	4499	4	days	day	NNS
cord-005453-4057qib7	4499	5	the	the	DT
cord-005453-4057qib7	4499	6	lung	lung	NN
cord-005453-4057qib7	4499	7	lesion	lesion	NN
cord-005453-4057qib7	4499	8	increased	increase	VBD
cord-005453-4057qib7	4499	9	in	in	IN
cord-005453-4057qib7	4499	10	size	size	NN
cord-005453-4057qib7	4499	11	to	to	IN
cord-005453-4057qib7	4499	12	52x30x32	52x30x32	CD
cord-005453-4057qib7	4499	13	mm	mm	NNS
cord-005453-4057qib7	4499	14	and	and	CC
cord-005453-4057qib7	4499	15	penetrated	penetrate	VBD
cord-005453-4057qib7	4499	16	in	in	IN
cord-005453-4057qib7	4499	17	the	the	DT
cord-005453-4057qib7	4499	18	bronchus	bronchus	NN
cord-005453-4057qib7	4499	19	.	.	.
cord-005453-4057qib7	4500	1	After	after	IN
cord-005453-4057qib7	4500	2	bronchoscopy	bronchoscopy	NN
cord-005453-4057qib7	4500	3	with	with	IN
cord-005453-4057qib7	4500	4	biopsy	biopsy	NN
cord-005453-4057qib7	4500	5	,	,	,
cord-005453-4057qib7	4500	6	PEM	pem	NN
cord-005453-4057qib7	4500	7	metastasis	metastasis	NN
cord-005453-4057qib7	4500	8	was	be	VBD
cord-005453-4057qib7	4500	9	histologically	histologically	RB
cord-005453-4057qib7	4500	10	confirmed	confirm	VBN
cord-005453-4057qib7	4500	11	.	.	.
cord-005453-4057qib7	4501	1	Moreover	moreover	RB
cord-005453-4057qib7	4501	2	,	,	,
cord-005453-4057qib7	4501	3	the	the	DT
cord-005453-4057qib7	4501	4	tumor	tumor	NN
cord-005453-4057qib7	4501	5	on	on	IN
cord-005453-4057qib7	4501	6	the	the	DT
cord-005453-4057qib7	4501	7	face	face	NN
cord-005453-4057qib7	4501	8	continued	continue	VBD
cord-005453-4057qib7	4501	9	to	to	TO
cord-005453-4057qib7	4501	10	grow	grow	VB
cord-005453-4057qib7	4501	11	.	.	.
cord-005453-4057qib7	4502	1	Therapy	therapy	NN
cord-005453-4057qib7	4502	2	with	with	IN
cord-005453-4057qib7	4502	3	cobimetinib	cobimetinib	NN
cord-005453-4057qib7	4502	4	and	and	CC
cord-005453-4057qib7	4502	5	vemurafenib	vemurafenib	NN
cord-005453-4057qib7	4502	6	was	be	VBD
cord-005453-4057qib7	4502	7	not	not	RB
cord-005453-4057qib7	4502	8	effective	effective	JJ
cord-005453-4057qib7	4502	9	and	and	CC
cord-005453-4057qib7	4502	10	patient	patient	JJ
cord-005453-4057qib7	4502	11	died	die	VBD
cord-005453-4057qib7	4502	12	from	from	IN
cord-005453-4057qib7	4502	13	progression	progression	NN
cord-005453-4057qib7	4502	14	of	of	IN
cord-005453-4057qib7	4502	15	PEM	PEM	NNP
cord-005453-4057qib7	4502	16	on	on	IN
cord-005453-4057qib7	4502	17	+98	+98	NNP
cord-005453-4057qib7	4502	18	day	day	NN
cord-005453-4057qib7	4502	19	after	after	IN
cord-005453-4057qib7	4502	20	HSCT	HSCT	NNP
cord-005453-4057qib7	4502	21	.	.	.
cord-005453-4057qib7	4503	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4503	2	:	:	:
cord-005453-4057qib7	4504	1	PEM	PEM	NNP
cord-005453-4057qib7	4504	2	was	be	VBD
cord-005453-4057qib7	4504	3	early	early	RB
cord-005453-4057qib7	4504	4	described	describe	VBN
cord-005453-4057qib7	4504	5	as	as	IN
cord-005453-4057qib7	4504	6	indolent	indolent	JJ
cord-005453-4057qib7	4504	7	tumor	tumor	NN
cord-005453-4057qib7	4504	8	with	with	IN
cord-005453-4057qib7	4504	9	rare	rare	JJ
cord-005453-4057qib7	4504	10	distant	distant	JJ
cord-005453-4057qib7	4504	11	metastasis	metastasis	NN
cord-005453-4057qib7	4504	12	and	and	CC
cord-005453-4057qib7	4504	13	favorable	favorable	JJ
cord-005453-4057qib7	4504	14	prognosis	prognosis	NN
cord-005453-4057qib7	4504	15	.	.	.
cord-005453-4057qib7	4505	1	We	-PRON-	PRP
cord-005453-4057qib7	4505	2	suspect	suspect	VBP
cord-005453-4057qib7	4505	3	that	that	IN
cord-005453-4057qib7	4505	4	PEM	PEM	NNP
cord-005453-4057qib7	4505	5	may	may	MD
cord-005453-4057qib7	4505	6	acquire	acquire	VB
cord-005453-4057qib7	4505	7	an	an	DT
cord-005453-4057qib7	4505	8	aggressive	aggressive	JJ
cord-005453-4057qib7	4505	9	course	course	NN
cord-005453-4057qib7	4505	10	in	in	IN
cord-005453-4057qib7	4505	11	the	the	DT
cord-005453-4057qib7	4505	12	absence	absence	NN
cord-005453-4057qib7	4505	13	of	of	IN
cord-005453-4057qib7	4505	14	immunological	immunological	JJ
cord-005453-4057qib7	4505	15	control	control	NN
cord-005453-4057qib7	4505	16	,	,	,
cord-005453-4057qib7	4505	17	especially	especially	RB
cord-005453-4057qib7	4505	18	in	in	IN
cord-005453-4057qib7	4505	19	high	high	JJ
cord-005453-4057qib7	4505	20	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	4505	21	patients	patient	NNS
cord-005453-4057qib7	4505	22	after	after	IN
cord-005453-4057qib7	4505	23	HSCT	HSCT	NNP
cord-005453-4057qib7	4505	24	.	.	.
cord-005453-4057qib7	4506	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4506	2	:	:	:
cord-005453-4057qib7	4506	3	Nothing	nothing	NN
cord-005453-4057qib7	4506	4	to	to	TO
cord-005453-4057qib7	4506	5	declare	declare	VB
cord-005453-4057qib7	4506	6	P208	P208	NNP
cord-005453-4057qib7	4506	7	Abstract	Abstract	NNP
cord-005453-4057qib7	4506	8	withdrawn	withdraw	VBD
cord-005453-4057qib7	4506	9	Lidia	Lidia	NNP
cord-005453-4057qib7	4506	10	Gartcheva	Gartcheva	NNP
cord-005453-4057qib7	4506	11	1	1	CD
cord-005453-4057qib7	4506	12	,	,	,
cord-005453-4057qib7	4506	13	Antoaneta	Antoaneta	NNP
cord-005453-4057qib7	4506	14	Mihova	Mihova	NNP
cord-005453-4057qib7	4506	15	1	1	CD
cord-005453-4057qib7	4506	16	,	,	,
cord-005453-4057qib7	4506	17	Penka	Penka	NNP
cord-005453-4057qib7	4506	18	Ganeva	Ganeva	NNP
cord-005453-4057qib7	4506	19	1	1	CD
cord-005453-4057qib7	4506	20	,	,	,
cord-005453-4057qib7	4506	21	Margarita	Margarita	NNP
cord-005453-4057qib7	4506	22	Guenova	Guenova	NNP
cord-005453-4057qib7	4506	23	1	1	CD
cord-005453-4057qib7	4507	1	,	,	,
cord-005453-4057qib7	4507	2	Branimir	Branimir	NNP
cord-005453-4057qib7	4507	3	Spassov	Spassov	NNP
cord-005453-4057qib7	4507	4	1	1	CD
cord-005453-4057qib7	4507	5	Background	Background	NNP
cord-005453-4057qib7	4507	6	:	:	:
cord-005453-4057qib7	4508	1	The	the	DT
cord-005453-4057qib7	4508	2	main	main	JJ
cord-005453-4057qib7	4508	3	objective	objective	NN
cord-005453-4057qib7	4508	4	of	of	IN
cord-005453-4057qib7	4508	5	the	the	DT
cord-005453-4057qib7	4508	6	study	study	NN
cord-005453-4057qib7	4508	7	is	be	VBZ
cord-005453-4057qib7	4508	8	to	to	TO
cord-005453-4057qib7	4508	9	assess	assess	VB
cord-005453-4057qib7	4508	10	the	the	DT
cord-005453-4057qib7	4508	11	dynamics	dynamic	NNS
cord-005453-4057qib7	4508	12	of	of	IN
cord-005453-4057qib7	4508	13	quantitative	quantitative	JJ
cord-005453-4057qib7	4508	14	and	and	CC
cord-005453-4057qib7	4508	15	qualitative	qualitative	JJ
cord-005453-4057qib7	4508	16	changes	change	NNS
cord-005453-4057qib7	4508	17	in	in	IN
cord-005453-4057qib7	4508	18	the	the	DT
cord-005453-4057qib7	4508	19	parameters	parameter	NNS
cord-005453-4057qib7	4508	20	of	of	IN
cord-005453-4057qib7	4508	21	the	the	DT
cord-005453-4057qib7	4508	22	B	b	NN
cord-005453-4057qib7	4508	23	cell	cell	NN
cord-005453-4057qib7	4508	24	population	population	NN
cord-005453-4057qib7	4508	25	and	and	CC
cord-005453-4057qib7	4508	26	the	the	DT
cord-005453-4057qib7	4508	27	production	production	NN
cord-005453-4057qib7	4508	28	of	of	IN
cord-005453-4057qib7	4508	29	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	4508	30	in	in	IN
cord-005453-4057qib7	4508	31	patients	patient	NNS
cord-005453-4057qib7	4508	32	after	after	IN
cord-005453-4057qib7	4508	33	autologous	autologous	JJ
cord-005453-4057qib7	4508	34	transplantation	transplantation	NN
cord-005453-4057qib7	4508	35	of	of	IN
cord-005453-4057qib7	4508	36	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4508	37	stem	stem	NN
cord-005453-4057qib7	4508	38	cells	cell	NNS
cord-005453-4057qib7	4508	39	in	in	IN
cord-005453-4057qib7	4508	40	the	the	DT
cord-005453-4057qib7	4508	41	course	course	NN
cord-005453-4057qib7	4508	42	of	of	IN
cord-005453-4057qib7	4508	43	recovery	recovery	NN
cord-005453-4057qib7	4508	44	of	of	IN
cord-005453-4057qib7	4508	45	the	the	DT
cord-005453-4057qib7	4508	46	immune	immune	JJ
cord-005453-4057qib7	4508	47	system	system	NN
cord-005453-4057qib7	4508	48	.	.	.
cord-005453-4057qib7	4509	1	Methods	method	NNS
cord-005453-4057qib7	4509	2	:	:	:
cord-005453-4057qib7	4509	3	56	56	CD
cord-005453-4057qib7	4509	4	patients	patient	NNS
cord-005453-4057qib7	4509	5	with	with	IN
cord-005453-4057qib7	4509	6	hematological	hematological	JJ
cord-005453-4057qib7	4509	7	neoplasms	neoplasm	NNS
cord-005453-4057qib7	4509	8	undergoing	undergo	VBG
cord-005453-4057qib7	4509	9	autologous	autologous	JJ
cord-005453-4057qib7	4509	10	transplantation	transplantation	NN
cord-005453-4057qib7	4509	11	were	be	VBD
cord-005453-4057qib7	4509	12	included	include	VBN
cord-005453-4057qib7	4509	13	in	in	IN
cord-005453-4057qib7	4509	14	the	the	DT
cord-005453-4057qib7	4509	15	study	study	NN
cord-005453-4057qib7	4509	16	:	:	:
cord-005453-4057qib7	4509	17	30	30	CD
cord-005453-4057qib7	4509	18	women	woman	NNS
cord-005453-4057qib7	4509	19	and	and	CC
cord-005453-4057qib7	4509	20	26	26	CD
cord-005453-4057qib7	4509	21	men	man	NNS
cord-005453-4057qib7	4509	22	,	,	,
cord-005453-4057qib7	4509	23	with	with	IN
cord-005453-4057qib7	4509	24	an	an	DT
cord-005453-4057qib7	4509	25	average	average	JJ
cord-005453-4057qib7	4509	26	age	age	NN
cord-005453-4057qib7	4509	27	of	of	IN
cord-005453-4057qib7	4509	28	31	31	CD
cord-005453-4057qib7	4509	29	years	year	NNS
cord-005453-4057qib7	4509	30	.	.	.
cord-005453-4057qib7	4510	1	Patients	patient	NNS
cord-005453-4057qib7	4510	2	were	be	VBD
cord-005453-4057qib7	4510	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	4510	4	with	with	IN
cord-005453-4057qib7	4510	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	4510	6	(	(	-LRB-
cord-005453-4057qib7	4510	7	n	n	NN
cord-005453-4057qib7	4510	8	=	=	SYM
cord-005453-4057qib7	4510	9	30	30	CD
cord-005453-4057qib7	4510	10	)	)	-RRB-
cord-005453-4057qib7	4510	11	,	,	,
cord-005453-4057qib7	4510	12	multiple	multiple	JJ
cord-005453-4057qib7	4510	13	myeloma	myeloma	NN
cord-005453-4057qib7	4510	14	(	(	-LRB-
cord-005453-4057qib7	4510	15	n=7	n=7	NNS
cord-005453-4057qib7	4510	16	)	)	-RRB-
cord-005453-4057qib7	4510	17	,	,	,
cord-005453-4057qib7	4510	18	leukemia	leukemia	NN
cord-005453-4057qib7	4510	19	(	(	-LRB-
cord-005453-4057qib7	4510	20	n	n	NN
cord-005453-4057qib7	4510	21	=	=	SYM
cord-005453-4057qib7	4510	22	7	7	CD
cord-005453-4057qib7	4510	23	)	)	-RRB-
cord-005453-4057qib7	4510	24	and	and	CC
cord-005453-4057qib7	4510	25	solid	solid	JJ
cord-005453-4057qib7	4510	26	tumors	tumor	NNS
cord-005453-4057qib7	4510	27	(	(	-LRB-
cord-005453-4057qib7	4510	28	n	n	NN
cord-005453-4057qib7	4510	29	=	=	SYM
cord-005453-4057qib7	4510	30	12	12	CD
cord-005453-4057qib7	4510	31	)	)	-RRB-
cord-005453-4057qib7	4510	32	.	.	.
cord-005453-4057qib7	4511	1	At	at	IN
cord-005453-4057qib7	4511	2	the	the	DT
cord-005453-4057qib7	4511	3	time	time	NN
cord-005453-4057qib7	4511	4	of	of	IN
cord-005453-4057qib7	4511	5	transplantation	transplantation	NN
cord-005453-4057qib7	4511	6	,	,	,
cord-005453-4057qib7	4511	7	16	16	CD
cord-005453-4057qib7	4511	8	patients	patient	NNS
cord-005453-4057qib7	4511	9	were	be	VBD
cord-005453-4057qib7	4511	10	in	in	IN
cord-005453-4057qib7	4511	11	complete	complete	JJ
cord-005453-4057qib7	4511	12	clinical	clinical	JJ
cord-005453-4057qib7	4511	13	remission	remission	NN
cord-005453-4057qib7	4511	14	or	or	CC
cord-005453-4057qib7	4511	15	at	at	IN
cord-005453-4057qib7	4511	16	least	least	JJS
cord-005453-4057qib7	4511	17	with	with	IN
cord-005453-4057qib7	4511	18	very	very	RB
cord-005453-4057qib7	4511	19	good	good	JJ
cord-005453-4057qib7	4511	20	partial	partial	JJ
cord-005453-4057qib7	4511	21	response	response	NN
cord-005453-4057qib7	4511	22	,	,	,
cord-005453-4057qib7	4511	23	30	30	CD
cord-005453-4057qib7	4511	24	patients	patient	NNS
cord-005453-4057qib7	4511	25	were	be	VBD
cord-005453-4057qib7	4511	26	in	in	IN
cord-005453-4057qib7	4511	27	partial	partial	JJ
cord-005453-4057qib7	4511	28	remission	remission	NN
cord-005453-4057qib7	4511	29	and	and	CC
cord-005453-4057qib7	4512	1	10	10	CD
cord-005453-4057qib7	4512	2	patients	patient	NNS
cord-005453-4057qib7	4512	3	-with	-with	CD
cord-005453-4057qib7	4512	4	progression	progression	NN
cord-005453-4057qib7	4512	5	.	.	.
cord-005453-4057qib7	4513	1	All	all	DT
cord-005453-4057qib7	4513	2	patients	patient	NNS
cord-005453-4057qib7	4513	3	were	be	VBD
cord-005453-4057qib7	4513	4	evaluated	evaluate	VBN
cord-005453-4057qib7	4513	5	in	in	IN
cord-005453-4057qib7	4513	6	nine	nine	CD
cord-005453-4057qib7	4513	7	time	time	NN
cord-005453-4057qib7	4513	8	points	point	VBZ
cord-005453-4057qib7	4513	9	through	through	IN
cord-005453-4057qib7	4513	10	356	356	CD
cord-005453-4057qib7	4513	11	examinations	examination	NNS
cord-005453-4057qib7	4513	12	by	by	IN
cord-005453-4057qib7	4513	13	clinical	clinical	JJ
cord-005453-4057qib7	4513	14	-	-	HYPH
cord-005453-4057qib7	4513	15	laboratory	laboratory	NN
cord-005453-4057qib7	4513	16	,	,	,
cord-005453-4057qib7	4513	17	flow	flow	NN
cord-005453-4057qib7	4513	18	cytometric	cytometric	NNP
cord-005453-4057qib7	4513	19	and	and	CC
cord-005453-4057qib7	4513	20	immunochemical	immunochemical	JJ
cord-005453-4057qib7	4513	21	methods	method	NNS
cord-005453-4057qib7	4513	22	.	.	.
cord-005453-4057qib7	4514	1	Results	result	NNS
cord-005453-4057qib7	4514	2	:	:	:
cord-005453-4057qib7	4515	1	The	the	DT
cord-005453-4057qib7	4515	2	percentage	percentage	NN
cord-005453-4057qib7	4515	3	of	of	IN
cord-005453-4057qib7	4515	4	CD19	CD19	NNP
cord-005453-4057qib7	4515	5	(	(	-LRB-
cord-005453-4057qib7	4515	6	+	+	NN
cord-005453-4057qib7	4515	7	)	)	-RRB-
cord-005453-4057qib7	4515	8	B	b	NN
cord-005453-4057qib7	4515	9	cells	cell	NNS
cord-005453-4057qib7	4515	10	reached	reach	VBD
cord-005453-4057qib7	4515	11	the	the	DT
cord-005453-4057qib7	4515	12	minimum	minimum	JJ
cord-005453-4057qib7	4515	13	values	value	NNS
cord-005453-4057qib7	4515	14	one	one	CD
cord-005453-4057qib7	4515	15	month	month	NN
cord-005453-4057qib7	4515	16	after	after	IN
cord-005453-4057qib7	4515	17	transplantation	transplantation	NN
cord-005453-4057qib7	4515	18	then	then	RB
cord-005453-4057qib7	4515	19	began	begin	VBD
cord-005453-4057qib7	4515	20	to	to	TO
cord-005453-4057qib7	4515	21	increase	increase	VB
cord-005453-4057qib7	4515	22	in	in	IN
cord-005453-4057qib7	4515	23	the	the	DT
cord-005453-4057qib7	4515	24	second	second	JJ
cord-005453-4057qib7	4515	25	month	month	NN
cord-005453-4057qib7	4515	26	reaching	reach	VBG
cord-005453-4057qib7	4515	27	a	a	DT
cord-005453-4057qib7	4515	28	plateau	plateau	NN
cord-005453-4057qib7	4515	29	around	around	IN
cord-005453-4057qib7	4515	30	the	the	DT
cord-005453-4057qib7	4515	31	mean	mean	JJ
cord-005453-4057qib7	4515	32	values	value	NNS
cord-005453-4057qib7	4515	33	in	in	IN
cord-005453-4057qib7	4515	34	the	the	DT
cord-005453-4057qib7	4515	35	period	period	NN
cord-005453-4057qib7	4515	36	6	6	CD
cord-005453-4057qib7	4515	37	-	-	SYM
cord-005453-4057qib7	4515	38	12	12	CD
cord-005453-4057qib7	4515	39	months	month	NNS
cord-005453-4057qib7	4515	40	after	after	IN
cord-005453-4057qib7	4515	41	transplantation	transplantation	NN
cord-005453-4057qib7	4515	42	.	.	.
cord-005453-4057qib7	4516	1	The	the	DT
cord-005453-4057qib7	4516	2	absolute	absolute	JJ
cord-005453-4057qib7	4516	3	number	number	NN
cord-005453-4057qib7	4516	4	remained	remain	VBD
cord-005453-4057qib7	4516	5	low	low	JJ
cord-005453-4057qib7	4516	6	during	during	IN
cord-005453-4057qib7	4516	7	the	the	DT
cord-005453-4057qib7	4516	8	entire	entire	JJ
cord-005453-4057qib7	4516	9	period	period	NN
cord-005453-4057qib7	4516	10	of	of	IN
cord-005453-4057qib7	4516	11	observation	observation	NN
cord-005453-4057qib7	4516	12	.	.	.
cord-005453-4057qib7	4517	1	The	the	DT
cord-005453-4057qib7	4517	2	amounts	amount	NNS
cord-005453-4057qib7	4517	3	of	of	IN
cord-005453-4057qib7	4517	4	IgG	IgG	NNP
cord-005453-4057qib7	4517	5	and	and	CC
cord-005453-4057qib7	4517	6	IgM	IgM	NNP
cord-005453-4057qib7	4517	7	serum	serum	NN
cord-005453-4057qib7	4517	8	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	4517	9	gradually	gradually	RB
cord-005453-4057qib7	4517	10	increased	increase	VBD
cord-005453-4057qib7	4517	11	within	within	IN
cord-005453-4057qib7	4517	12	the	the	DT
cord-005453-4057qib7	4517	13	reference	reference	NN
cord-005453-4057qib7	4517	14	range	range	NN
cord-005453-4057qib7	4517	15	throughout	throughout	IN
cord-005453-4057qib7	4517	16	the	the	DT
cord-005453-4057qib7	4517	17	entire	entire	JJ
cord-005453-4057qib7	4517	18	period	period	NN
cord-005453-4057qib7	4517	19	,	,	,
cord-005453-4057qib7	4517	20	while	while	IN
cord-005453-4057qib7	4517	21	the	the	DT
cord-005453-4057qib7	4517	22	IgA	IgA	NNP
cord-005453-4057qib7	4517	23	level	level	NN
cord-005453-4057qib7	4517	24	varied	varied	JJ
cord-005453-4057qib7	4517	25	around	around	IN
cord-005453-4057qib7	4517	26	the	the	DT
cord-005453-4057qib7	4517	27	lower	low	JJR
cord-005453-4057qib7	4517	28	reference	reference	NN
cord-005453-4057qib7	4517	29	range	range	NN
cord-005453-4057qib7	4517	30	.	.	.
cord-005453-4057qib7	4518	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4518	2	:	:	:
cord-005453-4057qib7	4519	1	Implementation	implementation	NN
cord-005453-4057qib7	4519	2	of	of	IN
cord-005453-4057qib7	4519	3	an	an	DT
cord-005453-4057qib7	4519	4	adequate	adequate	JJ
cord-005453-4057qib7	4519	5	humoral	humoral	JJ
cord-005453-4057qib7	4519	6	immune	immune	JJ
cord-005453-4057qib7	4519	7	response	response	NN
cord-005453-4057qib7	4519	8	is	be	VBZ
cord-005453-4057qib7	4519	9	hampered	hamper	VBN
cord-005453-4057qib7	4519	10	by	by	IN
cord-005453-4057qib7	4519	11	the	the	DT
cord-005453-4057qib7	4519	12	reduction	reduction	NN
cord-005453-4057qib7	4519	13	of	of	IN
cord-005453-4057qib7	4519	14	circulating	circulate	VBG
cord-005453-4057qib7	4519	15	B	b	NN
cord-005453-4057qib7	4519	16	cells	cell	NNS
cord-005453-4057qib7	4519	17	,	,	,
cord-005453-4057qib7	4519	18	suppressed	suppress	VBD
cord-005453-4057qib7	4519	19	proliferative	proliferative	JJ
cord-005453-4057qib7	4519	20	potential	potential	JJ
cord-005453-4057qib7	4519	21	and	and	CC
cord-005453-4057qib7	4519	22	functional	functional	JJ
cord-005453-4057qib7	4519	23	deficits	deficit	NNS
cord-005453-4057qib7	4519	24	.	.	.
cord-005453-4057qib7	4520	1	Restoration	restoration	NN
cord-005453-4057qib7	4520	2	of	of	IN
cord-005453-4057qib7	4520	3	B	b	NN
cord-005453-4057qib7	4520	4	-	-	HYPH
cord-005453-4057qib7	4520	5	cell	cell	NN
cord-005453-4057qib7	4520	6	function	function	NN
cord-005453-4057qib7	4520	7	occurs	occur	VBZ
cord-005453-4057qib7	4520	8	over	over	IN
cord-005453-4057qib7	4520	9	a	a	DT
cord-005453-4057qib7	4520	10	period	period	NN
cord-005453-4057qib7	4520	11	of	of	IN
cord-005453-4057qib7	4520	12	6	6	CD
cord-005453-4057qib7	4520	13	months	month	NNS
cord-005453-4057qib7	4520	14	to	to	IN
cord-005453-4057qib7	4520	15	2	2	CD
cord-005453-4057qib7	4520	16	years	year	NNS
cord-005453-4057qib7	4520	17	after	after	IN
cord-005453-4057qib7	4520	18	autologous	autologous	JJ
cord-005453-4057qib7	4520	19	transplantation	transplantation	NN
cord-005453-4057qib7	4520	20	.	.	.
cord-005453-4057qib7	4521	1	Clinical	clinical	JJ
cord-005453-4057qib7	4521	2	Trial	Trial	NNP
cord-005453-4057qib7	4521	3	Registry	Registry	NNP
cord-005453-4057qib7	4521	4	:	:	:
cord-005453-4057qib7	4521	5	no	no	DT
cord-005453-4057qib7	4521	6	clinical	clinical	JJ
cord-005453-4057qib7	4521	7	trials	trial	NNS
cord-005453-4057qib7	4522	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4522	2	:	:	:
cord-005453-4057qib7	4523	1	Nothing	nothing	NN
cord-005453-4057qib7	4523	2	to	to	TO
cord-005453-4057qib7	4523	3	declare	declare	VB
cord-005453-4057qib7	4523	4	Justyna	Justyna	NNP
cord-005453-4057qib7	4523	5	Background	Background	NNP
cord-005453-4057qib7	4523	6	:	:	:
cord-005453-4057qib7	4523	7	Allogeneic	allogeneic	NN
cord-005453-4057qib7	4523	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4523	9	stem	stem	NN
cord-005453-4057qib7	4523	10	cells	cell	NNS
cord-005453-4057qib7	4523	11	transplantation	transplantation	NN
cord-005453-4057qib7	4523	12	(	(	-LRB-
cord-005453-4057qib7	4523	13	allo	allo	NN
cord-005453-4057qib7	4523	14	-	-	HYPH
cord-005453-4057qib7	4523	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4523	16	)	)	-RRB-
cord-005453-4057qib7	4523	17	is	be	VBZ
cord-005453-4057qib7	4523	18	a	a	DT
cord-005453-4057qib7	4523	19	life	life	NN
cord-005453-4057qib7	4523	20	-	-	HYPH
cord-005453-4057qib7	4523	21	saving	save	VBG
cord-005453-4057qib7	4523	22	and	and	CC
cord-005453-4057qib7	4523	23	well	well	RB
cord-005453-4057qib7	4523	24	established	establish	VBN
cord-005453-4057qib7	4523	25	therapy	therapy	NN
cord-005453-4057qib7	4523	26	for	for	IN
cord-005453-4057qib7	4523	27	wide	wide	JJ
cord-005453-4057qib7	4523	28	range	range	NN
cord-005453-4057qib7	4523	29	of	of	IN
cord-005453-4057qib7	4523	30	diseases	disease	NNS
cord-005453-4057qib7	4523	31	.	.	.
cord-005453-4057qib7	4524	1	However	however	RB
cord-005453-4057qib7	4524	2	,	,	,
cord-005453-4057qib7	4524	3	it	-PRON-	PRP
cord-005453-4057qib7	4524	4	is	be	VBZ
cord-005453-4057qib7	4524	5	still	still	RB
cord-005453-4057qib7	4524	6	uncommon	uncommon	JJ
cord-005453-4057qib7	4524	7	treatment	treatment	NN
cord-005453-4057qib7	4524	8	for	for	IN
cord-005453-4057qib7	4524	9	infants	infant	NNS
cord-005453-4057qib7	4524	10	less	less	JJR
cord-005453-4057qib7	4524	11	than	than	IN
cord-005453-4057qib7	4524	12	12	12	CD
cord-005453-4057qib7	4524	13	months	month	NNS
cord-005453-4057qib7	4524	14	of	of	IN
cord-005453-4057qib7	4524	15	age	age	NN
cord-005453-4057qib7	4524	16	.	.	.
cord-005453-4057qib7	4525	1	The	the	DT
cord-005453-4057qib7	4525	2	data	datum	NNS
cord-005453-4057qib7	4525	3	about	about	IN
cord-005453-4057qib7	4525	4	indications	indication	NNS
cord-005453-4057qib7	4525	5	and	and	CC
cord-005453-4057qib7	4525	6	outcome	outcome	NN
cord-005453-4057qib7	4525	7	of	of	IN
cord-005453-4057qib7	4525	8	allo	allo	NN
cord-005453-4057qib7	4525	9	-	-	HYPH
cord-005453-4057qib7	4525	10	HSCT	HSCT	NNP
cord-005453-4057qib7	4525	11	in	in	IN
cord-005453-4057qib7	4525	12	the	the	DT
cord-005453-4057qib7	4525	13	youngest	young	JJS
cord-005453-4057qib7	4525	14	group	group	NN
cord-005453-4057qib7	4525	15	of	of	IN
cord-005453-4057qib7	4525	16	patients	patient	NNS
cord-005453-4057qib7	4525	17	is	be	VBZ
cord-005453-4057qib7	4525	18	sparse	sparse	JJ
cord-005453-4057qib7	4525	19	.	.	.
cord-005453-4057qib7	4526	1	The	the	DT
cord-005453-4057qib7	4526	2	primary	primary	JJ
cord-005453-4057qib7	4526	3	objective	objective	NN
cord-005453-4057qib7	4526	4	of	of	IN
cord-005453-4057qib7	4526	5	this	this	DT
cord-005453-4057qib7	4526	6	study	study	NN
cord-005453-4057qib7	4526	7	was	be	VBD
cord-005453-4057qib7	4526	8	to	to	TO
cord-005453-4057qib7	4526	9	assess	assess	VB
cord-005453-4057qib7	4526	10	the	the	DT
cord-005453-4057qib7	4526	11	incidence	incidence	NN
cord-005453-4057qib7	4526	12	,	,	,
cord-005453-4057qib7	4526	13	indications	indication	NNS
cord-005453-4057qib7	4526	14	,	,	,
cord-005453-4057qib7	4526	15	post	post	JJ
cord-005453-4057qib7	4526	16	-	-	JJ
cord-005453-4057qib7	4526	17	HSCT	hsct	JJ
cord-005453-4057qib7	4526	18	complications	complication	NNS
cord-005453-4057qib7	4526	19	and	and	CC
cord-005453-4057qib7	4526	20	general	general	JJ
cord-005453-4057qib7	4526	21	outcome	outcome	NN
cord-005453-4057qib7	4526	22	of	of	IN
cord-005453-4057qib7	4526	23	allo	allo	NN
cord-005453-4057qib7	4526	24	-	-	HYPH
cord-005453-4057qib7	4526	25	HSCT	HSCT	NNP
cord-005453-4057qib7	4526	26	among	among	IN
cord-005453-4057qib7	4526	27	infants	infant	NNS
cord-005453-4057qib7	4526	28	not	not	RB
cord-005453-4057qib7	4526	29	older	old	JJR
cord-005453-4057qib7	4526	30	than	than	IN
cord-005453-4057qib7	4526	31	12	12	CD
cord-005453-4057qib7	4526	32	months	month	NNS
cord-005453-4057qib7	4526	33	.	.	.
cord-005453-4057qib7	4527	1	Latter	latter	JJ
cord-005453-4057qib7	4527	2	sequelae	sequela	NNS
cord-005453-4057qib7	4527	3	of	of	IN
cord-005453-4057qib7	4527	4	HSCT	HSCT	NNP
cord-005453-4057qib7	4527	5	such	such	JJ
cord-005453-4057qib7	4527	6	as	as	IN
cord-005453-4057qib7	4527	7	physical	physical	JJ
cord-005453-4057qib7	4527	8	and	and	CC
cord-005453-4057qib7	4527	9	cognitive	cognitive	JJ
cord-005453-4057qib7	4527	10	development	development	NN
cord-005453-4057qib7	4527	11	were	be	VBD
cord-005453-4057qib7	4527	12	secondary	secondary	JJ
cord-005453-4057qib7	4527	13	aim	aim	NN
cord-005453-4057qib7	4527	14	of	of	IN
cord-005453-4057qib7	4527	15	this	this	DT
cord-005453-4057qib7	4527	16	study	study	NN
cord-005453-4057qib7	4527	17	.	.	.
cord-005453-4057qib7	4528	1	Methods	method	NNS
cord-005453-4057qib7	4528	2	:	:	:
cord-005453-4057qib7	4528	3	We	-PRON-	PRP
cord-005453-4057qib7	4528	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	4528	5	analyzed	analyze	VBD
cord-005453-4057qib7	4528	6	data	datum	NNS
cord-005453-4057qib7	4528	7	of	of	IN
cord-005453-4057qib7	4528	8	63	63	CD
cord-005453-4057qib7	4528	9	patients	patient	NNS
cord-005453-4057qib7	4528	10	who	who	WP
cord-005453-4057qib7	4528	11	underwent	undergo	VBD
cord-005453-4057qib7	4528	12	allo	allo	NN
cord-005453-4057qib7	4528	13	-	-	HYPH
cord-005453-4057qib7	4528	14	HSCT	HSCT	NNP
cord-005453-4057qib7	4528	15	before	before	IN
cord-005453-4057qib7	4528	16	1	1	CD
cord-005453-4057qib7	4528	17	year	year	NN
cord-005453-4057qib7	4528	18	of	of	IN
cord-005453-4057qib7	4528	19	age	age	NN
cord-005453-4057qib7	4528	20	in	in	IN
cord-005453-4057qib7	4528	21	Department	Department	NNP
cord-005453-4057qib7	4528	22	of	of	IN
cord-005453-4057qib7	4528	23	Pediatric	Pediatric	NNP
cord-005453-4057qib7	4528	24	Hematology	Hematology	NNP
cord-005453-4057qib7	4528	25	,	,	,
cord-005453-4057qib7	4528	26	Oncology	Oncology	NNP
cord-005453-4057qib7	4528	27	and	and	CC
cord-005453-4057qib7	4528	28	Bone	Bone	NNP
cord-005453-4057qib7	4528	29	Marrow	Marrow	NNP
cord-005453-4057qib7	4528	30	Transplantation	transplantation	NN
cord-005453-4057qib7	4528	31	in	in	IN
cord-005453-4057qib7	4528	32	Wrocław	Wrocław	NNP
cord-005453-4057qib7	4528	33	during	during	IN
cord-005453-4057qib7	4528	34	years	year	NNS
cord-005453-4057qib7	4528	35	1999	1999	CD
cord-005453-4057qib7	4528	36	-	-	SYM
cord-005453-4057qib7	4528	37	2017	2017	CD
cord-005453-4057qib7	4528	38	.	.	.
cord-005453-4057qib7	4529	1	Clinical	clinical	JJ
cord-005453-4057qib7	4529	2	and	and	CC
cord-005453-4057qib7	4529	3	epidemiological	epidemiological	JJ
cord-005453-4057qib7	4529	4	features	feature	NNS
cord-005453-4057qib7	4529	5	as	as	RB
cord-005453-4057qib7	4529	6	well	well	RB
cord-005453-4057qib7	4529	7	as	as	IN
cord-005453-4057qib7	4529	8	indications	indication	NNS
cord-005453-4057qib7	4529	9	for	for	IN
cord-005453-4057qib7	4529	10	transplantation	transplantation	NN
cord-005453-4057qib7	4529	11	,	,	,
cord-005453-4057qib7	4529	12	early	early	JJ
cord-005453-4057qib7	4529	13	and	and	CC
cord-005453-4057qib7	4529	14	late	late	JJ
cord-005453-4057qib7	4529	15	complications	complication	NNS
cord-005453-4057qib7	4529	16	and	and	CC
cord-005453-4057qib7	4529	17	general	general	JJ
cord-005453-4057qib7	4529	18	outcome	outcome	NN
cord-005453-4057qib7	4529	19	were	be	VBD
cord-005453-4057qib7	4529	20	assessed	assess	VBN
cord-005453-4057qib7	4529	21	.	.	.
cord-005453-4057qib7	4530	1	Results	result	NNS
cord-005453-4057qib7	4530	2	:	:	:
cord-005453-4057qib7	4531	1	Infants	infant	NNS
cord-005453-4057qib7	4531	2	who	who	WP
cord-005453-4057qib7	4531	3	underwent	undergo	VBD
cord-005453-4057qib7	4531	4	HSCT	HSCT	NNP
cord-005453-4057qib7	4531	5	in	in	IN
cord-005453-4057qib7	4531	6	our	-PRON-	PRP$
cord-005453-4057qib7	4531	7	Department	Department	NNP
cord-005453-4057qib7	4531	8	comprise	comprise	VBP
cord-005453-4057qib7	4531	9	8.2	8.2	CD
cord-005453-4057qib7	4531	10	%	%	NN
cord-005453-4057qib7	4531	11	of	of	IN
cord-005453-4057qib7	4531	12	all	all	DT
cord-005453-4057qib7	4531	13	patients	patient	NNS
cord-005453-4057qib7	4531	14	undergoing	undergo	VBG
cord-005453-4057qib7	4531	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4531	16	in	in	IN
cord-005453-4057qib7	4531	17	analyzed	analyze	VBN
cord-005453-4057qib7	4531	18	period	period	NN
cord-005453-4057qib7	4531	19	of	of	IN
cord-005453-4057qib7	4531	20	time	time	NN
cord-005453-4057qib7	4531	21	.	.	.
cord-005453-4057qib7	4532	1	Thirty	thirty	CD
cord-005453-4057qib7	4532	2	-	-	HYPH
cord-005453-4057qib7	4532	3	one	one	CD
cord-005453-4057qib7	4532	4	(	(	-LRB-
cord-005453-4057qib7	4532	5	49.2	49.2	CD
cord-005453-4057qib7	4532	6	%	%	NN
cord-005453-4057qib7	4532	7	)	)	-RRB-
cord-005453-4057qib7	4532	8	patients	patient	NNS
cord-005453-4057qib7	4532	9	received	receive	VBD
cord-005453-4057qib7	4532	10	stem	stem	NN
cord-005453-4057qib7	4532	11	cells	cell	NNS
cord-005453-4057qib7	4532	12	from	from	IN
cord-005453-4057qib7	4532	13	matched	match	VBN
cord-005453-4057qib7	4532	14	unrelated	unrelated	JJ
cord-005453-4057qib7	4532	15	donor	donor	NN
cord-005453-4057qib7	4532	16	(	(	-LRB-
cord-005453-4057qib7	4532	17	MUD	MUD	NNP
cord-005453-4057qib7	4532	18	)	)	-RRB-
cord-005453-4057qib7	4532	19	,	,	,
cord-005453-4057qib7	4532	20	26	26	CD
cord-005453-4057qib7	4532	21	(	(	-LRB-
cord-005453-4057qib7	4532	22	41.3	41.3	CD
cord-005453-4057qib7	4532	23	%	%	NN
cord-005453-4057qib7	4532	24	)	)	-RRB-
cord-005453-4057qib7	4532	25	from	from	IN
cord-005453-4057qib7	4532	26	mismatched	mismatched	JJ
cord-005453-4057qib7	4532	27	(	(	-LRB-
cord-005453-4057qib7	4532	28	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4532	29	)	)	-RRB-
cord-005453-4057qib7	4532	30	related	related	JJ
cord-005453-4057qib7	4532	31	donor	donor	NN
cord-005453-4057qib7	4532	32	(	(	-LRB-
cord-005453-4057qib7	4532	33	MMRD	MMRD	NNP
cord-005453-4057qib7	4532	34	)	)	-RRB-
cord-005453-4057qib7	4532	35	and	and	CC
cord-005453-4057qib7	4532	36	6	6	CD
cord-005453-4057qib7	4532	37	(	(	-LRB-
cord-005453-4057qib7	4532	38	9.5	9.5	CD
cord-005453-4057qib7	4532	39	%	%	NN
cord-005453-4057qib7	4532	40	)	)	-RRB-
cord-005453-4057qib7	4532	41	from	from	IN
cord-005453-4057qib7	4532	42	a	a	DT
cord-005453-4057qib7	4532	43	sibling	sibling	NN
cord-005453-4057qib7	4532	44	donor	donor	NN
cord-005453-4057qib7	4532	45	(	(	-LRB-
cord-005453-4057qib7	4532	46	MSD	MSD	NNP
cord-005453-4057qib7	4532	47	)	)	-RRB-
cord-005453-4057qib7	4532	48	.	.	.
cord-005453-4057qib7	4533	1	Non	non	JJ
cord-005453-4057qib7	4533	2	-	-	JJ
cord-005453-4057qib7	4533	3	malignant	malignant	JJ
cord-005453-4057qib7	4533	4	disorders	disorder	NNS
cord-005453-4057qib7	4533	5	were	be	VBD
cord-005453-4057qib7	4533	6	indication	indication	NN
cord-005453-4057qib7	4533	7	for	for	IN
cord-005453-4057qib7	4533	8	transplant	transplant	NN
cord-005453-4057qib7	4533	9	in	in	IN
cord-005453-4057qib7	4533	10	49	49	CD
cord-005453-4057qib7	4533	11	(	(	-LRB-
cord-005453-4057qib7	4533	12	77.8	77.8	CD
cord-005453-4057qib7	4533	13	%	%	NN
cord-005453-4057qib7	4533	14	)	)	-RRB-
cord-005453-4057qib7	4533	15	patients	patient	NNS
cord-005453-4057qib7	4533	16	and	and	CC
cord-005453-4057qib7	4533	17	malignant	malignant	JJ
cord-005453-4057qib7	4533	18	diseases	disease	NNS
cord-005453-4057qib7	4533	19	in	in	IN
cord-005453-4057qib7	4533	20	14	14	CD
cord-005453-4057qib7	4533	21	(	(	-LRB-
cord-005453-4057qib7	4533	22	22.2	22.2	CD
cord-005453-4057qib7	4533	23	%	%	NN
cord-005453-4057qib7	4533	24	)	)	-RRB-
cord-005453-4057qib7	4533	25	.	.	.
cord-005453-4057qib7	4534	1	Acute	acute	JJ
cord-005453-4057qib7	4534	2	graft	graft	NN
cord-005453-4057qib7	4534	3	versus	versus	IN
cord-005453-4057qib7	4534	4	host	host	NN
cord-005453-4057qib7	4534	5	disease	disease	NN
cord-005453-4057qib7	4534	6	(	(	-LRB-
cord-005453-4057qib7	4534	7	aGvHD	agvhd	NN
cord-005453-4057qib7	4534	8	)	)	-RRB-
cord-005453-4057qib7	4534	9	occurred	occur	VBD
cord-005453-4057qib7	4534	10	in	in	IN
cord-005453-4057qib7	4534	11	33	33	CD
cord-005453-4057qib7	4534	12	(	(	-LRB-
cord-005453-4057qib7	4534	13	52	52	CD
cord-005453-4057qib7	4534	14	%	%	NN
cord-005453-4057qib7	4534	15	)	)	-RRB-
cord-005453-4057qib7	4534	16	infants	infant	NNS
cord-005453-4057qib7	4534	17	,	,	,
cord-005453-4057qib7	4534	18	chronic	chronic	JJ
cord-005453-4057qib7	4534	19	graft	graft	NN
cord-005453-4057qib7	4534	20	versus	versus	IN
cord-005453-4057qib7	4534	21	host	host	NN
cord-005453-4057qib7	4534	22	disease	disease	NN
cord-005453-4057qib7	4534	23	(	(	-LRB-
cord-005453-4057qib7	4534	24	cGvHD	cGvHD	NNP
cord-005453-4057qib7	4534	25	)	)	-RRB-
cord-005453-4057qib7	4534	26	in	in	IN
cord-005453-4057qib7	4534	27	15	15	CD
cord-005453-4057qib7	4534	28	(	(	-LRB-
cord-005453-4057qib7	4534	29	24	24	CD
cord-005453-4057qib7	4534	30	%	%	NN
cord-005453-4057qib7	4534	31	)	)	-RRB-
cord-005453-4057qib7	4534	32	.	.	.
cord-005453-4057qib7	4535	1	Majority	majority	NN
cord-005453-4057qib7	4535	2	of	of	IN
cord-005453-4057qib7	4535	3	graft	graft	NN
cord-005453-4057qib7	4535	4	rejections	rejection	NNS
cord-005453-4057qib7	4535	5	were	be	VBD
cord-005453-4057qib7	4535	6	seen	see	VBN
cord-005453-4057qib7	4535	7	in	in	IN
cord-005453-4057qib7	4535	8	infants	infant	NNS
cord-005453-4057qib7	4535	9	transplanted	transplant	VBN
cord-005453-4057qib7	4535	10	from	from	IN
cord-005453-4057qib7	4535	11	MMRD	MMRD	NNP
cord-005453-4057qib7	4535	12	7(63.6	7(63.6	CD
cord-005453-4057qib7	4535	13	%	%	NN
cord-005453-4057qib7	4535	14	)	)	-RRB-
cord-005453-4057qib7	4535	15	,	,	,
cord-005453-4057qib7	4535	16	whereas	whereas	IN
cord-005453-4057qib7	4535	17	the	the	DT
cord-005453-4057qib7	4535	18	rest	rest	NN
cord-005453-4057qib7	4535	19	4	4	CD
cord-005453-4057qib7	4535	20	(	(	-LRB-
cord-005453-4057qib7	4535	21	36.4	36.4	CD
cord-005453-4057qib7	4535	22	%	%	NN
cord-005453-4057qib7	4535	23	)	)	-RRB-
cord-005453-4057qib7	4535	24	was	be	VBD
cord-005453-4057qib7	4535	25	associated	associate	VBN
cord-005453-4057qib7	4535	26	with	with	IN
cord-005453-4057qib7	4535	27	MUD	mud	NN
cord-005453-4057qib7	4535	28	.	.	.
cord-005453-4057qib7	4536	1	Median	median	JJ
cord-005453-4057qib7	4536	2	follow	follow	NN
cord-005453-4057qib7	4536	3	-	-	HYPH
cord-005453-4057qib7	4536	4	up	up	NN
cord-005453-4057qib7	4536	5	in	in	IN
cord-005453-4057qib7	4536	6	study	study	NN
cord-005453-4057qib7	4536	7	cohort	cohort	NN
cord-005453-4057qib7	4536	8	was	be	VBD
cord-005453-4057qib7	4536	9	860	860	CD
cord-005453-4057qib7	4536	10	days	day	NNS
cord-005453-4057qib7	4536	11	,	,	,
cord-005453-4057qib7	4536	12	1148	1148	CD
cord-005453-4057qib7	4536	13	days	day	NNS
cord-005453-4057qib7	4536	14	for	for	IN
cord-005453-4057qib7	4536	15	alive	alive	JJ
cord-005453-4057qib7	4536	16	patients	patient	NNS
cord-005453-4057qib7	4536	17	(	(	-LRB-
cord-005453-4057qib7	4536	18	range	range	VBP
cord-005453-4057qib7	4536	19	72	72	CD
cord-005453-4057qib7	4536	20	days-19.5	days-19.5	NNP
cord-005453-4057qib7	4536	21	yrs	yr	NNS
cord-005453-4057qib7	4536	22	)	)	-RRB-
cord-005453-4057qib7	4536	23	and	and	CC
cord-005453-4057qib7	4536	24	72	72	CD
cord-005453-4057qib7	4536	25	days	day	NNS
cord-005453-4057qib7	4536	26	for	for	IN
cord-005453-4057qib7	4536	27	those	those	DT
cord-005453-4057qib7	4536	28	deceased	deceased	JJ
cord-005453-4057qib7	4536	29	(	(	-LRB-
cord-005453-4057qib7	4536	30	range	range	NN
cord-005453-4057qib7	4536	31	3	3	CD
cord-005453-4057qib7	4536	32	days-341	days-341	NNP
cord-005453-4057qib7	4536	33	days	day	NNS
cord-005453-4057qib7	4536	34	)	)	-RRB-
cord-005453-4057qib7	4536	35	.	.	.
cord-005453-4057qib7	4537	1	Overall	overall	JJ
cord-005453-4057qib7	4537	2	survival	survival	NN
cord-005453-4057qib7	4537	3	(	(	-LRB-
cord-005453-4057qib7	4537	4	OS	OS	NNP
cord-005453-4057qib7	4537	5	)	)	-RRB-
cord-005453-4057qib7	4537	6	in	in	IN
cord-005453-4057qib7	4537	7	study	study	NN
cord-005453-4057qib7	4537	8	cohort	cohort	NN
cord-005453-4057qib7	4537	9	was	be	VBD
cord-005453-4057qib7	4537	10	0.682	0.682	CD
cord-005453-4057qib7	4537	11	and	and	CC
cord-005453-4057qib7	4537	12	transplant	transplant	NN
cord-005453-4057qib7	4537	13	related	relate	VBN
cord-005453-4057qib7	4537	14	mortality	mortality	NN
cord-005453-4057qib7	4537	15	(	(	-LRB-
cord-005453-4057qib7	4537	16	TRM	TRM	NNP
cord-005453-4057qib7	4537	17	)	)	-RRB-
cord-005453-4057qib7	4537	18	was	be	VBD
cord-005453-4057qib7	4537	19	0.317	0.317	CD
cord-005453-4057qib7	4537	20	.	.	.
cord-005453-4057qib7	4538	1	In	in	IN
cord-005453-4057qib7	4538	2	children	child	NNS
cord-005453-4057qib7	4538	3	with	with	IN
cord-005453-4057qib7	4538	4	malignancy	malignancy	NN
cord-005453-4057qib7	4538	5	5	5	CD
cord-005453-4057qib7	4538	6	(	(	-LRB-
cord-005453-4057qib7	4538	7	35.2	35.2	CD
cord-005453-4057qib7	4538	8	%	%	NN
cord-005453-4057qib7	4538	9	)	)	-RRB-
cord-005453-4057qib7	4538	10	patients	patient	NNS
cord-005453-4057qib7	4538	11	died	die	VBD
cord-005453-4057qib7	4538	12	comparing	compare	VBG
cord-005453-4057qib7	4538	13	to	to	IN
cord-005453-4057qib7	4538	14	15	15	CD
cord-005453-4057qib7	4538	15	(	(	-LRB-
cord-005453-4057qib7	4538	16	30.6	30.6	CD
cord-005453-4057qib7	4538	17	%	%	NN
cord-005453-4057qib7	4538	18	)	)	-RRB-
cord-005453-4057qib7	4538	19	patients	patient	NNS
cord-005453-4057qib7	4538	20	in	in	IN
cord-005453-4057qib7	4538	21	non	non	JJ
cord-005453-4057qib7	4538	22	-	-	JJ
cord-005453-4057qib7	4538	23	malignant	malignant	JJ
cord-005453-4057qib7	4538	24	group	group	NN
cord-005453-4057qib7	4538	25	respectively	respectively	RB
cord-005453-4057qib7	4538	26	.	.	.
cord-005453-4057qib7	4539	1	Main	main	JJ
cord-005453-4057qib7	4539	2	cause	cause	NN
cord-005453-4057qib7	4539	3	of	of	IN
cord-005453-4057qib7	4539	4	death	death	NN
cord-005453-4057qib7	4539	5	in	in	IN
cord-005453-4057qib7	4539	6	analyzed	analyze	VBN
cord-005453-4057qib7	4539	7	group	group	NN
cord-005453-4057qib7	4539	8	of	of	IN
cord-005453-4057qib7	4539	9	infants	infant	NNS
cord-005453-4057qib7	4539	10	was	be	VBD
cord-005453-4057qib7	4539	11	infection	infection	NN
cord-005453-4057qib7	4539	12	(	(	-LRB-
cord-005453-4057qib7	4539	13	60	60	CD
cord-005453-4057qib7	4539	14	%	%	NN
cord-005453-4057qib7	4539	15	)	)	-RRB-
cord-005453-4057qib7	4539	16	.	.	.
cord-005453-4057qib7	4540	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4540	2	:	:	:
cord-005453-4057qib7	4540	3	1	1	CD
cord-005453-4057qib7	4540	4	.	.	.
cord-005453-4057qib7	4541	1	Allo	Allo	NNP
cord-005453-4057qib7	4541	2	-	-	HYPH
cord-005453-4057qib7	4541	3	HSCT	HSCT	NNP
cord-005453-4057qib7	4541	4	is	be	VBZ
cord-005453-4057qib7	4541	5	rarely	rarely	RB
cord-005453-4057qib7	4541	6	performed	perform	VBN
cord-005453-4057qib7	4541	7	in	in	IN
cord-005453-4057qib7	4541	8	children	child	NNS
cord-005453-4057qib7	4541	9	less	less	JJR
cord-005453-4057qib7	4541	10	than	than	IN
cord-005453-4057qib7	4541	11	12	12	CD
cord-005453-4057qib7	4541	12	months	month	NNS
cord-005453-4057qib7	4541	13	of	of	IN
cord-005453-4057qib7	4541	14	age	age	NN
cord-005453-4057qib7	4541	15	.	.	.
cord-005453-4057qib7	4542	1	2	2	LS
cord-005453-4057qib7	4542	2	.	.	.
cord-005453-4057qib7	4543	1	Majority	majority	NN
cord-005453-4057qib7	4543	2	of	of	IN
cord-005453-4057qib7	4543	3	those	those	DT
cord-005453-4057qib7	4543	4	patients	patient	NNS
cord-005453-4057qib7	4543	5	receive	receive	VBP
cord-005453-4057qib7	4543	6	stem	stem	NN
cord-005453-4057qib7	4543	7	cells	cell	NNS
cord-005453-4057qib7	4543	8	due	due	JJ
cord-005453-4057qib7	4543	9	to	to	IN
cord-005453-4057qib7	4543	10	non	non	JJ
cord-005453-4057qib7	4543	11	-	-	JJ
cord-005453-4057qib7	4543	12	malignant	malignant	JJ
cord-005453-4057qib7	4543	13	disorder	disorder	NN
cord-005453-4057qib7	4543	14	.	.	.
cord-005453-4057qib7	4544	1	3	3	LS
cord-005453-4057qib7	4544	2	.	.	.
cord-005453-4057qib7	4545	1	Among	among	IN
cord-005453-4057qib7	4545	2	youngest	young	JJS
cord-005453-4057qib7	4545	3	HSCT	HSCT	NNP
cord-005453-4057qib7	4545	4	recipients	recipient	NNS
cord-005453-4057qib7	4545	5	,	,	,
cord-005453-4057qib7	4545	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4545	7	transplant	transplant	NN
cord-005453-4057qib7	4545	8	are	be	VBP
cord-005453-4057qib7	4545	9	more	more	RBR
cord-005453-4057qib7	4545	10	common	common	JJ
cord-005453-4057qib7	4545	11	than	than	IN
cord-005453-4057qib7	4545	12	in	in	IN
cord-005453-4057qib7	4545	13	general	general	JJ
cord-005453-4057qib7	4545	14	pediatric	pediatric	JJ
cord-005453-4057qib7	4545	15	transplant	transplant	NN
cord-005453-4057qib7	4545	16	population	population	NN
cord-005453-4057qib7	4545	17	.	.	.
cord-005453-4057qib7	4546	1	4	4	LS
cord-005453-4057qib7	4546	2	.	.	.
cord-005453-4057qib7	4547	1	Graft	graft	NN
cord-005453-4057qib7	4547	2	rejection	rejection	NN
cord-005453-4057qib7	4547	3	is	be	VBZ
cord-005453-4057qib7	4547	4	a	a	DT
cord-005453-4057qib7	4547	5	significant	significant	JJ
cord-005453-4057qib7	4547	6	problem	problem	NN
cord-005453-4057qib7	4547	7	in	in	IN
cord-005453-4057qib7	4547	8	infants	infant	NNS
cord-005453-4057qib7	4547	9	transplanted	transplant	VBN
cord-005453-4057qib7	4547	10	from	from	IN
cord-005453-4057qib7	4547	11	MMRD	MMRD	NNP
cord-005453-4057qib7	4547	12	.	.	.
cord-005453-4057qib7	4548	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4548	2	:	:	:
cord-005453-4057qib7	4548	3	nothing	nothing	NN
cord-005453-4057qib7	4548	4	to	to	TO
cord-005453-4057qib7	4548	5	declare	declare	VB
cord-005453-4057qib7	4548	6	Unusual	unusual	JJ
cord-005453-4057qib7	4548	7	non	non	JJ
cord-005453-4057qib7	4548	8	-	-	JJ
cord-005453-4057qib7	4548	9	infectious	infectious	JJ
cord-005453-4057qib7	4548	10	lung	lung	NN
cord-005453-4057qib7	4548	11	complication	complication	NN
cord-005453-4057qib7	4548	12	after	after	IN
cord-005453-4057qib7	4548	13	allogeneic	allogeneic	JJ
cord-005453-4057qib7	4548	14	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	4548	15	stem	stem	NN
cord-005453-4057qib7	4548	16	cell	cell	NN
cord-005453-4057qib7	4548	17	transplantation	transplantation	NN
cord-005453-4057qib7	4548	18	Claudia	Claudia	NNP
cord-005453-4057qib7	4548	19	Lucia	Lucia	NNP
cord-005453-4057qib7	4548	20	Sossa	Sossa	NNP
cord-005453-4057qib7	4548	21	Melo	Melo	NNP
cord-005453-4057qib7	4548	22	1,2	1,2	CD
cord-005453-4057qib7	4548	23	,	,	,
cord-005453-4057qib7	4548	24	Manuel	Manuel	NNP
cord-005453-4057qib7	4548	25	Rosales	Rosales	NNP
cord-005453-4057qib7	4548	26	2	2	CD
cord-005453-4057qib7	4548	27	,	,	,
cord-005453-4057qib7	4549	1	Francisco	Francisco	NNP
cord-005453-4057qib7	4549	2	Fernando	Fernando	NNP
cord-005453-4057qib7	4549	3	Naranjo	Naranjo	NNP
cord-005453-4057qib7	4549	4	Junoy	Junoy	NNP
cord-005453-4057qib7	4549	5	1,2	1,2	CD
cord-005453-4057qib7	4549	6	,	,	,
cord-005453-4057qib7	4549	7	Sara	Sara	NNP
cord-005453-4057qib7	4549	8	Inés	Inés	NNP
cord-005453-4057qib7	4549	9	Jiménez	Jiménez	NNP
cord-005453-4057qib7	4549	10	1,2	1,2	CD
cord-005453-4057qib7	4549	11	,	,	,
cord-005453-4057qib7	4549	12	Luis	Luis	NNP
cord-005453-4057qib7	4549	13	Antonio	Antonio	NNP
cord-005453-4057qib7	4549	14	Salazar	Salazar	NNP
cord-005453-4057qib7	4549	15	1,2	1,2	CD
cord-005453-4057qib7	4549	16	,	,	,
cord-005453-4057qib7	4549	17	Angela	Angela	NNP
cord-005453-4057qib7	4549	18	María	María	NNP
cord-005453-4057qib7	4549	19	Peña	Peña	NNP
cord-005453-4057qib7	4549	20	1,2	1,2	CD
cord-005453-4057qib7	4549	21	,	,	,
cord-005453-4057qib7	4549	22	María	María	NNP
cord-005453-4057qib7	4549	23	Angélica	Angélica	NNP
cord-005453-4057qib7	4549	24	Chacón	Chacón	NNP
cord-005453-4057qib7	4549	25	Manosalva	Manosalva	NNP
cord-005453-4057qib7	4549	26	3	3	CD
cord-005453-4057qib7	4549	27	,	,	,
cord-005453-4057qib7	4549	28	Maria	Maria	NNP
cord-005453-4057qib7	4549	29	Luna	Luna	NNP
cord-005453-4057qib7	4549	30	-	-	HYPH
cord-005453-4057qib7	4549	31	González	González	NNP
cord-005453-4057qib7	4549	32	1	1	CD
cord-005453-4057qib7	4549	33	,	,	,
cord-005453-4057qib7	4549	34	Claudia	Claudia	NNP
cord-005453-4057qib7	4549	35	Marcela	Marcela	NNP
cord-005453-4057qib7	4549	36	Chalela	Chalela	NNP
cord-005453-4057qib7	4549	37	1	1	CD
cord-005453-4057qib7	4549	38	,	,	,
cord-005453-4057qib7	4549	39	Manuel	Manuel	NNP
cord-005453-4057qib7	4549	40	Ardila	Ardila	NNP
cord-005453-4057qib7	4549	41	-	-	HYPH
cord-005453-4057qib7	4549	42	Báez	Báez	NNP
cord-005453-4057qib7	4549	43	1	1	CD
cord-005453-4057qib7	4549	44	jirovecii	jirovecii	NNP
cord-005453-4057qib7	4549	45	infections	infection	NNS
cord-005453-4057qib7	4549	46	,	,	,
cord-005453-4057qib7	4549	47	viral	viral	JJ
cord-005453-4057qib7	4549	48	infections	infection	NNS
cord-005453-4057qib7	4549	49	or	or	CC
cord-005453-4057qib7	4549	50	Nocardia	Nocardia	NNP
cord-005453-4057qib7	4549	51	.	.	.
cord-005453-4057qib7	4550	1	We	-PRON-	PRP
cord-005453-4057qib7	4550	2	describe	describe	VBP
cord-005453-4057qib7	4550	3	the	the	DT
cord-005453-4057qib7	4550	4	case	case	NN
cord-005453-4057qib7	4550	5	of	of	IN
cord-005453-4057qib7	4550	6	a	a	DT
cord-005453-4057qib7	4550	7	patient	patient	NN
cord-005453-4057qib7	4550	8	with	with	IN
cord-005453-4057qib7	4550	9	Acute	acute	JJ
cord-005453-4057qib7	4550	10	Lymphoblastic	Lymphoblastic	NNP
cord-005453-4057qib7	4550	11	Leukemia	Leukemia	NNP
cord-005453-4057qib7	4550	12	(	(	-LRB-
cord-005453-4057qib7	4550	13	ALL	all	DT
cord-005453-4057qib7	4550	14	)	)	-RRB-
cord-005453-4057qib7	4550	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	4550	16	with	with	IN
cord-005453-4057qib7	4550	17	PAP	pap	NN
cord-005453-4057qib7	4550	18	associated	associate	VBN
cord-005453-4057qib7	4550	19	to	to	IN
cord-005453-4057qib7	4550	20	a	a	DT
cord-005453-4057qib7	4550	21	HSCT	HSCT	NNP
cord-005453-4057qib7	4550	22	and	and	CC
cord-005453-4057qib7	4550	23	pulmonary	pulmonary	JJ
cord-005453-4057qib7	4550	24	pneumocystis	pneumocystis	NN
cord-005453-4057qib7	4550	25	.	.	.
cord-005453-4057qib7	4551	1	Methods	method	NNS
cord-005453-4057qib7	4551	2	:	:	:
cord-005453-4057qib7	4552	1	A	a	DT
cord-005453-4057qib7	4552	2	55-year	55-year	JJ
cord-005453-4057qib7	4552	3	-	-	HYPH
cord-005453-4057qib7	4552	4	old	old	JJ
cord-005453-4057qib7	4552	5	Colombian	colombian	JJ
cord-005453-4057qib7	4552	6	female	female	JJ
cord-005453-4057qib7	4552	7	patient	patient	NN
cord-005453-4057qib7	4552	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	4552	9	with	with	IN
cord-005453-4057qib7	4552	10	B	b	NN
cord-005453-4057qib7	4552	11	-	-	HYPH
cord-005453-4057qib7	4552	12	precursor	precursor	NN
cord-005453-4057qib7	4552	13	ALL	all	DT
cord-005453-4057qib7	4552	14	of	of	IN
cord-005453-4057qib7	4552	15	high	high	JJ
cord-005453-4057qib7	4552	16	-	-	HYPH
cord-005453-4057qib7	4552	17	risk	risk	NN
cord-005453-4057qib7	4552	18	in	in	IN
cord-005453-4057qib7	4552	19	January	January	NNP
cord-005453-4057qib7	4552	20	2017	2017	CD
cord-005453-4057qib7	4552	21	,	,	,
cord-005453-4057qib7	4552	22	positive	positive	JJ
cord-005453-4057qib7	4552	23	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	4552	24	chromosome	chromosome	NN
cord-005453-4057qib7	4552	25	,	,	,
cord-005453-4057qib7	4552	26	positive	positive	JJ
cord-005453-4057qib7	4552	27	BCR	BCR	NNP
cord-005453-4057qib7	4552	28	/	/	SYM
cord-005453-4057qib7	4552	29	ABL	ABL	NNP
cord-005453-4057qib7	4552	30	in	in	IN
cord-005453-4057qib7	4552	31	February	February	NNP
cord-005453-4057qib7	4552	32	2017	2017	CD
cord-005453-4057qib7	4552	33	,	,	,
cord-005453-4057qib7	4552	34	infiltration	infiltration	NN
cord-005453-4057qib7	4552	35	to	to	IN
cord-005453-4057qib7	4552	36	the	the	DT
cord-005453-4057qib7	4552	37	Central	Central	NNP
cord-005453-4057qib7	4552	38	Nervous	Nervous	NNP
cord-005453-4057qib7	4552	39	System	System	NNP
cord-005453-4057qib7	4552	40	(	(	-LRB-
cord-005453-4057qib7	4552	41	CNS	CNS	NNP
cord-005453-4057qib7	4552	42	)	)	-RRB-
cord-005453-4057qib7	4552	43	,	,	,
cord-005453-4057qib7	4552	44	2.53	2.53	CD
cord-005453-4057qib7	4552	45	%	%	NN
cord-005453-4057qib7	4552	46	of	of	IN
cord-005453-4057qib7	4552	47	lymphoblasts	lymphoblast	NNS
cord-005453-4057qib7	4552	48	,	,	,
cord-005453-4057qib7	4552	49	and	and	CC
cord-005453-4057qib7	4552	50	karyotype	karyotype	NN
cord-005453-4057qib7	4552	51	without	without	IN
cord-005453-4057qib7	4552	52	legible	legible	JJ
cord-005453-4057qib7	4552	53	metaphases	metaphase	NNS
cord-005453-4057qib7	4552	54	.	.	.
cord-005453-4057qib7	4553	1	Refractory	refractory	JJ
cord-005453-4057qib7	4553	2	to	to	IN
cord-005453-4057qib7	4553	3	induction	induction	NN
cord-005453-4057qib7	4553	4	according	accord	VBG
cord-005453-4057qib7	4553	5	to	to	IN
cord-005453-4057qib7	4553	6	the	the	DT
cord-005453-4057qib7	4553	7	PETHEMA	PETHEMA	NNP
cord-005453-4057qib7	4553	8	protocol	protocol	NN
cord-005453-4057qib7	4553	9	(	(	-LRB-
cord-005453-4057qib7	4553	10	Vincristine	Vincristine	NNP
cord-005453-4057qib7	4553	11	,	,	,
cord-005453-4057qib7	4553	12	Daunorubicin	Daunorubicin	NNPS
cord-005453-4057qib7	4553	13	,	,	,
cord-005453-4057qib7	4553	14	Prednisone	Prednisone	NNP
cord-005453-4057qib7	4553	15	,	,	,
cord-005453-4057qib7	4553	16	L	l	NN
cord-005453-4057qib7	4553	17	-	-	HYPH
cord-005453-4057qib7	4553	18	asparaginase	asparaginase	NNP
cord-005453-4057qib7	4553	19	)	)	-RRB-
cord-005453-4057qib7	4553	20	with	with	IN
cord-005453-4057qib7	4553	21	presence	presence	NN
cord-005453-4057qib7	4553	22	of	of	IN
cord-005453-4057qib7	4553	23	13.9	13.9	CD
cord-005453-4057qib7	4553	24	%	%	NN
cord-005453-4057qib7	4553	25	blasts	blast	NNS
cord-005453-4057qib7	4553	26	at	at	IN
cord-005453-4057qib7	4553	27	the	the	DT
cord-005453-4057qib7	4553	28	end	end	NN
cord-005453-4057qib7	4553	29	of	of	IN
cord-005453-4057qib7	4553	30	the	the	DT
cord-005453-4057qib7	4553	31	induction	induction	NN
cord-005453-4057qib7	4553	32	.	.	.
cord-005453-4057qib7	4554	1	Re	re	NN
cord-005453-4057qib7	4554	2	-	-	NN
cord-005453-4057qib7	4554	3	induction	induction	NN
cord-005453-4057qib7	4554	4	was	be	VBD
cord-005453-4057qib7	4554	5	performed	perform	VBN
cord-005453-4057qib7	4554	6	with	with	IN
cord-005453-4057qib7	4554	7	the	the	DT
cord-005453-4057qib7	4554	8	FLAG	FLAG	NNP
cord-005453-4057qib7	4554	9	-	-	HYPH
cord-005453-4057qib7	4554	10	IDA	IDA	NNP
cord-005453-4057qib7	4554	11	protocol	protocol	NN
cord-005453-4057qib7	4554	12	(	(	-LRB-
cord-005453-4057qib7	4554	13	Idarubicin	Idarubicin	NNP
cord-005453-4057qib7	4554	14	,	,	,
cord-005453-4057qib7	4554	15	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	4554	16	,	,	,
cord-005453-4057qib7	4554	17	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	4554	18	)	)	-RRB-
cord-005453-4057qib7	4554	19	achieving	achieve	VBG
cord-005453-4057qib7	4554	20	complete	complete	JJ
cord-005453-4057qib7	4554	21	remission	remission	NN
cord-005453-4057qib7	4554	22	,	,	,
cord-005453-4057qib7	4554	23	obtaining	obtain	VBG
cord-005453-4057qib7	4554	24	Minimum	Minimum	NNP
cord-005453-4057qib7	4554	25	Residual	Residual	NNP
cord-005453-4057qib7	4554	26	Disease	Disease	NNP
cord-005453-4057qib7	4554	27	(	(	-LRB-
cord-005453-4057qib7	4554	28	MRD	MRD	NNP
cord-005453-4057qib7	4554	29	)	)	-RRB-
cord-005453-4057qib7	4554	30	<	<	NNP
cord-005453-4057qib7	4554	31	0.01	0.01	CD
cord-005453-4057qib7	4554	32	.	.	.
cord-005453-4057qib7	4555	1	Dasatinib	Dasatinib	NNP
cord-005453-4057qib7	4555	2	was	be	VBD
cord-005453-4057qib7	4555	3	initiated	initiate	VBN
cord-005453-4057qib7	4555	4	by	by	IN
cord-005453-4057qib7	4555	5	BCR	BCR	NNP
cord-005453-4057qib7	4555	6	/	/	SYM
cord-005453-4057qib7	4555	7	ABL	ABL	NNP
cord-005453-4057qib7	4555	8	expression	expression	NN
cord-005453-4057qib7	4555	9	and	and	CC
cord-005453-4057qib7	4555	10	CNS	CNS	NNP
cord-005453-4057qib7	4555	11	involvement	involvement	NN
cord-005453-4057qib7	4555	12	at	at	IN
cord-005453-4057qib7	4555	13	the	the	DT
cord-005453-4057qib7	4555	14	time	time	NN
cord-005453-4057qib7	4555	15	of	of	IN
cord-005453-4057qib7	4555	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	4555	17	.	.	.
cord-005453-4057qib7	4556	1	An	an	DT
cord-005453-4057qib7	4556	2	allogeneic	allogeneic	NN
cord-005453-4057qib7	4556	3	HSCT	HSCT	NNP
cord-005453-4057qib7	4556	4	was	be	VBD
cord-005453-4057qib7	4556	5	performed	perform	VBN
cord-005453-4057qib7	4556	6	,	,	,
cord-005453-4057qib7	4556	7	from	from	IN
cord-005453-4057qib7	4556	8	a	a	DT
cord-005453-4057qib7	4556	9	male	male	JJ
cord-005453-4057qib7	4556	10	brother	brother	NN
cord-005453-4057qib7	4556	11	donor	donor	NN
cord-005453-4057qib7	4556	12	,	,	,
cord-005453-4057qib7	4556	13	with	with	IN
cord-005453-4057qib7	4556	14	low	low	JJ
cord-005453-4057qib7	4556	15	intensity	intensity	NN
cord-005453-4057qib7	4556	16	conditioning	conditioning	NN
cord-005453-4057qib7	4556	17	TT	TT	NNP
cord-005453-4057qib7	4556	18	BUFLU	BUFLU	NNP
cord-005453-4057qib7	4556	19	and	and	CC
cord-005453-4057qib7	4556	20	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4556	21	of	of	IN
cord-005453-4057qib7	4556	22	Graft	graft	NN
cord-005453-4057qib7	4556	23	-	-	HYPH
cord-005453-4057qib7	4556	24	versus	versus	IN
cord-005453-4057qib7	4556	25	-	-	HYPH
cord-005453-4057qib7	4556	26	Host	host	NN
cord-005453-4057qib7	4556	27	Disease	Disease	NNP
cord-005453-4057qib7	4556	28	(	(	-LRB-
cord-005453-4057qib7	4556	29	GVHD	GVHD	NNP
cord-005453-4057qib7	4556	30	)	)	-RRB-
cord-005453-4057qib7	4556	31	with	with	IN
cord-005453-4057qib7	4556	32	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	4556	33	and	and	CC
cord-005453-4057qib7	4556	34	Sirolimus	Sirolimus	NNP
cord-005453-4057qib7	4556	35	.	.	.
cord-005453-4057qib7	4557	1	Patient	Patient	NNP
cord-005453-4057qib7	4557	2	showed	show	VBD
cord-005453-4057qib7	4557	3	early	early	JJ
cord-005453-4057qib7	4557	4	posttransplant	posttransplant	NN
cord-005453-4057qib7	4557	5	complications	complication	NNS
cord-005453-4057qib7	4557	6	,	,	,
cord-005453-4057qib7	4557	7	given	give	VBN
cord-005453-4057qib7	4557	8	the	the	DT
cord-005453-4057qib7	4557	9	reactivation	reactivation	NN
cord-005453-4057qib7	4557	10	of	of	IN
cord-005453-4057qib7	4557	11	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	4557	12	and	and	CC
cord-005453-4057qib7	4557	13	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	4557	14	cystitis	cystitis	NN
cord-005453-4057qib7	4557	15	grade	grade	NN
cord-005453-4057qib7	4557	16	I	-PRON-	PRP
cord-005453-4057qib7	4557	17	due	due	JJ
cord-005453-4057qib7	4557	18	to	to	IN
cord-005453-4057qib7	4557	19	adenovirus	adenovirus	NN
cord-005453-4057qib7	4557	20	.	.	.
cord-005453-4057qib7	4558	1	Late	late	JJ
cord-005453-4057qib7	4558	2	complications	complication	NNS
cord-005453-4057qib7	4558	3	such	such	JJ
cord-005453-4057qib7	4558	4	us	-PRON-	PRP
cord-005453-4057qib7	4558	5	GVHD	GVHD	NNP
cord-005453-4057qib7	4558	6	at	at	IN
cord-005453-4057qib7	4558	7	the	the	DT
cord-005453-4057qib7	4558	8	cutaneous	cutaneous	JJ
cord-005453-4057qib7	4558	9	level	level	NN
cord-005453-4057qib7	4558	10	and	and	CC
cord-005453-4057qib7	4559	1	subsequent	subsequent	JJ
cord-005453-4057qib7	4559	2	hepatic	hepatic	JJ
cord-005453-4057qib7	4559	3	and	and	CC
cord-005453-4057qib7	4559	4	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	4559	5	involvement	involvement	NN
cord-005453-4057qib7	4559	6	were	be	VBD
cord-005453-4057qib7	4559	7	seen	see	VBN
cord-005453-4057qib7	4559	8	too	too	RB
cord-005453-4057qib7	4559	9	,	,	,
cord-005453-4057qib7	4559	10	for	for	IN
cord-005453-4057qib7	4559	11	which	which	WDT
cord-005453-4057qib7	4559	12	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4559	13	therapy	therapy	NN
cord-005453-4057qib7	4559	14	was	be	VBD
cord-005453-4057qib7	4559	15	administered	administer	VBN
cord-005453-4057qib7	4559	16	with	with	IN
cord-005453-4057qib7	4559	17	high	high	JJ
cord-005453-4057qib7	4559	18	doses	dose	NNS
cord-005453-4057qib7	4559	19	of	of	IN
cord-005453-4057qib7	4559	20	systemic	systemic	JJ
cord-005453-4057qib7	4559	21	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	4559	22	.	.	.
cord-005453-4057qib7	4560	1	Results	result	NNS
cord-005453-4057qib7	4560	2	:	:	:
cord-005453-4057qib7	4561	1	Patient	Patient	NNP
cord-005453-4057qib7	4561	2	was	be	VBD
cord-005453-4057qib7	4561	3	hospitalized	hospitalize	VBN
cord-005453-4057qib7	4561	4	on	on	IN
cord-005453-4057qib7	4561	5	day	day	NN
cord-005453-4057qib7	4561	6	+270	+270	NNP
cord-005453-4057qib7	4561	7	posttransplantation	posttransplantation	NN
cord-005453-4057qib7	4561	8	due	due	IN
cord-005453-4057qib7	4561	9	to	to	IN
cord-005453-4057qib7	4561	10	febrile	febrile	JJ
cord-005453-4057qib7	4561	11	neutropenia	neutropenia	NN
cord-005453-4057qib7	4561	12	and	and	CC
cord-005453-4057qib7	4561	13	respiratory	respiratory	JJ
cord-005453-4057qib7	4561	14	symptoms	symptom	NNS
cord-005453-4057qib7	4561	15	,	,	,
cord-005453-4057qib7	4561	16	with	with	IN
cord-005453-4057qib7	4561	17	normal	normal	JJ
cord-005453-4057qib7	4561	18	chest	chest	NN
cord-005453-4057qib7	4561	19	CT	CT	NNP
cord-005453-4057qib7	4561	20	,	,	,
cord-005453-4057qib7	4561	21	and	and	CC
cord-005453-4057qib7	4561	22	CT	CT	NNP
cord-005453-4057qib7	4561	23	of	of	IN
cord-005453-4057qib7	4561	24	paranasal	paranasal	NNP
cord-005453-4057qib7	4561	25	sinuses	sinus	NNS
cord-005453-4057qib7	4561	26	with	with	IN
cord-005453-4057qib7	4561	27	acute	acute	JJ
cord-005453-4057qib7	4561	28	pansinusitis	pansinusitis	NN
cord-005453-4057qib7	4561	29	,	,	,
cord-005453-4057qib7	4561	30	for	for	IN
cord-005453-4057qib7	4561	31	which	which	WDT
cord-005453-4057qib7	4561	32	she	-PRON-	PRP
cord-005453-4057qib7	4561	33	received	receive	VBD
cord-005453-4057qib7	4561	34	Meropenem	Meropenem	NNP
cord-005453-4057qib7	4561	35	1gr	1gr	NNP
cord-005453-4057qib7	4561	36	intravenously	intravenously	RB
cord-005453-4057qib7	4561	37	every	every	DT
cord-005453-4057qib7	4561	38	8	8	CD
cord-005453-4057qib7	4561	39	hours	hour	NNS
cord-005453-4057qib7	4561	40	plus	plus	CC
cord-005453-4057qib7	4561	41	Vancomycin	Vancomycin	NNP
cord-005453-4057qib7	4561	42	1gr	1gr	NNP
cord-005453-4057qib7	4561	43	intravenously	intravenously	RB
cord-005453-4057qib7	4561	44	every	every	DT
cord-005453-4057qib7	4561	45	12	12	CD
cord-005453-4057qib7	4561	46	hours	hour	NNS
cord-005453-4057qib7	4561	47	during	during	IN
cord-005453-4057qib7	4561	48	14	14	CD
cord-005453-4057qib7	4561	49	days	day	NNS
cord-005453-4057qib7	4561	50	with	with	IN
cord-005453-4057qib7	4561	51	symptom	symptom	NN
cord-005453-4057qib7	4561	52	resolution	resolution	NN
cord-005453-4057qib7	4561	53	.	.	.
cord-005453-4057qib7	4562	1	She	-PRON-	PRP
cord-005453-4057qib7	4562	2	remained	remain	VBD
cord-005453-4057qib7	4562	3	hospitalized	hospitalize	VBN
cord-005453-4057qib7	4562	4	for	for	IN
cord-005453-4057qib7	4562	5	cytopenias	cytopenia	NNS
cord-005453-4057qib7	4562	6	with	with	IN
cord-005453-4057qib7	4562	7	normal	normal	JJ
cord-005453-4057qib7	4562	8	bone	bone	NN
cord-005453-4057qib7	4562	9	marrow	marrow	NN
cord-005453-4057qib7	4562	10	and	and	CC
cord-005453-4057qib7	4562	11	100	100	CD
cord-005453-4057qib7	4562	12	%	%	NN
cord-005453-4057qib7	4562	13	chimerism	chimerism	NN
cord-005453-4057qib7	4562	14	.	.	.
cord-005453-4057qib7	4563	1	On	on	IN
cord-005453-4057qib7	4563	2	day	day	NN
cord-005453-4057qib7	4563	3	+291	+291	NNP
cord-005453-4057qib7	4563	4	posttransplant	posttransplant	NNP
cord-005453-4057qib7	4563	5	she	-PRON-	PRP
cord-005453-4057qib7	4563	6	presented	present	VBD
cord-005453-4057qib7	4563	7	fever	fever	NN
cord-005453-4057qib7	4563	8	and	and	CC
cord-005453-4057qib7	4563	9	leukocytosis	leukocytosis	NN
cord-005453-4057qib7	4563	10	,	,	,
cord-005453-4057qib7	4563	11	with	with	IN
cord-005453-4057qib7	4563	12	acute	acute	JJ
cord-005453-4057qib7	4563	13	respiratory	respiratory	JJ
cord-005453-4057qib7	4563	14	failure	failure	NN
cord-005453-4057qib7	4563	15	with	with	IN
cord-005453-4057qib7	4563	16	chest	chest	NN
cord-005453-4057qib7	4563	17	CT	CT	NNP
cord-005453-4057qib7	4563	18	that	that	WDT
cord-005453-4057qib7	4563	19	showed	show	VBD
cord-005453-4057qib7	4563	20	bilateral	bilateral	JJ
cord-005453-4057qib7	4563	21	alveolar	alveolar	JJ
cord-005453-4057qib7	4563	22	occupation	occupation	NN
cord-005453-4057qib7	4563	23	,	,	,
cord-005453-4057qib7	4563	24	"	"	``
cord-005453-4057qib7	4563	25	crazy	crazy	JJ
cord-005453-4057qib7	4563	26	-	-	HYPH
cord-005453-4057qib7	4563	27	paving	pave	VBG
cord-005453-4057qib7	4563	28	"	"	''
cord-005453-4057qib7	4563	29	pattern	pattern	NN
cord-005453-4057qib7	4563	30	and	and	CC
cord-005453-4057qib7	4563	31	frosted	frosted	JJ
cord-005453-4057qib7	4563	32	glass	glass	NN
cord-005453-4057qib7	4563	33	(	(	-LRB-
cord-005453-4057qib7	4563	34	see	see	VB
cord-005453-4057qib7	4563	35	image	image	NN
cord-005453-4057qib7	4563	36	)	)	-RRB-
cord-005453-4057qib7	4563	37	,	,	,
cord-005453-4057qib7	4563	38	so	so	IN
cord-005453-4057qib7	4563	39	diagnostic	diagnostic	JJ
cord-005453-4057qib7	4563	40	fibro	fibro	NN
cord-005453-4057qib7	4563	41	-	-	HYPH
cord-005453-4057qib7	4563	42	bronchoscopy	bronchoscopy	NN
cord-005453-4057qib7	4563	43	was	be	VBD
cord-005453-4057qib7	4563	44	performed	perform	VBN
cord-005453-4057qib7	4563	45	,	,	,
cord-005453-4057qib7	4563	46	reporting	report	VBG
cord-005453-4057qib7	4563	47	postoperatively	postoperatively	RB
cord-005453-4057qib7	4563	48	for	for	IN
cord-005453-4057qib7	4563	49	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	4563	50	jirovecii	jirovecii	NNP
cord-005453-4057qib7	4563	51	.	.	.
cord-005453-4057qib7	4564	1	She	-PRON-	PRP
cord-005453-4057qib7	4564	2	received	receive	VBD
cord-005453-4057qib7	4564	3	21	21	CD
cord-005453-4057qib7	4564	4	days	day	NNS
cord-005453-4057qib7	4564	5	of	of	IN
cord-005453-4057qib7	4564	6	Trimethoprim	Trimethoprim	NNP
cord-005453-4057qib7	4564	7	-	-	HYPH
cord-005453-4057qib7	4564	8	sulfamethoxazole	sulfamethoxazole	NNP
cord-005453-4057qib7	4564	9	,	,	,
cord-005453-4057qib7	4564	10	with	with	IN
cord-005453-4057qib7	4564	11	a	a	DT
cord-005453-4057qib7	4564	12	torpid	torpid	JJ
cord-005453-4057qib7	4564	13	evolution	evolution	NN
cord-005453-4057qib7	4564	14	requiring	require	VBG
cord-005453-4057qib7	4564	15	mechanical	mechanical	JJ
cord-005453-4057qib7	4564	16	ventilation	ventilation	NN
cord-005453-4057qib7	4564	17	and	and	CC
cord-005453-4057qib7	4564	18	tracheostomy	tracheostomy	NN
cord-005453-4057qib7	4564	19	,	,	,
cord-005453-4057qib7	4564	20	persisting	persist	VBG
cord-005453-4057qib7	4564	21	with	with	IN
cord-005453-4057qib7	4564	22	hypoxemia	hypoxemia	NN
cord-005453-4057qib7	4564	23	.	.	.
cord-005453-4057qib7	4565	1	The	the	DT
cord-005453-4057qib7	4565	2	report	report	NN
cord-005453-4057qib7	4565	3	of	of	IN
cord-005453-4057qib7	4565	4	cultures	culture	NNS
cord-005453-4057qib7	4565	5	for	for	IN
cord-005453-4057qib7	4565	6	fungi	fungus	NNS
cord-005453-4057qib7	4565	7	,	,	,
cord-005453-4057qib7	4565	8	mycobacteria	mycobacterium	NNS
cord-005453-4057qib7	4565	9	,	,	,
cord-005453-4057qib7	4565	10	and	and	CC
cord-005453-4057qib7	4565	11	respiratory	respiratory	JJ
cord-005453-4057qib7	4565	12	panel	panel	NN
cord-005453-4057qib7	4565	13	of	of	IN
cord-005453-4057qib7	4565	14	FilmArray	FilmArray	NNP
cord-005453-4057qib7	4565	15	were	be	VBD
cord-005453-4057qib7	4565	16	negative	negative	JJ
cord-005453-4057qib7	4565	17	.	.	.
cord-005453-4057qib7	4566	1	A	a	DT
cord-005453-4057qib7	4566	2	pathology	pathology	NN
cord-005453-4057qib7	4566	3	report	report	NN
cord-005453-4057qib7	4566	4	was	be	VBD
cord-005453-4057qib7	4566	5	obtained	obtain	VBN
cord-005453-4057qib7	4566	6	with	with	IN
cord-005453-4057qib7	4566	7	30	30	CD
cord-005453-4057qib7	4566	8	%	%	NN
cord-005453-4057qib7	4566	9	neutrophils	neutrophil	NNS
cord-005453-4057qib7	4566	10	,	,	,
cord-005453-4057qib7	4566	11	as	as	RB
cord-005453-4057qib7	4566	12	well	well	RB
cord-005453-4057qib7	4566	13	as	as	IN
cord-005453-4057qib7	4566	14	PAS	pas	NN
cord-005453-4057qib7	4566	15	staining	stain	VBG
cord-005453-4057qib7	4566	16	with	with	IN
cord-005453-4057qib7	4566	17	acellular	acellular	JJ
cord-005453-4057qib7	4566	18	pink	pink	JJ
cord-005453-4057qib7	4566	19	material	material	NN
cord-005453-4057qib7	4566	20	and	and	CC
cord-005453-4057qib7	4566	21	elevated	elevated	JJ
cord-005453-4057qib7	4566	22	serum	serum	NN
cord-005453-4057qib7	4566	23	LDH	LDH	NNP
cord-005453-4057qib7	4566	24	,	,	,
cord-005453-4057qib7	4566	25	with	with	IN
cord-005453-4057qib7	4566	26	a	a	DT
cord-005453-4057qib7	4566	27	diagnosis	diagnosis	NN
cord-005453-4057qib7	4566	28	of	of	IN
cord-005453-4057qib7	4566	29	secondary	secondary	JJ
cord-005453-4057qib7	4566	30	PAP	pap	NN
cord-005453-4057qib7	4566	31	.	.	.
cord-005453-4057qib7	4567	1	The	the	DT
cord-005453-4057qib7	4567	2	patient	patient	NN
cord-005453-4057qib7	4567	3	continued	continue	VBD
cord-005453-4057qib7	4567	4	with	with	IN
cord-005453-4057qib7	4567	5	poor	poor	JJ
cord-005453-4057qib7	4567	6	general	general	JJ
cord-005453-4057qib7	4567	7	condition	condition	NN
cord-005453-4057qib7	4567	8	,	,	,
cord-005453-4057qib7	4567	9	refractory	refractory	JJ
cord-005453-4057qib7	4567	10	hypoxemia	hypoxemia	NN
cord-005453-4057qib7	4567	11	,	,	,
cord-005453-4057qib7	4567	12	high	high	JJ
cord-005453-4057qib7	4567	13	ventilatory	ventilatory	NN
cord-005453-4057qib7	4567	14	parameters	parameter	NNS
cord-005453-4057qib7	4567	15	and	and	CC
cord-005453-4057qib7	4567	16	hemodynamic	hemodynamic	JJ
cord-005453-4057qib7	4567	17	instability	instability	NN
cord-005453-4057qib7	4567	18	,	,	,
cord-005453-4057qib7	4567	19	due	due	IN
cord-005453-4057qib7	4567	20	to	to	IN
cord-005453-4057qib7	4567	21	which	which	WDT
cord-005453-4057qib7	4567	22	she	-PRON-	PRP
cord-005453-4057qib7	4567	23	was	be	VBD
cord-005453-4057qib7	4567	24	not	not	RB
cord-005453-4057qib7	4567	25	able	able	JJ
cord-005453-4057qib7	4567	26	to	to	TO
cord-005453-4057qib7	4567	27	be	be	VB
cord-005453-4057qib7	4567	28	a	a	DT
cord-005453-4057qib7	4567	29	candidate	candidate	NN
cord-005453-4057qib7	4567	30	for	for	IN
cord-005453-4057qib7	4567	31	treatment	treatment	NN
cord-005453-4057qib7	4567	32	with	with	IN
cord-005453-4057qib7	4567	33	total	total	JJ
cord-005453-4057qib7	4567	34	pulmonary	pulmonary	JJ
cord-005453-4057qib7	4567	35	lavage	lavage	NN
cord-005453-4057qib7	4567	36	;	;	:
cord-005453-4057qib7	4567	37	leading	lead	VBG
cord-005453-4057qib7	4567	38	to	to	IN
cord-005453-4057qib7	4567	39	multi	multi	JJ
cord-005453-4057qib7	4567	40	-	-	JJ
cord-005453-4057qib7	4567	41	organ	organ	JJ
cord-005453-4057qib7	4567	42	failure	failure	NN
cord-005453-4057qib7	4567	43	and	and	CC
cord-005453-4057qib7	4567	44	later	later	RB
cord-005453-4057qib7	4567	45	death	death	NN
cord-005453-4057qib7	4567	46	.	.	.
cord-005453-4057qib7	4568	1	[	[	-LRB-
cord-005453-4057qib7	4568	2	[	[	-LRB-
cord-005453-4057qib7	4568	3	P211	p211	CD
cord-005453-4057qib7	4568	4	Image	image	NN
cord-005453-4057qib7	4568	5	]	]	-RRB-
cord-005453-4057qib7	4568	6	1	1	CD
cord-005453-4057qib7	4568	7	.	.	.
cord-005453-4057qib7	4569	1	High	high	JJ
cord-005453-4057qib7	4569	2	resolution	resolution	NN
cord-005453-4057qib7	4569	3	chest	chest	NN
cord-005453-4057qib7	4569	4	CT	CT	NNP
cord-005453-4057qib7	4569	5	.	.	.
cord-005453-4057qib7	4570	1	Sample	sample	JJ
cord-005453-4057qib7	4570	2	opacification	opacification	NN
cord-005453-4057qib7	4570	3	in	in	IN
cord-005453-4057qib7	4570	4	frosted	frosted	JJ
cord-005453-4057qib7	4570	5	glass	glass	NN
cord-005453-4057qib7	4570	6	(	(	-LRB-
cord-005453-4057qib7	4570	7	A	a	NN
cord-005453-4057qib7	4570	8	)	)	-RRB-
cord-005453-4057qib7	4570	9	and	and	CC
cord-005453-4057qib7	4570	10	pattern	pattern	NN
cord-005453-4057qib7	4570	11	'	'	''
cord-005453-4057qib7	4570	12	'	'	''
cord-005453-4057qib7	4570	13	Crazypaving	Crazypaving	NNP
cord-005453-4057qib7	4570	14	'	'	''
cord-005453-4057qib7	4570	15	'	'	''
cord-005453-4057qib7	4570	16	(	(	-LRB-
cord-005453-4057qib7	4570	17	B	b	NN
cord-005453-4057qib7	4570	18	)	)	-RRB-
cord-005453-4057qib7	4570	19	]	]	-RRB-
cord-005453-4057qib7	4571	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4571	2	:	:	:
cord-005453-4057qib7	4572	1	The	the	DT
cord-005453-4057qib7	4572	2	importance	importance	NN
cord-005453-4057qib7	4572	3	of	of	IN
cord-005453-4057qib7	4572	4	considering	consider	VBG
cord-005453-4057qib7	4572	5	the	the	DT
cord-005453-4057qib7	4572	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	4572	7	of	of	IN
cord-005453-4057qib7	4572	8	PAP	pap	NN
cord-005453-4057qib7	4572	9	as	as	IN
cord-005453-4057qib7	4572	10	a	a	DT
cord-005453-4057qib7	4572	11	noninfectious	noninfectious	JJ
cord-005453-4057qib7	4572	12	pulmonary	pulmonary	JJ
cord-005453-4057qib7	4572	13	complication	complication	NN
cord-005453-4057qib7	4572	14	in	in	IN
cord-005453-4057qib7	4572	15	patients	patient	NNS
cord-005453-4057qib7	4572	16	with	with	IN
cord-005453-4057qib7	4572	17	allogenic	allogenic	JJ
cord-005453-4057qib7	4572	18	HSCT	HSCT	NNP
cord-005453-4057qib7	4572	19	despite	despite	IN
cord-005453-4057qib7	4572	20	its	-PRON-	PRP$
cord-005453-4057qib7	4572	21	low	low	JJ
cord-005453-4057qib7	4572	22	incidence	incidence	NN
cord-005453-4057qib7	4572	23	is	be	VBZ
cord-005453-4057qib7	4572	24	recognized	recognize	VBN
cord-005453-4057qib7	4572	25	.	.	.
cord-005453-4057qib7	4573	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4573	2	:	:	:
cord-005453-4057qib7	4573	3	Nothing	nothing	NN
cord-005453-4057qib7	4573	4	to	to	TO
cord-005453-4057qib7	4573	5	declare	declare	VB
cord-005453-4057qib7	4573	6	Methods	method	NNS
cord-005453-4057qib7	4573	7	:	:	:
cord-005453-4057qib7	4573	8	Once	once	IN
cord-005453-4057qib7	4573	9	the	the	DT
cord-005453-4057qib7	4573	10	project	project	NN
cord-005453-4057qib7	4573	11	was	be	VBD
cord-005453-4057qib7	4573	12	approved	approve	VBN
cord-005453-4057qib7	4573	13	by	by	IN
cord-005453-4057qib7	4573	14	the	the	DT
cord-005453-4057qib7	4573	15	Clinical	Clinical	NNP
cord-005453-4057qib7	4573	16	Trials	Trials	NNPS
cord-005453-4057qib7	4573	17	and	and	CC
cord-005453-4057qib7	4573	18	Ethics	Ethics	NNP
cord-005453-4057qib7	4573	19	Committee	Committee	NNP
cord-005453-4057qib7	4573	20	,	,	,
cord-005453-4057qib7	4573	21	154	154	CD
cord-005453-4057qib7	4573	22	pairs	pair	NNS
cord-005453-4057qib7	4573	23	of	of	IN
cord-005453-4057qib7	4573	24	blood	blood	NN
cord-005453-4057qib7	4573	25	samples	sample	NNS
cord-005453-4057qib7	4573	26	were	be	VBD
cord-005453-4057qib7	4573	27	drawn	draw	VBN
cord-005453-4057qib7	4573	28	(	(	-LRB-
cord-005453-4057qib7	4573	29	154	154	CD
cord-005453-4057qib7	4573	30	from	from	IN
cord-005453-4057qib7	4573	31	PICC	PICC	NNP
cord-005453-4057qib7	4573	32	line	line	NN
cord-005453-4057qib7	4573	33	and	and	CC
cord-005453-4057qib7	4573	34	154	154	CD
cord-005453-4057qib7	4573	35	from	from	IN
cord-005453-4057qib7	4573	36	venepuncture	venepuncture	NN
cord-005453-4057qib7	4573	37	)	)	-RRB-
cord-005453-4057qib7	4573	38	from	from	IN
cord-005453-4057qib7	4573	39	33	33	CD
cord-005453-4057qib7	4573	40	voluntary	voluntary	JJ
cord-005453-4057qib7	4573	41	allo	allo	NN
cord-005453-4057qib7	4573	42	-	-	HYPH
cord-005453-4057qib7	4573	43	HSCT	HSCT	NNP
cord-005453-4057qib7	4573	44	recipients	recipient	NNS
cord-005453-4057qib7	4573	45	who	who	WP
cord-005453-4057qib7	4573	46	were	be	VBD
cord-005453-4057qib7	4573	47	receiving	receive	VBG
cord-005453-4057qib7	4573	48	continuous	continuous	JJ
cord-005453-4057qib7	4573	49	infusion	infusion	NN
cord-005453-4057qib7	4573	50	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	4573	51	from	from	IN
cord-005453-4057qib7	4573	52	February	February	NNP
cord-005453-4057qib7	4573	53	through	through	IN
cord-005453-4057qib7	4573	54	August	August	NNP
cord-005453-4057qib7	4573	55	2018	2018	CD
cord-005453-4057qib7	4573	56	.	.	.
cord-005453-4057qib7	4574	1	The	the	DT
cord-005453-4057qib7	4574	2	pts	pts	NN
cord-005453-4057qib7	4574	3	had	have	VBD
cord-005453-4057qib7	4574	4	inserted	insert	VBN
cord-005453-4057qib7	4574	5	a	a	DT
cord-005453-4057qib7	4574	6	double	double	JJ
cord-005453-4057qib7	4574	7	-	-	HYPH
cord-005453-4057qib7	4574	8	lumen	lumen	NN
cord-005453-4057qib7	4574	9	polyurethane	polyurethane	NN
cord-005453-4057qib7	4574	10	PICC	PICC	NNP
cord-005453-4057qib7	4574	11	.	.	.
cord-005453-4057qib7	4575	1	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	4575	2	was	be	VBD
cord-005453-4057qib7	4575	3	always	always	RB
cord-005453-4057qib7	4575	4	administered	administer	VBN
cord-005453-4057qib7	4575	5	through	through	IN
cord-005453-4057qib7	4575	6	the	the	DT
cord-005453-4057qib7	4575	7	red	red	JJ
cord-005453-4057qib7	4575	8	line	line	NN
cord-005453-4057qib7	4575	9	,	,	,
cord-005453-4057qib7	4575	10	and	and	CC
cord-005453-4057qib7	4575	11	the	the	DT
cord-005453-4057qib7	4575	12	blood	blood	NN
cord-005453-4057qib7	4575	13	draw	draw	VBP
cord-005453-4057qib7	4575	14	always	always	RB
cord-005453-4057qib7	4575	15	performed	perform	VBN
cord-005453-4057qib7	4575	16	through	through	IN
cord-005453-4057qib7	4575	17	the	the	DT
cord-005453-4057qib7	4575	18	purple	purple	JJ
cord-005453-4057qib7	4575	19	line	line	NN
cord-005453-4057qib7	4575	20	.	.	.
cord-005453-4057qib7	4576	1	All	all	DT
cord-005453-4057qib7	4576	2	of	of	IN
cord-005453-4057qib7	4576	3	the	the	DT
cord-005453-4057qib7	4576	4	patients	patient	NNS
cord-005453-4057qib7	4576	5	signed	sign	VBD
cord-005453-4057qib7	4576	6	the	the	DT
cord-005453-4057qib7	4576	7	informed	informed	JJ
cord-005453-4057qib7	4576	8	consent	consent	NN
cord-005453-4057qib7	4576	9	.	.	.
cord-005453-4057qib7	4577	1	22	22	CD
cord-005453-4057qib7	4577	2	were	be	VBD
cord-005453-4057qib7	4577	3	male	male	JJ
cord-005453-4057qib7	4577	4	and	and	CC
cord-005453-4057qib7	4577	5	11	11	CD
cord-005453-4057qib7	4577	6	women	woman	NNS
cord-005453-4057qib7	4577	7	.	.	.
cord-005453-4057qib7	4578	1	Median	median	JJ
cord-005453-4057qib7	4578	2	age	age	NN
cord-005453-4057qib7	4578	3	was	be	VBD
cord-005453-4057qib7	4578	4	55	55	CD
cord-005453-4057qib7	4578	5	years	year	NNS
cord-005453-4057qib7	4578	6	(	(	-LRB-
cord-005453-4057qib7	4578	7	30	30	CD
cord-005453-4057qib7	4578	8	-	-	SYM
cord-005453-4057qib7	4578	9	68	68	CD
cord-005453-4057qib7	4578	10	)	)	-RRB-
cord-005453-4057qib7	4578	11	.	.	.
cord-005453-4057qib7	4579	1	24	24	CD
cord-005453-4057qib7	4579	2	of	of	IN
cord-005453-4057qib7	4579	3	the	the	DT
cord-005453-4057qib7	4579	4	venepunctures	venepuncture	NNS
cord-005453-4057qib7	4579	5	were	be	VBD
cord-005453-4057qib7	4579	6	carried	carry	VBN
cord-005453-4057qib7	4579	7	out	out	RP
cord-005453-4057qib7	4579	8	in	in	IN
cord-005453-4057qib7	4579	9	the	the	DT
cord-005453-4057qib7	4579	10	arm	arm	NN
cord-005453-4057qib7	4579	11	where	where	WRB
cord-005453-4057qib7	4579	12	the	the	DT
cord-005453-4057qib7	4579	13	PICC	PICC	NNP
cord-005453-4057qib7	4579	14	was	be	VBD
cord-005453-4057qib7	4579	15	set	set	VBN
cord-005453-4057qib7	4579	16	,	,	,
cord-005453-4057qib7	4579	17	and	and	CC
cord-005453-4057qib7	4579	18	the	the	DT
cord-005453-4057qib7	4579	19	other	other	JJ
cord-005453-4057qib7	4579	20	130	130	CD
cord-005453-4057qib7	4579	21	from	from	IN
cord-005453-4057qib7	4579	22	the	the	DT
cord-005453-4057qib7	4579	23	contralateral	contralateral	JJ
cord-005453-4057qib7	4579	24	arm	arm	NN
cord-005453-4057qib7	4579	25	.	.	.
cord-005453-4057qib7	4580	1	A	a	DT
cord-005453-4057qib7	4580	2	limited	limited	JJ
cord-005453-4057qib7	4580	3	group	group	NN
cord-005453-4057qib7	4580	4	of	of	IN
cord-005453-4057qib7	4580	5	nurses	nurse	NNS
cord-005453-4057qib7	4580	6	performed	perform	VBD
cord-005453-4057qib7	4580	7	the	the	DT
cord-005453-4057qib7	4580	8	extractions	extraction	NNS
cord-005453-4057qib7	4580	9	of	of	IN
cord-005453-4057qib7	4580	10	the	the	DT
cord-005453-4057qib7	4580	11	samples	sample	NNS
cord-005453-4057qib7	4580	12	.	.	.
cord-005453-4057qib7	4581	1	Results	result	NNS
cord-005453-4057qib7	4581	2	:	:	:
cord-005453-4057qib7	4582	1	As	as	IN
cord-005453-4057qib7	4582	2	shown	show	VBN
cord-005453-4057qib7	4582	3	in	in	IN
cord-005453-4057qib7	4582	4	the	the	DT
cord-005453-4057qib7	4582	5	table	table	NN
cord-005453-4057qib7	4582	6	,	,	,
cord-005453-4057qib7	4582	7	tacrolimus	tacrolimus	RB
cord-005453-4057qib7	4582	8	trough	trough	NN
cord-005453-4057qib7	4582	9	levels	level	NNS
cord-005453-4057qib7	4582	10	determined	determine	VBN
cord-005453-4057qib7	4582	11	in	in	IN
cord-005453-4057qib7	4582	12	blood	blood	NN
cord-005453-4057qib7	4582	13	from	from	IN
cord-005453-4057qib7	4582	14	venepuncture	venepuncture	NN
cord-005453-4057qib7	4582	15	were	be	VBD
cord-005453-4057qib7	4582	16	similar	similar	JJ
cord-005453-4057qib7	4582	17	to	to	IN
cord-005453-4057qib7	4582	18	those	those	DT
cord-005453-4057qib7	4582	19	in	in	IN
cord-005453-4057qib7	4582	20	blood	blood	NN
cord-005453-4057qib7	4582	21	drawn	draw	VBN
cord-005453-4057qib7	4582	22	through	through	IN
cord-005453-4057qib7	4582	23	the	the	DT
cord-005453-4057qib7	4582	24	PICC	PICC	NNP
cord-005453-4057qib7	4582	25	(	(	-LRB-
cord-005453-4057qib7	4582	26	median	median	NN
cord-005453-4057qib7	4582	27	:	:	:
cord-005453-4057qib7	4582	28	10.7	10.7	CD
cord-005453-4057qib7	4582	29	vs	vs	IN
cord-005453-4057qib7	4582	30	11.1	11.1	CD
cord-005453-4057qib7	4582	31	ng	ng	NNP
cord-005453-4057qib7	4582	32	/	/	SYM
cord-005453-4057qib7	4582	33	mL	mL	NNP
cord-005453-4057qib7	4582	34	)	)	-RRB-
cord-005453-4057qib7	4582	35	.	.	.
cord-005453-4057qib7	4583	1	When	when	WRB
cord-005453-4057qib7	4583	2	comparing	compare	VBG
cord-005453-4057qib7	4583	3	one	one	CD
cord-005453-4057qib7	4583	4	by	by	IN
cord-005453-4057qib7	4583	5	one	one	CD
cord-005453-4057qib7	4583	6	in	in	IN
cord-005453-4057qib7	4583	7	the	the	DT
cord-005453-4057qib7	4583	8	individual	individual	JJ
cord-005453-4057qib7	4583	9	patients	patient	NNS
cord-005453-4057qib7	4583	10	,	,	,
cord-005453-4057qib7	4583	11	the	the	DT
cord-005453-4057qib7	4583	12	differences	difference	NNS
cord-005453-4057qib7	4583	13	were	be	VBD
cord-005453-4057qib7	4583	14	not	not	RB
cord-005453-4057qib7	4583	15	significant	significant	JJ
cord-005453-4057qib7	4583	16	,	,	,
cord-005453-4057qib7	4583	17	and	and	CC
cord-005453-4057qib7	4583	18	changed	change	VBD
cord-005453-4057qib7	4583	19	the	the	DT
cord-005453-4057qib7	4583	20	dosing	dosing	NN
cord-005453-4057qib7	4583	21	prescription	prescription	NN
cord-005453-4057qib7	4583	22	in	in	IN
cord-005453-4057qib7	4583	23	no	no	DT
cord-005453-4057qib7	4583	24	cases	case	NNS
cord-005453-4057qib7	4583	25	.	.	.
cord-005453-4057qib7	4584	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4584	2	:	:	:
cord-005453-4057qib7	4585	1	In	in	IN
cord-005453-4057qib7	4585	2	our	-PRON-	PRP$
cord-005453-4057qib7	4585	3	experience	experience	NN
cord-005453-4057qib7	4585	4	,	,	,
cord-005453-4057qib7	4585	5	there	there	EX
cord-005453-4057qib7	4585	6	are	be	VBP
cord-005453-4057qib7	4585	7	not	not	RB
cord-005453-4057qib7	4585	8	significant	significant	JJ
cord-005453-4057qib7	4585	9	differences	difference	NNS
cord-005453-4057qib7	4585	10	in	in	IN
cord-005453-4057qib7	4585	11	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	4585	12	levels	level	NNS
cord-005453-4057qib7	4585	13	draw	draw	VBP
cord-005453-4057qib7	4585	14	from	from	IN
cord-005453-4057qib7	4585	15	the	the	DT
cord-005453-4057qib7	4585	16	PICC	PICC	NNP
cord-005453-4057qib7	4585	17	line	line	NN
cord-005453-4057qib7	4585	18	,	,	,
cord-005453-4057qib7	4585	19	compared	compare	VBN
cord-005453-4057qib7	4585	20	with	with	IN
cord-005453-4057qib7	4585	21	a	a	DT
cord-005453-4057qib7	4585	22	peripheral	peripheral	JJ
cord-005453-4057qib7	4585	23	site	site	NN
cord-005453-4057qib7	4585	24	.	.	.
cord-005453-4057qib7	4586	1	So	so	RB
cord-005453-4057qib7	4586	2	,	,	,
cord-005453-4057qib7	4586	3	in	in	IN
cord-005453-4057qib7	4586	4	our	-PRON-	PRP$
cord-005453-4057qib7	4586	5	opinion	opinion	NN
cord-005453-4057qib7	4586	6	,	,	,
cord-005453-4057qib7	4586	7	if	if	IN
cord-005453-4057qib7	4586	8	the	the	DT
cord-005453-4057qib7	4586	9	line	line	NN
cord-005453-4057qib7	4586	10	for	for	IN
cord-005453-4057qib7	4586	11	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	4586	12	infusion	infusion	NN
cord-005453-4057qib7	4586	13	is	be	VBZ
cord-005453-4057qib7	4586	14	properly	properly	RB
cord-005453-4057qib7	4586	15	identified	identify	VBN
cord-005453-4057qib7	4586	16	and	and	CC
cord-005453-4057qib7	4586	17	the	the	DT
cord-005453-4057qib7	4586	18	one	one	NN
cord-005453-4057qib7	4586	19	used	use	VBN
cord-005453-4057qib7	4586	20	for	for	IN
cord-005453-4057qib7	4586	21	the	the	DT
cord-005453-4057qib7	4586	22	sample	sample	NN
cord-005453-4057qib7	4586	23	draw	draw	NN
cord-005453-4057qib7	4586	24	is	be	VBZ
cord-005453-4057qib7	4586	25	the	the	DT
cord-005453-4057qib7	4586	26	alternative	alternative	JJ
cord-005453-4057qib7	4586	27	one	one	NN
cord-005453-4057qib7	4586	28	,	,	,
cord-005453-4057qib7	4586	29	venepunctures	venepuncture	VBZ
cord-005453-4057qib7	4586	30	to	to	TO
cord-005453-4057qib7	4586	31	obtain	obtain	VB
cord-005453-4057qib7	4586	32	sample	sample	NN
cord-005453-4057qib7	4586	33	from	from	IN
cord-005453-4057qib7	4586	34	peripheral	peripheral	JJ
cord-005453-4057qib7	4586	35	sites	site	NNS
cord-005453-4057qib7	4586	36	are	be	VBP
cord-005453-4057qib7	4586	37	not	not	RB
cord-005453-4057qib7	4586	38	justified	justified	JJ
cord-005453-4057qib7	4586	39	for	for	IN
cord-005453-4057qib7	4586	40	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	4586	41	levels	level	NNS
cord-005453-4057qib7	4586	42	measurements	measurement	NNS
cord-005453-4057qib7	4586	43	.	.	.
cord-005453-4057qib7	4587	1	Background	background	NN
cord-005453-4057qib7	4587	2	:	:	:
cord-005453-4057qib7	4588	1	Patients	patient	NNS
cord-005453-4057qib7	4588	2	undergoing	undergo	VBG
cord-005453-4057qib7	4588	3	a	a	DT
cord-005453-4057qib7	4588	4	HSCT	HSCT	NNP
cord-005453-4057qib7	4588	5	may	may	MD
cord-005453-4057qib7	4588	6	require	require	VB
cord-005453-4057qib7	4588	7	ICU	ICU	NNP
cord-005453-4057qib7	4588	8	admission	admission	NN
cord-005453-4057qib7	4588	9	due	due	IN
cord-005453-4057qib7	4588	10	to	to	IN
cord-005453-4057qib7	4588	11	transplant	transplant	NN
cord-005453-4057qib7	4588	12	-	-	HYPH
cord-005453-4057qib7	4588	13	related	relate	VBN
cord-005453-4057qib7	4588	14	toxicities	toxicity	NNS
cord-005453-4057qib7	4588	15	.	.	.
cord-005453-4057qib7	4589	1	The	the	DT
cord-005453-4057qib7	4589	2	aim	aim	NN
cord-005453-4057qib7	4589	3	of	of	IN
cord-005453-4057qib7	4589	4	this	this	DT
cord-005453-4057qib7	4589	5	study	study	NN
cord-005453-4057qib7	4589	6	was	be	VBD
cord-005453-4057qib7	4589	7	to	to	TO
cord-005453-4057qib7	4589	8	analyse	analyse	VB
cord-005453-4057qib7	4589	9	a	a	DT
cord-005453-4057qib7	4589	10	single	single	JJ
cord-005453-4057qib7	4589	11	centre	centre	NN
cord-005453-4057qib7	4589	12	experience	experience	NN
cord-005453-4057qib7	4589	13	with	with	IN
cord-005453-4057qib7	4589	14	HSCT	HSCT	NNP
cord-005453-4057qib7	4589	15	patients	patient	NNS
cord-005453-4057qib7	4589	16	requiring	require	VBG
cord-005453-4057qib7	4589	17	ICU	ICU	NNP
cord-005453-4057qib7	4589	18	admission	admission	NN
cord-005453-4057qib7	4589	19	and	and	CC
cord-005453-4057qib7	4589	20	the	the	DT
cord-005453-4057qib7	4589	21	factors	factor	NNS
cord-005453-4057qib7	4589	22	affecting	affect	VBG
cord-005453-4057qib7	4589	23	outcome	outcome	NN
cord-005453-4057qib7	4589	24	.	.	.
cord-005453-4057qib7	4590	1	Methods	method	NNS
cord-005453-4057qib7	4590	2	:	:	:
cord-005453-4057qib7	4590	3	We	-PRON-	PRP
cord-005453-4057qib7	4590	4	included	include	VBD
cord-005453-4057qib7	4590	5	all	all	DT
cord-005453-4057qib7	4590	6	adult	adult	NN
cord-005453-4057qib7	4590	7	patients	patient	NNS
cord-005453-4057qib7	4590	8	(	(	-LRB-
cord-005453-4057qib7	4590	9	age	age	NN
cord-005453-4057qib7	4590	10	>	>	XX
cord-005453-4057qib7	4590	11	=	=	SYM
cord-005453-4057qib7	4590	12	18	18	CD
cord-005453-4057qib7	4590	13	)	)	-RRB-
cord-005453-4057qib7	4590	14	who	who	WP
cord-005453-4057qib7	4590	15	had	have	VBD
cord-005453-4057qib7	4590	16	an	an	DT
cord-005453-4057qib7	4590	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	4590	18	or	or	CC
cord-005453-4057qib7	4590	19	autologous	autologous	JJ
cord-005453-4057qib7	4590	20	HSCT	HSCT	NNP
cord-005453-4057qib7	4590	21	during	during	IN
cord-005453-4057qib7	4590	22	2017	2017	CD
cord-005453-4057qib7	4591	1	(	(	-LRB-
cord-005453-4057qib7	4591	2	D0	d0	NN
cord-005453-4057qib7	4591	3	between	between	IN
cord-005453-4057qib7	4591	4	1	1	CD
cord-005453-4057qib7	4591	5	-	-	HYPH
cord-005453-4057qib7	4591	6	1	1	CD
cord-005453-4057qib7	4591	7	-	-	HYPH
cord-005453-4057qib7	4591	8	2017	2017	CD
cord-005453-4057qib7	4591	9	to	to	IN
cord-005453-4057qib7	4591	10	31	31	CD
cord-005453-4057qib7	4591	11	-	-	HYPH
cord-005453-4057qib7	4591	12	12	12	CD
cord-005453-4057qib7	4591	13	-	-	HYPH
cord-005453-4057qib7	4591	14	2017	2017	CD
cord-005453-4057qib7	4591	15	)	)	-RRB-
cord-005453-4057qib7	4591	16	at	at	IN
cord-005453-4057qib7	4591	17	St.	St.	NNP
cord-005453-4057qib7	4591	18	George	George	NNP
cord-005453-4057qib7	4591	19	's	's	POS
cord-005453-4057qib7	4591	20	Hospital	Hospital	NNP
cord-005453-4057qib7	4591	21	.	.	.
cord-005453-4057qib7	4592	1	Data	datum	NNS
cord-005453-4057qib7	4592	2	was	be	VBD
cord-005453-4057qib7	4592	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	4592	4	collected	collect	VBN
cord-005453-4057qib7	4592	5	from	from	IN
cord-005453-4057qib7	4592	6	patients	patient	NNS
cord-005453-4057qib7	4592	7	'	'	POS
cord-005453-4057qib7	4592	8	notes	note	NNS
cord-005453-4057qib7	4592	9	.	.	.
cord-005453-4057qib7	4593	1	ICU	ICU	NNP
cord-005453-4057qib7	4593	2	outcome	outcome	NN
cord-005453-4057qib7	4593	3	and	and	CC
cord-005453-4057qib7	4593	4	100-day	100-day	JJ
cord-005453-4057qib7	4593	5	survival	survival	NN
cord-005453-4057qib7	4593	6	were	be	VBD
cord-005453-4057qib7	4593	7	analysed	analyse	VBN
cord-005453-4057qib7	4593	8	.	.	.
cord-005453-4057qib7	4594	1	For	for	IN
cord-005453-4057qib7	4594	2	those	those	DT
cord-005453-4057qib7	4594	3	patients	patient	NNS
cord-005453-4057qib7	4594	4	who	who	WP
cord-005453-4057qib7	4594	5	were	be	VBD
cord-005453-4057qib7	4594	6	admitted	admit	VBN
cord-005453-4057qib7	4594	7	to	to	IN
cord-005453-4057qib7	4594	8	ICU	ICU	NNP
cord-005453-4057qib7	4594	9	more	more	JJR
cord-005453-4057qib7	4594	10	than	than	IN
cord-005453-4057qib7	4594	11	once	once	RB
cord-005453-4057qib7	4594	12	,	,	,
cord-005453-4057qib7	4594	13	outcome	outcome	NN
cord-005453-4057qib7	4594	14	was	be	VBD
cord-005453-4057qib7	4594	15	analysed	analyse	VBN
cord-005453-4057qib7	4594	16	from	from	IN
cord-005453-4057qib7	4594	17	their	-PRON-	PRP$
cord-005453-4057qib7	4594	18	last	last	JJ
cord-005453-4057qib7	4594	19	ICU	ICU	NNP
cord-005453-4057qib7	4594	20	admission	admission	NN
cord-005453-4057qib7	4594	21	.	.	.
cord-005453-4057qib7	4595	1	Results	result	NNS
cord-005453-4057qib7	4595	2	:	:	:
cord-005453-4057qib7	4595	3	20	20	CD
cord-005453-4057qib7	4595	4	allograft	allograft	NN
cord-005453-4057qib7	4595	5	patients	patient	NNS
cord-005453-4057qib7	4595	6	were	be	VBD
cord-005453-4057qib7	4595	7	included	include	VBN
cord-005453-4057qib7	4595	8	.	.	.
cord-005453-4057qib7	4596	1	14	14	CD
cord-005453-4057qib7	4596	2	were	be	VBD
cord-005453-4057qib7	4596	3	male	male	JJ
cord-005453-4057qib7	4596	4	,	,	,
cord-005453-4057qib7	4596	5	with	with	IN
cord-005453-4057qib7	4596	6	a	a	DT
cord-005453-4057qib7	4596	7	median	median	JJ
cord-005453-4057qib7	4596	8	age	age	NN
cord-005453-4057qib7	4596	9	47	47	CD
cord-005453-4057qib7	4596	10	years	year	NNS
cord-005453-4057qib7	4597	1	(	(	-LRB-
cord-005453-4057qib7	4597	2	range	range	NNP
cord-005453-4057qib7	4597	3	23	23	CD
cord-005453-4057qib7	4597	4	-	-	SYM
cord-005453-4057qib7	4597	5	68	68	CD
cord-005453-4057qib7	4597	6	years	year	NNS
cord-005453-4057qib7	4597	7	)	)	-RRB-
cord-005453-4057qib7	4597	8	.	.	.
cord-005453-4057qib7	4598	1	6	6	CD
cord-005453-4057qib7	4598	2	were	be	VBD
cord-005453-4057qib7	4598	3	female	female	JJ
cord-005453-4057qib7	4598	4	,	,	,
cord-005453-4057qib7	4598	5	with	with	IN
cord-005453-4057qib7	4598	6	median	median	JJ
cord-005453-4057qib7	4598	7	age	age	NN
cord-005453-4057qib7	4598	8	61	61	CD
cord-005453-4057qib7	4598	9	years	year	NNS
cord-005453-4057qib7	4599	1	(	(	-LRB-
cord-005453-4057qib7	4599	2	range	range	NNP
cord-005453-4057qib7	4599	3	51	51	CD
cord-005453-4057qib7	4599	4	-	-	SYM
cord-005453-4057qib7	4599	5	67	67	CD
cord-005453-4057qib7	4599	6	years	year	NNS
cord-005453-4057qib7	4599	7	)	)	-RRB-
cord-005453-4057qib7	4599	8	.	.	.
cord-005453-4057qib7	4600	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	4600	2	N	n	CD
cord-005453-4057qib7	4600	3	(	(	-LRB-
cord-005453-4057qib7	4600	4	%	%	NN
cord-005453-4057qib7	4600	5	)	)	-RRB-
cord-005453-4057qib7	4600	6	includes	include	VBZ
cord-005453-4057qib7	4600	7	ALL	all	DT
cord-005453-4057qib7	4600	8	3	3	CD
cord-005453-4057qib7	4600	9	(	(	-LRB-
cord-005453-4057qib7	4600	10	15	15	CD
cord-005453-4057qib7	4600	11	%	%	NN
cord-005453-4057qib7	4600	12	)	)	-RRB-
cord-005453-4057qib7	4600	13	,	,	,
cord-005453-4057qib7	4600	14	AML	AML	NNP
cord-005453-4057qib7	4600	15	7	7	CD
cord-005453-4057qib7	4600	16	(	(	-LRB-
cord-005453-4057qib7	4600	17	35	35	CD
cord-005453-4057qib7	4600	18	%	%	NN
cord-005453-4057qib7	4600	19	)	)	-RRB-
cord-005453-4057qib7	4600	20	,	,	,
cord-005453-4057qib7	4600	21	aCML	acml	JJ
cord-005453-4057qib7	4600	22	1	1	CD
cord-005453-4057qib7	4600	23	(	(	-LRB-
cord-005453-4057qib7	4600	24	5	5	CD
cord-005453-4057qib7	4600	25	%	%	NN
cord-005453-4057qib7	4600	26	)	)	-RRB-
cord-005453-4057qib7	4600	27	,	,	,
cord-005453-4057qib7	4600	28	CMML	CMML	NNP
cord-005453-4057qib7	4600	29	3	3	CD
cord-005453-4057qib7	4600	30	(	(	-LRB-
cord-005453-4057qib7	4600	31	15	15	CD
cord-005453-4057qib7	4600	32	%	%	NN
cord-005453-4057qib7	4600	33	)	)	-RRB-
cord-005453-4057qib7	4600	34	,	,	,
cord-005453-4057qib7	4600	35	HL	HL	NNP
cord-005453-4057qib7	4600	36	1	1	CD
cord-005453-4057qib7	4600	37	(	(	-LRB-
cord-005453-4057qib7	4600	38	5	5	CD
cord-005453-4057qib7	4600	39	%	%	NN
cord-005453-4057qib7	4600	40	)	)	-RRB-
cord-005453-4057qib7	4600	41	,	,	,
cord-005453-4057qib7	4600	42	MDS	MDS	NNP
cord-005453-4057qib7	4600	43	2	2	CD
cord-005453-4057qib7	4600	44	(	(	-LRB-
cord-005453-4057qib7	4600	45	10	10	CD
cord-005453-4057qib7	4600	46	%	%	NN
cord-005453-4057qib7	4600	47	)	)	-RRB-
cord-005453-4057qib7	4600	48	,	,	,
cord-005453-4057qib7	4600	49	MDS	MDS	NNP
cord-005453-4057qib7	4600	50	/	/	SYM
cord-005453-4057qib7	4600	51	MPN	MPN	NNP
cord-005453-4057qib7	4600	52	1	1	CD
cord-005453-4057qib7	4600	53	(	(	-LRB-
cord-005453-4057qib7	4600	54	5	5	CD
cord-005453-4057qib7	4600	55	%	%	NN
cord-005453-4057qib7	4600	56	)	)	-RRB-
cord-005453-4057qib7	4600	57	,	,	,
cord-005453-4057qib7	4600	58	FL	FL	NNP
cord-005453-4057qib7	4600	59	1	1	CD
cord-005453-4057qib7	4600	60	(	(	-LRB-
cord-005453-4057qib7	4600	61	5	5	CD
cord-005453-4057qib7	4600	62	%	%	NN
cord-005453-4057qib7	4600	63	)	)	-RRB-
cord-005453-4057qib7	4600	64	,	,	,
cord-005453-4057qib7	4600	65	SCD	SCD	NNP
cord-005453-4057qib7	4600	66	1	1	CD
cord-005453-4057qib7	4600	67	(	(	-LRB-
cord-005453-4057qib7	4600	68	5	5	CD
cord-005453-4057qib7	4600	69	%	%	NN
cord-005453-4057qib7	4600	70	)	)	-RRB-
cord-005453-4057qib7	4600	71	.	.	.
cord-005453-4057qib7	4601	1	Sixteen	sixteen	CD
cord-005453-4057qib7	4601	2	(	(	-LRB-
cord-005453-4057qib7	4601	3	80	80	CD
cord-005453-4057qib7	4601	4	%	%	NN
cord-005453-4057qib7	4601	5	)	)	-RRB-
cord-005453-4057qib7	4602	1	patients	patient	NNS
cord-005453-4057qib7	4602	2	received	receive	VBD
cord-005453-4057qib7	4602	3	their	-PRON-	PRP$
cord-005453-4057qib7	4602	4	first	first	JJ
cord-005453-4057qib7	4602	5	transplant	transplant	NN
cord-005453-4057qib7	4602	6	,	,	,
cord-005453-4057qib7	4602	7	4	4	CD
cord-005453-4057qib7	4602	8	(	(	-LRB-
cord-005453-4057qib7	4602	9	20	20	CD
cord-005453-4057qib7	4602	10	%	%	NN
cord-005453-4057qib7	4602	11	)	)	-RRB-
cord-005453-4057qib7	4602	12	received	receive	VBD
cord-005453-4057qib7	4602	13	second	second	JJ
cord-005453-4057qib7	4602	14	transplant	transplant	NN
cord-005453-4057qib7	4602	15	.	.	.
cord-005453-4057qib7	4603	1	Eight	eight	CD
cord-005453-4057qib7	4603	2	(	(	-LRB-
cord-005453-4057qib7	4603	3	40	40	CD
cord-005453-4057qib7	4603	4	%	%	NN
cord-005453-4057qib7	4603	5	)	)	-RRB-
cord-005453-4057qib7	4604	1	patients	patient	NNS
cord-005453-4057qib7	4604	2	had	have	VBD
cord-005453-4057qib7	4604	3	sibling	sibling	NN
cord-005453-4057qib7	4604	4	donor	donor	NN
cord-005453-4057qib7	4604	5	,	,	,
cord-005453-4057qib7	4604	6	12	12	CD
cord-005453-4057qib7	4604	7	patients	patient	NNS
cord-005453-4057qib7	4604	8	(	(	-LRB-
cord-005453-4057qib7	4604	9	60	60	CD
cord-005453-4057qib7	4604	10	%	%	NN
cord-005453-4057qib7	4604	11	)	)	-RRB-
cord-005453-4057qib7	4604	12	had	have	VBD
cord-005453-4057qib7	4604	13	unrelated	unrelated	JJ
cord-005453-4057qib7	4604	14	donor	donor	NN
cord-005453-4057qib7	4604	15	.	.	.
cord-005453-4057qib7	4605	1	Sixteen	sixteen	CD
cord-005453-4057qib7	4605	2	(	(	-LRB-
cord-005453-4057qib7	4605	3	80	80	CD
cord-005453-4057qib7	4605	4	%	%	NN
cord-005453-4057qib7	4605	5	)	)	-RRB-
cord-005453-4057qib7	4606	1	patients	patient	NNS
cord-005453-4057qib7	4606	2	had	have	VBD
cord-005453-4057qib7	4606	3	10/10	10/10	CD
cord-005453-4057qib7	4606	4	matched	match	VBN
cord-005453-4057qib7	4606	5	donor	donor	NN
cord-005453-4057qib7	4606	6	,	,	,
cord-005453-4057qib7	4606	7	2	2	CD
cord-005453-4057qib7	4606	8	(	(	-LRB-
cord-005453-4057qib7	4606	9	10	10	CD
cord-005453-4057qib7	4606	10	%	%	NN
cord-005453-4057qib7	4606	11	)	)	-RRB-
cord-005453-4057qib7	4607	1	patients	patient	NNS
cord-005453-4057qib7	4607	2	had	have	VBD
cord-005453-4057qib7	4607	3	9/	9/	CD
cord-005453-4057qib7	4607	4	10	10	CD
cord-005453-4057qib7	4607	5	matched	match	VBN
cord-005453-4057qib7	4607	6	donor	donor	NN
cord-005453-4057qib7	4607	7	,	,	,
cord-005453-4057qib7	4607	8	2	2	CD
cord-005453-4057qib7	4607	9	(	(	-LRB-
cord-005453-4057qib7	4607	10	10	10	CD
cord-005453-4057qib7	4607	11	%	%	NN
cord-005453-4057qib7	4607	12	)	)	-RRB-
cord-005453-4057qib7	4608	1	patients	patient	NNS
cord-005453-4057qib7	4608	2	had	have	VBD
cord-005453-4057qib7	4608	3	8/10	8/10	CD
cord-005453-4057qib7	4608	4	matched	match	VBN
cord-005453-4057qib7	4608	5	donor	donor	NN
cord-005453-4057qib7	4608	6	.	.	.
cord-005453-4057qib7	4609	1	Nineteen	nineteen	CD
cord-005453-4057qib7	4609	2	(	(	-LRB-
cord-005453-4057qib7	4609	3	95	95	CD
cord-005453-4057qib7	4609	4	%	%	NN
cord-005453-4057qib7	4609	5	)	)	-RRB-
cord-005453-4057qib7	4609	6	received	receive	VBD
cord-005453-4057qib7	4609	7	Reduced	reduce	VBN
cord-005453-4057qib7	4609	8	Intensity	intensity	NN
cord-005453-4057qib7	4609	9	Conditioning	Conditioning	NNP
cord-005453-4057qib7	4609	10	(	(	-LRB-
cord-005453-4057qib7	4609	11	RIC	RIC	NNP
cord-005453-4057qib7	4609	12	)	)	-RRB-
cord-005453-4057qib7	4609	13	,	,	,
cord-005453-4057qib7	4609	14	one	one	CD
cord-005453-4057qib7	4609	15	(	(	-LRB-
cord-005453-4057qib7	4609	16	5	5	CD
cord-005453-4057qib7	4609	17	%	%	NN
cord-005453-4057qib7	4609	18	)	)	-RRB-
cord-005453-4057qib7	4609	19	received	receive	VBD
cord-005453-4057qib7	4609	20	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	4609	21	(	(	-LRB-
cord-005453-4057qib7	4609	22	MA	MA	NNP
cord-005453-4057qib7	4609	23	)	)	-RRB-
cord-005453-4057qib7	4609	24	conditioning	conditioning	NN
cord-005453-4057qib7	4609	25	.	.	.
cord-005453-4057qib7	4610	1	Majority	majority	NN
cord-005453-4057qib7	4610	2	of	of	IN
cord-005453-4057qib7	4610	3	RIC	RIC	NNP
cord-005453-4057qib7	4610	4	allo	allo	NNP
cord-005453-4057qib7	4610	5	-	-	HYPH
cord-005453-4057qib7	4610	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4610	7	patients	patient	NNS
cord-005453-4057qib7	4610	8	were	be	VBD
cord-005453-4057qib7	4610	9	conditioned	condition	VBN
cord-005453-4057qib7	4610	10	with	with	IN
cord-005453-4057qib7	4610	11	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	4610	12	,	,	,
cord-005453-4057qib7	4610	13	Mephalan	Mephalan	NNP
cord-005453-4057qib7	4610	14	,	,	,
cord-005453-4057qib7	4610	15	Campath	Campath	NNP
cord-005453-4057qib7	4610	16	(	(	-LRB-
cord-005453-4057qib7	4610	17	FMC	FMC	NNP
cord-005453-4057qib7	4610	18	)	)	-RRB-
cord-005453-4057qib7	4610	19	.	.	.
cord-005453-4057qib7	4611	1	A	a	DT
cord-005453-4057qib7	4611	2	small	small	JJ
cord-005453-4057qib7	4611	3	number	number	NN
cord-005453-4057qib7	4611	4	were	be	VBD
cord-005453-4057qib7	4611	5	conditioned	condition	VBN
cord-005453-4057qib7	4611	6	with	with	IN
cord-005453-4057qib7	4611	7	busulfan	busulfan	NN
cord-005453-4057qib7	4611	8	,	,	,
cord-005453-4057qib7	4611	9	fludarabine	fludarabine	NN
cord-005453-4057qib7	4611	10	and	and	CC
cord-005453-4057qib7	4611	11	ATG	ATG	NNP
cord-005453-4057qib7	4611	12	.	.	.
cord-005453-4057qib7	4612	1	The	the	DT
cord-005453-4057qib7	4612	2	MA	MA	NNP
cord-005453-4057qib7	4612	3	allo	allo	NNP
cord-005453-4057qib7	4612	4	-	-	HYPH
cord-005453-4057qib7	4612	5	HSCT	HSCT	NNP
cord-005453-4057qib7	4612	6	patient	patient	NN
cord-005453-4057qib7	4612	7	was	be	VBD
cord-005453-4057qib7	4612	8	conditioned	condition	VBN
cord-005453-4057qib7	4612	9	with	with	IN
cord-005453-4057qib7	4612	10	TBI	TBI	NNP
cord-005453-4057qib7	4612	11	,	,	,
cord-005453-4057qib7	4612	12	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	4612	13	.	.	.
cord-005453-4057qib7	4613	1	GvHD	GvHD	NNP
cord-005453-4057qib7	4613	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4613	3	was	be	VBD
cord-005453-4057qib7	4613	4	ciclosporin	ciclosporin	NN
cord-005453-4057qib7	4613	5	alone	alone	RB
cord-005453-4057qib7	4613	6	starting	start	VBG
cord-005453-4057qib7	4613	7	on	on	IN
cord-005453-4057qib7	4613	8	day	day	NN
cord-005453-4057qib7	4613	9	-1	-1	.
cord-005453-4057qib7	4613	10	with	with	IN
cord-005453-4057qib7	4613	11	a	a	DT
cord-005453-4057qib7	4613	12	target	target	NN
cord-005453-4057qib7	4613	13	level	level	NN
cord-005453-4057qib7	4613	14	of	of	IN
cord-005453-4057qib7	4613	15	150	150	CD
cord-005453-4057qib7	4613	16	-	-	SYM
cord-005453-4057qib7	4613	17	250	250	CD
cord-005453-4057qib7	4613	18	ug	ug	NNP
cord-005453-4057qib7	4613	19	/	/	SYM
cord-005453-4057qib7	4613	20	L	l	NN
cord-005453-4057qib7	4613	21	for	for	IN
cord-005453-4057qib7	4613	22	all	all	DT
cord-005453-4057qib7	4613	23	RIC	RIC	NNP
cord-005453-4057qib7	4613	24	and	and	CC
cord-005453-4057qib7	4613	25	ciclosporin	ciclosporin	NNP
cord-005453-4057qib7	4613	26	and	and	CC
cord-005453-4057qib7	4613	27	methotrexate	methotrexate	NNP
cord-005453-4057qib7	4613	28	for	for	IN
cord-005453-4057qib7	4613	29	the	the	DT
cord-005453-4057qib7	4613	30	MA	MA	NNP
cord-005453-4057qib7	4613	31	patients	patient	NNS
cord-005453-4057qib7	4613	32	.	.	.
cord-005453-4057qib7	4614	1	Two	two	CD
cord-005453-4057qib7	4614	2	(	(	-LRB-
cord-005453-4057qib7	4614	3	10	10	CD
cord-005453-4057qib7	4614	4	%	%	NN
cord-005453-4057qib7	4614	5	)	)	-RRB-
cord-005453-4057qib7	4614	6	allograft	allograft	NN
cord-005453-4057qib7	4614	7	patients	patient	NNS
cord-005453-4057qib7	4614	8	were	be	VBD
cord-005453-4057qib7	4614	9	admitted	admit	VBN
cord-005453-4057qib7	4614	10	to	to	IN
cord-005453-4057qib7	4614	11	ICU	ICU	NNP
cord-005453-4057qib7	4614	12	on	on	IN
cord-005453-4057qib7	4614	13	three	three	CD
cord-005453-4057qib7	4614	14	occasions	occasion	NNS
cord-005453-4057qib7	4614	15	.	.	.
cord-005453-4057qib7	4615	1	Both	both	DT
cord-005453-4057qib7	4615	2	patients	patient	NNS
cord-005453-4057qib7	4615	3	were	be	VBD
cord-005453-4057qib7	4615	4	male	male	JJ
cord-005453-4057qib7	4615	5	,	,	,
cord-005453-4057qib7	4615	6	58	58	CD
cord-005453-4057qib7	4615	7	and	and	CC
cord-005453-4057qib7	4615	8	68	68	CD
cord-005453-4057qib7	4615	9	years	year	NNS
cord-005453-4057qib7	4615	10	old	old	JJ
cord-005453-4057qib7	4615	11	.	.	.
cord-005453-4057qib7	4616	1	One	one	CD
cord-005453-4057qib7	4616	2	had	have	VBD
cord-005453-4057qib7	4616	3	MMUD	MMUD	NNP
cord-005453-4057qib7	4616	4	allograft	allograft	NN
cord-005453-4057qib7	4616	5	for	for	IN
cord-005453-4057qib7	4616	6	MDS	MDS	NNP
cord-005453-4057qib7	4616	7	/	/	SYM
cord-005453-4057qib7	4616	8	MPN	MPN	NNP
cord-005453-4057qib7	4616	9	.	.	.
cord-005453-4057qib7	4617	1	The	the	DT
cord-005453-4057qib7	4617	2	other	other	JJ
cord-005453-4057qib7	4617	3	had	have	VBD
cord-005453-4057qib7	4617	4	2	2	CD
cord-005453-4057qib7	4617	5	nd	nd	NNP
cord-005453-4057qib7	4617	6	MUD	mud	NN
cord-005453-4057qib7	4617	7	allograft	allograft	NN
cord-005453-4057qib7	4617	8	for	for	IN
cord-005453-4057qib7	4617	9	relapsed	relapse	VBN
cord-005453-4057qib7	4617	10	AML	AML	NNP
cord-005453-4057qib7	4617	11	.	.	.
cord-005453-4057qib7	4618	1	The	the	DT
cord-005453-4057qib7	4618	2	reasons	reason	NNS
cord-005453-4057qib7	4618	3	for	for	IN
cord-005453-4057qib7	4618	4	ICU	ICU	NNP
cord-005453-4057qib7	4618	5	admission	admission	NN
cord-005453-4057qib7	4618	6	include	include	VBP
cord-005453-4057qib7	4618	7	sepsis	sepsis	NN
cord-005453-4057qib7	4618	8	,	,	,
cord-005453-4057qib7	4618	9	cardiac	cardiac	JJ
cord-005453-4057qib7	4618	10	arrest	arrest	NN
cord-005453-4057qib7	4618	11	and	and	CC
cord-005453-4057qib7	4618	12	respiratory	respiratory	JJ
cord-005453-4057qib7	4618	13	failure	failure	NN
cord-005453-4057qib7	4618	14	.	.	.
cord-005453-4057qib7	4619	1	The	the	DT
cord-005453-4057qib7	4619	2	median	median	JJ
cord-005453-4057qib7	4619	3	duration	duration	NN
cord-005453-4057qib7	4619	4	of	of	IN
cord-005453-4057qib7	4619	5	ICU	ICU	NNP
cord-005453-4057qib7	4619	6	admission	admission	NN
cord-005453-4057qib7	4619	7	was	be	VBD
cord-005453-4057qib7	4619	8	5	5	CD
cord-005453-4057qib7	4619	9	days	day	NNS
cord-005453-4057qib7	4619	10	(	(	-LRB-
cord-005453-4057qib7	4619	11	range	range	NNP
cord-005453-4057qib7	4619	12	2	2	CD
cord-005453-4057qib7	4619	13	-	-	SYM
cord-005453-4057qib7	4619	14	9	9	CD
cord-005453-4057qib7	4619	15	)	)	-RRB-
cord-005453-4057qib7	4619	16	.	.	.
cord-005453-4057qib7	4620	1	There	there	EX
cord-005453-4057qib7	4620	2	were	be	VBD
cord-005453-4057qib7	4620	3	2	2	CD
cord-005453-4057qib7	4620	4	deaths	death	NNS
cord-005453-4057qib7	4620	5	within	within	IN
cord-005453-4057qib7	4620	6	100	100	CD
cord-005453-4057qib7	4620	7	days	day	NNS
cord-005453-4057qib7	4620	8	of	of	IN
cord-005453-4057qib7	4620	9	transplant	transplant	NN
cord-005453-4057qib7	4620	10	.	.	.
cord-005453-4057qib7	4621	1	One	one	CD
cord-005453-4057qib7	4621	2	patient	patient	NN
cord-005453-4057qib7	4621	3	died	die	VBD
cord-005453-4057qib7	4621	4	on	on	IN
cord-005453-4057qib7	4621	5	day	day	NN
cord-005453-4057qib7	4621	6	+11	+11	NNS
cord-005453-4057qib7	4621	7	during	during	IN
cord-005453-4057qib7	4621	8	his	-PRON-	PRP$
cord-005453-4057qib7	4621	9	second	second	JJ
cord-005453-4057qib7	4621	10	ICU	ICU	NNP
cord-005453-4057qib7	4621	11	admission	admission	NN
cord-005453-4057qib7	4621	12	with	with	IN
cord-005453-4057qib7	4621	13	multi	multi	JJ
cord-005453-4057qib7	4621	14	organ	organ	NN
cord-005453-4057qib7	4621	15	failure	failure	NN
cord-005453-4057qib7	4621	16	(	(	-LRB-
cord-005453-4057qib7	4621	17	MOF	MOF	NNP
cord-005453-4057qib7	4621	18	)	)	-RRB-
cord-005453-4057qib7	4621	19	.	.	.
cord-005453-4057qib7	4622	1	One	one	CD
cord-005453-4057qib7	4622	2	patient	patient	NN
cord-005453-4057qib7	4622	3	died	die	VBD
cord-005453-4057qib7	4622	4	after	after	IN
cord-005453-4057qib7	4622	5	ICU	ICU	NNP
cord-005453-4057qib7	4622	6	discharge	discharge	NN
cord-005453-4057qib7	4622	7	on	on	IN
cord-005453-4057qib7	4622	8	day	day	NN
cord-005453-4057qib7	4622	9	+23	+23	CD
cord-005453-4057qib7	4622	10	with	with	IN
cord-005453-4057qib7	4622	11	relapsed	relapsed	JJ
cord-005453-4057qib7	4622	12	disease	disease	NN
cord-005453-4057qib7	4622	13	,	,	,
cord-005453-4057qib7	4622	14	bronchopneumonia	bronchopneumonia	NN
cord-005453-4057qib7	4622	15	with	with	IN
cord-005453-4057qib7	4622	16	disseminated	disseminate	VBN
cord-005453-4057qib7	4622	17	fungal	fungal	JJ
cord-005453-4057qib7	4622	18	infection	infection	NN
cord-005453-4057qib7	4622	19	.	.	.
cord-005453-4057qib7	4623	1	ICU	ICU	NNP
cord-005453-4057qib7	4623	2	mortality	mortality	NN
cord-005453-4057qib7	4623	3	rate	rate	NN
cord-005453-4057qib7	4623	4	was	be	VBD
cord-005453-4057qib7	4623	5	50	50	CD
cord-005453-4057qib7	4623	6	%	%	NN
cord-005453-4057qib7	4623	7	,	,	,
cord-005453-4057qib7	4623	8	and	and	CC
cord-005453-4057qib7	4623	9	100-day	100-day	JJ
cord-005453-4057qib7	4623	10	mortality	mortality	NN
cord-005453-4057qib7	4623	11	rate	rate	NN
cord-005453-4057qib7	4623	12	was	be	VBD
cord-005453-4057qib7	4623	13	10	10	CD
cord-005453-4057qib7	4623	14	%	%	NN
cord-005453-4057qib7	4623	15	.	.	.
cord-005453-4057qib7	4624	1	Nineteen	nineteen	CD
cord-005453-4057qib7	4624	2	autologous	autologous	JJ
cord-005453-4057qib7	4624	3	patients	patient	NNS
cord-005453-4057qib7	4624	4	were	be	VBD
cord-005453-4057qib7	4624	5	included	include	VBN
cord-005453-4057qib7	4624	6	(	(	-LRB-
cord-005453-4057qib7	4624	7	median	median	JJ
cord-005453-4057qib7	4624	8	age	age	NN
cord-005453-4057qib7	4624	9	61	61	CD
cord-005453-4057qib7	4624	10	(	(	-LRB-
cord-005453-4057qib7	4624	11	range	range	NNP
cord-005453-4057qib7	4624	12	36	36	CD
cord-005453-4057qib7	4624	13	-	-	SYM
cord-005453-4057qib7	4624	14	71	71	CD
cord-005453-4057qib7	4624	15	years	year	NNS
cord-005453-4057qib7	4624	16	)	)	-RRB-
cord-005453-4057qib7	4624	17	)	)	-RRB-
cord-005453-4057qib7	4624	18	,	,	,
cord-005453-4057qib7	4624	19	16	16	CD
cord-005453-4057qib7	4624	20	(	(	-LRB-
cord-005453-4057qib7	4624	21	84	84	CD
cord-005453-4057qib7	4624	22	%	%	NN
cord-005453-4057qib7	4624	23	)	)	-RRB-
cord-005453-4057qib7	4624	24	were	be	VBD
cord-005453-4057qib7	4624	25	myeloma	myeloma	NN
cord-005453-4057qib7	4624	26	patients	patient	NNS
cord-005453-4057qib7	4624	27	who	who	WP
cord-005453-4057qib7	4624	28	were	be	VBD
cord-005453-4057qib7	4624	29	conditioned	condition	VBN
cord-005453-4057qib7	4624	30	with	with	IN
cord-005453-4057qib7	4624	31	melphalan	melphalan	NNP
cord-005453-4057qib7	4624	32	,	,	,
cord-005453-4057qib7	4624	33	3	3	CD
cord-005453-4057qib7	4624	34	(	(	-LRB-
cord-005453-4057qib7	4624	35	16	16	CD
cord-005453-4057qib7	4624	36	%	%	NN
cord-005453-4057qib7	4624	37	)	)	-RRB-
cord-005453-4057qib7	4624	38	were	be	VBD
cord-005453-4057qib7	4624	39	lymphoma	lymphoma	NN
cord-005453-4057qib7	4624	40	patients	patient	NNS
cord-005453-4057qib7	4624	41	who	who	WP
cord-005453-4057qib7	4624	42	were	be	VBD
cord-005453-4057qib7	4624	43	conditioned	condition	VBN
cord-005453-4057qib7	4624	44	with	with	IN
cord-005453-4057qib7	4624	45	BEAM	BEAM	NNP
cord-005453-4057qib7	4624	46	.	.	.
cord-005453-4057qib7	4625	1	The	the	DT
cord-005453-4057qib7	4625	2	ICU	ICU	NNP
cord-005453-4057qib7	4625	3	admission	admission	NN
cord-005453-4057qib7	4625	4	was	be	VBD
cord-005453-4057qib7	4625	5	0	0	CD
cord-005453-4057qib7	4625	6	%	%	NN
cord-005453-4057qib7	4625	7	.	.	.
cord-005453-4057qib7	4626	1	The	the	DT
cord-005453-4057qib7	4626	2	100-day	100-day	JJ
cord-005453-4057qib7	4626	3	mortality	mortality	NN
cord-005453-4057qib7	4626	4	rate	rate	NN
cord-005453-4057qib7	4626	5	was	be	VBD
cord-005453-4057qib7	4626	6	0	0	CD
cord-005453-4057qib7	4626	7	%	%	NN
cord-005453-4057qib7	4626	8	.	.	.
cord-005453-4057qib7	4627	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4627	2	:	:	:
cord-005453-4057qib7	4628	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4628	2	centre	centre	NN
cord-005453-4057qib7	4628	3	's	's	POS
cord-005453-4057qib7	4628	4	ICU	ICU	NNP
cord-005453-4057qib7	4628	5	admission	admission	NN
cord-005453-4057qib7	4628	6	rate	rate	NN
cord-005453-4057qib7	4628	7	,	,	,
cord-005453-4057qib7	4628	8	ICU	ICU	NNP
cord-005453-4057qib7	4628	9	mortality	mortality	NN
cord-005453-4057qib7	4628	10	rate	rate	NN
cord-005453-4057qib7	4628	11	,	,	,
cord-005453-4057qib7	4628	12	cause	cause	NN
cord-005453-4057qib7	4628	13	of	of	IN
cord-005453-4057qib7	4628	14	ICU	ICU	NNP
cord-005453-4057qib7	4628	15	admission	admission	NN
cord-005453-4057qib7	4628	16	in	in	IN
cord-005453-4057qib7	4628	17	allo	allo	NNP
cord-005453-4057qib7	4628	18	-	-	HYPH
cord-005453-4057qib7	4628	19	HSCT	HSCT	NNP
cord-005453-4057qib7	4628	20	patients	patient	NNS
cord-005453-4057qib7	4628	21	and	and	CC
cord-005453-4057qib7	4628	22	autologous	autologous	JJ
cord-005453-4057qib7	4628	23	patients	patient	NNS
cord-005453-4057qib7	4628	24	is	be	VBZ
cord-005453-4057qib7	4628	25	comparable	comparable	JJ
cord-005453-4057qib7	4628	26	to	to	IN
cord-005453-4057qib7	4628	27	literature	literature	NN
cord-005453-4057qib7	4628	28	reports	report	NNS
cord-005453-4057qib7	4628	29	.	.	.
cord-005453-4057qib7	4629	1	Autologous	autologous	JJ
cord-005453-4057qib7	4629	2	transplant	transplant	NN
cord-005453-4057qib7	4629	3	is	be	VBZ
cord-005453-4057qib7	4629	4	safe	safe	JJ
cord-005453-4057qib7	4629	5	with	with	IN
cord-005453-4057qib7	4629	6	no	no	DT
cord-005453-4057qib7	4629	7	deaths	death	NNS
cord-005453-4057qib7	4629	8	and	and	CC
cord-005453-4057qib7	4629	9	ICU	ICU	NNP
cord-005453-4057qib7	4629	10	admissions	admission	NNS
cord-005453-4057qib7	4629	11	despite	despite	IN
cord-005453-4057qib7	4629	12	an	an	DT
cord-005453-4057qib7	4629	13	older	old	JJR
cord-005453-4057qib7	4629	14	age	age	NN
cord-005453-4057qib7	4629	15	.	.	.
cord-005453-4057qib7	4630	1	The	the	DT
cord-005453-4057qib7	4630	2	mortality	mortality	NN
cord-005453-4057qib7	4630	3	rate	rate	NN
cord-005453-4057qib7	4630	4	for	for	IN
cord-005453-4057qib7	4630	5	allo	allo	NN
cord-005453-4057qib7	4630	6	-	-	HYPH
cord-005453-4057qib7	4630	7	HSCT	HSCT	NNP
cord-005453-4057qib7	4630	8	patients	patient	NNS
cord-005453-4057qib7	4630	9	requiring	require	VBG
cord-005453-4057qib7	4630	10	ICU	ICU	NNP
cord-005453-4057qib7	4630	11	admission	admission	NN
cord-005453-4057qib7	4630	12	remain	remain	VBP
cord-005453-4057qib7	4630	13	high	high	JJ
cord-005453-4057qib7	4630	14	.	.	.
cord-005453-4057qib7	4631	1	All	all	DT
cord-005453-4057qib7	4631	2	patients	patient	NNS
cord-005453-4057qib7	4631	3	were	be	VBD
cord-005453-4057qib7	4631	4	appropriately	appropriately	RB
cord-005453-4057qib7	4631	5	referred	refer	VBN
cord-005453-4057qib7	4631	6	to	to	IN
cord-005453-4057qib7	4631	7	ICU	ICU	NNP
cord-005453-4057qib7	4631	8	and	and	CC
cord-005453-4057qib7	4631	9	there	there	EX
cord-005453-4057qib7	4631	10	was	be	VBD
cord-005453-4057qib7	4631	11	no	no	DT
cord-005453-4057qib7	4631	12	one	one	NN
cord-005453-4057qib7	4631	13	who	who	WP
cord-005453-4057qib7	4631	14	was	be	VBD
cord-005453-4057qib7	4631	15	denied	deny	VBN
cord-005453-4057qib7	4631	16	ICU	ICU	NNP
cord-005453-4057qib7	4631	17	admission	admission	NN
cord-005453-4057qib7	4631	18	.	.	.
cord-005453-4057qib7	4632	1	This	this	DT
cord-005453-4057qib7	4632	2	analysis	analysis	NN
cord-005453-4057qib7	4632	3	is	be	VBZ
cord-005453-4057qib7	4632	4	being	be	VBG
cord-005453-4057qib7	4632	5	extended	extend	VBN
cord-005453-4057qib7	4632	6	to	to	IN
cord-005453-4057qib7	4632	7	preceding	precede	VBG
cord-005453-4057qib7	4632	8	years	year	NNS
cord-005453-4057qib7	4632	9	.	.	.
cord-005453-4057qib7	4633	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4633	2	:	:	:
cord-005453-4057qib7	4633	3	Nothing	nothing	NN
cord-005453-4057qib7	4633	4	to	to	TO
cord-005453-4057qib7	4633	5	declare	declare	VB
cord-005453-4057qib7	4633	6	Liposomal	Liposomal	NNP
cord-005453-4057qib7	4633	7	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	4633	8	for	for	IN
cord-005453-4057qib7	4633	9	the	the	DT
cord-005453-4057qib7	4633	10	treatment	treatment	NN
cord-005453-4057qib7	4633	11	of	of	IN
cord-005453-4057qib7	4633	12	iatrogenic	iatrogenic	JJ
cord-005453-4057qib7	4633	13	kaposi	kaposi	NNP
cord-005453-4057qib7	4633	14	sarcoma	sarcoma	NN
cord-005453-4057qib7	4633	15	following	follow	VBG
cord-005453-4057qib7	4633	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4633	17	stem	stem	NN
cord-005453-4057qib7	4633	18	cell	cell	NN
cord-005453-4057qib7	4633	19	transplantation	transplantation	NN
cord-005453-4057qib7	4633	20	Background	background	NN
cord-005453-4057qib7	4633	21	:	:	:
cord-005453-4057qib7	4634	1	Iatrogenic	iatrogenic	JJ
cord-005453-4057qib7	4634	2	Kaposi	Kaposi	NNP
cord-005453-4057qib7	4634	3	's	's	POS
cord-005453-4057qib7	4634	4	Sarcoma	Sarcoma	NNP
cord-005453-4057qib7	4634	5	(	(	-LRB-
cord-005453-4057qib7	4634	6	iKS	iKS	NNP
cord-005453-4057qib7	4634	7	)	)	-RRB-
cord-005453-4057qib7	4634	8	represent	represent	VB
cord-005453-4057qib7	4634	9	a	a	DT
cord-005453-4057qib7	4634	10	rare	rare	JJ
cord-005453-4057qib7	4634	11	complication	complication	NN
cord-005453-4057qib7	4634	12	after	after	IN
cord-005453-4057qib7	4634	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4634	14	stem	stem	NN
cord-005453-4057qib7	4634	15	cell	cell	NN
cord-005453-4057qib7	4634	16	transplantation	transplantation	NN
cord-005453-4057qib7	4634	17	(	(	-LRB-
cord-005453-4057qib7	4634	18	HSCT	HSCT	NNP
cord-005453-4057qib7	4634	19	)	)	-RRB-
cord-005453-4057qib7	4634	20	,	,	,
cord-005453-4057qib7	4634	21	related	relate	VBN
cord-005453-4057qib7	4634	22	to	to	IN
cord-005453-4057qib7	4634	23	HHV-8	HHV-8	NNP
cord-005453-4057qib7	4634	24	infection	infection	NN
cord-005453-4057qib7	4634	25	in	in	IN
cord-005453-4057qib7	4634	26	HIVnegative	hivnegative	JJ
cord-005453-4057qib7	4634	27	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	4634	28	patients	patient	NNS
cord-005453-4057qib7	4634	29	(	(	-LRB-
cord-005453-4057qib7	4634	30	pts	pt	NNS
cord-005453-4057qib7	4634	31	)	)	-RRB-
cord-005453-4057qib7	4634	32	.	.	.
cord-005453-4057qib7	4635	1	Methods	method	NNS
cord-005453-4057qib7	4635	2	:	:	:
cord-005453-4057qib7	4636	1	We	-PRON-	PRP
cord-005453-4057qib7	4636	2	describe	describe	VBP
cord-005453-4057qib7	4636	3	a	a	DT
cord-005453-4057qib7	4636	4	case	case	NN
cord-005453-4057qib7	4636	5	of	of	IN
cord-005453-4057qib7	4636	6	iKS	iKS	NNP
cord-005453-4057qib7	4636	7	occurred	occur	VBD
cord-005453-4057qib7	4636	8	after	after	IN
cord-005453-4057qib7	4636	9	an	an	DT
cord-005453-4057qib7	4636	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	4636	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4637	1	and	and	CC
cord-005453-4057qib7	4637	2	we	-PRON-	PRP
cord-005453-4057qib7	4637	3	provide	provide	VBP
cord-005453-4057qib7	4637	4	a	a	DT
cord-005453-4057qib7	4637	5	review	review	NN
cord-005453-4057qib7	4637	6	of	of	IN
cord-005453-4057qib7	4637	7	the	the	DT
cord-005453-4057qib7	4637	8	literature	literature	NN
cord-005453-4057qib7	4637	9	using	use	VBG
cord-005453-4057qib7	4637	10	Pub	Pub	NNP
cord-005453-4057qib7	4637	11	Med	Med	NNP
cord-005453-4057qib7	4637	12	.	.	.
cord-005453-4057qib7	4638	1	Results	result	NNS
cord-005453-4057qib7	4638	2	:	:	:
cord-005453-4057qib7	4639	1	A	a	DT
cord-005453-4057qib7	4639	2	70-year	70-year	JJ
cord-005453-4057qib7	4639	3	-	-	HYPH
cord-005453-4057qib7	4639	4	old	old	JJ
cord-005453-4057qib7	4639	5	man	man	NN
cord-005453-4057qib7	4639	6	,	,	,
cord-005453-4057qib7	4639	7	HIV	HIV	NNP
cord-005453-4057qib7	4639	8	-	-	HYPH
cord-005453-4057qib7	4639	9	negative	negative	JJ
cord-005453-4057qib7	4639	10	,	,	,
cord-005453-4057qib7	4639	11	received	receive	VBD
cord-005453-4057qib7	4639	12	full	full	JJ
cord-005453-4057qib7	4639	13	HLA	HLA	NNP
cord-005453-4057qib7	4639	14	-	-	HYPH
cord-005453-4057qib7	4639	15	matched	match	VBN
cord-005453-4057qib7	4639	16	related	relate	VBN
cord-005453-4057qib7	4639	17	HSCT	HSCT	NNP
cord-005453-4057qib7	4639	18	after	after	IN
cord-005453-4057qib7	4639	19	a	a	DT
cord-005453-4057qib7	4639	20	reduced	reduce	VBN
cord-005453-4057qib7	4639	21	intensity	intensity	NN
cord-005453-4057qib7	4639	22	conditioning	conditioning	NN
cord-005453-4057qib7	4639	23	regimen	regimen	NN
cord-005453-4057qib7	4639	24	for	for	IN
cord-005453-4057qib7	4639	25	relapsed	relapse	VBN
cord-005453-4057qib7	4639	26	AML	AML	NNP
cord-005453-4057qib7	4639	27	.	.	.
cord-005453-4057qib7	4640	1	GvHD	GvHD	NNP
cord-005453-4057qib7	4640	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4640	3	was	be	VBD
cord-005453-4057qib7	4640	4	based	base	VBN
cord-005453-4057qib7	4640	5	on	on	IN
cord-005453-4057qib7	4640	6	ATG	ATG	NNP
cord-005453-4057qib7	4640	7	(	(	-LRB-
cord-005453-4057qib7	4640	8	Fresenius	Fresenius	NNP
cord-005453-4057qib7	4640	9	30	30	CD
cord-005453-4057qib7	4640	10	mg	mg	NNP
cord-005453-4057qib7	4640	11	/	/	SYM
cord-005453-4057qib7	4640	12	Kg	Kg	NNP
cord-005453-4057qib7	4640	13	)	)	-RRB-
cord-005453-4057qib7	4640	14	,	,	,
cord-005453-4057qib7	4640	15	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	4640	16	(	(	-LRB-
cord-005453-4057qib7	4640	17	Cya	Cya	NNP
cord-005453-4057qib7	4640	18	)	)	-RRB-
cord-005453-4057qib7	4640	19	and	and	CC
cord-005453-4057qib7	4640	20	methotrexate	methotrexate	NNP
cord-005453-4057qib7	4640	21	.	.	.
cord-005453-4057qib7	4641	1	No	no	DT
cord-005453-4057qib7	4641	2	severe	severe	JJ
cord-005453-4057qib7	4641	3	complication	complication	NN
cord-005453-4057qib7	4641	4	occurred	occur	VBD
cord-005453-4057qib7	4641	5	in	in	IN
cord-005453-4057qib7	4641	6	the	the	DT
cord-005453-4057qib7	4641	7	first	first	JJ
cord-005453-4057qib7	4641	8	100	100	CD
cord-005453-4057qib7	4641	9	days	day	NNS
cord-005453-4057qib7	4641	10	after	after	IN
cord-005453-4057qib7	4641	11	transplant	transplant	NN
cord-005453-4057qib7	4641	12	.	.	.
cord-005453-4057qib7	4642	1	Shortly	shortly	RB
cord-005453-4057qib7	4642	2	after	after	IN
cord-005453-4057qib7	4642	3	Cya	Cya	NNP
cord-005453-4057qib7	4642	4	withdrawal	withdrawal	NN
cord-005453-4057qib7	4642	5	,	,	,
cord-005453-4057qib7	4642	6	he	-PRON-	PRP
cord-005453-4057qib7	4642	7	developed	develop	VBD
cord-005453-4057qib7	4642	8	grade	grade	NN
cord-005453-4057qib7	4642	9	I	-PRON-	PRP
cord-005453-4057qib7	4642	10	acute	acute	JJ
cord-005453-4057qib7	4642	11	GvHD	GvHD	NNP
cord-005453-4057qib7	4642	12	.	.	.
cord-005453-4057qib7	4643	1	GvHD	GvHD	NNP
cord-005453-4057qib7	4643	2	resolved	resolve	VBN
cord-005453-4057qib7	4643	3	after	after	IN
cord-005453-4057qib7	4643	4	restarting	restart	VBG
cord-005453-4057qib7	4643	5	Cya	Cya	NNP
cord-005453-4057qib7	4643	6	.	.	.
cord-005453-4057qib7	4644	1	At	at	IN
cord-005453-4057qib7	4644	2	fifth	fifth	JJ
cord-005453-4057qib7	4644	3	month	month	NN
cord-005453-4057qib7	4644	4	after	after	IN
cord-005453-4057qib7	4644	5	transplant	transplant	NN
cord-005453-4057qib7	4644	6	,	,	,
cord-005453-4057qib7	4644	7	the	the	DT
cord-005453-4057qib7	4644	8	patient	patient	NN
cord-005453-4057qib7	4644	9	developed	develop	VBD
cord-005453-4057qib7	4644	10	several	several	JJ
cord-005453-4057qib7	4644	11	red	red	JJ
cord-005453-4057qib7	4644	12	and	and	CC
cord-005453-4057qib7	4644	13	purple	purple	JJ
cord-005453-4057qib7	4644	14	angiomatous	angiomatous	JJ
cord-005453-4057qib7	4644	15	plaque	plaque	NN
cord-005453-4057qib7	4644	16	and	and	CC
cord-005453-4057qib7	4644	17	nodules	nodule	NNS
cord-005453-4057qib7	4644	18	involving	involve	VBG
cord-005453-4057qib7	4644	19	the	the	DT
cord-005453-4057qib7	4644	20	skin	skin	NN
cord-005453-4057qib7	4644	21	of	of	IN
cord-005453-4057qib7	4644	22	both	both	DT
cord-005453-4057qib7	4644	23	lower	low	JJR
cord-005453-4057qib7	4644	24	limbs	limb	NNS
cord-005453-4057qib7	4644	25	,	,	,
cord-005453-4057qib7	4644	26	right	right	JJ
cord-005453-4057qib7	4644	27	arm	arm	NN
cord-005453-4057qib7	4644	28	and	and	CC
cord-005453-4057qib7	4644	29	the	the	DT
cord-005453-4057qib7	4644	30	nose	nose	NN
cord-005453-4057qib7	4644	31	(	(	-LRB-
cord-005453-4057qib7	4644	32	figure	figure	NN
cord-005453-4057qib7	4644	33	1	1	CD
cord-005453-4057qib7	4644	34	)	)	-RRB-
cord-005453-4057qib7	4644	35	.	.	.
cord-005453-4057qib7	4645	1	Skin	skin	NN
cord-005453-4057qib7	4645	2	biopsy	biopsy	NN
cord-005453-4057qib7	4645	3	revealed	reveal	VBD
cord-005453-4057qib7	4645	4	multiple	multiple	JJ
cord-005453-4057qib7	4645	5	localizations	localization	NNS
cord-005453-4057qib7	4645	6	of	of	IN
cord-005453-4057qib7	4645	7	iKS	iKS	NNP
cord-005453-4057qib7	4645	8	and	and	CC
cord-005453-4057qib7	4645	9	positive	positive	JJ
cord-005453-4057qib7	4645	10	HHV-8	HHV-8	NNP
cord-005453-4057qib7	4645	11	viremia	viremia	NN
cord-005453-4057qib7	4645	12	was	be	VBD
cord-005453-4057qib7	4645	13	detected	detect	VBN
cord-005453-4057qib7	4645	14	in	in	IN
cord-005453-4057qib7	4645	15	the	the	DT
cord-005453-4057qib7	4645	16	peripheral	peripheral	JJ
cord-005453-4057qib7	4645	17	blood	blood	NN
cord-005453-4057qib7	4645	18	.	.	.
cord-005453-4057qib7	4646	1	A	a	DT
cord-005453-4057qib7	4646	2	visceral	visceral	JJ
cord-005453-4057qib7	4646	3	involvement	involvement	NN
cord-005453-4057qib7	4646	4	was	be	VBD
cord-005453-4057qib7	4646	5	excluded	exclude	VBN
cord-005453-4057qib7	4646	6	.	.	.
cord-005453-4057qib7	4647	1	Patient	Patient	NNP
cord-005453-4057qib7	4647	2	was	be	VBD
cord-005453-4057qib7	4647	3	treated	treat	VBN
cord-005453-4057qib7	4647	4	with	with	IN
cord-005453-4057qib7	4647	5	Cya	Cya	NNP
cord-005453-4057qib7	4647	6	tapering	taper	VBG
cord-005453-4057qib7	4647	7	and	and	CC
cord-005453-4057qib7	4648	1	nine	nine	CD
cord-005453-4057qib7	4648	2	courses	course	NNS
cord-005453-4057qib7	4648	3	of	of	IN
cord-005453-4057qib7	4648	4	liposomal	liposomal	JJ
cord-005453-4057qib7	4648	5	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	4648	6	20	20	CD
cord-005453-4057qib7	4648	7	mg	mg	NNP
cord-005453-4057qib7	4648	8	/	/	SYM
cord-005453-4057qib7	4648	9	m2	m2	NNP
cord-005453-4057qib7	4648	10	every	every	DT
cord-005453-4057qib7	4648	11	15	15	CD
cord-005453-4057qib7	4648	12	days	day	NNS
cord-005453-4057qib7	4648	13	,	,	,
cord-005453-4057qib7	4648	14	obtaining	obtain	VBG
cord-005453-4057qib7	4648	15	a	a	DT
cord-005453-4057qib7	4648	16	negativity	negativity	NN
cord-005453-4057qib7	4648	17	of	of	IN
cord-005453-4057qib7	4648	18	HHV-8	HHV-8	NNP
cord-005453-4057qib7	4648	19	viremia	viremia	NN
cord-005453-4057qib7	4648	20	and	and	CC
cord-005453-4057qib7	4648	21	partial	partial	JJ
cord-005453-4057qib7	4648	22	response	response	NN
cord-005453-4057qib7	4648	23	of	of	IN
cord-005453-4057qib7	4648	24	the	the	DT
cord-005453-4057qib7	4648	25	skin	skin	NN
cord-005453-4057qib7	4648	26	lesions	lesion	NNS
cord-005453-4057qib7	4648	27	.	.	.
cord-005453-4057qib7	4649	1	At	at	IN
cord-005453-4057qib7	4649	2	last	last	JJ
cord-005453-4057qib7	4649	3	follow	follow	NN
cord-005453-4057qib7	4649	4	up	up	RP
cord-005453-4057qib7	4649	5	,	,	,
cord-005453-4057qib7	4649	6	at	at	IN
cord-005453-4057qib7	4649	7	15	15	CD
cord-005453-4057qib7	4649	8	months	month	NNS
cord-005453-4057qib7	4649	9	after	after	IN
cord-005453-4057qib7	4649	10	transplant	transplant	NN
cord-005453-4057qib7	4649	11	,	,	,
cord-005453-4057qib7	4649	12	the	the	DT
cord-005453-4057qib7	4649	13	patient	patient	NN
cord-005453-4057qib7	4649	14	was	be	VBD
cord-005453-4057qib7	4649	15	in	in	IN
cord-005453-4057qib7	4649	16	complete	complete	JJ
cord-005453-4057qib7	4649	17	remission	remission	NN
cord-005453-4057qib7	4649	18	(	(	-LRB-
cord-005453-4057qib7	4649	19	CR	CR	NNP
cord-005453-4057qib7	4649	20	)	)	-RRB-
cord-005453-4057qib7	4649	21	for	for	IN
cord-005453-4057qib7	4649	22	AML	AML	NNP
cord-005453-4057qib7	4649	23	,	,	,
cord-005453-4057qib7	4649	24	Cya	Cya	NNP
cord-005453-4057qib7	4649	25	-	-	HYPH
cord-005453-4057qib7	4649	26	free	free	JJ
cord-005453-4057qib7	4649	27	without	without	IN
cord-005453-4057qib7	4649	28	signs	sign	NNS
cord-005453-4057qib7	4649	29	of	of	IN
cord-005453-4057qib7	4649	30	GvHD	gvhd	NN
cord-005453-4057qib7	4649	31	recurrence	recurrence	NN
cord-005453-4057qib7	4649	32	and	and	CC
cord-005453-4057qib7	4649	33	with	with	IN
cord-005453-4057qib7	4649	34	his	-PRON-	PRP$
cord-005453-4057qib7	4649	35	single	single	JJ
cord-005453-4057qib7	4649	36	stable	stable	JJ
cord-005453-4057qib7	4649	37	residual	residual	JJ
cord-005453-4057qib7	4649	38	iKS	iks	DT
cord-005453-4057qib7	4649	39	lesion	lesion	NN
cord-005453-4057qib7	4649	40	on	on	IN
cord-005453-4057qib7	4649	41	his	-PRON-	PRP$
cord-005453-4057qib7	4649	42	left	left	JJ
cord-005453-4057qib7	4649	43	limb	limb	NN
cord-005453-4057qib7	4649	44	,	,	,
cord-005453-4057qib7	4649	45	currently	currently	RB
cord-005453-4057qib7	4649	46	waiting	wait	VBG
cord-005453-4057qib7	4649	47	for	for	IN
cord-005453-4057qib7	4649	48	local	local	JJ
cord-005453-4057qib7	4649	49	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	4649	50	.	.	.
cord-005453-4057qib7	4650	1	We	-PRON-	PRP
cord-005453-4057qib7	4650	2	found	find	VBD
cord-005453-4057qib7	4650	3	additional	additional	JJ
cord-005453-4057qib7	4650	4	18	18	CD
cord-005453-4057qib7	4650	5	iKS	iKS	NNP
cord-005453-4057qib7	4650	6	published	publish	VBN
cord-005453-4057qib7	4650	7	cases	case	NNS
cord-005453-4057qib7	4650	8	after	after	IN
cord-005453-4057qib7	4650	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4650	10	.	.	.
cord-005453-4057qib7	4651	1	Most	Most	JJS
cord-005453-4057qib7	4651	2	of	of	IN
cord-005453-4057qib7	4651	3	post	post	JJ
cord-005453-4057qib7	4651	4	-	-	JJ
cord-005453-4057qib7	4651	5	HSCT	hsct	JJ
cord-005453-4057qib7	4651	6	iKS	iKS	NNP
cord-005453-4057qib7	4651	7	were	be	VBD
cord-005453-4057qib7	4651	8	secondary	secondary	JJ
cord-005453-4057qib7	4651	9	to	to	IN
cord-005453-4057qib7	4651	10	an	an	DT
cord-005453-4057qib7	4651	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	4651	12	-	-	HYPH
cord-005453-4057qib7	4651	13	HSCT	HSCT	NNP
cord-005453-4057qib7	4651	14	(	(	-LRB-
cord-005453-4057qib7	4651	15	16	16	CD
cord-005453-4057qib7	4651	16	out	out	IN
cord-005453-4057qib7	4651	17	of	of	IN
cord-005453-4057qib7	4651	18	19	19	CD
cord-005453-4057qib7	4651	19	,	,	,
cord-005453-4057qib7	4651	20	84.2	84.2	CD
cord-005453-4057qib7	4651	21	%	%	NN
cord-005453-4057qib7	4651	22	)	)	-RRB-
cord-005453-4057qib7	4651	23	and	and	CC
cord-005453-4057qib7	4651	24	occurred	occur	VBD
cord-005453-4057qib7	4651	25	in	in	IN
cord-005453-4057qib7	4651	26	adult	adult	NN
cord-005453-4057qib7	4651	27	(	(	-LRB-
cord-005453-4057qib7	4651	28	78,9	78,9	CD
cord-005453-4057qib7	4651	29	%	%	NN
cord-005453-4057qib7	4651	30	)	)	-RRB-
cord-005453-4057qib7	4651	31	and	and	CC
cord-005453-4057qib7	4651	32	male	male	NN
cord-005453-4057qib7	4651	33	(	(	-LRB-
cord-005453-4057qib7	4651	34	68,4	68,4	CD
cord-005453-4057qib7	4651	35	%	%	NN
cord-005453-4057qib7	4651	36	)	)	-RRB-
cord-005453-4057qib7	4651	37	pts	pts	NN
cord-005453-4057qib7	4651	38	.	.	.
cord-005453-4057qib7	4652	1	Median	median	JJ
cord-005453-4057qib7	4652	2	age	age	NN
cord-005453-4057qib7	4652	3	at	at	IN
cord-005453-4057qib7	4652	4	the	the	DT
cord-005453-4057qib7	4652	5	time	time	NN
cord-005453-4057qib7	4652	6	of	of	IN
cord-005453-4057qib7	4652	7	iKS	iks	DT
cord-005453-4057qib7	4652	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	4652	9	was	be	VBD
cord-005453-4057qib7	4652	10	47.5	47.5	CD
cord-005453-4057qib7	4652	11	years	year	NNS
cord-005453-4057qib7	4653	1	(	(	-LRB-
cord-005453-4057qib7	4653	2	range	range	NNP
cord-005453-4057qib7	4653	3	7	7	CD
cord-005453-4057qib7	4653	4	-	-	SYM
cord-005453-4057qib7	4653	5	70	70	CD
cord-005453-4057qib7	4653	6	)	)	-RRB-
cord-005453-4057qib7	4653	7	.	.	.
cord-005453-4057qib7	4654	1	Thirteen	thirteen	CD
cord-005453-4057qib7	4654	2	pts	pt	NNS
cord-005453-4057qib7	4654	3	(	(	-LRB-
cord-005453-4057qib7	4654	4	68.4	68.4	CD
cord-005453-4057qib7	4654	5	%	%	NN
cord-005453-4057qib7	4654	6	)	)	-RRB-
cord-005453-4057qib7	4654	7	had	have	VBD
cord-005453-4057qib7	4654	8	Mediterranean	mediterranean	JJ
cord-005453-4057qib7	4654	9	origin	origin	NN
cord-005453-4057qib7	4654	10	.	.	.
cord-005453-4057qib7	4655	1	The	the	DT
cord-005453-4057qib7	4655	2	most	most	RBS
cord-005453-4057qib7	4655	3	frequent	frequent	JJ
cord-005453-4057qib7	4655	4	underlying	underlying	JJ
cord-005453-4057qib7	4655	5	disease	disease	NN
cord-005453-4057qib7	4655	6	was	be	VBD
cord-005453-4057qib7	4655	7	AML	AML	NNP
cord-005453-4057qib7	4655	8	(	(	-LRB-
cord-005453-4057qib7	4655	9	47.4	47.4	CD
cord-005453-4057qib7	4655	10	%	%	NN
cord-005453-4057qib7	4655	11	)	)	-RRB-
cord-005453-4057qib7	4655	12	.	.	.
cord-005453-4057qib7	4656	1	GvHD	GvHD	NNP
cord-005453-4057qib7	4656	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4656	3	was	be	VBD
cord-005453-4057qib7	4656	4	primary	primary	JJ
cord-005453-4057qib7	4656	5	based	base	VBN
cord-005453-4057qib7	4656	6	on	on	IN
cord-005453-4057qib7	4656	7	calcineurin	calcineurin	JJ
cord-005453-4057qib7	4656	8	inhibitor	inhibitor	NN
cord-005453-4057qib7	4656	9	.	.	.
cord-005453-4057qib7	4657	1	Half	half	NN
cord-005453-4057qib7	4657	2	of	of	IN
cord-005453-4057qib7	4657	3	the	the	DT
cord-005453-4057qib7	4657	4	pts	pts	NN
cord-005453-4057qib7	4657	5	developed	develop	VBD
cord-005453-4057qib7	4657	6	GvHD	GvHD	NNP
cord-005453-4057qib7	4657	7	and	and	CC
cord-005453-4057qib7	4657	8	were	be	VBD
cord-005453-4057qib7	4657	9	treated	treat	VBN
cord-005453-4057qib7	4657	10	with	with	IN
cord-005453-4057qib7	4657	11	steroid	steroid	NN
cord-005453-4057qib7	4657	12	and	and	CC
cord-005453-4057qib7	4657	13	other	other	JJ
cord-005453-4057qib7	4657	14	immune	immune	JJ
cord-005453-4057qib7	4657	15	suppressive	suppressive	JJ
cord-005453-4057qib7	4657	16	drugs	drug	NNS
cord-005453-4057qib7	4657	17	.	.	.
cord-005453-4057qib7	4658	1	Median	median	JJ
cord-005453-4057qib7	4658	2	time	time	NN
cord-005453-4057qib7	4658	3	between	between	IN
cord-005453-4057qib7	4658	4	the	the	DT
cord-005453-4057qib7	4658	5	HSCT	HSCT	NNP
cord-005453-4057qib7	4658	6	and	and	CC
cord-005453-4057qib7	4658	7	the	the	DT
cord-005453-4057qib7	4658	8	occurrence	occurrence	NN
cord-005453-4057qib7	4658	9	of	of	IN
cord-005453-4057qib7	4658	10	iKS	iKS	NNP
cord-005453-4057qib7	4658	11	was	be	VBD
cord-005453-4057qib7	4658	12	8.5	8.5	CD
cord-005453-4057qib7	4658	13	months	month	NNS
cord-005453-4057qib7	4658	14	(	(	-LRB-
cord-005453-4057qib7	4658	15	range	range	NN
cord-005453-4057qib7	4658	16	.	.	.
cord-005453-4057qib7	4659	1	Cutaneous	cutaneous	JJ
cord-005453-4057qib7	4659	2	iKS	iKS	NNP
cord-005453-4057qib7	4659	3	was	be	VBD
cord-005453-4057qib7	4659	4	the	the	DT
cord-005453-4057qib7	4659	5	prevalent	prevalent	JJ
cord-005453-4057qib7	4659	6	form	form	NN
cord-005453-4057qib7	4659	7	of	of	IN
cord-005453-4057qib7	4659	8	manifestation	manifestation	NN
cord-005453-4057qib7	4659	9	,	,	,
cord-005453-4057qib7	4659	10	however	however	RB
cord-005453-4057qib7	4659	11	visceral	visceral	JJ
cord-005453-4057qib7	4659	12	involvement	involvement	NN
cord-005453-4057qib7	4659	13	was	be	VBD
cord-005453-4057qib7	4659	14	reported	report	VBN
cord-005453-4057qib7	4659	15	in	in	IN
cord-005453-4057qib7	4659	16	7	7	CD
cord-005453-4057qib7	4659	17	pts	pts	NN
cord-005453-4057qib7	4659	18	(	(	-LRB-
cord-005453-4057qib7	4659	19	36.8	36.8	CD
cord-005453-4057qib7	4659	20	%	%	NN
cord-005453-4057qib7	4659	21	)	)	-RRB-
cord-005453-4057qib7	4659	22	.	.	.
cord-005453-4057qib7	4660	1	In	in	IN
cord-005453-4057qib7	4660	2	four	four	CD
cord-005453-4057qib7	4660	3	cases	case	NNS
cord-005453-4057qib7	4660	4	(	(	-LRB-
cord-005453-4057qib7	4660	5	21.1	21.1	CD
cord-005453-4057qib7	4660	6	%	%	NN
cord-005453-4057qib7	4660	7	)	)	-RRB-
cord-005453-4057qib7	4660	8	an	an	DT
cord-005453-4057qib7	4660	9	HHV-8	HHV-8	NNP
cord-005453-4057qib7	4660	10	associated	associate	VBN
cord-005453-4057qib7	4660	11	BM	BM	NNP
cord-005453-4057qib7	4660	12	failure	failure	NN
cord-005453-4057qib7	4660	13	was	be	VBD
cord-005453-4057qib7	4660	14	report	report	NN
cord-005453-4057qib7	4660	15	.	.	.
cord-005453-4057qib7	4661	1	Immune	immune	JJ
cord-005453-4057qib7	4661	2	suppression	suppression	NN
cord-005453-4057qib7	4661	3	drugs	drug	NNS
cord-005453-4057qib7	4661	4	tapering	taper	VBG
cord-005453-4057qib7	4661	5	(	(	-LRB-
cord-005453-4057qib7	4661	6	36.8	36.8	CD
cord-005453-4057qib7	4661	7	%	%	NN
cord-005453-4057qib7	4661	8	)	)	-RRB-
cord-005453-4057qib7	4661	9	and	and	CC
cord-005453-4057qib7	4661	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	4661	11	(	(	-LRB-
cord-005453-4057qib7	4661	12	26.3	26.3	CD
cord-005453-4057qib7	4661	13	%	%	NN
cord-005453-4057qib7	4661	14	)	)	-RRB-
cord-005453-4057qib7	4662	1	were	be	VBD
cord-005453-4057qib7	4662	2	the	the	DT
cord-005453-4057qib7	4662	3	most	most	RBS
cord-005453-4057qib7	4662	4	frequent	frequent	JJ
cord-005453-4057qib7	4662	5	actions	action	NNS
cord-005453-4057qib7	4662	6	taken	take	VBN
cord-005453-4057qib7	4662	7	after	after	IN
cord-005453-4057qib7	4662	8	the	the	DT
cord-005453-4057qib7	4662	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	4662	10	of	of	IN
cord-005453-4057qib7	4662	11	iKS	iKS	NNP
cord-005453-4057qib7	4662	12	.	.	.
cord-005453-4057qib7	4663	1	In	in	IN
cord-005453-4057qib7	4663	2	most	most	JJS
cord-005453-4057qib7	4663	3	cases	case	NNS
cord-005453-4057qib7	4663	4	,	,	,
cord-005453-4057qib7	4663	5	liposomal	liposomal	JJ
cord-005453-4057qib7	4663	6	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	4663	7	was	be	VBD
cord-005453-4057qib7	4663	8	used	use	VBN
cord-005453-4057qib7	4663	9	as	as	IN
cord-005453-4057qib7	4663	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	4663	11	.	.	.
cord-005453-4057qib7	4664	1	CR	cr	NN
cord-005453-4057qib7	4664	2	rate	rate	NN
cord-005453-4057qib7	4664	3	was	be	VBD
cord-005453-4057qib7	4664	4	high	high	JJ
cord-005453-4057qib7	4664	5	,	,	,
cord-005453-4057qib7	4664	6	63.2	63.2	CD
cord-005453-4057qib7	4664	7	%	%	NN
cord-005453-4057qib7	4664	8	,	,	,
cord-005453-4057qib7	4664	9	whereas	whereas	IN
cord-005453-4057qib7	4664	10	progression	progression	NN
cord-005453-4057qib7	4664	11	disease	disease	NN
cord-005453-4057qib7	4664	12	occurred	occur	VBD
cord-005453-4057qib7	4664	13	in	in	IN
cord-005453-4057qib7	4664	14	5	5	CD
cord-005453-4057qib7	4664	15	out	out	RB
cord-005453-4057qib7	4664	16	19	19	CD
cord-005453-4057qib7	4664	17	pts	pt	NNS
cord-005453-4057qib7	4664	18	(	(	-LRB-
cord-005453-4057qib7	4664	19	26.3	26.3	CD
cord-005453-4057qib7	4664	20	%	%	NN
cord-005453-4057qib7	4664	21	)	)	-RRB-
cord-005453-4057qib7	4664	22	,	,	,
cord-005453-4057qib7	4664	23	all	all	DT
cord-005453-4057qib7	4664	24	of	of	IN
cord-005453-4057qib7	4664	25	which	which	WDT
cord-005453-4057qib7	4664	26	had	have	VBD
cord-005453-4057qib7	4664	27	visceral	visceral	JJ
cord-005453-4057qib7	4664	28	involvement	involvement	NN
cord-005453-4057qib7	4664	29	.	.	.
cord-005453-4057qib7	4665	1	In	in	IN
cord-005453-4057qib7	4665	2	3	3	CD
cord-005453-4057qib7	4665	3	pts	pts	NN
cord-005453-4057qib7	4665	4	(	(	-LRB-
cord-005453-4057qib7	4665	5	15.8	15.8	CD
cord-005453-4057qib7	4665	6	%	%	NN
cord-005453-4057qib7	4665	7	)	)	-RRB-
cord-005453-4057qib7	4665	8	,	,	,
cord-005453-4057qib7	4665	9	iKS	iKS	NNP
cord-005453-4057qib7	4665	10	was	be	VBD
cord-005453-4057qib7	4665	11	the	the	DT
cord-005453-4057qib7	4665	12	cause	cause	NN
cord-005453-4057qib7	4665	13	of	of	IN
cord-005453-4057qib7	4665	14	death	death	NN
cord-005453-4057qib7	4665	15	.	.	.
cord-005453-4057qib7	4666	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4666	2	:	:	:
cord-005453-4057qib7	4667	1	Withdrawn	withdraw	VBN
cord-005453-4057qib7	4667	2	of	of	IN
cord-005453-4057qib7	4667	3	immune	immune	JJ
cord-005453-4057qib7	4667	4	suppression	suppression	NN
cord-005453-4057qib7	4667	5	drugs	drug	NNS
cord-005453-4057qib7	4667	6	and	and	CC
cord-005453-4057qib7	4667	7	anthracycline	anthracycline	NN
cord-005453-4057qib7	4667	8	based	base	VBN
cord-005453-4057qib7	4667	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	4667	10	can	can	MD
cord-005453-4057qib7	4667	11	represent	represent	VB
cord-005453-4057qib7	4667	12	a	a	DT
cord-005453-4057qib7	4667	13	feasible	feasible	JJ
cord-005453-4057qib7	4667	14	treatment	treatment	NN
cord-005453-4057qib7	4667	15	option	option	NN
cord-005453-4057qib7	4667	16	for	for	IN
cord-005453-4057qib7	4667	17	pts	pt	NNS
cord-005453-4057qib7	4667	18	with	with	IN
cord-005453-4057qib7	4667	19	iKS	iKS	NNP
cord-005453-4057qib7	4667	20	after	after	IN
cord-005453-4057qib7	4667	21	HSCT	HSCT	NNP
cord-005453-4057qib7	4667	22	.	.	.
cord-005453-4057qib7	4668	1	Clinical	clinical	JJ
cord-005453-4057qib7	4668	2	Background	background	NN
cord-005453-4057qib7	4668	3	:	:	:
cord-005453-4057qib7	4669	1	Acquired	acquire	VBN
cord-005453-4057qib7	4670	1	Haemophilia	Haemophilia	NNP
cord-005453-4057qib7	4670	2	A	a	DT
cord-005453-4057qib7	4670	3	(	(	-LRB-
cord-005453-4057qib7	4670	4	AHA	aha	UH
cord-005453-4057qib7	4670	5	)	)	-RRB-
cord-005453-4057qib7	4670	6	is	be	VBZ
cord-005453-4057qib7	4670	7	an	an	DT
cord-005453-4057qib7	4670	8	autoimmune	autoimmune	JJ
cord-005453-4057qib7	4670	9	disease	disease	NN
cord-005453-4057qib7	4670	10	caused	cause	VBN
cord-005453-4057qib7	4670	11	by	by	IN
cord-005453-4057qib7	4670	12	the	the	DT
cord-005453-4057qib7	4670	13	spontaneous	spontaneous	JJ
cord-005453-4057qib7	4670	14	production	production	NN
cord-005453-4057qib7	4670	15	of	of	IN
cord-005453-4057qib7	4670	16	neutralizing	neutralize	VBG
cord-005453-4057qib7	4670	17	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	4670	18	G	G	NNP
cord-005453-4057qib7	4670	19	(	(	-LRB-
cord-005453-4057qib7	4670	20	IgG	IgG	NNP
cord-005453-4057qib7	4670	21	)	)	-RRB-
cord-005453-4057qib7	4670	22	autoantibodies	autoantibody	NNS
cord-005453-4057qib7	4670	23	(	(	-LRB-
cord-005453-4057qib7	4670	24	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4670	25	)	)	-RRB-
cord-005453-4057qib7	4670	26	targeting	target	VBG
cord-005453-4057qib7	4670	27	endogenous	endogenous	JJ
cord-005453-4057qib7	4670	28	FVIII	FVIII	NNP
cord-005453-4057qib7	4670	29	.	.	.
cord-005453-4057qib7	4671	1	Treatment	treatment	NN
cord-005453-4057qib7	4671	2	of	of	IN
cord-005453-4057qib7	4671	3	these	these	DT
cord-005453-4057qib7	4671	4	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4671	5	presents	present	VBZ
cord-005453-4057qib7	4671	6	additional	additional	JJ
cord-005453-4057qib7	4671	7	challenges	challenge	NNS
cord-005453-4057qib7	4671	8	in	in	IN
cord-005453-4057qib7	4671	9	a	a	DT
cord-005453-4057qib7	4671	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4671	11	stem	stem	NN
cord-005453-4057qib7	4671	12	cell	cell	NN
cord-005453-4057qib7	4671	13	transplantation	transplantation	NN
cord-005453-4057qib7	4671	14	(	(	-LRB-
cord-005453-4057qib7	4671	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4671	16	)	)	-RRB-
cord-005453-4057qib7	4671	17	recipient	recipient	NN
cord-005453-4057qib7	4671	18	,	,	,
cord-005453-4057qib7	4671	19	because	because	IN
cord-005453-4057qib7	4671	20	preservation	preservation	NN
cord-005453-4057qib7	4671	21	of	of	IN
cord-005453-4057qib7	4671	22	the	the	DT
cord-005453-4057qib7	4671	23	graft	graft	NN
cord-005453-4057qib7	4671	24	that	that	WDT
cord-005453-4057qib7	4671	25	restores	restore	VBZ
cord-005453-4057qib7	4671	26	a	a	DT
cord-005453-4057qib7	4671	27	normal	normal	JJ
cord-005453-4057qib7	4671	28	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	4671	29	is	be	VBZ
cord-005453-4057qib7	4671	30	critical	critical	JJ
cord-005453-4057qib7	4671	31	.	.	.
cord-005453-4057qib7	4672	1	Here	here	RB
cord-005453-4057qib7	4672	2	we	-PRON-	PRP
cord-005453-4057qib7	4672	3	describe	describe	VBP
cord-005453-4057qib7	4672	4	the	the	DT
cord-005453-4057qib7	4672	5	management	management	NN
cord-005453-4057qib7	4672	6	of	of	IN
cord-005453-4057qib7	4672	7	a	a	DT
cord-005453-4057qib7	4672	8	case	case	NN
cord-005453-4057qib7	4672	9	of	of	IN
cord-005453-4057qib7	4672	10	AHA	AHA	NNP
cord-005453-4057qib7	4672	11	in	in	IN
cord-005453-4057qib7	4672	12	an	an	DT
cord-005453-4057qib7	4672	13	acute	acute	JJ
cord-005453-4057qib7	4672	14	myeloid	myeloid	NN
cord-005453-4057qib7	4672	15	leukemia	leukemia	NN
cord-005453-4057qib7	4672	16	patient	patient	NN
cord-005453-4057qib7	4672	17	following	follow	VBG
cord-005453-4057qib7	4672	18	HSCT	HSCT	NNP
cord-005453-4057qib7	4672	19	.	.	.
cord-005453-4057qib7	4673	1	Methods	method	NNS
cord-005453-4057qib7	4673	2	:	:	:
cord-005453-4057qib7	4674	1	The	the	DT
cord-005453-4057qib7	4674	2	clinical	clinical	JJ
cord-005453-4057qib7	4674	3	,	,	,
cord-005453-4057qib7	4674	4	laboratory	laboratory	NN
cord-005453-4057qib7	4674	5	and	and	CC
cord-005453-4057qib7	4674	6	molecular	molecular	JJ
cord-005453-4057qib7	4674	7	aspects	aspect	NNS
cord-005453-4057qib7	4674	8	of	of	IN
cord-005453-4057qib7	4674	9	a	a	DT
cord-005453-4057qib7	4674	10	56-year	56-year	JJ
cord-005453-4057qib7	4674	11	-	-	HYPH
cord-005453-4057qib7	4674	12	old	old	JJ
cord-005453-4057qib7	4674	13	Italian	italian	JJ
cord-005453-4057qib7	4674	14	male	male	NN
cord-005453-4057qib7	4674	15	who	who	WP
cord-005453-4057qib7	4674	16	developed	develop	VBD
cord-005453-4057qib7	4674	17	AHA	AHA	NNP
cord-005453-4057qib7	4674	18	after	after	IN
cord-005453-4057qib7	4674	19	allogenic	allogenic	JJ
cord-005453-4057qib7	4674	20	bone	bone	NN
cord-005453-4057qib7	4674	21	marrow	marrow	NN
cord-005453-4057qib7	4674	22	transplantation	transplantation	NN
cord-005453-4057qib7	4674	23	were	be	VBD
cord-005453-4057qib7	4674	24	collected	collect	VBN
cord-005453-4057qib7	4674	25	and	and	CC
cord-005453-4057qib7	4674	26	presented	present	VBN
cord-005453-4057qib7	4674	27	in	in	IN
cord-005453-4057qib7	4674	28	order	order	NN
cord-005453-4057qib7	4674	29	to	to	TO
cord-005453-4057qib7	4674	30	show	show	VB
cord-005453-4057qib7	4674	31	how	how	WRB
cord-005453-4057qib7	4674	32	we	-PRON-	PRP
cord-005453-4057qib7	4674	33	diagnose	diagnose	VBP
cord-005453-4057qib7	4674	34	and	and	CC
cord-005453-4057qib7	4674	35	manage	manage	VBP
cord-005453-4057qib7	4674	36	this	this	DT
cord-005453-4057qib7	4674	37	severe	severe	JJ
cord-005453-4057qib7	4674	38	but	but	CC
cord-005453-4057qib7	4674	39	rare	rare	JJ
cord-005453-4057qib7	4674	40	complication	complication	NN
cord-005453-4057qib7	4674	41	within	within	IN
cord-005453-4057qib7	4674	42	the	the	DT
cord-005453-4057qib7	4674	43	special	special	JJ
cord-005453-4057qib7	4674	44	setting	setting	NN
cord-005453-4057qib7	4674	45	of	of	IN
cord-005453-4057qib7	4674	46	HSCT	HSCT	NNP
cord-005453-4057qib7	4674	47	.	.	.
cord-005453-4057qib7	4675	1	Results	result	NNS
cord-005453-4057qib7	4675	2	:	:	:
cord-005453-4057qib7	4676	1	A	a	DT
cord-005453-4057qib7	4676	2	56-years	56-years	CD
cord-005453-4057qib7	4676	3	-	-	HYPH
cord-005453-4057qib7	4676	4	old	old	JJ
cord-005453-4057qib7	4676	5	man	man	NN
cord-005453-4057qib7	4676	6	with	with	IN
cord-005453-4057qib7	4676	7	a	a	DT
cord-005453-4057qib7	4676	8	FLT-3	FLT-3	NNP
cord-005453-4057qib7	4677	1	ITD	ITD	NNP
cord-005453-4057qib7	4677	2	,	,	,
cord-005453-4057qib7	4677	3	NPM-1	NPM-1	NNP
cord-005453-4057qib7	4677	4	,	,	,
cord-005453-4057qib7	4677	5	RUNX1-RUNX1T1	runx1-runx1t1	NN
cord-005453-4057qib7	4677	6	and	and	CC
cord-005453-4057qib7	4677	7	CBFB	CBFB	NNP
cord-005453-4057qib7	4677	8	-	-	HYPH
cord-005453-4057qib7	4677	9	MYH11	MYH11	NNP
cord-005453-4057qib7	4678	1	negative	negative	JJ
cord-005453-4057qib7	4678	2	,	,	,
cord-005453-4057qib7	4678	3	not	not	RB
cord-005453-4057qib7	4678	4	differentiated	differentiate	VBN
cord-005453-4057qib7	4679	1	,	,	,
cord-005453-4057qib7	4679	2	chromosomally	chromosomally	RB
cord-005453-4057qib7	4679	3	normal	normal	JJ
cord-005453-4057qib7	4679	4	acute	acute	JJ
cord-005453-4057qib7	4679	5	myeloid	myeloid	NN
cord-005453-4057qib7	4679	6	leukemia	leukemia	NN
cord-005453-4057qib7	4679	7	(	(	-LRB-
cord-005453-4057qib7	4679	8	AML	AML	NNP
cord-005453-4057qib7	4679	9	)	)	-RRB-
cord-005453-4057qib7	4679	10	in	in	IN
cord-005453-4057qib7	4679	11	third	third	JJ
cord-005453-4057qib7	4679	12	complete	complete	JJ
cord-005453-4057qib7	4679	13	remission	remission	NN
cord-005453-4057qib7	4679	14	(	(	-LRB-
cord-005453-4057qib7	4679	15	CR	CR	NNP
cord-005453-4057qib7	4679	16	)	)	-RRB-
cord-005453-4057qib7	4679	17	was	be	VBD
cord-005453-4057qib7	4679	18	submitted	submit	VBN
cord-005453-4057qib7	4679	19	to	to	IN
cord-005453-4057qib7	4679	20	a	a	DT
cord-005453-4057qib7	4679	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4679	22	stem	stem	NN
cord-005453-4057qib7	4679	23	cell	cell	NN
cord-005453-4057qib7	4679	24	transplantation	transplantation	NN
cord-005453-4057qib7	4679	25	(	(	-LRB-
cord-005453-4057qib7	4679	26	HSCT	HSCT	NNP
cord-005453-4057qib7	4679	27	)	)	-RRB-
cord-005453-4057qib7	4679	28	from	from	IN
cord-005453-4057qib7	4679	29	his	-PRON-	PRP$
cord-005453-4057qib7	4679	30	haploidentical	haploidentical	JJ
cord-005453-4057qib7	4679	31	son	son	NN
cord-005453-4057qib7	4679	32	.	.	.
cord-005453-4057qib7	4680	1	The	the	DT
cord-005453-4057qib7	4680	2	conditioning	conditioning	NN
cord-005453-4057qib7	4680	3	regimen	regimen	NN
cord-005453-4057qib7	4680	4	consisted	consist	VBD
cord-005453-4057qib7	4680	5	of	of	IN
cord-005453-4057qib7	4680	6	Oncothiotepa	Oncothiotepa	NNP
cord-005453-4057qib7	4680	7	,	,	,
cord-005453-4057qib7	4680	8	Busulfan	Busulfan	NNP
cord-005453-4057qib7	4680	9	and	and	CC
cord-005453-4057qib7	4680	10	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	4680	11	and	and	CC
cord-005453-4057qib7	4680	12	was	be	VBD
cord-005453-4057qib7	4680	13	followed	follow	VBN
cord-005453-4057qib7	4680	14	by	by	IN
cord-005453-4057qib7	4680	15	the	the	DT
cord-005453-4057qib7	4680	16	infusion	infusion	NN
cord-005453-4057qib7	4680	17	of	of	IN
cord-005453-4057qib7	4680	18	a	a	DT
cord-005453-4057qib7	4680	19	T	t	NN
cord-005453-4057qib7	4680	20	-	-	HYPH
cord-005453-4057qib7	4680	21	cell	cell	NN
cord-005453-4057qib7	4680	22	depleted	deplete	VBN
cord-005453-4057qib7	4680	23	bone	bone	NN
cord-005453-4057qib7	4680	24	marrow	marrow	NN
cord-005453-4057qib7	4680	25	graft	graft	NN
cord-005453-4057qib7	4680	26	.	.	.
cord-005453-4057qib7	4681	1	GVHD	GVHD	NNP
cord-005453-4057qib7	4681	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4681	3	consisted	consist	VBD
cord-005453-4057qib7	4681	4	of	of	IN
cord-005453-4057qib7	4681	5	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	4681	6	A	A	NNP
cord-005453-4057qib7	4681	7	(	(	-LRB-
cord-005453-4057qib7	4681	8	CsA	csa	NN
cord-005453-4057qib7	4681	9	)	)	-RRB-
cord-005453-4057qib7	4681	10	and	and	CC
cord-005453-4057qib7	4681	11	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	4681	12	mophetyl	mophetyl	NNP
cord-005453-4057qib7	4681	13	(	(	-LRB-
cord-005453-4057qib7	4681	14	MMF	MMF	NNP
cord-005453-4057qib7	4681	15	)	)	-RRB-
cord-005453-4057qib7	4681	16	.	.	.
cord-005453-4057qib7	4682	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	4682	2	engraftment	engraftment	NN
cord-005453-4057qib7	4682	3	occurred	occur	VBD
cord-005453-4057qib7	4682	4	on	on	IN
cord-005453-4057qib7	4682	5	day	day	NN
cord-005453-4057qib7	4682	6	+24	+24	CD
cord-005453-4057qib7	4682	7	.	.	.
cord-005453-4057qib7	4683	1	Recipient	Recipient	NNP
cord-005453-4057qib7	4683	2	's	's	POS
cord-005453-4057qib7	4683	3	autoimmunity	autoimmunity	NN
cord-005453-4057qib7	4683	4	was	be	VBD
cord-005453-4057qib7	4683	5	negative	negative	JJ
cord-005453-4057qib7	4683	6	.	.	.
cord-005453-4057qib7	4684	1	At	at	IN
cord-005453-4057qib7	4684	2	27	27	CD
cord-005453-4057qib7	4684	3	months	month	NNS
cord-005453-4057qib7	4684	4	post	post	NN
cord-005453-4057qib7	4684	5	-	-	NN
cord-005453-4057qib7	4684	6	transplantation	transplantation	JJ
cord-005453-4057qib7	4684	7	the	the	DT
cord-005453-4057qib7	4684	8	patient	patient	NN
cord-005453-4057qib7	4684	9	received	receive	VBD
cord-005453-4057qib7	4684	10	an	an	DT
cord-005453-4057qib7	4684	11	antipneumococcal	antipneumococcal	JJ
cord-005453-4057qib7	4684	12	vaccination	vaccination	NN
cord-005453-4057qib7	4684	13	.	.	.
cord-005453-4057qib7	4685	1	Fifteen	fifteen	CD
cord-005453-4057qib7	4685	2	days	day	NNS
cord-005453-4057qib7	4685	3	post	post	NN
cord-005453-4057qib7	4685	4	-	-	JJ
cord-005453-4057qib7	4685	5	vaccination	vaccination	VB
cord-005453-4057qib7	4685	6	the	the	DT
cord-005453-4057qib7	4685	7	patient	patient	NN
cord-005453-4057qib7	4685	8	was	be	VBD
cord-005453-4057qib7	4685	9	admitted	admit	VBN
cord-005453-4057qib7	4685	10	to	to	IN
cord-005453-4057qib7	4685	11	our	-PRON-	PRP$
cord-005453-4057qib7	4685	12	in	in	IN
cord-005453-4057qib7	4685	13	-	-	HYPH
cord-005453-4057qib7	4685	14	patient	patient	NN
cord-005453-4057qib7	4685	15	ward	ward	NN
cord-005453-4057qib7	4685	16	due	due	IN
cord-005453-4057qib7	4685	17	to	to	IN
cord-005453-4057qib7	4685	18	general	general	JJ
cord-005453-4057qib7	4685	19	malaise	malaise	NN
cord-005453-4057qib7	4685	20	,	,	,
cord-005453-4057qib7	4685	21	diffuse	diffuse	VB
cord-005453-4057qib7	4685	22	muscle	muscle	NN
cord-005453-4057qib7	4685	23	and	and	CC
cord-005453-4057qib7	4685	24	joint	joint	JJ
cord-005453-4057qib7	4685	25	pains	pain	NNS
cord-005453-4057qib7	4685	26	,	,	,
cord-005453-4057qib7	4685	27	cutaneous	cutaneous	JJ
cord-005453-4057qib7	4685	28	bleedings	bleeding	NNS
cord-005453-4057qib7	4685	29	,	,	,
cord-005453-4057qib7	4685	30	oedemas	oedemas	NNP
cord-005453-4057qib7	4685	31	,	,	,
cord-005453-4057qib7	4685	32	hyperchromic	hyperchromic	JJ
cord-005453-4057qib7	4685	33	urines	urine	NNS
cord-005453-4057qib7	4685	34	and	and	CC
cord-005453-4057qib7	4685	35	constipation	constipation	NN
cord-005453-4057qib7	4685	36	.	.	.
cord-005453-4057qib7	4686	1	Physical	physical	JJ
cord-005453-4057qib7	4686	2	examination	examination	NN
cord-005453-4057qib7	4686	3	revealed	reveal	VBD
cord-005453-4057qib7	4686	4	diffuse	diffuse	JJ
cord-005453-4057qib7	4686	5	ecchymosis	ecchymosis	NN
cord-005453-4057qib7	4686	6	,	,	,
cord-005453-4057qib7	4686	7	swelling	swelling	NN
cord-005453-4057qib7	4686	8	of	of	IN
cord-005453-4057qib7	4686	9	deep	deep	JJ
cord-005453-4057qib7	4686	10	muscles	muscle	NNS
cord-005453-4057qib7	4686	11	with	with	IN
cord-005453-4057qib7	4686	12	a	a	DT
cord-005453-4057qib7	4686	13	progressive	progressive	JJ
cord-005453-4057qib7	4686	14	functional	functional	JJ
cord-005453-4057qib7	4686	15	disability	disability	NN
cord-005453-4057qib7	4686	16	due	due	IN
cord-005453-4057qib7	4686	17	to	to	IN
cord-005453-4057qib7	4686	18	hematomas	hematoma	NNS
cord-005453-4057qib7	4686	19	and	and	CC
cord-005453-4057qib7	4686	20	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	4686	21	suffusions	suffusion	NNS
cord-005453-4057qib7	4686	22	of	of	IN
cord-005453-4057qib7	4686	23	the	the	DT
cord-005453-4057qib7	4686	24	tongue	tongue	NN
cord-005453-4057qib7	4686	25	frenulum	frenulum	NN
cord-005453-4057qib7	4686	26	.	.	.
cord-005453-4057qib7	4687	1	and	and	CC
cord-005453-4057qib7	4687	2	anti	anti	JJ
cord-005453-4057qib7	4687	3	-	-	JJ
cord-005453-4057qib7	4687	4	factor	factor	NN
cord-005453-4057qib7	4687	5	VIII	VIII	NNP
cord-005453-4057qib7	4687	6	inhibitors	inhibitor	NNS
cord-005453-4057qib7	4687	7	6.46	6.46	CD
cord-005453-4057qib7	4687	8	BU	BU	NNP
cord-005453-4057qib7	4687	9	/	/	SYM
cord-005453-4057qib7	4687	10	ml	ml	NN
cord-005453-4057qib7	4687	11	(	(	-LRB-
cord-005453-4057qib7	4687	12	high	high	JJ
cord-005453-4057qib7	4687	13	titers	titer	NNS
cord-005453-4057qib7	4688	1	>	>	XX
cord-005453-4057qib7	4689	1	5	5	CD
cord-005453-4057qib7	4689	2	BU	BU	NNP
cord-005453-4057qib7	4689	3	/	/	SYM
cord-005453-4057qib7	4689	4	ml	ml	NN
cord-005453-4057qib7	4689	5	)	)	-RRB-
cord-005453-4057qib7	4689	6	.	.	.
cord-005453-4057qib7	4690	1	Thus	thus	RB
cord-005453-4057qib7	4690	2	,	,	,
cord-005453-4057qib7	4690	3	a	a	DT
cord-005453-4057qib7	4690	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	4690	5	of	of	IN
cord-005453-4057qib7	4690	6	acquired	acquire	VBN
cord-005453-4057qib7	4690	7	autoimmune	autoimmune	JJ
cord-005453-4057qib7	4690	8	Haemophilia	Haemophilia	NNP
cord-005453-4057qib7	4690	9	A	A	NNP
cord-005453-4057qib7	4690	10	was	be	VBD
cord-005453-4057qib7	4690	11	made	make	VBN
cord-005453-4057qib7	4690	12	and	and	CC
cord-005453-4057qib7	4690	13	treatment	treatment	NN
cord-005453-4057qib7	4690	14	with	with	IN
cord-005453-4057qib7	4690	15	FEIBA	FEIBA	NNP
cord-005453-4057qib7	4690	16	combined	combine	VBN
cord-005453-4057qib7	4690	17	with	with	IN
cord-005453-4057qib7	4690	18	prednisone	prednisone	NNP
cord-005453-4057qib7	4690	19	was	be	VBD
cord-005453-4057qib7	4690	20	started	start	VBN
cord-005453-4057qib7	4690	21	.	.	.
cord-005453-4057qib7	4691	1	Patient	Patient	NNP
cord-005453-4057qib7	4691	2	's	's	POS
cord-005453-4057qib7	4691	3	clinical	clinical	JJ
cord-005453-4057qib7	4691	4	conditions	condition	NNS
cord-005453-4057qib7	4691	5	dramatically	dramatically	RB
cord-005453-4057qib7	4691	6	improved	improve	VBD
cord-005453-4057qib7	4691	7	as	as	IN
cord-005453-4057qib7	4691	8	he	-PRON-	PRP
cord-005453-4057qib7	4691	9	referred	refer	VBD
cord-005453-4057qib7	4691	10	an	an	DT
cord-005453-4057qib7	4691	11	improvement	improvement	NN
cord-005453-4057qib7	4691	12	of	of	IN
cord-005453-4057qib7	4691	13	movements	movement	NNS
cord-005453-4057qib7	4691	14	and	and	CC
cord-005453-4057qib7	4691	15	the	the	DT
cord-005453-4057qib7	4691	16	resolution	resolution	NN
cord-005453-4057qib7	4691	17	of	of	IN
cord-005453-4057qib7	4691	18	joint	joint	JJ
cord-005453-4057qib7	4691	19	and	and	CC
cord-005453-4057qib7	4691	20	muscle	muscle	NN
cord-005453-4057qib7	4691	21	pains	pain	NNS
cord-005453-4057qib7	4691	22	despite	despite	IN
cord-005453-4057qib7	4691	23	the	the	DT
cord-005453-4057qib7	4691	24	persistence	persistence	NN
cord-005453-4057qib7	4691	25	of	of	IN
cord-005453-4057qib7	4691	26	deep	deep	JJ
cord-005453-4057qib7	4691	27	hematomas	hematoma	NNS
cord-005453-4057qib7	4691	28	just	just	RB
cord-005453-4057qib7	4691	29	after	after	IN
cord-005453-4057qib7	4691	30	one	one	CD
cord-005453-4057qib7	4691	31	day	day	NN
cord-005453-4057qib7	4691	32	of	of	IN
cord-005453-4057qib7	4691	33	treatment	treatment	NN
cord-005453-4057qib7	4691	34	that	that	WDT
cord-005453-4057qib7	4691	35	had	have	VBD
cord-005453-4057qib7	4691	36	determined	determine	VBN
cord-005453-4057qib7	4691	37	an	an	DT
cord-005453-4057qib7	4691	38	increase	increase	NN
cord-005453-4057qib7	4691	39	of	of	IN
cord-005453-4057qib7	4691	40	FVIII	FVIII	NNP
cord-005453-4057qib7	4691	41	:	:	:
cord-005453-4057qib7	4692	1	C	C	NNP
cord-005453-4057qib7	4692	2	value	value	NN
cord-005453-4057qib7	4692	3	to	to	IN
cord-005453-4057qib7	4692	4	1.32	1.32	CD
cord-005453-4057qib7	4692	5	%	%	NN
cord-005453-4057qib7	4692	6	and	and	CC
cord-005453-4057qib7	4692	7	an	an	DT
cord-005453-4057qib7	4692	8	improvement	improvement	NN
cord-005453-4057qib7	4692	9	of	of	IN
cord-005453-4057qib7	4692	10	aPTT	aptt	CD
cord-005453-4057qib7	4692	11	to	to	IN
cord-005453-4057qib7	4692	12	47.06	47.06	CD
cord-005453-4057qib7	4692	13	seconds	second	NNS
cord-005453-4057qib7	4692	14	.	.	.
cord-005453-4057qib7	4693	1	On	on	IN
cord-005453-4057qib7	4693	2	the	the	DT
cord-005453-4057qib7	4693	3	following	follow	VBG
cord-005453-4057qib7	4693	4	medical	medical	JJ
cord-005453-4057qib7	4693	5	checks	check	NNS
cord-005453-4057qib7	4693	6	physical	physical	JJ
cord-005453-4057qib7	4693	7	examination	examination	NN
cord-005453-4057qib7	4693	8	showed	show	VBD
cord-005453-4057qib7	4693	9	the	the	DT
cord-005453-4057qib7	4693	10	progressive	progressive	JJ
cord-005453-4057qib7	4693	11	disappearance	disappearance	NN
cord-005453-4057qib7	4693	12	of	of	IN
cord-005453-4057qib7	4693	13	deep	deep	JJ
cord-005453-4057qib7	4693	14	muscle	muscle	NN
cord-005453-4057qib7	4693	15	hematomas	hematoma	NNS
cord-005453-4057qib7	4693	16	,	,	,
cord-005453-4057qib7	4693	17	and	and	CC
cord-005453-4057qib7	4693	18	normal	normal	JJ
cord-005453-4057qib7	4693	19	values	value	NNS
cord-005453-4057qib7	4693	20	of	of	IN
cord-005453-4057qib7	4693	21	FVIII	FVIII	NNS
cord-005453-4057qib7	4693	22	:	:	:
cord-005453-4057qib7	4694	1	C.	C.	NNP
cord-005453-4057qib7	4694	2	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	4694	3	:	:	:
cord-005453-4057qib7	4695	1	AHA	AHA	NNP
cord-005453-4057qib7	4695	2	is	be	VBZ
cord-005453-4057qib7	4695	3	a	a	DT
cord-005453-4057qib7	4695	4	rare	rare	JJ
cord-005453-4057qib7	4695	5	but	but	CC
cord-005453-4057qib7	4695	6	severe	severe	JJ
cord-005453-4057qib7	4695	7	complication	complication	NN
cord-005453-4057qib7	4695	8	following	follow	VBG
cord-005453-4057qib7	4695	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4696	1	and	and	CC
cord-005453-4057qib7	4696	2	it	-PRON-	PRP
cord-005453-4057qib7	4696	3	could	could	MD
cord-005453-4057qib7	4696	4	appear	appear	VB
cord-005453-4057qib7	4696	5	years	year	NNS
cord-005453-4057qib7	4696	6	afterengraftment	afterengraftment	JJ
cord-005453-4057qib7	4696	7	.	.	.
cord-005453-4057qib7	4697	1	A	a	DT
cord-005453-4057qib7	4697	2	prompt	prompt	JJ
cord-005453-4057qib7	4697	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	4697	4	and	and	CC
cord-005453-4057qib7	4697	5	an	an	DT
cord-005453-4057qib7	4697	6	early	early	JJ
cord-005453-4057qib7	4697	7	treatment	treatment	NN
cord-005453-4057qib7	4697	8	with	with	IN
cord-005453-4057qib7	4697	9	FEIBA	FEIBA	NNP
cord-005453-4057qib7	4697	10	and	and	CC
cord-005453-4057qib7	4697	11	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	4697	12	are	be	VBP
cord-005453-4057qib7	4697	13	necessary	necessary	JJ
cord-005453-4057qib7	4697	14	to	to	TO
cord-005453-4057qib7	4697	15	avoid	avoid	VB
cord-005453-4057qib7	4697	16	life	life	NN
cord-005453-4057qib7	4697	17	-	-	HYPH
cord-005453-4057qib7	4697	18	threatening	threaten	VBG
cord-005453-4057qib7	4697	19	sequelae	sequela	NNS
cord-005453-4057qib7	4697	20	.	.	.
cord-005453-4057qib7	4698	1	The	the	DT
cord-005453-4057qib7	4698	2	inclusion	inclusion	NN
cord-005453-4057qib7	4698	3	of	of	IN
cord-005453-4057qib7	4698	4	the	the	DT
cord-005453-4057qib7	4698	5	coagulation	coagulation	NN
cord-005453-4057qib7	4698	6	panel	panel	NN
cord-005453-4057qib7	4698	7	in	in	IN
cord-005453-4057qib7	4698	8	the	the	DT
cord-005453-4057qib7	4698	9	laboratory	laboratory	NN
cord-005453-4057qib7	4698	10	exams	exam	NNS
cord-005453-4057qib7	4698	11	performed	perform	VBN
cord-005453-4057qib7	4698	12	during	during	IN
cord-005453-4057qib7	4698	13	the	the	DT
cord-005453-4057qib7	4698	14	follow	follow	NN
cord-005453-4057qib7	4698	15	-	-	HYPH
cord-005453-4057qib7	4698	16	up	up	NN
cord-005453-4057qib7	4698	17	is	be	VBZ
cord-005453-4057qib7	4698	18	advisable	advisable	JJ
cord-005453-4057qib7	4698	19	in	in	IN
cord-005453-4057qib7	4698	20	order	order	NN
cord-005453-4057qib7	4698	21	to	to	TO
cord-005453-4057qib7	4698	22	early	early	RB
cord-005453-4057qib7	4698	23	detect	detect	VB
cord-005453-4057qib7	4698	24	this	this	DT
cord-005453-4057qib7	4698	25	life	life	NN
cord-005453-4057qib7	4698	26	-	-	HYPH
cord-005453-4057qib7	4698	27	threatening	threaten	VBG
cord-005453-4057qib7	4698	28	complication	complication	NN
cord-005453-4057qib7	4698	29	.	.	.
cord-005453-4057qib7	4699	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4699	2	:	:	:
cord-005453-4057qib7	4699	3	Nothing	nothing	NN
cord-005453-4057qib7	4699	4	to	to	TO
cord-005453-4057qib7	4699	5	declare	declare	VB
cord-005453-4057qib7	4699	6	Background	background	NN
cord-005453-4057qib7	4699	7	:	:	:
cord-005453-4057qib7	4700	1	Splanchnic	splanchnic	JJ
cord-005453-4057qib7	4700	2	thrombosis	thrombosis	NN
cord-005453-4057qib7	4700	3	is	be	VBZ
cord-005453-4057qib7	4700	4	an	an	DT
cord-005453-4057qib7	4700	5	uncommon	uncommon	JJ
cord-005453-4057qib7	4700	6	complication	complication	NN
cord-005453-4057qib7	4700	7	of	of	IN
cord-005453-4057qib7	4700	8	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	4700	9	and	and	CC
cord-005453-4057qib7	4700	10	a	a	DT
cord-005453-4057qib7	4700	11	controindication	controindication	NN
cord-005453-4057qib7	4700	12	to	to	TO
cord-005453-4057qib7	4700	13	proceed	proceed	VB
cord-005453-4057qib7	4700	14	to	to	IN
cord-005453-4057qib7	4700	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4700	16	stem	stem	NN
cord-005453-4057qib7	4700	17	cell	cell	NN
cord-005453-4057qib7	4700	18	transplantation	transplantation	NN
cord-005453-4057qib7	4700	19	(	(	-LRB-
cord-005453-4057qib7	4700	20	HSCT	HSCT	NNP
cord-005453-4057qib7	4700	21	)	)	-RRB-
cord-005453-4057qib7	4700	22	due	due	IN
cord-005453-4057qib7	4700	23	to	to	IN
cord-005453-4057qib7	4700	24	the	the	DT
cord-005453-4057qib7	4700	25	risk	risk	NN
cord-005453-4057qib7	4700	26	of	of	IN
cord-005453-4057qib7	4700	27	additional	additional	JJ
cord-005453-4057qib7	4700	28	vascular	vascular	JJ
cord-005453-4057qib7	4700	29	and	and	CC
cord-005453-4057qib7	4700	30	endothelial	endothelial	JJ
cord-005453-4057qib7	4700	31	complications	complication	NNS
cord-005453-4057qib7	4700	32	.	.	.
cord-005453-4057qib7	4701	1	We	-PRON-	PRP
cord-005453-4057qib7	4701	2	present	present	VBP
cord-005453-4057qib7	4701	3	a	a	DT
cord-005453-4057qib7	4701	4	patient	patient	NN
cord-005453-4057qib7	4701	5	with	with	IN
cord-005453-4057qib7	4701	6	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	4701	7	(	(	-LRB-
cord-005453-4057qib7	4701	8	MF	MF	NNP
cord-005453-4057qib7	4701	9	)	)	-RRB-
cord-005453-4057qib7	4701	10	that	that	WDT
cord-005453-4057qib7	4701	11	proceeded	proceed	VBD
cord-005453-4057qib7	4701	12	to	to	IN
cord-005453-4057qib7	4701	13	HSCT	HSCT	NNP
cord-005453-4057qib7	4701	14	from	from	IN
cord-005453-4057qib7	4701	15	an	an	DT
cord-005453-4057qib7	4701	16	unrelated	unrelated	JJ
cord-005453-4057qib7	4701	17	donor	donor	NN
cord-005453-4057qib7	4701	18	,	,	,
cord-005453-4057qib7	4701	19	despite	despite	IN
cord-005453-4057qib7	4701	20	splanchnic	splanchnic	JJ
cord-005453-4057qib7	4701	21	thrombosis	thrombosis	NN
cord-005453-4057qib7	4701	22	unresolved	unresolved	JJ
cord-005453-4057qib7	4701	23	after	after	IN
cord-005453-4057qib7	4701	24	heparin	heparin	JJ
cord-005453-4057qib7	4701	25	treatment	treatment	NN
cord-005453-4057qib7	4701	26	and	and	CC
cord-005453-4057qib7	4701	27	unable	unable	JJ
cord-005453-4057qib7	4701	28	to	to	TO
cord-005453-4057qib7	4701	29	proceed	proceed	VB
cord-005453-4057qib7	4701	30	to	to	IN
cord-005453-4057qib7	4701	31	surgical	surgical	JJ
cord-005453-4057qib7	4701	32	treatment	treatment	NN
cord-005453-4057qib7	4701	33	due	due	IN
cord-005453-4057qib7	4701	34	to	to	IN
cord-005453-4057qib7	4701	35	severe	severe	JJ
cord-005453-4057qib7	4701	36	thrombocytemia	thrombocytemia	NN
cord-005453-4057qib7	4701	37	.	.	.
cord-005453-4057qib7	4702	1	Methods	method	NNS
cord-005453-4057qib7	4702	2	:	:	:
cord-005453-4057qib7	4703	1	A	a	DT
cord-005453-4057qib7	4703	2	67-year	67-year	JJ
cord-005453-4057qib7	4703	3	woman	woman	NN
cord-005453-4057qib7	4703	4	with	with	IN
cord-005453-4057qib7	4703	5	MF	MF	NNP
cord-005453-4057qib7	4703	6	secondary	secondary	JJ
cord-005453-4057qib7	4703	7	to	to	IN
cord-005453-4057qib7	4703	8	essential	essential	JJ
cord-005453-4057qib7	4703	9	thrombocythemia	thrombocythemia	NN
cord-005453-4057qib7	4703	10	,	,	,
cord-005453-4057qib7	4703	11	with	with	IN
cord-005453-4057qib7	4703	12	intermediate-2	intermediate-2	NNP
cord-005453-4057qib7	4703	13	score	score	NN
cord-005453-4057qib7	4703	14	according	accord	VBG
cord-005453-4057qib7	4703	15	Dynamic	Dynamic	NNP
cord-005453-4057qib7	4703	16	International	International	NNP
cord-005453-4057qib7	4703	17	Prognostic	Prognostic	NNP
cord-005453-4057qib7	4703	18	Staging	Staging	NNP
cord-005453-4057qib7	4703	19	System	System	NNP
cord-005453-4057qib7	4703	20	(	(	-LRB-
cord-005453-4057qib7	4703	21	DIPSS	DIPSS	NNP
cord-005453-4057qib7	4703	22	)	)	-RRB-
cord-005453-4057qib7	4703	23	and	and	CC
cord-005453-4057qib7	4703	24	with	with	IN
cord-005453-4057qib7	4703	25	extreme	extreme	JJ
cord-005453-4057qib7	4703	26	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	4703	27	(	(	-LRB-
cord-005453-4057qib7	4703	28	maximum	maximum	JJ
cord-005453-4057qib7	4703	29	diameter	diameter	NN
cord-005453-4057qib7	4703	30	30	30	CD
cord-005453-4057qib7	4703	31	cm	cm	NN
cord-005453-4057qib7	4703	32	)	)	-RRB-
cord-005453-4057qib7	4703	33	,	,	,
cord-005453-4057qib7	4703	34	refractory	refractory	JJ
cord-005453-4057qib7	4703	35	to	to	IN
cord-005453-4057qib7	4703	36	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	4703	37	,	,	,
cord-005453-4057qib7	4703	38	showed	show	VBD
cord-005453-4057qib7	4703	39	an	an	DT
cord-005453-4057qib7	4703	40	extensive	extensive	JJ
cord-005453-4057qib7	4703	41	thrombosis	thrombosis	NN
cord-005453-4057qib7	4703	42	of	of	IN
cord-005453-4057qib7	4703	43	the	the	DT
cord-005453-4057qib7	4703	44	portal	portal	JJ
cord-005453-4057qib7	4703	45	and	and	CC
cord-005453-4057qib7	4703	46	splenic	splenic	JJ
cord-005453-4057qib7	4703	47	veins	vein	NNS
cord-005453-4057qib7	4703	48	,	,	,
cord-005453-4057qib7	4703	49	unresolved	unresolved	JJ
cord-005453-4057qib7	4703	50	after	after	IN
cord-005453-4057qib7	4703	51	4-week	4-week	CD
cord-005453-4057qib7	4703	52	heparin	heparin	NN
cord-005453-4057qib7	4703	53	therapy	therapy	NN
cord-005453-4057qib7	4703	54	,	,	,
cord-005453-4057qib7	4703	55	at	at	IN
cord-005453-4057qib7	4703	56	the	the	DT
cord-005453-4057qib7	4703	57	time	time	NN
cord-005453-4057qib7	4703	58	of	of	IN
cord-005453-4057qib7	4703	59	availability	availability	NN
cord-005453-4057qib7	4703	60	of	of	IN
cord-005453-4057qib7	4703	61	an	an	DT
cord-005453-4057qib7	4703	62	HLA	HLA	NNP
cord-005453-4057qib7	4703	63	(	(	-LRB-
cord-005453-4057qib7	4703	64	8/8	8/8	CD
cord-005453-4057qib7	4703	65	)	)	-RRB-
cord-005453-4057qib7	4703	66	and	and	CC
cord-005453-4057qib7	4703	67	ABO	ABO	NNP
cord-005453-4057qib7	4703	68	matched	match	VBD
cord-005453-4057qib7	4703	69	unrelated	unrelated	JJ
cord-005453-4057qib7	4703	70	donor	donor	NN
cord-005453-4057qib7	4703	71	.	.	.
cord-005453-4057qib7	4704	1	She	-PRON-	PRP
cord-005453-4057qib7	4704	2	received	receive	VBD
cord-005453-4057qib7	4704	3	a	a	DT
cord-005453-4057qib7	4704	4	conditioning	conditioning	NN
cord-005453-4057qib7	4704	5	regimen	regimen	NN
cord-005453-4057qib7	4704	6	including	include	VBG
cord-005453-4057qib7	4704	7	fludarabine	fludarabine	NN
cord-005453-4057qib7	4704	8	and	and	CC
cord-005453-4057qib7	4704	9	thiotepa	thiotepa	NNP
cord-005453-4057qib7	4704	10	and	and	CC
cord-005453-4057qib7	4704	11	a	a	DT
cord-005453-4057qib7	4704	12	GvHD	gvhd	NN
cord-005453-4057qib7	4704	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4704	14	with	with	IN
cord-005453-4057qib7	4704	15	ATG	ATG	NNP
cord-005453-4057qib7	4704	16	thymoglobuline	thymoglobuline	NN
cord-005453-4057qib7	4704	17	,	,	,
cord-005453-4057qib7	4704	18	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	4704	19	and	and	CC
cord-005453-4057qib7	4704	20	methotrexate	methotrexate	NNP
cord-005453-4057qib7	4704	21	,	,	,
cord-005453-4057qib7	4704	22	followed	follow	VBN
cord-005453-4057qib7	4704	23	by	by	IN
cord-005453-4057qib7	4704	24	the	the	DT
cord-005453-4057qib7	4704	25	reinfusion	reinfusion	NN
cord-005453-4057qib7	4704	26	of	of	IN
cord-005453-4057qib7	4704	27	5.8x10	5.8x10	CD
cord-005453-4057qib7	4704	28	6	6	CD
cord-005453-4057qib7	4704	29	/kg	/kg	.
cord-005453-4057qib7	4704	30	CD34	CD34	NNP
cord-005453-4057qib7	4704	31	+	+	CC
cord-005453-4057qib7	4704	32	PBSC	PBSC	NNP
cord-005453-4057qib7	4704	33	.	.	.
cord-005453-4057qib7	4705	1	At	at	IN
cord-005453-4057qib7	4705	2	the	the	DT
cord-005453-4057qib7	4705	3	time	time	NN
cord-005453-4057qib7	4705	4	of	of	IN
cord-005453-4057qib7	4705	5	transplant	transplant	NN
cord-005453-4057qib7	4705	6	we	-PRON-	PRP
cord-005453-4057qib7	4705	7	were	be	VBD
cord-005453-4057qib7	4705	8	aware	aware	JJ
cord-005453-4057qib7	4705	9	of	of	IN
cord-005453-4057qib7	4705	10	an	an	DT
cord-005453-4057qib7	4705	11	high	high	JJ
cord-005453-4057qib7	4705	12	risk	risk	NN
cord-005453-4057qib7	4705	13	of	of	IN
cord-005453-4057qib7	4705	14	developing	develop	VBG
cord-005453-4057qib7	4705	15	SOS	SOS	NNP
cord-005453-4057qib7	4705	16	,	,	,
cord-005453-4057qib7	4705	17	on	on	IN
cord-005453-4057qib7	4705	18	the	the	DT
cord-005453-4057qib7	4705	19	basis	basis	NN
cord-005453-4057qib7	4705	20	of	of	IN
cord-005453-4057qib7	4705	21	the	the	DT
cord-005453-4057qib7	4705	22	older	old	JJR
cord-005453-4057qib7	4705	23	age	age	NN
cord-005453-4057qib7	4705	24	of	of	IN
cord-005453-4057qib7	4705	25	the	the	DT
cord-005453-4057qib7	4705	26	recipient	recipient	NN
cord-005453-4057qib7	4705	27	,	,	,
cord-005453-4057qib7	4705	28	the	the	DT
cord-005453-4057qib7	4705	29	unrelated	unrelated	JJ
cord-005453-4057qib7	4705	30	donor	donor	NN
cord-005453-4057qib7	4705	31	,	,	,
cord-005453-4057qib7	4705	32	the	the	DT
cord-005453-4057qib7	4705	33	advanced	advanced	JJ
cord-005453-4057qib7	4705	34	stage	stage	NN
cord-005453-4057qib7	4705	35	of	of	IN
cord-005453-4057qib7	4705	36	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	4705	37	and	and	CC
cord-005453-4057qib7	4705	38	the	the	DT
cord-005453-4057qib7	4705	39	ferritin	ferritin	NN
cord-005453-4057qib7	4705	40	serum	serum	NN
cord-005453-4057qib7	4705	41	level	level	NN
cord-005453-4057qib7	4705	42	of	of	IN
cord-005453-4057qib7	4705	43	2.223	2.223	CD
cord-005453-4057qib7	4705	44	ng	ng	NNP
cord-005453-4057qib7	4705	45	/	/	SYM
cord-005453-4057qib7	4705	46	mg	mg	NNP
cord-005453-4057qib7	4705	47	.	.	.
cord-005453-4057qib7	4706	1	Results	result	NNS
cord-005453-4057qib7	4706	2	:	:	:
cord-005453-4057qib7	4707	1	On	on	IN
cord-005453-4057qib7	4707	2	day	day	NN
cord-005453-4057qib7	4707	3	+9	+9	XX
cord-005453-4057qib7	4707	4	after	after	IN
cord-005453-4057qib7	4707	5	HSCT	HSCT	NNP
cord-005453-4057qib7	4707	6	SOS	SOS	NNP
cord-005453-4057qib7	4707	7	complicated	complicate	VBD
cord-005453-4057qib7	4707	8	the	the	DT
cord-005453-4057qib7	4707	9	aplasia	aplasia	NNP
cord-005453-4057qib7	4707	10	phase	phase	NN
cord-005453-4057qib7	4707	11	,	,	,
cord-005453-4057qib7	4707	12	characterized	characterize	VBN
cord-005453-4057qib7	4707	13	by	by	IN
cord-005453-4057qib7	4707	14	jaundice	jaundice	NN
cord-005453-4057qib7	4707	15	,	,	,
cord-005453-4057qib7	4707	16	ascites	ascites	NN
cord-005453-4057qib7	4707	17	,	,	,
cord-005453-4057qib7	4707	18	weight	weight	NN
cord-005453-4057qib7	4707	19	gain	gain	NN
cord-005453-4057qib7	4707	20	,	,	,
cord-005453-4057qib7	4707	21	progressive	progressive	JJ
cord-005453-4057qib7	4707	22	increase	increase	NN
cord-005453-4057qib7	4707	23	in	in	IN
cord-005453-4057qib7	4707	24	creatinine	creatinine	NN
cord-005453-4057qib7	4707	25	and	and	CC
cord-005453-4057qib7	4707	26	bilirubin	bilirubin	JJ
cord-005453-4057qib7	4707	27	serum	serum	NN
cord-005453-4057qib7	4707	28	levels	level	NNS
cord-005453-4057qib7	4707	29	.	.	.
cord-005453-4057qib7	4708	1	An	an	DT
cord-005453-4057qib7	4708	2	ultrasound	ultrasound	NN
cord-005453-4057qib7	4708	3	of	of	IN
cord-005453-4057qib7	4708	4	abdomen	abdomen	NN
cord-005453-4057qib7	4708	5	confirmed	confirm	VBD
cord-005453-4057qib7	4708	6	an	an	DT
cord-005453-4057qib7	4708	7	unchanged	unchanged	JJ
cord-005453-4057qib7	4708	8	thrombosis	thrombosis	NN
cord-005453-4057qib7	4708	9	extension	extension	NN
cord-005453-4057qib7	4708	10	and	and	CC
cord-005453-4057qib7	4708	11	the	the	DT
cord-005453-4057qib7	4708	12	development	development	NN
cord-005453-4057qib7	4708	13	of	of	IN
cord-005453-4057qib7	4708	14	ascites	ascite	NNS
cord-005453-4057qib7	4708	15	.	.	.
cord-005453-4057qib7	4709	1	On	on	IN
cord-005453-4057qib7	4709	2	day	day	NN
cord-005453-4057qib7	4709	3	+10	+10	NFP
cord-005453-4057qib7	4709	4	the	the	DT
cord-005453-4057qib7	4709	5	patient	patient	NN
cord-005453-4057qib7	4709	6	was	be	VBD
cord-005453-4057qib7	4709	7	categorized	categorize	VBN
cord-005453-4057qib7	4709	8	as	as	IN
cord-005453-4057qib7	4709	9	very	very	RB
cord-005453-4057qib7	4709	10	severe	severe	JJ
cord-005453-4057qib7	4709	11	SOS	SOS	NNP
cord-005453-4057qib7	4709	12	stage	stage	NN
cord-005453-4057qib7	4709	13	,	,	,
cord-005453-4057qib7	4709	14	according	accord	VBG
cord-005453-4057qib7	4709	15	to	to	IN
cord-005453-4057qib7	4709	16	EBMT	EBMT	NNP
cord-005453-4057qib7	4709	17	severity	severity	NN
cord-005453-4057qib7	4709	18	criteria	criterion	NNS
cord-005453-4057qib7	4709	19	,	,	,
cord-005453-4057qib7	4709	20	because	because	IN
cord-005453-4057qib7	4709	21	of	of	IN
cord-005453-4057qib7	4709	22	doubling	doubling	NN
cord-005453-4057qib7	4709	23	of	of	IN
cord-005453-4057qib7	4709	24	bilirubin	bilirubin	JJ
cord-005453-4057qib7	4709	25	serum	serum	NN
cord-005453-4057qib7	4709	26	level	level	NN
cord-005453-4057qib7	4709	27	in	in	IN
cord-005453-4057qib7	4709	28	48	48	CD
cord-005453-4057qib7	4709	29	hours	hour	NNS
cord-005453-4057qib7	4709	30	and	and	CC
cord-005453-4057qib7	4709	31	a	a	DT
cord-005453-4057qib7	4709	32	20	20	CD
cord-005453-4057qib7	4709	33	%	%	NN
cord-005453-4057qib7	4709	34	increase	increase	NN
cord-005453-4057qib7	4709	35	in	in	IN
cord-005453-4057qib7	4709	36	comparison	comparison	NN
cord-005453-4057qib7	4709	37	with	with	IN
cord-005453-4057qib7	4709	38	her	-PRON-	PRP$
cord-005453-4057qib7	4709	39	baseline	baseline	JJ
cord-005453-4057qib7	4709	40	weight	weight	NN
cord-005453-4057qib7	4709	41	.	.	.
cord-005453-4057qib7	4710	1	Therefore	therefore	RB
cord-005453-4057qib7	4710	2	,	,	,
cord-005453-4057qib7	4710	3	defibrotide	defibrotide	NNP
cord-005453-4057qib7	4710	4	was	be	VBD
cord-005453-4057qib7	4710	5	promptly	promptly	RB
cord-005453-4057qib7	4710	6	started	start	VBN
cord-005453-4057qib7	4710	7	in	in	IN
cord-005453-4057qib7	4710	8	association	association	NN
cord-005453-4057qib7	4710	9	with	with	IN
cord-005453-4057qib7	4710	10	diuretic	diuretic	JJ
cord-005453-4057qib7	4710	11	therapy	therapy	NN
cord-005453-4057qib7	4710	12	.	.	.
cord-005453-4057qib7	4711	1	The	the	DT
cord-005453-4057qib7	4711	2	treatment	treatment	NN
cord-005453-4057qib7	4711	3	was	be	VBD
cord-005453-4057qib7	4711	4	continued	continue	VBN
cord-005453-4057qib7	4711	5	for	for	IN
cord-005453-4057qib7	4711	6	3	3	CD
cord-005453-4057qib7	4711	7	weeks	week	NNS
cord-005453-4057qib7	4711	8	and	and	CC
cord-005453-4057qib7	4711	9	allowed	allow	VBD
cord-005453-4057qib7	4711	10	gradual	gradual	JJ
cord-005453-4057qib7	4711	11	restoration	restoration	NN
cord-005453-4057qib7	4711	12	of	of	IN
cord-005453-4057qib7	4711	13	the	the	DT
cord-005453-4057qib7	4711	14	water	water	NN
cord-005453-4057qib7	4711	15	balance	balance	NN
cord-005453-4057qib7	4711	16	and	and	CC
cord-005453-4057qib7	4711	17	normalization	normalization	NN
cord-005453-4057qib7	4711	18	of	of	IN
cord-005453-4057qib7	4711	19	bilirubin	bilirubin	JJ
cord-005453-4057qib7	4711	20	serum	serum	NN
cord-005453-4057qib7	4711	21	level	level	NN
cord-005453-4057qib7	4711	22	.	.	.
cord-005453-4057qib7	4712	1	At	at	IN
cord-005453-4057qib7	4712	2	the	the	DT
cord-005453-4057qib7	4712	3	last	last	JJ
cord-005453-4057qib7	4712	4	follow	follow	NN
cord-005453-4057qib7	4712	5	-	-	HYPH
cord-005453-4057qib7	4712	6	up	up	NN
cord-005453-4057qib7	4712	7	,	,	,
cord-005453-4057qib7	4712	8	6	6	CD
cord-005453-4057qib7	4712	9	months	month	NNS
cord-005453-4057qib7	4712	10	after	after	IN
cord-005453-4057qib7	4712	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4712	12	,	,	,
cord-005453-4057qib7	4712	13	the	the	DT
cord-005453-4057qib7	4712	14	patient	patient	NN
cord-005453-4057qib7	4712	15	shows	show	VBZ
cord-005453-4057qib7	4712	16	the	the	DT
cord-005453-4057qib7	4712	17	persistence	persistence	NN
cord-005453-4057qib7	4712	18	of	of	IN
cord-005453-4057qib7	4712	19	a	a	DT
cord-005453-4057qib7	4712	20	non	non	JJ
cord-005453-4057qib7	4712	21	-	-	JJ
cord-005453-4057qib7	4712	22	transfusion	transfusion	JJ
cord-005453-4057qib7	4712	23	dependent	dependent	JJ
cord-005453-4057qib7	4712	24	anemia	anemia	NN
cord-005453-4057qib7	4712	25	,	,	,
cord-005453-4057qib7	4712	26	platelets	platelet	VBZ
cord-005453-4057qib7	4712	27	80.000x10	80.000x10	CD
cord-005453-4057qib7	4712	28	^	^	SYM
cord-005453-4057qib7	4712	29	3	3	CD
cord-005453-4057qib7	4712	30	/	/	SYM
cord-005453-4057qib7	4712	31	uL	ul	NN
cord-005453-4057qib7	4712	32	,	,	,
cord-005453-4057qib7	4712	33	palpable	palpable	JJ
cord-005453-4057qib7	4712	34	spleen	spleen	NN
cord-005453-4057qib7	4712	35	4	4	CD
cord-005453-4057qib7	4712	36	cm	cm	NNS
cord-005453-4057qib7	4712	37	below	below	IN
cord-005453-4057qib7	4712	38	the	the	DT
cord-005453-4057qib7	4712	39	rib	rib	NN
cord-005453-4057qib7	4712	40	,	,	,
cord-005453-4057qib7	4712	41	>	>	XX
cord-005453-4057qib7	4712	42	95	95	CD
cord-005453-4057qib7	4712	43	%	%	NN
cord-005453-4057qib7	4712	44	allogeneic	allogeneic	NN
cord-005453-4057qib7	4712	45	chimerism	chimerism	NN
cord-005453-4057qib7	4712	46	in	in	IN
cord-005453-4057qib7	4712	47	the	the	DT
cord-005453-4057qib7	4712	48	granulocytic	granulocytic	JJ
cord-005453-4057qib7	4712	49	compartment	compartment	NN
cord-005453-4057qib7	4712	50	and	and	CC
cord-005453-4057qib7	4712	51	90	90	CD
cord-005453-4057qib7	4712	52	%	%	NN
cord-005453-4057qib7	4712	53	in	in	IN
cord-005453-4057qib7	4712	54	the	the	DT
cord-005453-4057qib7	4712	55	T	T	NNP
cord-005453-4057qib7	4712	56	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	4712	57	compartment	compartment	NN
cord-005453-4057qib7	4712	58	.	.	.
cord-005453-4057qib7	4713	1	Splanchnic	splanchnic	JJ
cord-005453-4057qib7	4713	2	thrombosis	thrombosis	NN
cord-005453-4057qib7	4713	3	is	be	VBZ
cord-005453-4057qib7	4713	4	partially	partially	RB
cord-005453-4057qib7	4713	5	recanalized	recanalize	VBN
cord-005453-4057qib7	4713	6	and	and	CC
cord-005453-4057qib7	4713	7	replaced	replace	VBN
cord-005453-4057qib7	4713	8	by	by	IN
cord-005453-4057qib7	4713	9	collateral	collateral	JJ
cord-005453-4057qib7	4713	10	circles	circle	NNS
cord-005453-4057qib7	4713	11	with	with	IN
cord-005453-4057qib7	4713	12	cavernous	cavernous	JJ
cord-005453-4057qib7	4713	13	aspects	aspect	NNS
cord-005453-4057qib7	4713	14	.	.	.
cord-005453-4057qib7	4714	1	The	the	DT
cord-005453-4057qib7	4714	2	patient	patient	NN
cord-005453-4057qib7	4714	3	is	be	VBZ
cord-005453-4057qib7	4714	4	on	on	IN
cord-005453-4057qib7	4714	5	treatment	treatment	NN
cord-005453-4057qib7	4714	6	with	with	IN
cord-005453-4057qib7	4714	7	fondaparinux	fondaparinux	NNP
cord-005453-4057qib7	4714	8	and	and	CC
cord-005453-4057qib7	4714	9	has	have	VBZ
cord-005453-4057qib7	4714	10	shown	show	VBN
cord-005453-4057qib7	4714	11	neither	neither	CC
cord-005453-4057qib7	4714	12	significant	significant	JJ
cord-005453-4057qib7	4714	13	infectious	infectious	JJ
cord-005453-4057qib7	4714	14	episodes	episode	NNS
cord-005453-4057qib7	4714	15	or	or	CC
cord-005453-4057qib7	4714	16	acute	acute	JJ
cord-005453-4057qib7	4714	17	or	or	CC
cord-005453-4057qib7	4714	18	chronic	chronic	JJ
cord-005453-4057qib7	4714	19	GvHD	gvhd	NN
cord-005453-4057qib7	4714	20	.	.	.
cord-005453-4057qib7	4715	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4715	2	:	:	:
cord-005453-4057qib7	4716	1	We	-PRON-	PRP
cord-005453-4057qib7	4716	2	conclude	conclude	VBP
cord-005453-4057qib7	4716	3	that	that	IN
cord-005453-4057qib7	4716	4	defibrotide	defibrotide	NN
cord-005453-4057qib7	4716	5	treatment	treatment	NN
cord-005453-4057qib7	4716	6	allowed	allow	VBN
cord-005453-4057qib7	4716	7	to	to	TO
cord-005453-4057qib7	4716	8	perform	perform	VB
cord-005453-4057qib7	4716	9	a	a	DT
cord-005453-4057qib7	4716	10	successfull	successfull	JJ
cord-005453-4057qib7	4716	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	4716	12	transplant	transplant	NN
cord-005453-4057qib7	4716	13	in	in	IN
cord-005453-4057qib7	4716	14	a	a	DT
cord-005453-4057qib7	4716	15	patient	patient	NN
cord-005453-4057qib7	4716	16	with	with	IN
cord-005453-4057qib7	4716	17	MF	MF	NNP
cord-005453-4057qib7	4716	18	associated	associate	VBN
cord-005453-4057qib7	4716	19	with	with	IN
cord-005453-4057qib7	4716	20	an	an	DT
cord-005453-4057qib7	4716	21	overt	overt	JJ
cord-005453-4057qib7	4716	22	picture	picture	NN
cord-005453-4057qib7	4716	23	of	of	IN
cord-005453-4057qib7	4716	24	splanchnic	splanchnic	JJ
cord-005453-4057qib7	4716	25	thrombosis	thrombosis	NN
cord-005453-4057qib7	4716	26	.	.	.
cord-005453-4057qib7	4717	1	Background	background	NN
cord-005453-4057qib7	4717	2	:	:	:
cord-005453-4057qib7	4718	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4718	2	stem	stem	NN
cord-005453-4057qib7	4718	3	cell	cell	NN
cord-005453-4057qib7	4718	4	transplantation	transplantation	NN
cord-005453-4057qib7	4718	5	(	(	-LRB-
cord-005453-4057qib7	4718	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4718	7	)	)	-RRB-
cord-005453-4057qib7	4718	8	is	be	VBZ
cord-005453-4057qib7	4718	9	associated	associate	VBN
cord-005453-4057qib7	4718	10	with	with	IN
cord-005453-4057qib7	4718	11	an	an	DT
cord-005453-4057qib7	4718	12	increased	increase	VBN
cord-005453-4057qib7	4718	13	incidence	incidence	NN
cord-005453-4057qib7	4718	14	of	of	IN
cord-005453-4057qib7	4718	15	secondary	secondary	JJ
cord-005453-4057qib7	4718	16	malignancies	malignancy	NNS
cord-005453-4057qib7	4718	17	including	include	VBG
cord-005453-4057qib7	4718	18	skin	skin	NN
cord-005453-4057qib7	4718	19	cancer	cancer	NN
cord-005453-4057qib7	4718	20	.	.	.
cord-005453-4057qib7	4719	1	Squamous	squamous	JJ
cord-005453-4057qib7	4719	2	cell	cell	NN
cord-005453-4057qib7	4719	3	carcinoma	carcinoma	NN
cord-005453-4057qib7	4719	4	(	(	-LRB-
cord-005453-4057qib7	4719	5	SCC	SCC	NNP
cord-005453-4057qib7	4719	6	)	)	-RRB-
cord-005453-4057qib7	4719	7	is	be	VBZ
cord-005453-4057qib7	4719	8	the	the	DT
cord-005453-4057qib7	4719	9	most	most	RBS
cord-005453-4057qib7	4719	10	common	common	JJ
cord-005453-4057qib7	4719	11	type	type	NN
cord-005453-4057qib7	4719	12	in	in	IN
cord-005453-4057qib7	4719	13	patients	patient	NNS
cord-005453-4057qib7	4719	14	who	who	WP
cord-005453-4057qib7	4719	15	are	be	VBP
cord-005453-4057qib7	4719	16	receiving	receive	VBG
cord-005453-4057qib7	4719	17	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4719	18	therapy	therapy	NN
cord-005453-4057qib7	4719	19	and	and	CC
cord-005453-4057qib7	4719	20	chronic	chronic	JJ
cord-005453-4057qib7	4719	21	graft	graft	NN
cord-005453-4057qib7	4719	22	-	-	HYPH
cord-005453-4057qib7	4719	23	versus	versus	IN
cord-005453-4057qib7	4719	24	-	-	HYPH
cord-005453-4057qib7	4719	25	host	host	NN
cord-005453-4057qib7	4719	26	disease	disease	NN
cord-005453-4057qib7	4719	27	(	(	-LRB-
cord-005453-4057qib7	4719	28	cGVHD	cGVHD	NNP
cord-005453-4057qib7	4719	29	)	)	-RRB-
cord-005453-4057qib7	4719	30	appears	appear	VBZ
cord-005453-4057qib7	4719	31	to	to	TO
cord-005453-4057qib7	4719	32	be	be	VB
cord-005453-4057qib7	4719	33	an	an	DT
cord-005453-4057qib7	4719	34	important	important	JJ
cord-005453-4057qib7	4719	35	risk	risk	NN
cord-005453-4057qib7	4719	36	factor	factor	NN
cord-005453-4057qib7	4719	37	for	for	IN
cord-005453-4057qib7	4719	38	its	-PRON-	PRP$
cord-005453-4057qib7	4719	39	development	development	NN
cord-005453-4057qib7	4719	40	.	.	.
cord-005453-4057qib7	4720	1	Recent	recent	JJ
cord-005453-4057qib7	4720	2	studies	study	NNS
cord-005453-4057qib7	4720	3	describe	describe	VBP
cord-005453-4057qib7	4720	4	voriconazole	voriconazole	NN
cord-005453-4057qib7	4720	5	exposure	exposure	NN
cord-005453-4057qib7	4720	6	as	as	IN
cord-005453-4057qib7	4720	7	an	an	DT
cord-005453-4057qib7	4720	8	independent	independent	JJ
cord-005453-4057qib7	4720	9	factor	factor	NN
cord-005453-4057qib7	4720	10	that	that	WDT
cord-005453-4057qib7	4720	11	may	may	MD
cord-005453-4057qib7	4720	12	contribute	contribute	VB
cord-005453-4057qib7	4720	13	to	to	IN
cord-005453-4057qib7	4720	14	this	this	DT
cord-005453-4057qib7	4720	15	increased	increase	VBN
cord-005453-4057qib7	4720	16	risk	risk	NN
cord-005453-4057qib7	4720	17	as	as	RB
cord-005453-4057qib7	4720	18	well	well	RB
cord-005453-4057qib7	4720	19	.	.	.
cord-005453-4057qib7	4721	1	In	in	IN
cord-005453-4057qib7	4721	2	our	-PRON-	PRP$
cord-005453-4057qib7	4721	3	best	good	JJS
cord-005453-4057qib7	4721	4	knowledge	knowledge	NN
cord-005453-4057qib7	4721	5	,	,	,
cord-005453-4057qib7	4721	6	no	no	DT
cord-005453-4057qib7	4721	7	cases	case	NNS
cord-005453-4057qib7	4721	8	of	of	IN
cord-005453-4057qib7	4721	9	SCC	SCC	NNP
cord-005453-4057qib7	4721	10	have	have	VBP
cord-005453-4057qib7	4721	11	been	be	VBN
cord-005453-4057qib7	4721	12	reported	report	VBN
cord-005453-4057qib7	4721	13	in	in	IN
cord-005453-4057qib7	4721	14	pediatric	pediatric	JJ
cord-005453-4057qib7	4721	15	allogeneic	allogeneic	NN
cord-005453-4057qib7	4721	16	HSCT	HSCT	NNP
cord-005453-4057qib7	4721	17	to	to	IN
cord-005453-4057qib7	4721	18	date	date	NN
cord-005453-4057qib7	4721	19	.	.	.
cord-005453-4057qib7	4722	1	Methods	method	NNS
cord-005453-4057qib7	4722	2	:	:	:
cord-005453-4057qib7	4722	3	We	-PRON-	PRP
cord-005453-4057qib7	4722	4	present	present	VBP
cord-005453-4057qib7	4722	5	a	a	DT
cord-005453-4057qib7	4722	6	case	case	NN
cord-005453-4057qib7	4722	7	report	report	NN
cord-005453-4057qib7	4722	8	of	of	IN
cord-005453-4057qib7	4722	9	a	a	DT
cord-005453-4057qib7	4722	10	9	9	CD
cord-005453-4057qib7	4722	11	year	year	NN
cord-005453-4057qib7	4722	12	-	-	HYPH
cord-005453-4057qib7	4722	13	old	old	JJ
cord-005453-4057qib7	4722	14	boy	boy	NN
cord-005453-4057qib7	4722	15	who	who	WP
cord-005453-4057qib7	4722	16	developed	develop	VBD
cord-005453-4057qib7	4722	17	a	a	DT
cord-005453-4057qib7	4722	18	SCC	SCC	NNP
cord-005453-4057qib7	4722	19	with	with	IN
cord-005453-4057qib7	4722	20	high	high	JJ
cord-005453-4057qib7	4722	21	-	-	HYPH
cord-005453-4057qib7	4722	22	risk	risk	NN
cord-005453-4057qib7	4722	23	features	feature	VBZ
cord-005453-4057qib7	4722	24	six	six	CD
cord-005453-4057qib7	4722	25	years	year	NNS
cord-005453-4057qib7	4722	26	after	after	IN
cord-005453-4057qib7	4722	27	undergoing	undergo	VBG
cord-005453-4057qib7	4722	28	hematopopoietic	hematopopoietic	JJ
cord-005453-4057qib7	4722	29	stem	stem	NN
cord-005453-4057qib7	4722	30	cell	cell	NN
cord-005453-4057qib7	4722	31	transplant	transplant	NN
cord-005453-4057qib7	4722	32	.	.	.
cord-005453-4057qib7	4723	1	Results	result	NNS
cord-005453-4057qib7	4723	2	:	:	:
cord-005453-4057qib7	4724	1	A	a	DT
cord-005453-4057qib7	4724	2	9	9	CD
cord-005453-4057qib7	4724	3	year	year	NN
cord-005453-4057qib7	4724	4	-	-	HYPH
cord-005453-4057qib7	4724	5	old	old	JJ
cord-005453-4057qib7	4724	6	boy	boy	NN
cord-005453-4057qib7	4724	7	with	with	IN
cord-005453-4057qib7	4724	8	acute	acute	JJ
cord-005453-4057qib7	4724	9	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	4724	10	leukemia	leukemia	NN
cord-005453-4057qib7	4724	11	(	(	-LRB-
cord-005453-4057qib7	4724	12	ALL	all	DT
cord-005453-4057qib7	4724	13	)	)	-RRB-
cord-005453-4057qib7	4724	14	underwent	undergo	VBD
cord-005453-4057qib7	4724	15	a	a	DT
cord-005453-4057qib7	4724	16	matched	match	VBN
cord-005453-4057qib7	4724	17	unrelated	unrelated	JJ
cord-005453-4057qib7	4724	18	bone	bone	NN
cord-005453-4057qib7	4724	19	marrow	marrow	NN
cord-005453-4057qib7	4724	20	transplant	transplant	NN
cord-005453-4057qib7	4724	21	7	7	CD
cord-005453-4057qib7	4724	22	years	year	NNS
cord-005453-4057qib7	4724	23	ago	ago	RB
cord-005453-4057qib7	4724	24	.	.	.
cord-005453-4057qib7	4725	1	He	-PRON-	PRP
cord-005453-4057qib7	4725	2	developed	develop	VBD
cord-005453-4057qib7	4725	3	grade	grade	NN
cord-005453-4057qib7	4725	4	IV	IV	NNP
cord-005453-4057qib7	4725	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	4725	6	followed	follow	VBN
cord-005453-4057qib7	4725	7	by	by	IN
cord-005453-4057qib7	4725	8	extensive	extensive	JJ
cord-005453-4057qib7	4725	9	cGVHD	cgvhd	NN
cord-005453-4057qib7	4725	10	with	with	IN
cord-005453-4057qib7	4725	11	generalized	generalized	JJ
cord-005453-4057qib7	4725	12	scleroderma	scleroderma	NNS
cord-005453-4057qib7	4725	13	.	.	.
cord-005453-4057qib7	4726	1	He	-PRON-	PRP
cord-005453-4057qib7	4726	2	required	require	VBD
cord-005453-4057qib7	4726	3	intensive	intensive	JJ
cord-005453-4057qib7	4726	4	and	and	CC
cord-005453-4057qib7	4726	5	continued	continued	JJ
cord-005453-4057qib7	4726	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4726	7	therapy	therapy	NN
cord-005453-4057qib7	4726	8	and	and	CC
cord-005453-4057qib7	4726	9	was	be	VBD
cord-005453-4057qib7	4726	10	on	on	IN
cord-005453-4057qib7	4726	11	prolonged	prolong	VBN
cord-005453-4057qib7	4726	12	antifungal	antifungal	JJ
cord-005453-4057qib7	4726	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4726	14	with	with	IN
cord-005453-4057qib7	4726	15	voriconazole	voriconazole	NNP
cord-005453-4057qib7	4726	16	.	.	.
cord-005453-4057qib7	4727	1	In	in	IN
cord-005453-4057qib7	4727	2	March	March	NNP
cord-005453-4057qib7	4727	3	2017	2017	CD
cord-005453-4057qib7	4727	4	,	,	,
cord-005453-4057qib7	4727	5	he	-PRON-	PRP
cord-005453-4057qib7	4727	6	developed	develop	VBD
cord-005453-4057qib7	4727	7	SCC	SCC	NNP
cord-005453-4057qib7	4727	8	involving	involve	VBG
cord-005453-4057qib7	4727	9	left	leave	VBN
cord-005453-4057qib7	4727	10	temporal	temporal	JJ
cord-005453-4057qib7	4727	11	region	region	NN
cord-005453-4057qib7	4727	12	that	that	WDT
cord-005453-4057qib7	4727	13	was	be	VBD
cord-005453-4057qib7	4727	14	completely	completely	RB
cord-005453-4057qib7	4727	15	excised	excise	VBN
cord-005453-4057qib7	4727	16	.	.	.
cord-005453-4057qib7	4728	1	Two	two	CD
cord-005453-4057qib7	4728	2	months	month	NNS
cord-005453-4057qib7	4728	3	later	later	RB
cord-005453-4057qib7	4728	4	,	,	,
cord-005453-4057qib7	4728	5	more	more	JJR
cord-005453-4057qib7	4728	6	lesions	lesion	NNS
cord-005453-4057qib7	4728	7	in	in	IN
cord-005453-4057qib7	4728	8	scalp	scalp	NN
cord-005453-4057qib7	4728	9	and	and	CC
cord-005453-4057qib7	4728	10	nose	nose	NN
cord-005453-4057qib7	4728	11	were	be	VBD
cord-005453-4057qib7	4728	12	noted	note	VBN
cord-005453-4057qib7	4728	13	and	and	CC
cord-005453-4057qib7	4728	14	intralesion	intralesion	NN
cord-005453-4057qib7	4728	15	treatment	treatment	NN
cord-005453-4057qib7	4728	16	with	with	IN
cord-005453-4057qib7	4728	17	methotrexate	methotrexate	NNP
cord-005453-4057qib7	4728	18	was	be	VBD
cord-005453-4057qib7	4728	19	started	start	VBN
cord-005453-4057qib7	4728	20	.	.	.
cord-005453-4057qib7	4729	1	However	however	RB
cord-005453-4057qib7	4729	2	,	,	,
cord-005453-4057qib7	4729	3	an	an	DT
cord-005453-4057qib7	4729	4	unfavorable	unfavorable	JJ
cord-005453-4057qib7	4729	5	evolution	evolution	NN
cord-005453-4057qib7	4729	6	was	be	VBD
cord-005453-4057qib7	4729	7	noted	note	VBN
cord-005453-4057qib7	4729	8	and	and	CC
cord-005453-4057qib7	4729	9	he	-PRON-	PRP
cord-005453-4057qib7	4729	10	was	be	VBD
cord-005453-4057qib7	4729	11	put	put	VBN
cord-005453-4057qib7	4729	12	on	on	IN
cord-005453-4057qib7	4729	13	systemic	systemic	JJ
cord-005453-4057qib7	4729	14	treatment	treatment	NN
cord-005453-4057qib7	4729	15	including	include	VBG
cord-005453-4057qib7	4729	16	Cisplatin	Cisplatin	NNP
cord-005453-4057qib7	4729	17	and	and	CC
cord-005453-4057qib7	4729	18	Cetuximab	Cetuximab	NNP
cord-005453-4057qib7	4729	19	receiving	receive	VBG
cord-005453-4057qib7	4729	20	the	the	DT
cord-005453-4057qib7	4729	21	whole	whole	JJ
cord-005453-4057qib7	4729	22	scheme	scheme	NN
cord-005453-4057qib7	4729	23	from	from	IN
cord-005453-4057qib7	4729	24	January	January	NNP
cord-005453-4057qib7	4729	25	to	to	IN
cord-005453-4057qib7	4729	26	March	March	NNP
cord-005453-4057qib7	4729	27	2018	2018	CD
cord-005453-4057qib7	4729	28	and	and	CC
cord-005453-4057qib7	4729	29	continuing	continue	VBG
cord-005453-4057qib7	4729	30	only	only	RB
cord-005453-4057qib7	4729	31	with	with	IN
cord-005453-4057qib7	4729	32	Cetuximab	Cetuximab	NNP
cord-005453-4057qib7	4729	33	,	,	,
cord-005453-4057qib7	4729	34	ten	ten	CD
cord-005453-4057qib7	4729	35	doses	dose	NNS
cord-005453-4057qib7	4729	36	in	in	IN
cord-005453-4057qib7	4729	37	total	total	NN
cord-005453-4057qib7	4729	38	,	,	,
cord-005453-4057qib7	4729	39	until	until	IN
cord-005453-4057qib7	4729	40	May	May	NNP
cord-005453-4057qib7	4729	41	,	,	,
cord-005453-4057qib7	4729	42	for	for	IN
cord-005453-4057qib7	4729	43	unaceptable	unaceptable	JJ
cord-005453-4057qib7	4729	44	and	and	CC
cord-005453-4057qib7	4729	45	severe	severe	JJ
cord-005453-4057qib7	4729	46	tubulopathy	tubulopathy	NNP
cord-005453-4057qib7	4729	47	that	that	WDT
cord-005453-4057qib7	4729	48	required	require	VBD
cord-005453-4057qib7	4729	49	admission	admission	NN
cord-005453-4057qib7	4729	50	at	at	IN
cord-005453-4057qib7	4729	51	the	the	DT
cord-005453-4057qib7	4729	52	hospital	hospital	NN
cord-005453-4057qib7	4729	53	in	in	IN
cord-005453-4057qib7	4729	54	several	several	JJ
cord-005453-4057qib7	4729	55	ocassions	ocassion	NNS
cord-005453-4057qib7	4729	56	.	.	.
cord-005453-4057qib7	4730	1	He	-PRON-	PRP
cord-005453-4057qib7	4730	2	achieved	achieve	VBD
cord-005453-4057qib7	4730	3	a	a	DT
cord-005453-4057qib7	4730	4	very	very	RB
cord-005453-4057qib7	4730	5	good	good	JJ
cord-005453-4057qib7	4730	6	partial	partial	JJ
cord-005453-4057qib7	4730	7	response	response	NN
cord-005453-4057qib7	4730	8	but	but	CC
cord-005453-4057qib7	4730	9	progression	progression	NN
cord-005453-4057qib7	4730	10	was	be	VBD
cord-005453-4057qib7	4730	11	noted	note	VBN
cord-005453-4057qib7	4730	12	shortly	shortly	RB
cord-005453-4057qib7	4730	13	in	in	IN
cord-005453-4057qib7	4730	14	follow	follow	NN
cord-005453-4057qib7	4730	15	up	up	RP
cord-005453-4057qib7	4730	16	.	.	.
cord-005453-4057qib7	4731	1	At	at	IN
cord-005453-4057qib7	4731	2	this	this	DT
cord-005453-4057qib7	4731	3	point	point	NN
cord-005453-4057qib7	4731	4	,	,	,
cord-005453-4057qib7	4731	5	non	non	JJ
cord-005453-4057qib7	4731	6	curative	curative	JJ
cord-005453-4057qib7	4731	7	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4731	8	options	option	NNS
cord-005453-4057qib7	4731	9	were	be	VBD
cord-005453-4057qib7	4731	10	found	find	VBN
cord-005453-4057qib7	4731	11	and	and	CC
cord-005453-4057qib7	4731	12	he	-PRON-	PRP
cord-005453-4057qib7	4731	13	was	be	VBD
cord-005453-4057qib7	4731	14	put	put	VBN
cord-005453-4057qib7	4731	15	on	on	IN
cord-005453-4057qib7	4731	16	intralesion	intralesion	NN
cord-005453-4057qib7	4731	17	methotrexate	methotrexate	NNP
cord-005453-4057qib7	4731	18	and	and	CC
cord-005453-4057qib7	4731	19	photodynamic	photodynamic	NNP
cord-005453-4057qib7	4731	20	theraphy	theraphy	NN
cord-005453-4057qib7	4731	21	in	in	IN
cord-005453-4057qib7	4731	22	a	a	DT
cord-005453-4057qib7	4731	23	weekly	weekly	JJ
cord-005453-4057qib7	4731	24	basis	basis	NN
cord-005453-4057qib7	4731	25	with	with	IN
cord-005453-4057qib7	4731	26	palliative	palliative	JJ
cord-005453-4057qib7	4731	27	intention	intention	NN
cord-005453-4057qib7	4731	28	.	.	.
cord-005453-4057qib7	4732	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	4732	2	,	,	,
cord-005453-4057qib7	4732	3	tumor	tumor	NN
cord-005453-4057qib7	4732	4	growth	growth	NN
cord-005453-4057qib7	4732	5	was	be	VBD
cord-005453-4057qib7	4732	6	fast	fast	JJ
cord-005453-4057qib7	4732	7	and	and	CC
cord-005453-4057qib7	4732	8	patient	patient	NN
cord-005453-4057qib7	4732	9	passed	pass	VBD
cord-005453-4057qib7	4732	10	away	away	RB
cord-005453-4057qib7	4732	11	in	in	IN
cord-005453-4057qib7	4732	12	August	August	NNP
cord-005453-4057qib7	4732	13	2018	2018	CD
cord-005453-4057qib7	4732	14	,	,	,
cord-005453-4057qib7	4732	15	fifteen	fifteen	CD
cord-005453-4057qib7	4732	16	months	month	NNS
cord-005453-4057qib7	4732	17	after	after	IN
cord-005453-4057qib7	4732	18	squamous	squamous	JJ
cord-005453-4057qib7	4732	19	cell	cell	NN
cord-005453-4057qib7	4732	20	carcinoma	carcinoma	NN
cord-005453-4057qib7	4732	21	diagnosis	diagnosis	NN
cord-005453-4057qib7	4732	22	,	,	,
cord-005453-4057qib7	4732	23	due	due	IN
cord-005453-4057qib7	4732	24	to	to	IN
cord-005453-4057qib7	4732	25	tumoral	tumoral	JJ
cord-005453-4057qib7	4732	26	progression	progression	NN
cord-005453-4057qib7	4732	27	.	.	.
cord-005453-4057qib7	4733	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4733	2	:	:	:
cord-005453-4057qib7	4734	1	1	1	LS
cord-005453-4057qib7	4734	2	)	)	-RRB-
cord-005453-4057qib7	4734	3	SCC	SCC	NNP
cord-005453-4057qib7	4734	4	is	be	VBZ
cord-005453-4057qib7	4734	5	a	a	DT
cord-005453-4057qib7	4734	6	rare	rare	JJ
cord-005453-4057qib7	4734	7	,	,	,
cord-005453-4057qib7	4734	8	non	non	JJ
cord-005453-4057qib7	4734	9	-	-	JJ
cord-005453-4057qib7	4734	10	previously	previously	RB
cord-005453-4057qib7	4734	11	described	describe	VBN
cord-005453-4057qib7	4734	12	,	,	,
cord-005453-4057qib7	4734	13	secondary	secondary	JJ
cord-005453-4057qib7	4734	14	malignancy	malignancy	NN
cord-005453-4057qib7	4734	15	in	in	IN
cord-005453-4057qib7	4734	16	children	child	NNS
cord-005453-4057qib7	4734	17	undergoing	undergo	VBG
cord-005453-4057qib7	4734	18	HSCT	HSCT	NNP
cord-005453-4057qib7	4734	19	.	.	.
cord-005453-4057qib7	4735	1	2	2	LS
cord-005453-4057qib7	4735	2	)	)	-RRB-
cord-005453-4057qib7	4735	3	High	high	JJ
cord-005453-4057qib7	4735	4	-	-	HYPH
cord-005453-4057qib7	4735	5	risk	risk	NN
cord-005453-4057qib7	4735	6	features	feature	VBZ
cord-005453-4057qib7	4735	7	SCC	SCC	NNP
cord-005453-4057qib7	4735	8	constitutes	constitute	VBZ
cord-005453-4057qib7	4735	9	an	an	DT
cord-005453-4057qib7	4735	10	aggresive	aggresive	JJ
cord-005453-4057qib7	4735	11	disease	disease	NN
cord-005453-4057qib7	4735	12	with	with	IN
cord-005453-4057qib7	4735	13	a	a	DT
cord-005453-4057qib7	4735	14	median	median	JJ
cord-005453-4057qib7	4735	15	overall	overall	JJ
cord-005453-4057qib7	4735	16	survival	survival	NN
cord-005453-4057qib7	4735	17	below	below	IN
cord-005453-4057qib7	4735	18	1	1	CD
cord-005453-4057qib7	4735	19	year	year	NN
cord-005453-4057qib7	4735	20	.	.	.
cord-005453-4057qib7	4736	1	3	3	LS
cord-005453-4057qib7	4736	2	)	)	-RRB-
cord-005453-4057qib7	4736	3	cGVHD	cGVHD	NNP
cord-005453-4057qib7	4736	4	appears	appear	VBZ
cord-005453-4057qib7	4736	5	to	to	TO
cord-005453-4057qib7	4736	6	be	be	VB
cord-005453-4057qib7	4736	7	an	an	DT
cord-005453-4057qib7	4736	8	important	important	JJ
cord-005453-4057qib7	4736	9	risk	risk	NN
cord-005453-4057qib7	4736	10	factor	factor	NN
cord-005453-4057qib7	4736	11	for	for	IN
cord-005453-4057qib7	4736	12	its	-PRON-	PRP$
cord-005453-4057qib7	4736	13	development	development	NN
cord-005453-4057qib7	4736	14	.	.	.
cord-005453-4057qib7	4737	1	4	4	LS
cord-005453-4057qib7	4737	2	)	)	-RRB-
cord-005453-4057qib7	4738	1	Voriconazole	Voriconazole	NNP
cord-005453-4057qib7	4738	2	induced	induced	NN
cord-005453-4057qib7	4738	3	-	-	:
cord-005453-4057qib7	4738	4	photosensitivity	photosensitivity	NN
cord-005453-4057qib7	4738	5	might	may	MD
cord-005453-4057qib7	4738	6	have	have	VB
cord-005453-4057qib7	4738	7	played	play	VBN
cord-005453-4057qib7	4738	8	a	a	DT
cord-005453-4057qib7	4738	9	role	role	NN
cord-005453-4057qib7	4738	10	.	.	.
cord-005453-4057qib7	4739	1	5	5	LS
cord-005453-4057qib7	4739	2	)	)	-RRB-
cord-005453-4057qib7	4740	1	Cisplatin	cisplatin	NN
cord-005453-4057qib7	4740	2	based	base	VBN
cord-005453-4057qib7	4740	3	regimens	regimen	NNS
cord-005453-4057qib7	4740	4	+	+	CC
cord-005453-4057qib7	4741	1	/-Cetuximab	/-Cetuximab	,
cord-005453-4057qib7	4741	2	are	be	VBP
cord-005453-4057qib7	4741	3	a	a	DT
cord-005453-4057qib7	4741	4	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4741	5	option	option	NN
cord-005453-4057qib7	4741	6	in	in	IN
cord-005453-4057qib7	4741	7	disseminated	disseminate	VBN
cord-005453-4057qib7	4741	8	and/or	and/or	CC
cord-005453-4057qib7	4741	9	high	high	JJ
cord-005453-4057qib7	4741	10	risk	risk	NN
cord-005453-4057qib7	4741	11	cases	case	NNS
cord-005453-4057qib7	4741	12	.	.	.
cord-005453-4057qib7	4742	1	As	as	IN
cord-005453-4057qib7	4742	2	outcomes	outcome	NNS
cord-005453-4057qib7	4742	3	are	be	VBP
cord-005453-4057qib7	4742	4	unsatisfactory	unsatisfactory	JJ
cord-005453-4057qib7	4742	5	in	in	IN
cord-005453-4057qib7	4742	6	these	these	DT
cord-005453-4057qib7	4742	7	cases	case	NNS
cord-005453-4057qib7	4742	8	,	,	,
cord-005453-4057qib7	4742	9	alternative	alternative	JJ
cord-005453-4057qib7	4742	10	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4742	11	options	option	NNS
cord-005453-4057qib7	4742	12	need	need	VBP
cord-005453-4057qib7	4742	13	to	to	TO
cord-005453-4057qib7	4742	14	be	be	VB
cord-005453-4057qib7	4742	15	explored	explore	VBN
cord-005453-4057qib7	4742	16	.	.	.
cord-005453-4057qib7	4743	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4743	2	Background	background	NN
cord-005453-4057qib7	4743	3	:	:	:
cord-005453-4057qib7	4743	4	Pregnancy	pregnancy	NN
cord-005453-4057qib7	4743	5	is	be	VBZ
cord-005453-4057qib7	4743	6	a	a	DT
cord-005453-4057qib7	4743	7	rare	rare	JJ
cord-005453-4057qib7	4743	8	event	event	NN
cord-005453-4057qib7	4743	9	after	after	IN
cord-005453-4057qib7	4743	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	4743	11	stem	stem	NN
cord-005453-4057qib7	4743	12	cell	cell	NN
cord-005453-4057qib7	4743	13	transplantation	transplantation	NN
cord-005453-4057qib7	4743	14	(	(	-LRB-
cord-005453-4057qib7	4743	15	SCT	SCT	NNP
cord-005453-4057qib7	4743	16	)	)	-RRB-
cord-005453-4057qib7	4743	17	for	for	IN
cord-005453-4057qib7	4743	18	acute	acute	JJ
cord-005453-4057qib7	4743	19	leukemia	leukemia	NN
cord-005453-4057qib7	4743	20	.	.	.
cord-005453-4057qib7	4744	1	Here	here	RB
cord-005453-4057qib7	4744	2	we	-PRON-	PRP
cord-005453-4057qib7	4744	3	report	report	VBP
cord-005453-4057qib7	4744	4	,	,	,
cord-005453-4057qib7	4744	5	to	to	IN
cord-005453-4057qib7	4744	6	the	the	DT
cord-005453-4057qib7	4744	7	best	good	JJS
cord-005453-4057qib7	4744	8	of	of	IN
cord-005453-4057qib7	4744	9	our	-PRON-	PRP$
cord-005453-4057qib7	4744	10	knowledge	knowledge	NN
cord-005453-4057qib7	4744	11	,	,	,
cord-005453-4057qib7	4744	12	for	for	IN
cord-005453-4057qib7	4744	13	the	the	DT
cord-005453-4057qib7	4744	14	first	first	JJ
cord-005453-4057qib7	4744	15	time	time	NN
cord-005453-4057qib7	4744	16	on	on	IN
cord-005453-4057qib7	4744	17	a	a	DT
cord-005453-4057qib7	4744	18	successful	successful	JJ
cord-005453-4057qib7	4744	19	pregnancy	pregnancy	NN
cord-005453-4057qib7	4744	20	after	after	IN
cord-005453-4057qib7	4744	21	treosulfan	treosulfan	NNP
cord-005453-4057qib7	4744	22	-	-	HYPH
cord-005453-4057qib7	4744	23	based	base	VBN
cord-005453-4057qib7	4744	24	conditioning	conditioning	NN
cord-005453-4057qib7	4744	25	.	.	.
cord-005453-4057qib7	4745	1	Methods	method	NNS
cord-005453-4057qib7	4745	2	:	:	:
cord-005453-4057qib7	4746	1	A	a	DT
cord-005453-4057qib7	4746	2	29-year	29-year	JJ
cord-005453-4057qib7	4746	3	old	old	JJ
cord-005453-4057qib7	4746	4	woman	woman	NN
cord-005453-4057qib7	4746	5	was	be	VBD
cord-005453-4057qib7	4746	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	4746	7	with	with	IN
cord-005453-4057qib7	4746	8	acute	acute	JJ
cord-005453-4057qib7	4746	9	myeloid	myeloid	NN
cord-005453-4057qib7	4746	10	leukemia	leukemia	NN
cord-005453-4057qib7	4746	11	(	(	-LRB-
cord-005453-4057qib7	4746	12	AML	AML	NNP
cord-005453-4057qib7	4746	13	)	)	-RRB-
cord-005453-4057qib7	4746	14	secondary	secondary	JJ
cord-005453-4057qib7	4746	15	to	to	IN
cord-005453-4057qib7	4746	16	chronic	chronic	JJ
cord-005453-4057qib7	4746	17	myelomonocytic	myelomonocytic	JJ
cord-005453-4057qib7	4746	18	leukemia	leukemia	NN
cord-005453-4057qib7	4746	19	in	in	IN
cord-005453-4057qib7	4746	20	July	July	NNP
cord-005453-4057qib7	4746	21	2015	2015	CD
cord-005453-4057qib7	4746	22	.	.	.
cord-005453-4057qib7	4747	1	Ovarian	ovarian	JJ
cord-005453-4057qib7	4747	2	preservation	preservation	NN
cord-005453-4057qib7	4747	3	was	be	VBD
cord-005453-4057qib7	4747	4	performed	perform	VBN
cord-005453-4057qib7	4747	5	by	by	IN
cord-005453-4057qib7	4747	6	leuprolide	leuprolide	JJ
cord-005453-4057qib7	4747	7	acetate	acetate	NN
cord-005453-4057qib7	4747	8	depot	depot	NN
cord-005453-4057qib7	4747	9	injection	injection	NN
cord-005453-4057qib7	4747	10	prior	prior	RB
cord-005453-4057qib7	4747	11	to	to	IN
cord-005453-4057qib7	4747	12	cytostatic	cytostatic	JJ
cord-005453-4057qib7	4747	13	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	4747	14	.	.	.
cord-005453-4057qib7	4748	1	Of	of	IN
cord-005453-4057qib7	4748	2	note	note	VB
cord-005453-4057qib7	4748	3	,	,	,
cord-005453-4057qib7	4748	4	no	no	DT
cord-005453-4057qib7	4748	5	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	4748	6	of	of	IN
cord-005453-4057qib7	4748	7	oocytes	oocyte	NNS
cord-005453-4057qib7	4748	8	or	or	CC
cord-005453-4057qib7	4748	9	ovarian	ovarian	JJ
cord-005453-4057qib7	4748	10	tissue	tissue	NN
cord-005453-4057qib7	4748	11	was	be	VBD
cord-005453-4057qib7	4748	12	conducted	conduct	VBN
cord-005453-4057qib7	4748	13	.	.	.
cord-005453-4057qib7	4749	1	She	-PRON-	PRP
cord-005453-4057qib7	4749	2	received	receive	VBD
cord-005453-4057qib7	4749	3	two	two	CD
cord-005453-4057qib7	4749	4	cycles	cycle	NNS
cord-005453-4057qib7	4749	5	of	of	IN
cord-005453-4057qib7	4749	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	4749	7	consisting	consist	VBG
cord-005453-4057qib7	4749	8	of	of	IN
cord-005453-4057qib7	4749	9	idarubicine	idarubicine	NNP
cord-005453-4057qib7	4749	10	(	(	-LRB-
cord-005453-4057qib7	4749	11	12mg	12mg	NNP
cord-005453-4057qib7	4749	12	/	/	SYM
cord-005453-4057qib7	4749	13	m²	m²	NNP
cord-005453-4057qib7	4749	14	on	on	IN
cord-005453-4057qib7	4749	15	day	day	NN
cord-005453-4057qib7	4749	16	1	1	CD
cord-005453-4057qib7	4749	17	-	-	SYM
cord-005453-4057qib7	4749	18	3	3	CD
cord-005453-4057qib7	4749	19	)	)	-RRB-
cord-005453-4057qib7	4749	20	and	and	CC
cord-005453-4057qib7	4749	21	cytarabine	cytarabine	NNP
cord-005453-4057qib7	4749	22	(	(	-LRB-
cord-005453-4057qib7	4749	23	1000mg	1000mg	NNP
cord-005453-4057qib7	4749	24	/	/	SYM
cord-005453-4057qib7	4749	25	m²	m²	NN
cord-005453-4057qib7	4749	26	b.i.d	b.i.d	NN
cord-005453-4057qib7	4749	27	.	.	.
cord-005453-4057qib7	4750	1	on	on	IN
cord-005453-4057qib7	4750	2	days	day	NNS
cord-005453-4057qib7	4750	3	1	1	CD
cord-005453-4057qib7	4750	4	,	,	,
cord-005453-4057qib7	4750	5	3	3	CD
cord-005453-4057qib7	4750	6	,	,	,
cord-005453-4057qib7	4750	7	5	5	CD
cord-005453-4057qib7	4750	8	and	and	CC
cord-005453-4057qib7	4750	9	7	7	CD
cord-005453-4057qib7	4750	10	)	)	-RRB-
cord-005453-4057qib7	4750	11	.	.	.
cord-005453-4057qib7	4751	1	Due	due	IN
cord-005453-4057qib7	4751	2	to	to	IN
cord-005453-4057qib7	4751	3	secondary	secondary	JJ
cord-005453-4057qib7	4751	4	origin	origin	NN
cord-005453-4057qib7	4751	5	of	of	IN
cord-005453-4057qib7	4751	6	AML	AML	NNP
cord-005453-4057qib7	4751	7	SCT	SCT	NNP
cord-005453-4057qib7	4751	8	was	be	VBD
cord-005453-4057qib7	4751	9	performed	perform	VBN
cord-005453-4057qib7	4751	10	in	in	IN
cord-005453-4057qib7	4751	11	first	first	JJ
cord-005453-4057qib7	4751	12	complete	complete	JJ
cord-005453-4057qib7	4751	13	remission	remission	NN
cord-005453-4057qib7	4751	14	of	of	IN
cord-005453-4057qib7	4751	15	AML	AML	NNP
cord-005453-4057qib7	4751	16	after	after	IN
cord-005453-4057qib7	4751	17	conditioning	condition	VBG
cord-005453-4057qib7	4751	18	with	with	IN
cord-005453-4057qib7	4751	19	treosulfan	treosulfan	NNP
cord-005453-4057qib7	4751	20	(	(	-LRB-
cord-005453-4057qib7	4751	21	14g/	14g/	CD
cord-005453-4057qib7	4751	22	m²	m²	NN
cord-005453-4057qib7	4751	23	days	day	NNS
cord-005453-4057qib7	4751	24	3	3	CD
cord-005453-4057qib7	4751	25	-	-	SYM
cord-005453-4057qib7	4751	26	5	5	CD
cord-005453-4057qib7	4751	27	)	)	-RRB-
cord-005453-4057qib7	4751	28	and	and	CC
cord-005453-4057qib7	4751	29	fludarabine	fludarabine	NNP
cord-005453-4057qib7	4751	30	(	(	-LRB-
cord-005453-4057qib7	4751	31	30mg	30mg	NNP
cord-005453-4057qib7	4751	32	/	/	SYM
cord-005453-4057qib7	4751	33	m²	m²	NN
cord-005453-4057qib7	4751	34	days	day	NNS
cord-005453-4057qib7	4751	35	1	1	CD
cord-005453-4057qib7	4751	36	-	-	SYM
cord-005453-4057qib7	4751	37	5	5	CD
cord-005453-4057qib7	4751	38	)	)	-RRB-
cord-005453-4057qib7	4751	39	.	.	.
cord-005453-4057qib7	4752	1	She	-PRON-	PRP
cord-005453-4057qib7	4752	2	received	receive	VBD
cord-005453-4057qib7	4752	3	4.94×10	4.94×10	CD
cord-005453-4057qib7	4752	4	6	6	CD
cord-005453-4057qib7	4752	5	CD34-positive	cd34-positive	CD
cord-005453-4057qib7	4752	6	cells	cell	NNS
cord-005453-4057qib7	4752	7	per	per	IN
cord-005453-4057qib7	4752	8	kilogram	kilogram	NN
cord-005453-4057qib7	4752	9	body	body	NN
cord-005453-4057qib7	4752	10	weight	weight	NN
cord-005453-4057qib7	4752	11	from	from	IN
cord-005453-4057qib7	4752	12	a	a	DT
cord-005453-4057qib7	4752	13	HLA	HLA	NNP
cord-005453-4057qib7	4752	14	-	-	HYPH
cord-005453-4057qib7	4752	15	matched	match	VBN
cord-005453-4057qib7	4752	16	unrelated	unrelated	JJ
cord-005453-4057qib7	4752	17	donor	donor	NN
cord-005453-4057qib7	4752	18	.	.	.
cord-005453-4057qib7	4753	1	Results	result	NNS
cord-005453-4057qib7	4753	2	:	:	:
cord-005453-4057qib7	4754	1	Follow	follow	VB
cord-005453-4057qib7	4754	2	-	-	HYPH
cord-005453-4057qib7	4754	3	up	up	RP
cord-005453-4057qib7	4754	4	bone	bone	NN
cord-005453-4057qib7	4754	5	marrow	marrow	NN
cord-005453-4057qib7	4754	6	aspirates	aspirate	NNS
cord-005453-4057qib7	4754	7	showed	show	VBD
cord-005453-4057qib7	4754	8	continuous	continuous	JJ
cord-005453-4057qib7	4754	9	complete	complete	JJ
cord-005453-4057qib7	4754	10	remission	remission	NN
cord-005453-4057qib7	4754	11	of	of	IN
cord-005453-4057qib7	4754	12	AML	AML	NNP
cord-005453-4057qib7	4754	13	.	.	.
cord-005453-4057qib7	4755	1	Seven	seven	CD
cord-005453-4057qib7	4755	2	months	month	NNS
cord-005453-4057qib7	4755	3	after	after	IN
cord-005453-4057qib7	4755	4	SCT	SCT	NNP
cord-005453-4057qib7	4755	5	she	-PRON-	PRP
cord-005453-4057qib7	4755	6	became	become	VBD
cord-005453-4057qib7	4755	7	pregnant	pregnant	JJ
cord-005453-4057qib7	4755	8	,	,	,
cord-005453-4057qib7	4755	9	but	but	CC
cord-005453-4057qib7	4755	10	decided	decide	VBD
cord-005453-4057qib7	4755	11	for	for	IN
cord-005453-4057qib7	4755	12	induced	induce	VBN
cord-005453-4057qib7	4755	13	abortion	abortion	NN
cord-005453-4057qib7	4755	14	.	.	.
cord-005453-4057qib7	4756	1	In	in	IN
cord-005453-4057qib7	4756	2	January	January	NNP
cord-005453-4057qib7	4756	3	2018	2018	CD
cord-005453-4057qib7	4756	4	,	,	,
cord-005453-4057qib7	4756	5	25	25	CD
cord-005453-4057qib7	4756	6	months	month	NNS
cord-005453-4057qib7	4756	7	after	after	IN
cord-005453-4057qib7	4756	8	HSCT	HSCT	NNP
cord-005453-4057qib7	4756	9	she	-PRON-	PRP
cord-005453-4057qib7	4756	10	became	become	VBD
cord-005453-4057qib7	4756	11	pregnant	pregnant	JJ
cord-005453-4057qib7	4756	12	again	again	RB
cord-005453-4057qib7	4756	13	and	and	CC
cord-005453-4057qib7	4756	14	desired	desire	VBD
cord-005453-4057qib7	4756	15	the	the	DT
cord-005453-4057qib7	4756	16	child	child	NN
cord-005453-4057qib7	4756	17	.	.	.
cord-005453-4057qib7	4757	1	Medical	medical	JJ
cord-005453-4057qib7	4757	2	examinations	examination	NNS
cord-005453-4057qib7	4757	3	were	be	VBD
cord-005453-4057qib7	4757	4	performed	perform	VBN
cord-005453-4057qib7	4757	5	monthly	monthly	RB
cord-005453-4057qib7	4757	6	on	on	IN
cord-005453-4057qib7	4757	7	an	an	DT
cord-005453-4057qib7	4757	8	outpatient	outpatient	NN
cord-005453-4057qib7	4757	9	basis	basis	NN
cord-005453-4057qib7	4757	10	in	in	IN
cord-005453-4057qib7	4757	11	stringent	stringent	JJ
cord-005453-4057qib7	4757	12	cooperation	cooperation	NN
cord-005453-4057qib7	4757	13	with	with	IN
cord-005453-4057qib7	4757	14	the	the	DT
cord-005453-4057qib7	4757	15	maternity	maternity	NN
cord-005453-4057qib7	4757	16	clinic	clinic	NN
cord-005453-4057qib7	4757	17	.	.	.
cord-005453-4057qib7	4758	1	The	the	DT
cord-005453-4057qib7	4758	2	course	course	NN
cord-005453-4057qib7	4758	3	of	of	IN
cord-005453-4057qib7	4758	4	pregnancy	pregnancy	NN
cord-005453-4057qib7	4758	5	was	be	VBD
cord-005453-4057qib7	4758	6	unremarkable	unremarkable	JJ
cord-005453-4057qib7	4758	7	,	,	,
cord-005453-4057qib7	4758	8	although	although	IN
cord-005453-4057qib7	4758	9	she	-PRON-	PRP
cord-005453-4057qib7	4758	10	was	be	VBD
cord-005453-4057qib7	4758	11	hospitalized	hospitalize	VBN
cord-005453-4057qib7	4758	12	due	due	IN
cord-005453-4057qib7	4758	13	to	to	IN
cord-005453-4057qib7	4758	14	premature	premature	JJ
cord-005453-4057qib7	4758	15	labor	labor	NN
cord-005453-4057qib7	4758	16	in	in	IN
cord-005453-4057qib7	4758	17	the	the	DT
cord-005453-4057qib7	4758	18	34	34	CD
cord-005453-4057qib7	4758	19	th	th	CD
cord-005453-4057qib7	4758	20	week	week	NN
cord-005453-4057qib7	4758	21	of	of	IN
cord-005453-4057qib7	4758	22	pregnancy	pregnancy	NN
cord-005453-4057qib7	4758	23	.	.	.
cord-005453-4057qib7	4759	1	However	however	RB
cord-005453-4057qib7	4759	2	,	,	,
cord-005453-4057qib7	4759	3	gynecological	gynecological	JJ
cord-005453-4057qib7	4759	4	examination	examination	NN
cord-005453-4057qib7	4759	5	showed	show	VBD
cord-005453-4057qib7	4759	6	no	no	DT
cord-005453-4057qib7	4759	7	clinical	clinical	JJ
cord-005453-4057qib7	4759	8	significant	significant	JJ
cord-005453-4057qib7	4759	9	findings	finding	NNS
cord-005453-4057qib7	4759	10	,	,	,
cord-005453-4057qib7	4759	11	so	so	IN
cord-005453-4057qib7	4759	12	that	that	DT
cord-005453-4057qib7	4759	13	section	section	NN
cord-005453-4057qib7	4759	14	was	be	VBD
cord-005453-4057qib7	4759	15	planned	plan	VBN
cord-005453-4057qib7	4760	1	and	and	CC
cord-005453-4057qib7	4760	2	she	-PRON-	PRP
cord-005453-4057qib7	4760	3	could	could	MD
cord-005453-4057qib7	4760	4	be	be	VB
cord-005453-4057qib7	4760	5	discharged	discharge	VBN
cord-005453-4057qib7	4760	6	again	again	RB
cord-005453-4057qib7	4760	7	.	.	.
cord-005453-4057qib7	4761	1	In	in	IN
cord-005453-4057qib7	4761	2	the	the	DT
cord-005453-4057qib7	4761	3	38	38	CD
cord-005453-4057qib7	4761	4	th	th	CD
cord-005453-4057qib7	4761	5	week	week	NN
cord-005453-4057qib7	4761	6	of	of	IN
cord-005453-4057qib7	4761	7	pregnancy	pregnancy	NN
cord-005453-4057qib7	4761	8	she	-PRON-	PRP
cord-005453-4057qib7	4761	9	gave	give	VBD
cord-005453-4057qib7	4761	10	birth	birth	NN
cord-005453-4057qib7	4761	11	to	to	IN
cord-005453-4057qib7	4761	12	a	a	DT
cord-005453-4057qib7	4761	13	healthy	healthy	JJ
cord-005453-4057qib7	4761	14	girl	girl	NN
cord-005453-4057qib7	4761	15	(	(	-LRB-
cord-005453-4057qib7	4761	16	50	50	CD
cord-005453-4057qib7	4761	17	cm	cm	NNS
cord-005453-4057qib7	4761	18	,	,	,
cord-005453-4057qib7	4761	19	2810	2810	CD
cord-005453-4057qib7	4761	20	g	g	NN
cord-005453-4057qib7	4761	21	)	)	-RRB-
cord-005453-4057qib7	4761	22	by	by	IN
cord-005453-4057qib7	4761	23	cesarean	cesarean	NN
cord-005453-4057qib7	4761	24	section	section	NN
cord-005453-4057qib7	4761	25	.	.	.
cord-005453-4057qib7	4762	1	Peripartum	Peripartum	NNP
cord-005453-4057qib7	4762	2	she	-PRON-	PRP
cord-005453-4057qib7	4762	3	developed	develop	VBD
cord-005453-4057qib7	4762	4	hypoethesia	hypoethesia	NNP
cord-005453-4057qib7	4762	5	of	of	IN
cord-005453-4057qib7	4762	6	the	the	DT
cord-005453-4057qib7	4762	7	left	left	JJ
cord-005453-4057qib7	4762	8	body	body	NN
cord-005453-4057qib7	4762	9	half	half	NN
cord-005453-4057qib7	4762	10	.	.	.
cord-005453-4057qib7	4763	1	Neurological	neurological	JJ
cord-005453-4057qib7	4763	2	examination	examination	NN
cord-005453-4057qib7	4763	3	showed	show	VBD
cord-005453-4057qib7	4763	4	no	no	DT
cord-005453-4057qib7	4763	5	abnormalities	abnormality	NNS
cord-005453-4057qib7	4763	6	and	and	CC
cord-005453-4057qib7	4763	7	she	-PRON-	PRP
cord-005453-4057qib7	4763	8	recovered	recover	VBD
cord-005453-4057qib7	4763	9	immediately	immediately	RB
cord-005453-4057qib7	4763	10	.	.	.
cord-005453-4057qib7	4764	1	There	there	EX
cord-005453-4057qib7	4764	2	were	be	VBD
cord-005453-4057qib7	4764	3	no	no	DT
cord-005453-4057qib7	4764	4	other	other	JJ
cord-005453-4057qib7	4764	5	postpartum	postpartum	NN
cord-005453-4057qib7	4764	6	complications	complication	NNS
cord-005453-4057qib7	4764	7	.	.	.
cord-005453-4057qib7	4765	1	Breastfeeding	breastfeeding	NN
cord-005453-4057qib7	4765	2	was	be	VBD
cord-005453-4057qib7	4765	3	established	establish	VBN
cord-005453-4057qib7	4765	4	but	but	CC
cord-005453-4057qib7	4765	5	additional	additional	JJ
cord-005453-4057qib7	4765	6	food	food	NN
cord-005453-4057qib7	4765	7	was	be	VBD
cord-005453-4057qib7	4765	8	necessary	necessary	JJ
cord-005453-4057qib7	4765	9	for	for	IN
cord-005453-4057qib7	4765	10	a	a	DT
cord-005453-4057qib7	4765	11	sufficient	sufficient	JJ
cord-005453-4057qib7	4765	12	nutrition	nutrition	NN
cord-005453-4057qib7	4765	13	of	of	IN
cord-005453-4057qib7	4765	14	the	the	DT
cord-005453-4057qib7	4765	15	child	child	NN
cord-005453-4057qib7	4765	16	.	.	.
cord-005453-4057qib7	4766	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4766	2	:	:	:
cord-005453-4057qib7	4767	1	This	this	DT
cord-005453-4057qib7	4767	2	case	case	NN
cord-005453-4057qib7	4767	3	of	of	IN
cord-005453-4057qib7	4767	4	successful	successful	JJ
cord-005453-4057qib7	4767	5	pregnancy	pregnancy	NN
cord-005453-4057qib7	4767	6	following	follow	VBG
cord-005453-4057qib7	4767	7	SCT	SCT	NNP
cord-005453-4057qib7	4767	8	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	4767	9	that	that	IN
cord-005453-4057qib7	4767	10	fertility	fertility	NN
cord-005453-4057qib7	4767	11	can	can	MD
cord-005453-4057qib7	4767	12	recover	recover	VB
cord-005453-4057qib7	4767	13	after	after	IN
cord-005453-4057qib7	4767	14	treosulfan	treosulfan	NNP
cord-005453-4057qib7	4767	15	-	-	HYPH
cord-005453-4057qib7	4767	16	based	base	VBN
cord-005453-4057qib7	4767	17	conditioning	conditioning	NN
cord-005453-4057qib7	4767	18	.	.	.
cord-005453-4057qib7	4768	1	However	however	RB
cord-005453-4057qib7	4768	2	,	,	,
cord-005453-4057qib7	4768	3	detailed	detailed	JJ
cord-005453-4057qib7	4768	4	studies	study	NNS
cord-005453-4057qib7	4768	5	of	of	IN
cord-005453-4057qib7	4768	6	ovarian	ovarian	JJ
cord-005453-4057qib7	4768	7	function	function	NN
cord-005453-4057qib7	4768	8	and	and	CC
cord-005453-4057qib7	4768	9	fertility	fertility	NN
cord-005453-4057qib7	4768	10	are	be	VBP
cord-005453-4057qib7	4768	11	necessary	necessary	JJ
cord-005453-4057qib7	4768	12	to	to	TO
cord-005453-4057qib7	4768	13	gain	gain	VB
cord-005453-4057qib7	4768	14	more	more	JJR
cord-005453-4057qib7	4768	15	insight	insight	NN
cord-005453-4057qib7	4768	16	into	into	IN
cord-005453-4057qib7	4768	17	the	the	DT
cord-005453-4057qib7	4768	18	risk	risk	NN
cord-005453-4057qib7	4768	19	of	of	IN
cord-005453-4057qib7	4768	20	premature	premature	JJ
cord-005453-4057qib7	4768	21	ovarian	ovarian	JJ
cord-005453-4057qib7	4768	22	failure	failure	NN
cord-005453-4057qib7	4768	23	.	.	.
cord-005453-4057qib7	4769	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4769	2	:	:	:
cord-005453-4057qib7	4769	3	Nothing	nothing	NN
cord-005453-4057qib7	4769	4	to	to	TO
cord-005453-4057qib7	4769	5	declare	declare	VB
cord-005453-4057qib7	4769	6	.	.	.
cord-005453-4057qib7	4770	1	Experimental	experimental	JJ
cord-005453-4057qib7	4770	2	stem	stem	NN
cord-005453-4057qib7	4770	3	cell	cell	NN
cord-005453-4057qib7	4770	4	transplantation	transplantation	NN
cord-005453-4057qib7	4770	5	P219	P219	VBZ
cord-005453-4057qib7	4770	6	CD19-cart	cd19-cart	CD
cord-005453-4057qib7	4770	7	therapy	therapy	NN
cord-005453-4057qib7	4770	8	before	before	IN
cord-005453-4057qib7	4770	9	allo	allo	NN
cord-005453-4057qib7	4770	10	-	-	HYPH
cord-005453-4057qib7	4770	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4770	12	in	in	IN
cord-005453-4057qib7	4770	13	children	child	NNS
cord-005453-4057qib7	4770	14	and	and	CC
cord-005453-4057qib7	4770	15	adolescents	adolescent	NNS
cord-005453-4057qib7	4770	16	patients	patient	NNS
cord-005453-4057qib7	4770	17	who	who	WP
cord-005453-4057qib7	4770	18	diagnosed	diagnose	VBD
cord-005453-4057qib7	4770	19	R	r	NN
cord-005453-4057qib7	4770	20	/	/	SYM
cord-005453-4057qib7	4770	21	R	r	NN
cord-005453-4057qib7	4770	22	B	b	NN
cord-005453-4057qib7	4770	23	-	-	,
cord-005453-4057qib7	4770	24	all	all	DT
cord-005453-4057qib7	4770	25	with	with	IN
cord-005453-4057qib7	4770	26	E2A	e2a	FW
cord-005453-4057qib7	4770	27	-	-	HYPH
cord-005453-4057qib7	4770	28	PBX1	PBX1	NNP
cord-005453-4057qib7	4770	29	Background	Background	NNP
cord-005453-4057qib7	4770	30	:	:	:
cord-005453-4057qib7	4771	1	B	b	LS
cord-005453-4057qib7	4771	2	-	-	:
cord-005453-4057qib7	4771	3	ALL	all	DT
cord-005453-4057qib7	4771	4	with	with	IN
cord-005453-4057qib7	4771	5	E2A	e2a	FW
cord-005453-4057qib7	4771	6	-	-	HYPH
cord-005453-4057qib7	4771	7	PBX1	PBX1	NNP
cord-005453-4057qib7	4771	8	in	in	IN
cord-005453-4057qib7	4771	9	children	child	NNS
cord-005453-4057qib7	4771	10	and	and	CC
cord-005453-4057qib7	4771	11	adolescents	adolescent	NNS
cord-005453-4057qib7	4771	12	is	be	VBZ
cord-005453-4057qib7	4771	13	described	describe	VBN
cord-005453-4057qib7	4771	14	with	with	IN
cord-005453-4057qib7	4771	15	favourable	favourable	JJ
cord-005453-4057qib7	4771	16	prognosis	prognosis	NN
cord-005453-4057qib7	4771	17	.	.	.
cord-005453-4057qib7	4772	1	But	but	CC
cord-005453-4057qib7	4772	2	there	there	EX
cord-005453-4057qib7	4772	3	are	be	VBP
cord-005453-4057qib7	4772	4	more	more	JJR
cord-005453-4057qib7	4772	5	than	than	IN
cord-005453-4057qib7	4772	6	10	10	CD
cord-005453-4057qib7	4772	7	%	%	NN
cord-005453-4057qib7	4772	8	patients	patient	NNS
cord-005453-4057qib7	4772	9	with	with	IN
cord-005453-4057qib7	4772	10	E2A	e2a	NN
cord-005453-4057qib7	4772	11	-	-	HYPH
cord-005453-4057qib7	4772	12	PBX1	PBX1	NNP
cord-005453-4057qib7	4772	13	diagnosed	diagnose	VBD
cord-005453-4057qib7	4772	14	as	as	IN
cord-005453-4057qib7	4772	15	relapsed	relapse	VBN
cord-005453-4057qib7	4772	16	or	or	CC
cord-005453-4057qib7	4772	17	refractory	refractory	JJ
cord-005453-4057qib7	4772	18	.	.	.
cord-005453-4057qib7	4773	1	The	the	DT
cord-005453-4057qib7	4773	2	results	result	NNS
cord-005453-4057qib7	4773	3	of	of	IN
cord-005453-4057qib7	4773	4	Allo	Allo	NNP
cord-005453-4057qib7	4773	5	-	-	HYPH
cord-005453-4057qib7	4773	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4773	7	in	in	IN
cord-005453-4057qib7	4773	8	children	child	NNS
cord-005453-4057qib7	4773	9	and	and	CC
cord-005453-4057qib7	4773	10	adolescents	adolescent	NNS
cord-005453-4057qib7	4773	11	with	with	IN
cord-005453-4057qib7	4773	12	this	this	DT
cord-005453-4057qib7	4773	13	group	group	NN
cord-005453-4057qib7	4773	14	leukemia	leukemia	NN
cord-005453-4057qib7	4773	15	in	in	IN
cord-005453-4057qib7	4773	16	our	-PRON-	PRP$
cord-005453-4057qib7	4773	17	center	center	NN
cord-005453-4057qib7	4773	18	was	be	VBD
cord-005453-4057qib7	4773	19	analyzed	analyze	VBN
cord-005453-4057qib7	4773	20	in	in	IN
cord-005453-4057qib7	4773	21	order	order	NN
cord-005453-4057qib7	4773	22	to	to	TO
cord-005453-4057qib7	4773	23	understand	understand	VB
cord-005453-4057qib7	4773	24	the	the	DT
cord-005453-4057qib7	4773	25	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4773	26	effect	effect	NN
cord-005453-4057qib7	4773	27	of	of	IN
cord-005453-4057qib7	4773	28	CD19-CART	CD19-CART	NNP
cord-005453-4057qib7	4773	29	on	on	IN
cord-005453-4057qib7	4773	30	the	the	DT
cord-005453-4057qib7	4773	31	patients	patient	NNS
cord-005453-4057qib7	4773	32	.	.	.
cord-005453-4057qib7	4774	1	Methods	method	NNS
cord-005453-4057qib7	4774	2	:	:	:
cord-005453-4057qib7	4774	3	Retrospective	retrospective	JJ
cord-005453-4057qib7	4774	4	analysis	analysis	NN
cord-005453-4057qib7	4774	5	,	,	,
cord-005453-4057qib7	4774	6	from	from	IN
cord-005453-4057qib7	4774	7	June	June	NNP
cord-005453-4057qib7	4774	8	1st	1st	NN
cord-005453-4057qib7	4774	9	,	,	,
cord-005453-4057qib7	4774	10	2012	2012	CD
cord-005453-4057qib7	4774	11	to	to	IN
cord-005453-4057qib7	4774	12	July	July	NNP
cord-005453-4057qib7	4774	13	31,2018	31,2018	NNP
cord-005453-4057qib7	4774	14	,	,	,
cord-005453-4057qib7	4774	15	all	all	DT
cord-005453-4057qib7	4774	16	children	child	NNS
cord-005453-4057qib7	4774	17	and	and	CC
cord-005453-4057qib7	4774	18	adolescents	adolescent	NNS
cord-005453-4057qib7	4774	19	diagnosed	diagnose	VBD
cord-005453-4057qib7	4774	20	relapse	relapse	NN
cord-005453-4057qib7	4774	21	or	or	CC
cord-005453-4057qib7	4774	22	refractory	refractory	JJ
cord-005453-4057qib7	4774	23	B	b	NN
cord-005453-4057qib7	4774	24	-	-	,
cord-005453-4057qib7	4774	25	ALL	all	DT
cord-005453-4057qib7	4774	26	with	with	IN
cord-005453-4057qib7	4774	27	E2A	e2a	FW
cord-005453-4057qib7	4774	28	-	-	HYPH
cord-005453-4057qib7	4774	29	PBX1	PBX1	NNP
cord-005453-4057qib7	4774	30	who	who	WP
cord-005453-4057qib7	4774	31	received	receive	VBD
cord-005453-4057qib7	4774	32	Allo	Allo	NNP
cord-005453-4057qib7	4774	33	-	-	HYPH
cord-005453-4057qib7	4774	34	HSCT	HSCT	NNP
cord-005453-4057qib7	4774	35	,	,	,
cord-005453-4057qib7	4774	36	total	total	JJ
cord-005453-4057qib7	4774	37	30	30	CD
cord-005453-4057qib7	4774	38	cases	case	NNS
cord-005453-4057qib7	4774	39	.	.	.
cord-005453-4057qib7	4775	1	All	all	DT
cord-005453-4057qib7	4775	2	patients	patient	NNS
cord-005453-4057qib7	4775	3	was	be	VBD
cord-005453-4057qib7	4775	4	divided	divide	VBN
cord-005453-4057qib7	4775	5	into	into	IN
cord-005453-4057qib7	4775	6	two	two	CD
cord-005453-4057qib7	4775	7	groups	group	NNS
cord-005453-4057qib7	4775	8	depending	depend	VBG
cord-005453-4057qib7	4775	9	on	on	IN
cord-005453-4057qib7	4775	10	whether	whether	IN
cord-005453-4057qib7	4775	11	or	or	CC
cord-005453-4057qib7	4775	12	not	not	RB
cord-005453-4057qib7	4775	13	accepted	accept	VBN
cord-005453-4057qib7	4775	14	CD19-CART	CD19-CART	NNP
cord-005453-4057qib7	4775	15	before	before	IN
cord-005453-4057qib7	4775	16	Allo	Allo	NNP
cord-005453-4057qib7	4775	17	-	-	HYPH
cord-005453-4057qib7	4775	18	HSCT	HSCT	NNP
cord-005453-4057qib7	4775	19	.	.	.
cord-005453-4057qib7	4776	1	According	accord	VBG
cord-005453-4057qib7	4776	2	to	to	IN
cord-005453-4057qib7	4776	3	FCM	FCM	NNP
cord-005453-4057qib7	4776	4	-	-	HYPH
cord-005453-4057qib7	4776	5	MRD	MRD	NNP
cord-005453-4057qib7	4776	6	and	and	CC
cord-005453-4057qib7	4776	7	E2A	e2a	JJ
cord-005453-4057qib7	4776	8	-	-	HYPH
cord-005453-4057qib7	4776	9	PBX1	PBX1	NNP
cord-005453-4057qib7	4776	10	level	level	NN
cord-005453-4057qib7	4776	11	before	before	IN
cord-005453-4057qib7	4776	12	Allo	Allo	NNP
cord-005453-4057qib7	4776	13	-	-	HYPH
cord-005453-4057qib7	4776	14	HSCT	HSCT	NNP
cord-005453-4057qib7	4776	15	,	,	,
cord-005453-4057qib7	4776	16	OS	OS	NNP
cord-005453-4057qib7	4776	17	LFS	lfs	NN
cord-005453-4057qib7	4776	18	and	and	CC
cord-005453-4057qib7	4776	19	cumulative	cumulative	JJ
cord-005453-4057qib7	4776	20	recurrence	recurrence	NN
cord-005453-4057qib7	4776	21	rate	rate	NN
cord-005453-4057qib7	4776	22	were	be	VBD
cord-005453-4057qib7	4776	23	analyzed	analyze	VBN
cord-005453-4057qib7	4776	24	.	.	.
cord-005453-4057qib7	4777	1	R	R	NNP
cord-005453-4057qib7	4777	2	3.2.0	3.2.0	CD
cord-005453-4057qib7	4777	3	was	be	VBD
cord-005453-4057qib7	4777	4	used	use	VBN
cord-005453-4057qib7	4777	5	as	as	IN
cord-005453-4057qib7	4777	6	Statistical	statistical	JJ
cord-005453-4057qib7	4777	7	analysis	analysis	NN
cord-005453-4057qib7	4777	8	software	software	NN
cord-005453-4057qib7	4777	9	.	.	.
cord-005453-4057qib7	4778	1	Results	result	NNS
cord-005453-4057qib7	4778	2	Conclusions	conclusion	NNS
cord-005453-4057qib7	4778	3	:	:	:
cord-005453-4057qib7	4778	4	1	1	CD
cord-005453-4057qib7	4778	5	.	.	.
cord-005453-4057qib7	4779	1	For	for	IN
cord-005453-4057qib7	4779	2	R	r	NN
cord-005453-4057qib7	4779	3	/	/	SYM
cord-005453-4057qib7	4779	4	R	r	NN
cord-005453-4057qib7	4779	5	B	b	NN
cord-005453-4057qib7	4779	6	-	-	,
cord-005453-4057qib7	4779	7	ALL	all	RB
cord-005453-4057qib7	4779	8	with	with	IN
cord-005453-4057qib7	4779	9	E2A	e2a	FW
cord-005453-4057qib7	4779	10	-	-	HYPH
cord-005453-4057qib7	4779	11	PBX1	PBX1	NNP
cord-005453-4057qib7	4779	12	in	in	IN
cord-005453-4057qib7	4779	13	children	child	NNS
cord-005453-4057qib7	4779	14	and	and	CC
cord-005453-4057qib7	4779	15	adolescents	adolescent	NNS
cord-005453-4057qib7	4779	16	,	,	,
cord-005453-4057qib7	4779	17	FCM	FCM	NNP
cord-005453-4057qib7	4779	18	-	-	HYPH
cord-005453-4057qib7	4779	19	MRD	MRD	NNP
cord-005453-4057qib7	4779	20	pre	pre	JJ
cord-005453-4057qib7	4779	21	-	-	NN
cord-005453-4057qib7	4779	22	transplant	transplant	NN
cord-005453-4057qib7	4779	23	has	have	VBZ
cord-005453-4057qib7	4779	24	n't	not	RB
cord-005453-4057qib7	4779	25	obvious	obvious	JJ
cord-005453-4057qib7	4779	26	effect	effect	NN
cord-005453-4057qib7	4779	27	on	on	IN
cord-005453-4057qib7	4779	28	the	the	DT
cord-005453-4057qib7	4779	29	outcome	outcome	NN
cord-005453-4057qib7	4779	30	of	of	IN
cord-005453-4057qib7	4779	31	Allo	Allo	NNP
cord-005453-4057qib7	4779	32	-	-	HYPH
cord-005453-4057qib7	4779	33	HSCT	HSCT	NNP
cord-005453-4057qib7	4779	34	,	,	,
cord-005453-4057qib7	4779	35	while	while	IN
cord-005453-4057qib7	4779	36	the	the	DT
cord-005453-4057qib7	4779	37	level	level	NN
cord-005453-4057qib7	4779	38	of	of	IN
cord-005453-4057qib7	4779	39	E2A	e2a	NN
cord-005453-4057qib7	4779	40	-	-	HYPH
cord-005453-4057qib7	4779	41	PBX1	PBX1	NNP
cord-005453-4057qib7	4779	42	has	have	VBZ
cord-005453-4057qib7	4779	43	obvious	obvious	JJ
cord-005453-4057qib7	4779	44	effect	effect	NN
cord-005453-4057qib7	4779	45	.	.	.
cord-005453-4057qib7	4780	1	The	the	DT
cord-005453-4057qib7	4780	2	out	out	NN
cord-005453-4057qib7	4780	3	come	come	NN
cord-005453-4057qib7	4780	4	of	of	IN
cord-005453-4057qib7	4780	5	E2A	e2a	NN
cord-005453-4057qib7	4780	6	-	-	HYPH
cord-005453-4057qib7	4780	7	PBX1	PBX1	NNP
cord-005453-4057qib7	4780	8	negative	negative	JJ
cord-005453-4057qib7	4780	9	group	group	NN
cord-005453-4057qib7	4780	10	was	be	VBD
cord-005453-4057qib7	4780	11	obviously	obviously	RB
cord-005453-4057qib7	4780	12	better	well	JJR
cord-005453-4057qib7	4780	13	than	than	IN
cord-005453-4057qib7	4780	14	positive	positive	JJ
cord-005453-4057qib7	4780	15	group	group	NN
cord-005453-4057qib7	4780	16	.	.	.
cord-005453-4057qib7	4781	1	2	2	LS
cord-005453-4057qib7	4781	2	.	.	.
cord-005453-4057qib7	4782	1	CD19-CART	cd19-cart	NN
cord-005453-4057qib7	4782	2	can	can	MD
cord-005453-4057qib7	4782	3	obviously	obviously	RB
cord-005453-4057qib7	4782	4	improve	improve	VB
cord-005453-4057qib7	4782	5	the	the	DT
cord-005453-4057qib7	4782	6	OS	OS	NNP
cord-005453-4057qib7	4782	7	and	and	CC
cord-005453-4057qib7	4782	8	LFS	lfs	NN
cord-005453-4057qib7	4782	9	,	,	,
cord-005453-4057qib7	4782	10	it	-PRON-	PRP
cord-005453-4057qib7	4782	11	is	be	VBZ
cord-005453-4057qib7	4782	12	mainly	mainly	RB
cord-005453-4057qib7	4782	13	because	because	IN
cord-005453-4057qib7	4782	14	of	of	IN
cord-005453-4057qib7	4782	15	CD19-CART	CD19-CART	NNP
cord-005453-4057qib7	4782	16	can	can	MD
cord-005453-4057qib7	4782	17	makes	make	VBZ
cord-005453-4057qib7	4782	18	more	more	JJR
cord-005453-4057qib7	4782	19	patients	patient	NNS
cord-005453-4057qib7	4782	20	fusion	fusion	NN
cord-005453-4057qib7	4782	21	to	to	IN
cord-005453-4057qib7	4782	22	zero	zero	CD
cord-005453-4057qib7	4782	23	.	.	.
cord-005453-4057qib7	4783	1	3	3	LS
cord-005453-4057qib7	4783	2	.	.	.
cord-005453-4057qib7	4784	1	For	for	IN
cord-005453-4057qib7	4784	2	R	r	NN
cord-005453-4057qib7	4784	3	/	/	SYM
cord-005453-4057qib7	4784	4	R	r	NN
cord-005453-4057qib7	4784	5	B	b	NN
cord-005453-4057qib7	4784	6	-	-	,
cord-005453-4057qib7	4784	7	ALL	all	RB
cord-005453-4057qib7	4784	8	with	with	IN
cord-005453-4057qib7	4784	9	E2A	e2a	FW
cord-005453-4057qib7	4784	10	-	-	HYPH
cord-005453-4057qib7	4784	11	PBX1	PBX1	NNP
cord-005453-4057qib7	4784	12	in	in	IN
cord-005453-4057qib7	4784	13	children	child	NNS
cord-005453-4057qib7	4784	14	and	and	CC
cord-005453-4057qib7	4784	15	adolescents	adolescent	NNS
cord-005453-4057qib7	4784	16	,	,	,
cord-005453-4057qib7	4784	17	if	if	IN
cord-005453-4057qib7	4784	18	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	4784	19	ca	can	MD
cord-005453-4057qib7	4784	20	n't	not	RB
cord-005453-4057qib7	4784	21	make	make	VB
cord-005453-4057qib7	4784	22	the	the	DT
cord-005453-4057qib7	4784	23	fusion	fusion	NN
cord-005453-4057qib7	4784	24	to	to	IN
cord-005453-4057qib7	4784	25	zero	zero	CD
cord-005453-4057qib7	4784	26	.	.	.
cord-005453-4057qib7	4785	1	It	-PRON-	PRP
cord-005453-4057qib7	4785	2	is	be	VBZ
cord-005453-4057qib7	4785	3	suggested	suggest	VBN
cord-005453-4057qib7	4785	4	to	to	TO
cord-005453-4057qib7	4785	5	accept	accept	VB
cord-005453-4057qib7	4785	6	CD19-CART	CD19-CART	NNP
cord-005453-4057qib7	4785	7	therapy	therapy	NN
cord-005453-4057qib7	4785	8	to	to	TO
cord-005453-4057qib7	4785	9	make	make	VB
cord-005453-4057qib7	4785	10	the	the	DT
cord-005453-4057qib7	4785	11	fusion	fusion	NN
cord-005453-4057qib7	4785	12	zero	zero	CD
cord-005453-4057qib7	4785	13	.	.	.
cord-005453-4057qib7	4786	1	It	-PRON-	PRP
cord-005453-4057qib7	4786	2	can	can	MD
cord-005453-4057qib7	4786	3	improve	improve	VB
cord-005453-4057qib7	4786	4	the	the	DT
cord-005453-4057qib7	4786	5	outcome	outcome	NN
cord-005453-4057qib7	4786	6	of	of	IN
cord-005453-4057qib7	4786	7	OS	OS	NNP
cord-005453-4057qib7	4786	8	and	and	CC
cord-005453-4057qib7	4786	9	LFS	lfs	NN
cord-005453-4057qib7	4786	10	.	.	.
cord-005453-4057qib7	4787	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4787	2	Background	background	NN
cord-005453-4057qib7	4787	3	:	:	:
cord-005453-4057qib7	4787	4	Currently	currently	RB
cord-005453-4057qib7	4787	5	,	,	,
cord-005453-4057qib7	4787	6	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	4787	7	stem	stem	NN
cord-005453-4057qib7	4787	8	cell	cell	NN
cord-005453-4057qib7	4787	9	transplantation	transplantation	NN
cord-005453-4057qib7	4787	10	(	(	-LRB-
cord-005453-4057qib7	4787	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4787	12	)	)	-RRB-
cord-005453-4057qib7	4787	13	represents	represent	VBZ
cord-005453-4057qib7	4787	14	the	the	DT
cord-005453-4057qib7	4787	15	only	only	JJ
cord-005453-4057qib7	4787	16	curative	curative	JJ
cord-005453-4057qib7	4787	17	treatment	treatment	NN
cord-005453-4057qib7	4787	18	for	for	IN
cord-005453-4057qib7	4787	19	numerous	numerous	JJ
cord-005453-4057qib7	4787	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4787	21	malignancies	malignancy	NNS
cord-005453-4057qib7	4787	22	like	like	IN
cord-005453-4057qib7	4787	23	leukemias	leukemia	NNS
cord-005453-4057qib7	4787	24	,	,	,
cord-005453-4057qib7	4787	25	immune	immune	JJ
cord-005453-4057qib7	4787	26	deficiencies	deficiency	NNS
cord-005453-4057qib7	4787	27	or	or	CC
cord-005453-4057qib7	4787	28	metabolic	metabolic	JJ
cord-005453-4057qib7	4787	29	diseases	disease	NNS
cord-005453-4057qib7	4787	30	.	.	.
cord-005453-4057qib7	4788	1	CD34	CD34	NNP
cord-005453-4057qib7	4788	2	serves	serve	VBZ
cord-005453-4057qib7	4788	3	a	a	DT
cord-005453-4057qib7	4788	4	quality	quality	NN
cord-005453-4057qib7	4788	5	marker	marker	NN
cord-005453-4057qib7	4788	6	for	for	IN
cord-005453-4057qib7	4788	7	stem	stem	NN
cord-005453-4057qib7	4788	8	cell	cell	NN
cord-005453-4057qib7	4788	9	grafts	graft	NNS
cord-005453-4057qib7	4788	10	,	,	,
cord-005453-4057qib7	4788	11	which	which	WDT
cord-005453-4057qib7	4788	12	is	be	VBZ
cord-005453-4057qib7	4788	13	not	not	RB
cord-005453-4057qib7	4788	14	solely	solely	RB
cord-005453-4057qib7	4788	15	expressed	express	VBN
cord-005453-4057qib7	4788	16	on	on	IN
cord-005453-4057qib7	4788	17	stem	stem	NN
cord-005453-4057qib7	4788	18	cells	cell	NNS
cord-005453-4057qib7	4788	19	but	but	CC
cord-005453-4057qib7	4788	20	also	also	RB
cord-005453-4057qib7	4788	21	on	on	IN
cord-005453-4057qib7	4788	22	a	a	DT
cord-005453-4057qib7	4788	23	variety	variety	NN
cord-005453-4057qib7	4788	24	of	of	IN
cord-005453-4057qib7	4788	25	progenitors	progenitor	NNS
cord-005453-4057qib7	4788	26	.	.	.
cord-005453-4057qib7	4789	1	The	the	DT
cord-005453-4057qib7	4789	2	role	role	NN
cord-005453-4057qib7	4789	3	and	and	CC
cord-005453-4057qib7	4789	4	the	the	DT
cord-005453-4057qib7	4789	5	impact	impact	NN
cord-005453-4057qib7	4789	6	of	of	IN
cord-005453-4057qib7	4789	7	these	these	DT
cord-005453-4057qib7	4789	8	subpopulations	subpopulation	NNS
cord-005453-4057qib7	4789	9	remains	remain	VBZ
cord-005453-4057qib7	4789	10	unknown	unknown	JJ
cord-005453-4057qib7	4789	11	.	.	.
cord-005453-4057qib7	4790	1	We	-PRON-	PRP
cord-005453-4057qib7	4790	2	made	make	VBD
cord-005453-4057qib7	4790	3	use	use	NN
cord-005453-4057qib7	4790	4	of	of	IN
cord-005453-4057qib7	4790	5	our	-PRON-	PRP$
cord-005453-4057qib7	4790	6	genetic	genetic	JJ
cord-005453-4057qib7	4790	7	barcode	barcode	NN
cord-005453-4057qib7	4790	8	system	system	NN
cord-005453-4057qib7	4790	9	to	to	TO
cord-005453-4057qib7	4790	10	analyze	analyze	VB
cord-005453-4057qib7	4790	11	the	the	DT
cord-005453-4057qib7	4790	12	influence	influence	NN
cord-005453-4057qib7	4790	13	and	and	CC
cord-005453-4057qib7	4790	14	contribution	contribution	NN
cord-005453-4057qib7	4790	15	during	during	IN
cord-005453-4057qib7	4790	16	reconstitution	reconstitution	NN
cord-005453-4057qib7	4790	17	on	on	IN
cord-005453-4057qib7	4790	18	a	a	DT
cord-005453-4057qib7	4790	19	clonal	clonal	JJ
cord-005453-4057qib7	4790	20	level	level	NN
cord-005453-4057qib7	4790	21	.	.	.
cord-005453-4057qib7	4791	1	Methods	method	NNS
cord-005453-4057qib7	4791	2	:	:	:
cord-005453-4057qib7	4792	1	Fluorescence	fluorescence	NN
cord-005453-4057qib7	4792	2	activated	activate	VBD
cord-005453-4057qib7	4792	3	cell	cell	NN
cord-005453-4057qib7	4792	4	sorting	sorting	NN
cord-005453-4057qib7	4792	5	(	(	-LRB-
cord-005453-4057qib7	4792	6	FACS	FACS	NNP
cord-005453-4057qib7	4792	7	)	)	-RRB-
cord-005453-4057qib7	4792	8	was	be	VBD
cord-005453-4057qib7	4792	9	used	use	VBN
cord-005453-4057qib7	4792	10	to	to	TO
cord-005453-4057qib7	4792	11	sort	sort	VB
cord-005453-4057qib7	4792	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4792	13	stem	stem	NN
cord-005453-4057qib7	4792	14	and	and	CC
cord-005453-4057qib7	4792	15	progenitor	progenitor	NN
cord-005453-4057qib7	4792	16	populations	population	NNS
cord-005453-4057qib7	4792	17	,	,	,
cord-005453-4057qib7	4792	18	namely	namely	RB
cord-005453-4057qib7	4792	19	HSCs	hscs	NN
cord-005453-4057qib7	4792	20	,	,	,
cord-005453-4057qib7	4792	21	MPPs	mpp	NNS
cord-005453-4057qib7	4792	22	,	,	,
cord-005453-4057qib7	4792	23	CMPs	cmps	NN
cord-005453-4057qib7	4792	24	and	and	CC
cord-005453-4057qib7	4792	25	CLPs	clp	NNS
cord-005453-4057qib7	4792	26	,	,	,
cord-005453-4057qib7	4792	27	which	which	WDT
cord-005453-4057qib7	4792	28	were	be	VBD
cord-005453-4057qib7	4792	29	lentivirally	lentivirally	RB
cord-005453-4057qib7	4792	30	transduced	transduce	VBN
cord-005453-4057qib7	4792	31	with	with	IN
cord-005453-4057qib7	4792	32	our	-PRON-	PRP$
cord-005453-4057qib7	4792	33	previously	previously	RB
cord-005453-4057qib7	4792	34	established	establish	VBN
cord-005453-4057qib7	4792	35	BC32	BC32	NNP
cord-005453-4057qib7	4792	36	barcoding	barcoding	NN
cord-005453-4057qib7	4792	37	system	system	NN
cord-005453-4057qib7	4792	38	.	.	.
cord-005453-4057qib7	4793	1	After	after	IN
cord-005453-4057qib7	4793	2	mixing	mix	VBG
cord-005453-4057qib7	4793	3	the	the	DT
cord-005453-4057qib7	4793	4	marked	marked	JJ
cord-005453-4057qib7	4793	5	cells	cell	NNS
cord-005453-4057qib7	4793	6	with	with	IN
cord-005453-4057qib7	4793	7	bone	bone	NN
cord-005453-4057qib7	4793	8	marrow	marrow	NN
cord-005453-4057qib7	4793	9	support	support	NN
cord-005453-4057qib7	4793	10	,	,	,
cord-005453-4057qib7	4793	11	lethally	lethally	RB
cord-005453-4057qib7	4793	12	irradiated	irradiate	VBN
cord-005453-4057qib7	4793	13	recipient	recipient	NN
cord-005453-4057qib7	4793	14	animals	animal	NNS
cord-005453-4057qib7	4793	15	were	be	VBD
cord-005453-4057qib7	4793	16	and	and	CC
cord-005453-4057qib7	4793	17	transplanted	transplant	VBN
cord-005453-4057qib7	4793	18	and	and	CC
cord-005453-4057qib7	4793	19	monitored	monitor	VBD
cord-005453-4057qib7	4793	20	over	over	IN
cord-005453-4057qib7	4793	21	16	16	CD
cord-005453-4057qib7	4793	22	weeks	week	NNS
cord-005453-4057qib7	4793	23	.	.	.
cord-005453-4057qib7	4794	1	We	-PRON-	PRP
cord-005453-4057qib7	4794	2	focused	focus	VBD
cord-005453-4057qib7	4794	3	on	on	IN
cord-005453-4057qib7	4794	4	bone	bone	NN
cord-005453-4057qib7	4794	5	marrow	marrow	NN
cord-005453-4057qib7	4794	6	,	,	,
cord-005453-4057qib7	4794	7	blood	blood	NN
cord-005453-4057qib7	4794	8	,	,	,
cord-005453-4057qib7	4794	9	spleen	spleen	NN
cord-005453-4057qib7	4794	10	and	and	CC
cord-005453-4057qib7	4794	11	thymus	thymus	NN
cord-005453-4057qib7	4794	12	,	,	,
cord-005453-4057qib7	4794	13	on	on	IN
cord-005453-4057qib7	4794	14	chosen	choose	VBN
cord-005453-4057qib7	4794	15	endpoints	endpoint	NNS
cord-005453-4057qib7	4794	16	(	(	-LRB-
cord-005453-4057qib7	4794	17	1w	1w	NNP
cord-005453-4057qib7	4794	18	,	,	,
cord-005453-4057qib7	4794	19	3w	3w	NNP
cord-005453-4057qib7	4794	20	,	,	,
cord-005453-4057qib7	4794	21	8w	8w	NNP
cord-005453-4057qib7	4794	22	,	,	,
cord-005453-4057qib7	4794	23	16w	16w	CD
cord-005453-4057qib7	4794	24	)	)	-RRB-
cord-005453-4057qib7	4794	25	and	and	CC
cord-005453-4057qib7	4794	26	samples	sample	NNS
cord-005453-4057qib7	4794	27	were	be	VBD
cord-005453-4057qib7	4794	28	used	use	VBN
cord-005453-4057qib7	4794	29	to	to	TO
cord-005453-4057qib7	4794	30	analyze	analyze	VB
cord-005453-4057qib7	4794	31	the	the	DT
cord-005453-4057qib7	4794	32	contribution	contribution	NN
cord-005453-4057qib7	4794	33	of	of	IN
cord-005453-4057qib7	4794	34	the	the	DT
cord-005453-4057qib7	4794	35	subpopulations	subpopulation	NNS
cord-005453-4057qib7	4794	36	during	during	IN
cord-005453-4057qib7	4794	37	the	the	DT
cord-005453-4057qib7	4794	38	reconstitution	reconstitution	NN
cord-005453-4057qib7	4794	39	process	process	NN
cord-005453-4057qib7	4794	40	based	base	VBN
cord-005453-4057qib7	4794	41	on	on	IN
cord-005453-4057qib7	4794	42	fluorescent	fluorescent	JJ
cord-005453-4057qib7	4794	43	protein	protein	NN
cord-005453-4057qib7	4794	44	(	(	-LRB-
cord-005453-4057qib7	4794	45	FP	FP	NNP
cord-005453-4057qib7	4794	46	)	)	-RRB-
cord-005453-4057qib7	4794	47	expression	expression	NN
cord-005453-4057qib7	4794	48	.	.	.
cord-005453-4057qib7	4795	1	To	to	TO
cord-005453-4057qib7	4795	2	investigate	investigate	VB
cord-005453-4057qib7	4795	3	the	the	DT
cord-005453-4057qib7	4795	4	clonal	clonal	JJ
cord-005453-4057qib7	4795	5	contribution	contribution	NN
cord-005453-4057qib7	4795	6	in	in	IN
cord-005453-4057qib7	4795	7	different	different	JJ
cord-005453-4057qib7	4795	8	organs	organ	NNS
cord-005453-4057qib7	4795	9	,	,	,
cord-005453-4057qib7	4795	10	we	-PRON-	PRP
cord-005453-4057qib7	4795	11	performed	perform	VBD
cord-005453-4057qib7	4795	12	next	next	JJ
cord-005453-4057qib7	4795	13	generation	generation	NN
cord-005453-4057qib7	4795	14	sequencing	sequencing	NN
cord-005453-4057qib7	4795	15	(	(	-LRB-
cord-005453-4057qib7	4795	16	NGS	NGS	NNP
cord-005453-4057qib7	4795	17	)	)	-RRB-
cord-005453-4057qib7	4795	18	and	and	CC
cord-005453-4057qib7	4795	19	frequencies	frequency	NNS
cord-005453-4057qib7	4795	20	of	of	IN
cord-005453-4057qib7	4795	21	unique	unique	JJ
cord-005453-4057qib7	4795	22	barcodes	barcode	NNS
cord-005453-4057qib7	4795	23	in	in	IN
cord-005453-4057qib7	4795	24	a	a	DT
cord-005453-4057qib7	4795	25	sample	sample	NN
cord-005453-4057qib7	4795	26	were	be	VBD
cord-005453-4057qib7	4795	27	analyzed	analyze	VBN
cord-005453-4057qib7	4795	28	by	by	IN
cord-005453-4057qib7	4795	29	bioinformatical	bioinformatical	JJ
cord-005453-4057qib7	4795	30	approaches	approach	NNS
cord-005453-4057qib7	4795	31	.	.	.
cord-005453-4057qib7	4796	1	Results	result	NNS
cord-005453-4057qib7	4796	2	:	:	:
cord-005453-4057qib7	4797	1	A	a	DT
cord-005453-4057qib7	4797	2	maximum	maximum	NN
cord-005453-4057qib7	4797	3	of	of	IN
cord-005453-4057qib7	4797	4	15	15	CD
cord-005453-4057qib7	4797	5	%	%	NN
cord-005453-4057qib7	4797	6	of	of	IN
cord-005453-4057qib7	4797	7	cells	cell	NNS
cord-005453-4057qib7	4797	8	expressed	express	VBD
cord-005453-4057qib7	4797	9	the	the	DT
cord-005453-4057qib7	4797	10	encoded	encode	VBN
cord-005453-4057qib7	4797	11	FPs	fp	NNS
cord-005453-4057qib7	4797	12	,	,	,
cord-005453-4057qib7	4797	13	which	which	WDT
cord-005453-4057qib7	4797	14	were	be	VBD
cord-005453-4057qib7	4797	15	mostly	mostly	RB
cord-005453-4057qib7	4797	16	derived	derive	VBN
cord-005453-4057qib7	4797	17	from	from	IN
cord-005453-4057qib7	4797	18	the	the	DT
cord-005453-4057qib7	4797	19	HSCs	hscs	NN
cord-005453-4057qib7	4797	20	and	and	CC
cord-005453-4057qib7	4797	21	MPPs	mpp	NNS
cord-005453-4057qib7	4797	22	.	.	.
cord-005453-4057qib7	4798	1	CMP	cmp	NN
cord-005453-4057qib7	4798	2	-	-	HYPH
cord-005453-4057qib7	4798	3	derived	derive	VBN
cord-005453-4057qib7	4798	4	cells	cell	NNS
cord-005453-4057qib7	4798	5	were	be	VBD
cord-005453-4057qib7	4798	6	only	only	RB
cord-005453-4057qib7	4798	7	detected	detect	VBN
cord-005453-4057qib7	4798	8	1	1	CD
cord-005453-4057qib7	4798	9	week	week	NN
cord-005453-4057qib7	4798	10	after	after	IN
cord-005453-4057qib7	4798	11	transplantation	transplantation	NN
cord-005453-4057qib7	4798	12	in	in	IN
cord-005453-4057qib7	4798	13	the	the	DT
cord-005453-4057qib7	4798	14	myeloid	myeloid	NN
cord-005453-4057qib7	4798	15	compartment	compartment	NN
cord-005453-4057qib7	4798	16	.	.	.
cord-005453-4057qib7	4799	1	Cells	cell	NNS
cord-005453-4057qib7	4799	2	derived	derive	VBN
cord-005453-4057qib7	4799	3	from	from	IN
cord-005453-4057qib7	4799	4	the	the	DT
cord-005453-4057qib7	4799	5	CLPs	clps	NN
cord-005453-4057qib7	4799	6	were	be	VBD
cord-005453-4057qib7	4799	7	not	not	RB
cord-005453-4057qib7	4799	8	detected	detect	VBN
cord-005453-4057qib7	4799	9	at	at	IN
cord-005453-4057qib7	4799	10	any	any	DT
cord-005453-4057qib7	4799	11	time	time	NN
cord-005453-4057qib7	4799	12	point	point	NN
cord-005453-4057qib7	4799	13	.	.	.
cord-005453-4057qib7	4800	1	We	-PRON-	PRP
cord-005453-4057qib7	4800	2	analyzed	analyze	VBD
cord-005453-4057qib7	4800	3	the	the	DT
cord-005453-4057qib7	4800	4	barcode	barcode	NN
cord-005453-4057qib7	4800	5	content	content	NN
cord-005453-4057qib7	4800	6	of	of	IN
cord-005453-4057qib7	4800	7	the	the	DT
cord-005453-4057qib7	4800	8	differently	differently	RB
cord-005453-4057qib7	4800	9	marked	marked	JJ
cord-005453-4057qib7	4800	10	cells	cell	NNS
cord-005453-4057qib7	4800	11	after	after	IN
cord-005453-4057qib7	4800	12	next	next	JJ
cord-005453-4057qib7	4800	13	-	-	HYPH
cord-005453-4057qib7	4800	14	generation	generation	NN
cord-005453-4057qib7	4800	15	-	-	HYPH
cord-005453-4057qib7	4800	16	sequencing	sequencing	NN
cord-005453-4057qib7	4800	17	.	.	.
cord-005453-4057qib7	4801	1	In	in	IN
cord-005453-4057qib7	4801	2	accordance	accordance	NN
cord-005453-4057qib7	4801	3	with	with	IN
cord-005453-4057qib7	4801	4	the	the	DT
cord-005453-4057qib7	4801	5	FACS	FACS	NNP
cord-005453-4057qib7	4801	6	data	datum	NNS
cord-005453-4057qib7	4801	7	,	,	,
cord-005453-4057qib7	4801	8	the	the	DT
cord-005453-4057qib7	4801	9	majority	majority	NN
cord-005453-4057qib7	4801	10	of	of	IN
cord-005453-4057qib7	4801	11	the	the	DT
cord-005453-4057qib7	4801	12	clones	clone	NNS
cord-005453-4057qib7	4801	13	during	during	IN
cord-005453-4057qib7	4801	14	the	the	DT
cord-005453-4057qib7	4801	15	16	16	CD
cord-005453-4057qib7	4801	16	weeks	week	NNS
cord-005453-4057qib7	4801	17	of	of	IN
cord-005453-4057qib7	4801	18	observation	observation	NN
cord-005453-4057qib7	4801	19	are	be	VBP
cord-005453-4057qib7	4801	20	derived	derive	VBN
cord-005453-4057qib7	4801	21	from	from	IN
cord-005453-4057qib7	4801	22	HSCs	hscs	NN
cord-005453-4057qib7	4801	23	and	and	CC
cord-005453-4057qib7	4801	24	MPPs	mpp	NNS
cord-005453-4057qib7	4801	25	.	.	.
cord-005453-4057qib7	4802	1	CMP	cmp	NN
cord-005453-4057qib7	4802	2	-	-	HYPH
cord-005453-4057qib7	4802	3	derived	derive	VBN
cord-005453-4057qib7	4802	4	clones	clone	NNS
cord-005453-4057qib7	4802	5	were	be	VBD
cord-005453-4057qib7	4802	6	only	only	RB
cord-005453-4057qib7	4802	7	contributing	contribute	VBG
cord-005453-4057qib7	4802	8	during	during	IN
cord-005453-4057qib7	4802	9	the	the	DT
cord-005453-4057qib7	4802	10	first	first	JJ
cord-005453-4057qib7	4802	11	weeks	week	NNS
cord-005453-4057qib7	4802	12	and	and	CC
cord-005453-4057qib7	4802	13	CLP	clp	NN
cord-005453-4057qib7	4802	14	-	-	HYPH
cord-005453-4057qib7	4802	15	derived	derive	VBN
cord-005453-4057qib7	4802	16	clones	clone	NNS
cord-005453-4057qib7	4802	17	are	be	VBP
cord-005453-4057qib7	4802	18	barely	barely	RB
cord-005453-4057qib7	4802	19	detectable	detectable	JJ
cord-005453-4057qib7	4802	20	.	.	.
cord-005453-4057qib7	4803	1	We	-PRON-	PRP
cord-005453-4057qib7	4803	2	did	do	VBD
cord-005453-4057qib7	4803	3	not	not	RB
cord-005453-4057qib7	4803	4	observe	observe	VB
cord-005453-4057qib7	4803	5	any	any	DT
cord-005453-4057qib7	4803	6	major	major	JJ
cord-005453-4057qib7	4803	7	differences	difference	NNS
cord-005453-4057qib7	4803	8	with	with	IN
cord-005453-4057qib7	4803	9	regard	regard	NN
cord-005453-4057qib7	4803	10	to	to	IN
cord-005453-4057qib7	4803	11	age	age	NN
cord-005453-4057qib7	4803	12	of	of	IN
cord-005453-4057qib7	4803	13	donor	donor	NN
cord-005453-4057qib7	4803	14	or	or	CC
cord-005453-4057qib7	4803	15	recipient	recipient	NN
cord-005453-4057qib7	4803	16	,	,	,
cord-005453-4057qib7	4803	17	despite	despite	IN
cord-005453-4057qib7	4803	18	the	the	DT
cord-005453-4057qib7	4803	19	total	total	JJ
cord-005453-4057qib7	4803	20	number	number	NN
cord-005453-4057qib7	4803	21	of	of	IN
cord-005453-4057qib7	4803	22	clones	clone	NNS
cord-005453-4057qib7	4803	23	is	be	VBZ
cord-005453-4057qib7	4803	24	higher	high	JJR
cord-005453-4057qib7	4803	25	in	in	IN
cord-005453-4057qib7	4803	26	the	the	DT
cord-005453-4057qib7	4803	27	group	group	NN
cord-005453-4057qib7	4803	28	,	,	,
cord-005453-4057qib7	4803	29	which	which	WDT
cord-005453-4057qib7	4803	30	received	receive	VBD
cord-005453-4057qib7	4803	31	the	the	DT
cord-005453-4057qib7	4803	32	"	"	``
cord-005453-4057qib7	4803	33	aged	aged	JJ
cord-005453-4057qib7	4803	34	"	"	''
cord-005453-4057qib7	4803	35	graft	graft	NN
cord-005453-4057qib7	4803	36	,	,	,
cord-005453-4057qib7	4803	37	independently	independently	RB
cord-005453-4057qib7	4803	38	from	from	IN
cord-005453-4057qib7	4803	39	the	the	DT
cord-005453-4057qib7	4803	40	transduced	transduce	VBN
cord-005453-4057qib7	4803	41	cell	cell	NN
cord-005453-4057qib7	4803	42	population	population	NN
cord-005453-4057qib7	4803	43	.	.	.
cord-005453-4057qib7	4804	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4804	2	:	:	:
cord-005453-4057qib7	4805	1	Here	here	RB
cord-005453-4057qib7	4805	2	we	-PRON-	PRP
cord-005453-4057qib7	4805	3	show	show	VBP
cord-005453-4057qib7	4805	4	the	the	DT
cord-005453-4057qib7	4805	5	suitability	suitability	NN
cord-005453-4057qib7	4805	6	of	of	IN
cord-005453-4057qib7	4805	7	our	-PRON-	PRP$
cord-005453-4057qib7	4805	8	highly	highly	RB
cord-005453-4057qib7	4805	9	complex	complex	JJ
cord-005453-4057qib7	4805	10	multi	multi	JJ
cord-005453-4057qib7	4805	11	-	-	JJ
cord-005453-4057qib7	4805	12	color	color	JJ
cord-005453-4057qib7	4805	13	barcode	barcode	NN
cord-005453-4057qib7	4805	14	system	system	NN
cord-005453-4057qib7	4805	15	to	to	TO
cord-005453-4057qib7	4805	16	study	study	VB
cord-005453-4057qib7	4805	17	the	the	DT
cord-005453-4057qib7	4805	18	clonal	clonal	JJ
cord-005453-4057qib7	4805	19	contribution	contribution	NN
cord-005453-4057qib7	4805	20	of	of	IN
cord-005453-4057qib7	4805	21	HSCs	hscs	NN
cord-005453-4057qib7	4805	22	and	and	CC
cord-005453-4057qib7	4805	23	three	three	CD
cord-005453-4057qib7	4805	24	progenitor	progenitor	NN
cord-005453-4057qib7	4805	25	populations	population	NNS
cord-005453-4057qib7	4805	26	after	after	IN
cord-005453-4057qib7	4805	27	HSCT	HSCT	NNP
cord-005453-4057qib7	4805	28	.	.	.
cord-005453-4057qib7	4806	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4806	2	results	result	NNS
cord-005453-4057qib7	4806	3	will	will	MD
cord-005453-4057qib7	4806	4	contribute	contribute	VB
cord-005453-4057qib7	4806	5	to	to	IN
cord-005453-4057qib7	4806	6	a	a	DT
cord-005453-4057qib7	4806	7	better	well	JJR
cord-005453-4057qib7	4806	8	understanding	understanding	NN
cord-005453-4057qib7	4806	9	how	how	WRB
cord-005453-4057qib7	4806	10	these	these	DT
cord-005453-4057qib7	4806	11	different	different	JJ
cord-005453-4057qib7	4806	12	populations	population	NNS
cord-005453-4057qib7	4806	13	interact	interact	VBP
cord-005453-4057qib7	4806	14	to	to	TO
cord-005453-4057qib7	4806	15	support	support	VB
cord-005453-4057qib7	4806	16	the	the	DT
cord-005453-4057qib7	4806	17	establishment	establishment	NN
cord-005453-4057qib7	4806	18	of	of	IN
cord-005453-4057qib7	4806	19	a	a	DT
cord-005453-4057qib7	4806	20	new	new	JJ
cord-005453-4057qib7	4806	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4806	22	system	system	NN
cord-005453-4057qib7	4806	23	.	.	.
cord-005453-4057qib7	4807	1	Emphasized	emphasize	VBN
cord-005453-4057qib7	4807	2	by	by	IN
cord-005453-4057qib7	4807	3	the	the	DT
cord-005453-4057qib7	4807	4	variability	variability	NN
cord-005453-4057qib7	4807	5	in	in	IN
cord-005453-4057qib7	4807	6	data	datum	NNS
cord-005453-4057qib7	4807	7	of	of	IN
cord-005453-4057qib7	4807	8	graft	graft	NN
cord-005453-4057qib7	4807	9	and	and	CC
cord-005453-4057qib7	4807	10	recipient	recipient	NN
cord-005453-4057qib7	4807	11	age	age	NN
cord-005453-4057qib7	4807	12	,	,	,
cord-005453-4057qib7	4807	13	this	this	DT
cord-005453-4057qib7	4807	14	comprehensive	comprehensive	JJ
cord-005453-4057qib7	4807	15	analysis	analysis	NN
cord-005453-4057qib7	4807	16	gives	give	VBZ
cord-005453-4057qib7	4807	17	rise	rise	NN
cord-005453-4057qib7	4807	18	to	to	IN
cord-005453-4057qib7	4807	19	an	an	DT
cord-005453-4057qib7	4807	20	impression	impression	NN
cord-005453-4057qib7	4807	21	to	to	IN
cord-005453-4057qib7	4807	22	the	the	DT
cord-005453-4057qib7	4807	23	necessity	necessity	NN
cord-005453-4057qib7	4807	24	of	of	IN
cord-005453-4057qib7	4807	25	personalized	personalized	JJ
cord-005453-4057qib7	4807	26	graft	graft	NN
cord-005453-4057qib7	4807	27	composition	composition	NN
cord-005453-4057qib7	4807	28	,	,	,
cord-005453-4057qib7	4807	29	by	by	IN
cord-005453-4057qib7	4807	30	which	which	WDT
cord-005453-4057qib7	4807	31	treatment	treatment	NN
cord-005453-4057qib7	4807	32	success	success	NN
cord-005453-4057qib7	4807	33	could	could	MD
cord-005453-4057qib7	4807	34	be	be	VB
cord-005453-4057qib7	4807	35	influenced	influence	VBN
cord-005453-4057qib7	4807	36	.	.	.
cord-005453-4057qib7	4808	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4808	2	:	:	:
cord-005453-4057qib7	4808	3	Nothing	nothing	NN
cord-005453-4057qib7	4808	4	to	to	TO
cord-005453-4057qib7	4808	5	declare	declare	VB
cord-005453-4057qib7	4808	6	Survival	survival	NN
cord-005453-4057qib7	4808	7	and	and	CC
cord-005453-4057qib7	4808	8	fate	fate	NN
cord-005453-4057qib7	4808	9	of	of	IN
cord-005453-4057qib7	4808	10	adipose	adipose	JJ
cord-005453-4057qib7	4808	11	derived	derive	VBN
cord-005453-4057qib7	4808	12	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	4808	13	stem	stem	NN
cord-005453-4057qib7	4808	14	cells	cell	NNS
cord-005453-4057qib7	4808	15	in	in	IN
cord-005453-4057qib7	4808	16	a	a	DT
cord-005453-4057qib7	4808	17	rat	rat	NN
cord-005453-4057qib7	4808	18	brain	brain	NN
cord-005453-4057qib7	4808	19	injury	injury	NN
cord-005453-4057qib7	4808	20	model	model	NN
cord-005453-4057qib7	4808	21	Background	Background	NNP
cord-005453-4057qib7	4808	22	:	:	:
cord-005453-4057qib7	4809	1	Mesenchymal	Mesenchymal	NNS
cord-005453-4057qib7	4809	2	stem	stem	VBP
cord-005453-4057qib7	4809	3	cells	cell	NNS
cord-005453-4057qib7	4809	4	have	have	VBP
cord-005453-4057qib7	4809	5	been	be	VBN
cord-005453-4057qib7	4809	6	identified	identify	VBN
cord-005453-4057qib7	4809	7	as	as	IN
cord-005453-4057qib7	4809	8	promising	promising	JJ
cord-005453-4057qib7	4809	9	candidates	candidate	NNS
cord-005453-4057qib7	4809	10	in	in	IN
cord-005453-4057qib7	4809	11	the	the	DT
cord-005453-4057qib7	4809	12	treatment	treatment	NN
cord-005453-4057qib7	4809	13	of	of	IN
cord-005453-4057qib7	4809	14	Central	central	JJ
cord-005453-4057qib7	4809	15	nervous	nervous	JJ
cord-005453-4057qib7	4809	16	System	system	NN
cord-005453-4057qib7	4809	17	(	(	-LRB-
cord-005453-4057qib7	4809	18	CNS	CNS	NNP
cord-005453-4057qib7	4809	19	)	)	-RRB-
cord-005453-4057qib7	4809	20	injury	injury	NN
cord-005453-4057qib7	4809	21	through	through	IN
cord-005453-4057qib7	4809	22	neurotrophic	neurotrophic	JJ
cord-005453-4057qib7	4809	23	support	support	NN
cord-005453-4057qib7	4809	24	and	and	CC
cord-005453-4057qib7	4809	25	immunomodulation	immunomodulation	NN
cord-005453-4057qib7	4809	26	.	.	.
cord-005453-4057qib7	4810	1	Adipose	adipose	JJ
cord-005453-4057qib7	4810	2	tissue	tissue	NN
cord-005453-4057qib7	4810	3	is	be	VBZ
cord-005453-4057qib7	4810	4	an	an	DT
cord-005453-4057qib7	4810	5	attractive	attractive	JJ
cord-005453-4057qib7	4810	6	source	source	NN
cord-005453-4057qib7	4810	7	of	of	IN
cord-005453-4057qib7	4810	8	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	4810	9	stromal	stromal	JJ
cord-005453-4057qib7	4810	10	/	/	SYM
cord-005453-4057qib7	4810	11	stem	stem	NN
cord-005453-4057qib7	4810	12	cells	cell	NNS
cord-005453-4057qib7	4810	13	(	(	-LRB-
cord-005453-4057qib7	4810	14	ASCs	ASCs	NNP
cord-005453-4057qib7	4810	15	)	)	-RRB-
cord-005453-4057qib7	4810	16	for	for	IN
cord-005453-4057qib7	4810	17	regenerative	regenerative	JJ
cord-005453-4057qib7	4810	18	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4810	19	applications	application	NNS
cord-005453-4057qib7	4810	20	because	because	IN
cord-005453-4057qib7	4810	21	they	-PRON-	PRP
cord-005453-4057qib7	4810	22	can	can	MD
cord-005453-4057qib7	4810	23	be	be	VB
cord-005453-4057qib7	4810	24	harvested	harvest	VBN
cord-005453-4057qib7	4810	25	from	from	IN
cord-005453-4057qib7	4810	26	autologous	autologous	JJ
cord-005453-4057qib7	4810	27	donors	donor	NNS
cord-005453-4057qib7	4810	28	with	with	IN
cord-005453-4057qib7	4810	29	minimally	minimally	RB
cord-005453-4057qib7	4810	30	invasive	invasive	JJ
cord-005453-4057qib7	4810	31	methods	method	NNS
cord-005453-4057qib7	4810	32	,	,	,
cord-005453-4057qib7	4810	33	can	can	MD
cord-005453-4057qib7	4810	34	be	be	VB
cord-005453-4057qib7	4810	35	rapidly	rapidly	RB
cord-005453-4057qib7	4810	36	expanded	expand	VBN
cord-005453-4057qib7	4810	37	ex	ex	FW
cord-005453-4057qib7	4810	38	vivo	vivo	FW
cord-005453-4057qib7	4810	39	,	,	,
cord-005453-4057qib7	4810	40	show	show	VBP
cord-005453-4057qib7	4810	41	low	low	JJ
cord-005453-4057qib7	4810	42	immunogenicity	immunogenicity	NN
cord-005453-4057qib7	4810	43	if	if	IN
cord-005453-4057qib7	4810	44	allogeneic	allogeneic	NN
cord-005453-4057qib7	4810	45	,	,	,
cord-005453-4057qib7	4810	46	and	and	CC
cord-005453-4057qib7	4810	47	can	can	MD
cord-005453-4057qib7	4810	48	be	be	VB
cord-005453-4057qib7	4810	49	used	use	VBN
cord-005453-4057qib7	4810	50	in	in	IN
cord-005453-4057qib7	4810	51	autologous	autologous	JJ
cord-005453-4057qib7	4810	52	or	or	CC
cord-005453-4057qib7	4810	53	heterologous	heterologous	JJ
cord-005453-4057qib7	4810	54	settings	setting	NNS
cord-005453-4057qib7	4810	55	.	.	.
cord-005453-4057qib7	4811	1	The	the	DT
cord-005453-4057qib7	4811	2	present	present	JJ
cord-005453-4057qib7	4811	3	study	study	NN
cord-005453-4057qib7	4811	4	examines	examine	VBZ
cord-005453-4057qib7	4811	5	the	the	DT
cord-005453-4057qib7	4811	6	fate	fate	NN
cord-005453-4057qib7	4811	7	and	and	CC
cord-005453-4057qib7	4811	8	effects	effect	NNS
cord-005453-4057qib7	4811	9	of	of	IN
cord-005453-4057qib7	4811	10	intracerebroventricularly	intracerebroventricularly	FW
cord-005453-4057qib7	4811	11	(	(	-LRB-
cord-005453-4057qib7	4811	12	ICV	ICV	NNP
cord-005453-4057qib7	4811	13	)	)	-RRB-
cord-005453-4057qib7	4811	14	transplanted	transplant	VBD
cord-005453-4057qib7	4811	15	ASCs	ascs	NN
cord-005453-4057qib7	4811	16	in	in	IN
cord-005453-4057qib7	4811	17	a	a	DT
cord-005453-4057qib7	4811	18	traumatic	traumatic	JJ
cord-005453-4057qib7	4811	19	brain	brain	NN
cord-005453-4057qib7	4811	20	injury	injury	NN
cord-005453-4057qib7	4811	21	(	(	-LRB-
cord-005453-4057qib7	4811	22	TBI	TBI	NNP
cord-005453-4057qib7	4811	23	)	)	-RRB-
cord-005453-4057qib7	4811	24	model	model	NN
cord-005453-4057qib7	4811	25	.	.	.
cord-005453-4057qib7	4812	1	Methods	method	NNS
cord-005453-4057qib7	4812	2	:	:	:
cord-005453-4057qib7	4812	3	ASCs	asc	NNS
cord-005453-4057qib7	4812	4	were	be	VBD
cord-005453-4057qib7	4812	5	isolated	isolate	VBN
cord-005453-4057qib7	4812	6	from	from	IN
cord-005453-4057qib7	4812	7	inguinal	inguinal	JJ
cord-005453-4057qib7	4812	8	fat	fat	JJ
cord-005453-4057qib7	4812	9	pad	pad	NN
cord-005453-4057qib7	4812	10	of	of	IN
cord-005453-4057qib7	4812	11	adult	adult	NN
cord-005453-4057qib7	4812	12	Wistar	Wistar	NNP
cord-005453-4057qib7	4812	13	rats	rat	NNS
cord-005453-4057qib7	4812	14	under	under	IN
cord-005453-4057qib7	4812	15	sterile	sterile	JJ
cord-005453-4057qib7	4812	16	conditions	condition	NNS
cord-005453-4057qib7	4812	17	and	and	CC
cord-005453-4057qib7	4812	18	cultured	cultured	JJ
cord-005453-4057qib7	4812	19	according	accord	VBG
cord-005453-4057qib7	4812	20	to	to	IN
cord-005453-4057qib7	4812	21	standard	standard	JJ
cord-005453-4057qib7	4812	22	procedures	procedure	NNS
cord-005453-4057qib7	4812	23	.	.	.
cord-005453-4057qib7	4813	1	ASCs	ASCs	NNP
cord-005453-4057qib7	4813	2	at	at	IN
cord-005453-4057qib7	4813	3	passage	passage	NN
cord-005453-4057qib7	4813	4	2	2	CD
cord-005453-4057qib7	4813	5	(	(	-LRB-
cord-005453-4057qib7	4813	6	2x10	2x10	CD
cord-005453-4057qib7	4813	7	5	5	CD
cord-005453-4057qib7	4813	8	cells	cell	NNS
cord-005453-4057qib7	4813	9	)	)	-RRB-
cord-005453-4057qib7	4813	10	were	be	VBD
cord-005453-4057qib7	4813	11	seeded	seed	VBN
cord-005453-4057qib7	4813	12	and	and	CC
cord-005453-4057qib7	4813	13	transfected	transfecte	VBN
cord-005453-4057qib7	4813	14	with	with	IN
cord-005453-4057qib7	4813	15	Sleeping	sleep	VBG
cord-005453-4057qib7	4813	16	Beauty	Beauty	NNP
cord-005453-4057qib7	4813	17	transposase	transposase	NN
cord-005453-4057qib7	4813	18	and	and	CC
cord-005453-4057qib7	4813	19	pT2	pT2	VBD
cord-005453-4057qib7	4813	20	Venus	Venus	NNP
cord-005453-4057qib7	4813	21	-	-	HYPH
cord-005453-4057qib7	4813	22	neo	neo	NNP
cord-005453-4057qib7	4813	23	R	R	NNP
cord-005453-4057qib7	4813	24	plasmids	plasmid	NNS
cord-005453-4057qib7	4813	25	.	.	.
cord-005453-4057qib7	4814	1	Selection	selection	NN
cord-005453-4057qib7	4814	2	with	with	IN
cord-005453-4057qib7	4814	3	G418	G418	NNP
cord-005453-4057qib7	4814	4	antibiotic	antibiotic	NN
cord-005453-4057qib7	4814	5	resulted	result	VBD
cord-005453-4057qib7	4814	6	in	in	IN
cord-005453-4057qib7	4814	7	the	the	DT
cord-005453-4057qib7	4814	8	generation	generation	NN
cord-005453-4057qib7	4814	9	of	of	IN
cord-005453-4057qib7	4814	10	a	a	DT
cord-005453-4057qib7	4814	11	homogeneous	homogeneous	JJ
cord-005453-4057qib7	4814	12	ASC	ASC	NNP
cord-005453-4057qib7	4814	13	population	population	NN
cord-005453-4057qib7	4814	14	which	which	WDT
cord-005453-4057qib7	4814	15	expressed	express	VBD
cord-005453-4057qib7	4814	16	fluorescent	fluorescent	JJ
cord-005453-4057qib7	4814	17	Venus	Venus	NNP
cord-005453-4057qib7	4814	18	protein	protein	NN
cord-005453-4057qib7	4814	19	for	for	IN
cord-005453-4057qib7	4814	20	several	several	JJ
cord-005453-4057qib7	4814	21	passages	passage	NNS
cord-005453-4057qib7	4814	22	,	,	,
cord-005453-4057qib7	4814	23	Phenotypic	phenotypic	JJ
cord-005453-4057qib7	4814	24	characterization	characterization	NN
cord-005453-4057qib7	4814	25	showed	show	VBD
cord-005453-4057qib7	4814	26	that	that	IN
cord-005453-4057qib7	4814	27	these	these	DT
cord-005453-4057qib7	4814	28	cells	cell	NNS
cord-005453-4057qib7	4814	29	were	be	VBD
cord-005453-4057qib7	4814	30	99.6	99.6	CD
cord-005453-4057qib7	4814	31	%	%	NN
cord-005453-4057qib7	4814	32	double	double	JJ
cord-005453-4057qib7	4814	33	positive	positive	JJ
cord-005453-4057qib7	4814	34	for	for	IN
cord-005453-4057qib7	4814	35	CD44	CD44	NNP
cord-005453-4057qib7	4814	36	and	and	CC
cord-005453-4057qib7	4814	37	CD90	CD90	NNP
cord-005453-4057qib7	4814	38	stem	stem	VBP
cord-005453-4057qib7	4814	39	cell	cell	NN
cord-005453-4057qib7	4814	40	markers	marker	NNS
cord-005453-4057qib7	4814	41	,	,	,
cord-005453-4057qib7	4814	42	verifying	verify	VBG
cord-005453-4057qib7	4814	43	their	-PRON-	PRP$
cord-005453-4057qib7	4814	44	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	4814	45	origin	origin	NN
cord-005453-4057qib7	4814	46	.	.	.
cord-005453-4057qib7	4815	1	TBI	TBI	NNP
cord-005453-4057qib7	4815	2	was	be	VBD
cord-005453-4057qib7	4815	3	induced	induce	VBN
cord-005453-4057qib7	4815	4	by	by	IN
cord-005453-4057qib7	4815	5	stereotactic	stereotactic	JJ
cord-005453-4057qib7	4815	6	surgery	surgery	NN
cord-005453-4057qib7	4815	7	under	under	IN
cord-005453-4057qib7	4815	8	deep	deep	JJ
cord-005453-4057qib7	4815	9	anaesthesia	anaesthesia	NN
cord-005453-4057qib7	4815	10	and	and	CC
cord-005453-4057qib7	4815	11	subsequently	subsequently	RB
cord-005453-4057qib7	4815	12	ICV	ICV	NNP
cord-005453-4057qib7	4815	13	transplantation	transplantation	NN
cord-005453-4057qib7	4815	14	of	of	IN
cord-005453-4057qib7	4815	15	Venus+	Venus+	NNP
cord-005453-4057qib7	4815	16	ASCs	ASCs	NNP
cord-005453-4057qib7	4815	17	was	be	VBD
cord-005453-4057qib7	4815	18	performed	perform	VBN
cord-005453-4057qib7	4815	19	on	on	IN
cord-005453-4057qib7	4815	20	adult	adult	NN
cord-005453-4057qib7	4815	21	Wistar	Wistar	NNP
cord-005453-4057qib7	4815	22	rats	rat	NNS
cord-005453-4057qib7	4815	23	.	.	.
cord-005453-4057qib7	4816	1	Normal	normal	JJ
cord-005453-4057qib7	4816	2	ASCs	asc	NNS
cord-005453-4057qib7	4816	3	-	-	HYPH
cord-005453-4057qib7	4816	4	transplanted	transplant	VBN
cord-005453-4057qib7	4816	5	and	and	CC
cord-005453-4057qib7	4816	6	TBI	TBI	NNP
cord-005453-4057qib7	4816	7	-	-	HYPH
cord-005453-4057qib7	4816	8	saline	saline	NN
cord-005453-4057qib7	4816	9	transplanted	transplant	VBN
cord-005453-4057qib7	4816	10	rats	rat	NNS
cord-005453-4057qib7	4816	11	were	be	VBD
cord-005453-4057qib7	4816	12	used	use	VBN
cord-005453-4057qib7	4816	13	as	as	IN
cord-005453-4057qib7	4816	14	controls	control	NNS
cord-005453-4057qib7	4816	15	.	.	.
cord-005453-4057qib7	4817	1	The	the	DT
cord-005453-4057qib7	4817	2	proliferation	proliferation	NN
cord-005453-4057qib7	4817	3	,	,	,
cord-005453-4057qib7	4817	4	migration	migration	NN
cord-005453-4057qib7	4817	5	,	,	,
cord-005453-4057qib7	4817	6	survival	survival	NN
cord-005453-4057qib7	4817	7	and	and	CC
cord-005453-4057qib7	4817	8	fate	fate	NN
cord-005453-4057qib7	4817	9	of	of	IN
cord-005453-4057qib7	4817	10	transplanted	transplanted	JJ
cord-005453-4057qib7	4817	11	ASCs	asc	NNS
cord-005453-4057qib7	4817	12	and	and	CC
cord-005453-4057qib7	4817	13	their	-PRON-	PRP$
cord-005453-4057qib7	4817	14	effect	effect	NN
cord-005453-4057qib7	4817	15	on	on	IN
cord-005453-4057qib7	4817	16	injury	injury	NN
cord-005453-4057qib7	4817	17	restoration	restoration	NN
cord-005453-4057qib7	4817	18	were	be	VBD
cord-005453-4057qib7	4817	19	examined	examine	VBN
cord-005453-4057qib7	4817	20	six	six	CD
cord-005453-4057qib7	4817	21	weeks	week	NNS
cord-005453-4057qib7	4817	22	post	post	NN
cord-005453-4057qib7	4817	23	transplantation	transplantation	NN
cord-005453-4057qib7	4817	24	(	(	-LRB-
cord-005453-4057qib7	4817	25	PT	PT	NNP
cord-005453-4057qib7	4817	26	)	)	-RRB-
cord-005453-4057qib7	4817	27	.	.	.
cord-005453-4057qib7	4818	1	Results	result	NNS
cord-005453-4057qib7	4818	2	:	:	:
cord-005453-4057qib7	4819	1	Six	six	CD
cord-005453-4057qib7	4819	2	weeks	week	NNS
cord-005453-4057qib7	4819	3	PT	PT	NNP
cord-005453-4057qib7	4819	4	ASCs	asc	NNS
cord-005453-4057qib7	4819	5	expressed	express	VBD
cord-005453-4057qib7	4819	6	the	the	DT
cord-005453-4057qib7	4819	7	fluorescence	fluorescence	NN
cord-005453-4057qib7	4819	8	Venus	Venus	NNP
cord-005453-4057qib7	4819	9	protein	protein	NN
cord-005453-4057qib7	4819	10	and	and	CC
cord-005453-4057qib7	4819	11	therefore	therefore	RB
cord-005453-4057qib7	4819	12	were	be	VBD
cord-005453-4057qib7	4819	13	identified	identify	VBN
cord-005453-4057qib7	4819	14	in	in	IN
cord-005453-4057qib7	4819	15	brain	brain	NN
cord-005453-4057qib7	4819	16	parenchyma	parenchyma	NN
cord-005453-4057qib7	4819	17	.	.	.
cord-005453-4057qib7	4820	1	Their	-PRON-	PRP$
cord-005453-4057qib7	4820	2	presence	presence	NN
cord-005453-4057qib7	4820	3	into	into	IN
cord-005453-4057qib7	4820	4	brain	brain	NN
cord-005453-4057qib7	4820	5	was	be	VBD
cord-005453-4057qib7	4820	6	also	also	RB
cord-005453-4057qib7	4820	7	confirmed	confirm	VBN
cord-005453-4057qib7	4820	8	by	by	IN
cord-005453-4057qib7	4820	9	Masson	Masson	NNP
cord-005453-4057qib7	4820	10	trichrome	trichrome	JJ
cord-005453-4057qib7	4820	11	staining	staining	NN
cord-005453-4057qib7	4820	12	,	,	,
cord-005453-4057qib7	4820	13	which	which	WDT
cord-005453-4057qib7	4820	14	revealed	reveal	VBD
cord-005453-4057qib7	4820	15	their	-PRON-	PRP$
cord-005453-4057qib7	4820	16	collagen	collagen	NN
cord-005453-4057qib7	4820	17	depositions	deposition	NNS
cord-005453-4057qib7	4820	18	.	.	.
cord-005453-4057qib7	4821	1	ASCs	asc	NNS
cord-005453-4057qib7	4821	2	were	be	VBD
cord-005453-4057qib7	4821	3	found	find	VBN
cord-005453-4057qib7	4821	4	in	in	IN
cord-005453-4057qib7	4821	5	lesser	less	JJR
cord-005453-4057qib7	4821	6	numbers	number	NNS
cord-005453-4057qib7	4821	7	compared	compare	VBN
cord-005453-4057qib7	4821	8	to	to	IN
cord-005453-4057qib7	4821	9	those	those	DT
cord-005453-4057qib7	4821	10	transplanted	transplant	VBN
cord-005453-4057qib7	4821	11	and	and	CC
cord-005453-4057qib7	4821	12	exhibited	exhibit	VBD
cord-005453-4057qib7	4821	13	no	no	DT
cord-005453-4057qib7	4821	14	proliferative	proliferative	JJ
cord-005453-4057qib7	4821	15	activity	activity	NN
cord-005453-4057qib7	4821	16	.	.	.
cord-005453-4057qib7	4822	1	ASCs	asc	NNS
cord-005453-4057qib7	4822	2	were	be	VBD
cord-005453-4057qib7	4822	3	found	find	VBN
cord-005453-4057qib7	4822	4	scattered	scatter	VBN
cord-005453-4057qib7	4822	5	distributed	distribute	VBN
cord-005453-4057qib7	4822	6	in	in	IN
cord-005453-4057qib7	4822	7	brain	brain	NN
cord-005453-4057qib7	4822	8	as	as	IN
cord-005453-4057qib7	4822	9	individual	individual	JJ
cord-005453-4057qib7	4822	10	cells	cell	NNS
cord-005453-4057qib7	4822	11	,	,	,
cord-005453-4057qib7	4822	12	and	and	CC
cord-005453-4057qib7	4822	13	there	there	EX
cord-005453-4057qib7	4822	14	were	be	VBD
cord-005453-4057qib7	4822	15	no	no	DT
cord-005453-4057qib7	4822	16	aggregates	aggregate	NNS
cord-005453-4057qib7	4822	17	of	of	IN
cord-005453-4057qib7	4822	18	ASCs	asc	NNS
cord-005453-4057qib7	4822	19	or	or	CC
cord-005453-4057qib7	4822	20	mass	mass	JJ
cord-005453-4057qib7	4822	21	formation	formation	NN
cord-005453-4057qib7	4822	22	into	into	IN
cord-005453-4057qib7	4822	23	lateral	lateral	JJ
cord-005453-4057qib7	4822	24	ventricles	ventricle	NNS
cord-005453-4057qib7	4822	25	.	.	.
cord-005453-4057qib7	4823	1	Extensive	extensive	JJ
cord-005453-4057qib7	4823	2	migration	migration	NN
cord-005453-4057qib7	4823	3	of	of	IN
cord-005453-4057qib7	4823	4	ASCs	ascs	NN
cord-005453-4057qib7	4823	5	was	be	VBD
cord-005453-4057qib7	4823	6	mainly	mainly	RB
cord-005453-4057qib7	4823	7	performed	perform	VBN
cord-005453-4057qib7	4823	8	through	through	IN
cord-005453-4057qib7	4823	9	white	white	JJ
cord-005453-4057qib7	4823	10	matter	matter	NN
cord-005453-4057qib7	4823	11	tracks	track	NNS
cord-005453-4057qib7	4823	12	in	in	IN
cord-005453-4057qib7	4823	13	the	the	DT
cord-005453-4057qib7	4823	14	corpus	corpus	NNP
cord-005453-4057qib7	4823	15	callosum	callosum	NNP
cord-005453-4057qib7	4823	16	and	and	CC
cord-005453-4057qib7	4823	17	fimbria	fimbria	NNP
cord-005453-4057qib7	4823	18	of	of	IN
cord-005453-4057qib7	4823	19	hippocampus	hippocampus	NNP
cord-005453-4057qib7	4823	20	.	.	.
cord-005453-4057qib7	4824	1	Six	six	CD
cord-005453-4057qib7	4824	2	weeks	week	NNS
cord-005453-4057qib7	4824	3	PT	PT	NNP
cord-005453-4057qib7	4824	4	ASCs	asc	NNS
cord-005453-4057qib7	4824	5	retained	retain	VBD
cord-005453-4057qib7	4824	6	the	the	DT
cord-005453-4057qib7	4824	7	characteristics	characteristic	NNS
cord-005453-4057qib7	4824	8	of	of	IN
cord-005453-4057qib7	4824	9	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	4824	10	cells	cell	NNS
cord-005453-4057qib7	4824	11	and	and	CC
cord-005453-4057qib7	4824	12	did	do	VBD
cord-005453-4057qib7	4824	13	not	not	RB
cord-005453-4057qib7	4824	14	differentiate	differentiate	VB
cord-005453-4057qib7	4824	15	into	into	IN
cord-005453-4057qib7	4824	16	cells	cell	NNS
cord-005453-4057qib7	4824	17	of	of	IN
cord-005453-4057qib7	4824	18	neural	neural	JJ
cord-005453-4057qib7	4824	19	lineage	lineage	NN
cord-005453-4057qib7	4824	20	.	.	.
cord-005453-4057qib7	4825	1	ASCs	ASCs	NNP
cord-005453-4057qib7	4825	2	exhibited	exhibit	VBD
cord-005453-4057qib7	4825	3	limited	limited	JJ
cord-005453-4057qib7	4825	4	long	long	JJ
cord-005453-4057qib7	4825	5	-	-	HYPH
cord-005453-4057qib7	4825	6	term	term	NN
cord-005453-4057qib7	4825	7	survival	survival	NN
cord-005453-4057qib7	4825	8	,	,	,
cord-005453-4057qib7	4825	9	which	which	WDT
cord-005453-4057qib7	4825	10	is	be	VBZ
cord-005453-4057qib7	4825	11	restricted	restrict	VBN
cord-005453-4057qib7	4825	12	in	in	IN
cord-005453-4057qib7	4825	13	perivascular	perivascular	JJ
cord-005453-4057qib7	4825	14	areas	area	NNS
cord-005453-4057qib7	4825	15	probably	probably	RB
cord-005453-4057qib7	4825	16	contributing	contribute	VBG
cord-005453-4057qib7	4825	17	to	to	IN
cord-005453-4057qib7	4825	18	vascular	vascular	JJ
cord-005453-4057qib7	4825	19	formation	formation	NN
cord-005453-4057qib7	4825	20	.	.	.
cord-005453-4057qib7	4826	1	Homing	homing	NN
cord-005453-4057qib7	4826	2	of	of	IN
cord-005453-4057qib7	4826	3	ASCs	ascs	NN
cord-005453-4057qib7	4826	4	into	into	IN
cord-005453-4057qib7	4826	5	peri	peri	NN
cord-005453-4057qib7	4826	6	-	-	HYPH
cord-005453-4057qib7	4826	7	injured	injured	JJ
cord-005453-4057qib7	4826	8	area	area	NN
cord-005453-4057qib7	4826	9	was	be	VBD
cord-005453-4057qib7	4826	10	detected	detect	VBN
cord-005453-4057qib7	4826	11	in	in	IN
cord-005453-4057qib7	4826	12	half	half	NN
cord-005453-4057qib7	4826	13	of	of	IN
cord-005453-4057qib7	4826	14	the	the	DT
cord-005453-4057qib7	4826	15	animals	animal	NNS
cord-005453-4057qib7	4826	16	and	and	CC
cord-005453-4057qib7	4826	17	achieved	achieve	VBN
cord-005453-4057qib7	4826	18	through	through	IN
cord-005453-4057qib7	4826	19	the	the	DT
cord-005453-4057qib7	4826	20	corpus	corpus	NNP
cord-005453-4057qib7	4826	21	callosum	callosum	NNP
cord-005453-4057qib7	4826	22	,	,	,
cord-005453-4057qib7	4826	23	as	as	IN
cord-005453-4057qib7	4826	24	revealed	reveal	VBN
cord-005453-4057qib7	4826	25	by	by	IN
cord-005453-4057qib7	4826	26	the	the	DT
cord-005453-4057qib7	4826	27	collagen	collagen	NN
cord-005453-4057qib7	4826	28	depositions	deposition	NNS
cord-005453-4057qib7	4826	29	,	,	,
cord-005453-4057qib7	4826	30	in	in	IN
cord-005453-4057qib7	4826	31	this	this	DT
cord-005453-4057qib7	4826	32	white	white	JJ
cord-005453-4057qib7	4826	33	matter	matter	NN
cord-005453-4057qib7	4826	34	track	track	NN
cord-005453-4057qib7	4826	35	.	.	.
cord-005453-4057qib7	4827	1	Transplanted	transplanted	JJ
cord-005453-4057qib7	4827	2	ASCs	ASCs	NNP
cord-005453-4057qib7	4827	3	reduced	reduce	VBD
cord-005453-4057qib7	4827	4	the	the	DT
cord-005453-4057qib7	4827	5	area	area	NN
cord-005453-4057qib7	4827	6	of	of	IN
cord-005453-4057qib7	4827	7	TBI	TBI	NNP
cord-005453-4057qib7	4827	8	cavity	cavity	NN
cord-005453-4057qib7	4827	9	and	and	CC
cord-005453-4057qib7	4827	10	did	do	VBD
cord-005453-4057qib7	4827	11	not	not	RB
cord-005453-4057qib7	4827	12	enhance	enhance	VB
cord-005453-4057qib7	4827	13	the	the	DT
cord-005453-4057qib7	4827	14	astroglial	astroglial	JJ
cord-005453-4057qib7	4827	15	scarring	scarring	NN
cord-005453-4057qib7	4827	16	in	in	IN
cord-005453-4057qib7	4827	17	peri	peri	NN
cord-005453-4057qib7	4827	18	-	-	HYPH
cord-005453-4057qib7	4827	19	injured	injured	JJ
cord-005453-4057qib7	4827	20	area	area	NN
cord-005453-4057qib7	4827	21	.	.	.
cord-005453-4057qib7	4828	1	In	in	IN
cord-005453-4057qib7	4828	2	TBI	TBI	NNP
cord-005453-4057qib7	4828	3	+	+	CC
cord-005453-4057qib7	4828	4	ASCs	asc	NNS
cord-005453-4057qib7	4828	5	transplanted	transplant	VBN
cord-005453-4057qib7	4828	6	animals	animal	NNS
cord-005453-4057qib7	4828	7	,	,	,
cord-005453-4057qib7	4828	8	the	the	DT
cord-005453-4057qib7	4828	9	cortical	cortical	JJ
cord-005453-4057qib7	4828	10	injury	injury	NN
cord-005453-4057qib7	4828	11	site	site	NN
cord-005453-4057qib7	4828	12	,	,	,
cord-005453-4057qib7	4828	13	showed	show	VBD
cord-005453-4057qib7	4828	14	a	a	DT
cord-005453-4057qib7	4828	15	significantly	significantly	RB
cord-005453-4057qib7	4828	16	smaller	small	JJR
cord-005453-4057qib7	4828	17	volume	volume	NN
cord-005453-4057qib7	4828	18	and	and	CC
cord-005453-4057qib7	4828	19	lower	low	JJR
cord-005453-4057qib7	4828	20	%	%	NN
cord-005453-4057qib7	4828	21	tissue	tissue	NN
cord-005453-4057qib7	4828	22	loss	loss	NN
cord-005453-4057qib7	4828	23	compared	compare	VBN
cord-005453-4057qib7	4828	24	to	to	IN
cord-005453-4057qib7	4828	25	that	that	DT
cord-005453-4057qib7	4828	26	of	of	IN
cord-005453-4057qib7	4828	27	TBI+vehicle	TBI+vehicle	NNP
cord-005453-4057qib7	4828	28	animals	animal	NNS
cord-005453-4057qib7	4828	29	(	(	-LRB-
cord-005453-4057qib7	4828	30	1.90	1.90	CD
cord-005453-4057qib7	4828	31	±0.38	±0.38	NN
cord-005453-4057qib7	4828	32	mm	mm	NNP
cord-005453-4057qib7	4828	33	3	3	CD
cord-005453-4057qib7	4828	34	and	and	CC
cord-005453-4057qib7	4828	35	12.25±2.83	12.25±2.83	CD
cord-005453-4057qib7	4828	36	%	%	NN
cord-005453-4057qib7	4828	37	respectively	respectively	RB
cord-005453-4057qib7	4828	38	,	,	,
cord-005453-4057qib7	4828	39	versus	versus	IN
cord-005453-4057qib7	4828	40	1.12	1.12	CD
cord-005453-4057qib7	4828	41	±0.34	±0.34	NN
cord-005453-4057qib7	4828	42	mm	mm	NNP
cord-005453-4057qib7	4828	43	3	3	CD
cord-005453-4057qib7	4828	44	and	and	CC
cord-005453-4057qib7	4828	45	6.57±1.67	6.57±1.67	CD
cord-005453-4057qib7	4828	46	%	%	NN
cord-005453-4057qib7	4828	47	,	,	,
cord-005453-4057qib7	4828	48	P=0.015	P=0.015	NNP
cord-005453-4057qib7	4828	49	and	and	CC
cord-005453-4057qib7	4828	50	P=0.019	P=0.019	NNP
cord-005453-4057qib7	4828	51	respectively	respectively	RB
cord-005453-4057qib7	4828	52	)	)	-RRB-
cord-005453-4057qib7	4828	53	.	.	.
cord-005453-4057qib7	4829	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4829	2	:	:	:
cord-005453-4057qib7	4830	1	Considering	consider	VBG
cord-005453-4057qib7	4830	2	the	the	DT
cord-005453-4057qib7	4830	3	effects	effect	NNS
cord-005453-4057qib7	4830	4	of	of	IN
cord-005453-4057qib7	4830	5	ASCs	asc	NNS
cord-005453-4057qib7	4830	6	on	on	IN
cord-005453-4057qib7	4830	7	inflammation	inflammation	NN
cord-005453-4057qib7	4830	8	and	and	CC
cord-005453-4057qib7	4830	9	regeneration	regeneration	NN
cord-005453-4057qib7	4830	10	,	,	,
cord-005453-4057qib7	4830	11	we	-PRON-	PRP
cord-005453-4057qib7	4830	12	suggest	suggest	VBP
cord-005453-4057qib7	4830	13	that	that	IN
cord-005453-4057qib7	4830	14	their	-PRON-	PRP$
cord-005453-4057qib7	4830	15	transplantation	transplantation	NN
cord-005453-4057qib7	4830	16	after	after	IN
cord-005453-4057qib7	4830	17	brain	brain	NN
cord-005453-4057qib7	4830	18	injury	injury	NN
cord-005453-4057qib7	4830	19	may	may	MD
cord-005453-4057qib7	4830	20	promote	promote	VB
cord-005453-4057qib7	4830	21	host	host	NN
cord-005453-4057qib7	4830	22	brain	brain	NN
cord-005453-4057qib7	4830	23	repair	repair	NN
cord-005453-4057qib7	4830	24	mechanisms	mechanism	NNS
cord-005453-4057qib7	4830	25	.	.	.
cord-005453-4057qib7	4831	1	ASCs	ascs	JJ
cord-005453-4057qib7	4831	2	transplantation	transplantation	NN
cord-005453-4057qib7	4831	3	may	may	MD
cord-005453-4057qib7	4831	4	be	be	VB
cord-005453-4057qib7	4831	5	beneficial	beneficial	JJ
cord-005453-4057qib7	4831	6	in	in	IN
cord-005453-4057qib7	4831	7	TBI	TBI	NNP
cord-005453-4057qib7	4831	8	,	,	,
cord-005453-4057qib7	4831	9	however	however	RB
cord-005453-4057qib7	4831	10	some	some	DT
cord-005453-4057qib7	4831	11	of	of	IN
cord-005453-4057qib7	4831	12	its	-PRON-	PRP$
cord-005453-4057qib7	4831	13	effects	effect	NNS
cord-005453-4057qib7	4831	14	need	need	VBP
cord-005453-4057qib7	4831	15	careful	careful	JJ
cord-005453-4057qib7	4831	16	and	and	CC
cord-005453-4057qib7	4831	17	indepth	indepth	JJ
cord-005453-4057qib7	4831	18	evaluation	evaluation	NN
cord-005453-4057qib7	4831	19	.	.	.
cord-005453-4057qib7	4832	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4832	2	:	:	:
cord-005453-4057qib7	4832	3	Nothing	nothing	NN
cord-005453-4057qib7	4832	4	to	to	TO
cord-005453-4057qib7	4832	5	declare	declare	VB
cord-005453-4057qib7	4832	6	Xie	Xie	NNP
cord-005453-4057qib7	4832	7	-	-	HYPH
cord-005453-4057qib7	4832	8	Na	Na	NNP
cord-005453-4057qib7	4832	9	Cao	Cao	NNP
cord-005453-4057qib7	4832	10	1	1	CD
cord-005453-4057qib7	4832	11	,	,	,
cord-005453-4057qib7	4832	12	Yuan	Yuan	NNP
cord-005453-4057qib7	4832	13	Kong	Kong	NNP
cord-005453-4057qib7	4832	14	1	1	CD
cord-005453-4057qib7	4832	15	,	,	,
cord-005453-4057qib7	4832	16	Zhong	Zhong	NNP
cord-005453-4057qib7	4832	17	-	-	HYPH
cord-005453-4057qib7	4832	18	Shi	Shi	NNP
cord-005453-4057qib7	4832	19	Lyu	Lyu	NNP
cord-005453-4057qib7	4832	20	1,2	1,2	CD
cord-005453-4057qib7	4832	21	,	,	,
cord-005453-4057qib7	4832	22	Qi	Qi	NNP
cord-005453-4057qib7	4832	23	Wen	Wen	NNP
cord-005453-4057qib7	4832	24	1	1	CD
cord-005453-4057qib7	4832	25	,	,	,
cord-005453-4057qib7	4832	26	Min	Min	NNP
cord-005453-4057qib7	4832	27	-	-	HYPH
cord-005453-4057qib7	4832	28	Min	Min	NNP
cord-005453-4057qib7	4832	29	Shi	Shi	NNP
cord-005453-4057qib7	4832	30	1,2	1,2	CD
cord-005453-4057qib7	4832	31	,	,	,
cord-005453-4057qib7	4832	32	Qian	Qian	NNP
cord-005453-4057qib7	4832	33	-	-	HYPH
cord-005453-4057qib7	4832	34	Yu	Yu	NNP
cord-005453-4057qib7	4832	35	Sun	Sun	NNP
cord-005453-4057qib7	4832	36	1	1	CD
cord-005453-4057qib7	4832	37	,	,	,
cord-005453-4057qib7	4832	38	Yu	Yu	NNP
cord-005453-4057qib7	4832	39	-	-	HYPH
cord-005453-4057qib7	4832	40	Hong	Hong	NNP
cord-005453-4057qib7	4832	41	Chen	Chen	NNP
cord-005453-4057qib7	4832	42	1	1	CD
cord-005453-4057qib7	4832	43	,	,	,
cord-005453-4057qib7	4832	44	Yu	Yu	NNP
cord-005453-4057qib7	4832	45	Wang	Wang	NNP
cord-005453-4057qib7	4832	46	1	1	CD
cord-005453-4057qib7	4832	47	,	,	,
cord-005453-4057qib7	4832	48	Lan	Lan	NNP
cord-005453-4057qib7	4832	49	-	-	HYPH
cord-005453-4057qib7	4832	50	Ping	Ping	NNP
cord-005453-4057qib7	4832	51	Xu	Xu	NNP
cord-005453-4057qib7	4832	52	1	1	CD
cord-005453-4057qib7	4833	1	,	,	,
cord-005453-4057qib7	4833	2	Xiao	Xiao	NNP
cord-005453-4057qib7	4833	3	-	-	HYPH
cord-005453-4057qib7	4833	4	Hui	Hui	NNP
cord-005453-4057qib7	4833	5	Zhang	Zhang	NNP
cord-005453-4057qib7	4833	6	1	1	CD
cord-005453-4057qib7	4833	7	,	,	,
cord-005453-4057qib7	4833	8	Xiao	Xiao	NNP
cord-005453-4057qib7	4833	9	-	-	HYPH
cord-005453-4057qib7	4833	10	Jun	Jun	NNP
cord-005453-4057qib7	4833	11	Huang	Huang	NNP
cord-005453-4057qib7	4834	1	1,2	1,2	LS
cord-005453-4057qib7	4835	1	Background	background	NN
cord-005453-4057qib7	4835	2	:	:	:
cord-005453-4057qib7	4836	1	Poor	poor	JJ
cord-005453-4057qib7	4836	2	graft	graft	NN
cord-005453-4057qib7	4836	3	function	function	NN
cord-005453-4057qib7	4836	4	(	(	-LRB-
cord-005453-4057qib7	4836	5	PGF	PGF	NNP
cord-005453-4057qib7	4836	6	)	)	-RRB-
cord-005453-4057qib7	4836	7	remains	remain	VBZ
cord-005453-4057qib7	4836	8	a	a	DT
cord-005453-4057qib7	4836	9	serious	serious	JJ
cord-005453-4057qib7	4836	10	complication	complication	NN
cord-005453-4057qib7	4836	11	after	after	IN
cord-005453-4057qib7	4836	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	4836	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4836	14	stem	stem	NN
cord-005453-4057qib7	4836	15	cell	cell	NN
cord-005453-4057qib7	4836	16	transplantation	transplantation	NN
cord-005453-4057qib7	4836	17	(	(	-LRB-
cord-005453-4057qib7	4836	18	allo	allo	NN
cord-005453-4057qib7	4836	19	-	-	HYPH
cord-005453-4057qib7	4836	20	HSCT	HSCT	NNP
cord-005453-4057qib7	4836	21	)	)	-RRB-
cord-005453-4057qib7	4836	22	.	.	.
cord-005453-4057qib7	4837	1	Our	-PRON-	PRP$
cord-005453-4057qib7	4837	2	previous	previous	JJ
cord-005453-4057qib7	4837	3	work	work	NN
cord-005453-4057qib7	4837	4	reported	report	VBD
cord-005453-4057qib7	4837	5	that	that	IN
cord-005453-4057qib7	4837	6	abnormal	abnormal	JJ
cord-005453-4057qib7	4837	7	bone	bone	NN
cord-005453-4057qib7	4837	8	marrow	marrow	NN
cord-005453-4057qib7	4837	9	(	(	-LRB-
cord-005453-4057qib7	4837	10	BM	BM	NNP
cord-005453-4057qib7	4837	11	)	)	-RRB-
cord-005453-4057qib7	4837	12	endothelial	endothelial	JJ
cord-005453-4057qib7	4837	13	cells	cell	NNS
cord-005453-4057qib7	4837	14	(	(	-LRB-
cord-005453-4057qib7	4837	15	ECs	ec	NNS
cord-005453-4057qib7	4837	16	)	)	-RRB-
cord-005453-4057qib7	4837	17	were	be	VBD
cord-005453-4057qib7	4837	18	involved	involve	VBN
cord-005453-4057qib7	4837	19	in	in	IN
cord-005453-4057qib7	4837	20	the	the	DT
cord-005453-4057qib7	4837	21	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	4837	22	of	of	IN
cord-005453-4057qib7	4837	23	PGF	PGF	NNP
cord-005453-4057qib7	4837	24	patients	patient	NNS
cord-005453-4057qib7	4837	25	after	after	IN
cord-005453-4057qib7	4837	26	allo	allo	NN
cord-005453-4057qib7	4837	27	-	-	HYPH
cord-005453-4057qib7	4837	28	HSCT	HSCT	NNP
cord-005453-4057qib7	4837	29	(	(	-LRB-
cord-005453-4057qib7	4837	30	BBMT2013	BBMT2013	NNP
cord-005453-4057qib7	4837	31	;	;	:
cord-005453-4057qib7	4837	32	BMT	BMT	NNP
cord-005453-4057qib7	4837	33	2016	2016	CD
cord-005453-4057qib7	4837	34	;	;	:
cord-005453-4057qib7	4837	35	Blood2016	Blood2016	NNP
cord-005453-4057qib7	4837	36	)	)	-RRB-
cord-005453-4057qib7	4837	37	,	,	,
cord-005453-4057qib7	4837	38	but	but	CC
cord-005453-4057qib7	4837	39	the	the	DT
cord-005453-4057qib7	4837	40	explicit	explicit	JJ
cord-005453-4057qib7	4837	41	mechanism	mechanism	NN
cord-005453-4057qib7	4837	42	requires	require	VBZ
cord-005453-4057qib7	4837	43	further	further	JJ
cord-005453-4057qib7	4837	44	clarification	clarification	NN
cord-005453-4057qib7	4837	45	.	.	.
cord-005453-4057qib7	4838	1	Autophagy	Autophagy	NNP
cord-005453-4057qib7	4838	2	is	be	VBZ
cord-005453-4057qib7	4838	3	a	a	DT
cord-005453-4057qib7	4838	4	self	self	NN
cord-005453-4057qib7	4838	5	-	-	HYPH
cord-005453-4057qib7	4838	6	degradative	degradative	NN
cord-005453-4057qib7	4838	7	process	process	NN
cord-005453-4057qib7	4838	8	responsible	responsible	JJ
cord-005453-4057qib7	4838	9	for	for	IN
cord-005453-4057qib7	4838	10	the	the	DT
cord-005453-4057qib7	4838	11	elimination	elimination	NN
cord-005453-4057qib7	4838	12	of	of	IN
cord-005453-4057qib7	4838	13	cytosolic	cytosolic	JJ
cord-005453-4057qib7	4838	14	components	component	NNS
cord-005453-4057qib7	4838	15	including	include	VBG
cord-005453-4057qib7	4838	16	proteins	protein	NNS
cord-005453-4057qib7	4838	17	and	and	CC
cord-005453-4057qib7	4838	18	damaged	damage	VBN
cord-005453-4057qib7	4838	19	organelles	organelle	NNS
cord-005453-4057qib7	4838	20	.	.	.
cord-005453-4057qib7	4839	1	Recent	recent	JJ
cord-005453-4057qib7	4839	2	findings	finding	NNS
cord-005453-4057qib7	4839	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	4839	4	that	that	IN
cord-005453-4057qib7	4839	5	stimulation	stimulation	NN
cord-005453-4057qib7	4839	6	of	of	IN
cord-005453-4057qib7	4839	7	autophagy	autophagy	NN
cord-005453-4057qib7	4839	8	could	could	MD
cord-005453-4057qib7	4839	9	reduce	reduce	VB
cord-005453-4057qib7	4839	10	oxidative	oxidative	JJ
cord-005453-4057qib7	4839	11	status	status	NN
cord-005453-4057qib7	4839	12	and	and	CC
cord-005453-4057qib7	4839	13	angiogenic	angiogenic	JJ
cord-005453-4057qib7	4839	14	potential	potential	NN
cord-005453-4057qib7	4839	15	in	in	IN
cord-005453-4057qib7	4839	16	ECsafter	ECsafter	NNP
cord-005453-4057qib7	4839	17	high	high	JJ
cord-005453-4057qib7	4839	18	-	-	HYPH
cord-005453-4057qib7	4839	19	glucose	glucose	NN
cord-005453-4057qib7	4839	20	exposure	exposure	NN
cord-005453-4057qib7	4839	21	,	,	,
cord-005453-4057qib7	4839	22	from	from	IN
cord-005453-4057qib7	4839	23	diabetic	diabetic	JJ
cord-005453-4057qib7	4839	24	patients	patient	NNS
cord-005453-4057qib7	4839	25	.	.	.
cord-005453-4057qib7	4840	1	However	however	RB
cord-005453-4057qib7	4840	2	,	,	,
cord-005453-4057qib7	4840	3	little	little	JJ
cord-005453-4057qib7	4840	4	is	be	VBZ
cord-005453-4057qib7	4840	5	known	know	VBN
cord-005453-4057qib7	4840	6	regarding	regard	VBG
cord-005453-4057qib7	4840	7	the	the	DT
cord-005453-4057qib7	4840	8	autophagy	autophagy	NN
cord-005453-4057qib7	4840	9	of	of	IN
cord-005453-4057qib7	4840	10	BM	BM	NNP
cord-005453-4057qib7	4840	11	ECs	ECs	NNP
cord-005453-4057qib7	4840	12	in	in	IN
cord-005453-4057qib7	4840	13	PGF	PGF	NNP
cord-005453-4057qib7	4840	14	patients	patient	NNS
cord-005453-4057qib7	4840	15	.	.	.
cord-005453-4057qib7	4841	1	Therefore	therefore	RB
cord-005453-4057qib7	4841	2	,	,	,
cord-005453-4057qib7	4841	3	the	the	DT
cord-005453-4057qib7	4841	4	current	current	JJ
cord-005453-4057qib7	4841	5	study	study	NN
cord-005453-4057qib7	4841	6	was	be	VBD
cord-005453-4057qib7	4841	7	performed	perform	VBN
cord-005453-4057qib7	4841	8	to	to	TO
cord-005453-4057qib7	4841	9	evaluate	evaluate	VB
cord-005453-4057qib7	4841	10	whether	whether	IN
cord-005453-4057qib7	4841	11	autophagy	autophagy	NN
cord-005453-4057qib7	4841	12	in	in	IN
cord-005453-4057qib7	4841	13	BM	BM	NNP
cord-005453-4057qib7	4841	14	ECs	ECs	NNP
cord-005453-4057qib7	4841	15	play	play	VBP
cord-005453-4057qib7	4841	16	a	a	DT
cord-005453-4057qib7	4841	17	role	role	NN
cord-005453-4057qib7	4841	18	in	in	IN
cord-005453-4057qib7	4841	19	the	the	DT
cord-005453-4057qib7	4841	20	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	4841	21	of	of	IN
cord-005453-4057qib7	4841	22	PGF	PGF	NNP
cord-005453-4057qib7	4841	23	.	.	.
cord-005453-4057qib7	4842	1	Moreover	moreover	RB
cord-005453-4057qib7	4842	2	,	,	,
cord-005453-4057qib7	4842	3	to	to	TO
cord-005453-4057qib7	4842	4	investigate	investigate	VB
cord-005453-4057qib7	4842	5	the	the	DT
cord-005453-4057qib7	4842	6	effects	effect	NNS
cord-005453-4057qib7	4842	7	of	of	IN
cord-005453-4057qib7	4842	8	autophagic	autophagic	JJ
cord-005453-4057qib7	4842	9	regulation	regulation	NN
cord-005453-4057qib7	4842	10	on	on	IN
cord-005453-4057qib7	4842	11	ECs	ec	NNS
cord-005453-4057qib7	4842	12	and	and	CC
cord-005453-4057qib7	4842	13	thereby	thereby	RB
cord-005453-4057qib7	4842	14	regulating	regulate	VBG
cord-005453-4057qib7	4842	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4842	16	stem	stem	NN
cord-005453-4057qib7	4842	17	cell	cell	NN
cord-005453-4057qib7	4842	18	(	(	-LRB-
cord-005453-4057qib7	4842	19	HSCs	HSCs	NNP
cord-005453-4057qib7	4842	20	)	)	-RRB-
cord-005453-4057qib7	4842	21	.	.	.
cord-005453-4057qib7	4843	1	Methods	method	NNS
cord-005453-4057qib7	4843	2	:	:	:
cord-005453-4057qib7	4843	3	In	in	IN
cord-005453-4057qib7	4843	4	the	the	DT
cord-005453-4057qib7	4843	5	prospective	prospective	JJ
cord-005453-4057qib7	4843	6	case	case	NN
cord-005453-4057qib7	4843	7	-	-	HYPH
cord-005453-4057qib7	4843	8	control	control	NN
cord-005453-4057qib7	4843	9	study	study	NN
cord-005453-4057qib7	4843	10	,	,	,
cord-005453-4057qib7	4843	11	the	the	DT
cord-005453-4057qib7	4843	12	autophagy	autophagy	NN
cord-005453-4057qib7	4843	13	levels	level	NNS
cord-005453-4057qib7	4843	14	were	be	VBD
cord-005453-4057qib7	4843	15	compared	compare	VBN
cord-005453-4057qib7	4843	16	in	in	IN
cord-005453-4057qib7	4843	17	BM	BM	NNP
cord-005453-4057qib7	4843	18	ECs	ECs	NNP
cord-005453-4057qib7	4843	19	from	from	IN
cord-005453-4057qib7	4843	20	PGF	PGF	NNP
cord-005453-4057qib7	4843	21	patients	patient	NNS
cord-005453-4057qib7	4843	22	,	,	,
cord-005453-4057qib7	4843	23	and	and	CC
cord-005453-4057qib7	4843	24	their	-PRON-	PRP$
cord-005453-4057qib7	4843	25	matched	match	VBN
cord-005453-4057qib7	4843	26	good	good	JJ
cord-005453-4057qib7	4843	27	graft	graft	NN
cord-005453-4057qib7	4843	28	function	function	NN
cord-005453-4057qib7	4843	29	(	(	-LRB-
cord-005453-4057qib7	4843	30	GGF	GGF	NNP
cord-005453-4057qib7	4843	31	)	)	-RRB-
cord-005453-4057qib7	4843	32	patients	patient	NNS
cord-005453-4057qib7	4843	33	.	.	.
cord-005453-4057qib7	4844	1	The	the	DT
cord-005453-4057qib7	4844	2	expression	expression	NN
cord-005453-4057qib7	4844	3	levels	level	NNS
cord-005453-4057qib7	4844	4	of	of	IN
cord-005453-4057qib7	4844	5	autophagy	autophagy	NN
cord-005453-4057qib7	4844	6	-	-	HYPH
cord-005453-4057qib7	4844	7	related	relate	VBN
cord-005453-4057qib7	4844	8	markers	marker	NNS
cord-005453-4057qib7	4844	9	(	(	-LRB-
cord-005453-4057qib7	4844	10	LC3	LC3	NNP
cord-005453-4057qib7	4844	11	,	,	,
cord-005453-4057qib7	4844	12	Beclin1	Beclin1	NNP
cord-005453-4057qib7	4844	13	,	,	,
cord-005453-4057qib7	4844	14	and	and	CC
cord-005453-4057qib7	4844	15	P62	P62	NNP
cord-005453-4057qib7	4844	16	)	)	-RRB-
cord-005453-4057qib7	4844	17	,	,	,
cord-005453-4057qib7	4844	18	and	and	CC
cord-005453-4057qib7	4844	19	intracellular	intracellular	JJ
cord-005453-4057qib7	4844	20	autophagosomes	autophagosome	NNS
cord-005453-4057qib7	4844	21	were	be	VBD
cord-005453-4057qib7	4844	22	detected	detect	VBN
cord-005453-4057qib7	4844	23	by	by	IN
cord-005453-4057qib7	4844	24	immunohistochemical	immunohistochemical	JJ
cord-005453-4057qib7	4844	25	staining	staining	NN
cord-005453-4057qib7	4844	26	,	,	,
cord-005453-4057qib7	4844	27	flow	flow	NN
cord-005453-4057qib7	4844	28	cytometry	cytometry	NN
cord-005453-4057qib7	4844	29	,	,	,
cord-005453-4057qib7	4844	30	western	western	JJ
cord-005453-4057qib7	4844	31	blot	blot	NN
cord-005453-4057qib7	4844	32	and	and	CC
cord-005453-4057qib7	4844	33	transmission	transmission	NN
cord-005453-4057qib7	4844	34	electron	electron	NN
cord-005453-4057qib7	4844	35	microscopy	microscopy	NN
cord-005453-4057qib7	4844	36	.	.	.
cord-005453-4057qib7	4845	1	Subsequently	subsequently	RB
cord-005453-4057qib7	4845	2	,	,	,
cord-005453-4057qib7	4845	3	rapamycin	rapamycin	JJ
cord-005453-4057qib7	4845	4	(	(	-LRB-
cord-005453-4057qib7	4845	5	the	the	DT
cord-005453-4057qib7	4845	6	autophagy	autophagy	NN
cord-005453-4057qib7	4845	7	activators	activator	NNS
cord-005453-4057qib7	4845	8	)	)	-RRB-
cord-005453-4057qib7	4845	9	or	or	CC
cord-005453-4057qib7	4845	10	hydroxychloroquine	hydroxychloroquine	NNP
cord-005453-4057qib7	4845	11	(	(	-LRB-
cord-005453-4057qib7	4845	12	HCQ	HCQ	NNP
cord-005453-4057qib7	4845	13	,	,	,
cord-005453-4057qib7	4845	14	the	the	DT
cord-005453-4057qib7	4845	15	autophagy	autophagy	NN
cord-005453-4057qib7	4845	16	inhibitor	inhibitor	NN
cord-005453-4057qib7	4845	17	)	)	-RRB-
cord-005453-4057qib7	4845	18	were	be	VBD
cord-005453-4057qib7	4845	19	administrated	administrate	VBN
cord-005453-4057qib7	4845	20	tothe	tothe	DT
cord-005453-4057qib7	4845	21	7-day	7-day	JJ
cord-005453-4057qib7	4845	22	cultivated	cultivate	VBN
cord-005453-4057qib7	4845	23	BM	BM	NNP
cord-005453-4057qib7	4845	24	ECs	ECs	NNP
cord-005453-4057qib7	4845	25	and	and	CC
cord-005453-4057qib7	4845	26	Human	Human	NNP
cord-005453-4057qib7	4845	27	Umbilical	Umbilical	NNP
cord-005453-4057qib7	4845	28	Vein	Vein	NNP
cord-005453-4057qib7	4845	29	Endothelial	Endothelial	NNP
cord-005453-4057qib7	4845	30	Cells	cell	NNS
cord-005453-4057qib7	4845	31	(	(	-LRB-
cord-005453-4057qib7	4845	32	HUVECs	huvec	NNS
cord-005453-4057qib7	4845	33	)	)	-RRB-
cord-005453-4057qib7	4845	34	,	,	,
cord-005453-4057qib7	4845	35	respectively	respectively	RB
cord-005453-4057qib7	4845	36	.	.	.
cord-005453-4057qib7	4846	1	The	the	DT
cord-005453-4057qib7	4846	2	autophagic	autophagic	NN
cord-005453-4057qib7	4846	3	vacuoleswere	vacuoleswere	RB
cord-005453-4057qib7	4846	4	detected	detect	VBN
cord-005453-4057qib7	4846	5	by	by	IN
cord-005453-4057qib7	4846	6	Monodansylcadaverine	Monodansylcadaverine	NNP
cord-005453-4057qib7	4846	7	(	(	-LRB-
cord-005453-4057qib7	4846	8	MDC	MDC	NNP
cord-005453-4057qib7	4846	9	)	)	-RRB-
cord-005453-4057qib7	4846	10	staining	stain	VBG
cord-005453-4057qib7	4846	11	assay	assay	NN
cord-005453-4057qib7	4846	12	.	.	.
cord-005453-4057qib7	4847	1	The	the	DT
cord-005453-4057qib7	4847	2	BM	BM	NNP
cord-005453-4057qib7	4847	3	ECsand	ECsand	NNP
cord-005453-4057qib7	4847	4	HUVECs	huvec	NNS
cord-005453-4057qib7	4847	5	were	be	VBD
cord-005453-4057qib7	4847	6	evaluated	evaluate	VBN
cord-005453-4057qib7	4847	7	by	by	IN
cord-005453-4057qib7	4847	8	cell	cell	NN
cord-005453-4057qib7	4847	9	counting	counting	NN
cord-005453-4057qib7	4847	10	,	,	,
cord-005453-4057qib7	4847	11	DiI	dii	NN
cord-005453-4057qib7	4847	12	-	-	HYPH
cord-005453-4057qib7	4847	13	Ac	Ac	NNP
cord-005453-4057qib7	4847	14	-	-	HYPH
cord-005453-4057qib7	4847	15	LDL	LDL	NNP
cord-005453-4057qib7	4847	16	and	and	CC
cord-005453-4057qib7	4847	17	FITC	FITC	NNP
cord-005453-4057qib7	4847	18	-	-	HYPH
cord-005453-4057qib7	4847	19	lectin	lectin	NN
cord-005453-4057qib7	4847	20	-	-	:
cord-005453-4057qib7	4847	21	UEA-1	UEA-1	NNP
cord-005453-4057qib7	4847	22	double	double	JJ
cord-005453-4057qib7	4847	23	staining	staining	NN
cord-005453-4057qib7	4847	24	,	,	,
cord-005453-4057qib7	4847	25	migration	migration	NN
cord-005453-4057qib7	4847	26	,	,	,
cord-005453-4057qib7	4847	27	cell	cell	NN
cord-005453-4057qib7	4847	28	proliferation	proliferation	NN
cord-005453-4057qib7	4847	29	,	,	,
cord-005453-4057qib7	4847	30	and	and	CC
cord-005453-4057qib7	4847	31	levels	level	NNS
cord-005453-4057qib7	4847	32	of	of	IN
cord-005453-4057qib7	4847	33	reactive	reactive	JJ
cord-005453-4057qib7	4847	34	oxygen	oxygen	NN
cord-005453-4057qib7	4847	35	species	specie	NNS
cord-005453-4057qib7	4847	36	(	(	-LRB-
cord-005453-4057qib7	4847	37	ROS	ROS	NNP
cord-005453-4057qib7	4847	38	)	)	-RRB-
cord-005453-4057qib7	4847	39	.	.	.
cord-005453-4057qib7	4848	1	To	to	TO
cord-005453-4057qib7	4848	2	explore	explore	VB
cord-005453-4057qib7	4848	3	whether	whether	IN
cord-005453-4057qib7	4848	4	autophagy	autophagy	NN
cord-005453-4057qib7	4848	5	would	would	MD
cord-005453-4057qib7	4848	6	affect	affect	VB
cord-005453-4057qib7	4848	7	the	the	DT
cord-005453-4057qib7	4848	8	ability	ability	NN
cord-005453-4057qib7	4848	9	of	of	IN
cord-005453-4057qib7	4848	10	BM	BM	NNP
cord-005453-4057qib7	4848	11	ECs	ECs	NNP
cord-005453-4057qib7	4848	12	to	to	TO
cord-005453-4057qib7	4848	13	support	support	VB
cord-005453-4057qib7	4848	14	HSCs	hscs	NN
cord-005453-4057qib7	4848	15	in	in	IN
cord-005453-4057qib7	4848	16	vitro	vitro	FW
cord-005453-4057qib7	4848	17	,	,	,
cord-005453-4057qib7	4848	18	BM	BM	NNP
cord-005453-4057qib7	4848	19	CD34	CD34	NNP
cord-005453-4057qib7	4848	20	+	+	CC
cord-005453-4057qib7	4848	21	cells	cell	NNS
cord-005453-4057qib7	4848	22	from	from	IN
cord-005453-4057qib7	4848	23	healthy	healthy	JJ
cord-005453-4057qib7	4848	24	donors	donor	NNS
cord-005453-4057qib7	4848	25	were	be	VBD
cord-005453-4057qib7	4848	26	co	co	JJ
cord-005453-4057qib7	4848	27	-	-	JJ
cord-005453-4057qib7	4848	28	cultured	cultured	JJ
cord-005453-4057qib7	4848	29	with	with	IN
cord-005453-4057qib7	4848	30	cultivated	cultivate	VBN
cord-005453-4057qib7	4848	31	BM	BM	NNP
cord-005453-4057qib7	4848	32	ECs	ECs	NNP
cord-005453-4057qib7	4848	33	and	and	CC
cord-005453-4057qib7	4848	34	HUVECs	huvec	NNS
cord-005453-4057qib7	4848	35	.	.	.
cord-005453-4057qib7	4849	1	Colony	colony	NN
cord-005453-4057qib7	4849	2	-	-	HYPH
cord-005453-4057qib7	4849	3	forming	form	VBG
cord-005453-4057qib7	4849	4	unit	unit	NN
cord-005453-4057qib7	4849	5	(	(	-LRB-
cord-005453-4057qib7	4849	6	CFU	CFU	NNP
cord-005453-4057qib7	4849	7	)	)	-RRB-
cord-005453-4057qib7	4849	8	and	and	CC
cord-005453-4057qib7	4849	9	the	the	DT
cord-005453-4057qib7	4849	10	apoptosis	apoptosis	NN
cord-005453-4057qib7	4849	11	of	of	IN
cord-005453-4057qib7	4849	12	co	co	JJ
cord-005453-4057qib7	4849	13	-	-	JJ
cord-005453-4057qib7	4849	14	cultured	cultured	JJ
cord-005453-4057qib7	4849	15	HSCs	hsc	NNS
cord-005453-4057qib7	4849	16	were	be	VBD
cord-005453-4057qib7	4849	17	analyzed	analyze	VBN
cord-005453-4057qib7	4849	18	.	.	.
cord-005453-4057qib7	4850	1	Results	result	NNS
cord-005453-4057qib7	4850	2	:	:	:
cord-005453-4057qib7	4851	1	The	the	DT
cord-005453-4057qib7	4851	2	defective	defective	JJ
cord-005453-4057qib7	4851	3	autophagy	autophagy	NN
cord-005453-4057qib7	4851	4	in	in	IN
cord-005453-4057qib7	4851	5	BM	BM	NNP
cord-005453-4057qib7	4851	6	ECs	ECs	NNP
cord-005453-4057qib7	4851	7	,	,	,
cord-005453-4057qib7	4851	8	characterized	characterize	VBN
cord-005453-4057qib7	4851	9	by	by	IN
cord-005453-4057qib7	4851	10	decreased	decrease	VBN
cord-005453-4057qib7	4851	11	intracellular	intracellular	JJ
cord-005453-4057qib7	4851	12	autophagosomes	autophagosome	NNS
cord-005453-4057qib7	4851	13	and	and	CC
cord-005453-4057qib7	4851	14	autophagic	autophagic	JJ
cord-005453-4057qib7	4851	15	vacuoles	vacuole	NNS
cord-005453-4057qib7	4851	16	,	,	,
cord-005453-4057qib7	4851	17	decreased	decrease	VBD
cord-005453-4057qib7	4851	18	expression	expression	NN
cord-005453-4057qib7	4851	19	of	of	IN
cord-005453-4057qib7	4851	20	LC3-II	lc3-ii	NN
cord-005453-4057qib7	4851	21	and	and	CC
cord-005453-4057qib7	4851	22	Beclin1	Beclin1	NNP
cord-005453-4057qib7	4851	23	,	,	,
cord-005453-4057qib7	4851	24	and	and	CC
cord-005453-4057qib7	4851	25	high	high	JJ
cord-005453-4057qib7	4851	26	level	level	NN
cord-005453-4057qib7	4851	27	of	of	IN
cord-005453-4057qib7	4851	28	P62	P62	NNP
cord-005453-4057qib7	4851	29	,	,	,
cord-005453-4057qib7	4851	30	were	be	VBD
cord-005453-4057qib7	4851	31	observed	observe	VBN
cord-005453-4057qib7	4851	32	in	in	IN
cord-005453-4057qib7	4851	33	PGF	PGF	NNP
cord-005453-4057qib7	4851	34	patients	patient	NNS
cord-005453-4057qib7	4851	35	compared	compare	VBN
cord-005453-4057qib7	4851	36	with	with	IN
cord-005453-4057qib7	4851	37	GGF	GGF	NNP
cord-005453-4057qib7	4851	38	patients	patient	NNS
cord-005453-4057qib7	4851	39	.	.	.
cord-005453-4057qib7	4852	1	Moreover	moreover	RB
cord-005453-4057qib7	4852	2	,	,	,
cord-005453-4057qib7	4852	3	the	the	DT
cord-005453-4057qib7	4852	4	coculture	coculture	NN
cord-005453-4057qib7	4852	5	of	of	IN
cord-005453-4057qib7	4852	6	BM	BM	NNP
cord-005453-4057qib7	4852	7	CD34	CD34	NNP
cord-005453-4057qib7	4852	8	+	+	CC
cord-005453-4057qib7	4852	9	cells	cell	NNS
cord-005453-4057qib7	4852	10	with	with	IN
cord-005453-4057qib7	4852	11	BM	BM	NNP
cord-005453-4057qib7	4852	12	ECs	ECs	NNP
cord-005453-4057qib7	4852	13	showed	show	VBD
cord-005453-4057qib7	4852	14	significant	significant	JJ
cord-005453-4057qib7	4852	15	deficient	deficient	JJ
cord-005453-4057qib7	4852	16	CFU	cfu	NN
cord-005453-4057qib7	4852	17	plating	plating	NN
cord-005453-4057qib7	4852	18	efficiency	efficiency	NN
cord-005453-4057qib7	4852	19	,	,	,
cord-005453-4057qib7	4852	20	and	and	CC
cord-005453-4057qib7	4852	21	increased	increase	VBN
cord-005453-4057qib7	4852	22	apoptosis	apoptosis	NN
cord-005453-4057qib7	4852	23	of	of	IN
cord-005453-4057qib7	4852	24	CD34	CD34	NNP
cord-005453-4057qib7	4852	25	+	+	CC
cord-005453-4057qib7	4852	26	cells	cell	NNS
cord-005453-4057qib7	4852	27	in	in	IN
cord-005453-4057qib7	4852	28	PGF	PGF	NNP
cord-005453-4057qib7	4852	29	patients	patient	NNS
cord-005453-4057qib7	4852	30	.	.	.
cord-005453-4057qib7	4853	1	In	in	IN
cord-005453-4057qib7	4853	2	vitro	vitro	FW
cord-005453-4057qib7	4853	3	upregulation	upregulation	NN
cord-005453-4057qib7	4853	4	of	of	IN
cord-005453-4057qib7	4853	5	autophagy	autophagy	NN
cord-005453-4057qib7	4853	6	by	by	IN
cord-005453-4057qib7	4853	7	rapamycin	rapamycin	NNS
cord-005453-4057qib7	4853	8	quantitatively	quantitatively	RB
cord-005453-4057qib7	4853	9	and	and	CC
cord-005453-4057qib7	4853	10	functionally	functionally	RB
cord-005453-4057qib7	4853	11	improved	improve	VBN
cord-005453-4057qib7	4853	12	BM	BM	NNP
cord-005453-4057qib7	4853	13	ECsand	ECsand	NNP
cord-005453-4057qib7	4853	14	HUVECs	huvec	NNS
cord-005453-4057qib7	4853	15	,	,	,
cord-005453-4057qib7	4853	16	which	which	WDT
cord-005453-4057qib7	4853	17	manifested	manifest	VBD
cord-005453-4057qib7	4853	18	as	as	IN
cord-005453-4057qib7	4853	19	more	more	JJR
cord-005453-4057qib7	4853	20	DiI	dii	NN
cord-005453-4057qib7	4853	21	-	-	HYPH
cord-005453-4057qib7	4853	22	Ac	ac	NN
cord-005453-4057qib7	4853	23	-	-	HYPH
cord-005453-4057qib7	4853	24	LDL	LDL	NNP
cord-005453-4057qib7	4853	25	and	and	CC
cord-005453-4057qib7	4853	26	FITC	FITC	NNP
cord-005453-4057qib7	4853	27	-	-	HYPH
cord-005453-4057qib7	4853	28	lectin	lectin	NN
cord-005453-4057qib7	4853	29	-	-	:
cord-005453-4057qib7	4853	30	UEA-1	UEA-1	NNP
cord-005453-4057qib7	4853	31	double	double	JJ
cord-005453-4057qib7	4853	32	stained	stained	JJ
cord-005453-4057qib7	4853	33	cells	cell	NNS
cord-005453-4057qib7	4853	34	,	,	,
cord-005453-4057qib7	4853	35	increased	increase	VBN
cord-005453-4057qib7	4853	36	capacities	capacity	NNS
cord-005453-4057qib7	4853	37	of	of	IN
cord-005453-4057qib7	4853	38	migration	migration	NN
cord-005453-4057qib7	4853	39	,	,	,
cord-005453-4057qib7	4853	40	lower	low	JJR
cord-005453-4057qib7	4853	41	levels	level	NNS
cord-005453-4057qib7	4853	42	of	of	IN
cord-005453-4057qib7	4853	43	ROS	ROS	NNP
cord-005453-4057qib7	4853	44	and	and	CC
cord-005453-4057qib7	4853	45	apoptosis	apoptosis	NN
cord-005453-4057qib7	4853	46	via	via	IN
cord-005453-4057qib7	4853	47	regulating	regulate	VBG
cord-005453-4057qib7	4853	48	Beclin1	Beclin1	NNP
cord-005453-4057qib7	4853	49	pathway	pathway	NN
cord-005453-4057qib7	4853	50	,	,	,
cord-005453-4057qib7	4853	51	whereas	whereas	IN
cord-005453-4057qib7	4853	52	inhibition	inhibition	NN
cord-005453-4057qib7	4853	53	of	of	IN
cord-005453-4057qib7	4853	54	autophagy	autophagy	NN
cord-005453-4057qib7	4853	55	by	by	IN
cord-005453-4057qib7	4853	56	HCQ	HCQ	NNP
cord-005453-4057qib7	4853	57	aggravated	aggravate	VBD
cord-005453-4057qib7	4853	58	the	the	DT
cord-005453-4057qib7	4853	59	HUVECs	huvec	NNS
cord-005453-4057qib7	4853	60	and	and	CC
cord-005453-4057qib7	4853	61	BM	BM	NNP
cord-005453-4057qib7	4853	62	ECs	ECs	NNP
cord-005453-4057qib7	4853	63	from	from	IN
cord-005453-4057qib7	4853	64	PGF	PGF	NNP
cord-005453-4057qib7	4853	65	patients	patient	NNS
cord-005453-4057qib7	4853	66	.	.	.
cord-005453-4057qib7	4854	1	Furthermore	furthermore	RB
cord-005453-4057qib7	4854	2	,	,	,
cord-005453-4057qib7	4854	3	in	in	IN
cord-005453-4057qib7	4854	4	vitro	vitro	FW
cord-005453-4057qib7	4854	5	upregulation	upregulation	NN
cord-005453-4057qib7	4854	6	of	of	IN
cord-005453-4057qib7	4854	7	autophagy	autophagy	NN
cord-005453-4057qib7	4854	8	by	by	IN
cord-005453-4057qib7	4854	9	rapamycin	rapamycin	NN
cord-005453-4057qib7	4854	10	significant	significant	JJ
cord-005453-4057qib7	4854	11	improved	improve	VBD
cord-005453-4057qib7	4854	12	CFU	CFU	NNP
cord-005453-4057qib7	4854	13	plating	plating	NN
cord-005453-4057qib7	4854	14	efficiency	efficiency	NN
cord-005453-4057qib7	4854	15	,	,	,
cord-005453-4057qib7	4854	16	and	and	CC
cord-005453-4057qib7	4854	17	decreased	decrease	VBD
cord-005453-4057qib7	4854	18	apoptosis	apoptosis	NN
cord-005453-4057qib7	4854	19	in	in	IN
cord-005453-4057qib7	4854	20	BM	BM	NNP
cord-005453-4057qib7	4854	21	HSCs	HSCs	NNP
cord-005453-4057qib7	4854	22	co	co	NN
cord-005453-4057qib7	4854	23	-	-	JJ
cord-005453-4057qib7	4854	24	cultured	cultured	JJ
cord-005453-4057qib7	4854	25	with	with	IN
cord-005453-4057qib7	4854	26	HUVECs	huvec	NNS
cord-005453-4057qib7	4854	27	and	and	CC
cord-005453-4057qib7	4854	28	BM	BM	NNP
cord-005453-4057qib7	4854	29	ECs	ECs	NNP
cord-005453-4057qib7	4854	30	from	from	IN
cord-005453-4057qib7	4854	31	PGF	PGF	NNP
cord-005453-4057qib7	4854	32	patients	patient	NNS
cord-005453-4057qib7	4854	33	.	.	.
cord-005453-4057qib7	4855	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4855	2	:	:	:
cord-005453-4057qib7	4856	1	These	these	DT
cord-005453-4057qib7	4856	2	findings	finding	NNS
cord-005453-4057qib7	4856	3	suggest	suggest	VBP
cord-005453-4057qib7	4856	4	that	that	IN
cord-005453-4057qib7	4856	5	defective	defective	JJ
cord-005453-4057qib7	4856	6	autophagy	autophagy	NN
cord-005453-4057qib7	4856	7	in	in	IN
cord-005453-4057qib7	4856	8	BM	BM	NNP
cord-005453-4057qib7	4856	9	ECs	ECs	NNP
cord-005453-4057qib7	4856	10	may	may	MD
cord-005453-4057qib7	4856	11	be	be	VB
cord-005453-4057qib7	4856	12	involved	involve	VBN
cord-005453-4057qib7	4856	13	in	in	IN
cord-005453-4057qib7	4856	14	the	the	DT
cord-005453-4057qib7	4856	15	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	4856	16	of	of	IN
cord-005453-4057qib7	4856	17	PGF	PGF	NNP
cord-005453-4057qib7	4856	18	.	.	.
cord-005453-4057qib7	4857	1	The	the	DT
cord-005453-4057qib7	4857	2	effect	effect	NN
cord-005453-4057qib7	4857	3	of	of	IN
cord-005453-4057qib7	4857	4	rapamycin	rapamycin	NNS
cord-005453-4057qib7	4857	5	in	in	IN
cord-005453-4057qib7	4857	6	PGFpatients	pgfpatient	NNS
cord-005453-4057qib7	4857	7	is	be	VBZ
cord-005453-4057qib7	4857	8	potentially	potentially	RB
cord-005453-4057qib7	4857	9	mediated	mediate	VBN
cord-005453-4057qib7	4857	10	by	by	IN
cord-005453-4057qib7	4857	11	improving	improve	VBG
cord-005453-4057qib7	4857	12	the	the	DT
cord-005453-4057qib7	4857	13	dysfunctional	dysfunctional	JJ
cord-005453-4057qib7	4857	14	BM	BM	NNP
cord-005453-4057qib7	4857	15	ECsto	ECsto	NNP
cord-005453-4057qib7	4857	16	support	support	NN
cord-005453-4057qib7	4857	17	HSCs	hscs	NN
cord-005453-4057qib7	4857	18	.	.	.
cord-005453-4057qib7	4858	1	Therefore	therefore	RB
cord-005453-4057qib7	4858	2	,	,	,
cord-005453-4057qib7	4858	3	it	-PRON-	PRP
cord-005453-4057qib7	4858	4	would	would	MD
cord-005453-4057qib7	4858	5	be	be	VB
cord-005453-4057qib7	4858	6	of	of	IN
cord-005453-4057qib7	4858	7	value	value	NN
cord-005453-4057qib7	4858	8	to	to	TO
cord-005453-4057qib7	4858	9	investigate	investigate	VB
cord-005453-4057qib7	4858	10	whether	whether	IN
cord-005453-4057qib7	4858	11	upregulating	upregulating	NN
cord-005453-4057qib7	4858	12	of	of	IN
cord-005453-4057qib7	4858	13	cytoprotective	cytoprotective	JJ
cord-005453-4057qib7	4858	14	autophagy	autophagy	NN
cord-005453-4057qib7	4858	15	of	of	IN
cord-005453-4057qib7	4858	16	BM	BM	NNP
cord-005453-4057qib7	4858	17	ECs	ECs	NNP
cord-005453-4057qib7	4858	18	may	may	MD
cord-005453-4057qib7	4858	19	ameliorate	ameliorate	VB
cord-005453-4057qib7	4858	20	PGF	PGF	NNP
cord-005453-4057qib7	4858	21	,	,	,
cord-005453-4057qib7	4858	22	thereby	thereby	RB
cord-005453-4057qib7	4858	23	providing	provide	VBG
cord-005453-4057qib7	4858	24	a	a	DT
cord-005453-4057qib7	4858	25	novel	novel	JJ
cord-005453-4057qib7	4858	26	clinical	clinical	JJ
cord-005453-4057qib7	4858	27	intervention	intervention	NN
cord-005453-4057qib7	4858	28	for	for	IN
cord-005453-4057qib7	4858	29	PGF	PGF	NNP
cord-005453-4057qib7	4858	30	in	in	IN
cord-005453-4057qib7	4858	31	the	the	DT
cord-005453-4057qib7	4858	32	future	future	NN
cord-005453-4057qib7	4858	33	.	.	.
cord-005453-4057qib7	4859	1	Clinical	clinical	JJ
cord-005453-4057qib7	4859	2	Background	background	NN
cord-005453-4057qib7	4859	3	:	:	:
cord-005453-4057qib7	4859	4	Heparanase	Heparanase	NNP
cord-005453-4057qib7	4859	5	(	(	-LRB-
cord-005453-4057qib7	4859	6	HPSE	HPSE	NNP
cord-005453-4057qib7	4859	7	)	)	-RRB-
cord-005453-4057qib7	4859	8	in	in	IN
cord-005453-4057qib7	4859	9	an	an	DT
cord-005453-4057qib7	4859	10	endoβ	endoβ	NN
cord-005453-4057qib7	4859	11	-	-	HYPH
cord-005453-4057qib7	4859	12	glucuronidase	glucuronidase	NN
cord-005453-4057qib7	4859	13	that	that	WDT
cord-005453-4057qib7	4859	14	specifically	specifically	RB
cord-005453-4057qib7	4859	15	cleaves	cleave	VBZ
cord-005453-4057qib7	4859	16	the	the	DT
cord-005453-4057qib7	4859	17	saccaride	saccaride	JJ
cord-005453-4057qib7	4859	18	chains	chain	NNS
cord-005453-4057qib7	4859	19	of	of	IN
cord-005453-4057qib7	4859	20	heparan	heparan	JJ
cord-005453-4057qib7	4859	21	sulphate	sulphate	NN
cord-005453-4057qib7	4859	22	proteoglycans	proteoglycan	NNS
cord-005453-4057qib7	4859	23	(	(	-LRB-
cord-005453-4057qib7	4859	24	HS	HS	NNP
cord-005453-4057qib7	4859	25	)	)	-RRB-
cord-005453-4057qib7	4859	26	,	,	,
cord-005453-4057qib7	4859	27	leading	lead	VBG
cord-005453-4057qib7	4859	28	to	to	IN
cord-005453-4057qib7	4859	29	a	a	DT
cord-005453-4057qib7	4859	30	loss	loss	NN
cord-005453-4057qib7	4859	31	of	of	IN
cord-005453-4057qib7	4859	32	integrity	integrity	NN
cord-005453-4057qib7	4859	33	of	of	IN
cord-005453-4057qib7	4859	34	the	the	DT
cord-005453-4057qib7	4859	35	extracellular	extracellular	JJ
cord-005453-4057qib7	4859	36	matrix	matrix	NN
cord-005453-4057qib7	4859	37	and	and	CC
cord-005453-4057qib7	4859	38	to	to	TO
cord-005453-4057qib7	4859	39	release	release	VB
cord-005453-4057qib7	4859	40	of	of	IN
cord-005453-4057qib7	4859	41	HS	HS	NNP
cord-005453-4057qib7	4859	42	-	-	HYPH
cord-005453-4057qib7	4859	43	bound	bind	VBN
cord-005453-4057qib7	4859	44	cytokines	cytokine	NNS
cord-005453-4057qib7	4859	45	,	,	,
cord-005453-4057qib7	4859	46	chemokines	chemokine	NNS
cord-005453-4057qib7	4859	47	,	,	,
cord-005453-4057qib7	4859	48	angiogenic	angiogenic	NN
cord-005453-4057qib7	4859	49	and	and	CC
cord-005453-4057qib7	4859	50	growth	growth	NN
cord-005453-4057qib7	4859	51	factors	factor	NNS
cord-005453-4057qib7	4859	52	.	.	.
cord-005453-4057qib7	4860	1	HPSE	HPSE	NNP
cord-005453-4057qib7	4860	2	gene	gene	NN
cord-005453-4057qib7	4860	3	is	be	VBZ
cord-005453-4057qib7	4860	4	polymorphic	polymorphic	JJ
cord-005453-4057qib7	4860	5	and	and	CC
cord-005453-4057qib7	4860	6	includes	include	VBZ
cord-005453-4057qib7	4860	7	approximately	approximately	RB
cord-005453-4057qib7	4860	8	300	300	CD
cord-005453-4057qib7	4860	9	SNPs	snp	NNS
cord-005453-4057qib7	4860	10	.	.	.
cord-005453-4057qib7	4861	1	The	the	DT
cord-005453-4057qib7	4861	2	combination	combination	NN
cord-005453-4057qib7	4861	3	of	of	IN
cord-005453-4057qib7	4861	4	two	two	CD
cord-005453-4057qib7	4861	5	SNPs	SNPs	NNPS
cord-005453-4057qib7	4861	6	,	,	,
cord-005453-4057qib7	4861	7	rs4693608	rs4693608	NNP
cord-005453-4057qib7	4861	8	and	and	CC
cord-005453-4057qib7	4861	9	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4861	10	,	,	,
cord-005453-4057qib7	4861	11	are	be	VBP
cord-005453-4057qib7	4861	12	involved	involve	VBN
cord-005453-4057qib7	4861	13	in	in	IN
cord-005453-4057qib7	4861	14	the	the	DT
cord-005453-4057qib7	4861	15	regulation	regulation	NN
cord-005453-4057qib7	4861	16	of	of	IN
cord-005453-4057qib7	4861	17	HPSE	HPSE	NNP
cord-005453-4057qib7	4861	18	expression	expression	NN
cord-005453-4057qib7	4861	19	with	with	IN
cord-005453-4057qib7	4861	20	an	an	DT
cord-005453-4057qib7	4861	21	inverse	inverse	JJ
cord-005453-4057qib7	4861	22	correlation	correlation	NN
cord-005453-4057qib7	4861	23	between	between	IN
cord-005453-4057qib7	4861	24	mRNA	mRNA	NNP
cord-005453-4057qib7	4861	25	expression	expression	NN
cord-005453-4057qib7	4861	26	and	and	CC
cord-005453-4057qib7	4861	27	protein	protein	NN
cord-005453-4057qib7	4861	28	levels	level	NNS
cord-005453-4057qib7	4861	29	:	:	:
cord-005453-4057qib7	4861	30	GG	GG	NNP
cord-005453-4057qib7	4861	31	-	-	HYPH
cord-005453-4057qib7	4861	32	CC	CC	NNP
cord-005453-4057qib7	4861	33	,	,	,
cord-005453-4057qib7	4861	34	GG	GG	NNP
cord-005453-4057qib7	4861	35	-	-	HYPH
cord-005453-4057qib7	4861	36	CT	CT	NNP
cord-005453-4057qib7	4861	37	,	,	,
cord-005453-4057qib7	4861	38	GG	GG	NNP
cord-005453-4057qib7	4861	39	-	-	HYPH
cord-005453-4057qib7	4861	40	TT	TT	NNP
cord-005453-4057qib7	4861	41	,	,	,
cord-005453-4057qib7	4861	42	GA	GA	NNP
cord-005453-4057qib7	4861	43	-	-	HYPH
cord-005453-4057qib7	4861	44	CC	CC	NNP
cord-005453-4057qib7	4861	45	(	(	-LRB-
cord-005453-4057qib7	4861	46	Low	low	JJ
cord-005453-4057qib7	4861	47	group	group	NN
cord-005453-4057qib7	4861	48	)	)	-RRB-
cord-005453-4057qib7	4861	49	expressed	express	VBD
cord-005453-4057qib7	4861	50	high	high	JJ
cord-005453-4057qib7	4861	51	HPSE	HPSE	NNP
cord-005453-4057qib7	4861	52	concentration	concentration	NN
cord-005453-4057qib7	4861	53	;	;	:
cord-005453-4057qib7	4861	54	GA	GA	NNP
cord-005453-4057qib7	4861	55	-	-	HYPH
cord-005453-4057qib7	4861	56	CT	CT	NNP
cord-005453-4057qib7	4861	57	and	and	CC
cord-005453-4057qib7	4861	58	GA	GA	NNP
cord-005453-4057qib7	4861	59	-	-	HYPH
cord-005453-4057qib7	4861	60	TT	TT	NNP
cord-005453-4057qib7	4861	61	(	(	-LRB-
cord-005453-4057qib7	4861	62	Median	median	JJ
cord-005453-4057qib7	4861	63	group	group	NN
cord-005453-4057qib7	4861	64	)	)	-RRB-
cord-005453-4057qib7	4861	65	expressed	express	VBD
cord-005453-4057qib7	4861	66	intermediate	intermediate	JJ
cord-005453-4057qib7	4861	67	HPSE	HPSE	NNP
cord-005453-4057qib7	4861	68	levels	level	NNS
cord-005453-4057qib7	4861	69	;	;	:
cord-005453-4057qib7	4861	70	AA	AA	NNP
cord-005453-4057qib7	4861	71	-	-	HYPH
cord-005453-4057qib7	4861	72	TT	TT	NNP
cord-005453-4057qib7	4861	73	and	and	CC
cord-005453-4057qib7	4861	74	AA	AA	NNP
cord-005453-4057qib7	4861	75	-	-	HYPH
cord-005453-4057qib7	4861	76	CT	CT	NNP
cord-005453-4057qib7	4861	77	expressed	express	VBD
cord-005453-4057qib7	4861	78	low	low	JJ
cord-005453-4057qib7	4861	79	HPSE	HPSE	NNP
cord-005453-4057qib7	4861	80	concentration	concentration	NN
cord-005453-4057qib7	4861	81	(	(	-LRB-
cord-005453-4057qib7	4861	82	High	high	JJ
cord-005453-4057qib7	4861	83	group	group	NN
cord-005453-4057qib7	4861	84	)	)	-RRB-
cord-005453-4057qib7	4861	85	.	.	.
cord-005453-4057qib7	4862	1	We	-PRON-	PRP
cord-005453-4057qib7	4862	2	studied	study	VBD
cord-005453-4057qib7	4862	3	HPSE	HPSE	NNP
cord-005453-4057qib7	4862	4	SNPs	snp	NNS
cord-005453-4057qib7	4862	5	in	in	IN
cord-005453-4057qib7	4862	6	the	the	DT
cord-005453-4057qib7	4862	7	allogeneic	allogeneic	NN
cord-005453-4057qib7	4862	8	stem	stem	NN
cord-005453-4057qib7	4862	9	cell	cell	NN
cord-005453-4057qib7	4862	10	transplantation	transplantation	NN
cord-005453-4057qib7	4862	11	(	(	-LRB-
cord-005453-4057qib7	4862	12	HSCT	HSCT	NNP
cord-005453-4057qib7	4862	13	)	)	-RRB-
cord-005453-4057qib7	4862	14	setting	set	VBG
cord-005453-4057qib7	4862	15	to	to	TO
cord-005453-4057qib7	4862	16	evaluate	evaluate	VB
cord-005453-4057qib7	4862	17	a	a	DT
cord-005453-4057qib7	4862	18	possible	possible	JJ
cord-005453-4057qib7	4862	19	association	association	NN
cord-005453-4057qib7	4862	20	with	with	IN
cord-005453-4057qib7	4862	21	post	post	JJ
cord-005453-4057qib7	4862	22	-	-	JJ
cord-005453-4057qib7	4862	23	HSCT	hsct	JJ
cord-005453-4057qib7	4862	24	outcomes	outcome	NNS
cord-005453-4057qib7	4862	25	.	.	.
cord-005453-4057qib7	4863	1	Methods	method	NNS
cord-005453-4057qib7	4863	2	:	:	:
cord-005453-4057qib7	4863	3	We	-PRON-	PRP
cord-005453-4057qib7	4863	4	enrolled	enrol	VBD
cord-005453-4057qib7	4863	5	228	228	CD
cord-005453-4057qib7	4863	6	patients	patient	NNS
cord-005453-4057qib7	4863	7	submitted	submit	VBN
cord-005453-4057qib7	4863	8	to	to	IN
cord-005453-4057qib7	4863	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4863	10	in	in	IN
cord-005453-4057qib7	4863	11	our	-PRON-	PRP$
cord-005453-4057qib7	4863	12	department	department	NN
cord-005453-4057qib7	4863	13	since	since	IN
cord-005453-4057qib7	4863	14	2005	2005	CD
cord-005453-4057qib7	4863	15	to	to	IN
cord-005453-4057qib7	4863	16	2016	2016	CD
cord-005453-4057qib7	4863	17	.	.	.
cord-005453-4057qib7	4864	1	For	for	IN
cord-005453-4057qib7	4864	2	each	each	DT
cord-005453-4057qib7	4864	3	couple	couple	NN
cord-005453-4057qib7	4864	4	recipient	recipient	NN
cord-005453-4057qib7	4864	5	-	-	HYPH
cord-005453-4057qib7	4864	6	donor	donor	NN
cord-005453-4057qib7	4864	7	,	,	,
cord-005453-4057qib7	4864	8	rs4693608	rs4693608	NNP
cord-005453-4057qib7	4864	9	SNP	SNP	NNP
cord-005453-4057qib7	4864	10	was	be	VBD
cord-005453-4057qib7	4864	11	genotyped	genotype	VBN
cord-005453-4057qib7	4864	12	using	use	VBG
cord-005453-4057qib7	4864	13	restriction	restriction	NN
cord-005453-4057qib7	4864	14	fragment	fragment	NN
cord-005453-4057qib7	4864	15	lenght	lenght	NN
cord-005453-4057qib7	4864	16	polymorphism	polymorphism	NN
cord-005453-4057qib7	4864	17	assay	assay	NN
cord-005453-4057qib7	4864	18	,	,	,
cord-005453-4057qib7	4864	19	whereas	whereas	IN
cord-005453-4057qib7	4864	20	for	for	IN
cord-005453-4057qib7	4864	21	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4864	22	SNP	SNP	NNP
cord-005453-4057qib7	4864	23	an	an	DT
cord-005453-4057qib7	4864	24	allele	allele	NN
cord-005453-4057qib7	4864	25	-	-	HYPH
cord-005453-4057qib7	4864	26	specific	specific	JJ
cord-005453-4057qib7	4864	27	polimerase	polimerase	NN
cord-005453-4057qib7	4864	28	chain	chain	NN
cord-005453-4057qib7	4864	29	reaction	reaction	NN
cord-005453-4057qib7	4864	30	was	be	VBD
cord-005453-4057qib7	4864	31	applied	apply	VBN
cord-005453-4057qib7	4864	32	.	.	.
cord-005453-4057qib7	4865	1	HPSE	HPSE	NNP
cord-005453-4057qib7	4865	2	genotype	genotype	NN
cord-005453-4057qib7	4865	3	distribution	distribution	NN
cord-005453-4057qib7	4865	4	was	be	VBD
cord-005453-4057qib7	4865	5	compared	compare	VBN
cord-005453-4057qib7	4865	6	in	in	IN
cord-005453-4057qib7	4865	7	different	different	JJ
cord-005453-4057qib7	4865	8	groups	group	NNS
cord-005453-4057qib7	4865	9	according	accord	VBG
cord-005453-4057qib7	4865	10	to	to	IN
cord-005453-4057qib7	4865	11	post	post	JJ
cord-005453-4057qib7	4865	12	-	-	JJ
cord-005453-4057qib7	4865	13	HSCT	hsct	JJ
cord-005453-4057qib7	4865	14	outcome	outcome	NN
cord-005453-4057qib7	4865	15	:	:	:
cord-005453-4057qib7	4865	16	graft	graft	NN
cord-005453-4057qib7	4865	17	-	-	HYPH
cord-005453-4057qib7	4865	18	versus	versus	IN
cord-005453-4057qib7	4865	19	-	-	HYPH
cord-005453-4057qib7	4865	20	host	host	NN
cord-005453-4057qib7	4865	21	disease	disease	NN
cord-005453-4057qib7	4865	22	(	(	-LRB-
cord-005453-4057qib7	4865	23	GvHD	GvHD	NNP
cord-005453-4057qib7	4865	24	)	)	-RRB-
cord-005453-4057qib7	4865	25	,	,	,
cord-005453-4057qib7	4865	26	transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	4865	27	mortality	mortality	NN
cord-005453-4057qib7	4865	28	(	(	-LRB-
cord-005453-4057qib7	4865	29	TRM	TRM	NNP
cord-005453-4057qib7	4865	30	)	)	-RRB-
cord-005453-4057qib7	4865	31	,	,	,
cord-005453-4057qib7	4865	32	overall	overall	JJ
cord-005453-4057qib7	4865	33	survival	survival	NN
cord-005453-4057qib7	4865	34	(	(	-LRB-
cord-005453-4057qib7	4865	35	OS	OS	NNP
cord-005453-4057qib7	4865	36	)	)	-RRB-
cord-005453-4057qib7	4865	37	,	,	,
cord-005453-4057qib7	4865	38	infectious	infectious	JJ
cord-005453-4057qib7	4865	39	complication	complication	NN
cord-005453-4057qib7	4865	40	and	and	CC
cord-005453-4057qib7	4865	41	disease	disease	NN
cord-005453-4057qib7	4865	42	-	-	HYPH
cord-005453-4057qib7	4865	43	free	free	JJ
cord-005453-4057qib7	4865	44	survival	survival	NN
cord-005453-4057qib7	4865	45	(	(	-LRB-
cord-005453-4057qib7	4865	46	DFS	DFS	NNP
cord-005453-4057qib7	4865	47	)	)	-RRB-
cord-005453-4057qib7	4865	48	.	.	.
cord-005453-4057qib7	4866	1	Statistical	statistical	JJ
cord-005453-4057qib7	4866	2	analysis	analysis	NN
cord-005453-4057qib7	4866	3	was	be	VBD
cord-005453-4057qib7	4866	4	performed	perform	VBN
cord-005453-4057qib7	4866	5	using	use	VBG
cord-005453-4057qib7	4866	6	NCSS	NCSS	NNP
cord-005453-4057qib7	4866	7	10	10	CD
cord-005453-4057qib7	4866	8	.	.	.
cord-005453-4057qib7	4867	1	Results	result	NNS
cord-005453-4057qib7	4867	2	:	:	:
cord-005453-4057qib7	4868	1	Distribution	distribution	NN
cord-005453-4057qib7	4868	2	of	of	IN
cord-005453-4057qib7	4868	3	rs4693608	rs4693608	NNP
cord-005453-4057qib7	4868	4	SNP	SNP	NNP
cord-005453-4057qib7	4868	5	was	be	VBD
cord-005453-4057qib7	4868	6	as	as	IN
cord-005453-4057qib7	4868	7	follows	follow	VBZ
cord-005453-4057qib7	4868	8	:	:	:
cord-005453-4057qib7	4868	9	GG	GG	NNP
cord-005453-4057qib7	4868	10	16.7	16.7	CD
cord-005453-4057qib7	4868	11	%	%	NN
cord-005453-4057qib7	4868	12	,	,	,
cord-005453-4057qib7	4868	13	GA	GA	NNP
cord-005453-4057qib7	4868	14	49.8	49.8	CD
cord-005453-4057qib7	4868	15	%	%	NN
cord-005453-4057qib7	4868	16	and	and	CC
cord-005453-4057qib7	4868	17	AA	AA	NNP
cord-005453-4057qib7	4868	18	33.5	33.5	CD
cord-005453-4057qib7	4868	19	%	%	NN
cord-005453-4057qib7	4868	20	among	among	IN
cord-005453-4057qib7	4868	21	recipients	recipient	NNS
cord-005453-4057qib7	4868	22	and	and	CC
cord-005453-4057qib7	4868	23	17.6	17.6	CD
cord-005453-4057qib7	4868	24	%	%	NN
cord-005453-4057qib7	4868	25	,	,	,
cord-005453-4057qib7	4868	26	53.3	53.3	CD
cord-005453-4057qib7	4868	27	%	%	NN
cord-005453-4057qib7	4868	28	and	and	CC
cord-005453-4057qib7	4868	29	29.1	29.1	CD
cord-005453-4057qib7	4868	30	%	%	NN
cord-005453-4057qib7	4868	31	among	among	IN
cord-005453-4057qib7	4868	32	donors	donor	NNS
cord-005453-4057qib7	4868	33	,	,	,
cord-005453-4057qib7	4868	34	respectively	respectively	RB
cord-005453-4057qib7	4868	35	.	.	.
cord-005453-4057qib7	4869	1	Hardy	Hardy	NNP
cord-005453-4057qib7	4869	2	-	-	HYPH
cord-005453-4057qib7	4869	3	Weinberg	Weinberg	NNP
cord-005453-4057qib7	4869	4	equilibrium	equilibrium	NN
cord-005453-4057qib7	4869	5	(	(	-LRB-
cord-005453-4057qib7	4869	6	HWe	HWe	NNS
cord-005453-4057qib7	4869	7	)	)	-RRB-
cord-005453-4057qib7	4869	8	was	be	VBD
cord-005453-4057qib7	4869	9	respected	respect	VBN
cord-005453-4057qib7	4869	10	.	.	.
cord-005453-4057qib7	4870	1	Distribution	distribution	NN
cord-005453-4057qib7	4870	2	of	of	IN
cord-005453-4057qib7	4870	3	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4870	4	SNP	SNP	NNP
cord-005453-4057qib7	4870	5	was	be	VBD
cord-005453-4057qib7	4870	6	as	as	IN
cord-005453-4057qib7	4870	7	follows	follow	VBZ
cord-005453-4057qib7	4870	8	:	:	:
cord-005453-4057qib7	4870	9	CC	CC	NNP
cord-005453-4057qib7	4870	10	15.1	15.1	CD
cord-005453-4057qib7	4870	11	%	%	NN
cord-005453-4057qib7	4870	12	,	,	,
cord-005453-4057qib7	4870	13	CT	CT	NNP
cord-005453-4057qib7	4870	14	37.8	37.8	CD
cord-005453-4057qib7	4870	15	%	%	NN
cord-005453-4057qib7	4870	16	and	and	CC
cord-005453-4057qib7	4870	17	TT	TT	NNP
cord-005453-4057qib7	4870	18	37.8	37.8	CD
cord-005453-4057qib7	4870	19	%	%	NN
cord-005453-4057qib7	4870	20	among	among	IN
cord-005453-4057qib7	4870	21	recipients	recipient	NNS
cord-005453-4057qib7	4870	22	and	and	CC
cord-005453-4057qib7	4870	23	15.3	15.3	CD
cord-005453-4057qib7	4870	24	%	%	NN
cord-005453-4057qib7	4870	25	,	,	,
cord-005453-4057qib7	4870	26	36	36	CD
cord-005453-4057qib7	4870	27	%	%	NN
cord-005453-4057qib7	4870	28	and	and	CC
cord-005453-4057qib7	4870	29	48.7	48.7	CD
cord-005453-4057qib7	4870	30	%	%	NN
cord-005453-4057qib7	4870	31	among	among	IN
cord-005453-4057qib7	4870	32	donors	donor	NNS
cord-005453-4057qib7	4870	33	,	,	,
cord-005453-4057qib7	4870	34	respectively	respectively	RB
cord-005453-4057qib7	4870	35	.	.	.
cord-005453-4057qib7	4871	1	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4871	2	SNP	SNP	NNP
cord-005453-4057qib7	4871	3	distribution	distribution	NN
cord-005453-4057qib7	4871	4	did	do	VBD
cord-005453-4057qib7	4871	5	not	not	RB
cord-005453-4057qib7	4871	6	respect	respect	VB
cord-005453-4057qib7	4871	7	the	the	DT
cord-005453-4057qib7	4871	8	HWe	HWe	NNS
cord-005453-4057qib7	4871	9	.	.	.
cord-005453-4057qib7	4872	1	An	an	DT
cord-005453-4057qib7	4872	2	association	association	NN
cord-005453-4057qib7	4872	3	was	be	VBD
cord-005453-4057qib7	4872	4	found	find	VBN
cord-005453-4057qib7	4872	5	between	between	IN
cord-005453-4057qib7	4872	6	recipient	recipient	NN
cord-005453-4057qib7	4872	7	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4872	8	SNP	SNP	NNP
cord-005453-4057qib7	4872	9	and	and	CC
cord-005453-4057qib7	4872	10	the	the	DT
cord-005453-4057qib7	4872	11	cumulative	cumulative	JJ
cord-005453-4057qib7	4872	12	incidence	incidence	NN
cord-005453-4057qib7	4872	13	of	of	IN
cord-005453-4057qib7	4872	14	aGvHD	agvhd	NN
cord-005453-4057qib7	4872	15	among	among	IN
cord-005453-4057qib7	4872	16	patients	patient	NNS
cord-005453-4057qib7	4872	17	submitted	submit	VBN
cord-005453-4057qib7	4872	18	to	to	IN
cord-005453-4057qib7	4872	19	a	a	DT
cord-005453-4057qib7	4872	20	reduced	reduce	VBN
cord-005453-4057qib7	4872	21	intensity	intensity	NN
cord-005453-4057qib7	4872	22	conditioning	conditioning	NN
cord-005453-4057qib7	4872	23	(	(	-LRB-
cord-005453-4057qib7	4872	24	RIC	RIC	NNP
cord-005453-4057qib7	4872	25	)	)	-RRB-
cord-005453-4057qib7	4872	26	:	:	:
cord-005453-4057qib7	4872	27	37.3	37.3	CD
cord-005453-4057qib7	4872	28	%	%	NN
cord-005453-4057qib7	4872	29	for	for	IN
cord-005453-4057qib7	4872	30	TT	TT	NNP
cord-005453-4057qib7	4872	31	genotype	genotype	NN
cord-005453-4057qib7	4872	32	and	and	CC
cord-005453-4057qib7	4872	33	69	69	CD
cord-005453-4057qib7	4872	34	%	%	NN
cord-005453-4057qib7	4872	35	for	for	IN
cord-005453-4057qib7	4872	36	CT	CT	NNP
cord-005453-4057qib7	4872	37	or	or	CC
cord-005453-4057qib7	4872	38	CC	CC	NNP
cord-005453-4057qib7	4872	39	genotype	genotype	NN
cord-005453-4057qib7	4872	40	(	(	-LRB-
cord-005453-4057qib7	4872	41	p=0.03	p=0.03	NN
cord-005453-4057qib7	4872	42	)	)	-RRB-
cord-005453-4057qib7	4872	43	.	.	.
cord-005453-4057qib7	4873	1	on	on	IN
cord-005453-4057qib7	4873	2	the	the	DT
cord-005453-4057qib7	4873	3	other	other	JJ
cord-005453-4057qib7	4873	4	hand	hand	NN
cord-005453-4057qib7	4873	5	,	,	,
cord-005453-4057qib7	4873	6	an	an	DT
cord-005453-4057qib7	4873	7	association	association	NN
cord-005453-4057qib7	4873	8	was	be	VBD
cord-005453-4057qib7	4873	9	identified	identify	VBN
cord-005453-4057qib7	4873	10	between	between	IN
cord-005453-4057qib7	4873	11	donor	donor	NN
cord-005453-4057qib7	4873	12	rs4693608	rs4693608	NNP
cord-005453-4057qib7	4873	13	/	/	,
cord-005453-4057qib7	4873	14	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4873	15	SNPs	SNPs	NNPS
cord-005453-4057qib7	4873	16	combination	combination	NN
cord-005453-4057qib7	4873	17	and	and	CC
cord-005453-4057qib7	4873	18	the	the	DT
cord-005453-4057qib7	4873	19	cumulative	cumulative	JJ
cord-005453-4057qib7	4873	20	incidence	incidence	NN
cord-005453-4057qib7	4873	21	of	of	IN
cord-005453-4057qib7	4873	22	aGvHD	agvhd	NN
cord-005453-4057qib7	4873	23	:	:	:
cord-005453-4057qib7	4873	24	81.5	81.5	CD
cord-005453-4057qib7	4873	25	%	%	NN
cord-005453-4057qib7	4873	26	for	for	IN
cord-005453-4057qib7	4873	27	Low	low	JJ
cord-005453-4057qib7	4873	28	group	group	NN
cord-005453-4057qib7	4873	29	donor	donor	NN
cord-005453-4057qib7	4873	30	,	,	,
cord-005453-4057qib7	4873	31	48	48	CD
cord-005453-4057qib7	4873	32	%	%	NN
cord-005453-4057qib7	4873	33	for	for	IN
cord-005453-4057qib7	4873	34	Median	median	JJ
cord-005453-4057qib7	4873	35	group	group	NN
cord-005453-4057qib7	4873	36	donor	donor	NN
cord-005453-4057qib7	4873	37	and	and	CC
cord-005453-4057qib7	4873	38	40.8	40.8	CD
cord-005453-4057qib7	4873	39	%	%	NN
cord-005453-4057qib7	4873	40	for	for	IN
cord-005453-4057qib7	4873	41	High	high	JJ
cord-005453-4057qib7	4873	42	group	group	NN
cord-005453-4057qib7	4873	43	donor	donor	NN
cord-005453-4057qib7	4873	44	(	(	-LRB-
cord-005453-4057qib7	4873	45	p=0.04	p=0.04	NNP
cord-005453-4057qib7	4873	46	)	)	-RRB-
cord-005453-4057qib7	4873	47	.	.	.
cord-005453-4057qib7	4874	1	Conversely	conversely	RB
cord-005453-4057qib7	4874	2	,	,	,
cord-005453-4057qib7	4874	3	AA	AA	NNP
cord-005453-4057qib7	4874	4	genotype	genotype	NN
cord-005453-4057qib7	4874	5	for	for	IN
cord-005453-4057qib7	4874	6	donor	donor	NN
cord-005453-4057qib7	4874	7	rs4693608	rs4693608	NNP
cord-005453-4057qib7	4874	8	resulted	result	VBD
cord-005453-4057qib7	4874	9	independent	independent	JJ
cord-005453-4057qib7	4874	10	risk	risk	NN
cord-005453-4057qib7	4874	11	factor	factor	NN
cord-005453-4057qib7	4874	12	for	for	IN
cord-005453-4057qib7	4874	13	cGvHD	cGvHD	NNP
cord-005453-4057qib7	4874	14	de	de	FW
cord-005453-4057qib7	4874	15	novo	novo	NNP
cord-005453-4057qib7	4874	16	development	development	NN
cord-005453-4057qib7	4874	17	(	(	-LRB-
cord-005453-4057qib7	4874	18	p=0.049	p=0.049	NNP
cord-005453-4057qib7	4874	19	,	,	,
cord-005453-4057qib7	4874	20	OD	OD	NNP
cord-005453-4057qib7	4874	21	2.1	2.1	CD
cord-005453-4057qib7	4874	22	)	)	-RRB-
cord-005453-4057qib7	4874	23	together	together	RB
cord-005453-4057qib7	4874	24	to	to	IN
cord-005453-4057qib7	4874	25	donor	donor	NN
cord-005453-4057qib7	4874	26	-	-	HYPH
cord-005453-4057qib7	4874	27	recipient	recipient	NN
cord-005453-4057qib7	4874	28	sex	sex	NN
cord-005453-4057qib7	4874	29	mismatch	mismatch	NN
cord-005453-4057qib7	4874	30	(	(	-LRB-
cord-005453-4057qib7	4874	31	female	female	JJ
cord-005453-4057qib7	4874	32	donor	donor	NN
cord-005453-4057qib7	4874	33	to	to	IN
cord-005453-4057qib7	4874	34	male	male	JJ
cord-005453-4057qib7	4874	35	recipient	recipient	NN
cord-005453-4057qib7	4874	36	vs.	vs.	FW
cord-005453-4057qib7	4874	37	others	other	NNS
cord-005453-4057qib7	4874	38	:	:	:
cord-005453-4057qib7	4875	1	p=0.005	p=0.005	NNP
cord-005453-4057qib7	4875	2	,	,	,
cord-005453-4057qib7	4875	3	OD	OD	NNP
cord-005453-4057qib7	4875	4	3.56	3.56	CD
cord-005453-4057qib7	4875	5	)	)	-RRB-
cord-005453-4057qib7	4875	6	.	.	.
cord-005453-4057qib7	4876	1	Considering	consider	VBG
cord-005453-4057qib7	4876	2	CMV	CMV	NNP
cord-005453-4057qib7	4876	3	reactivation	reactivation	NN
cord-005453-4057qib7	4876	4	rate	rate	NN
cord-005453-4057qib7	4876	5	after	after	IN
cord-005453-4057qib7	4876	6	HSCT	HSCT	NNP
cord-005453-4057qib7	4876	7	,	,	,
cord-005453-4057qib7	4876	8	an	an	DT
cord-005453-4057qib7	4876	9	association	association	NN
cord-005453-4057qib7	4876	10	was	be	VBD
cord-005453-4057qib7	4876	11	observed	observe	VBN
cord-005453-4057qib7	4876	12	according	accord	VBG
cord-005453-4057qib7	4876	13	to	to	IN
cord-005453-4057qib7	4876	14	recipient	recipient	NN
cord-005453-4057qib7	4876	15	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4876	16	SNP	SNP	NNP
cord-005453-4057qib7	4876	17	:	:	:
cord-005453-4057qib7	4877	1	82	82	CD
cord-005453-4057qib7	4877	2	%	%	NN
cord-005453-4057qib7	4877	3	for	for	IN
cord-005453-4057qib7	4877	4	CC	CC	NNP
cord-005453-4057qib7	4877	5	genotype	genotype	NN
cord-005453-4057qib7	4877	6	,	,	,
cord-005453-4057qib7	4877	7	63.5	63.5	CD
cord-005453-4057qib7	4877	8	%	%	NN
cord-005453-4057qib7	4877	9	for	for	IN
cord-005453-4057qib7	4877	10	CT	CT	NNP
cord-005453-4057qib7	4877	11	genotype	genotype	NN
cord-005453-4057qib7	4877	12	and	and	CC
cord-005453-4057qib7	4877	13	57.1	57.1	CD
cord-005453-4057qib7	4877	14	%	%	NN
cord-005453-4057qib7	4877	15	for	for	IN
cord-005453-4057qib7	4877	16	TT	TT	NNP
cord-005453-4057qib7	4877	17	genotype	genotype	NN
cord-005453-4057qib7	4877	18	(	(	-LRB-
cord-005453-4057qib7	4877	19	p=0.049	p=0.049	NNP
cord-005453-4057qib7	4877	20	)	)	-RRB-
cord-005453-4057qib7	4877	21	.	.	.
cord-005453-4057qib7	4878	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	4878	2	analysis	analysis	NN
cord-005453-4057qib7	4878	3	confirmed	confirm	VBD
cord-005453-4057qib7	4878	4	recipient	recipient	NN
cord-005453-4057qib7	4878	5	rs4364254	rs4364254	NNP
cord-005453-4057qib7	4878	6	SNP	SNP	NNP
cord-005453-4057qib7	4878	7	as	as	IN
cord-005453-4057qib7	4878	8	independent	independent	JJ
cord-005453-4057qib7	4878	9	risk	risk	NN
cord-005453-4057qib7	4878	10	factor	factor	NN
cord-005453-4057qib7	4878	11	for	for	IN
cord-005453-4057qib7	4878	12	CMV	CMV	NNP
cord-005453-4057qib7	4878	13	reactivation	reactivation	NN
cord-005453-4057qib7	4878	14	after	after	IN
cord-005453-4057qib7	4878	15	HSCT	HSCT	NNP
cord-005453-4057qib7	4878	16	(	(	-LRB-
cord-005453-4057qib7	4878	17	p=0.04	p=0.04	NNP
cord-005453-4057qib7	4878	18	,	,	,
cord-005453-4057qib7	4878	19	OD	OD	NNP
cord-005453-4057qib7	4878	20	2.62	2.62	CD
cord-005453-4057qib7	4878	21	)	)	-RRB-
cord-005453-4057qib7	4878	22	together	together	RB
cord-005453-4057qib7	4878	23	with	with	IN
cord-005453-4057qib7	4878	24	recipient	recipient	NN
cord-005453-4057qib7	4878	25	CMV	CMV	NNP
cord-005453-4057qib7	4878	26	serostatus	serostatus	NN
cord-005453-4057qib7	4878	27	at	at	IN
cord-005453-4057qib7	4878	28	transplant	transplant	NN
cord-005453-4057qib7	4878	29	(	(	-LRB-
cord-005453-4057qib7	4878	30	positive	positive	JJ
cord-005453-4057qib7	4878	31	vs.	vs.	FW
cord-005453-4057qib7	4878	32	negative	negative	JJ
cord-005453-4057qib7	4878	33	:	:	:
cord-005453-4057qib7	4878	34	p	p	NN
cord-005453-4057qib7	4878	35	<	<	XX
cord-005453-4057qib7	4878	36	0.01	0.01	CD
cord-005453-4057qib7	4878	37	,	,	,
cord-005453-4057qib7	4878	38	OD	OD	NNP
cord-005453-4057qib7	4878	39	8.49	8.49	CD
cord-005453-4057qib7	4878	40	)	)	-RRB-
cord-005453-4057qib7	4878	41	.	.	.
cord-005453-4057qib7	4879	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4879	2	:	:	:
cord-005453-4057qib7	4880	1	HPSE	HPSE	NNP
cord-005453-4057qib7	4880	2	role	role	NN
cord-005453-4057qib7	4880	3	was	be	VBD
cord-005453-4057qib7	4880	4	widely	widely	RB
cord-005453-4057qib7	4880	5	studied	study	VBN
cord-005453-4057qib7	4880	6	in	in	IN
cord-005453-4057qib7	4880	7	the	the	DT
cord-005453-4057qib7	4880	8	setting	setting	NN
cord-005453-4057qib7	4880	9	of	of	IN
cord-005453-4057qib7	4880	10	inflammation	inflammation	NN
cord-005453-4057qib7	4880	11	,	,	,
cord-005453-4057qib7	4880	12	autoimmune	autoimmune	JJ
cord-005453-4057qib7	4880	13	diseases	disease	NNS
cord-005453-4057qib7	4880	14	,	,	,
cord-005453-4057qib7	4880	15	hematological	hematological	JJ
cord-005453-4057qib7	4880	16	disease	disease	NN
cord-005453-4057qib7	4880	17	and	and	CC
cord-005453-4057qib7	4880	18	tumor	tumor	NN
cord-005453-4057qib7	4880	19	.	.	.
cord-005453-4057qib7	4881	1	However	however	RB
cord-005453-4057qib7	4881	2	,	,	,
cord-005453-4057qib7	4881	3	it	-PRON-	PRP
cord-005453-4057qib7	4881	4	still	still	RB
cord-005453-4057qib7	4881	5	remains	remain	VBZ
cord-005453-4057qib7	4881	6	debated	debate	VBN
cord-005453-4057qib7	4881	7	the	the	DT
cord-005453-4057qib7	4881	8	inducing	inducing	JJ
cord-005453-4057qib7	4881	9	or	or	CC
cord-005453-4057qib7	4881	10	protective	protective	JJ
cord-005453-4057qib7	4881	11	activity	activity	NN
cord-005453-4057qib7	4881	12	of	of	IN
cord-005453-4057qib7	4881	13	HPSE	HPSE	NNP
cord-005453-4057qib7	4881	14	in	in	IN
cord-005453-4057qib7	4881	15	the	the	DT
cord-005453-4057qib7	4881	16	setting	setting	NN
cord-005453-4057qib7	4881	17	of	of	IN
cord-005453-4057qib7	4881	18	GvHD	GvHD	NNP
cord-005453-4057qib7	4881	19	.	.	.
cord-005453-4057qib7	4882	1	Obviously	obviously	RB
cord-005453-4057qib7	4882	2	,	,	,
cord-005453-4057qib7	4882	3	our	-PRON-	PRP$
cord-005453-4057qib7	4882	4	results	result	NNS
cord-005453-4057qib7	4882	5	need	need	VBP
cord-005453-4057qib7	4882	6	to	to	TO
cord-005453-4057qib7	4882	7	be	be	VB
cord-005453-4057qib7	4882	8	confirmed	confirm	VBN
cord-005453-4057qib7	4882	9	in	in	IN
cord-005453-4057qib7	4882	10	a	a	DT
cord-005453-4057qib7	4882	11	validation	validation	NN
cord-005453-4057qib7	4882	12	cohort	cohort	NN
cord-005453-4057qib7	4882	13	.	.	.
cord-005453-4057qib7	4883	1	Clinical	clinical	JJ
cord-005453-4057qib7	4883	2	Trial	Trial	NNP
cord-005453-4057qib7	4883	3	Registry	Registry	NNP
cord-005453-4057qib7	4883	4	:	:	:
cord-005453-4057qib7	4884	1	NA	NA	NNP
cord-005453-4057qib7	4884	2	Disclosure	disclosure	NN
cord-005453-4057qib7	4884	3	:	:	:
cord-005453-4057qib7	4884	4	Nothing	nothing	NN
cord-005453-4057qib7	4884	5	to	to	TO
cord-005453-4057qib7	4884	6	declare	declare	VB
cord-005453-4057qib7	4884	7	Novel	Novel	NNP
cord-005453-4057qib7	4884	8	protocol	protocol	NN
cord-005453-4057qib7	4884	9	for	for	IN
cord-005453-4057qib7	4884	10	autologous	autologous	JJ
cord-005453-4057qib7	4884	11	HSCT	HSCT	NNP
cord-005453-4057qib7	4884	12	in	in	IN
cord-005453-4057qib7	4884	13	patients	patient	NNS
cord-005453-4057qib7	4884	14	with	with	IN
cord-005453-4057qib7	4884	15	high	high	JJ
cord-005453-4057qib7	4884	16	risk	risk	NN
cord-005453-4057qib7	4884	17	of	of	IN
cord-005453-4057qib7	4884	18	complications	complication	NNS
cord-005453-4057qib7	4884	19	:	:	:
cord-005453-4057qib7	4885	1	Ambulatory	ambulatory	JJ
cord-005453-4057qib7	4885	2	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	4885	3	and	and	CC
cord-005453-4057qib7	4885	4	transplantation	transplantation	NN
cord-005453-4057qib7	4885	5	of	of	IN
cord-005453-4057qib7	4885	6	fresh	fresh	JJ
cord-005453-4057qib7	4885	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4885	8	stem	stem	NN
cord-005453-4057qib7	4885	9	cells	cell	NNS
cord-005453-4057qib7	4885	10	with	with	IN
cord-005453-4057qib7	4885	11	backup	backup	JJ
cord-005453-4057qib7	4885	12	storage	storage	NN
cord-005453-4057qib7	4885	13	Background	background	NN
cord-005453-4057qib7	4885	14	:	:	:
cord-005453-4057qib7	4885	15	Autologous	autologous	JJ
cord-005453-4057qib7	4885	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4885	17	stem	stem	NN
cord-005453-4057qib7	4885	18	cell	cell	NN
cord-005453-4057qib7	4885	19	transplantation	transplantation	NN
cord-005453-4057qib7	4885	20	(	(	-LRB-
cord-005453-4057qib7	4885	21	AHSCT	AHSCT	NNP
cord-005453-4057qib7	4885	22	)	)	-RRB-
cord-005453-4057qib7	4885	23	is	be	VBZ
cord-005453-4057qib7	4885	24	standard	standard	JJ
cord-005453-4057qib7	4885	25	of	of	IN
cord-005453-4057qib7	4885	26	treatment	treatment	NN
cord-005453-4057qib7	4885	27	in	in	IN
cord-005453-4057qib7	4885	28	many	many	JJ
cord-005453-4057qib7	4885	29	patients	patient	NNS
cord-005453-4057qib7	4885	30	with	with	IN
cord-005453-4057qib7	4885	31	high	high	JJ
cord-005453-4057qib7	4885	32	risk	risk	NN
cord-005453-4057qib7	4885	33	of	of	IN
cord-005453-4057qib7	4885	34	complications	complication	NNS
cord-005453-4057qib7	4885	35	:	:	:
cord-005453-4057qib7	4885	36	dialysed	dialyse	VBN
cord-005453-4057qib7	4885	37	patients	patient	NNS
cord-005453-4057qib7	4885	38	,	,	,
cord-005453-4057qib7	4885	39	patients	patient	NNS
cord-005453-4057qib7	4885	40	with	with	IN
cord-005453-4057qib7	4885	41	heart	heart	NN
cord-005453-4057qib7	4885	42	and	and	CC
cord-005453-4057qib7	4885	43	kidney	kidney	NN
cord-005453-4057qib7	4885	44	amyloidosis	amyloidosis	NN
cord-005453-4057qib7	4885	45	or	or	CC
cord-005453-4057qib7	4885	46	patients	patient	NNS
cord-005453-4057qib7	4885	47	with	with	IN
cord-005453-4057qib7	4885	48	systemic	systemic	JJ
cord-005453-4057qib7	4885	49	sclerosis	sclerosis	NN
cord-005453-4057qib7	4885	50	.	.	.
cord-005453-4057qib7	4886	1	We	-PRON-	PRP
cord-005453-4057qib7	4886	2	introduced	introduce	VBD
cord-005453-4057qib7	4886	3	recently	recently	RB
cord-005453-4057qib7	4886	4	a	a	DT
cord-005453-4057qib7	4886	5	novel	novel	JJ
cord-005453-4057qib7	4886	6	protocol	protocol	NN
cord-005453-4057qib7	4886	7	for	for	IN
cord-005453-4057qib7	4886	8	AHSCT	AHSCT	NNP
cord-005453-4057qib7	4886	9	:	:	:
cord-005453-4057qib7	4886	10	combination	combination	NN
cord-005453-4057qib7	4886	11	of	of	IN
cord-005453-4057qib7	4886	12	ambulatory	ambulatory	JJ
cord-005453-4057qib7	4886	13	mobilization	mobilization	NN
cord-005453-4057qib7	4886	14	with	with	IN
cord-005453-4057qib7	4886	15	very	very	RB
cord-005453-4057qib7	4886	16	low	low	JJ
cord-005453-4057qib7	4886	17	doses	dose	NNS
cord-005453-4057qib7	4886	18	of	of	IN
cord-005453-4057qib7	4886	19	Ara	Ara	NNP
cord-005453-4057qib7	4886	20	-	-	HYPH
cord-005453-4057qib7	4886	21	C	C	NNP
cord-005453-4057qib7	4886	22	and	and	CC
cord-005453-4057qib7	4886	23	G	G	NNP
cord-005453-4057qib7	4886	24	-	-	HYPH
cord-005453-4057qib7	4886	25	CSF	csf	NN
cord-005453-4057qib7	4886	26	connected	connect	VBN
cord-005453-4057qib7	4886	27	with	with	IN
cord-005453-4057qib7	4886	28	direct	direct	JJ
cord-005453-4057qib7	4886	29	AHSCT	AHSCT	NNP
cord-005453-4057qib7	4886	30	with	with	IN
cord-005453-4057qib7	4886	31	fresh	fresh	JJ
cord-005453-4057qib7	4886	32	cells	cell	NNS
cord-005453-4057qib7	4886	33	.	.	.
cord-005453-4057qib7	4887	1	This	this	DT
cord-005453-4057qib7	4887	2	protocol	protocol	NN
cord-005453-4057qib7	4887	3	allowed	allow	VBD
cord-005453-4057qib7	4887	4	us	-PRON-	PRP
cord-005453-4057qib7	4887	5	to	to	TO
cord-005453-4057qib7	4887	6	reduce	reduce	VB
cord-005453-4057qib7	4887	7	the	the	DT
cord-005453-4057qib7	4887	8	transplant	transplant	NN
cord-005453-4057qib7	4887	9	risk	risk	NN
cord-005453-4057qib7	4887	10	in	in	IN
cord-005453-4057qib7	4887	11	various	various	JJ
cord-005453-4057qib7	4887	12	patient	patient	NN
cord-005453-4057qib7	4887	13	groups	group	NNS
cord-005453-4057qib7	4887	14	traditionally	traditionally	RB
cord-005453-4057qib7	4887	15	connected	connect	VBN
cord-005453-4057qib7	4887	16	with	with	IN
cord-005453-4057qib7	4887	17	high	high	JJ
cord-005453-4057qib7	4887	18	risk	risk	NN
cord-005453-4057qib7	4887	19	of	of	IN
cord-005453-4057qib7	4887	20	complications	complication	NNS
cord-005453-4057qib7	4887	21	.	.	.
cord-005453-4057qib7	4888	1	In	in	IN
cord-005453-4057qib7	4888	2	this	this	DT
cord-005453-4057qib7	4888	3	work	work	NN
cord-005453-4057qib7	4888	4	we	-PRON-	PRP
cord-005453-4057qib7	4888	5	summarize	summarize	VBP
cord-005453-4057qib7	4888	6	the	the	DT
cord-005453-4057qib7	4888	7	experience	experience	NN
cord-005453-4057qib7	4888	8	in	in	IN
cord-005453-4057qib7	4888	9	such	such	JJ
cord-005453-4057qib7	4888	10	high	high	JJ
cord-005453-4057qib7	4888	11	risk	risk	NN
cord-005453-4057qib7	4888	12	patients	patient	NNS
cord-005453-4057qib7	4888	13	.	.	.
cord-005453-4057qib7	4889	1	Methods	method	NNS
cord-005453-4057qib7	4889	2	:	:	:
cord-005453-4057qib7	4890	1	The	the	DT
cord-005453-4057qib7	4890	2	prospectively	prospectively	RB
cord-005453-4057qib7	4890	3	collected	collect	VBN
cord-005453-4057qib7	4890	4	database	database	NN
cord-005453-4057qib7	4890	5	of	of	IN
cord-005453-4057qib7	4890	6	patients	patient	NNS
cord-005453-4057qib7	4890	7	after	after	IN
cord-005453-4057qib7	4890	8	AHSCT	AHSCT	NNP
cord-005453-4057qib7	4890	9	was	be	VBD
cord-005453-4057qib7	4890	10	searched	search	VBN
cord-005453-4057qib7	4890	11	for	for	IN
cord-005453-4057qib7	4890	12	patients	patient	NNS
cord-005453-4057qib7	4890	13	who	who	WP
cord-005453-4057qib7	4890	14	underwent	undergo	VBD
cord-005453-4057qib7	4890	15	AHSCT	AHSCT	NNP
cord-005453-4057qib7	4890	16	after	after	IN
cord-005453-4057qib7	4890	17	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	4890	18	with	with	IN
cord-005453-4057qib7	4890	19	Ara	Ara	NNP
cord-005453-4057qib7	4890	20	-	-	HYPH
cord-005453-4057qib7	4890	21	C	C	NNP
cord-005453-4057qib7	4890	22	and	and	CC
cord-005453-4057qib7	4890	23	transplantation	transplantation	NN
cord-005453-4057qib7	4890	24	with	with	IN
cord-005453-4057qib7	4890	25	fresh	fresh	JJ
cord-005453-4057qib7	4890	26	cells	cell	NNS
cord-005453-4057qib7	4890	27	and	and	CC
cord-005453-4057qib7	4890	28	who	who	WP
cord-005453-4057qib7	4890	29	fulfilled	fulfil	VBD
cord-005453-4057qib7	4890	30	at	at	IN
cord-005453-4057qib7	4890	31	least	least	RBS
cord-005453-4057qib7	4890	32	one	one	CD
cord-005453-4057qib7	4890	33	study	study	NN
cord-005453-4057qib7	4890	34	inclusion	inclusion	NN
cord-005453-4057qib7	4890	35	criteria	criterion	NNS
cord-005453-4057qib7	4890	36	:	:	:
cord-005453-4057qib7	4890	37	a	a	LS
cord-005453-4057qib7	4890	38	)	)	-RRB-
cord-005453-4057qib7	4890	39	dependence	dependence	NN
cord-005453-4057qib7	4890	40	on	on	IN
cord-005453-4057qib7	4890	41	dialysis	dialysis	NN
cord-005453-4057qib7	4890	42	b	b	NN
cord-005453-4057qib7	4890	43	)	)	-RRB-
cord-005453-4057qib7	4890	44	amyloidosis	amyloidosis	NN
cord-005453-4057qib7	4890	45	c	c	NN
cord-005453-4057qib7	4890	46	)	)	-RRB-
cord-005453-4057qib7	4890	47	systemic	systemic	JJ
cord-005453-4057qib7	4890	48	sclerosis	sclerosis	NNP
cord-005453-4057qib7	4890	49	d	d	NN
cord-005453-4057qib7	4890	50	)	)	-RRB-
cord-005453-4057qib7	4890	51	disqualification	disqualification	NN
cord-005453-4057qib7	4890	52	from	from	IN
cord-005453-4057qib7	4890	53	transplantation	transplantation	NN
cord-005453-4057qib7	4890	54	at	at	IN
cord-005453-4057qib7	4890	55	other	other	JJ
cord-005453-4057qib7	4890	56	centre	centre	NN
cord-005453-4057qib7	4890	57	due	due	IN
cord-005453-4057qib7	4890	58	to	to	IN
cord-005453-4057qib7	4890	59	the	the	DT
cord-005453-4057qib7	4890	60	high	high	JJ
cord-005453-4057qib7	4890	61	risk	risk	NN
cord-005453-4057qib7	4890	62	of	of	IN
cord-005453-4057qib7	4890	63	complications	complication	NNS
cord-005453-4057qib7	4890	64	.	.	.
cord-005453-4057qib7	4891	1	There	there	EX
cord-005453-4057qib7	4891	2	were	be	VBD
cord-005453-4057qib7	4891	3	together	together	RB
cord-005453-4057qib7	4891	4	19	19	CD
cord-005453-4057qib7	4891	5	patients	patient	NNS
cord-005453-4057qib7	4891	6	selected	select	VBN
cord-005453-4057qib7	4891	7	for	for	IN
cord-005453-4057qib7	4891	8	this	this	DT
cord-005453-4057qib7	4891	9	analysis	analysis	NN
cord-005453-4057qib7	4891	10	-9	-9	NN
cord-005453-4057qib7	4891	11	with	with	IN
cord-005453-4057qib7	4891	12	amyloidosis	amyloidosis	NN
cord-005453-4057qib7	4891	13	(	(	-LRB-
cord-005453-4057qib7	4891	14	6	6	CD
cord-005453-4057qib7	4891	15	with	with	IN
cord-005453-4057qib7	4891	16	≥	≥	CD
cord-005453-4057qib7	4891	17	2	2	CD
cord-005453-4057qib7	4891	18	organs	organ	NNS
cord-005453-4057qib7	4891	19	involved	involve	VBN
cord-005453-4057qib7	4891	20	)	)	-RRB-
cord-005453-4057qib7	4891	21	,	,	,
cord-005453-4057qib7	4891	22	9	9	CD
cord-005453-4057qib7	4891	23	dialysed	dialyse	VBD
cord-005453-4057qib7	4891	24	,	,	,
cord-005453-4057qib7	4891	25	2	2	CD
cord-005453-4057qib7	4891	26	with	with	IN
cord-005453-4057qib7	4891	27	systemic	systemic	JJ
cord-005453-4057qib7	4891	28	sclerosis	sclerosis	NN
cord-005453-4057qib7	4891	29	,	,	,
cord-005453-4057qib7	4891	30	2	2	CD
cord-005453-4057qib7	4891	31	unfit	unfit	JJ
cord-005453-4057qib7	4891	32	at	at	IN
cord-005453-4057qib7	4891	33	other	other	JJ
cord-005453-4057qib7	4891	34	centre	centre	NN
cord-005453-4057qib7	4891	35	.	.	.
cord-005453-4057qib7	4892	1	The	the	DT
cord-005453-4057qib7	4892	2	database	database	NN
cord-005453-4057qib7	4892	3	included	include	VBD
cord-005453-4057qib7	4892	4	prospectively	prospectively	RB
cord-005453-4057qib7	4892	5	recorded	record	VBN
cord-005453-4057qib7	4892	6	serious	serious	JJ
cord-005453-4057qib7	4892	7	adverse	adverse	JJ
cord-005453-4057qib7	4892	8	events	event	NNS
cord-005453-4057qib7	4892	9	during	during	IN
cord-005453-4057qib7	4892	10	the	the	DT
cord-005453-4057qib7	4892	11	mobilization	mobilization	NN
cord-005453-4057qib7	4892	12	and	and	CC
cord-005453-4057qib7	4892	13	transplantation	transplantation	NN
cord-005453-4057qib7	4892	14	.	.	.
cord-005453-4057qib7	4893	1	Results	result	NNS
cord-005453-4057qib7	4893	2	:	:	:
cord-005453-4057qib7	4894	1	There	there	EX
cord-005453-4057qib7	4894	2	were	be	VBD
cord-005453-4057qib7	4894	3	20	20	CD
cord-005453-4057qib7	4894	4	transplantations	transplantation	NNS
cord-005453-4057qib7	4894	5	performed	perform	VBN
cord-005453-4057qib7	4894	6	in	in	IN
cord-005453-4057qib7	4894	7	this	this	DT
cord-005453-4057qib7	4894	8	group	group	NN
cord-005453-4057qib7	4894	9	of	of	IN
cord-005453-4057qib7	4894	10	patients	patient	NNS
cord-005453-4057qib7	4894	11	.	.	.
cord-005453-4057qib7	4895	1	Mortality	mortality	NN
cord-005453-4057qib7	4895	2	was	be	VBD
cord-005453-4057qib7	4895	3	0	0	CD
cord-005453-4057qib7	4895	4	%	%	NN
cord-005453-4057qib7	4895	5	at	at	IN
cord-005453-4057qib7	4895	6	100	100	CD
cord-005453-4057qib7	4895	7	days	day	NNS
cord-005453-4057qib7	4895	8	.	.	.
cord-005453-4057qib7	4896	1	All	all	DT
cord-005453-4057qib7	4896	2	patients	patient	NNS
cord-005453-4057qib7	4896	3	underwent	undergo	VBD
cord-005453-4057qib7	4896	4	successful	successful	JJ
cord-005453-4057qib7	4896	5	ambulatory	ambulatory	JJ
cord-005453-4057qib7	4896	6	mobilization	mobilization	NN
cord-005453-4057qib7	4896	7	.	.	.
cord-005453-4057qib7	4897	1	All	all	DT
cord-005453-4057qib7	4897	2	patients	patient	NNS
cord-005453-4057qib7	4897	3	received	receive	VBD
cord-005453-4057qib7	4897	4	Mephalan	Mephalan	NNP
cord-005453-4057qib7	4897	5	conditioning	conditioning	NN
cord-005453-4057qib7	4897	6	with	with	IN
cord-005453-4057qib7	4897	7	single	single	JJ
cord-005453-4057qib7	4897	8	infusion	infusion	NN
cord-005453-4057qib7	4897	9	with	with	IN
cord-005453-4057qib7	4897	10	median	median	JJ
cord-005453-4057qib7	4897	11	dose	dose	NN
cord-005453-4057qib7	4897	12	of	of	IN
cord-005453-4057qib7	4897	13	200mg	200mg	NNP
cord-005453-4057qib7	4897	14	/	/	SYM
cord-005453-4057qib7	4897	15	m2	m2	NNP
cord-005453-4057qib7	4897	16	(	(	-LRB-
cord-005453-4057qib7	4897	17	MIN	MIN	NNP
cord-005453-4057qib7	4897	18	140	140	CD
cord-005453-4057qib7	4897	19	,	,	,
cord-005453-4057qib7	4897	20	MAX	MAX	NNP
cord-005453-4057qib7	4897	21	200	200	CD
cord-005453-4057qib7	4897	22	)	)	-RRB-
cord-005453-4057qib7	4897	23	.	.	.
cord-005453-4057qib7	4898	1	Mean	mean	JJ
cord-005453-4057qib7	4898	2	engraftment	engraftment	NN
cord-005453-4057qib7	4898	3	was	be	VBD
cord-005453-4057qib7	4898	4	10.5	10.5	CD
cord-005453-4057qib7	4898	5	days	day	NNS
cord-005453-4057qib7	4898	6	for	for	IN
cord-005453-4057qib7	4898	7	white	white	JJ
cord-005453-4057qib7	4898	8	blood	blood	NN
cord-005453-4057qib7	4898	9	cells	cell	NNS
cord-005453-4057qib7	4898	10	and	and	CC
cord-005453-4057qib7	4898	11	12.7	12.7	CD
cord-005453-4057qib7	4898	12	days	day	NNS
cord-005453-4057qib7	4898	13	for	for	IN
cord-005453-4057qib7	4898	14	PLT	PLT	NNP
cord-005453-4057qib7	4898	15	over	over	IN
cord-005453-4057qib7	4898	16	20	20	CD
cord-005453-4057qib7	4898	17	G	G	NNP
cord-005453-4057qib7	4898	18	/	/	SYM
cord-005453-4057qib7	4898	19	L.	L.	NNP
cord-005453-4057qib7	4899	1	The	the	DT
cord-005453-4057qib7	4899	2	rate	rate	NN
cord-005453-4057qib7	4899	3	of	of	IN
cord-005453-4057qib7	4899	4	complications	complication	NNS
cord-005453-4057qib7	4899	5	was	be	VBD
cord-005453-4057qib7	4899	6	low	low	JJ
cord-005453-4057qib7	4899	7	with	with	IN
cord-005453-4057qib7	4899	8	7	7	CD
cord-005453-4057qib7	4899	9	cases	case	NNS
cord-005453-4057qib7	4899	10	of	of	IN
cord-005453-4057qib7	4899	11	neutropenic	neutropenic	RB
cord-005453-4057qib7	4899	12	fewer	few	JJR
cord-005453-4057qib7	4899	13	,	,	,
cord-005453-4057qib7	4899	14	1	1	CD
cord-005453-4057qib7	4899	15	single	single	JJ
cord-005453-4057qib7	4899	16	bacterial	bacterial	JJ
cord-005453-4057qib7	4899	17	culture	culture	NN
cord-005453-4057qib7	4899	18	with	with	IN
cord-005453-4057qib7	4899	19	Staphylococcus	Staphylococcus	NNP
cord-005453-4057qib7	4899	20	Epidermidis	Epidermidis	NNP
cord-005453-4057qib7	4899	21	without	without	IN
cord-005453-4057qib7	4899	22	clinical	clinical	JJ
cord-005453-4057qib7	4899	23	signs	sign	NNS
cord-005453-4057qib7	4899	24	of	of	IN
cord-005453-4057qib7	4899	25	infection	infection	NN
cord-005453-4057qib7	4899	26	,	,	,
cord-005453-4057qib7	4899	27	median	median	JJ
cord-005453-4057qib7	4899	28	mucositis	mucositis	JJ
cord-005453-4057qib7	4899	29	grade	grade	NN
cord-005453-4057qib7	4899	30	of	of	IN
cord-005453-4057qib7	4899	31	0.4	0.4	CD
cord-005453-4057qib7	4899	32	and	and	CC
cord-005453-4057qib7	4899	33	without	without	IN
cord-005453-4057qib7	4899	34	patients	patient	NNS
cord-005453-4057qib7	4899	35	on	on	IN
cord-005453-4057qib7	4899	36	parenteral	parenteral	JJ
cord-005453-4057qib7	4899	37	nutrition	nutrition	NN
cord-005453-4057qib7	4899	38	.	.	.
cord-005453-4057qib7	4900	1	The	the	DT
cord-005453-4057qib7	4900	2	median	median	JJ
cord-005453-4057qib7	4900	3	time	time	NN
cord-005453-4057qib7	4900	4	of	of	IN
cord-005453-4057qib7	4900	5	hospitalization	hospitalization	NN
cord-005453-4057qib7	4900	6	was	be	VBD
cord-005453-4057qib7	4900	7	19	19	CD
cord-005453-4057qib7	4900	8	days	day	NNS
cord-005453-4057qib7	4900	9	(	(	-LRB-
cord-005453-4057qib7	4900	10	MIN	MIN	NNP
cord-005453-4057qib7	4900	11	14	14	CD
cord-005453-4057qib7	4900	12	,	,	,
cord-005453-4057qib7	4900	13	MAX	MAX	NNP
cord-005453-4057qib7	4900	14	29	29	CD
cord-005453-4057qib7	4900	15	)	)	-RRB-
cord-005453-4057qib7	4900	16	.	.	.
cord-005453-4057qib7	4901	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4901	2	:	:	:
cord-005453-4057qib7	4902	1	We	-PRON-	PRP
cord-005453-4057qib7	4902	2	present	present	VBP
cord-005453-4057qib7	4902	3	here	here	RB
cord-005453-4057qib7	4902	4	novel	novel	JJ
cord-005453-4057qib7	4902	5	protocol	protocol	NN
cord-005453-4057qib7	4902	6	of	of	IN
cord-005453-4057qib7	4902	7	transplantation	transplantation	NN
cord-005453-4057qib7	4902	8	combining	combine	VBG
cord-005453-4057qib7	4902	9	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	4902	10	and	and	CC
cord-005453-4057qib7	4902	11	AHSCT	AHSCT	NNP
cord-005453-4057qib7	4902	12	with	with	IN
cord-005453-4057qib7	4902	13	fresh	fresh	JJ
cord-005453-4057qib7	4902	14	cells	cell	NNS
cord-005453-4057qib7	4902	15	with	with	IN
cord-005453-4057qib7	4902	16	excellent	excellent	JJ
cord-005453-4057qib7	4902	17	safety	safety	NN
cord-005453-4057qib7	4902	18	profile	profile	NN
cord-005453-4057qib7	4902	19	among	among	IN
cord-005453-4057qib7	4902	20	most	most	RBS
cord-005453-4057qib7	4902	21	severely	severely	RB
cord-005453-4057qib7	4902	22	ill	ill	JJ
cord-005453-4057qib7	4902	23	patients	patient	NNS
cord-005453-4057qib7	4902	24	allowing	allow	VBG
cord-005453-4057qib7	4902	25	for	for	IN
cord-005453-4057qib7	4902	26	safe	safe	JJ
cord-005453-4057qib7	4902	27	and	and	CC
cord-005453-4057qib7	4902	28	efficient	efficient	JJ
cord-005453-4057qib7	4902	29	transplants	transplant	NNS
cord-005453-4057qib7	4902	30	.	.	.
cord-005453-4057qib7	4903	1	With	with	IN
cord-005453-4057qib7	4903	2	this	this	DT
cord-005453-4057qib7	4903	3	protocol	protocol	NN
cord-005453-4057qib7	4903	4	we	-PRON-	PRP
cord-005453-4057qib7	4903	5	were	be	VBD
cord-005453-4057qib7	4903	6	able	able	JJ
cord-005453-4057qib7	4903	7	to	to	TO
cord-005453-4057qib7	4903	8	overcome	overcome	VB
cord-005453-4057qib7	4903	9	multiple	multiple	JJ
cord-005453-4057qib7	4903	10	risk	risk	NN
cord-005453-4057qib7	4903	11	factors	factor	NNS
cord-005453-4057qib7	4903	12	and	and	CC
cord-005453-4057qib7	4903	13	perform	perform	VB
cord-005453-4057qib7	4903	14	full	full	JJ
cord-005453-4057qib7	4903	15	intensity	intensity	NN
cord-005453-4057qib7	4903	16	transplantation	transplantation	NN
cord-005453-4057qib7	4903	17	in	in	IN
cord-005453-4057qib7	4903	18	very	very	RB
cord-005453-4057qib7	4903	19	fragile	fragile	JJ
cord-005453-4057qib7	4903	20	patients	patient	NNS
cord-005453-4057qib7	4903	21	.	.	.
cord-005453-4057qib7	4904	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4904	2	:	:	:
cord-005453-4057qib7	4904	3	Nothing	nothing	NN
cord-005453-4057qib7	4904	4	to	to	TO
cord-005453-4057qib7	4904	5	declare	declare	VB
cord-005453-4057qib7	4904	6	Single	single	JJ
cord-005453-4057qib7	4904	7	umbilical	umbilical	JJ
cord-005453-4057qib7	4904	8	cord	cord	NN
cord-005453-4057qib7	4904	9	blood	blood	NN
cord-005453-4057qib7	4904	10	transplantation	transplantation	NN
cord-005453-4057qib7	4904	11	provides	provide	VBZ
cord-005453-4057qib7	4904	12	durable	durable	JJ
cord-005453-4057qib7	4904	13	disease	disease	NN
cord-005453-4057qib7	4904	14	remission	remission	NN
cord-005453-4057qib7	4904	15	of	of	IN
cord-005453-4057qib7	4904	16	advanced	advanced	JJ
cord-005453-4057qib7	4904	17	hematological	hematological	JJ
cord-005453-4057qib7	4904	18	malignancies	malignancy	NNS
cord-005453-4057qib7	4904	19	in	in	IN
cord-005453-4057qib7	4904	20	elderly	elderly	JJ
cord-005453-4057qib7	4904	21	patients	patient	NNS
cord-005453-4057qib7	4905	1	Background	background	NN
cord-005453-4057qib7	4905	2	:	:	:
cord-005453-4057qib7	4906	1	Although	although	IN
cord-005453-4057qib7	4906	2	allogeneic	allogeneic	IN
cord-005453-4057qib7	4906	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4906	4	stem	stem	NN
cord-005453-4057qib7	4906	5	cell	cell	NN
cord-005453-4057qib7	4906	6	transplantation	transplantation	NN
cord-005453-4057qib7	4906	7	(	(	-LRB-
cord-005453-4057qib7	4906	8	allo	allo	NNP
cord-005453-4057qib7	4906	9	HSCT	HSCT	NNP
cord-005453-4057qib7	4906	10	)	)	-RRB-
cord-005453-4057qib7	4906	11	is	be	VBZ
cord-005453-4057qib7	4906	12	potentially	potentially	RB
cord-005453-4057qib7	4906	13	curative	curative	JJ
cord-005453-4057qib7	4906	14	therapy	therapy	NN
cord-005453-4057qib7	4906	15	in	in	IN
cord-005453-4057qib7	4906	16	a	a	DT
cord-005453-4057qib7	4906	17	variety	variety	NN
cord-005453-4057qib7	4906	18	of	of	IN
cord-005453-4057qib7	4906	19	hematological	hematological	JJ
cord-005453-4057qib7	4906	20	malignancies	malignancy	NNS
cord-005453-4057qib7	4906	21	,	,	,
cord-005453-4057qib7	4906	22	little	little	JJ
cord-005453-4057qib7	4906	23	has	have	VBZ
cord-005453-4057qib7	4906	24	been	be	VBN
cord-005453-4057qib7	4906	25	reported	report	VBN
cord-005453-4057qib7	4906	26	of	of	IN
cord-005453-4057qib7	4906	27	the	the	DT
cord-005453-4057qib7	4906	28	outcome	outcome	NN
cord-005453-4057qib7	4906	29	for	for	IN
cord-005453-4057qib7	4906	30	elderly	elderly	JJ
cord-005453-4057qib7	4906	31	patients	patient	NNS
cord-005453-4057qib7	4906	32	who	who	WP
cord-005453-4057qib7	4906	33	are	be	VBP
cord-005453-4057qib7	4906	34	not	not	RB
cord-005453-4057qib7	4906	35	in	in	IN
cord-005453-4057qib7	4906	36	remission	remission	NN
cord-005453-4057qib7	4906	37	at	at	IN
cord-005453-4057qib7	4906	38	transplantation	transplantation	NN
cord-005453-4057qib7	4906	39	.	.	.
cord-005453-4057qib7	4907	1	But	but	CC
cord-005453-4057qib7	4907	2	it	-PRON-	PRP
cord-005453-4057qib7	4907	3	has	have	VBZ
cord-005453-4057qib7	4907	4	been	be	VBN
cord-005453-4057qib7	4907	5	pointed	point	VBN
cord-005453-4057qib7	4907	6	out	out	RP
cord-005453-4057qib7	4907	7	that	that	IN
cord-005453-4057qib7	4907	8	recipient	recipient	NN
cord-005453-4057qib7	4907	9	age	age	NN
cord-005453-4057qib7	4907	10	alone	alone	RB
cord-005453-4057qib7	4907	11	can	can	MD
cord-005453-4057qib7	4907	12	not	not	RB
cord-005453-4057qib7	4907	13	be	be	VB
cord-005453-4057qib7	4907	14	regarded	regard	VBN
cord-005453-4057qib7	4907	15	as	as	IN
cord-005453-4057qib7	4907	16	contraindication	contraindication	NN
cord-005453-4057qib7	4907	17	for	for	IN
cord-005453-4057qib7	4907	18	allo	allo	NNP
cord-005453-4057qib7	4907	19	HSCT	HSCT	NNP
cord-005453-4057qib7	4907	20	in	in	IN
cord-005453-4057qib7	4907	21	the	the	DT
cord-005453-4057qib7	4907	22	literature	literature	NN
cord-005453-4057qib7	4907	23	recently	recently	RB
cord-005453-4057qib7	4907	24	,	,	,
cord-005453-4057qib7	4907	25	supported	support	VBN
cord-005453-4057qib7	4907	26	by	by	IN
cord-005453-4057qib7	4907	27	suitable	suitable	JJ
cord-005453-4057qib7	4907	28	donor	donor	NN
cord-005453-4057qib7	4907	29	,	,	,
cord-005453-4057qib7	4907	30	conditioning	conditioning	NN
cord-005453-4057qib7	4907	31	regimens	regimen	NNS
cord-005453-4057qib7	4907	32	and	and	CC
cord-005453-4057qib7	4907	33	appropriate	appropriate	JJ
cord-005453-4057qib7	4907	34	management	management	NN
cord-005453-4057qib7	4907	35	of	of	IN
cord-005453-4057qib7	4907	36	complications	complication	NNS
cord-005453-4057qib7	4907	37	.	.	.
cord-005453-4057qib7	4908	1	We	-PRON-	PRP
cord-005453-4057qib7	4908	2	conducted	conduct	VBD
cord-005453-4057qib7	4908	3	a	a	DT
cord-005453-4057qib7	4908	4	retrospective	retrospective	JJ
cord-005453-4057qib7	4908	5	study	study	NN
cord-005453-4057qib7	4908	6	of	of	IN
cord-005453-4057qib7	4908	7	elderly	elderly	JJ
cord-005453-4057qib7	4908	8	patients	patient	NNS
cord-005453-4057qib7	4908	9	who	who	WP
cord-005453-4057qib7	4908	10	had	have	VBD
cord-005453-4057qib7	4908	11	advanced	advanced	JJ
cord-005453-4057qib7	4908	12	hematologic	hematologic	JJ
cord-005453-4057qib7	4908	13	malignancies	malignancy	NNS
cord-005453-4057qib7	4908	14	to	to	TO
cord-005453-4057qib7	4908	15	elucidate	elucidate	VB
cord-005453-4057qib7	4908	16	the	the	DT
cord-005453-4057qib7	4908	17	outcome	outcome	NN
cord-005453-4057qib7	4908	18	of	of	IN
cord-005453-4057qib7	4908	19	single	single	JJ
cord-005453-4057qib7	4908	20	umbilical	umbilical	JJ
cord-005453-4057qib7	4908	21	cord	cord	NN
cord-005453-4057qib7	4908	22	blood	blood	NN
cord-005453-4057qib7	4908	23	transplantation	transplantation	NN
cord-005453-4057qib7	4908	24	(	(	-LRB-
cord-005453-4057qib7	4908	25	sUCBT	sucbt	NN
cord-005453-4057qib7	4908	26	)	)	-RRB-
cord-005453-4057qib7	4908	27	in	in	IN
cord-005453-4057qib7	4908	28	Toranomon	Toranomon	NNP
cord-005453-4057qib7	4908	29	Hospital	Hospital	NNP
cord-005453-4057qib7	4908	30	Kajigaya	Kajigaya	NNP
cord-005453-4057qib7	4908	31	,	,	,
cord-005453-4057qib7	4908	32	Japan	Japan	NNP
cord-005453-4057qib7	4908	33	.	.	.
cord-005453-4057qib7	4909	1	Methods	method	NNS
cord-005453-4057qib7	4910	1	:	:	:
cord-005453-4057qib7	4910	2	We	-PRON-	PRP
cord-005453-4057qib7	4910	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	4910	4	investigated	investigate	VBD
cord-005453-4057qib7	4910	5	the	the	DT
cord-005453-4057qib7	4910	6	outcomes	outcome	NNS
cord-005453-4057qib7	4910	7	of	of	IN
cord-005453-4057qib7	4910	8	19	19	CD
cord-005453-4057qib7	4910	9	patients	patient	NNS
cord-005453-4057qib7	4910	10	aged	age	VBN
cord-005453-4057qib7	4910	11	over	over	IN
cord-005453-4057qib7	4910	12	65	65	CD
cord-005453-4057qib7	4910	13	who	who	WP
cord-005453-4057qib7	4910	14	underwent	undergo	VBD
cord-005453-4057qib7	4910	15	their	-PRON-	PRP$
cord-005453-4057qib7	4910	16	first	first	JJ
cord-005453-4057qib7	4910	17	UCBT	UCBT	NNP
cord-005453-4057qib7	4910	18	from	from	IN
cord-005453-4057qib7	4910	19	June	June	NNP
cord-005453-4057qib7	4910	20	2013	2013	CD
cord-005453-4057qib7	4910	21	to	to	IN
cord-005453-4057qib7	4910	22	December	December	NNP
cord-005453-4057qib7	4910	23	2017	2017	CD
cord-005453-4057qib7	4910	24	in	in	IN
cord-005453-4057qib7	4910	25	our	-PRON-	PRP$
cord-005453-4057qib7	4910	26	medical	medical	JJ
cord-005453-4057qib7	4910	27	center	center	NN
cord-005453-4057qib7	4910	28	.	.	.
cord-005453-4057qib7	4911	1	Results	result	NNS
cord-005453-4057qib7	4911	2	:	:	:
cord-005453-4057qib7	4912	1	Diseases	disease	NNS
cord-005453-4057qib7	4912	2	included	include	VBD
cord-005453-4057qib7	4912	3	acute	acute	JJ
cord-005453-4057qib7	4912	4	myelogenous	myelogenous	NN
cord-005453-4057qib7	4912	5	leukemia	leukemia	NN
cord-005453-4057qib7	4912	6	(	(	-LRB-
cord-005453-4057qib7	4912	7	n=12	n=12	NNP
cord-005453-4057qib7	4912	8	)	)	-RRB-
cord-005453-4057qib7	4912	9	,	,	,
cord-005453-4057qib7	4912	10	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	4912	11	syndrome	syndrome	NN
cord-005453-4057qib7	4912	12	(	(	-LRB-
cord-005453-4057qib7	4912	13	n=3	n=3	NN
cord-005453-4057qib7	4912	14	)	)	-RRB-
cord-005453-4057qib7	4912	15	,	,	,
cord-005453-4057qib7	4912	16	adult	adult	NN
cord-005453-4057qib7	4912	17	T	t	NN
cord-005453-4057qib7	4912	18	-	-	HYPH
cord-005453-4057qib7	4912	19	cell	cell	NN
cord-005453-4057qib7	4912	20	leukemia	leukemia	NN
cord-005453-4057qib7	4912	21	/	/	SYM
cord-005453-4057qib7	4912	22	lymphoma	lymphoma	NN
cord-005453-4057qib7	4912	23	(	(	-LRB-
cord-005453-4057qib7	4912	24	n=2	n=2	NNP
cord-005453-4057qib7	4912	25	)	)	-RRB-
cord-005453-4057qib7	4912	26	,	,	,
cord-005453-4057qib7	4912	27	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	4912	28	(	(	-LRB-
cord-005453-4057qib7	4912	29	n=1	n=1	NNP
cord-005453-4057qib7	4912	30	)	)	-RRB-
cord-005453-4057qib7	4912	31	and	and	CC
cord-005453-4057qib7	4912	32	chronic	chronic	JJ
cord-005453-4057qib7	4912	33	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	4912	34	leukemia	leukemia	NN
cord-005453-4057qib7	4912	35	(	(	-LRB-
cord-005453-4057qib7	4912	36	n=1	n=1	NN
cord-005453-4057qib7	4912	37	)	)	-RRB-
cord-005453-4057qib7	4912	38	.	.	.
cord-005453-4057qib7	4913	1	The	the	DT
cord-005453-4057qib7	4913	2	median	median	JJ
cord-005453-4057qib7	4913	3	age	age	NN
cord-005453-4057qib7	4913	4	at	at	IN
cord-005453-4057qib7	4913	5	transplantation	transplantation	NN
cord-005453-4057qib7	4913	6	was	be	VBD
cord-005453-4057qib7	4913	7	69	69	CD
cord-005453-4057qib7	4913	8	years	year	NNS
cord-005453-4057qib7	4914	1	(	(	-LRB-
cord-005453-4057qib7	4914	2	range	range	NN
cord-005453-4057qib7	4914	3	,	,	,
cord-005453-4057qib7	4914	4	65	65	CD
cord-005453-4057qib7	4914	5	-	-	SYM
cord-005453-4057qib7	4914	6	75	75	CD
cord-005453-4057qib7	4914	7	)	)	-RRB-
cord-005453-4057qib7	4914	8	and	and	CC
cord-005453-4057qib7	4914	9	follow	follow	NN
cord-005453-4057qib7	4914	10	-	-	HYPH
cord-005453-4057qib7	4914	11	up	up	NN
cord-005453-4057qib7	4914	12	for	for	IN
cord-005453-4057qib7	4914	13	survivor	survivor	NN
cord-005453-4057qib7	4914	14	post	post	NN
cord-005453-4057qib7	4914	15	transplantation	transplantation	NN
cord-005453-4057qib7	4914	16	was	be	VBD
cord-005453-4057qib7	4914	17	642	642	CD
cord-005453-4057qib7	4914	18	day	day	NN
cord-005453-4057qib7	4914	19	(	(	-LRB-
cord-005453-4057qib7	4914	20	range	range	NN
cord-005453-4057qib7	4914	21	,	,	,
cord-005453-4057qib7	4914	22	391	391	CD
cord-005453-4057qib7	4914	23	-	-	HYPH
cord-005453-4057qib7	4914	24	767	767	NNP
cord-005453-4057qib7	4914	25	)	)	-RRB-
cord-005453-4057qib7	4914	26	.	.	.
cord-005453-4057qib7	4915	1	All	all	DT
cord-005453-4057qib7	4915	2	patients	patient	NNS
cord-005453-4057qib7	4915	3	were	be	VBD
cord-005453-4057qib7	4915	4	not	not	RB
cord-005453-4057qib7	4915	5	in	in	IN
cord-005453-4057qib7	4915	6	complete	complete	JJ
cord-005453-4057qib7	4915	7	remission	remission	NN
cord-005453-4057qib7	4915	8	(	(	-LRB-
cord-005453-4057qib7	4915	9	CR	CR	NNP
cord-005453-4057qib7	4915	10	)	)	-RRB-
cord-005453-4057qib7	4915	11	at	at	IN
cord-005453-4057qib7	4915	12	the	the	DT
cord-005453-4057qib7	4915	13	time	time	NN
cord-005453-4057qib7	4915	14	of	of	IN
cord-005453-4057qib7	4915	15	transplantation	transplantation	NN
cord-005453-4057qib7	4915	16	.	.	.
cord-005453-4057qib7	4916	1	Reduced	reduced	JJ
cord-005453-4057qib7	4916	2	intensity	intensity	NN
cord-005453-4057qib7	4916	3	conditioning	conditioning	NN
cord-005453-4057qib7	4916	4	(	(	-LRB-
cord-005453-4057qib7	4916	5	RIC	RIC	NNP
cord-005453-4057qib7	4916	6	)	)	-RRB-
cord-005453-4057qib7	4916	7	regimens	regimen	NNS
cord-005453-4057qib7	4916	8	were	be	VBD
cord-005453-4057qib7	4916	9	used	use	VBN
cord-005453-4057qib7	4916	10	in	in	IN
cord-005453-4057qib7	4916	11	10	10	CD
cord-005453-4057qib7	4916	12	patients	patient	NNS
cord-005453-4057qib7	4916	13	.	.	.
cord-005453-4057qib7	4917	1	All	all	DT
cord-005453-4057qib7	4917	2	patients	patient	NNS
cord-005453-4057qib7	4917	3	received	receive	VBD
cord-005453-4057qib7	4917	4	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	4917	5	and	and	CC
cord-005453-4057qib7	4917	6	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	4917	7	mofetil	mofetil	NNP
cord-005453-4057qib7	4917	8	as	as	IN
cord-005453-4057qib7	4917	9	graftversus	graftversus	NNP
cord-005453-4057qib7	4917	10	-	-	HYPH
cord-005453-4057qib7	4917	11	host	host	NN
cord-005453-4057qib7	4917	12	disease	disease	NN
cord-005453-4057qib7	4917	13	(	(	-LRB-
cord-005453-4057qib7	4917	14	GVHD	GVHD	NNP
cord-005453-4057qib7	4917	15	)	)	-RRB-
cord-005453-4057qib7	4917	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	4917	17	.	.	.
cord-005453-4057qib7	4918	1	All	all	DT
cord-005453-4057qib7	4918	2	cases	case	NNS
cord-005453-4057qib7	4918	3	except	except	IN
cord-005453-4057qib7	4918	4	4	4	CD
cord-005453-4057qib7	4918	5	early	early	JJ
cord-005453-4057qib7	4918	6	death	death	NN
cord-005453-4057qib7	4918	7	achieved	achieve	VBD
cord-005453-4057qib7	4918	8	neutrophil	neutrophil	NN
cord-005453-4057qib7	4918	9	recovery	recovery	NN
cord-005453-4057qib7	4918	10	at	at	IN
cord-005453-4057qib7	4918	11	median	median	NN
cord-005453-4057qib7	4918	12	18	18	CD
cord-005453-4057qib7	4918	13	days	day	NNS
cord-005453-4057qib7	4918	14	(	(	-LRB-
cord-005453-4057qib7	4918	15	range	range	NN
cord-005453-4057qib7	4918	16	,	,	,
cord-005453-4057qib7	4918	17	13	13	CD
cord-005453-4057qib7	4918	18	-	-	SYM
cord-005453-4057qib7	4918	19	28	28	CD
cord-005453-4057qib7	4918	20	)	)	-RRB-
cord-005453-4057qib7	4918	21	.	.	.
cord-005453-4057qib7	4919	1	At	at	IN
cord-005453-4057qib7	4919	2	1	1	CD
cord-005453-4057qib7	4919	3	year	year	NN
cord-005453-4057qib7	4919	4	,	,	,
cord-005453-4057qib7	4919	5	overall	overall	JJ
cord-005453-4057qib7	4919	6	survival	survival	NN
cord-005453-4057qib7	4919	7	(	(	-LRB-
cord-005453-4057qib7	4919	8	OS	os	NN
cord-005453-4057qib7	4919	9	)	)	-RRB-
cord-005453-4057qib7	4919	10	rate	rate	NN
cord-005453-4057qib7	4919	11	and	and	CC
cord-005453-4057qib7	4919	12	disease	disease	NN
cord-005453-4057qib7	4919	13	free	free	JJ
cord-005453-4057qib7	4919	14	survival	survival	NN
cord-005453-4057qib7	4919	15	(	(	-LRB-
cord-005453-4057qib7	4919	16	DFS	DFS	NNP
cord-005453-4057qib7	4919	17	)	)	-RRB-
cord-005453-4057qib7	4919	18	were	be	VBD
cord-005453-4057qib7	4919	19	31,6	31,6	CD
cord-005453-4057qib7	4919	20	%	%	NN
cord-005453-4057qib7	4919	21	(	(	-LRB-
cord-005453-4057qib7	4919	22	95	95	CD
cord-005453-4057qib7	4919	23	%	%	NN
cord-005453-4057qib7	4919	24	confidence	confidence	NN
cord-005453-4057qib7	4919	25	interval	interval	NN
cord-005453-4057qib7	4919	26	(	(	-LRB-
cord-005453-4057qib7	4919	27	CI	CI	NNP
cord-005453-4057qib7	4919	28	)	)	-RRB-
cord-005453-4057qib7	4919	29	,	,	,
cord-005453-4057qib7	4919	30	12.9	12.9	CD
cord-005453-4057qib7	4919	31	-	-	SYM
cord-005453-4057qib7	4919	32	52.2	52.2	CD
cord-005453-4057qib7	4919	33	)	)	-RRB-
cord-005453-4057qib7	4919	34	.	.	.
cord-005453-4057qib7	4920	1	We	-PRON-	PRP
cord-005453-4057qib7	4920	2	performed	perform	VBD
cord-005453-4057qib7	4920	3	univariate	univariate	JJ
cord-005453-4057qib7	4920	4	analysis	analysis	NN
cord-005453-4057qib7	4920	5	to	to	TO
cord-005453-4057qib7	4920	6	identify	identify	VB
cord-005453-4057qib7	4920	7	the	the	DT
cord-005453-4057qib7	4920	8	factor	factor	NN
cord-005453-4057qib7	4920	9	that	that	WDT
cord-005453-4057qib7	4920	10	influenced	influence	VBD
cord-005453-4057qib7	4920	11	OS	OS	NNP
cord-005453-4057qib7	4920	12	at	at	IN
cord-005453-4057qib7	4920	13	1	1	CD
cord-005453-4057qib7	4920	14	year	year	NN
cord-005453-4057qib7	4920	15	,	,	,
cord-005453-4057qib7	4920	16	but	but	CC
cord-005453-4057qib7	4920	17	no	no	DT
cord-005453-4057qib7	4920	18	statistical	statistical	JJ
cord-005453-4057qib7	4920	19	significance	significance	NN
cord-005453-4057qib7	4920	20	was	be	VBD
cord-005453-4057qib7	4920	21	demonstrated	demonstrate	VBN
cord-005453-4057qib7	4920	22	at	at	IN
cord-005453-4057qib7	4920	23	the	the	DT
cord-005453-4057qib7	4920	24	age	age	NN
cord-005453-4057qib7	4920	25	of	of	IN
cord-005453-4057qib7	4920	26	transplantation	transplantation	NN
cord-005453-4057qib7	4920	27	(	(	-LRB-
cord-005453-4057qib7	4920	28	Aged	aged	JJ
cord-005453-4057qib7	4920	29	65	65	CD
cord-005453-4057qib7	4920	30	to	to	TO
cord-005453-4057qib7	4920	31	69	69	CD
cord-005453-4057qib7	4920	32	vs.	vs.	NN
cord-005453-4057qib7	4920	33	≧70	≧70	CD
cord-005453-4057qib7	4920	34	,	,	,
cord-005453-4057qib7	4920	35	33.3	33.3	CD
cord-005453-4057qib7	4920	36	%	%	NN
cord-005453-4057qib7	4920	37	(	(	-LRB-
cord-005453-4057qib7	4920	38	95	95	CD
cord-005453-4057qib7	4920	39	%	%	NN
cord-005453-4057qib7	4920	40	CI	CI	NNP
cord-005453-4057qib7	4920	41	,	,	,
cord-005453-4057qib7	4920	42	10.3	10.3	CD
cord-005453-4057qib7	4920	43	-	-	HYPH
cord-005453-4057qib7	4920	44	58.8	58.8	CD
cord-005453-4057qib7	4920	45	)	)	-RRB-
cord-005453-4057qib7	4920	46	vs.	vs.	IN
cord-005453-4057qib7	4920	47	42.9	42.9	CD
cord-005453-4057qib7	4920	48	%	%	NN
cord-005453-4057qib7	4920	49	(	(	-LRB-
cord-005453-4057qib7	4920	50	95	95	CD
cord-005453-4057qib7	4920	51	%	%	NN
cord-005453-4057qib7	4920	52	CI	CI	NNP
cord-005453-4057qib7	4920	53	,	,	,
cord-005453-4057qib7	4920	54	9.8	9.8	CD
cord-005453-4057qib7	4920	55	-	-	HYPH
cord-005453-4057qib7	4920	56	73.4	73.4	CD
cord-005453-4057qib7	4920	57	)	)	-RRB-
cord-005453-4057qib7	4920	58	,	,	,
cord-005453-4057qib7	4920	59	p=0.68	p=0.68	NN
cord-005453-4057qib7	4920	60	)	)	-RRB-
cord-005453-4057qib7	4920	61	.	.	.
cord-005453-4057qib7	4921	1	The	the	DT
cord-005453-4057qib7	4921	2	cumulative	cumulative	JJ
cord-005453-4057qib7	4921	3	incidence	incidence	NN
cord-005453-4057qib7	4921	4	of	of	IN
cord-005453-4057qib7	4921	5	non	non	JJ
cord-005453-4057qib7	4921	6	-	-	JJ
cord-005453-4057qib7	4921	7	relapse	relapse	JJ
cord-005453-4057qib7	4921	8	mortality	mortality	NN
cord-005453-4057qib7	4921	9	(	(	-LRB-
cord-005453-4057qib7	4921	10	NRM	NRM	NNP
cord-005453-4057qib7	4921	11	)	)	-RRB-
cord-005453-4057qib7	4921	12	at	at	IN
cord-005453-4057qib7	4921	13	100	100	CD
cord-005453-4057qib7	4921	14	days	day	NNS
cord-005453-4057qib7	4921	15	was	be	VBD
cord-005453-4057qib7	4921	16	47.4	47.4	CD
cord-005453-4057qib7	4921	17	%	%	NN
cord-005453-4057qib7	4921	18	(	(	-LRB-
cord-005453-4057qib7	4921	19	95	95	CD
cord-005453-4057qib7	4921	20	%	%	NN
cord-005453-4057qib7	4921	21	CI	CI	NNP
cord-005453-4057qib7	4921	22	,	,	,
cord-005453-4057qib7	4921	23	23.6	23.6	CD
cord-005453-4057qib7	4921	24	-	-	HYPH
cord-005453-4057qib7	4921	25	67.9	67.9	CD
cord-005453-4057qib7	4921	26	%	%	NN
cord-005453-4057qib7	4921	27	)	)	-RRB-
cord-005453-4057qib7	4921	28	and	and	CC
cord-005453-4057qib7	4921	29	relapse	relapse	VB
cord-005453-4057qib7	4921	30	at	at	IN
cord-005453-4057qib7	4921	31	1	1	CD
cord-005453-4057qib7	4921	32	year	year	NN
cord-005453-4057qib7	4921	33	was	be	VBD
cord-005453-4057qib7	4921	34	9.1	9.1	CD
cord-005453-4057qib7	4921	35	%	%	NN
cord-005453-4057qib7	4921	36	(	(	-LRB-
cord-005453-4057qib7	4921	37	95	95	CD
cord-005453-4057qib7	4921	38	%	%	NN
cord-005453-4057qib7	4921	39	CI	CI	NNP
cord-005453-4057qib7	4921	40	,	,	,
cord-005453-4057qib7	4921	41	0.0	0.0	CD
cord-005453-4057qib7	4921	42	-	-	HYPH
cord-005453-4057qib7	4921	43	24.6	24.6	CD
cord-005453-4057qib7	4921	44	%	%	NN
cord-005453-4057qib7	4921	45	)	)	-RRB-
cord-005453-4057qib7	4921	46	.	.	.
cord-005453-4057qib7	4922	1	Only	only	RB
cord-005453-4057qib7	4922	2	two	two	CD
cord-005453-4057qib7	4922	3	patients	patient	NNS
cord-005453-4057qib7	4922	4	developed	develop	VBD
cord-005453-4057qib7	4922	5	acute	acute	JJ
cord-005453-4057qib7	4922	6	GVHD(II	GVHD(II	NNP
cord-005453-4057qib7	4922	7	-	-	HYPH
cord-005453-4057qib7	4922	8	IV	IV	NNP
cord-005453-4057qib7	4922	9	)	)	-RRB-
cord-005453-4057qib7	4922	10	and	and	CC
cord-005453-4057qib7	4922	11	one	one	CD
cord-005453-4057qib7	4922	12	developed	develop	VBD
cord-005453-4057qib7	4922	13	severe	severe	JJ
cord-005453-4057qib7	4922	14	GVHD	GVHD	NNP
cord-005453-4057qib7	4922	15	at	at	IN
cord-005453-4057qib7	4922	16	49	49	CD
cord-005453-4057qib7	4922	17	days	day	NNS
cord-005453-4057qib7	4922	18	after	after	IN
cord-005453-4057qib7	4922	19	transplantation	transplantation	NN
cord-005453-4057qib7	4922	20	.	.	.
cord-005453-4057qib7	4923	1	The	the	DT
cord-005453-4057qib7	4923	2	main	main	JJ
cord-005453-4057qib7	4923	3	causes	cause	NNS
cord-005453-4057qib7	4923	4	of	of	IN
cord-005453-4057qib7	4923	5	death	death	NN
cord-005453-4057qib7	4923	6	was	be	VBD
cord-005453-4057qib7	4923	7	infection	infection	NN
cord-005453-4057qib7	4923	8	(	(	-LRB-
cord-005453-4057qib7	4923	9	n=10	n=10	NNP
cord-005453-4057qib7	4923	10	)	)	-RRB-
cord-005453-4057qib7	4923	11	,	,	,
cord-005453-4057qib7	4923	12	including	include	VBG
cord-005453-4057qib7	4923	13	sepsis	sepsis	NN
cord-005453-4057qib7	4923	14	(	(	-LRB-
cord-005453-4057qib7	4923	15	n=8	n=8	NN
cord-005453-4057qib7	4923	16	)	)	-RRB-
cord-005453-4057qib7	4923	17	and	and	CC
cord-005453-4057qib7	4923	18	viral	viral	JJ
cord-005453-4057qib7	4923	19	encephalitis	encephalitis	NN
cord-005453-4057qib7	4923	20	(	(	-LRB-
cord-005453-4057qib7	4923	21	n=2	n=2	NNS
cord-005453-4057qib7	4923	22	)	)	-RRB-
cord-005453-4057qib7	4923	23	,	,	,
cord-005453-4057qib7	4923	24	followed	follow	VBN
cord-005453-4057qib7	4923	25	by	by	IN
cord-005453-4057qib7	4923	26	idiopathic	idiopathic	JJ
cord-005453-4057qib7	4923	27	pneumonia	pneumonia	NN
cord-005453-4057qib7	4923	28	syndrome	syndrome	NN
cord-005453-4057qib7	4923	29	(	(	-LRB-
cord-005453-4057qib7	4923	30	n=2	n=2	NNP
cord-005453-4057qib7	4923	31	)	)	-RRB-
cord-005453-4057qib7	4923	32	and	and	CC
cord-005453-4057qib7	4923	33	thrombotic	thrombotic	JJ
cord-005453-4057qib7	4923	34	microangiopathy	microangiopathy	NNP
cord-005453-4057qib7	4923	35	(	(	-LRB-
cord-005453-4057qib7	4923	36	n=1	n=1	UH
cord-005453-4057qib7	4923	37	)	)	-RRB-
cord-005453-4057qib7	4923	38	during	during	IN
cord-005453-4057qib7	4923	39	the	the	DT
cord-005453-4057qib7	4923	40	early	early	JJ
cord-005453-4057qib7	4923	41	phase	phase	NN
cord-005453-4057qib7	4923	42	of	of	IN
cord-005453-4057qib7	4923	43	transplantation	transplantation	NN
cord-005453-4057qib7	4923	44	.	.	.
cord-005453-4057qib7	4924	1	In	in	IN
cord-005453-4057qib7	4924	2	contrast	contrast	NN
cord-005453-4057qib7	4924	3	,	,	,
cord-005453-4057qib7	4924	4	no	no	DT
cord-005453-4057qib7	4924	5	patients	patient	NNS
cord-005453-4057qib7	4924	6	died	die	VBD
cord-005453-4057qib7	4924	7	of	of	IN
cord-005453-4057qib7	4924	8	recurrence	recurrence	NN
cord-005453-4057qib7	4924	9	.	.	.
cord-005453-4057qib7	4925	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4925	2	:	:	:
cord-005453-4057qib7	4926	1	Although	although	IN
cord-005453-4057qib7	4926	2	our	-PRON-	PRP$
cord-005453-4057qib7	4926	3	report	report	NN
cord-005453-4057qib7	4926	4	consisted	consist	VBD
cord-005453-4057qib7	4926	5	relapsed/	relapsed/	NNP
cord-005453-4057qib7	4926	6	refractory	refractory	JJ
cord-005453-4057qib7	4926	7	disease	disease	NN
cord-005453-4057qib7	4926	8	of	of	IN
cord-005453-4057qib7	4926	9	elderly	elderly	JJ
cord-005453-4057qib7	4926	10	patients	patient	NNS
cord-005453-4057qib7	4926	11	at	at	IN
cord-005453-4057qib7	4926	12	the	the	DT
cord-005453-4057qib7	4926	13	time	time	NN
cord-005453-4057qib7	4926	14	of	of	IN
cord-005453-4057qib7	4926	15	sUCBT	sUCBT	NNS
cord-005453-4057qib7	4926	16	,	,	,
cord-005453-4057qib7	4926	17	durable	durable	JJ
cord-005453-4057qib7	4926	18	remission	remission	NN
cord-005453-4057qib7	4926	19	and	and	CC
cord-005453-4057qib7	4926	20	lower	low	JJR
cord-005453-4057qib7	4926	21	incidence	incidence	NN
cord-005453-4057qib7	4926	22	of	of	IN
cord-005453-4057qib7	4926	23	GVHD	GVHD	NNP
cord-005453-4057qib7	4926	24	could	could	MD
cord-005453-4057qib7	4926	25	be	be	VB
cord-005453-4057qib7	4926	26	noteworthy	noteworthy	JJ
cord-005453-4057qib7	4926	27	compared	compare	VBN
cord-005453-4057qib7	4926	28	with	with	IN
cord-005453-4057qib7	4926	29	previous	previous	JJ
cord-005453-4057qib7	4926	30	reports	report	NNS
cord-005453-4057qib7	4926	31	.	.	.
cord-005453-4057qib7	4927	1	Further	further	JJ
cord-005453-4057qib7	4927	2	strategies	strategy	NNS
cord-005453-4057qib7	4927	3	to	to	TO
cord-005453-4057qib7	4927	4	reduce	reduce	VB
cord-005453-4057qib7	4927	5	the	the	DT
cord-005453-4057qib7	4927	6	rate	rate	NN
cord-005453-4057qib7	4927	7	of	of	IN
cord-005453-4057qib7	4927	8	NRM	NRM	NNP
cord-005453-4057qib7	4927	9	and	and	CC
cord-005453-4057qib7	4927	10	longer	long	JJR
cord-005453-4057qib7	4927	11	duration	duration	NN
cord-005453-4057qib7	4927	12	of	of	IN
cord-005453-4057qib7	4927	13	follow	follow	NN
cord-005453-4057qib7	4927	14	up	up	RP
cord-005453-4057qib7	4927	15	would	would	MD
cord-005453-4057qib7	4927	16	be	be	VB
cord-005453-4057qib7	4927	17	warranted	warrant	VBN
cord-005453-4057qib7	4927	18	.	.	.
cord-005453-4057qib7	4928	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4928	2	Background	Background	NNP
cord-005453-4057qib7	4928	3	:	:	:
cord-005453-4057qib7	4928	4	Pearson	Pearson	NNP
cord-005453-4057qib7	4928	5	syndrome	syndrome	NN
cord-005453-4057qib7	4928	6	and	and	CC
cord-005453-4057qib7	4928	7	Kearns	Kearns	NNP
cord-005453-4057qib7	4928	8	-	-	HYPH
cord-005453-4057qib7	4928	9	Sayre	Sayre	NNP
cord-005453-4057qib7	4928	10	syndrome	syndrome	NN
cord-005453-4057qib7	4928	11	are	be	VBP
cord-005453-4057qib7	4928	12	metabolic	metabolic	JJ
cord-005453-4057qib7	4928	13	disorders	disorder	NNS
cord-005453-4057qib7	4928	14	caused	cause	VBN
cord-005453-4057qib7	4928	15	by	by	IN
cord-005453-4057qib7	4928	16	a	a	DT
cord-005453-4057qib7	4928	17	de	de	JJ
cord-005453-4057qib7	4928	18	-	-	JJ
cord-005453-4057qib7	4928	19	novo	novo	JJ
cord-005453-4057qib7	4928	20	deletion	deletion	NN
cord-005453-4057qib7	4928	21	in	in	IN
cord-005453-4057qib7	4928	22	the	the	DT
cord-005453-4057qib7	4928	23	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4928	24	DNA	dna	NN
cord-005453-4057qib7	4928	25	(	(	-LRB-
cord-005453-4057qib7	4928	26	mtDNA	mtDNA	NNP
cord-005453-4057qib7	4928	27	)	)	-RRB-
cord-005453-4057qib7	4928	28	.	.	.
cord-005453-4057qib7	4929	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	4929	2	stem	stem	VBP
cord-005453-4057qib7	4929	3	cell	cell	NN
cord-005453-4057qib7	4929	4	transplantation	transplantation	NN
cord-005453-4057qib7	4929	5	has	have	VBZ
cord-005453-4057qib7	4929	6	shown	show	VBN
cord-005453-4057qib7	4929	7	to	to	TO
cord-005453-4057qib7	4929	8	improve	improve	VB
cord-005453-4057qib7	4929	9	metabolic	metabolic	JJ
cord-005453-4057qib7	4929	10	function	function	NN
cord-005453-4057qib7	4929	11	in	in	IN
cord-005453-4057qib7	4929	12	distal	distal	JJ
cord-005453-4057qib7	4929	13	organs	organ	NNS
cord-005453-4057qib7	4929	14	in	in	IN
cord-005453-4057qib7	4929	15	several	several	JJ
cord-005453-4057qib7	4929	16	metabolic	metabolic	JJ
cord-005453-4057qib7	4929	17	disorders	disorder	NNS
cord-005453-4057qib7	4929	18	,	,	,
cord-005453-4057qib7	4929	19	but	but	CC
cord-005453-4057qib7	4929	20	bears	bear	VBZ
cord-005453-4057qib7	4929	21	significant	significant	JJ
cord-005453-4057qib7	4929	22	morbidity	morbidity	NN
cord-005453-4057qib7	4929	23	and	and	CC
cord-005453-4057qib7	4929	24	mortality	mortality	NN
cord-005453-4057qib7	4929	25	,	,	,
cord-005453-4057qib7	4929	26	especially	especially	RB
cord-005453-4057qib7	4929	27	for	for	IN
cord-005453-4057qib7	4929	28	patients	patient	NNS
cord-005453-4057qib7	4929	29	with	with	IN
cord-005453-4057qib7	4929	30	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4929	31	disorders	disorder	NNS
cord-005453-4057qib7	4929	32	.	.	.
cord-005453-4057qib7	4930	1	Novel	novel	JJ
cord-005453-4057qib7	4930	2	gene	gene	NN
cord-005453-4057qib7	4930	3	therapies	therapy	NNS
cord-005453-4057qib7	4930	4	may	may	MD
cord-005453-4057qib7	4930	5	correct	correct	VB
cord-005453-4057qib7	4930	6	diseases	disease	NNS
cord-005453-4057qib7	4930	7	rising	rise	VBG
cord-005453-4057qib7	4930	8	from	from	IN
cord-005453-4057qib7	4930	9	genomic	genomic	JJ
cord-005453-4057qib7	4930	10	DNA	dna	NN
cord-005453-4057qib7	4930	11	mutations	mutation	NNS
cord-005453-4057qib7	4930	12	,	,	,
cord-005453-4057qib7	4930	13	but	but	CC
cord-005453-4057qib7	4930	14	targeting	target	VBG
cord-005453-4057qib7	4930	15	the	the	DT
cord-005453-4057qib7	4930	16	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4930	17	DNA	dna	NN
cord-005453-4057qib7	4930	18	is	be	VBZ
cord-005453-4057qib7	4930	19	complex	complex	JJ
cord-005453-4057qib7	4930	20	.	.	.
cord-005453-4057qib7	4931	1	Mitochondria	mitochondrion	NNS
cord-005453-4057qib7	4931	2	are	be	VBP
cord-005453-4057qib7	4931	3	able	able	JJ
cord-005453-4057qib7	4931	4	to	to	TO
cord-005453-4057qib7	4931	5	transfer	transfer	VB
cord-005453-4057qib7	4931	6	into	into	IN
cord-005453-4057qib7	4931	7	cells	cell	NNS
cord-005453-4057qib7	4931	8	and	and	CC
cord-005453-4057qib7	4931	9	between	between	IN
cord-005453-4057qib7	4931	10	cells	cell	NNS
cord-005453-4057qib7	4931	11	,	,	,
cord-005453-4057qib7	4931	12	as	as	IN
cord-005453-4057qib7	4931	13	seen	see	VBN
cord-005453-4057qib7	4931	14	in	in	IN
cord-005453-4057qib7	4931	15	preclinical	preclinical	JJ
cord-005453-4057qib7	4931	16	models	model	NNS
cord-005453-4057qib7	4931	17	of	of	IN
cord-005453-4057qib7	4931	18	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4931	19	and	and	CC
cord-005453-4057qib7	4931	20	other	other	JJ
cord-005453-4057qib7	4931	21	metabolic	metabolic	JJ
cord-005453-4057qib7	4931	22	disorders	disorder	NNS
cord-005453-4057qib7	4931	23	.	.	.
cord-005453-4057qib7	4932	1	Here	here	RB
cord-005453-4057qib7	4932	2	,	,	,
cord-005453-4057qib7	4932	3	we	-PRON-	PRP
cord-005453-4057qib7	4932	4	introduce	introduce	VBP
cord-005453-4057qib7	4932	5	a	a	DT
cord-005453-4057qib7	4932	6	novel	novel	JJ
cord-005453-4057qib7	4932	7	concept	concept	NN
cord-005453-4057qib7	4932	8	of	of	IN
cord-005453-4057qib7	4932	9	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4932	10	augmentation	augmentation	NN
cord-005453-4057qib7	4932	11	therapy	therapy	NN
cord-005453-4057qib7	4932	12	(	(	-LRB-
cord-005453-4057qib7	4932	13	MAT	MAT	NNP
cord-005453-4057qib7	4932	14	)	)	-RRB-
cord-005453-4057qib7	4932	15	of	of	IN
cord-005453-4057qib7	4932	16	autologous	autologous	JJ
cord-005453-4057qib7	4932	17	CD34	CD34	NNP
cord-005453-4057qib7	4932	18	+	+	CC
cord-005453-4057qib7	4932	19	cells	cell	NNS
cord-005453-4057qib7	4932	20	in	in	IN
cord-005453-4057qib7	4932	21	4	4	CD
cord-005453-4057qib7	4932	22	children	child	NNS
cord-005453-4057qib7	4932	23	with	with	IN
cord-005453-4057qib7	4932	24	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4932	25	deletion	deletion	NN
cord-005453-4057qib7	4932	26	syndromes	syndrome	NNS
cord-005453-4057qib7	4932	27	.	.	.
cord-005453-4057qib7	4933	1	Methods	method	NNS
cord-005453-4057qib7	4933	2	:	:	:
cord-005453-4057qib7	4933	3	Patients	patient	NNS
cord-005453-4057qib7	4933	4	were	be	VBD
cord-005453-4057qib7	4933	5	treated	treat	VBN
cord-005453-4057qib7	4933	6	under	under	IN
cord-005453-4057qib7	4933	7	a	a	DT
cord-005453-4057qib7	4933	8	compassionateuse	compassionateuse	NN
cord-005453-4057qib7	4933	9	program	program	NN
cord-005453-4057qib7	4933	10	,	,	,
cord-005453-4057qib7	4933	11	approved	approve	VBN
cord-005453-4057qib7	4933	12	by	by	IN
cord-005453-4057qib7	4933	13	the	the	DT
cord-005453-4057qib7	4933	14	Sheba	Sheba	NNP
cord-005453-4057qib7	4933	15	Medical	Medical	NNP
cord-005453-4057qib7	4933	16	Center	Center	NNP
cord-005453-4057qib7	4933	17	IRB	IRB	NNP
cord-005453-4057qib7	4933	18	and	and	CC
cord-005453-4057qib7	4933	19	the	the	DT
cord-005453-4057qib7	4933	20	Israeli	israeli	JJ
cord-005453-4057qib7	4933	21	Ministry	Ministry	NNP
cord-005453-4057qib7	4933	22	of	of	IN
cord-005453-4057qib7	4933	23	Health	Health	NNP
cord-005453-4057qib7	4933	24	.	.	.
cord-005453-4057qib7	4934	1	Briefly	briefly	RB
cord-005453-4057qib7	4934	2	,	,	,
cord-005453-4057qib7	4934	3	mobilization	mobilization	NN
cord-005453-4057qib7	4934	4	was	be	VBD
cord-005453-4057qib7	4934	5	performed	perform	VBN
cord-005453-4057qib7	4934	6	using	use	VBG
cord-005453-4057qib7	4934	7	GCSF	GCSF	NNP
cord-005453-4057qib7	4934	8	alone	alone	JJ
cord-005453-4057qib7	4934	9	(	(	-LRB-
cord-005453-4057qib7	4934	10	n=1	n=1	JJ
cord-005453-4057qib7	4934	11	)	)	-RRB-
cord-005453-4057qib7	4934	12	or	or	CC
cord-005453-4057qib7	4934	13	in	in	IN
cord-005453-4057qib7	4934	14	addition	addition	NN
cord-005453-4057qib7	4934	15	to	to	IN
cord-005453-4057qib7	4934	16	plerixafor	plerixafor	NN
cord-005453-4057qib7	4934	17	(	(	-LRB-
cord-005453-4057qib7	4934	18	n=3	n=3	NN
cord-005453-4057qib7	4934	19	)	)	-RRB-
cord-005453-4057qib7	4934	20	.	.	.
cord-005453-4057qib7	4935	1	CD34	CD34	NNP
cord-005453-4057qib7	4935	2	+	+	CC
cord-005453-4057qib7	4935	3	cells	cell	NNS
cord-005453-4057qib7	4935	4	were	be	VBD
cord-005453-4057qib7	4935	5	isolated	isolate	VBN
cord-005453-4057qib7	4935	6	via	via	IN
cord-005453-4057qib7	4935	7	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	4935	8	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	4935	9	system	system	NN
cord-005453-4057qib7	4935	10	and	and	CC
cord-005453-4057qib7	4935	11	co	co	NN
cord-005453-4057qib7	4935	12	-	-	JJ
cord-005453-4057qib7	4935	13	cultured	cultured	JJ
cord-005453-4057qib7	4935	14	with	with	IN
cord-005453-4057qib7	4935	15	maternal	maternal	JJ
cord-005453-4057qib7	4935	16	mitochondria	mitochondrion	NNS
cord-005453-4057qib7	4935	17	,	,	,
cord-005453-4057qib7	4935	18	drawn	draw	VBN
cord-005453-4057qib7	4935	19	from	from	IN
cord-005453-4057qib7	4935	20	peripheral	peripheral	JJ
cord-005453-4057qib7	4935	21	blood	blood	NN
cord-005453-4057qib7	4935	22	and	and	CC
cord-005453-4057qib7	4935	23	confirmed	confirm	VBD
cord-005453-4057qib7	4935	24	nondeleted	nondeleted	JJ
cord-005453-4057qib7	4935	25	,	,	,
cord-005453-4057qib7	4935	26	for	for	IN
cord-005453-4057qib7	4935	27	24	24	CD
cord-005453-4057qib7	4935	28	hours	hour	NNS
cord-005453-4057qib7	4935	29	,	,	,
cord-005453-4057qib7	4935	30	and	and	CC
cord-005453-4057qib7	4935	31	re	re	VBN
cord-005453-4057qib7	4935	32	-	-	VBN
cord-005453-4057qib7	4935	33	infused	infused	JJ
cord-005453-4057qib7	4935	34	to	to	IN
cord-005453-4057qib7	4935	35	the	the	DT
cord-005453-4057qib7	4935	36	patient	patient	NN
cord-005453-4057qib7	4935	37	without	without	IN
cord-005453-4057qib7	4935	38	any	any	DT
cord-005453-4057qib7	4935	39	conditioning	conditioning	NN
cord-005453-4057qib7	4935	40	.	.	.
cord-005453-4057qib7	4936	1	Patients	patient	NNS
cord-005453-4057qib7	4936	2	were	be	VBD
cord-005453-4057qib7	4936	3	followed	follow	VBN
cord-005453-4057qib7	4936	4	for	for	IN
cord-005453-4057qib7	4936	5	clinical	clinical	JJ
cord-005453-4057qib7	4936	6	and	and	CC
cord-005453-4057qib7	4936	7	metabolic	metabolic	JJ
cord-005453-4057qib7	4936	8	parameters	parameter	NNS
cord-005453-4057qib7	4936	9	.	.	.
cord-005453-4057qib7	4937	1	Results	result	NNS
cord-005453-4057qib7	4937	2	:	:	:
cord-005453-4057qib7	4938	1	All	all	DT
cord-005453-4057qib7	4938	2	four	four	CD
cord-005453-4057qib7	4938	3	patients	patient	NNS
cord-005453-4057qib7	4938	4	presented	present	VBN
cord-005453-4057qib7	4938	5	with	with	IN
cord-005453-4057qib7	4938	6	different	different	JJ
cord-005453-4057qib7	4938	7	deletions	deletion	NNS
cord-005453-4057qib7	4938	8	in	in	IN
cord-005453-4057qib7	4938	9	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4938	10	DNA	dna	NN
cord-005453-4057qib7	4938	11	,	,	,
cord-005453-4057qib7	4938	12	and	and	CC
cord-005453-4057qib7	4938	13	different	different	JJ
cord-005453-4057qib7	4938	14	baseline	baseline	JJ
cord-005453-4057qib7	4938	15	characteristics	characteristic	NNS
cord-005453-4057qib7	4938	16	,	,	,
cord-005453-4057qib7	4938	17	and	and	CC
cord-005453-4057qib7	4938	18	were	be	VBD
cord-005453-4057qib7	4938	19	treated	treat	VBN
cord-005453-4057qib7	4938	20	at	at	IN
cord-005453-4057qib7	4938	21	the	the	DT
cord-005453-4057qib7	4938	22	age	age	NN
cord-005453-4057qib7	4938	23	of	of	IN
cord-005453-4057qib7	4938	24	6.5	6.5	CD
cord-005453-4057qib7	4938	25	,	,	,
cord-005453-4057qib7	4938	26	7	7	CD
cord-005453-4057qib7	4938	27	,	,	,
cord-005453-4057qib7	4938	28	11	11	CD
cord-005453-4057qib7	4938	29	and	and	CC
cord-005453-4057qib7	4938	30	14	14	CD
cord-005453-4057qib7	4938	31	years	year	NNS
cord-005453-4057qib7	4938	32	.	.	.
cord-005453-4057qib7	4939	1	Despite	despite	IN
cord-005453-4057qib7	4939	2	normal	normal	JJ
cord-005453-4057qib7	4939	3	CBC	CBC	NNP
cord-005453-4057qib7	4939	4	,	,	,
cord-005453-4057qib7	4939	5	significant	significant	JJ
cord-005453-4057qib7	4939	6	bone	bone	NN
cord-005453-4057qib7	4939	7	marrow	marrow	NN
cord-005453-4057qib7	4939	8	hypocellularity	hypocellularity	NN
cord-005453-4057qib7	4939	9	was	be	VBD
cord-005453-4057qib7	4939	10	seen	see	VBN
cord-005453-4057qib7	4939	11	in	in	IN
cord-005453-4057qib7	4939	12	3	3	CD
cord-005453-4057qib7	4939	13	evaluated	evaluate	VBN
cord-005453-4057qib7	4939	14	patients	patient	NNS
cord-005453-4057qib7	4939	15	(	(	-LRB-
cord-005453-4057qib7	4939	16	20	20	CD
cord-005453-4057qib7	4939	17	%	%	NN
cord-005453-4057qib7	4939	18	,	,	,
cord-005453-4057qib7	4939	19	30	30	CD
cord-005453-4057qib7	4939	20	%	%	NN
cord-005453-4057qib7	4939	21	and	and	CC
cord-005453-4057qib7	4939	22	50	50	CD
cord-005453-4057qib7	4939	23	%	%	NN
cord-005453-4057qib7	4939	24	cellularity	cellularity	NN
cord-005453-4057qib7	4939	25	at	at	IN
cord-005453-4057qib7	4939	26	age	age	NN
cord-005453-4057qib7	4939	27	7	7	CD
cord-005453-4057qib7	4939	28	,	,	,
cord-005453-4057qib7	4939	29	11	11	CD
cord-005453-4057qib7	4939	30	and	and	CC
cord-005453-4057qib7	4939	31	14	14	CD
cord-005453-4057qib7	4939	32	)	)	-RRB-
cord-005453-4057qib7	4939	33	,	,	,
cord-005453-4057qib7	4939	34	which	which	WDT
cord-005453-4057qib7	4939	35	correlated	correlate	VBD
cord-005453-4057qib7	4939	36	with	with	IN
cord-005453-4057qib7	4939	37	low	low	JJ
cord-005453-4057qib7	4939	38	colony	colony	NN
cord-005453-4057qib7	4939	39	forming	form	VBG
cord-005453-4057qib7	4939	40	unit	unit	NN
cord-005453-4057qib7	4939	41	capacity	capacity	NN
cord-005453-4057qib7	4939	42	of	of	IN
cord-005453-4057qib7	4939	43	patients	patient	NNS
cord-005453-4057qib7	4939	44	and	and	CC
cord-005453-4057qib7	4939	45	low	low	JJ
cord-005453-4057qib7	4939	46	yield	yield	NN
cord-005453-4057qib7	4939	47	of	of	IN
cord-005453-4057qib7	4939	48	CD34	CD34	NNP
cord-005453-4057qib7	4939	49	+	+	CC
cord-005453-4057qib7	4939	50	mobilization	mobilization	NN
cord-005453-4057qib7	4939	51	in	in	IN
cord-005453-4057qib7	4939	52	the	the	DT
cord-005453-4057qib7	4939	53	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	4939	54	product	product	NN
cord-005453-4057qib7	4939	55	.	.	.
cord-005453-4057qib7	4940	1	Patients	patient	NNS
cord-005453-4057qib7	4940	2	received	receive	VBN
cord-005453-4057qib7	4940	3	on	on	IN
cord-005453-4057qib7	4940	4	average	average	JJ
cord-005453-4057qib7	4940	5	2x10	2x10	CD
cord-005453-4057qib7	4940	6	6	6	CD
cord-005453-4057qib7	4940	7	enriched	enrich	VBN
cord-005453-4057qib7	4940	8	cells	cell	NNS
cord-005453-4057qib7	4940	9	/	/	SYM
cord-005453-4057qib7	4940	10	kg	kg	NN
cord-005453-4057qib7	4940	11	(	(	-LRB-
cord-005453-4057qib7	4940	12	range	range	NN
cord-005453-4057qib7	4940	13	,	,	,
cord-005453-4057qib7	4940	14	1.1	1.1	CD
cord-005453-4057qib7	4940	15	-2.8	-2.8	CD
cord-005453-4057qib7	4940	16	)	)	-RRB-
cord-005453-4057qib7	4940	17	,	,	,
cord-005453-4057qib7	4940	18	and	and	CC
cord-005453-4057qib7	4940	19	the	the	DT
cord-005453-4057qib7	4940	20	median	median	JJ
cord-005453-4057qib7	4940	21	enrichment	enrichment	NN
cord-005453-4057qib7	4940	22	of	of	IN
cord-005453-4057qib7	4940	23	CD34	CD34	NNP
cord-005453-4057qib7	4940	24	+	+	CC
cord-005453-4057qib7	4940	25	cells	cell	NNS
cord-005453-4057qib7	4940	26	was	be	VBD
cord-005453-4057qib7	4940	27	135	135	CD
cord-005453-4057qib7	4940	28	%	%	NN
cord-005453-4057qib7	4940	29	(	(	-LRB-
cord-005453-4057qib7	4940	30	range	range	NN
cord-005453-4057qib7	4940	31	,	,	,
cord-005453-4057qib7	4940	32	103	103	CD
cord-005453-4057qib7	4940	33	-	-	SYM
cord-005453-4057qib7	4940	34	162	162	CD
cord-005453-4057qib7	4940	35	%	%	NN
cord-005453-4057qib7	4940	36	)	)	-RRB-
cord-005453-4057qib7	4940	37	.	.	.
cord-005453-4057qib7	4941	1	No	no	DT
cord-005453-4057qib7	4941	2	infusion	infusion	NN
cord-005453-4057qib7	4941	3	reactions	reaction	NNS
cord-005453-4057qib7	4941	4	occurred	occur	VBD
cord-005453-4057qib7	4941	5	,	,	,
cord-005453-4057qib7	4941	6	and	and	CC
cord-005453-4057qib7	4941	7	the	the	DT
cord-005453-4057qib7	4941	8	only	only	JJ
cord-005453-4057qib7	4941	9	severe	severe	JJ
cord-005453-4057qib7	4941	10	adverse	adverse	JJ
cord-005453-4057qib7	4941	11	events	event	NNS
cord-005453-4057qib7	4941	12	of	of	IN
cord-005453-4057qib7	4941	13	this	this	DT
cord-005453-4057qib7	4941	14	cellular	cellular	JJ
cord-005453-4057qib7	4941	15	therapy	therapy	NN
cord-005453-4057qib7	4941	16	were	be	VBD
cord-005453-4057qib7	4941	17	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	4941	18	-	-	HYPH
cord-005453-4057qib7	4941	19	related	relate	VBN
cord-005453-4057qib7	4941	20	anemia	anemia	NN
cord-005453-4057qib7	4941	21	,	,	,
cord-005453-4057qib7	4941	22	hypokalemia	hypokalemia	NN
cord-005453-4057qib7	4941	23	,	,	,
cord-005453-4057qib7	4941	24	hypocalcemia	hypocalcemia	NN
cord-005453-4057qib7	4941	25	and	and	CC
cord-005453-4057qib7	4941	26	alkalosis	alkalosis	NN
cord-005453-4057qib7	4941	27	,	,	,
cord-005453-4057qib7	4941	28	all	all	DT
cord-005453-4057qib7	4941	29	resolved	resolve	VBN
cord-005453-4057qib7	4941	30	promptly	promptly	RB
cord-005453-4057qib7	4941	31	with	with	IN
cord-005453-4057qib7	4941	32	proper	proper	JJ
cord-005453-4057qib7	4941	33	supplementation	supplementation	NN
cord-005453-4057qib7	4941	34	.	.	.
cord-005453-4057qib7	4942	1	Follow	follow	VB
cord-005453-4057qib7	4942	2	-	-	HYPH
cord-005453-4057qib7	4942	3	up	up	RP
cord-005453-4057qib7	4942	4	duration	duration	NN
cord-005453-4057qib7	4942	5	is	be	VBZ
cord-005453-4057qib7	4942	6	variable	variable	JJ
cord-005453-4057qib7	4942	7	,	,	,
cord-005453-4057qib7	4942	8	ranging	range	VBG
cord-005453-4057qib7	4942	9	5	5	CD
cord-005453-4057qib7	4942	10	-	-	SYM
cord-005453-4057qib7	4942	11	22	22	CD
cord-005453-4057qib7	4942	12	months	month	NNS
cord-005453-4057qib7	4942	13	.	.	.
cord-005453-4057qib7	4943	1	We	-PRON-	PRP
cord-005453-4057qib7	4943	2	were	be	VBD
cord-005453-4057qib7	4943	3	able	able	JJ
cord-005453-4057qib7	4943	4	to	to	TO
cord-005453-4057qib7	4943	5	show	show	VB
cord-005453-4057qib7	4943	6	improvement	improvement	NN
cord-005453-4057qib7	4943	7	in	in	IN
cord-005453-4057qib7	4943	8	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4943	9	heteroplasmy	heteroplasmy	NNP
cord-005453-4057qib7	4943	10	(	(	-LRB-
cord-005453-4057qib7	4943	11	proportion	proportion	NN
cord-005453-4057qib7	4943	12	of	of	IN
cord-005453-4057qib7	4943	13	deleted	delete	VBN
cord-005453-4057qib7	4943	14	mtDNA	mtdna	NN
cord-005453-4057qib7	4943	15	of	of	IN
cord-005453-4057qib7	4943	16	total	total	JJ
cord-005453-4057qib7	4943	17	mitochondrial	mitochondrial	JJ
cord-005453-4057qib7	4943	18	DNA	dna	NN
cord-005453-4057qib7	4943	19	)	)	-RRB-
cord-005453-4057qib7	4943	20	and	and	CC
cord-005453-4057qib7	4943	21	in	in	IN
cord-005453-4057qib7	4943	22	normal	normal	JJ
cord-005453-4057qib7	4943	23	mtDNA	mtdna	NN
cord-005453-4057qib7	4943	24	content	content	NN
cord-005453-4057qib7	4943	25	,	,	,
cord-005453-4057qib7	4943	26	starting	start	VBG
cord-005453-4057qib7	4943	27	1	1	CD
cord-005453-4057qib7	4943	28	-	-	SYM
cord-005453-4057qib7	4943	29	5	5	CD
cord-005453-4057qib7	4943	30	months	month	NNS
cord-005453-4057qib7	4943	31	from	from	IN
cord-005453-4057qib7	4943	32	cell	cell	NN
cord-005453-4057qib7	4943	33	therapy	therapy	NN
cord-005453-4057qib7	4943	34	,	,	,
cord-005453-4057qib7	4943	35	which	which	WDT
cord-005453-4057qib7	4943	36	correlated	correlate	VBD
cord-005453-4057qib7	4943	37	with	with	IN
cord-005453-4057qib7	4943	38	improved	improve	VBN
cord-005453-4057qib7	4943	39	ATP	ATP	NNP
cord-005453-4057qib7	4943	40	production	production	NN
cord-005453-4057qib7	4943	41	in	in	IN
cord-005453-4057qib7	4943	42	peripheral	peripheral	JJ
cord-005453-4057qib7	4943	43	blood	blood	NN
cord-005453-4057qib7	4943	44	derived	derive	VBN
cord-005453-4057qib7	4943	45	mononuclear	mononuclear	NN
cord-005453-4057qib7	4943	46	cells	cell	NNS
cord-005453-4057qib7	4943	47	.	.	.
cord-005453-4057qib7	4944	1	Clinically	clinically	RB
cord-005453-4057qib7	4944	2	,	,	,
cord-005453-4057qib7	4944	3	patients	patient	NNS
cord-005453-4057qib7	4944	4	showed	show	VBD
cord-005453-4057qib7	4944	5	improvement	improvement	NN
cord-005453-4057qib7	4944	6	in	in	IN
cord-005453-4057qib7	4944	7	aerobic	aerobic	JJ
cord-005453-4057qib7	4944	8	function	function	NN
cord-005453-4057qib7	4944	9	and	and	CC
cord-005453-4057qib7	4944	10	endurance	endurance	NN
cord-005453-4057qib7	4944	11	(	(	-LRB-
cord-005453-4057qib7	4944	12	measured	measure	VBN
cord-005453-4057qib7	4944	13	by	by	IN
cord-005453-4057qib7	4944	14	the	the	DT
cord-005453-4057qib7	4944	15	half	half	JJ
cord-005453-4057qib7	4944	16	-	-	HYPH
cord-005453-4057qib7	4944	17	Bruce	Bruce	NNP
cord-005453-4057qib7	4944	18	protocol	protocol	NN
cord-005453-4057qib7	4944	19	,	,	,
cord-005453-4057qib7	4944	20	sit	sit	VB
cord-005453-4057qib7	4944	21	-	-	HYPH
cord-005453-4057qib7	4944	22	to	to	TO
cord-005453-4057qib7	4944	23	-	-	HYPH
cord-005453-4057qib7	4944	24	stand	stand	VB
cord-005453-4057qib7	4944	25	test	test	NN
cord-005453-4057qib7	4944	26	and	and	CC
cord-005453-4057qib7	4944	27	6-minute	6-minute	CD
cord-005453-4057qib7	4944	28	walk	walk	NN
cord-005453-4057qib7	4944	29	test	test	NN
cord-005453-4057qib7	4944	30	)	)	-RRB-
cord-005453-4057qib7	4944	31	,	,	,
cord-005453-4057qib7	4944	32	muscle	muscle	NN
cord-005453-4057qib7	4944	33	strength	strength	NN
cord-005453-4057qib7	4944	34	(	(	-LRB-
cord-005453-4057qib7	4944	35	hand	hand	NN
cord-005453-4057qib7	4944	36	-	-	HYPH
cord-005453-4057qib7	4944	37	held	hold	VBN
cord-005453-4057qib7	4944	38	dynamometry	dynamometry	NN
cord-005453-4057qib7	4944	39	)	)	-RRB-
cord-005453-4057qib7	4944	40	,	,	,
cord-005453-4057qib7	4944	41	and	and	CC
cord-005453-4057qib7	4944	42	in	in	IN
cord-005453-4057qib7	4944	43	quality	quality	NN
cord-005453-4057qib7	4944	44	of	of	IN
cord-005453-4057qib7	4944	45	life	life	NN
cord-005453-4057qib7	4944	46	,	,	,
cord-005453-4057qib7	4944	47	measured	measure	VBN
cord-005453-4057qib7	4944	48	by	by	IN
cord-005453-4057qib7	4944	49	the	the	DT
cord-005453-4057qib7	4944	50	international	international	JJ
cord-005453-4057qib7	4944	51	pediatric	pediatric	JJ
cord-005453-4057qib7	4944	52	metabolic	metabolic	JJ
cord-005453-4057qib7	4944	53	disability	disability	NN
cord-005453-4057qib7	4944	54	scale	scale	NN
cord-005453-4057qib7	4944	55	.	.	.
cord-005453-4057qib7	4945	1	No	no	DT
cord-005453-4057qib7	4945	2	metabolic	metabolic	JJ
cord-005453-4057qib7	4945	3	crises	crisis	NNS
cord-005453-4057qib7	4945	4	occurred	occur	VBD
cord-005453-4057qib7	4945	5	following	follow	VBG
cord-005453-4057qib7	4945	6	cell	cell	NN
cord-005453-4057qib7	4945	7	infusion	infusion	NN
cord-005453-4057qib7	4945	8	.	.	.
cord-005453-4057qib7	4946	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4946	2	:	:	:
cord-005453-4057qib7	4947	1	Patients	patient	NNS
cord-005453-4057qib7	4947	2	with	with	IN
cord-005453-4057qib7	4947	3	deletion	deletion	NN
cord-005453-4057qib7	4947	4	in	in	IN
cord-005453-4057qib7	4947	5	mtDNA	mtdna	NN
cord-005453-4057qib7	4947	6	have	have	VBP
cord-005453-4057qib7	4947	7	metabolic	metabolic	JJ
cord-005453-4057qib7	4947	8	dysfunction	dysfunction	NN
cord-005453-4057qib7	4947	9	,	,	,
cord-005453-4057qib7	4947	10	including	include	VBG
cord-005453-4057qib7	4947	11	poor	poor	JJ
cord-005453-4057qib7	4947	12	bone	bone	NN
cord-005453-4057qib7	4947	13	marrow	marrow	NN
cord-005453-4057qib7	4947	14	cellularity	cellularity	NN
cord-005453-4057qib7	4947	15	and	and	CC
cord-005453-4057qib7	4947	16	function	function	NN
cord-005453-4057qib7	4947	17	.	.	.
cord-005453-4057qib7	4948	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4948	2	stem	stem	NN
cord-005453-4057qib7	4948	3	cells	cell	NNS
cord-005453-4057qib7	4948	4	in	in	IN
cord-005453-4057qib7	4948	5	patients	patient	NNS
cord-005453-4057qib7	4948	6	with	with	IN
cord-005453-4057qib7	4948	7	mtDNA	mtdna	JJ
cord-005453-4057qib7	4948	8	deletions	deletion	NNS
cord-005453-4057qib7	4948	9	can	can	MD
cord-005453-4057qib7	4948	10	be	be	VB
cord-005453-4057qib7	4948	11	enriched	enrich	VBN
cord-005453-4057qib7	4948	12	with	with	IN
cord-005453-4057qib7	4948	13	normal	normal	JJ
cord-005453-4057qib7	4948	14	mitochondria	mitochondrion	NNS
cord-005453-4057qib7	4948	15	,	,	,
cord-005453-4057qib7	4948	16	via	via	IN
cord-005453-4057qib7	4948	17	MAT	MAT	NNP
cord-005453-4057qib7	4948	18	,	,	,
cord-005453-4057qib7	4948	19	as	as	IN
cord-005453-4057qib7	4948	20	first	first	JJ
cord-005453-4057qib7	4948	21	shown	show	VBN
cord-005453-4057qib7	4948	22	in	in	IN
cord-005453-4057qib7	4948	23	our	-PRON-	PRP$
cord-005453-4057qib7	4948	24	patients	patient	NNS
cord-005453-4057qib7	4948	25	.	.	.
cord-005453-4057qib7	4949	1	This	this	DT
cord-005453-4057qib7	4949	2	novel	novel	NN
cord-005453-4057qib7	4949	3	process	process	NN
cord-005453-4057qib7	4949	4	is	be	VBZ
cord-005453-4057qib7	4949	5	safe	safe	JJ
cord-005453-4057qib7	4949	6	and	and	CC
cord-005453-4057qib7	4949	7	results	result	NNS
cord-005453-4057qib7	4949	8	in	in	IN
cord-005453-4057qib7	4949	9	increase	increase	NN
cord-005453-4057qib7	4949	10	in	in	IN
cord-005453-4057qib7	4949	11	the	the	DT
cord-005453-4057qib7	4949	12	normal	normal	JJ
cord-005453-4057qib7	4949	13	mtDNA	mtdna	NN
cord-005453-4057qib7	4949	14	in	in	IN
cord-005453-4057qib7	4949	15	peripheral	peripheral	JJ
cord-005453-4057qib7	4949	16	blood	blood	NN
cord-005453-4057qib7	4949	17	of	of	IN
cord-005453-4057qib7	4949	18	patients	patient	NNS
cord-005453-4057qib7	4949	19	,	,	,
cord-005453-4057qib7	4949	20	and	and	CC
cord-005453-4057qib7	4949	21	in	in	IN
cord-005453-4057qib7	4949	22	improved	improve	VBN
cord-005453-4057qib7	4949	23	metabolic	metabolic	JJ
cord-005453-4057qib7	4949	24	and	and	CC
cord-005453-4057qib7	4949	25	clinical	clinical	JJ
cord-005453-4057qib7	4949	26	function	function	NN
cord-005453-4057qib7	4949	27	.	.	.
cord-005453-4057qib7	4950	1	Clinical	clinical	JJ
cord-005453-4057qib7	4950	2	Trial	Trial	NNP
cord-005453-4057qib7	4950	3	Registry	Registry	NNP
cord-005453-4057qib7	4950	4	:	:	:
cord-005453-4057qib7	4951	1	Clinicaltrials.gov	Clinicaltrials.gov	NNP
cord-005453-4057qib7	4952	1	NCT03384420	NCT03384420	NNP
cord-005453-4057qib7	4952	2	Disclosure	Disclosure	NNP
cord-005453-4057qib7	4952	3	:	:	:
cord-005453-4057qib7	4953	1	Moria	Moria	NNP
cord-005453-4057qib7	4953	2	Blumkin	Blumkin	NNP
cord-005453-4057qib7	4953	3	,	,	,
cord-005453-4057qib7	4953	4	Noa	Noa	NNP
cord-005453-4057qib7	4953	5	Sher	Sher	NNP
cord-005453-4057qib7	4953	6	and	and	CC
cord-005453-4057qib7	4953	7	Natalie	Natalie	NNP
cord-005453-4057qib7	4953	8	Yivgi	Yivgi	NNP
cord-005453-4057qib7	4953	9	Ohana	Ohana	NNP
cord-005453-4057qib7	4954	1	-Minovia	-Minovia	NNP
cord-005453-4057qib7	4954	2	Therapeutics	therapeutic	NNS
cord-005453-4057qib7	4954	3	,	,	,
cord-005453-4057qib7	4954	4	employment	employment	NN
cord-005453-4057qib7	4954	5	P227	p227	NN
cord-005453-4057qib7	4954	6	High	high	JJ
cord-005453-4057qib7	4954	7	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	4954	8	efficiency	efficiency	NN
cord-005453-4057qib7	4954	9	of	of	IN
cord-005453-4057qib7	4954	10	alpharetrovirally	alpharetrovirally	RB
cord-005453-4057qib7	4954	11	engineered	engineer	VBN
cord-005453-4057qib7	4954	12	CD19-specific	cd19-specific	CD
cord-005453-4057qib7	4954	13	chimeric	chimeric	JJ
cord-005453-4057qib7	4954	14	antigen	antigen	NN
cord-005453-4057qib7	4954	15	receptor	receptor	NN
cord-005453-4057qib7	4954	16	natural	natural	JJ
cord-005453-4057qib7	4954	17	killer	killer	NN
cord-005453-4057qib7	4954	18	cells	cell	NNS
cord-005453-4057qib7	4954	19	for	for	IN
cord-005453-4057qib7	4954	20	treatment	treatment	NN
cord-005453-4057qib7	4954	21	of	of	IN
cord-005453-4057qib7	4954	22	acute	acute	JJ
cord-005453-4057qib7	4954	23	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	4954	24	leukemia	leukemia	NN
cord-005453-4057qib7	4954	25	Stephan	Stephan	NNP
cord-005453-4057qib7	4954	26	Müller	Müller	NNP
cord-005453-4057qib7	4954	27	1	1	CD
cord-005453-4057qib7	4954	28	,	,	,
cord-005453-4057qib7	4954	29	Tobias	Tobias	NNP
cord-005453-4057qib7	4954	30	Bexte	Bexte	NNP
cord-005453-4057qib7	4954	31	1	1	CD
cord-005453-4057qib7	4954	32	,	,	,
cord-005453-4057qib7	4954	33	Annekathrin	Annekathrin	NNP
cord-005453-4057qib7	4954	34	Heinze	Heinze	NNP
cord-005453-4057qib7	4954	35	1	1	CD
cord-005453-4057qib7	4954	36	,	,	,
cord-005453-4057qib7	4954	37	Franziska	Franziska	NNP
cord-005453-4057qib7	4954	38	Schenk	Schenk	NNP
cord-005453-4057qib7	4954	39	2	2	CD
cord-005453-4057qib7	4954	40	,	,	,
cord-005453-4057qib7	4954	41	Axel	Axel	NNP
cord-005453-4057qib7	4954	42	Schambach	Schambach	NNP
cord-005453-4057qib7	4954	43	3	3	CD
cord-005453-4057qib7	4954	44	,	,	,
cord-005453-4057qib7	4954	45	Winfried	Winfried	NNP
cord-005453-4057qib7	4954	46	S.	S.	NNP
cord-005453-4057qib7	4954	47	Wels	Wels	NNP
cord-005453-4057qib7	4954	48	4,5	4,5	CD
cord-005453-4057qib7	4954	49	,	,	,
cord-005453-4057qib7	4954	50	Ute	Ute	NNP
cord-005453-4057qib7	4954	51	Modlich	Modlich	NNP
cord-005453-4057qib7	4954	52	2	2	CD
cord-005453-4057qib7	4954	53	,	,	,
cord-005453-4057qib7	4954	54	Evelyn	Evelyn	NNP
cord-005453-4057qib7	4954	55	Ullrich	Ullrich	NNP
cord-005453-4057qib7	4954	56	1	1	CD
cord-005453-4057qib7	4954	57	,	,	,
cord-005453-4057qib7	4955	1	5	5	CD
cord-005453-4057qib7	4955	2	Background	background	NN
cord-005453-4057qib7	4955	3	:	:	:
cord-005453-4057qib7	4956	1	Autologous	autologous	JJ
cord-005453-4057qib7	4956	2	chimeric	chimeric	JJ
cord-005453-4057qib7	4956	3	antigen	antigen	NN
cord-005453-4057qib7	4956	4	receptormodified	receptormodifie	VBN
cord-005453-4057qib7	4956	5	(	(	-LRB-
cord-005453-4057qib7	4956	6	CAR	car	NN
cord-005453-4057qib7	4956	7	)	)	-RRB-
cord-005453-4057qib7	4956	8	T	t	NN
cord-005453-4057qib7	4956	9	cells	cell	NNS
cord-005453-4057qib7	4956	10	with	with	IN
cord-005453-4057qib7	4956	11	specificity	specificity	NN
cord-005453-4057qib7	4956	12	for	for	IN
cord-005453-4057qib7	4956	13	CD19	CD19	NNP
cord-005453-4057qib7	4956	14	showed	show	VBD
cord-005453-4057qib7	4956	15	potent	potent	JJ
cord-005453-4057qib7	4956	16	antitumor	antitumor	JJ
cord-005453-4057qib7	4956	17	efficacy	efficacy	NN
cord-005453-4057qib7	4956	18	in	in	IN
cord-005453-4057qib7	4956	19	clinical	clinical	JJ
cord-005453-4057qib7	4956	20	trials	trial	NNS
cord-005453-4057qib7	4956	21	regarding	regard	VBG
cord-005453-4057qib7	4956	22	relapsed	relapse	VBN
cord-005453-4057qib7	4956	23	and	and	CC
cord-005453-4057qib7	4956	24	refractory	refractory	JJ
cord-005453-4057qib7	4956	25	acute	acute	JJ
cord-005453-4057qib7	4956	26	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	4956	27	leukemia	leukemia	NN
cord-005453-4057qib7	4956	28	(	(	-LRB-
cord-005453-4057qib7	4956	29	ALL	all	DT
cord-005453-4057qib7	4956	30	)	)	-RRB-
cord-005453-4057qib7	4956	31	.	.	.
cord-005453-4057qib7	4957	1	Natural	natural	JJ
cord-005453-4057qib7	4957	2	killer	killer	NN
cord-005453-4057qib7	4957	3	(	(	-LRB-
cord-005453-4057qib7	4957	4	NK	NK	NNP
cord-005453-4057qib7	4957	5	)	)	-RRB-
cord-005453-4057qib7	4957	6	cells	cell	NNS
cord-005453-4057qib7	4957	7	are	be	VBP
cord-005453-4057qib7	4957	8	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	4957	9	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	4957	10	that	that	WDT
cord-005453-4057qib7	4957	11	are	be	VBP
cord-005453-4057qib7	4957	12	capable	capable	JJ
cord-005453-4057qib7	4957	13	to	to	TO
cord-005453-4057qib7	4957	14	kill	kill	VB
cord-005453-4057qib7	4957	15	their	-PRON-	PRP$
cord-005453-4057qib7	4957	16	targets	target	NNS
cord-005453-4057qib7	4957	17	in	in	IN
cord-005453-4057qib7	4957	18	a	a	DT
cord-005453-4057qib7	4957	19	non	non	JJ
cord-005453-4057qib7	4957	20	-	-	JJ
cord-005453-4057qib7	4957	21	specific	specific	JJ
cord-005453-4057qib7	4957	22	manner	manner	NN
cord-005453-4057qib7	4957	23	and	and	CC
cord-005453-4057qib7	4957	24	additionally	additionally	RB
cord-005453-4057qib7	4957	25	do	do	VBP
cord-005453-4057qib7	4957	26	not	not	RB
cord-005453-4057qib7	4957	27	cause	cause	VB
cord-005453-4057qib7	4957	28	GvHD	GvHD	NNP
cord-005453-4057qib7	4957	29	.	.	.
cord-005453-4057qib7	4958	1	Therefore	therefore	RB
cord-005453-4057qib7	4958	2	,	,	,
cord-005453-4057qib7	4958	3	using	use	VBG
cord-005453-4057qib7	4958	4	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4958	5	-	-	HYPH
cord-005453-4057qib7	4958	6	NK	NK	NNP
cord-005453-4057qib7	4958	7	cells	cell	NNS
cord-005453-4057qib7	4958	8	exhibits	exhibit	VBZ
cord-005453-4057qib7	4958	9	several	several	JJ
cord-005453-4057qib7	4958	10	advantages	advantage	NNS
cord-005453-4057qib7	4958	11	,	,	,
cord-005453-4057qib7	4958	12	such	such	JJ
cord-005453-4057qib7	4958	13	as	as	IN
cord-005453-4057qib7	4958	14	safety	safety	NN
cord-005453-4057qib7	4958	15	in	in	IN
cord-005453-4057qib7	4958	16	clinical	clinical	JJ
cord-005453-4057qib7	4958	17	use	use	NN
cord-005453-4057qib7	4958	18	,	,	,
cord-005453-4057qib7	4958	19	possible	possible	JJ
cord-005453-4057qib7	4958	20	allogenic	allogenic	JJ
cord-005453-4057qib7	4958	21	settings	setting	NNS
cord-005453-4057qib7	4958	22	and	and	CC
cord-005453-4057qib7	4958	23	the	the	DT
cord-005453-4057qib7	4958	24	potential	potential	NN
cord-005453-4057qib7	4958	25	to	to	TO
cord-005453-4057qib7	4958	26	also	also	RB
cord-005453-4057qib7	4958	27	attack	attack	VB
cord-005453-4057qib7	4958	28	heterologous	heterologous	NNP
cord-005453-4057qib7	4958	29	leukemia	leukemia	NN
cord-005453-4057qib7	4958	30	cells	cell	NNS
cord-005453-4057qib7	4958	31	which	which	WDT
cord-005453-4057qib7	4958	32	lost	lose	VBD
cord-005453-4057qib7	4958	33	CD19	CD19	NNP
cord-005453-4057qib7	4958	34	.	.	.
cord-005453-4057qib7	4959	1	Previous	previous	JJ
cord-005453-4057qib7	4959	2	approaches	approach	NNS
cord-005453-4057qib7	4959	3	used	use	VBD
cord-005453-4057qib7	4959	4	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4959	5	-	-	HYPH
cord-005453-4057qib7	4959	6	NK	NK	NNP
cord-005453-4057qib7	4959	7	cells	cell	NNS
cord-005453-4057qib7	4959	8	pre	pre	VBP
cord-005453-4057qib7	4959	9	-	-	JJ
cord-005453-4057qib7	4959	10	stimulated	stimulate	VBN
cord-005453-4057qib7	4959	11	by	by	IN
cord-005453-4057qib7	4959	12	feeder	feeder	NN
cord-005453-4057qib7	4959	13	cells	cell	NNS
cord-005453-4057qib7	4959	14	,	,	,
cord-005453-4057qib7	4959	15	bearing	bear	VBG
cord-005453-4057qib7	4959	16	potential	potential	JJ
cord-005453-4057qib7	4959	17	risks	risk	NNS
cord-005453-4057qib7	4959	18	.	.	.
cord-005453-4057qib7	4960	1	Thus	thus	RB
cord-005453-4057qib7	4960	2	,	,	,
cord-005453-4057qib7	4960	3	we	-PRON-	PRP
cord-005453-4057qib7	4960	4	focused	focus	VBD
cord-005453-4057qib7	4960	5	on	on	IN
cord-005453-4057qib7	4960	6	the	the	DT
cord-005453-4057qib7	4960	7	optimization	optimization	NN
cord-005453-4057qib7	4960	8	of	of	IN
cord-005453-4057qib7	4960	9	generating	generate	VBG
cord-005453-4057qib7	4960	10	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4960	11	-	-	HYPH
cord-005453-4057qib7	4960	12	NK	nk	NN
cord-005453-4057qib7	4960	13	cells	cell	NNS
cord-005453-4057qib7	4960	14	by	by	IN
cord-005453-4057qib7	4960	15	viral	viral	JJ
cord-005453-4057qib7	4960	16	transduction	transduction	NN
cord-005453-4057qib7	4960	17	under	under	IN
cord-005453-4057qib7	4960	18	feeder	feeder	NN
cord-005453-4057qib7	4960	19	-	-	HYPH
cord-005453-4057qib7	4960	20	cell	cell	NN
cord-005453-4057qib7	4960	21	free	free	JJ
cord-005453-4057qib7	4960	22	conditions	condition	NNS
cord-005453-4057qib7	4960	23	.	.	.
cord-005453-4057qib7	4961	1	Methods	method	NNS
cord-005453-4057qib7	4961	2	:	:	:
cord-005453-4057qib7	4961	3	Human	human	JJ
cord-005453-4057qib7	4961	4	NK	NK	NNP
cord-005453-4057qib7	4961	5	cells	cell	NNS
cord-005453-4057qib7	4961	6	were	be	VBD
cord-005453-4057qib7	4961	7	isolated	isolate	VBN
cord-005453-4057qib7	4961	8	from	from	IN
cord-005453-4057qib7	4961	9	healthy	healthy	JJ
cord-005453-4057qib7	4961	10	donor	donor	NN
cord-005453-4057qib7	4961	11	peripheral	peripheral	JJ
cord-005453-4057qib7	4961	12	blood	blood	NN
cord-005453-4057qib7	4961	13	mononuclear	mononuclear	NN
cord-005453-4057qib7	4961	14	cells	cell	NNS
cord-005453-4057qib7	4961	15	via	via	IN
cord-005453-4057qib7	4961	16	CD56	CD56	NNP
cord-005453-4057qib7	4961	17	negative	negative	JJ
cord-005453-4057qib7	4961	18	selection	selection	NN
cord-005453-4057qib7	4961	19	.	.	.
cord-005453-4057qib7	4962	1	After	after	IN
cord-005453-4057qib7	4962	2	a	a	DT
cord-005453-4057qib7	4962	3	feeder	feeder	NN
cord-005453-4057qib7	4962	4	-	-	HYPH
cord-005453-4057qib7	4962	5	cell	cell	NN
cord-005453-4057qib7	4962	6	free	free	JJ
cord-005453-4057qib7	4962	7	expansion	expansion	NN
cord-005453-4057qib7	4962	8	phase	phase	NN
cord-005453-4057qib7	4962	9	with	with	IN
cord-005453-4057qib7	4962	10	interleukin	interleukin	NN
cord-005453-4057qib7	4962	11	15	15	CD
cord-005453-4057qib7	4962	12	,	,	,
cord-005453-4057qib7	4962	13	transductions	transduction	NNS
cord-005453-4057qib7	4962	14	were	be	VBD
cord-005453-4057qib7	4962	15	performed	perform	VBN
cord-005453-4057qib7	4962	16	with	with	IN
cord-005453-4057qib7	4962	17	an	an	DT
cord-005453-4057qib7	4962	18	EGFP	EGFP	NNP
cord-005453-4057qib7	4962	19	or	or	CC
cord-005453-4057qib7	4962	20	a	a	DT
cord-005453-4057qib7	4962	21	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	4962	22	encoding	encoding	NN
cord-005453-4057qib7	4962	23	vector	vector	NN
cord-005453-4057qib7	4962	24	at	at	IN
cord-005453-4057qib7	4962	25	different	different	JJ
cord-005453-4057qib7	4962	26	multiplicities	multiplicity	NNS
cord-005453-4057qib7	4962	27	of	of	IN
cord-005453-4057qib7	4962	28	infection	infection	NN
cord-005453-4057qib7	4962	29	(	(	-LRB-
cord-005453-4057qib7	4962	30	MOI	MOI	NNP
cord-005453-4057qib7	4962	31	)	)	-RRB-
cord-005453-4057qib7	4962	32	.	.	.
cord-005453-4057qib7	4963	1	To	to	TO
cord-005453-4057qib7	4963	2	optimize	optimize	VB
cord-005453-4057qib7	4963	3	gene	gene	NN
cord-005453-4057qib7	4963	4	modification	modification	NN
cord-005453-4057qib7	4963	5	different	different	JJ
cord-005453-4057qib7	4963	6	transduction	transduction	NN
cord-005453-4057qib7	4963	7	enhancers	enhancer	NNS
cord-005453-4057qib7	4963	8	(	(	-LRB-
cord-005453-4057qib7	4963	9	Retronectin	Retronectin	NNP
cord-005453-4057qib7	4963	10	and	and	CC
cord-005453-4057qib7	4963	11	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4963	12	)	)	-RRB-
cord-005453-4057qib7	4963	13	and	and	CC
cord-005453-4057qib7	4963	14	viral	viral	JJ
cord-005453-4057qib7	4963	15	vector	vector	NN
cord-005453-4057qib7	4963	16	systems	system	NNS
cord-005453-4057qib7	4963	17	(	(	-LRB-
cord-005453-4057qib7	4963	18	lentiviral	lentiviral	NNP
cord-005453-4057qib7	4963	19	and	and	CC
cord-005453-4057qib7	4963	20	alpharetroviral	alpharetroviral	NNP
cord-005453-4057qib7	4963	21	)	)	-RRB-
cord-005453-4057qib7	4963	22	were	be	VBD
cord-005453-4057qib7	4963	23	compared	compare	VBN
cord-005453-4057qib7	4963	24	.	.	.
cord-005453-4057qib7	4964	1	Finally	finally	RB
cord-005453-4057qib7	4964	2	,	,	,
cord-005453-4057qib7	4964	3	generated	generate	VBD
cord-005453-4057qib7	4964	4	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4964	5	-	-	HYPH
cord-005453-4057qib7	4964	6	NK	NK	NNP
cord-005453-4057qib7	4964	7	cells	cell	NNS
cord-005453-4057qib7	4964	8	were	be	VBD
cord-005453-4057qib7	4964	9	tested	test	VBN
cord-005453-4057qib7	4964	10	in	in	IN
cord-005453-4057qib7	4964	11	their	-PRON-	PRP$
cord-005453-4057qib7	4964	12	ability	ability	NN
cord-005453-4057qib7	4964	13	to	to	TO
cord-005453-4057qib7	4964	14	kill	kill	VB
cord-005453-4057qib7	4964	15	CD19positive	CD19positive	NNP
cord-005453-4057qib7	4964	16	and	and	CC
cord-005453-4057qib7	4964	17	CD19-negative	cd19-negative	JJ
cord-005453-4057qib7	4964	18	cell	cell	NN
cord-005453-4057qib7	4964	19	lines	line	NNS
cord-005453-4057qib7	4964	20	.	.	.
cord-005453-4057qib7	4965	1	Results	result	NNS
cord-005453-4057qib7	4965	2	:	:	:
cord-005453-4057qib7	4965	3	NK	NK	NNP
cord-005453-4057qib7	4965	4	cells	cell	NNS
cord-005453-4057qib7	4965	5	transduced	transduce	VBN
cord-005453-4057qib7	4965	6	with	with	IN
cord-005453-4057qib7	4965	7	a	a	DT
cord-005453-4057qib7	4965	8	lentiviral	lentiviral	JJ
cord-005453-4057qib7	4965	9	EGFP	EGFP	NNP
cord-005453-4057qib7	4965	10	encoding	encoding	NN
cord-005453-4057qib7	4965	11	vector	vector	NN
cord-005453-4057qib7	4965	12	or	or	CC
cord-005453-4057qib7	4965	13	a	a	DT
cord-005453-4057qib7	4965	14	lentiviral	lentiviral	JJ
cord-005453-4057qib7	4965	15	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	4965	16	vector	vector	NN
cord-005453-4057qib7	4965	17	using	use	VBG
cord-005453-4057qib7	4965	18	Retronectin	Retronectin	NNP
cord-005453-4057qib7	4965	19	and	and	CC
cord-005453-4057qib7	4965	20	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4965	21	showed	show	VBD
cord-005453-4057qib7	4965	22	similar	similar	JJ
cord-005453-4057qib7	4965	23	transduction	transduction	NN
cord-005453-4057qib7	4965	24	efficiencies	efficiency	NNS
cord-005453-4057qib7	4965	25	for	for	IN
cord-005453-4057qib7	4965	26	both	both	DT
cord-005453-4057qib7	4965	27	transduction	transduction	NN
cord-005453-4057qib7	4965	28	enhancers	enhancer	NNS
cord-005453-4057qib7	4965	29	(	(	-LRB-
cord-005453-4057qib7	4965	30	EGFP	EGFP	NNP
cord-005453-4057qib7	4965	31	:	:	:
cord-005453-4057qib7	4966	1	Retronectin	Retronectin	NNP
cord-005453-4057qib7	4966	2	MOI	MOI	NNP
cord-005453-4057qib7	4966	3	10	10	CD
cord-005453-4057qib7	4966	4	:	:	:
cord-005453-4057qib7	4966	5	12.9	12.9	CD
cord-005453-4057qib7	4966	6	%	%	NN
cord-005453-4057qib7	4966	7	;	;	:
cord-005453-4057qib7	4966	8	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4966	9	MOI	MOI	NNP
cord-005453-4057qib7	4966	10	10	10	CD
cord-005453-4057qib7	4966	11	:	:	SYM
cord-005453-4057qib7	4966	12	12.8	12.8	CD
cord-005453-4057qib7	4966	13	%	%	NN
cord-005453-4057qib7	4966	14	;	;	.
cord-005453-4057qib7	4967	1	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4967	2	:	:	:
cord-005453-4057qib7	4967	3	Retronectin	Retronectin	NNP
cord-005453-4057qib7	4967	4	MOI	MOI	NNP
cord-005453-4057qib7	4967	5	5	5	CD
cord-005453-4057qib7	4967	6	:	:	:
cord-005453-4057qib7	4967	7	10.7	10.7	CD
cord-005453-4057qib7	4967	8	%	%	NN
cord-005453-4057qib7	4967	9	,	,	,
cord-005453-4057qib7	4967	10	MOI	MOI	NNP
cord-005453-4057qib7	4967	11	10	10	CD
cord-005453-4057qib7	4967	12	:	:	SYM
cord-005453-4057qib7	4967	13	9.2	9.2	CD
cord-005453-4057qib7	4967	14	%	%	NN
cord-005453-4057qib7	4967	15	;	;	:
cord-005453-4057qib7	4967	16	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4967	17	MOI	MOI	NNP
cord-005453-4057qib7	4967	18	5	5	CD
cord-005453-4057qib7	4967	19	:	:	:
cord-005453-4057qib7	4967	20	11.3	11.3	CD
cord-005453-4057qib7	4967	21	%	%	NN
cord-005453-4057qib7	4967	22	,	,	,
cord-005453-4057qib7	4967	23	MOI	MOI	NNP
cord-005453-4057qib7	4967	24	10	10	CD
cord-005453-4057qib7	4967	25	:	:	SYM
cord-005453-4057qib7	4967	26	14.4	14.4	CD
cord-005453-4057qib7	4967	27	%	%	NN
cord-005453-4057qib7	4967	28	)	)	-RRB-
cord-005453-4057qib7	4967	29	.	.	.
cord-005453-4057qib7	4968	1	The	the	DT
cord-005453-4057qib7	4968	2	generated	generate	VBN
cord-005453-4057qib7	4968	3	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4968	4	-	-	HYPH
cord-005453-4057qib7	4968	5	NK	NK	NNP
cord-005453-4057qib7	4968	6	cells	cell	NNS
cord-005453-4057qib7	4968	7	showed	show	VBD
cord-005453-4057qib7	4968	8	increased	increase	VBN
cord-005453-4057qib7	4968	9	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	4968	10	capacity	capacity	NN
cord-005453-4057qib7	4968	11	against	against	IN
cord-005453-4057qib7	4968	12	CD19-positive	cd19-positive	CD
cord-005453-4057qib7	4968	13	cells	cell	NNS
cord-005453-4057qib7	4968	14	compared	compare	VBN
cord-005453-4057qib7	4968	15	to	to	IN
cord-005453-4057qib7	4968	16	nontransduced	nontransduced	JJ
cord-005453-4057qib7	4968	17	(	(	-LRB-
cord-005453-4057qib7	4968	18	NT	NT	NNP
cord-005453-4057qib7	4968	19	)	)	-RRB-
cord-005453-4057qib7	4968	20	NK	NK	NNP
cord-005453-4057qib7	4968	21	cells	cell	NNS
cord-005453-4057qib7	4968	22	(	(	-LRB-
cord-005453-4057qib7	4968	23	72.7	72.7	CD
cord-005453-4057qib7	4968	24	%	%	NN
cord-005453-4057qib7	4968	25	vs.	vs.	IN
cord-005453-4057qib7	4968	26	23.6	23.6	CD
cord-005453-4057qib7	4968	27	%	%	NN
cord-005453-4057qib7	4968	28	,	,	,
cord-005453-4057qib7	4968	29	effector	effector	JJ
cord-005453-4057qib7	4968	30	to	to	IN
cord-005453-4057qib7	4968	31	target	target	NN
cord-005453-4057qib7	4968	32	(	(	-LRB-
cord-005453-4057qib7	4968	33	E	e	NN
cord-005453-4057qib7	4968	34	:	:	:
cord-005453-4057qib7	4968	35	T	T	NNP
cord-005453-4057qib7	4968	36	)	)	-RRB-
cord-005453-4057qib7	4968	37	ratio	ratio	NN
cord-005453-4057qib7	4968	38	1:1	1:1	CD
cord-005453-4057qib7	4968	39	)	)	-RRB-
cord-005453-4057qib7	4968	40	.	.	.
cord-005453-4057qib7	4969	1	Both	both	DT
cord-005453-4057qib7	4969	2	NK	NK	NNP
cord-005453-4057qib7	4969	3	cell	cell	NN
cord-005453-4057qib7	4969	4	populations	population	NNS
cord-005453-4057qib7	4969	5	were	be	VBD
cord-005453-4057qib7	4969	6	equally	equally	RB
cord-005453-4057qib7	4969	7	efficient	efficient	JJ
cord-005453-4057qib7	4969	8	in	in	IN
cord-005453-4057qib7	4969	9	killing	kill	VBG
cord-005453-4057qib7	4969	10	CD19-negative	cd19-negative	CD
cord-005453-4057qib7	4969	11	cells	cell	NNS
cord-005453-4057qib7	4969	12	(	(	-LRB-
cord-005453-4057qib7	4969	13	30.5	30.5	CD
cord-005453-4057qib7	4969	14	%	%	NN
cord-005453-4057qib7	4969	15	vs.	vs.	CC
cord-005453-4057qib7	4969	16	25.7	25.7	CD
cord-005453-4057qib7	4969	17	%	%	NN
cord-005453-4057qib7	4969	18	)	)	-RRB-
cord-005453-4057qib7	4969	19	.	.	.
cord-005453-4057qib7	4970	1	Alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	4970	2	transduction	transduction	NN
cord-005453-4057qib7	4970	3	of	of	IN
cord-005453-4057qib7	4970	4	NK	NK	NNP
cord-005453-4057qib7	4970	5	cells	cell	NNS
cord-005453-4057qib7	4970	6	with	with	IN
cord-005453-4057qib7	4970	7	an	an	DT
cord-005453-4057qib7	4970	8	EGFP	EGFP	NNP
cord-005453-4057qib7	4970	9	encoding	encoding	NN
cord-005453-4057qib7	4970	10	vector	vector	NN
cord-005453-4057qib7	4970	11	showed	show	VBD
cord-005453-4057qib7	4970	12	higher	high	JJR
cord-005453-4057qib7	4970	13	transduction	transduction	NN
cord-005453-4057qib7	4970	14	rates	rate	NNS
cord-005453-4057qib7	4970	15	with	with	IN
cord-005453-4057qib7	4970	16	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4970	17	than	than	IN
cord-005453-4057qib7	4970	18	with	with	IN
cord-005453-4057qib7	4970	19	Retronectin	Retronectin	NNP
cord-005453-4057qib7	4970	20	(	(	-LRB-
cord-005453-4057qib7	4970	21	Retronectin	Retronectin	NNP
cord-005453-4057qib7	4970	22	MOI	MOI	NNP
cord-005453-4057qib7	4970	23	1	1	CD
cord-005453-4057qib7	4970	24	:	:	:
cord-005453-4057qib7	4970	25	5.3	5.3	CD
cord-005453-4057qib7	4970	26	%	%	NN
cord-005453-4057qib7	4970	27	,	,	,
cord-005453-4057qib7	4970	28	MOI	MOI	NNP
cord-005453-4057qib7	4970	29	5	5	CD
cord-005453-4057qib7	4970	30	:	:	:
cord-005453-4057qib7	4970	31	9.7	9.7	CD
cord-005453-4057qib7	4970	32	%	%	NN
cord-005453-4057qib7	4970	33	;	;	:
cord-005453-4057qib7	4970	34	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4970	35	MOI	MOI	NNP
cord-005453-4057qib7	4970	36	1	1	CD
cord-005453-4057qib7	4970	37	:	:	:
cord-005453-4057qib7	4970	38	55.3	55.3	CD
cord-005453-4057qib7	4970	39	%	%	NN
cord-005453-4057qib7	4970	40	,	,	,
cord-005453-4057qib7	4970	41	MOI	MOI	NNP
cord-005453-4057qib7	4970	42	5	5	CD
cord-005453-4057qib7	4970	43	:	:	:
cord-005453-4057qib7	4970	44	51.6	51.6	CD
cord-005453-4057qib7	4970	45	%	%	NN
cord-005453-4057qib7	4970	46	)	)	-RRB-
cord-005453-4057qib7	4970	47	.	.	.
cord-005453-4057qib7	4971	1	Further	further	RB
cord-005453-4057qib7	4971	2	using	use	VBG
cord-005453-4057qib7	4971	3	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4971	4	,	,	,
cord-005453-4057qib7	4971	5	similar	similar	JJ
cord-005453-4057qib7	4971	6	transduction	transduction	NN
cord-005453-4057qib7	4971	7	efficiencies	efficiency	NNS
cord-005453-4057qib7	4971	8	could	could	MD
cord-005453-4057qib7	4971	9	be	be	VB
cord-005453-4057qib7	4971	10	achieved	achieve	VBN
cord-005453-4057qib7	4971	11	with	with	IN
cord-005453-4057qib7	4971	12	an	an	DT
cord-005453-4057qib7	4971	13	alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	4971	14	CD19-CAR	cd19-car	JJ
cord-005453-4057qib7	4971	15	encoding	encoding	NN
cord-005453-4057qib7	4971	16	vector	vector	NN
cord-005453-4057qib7	4971	17	(	(	-LRB-
cord-005453-4057qib7	4971	18	MOI	MOI	NNP
cord-005453-4057qib7	4971	19	1	1	CD
cord-005453-4057qib7	4971	20	:	:	:
cord-005453-4057qib7	4971	21	11.1	11.1	CD
cord-005453-4057qib7	4971	22	%	%	NN
cord-005453-4057qib7	4971	23	,	,	,
cord-005453-4057qib7	4971	24	MOI	MOI	NNP
cord-005453-4057qib7	4971	25	5	5	CD
cord-005453-4057qib7	4971	26	:	:	:
cord-005453-4057qib7	4971	27	49.2	49.2	CD
cord-005453-4057qib7	4971	28	%	%	NN
cord-005453-4057qib7	4971	29	,	,	,
cord-005453-4057qib7	4971	30	MOI	MOI	NNP
cord-005453-4057qib7	4971	31	10	10	CD
cord-005453-4057qib7	4971	32	:	:	:
cord-005453-4057qib7	4971	33	68.9	68.9	CD
cord-005453-4057qib7	4971	34	%	%	NN
cord-005453-4057qib7	4971	35	)	)	-RRB-
cord-005453-4057qib7	4971	36	,	,	,
cord-005453-4057qib7	4971	37	outperforming	outperform	VBG
cord-005453-4057qib7	4971	38	the	the	DT
cord-005453-4057qib7	4971	39	efficiencies	efficiency	NNS
cord-005453-4057qib7	4971	40	of	of	IN
cord-005453-4057qib7	4971	41	lentivirally	lentivirally	RB
cord-005453-4057qib7	4971	42	generated	generate	VBN
cord-005453-4057qib7	4971	43	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4971	44	-	-	HYPH
cord-005453-4057qib7	4971	45	NK	NK	NNP
cord-005453-4057qib7	4971	46	cells	cell	NNS
cord-005453-4057qib7	4971	47	in	in	IN
cord-005453-4057qib7	4971	48	the	the	DT
cord-005453-4057qib7	4971	49	same	same	JJ
cord-005453-4057qib7	4971	50	experiments	experiment	NNS
cord-005453-4057qib7	4971	51	(	(	-LRB-
cord-005453-4057qib7	4971	52	MOI	MOI	NNP
cord-005453-4057qib7	4971	53	1	1	CD
cord-005453-4057qib7	4971	54	:	:	:
cord-005453-4057qib7	4971	55	1.5	1.5	CD
cord-005453-4057qib7	4971	56	%	%	NN
cord-005453-4057qib7	4971	57	,	,	,
cord-005453-4057qib7	4971	58	MOI	MOI	NNP
cord-005453-4057qib7	4971	59	5	5	CD
cord-005453-4057qib7	4971	60	:	:	:
cord-005453-4057qib7	4971	61	8.4	8.4	CD
cord-005453-4057qib7	4971	62	%	%	NN
cord-005453-4057qib7	4971	63	,	,	,
cord-005453-4057qib7	4971	64	MOI	MOI	NNP
cord-005453-4057qib7	4971	65	10	10	CD
cord-005453-4057qib7	4971	66	:	:	SYM
cord-005453-4057qib7	4971	67	14.9	14.9	CD
cord-005453-4057qib7	4971	68	%	%	NN
cord-005453-4057qib7	4971	69	)	)	-RRB-
cord-005453-4057qib7	4971	70	.	.	.
cord-005453-4057qib7	4972	1	Additionally	additionally	RB
cord-005453-4057qib7	4972	2	,	,	,
cord-005453-4057qib7	4972	3	alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	4972	4	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4972	5	-	-	HYPH
cord-005453-4057qib7	4972	6	NK	NK	NNP
cord-005453-4057qib7	4972	7	cells	cell	NNS
cord-005453-4057qib7	4972	8	showed	show	VBD
cord-005453-4057qib7	4972	9	a	a	DT
cord-005453-4057qib7	4972	10	higher	high	JJR
cord-005453-4057qib7	4972	11	cell	cell	NN
cord-005453-4057qib7	4972	12	killing	killing	NN
cord-005453-4057qib7	4972	13	activity	activity	NN
cord-005453-4057qib7	4972	14	against	against	IN
cord-005453-4057qib7	4972	15	CD19-positive	CD19-positive	NNP
cord-005453-4057qib7	4972	16	cells	cell	NNS
cord-005453-4057qib7	4972	17	than	than	IN
cord-005453-4057qib7	4972	18	lentiviral	lentiviral	JJ
cord-005453-4057qib7	4972	19	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4972	20	-	-	HYPH
cord-005453-4057qib7	4972	21	NK	NK	NNP
cord-005453-4057qib7	4972	22	cells	cell	NNS
cord-005453-4057qib7	4972	23	or	or	CC
cord-005453-4057qib7	4972	24	NT	NT	NNP
cord-005453-4057qib7	4972	25	-	-	HYPH
cord-005453-4057qib7	4972	26	NK	NK	NNP
cord-005453-4057qib7	4972	27	cells	cell	NNS
cord-005453-4057qib7	4972	28	(	(	-LRB-
cord-005453-4057qib7	4972	29	90.5	90.5	CD
cord-005453-4057qib7	4972	30	%	%	NN
cord-005453-4057qib7	4972	31	vs.	vs.	IN
cord-005453-4057qib7	4972	32	62.5	62.5	CD
cord-005453-4057qib7	4972	33	%	%	NN
cord-005453-4057qib7	4972	34	vs.	vs.	IN
cord-005453-4057qib7	4972	35	9	9	CD
cord-005453-4057qib7	4972	36	%	%	NN
cord-005453-4057qib7	4972	37	,	,	,
cord-005453-4057qib7	4972	38	E	e	NN
cord-005453-4057qib7	4972	39	:	:	:
cord-005453-4057qib7	4972	40	T	t	NN
cord-005453-4057qib7	4972	41	ratio	ratio	NN
cord-005453-4057qib7	4972	42	1:1	1:1	CD
cord-005453-4057qib7	4972	43	)	)	-RRB-
cord-005453-4057qib7	4972	44	.	.	.
cord-005453-4057qib7	4973	1	Interestingly	interestingly	RB
cord-005453-4057qib7	4973	2	,	,	,
cord-005453-4057qib7	4973	3	similar	similar	JJ
cord-005453-4057qib7	4973	4	killing	killing	NN
cord-005453-4057qib7	4973	5	activities	activity	NNS
cord-005453-4057qib7	4973	6	were	be	VBD
cord-005453-4057qib7	4973	7	achieved	achieve	VBN
cord-005453-4057qib7	4973	8	with	with	IN
cord-005453-4057qib7	4973	9	an	an	DT
cord-005453-4057qib7	4973	10	E	e	NN
cord-005453-4057qib7	4973	11	:	:	:
cord-005453-4057qib7	4973	12	T	t	NN
cord-005453-4057qib7	4973	13	ratio	ratio	NN
cord-005453-4057qib7	4973	14	of	of	IN
cord-005453-4057qib7	4973	15	0.5:1	0.5:1	CD
cord-005453-4057qib7	4974	1	(	(	-LRB-
cord-005453-4057qib7	4974	2	88.9	88.9	CD
cord-005453-4057qib7	4974	3	%	%	NN
cord-005453-4057qib7	4974	4	vs.	vs.	IN
cord-005453-4057qib7	4974	5	58.3	58.3	CD
cord-005453-4057qib7	4974	6	%	%	NN
cord-005453-4057qib7	4974	7	vs.	vs.	IN
cord-005453-4057qib7	4974	8	10.3	10.3	CD
cord-005453-4057qib7	4974	9	%	%	NN
cord-005453-4057qib7	4974	10	)	)	-RRB-
cord-005453-4057qib7	4974	11	and	and	CC
cord-005453-4057qib7	4974	12	alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	4974	13	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4974	14	-	-	HYPH
cord-005453-4057qib7	4974	15	NK	NK	NNP
cord-005453-4057qib7	4974	16	cells	cell	NNS
cord-005453-4057qib7	4974	17	remained	remain	VBD
cord-005453-4057qib7	4974	18	a	a	DT
cord-005453-4057qib7	4974	19	stable	stable	JJ
cord-005453-4057qib7	4974	20	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	4974	21	level	level	NN
cord-005453-4057qib7	4974	22	at	at	IN
cord-005453-4057qib7	4974	23	lower	low	JJR
cord-005453-4057qib7	4974	24	cell	cell	NN
cord-005453-4057qib7	4974	25	concentrations	concentration	NNS
cord-005453-4057qib7	4974	26	down	down	IN
cord-005453-4057qib7	4974	27	to	to	IN
cord-005453-4057qib7	4974	28	an	an	DT
cord-005453-4057qib7	4974	29	E	e	NN
cord-005453-4057qib7	4974	30	:	:	:
cord-005453-4057qib7	4974	31	T	t	NN
cord-005453-4057qib7	4974	32	ratio	ratio	NN
cord-005453-4057qib7	4974	33	of	of	IN
cord-005453-4057qib7	4974	34	0.1:1	0.1:1	NNP
cord-005453-4057qib7	4974	35	.	.	.
cord-005453-4057qib7	4975	1	All	all	DT
cord-005453-4057qib7	4975	2	three	three	CD
cord-005453-4057qib7	4975	3	NK	NK	NNP
cord-005453-4057qib7	4975	4	cell	cell	NN
cord-005453-4057qib7	4975	5	populations	population	NNS
cord-005453-4057qib7	4975	6	were	be	VBD
cord-005453-4057qib7	4975	7	equally	equally	RB
cord-005453-4057qib7	4975	8	efficient	efficient	JJ
cord-005453-4057qib7	4975	9	in	in	IN
cord-005453-4057qib7	4975	10	killing	kill	VBG
cord-005453-4057qib7	4975	11	CD19negative	cd19negative	JJ
cord-005453-4057qib7	4975	12	cells	cell	NNS
cord-005453-4057qib7	4975	13	(	(	-LRB-
cord-005453-4057qib7	4975	14	16.4	16.4	CD
cord-005453-4057qib7	4975	15	%	%	NN
cord-005453-4057qib7	4975	16	vs.	vs.	IN
cord-005453-4057qib7	4975	17	23.6	23.6	CD
cord-005453-4057qib7	4975	18	%	%	NN
cord-005453-4057qib7	4975	19	vs.	vs.	IN
cord-005453-4057qib7	4975	20	12.3	12.3	CD
cord-005453-4057qib7	4975	21	%	%	NN
cord-005453-4057qib7	4975	22	,	,	,
cord-005453-4057qib7	4975	23	E	e	NN
cord-005453-4057qib7	4975	24	:	:	:
cord-005453-4057qib7	4975	25	T	t	NN
cord-005453-4057qib7	4975	26	ratio	ratio	NN
cord-005453-4057qib7	4975	27	1:1	1:1	CD
cord-005453-4057qib7	4975	28	)	)	-RRB-
cord-005453-4057qib7	4975	29	.	.	.
cord-005453-4057qib7	4976	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	4976	2	:	:	:
cord-005453-4057qib7	4977	1	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4977	2	-	-	HYPH
cord-005453-4057qib7	4977	3	NK	NK	NNP
cord-005453-4057qib7	4977	4	cells	cell	NNS
cord-005453-4057qib7	4977	5	can	can	MD
cord-005453-4057qib7	4977	6	be	be	VB
cord-005453-4057qib7	4977	7	successfully	successfully	RB
cord-005453-4057qib7	4977	8	generated	generate	VBN
cord-005453-4057qib7	4977	9	under	under	IN
cord-005453-4057qib7	4977	10	feeder	feeder	NN
cord-005453-4057qib7	4977	11	-	-	HYPH
cord-005453-4057qib7	4977	12	cell	cell	NN
cord-005453-4057qib7	4977	13	free	free	JJ
cord-005453-4057qib7	4977	14	conditions	condition	NNS
cord-005453-4057qib7	4977	15	using	use	VBG
cord-005453-4057qib7	4977	16	different	different	JJ
cord-005453-4057qib7	4977	17	transduction	transduction	NN
cord-005453-4057qib7	4977	18	enhancers	enhancer	NNS
cord-005453-4057qib7	4977	19	and	and	CC
cord-005453-4057qib7	4977	20	viral	viral	JJ
cord-005453-4057qib7	4977	21	vector	vector	NN
cord-005453-4057qib7	4977	22	systems	system	NNS
cord-005453-4057qib7	4977	23	.	.	.
cord-005453-4057qib7	4978	1	These	these	DT
cord-005453-4057qib7	4978	2	data	datum	NNS
cord-005453-4057qib7	4978	3	suggest	suggest	VBP
cord-005453-4057qib7	4978	4	the	the	DT
cord-005453-4057qib7	4978	5	usage	usage	NN
cord-005453-4057qib7	4978	6	of	of	IN
cord-005453-4057qib7	4978	7	Vectofusin-1	Vectofusin-1	NNP
cord-005453-4057qib7	4978	8	in	in	IN
cord-005453-4057qib7	4978	9	combination	combination	NN
cord-005453-4057qib7	4978	10	with	with	IN
cord-005453-4057qib7	4978	11	alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	4978	12	vectors	vector	NNS
cord-005453-4057qib7	4978	13	to	to	TO
cord-005453-4057qib7	4978	14	genetically	genetically	RB
cord-005453-4057qib7	4978	15	modify	modify	VB
cord-005453-4057qib7	4978	16	NK	NK	NNP
cord-005453-4057qib7	4978	17	cells	cell	NNS
cord-005453-4057qib7	4978	18	to	to	TO
cord-005453-4057qib7	4978	19	achieve	achieve	VB
cord-005453-4057qib7	4978	20	sufficient	sufficient	JJ
cord-005453-4057qib7	4978	21	amounts	amount	NNS
cord-005453-4057qib7	4978	22	of	of	IN
cord-005453-4057qib7	4978	23	transduced	transduce	VBN
cord-005453-4057qib7	4978	24	cells	cell	NNS
cord-005453-4057qib7	4978	25	.	.	.
cord-005453-4057qib7	4979	1	These	these	DT
cord-005453-4057qib7	4979	2	CD19-CAR	CD19-CAR	NNP
cord-005453-4057qib7	4979	3	-	-	HYPH
cord-005453-4057qib7	4979	4	NK	NK	NNP
cord-005453-4057qib7	4979	5	cells	cell	NNS
cord-005453-4057qib7	4979	6	mediate	mediate	VBP
cord-005453-4057qib7	4979	7	high	high	JJ
cord-005453-4057qib7	4979	8	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	4979	9	and	and	CC
cord-005453-4057qib7	4979	10	therefore	therefore	RB
cord-005453-4057qib7	4979	11	may	may	MD
cord-005453-4057qib7	4979	12	offer	offer	VB
cord-005453-4057qib7	4979	13	a	a	DT
cord-005453-4057qib7	4979	14	new	new	JJ
cord-005453-4057qib7	4979	15	therapeutic	therapeutic	JJ
cord-005453-4057qib7	4979	16	option	option	NN
cord-005453-4057qib7	4979	17	in	in	IN
cord-005453-4057qib7	4979	18	the	the	DT
cord-005453-4057qib7	4979	19	treatment	treatment	NN
cord-005453-4057qib7	4979	20	of	of	IN
cord-005453-4057qib7	4979	21	ALL	all	DT
cord-005453-4057qib7	4979	22	.	.	.
cord-005453-4057qib7	4980	1	Disclosure	disclosure	NN
cord-005453-4057qib7	4980	2	:	:	:
cord-005453-4057qib7	4981	1	Axel	Axel	NNP
cord-005453-4057qib7	4981	2	Schambach	Schambach	NNP
cord-005453-4057qib7	4981	3	is	be	VBZ
cord-005453-4057qib7	4981	4	an	an	DT
cord-005453-4057qib7	4981	5	inventor	inventor	NN
cord-005453-4057qib7	4981	6	on	on	IN
cord-005453-4057qib7	4981	7	a	a	DT
cord-005453-4057qib7	4981	8	patent	patent	NN
cord-005453-4057qib7	4981	9	describing	describe	VBG
cord-005453-4057qib7	4981	10	alpharetroviral	alpharetroviral	JJ
cord-005453-4057qib7	4981	11	SIN	sin	NN
cord-005453-4057qib7	4981	12	vectors	vector	NNS
cord-005453-4057qib7	4981	13	.	.	.
cord-005453-4057qib7	4982	1	Winfried	Winfried	NNP
cord-005453-4057qib7	4982	2	S.	S.	NNP
cord-005453-4057qib7	4982	3	Wels	Wels	NNP
cord-005453-4057qib7	4982	4	is	be	VBZ
cord-005453-4057qib7	4982	5	an	an	DT
cord-005453-4057qib7	4982	6	inventor	inventor	NN
cord-005453-4057qib7	4982	7	on	on	IN
cord-005453-4057qib7	4982	8	a	a	DT
cord-005453-4057qib7	4982	9	patent	patent	NN
cord-005453-4057qib7	4982	10	describing	describe	VBG
cord-005453-4057qib7	4982	11	chimeric	chimeric	JJ
cord-005453-4057qib7	4982	12	antigen	antigen	NN
cord-005453-4057qib7	4982	13	receptors	receptor	NNS
cord-005453-4057qib7	4982	14	with	with	IN
cord-005453-4057qib7	4982	15	an	an	DT
cord-005453-4057qib7	4982	16	optimized	optimize	VBN
cord-005453-4057qib7	4982	17	hinge	hinge	NN
cord-005453-4057qib7	4982	18	region	region	NN
cord-005453-4057qib7	4982	19	.	.	.
cord-005453-4057qib7	4983	1	The	the	DT
cord-005453-4057qib7	4983	2	remaining	remain	VBG
cord-005453-4057qib7	4983	3	authors	author	NNS
cord-005453-4057qib7	4983	4	have	have	VBP
cord-005453-4057qib7	4983	5	nothing	nothing	NN
cord-005453-4057qib7	4983	6	to	to	TO
cord-005453-4057qib7	4983	7	disclose	disclose	VB
cord-005453-4057qib7	4983	8	.	.	.
cord-005453-4057qib7	4984	1	Graft	graft	NN
cord-005453-4057qib7	4984	2	-	-	HYPH
cord-005453-4057qib7	4984	3	versus	versus	IN
cord-005453-4057qib7	4984	4	-	-	HYPH
cord-005453-4057qib7	4984	5	host	host	NN
cord-005453-4057qib7	4984	6	diseaseclinical	diseaseclinical	JJ
cord-005453-4057qib7	4984	7	Walter	Walter	NNP
cord-005453-4057qib7	4984	8	Spindelböck	Spindelböck	NNP
cord-005453-4057qib7	4984	9	1	1	CD
cord-005453-4057qib7	4984	10	,	,	,
cord-005453-4057qib7	4985	1	Bianca	Bianca	NNP
cord-005453-4057qib7	4985	2	Huber	Huber	NNP
cord-005453-4057qib7	4985	3	-	-	HYPH
cord-005453-4057qib7	4985	4	Krassnitzer	Krassnitzer	NNP
cord-005453-4057qib7	4985	5	1	1	CD
cord-005453-4057qib7	4985	6	,	,	,
cord-005453-4057qib7	4985	7	Barbara	Barbara	NNP
cord-005453-4057qib7	4985	8	Uhl	Uhl	NNP
cord-005453-4057qib7	4985	9	1	1	CD
cord-005453-4057qib7	4985	10	,	,	,
cord-005453-4057qib7	4985	11	Gregor	Gregor	NNP
cord-005453-4057qib7	4985	12	Gorkiewicz	Gorkiewicz	NNP
cord-005453-4057qib7	4985	13	1	1	CD
cord-005453-4057qib7	4985	14	,	,	,
cord-005453-4057qib7	4985	15	Hildegard	Hildegard	NNP
cord-005453-4057qib7	4985	16	Greinix	Greinix	NNP
cord-005453-4057qib7	4985	17	1	1	CD
cord-005453-4057qib7	4985	18	,	,	,
cord-005453-4057qib7	4985	19	Christoph	Christoph	NNP
cord-005453-4057qib7	4985	20	Högenauer	Högenauer	NNP
cord-005453-4057qib7	4985	21	1	1	CD
cord-005453-4057qib7	4985	22	,	,	,
cord-005453-4057qib7	4985	23	Peter	Peter	NNP
cord-005453-4057qib7	4985	24	Neumeister	Neumeister	NNP
cord-005453-4057qib7	4985	25	1	1	CD
cord-005453-4057qib7	4985	26	Background	Background	NNP
cord-005453-4057qib7	4985	27	:	:	:
cord-005453-4057qib7	4985	28	Steroid	steroid	JJ
cord-005453-4057qib7	4985	29	-	-	HYPH
cord-005453-4057qib7	4985	30	refractory	refractory	JJ
cord-005453-4057qib7	4985	31	acute	acute	JJ
cord-005453-4057qib7	4985	32	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	4985	33	(	(	-LRB-
cord-005453-4057qib7	4985	34	GI	GI	NNP
cord-005453-4057qib7	4985	35	)	)	-RRB-
cord-005453-4057qib7	4985	36	graft	graft	NN
cord-005453-4057qib7	4985	37	-	-	HYPH
cord-005453-4057qib7	4985	38	versus	versus	IN
cord-005453-4057qib7	4985	39	-	-	HYPH
cord-005453-4057qib7	4985	40	host	host	NN
cord-005453-4057qib7	4985	41	disease	disease	NN
cord-005453-4057qib7	4985	42	(	(	-LRB-
cord-005453-4057qib7	4985	43	aGvHD	agvhd	NN
cord-005453-4057qib7	4985	44	)	)	-RRB-
cord-005453-4057qib7	4985	45	is	be	VBZ
cord-005453-4057qib7	4985	46	a	a	DT
cord-005453-4057qib7	4985	47	severe	severe	JJ
cord-005453-4057qib7	4985	48	complication	complication	NN
cord-005453-4057qib7	4985	49	of	of	IN
cord-005453-4057qib7	4985	50	allogeneic	allogeneic	NN
cord-005453-4057qib7	4985	51	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	4985	52	stem	stem	NN
cord-005453-4057qib7	4985	53	cell	cell	NN
cord-005453-4057qib7	4985	54	transplantation	transplantation	NN
cord-005453-4057qib7	4985	55	(	(	-LRB-
cord-005453-4057qib7	4985	56	allo	allo	NN
cord-005453-4057qib7	4985	57	-	-	HYPH
cord-005453-4057qib7	4985	58	HSCT	HSCT	NNP
cord-005453-4057qib7	4985	59	)	)	-RRB-
cord-005453-4057qib7	4985	60	associated	associate	VBD
cord-005453-4057qib7	4985	61	with	with	IN
cord-005453-4057qib7	4985	62	a	a	DT
cord-005453-4057qib7	4985	63	high	high	JJ
cord-005453-4057qib7	4985	64	mortality	mortality	NN
cord-005453-4057qib7	4985	65	rate	rate	NN
cord-005453-4057qib7	4985	66	.	.	.
cord-005453-4057qib7	4986	1	Loss	loss	NN
cord-005453-4057qib7	4986	2	of	of	IN
cord-005453-4057qib7	4986	3	intestinal	intestinal	JJ
cord-005453-4057qib7	4986	4	bacterial	bacterial	JJ
cord-005453-4057qib7	4986	5	diversity	diversity	NN
cord-005453-4057qib7	4986	6	is	be	VBZ
cord-005453-4057qib7	4986	7	thought	think	VBN
cord-005453-4057qib7	4986	8	to	to	TO
cord-005453-4057qib7	4986	9	be	be	VB
cord-005453-4057qib7	4986	10	associated	associate	VBN
cord-005453-4057qib7	4986	11	with	with	IN
cord-005453-4057qib7	4986	12	severity	severity	NN
cord-005453-4057qib7	4986	13	of	of	IN
cord-005453-4057qib7	4986	14	GI	GI	NNP
cord-005453-4057qib7	4986	15	-	-	HYPH
cord-005453-4057qib7	4986	16	aGvHD	aGvHD	NNP
cord-005453-4057qib7	4986	17	and	and	CC
cord-005453-4057qib7	4986	18	an	an	DT
cord-005453-4057qib7	4986	19	impaired	impaired	JJ
cord-005453-4057qib7	4986	20	intestinal	intestinal	JJ
cord-005453-4057qib7	4986	21	microbiota	microbiota	NN
cord-005453-4057qib7	4986	22	with	with	IN
cord-005453-4057qib7	4986	23	reduced	reduce	VBN
cord-005453-4057qib7	4986	24	diversity	diversity	NN
cord-005453-4057qib7	4986	25	is	be	VBZ
cord-005453-4057qib7	4986	26	an	an	DT
cord-005453-4057qib7	4986	27	independent	independent	JJ
cord-005453-4057qib7	4986	28	predictor	predictor	NN
cord-005453-4057qib7	4986	29	of	of	IN
cord-005453-4057qib7	4986	30	mortality	mortality	NN
cord-005453-4057qib7	4986	31	.	.	.
cord-005453-4057qib7	4987	1	Methods	method	NNS
cord-005453-4057qib7	4987	2	:	:	:
cord-005453-4057qib7	4988	1	The	the	DT
cord-005453-4057qib7	4988	2	fecal	fecal	JJ
cord-005453-4057qib7	4988	3	microbiota	microbiota	NN
cord-005453-4057qib7	4988	4	transplantation	transplantation	NN
cord-005453-4057qib7	4988	5	(	(	-LRB-
cord-005453-4057qib7	4988	6	FMT	fmt	NN
cord-005453-4057qib7	4988	7	)	)	-RRB-
cord-005453-4057qib7	4988	8	procedures	procedure	NNS
cord-005453-4057qib7	4988	9	were	be	VBD
cord-005453-4057qib7	4988	10	performed	perform	VBN
cord-005453-4057qib7	4988	11	according	accord	VBG
cord-005453-4057qib7	4988	12	to	to	IN
cord-005453-4057qib7	4988	13	a	a	DT
cord-005453-4057qib7	4988	14	protocol	protocol	NN
cord-005453-4057qib7	4988	15	approved	approve	VBN
cord-005453-4057qib7	4988	16	by	by	IN
cord-005453-4057qib7	4988	17	the	the	DT
cord-005453-4057qib7	4988	18	local	local	JJ
cord-005453-4057qib7	4988	19	ethical	ethical	JJ
cord-005453-4057qib7	4988	20	committee	committee	NN
cord-005453-4057qib7	4988	21	(	(	-LRB-
cord-005453-4057qib7	4988	22	29	29	CD
cord-005453-4057qib7	4988	23	-	-	HYPH
cord-005453-4057qib7	4988	24	027ex	027ex	NN
cord-005453-4057qib7	4988	25	16/17	16/17	CD
cord-005453-4057qib7	4988	26	)	)	-RRB-
cord-005453-4057qib7	4988	27	after	after	IN
cord-005453-4057qib7	4988	28	obtaining	obtain	VBG
cord-005453-4057qib7	4988	29	informed	informed	JJ
cord-005453-4057qib7	4988	30	consent	consent	NN
cord-005453-4057qib7	4988	31	.	.	.
cord-005453-4057qib7	4989	1	Donors	donor	NNS
cord-005453-4057qib7	4989	2	were	be	VBD
cord-005453-4057qib7	4989	3	healthy	healthy	JJ
cord-005453-4057qib7	4989	4	adult	adult	NN
cord-005453-4057qib7	4989	5	subjects	subject	NNS
cord-005453-4057qib7	4989	6	screened	screen	VBN
cord-005453-4057qib7	4989	7	for	for	IN
cord-005453-4057qib7	4989	8	potential	potential	JJ
cord-005453-4057qib7	4989	9	infections	infection	NNS
cord-005453-4057qib7	4989	10	by	by	IN
cord-005453-4057qib7	4989	11	serologic	serologic	NN
cord-005453-4057qib7	4989	12	and	and	CC
cord-005453-4057qib7	4989	13	microbiologic	microbiologic	JJ
cord-005453-4057qib7	4989	14	tests	test	NNS
cord-005453-4057qib7	4989	15	according	accord	VBG
cord-005453-4057qib7	4989	16	to	to	IN
cord-005453-4057qib7	4989	17	local	local	JJ
cord-005453-4057qib7	4989	18	standards	standard	NNS
cord-005453-4057qib7	4989	19	.	.	.
cord-005453-4057qib7	4990	1	Donor	donor	NN
cord-005453-4057qib7	4990	2	stool	stool	NN
cord-005453-4057qib7	4990	3	was	be	VBD
cord-005453-4057qib7	4990	4	diluted	dilute	VBN
cord-005453-4057qib7	4990	5	with	with	IN
cord-005453-4057qib7	4990	6	saline	saline	NN
cord-005453-4057qib7	4990	7	and	and	CC
cord-005453-4057qib7	4990	8	homogenized	homogenize	VBN
cord-005453-4057qib7	4990	9	to	to	IN
cord-005453-4057qib7	4990	10	a	a	DT
cord-005453-4057qib7	4990	11	volume	volume	NN
cord-005453-4057qib7	4990	12	of~250	of~250	NNP
cord-005453-4057qib7	4990	13	ml	ml	XX
cord-005453-4057qib7	4990	14	fecal	fecal	JJ
cord-005453-4057qib7	4990	15	solution	solution	NN
cord-005453-4057qib7	4990	16	for	for	IN
cord-005453-4057qib7	4990	17	instillation	instillation	NN
cord-005453-4057qib7	4990	18	into	into	IN
cord-005453-4057qib7	4990	19	the	the	DT
cord-005453-4057qib7	4990	20	terminal	terminal	JJ
cord-005453-4057qib7	4990	21	ileum	ileum	NN
cord-005453-4057qib7	4990	22	and	and	CC
cord-005453-4057qib7	4990	23	caecum	caecum	NN
cord-005453-4057qib7	4990	24	via	via	IN
cord-005453-4057qib7	4990	25	colonoscope	colonoscope	NN
cord-005453-4057qib7	4990	26	.	.	.
cord-005453-4057qib7	4991	1	Microbiota	Microbiota	NNP
cord-005453-4057qib7	4991	2	sequencing	sequencing	NN
cord-005453-4057qib7	4991	3	analysis	analysis	NN
cord-005453-4057qib7	4991	4	of	of	IN
cord-005453-4057qib7	4991	5	16s	16s	NNPS
cord-005453-4057qib7	4991	6	rDNA	rDNA	NNP
cord-005453-4057qib7	4991	7	was	be	VBD
cord-005453-4057qib7	4991	8	performed	perform	VBN
cord-005453-4057qib7	4991	9	before	before	IN
cord-005453-4057qib7	4991	10	FMTs	fmt	NNS
cord-005453-4057qib7	4991	11	and	and	CC
cord-005453-4057qib7	4991	12	afterwards	afterwards	RB
cord-005453-4057qib7	4991	13	at	at	IN
cord-005453-4057qib7	4991	14	predefined	predefined	JJ
cord-005453-4057qib7	4991	15	timepoints	timepoint	NNS
cord-005453-4057qib7	4991	16	.	.	.
cord-005453-4057qib7	4992	1	Results	result	NNS
cord-005453-4057qib7	4992	2	:	:	:
cord-005453-4057qib7	4993	1	We	-PRON-	PRP
cord-005453-4057qib7	4993	2	report	report	VBP
cord-005453-4057qib7	4993	3	the	the	DT
cord-005453-4057qib7	4993	4	outcome	outcome	NN
cord-005453-4057qib7	4993	5	of	of	IN
cord-005453-4057qib7	4993	6	nine	nine	CD
cord-005453-4057qib7	4993	7	patients	patient	NNS
cord-005453-4057qib7	4993	8	refractory	refractory	JJ
cord-005453-4057qib7	4993	9	to	to	IN
cord-005453-4057qib7	4993	10	3	3	CD
cord-005453-4057qib7	4993	11	-	-	SYM
cord-005453-4057qib7	4993	12	6	6	CD
cord-005453-4057qib7	4993	13	lines	line	NNS
cord-005453-4057qib7	4993	14	of	of	IN
cord-005453-4057qib7	4993	15	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4993	16	therapies	therapy	NNS
cord-005453-4057qib7	4993	17	with	with	IN
cord-005453-4057qib7	4993	18	lower	low	JJR
cord-005453-4057qib7	4993	19	GI	gi	NN
cord-005453-4057qib7	4993	20	-	-	HYPH
cord-005453-4057qib7	4993	21	stage	stage	NN
cord-005453-4057qib7	4993	22	III	III	NNP
cord-005453-4057qib7	4993	23	(	(	-LRB-
cord-005453-4057qib7	4993	24	n=1	n=1	NN
cord-005453-4057qib7	4993	25	)	)	-RRB-
cord-005453-4057qib7	4993	26	or	or	CC
cord-005453-4057qib7	4993	27	IV	IV	NNP
cord-005453-4057qib7	4993	28	(	(	-LRB-
cord-005453-4057qib7	4993	29	n=8	n=8	NN
cord-005453-4057qib7	4993	30	)	)	-RRB-
cord-005453-4057qib7	4993	31	aGvHD	aGvHD	.
cord-005453-4057qib7	4993	32	following	follow	VBG
cord-005453-4057qib7	4993	33	repetitive	repetitive	JJ
cord-005453-4057qib7	4993	34	FMTs	fmt	NNS
cord-005453-4057qib7	4993	35	from	from	IN
cord-005453-4057qib7	4993	36	a	a	DT
cord-005453-4057qib7	4993	37	single	single	JJ
cord-005453-4057qib7	4993	38	donor	donor	NN
cord-005453-4057qib7	4993	39	.	.	.
cord-005453-4057qib7	4994	1	All	all	DT
cord-005453-4057qib7	4994	2	patients	patient	NNS
cord-005453-4057qib7	4994	3	had	have	VBD
cord-005453-4057qib7	4994	4	received	receive	VBN
cord-005453-4057qib7	4994	5	an	an	DT
cord-005453-4057qib7	4994	6	allo	allo	NN
cord-005453-4057qib7	4994	7	-	-	HYPH
cord-005453-4057qib7	4994	8	HSCT	HSCT	NNP
cord-005453-4057qib7	4994	9	for	for	IN
cord-005453-4057qib7	4994	10	MDS	MDS	NNP
cord-005453-4057qib7	4994	11	(	(	-LRB-
cord-005453-4057qib7	4994	12	n=3	n=3	NN
cord-005453-4057qib7	4994	13	)	)	-RRB-
cord-005453-4057qib7	4994	14	,	,	,
cord-005453-4057qib7	4994	15	AML	AML	NNP
cord-005453-4057qib7	4994	16	(	(	-LRB-
cord-005453-4057qib7	4994	17	n=4	n=4	NNP
cord-005453-4057qib7	4994	18	)	)	-RRB-
cord-005453-4057qib7	4994	19	,	,	,
cord-005453-4057qib7	4994	20	PMF	PMF	NNP
cord-005453-4057qib7	4994	21	(	(	-LRB-
cord-005453-4057qib7	4994	22	n=1	n=1	NNP
cord-005453-4057qib7	4994	23	)	)	-RRB-
cord-005453-4057qib7	4994	24	and	and	CC
cord-005453-4057qib7	4994	25	MM	MM	NNP
cord-005453-4057qib7	4994	26	(	(	-LRB-
cord-005453-4057qib7	4994	27	n=1	n=1	FW
cord-005453-4057qib7	4994	28	)	)	-RRB-
cord-005453-4057qib7	4994	29	following	follow	VBG
cord-005453-4057qib7	4994	30	a	a	DT
cord-005453-4057qib7	4994	31	reduced	reduce	VBN
cord-005453-4057qib7	4994	32	intensity	intensity	NN
cord-005453-4057qib7	4994	33	(	(	-LRB-
cord-005453-4057qib7	4994	34	n=5	n=5	NNP
cord-005453-4057qib7	4994	35	)	)	-RRB-
cord-005453-4057qib7	4994	36	or	or	CC
cord-005453-4057qib7	4994	37	MAC	MAC	NNP
cord-005453-4057qib7	4994	38	(	(	-LRB-
cord-005453-4057qib7	4994	39	n=4	n=4	JJ
cord-005453-4057qib7	4994	40	)	)	-RRB-
cord-005453-4057qib7	4994	41	conditioning	conditioning	NN
cord-005453-4057qib7	4994	42	regimen	regimen	NN
cord-005453-4057qib7	4994	43	using	use	VBG
cord-005453-4057qib7	4994	44	PBSC	PBSC	NNP
cord-005453-4057qib7	4994	45	as	as	IN
cord-005453-4057qib7	4994	46	stem	stem	NN
cord-005453-4057qib7	4994	47	cell	cell	NN
cord-005453-4057qib7	4994	48	source	source	NN
cord-005453-4057qib7	4994	49	.	.	.
cord-005453-4057qib7	4995	1	After	after	IN
cord-005453-4057qib7	4995	2	an	an	DT
cord-005453-4057qib7	4995	3	onset	onset	NN
cord-005453-4057qib7	4995	4	of	of	IN
cord-005453-4057qib7	4995	5	lower	low	JJR
cord-005453-4057qib7	4995	6	GI	GI	NNP
cord-005453-4057qib7	4995	7	aGvHD	agvhd	NN
cord-005453-4057qib7	4995	8	between	between	IN
cord-005453-4057qib7	4995	9	11	11	CD
cord-005453-4057qib7	4995	10	-	-	SYM
cord-005453-4057qib7	4995	11	465	465	CD
cord-005453-4057qib7	4995	12	days	day	NNS
cord-005453-4057qib7	4995	13	after	after	IN
cord-005453-4057qib7	4995	14	allo	allo	NN
cord-005453-4057qib7	4995	15	-	-	HYPH
cord-005453-4057qib7	4995	16	HSCT	HSCT	NNP
cord-005453-4057qib7	4995	17	,	,	,
cord-005453-4057qib7	4995	18	nine	nine	CD
cord-005453-4057qib7	4995	19	patients	patient	NNS
cord-005453-4057qib7	4995	20	refractory	refractory	JJ
cord-005453-4057qib7	4995	21	to	to	IN
cord-005453-4057qib7	4995	22	several	several	JJ
cord-005453-4057qib7	4995	23	lines	line	NNS
cord-005453-4057qib7	4995	24	of	of	IN
cord-005453-4057qib7	4995	25	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	4995	26	therapies	therapy	NNS
cord-005453-4057qib7	4995	27	received	receive	VBD
cord-005453-4057qib7	4995	28	1	1	CD
cord-005453-4057qib7	4995	29	-	-	SYM
cord-005453-4057qib7	4995	30	6	6	CD
cord-005453-4057qib7	4995	31	FMTs	fmt	NNS
cord-005453-4057qib7	4995	32	(	(	-LRB-
cord-005453-4057qib7	4995	33	6	6	CD
cord-005453-4057qib7	4995	34	patients	patient	NNS
cord-005453-4057qib7	4995	35	were	be	VBD
cord-005453-4057qib7	4995	36	treated	treat	VBN
cord-005453-4057qib7	4995	37	with	with	IN
cord-005453-4057qib7	4995	38	more	more	JJR
cord-005453-4057qib7	4995	39	than	than	IN
cord-005453-4057qib7	4995	40	2	2	CD
cord-005453-4057qib7	4995	41	FMTs	fmt	NNS
cord-005453-4057qib7	4995	42	,	,	,
cord-005453-4057qib7	4995	43	in	in	IN
cord-005453-4057qib7	4995	44	3	3	CD
cord-005453-4057qib7	4995	45	patients	patient	NNS
cord-005453-4057qib7	4995	46	FMT	fmt	NN
cord-005453-4057qib7	4995	47	was	be	VBD
cord-005453-4057qib7	4995	48	only	only	RB
cord-005453-4057qib7	4995	49	administered	administer	VBN
cord-005453-4057qib7	4995	50	once	once	RB
cord-005453-4057qib7	4995	51	or	or	CC
cord-005453-4057qib7	4995	52	twice	twice	RB
cord-005453-4057qib7	4995	53	)	)	-RRB-
cord-005453-4057qib7	4995	54	mostly	mostly	RB
cord-005453-4057qib7	4995	55	in	in	IN
cord-005453-4057qib7	4995	56	weekly	weekly	JJ
cord-005453-4057qib7	4995	57	intervals	interval	NNS
cord-005453-4057qib7	4995	58	.	.	.
cord-005453-4057qib7	4996	1	Five	five	CD
cord-005453-4057qib7	4996	2	patients	patient	NNS
cord-005453-4057qib7	4996	3	achieved	achieve	VBD
cord-005453-4057qib7	4996	4	a	a	DT
cord-005453-4057qib7	4996	5	clinical	clinical	JJ
cord-005453-4057qib7	4996	6	complete	complete	JJ
cord-005453-4057qib7	4996	7	response	response	NN
cord-005453-4057qib7	4996	8	with	with	IN
cord-005453-4057qib7	4996	9	resolved	resolve	VBN
cord-005453-4057qib7	4996	10	diarrhea	diarrhea	NN
cord-005453-4057qib7	4996	11	and	and	CC
cord-005453-4057qib7	4996	12	no	no	DT
cord-005453-4057qib7	4996	13	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	4996	14	complaints	complaint	NNS
cord-005453-4057qib7	4996	15	,	,	,
cord-005453-4057qib7	4996	16	and	and	CC
cord-005453-4057qib7	4996	17	four	four	CD
cord-005453-4057qib7	4996	18	of	of	IN
cord-005453-4057qib7	4996	19	these	these	DT
cord-005453-4057qib7	4996	20	could	could	MD
cord-005453-4057qib7	4996	21	be	be	VB
cord-005453-4057qib7	4996	22	discharged	discharge	VBN
cord-005453-4057qib7	4996	23	without	without	IN
cord-005453-4057qib7	4996	24	GvHD	gvhd	NN
cord-005453-4057qib7	4996	25	symptoms	symptom	NNS
cord-005453-4057qib7	4996	26	.	.	.
cord-005453-4057qib7	4997	1	Two	two	CD
cord-005453-4057qib7	4997	2	patients	patient	NNS
cord-005453-4057qib7	4997	3	(	(	-LRB-
cord-005453-4057qib7	4997	4	PR	PR	NNP
cord-005453-4057qib7	4997	5	,	,	,
cord-005453-4057qib7	4997	6	NC	NC	NNP
cord-005453-4057qib7	4997	7	)	)	-RRB-
cord-005453-4057qib7	4997	8	were	be	VBD
cord-005453-4057qib7	4997	9	discontinued	discontinue	VBN
cord-005453-4057qib7	4997	10	after	after	IN
cord-005453-4057qib7	4997	11	2	2	CD
cord-005453-4057qib7	4997	12	or	or	CC
cord-005453-4057qib7	4997	13	3	3	CD
cord-005453-4057qib7	4997	14	FMTs	fmt	NNS
cord-005453-4057qib7	4997	15	in	in	IN
cord-005453-4057qib7	4997	16	PR	PR	NNP
cord-005453-4057qib7	4997	17	or	or	CC
cord-005453-4057qib7	4997	18	NC	NC	NNP
cord-005453-4057qib7	4997	19	due	due	JJ
cord-005453-4057qib7	4997	20	to	to	IN
cord-005453-4057qib7	4997	21	concomitant	concomitant	JJ
cord-005453-4057qib7	4997	22	infections	infection	NNS
cord-005453-4057qib7	4997	23	(	(	-LRB-
cord-005453-4057qib7	4997	24	Metapneumoviral	Metapneumoviral	NNP
cord-005453-4057qib7	4997	25	pneumonia	pneumonia	NN
cord-005453-4057qib7	4997	26	,	,	,
cord-005453-4057qib7	4997	27	CMV	CMV	NNP
cord-005453-4057qib7	4997	28	gastroenteritis	gastroenteritis	NN
cord-005453-4057qib7	4997	29	)	)	-RRB-
cord-005453-4057qib7	4997	30	,	,	,
cord-005453-4057qib7	4997	31	the	the	DT
cord-005453-4057qib7	4997	32	2	2	CD
cord-005453-4057qib7	4997	33	other	other	JJ
cord-005453-4057qib7	4997	34	non	non	NNS
cord-005453-4057qib7	4997	35	-	-	NNS
cord-005453-4057qib7	4997	36	responders	responder	NNS
cord-005453-4057qib7	4997	37	succumbed	succumb	VBD
cord-005453-4057qib7	4997	38	to	to	IN
cord-005453-4057qib7	4997	39	GvHDrelated	gvhdrelate	VBN
cord-005453-4057qib7	4997	40	infectious	infectious	JJ
cord-005453-4057qib7	4997	41	complications	complication	NNS
cord-005453-4057qib7	4997	42	.	.	.
cord-005453-4057qib7	4998	1	The	the	DT
cord-005453-4057qib7	4998	2	establishment	establishment	NN
cord-005453-4057qib7	4998	3	of	of	IN
cord-005453-4057qib7	4998	4	donors	donor	NNS
cord-005453-4057qib7	4998	5	'	'	POS
cord-005453-4057qib7	4998	6	microbiota	microbiota	NN
cord-005453-4057qib7	4998	7	with	with	IN
cord-005453-4057qib7	4998	8	the	the	DT
cord-005453-4057qib7	4998	9	emergence	emergence	NN
cord-005453-4057qib7	4998	10	of	of	IN
cord-005453-4057qib7	4998	11	new	new	JJ
cord-005453-4057qib7	4998	12	taxa	taxon	NNS
cord-005453-4057qib7	4998	13	,	,	,
cord-005453-4057qib7	4998	14	an	an	DT
cord-005453-4057qib7	4998	15	increase	increase	NN
cord-005453-4057qib7	4998	16	in	in	IN
cord-005453-4057qib7	4998	17	bacterial	bacterial	JJ
cord-005453-4057qib7	4998	18	richness	richness	NN
cord-005453-4057qib7	4998	19	/	/	SYM
cord-005453-4057qib7	4998	20	diversity	diversity	NN
cord-005453-4057qib7	4998	21	,	,	,
cord-005453-4057qib7	4998	22	and	and	CC
cord-005453-4057qib7	4998	23	the	the	DT
cord-005453-4057qib7	4998	24	disappearance	disappearance	NN
cord-005453-4057qib7	4998	25	of	of	IN
cord-005453-4057qib7	4998	26	the	the	DT
cord-005453-4057qib7	4998	27	"	"	``
cord-005453-4057qib7	4998	28	enterococcus	enterococcus	NN
cord-005453-4057qib7	4998	29	signature	signature	NN
cord-005453-4057qib7	4998	30	"	"	''
cord-005453-4057qib7	4998	31	were	be	VBD
cord-005453-4057qib7	4998	32	associated	associate	VBN
cord-005453-4057qib7	4998	33	with	with	IN
cord-005453-4057qib7	4998	34	disease	disease	NN
cord-005453-4057qib7	4998	35	control	control	NN
cord-005453-4057qib7	4998	36	and	and	CC
cord-005453-4057qib7	4998	37	response	response	NN
cord-005453-4057qib7	4998	38	to	to	IN
cord-005453-4057qib7	4998	39	FMT	FMT	NNP
cord-005453-4057qib7	4998	40	.	.	.
cord-005453-4057qib7	4999	1	Except	except	IN
cord-005453-4057qib7	4999	2	the	the	DT
cord-005453-4057qib7	4999	3	possible	possible	JJ
cord-005453-4057qib7	4999	4	transmission	transmission	NN
cord-005453-4057qib7	4999	5	of	of	IN
cord-005453-4057qib7	4999	6	Adenovirus	Adenovirus	NNP
cord-005453-4057qib7	4999	7	by	by	IN
cord-005453-4057qib7	4999	8	FMT	FMT	NNP
cord-005453-4057qib7	4999	9	in	in	IN
cord-005453-4057qib7	4999	10	one	one	CD
cord-005453-4057qib7	4999	11	patient	patient	NN
cord-005453-4057qib7	4999	12	,	,	,
cord-005453-4057qib7	4999	13	no	no	DT
cord-005453-4057qib7	4999	14	other	other	JJ
cord-005453-4057qib7	4999	15	immediate	immediate	JJ
cord-005453-4057qib7	4999	16	procedure	procedure	NN
cord-005453-4057qib7	4999	17	-	-	HYPH
cord-005453-4057qib7	4999	18	related	relate	VBN
cord-005453-4057qib7	4999	19	infections	infection	NNS
cord-005453-4057qib7	4999	20	or	or	CC
cord-005453-4057qib7	4999	21	other	other	JJ
cord-005453-4057qib7	4999	22	side	side	NN
cord-005453-4057qib7	4999	23	effects	effect	NNS
cord-005453-4057qib7	4999	24	were	be	VBD
cord-005453-4057qib7	4999	25	observed	observe	VBN
cord-005453-4057qib7	4999	26	.	.	.
cord-005453-4057qib7	5000	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5000	2	:	:	:
cord-005453-4057qib7	5001	1	Restoration	restoration	NN
cord-005453-4057qib7	5001	2	of	of	IN
cord-005453-4057qib7	5001	3	dysbiosis	dysbiosis	NN
cord-005453-4057qib7	5001	4	by	by	IN
cord-005453-4057qib7	5001	5	FMT	FMT	NNP
cord-005453-4057qib7	5001	6	might	may	MD
cord-005453-4057qib7	5001	7	represent	represent	VB
cord-005453-4057qib7	5001	8	a	a	DT
cord-005453-4057qib7	5001	9	promising	promising	JJ
cord-005453-4057qib7	5001	10	novel	novel	JJ
cord-005453-4057qib7	5001	11	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5001	12	approach	approach	NN
cord-005453-4057qib7	5001	13	for	for	IN
cord-005453-4057qib7	5001	14	a	a	DT
cord-005453-4057qib7	5001	15	subset	subset	NN
cord-005453-4057qib7	5001	16	of	of	IN
cord-005453-4057qib7	5001	17	patients	patient	NNS
cord-005453-4057qib7	5001	18	with	with	IN
cord-005453-4057qib7	5001	19	refractory	refractory	JJ
cord-005453-4057qib7	5001	20	lower	low	JJR
cord-005453-4057qib7	5001	21	GI	GI	NNP
cord-005453-4057qib7	5001	22	-	-	HYPH
cord-005453-4057qib7	5001	23	aGvHD	agvhd	NN
cord-005453-4057qib7	5001	24	.	.	.
cord-005453-4057qib7	5002	1	Vigorous	vigorous	JJ
cord-005453-4057qib7	5002	2	donor	donor	NN
cord-005453-4057qib7	5002	3	screening	screening	NN
cord-005453-4057qib7	5002	4	for	for	IN
cord-005453-4057qib7	5002	5	infectious	infectious	JJ
cord-005453-4057qib7	5002	6	disease	disease	NN
cord-005453-4057qib7	5002	7	is	be	VBZ
cord-005453-4057qib7	5002	8	mandatory	mandatory	JJ
cord-005453-4057qib7	5002	9	.	.	.
cord-005453-4057qib7	5003	1	Clinical	clinical	JJ
cord-005453-4057qib7	5003	2	Background	background	NN
cord-005453-4057qib7	5003	3	:	:	:
cord-005453-4057qib7	5004	1	Migration	migration	NN
cord-005453-4057qib7	5004	2	of	of	IN
cord-005453-4057qib7	5004	3	allo	allo	NN
cord-005453-4057qib7	5004	4	-	-	HYPH
cord-005453-4057qib7	5004	5	activated	activate	VBN
cord-005453-4057qib7	5004	6	donor	donor	NN
cord-005453-4057qib7	5004	7	effector	effector	NN
cord-005453-4057qib7	5004	8	Tcells	Tcells	NNP
cord-005453-4057qib7	5004	9	from	from	IN
cord-005453-4057qib7	5004	10	lymphoid	lymphoid	JJ
cord-005453-4057qib7	5004	11	tissues	tissue	NNS
cord-005453-4057qib7	5004	12	to	to	TO
cord-005453-4057qib7	5004	13	target	target	VB
cord-005453-4057qib7	5004	14	organs	organ	NNS
cord-005453-4057qib7	5004	15	is	be	VBZ
cord-005453-4057qib7	5004	16	an	an	DT
cord-005453-4057qib7	5004	17	important	important	JJ
cord-005453-4057qib7	5004	18	step	step	NN
cord-005453-4057qib7	5004	19	in	in	IN
cord-005453-4057qib7	5004	20	acute	acute	JJ
cord-005453-4057qib7	5004	21	graft	graft	NN
cord-005453-4057qib7	5004	22	versus	versus	IN
cord-005453-4057qib7	5004	23	host	host	NN
cord-005453-4057qib7	5004	24	disease	disease	NN
cord-005453-4057qib7	5004	25	(	(	-LRB-
cord-005453-4057qib7	5004	26	GvHD	GvHD	NNP
cord-005453-4057qib7	5004	27	)	)	-RRB-
cord-005453-4057qib7	5004	28	.	.	.
cord-005453-4057qib7	5005	1	The	the	DT
cord-005453-4057qib7	5005	2	sphingosine-1-phosphate-1	sphingosine-1-phosphate-1	NNP
cord-005453-4057qib7	5005	3	(	(	-LRB-
cord-005453-4057qib7	5005	4	S1P1	S1P1	NNP
cord-005453-4057qib7	5005	5	)	)	-RRB-
cord-005453-4057qib7	5005	6	receptor	receptor	NN
cord-005453-4057qib7	5005	7	plays	play	VBZ
cord-005453-4057qib7	5005	8	a	a	DT
cord-005453-4057qib7	5005	9	crucial	crucial	JJ
cord-005453-4057qib7	5005	10	role	role	NN
cord-005453-4057qib7	5005	11	in	in	IN
cord-005453-4057qib7	5005	12	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5005	13	trafficking	trafficking	NN
cord-005453-4057qib7	5005	14	.	.	.
cord-005453-4057qib7	5006	1	Data	datum	NNS
cord-005453-4057qib7	5006	2	from	from	IN
cord-005453-4057qib7	5006	3	animal	animal	NN
cord-005453-4057qib7	5006	4	models	model	NNS
cord-005453-4057qib7	5006	5	suggest	suggest	VBP
cord-005453-4057qib7	5006	6	that	that	IN
cord-005453-4057qib7	5006	7	pharmacological	pharmacological	JJ
cord-005453-4057qib7	5006	8	modulation	modulation	NN
cord-005453-4057qib7	5006	9	of	of	IN
cord-005453-4057qib7	5006	10	the	the	DT
cord-005453-4057qib7	5006	11	S1P1	S1P1	NNP
cord-005453-4057qib7	5006	12	receptor	receptor	NN
cord-005453-4057qib7	5006	13	reduces	reduce	VBZ
cord-005453-4057qib7	5006	14	GvHD	GvHD	NNP
cord-005453-4057qib7	5006	15	and	and	CC
cord-005453-4057qib7	5006	16	improves	improve	VBZ
cord-005453-4057qib7	5006	17	mortality	mortality	NN
cord-005453-4057qib7	5006	18	.	.	.
cord-005453-4057qib7	5007	1	We	-PRON-	PRP
cord-005453-4057qib7	5007	2	investigated	investigate	VBD
cord-005453-4057qib7	5007	3	this	this	DT
cord-005453-4057qib7	5007	4	mode	mode	NN
cord-005453-4057qib7	5007	5	of	of	IN
cord-005453-4057qib7	5007	6	action	action	NN
cord-005453-4057qib7	5007	7	by	by	IN
cord-005453-4057qib7	5007	8	using	use	VBG
cord-005453-4057qib7	5007	9	the	the	DT
cord-005453-4057qib7	5007	10	secondgeneration	secondgeneration	NN
cord-005453-4057qib7	5007	11	S1P1	S1P1	NNP
cord-005453-4057qib7	5007	12	modulator	modulator	NN
cord-005453-4057qib7	5007	13	KRP203	krp203	NN
cord-005453-4057qib7	5007	14	for	for	IN
cord-005453-4057qib7	5007	15	the	the	DT
cord-005453-4057qib7	5007	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5007	17	of	of	IN
cord-005453-4057qib7	5007	18	GvHD	GvHD	NNP
cord-005453-4057qib7	5007	19	in	in	IN
cord-005453-4057qib7	5007	20	a	a	DT
cord-005453-4057qib7	5007	21	pilot	pilot	NN
cord-005453-4057qib7	5007	22	clinical	clinical	JJ
cord-005453-4057qib7	5007	23	trial	trial	NN
cord-005453-4057qib7	5007	24	in	in	IN
cord-005453-4057qib7	5007	25	patients	patient	NNS
cord-005453-4057qib7	5007	26	undergoing	undergo	VBG
cord-005453-4057qib7	5007	27	allogeneic	allogeneic	IN
cord-005453-4057qib7	5007	28	HSCT	HSCT	NNP
cord-005453-4057qib7	5007	29	.	.	.
cord-005453-4057qib7	5008	1	Methods	method	NNS
cord-005453-4057qib7	5008	2	:	:	:
cord-005453-4057qib7	5009	1	A	a	DT
cord-005453-4057qib7	5009	2	multi	multi	JJ
cord-005453-4057qib7	5009	3	-	-	JJ
cord-005453-4057qib7	5009	4	centric	centric	JJ
cord-005453-4057qib7	5009	5	,	,	,
cord-005453-4057qib7	5009	6	Phase	phase	NN
cord-005453-4057qib7	5009	7	1b	1b	CD
cord-005453-4057qib7	5009	8	,	,	,
cord-005453-4057qib7	5009	9	prospective	prospective	JJ
cord-005453-4057qib7	5009	10	,	,	,
cord-005453-4057qib7	5009	11	open	open	JJ
cord-005453-4057qib7	5009	12	label	label	NN
cord-005453-4057qib7	5009	13	,	,	,
cord-005453-4057qib7	5009	14	two	two	CD
cord-005453-4057qib7	5009	15	-	-	HYPH
cord-005453-4057qib7	5009	16	part	part	NN
cord-005453-4057qib7	5009	17	study	study	NN
cord-005453-4057qib7	5009	18	was	be	VBD
cord-005453-4057qib7	5009	19	conducted	conduct	VBN
cord-005453-4057qib7	5009	20	to	to	TO
cord-005453-4057qib7	5009	21	evaluate	evaluate	VB
cord-005453-4057qib7	5009	22	the	the	DT
cord-005453-4057qib7	5009	23	safety	safety	NN
cord-005453-4057qib7	5009	24	,	,	,
cord-005453-4057qib7	5009	25	tolerability	tolerability	NN
cord-005453-4057qib7	5009	26	and	and	CC
cord-005453-4057qib7	5009	27	pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	5009	28	of	of	IN
cord-005453-4057qib7	5009	29	KRP203	krp203	DT
cord-005453-4057qib7	5009	30	in	in	IN
cord-005453-4057qib7	5009	31	patients	patient	NNS
cord-005453-4057qib7	5009	32	undergoing	undergo	VBG
cord-005453-4057qib7	5009	33	allogeneic	allogeneic	IN
cord-005453-4057qib7	5009	34	HSCT	HSCT	NNP
cord-005453-4057qib7	5009	35	for	for	IN
cord-005453-4057qib7	5009	36	hematological	hematological	JJ
cord-005453-4057qib7	5009	37	malignancies	malignancy	NNS
cord-005453-4057qib7	5009	38	.	.	.
cord-005453-4057qib7	5010	1	Primary	primary	JJ
cord-005453-4057qib7	5010	2	endpoint	endpoint	NN
cord-005453-4057qib7	5010	3	was	be	VBD
cord-005453-4057qib7	5010	4	safety	safety	NN
cord-005453-4057qib7	5010	5	.	.	.
cord-005453-4057qib7	5011	1	Initial	initial	JJ
cord-005453-4057qib7	5011	2	efficacy	efficacy	NN
cord-005453-4057qib7	5011	3	was	be	VBD
cord-005453-4057qib7	5011	4	explored	explore	VBN
cord-005453-4057qib7	5011	5	based	base	VBN
cord-005453-4057qib7	5011	6	on	on	IN
cord-005453-4057qib7	5011	7	the	the	DT
cord-005453-4057qib7	5011	8	incidence	incidence	NN
cord-005453-4057qib7	5011	9	of	of	IN
cord-005453-4057qib7	5011	10	GvHD	gvhd	NN
cord-005453-4057qib7	5011	11	,	,	,
cord-005453-4057qib7	5011	12	mortality	mortality	NN
cord-005453-4057qib7	5011	13	and	and	CC
cord-005453-4057qib7	5011	14	relapse	relapse	NN
cord-005453-4057qib7	5011	15	.	.	.
cord-005453-4057qib7	5012	1	Part	part	NN
cord-005453-4057qib7	5012	2	1	1	CD
cord-005453-4057qib7	5012	3	was	be	VBD
cord-005453-4057qib7	5012	4	a	a	DT
cord-005453-4057qib7	5012	5	single	single	JJ
cord-005453-4057qib7	5012	6	arm	arm	NN
cord-005453-4057qib7	5012	7	open	open	JJ
cord-005453-4057qib7	5012	8	label	label	NN
cord-005453-4057qib7	5012	9	study	study	NN
cord-005453-4057qib7	5012	10	to	to	TO
cord-005453-4057qib7	5012	11	investigate	investigate	VB
cord-005453-4057qib7	5012	12	the	the	DT
cord-005453-4057qib7	5012	13	safety	safety	NN
cord-005453-4057qib7	5012	14	of	of	IN
cord-005453-4057qib7	5012	15	3	3	CD
cord-005453-4057qib7	5012	16	mg	mg	NNP
cord-005453-4057qib7	5012	17	/	/	SYM
cord-005453-4057qib7	5012	18	day	day	NN
cord-005453-4057qib7	5012	19	KRP203	KRP203	NNP
cord-005453-4057qib7	5012	20	added	add	VBD
cord-005453-4057qib7	5012	21	to	to	IN
cord-005453-4057qib7	5012	22	standard	standard	NN
cord-005453-4057qib7	5012	23	of	of	IN
cord-005453-4057qib7	5012	24	care	care	NN
cord-005453-4057qib7	5012	25	GvHD	GvHD	NNP
cord-005453-4057qib7	5012	26	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5012	27	(	(	-LRB-
cord-005453-4057qib7	5012	28	CsA	CsA	NNP
cord-005453-4057qib7	5012	29	/	/	SYM
cord-005453-4057qib7	5012	30	MTX	MTX	NNP
cord-005453-4057qib7	5012	31	)	)	-RRB-
cord-005453-4057qib7	5012	32	in	in	IN
cord-005453-4057qib7	5012	33	10	10	CD
cord-005453-4057qib7	5012	34	patients	patient	NNS
cord-005453-4057qib7	5012	35	.	.	.
cord-005453-4057qib7	5013	1	Part	part	NN
cord-005453-4057qib7	5013	2	2	2	CD
cord-005453-4057qib7	5013	3	was	be	VBD
cord-005453-4057qib7	5013	4	a	a	DT
cord-005453-4057qib7	5013	5	randomized	randomized	JJ
cord-005453-4057qib7	5013	6	two	two	CD
cord-005453-4057qib7	5013	7	-	-	HYPH
cord-005453-4057qib7	5013	8	arm	arm	NN
cord-005453-4057qib7	5013	9	open	open	JJ
cord-005453-4057qib7	5013	10	label	label	NN
cord-005453-4057qib7	5013	11	study	study	NN
cord-005453-4057qib7	5013	12	to	to	TO
cord-005453-4057qib7	5013	13	compare	compare	VB
cord-005453-4057qib7	5013	14	the	the	DT
cord-005453-4057qib7	5013	15	safety	safety	NN
cord-005453-4057qib7	5013	16	,	,	,
cord-005453-4057qib7	5013	17	efficacy	efficacy	NN
cord-005453-4057qib7	5013	18	and	and	CC
cord-005453-4057qib7	5013	19	PK	PK	NNP
cord-005453-4057qib7	5013	20	of	of	IN
cord-005453-4057qib7	5013	21	3	3	CD
cord-005453-4057qib7	5013	22	mg	mg	NNP
cord-005453-4057qib7	5013	23	/	/	SYM
cord-005453-4057qib7	5013	24	day	day	NN
cord-005453-4057qib7	5013	25	of	of	IN
cord-005453-4057qib7	5013	26	KRP203	KRP203	NNP
cord-005453-4057qib7	5013	27	in	in	IN
cord-005453-4057qib7	5013	28	combination	combination	NN
cord-005453-4057qib7	5013	29	with	with	IN
cord-005453-4057qib7	5013	30	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	5013	31	/	/	SYM
cord-005453-4057qib7	5013	32	MTX	MTX	NNP
cord-005453-4057qib7	5013	33	to	to	IN
cord-005453-4057qib7	5013	34	1	1	CD
cord-005453-4057qib7	5013	35	mg	mg	CD
cord-005453-4057qib7	5013	36	/	/	SYM
cord-005453-4057qib7	5013	37	day	day	NN
cord-005453-4057qib7	5013	38	of	of	IN
cord-005453-4057qib7	5013	39	KRP203	KRP203	NNP
cord-005453-4057qib7	5013	40	in	in	IN
cord-005453-4057qib7	5013	41	combination	combination	NN
cord-005453-4057qib7	5013	42	with	with	IN
cord-005453-4057qib7	5013	43	CsA	CsA	NNP
cord-005453-4057qib7	5013	44	/	/	SYM
cord-005453-4057qib7	5013	45	MTX	MTX	NNP
cord-005453-4057qib7	5013	46	in	in	IN
cord-005453-4057qib7	5013	47	13	13	CD
cord-005453-4057qib7	5013	48	patients	patient	NNS
cord-005453-4057qib7	5013	49	.	.	.
cord-005453-4057qib7	5014	1	In	in	IN
cord-005453-4057qib7	5014	2	both	both	DT
cord-005453-4057qib7	5014	3	parts	part	NNS
cord-005453-4057qib7	5014	4	,	,	,
cord-005453-4057qib7	5014	5	treatment	treatment	NN
cord-005453-4057qib7	5014	6	with	with	IN
cord-005453-4057qib7	5014	7	KRP203	KRP203	NNP
cord-005453-4057qib7	5014	8	was	be	VBD
cord-005453-4057qib7	5014	9	initiated	initiate	VBN
cord-005453-4057qib7	5014	10	10	10	CD
cord-005453-4057qib7	5014	11	days	day	NNS
cord-005453-4057qib7	5014	12	before	before	IN
cord-005453-4057qib7	5014	13	HSCT	HSCT	NNP
cord-005453-4057qib7	5014	14	and	and	CC
cord-005453-4057qib7	5014	15	continued	continue	VBD
cord-005453-4057qib7	5014	16	for	for	IN
cord-005453-4057qib7	5014	17	an	an	DT
cord-005453-4057qib7	5014	18	additional	additional	JJ
cord-005453-4057qib7	5014	19	100	100	CD
cord-005453-4057qib7	5014	20	days	day	NNS
cord-005453-4057qib7	5014	21	.	.	.
cord-005453-4057qib7	5015	1	Patients	patient	NNS
cord-005453-4057qib7	5015	2	were	be	VBD
cord-005453-4057qib7	5015	3	followed	follow	VBN
cord-005453-4057qib7	5015	4	up	up	RP
cord-005453-4057qib7	5015	5	for	for	IN
cord-005453-4057qib7	5015	6	up	up	IN
cord-005453-4057qib7	5015	7	to	to	TO
cord-005453-4057qib7	5015	8	2	2	CD
cord-005453-4057qib7	5015	9	years	year	NNS
cord-005453-4057qib7	5015	10	.	.	.
cord-005453-4057qib7	5016	1	Results	result	NNS
cord-005453-4057qib7	5016	2	:	:	:
cord-005453-4057qib7	5016	3	23	23	CD
cord-005453-4057qib7	5016	4	patients	patient	NNS
cord-005453-4057qib7	5016	5	were	be	VBD
cord-005453-4057qib7	5016	6	included	include	VBN
cord-005453-4057qib7	5016	7	in	in	IN
cord-005453-4057qib7	5016	8	the	the	DT
cord-005453-4057qib7	5016	9	study	study	NN
cord-005453-4057qib7	5016	10	.	.	.
cord-005453-4057qib7	5017	1	16	16	CD
cord-005453-4057qib7	5017	2	of	of	IN
cord-005453-4057qib7	5017	3	23	23	CD
cord-005453-4057qib7	5017	4	patients	patient	NNS
cord-005453-4057qib7	5017	5	completed	complete	VBD
cord-005453-4057qib7	5017	6	the	the	DT
cord-005453-4057qib7	5017	7	110-day	110-day	CD
cord-005453-4057qib7	5017	8	treatment	treatment	NN
cord-005453-4057qib7	5017	9	with	with	IN
cord-005453-4057qib7	5017	10	KRP203	KRP203	NNP
cord-005453-4057qib7	5017	11	at	at	IN
cord-005453-4057qib7	5017	12	the	the	DT
cord-005453-4057qib7	5017	13	assigned	assign	VBN
cord-005453-4057qib7	5017	14	doses	dose	NNS
cord-005453-4057qib7	5017	15	.	.	.
cord-005453-4057qib7	5018	1	Median	median	JJ
cord-005453-4057qib7	5018	2	duration	duration	NN
cord-005453-4057qib7	5018	3	of	of	IN
cord-005453-4057qib7	5018	4	follow	follow	NN
cord-005453-4057qib7	5018	5	-	-	HYPH
cord-005453-4057qib7	5018	6	up	up	NN
cord-005453-4057qib7	5018	7	was	be	VBD
cord-005453-4057qib7	5018	8	264	264	CD
cord-005453-4057qib7	5018	9	days	day	NNS
cord-005453-4057qib7	5018	10	(	(	-LRB-
cord-005453-4057qib7	5018	11	range	range	VBP
cord-005453-4057qib7	5018	12	153	153	CD
cord-005453-4057qib7	5018	13	to	to	TO
cord-005453-4057qib7	5018	14	271	271	CD
cord-005453-4057qib7	5018	15	days	day	NNS
cord-005453-4057qib7	5018	16	)	)	-RRB-
cord-005453-4057qib7	5018	17	.	.	.
cord-005453-4057qib7	5019	1	KRP203	KRP203	NNP
cord-005453-4057qib7	5019	2	was	be	VBD
cord-005453-4057qib7	5019	3	safe	safe	JJ
cord-005453-4057qib7	5019	4	and	and	CC
cord-005453-4057qib7	5019	5	well	well	RB
cord-005453-4057qib7	5019	6	tolerated	tolerate	VBN
cord-005453-4057qib7	5019	7	.	.	.
cord-005453-4057qib7	5020	1	11	11	CD
cord-005453-4057qib7	5020	2	serious	serious	JJ
cord-005453-4057qib7	5020	3	adverse	adverse	JJ
cord-005453-4057qib7	5020	4	events	event	NNS
cord-005453-4057qib7	5020	5	(	(	-LRB-
cord-005453-4057qib7	5020	6	SAEs	SAEs	NNP
cord-005453-4057qib7	5020	7	)	)	-RRB-
cord-005453-4057qib7	5020	8	suspected	suspect	VBN
cord-005453-4057qib7	5020	9	to	to	TO
cord-005453-4057qib7	5020	10	be	be	VB
cord-005453-4057qib7	5020	11	related	relate	VBN
cord-005453-4057qib7	5020	12	to	to	IN
cord-005453-4057qib7	5020	13	KRP203	KRP203	NNP
cord-005453-4057qib7	5020	14	were	be	VBD
cord-005453-4057qib7	5020	15	observed	observe	VBN
cord-005453-4057qib7	5020	16	.	.	.
cord-005453-4057qib7	5021	1	Macular	macular	JJ
cord-005453-4057qib7	5021	2	edema	edema	NN
cord-005453-4057qib7	5021	3	(	(	-LRB-
cord-005453-4057qib7	5021	4	n=3	n=3	NN
cord-005453-4057qib7	5021	5	)	)	-RRB-
cord-005453-4057qib7	5021	6	and	and	CC
cord-005453-4057qib7	5021	7	peripheral	peripheral	JJ
cord-005453-4057qib7	5021	8	edema	edema	NN
cord-005453-4057qib7	5021	9	(	(	-LRB-
cord-005453-4057qib7	5021	10	n=1	n=1	FW
cord-005453-4057qib7	5021	11	)	)	-RRB-
cord-005453-4057qib7	5022	1	as	as	IN
cord-005453-4057qib7	5022	2	S1P	s1p	CD
cord-005453-4057qib7	5022	3	related	relate	VBN
cord-005453-4057qib7	5022	4	adverse	adverse	JJ
cord-005453-4057qib7	5022	5	events	event	NNS
cord-005453-4057qib7	5022	6	occurred	occur	VBD
cord-005453-4057qib7	5022	7	and	and	CC
cord-005453-4057qib7	5022	8	resolved	resolve	VBD
cord-005453-4057qib7	5022	9	without	without	IN
cord-005453-4057qib7	5022	10	sequelae	sequela	NNS
cord-005453-4057qib7	5022	11	.	.	.
cord-005453-4057qib7	5023	1	Of	of	IN
cord-005453-4057qib7	5023	2	note	note	NN
cord-005453-4057qib7	5023	3	,	,	,
cord-005453-4057qib7	5023	4	the	the	DT
cord-005453-4057qib7	5023	5	incidence	incidence	NN
cord-005453-4057qib7	5023	6	of	of	IN
cord-005453-4057qib7	5023	7	macular	macular	JJ
cord-005453-4057qib7	5023	8	edema	edema	NN
cord-005453-4057qib7	5023	9	in	in	IN
cord-005453-4057qib7	5023	10	HSCT	HSCT	NNP
cord-005453-4057qib7	5023	11	recipients	recipient	NNS
cord-005453-4057qib7	5023	12	is	be	VBZ
cord-005453-4057qib7	5023	13	unknown	unknown	JJ
cord-005453-4057qib7	5023	14	.	.	.
cord-005453-4057qib7	5024	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	5024	2	engraftment	engraftment	NN
cord-005453-4057qib7	5024	3	was	be	VBD
cord-005453-4057qib7	5024	4	confirmed	confirm	VBN
cord-005453-4057qib7	5024	5	in	in	IN
cord-005453-4057qib7	5024	6	all	all	DT
cord-005453-4057qib7	5024	7	patients	patient	NNS
cord-005453-4057qib7	5024	8	with	with	IN
cord-005453-4057qib7	5024	9	a	a	DT
cord-005453-4057qib7	5024	10	median	median	NN
cord-005453-4057qib7	5024	11	of	of	IN
cord-005453-4057qib7	5024	12	16	16	CD
cord-005453-4057qib7	5024	13	days	day	NNS
cord-005453-4057qib7	5024	14	(	(	-LRB-
cord-005453-4057qib7	5024	15	range	range	VBP
cord-005453-4057qib7	5024	16	12	12	CD
cord-005453-4057qib7	5024	17	to	to	TO
cord-005453-4057qib7	5024	18	45	45	CD
cord-005453-4057qib7	5024	19	days	day	NNS
cord-005453-4057qib7	5024	20	)	)	-RRB-
cord-005453-4057qib7	5024	21	.	.	.
cord-005453-4057qib7	5025	1	5	5	CD
cord-005453-4057qib7	5025	2	of	of	IN
cord-005453-4057qib7	5025	3	23	23	CD
cord-005453-4057qib7	5025	4	patients	patient	NNS
cord-005453-4057qib7	5025	5	presented	present	VBN
cord-005453-4057qib7	5025	6	with	with	IN
cord-005453-4057qib7	5025	7	Grade	Grade	NNP
cord-005453-4057qib7	5025	8	III	III	NNP
cord-005453-4057qib7	5025	9	or	or	CC
cord-005453-4057qib7	5025	10	IV	IV	NNP
cord-005453-4057qib7	5025	11	acute	acute	JJ
cord-005453-4057qib7	5025	12	GvHD	GvHD	NNP
cord-005453-4057qib7	5025	13	(	(	-LRB-
cord-005453-4057qib7	5025	14	on	on	IN
cord-005453-4057qib7	5025	15	Days	day	NNS
cord-005453-4057qib7	5025	16	50	50	CD
cord-005453-4057qib7	5025	17	,	,	,
cord-005453-4057qib7	5025	18	56	56	CD
cord-005453-4057qib7	5025	19	,	,	,
cord-005453-4057qib7	5025	20	68	68	CD
cord-005453-4057qib7	5025	21	,	,	,
cord-005453-4057qib7	5025	22	99	99	CD
cord-005453-4057qib7	5025	23	and	and	CC
cord-005453-4057qib7	5025	24	102	102	CD
cord-005453-4057qib7	5025	25	)	)	-RRB-
cord-005453-4057qib7	5025	26	.	.	.
cord-005453-4057qib7	5026	1	No	no	DT
cord-005453-4057qib7	5026	2	GvHD	gvhd	NN
cord-005453-4057qib7	5026	3	or	or	CC
cord-005453-4057qib7	5026	4	infection	infection	NN
cord-005453-4057qib7	5026	5	related	relate	VBN
cord-005453-4057qib7	5026	6	death	death	NN
cord-005453-4057qib7	5026	7	occurred	occur	VBD
cord-005453-4057qib7	5026	8	during	during	IN
cord-005453-4057qib7	5026	9	the	the	DT
cord-005453-4057qib7	5026	10	first	first	JJ
cord-005453-4057qib7	5026	11	100	100	CD
cord-005453-4057qib7	5026	12	days	day	NNS
cord-005453-4057qib7	5026	13	.	.	.
cord-005453-4057qib7	5027	1	100-day	100-day	JJ
cord-005453-4057qib7	5027	2	survival	survival	NN
cord-005453-4057qib7	5027	3	was	be	VBD
cord-005453-4057qib7	5027	4	96	96	CD
cord-005453-4057qib7	5027	5	%	%	NN
cord-005453-4057qib7	5027	6	,	,	,
cord-005453-4057qib7	5027	7	with	with	IN
cord-005453-4057qib7	5027	8	no	no	DT
cord-005453-4057qib7	5027	9	death	death	NN
cord-005453-4057qib7	5027	10	occurring	occur	VBG
cord-005453-4057qib7	5027	11	during	during	IN
cord-005453-4057qib7	5027	12	KRP203	krp203	DT
cord-005453-4057qib7	5027	13	treatment	treatment	NN
cord-005453-4057qib7	5027	14	.	.	.
cord-005453-4057qib7	5028	1	1	1	CD
cord-005453-4057qib7	5028	2	death	death	NN
cord-005453-4057qib7	5028	3	occurred	occur	VBD
cord-005453-4057qib7	5028	4	on	on	IN
cord-005453-4057qib7	5028	5	Study	Study	NNP
cord-005453-4057qib7	5028	6	Day	Day	NNP
cord-005453-4057qib7	5028	7	90	90	CD
cord-005453-4057qib7	5028	8	due	due	IN
cord-005453-4057qib7	5028	9	to	to	IN
cord-005453-4057qib7	5028	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	5028	11	relapse	relapse	NN
cord-005453-4057qib7	5028	12	.	.	.
cord-005453-4057qib7	5029	1	A	a	DT
cord-005453-4057qib7	5029	2	second	second	JJ
cord-005453-4057qib7	5029	3	death	death	NN
cord-005453-4057qib7	5029	4	occurred	occur	VBD
cord-005453-4057qib7	5029	5	on	on	IN
cord-005453-4057qib7	5029	6	Study	Study	NNP
cord-005453-4057qib7	5029	7	Day	Day	NNP
cord-005453-4057qib7	5029	8	121	121	CD
cord-005453-4057qib7	5029	9	due	due	JJ
cord-005453-4057qib7	5029	10	to	to	IN
cord-005453-4057qib7	5029	11	liver	liver	NN
cord-005453-4057qib7	5029	12	GvHD	GvHD	NNP
cord-005453-4057qib7	5029	13	.	.	.
cord-005453-4057qib7	5030	1	Four	four	CD
cord-005453-4057qib7	5030	2	patients	patient	NNS
cord-005453-4057qib7	5030	3	died	die	VBD
cord-005453-4057qib7	5030	4	in	in	IN
cord-005453-4057qib7	5030	5	the	the	DT
cord-005453-4057qib7	5030	6	follow	follow	VB
cord-005453-4057qib7	5030	7	-	-	HYPH
cord-005453-4057qib7	5030	8	up	up	NN
cord-005453-4057qib7	5030	9	period	period	NN
cord-005453-4057qib7	5030	10	due	due	IN
cord-005453-4057qib7	5030	11	to	to	IN
cord-005453-4057qib7	5030	12	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	5030	13	GVHD	GVHD	NNP
cord-005453-4057qib7	5030	14	(	(	-LRB-
cord-005453-4057qib7	5030	15	Day	Day	NNP
cord-005453-4057qib7	5030	16	265	265	CD
cord-005453-4057qib7	5030	17	)	)	-RRB-
cord-005453-4057qib7	5030	18	,	,	,
cord-005453-4057qib7	5030	19	aspiration	aspiration	NN
cord-005453-4057qib7	5030	20	pneumonia	pneumonia	NN
cord-005453-4057qib7	5030	21	(	(	-LRB-
cord-005453-4057qib7	5030	22	Day	Day	NNP
cord-005453-4057qib7	5030	23	327	327	CD
cord-005453-4057qib7	5030	24	)	)	-RRB-
cord-005453-4057qib7	5030	25	and	and	CC
cord-005453-4057qib7	5030	26	relapse	relapse	NN
cord-005453-4057qib7	5030	27	(	(	-LRB-
cord-005453-4057qib7	5030	28	Day	day	NN
cord-005453-4057qib7	5030	29	533	533	CD
cord-005453-4057qib7	5030	30	and	and	CC
cord-005453-4057qib7	5030	31	Day	Day	NNP
cord-005453-4057qib7	5030	32	877	877	CD
cord-005453-4057qib7	5030	33	)	)	-RRB-
cord-005453-4057qib7	5030	34	.	.	.
cord-005453-4057qib7	5031	1	The	the	DT
cord-005453-4057qib7	5031	2	Kaplan	Kaplan	NNP
cord-005453-4057qib7	5031	3	-	-	HYPH
cord-005453-4057qib7	5031	4	Meier	Meier	NNP
cord-005453-4057qib7	5031	5	estimate	estimate	NN
cord-005453-4057qib7	5031	6	of	of	IN
cord-005453-4057qib7	5031	7	overall	overall	JJ
cord-005453-4057qib7	5031	8	survival	survival	NN
cord-005453-4057qib7	5031	9	at	at	IN
cord-005453-4057qib7	5031	10	1	1	CD
cord-005453-4057qib7	5031	11	year	year	NN
cord-005453-4057qib7	5031	12	was	be	VBD
cord-005453-4057qib7	5031	13	0.75	0.75	CD
cord-005453-4057qib7	5031	14	.	.	.
cord-005453-4057qib7	5032	1	When	when	WRB
cord-005453-4057qib7	5032	2	comparing	compare	VBG
cord-005453-4057qib7	5032	3	the	the	DT
cord-005453-4057qib7	5032	4	data	datum	NNS
cord-005453-4057qib7	5032	5	from	from	IN
cord-005453-4057qib7	5032	6	the	the	DT
cord-005453-4057qib7	5032	7	two	two	CD
cord-005453-4057qib7	5032	8	dose	dose	NN
cord-005453-4057qib7	5032	9	groups	group	NNS
cord-005453-4057qib7	5032	10	(	(	-LRB-
cord-005453-4057qib7	5032	11	1	1	CD
cord-005453-4057qib7	5032	12	and	and	CC
cord-005453-4057qib7	5032	13	3	3	CD
cord-005453-4057qib7	5032	14	mg	mg	NN
cord-005453-4057qib7	5032	15	KRP203	KRP203	NNP
cord-005453-4057qib7	5032	16	)	)	-RRB-
cord-005453-4057qib7	5032	17	,	,	,
cord-005453-4057qib7	5032	18	no	no	DT
cord-005453-4057qib7	5032	19	major	major	JJ
cord-005453-4057qib7	5032	20	differences	difference	NNS
cord-005453-4057qib7	5032	21	in	in	IN
cord-005453-4057qib7	5032	22	safety	safety	NN
cord-005453-4057qib7	5032	23	,	,	,
cord-005453-4057qib7	5032	24	engraftment	engraftment	NN
cord-005453-4057qib7	5032	25	,	,	,
cord-005453-4057qib7	5032	26	GvHD	gvhd	JJ
cord-005453-4057qib7	5032	27	rate	rate	NN
cord-005453-4057qib7	5032	28	or	or	CC
cord-005453-4057qib7	5032	29	mortality	mortality	NN
cord-005453-4057qib7	5032	30	were	be	VBD
cord-005453-4057qib7	5032	31	observed	observe	VBN
cord-005453-4057qib7	5032	32	.	.	.
cord-005453-4057qib7	5033	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5033	2	:	:	:
cord-005453-4057qib7	5034	1	This	this	DT
cord-005453-4057qib7	5034	2	clinical	clinical	JJ
cord-005453-4057qib7	5034	3	trial	trial	NN
cord-005453-4057qib7	5034	4	was	be	VBD
cord-005453-4057qib7	5034	5	the	the	DT
cord-005453-4057qib7	5034	6	first	first	JJ
cord-005453-4057qib7	5034	7	to	to	TO
cord-005453-4057qib7	5034	8	test	test	VB
cord-005453-4057qib7	5034	9	S1P	s1p	CD
cord-005453-4057qib7	5034	10	modulation	modulation	NN
cord-005453-4057qib7	5034	11	in	in	IN
cord-005453-4057qib7	5034	12	this	this	DT
cord-005453-4057qib7	5034	13	population	population	NN
cord-005453-4057qib7	5034	14	.	.	.
cord-005453-4057qib7	5035	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5035	2	data	datum	NNS
cord-005453-4057qib7	5035	3	suggest	suggest	VBP
cord-005453-4057qib7	5035	4	that	that	IN
cord-005453-4057qib7	5035	5	KRP203	KRP203	NNP
cord-005453-4057qib7	5035	6	had	have	VBD
cord-005453-4057qib7	5035	7	no	no	DT
cord-005453-4057qib7	5035	8	negative	negative	JJ
cord-005453-4057qib7	5035	9	impact	impact	NN
cord-005453-4057qib7	5035	10	on	on	IN
cord-005453-4057qib7	5035	11	engraftment	engraftment	NN
cord-005453-4057qib7	5035	12	and	and	CC
cord-005453-4057qib7	5035	13	overall	overall	RB
cord-005453-4057qib7	5035	14	,	,	,
cord-005453-4057qib7	5035	15	was	be	VBD
cord-005453-4057qib7	5035	16	safe	safe	JJ
cord-005453-4057qib7	5035	17	,	,	,
cord-005453-4057qib7	5035	18	and	and	CC
cord-005453-4057qib7	5035	19	well	well	RB
cord-005453-4057qib7	5035	20	tolerated	tolerate	VBN
cord-005453-4057qib7	5035	21	.	.	.
cord-005453-4057qib7	5036	1	Based	base	VBN
cord-005453-4057qib7	5036	2	on	on	IN
cord-005453-4057qib7	5036	3	exploratory	exploratory	JJ
cord-005453-4057qib7	5036	4	data	datum	NNS
cord-005453-4057qib7	5036	5	,	,	,
cord-005453-4057qib7	5036	6	when	when	WRB
cord-005453-4057qib7	5036	7	comparing	compare	VBG
cord-005453-4057qib7	5036	8	to	to	IN
cord-005453-4057qib7	5036	9	matched	match	VBN
cord-005453-4057qib7	5036	10	historical	historical	JJ
cord-005453-4057qib7	5036	11	mortality	mortality	NN
cord-005453-4057qib7	5036	12	data	datum	NNS
cord-005453-4057qib7	5036	13	,	,	,
cord-005453-4057qib7	5036	14	KRP203	KRP203	NNP
cord-005453-4057qib7	5036	15	may	may	MD
cord-005453-4057qib7	5036	16	have	have	VB
cord-005453-4057qib7	5036	17	favorable	favorable	JJ
cord-005453-4057qib7	5036	18	effects	effect	NNS
cord-005453-4057qib7	5036	19	on	on	IN
cord-005453-4057qib7	5036	20	overall	overall	JJ
cord-005453-4057qib7	5036	21	survival	survival	NN
cord-005453-4057qib7	5036	22	(	(	-LRB-
cord-005453-4057qib7	5036	23	Figure	figure	NN
cord-005453-4057qib7	5036	24	1	1	CD
cord-005453-4057qib7	5036	25	)	)	-RRB-
cord-005453-4057qib7	5036	26	.	.	.
cord-005453-4057qib7	5037	1	Background	background	NN
cord-005453-4057qib7	5037	2	:	:	:
cord-005453-4057qib7	5038	1	Uric	uric	JJ
cord-005453-4057qib7	5038	2	acid	acid	NN
cord-005453-4057qib7	5038	3	is	be	VBZ
cord-005453-4057qib7	5038	4	a	a	DT
cord-005453-4057qib7	5038	5	danger	danger	NN
cord-005453-4057qib7	5038	6	signal	signal	NN
cord-005453-4057qib7	5038	7	contributing	contribute	VBG
cord-005453-4057qib7	5038	8	to	to	IN
cord-005453-4057qib7	5038	9	inflammation	inflammation	NN
cord-005453-4057qib7	5038	10	.	.	.
cord-005453-4057qib7	5039	1	Relevance	relevance	NN
cord-005453-4057qib7	5039	2	to	to	IN
cord-005453-4057qib7	5039	3	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5039	4	has	have	VBZ
cord-005453-4057qib7	5039	5	been	be	VBN
cord-005453-4057qib7	5039	6	demonstrated	demonstrate	VBN
cord-005453-4057qib7	5039	7	in	in	IN
cord-005453-4057qib7	5039	8	preclinical	preclinical	JJ
cord-005453-4057qib7	5039	9	models	model	NNS
cord-005453-4057qib7	5039	10	:	:	:
cord-005453-4057qib7	5039	11	the	the	DT
cord-005453-4057qib7	5039	12	depletion	depletion	NN
cord-005453-4057qib7	5039	13	of	of	IN
cord-005453-4057qib7	5039	14	uric	uric	NN
cord-005453-4057qib7	5039	15	acid	acid	NN
cord-005453-4057qib7	5039	16	led	lead	VBD
cord-005453-4057qib7	5039	17	to	to	IN
cord-005453-4057qib7	5039	18	improved	improve	VBN
cord-005453-4057qib7	5039	19	survival	survival	NN
cord-005453-4057qib7	5039	20	and	and	CC
cord-005453-4057qib7	5039	21	reduced	reduce	VBN
cord-005453-4057qib7	5039	22	GVHD	GVHD	NNP
cord-005453-4057qib7	5039	23	(	(	-LRB-
cord-005453-4057qib7	5039	24	J	J	NNP
cord-005453-4057qib7	5039	25	Exp	Exp	NNP
cord-005453-4057qib7	5039	26	Med	Med	NNP
cord-005453-4057qib7	5039	27	.	.	.
cord-005453-4057qib7	5039	28	2013	2013	CD
cord-005453-4057qib7	5039	29	Sep	Sep	NNP
cord-005453-4057qib7	5039	30	23;210(10):1899	23;210(10):1899	CD
cord-005453-4057qib7	5039	31	-	-	SYM
cord-005453-4057qib7	5039	32	910	910	CD
cord-005453-4057qib7	5039	33	)	)	-RRB-
cord-005453-4057qib7	5039	34	.	.	.
cord-005453-4057qib7	5040	1	Results	result	NNS
cord-005453-4057qib7	5040	2	of	of	IN
cord-005453-4057qib7	5040	3	a	a	DT
cord-005453-4057qib7	5040	4	clinical	clinical	JJ
cord-005453-4057qib7	5040	5	pilot	pilot	NN
cord-005453-4057qib7	5040	6	trial	trial	NN
cord-005453-4057qib7	5040	7	suggested	suggest	VBD
cord-005453-4057qib7	5040	8	that	that	IN
cord-005453-4057qib7	5040	9	peri	peri	NN
cord-005453-4057qib7	5040	10	-	-	HYPH
cord-005453-4057qib7	5040	11	transplant	transplant	NN
cord-005453-4057qib7	5040	12	uric	uric	NN
cord-005453-4057qib7	5040	13	acid	acid	NN
cord-005453-4057qib7	5040	14	depletion	depletion	NN
cord-005453-4057qib7	5040	15	reduce	reduce	VBP
cord-005453-4057qib7	5040	16	acute	acute	JJ
cord-005453-4057qib7	5040	17	GVHD	GVHD	NNP
cord-005453-4057qib7	5040	18	incidence	incidence	NN
cord-005453-4057qib7	5040	19	(	(	-LRB-
cord-005453-4057qib7	5040	20	BBMT	BBMT	NNP
cord-005453-4057qib7	5040	21	2014	2014	CD
cord-005453-4057qib7	5041	1	May;20(5):730	May;20(5):730	NNP
cord-005453-4057qib7	5041	2	-	-	HYPH
cord-005453-4057qib7	5041	3	4	4	CD
cord-005453-4057qib7	5041	4	)	)	-RRB-
cord-005453-4057qib7	5041	5	.	.	.
cord-005453-4057qib7	5042	1	Methods	method	NNS
cord-005453-4057qib7	5042	2	:	:	:
cord-005453-4057qib7	5043	1	This	this	DT
cord-005453-4057qib7	5043	2	international	international	JJ
cord-005453-4057qib7	5043	3	multicentric	multicentric	NNP
cord-005453-4057qib7	5043	4	study	study	NN
cord-005453-4057qib7	5043	5	aimed	aim	VBN
cord-005453-4057qib7	5043	6	to	to	TO
cord-005453-4057qib7	5043	7	study	study	VB
cord-005453-4057qib7	5043	8	the	the	DT
cord-005453-4057qib7	5043	9	association	association	NN
cord-005453-4057qib7	5043	10	of	of	IN
cord-005453-4057qib7	5043	11	uric	uric	NNP
cord-005453-4057qib7	5043	12	acid	acid	NN
cord-005453-4057qib7	5043	13	serum	serum	NN
cord-005453-4057qib7	5043	14	levels	level	NNS
cord-005453-4057qib7	5043	15	before	before	IN
cord-005453-4057qib7	5043	16	start	start	NN
cord-005453-4057qib7	5043	17	of	of	IN
cord-005453-4057qib7	5043	18	conditioning	conditioning	NN
cord-005453-4057qib7	5043	19	with	with	IN
cord-005453-4057qib7	5043	20	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5043	21	outcome	outcome	NN
cord-005453-4057qib7	5043	22	.	.	.
cord-005453-4057qib7	5044	1	Patients	patient	NNS
cord-005453-4057qib7	5044	2	with	with	IN
cord-005453-4057qib7	5044	3	acute	acute	JJ
cord-005453-4057qib7	5044	4	leukemia	leukemia	NN
cord-005453-4057qib7	5044	5	,	,	,
cord-005453-4057qib7	5044	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	5044	7	or	or	CC
cord-005453-4057qib7	5044	8	MDS	MDS	NNP
cord-005453-4057qib7	5044	9	receiving	receive	VBG
cord-005453-4057qib7	5044	10	a	a	DT
cord-005453-4057qib7	5044	11	matched	match	VBN
cord-005453-4057qib7	5044	12	sibling	sibling	NN
cord-005453-4057qib7	5044	13	alloSCT	allosct	NN
cord-005453-4057qib7	5044	14	for	for	IN
cord-005453-4057qib7	5044	15	the	the	DT
cord-005453-4057qib7	5044	16	first	first	JJ
cord-005453-4057qib7	5044	17	time	time	NN
cord-005453-4057qib7	5044	18	were	be	VBD
cord-005453-4057qib7	5044	19	considered	consider	VBN
cord-005453-4057qib7	5044	20	for	for	IN
cord-005453-4057qib7	5044	21	inclusion	inclusion	NN
cord-005453-4057qib7	5044	22	,	,	,
cord-005453-4057qib7	5044	23	regardless	regardless	RB
cord-005453-4057qib7	5044	24	of	of	IN
cord-005453-4057qib7	5044	25	conditionning	conditionning	NN
cord-005453-4057qib7	5044	26	.	.	.
cord-005453-4057qib7	5045	1	Data	datum	NNS
cord-005453-4057qib7	5045	2	were	be	VBD
cord-005453-4057qib7	5045	3	prospectively	prospectively	RB
cord-005453-4057qib7	5045	4	collected	collect	VBN
cord-005453-4057qib7	5045	5	between	between	IN
cord-005453-4057qib7	5045	6	8/2014	8/2014	NNS
cord-005453-4057qib7	5045	7	and	and	CC
cord-005453-4057qib7	5045	8	2/2018	2/2018	CD
cord-005453-4057qib7	5045	9	.	.	.
cord-005453-4057qib7	5046	1	A	a	DT
cord-005453-4057qib7	5046	2	comparison	comparison	NN
cord-005453-4057qib7	5046	3	of	of	IN
cord-005453-4057qib7	5046	4	outcomes	outcome	NNS
cord-005453-4057qib7	5046	5	between	between	IN
cord-005453-4057qib7	5046	6	patients	patient	NNS
cord-005453-4057qib7	5046	7	with	with	IN
cord-005453-4057qib7	5046	8	high	high	JJ
cord-005453-4057qib7	5046	9	and	and	CC
cord-005453-4057qib7	5046	10	low	low	JJ
cord-005453-4057qib7	5046	11	uric	uric	NN
cord-005453-4057qib7	5046	12	acid	acid	NN
cord-005453-4057qib7	5046	13	level	level	NN
cord-005453-4057qib7	5046	14	was	be	VBD
cord-005453-4057qib7	5046	15	performed	perform	VBN
cord-005453-4057qib7	5046	16	using	use	VBG
cord-005453-4057qib7	5046	17	univariate	univariate	JJ
cord-005453-4057qib7	5046	18	analysis	analysis	NN
cord-005453-4057qib7	5046	19	and	and	CC
cord-005453-4057qib7	5046	20	multivariate	multivariate	JJ
cord-005453-4057qib7	5046	21	analysis	analysis	NN
cord-005453-4057qib7	5046	22	using	use	VBG
cord-005453-4057qib7	5046	23	cause	cause	NN
cord-005453-4057qib7	5046	24	-	-	HYPH
cord-005453-4057qib7	5046	25	specific	specific	JJ
cord-005453-4057qib7	5046	26	Cox	Cox	NNP
cord-005453-4057qib7	5046	27	model	model	NN
cord-005453-4057qib7	5046	28	.	.	.
cord-005453-4057qib7	5047	1	Variables	variable	NNS
cord-005453-4057qib7	5047	2	included	include	VBN
cord-005453-4057qib7	5047	3	in	in	IN
cord-005453-4057qib7	5047	4	the	the	DT
cord-005453-4057qib7	5047	5	multivariate	multivariate	JJ
cord-005453-4057qib7	5047	6	analyses	analysis	NNS
cord-005453-4057qib7	5047	7	were	be	VBD
cord-005453-4057qib7	5047	8	age	age	NN
cord-005453-4057qib7	5047	9	,	,	,
cord-005453-4057qib7	5047	10	sex	sex	NN
cord-005453-4057qib7	5047	11	mismatch	mismatch	NN
cord-005453-4057qib7	5047	12	,	,	,
cord-005453-4057qib7	5047	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	5047	14	,	,	,
cord-005453-4057qib7	5047	15	disease	disease	NN
cord-005453-4057qib7	5047	16	status	status	NN
cord-005453-4057qib7	5047	17	,	,	,
cord-005453-4057qib7	5047	18	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	5047	19	score	score	NN
cord-005453-4057qib7	5047	20	,	,	,
cord-005453-4057qib7	5047	21	number	number	NN
cord-005453-4057qib7	5047	22	of	of	IN
cord-005453-4057qib7	5047	23	CD34	CD34	NNP
cord-005453-4057qib7	5047	24	cells	cell	NNS
cord-005453-4057qib7	5047	25	given	give	VBN
cord-005453-4057qib7	5047	26	,	,	,
cord-005453-4057qib7	5047	27	intensity	intensity	NN
cord-005453-4057qib7	5047	28	of	of	IN
cord-005453-4057qib7	5047	29	conditioning	conditioning	NN
cord-005453-4057qib7	5047	30	,	,	,
cord-005453-4057qib7	5047	31	type	type	NN
cord-005453-4057qib7	5047	32	of	of	IN
cord-005453-4057qib7	5047	33	GVHD	GVHD	NNP
cord-005453-4057qib7	5047	34	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5047	35	,	,	,
cord-005453-4057qib7	5047	36	ATG	ATG	NNP
cord-005453-4057qib7	5047	37	use	use	NN
cord-005453-4057qib7	5047	38	,	,	,
cord-005453-4057qib7	5047	39	time	time	NN
cord-005453-4057qib7	5047	40	from	from	IN
cord-005453-4057qib7	5047	41	diagnosis	diagnosis	NN
cord-005453-4057qib7	5047	42	to	to	IN
cord-005453-4057qib7	5047	43	transplant	transplant	NN
cord-005453-4057qib7	5047	44	,	,	,
cord-005453-4057qib7	5047	45	year	year	NN
cord-005453-4057qib7	5047	46	of	of	IN
cord-005453-4057qib7	5047	47	transplant	transplant	NN
cord-005453-4057qib7	5047	48	and	and	CC
cord-005453-4057qib7	5047	49	CMV	CMV	NNP
cord-005453-4057qib7	5047	50	status	status	NN
cord-005453-4057qib7	5047	51	.	.	.
cord-005453-4057qib7	5048	1	Results	result	NNS
cord-005453-4057qib7	5048	2	:	:	:
cord-005453-4057qib7	5049	1	Twenty	twenty	CD
cord-005453-4057qib7	5049	2	centers	center	NNS
cord-005453-4057qib7	5049	3	from	from	IN
cord-005453-4057qib7	5049	4	10	10	CD
cord-005453-4057qib7	5049	5	European	european	JJ
cord-005453-4057qib7	5049	6	countries	country	NNS
cord-005453-4057qib7	5049	7	reported	report	VBD
cord-005453-4057qib7	5049	8	data	datum	NNS
cord-005453-4057qib7	5049	9	on	on	IN
cord-005453-4057qib7	5049	10	385	385	CD
cord-005453-4057qib7	5049	11	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5049	12	recipients	recipient	NNS
cord-005453-4057qib7	5049	13	.	.	.
cord-005453-4057qib7	5050	1	Patient	patient	JJ
cord-005453-4057qib7	5050	2	characteristics	characteristic	NNS
cord-005453-4057qib7	5050	3	are	be	VBP
cord-005453-4057qib7	5050	4	given	give	VBN
cord-005453-4057qib7	5050	5	in	in	IN
cord-005453-4057qib7	5050	6	Table	Table	NNP
cord-005453-4057qib7	5050	7	1	1	CD
cord-005453-4057qib7	5050	8	.	.	.
cord-005453-4057qib7	5051	1	The	the	DT
cord-005453-4057qib7	5051	2	uric	uric	NN
cord-005453-4057qib7	5051	3	acid	acid	NN
cord-005453-4057qib7	5051	4	cut	cut	VBN
cord-005453-4057qib7	5051	5	off	off	RP
cord-005453-4057qib7	5051	6	point	point	NN
cord-005453-4057qib7	5051	7	was	be	VBD
cord-005453-4057qib7	5051	8	determined	determine	VBN
cord-005453-4057qib7	5051	9	at	at	IN
cord-005453-4057qib7	5051	10	4.3mg	4.3mg	CD
cord-005453-4057qib7	5051	11	/	/	SYM
cord-005453-4057qib7	5051	12	dl	dl	NN
cord-005453-4057qib7	5051	13	(	(	-LRB-
cord-005453-4057qib7	5051	14	median	median	NN
cord-005453-4057qib7	5051	15	of	of	IN
cord-005453-4057qib7	5051	16	measured	measure	VBN
cord-005453-4057qib7	5051	17	uric	uric	NN
cord-005453-4057qib7	5051	18	acid	acid	NN
cord-005453-4057qib7	5051	19	levels	level	NNS
cord-005453-4057qib7	5051	20	)	)	-RRB-
cord-005453-4057qib7	5051	21	.	.	.
cord-005453-4057qib7	5052	1	Overall	overall	JJ
cord-005453-4057qib7	5052	2	survival	survival	NN
cord-005453-4057qib7	5052	3	(	(	-LRB-
cord-005453-4057qib7	5052	4	OS	OS	NNP
cord-005453-4057qib7	5052	5	)	)	-RRB-
cord-005453-4057qib7	5052	6	and	and	CC
cord-005453-4057qib7	5052	7	progression	progression	NN
cord-005453-4057qib7	5052	8	free	free	JJ
cord-005453-4057qib7	5052	9	survival	survival	NN
cord-005453-4057qib7	5052	10	(	(	-LRB-
cord-005453-4057qib7	5052	11	PFS	PFS	NNP
cord-005453-4057qib7	5052	12	)	)	-RRB-
cord-005453-4057qib7	5052	13	of	of	IN
cord-005453-4057qib7	5052	14	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5052	15	recipients	recipient	NNS
cord-005453-4057qib7	5052	16	with	with	IN
cord-005453-4057qib7	5052	17	uric	uric	NN
cord-005453-4057qib7	5052	18	acid	acid	NN
cord-005453-4057qib7	5052	19	levels	level	NNS
cord-005453-4057qib7	5052	20	above	above	IN
cord-005453-4057qib7	5052	21	cut	cut	VBD
cord-005453-4057qib7	5052	22	off	off	RP
cord-005453-4057qib7	5052	23	measured	measure	VBN
cord-005453-4057qib7	5052	24	before	before	IN
cord-005453-4057qib7	5052	25	start	start	NN
cord-005453-4057qib7	5052	26	of	of	IN
cord-005453-4057qib7	5052	27	conditioning	conditioning	NN
cord-005453-4057qib7	5052	28	were	be	VBD
cord-005453-4057qib7	5052	29	significantly	significantly	RB
cord-005453-4057qib7	5052	30	shorter	short	JJR
cord-005453-4057qib7	5052	31	(	(	-LRB-
cord-005453-4057qib7	5052	32	Figure	figure	NN
cord-005453-4057qib7	5052	33	1A	1a	NN
cord-005453-4057qib7	5052	34	,	,	,
cord-005453-4057qib7	5052	35	OS	OS	NNP
cord-005453-4057qib7	5052	36	univariate	univariate	JJ
cord-005453-4057qib7	5052	37	HR=2.4	HR=2.4	NNP
cord-005453-4057qib7	5052	38	CI=1.6	CI=1.6	NNP
cord-005453-4057qib7	5052	39	-	-	HYPH
cord-005453-4057qib7	5052	40	3.7	3.7	CD
cord-005453-4057qib7	5052	41	p	p	NN
cord-005453-4057qib7	5052	42	<	<	XX
cord-005453-4057qib7	5052	43	0.001	0.001	XX
cord-005453-4057qib7	5052	44	;	;	:
cord-005453-4057qib7	5052	45	multivariate	multivariate	JJ
cord-005453-4057qib7	5052	46	HR=2.8	HR=2.8	NNP
cord-005453-4057qib7	5052	47	,	,	,
cord-005453-4057qib7	5052	48	CI=1.7	CI=1.7	NNP
cord-005453-4057qib7	5052	49	-	-	HYPH
cord-005453-4057qib7	5052	50	4.7	4.7	CD
cord-005453-4057qib7	5052	51	,	,	,
cord-005453-4057qib7	5052	52	p	p	NN
cord-005453-4057qib7	5052	53	<	<	XX
cord-005453-4057qib7	5052	54	0.0001	0.0001	CD
cord-005453-4057qib7	5052	55	)	)	-RRB-
cord-005453-4057qib7	5052	56	(	(	-LRB-
cord-005453-4057qib7	5052	57	Figure	figure	NN
cord-005453-4057qib7	5052	58	1B	1b	NN
cord-005453-4057qib7	5052	59	,	,	,
cord-005453-4057qib7	5052	60	PFS	PFS	NNP
cord-005453-4057qib7	5052	61	univariate	univariate	JJ
cord-005453-4057qib7	5053	1	HR=2	HR=2	NNP
cord-005453-4057qib7	5053	2	CI=1.1	CI=1.1	NNP
cord-005453-4057qib7	5053	3	-	-	HYPH
cord-005453-4057qib7	5053	4	3.7	3.7	CD
cord-005453-4057qib7	5053	5	p=0.02	p=0.02	NN
cord-005453-4057qib7	5053	6	;	;	,
cord-005453-4057qib7	5053	7	multivariate	multivariate	JJ
cord-005453-4057qib7	5053	8	HR=2.7	HR=2.7	NNP
cord-005453-4057qib7	5053	9	,	,	,
cord-005453-4057qib7	5053	10	CI=1.4	CI=1.4	NNP
cord-005453-4057qib7	5053	11	-	-	HYPH
cord-005453-4057qib7	5053	12	5	5	CD
cord-005453-4057qib7	5053	13	,	,	,
cord-005453-4057qib7	5053	14	p=0.003	p=0.003	NNP
cord-005453-4057qib7	5053	15	)	)	-RRB-
cord-005453-4057qib7	5053	16	.	.	.
cord-005453-4057qib7	5054	1	Nonrelapse	nonrelapse	JJ
cord-005453-4057qib7	5054	2	mortality	mortality	NN
cord-005453-4057qib7	5054	3	was	be	VBD
cord-005453-4057qib7	5054	4	significantly	significantly	RB
cord-005453-4057qib7	5054	5	increased	increase	VBN
cord-005453-4057qib7	5054	6	in	in	IN
cord-005453-4057qib7	5054	7	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5054	8	recipients	recipient	NNS
cord-005453-4057qib7	5054	9	with	with	IN
cord-005453-4057qib7	5054	10	high	high	JJ
cord-005453-4057qib7	5054	11	uric	uric	NN
cord-005453-4057qib7	5054	12	acid	acid	NN
cord-005453-4057qib7	5054	13	levels	level	NNS
cord-005453-4057qib7	5054	14	prior	prior	RB
cord-005453-4057qib7	5054	15	to	to	TO
cord-005453-4057qib7	5054	16	start	start	NN
cord-005453-4057qib7	5054	17	of	of	IN
cord-005453-4057qib7	5054	18	conditioning	conditioning	NN
cord-005453-4057qib7	5055	1	(	(	-LRB-
cord-005453-4057qib7	5055	2	univariate	univariate	JJ
cord-005453-4057qib7	5055	3	HR=2	HR=2	NNP
cord-005453-4057qib7	5055	4	CI=1.1	CI=1.1	NNP
cord-005453-4057qib7	5055	5	-	-	HYPH
cord-005453-4057qib7	5055	6	3.7	3.7	CD
cord-005453-4057qib7	5055	7	p=0.018	p=0.018	NNS
cord-005453-4057qib7	5055	8	;	;	,
cord-005453-4057qib7	5055	9	multivariate	multivariate	JJ
cord-005453-4057qib7	5055	10	HR=2.65	HR=2.65	NNP
cord-005453-4057qib7	5055	11	,	,	,
cord-005453-4057qib7	5055	12	CI=1.41	CI=1.41	NNP
cord-005453-4057qib7	5055	13	-	-	HYPH
cord-005453-4057qib7	5055	14	5.01	5.01	CD
cord-005453-4057qib7	5055	15	,	,	,
cord-005453-4057qib7	5055	16	p=0.003	p=0.003	NNP
cord-005453-4057qib7	5055	17	)	)	-RRB-
cord-005453-4057qib7	5055	18	.	.	.
cord-005453-4057qib7	5056	1	In	in	IN
cord-005453-4057qib7	5056	2	addition	addition	NN
cord-005453-4057qib7	5056	3	,	,	,
cord-005453-4057qib7	5056	4	there	there	EX
cord-005453-4057qib7	5056	5	was	be	VBD
cord-005453-4057qib7	5056	6	a	a	DT
cord-005453-4057qib7	5056	7	non	non	JJ
cord-005453-4057qib7	5056	8	-	-	JJ
cord-005453-4057qib7	5056	9	significant	significant	JJ
cord-005453-4057qib7	5056	10	trend	trend	NN
cord-005453-4057qib7	5056	11	towards	towards	IN
cord-005453-4057qib7	5056	12	higher	high	JJR
cord-005453-4057qib7	5056	13	acute	acute	JJ
cord-005453-4057qib7	5056	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5056	15	incidence	incidence	NN
cord-005453-4057qib7	5056	16	(	(	-LRB-
cord-005453-4057qib7	5056	17	GVHD	GVHD	NNP
cord-005453-4057qib7	5056	18	Grades	Grades	NNPS
cord-005453-4057qib7	5056	19	II	II	NNP
cord-005453-4057qib7	5056	20	-	-	HYPH
cord-005453-4057qib7	5056	21	IV	IV	NNP
cord-005453-4057qib7	5056	22	univariate	univariate	JJ
cord-005453-4057qib7	5056	23	HR=1.2	hr=1.2	NN
cord-005453-4057qib7	5057	1	CI=0.8	ci=0.8	NN
cord-005453-4057qib7	5057	2	-	-	HYPH
cord-005453-4057qib7	5057	3	1.9	1.9	CD
cord-005453-4057qib7	5057	4	p=0.4	p=0.4	NNPS
cord-005453-4057qib7	5058	1	;	;	:
cord-005453-4057qib7	5058	2	multivariate	multivariate	JJ
cord-005453-4057qib7	5058	3	HR=1.5	HR=1.5	NNP
cord-005453-4057qib7	5058	4	CI=1	CI=1	NNP
cord-005453-4057qib7	5058	5	-	-	HYPH
cord-005453-4057qib7	5058	6	2.4	2.4	CD
cord-005453-4057qib7	5058	7	,	,	,
cord-005453-4057qib7	5058	8	p=0.08	p=0.08	NNP
cord-005453-4057qib7	5058	9	)	)	-RRB-
cord-005453-4057qib7	5058	10	in	in	IN
cord-005453-4057qib7	5058	11	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5058	12	recipients	recipient	NNS
cord-005453-4057qib7	5058	13	with	with	IN
cord-005453-4057qib7	5058	14	uric	uric	NN
cord-005453-4057qib7	5058	15	acid	acid	NN
cord-005453-4057qib7	5058	16	levels	level	NNS
cord-005453-4057qib7	5058	17	above	above	IN
cord-005453-4057qib7	5058	18	cut	cut	VBD
cord-005453-4057qib7	5058	19	off	off	RP
cord-005453-4057qib7	5058	20	before	before	IN
cord-005453-4057qib7	5058	21	transplantation	transplantation	NN
cord-005453-4057qib7	5058	22	.	.	.
cord-005453-4057qib7	5059	1	Finally	finally	RB
cord-005453-4057qib7	5059	2	,	,	,
cord-005453-4057qib7	5059	3	the	the	DT
cord-005453-4057qib7	5059	4	incidence	incidence	NN
cord-005453-4057qib7	5059	5	of	of	IN
cord-005453-4057qib7	5059	6	relapse	relapse	NN
cord-005453-4057qib7	5059	7	after	after	IN
cord-005453-4057qib7	5059	8	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5059	9	was	be	VBD
cord-005453-4057qib7	5059	10	moderately	moderately	RB
cord-005453-4057qib7	5059	11	increased	increase	VBN
cord-005453-4057qib7	5059	12	in	in	IN
cord-005453-4057qib7	5059	13	the	the	DT
cord-005453-4057qib7	5059	14	cohort	cohort	NN
cord-005453-4057qib7	5059	15	with	with	IN
cord-005453-4057qib7	5059	16	higher	high	JJR
cord-005453-4057qib7	5059	17	uric	uric	NN
cord-005453-4057qib7	5059	18	acid	acid	NN
cord-005453-4057qib7	5059	19	levels	level	NNS
cord-005453-4057qib7	5059	20	(	(	-LRB-
cord-005453-4057qib7	5059	21	univariate	univariate	JJ
cord-005453-4057qib7	5059	22	HR=1.6	HR=1.6	NNP
cord-005453-4057qib7	5059	23	CI=1	CI=1	NNP
cord-005453-4057qib7	5059	24	-	-	HYPH
cord-005453-4057qib7	5059	25	2.5	2.5	CD
cord-005453-4057qib7	5059	26	p=0.09	p=0.09	NN
cord-005453-4057qib7	5059	27	;	;	,
cord-005453-4057qib7	5059	28	multivariate	multivariate	JJ
cord-005453-4057qib7	5059	29	HR=1.59	hr=1.59	XX
cord-005453-4057qib7	5059	30	,	,	.
cord-005453-4057qib7	5060	1	CI=1.02	ci=1.02	LS
cord-005453-4057qib7	5060	2	-	-	HYPH
cord-005453-4057qib7	5060	3	2.49	2.49	CD
cord-005453-4057qib7	5060	4	,	,	,
cord-005453-4057qib7	5060	5	p=0.04	p=0.04	NNP
cord-005453-4057qib7	5060	6	)	)	-RRB-
cord-005453-4057qib7	5060	7	.	.	.
cord-005453-4057qib7	5061	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5061	2	:	:	:
cord-005453-4057qib7	5062	1	High	high	JJ
cord-005453-4057qib7	5062	2	uric	uric	NN
cord-005453-4057qib7	5062	3	acid	acid	NN
cord-005453-4057qib7	5062	4	levels	level	NNS
cord-005453-4057qib7	5062	5	before	before	IN
cord-005453-4057qib7	5062	6	start	start	NN
cord-005453-4057qib7	5062	7	of	of	IN
cord-005453-4057qib7	5062	8	conditioning	conditioning	NN
cord-005453-4057qib7	5062	9	correlate	correlate	VBP
cord-005453-4057qib7	5062	10	with	with	IN
cord-005453-4057qib7	5062	11	high	high	JJ
cord-005453-4057qib7	5062	12	mortality	mortality	NN
cord-005453-4057qib7	5062	13	after	after	IN
cord-005453-4057qib7	5062	14	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5062	15	.	.	.
cord-005453-4057qib7	5063	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5063	2	results	result	NNS
cord-005453-4057qib7	5063	3	can	can	MD
cord-005453-4057qib7	5063	4	serve	serve	VB
cord-005453-4057qib7	5063	5	as	as	IN
cord-005453-4057qib7	5063	6	rationale	rationale	NN
cord-005453-4057qib7	5063	7	for	for	IN
cord-005453-4057qib7	5063	8	clinical	clinical	JJ
cord-005453-4057qib7	5063	9	trials	trial	NNS
cord-005453-4057qib7	5063	10	on	on	IN
cord-005453-4057qib7	5063	11	depletion	depletion	NN
cord-005453-4057qib7	5063	12	of	of	IN
cord-005453-4057qib7	5063	13	uric	uric	NN
cord-005453-4057qib7	5063	14	acid	acid	NN
cord-005453-4057qib7	5063	15	during	during	IN
cord-005453-4057qib7	5063	16	alloSCT	alloSCT	NNP
cord-005453-4057qib7	5063	17	.	.	.
cord-005453-4057qib7	5064	1	Results	result	NNS
cord-005453-4057qib7	5064	2	:	:	:
cord-005453-4057qib7	5065	1	We	-PRON-	PRP
cord-005453-4057qib7	5065	2	found	find	VBD
cord-005453-4057qib7	5065	3	significant	significant	JJ
cord-005453-4057qib7	5065	4	correlation	correlation	NN
cord-005453-4057qib7	5065	5	between	between	IN
cord-005453-4057qib7	5065	6	donors	donor	NNS
cord-005453-4057qib7	5065	7	'	'	POS
cord-005453-4057qib7	5065	8	CTLA-4	CTLA-4	NNS
cord-005453-4057qib7	5065	9	+49A	+49A	NNP
cord-005453-4057qib7	5066	1	>	>	XX
cord-005453-4057qib7	5067	1	G	g	NN
cord-005453-4057qib7	5067	2	polymorphism	polymorphism	NN
cord-005453-4057qib7	5067	3	and	and	CC
cord-005453-4057qib7	5067	4	HSCT	HSCT	NNP
cord-005453-4057qib7	5067	5	outcome	outcome	NN
cord-005453-4057qib7	5067	6	.	.	.
cord-005453-4057qib7	5068	1	Genotype	Genotype	NNP
cord-005453-4057qib7	5068	2	AA	AA	NNP
cord-005453-4057qib7	5068	3	was	be	VBD
cord-005453-4057qib7	5068	4	present	present	JJ
cord-005453-4057qib7	5068	5	in	in	IN
cord-005453-4057qib7	5068	6	170	170	CD
cord-005453-4057qib7	5068	7	donors	donor	NNS
cord-005453-4057qib7	5068	8	,	,	,
cord-005453-4057qib7	5068	9	AG	AG	NNP
cord-005453-4057qib7	5068	10	in	in	IN
cord-005453-4057qib7	5068	11	183	183	CD
cord-005453-4057qib7	5068	12	donors	donor	NNS
cord-005453-4057qib7	5068	13	and	and	CC
cord-005453-4057qib7	5068	14	44	44	CD
cord-005453-4057qib7	5068	15	donors	donor	NNS
cord-005453-4057qib7	5068	16	was	be	VBD
cord-005453-4057qib7	5068	17	homozygous	homozygous	JJ
cord-005453-4057qib7	5068	18	for	for	IN
cord-005453-4057qib7	5068	19	G	g	NN
cord-005453-4057qib7	5068	20	allele	allele	NN
cord-005453-4057qib7	5068	21	.	.	.
cord-005453-4057qib7	5069	1	Recipients	recipient	NNS
cord-005453-4057qib7	5069	2	who	who	WP
cord-005453-4057qib7	5069	3	received	receive	VBD
cord-005453-4057qib7	5069	4	graft	graft	NN
cord-005453-4057qib7	5069	5	from	from	IN
cord-005453-4057qib7	5069	6	G	g	NN
cord-005453-4057qib7	5069	7	allele	allele	NN
cord-005453-4057qib7	5069	8	carrier	carrier	NN
cord-005453-4057qib7	5069	9	donors	donor	NNS
cord-005453-4057qib7	5069	10	showed	show	VBD
cord-005453-4057qib7	5069	11	significantly	significantly	RB
cord-005453-4057qib7	5069	12	increased	increase	VBN
cord-005453-4057qib7	5069	13	cumulative	cumulative	JJ
cord-005453-4057qib7	5069	14	incidence	incidence	NN
cord-005453-4057qib7	5069	15	of	of	IN
cord-005453-4057qib7	5069	16	relapse	relapse	NN
cord-005453-4057qib7	5069	17	(	(	-LRB-
cord-005453-4057qib7	5069	18	at	at	IN
cord-005453-4057qib7	5069	19	24	24	CD
cord-005453-4057qib7	5069	20	months	month	NNS
cord-005453-4057qib7	5069	21	AA	AA	NNP
cord-005453-4057qib7	5069	22	:	:	:
cord-005453-4057qib7	5069	23	20.7	20.7	CD
cord-005453-4057qib7	5069	24	%	%	NN
cord-005453-4057qib7	5069	25	,	,	,
cord-005453-4057qib7	5069	26	AG	AG	NNP
cord-005453-4057qib7	5069	27	:	:	:
cord-005453-4057qib7	5069	28	23.6	23.6	CD
cord-005453-4057qib7	5069	29	%	%	NN
cord-005453-4057qib7	5069	30	and	and	CC
cord-005453-4057qib7	5069	31	GG	GG	NNP
cord-005453-4057qib7	5069	32	:	:	:
cord-005453-4057qib7	5069	33	34.3	34.3	CD
cord-005453-4057qib7	5069	34	%	%	NN
cord-005453-4057qib7	5069	35	;	;	:
cord-005453-4057qib7	5069	36	p=0.04	p=0.04	NNP
cord-005453-4057qib7	5069	37	)	)	-RRB-
cord-005453-4057qib7	5069	38	.	.	.
cord-005453-4057qib7	5070	1	On	on	IN
cord-005453-4057qib7	5070	2	contrary	contrary	JJ
cord-005453-4057qib7	5070	3	,	,	,
cord-005453-4057qib7	5070	4	the	the	DT
cord-005453-4057qib7	5070	5	frequency	frequency	NN
cord-005453-4057qib7	5070	6	of	of	IN
cord-005453-4057qib7	5070	7	the	the	DT
cord-005453-4057qib7	5070	8	acute	acute	JJ
cord-005453-4057qib7	5070	9	GvHD	GvHD	NNP
cord-005453-4057qib7	5070	10	grades	grade	NNS
cord-005453-4057qib7	5070	11	III	III	NNP
cord-005453-4057qib7	5070	12	-	-	HYPH
cord-005453-4057qib7	5070	13	IV	IV	NNP
cord-005453-4057qib7	5070	14	and	and	CC
cord-005453-4057qib7	5070	15	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	5070	16	(	(	-LRB-
cord-005453-4057qib7	5070	17	CMV	CMV	NNP
cord-005453-4057qib7	5070	18	)	)	-RRB-
cord-005453-4057qib7	5070	19	reactivation	reactivation	NN
cord-005453-4057qib7	5070	20	/	/	SYM
cord-005453-4057qib7	5070	21	disease	disease	NN
cord-005453-4057qib7	5070	22	decreased	decrease	VBD
cord-005453-4057qib7	5070	23	according	accord	VBG
cord-005453-4057qib7	5070	24	to	to	IN
cord-005453-4057qib7	5070	25	the	the	DT
cord-005453-4057qib7	5070	26	presence	presence	NN
cord-005453-4057qib7	5070	27	of	of	IN
cord-005453-4057qib7	5070	28	the	the	DT
cord-005453-4057qib7	5070	29	G	g	NN
cord-005453-4057qib7	5070	30	allele	allele	NN
cord-005453-4057qib7	5070	31	in	in	IN
cord-005453-4057qib7	5070	32	the	the	DT
cord-005453-4057qib7	5070	33	donor	donor	NN
cord-005453-4057qib7	5070	34	CTLA-4	CTLA-4	NNS
cord-005453-4057qib7	5070	35	genotype	genotype	NN
cord-005453-4057qib7	5070	36	[	[	-LRB-
cord-005453-4057qib7	5070	37	aGvHD	agvhd	NN
cord-005453-4057qib7	5070	38	:	:	:
cord-005453-4057qib7	5070	39	AA	aa	NN
cord-005453-4057qib7	5070	40	:	:	:
cord-005453-4057qib7	5070	41	20	20	CD
cord-005453-4057qib7	5070	42	%	%	NN
cord-005453-4057qib7	5070	43	,	,	,
cord-005453-4057qib7	5070	44	AG	AG	NNP
cord-005453-4057qib7	5070	45	:	:	:
cord-005453-4057qib7	5070	46	12	12	CD
cord-005453-4057qib7	5070	47	%	%	NN
cord-005453-4057qib7	5070	48	,	,	,
cord-005453-4057qib7	5070	49	GG	GG	NNP
cord-005453-4057qib7	5070	50	:	:	:
cord-005453-4057qib7	5070	51	5	5	CD
cord-005453-4057qib7	5070	52	%	%	NN
cord-005453-4057qib7	5070	53	;	;	:
cord-005453-4057qib7	5070	54	p=	p=	JJ
cord-005453-4057qib7	5070	55	0.014	0.014	CD
cord-005453-4057qib7	5070	56	;	;	:
cord-005453-4057qib7	5070	57	CMV	CMV	NNP
cord-005453-4057qib7	5070	58	:	:	:
cord-005453-4057qib7	5070	59	AA	AA	NNP
cord-005453-4057qib7	5070	60	:	:	:
cord-005453-4057qib7	5070	61	24	24	CD
cord-005453-4057qib7	5070	62	%	%	NN
cord-005453-4057qib7	5070	63	,	,	,
cord-005453-4057qib7	5070	64	AG	AG	NNP
cord-005453-4057qib7	5070	65	:	:	:
cord-005453-4057qib7	5070	66	16	16	CD
cord-005453-4057qib7	5070	67	%	%	NN
cord-005453-4057qib7	5070	68	,	,	,
cord-005453-4057qib7	5070	69	GG	GG	NNP
cord-005453-4057qib7	5070	70	:	:	:
cord-005453-4057qib7	5070	71	9	9	CD
cord-005453-4057qib7	5070	72	%	%	NN
cord-005453-4057qib7	5070	73	;	;	:
cord-005453-4057qib7	5070	74	p=	p=	JJ
cord-005453-4057qib7	5070	75	0.039	0.039	CD
cord-005453-4057qib7	5070	76	]	]	-RRB-
cord-005453-4057qib7	5070	77	.	.	.
cord-005453-4057qib7	5071	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	5071	2	incidence	incidence	NN
cord-005453-4057qib7	5071	3	of	of	IN
cord-005453-4057qib7	5071	4	aGvHD	agvhd	NN
cord-005453-4057qib7	5071	5	was	be	VBD
cord-005453-4057qib7	5071	6	also	also	RB
cord-005453-4057qib7	5071	7	markedly	markedly	RB
cord-005453-4057qib7	5071	8	decreased	decrease	VBN
cord-005453-4057qib7	5071	9	among	among	IN
cord-005453-4057qib7	5071	10	patients	patient	NNS
cord-005453-4057qib7	5071	11	with	with	IN
cord-005453-4057qib7	5071	12	G	g	NN
cord-005453-4057qib7	5071	13	allele	allele	NN
cord-005453-4057qib7	5071	14	carrier	carrier	NN
cord-005453-4057qib7	5071	15	donors	donor	NNS
cord-005453-4057qib7	5071	16	(	(	-LRB-
cord-005453-4057qib7	5071	17	at	at	IN
cord-005453-4057qib7	5071	18	100	100	CD
cord-005453-4057qib7	5071	19	days	day	NNS
cord-005453-4057qib7	5071	20	AA	AA	NNP
cord-005453-4057qib7	5071	21	:	:	:
cord-005453-4057qib7	5071	22	19.9	19.9	CD
cord-005453-4057qib7	5071	23	%	%	NN
cord-005453-4057qib7	5071	24	,	,	,
cord-005453-4057qib7	5071	25	AG	AG	NNP
cord-005453-4057qib7	5071	26	:	:	:
cord-005453-4057qib7	5071	27	10.4	10.4	CD
cord-005453-4057qib7	5071	28	%	%	NN
cord-005453-4057qib7	5071	29	,	,	,
cord-005453-4057qib7	5071	30	GG	GG	NNP
cord-005453-4057qib7	5071	31	:	:	:
cord-005453-4057qib7	5071	32	6.4	6.4	CD
cord-005453-4057qib7	5071	33	%	%	NN
cord-005453-4057qib7	5071	34	;	;	,
cord-005453-4057qib7	5071	35	p=0.01	p=0.01	NNP
cord-005453-4057qib7	5071	36	)	)	-RRB-
cord-005453-4057qib7	5071	37	.	.	.
cord-005453-4057qib7	5072	1	Donor	donor	NN
cord-005453-4057qib7	5072	2	genotype	genotype	NN
cord-005453-4057qib7	5072	3	similarly	similarly	RB
cord-005453-4057qib7	5072	4	influenced	influence	VBD
cord-005453-4057qib7	5072	5	HSCT	HSCT	NNP
cord-005453-4057qib7	5072	6	outcome	outcome	NN
cord-005453-4057qib7	5072	7	in	in	IN
cord-005453-4057qib7	5072	8	MUD	MUD	NNP
cord-005453-4057qib7	5072	9	donor	donor	NN
cord-005453-4057qib7	5072	10	and	and	CC
cord-005453-4057qib7	5072	11	MAC	MAC	NNP
cord-005453-4057qib7	5072	12	conditioning	conditioning	NN
cord-005453-4057qib7	5072	13	subgroups	subgroup	NNS
cord-005453-4057qib7	5072	14	.	.	.
cord-005453-4057qib7	5073	1	Overall	overall	JJ
cord-005453-4057qib7	5073	2	survival	survival	NN
cord-005453-4057qib7	5073	3	(	(	-LRB-
cord-005453-4057qib7	5073	4	OS	OS	NNP
cord-005453-4057qib7	5073	5	)	)	-RRB-
cord-005453-4057qib7	5073	6	was	be	VBD
cord-005453-4057qib7	5073	7	not	not	RB
cord-005453-4057qib7	5073	8	different	different	JJ
cord-005453-4057qib7	5073	9	in	in	IN
cord-005453-4057qib7	5073	10	patient	patient	JJ
cord-005453-4057qib7	5073	11	subgroups	subgroup	NNS
cord-005453-4057qib7	5073	12	according	accord	VBG
cord-005453-4057qib7	5073	13	to	to	IN
cord-005453-4057qib7	5073	14	donor	donor	NN
cord-005453-4057qib7	5073	15	genotypes	genotype	NNS
cord-005453-4057qib7	5073	16	[	[	-LRB-
cord-005453-4057qib7	5073	17	OS	os	NN
cord-005453-4057qib7	5073	18	at	at	IN
cord-005453-4057qib7	5073	19	24	24	CD
cord-005453-4057qib7	5073	20	months	month	NNS
cord-005453-4057qib7	5073	21	:	:	:
cord-005453-4057qib7	5073	22	AA	aa	NN
cord-005453-4057qib7	5073	23	:	:	:
cord-005453-4057qib7	5073	24	55.5	55.5	CD
cord-005453-4057qib7	5073	25	±3.8	±3.8	NNP
cord-005453-4057qib7	5073	26	%	%	NN
cord-005453-4057qib7	5073	27	,	,	,
cord-005453-4057qib7	5073	28	AG	AG	NNP
cord-005453-4057qib7	5073	29	:	:	:
cord-005453-4057qib7	5073	30	54.4±3.7	54.4±3.7	CD
cord-005453-4057qib7	5073	31	%	%	NN
cord-005453-4057qib7	5073	32	,	,	,
cord-005453-4057qib7	5073	33	GG	GG	NNP
cord-005453-4057qib7	5073	34	:	:	:
cord-005453-4057qib7	5073	35	49.4±7.6	49.4±7.6	CD
cord-005453-4057qib7	5073	36	%	%	NN
cord-005453-4057qib7	5073	37	;	;	:
cord-005453-4057qib7	5073	38	p=	p=	NN
cord-005453-4057qib7	5073	39	0.68	0.68	CD
cord-005453-4057qib7	5073	40	]	]	-RRB-
cord-005453-4057qib7	5073	41	.	.	.
cord-005453-4057qib7	5074	1	We	-PRON-	PRP
cord-005453-4057qib7	5074	2	did	do	VBD
cord-005453-4057qib7	5074	3	not	not	RB
cord-005453-4057qib7	5074	4	find	find	VB
cord-005453-4057qib7	5074	5	any	any	DT
cord-005453-4057qib7	5074	6	correlation	correlation	NN
cord-005453-4057qib7	5074	7	between	between	IN
cord-005453-4057qib7	5074	8	recipients	recipient	NNS
cord-005453-4057qib7	5074	9	'	'	POS
cord-005453-4057qib7	5074	10	CTLA-4	CTLA-4	NNS
cord-005453-4057qib7	5074	11	+49A	+49A	NNP
cord-005453-4057qib7	5075	1	>	>	XX
cord-005453-4057qib7	5076	1	G	g	NN
cord-005453-4057qib7	5076	2	polymorphism	polymorphism	NN
cord-005453-4057qib7	5076	3	and	and	CC
cord-005453-4057qib7	5076	4	HSCT	HSCT	NNP
cord-005453-4057qib7	5076	5	outcome	outcome	NN
cord-005453-4057qib7	5076	6	.	.	.
cord-005453-4057qib7	5077	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5077	2	:	:	:
cord-005453-4057qib7	5078	1	Several	several	JJ
cord-005453-4057qib7	5078	2	CTLA-4	CTLA-4	NNS
cord-005453-4057qib7	5078	3	SNPs	snp	NNS
cord-005453-4057qib7	5078	4	have	have	VBP
cord-005453-4057qib7	5078	5	previously	previously	RB
cord-005453-4057qib7	5078	6	been	be	VBN
cord-005453-4057qib7	5078	7	described	describe	VBN
cord-005453-4057qib7	5078	8	to	to	TO
cord-005453-4057qib7	5078	9	be	be	VB
cord-005453-4057qib7	5078	10	associated	associate	VBN
cord-005453-4057qib7	5078	11	with	with	IN
cord-005453-4057qib7	5078	12	relapse	relapse	NN
cord-005453-4057qib7	5078	13	rate	rate	NN
cord-005453-4057qib7	5078	14	,	,	,
cord-005453-4057qib7	5078	15	incidence	incidence	NN
cord-005453-4057qib7	5078	16	of	of	IN
cord-005453-4057qib7	5078	17	aGvHD	agvhd	NN
cord-005453-4057qib7	5078	18	and	and	CC
cord-005453-4057qib7	5078	19	OS	OS	NNP
cord-005453-4057qib7	5078	20	,	,	,
cord-005453-4057qib7	5078	21	but	but	CC
cord-005453-4057qib7	5078	22	results	result	NNS
cord-005453-4057qib7	5078	23	are	be	VBP
cord-005453-4057qib7	5078	24	often	often	RB
cord-005453-4057qib7	5078	25	contradictory	contradictory	JJ
cord-005453-4057qib7	5078	26	in	in	IN
cord-005453-4057qib7	5078	27	the	the	DT
cord-005453-4057qib7	5078	28	publications	publication	NNS
cord-005453-4057qib7	5078	29	.	.	.
cord-005453-4057qib7	5079	1	In	in	IN
cord-005453-4057qib7	5079	2	our	-PRON-	PRP$
cord-005453-4057qib7	5079	3	study	study	NN
cord-005453-4057qib7	5079	4	,	,	,
cord-005453-4057qib7	5079	5	CTLA-4	CTLA-4	NNP
cord-005453-4057qib7	5079	6	+49A	+49A	NNP
cord-005453-4057qib7	5080	1	>	>	XX
cord-005453-4057qib7	5081	1	G	g	NN
cord-005453-4057qib7	5081	2	polymorphism	polymorphism	NN
cord-005453-4057qib7	5081	3	of	of	IN
cord-005453-4057qib7	5081	4	HSCT	HSCT	NNP
cord-005453-4057qib7	5081	5	donors	donor	NNS
cord-005453-4057qib7	5081	6	influenced	influence	VBD
cord-005453-4057qib7	5081	7	risk	risk	NN
cord-005453-4057qib7	5081	8	of	of	IN
cord-005453-4057qib7	5081	9	relapse	relapse	NN
cord-005453-4057qib7	5081	10	,	,	,
cord-005453-4057qib7	5081	11	aGvHD	agvhd	NN
cord-005453-4057qib7	5081	12	,	,	,
cord-005453-4057qib7	5081	13	CMV	CMV	NNP
cord-005453-4057qib7	5081	14	and	and	CC
cord-005453-4057qib7	5081	15	cause	cause	NN
cord-005453-4057qib7	5081	16	of	of	IN
cord-005453-4057qib7	5081	17	death	death	NN
cord-005453-4057qib7	5081	18	,	,	,
cord-005453-4057qib7	5081	19	but	but	CC
cord-005453-4057qib7	5081	20	not	not	RB
cord-005453-4057qib7	5081	21	overall	overall	JJ
cord-005453-4057qib7	5081	22	survival	survival	NN
cord-005453-4057qib7	5081	23	.	.	.
cord-005453-4057qib7	5082	1	The	the	DT
cord-005453-4057qib7	5082	2	genotyping	genotyping	NN
cord-005453-4057qib7	5082	3	of	of	IN
cord-005453-4057qib7	5082	4	CTLA-4	CTLA-4	NNS
cord-005453-4057qib7	5082	5	+49A	+49A	NNP
cord-005453-4057qib7	5083	1	>	>	XX
cord-005453-4057qib7	5084	1	G	g	NN
cord-005453-4057qib7	5084	2	polymorphism	polymorphism	NN
cord-005453-4057qib7	5084	3	in	in	IN
cord-005453-4057qib7	5084	4	donors	donor	NNS
cord-005453-4057qib7	5084	5	may	may	MD
cord-005453-4057qib7	5084	6	help	help	VB
cord-005453-4057qib7	5084	7	in	in	IN
cord-005453-4057qib7	5084	8	the	the	DT
cord-005453-4057qib7	5084	9	risk	risk	NN
cord-005453-4057qib7	5084	10	assessment	assessment	NN
cord-005453-4057qib7	5084	11	process	process	NN
cord-005453-4057qib7	5084	12	and	and	CC
cord-005453-4057qib7	5084	13	the	the	DT
cord-005453-4057qib7	5084	14	choice	choice	NN
cord-005453-4057qib7	5084	15	of	of	IN
cord-005453-4057qib7	5084	16	personalised	personalised	JJ
cord-005453-4057qib7	5084	17	therapy	therapy	NN
cord-005453-4057qib7	5084	18	.	.	.
cord-005453-4057qib7	5085	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5085	2	:	:	:
cord-005453-4057qib7	5085	3	Nothing	nothing	NN
cord-005453-4057qib7	5085	4	to	to	TO
cord-005453-4057qib7	5085	5	declare	declare	VB
cord-005453-4057qib7	5085	6	.	.	.
cord-005453-4057qib7	5086	1	Background	background	NN
cord-005453-4057qib7	5086	2	:	:	:
cord-005453-4057qib7	5087	1	Although	although	IN
cord-005453-4057qib7	5087	2	steroids	steroid	NNS
cord-005453-4057qib7	5087	3	remain	remain	VBP
cord-005453-4057qib7	5087	4	first	first	JJ
cord-005453-4057qib7	5087	5	-	-	HYPH
cord-005453-4057qib7	5087	6	line	line	NN
cord-005453-4057qib7	5087	7	therapy	therapy	NN
cord-005453-4057qib7	5087	8	for	for	IN
cord-005453-4057qib7	5087	9	the	the	DT
cord-005453-4057qib7	5087	10	treatment	treatment	NN
cord-005453-4057qib7	5087	11	of	of	IN
cord-005453-4057qib7	5087	12	acute	acute	JJ
cord-005453-4057qib7	5087	13	graft	graft	NN
cord-005453-4057qib7	5087	14	versus	versus	IN
cord-005453-4057qib7	5087	15	host	host	NN
cord-005453-4057qib7	5087	16	disease	disease	NN
cord-005453-4057qib7	5087	17	(	(	-LRB-
cord-005453-4057qib7	5087	18	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5087	19	)	)	-RRB-
cord-005453-4057qib7	5087	20	,	,	,
cord-005453-4057qib7	5087	21	response	response	NN
cord-005453-4057qib7	5087	22	rates	rate	NNS
cord-005453-4057qib7	5087	23	in	in	IN
cord-005453-4057qib7	5087	24	patients	patient	NNS
cord-005453-4057qib7	5087	25	with	with	IN
cord-005453-4057qib7	5087	26	grade	grade	NN
cord-005453-4057qib7	5087	27	III	III	NNP
cord-005453-4057qib7	5087	28	-	-	HYPH
cord-005453-4057qib7	5087	29	IV	IV	NNP
cord-005453-4057qib7	5087	30	disease	disease	NN
cord-005453-4057qib7	5087	31	are	be	VBP
cord-005453-4057qib7	5087	32	poor	poor	JJ
cord-005453-4057qib7	5087	33	,	,	,
cord-005453-4057qib7	5087	34	with	with	IN
cord-005453-4057qib7	5087	35	no	no	DT
cord-005453-4057qib7	5087	36	apparent	apparent	JJ
cord-005453-4057qib7	5087	37	improvement	improvement	NN
cord-005453-4057qib7	5087	38	in	in	IN
cord-005453-4057qib7	5087	39	survival	survival	NN
cord-005453-4057qib7	5087	40	over	over	IN
cord-005453-4057qib7	5087	41	the	the	DT
cord-005453-4057qib7	5087	42	past	past	JJ
cord-005453-4057qib7	5087	43	15	15	CD
cord-005453-4057qib7	5087	44	years	year	NNS
cord-005453-4057qib7	5087	45	.	.	.
cord-005453-4057qib7	5088	1	We	-PRON-	PRP
cord-005453-4057qib7	5088	2	performed	perform	VBD
cord-005453-4057qib7	5088	3	a	a	DT
cord-005453-4057qib7	5088	4	prospective	prospective	JJ
cord-005453-4057qib7	5088	5	,	,	,
cord-005453-4057qib7	5088	6	multicenter	multicenter	JJ
cord-005453-4057qib7	5088	7	trial	trial	NN
cord-005453-4057qib7	5088	8	to	to	TO
cord-005453-4057qib7	5088	9	assess	assess	VB
cord-005453-4057qib7	5088	10	the	the	DT
cord-005453-4057qib7	5088	11	efficacy	efficacy	NN
cord-005453-4057qib7	5088	12	and	and	CC
cord-005453-4057qib7	5088	13	safety	safety	NN
cord-005453-4057qib7	5088	14	of	of	IN
cord-005453-4057qib7	5088	15	the	the	DT
cord-005453-4057qib7	5088	16	combination	combination	NN
cord-005453-4057qib7	5088	17	of	of	IN
cord-005453-4057qib7	5088	18	ruxolitinib	ruxolitinib	NN
cord-005453-4057qib7	5088	19	and	and	CC
cord-005453-4057qib7	5088	20	etanercept	etanercept	NNP
cord-005453-4057qib7	5088	21	as	as	IN
cord-005453-4057qib7	5088	22	a	a	DT
cord-005453-4057qib7	5088	23	novel	novel	JJ
cord-005453-4057qib7	5088	24	approach	approach	NN
cord-005453-4057qib7	5088	25	to	to	TO
cord-005453-4057qib7	5088	26	treat	treat	VB
cord-005453-4057qib7	5088	27	grades	grade	NNS
cord-005453-4057qib7	5088	28	III	III	NNP
cord-005453-4057qib7	5088	29	-	-	HYPH
cord-005453-4057qib7	5088	30	IV	IV	NNP
cord-005453-4057qib7	5088	31	SR	SR	NNP
cord-005453-4057qib7	5088	32	-	-	HYPH
cord-005453-4057qib7	5088	33	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5088	34	.	.	.
cord-005453-4057qib7	5089	1	Methods	method	NNS
cord-005453-4057qib7	5089	2	:	:	:
cord-005453-4057qib7	5090	1	Forty	forty	CD
cord-005453-4057qib7	5090	2	malignant	malignant	JJ
cord-005453-4057qib7	5090	3	hematologic	hematologic	JJ
cord-005453-4057qib7	5090	4	disease	disease	NN
cord-005453-4057qib7	5090	5	patients	patient	NNS
cord-005453-4057qib7	5090	6	with	with	IN
cord-005453-4057qib7	5090	7	grades	grade	NNS
cord-005453-4057qib7	5090	8	III	III	NNP
cord-005453-4057qib7	5090	9	-	-	HYPH
cord-005453-4057qib7	5090	10	IV	IV	NNP
cord-005453-4057qib7	5090	11	SR	SR	NNP
cord-005453-4057qib7	5090	12	-	-	HYPH
cord-005453-4057qib7	5090	13	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5091	1	after	after	IN
cord-005453-4057qib7	5091	2	allo	allo	NNP
cord-005453-4057qib7	5091	3	-	-	HYPH
cord-005453-4057qib7	5091	4	SCT	SCT	NNP
cord-005453-4057qib7	5091	5	from	from	IN
cord-005453-4057qib7	5091	6	three	three	CD
cord-005453-4057qib7	5091	7	centers	center	NNS
cord-005453-4057qib7	5091	8	in	in	IN
cord-005453-4057qib7	5091	9	East	East	NNP
cord-005453-4057qib7	5091	10	China	China	NNP
cord-005453-4057qib7	5091	11	were	be	VBD
cord-005453-4057qib7	5091	12	enrolled	enrol	VBN
cord-005453-4057qib7	5091	13	from	from	IN
cord-005453-4057qib7	5091	14	January	January	NNP
cord-005453-4057qib7	5091	15	2017	2017	CD
cord-005453-4057qib7	5091	16	to	to	IN
cord-005453-4057qib7	5091	17	June	June	NNP
cord-005453-4057qib7	5091	18	2018	2018	CD
cord-005453-4057qib7	5091	19	.	.	.
cord-005453-4057qib7	5092	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5092	2	was	be	VBD
cord-005453-4057qib7	5092	3	initiated	initiate	VBN
cord-005453-4057qib7	5092	4	at	at	IN
cord-005453-4057qib7	5092	5	a	a	DT
cord-005453-4057qib7	5092	6	dose	dose	NN
cord-005453-4057qib7	5092	7	of	of	IN
cord-005453-4057qib7	5092	8	5	5	CD
cord-005453-4057qib7	5092	9	-	-	SYM
cord-005453-4057qib7	5092	10	10	10	CD
cord-005453-4057qib7	5092	11	mg	mg	NNP
cord-005453-4057qib7	5092	12	BID	BID	NNP
cord-005453-4057qib7	5092	13	for	for	IN
cord-005453-4057qib7	5092	14	2	2	CD
cord-005453-4057qib7	5092	15	months	month	NNS
cord-005453-4057qib7	5092	16	,	,	,
cord-005453-4057qib7	5092	17	and	and	CC
cord-005453-4057qib7	5092	18	then	then	RB
cord-005453-4057qib7	5092	19	tapered	tapered	JJ
cord-005453-4057qib7	5092	20	gradually	gradually	RB
cord-005453-4057qib7	5092	21	for	for	IN
cord-005453-4057qib7	5092	22	another	another	DT
cord-005453-4057qib7	5092	23	one	one	CD
cord-005453-4057qib7	5092	24	month	month	NN
cord-005453-4057qib7	5092	25	.	.	.
cord-005453-4057qib7	5093	1	Etanercept	Etanercept	NNP
cord-005453-4057qib7	5093	2	was	be	VBD
cord-005453-4057qib7	5093	3	administrated	administrate	VBN
cord-005453-4057qib7	5093	4	at	at	IN
cord-005453-4057qib7	5093	5	25	25	CD
cord-005453-4057qib7	5093	6	mg	mg	NNP
cord-005453-4057qib7	5093	7	BIW	BIW	NNP
cord-005453-4057qib7	5093	8	for	for	IN
cord-005453-4057qib7	5093	9	2	2	CD
cord-005453-4057qib7	5093	10	-	-	SYM
cord-005453-4057qib7	5093	11	8	8	CD
cord-005453-4057qib7	5093	12	weeks	week	NNS
cord-005453-4057qib7	5093	13	.	.	.
cord-005453-4057qib7	5094	1	Results	result	NNS
cord-005453-4057qib7	5094	2	:	:	:
cord-005453-4057qib7	5095	1	The	the	DT
cord-005453-4057qib7	5095	2	median	median	JJ
cord-005453-4057qib7	5095	3	age	age	NN
cord-005453-4057qib7	5095	4	of	of	IN
cord-005453-4057qib7	5095	5	patients	patient	NNS
cord-005453-4057qib7	5095	6	was	be	VBD
cord-005453-4057qib7	5095	7	25	25	CD
cord-005453-4057qib7	5096	1	(	(	-LRB-
cord-005453-4057qib7	5096	2	range	range	NNP
cord-005453-4057qib7	5096	3	15	15	CD
cord-005453-4057qib7	5096	4	-	-	SYM
cord-005453-4057qib7	5096	5	59	59	CD
cord-005453-4057qib7	5096	6	)	)	-RRB-
cord-005453-4057qib7	5096	7	years	year	NNS
cord-005453-4057qib7	5096	8	.	.	.
cord-005453-4057qib7	5097	1	At	at	IN
cord-005453-4057qib7	5097	2	day	day	NN
cord-005453-4057qib7	5097	3	30	30	CD
cord-005453-4057qib7	5097	4	after	after	IN
cord-005453-4057qib7	5097	5	the	the	DT
cord-005453-4057qib7	5097	6	combination	combination	NN
cord-005453-4057qib7	5097	7	treatment	treatment	NN
cord-005453-4057qib7	5097	8	,	,	,
cord-005453-4057qib7	5097	9	the	the	DT
cord-005453-4057qib7	5097	10	overall	overall	JJ
cord-005453-4057qib7	5097	11	response	response	NN
cord-005453-4057qib7	5097	12	rate	rate	NN
cord-005453-4057qib7	5097	13	(	(	-LRB-
cord-005453-4057qib7	5097	14	ORR	ORR	NNP
cord-005453-4057qib7	5097	15	)	)	-RRB-
cord-005453-4057qib7	5097	16	was	be	VBD
cord-005453-4057qib7	5097	17	90	90	CD
cord-005453-4057qib7	5097	18	%	%	NN
cord-005453-4057qib7	5097	19	including	include	VBG
cord-005453-4057qib7	5097	20	30	30	CD
cord-005453-4057qib7	5097	21	CRs	cr	NNS
cord-005453-4057qib7	5097	22	(	(	-LRB-
cord-005453-4057qib7	5097	23	75	75	CD
cord-005453-4057qib7	5097	24	%	%	NN
cord-005453-4057qib7	5097	25	)	)	-RRB-
cord-005453-4057qib7	5097	26	and	and	CC
cord-005453-4057qib7	5097	27	6	6	CD
cord-005453-4057qib7	5097	28	PRs	pr	NNS
cord-005453-4057qib7	5097	29	(	(	-LRB-
cord-005453-4057qib7	5097	30	15	15	CD
cord-005453-4057qib7	5097	31	%	%	NN
cord-005453-4057qib7	5097	32	)	)	-RRB-
cord-005453-4057qib7	5097	33	.	.	.
cord-005453-4057qib7	5098	1	The	the	DT
cord-005453-4057qib7	5098	2	median	median	JJ
cord-005453-4057qib7	5098	3	time	time	NN
cord-005453-4057qib7	5098	4	to	to	IN
cord-005453-4057qib7	5098	5	the	the	DT
cord-005453-4057qib7	5098	6	optimal	optimal	JJ
cord-005453-4057qib7	5098	7	response	response	NN
cord-005453-4057qib7	5098	8	was	be	VBD
cord-005453-4057qib7	5098	9	13	13	CD
cord-005453-4057qib7	5099	1	(	(	-LRB-
cord-005453-4057qib7	5099	2	range	range	NNP
cord-005453-4057qib7	5099	3	3	3	CD
cord-005453-4057qib7	5099	4	-	-	SYM
cord-005453-4057qib7	5099	5	34	34	CD
cord-005453-4057qib7	5099	6	)	)	-RRB-
cord-005453-4057qib7	5099	7	days	day	NNS
cord-005453-4057qib7	5099	8	.	.	.
cord-005453-4057qib7	5100	1	The	the	DT
cord-005453-4057qib7	5100	2	incidences	incidence	NNS
cord-005453-4057qib7	5100	3	of	of	IN
cord-005453-4057qib7	5100	4	CR	cr	NN
cord-005453-4057qib7	5100	5	per	per	IN
cord-005453-4057qib7	5100	6	organ	organ	NN
cord-005453-4057qib7	5100	7	were	be	VBD
cord-005453-4057qib7	5100	8	95.7	95.7	CD
cord-005453-4057qib7	5100	9	%	%	NN
cord-005453-4057qib7	5100	10	,	,	,
cord-005453-4057qib7	5100	11	80.8	80.8	CD
cord-005453-4057qib7	5100	12	%	%	NN
cord-005453-4057qib7	5100	13	,	,	,
cord-005453-4057qib7	5100	14	and	and	CC
cord-005453-4057qib7	5100	15	80	80	CD
cord-005453-4057qib7	5100	16	%	%	NN
cord-005453-4057qib7	5100	17	for	for	IN
cord-005453-4057qib7	5100	18	skin	skin	NN
cord-005453-4057qib7	5100	19	,	,	,
cord-005453-4057qib7	5100	20	liver	liver	NN
cord-005453-4057qib7	5100	21	,	,	,
cord-005453-4057qib7	5100	22	and	and	CC
cord-005453-4057qib7	5100	23	gut	gut	NN
cord-005453-4057qib7	5100	24	,	,	,
cord-005453-4057qib7	5100	25	respectively	respectively	RB
cord-005453-4057qib7	5100	26	.	.	.
cord-005453-4057qib7	5101	1	The	the	DT
cord-005453-4057qib7	5101	2	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5101	3	relapse	relapse	NN
cord-005453-4057qib7	5101	4	rate	rate	NN
cord-005453-4057qib7	5101	5	was	be	VBD
cord-005453-4057qib7	5101	6	analyzed	analyze	VBN
cord-005453-4057qib7	5101	7	for	for	IN
cord-005453-4057qib7	5101	8	the	the	DT
cord-005453-4057qib7	5101	9	patients	patient	NNS
cord-005453-4057qib7	5101	10	who	who	WP
cord-005453-4057qib7	5101	11	had	have	VBD
cord-005453-4057qib7	5101	12	achieved	achieve	VBN
cord-005453-4057qib7	5101	13	CR	CR	NNP
cord-005453-4057qib7	5101	14	or	or	CC
cord-005453-4057qib7	5101	15	PR	PR	NNP
cord-005453-4057qib7	5101	16	and	and	CC
cord-005453-4057qib7	5101	17	survived	survive	VBD
cord-005453-4057qib7	5101	18	beyond	beyond	IN
cord-005453-4057qib7	5101	19	60	60	CD
cord-005453-4057qib7	5101	20	days	day	NNS
cord-005453-4057qib7	5101	21	.	.	.
cord-005453-4057qib7	5102	1	Relapses	relapse	NNS
cord-005453-4057qib7	5102	2	in	in	IN
cord-005453-4057qib7	5102	3	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5102	4	occurred	occur	VBD
cord-005453-4057qib7	5102	5	in	in	IN
cord-005453-4057qib7	5102	6	9.38	9.38	CD
cord-005453-4057qib7	5102	7	%	%	NN
cord-005453-4057qib7	5102	8	(	(	-LRB-
cord-005453-4057qib7	5102	9	3/	3/	CD
cord-005453-4057qib7	5102	10	32	32	CD
cord-005453-4057qib7	5102	11	)	)	-RRB-
cord-005453-4057qib7	5102	12	of	of	IN
cord-005453-4057qib7	5102	13	responsive	responsive	JJ
cord-005453-4057qib7	5102	14	patients	patient	NNS
cord-005453-4057qib7	5102	15	.	.	.
cord-005453-4057qib7	5103	1	The	the	DT
cord-005453-4057qib7	5103	2	patients	patient	NNS
cord-005453-4057qib7	5103	3	who	who	WP
cord-005453-4057qib7	5103	4	received	receive	VBD
cord-005453-4057qib7	5103	5	ruxolitinib	ruxolitinib	NN
cord-005453-4057qib7	5103	6	within	within	IN
cord-005453-4057qib7	5103	7	14	14	CD
cord-005453-4057qib7	5103	8	days	day	NNS
cord-005453-4057qib7	5103	9	after	after	IN
cord-005453-4057qib7	5103	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5103	11	onset	onset	NN
cord-005453-4057qib7	5103	12	have	have	VBP
cord-005453-4057qib7	5103	13	a	a	DT
cord-005453-4057qib7	5103	14	significant	significant	JJ
cord-005453-4057qib7	5103	15	higher	high	JJR
cord-005453-4057qib7	5103	16	CR	cr	NN
cord-005453-4057qib7	5103	17	rate	rate	NN
cord-005453-4057qib7	5103	18	that	that	IN
cord-005453-4057qib7	5103	19	those	those	DT
cord-005453-4057qib7	5103	20	with	with	IN
cord-005453-4057qib7	5103	21	delayed	delay	VBN
cord-005453-4057qib7	5103	22	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	5103	23	therapy	therapy	NN
cord-005453-4057qib7	5103	24	(	(	-LRB-
cord-005453-4057qib7	5103	25	96.2	96.2	CD
cord-005453-4057qib7	5103	26	%	%	NN
cord-005453-4057qib7	5103	27	vs.	vs.	IN
cord-005453-4057qib7	5103	28	42.9	42.9	CD
cord-005453-4057qib7	5103	29	%	%	NN
cord-005453-4057qib7	5103	30	,	,	,
cord-005453-4057qib7	5103	31	p=0.001	p=0.001	NNP
cord-005453-4057qib7	5103	32	)	)	-RRB-
cord-005453-4057qib7	5103	33	.	.	.
cord-005453-4057qib7	5104	1	And	and	CC
cord-005453-4057qib7	5104	2	the	the	DT
cord-005453-4057qib7	5104	3	patients	patient	NNS
cord-005453-4057qib7	5104	4	without	without	IN
cord-005453-4057qib7	5104	5	gut	gut	NN
cord-005453-4057qib7	5104	6	infections	infection	NNS
cord-005453-4057qib7	5104	7	have	have	VBP
cord-005453-4057qib7	5104	8	a	a	DT
cord-005453-4057qib7	5104	9	significant	significant	JJ
cord-005453-4057qib7	5104	10	higher	high	JJR
cord-005453-4057qib7	5104	11	CR	cr	NN
cord-005453-4057qib7	5104	12	rate	rate	NN
cord-005453-4057qib7	5104	13	than	than	IN
cord-005453-4057qib7	5104	14	infected	infected	JJ
cord-005453-4057qib7	5104	15	cohort	cohort	NN
cord-005453-4057qib7	5104	16	(	(	-LRB-
cord-005453-4057qib7	5104	17	92.6	92.6	CD
cord-005453-4057qib7	5104	18	%	%	NN
cord-005453-4057qib7	5104	19	vs.	vs.	IN
cord-005453-4057qib7	5104	20	46.2	46.2	CD
cord-005453-4057qib7	5104	21	%	%	NN
cord-005453-4057qib7	5104	22	,	,	,
cord-005453-4057qib7	5104	23	p=0.002	p=0.002	NNP
cord-005453-4057qib7	5104	24	)	)	-RRB-
cord-005453-4057qib7	5104	25	.	.	.
cord-005453-4057qib7	5105	1	By	by	IN
cord-005453-4057qib7	5105	2	logistic	logistic	JJ
cord-005453-4057qib7	5105	3	regression	regression	NN
cord-005453-4057qib7	5105	4	analysis	analysis	NN
cord-005453-4057qib7	5105	5	,	,	,
cord-005453-4057qib7	5105	6	the	the	DT
cord-005453-4057qib7	5105	7	time	time	NN
cord-005453-4057qib7	5105	8	from	from	IN
cord-005453-4057qib7	5105	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5105	10	to	to	IN
cord-005453-4057qib7	5105	11	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5105	12	(	(	-LRB-
cord-005453-4057qib7	5105	13	RR=4.17	rr=4.17	UH
cord-005453-4057qib7	5105	14	,	,	,
cord-005453-4057qib7	5105	15	p=0.011	p=0.011	NNP
cord-005453-4057qib7	5105	16	)	)	-RRB-
cord-005453-4057qib7	5105	17	and	and	CC
cord-005453-4057qib7	5105	18	gut	gut	VB
cord-005453-4057qib7	5105	19	infection	infection	NN
cord-005453-4057qib7	5105	20	(	(	-LRB-
cord-005453-4057qib7	5105	21	RR=3.31	RR=3.31	NNS
cord-005453-4057qib7	5105	22	,	,	,
cord-005453-4057qib7	5105	23	p=0.031	p=0.031	NNP
cord-005453-4057qib7	5105	24	)	)	-RRB-
cord-005453-4057qib7	5105	25	were	be	VBD
cord-005453-4057qib7	5105	26	independent	independent	JJ
cord-005453-4057qib7	5105	27	predictors	predictor	NNS
cord-005453-4057qib7	5105	28	for	for	IN
cord-005453-4057qib7	5105	29	incomplete	incomplete	JJ
cord-005453-4057qib7	5105	30	response	response	NN
cord-005453-4057qib7	5105	31	.	.	.
cord-005453-4057qib7	5106	1	Thirteen	thirteen	CD
cord-005453-4057qib7	5106	2	patients	patient	NNS
cord-005453-4057qib7	5106	3	(	(	-LRB-
cord-005453-4057qib7	5106	4	13/40	13/40	CD
cord-005453-4057qib7	5106	5	,	,	,
cord-005453-4057qib7	5106	6	32.5	32.5	CD
cord-005453-4057qib7	5106	7	%	%	NN
cord-005453-4057qib7	5106	8	)	)	-RRB-
cord-005453-4057qib7	5106	9	suffered	suffer	VBD
cord-005453-4057qib7	5106	10	from	from	IN
cord-005453-4057qib7	5106	11	at	at	RB
cord-005453-4057qib7	5106	12	least	least	JJS
cord-005453-4057qib7	5106	13	1	1	CD
cord-005453-4057qib7	5106	14	infectious	infectious	JJ
cord-005453-4057qib7	5106	15	episode	episode	NN
cord-005453-4057qib7	5106	16	after	after	IN
cord-005453-4057qib7	5106	17	the	the	DT
cord-005453-4057qib7	5106	18	start	start	NN
cord-005453-4057qib7	5106	19	of	of	IN
cord-005453-4057qib7	5106	20	the	the	DT
cord-005453-4057qib7	5106	21	combination	combination	NN
cord-005453-4057qib7	5106	22	therapy	therapy	NN
cord-005453-4057qib7	5106	23	,	,	,
cord-005453-4057qib7	5106	24	and	and	CC
cord-005453-4057qib7	5106	25	pulmonary	pulmonary	JJ
cord-005453-4057qib7	5106	26	infectious	infectious	JJ
cord-005453-4057qib7	5106	27	diseases	disease	NNS
cord-005453-4057qib7	5106	28	was	be	VBD
cord-005453-4057qib7	5106	29	a	a	DT
cord-005453-4057qib7	5106	30	frequent	frequent	JJ
cord-005453-4057qib7	5106	31	complication	complication	NN
cord-005453-4057qib7	5106	32	(	(	-LRB-
cord-005453-4057qib7	5106	33	9/40	9/40	CD
cord-005453-4057qib7	5106	34	,	,	,
cord-005453-4057qib7	5106	35	22.5	22.5	CD
cord-005453-4057qib7	5106	36	%	%	NN
cord-005453-4057qib7	5106	37	)	)	-RRB-
cord-005453-4057qib7	5106	38	.	.	.
cord-005453-4057qib7	5107	1	III	III	NNP
cord-005453-4057qib7	5107	2	-	-	HYPH
cord-005453-4057qib7	5107	3	IV	IV	NNP
cord-005453-4057qib7	5107	4	Cytopenia	Cytopenia	NNP
cord-005453-4057qib7	5107	5	and	and	CC
cord-005453-4057qib7	5107	6	CMVreactivation	CMVreactivation	NNP
cord-005453-4057qib7	5107	7	were	be	VBD
cord-005453-4057qib7	5107	8	observed	observe	VBN
cord-005453-4057qib7	5107	9	in	in	IN
cord-005453-4057qib7	5107	10	30	30	CD
cord-005453-4057qib7	5107	11	%	%	NN
cord-005453-4057qib7	5107	12	and	and	CC
cord-005453-4057qib7	5107	13	47.5	47.5	CD
cord-005453-4057qib7	5107	14	%	%	NN
cord-005453-4057qib7	5107	15	of	of	IN
cord-005453-4057qib7	5107	16	patients	patient	NNS
cord-005453-4057qib7	5107	17	.	.	.
cord-005453-4057qib7	5108	1	The	the	DT
cord-005453-4057qib7	5108	2	1-year	1-year	CD
cord-005453-4057qib7	5108	3	overall	overall	JJ
cord-005453-4057qib7	5108	4	survival	survival	NN
cord-005453-4057qib7	5108	5	(	(	-LRB-
cord-005453-4057qib7	5108	6	OS	OS	NNP
cord-005453-4057qib7	5108	7	)	)	-RRB-
cord-005453-4057qib7	5108	8	after	after	IN
cord-005453-4057qib7	5108	9	initiation	initiation	NN
cord-005453-4057qib7	5108	10	of	of	IN
cord-005453-4057qib7	5108	11	the	the	DT
cord-005453-4057qib7	5108	12	combination	combination	NN
cord-005453-4057qib7	5108	13	therapy	therapy	NN
cord-005453-4057qib7	5108	14	were	be	VBD
cord-005453-4057qib7	5108	15	76.8	76.8	CD
cord-005453-4057qib7	5108	16	%	%	NN
cord-005453-4057qib7	5108	17	.	.	.
cord-005453-4057qib7	5109	1	The	the	DT
cord-005453-4057qib7	5109	2	1-year	1-year	CD
cord-005453-4057qib7	5109	3	NRM	NRM	NNP
cord-005453-4057qib7	5109	4	and	and	CC
cord-005453-4057qib7	5109	5	relapse	relapse	NN
cord-005453-4057qib7	5109	6	incidence	incidence	NN
cord-005453-4057qib7	5109	7	was	be	VBD
cord-005453-4057qib7	5109	8	17.9	17.9	CD
cord-005453-4057qib7	5109	9	%	%	NN
cord-005453-4057qib7	5109	10	and	and	CC
cord-005453-4057qib7	5109	11	19.9	19.9	CD
cord-005453-4057qib7	5109	12	%	%	NN
cord-005453-4057qib7	5109	13	,	,	,
cord-005453-4057qib7	5109	14	respectively	respectively	RB
cord-005453-4057qib7	5109	15	.	.	.
cord-005453-4057qib7	5110	1	Patients	patient	NNS
cord-005453-4057qib7	5110	2	with	with	IN
cord-005453-4057qib7	5110	3	complete	complete	JJ
cord-005453-4057qib7	5110	4	response	response	NN
cord-005453-4057qib7	5110	5	on	on	IN
cord-005453-4057qib7	5110	6	day	day	NN
cord-005453-4057qib7	5110	7	30	30	CD
cord-005453-4057qib7	5110	8	had	have	VBD
cord-005453-4057qib7	5110	9	significantly	significantly	RB
cord-005453-4057qib7	5110	10	higher	high	JJR
cord-005453-4057qib7	5110	11	OS	OS	NNP
cord-005453-4057qib7	5110	12	probability	probability	NN
cord-005453-4057qib7	5110	13	than	than	IN
cord-005453-4057qib7	5110	14	non	non	JJ
cord-005453-4057qib7	5110	15	-	-	JJ
cord-005453-4057qib7	5110	16	CR	cr	JJ
cord-005453-4057qib7	5110	17	patients	patient	NNS
cord-005453-4057qib7	5110	18	(	(	-LRB-
cord-005453-4057qib7	5110	19	1-year	1-year	CD
cord-005453-4057qib7	5110	20	OS	os	NN
cord-005453-4057qib7	5110	21	:	:	:
cord-005453-4057qib7	5110	22	86.1	86.1	CD
cord-005453-4057qib7	5110	23	%	%	NN
cord-005453-4057qib7	5110	24	vs	vs	IN
cord-005453-4057qib7	5110	25	48.0	48.0	CD
cord-005453-4057qib7	5110	26	%	%	NN
cord-005453-4057qib7	5110	27	,	,	,
cord-005453-4057qib7	5110	28	p=0.01	p=0.01	NNP
cord-005453-4057qib7	5110	29	)	)	-RRB-
cord-005453-4057qib7	5110	30	.	.	.
cord-005453-4057qib7	5111	1	Compared	compare	VBN
cord-005453-4057qib7	5111	2	with	with	IN
cord-005453-4057qib7	5111	3	the	the	DT
cord-005453-4057qib7	5111	4	historical	historical	JJ
cord-005453-4057qib7	5111	5	cohort	cohort	NN
cord-005453-4057qib7	5111	6	of	of	IN
cord-005453-4057qib7	5111	7	basiliximab	basiliximab	NNP
cord-005453-4057qib7	5111	8	and	and	CC
cord-005453-4057qib7	5111	9	etanercept	etanercept	NNP
cord-005453-4057qib7	5111	10	for	for	IN
cord-005453-4057qib7	5111	11	SR	SR	NNP
cord-005453-4057qib7	5111	12	-	-	HYPH
cord-005453-4057qib7	5111	13	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5111	14	in	in	IN
cord-005453-4057qib7	5111	15	our	-PRON-	PRP$
cord-005453-4057qib7	5111	16	center	center	NN
cord-005453-4057qib7	5111	17	(	(	-LRB-
cord-005453-4057qib7	5111	18	n=31	n=31	NNP
cord-005453-4057qib7	5111	19	)	)	-RRB-
cord-005453-4057qib7	5111	20	,	,	,
cord-005453-4057qib7	5111	21	no	no	DT
cord-005453-4057qib7	5111	22	significant	significant	JJ
cord-005453-4057qib7	5111	23	difference	difference	NN
cord-005453-4057qib7	5111	24	was	be	VBD
cord-005453-4057qib7	5111	25	found	find	VBN
cord-005453-4057qib7	5111	26	on	on	IN
cord-005453-4057qib7	5111	27	the	the	DT
cord-005453-4057qib7	5111	28	baseline	baseline	NN
cord-005453-4057qib7	5111	29	.	.	.
cord-005453-4057qib7	5112	1	Although	although	IN
cord-005453-4057qib7	5112	2	the	the	DT
cord-005453-4057qib7	5112	3	ORR	ORR	NNP
cord-005453-4057qib7	5112	4	in	in	IN
cord-005453-4057qib7	5112	5	patients	patient	NNS
cord-005453-4057qib7	5112	6	treated	treat	VBN
cord-005453-4057qib7	5112	7	with	with	IN
cord-005453-4057qib7	5112	8	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5112	9	and	and	CC
cord-005453-4057qib7	5112	10	etanercept	etanercept	NNP
cord-005453-4057qib7	5112	11	is	be	VBZ
cord-005453-4057qib7	5112	12	identical	identical	JJ
cord-005453-4057qib7	5112	13	with	with	IN
cord-005453-4057qib7	5112	14	the	the	DT
cord-005453-4057qib7	5112	15	historical	historical	JJ
cord-005453-4057qib7	5112	16	cohort	cohort	NN
cord-005453-4057qib7	5112	17	,	,	,
cord-005453-4057qib7	5112	18	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5112	19	group	group	NN
cord-005453-4057qib7	5112	20	achieved	achieve	VBD
cord-005453-4057qib7	5112	21	rapider	rapider	NN
cord-005453-4057qib7	5112	22	remissions	remission	NNS
cord-005453-4057qib7	5112	23	in	in	IN
cord-005453-4057qib7	5112	24	liver	liver	NN
cord-005453-4057qib7	5112	25	aGVHD	agvhd	NN
cord-005453-4057qib7	5112	26	and	and	CC
cord-005453-4057qib7	5112	27	gut	gut	VB
cord-005453-4057qib7	5112	28	aGVHD	agvhd	NN
cord-005453-4057qib7	5112	29	than	than	IN
cord-005453-4057qib7	5112	30	the	the	DT
cord-005453-4057qib7	5112	31	historical	historical	JJ
cord-005453-4057qib7	5112	32	cohort	cohort	NN
cord-005453-4057qib7	5112	33	(	(	-LRB-
cord-005453-4057qib7	5112	34	gut	gut	VB
cord-005453-4057qib7	5112	35	aGVHD	agvhd	NN
cord-005453-4057qib7	5112	36	:	:	:
cord-005453-4057qib7	5113	1	11	11	CD
cord-005453-4057qib7	5113	2	days	day	NNS
cord-005453-4057qib7	5113	3	vs.	vs.	IN
cord-005453-4057qib7	5113	4	17	17	CD
cord-005453-4057qib7	5113	5	days	day	NNS
cord-005453-4057qib7	5113	6	,	,	,
cord-005453-4057qib7	5113	7	p=0.026	p=0.026	NN
cord-005453-4057qib7	5113	8	;	;	:
cord-005453-4057qib7	5113	9	liver	liver	NNP
cord-005453-4057qib7	5113	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5113	11	:	:	:
cord-005453-4057qib7	5113	12	21	21	CD
cord-005453-4057qib7	5113	13	days	day	NNS
cord-005453-4057qib7	5113	14	vs.	vs.	IN
cord-005453-4057qib7	5113	15	28	28	CD
cord-005453-4057qib7	5113	16	days	day	NNS
cord-005453-4057qib7	5113	17	,	,	,
cord-005453-4057qib7	5113	18	p=0.039	p=0.039	NNP
cord-005453-4057qib7	5113	19	)	)	-RRB-
cord-005453-4057qib7	5113	20	,	,	.
cord-005453-4057qib7	5114	1	Thus	thus	RB
cord-005453-4057qib7	5114	2	,	,	,
cord-005453-4057qib7	5114	3	with	with	IN
cord-005453-4057qib7	5114	4	regard	regard	NN
cord-005453-4057qib7	5114	5	to	to	IN
cord-005453-4057qib7	5114	6	hospital	hospital	NN
cord-005453-4057qib7	5114	7	stay	stay	NN
cord-005453-4057qib7	5114	8	after	after	IN
cord-005453-4057qib7	5114	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5114	10	onset	onset	NN
cord-005453-4057qib7	5114	11	,	,	,
cord-005453-4057qib7	5114	12	the	the	DT
cord-005453-4057qib7	5114	13	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5114	14	cohort	cohort	NN
cord-005453-4057qib7	5114	15	stayed	stay	VBD
cord-005453-4057qib7	5114	16	shorter	short	JJR
cord-005453-4057qib7	5114	17	(	(	-LRB-
cord-005453-4057qib7	5114	18	median	median	NN
cord-005453-4057qib7	5114	19	:	:	:
cord-005453-4057qib7	5114	20	18	18	CD
cord-005453-4057qib7	5114	21	days	day	NNS
cord-005453-4057qib7	5114	22	vs.	vs.	IN
cord-005453-4057qib7	5114	23	29	29	CD
cord-005453-4057qib7	5114	24	days	day	NNS
cord-005453-4057qib7	5114	25	,	,	,
cord-005453-4057qib7	5114	26	p=0.005	p=0.005	NNP
cord-005453-4057qib7	5114	27	)	)	-RRB-
cord-005453-4057qib7	5114	28	than	than	IN
cord-005453-4057qib7	5114	29	basiliximab	basiliximab	NNP
cord-005453-4057qib7	5114	30	cohort	cohort	NN
cord-005453-4057qib7	5114	31	.	.	.
cord-005453-4057qib7	5115	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5115	2	:	:	:
cord-005453-4057qib7	5116	1	Combined	combine	VBN
cord-005453-4057qib7	5116	2	treatment	treatment	NN
cord-005453-4057qib7	5116	3	with	with	IN
cord-005453-4057qib7	5116	4	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5116	5	and	and	CC
cord-005453-4057qib7	5116	6	etanercept	etanercept	NNP
cord-005453-4057qib7	5116	7	resulted	result	VBD
cord-005453-4057qib7	5116	8	in	in	IN
cord-005453-4057qib7	5116	9	a	a	DT
cord-005453-4057qib7	5116	10	rapid	rapid	JJ
cord-005453-4057qib7	5116	11	CR	cr	NN
cord-005453-4057qib7	5116	12	to	to	IN
cord-005453-4057qib7	5116	13	visceral	visceral	JJ
cord-005453-4057qib7	5116	14	aGVHD	agvhd	NN
cord-005453-4057qib7	5117	1	and	and	CC
cord-005453-4057qib7	5117	2	meanwhile	meanwhile	RB
cord-005453-4057qib7	5117	3	reserve	reserve	VB
cord-005453-4057qib7	5117	4	graft	graft	NN
cord-005453-4057qib7	5117	5	anti	anti	NN
cord-005453-4057qib7	5117	6	-	-	JJ
cord-005453-4057qib7	5117	7	leukemia	leukemia	JJ
cord-005453-4057qib7	5117	8	(	(	-LRB-
cord-005453-4057qib7	5117	9	GVL	gvl	NN
cord-005453-4057qib7	5117	10	)	)	-RRB-
cord-005453-4057qib7	5117	11	effect	effect	NN
cord-005453-4057qib7	5117	12	as	as	IN
cord-005453-4057qib7	5117	13	the	the	DT
cord-005453-4057qib7	5117	14	relapse	relapse	NN
cord-005453-4057qib7	5117	15	rate	rate	NN
cord-005453-4057qib7	5117	16	of	of	IN
cord-005453-4057qib7	5117	17	primary	primary	JJ
cord-005453-4057qib7	5117	18	disease	disease	NN
cord-005453-4057qib7	5117	19	is	be	VBZ
cord-005453-4057qib7	5117	20	relatively	relatively	RB
cord-005453-4057qib7	5117	21	lower	low	JJR
cord-005453-4057qib7	5117	22	.	.	.
cord-005453-4057qib7	5118	1	The	the	DT
cord-005453-4057qib7	5118	2	various	various	JJ
cord-005453-4057qib7	5118	3	infection	infection	NN
cord-005453-4057qib7	5118	4	complications	complication	NNS
cord-005453-4057qib7	5118	5	associated	associate	VBN
cord-005453-4057qib7	5118	6	with	with	IN
cord-005453-4057qib7	5118	7	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	5118	8	merit	merit	NN
cord-005453-4057qib7	5118	9	more	more	JJR
cord-005453-4057qib7	5118	10	attention	attention	NN
cord-005453-4057qib7	5118	11	.	.	.
cord-005453-4057qib7	5119	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5119	2	:	:	:
cord-005453-4057qib7	5119	3	Nothing	nothing	NN
cord-005453-4057qib7	5119	4	to	to	TO
cord-005453-4057qib7	5119	5	declare	declare	VB
cord-005453-4057qib7	5119	6	Background	background	NN
cord-005453-4057qib7	5119	7	:	:	:
cord-005453-4057qib7	5119	8	Graft	graft	NN
cord-005453-4057qib7	5119	9	-	-	HYPH
cord-005453-4057qib7	5119	10	versus	versus	IN
cord-005453-4057qib7	5119	11	-	-	HYPH
cord-005453-4057qib7	5119	12	host	host	NN
cord-005453-4057qib7	5119	13	disease	disease	NN
cord-005453-4057qib7	5119	14	(	(	-LRB-
cord-005453-4057qib7	5119	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5119	16	)	)	-RRB-
cord-005453-4057qib7	5119	17	remains	remain	VBZ
cord-005453-4057qib7	5119	18	one	one	CD
cord-005453-4057qib7	5119	19	of	of	IN
cord-005453-4057qib7	5119	20	the	the	DT
cord-005453-4057qib7	5119	21	main	main	JJ
cord-005453-4057qib7	5119	22	life	life	NN
cord-005453-4057qib7	5119	23	-	-	HYPH
cord-005453-4057qib7	5119	24	threatening	threaten	VBG
cord-005453-4057qib7	5119	25	complications	complication	NNS
cord-005453-4057qib7	5119	26	after	after	IN
cord-005453-4057qib7	5119	27	allo	allo	NN
cord-005453-4057qib7	5119	28	-	-	HYPH
cord-005453-4057qib7	5119	29	HSCT	HSCT	NNP
cord-005453-4057qib7	5119	30	,	,	,
cord-005453-4057qib7	5119	31	especially	especially	RB
cord-005453-4057qib7	5119	32	in	in	IN
cord-005453-4057qib7	5119	33	patients	patient	NNS
cord-005453-4057qib7	5119	34	with	with	IN
cord-005453-4057qib7	5119	35	non	non	JJ
cord-005453-4057qib7	5119	36	-	-	JJ
cord-005453-4057qib7	5119	37	malignant	malignant	JJ
cord-005453-4057qib7	5119	38	diseases	disease	NNS
cord-005453-4057qib7	5119	39	.	.	.
cord-005453-4057qib7	5120	1	The	the	DT
cord-005453-4057qib7	5120	2	standard	standard	JJ
cord-005453-4057qib7	5120	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5120	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5120	5	strategy	strategy	NN
cord-005453-4057qib7	5120	6	is	be	VBZ
cord-005453-4057qib7	5120	7	mostly	mostly	RB
cord-005453-4057qib7	5120	8	based	base	VBN
cord-005453-4057qib7	5120	9	on	on	IN
cord-005453-4057qib7	5120	10	the	the	DT
cord-005453-4057qib7	5120	11	use	use	NN
cord-005453-4057qib7	5120	12	of	of	IN
cord-005453-4057qib7	5120	13	calcineurin	calcineurin	NN
cord-005453-4057qib7	5120	14	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5120	15	alone	alone	RB
cord-005453-4057qib7	5120	16	or	or	CC
cord-005453-4057qib7	5120	17	in	in	IN
cord-005453-4057qib7	5120	18	combination	combination	NN
cord-005453-4057qib7	5120	19	with	with	IN
cord-005453-4057qib7	5120	20	other	other	JJ
cord-005453-4057qib7	5120	21	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5121	1	(	(	-LRB-
cord-005453-4057qib7	5121	2	IS	be	VBZ
cord-005453-4057qib7	5121	3	)	)	-RRB-
cord-005453-4057qib7	5121	4	Post	post	JJ
cord-005453-4057qib7	5121	5	-	-	NN
cord-005453-4057qib7	5121	6	transplant	transplant	NN
cord-005453-4057qib7	5121	7	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	5121	8	(	(	-LRB-
cord-005453-4057qib7	5121	9	PTCy	PTCy	NNP
cord-005453-4057qib7	5121	10	)	)	-RRB-
cord-005453-4057qib7	5121	11	is	be	VBZ
cord-005453-4057qib7	5121	12	effective	effective	JJ
cord-005453-4057qib7	5121	13	GVHD	GVHD	NNP
cord-005453-4057qib7	5121	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5121	15	optiont	optiont	NN
cord-005453-4057qib7	5121	16	for	for	IN
cord-005453-4057qib7	5121	17	adult	adult	NN
cord-005453-4057qib7	5121	18	patients	patient	NNS
cord-005453-4057qib7	5121	19	(	(	-LRB-
cord-005453-4057qib7	5121	20	pts	pts	NNP
cord-005453-4057qib7	5121	21	)	)	-RRB-
cord-005453-4057qib7	5121	22	,	,	,
cord-005453-4057qib7	5121	23	but	but	CC
cord-005453-4057qib7	5121	24	has	have	VBZ
cord-005453-4057qib7	5121	25	limited	limit	VBN
cord-005453-4057qib7	5121	26	data	datum	NNS
cord-005453-4057qib7	5121	27	in	in	IN
cord-005453-4057qib7	5121	28	children	child	NNS
cord-005453-4057qib7	5121	29	.	.	.
cord-005453-4057qib7	5122	1	Methods	method	NNS
cord-005453-4057qib7	5122	2	:	:	:
cord-005453-4057qib7	5123	1	The	the	DT
cord-005453-4057qib7	5123	2	study	study	NN
cord-005453-4057qib7	5123	3	aim	aim	NN
cord-005453-4057qib7	5123	4	was	be	VBD
cord-005453-4057qib7	5123	5	to	to	TO
cord-005453-4057qib7	5123	6	evaluate	evaluate	VB
cord-005453-4057qib7	5123	7	PTCy	PTCy	NNS
cord-005453-4057qib7	5123	8	as	as	IN
cord-005453-4057qib7	5123	9	GVHD	GVHD	NNP
cord-005453-4057qib7	5123	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5123	11	in	in	IN
cord-005453-4057qib7	5123	12	pediatric	pediatric	JJ
cord-005453-4057qib7	5123	13	pts	pts	NN
cord-005453-4057qib7	5123	14	with	with	IN
cord-005453-4057qib7	5123	15	inherited	inherit	VBN
cord-005453-4057qib7	5123	16	disorders	disorder	NNS
cord-005453-4057qib7	5123	17	undergoing	undergo	VBG
cord-005453-4057qib7	5123	18	allo	allo	NN
cord-005453-4057qib7	5123	19	-	-	HYPH
cord-005453-4057qib7	5123	20	HSCT	HSCT	NNP
cord-005453-4057qib7	5123	21	.	.	.
cord-005453-4057qib7	5124	1	96	96	CD
cord-005453-4057qib7	5124	2	pts	pt	NNS
cord-005453-4057qib7	5124	3	,	,	,
cord-005453-4057qib7	5124	4	the	the	DT
cord-005453-4057qib7	5124	5	most	most	JJS
cord-005453-4057qib7	5124	6	of	of	IN
cord-005453-4057qib7	5124	7	them	-PRON-	PRP
cord-005453-4057qib7	5124	8	are	be	VBP
cord-005453-4057qib7	5124	9	pediatric	pediatric	JJ
cord-005453-4057qib7	5124	10	age	age	NN
cord-005453-4057qib7	5124	11	(	(	-LRB-
cord-005453-4057qib7	5124	12	median	median	JJ
cord-005453-4057qib7	5124	13	age	age	NN
cord-005453-4057qib7	5124	14	-3	-3	NNP
cord-005453-4057qib7	5125	1	y.o	y.o	NNP
cord-005453-4057qib7	5125	2	.	.	NNP
cord-005453-4057qib7	5125	3	,	,	,
cord-005453-4057qib7	5125	4	range	range	NNP
cord-005453-4057qib7	5125	5	7	7	CD
cord-005453-4057qib7	5125	6	month	month	NN
cord-005453-4057qib7	5126	1	-30	-30	NNP
cord-005453-4057qib7	5127	1	y.o	y.o	NNP
cord-005453-4057qib7	5127	2	.	.	NNP
cord-005453-4057qib7	5127	3	)	)	-RRB-
cord-005453-4057qib7	5128	1	with	with	IN
cord-005453-4057qib7	5128	2	different	different	JJ
cord-005453-4057qib7	5128	3	types	type	NNS
cord-005453-4057qib7	5128	4	inherited	inherit	VBN
cord-005453-4057qib7	5128	5	disorders	disorder	NNS
cord-005453-4057qib7	5128	6	(	(	-LRB-
cord-005453-4057qib7	5128	7	β	β	NN
cord-005453-4057qib7	5128	8	-	-	HYPH
cord-005453-4057qib7	5128	9	thalassemia	thalassemia	NN
cord-005453-4057qib7	5128	10	-10	-10	NN
cord-005453-4057qib7	5128	11	,	,	,
cord-005453-4057qib7	5128	12	bone	bone	NN
cord-005453-4057qib7	5128	13	marrow	marrow	NN
cord-005453-4057qib7	5128	14	failure	failure	NN
cord-005453-4057qib7	5128	15	syndromes	syndrome	NNS
cord-005453-4057qib7	5128	16	-26	-26	CD
cord-005453-4057qib7	5128	17	,	,	,
cord-005453-4057qib7	5128	18	storage	storage	NN
cord-005453-4057qib7	5128	19	diseases	disease	NNS
cord-005453-4057qib7	5128	20	-46	-46	NN
cord-005453-4057qib7	5128	21	,	,	,
cord-005453-4057qib7	5128	22	primary	primary	JJ
cord-005453-4057qib7	5128	23	immunodeficiencydisorders	immunodeficiencydisorder	NNS
cord-005453-4057qib7	5128	24	-14	-14	CD
cord-005453-4057qib7	5128	25	)	)	-RRB-
cord-005453-4057qib7	5128	26	were	be	VBD
cord-005453-4057qib7	5128	27	inrolled	inrolle	VBN
cord-005453-4057qib7	5128	28	in	in	IN
cord-005453-4057qib7	5128	29	retrospective	retrospective	JJ
cord-005453-4057qib7	5128	30	study	study	NN
cord-005453-4057qib7	5128	31	.	.	.
cord-005453-4057qib7	5129	1	Donor	donor	NN
cord-005453-4057qib7	5129	2	type	type	NN
cord-005453-4057qib7	5129	3	was	be	VBD
cord-005453-4057qib7	5129	4	:	:	:
cord-005453-4057qib7	5129	5	matched	match	VBN
cord-005453-4057qib7	5129	6	/	/	SYM
cord-005453-4057qib7	5129	7	mismatched	mismatch	VBN
cord-005453-4057qib7	5129	8	unrelated	unrelated	JJ
cord-005453-4057qib7	5129	9	(	(	-LRB-
cord-005453-4057qib7	5129	10	MUD	mud	NN
cord-005453-4057qib7	5129	11	/	/	SYM
cord-005453-4057qib7	5129	12	MMUD	MMUD	NNP
cord-005453-4057qib7	5129	13	)	)	-RRB-
cord-005453-4057qib7	5129	14	-69	-69	NNP
cord-005453-4057qib7	5129	15	,	,	,
cord-005453-4057qib7	5129	16	matched	match	VBD
cord-005453-4057qib7	5129	17	related	related	JJ
cord-005453-4057qib7	5129	18	donor	donor	NN
cord-005453-4057qib7	5129	19	(	(	-LRB-
cord-005453-4057qib7	5129	20	MRD)-15	MRD)-15	NNP
cord-005453-4057qib7	5129	21	,	,	,
cord-005453-4057qib7	5129	22	haploidentical	haploidentical	NNP
cord-005453-4057qib7	5129	23	(	(	-LRB-
cord-005453-4057qib7	5129	24	haplo	haplo	NNP
cord-005453-4057qib7	5129	25	)	)	-RRB-
cord-005453-4057qib7	5129	26	-12	-12	CD
cord-005453-4057qib7	5129	27	.	.	.
cord-005453-4057qib7	5130	1	Conditioning	conditioning	NN
cord-005453-4057qib7	5130	2	regimen	regimen	NN
cord-005453-4057qib7	5130	3	was	be	VBD
cord-005453-4057qib7	5130	4	:	:	:
cord-005453-4057qib7	5130	5	myeloablative	myeloablative	NNP
cord-005453-4057qib7	5130	6	(	(	-LRB-
cord-005453-4057qib7	5130	7	MAC	MAC	NNP
cord-005453-4057qib7	5130	8	)	)	-RRB-
cord-005453-4057qib7	5130	9	-43	-43	NN
cord-005453-4057qib7	5130	10	,	,	,
cord-005453-4057qib7	5131	1	reduce	reduce	VB
cord-005453-4057qib7	5131	2	-	-	HYPH
cord-005453-4057qib7	5131	3	intensity	intensity	NN
cord-005453-4057qib7	5131	4	(	(	-LRB-
cord-005453-4057qib7	5131	5	RIC	RIC	NNP
cord-005453-4057qib7	5131	6	)	)	-RRB-
cord-005453-4057qib7	5131	7	-53	-53	NNP
cord-005453-4057qib7	5131	8	.	.	.
cord-005453-4057qib7	5132	1	Graft	graft	NN
cord-005453-4057qib7	5132	2	sourse	sourse	NN
cord-005453-4057qib7	5132	3	was	be	VBD
cord-005453-4057qib7	5132	4	:	:	:
cord-005453-4057qib7	5132	5	bone	bone	NN
cord-005453-4057qib7	5132	6	marrow	marrow	NN
cord-005453-4057qib7	5132	7	(	(	-LRB-
cord-005453-4057qib7	5132	8	BM	BM	NNP
cord-005453-4057qib7	5132	9	)	)	-RRB-
cord-005453-4057qib7	5132	10	-68	-68	NNP
cord-005453-4057qib7	5132	11	,	,	,
cord-005453-4057qib7	5132	12	peripheral	peripheral	JJ
cord-005453-4057qib7	5132	13	blood	blood	NN
cord-005453-4057qib7	5132	14	stem	stem	NN
cord-005453-4057qib7	5132	15	cells	cell	NNS
cord-005453-4057qib7	5132	16	(	(	-LRB-
cord-005453-4057qib7	5132	17	PBSC	PBSC	NNP
cord-005453-4057qib7	5132	18	)	)	-RRB-
cord-005453-4057qib7	5132	19	-26	-26	CD
cord-005453-4057qib7	5132	20	,	,	,
cord-005453-4057qib7	5132	21	combintions	combintion	NNS
cord-005453-4057qib7	5132	22	BM	BM	NNP
cord-005453-4057qib7	5132	23	+	+	CC
cord-005453-4057qib7	5132	24	PBSC	PBSC	NNP
cord-005453-4057qib7	5132	25	/	/	SYM
cord-005453-4057qib7	5132	26	BM+cord	BM+cord	NNP
cord-005453-4057qib7	5132	27	blood	blood	NN
cord-005453-4057qib7	5132	28	-2	-2	CD
cord-005453-4057qib7	5132	29	.	.	.
cord-005453-4057qib7	5133	1	PTCy	PTCy	NNS
cord-005453-4057qib7	5133	2	50	50	CD
cord-005453-4057qib7	5134	1	mg	mg	NNP
cord-005453-4057qib7	5134	2	/	/	SYM
cord-005453-4057qib7	5134	3	kg	kg	NNP
cord-005453-4057qib7	5134	4	days	day	NNS
cord-005453-4057qib7	5134	5	+3	+3	NNP
cord-005453-4057qib7	5134	6	,	,	,
cord-005453-4057qib7	5134	7	+4	+4	FW
cord-005453-4057qib7	5134	8	based	base	VBN
cord-005453-4057qib7	5134	9	GVHD	GVHD	NNP
cord-005453-4057qib7	5134	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5134	11	recived	recive	VBD
cord-005453-4057qib7	5134	12	33	33	CD
cord-005453-4057qib7	5134	13	pts	pt	NNS
cord-005453-4057qib7	5134	14	.	.	.
cord-005453-4057qib7	5135	1	,	,	,
cord-005453-4057qib7	5135	2	standart	standart	NNP
cord-005453-4057qib7	5135	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5135	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5135	5	based	base	VBN
cord-005453-4057qib7	5135	6	on	on	IN
cord-005453-4057qib7	5135	7	calcineurin	calcineurin	NNP
cord-005453-4057qib7	5135	8	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5135	9	-63	-63	NNP
cord-005453-4057qib7	5135	10	pts	pt	NNS
cord-005453-4057qib7	5135	11	.	.	.
cord-005453-4057qib7	5136	1	Results	result	NNS
cord-005453-4057qib7	5136	2	:	:	:
cord-005453-4057qib7	5137	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	5137	2	incidence	incidence	NN
cord-005453-4057qib7	5137	3	(	(	-LRB-
cord-005453-4057qib7	5137	4	CI	CI	NNP
cord-005453-4057qib7	5137	5	)	)	-RRB-
cord-005453-4057qib7	5137	6	of	of	IN
cord-005453-4057qib7	5137	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5137	8	was	be	VBD
cord-005453-4057qib7	5137	9	48	48	CD
cord-005453-4057qib7	5137	10	%	%	NN
cord-005453-4057qib7	5137	11	.	.	.
cord-005453-4057qib7	5138	1	Grade	grade	NN
cord-005453-4057qib7	5138	2	2	2	CD
cord-005453-4057qib7	5138	3	-	-	SYM
cord-005453-4057qib7	5138	4	4	4	CD
cord-005453-4057qib7	5138	5	,	,	,
cord-005453-4057qib7	5138	6	3	3	CD
cord-005453-4057qib7	5138	7	-	-	SYM
cord-005453-4057qib7	5138	8	4	4	CD
cord-005453-4057qib7	5138	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5138	10	were	be	VBD
cord-005453-4057qib7	5138	11	40	40	CD
cord-005453-4057qib7	5138	12	%	%	NN
cord-005453-4057qib7	5138	13	and	and	CC
cord-005453-4057qib7	5138	14	22	22	CD
cord-005453-4057qib7	5138	15	%	%	NN
cord-005453-4057qib7	5138	16	respectively	respectively	RB
cord-005453-4057qib7	5138	17	.	.	.
cord-005453-4057qib7	5139	1	PTCy	PTCy	NNP
cord-005453-4057qib7	5139	2	based	base	VBN
cord-005453-4057qib7	5139	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5139	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5139	5	reduced	reduce	VBN
cord-005453-4057qib7	5139	6	CI	CI	NNP
cord-005453-4057qib7	5139	7	of	of	IN
cord-005453-4057qib7	5139	8	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5139	9	(	(	-LRB-
cord-005453-4057qib7	5139	10	35	35	CD
cord-005453-4057qib7	5139	11	%	%	NN
cord-005453-4057qib7	5139	12	vs	vs	IN
cord-005453-4057qib7	5139	13	56	56	CD
cord-005453-4057qib7	5139	14	%	%	NN
cord-005453-4057qib7	5139	15	,	,	,
cord-005453-4057qib7	5139	16	p=0,025	p=0,025	NNP
cord-005453-4057qib7	5139	17	)	)	-RRB-
cord-005453-4057qib7	5139	18	.	.	.
cord-005453-4057qib7	5140	1	Another	another	DT
cord-005453-4057qib7	5140	2	reduce	reduce	NN
cord-005453-4057qib7	5140	3	CI	CI	NNP
cord-005453-4057qib7	5140	4	of	of	IN
cord-005453-4057qib7	5140	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5140	6	factors	factor	NNS
cord-005453-4057qib7	5141	1	were	be	VBD
cord-005453-4057qib7	5141	2	MAC	MAC	NNP
cord-005453-4057qib7	5141	3	(	(	-LRB-
cord-005453-4057qib7	5141	4	31	31	CD
cord-005453-4057qib7	5141	5	%	%	NN
cord-005453-4057qib7	5141	6	vs	vs	IN
cord-005453-4057qib7	5141	7	59	59	CD
cord-005453-4057qib7	5141	8	%	%	NN
cord-005453-4057qib7	5141	9	in	in	IN
cord-005453-4057qib7	5141	10	RIC	RIC	NNP
cord-005453-4057qib7	5141	11	pts	pts	NNP
cord-005453-4057qib7	5141	12	group	group	NN
cord-005453-4057qib7	5141	13	,	,	,
cord-005453-4057qib7	5141	14	p=0,044	p=0,044	NNP
cord-005453-4057qib7	5141	15	)	)	-RRB-
cord-005453-4057qib7	5141	16	,	,	,
cord-005453-4057qib7	5141	17	MRD	MRD	NNP
cord-005453-4057qib7	5141	18	(	(	-LRB-
cord-005453-4057qib7	5141	19	13	13	CD
cord-005453-4057qib7	5141	20	%	%	NN
cord-005453-4057qib7	5141	21	vs	vs	IN
cord-005453-4057qib7	5141	22	44	44	CD
cord-005453-4057qib7	5141	23	%	%	NN
cord-005453-4057qib7	5141	24	in	in	IN
cord-005453-4057qib7	5141	25	haplo	haplo	NNP
cord-005453-4057qib7	5141	26	group	group	NN
cord-005453-4057qib7	5141	27	vs	vs	IN
cord-005453-4057qib7	5141	28	56	56	CD
cord-005453-4057qib7	5141	29	%	%	NN
cord-005453-4057qib7	5141	30	in	in	IN
cord-005453-4057qib7	5141	31	MUD	MUD	NNP
cord-005453-4057qib7	5141	32	/	/	SYM
cord-005453-4057qib7	5141	33	MMUD	MMUD	NNP
cord-005453-4057qib7	5141	34	group	group	NN
cord-005453-4057qib7	5141	35	,	,	,
cord-005453-4057qib7	5141	36	p=0,024	p=0,024	NNP
cord-005453-4057qib7	5141	37	)	)	-RRB-
cord-005453-4057qib7	5141	38	,	,	,
cord-005453-4057qib7	5141	39	BM	BM	NNP
cord-005453-4057qib7	5141	40	as	as	IN
cord-005453-4057qib7	5141	41	a	a	DT
cord-005453-4057qib7	5141	42	transplant	transplant	NN
cord-005453-4057qib7	5141	43	source	source	NN
cord-005453-4057qib7	5141	44	(	(	-LRB-
cord-005453-4057qib7	5141	45	44	44	CD
cord-005453-4057qib7	5141	46	%	%	NN
cord-005453-4057qib7	5141	47	vs	vs	IN
cord-005453-4057qib7	5141	48	62	62	CD
cord-005453-4057qib7	5141	49	%	%	NN
cord-005453-4057qib7	5141	50	in	in	IN
cord-005453-4057qib7	5141	51	PBSC	PBSC	NNP
cord-005453-4057qib7	5141	52	group	group	NN
cord-005453-4057qib7	5141	53	,	,	,
cord-005453-4057qib7	5141	54	p=0,05	p=0,05	NNP
cord-005453-4057qib7	5141	55	)	)	-RRB-
cord-005453-4057qib7	5141	56	.	.	.
cord-005453-4057qib7	5142	1	In	in	IN
cord-005453-4057qib7	5142	2	a	a	DT
cord-005453-4057qib7	5142	3	multivariate	multivariate	JJ
cord-005453-4057qib7	5142	4	analysis	analysis	NN
cord-005453-4057qib7	5142	5	MAC	mac	NN
cord-005453-4057qib7	5143	1	(	(	-LRB-
cord-005453-4057qib7	5143	2	HR	HR	NNP
cord-005453-4057qib7	5143	3	2,6	2,6	CD
cord-005453-4057qib7	5143	4	95%CI	95%ci	CD
cord-005453-4057qib7	5143	5	1,7	1,7	CD
cord-005453-4057qib7	5143	6	-	-	HYPH
cord-005453-4057qib7	5143	7	6	6	CD
cord-005453-4057qib7	5143	8	,	,	,
cord-005453-4057qib7	5143	9	,	,	,
cord-005453-4057qib7	5143	10	p=0,02	p=0,02	NNP
cord-005453-4057qib7	5143	11	)	)	-RRB-
cord-005453-4057qib7	5143	12	,	,	,
cord-005453-4057qib7	5143	13	time	time	NN
cord-005453-4057qib7	5143	14	from	from	IN
cord-005453-4057qib7	5143	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	5143	16	to	to	IN
cord-005453-4057qib7	5143	17	allo	allo	NN
cord-005453-4057qib7	5143	18	-	-	HYPH
cord-005453-4057qib7	5143	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5143	20	less	less	RBR
cord-005453-4057qib7	5143	21	then	then	RB
cord-005453-4057qib7	5143	22	22	22	CD
cord-005453-4057qib7	5143	23	month	month	NN
cord-005453-4057qib7	5143	24	(	(	-LRB-
cord-005453-4057qib7	5143	25	HR	HR	NNP
cord-005453-4057qib7	5143	26	2,6	2,6	CD
cord-005453-4057qib7	5143	27	95%CI	95%ci	CD
cord-005453-4057qib7	5143	28	1,1	1,1	CD
cord-005453-4057qib7	5143	29	-	-	HYPH
cord-005453-4057qib7	5143	30	6,2	6,2	CD
cord-005453-4057qib7	5143	31	,	,	,
cord-005453-4057qib7	5143	32	p=0,03	p=0,03	NNP
cord-005453-4057qib7	5143	33	)	)	-RRB-
cord-005453-4057qib7	5143	34	were	be	VBD
cord-005453-4057qib7	5143	35	predictive	predictive	JJ
cord-005453-4057qib7	5143	36	for	for	IN
cord-005453-4057qib7	5143	37	reducing	reduce	VBG
cord-005453-4057qib7	5143	38	CI	CI	NNP
cord-005453-4057qib7	5143	39	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5143	40	.	.	.
cord-005453-4057qib7	5144	1	For	for	IN
cord-005453-4057qib7	5144	2	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5144	3	2	2	CD
cord-005453-4057qib7	5144	4	-	-	SYM
cord-005453-4057qib7	5144	5	4	4	CD
cord-005453-4057qib7	5144	6	st	st	NNP
cord-005453-4057qib7	5144	7	.	.	NNP
cord-005453-4057qib7	5144	8	significant	significant	JJ
cord-005453-4057qib7	5144	9	factor	factor	NN
cord-005453-4057qib7	5144	10	increase	increase	NN
cord-005453-4057qib7	5145	1	CI	CI	NNP
cord-005453-4057qib7	5145	2	was	be	VBD
cord-005453-4057qib7	5145	3	female	female	JJ
cord-005453-4057qib7	5145	4	donor	donor	NN
cord-005453-4057qib7	5145	5	both	both	CC
cord-005453-4057qib7	5145	6	in	in	IN
cord-005453-4057qib7	5145	7	univariate	univariate	JJ
cord-005453-4057qib7	5145	8	(	(	-LRB-
cord-005453-4057qib7	5145	9	51	51	CD
cord-005453-4057qib7	5145	10	%	%	NN
cord-005453-4057qib7	5145	11	vs	vs	IN
cord-005453-4057qib7	5145	12	34	34	CD
cord-005453-4057qib7	5145	13	%	%	NN
cord-005453-4057qib7	5145	14	,	,	,
cord-005453-4057qib7	5145	15	p=0,04	p=0,04	NNP
cord-005453-4057qib7	5145	16	)	)	-RRB-
cord-005453-4057qib7	5145	17	and	and	CC
cord-005453-4057qib7	5145	18	multivariate	multivariate	JJ
cord-005453-4057qib7	5145	19	analysis	analysis	NN
cord-005453-4057qib7	5145	20	(	(	-LRB-
cord-005453-4057qib7	5146	1	HR	HR	NNP
cord-005453-4057qib7	5146	2	0,7	0,7	CD
cord-005453-4057qib7	5147	1	95%CI	95%ci	CD
cord-005453-4057qib7	5147	2	0,2	0,2	CD
cord-005453-4057qib7	5147	3	-	-	HYPH
cord-005453-4057qib7	5147	4	0,8	0,8	CD
cord-005453-4057qib7	5148	1	,	,	,
cord-005453-4057qib7	5148	2	p=0,02).5	p=0,02).5	CD
cord-005453-4057qib7	5148	3	years	year	NNS
cord-005453-4057qib7	5148	4	overall	overall	JJ
cord-005453-4057qib7	5148	5	survival	survival	NN
cord-005453-4057qib7	5148	6	(	(	-LRB-
cord-005453-4057qib7	5148	7	OS	OS	NNP
cord-005453-4057qib7	5148	8	)	)	-RRB-
cord-005453-4057qib7	5148	9	was	be	VBD
cord-005453-4057qib7	5148	10	60	60	CD
cord-005453-4057qib7	5148	11	%	%	NN
cord-005453-4057qib7	5148	12	.	.	.
cord-005453-4057qib7	5149	1	Improving	improve	VBG
cord-005453-4057qib7	5149	2	OS	os	NN
cord-005453-4057qib7	5149	3	factors	factor	NNS
cord-005453-4057qib7	5149	4	were	be	VBD
cord-005453-4057qib7	5149	5	:	:	:
cord-005453-4057qib7	5150	1	transplant	transplant	NN
cord-005453-4057qib7	5150	2	age	age	NN
cord-005453-4057qib7	5150	3	younger	young	JJR
cord-005453-4057qib7	5151	1	then	then	RB
cord-005453-4057qib7	5151	2	5	5	CD
cord-005453-4057qib7	5152	1	y.o	y.o	NNP
cord-005453-4057qib7	5152	2	.	.	.
cord-005453-4057qib7	5153	1	(	(	-LRB-
cord-005453-4057qib7	5153	2	80	80	CD
cord-005453-4057qib7	5153	3	%	%	NN
cord-005453-4057qib7	5153	4	vs	vs	IN
cord-005453-4057qib7	5153	5	35	35	CD
cord-005453-4057qib7	5153	6	%	%	NN
cord-005453-4057qib7	5153	7	,	,	,
cord-005453-4057qib7	5153	8	p=0,000	p=0,000	NNP
cord-005453-4057qib7	5153	9	)	)	-RRB-
cord-005453-4057qib7	5153	10	,	,	,
cord-005453-4057qib7	5153	11	time	time	NN
cord-005453-4057qib7	5153	12	from	from	IN
cord-005453-4057qib7	5153	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	5153	14	to	to	IN
cord-005453-4057qib7	5153	15	allo	allo	NN
cord-005453-4057qib7	5153	16	-	-	HYPH
cord-005453-4057qib7	5153	17	HSCT	HSCT	NNP
cord-005453-4057qib7	5153	18	less	less	RBR
cord-005453-4057qib7	5153	19	then	then	RB
cord-005453-4057qib7	5153	20	22	22	CD
cord-005453-4057qib7	5153	21	month	month	NN
cord-005453-4057qib7	5153	22	(	(	-LRB-
cord-005453-4057qib7	5153	23	72	72	CD
cord-005453-4057qib7	5153	24	%	%	NN
cord-005453-4057qib7	5153	25	vs	vs	IN
cord-005453-4057qib7	5153	26	38	38	CD
cord-005453-4057qib7	5153	27	%	%	NN
cord-005453-4057qib7	5153	28	,	,	,
cord-005453-4057qib7	5153	29	p=0,000	p=0,000	NNP
cord-005453-4057qib7	5153	30	)	)	-RRB-
cord-005453-4057qib7	5153	31	,	,	,
cord-005453-4057qib7	5153	32	engraftment	engraftment	NNP
cord-005453-4057qib7	5153	33	(	(	-LRB-
cord-005453-4057qib7	5153	34	72	72	CD
cord-005453-4057qib7	5153	35	%	%	NN
cord-005453-4057qib7	5153	36	vs	vs	IN
cord-005453-4057qib7	5153	37	22	22	CD
cord-005453-4057qib7	5153	38	%	%	NN
cord-005453-4057qib7	5153	39	,	,	,
cord-005453-4057qib7	5153	40	p=0,000	p=0,000	NNP
cord-005453-4057qib7	5153	41	)	)	-RRB-
cord-005453-4057qib7	5153	42	.	.	.
cord-005453-4057qib7	5154	1	In	in	IN
cord-005453-4057qib7	5154	2	a	a	DT
cord-005453-4057qib7	5154	3	multivariate	multivariate	JJ
cord-005453-4057qib7	5154	4	analysis	analysis	NN
cord-005453-4057qib7	5154	5	only	only	RB
cord-005453-4057qib7	5154	6	transplant	transplant	NN
cord-005453-4057qib7	5154	7	age	age	NN
cord-005453-4057qib7	5155	1	younger	young	JJR
cord-005453-4057qib7	5156	1	then	then	RB
cord-005453-4057qib7	5156	2	5	5	CD
cord-005453-4057qib7	5157	1	y.o	y.o	NNP
cord-005453-4057qib7	5157	2	.	.	.
cord-005453-4057qib7	5158	1	(	(	-LRB-
cord-005453-4057qib7	5158	2	HR	HR	NNP
cord-005453-4057qib7	5158	3	3	3	CD
cord-005453-4057qib7	5158	4	,	,	,
cord-005453-4057qib7	5158	5	3	3	CD
cord-005453-4057qib7	5158	6	95%CI	95%ci	CD
cord-005453-4057qib7	5158	7	1	1	CD
cord-005453-4057qib7	5158	8	,	,	,
cord-005453-4057qib7	5158	9	(	(	-LRB-
cord-005453-4057qib7	5158	10	4	4	LS
cord-005453-4057qib7	5158	11	)	)	-RRB-
cord-005453-4057qib7	5158	12	(	(	-LRB-
cord-005453-4057qib7	5158	13	5	5	LS
cord-005453-4057qib7	5158	14	)	)	-RRB-
cord-005453-4057qib7	5158	15	(	(	-LRB-
cord-005453-4057qib7	5158	16	6	6	LS
cord-005453-4057qib7	5158	17	)	)	-RRB-
cord-005453-4057qib7	5158	18	(	(	-LRB-
cord-005453-4057qib7	5158	19	7	7	LS
cord-005453-4057qib7	5158	20	)	)	-RRB-
cord-005453-4057qib7	5158	21	(	(	-LRB-
cord-005453-4057qib7	5158	22	8)	8)	NNP
cord-005453-4057qib7	5158	23	p=0	p=0	NNP
cord-005453-4057qib7	5158	24	,	,	,
cord-005453-4057qib7	5158	25	006	006	CD
cord-005453-4057qib7	5158	26	)	)	-RRB-
cord-005453-4057qib7	5158	27	and	and	CC
cord-005453-4057qib7	5158	28	engraftment	engraftment	NNP
cord-005453-4057qib7	5158	29	(	(	-LRB-
cord-005453-4057qib7	5158	30	HR	hr	NN
cord-005453-4057qib7	5158	31	0,3	0,3	CD
cord-005453-4057qib7	5158	32	95%CI	95%ci	CD
cord-005453-4057qib7	5158	33	0,1	0,1	CD
cord-005453-4057qib7	5158	34	-	-	HYPH
cord-005453-4057qib7	5158	35	0,7	0,7	CD
cord-005453-4057qib7	5158	36	,	,	,
cord-005453-4057qib7	5158	37	p=0,005	p=0,005	NNP
cord-005453-4057qib7	5158	38	)	)	-RRB-
cord-005453-4057qib7	5158	39	were	be	VBD
cord-005453-4057qib7	5158	40	predictive	predictive	JJ
cord-005453-4057qib7	5158	41	for	for	IN
cord-005453-4057qib7	5158	42	OS	OS	NNP
cord-005453-4057qib7	5158	43	.	.	.
cord-005453-4057qib7	5159	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5159	2	:	:	:
cord-005453-4057qib7	5160	1	PTCy	PTCy	NNP
cord-005453-4057qib7	5160	2	-	-	HYPH
cord-005453-4057qib7	5160	3	based	base	VBN
cord-005453-4057qib7	5160	4	GVHD	GVHD	NNP
cord-005453-4057qib7	5160	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5160	6	can	can	MD
cord-005453-4057qib7	5160	7	be	be	VB
cord-005453-4057qib7	5160	8	effective	effective	JJ
cord-005453-4057qib7	5160	9	options	option	NNS
cord-005453-4057qib7	5160	10	for	for	IN
cord-005453-4057qib7	5160	11	reduce	reduce	VB
cord-005453-4057qib7	5160	12	risk	risk	NN
cord-005453-4057qib7	5160	13	of	of	IN
cord-005453-4057qib7	5160	14	acute	acute	JJ
cord-005453-4057qib7	5160	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5160	16	.	.	.
cord-005453-4057qib7	5161	1	Using	use	VBG
cord-005453-4057qib7	5161	2	unrelated	unrelated	JJ
cord-005453-4057qib7	5161	3	donors	donor	NNS
cord-005453-4057qib7	5161	4	,	,	,
cord-005453-4057qib7	5161	5	bone	bone	NN
cord-005453-4057qib7	5161	6	marrow	marrow	NN
cord-005453-4057qib7	5161	7	as	as	IN
cord-005453-4057qib7	5161	8	transplant	transplant	NN
cord-005453-4057qib7	5161	9	source	source	NN
cord-005453-4057qib7	5161	10	and	and	CC
cord-005453-4057qib7	5161	11	MAC	MAC	NNP
cord-005453-4057qib7	5161	12	can	can	MD
cord-005453-4057qib7	5161	13	reduce	reduce	VB
cord-005453-4057qib7	5161	14	CI	CI	NNP
cord-005453-4057qib7	5161	15	of	of	IN
cord-005453-4057qib7	5161	16	GVHD	GVHD	NNP
cord-005453-4057qib7	5161	17	.	.	.
cord-005453-4057qib7	5162	1	Performing	perform	VBG
cord-005453-4057qib7	5162	2	allo	allo	NN
cord-005453-4057qib7	5162	3	-	-	HYPH
cord-005453-4057qib7	5162	4	HSCR	HSCR	NNP
cord-005453-4057qib7	5162	5	earlier	early	RBR
cord-005453-4057qib7	5162	6	from	from	IN
cord-005453-4057qib7	5162	7	diagnos	diagnos	NNP
cord-005453-4057qib7	5162	8	and	and	CC
cord-005453-4057qib7	5162	9	in	in	IN
cord-005453-4057qib7	5162	10	earlier	early	JJR
cord-005453-4057qib7	5162	11	age	age	NN
cord-005453-4057qib7	5162	12	can	can	MD
cord-005453-4057qib7	5162	13	improve	improve	VB
cord-005453-4057qib7	5162	14	OS	OS	NNP
cord-005453-4057qib7	5162	15	patients	patient	NNS
cord-005453-4057qib7	5162	16	with	with	IN
cord-005453-4057qib7	5162	17	inherited	inherit	VBN
cord-005453-4057qib7	5162	18	disorders	disorder	NNS
cord-005453-4057qib7	5162	19	Background	background	NN
cord-005453-4057qib7	5162	20	:	:	:
cord-005453-4057qib7	5162	21	Diarrhea	diarrhea	NN
cord-005453-4057qib7	5162	22	is	be	VBZ
cord-005453-4057qib7	5162	23	a	a	DT
cord-005453-4057qib7	5162	24	frequent	frequent	JJ
cord-005453-4057qib7	5162	25	complication	complication	NN
cord-005453-4057qib7	5162	26	after	after	IN
cord-005453-4057qib7	5162	27	allo	allo	NN
cord-005453-4057qib7	5162	28	-	-	HYPH
cord-005453-4057qib7	5162	29	SCT	SCT	NNP
cord-005453-4057qib7	5162	30	.	.	.
cord-005453-4057qib7	5163	1	At	at	IN
cord-005453-4057qib7	5163	2	onset	onset	NN
cord-005453-4057qib7	5163	3	it	-PRON-	PRP
cord-005453-4057qib7	5163	4	is	be	VBZ
cord-005453-4057qib7	5163	5	often	often	RB
cord-005453-4057qib7	5163	6	difficult	difficult	JJ
cord-005453-4057qib7	5163	7	to	to	TO
cord-005453-4057qib7	5163	8	differentiate	differentiate	VB
cord-005453-4057qib7	5163	9	GI	GI	NNP
cord-005453-4057qib7	5163	10	GvHD	GvHD	NNP
cord-005453-4057qib7	5163	11	from	from	IN
cord-005453-4057qib7	5163	12	other	other	JJ
cord-005453-4057qib7	5163	13	causes	cause	NNS
cord-005453-4057qib7	5163	14	of	of	IN
cord-005453-4057qib7	5163	15	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	5163	16	.	.	.
cord-005453-4057qib7	5164	1	Recently	recently	RB
cord-005453-4057qib7	5164	2	,	,	,
cord-005453-4057qib7	5164	3	non	non	JJ
cord-005453-4057qib7	5164	4	-	-	JJ
cord-005453-4057qib7	5164	5	invasive	invasive	JJ
cord-005453-4057qib7	5164	6	tests	test	NNS
cord-005453-4057qib7	5164	7	,	,	,
cord-005453-4057qib7	5164	8	such	such	JJ
cord-005453-4057qib7	5164	9	as	as	IN
cord-005453-4057qib7	5164	10	fecal	fecal	JJ
cord-005453-4057qib7	5164	11	calprotectin	calprotectin	NNP
cord-005453-4057qib7	5164	12	(	(	-LRB-
cord-005453-4057qib7	5164	13	FC	FC	NNP
cord-005453-4057qib7	5164	14	)	)	-RRB-
cord-005453-4057qib7	5164	15	,	,	,
cord-005453-4057qib7	5164	16	have	have	VBP
cord-005453-4057qib7	5164	17	been	be	VBN
cord-005453-4057qib7	5164	18	validated	validate	VBN
cord-005453-4057qib7	5164	19	as	as	IN
cord-005453-4057qib7	5164	20	markers	marker	NNS
cord-005453-4057qib7	5164	21	of	of	IN
cord-005453-4057qib7	5164	22	gut	gut	NN
cord-005453-4057qib7	5164	23	inflammation	inflammation	NN
cord-005453-4057qib7	5164	24	in	in	IN
cord-005453-4057qib7	5164	25	patients	patient	NNS
cord-005453-4057qib7	5164	26	with	with	IN
cord-005453-4057qib7	5164	27	Inflammatory	inflammatory	JJ
cord-005453-4057qib7	5164	28	Bowel	Bowel	NNP
cord-005453-4057qib7	5164	29	Disease	Disease	NNP
cord-005453-4057qib7	5164	30	,	,	,
cord-005453-4057qib7	5164	31	but	but	CC
cord-005453-4057qib7	5164	32	only	only	RB
cord-005453-4057qib7	5164	33	a	a	DT
cord-005453-4057qib7	5164	34	few	few	JJ
cord-005453-4057qib7	5164	35	studies	study	NNS
cord-005453-4057qib7	5164	36	have	have	VBP
cord-005453-4057qib7	5164	37	been	be	VBN
cord-005453-4057qib7	5164	38	published	publish	VBN
cord-005453-4057qib7	5164	39	regarding	regard	VBG
cord-005453-4057qib7	5164	40	its	-PRON-	PRP$
cord-005453-4057qib7	5164	41	use	use	NN
cord-005453-4057qib7	5164	42	as	as	IN
cord-005453-4057qib7	5164	43	a	a	DT
cord-005453-4057qib7	5164	44	diagnostic	diagnostic	JJ
cord-005453-4057qib7	5164	45	marker	marker	NN
cord-005453-4057qib7	5164	46	in	in	IN
cord-005453-4057qib7	5164	47	GI	GI	NNP
cord-005453-4057qib7	5164	48	GvHD	GvHD	NNP
cord-005453-4057qib7	5164	49	.	.	.
cord-005453-4057qib7	5165	1	Methods	method	NNS
cord-005453-4057qib7	5165	2	:	:	:
cord-005453-4057qib7	5166	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5166	2	aim	aim	NN
cord-005453-4057qib7	5166	3	in	in	IN
cord-005453-4057qib7	5166	4	this	this	DT
cord-005453-4057qib7	5166	5	study	study	NN
cord-005453-4057qib7	5166	6	was	be	VBD
cord-005453-4057qib7	5166	7	to	to	TO
cord-005453-4057qib7	5166	8	explore	explore	VB
cord-005453-4057qib7	5166	9	the	the	DT
cord-005453-4057qib7	5166	10	levels	level	NNS
cord-005453-4057qib7	5166	11	of	of	IN
cord-005453-4057qib7	5166	12	FC	FC	NNP
cord-005453-4057qib7	5166	13	in	in	IN
cord-005453-4057qib7	5166	14	allo	allo	NNP
cord-005453-4057qib7	5166	15	-	-	HYPH
cord-005453-4057qib7	5166	16	SCT	SCT	NNP
cord-005453-4057qib7	5166	17	recipients	recipient	NNS
cord-005453-4057qib7	5166	18	with	with	IN
cord-005453-4057qib7	5166	19	new	new	JJ
cord-005453-4057qib7	5166	20	-	-	HYPH
cord-005453-4057qib7	5166	21	onset	onset	NN
cord-005453-4057qib7	5166	22	diarrhea	diarrhea	NN
cord-005453-4057qib7	5166	23	.	.	.
cord-005453-4057qib7	5167	1	So	so	RB
cord-005453-4057qib7	5167	2	far	far	RB
cord-005453-4057qib7	5167	3	we	-PRON-	PRP
cord-005453-4057qib7	5167	4	have	have	VBP
cord-005453-4057qib7	5167	5	included	include	VBN
cord-005453-4057qib7	5167	6	43	43	CD
cord-005453-4057qib7	5167	7	allo	allo	NN
cord-005453-4057qib7	5167	8	-	-	HYPH
cord-005453-4057qib7	5167	9	SCT	SCT	NNP
cord-005453-4057qib7	5167	10	recipients	recipient	NNS
cord-005453-4057qib7	5167	11	who	who	WP
cord-005453-4057qib7	5167	12	developed	develop	VBD
cord-005453-4057qib7	5167	13	acute	acute	JJ
cord-005453-4057qib7	5167	14	diarrhea	diarrhea	NN
cord-005453-4057qib7	5167	15	≥	≥	CD
cord-005453-4057qib7	5167	16	stage	stage	NN
cord-005453-4057qib7	5167	17	2	2	CD
cord-005453-4057qib7	5167	18	-	-	SYM
cord-005453-4057qib7	5167	19	4	4	CD
cord-005453-4057qib7	5167	20	at	at	IN
cord-005453-4057qib7	5167	21	a	a	DT
cord-005453-4057qib7	5167	22	median	median	NN
cord-005453-4057qib7	5167	23	of	of	IN
cord-005453-4057qib7	5167	24	75	75	CD
cord-005453-4057qib7	5167	25	days	day	NNS
cord-005453-4057qib7	5167	26	(	(	-LRB-
cord-005453-4057qib7	5167	27	range:12	range:12	NNP
cord-005453-4057qib7	5167	28	-	-	HYPH
cord-005453-4057qib7	5167	29	328	328	CD
cord-005453-4057qib7	5167	30	)	)	-RRB-
cord-005453-4057qib7	5167	31	post	post	NN
cord-005453-4057qib7	5167	32	allo	allo	NN
cord-005453-4057qib7	5167	33	-	-	HYPH
cord-005453-4057qib7	5167	34	SCT	SCT	NNP
cord-005453-4057qib7	5167	35	.	.	.
cord-005453-4057qib7	5168	1	Stool	stool	NN
cord-005453-4057qib7	5168	2	samples	sample	NNS
cord-005453-4057qib7	5168	3	were	be	VBD
cord-005453-4057qib7	5168	4	analyzed	analyze	VBN
cord-005453-4057qib7	5168	5	as	as	RB
cord-005453-4057qib7	5168	6	soon	soon	RB
cord-005453-4057qib7	5168	7	as	as	IN
cord-005453-4057qib7	5168	8	possible	possible	JJ
cord-005453-4057qib7	5168	9	after	after	IN
cord-005453-4057qib7	5168	10	the	the	DT
cord-005453-4057qib7	5168	11	onset	onset	NN
cord-005453-4057qib7	5168	12	of	of	IN
cord-005453-4057qib7	5168	13	diarrhea	diarrhea	NN
cord-005453-4057qib7	5168	14	.	.	.
cord-005453-4057qib7	5169	1	FC	FC	NNP
cord-005453-4057qib7	5169	2	levels	level	NNS
cord-005453-4057qib7	5169	3	were	be	VBD
cord-005453-4057qib7	5169	4	determined	determine	VBN
cord-005453-4057qib7	5169	5	in	in	IN
cord-005453-4057qib7	5169	6	addition	addition	NN
cord-005453-4057qib7	5169	7	to	to	IN
cord-005453-4057qib7	5169	8	an	an	DT
cord-005453-4057qib7	5169	9	extensive	extensive	JJ
cord-005453-4057qib7	5169	10	microbiological	microbiological	JJ
cord-005453-4057qib7	5169	11	panel	panel	NN
cord-005453-4057qib7	5169	12	for	for	IN
cord-005453-4057qib7	5169	13	infectious	infectious	JJ
cord-005453-4057qib7	5169	14	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	5169	15	(	(	-LRB-
cord-005453-4057qib7	5169	16	including	include	VBG
cord-005453-4057qib7	5169	17	norovirus	norovirus	NN
cord-005453-4057qib7	5169	18	PCR	PCR	NNP
cord-005453-4057qib7	5169	19	and	and	CC
cord-005453-4057qib7	5169	20	C.	C.	NNP
cord-005453-4057qib7	5169	21	difficile	difficile	NN
cord-005453-4057qib7	5169	22	associated	associate	VBN
cord-005453-4057qib7	5169	23	diarrhea	diarrhea	NN
cord-005453-4057qib7	5169	24	)	)	-RRB-
cord-005453-4057qib7	5169	25	.	.	.
cord-005453-4057qib7	5170	1	Endoscopies	endoscopy	NNS
cord-005453-4057qib7	5170	2	for	for	IN
cord-005453-4057qib7	5170	3	histologic	histologic	JJ
cord-005453-4057qib7	5170	4	analysis	analysis	NN
cord-005453-4057qib7	5170	5	were	be	VBD
cord-005453-4057qib7	5170	6	performed	perform	VBN
cord-005453-4057qib7	5170	7	according	accord	VBG
cord-005453-4057qib7	5170	8	to	to	IN
cord-005453-4057qib7	5170	9	the	the	DT
cord-005453-4057qib7	5170	10	treating	treat	VBG
cord-005453-4057qib7	5170	11	physicians	physician	NNS
cord-005453-4057qib7	5170	12	'	'	POS
cord-005453-4057qib7	5170	13	discretion	discretion	NN
cord-005453-4057qib7	5170	14	(	(	-LRB-
cord-005453-4057qib7	5170	15	n=15	n=15	NNP
cord-005453-4057qib7	5170	16	)	)	-RRB-
cord-005453-4057qib7	5170	17	.	.	.
cord-005453-4057qib7	5171	1	Results	result	NNS
cord-005453-4057qib7	5171	2	:	:	:
cord-005453-4057qib7	5172	1	Patients	patient	NNS
cord-005453-4057qib7	5172	2	characteristics	characteristic	NNS
cord-005453-4057qib7	5172	3	are	be	VBP
cord-005453-4057qib7	5172	4	summarized	summarize	VBN
cord-005453-4057qib7	5172	5	in	in	IN
cord-005453-4057qib7	5172	6	Table	Table	NNP
cord-005453-4057qib7	5172	7	 	 	_SP
cord-005453-4057qib7	5172	8	1	1	CD
cord-005453-4057qib7	5172	9	.	.	.
cord-005453-4057qib7	5173	1	Median	median	JJ
cord-005453-4057qib7	5173	2	follow	follow	NN
cord-005453-4057qib7	5173	3	-	-	HYPH
cord-005453-4057qib7	5173	4	up	up	NN
cord-005453-4057qib7	5173	5	for	for	IN
cord-005453-4057qib7	5173	6	survivors	survivor	NNS
cord-005453-4057qib7	5173	7	was	be	VBD
cord-005453-4057qib7	5173	8	524	524	CD
cord-005453-4057qib7	5173	9	days	day	NNS
cord-005453-4057qib7	5173	10	(	(	-LRB-
cord-005453-4057qib7	5173	11	range:151	range:151	NNP
cord-005453-4057qib7	5173	12	-	-	HYPH
cord-005453-4057qib7	5173	13	1834	1834	CD
cord-005453-4057qib7	5173	14	)	)	-RRB-
cord-005453-4057qib7	5173	15	.	.	.
cord-005453-4057qib7	5174	1	Twenty	twenty	CD
cord-005453-4057qib7	5174	2	-	-	HYPH
cord-005453-4057qib7	5174	3	eight	eight	CD
cord-005453-4057qib7	5174	4	patients	patient	NNS
cord-005453-4057qib7	5174	5	(	(	-LRB-
cord-005453-4057qib7	5174	6	65	65	CD
cord-005453-4057qib7	5174	7	%	%	NN
cord-005453-4057qib7	5174	8	)	)	-RRB-
cord-005453-4057qib7	5174	9	were	be	VBD
cord-005453-4057qib7	5174	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	5174	11	of	of	IN
cord-005453-4057qib7	5174	12	GI	GI	NNP
cord-005453-4057qib7	5174	13	-	-	HYPH
cord-005453-4057qib7	5174	14	GvHD	GvHD	NNP
cord-005453-4057qib7	5174	15	.	.	.
cord-005453-4057qib7	5175	1	The	the	DT
cord-005453-4057qib7	5175	2	additional	additional	JJ
cord-005453-4057qib7	5175	3	causes	cause	NNS
cord-005453-4057qib7	5175	4	of	of	IN
cord-005453-4057qib7	5175	5	diarrhea	diarrhea	NN
cord-005453-4057qib7	5175	6	were	be	VBD
cord-005453-4057qib7	5175	7	:	:	:
cord-005453-4057qib7	5175	8	drug	drug	NN
cord-005453-4057qib7	5175	9	-	-	HYPH
cord-005453-4057qib7	5175	10	related	relate	VBN
cord-005453-4057qib7	5175	11	enterotoxicity	enterotoxicity	NN
cord-005453-4057qib7	5175	12	(	(	-LRB-
cord-005453-4057qib7	5175	13	n=6	n=6	NNP
cord-005453-4057qib7	5175	14	)	)	-RRB-
cord-005453-4057qib7	5175	15	,	,	,
cord-005453-4057qib7	5175	16	viral	viral	JJ
cord-005453-4057qib7	5175	17	enteritis	enteritis	NN
cord-005453-4057qib7	5175	18	(	(	-LRB-
cord-005453-4057qib7	5175	19	n=2	n=2	NNS
cord-005453-4057qib7	5175	20	)	)	-RRB-
cord-005453-4057qib7	5175	21	,	,	,
cord-005453-4057qib7	5175	22	food	food	NN
cord-005453-4057qib7	5175	23	intolerance	intolerance	NN
cord-005453-4057qib7	5175	24	(	(	-LRB-
cord-005453-4057qib7	5175	25	n=2	n=2	NNS
cord-005453-4057qib7	5175	26	)	)	-RRB-
cord-005453-4057qib7	5175	27	,	,	,
cord-005453-4057qib7	5175	28	C.jejuni	C.jejuni	NNP
cord-005453-4057qib7	5175	29	-	-	HYPH
cord-005453-4057qib7	5175	30	enteritis	enteritis	NN
cord-005453-4057qib7	5175	31	(	(	-LRB-
cord-005453-4057qib7	5175	32	n=1	n=1	CD
cord-005453-4057qib7	5175	33	)	)	-RRB-
cord-005453-4057qib7	5175	34	,	,	,
cord-005453-4057qib7	5175	35	and	and	CC
cord-005453-4057qib7	5175	36	non	non	JJ
cord-005453-4057qib7	5175	37	-	-	JJ
cord-005453-4057qib7	5175	38	specific	specific	JJ
cord-005453-4057qib7	5175	39	causes	cause	NNS
cord-005453-4057qib7	5175	40	(	(	-LRB-
cord-005453-4057qib7	5175	41	n=4	n=4	NNS
cord-005453-4057qib7	5175	42	)	)	-RRB-
cord-005453-4057qib7	5175	43	.	.	.
cord-005453-4057qib7	5176	1	The	the	DT
cord-005453-4057qib7	5176	2	concentration	concentration	NN
cord-005453-4057qib7	5176	3	of	of	IN
cord-005453-4057qib7	5176	4	FC	FC	NNP
cord-005453-4057qib7	5176	5	was	be	VBD
cord-005453-4057qib7	5176	6	higher	high	JJR
cord-005453-4057qib7	5176	7	in	in	IN
cord-005453-4057qib7	5176	8	patients	patient	NNS
cord-005453-4057qib7	5176	9	with	with	IN
cord-005453-4057qib7	5176	10	GI	GI	NNP
cord-005453-4057qib7	5176	11	GvHD	GvHD	NNP
cord-005453-4057qib7	5176	12	vs.	vs.	IN
cord-005453-4057qib7	5176	13	other	other	JJ
cord-005453-4057qib7	5176	14	causes	cause	NNS
cord-005453-4057qib7	5176	15	of	of	IN
cord-005453-4057qib7	5176	16	diarrhea	diarrhea	NN
cord-005453-4057qib7	5176	17	(	(	-LRB-
cord-005453-4057qib7	5176	18	544μg	544μg	NN
cord-005453-4057qib7	5176	19	/	/	SYM
cord-005453-4057qib7	5176	20	g	g	NN
cord-005453-4057qib7	5177	1	+	+	CC
cord-005453-4057qib7	5177	2	/-71	/-71	CD
cord-005453-4057qib7	5177	3	vs.	vs.	NN
cord-005453-4057qib7	5177	4	58	58	CD
cord-005453-4057qib7	5177	5	μg/	μg/	NN
cord-005453-4057qib7	5178	1	g	g	NNP
cord-005453-4057qib7	5179	1	+	+	CC
cord-005453-4057qib7	5179	2	/-33	/-33	NNP
cord-005453-4057qib7	5179	3	,	,	,
cord-005453-4057qib7	5179	4	p=	p=	NNP
cord-005453-4057qib7	5179	5	0.03	0.03	CD
cord-005453-4057qib7	5179	6	)	)	-RRB-
cord-005453-4057qib7	5179	7	.	.	.
cord-005453-4057qib7	5180	1	Patients	patient	NNS
cord-005453-4057qib7	5180	2	who	who	WP
cord-005453-4057qib7	5180	3	did	do	VBD
cord-005453-4057qib7	5180	4	not	not	RB
cord-005453-4057qib7	5180	5	develop	develop	VB
cord-005453-4057qib7	5180	6	severe	severe	JJ
cord-005453-4057qib7	5180	7	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	5180	8	had	have	VBD
cord-005453-4057qib7	5180	9	normal	normal	JJ
cord-005453-4057qib7	5180	10	to	to	IN
cord-005453-4057qib7	5180	11	slightly	slightly	RB
cord-005453-4057qib7	5180	12	raised	raise	VBN
cord-005453-4057qib7	5180	13	calprotectin	calprotectin	NNS
cord-005453-4057qib7	5180	14	at	at	IN
cord-005453-4057qib7	5180	15	the	the	DT
cord-005453-4057qib7	5180	16	onset	onset	NN
cord-005453-4057qib7	5180	17	of	of	IN
cord-005453-4057qib7	5180	18	diarrhea	diarrhea	NN
cord-005453-4057qib7	5180	19	[	[	-LRB-
cord-005453-4057qib7	5180	20	<	<	XX
cord-005453-4057qib7	5180	21	100	100	CD
cord-005453-4057qib7	5180	22	-	-	HYPH
cord-005453-4057qib7	5180	23	150	150	CD
cord-005453-4057qib7	5180	24	in	in	IN
cord-005453-4057qib7	5180	25	16	16	CD
cord-005453-4057qib7	5180	26	out	out	IN
cord-005453-4057qib7	5180	27	of	of	IN
cord-005453-4057qib7	5180	28	19	19	CD
cord-005453-4057qib7	5180	29	(	(	-LRB-
cord-005453-4057qib7	5180	30	89	89	CD
cord-005453-4057qib7	5180	31	%	%	NN
cord-005453-4057qib7	5180	32	)	)	-RRB-
cord-005453-4057qib7	5180	33	cases	case	NNS
cord-005453-4057qib7	5180	34	]	]	-RRB-
cord-005453-4057qib7	5180	35	,	,	,
cord-005453-4057qib7	5180	36	including	include	VBG
cord-005453-4057qib7	5180	37	100	100	CD
cord-005453-4057qib7	5180	38	%	%	NN
cord-005453-4057qib7	5180	39	(	(	-LRB-
cord-005453-4057qib7	5180	40	6/6	6/6	CD
cord-005453-4057qib7	5180	41	)	)	-RRB-
cord-005453-4057qib7	5180	42	of	of	IN
cord-005453-4057qib7	5180	43	patients	patient	NNS
cord-005453-4057qib7	5180	44	with	with	IN
cord-005453-4057qib7	5180	45	enterotoxic	enterotoxic	JJ
cord-005453-4057qib7	5180	46	drug	drug	NN
cord-005453-4057qib7	5180	47	-	-	HYPH
cord-005453-4057qib7	5180	48	related	relate	VBN
cord-005453-4057qib7	5180	49	diarrhea	diarrhea	NN
cord-005453-4057qib7	5180	50	.	.	.
cord-005453-4057qib7	5181	1	Among	among	IN
cord-005453-4057qib7	5181	2	the	the	DT
cord-005453-4057qib7	5181	3	28	28	CD
cord-005453-4057qib7	5181	4	patients	patient	NNS
cord-005453-4057qib7	5181	5	with	with	IN
cord-005453-4057qib7	5181	6	GI	GI	NNP
cord-005453-4057qib7	5181	7	-	-	HYPH
cord-005453-4057qib7	5181	8	GvHD	GvHD	NNP
cord-005453-4057qib7	5181	9	,	,	,
cord-005453-4057qib7	5181	10	13	13	CD
cord-005453-4057qib7	5181	11	(	(	-LRB-
cord-005453-4057qib7	5181	12	30.2	30.2	CD
cord-005453-4057qib7	5181	13	%	%	NN
cord-005453-4057qib7	5181	14	)	)	-RRB-
cord-005453-4057qib7	5181	15	were	be	VBD
cord-005453-4057qib7	5181	16	later	later	RB
cord-005453-4057qib7	5181	17	found	find	VBN
cord-005453-4057qib7	5181	18	to	to	TO
cord-005453-4057qib7	5181	19	be	be	VB
cord-005453-4057qib7	5181	20	steroid	steroid	NN
cord-005453-4057qib7	5181	21	-	-	HYPH
cord-005453-4057qib7	5181	22	resistant	resistant	JJ
cord-005453-4057qib7	5181	23	.	.	.
cord-005453-4057qib7	5182	1	As	as	IN
cord-005453-4057qib7	5182	2	shown	show	VBN
cord-005453-4057qib7	5182	3	in	in	IN
cord-005453-4057qib7	5182	4	Figure	figure	NN
cord-005453-4057qib7	5182	5	1	1	CD
cord-005453-4057qib7	5182	6	,	,	,
cord-005453-4057qib7	5182	7	we	-PRON-	PRP
cord-005453-4057qib7	5182	8	found	find	VBD
cord-005453-4057qib7	5182	9	a	a	DT
cord-005453-4057qib7	5182	10	significant	significant	JJ
cord-005453-4057qib7	5182	11	association	association	NN
cord-005453-4057qib7	5182	12	between	between	IN
cord-005453-4057qib7	5182	13	high	high	JJ
cord-005453-4057qib7	5182	14	FC	FC	NNP
cord-005453-4057qib7	5182	15	(	(	-LRB-
cord-005453-4057qib7	5182	16	≥400μg	≥400μg	NNP
cord-005453-4057qib7	5182	17	/	/	SYM
cord-005453-4057qib7	5182	18	g	g	NN
cord-005453-4057qib7	5182	19	)	)	-RRB-
cord-005453-4057qib7	5182	20	and	and	CC
cord-005453-4057qib7	5182	21	severe	severe	JJ
cord-005453-4057qib7	5182	22	-	-	HYPH
cord-005453-4057qib7	5182	23	refractory	refractory	JJ
cord-005453-4057qib7	5182	24	GvHD	gvhd	NN
cord-005453-4057qib7	5182	25	(	(	-LRB-
cord-005453-4057qib7	5182	26	HR	HR	NNP
cord-005453-4057qib7	5182	27	5.7	5.7	CD
cord-005453-4057qib7	5182	28	,	,	,
cord-005453-4057qib7	5182	29	p=0.01	p=0.01	NNP
cord-005453-4057qib7	5182	30	)	)	-RRB-
cord-005453-4057qib7	5182	31	.	.	.
cord-005453-4057qib7	5183	1	Of	of	IN
cord-005453-4057qib7	5183	2	note	note	VB
cord-005453-4057qib7	5183	3	,	,	,
cord-005453-4057qib7	5183	4	high	high	JJ
cord-005453-4057qib7	5183	5	values	value	NNS
cord-005453-4057qib7	5183	6	of	of	IN
cord-005453-4057qib7	5183	7	FC	FC	NNP
cord-005453-4057qib7	5183	8	were	be	VBD
cord-005453-4057qib7	5183	9	also	also	RB
cord-005453-4057qib7	5183	10	found	find	VBN
cord-005453-4057qib7	5183	11	in	in	IN
cord-005453-4057qib7	5183	12	3	3	CD
cord-005453-4057qib7	5183	13	patients	patient	NNS
cord-005453-4057qib7	5183	14	with	with	IN
cord-005453-4057qib7	5183	15	severe	severe	JJ
cord-005453-4057qib7	5183	16	infectious	infectious	JJ
cord-005453-4057qib7	5183	17	enteritis	enteritis	NN
cord-005453-4057qib7	5183	18	(	(	-LRB-
cord-005453-4057qib7	5183	19	norovirus	norovirus	NN
cord-005453-4057qib7	5183	20	,	,	,
cord-005453-4057qib7	5183	21	adenovirus	adenovirus	NN
cord-005453-4057qib7	5183	22	and	and	CC
cord-005453-4057qib7	5183	23	C.jejuni	C.jejuni	NNP
cord-005453-4057qib7	5183	24	infections	infection	NNS
cord-005453-4057qib7	5183	25	)	)	-RRB-
cord-005453-4057qib7	5183	26	,	,	,
cord-005453-4057qib7	5183	27	with	with	IN
cord-005453-4057qib7	5183	28	baseline	baseline	JJ
cord-005453-4057qib7	5183	29	FC>800	FC>800	NNP
cord-005453-4057qib7	5183	30	μg	μg	NNP
cord-005453-4057qib7	5183	31	/	/	SYM
cord-005453-4057qib7	5183	32	g	g	NN
cord-005453-4057qib7	5183	33	,	,	,
cord-005453-4057qib7	5183	34	respectively	respectively	RB
cord-005453-4057qib7	5183	35	.	.	.
cord-005453-4057qib7	5184	1	Overall	overall	JJ
cord-005453-4057qib7	5184	2	survival	survival	NN
cord-005453-4057qib7	5184	3	was	be	VBD
cord-005453-4057qib7	5184	4	78	78	CD
cord-005453-4057qib7	5184	5	%	%	NN
cord-005453-4057qib7	5185	1	(	(	-LRB-
cord-005453-4057qib7	5185	2	IC95%:65	ic95%:65	NN
cord-005453-4057qib7	5185	3	-	-	HYPH
cord-005453-4057qib7	5185	4	91	91	CD
cord-005453-4057qib7	5185	5	)	)	-RRB-
cord-005453-4057qib7	5186	1	at	at	IN
cord-005453-4057qib7	5186	2	12	12	CD
cord-005453-4057qib7	5186	3	months	month	NNS
cord-005453-4057qib7	5186	4	.	.	.
cord-005453-4057qib7	5187	1	Hypoalbuminemia	Hypoalbuminemia	NNP
cord-005453-4057qib7	5187	2	and	and	CC
cord-005453-4057qib7	5187	3	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	5187	4	were	be	VBD
cord-005453-4057qib7	5187	5	the	the	DT
cord-005453-4057qib7	5187	6	only	only	JJ
cord-005453-4057qib7	5187	7	variables	variable	NNS
cord-005453-4057qib7	5187	8	linked	link	VBN
cord-005453-4057qib7	5187	9	to	to	IN
cord-005453-4057qib7	5187	10	1-yr	1-yr	CD
cord-005453-4057qib7	5187	11	OS	os	NN
cord-005453-4057qib7	5187	12	in	in	IN
cord-005453-4057qib7	5187	13	univariate	univariate	JJ
cord-005453-4057qib7	5187	14	analysis	analysis	NN
cord-005453-4057qib7	5187	15	,	,	,
cord-005453-4057qib7	5187	16	regardless	regardless	RB
cord-005453-4057qib7	5187	17	of	of	IN
cord-005453-4057qib7	5187	18	the	the	DT
cord-005453-4057qib7	5187	19	cause	cause	NN
cord-005453-4057qib7	5187	20	of	of	IN
cord-005453-4057qib7	5187	21	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	5187	22	.	.	.
cord-005453-4057qib7	5188	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5188	2	:	:	:
cord-005453-4057qib7	5189	1	In	in	IN
cord-005453-4057qib7	5189	2	the	the	DT
cord-005453-4057qib7	5189	3	absence	absence	NN
cord-005453-4057qib7	5189	4	of	of	IN
cord-005453-4057qib7	5189	5	standarized	standarized	JJ
cord-005453-4057qib7	5189	6	(	(	-LRB-
cord-005453-4057qib7	5189	7	and	and	CC
cord-005453-4057qib7	5189	8	expensive	expensive	JJ
cord-005453-4057qib7	5189	9	)	)	-RRB-
cord-005453-4057qib7	5189	10	biomarker	biomarker	NN
cord-005453-4057qib7	5189	11	panels	panel	NNS
cord-005453-4057qib7	5189	12	for	for	IN
cord-005453-4057qib7	5189	13	analyzing	analyze	VBG
cord-005453-4057qib7	5189	14	and	and	CC
cord-005453-4057qib7	5189	15	predicting	predict	VBG
cord-005453-4057qib7	5189	16	GVHD	GVHD	NNP
cord-005453-4057qib7	5189	17	onset	onset	NN
cord-005453-4057qib7	5189	18	and	and	CC
cord-005453-4057qib7	5189	19	outcomes	outcome	NNS
cord-005453-4057qib7	5189	20	,	,	,
cord-005453-4057qib7	5189	21	the	the	DT
cord-005453-4057qib7	5189	22	FC	FC	NNP
cord-005453-4057qib7	5189	23	test	test	NN
cord-005453-4057qib7	5189	24	may	may	MD
cord-005453-4057qib7	5189	25	be	be	VB
cord-005453-4057qib7	5189	26	an	an	DT
cord-005453-4057qib7	5189	27	useful	useful	JJ
cord-005453-4057qib7	5189	28	tool	tool	NN
cord-005453-4057qib7	5189	29	in	in	IN
cord-005453-4057qib7	5189	30	the	the	DT
cord-005453-4057qib7	5189	31	allo	allo	NNP
cord-005453-4057qib7	5189	32	-	-	HYPH
cord-005453-4057qib7	5189	33	SCT	sct	NN
cord-005453-4057qib7	5189	34	setting	setting	NN
cord-005453-4057qib7	5189	35	.	.	.
cord-005453-4057qib7	5190	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5190	2	initial	initial	JJ
cord-005453-4057qib7	5190	3	results	result	NNS
cord-005453-4057qib7	5190	4	show	show	VBP
cord-005453-4057qib7	5190	5	that	that	IN
cord-005453-4057qib7	5190	6	FC	FC	NNP
cord-005453-4057qib7	5190	7	is	be	VBZ
cord-005453-4057qib7	5190	8	helpful	helpful	JJ
cord-005453-4057qib7	5190	9	in	in	IN
cord-005453-4057qib7	5190	10	predicting	predict	VBG
cord-005453-4057qib7	5190	11	mild	mild	JJ
cord-005453-4057qib7	5190	12	causes	cause	NNS
cord-005453-4057qib7	5190	13	of	of	IN
cord-005453-4057qib7	5190	14	diarrhea	diarrhea	NN
cord-005453-4057qib7	5190	15	and	and	CC
cord-005453-4057qib7	5190	16	to	to	TO
cord-005453-4057qib7	5190	17	identify	identify	VB
cord-005453-4057qib7	5190	18	patients	patient	NNS
cord-005453-4057qib7	5190	19	with	with	IN
cord-005453-4057qib7	5190	20	a	a	DT
cord-005453-4057qib7	5190	21	high	high	JJ
cord-005453-4057qib7	5190	22	probability	probability	NN
cord-005453-4057qib7	5190	23	of	of	IN
cord-005453-4057qib7	5190	24	developing	develop	VBG
cord-005453-4057qib7	5190	25	severe	severe	JJ
cord-005453-4057qib7	5190	26	(	(	-LRB-
cord-005453-4057qib7	5190	27	and	and	CC
cord-005453-4057qib7	5190	28	potentially	potentially	RB
cord-005453-4057qib7	5190	29	steroid	steroid	JJ
cord-005453-4057qib7	5190	30	-	-	HYPH
cord-005453-4057qib7	5190	31	refractory	refractory	JJ
cord-005453-4057qib7	5190	32	)	)	-RRB-
cord-005453-4057qib7	5190	33	GI	GI	NNP
cord-005453-4057qib7	5190	34	GvHD	GvHD	NNP
cord-005453-4057qib7	5190	35	,	,	,
cord-005453-4057qib7	5190	36	although	although	IN
cord-005453-4057qib7	5190	37	high	high	JJ
cord-005453-4057qib7	5190	38	levels	level	NNS
cord-005453-4057qib7	5190	39	are	be	VBP
cord-005453-4057qib7	5190	40	also	also	RB
cord-005453-4057qib7	5190	41	found	find	VBN
cord-005453-4057qib7	5190	42	in	in	IN
cord-005453-4057qib7	5190	43	severe	severe	JJ
cord-005453-4057qib7	5190	44	infectious	infectious	JJ
cord-005453-4057qib7	5190	45	enteritis	enteritis	NN
cord-005453-4057qib7	5190	46	.	.	.
cord-005453-4057qib7	5191	1	Background	background	NN
cord-005453-4057qib7	5191	2	:	:	:
cord-005453-4057qib7	5192	1	There	there	EX
cord-005453-4057qib7	5192	2	is	be	VBZ
cord-005453-4057qib7	5192	3	an	an	DT
cord-005453-4057qib7	5192	4	urgent	urgent	JJ
cord-005453-4057qib7	5192	5	need	need	NN
cord-005453-4057qib7	5192	6	for	for	IN
cord-005453-4057qib7	5192	7	effective	effective	JJ
cord-005453-4057qib7	5192	8	therapy	therapy	NN
cord-005453-4057qib7	5192	9	for	for	IN
cord-005453-4057qib7	5192	10	severe	severe	JJ
cord-005453-4057qib7	5192	11	acute	acute	JJ
cord-005453-4057qib7	5192	12	GVHD	GVHD	NNP
cord-005453-4057qib7	5192	13	.	.	.
cord-005453-4057qib7	5193	1	Results	result	NNS
cord-005453-4057qib7	5193	2	of	of	IN
cord-005453-4057qib7	5193	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5193	4	therapies	therapy	NNS
cord-005453-4057qib7	5193	5	beyond	beyond	IN
cord-005453-4057qib7	5193	6	6	6	CD
cord-005453-4057qib7	5193	7	months	month	NNS
cord-005453-4057qib7	5193	8	are	be	VBP
cord-005453-4057qib7	5193	9	rarely	rarely	RB
cord-005453-4057qib7	5193	10	reported	report	VBN
cord-005453-4057qib7	5193	11	.	.	.
cord-005453-4057qib7	5194	1	We	-PRON-	PRP
cord-005453-4057qib7	5194	2	here	here	RB
cord-005453-4057qib7	5194	3	report	report	VBP
cord-005453-4057qib7	5194	4	a	a	DT
cord-005453-4057qib7	5194	5	median	median	JJ
cord-005453-4057qib7	5194	6	follow	follow	NN
cord-005453-4057qib7	5194	7	-	-	HYPH
cord-005453-4057qib7	5194	8	up	up	NN
cord-005453-4057qib7	5194	9	of	of	IN
cord-005453-4057qib7	5194	10	4	4	CD
cord-005453-4057qib7	5194	11	years	year	NNS
cord-005453-4057qib7	5194	12	.	.	.
cord-005453-4057qib7	5195	1	We	-PRON-	PRP
cord-005453-4057qib7	5195	2	introduced	introduce	VBD
cord-005453-4057qib7	5195	3	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	5195	4	stromal	stromal	JJ
cord-005453-4057qib7	5195	5	cells	cell	NNS
cord-005453-4057qib7	5195	6	as	as	IN
cord-005453-4057qib7	5195	7	therapy	therapy	NN
cord-005453-4057qib7	5195	8	for	for	IN
cord-005453-4057qib7	5195	9	severe	severe	JJ
cord-005453-4057qib7	5195	10	acute	acute	JJ
cord-005453-4057qib7	5195	11	GVHD	GVHD	NNP
cord-005453-4057qib7	5195	12	,	,	,
cord-005453-4057qib7	5195	13	with	with	IN
cord-005453-4057qib7	5195	14	a	a	DT
cord-005453-4057qib7	5195	15	dramatic	dramatic	JJ
cord-005453-4057qib7	5195	16	response	response	NN
cord-005453-4057qib7	5195	17	in	in	IN
cord-005453-4057qib7	5195	18	some	some	DT
cord-005453-4057qib7	5195	19	,	,	,
cord-005453-4057qib7	5195	20	but	but	CC
cord-005453-4057qib7	5195	21	not	not	RB
cord-005453-4057qib7	5195	22	all	all	DT
cord-005453-4057qib7	5195	23	patients	patient	NNS
cord-005453-4057qib7	5195	24	.	.	.
cord-005453-4057qib7	5196	1	The	the	DT
cord-005453-4057qib7	5196	2	placenta	placenta	NN
cord-005453-4057qib7	5196	3	protects	protect	VBZ
cord-005453-4057qib7	5196	4	the	the	DT
cord-005453-4057qib7	5196	5	fetus	fetus	NN
cord-005453-4057qib7	5196	6	from	from	IN
cord-005453-4057qib7	5196	7	the	the	DT
cord-005453-4057qib7	5196	8	mothers	mother	NNS
cord-005453-4057qib7	5196	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	5196	10	immune	immune	JJ
cord-005453-4057qib7	5196	11	system	system	NN
cord-005453-4057qib7	5196	12	during	during	IN
cord-005453-4057qib7	5196	13	pregnancy	pregnancy	NN
cord-005453-4057qib7	5196	14	.	.	.
cord-005453-4057qib7	5197	1	We	-PRON-	PRP
cord-005453-4057qib7	5197	2	found	find	VBD
cord-005453-4057qib7	5197	3	that	that	IN
cord-005453-4057qib7	5197	4	maternal	maternal	JJ
cord-005453-4057qib7	5197	5	stromal	stromal	NN
cord-005453-4057qib7	5197	6	cells	cell	NNS
cord-005453-4057qib7	5197	7	from	from	IN
cord-005453-4057qib7	5197	8	the	the	DT
cord-005453-4057qib7	5197	9	fetal	fetal	JJ
cord-005453-4057qib7	5197	10	membrane	membrane	NN
cord-005453-4057qib7	5197	11	,	,	,
cord-005453-4057qib7	5197	12	so	so	CC
cord-005453-4057qib7	5197	13	called	call	VBN
cord-005453-4057qib7	5197	14	decidua	decidua	NN
cord-005453-4057qib7	5197	15	stromal	stromal	NN
cord-005453-4057qib7	5197	16	cells	cell	NNS
cord-005453-4057qib7	5197	17	(	(	-LRB-
cord-005453-4057qib7	5197	18	DSCs	dsc	NNS
cord-005453-4057qib7	5197	19	)	)	-RRB-
cord-005453-4057qib7	5197	20	were	be	VBD
cord-005453-4057qib7	5197	21	more	more	RBR
cord-005453-4057qib7	5197	22	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5197	23	than	than	IN
cord-005453-4057qib7	5197	24	other	other	JJ
cord-005453-4057qib7	5197	25	sources	source	NNS
cord-005453-4057qib7	5197	26	of	of	IN
cord-005453-4057qib7	5197	27	stromal	stromal	JJ
cord-005453-4057qib7	5197	28	cells	cell	NNS
cord-005453-4057qib7	5197	29	.	.	.
cord-005453-4057qib7	5198	1	Methods	method	NNS
cord-005453-4057qib7	5198	2	:	:	:
cord-005453-4057qib7	5198	3	We	-PRON-	PRP
cord-005453-4057qib7	5198	4	treated	treat	VBD
cord-005453-4057qib7	5198	5	21	21	CD
cord-005453-4057qib7	5198	6	patients	patient	NNS
cord-005453-4057qib7	5198	7	,	,	,
cord-005453-4057qib7	5198	8	median	median	NN
cord-005453-4057qib7	5198	9	49	49	CD
cord-005453-4057qib7	5198	10	years	year	NNS
cord-005453-4057qib7	5198	11	of	of	IN
cord-005453-4057qib7	5198	12	age	age	NN
cord-005453-4057qib7	5198	13	(	(	-LRB-
cord-005453-4057qib7	5198	14	range	range	VBP
cord-005453-4057qib7	5198	15	1.6	1.6	CD
cord-005453-4057qib7	5198	16	-	-	SYM
cord-005453-4057qib7	5198	17	72	72	CD
cord-005453-4057qib7	5198	18	)	)	-RRB-
cord-005453-4057qib7	5198	19	for	for	IN
cord-005453-4057qib7	5198	20	severe	severe	JJ
cord-005453-4057qib7	5198	21	acute	acute	JJ
cord-005453-4057qib7	5198	22	GVHD	GVHD	NNP
cord-005453-4057qib7	5198	23	.	.	.
cord-005453-4057qib7	5199	1	All	all	DT
cord-005453-4057qib7	5199	2	had	have	VBD
cord-005453-4057qib7	5199	3	biopsy	biopsy	NN
cord-005453-4057qib7	5199	4	proven	prove	VBN
cord-005453-4057qib7	5199	5	gastro	gastro	JJ
cord-005453-4057qib7	5199	6	-	-	JJ
cord-005453-4057qib7	5199	7	intestinal	intestinal	JJ
cord-005453-4057qib7	5199	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5199	9	.	.	.
cord-005453-4057qib7	5200	1	All	all	DT
cord-005453-4057qib7	5200	2	were	be	VBD
cord-005453-4057qib7	5200	3	steroid	steroid	NN
cord-005453-4057qib7	5200	4	refractory,11	refractory,11	NN
cord-005453-4057qib7	5200	5	after	after	IN
cord-005453-4057qib7	5200	6	>	>	XX
cord-005453-4057qib7	5200	7	7days	7days	CD
cord-005453-4057qib7	5200	8	or	or	CC
cord-005453-4057qib7	5200	9	with	with	IN
cord-005453-4057qib7	5200	10	progression	progression	NN
cord-005453-4057qib7	5200	11	and	and	CC
cord-005453-4057qib7	5200	12	10	10	CD
cord-005453-4057qib7	5200	13	after	after	IN
cord-005453-4057qib7	5200	14	>	>	XX
cord-005453-4057qib7	5200	15	3	3	CD
cord-005453-4057qib7	5200	16	days	day	NNS
cord-005453-4057qib7	5200	17	.	.	.
cord-005453-4057qib7	5201	1	We	-PRON-	PRP
cord-005453-4057qib7	5201	2	used	use	VBD
cord-005453-4057qib7	5201	3	an	an	DT
cord-005453-4057qib7	5201	4	improved	improved	JJ
cord-005453-4057qib7	5201	5	protocol	protocol	NN
cord-005453-4057qib7	5201	6	where	where	WRB
cord-005453-4057qib7	5201	7	DSCs	dsc	NNS
cord-005453-4057qib7	5201	8	were	be	VBD
cord-005453-4057qib7	5201	9	thawed	thaw	VBN
cord-005453-4057qib7	5201	10	and	and	CC
cord-005453-4057qib7	5201	11	infused	infuse	VBN
cord-005453-4057qib7	5201	12	in	in	IN
cord-005453-4057qib7	5201	13	a	a	DT
cord-005453-4057qib7	5201	14	buffer	buffer	NN
cord-005453-4057qib7	5201	15	with	with	IN
cord-005453-4057qib7	5201	16	5	5	CD
cord-005453-4057qib7	5201	17	%	%	NN
cord-005453-4057qib7	5201	18	albumin	albumin	NN
cord-005453-4057qib7	5201	19	.	.	.
cord-005453-4057qib7	5202	1	DSCs	DSCs	NNP
cord-005453-4057qib7	5202	2	were	be	VBD
cord-005453-4057qib7	5202	3	given	give	VBN
cord-005453-4057qib7	5202	4	at	at	IN
cord-005453-4057qib7	5202	5	a	a	DT
cord-005453-4057qib7	5202	6	median	median	JJ
cord-005453-4057qib7	5202	7	dose	dose	NN
cord-005453-4057qib7	5202	8	of	of	IN
cord-005453-4057qib7	5202	9	1.2	1.2	CD
cord-005453-4057qib7	5202	10	(	(	-LRB-
cord-005453-4057qib7	5202	11	0.9	0.9	CD
cord-005453-4057qib7	5202	12	-	-	SYM
cord-005453-4057qib7	5202	13	2.9	2.9	CD
cord-005453-4057qib7	5202	14	)	)	-RRB-
cord-005453-4057qib7	5202	15	x	x	SYM
cord-005453-4057qib7	5202	16	10	10	CD
cord-005453-4057qib7	5202	17	6	6	CD
cord-005453-4057qib7	5202	18	cells	cell	NNS
cord-005453-4057qib7	5202	19	/	/	SYM
cord-005453-4057qib7	5202	20	kg	kg	NNS
cord-005453-4057qib7	5202	21	and	and	CC
cord-005453-4057qib7	5202	22	2(1	2(1	NNP
cord-005453-4057qib7	5202	23	-	-	HYPH
cord-005453-4057qib7	5202	24	6	6	CD
cord-005453-4057qib7	5202	25	)	)	-RRB-
cord-005453-4057qib7	5202	26	doses	dose	NNS
cord-005453-4057qib7	5202	27	,	,	,
cord-005453-4057qib7	5202	28	given	give	VBN
cord-005453-4057qib7	5202	29	one	one	CD
cord-005453-4057qib7	5202	30	week	week	NN
cord-005453-4057qib7	5202	31	apart	apart	RB
cord-005453-4057qib7	5202	32	.	.	.
cord-005453-4057qib7	5203	1	Viability	viability	NN
cord-005453-4057qib7	5203	2	of	of	IN
cord-005453-4057qib7	5203	3	frozen	frozen	JJ
cord-005453-4057qib7	5203	4	and	and	CC
cord-005453-4057qib7	5203	5	thawed	thaw	VBN
cord-005453-4057qib7	5203	6	DSCs	dsc	NNS
cord-005453-4057qib7	5203	7	was	be	VBD
cord-005453-4057qib7	5203	8	95	95	CD
cord-005453-4057qib7	5203	9	%	%	NN
cord-005453-4057qib7	5203	10	(	(	-LRB-
cord-005453-4057qib7	5203	11	89	89	CD
cord-005453-4057qib7	5203	12	-	-	SYM
cord-005453-4057qib7	5203	13	100	100	CD
cord-005453-4057qib7	5203	14	)	)	-RRB-
cord-005453-4057qib7	5203	15	and	and	CC
cord-005453-4057qib7	5203	16	cell	cell	NN
cord-005453-4057qib7	5203	17	passage	passage	NN
cord-005453-4057qib7	5203	18	was	be	VBD
cord-005453-4057qib7	5203	19	4	4	CD
cord-005453-4057qib7	5203	20	(	(	-LRB-
cord-005453-4057qib7	5203	21	2	2	CD
cord-005453-4057qib7	5203	22	-	-	SYM
cord-005453-4057qib7	5203	23	4	4	CD
cord-005453-4057qib7	5203	24	)	)	-RRB-
cord-005453-4057qib7	5203	25	.	.	.
cord-005453-4057qib7	5204	1	Results	result	NNS
cord-005453-4057qib7	5204	2	:	:	:
cord-005453-4057qib7	5205	1	Complete	complete	JJ
cord-005453-4057qib7	5205	2	resolution	resolution	NN
cord-005453-4057qib7	5205	3	of	of	IN
cord-005453-4057qib7	5205	4	GVHD	GVHD	NNP
cord-005453-4057qib7	5205	5	was	be	VBD
cord-005453-4057qib7	5205	6	seen	see	VBN
cord-005453-4057qib7	5205	7	in	in	IN
cord-005453-4057qib7	5205	8	11	11	CD
cord-005453-4057qib7	5205	9	patients	patient	NNS
cord-005453-4057qib7	5205	10	and	and	CC
cord-005453-4057qib7	5205	11	10	10	CD
cord-005453-4057qib7	5205	12	had	have	VBD
cord-005453-4057qib7	5205	13	a	a	DT
cord-005453-4057qib7	5205	14	partial	partial	JJ
cord-005453-4057qib7	5205	15	response	response	NN
cord-005453-4057qib7	5205	16	.	.	.
cord-005453-4057qib7	5206	1	The	the	DT
cord-005453-4057qib7	5206	2	cumulative	cumulative	JJ
cord-005453-4057qib7	5206	3	incidence	incidence	NN
cord-005453-4057qib7	5206	4	of	of	IN
cord-005453-4057qib7	5206	5	chronic	chronic	JJ
cord-005453-4057qib7	5206	6	GVHD	GVHD	NNP
cord-005453-4057qib7	5206	7	was	be	VBD
cord-005453-4057qib7	5206	8	52	52	CD
cord-005453-4057qib7	5206	9	%	%	NN
cord-005453-4057qib7	5206	10	.	.	.
cord-005453-4057qib7	5207	1	Six	six	CD
cord-005453-4057qib7	5207	2	had	have	VBD
cord-005453-4057qib7	5207	3	mild	mild	JJ
cord-005453-4057qib7	5207	4	,	,	,
cord-005453-4057qib7	5207	5	4	4	CD
cord-005453-4057qib7	5207	6	moderate	moderate	JJ
cord-005453-4057qib7	5207	7	and	and	CC
cord-005453-4057qib7	5207	8	one	one	CD
cord-005453-4057qib7	5207	9	severe	severe	JJ
cord-005453-4057qib7	5207	10	NIH	NIH	NNP
cord-005453-4057qib7	5207	11	overall	overall	JJ
cord-005453-4057qib7	5207	12	GVHD	GVHD	NNP
cord-005453-4057qib7	5207	13	severity	severity	NN
cord-005453-4057qib7	5207	14	scoring	scoring	NN
cord-005453-4057qib7	5207	15	.	.	.
cord-005453-4057qib7	5208	1	Nine	nine	CD
cord-005453-4057qib7	5208	2	patients	patient	NNS
cord-005453-4057qib7	5208	3	died	die	VBD
cord-005453-4057qib7	5208	4	,	,	,
cord-005453-4057qib7	5208	5	3	3	CD
cord-005453-4057qib7	5208	6	from	from	IN
cord-005453-4057qib7	5208	7	relapse	relapse	NN
cord-005453-4057qib7	5208	8	,	,	,
cord-005453-4057qib7	5208	9	1	1	CD
cord-005453-4057qib7	5208	10	acute	acute	JJ
cord-005453-4057qib7	5208	11	GVHD	GVHD	NNP
cord-005453-4057qib7	5208	12	and	and	CC
cord-005453-4057qib7	5208	13	septicemia	septicemia	NN
cord-005453-4057qib7	5208	14	,	,	,
cord-005453-4057qib7	5208	15	1	1	CD
cord-005453-4057qib7	5208	16	zygomycetes	zygomycetes	NN
cord-005453-4057qib7	5208	17	infection	infection	NN
cord-005453-4057qib7	5208	18	,	,	,
cord-005453-4057qib7	5208	19	1	1	CD
cord-005453-4057qib7	5208	20	liver	liver	NN
cord-005453-4057qib7	5208	21	insufficiency	insufficiency	NN
cord-005453-4057qib7	5208	22	,	,	,
cord-005453-4057qib7	5208	23	1	1	CD
cord-005453-4057qib7	5208	24	cerebral	cerebral	JJ
cord-005453-4057qib7	5208	25	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	5208	26	,	,	,
cord-005453-4057qib7	5208	27	1multiorgan	1multiorgan	CD
cord-005453-4057qib7	5208	28	failure	failure	NN
cord-005453-4057qib7	5208	29	and	and	CC
cord-005453-4057qib7	5208	30	1	1	CD
cord-005453-4057qib7	5208	31	chronic	chronic	JJ
cord-005453-4057qib7	5208	32	GVHD	GVHD	NNP
cord-005453-4057qib7	5208	33	with	with	IN
cord-005453-4057qib7	5208	34	obstructive	obstructive	JJ
cord-005453-4057qib7	5208	35	bronchiolitis	bronchiolitis	NN
cord-005453-4057qib7	5208	36	.	.	.
cord-005453-4057qib7	5209	1	Four	four	CD
cord-005453-4057qib7	5209	2	years	year	NNS
cord-005453-4057qib7	5209	3	transplant	transplant	NN
cord-005453-4057qib7	5209	4	related	relate	VBN
cord-005453-4057qib7	5209	5	mortalliy	mortalliy	NNP
cord-005453-4057qib7	5209	6	was	be	VBD
cord-005453-4057qib7	5209	7	28.6	28.6	CD
cord-005453-4057qib7	5209	8	%	%	NN
cord-005453-4057qib7	5209	9	and	and	CC
cord-005453-4057qib7	5209	10	overall	overall	JJ
cord-005453-4057qib7	5209	11	survival	survival	NN
cord-005453-4057qib7	5209	12	was	be	VBD
cord-005453-4057qib7	5209	13	57	57	CD
cord-005453-4057qib7	5209	14	%	%	NN
cord-005453-4057qib7	5209	15	.	.	.
cord-005453-4057qib7	5210	1	Survival	survival	NN
cord-005453-4057qib7	5210	2	was	be	VBD
cord-005453-4057qib7	5210	3	not	not	RB
cord-005453-4057qib7	5210	4	significantly	significantly	RB
cord-005453-4057qib7	5210	5	worse	bad	JJR
cord-005453-4057qib7	5211	1	(	(	-LRB-
cord-005453-4057qib7	5211	2	p=0.33	p=0.33	NNP
cord-005453-4057qib7	5211	3	)	)	-RRB-
cord-005453-4057qib7	5211	4	than	than	IN
cord-005453-4057qib7	5211	5	66	66	CD
cord-005453-4057qib7	5211	6	%	%	NN
cord-005453-4057qib7	5211	7	for	for	IN
cord-005453-4057qib7	5211	8	all	all	DT
cord-005453-4057qib7	5211	9	293	293	CD
cord-005453-4057qib7	5211	10	patients	patient	NNS
cord-005453-4057qib7	5211	11	undergoing	undergo	VBG
cord-005453-4057qib7	5211	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	5211	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5211	14	cell	cell	NN
cord-005453-4057qib7	5211	15	transplantation	transplantation	NN
cord-005453-4057qib7	5211	16	during	during	IN
cord-005453-4057qib7	5211	17	the	the	DT
cord-005453-4057qib7	5211	18	same	same	JJ
cord-005453-4057qib7	5211	19	period	period	NN
cord-005453-4057qib7	5211	20	2012	2012	CD
cord-005453-4057qib7	5211	21	-	-	SYM
cord-005453-4057qib7	5211	22	2015	2015	CD
cord-005453-4057qib7	5211	23	.	.	.
cord-005453-4057qib7	5212	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5212	2	:	:	:
cord-005453-4057qib7	5213	1	To	to	TO
cord-005453-4057qib7	5213	2	conclude	conclude	VB
cord-005453-4057qib7	5213	3	,	,	,
cord-005453-4057qib7	5213	4	DSCs	DSCs	NNP
cord-005453-4057qib7	5213	5	seems	seem	VBZ
cord-005453-4057qib7	5213	6	to	to	TO
cord-005453-4057qib7	5213	7	be	be	VB
cord-005453-4057qib7	5213	8	a	a	DT
cord-005453-4057qib7	5213	9	promising	promising	JJ
cord-005453-4057qib7	5213	10	therapy	therapy	NN
cord-005453-4057qib7	5213	11	for	for	IN
cord-005453-4057qib7	5213	12	severe	severe	JJ
cord-005453-4057qib7	5213	13	acute	acute	JJ
cord-005453-4057qib7	5213	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5213	15	.	.	.
cord-005453-4057qib7	5214	1	Randomized	randomized	JJ
cord-005453-4057qib7	5214	2	trials	trial	NNS
cord-005453-4057qib7	5214	3	are	be	VBP
cord-005453-4057qib7	5214	4	under	under	IN
cord-005453-4057qib7	5214	5	way	way	NN
cord-005453-4057qib7	5214	6	.	.	.
cord-005453-4057qib7	5215	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5215	2	:	:	:
cord-005453-4057qib7	5215	3	Nothing	nothing	NN
cord-005453-4057qib7	5215	4	to	to	TO
cord-005453-4057qib7	5215	5	declare	declare	VB
cord-005453-4057qib7	5215	6	P237	P237	NNP
cord-005453-4057qib7	5215	7	Anti	anti	JJ
cord-005453-4057qib7	5215	8	-	-	JJ
cord-005453-4057qib7	5215	9	apoptotic	apoptotic	JJ
cord-005453-4057qib7	5215	10	protein	protein	NN
cord-005453-4057qib7	5215	11	BCL-2	BCL-2	NNP
cord-005453-4057qib7	5215	12	is	be	VBZ
cord-005453-4057qib7	5215	13	upregulated	upregulate	VBN
cord-005453-4057qib7	5215	14	in	in	IN
cord-005453-4057qib7	5215	15	graftversus	graftversus	NNP
cord-005453-4057qib7	5215	16	-	-	HYPH
cord-005453-4057qib7	5215	17	host	host	NN
cord-005453-4057qib7	5215	18	disease	disease	NN
cord-005453-4057qib7	5215	19	stem	stem	NN
cord-005453-4057qib7	5215	20	cell	cell	NN
cord-005453-4057qib7	5215	21	transplantation	transplantation	NN
cord-005453-4057qib7	5215	22	(	(	-LRB-
cord-005453-4057qib7	5215	23	allo	allo	NN
cord-005453-4057qib7	5215	24	-	-	HYPH
cord-005453-4057qib7	5215	25	HSCT	HSCT	NNP
cord-005453-4057qib7	5215	26	)	)	-RRB-
cord-005453-4057qib7	5215	27	with	with	IN
cord-005453-4057qib7	5215	28	30	30	CD
cord-005453-4057qib7	5215	29	-	-	SYM
cord-005453-4057qib7	5215	30	80	80	CD
cord-005453-4057qib7	5215	31	%	%	NN
cord-005453-4057qib7	5215	32	developing	develop	VBG
cord-005453-4057qib7	5215	33	either	either	CC
cord-005453-4057qib7	5215	34	acute	acute	JJ
cord-005453-4057qib7	5215	35	or	or	CC
cord-005453-4057qib7	5215	36	chronic	chronic	JJ
cord-005453-4057qib7	5215	37	GVHD	GVHD	NNP
cord-005453-4057qib7	5215	38	.	.	.
cord-005453-4057qib7	5216	1	Recently	recently	RB
cord-005453-4057qib7	5216	2	,	,	,
cord-005453-4057qib7	5216	3	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5216	4	inhibitor	inhibitor	NN
cord-005453-4057qib7	5216	5	Venetoclax	Venetoclax	NNP
cord-005453-4057qib7	5216	6	was	be	VBD
cord-005453-4057qib7	5216	7	approved	approve	VBN
cord-005453-4057qib7	5216	8	for	for	IN
cord-005453-4057qib7	5216	9	treatment	treatment	NN
cord-005453-4057qib7	5216	10	of	of	IN
cord-005453-4057qib7	5216	11	chronic	chronic	JJ
cord-005453-4057qib7	5216	12	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	5216	13	leukemia	leukemia	NN
cord-005453-4057qib7	5216	14	.	.	.
cord-005453-4057qib7	5217	1	Induction	induction	NN
cord-005453-4057qib7	5217	2	of	of	IN
cord-005453-4057qib7	5217	3	apoptosis	apoptosis	NN
cord-005453-4057qib7	5217	4	and	and	CC
cord-005453-4057qib7	5217	5	depletion	depletion	NN
cord-005453-4057qib7	5217	6	of	of	IN
cord-005453-4057qib7	5217	7	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5217	8	subpopulations	subpopulation	NNS
cord-005453-4057qib7	5217	9	e.g.	e.g.	RB
cord-005453-4057qib7	5217	10	follicular	follicular	JJ
cord-005453-4057qib7	5217	11	B	b	NN
cord-005453-4057qib7	5217	12	-	-	HYPH
cord-005453-4057qib7	5217	13	cells	cell	NNS
cord-005453-4057qib7	5217	14	or	or	CC
cord-005453-4057qib7	5217	15	CD4	CD4	NNP
cord-005453-4057qib7	5217	16	+	+	CC
cord-005453-4057qib7	5217	17	and	and	CC
cord-005453-4057qib7	5217	18	CD8	CD8	NNP
cord-005453-4057qib7	5217	19	+	+	CC
cord-005453-4057qib7	5217	20	T	T	NNP
cord-005453-4057qib7	5217	21	-	-	HYPH
cord-005453-4057qib7	5217	22	cells	cell	NNS
cord-005453-4057qib7	5217	23	led	lead	VBD
cord-005453-4057qib7	5217	24	to	to	IN
cord-005453-4057qib7	5217	25	further	further	JJ
cord-005453-4057qib7	5217	26	exploration	exploration	NN
cord-005453-4057qib7	5217	27	in	in	IN
cord-005453-4057qib7	5217	28	autoimmune	autoimmune	JJ
cord-005453-4057qib7	5217	29	disease	disease	NN
cord-005453-4057qib7	5217	30	.	.	.
cord-005453-4057qib7	5218	1	Methods	method	NNS
cord-005453-4057qib7	5218	2	:	:	:
cord-005453-4057qib7	5218	3	To	to	TO
cord-005453-4057qib7	5218	4	establish	establish	VB
cord-005453-4057qib7	5218	5	expression	expression	NN
cord-005453-4057qib7	5218	6	levels	level	NNS
cord-005453-4057qib7	5218	7	of	of	IN
cord-005453-4057qib7	5218	8	genes	gene	NNS
cord-005453-4057qib7	5218	9	in	in	IN
cord-005453-4057qib7	5218	10	the	the	DT
cord-005453-4057qib7	5218	11	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5218	12	pathway	pathway	NN
cord-005453-4057qib7	5218	13	,	,	,
cord-005453-4057qib7	5218	14	low	low	JJ
cord-005453-4057qib7	5218	15	-	-	HYPH
cord-005453-4057qib7	5218	16	input	input	NN
cord-005453-4057qib7	5218	17	RNA	RNA	NNP
cord-005453-4057qib7	5218	18	sequencing	sequencing	NN
cord-005453-4057qib7	5218	19	was	be	VBD
cord-005453-4057qib7	5218	20	performed	perform	VBN
cord-005453-4057qib7	5218	21	on	on	IN
cord-005453-4057qib7	5218	22	T	T	NNP
cord-005453-4057qib7	5218	23	cells	cell	NNS
cord-005453-4057qib7	5218	24	isolated	isolate	VBN
cord-005453-4057qib7	5218	25	from	from	IN
cord-005453-4057qib7	5218	26	non	non	JJ
cord-005453-4057qib7	5218	27	-	-	JJ
cord-005453-4057qib7	5218	28	inflamed	inflamed	JJ
cord-005453-4057qib7	5218	29	skin	skin	NN
cord-005453-4057qib7	5218	30	and	and	CC
cord-005453-4057qib7	5218	31	peripheral	peripheral	JJ
cord-005453-4057qib7	5218	32	blood	blood	NN
cord-005453-4057qib7	5218	33	of	of	IN
cord-005453-4057qib7	5218	34	HSCT	HSCT	NNP
cord-005453-4057qib7	5218	35	recipients	recipient	NNS
cord-005453-4057qib7	5218	36	at	at	IN
cord-005453-4057qib7	5218	37	5	5	CD
cord-005453-4057qib7	5218	38	different	different	JJ
cord-005453-4057qib7	5218	39	time	time	NN
cord-005453-4057qib7	5218	40	points	point	NNS
cord-005453-4057qib7	5218	41	before	before	RB
cord-005453-4057qib7	5218	42	until	until	IN
cord-005453-4057qib7	5218	43	1	1	CD
cord-005453-4057qib7	5218	44	year	year	NN
cord-005453-4057qib7	5218	45	after	after	IN
cord-005453-4057qib7	5218	46	transplantation	transplantation	NN
cord-005453-4057qib7	5218	47	.	.	.
cord-005453-4057qib7	5219	1	Furthermore	furthermore	RB
cord-005453-4057qib7	5219	2	,	,	,
cord-005453-4057qib7	5219	3	we	-PRON-	PRP
cord-005453-4057qib7	5219	4	analyzed	analyze	VBD
cord-005453-4057qib7	5219	5	blood	blood	NN
cord-005453-4057qib7	5219	6	,	,	,
cord-005453-4057qib7	5219	7	lung	lung	NN
cord-005453-4057qib7	5219	8	,	,	,
cord-005453-4057qib7	5219	9	gut	gut	NN
cord-005453-4057qib7	5219	10	and	and	CC
cord-005453-4057qib7	5219	11	skin	skin	NN
cord-005453-4057qib7	5219	12	samples	sample	NNS
cord-005453-4057qib7	5219	13	of	of	IN
cord-005453-4057qib7	5219	14	105	105	CD
cord-005453-4057qib7	5219	15	patients	patient	NNS
cord-005453-4057qib7	5219	16	post	post	VBP
cord-005453-4057qib7	5219	17	allo	allo	NN
cord-005453-4057qib7	5219	18	-	-	HYPH
cord-005453-4057qib7	5219	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5219	20	with	with	IN
cord-005453-4057qib7	5219	21	and	and	CC
cord-005453-4057qib7	5219	22	without	without	IN
cord-005453-4057qib7	5219	23	previously	previously	RB
cord-005453-4057qib7	5219	24	untreated	untreated	JJ
cord-005453-4057qib7	5219	25	acute	acute	JJ
cord-005453-4057qib7	5219	26	or	or	CC
cord-005453-4057qib7	5219	27	chronic	chronic	JJ
cord-005453-4057qib7	5219	28	GVHD	GVHD	NNP
cord-005453-4057qib7	5219	29	by	by	IN
cord-005453-4057qib7	5219	30	RT	RT	NNP
cord-005453-4057qib7	5219	31	-	-	HYPH
cord-005453-4057qib7	5219	32	PCR	PCR	NNP
cord-005453-4057qib7	5219	33	,	,	,
cord-005453-4057qib7	5219	34	flow	flow	NN
cord-005453-4057qib7	5219	35	cytometry	cytometry	NN
cord-005453-4057qib7	5219	36	and	and	CC
cord-005453-4057qib7	5219	37	tissue	tissue	NN
cord-005453-4057qib7	5219	38	immunofluorescence	immunofluorescence	NN
cord-005453-4057qib7	5219	39	.	.	.
cord-005453-4057qib7	5220	1	[	[	-LRB-
cord-005453-4057qib7	5220	2	[	[	-LRB-
cord-005453-4057qib7	5220	3	P237	p237	CD
cord-005453-4057qib7	5220	4	Image	image	NN
cord-005453-4057qib7	5220	5	]	]	-RRB-
cord-005453-4057qib7	5220	6	1	1	CD
cord-005453-4057qib7	5220	7	.	.	.
cord-005453-4057qib7	5221	1	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5221	2	is	be	VBZ
cord-005453-4057qib7	5221	3	up	up	RB
cord-005453-4057qib7	5221	4	-	-	HYPH
cord-005453-4057qib7	5221	5	regulated	regulate	VBN
cord-005453-4057qib7	5221	6	in	in	IN
cord-005453-4057qib7	5221	7	T	T	NNP
cord-005453-4057qib7	5221	8	and	and	CC
cord-005453-4057qib7	5221	9	B	b	NN
cord-005453-4057qib7	5221	10	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	5221	11	of	of	IN
cord-005453-4057qib7	5221	12	acute	acute	JJ
cord-005453-4057qib7	5221	13	and	and	CC
cord-005453-4057qib7	5221	14	chronic	chronic	JJ
cord-005453-4057qib7	5221	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5221	16	lesions	lesion	NNS
cord-005453-4057qib7	5221	17	.	.	.
cord-005453-4057qib7	5221	18	]	]	-RRB-
cord-005453-4057qib7	5222	1	Results	result	NNS
cord-005453-4057qib7	5222	2	:	:	:
cord-005453-4057qib7	5223	1	RNA	rna	NN
cord-005453-4057qib7	5223	2	-	-	HYPH
cord-005453-4057qib7	5223	3	sequencing	sequencing	NN
cord-005453-4057qib7	5223	4	revealed	reveal	VBD
cord-005453-4057qib7	5223	5	that	that	IN
cord-005453-4057qib7	5223	6	T	T	NNP
cord-005453-4057qib7	5223	7	cells	cell	NNS
cord-005453-4057qib7	5223	8	upregulated	upregulate	VBD
cord-005453-4057qib7	5223	9	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5223	10	upon	upon	IN
cord-005453-4057qib7	5223	11	conditioning	conditioning	NN
cord-005453-4057qib7	5223	12	treatment	treatment	NN
cord-005453-4057qib7	5223	13	(	(	-LRB-
cord-005453-4057qib7	5223	14	day	day	NN
cord-005453-4057qib7	5223	15	0	0	CD
cord-005453-4057qib7	5223	16	)	)	-RRB-
cord-005453-4057qib7	5223	17	and	and	CC
cord-005453-4057qib7	5223	18	cells	cell	NNS
cord-005453-4057qib7	5223	19	of	of	IN
cord-005453-4057qib7	5223	20	patients	patient	NNS
cord-005453-4057qib7	5223	21	who	who	WP
cord-005453-4057qib7	5223	22	later	later	RB
cord-005453-4057qib7	5223	23	developed	develop	VBD
cord-005453-4057qib7	5223	24	GVHD	GVHD	NNP
cord-005453-4057qib7	5223	25	failed	fail	VBD
cord-005453-4057qib7	5223	26	to	to	TO
cord-005453-4057qib7	5223	27	downregulate	downregulate	VB
cord-005453-4057qib7	5223	28	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5223	29	after	after	IN
cord-005453-4057qib7	5223	30	transplantation	transplantation	NN
cord-005453-4057qib7	5223	31	(	(	-LRB-
cord-005453-4057qib7	5223	32	day+14	day+14	CD
cord-005453-4057qib7	5223	33	,	,	,
cord-005453-4057qib7	5223	34	day+100	day+100	NNP
cord-005453-4057qib7	5223	35	)	)	-RRB-
cord-005453-4057qib7	5223	36	.	.	.
cord-005453-4057qib7	5224	1	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5224	2	protein	protein	NN
cord-005453-4057qib7	5224	3	levels	level	NNS
cord-005453-4057qib7	5224	4	were	be	VBD
cord-005453-4057qib7	5224	5	elevated	elevate	VBN
cord-005453-4057qib7	5224	6	in	in	IN
cord-005453-4057qib7	5224	7	overall	overall	JJ
cord-005453-4057qib7	5224	8	leukocytes	leukocyte	NNS
cord-005453-4057qib7	5224	9	and	and	CC
cord-005453-4057qib7	5224	10	pathogenic	pathogenic	JJ
cord-005453-4057qib7	5224	11	cell	cell	NN
cord-005453-4057qib7	5224	12	subsets	subset	NNS
cord-005453-4057qib7	5224	13	including	include	VBG
cord-005453-4057qib7	5224	14	monocytes	monocyte	NNS
cord-005453-4057qib7	5224	15	,	,	,
cord-005453-4057qib7	5224	16	CD8	CD8	NNP
cord-005453-4057qib7	5224	17	+	+	CC
cord-005453-4057qib7	5224	18	T	T	NNP
cord-005453-4057qib7	5224	19	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	5224	20	and	and	CC
cord-005453-4057qib7	5224	21	NKT	NKT	NNP
cord-005453-4057qib7	5224	22	cells	cell	NNS
cord-005453-4057qib7	5224	23	showed	show	VBD
cord-005453-4057qib7	5224	24	significantly	significantly	RB
cord-005453-4057qib7	5224	25	higher	high	JJR
cord-005453-4057qib7	5224	26	expression	expression	NN
cord-005453-4057qib7	5224	27	of	of	IN
cord-005453-4057qib7	5224	28	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5224	29	in	in	IN
cord-005453-4057qib7	5224	30	peripheral	peripheral	JJ
cord-005453-4057qib7	5224	31	blood	blood	NN
cord-005453-4057qib7	5224	32	of	of	IN
cord-005453-4057qib7	5224	33	GVHD	GVHD	NNP
cord-005453-4057qib7	5224	34	patients	patient	NNS
cord-005453-4057qib7	5224	35	as	as	IN
cord-005453-4057qib7	5224	36	compared	compare	VBN
cord-005453-4057qib7	5224	37	to	to	IN
cord-005453-4057qib7	5224	38	healthy	healthy	JJ
cord-005453-4057qib7	5224	39	controls	control	NNS
cord-005453-4057qib7	5224	40	.	.	.
cord-005453-4057qib7	5225	1	These	these	DT
cord-005453-4057qib7	5225	2	results	result	NNS
cord-005453-4057qib7	5225	3	could	could	MD
cord-005453-4057qib7	5225	4	be	be	VB
cord-005453-4057qib7	5225	5	recapitulated	recapitulate	VBN
cord-005453-4057qib7	5225	6	in	in	IN
cord-005453-4057qib7	5225	7	tissue	tissue	NN
cord-005453-4057qib7	5225	8	samples	sample	NNS
cord-005453-4057qib7	5225	9	,	,	,
cord-005453-4057qib7	5225	10	where	where	WRB
cord-005453-4057qib7	5225	11	disease	disease	NN
cord-005453-4057qib7	5225	12	-	-	HYPH
cord-005453-4057qib7	5225	13	promoting	promote	VBG
cord-005453-4057qib7	5225	14	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	5225	15	(	(	-LRB-
cord-005453-4057qib7	5225	16	T	T	NNP
cord-005453-4057qib7	5225	17	,	,	,
cord-005453-4057qib7	5225	18	B	B	NNP
cord-005453-4057qib7	5225	19	,	,	,
cord-005453-4057qib7	5225	20	NK	NK	NNP
cord-005453-4057qib7	5225	21	,	,	,
cord-005453-4057qib7	5225	22	NKT	NKT	NNP
cord-005453-4057qib7	5225	23	)	)	-RRB-
cord-005453-4057qib7	5225	24	were	be	VBD
cord-005453-4057qib7	5225	25	numerically	numerically	RB
cord-005453-4057qib7	5225	26	expanded	expand	VBN
cord-005453-4057qib7	5225	27	and	and	CC
cord-005453-4057qib7	5225	28	expressed	express	VBD
cord-005453-4057qib7	5225	29	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5225	30	in	in	IN
cord-005453-4057qib7	5225	31	acute	acute	JJ
cord-005453-4057qib7	5225	32	and	and	CC
cord-005453-4057qib7	5225	33	chronic	chronic	JJ
cord-005453-4057qib7	5225	34	GVHD	GVHD	NNP
cord-005453-4057qib7	5225	35	skin	skin	NN
cord-005453-4057qib7	5225	36	lesions	lesion	NNS
cord-005453-4057qib7	5225	37	.	.	.
cord-005453-4057qib7	5226	1	Notably	notably	RB
cord-005453-4057qib7	5226	2	,	,	,
cord-005453-4057qib7	5226	3	non	non	JJ
cord-005453-4057qib7	5226	4	-	-	JJ
cord-005453-4057qib7	5226	5	pathogenic	pathogenic	JJ
cord-005453-4057qib7	5226	6	cell	cell	NN
cord-005453-4057qib7	5226	7	types	type	NNS
cord-005453-4057qib7	5226	8	such	such	JJ
cord-005453-4057qib7	5226	9	as	as	IN
cord-005453-4057qib7	5226	10	keratinocytes	keratinocyte	NNS
cord-005453-4057qib7	5226	11	did	do	VBD
cord-005453-4057qib7	5226	12	not	not	RB
cord-005453-4057qib7	5226	13	exhibit	exhibit	VB
cord-005453-4057qib7	5226	14	increased	increase	VBN
cord-005453-4057qib7	5226	15	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5226	16	expression	expression	NN
cord-005453-4057qib7	5226	17	compared	compare	VBN
cord-005453-4057qib7	5226	18	to	to	TO
cord-005453-4057qib7	5226	19	control	control	VB
cord-005453-4057qib7	5226	20	samples	sample	NNS
cord-005453-4057qib7	5226	21	from	from	IN
cord-005453-4057qib7	5226	22	HSCT	HSCT	NNP
cord-005453-4057qib7	5226	23	recipients	recipient	NNS
cord-005453-4057qib7	5226	24	and	and	CC
cord-005453-4057qib7	5226	25	healthy	healthy	JJ
cord-005453-4057qib7	5226	26	donors	donor	NNS
cord-005453-4057qib7	5226	27	.	.	.
cord-005453-4057qib7	5227	1	While	while	IN
cord-005453-4057qib7	5227	2	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5227	3	RNA	RNA	NNP
cord-005453-4057qib7	5227	4	expression	expression	NN
cord-005453-4057qib7	5227	5	did	do	VBD
cord-005453-4057qib7	5227	6	not	not	RB
cord-005453-4057qib7	5227	7	depend	depend	VB
cord-005453-4057qib7	5227	8	on	on	IN
cord-005453-4057qib7	5227	9	type	type	NN
cord-005453-4057qib7	5227	10	of	of	IN
cord-005453-4057qib7	5227	11	conditioning	conditioning	NN
cord-005453-4057qib7	5227	12	(	(	-LRB-
cord-005453-4057qib7	5227	13	MAC	MAC	NNP
cord-005453-4057qib7	5227	14	vs.	vs.	FW
cord-005453-4057qib7	5227	15	RIC	RIC	NNP
cord-005453-4057qib7	5227	16	)	)	-RRB-
cord-005453-4057qib7	5227	17	or	or	CC
cord-005453-4057qib7	5227	18	GVHD	GVHD	NNP
cord-005453-4057qib7	5227	19	grade	grade	NN
cord-005453-4057qib7	5227	20	,	,	,
cord-005453-4057qib7	5227	21	it	-PRON-	PRP
cord-005453-4057qib7	5227	22	correlated	correlate	VBD
cord-005453-4057qib7	5227	23	to	to	IN
cord-005453-4057qib7	5227	24	disease	disease	NN
cord-005453-4057qib7	5227	25	severity	severity	NN
cord-005453-4057qib7	5227	26	and	and	CC
cord-005453-4057qib7	5227	27	was	be	VBD
cord-005453-4057qib7	5227	28	significantly	significantly	RB
cord-005453-4057qib7	5227	29	elevated	elevate	VBN
cord-005453-4057qib7	5227	30	in	in	IN
cord-005453-4057qib7	5227	31	biopsies	biopsy	NNS
cord-005453-4057qib7	5227	32	of	of	IN
cord-005453-4057qib7	5227	33	patients	patient	NNS
cord-005453-4057qib7	5227	34	with	with	IN
cord-005453-4057qib7	5227	35	steroidrefractory	steroidrefractory	NNP
cord-005453-4057qib7	5227	36	GVHD	GVHD	NNP
cord-005453-4057qib7	5227	37	.	.	.
cord-005453-4057qib7	5228	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5228	2	:	:	:
cord-005453-4057qib7	5229	1	We	-PRON-	PRP
cord-005453-4057qib7	5229	2	could	could	MD
cord-005453-4057qib7	5229	3	show	show	VB
cord-005453-4057qib7	5229	4	exclusive	exclusive	JJ
cord-005453-4057qib7	5229	5	upregulation	upregulation	NN
cord-005453-4057qib7	5229	6	of	of	IN
cord-005453-4057qib7	5229	7	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5229	8	in	in	IN
cord-005453-4057qib7	5229	9	GVHD	GVHD	NNP
cord-005453-4057qib7	5229	10	-	-	HYPH
cord-005453-4057qib7	5229	11	mediating	mediate	VBG
cord-005453-4057qib7	5229	12	cell	cell	NN
cord-005453-4057qib7	5229	13	types	type	NNS
cord-005453-4057qib7	5229	14	in	in	IN
cord-005453-4057qib7	5229	15	peripheral	peripheral	JJ
cord-005453-4057qib7	5229	16	blood	blood	NN
cord-005453-4057qib7	5229	17	and	and	CC
cord-005453-4057qib7	5229	18	tissue	tissue	NN
cord-005453-4057qib7	5229	19	samples	sample	NNS
cord-005453-4057qib7	5229	20	affected	affect	VBN
cord-005453-4057qib7	5229	21	by	by	IN
cord-005453-4057qib7	5229	22	GVHD	GVHD	NNP
cord-005453-4057qib7	5229	23	,	,	,
cord-005453-4057qib7	5229	24	correlating	correlate	VBG
cord-005453-4057qib7	5229	25	to	to	IN
cord-005453-4057qib7	5229	26	GVHD	GVHD	NNP
cord-005453-4057qib7	5229	27	severity	severity	NN
cord-005453-4057qib7	5229	28	and	and	CC
cord-005453-4057qib7	5229	29	response	response	NN
cord-005453-4057qib7	5229	30	to	to	IN
cord-005453-4057qib7	5229	31	first	first	JJ
cord-005453-4057qib7	5229	32	-	-	HYPH
cord-005453-4057qib7	5229	33	line	line	NN
cord-005453-4057qib7	5229	34	therapy	therapy	NN
cord-005453-4057qib7	5229	35	.	.	.
cord-005453-4057qib7	5230	1	Thus	thus	RB
cord-005453-4057qib7	5230	2	,	,	,
cord-005453-4057qib7	5230	3	Bcl-2	Bcl-2	NNP
cord-005453-4057qib7	5230	4	inhibition	inhibition	NN
cord-005453-4057qib7	5230	5	may	may	MD
cord-005453-4057qib7	5230	6	present	present	VB
cord-005453-4057qib7	5230	7	a	a	DT
cord-005453-4057qib7	5230	8	novel	novel	NN
cord-005453-4057qib7	5230	9	and	and	CC
cord-005453-4057qib7	5230	10	urgently	urgently	RB
cord-005453-4057qib7	5230	11	needed	need	VBN
cord-005453-4057qib7	5230	12	targeted	target	VBN
cord-005453-4057qib7	5230	13	therapy	therapy	NN
cord-005453-4057qib7	5230	14	in	in	IN
cord-005453-4057qib7	5230	15	treatment	treatment	NN
cord-005453-4057qib7	5230	16	of	of	IN
cord-005453-4057qib7	5230	17	steroid	steroid	NN
cord-005453-4057qib7	5230	18	-	-	HYPH
cord-005453-4057qib7	5230	19	refractory	refractory	JJ
cord-005453-4057qib7	5230	20	acute	acute	NN
cord-005453-4057qib7	5230	21	and	and	CC
cord-005453-4057qib7	5230	22	chronic	chronic	JJ
cord-005453-4057qib7	5230	23	GVHD	GVHD	NNP
cord-005453-4057qib7	5230	24	.	.	.
cord-005453-4057qib7	5231	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5231	2	:	:	:
cord-005453-4057qib7	5231	3	Supported	support	VBN
cord-005453-4057qib7	5231	4	by	by	IN
cord-005453-4057qib7	5231	5	a	a	DT
cord-005453-4057qib7	5231	6	DOCmed	DOCmed	NNP
cord-005453-4057qib7	5231	7	fellowship	fellowship	NN
cord-005453-4057qib7	5231	8	od	od	NN
cord-005453-4057qib7	5231	9	the	the	DT
cord-005453-4057qib7	5231	10	Austrain	Austrain	NNP
cord-005453-4057qib7	5231	11	Academy	Academy	NNP
cord-005453-4057qib7	5231	12	of	of	IN
cord-005453-4057qib7	5231	13	Sciences	Sciences	NNPS
cord-005453-4057qib7	5231	14	Background	Background	NNP
cord-005453-4057qib7	5231	15	:	:	:
cord-005453-4057qib7	5232	1	Graft	graft	NN
cord-005453-4057qib7	5232	2	-	-	HYPH
cord-005453-4057qib7	5232	3	versus	versus	IN
cord-005453-4057qib7	5232	4	-	-	HYPH
cord-005453-4057qib7	5232	5	host	host	NN
cord-005453-4057qib7	5232	6	disease	disease	NN
cord-005453-4057qib7	5232	7	(	(	-LRB-
cord-005453-4057qib7	5232	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5232	9	)	)	-RRB-
cord-005453-4057qib7	5232	10	represents	represent	VBZ
cord-005453-4057qib7	5232	11	a	a	DT
cord-005453-4057qib7	5232	12	major	major	JJ
cord-005453-4057qib7	5232	13	contributor	contributor	NN
cord-005453-4057qib7	5232	14	to	to	IN
cord-005453-4057qib7	5232	15	morbidity	morbidity	NN
cord-005453-4057qib7	5232	16	and	and	CC
cord-005453-4057qib7	5232	17	mortality	mortality	NN
cord-005453-4057qib7	5232	18	in	in	IN
cord-005453-4057qib7	5232	19	recipients	recipient	NNS
cord-005453-4057qib7	5232	20	of	of	IN
cord-005453-4057qib7	5232	21	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5232	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5232	23	cell	cell	NN
cord-005453-4057qib7	5232	24	transplants	transplant	NNS
cord-005453-4057qib7	5232	25	(	(	-LRB-
cord-005453-4057qib7	5232	26	HCT	HCT	NNP
cord-005453-4057qib7	5232	27	)	)	-RRB-
cord-005453-4057qib7	5232	28	.	.	.
cord-005453-4057qib7	5233	1	Several	several	JJ
cord-005453-4057qib7	5233	2	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5233	3	strategies	strategy	NNS
cord-005453-4057qib7	5233	4	exist	exist	VBP
cord-005453-4057qib7	5233	5	for	for	IN
cord-005453-4057qib7	5233	6	GVHD	GVHD	NNP
cord-005453-4057qib7	5233	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5233	8	and	and	CC
cord-005453-4057qib7	5233	9	include	include	VBP
cord-005453-4057qib7	5233	10	post	post	JJ
cord-005453-4057qib7	5233	11	-	-	JJ
cord-005453-4057qib7	5233	12	transplant	transplant	NN
cord-005453-4057qib7	5233	13	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	5233	14	(	(	-LRB-
cord-005453-4057qib7	5233	15	PTCy	PTCy	NNP
cord-005453-4057qib7	5233	16	)	)	-RRB-
cord-005453-4057qib7	5233	17	and	and	CC
cord-005453-4057qib7	5233	18	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	5233	19	globulin	globulin	NNP
cord-005453-4057qib7	5233	20	(	(	-LRB-
cord-005453-4057qib7	5233	21	ATG	ATG	NNP
cord-005453-4057qib7	5233	22	)	)	-RRB-
cord-005453-4057qib7	5233	23	.	.	.
cord-005453-4057qib7	5234	1	While	while	IN
cord-005453-4057qib7	5234	2	several	several	JJ
cord-005453-4057qib7	5234	3	groups	group	NNS
cord-005453-4057qib7	5234	4	have	have	VBP
cord-005453-4057qib7	5234	5	described	describe	VBN
cord-005453-4057qib7	5234	6	the	the	DT
cord-005453-4057qib7	5234	7	use	use	NN
cord-005453-4057qib7	5234	8	of	of	IN
cord-005453-4057qib7	5234	9	PTCy	PTCy	NNS
cord-005453-4057qib7	5234	10	in	in	IN
cord-005453-4057qib7	5234	11	younger	young	JJR
cord-005453-4057qib7	5234	12	patients	patient	NNS
cord-005453-4057qib7	5234	13	,	,	,
cord-005453-4057qib7	5234	14	there	there	EX
cord-005453-4057qib7	5234	15	is	be	VBZ
cord-005453-4057qib7	5234	16	a	a	DT
cord-005453-4057qib7	5234	17	paucity	paucity	NN
cord-005453-4057qib7	5234	18	of	of	IN
cord-005453-4057qib7	5234	19	data	datum	NNS
cord-005453-4057qib7	5234	20	about	about	IN
cord-005453-4057qib7	5234	21	the	the	DT
cord-005453-4057qib7	5234	22	efficacy	efficacy	NN
cord-005453-4057qib7	5234	23	of	of	IN
cord-005453-4057qib7	5234	24	PTCy	PTCy	NNS
cord-005453-4057qib7	5234	25	in	in	IN
cord-005453-4057qib7	5234	26	older	old	JJR
cord-005453-4057qib7	5234	27	individuals	individual	NNS
cord-005453-4057qib7	5234	28	,	,	,
cord-005453-4057qib7	5234	29	particularly	particularly	RB
cord-005453-4057qib7	5234	30	when	when	WRB
cord-005453-4057qib7	5234	31	combined	combine	VBN
cord-005453-4057qib7	5234	32	with	with	IN
cord-005453-4057qib7	5234	33	ATG	ATG	NNP
cord-005453-4057qib7	5234	34	.	.	.
cord-005453-4057qib7	5235	1	We	-PRON-	PRP
cord-005453-4057qib7	5235	2	investigated	investigate	VBD
cord-005453-4057qib7	5235	3	the	the	DT
cord-005453-4057qib7	5235	4	combined	combined	JJ
cord-005453-4057qib7	5235	5	effect	effect	NN
cord-005453-4057qib7	5235	6	of	of	IN
cord-005453-4057qib7	5235	7	PTCy	PTCy	NNS
cord-005453-4057qib7	5235	8	with	with	IN
cord-005453-4057qib7	5235	9	ATG	ATG	NNP
cord-005453-4057qib7	5235	10	on	on	IN
cord-005453-4057qib7	5235	11	transplant	transplant	NN
cord-005453-4057qib7	5235	12	outcomes	outcome	NNS
cord-005453-4057qib7	5235	13	in	in	IN
cord-005453-4057qib7	5235	14	older	old	JJR
cord-005453-4057qib7	5235	15	patients	patient	NNS
cord-005453-4057qib7	5235	16	at	at	IN
cord-005453-4057qib7	5235	17	Princess	Princess	NNP
cord-005453-4057qib7	5235	18	Margaret	Margaret	NNP
cord-005453-4057qib7	5235	19	Cancer	Cancer	NNP
cord-005453-4057qib7	5235	20	Centre	Centre	NNP
cord-005453-4057qib7	5235	21	,	,	,
cord-005453-4057qib7	5235	22	Toronto	Toronto	NNP
cord-005453-4057qib7	5235	23	,	,	,
cord-005453-4057qib7	5235	24	Canada	Canada	NNP
cord-005453-4057qib7	5235	25	.	.	.
cord-005453-4057qib7	5236	1	Methods	method	NNS
cord-005453-4057qib7	5236	2	:	:	:
cord-005453-4057qib7	5237	1	This	this	DT
cord-005453-4057qib7	5237	2	retrospective	retrospective	JJ
cord-005453-4057qib7	5237	3	study	study	NN
cord-005453-4057qib7	5237	4	included	include	VBD
cord-005453-4057qib7	5237	5	all	all	DT
cord-005453-4057qib7	5237	6	patients	patient	NNS
cord-005453-4057qib7	5237	7	age	age	NN
cord-005453-4057qib7	5237	8	≥60	≥60	XX
cord-005453-4057qib7	5237	9	who	who	WP
cord-005453-4057qib7	5237	10	underwent	undergo	VBD
cord-005453-4057qib7	5237	11	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5237	12	HCT	hct	NN
cord-005453-4057qib7	5237	13	for	for	IN
cord-005453-4057qib7	5237	14	any	any	DT
cord-005453-4057qib7	5237	15	indication	indication	NN
cord-005453-4057qib7	5237	16	at	at	IN
cord-005453-4057qib7	5237	17	our	-PRON-	PRP$
cord-005453-4057qib7	5237	18	centre	centre	NN
cord-005453-4057qib7	5237	19	between	between	IN
cord-005453-4057qib7	5237	20	December	December	NNP
cord-005453-4057qib7	5237	21	2013	2013	CD
cord-005453-4057qib7	5237	22	and	and	CC
cord-005453-4057qib7	5237	23	July	July	NNP
cord-005453-4057qib7	5237	24	2017	2017	CD
cord-005453-4057qib7	5237	25	.	.	.
cord-005453-4057qib7	5238	1	Overall	overall	JJ
cord-005453-4057qib7	5238	2	survival	survival	NN
cord-005453-4057qib7	5238	3	(	(	-LRB-
cord-005453-4057qib7	5238	4	OS	OS	NNP
cord-005453-4057qib7	5238	5	)	)	-RRB-
cord-005453-4057qib7	5238	6	was	be	VBD
cord-005453-4057qib7	5238	7	calculated	calculate	VBN
cord-005453-4057qib7	5238	8	using	use	VBG
cord-005453-4057qib7	5238	9	Kaplan	Kaplan	NNP
cord-005453-4057qib7	5238	10	-	-	HYPH
cord-005453-4057qib7	5238	11	Meier	Meier	NNP
cord-005453-4057qib7	5238	12	analysis	analysis	NN
cord-005453-4057qib7	5238	13	and	and	CC
cord-005453-4057qib7	5238	14	multivariable	multivariable	JJ
cord-005453-4057qib7	5238	15	Cox	Cox	NNP
cord-005453-4057qib7	5238	16	proportional	proportional	JJ
cord-005453-4057qib7	5238	17	hazards	hazard	NNS
cord-005453-4057qib7	5238	18	regression	regression	NN
cord-005453-4057qib7	5238	19	.	.	.
cord-005453-4057qib7	5239	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	5239	2	incidence	incidence	NN
cord-005453-4057qib7	5239	3	of	of	IN
cord-005453-4057qib7	5239	4	relapse	relapse	NN
cord-005453-4057qib7	5239	5	(	(	-LRB-
cord-005453-4057qib7	5239	6	CIR	CIR	NNP
cord-005453-4057qib7	5239	7	)	)	-RRB-
cord-005453-4057qib7	5239	8	and	and	CC
cord-005453-4057qib7	5239	9	non	non	JJ
cord-005453-4057qib7	5239	10	-	-	JJ
cord-005453-4057qib7	5239	11	relapse	relapse	JJ
cord-005453-4057qib7	5239	12	mortality	mortality	NN
cord-005453-4057qib7	5239	13	(	(	-LRB-
cord-005453-4057qib7	5239	14	NRM	NRM	NNP
cord-005453-4057qib7	5239	15	)	)	-RRB-
cord-005453-4057qib7	5239	16	were	be	VBD
cord-005453-4057qib7	5239	17	calculated	calculate	VBN
cord-005453-4057qib7	5239	18	using	use	VBG
cord-005453-4057qib7	5239	19	competing	compete	VBG
cord-005453-4057qib7	5239	20	risk	risk	NN
cord-005453-4057qib7	5239	21	regression	regression	NN
cord-005453-4057qib7	5239	22	(	(	-LRB-
cord-005453-4057qib7	5239	23	Fine	fine	JJ
cord-005453-4057qib7	5239	24	and	and	CC
cord-005453-4057qib7	5239	25	Gray	gray	JJ
cord-005453-4057qib7	5239	26	method	method	NN
cord-005453-4057qib7	5239	27	)	)	-RRB-
cord-005453-4057qib7	5239	28	.	.	.
cord-005453-4057qib7	5240	1	Incidences	incidence	NNS
cord-005453-4057qib7	5240	2	of	of	IN
cord-005453-4057qib7	5240	3	acute	acute	JJ
cord-005453-4057qib7	5240	4	(	(	-LRB-
cord-005453-4057qib7	5240	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5240	6	)	)	-RRB-
cord-005453-4057qib7	5240	7	and	and	CC
cord-005453-4057qib7	5240	8	chronic	chronic	JJ
cord-005453-4057qib7	5240	9	(	(	-LRB-
cord-005453-4057qib7	5240	10	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5240	11	)	)	-RRB-
cord-005453-4057qib7	5240	12	were	be	VBD
cord-005453-4057qib7	5240	13	compared	compare	VBN
cord-005453-4057qib7	5240	14	using	use	VBG
cord-005453-4057qib7	5240	15	the	the	DT
cord-005453-4057qib7	5240	16	Fisher	Fisher	NNP
cord-005453-4057qib7	5240	17	's	's	POS
cord-005453-4057qib7	5240	18	exact	exact	JJ
cord-005453-4057qib7	5240	19	test	test	NN
cord-005453-4057qib7	5240	20	.	.	.
cord-005453-4057qib7	5241	1	Results	result	NNS
cord-005453-4057qib7	5241	2	:	:	:
cord-005453-4057qib7	5242	1	Of	of	IN
cord-005453-4057qib7	5242	2	133	133	CD
cord-005453-4057qib7	5242	3	patients	patient	NNS
cord-005453-4057qib7	5242	4	,	,	,
cord-005453-4057qib7	5242	5	84	84	CD
cord-005453-4057qib7	5242	6	(	(	-LRB-
cord-005453-4057qib7	5242	7	63	63	CD
cord-005453-4057qib7	5242	8	%	%	NN
cord-005453-4057qib7	5242	9	)	)	-RRB-
cord-005453-4057qib7	5242	10	were	be	VBD
cord-005453-4057qib7	5242	11	male	male	JJ
cord-005453-4057qib7	5242	12	.	.	.
cord-005453-4057qib7	5243	1	Median	median	JJ
cord-005453-4057qib7	5243	2	age	age	NN
cord-005453-4057qib7	5243	3	was	be	VBD
cord-005453-4057qib7	5243	4	65	65	CD
cord-005453-4057qib7	5244	1	(	(	-LRB-
cord-005453-4057qib7	5244	2	range	range	NNP
cord-005453-4057qib7	5244	3	60	60	CD
cord-005453-4057qib7	5244	4	-	-	SYM
cord-005453-4057qib7	5244	5	74	74	CD
cord-005453-4057qib7	5244	6	)	)	-RRB-
cord-005453-4057qib7	5244	7	and	and	CC
cord-005453-4057qib7	5244	8	median	median	JJ
cord-005453-4057qib7	5244	9	follow	follow	NN
cord-005453-4057qib7	5244	10	-	-	HYPH
cord-005453-4057qib7	5244	11	up	up	NN
cord-005453-4057qib7	5244	12	among	among	IN
cord-005453-4057qib7	5244	13	survivors	survivor	NNS
cord-005453-4057qib7	5244	14	was	be	VBD
cord-005453-4057qib7	5244	15	28	28	CD
cord-005453-4057qib7	5244	16	months	month	NNS
cord-005453-4057qib7	5244	17	(	(	-LRB-
cord-005453-4057qib7	5244	18	range	range	VBP
cord-005453-4057qib7	5244	19	6	6	CD
cord-005453-4057qib7	5244	20	-	-	SYM
cord-005453-4057qib7	5244	21	60	60	CD
cord-005453-4057qib7	5244	22	)	)	-RRB-
cord-005453-4057qib7	5244	23	.	.	.
cord-005453-4057qib7	5245	1	Acute	acute	JJ
cord-005453-4057qib7	5245	2	myeloid	myeloid	NN
cord-005453-4057qib7	5245	3	leukaemia	leukaemia	NN
cord-005453-4057qib7	5245	4	(	(	-LRB-
cord-005453-4057qib7	5245	5	AML	AML	NNP
cord-005453-4057qib7	5245	6	)	)	-RRB-
cord-005453-4057qib7	5245	7	was	be	VBD
cord-005453-4057qib7	5245	8	the	the	DT
cord-005453-4057qib7	5245	9	most	most	RBS
cord-005453-4057qib7	5245	10	common	common	JJ
cord-005453-4057qib7	5245	11	indication	indication	NN
cord-005453-4057qib7	5245	12	for	for	IN
cord-005453-4057qib7	5245	13	HCT	HCT	NNP
cord-005453-4057qib7	5245	14	(	(	-LRB-
cord-005453-4057qib7	5245	15	57	57	CD
cord-005453-4057qib7	5245	16	patients	patient	NNS
cord-005453-4057qib7	5245	17	,	,	,
cord-005453-4057qib7	5245	18	43	43	CD
cord-005453-4057qib7	5245	19	%	%	NN
cord-005453-4057qib7	5245	20	)	)	-RRB-
cord-005453-4057qib7	5245	21	,	,	,
cord-005453-4057qib7	5245	22	followed	follow	VBN
cord-005453-4057qib7	5245	23	by	by	IN
cord-005453-4057qib7	5245	24	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	5245	25	syndrome	syndrome	NN
cord-005453-4057qib7	5245	26	(	(	-LRB-
cord-005453-4057qib7	5245	27	37	37	CD
cord-005453-4057qib7	5245	28	patients	patient	NNS
cord-005453-4057qib7	5245	29	,	,	,
cord-005453-4057qib7	5245	30	28	28	CD
cord-005453-4057qib7	5245	31	%	%	NN
cord-005453-4057qib7	5245	32	)	)	-RRB-
cord-005453-4057qib7	5245	33	and	and	CC
cord-005453-4057qib7	5245	34	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	5245	35	(	(	-LRB-
cord-005453-4057qib7	5245	36	17	17	CD
cord-005453-4057qib7	5245	37	patients	patient	NNS
cord-005453-4057qib7	5245	38	,	,	,
cord-005453-4057qib7	5245	39	13	13	CD
cord-005453-4057qib7	5245	40	%	%	NN
cord-005453-4057qib7	5245	41	)	)	-RRB-
cord-005453-4057qib7	5245	42	.	.	.
cord-005453-4057qib7	5246	1	Eightyfour	Eightyfour	NNP
cord-005453-4057qib7	5246	2	(	(	-LRB-
cord-005453-4057qib7	5246	3	63	63	CD
cord-005453-4057qib7	5246	4	%	%	NN
cord-005453-4057qib7	5246	5	)	)	-RRB-
cord-005453-4057qib7	5247	1	patients	patient	NNS
cord-005453-4057qib7	5247	2	had	have	VBD
cord-005453-4057qib7	5247	3	a	a	DT
cord-005453-4057qib7	5247	4	matched	match	VBN
cord-005453-4057qib7	5247	5	unrelated	unrelated	JJ
cord-005453-4057qib7	5247	6	donor	donor	NN
cord-005453-4057qib7	5247	7	,	,	,
cord-005453-4057qib7	5247	8	37	37	CD
cord-005453-4057qib7	5247	9	(	(	-LRB-
cord-005453-4057qib7	5247	10	28	28	CD
cord-005453-4057qib7	5247	11	%	%	NN
cord-005453-4057qib7	5247	12	)	)	-RRB-
cord-005453-4057qib7	5247	13	had	have	VBD
cord-005453-4057qib7	5247	14	a	a	DT
cord-005453-4057qib7	5247	15	matched	match	VBN
cord-005453-4057qib7	5247	16	related	related	JJ
cord-005453-4057qib7	5247	17	donor	donor	NN
cord-005453-4057qib7	5247	18	and	and	CC
cord-005453-4057qib7	5247	19	12	12	CD
cord-005453-4057qib7	5247	20	(	(	-LRB-
cord-005453-4057qib7	5247	21	9	9	CD
cord-005453-4057qib7	5247	22	%	%	NN
cord-005453-4057qib7	5247	23	)	)	-RRB-
cord-005453-4057qib7	5247	24	had	have	VBD
cord-005453-4057qib7	5247	25	a	a	DT
cord-005453-4057qib7	5247	26	haploidentical	haploidentical	JJ
cord-005453-4057qib7	5247	27	donor	donor	NN
cord-005453-4057qib7	5247	28	.	.	.
cord-005453-4057qib7	5248	1	One	one	CD
cord-005453-4057qib7	5248	2	hundred	hundred	CD
cord-005453-4057qib7	5248	3	twenty	twenty	CD
cord-005453-4057qib7	5248	4	-	-	HYPH
cord-005453-4057qib7	5248	5	five	five	CD
cord-005453-4057qib7	5248	6	(	(	-LRB-
cord-005453-4057qib7	5248	7	94	94	CD
cord-005453-4057qib7	5248	8	%	%	NN
cord-005453-4057qib7	5248	9	)	)	-RRB-
cord-005453-4057qib7	5248	10	patients	patient	NNS
cord-005453-4057qib7	5248	11	received	receive	VBD
cord-005453-4057qib7	5248	12	reduced	reduced	JJ
cord-005453-4057qib7	5248	13	intensity	intensity	NN
cord-005453-4057qib7	5248	14	conditioning	conditioning	NN
cord-005453-4057qib7	5248	15	.	.	.
cord-005453-4057qib7	5249	1	Sixty	sixty	CD
cord-005453-4057qib7	5249	2	-	-	HYPH
cord-005453-4057qib7	5249	3	two	two	CD
cord-005453-4057qib7	5249	4	(	(	-LRB-
cord-005453-4057qib7	5249	5	47	47	CD
cord-005453-4057qib7	5249	6	%	%	NN
cord-005453-4057qib7	5249	7	)	)	-RRB-
cord-005453-4057qib7	5249	8	patients	patient	NNS
cord-005453-4057qib7	5249	9	received	receive	VBD
cord-005453-4057qib7	5249	10	PTCy	PTCy	NNS
cord-005453-4057qib7	5249	11	combined	combine	VBN
cord-005453-4057qib7	5249	12	with	with	IN
cord-005453-4057qib7	5249	13	ATG	ATG	NNP
cord-005453-4057qib7	5249	14	(	(	-LRB-
cord-005453-4057qib7	5249	15	4.5	4.5	CD
cord-005453-4057qib7	5249	16	mg	mg	NNP
cord-005453-4057qib7	5249	17	/	/	SYM
cord-005453-4057qib7	5249	18	kg	kg	NNP
cord-005453-4057qib7	5249	19	)	)	-RRB-
cord-005453-4057qib7	5249	20	while	while	IN
cord-005453-4057qib7	5249	21	71	71	CD
cord-005453-4057qib7	5249	22	(	(	-LRB-
cord-005453-4057qib7	5249	23	53	53	CD
cord-005453-4057qib7	5249	24	%	%	NN
cord-005453-4057qib7	5249	25	)	)	-RRB-
cord-005453-4057qib7	5249	26	received	receive	VBD
cord-005453-4057qib7	5249	27	other	other	JJ
cord-005453-4057qib7	5249	28	forms	form	NNS
cord-005453-4057qib7	5249	29	of	of	IN
cord-005453-4057qib7	5249	30	GVHD	GVHD	NNP
cord-005453-4057qib7	5249	31	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5249	32	.	.	.
cord-005453-4057qib7	5250	1	OS	OS	NNP
cord-005453-4057qib7	5250	2	at	at	IN
cord-005453-4057qib7	5250	3	2	2	CD
cord-005453-4057qib7	5250	4	years	year	NNS
cord-005453-4057qib7	5250	5	was	be	VBD
cord-005453-4057qib7	5250	6	46	46	CD
cord-005453-4057qib7	5250	7	%	%	NN
cord-005453-4057qib7	5250	8	(	(	-LRB-
cord-005453-4057qib7	5250	9	95	95	CD
cord-005453-4057qib7	5250	10	%	%	NN
cord-005453-4057qib7	5250	11	confidence	confidence	NN
cord-005453-4057qib7	5250	12	interval	interval	NN
cord-005453-4057qib7	5250	13	(	(	-LRB-
cord-005453-4057qib7	5250	14	CI	CI	NNP
cord-005453-4057qib7	5250	15	)	)	-RRB-
cord-005453-4057qib7	5250	16	37	37	CD
cord-005453-4057qib7	5250	17	-	-	SYM
cord-005453-4057qib7	5250	18	54	54	CD
cord-005453-4057qib7	5250	19	)	)	-RRB-
cord-005453-4057qib7	5250	20	in	in	IN
cord-005453-4057qib7	5250	21	the	the	DT
cord-005453-4057qib7	5250	22	entire	entire	JJ
cord-005453-4057qib7	5250	23	cohort	cohort	NN
cord-005453-4057qib7	5250	24	.	.	.
cord-005453-4057qib7	5251	1	Patients	patient	NNS
cord-005453-4057qib7	5251	2	who	who	WP
cord-005453-4057qib7	5251	3	received	receive	VBD
cord-005453-4057qib7	5251	4	PTCy	PTCy	NNS
cord-005453-4057qib7	5251	5	with	with	IN
cord-005453-4057qib7	5251	6	ATG	ATG	NNP
cord-005453-4057qib7	5251	7	had	have	VBD
cord-005453-4057qib7	5251	8	a	a	DT
cord-005453-4057qib7	5251	9	superior	superior	JJ
cord-005453-4057qib7	5251	10	2-year	2-year	CD
cord-005453-4057qib7	5251	11	OS	os	NN
cord-005453-4057qib7	5251	12	compared	compare	VBN
cord-005453-4057qib7	5251	13	with	with	IN
cord-005453-4057qib7	5251	14	other	other	JJ
cord-005453-4057qib7	5251	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5251	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5251	17	regimens	regimen	NNS
cord-005453-4057qib7	5251	18	(	(	-LRB-
cord-005453-4057qib7	5251	19	Figure	figure	NN
cord-005453-4057qib7	5251	20	1A	1a	NN
cord-005453-4057qib7	5251	21	):	):	NNP
cord-005453-4057qib7	5251	22	57	57	CD
cord-005453-4057qib7	5251	23	%	%	NN
cord-005453-4057qib7	5251	24	(	(	-LRB-
cord-005453-4057qib7	5251	25	95	95	CD
cord-005453-4057qib7	5251	26	%	%	NN
cord-005453-4057qib7	5251	27	CI	CI	NNP
cord-005453-4057qib7	5251	28	44	44	CD
cord-005453-4057qib7	5251	29	-	-	SYM
cord-005453-4057qib7	5251	30	69	69	CD
cord-005453-4057qib7	5251	31	)	)	-RRB-
cord-005453-4057qib7	5251	32	vs.	vs.	IN
cord-005453-4057qib7	5251	33	37	37	CD
cord-005453-4057qib7	5251	34	%	%	NN
cord-005453-4057qib7	5251	35	(	(	-LRB-
cord-005453-4057qib7	5251	36	95	95	CD
cord-005453-4057qib7	5251	37	%	%	NN
cord-005453-4057qib7	5251	38	CI	CI	NNP
cord-005453-4057qib7	5251	39	26	26	CD
cord-005453-4057qib7	5251	40	-	-	SYM
cord-005453-4057qib7	5251	41	49	49	CD
cord-005453-4057qib7	5251	42	)	)	-RRB-
cord-005453-4057qib7	5251	43	,	,	,
cord-005453-4057qib7	5251	44	respectively	respectively	RB
cord-005453-4057qib7	5251	45	(	(	-LRB-
cord-005453-4057qib7	5251	46	HR=0.6	hr=0.6	NN
cord-005453-4057qib7	5251	47	,	,	,
cord-005453-4057qib7	5251	48	95	95	CD
cord-005453-4057qib7	5251	49	%	%	NN
cord-005453-4057qib7	5251	50	CI	CI	NNP
cord-005453-4057qib7	5251	51	0.4	0.4	CD
cord-005453-4057qib7	5251	52	-	-	SYM
cord-005453-4057qib7	5251	53	0.9	0.9	CD
cord-005453-4057qib7	5251	54	,	,	,
cord-005453-4057qib7	5251	55	P=0.02	P=0.02	NNP
cord-005453-4057qib7	5251	56	)	)	-RRB-
cord-005453-4057qib7	5251	57	.	.	.
cord-005453-4057qib7	5252	1	The	the	DT
cord-005453-4057qib7	5252	2	2-year	2-year	CD
cord-005453-4057qib7	5252	3	NRM	NRM	NNP
cord-005453-4057qib7	5252	4	for	for	IN
cord-005453-4057qib7	5252	5	the	the	DT
cord-005453-4057qib7	5252	6	entire	entire	JJ
cord-005453-4057qib7	5252	7	cohort	cohort	NN
cord-005453-4057qib7	5252	8	was	be	VBD
cord-005453-4057qib7	5252	9	37	37	CD
cord-005453-4057qib7	5252	10	%	%	NN
cord-005453-4057qib7	5252	11	(	(	-LRB-
cord-005453-4057qib7	5252	12	95	95	CD
cord-005453-4057qib7	5252	13	%	%	NN
cord-005453-4057qib7	5252	14	CI	CI	NNP
cord-005453-4057qib7	5252	15	,	,	,
cord-005453-4057qib7	5252	16	29	29	CD
cord-005453-4057qib7	5252	17	-	-	SYM
cord-005453-4057qib7	5252	18	46	46	CD
cord-005453-4057qib7	5252	19	)	)	-RRB-
cord-005453-4057qib7	5252	20	.	.	.
cord-005453-4057qib7	5253	1	Patients	patient	NNS
cord-005453-4057qib7	5253	2	who	who	WP
cord-005453-4057qib7	5253	3	received	receive	VBD
cord-005453-4057qib7	5253	4	PTCy	PTCy	NNS
cord-005453-4057qib7	5253	5	with	with	IN
cord-005453-4057qib7	5253	6	ATG	ATG	NNP
cord-005453-4057qib7	5253	7	had	have	VBD
cord-005453-4057qib7	5253	8	a	a	DT
cord-005453-4057qib7	5253	9	lower	low	JJR
cord-005453-4057qib7	5253	10	2-year	2-year	CD
cord-005453-4057qib7	5253	11	NRM	NRM	NNP
cord-005453-4057qib7	5253	12	compared	compare	VBN
cord-005453-4057qib7	5253	13	to	to	IN
cord-005453-4057qib7	5253	14	those	those	DT
cord-005453-4057qib7	5253	15	who	who	WP
cord-005453-4057qib7	5253	16	did	do	VBD
cord-005453-4057qib7	5253	17	not	not	RB
cord-005453-4057qib7	5253	18	(	(	-LRB-
cord-005453-4057qib7	5253	19	Figure	figure	NN
cord-005453-4057qib7	5253	20	1B	1b	CD
cord-005453-4057qib7	5254	1	):	):	NNP
cord-005453-4057qib7	5255	1	23	23	CD
cord-005453-4057qib7	5255	2	%	%	NN
cord-005453-4057qib7	5255	3	(	(	-LRB-
cord-005453-4057qib7	5255	4	95	95	CD
cord-005453-4057qib7	5255	5	%	%	NN
cord-005453-4057qib7	5255	6	CI	CI	NNP
cord-005453-4057qib7	5255	7	13	13	CD
cord-005453-4057qib7	5255	8	-	-	SYM
cord-005453-4057qib7	5255	9	34	34	CD
cord-005453-4057qib7	5255	10	)	)	-RRB-
cord-005453-4057qib7	5255	11	vs.	vs.	IN
cord-005453-4057qib7	5255	12	49	49	CD
cord-005453-4057qib7	5255	13	%	%	NN
cord-005453-4057qib7	5255	14	(	(	-LRB-
cord-005453-4057qib7	5255	15	95	95	CD
cord-005453-4057qib7	5255	16	%	%	NN
cord-005453-4057qib7	5255	17	CI	CI	NNP
cord-005453-4057qib7	5255	18	37	37	CD
cord-005453-4057qib7	5255	19	-	-	SYM
cord-005453-4057qib7	5255	20	60	60	CD
cord-005453-4057qib7	5255	21	)	)	-RRB-
cord-005453-4057qib7	5255	22	,	,	,
cord-005453-4057qib7	5255	23	respectively	respectively	RB
cord-005453-4057qib7	5255	24	(	(	-LRB-
cord-005453-4057qib7	5255	25	HR=0.4	HR=0.4	NNS
cord-005453-4057qib7	5255	26	,	,	,
cord-005453-4057qib7	5255	27	95	95	CD
cord-005453-4057qib7	5255	28	%	%	NN
cord-005453-4057qib7	5255	29	CI	CI	NNP
cord-005453-4057qib7	5255	30	0.2	0.2	CD
cord-005453-4057qib7	5255	31	-	-	SYM
cord-005453-4057qib7	5255	32	0.7	0.7	CD
cord-005453-4057qib7	5255	33	,	,	,
cord-005453-4057qib7	5255	34	P=0.002	P=0.002	NNP
cord-005453-4057qib7	5255	35	)	)	-RRB-
cord-005453-4057qib7	5255	36	.	.	.
cord-005453-4057qib7	5256	1	The	the	DT
cord-005453-4057qib7	5256	2	2-year	2-year	CD
cord-005453-4057qib7	5256	3	CIR	CIR	NNP
cord-005453-4057qib7	5256	4	in	in	IN
cord-005453-4057qib7	5256	5	the	the	DT
cord-005453-4057qib7	5256	6	whole	whole	JJ
cord-005453-4057qib7	5256	7	group	group	NN
cord-005453-4057qib7	5256	8	was	be	VBD
cord-005453-4057qib7	5256	9	24	24	CD
cord-005453-4057qib7	5256	10	%	%	NN
cord-005453-4057qib7	5256	11	(	(	-LRB-
cord-005453-4057qib7	5256	12	95	95	CD
cord-005453-4057qib7	5256	13	%	%	NN
cord-005453-4057qib7	5256	14	CI	CI	NNP
cord-005453-4057qib7	5256	15	17	17	CD
cord-005453-4057qib7	5256	16	-	-	SYM
cord-005453-4057qib7	5256	17	32	32	CD
cord-005453-4057qib7	5256	18	)	)	-RRB-
cord-005453-4057qib7	5256	19	.	.	.
cord-005453-4057qib7	5257	1	Use	Use	NNP
cord-005453-4057qib7	5257	2	of	of	IN
cord-005453-4057qib7	5257	3	PTCy	PTCy	NNPS
cord-005453-4057qib7	5257	4	with	with	IN
cord-005453-4057qib7	5257	5	ATG	ATG	NNP
cord-005453-4057qib7	5257	6	was	be	VBD
cord-005453-4057qib7	5257	7	associated	associate	VBN
cord-005453-4057qib7	5257	8	with	with	IN
cord-005453-4057qib7	5257	9	a	a	DT
cord-005453-4057qib7	5257	10	modest	modest	JJ
cord-005453-4057qib7	5257	11	increase	increase	NN
cord-005453-4057qib7	5257	12	in	in	IN
cord-005453-4057qib7	5257	13	CIR	CIR	NNP
cord-005453-4057qib7	5257	14	at	at	IN
cord-005453-4057qib7	5257	15	two	two	CD
cord-005453-4057qib7	5257	16	years	year	NNS
cord-005453-4057qib7	5257	17	(	(	-LRB-
cord-005453-4057qib7	5257	18	Figure	figure	NN
cord-005453-4057qib7	5257	19	 	 	_SP
cord-005453-4057qib7	5257	20	1C	1C	NNP
cord-005453-4057qib7	5257	21	):	):	NNP
cord-005453-4057qib7	5257	22	35	35	CD
cord-005453-4057qib7	5257	23	%	%	NN
cord-005453-4057qib7	5257	24	(	(	-LRB-
cord-005453-4057qib7	5257	25	95	95	CD
cord-005453-4057qib7	5257	26	%	%	NN
cord-005453-4057qib7	5257	27	CI	CI	NNP
cord-005453-4057qib7	5257	28	22	22	CD
cord-005453-4057qib7	5257	29	-	-	SYM
cord-005453-4057qib7	5257	30	49	49	CD
cord-005453-4057qib7	5257	31	)	)	-RRB-
cord-005453-4057qib7	5257	32	vs.	vs.	IN
cord-005453-4057qib7	5257	33	16	16	CD
cord-005453-4057qib7	5257	34	%	%	NN
cord-005453-4057qib7	5257	35	(	(	-LRB-
cord-005453-4057qib7	5257	36	95	95	CD
cord-005453-4057qib7	5257	37	%	%	NN
cord-005453-4057qib7	5257	38	8	8	CD
cord-005453-4057qib7	5257	39	-	-	SYM
cord-005453-4057qib7	5257	40	25	25	CD
cord-005453-4057qib7	5257	41	)	)	-RRB-
cord-005453-4057qib7	5257	42	,	,	,
cord-005453-4057qib7	5257	43	respectively	respectively	RB
cord-005453-4057qib7	5257	44	(	(	-LRB-
cord-005453-4057qib7	5257	45	HR=2.1	hr=2.1	NN
cord-005453-4057qib7	5258	1	,	,	,
cord-005453-4057qib7	5258	2	95	95	CD
cord-005453-4057qib7	5258	3	%	%	NN
cord-005453-4057qib7	5258	4	CI	CI	NNP
cord-005453-4057qib7	5258	5	1.0	1.0	CD
cord-005453-4057qib7	5258	6	-	-	SYM
cord-005453-4057qib7	5258	7	4.0	4.0	CD
cord-005453-4057qib7	5258	8	,	,	,
cord-005453-4057qib7	5258	9	P=0.04	P=0.04	NNP
cord-005453-4057qib7	5258	10	)	)	-RRB-
cord-005453-4057qib7	5258	11	.	.	.
cord-005453-4057qib7	5259	1	There	there	EX
cord-005453-4057qib7	5259	2	was	be	VBD
cord-005453-4057qib7	5259	3	a	a	DT
cord-005453-4057qib7	5259	4	trend	trend	NN
cord-005453-4057qib7	5259	5	toward	toward	IN
cord-005453-4057qib7	5259	6	lower	low	JJR
cord-005453-4057qib7	5259	7	incidence	incidence	NN
cord-005453-4057qib7	5259	8	of	of	IN
cord-005453-4057qib7	5259	9	grade	grade	NN
cord-005453-4057qib7	5259	10	II	II	NNP
cord-005453-4057qib7	5259	11	-	-	HYPH
cord-005453-4057qib7	5259	12	IV	IV	NNP
cord-005453-4057qib7	5259	13	aGVHD	agvhd	NN
cord-005453-4057qib7	5259	14	among	among	IN
cord-005453-4057qib7	5259	15	patients	patient	NNS
cord-005453-4057qib7	5259	16	who	who	WP
cord-005453-4057qib7	5259	17	received	receive	VBD
cord-005453-4057qib7	5259	18	PTCy	PTCy	NNS
cord-005453-4057qib7	5259	19	with	with	IN
cord-005453-4057qib7	5259	20	ATG	ATG	NNP
cord-005453-4057qib7	5259	21	compared	compare	VBN
cord-005453-4057qib7	5259	22	to	to	IN
cord-005453-4057qib7	5259	23	those	those	DT
cord-005453-4057qib7	5259	24	who	who	WP
cord-005453-4057qib7	5259	25	did	do	VBD
cord-005453-4057qib7	5259	26	not	not	RB
cord-005453-4057qib7	5259	27	:	:	:
cord-005453-4057qib7	5259	28	15	15	CD
cord-005453-4057qib7	5259	29	%	%	NN
cord-005453-4057qib7	5259	30	vs.	vs.	CC
cord-005453-4057qib7	5259	31	30	30	CD
cord-005453-4057qib7	5259	32	%	%	NN
cord-005453-4057qib7	5259	33	(	(	-LRB-
cord-005453-4057qib7	5259	34	P=0.06	P=0.06	NNP
cord-005453-4057qib7	5259	35	)	)	-RRB-
cord-005453-4057qib7	5259	36	.	.	.
cord-005453-4057qib7	5260	1	The	the	DT
cord-005453-4057qib7	5260	2	incidence	incidence	NN
cord-005453-4057qib7	5260	3	of	of	IN
cord-005453-4057qib7	5260	4	grade	grade	NN
cord-005453-4057qib7	5260	5	II	II	NNP
cord-005453-4057qib7	5260	6	-	-	HYPH
cord-005453-4057qib7	5260	7	IV	IV	NNP
cord-005453-4057qib7	5260	8	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5260	9	was	be	VBD
cord-005453-4057qib7	5260	10	lower	low	JJR
cord-005453-4057qib7	5260	11	in	in	IN
cord-005453-4057qib7	5260	12	individuals	individual	NNS
cord-005453-4057qib7	5260	13	who	who	WP
cord-005453-4057qib7	5260	14	received	receive	VBD
cord-005453-4057qib7	5260	15	PTCy	PTCy	NNS
cord-005453-4057qib7	5260	16	with	with	IN
cord-005453-4057qib7	5260	17	ATG	ATG	NNP
cord-005453-4057qib7	5260	18	compared	compare	VBN
cord-005453-4057qib7	5260	19	to	to	IN
cord-005453-4057qib7	5260	20	those	those	DT
cord-005453-4057qib7	5260	21	who	who	WP
cord-005453-4057qib7	5260	22	did	do	VBD
cord-005453-4057qib7	5260	23	not	not	RB
cord-005453-4057qib7	5260	24	:	:	:
cord-005453-4057qib7	5260	25	26	26	CD
cord-005453-4057qib7	5260	26	%	%	NN
cord-005453-4057qib7	5260	27	vs.	vs.	IN
cord-005453-4057qib7	5260	28	45	45	CD
cord-005453-4057qib7	5260	29	%	%	NN
cord-005453-4057qib7	5260	30	(	(	-LRB-
cord-005453-4057qib7	5260	31	P=0.03	p=0.03	NN
cord-005453-4057qib7	5260	32	)	)	-RRB-
cord-005453-4057qib7	5260	33	.	.	.
cord-005453-4057qib7	5261	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5261	2	:	:	:
cord-005453-4057qib7	5262	1	In	in	IN
cord-005453-4057qib7	5262	2	older	old	JJR
cord-005453-4057qib7	5262	3	HCT	hct	NN
cord-005453-4057qib7	5262	4	recipients	recipient	NNS
cord-005453-4057qib7	5262	5	,	,	,
cord-005453-4057qib7	5262	6	use	use	NN
cord-005453-4057qib7	5262	7	of	of	IN
cord-005453-4057qib7	5262	8	PTCy	PTCy	NNS
cord-005453-4057qib7	5262	9	combined	combine	VBN
cord-005453-4057qib7	5262	10	with	with	IN
cord-005453-4057qib7	5262	11	ATG	ATG	NNP
cord-005453-4057qib7	5262	12	is	be	VBZ
cord-005453-4057qib7	5262	13	associated	associate	VBN
cord-005453-4057qib7	5262	14	with	with	IN
cord-005453-4057qib7	5262	15	improved	improved	JJ
cord-005453-4057qib7	5262	16	OS	OS	NNP
cord-005453-4057qib7	5262	17	,	,	,
cord-005453-4057qib7	5262	18	lower	low	JJR
cord-005453-4057qib7	5262	19	NRM	NRM	NNP
cord-005453-4057qib7	5262	20	,	,	,
cord-005453-4057qib7	5262	21	decreased	decrease	VBD
cord-005453-4057qib7	5262	22	risk	risk	NN
cord-005453-4057qib7	5262	23	of	of	IN
cord-005453-4057qib7	5262	24	both	both	CC
cord-005453-4057qib7	5262	25	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5262	26	and	and	CC
cord-005453-4057qib7	5262	27	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5262	28	and	and	CC
cord-005453-4057qib7	5262	29	a	a	DT
cord-005453-4057qib7	5262	30	modest	modest	JJ
cord-005453-4057qib7	5262	31	increase	increase	NN
cord-005453-4057qib7	5262	32	in	in	IN
cord-005453-4057qib7	5262	33	relapse	relapse	NN
cord-005453-4057qib7	5262	34	risk	risk	NN
cord-005453-4057qib7	5262	35	.	.	.
cord-005453-4057qib7	5263	1	Therefore	therefore	RB
cord-005453-4057qib7	5263	2	the	the	DT
cord-005453-4057qib7	5263	3	PTCy	PTCy	NNS
cord-005453-4057qib7	5263	4	with	with	IN
cord-005453-4057qib7	5263	5	ATG	ATG	NNP
cord-005453-4057qib7	5263	6	combination	combination	NN
cord-005453-4057qib7	5263	7	represents	represent	VBZ
cord-005453-4057qib7	5263	8	an	an	DT
cord-005453-4057qib7	5263	9	effective	effective	JJ
cord-005453-4057qib7	5263	10	strategy	strategy	NN
cord-005453-4057qib7	5263	11	for	for	IN
cord-005453-4057qib7	5263	12	GVHD	GVHD	NNP
cord-005453-4057qib7	5263	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5263	14	in	in	IN
cord-005453-4057qib7	5263	15	older	old	JJR
cord-005453-4057qib7	5263	16	allogeneic	allogeneic	IN
cord-005453-4057qib7	5263	17	HCT	hct	NN
cord-005453-4057qib7	5263	18	recipients	recipient	NNS
cord-005453-4057qib7	5263	19	.	.	.
cord-005453-4057qib7	5264	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5264	2	:	:	:
cord-005453-4057qib7	5265	1	The	the	DT
cord-005453-4057qib7	5265	2	authors	author	NNS
cord-005453-4057qib7	5265	3	have	have	VBP
cord-005453-4057qib7	5265	4	no	no	DT
cord-005453-4057qib7	5265	5	conflict	conflict	NN
cord-005453-4057qib7	5265	6	of	of	IN
cord-005453-4057qib7	5265	7	interest	interest	NN
cord-005453-4057qib7	5265	8	to	to	TO
cord-005453-4057qib7	5265	9	declare	declare	VB
cord-005453-4057qib7	5265	10	.	.	.
cord-005453-4057qib7	5266	1	Outcome	outcome	NN
cord-005453-4057qib7	5266	2	of	of	IN
cord-005453-4057qib7	5266	3	severe	severe	JJ
cord-005453-4057qib7	5266	4	graft	graft	NN
cord-005453-4057qib7	5266	5	versus	versus	IN
cord-005453-4057qib7	5266	6	host	host	NN
cord-005453-4057qib7	5266	7	disease	disease	NN
cord-005453-4057qib7	5266	8	in	in	IN
cord-005453-4057qib7	5266	9	pediatric	pediatric	JJ
cord-005453-4057qib7	5266	10	patients	patient	NNS
cord-005453-4057qib7	5266	11	with	with	IN
cord-005453-4057qib7	5266	12	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	5266	13	diseases	disease	NNS
cord-005453-4057qib7	5266	14	after	after	IN
cord-005453-4057qib7	5266	15	allogeneic	allogeneic	NN
cord-005453-4057qib7	5266	16	bone	bone	NN
cord-005453-4057qib7	5266	17	marrow	marrow	NN
cord-005453-4057qib7	5266	18	transplantation	transplantation	NN
cord-005453-4057qib7	5266	19	.	.	.
cord-005453-4057qib7	5267	1	A	a	DT
cord-005453-4057qib7	5267	2	single	single	JJ
cord-005453-4057qib7	5267	3	center	center	NN
cord-005453-4057qib7	5267	4	experience	experience	NN
cord-005453-4057qib7	5267	5	Irina	Irina	NNP
cord-005453-4057qib7	5267	6	Zaidman	Zaidman	NNP
cord-005453-4057qib7	5267	7	1	1	CD
cord-005453-4057qib7	5267	8	,	,	,
cord-005453-4057qib7	5267	9	Sigal	Sigal	NNP
cord-005453-4057qib7	5267	10	Grisariu	Grisariu	NNP
cord-005453-4057qib7	5267	11	1	1	CD
cord-005453-4057qib7	5267	12	,	,	,
cord-005453-4057qib7	5267	13	Batia	Batia	NNP
cord-005453-4057qib7	5267	14	Avni	Avni	NNP
cord-005453-4057qib7	5267	15	1	1	CD
cord-005453-4057qib7	5267	16	,	,	,
cord-005453-4057qib7	5268	1	Ehud	Ehud	NNP
cord-005453-4057qib7	5268	2	Even	even	RB
cord-005453-4057qib7	5268	3	-	-	:
cord-005453-4057qib7	5268	4	Or	or	CC
cord-005453-4057qib7	5268	5	1	1	CD
cord-005453-4057qib7	5268	6	,	,	,
cord-005453-4057qib7	5268	7	Bella	Bella	NNP
cord-005453-4057qib7	5268	8	Shadur	Shadur	NNP
cord-005453-4057qib7	5268	9	1	1	CD
cord-005453-4057qib7	5268	10	,	,	,
cord-005453-4057qib7	5268	11	Adeeb	Adeeb	NNP
cord-005453-4057qib7	5268	12	Nasereddin	Nasereddin	NNP
cord-005453-4057qib7	5268	13	1	1	CD
cord-005453-4057qib7	5268	14	,	,	,
cord-005453-4057qib7	5268	15	Polina	Polina	NNP
cord-005453-4057qib7	5268	16	Stepensky	Stepensky	NNP
cord-005453-4057qib7	5268	17	1	1	CD
cord-005453-4057qib7	5268	18	Background	Background	NNP
cord-005453-4057qib7	5268	19	:	:	:
cord-005453-4057qib7	5269	1	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	5269	2	Stem	Stem	NNP
cord-005453-4057qib7	5269	3	Cell	cell	NN
cord-005453-4057qib7	5269	4	Transplantation	transplantation	NN
cord-005453-4057qib7	5269	5	(	(	-LRB-
cord-005453-4057qib7	5269	6	HSCT	HSCT	NNP
cord-005453-4057qib7	5269	7	)	)	-RRB-
cord-005453-4057qib7	5269	8	remained	remain	VBD
cord-005453-4057qib7	5269	9	the	the	DT
cord-005453-4057qib7	5269	10	only	only	JJ
cord-005453-4057qib7	5269	11	curative	curative	JJ
cord-005453-4057qib7	5269	12	option	option	NN
cord-005453-4057qib7	5269	13	for	for	IN
cord-005453-4057qib7	5269	14	many	many	JJ
cord-005453-4057qib7	5269	15	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	5269	16	diseases	disease	NNS
cord-005453-4057qib7	5269	17	in	in	IN
cord-005453-4057qib7	5269	18	pediatric	pediatric	JJ
cord-005453-4057qib7	5269	19	patients	patient	NNS
cord-005453-4057qib7	5269	20	.	.	.
cord-005453-4057qib7	5270	1	Survival	survival	NN
cord-005453-4057qib7	5270	2	after	after	IN
cord-005453-4057qib7	5270	3	HSCT	HSCT	NNP
cord-005453-4057qib7	5270	4	has	have	VBZ
cord-005453-4057qib7	5270	5	improved	improve	VBN
cord-005453-4057qib7	5270	6	the	the	DT
cord-005453-4057qib7	5270	7	last	last	JJ
cord-005453-4057qib7	5270	8	few	few	JJ
cord-005453-4057qib7	5270	9	years	year	NNS
cord-005453-4057qib7	5270	10	due	due	JJ
cord-005453-4057qib7	5270	11	to	to	IN
cord-005453-4057qib7	5270	12	significant	significant	JJ
cord-005453-4057qib7	5270	13	advancement	advancement	NN
cord-005453-4057qib7	5270	14	in	in	IN
cord-005453-4057qib7	5270	15	human	human	JJ
cord-005453-4057qib7	5270	16	leukocyte	leukocyte	NN
cord-005453-4057qib7	5270	17	antigens	antigen	NNS
cord-005453-4057qib7	5270	18	(	(	-LRB-
cord-005453-4057qib7	5270	19	HLA	HLA	NNP
cord-005453-4057qib7	5270	20	)	)	-RRB-
cord-005453-4057qib7	5270	21	typing	typing	NN
cord-005453-4057qib7	5270	22	techniques	technique	NNS
cord-005453-4057qib7	5270	23	,	,	,
cord-005453-4057qib7	5270	24	less	less	RBR
cord-005453-4057qib7	5270	25	toxic	toxic	JJ
cord-005453-4057qib7	5270	26	conditioning	conditioning	NN
cord-005453-4057qib7	5270	27	regimens	regimen	NNS
cord-005453-4057qib7	5270	28	and	and	CC
cord-005453-4057qib7	5270	29	better	well	JJR
cord-005453-4057qib7	5270	30	supportive	supportive	JJ
cord-005453-4057qib7	5270	31	care	care	NN
cord-005453-4057qib7	5270	32	and	and	CC
cord-005453-4057qib7	5270	33	resulted	result	VBD
cord-005453-4057qib7	5270	34	to	to	IN
cord-005453-4057qib7	5270	35	90	90	CD
cord-005453-4057qib7	5270	36	%	%	NN
cord-005453-4057qib7	5270	37	survival	survival	NN
cord-005453-4057qib7	5270	38	and	and	CC
cord-005453-4057qib7	5270	39	cure	cure	NN
cord-005453-4057qib7	5270	40	in	in	IN
cord-005453-4057qib7	5270	41	some	some	DT
cord-005453-4057qib7	5270	42	non	non	JJ
cord-005453-4057qib7	5270	43	malignant	malignant	JJ
cord-005453-4057qib7	5270	44	diseases	disease	NNS
cord-005453-4057qib7	5270	45	.	.	.
cord-005453-4057qib7	5271	1	Graft	graft	NN
cord-005453-4057qib7	5271	2	-	-	HYPH
cord-005453-4057qib7	5271	3	versus	versus	IN
cord-005453-4057qib7	5271	4	-	-	HYPH
cord-005453-4057qib7	5271	5	host	host	NN
cord-005453-4057qib7	5271	6	disease	disease	NN
cord-005453-4057qib7	5271	7	(	(	-LRB-
cord-005453-4057qib7	5271	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5271	9	)	)	-RRB-
cord-005453-4057qib7	5271	10	remains	remain	VBZ
cord-005453-4057qib7	5271	11	a	a	DT
cord-005453-4057qib7	5271	12	major	major	JJ
cord-005453-4057qib7	5271	13	complication	complication	NN
cord-005453-4057qib7	5271	14	of	of	IN
cord-005453-4057qib7	5271	15	HSCT	HSCT	NNP
cord-005453-4057qib7	5271	16	and	and	CC
cord-005453-4057qib7	5271	17	leading	leading	JJ
cord-005453-4057qib7	5271	18	cause	cause	NN
cord-005453-4057qib7	5271	19	of	of	IN
cord-005453-4057qib7	5271	20	morbidity	morbidity	NN
cord-005453-4057qib7	5271	21	and	and	CC
cord-005453-4057qib7	5271	22	mortality	mortality	NN
cord-005453-4057qib7	5271	23	.	.	.
cord-005453-4057qib7	5272	1	Prognosis	prognosis	NN
cord-005453-4057qib7	5272	2	of	of	IN
cord-005453-4057qib7	5272	3	patients	patient	NNS
cord-005453-4057qib7	5272	4	with	with	IN
cord-005453-4057qib7	5272	5	high	high	JJ
cord-005453-4057qib7	5272	6	grade	grade	NN
cord-005453-4057qib7	5272	7	GVHD	GVHD	NNP
cord-005453-4057qib7	5272	8	is	be	VBZ
cord-005453-4057qib7	5272	9	dismal	dismal	JJ
cord-005453-4057qib7	5272	10	and	and	CC
cord-005453-4057qib7	5272	11	survival	survival	NN
cord-005453-4057qib7	5272	12	rate	rate	NN
cord-005453-4057qib7	5272	13	varies	vary	VBZ
cord-005453-4057qib7	5272	14	between	between	IN
cord-005453-4057qib7	5272	15	25	25	CD
cord-005453-4057qib7	5272	16	%	%	NN
cord-005453-4057qib7	5272	17	to	to	IN
cord-005453-4057qib7	5272	18	55	55	CD
cord-005453-4057qib7	5272	19	%	%	NN
cord-005453-4057qib7	5272	20	in	in	IN
cord-005453-4057qib7	5272	21	pediatric	pediatric	JJ
cord-005453-4057qib7	5272	22	patients	patient	NNS
cord-005453-4057qib7	5272	23	.	.	.
cord-005453-4057qib7	5273	1	Methods	method	NNS
cord-005453-4057qib7	5273	2	:	:	:
cord-005453-4057qib7	5274	1	The	the	DT
cord-005453-4057qib7	5274	2	retrospective	retrospective	JJ
cord-005453-4057qib7	5274	3	study	study	NN
cord-005453-4057qib7	5274	4	included	include	VBD
cord-005453-4057qib7	5274	5	patients	patient	NNS
cord-005453-4057qib7	5274	6	with	with	IN
cord-005453-4057qib7	5274	7	non	non	JJ
cord-005453-4057qib7	5274	8	malignant	malignant	JJ
cord-005453-4057qib7	5274	9	diseases	disease	NNS
cord-005453-4057qib7	5274	10	who	who	WP
cord-005453-4057qib7	5274	11	underwent	undergo	VBD
cord-005453-4057qib7	5274	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5274	13	HSCT	HSCT	NNP
cord-005453-4057qib7	5274	14	at	at	IN
cord-005453-4057qib7	5274	15	Hadassah	Hadassah	NNP
cord-005453-4057qib7	5274	16	Medical	Medical	NNP
cord-005453-4057qib7	5274	17	Center	Center	NNP
cord-005453-4057qib7	5274	18	from	from	IN
cord-005453-4057qib7	5274	19	2008	2008	CD
cord-005453-4057qib7	5274	20	to	to	IN
cord-005453-4057qib7	5274	21	2018	2018	CD
cord-005453-4057qib7	5274	22	.	.	.
cord-005453-4057qib7	5275	1	The	the	DT
cord-005453-4057qib7	5275	2	collected	collect	VBN
cord-005453-4057qib7	5275	3	data	datum	NNS
cord-005453-4057qib7	5275	4	included	include	VBD
cord-005453-4057qib7	5275	5	patient´s	patient´s	NNP
cord-005453-4057qib7	5275	6	clinical	clinical	JJ
cord-005453-4057qib7	5275	7	data	datum	NNS
cord-005453-4057qib7	5275	8	and	and	CC
cord-005453-4057qib7	5275	9	transplant	transplant	NN
cord-005453-4057qib7	5275	10	characteristics	characteristic	NNS
cord-005453-4057qib7	5275	11	.	.	.
cord-005453-4057qib7	5276	1	The	the	DT
cord-005453-4057qib7	5276	2	study	study	NN
cord-005453-4057qib7	5276	3	was	be	VBD
cord-005453-4057qib7	5276	4	approved	approve	VBN
cord-005453-4057qib7	5276	5	by	by	IN
cord-005453-4057qib7	5276	6	the	the	DT
cord-005453-4057qib7	5276	7	institutional	institutional	JJ
cord-005453-4057qib7	5276	8	Helsinki	Helsinki	NNP
cord-005453-4057qib7	5276	9	committee	committee	NN
cord-005453-4057qib7	5276	10	.	.	.
cord-005453-4057qib7	5277	1	Results	result	NNS
cord-005453-4057qib7	5277	2	:	:	:
cord-005453-4057qib7	5278	1	182	182	CD
cord-005453-4057qib7	5278	2	children	child	NNS
cord-005453-4057qib7	5278	3	with	with	IN
cord-005453-4057qib7	5278	4	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	5278	5	diseases	disease	NNS
cord-005453-4057qib7	5278	6	underwent	undergo	VBD
cord-005453-4057qib7	5278	7	194	194	CD
cord-005453-4057qib7	5278	8	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	5278	9	Bone	Bone	NNP
cord-005453-4057qib7	5278	10	Marrow	Marrow	NNP
cord-005453-4057qib7	5278	11	Transplantations	Transplantations	NNP
cord-005453-4057qib7	5278	12	in	in	IN
cord-005453-4057qib7	5278	13	Hadassah	Hadassah	NNP
cord-005453-4057qib7	5278	14	University	University	NNP
cord-005453-4057qib7	5278	15	Hospital	Hospital	NNP
cord-005453-4057qib7	5278	16	during	during	IN
cord-005453-4057qib7	5278	17	ten	ten	CD
cord-005453-4057qib7	5278	18	years	year	NNS
cord-005453-4057qib7	5278	19	period	period	NN
cord-005453-4057qib7	5278	20	.	.	.
cord-005453-4057qib7	5279	1	Fifty	fifty	CD
cord-005453-4057qib7	5279	2	seven	seven	CD
cord-005453-4057qib7	5279	3	patients	patient	NNS
cord-005453-4057qib7	5279	4	(	(	-LRB-
cord-005453-4057qib7	5279	5	31	31	CD
cord-005453-4057qib7	5279	6	%	%	NN
cord-005453-4057qib7	5279	7	)	)	-RRB-
cord-005453-4057qib7	5279	8	developed	develop	VBD
cord-005453-4057qib7	5279	9	AGVHD	AGVHD	NNP
cord-005453-4057qib7	5279	10	grade	grade	NN
cord-005453-4057qib7	5279	11	1	1	CD
cord-005453-4057qib7	5279	12	-	-	SYM
cord-005453-4057qib7	5279	13	4	4	CD
cord-005453-4057qib7	5279	14	,	,	,
cord-005453-4057qib7	5279	15	twenty	twenty	CD
cord-005453-4057qib7	5279	16	five	five	CD
cord-005453-4057qib7	5279	17	of	of	IN
cord-005453-4057qib7	5279	18	them	-PRON-	PRP
cord-005453-4057qib7	5279	19	(	(	-LRB-
cord-005453-4057qib7	5279	20	13.7	13.7	CD
cord-005453-4057qib7	5279	21	%	%	NN
cord-005453-4057qib7	5279	22	)	)	-RRB-
cord-005453-4057qib7	5279	23	grade	grade	NN
cord-005453-4057qib7	5279	24	3	3	CD
cord-005453-4057qib7	5279	25	-	-	SYM
cord-005453-4057qib7	5279	26	4	4	CD
cord-005453-4057qib7	5279	27	.	.	.
cord-005453-4057qib7	5280	1	Median	median	JJ
cord-005453-4057qib7	5280	2	age	age	NN
cord-005453-4057qib7	5280	3	was	be	VBD
cord-005453-4057qib7	5280	4	6.34	6.34	CD
cord-005453-4057qib7	5281	1	(	(	-LRB-
cord-005453-4057qib7	5281	2	range	range	NN
cord-005453-4057qib7	5281	3	0.37	0.37	CD
cord-005453-4057qib7	5281	4	-	-	SYM
cord-005453-4057qib7	5281	5	17.7	17.7	CD
cord-005453-4057qib7	5281	6	)	)	-RRB-
cord-005453-4057qib7	5281	7	,	,	,
cord-005453-4057qib7	5281	8	most	most	JJS
cord-005453-4057qib7	5281	9	patients	patient	NNS
cord-005453-4057qib7	5281	10	were	be	VBD
cord-005453-4057qib7	5281	11	males	male	NNS
cord-005453-4057qib7	5281	12	(	(	-LRB-
cord-005453-4057qib7	5281	13	17	17	CD
cord-005453-4057qib7	5281	14	males	male	NNS
cord-005453-4057qib7	5281	15	,	,	,
cord-005453-4057qib7	5281	16	8	8	CD
cord-005453-4057qib7	5281	17	females	female	NNS
cord-005453-4057qib7	5281	18	)	)	-RRB-
cord-005453-4057qib7	5281	19	.	.	.
cord-005453-4057qib7	5282	1	9	9	CD
cord-005453-4057qib7	5282	2	patients	patient	NNS
cord-005453-4057qib7	5282	3	underwent	undergo	VBD
cord-005453-4057qib7	5282	4	BMT	BMT	NNP
cord-005453-4057qib7	5282	5	from	from	IN
cord-005453-4057qib7	5282	6	fully	fully	RB
cord-005453-4057qib7	5282	7	matched	match	VBN
cord-005453-4057qib7	5282	8	family	family	NN
cord-005453-4057qib7	5282	9	members	member	NNS
cord-005453-4057qib7	5282	10	,	,	,
cord-005453-4057qib7	5282	11	6	6	CD
cord-005453-4057qib7	5282	12	children	child	NNS
cord-005453-4057qib7	5282	13	were	be	VBD
cord-005453-4057qib7	5282	14	transplanted	transplant	VBN
cord-005453-4057qib7	5282	15	from	from	IN
cord-005453-4057qib7	5282	16	matched	match	VBN
cord-005453-4057qib7	5282	17	unrelated	unrelated	JJ
cord-005453-4057qib7	5282	18	donors	donor	NNS
cord-005453-4057qib7	5282	19	and	and	CC
cord-005453-4057qib7	5282	20	10	10	CD
cord-005453-4057qib7	5282	21	from	from	IN
cord-005453-4057qib7	5282	22	mismatched	mismatched	JJ
cord-005453-4057qib7	5282	23	donors	donor	NNS
cord-005453-4057qib7	5282	24	.	.	.
cord-005453-4057qib7	5283	1	Twenty	twenty	CD
cord-005453-4057qib7	5283	2	one	one	CD
cord-005453-4057qib7	5283	3	of	of	IN
cord-005453-4057qib7	5283	4	25	25	CD
cord-005453-4057qib7	5283	5	patients	patient	NNS
cord-005453-4057qib7	5283	6	with	with	IN
cord-005453-4057qib7	5283	7	severe	severe	JJ
cord-005453-4057qib7	5283	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5283	9	(	(	-LRB-
cord-005453-4057qib7	5283	10	83	83	CD
cord-005453-4057qib7	5283	11	%	%	NN
cord-005453-4057qib7	5283	12	)	)	-RRB-
cord-005453-4057qib7	5283	13	survived	survive	VBD
cord-005453-4057qib7	5283	14	.	.	.
cord-005453-4057qib7	5284	1	Four	four	CD
cord-005453-4057qib7	5284	2	patients	patient	NNS
cord-005453-4057qib7	5284	3	(	(	-LRB-
cord-005453-4057qib7	5284	4	17	17	CD
cord-005453-4057qib7	5284	5	%	%	NN
cord-005453-4057qib7	5284	6	)	)	-RRB-
cord-005453-4057qib7	5284	7	died	die	VBD
cord-005453-4057qib7	5284	8	from	from	IN
cord-005453-4057qib7	5284	9	severe	severe	JJ
cord-005453-4057qib7	5284	10	GVHD	GVHD	NNP
cord-005453-4057qib7	5284	11	and	and	CC
cord-005453-4057qib7	5284	12	complications	complication	NNS
cord-005453-4057qib7	5284	13	of	of	IN
cord-005453-4057qib7	5284	14	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5284	15	treatment	treatment	NN
cord-005453-4057qib7	5284	16	.	.	.
cord-005453-4057qib7	5285	1	3	3	CD
cord-005453-4057qib7	5285	2	of	of	IN
cord-005453-4057qib7	5285	3	4	4	CD
cord-005453-4057qib7	5285	4	deceased	deceased	JJ
cord-005453-4057qib7	5285	5	patients	patient	NNS
cord-005453-4057qib7	5285	6	were	be	VBD
cord-005453-4057qib7	5285	7	transplanted	transplant	VBN
cord-005453-4057qib7	5285	8	from	from	IN
cord-005453-4057qib7	5285	9	mismatched	mismatched	JJ
cord-005453-4057qib7	5285	10	donor	donor	NN
cord-005453-4057qib7	5285	11	,	,	,
cord-005453-4057qib7	5285	12	in	in	IN
cord-005453-4057qib7	5285	13	3	3	CD
cord-005453-4057qib7	5285	14	of	of	IN
cord-005453-4057qib7	5285	15	4	4	CD
cord-005453-4057qib7	5285	16	cases	case	NNS
cord-005453-4057qib7	5285	17	the	the	DT
cord-005453-4057qib7	5285	18	age	age	NN
cord-005453-4057qib7	5285	19	of	of	IN
cord-005453-4057qib7	5285	20	donor	donor	NN
cord-005453-4057qib7	5285	21	was	be	VBD
cord-005453-4057qib7	5285	22	advanced	advanced	JJ
cord-005453-4057qib7	5285	23	,	,	,
cord-005453-4057qib7	5285	24	2	2	CD
cord-005453-4057qib7	5285	25	of	of	IN
cord-005453-4057qib7	5285	26	4	4	CD
cord-005453-4057qib7	5285	27	patients	patient	NNS
cord-005453-4057qib7	5285	28	developed	develop	VBD
cord-005453-4057qib7	5285	29	severe	severe	JJ
cord-005453-4057qib7	5285	30	GVHD	GVHD	NNP
cord-005453-4057qib7	5285	31	and	and	CC
cord-005453-4057qib7	5285	32	died	die	VBD
cord-005453-4057qib7	5285	33	after	after	IN
cord-005453-4057qib7	5285	34	second	second	JJ
cord-005453-4057qib7	5285	35	HSCT	HSCT	NNP
cord-005453-4057qib7	5285	36	.	.	.
cord-005453-4057qib7	5286	1	All	all	DT
cord-005453-4057qib7	5286	2	4	4	CD
cord-005453-4057qib7	5286	3	patients	patient	NNS
cord-005453-4057qib7	5286	4	were	be	VBD
cord-005453-4057qib7	5286	5	refractory	refractory	JJ
cord-005453-4057qib7	5286	6	to	to	IN
cord-005453-4057qib7	5286	7	different	different	JJ
cord-005453-4057qib7	5286	8	treatment	treatment	NN
cord-005453-4057qib7	5286	9	modalities	modality	NNS
cord-005453-4057qib7	5286	10	.	.	.
cord-005453-4057qib7	5287	1	Three	three	CD
cord-005453-4057qib7	5287	2	of	of	IN
cord-005453-4057qib7	5287	3	4	4	CD
cord-005453-4057qib7	5287	4	patients	patient	NNS
cord-005453-4057qib7	5287	5	died	die	VBD
cord-005453-4057qib7	5287	6	in	in	IN
cord-005453-4057qib7	5287	7	2012	2012	CD
cord-005453-4057qib7	5287	8	and	and	CC
cord-005453-4057qib7	5287	9	one	one	CD
cord-005453-4057qib7	5287	10	in	in	IN
cord-005453-4057qib7	5287	11	2015	2015	CD
cord-005453-4057qib7	5287	12	,	,	,
cord-005453-4057qib7	5287	13	it	-PRON-	PRP
cord-005453-4057qib7	5287	14	was	be	VBD
cord-005453-4057qib7	5287	15	no	no	DT
cord-005453-4057qib7	5287	16	death	death	NN
cord-005453-4057qib7	5287	17	from	from	IN
cord-005453-4057qib7	5287	18	severe	severe	JJ
cord-005453-4057qib7	5287	19	GVHD	GVHD	NNP
cord-005453-4057qib7	5287	20	in	in	IN
cord-005453-4057qib7	5287	21	12	12	CD
cord-005453-4057qib7	5287	22	patients	patient	NNS
cord-005453-4057qib7	5287	23	that	that	WDT
cord-005453-4057qib7	5287	24	were	be	VBD
cord-005453-4057qib7	5287	25	transplanted	transplant	VBN
cord-005453-4057qib7	5287	26	and	and	CC
cord-005453-4057qib7	5287	27	developed	develop	VBN
cord-005453-4057qib7	5287	28	high	high	JJ
cord-005453-4057qib7	5287	29	grade	grade	NN
cord-005453-4057qib7	5287	30	GVHD	GVHD	NNP
cord-005453-4057qib7	5287	31	after	after	IN
cord-005453-4057qib7	5287	32	2015	2015	CD
cord-005453-4057qib7	5287	33	.	.	.
cord-005453-4057qib7	5288	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5288	2	:	:	:
cord-005453-4057qib7	5289	1	The	the	DT
cord-005453-4057qib7	5289	2	results	result	NNS
cord-005453-4057qib7	5289	3	of	of	IN
cord-005453-4057qib7	5289	4	this	this	DT
cord-005453-4057qib7	5289	5	study	study	NN
cord-005453-4057qib7	5289	6	show	show	VBP
cord-005453-4057qib7	5289	7	a	a	DT
cord-005453-4057qib7	5289	8	high	high	JJ
cord-005453-4057qib7	5289	9	survival	survival	NN
cord-005453-4057qib7	5289	10	rate	rate	NN
cord-005453-4057qib7	5289	11	of	of	IN
cord-005453-4057qib7	5289	12	83	83	CD
cord-005453-4057qib7	5289	13	%	%	NN
cord-005453-4057qib7	5289	14	in	in	IN
cord-005453-4057qib7	5289	15	pediatric	pediatric	JJ
cord-005453-4057qib7	5289	16	patients	patient	NNS
cord-005453-4057qib7	5289	17	with	with	IN
cord-005453-4057qib7	5289	18	non	non	JJ
cord-005453-4057qib7	5289	19	malignant	malignant	JJ
cord-005453-4057qib7	5289	20	diseases	disease	NNS
cord-005453-4057qib7	5289	21	and	and	CC
cord-005453-4057qib7	5289	22	severe	severe	JJ
cord-005453-4057qib7	5289	23	GVHD	GVHD	NNP
cord-005453-4057qib7	5289	24	.	.	.
cord-005453-4057qib7	5290	1	Significant	significant	JJ
cord-005453-4057qib7	5290	2	risk	risk	NN
cord-005453-4057qib7	5290	3	factors	factor	NNS
cord-005453-4057qib7	5290	4	for	for	IN
cord-005453-4057qib7	5290	5	mortality	mortality	NN
cord-005453-4057qib7	5290	6	in	in	IN
cord-005453-4057qib7	5290	7	our	-PRON-	PRP$
cord-005453-4057qib7	5290	8	group	group	NN
cord-005453-4057qib7	5290	9	included	include	VBD
cord-005453-4057qib7	5290	10	mismatched	mismatched	JJ
cord-005453-4057qib7	5290	11	donor	donor	NN
cord-005453-4057qib7	5290	12	,	,	,
cord-005453-4057qib7	5290	13	advanced	advanced	JJ
cord-005453-4057qib7	5290	14	age	age	NN
cord-005453-4057qib7	5290	15	of	of	IN
cord-005453-4057qib7	5290	16	donor	donor	NN
cord-005453-4057qib7	5290	17	and	and	CC
cord-005453-4057qib7	5290	18	second	second	JJ
cord-005453-4057qib7	5290	19	transplant	transplant	NN
cord-005453-4057qib7	5290	20	.	.	.
cord-005453-4057qib7	5291	1	Trend	trend	NN
cord-005453-4057qib7	5291	2	to	to	IN
cord-005453-4057qib7	5291	3	better	well	JJR
cord-005453-4057qib7	5291	4	survival	survival	NN
cord-005453-4057qib7	5291	5	was	be	VBD
cord-005453-4057qib7	5291	6	observed	observe	VBN
cord-005453-4057qib7	5291	7	after	after	IN
cord-005453-4057qib7	5291	8	2015	2015	CD
cord-005453-4057qib7	5291	9	.	.	.
cord-005453-4057qib7	5292	1	Additional	additional	JJ
cord-005453-4057qib7	5292	2	multicentral	multicentral	JJ
cord-005453-4057qib7	5292	3	studies	study	NNS
cord-005453-4057qib7	5292	4	analyzed	analyze	VBD
cord-005453-4057qib7	5292	5	the	the	DT
cord-005453-4057qib7	5292	6	outcomes	outcome	NNS
cord-005453-4057qib7	5292	7	of	of	IN
cord-005453-4057qib7	5292	8	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5292	9	in	in	IN
cord-005453-4057qib7	5292	10	pediatric	pediatric	JJ
cord-005453-4057qib7	5292	11	patients	patient	NNS
cord-005453-4057qib7	5292	12	with	with	IN
cord-005453-4057qib7	5292	13	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	5292	14	diseases	disease	NNS
cord-005453-4057qib7	5292	15	are	be	VBP
cord-005453-4057qib7	5292	16	urgently	urgently	RB
cord-005453-4057qib7	5292	17	required	require	VBN
cord-005453-4057qib7	5292	18	.	.	.
cord-005453-4057qib7	5293	1	Background	background	NN
cord-005453-4057qib7	5293	2	:	:	:
cord-005453-4057qib7	5294	1	Chronic	Chronic	NNP
cord-005453-4057qib7	5294	2	Graft	graft	NN
cord-005453-4057qib7	5294	3	-	-	HYPH
cord-005453-4057qib7	5294	4	versus	versus	IN
cord-005453-4057qib7	5294	5	-	-	HYPH
cord-005453-4057qib7	5294	6	Host	host	NN
cord-005453-4057qib7	5294	7	Disease	Disease	NNP
cord-005453-4057qib7	5294	8	(	(	-LRB-
cord-005453-4057qib7	5294	9	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5294	10	)	)	-RRB-
cord-005453-4057qib7	5294	11	is	be	VBZ
cord-005453-4057qib7	5294	12	a	a	DT
cord-005453-4057qib7	5294	13	serious	serious	JJ
cord-005453-4057qib7	5294	14	late	late	JJ
cord-005453-4057qib7	5294	15	complication	complication	NN
cord-005453-4057qib7	5294	16	after	after	IN
cord-005453-4057qib7	5294	17	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5294	18	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5294	19	stem	stem	NN
cord-005453-4057qib7	5294	20	cell	cell	NN
cord-005453-4057qib7	5294	21	transplantation	transplantation	NN
cord-005453-4057qib7	5294	22	(	(	-LRB-
cord-005453-4057qib7	5294	23	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5294	24	)	)	-RRB-
cord-005453-4057qib7	5294	25	with	with	IN
cord-005453-4057qib7	5294	26	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	5294	27	presentation	presentation	NN
cord-005453-4057qib7	5294	28	and	and	CC
cord-005453-4057qib7	5294	29	still	still	RB
cord-005453-4057qib7	5294	30	poorly	poorly	RB
cord-005453-4057qib7	5294	31	understood	understand	VBD
cord-005453-4057qib7	5294	32	pathophysiology	pathophysiology	NN
cord-005453-4057qib7	5294	33	including	include	VBG
cord-005453-4057qib7	5294	34	inflammation	inflammation	NN
cord-005453-4057qib7	5294	35	and	and	CC
cord-005453-4057qib7	5294	36	endothelial	endothelial	JJ
cord-005453-4057qib7	5294	37	dysfunction	dysfunction	NN
cord-005453-4057qib7	5294	38	.	.	.
cord-005453-4057qib7	5295	1	Factor	factor	NN
cord-005453-4057qib7	5295	2	VIII	VIII	NNP
cord-005453-4057qib7	5295	3	(	(	-LRB-
cord-005453-4057qib7	5295	4	FVIII	FVIII	NNP
cord-005453-4057qib7	5295	5	)	)	-RRB-
cord-005453-4057qib7	5295	6	and	and	CC
cord-005453-4057qib7	5295	7	von	von	NNP
cord-005453-4057qib7	5295	8	Willebrand	Willebrand	NNP
cord-005453-4057qib7	5295	9	Factor	Factor	NNP
cord-005453-4057qib7	5295	10	(	(	-LRB-
cord-005453-4057qib7	5295	11	VWF	VWF	NNP
cord-005453-4057qib7	5295	12	)	)	-RRB-
cord-005453-4057qib7	5295	13	are	be	VBP
cord-005453-4057qib7	5295	14	coagulation	coagulation	NN
cord-005453-4057qib7	5295	15	factors	factor	NNS
cord-005453-4057qib7	5295	16	but	but	CC
cord-005453-4057qib7	5295	17	also	also	RB
cord-005453-4057qib7	5295	18	known	know	VBN
cord-005453-4057qib7	5295	19	indicators	indicator	NNS
cord-005453-4057qib7	5295	20	of	of	IN
cord-005453-4057qib7	5295	21	endothelial	endothelial	JJ
cord-005453-4057qib7	5295	22	dysfunction	dysfunction	NN
cord-005453-4057qib7	5295	23	and	and	CC
cord-005453-4057qib7	5295	24	inflammation	inflammation	NN
cord-005453-4057qib7	5295	25	in	in	IN
cord-005453-4057qib7	5295	26	different	different	JJ
cord-005453-4057qib7	5295	27	settings	setting	NNS
cord-005453-4057qib7	5295	28	,	,	,
cord-005453-4057qib7	5295	29	and	and	CC
cord-005453-4057qib7	5295	30	therefore	therefore	RB
cord-005453-4057qib7	5295	31	could	could	MD
cord-005453-4057qib7	5295	32	serve	serve	VB
cord-005453-4057qib7	5295	33	as	as	RB
cord-005453-4057qib7	5295	34	interesting	interesting	JJ
cord-005453-4057qib7	5295	35	candidate	candidate	NN
cord-005453-4057qib7	5295	36	biomarkers	biomarker	NNS
cord-005453-4057qib7	5295	37	of	of	IN
cord-005453-4057qib7	5295	38	cGvHD	cgvhd	NN
cord-005453-4057qib7	5295	39	.	.	.
cord-005453-4057qib7	5296	1	Methods	method	NNS
cord-005453-4057qib7	5296	2	:	:	:
cord-005453-4057qib7	5296	3	Since	since	IN
cord-005453-4057qib7	5296	4	2013	2013	CD
cord-005453-4057qib7	5296	5	patients	patient	NNS
cord-005453-4057qib7	5296	6	after	after	IN
cord-005453-4057qib7	5296	7	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5296	8	were	be	VBD
cord-005453-4057qib7	5296	9	assessed	assess	VBN
cord-005453-4057qib7	5296	10	by	by	IN
cord-005453-4057qib7	5296	11	the	the	DT
cord-005453-4057qib7	5296	12	Multidisciplinary	Multidisciplinary	NNP
cord-005453-4057qib7	5296	13	cGvHD	cgvhd	NN
cord-005453-4057qib7	5296	14	team	team	NN
cord-005453-4057qib7	5296	15	at	at	IN
cord-005453-4057qib7	5296	16	the	the	DT
cord-005453-4057qib7	5296	17	University	University	NNP
cord-005453-4057qib7	5296	18	Hospital	Hospital	NNP
cord-005453-4057qib7	5296	19	Center	Center	NNP
cord-005453-4057qib7	5296	20	Zagreb	Zagreb	NNP
cord-005453-4057qib7	5296	21	,	,	,
cord-005453-4057qib7	5296	22	Croatia	Croatia	NNP
cord-005453-4057qib7	5296	23	,	,	,
cord-005453-4057qib7	5296	24	using	use	VBG
cord-005453-4057qib7	5296	25	established	establish	VBN
cord-005453-4057qib7	5296	26	NIH	NIH	NNP
cord-005453-4057qib7	5296	27	cGvHD	cgvhd	RB
cord-005453-4057qib7	5296	28	-	-	HYPH
cord-005453-4057qib7	5296	29	related	relate	VBN
cord-005453-4057qib7	5296	30	measurements	measurement	NNS
cord-005453-4057qib7	5296	31	.	.	.
cord-005453-4057qib7	5297	1	An	an	DT
cord-005453-4057qib7	5297	2	extensive	extensive	JJ
cord-005453-4057qib7	5297	3	history	history	NN
cord-005453-4057qib7	5297	4	,	,	,
cord-005453-4057qib7	5297	5	physical	physical	JJ
cord-005453-4057qib7	5297	6	and	and	CC
cord-005453-4057qib7	5297	7	laboratory	laboratory	NN
cord-005453-4057qib7	5297	8	evaluations	evaluation	NNS
cord-005453-4057qib7	5297	9	were	be	VBD
cord-005453-4057qib7	5297	10	performed	perform	VBN
cord-005453-4057qib7	5297	11	,	,	,
cord-005453-4057qib7	5297	12	including	include	VBG
cord-005453-4057qib7	5297	13	FVIII	FVIII	NNP
cord-005453-4057qib7	5297	14	,	,	,
cord-005453-4057qib7	5297	15	VWF	VWF	NNP
cord-005453-4057qib7	5297	16	:	:	:
cord-005453-4057qib7	5298	1	Ag	Ag	NNP
cord-005453-4057qib7	5298	2	and	and	CC
cord-005453-4057qib7	5298	3	VWF	VWF	NNP
cord-005453-4057qib7	5298	4	:	:	:
cord-005453-4057qib7	5299	1	Ac	Ac	NNP
cord-005453-4057qib7	5299	2	analysis	analysis	NN
cord-005453-4057qib7	5299	3	.	.	.
cord-005453-4057qib7	5300	1	Descriptive	descriptive	JJ
cord-005453-4057qib7	5300	2	statistic	statistic	NN
cord-005453-4057qib7	5300	3	and	and	CC
cord-005453-4057qib7	5300	4	non	non	JJ
cord-005453-4057qib7	5300	5	-	-	JJ
cord-005453-4057qib7	5300	6	parametric	parametric	JJ
cord-005453-4057qib7	5300	7	analyses	analysis	NNS
cord-005453-4057qib7	5300	8	were	be	VBD
cord-005453-4057qib7	5300	9	performed	perform	VBN
cord-005453-4057qib7	5300	10	.	.	.
cord-005453-4057qib7	5301	1	Variables	variable	NNS
cord-005453-4057qib7	5301	2	that	that	WDT
cord-005453-4057qib7	5301	3	showed	show	VBD
cord-005453-4057qib7	5301	4	significant	significant	JJ
cord-005453-4057qib7	5301	5	univariate	univariate	JJ
cord-005453-4057qib7	5301	6	correlations	correlation	NNS
cord-005453-4057qib7	5301	7	were	be	VBD
cord-005453-4057qib7	5301	8	used	use	VBN
cord-005453-4057qib7	5301	9	in	in	IN
cord-005453-4057qib7	5301	10	multivariate	multivariate	JJ
cord-005453-4057qib7	5301	11	logistic	logistic	JJ
cord-005453-4057qib7	5301	12	regression	regression	NN
cord-005453-4057qib7	5301	13	(	(	-LRB-
cord-005453-4057qib7	5301	14	MLR	MLR	NNP
cord-005453-4057qib7	5301	15	)	)	-RRB-
cord-005453-4057qib7	5301	16	to	to	TO
cord-005453-4057qib7	5301	17	identify	identify	VB
cord-005453-4057qib7	5301	18	the	the	DT
cord-005453-4057qib7	5301	19	most	most	RBS
cord-005453-4057qib7	5301	20	predictive	predictive	JJ
cord-005453-4057qib7	5301	21	for	for	IN
cord-005453-4057qib7	5301	22	FVIII	FVIII	NNP
cord-005453-4057qib7	5301	23	,	,	,
cord-005453-4057qib7	5301	24	VWF	VWF	NNP
cord-005453-4057qib7	5301	25	:	:	:
cord-005453-4057qib7	5302	1	Ag	Ag	NNP
cord-005453-4057qib7	5302	2	and	and	CC
cord-005453-4057qib7	5302	3	VWF	VWF	NNP
cord-005453-4057qib7	5302	4	:	:	:
cord-005453-4057qib7	5303	1	Ac	Ac	NNP
cord-005453-4057qib7	5303	2	in	in	IN
cord-005453-4057qib7	5303	3	cGvHD	cgvhd	NN
cord-005453-4057qib7	5303	4	patients	patient	NNS
cord-005453-4057qib7	5303	5	.	.	.
cord-005453-4057qib7	5304	1	Results	result	NNS
cord-005453-4057qib7	5304	2	:	:	:
cord-005453-4057qib7	5304	3	70	70	CD
cord-005453-4057qib7	5304	4	cGvHD	cgvhd	NN
cord-005453-4057qib7	5304	5	patients	patient	NNS
cord-005453-4057qib7	5304	6	and	and	CC
cord-005453-4057qib7	5304	7	41	41	CD
cord-005453-4057qib7	5304	8	controls	control	NNS
cord-005453-4057qib7	5304	9	(	(	-LRB-
cord-005453-4057qib7	5304	10	subjects	subject	NNS
cord-005453-4057qib7	5304	11	after	after	IN
cord-005453-4057qib7	5304	12	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5304	13	without	without	IN
cord-005453-4057qib7	5304	14	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5304	15	)	)	-RRB-
cord-005453-4057qib7	5304	16	were	be	VBD
cord-005453-4057qib7	5304	17	analysed	analyse	VBN
cord-005453-4057qib7	5304	18	.	.	.
cord-005453-4057qib7	5305	1	Median	median	JJ
cord-005453-4057qib7	5305	2	age	age	NN
cord-005453-4057qib7	5305	3	of	of	IN
cord-005453-4057qib7	5305	4	cGvHD	cgvhd	NN
cord-005453-4057qib7	5305	5	patients	patient	NNS
cord-005453-4057qib7	5305	6	was	be	VBD
cord-005453-4057qib7	5305	7	42	42	CD
cord-005453-4057qib7	5305	8	(	(	-LRB-
cord-005453-4057qib7	5305	9	9	9	CD
cord-005453-4057qib7	5305	10	-	-	SYM
cord-005453-4057qib7	5305	11	65	65	CD
cord-005453-4057qib7	5305	12	)	)	-RRB-
cord-005453-4057qib7	5305	13	years	year	NNS
cord-005453-4057qib7	5305	14	,	,	,
cord-005453-4057qib7	5305	15	50	50	CD
cord-005453-4057qib7	5305	16	%	%	NN
cord-005453-4057qib7	5305	17	females	female	NNS
cord-005453-4057qib7	5305	18	,	,	,
cord-005453-4057qib7	5305	19	91.5	91.5	CD
cord-005453-4057qib7	5305	20	%	%	NN
cord-005453-4057qib7	5305	21	underwent	undergo	VBD
cord-005453-4057qib7	5305	22	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5305	23	for	for	IN
cord-005453-4057qib7	5305	24	hematologic	hematologic	JJ
cord-005453-4057qib7	5305	25	malignancies	malignancy	NNS
cord-005453-4057qib7	5305	26	,	,	,
cord-005453-4057qib7	5305	27	55.7	55.7	CD
cord-005453-4057qib7	5305	28	%	%	NN
cord-005453-4057qib7	5305	29	had	have	VBD
cord-005453-4057qib7	5305	30	myeloablative	myeloablative	JJ
cord-005453-4057qib7	5305	31	conditioning	conditioning	NN
cord-005453-4057qib7	5305	32	and	and	CC
cord-005453-4057qib7	5305	33	52.9	52.9	CD
cord-005453-4057qib7	5305	34	%	%	NN
cord-005453-4057qib7	5305	35	matched	match	VBN
cord-005453-4057qib7	5305	36	related	related	JJ
cord-005453-4057qib7	5305	37	donor	donor	NN
cord-005453-4057qib7	5305	38	.	.	.
cord-005453-4057qib7	5306	1	Median	median	JJ
cord-005453-4057qib7	5306	2	time	time	NN
cord-005453-4057qib7	5306	3	from	from	IN
cord-005453-4057qib7	5306	4	HSCT	HSCT	NNP
cord-005453-4057qib7	5306	5	to	to	TO
cord-005453-4057qib7	5306	6	study	study	VB
cord-005453-4057qib7	5306	7	was	be	VBD
cord-005453-4057qib7	5306	8	450.5	450.5	CD
cord-005453-4057qib7	5306	9	days	day	NNS
cord-005453-4057qib7	5306	10	and	and	CC
cord-005453-4057qib7	5306	11	from	from	IN
cord-005453-4057qib7	5306	12	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5306	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	5306	14	to	to	TO
cord-005453-4057qib7	5306	15	study	study	VB
cord-005453-4057qib7	5306	16	82	82	CD
cord-005453-4057qib7	5306	17	days	day	NNS
cord-005453-4057qib7	5306	18	.	.	.
cord-005453-4057qib7	5307	1	There	there	EX
cord-005453-4057qib7	5307	2	were	be	VBD
cord-005453-4057qib7	5307	3	no	no	DT
cord-005453-4057qib7	5307	4	demographic	demographic	JJ
cord-005453-4057qib7	5308	1	neither	neither	DT
cord-005453-4057qib7	5308	2	transplant	transplant	NN
cord-005453-4057qib7	5308	3	related	relate	VBD
cord-005453-4057qib7	5308	4	significant	significant	JJ
cord-005453-4057qib7	5308	5	differences	difference	NNS
cord-005453-4057qib7	5308	6	between	between	IN
cord-005453-4057qib7	5308	7	cGvHD	cgvhd	NN
cord-005453-4057qib7	5308	8	patients	patient	NNS
cord-005453-4057qib7	5308	9	and	and	CC
cord-005453-4057qib7	5308	10	controls	control	NNS
cord-005453-4057qib7	5308	11	beside	beside	IN
cord-005453-4057qib7	5308	12	stem	stem	NN
cord-005453-4057qib7	5308	13	cell	cell	NN
cord-005453-4057qib7	5308	14	source	source	NN
cord-005453-4057qib7	5308	15	(	(	-LRB-
cord-005453-4057qib7	5308	16	peripheral	peripheral	JJ
cord-005453-4057qib7	5308	17	blood	blood	NN
cord-005453-4057qib7	5308	18	71.4	71.4	CD
cord-005453-4057qib7	5308	19	%	%	NN
cord-005453-4057qib7	5308	20	vs	vs	IN
cord-005453-4057qib7	5308	21	51.2	51.2	CD
cord-005453-4057qib7	5308	22	%	%	NN
cord-005453-4057qib7	5308	23	,	,	,
cord-005453-4057qib7	5308	24	p=0.041	p=0.041	NNP
cord-005453-4057qib7	5308	25	)	)	-RRB-
cord-005453-4057qib7	5308	26	and	and	CC
cord-005453-4057qib7	5308	27	history	history	NN
cord-005453-4057qib7	5308	28	of	of	IN
cord-005453-4057qib7	5308	29	acute	acute	JJ
cord-005453-4057qib7	5308	30	GvHD	GvHD	NNP
cord-005453-4057qib7	5308	31	(	(	-LRB-
cord-005453-4057qib7	5308	32	70.0	70.0	CD
cord-005453-4057qib7	5308	33	%	%	NN
cord-005453-4057qib7	5308	34	vs	vs	IN
cord-005453-4057qib7	5308	35	22.0	22.0	CD
cord-005453-4057qib7	5308	36	%	%	NN
cord-005453-4057qib7	5308	37	,	,	,
cord-005453-4057qib7	5308	38	p	p	NN
cord-005453-4057qib7	5308	39	<	<	XX
cord-005453-4057qib7	5308	40	0.001	0.001	CD
cord-005453-4057qib7	5308	41	)	)	-RRB-
cord-005453-4057qib7	5308	42	.	.	.
cord-005453-4057qib7	5309	1	Majority	majority	NN
cord-005453-4057qib7	5309	2	of	of	IN
cord-005453-4057qib7	5309	3	patients	patient	NNS
cord-005453-4057qib7	5309	4	had	have	VBD
cord-005453-4057qib7	5309	5	moderate	moderate	JJ
cord-005453-4057qib7	5309	6	(	(	-LRB-
cord-005453-4057qib7	5309	7	52.9	52.9	CD
cord-005453-4057qib7	5309	8	%	%	NN
cord-005453-4057qib7	5309	9	)	)	-RRB-
cord-005453-4057qib7	5309	10	or	or	CC
cord-005453-4057qib7	5309	11	severe	severe	JJ
cord-005453-4057qib7	5309	12	(	(	-LRB-
cord-005453-4057qib7	5309	13	42.6	42.6	CD
cord-005453-4057qib7	5309	14	%	%	NN
cord-005453-4057qib7	5309	15	)	)	-RRB-
cord-005453-4057qib7	5310	1	NIH	NIH	NNP
cord-005453-4057qib7	5310	2	global	global	JJ
cord-005453-4057qib7	5310	3	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5310	4	score	score	NN
cord-005453-4057qib7	5310	5	,	,	,
cord-005453-4057qib7	5310	6	57.2	57.2	CD
cord-005453-4057qib7	5310	7	%	%	NN
cord-005453-4057qib7	5310	8	active	active	JJ
cord-005453-4057qib7	5310	9	cGvHD	cgvhd	NN
cord-005453-4057qib7	5310	10	by	by	IN
cord-005453-4057qib7	5310	11	clinician´s	clinician´s	NNP
cord-005453-4057qib7	5310	12	impression	impression	NN
cord-005453-4057qib7	5310	13	.	.	.
cord-005453-4057qib7	5311	1	Median	median	JJ
cord-005453-4057qib7	5311	2	number	number	NN
cord-005453-4057qib7	5311	3	of	of	IN
cord-005453-4057qib7	5311	4	organs	organ	NNS
cord-005453-4057qib7	5311	5	involved	involve	VBN
cord-005453-4057qib7	5311	6	by	by	IN
cord-005453-4057qib7	5311	7	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5311	8	was	be	VBD
cord-005453-4057qib7	5311	9	3	3	CD
cord-005453-4057qib7	5311	10	(	(	-LRB-
cord-005453-4057qib7	5311	11	1	1	CD
cord-005453-4057qib7	5311	12	-	-	SYM
cord-005453-4057qib7	5311	13	6	6	CD
cord-005453-4057qib7	5311	14	)	)	-RRB-
cord-005453-4057qib7	5311	15	,	,	,
cord-005453-4057qib7	5311	16	and	and	CC
cord-005453-4057qib7	5311	17	the	the	DT
cord-005453-4057qib7	5311	18	most	most	RBS
cord-005453-4057qib7	5311	19	frequently	frequently	RB
cord-005453-4057qib7	5311	20	involved	involve	VBN
cord-005453-4057qib7	5311	21	organs	organ	NNS
cord-005453-4057qib7	5311	22	were	be	VBD
cord-005453-4057qib7	5311	23	mouth	mouth	NN
cord-005453-4057qib7	5311	24	,	,	,
cord-005453-4057qib7	5311	25	skin	skin	NN
cord-005453-4057qib7	5311	26	and	and	CC
cord-005453-4057qib7	5311	27	eyes	eye	NNS
cord-005453-4057qib7	5311	28	(	(	-LRB-
cord-005453-4057qib7	5311	29	52.0	52.0	CD
cord-005453-4057qib7	5311	30	%	%	NN
cord-005453-4057qib7	5311	31	each	each	DT
cord-005453-4057qib7	5311	32	)	)	-RRB-
cord-005453-4057qib7	5311	33	.	.	.
cord-005453-4057qib7	5312	1	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5312	2	patients	patient	NNS
cord-005453-4057qib7	5312	3	compared	compare	VBN
cord-005453-4057qib7	5312	4	to	to	IN
cord-005453-4057qib7	5312	5	controls	control	NNS
cord-005453-4057qib7	5312	6	had	have	VBD
cord-005453-4057qib7	5312	7	higher	high	JJR
cord-005453-4057qib7	5312	8	FVIII	FVIII	NNP
cord-005453-4057qib7	5312	9	levels	level	NNS
cord-005453-4057qib7	5312	10	(	(	-LRB-
cord-005453-4057qib7	5312	11	median	median	JJ
cord-005453-4057qib7	5312	12	206	206	CD
cord-005453-4057qib7	5312	13	(	(	-LRB-
cord-005453-4057qib7	5312	14	52	52	CD
cord-005453-4057qib7	5312	15	-	-	SYM
cord-005453-4057qib7	5312	16	453)%	453)%	CD
cord-005453-4057qib7	5312	17	vs	vs	IN
cord-005453-4057qib7	5312	18	182	182	CD
cord-005453-4057qib7	5312	19	(	(	-LRB-
cord-005453-4057qib7	5312	20	51	51	CD
cord-005453-4057qib7	5312	21	-	-	SYM
cord-005453-4057qib7	5312	22	406)%	406)%	CD
cord-005453-4057qib7	5312	23	,	,	,
cord-005453-4057qib7	5312	24	p=0.044	p=0.044	NNS
cord-005453-4057qib7	5313	1	,	,	,
cord-005453-4057qib7	5313	2	reference	reference	NN
cord-005453-4057qib7	5313	3	range	range	NN
cord-005453-4057qib7	5313	4	50	50	CD
cord-005453-4057qib7	5313	5	-	-	SYM
cord-005453-4057qib7	5313	6	149	149	CD
cord-005453-4057qib7	5313	7	%	%	NN
cord-005453-4057qib7	5313	8	)	)	-RRB-
cord-005453-4057qib7	5313	9	and	and	CC
cord-005453-4057qib7	5313	10	higher	high	JJR
cord-005453-4057qib7	5313	11	VWF	VWF	NNP
cord-005453-4057qib7	5313	12	:	:	:
cord-005453-4057qib7	5314	1	Ag	Ag	NNP
cord-005453-4057qib7	5314	2	(	(	-LRB-
cord-005453-4057qib7	5314	3	median	median	JJ
cord-005453-4057qib7	5314	4	261.6	261.6	CD
cord-005453-4057qib7	5314	5	(	(	-LRB-
cord-005453-4057qib7	5314	6	76.6	76.6	CD
cord-005453-4057qib7	5314	7	-	-	HYPH
cord-005453-4057qib7	5314	8	601)%	601)%	CD
cord-005453-4057qib7	5315	1	vs	vs	IN
cord-005453-4057qib7	5315	2	203.2	203.2	CD
cord-005453-4057qib7	5315	3	(	(	-LRB-
cord-005453-4057qib7	5315	4	51.9	51.9	CD
cord-005453-4057qib7	5315	5	-	-	SYM
cord-005453-4057qib7	5315	6	600)%	600)%	CD
cord-005453-4057qib7	5315	7	,	,	,
cord-005453-4057qib7	5315	8	p=0.030	p=0.030	NNP
cord-005453-4057qib7	5315	9	,	,	,
cord-005453-4057qib7	5315	10	reference	reference	NN
cord-005453-4057qib7	5315	11	range	range	NN
cord-005453-4057qib7	5315	12	50	50	CD
cord-005453-4057qib7	5315	13	-	-	SYM
cord-005453-4057qib7	5315	14	160	160	CD
cord-005453-4057qib7	5315	15	%	%	NN
cord-005453-4057qib7	5315	16	)	)	-RRB-
cord-005453-4057qib7	5315	17	,	,	,
cord-005453-4057qib7	5315	18	while	while	IN
cord-005453-4057qib7	5315	19	VWF	VWF	NNP
cord-005453-4057qib7	5315	20	:	:	:
cord-005453-4057qib7	5316	1	Ac	Ac	NNP
cord-005453-4057qib7	5316	2	showed	show	VBD
cord-005453-4057qib7	5316	3	a	a	DT
cord-005453-4057qib7	5316	4	trend	trend	NN
cord-005453-4057qib7	5316	5	toward	toward	IN
cord-005453-4057qib7	5316	6	higher	high	JJR
cord-005453-4057qib7	5316	7	levels	level	NNS
cord-005453-4057qib7	5316	8	among	among	IN
cord-005453-4057qib7	5316	9	patients	patient	NNS
cord-005453-4057qib7	5316	10	(	(	-LRB-
cord-005453-4057qib7	5316	11	median	median	JJ
cord-005453-4057qib7	5316	12	253.4	253.4	CD
cord-005453-4057qib7	5316	13	(	(	-LRB-
cord-005453-4057qib7	5316	14	54	54	CD
cord-005453-4057qib7	5316	15	-	-	SYM
cord-005453-4057qib7	5316	16	601)%	601)%	CD
cord-005453-4057qib7	5316	17	vs	vs	IN
cord-005453-4057qib7	5316	18	178	178	CD
cord-005453-4057qib7	5316	19	(	(	-LRB-
cord-005453-4057qib7	5316	20	48.6	48.6	CD
cord-005453-4057qib7	5316	21	-	-	SYM
cord-005453-4057qib7	5316	22	601)%	601)%	CD
cord-005453-4057qib7	5316	23	,	,	,
cord-005453-4057qib7	5316	24	p=0.084	p=0.084	NNP
cord-005453-4057qib7	5317	1	,	,	,
cord-005453-4057qib7	5317	2	reference	reference	NN
cord-005453-4057qib7	5317	3	range	range	NN
cord-005453-4057qib7	5317	4	50	50	CD
cord-005453-4057qib7	5317	5	-	-	SYM
cord-005453-4057qib7	5317	6	150	150	CD
cord-005453-4057qib7	5317	7	%	%	NN
cord-005453-4057qib7	5317	8	)	)	-RRB-
cord-005453-4057qib7	5317	9	.	.	.
cord-005453-4057qib7	5318	1	Patients	patient	NNS
cord-005453-4057qib7	5318	2	had	have	VBD
cord-005453-4057qib7	5318	3	higher	high	JJR
cord-005453-4057qib7	5318	4	GGT	ggt	NN
cord-005453-4057qib7	5318	5	(	(	-LRB-
cord-005453-4057qib7	5318	6	p=0.002	p=0.002	NNP
cord-005453-4057qib7	5318	7	)	)	-RRB-
cord-005453-4057qib7	5318	8	,	,	,
cord-005453-4057qib7	5318	9	lower	lower	VB
cord-005453-4057qib7	5318	10	anticardiolipin	anticardiolipin	NNP
cord-005453-4057qib7	5318	11	IgG	IgG	NNP
cord-005453-4057qib7	5318	12	(	(	-LRB-
cord-005453-4057qib7	5318	13	p=0.001	p=0.001	NNP
cord-005453-4057qib7	5318	14	)	)	-RRB-
cord-005453-4057qib7	5318	15	and	and	CC
cord-005453-4057qib7	5318	16	IgM	IgM	NNP
cord-005453-4057qib7	5318	17	(	(	-LRB-
cord-005453-4057qib7	5318	18	p=0.003	p=0.003	NNP
cord-005453-4057qib7	5318	19	)	)	-RRB-
cord-005453-4057qib7	5318	20	,	,	,
cord-005453-4057qib7	5318	21	and	and	CC
cord-005453-4057qib7	5318	22	lower	low	JJR
cord-005453-4057qib7	5318	23	albumin	albumin	NN
cord-005453-4057qib7	5318	24	(	(	-LRB-
cord-005453-4057qib7	5318	25	p=0.018	p=0.018	NNP
cord-005453-4057qib7	5318	26	)	)	-RRB-
cord-005453-4057qib7	5318	27	than	than	IN
cord-005453-4057qib7	5318	28	controls	control	NNS
cord-005453-4057qib7	5318	29	,	,	,
cord-005453-4057qib7	5318	30	without	without	IN
cord-005453-4057qib7	5318	31	differences	difference	NNS
cord-005453-4057qib7	5318	32	between	between	IN
cord-005453-4057qib7	5318	33	other	other	JJ
cord-005453-4057qib7	5318	34	laboratory	laboratory	NN
cord-005453-4057qib7	5318	35	parameters	parameter	NNS
cord-005453-4057qib7	5318	36	.	.	.
cord-005453-4057qib7	5319	1	Univariate	Univariate	NNP
cord-005453-4057qib7	5319	2	analysis	analysis	NN
cord-005453-4057qib7	5319	3	showed	show	VBD
cord-005453-4057qib7	5319	4	that	that	IN
cord-005453-4057qib7	5319	5	among	among	IN
cord-005453-4057qib7	5319	6	cGvHD	cgvhd	NN
cord-005453-4057qib7	5319	7	patients	patient	NNS
cord-005453-4057qib7	5319	8	higher	high	JJR
cord-005453-4057qib7	5319	9	FVIII	FVIII	NNP
cord-005453-4057qib7	5319	10	was	be	VBD
cord-005453-4057qib7	5319	11	associated	associate	VBN
cord-005453-4057qib7	5319	12	with	with	IN
cord-005453-4057qib7	5319	13	worse	bad	JJR
cord-005453-4057qib7	5319	14	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	5319	15	score	score	NN
cord-005453-4057qib7	5319	16	(	(	-LRB-
cord-005453-4057qib7	5319	17	KS	KS	NNP
cord-005453-4057qib7	5319	18	)	)	-RRB-
cord-005453-4057qib7	5319	19	(	(	-LRB-
cord-005453-4057qib7	5319	20	p=0.031	p=0.031	NNP
cord-005453-4057qib7	5319	21	)	)	-RRB-
cord-005453-4057qib7	5319	22	and	and	CC
cord-005453-4057qib7	5319	23	performance	performance	NN
cord-005453-4057qib7	5319	24	score	score	NN
cord-005453-4057qib7	5319	25	(	(	-LRB-
cord-005453-4057qib7	5319	26	PS	PS	NNP
cord-005453-4057qib7	5319	27	)	)	-RRB-
cord-005453-4057qib7	5319	28	(	(	-LRB-
cord-005453-4057qib7	5319	29	p=0.030	p=0.030	NNP
cord-005453-4057qib7	5319	30	)	)	-RRB-
cord-005453-4057qib7	5319	31	,	,	,
cord-005453-4057qib7	5319	32	higher	high	JJR
cord-005453-4057qib7	5319	33	leukocytes	leukocyte	NNS
cord-005453-4057qib7	5319	34	(	(	-LRB-
cord-005453-4057qib7	5319	35	p=0.031	p=0.031	NNP
cord-005453-4057qib7	5319	36	)	)	-RRB-
cord-005453-4057qib7	5319	37	,	,	,
cord-005453-4057qib7	5319	38	cholesterol	cholesterol	NN
cord-005453-4057qib7	5319	39	(	(	-LRB-
cord-005453-4057qib7	5319	40	p=0.003	p=0.003	NNP
cord-005453-4057qib7	5319	41	)	)	-RRB-
cord-005453-4057qib7	5319	42	,	,	,
cord-005453-4057qib7	5319	43	triglycerides	triglyceride	NNS
cord-005453-4057qib7	5319	44	,	,	,
cord-005453-4057qib7	5319	45	AST	AST	NNP
cord-005453-4057qib7	5319	46	,	,	,
cord-005453-4057qib7	5319	47	ALT	ALT	NNP
cord-005453-4057qib7	5319	48	,	,	,
cord-005453-4057qib7	5319	49	GGT	GGT	NNP
cord-005453-4057qib7	5319	50	,	,	,
cord-005453-4057qib7	5319	51	LDH	LDH	NNP
cord-005453-4057qib7	5319	52	,	,	,
cord-005453-4057qib7	5319	53	and	and	CC
cord-005453-4057qib7	5319	54	lower	low	JJR
cord-005453-4057qib7	5319	55	albumin	albumin	NN
cord-005453-4057qib7	5319	56	.	.	.
cord-005453-4057qib7	5320	1	Higher	high	JJR
cord-005453-4057qib7	5320	2	VWF	VWF	NNP
cord-005453-4057qib7	5320	3	:	:	:
cord-005453-4057qib7	5321	1	Ag	Ag	NNP
cord-005453-4057qib7	5321	2	and	and	CC
cord-005453-4057qib7	5321	3	VWF	VWF	NNP
cord-005453-4057qib7	5321	4	:	:	:
cord-005453-4057qib7	5321	5	Ac	Ac	NNP
cord-005453-4057qib7	5321	6	in	in	IN
cord-005453-4057qib7	5321	7	cGvHD	cgvhd	NN
cord-005453-4057qib7	5321	8	patients	patient	NNS
cord-005453-4057qib7	5321	9	were	be	VBD
cord-005453-4057qib7	5321	10	associated	associate	VBN
cord-005453-4057qib7	5321	11	with	with	IN
cord-005453-4057qib7	5321	12	worse	bad	JJR
cord-005453-4057qib7	5321	13	KS	KS	NNP
cord-005453-4057qib7	5321	14	and	and	CC
cord-005453-4057qib7	5321	15	PS	PS	NNP
cord-005453-4057qib7	5321	16	(	(	-LRB-
cord-005453-4057qib7	5321	17	p	p	NN
cord-005453-4057qib7	5321	18	<	<	XX
cord-005453-4057qib7	5321	19	0.001	0.001	CD
cord-005453-4057qib7	5321	20	)	)	-RRB-
cord-005453-4057qib7	5321	21	,	,	,
cord-005453-4057qib7	5321	22	with	with	IN
cord-005453-4057qib7	5321	23	more	more	RBR
cord-005453-4057qib7	5321	24	active	active	JJ
cord-005453-4057qib7	5321	25	cGvHD	cgvhd	NN
cord-005453-4057qib7	5321	26	(	(	-LRB-
cord-005453-4057qib7	5321	27	p	p	NN
cord-005453-4057qib7	5321	28	<	<	XX
cord-005453-4057qib7	5321	29	0.001	0.001	CD
cord-005453-4057qib7	5321	30	)	)	-RRB-
cord-005453-4057qib7	5321	31	,	,	,
cord-005453-4057qib7	5321	32	worse	bad	JJR
cord-005453-4057qib7	5321	33	NIH	NIH	NNP
cord-005453-4057qib7	5321	34	cGvHD	cgvhd	NN
cord-005453-4057qib7	5321	35	liver	liver	NN
cord-005453-4057qib7	5321	36	(	(	-LRB-
cord-005453-4057qib7	5321	37	p=0.042	p=0.042	NNP
cord-005453-4057qib7	5321	38	;	;	:
cord-005453-4057qib7	5321	39	p=0.039	p=0.039	JJ
cord-005453-4057qib7	5321	40	)	)	-RRB-
cord-005453-4057qib7	5321	41	and	and	CC
cord-005453-4057qib7	5321	42	NIH	NIH	NNP
cord-005453-4057qib7	5321	43	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5321	44	mouth	mouth	NN
cord-005453-4057qib7	5321	45	(	(	-LRB-
cord-005453-4057qib7	5321	46	p=0.012	p=0.012	NNP
cord-005453-4057qib7	5321	47	;	;	.
cord-005453-4057qib7	5322	1	p=0.009	p=0.009	NNP
cord-005453-4057qib7	5322	2	)	)	-RRB-
cord-005453-4057qib7	5322	3	,	,	,
cord-005453-4057qib7	5322	4	higher	high	JJR
cord-005453-4057qib7	5322	5	total	total	JJ
cord-005453-4057qib7	5322	6	NIH	NIH	NNP
cord-005453-4057qib7	5322	7	score	score	NN
cord-005453-4057qib7	5322	8	(	(	-LRB-
cord-005453-4057qib7	5322	9	p=0.044	p=0.044	NNS
cord-005453-4057qib7	5322	10	;	;	:
cord-005453-4057qib7	5322	11	p=0.005	p=0.005	NNP
cord-005453-4057qib7	5322	12	)	)	-RRB-
cord-005453-4057qib7	5322	13	,	,	,
cord-005453-4057qib7	5322	14	higher	high	JJR
cord-005453-4057qib7	5322	15	number	number	NN
cord-005453-4057qib7	5322	16	organs	organ	NNS
cord-005453-4057qib7	5322	17	involved	involve	VBN
cord-005453-4057qib7	5322	18	(	(	-LRB-
cord-005453-4057qib7	5322	19	p=0.013	p=0.013	NN
cord-005453-4057qib7	5322	20	;	;	:
cord-005453-4057qib7	5322	21	p=0.003	p=0.003	NNP
cord-005453-4057qib7	5322	22	)	)	-RRB-
cord-005453-4057qib7	5322	23	,	,	,
cord-005453-4057qib7	5322	24	higher	high	JJR
cord-005453-4057qib7	5322	25	ESR	ESR	NNP
cord-005453-4057qib7	5322	26	,	,	,
cord-005453-4057qib7	5322	27	monocytes	monocyte	NNS
cord-005453-4057qib7	5322	28	,	,	,
cord-005453-4057qib7	5322	29	Ddimers	Ddimers	NNPS
cord-005453-4057qib7	5322	30	,	,	,
cord-005453-4057qib7	5322	31	AST	AST	NNP
cord-005453-4057qib7	5322	32	,	,	,
cord-005453-4057qib7	5322	33	ALT	ALT	NNP
cord-005453-4057qib7	5322	34	,	,	,
cord-005453-4057qib7	5322	35	GGT	GGT	NNP
cord-005453-4057qib7	5322	36	,	,	,
cord-005453-4057qib7	5322	37	LDH	LDH	NNP
cord-005453-4057qib7	5322	38	,	,	,
cord-005453-4057qib7	5322	39	triglycerides	triglyceride	NNS
cord-005453-4057qib7	5322	40	,	,	,
cord-005453-4057qib7	5322	41	β-2-microglobulin	β-2-microglobulin	ADD
cord-005453-4057qib7	5322	42	,	,	,
cord-005453-4057qib7	5322	43	ferritin	ferritin	NN
cord-005453-4057qib7	5322	44	,	,	,
cord-005453-4057qib7	5322	45	total	total	JJ
cord-005453-4057qib7	5322	46	proteins	protein	NNS
cord-005453-4057qib7	5322	47	,	,	,
cord-005453-4057qib7	5322	48	IgA	iga	NN
cord-005453-4057qib7	5322	49	and	and	CC
cord-005453-4057qib7	5322	50	lower	low	JJR
cord-005453-4057qib7	5322	51	albumin	albumin	NN
cord-005453-4057qib7	5322	52	.	.	.
cord-005453-4057qib7	5323	1	MLR	MLR	NNP
cord-005453-4057qib7	5323	2	analysis	analysis	NN
cord-005453-4057qib7	5323	3	showed	show	VBD
cord-005453-4057qib7	5323	4	leukocytes	leukocyte	NNS
cord-005453-4057qib7	5323	5	(	(	-LRB-
cord-005453-4057qib7	5323	6	p=0.018	p=0.018	NNP
cord-005453-4057qib7	5323	7	)	)	-RRB-
cord-005453-4057qib7	5324	1	and	and	CC
cord-005453-4057qib7	5324	2	cholesterol	cholesterol	NN
cord-005453-4057qib7	5324	3	(	(	-LRB-
cord-005453-4057qib7	5324	4	p=0.010	p=0.010	ADD
cord-005453-4057qib7	5324	5	)	)	-RRB-
cord-005453-4057qib7	5325	1	as	as	IN
cord-005453-4057qib7	5325	2	the	the	DT
cord-005453-4057qib7	5325	3	strongest	strong	JJS
cord-005453-4057qib7	5325	4	predictor	predictor	NN
cord-005453-4057qib7	5325	5	of	of	IN
cord-005453-4057qib7	5325	6	FVIII	FVIII	NNP
cord-005453-4057qib7	5325	7	(	(	-LRB-
cord-005453-4057qib7	5325	8	r2=49.8	r2=49.8	NNP
cord-005453-4057qib7	5325	9	%	%	NN
cord-005453-4057qib7	5325	10	;	;	:
cord-005453-4057qib7	5325	11	p	p	NN
cord-005453-4057qib7	5325	12	<	<	XX
cord-005453-4057qib7	5325	13	0.001	0.001	CD
cord-005453-4057qib7	5325	14	)	)	-RRB-
cord-005453-4057qib7	5325	15	,	,	,
cord-005453-4057qib7	5325	16	while	while	IN
cord-005453-4057qib7	5325	17	strongest	strong	JJS
cord-005453-4057qib7	5325	18	predictor	predictor	NN
cord-005453-4057qib7	5325	19	of	of	IN
cord-005453-4057qib7	5325	20	VWF	VWF	NNP
cord-005453-4057qib7	5325	21	:	:	:
cord-005453-4057qib7	5326	1	Ac	Ac	NNP
cord-005453-4057qib7	5326	2	was	be	VBD
cord-005453-4057qib7	5326	3	number	number	NN
cord-005453-4057qib7	5326	4	of	of	IN
cord-005453-4057qib7	5326	5	organs	organ	NNS
cord-005453-4057qib7	5326	6	involved	involve	VBN
cord-005453-4057qib7	5326	7	by	by	IN
cord-005453-4057qib7	5326	8	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5326	9	(	(	-LRB-
cord-005453-4057qib7	5326	10	r2=71.7	r2=71.7	NN
cord-005453-4057qib7	5326	11	%	%	NN
cord-005453-4057qib7	5326	12	;	;	:
cord-005453-4057qib7	5326	13	p=0.031	p=0.031	NNP
cord-005453-4057qib7	5326	14	)	)	-RRB-
cord-005453-4057qib7	5326	15	.	.	.
cord-005453-4057qib7	5327	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5327	2	:	:	:
cord-005453-4057qib7	5328	1	Results	result	NNS
cord-005453-4057qib7	5328	2	of	of	IN
cord-005453-4057qib7	5328	3	this	this	DT
cord-005453-4057qib7	5328	4	study	study	NN
cord-005453-4057qib7	5328	5	detected	detect	VBD
cord-005453-4057qib7	5328	6	high	high	JJ
cord-005453-4057qib7	5328	7	FVIII	FVIII	NNP
cord-005453-4057qib7	5328	8	and	and	CC
cord-005453-4057qib7	5328	9	VWF	VWF	NNP
cord-005453-4057qib7	5328	10	levels	level	NNS
cord-005453-4057qib7	5328	11	in	in	IN
cord-005453-4057qib7	5328	12	cGvHD	cgvhd	NN
cord-005453-4057qib7	5328	13	patients	patient	NNS
cord-005453-4057qib7	5328	14	with	with	IN
cord-005453-4057qib7	5328	15	possible	possible	JJ
cord-005453-4057qib7	5328	16	reflections	reflection	NNS
cord-005453-4057qib7	5328	17	to	to	IN
cord-005453-4057qib7	5328	18	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5328	19	manifestations	manifestation	NNS
cord-005453-4057qib7	5328	20	,	,	,
cord-005453-4057qib7	5328	21	what	what	WP
cord-005453-4057qib7	5328	22	needs	need	VBZ
cord-005453-4057qib7	5328	23	to	to	TO
cord-005453-4057qib7	5328	24	be	be	VB
cord-005453-4057qib7	5328	25	further	further	RB
cord-005453-4057qib7	5328	26	confirmed	confirm	VBN
cord-005453-4057qib7	5328	27	in	in	IN
cord-005453-4057qib7	5328	28	larger	large	JJR
cord-005453-4057qib7	5328	29	longitudinal	longitudinal	JJ
cord-005453-4057qib7	5328	30	studies	study	NNS
cord-005453-4057qib7	5328	31	.	.	.
cord-005453-4057qib7	5329	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5329	2	:	:	:
cord-005453-4057qib7	5330	1	This	this	DT
cord-005453-4057qib7	5330	2	work	work	NN
cord-005453-4057qib7	5330	3	was	be	VBD
cord-005453-4057qib7	5330	4	supported	support	VBN
cord-005453-4057qib7	5330	5	,	,	,
cord-005453-4057qib7	5330	6	in	in	IN
cord-005453-4057qib7	5330	7	part	part	NN
cord-005453-4057qib7	5330	8	,	,	,
cord-005453-4057qib7	5330	9	by	by	IN
cord-005453-4057qib7	5330	10	the	the	DT
cord-005453-4057qib7	5330	11	Unity	Unity	NNP
cord-005453-4057qib7	5330	12	Through	Through	NNP
cord-005453-4057qib7	5330	13	Knowledge	Knowledge	NNP
cord-005453-4057qib7	5330	14	Fund	Fund	NNP
cord-005453-4057qib7	5330	15	project	project	NN
cord-005453-4057qib7	5330	16	entitled	entitle	VBN
cord-005453-4057qib7	5330	17	"	"	``
cord-005453-4057qib7	5330	18	Clinical	clinical	JJ
cord-005453-4057qib7	5330	19	and	and	CC
cord-005453-4057qib7	5330	20	biological	biological	JJ
cord-005453-4057qib7	5330	21	factors	factor	NNS
cord-005453-4057qib7	5330	22	determining	determine	VBG
cord-005453-4057qib7	5330	23	severity	severity	NN
cord-005453-4057qib7	5330	24	and	and	CC
cord-005453-4057qib7	5330	25	activity	activity	NN
cord-005453-4057qib7	5330	26	of	of	IN
cord-005453-4057qib7	5330	27	chronic	chronic	JJ
cord-005453-4057qib7	5330	28	Graft	graft	NN
cord-005453-4057qib7	5330	29	-	-	HYPH
cord-005453-4057qib7	5330	30	versus	versus	IN
cord-005453-4057qib7	5330	31	-	-	HYPH
cord-005453-4057qib7	5330	32	Host	host	NN
cord-005453-4057qib7	5330	33	disease	disease	NN
cord-005453-4057qib7	5330	34	after	after	IN
cord-005453-4057qib7	5330	35	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5330	36	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5330	37	stem	stem	NN
cord-005453-4057qib7	5330	38	cell	cell	NN
cord-005453-4057qib7	5330	39	transplantation	transplantation	NN
cord-005453-4057qib7	5330	40	"	"	''
cord-005453-4057qib7	5330	41	,	,	,
cord-005453-4057qib7	5330	42	and	and	CC
cord-005453-4057qib7	5330	43	also	also	RB
cord-005453-4057qib7	5330	44	,	,	,
cord-005453-4057qib7	5330	45	in	in	IN
cord-005453-4057qib7	5330	46	part	part	NN
cord-005453-4057qib7	5330	47	,	,	,
cord-005453-4057qib7	5330	48	by	by	IN
cord-005453-4057qib7	5330	49	the	the	DT
cord-005453-4057qib7	5330	50	Croatian	Croatian	NNP
cord-005453-4057qib7	5330	51	Science	Science	NNP
cord-005453-4057qib7	5330	52	Foundation	Foundation	NNP
cord-005453-4057qib7	5330	53	project	project	NN
cord-005453-4057qib7	5330	54	entitled	entitle	VBN
cord-005453-4057qib7	5330	55	"	"	``
cord-005453-4057qib7	5330	56	New	new	JJ
cord-005453-4057qib7	5330	57	biomarkers	biomarker	NNS
cord-005453-4057qib7	5330	58	for	for	IN
cord-005453-4057qib7	5330	59	chronic	chronic	JJ
cord-005453-4057qib7	5330	60	Graft	graft	NN
cord-005453-4057qib7	5330	61	-	-	HYPH
cord-005453-4057qib7	5330	62	versus	versus	IN
cord-005453-4057qib7	5330	63	-	-	HYPH
cord-005453-4057qib7	5330	64	Host	host	NN
cord-005453-4057qib7	5330	65	disease	disease	NN
cord-005453-4057qib7	5330	66	"	"	''
cord-005453-4057qib7	5330	67	.	.	.
cord-005453-4057qib7	5331	1	Antonela	Antonela	NNP
cord-005453-4057qib7	5331	2	Samardzic	Samardzic	NNP
cord-005453-4057qib7	5331	3	-Work	-Work	NNP
cord-005453-4057qib7	5332	1	financed	finance	VBN
cord-005453-4057qib7	5332	2	by	by	IN
cord-005453-4057qib7	5332	3	the	the	DT
cord-005453-4057qib7	5332	4	Croatian	Croatian	NNP
cord-005453-4057qib7	5332	5	Science	Science	NNP
cord-005453-4057qib7	5332	6	Fondations`"Young	Fondations`"Young	.
cord-005453-4057qib7	5333	1	researchers`career	researchers`career	NNP
cord-005453-4057qib7	5333	2	development	development	NN
cord-005453-4057qib7	5333	3	project	project	NN
cord-005453-4057qib7	5333	4	-training	-training	NN
cord-005453-4057qib7	5333	5	of	of	IN
cord-005453-4057qib7	5333	6	doctoral	doctoral	JJ
cord-005453-4057qib7	5333	7	students	student	NNS
cord-005453-4057qib7	5334	1	"	"	``
cord-005453-4057qib7	5334	2	Background	background	NN
cord-005453-4057qib7	5334	3	:	:	:
cord-005453-4057qib7	5335	1	Thrombotic	thrombotic	JJ
cord-005453-4057qib7	5335	2	microangiopathy	microangiopathy	NN
cord-005453-4057qib7	5335	3	(	(	-LRB-
cord-005453-4057qib7	5335	4	TMA	TMA	NNP
cord-005453-4057qib7	5335	5	)	)	-RRB-
cord-005453-4057qib7	5335	6	is	be	VBZ
cord-005453-4057qib7	5335	7	a	a	DT
cord-005453-4057qib7	5335	8	severe	severe	JJ
cord-005453-4057qib7	5335	9	complication	complication	NN
cord-005453-4057qib7	5335	10	of	of	IN
cord-005453-4057qib7	5335	11	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5335	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5335	13	cell	cell	NN
cord-005453-4057qib7	5335	14	transplantation	transplantation	NN
cord-005453-4057qib7	5335	15	(	(	-LRB-
cord-005453-4057qib7	5335	16	HCT	HCT	NNP
cord-005453-4057qib7	5335	17	)	)	-RRB-
cord-005453-4057qib7	5335	18	with	with	IN
cord-005453-4057qib7	5335	19	multisystem	multisystem	JJ
cord-005453-4057qib7	5335	20	involvement	involvement	NN
cord-005453-4057qib7	5335	21	.	.	.
cord-005453-4057qib7	5336	1	A	a	DT
cord-005453-4057qib7	5336	2	few	few	JJ
cord-005453-4057qib7	5336	3	recent	recent	JJ
cord-005453-4057qib7	5336	4	reports	report	NNS
cord-005453-4057qib7	5336	5	have	have	VBP
cord-005453-4057qib7	5336	6	recognized	recognize	VBN
cord-005453-4057qib7	5336	7	evidence	evidence	NN
cord-005453-4057qib7	5336	8	of	of	IN
cord-005453-4057qib7	5336	9	TMA	TMA	NNP
cord-005453-4057qib7	5336	10	in	in	IN
cord-005453-4057qib7	5336	11	the	the	DT
cord-005453-4057qib7	5336	12	intestinal	intestinal	JJ
cord-005453-4057qib7	5336	13	vasculature	vasculature	NN
cord-005453-4057qib7	5336	14	(	(	-LRB-
cord-005453-4057qib7	5336	15	intestinal	intestinal	JJ
cord-005453-4057qib7	5336	16	TMA	TMA	NNP
cord-005453-4057qib7	5336	17	/	/	SYM
cord-005453-4057qib7	5336	18	iTMA	itma	NN
cord-005453-4057qib7	5336	19	)	)	-RRB-
cord-005453-4057qib7	5336	20	of	of	IN
cord-005453-4057qib7	5336	21	patients	patient	NNS
cord-005453-4057qib7	5336	22	with	with	IN
cord-005453-4057qib7	5336	23	graft	graft	NN
cord-005453-4057qib7	5336	24	-	-	HYPH
cord-005453-4057qib7	5336	25	versus	versus	IN
cord-005453-4057qib7	5336	26	-	-	HYPH
cord-005453-4057qib7	5336	27	host	host	NN
cord-005453-4057qib7	5336	28	disease	disease	NN
cord-005453-4057qib7	5336	29	(	(	-LRB-
cord-005453-4057qib7	5336	30	GVHD	GVHD	NNP
cord-005453-4057qib7	5336	31	)	)	-RRB-
cord-005453-4057qib7	5336	32	with	with	IN
cord-005453-4057qib7	5336	33	or	or	CC
cord-005453-4057qib7	5336	34	without	without	IN
cord-005453-4057qib7	5336	35	TMA	TMA	NNP
cord-005453-4057qib7	5336	36	.	.	.
cord-005453-4057qib7	5337	1	We	-PRON-	PRP
cord-005453-4057qib7	5337	2	aimed	aim	VBD
cord-005453-4057qib7	5337	3	to	to	TO
cord-005453-4057qib7	5337	4	identify	identify	VB
cord-005453-4057qib7	5337	5	patients	patient	NNS
cord-005453-4057qib7	5337	6	with	with	IN
cord-005453-4057qib7	5337	7	iTMA	itma	PRP
cord-005453-4057qib7	5337	8	and	and	CC
cord-005453-4057qib7	5337	9	describe	describe	VB
cord-005453-4057qib7	5337	10	histological	histological	JJ
cord-005453-4057qib7	5337	11	,	,	,
cord-005453-4057qib7	5337	12	clinical	clinical	JJ
cord-005453-4057qib7	5337	13	and	and	CC
cord-005453-4057qib7	5337	14	prognostic	prognostic	JJ
cord-005453-4057qib7	5337	15	features	feature	NNS
cord-005453-4057qib7	5337	16	.	.	.
cord-005453-4057qib7	5338	1	Methods	method	NNS
cord-005453-4057qib7	5338	2	:	:	:
cord-005453-4057qib7	5338	3	We	-PRON-	PRP
cord-005453-4057qib7	5338	4	prospectively	prospectively	RB
cord-005453-4057qib7	5338	5	evaluated	evaluate	VBD
cord-005453-4057qib7	5338	6	available	available	JJ
cord-005453-4057qib7	5338	7	endoscopic	endoscopic	JJ
cord-005453-4057qib7	5338	8	samples	sample	NNS
cord-005453-4057qib7	5338	9	(	(	-LRB-
cord-005453-4057qib7	5338	10	stomach	stomach	NN
cord-005453-4057qib7	5338	11	and/or	and/or	CC
cord-005453-4057qib7	5338	12	colon	colon	NN
cord-005453-4057qib7	5338	13	)	)	-RRB-
cord-005453-4057qib7	5338	14	from	from	IN
cord-005453-4057qib7	5338	15	consecutive	consecutive	JJ
cord-005453-4057qib7	5338	16	adult	adult	NN
cord-005453-4057qib7	5338	17	HCT	hct	NN
cord-005453-4057qib7	5338	18	recipients	recipient	NNS
cord-005453-4057qib7	5338	19	for	for	IN
cord-005453-4057qib7	5338	20	previously	previously	RB
cord-005453-4057qib7	5338	21	described	describe	VBN
cord-005453-4057qib7	5338	22	histopathologic	histopathologic	JJ
cord-005453-4057qib7	5338	23	signs	sign	NNS
cord-005453-4057qib7	5338	24	of	of	IN
cord-005453-4057qib7	5338	25	iTMA	itma	JJ
cord-005453-4057qib7	5338	26	(	(	-LRB-
cord-005453-4057qib7	5338	27	January	January	NNP
cord-005453-4057qib7	5338	28	2017-September	2017-september	CD
cord-005453-4057qib7	5338	29	2018	2018	CD
cord-005453-4057qib7	5338	30	)	)	-RRB-
cord-005453-4057qib7	5338	31	.	.	.
cord-005453-4057qib7	5339	1	Systemic	systemic	JJ
cord-005453-4057qib7	5339	2	TMA	TMA	NNP
cord-005453-4057qib7	5339	3	was	be	VBD
cord-005453-4057qib7	5339	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	5339	5	according	accord	VBG
cord-005453-4057qib7	5339	6	to	to	IN
cord-005453-4057qib7	5339	7	the	the	DT
cord-005453-4057qib7	5339	8	International	International	NNP
cord-005453-4057qib7	5339	9	Working	Working	NNP
cord-005453-4057qib7	5339	10	Group	Group	NNP
cord-005453-4057qib7	5339	11	Criteria	Criteria	NNP
cord-005453-4057qib7	5339	12	.	.	.
cord-005453-4057qib7	5340	1	We	-PRON-	PRP
cord-005453-4057qib7	5340	2	compared	compare	VBD
cord-005453-4057qib7	5340	3	findings	finding	NNS
cord-005453-4057qib7	5340	4	among	among	IN
cord-005453-4057qib7	5340	5	3	3	CD
cord-005453-4057qib7	5340	6	clinical	clinical	JJ
cord-005453-4057qib7	5340	7	groups	group	NNS
cord-005453-4057qib7	5340	8	:	:	:
cord-005453-4057qib7	5341	1	GVHD	GVHD	NNP
cord-005453-4057qib7	5341	2	/	/	SYM
cord-005453-4057qib7	5341	3	systemic	systemic	JJ
cord-005453-4057qib7	5341	4	TMA	TMA	NNP
cord-005453-4057qib7	5341	5	,	,	,
cord-005453-4057qib7	5341	6	GVHD	GVHD	NNP
cord-005453-4057qib7	5341	7	/	/	,
cord-005453-4057qib7	5341	8	no	no	DT
cord-005453-4057qib7	5341	9	systemic	systemic	JJ
cord-005453-4057qib7	5341	10	TMA	tma	NN
cord-005453-4057qib7	5341	11	and	and	CC
cord-005453-4057qib7	5341	12	no	no	DT
cord-005453-4057qib7	5341	13	GVHD/	GVHD/	NNP
cord-005453-4057qib7	5342	1	no	no	DT
cord-005453-4057qib7	5342	2	TMA	TMA	NNP
cord-005453-4057qib7	5342	3	.	.	.
cord-005453-4057qib7	5343	1	Results	result	NNS
cord-005453-4057qib7	5343	2	:	:	:
cord-005453-4057qib7	5344	1	We	-PRON-	PRP
cord-005453-4057qib7	5344	2	studied	study	VBD
cord-005453-4057qib7	5344	3	20	20	CD
cord-005453-4057qib7	5344	4	patients	patient	NNS
cord-005453-4057qib7	5344	5	,	,	,
cord-005453-4057qib7	5344	6	5	5	CD
cord-005453-4057qib7	5344	7	classified	classify	VBN
cord-005453-4057qib7	5344	8	as	as	IN
cord-005453-4057qib7	5344	9	GVHD/	GVHD/	NNP
cord-005453-4057qib7	5344	10	systemic	systemic	JJ
cord-005453-4057qib7	5344	11	TMA	TMA	NNP
cord-005453-4057qib7	5344	12	,	,	,
cord-005453-4057qib7	5344	13	11	11	CD
cord-005453-4057qib7	5344	14	GVHD/	GVHD/	NNP
cord-005453-4057qib7	5345	1	no	no	DT
cord-005453-4057qib7	5345	2	systemic	systemic	JJ
cord-005453-4057qib7	5345	3	TMA	TMA	NNP
cord-005453-4057qib7	5345	4	and	and	CC
cord-005453-4057qib7	5345	5	4	4	CD
cord-005453-4057qib7	5345	6	no	no	DT
cord-005453-4057qib7	5345	7	GVHD/	GVHD/	NNP
cord-005453-4057qib7	5346	1	no	no	DT
cord-005453-4057qib7	5346	2	TMA	TMA	NNP
cord-005453-4057qib7	5346	3	.	.	.
cord-005453-4057qib7	5347	1	Baseline	baseline	JJ
cord-005453-4057qib7	5347	2	transplant	transplant	NN
cord-005453-4057qib7	5347	3	characteristics	characteristic	NNS
cord-005453-4057qib7	5347	4	(	(	-LRB-
cord-005453-4057qib7	5347	5	age	age	NN
cord-005453-4057qib7	5347	6	,	,	,
cord-005453-4057qib7	5347	7	donor	donor	NN
cord-005453-4057qib7	5347	8	,	,	,
cord-005453-4057qib7	5347	9	HLA	HLA	NNP
cord-005453-4057qib7	5347	10	matching	matching	NN
cord-005453-4057qib7	5347	11	,	,	,
cord-005453-4057qib7	5347	12	conditioning	conditioning	NN
cord-005453-4057qib7	5347	13	)	)	-RRB-
cord-005453-4057qib7	5347	14	did	do	VBD
cord-005453-4057qib7	5347	15	not	not	RB
cord-005453-4057qib7	5347	16	differ	differ	VB
cord-005453-4057qib7	5347	17	significantly	significantly	RB
cord-005453-4057qib7	5347	18	among	among	IN
cord-005453-4057qib7	5347	19	groups	group	NNS
cord-005453-4057qib7	5347	20	.	.	.
cord-005453-4057qib7	5348	1	Histological	Histological	NNP
cord-005453-4057qib7	5348	2	features	feature	NNS
cord-005453-4057qib7	5348	3	of	of	IN
cord-005453-4057qib7	5348	4	iTMA	itma	NN
cord-005453-4057qib7	5348	5	,	,	,
cord-005453-4057qib7	5348	6	including	include	VBG
cord-005453-4057qib7	5348	7	loss	loss	NN
cord-005453-4057qib7	5348	8	of	of	IN
cord-005453-4057qib7	5348	9	glands	gland	NNS
cord-005453-4057qib7	5348	10	,	,	,
cord-005453-4057qib7	5348	11	total	total	JJ
cord-005453-4057qib7	5348	12	denudation	denudation	NN
cord-005453-4057qib7	5348	13	of	of	IN
cord-005453-4057qib7	5348	14	mucosa	mucosa	NN
cord-005453-4057qib7	5348	15	,	,	,
cord-005453-4057qib7	5348	16	apoptosis	apoptosis	NN
cord-005453-4057qib7	5348	17	and	and	CC
cord-005453-4057qib7	5348	18	detachment	detachment	NN
cord-005453-4057qib7	5348	19	of	of	IN
cord-005453-4057qib7	5348	20	endothelial	endothelial	JJ
cord-005453-4057qib7	5348	21	cells	cell	NNS
cord-005453-4057qib7	5348	22	,	,	,
cord-005453-4057qib7	5348	23	intraluminal	intraluminal	JJ
cord-005453-4057qib7	5348	24	fibrin	fibrin	NN
cord-005453-4057qib7	5348	25	,	,	,
cord-005453-4057qib7	5348	26	intraluminal	intraluminal	JJ
cord-005453-4057qib7	5348	27	microthrombi	microthrombi	NN
cord-005453-4057qib7	5348	28	and	and	CC
cord-005453-4057qib7	5348	29	mucosal	mucosal	JJ
cord-005453-4057qib7	5348	30	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	5348	31	were	be	VBD
cord-005453-4057qib7	5348	32	found	find	VBN
cord-005453-4057qib7	5348	33	in	in	IN
cord-005453-4057qib7	5348	34	6	6	CD
cord-005453-4057qib7	5348	35	patients	patient	NNS
cord-005453-4057qib7	5348	36	.	.	.
cord-005453-4057qib7	5349	1	Previously	previously	RB
cord-005453-4057qib7	5349	2	described	describe	VBN
cord-005453-4057qib7	5349	3	features	feature	NNS
cord-005453-4057qib7	5349	4	of	of	IN
cord-005453-4057qib7	5349	5	intraluminal	intraluminal	JJ
cord-005453-4057qib7	5349	6	schistocytes	schistocyte	NNS
cord-005453-4057qib7	5349	7	were	be	VBD
cord-005453-4057qib7	5349	8	not	not	RB
cord-005453-4057qib7	5349	9	observed	observe	VBN
cord-005453-4057qib7	5349	10	in	in	IN
cord-005453-4057qib7	5349	11	our	-PRON-	PRP$
cord-005453-4057qib7	5349	12	patients	patient	NNS
cord-005453-4057qib7	5349	13	.	.	.
cord-005453-4057qib7	5350	1	Interestingly	interestingly	RB
cord-005453-4057qib7	5350	2	,	,	,
cord-005453-4057qib7	5350	3	loss	loss	NN
cord-005453-4057qib7	5350	4	of	of	IN
cord-005453-4057qib7	5350	5	glands	gland	NNS
cord-005453-4057qib7	5350	6	,	,	,
cord-005453-4057qib7	5350	7	total	total	JJ
cord-005453-4057qib7	5350	8	denudation	denudation	NN
cord-005453-4057qib7	5350	9	of	of	IN
cord-005453-4057qib7	5350	10	mucosa	mucosa	NN
cord-005453-4057qib7	5350	11	,	,	,
cord-005453-4057qib7	5350	12	apoptosis	apoptosis	NN
cord-005453-4057qib7	5350	13	and	and	CC
cord-005453-4057qib7	5350	14	detachment	detachment	NN
cord-005453-4057qib7	5350	15	of	of	IN
cord-005453-4057qib7	5350	16	endothelial	endothelial	JJ
cord-005453-4057qib7	5350	17	cells	cell	NNS
cord-005453-4057qib7	5350	18	were	be	VBD
cord-005453-4057qib7	5350	19	also	also	RB
cord-005453-4057qib7	5350	20	found	find	VBN
cord-005453-4057qib7	5350	21	in	in	IN
cord-005453-4057qib7	5350	22	patients	patient	NNS
cord-005453-4057qib7	5350	23	with	with	IN
cord-005453-4057qib7	5350	24	GVHD	GVHD	NNP
cord-005453-4057qib7	5350	25	and	and	CC
cord-005453-4057qib7	5350	26	no	no	DT
cord-005453-4057qib7	5350	27	iTMA	itma	RB
cord-005453-4057qib7	5350	28	,	,	,
cord-005453-4057qib7	5350	29	suggesting	suggest	VBG
cord-005453-4057qib7	5350	30	that	that	IN
cord-005453-4057qib7	5350	31	these	these	DT
cord-005453-4057qib7	5350	32	features	feature	NNS
cord-005453-4057qib7	5350	33	are	be	VBP
cord-005453-4057qib7	5350	34	not	not	RB
cord-005453-4057qib7	5350	35	pathognomonic	pathognomonic	JJ
cord-005453-4057qib7	5350	36	of	of	IN
cord-005453-4057qib7	5350	37	iTMA	itma	PRP
cord-005453-4057qib7	5350	38	.	.	.
cord-005453-4057qib7	5351	1	Among	among	IN
cord-005453-4057qib7	5351	2	6	6	CD
cord-005453-4057qib7	5351	3	iTMA	iTMA	NNS
cord-005453-4057qib7	5351	4	patients	patient	NNS
cord-005453-4057qib7	5351	5	,	,	,
cord-005453-4057qib7	5351	6	two	two	CD
cord-005453-4057qib7	5351	7	patients	patient	NNS
cord-005453-4057qib7	5351	8	were	be	VBD
cord-005453-4057qib7	5351	9	classified	classify	VBN
cord-005453-4057qib7	5351	10	in	in	IN
cord-005453-4057qib7	5351	11	the	the	DT
cord-005453-4057qib7	5351	12	clinical	clinical	JJ
cord-005453-4057qib7	5351	13	group	group	NN
cord-005453-4057qib7	5351	14	of	of	IN
cord-005453-4057qib7	5351	15	acute	acute	JJ
cord-005453-4057qib7	5351	16	GVHD	GVHD	NNP
cord-005453-4057qib7	5351	17	/	/	SYM
cord-005453-4057qib7	5351	18	systemic	systemic	JJ
cord-005453-4057qib7	5351	19	TMA	TMA	NNP
cord-005453-4057qib7	5351	20	,	,	,
cord-005453-4057qib7	5351	21	while	while	IN
cord-005453-4057qib7	5351	22	the	the	DT
cord-005453-4057qib7	5351	23	other	other	JJ
cord-005453-4057qib7	5351	24	4	4	CD
cord-005453-4057qib7	5351	25	patients	patient	NNS
cord-005453-4057qib7	5351	26	had	have	VBD
cord-005453-4057qib7	5351	27	clinical	clinical	JJ
cord-005453-4057qib7	5351	28	and	and	CC
cord-005453-4057qib7	5351	29	histopathological	histopathological	JJ
cord-005453-4057qib7	5351	30	features	feature	NNS
cord-005453-4057qib7	5351	31	of	of	IN
cord-005453-4057qib7	5351	32	iTMA	iTMA	NNS
cord-005453-4057qib7	5351	33	and	and	CC
cord-005453-4057qib7	5351	34	severe	severe	JJ
cord-005453-4057qib7	5351	35	grade	grade	NN
cord-005453-4057qib7	5351	36	III	III	NNP
cord-005453-4057qib7	5351	37	-	-	HYPH
cord-005453-4057qib7	5351	38	IV	IV	NNP
cord-005453-4057qib7	5351	39	steroid	steroid	NN
cord-005453-4057qib7	5351	40	-	-	HYPH
cord-005453-4057qib7	5351	41	refractory	refractory	JJ
cord-005453-4057qib7	5351	42	acute	acute	JJ
cord-005453-4057qib7	5351	43	GVHD	GVHD	NNP
cord-005453-4057qib7	5351	44	(	(	-LRB-
cord-005453-4057qib7	5351	45	3	3	CD
cord-005453-4057qib7	5351	46	patients	patient	NNS
cord-005453-4057qib7	5351	47	)	)	-RRB-
cord-005453-4057qib7	5351	48	or	or	CC
cord-005453-4057qib7	5351	49	extensive	extensive	JJ
cord-005453-4057qib7	5351	50	chronic	chronic	JJ
cord-005453-4057qib7	5351	51	GVHD	GVHD	NNP
cord-005453-4057qib7	5351	52	(	(	-LRB-
cord-005453-4057qib7	5351	53	1	1	CD
cord-005453-4057qib7	5351	54	patient	patient	NN
cord-005453-4057qib7	5351	55	)	)	-RRB-
cord-005453-4057qib7	5351	56	but	but	CC
cord-005453-4057qib7	5351	57	no	no	DT
cord-005453-4057qib7	5351	58	evidence	evidence	NN
cord-005453-4057qib7	5351	59	of	of	IN
cord-005453-4057qib7	5351	60	systemic	systemic	JJ
cord-005453-4057qib7	5351	61	TMA	TMA	NNP
cord-005453-4057qib7	5351	62	.	.	.
cord-005453-4057qib7	5352	1	In	in	IN
cord-005453-4057qib7	5352	2	the	the	DT
cord-005453-4057qib7	5352	3	majority	majority	NN
cord-005453-4057qib7	5352	4	of	of	IN
cord-005453-4057qib7	5352	5	patients	patient	NNS
cord-005453-4057qib7	5352	6	(	(	-LRB-
cord-005453-4057qib7	5352	7	5/6	5/6	CD
cord-005453-4057qib7	5352	8	)	)	-RRB-
cord-005453-4057qib7	5352	9	,	,	,
cord-005453-4057qib7	5352	10	iTMA	itma	PRP
cord-005453-4057qib7	5352	11	occurred	occur	VBD
cord-005453-4057qib7	5352	12	during	during	IN
cord-005453-4057qib7	5352	13	the	the	DT
cord-005453-4057qib7	5352	14	early	early	JJ
cord-005453-4057qib7	5352	15	posttransplant	posttransplant	NN
cord-005453-4057qib7	5352	16	period	period	NN
cord-005453-4057qib7	5352	17	at	at	IN
cord-005453-4057qib7	5352	18	1.7	1.7	CD
cord-005453-4057qib7	5352	19	(	(	-LRB-
cord-005453-4057qib7	5352	20	0.9	0.9	CD
cord-005453-4057qib7	5352	21	-	-	SYM
cord-005453-4057qib7	5352	22	4	4	CD
cord-005453-4057qib7	5352	23	)	)	-RRB-
cord-005453-4057qib7	5352	24	months	month	NNS
cord-005453-4057qib7	5352	25	.	.	.
cord-005453-4057qib7	5353	1	Clinical	clinical	JJ
cord-005453-4057qib7	5353	2	features	feature	NNS
cord-005453-4057qib7	5353	3	(	(	-LRB-
cord-005453-4057qib7	5353	4	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	5353	5	bleeding	bleeding	NN
cord-005453-4057qib7	5353	6	,	,	,
cord-005453-4057qib7	5353	7	diarrhea	diarrhea	NN
cord-005453-4057qib7	5353	8	,	,	,
cord-005453-4057qib7	5353	9	pain	pain	NN
cord-005453-4057qib7	5353	10	,	,	,
cord-005453-4057qib7	5353	11	nausea	nausea	NN
cord-005453-4057qib7	5353	12	)	)	-RRB-
cord-005453-4057qib7	5353	13	presented	present	VBD
cord-005453-4057qib7	5353	14	no	no	DT
cord-005453-4057qib7	5353	15	differences	difference	NNS
cord-005453-4057qib7	5353	16	between	between	IN
cord-005453-4057qib7	5353	17	patients	patient	NNS
cord-005453-4057qib7	5353	18	with	with	IN
cord-005453-4057qib7	5353	19	or	or	CC
cord-005453-4057qib7	5353	20	without	without	IN
cord-005453-4057qib7	5353	21	iTMA	itma	PRP
cord-005453-4057qib7	5353	22	.	.	.
cord-005453-4057qib7	5354	1	Prognosis	prognosis	NN
cord-005453-4057qib7	5354	2	was	be	VBD
cord-005453-4057qib7	5354	3	poor	poor	JJ
cord-005453-4057qib7	5354	4	for	for	IN
cord-005453-4057qib7	5354	5	patients	patient	NNS
cord-005453-4057qib7	5354	6	with	with	IN
cord-005453-4057qib7	5354	7	iTMA	itma	PRP
cord-005453-4057qib7	5354	8	who	who	WP
cord-005453-4057qib7	5354	9	suffered	suffer	VBD
cord-005453-4057qib7	5354	10	from	from	IN
cord-005453-4057qib7	5354	11	a	a	DT
cord-005453-4057qib7	5354	12	significantly	significantly	RB
cord-005453-4057qib7	5354	13	higher	high	JJR
cord-005453-4057qib7	5354	14	mortality	mortality	NN
cord-005453-4057qib7	5354	15	rate	rate	NN
cord-005453-4057qib7	5354	16	of	of	IN
cord-005453-4057qib7	5354	17	83	83	CD
cord-005453-4057qib7	5354	18	%	%	NN
cord-005453-4057qib7	5354	19	compared	compare	VBN
cord-005453-4057qib7	5354	20	to	to	IN
cord-005453-4057qib7	5354	21	the	the	DT
cord-005453-4057qib7	5354	22	rest	rest	NN
cord-005453-4057qib7	5354	23	patient	patient	JJ
cord-005453-4057qib7	5354	24	population	population	NN
cord-005453-4057qib7	5354	25	(	(	-LRB-
cord-005453-4057qib7	5354	26	p=0.014	p=0.014	NNS
cord-005453-4057qib7	5354	27	)	)	-RRB-
cord-005453-4057qib7	5354	28	.	.	.
cord-005453-4057qib7	5355	1	With	with	IN
cord-005453-4057qib7	5355	2	a	a	DT
cord-005453-4057qib7	5355	3	median	median	JJ
cord-005453-4057qib7	5355	4	follow	follow	NN
cord-005453-4057qib7	5355	5	-	-	HYPH
cord-005453-4057qib7	5355	6	up	up	NN
cord-005453-4057qib7	5355	7	of	of	IN
cord-005453-4057qib7	5355	8	11.1	11.1	CD
cord-005453-4057qib7	5355	9	(	(	-LRB-
cord-005453-4057qib7	5355	10	2.1	2.1	CD
cord-005453-4057qib7	5355	11	-	-	SYM
cord-005453-4057qib7	5355	12	67.5	67.5	CD
cord-005453-4057qib7	5355	13	)	)	-RRB-
cord-005453-4057qib7	5355	14	months	month	NNS
cord-005453-4057qib7	5355	15	,	,	,
cord-005453-4057qib7	5355	16	1year	1year	CD
cord-005453-4057qib7	5355	17	overall	overall	JJ
cord-005453-4057qib7	5355	18	survival	survival	NN
cord-005453-4057qib7	5355	19	probability	probability	NN
cord-005453-4057qib7	5355	20	(	(	-LRB-
cord-005453-4057qib7	5355	21	OS	OS	NNP
cord-005453-4057qib7	5355	22	)	)	-RRB-
cord-005453-4057qib7	5355	23	was	be	VBD
cord-005453-4057qib7	5355	24	22.2	22.2	CD
cord-005453-4057qib7	5355	25	for	for	IN
cord-005453-4057qib7	5355	26	iTMA	iTMA	NNS
cord-005453-4057qib7	5355	27	,	,	,
cord-005453-4057qib7	5355	28	55	55	CD
cord-005453-4057qib7	5355	29	%	%	NN
cord-005453-4057qib7	5355	30	for	for	IN
cord-005453-4057qib7	5355	31	GVHD	GVHD	NNP
cord-005453-4057qib7	5355	32	and	and	CC
cord-005453-4057qib7	5355	33	60	60	CD
cord-005453-4057qib7	5355	34	%	%	NN
cord-005453-4057qib7	5355	35	for	for	IN
cord-005453-4057qib7	5355	36	systemic	systemic	JJ
cord-005453-4057qib7	5355	37	TMA	TMA	NNP
cord-005453-4057qib7	5355	38	.	.	.
cord-005453-4057qib7	5356	1	Unfavorable	unfavorable	JJ
cord-005453-4057qib7	5356	2	predictive	predictive	JJ
cord-005453-4057qib7	5356	3	factors	factor	NNS
cord-005453-4057qib7	5356	4	for	for	IN
cord-005453-4057qib7	5356	5	OS	OS	NNP
cord-005453-4057qib7	5356	6	were	be	VBD
cord-005453-4057qib7	5356	7	iTMA	itma	XX
cord-005453-4057qib7	5357	1	(	(	-LRB-
cord-005453-4057qib7	5357	2	p=0.048	p=0.048	NNP
cord-005453-4057qib7	5357	3	)	)	-RRB-
cord-005453-4057qib7	5357	4	,	,	,
cord-005453-4057qib7	5357	5	HLA	HLA	NNP
cord-005453-4057qib7	5357	6	mismatched	mismatched	JJ
cord-005453-4057qib7	5357	7	donors	donor	NNS
cord-005453-4057qib7	5357	8	(	(	-LRB-
cord-005453-4057qib7	5357	9	p=0.008	p=0.008	NNP
cord-005453-4057qib7	5357	10	)	)	-RRB-
cord-005453-4057qib7	5357	11	and	and	CC
cord-005453-4057qib7	5357	12	gastro	gastro	JJ
cord-005453-4057qib7	5357	13	-	-	JJ
cord-005453-4057qib7	5357	14	intestinal	intestinal	JJ
cord-005453-4057qib7	5357	15	bleeding	bleeding	NN
cord-005453-4057qib7	5357	16	(	(	-LRB-
cord-005453-4057qib7	5357	17	p=0.021	p=0.021	NNP
cord-005453-4057qib7	5357	18	)	)	-RRB-
cord-005453-4057qib7	5357	19	.	.	.
cord-005453-4057qib7	5358	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5358	2	:	:	:
cord-005453-4057qib7	5359	1	Intestinal	intestinal	JJ
cord-005453-4057qib7	5359	2	TMA	TMA	NNP
cord-005453-4057qib7	5359	3	has	have	VBZ
cord-005453-4057qib7	5359	4	emerged	emerge	VBN
cord-005453-4057qib7	5359	5	as	as	IN
cord-005453-4057qib7	5359	6	a	a	DT
cord-005453-4057qib7	5359	7	novel	novel	JJ
cord-005453-4057qib7	5359	8	distinct	distinct	JJ
cord-005453-4057qib7	5359	9	entity	entity	NN
cord-005453-4057qib7	5359	10	in	in	IN
cord-005453-4057qib7	5359	11	patients	patient	NNS
cord-005453-4057qib7	5359	12	with	with	IN
cord-005453-4057qib7	5359	13	GVHD	GVHD	NNP
cord-005453-4057qib7	5359	14	and/or	and/or	CC
cord-005453-4057qib7	5359	15	systemic	systemic	JJ
cord-005453-4057qib7	5359	16	TMA	tma	NN
cord-005453-4057qib7	5359	17	.	.	.
cord-005453-4057qib7	5360	1	Distinct	distinct	JJ
cord-005453-4057qib7	5360	2	histological	histological	JJ
cord-005453-4057qib7	5360	3	features	feature	NNS
cord-005453-4057qib7	5360	4	may	may	MD
cord-005453-4057qib7	5360	5	be	be	VB
cord-005453-4057qib7	5360	6	useful	useful	JJ
cord-005453-4057qib7	5360	7	in	in	IN
cord-005453-4057qib7	5360	8	differential	differential	JJ
cord-005453-4057qib7	5360	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	5360	10	of	of	IN
cord-005453-4057qib7	5360	11	these	these	DT
cord-005453-4057qib7	5360	12	severe	severe	JJ
cord-005453-4057qib7	5360	13	HCT	hct	NN
cord-005453-4057qib7	5360	14	complications	complication	NNS
cord-005453-4057qib7	5360	15	.	.	.
cord-005453-4057qib7	5361	1	Mortality	mortality	NN
cord-005453-4057qib7	5361	2	rates	rate	NNS
cord-005453-4057qib7	5361	3	higher	high	JJR
cord-005453-4057qib7	5361	4	than	than	IN
cord-005453-4057qib7	5361	5	those	those	DT
cord-005453-4057qib7	5361	6	of	of	IN
cord-005453-4057qib7	5361	7	systemic	systemic	JJ
cord-005453-4057qib7	5361	8	TMA	TMA	NNP
cord-005453-4057qib7	5361	9	highlight	highlight	VBP
cord-005453-4057qib7	5361	10	the	the	DT
cord-005453-4057qib7	5361	11	need	need	NN
cord-005453-4057qib7	5361	12	of	of	IN
cord-005453-4057qib7	5361	13	proper	proper	JJ
cord-005453-4057qib7	5361	14	recognition	recognition	NN
cord-005453-4057qib7	5361	15	of	of	IN
cord-005453-4057qib7	5361	16	iTMA	itma	XX
cord-005453-4057qib7	5361	17	that	that	WDT
cord-005453-4057qib7	5361	18	needs	need	VBZ
cord-005453-4057qib7	5361	19	to	to	TO
cord-005453-4057qib7	5361	20	be	be	VB
cord-005453-4057qib7	5361	21	further	further	RB
cord-005453-4057qib7	5361	22	studied	study	VBN
cord-005453-4057qib7	5361	23	in	in	IN
cord-005453-4057qib7	5361	24	terms	term	NNS
cord-005453-4057qib7	5361	25	of	of	IN
cord-005453-4057qib7	5361	26	diagnostic	diagnostic	JJ
cord-005453-4057qib7	5361	27	and	and	CC
cord-005453-4057qib7	5361	28	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5361	29	potential	potential	NN
cord-005453-4057qib7	5361	30	.	.	.
cord-005453-4057qib7	5362	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5362	2	:	:	:
cord-005453-4057qib7	5363	1	E.G.	E.G.	NNS
cord-005453-4057qib7	5363	2	was	be	VBD
cord-005453-4057qib7	5363	3	supported	support	VBN
cord-005453-4057qib7	5363	4	by	by	IN
cord-005453-4057qib7	5363	5	the	the	DT
cord-005453-4057qib7	5363	6	European	European	NNP
cord-005453-4057qib7	5363	7	Hematology	Hematology	NNP
cord-005453-4057qib7	5363	8	Association	Association	NNP
cord-005453-4057qib7	5363	9	Clinical	Clinical	NNP
cord-005453-4057qib7	5363	10	Research	Research	NNP
cord-005453-4057qib7	5363	11	Grant	Grant	NNP
cord-005453-4057qib7	5363	12	.	.	.
cord-005453-4057qib7	5364	1	The	the	DT
cord-005453-4057qib7	5364	2	remaining	remain	VBG
cord-005453-4057qib7	5364	3	authors	author	NNS
cord-005453-4057qib7	5364	4	declare	declare	VBP
cord-005453-4057qib7	5364	5	no	no	DT
cord-005453-4057qib7	5364	6	competing	compete	VBG
cord-005453-4057qib7	5364	7	financial	financial	JJ
cord-005453-4057qib7	5364	8	interest	interest	NN
cord-005453-4057qib7	5364	9	.	.	.
cord-005453-4057qib7	5365	1	The	the	DT
cord-005453-4057qib7	5365	2	beneficial	beneficial	JJ
cord-005453-4057qib7	5365	3	effects	effect	NNS
cord-005453-4057qib7	5365	4	of	of	IN
cord-005453-4057qib7	5365	5	thrombomodulin	thrombomodulin	NN
cord-005453-4057qib7	5365	6	gene	gene	NN
cord-005453-4057qib7	5365	7	polymorphisms	polymorphism	NNS
cord-005453-4057qib7	5365	8	after	after	IN
cord-005453-4057qib7	5365	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5365	10	stem	stem	NN
cord-005453-4057qib7	5365	11	cell	cell	NN
cord-005453-4057qib7	5365	12	transplantation	transplantation	NN
cord-005453-4057qib7	5365	13	Background	background	NN
cord-005453-4057qib7	5365	14	:	:	:
cord-005453-4057qib7	5365	15	Chronic	chronic	JJ
cord-005453-4057qib7	5365	16	graft	graft	NN
cord-005453-4057qib7	5365	17	-	-	HYPH
cord-005453-4057qib7	5365	18	versus	versus	IN
cord-005453-4057qib7	5365	19	-	-	HYPH
cord-005453-4057qib7	5365	20	host	host	NN
cord-005453-4057qib7	5365	21	disease	disease	NN
cord-005453-4057qib7	5365	22	(	(	-LRB-
cord-005453-4057qib7	5365	23	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5365	24	)	)	-RRB-
cord-005453-4057qib7	5365	25	remains	remain	VBZ
cord-005453-4057qib7	5365	26	the	the	DT
cord-005453-4057qib7	5365	27	major	major	JJ
cord-005453-4057qib7	5365	28	cause	cause	NN
cord-005453-4057qib7	5365	29	of	of	IN
cord-005453-4057qib7	5365	30	late	late	JJ
cord-005453-4057qib7	5365	31	morbidity	morbidity	NN
cord-005453-4057qib7	5365	32	and	and	CC
cord-005453-4057qib7	5365	33	mortality	mortality	NN
cord-005453-4057qib7	5365	34	after	after	IN
cord-005453-4057qib7	5365	35	allogeneic	allogeneic	NN
cord-005453-4057qib7	5365	36	blood	blood	NN
cord-005453-4057qib7	5365	37	and	and	CC
cord-005453-4057qib7	5365	38	marrow	marrow	NN
cord-005453-4057qib7	5365	39	transplantation	transplantation	NN
cord-005453-4057qib7	5365	40	.	.	.
cord-005453-4057qib7	5366	1	Treatment	treatment	NN
cord-005453-4057qib7	5366	2	options	option	NNS
cord-005453-4057qib7	5366	3	for	for	IN
cord-005453-4057qib7	5366	4	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5366	5	,	,	,
cord-005453-4057qib7	5366	6	particularly	particularly	RB
cord-005453-4057qib7	5366	7	its	-PRON-	PRP$
cord-005453-4057qib7	5366	8	sclerotic	sclerotic	JJ
cord-005453-4057qib7	5366	9	forms	form	NNS
cord-005453-4057qib7	5366	10	remain	remain	VBP
cord-005453-4057qib7	5366	11	limited	limited	JJ
cord-005453-4057qib7	5366	12	.	.	.
cord-005453-4057qib7	5367	1	Active	active	JJ
cord-005453-4057qib7	5367	2	Hedgehog	Hedgehog	NNP
cord-005453-4057qib7	5367	3	(	(	-LRB-
cord-005453-4057qib7	5367	4	Hh	Hh	NNP
cord-005453-4057qib7	5367	5	)	)	-RRB-
cord-005453-4057qib7	5367	6	signaling	signaling	NN
cord-005453-4057qib7	5367	7	was	be	VBD
cord-005453-4057qib7	5367	8	shown	show	VBN
cord-005453-4057qib7	5367	9	as	as	IN
cord-005453-4057qib7	5367	10	a	a	DT
cord-005453-4057qib7	5367	11	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5367	12	target	target	NN
cord-005453-4057qib7	5367	13	in	in	IN
cord-005453-4057qib7	5367	14	both	both	DT
cord-005453-4057qib7	5367	15	mouse	mouse	NN
cord-005453-4057qib7	5367	16	and	and	CC
cord-005453-4057qib7	5367	17	human	human	JJ
cord-005453-4057qib7	5367	18	cGVHD	cgvhd	NN
cord-005453-4057qib7	5367	19	,	,	,
cord-005453-4057qib7	5367	20	with	with	IN
cord-005453-4057qib7	5367	21	limited	limited	JJ
cord-005453-4057qib7	5367	22	efficacy	efficacy	NN
cord-005453-4057qib7	5367	23	and	and	CC
cord-005453-4057qib7	5367	24	significant	significant	JJ
cord-005453-4057qib7	5367	25	toxicities	toxicity	NNS
cord-005453-4057qib7	5367	26	described	describe	VBN
cord-005453-4057qib7	5367	27	in	in	IN
cord-005453-4057qib7	5367	28	a	a	DT
cord-005453-4057qib7	5367	29	published	publish	VBN
cord-005453-4057qib7	5367	30	clinical	clinical	JJ
cord-005453-4057qib7	5367	31	trial	trial	NN
cord-005453-4057qib7	5367	32	(	(	-LRB-
cord-005453-4057qib7	5367	33	DeFilipp	DeFilipp	NNP
cord-005453-4057qib7	5367	34	,	,	,
cord-005453-4057qib7	5367	35	2017	2017	CD
cord-005453-4057qib7	5367	36	)	)	-RRB-
cord-005453-4057qib7	5367	37	.	.	.
cord-005453-4057qib7	5368	1	Methods	method	NNS
cord-005453-4057qib7	5368	2	:	:	:
cord-005453-4057qib7	5368	3	Adult	adult	NN
cord-005453-4057qib7	5368	4	patients	patient	NNS
cord-005453-4057qib7	5368	5	with	with	IN
cord-005453-4057qib7	5368	6	steroid	steroid	NN
cord-005453-4057qib7	5368	7	refractory	refractory	JJ
cord-005453-4057qib7	5368	8	sclerodermatous	sclerodermatous	JJ
cord-005453-4057qib7	5368	9	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5368	10	,	,	,
cord-005453-4057qib7	5368	11	defined	define	VBN
cord-005453-4057qib7	5368	12	as	as	IN
cord-005453-4057qib7	5368	13	requiring	require	VBG
cord-005453-4057qib7	5368	14	>	>	XX
cord-005453-4057qib7	5369	1	0.5	0.5	CD
cord-005453-4057qib7	5369	2	mg	mg	NNP
cord-005453-4057qib7	5369	3	/	/	SYM
cord-005453-4057qib7	5369	4	kg	kg	NNP
cord-005453-4057qib7	5369	5	/	/	SYM
cord-005453-4057qib7	5369	6	day	day	NN
cord-005453-4057qib7	5369	7	of	of	IN
cord-005453-4057qib7	5369	8	prednisone	prednisone	NNP
cord-005453-4057qib7	5369	9	dose	dose	NN
cord-005453-4057qib7	5369	10	equivalent	equivalent	NN
cord-005453-4057qib7	5369	11	(	(	-LRB-
cord-005453-4057qib7	5369	12	PDE	PDE	NNP
cord-005453-4057qib7	5369	13	)	)	-RRB-
cord-005453-4057qib7	5369	14	,	,	,
cord-005453-4057qib7	5369	15	or	or	CC
cord-005453-4057qib7	5369	16	need	need	VB
cord-005453-4057qib7	5369	17	for	for	IN
cord-005453-4057qib7	5369	18	second	second	JJ
cord-005453-4057qib7	5369	19	-	-	HYPH
cord-005453-4057qib7	5369	20	or	or	CC
cord-005453-4057qib7	5369	21	third	third	JJ
cord-005453-4057qib7	5369	22	-	-	HYPH
cord-005453-4057qib7	5369	23	line	line	NN
cord-005453-4057qib7	5369	24	therapy	therapy	NN
cord-005453-4057qib7	5369	25	beyond	beyond	IN
cord-005453-4057qib7	5369	26	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5369	27	and	and	CC
cord-005453-4057qib7	5369	28	calcineurin	calcineurin	NN
cord-005453-4057qib7	5369	29	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5369	30	or	or	CC
cord-005453-4057qib7	5369	31	sirolimus	sirolimus	NNP
cord-005453-4057qib7	5369	32	were	be	VBD
cord-005453-4057qib7	5369	33	eligible	eligible	JJ
cord-005453-4057qib7	5369	34	for	for	IN
cord-005453-4057qib7	5369	35	this	this	DT
cord-005453-4057qib7	5369	36	open	open	JJ
cord-005453-4057qib7	5369	37	label	label	NN
cord-005453-4057qib7	5369	38	study	study	NN
cord-005453-4057qib7	5369	39	of	of	IN
cord-005453-4057qib7	5369	40	vismodegib	vismodegib	NNP
cord-005453-4057qib7	5369	41	,	,	,
cord-005453-4057qib7	5369	42	a	a	DT
cord-005453-4057qib7	5369	43	first	first	JJ
cord-005453-4057qib7	5369	44	generation	generation	NN
cord-005453-4057qib7	5369	45	Hh	Hh	NNP
cord-005453-4057qib7	5369	46	pathway	pathway	NN
cord-005453-4057qib7	5369	47	inhibitor	inhibitor	NN
cord-005453-4057qib7	5369	48	.	.	.
cord-005453-4057qib7	5370	1	Primary	primary	JJ
cord-005453-4057qib7	5370	2	endpoint	endpoint	NN
cord-005453-4057qib7	5370	3	was	be	VBD
cord-005453-4057qib7	5370	4	failure	failure	NN
cord-005453-4057qib7	5370	5	free	free	JJ
cord-005453-4057qib7	5370	6	survival	survival	NN
cord-005453-4057qib7	5370	7	,	,	,
cord-005453-4057qib7	5370	8	defined	define	VBN
cord-005453-4057qib7	5370	9	as	as	IN
cord-005453-4057qib7	5370	10	absence	absence	NN
cord-005453-4057qib7	5370	11	of	of	IN
cord-005453-4057qib7	5370	12	non	non	JJ
cord-005453-4057qib7	5370	13	-	-	JJ
cord-005453-4057qib7	5370	14	relapse	relapse	JJ
cord-005453-4057qib7	5370	15	mortality	mortality	NN
cord-005453-4057qib7	5370	16	,	,	,
cord-005453-4057qib7	5370	17	no	no	DT
cord-005453-4057qib7	5370	18	recurrent	recurrent	JJ
cord-005453-4057qib7	5370	19	malignancy	malignancy	NN
cord-005453-4057qib7	5370	20	,	,	,
cord-005453-4057qib7	5370	21	steroid	steroid	NN
cord-005453-4057qib7	5370	22	dose	dose	NN
cord-005453-4057qib7	5370	23	at	at	IN
cord-005453-4057qib7	5370	24	6	6	CD
cord-005453-4057qib7	5370	25	months	month	NNS
cord-005453-4057qib7	5370	26	=	=	NFP
cord-005453-4057qib7	5371	1	<	<	XX
cord-005453-4057qib7	5371	2	0.2	0.2	CD
cord-005453-4057qib7	5371	3	mg	mg	NNP
cord-005453-4057qib7	5371	4	/	/	SYM
cord-005453-4057qib7	5371	5	kg	kg	NNP
cord-005453-4057qib7	5371	6	/	/	SYM
cord-005453-4057qib7	5371	7	day	day	NN
cord-005453-4057qib7	5371	8	of	of	IN
cord-005453-4057qib7	5371	9	PDE	PDE	NNP
cord-005453-4057qib7	5371	10	,	,	,
cord-005453-4057qib7	5371	11	and	and	CC
cord-005453-4057qib7	5371	12	no	no	DT
cord-005453-4057qib7	5371	13	addition	addition	NN
cord-005453-4057qib7	5371	14	of	of	IN
cord-005453-4057qib7	5371	15	new	new	JJ
cord-005453-4057qib7	5371	16	systemic	systemic	JJ
cord-005453-4057qib7	5371	17	treatment	treatment	NN
cord-005453-4057qib7	5371	18	.	.	.
cord-005453-4057qib7	5372	1	Vismodegib	Vismodegib	NNP
cord-005453-4057qib7	5372	2	was	be	VBD
cord-005453-4057qib7	5372	3	administered	administer	VBN
cord-005453-4057qib7	5372	4	orally	orally	RB
cord-005453-4057qib7	5372	5	for	for	IN
cord-005453-4057qib7	5372	6	6	6	CD
cord-005453-4057qib7	5372	7	-	-	SYM
cord-005453-4057qib7	5372	8	12	12	CD
cord-005453-4057qib7	5372	9	months	month	NNS
cord-005453-4057qib7	5372	10	,	,	,
cord-005453-4057qib7	5372	11	with	with	IN
cord-005453-4057qib7	5372	12	dose	dose	JJ
cord-005453-4057qib7	5372	13	reductions	reduction	NNS
cord-005453-4057qib7	5372	14	at	at	IN
cord-005453-4057qib7	5372	15	development	development	NN
cord-005453-4057qib7	5372	16	of	of	IN
cord-005453-4057qib7	5372	17	toxicities	toxicity	NNS
cord-005453-4057qib7	5372	18	.	.	.
cord-005453-4057qib7	5373	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	5373	2	blood	blood	NN
cord-005453-4057qib7	5373	3	mononuclear	mononuclear	NN
cord-005453-4057qib7	5373	4	cells	cell	NNS
cord-005453-4057qib7	5373	5	were	be	VBD
cord-005453-4057qib7	5373	6	isolated	isolate	VBN
cord-005453-4057qib7	5373	7	from	from	IN
cord-005453-4057qib7	5373	8	samples	sample	NNS
cord-005453-4057qib7	5373	9	collected	collect	VBN
cord-005453-4057qib7	5373	10	at	at	IN
cord-005453-4057qib7	5373	11	treatment	treatment	NN
cord-005453-4057qib7	5373	12	initiation	initiation	NN
cord-005453-4057qib7	5373	13	and	and	CC
cord-005453-4057qib7	5373	14	every	every	DT
cord-005453-4057qib7	5373	15	three	three	CD
cord-005453-4057qib7	5373	16	months	month	NNS
cord-005453-4057qib7	5373	17	thereafter	thereafter	RB
cord-005453-4057qib7	5373	18	.	.	.
cord-005453-4057qib7	5374	1	The	the	DT
cord-005453-4057qib7	5374	2	immune	immune	JJ
cord-005453-4057qib7	5374	3	profile	profile	NN
cord-005453-4057qib7	5374	4	of	of	IN
cord-005453-4057qib7	5374	5	circulating	circulate	VBG
cord-005453-4057qib7	5374	6	B	b	NN
cord-005453-4057qib7	5374	7	cells	cell	NNS
cord-005453-4057qib7	5374	8	was	be	VBD
cord-005453-4057qib7	5374	9	analyzed	analyze	VBN
cord-005453-4057qib7	5374	10	by	by	IN
cord-005453-4057qib7	5374	11	flow	flow	NN
cord-005453-4057qib7	5374	12	cytometry	cytometry	NN
cord-005453-4057qib7	5374	13	and	and	CC
cord-005453-4057qib7	5374	14	T	t	NN
cord-005453-4057qib7	5374	15	helper	helper	NN
cord-005453-4057qib7	5374	16	polarization	polarization	NN
cord-005453-4057qib7	5374	17	by	by	IN
cord-005453-4057qib7	5374	18	qRT	qRT	NNP
cord-005453-4057qib7	5374	19	-	-	HYPH
cord-005453-4057qib7	5374	20	PCR	PCR	NNP
cord-005453-4057qib7	5374	21	of	of	IN
cord-005453-4057qib7	5374	22	sortpurified	sortpurifie	VBN
cord-005453-4057qib7	5374	23	CD4	CD4	NNP
cord-005453-4057qib7	5374	24	+	+	CC
cord-005453-4057qib7	5374	25	T	t	NN
cord-005453-4057qib7	5374	26	cells	cell	NNS
cord-005453-4057qib7	5374	27	.	.	.
cord-005453-4057qib7	5375	1	Results	result	NNS
cord-005453-4057qib7	5375	2	:	:	:
cord-005453-4057qib7	5376	1	At	at	IN
cord-005453-4057qib7	5376	2	the	the	DT
cord-005453-4057qib7	5376	3	time	time	NN
cord-005453-4057qib7	5376	4	of	of	IN
cord-005453-4057qib7	5376	5	interim	interim	JJ
cord-005453-4057qib7	5376	6	analysis	analysis	NN
cord-005453-4057qib7	5376	7	,	,	,
cord-005453-4057qib7	5376	8	6	6	CD
cord-005453-4057qib7	5376	9	patients	patient	NNS
cord-005453-4057qib7	5376	10	were	be	VBD
cord-005453-4057qib7	5376	11	evaluated	evaluate	VBN
cord-005453-4057qib7	5376	12	.	.	.
cord-005453-4057qib7	5377	1	3	3	CD
cord-005453-4057qib7	5377	2	patients	patient	NNS
cord-005453-4057qib7	5377	3	completed	complete	VBN
cord-005453-4057qib7	5377	4	6	6	CD
cord-005453-4057qib7	5377	5	months	month	NNS
cord-005453-4057qib7	5377	6	of	of	IN
cord-005453-4057qib7	5377	7	treatment	treatment	NN
cord-005453-4057qib7	5377	8	and	and	CC
cord-005453-4057qib7	5377	9	five	five	CD
cord-005453-4057qib7	5377	10	patients	patient	NNS
cord-005453-4057qib7	5377	11	completed	complete	VBN
cord-005453-4057qib7	5377	12	3	3	CD
cord-005453-4057qib7	5377	13	months	month	NNS
cord-005453-4057qib7	5377	14	of	of	IN
cord-005453-4057qib7	5377	15	treatment	treatment	NN
cord-005453-4057qib7	5377	16	.	.	.
cord-005453-4057qib7	5378	1	Therapy	therapy	NN
cord-005453-4057qib7	5378	2	was	be	VBD
cord-005453-4057qib7	5378	3	discontinued	discontinue	VBN
cord-005453-4057qib7	5378	4	in	in	IN
cord-005453-4057qib7	5378	5	3	3	CD
cord-005453-4057qib7	5378	6	patients	patient	NNS
cord-005453-4057qib7	5378	7	prior	prior	RB
cord-005453-4057qib7	5378	8	to	to	IN
cord-005453-4057qib7	5378	9	6	6	CD
cord-005453-4057qib7	5378	10	months	month	NNS
cord-005453-4057qib7	5378	11	due	due	JJ
cord-005453-4057qib7	5378	12	to	to	IN
cord-005453-4057qib7	5378	13	treatment	treatment	NN
cord-005453-4057qib7	5378	14	-	-	HYPH
cord-005453-4057qib7	5378	15	related	relate	VBN
cord-005453-4057qib7	5378	16	(	(	-LRB-
cord-005453-4057qib7	5378	17	n=2	n=2	NNS
cord-005453-4057qib7	5378	18	)	)	-RRB-
cord-005453-4057qib7	5378	19	and	and	CC
cord-005453-4057qib7	5378	20	unrelated	unrelated	JJ
cord-005453-4057qib7	5378	21	(	(	-LRB-
cord-005453-4057qib7	5378	22	n=1	n=1	JJ
cord-005453-4057qib7	5378	23	)	)	-RRB-
cord-005453-4057qib7	5378	24	side	side	NN
cord-005453-4057qib7	5378	25	effects	effect	NNS
cord-005453-4057qib7	5378	26	.	.	.
cord-005453-4057qib7	5379	1	Most	Most	JJS
cord-005453-4057qib7	5379	2	patients	patient	NNS
cord-005453-4057qib7	5379	3	experienced	experience	VBD
cord-005453-4057qib7	5379	4	grade	grade	NN
cord-005453-4057qib7	5379	5	2	2	CD
cord-005453-4057qib7	5379	6	toxicities	toxicity	NNS
cord-005453-4057qib7	5379	7	(	(	-LRB-
cord-005453-4057qib7	5379	8	muscle	muscle	NN
cord-005453-4057qib7	5379	9	cramps	cramp	NNS
cord-005453-4057qib7	5379	10	and	and	CC
cord-005453-4057qib7	5379	11	dysgeusia	dysgeusia	NNP
cord-005453-4057qib7	5379	12	)	)	-RRB-
cord-005453-4057qib7	5379	13	,	,	,
cord-005453-4057qib7	5379	14	with	with	IN
cord-005453-4057qib7	5379	15	only	only	RB
cord-005453-4057qib7	5379	16	a	a	DT
cord-005453-4057qib7	5379	17	single	single	JJ
cord-005453-4057qib7	5379	18	grade	grade	NN
cord-005453-4057qib7	5379	19	3	3	CD
cord-005453-4057qib7	5379	20	toxicity	toxicity	NN
cord-005453-4057qib7	5379	21	(	(	-LRB-
cord-005453-4057qib7	5379	22	weight	weight	NN
cord-005453-4057qib7	5379	23	loss	loss	NN
cord-005453-4057qib7	5379	24	)	)	-RRB-
cord-005453-4057qib7	5379	25	.	.	.
cord-005453-4057qib7	5380	1	5	5	CD
cord-005453-4057qib7	5380	2	patients	patient	NNS
cord-005453-4057qib7	5380	3	who	who	WP
cord-005453-4057qib7	5380	4	completed	complete	VBD
cord-005453-4057qib7	5380	5	3	3	CD
cord-005453-4057qib7	5380	6	months	month	NNS
cord-005453-4057qib7	5380	7	of	of	IN
cord-005453-4057qib7	5380	8	therapy	therapy	NN
cord-005453-4057qib7	5380	9	demonstrated	demonstrate	VBD
cord-005453-4057qib7	5380	10	partial	partial	JJ
cord-005453-4057qib7	5380	11	response	response	NN
cord-005453-4057qib7	5380	12	,	,	,
cord-005453-4057qib7	5380	13	and	and	CC
cord-005453-4057qib7	5380	14	overall	overall	RB
cord-005453-4057qib7	5380	15	,	,	,
cord-005453-4057qib7	5380	16	the	the	DT
cord-005453-4057qib7	5380	17	primary	primary	JJ
cord-005453-4057qib7	5380	18	endpoint	endpoint	NN
cord-005453-4057qib7	5380	19	was	be	VBD
cord-005453-4057qib7	5380	20	reached	reach	VBN
cord-005453-4057qib7	5380	21	in	in	IN
cord-005453-4057qib7	5380	22	50	50	CD
cord-005453-4057qib7	5380	23	%	%	NN
cord-005453-4057qib7	5380	24	(	(	-LRB-
cord-005453-4057qib7	5380	25	3/6	3/6	CD
cord-005453-4057qib7	5380	26	)	)	-RRB-
cord-005453-4057qib7	5380	27	of	of	IN
cord-005453-4057qib7	5380	28	patients	patient	NNS
cord-005453-4057qib7	5380	29	.	.	.
cord-005453-4057qib7	5381	1	In	in	IN
cord-005453-4057qib7	5381	2	2	2	CD
cord-005453-4057qib7	5381	3	patients	patient	NNS
cord-005453-4057qib7	5381	4	who	who	WP
cord-005453-4057qib7	5381	5	discontinued	discontinue	VBD
cord-005453-4057qib7	5381	6	vismodegib	vismodegib	NNP
cord-005453-4057qib7	5381	7	,	,	,
cord-005453-4057qib7	5381	8	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5381	9	worsened	worsen	VBD
cord-005453-4057qib7	5381	10	acutely	acutely	RB
cord-005453-4057qib7	5381	11	after	after	IN
cord-005453-4057qib7	5381	12	discontinuation	discontinuation	NN
cord-005453-4057qib7	5381	13	.	.	.
cord-005453-4057qib7	5382	1	Correlative	correlative	JJ
cord-005453-4057qib7	5382	2	analysis	analysis	NN
cord-005453-4057qib7	5382	3	of	of	IN
cord-005453-4057qib7	5382	4	immune	immune	JJ
cord-005453-4057qib7	5382	5	cellular	cellular	JJ
cord-005453-4057qib7	5382	6	subsets	subset	NNS
cord-005453-4057qib7	5382	7	in	in	IN
cord-005453-4057qib7	5382	8	peripheral	peripheral	JJ
cord-005453-4057qib7	5382	9	blood	blood	NN
cord-005453-4057qib7	5382	10	in	in	IN
cord-005453-4057qib7	5382	11	4	4	CD
cord-005453-4057qib7	5382	12	paired	pair	VBN
cord-005453-4057qib7	5382	13	samples	sample	NNS
cord-005453-4057qib7	5382	14	(	(	-LRB-
cord-005453-4057qib7	5382	15	pre	pre	JJ
cord-005453-4057qib7	5382	16	-	-	JJ
cord-005453-4057qib7	5382	17	treatment	treatment	NN
cord-005453-4057qib7	5382	18	and	and	CC
cord-005453-4057qib7	5382	19	month	month	NN
cord-005453-4057qib7	5382	20	3	3	CD
cord-005453-4057qib7	5382	21	of	of	IN
cord-005453-4057qib7	5382	22	therapy	therapy	NN
cord-005453-4057qib7	5382	23	)	)	-RRB-
cord-005453-4057qib7	5382	24	documented	document	VBD
cord-005453-4057qib7	5382	25	modulation	modulation	NN
cord-005453-4057qib7	5382	26	of	of	IN
cord-005453-4057qib7	5382	27	B	b	NN
cord-005453-4057qib7	5382	28	cell	cell	NN
cord-005453-4057qib7	5382	29	subsets	subset	NNS
cord-005453-4057qib7	5382	30	pathogenic	pathogenic	JJ
cord-005453-4057qib7	5382	31	in	in	IN
cord-005453-4057qib7	5382	32	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5383	1	(	(	-LRB-
cord-005453-4057qib7	5383	2	pregerminal	pregerminal	NNP
cord-005453-4057qib7	5383	3	center	center	NNP
cord-005453-4057qib7	5383	4	and	and	CC
cord-005453-4057qib7	5383	5	plasmablast	plasmablast	NN
cord-005453-4057qib7	5383	6	-	-	HYPH
cord-005453-4057qib7	5383	7	like	like	JJ
cord-005453-4057qib7	5383	8	B	b	NN
cord-005453-4057qib7	5383	9	cells	cell	NNS
cord-005453-4057qib7	5383	10	)	)	-RRB-
cord-005453-4057qib7	5383	11	and	and	CC
cord-005453-4057qib7	5383	12	diminished	diminish	VBD
cord-005453-4057qib7	5383	13	T	T	NNP
cord-005453-4057qib7	5383	14	helper	helper	NN
cord-005453-4057qib7	5383	15	2	2	CD
cord-005453-4057qib7	5383	16	polarization	polarization	NN
cord-005453-4057qib7	5383	17	in	in	IN
cord-005453-4057qib7	5383	18	CD4	CD4	NNP
cord-005453-4057qib7	5383	19	T	T	NNP
cord-005453-4057qib7	5383	20	cells	cell	NNS
cord-005453-4057qib7	5383	21	.	.	.
cord-005453-4057qib7	5384	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5384	2	:	:	:
cord-005453-4057qib7	5385	1	Overall	overall	RB
cord-005453-4057qib7	5385	2	,	,	,
cord-005453-4057qib7	5385	3	use	use	NN
cord-005453-4057qib7	5385	4	of	of	IN
cord-005453-4057qib7	5385	5	vismodegib	vismodegib	NNP
cord-005453-4057qib7	5385	6	was	be	VBD
cord-005453-4057qib7	5385	7	associated	associate	VBN
cord-005453-4057qib7	5385	8	with	with	IN
cord-005453-4057qib7	5385	9	potential	potential	JJ
cord-005453-4057qib7	5385	10	clinical	clinical	JJ
cord-005453-4057qib7	5385	11	efficacy	efficacy	NN
cord-005453-4057qib7	5385	12	in	in	IN
cord-005453-4057qib7	5385	13	sclerodermatous	sclerodermatous	JJ
cord-005453-4057qib7	5385	14	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5385	15	with	with	IN
cord-005453-4057qib7	5385	16	possible	possible	JJ
cord-005453-4057qib7	5385	17	mechanistic	mechanistic	JJ
cord-005453-4057qib7	5385	18	evidence	evidence	NN
cord-005453-4057qib7	5385	19	arising	arise	VBG
cord-005453-4057qib7	5385	20	in	in	IN
cord-005453-4057qib7	5385	21	correlative	correlative	JJ
cord-005453-4057qib7	5385	22	studies	study	NNS
cord-005453-4057qib7	5385	23	.	.	.
cord-005453-4057qib7	5386	1	While	while	IN
cord-005453-4057qib7	5386	2	side	side	NN
cord-005453-4057qib7	5386	3	effects	effect	NNS
cord-005453-4057qib7	5386	4	were	be	VBD
cord-005453-4057qib7	5386	5	common	common	JJ
cord-005453-4057qib7	5386	6	,	,	,
cord-005453-4057qib7	5386	7	further	further	JJ
cord-005453-4057qib7	5386	8	studies	study	NNS
cord-005453-4057qib7	5386	9	of	of	IN
cord-005453-4057qib7	5386	10	Hh	Hh	NNP
cord-005453-4057qib7	5386	11	inhibition	inhibition	NN
cord-005453-4057qib7	5386	12	in	in	IN
cord-005453-4057qib7	5386	13	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5386	14	are	be	VBP
cord-005453-4057qib7	5386	15	warranted	warrant	VBN
cord-005453-4057qib7	5386	16	.	.	.
cord-005453-4057qib7	5387	1	Future	future	JJ
cord-005453-4057qib7	5387	2	studies	study	NNS
cord-005453-4057qib7	5387	3	should	should	MD
cord-005453-4057qib7	5387	4	employ	employ	VB
cord-005453-4057qib7	5387	5	adjusted	adjust	VBN
cord-005453-4057qib7	5387	6	dosing	dose	VBG
cord-005453-4057qib7	5387	7	regimens	regimen	NNS
cord-005453-4057qib7	5387	8	,	,	,
cord-005453-4057qib7	5387	9	along	along	IN
cord-005453-4057qib7	5387	10	with	with	IN
cord-005453-4057qib7	5387	11	supportive	supportive	JJ
cord-005453-4057qib7	5387	12	care	care	NN
cord-005453-4057qib7	5387	13	interventions	intervention	NNS
cord-005453-4057qib7	5387	14	to	to	TO
cord-005453-4057qib7	5387	15	offset	offset	VB
cord-005453-4057qib7	5387	16	side	side	NN
cord-005453-4057qib7	5387	17	effects	effect	NNS
cord-005453-4057qib7	5387	18	,	,	,
cord-005453-4057qib7	5387	19	and	and	CC
cord-005453-4057qib7	5387	20	testing	testing	NN
cord-005453-4057qib7	5387	21	of	of	IN
cord-005453-4057qib7	5387	22	novel	novel	NN
cord-005453-4057qib7	5387	23	Hh	Hh	NNP
cord-005453-4057qib7	5387	24	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5387	25	with	with	IN
cord-005453-4057qib7	5387	26	enhanced	enhanced	JJ
cord-005453-4057qib7	5387	27	safety	safety	NN
cord-005453-4057qib7	5387	28	profiles	profile	NNS
cord-005453-4057qib7	5387	29	.	.	.
cord-005453-4057qib7	5388	1	Clinical	clinical	JJ
cord-005453-4057qib7	5388	2	Background	background	NN
cord-005453-4057qib7	5388	3	:	:	:
cord-005453-4057qib7	5388	4	Graft	graft	NN
cord-005453-4057qib7	5388	5	-	-	HYPH
cord-005453-4057qib7	5388	6	versus	versus	IN
cord-005453-4057qib7	5388	7	-	-	HYPH
cord-005453-4057qib7	5388	8	host	host	NN
cord-005453-4057qib7	5388	9	disease	disease	NN
cord-005453-4057qib7	5388	10	(	(	-LRB-
cord-005453-4057qib7	5388	11	GVHD	GVHD	NNP
cord-005453-4057qib7	5388	12	)	)	-RRB-
cord-005453-4057qib7	5388	13	results	result	VBZ
cord-005453-4057qib7	5388	14	from	from	IN
cord-005453-4057qib7	5388	15	recognition	recognition	NN
cord-005453-4057qib7	5388	16	of	of	IN
cord-005453-4057qib7	5388	17	host	host	NN
cord-005453-4057qib7	5388	18	antigens	antigen	NNS
cord-005453-4057qib7	5388	19	by	by	IN
cord-005453-4057qib7	5388	20	donor	donor	NN
cord-005453-4057qib7	5388	21	T	t	NN
cord-005453-4057qib7	5388	22	cells	cell	NNS
cord-005453-4057qib7	5388	23	following	follow	VBG
cord-005453-4057qib7	5388	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	5388	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5388	26	stem	stem	NN
cord-005453-4057qib7	5388	27	cell	cell	NN
cord-005453-4057qib7	5388	28	transplantation	transplantation	NN
cord-005453-4057qib7	5388	29	(	(	-LRB-
cord-005453-4057qib7	5388	30	SCT	SCT	NNP
cord-005453-4057qib7	5388	31	)	)	-RRB-
cord-005453-4057qib7	5388	32	.	.	.
cord-005453-4057qib7	5389	1	We	-PRON-	PRP
cord-005453-4057qib7	5389	2	tested	test	VBD
cord-005453-4057qib7	5389	3	the	the	DT
cord-005453-4057qib7	5389	4	hypothesis	hypothesis	NN
cord-005453-4057qib7	5389	5	that	that	IN
cord-005453-4057qib7	5389	6	somatic	somatic	JJ
cord-005453-4057qib7	5389	7	neomutations	neomutation	NNS
cord-005453-4057qib7	5389	8	occurring	occur	VBG
cord-005453-4057qib7	5389	9	after	after	IN
cord-005453-4057qib7	5389	10	SCT	SCT	NNP
cord-005453-4057qib7	5389	11	from	from	IN
cord-005453-4057qib7	5389	12	donor	donor	NN
cord-005453-4057qib7	5389	13	and/or	and/or	CC
cord-005453-4057qib7	5389	14	recipient	recipient	NN
cord-005453-4057qib7	5389	15	DNA	DNA	NNP
cord-005453-4057qib7	5389	16	may	may	MD
cord-005453-4057qib7	5389	17	trigger	trigger	VB
cord-005453-4057qib7	5389	18	GVHD	GVHD	NNP
cord-005453-4057qib7	5389	19	.	.	.
cord-005453-4057qib7	5390	1	Methods	method	NNS
cord-005453-4057qib7	5390	2	:	:	:
cord-005453-4057qib7	5390	3	We	-PRON-	PRP
cord-005453-4057qib7	5390	4	longitudinally	longitudinally	RB
cord-005453-4057qib7	5390	5	analyzed	analyze	VBD
cord-005453-4057qib7	5390	6	both	both	CC
cord-005453-4057qib7	5390	7	constitutive	constitutive	JJ
cord-005453-4057qib7	5390	8	and	and	CC
cord-005453-4057qib7	5390	9	somatic	somatic	JJ
cord-005453-4057qib7	5390	10	mutations	mutation	NNS
cord-005453-4057qib7	5390	11	by	by	IN
cord-005453-4057qib7	5390	12	whole	whole	JJ
cord-005453-4057qib7	5390	13	exome	exome	NN
cord-005453-4057qib7	5390	14	sequencing	sequencing	NN
cord-005453-4057qib7	5390	15	(	(	-LRB-
cord-005453-4057qib7	5390	16	WES	WES	NNP
cord-005453-4057qib7	5390	17	)	)	-RRB-
cord-005453-4057qib7	5390	18	in	in	IN
cord-005453-4057qib7	5390	19	2	2	CD
cord-005453-4057qib7	5390	20	patients	patient	NNS
cord-005453-4057qib7	5390	21	who	who	WP
cord-005453-4057qib7	5390	22	received	receive	VBD
cord-005453-4057qib7	5390	23	SCT	SCT	NNP
cord-005453-4057qib7	5390	24	from	from	IN
cord-005453-4057qib7	5390	25	a	a	DT
cord-005453-4057qib7	5390	26	sex	sex	NN
cord-005453-4057qib7	5390	27	-	-	HYPH
cord-005453-4057qib7	5390	28	matched	match	VBN
cord-005453-4057qib7	5390	29	HLAidentical	hlaidentical	JJ
cord-005453-4057qib7	5390	30	sibling	sibling	NN
cord-005453-4057qib7	5390	31	for	for	IN
cord-005453-4057qib7	5390	32	NPM1	NPM1	NNP
cord-005453-4057qib7	5390	33	mutated	mutated	JJ
cord-005453-4057qib7	5390	34	acute	acute	JJ
cord-005453-4057qib7	5390	35	myeloid	myeloid	NN
cord-005453-4057qib7	5390	36	leukemia	leukemia	NN
cord-005453-4057qib7	5390	37	(	(	-LRB-
cord-005453-4057qib7	5390	38	Pt#1	pt#1	NN
cord-005453-4057qib7	5390	39	)	)	-RRB-
cord-005453-4057qib7	5390	40	and	and	CC
cord-005453-4057qib7	5390	41	JAK2	JAK2	NNP
cord-005453-4057qib7	5390	42	V617F	v617f	RB
cord-005453-4057qib7	5390	43	mutated	mutate	VBD
cord-005453-4057qib7	5390	44	primary	primary	JJ
cord-005453-4057qib7	5390	45	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	5390	46	(	(	-LRB-
cord-005453-4057qib7	5390	47	Pt#2	pt#2	CD
cord-005453-4057qib7	5390	48	)	)	-RRB-
cord-005453-4057qib7	5390	49	.	.	.
cord-005453-4057qib7	5391	1	Both	both	DT
cord-005453-4057qib7	5391	2	patients	patient	NNS
cord-005453-4057qib7	5391	3	were	be	VBD
cord-005453-4057qib7	5391	4	initially	initially	RB
cord-005453-4057qib7	5391	5	refractory	refractory	JJ
cord-005453-4057qib7	5391	6	to	to	IN
cord-005453-4057qib7	5391	7	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	5391	8	,	,	,
cord-005453-4057qib7	5391	9	i.e.	i.e.	FW
cord-005453-4057qib7	5391	10	not	not	RB
cord-005453-4057qib7	5391	11	displaying	display	VBG
cord-005453-4057qib7	5391	12	any	any	DT
cord-005453-4057qib7	5391	13	signs	sign	NNS
cord-005453-4057qib7	5391	14	of	of	IN
cord-005453-4057qib7	5391	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5391	16	,	,	,
cord-005453-4057qib7	5391	17	even	even	RB
cord-005453-4057qib7	5391	18	after	after	IN
cord-005453-4057qib7	5391	19	several	several	JJ
cord-005453-4057qib7	5391	20	donor	donor	NN
cord-005453-4057qib7	5391	21	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5391	22	infusions	infusion	NNS
cord-005453-4057qib7	5391	23	.	.	.
cord-005453-4057qib7	5392	1	Acute	acute	JJ
cord-005453-4057qib7	5392	2	gut	gut	NN
cord-005453-4057qib7	5392	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5392	4	finally	finally	RB
cord-005453-4057qib7	5392	5	occurred	occur	VBD
cord-005453-4057qib7	5392	6	after	after	IN
cord-005453-4057qib7	5392	7	a	a	DT
cord-005453-4057qib7	5392	8	further	further	JJ
cord-005453-4057qib7	5392	9	DLI	DLI	NNP
cord-005453-4057qib7	5392	10	preceded	precede	VBN
cord-005453-4057qib7	5392	11	by	by	IN
cord-005453-4057qib7	5392	12	a	a	DT
cord-005453-4057qib7	5392	13	lymphodepleting	lymphodepleting	NN
cord-005453-4057qib7	5392	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	5392	15	.	.	.
cord-005453-4057qib7	5393	1	In	in	IN
cord-005453-4057qib7	5393	2	Pt#2	Pt#2	NNS
cord-005453-4057qib7	5393	3	,	,	,
cord-005453-4057qib7	5393	4	GVHD	GVHD	NNP
cord-005453-4057qib7	5393	5	correlated	correlate	VBD
cord-005453-4057qib7	5393	6	with	with	IN
cord-005453-4057qib7	5393	7	a	a	DT
cord-005453-4057qib7	5393	8	graft	graft	NN
cord-005453-4057qib7	5393	9	-	-	HYPH
cord-005453-4057qib7	5393	10	versus	versus	IN
cord-005453-4057qib7	5393	11	-	-	HYPH
cord-005453-4057qib7	5393	12	tumor	tumor	NN
cord-005453-4057qib7	5393	13	effect	effect	NN
cord-005453-4057qib7	5393	14	.	.	.
cord-005453-4057qib7	5394	1	WES	WES	NNP
cord-005453-4057qib7	5394	2	was	be	VBD
cord-005453-4057qib7	5394	3	performed	perform	VBN
cord-005453-4057qib7	5394	4	on	on	IN
cord-005453-4057qib7	5394	5	DNA	DNA	NNP
cord-005453-4057qib7	5394	6	from	from	IN
cord-005453-4057qib7	5394	7	recipient	recipient	NN
cord-005453-4057qib7	5394	8	saliva	saliva	NN
cord-005453-4057qib7	5394	9	and	and	CC
cord-005453-4057qib7	5394	10	donor	donor	NN
cord-005453-4057qib7	5394	11	PBMCs	pbmc	NNS
cord-005453-4057qib7	5394	12	(	(	-LRB-
cord-005453-4057qib7	5394	13	germline	germline	JJ
cord-005453-4057qib7	5394	14	samples	sample	NNS
cord-005453-4057qib7	5394	15	)	)	-RRB-
cord-005453-4057qib7	5394	16	and	and	CC
cord-005453-4057qib7	5394	17	from	from	IN
cord-005453-4057qib7	5394	18	sequential	sequential	JJ
cord-005453-4057qib7	5394	19	post	post	JJ
cord-005453-4057qib7	5394	20	-	-	JJ
cord-005453-4057qib7	5394	21	SCT	sct	JJ
cord-005453-4057qib7	5394	22	PBMCs	pbmcs	JJ
cord-005453-4057qib7	5394	23	samples	sample	VBZ
cord-005453-4057qib7	5394	24	on	on	IN
cord-005453-4057qib7	5394	25	a	a	DT
cord-005453-4057qib7	5394	26	HiSeq2500	HiSeq2500	NNP
cord-005453-4057qib7	5394	27	Illumina	Illumina	NNP
cord-005453-4057qib7	5394	28	with	with	IN
cord-005453-4057qib7	5394	29	2x100bp	2x100bp	CD
cord-005453-4057qib7	5394	30	paired	pair	VBN
cord-005453-4057qib7	5394	31	-	-	HYPH
cord-005453-4057qib7	5394	32	end	end	NN
cord-005453-4057qib7	5394	33	reads	read	VBZ
cord-005453-4057qib7	5394	34	at	at	IN
cord-005453-4057qib7	5394	35	a	a	DT
cord-005453-4057qib7	5394	36	mean	mean	JJ
cord-005453-4057qib7	5394	37	depth	depth	NN
cord-005453-4057qib7	5394	38	of	of	IN
cord-005453-4057qib7	5394	39	coverage	coverage	NN
cord-005453-4057qib7	5394	40	of	of	IN
cord-005453-4057qib7	5394	41	190	190	CD
cord-005453-4057qib7	5394	42	-	-	HYPH
cord-005453-4057qib7	5394	43	210X.	210x.	CD
cord-005453-4057qib7	5394	44	Germline	Germline	NNP
cord-005453-4057qib7	5394	45	and	and	CC
cord-005453-4057qib7	5394	46	somatic	somatic	JJ
cord-005453-4057qib7	5394	47	mutations	mutation	NNS
cord-005453-4057qib7	5394	48	were	be	VBD
cord-005453-4057qib7	5394	49	determined	determine	VBN
cord-005453-4057qib7	5394	50	using	use	VBG
cord-005453-4057qib7	5394	51	in	in	IN
cord-005453-4057qib7	5394	52	-	-	HYPH
cord-005453-4057qib7	5394	53	house	house	NN
cord-005453-4057qib7	5394	54	bioinformatic	bioinformatic	JJ
cord-005453-4057qib7	5394	55	pipelines	pipeline	NNS
cord-005453-4057qib7	5394	56	(	(	-LRB-
cord-005453-4057qib7	5394	57	named	name	VBN
cord-005453-4057qib7	5394	58	Ewok	Ewok	NNP
cord-005453-4057qib7	5394	59	from	from	IN
cord-005453-4057qib7	5394	60	the	the	DT
cord-005453-4057qib7	5394	61	Curie	Curie	NNP
cord-005453-4057qib7	5394	62	Institute	Institute	NNP
cord-005453-4057qib7	5394	63	and	and	CC
cord-005453-4057qib7	5394	64	Smaug	Smaug	NNP
cord-005453-4057qib7	5394	65	from	from	IN
cord-005453-4057qib7	5394	66	the	the	DT
cord-005453-4057qib7	5394	67	Henri	Henri	NNP
cord-005453-4057qib7	5394	68	Mondor	Mondor	NNP
cord-005453-4057qib7	5394	69	hospital	hospital	NN
cord-005453-4057qib7	5394	70	)	)	-RRB-
cord-005453-4057qib7	5394	71	,	,	,
cord-005453-4057qib7	5394	72	using	use	VBG
cord-005453-4057qib7	5394	73	briefly	briefly	RB
cord-005453-4057qib7	5394	74	GATK	GATK	NNP
cord-005453-4057qib7	5394	75	as	as	IN
cord-005453-4057qib7	5394	76	variant	variant	NN
cord-005453-4057qib7	5394	77	caller	caller	NN
cord-005453-4057qib7	5394	78	for	for	IN
cord-005453-4057qib7	5394	79	germline	germline	JJ
cord-005453-4057qib7	5394	80	samples	sample	NNS
cord-005453-4057qib7	5394	81	,	,	,
cord-005453-4057qib7	5394	82	and	and	CC
cord-005453-4057qib7	5394	83	a	a	DT
cord-005453-4057qib7	5394	84	combination	combination	NN
cord-005453-4057qib7	5394	85	of	of	IN
cord-005453-4057qib7	5394	86	3	3	CD
cord-005453-4057qib7	5394	87	variant	variant	NN
cord-005453-4057qib7	5394	88	callers	caller	NNS
cord-005453-4057qib7	5394	89	for	for	IN
cord-005453-4057qib7	5394	90	matched	match	VBN
cord-005453-4057qib7	5394	91	normaltumor	normaltumor	JJ
cord-005453-4057qib7	5394	92	pairs	pair	NNS
cord-005453-4057qib7	5394	93	.	.	.
cord-005453-4057qib7	5395	1	We	-PRON-	PRP
cord-005453-4057qib7	5395	2	adjusted	adjust	VBD
cord-005453-4057qib7	5395	3	parameters	parameter	NNS
cord-005453-4057qib7	5395	4	to	to	TO
cord-005453-4057qib7	5395	5	detect	detect	VB
cord-005453-4057qib7	5395	6	somatic	somatic	JJ
cord-005453-4057qib7	5395	7	mutations	mutation	NNS
cord-005453-4057qib7	5395	8	at	at	IN
cord-005453-4057qib7	5395	9	a	a	DT
cord-005453-4057qib7	5395	10	minimal	minimal	JJ
cord-005453-4057qib7	5395	11	variant	variant	JJ
cord-005453-4057qib7	5395	12	allelic	allelic	JJ
cord-005453-4057qib7	5395	13	frequency	frequency	NN
cord-005453-4057qib7	5395	14	(	(	-LRB-
cord-005453-4057qib7	5395	15	VAF	VAF	NNP
cord-005453-4057qib7	5395	16	)	)	-RRB-
cord-005453-4057qib7	5395	17	of	of	IN
cord-005453-4057qib7	5395	18	5	5	CD
cord-005453-4057qib7	5395	19	%	%	NN
cord-005453-4057qib7	5395	20	compared	compare	VBN
cord-005453-4057qib7	5395	21	to	to	IN
cord-005453-4057qib7	5395	22	recipient	recipient	NN
cord-005453-4057qib7	5395	23	and	and	CC
cord-005453-4057qib7	5395	24	donor	donor	NN
cord-005453-4057qib7	5395	25	germline	germline	NN
cord-005453-4057qib7	5395	26	for	for	IN
cord-005453-4057qib7	5395	27	all	all	DT
cord-005453-4057qib7	5395	28	variations	variation	NNS
cord-005453-4057qib7	5395	29	(	(	-LRB-
cord-005453-4057qib7	5395	30	minimal	minimal	JJ
cord-005453-4057qib7	5395	31	coverage	coverage	NN
cord-005453-4057qib7	5395	32	=	=	SYM
cord-005453-4057qib7	5395	33	8X	8x	CD
cord-005453-4057qib7	5395	34	for	for	IN
cord-005453-4057qib7	5395	35	germline	germline	NN
cord-005453-4057qib7	5395	36	and	and	CC
cord-005453-4057qib7	5395	37	5X	5x	CD
cord-005453-4057qib7	5395	38	for	for	IN
cord-005453-4057qib7	5395	39	tumor	tumor	NN
cord-005453-4057qib7	5395	40	sample	sample	NN
cord-005453-4057qib7	5395	41	)	)	-RRB-
cord-005453-4057qib7	5395	42	.	.	.
cord-005453-4057qib7	5396	1	Results	result	NNS
cord-005453-4057qib7	5396	2	:	:	:
cord-005453-4057qib7	5397	1	WES	WES	NNP
cord-005453-4057qib7	5397	2	allowed	allow	VBD
cord-005453-4057qib7	5397	3	detecting	detect	VBG
cord-005453-4057qib7	5397	4	somatic	somatic	JJ
cord-005453-4057qib7	5397	5	driver	driver	NN
cord-005453-4057qib7	5397	6	mutations	mutation	NNS
cord-005453-4057qib7	5397	7	explaining	explain	VBG
cord-005453-4057qib7	5397	8	AML	AML	NNP
cord-005453-4057qib7	5397	9	and	and	CC
cord-005453-4057qib7	5397	10	PMF	PMF	NNP
cord-005453-4057qib7	5397	11	for	for	IN
cord-005453-4057qib7	5397	12	both	both	DT
cord-005453-4057qib7	5397	13	patients	patient	NNS
cord-005453-4057qib7	5397	14	in	in	IN
cord-005453-4057qib7	5397	15	the	the	DT
cord-005453-4057qib7	5397	16	initial	initial	JJ
cord-005453-4057qib7	5397	17	timepoint	timepoint	NN
cord-005453-4057qib7	5397	18	and	and	CC
cord-005453-4057qib7	5397	19	all	all	PDT
cord-005453-4057qib7	5397	20	these	these	DT
cord-005453-4057qib7	5397	21	driver	driver	NN
cord-005453-4057qib7	5397	22	mutations	mutation	NNS
cord-005453-4057qib7	5397	23	disappeared	disappear	VBD
cord-005453-4057qib7	5397	24	at	at	IN
cord-005453-4057qib7	5397	25	the	the	DT
cord-005453-4057qib7	5397	26	following	follow	VBG
cord-005453-4057qib7	5397	27	timepoints	timepoint	NNS
cord-005453-4057qib7	5397	28	.	.	.
cord-005453-4057qib7	5398	1	As	as	IN
cord-005453-4057qib7	5398	2	expected	expect	VBN
cord-005453-4057qib7	5398	3	,	,	,
cord-005453-4057qib7	5398	4	the	the	DT
cord-005453-4057qib7	5398	5	somatic	somatic	JJ
cord-005453-4057qib7	5398	6	variant	variant	NN
cord-005453-4057qib7	5398	7	rate	rate	NN
cord-005453-4057qib7	5398	8	was	be	VBD
cord-005453-4057qib7	5398	9	10x	10x	CD
cord-005453-4057qib7	5398	10	higher	high	JJR
cord-005453-4057qib7	5398	11	in	in	IN
cord-005453-4057qib7	5398	12	Pt#1	Pt#1	NNP
cord-005453-4057qib7	5398	13	with	with	IN
cord-005453-4057qib7	5398	14	AML	AML	NNP
cord-005453-4057qib7	5398	15	than	than	IN
cord-005453-4057qib7	5398	16	in	in	IN
cord-005453-4057qib7	5398	17	Pt#2	Pt#2	NNS
cord-005453-4057qib7	5398	18	with	with	IN
cord-005453-4057qib7	5398	19	PMF	PMF	NNP
cord-005453-4057qib7	5398	20	at	at	IN
cord-005453-4057qib7	5398	21	each	each	DT
cord-005453-4057qib7	5398	22	timepoint	timepoint	NN
cord-005453-4057qib7	5398	23	,	,	,
cord-005453-4057qib7	5398	24	except	except	IN
cord-005453-4057qib7	5398	25	for	for	IN
cord-005453-4057qib7	5398	26	the	the	DT
cord-005453-4057qib7	5398	27	final	final	JJ
cord-005453-4057qib7	5398	28	GVHD	GVHD	NNP
cord-005453-4057qib7	5398	29	timepoint	timepoint	NN
cord-005453-4057qib7	5398	30	.	.	.
cord-005453-4057qib7	5399	1	Indeed	indeed	RB
cord-005453-4057qib7	5399	2	,	,	,
cord-005453-4057qib7	5399	3	at	at	IN
cord-005453-4057qib7	5399	4	this	this	DT
cord-005453-4057qib7	5399	5	final	final	JJ
cord-005453-4057qib7	5399	6	point	point	NN
cord-005453-4057qib7	5399	7	,	,	,
cord-005453-4057qib7	5399	8	the	the	DT
cord-005453-4057qib7	5399	9	somatic	somatic	JJ
cord-005453-4057qib7	5399	10	variant	variant	NN
cord-005453-4057qib7	5399	11	rate	rate	NN
cord-005453-4057qib7	5399	12	dramatically	dramatically	RB
cord-005453-4057qib7	5399	13	decreased	decrease	VBD
cord-005453-4057qib7	5399	14	by	by	IN
cord-005453-4057qib7	5399	15	80	80	CD
cord-005453-4057qib7	5399	16	%	%	NN
cord-005453-4057qib7	5399	17	as	as	IN
cord-005453-4057qib7	5399	18	compared	compare	VBN
cord-005453-4057qib7	5399	19	to	to	IN
cord-005453-4057qib7	5399	20	previous	previous	JJ
cord-005453-4057qib7	5399	21	timepoints	timepoint	NNS
cord-005453-4057qib7	5399	22	.	.	.
cord-005453-4057qib7	5400	1	By	by	IN
cord-005453-4057qib7	5400	2	subtracting	subtract	VBG
cord-005453-4057qib7	5400	3	variants	variant	NNS
cord-005453-4057qib7	5400	4	detected	detect	VBD
cord-005453-4057qib7	5400	5	pre	pre	JJ
cord-005453-4057qib7	5400	6	-	-	JJ
cord-005453-4057qib7	5400	7	and	and	CC
cord-005453-4057qib7	5400	8	post	post	JJ
cord-005453-4057qib7	5400	9	-	-	JJ
cord-005453-4057qib7	5400	10	SCT	sct	NN
cord-005453-4057qib7	5400	11	from	from	IN
cord-005453-4057qib7	5400	12	those	those	DT
cord-005453-4057qib7	5400	13	identified	identify	VBN
cord-005453-4057qib7	5400	14	at	at	IN
cord-005453-4057qib7	5400	15	the	the	DT
cord-005453-4057qib7	5400	16	ultimate	ultimate	JJ
cord-005453-4057qib7	5400	17	time	time	NN
cord-005453-4057qib7	5400	18	-	-	HYPH
cord-005453-4057qib7	5400	19	point	point	NN
cord-005453-4057qib7	5400	20	of	of	IN
cord-005453-4057qib7	5400	21	GVHD	GVHD	NNP
cord-005453-4057qib7	5400	22	occurrence	occurrence	NN
cord-005453-4057qib7	5400	23	,	,	,
cord-005453-4057qib7	5400	24	we	-PRON-	PRP
cord-005453-4057qib7	5400	25	created	create	VBD
cord-005453-4057qib7	5400	26	2	2	CD
cord-005453-4057qib7	5400	27	sets	set	NNS
cord-005453-4057qib7	5400	28	of	of	IN
cord-005453-4057qib7	5400	29	5	5	CD
cord-005453-4057qib7	5400	30	and	and	CC
cord-005453-4057qib7	5400	31	7	7	CD
cord-005453-4057qib7	5400	32	variants	variant	NNS
cord-005453-4057qib7	5400	33	respectively	respectively	RB
cord-005453-4057qib7	5400	34	for	for	IN
cord-005453-4057qib7	5400	35	each	each	DT
cord-005453-4057qib7	5400	36	patient	patient	NN
cord-005453-4057qib7	5400	37	(	(	-LRB-
cord-005453-4057qib7	5400	38	keeping	keep	VBG
cord-005453-4057qib7	5400	39	only	only	RB
cord-005453-4057qib7	5400	40	variants	variant	NNS
cord-005453-4057qib7	5400	41	with	with	IN
cord-005453-4057qib7	5400	42	at	at	RB
cord-005453-4057qib7	5400	43	least	least	JJS
cord-005453-4057qib7	5400	44	4	4	CD
cord-005453-4057qib7	5400	45	reads	read	NNS
cord-005453-4057qib7	5400	46	of	of	IN
cord-005453-4057qib7	5400	47	mutated	mutate	VBN
cord-005453-4057qib7	5400	48	DNA	dna	NN
cord-005453-4057qib7	5400	49	)	)	-RRB-
cord-005453-4057qib7	5400	50	.	.	.
cord-005453-4057qib7	5401	1	These	these	DT
cord-005453-4057qib7	5401	2	variants	variant	NNS
cord-005453-4057qib7	5401	3	can	can	MD
cord-005453-4057qib7	5401	4	be	be	VB
cord-005453-4057qib7	5401	5	classified	classify	VBN
cord-005453-4057qib7	5401	6	in	in	IN
cord-005453-4057qib7	5401	7	2	2	CD
cord-005453-4057qib7	5401	8	categories	category	NNS
cord-005453-4057qib7	5401	9	:	:	:
cord-005453-4057qib7	5402	1	(	(	-LRB-
cord-005453-4057qib7	5402	2	i	i	NN
cord-005453-4057qib7	5402	3	)	)	-RRB-
cord-005453-4057qib7	5402	4	those	those	DT
cord-005453-4057qib7	5402	5	with	with	IN
cord-005453-4057qib7	5402	6	only	only	RB
cord-005453-4057qib7	5402	7	with	with	IN
cord-005453-4057qib7	5402	8	a	a	DT
cord-005453-4057qib7	5402	9	slight	slight	JJ
cord-005453-4057qib7	5402	10	increase	increase	NN
cord-005453-4057qib7	5402	11	at	at	IN
cord-005453-4057qib7	5402	12	time	time	NN
cord-005453-4057qib7	5402	13	of	of	IN
cord-005453-4057qib7	5402	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5402	15	,	,	,
cord-005453-4057qib7	5402	16	i.e.	i.e.	FW
cord-005453-4057qib7	5402	17	≤	≤	NN
cord-005453-4057qib7	5402	18	2-fold	2-fold	CD
cord-005453-4057qib7	5402	19	compared	compare	VBN
cord-005453-4057qib7	5402	20	to	to	IN
cord-005453-4057qib7	5402	21	highest	high	JJS
cord-005453-4057qib7	5402	22	previous	previous	JJ
cord-005453-4057qib7	5402	23	VAF	VAF	NNP
cord-005453-4057qib7	5402	24	(	(	-LRB-
cord-005453-4057qib7	5402	25	LRRC43	lrrc43	UH
cord-005453-4057qib7	5402	26	,	,	,
cord-005453-4057qib7	5402	27	OR8U1	or8u1	RB
cord-005453-4057qib7	5402	28	,	,	,
cord-005453-4057qib7	5402	29	OR10G9	OR10G9	NNP
cord-005453-4057qib7	5402	30	,	,	,
cord-005453-4057qib7	5402	31	ALPP	ALPP	NNP
cord-005453-4057qib7	5402	32	,	,	,
cord-005453-4057qib7	5402	33	FRG1	FRG1	NNP
cord-005453-4057qib7	5402	34	,	,	,
cord-005453-4057qib7	5402	35	FRG2B	FRG2B	NNP
cord-005453-4057qib7	5402	36	and	and	CC
cord-005453-4057qib7	5402	37	LILRB3	LILRB3	NNP
cord-005453-4057qib7	5402	38	genes	gene	NNS
cord-005453-4057qib7	5402	39	)	)	-RRB-
cord-005453-4057qib7	5402	40	,	,	,
cord-005453-4057qib7	5402	41	and	and	CC
cord-005453-4057qib7	5402	42	(	(	-LRB-
cord-005453-4057qib7	5402	43	ii	ii	NN
cord-005453-4057qib7	5402	44	)	)	-RRB-
cord-005453-4057qib7	5402	45	those	those	DT
cord-005453-4057qib7	5402	46	with	with	IN
cord-005453-4057qib7	5402	47	a	a	DT
cord-005453-4057qib7	5402	48	significant	significant	JJ
cord-005453-4057qib7	5402	49	increase	increase	NN
cord-005453-4057qib7	5402	50	at	at	IN
cord-005453-4057qib7	5402	51	that	that	DT
cord-005453-4057qib7	5402	52	time	time	NN
cord-005453-4057qib7	5402	53	,	,	,
cord-005453-4057qib7	5402	54	i.e.	i.e.	FW
cord-005453-4057qib7	5402	55	>	>	XX
cord-005453-4057qib7	5402	56	2-fold	2-fold	CD
cord-005453-4057qib7	5402	57	compared	compare	VBN
cord-005453-4057qib7	5402	58	to	to	IN
cord-005453-4057qib7	5402	59	highest	high	JJS
cord-005453-4057qib7	5402	60	previous	previous	JJ
cord-005453-4057qib7	5402	61	VAF	VAF	NNP
cord-005453-4057qib7	5402	62	(	(	-LRB-
cord-005453-4057qib7	5402	63	PHF2	PHF2	NNP
cord-005453-4057qib7	5402	64	,	,	,
cord-005453-4057qib7	5402	65	SMPD1	SMPD1	NNP
cord-005453-4057qib7	5402	66	,	,	,
cord-005453-4057qib7	5402	67	ERCC8	ERCC8	NNP
cord-005453-4057qib7	5402	68	and	and	CC
cord-005453-4057qib7	5402	69	KRTAP9	KRTAP9	NNS
cord-005453-4057qib7	5402	70	-	-	HYPH
cord-005453-4057qib7	5402	71	1	1	CD
cord-005453-4057qib7	5402	72	genes	gene	NNS
cord-005453-4057qib7	5402	73	)	)	-RRB-
cord-005453-4057qib7	5402	74	.	.	.
cord-005453-4057qib7	5403	1	None	none	NN
cord-005453-4057qib7	5403	2	of	of	IN
cord-005453-4057qib7	5403	3	the	the	DT
cord-005453-4057qib7	5403	4	variants	variant	NNS
cord-005453-4057qib7	5403	5	or	or	CC
cord-005453-4057qib7	5403	6	genes	gene	NNS
cord-005453-4057qib7	5403	7	involved	involve	VBN
cord-005453-4057qib7	5403	8	was	be	VBD
cord-005453-4057qib7	5403	9	common	common	JJ
cord-005453-4057qib7	5403	10	between	between	IN
cord-005453-4057qib7	5403	11	the	the	DT
cord-005453-4057qib7	5403	12	2	2	CD
cord-005453-4057qib7	5403	13	patients	patient	NNS
cord-005453-4057qib7	5403	14	.	.	.
cord-005453-4057qib7	5404	1	Ontology	ontology	NN
cord-005453-4057qib7	5404	2	classification	classification	NN
cord-005453-4057qib7	5404	3	of	of	IN
cord-005453-4057qib7	5404	4	mutated	mutate	VBN
cord-005453-4057qib7	5404	5	genes	gene	NNS
cord-005453-4057qib7	5404	6	showed	show	VBD
cord-005453-4057qib7	5404	7	the	the	DT
cord-005453-4057qib7	5404	8	implication	implication	NN
cord-005453-4057qib7	5404	9	of	of	IN
cord-005453-4057qib7	5404	10	some	some	DT
cord-005453-4057qib7	5404	11	of	of	IN
cord-005453-4057qib7	5404	12	them	-PRON-	PRP
cord-005453-4057qib7	5404	13	in	in	IN
cord-005453-4057qib7	5404	14	cell	cell	NN
cord-005453-4057qib7	5404	15	death	death	NN
cord-005453-4057qib7	5404	16	,	,	,
cord-005453-4057qib7	5404	17	regulation	regulation	NN
cord-005453-4057qib7	5404	18	of	of	IN
cord-005453-4057qib7	5404	19	MAP	map	NN
cord-005453-4057qib7	5404	20	kinase	kinase	NN
cord-005453-4057qib7	5404	21	activity	activity	NN
cord-005453-4057qib7	5404	22	,	,	,
cord-005453-4057qib7	5404	23	mRNA	mrna	NN
cord-005453-4057qib7	5404	24	splicing	splicing	NN
cord-005453-4057qib7	5404	25	and	and	CC
cord-005453-4057qib7	5404	26	immune	immune	JJ
cord-005453-4057qib7	5404	27	system	system	NN
cord-005453-4057qib7	5404	28	process	process	NN
cord-005453-4057qib7	5404	29	,	,	,
cord-005453-4057qib7	5404	30	making	make	VBG
cord-005453-4057qib7	5404	31	them	-PRON-	PRP
cord-005453-4057qib7	5404	32	good	good	JJ
cord-005453-4057qib7	5404	33	candidates	candidate	NNS
cord-005453-4057qib7	5404	34	for	for	IN
cord-005453-4057qib7	5404	35	further	further	JJ
cord-005453-4057qib7	5404	36	studies	study	NNS
cord-005453-4057qib7	5404	37	.	.	.
cord-005453-4057qib7	5405	1	Identification	identification	NN
cord-005453-4057qib7	5405	2	of	of	IN
cord-005453-4057qib7	5405	3	variants	variant	NNS
cord-005453-4057qib7	5405	4	appearing	appear	VBG
cord-005453-4057qib7	5405	5	pre	pre	JJ
cord-005453-4057qib7	5405	6	-	-	JJ
cord-005453-4057qib7	5405	7	GVH	gvh	JJ
cord-005453-4057qib7	5405	8	and	and	CC
cord-005453-4057qib7	5405	9	turning	turn	VBG
cord-005453-4057qib7	5405	10	off	off	RP
cord-005453-4057qib7	5405	11	at	at	IN
cord-005453-4057qib7	5405	12	time	time	NN
cord-005453-4057qib7	5405	13	of	of	IN
cord-005453-4057qib7	5405	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5406	1	is	be	VBZ
cord-005453-4057qib7	5406	2	ongoing	ongoing	JJ
cord-005453-4057qib7	5406	3	to	to	TO
cord-005453-4057qib7	5406	4	unveil	unveil	VB
cord-005453-4057qib7	5406	5	putative	putative	JJ
cord-005453-4057qib7	5406	6	neoantigens	neoantigen	NNS
cord-005453-4057qib7	5406	7	that	that	WDT
cord-005453-4057qib7	5406	8	could	could	MD
cord-005453-4057qib7	5406	9	trigger	trigger	VB
cord-005453-4057qib7	5406	10	the	the	DT
cord-005453-4057qib7	5406	11	alloreactive	alloreactive	JJ
cord-005453-4057qib7	5406	12	response	response	NN
cord-005453-4057qib7	5406	13	.	.	.
cord-005453-4057qib7	5407	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5407	2	:	:	:
cord-005453-4057qib7	5408	1	Using	use	VBG
cord-005453-4057qib7	5408	2	a	a	DT
cord-005453-4057qib7	5408	3	comprehensive	comprehensive	JJ
cord-005453-4057qib7	5408	4	,	,	,
cord-005453-4057qib7	5408	5	pre	pre	JJ
cord-005453-4057qib7	5408	6	-	-	JJ
cord-005453-4057qib7	5408	7	and	and	CC
cord-005453-4057qib7	5408	8	post	post	JJ
cord-005453-4057qib7	5408	9	-	-	JJ
cord-005453-4057qib7	5408	10	SCT	SCT	NNP
cord-005453-4057qib7	5408	11	,	,	,
cord-005453-4057qib7	5408	12	WES	WES	NNP
cord-005453-4057qib7	5408	13	of	of	IN
cord-005453-4057qib7	5408	14	donor	donor	NN
cord-005453-4057qib7	5408	15	/	/	SYM
cord-005453-4057qib7	5408	16	recipient	recipient	NN
cord-005453-4057qib7	5408	17	pairs	pair	NNS
cord-005453-4057qib7	5408	18	,	,	,
cord-005453-4057qib7	5408	19	we	-PRON-	PRP
cord-005453-4057qib7	5408	20	identified	identify	VBD
cord-005453-4057qib7	5408	21	several	several	JJ
cord-005453-4057qib7	5408	22	neomutations	neomutation	NNS
cord-005453-4057qib7	5408	23	from	from	IN
cord-005453-4057qib7	5408	24	donor	donor	NN
cord-005453-4057qib7	5408	25	and/or	and/or	CC
cord-005453-4057qib7	5408	26	recipient	recipient	NN
cord-005453-4057qib7	5408	27	DNA	dna	NN
cord-005453-4057qib7	5408	28	correlating	correlate	VBG
cord-005453-4057qib7	5408	29	with	with	IN
cord-005453-4057qib7	5408	30	GVH	GVH	NNP
cord-005453-4057qib7	5408	31	/	/	SYM
cord-005453-4057qib7	5408	32	GVT	GVT	NNP
cord-005453-4057qib7	5408	33	effect	effect	NN
cord-005453-4057qib7	5408	34	development	development	NN
cord-005453-4057qib7	5408	35	.	.	.
cord-005453-4057qib7	5409	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5409	2	Results	result	NNS
cord-005453-4057qib7	5409	3	:	:	:
cord-005453-4057qib7	5410	1	A	a	DT
cord-005453-4057qib7	5410	2	total	total	NN
cord-005453-4057qib7	5410	3	of	of	IN
cord-005453-4057qib7	5410	4	169	169	CD
cord-005453-4057qib7	5410	5	patients	patient	NNS
cord-005453-4057qib7	5410	6	experienced	experience	VBD
cord-005453-4057qib7	5410	7	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5410	8	,	,	,
cord-005453-4057qib7	5410	9	and	and	CC
cord-005453-4057qib7	5410	10	mild	mild	JJ
cord-005453-4057qib7	5410	11	,	,	,
cord-005453-4057qib7	5410	12	moderate	moderate	JJ
cord-005453-4057qib7	5410	13	,	,	,
cord-005453-4057qib7	5410	14	and	and	CC
cord-005453-4057qib7	5410	15	severe	severe	JJ
cord-005453-4057qib7	5410	16	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5410	17	were	be	VBD
cord-005453-4057qib7	5410	18	observed	observe	VBN
cord-005453-4057qib7	5410	19	in	in	IN
cord-005453-4057qib7	5410	20	66	66	CD
cord-005453-4057qib7	5410	21	,	,	,
cord-005453-4057qib7	5410	22	67	67	CD
cord-005453-4057qib7	5410	23	,	,	,
cord-005453-4057qib7	5410	24	and	and	CC
cord-005453-4057qib7	5410	25	36	36	CD
cord-005453-4057qib7	5410	26	patients	patient	NNS
cord-005453-4057qib7	5410	27	,	,	,
cord-005453-4057qib7	5410	28	respectively	respectively	RB
cord-005453-4057qib7	5410	29	.	.	.
cord-005453-4057qib7	5411	1	The	the	DT
cord-005453-4057qib7	5411	2	2-year	2-year	CD
cord-005453-4057qib7	5411	3	cumulative	cumulative	JJ
cord-005453-4057qib7	5411	4	incidence	incidence	NN
cord-005453-4057qib7	5411	5	of	of	IN
cord-005453-4057qib7	5411	6	total	total	JJ
cord-005453-4057qib7	5411	7	cGVHD	cgvhd	NN
cord-005453-4057qib7	5411	8	was	be	VBD
cord-005453-4057qib7	5411	9	60.5	60.5	CD
cord-005453-4057qib7	5411	10	%	%	NN
cord-005453-4057qib7	5411	11	(	(	-LRB-
cord-005453-4057qib7	5411	12	95	95	CD
cord-005453-4057qib7	5411	13	%	%	NN
cord-005453-4057qib7	5411	14	CI	CI	NNP
cord-005453-4057qib7	5411	15	,	,	,
cord-005453-4057qib7	5411	16	54.7	54.7	CD
cord-005453-4057qib7	5411	17	-	-	HYPH
cord-005453-4057qib7	5411	18	66.3	66.3	CD
cord-005453-4057qib7	5411	19	%	%	NN
cord-005453-4057qib7	5411	20	)	)	-RRB-
cord-005453-4057qib7	5411	21	,	,	,
cord-005453-4057qib7	5411	22	and	and	CC
cord-005453-4057qib7	5411	23	the	the	DT
cord-005453-4057qib7	5411	24	2-year	2-year	CD
cord-005453-4057qib7	5411	25	cumulative	cumulative	JJ
cord-005453-4057qib7	5411	26	incidence	incidence	NN
cord-005453-4057qib7	5411	27	of	of	IN
cord-005453-4057qib7	5411	28	moderate	moderate	JJ
cord-005453-4057qib7	5411	29	to	to	TO
cord-005453-4057qib7	5411	30	severe	severe	JJ
cord-005453-4057qib7	5411	31	and	and	CC
cord-005453-4057qib7	5411	32	severe	severe	JJ
cord-005453-4057qib7	5411	33	cGVHD	cgvhd	NN
cord-005453-4057qib7	5411	34	was	be	VBD
cord-005453-4057qib7	5411	35	36.6	36.6	CD
cord-005453-4057qib7	5411	36	%	%	NN
cord-005453-4057qib7	5411	37	(	(	-LRB-
cord-005453-4057qib7	5411	38	95	95	CD
cord-005453-4057qib7	5411	39	%	%	NN
cord-005453-4057qib7	5411	40	CI	CI	NNP
cord-005453-4057qib7	5411	41	,	,	,
cord-005453-4057qib7	5411	42	30.9	30.9	CD
cord-005453-4057qib7	5411	43	-	-	SYM
cord-005453-4057qib7	5411	44	42.3	42.3	CD
cord-005453-4057qib7	5411	45	%	%	NN
cord-005453-4057qib7	5411	46	)	)	-RRB-
cord-005453-4057qib7	5411	47	and	and	CC
cord-005453-4057qib7	5411	48	12.7	12.7	CD
cord-005453-4057qib7	5411	49	%	%	NN
cord-005453-4057qib7	5411	50	(	(	-LRB-
cord-005453-4057qib7	5411	51	95	95	CD
cord-005453-4057qib7	5411	52	%	%	NN
cord-005453-4057qib7	5411	53	CI	CI	NNP
cord-005453-4057qib7	5411	54	,	,	,
cord-005453-4057qib7	5411	55	8.8	8.8	CD
cord-005453-4057qib7	5411	56	-	-	SYM
cord-005453-4057qib7	5411	57	16.6	16.6	CD
cord-005453-4057qib7	5411	58	%	%	NN
cord-005453-4057qib7	5411	59	)	)	-RRB-
cord-005453-4057qib7	5411	60	,	,	,
cord-005453-4057qib7	5411	61	respectively	respectively	RB
cord-005453-4057qib7	5411	62	.	.	.
cord-005453-4057qib7	5412	1	The	the	DT
cord-005453-4057qib7	5412	2	patients	patient	NNS
cord-005453-4057qib7	5412	3	who	who	WP
cord-005453-4057qib7	5412	4	had	have	VBD
cord-005453-4057qib7	5412	5	3	3	CD
cord-005453-4057qib7	5412	6	loci	locus	NNS
cord-005453-4057qib7	5412	7	mismatched	mismatch	VBN
cord-005453-4057qib7	5412	8	had	have	VBD
cord-005453-4057qib7	5412	9	a	a	DT
cord-005453-4057qib7	5412	10	higher	high	JJR
cord-005453-4057qib7	5412	11	2-year	2-year	CD
cord-005453-4057qib7	5412	12	cumulative	cumulative	JJ
cord-005453-4057qib7	5412	13	incidence	incidence	NN
cord-005453-4057qib7	5412	14	of	of	IN
cord-005453-4057qib7	5412	15	total	total	JJ
cord-005453-4057qib7	5412	16	cGVHD	cgvhd	NN
cord-005453-4057qib7	5412	17	(	(	-LRB-
cord-005453-4057qib7	5412	18	66.2	66.2	CD
cord-005453-4057qib7	5412	19	%	%	NN
cord-005453-4057qib7	5412	20	vs.	vs.	CC
cord-005453-4057qib7	5412	21	54.5	54.5	CD
cord-005453-4057qib7	5412	22	%	%	NN
cord-005453-4057qib7	5412	23	,	,	,
cord-005453-4057qib7	5412	24	P=0.025	P=0.025	NNP
cord-005453-4057qib7	5412	25	)	)	-RRB-
cord-005453-4057qib7	5412	26	and	and	CC
cord-005453-4057qib7	5412	27	moderate	moderate	JJ
cord-005453-4057qib7	5412	28	to	to	IN
cord-005453-4057qib7	5412	29	severe	severe	JJ
cord-005453-4057qib7	5412	30	cGVHD	cgvhd	NN
cord-005453-4057qib7	5412	31	(	(	-LRB-
cord-005453-4057qib7	5412	32	42.3	42.3	CD
cord-005453-4057qib7	5412	33	%	%	NN
cord-005453-4057qib7	5412	34	vs.	vs.	CC
cord-005453-4057qib7	5412	35	30.6	30.6	CD
cord-005453-4057qib7	5412	36	%	%	NN
cord-005453-4057qib7	5412	37	,	,	,
cord-005453-4057qib7	5412	38	P=0.028	p=0.028	NN
cord-005453-4057qib7	5412	39	)	)	-RRB-
cord-005453-4057qib7	5412	40	compared	compare	VBN
cord-005453-4057qib7	5412	41	to	to	IN
cord-005453-4057qib7	5412	42	those	those	DT
cord-005453-4057qib7	5412	43	of	of	IN
cord-005453-4057qib7	5412	44	the	the	DT
cord-005453-4057qib7	5412	45	patients	patient	NNS
cord-005453-4057qib7	5412	46	who	who	WP
cord-005453-4057qib7	5412	47	had	have	VBD
cord-005453-4057qib7	5412	48	1	1	CD
cord-005453-4057qib7	5412	49	-	-	SYM
cord-005453-4057qib7	5412	50	2	2	CD
cord-005453-4057qib7	5412	51	loci	locus	NNS
cord-005453-4057qib7	5412	52	mismatched	mismatch	VBN
cord-005453-4057qib7	5412	53	.	.	.
cord-005453-4057qib7	5413	1	The	the	DT
cord-005453-4057qib7	5413	2	patients	patient	NNS
cord-005453-4057qib7	5413	3	who	who	WP
cord-005453-4057qib7	5413	4	had	have	VBD
cord-005453-4057qib7	5413	5	maternal	maternal	JJ
cord-005453-4057qib7	5413	6	donors	donor	NNS
cord-005453-4057qib7	5413	7	had	have	VBD
cord-005453-4057qib7	5413	8	a	a	DT
cord-005453-4057qib7	5413	9	higher	high	JJR
cord-005453-4057qib7	5413	10	2-year	2-year	CD
cord-005453-4057qib7	5413	11	cumulative	cumulative	JJ
cord-005453-4057qib7	5413	12	incidence	incidence	NN
cord-005453-4057qib7	5413	13	of	of	IN
cord-005453-4057qib7	5413	14	moderate	moderate	JJ
cord-005453-4057qib7	5413	15	to	to	IN
cord-005453-4057qib7	5413	16	severe	severe	JJ
cord-005453-4057qib7	5413	17	cGVHD	cgvhd	NN
cord-005453-4057qib7	5413	18	(	(	-LRB-
cord-005453-4057qib7	5413	19	50.8	50.8	CD
cord-005453-4057qib7	5413	20	%	%	NN
cord-005453-4057qib7	5413	21	vs.	vs.	CC
cord-005453-4057qib7	5413	22	32.7	32.7	CD
cord-005453-4057qib7	5413	23	%	%	NN
cord-005453-4057qib7	5413	24	,	,	,
cord-005453-4057qib7	5413	25	P=0.018	P=0.018	NNP
cord-005453-4057qib7	5413	26	)	)	-RRB-
cord-005453-4057qib7	5413	27	compared	compare	VBD
cord-005453-4057qib7	5413	28	to	to	IN
cord-005453-4057qib7	5413	29	that	that	DT
cord-005453-4057qib7	5413	30	of	of	IN
cord-005453-4057qib7	5413	31	the	the	DT
cord-005453-4057qib7	5413	32	patients	patient	NNS
cord-005453-4057qib7	5413	33	who	who	WP
cord-005453-4057qib7	5413	34	had	have	VBD
cord-005453-4057qib7	5413	35	other	other	JJ
cord-005453-4057qib7	5413	36	donors	donor	NNS
cord-005453-4057qib7	5413	37	.	.	.
cord-005453-4057qib7	5414	1	The	the	DT
cord-005453-4057qib7	5414	2	patients	patient	NNS
cord-005453-4057qib7	5414	3	who	who	WP
cord-005453-4057qib7	5414	4	had	have	VBD
cord-005453-4057qib7	5414	5	grade	grade	NN
cord-005453-4057qib7	5414	6	III	III	NNP
cord-005453-4057qib7	5414	7	to	to	IN
cord-005453-4057qib7	5414	8	IV	IV	NNP
cord-005453-4057qib7	5414	9	acute	acute	JJ
cord-005453-4057qib7	5414	10	graft	graft	NN
cord-005453-4057qib7	5414	11	-	-	HYPH
cord-005453-4057qib7	5414	12	versus	versus	IN
cord-005453-4057qib7	5414	13	-	-	HYPH
cord-005453-4057qib7	5414	14	host	host	NN
cord-005453-4057qib7	5414	15	(	(	-LRB-
cord-005453-4057qib7	5414	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5414	17	)	)	-RRB-
cord-005453-4057qib7	5414	18	had	have	VBD
cord-005453-4057qib7	5414	19	a	a	DT
cord-005453-4057qib7	5414	20	higher	high	JJR
cord-005453-4057qib7	5414	21	2-year	2-year	CD
cord-005453-4057qib7	5414	22	cumulative	cumulative	JJ
cord-005453-4057qib7	5414	23	incidence	incidence	NN
cord-005453-4057qib7	5414	24	of	of	IN
cord-005453-4057qib7	5414	25	total	total	JJ
cord-005453-4057qib7	5414	26	cGVHD	cgvhd	NN
cord-005453-4057qib7	5414	27	(	(	-LRB-
cord-005453-4057qib7	5414	28	91.7	91.7	CD
cord-005453-4057qib7	5414	29	%	%	NN
cord-005453-4057qib7	5414	30	vs.	vs.	IN
cord-005453-4057qib7	5414	31	50.0	50.0	CD
cord-005453-4057qib7	5414	32	%	%	NN
cord-005453-4057qib7	5414	33	,	,	,
cord-005453-4057qib7	5414	34	P	p	NN
cord-005453-4057qib7	5414	35	<	<	XX
cord-005453-4057qib7	5414	36	0.001	0.001	CD
cord-005453-4057qib7	5414	37	)	)	-RRB-
cord-005453-4057qib7	5414	38	and	and	CC
cord-005453-4057qib7	5414	39	moderate	moderate	JJ
cord-005453-4057qib7	5414	40	to	to	IN
cord-005453-4057qib7	5414	41	severe	severe	JJ
cord-005453-4057qib7	5414	42	cGVHD	cgvhd	NN
cord-005453-4057qib7	5414	43	(	(	-LRB-
cord-005453-4057qib7	5414	44	70.8	70.8	CD
cord-005453-4057qib7	5414	45	%	%	NN
cord-005453-4057qib7	5414	46	vs.	vs.	IN
cord-005453-4057qib7	5414	47	26	26	CD
cord-005453-4057qib7	5414	48	.3	.3	CD
cord-005453-4057qib7	5414	49	%	%	NN
cord-005453-4057qib7	5414	50	,	,	,
cord-005453-4057qib7	5414	51	P	p	NN
cord-005453-4057qib7	5414	52	<	<	XX
cord-005453-4057qib7	5414	53	0.001	0.001	CD
cord-005453-4057qib7	5414	54	)	)	-RRB-
cord-005453-4057qib7	5414	55	compared	compare	VBD
cord-005453-4057qib7	5414	56	to	to	IN
cord-005453-4057qib7	5414	57	those	those	DT
cord-005453-4057qib7	5414	58	of	of	IN
cord-005453-4057qib7	5414	59	the	the	DT
cord-005453-4057qib7	5414	60	patients	patient	NNS
cord-005453-4057qib7	5414	61	without	without	IN
cord-005453-4057qib7	5414	62	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5414	63	.	.	.
cord-005453-4057qib7	5415	1	In	in	IN
cord-005453-4057qib7	5415	2	multivariate	multivariate	JJ
cord-005453-4057qib7	5415	3	analysis	analysis	NN
cord-005453-4057qib7	5415	4	,	,	,
cord-005453-4057qib7	5415	5	grade	grade	NN
cord-005453-4057qib7	5415	6	III	III	NNP
cord-005453-4057qib7	5415	7	to	to	IN
cord-005453-4057qib7	5415	8	IV	IV	NNP
cord-005453-4057qib7	5415	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5415	10	was	be	VBD
cord-005453-4057qib7	5415	11	the	the	DT
cord-005453-4057qib7	5415	12	only	only	JJ
cord-005453-4057qib7	5415	13	independent	independent	JJ
cord-005453-4057qib7	5415	14	risk	risk	NN
cord-005453-4057qib7	5415	15	factor	factor	NN
cord-005453-4057qib7	5415	16	for	for	IN
cord-005453-4057qib7	5415	17	total	total	JJ
cord-005453-4057qib7	5415	18	cGVHD	cgvhd	NN
cord-005453-4057qib7	5416	1	(	(	-LRB-
cord-005453-4057qib7	5416	2	HR=2.6	hr=2.6	NN
cord-005453-4057qib7	5416	3	,	,	,
cord-005453-4057qib7	5416	4	95%CI	95%ci	CD
cord-005453-4057qib7	5416	5	,	,	,
cord-005453-4057qib7	5416	6	1.6	1.6	CD
cord-005453-4057qib7	5416	7	-	-	SYM
cord-005453-4057qib7	5416	8	4.2	4.2	CD
cord-005453-4057qib7	5416	9	;	;	:
cord-005453-4057qib7	5416	10	P	p	NN
cord-005453-4057qib7	5416	11	<	<	XX
cord-005453-4057qib7	5416	12	0.001	0.001	CD
cord-005453-4057qib7	5416	13	)	)	-RRB-
cord-005453-4057qib7	5416	14	and	and	CC
cord-005453-4057qib7	5416	15	moderate	moderate	JJ
cord-005453-4057qib7	5416	16	to	to	TO
cord-005453-4057qib7	5416	17	severe	severe	JJ
cord-005453-4057qib7	5416	18	cGVHD	cgvhd	NN
cord-005453-4057qib7	5417	1	(	(	-LRB-
cord-005453-4057qib7	5417	2	HR=3.8	HR=3.8	NNP
cord-005453-4057qib7	5417	3	,	,	,
cord-005453-4057qib7	5417	4	95%CI	95%ci	CD
cord-005453-4057qib7	5417	5	,	,	,
cord-005453-4057qib7	5417	6	2.1	2.1	CD
cord-005453-4057qib7	5417	7	-	-	SYM
cord-005453-4057qib7	5417	8	6.7	6.7	CD
cord-005453-4057qib7	5417	9	;	;	:
cord-005453-4057qib7	5417	10	P	p	NN
cord-005453-4057qib7	5417	11	<	<	XX
cord-005453-4057qib7	5417	12	0.001	0.001	CD
cord-005453-4057qib7	5417	13	)	)	-RRB-
cord-005453-4057qib7	5417	14	.	.	.
cord-005453-4057qib7	5418	1	In	in	IN
cord-005453-4057qib7	5418	2	the	the	DT
cord-005453-4057qib7	5418	3	model	model	NN
cord-005453-4057qib7	5418	4	excluding	exclude	VBG
cord-005453-4057qib7	5418	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5418	6	,	,	,
cord-005453-4057qib7	5418	7	maternal	maternal	JJ
cord-005453-4057qib7	5418	8	donor	donor	NN
cord-005453-4057qib7	5418	9	was	be	VBD
cord-005453-4057qib7	5418	10	the	the	DT
cord-005453-4057qib7	5418	11	risk	risk	NN
cord-005453-4057qib7	5418	12	factor	factor	NN
cord-005453-4057qib7	5418	13	for	for	IN
cord-005453-4057qib7	5418	14	moderate	moderate	JJ
cord-005453-4057qib7	5418	15	to	to	TO
cord-005453-4057qib7	5418	16	severe	severe	JJ
cord-005453-4057qib7	5418	17	cGVHD	cgvhd	NN
cord-005453-4057qib7	5419	1	(	(	-LRB-
cord-005453-4057qib7	5419	2	HR=1.5	hr=1.5	NN
cord-005453-4057qib7	5419	3	,	,	,
cord-005453-4057qib7	5419	4	95%CI	95%ci	CD
cord-005453-4057qib7	5419	5	,	,	,
cord-005453-4057qib7	5419	6	1.1	1.1	CD
cord-005453-4057qib7	5419	7	-	-	SYM
cord-005453-4057qib7	5419	8	2.3	2.3	CD
cord-005453-4057qib7	5419	9	;	;	:
cord-005453-4057qib7	5419	10	P=0.030	p=0.030	NN
cord-005453-4057qib7	5419	11	)	)	-RRB-
cord-005453-4057qib7	5419	12	.	.	.
cord-005453-4057qib7	5420	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5420	2	:	:	:
cord-005453-4057qib7	5421	1	We	-PRON-	PRP
cord-005453-4057qib7	5421	2	observe	observe	VBP
cord-005453-4057qib7	5421	3	that	that	DT
cord-005453-4057qib7	5421	4	severe	severe	JJ
cord-005453-4057qib7	5421	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5421	6	was	be	VBD
cord-005453-4057qib7	5421	7	the	the	DT
cord-005453-4057qib7	5421	8	most	most	RBS
cord-005453-4057qib7	5421	9	important	important	JJ
cord-005453-4057qib7	5421	10	risk	risk	NN
cord-005453-4057qib7	5421	11	factors	factor	NNS
cord-005453-4057qib7	5421	12	for	for	IN
cord-005453-4057qib7	5421	13	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5421	14	after	after	IN
cord-005453-4057qib7	5421	15	haplo	haplo	NN
cord-005453-4057qib7	5421	16	-	-	HYPH
cord-005453-4057qib7	5421	17	HSCT	HSCT	NNP
cord-005453-4057qib7	5421	18	,	,	,
cord-005453-4057qib7	5421	19	and	and	CC
cord-005453-4057qib7	5421	20	further	further	JJ
cord-005453-4057qib7	5421	21	interventions	intervention	NNS
cord-005453-4057qib7	5421	22	should	should	MD
cord-005453-4057qib7	5421	23	be	be	VB
cord-005453-4057qib7	5421	24	considered	consider	VBN
cord-005453-4057qib7	5421	25	in	in	IN
cord-005453-4057qib7	5421	26	these	these	DT
cord-005453-4057qib7	5421	27	patients	patient	NNS
cord-005453-4057qib7	5421	28	to	to	TO
cord-005453-4057qib7	5421	29	prevent	prevent	VB
cord-005453-4057qib7	5421	30	severe	severe	JJ
cord-005453-4057qib7	5421	31	cGVHD	cgvhd	NN
cord-005453-4057qib7	5421	32	.	.	.
cord-005453-4057qib7	5422	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5422	2	:	:	:
cord-005453-4057qib7	5423	1	None	none	NN
cord-005453-4057qib7	5423	2	of	of	IN
cord-005453-4057qib7	5423	3	the	the	DT
cord-005453-4057qib7	5423	4	authors	author	NNS
cord-005453-4057qib7	5423	5	have	have	VBP
cord-005453-4057qib7	5423	6	any	any	DT
cord-005453-4057qib7	5423	7	potential	potential	JJ
cord-005453-4057qib7	5423	8	financial	financial	JJ
cord-005453-4057qib7	5423	9	conflict	conflict	NN
cord-005453-4057qib7	5423	10	of	of	IN
cord-005453-4057qib7	5423	11	interest	interest	NN
cord-005453-4057qib7	5423	12	related	relate	VBN
cord-005453-4057qib7	5423	13	to	to	IN
cord-005453-4057qib7	5423	14	this	this	DT
cord-005453-4057qib7	5423	15	manuscript	manuscript	NN
cord-005453-4057qib7	5423	16	.	.	.
cord-005453-4057qib7	5424	1	Background	background	NN
cord-005453-4057qib7	5424	2	:	:	:
cord-005453-4057qib7	5425	1	Extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5425	2	photopheresis	photopheresis	NN
cord-005453-4057qib7	5425	3	(	(	-LRB-
cord-005453-4057qib7	5425	4	ECP	ECP	NNP
cord-005453-4057qib7	5425	5	)	)	-RRB-
cord-005453-4057qib7	5425	6	has	have	VBZ
cord-005453-4057qib7	5425	7	been	be	VBN
cord-005453-4057qib7	5425	8	successfully	successfully	RB
cord-005453-4057qib7	5425	9	used	use	VBN
cord-005453-4057qib7	5425	10	for	for	IN
cord-005453-4057qib7	5425	11	the	the	DT
cord-005453-4057qib7	5425	12	treatment	treatment	NN
cord-005453-4057qib7	5425	13	of	of	IN
cord-005453-4057qib7	5425	14	graft	graft	NN
cord-005453-4057qib7	5425	15	-	-	HYPH
cord-005453-4057qib7	5425	16	versus	versus	IN
cord-005453-4057qib7	5425	17	-	-	HYPH
cord-005453-4057qib7	5425	18	host	host	NN
cord-005453-4057qib7	5425	19	disease	disease	NN
cord-005453-4057qib7	5425	20	(	(	-LRB-
cord-005453-4057qib7	5425	21	GvHD	GvHD	NNP
cord-005453-4057qib7	5425	22	)	)	-RRB-
cord-005453-4057qib7	5425	23	.	.	.
cord-005453-4057qib7	5426	1	ECP	ECP	NNP
cord-005453-4057qib7	5426	2	therapy	therapy	NN
cord-005453-4057qib7	5426	3	might	may	MD
cord-005453-4057qib7	5426	4	restore	restore	VB
cord-005453-4057qib7	5426	5	the	the	DT
cord-005453-4057qib7	5426	6	balance	balance	NN
cord-005453-4057qib7	5426	7	between	between	IN
cord-005453-4057qib7	5426	8	effector	effector	NN
cord-005453-4057qib7	5426	9	and	and	CC
cord-005453-4057qib7	5426	10	regulatory	regulatory	JJ
cord-005453-4057qib7	5426	11	cells	cell	NNS
cord-005453-4057qib7	5426	12	which	which	WDT
cord-005453-4057qib7	5426	13	is	be	VBZ
cord-005453-4057qib7	5426	14	severely	severely	RB
cord-005453-4057qib7	5426	15	impaired	impaired	JJ
cord-005453-4057qib7	5426	16	in	in	IN
cord-005453-4057qib7	5426	17	GvHD	GvHD	NNP
cord-005453-4057qib7	5426	18	.	.	.
cord-005453-4057qib7	5427	1	NK	NK	NNP
cord-005453-4057qib7	5427	2	cells	cell	NNS
cord-005453-4057qib7	5427	3	are	be	VBP
cord-005453-4057qib7	5427	4	the	the	DT
cord-005453-4057qib7	5427	5	first	first	JJ
cord-005453-4057qib7	5427	6	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5427	7	subset	subset	VBN
cord-005453-4057qib7	5427	8	to	to	TO
cord-005453-4057qib7	5427	9	be	be	VB
cord-005453-4057qib7	5427	10	reconstituted	reconstitute	VBN
cord-005453-4057qib7	5427	11	after	after	IN
cord-005453-4057qib7	5427	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5427	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5427	14	stem	stem	NN
cord-005453-4057qib7	5427	15	cell	cell	NN
cord-005453-4057qib7	5427	16	transplantation	transplantation	NN
cord-005453-4057qib7	5427	17	(	(	-LRB-
cord-005453-4057qib7	5427	18	allo	allo	NN
cord-005453-4057qib7	5427	19	-	-	HYPH
cord-005453-4057qib7	5427	20	HSCT	HSCT	NNP
cord-005453-4057qib7	5427	21	)	)	-RRB-
cord-005453-4057qib7	5427	22	.	.	.
cord-005453-4057qib7	5428	1	As	as	IN
cord-005453-4057qib7	5428	2	an	an	DT
cord-005453-4057qib7	5428	3	important	important	JJ
cord-005453-4057qib7	5428	4	innate	innate	JJ
cord-005453-4057qib7	5428	5	immune	immune	JJ
cord-005453-4057qib7	5428	6	cell	cell	NN
cord-005453-4057qib7	5428	7	population	population	NN
cord-005453-4057qib7	5428	8	,	,	,
cord-005453-4057qib7	5428	9	NK	NK	NNP
cord-005453-4057qib7	5428	10	cells	cell	NNS
cord-005453-4057qib7	5428	11	can	can	MD
cord-005453-4057qib7	5428	12	temporally	temporally	RB
cord-005453-4057qib7	5428	13	bridge	bridge	VB
cord-005453-4057qib7	5428	14	the	the	DT
cord-005453-4057qib7	5428	15	transient	transient	JJ
cord-005453-4057qib7	5428	16	period	period	NN
cord-005453-4057qib7	5428	17	of	of	IN
cord-005453-4057qib7	5428	18	T	t	NN
cord-005453-4057qib7	5428	19	-	-	HYPH
cord-005453-4057qib7	5428	20	cell	cell	NN
cord-005453-4057qib7	5428	21	deficiency	deficiency	NN
cord-005453-4057qib7	5428	22	post	post	FW
cord-005453-4057qib7	5428	23	allo	allo	FW
cord-005453-4057qib7	5428	24	-	-	HYPH
cord-005453-4057qib7	5428	25	HSCT	HSCT	NNP
cord-005453-4057qib7	5428	26	,	,	,
cord-005453-4057qib7	5428	27	by	by	IN
cord-005453-4057qib7	5428	28	protection	protection	NN
cord-005453-4057qib7	5428	29	from	from	IN
cord-005453-4057qib7	5428	30	opportunistic	opportunistic	JJ
cord-005453-4057qib7	5428	31	infections	infection	NNS
cord-005453-4057qib7	5428	32	and	and	CC
cord-005453-4057qib7	5428	33	prevention	prevention	NN
cord-005453-4057qib7	5428	34	of	of	IN
cord-005453-4057qib7	5428	35	leukemic	leukemic	JJ
cord-005453-4057qib7	5428	36	relapse	relapse	NN
cord-005453-4057qib7	5428	37	by	by	IN
cord-005453-4057qib7	5428	38	graft	graft	NN
cord-005453-4057qib7	5428	39	-	-	HYPH
cord-005453-4057qib7	5428	40	versus	versus	IN
cord-005453-4057qib7	5428	41	-	-	HYPH
cord-005453-4057qib7	5428	42	leukemia	leukemia	NN
cord-005453-4057qib7	5428	43	(	(	-LRB-
cord-005453-4057qib7	5428	44	GvL	gvl	NN
cord-005453-4057qib7	5428	45	)	)	-RRB-
cord-005453-4057qib7	5428	46	effect	effect	NN
cord-005453-4057qib7	5428	47	.	.	.
cord-005453-4057qib7	5429	1	NK	NK	NNP
cord-005453-4057qib7	5429	2	cells	cell	NNS
cord-005453-4057qib7	5429	3	not	not	RB
cord-005453-4057qib7	5429	4	only	only	RB
cord-005453-4057qib7	5429	5	preserve	preserve	VBP
cord-005453-4057qib7	5429	6	homeostasis	homeostasis	NN
cord-005453-4057qib7	5429	7	through	through	IN
cord-005453-4057qib7	5429	8	targeted	target	VBN
cord-005453-4057qib7	5429	9	killing	killing	NN
cord-005453-4057qib7	5429	10	of	of	IN
cord-005453-4057qib7	5429	11	allo	allo	NN
cord-005453-4057qib7	5429	12	-	-	HYPH
cord-005453-4057qib7	5429	13	reactive	reactive	JJ
cord-005453-4057qib7	5429	14	T	t	NN
cord-005453-4057qib7	5429	15	cells	cell	NNS
cord-005453-4057qib7	5429	16	and	and	CC
cord-005453-4057qib7	5429	17	thereby	thereby	RB
cord-005453-4057qib7	5429	18	control	control	VB
cord-005453-4057qib7	5429	19	GvHD	GvHD	NNP
cord-005453-4057qib7	5429	20	but	but	CC
cord-005453-4057qib7	5429	21	also	also	RB
cord-005453-4057qib7	5429	22	enhance	enhance	VB
cord-005453-4057qib7	5429	23	inflammation	inflammation	NN
cord-005453-4057qib7	5429	24	by	by	IN
cord-005453-4057qib7	5429	25	secretion	secretion	NN
cord-005453-4057qib7	5429	26	of	of	IN
cord-005453-4057qib7	5429	27	TNF	TNF	NNP
cord-005453-4057qib7	5429	28	-	-	HYPH
cord-005453-4057qib7	5429	29	α	α	NNP
cord-005453-4057qib7	5429	30	and	and	CC
cord-005453-4057qib7	5429	31	IFN	IFN	NNP
cord-005453-4057qib7	5429	32	-	-	HYPH
cord-005453-4057qib7	5429	33	γ	γ	NNP
cord-005453-4057qib7	5429	34	and	and	CC
cord-005453-4057qib7	5429	35	thereby	thereby	RB
cord-005453-4057qib7	5429	36	promote	promote	VB
cord-005453-4057qib7	5429	37	GvHD	GvHD	NNP
cord-005453-4057qib7	5429	38	.	.	.
cord-005453-4057qib7	5430	1	Therefore	therefore	RB
cord-005453-4057qib7	5430	2	,	,	,
cord-005453-4057qib7	5430	3	we	-PRON-	PRP
cord-005453-4057qib7	5430	4	investigated	investigate	VBD
cord-005453-4057qib7	5430	5	here	here	RB
cord-005453-4057qib7	5430	6	the	the	DT
cord-005453-4057qib7	5430	7	role	role	NN
cord-005453-4057qib7	5430	8	of	of	IN
cord-005453-4057qib7	5430	9	NK	NK	NNP
cord-005453-4057qib7	5430	10	cells	cell	NNS
cord-005453-4057qib7	5430	11	in	in	IN
cord-005453-4057qib7	5430	12	GvHD	gvhd	NN
cord-005453-4057qib7	5430	13	patients	patient	NNS
cord-005453-4057qib7	5430	14	under	under	IN
cord-005453-4057qib7	5430	15	ECP	ECP	NNP
cord-005453-4057qib7	5430	16	therapy	therapy	NN
cord-005453-4057qib7	5430	17	.	.	.
cord-005453-4057qib7	5431	1	Methods	method	NNS
cord-005453-4057qib7	5431	2	:	:	:
cord-005453-4057qib7	5432	1	Thirty	thirty	CD
cord-005453-4057qib7	5432	2	four	four	CD
cord-005453-4057qib7	5432	3	patients	patient	NNS
cord-005453-4057qib7	5432	4	with	with	IN
cord-005453-4057qib7	5432	5	steroid	steroid	NN
cord-005453-4057qib7	5432	6	-	-	HYPH
cord-005453-4057qib7	5432	7	refractory/	refractory/	CD
cord-005453-4057qib7	5432	8	resistant	resistant	JJ
cord-005453-4057qib7	5432	9	aGvHD	agvhd	NN
cord-005453-4057qib7	5432	10	≥	≥	CD
cord-005453-4057qib7	5432	11	II	II	NNP
cord-005453-4057qib7	5432	12	°	°	NNS
cord-005453-4057qib7	5432	13	and	and	CC
cord-005453-4057qib7	5432	14	moderate	moderate	JJ
cord-005453-4057qib7	5432	15	to	to	IN
cord-005453-4057qib7	5432	16	severe	severe	JJ
cord-005453-4057qib7	5432	17	cGvHD	cgvhd	NN
cord-005453-4057qib7	5432	18	received	receive	VBD
cord-005453-4057qib7	5432	19	ECP	ECP	NNP
cord-005453-4057qib7	5432	20	therapy	therapy	NN
cord-005453-4057qib7	5432	21	which	which	WDT
cord-005453-4057qib7	5432	22	performed	perform	VBD
cord-005453-4057qib7	5432	23	according	accord	VBG
cord-005453-4057qib7	5432	24	to	to	IN
cord-005453-4057qib7	5432	25	the	the	DT
cord-005453-4057qib7	5432	26	guidelines	guideline	NNS
cord-005453-4057qib7	5432	27	.	.	.
cord-005453-4057qib7	5433	1	Glucksberg	Glucksberg	NNP
cord-005453-4057qib7	5433	2	and	and	CC
cord-005453-4057qib7	5433	3	NIH	NIH	NNP
cord-005453-4057qib7	5433	4	criteria	criterion	NNS
cord-005453-4057qib7	5433	5	were	be	VBD
cord-005453-4057qib7	5433	6	used	use	VBN
cord-005453-4057qib7	5433	7	for	for	IN
cord-005453-4057qib7	5433	8	clinical	clinical	JJ
cord-005453-4057qib7	5433	9	staging	staging	NN
cord-005453-4057qib7	5433	10	of	of	IN
cord-005453-4057qib7	5433	11	aGvHD	agvhd	NN
cord-005453-4057qib7	5433	12	and	and	CC
cord-005453-4057qib7	5433	13	cGvHD	cgvhd	NN
cord-005453-4057qib7	5433	14	under	under	IN
cord-005453-4057qib7	5433	15	ECP	ECP	NNP
cord-005453-4057qib7	5433	16	therapy	therapy	NN
cord-005453-4057qib7	5433	17	,	,	,
cord-005453-4057qib7	5433	18	respectively	respectively	RB
cord-005453-4057qib7	5433	19	.	.	.
cord-005453-4057qib7	5434	1	The	the	DT
cord-005453-4057qib7	5434	2	comprehensive	comprehensive	JJ
cord-005453-4057qib7	5434	3	phenotypical	phenotypical	JJ
cord-005453-4057qib7	5434	4	analysis	analysis	NN
cord-005453-4057qib7	5434	5	of	of	IN
cord-005453-4057qib7	5434	6	NK	NK	NNP
cord-005453-4057qib7	5434	7	cells	cell	NNS
cord-005453-4057qib7	5434	8	was	be	VBD
cord-005453-4057qib7	5434	9	evaluated	evaluate	VBN
cord-005453-4057qib7	5434	10	by	by	IN
cord-005453-4057qib7	5434	11	multicolor	multicolor	JJ
cord-005453-4057qib7	5434	12	flow	flow	NN
cord-005453-4057qib7	5434	13	cytometry	cytometry	NN
cord-005453-4057qib7	5434	14	.	.	.
cord-005453-4057qib7	5435	1	NK	NK	NNP
cord-005453-4057qib7	5435	2	activity	activity	NN
cord-005453-4057qib7	5435	3	in	in	IN
cord-005453-4057qib7	5435	4	terms	term	NNS
cord-005453-4057qib7	5435	5	of	of	IN
cord-005453-4057qib7	5435	6	killing	killing	NN
cord-005453-4057qib7	5435	7	function	function	NN
cord-005453-4057qib7	5435	8	,	,	,
cord-005453-4057qib7	5435	9	cytokine	cytokine	NN
cord-005453-4057qib7	5435	10	release	release	NN
cord-005453-4057qib7	5435	11	capacity	capacity	NN
cord-005453-4057qib7	5435	12	and	and	CC
cord-005453-4057qib7	5435	13	proliferation	proliferation	NN
cord-005453-4057qib7	5435	14	function	function	NN
cord-005453-4057qib7	5435	15	was	be	VBD
cord-005453-4057qib7	5435	16	monitored	monitor	VBN
cord-005453-4057qib7	5435	17	by	by	IN
cord-005453-4057qib7	5435	18	chromium-51	chromium-51	NNP
cord-005453-4057qib7	5435	19	release	release	NN
cord-005453-4057qib7	5435	20	assay	assay	NN
cord-005453-4057qib7	5435	21	,	,	,
cord-005453-4057qib7	5435	22	intracellular	intracellular	JJ
cord-005453-4057qib7	5435	23	cytokine	cytokine	NN
cord-005453-4057qib7	5435	24	staining	staining	NN
cord-005453-4057qib7	5435	25	and	and	CC
cord-005453-4057qib7	5435	26	CFSE	CFSE	NNP
cord-005453-4057qib7	5435	27	staining	staining	NN
cord-005453-4057qib7	5435	28	,	,	,
cord-005453-4057qib7	5435	29	respectively	respectively	RB
cord-005453-4057qib7	5435	30	.	.	.
cord-005453-4057qib7	5436	1	Results	result	NNS
cord-005453-4057qib7	5436	2	:	:	:
cord-005453-4057qib7	5437	1	Five	five	CD
cord-005453-4057qib7	5437	2	different	different	JJ
cord-005453-4057qib7	5437	3	NK	NK	NNP
cord-005453-4057qib7	5437	4	cell	cell	NN
cord-005453-4057qib7	5437	5	subsets	subset	NNS
cord-005453-4057qib7	5437	6	were	be	VBD
cord-005453-4057qib7	5437	7	defined	define	VBN
cord-005453-4057qib7	5437	8	based	base	VBN
cord-005453-4057qib7	5437	9	on	on	IN
cord-005453-4057qib7	5437	10	CD56	CD56	NNP
cord-005453-4057qib7	5437	11	and	and	CC
cord-005453-4057qib7	5437	12	CD16	CD16	NNP
cord-005453-4057qib7	5437	13	expression	expression	NN
cord-005453-4057qib7	5437	14	.	.	.
cord-005453-4057qib7	5438	1	CD56	cd56	NN
cord-005453-4057qib7	5438	2	bri	bri	NNP
cord-005453-4057qib7	5438	3	NK	NK	NNP
cord-005453-4057qib7	5438	4	cells	cell	NNS
cord-005453-4057qib7	5438	5	displayed	display	VBD
cord-005453-4057qib7	5438	6	an	an	DT
cord-005453-4057qib7	5438	7	immature	immature	JJ
cord-005453-4057qib7	5438	8	and	and	CC
cord-005453-4057qib7	5438	9	activation	activation	NN
cord-005453-4057qib7	5438	10	profile	profile	NN
cord-005453-4057qib7	5438	11	with	with	IN
cord-005453-4057qib7	5438	12	high	high	JJ
cord-005453-4057qib7	5438	13	expression	expression	NN
cord-005453-4057qib7	5438	14	of	of	IN
cord-005453-4057qib7	5438	15	CD62L	cd62l	NN
cord-005453-4057qib7	5438	16	and	and	CC
cord-005453-4057qib7	5438	17	NKG2D.	NKG2D.	NNP
cord-005453-4057qib7	5438	18	aGvHD	aGvHD	NNP
cord-005453-4057qib7	5438	19	patients	patient	NNS
cord-005453-4057qib7	5438	20	had	have	VBD
cord-005453-4057qib7	5438	21	a	a	DT
cord-005453-4057qib7	5438	22	higher	high	JJR
cord-005453-4057qib7	5438	23	frequency	frequency	NN
cord-005453-4057qib7	5438	24	of	of	IN
cord-005453-4057qib7	5438	25	CD56	CD56	NNP
cord-005453-4057qib7	5438	26	bri	bri	NNP
cord-005453-4057qib7	5438	27	NK	NK	NNP
cord-005453-4057qib7	5438	28	cells	cell	NNS
cord-005453-4057qib7	5438	29	when	when	WRB
cord-005453-4057qib7	5438	30	compared	compare	VBN
cord-005453-4057qib7	5438	31	with	with	IN
cord-005453-4057qib7	5438	32	HDs	hd	NNS
cord-005453-4057qib7	5438	33	and	and	CC
cord-005453-4057qib7	5438	34	cGvHD	cgvhd	NN
cord-005453-4057qib7	5438	35	patients	patient	NNS
cord-005453-4057qib7	5438	36	,	,	,
cord-005453-4057qib7	5438	37	who	who	WP
cord-005453-4057qib7	5438	38	were	be	VBD
cord-005453-4057qib7	5438	39	characterized	characterize	VBN
cord-005453-4057qib7	5438	40	by	by	IN
cord-005453-4057qib7	5438	41	significant	significant	JJ
cord-005453-4057qib7	5438	42	increase	increase	NN
cord-005453-4057qib7	5438	43	of	of	IN
cord-005453-4057qib7	5438	44	the	the	DT
cord-005453-4057qib7	5438	45	CD56	CD56	NNP
cord-005453-4057qib7	5438	46	dim	dim	NN
cord-005453-4057qib7	5438	47	CD16	CD16	NNP
cord-005453-4057qib7	5439	1	+	+	CC
cord-005453-4057qib7	5440	1	and	and	CC
cord-005453-4057qib7	5440	2	CD56	CD56	NNP
cord-005453-4057qib7	5440	3	-CD16	-CD16	VBD
cord-005453-4057qib7	5440	4	+	+	CC
cord-005453-4057qib7	5441	1	NK	NK	NNP
cord-005453-4057qib7	5441	2	cell	cell	NN
cord-005453-4057qib7	5441	3	subsets	subset	NNS
cord-005453-4057qib7	5441	4	with	with	IN
cord-005453-4057qib7	5441	5	high	high	JJ
cord-005453-4057qib7	5441	6	expression	expression	NN
cord-005453-4057qib7	5441	7	of	of	IN
cord-005453-4057qib7	5441	8	differentiation	differentiation	NN
cord-005453-4057qib7	5441	9	markers	marker	NNS
cord-005453-4057qib7	5441	10	CD11b	CD11b	NNS
cord-005453-4057qib7	5441	11	and	and	CC
cord-005453-4057qib7	5441	12	CD57	CD57	NNP
cord-005453-4057qib7	5441	13	.	.	.
cord-005453-4057qib7	5442	1	Of	of	IN
cord-005453-4057qib7	5442	2	note	note	NN
cord-005453-4057qib7	5442	3	,	,	,
cord-005453-4057qib7	5442	4	CD56	CD56	NNP
cord-005453-4057qib7	5442	5	bri	bri	NNP
cord-005453-4057qib7	5442	6	CD16	CD16	NNP
cord-005453-4057qib7	5442	7	-NK	-NK	HYPH
cord-005453-4057qib7	5442	8	cells	cell	NNS
cord-005453-4057qib7	5442	9	could	could	MD
cord-005453-4057qib7	5442	10	serve	serve	VB
cord-005453-4057qib7	5442	11	as	as	IN
cord-005453-4057qib7	5442	12	a	a	DT
cord-005453-4057qib7	5442	13	novel	novel	JJ
cord-005453-4057qib7	5442	14	predictive	predictive	JJ
cord-005453-4057qib7	5442	15	biomarker	biomarker	NN
cord-005453-4057qib7	5442	16	for	for	IN
cord-005453-4057qib7	5442	17	the	the	DT
cord-005453-4057qib7	5442	18	response	response	NN
cord-005453-4057qib7	5442	19	of	of	IN
cord-005453-4057qib7	5442	20	aGvHD	agvhd	NN
cord-005453-4057qib7	5442	21	patients	patient	NNS
cord-005453-4057qib7	5442	22	to	to	IN
cord-005453-4057qib7	5442	23	ECP	ECP	NNP
cord-005453-4057qib7	5442	24	treatment	treatment	NN
cord-005453-4057qib7	5442	25	.	.	.
cord-005453-4057qib7	5443	1	In	in	IN
cord-005453-4057qib7	5443	2	responding	respond	VBG
cord-005453-4057qib7	5443	3	aGvHD	agvhd	NN
cord-005453-4057qib7	5443	4	patients	patient	NNS
cord-005453-4057qib7	5443	5	,	,	,
cord-005453-4057qib7	5443	6	an	an	DT
cord-005453-4057qib7	5443	7	increase	increase	NN
cord-005453-4057qib7	5443	8	of	of	IN
cord-005453-4057qib7	5443	9	CD56	CD56	NNP
cord-005453-4057qib7	5443	10	bri	bri	NNP
cord-005453-4057qib7	5443	11	NK	NK	NNP
cord-005453-4057qib7	5443	12	cells	cell	NNS
cord-005453-4057qib7	5443	13	was	be	VBD
cord-005453-4057qib7	5443	14	observed	observe	VBN
cord-005453-4057qib7	5443	15	already	already	RB
cord-005453-4057qib7	5443	16	during	during	IN
cord-005453-4057qib7	5443	17	the	the	DT
cord-005453-4057qib7	5443	18	early	early	JJ
cord-005453-4057qib7	5443	19	ECP	ECP	NNP
cord-005453-4057qib7	5443	20	treatment	treatment	NN
cord-005453-4057qib7	5443	21	phase	phase	NN
cord-005453-4057qib7	5443	22	,	,	,
cord-005453-4057qib7	5443	23	suggesting	suggest	VBG
cord-005453-4057qib7	5443	24	immune	immune	JJ
cord-005453-4057qib7	5443	25	reconstitution	reconstitution	NN
cord-005453-4057qib7	5443	26	.	.	.
cord-005453-4057qib7	5444	1	After	after	IN
cord-005453-4057qib7	5444	2	priming	prime	VBG
cord-005453-4057qib7	5444	3	of	of	IN
cord-005453-4057qib7	5444	4	the	the	DT
cord-005453-4057qib7	5444	5	progenitors	progenitor	NNS
cord-005453-4057qib7	5444	6	,	,	,
cord-005453-4057qib7	5444	7	ECP	ECP	NNP
cord-005453-4057qib7	5444	8	could	could	MD
cord-005453-4057qib7	5444	9	differentiate	differentiate	VB
cord-005453-4057qib7	5444	10	immature	immature	JJ
cord-005453-4057qib7	5444	11	CD56	CD56	NNP
cord-005453-4057qib7	5444	12	bri	bri	NNP
cord-005453-4057qib7	5444	13	NK	NK	NNP
cord-005453-4057qib7	5444	14	cells	cell	NNS
cord-005453-4057qib7	5444	15	into	into	IN
cord-005453-4057qib7	5444	16	mature	mature	JJ
cord-005453-4057qib7	5444	17	CD56	CD56	NNP
cord-005453-4057qib7	5444	18	dim	dim	NN
cord-005453-4057qib7	5444	19	NK	NK	NNP
cord-005453-4057qib7	5444	20	cells	cell	NNS
cord-005453-4057qib7	5444	21	with	with	IN
cord-005453-4057qib7	5444	22	reduction	reduction	NN
cord-005453-4057qib7	5444	23	of	of	IN
cord-005453-4057qib7	5444	24	CD62L	cd62l	NN
cord-005453-4057qib7	5444	25	on	on	IN
cord-005453-4057qib7	5444	26	CD56	CD56	NNP
cord-005453-4057qib7	5444	27	bri	bri	NNP
cord-005453-4057qib7	5444	28	NK	NK	NNP
cord-005453-4057qib7	5444	29	cells	cell	NNS
cord-005453-4057qib7	5444	30	.	.	.
cord-005453-4057qib7	5445	1	Moreover	moreover	RB
cord-005453-4057qib7	5445	2	,	,	,
cord-005453-4057qib7	5445	3	CD56	CD56	NNP
cord-005453-4057qib7	5445	4	dim	dim	NN
cord-005453-4057qib7	5445	5	NK	NK	NNP
cord-005453-4057qib7	5445	6	cells	cell	NNS
cord-005453-4057qib7	5445	7	could	could	MD
cord-005453-4057qib7	5445	8	further	further	RB
cord-005453-4057qib7	5445	9	be	be	VB
cord-005453-4057qib7	5445	10	matured	mature	VBN
cord-005453-4057qib7	5445	11	through	through	IN
cord-005453-4057qib7	5445	12	upregulation	upregulation	NN
cord-005453-4057qib7	5445	13	of	of	IN
cord-005453-4057qib7	5445	14	CD57	cd57	JJ
cord-005453-4057qib7	5445	15	expression	expression	NN
cord-005453-4057qib7	5445	16	by	by	IN
cord-005453-4057qib7	5445	17	ECP	ECP	NNP
cord-005453-4057qib7	5445	18	.	.	.
cord-005453-4057qib7	5446	1	Notably	notably	RB
cord-005453-4057qib7	5446	2	,	,	,
cord-005453-4057qib7	5446	3	ECP	ECP	NNP
cord-005453-4057qib7	5446	4	therapy	therapy	NN
cord-005453-4057qib7	5446	5	could	could	MD
cord-005453-4057qib7	5446	6	shift	shift	VB
cord-005453-4057qib7	5446	7	the	the	DT
cord-005453-4057qib7	5446	8	NK	NK	NNP
cord-005453-4057qib7	5446	9	cells	cell	NNS
cord-005453-4057qib7	5446	10	from	from	IN
cord-005453-4057qib7	5446	11	a	a	DT
cord-005453-4057qib7	5446	12	cytotoxic	cytotoxic	NN
cord-005453-4057qib7	5446	13	to	to	IN
cord-005453-4057qib7	5446	14	a	a	DT
cord-005453-4057qib7	5446	15	regulatory	regulatory	JJ
cord-005453-4057qib7	5446	16	phenotype	phenotype	NN
cord-005453-4057qib7	5446	17	within	within	IN
cord-005453-4057qib7	5446	18	the	the	DT
cord-005453-4057qib7	5446	19	CD56	CD56	NNP
cord-005453-4057qib7	5446	20	bri	bri	NNP
cord-005453-4057qib7	5446	21	NK	NK	NNP
cord-005453-4057qib7	5446	22	cells	cell	NNS
cord-005453-4057qib7	5446	23	.	.	.
cord-005453-4057qib7	5447	1	In	in	IN
cord-005453-4057qib7	5447	2	spite	spite	NN
cord-005453-4057qib7	5447	3	the	the	DT
cord-005453-4057qib7	5447	4	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	5447	5	effect	effect	NN
cord-005453-4057qib7	5447	6	of	of	IN
cord-005453-4057qib7	5447	7	ECP	ECP	NNP
cord-005453-4057qib7	5447	8	on	on	IN
cord-005453-4057qib7	5447	9	NK	NK	NNP
cord-005453-4057qib7	5447	10	cells	cell	NNS
cord-005453-4057qib7	5447	11	,	,	,
cord-005453-4057qib7	5447	12	NK	NK	NNP
cord-005453-4057qib7	5447	13	activity	activity	NN
cord-005453-4057qib7	5447	14	could	could	MD
cord-005453-4057qib7	5447	15	be	be	VB
cord-005453-4057qib7	5447	16	kept	keep	VBN
cord-005453-4057qib7	5447	17	intact	intact	JJ
cord-005453-4057qib7	5447	18	under	under	IN
cord-005453-4057qib7	5447	19	ECP	ECP	NNP
cord-005453-4057qib7	5447	20	therapy	therapy	NN
cord-005453-4057qib7	5447	21	.	.	.
cord-005453-4057qib7	5448	1	The	the	DT
cord-005453-4057qib7	5448	2	killing	killing	NN
cord-005453-4057qib7	5448	3	activity	activity	NN
cord-005453-4057qib7	5448	4	of	of	IN
cord-005453-4057qib7	5448	5	NK	NK	NNP
cord-005453-4057qib7	5448	6	cells	cell	NNS
cord-005453-4057qib7	5448	7	was	be	VBD
cord-005453-4057qib7	5448	8	stable	stable	JJ
cord-005453-4057qib7	5448	9	as	as	IN
cord-005453-4057qib7	5448	10	confirmed	confirm	VBN
cord-005453-4057qib7	5448	11	by	by	IN
cord-005453-4057qib7	5448	12	a	a	DT
cord-005453-4057qib7	5448	13	51	51	CD
cord-005453-4057qib7	5448	14	Cr	cr	NN
cord-005453-4057qib7	5448	15	release	release	NN
cord-005453-4057qib7	5448	16	assay	assay	NN
cord-005453-4057qib7	5448	17	.	.	.
cord-005453-4057qib7	5449	1	ECP	ECP	NNP
cord-005453-4057qib7	5449	2	therapy	therapy	NN
cord-005453-4057qib7	5449	3	had	have	VBD
cord-005453-4057qib7	5449	4	no	no	DT
cord-005453-4057qib7	5449	5	negative	negative	JJ
cord-005453-4057qib7	5449	6	effect	effect	NN
cord-005453-4057qib7	5449	7	on	on	IN
cord-005453-4057qib7	5449	8	the	the	DT
cord-005453-4057qib7	5449	9	quantity	quantity	NN
cord-005453-4057qib7	5449	10	and	and	CC
cord-005453-4057qib7	5449	11	quality	quality	NN
cord-005453-4057qib7	5449	12	of	of	IN
cord-005453-4057qib7	5449	13	cytokine	cytokine	NN
cord-005453-4057qib7	5449	14	release	release	NN
cord-005453-4057qib7	5449	15	by	by	IN
cord-005453-4057qib7	5449	16	NK	NK	NNP
cord-005453-4057qib7	5449	17	cells	cell	NNS
cord-005453-4057qib7	5449	18	upon	upon	IN
cord-005453-4057qib7	5449	19	K562	k562	CD
cord-005453-4057qib7	5449	20	stimulation	stimulation	NN
cord-005453-4057qib7	5449	21	.	.	.
cord-005453-4057qib7	5450	1	Especially	especially	RB
cord-005453-4057qib7	5450	2	,	,	,
cord-005453-4057qib7	5450	3	the	the	DT
cord-005453-4057qib7	5450	4	polyfunctionality	polyfunctionality	NN
cord-005453-4057qib7	5450	5	of	of	IN
cord-005453-4057qib7	5450	6	NK	NK	NNP
cord-005453-4057qib7	5450	7	cells	cell	NNS
cord-005453-4057qib7	5450	8	was	be	VBD
cord-005453-4057qib7	5450	9	not	not	RB
cord-005453-4057qib7	5450	10	altered	alter	VBN
cord-005453-4057qib7	5450	11	significantly	significantly	RB
cord-005453-4057qib7	5450	12	by	by	IN
cord-005453-4057qib7	5450	13	the	the	DT
cord-005453-4057qib7	5450	14	ECP	ECP	NNP
cord-005453-4057qib7	5450	15	therapy	therapy	NN
cord-005453-4057qib7	5450	16	.	.	.
cord-005453-4057qib7	5451	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5451	2	:	:	:
cord-005453-4057qib7	5451	3	NK	NK	NNP
cord-005453-4057qib7	5451	4	cells	cell	NNS
cord-005453-4057qib7	5451	5	play	play	VBP
cord-005453-4057qib7	5451	6	an	an	DT
cord-005453-4057qib7	5451	7	important	important	JJ
cord-005453-4057qib7	5451	8	role	role	NN
cord-005453-4057qib7	5451	9	in	in	IN
cord-005453-4057qib7	5451	10	GvHD	GvHD	NNP
cord-005453-4057qib7	5451	11	and	and	CC
cord-005453-4057qib7	5451	12	could	could	MD
cord-005453-4057qib7	5451	13	serve	serve	VB
cord-005453-4057qib7	5451	14	as	as	IN
cord-005453-4057qib7	5451	15	a	a	DT
cord-005453-4057qib7	5451	16	predictive	predictive	JJ
cord-005453-4057qib7	5451	17	cell	cell	NN
cord-005453-4057qib7	5451	18	population	population	NN
cord-005453-4057qib7	5451	19	for	for	IN
cord-005453-4057qib7	5451	20	the	the	DT
cord-005453-4057qib7	5451	21	clinical	clinical	JJ
cord-005453-4057qib7	5451	22	response	response	NN
cord-005453-4057qib7	5451	23	to	to	IN
cord-005453-4057qib7	5451	24	ECP	ECP	NNP
cord-005453-4057qib7	5451	25	therapy	therapy	NN
cord-005453-4057qib7	5451	26	.	.	.
cord-005453-4057qib7	5452	1	In	in	IN
cord-005453-4057qib7	5452	2	the	the	DT
cord-005453-4057qib7	5452	3	current	current	JJ
cord-005453-4057qib7	5452	4	study	study	NN
cord-005453-4057qib7	5452	5	,	,	,
cord-005453-4057qib7	5452	6	ECP	ECP	NNP
cord-005453-4057qib7	5452	7	influenced	influence	VBD
cord-005453-4057qib7	5452	8	the	the	DT
cord-005453-4057qib7	5452	9	differentiation	differentiation	NN
cord-005453-4057qib7	5452	10	,	,	,
cord-005453-4057qib7	5452	11	maturation	maturation	NN
cord-005453-4057qib7	5452	12	and	and	CC
cord-005453-4057qib7	5452	13	education	education	NN
cord-005453-4057qib7	5452	14	of	of	IN
cord-005453-4057qib7	5452	15	NK	NK	NNP
cord-005453-4057qib7	5452	16	cells	cell	NNS
cord-005453-4057qib7	5452	17	ameliorating	ameliorate	VBG
cord-005453-4057qib7	5452	18	GvHD	GvHD	NNP
cord-005453-4057qib7	5452	19	without	without	IN
cord-005453-4057qib7	5452	20	comprising	comprise	VBG
cord-005453-4057qib7	5452	21	the	the	DT
cord-005453-4057qib7	5452	22	antiviral	antiviral	JJ
cord-005453-4057qib7	5452	23	immune	immune	JJ
cord-005453-4057qib7	5452	24	defense	defense	NN
cord-005453-4057qib7	5452	25	and	and	CC
cord-005453-4057qib7	5452	26	GvL	gvl	NN
cord-005453-4057qib7	5452	27	effect	effect	NN
cord-005453-4057qib7	5452	28	.	.	.
cord-005453-4057qib7	5453	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5453	2	:	:	:
cord-005453-4057qib7	5454	1	The	the	DT
cord-005453-4057qib7	5454	2	authors	author	NNS
cord-005453-4057qib7	5454	3	declare	declare	VBP
cord-005453-4057qib7	5454	4	no	no	DT
cord-005453-4057qib7	5454	5	competing	compete	VBG
cord-005453-4057qib7	5454	6	financial	financial	JJ
cord-005453-4057qib7	5454	7	interests	interest	NNS
cord-005453-4057qib7	5454	8	,	,	,
cord-005453-4057qib7	5454	9	except	except	IN
cord-005453-4057qib7	5454	10	the	the	DT
cord-005453-4057qib7	5454	11	following	following	NN
cord-005453-4057qib7	5454	12	:	:	:
cord-005453-4057qib7	5454	13	Therakos	Therakos	NNP
cord-005453-4057qib7	5454	14	Mallinckrodt	Mallinckrodt	NNP
cord-005453-4057qib7	5454	15	gave	give	VBD
cord-005453-4057qib7	5454	16	a	a	DT
cord-005453-4057qib7	5454	17	financial	financial	JJ
cord-005453-4057qib7	5454	18	support	support	NN
cord-005453-4057qib7	5454	19	to	to	IN
cord-005453-4057qib7	5454	20	AS	AS	NNP
cord-005453-4057qib7	5454	21	and	and	CC
cord-005453-4057qib7	5454	22	MS	MS	NNP
cord-005453-4057qib7	5454	23	for	for	IN
cord-005453-4057qib7	5454	24	the	the	DT
cord-005453-4057qib7	5454	25	documentation	documentation	NN
cord-005453-4057qib7	5454	26	of	of	IN
cord-005453-4057qib7	5454	27	the	the	DT
cord-005453-4057qib7	5454	28	clinical	clinical	JJ
cord-005453-4057qib7	5454	29	course	course	NN
cord-005453-4057qib7	5454	30	and	and	CC
cord-005453-4057qib7	5454	31	for	for	IN
cord-005453-4057qib7	5454	32	the	the	DT
cord-005453-4057qib7	5454	33	analysis	analysis	NN
cord-005453-4057qib7	5454	34	of	of	IN
cord-005453-4057qib7	5454	35	immune	immune	JJ
cord-005453-4057qib7	5454	36	cells	cell	NNS
cord-005453-4057qib7	5454	37	of	of	IN
cord-005453-4057qib7	5454	38	the	the	DT
cord-005453-4057qib7	5454	39	patients	patient	NNS
cord-005453-4057qib7	5454	40	,	,	,
cord-005453-4057qib7	5454	41	PW	PW	NNP
cord-005453-4057qib7	5454	42	has	have	VBZ
cord-005453-4057qib7	5454	43	Honoraria	Honoraria	NNP
cord-005453-4057qib7	5454	44	and	and	CC
cord-005453-4057qib7	5454	45	membership	membership	NN
cord-005453-4057qib7	5454	46	on	on	IN
cord-005453-4057qib7	5454	47	Advisory	Advisory	NNP
cord-005453-4057qib7	5454	48	Boards	Boards	NNP
cord-005453-4057qib7	5454	49	for	for	IN
cord-005453-4057qib7	5454	50	Sanofi	Sanofi	NNP
cord-005453-4057qib7	5454	51	-	-	HYPH
cord-005453-4057qib7	5454	52	Aventis	Aventis	NNP
cord-005453-4057qib7	5454	53	.	.	.
cord-005453-4057qib7	5455	1	Abstract	Abstract	NNP
cord-005453-4057qib7	5455	2	withdrawn	withdraw	VBN
cord-005453-4057qib7	5455	3	.	.	.
cord-005453-4057qib7	5456	1	Cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	5456	2	levels	level	NNS
cord-005453-4057qib7	5456	3	>	>	XX
cord-005453-4057qib7	5457	1	200µG	200µG	NNP
cord-005453-4057qib7	5457	2	/	/	SYM
cord-005453-4057qib7	5457	3	L	L	NNP
cord-005453-4057qib7	5457	4	on	on	IN
cord-005453-4057qib7	5457	5	day	day	NN
cord-005453-4057qib7	5457	6	10	10	CD
cord-005453-4057qib7	5457	7	post	post	JJ
cord-005453-4057qib7	5457	8	-	-	JJ
cord-005453-4057qib7	5457	9	transplant	transplant	NN
cord-005453-4057qib7	5457	10	was	be	VBD
cord-005453-4057qib7	5457	11	associated	associate	VBN
cord-005453-4057qib7	5457	12	with	with	IN
cord-005453-4057qib7	5457	13	significantly	significantly	RB
cord-005453-4057qib7	5457	14	reduced	reduce	VBN
cord-005453-4057qib7	5457	15	acute	acute	JJ
cord-005453-4057qib7	5457	16	graftversus	graftversus	NN
cord-005453-4057qib7	5457	17	-	-	HYPH
cord-005453-4057qib7	5457	18	host	host	NN
cord-005453-4057qib7	5457	19	disease	disease	NN
cord-005453-4057qib7	5457	20	following	follow	VBG
cord-005453-4057qib7	5457	21	allogeneic	allogeneic	IN
cord-005453-4057qib7	5457	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5457	23	stem	stem	NN
cord-005453-4057qib7	5457	24	cell	cell	NN
cord-005453-4057qib7	5457	25	transplantation	transplantation	NN
cord-005453-4057qib7	5457	26	Monica	Monica	NNP
cord-005453-4057qib7	5457	27	Bianchi	Bianchi	NNP
cord-005453-4057qib7	5457	28	1	1	CD
cord-005453-4057qib7	5458	1	,	,	,
cord-005453-4057qib7	5458	2	Dominik	Dominik	NNP
cord-005453-4057qib7	5458	3	Heim	Heim	NNP
cord-005453-4057qib7	5458	4	1	1	CD
cord-005453-4057qib7	5458	5	,	,	,
cord-005453-4057qib7	5458	6	Claudia	Claudia	NNP
cord-005453-4057qib7	5458	7	Lengerke	Lengerke	NNP
cord-005453-4057qib7	5458	8	1	1	CD
cord-005453-4057qib7	5458	9	,	,	,
cord-005453-4057qib7	5458	10	Martina	Martina	NNP
cord-005453-4057qib7	5458	11	Kleber	Kleber	NNP
cord-005453-4057qib7	5458	12	1	1	CD
cord-005453-4057qib7	5458	13	,	,	,
cord-005453-4057qib7	5458	14	Dimitrios	Dimitrios	NNP
cord-005453-4057qib7	5458	15	Tsakiris	Tsakiris	NNP
cord-005453-4057qib7	5458	16	1	1	CD
cord-005453-4057qib7	5458	17	,	,	,
cord-005453-4057qib7	5458	18	Jakob	Jakob	NNP
cord-005453-4057qib7	5458	19	Passweg	Passweg	NNP
cord-005453-4057qib7	5458	20	1	1	CD
cord-005453-4057qib7	5458	21	,	,	,
cord-005453-4057qib7	5458	22	Alexandar	Alexandar	NNP
cord-005453-4057qib7	5458	23	Tzankov	Tzankov	NNP
cord-005453-4057qib7	5458	24	2	2	CD
cord-005453-4057qib7	5458	25	,	,	,
cord-005453-4057qib7	5458	26	Michael	Michael	NNP
cord-005453-4057qib7	5458	27	Medinger	Medinger	NNP
cord-005453-4057qib7	5458	28	1	1	CD
cord-005453-4057qib7	5458	29	Background	Background	NNP
cord-005453-4057qib7	5458	30	:	:	:
cord-005453-4057qib7	5459	1	Acute	acute	JJ
cord-005453-4057qib7	5459	2	Graft	graft	NN
cord-005453-4057qib7	5459	3	-	-	HYPH
cord-005453-4057qib7	5459	4	versus	versus	IN
cord-005453-4057qib7	5459	5	-	-	HYPH
cord-005453-4057qib7	5459	6	host	host	NN
cord-005453-4057qib7	5459	7	disease	disease	NN
cord-005453-4057qib7	5459	8	(	(	-LRB-
cord-005453-4057qib7	5459	9	aGvHD	agvhd	NN
cord-005453-4057qib7	5459	10	)	)	-RRB-
cord-005453-4057qib7	5459	11	remains	remain	VBZ
cord-005453-4057qib7	5459	12	a	a	DT
cord-005453-4057qib7	5459	13	major	major	JJ
cord-005453-4057qib7	5459	14	complication	complication	NN
cord-005453-4057qib7	5459	15	of	of	IN
cord-005453-4057qib7	5459	16	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5459	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5459	18	stem	stem	NN
cord-005453-4057qib7	5459	19	cell	cell	NN
cord-005453-4057qib7	5459	20	transplantation	transplantation	NN
cord-005453-4057qib7	5459	21	(	(	-LRB-
cord-005453-4057qib7	5459	22	allo	allo	NN
cord-005453-4057qib7	5459	23	-	-	HYPH
cord-005453-4057qib7	5459	24	HSCT	HSCT	NNP
cord-005453-4057qib7	5459	25	)	)	-RRB-
cord-005453-4057qib7	5459	26	.	.	.
cord-005453-4057qib7	5460	1	Affected	affected	JJ
cord-005453-4057qib7	5460	2	patients	patient	NNS
cord-005453-4057qib7	5460	3	,	,	,
cord-005453-4057qib7	5460	4	especially	especially	RB
cord-005453-4057qib7	5460	5	with	with	IN
cord-005453-4057qib7	5460	6	steroid	steroid	JJ
cord-005453-4057qib7	5460	7	-	-	HYPH
cord-005453-4057qib7	5460	8	refractory	refractory	JJ
cord-005453-4057qib7	5460	9	aGvHD	agvhd	NN
cord-005453-4057qib7	5460	10	,	,	,
cord-005453-4057qib7	5460	11	have	have	VBP
cord-005453-4057qib7	5460	12	a	a	DT
cord-005453-4057qib7	5460	13	very	very	RB
cord-005453-4057qib7	5460	14	poor	poor	JJ
cord-005453-4057qib7	5460	15	prognosis	prognosis	NN
cord-005453-4057qib7	5460	16	.	.	.
cord-005453-4057qib7	5461	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5461	2	with	with	IN
cord-005453-4057qib7	5461	3	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	5461	4	A	a	NN
cord-005453-4057qib7	5461	5	(	(	-LRB-
cord-005453-4057qib7	5461	6	CsA	CsA	NNP
cord-005453-4057qib7	5461	7	)	)	-RRB-
cord-005453-4057qib7	5461	8	is	be	VBZ
cord-005453-4057qib7	5461	9	the	the	DT
cord-005453-4057qib7	5461	10	backbone	backbone	NN
cord-005453-4057qib7	5461	11	of	of	IN
cord-005453-4057qib7	5461	12	GvHD	GvHD	NNP
cord-005453-4057qib7	5461	13	prevention	prevention	NN
cord-005453-4057qib7	5461	14	in	in	IN
cord-005453-4057qib7	5461	15	most	most	JJS
cord-005453-4057qib7	5461	16	conditioning	conditioning	NN
cord-005453-4057qib7	5461	17	regimens	regimen	NNS
cord-005453-4057qib7	5461	18	.	.	.
cord-005453-4057qib7	5462	1	Methods	method	NNS
cord-005453-4057qib7	5462	2	:	:	:
cord-005453-4057qib7	5462	3	In	in	IN
cord-005453-4057qib7	5462	4	a	a	DT
cord-005453-4057qib7	5462	5	retrospective	retrospective	JJ
cord-005453-4057qib7	5462	6	analysis	analysis	NN
cord-005453-4057qib7	5462	7	of	of	IN
cord-005453-4057qib7	5462	8	patients	patient	NNS
cord-005453-4057qib7	5462	9	treated	treat	VBN
cord-005453-4057qib7	5462	10	with	with	IN
cord-005453-4057qib7	5462	11	allo	allo	NN
cord-005453-4057qib7	5462	12	-	-	HYPH
cord-005453-4057qib7	5462	13	HSCT	HSCT	NNP
cord-005453-4057qib7	5462	14	,	,	,
cord-005453-4057qib7	5462	15	we	-PRON-	PRP
cord-005453-4057qib7	5462	16	correlated	correlate	VBD
cord-005453-4057qib7	5462	17	CsA	csa	NN
cord-005453-4057qib7	5462	18	levels	level	NNS
cord-005453-4057qib7	5462	19	at	at	IN
cord-005453-4057qib7	5462	20	the	the	DT
cord-005453-4057qib7	5462	21	day	day	NN
cord-005453-4057qib7	5462	22	of	of	IN
cord-005453-4057qib7	5462	23	transplantation	transplantation	NN
cord-005453-4057qib7	5462	24	(	(	-LRB-
cord-005453-4057qib7	5462	25	day	day	NN
cord-005453-4057qib7	5462	26	0	0	CD
cord-005453-4057qib7	5462	27	)	)	-RRB-
cord-005453-4057qib7	5462	28	and	and	CC
cord-005453-4057qib7	5462	29	day	day	NN
cord-005453-4057qib7	5462	30	+10	+10	CD
cord-005453-4057qib7	5462	31	with	with	IN
cord-005453-4057qib7	5462	32	the	the	DT
cord-005453-4057qib7	5462	33	incidence	incidence	NN
cord-005453-4057qib7	5462	34	of	of	IN
cord-005453-4057qib7	5462	35	acute	acute	JJ
cord-005453-4057qib7	5462	36	and	and	CC
cord-005453-4057qib7	5462	37	chronic	chronic	JJ
cord-005453-4057qib7	5462	38	GvHD	GvHD	NNP
cord-005453-4057qib7	5462	39	.	.	.
cord-005453-4057qib7	5463	1	We	-PRON-	PRP
cord-005453-4057qib7	5463	2	postulate	postulate	VBP
cord-005453-4057qib7	5463	3	that	that	IN
cord-005453-4057qib7	5463	4	higher	high	JJR
cord-005453-4057qib7	5463	5	target	target	NN
cord-005453-4057qib7	5463	6	CsA	csa	NN
cord-005453-4057qib7	5463	7	levels	level	NNS
cord-005453-4057qib7	5463	8	>	>	NFP
cord-005453-4057qib7	5463	9	200μg	200μg	NNP
cord-005453-4057qib7	5463	10	/	/	SYM
cord-005453-4057qib7	5463	11	L	L	NNP
cord-005453-4057qib7	5463	12	will	will	MD
cord-005453-4057qib7	5463	13	result	result	VB
cord-005453-4057qib7	5463	14	in	in	IN
cord-005453-4057qib7	5463	15	a	a	DT
cord-005453-4057qib7	5463	16	lower	low	JJR
cord-005453-4057qib7	5463	17	incidence	incidence	NN
cord-005453-4057qib7	5463	18	rate	rate	NN
cord-005453-4057qib7	5463	19	especially	especially	RB
cord-005453-4057qib7	5463	20	of	of	IN
cord-005453-4057qib7	5463	21	aGvHD	agvhd	NN
cord-005453-4057qib7	5463	22	after	after	IN
cord-005453-4057qib7	5463	23	allo	allo	NN
cord-005453-4057qib7	5463	24	-	-	HYPH
cord-005453-4057qib7	5463	25	HSCT	HSCT	NNP
cord-005453-4057qib7	5463	26	.	.	.
cord-005453-4057qib7	5464	1	Results	result	NNS
cord-005453-4057qib7	5464	2	:	:	:
cord-005453-4057qib7	5465	1	We	-PRON-	PRP
cord-005453-4057qib7	5465	2	assessed	assess	VBD
cord-005453-4057qib7	5465	3	660	660	CD
cord-005453-4057qib7	5465	4	patients	patient	NNS
cord-005453-4057qib7	5465	5	with	with	IN
cord-005453-4057qib7	5465	6	either	either	CC
cord-005453-4057qib7	5465	7	AML	AML	NNP
cord-005453-4057qib7	5465	8	n=248	n=248	NNP
cord-005453-4057qib7	5465	9	,	,	,
cord-005453-4057qib7	5465	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	5465	11	/	/	SYM
cord-005453-4057qib7	5465	12	myeloma	myeloma	NN
cord-005453-4057qib7	5466	1	n=127	n=127	NNP
cord-005453-4057qib7	5466	2	,	,	,
cord-005453-4057qib7	5466	3	MDS	MDS	NNP
cord-005453-4057qib7	5466	4	/	/	SYM
cord-005453-4057qib7	5466	5	MPN	MPN	NNP
cord-005453-4057qib7	5466	6	n=124	n=124	NNP
cord-005453-4057qib7	5466	7	,	,	,
cord-005453-4057qib7	5467	1	ALL	all	DT
cord-005453-4057qib7	5467	2	n=79	n=79	RB
cord-005453-4057qib7	5467	3	,	,	,
cord-005453-4057qib7	5467	4	CLL	CLL	NNP
cord-005453-4057qib7	5467	5	n=36	n=36	NNS
cord-005453-4057qib7	5467	6	,	,	,
cord-005453-4057qib7	5467	7	CML	CML	NNP
cord-005453-4057qib7	5467	8	n=23	n=23	NNP
cord-005453-4057qib7	5467	9	,	,	,
cord-005453-4057qib7	5467	10	or	or	CC
cord-005453-4057qib7	5467	11	bone	bone	NN
cord-005453-4057qib7	5467	12	marrow	marrow	NN
cord-005453-4057qib7	5467	13	failure	failure	NN
cord-005453-4057qib7	5467	14	n=22	n=22	NNP
cord-005453-4057qib7	5467	15	.	.	.
cord-005453-4057qib7	5468	1	In	in	IN
cord-005453-4057qib7	5468	2	patients	patient	NNS
cord-005453-4057qib7	5468	3	with	with	IN
cord-005453-4057qib7	5468	4	clinically	clinically	RB
cord-005453-4057qib7	5468	5	relevant	relevant	JJ
cord-005453-4057qib7	5468	6	aGvHD	agvhd	NN
cord-005453-4057qib7	5468	7	grade	grade	NN
cord-005453-4057qib7	5468	8	≥2	≥2	NNP
cord-005453-4057qib7	5468	9	,	,	,
cord-005453-4057qib7	5468	10	mean	mean	VB
cord-005453-4057qib7	5468	11	CsA	csa	NN
cord-005453-4057qib7	5468	12	levels	level	NNS
cord-005453-4057qib7	5468	13	was	be	VBD
cord-005453-4057qib7	5468	14	lower	low	JJR
cord-005453-4057qib7	5468	15	on	on	IN
cord-005453-4057qib7	5468	16	day	day	NN
cord-005453-4057qib7	5468	17	0	0	CD
cord-005453-4057qib7	5468	18	and	and	CC
cord-005453-4057qib7	5468	19	day	day	NN
cord-005453-4057qib7	5468	20	+10	+10	CD
cord-005453-4057qib7	5468	21	(	(	-LRB-
cord-005453-4057qib7	5468	22	142±88	142±88	CD
cord-005453-4057qib7	5468	23	μg	μg	NNP
cord-005453-4057qib7	5468	24	/	/	SYM
cord-005453-4057qib7	5468	25	L	L	NNP
cord-005453-4057qib7	5468	26	;	;	:
cord-005453-4057qib7	5468	27	and	and	CC
cord-005453-4057qib7	5468	28	183±64	183±64	CD
cord-005453-4057qib7	5468	29	μg	μg	NNP
cord-005453-4057qib7	5468	30	/	/	SYM
cord-005453-4057qib7	5468	31	L	L	NNP
cord-005453-4057qib7	5468	32	;	;	:
cord-005453-4057qib7	5468	33	respectively	respectively	RB
cord-005453-4057qib7	5468	34	)	)	-RRB-
cord-005453-4057qib7	5468	35	compared	compare	VBN
cord-005453-4057qib7	5468	36	to	to	IN
cord-005453-4057qib7	5468	37	patients	patient	NNS
cord-005453-4057qib7	5468	38	without	without	IN
cord-005453-4057qib7	5468	39	aGvHD	agvhd	NN
cord-005453-4057qib7	5468	40	(	(	-LRB-
cord-005453-4057qib7	5468	41	156±81	156±81	CD
cord-005453-4057qib7	5468	42	μg	μg	NNP
cord-005453-4057qib7	5468	43	/	/	SYM
cord-005453-4057qib7	5468	44	L	L	NNP
cord-005453-4057qib7	5468	45	;	;	:
cord-005453-4057qib7	5468	46	and	and	CC
cord-005453-4057qib7	5468	47	207±67	207±67	CD
cord-005453-4057qib7	5468	48	μg	μg	NNP
cord-005453-4057qib7	5468	49	/	/	SYM
cord-005453-4057qib7	5468	50	L	L	NNP
cord-005453-4057qib7	5468	51	;	;	:
cord-005453-4057qib7	5468	52	respectively	respectively	RB
cord-005453-4057qib7	5468	53	;	;	:
cord-005453-4057qib7	5468	54	day	day	NN
cord-005453-4057qib7	5468	55	0	0	CD
cord-005453-4057qib7	5468	56	:	:	:
cord-005453-4057qib7	5468	57	p=0.003	p=0.003	NNP
cord-005453-4057qib7	5468	58	;	;	:
cord-005453-4057qib7	5468	59	day	day	NN
cord-005453-4057qib7	5468	60	+10	+10	CD
cord-005453-4057qib7	5468	61	:	:	:
cord-005453-4057qib7	5469	1	p=7.57	p=7.57	NN
cord-005453-4057qib7	5469	2	x	x	NN
cord-005453-4057qib7	5469	3	10	10	CD
cord-005453-4057qib7	5469	4	-9	-9	NNP
cord-005453-4057qib7	5469	5	)	)	-RRB-
cord-005453-4057qib7	5469	6	.	.	.
cord-005453-4057qib7	5470	1	In	in	IN
cord-005453-4057qib7	5470	2	patients	patient	NNS
cord-005453-4057qib7	5470	3	with	with	IN
cord-005453-4057qib7	5470	4	CsA	csa	NN
cord-005453-4057qib7	5470	5	level	level	NN
cord-005453-4057qib7	5470	6	<	<	XX
cord-005453-4057qib7	5471	1	200	200	CD
cord-005453-4057qib7	5471	2	μg	μg	NNP
cord-005453-4057qib7	5471	3	/	/	SYM
cord-005453-4057qib7	5471	4	L	L	NNP
cord-005453-4057qib7	5471	5	,	,	,
cord-005453-4057qib7	5471	6	the	the	DT
cord-005453-4057qib7	5471	7	incidence	incidence	NN
cord-005453-4057qib7	5471	8	of	of	IN
cord-005453-4057qib7	5471	9	aGvHD	agvhd	NN
cord-005453-4057qib7	5471	10	was	be	VBD
cord-005453-4057qib7	5471	11	significantly	significantly	RB
cord-005453-4057qib7	5471	12	more	more	RBR
cord-005453-4057qib7	5471	13	frequent	frequent	JJ
cord-005453-4057qib7	5471	14	compared	compare	VBN
cord-005453-4057qib7	5471	15	to	to	IN
cord-005453-4057qib7	5471	16	patients	patient	NNS
cord-005453-4057qib7	5471	17	with	with	IN
cord-005453-4057qib7	5471	18	CsA	csa	NN
cord-005453-4057qib7	5471	19	levels	level	NNS
cord-005453-4057qib7	5471	20	>	>	XX
cord-005453-4057qib7	5472	1	200	200	CD
cord-005453-4057qib7	5472	2	μg	μg	NNP
cord-005453-4057qib7	5472	3	/	/	SYM
cord-005453-4057qib7	5472	4	L	L	NNP
cord-005453-4057qib7	5472	5	[	[	-LRB-
cord-005453-4057qib7	5472	6	(	(	-LRB-
cord-005453-4057qib7	5472	7	234/356	234/356	CD
cord-005453-4057qib7	5472	8	;	;	:
cord-005453-4057qib7	5472	9	66	66	CD
cord-005453-4057qib7	5472	10	%	%	NN
cord-005453-4057qib7	5472	11	)	)	-RRB-
cord-005453-4057qib7	5473	1	versus	versus	IN
cord-005453-4057qib7	5473	2	91/248	91/248	CD
cord-005453-4057qib7	5473	3	(	(	-LRB-
cord-005453-4057qib7	5473	4	37	37	CD
cord-005453-4057qib7	5473	5	%	%	NN
cord-005453-4057qib7	5473	6	)	)	-RRB-
cord-005453-4057qib7	5473	7	;	;	:
cord-005453-4057qib7	5473	8	p=	p=	NN
cord-005453-4057qib7	5473	9	1.34	1.34	CD
cord-005453-4057qib7	5473	10	x	x	SYM
cord-005453-4057qib7	5473	11	10	10	CD
cord-005453-4057qib7	5473	12	-12	-12	CD
cord-005453-4057qib7	5473	13	]	]	-RRB-
cord-005453-4057qib7	5473	14	.	.	.
cord-005453-4057qib7	5474	1	In	in	IN
cord-005453-4057qib7	5474	2	patients	patient	NNS
cord-005453-4057qib7	5474	3	with	with	IN
cord-005453-4057qib7	5474	4	cGvHD	cGvHD	NNP
cord-005453-4057qib7	5474	5	,	,	,
cord-005453-4057qib7	5474	6	there	there	EX
cord-005453-4057qib7	5474	7	was	be	VBD
cord-005453-4057qib7	5474	8	no	no	DT
cord-005453-4057qib7	5474	9	significant	significant	JJ
cord-005453-4057qib7	5474	10	difference	difference	NN
cord-005453-4057qib7	5474	11	between	between	IN
cord-005453-4057qib7	5474	12	CsA	csa	NN
cord-005453-4057qib7	5474	13	levels	level	NNS
cord-005453-4057qib7	5474	14	<	<	XX
cord-005453-4057qib7	5475	1	200	200	CD
cord-005453-4057qib7	5475	2	μg	μg	NNP
cord-005453-4057qib7	5475	3	/	/	SYM
cord-005453-4057qib7	5475	4	L	L	NNP
cord-005453-4057qib7	5475	5	(	(	-LRB-
cord-005453-4057qib7	5475	6	128/330	128/330	NNP
cord-005453-4057qib7	5475	7	)	)	-RRB-
cord-005453-4057qib7	5475	8	compared	compare	VBN
cord-005453-4057qib7	5475	9	to	to	IN
cord-005453-4057qib7	5475	10	CsA	csa	NN
cord-005453-4057qib7	5475	11	levels	level	NNS
cord-005453-4057qib7	5475	12	>	>	XX
cord-005453-4057qib7	5475	13	200	200	CD
cord-005453-4057qib7	5475	14	μg	μg	NNP
cord-005453-4057qib7	5475	15	/	/	SYM
cord-005453-4057qib7	5475	16	L	L	NNP
cord-005453-4057qib7	5475	17	(	(	-LRB-
cord-005453-4057qib7	5475	18	96/	96/	NN
cord-005453-4057qib7	5475	19	233	233	CD
cord-005453-4057qib7	5475	20	;	;	:
cord-005453-4057qib7	5475	21	p=0.312	p=0.312	NNP
cord-005453-4057qib7	5475	22	)	)	-RRB-
cord-005453-4057qib7	5475	23	.	.	.
cord-005453-4057qib7	5476	1	The	the	DT
cord-005453-4057qib7	5476	2	optimal	optimal	JJ
cord-005453-4057qib7	5476	3	CsA	csa	NN
cord-005453-4057qib7	5476	4	cut	cut	VBN
cord-005453-4057qib7	5476	5	-	-	HYPH
cord-005453-4057qib7	5476	6	off	off	RP
cord-005453-4057qib7	5476	7	level	level	NN
cord-005453-4057qib7	5476	8	for	for	IN
cord-005453-4057qib7	5476	9	the	the	DT
cord-005453-4057qib7	5476	10	prevention	prevention	NN
cord-005453-4057qib7	5476	11	(	(	-LRB-
cord-005453-4057qib7	5476	12	i.e.	i.e.	FW
cord-005453-4057qib7	5476	13	roughly	roughly	RB
cord-005453-4057qib7	5476	14	50	50	CD
cord-005453-4057qib7	5476	15	%	%	NN
cord-005453-4057qib7	5476	16	incidence	incidence	NN
cord-005453-4057qib7	5476	17	reduction	reduction	NN
cord-005453-4057qib7	5476	18	)	)	-RRB-
cord-005453-4057qib7	5476	19	of	of	IN
cord-005453-4057qib7	5476	20	aGvHD	agvhd	NN
cord-005453-4057qib7	5476	21	was	be	VBD
cord-005453-4057qib7	5476	22	>	>	NFP
cord-005453-4057qib7	5476	23	201	201	CD
cord-005453-4057qib7	5476	24	μg	μg	NNP
cord-005453-4057qib7	5476	25	/	/	SYM
cord-005453-4057qib7	5476	26	L	l	NN
cord-005453-4057qib7	5476	27	at	at	IN
cord-005453-4057qib7	5476	28	day	day	NN
cord-005453-4057qib7	5476	29	0	0	NFP
cord-005453-4057qib7	5476	30	and	and	CC
cord-005453-4057qib7	5476	31	>	>	SYM
cord-005453-4057qib7	5476	32	195	195	CD
cord-005453-4057qib7	5476	33	μg	μg	NNP
cord-005453-4057qib7	5476	34	/	/	SYM
cord-005453-4057qib7	5476	35	L	l	NN
cord-005453-4057qib7	5476	36	at	at	IN
cord-005453-4057qib7	5476	37	day	day	NN
cord-005453-4057qib7	5476	38	+10	+10	CD
cord-005453-4057qib7	5477	1	(	(	-LRB-
cord-005453-4057qib7	5477	2	Figure	figure	NN
cord-005453-4057qib7	5477	3	1	1	CD
cord-005453-4057qib7	5477	4	)	)	-RRB-
cord-005453-4057qib7	5478	1	In	in	IN
cord-005453-4057qib7	5478	2	a	a	DT
cord-005453-4057qib7	5478	3	competing	compete	VBG
cord-005453-4057qib7	5478	4	risk	risk	NN
cord-005453-4057qib7	5478	5	analysis	analysis	NN
cord-005453-4057qib7	5478	6	,	,	,
cord-005453-4057qib7	5478	7	time	time	NN
cord-005453-4057qib7	5478	8	to	to	IN
cord-005453-4057qib7	5478	9	aGvHD	agvhd	NN
cord-005453-4057qib7	5478	10	grade	grade	NN
cord-005453-4057qib7	5478	11	≥2	≥2	NNP
cord-005453-4057qib7	5478	12	(	(	-LRB-
cord-005453-4057qib7	5478	13	using	use	VBG
cord-005453-4057qib7	5478	14	death	death	NN
cord-005453-4057qib7	5478	15	of	of	IN
cord-005453-4057qib7	5478	16	other	other	JJ
cord-005453-4057qib7	5478	17	causes	cause	NNS
cord-005453-4057qib7	5478	18	as	as	IN
cord-005453-4057qib7	5478	19	competing	compete	VBG
cord-005453-4057qib7	5478	20	risk	risk	NN
cord-005453-4057qib7	5478	21	)	)	-RRB-
cord-005453-4057qib7	5478	22	was	be	VBD
cord-005453-4057qib7	5478	23	associated	associate	VBN
cord-005453-4057qib7	5478	24	with	with	IN
cord-005453-4057qib7	5478	25	CsA	csa	NN
cord-005453-4057qib7	5478	26	levels	level	NNS
cord-005453-4057qib7	5478	27	>	>	XX
cord-005453-4057qib7	5479	1	200	200	CD
cord-005453-4057qib7	5479	2	μg	μg	NNP
cord-005453-4057qib7	5479	3	/	/	SYM
cord-005453-4057qib7	5479	4	L	L	NNP
cord-005453-4057qib7	5479	5	on	on	IN
cord-005453-4057qib7	5479	6	day	day	NN
cord-005453-4057qib7	5479	7	0	0	CD
cord-005453-4057qib7	5479	8	and	and	CC
cord-005453-4057qib7	5479	9	on	on	IN
cord-005453-4057qib7	5479	10	day	day	NN
cord-005453-4057qib7	5479	11	10	10	CD
cord-005453-4057qib7	5479	12	,	,	,
cord-005453-4057qib7	5479	13	unrelated	unrelated	JJ
cord-005453-4057qib7	5479	14	donors	donor	NNS
cord-005453-4057qib7	5479	15	,	,	,
cord-005453-4057qib7	5479	16	myeloablative	myeloablative	NNP
cord-005453-4057qib7	5479	17	conditioning	conditioning	NN
cord-005453-4057qib7	5479	18	(	(	-LRB-
cord-005453-4057qib7	5479	19	MAC	MAC	NNP
cord-005453-4057qib7	5479	20	)	)	-RRB-
cord-005453-4057qib7	5479	21	,	,	,
cord-005453-4057qib7	5479	22	and	and	CC
cord-005453-4057qib7	5479	23	for	for	IN
cord-005453-4057qib7	5479	24	the	the	DT
cord-005453-4057qib7	5479	25	diagnosis	diagnosis	NN
cord-005453-4057qib7	5479	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	5479	27	/	/	SYM
cord-005453-4057qib7	5479	28	myeloma	myeloma	NN
cord-005453-4057qib7	5479	29	.	.	.
cord-005453-4057qib7	5480	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5480	2	:	:	:
cord-005453-4057qib7	5481	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5481	2	data	data	NN
cord-005453-4057qib7	5481	3	support	support	VBP
cord-005453-4057qib7	5481	4	close	close	JJ
cord-005453-4057qib7	5481	5	monitoring	monitoring	NN
cord-005453-4057qib7	5481	6	with	with	IN
cord-005453-4057qib7	5481	7	active	active	JJ
cord-005453-4057qib7	5481	8	adjustments	adjustment	NNS
cord-005453-4057qib7	5481	9	of	of	IN
cord-005453-4057qib7	5481	10	CsA	csa	NN
cord-005453-4057qib7	5481	11	dosing	dosing	NN
cord-005453-4057qib7	5481	12	to	to	TO
cord-005453-4057qib7	5481	13	maintain	maintain	VB
cord-005453-4057qib7	5481	14	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5481	15	CsA	csa	NN
cord-005453-4057qib7	5481	16	levels	level	NNS
cord-005453-4057qib7	5481	17	above	above	IN
cord-005453-4057qib7	5481	18	195	195	CD
cord-005453-4057qib7	5481	19	μg	μg	NNP
cord-005453-4057qib7	5481	20	/	/	SYM
cord-005453-4057qib7	5481	21	L	L	NNP
cord-005453-4057qib7	5481	22	in	in	IN
cord-005453-4057qib7	5481	23	the	the	DT
cord-005453-4057qib7	5481	24	first	first	JJ
cord-005453-4057qib7	5481	25	10	10	CD
cord-005453-4057qib7	5481	26	days	day	NNS
cord-005453-4057qib7	5481	27	of	of	IN
cord-005453-4057qib7	5481	28	allo	allo	NN
cord-005453-4057qib7	5481	29	-	-	HYPH
cord-005453-4057qib7	5481	30	HCST	HCST	NNP
cord-005453-4057qib7	5481	31	to	to	TO
cord-005453-4057qib7	5481	32	reduce	reduce	VB
cord-005453-4057qib7	5481	33	aGvHD	agvhd	NN
cord-005453-4057qib7	5481	34	.	.	.
cord-005453-4057qib7	5482	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5482	2	:	:	:
cord-005453-4057qib7	5483	1	Noting	note	VBG
cord-005453-4057qib7	5483	2	to	to	TO
cord-005453-4057qib7	5483	3	declare	declare	VB
cord-005453-4057qib7	5483	4	.	.	.
cord-005453-4057qib7	5484	1	Liposomal	Liposomal	NNP
cord-005453-4057qib7	5484	2	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	5485	1	a	a	LS
cord-005453-4057qib7	5485	2	for	for	IN
cord-005453-4057qib7	5485	3	inhalation	inhalation	NN
cord-005453-4057qib7	5485	4	(	(	-LRB-
cord-005453-4057qib7	5485	5	L	L	NNP
cord-005453-4057qib7	5485	6	-	-	HYPH
cord-005453-4057qib7	5485	7	CSA	CSA	NNP
cord-005453-4057qib7	5485	8	-	-	HYPH
cord-005453-4057qib7	5485	9	I	I	NNP
cord-005453-4057qib7	5485	10	)	)	-RRB-
cord-005453-4057qib7	5486	1	to	to	TO
cord-005453-4057qib7	5486	2	treat	treat	VB
cord-005453-4057qib7	5486	3	bronchiolitis	bronchiolitis	NNP
cord-005453-4057qib7	5486	4	obliterans	obliterans	NNP
cord-005453-4057qib7	5486	5	syndrome	syndrome	NN
cord-005453-4057qib7	5486	6	:	:	:
cord-005453-4057qib7	5486	7	Novel	novel	JJ
cord-005453-4057qib7	5486	8	formulation	formulation	NN
cord-005453-4057qib7	5486	9	with	with	IN
cord-005453-4057qib7	5486	10	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5486	11	potential	potential	NN
cord-005453-4057qib7	5486	12	for	for	IN
cord-005453-4057qib7	5486	13	patients	patient	NNS
cord-005453-4057qib7	5486	14	with	with	IN
cord-005453-4057qib7	5486	15	BOS	BOS	NNP
cord-005453-4057qib7	5486	16	following	follow	VBG
cord-005453-4057qib7	5486	17	allo	allo	NN
cord-005453-4057qib7	5486	18	-	-	HYPH
cord-005453-4057qib7	5486	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5486	20	Noreen	Noreen	NNP
cord-005453-4057qib7	5486	21	Roth	Roth	NNP
cord-005453-4057qib7	5486	22	Henig	Henig	NNP
cord-005453-4057qib7	5486	23	1	1	CD
cord-005453-4057qib7	5486	24	,	,	,
cord-005453-4057qib7	5486	25	Emilie	Emilie	NNP
cord-005453-4057qib7	5486	26	Hofstetter	Hofstetter	NNP
cord-005453-4057qib7	5486	27	2	2	CD
cord-005453-4057qib7	5486	28	,	,	,
cord-005453-4057qib7	5486	29	Dominik	Dominik	NNP
cord-005453-4057qib7	5486	30	Kappeler	Kappeler	NNP
cord-005453-4057qib7	5486	31	3	3	CD
cord-005453-4057qib7	5486	32	,	,	,
cord-005453-4057qib7	5486	33	Gerhard	Gerhard	NNP
cord-005453-4057qib7	5486	34	Boerner	Boerner	NNP
cord-005453-4057qib7	5486	35	3	3	CD
cord-005453-4057qib7	5486	36	Background	Background	NNP
cord-005453-4057qib7	5486	37	:	:	:
cord-005453-4057qib7	5487	1	Bronchiolitis	Bronchiolitis	NNP
cord-005453-4057qib7	5487	2	obliterans	obliterans	NNP
cord-005453-4057qib7	5487	3	syndrome	syndrome	NN
cord-005453-4057qib7	5487	4	(	(	-LRB-
cord-005453-4057qib7	5487	5	BOS	BOS	NNP
cord-005453-4057qib7	5487	6	)	)	-RRB-
cord-005453-4057qib7	5487	7	is	be	VBZ
cord-005453-4057qib7	5487	8	a	a	DT
cord-005453-4057qib7	5487	9	rapidly	rapidly	RB
cord-005453-4057qib7	5487	10	progressive	progressive	JJ
cord-005453-4057qib7	5487	11	lung	lung	NN
cord-005453-4057qib7	5487	12	disease	disease	NN
cord-005453-4057qib7	5487	13	caused	cause	VBN
cord-005453-4057qib7	5487	14	by	by	IN
cord-005453-4057qib7	5487	15	T	t	NN
cord-005453-4057qib7	5487	16	-	-	HYPH
cord-005453-4057qib7	5487	17	cell	cell	NN
cord-005453-4057qib7	5487	18	mediated	mediate	VBN
cord-005453-4057qib7	5487	19	inflammation	inflammation	NN
cord-005453-4057qib7	5487	20	that	that	WDT
cord-005453-4057qib7	5487	21	leads	lead	VBZ
cord-005453-4057qib7	5487	22	to	to	IN
cord-005453-4057qib7	5487	23	blockage	blockage	NN
cord-005453-4057qib7	5487	24	of	of	IN
cord-005453-4057qib7	5487	25	bronchioles	bronchiole	NNS
cord-005453-4057qib7	5487	26	,	,	,
cord-005453-4057qib7	5487	27	leading	lead	VBG
cord-005453-4057qib7	5487	28	to	to	IN
cord-005453-4057qib7	5487	29	respiratory	respiratory	JJ
cord-005453-4057qib7	5487	30	failure	failure	NN
cord-005453-4057qib7	5487	31	and	and	CC
cord-005453-4057qib7	5487	32	death	death	NN
cord-005453-4057qib7	5487	33	shortly	shortly	RB
cord-005453-4057qib7	5487	34	after	after	IN
cord-005453-4057qib7	5487	35	diagnosis	diagnosis	NN
cord-005453-4057qib7	5487	36	.	.	.
cord-005453-4057qib7	5488	1	Approximately	approximately	RB
cord-005453-4057qib7	5488	2	4	4	CD
cord-005453-4057qib7	5488	3	%	%	NN
cord-005453-4057qib7	5488	4	to	to	TO
cord-005453-4057qib7	5488	5	10	10	CD
cord-005453-4057qib7	5488	6	%	%	NN
cord-005453-4057qib7	5488	7	of	of	IN
cord-005453-4057qib7	5488	8	patients	patient	NNS
cord-005453-4057qib7	5488	9	who	who	WP
cord-005453-4057qib7	5488	10	undergo	undergo	VBP
cord-005453-4057qib7	5488	11	allogeneic	allogeneic	IN
cord-005453-4057qib7	5488	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5488	13	stem	stem	NN
cord-005453-4057qib7	5488	14	cell	cell	NN
cord-005453-4057qib7	5488	15	transplant	transplant	NN
cord-005453-4057qib7	5488	16	(	(	-LRB-
cord-005453-4057qib7	5488	17	allo	allo	NN
cord-005453-4057qib7	5488	18	-	-	HYPH
cord-005453-4057qib7	5488	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5488	20	)	)	-RRB-
cord-005453-4057qib7	5488	21	will	will	MD
cord-005453-4057qib7	5488	22	develop	develop	VB
cord-005453-4057qib7	5488	23	BOS	BOS	NNP
cord-005453-4057qib7	5488	24	,	,	,
cord-005453-4057qib7	5488	25	with	with	IN
cord-005453-4057qib7	5488	26	72	72	CD
cord-005453-4057qib7	5488	27	-	-	SYM
cord-005453-4057qib7	5488	28	100	100	CD
cord-005453-4057qib7	5488	29	%	%	NN
cord-005453-4057qib7	5488	30	developing	develop	VBG
cord-005453-4057qib7	5488	31	BOS	BOS	NNP
cord-005453-4057qib7	5488	32	as	as	IN
cord-005453-4057qib7	5488	33	a	a	DT
cord-005453-4057qib7	5488	34	respiratory	respiratory	JJ
cord-005453-4057qib7	5488	35	form	form	NN
cord-005453-4057qib7	5488	36	chronic	chronic	JJ
cord-005453-4057qib7	5488	37	graft	graft	NN
cord-005453-4057qib7	5488	38	-	-	HYPH
cord-005453-4057qib7	5488	39	vs	vs	IN
cord-005453-4057qib7	5488	40	-	-	HYPH
cord-005453-4057qib7	5488	41	host	host	NN
cord-005453-4057qib7	5488	42	disease	disease	NN
cord-005453-4057qib7	5488	43	(	(	-LRB-
cord-005453-4057qib7	5488	44	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5488	45	)	)	-RRB-
cord-005453-4057qib7	5488	46	in	in	IN
cord-005453-4057qib7	5488	47	addition	addition	NN
cord-005453-4057qib7	5488	48	to	to	IN
cord-005453-4057qib7	5488	49	other	other	JJ
cord-005453-4057qib7	5488	50	signs	sign	NNS
cord-005453-4057qib7	5488	51	of	of	IN
cord-005453-4057qib7	5488	52	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5488	53	.	.	.
cord-005453-4057qib7	5489	1	Mean	mean	JJ
cord-005453-4057qib7	5489	2	time	time	NN
cord-005453-4057qib7	5489	3	to	to	IN
cord-005453-4057qib7	5489	4	BOS	BOS	NNP
cord-005453-4057qib7	5489	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	5489	6	ranges	range	VBZ
cord-005453-4057qib7	5489	7	from	from	IN
cord-005453-4057qib7	5489	8	273	273	CD
cord-005453-4057qib7	5489	9	to	to	TO
cord-005453-4057qib7	5489	10	547	547	CD
cord-005453-4057qib7	5489	11	days	day	NNS
cord-005453-4057qib7	5489	12	post	post	NN
cord-005453-4057qib7	5489	13	-	-	NN
cord-005453-4057qib7	5489	14	transplant	transplant	NN
cord-005453-4057qib7	5489	15	.	.	.
cord-005453-4057qib7	5490	1	The	the	DT
cord-005453-4057qib7	5490	2	histopathology	histopathology	NN
cord-005453-4057qib7	5490	3	of	of	IN
cord-005453-4057qib7	5490	4	BOS	BOS	NNP
cord-005453-4057qib7	5490	5	after	after	IN
cord-005453-4057qib7	5490	6	allo	allo	NN
cord-005453-4057qib7	5490	7	-	-	HYPH
cord-005453-4057qib7	5490	8	HSCT	HSCT	NNP
cord-005453-4057qib7	5490	9	and	and	CC
cord-005453-4057qib7	5490	10	lung	lung	NN
cord-005453-4057qib7	5490	11	transplantation	transplantation	NN
cord-005453-4057qib7	5490	12	is	be	VBZ
cord-005453-4057qib7	5490	13	identical	identical	JJ
cord-005453-4057qib7	5490	14	.	.	.
cord-005453-4057qib7	5491	1	Early	early	JJ
cord-005453-4057qib7	5491	2	studies	study	NNS
cord-005453-4057qib7	5491	3	of	of	IN
cord-005453-4057qib7	5491	4	L	L	NNP
cord-005453-4057qib7	5491	5	-	-	HYPH
cord-005453-4057qib7	5491	6	CsA	CsA	NNP
cord-005453-4057qib7	5491	7	-	-	:
cord-005453-4057qib7	5491	8	i	i	NNP
cord-005453-4057qib7	5491	9	for	for	IN
cord-005453-4057qib7	5491	10	the	the	DT
cord-005453-4057qib7	5491	11	prevention	prevention	NN
cord-005453-4057qib7	5491	12	of	of	IN
cord-005453-4057qib7	5491	13	BOS	BOS	NNP
cord-005453-4057qib7	5491	14	in	in	IN
cord-005453-4057qib7	5491	15	lung	lung	NN
cord-005453-4057qib7	5491	16	transplant	transplant	NN
cord-005453-4057qib7	5491	17	recipients	recipient	NNS
cord-005453-4057qib7	5491	18	demonstrated	demonstrate	VBD
cord-005453-4057qib7	5491	19	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5491	20	benefit	benefit	NN
cord-005453-4057qib7	5491	21	.	.	.
cord-005453-4057qib7	5492	1	L	l	NN
cord-005453-4057qib7	5492	2	-	-	HYPH
cord-005453-4057qib7	5492	3	CsA	CsA	NNP
cord-005453-4057qib7	5493	1	-i	-i	NNP
cord-005453-4057qib7	5493	2	is	be	VBZ
cord-005453-4057qib7	5493	3	a	a	DT
cord-005453-4057qib7	5493	4	novel	novel	NN
cord-005453-4057qib7	5493	5	,	,	,
cord-005453-4057qib7	5493	6	liposomal	liposomal	IN
cord-005453-4057qib7	5493	7	formulation	formulation	NN
cord-005453-4057qib7	5493	8	of	of	IN
cord-005453-4057qib7	5493	9	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	5493	10	administered	administer	VBN
cord-005453-4057qib7	5493	11	via	via	IN
cord-005453-4057qib7	5493	12	a	a	DT
cord-005453-4057qib7	5493	13	PARI	PARI	NNP
cord-005453-4057qib7	5493	14	investigational	investigational	JJ
cord-005453-4057qib7	5493	15	eFlow	eflow	NN
cord-005453-4057qib7	5493	16	â	â	CD
cord-005453-4057qib7	5493	17	nebulizer	nebulizer	NN
cord-005453-4057qib7	5493	18	which	which	WDT
cord-005453-4057qib7	5493	19	delivers	deliver	VBZ
cord-005453-4057qib7	5493	20	a	a	DT
cord-005453-4057qib7	5493	21	potent	potent	JJ
cord-005453-4057qib7	5493	22	immunosuppressant	immunosuppressant	RB
cord-005453-4057qib7	5493	23	to	to	IN
cord-005453-4057qib7	5493	24	the	the	DT
cord-005453-4057qib7	5493	25	site	site	NN
cord-005453-4057qib7	5493	26	of	of	IN
cord-005453-4057qib7	5493	27	disease	disease	NN
cord-005453-4057qib7	5493	28	.	.	.
cord-005453-4057qib7	5494	1	Pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	5494	2	and	and	CC
cord-005453-4057qib7	5494	3	tolerability	tolerability	NN
cord-005453-4057qib7	5494	4	of	of	IN
cord-005453-4057qib7	5494	5	L	l	NN
cord-005453-4057qib7	5494	6	-	-	HYPH
cord-005453-4057qib7	5494	7	CsA	CsA	NNP
cord-005453-4057qib7	5494	8	-	-	:
cord-005453-4057qib7	5494	9	i	i	PRP
cord-005453-4057qib7	5494	10	is	be	VBZ
cord-005453-4057qib7	5494	11	presented	present	VBN
cord-005453-4057qib7	5494	12	.	.	.
cord-005453-4057qib7	5495	1	Methods	method	NNS
cord-005453-4057qib7	5495	2	:	:	:
cord-005453-4057qib7	5496	1	Retrospective	retrospective	JJ
cord-005453-4057qib7	5496	2	review	review	NN
cord-005453-4057qib7	5496	3	of	of	IN
cord-005453-4057qib7	5496	4	two	two	CD
cord-005453-4057qib7	5496	5	clinical	clinical	JJ
cord-005453-4057qib7	5496	6	studies	study	NNS
cord-005453-4057qib7	5496	7	of	of	IN
cord-005453-4057qib7	5496	8	L	L	NNP
cord-005453-4057qib7	5496	9	-	-	HYPH
cord-005453-4057qib7	5496	10	CsA	CsA	NNP
cord-005453-4057qib7	5496	11	-	-	:
cord-005453-4057qib7	5496	12	i	i	NNP
cord-005453-4057qib7	5496	13	(	(	-LRB-
cord-005453-4057qib7	5496	14	isotonic	isotonic	JJ
cord-005453-4057qib7	5496	15	,	,	,
cord-005453-4057qib7	5496	16	4mg	4mg	JJ
cord-005453-4057qib7	5496	17	/	/	SYM
cord-005453-4057qib7	5496	18	mL	ml	NN
cord-005453-4057qib7	5496	19	)	)	-RRB-
cord-005453-4057qib7	5496	20	for	for	IN
cord-005453-4057qib7	5496	21	BOS	BOS	NNP
cord-005453-4057qib7	5496	22	associated	associate	VBN
cord-005453-4057qib7	5496	23	with	with	IN
cord-005453-4057qib7	5496	24	lung	lung	NN
cord-005453-4057qib7	5496	25	transplantation	transplantation	NN
cord-005453-4057qib7	5496	26	.	.	.
cord-005453-4057qib7	5497	1	Both	both	DT
cord-005453-4057qib7	5497	2	studies	study	NNS
cord-005453-4057qib7	5497	3	had	have	VBD
cord-005453-4057qib7	5497	4	a	a	DT
cord-005453-4057qib7	5497	5	control	control	NN
cord-005453-4057qib7	5497	6	arm	arm	NN
cord-005453-4057qib7	5497	7	and	and	CC
cord-005453-4057qib7	5497	8	results	result	NNS
cord-005453-4057qib7	5497	9	reported	report	VBN
cord-005453-4057qib7	5497	10	here	here	RB
cord-005453-4057qib7	5497	11	are	be	VBP
cord-005453-4057qib7	5497	12	for	for	IN
cord-005453-4057qib7	5497	13	patients	patient	NNS
cord-005453-4057qib7	5497	14	who	who	WP
cord-005453-4057qib7	5497	15	received	receive	VBD
cord-005453-4057qib7	5497	16	L	l	NN
cord-005453-4057qib7	5497	17	-	-	HYPH
cord-005453-4057qib7	5497	18	CsA	CsA	NNP
cord-005453-4057qib7	5497	19	-	-	:
cord-005453-4057qib7	5497	20	i	i	PRP
cord-005453-4057qib7	5497	21	.	.	.
cord-005453-4057qib7	5498	1	Subjects	subject	NNS
cord-005453-4057qib7	5498	2	received	receive	VBD
cord-005453-4057qib7	5498	3	5	5	CD
cord-005453-4057qib7	5498	4	mg	mg	NN
cord-005453-4057qib7	5498	5	(	(	-LRB-
cord-005453-4057qib7	5498	6	single	single	JJ
cord-005453-4057qib7	5498	7	lung	lung	NN
cord-005453-4057qib7	5498	8	transplant	transplant	NN
cord-005453-4057qib7	5498	9	)	)	-RRB-
cord-005453-4057qib7	5498	10	and	and	CC
cord-005453-4057qib7	5498	11	10	10	CD
cord-005453-4057qib7	5498	12	mg	mg	NNS
cord-005453-4057qib7	5498	13	(	(	-LRB-
cord-005453-4057qib7	5498	14	double	double	JJ
cord-005453-4057qib7	5498	15	lung	lung	NN
cord-005453-4057qib7	5498	16	transplant	transplant	NN
cord-005453-4057qib7	5498	17	)	)	-RRB-
cord-005453-4057qib7	5498	18	bid	bid	VBD
cord-005453-4057qib7	5498	19	via	via	IN
cord-005453-4057qib7	5498	20	inhalation	inhalation	NN
cord-005453-4057qib7	5498	21	.	.	.
cord-005453-4057qib7	5499	1	Blood	blood	NN
cord-005453-4057qib7	5499	2	samples	sample	NNS
cord-005453-4057qib7	5499	3	for	for	IN
cord-005453-4057qib7	5499	4	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	5499	5	analysis	analysis	NN
cord-005453-4057qib7	5499	6	of	of	IN
cord-005453-4057qib7	5499	7	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	5499	8	A	a	DT
cord-005453-4057qib7	5499	9	concentrations	concentration	NNS
cord-005453-4057qib7	5499	10	were	be	VBD
cord-005453-4057qib7	5499	11	collected	collect	VBN
cord-005453-4057qib7	5499	12	before	before	IN
cord-005453-4057qib7	5499	13	inhalation	inhalation	NN
cord-005453-4057qib7	5499	14	,	,	,
cord-005453-4057qib7	5499	15	immediately	immediately	RB
cord-005453-4057qib7	5499	16	after	after	IN
cord-005453-4057qib7	5499	17	inhalation	inhalation	NN
cord-005453-4057qib7	5499	18	,	,	,
cord-005453-4057qib7	5499	19	and	and	CC
cord-005453-4057qib7	5499	20	thereafter	thereafter	RB
cord-005453-4057qib7	5499	21	in	in	IN
cord-005453-4057qib7	5499	22	intervals	interval	NNS
cord-005453-4057qib7	5499	23	of	of	IN
cord-005453-4057qib7	5499	24	15	15	CD
cord-005453-4057qib7	5499	25	,	,	,
cord-005453-4057qib7	5499	26	30	30	CD
cord-005453-4057qib7	5499	27	,	,	,
cord-005453-4057qib7	5499	28	60	60	CD
cord-005453-4057qib7	5499	29	min	min	NN
cord-005453-4057qib7	5499	30	and	and	CC
cord-005453-4057qib7	5499	31	2	2	CD
cord-005453-4057qib7	5499	32	,	,	,
cord-005453-4057qib7	5499	33	4	4	CD
cord-005453-4057qib7	5499	34	,	,	,
cord-005453-4057qib7	5499	35	8	8	CD
cord-005453-4057qib7	5499	36	and	and	CC
cord-005453-4057qib7	5499	37	12	12	CD
cord-005453-4057qib7	5499	38	hours	hour	NNS
cord-005453-4057qib7	5499	39	.	.	.
cord-005453-4057qib7	5500	1	Local	local	JJ
cord-005453-4057qib7	5500	2	and	and	CC
cord-005453-4057qib7	5500	3	general	general	JJ
cord-005453-4057qib7	5500	4	tolerability	tolerability	NN
cord-005453-4057qib7	5500	5	of	of	IN
cord-005453-4057qib7	5500	6	L	L	NNP
cord-005453-4057qib7	5500	7	-	-	HYPH
cord-005453-4057qib7	5500	8	CsA	CsA	NNP
cord-005453-4057qib7	5501	1	-i	-i	NNP
cord-005453-4057qib7	5501	2	was	be	VBD
cord-005453-4057qib7	5501	3	investigated	investigate	VBN
cord-005453-4057qib7	5501	4	.	.	.
cord-005453-4057qib7	5502	1	Results	result	NNS
cord-005453-4057qib7	5502	2	:	:	:
cord-005453-4057qib7	5503	1	Between	between	IN
cord-005453-4057qib7	5503	2	the	the	DT
cord-005453-4057qib7	5503	3	two	two	CD
cord-005453-4057qib7	5503	4	studies	study	NNS
cord-005453-4057qib7	5503	5	,	,	,
cord-005453-4057qib7	5503	6	85	85	CD
cord-005453-4057qib7	5503	7	subjects	subject	NNS
cord-005453-4057qib7	5503	8	received	receive	VBD
cord-005453-4057qib7	5503	9	either	either	CC
cord-005453-4057qib7	5503	10	5	5	CD
cord-005453-4057qib7	5503	11	or	or	CC
cord-005453-4057qib7	5503	12	10	10	CD
cord-005453-4057qib7	5503	13	mg	mg	NN
cord-005453-4057qib7	5503	14	bid	bid	NN
cord-005453-4057qib7	5503	15	of	of	IN
cord-005453-4057qib7	5503	16	L	l	NN
cord-005453-4057qib7	5503	17	-	-	HYPH
cord-005453-4057qib7	5503	18	CsA	CsA	NNP
cord-005453-4057qib7	5503	19	-	-	:
cord-005453-4057qib7	5503	20	i	i	PRP
cord-005453-4057qib7	5503	21	.	.	.
cord-005453-4057qib7	5504	1	Pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	5504	2	models	model	NNS
cord-005453-4057qib7	5504	3	predict	predict	VBP
cord-005453-4057qib7	5504	4	a	a	DT
cord-005453-4057qib7	5504	5	constant	constant	JJ
cord-005453-4057qib7	5504	6	drug	drug	NN
cord-005453-4057qib7	5504	7	level	level	NN
cord-005453-4057qib7	5504	8	in	in	IN
cord-005453-4057qib7	5504	9	the	the	DT
cord-005453-4057qib7	5504	10	lung	lung	NN
cord-005453-4057qib7	5504	11	.	.	.
cord-005453-4057qib7	5505	1	Maximum	maximum	JJ
cord-005453-4057qib7	5505	2	serum	serum	NN
cord-005453-4057qib7	5505	3	cyclosporine	cyclosporine	IN
cord-005453-4057qib7	5505	4	A	a	DT
cord-005453-4057qib7	5505	5	concentration	concentration	NN
cord-005453-4057qib7	5505	6	after	after	IN
cord-005453-4057qib7	5505	7	inhalation	inhalation	NN
cord-005453-4057qib7	5505	8	was	be	VBD
cord-005453-4057qib7	5505	9	57.42	57.42	CD
cord-005453-4057qib7	5505	10	±	±	CD
cord-005453-4057qib7	5505	11	34.26	34.26	CD
cord-005453-4057qib7	5505	12	ng	ng	NN
cord-005453-4057qib7	5505	13	/	/	SYM
cord-005453-4057qib7	5505	14	ml	ml	NN
cord-005453-4057qib7	5505	15	.	.	.
cord-005453-4057qib7	5506	1	Trough	trough	NN
cord-005453-4057qib7	5506	2	levels	level	NNS
cord-005453-4057qib7	5506	3	for	for	IN
cord-005453-4057qib7	5506	4	up	up	IN
cord-005453-4057qib7	5506	5	to	to	TO
cord-005453-4057qib7	5506	6	2-years	2-years	CD
cord-005453-4057qib7	5506	7	of	of	IN
cord-005453-4057qib7	5506	8	daily	daily	JJ
cord-005453-4057qib7	5506	9	administration	administration	NN
cord-005453-4057qib7	5506	10	was	be	VBD
cord-005453-4057qib7	5506	11	4	4	CD
cord-005453-4057qib7	5506	12	-	-	SYM
cord-005453-4057qib7	5506	13	5	5	CD
cord-005453-4057qib7	5506	14	ng	ng	NN
cord-005453-4057qib7	5506	15	/	/	SYM
cord-005453-4057qib7	5506	16	ml	ml	XX
cord-005453-4057qib7	5506	17	with	with	IN
cord-005453-4057qib7	5506	18	no	no	DT
cord-005453-4057qib7	5506	19	evidence	evidence	NN
cord-005453-4057qib7	5506	20	of	of	IN
cord-005453-4057qib7	5506	21	accumulation	accumulation	NN
cord-005453-4057qib7	5506	22	following	follow	VBG
cord-005453-4057qib7	5506	23	repeated	repeat	VBN
cord-005453-4057qib7	5506	24	exposure	exposure	NN
cord-005453-4057qib7	5506	25	.	.	.
cord-005453-4057qib7	5507	1	Tolerability	tolerability	NN
cord-005453-4057qib7	5507	2	data	datum	NNS
cord-005453-4057qib7	5507	3	was	be	VBD
cord-005453-4057qib7	5507	4	assessed	assess	VBN
cord-005453-4057qib7	5507	5	from	from	IN
cord-005453-4057qib7	5507	6	1068	1068	CD
cord-005453-4057qib7	5507	7	patient	patient	NN
cord-005453-4057qib7	5507	8	-	-	HYPH
cord-005453-4057qib7	5507	9	month	month	NN
cord-005453-4057qib7	5507	10	exposure	exposure	NN
cord-005453-4057qib7	5507	11	to	to	IN
cord-005453-4057qib7	5507	12	L	l	NN
cord-005453-4057qib7	5507	13	-	-	HYPH
cord-005453-4057qib7	5507	14	CsA	CsA	NNP
cord-005453-4057qib7	5507	15	-	-	:
cord-005453-4057qib7	5507	16	i	i	PRP
cord-005453-4057qib7	5507	17	.	.	.
cord-005453-4057qib7	5508	1	Reported	report	VBN
cord-005453-4057qib7	5508	2	symptoms	symptom	NNS
cord-005453-4057qib7	5508	3	were	be	VBD
cord-005453-4057qib7	5508	4	:	:	:
cord-005453-4057qib7	5508	5	pharyngeal	pharyngeal	JJ
cord-005453-4057qib7	5508	6	soreness	soreness	NN
cord-005453-4057qib7	5508	7	1	1	CD
cord-005453-4057qib7	5508	8	%	%	NN
cord-005453-4057qib7	5508	9	;	;	:
cord-005453-4057qib7	5508	10	cough	cough	NN
cord-005453-4057qib7	5508	11	22	22	CD
cord-005453-4057qib7	5508	12	%	%	NN
cord-005453-4057qib7	5508	13	;	;	:
cord-005453-4057qib7	5508	14	dyspnoea	dyspnoea	NNS
cord-005453-4057qib7	5508	15	7	7	CD
cord-005453-4057qib7	5508	16	%	%	NN
cord-005453-4057qib7	5508	17	;	;	,
cord-005453-4057qib7	5508	18	and	and	CC
cord-005453-4057qib7	5508	19	wheezing	wheeze	VBG
cord-005453-4057qib7	5508	20	1	1	CD
cord-005453-4057qib7	5508	21	%	%	NN
cord-005453-4057qib7	5508	22	.	.	.
cord-005453-4057qib7	5509	1	No	no	DT
cord-005453-4057qib7	5509	2	subject	subject	NN
cord-005453-4057qib7	5509	3	discontinued	discontinue	VBD
cord-005453-4057qib7	5509	4	due	due	IN
cord-005453-4057qib7	5509	5	to	to	IN
cord-005453-4057qib7	5509	6	intolerability	intolerability	NN
cord-005453-4057qib7	5509	7	.	.	.
cord-005453-4057qib7	5510	1	Inhalation	inhalation	NN
cord-005453-4057qib7	5510	2	time	time	NN
cord-005453-4057qib7	5510	3	is	be	VBZ
cord-005453-4057qib7	5510	4	on	on	IN
cord-005453-4057qib7	5510	5	average	average	JJ
cord-005453-4057qib7	5510	6	9	9	CD
cord-005453-4057qib7	5510	7	-	-	SYM
cord-005453-4057qib7	5510	8	13	13	CD
cord-005453-4057qib7	5510	9	min	min	NN
cord-005453-4057qib7	5510	10	.	.	.
cord-005453-4057qib7	5511	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5511	2	:	:	:
cord-005453-4057qib7	5512	1	L	l	NN
cord-005453-4057qib7	5512	2	-	-	HYPH
cord-005453-4057qib7	5512	3	CsA	CsA	NNP
cord-005453-4057qib7	5513	1	-i	-i	NNP
cord-005453-4057qib7	5513	2	provides	provide	VBZ
cord-005453-4057qib7	5513	3	high	high	JJ
cord-005453-4057qib7	5513	4	and	and	CC
cord-005453-4057qib7	5513	5	constant	constant	JJ
cord-005453-4057qib7	5513	6	concentrations	concentration	NNS
cord-005453-4057qib7	5513	7	to	to	IN
cord-005453-4057qib7	5513	8	the	the	DT
cord-005453-4057qib7	5513	9	airways	airway	NNS
cord-005453-4057qib7	5513	10	of	of	IN
cord-005453-4057qib7	5513	11	the	the	DT
cord-005453-4057qib7	5513	12	lungs	lung	NNS
cord-005453-4057qib7	5513	13	and	and	CC
cord-005453-4057qib7	5513	14	the	the	DT
cord-005453-4057qib7	5513	15	site	site	NN
cord-005453-4057qib7	5513	16	of	of	IN
cord-005453-4057qib7	5513	17	BOS	BOS	NNP
cord-005453-4057qib7	5513	18	.	.	.
cord-005453-4057qib7	5514	1	L	l	NN
cord-005453-4057qib7	5514	2	-	-	HYPH
cord-005453-4057qib7	5514	3	CsA	CsA	NNP
cord-005453-4057qib7	5515	1	-i	-i	NNP
cord-005453-4057qib7	5515	2	is	be	VBZ
cord-005453-4057qib7	5515	3	well	well	RB
cord-005453-4057qib7	5515	4	tolerated	tolerate	VBN
cord-005453-4057qib7	5515	5	in	in	IN
cord-005453-4057qib7	5515	6	lung	lung	NN
cord-005453-4057qib7	5515	7	transplant	transplant	NN
cord-005453-4057qib7	5515	8	patients	patient	NNS
cord-005453-4057qib7	5515	9	.	.	.
cord-005453-4057qib7	5516	1	Use	Use	NNP
cord-005453-4057qib7	5516	2	of	of	IN
cord-005453-4057qib7	5516	3	L	l	NN
cord-005453-4057qib7	5516	4	-	-	HYPH
cord-005453-4057qib7	5516	5	CsA	CsA	NNP
cord-005453-4057qib7	5516	6	-	-	:
cord-005453-4057qib7	5516	7	i	i	PRP
cord-005453-4057qib7	5516	8	instead	instead	RB
cord-005453-4057qib7	5516	9	of	of	IN
cord-005453-4057qib7	5516	10	augmentation	augmentation	NN
cord-005453-4057qib7	5516	11	of	of	IN
cord-005453-4057qib7	5516	12	systemic	systemic	JJ
cord-005453-4057qib7	5516	13	CsA	csa	NN
cord-005453-4057qib7	5516	14	reduces	reduce	VBZ
cord-005453-4057qib7	5516	15	the	the	DT
cord-005453-4057qib7	5516	16	total	total	JJ
cord-005453-4057qib7	5516	17	drug	drug	NN
cord-005453-4057qib7	5516	18	exposure	exposure	NN
cord-005453-4057qib7	5516	19	.	.	.
cord-005453-4057qib7	5517	1	A	a	DT
cord-005453-4057qib7	5517	2	multicentre	multicentre	NNP
cord-005453-4057qib7	5517	3	Phase	Phase	NNP
cord-005453-4057qib7	5517	4	2	2	CD
cord-005453-4057qib7	5517	5	safety	safety	NN
cord-005453-4057qib7	5517	6	and	and	CC
cord-005453-4057qib7	5517	7	exploratory	exploratory	JJ
cord-005453-4057qib7	5517	8	efficacy	efficacy	NN
cord-005453-4057qib7	5517	9	trial	trial	NN
cord-005453-4057qib7	5517	10	for	for	IN
cord-005453-4057qib7	5517	11	the	the	DT
cord-005453-4057qib7	5517	12	treatment	treatment	NN
cord-005453-4057qib7	5517	13	of	of	IN
cord-005453-4057qib7	5517	14	BOS	BOS	NNP
cord-005453-4057qib7	5517	15	in	in	IN
cord-005453-4057qib7	5517	16	allo	allo	NN
cord-005453-4057qib7	5517	17	-	-	HYPH
cord-005453-4057qib7	5517	18	HSCT	HSCT	NNP
cord-005453-4057qib7	5517	19	recipients	recipient	NNS
cord-005453-4057qib7	5517	20	is	be	VBZ
cord-005453-4057qib7	5517	21	underway	underway	JJ
cord-005453-4057qib7	5517	22	.	.	.
cord-005453-4057qib7	5518	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5518	2	Background	background	NN
cord-005453-4057qib7	5518	3	:	:	:
cord-005453-4057qib7	5518	4	There	there	EX
cord-005453-4057qib7	5518	5	are	be	VBP
cord-005453-4057qib7	5518	6	a	a	DT
cord-005453-4057qib7	5518	7	number	number	NN
cord-005453-4057qib7	5518	8	of	of	IN
cord-005453-4057qib7	5518	9	biomarkers	biomarker	NNS
cord-005453-4057qib7	5518	10	that	that	WDT
cord-005453-4057qib7	5518	11	predict	predict	VBP
cord-005453-4057qib7	5518	12	non	non	JJ
cord-005453-4057qib7	5518	13	-	-	JJ
cord-005453-4057qib7	5518	14	relapse	relapse	JJ
cord-005453-4057qib7	5518	15	mortality	mortality	NN
cord-005453-4057qib7	5518	16	(	(	-LRB-
cord-005453-4057qib7	5518	17	NRM	NRM	NNP
cord-005453-4057qib7	5518	18	)	)	-RRB-
cord-005453-4057qib7	5518	19	,	,	,
cord-005453-4057qib7	5518	20	graft	graft	NN
cord-005453-4057qib7	5518	21	-	-	HYPH
cord-005453-4057qib7	5518	22	versus	versus	IN
cord-005453-4057qib7	5518	23	-	-	HYPH
cord-005453-4057qib7	5518	24	host	host	NN
cord-005453-4057qib7	5518	25	disease	disease	NN
cord-005453-4057qib7	5518	26	(	(	-LRB-
cord-005453-4057qib7	5518	27	GVHD	GVHD	NNP
cord-005453-4057qib7	5518	28	)	)	-RRB-
cord-005453-4057qib7	5518	29	and	and	CC
cord-005453-4057qib7	5518	30	relapse	relapse	NN
cord-005453-4057qib7	5518	31	incidence	incidence	NN
cord-005453-4057qib7	5518	32	(	(	-LRB-
cord-005453-4057qib7	5518	33	RI	RI	NNP
cord-005453-4057qib7	5518	34	)	)	-RRB-
cord-005453-4057qib7	5518	35	after	after	IN
cord-005453-4057qib7	5518	36	conventional	conventional	JJ
cord-005453-4057qib7	5518	37	GVHD	GVHD	NNP
cord-005453-4057qib7	5518	38	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5518	39	based	base	VBN
cord-005453-4057qib7	5518	40	on	on	IN
cord-005453-4057qib7	5518	41	calcineurin	calcineurin	NNP
cord-005453-4057qib7	5518	42	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5518	43	with	with	IN
cord-005453-4057qib7	5518	44	or	or	CC
cord-005453-4057qib7	5518	45	without	without	IN
cord-005453-4057qib7	5518	46	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	5518	47	globulin	globulin	NNP
cord-005453-4057qib7	5518	48	.	.	.
cord-005453-4057qib7	5519	1	Currently	currently	RB
cord-005453-4057qib7	5519	2	there	there	EX
cord-005453-4057qib7	5519	3	is	be	VBZ
cord-005453-4057qib7	5519	4	limited	limited	JJ
cord-005453-4057qib7	5519	5	data	datum	NNS
cord-005453-4057qib7	5519	6	whether	whether	IN
cord-005453-4057qib7	5519	7	the	the	DT
cord-005453-4057qib7	5519	8	conventional	conventional	JJ
cord-005453-4057qib7	5519	9	predictive	predictive	JJ
cord-005453-4057qib7	5519	10	biomarkers	biomarker	NNS
cord-005453-4057qib7	5519	11	work	work	VBP
cord-005453-4057qib7	5519	12	with	with	IN
cord-005453-4057qib7	5519	13	posttransplantation	posttransplantation	NN
cord-005453-4057qib7	5519	14	cyclophosphamide	cyclophosphamide	NNP
cord-005453-4057qib7	5519	15	(	(	-LRB-
cord-005453-4057qib7	5519	16	PTCy	PTCy	NNP
cord-005453-4057qib7	5519	17	)	)	-RRB-
cord-005453-4057qib7	5519	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5519	19	.	.	.
cord-005453-4057qib7	5520	1	Methods	method	NNS
cord-005453-4057qib7	5520	2	:	:	:
cord-005453-4057qib7	5520	3	Prospective	prospective	JJ
cord-005453-4057qib7	5520	4	single	single	JJ
cord-005453-4057qib7	5520	5	-	-	HYPH
cord-005453-4057qib7	5520	6	center	center	NN
cord-005453-4057qib7	5520	7	study	study	NN
cord-005453-4057qib7	5520	8	in	in	IN
cord-005453-4057qib7	5520	9	2015	2015	CD
cord-005453-4057qib7	5520	10	-	-	SYM
cord-005453-4057qib7	5520	11	2016	2016	CD
cord-005453-4057qib7	5520	12	enrolled	enrol	VBD
cord-005453-4057qib7	5520	13	79	79	CD
cord-005453-4057qib7	5520	14	adult	adult	NN
cord-005453-4057qib7	5520	15	patients	patient	NNS
cord-005453-4057qib7	5520	16	with	with	IN
cord-005453-4057qib7	5520	17	acute	acute	JJ
cord-005453-4057qib7	5520	18	leukemia	leukemia	NN
cord-005453-4057qib7	5520	19	in	in	IN
cord-005453-4057qib7	5520	20	CR	CR	NNP
cord-005453-4057qib7	5520	21	(	(	-LRB-
cord-005453-4057qib7	5520	22	34	34	CD
cord-005453-4057qib7	5520	23	%	%	NN
cord-005453-4057qib7	5520	24	with	with	IN
cord-005453-4057qib7	5520	25	ALL	all	DT
cord-005453-4057qib7	5520	26	,	,	,
cord-005453-4057qib7	5520	27	66	66	CD
cord-005453-4057qib7	5520	28	%	%	NN
cord-005453-4057qib7	5520	29	with	with	IN
cord-005453-4057qib7	5520	30	AML	AML	NNP
cord-005453-4057qib7	5520	31	)	)	-RRB-
cord-005453-4057qib7	5520	32	.	.	.
cord-005453-4057qib7	5521	1	26	26	CD
cord-005453-4057qib7	5521	2	received	receive	VBD
cord-005453-4057qib7	5521	3	matched	match	VBN
cord-005453-4057qib7	5521	4	related	related	JJ
cord-005453-4057qib7	5521	5	bone	bone	NN
cord-005453-4057qib7	5521	6	marrow	marrow	NN
cord-005453-4057qib7	5521	7	(	(	-LRB-
cord-005453-4057qib7	5521	8	BM	BM	NNP
cord-005453-4057qib7	5521	9	)	)	-RRB-
cord-005453-4057qib7	5521	10	graft	graft	NN
cord-005453-4057qib7	5521	11	with	with	IN
cord-005453-4057qib7	5521	12	single	single	JJ
cord-005453-4057qib7	5521	13	-	-	HYPH
cord-005453-4057qib7	5521	14	agent	agent	NN
cord-005453-4057qib7	5521	15	PTCy	PTCy	NNS
cord-005453-4057qib7	5521	16	and	and	CC
cord-005453-4057qib7	5521	17	53	53	CD
cord-005453-4057qib7	5521	18	received	receive	VBD
cord-005453-4057qib7	5521	19	unrelated	unrelated	JJ
cord-005453-4057qib7	5521	20	peripheral	peripheral	JJ
cord-005453-4057qib7	5521	21	blood	blood	NN
cord-005453-4057qib7	5521	22	stem	stem	NN
cord-005453-4057qib7	5521	23	cell	cell	NN
cord-005453-4057qib7	5521	24	graft	graft	NN
cord-005453-4057qib7	5521	25	(	(	-LRB-
cord-005453-4057qib7	5521	26	PBSC	PBSC	NNP
cord-005453-4057qib7	5521	27	)	)	-RRB-
cord-005453-4057qib7	5521	28	with	with	IN
cord-005453-4057qib7	5521	29	PTCy	PTCy	NNS
cord-005453-4057qib7	5521	30	,	,	,
cord-005453-4057qib7	5521	31	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5521	32	and	and	CC
cord-005453-4057qib7	5521	33	MMF	mmf	NN
cord-005453-4057qib7	5521	34	.	.	.
cord-005453-4057qib7	5522	1	The	the	DT
cord-005453-4057qib7	5522	2	grafts	graft	NNS
cord-005453-4057qib7	5522	3	were	be	VBD
cord-005453-4057qib7	5522	4	studied	study	VBN
cord-005453-4057qib7	5522	5	by	by	IN
cord-005453-4057qib7	5522	6	flow	flow	NN
cord-005453-4057qib7	5522	7	cytometry	cytometry	NN
cord-005453-4057qib7	5522	8	(	(	-LRB-
cord-005453-4057qib7	5522	9	FACS	FACS	NNP
cord-005453-4057qib7	5522	10	Aria	Aria	NNP
cord-005453-4057qib7	5522	11	II	II	NNP
cord-005453-4057qib7	5522	12	,	,	,
cord-005453-4057qib7	5522	13	antibodies	antibody	NNS
cord-005453-4057qib7	5522	14	by	by	IN
cord-005453-4057qib7	5522	15	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	5522	16	biotec	biotec	NNP
cord-005453-4057qib7	5522	17	)	)	-RRB-
cord-005453-4057qib7	5522	18	.	.	.
cord-005453-4057qib7	5523	1	The	the	DT
cord-005453-4057qib7	5523	2	following	follow	VBG
cord-005453-4057qib7	5523	3	populations	population	NNS
cord-005453-4057qib7	5523	4	were	be	VBD
cord-005453-4057qib7	5523	5	analyzed	analyze	VBN
cord-005453-4057qib7	5523	6	:	:	:
cord-005453-4057qib7	5523	7	CD3	CD3	NNP
cord-005453-4057qib7	5523	8	,	,	,
cord-005453-4057qib7	5523	9	CD4	CD4	NNP
cord-005453-4057qib7	5523	10	,	,	,
cord-005453-4057qib7	5523	11	CD8	CD8	NNP
cord-005453-4057qib7	5523	12	,	,	,
cord-005453-4057qib7	5523	13	CD16CD56	CD16CD56	NNP
cord-005453-4057qib7	5523	14	,	,	,
cord-005453-4057qib7	5523	15	NKT	NKT	NNP
cord-005453-4057qib7	5523	16	,	,	,
cord-005453-4057qib7	5523	17	iNKT	inkt	NN
cord-005453-4057qib7	5523	18	,	,	,
cord-005453-4057qib7	5523	19	Treg	Treg	NNP
cord-005453-4057qib7	5523	20	,	,	,
cord-005453-4057qib7	5523	21	double	double	JJ
cord-005453-4057qib7	5523	22	-	-	HYPH
cord-005453-4057qib7	5523	23	positive	positive	JJ
cord-005453-4057qib7	5523	24	T	t	NN
cord-005453-4057qib7	5523	25	-	-	HYPH
cord-005453-4057qib7	5523	26	cells	cell	NNS
cord-005453-4057qib7	5523	27	,	,	,
cord-005453-4057qib7	5523	28	double	double	JJ
cord-005453-4057qib7	5523	29	-	-	HYPH
cord-005453-4057qib7	5523	30	negative	negative	JJ
cord-005453-4057qib7	5523	31	T	t	NN
cord-005453-4057qib7	5523	32	-	-	HYPH
cord-005453-4057qib7	5523	33	cells	cell	NNS
cord-005453-4057qib7	5523	34	,	,	,
cord-005453-4057qib7	5523	35	TCRalpha	tcralpha	NN
cord-005453-4057qib7	5523	36	/	/	SYM
cord-005453-4057qib7	5523	37	beta	beta	NN
cord-005453-4057qib7	5523	38	,	,	,
cord-005453-4057qib7	5523	39	TCR	TCR	NNP
cord-005453-4057qib7	5523	40	v11	v11	VBZ
cord-005453-4057qib7	5523	41	memory	memory	NN
cord-005453-4057qib7	5523	42	cells	cell	NNS
cord-005453-4057qib7	5523	43	.	.	.
cord-005453-4057qib7	5524	1	The	the	DT
cord-005453-4057qib7	5524	2	crypreserved	crypreserved	JJ
cord-005453-4057qib7	5524	3	plasma	plasma	NN
cord-005453-4057qib7	5524	4	from	from	IN
cord-005453-4057qib7	5524	5	were	be	VBD
cord-005453-4057qib7	5524	6	analysed	analyse	VBN
cord-005453-4057qib7	5524	7	by	by	IN
cord-005453-4057qib7	5524	8	ELISA	ELISA	NNP
cord-005453-4057qib7	5524	9	(	(	-LRB-
cord-005453-4057qib7	5524	10	commercial	commercial	JJ
cord-005453-4057qib7	5524	11	kits	kit	NNS
cord-005453-4057qib7	5524	12	by	by	IN
cord-005453-4057qib7	5524	13	eBioscience	eBioscience	NNP
cord-005453-4057qib7	5524	14	and	and	CC
cord-005453-4057qib7	5524	15	Critical	Critical	NNP
cord-005453-4057qib7	5524	16	Diagnostics	Diagnostics	NNPS
cord-005453-4057qib7	5524	17	)	)	-RRB-
cord-005453-4057qib7	5524	18	for	for	IN
cord-005453-4057qib7	5524	19	VEGF	VEGF	NNP
cord-005453-4057qib7	5524	20	A	a	DT
cord-005453-4057qib7	5524	21	soluble	soluble	JJ
cord-005453-4057qib7	5524	22	TNF	TNF	NNP
cord-005453-4057qib7	5524	23	receptor	receptor	NN
cord-005453-4057qib7	5524	24	(	(	-LRB-
cord-005453-4057qib7	5524	25	sTNFr	stnfr	ADD
cord-005453-4057qib7	5524	26	)	)	-RRB-
cord-005453-4057qib7	5524	27	,	,	,
cord-005453-4057qib7	5524	28	IL-8	IL-8	NNP
cord-005453-4057qib7	5524	29	,	,	,
cord-005453-4057qib7	5524	30	IL-6	IL-6	NNP
cord-005453-4057qib7	5524	31	,	,	,
cord-005453-4057qib7	5524	32	soluble	soluble	JJ
cord-005453-4057qib7	5524	33	IL-2	IL-2	NNP
cord-005453-4057qib7	5524	34	receptor	receptor	NN
cord-005453-4057qib7	5524	35	,	,	,
cord-005453-4057qib7	5524	36	ST2	ST2	NNP
cord-005453-4057qib7	5524	37	,	,	,
cord-005453-4057qib7	5524	38	IL-17	IL-17	NNP
cord-005453-4057qib7	5524	39	and	and	CC
cord-005453-4057qib7	5524	40	sTNFr	stnfr	ADD
cord-005453-4057qib7	5524	41	.	.	.
cord-005453-4057qib7	5525	1	The	the	DT
cord-005453-4057qib7	5525	2	above	above	RB
cord-005453-4057qib7	5525	3	mentioned	mention	VBN
cord-005453-4057qib7	5525	4	biomarkers	biomarker	NNS
cord-005453-4057qib7	5525	5	were	be	VBD
cord-005453-4057qib7	5525	6	tested	test	VBN
cord-005453-4057qib7	5525	7	in	in	IN
cord-005453-4057qib7	5525	8	logistic	logistic	JJ
cord-005453-4057qib7	5525	9	regression	regression	NN
cord-005453-4057qib7	5525	10	with	with	IN
cord-005453-4057qib7	5525	11	ROC	ROC	NNP
cord-005453-4057qib7	5525	12	analysis	analysis	NN
cord-005453-4057qib7	5525	13	,	,	,
cord-005453-4057qib7	5525	14	assays	assay	NNS
cord-005453-4057qib7	5525	15	with	with	IN
cord-005453-4057qib7	5525	16	AUC>0.600	AUC>0.600	NNP
cord-005453-4057qib7	5525	17	were	be	VBD
cord-005453-4057qib7	5525	18	selected	select	VBN
cord-005453-4057qib7	5525	19	for	for	IN
cord-005453-4057qib7	5525	20	analysis	analysis	NN
cord-005453-4057qib7	5525	21	in	in	IN
cord-005453-4057qib7	5525	22	Fyne	Fyne	NNP
cord-005453-4057qib7	5525	23	-	-	HYPH
cord-005453-4057qib7	5525	24	Gray	gray	JJ
cord-005453-4057qib7	5525	25	regression	regression	NN
cord-005453-4057qib7	5525	26	with	with	IN
cord-005453-4057qib7	5525	27	competing	compete	VBG
cord-005453-4057qib7	5525	28	risks	risk	NNS
cord-005453-4057qib7	5525	29	.	.	.
cord-005453-4057qib7	5526	1	Cut	cut	VB
cord-005453-4057qib7	5526	2	off	off	RP
cord-005453-4057qib7	5526	3	levels	level	NNS
cord-005453-4057qib7	5526	4	were	be	VBD
cord-005453-4057qib7	5526	5	determined	determine	VBN
cord-005453-4057qib7	5526	6	for	for	IN
cord-005453-4057qib7	5526	7	significant	significant	JJ
cord-005453-4057qib7	5526	8	parameters	parameter	NNS
cord-005453-4057qib7	5526	9	.	.	.
cord-005453-4057qib7	5527	1	Results	result	NNS
cord-005453-4057qib7	5527	2	:	:	:
cord-005453-4057qib7	5528	1	Median	median	JJ
cord-005453-4057qib7	5528	2	follow	follow	NN
cord-005453-4057qib7	5528	3	-	-	HYPH
cord-005453-4057qib7	5528	4	up	up	NN
cord-005453-4057qib7	5528	5	was	be	VBD
cord-005453-4057qib7	5528	6	19	19	CD
cord-005453-4057qib7	5528	7	months	month	NNS
cord-005453-4057qib7	5529	1	(	(	-LRB-
cord-005453-4057qib7	5529	2	range	range	NNP
cord-005453-4057qib7	5529	3	12	12	CD
cord-005453-4057qib7	5529	4	-	-	SYM
cord-005453-4057qib7	5529	5	30	30	CD
cord-005453-4057qib7	5529	6	)	)	-RRB-
cord-005453-4057qib7	5529	7	.	.	.
cord-005453-4057qib7	5530	1	In	in	IN
cord-005453-4057qib7	5530	2	the	the	DT
cord-005453-4057qib7	5530	3	whole	whole	JJ
cord-005453-4057qib7	5530	4	group	group	NN
cord-005453-4057qib7	5530	5	overall	overall	JJ
cord-005453-4057qib7	5530	6	survival	survival	NN
cord-005453-4057qib7	5530	7	(	(	-LRB-
cord-005453-4057qib7	5530	8	OS	OS	NNP
cord-005453-4057qib7	5530	9	)	)	-RRB-
cord-005453-4057qib7	5530	10	was	be	VBD
cord-005453-4057qib7	5530	11	77	77	CD
cord-005453-4057qib7	5530	12	%	%	NN
cord-005453-4057qib7	5530	13	,	,	,
cord-005453-4057qib7	5530	14	eventfree	eventfree	NNP
cord-005453-4057qib7	5530	15	survival	survival	NNP
cord-005453-4057qib7	5530	16	(	(	-LRB-
cord-005453-4057qib7	5530	17	EFS	EFS	NNP
cord-005453-4057qib7	5530	18	)	)	-RRB-
cord-005453-4057qib7	5530	19	73	73	CD
cord-005453-4057qib7	5530	20	%	%	NN
cord-005453-4057qib7	5530	21	,	,	,
cord-005453-4057qib7	5530	22	grade	grade	NN
cord-005453-4057qib7	5530	23	II	II	NNP
cord-005453-4057qib7	5530	24	-	-	HYPH
cord-005453-4057qib7	5530	25	IV	IV	NNP
cord-005453-4057qib7	5530	26	acute	acute	JJ
cord-005453-4057qib7	5530	27	GVHD	GVHD	NNP
cord-005453-4057qib7	5530	28	13	13	CD
cord-005453-4057qib7	5530	29	%	%	NN
cord-005453-4057qib7	5530	30	,	,	,
cord-005453-4057qib7	5530	31	moderate	moderate	JJ
cord-005453-4057qib7	5530	32	and	and	CC
cord-005453-4057qib7	5530	33	severe	severe	JJ
cord-005453-4057qib7	5530	34	(	(	-LRB-
cord-005453-4057qib7	5530	35	m&s	m&s	NN
cord-005453-4057qib7	5530	36	)	)	-RRB-
cord-005453-4057qib7	5530	37	chronic	chronic	JJ
cord-005453-4057qib7	5530	38	GVHD	GVHD	NNP
cord-005453-4057qib7	5530	39	20	20	CD
cord-005453-4057qib7	5530	40	%	%	NN
cord-005453-4057qib7	5530	41	,	,	,
cord-005453-4057qib7	5530	42	NRM	NRM	NNP
cord-005453-4057qib7	5530	43	6	6	CD
cord-005453-4057qib7	5530	44	%	%	NN
cord-005453-4057qib7	5530	45	,	,	,
cord-005453-4057qib7	5530	46	mortality	mortality	NN
cord-005453-4057qib7	5530	47	in	in	IN
cord-005453-4057qib7	5530	48	patients	patient	NNS
cord-005453-4057qib7	5530	49	with	with	IN
cord-005453-4057qib7	5530	50	GVHD	GVHD	NNP
cord-005453-4057qib7	5530	51	0	0	CD
cord-005453-4057qib7	5530	52	%	%	NN
cord-005453-4057qib7	5530	53	,	,	,
cord-005453-4057qib7	5530	54	RI	RI	NNP
cord-005453-4057qib7	5530	55	20	20	CD
cord-005453-4057qib7	5530	56	%	%	NN
cord-005453-4057qib7	5530	57	.	.	.
cord-005453-4057qib7	5531	1	There	there	EX
cord-005453-4057qib7	5531	2	was	be	VBD
cord-005453-4057qib7	5531	3	no	no	DT
cord-005453-4057qib7	5531	4	difference	difference	NN
cord-005453-4057qib7	5531	5	between	between	IN
cord-005453-4057qib7	5531	6	BM	BM	NNP
cord-005453-4057qib7	5531	7	/	/	SYM
cord-005453-4057qib7	5531	8	related	relate	VBN
cord-005453-4057qib7	5531	9	and	and	CC
cord-005453-4057qib7	5531	10	PBSC	PBSC	NNP
cord-005453-4057qib7	5531	11	/	/	SYM
cord-005453-4057qib7	5531	12	unrelated	unrelated	JJ
cord-005453-4057qib7	5531	13	grafts	graft	NNS
cord-005453-4057qib7	5531	14	in	in	IN
cord-005453-4057qib7	5531	15	the	the	DT
cord-005453-4057qib7	5531	16	incidence	incidence	NN
cord-005453-4057qib7	5531	17	of	of	IN
cord-005453-4057qib7	5531	18	GVHD	GVHD	NNP
cord-005453-4057qib7	5531	19	,	,	,
cord-005453-4057qib7	5531	20	NRM	NRM	NNP
cord-005453-4057qib7	5531	21	and	and	CC
cord-005453-4057qib7	5531	22	RI	RI	NNP
cord-005453-4057qib7	5531	23	(	(	-LRB-
cord-005453-4057qib7	5531	24	p>0.11	p>0.11	NNP
cord-005453-4057qib7	5531	25	)	)	-RRB-
cord-005453-4057qib7	5531	26	.	.	.
cord-005453-4057qib7	5532	1	The	the	DT
cord-005453-4057qib7	5532	2	only	only	JJ
cord-005453-4057qib7	5532	3	significant	significant	JJ
cord-005453-4057qib7	5532	4	predictor	predictor	NN
cord-005453-4057qib7	5532	5	of	of	IN
cord-005453-4057qib7	5532	6	acute	acute	JJ
cord-005453-4057qib7	5532	7	GVHD	GVHD	NNP
cord-005453-4057qib7	5532	8	were	be	VBD
cord-005453-4057qib7	5532	9	low	low	JJ
cord-005453-4057qib7	5532	10	levels	level	NNS
cord-005453-4057qib7	5532	11	of	of	IN
cord-005453-4057qib7	5532	12	IL-8	IL-8	NNP
cord-005453-4057qib7	5532	13	level	level	NN
cord-005453-4057qib7	5532	14	on	on	IN
cord-005453-4057qib7	5532	15	day+7	day+7	NNS
cord-005453-4057qib7	5532	16	(	(	-LRB-
cord-005453-4057qib7	5532	17	p=	p=	NNP
cord-005453-4057qib7	5532	18	0.0490	0.0490	CD
cord-005453-4057qib7	5532	19	,	,	,
cord-005453-4057qib7	5532	20	0	0	CD
cord-005453-4057qib7	5532	21	%	%	NN
cord-005453-4057qib7	5532	22	vs	vs	IN
cord-005453-4057qib7	5532	23	15	15	CD
cord-005453-4057qib7	5532	24	%	%	NN
cord-005453-4057qib7	5532	25	with	with	IN
cord-005453-4057qib7	5532	26	the	the	DT
cord-005453-4057qib7	5532	27	cut	cut	NN
cord-005453-4057qib7	5532	28	off	off	RP
cord-005453-4057qib7	5532	29	40	40	CD
cord-005453-4057qib7	5532	30	pg	pg	NNP
cord-005453-4057qib7	5532	31	/	/	SYM
cord-005453-4057qib7	5532	32	ml	ml	NN
cord-005453-4057qib7	5532	33	)	)	-RRB-
cord-005453-4057qib7	5532	34	.	.	.
cord-005453-4057qib7	5533	1	M&s	M&s	NNP
cord-005453-4057qib7	5533	2	chronic	chronic	NNP
cord-005453-4057qib7	5533	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5533	4	was	be	VBD
cord-005453-4057qib7	5533	5	predicted	predict	VBN
cord-005453-4057qib7	5533	6	only	only	RB
cord-005453-4057qib7	5533	7	by	by	IN
cord-005453-4057qib7	5533	8	the	the	DT
cord-005453-4057qib7	5533	9	high	high	JJ
cord-005453-4057qib7	5533	10	percentage	percentage	NN
cord-005453-4057qib7	5533	11	of	of	IN
cord-005453-4057qib7	5533	12	iNKT	inkt	JJ
cord-005453-4057qib7	5533	13	cells	cell	NNS
cord-005453-4057qib7	5533	14	in	in	IN
cord-005453-4057qib7	5533	15	the	the	DT
cord-005453-4057qib7	5533	16	graft	graft	NN
cord-005453-4057qib7	5533	17	(	(	-LRB-
cord-005453-4057qib7	5533	18	p=0.0003	p=0.0003	NNP
cord-005453-4057qib7	5533	19	,	,	,
cord-005453-4057qib7	5533	20	31	31	CD
cord-005453-4057qib7	5533	21	%	%	NN
cord-005453-4057qib7	5533	22	vs	vs	IN
cord-005453-4057qib7	5533	23	12	12	CD
cord-005453-4057qib7	5533	24	%	%	NN
cord-005453-4057qib7	5533	25	with	with	IN
cord-005453-4057qib7	5533	26	the	the	DT
cord-005453-4057qib7	5533	27	cut	cut	NN
cord-005453-4057qib7	5533	28	off	off	RP
cord-005453-4057qib7	5533	29	0.03	0.03	CD
cord-005453-4057qib7	5533	30	%	%	NN
cord-005453-4057qib7	5533	31	)	)	-RRB-
cord-005453-4057qib7	5533	32	.	.	.
cord-005453-4057qib7	5534	1	There	there	EX
cord-005453-4057qib7	5534	2	was	be	VBD
cord-005453-4057qib7	5534	3	a	a	DT
cord-005453-4057qib7	5534	4	correlation	correlation	NN
cord-005453-4057qib7	5534	5	between	between	IN
cord-005453-4057qib7	5534	6	IL-8	IL-8	NNP
cord-005453-4057qib7	5534	7	levels	level	NNS
cord-005453-4057qib7	5534	8	and	and	CC
cord-005453-4057qib7	5534	9	number	number	NN
cord-005453-4057qib7	5534	10	of	of	IN
cord-005453-4057qib7	5534	11	NK	NK	NNP
cord-005453-4057qib7	5534	12	cells	cell	NNS
cord-005453-4057qib7	5534	13	in	in	IN
cord-005453-4057qib7	5534	14	the	the	DT
cord-005453-4057qib7	5534	15	graft	graft	NN
cord-005453-4057qib7	5534	16	(	(	-LRB-
cord-005453-4057qib7	5534	17	p=0.02	p=0.02	NN
cord-005453-4057qib7	5534	18	)	)	-RRB-
cord-005453-4057qib7	5534	19	.	.	.
cord-005453-4057qib7	5535	1	NRM	NRM	NNP
cord-005453-4057qib7	5535	2	was	be	VBD
cord-005453-4057qib7	5535	3	related	relate	VBN
cord-005453-4057qib7	5535	4	to	to	IN
cord-005453-4057qib7	5535	5	infectious	infectious	JJ
cord-005453-4057qib7	5535	6	complications	complication	NNS
cord-005453-4057qib7	5535	7	,	,	,
cord-005453-4057qib7	5535	8	nonetheless	nonetheless	RB
cord-005453-4057qib7	5535	9	high	high	JJ
cord-005453-4057qib7	5535	10	levels	level	NNS
cord-005453-4057qib7	5535	11	of	of	IN
cord-005453-4057qib7	5535	12	VEGF	VEGF	NNP
cord-005453-4057qib7	5535	13	A	A	NNP
cord-005453-4057qib7	5535	14	on	on	IN
cord-005453-4057qib7	5535	15	day	day	NN
cord-005453-4057qib7	5535	16	0	0	NFP
cord-005453-4057qib7	5535	17	(	(	-LRB-
cord-005453-4057qib7	5535	18	p=	p=	NNP
cord-005453-4057qib7	5535	19	0.0458	0.0458	CD
cord-005453-4057qib7	5535	20	,	,	,
cord-005453-4057qib7	5535	21	16	16	CD
cord-005453-4057qib7	5535	22	%	%	NN
cord-005453-4057qib7	5535	23	vs	vs	IN
cord-005453-4057qib7	5535	24	0	0	CD
cord-005453-4057qib7	5535	25	%	%	NN
cord-005453-4057qib7	5535	26	with	with	IN
cord-005453-4057qib7	5535	27	the	the	DT
cord-005453-4057qib7	5535	28	cut	cut	NN
cord-005453-4057qib7	5535	29	off	off	RP
cord-005453-4057qib7	5535	30	100	100	CD
cord-005453-4057qib7	5535	31	ng	ng	NN
cord-005453-4057qib7	5535	32	/	/	SYM
cord-005453-4057qib7	5535	33	ml	ml	NNP
cord-005453-4057qib7	5535	34	)	)	-RRB-
cord-005453-4057qib7	5535	35	,	,	,
cord-005453-4057qib7	5535	36	ST2	ST2	NNP
cord-005453-4057qib7	5535	37	on	on	IN
cord-005453-4057qib7	5535	38	day+30	day+30	NNP
cord-005453-4057qib7	5535	39	(	(	-LRB-
cord-005453-4057qib7	5535	40	p=	p=	NNP
cord-005453-4057qib7	5535	41	0.0041	0.0041	CD
cord-005453-4057qib7	5535	42	,	,	,
cord-005453-4057qib7	5535	43	11	11	CD
cord-005453-4057qib7	5535	44	%	%	NN
cord-005453-4057qib7	5535	45	vs	vs	IN
cord-005453-4057qib7	5535	46	0	0	CD
cord-005453-4057qib7	5535	47	%	%	NN
cord-005453-4057qib7	5535	48	%	%	NN
cord-005453-4057qib7	5535	49	with	with	IN
cord-005453-4057qib7	5535	50	the	the	DT
cord-005453-4057qib7	5535	51	cut	cut	NN
cord-005453-4057qib7	5535	52	off	off	RP
cord-005453-4057qib7	5535	53	40	40	CD
cord-005453-4057qib7	5535	54	ng	ng	NNP
cord-005453-4057qib7	5535	55	/	/	SYM
cord-005453-4057qib7	5535	56	ml	ml	NN
cord-005453-4057qib7	5535	57	)	)	-RRB-
cord-005453-4057qib7	5535	58	and	and	CC
cord-005453-4057qib7	5535	59	low	low	JJ
cord-005453-4057qib7	5535	60	percentage	percentage	NN
cord-005453-4057qib7	5535	61	of	of	IN
cord-005453-4057qib7	5535	62	CD16+CD56-cells	cd16+cd56-cell	NNS
cord-005453-4057qib7	5535	63	in	in	IN
cord-005453-4057qib7	5535	64	the	the	DT
cord-005453-4057qib7	5535	65	graft	graft	NN
cord-005453-4057qib7	5535	66	(	(	-LRB-
cord-005453-4057qib7	5535	67	p=0.0215	p=0.0215	NN
cord-005453-4057qib7	5535	68	,	,	,
cord-005453-4057qib7	5535	69	22	22	CD
cord-005453-4057qib7	5535	70	%	%	NN
cord-005453-4057qib7	5535	71	vs	vs	IN
cord-005453-4057qib7	5535	72	2	2	CD
cord-005453-4057qib7	5535	73	%	%	NN
cord-005453-4057qib7	5535	74	with	with	IN
cord-005453-4057qib7	5535	75	the	the	DT
cord-005453-4057qib7	5535	76	cut	cut	NN
cord-005453-4057qib7	5535	77	off	off	RP
cord-005453-4057qib7	5535	78	1.3	1.3	CD
cord-005453-4057qib7	5535	79	%	%	NN
cord-005453-4057qib7	5535	80	)	)	-RRB-
cord-005453-4057qib7	5535	81	.	.	.
cord-005453-4057qib7	5536	1	The	the	DT
cord-005453-4057qib7	5536	2	identified	identify	VBN
cord-005453-4057qib7	5536	3	biomarkers	biomarker	NNS
cord-005453-4057qib7	5536	4	of	of	IN
cord-005453-4057qib7	5536	5	NRM	NRM	NNP
cord-005453-4057qib7	5536	6	had	have	VBD
cord-005453-4057qib7	5536	7	no	no	DT
cord-005453-4057qib7	5536	8	association	association	NN
cord-005453-4057qib7	5536	9	with	with	IN
cord-005453-4057qib7	5536	10	the	the	DT
cord-005453-4057qib7	5536	11	pre	pre	JJ
cord-005453-4057qib7	5536	12	-	-	JJ
cord-005453-4057qib7	5536	13	transplant	transplant	JJ
cord-005453-4057qib7	5536	14	CRP	crp	NN
cord-005453-4057qib7	5536	15	and	and	CC
cord-005453-4057qib7	5536	16	ferritin	ferritin	NN
cord-005453-4057qib7	5536	17	levels	level	NNS
cord-005453-4057qib7	5536	18	(	(	-LRB-
cord-005453-4057qib7	5536	19	p>0.4	p>0.4	NNS
cord-005453-4057qib7	5536	20	)	)	-RRB-
cord-005453-4057qib7	5536	21	.	.	.
cord-005453-4057qib7	5537	1	The	the	DT
cord-005453-4057qib7	5537	2	only	only	JJ
cord-005453-4057qib7	5537	3	significant	significant	JJ
cord-005453-4057qib7	5537	4	parameter	parameter	NN
cord-005453-4057qib7	5537	5	for	for	IN
cord-005453-4057qib7	5537	6	RI	RI	NNP
cord-005453-4057qib7	5537	7	was	be	VBD
cord-005453-4057qib7	5537	8	the	the	DT
cord-005453-4057qib7	5537	9	level	level	NN
cord-005453-4057qib7	5537	10	of	of	IN
cord-005453-4057qib7	5537	11	CD34	CD34	NNP
cord-005453-4057qib7	5537	12	cells	cell	NNS
cord-005453-4057qib7	5537	13	in	in	IN
cord-005453-4057qib7	5537	14	the	the	DT
cord-005453-4057qib7	5537	15	graft	graft	NN
cord-005453-4057qib7	5537	16	(	(	-LRB-
cord-005453-4057qib7	5537	17	p=0.0434	p=0.0434	NNS
cord-005453-4057qib7	5537	18	)	)	-RRB-
cord-005453-4057qib7	5537	19	.	.	.
cord-005453-4057qib7	5538	1	None	none	NN
cord-005453-4057qib7	5538	2	of	of	IN
cord-005453-4057qib7	5538	3	the	the	DT
cord-005453-4057qib7	5538	4	identified	identify	VBN
cord-005453-4057qib7	5538	5	biomarkers	biomarker	NNS
cord-005453-4057qib7	5538	6	significantly	significantly	RB
cord-005453-4057qib7	5538	7	predicted	predict	VBD
cord-005453-4057qib7	5538	8	overall	overall	JJ
cord-005453-4057qib7	5538	9	survival	survival	NN
cord-005453-4057qib7	5538	10	(	(	-LRB-
cord-005453-4057qib7	5538	11	p>0.09	p>0.09	NN
cord-005453-4057qib7	5538	12	)	)	-RRB-
cord-005453-4057qib7	5538	13	.	.	.
cord-005453-4057qib7	5539	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5539	2	:	:	:
cord-005453-4057qib7	5540	1	In	in	IN
cord-005453-4057qib7	5540	2	the	the	DT
cord-005453-4057qib7	5540	3	related	related	JJ
cord-005453-4057qib7	5540	4	and	and	CC
cord-005453-4057qib7	5540	5	unrelated	unrelated	JJ
cord-005453-4057qib7	5540	6	grafts	graft	NNS
cord-005453-4057qib7	5540	7	with	with	IN
cord-005453-4057qib7	5540	8	PTCy	PTCy	NNS
cord-005453-4057qib7	5540	9	the	the	DT
cord-005453-4057qib7	5540	10	study	study	NN
cord-005453-4057qib7	5540	11	of	of	IN
cord-005453-4057qib7	5540	12	biomarkers	biomarker	NNS
cord-005453-4057qib7	5540	13	has	have	VBZ
cord-005453-4057qib7	5540	14	low	low	JJ
cord-005453-4057qib7	5540	15	clinical	clinical	JJ
cord-005453-4057qib7	5540	16	utility	utility	NN
cord-005453-4057qib7	5540	17	due	due	IN
cord-005453-4057qib7	5540	18	to	to	IN
cord-005453-4057qib7	5540	19	very	very	RB
cord-005453-4057qib7	5540	20	low	low	JJ
cord-005453-4057qib7	5540	21	GVHD	gvhd	NN
cord-005453-4057qib7	5540	22	-	-	HYPH
cord-005453-4057qib7	5540	23	related	relate	VBN
cord-005453-4057qib7	5540	24	mortality	mortality	NN
cord-005453-4057qib7	5540	25	.	.	.
cord-005453-4057qib7	5541	1	However	however	RB
cord-005453-4057qib7	5541	2	ST2	ST2	NNP
cord-005453-4057qib7	5541	3	and	and	CC
cord-005453-4057qib7	5541	4	VEGF	VEGF	NNP
cord-005453-4057qib7	5541	5	A	A	NNP
cord-005453-4057qib7	5541	6	can	can	MD
cord-005453-4057qib7	5541	7	predict	predict	VB
cord-005453-4057qib7	5541	8	infection	infection	NN
cord-005453-4057qib7	5541	9	-	-	HYPH
cord-005453-4057qib7	5541	10	related	relate	VBN
cord-005453-4057qib7	5541	11	mortality	mortality	NN
cord-005453-4057qib7	5541	12	.	.	.
cord-005453-4057qib7	5542	1	Also	also	RB
cord-005453-4057qib7	5542	2	the	the	DT
cord-005453-4057qib7	5542	3	study	study	NN
cord-005453-4057qib7	5542	4	verified	verify	VBD
cord-005453-4057qib7	5542	5	previous	previous	JJ
cord-005453-4057qib7	5542	6	observations	observation	NNS
cord-005453-4057qib7	5542	7	that	that	IN
cord-005453-4057qib7	5542	8	high	high	JJ
cord-005453-4057qib7	5542	9	level	level	NN
cord-005453-4057qib7	5542	10	of	of	IN
cord-005453-4057qib7	5542	11	IL-8	IL-8	NNP
cord-005453-4057qib7	5542	12	is	be	VBZ
cord-005453-4057qib7	5542	13	associated	associate	VBN
cord-005453-4057qib7	5542	14	with	with	IN
cord-005453-4057qib7	5542	15	reduced	reduce	VBN
cord-005453-4057qib7	5542	16	GVHD	GVHD	NNP
cord-005453-4057qib7	5542	17	incidence	incidence	NN
cord-005453-4057qib7	5542	18	after	after	IN
cord-005453-4057qib7	5542	19	PTCy	PTCy	NNS
cord-005453-4057qib7	5542	20	1	1	CD
cord-005453-4057qib7	5542	21	and	and	CC
cord-005453-4057qib7	5542	22	identified	identify	VBD
cord-005453-4057qib7	5542	23	the	the	DT
cord-005453-4057qib7	5542	24	importance	importance	NN
cord-005453-4057qib7	5542	25	of	of	IN
cord-005453-4057qib7	5542	26	NK	NK	NNP
cord-005453-4057qib7	5542	27	and	and	CC
cord-005453-4057qib7	5542	28	iNKT	inkt	JJ
cord-005453-4057qib7	5542	29	cells	cell	NNS
cord-005453-4057qib7	5542	30	in	in	IN
cord-005453-4057qib7	5542	31	the	the	DT
cord-005453-4057qib7	5542	32	induction	induction	NN
cord-005453-4057qib7	5542	33	of	of	IN
cord-005453-4057qib7	5542	34	tolerance	tolerance	NN
cord-005453-4057qib7	5542	35	with	with	IN
cord-005453-4057qib7	5542	36	PTCy	PTCy	NNS
cord-005453-4057qib7	5542	37	.	.	.
cord-005453-4057qib7	5543	1	References	reference	NNS
cord-005453-4057qib7	5543	2	Background	Background	NNP
cord-005453-4057qib7	5543	3	:	:	:
cord-005453-4057qib7	5543	4	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5543	5	cell	cell	NN
cord-005453-4057qib7	5543	6	transplantation	transplantation	NN
cord-005453-4057qib7	5543	7	(	(	-LRB-
cord-005453-4057qib7	5543	8	HCT	HCT	NNP
cord-005453-4057qib7	5543	9	)	)	-RRB-
cord-005453-4057qib7	5543	10	is	be	VBZ
cord-005453-4057qib7	5543	11	the	the	DT
cord-005453-4057qib7	5543	12	only	only	JJ
cord-005453-4057qib7	5543	13	curative	curative	JJ
cord-005453-4057qib7	5543	14	approach	approach	NN
cord-005453-4057qib7	5543	15	for	for	IN
cord-005453-4057qib7	5543	16	many	many	JJ
cord-005453-4057qib7	5543	17	hematological	hematological	JJ
cord-005453-4057qib7	5543	18	malignancies	malignancy	NNS
cord-005453-4057qib7	5543	19	but	but	CC
cord-005453-4057qib7	5543	20	life	life	NN
cord-005453-4057qib7	5543	21	-	-	HYPH
cord-005453-4057qib7	5543	22	threatening	threaten	VBG
cord-005453-4057qib7	5543	23	toxicities	toxicity	NNS
cord-005453-4057qib7	5543	24	,	,	,
cord-005453-4057qib7	5543	25	such	such	JJ
cord-005453-4057qib7	5543	26	as	as	IN
cord-005453-4057qib7	5543	27	graft	graft	NN
cord-005453-4057qib7	5543	28	-	-	HYPH
cord-005453-4057qib7	5543	29	versushost	versushost	NN
cord-005453-4057qib7	5543	30	disease	disease	NN
cord-005453-4057qib7	5543	31	(	(	-LRB-
cord-005453-4057qib7	5543	32	GVHD	GVHD	NNP
cord-005453-4057qib7	5543	33	)	)	-RRB-
cord-005453-4057qib7	5543	34	and	and	CC
cord-005453-4057qib7	5543	35	infections	infection	NNS
cord-005453-4057qib7	5543	36	,	,	,
cord-005453-4057qib7	5543	37	still	still	RB
cord-005453-4057qib7	5543	38	limit	limit	VB
cord-005453-4057qib7	5543	39	its	-PRON-	PRP$
cord-005453-4057qib7	5543	40	fullpotential	fullpotential	JJ
cord-005453-4057qib7	5543	41	impact	impact	NN
cord-005453-4057qib7	5543	42	on	on	IN
cord-005453-4057qib7	5543	43	the	the	DT
cord-005453-4057qib7	5543	44	disease	disease	NN
cord-005453-4057qib7	5543	45	.	.	.
cord-005453-4057qib7	5544	1	Strategies	strategy	NNS
cord-005453-4057qib7	5544	2	for	for	IN
cord-005453-4057qib7	5544	3	keeping	keep	VBG
cord-005453-4057qib7	5544	4	alloHSCT	allohsct	RB
cord-005453-4057qib7	5544	5	more	more	RBR
cord-005453-4057qib7	5544	6	effective	effective	JJ
cord-005453-4057qib7	5544	7	and	and	CC
cord-005453-4057qib7	5544	8	safe	safe	JJ
cord-005453-4057qib7	5544	9	are	be	VBP
cord-005453-4057qib7	5544	10	needed	need	VBN
cord-005453-4057qib7	5544	11	in	in	IN
cord-005453-4057qib7	5544	12	order	order	NN
cord-005453-4057qib7	5544	13	to	to	TO
cord-005453-4057qib7	5544	14	reduce	reduce	VB
cord-005453-4057qib7	5544	15	morbidity	morbidity	NN
cord-005453-4057qib7	5544	16	while	while	IN
cord-005453-4057qib7	5544	17	improving	improve	VBG
cord-005453-4057qib7	5544	18	its	-PRON-	PRP$
cord-005453-4057qib7	5544	19	immunological	immunological	JJ
cord-005453-4057qib7	5544	20	effect	effect	NN
cord-005453-4057qib7	5544	21	to	to	TO
cord-005453-4057qib7	5544	22	control	control	VB
cord-005453-4057qib7	5544	23	disease	disease	NN
cord-005453-4057qib7	5544	24	relapse	relapse	VB
cord-005453-4057qib7	5544	25	.	.	.
cord-005453-4057qib7	5545	1	Post	post	JJ
cord-005453-4057qib7	5545	2	-	-	NN
cord-005453-4057qib7	5545	3	transplant	transplant	NN
cord-005453-4057qib7	5545	4	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	5545	5	(	(	-LRB-
cord-005453-4057qib7	5545	6	ptCy	ptcy	RB
cord-005453-4057qib7	5545	7	)	)	-RRB-
cord-005453-4057qib7	5545	8	has	have	VBZ
cord-005453-4057qib7	5545	9	been	be	VBN
cord-005453-4057qib7	5545	10	demonstrated	demonstrate	VBN
cord-005453-4057qib7	5545	11	to	to	TO
cord-005453-4057qib7	5545	12	improve	improve	VB
cord-005453-4057qib7	5545	13	acute	acute	JJ
cord-005453-4057qib7	5545	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5545	15	(	(	-LRB-
cord-005453-4057qib7	5545	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5545	17	)	)	-RRB-
cord-005453-4057qib7	5545	18	and	and	CC
cord-005453-4057qib7	5545	19	chronic	chronic	JJ
cord-005453-4057qib7	5545	20	GVHD	GVHD	NNP
cord-005453-4057qib7	5545	21	(	(	-LRB-
cord-005453-4057qib7	5545	22	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5545	23	)	)	-RRB-
cord-005453-4057qib7	5545	24	control	control	NN
cord-005453-4057qib7	5545	25	in	in	IN
cord-005453-4057qib7	5545	26	allogeneic	allogeneic	NN
cord-005453-4057qib7	5545	27	bone	bone	NN
cord-005453-4057qib7	5545	28	-	-	HYPH
cord-005453-4057qib7	5545	29	marrow	marrow	NN
cord-005453-4057qib7	5545	30	HCT	hct	NN
cord-005453-4057qib7	5545	31	from	from	IN
cord-005453-4057qib7	5545	32	identical	identical	JJ
cord-005453-4057qib7	5545	33	and	and	CC
cord-005453-4057qib7	5545	34	haploidentical	haploidentical	JJ
cord-005453-4057qib7	5545	35	donor	donor	NN
cord-005453-4057qib7	5545	36	.	.	.
cord-005453-4057qib7	5546	1	The	the	DT
cord-005453-4057qib7	5546	2	use	use	NN
cord-005453-4057qib7	5546	3	of	of	IN
cord-005453-4057qib7	5546	4	ptCy	ptcy	RB
cord-005453-4057qib7	5546	5	,	,	,
cord-005453-4057qib7	5546	6	after	after	IN
cord-005453-4057qib7	5546	7	peripheral	peripheral	JJ
cord-005453-4057qib7	5546	8	blood	blood	NN
cord-005453-4057qib7	5546	9	stem	stem	NN
cord-005453-4057qib7	5546	10	cell	cell	NN
cord-005453-4057qib7	5546	11	transplantation	transplantation	NN
cord-005453-4057qib7	5546	12	(	(	-LRB-
cord-005453-4057qib7	5546	13	alloPBSCT	alloPBSCT	NNP
cord-005453-4057qib7	5546	14	)	)	-RRB-
cord-005453-4057qib7	5546	15	from	from	IN
cord-005453-4057qib7	5546	16	HLA	HLA	NNP
cord-005453-4057qib7	5546	17	-	-	HYPH
cord-005453-4057qib7	5546	18	matched	match	VBN
cord-005453-4057qib7	5546	19	unrelated	unrelated	JJ
cord-005453-4057qib7	5546	20	/	/	SYM
cord-005453-4057qib7	5546	21	related	related	JJ
cord-005453-4057qib7	5546	22	donors	donor	NNS
cord-005453-4057qib7	5546	23	,	,	,
cord-005453-4057qib7	5546	24	has	have	VBZ
cord-005453-4057qib7	5546	25	been	be	VBN
cord-005453-4057qib7	5546	26	investigated	investigate	VBN
cord-005453-4057qib7	5546	27	by	by	IN
cord-005453-4057qib7	5546	28	our	-PRON-	PRP$
cord-005453-4057qib7	5546	29	group	group	NN
cord-005453-4057qib7	5546	30	in	in	IN
cord-005453-4057qib7	5546	31	a	a	DT
cord-005453-4057qib7	5546	32	clinical	clinical	JJ
cord-005453-4057qib7	5546	33	trial	trial	NN
cord-005453-4057qib7	5546	34	(	(	-LRB-
cord-005453-4057qib7	5546	35	NCT	NCT	NNP
cord-005453-4057qib7	5546	36	02300571	02300571	CD
cord-005453-4057qib7	5546	37	)	)	-RRB-
cord-005453-4057qib7	5546	38	and	and	CC
cord-005453-4057qib7	5546	39	preliminary	preliminary	JJ
cord-005453-4057qib7	5546	40	results	result	NNS
cord-005453-4057qib7	5546	41	were	be	VBD
cord-005453-4057qib7	5546	42	published	publish	VBN
cord-005453-4057qib7	5546	43	last	last	JJ
cord-005453-4057qib7	5546	44	year	year	NN
cord-005453-4057qib7	5546	45	.	.	.
cord-005453-4057qib7	5547	1	Here	here	RB
cord-005453-4057qib7	5547	2	we	-PRON-	PRP
cord-005453-4057qib7	5547	3	report	report	VBP
cord-005453-4057qib7	5547	4	updated	update	VBD
cord-005453-4057qib7	5547	5	efficacy	efficacy	NN
cord-005453-4057qib7	5547	6	and	and	CC
cord-005453-4057qib7	5547	7	safety	safety	NN
cord-005453-4057qib7	5547	8	data	datum	NNS
cord-005453-4057qib7	5547	9	about	about	IN
cord-005453-4057qib7	5547	10	the	the	DT
cord-005453-4057qib7	5547	11	expanded	expand	VBN
cord-005453-4057qib7	5547	12	cohort	cohort	NN
cord-005453-4057qib7	5547	13	of	of	IN
cord-005453-4057qib7	5547	14	patients	patient	NNS
cord-005453-4057qib7	5547	15	treated	treat	VBN
cord-005453-4057qib7	5547	16	with	with	IN
cord-005453-4057qib7	5547	17	ptCy	ptcy	RB
cord-005453-4057qib7	5547	18	followed	follow	VBN
cord-005453-4057qib7	5547	19	by	by	IN
cord-005453-4057qib7	5547	20	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	5547	21	and	and	CC
cord-005453-4057qib7	5547	22	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	5547	23	mofetil	mofetil	NNP
cord-005453-4057qib7	5548	1	(	(	-LRB-
cord-005453-4057qib7	5548	2	T	T	NNP
cord-005453-4057qib7	5548	3	/	/	SYM
cord-005453-4057qib7	5548	4	MMF	MMF	NNP
cord-005453-4057qib7	5548	5	)	)	-RRB-
cord-005453-4057qib7	5548	6	.	.	.
cord-005453-4057qib7	5549	1	Methods	method	NNS
cord-005453-4057qib7	5549	2	:	:	:
cord-005453-4057qib7	5550	1	We	-PRON-	PRP
cord-005453-4057qib7	5550	2	analysed	analyse	VBD
cord-005453-4057qib7	5550	3	data	datum	NNS
cord-005453-4057qib7	5550	4	about	about	IN
cord-005453-4057qib7	5550	5	71	71	CD
cord-005453-4057qib7	5550	6	consecutive	consecutive	JJ
cord-005453-4057qib7	5550	7	patients	patient	NNS
cord-005453-4057qib7	5550	8	with	with	IN
cord-005453-4057qib7	5550	9	high	high	JJ
cord-005453-4057qib7	5550	10	-	-	HYPH
cord-005453-4057qib7	5550	11	risk	risk	NN
cord-005453-4057qib7	5550	12	hematologic	hematologic	JJ
cord-005453-4057qib7	5550	13	malignancies	malignancy	NNS
cord-005453-4057qib7	5550	14	received	receive	VBD
cord-005453-4057qib7	5550	15	alloPBSCT	alloPBSCT	NNP
cord-005453-4057qib7	5550	16	from	from	IN
cord-005453-4057qib7	5550	17	HLA	HLA	NNP
cord-005453-4057qib7	5550	18	-	-	HYPH
cord-005453-4057qib7	5550	19	matched	match	VBN
cord-005453-4057qib7	5550	20	unrelated	unrelated	JJ
cord-005453-4057qib7	5550	21	/	/	SYM
cord-005453-4057qib7	5550	22	related	relate	VBN
cord-005453-4057qib7	5550	23	donors	donor	NNS
cord-005453-4057qib7	5550	24	between	between	IN
cord-005453-4057qib7	5550	25	March	March	NNP
cord-005453-4057qib7	5550	26	2011	2011	CD
cord-005453-4057qib7	5550	27	and	and	CC
cord-005453-4057qib7	5550	28	August	August	NNP
cord-005453-4057qib7	5550	29	2018	2018	CD
cord-005453-4057qib7	5550	30	.	.	.
cord-005453-4057qib7	5551	1	GVHD	GVHD	NNP
cord-005453-4057qib7	5551	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5551	3	was	be	VBD
cord-005453-4057qib7	5551	4	ptCy	ptcy	RB
cord-005453-4057qib7	5551	5	50	50	CD
cord-005453-4057qib7	5551	6	mg	mg	NNP
cord-005453-4057qib7	5551	7	/	/	SYM
cord-005453-4057qib7	5551	8	kg	kg	NNP
cord-005453-4057qib7	5551	9	(	(	-LRB-
cord-005453-4057qib7	5551	10	days	day	NNS
cord-005453-4057qib7	5551	11	+3	+3	NNP
cord-005453-4057qib7	5551	12	+4	+4	NN
cord-005453-4057qib7	5551	13	)	)	-RRB-
cord-005453-4057qib7	5551	14	,	,	,
cord-005453-4057qib7	5551	15	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	5551	16	from	from	IN
cord-005453-4057qib7	5551	17	day	day	NN
cord-005453-4057qib7	5551	18	+5	+5	NN
cord-005453-4057qib7	5551	19	and	and	CC
cord-005453-4057qib7	5551	20	MMF	mmf	NN
cord-005453-4057qib7	5551	21	from	from	IN
cord-005453-4057qib7	5551	22	day	day	NN
cord-005453-4057qib7	5551	23	+5	+5	NN
cord-005453-4057qib7	5551	24	to	to	IN
cord-005453-4057qib7	5551	25	day	day	NN
cord-005453-4057qib7	5551	26	+28	+28	NNS
cord-005453-4057qib7	5551	27	.	.	.
cord-005453-4057qib7	5552	1	Primary	primary	JJ
cord-005453-4057qib7	5552	2	objectives	objective	NNS
cord-005453-4057qib7	5552	3	were	be	VBD
cord-005453-4057qib7	5552	4	cumulative	cumulative	JJ
cord-005453-4057qib7	5552	5	incidence	incidence	NN
cord-005453-4057qib7	5552	6	of	of	IN
cord-005453-4057qib7	5552	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5552	8	and	and	CC
cord-005453-4057qib7	5552	9	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5552	10	.	.	.
cord-005453-4057qib7	5553	1	Secondary	secondary	JJ
cord-005453-4057qib7	5553	2	objectives	objective	NNS
cord-005453-4057qib7	5553	3	were	be	VBD
cord-005453-4057qib7	5553	4	event	event	NN
cord-005453-4057qib7	5553	5	-	-	HYPH
cord-005453-4057qib7	5553	6	free	free	JJ
cord-005453-4057qib7	5553	7	survival	survival	NN
cord-005453-4057qib7	5553	8	(	(	-LRB-
cord-005453-4057qib7	5553	9	EFS	EFS	NNP
cord-005453-4057qib7	5553	10	)	)	-RRB-
cord-005453-4057qib7	5553	11	,	,	,
cord-005453-4057qib7	5553	12	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5553	13	-	-	HYPH
cord-005453-4057qib7	5553	14	EFS	EFS	NNP
cord-005453-4057qib7	5553	15	,	,	,
cord-005453-4057qib7	5553	16	overall	overall	JJ
cord-005453-4057qib7	5553	17	survival	survival	NN
cord-005453-4057qib7	5553	18	(	(	-LRB-
cord-005453-4057qib7	5553	19	OS	OS	NNP
cord-005453-4057qib7	5553	20	)	)	-RRB-
cord-005453-4057qib7	5553	21	and	and	CC
cord-005453-4057qib7	5553	22	non	non	JJ
cord-005453-4057qib7	5553	23	-	-	JJ
cord-005453-4057qib7	5553	24	relapse	relapse	JJ
cord-005453-4057qib7	5553	25	mortality	mortality	NN
cord-005453-4057qib7	5553	26	(	(	-LRB-
cord-005453-4057qib7	5553	27	NRM	NRM	NNP
cord-005453-4057qib7	5553	28	)	)	-RRB-
cord-005453-4057qib7	5553	29	.	.	.
cord-005453-4057qib7	5554	1	Results	result	NNS
cord-005453-4057qib7	5554	2	:	:	:
cord-005453-4057qib7	5555	1	Patients	patient	NNS
cord-005453-4057qib7	5555	2	median	median	JJ
cord-005453-4057qib7	5555	3	age	age	NN
cord-005453-4057qib7	5555	4	at	at	IN
cord-005453-4057qib7	5555	5	transplant	transplant	NN
cord-005453-4057qib7	5555	6	was	be	VBD
cord-005453-4057qib7	5555	7	50	50	CD
cord-005453-4057qib7	5556	1	(	(	-LRB-
cord-005453-4057qib7	5556	2	range	range	NNP
cord-005453-4057qib7	5556	3	19	19	CD
cord-005453-4057qib7	5556	4	-	-	SYM
cord-005453-4057qib7	5556	5	74	74	CD
cord-005453-4057qib7	5556	6	)	)	-RRB-
cord-005453-4057qib7	5556	7	years	year	NNS
cord-005453-4057qib7	5556	8	.	.	.
cord-005453-4057qib7	5557	1	34	34	CD
cord-005453-4057qib7	5557	2	(	(	-LRB-
cord-005453-4057qib7	5557	3	48	48	CD
cord-005453-4057qib7	5557	4	%	%	NN
cord-005453-4057qib7	5557	5	)	)	-RRB-
cord-005453-4057qib7	5557	6	patients	patient	NNS
cord-005453-4057qib7	5557	7	were	be	VBD
cord-005453-4057qib7	5557	8	transplanted	transplant	VBN
cord-005453-4057qib7	5557	9	in	in	IN
cord-005453-4057qib7	5557	10	first	first	JJ
cord-005453-4057qib7	5557	11	complete	complete	JJ
cord-005453-4057qib7	5557	12	response	response	NN
cord-005453-4057qib7	5557	13	(	(	-LRB-
cord-005453-4057qib7	5557	14	CR	CR	NNP
cord-005453-4057qib7	5557	15	)	)	-RRB-
cord-005453-4057qib7	5557	16	,	,	,
cord-005453-4057qib7	5557	17	16	16	CD
cord-005453-4057qib7	5557	18	(	(	-LRB-
cord-005453-4057qib7	5557	19	23	23	CD
cord-005453-4057qib7	5557	20	%	%	NN
cord-005453-4057qib7	5557	21	)	)	-RRB-
cord-005453-4057qib7	5557	22	patients	patient	NNS
cord-005453-4057qib7	5557	23	in	in	IN
cord-005453-4057qib7	5557	24	second	second	JJ
cord-005453-4057qib7	5557	25	/	/	SYM
cord-005453-4057qib7	5557	26	third	third	JJ
cord-005453-4057qib7	5557	27	CR	CR	NNP
cord-005453-4057qib7	5557	28	,	,	,
cord-005453-4057qib7	5557	29	the	the	DT
cord-005453-4057qib7	5557	30	others	other	NNS
cord-005453-4057qib7	5557	31	in	in	IN
cord-005453-4057qib7	5557	32	disease	disease	NN
cord-005453-4057qib7	5557	33	control	control	NN
cord-005453-4057qib7	5557	34	.	.	.
cord-005453-4057qib7	5558	1	A	a	DT
cord-005453-4057qib7	5558	2	median	median	JJ
cord-005453-4057qib7	5558	3	dose	dose	NN
cord-005453-4057qib7	5558	4	of	of	IN
cord-005453-4057qib7	5558	5	7.0	7.0	CD
cord-005453-4057qib7	5558	6	(	(	-LRB-
cord-005453-4057qib7	5558	7	range	range	NNP
cord-005453-4057qib7	5558	8	2	2	CD
cord-005453-4057qib7	5558	9	-	-	SYM
cord-005453-4057qib7	5558	10	15	15	CD
cord-005453-4057qib7	5558	11	)	)	-RRB-
cord-005453-4057qib7	5559	1	x	x	SYM
cord-005453-4057qib7	5559	2	10	10	CD
cord-005453-4057qib7	5559	3	^	^	SYM
cord-005453-4057qib7	5559	4	6	6	CD
cord-005453-4057qib7	5559	5	CD34	CD34	NNP
cord-005453-4057qib7	5559	6	/	/	SYM
cord-005453-4057qib7	5559	7	kg	kg	NNS
cord-005453-4057qib7	5559	8	was	be	VBD
cord-005453-4057qib7	5559	9	infused	infuse	VBN
cord-005453-4057qib7	5559	10	.	.	.
cord-005453-4057qib7	5560	1	Primary	primary	JJ
cord-005453-4057qib7	5560	2	graft	graft	NN
cord-005453-4057qib7	5560	3	failure	failure	NN
cord-005453-4057qib7	5560	4	was	be	VBD
cord-005453-4057qib7	5560	5	observed	observe	VBN
cord-005453-4057qib7	5560	6	in	in	IN
cord-005453-4057qib7	5560	7	one	one	CD
cord-005453-4057qib7	5560	8	patient	patient	NN
cord-005453-4057qib7	5560	9	.	.	.
cord-005453-4057qib7	5561	1	All	all	DT
cord-005453-4057qib7	5561	2	patients	patient	NNS
cord-005453-4057qib7	5561	3	were	be	VBD
cord-005453-4057qib7	5561	4	off	off	IN
cord-005453-4057qib7	5561	5	MMF	MMF	NNP
cord-005453-4057qib7	5561	6	on	on	IN
cord-005453-4057qib7	5561	7	day	day	NN
cord-005453-4057qib7	5561	8	+28	+28	NNS
cord-005453-4057qib7	5561	9	,	,	,
cord-005453-4057qib7	5561	10	the	the	DT
cord-005453-4057qib7	5561	11	median	median	JJ
cord-005453-4057qib7	5561	12	day	day	NN
cord-005453-4057qib7	5561	13	of	of	IN
cord-005453-4057qib7	5561	14	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	5561	15	discontinuation	discontinuation	NN
cord-005453-4057qib7	5561	16	was	be	VBD
cord-005453-4057qib7	5561	17	112	112	CD
cord-005453-4057qib7	5562	1	(	(	-LRB-
cord-005453-4057qib7	5562	2	range	range	NNP
cord-005453-4057qib7	5562	3	39	39	CD
cord-005453-4057qib7	5562	4	-	-	SYM
cord-005453-4057qib7	5562	5	467	467	CD
cord-005453-4057qib7	5562	6	)	)	-RRB-
cord-005453-4057qib7	5562	7	.	.	.
cord-005453-4057qib7	5563	1	Eight	eight	CD
cord-005453-4057qib7	5563	2	out	out	IN
cord-005453-4057qib7	5563	3	of	of	IN
cord-005453-4057qib7	5563	4	71	71	CD
cord-005453-4057qib7	5563	5	(	(	-LRB-
cord-005453-4057qib7	5563	6	11	11	CD
cord-005453-4057qib7	5563	7	%	%	NN
cord-005453-4057qib7	5563	8	)	)	-RRB-
cord-005453-4057qib7	5563	9	patients	patient	NNS
cord-005453-4057qib7	5563	10	developed	develop	VBD
cord-005453-4057qib7	5563	11	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5563	12	,	,	,
cord-005453-4057qib7	5563	13	6	6	CD
cord-005453-4057qib7	5563	14	(	(	-LRB-
cord-005453-4057qib7	5563	15	8	8	CD
cord-005453-4057qib7	5563	16	%	%	NN
cord-005453-4057qib7	5563	17	)	)	-RRB-
cord-005453-4057qib7	5563	18	of	of	IN
cord-005453-4057qib7	5563	19	them	-PRON-	PRP
cord-005453-4057qib7	5563	20	were	be	VBD
cord-005453-4057qib7	5563	21	grade	grade	NN
cord-005453-4057qib7	5563	22	II	II	NNP
cord-005453-4057qib7	5563	23	-	-	HYPH
cord-005453-4057qib7	5563	24	III	III	NNP
cord-005453-4057qib7	5563	25	;	;	:
cord-005453-4057qib7	5563	26	median	median	JJ
cord-005453-4057qib7	5563	27	day	day	NN
cord-005453-4057qib7	5563	28	of	of	IN
cord-005453-4057qib7	5563	29	onset	onset	NN
cord-005453-4057qib7	5563	30	was	be	VBD
cord-005453-4057qib7	5563	31	day	day	NN
cord-005453-4057qib7	5563	32	68	68	CD
cord-005453-4057qib7	5564	1	(	(	-LRB-
cord-005453-4057qib7	5564	2	range	range	NN
cord-005453-4057qib7	5564	3	.	.	.
cord-005453-4057qib7	5565	1	No	no	DT
cord-005453-4057qib7	5565	2	grade	grade	NN
cord-005453-4057qib7	5565	3	IV	IV	NNP
cord-005453-4057qib7	5565	4	was	be	VBD
cord-005453-4057qib7	5565	5	observed	observe	VBN
cord-005453-4057qib7	5565	6	.	.	.
cord-005453-4057qib7	5566	1	No	no	DT
cord-005453-4057qib7	5566	2	cases	case	NNS
cord-005453-4057qib7	5566	3	of	of	IN
cord-005453-4057qib7	5566	4	late	late	JJ
cord-005453-4057qib7	5566	5	-	-	HYPH
cord-005453-4057qib7	5566	6	onset	onset	NN
cord-005453-4057qib7	5566	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5566	8	were	be	VBD
cord-005453-4057qib7	5566	9	reported	report	VBN
cord-005453-4057qib7	5566	10	.	.	.
cord-005453-4057qib7	5567	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	5567	2	incidence	incidence	NN
cord-005453-4057qib7	5567	3	of	of	IN
cord-005453-4057qib7	5567	4	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5567	5	was	be	VBD
cord-005453-4057qib7	5567	6	8	8	CD
cord-005453-4057qib7	5567	7	%	%	NN
cord-005453-4057qib7	5567	8	(	(	-LRB-
cord-005453-4057qib7	5567	9	6/	6/	CD
cord-005453-4057qib7	5567	10	71	71	CD
cord-005453-4057qib7	5567	11	)	)	-RRB-
cord-005453-4057qib7	5567	12	,	,	,
cord-005453-4057qib7	5567	13	median	median	JJ
cord-005453-4057qib7	5567	14	day	day	NN
cord-005453-4057qib7	5567	15	of	of	IN
cord-005453-4057qib7	5567	16	onset	onset	NN
cord-005453-4057qib7	5567	17	was	be	VBD
cord-005453-4057qib7	5567	18	162	162	CD
cord-005453-4057qib7	5568	1	(	(	-LRB-
cord-005453-4057qib7	5568	2	range	range	NNP
cord-005453-4057qib7	5568	3	140	140	CD
cord-005453-4057qib7	5568	4	-	-	SYM
cord-005453-4057qib7	5568	5	268	268	CD
cord-005453-4057qib7	5568	6	)	)	-RRB-
cord-005453-4057qib7	5568	7	.	.	.
cord-005453-4057qib7	5569	1	Systemic	systemic	JJ
cord-005453-4057qib7	5569	2	treatments	treatment	NNS
cord-005453-4057qib7	5569	3	were	be	VBD
cord-005453-4057qib7	5569	4	required	require	VBN
cord-005453-4057qib7	5569	5	,	,	,
cord-005453-4057qib7	5569	6	but	but	CC
cord-005453-4057qib7	5569	7	all	all	DT
cord-005453-4057qib7	5569	8	patients	patient	NNS
cord-005453-4057qib7	5569	9	were	be	VBD
cord-005453-4057qib7	5569	10	able	able	JJ
cord-005453-4057qib7	5569	11	to	to	TO
cord-005453-4057qib7	5569	12	discontinue	discontinue	VB
cord-005453-4057qib7	5569	13	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	5569	14	(	(	-LRB-
cord-005453-4057qib7	5569	15	IS	be	VBZ
cord-005453-4057qib7	5569	16	)	)	-RRB-
cord-005453-4057qib7	5569	17	.	.	.
cord-005453-4057qib7	5570	1	With	with	IN
cord-005453-4057qib7	5570	2	a	a	DT
cord-005453-4057qib7	5570	3	median	median	JJ
cord-005453-4057qib7	5570	4	follow	follow	NN
cord-005453-4057qib7	5570	5	-	-	HYPH
cord-005453-4057qib7	5570	6	up	up	NN
cord-005453-4057qib7	5570	7	of	of	IN
cord-005453-4057qib7	5570	8	22	22	CD
cord-005453-4057qib7	5570	9	(	(	-LRB-
cord-005453-4057qib7	5570	10	range	range	NNP
cord-005453-4057qib7	5570	11	4	4	CD
cord-005453-4057qib7	5570	12	-	-	SYM
cord-005453-4057qib7	5570	13	94	94	CD
cord-005453-4057qib7	5570	14	)	)	-RRB-
cord-005453-4057qib7	5570	15	months	month	NNS
cord-005453-4057qib7	5570	16	,	,	,
cord-005453-4057qib7	5570	17	EFS	EFS	NNP
cord-005453-4057qib7	5570	18	was	be	VBD
cord-005453-4057qib7	5570	19	58	58	CD
cord-005453-4057qib7	5570	20	%	%	NN
cord-005453-4057qib7	5570	21	,	,	,
cord-005453-4057qib7	5570	22	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5570	23	-	-	HYPH
cord-005453-4057qib7	5570	24	EFS	EFS	NNP
cord-005453-4057qib7	5570	25	was	be	VBD
cord-005453-4057qib7	5570	26	52	52	CD
cord-005453-4057qib7	5570	27	%	%	NN
cord-005453-4057qib7	5570	28	and	and	CC
cord-005453-4057qib7	5570	29	OS	OS	NNP
cord-005453-4057qib7	5570	30	was	be	VBD
cord-005453-4057qib7	5570	31	72	72	CD
cord-005453-4057qib7	5570	32	%	%	NN
cord-005453-4057qib7	5570	33	.	.	.
cord-005453-4057qib7	5571	1	Non	non	JJ
cord-005453-4057qib7	5571	2	-	-	JJ
cord-005453-4057qib7	5571	3	relapse	relapse	JJ
cord-005453-4057qib7	5571	4	mortality	mortality	NN
cord-005453-4057qib7	5571	5	(	(	-LRB-
cord-005453-4057qib7	5571	6	NRM	NRM	NNP
cord-005453-4057qib7	5571	7	)	)	-RRB-
cord-005453-4057qib7	5571	8	was	be	VBD
cord-005453-4057qib7	5571	9	3	3	CD
cord-005453-4057qib7	5571	10	%	%	NN
cord-005453-4057qib7	5571	11	(	(	-LRB-
cord-005453-4057qib7	5571	12	2/71	2/71	CD
cord-005453-4057qib7	5571	13	)	)	-RRB-
cord-005453-4057qib7	5571	14	:	:	:
cord-005453-4057qib7	5572	1	2	2	CD
cord-005453-4057qib7	5572	2	patients	patient	NNS
cord-005453-4057qib7	5572	3	died	die	VBD
cord-005453-4057qib7	5572	4	because	because	IN
cord-005453-4057qib7	5572	5	of	of	IN
cord-005453-4057qib7	5572	6	multidrug	multidrug	NN
cord-005453-4057qib7	5572	7	resistant	resistant	JJ
cord-005453-4057qib7	5572	8	bacteria	bacteria	NNS
cord-005453-4057qib7	5572	9	septicemia	septicemia	NN
cord-005453-4057qib7	5572	10	.	.	.
cord-005453-4057qib7	5573	1	Nowadays	nowadays	RB
cord-005453-4057qib7	5573	2	41	41	CD
cord-005453-4057qib7	5573	3	patients	patient	NNS
cord-005453-4057qib7	5573	4	are	be	VBP
cord-005453-4057qib7	5573	5	alive	alive	JJ
cord-005453-4057qib7	5573	6	with	with	IN
cord-005453-4057qib7	5573	7	no	no	DT
cord-005453-4057qib7	5573	8	evidence	evidence	NN
cord-005453-4057qib7	5573	9	of	of	IN
cord-005453-4057qib7	5573	10	disease	disease	NN
cord-005453-4057qib7	5573	11	,	,	,
cord-005453-4057qib7	5573	12	being	be	VBG
cord-005453-4057qib7	5573	13	continuously	continuously	RB
cord-005453-4057qib7	5573	14	off	off	RB
cord-005453-4057qib7	5573	15	IS	be	VBZ
cord-005453-4057qib7	5573	16	and	and	CC
cord-005453-4057qib7	5573	17	completely	completely	RB
cord-005453-4057qib7	5573	18	reintegrated	reintegrate	VBN
cord-005453-4057qib7	5573	19	in	in	IN
cord-005453-4057qib7	5573	20	their	-PRON-	PRP$
cord-005453-4057qib7	5573	21	normal	normal	JJ
cord-005453-4057qib7	5573	22	daily	daily	JJ
cord-005453-4057qib7	5573	23	life	life	NN
cord-005453-4057qib7	5573	24	activities	activity	NNS
cord-005453-4057qib7	5573	25	.	.	.
cord-005453-4057qib7	5574	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5574	2	:	:	:
cord-005453-4057qib7	5575	1	The	the	DT
cord-005453-4057qib7	5575	2	updated	update	VBN
cord-005453-4057qib7	5575	3	reported	report	VBD
cord-005453-4057qib7	5575	4	results	result	NNS
cord-005453-4057qib7	5575	5	confirm	confirm	VBP
cord-005453-4057qib7	5575	6	,	,	,
cord-005453-4057qib7	5575	7	in	in	IN
cord-005453-4057qib7	5575	8	a	a	DT
cord-005453-4057qib7	5575	9	larger	large	JJR
cord-005453-4057qib7	5575	10	cohort	cohort	NN
cord-005453-4057qib7	5575	11	of	of	IN
cord-005453-4057qib7	5575	12	patients	patient	NNS
cord-005453-4057qib7	5575	13	with	with	IN
cord-005453-4057qib7	5575	14	a	a	DT
cord-005453-4057qib7	5575	15	longer	long	RBR
cord-005453-4057qib7	5575	16	follow	follow	NN
cord-005453-4057qib7	5575	17	-	-	HYPH
cord-005453-4057qib7	5575	18	up	up	NN
cord-005453-4057qib7	5575	19	,	,	,
cord-005453-4057qib7	5575	20	that	that	IN
cord-005453-4057qib7	5575	21	ptCy	ptcy	RB
cord-005453-4057qib7	5575	22	after	after	IN
cord-005453-4057qib7	5575	23	PBSC	PBSC	NNP
cord-005453-4057qib7	5575	24	-	-	HYPH
cord-005453-4057qib7	5575	25	HCT	HCT	NNP
cord-005453-4057qib7	5575	26	is	be	VBZ
cord-005453-4057qib7	5575	27	highly	highly	RB
cord-005453-4057qib7	5575	28	active	active	JJ
cord-005453-4057qib7	5575	29	in	in	IN
cord-005453-4057qib7	5575	30	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5575	31	and	and	CC
cord-005453-4057qib7	5575	32	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5575	33	prevention	prevention	NN
cord-005453-4057qib7	5575	34	with	with	IN
cord-005453-4057qib7	5575	35	extremely	extremely	RB
cord-005453-4057qib7	5575	36	limited	limited	JJ
cord-005453-4057qib7	5575	37	NRM	NRM	NNP
cord-005453-4057qib7	5575	38	.	.	.
cord-005453-4057qib7	5576	1	This	this	DT
cord-005453-4057qib7	5576	2	strategy	strategy	NN
cord-005453-4057qib7	5576	3	,	,	,
cord-005453-4057qib7	5576	4	not	not	RB
cord-005453-4057qib7	5576	5	only	only	RB
cord-005453-4057qib7	5576	6	allowed	allow	VBN
cord-005453-4057qib7	5576	7	earlier	early	JJR
cord-005453-4057qib7	5576	8	discontinuation	discontinuation	NN
cord-005453-4057qib7	5576	9	of	of	IN
cord-005453-4057qib7	5576	10	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	5576	11	,	,	,
cord-005453-4057qib7	5576	12	but	but	CC
cord-005453-4057qib7	5576	13	also	also	RB
cord-005453-4057qib7	5576	14	reduced	reduce	VBD
cord-005453-4057qib7	5576	15	the	the	DT
cord-005453-4057qib7	5576	16	overall	overall	JJ
cord-005453-4057qib7	5576	17	time	time	NN
cord-005453-4057qib7	5576	18	of	of	IN
cord-005453-4057qib7	5576	19	exposure	exposure	NN
cord-005453-4057qib7	5576	20	to	to	IN
cord-005453-4057qib7	5576	21	IS	be	VBZ
cord-005453-4057qib7	5576	22	for	for	IN
cord-005453-4057qib7	5576	23	most	most	JJS
cord-005453-4057qib7	5576	24	of	of	IN
cord-005453-4057qib7	5576	25	the	the	DT
cord-005453-4057qib7	5576	26	patients	patient	NNS
cord-005453-4057qib7	5576	27	.	.	.
cord-005453-4057qib7	5577	1	All	all	PDT
cord-005453-4057qib7	5577	2	these	these	DT
cord-005453-4057qib7	5577	3	features	feature	NNS
cord-005453-4057qib7	5577	4	might	may	MD
cord-005453-4057qib7	5577	5	contribute	contribute	VB
cord-005453-4057qib7	5577	6	,	,	,
cord-005453-4057qib7	5577	7	in	in	IN
cord-005453-4057qib7	5577	8	the	the	DT
cord-005453-4057qib7	5577	9	future	future	NN
cord-005453-4057qib7	5577	10	,	,	,
cord-005453-4057qib7	5577	11	to	to	TO
cord-005453-4057qib7	5577	12	transform	transform	VB
cord-005453-4057qib7	5577	13	HCT	hct	NN
cord-005453-4057qib7	5577	14	into	into	IN
cord-005453-4057qib7	5577	15	a	a	DT
cord-005453-4057qib7	5577	16	safe	safe	JJ
cord-005453-4057qib7	5577	17	immunologic	immunologic	JJ
cord-005453-4057qib7	5577	18	platform	platform	NN
cord-005453-4057qib7	5577	19	that	that	WDT
cord-005453-4057qib7	5577	20	may	may	MD
cord-005453-4057qib7	5577	21	be	be	VB
cord-005453-4057qib7	5577	22	combined	combine	VBN
cord-005453-4057qib7	5577	23	with	with	IN
cord-005453-4057qib7	5577	24	advanced	advanced	JJ
cord-005453-4057qib7	5577	25	form	form	NN
cord-005453-4057qib7	5577	26	of	of	IN
cord-005453-4057qib7	5577	27	cellular	cellular	JJ
cord-005453-4057qib7	5577	28	therapies	therapy	NNS
cord-005453-4057qib7	5577	29	(	(	-LRB-
cord-005453-4057qib7	5577	30	CAR	CAR	NNP
cord-005453-4057qib7	5577	31	-	-	HYPH
cord-005453-4057qib7	5577	32	Tcells	Tcells	NNP
cord-005453-4057qib7	5577	33	)	)	-RRB-
cord-005453-4057qib7	5577	34	,	,	,
cord-005453-4057qib7	5577	35	aiming	aim	VBG
cord-005453-4057qib7	5577	36	to	to	TO
cord-005453-4057qib7	5577	37	increase	increase	VB
cord-005453-4057qib7	5577	38	safely	safely	RB
cord-005453-4057qib7	5577	39	the	the	DT
cord-005453-4057qib7	5577	40	graftversus	graftversus	NN
cord-005453-4057qib7	5577	41	-	-	HYPH
cord-005453-4057qib7	5577	42	tumor	tumor	NN
cord-005453-4057qib7	5577	43	effect	effect	NN
cord-005453-4057qib7	5577	44	.	.	.
cord-005453-4057qib7	5578	1	Clinical	clinical	JJ
cord-005453-4057qib7	5578	2	Methods	method	NNS
cord-005453-4057qib7	5578	3	:	:	:
cord-005453-4057qib7	5578	4	Pediatric	pediatric	JJ
cord-005453-4057qib7	5578	5	patients	patient	NNS
cord-005453-4057qib7	5578	6	(	(	-LRB-
cord-005453-4057qib7	5578	7	0	0	CD
cord-005453-4057qib7	5578	8	-	-	SYM
cord-005453-4057qib7	5578	9	21	21	CD
cord-005453-4057qib7	5578	10	years	year	NNS
cord-005453-4057qib7	5578	11	)	)	-RRB-
cord-005453-4057qib7	5578	12	with	with	IN
cord-005453-4057qib7	5578	13	NMD	NMD	NNP
cord-005453-4057qib7	5578	14	undergoing	undergo	VBG
cord-005453-4057qib7	5578	15	unrelated	unrelated	JJ
cord-005453-4057qib7	5578	16	HCT	HCT	NNP
cord-005453-4057qib7	5578	17	were	be	VBD
cord-005453-4057qib7	5578	18	eligible	eligible	JJ
cord-005453-4057qib7	5578	19	for	for	IN
cord-005453-4057qib7	5578	20	this	this	DT
cord-005453-4057qib7	5578	21	single	single	JJ
cord-005453-4057qib7	5578	22	center	center	NN
cord-005453-4057qib7	5578	23	,	,	,
cord-005453-4057qib7	5578	24	phase	phase	NN
cord-005453-4057qib7	5578	25	I	-PRON-	PRP
cord-005453-4057qib7	5578	26	trial	trial	NN
cord-005453-4057qib7	5578	27	.	.	.
cord-005453-4057qib7	5579	1	Following	follow	VBG
cord-005453-4057qib7	5579	2	reduced	reduced	JJ
cord-005453-4057qib7	5579	3	intensity	intensity	NN
cord-005453-4057qib7	5579	4	conditioning	conditioning	NN
cord-005453-4057qib7	5579	5	,	,	,
cord-005453-4057qib7	5579	6	abatacept	abatacept	NNP
cord-005453-4057qib7	5579	7	(	(	-LRB-
cord-005453-4057qib7	5579	8	10	10	CD
cord-005453-4057qib7	5579	9	mg	mg	NNP
cord-005453-4057qib7	5579	10	/	/	SYM
cord-005453-4057qib7	5579	11	kg	kg	NNP
cord-005453-4057qib7	5579	12	IV	IV	NNP
cord-005453-4057qib7	5579	13	on	on	IN
cord-005453-4057qib7	5579	14	days	day	NNS
cord-005453-4057qib7	5579	15	-1	-1	NNP
cord-005453-4057qib7	5579	16	,	,	,
cord-005453-4057qib7	5579	17	+5	+5	NN
cord-005453-4057qib7	5579	18	,	,	,
cord-005453-4057qib7	5579	19	+14	+14	CD
cord-005453-4057qib7	5579	20	,	,	,
cord-005453-4057qib7	5579	21	+28	+28	CD
cord-005453-4057qib7	5579	22	)	)	-RRB-
cord-005453-4057qib7	5579	23	was	be	VBD
cord-005453-4057qib7	5579	24	added	add	VBN
cord-005453-4057qib7	5579	25	to	to	IN
cord-005453-4057qib7	5579	26	standard	standard	JJ
cord-005453-4057qib7	5579	27	GVHD	GVHD	NNP
cord-005453-4057qib7	5579	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5579	29	(	(	-LRB-
cord-005453-4057qib7	5579	30	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	5579	31	,	,	,
cord-005453-4057qib7	5579	32	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	5579	33	mofetil	mofetil	NNP
cord-005453-4057qib7	5579	34	[	[	-LRB-
cord-005453-4057qib7	5579	35	MMF	MMF	NNP
cord-005453-4057qib7	5579	36	]	]	-RRB-
cord-005453-4057qib7	5579	37	)	)	-RRB-
cord-005453-4057qib7	5579	38	.	.	.
cord-005453-4057qib7	5580	1	Patients	patient	NNS
cord-005453-4057qib7	5580	2	were	be	VBD
cord-005453-4057qib7	5580	3	followed	follow	VBN
cord-005453-4057qib7	5580	4	for	for	IN
cord-005453-4057qib7	5580	5	2	2	CD
cord-005453-4057qib7	5580	6	years	year	NNS
cord-005453-4057qib7	5580	7	for	for	IN
cord-005453-4057qib7	5580	8	standard	standard	JJ
cord-005453-4057qib7	5580	9	HCT	HCT	NNP
cord-005453-4057qib7	5580	10	outcomes	outcome	NNS
cord-005453-4057qib7	5580	11	.	.	.
cord-005453-4057qib7	5581	1	[	[	-LRB-
cord-005453-4057qib7	5581	2	[	[	-LRB-
cord-005453-4057qib7	5581	3	P257	P257	NNP
cord-005453-4057qib7	5581	4	Image	image	NN
cord-005453-4057qib7	5581	5	]	]	-RRB-
cord-005453-4057qib7	5581	6	1	1	CD
cord-005453-4057qib7	5581	7	.	.	.
cord-005453-4057qib7	5582	1	Figure	figure	NN
cord-005453-4057qib7	5582	2	1	1	CD
cord-005453-4057qib7	5582	3	Results	result	NNS
cord-005453-4057qib7	5583	1	:	:	:
cord-005453-4057qib7	5583	2	Since	since	IN
cord-005453-4057qib7	5583	3	June	June	NNP
cord-005453-4057qib7	5583	4	2014	2014	CD
cord-005453-4057qib7	5583	5	,	,	,
cord-005453-4057qib7	5583	6	10	10	CD
cord-005453-4057qib7	5583	7	patients	patient	NNS
cord-005453-4057qib7	5583	8	have	have	VBP
cord-005453-4057qib7	5583	9	been	be	VBN
cord-005453-4057qib7	5583	10	enrolled	enrol	VBN
cord-005453-4057qib7	5583	11	and	and	CC
cord-005453-4057qib7	5583	12	transplanted	transplant	VBN
cord-005453-4057qib7	5583	13	(	(	-LRB-
cord-005453-4057qib7	5583	14	Table	table	NN
cord-005453-4057qib7	5583	15	1	1	CD
cord-005453-4057qib7	5583	16	,	,	,
cord-005453-4057qib7	5583	17	excluding	exclude	VBG
cord-005453-4057qib7	5583	18	#	#	$
cord-005453-4057qib7	5583	19	7	7	CD
cord-005453-4057qib7	5583	20	)	)	-RRB-
cord-005453-4057qib7	5583	21	.	.	.
cord-005453-4057qib7	5584	1	Donor	donor	NN
cord-005453-4057qib7	5584	2	source	source	NN
cord-005453-4057qib7	5584	3	was	be	VBD
cord-005453-4057qib7	5584	4	bone	bone	NN
cord-005453-4057qib7	5584	5	marrow	marrow	NN
cord-005453-4057qib7	5584	6	in	in	IN
cord-005453-4057qib7	5584	7	all	all	DT
cord-005453-4057qib7	5584	8	.	.	.
cord-005453-4057qib7	5585	1	With	with	IN
cord-005453-4057qib7	5585	2	median	median	JJ
cord-005453-4057qib7	5585	3	follow	follow	NN
cord-005453-4057qib7	5585	4	-	-	HYPH
cord-005453-4057qib7	5585	5	up	up	NN
cord-005453-4057qib7	5585	6	of	of	IN
cord-005453-4057qib7	5585	7	3.5	3.5	CD
cord-005453-4057qib7	5585	8	years	year	NNS
cord-005453-4057qib7	5585	9	,	,	,
cord-005453-4057qib7	5585	10	8	8	CD
cord-005453-4057qib7	5585	11	of	of	IN
cord-005453-4057qib7	5585	12	10	10	CD
cord-005453-4057qib7	5585	13	patients	patient	NNS
cord-005453-4057qib7	5585	14	survive	survive	VBP
cord-005453-4057qib7	5585	15	without	without	IN
cord-005453-4057qib7	5585	16	disease	disease	NN
cord-005453-4057qib7	5585	17	.	.	.
cord-005453-4057qib7	5586	1	Initial	initial	JJ
cord-005453-4057qib7	5586	2	engraftment	engraftment	NN
cord-005453-4057qib7	5586	3	was	be	VBD
cord-005453-4057qib7	5586	4	successful	successful	JJ
cord-005453-4057qib7	5586	5	in	in	IN
cord-005453-4057qib7	5586	6	9	9	CD
cord-005453-4057qib7	5586	7	,	,	,
cord-005453-4057qib7	5586	8	at	at	IN
cord-005453-4057qib7	5586	9	a	a	DT
cord-005453-4057qib7	5586	10	median	median	NN
cord-005453-4057qib7	5586	11	of	of	IN
cord-005453-4057qib7	5586	12	20	20	CD
cord-005453-4057qib7	5586	13	and	and	CC
cord-005453-4057qib7	5586	14	16	16	CD
cord-005453-4057qib7	5586	15	days	day	NNS
cord-005453-4057qib7	5586	16	,	,	,
cord-005453-4057qib7	5586	17	for	for	IN
cord-005453-4057qib7	5586	18	neutrophils	neutrophil	NNS
cord-005453-4057qib7	5586	19	and	and	CC
cord-005453-4057qib7	5586	20	platelets	platelet	NNS
cord-005453-4057qib7	5586	21	respectively	respectively	RB
cord-005453-4057qib7	5586	22	.	.	.
cord-005453-4057qib7	5587	1	One	one	CD
cord-005453-4057qib7	5587	2	patient	patient	NN
cord-005453-4057qib7	5587	3	(	(	-LRB-
cord-005453-4057qib7	5587	4	5	5	LS
cord-005453-4057qib7	5587	5	)	)	-RRB-
cord-005453-4057qib7	5587	6	had	have	VBD
cord-005453-4057qib7	5587	7	secondary	secondary	JJ
cord-005453-4057qib7	5587	8	graft	graft	NN
cord-005453-4057qib7	5587	9	rejection	rejection	NN
cord-005453-4057qib7	5587	10	in	in	IN
cord-005453-4057qib7	5587	11	the	the	DT
cord-005453-4057qib7	5587	12	setting	setting	NN
cord-005453-4057qib7	5587	13	of	of	IN
cord-005453-4057qib7	5587	14	viral	viral	JJ
cord-005453-4057qib7	5587	15	reactivation	reactivation	NN
cord-005453-4057qib7	5587	16	(	(	-LRB-
cord-005453-4057qib7	5587	17	CMV	CMV	NNP
cord-005453-4057qib7	5587	18	/	/	SYM
cord-005453-4057qib7	5587	19	EBV	EBV	NNP
cord-005453-4057qib7	5587	20	)	)	-RRB-
cord-005453-4057qib7	5587	21	,	,	,
cord-005453-4057qib7	5587	22	with	with	IN
cord-005453-4057qib7	5587	23	successful	successful	JJ
cord-005453-4057qib7	5587	24	engraftment	engraftment	NN
cord-005453-4057qib7	5587	25	following	follow	VBG
cord-005453-4057qib7	5587	26	a	a	DT
cord-005453-4057qib7	5587	27	2	2	CD
cord-005453-4057qib7	5587	28	nd	nd	NNP
cord-005453-4057qib7	5587	29	unrelated	unrelated	JJ
cord-005453-4057qib7	5587	30	HCT	HCT	NNP
cord-005453-4057qib7	5587	31	.	.	.
cord-005453-4057qib7	5588	1	In	in	IN
cord-005453-4057qib7	5588	2	8	8	CD
cord-005453-4057qib7	5588	3	engrafted	engraft	VBN
cord-005453-4057qib7	5588	4	patients	patient	NNS
cord-005453-4057qib7	5588	5	,	,	,
cord-005453-4057qib7	5588	6	myeloid	myeloid	JJ
cord-005453-4057qib7	5588	7	(	(	-LRB-
cord-005453-4057qib7	5588	8	CD33	CD33	NNP
cord-005453-4057qib7	5588	9	)	)	-RRB-
cord-005453-4057qib7	5588	10	chimerism	chimerism	NN
cord-005453-4057qib7	5588	11	was	be	VBD
cord-005453-4057qib7	5588	12	100	100	CD
cord-005453-4057qib7	5588	13	%	%	NN
cord-005453-4057qib7	5588	14	at	at	IN
cord-005453-4057qib7	5588	15	all	all	DT
cord-005453-4057qib7	5588	16	timepoints	timepoint	NNS
cord-005453-4057qib7	5588	17	;	;	:
cord-005453-4057qib7	5588	18	T	t	NN
cord-005453-4057qib7	5588	19	-	-	HYPH
cord-005453-4057qib7	5588	20	lymphoid	lymphoid	NNP
cord-005453-4057qib7	5588	21	(	(	-LRB-
cord-005453-4057qib7	5588	22	CD3	CD3	NNP
cord-005453-4057qib7	5588	23	)	)	-RRB-
cord-005453-4057qib7	5588	24	chimerism	chimerism	NN
cord-005453-4057qib7	5588	25	was	be	VBD
cord-005453-4057qib7	5588	26	mixed	mixed	JJ
cord-005453-4057qib7	5588	27	but	but	CC
cord-005453-4057qib7	5588	28	reached	reach	VBN
cord-005453-4057qib7	5588	29	>	>	XX
cord-005453-4057qib7	5589	1	/=95	/=95	:
cord-005453-4057qib7	5589	2	%	%	NN
cord-005453-4057qib7	5589	3	(	(	-LRB-
cord-005453-4057qib7	5589	4	Figure	figure	NN
cord-005453-4057qib7	5589	5	1	1	CD
cord-005453-4057qib7	5589	6	)	)	-RRB-
cord-005453-4057qib7	5589	7	.	.	.
cord-005453-4057qib7	5590	1	One	one	CD
cord-005453-4057qib7	5590	2	patient	patient	NN
cord-005453-4057qib7	5590	3	(	(	-LRB-
cord-005453-4057qib7	5590	4	7	7	CD
cord-005453-4057qib7	5590	5	)	)	-RRB-
cord-005453-4057qib7	5590	6	with	with	IN
cord-005453-4057qib7	5590	7	SAA	SAA	NNP
cord-005453-4057qib7	5590	8	had	have	VBD
cord-005453-4057qib7	5590	9	primary	primary	JJ
cord-005453-4057qib7	5590	10	graft	graft	NN
cord-005453-4057qib7	5590	11	rejection	rejection	NN
cord-005453-4057qib7	5590	12	in	in	IN
cord-005453-4057qib7	5590	13	the	the	DT
cord-005453-4057qib7	5590	14	setting	setting	NN
cord-005453-4057qib7	5590	15	of	of	IN
cord-005453-4057qib7	5590	16	inadequate	inadequate	JJ
cord-005453-4057qib7	5590	17	TNC	TNC	NNP
cord-005453-4057qib7	5590	18	dose	dose	NN
cord-005453-4057qib7	5590	19	(	(	-LRB-
cord-005453-4057qib7	5590	20	0.5	0.5	CD
cord-005453-4057qib7	5590	21	x	x	SYM
cord-005453-4057qib7	5590	22	10	10	CD
cord-005453-4057qib7	5590	23	8	8	CD
cord-005453-4057qib7	5590	24	/kg	/kg	CD
cord-005453-4057qib7	5590	25	)	)	-RRB-
cord-005453-4057qib7	5590	26	and	and	CC
cord-005453-4057qib7	5590	27	died	die	VBD
cord-005453-4057qib7	5590	28	from	from	IN
cord-005453-4057qib7	5590	29	marrow	marrow	NN
cord-005453-4057qib7	5590	30	aplasia	aplasia	NNP
cord-005453-4057qib7	5590	31	/	/	SYM
cord-005453-4057qib7	5590	32	infection	infection	NN
cord-005453-4057qib7	5590	33	despite	despite	IN
cord-005453-4057qib7	5590	34	2	2	CD
cord-005453-4057qib7	5590	35	nd	nd	NNP
cord-005453-4057qib7	5590	36	HCT	HCT	NNP
cord-005453-4057qib7	5590	37	.	.	.
cord-005453-4057qib7	5591	1	A	a	DT
cord-005453-4057qib7	5591	2	second	second	JJ
cord-005453-4057qib7	5591	3	death	death	NN
cord-005453-4057qib7	5591	4	from	from	IN
cord-005453-4057qib7	5591	5	Wilms	Wilms	NNP
cord-005453-4057qib7	5591	6	'	'	POS
cord-005453-4057qib7	5591	7	tumor	tumor	NN
cord-005453-4057qib7	5591	8	occurred	occur	VBD
cord-005453-4057qib7	5591	9	17	17	CD
cord-005453-4057qib7	5591	10	months	month	NNS
cord-005453-4057qib7	5591	11	post	post	VBP
cord-005453-4057qib7	5591	12	successful	successful	JJ
cord-005453-4057qib7	5591	13	HCT	hct	NN
cord-005453-4057qib7	5591	14	,	,	,
cord-005453-4057qib7	5591	15	in	in	IN
cord-005453-4057qib7	5591	16	a	a	DT
cord-005453-4057qib7	5591	17	patient	patient	NN
cord-005453-4057qib7	5591	18	(	(	-LRB-
cord-005453-4057qib7	5591	19	1	1	CD
cord-005453-4057qib7	5591	20	)	)	-RRB-
cord-005453-4057qib7	5591	21	with	with	IN
cord-005453-4057qib7	5591	22	DBA	dba	NN
cord-005453-4057qib7	5591	23	and	and	CC
cord-005453-4057qib7	5591	24	constitutional	constitutional	JJ
cord-005453-4057qib7	5591	25	chromosome	chromosome	NN
cord-005453-4057qib7	5591	26	abnormality	abnormality	NN
cord-005453-4057qib7	5591	27	.	.	.
cord-005453-4057qib7	5592	1	Except	except	IN
cord-005453-4057qib7	5592	2	patient	patient	NN
cord-005453-4057qib7	5592	3	7	7	CD
cord-005453-4057qib7	5592	4	,	,	,
cord-005453-4057qib7	5592	5	all	all	DT
cord-005453-4057qib7	5592	6	patients	patient	NNS
cord-005453-4057qib7	5592	7	received	receive	VBD
cord-005453-4057qib7	5592	8	4	4	CD
cord-005453-4057qib7	5592	9	doses	dose	NNS
cord-005453-4057qib7	5592	10	of	of	IN
cord-005453-4057qib7	5592	11	abatacept	abatacept	NNP
cord-005453-4057qib7	5592	12	,	,	,
cord-005453-4057qib7	5592	13	which	which	WDT
cord-005453-4057qib7	5592	14	was	be	VBD
cord-005453-4057qib7	5592	15	well	well	RB
cord-005453-4057qib7	5592	16	tolerated	tolerate	VBN
cord-005453-4057qib7	5592	17	,	,	,
cord-005453-4057qib7	5592	18	with	with	IN
cord-005453-4057qib7	5592	19	all	all	DT
cord-005453-4057qib7	5592	20	severe	severe	JJ
cord-005453-4057qib7	5592	21	adverse	adverse	JJ
cord-005453-4057qib7	5592	22	events	event	NNS
cord-005453-4057qib7	5592	23	expected	expect	VBN
cord-005453-4057qib7	5592	24	for	for	IN
cord-005453-4057qib7	5592	25	a	a	DT
cord-005453-4057qib7	5592	26	HCT	HCT	NNP
cord-005453-4057qib7	5592	27	population	population	NN
cord-005453-4057qib7	5592	28	.	.	.
cord-005453-4057qib7	5593	1	CMV	CMV	NNP
cord-005453-4057qib7	5593	2	and	and	CC
cord-005453-4057qib7	5593	3	EBV	EBV	NNP
cord-005453-4057qib7	5593	4	reactivation	reactivation	NN
cord-005453-4057qib7	5593	5	occurred	occur	VBD
cord-005453-4057qib7	5593	6	in	in	IN
cord-005453-4057qib7	5593	7	3	3	CD
cord-005453-4057qib7	5593	8	patients	patient	NNS
cord-005453-4057qib7	5593	9	each	each	DT
cord-005453-4057qib7	5593	10	,	,	,
cord-005453-4057qib7	5593	11	with	with	IN
cord-005453-4057qib7	5593	12	resolution	resolution	NN
cord-005453-4057qib7	5593	13	using	use	VBG
cord-005453-4057qib7	5593	14	standard	standard	JJ
cord-005453-4057qib7	5593	15	anti	anti	JJ
cord-005453-4057qib7	5593	16	-	-	JJ
cord-005453-4057qib7	5593	17	viral	viral	JJ
cord-005453-4057qib7	5593	18	therapy	therapy	NN
cord-005453-4057qib7	5593	19	.	.	.
cord-005453-4057qib7	5594	1	One	one	CD
cord-005453-4057qib7	5594	2	patient	patient	NN
cord-005453-4057qib7	5594	3	(	(	-LRB-
cord-005453-4057qib7	5594	4	6	6	CD
cord-005453-4057qib7	5594	5	)	)	-RRB-
cord-005453-4057qib7	5594	6	was	be	VBD
cord-005453-4057qib7	5594	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	5594	8	with	with	IN
cord-005453-4057qib7	5594	9	EBV	EBV	NNP
cord-005453-4057qib7	5594	10	-	-	HYPH
cord-005453-4057qib7	5594	11	driven	drive	VBN
cord-005453-4057qib7	5594	12	post	post	JJ
cord-005453-4057qib7	5594	13	-	-	JJ
cord-005453-4057qib7	5594	14	transplant	transplant	JJ
cord-005453-4057qib7	5594	15	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	5594	16	disease	disease	NN
cord-005453-4057qib7	5594	17	,	,	,
cord-005453-4057qib7	5594	18	which	which	WDT
cord-005453-4057qib7	5594	19	responded	respond	VBD
cord-005453-4057qib7	5594	20	to	to	IN
cord-005453-4057qib7	5594	21	rituximab	rituximab	NN
cord-005453-4057qib7	5594	22	and	and	CC
cord-005453-4057qib7	5594	23	immune	immune	JJ
cord-005453-4057qib7	5594	24	suppression	suppression	NN
cord-005453-4057qib7	5594	25	withdrawal	withdrawal	NN
cord-005453-4057qib7	5594	26	.	.	.
cord-005453-4057qib7	5595	1	No	no	DT
cord-005453-4057qib7	5595	2	patients	patient	NNS
cord-005453-4057qib7	5595	3	developed	develop	VBD
cord-005453-4057qib7	5595	4	severe	severe	JJ
cord-005453-4057qib7	5595	5	acute	acute	JJ
cord-005453-4057qib7	5595	6	(	(	-LRB-
cord-005453-4057qib7	5595	7	grade	grade	NN
cord-005453-4057qib7	5595	8	III	III	NNP
cord-005453-4057qib7	5595	9	-	-	HYPH
cord-005453-4057qib7	5595	10	IV	IV	NNP
cord-005453-4057qib7	5595	11	)	)	-RRB-
cord-005453-4057qib7	5595	12	or	or	CC
cord-005453-4057qib7	5595	13	chronic	chronic	JJ
cord-005453-4057qib7	5595	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5595	15	(	(	-LRB-
cord-005453-4057qib7	5595	16	Table	table	NN
cord-005453-4057qib7	5595	17	1	1	CD
cord-005453-4057qib7	5595	18	)	)	-RRB-
cord-005453-4057qib7	5595	19	,	,	,
cord-005453-4057qib7	5595	20	and	and	CC
cord-005453-4057qib7	5595	21	no	no	DT
cord-005453-4057qib7	5595	22	patients	patient	NNS
cord-005453-4057qib7	5595	23	required	require	VBD
cord-005453-4057qib7	5595	24	systemic	systemic	JJ
cord-005453-4057qib7	5595	25	immune	immune	JJ
cord-005453-4057qib7	5595	26	suppression	suppression	NN
cord-005453-4057qib7	5595	27	at	at	IN
cord-005453-4057qib7	5595	28	>	>	XX
cord-005453-4057qib7	5595	29	1	1	CD
cord-005453-4057qib7	5595	30	year	year	NN
cord-005453-4057qib7	5595	31	.	.	.
cord-005453-4057qib7	5596	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5596	2	:	:	:
cord-005453-4057qib7	5597	1	These	these	DT
cord-005453-4057qib7	5597	2	preliminary	preliminary	JJ
cord-005453-4057qib7	5597	3	data	datum	NNS
cord-005453-4057qib7	5597	4	suggest	suggest	VBP
cord-005453-4057qib7	5597	5	that	that	IN
cord-005453-4057qib7	5597	6	abatacept	abatacept	NNP
cord-005453-4057qib7	5597	7	can	can	MD
cord-005453-4057qib7	5597	8	be	be	VB
cord-005453-4057qib7	5597	9	safely	safely	RB
cord-005453-4057qib7	5597	10	added	add	VBN
cord-005453-4057qib7	5597	11	to	to	IN
cord-005453-4057qib7	5597	12	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	5597	13	and	and	CC
cord-005453-4057qib7	5597	14	MMF	MMF	NNP
cord-005453-4057qib7	5597	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5597	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5597	17	in	in	IN
cord-005453-4057qib7	5597	18	pediatric	pediatric	JJ
cord-005453-4057qib7	5597	19	patients	patient	NNS
cord-005453-4057qib7	5597	20	with	with	IN
cord-005453-4057qib7	5597	21	bone	bone	NN
cord-005453-4057qib7	5597	22	marrow	marrow	NN
cord-005453-4057qib7	5597	23	failure	failure	NN
cord-005453-4057qib7	5597	24	undergoing	undergo	VBG
cord-005453-4057qib7	5597	25	unrelated	unrelated	JJ
cord-005453-4057qib7	5597	26	donor	donor	NN
cord-005453-4057qib7	5597	27	HCT	hct	NN
cord-005453-4057qib7	5597	28	,	,	,
cord-005453-4057qib7	5597	29	with	with	IN
cord-005453-4057qib7	5597	30	encouraging	encouraging	JJ
cord-005453-4057qib7	5597	31	rates	rate	NNS
cord-005453-4057qib7	5597	32	of	of	IN
cord-005453-4057qib7	5597	33	GVHD	GVHD	NNP
cord-005453-4057qib7	5597	34	despite	despite	IN
cord-005453-4057qib7	5597	35	half	half	NN
cord-005453-4057qib7	5597	36	of	of	IN
cord-005453-4057qib7	5597	37	patients	patient	NNS
cord-005453-4057qib7	5597	38	having	have	VBG
cord-005453-4057qib7	5597	39	a	a	DT
cord-005453-4057qib7	5597	40	mismatched	mismatched	JJ
cord-005453-4057qib7	5597	41	(	(	-LRB-
cord-005453-4057qib7	5597	42	7/8	7/8	CD
cord-005453-4057qib7	5597	43	)	)	-RRB-
cord-005453-4057qib7	5597	44	donor	donor	NN
cord-005453-4057qib7	5597	45	.	.	.
cord-005453-4057qib7	5598	1	Given	give	VBN
cord-005453-4057qib7	5598	2	the	the	DT
cord-005453-4057qib7	5598	3	higher	high	JJR
cord-005453-4057qib7	5598	4	risk	risk	NN
cord-005453-4057qib7	5598	5	of	of	IN
cord-005453-4057qib7	5598	6	graft	graft	NN
cord-005453-4057qib7	5598	7	rejection	rejection	NN
cord-005453-4057qib7	5598	8	in	in	IN
cord-005453-4057qib7	5598	9	this	this	DT
cord-005453-4057qib7	5598	10	non	non	JJ
cord-005453-4057qib7	5598	11	-	-	JJ
cord-005453-4057qib7	5598	12	malignant	malignant	JJ
cord-005453-4057qib7	5598	13	cohort	cohort	NN
cord-005453-4057qib7	5598	14	,	,	,
cord-005453-4057qib7	5598	15	rejection	rejection	NN
cord-005453-4057qib7	5598	16	(	(	-LRB-
cord-005453-4057qib7	5598	17	in	in	IN
cord-005453-4057qib7	5598	18	addition	addition	NN
cord-005453-4057qib7	5598	19	to	to	IN
cord-005453-4057qib7	5598	20	GVHD	GVHD	NNP
cord-005453-4057qib7	5598	21	)	)	-RRB-
cord-005453-4057qib7	5598	22	will	will	MD
cord-005453-4057qib7	5598	23	be	be	VB
cord-005453-4057qib7	5598	24	a	a	DT
cord-005453-4057qib7	5598	25	primary	primary	JJ
cord-005453-4057qib7	5598	26	focus	focus	NN
cord-005453-4057qib7	5598	27	in	in	IN
cord-005453-4057qib7	5598	28	our	-PRON-	PRP$
cord-005453-4057qib7	5598	29	subsequent	subsequent	JJ
cord-005453-4057qib7	5598	30	multi	multi	JJ
cord-005453-4057qib7	5598	31	-	-	JJ
cord-005453-4057qib7	5598	32	center	center	JJ
cord-005453-4057qib7	5598	33	,	,	,
cord-005453-4057qib7	5598	34	phase	phase	NN
cord-005453-4057qib7	5598	35	2	2	CD
cord-005453-4057qib7	5598	36	trial	trial	NN
cord-005453-4057qib7	5598	37	.	.	.
cord-005453-4057qib7	5599	1	Clinical	clinical	JJ
cord-005453-4057qib7	5599	2	Trial	Trial	NNP
cord-005453-4057qib7	5599	3	Registry	Registry	NNP
cord-005453-4057qib7	5599	4	:	:	:
cord-005453-4057qib7	5599	5	ClinicalTrials	ClinicalTrials	NNP
cord-005453-4057qib7	5599	6	.	.	.
cord-005453-4057qib7	5600	1	GvHD	GvHD	NNP
cord-005453-4057qib7	5600	2	and	and	CC
cord-005453-4057qib7	5600	3	may	may	MD
cord-005453-4057qib7	5600	4	to	to	TO
cord-005453-4057qib7	5600	5	have	have	VB
cord-005453-4057qib7	5600	6	be	be	VB
cord-005453-4057qib7	5600	7	separated	separate	VBN
cord-005453-4057qib7	5600	8	from	from	IN
cord-005453-4057qib7	5600	9	from	from	IN
cord-005453-4057qib7	5600	10	toxicity	toxicity	NN
cord-005453-4057qib7	5600	11	to	to	IN
cord-005453-4057qib7	5600	12	infectious	infectious	JJ
cord-005453-4057qib7	5600	13	complications	complication	NNS
cord-005453-4057qib7	5600	14	in	in	IN
cord-005453-4057qib7	5600	15	the	the	DT
cord-005453-4057qib7	5600	16	early	early	JJ
cord-005453-4057qib7	5600	17	phase	phase	NN
cord-005453-4057qib7	5600	18	after	after	IN
cord-005453-4057qib7	5600	19	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5600	20	.	.	.
cord-005453-4057qib7	5601	1	Methods	method	NNS
cord-005453-4057qib7	5601	2	:	:	:
cord-005453-4057qib7	5601	3	From	from	IN
cord-005453-4057qib7	5601	4	our	-PRON-	PRP$
cord-005453-4057qib7	5601	5	files	file	NNS
cord-005453-4057qib7	5601	6	we	-PRON-	PRP
cord-005453-4057qib7	5601	7	identified	identify	VBD
cord-005453-4057qib7	5601	8	65	65	CD
cord-005453-4057qib7	5601	9	patients	patient	NNS
cord-005453-4057qib7	5601	10	which	which	WDT
cord-005453-4057qib7	5601	11	had	have	VBD
cord-005453-4057qib7	5601	12	upper	upper	JJ
cord-005453-4057qib7	5601	13	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	5601	14	tract	tract	NN
cord-005453-4057qib7	5601	15	endoscopy	endoscopy	NN
cord-005453-4057qib7	5601	16	after	after	IN
cord-005453-4057qib7	5601	17	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5601	18	in	in	RP
cord-005453-4057qib7	5601	19	with	with	IN
cord-005453-4057qib7	5601	20	biopsies	biopsy	NNS
cord-005453-4057qib7	5601	21	were	be	VBD
cord-005453-4057qib7	5601	22	taken	take	VBN
cord-005453-4057qib7	5601	23	from	from	IN
cord-005453-4057qib7	5601	24	the	the	DT
cord-005453-4057qib7	5601	25	esophagus	esophagus	NN
cord-005453-4057qib7	5601	26	,	,	,
cord-005453-4057qib7	5601	27	stomach	stomach	NN
cord-005453-4057qib7	5601	28	and	and	CC
cord-005453-4057qib7	5601	29	duodenum	duodenum	NN
cord-005453-4057qib7	5601	30	simultaneously	simultaneously	RB
cord-005453-4057qib7	5601	31	.	.	.
cord-005453-4057qib7	5602	1	Of	of	IN
cord-005453-4057qib7	5602	2	these	these	DT
cord-005453-4057qib7	5602	3	patients	patient	NNS
cord-005453-4057qib7	5602	4	14	14	CD
cord-005453-4057qib7	5602	5	were	be	VBD
cord-005453-4057qib7	5602	6	excluded	exclude	VBN
cord-005453-4057qib7	5602	7	because	because	IN
cord-005453-4057qib7	5602	8	of	of	IN
cord-005453-4057qib7	5602	9	infection	infection	NN
cord-005453-4057qib7	5602	10	,	,	,
cord-005453-4057qib7	5602	11	reflux	reflux	NN
cord-005453-4057qib7	5602	12	disease	disease	NN
cord-005453-4057qib7	5602	13	or	or	CC
cord-005453-4057qib7	5602	14	drug	drug	NN
cord-005453-4057qib7	5602	15	toxity	toxity	NN
cord-005453-4057qib7	5602	16	and	and	CC
cord-005453-4057qib7	5602	17	the	the	DT
cord-005453-4057qib7	5602	18	remaining	remain	VBG
cord-005453-4057qib7	5602	19	51	51	CD
cord-005453-4057qib7	5602	20	patients	patient	NNS
cord-005453-4057qib7	5602	21	were	be	VBD
cord-005453-4057qib7	5602	22	included	include	VBN
cord-005453-4057qib7	5602	23	in	in	IN
cord-005453-4057qib7	5602	24	our	-PRON-	PRP$
cord-005453-4057qib7	5602	25	study	study	NN
cord-005453-4057qib7	5602	26	.	.	.
cord-005453-4057qib7	5603	1	We	-PRON-	PRP
cord-005453-4057qib7	5603	2	evaluated	evaluate	VBD
cord-005453-4057qib7	5603	3	the	the	DT
cord-005453-4057qib7	5603	4	routine	routine	JJ
cord-005453-4057qib7	5603	5	stained	stain	VBN
cord-005453-4057qib7	5603	6	esophageal	esophageal	JJ
cord-005453-4057qib7	5603	7	biopsies	biopsy	NNS
cord-005453-4057qib7	5603	8	,	,	,
cord-005453-4057qib7	5603	9	applied	apply	VBD
cord-005453-4057qib7	5603	10	a	a	DT
cord-005453-4057qib7	5603	11	grading	grading	NN
cord-005453-4057qib7	5603	12	scheme	scheme	NN
cord-005453-4057qib7	5603	13	and	and	CC
cord-005453-4057qib7	5603	14	compared	compare	VBD
cord-005453-4057qib7	5603	15	the	the	DT
cord-005453-4057qib7	5603	16	histological	histological	JJ
cord-005453-4057qib7	5603	17	findings	finding	NNS
cord-005453-4057qib7	5603	18	with	with	IN
cord-005453-4057qib7	5603	19	those	those	DT
cord-005453-4057qib7	5603	20	within	within	IN
cord-005453-4057qib7	5603	21	the	the	DT
cord-005453-4057qib7	5603	22	stomach	stomach	NN
cord-005453-4057qib7	5603	23	and	and	CC
cord-005453-4057qib7	5603	24	duodenum	duodenum	NN
cord-005453-4057qib7	5603	25	,	,	,
cord-005453-4057qib7	5603	26	the	the	DT
cord-005453-4057qib7	5603	27	endoscopic	endoscopic	JJ
cord-005453-4057qib7	5603	28	findings	finding	NNS
cord-005453-4057qib7	5603	29	and	and	CC
cord-005453-4057qib7	5603	30	the	the	DT
cord-005453-4057qib7	5603	31	clinical	clinical	JJ
cord-005453-4057qib7	5603	32	course	course	NN
cord-005453-4057qib7	5603	33	.	.	.
cord-005453-4057qib7	5604	1	Results	result	NNS
cord-005453-4057qib7	5604	2	:	:	:
cord-005453-4057qib7	5605	1	In	in	IN
cord-005453-4057qib7	5605	2	32	32	CD
cord-005453-4057qib7	5605	3	of	of	IN
cord-005453-4057qib7	5605	4	51	51	CD
cord-005453-4057qib7	5605	5	biopsy	biopsy	NN
cord-005453-4057qib7	5605	6	samples	sample	NNS
cord-005453-4057qib7	5605	7	of	of	IN
cord-005453-4057qib7	5605	8	the	the	DT
cord-005453-4057qib7	5605	9	esophagus	esophagus	NN
cord-005453-4057qib7	5605	10	,	,	,
cord-005453-4057qib7	5605	11	we	-PRON-	PRP
cord-005453-4057qib7	5605	12	identified	identify	VBD
cord-005453-4057qib7	5605	13	histological	histological	JJ
cord-005453-4057qib7	5605	14	features	feature	NNS
cord-005453-4057qib7	5605	15	of	of	IN
cord-005453-4057qib7	5605	16	acute	acute	JJ
cord-005453-4057qib7	5605	17	GvHD	gvhd	NN
cord-005453-4057qib7	5605	18	,	,	,
cord-005453-4057qib7	5605	19	ranging	range	VBG
cord-005453-4057qib7	5605	20	from	from	IN
cord-005453-4057qib7	5605	21	vacuolar	vacuolar	NNP
cord-005453-4057qib7	5605	22	degeneration	degeneration	NN
cord-005453-4057qib7	5605	23	(	(	-LRB-
cord-005453-4057qib7	5605	24	grade	grade	NN
cord-005453-4057qib7	5605	25	1	1	CD
cord-005453-4057qib7	5605	26	)	)	-RRB-
cord-005453-4057qib7	5605	27	and	and	CC
cord-005453-4057qib7	5605	28	single	single	JJ
cord-005453-4057qib7	5605	29	-	-	HYPH
cord-005453-4057qib7	5605	30	cell	cell	NN
cord-005453-4057qib7	5605	31	apoptosis	apoptosis	NN
cord-005453-4057qib7	5605	32	(	(	-LRB-
cord-005453-4057qib7	5605	33	grade	grade	NN
cord-005453-4057qib7	5605	34	2	2	CD
cord-005453-4057qib7	5605	35	)	)	-RRB-
cord-005453-4057qib7	5605	36	to	to	IN
cord-005453-4057qib7	5605	37	the	the	DT
cord-005453-4057qib7	5605	38	formation	formation	NN
cord-005453-4057qib7	5605	39	of	of	IN
cord-005453-4057qib7	5605	40	clefts	cleft	NNS
cord-005453-4057qib7	5605	41	(	(	-LRB-
cord-005453-4057qib7	5605	42	grade	grade	NN
cord-005453-4057qib7	5605	43	3	3	CD
cord-005453-4057qib7	5605	44	)	)	-RRB-
cord-005453-4057qib7	5605	45	and	and	CC
cord-005453-4057qib7	5605	46	mucosa	mucosa	JJ
cord-005453-4057qib7	5605	47	denudation	denudation	NN
cord-005453-4057qib7	5605	48	in	in	IN
cord-005453-4057qib7	5605	49	advanced	advanced	JJ
cord-005453-4057qib7	5605	50	cases	case	NNS
cord-005453-4057qib7	5605	51	(	(	-LRB-
cord-005453-4057qib7	5605	52	grade	grade	NN
cord-005453-4057qib7	5605	53	4	4	CD
cord-005453-4057qib7	5605	54	)	)	-RRB-
cord-005453-4057qib7	5605	55	,	,	,
cord-005453-4057qib7	5605	56	resembling	resemble	VBG
cord-005453-4057qib7	5605	57	epithelial	epithelial	JJ
cord-005453-4057qib7	5605	58	lesions	lesion	NNS
cord-005453-4057qib7	5605	59	in	in	IN
cord-005453-4057qib7	5605	60	acute	acute	JJ
cord-005453-4057qib7	5605	61	GvHD	gvhd	NN
cord-005453-4057qib7	5605	62	of	of	IN
cord-005453-4057qib7	5605	63	the	the	DT
cord-005453-4057qib7	5605	64	skin	skin	NN
cord-005453-4057qib7	5605	65	.	.	.
cord-005453-4057qib7	5606	1	These	these	DT
cord-005453-4057qib7	5606	2	findings	finding	NNS
cord-005453-4057qib7	5606	3	correlated	correlate	VBD
cord-005453-4057qib7	5606	4	with	with	IN
cord-005453-4057qib7	5606	5	GvHD	gvhd	NN
cord-005453-4057qib7	5606	6	involving	involve	VBG
cord-005453-4057qib7	5606	7	the	the	DT
cord-005453-4057qib7	5606	8	stomach	stomach	NN
cord-005453-4057qib7	5606	9	and	and	CC
cord-005453-4057qib7	5606	10	duodenum	duodenum	NN
cord-005453-4057qib7	5606	11	and	and	CC
cord-005453-4057qib7	5606	12	the	the	DT
cord-005453-4057qib7	5606	13	clinical	clinical	JJ
cord-005453-4057qib7	5606	14	manifestations	manifestation	NNS
cord-005453-4057qib7	5606	15	of	of	IN
cord-005453-4057qib7	5606	16	GvHD	GvHD	NNP
cord-005453-4057qib7	5606	17	in	in	IN
cord-005453-4057qib7	5606	18	other	other	JJ
cord-005453-4057qib7	5606	19	organs	organ	NNS
cord-005453-4057qib7	5606	20	.	.	.
cord-005453-4057qib7	5607	1	Endoscopically	endoscopically	RB
cord-005453-4057qib7	5607	2	patients	patient	NNS
cord-005453-4057qib7	5607	3	with	with	IN
cord-005453-4057qib7	5607	4	GvHD	GvHD	NNP
cord-005453-4057qib7	5607	5	revealed	reveal	VBD
cord-005453-4057qib7	5607	6	signs	sign	NNS
cord-005453-4057qib7	5607	7	of	of	IN
cord-005453-4057qib7	5607	8	inflammation	inflammation	NN
cord-005453-4057qib7	5607	9	,	,	,
cord-005453-4057qib7	5607	10	ranging	range	VBG
cord-005453-4057qib7	5607	11	from	from	IN
cord-005453-4057qib7	5607	12	erythema	erythema	NN
cord-005453-4057qib7	5607	13	to	to	IN
cord-005453-4057qib7	5607	14	ulceration	ulceration	NN
cord-005453-4057qib7	5607	15	in	in	IN
cord-005453-4057qib7	5607	16	the	the	DT
cord-005453-4057qib7	5607	17	more	more	RBR
cord-005453-4057qib7	5607	18	advanced	advanced	JJ
cord-005453-4057qib7	5607	19	cases	case	NNS
cord-005453-4057qib7	5607	20	,	,	,
cord-005453-4057qib7	5607	21	sometimes	sometimes	RB
cord-005453-4057qib7	5607	22	reminiscent	reminiscent	JJ
cord-005453-4057qib7	5607	23	of	of	IN
cord-005453-4057qib7	5607	24	reflux	reflux	NN
cord-005453-4057qib7	5607	25	or	or	CC
cord-005453-4057qib7	5607	26	infection	infection	NN
cord-005453-4057qib7	5607	27	.	.	.
cord-005453-4057qib7	5608	1	Clinically	clinically	RB
cord-005453-4057qib7	5608	2	these	these	DT
cord-005453-4057qib7	5608	3	patients	patient	NNS
cord-005453-4057qib7	5608	4	had	have	VBD
cord-005453-4057qib7	5608	5	abdominal	abdominal	JJ
cord-005453-4057qib7	5608	6	discomfort	discomfort	NN
cord-005453-4057qib7	5608	7	ranging	range	VBG
cord-005453-4057qib7	5608	8	from	from	IN
cord-005453-4057qib7	5608	9	inappetence	inappetence	NN
cord-005453-4057qib7	5608	10	to	to	IN
cord-005453-4057qib7	5608	11	nausea	nausea	NN
cord-005453-4057qib7	5608	12	,	,	,
cord-005453-4057qib7	5608	13	accompanied	accompany	VBN
cord-005453-4057qib7	5608	14	by	by	IN
cord-005453-4057qib7	5608	15	emesis	emesis	NN
cord-005453-4057qib7	5608	16	or	or	CC
cord-005453-4057qib7	5608	17	diarrhea	diarrhea	NN
cord-005453-4057qib7	5608	18	and	and	CC
cord-005453-4057qib7	5608	19	weight	weight	NN
cord-005453-4057qib7	5608	20	loss	loss	NN
cord-005453-4057qib7	5608	21	.	.	.
cord-005453-4057qib7	5609	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5609	2	:	:	:
cord-005453-4057qib7	5610	1	We	-PRON-	PRP
cord-005453-4057qib7	5610	2	have	have	VBP
cord-005453-4057qib7	5610	3	shown	show	VBN
cord-005453-4057qib7	5610	4	that	that	IN
cord-005453-4057qib7	5610	5	acute	acute	JJ
cord-005453-4057qib7	5610	6	esophageal	esophageal	JJ
cord-005453-4057qib7	5610	7	GvHD	gvhd	NN
cord-005453-4057qib7	5610	8	occurs	occur	VBZ
cord-005453-4057qib7	5610	9	after	after	IN
cord-005453-4057qib7	5610	10	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5610	11	and	and	CC
cord-005453-4057qib7	5610	12	is	be	VBZ
cord-005453-4057qib7	5610	13	correlated	correlate	VBN
cord-005453-4057qib7	5610	14	with	with	IN
cord-005453-4057qib7	5610	15	acute	acute	JJ
cord-005453-4057qib7	5610	16	GvHD	gvhd	NN
cord-005453-4057qib7	5610	17	in	in	IN
cord-005453-4057qib7	5610	18	stomach	stomach	NN
cord-005453-4057qib7	5610	19	and	and	CC
cord-005453-4057qib7	5610	20	duodenum	duodenum	NN
cord-005453-4057qib7	5610	21	.	.	.
cord-005453-4057qib7	5611	1	It	-PRON-	PRP
cord-005453-4057qib7	5611	2	could	could	MD
cord-005453-4057qib7	5611	3	be	be	VB
cord-005453-4057qib7	5611	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	5611	5	and	and	CC
cord-005453-4057qib7	5611	6	graded	grade	VBN
cord-005453-4057qib7	5611	7	histologically	histologically	RB
cord-005453-4057qib7	5611	8	.	.	.
cord-005453-4057qib7	5612	1	The	the	DT
cord-005453-4057qib7	5612	2	endoscopic	endoscopic	JJ
cord-005453-4057qib7	5612	3	findings	finding	NNS
cord-005453-4057qib7	5612	4	are	be	VBP
cord-005453-4057qib7	5612	5	signs	sign	NNS
cord-005453-4057qib7	5612	6	of	of	IN
cord-005453-4057qib7	5612	7	inflammation	inflammation	NN
cord-005453-4057qib7	5612	8	.	.	.
cord-005453-4057qib7	5613	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5613	2	results	result	NNS
cord-005453-4057qib7	5613	3	may	may	MD
cord-005453-4057qib7	5613	4	help	help	VB
cord-005453-4057qib7	5613	5	to	to	TO
cord-005453-4057qib7	5613	6	establish	establish	VB
cord-005453-4057qib7	5613	7	the	the	DT
cord-005453-4057qib7	5613	8	histological	histological	JJ
cord-005453-4057qib7	5613	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	5613	10	of	of	IN
cord-005453-4057qib7	5613	11	acute	acute	JJ
cord-005453-4057qib7	5613	12	GvHD	gvhd	NN
cord-005453-4057qib7	5613	13	using	use	VBG
cord-005453-4057qib7	5613	14	endoscopic	endoscopic	JJ
cord-005453-4057qib7	5613	15	biopsies	biopsy	NNS
cord-005453-4057qib7	5613	16	from	from	IN
cord-005453-4057qib7	5613	17	the	the	DT
cord-005453-4057qib7	5613	18	esophagus	esophagus	NN
cord-005453-4057qib7	5613	19	and	and	CC
cord-005453-4057qib7	5613	20	to	to	TO
cord-005453-4057qib7	5613	21	explain	explain	VB
cord-005453-4057qib7	5613	22	the	the	DT
cord-005453-4057qib7	5613	23	alterations	alteration	NNS
cord-005453-4057qib7	5613	24	observed	observe	VBN
cord-005453-4057qib7	5613	25	in	in	IN
cord-005453-4057qib7	5613	26	the	the	DT
cord-005453-4057qib7	5613	27	esophageal	esophageal	JJ
cord-005453-4057qib7	5613	28	mucosa	mucosa	NN
cord-005453-4057qib7	5613	29	in	in	IN
cord-005453-4057qib7	5613	30	patients	patient	NNS
cord-005453-4057qib7	5613	31	after	after	IN
cord-005453-4057qib7	5613	32	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5613	33	.	.	.
cord-005453-4057qib7	5614	1	[	[	-LRB-
cord-005453-4057qib7	5614	2	Background	background	NN
cord-005453-4057qib7	5614	3	:	:	:
cord-005453-4057qib7	5614	4	Intestinal	intestinal	JJ
cord-005453-4057qib7	5614	5	acute	acute	JJ
cord-005453-4057qib7	5614	6	graft	graft	NN
cord-005453-4057qib7	5614	7	versus	versus	IN
cord-005453-4057qib7	5614	8	host	host	NN
cord-005453-4057qib7	5614	9	disease	disease	NN
cord-005453-4057qib7	5614	10	(	(	-LRB-
cord-005453-4057qib7	5614	11	aGvHD	agvhd	NN
cord-005453-4057qib7	5614	12	)	)	-RRB-
cord-005453-4057qib7	5614	13	is	be	VBZ
cord-005453-4057qib7	5614	14	a	a	DT
cord-005453-4057qib7	5614	15	major	major	JJ
cord-005453-4057qib7	5614	16	thread	thread	NN
cord-005453-4057qib7	5614	17	after	after	IN
cord-005453-4057qib7	5614	18	allogenic	allogenic	JJ
cord-005453-4057qib7	5614	19	hematological	hematological	JJ
cord-005453-4057qib7	5614	20	stem	stem	NN
cord-005453-4057qib7	5614	21	cell	cell	NN
cord-005453-4057qib7	5614	22	transplantation	transplantation	NN
cord-005453-4057qib7	5614	23	(	(	-LRB-
cord-005453-4057qib7	5614	24	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5614	25	)	)	-RRB-
cord-005453-4057qib7	5614	26	,	,	,
cord-005453-4057qib7	5614	27	with	with	IN
cord-005453-4057qib7	5614	28	a	a	DT
cord-005453-4057qib7	5614	29	high	high	JJ
cord-005453-4057qib7	5614	30	mortality	mortality	NN
cord-005453-4057qib7	5614	31	in	in	IN
cord-005453-4057qib7	5614	32	patients	patient	NNS
cord-005453-4057qib7	5614	33	which	which	WDT
cord-005453-4057qib7	5614	34	were	be	VBD
cord-005453-4057qib7	5614	35	refractory	refractory	JJ
cord-005453-4057qib7	5614	36	to	to	IN
cord-005453-4057qib7	5614	37	steroid	steroid	NN
cord-005453-4057qib7	5614	38	treatment	treatment	NN
cord-005453-4057qib7	5614	39	in	in	IN
cord-005453-4057qib7	5614	40	particular	particular	JJ
cord-005453-4057qib7	5614	41	.	.	.
cord-005453-4057qib7	5615	1	Recent	recent	JJ
cord-005453-4057qib7	5615	2	papers	paper	NNS
cord-005453-4057qib7	5615	3	point	point	VBP
cord-005453-4057qib7	5615	4	to	to	IN
cord-005453-4057qib7	5615	5	a	a	DT
cord-005453-4057qib7	5615	6	correlation	correlation	NN
cord-005453-4057qib7	5615	7	of	of	IN
cord-005453-4057qib7	5615	8	histological	histological	JJ
cord-005453-4057qib7	5615	9	grading	grading	NN
cord-005453-4057qib7	5615	10	of	of	IN
cord-005453-4057qib7	5615	11	intestinal	intestinal	JJ
cord-005453-4057qib7	5615	12	GvHD	gvhd	NN
cord-005453-4057qib7	5615	13	and	and	CC
cord-005453-4057qib7	5615	14	prognosis	prognosis	NN
cord-005453-4057qib7	5615	15	in	in	IN
cord-005453-4057qib7	5615	16	patient	patient	NN
cord-005453-4057qib7	5615	17	after	after	IN
cord-005453-4057qib7	5615	18	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5615	19	.	.	.
cord-005453-4057qib7	5616	1	However	however	RB
cord-005453-4057qib7	5616	2	a	a	DT
cord-005453-4057qib7	5616	3	comparison	comparison	NN
cord-005453-4057qib7	5616	4	with	with	IN
cord-005453-4057qib7	5616	5	clinical	clinical	JJ
cord-005453-4057qib7	5616	6	scores	score	NNS
cord-005453-4057qib7	5616	7	has	have	VBZ
cord-005453-4057qib7	5616	8	not	not	RB
cord-005453-4057qib7	5616	9	been	be	VBN
cord-005453-4057qib7	5616	10	performed	perform	VBN
cord-005453-4057qib7	5616	11	so	so	RB
cord-005453-4057qib7	5616	12	far	far	RB
cord-005453-4057qib7	5616	13	.	.	.
cord-005453-4057qib7	5617	1	Methods	method	NNS
cord-005453-4057qib7	5617	2	:	:	:
cord-005453-4057qib7	5617	3	In	in	IN
cord-005453-4057qib7	5617	4	this	this	DT
cord-005453-4057qib7	5617	5	analysis	analysis	NN
cord-005453-4057qib7	5617	6	,	,	,
cord-005453-4057qib7	5617	7	retrospective	retrospective	JJ
cord-005453-4057qib7	5617	8	data	datum	NNS
cord-005453-4057qib7	5617	9	from	from	IN
cord-005453-4057qib7	5617	10	89	89	CD
cord-005453-4057qib7	5617	11	patients	patient	NNS
cord-005453-4057qib7	5617	12	who	who	WP
cord-005453-4057qib7	5617	13	underwent	undergo	VBD
cord-005453-4057qib7	5617	14	endoscopy	endoscopy	NN
cord-005453-4057qib7	5617	15	due	due	IN
cord-005453-4057qib7	5617	16	to	to	IN
cord-005453-4057qib7	5617	17	clinical	clinical	JJ
cord-005453-4057qib7	5617	18	signs	sign	NNS
cord-005453-4057qib7	5617	19	of	of	IN
cord-005453-4057qib7	5617	20	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5617	21	(	(	-LRB-
cord-005453-4057qib7	5617	22	day	day	NN
cord-005453-4057qib7	5617	23	+20	+20	CD
cord-005453-4057qib7	5617	24	to	to	IN
cord-005453-4057qib7	5617	25	+200	+200	NNP
cord-005453-4057qib7	5617	26	after	after	IN
cord-005453-4057qib7	5617	27	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5617	28	)	)	-RRB-
cord-005453-4057qib7	5617	29	were	be	VBD
cord-005453-4057qib7	5617	30	evaluated	evaluate	VBN
cord-005453-4057qib7	5617	31	.	.	.
cord-005453-4057qib7	5618	1	Of	of	IN
cord-005453-4057qib7	5618	2	each	each	DT
cord-005453-4057qib7	5618	3	patient	patient	NN
cord-005453-4057qib7	5618	4	least	least	JJS
cord-005453-4057qib7	5618	5	3	3	CD
cord-005453-4057qib7	5618	6	biopsies	biopsy	NNS
cord-005453-4057qib7	5618	7	from	from	IN
cord-005453-4057qib7	5618	8	different	different	JJ
cord-005453-4057qib7	5618	9	sites	site	NNS
cord-005453-4057qib7	5618	10	of	of	IN
cord-005453-4057qib7	5618	11	the	the	DT
cord-005453-4057qib7	5618	12	colon	colon	NN
cord-005453-4057qib7	5618	13	which	which	WDT
cord-005453-4057qib7	5618	14	were	be	VBD
cord-005453-4057qib7	5618	15	taken	take	VBN
cord-005453-4057qib7	5618	16	simultaneously	simultaneously	RB
cord-005453-4057qib7	5618	17	.	.	.
cord-005453-4057qib7	5619	1	Of	of	IN
cord-005453-4057qib7	5619	2	each	each	DT
cord-005453-4057qib7	5619	3	biopsy	biopsy	NNP
cord-005453-4057qib7	5619	4	series	series	NN
cord-005453-4057qib7	5619	5	the	the	DT
cord-005453-4057qib7	5619	6	maximum	maximum	JJ
cord-005453-4057qib7	5619	7	histological	histological	JJ
cord-005453-4057qib7	5619	8	grad	grad	NN
cord-005453-4057qib7	5619	9	of	of	IN
cord-005453-4057qib7	5619	10	aGvHD	agvhd	NN
cord-005453-4057qib7	5619	11	according	accord	VBG
cord-005453-4057qib7	5619	12	to	to	IN
cord-005453-4057qib7	5619	13	the	the	DT
cord-005453-4057qib7	5619	14	Lerner	Lerner	NNP
cord-005453-4057qib7	5619	15	scheme	scheme	NN
cord-005453-4057qib7	5619	16	was	be	VBD
cord-005453-4057qib7	5619	17	obtained	obtain	VBN
cord-005453-4057qib7	5619	18	and	and	CC
cord-005453-4057qib7	5619	19	compared	compare	VBN
cord-005453-4057qib7	5619	20	with	with	IN
cord-005453-4057qib7	5619	21	the	the	DT
cord-005453-4057qib7	5619	22	Glucksberg	Glucksberg	NNP
cord-005453-4057qib7	5619	23	stage	stage	NN
cord-005453-4057qib7	5619	24	of	of	IN
cord-005453-4057qib7	5619	25	the	the	DT
cord-005453-4057qib7	5619	26	lower	low	JJR
cord-005453-4057qib7	5619	27	gastro	gastro	JJ
cord-005453-4057qib7	5619	28	intestinal	intestinal	JJ
cord-005453-4057qib7	5619	29	tract	tract	NN
cord-005453-4057qib7	5619	30	(	(	-LRB-
cord-005453-4057qib7	5619	31	GSLGI	GSLGI	NNP
cord-005453-4057qib7	5619	32	)	)	-RRB-
cord-005453-4057qib7	5619	33	and	and	CC
cord-005453-4057qib7	5619	34	the	the	DT
cord-005453-4057qib7	5619	35	overall	overall	JJ
cord-005453-4057qib7	5619	36	Glucksberg	Glucksberg	NNP
cord-005453-4057qib7	5619	37	grade	grade	NN
cord-005453-4057qib7	5619	38	(	(	-LRB-
cord-005453-4057qib7	5619	39	OGG	OGG	NNP
cord-005453-4057qib7	5619	40	)	)	-RRB-
cord-005453-4057qib7	5619	41	.	.	.
cord-005453-4057qib7	5620	1	These	these	DT
cord-005453-4057qib7	5620	2	three	three	CD
cord-005453-4057qib7	5620	3	grades	grade	NNS
cord-005453-4057qib7	5620	4	were	be	VBD
cord-005453-4057qib7	5620	5	compared	compare	VBN
cord-005453-4057qib7	5620	6	for	for	IN
cord-005453-4057qib7	5620	7	non	non	JJ
cord-005453-4057qib7	5620	8	-	-	JJ
cord-005453-4057qib7	5620	9	relaps	relaps	JJ
cord-005453-4057qib7	5620	10	related	relate	VBN
cord-005453-4057qib7	5620	11	mortality	mortality	NN
cord-005453-4057qib7	5620	12	using	use	VBG
cord-005453-4057qib7	5620	13	the	the	DT
cord-005453-4057qib7	5620	14	Log	Log	NNP
cord-005453-4057qib7	5620	15	-	-	HYPH
cord-005453-4057qib7	5620	16	Rank	Rank	NNP
cord-005453-4057qib7	5620	17	test	test	NN
cord-005453-4057qib7	5620	18	and	and	CC
cord-005453-4057qib7	5620	19	for	for	IN
cord-005453-4057qib7	5620	20	sensitivity	sensitivity	NN
cord-005453-4057qib7	5620	21	to	to	IN
cord-005453-4057qib7	5620	22	steroid	steroid	NN
cord-005453-4057qib7	5620	23	treatment	treatment	NN
cord-005453-4057qib7	5620	24	applying	apply	VBG
cord-005453-4057qib7	5620	25	the	the	DT
cord-005453-4057qib7	5620	26	Receiver	Receiver	NNP
cord-005453-4057qib7	5620	27	Operating	Operating	NNP
cord-005453-4057qib7	5620	28	Characteristic	characteristic	NN
cord-005453-4057qib7	5620	29	for	for	IN
cord-005453-4057qib7	5620	30	the	the	DT
cord-005453-4057qib7	5620	31	patients	patient	NNS
cord-005453-4057qib7	5620	32	who	who	WP
cord-005453-4057qib7	5620	33	received	receive	VBD
cord-005453-4057qib7	5620	34	steroid	steroid	JJ
cord-005453-4057qib7	5620	35	treatment	treatment	NN
cord-005453-4057qib7	5620	36	.	.	.
cord-005453-4057qib7	5621	1	For	for	IN
cord-005453-4057qib7	5621	2	these	these	DT
cord-005453-4057qib7	5621	3	patients	patient	NNS
cord-005453-4057qib7	5621	4	the	the	DT
cord-005453-4057qib7	5621	5	non	non	JJ
cord-005453-4057qib7	5621	6	-	-	JJ
cord-005453-4057qib7	5621	7	relaps	relaps	JJ
cord-005453-4057qib7	5621	8	related	relate	VBN
cord-005453-4057qib7	5621	9	mortality	mortality	NN
cord-005453-4057qib7	5621	10	for	for	IN
cord-005453-4057qib7	5621	11	responder	responder	NN
cord-005453-4057qib7	5621	12	and	and	CC
cord-005453-4057qib7	5621	13	non	non	JJ
cord-005453-4057qib7	5621	14	-	-	NN
cord-005453-4057qib7	5621	15	responder	responder	NN
cord-005453-4057qib7	5621	16	were	be	VBD
cord-005453-4057qib7	5621	17	calculated	calculate	VBN
cord-005453-4057qib7	5621	18	using	use	VBG
cord-005453-4057qib7	5621	19	also	also	RB
cord-005453-4057qib7	5621	20	Log	Log	NNP
cord-005453-4057qib7	5621	21	-	-	HYPH
cord-005453-4057qib7	5621	22	Rank	Rank	NNP
cord-005453-4057qib7	5621	23	test	test	NN
cord-005453-4057qib7	5621	24	.	.	.
cord-005453-4057qib7	5622	1	Results	result	NNS
cord-005453-4057qib7	5622	2	:	:	:
cord-005453-4057qib7	5623	1	The	the	DT
cord-005453-4057qib7	5623	2	histological	histological	JJ
cord-005453-4057qib7	5623	3	grade	grade	NN
cord-005453-4057qib7	5623	4	strongly	strongly	RB
cord-005453-4057qib7	5623	5	correlated	correlate	VBD
cord-005453-4057qib7	5623	6	with	with	IN
cord-005453-4057qib7	5623	7	the	the	DT
cord-005453-4057qib7	5623	8	survival	survival	NN
cord-005453-4057qib7	5623	9	(	(	-LRB-
cord-005453-4057qib7	5623	10	p=0.009	p=0.009	NN
cord-005453-4057qib7	5623	11	)	)	-RRB-
cord-005453-4057qib7	5623	12	.	.	.
cord-005453-4057qib7	5624	1	A	a	DT
cord-005453-4057qib7	5624	2	statistical	statistical	JJ
cord-005453-4057qib7	5624	3	significant	significant	JJ
cord-005453-4057qib7	5624	4	correlation	correlation	NN
cord-005453-4057qib7	5624	5	was	be	VBD
cord-005453-4057qib7	5624	6	also	also	RB
cord-005453-4057qib7	5624	7	found	find	VBN
cord-005453-4057qib7	5624	8	for	for	IN
cord-005453-4057qib7	5624	9	the	the	DT
cord-005453-4057qib7	5624	10	GSLGI	GSLGI	NNP
cord-005453-4057qib7	5624	11	(	(	-LRB-
cord-005453-4057qib7	5624	12	p=0.02	p=0.02	NNP
cord-005453-4057qib7	5624	13	)	)	-RRB-
cord-005453-4057qib7	5624	14	,	,	,
cord-005453-4057qib7	5624	15	whereas	whereas	IN
cord-005453-4057qib7	5624	16	the	the	DT
cord-005453-4057qib7	5624	17	OGG	OGG	NNP
cord-005453-4057qib7	5624	18	revealed	reveal	VBD
cord-005453-4057qib7	5624	19	no	no	DT
cord-005453-4057qib7	5624	20	significant	significant	JJ
cord-005453-4057qib7	5624	21	correlation	correlation	NN
cord-005453-4057qib7	5624	22	(	(	-LRB-
cord-005453-4057qib7	5624	23	p=0.09	p=0.09	NN
cord-005453-4057qib7	5624	24	)	)	-RRB-
cord-005453-4057qib7	5624	25	.	.	.
cord-005453-4057qib7	5625	1	Non	non	JJ
cord-005453-4057qib7	5625	2	-	-	NN
cord-005453-4057qib7	5625	3	relaps	relaps	JJ
cord-005453-4057qib7	5625	4	related	relate	VBN
cord-005453-4057qib7	5625	5	mortality	mortality	NN
cord-005453-4057qib7	5625	6	was	be	VBD
cord-005453-4057qib7	5625	7	mainly	mainly	RB
cord-005453-4057qib7	5625	8	related	relate	VBN
cord-005453-4057qib7	5625	9	to	to	IN
cord-005453-4057qib7	5625	10	infection	infection	NN
cord-005453-4057qib7	5625	11	or	or	CC
cord-005453-4057qib7	5625	12	sepsis	sepsis	NN
cord-005453-4057qib7	5625	13	(	(	-LRB-
cord-005453-4057qib7	5625	14	in	in	IN
cord-005453-4057qib7	5625	15	32/56	32/56	CD
cord-005453-4057qib7	5625	16	patients	patient	NNS
cord-005453-4057qib7	5625	17	who	who	WP
cord-005453-4057qib7	5625	18	died	die	VBD
cord-005453-4057qib7	5625	19	)	)	-RRB-
cord-005453-4057qib7	5625	20	.	.	.
cord-005453-4057qib7	5626	1	-Eighty	-Eighty	:
cord-005453-4057qib7	5626	2	-	-	:
cord-005453-4057qib7	5626	3	one	one	CD
cord-005453-4057qib7	5626	4	of	of	IN
cord-005453-4057qib7	5626	5	the	the	DT
cord-005453-4057qib7	5626	6	patients	patient	NNS
cord-005453-4057qib7	5626	7	received	receive	VBD
cord-005453-4057qib7	5626	8	steroid	steroid	NN
cord-005453-4057qib7	5626	9	therapy	therapy	NN
cord-005453-4057qib7	5626	10	.	.	.
cord-005453-4057qib7	5627	1	The	the	DT
cord-005453-4057qib7	5627	2	sensitivity	sensitivity	NN
cord-005453-4057qib7	5627	3	to	to	IN
cord-005453-4057qib7	5627	4	the	the	DT
cord-005453-4057qib7	5627	5	steroid	steroid	NN
cord-005453-4057qib7	5627	6	therapy	therapy	NN
cord-005453-4057qib7	5627	7	correlated	correlate	VBN
cord-005453-4057qib7	5627	8	with	with	IN
cord-005453-4057qib7	5627	9	each	each	DT
cord-005453-4057qib7	5627	10	of	of	IN
cord-005453-4057qib7	5627	11	the	the	DT
cord-005453-4057qib7	5627	12	three	three	CD
cord-005453-4057qib7	5627	13	scores	score	NNS
cord-005453-4057qib7	5627	14	(	(	-LRB-
cord-005453-4057qib7	5627	15	p	p	NN
cord-005453-4057qib7	5627	16	<	<	XX
cord-005453-4057qib7	5627	17	0.0001	0.0001	CD
cord-005453-4057qib7	5627	18	)	)	-RRB-
cord-005453-4057qib7	5627	19	but	but	CC
cord-005453-4057qib7	5627	20	was	be	VBD
cord-005453-4057qib7	5627	21	the	the	DT
cord-005453-4057qib7	5627	22	strongest	strong	JJS
cord-005453-4057qib7	5627	23	for	for	IN
cord-005453-4057qib7	5627	24	GSLGI	GSLGI	NNP
cord-005453-4057qib7	5628	1	(	(	-LRB-
cord-005453-4057qib7	5628	2	Area	area	NN
cord-005453-4057qib7	5628	3	under	under	IN
cord-005453-4057qib7	5628	4	the	the	DT
cord-005453-4057qib7	5628	5	curve	curve	NN
cord-005453-4057qib7	5628	6	(	(	-LRB-
cord-005453-4057qib7	5628	7	AUC	AUC	NNP
cord-005453-4057qib7	5628	8	)	)	-RRB-
cord-005453-4057qib7	5628	9	0.829	0.829	CD
cord-005453-4057qib7	5628	10	)	)	-RRB-
cord-005453-4057qib7	5628	11	,	,	,
cord-005453-4057qib7	5628	12	compared	compare	VBN
cord-005453-4057qib7	5628	13	to	to	IN
cord-005453-4057qib7	5628	14	OGG	OGG	NNP
cord-005453-4057qib7	5628	15	(	(	-LRB-
cord-005453-4057qib7	5628	16	AUC	AUC	NNP
cord-005453-4057qib7	5628	17	0.795	0.795	CD
cord-005453-4057qib7	5628	18	)	)	-RRB-
cord-005453-4057qib7	5628	19	and	and	CC
cord-005453-4057qib7	5628	20	the	the	DT
cord-005453-4057qib7	5628	21	histological	histological	JJ
cord-005453-4057qib7	5628	22	score	score	NN
cord-005453-4057qib7	5628	23	(	(	-LRB-
cord-005453-4057qib7	5628	24	AUC	AUC	NNP
cord-005453-4057qib7	5628	25	0.691	0.691	CD
cord-005453-4057qib7	5628	26	)	)	-RRB-
cord-005453-4057qib7	5628	27	.	.	.
cord-005453-4057qib7	5629	1	The	the	DT
cord-005453-4057qib7	5629	2	survival	survival	NN
cord-005453-4057qib7	5629	3	of	of	IN
cord-005453-4057qib7	5629	4	the	the	DT
cord-005453-4057qib7	5629	5	patients	patient	NNS
cord-005453-4057qib7	5629	6	,	,	,
cord-005453-4057qib7	5629	7	which	which	WDT
cord-005453-4057qib7	5629	8	were	be	VBD
cord-005453-4057qib7	5629	9	sensitive	sensitive	JJ
cord-005453-4057qib7	5629	10	to	to	IN
cord-005453-4057qib7	5629	11	steroid	steroid	NN
cord-005453-4057qib7	5629	12	treatment	treatment	NN
cord-005453-4057qib7	5629	13	was	be	VBD
cord-005453-4057qib7	5629	14	significantly	significantly	RB
cord-005453-4057qib7	5629	15	better	well	JJR
cord-005453-4057qib7	5629	16	than	than	IN
cord-005453-4057qib7	5629	17	those	those	DT
cord-005453-4057qib7	5629	18	of	of	IN
cord-005453-4057qib7	5629	19	steroid	steroid	NN
cord-005453-4057qib7	5629	20	refractory	refractory	JJ
cord-005453-4057qib7	5629	21	patients	patient	NNS
cord-005453-4057qib7	5629	22	(	(	-LRB-
cord-005453-4057qib7	5629	23	p=0.005	p=0.005	NNP
cord-005453-4057qib7	5629	24	)	)	-RRB-
cord-005453-4057qib7	5629	25	.	.	.
cord-005453-4057qib7	5630	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5630	2	:	:	:
cord-005453-4057qib7	5631	1	We	-PRON-	PRP
cord-005453-4057qib7	5631	2	found	find	VBD
cord-005453-4057qib7	5631	3	that	that	IN
cord-005453-4057qib7	5631	4	histological	histological	JJ
cord-005453-4057qib7	5631	5	and	and	CC
cord-005453-4057qib7	5631	6	clinical	clinical	JJ
cord-005453-4057qib7	5631	7	grading	grading	NN
cord-005453-4057qib7	5631	8	in	in	IN
cord-005453-4057qib7	5631	9	patients	patient	NNS
cord-005453-4057qib7	5631	10	after	after	IN
cord-005453-4057qib7	5631	11	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	5631	12	with	with	IN
cord-005453-4057qib7	5631	13	intestinal	intestinal	JJ
cord-005453-4057qib7	5631	14	GvHD	GvHD	NNP
cord-005453-4057qib7	5631	15	was	be	VBD
cord-005453-4057qib7	5631	16	correlated	correlate	VBN
cord-005453-4057qib7	5631	17	with	with	IN
cord-005453-4057qib7	5631	18	survival	survival	NN
cord-005453-4057qib7	5631	19	and	and	CC
cord-005453-4057qib7	5631	20	respond	respond	VB
cord-005453-4057qib7	5631	21	to	to	IN
cord-005453-4057qib7	5631	22	steroid	steroid	NN
cord-005453-4057qib7	5631	23	treatment	treatment	NN
cord-005453-4057qib7	5631	24	.	.	.
cord-005453-4057qib7	5632	1	Histological	Histological	NNP
cord-005453-4057qib7	5632	2	scoring	scoring	NN
cord-005453-4057qib7	5632	3	may	may	MD
cord-005453-4057qib7	5632	4	predict	predict	VB
cord-005453-4057qib7	5632	5	survival	survival	NN
cord-005453-4057qib7	5632	6	more	more	RBR
cord-005453-4057qib7	5632	7	precisely	precisely	RB
cord-005453-4057qib7	5632	8	than	than	IN
cord-005453-4057qib7	5632	9	OGG	ogg	NN
cord-005453-4057qib7	5632	10	and	and	CC
cord-005453-4057qib7	5632	11	GSLGI	GSLGI	NNP
cord-005453-4057qib7	5632	12	but	but	CC
cord-005453-4057qib7	5632	13	did	do	VBD
cord-005453-4057qib7	5632	14	not	not	RB
cord-005453-4057qib7	5632	15	add	add	VB
cord-005453-4057qib7	5632	16	substantial	substantial	JJ
cord-005453-4057qib7	5632	17	information	information	NN
cord-005453-4057qib7	5632	18	to	to	IN
cord-005453-4057qib7	5632	19	the	the	DT
cord-005453-4057qib7	5632	20	prediction	prediction	NN
cord-005453-4057qib7	5632	21	of	of	IN
cord-005453-4057qib7	5632	22	treatment	treatment	NN
cord-005453-4057qib7	5632	23	response	response	NN
cord-005453-4057qib7	5632	24	.	.	.
cord-005453-4057qib7	5633	1	[	[	-LRB-
cord-005453-4057qib7	5633	2	Emerging	emerge	VBG
cord-005453-4057qib7	5633	3	evidences	evidence	NNS
cord-005453-4057qib7	5633	4	suggest	suggest	VBP
cord-005453-4057qib7	5633	5	that	that	IN
cord-005453-4057qib7	5633	6	regulatory	regulatory	JJ
cord-005453-4057qib7	5633	7	B	b	NN
cord-005453-4057qib7	5633	8	cells	cell	NNS
cord-005453-4057qib7	5633	9	(	(	-LRB-
cord-005453-4057qib7	5633	10	Bregs	Bregs	NNP
cord-005453-4057qib7	5633	11	)	)	-RRB-
cord-005453-4057qib7	5633	12	play	play	VB
cord-005453-4057qib7	5633	13	essential	essential	JJ
cord-005453-4057qib7	5633	14	roles	role	NNS
cord-005453-4057qib7	5633	15	in	in	IN
cord-005453-4057qib7	5633	16	inflammation	inflammation	NN
cord-005453-4057qib7	5633	17	,	,	,
cord-005453-4057qib7	5633	18	autoimmune	autoimmune	JJ
cord-005453-4057qib7	5633	19	diseases	disease	NNS
cord-005453-4057qib7	5633	20	and	and	CC
cord-005453-4057qib7	5633	21	tumors	tumor	NNS
cord-005453-4057qib7	5633	22	.	.	.
cord-005453-4057qib7	5634	1	Few	few	JJ
cord-005453-4057qib7	5634	2	data	datum	NNS
cord-005453-4057qib7	5634	3	exist	exist	VBP
cord-005453-4057qib7	5634	4	about	about	IN
cord-005453-4057qib7	5634	5	the	the	DT
cord-005453-4057qib7	5634	6	role	role	NN
cord-005453-4057qib7	5634	7	of	of	IN
cord-005453-4057qib7	5634	8	Bregs	Bregs	NNP
cord-005453-4057qib7	5634	9	in	in	IN
cord-005453-4057qib7	5634	10	the	the	DT
cord-005453-4057qib7	5634	11	contest	contest	NN
cord-005453-4057qib7	5634	12	of	of	IN
cord-005453-4057qib7	5634	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5634	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	5634	15	stem	stem	NN
cord-005453-4057qib7	5634	16	cell	cell	NN
cord-005453-4057qib7	5634	17	transplantation	transplantation	NN
cord-005453-4057qib7	5634	18	(	(	-LRB-
cord-005453-4057qib7	5634	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5634	20	)	)	-RRB-
cord-005453-4057qib7	5634	21	.	.	.
cord-005453-4057qib7	5635	1	Some	some	DT
cord-005453-4057qib7	5635	2	authors	author	NNS
cord-005453-4057qib7	5635	3	have	have	VBP
cord-005453-4057qib7	5635	4	observed	observe	VBN
cord-005453-4057qib7	5635	5	that	that	IN
cord-005453-4057qib7	5635	6	Bregs	Bregs	NNP
cord-005453-4057qib7	5635	7	from	from	IN
cord-005453-4057qib7	5635	8	patients	patient	NNS
cord-005453-4057qib7	5635	9	with	with	IN
cord-005453-4057qib7	5635	10	chronic	chronic	JJ
cord-005453-4057qib7	5635	11	graft	graft	NN
cord-005453-4057qib7	5635	12	-	-	HYPH
cord-005453-4057qib7	5635	13	versus	versus	IN
cord-005453-4057qib7	5635	14	-	-	HYPH
cord-005453-4057qib7	5635	15	host	host	NN
cord-005453-4057qib7	5635	16	disease	disease	NN
cord-005453-4057qib7	5635	17	(	(	-LRB-
cord-005453-4057qib7	5635	18	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5635	19	)	)	-RRB-
cord-005453-4057qib7	5635	20	were	be	VBD
cord-005453-4057qib7	5635	21	less	less	RBR
cord-005453-4057qib7	5635	22	frequent	frequent	JJ
cord-005453-4057qib7	5635	23	and	and	CC
cord-005453-4057qib7	5635	24	less	less	RBR
cord-005453-4057qib7	5635	25	likely	likely	JJ
cord-005453-4057qib7	5635	26	to	to	TO
cord-005453-4057qib7	5635	27	produce	produce	VB
cord-005453-4057qib7	5636	1	IL-10	IL-10	NNP
cord-005453-4057qib7	5636	2	than	than	IN
cord-005453-4057qib7	5636	3	Bregs	Bregs	NNP
cord-005453-4057qib7	5636	4	as	as	IN
cord-005453-4057qib7	5636	5	compared	compare	VBN
cord-005453-4057qib7	5636	6	to	to	IN
cord-005453-4057qib7	5636	7	healthy	healthy	JJ
cord-005453-4057qib7	5636	8	donors	donor	NNS
cord-005453-4057qib7	5636	9	or	or	CC
cord-005453-4057qib7	5636	10	patients	patient	NNS
cord-005453-4057qib7	5636	11	without	without	IN
cord-005453-4057qib7	5636	12	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5636	13	.	.	.
cord-005453-4057qib7	5637	1	These	these	DT
cord-005453-4057qib7	5637	2	findings	finding	NNS
cord-005453-4057qib7	5637	3	suggest	suggest	VBP
cord-005453-4057qib7	5637	4	that	that	IN
cord-005453-4057qib7	5637	5	Bregs	Bregs	NNP
cord-005453-4057qib7	5637	6	may	may	MD
cord-005453-4057qib7	5637	7	be	be	VB
cord-005453-4057qib7	5637	8	involved	involve	VBN
cord-005453-4057qib7	5637	9	in	in	IN
cord-005453-4057qib7	5637	10	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5637	11	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	5637	12	.	.	.
cord-005453-4057qib7	5638	1	The	the	DT
cord-005453-4057qib7	5638	2	purpose	purpose	NN
cord-005453-4057qib7	5638	3	of	of	IN
cord-005453-4057qib7	5638	4	our	-PRON-	PRP$
cord-005453-4057qib7	5638	5	study	study	NN
cord-005453-4057qib7	5638	6	was	be	VBD
cord-005453-4057qib7	5638	7	to	to	TO
cord-005453-4057qib7	5638	8	evaluate	evaluate	VB
cord-005453-4057qib7	5638	9	a	a	DT
cord-005453-4057qib7	5638	10	possible	possible	JJ
cord-005453-4057qib7	5638	11	role	role	NN
cord-005453-4057qib7	5638	12	of	of	IN
cord-005453-4057qib7	5638	13	B	b	NN
cord-005453-4057qib7	5638	14	cell	cell	NN
cord-005453-4057qib7	5638	15	subsets	subset	NNS
cord-005453-4057qib7	5638	16	on	on	IN
cord-005453-4057qib7	5638	17	GVHD	GVHD	NNP
cord-005453-4057qib7	5638	18	occurrence	occurrence	NN
cord-005453-4057qib7	5638	19	.	.	.
cord-005453-4057qib7	5639	1	Methods	method	NNS
cord-005453-4057qib7	5639	2	:	:	:
cord-005453-4057qib7	5639	3	Lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5639	4	subset	subset	JJ
cord-005453-4057qib7	5639	5	enumeration	enumeration	NN
cord-005453-4057qib7	5639	6	was	be	VBD
cord-005453-4057qib7	5639	7	performed	perform	VBN
cord-005453-4057qib7	5639	8	by	by	IN
cord-005453-4057qib7	5639	9	AQUIOS	AQUIOS	NNP
cord-005453-4057qib7	5639	10	CL	CL	NNP
cord-005453-4057qib7	5639	11	Flow	Flow	NNP
cord-005453-4057qib7	5639	12	Cytometer	Cytometer	NNP
cord-005453-4057qib7	5639	13	(	(	-LRB-
cord-005453-4057qib7	5639	14	Beckman	Beckman	NNP
cord-005453-4057qib7	5639	15	Coulter	Coulter	NNP
cord-005453-4057qib7	5639	16	)	)	-RRB-
cord-005453-4057qib7	5639	17	,	,	,
cord-005453-4057qib7	5639	18	a	a	DT
cord-005453-4057qib7	5639	19	quantitative	quantitative	JJ
cord-005453-4057qib7	5639	20	automated	automate	VBN
cord-005453-4057qib7	5639	21	analyzer	analyzer	NN
cord-005453-4057qib7	5639	22	that	that	WDT
cord-005453-4057qib7	5639	23	performs	perform	VBZ
cord-005453-4057qib7	5639	24	two	two	CD
cord-005453-4057qib7	5639	25	diagnostic	diagnostic	JJ
cord-005453-4057qib7	5639	26	panels	panel	NNS
cord-005453-4057qib7	5639	27	:	:	:
cord-005453-4057qib7	5640	1	Tetra-1	Tetra-1	NNP
cord-005453-4057qib7	5640	2	CD45-FITC	CD45-FITC	NNP
cord-005453-4057qib7	5640	3	/	/	SYM
cord-005453-4057qib7	5640	4	CD4-RD1/	CD4-RD1/	NNP
cord-005453-4057qib7	5640	5	CD8-ECD	CD8-ECD	NNP
cord-005453-4057qib7	5640	6	/	/	SYM
cord-005453-4057qib7	5640	7	CD3-PC5	CD3-PC5	NNP
cord-005453-4057qib7	5640	8	and	and	CC
cord-005453-4057qib7	5640	9	Tetra-2	Tetra-2	NNPS
cord-005453-4057qib7	5640	10	CD45-FITC	CD45-FITC	NNP
cord-005453-4057qib7	5640	11	/	/	SYM
cord-005453-4057qib7	5640	12	CD56	CD56	NNP
cord-005453-4057qib7	5640	13	+	+	CC
cord-005453-4057qib7	5640	14	CD16-RD1	cd16-rd1	NN
cord-005453-4057qib7	5640	15	/	/	SYM
cord-005453-4057qib7	5640	16	CD19-ECD	cd19-ecd	NN
cord-005453-4057qib7	5640	17	/	/	SYM
cord-005453-4057qib7	5640	18	CD3-PC5	cd3-pc5	NN
cord-005453-4057qib7	5640	19	.	.	.
cord-005453-4057qib7	5641	1	B	b	NN
cord-005453-4057qib7	5641	2	cell	cell	NN
cord-005453-4057qib7	5641	3	subsets	subset	NNS
cord-005453-4057qib7	5641	4	(	(	-LRB-
cord-005453-4057qib7	5641	5	Memory	memory	NN
cord-005453-4057qib7	5641	6	,	,	,
cord-005453-4057qib7	5641	7	Mature	Mature	NNP
cord-005453-4057qib7	5641	8	and	and	CC
cord-005453-4057qib7	5641	9	Transitional	Transitional	NNP
cord-005453-4057qib7	5641	10	B	B	NNP
cord-005453-4057qib7	5641	11	cells	cell	NNS
cord-005453-4057qib7	5641	12	)	)	-RRB-
cord-005453-4057qib7	5641	13	on	on	IN
cord-005453-4057qib7	5641	14	peripheral	peripheral	JJ
cord-005453-4057qib7	5641	15	blood	blood	NN
cord-005453-4057qib7	5641	16	samples	sample	NNS
cord-005453-4057qib7	5641	17	were	be	VBD
cord-005453-4057qib7	5641	18	analyzed	analyze	VBN
cord-005453-4057qib7	5641	19	by	by	IN
cord-005453-4057qib7	5641	20	AQUIOS	AQUIOS	NNP
cord-005453-4057qib7	5641	21	Designer	Designer	NNP
cord-005453-4057qib7	5641	22	Software	Software	NNP
cord-005453-4057qib7	5641	23	,	,	,
cord-005453-4057qib7	5641	24	a	a	DT
cord-005453-4057qib7	5641	25	tool	tool	NN
cord-005453-4057qib7	5641	26	for	for	IN
cord-005453-4057qib7	5641	27	the	the	DT
cord-005453-4057qib7	5641	28	creation	creation	NN
cord-005453-4057qib7	5641	29	of	of	IN
cord-005453-4057qib7	5641	30	user	user	NN
cord-005453-4057qib7	5641	31	-	-	HYPH
cord-005453-4057qib7	5641	32	defined	define	VBN
cord-005453-4057qib7	5641	33	applications	application	NNS
cord-005453-4057qib7	5641	34	.	.	.
cord-005453-4057qib7	5642	1	Panel-1	Panel-1	NNP
cord-005453-4057qib7	5643	1	CD19-FITC	CD19-FITC	NNP
cord-005453-4057qib7	5643	2	/	/	SYM
cord-005453-4057qib7	5643	3	CD10-PE	CD10-PE	NNP
cord-005453-4057qib7	5643	4	/	/	SYM
cord-005453-4057qib7	5643	5	CD38-ECD	CD38-ECD	NNP
cord-005453-4057qib7	5643	6	/	/	SYM
cord-005453-4057qib7	5643	7	CD24-PC5	CD24-PC5	NNP
cord-005453-4057qib7	5643	8	/	/	SYM
cord-005453-4057qib7	5643	9	CD27-PC7	CD27-PC7	NNP
cord-005453-4057qib7	5643	10	and	and	CC
cord-005453-4057qib7	5643	11	Panel-2	Panel-2	NNP
cord-005453-4057qib7	5644	1	CD19-FITC	CD19-FITC	NNP
cord-005453-4057qib7	5644	2	/	/	SYM
cord-005453-4057qib7	5644	3	CD5-PE	cd5-pe	NN
cord-005453-4057qib7	5644	4	/	/	SYM
cord-005453-4057qib7	5644	5	CD38-ECD	CD38-ECD	NNP
cord-005453-4057qib7	5644	6	/	/	SYM
cord-005453-4057qib7	5644	7	CD24-PC5/	CD24-PC5/	NNP
cord-005453-4057qib7	5644	8	CD20-PC7	CD20-PC7	NNS
cord-005453-4057qib7	5644	9	were	be	VBD
cord-005453-4057qib7	5644	10	specifically	specifically	RB
cord-005453-4057qib7	5644	11	designed	design	VBN
cord-005453-4057qib7	5644	12	by	by	IN
cord-005453-4057qib7	5644	13	Beckman	Beckman	NNP
cord-005453-4057qib7	5644	14	Coulter	Coulter	NNP
cord-005453-4057qib7	5644	15	for	for	IN
cord-005453-4057qib7	5644	16	our	-PRON-	PRP$
cord-005453-4057qib7	5644	17	center	center	NN
cord-005453-4057qib7	5644	18	.	.	.
cord-005453-4057qib7	5645	1	The	the	DT
cord-005453-4057qib7	5645	2	flow	flow	NN
cord-005453-4057qib7	5645	3	cytometric	cytometric	NN
cord-005453-4057qib7	5645	4	analysis	analysis	NN
cord-005453-4057qib7	5645	5	was	be	VBD
cord-005453-4057qib7	5645	6	performed	perform	VBN
cord-005453-4057qib7	5645	7	as	as	IN
cord-005453-4057qib7	5645	8	follows	follow	VBZ
cord-005453-4057qib7	5645	9	:	:	:
cord-005453-4057qib7	5645	10	in	in	IN
cord-005453-4057qib7	5645	11	donors	donor	NNS
cord-005453-4057qib7	5645	12	and	and	CC
cord-005453-4057qib7	5645	13	patients	patient	NNS
cord-005453-4057qib7	5645	14	at	at	IN
cord-005453-4057qib7	5645	15	basal	basal	NN
cord-005453-4057qib7	5645	16	level	level	NN
cord-005453-4057qib7	5645	17	;	;	:
cord-005453-4057qib7	5645	18	on	on	IN
cord-005453-4057qib7	5645	19	graft	graft	NN
cord-005453-4057qib7	5645	20	products	product	NNS
cord-005453-4057qib7	5645	21	and	and	CC
cord-005453-4057qib7	5645	22	in	in	IN
cord-005453-4057qib7	5645	23	patients	patient	NNS
cord-005453-4057qib7	5645	24	at	at	IN
cord-005453-4057qib7	5645	25	days	day	NNS
cord-005453-4057qib7	5645	26	+30	+30	CD
cord-005453-4057qib7	5645	27	,	,	,
cord-005453-4057qib7	5645	28	+60	+60	NNP
cord-005453-4057qib7	5645	29	,	,	,
cord-005453-4057qib7	5645	30	+90	+90	CD
cord-005453-4057qib7	5645	31	,	,	,
cord-005453-4057qib7	5645	32	+120	+120	NNP
cord-005453-4057qib7	5645	33	after	after	IN
cord-005453-4057qib7	5645	34	HSCT	HSCT	NNP
cord-005453-4057qib7	5645	35	.	.	.
cord-005453-4057qib7	5646	1	Statistical	statistical	JJ
cord-005453-4057qib7	5646	2	significance	significance	NN
cord-005453-4057qib7	5646	3	was	be	VBD
cord-005453-4057qib7	5646	4	assessed	assess	VBN
cord-005453-4057qib7	5646	5	with	with	IN
cord-005453-4057qib7	5646	6	Prism	Prism	NNP
cord-005453-4057qib7	5646	7	software	software	NN
cord-005453-4057qib7	5646	8	(	(	-LRB-
cord-005453-4057qib7	5646	9	GraphPad	GraphPad	NNP
cord-005453-4057qib7	5646	10	)	)	-RRB-
cord-005453-4057qib7	5646	11	by	by	IN
cord-005453-4057qib7	5646	12	Mann	Mann	NNP
cord-005453-4057qib7	5646	13	Withney	Withney	NNP
cord-005453-4057qib7	5646	14	test	test	NN
cord-005453-4057qib7	5646	15	.	.	.
cord-005453-4057qib7	5647	1	P	p	NN
cord-005453-4057qib7	5647	2	<	<	XX
cord-005453-4057qib7	5647	3	0.05	0.05	CD
cord-005453-4057qib7	5647	4	was	be	VBD
cord-005453-4057qib7	5647	5	considered	consider	VBN
cord-005453-4057qib7	5647	6	statistically	statistically	RB
cord-005453-4057qib7	5647	7	significant	significant	JJ
cord-005453-4057qib7	5647	8	.	.	.
cord-005453-4057qib7	5648	1	Results	result	NNS
cord-005453-4057qib7	5648	2	:	:	:
cord-005453-4057qib7	5649	1	Actually	actually	RB
cord-005453-4057qib7	5649	2	we	-PRON-	PRP
cord-005453-4057qib7	5649	3	enrolled	enrol	VBD
cord-005453-4057qib7	5649	4	84	84	CD
cord-005453-4057qib7	5649	5	patients	patient	NNS
cord-005453-4057qib7	5649	6	submitted	submit	VBN
cord-005453-4057qib7	5649	7	to	to	IN
cord-005453-4057qib7	5649	8	HSCT	HSCT	NNP
cord-005453-4057qib7	5649	9	in	in	IN
cord-005453-4057qib7	5649	10	our	-PRON-	PRP$
cord-005453-4057qib7	5649	11	center	center	NN
cord-005453-4057qib7	5649	12	from	from	IN
cord-005453-4057qib7	5649	13	November	November	NNP
cord-005453-4057qib7	5649	14	2017	2017	CD
cord-005453-4057qib7	5649	15	.	.	.
cord-005453-4057qib7	5650	1	A	a	DT
cord-005453-4057qib7	5650	2	preliminary	preliminary	JJ
cord-005453-4057qib7	5650	3	statistical	statistical	JJ
cord-005453-4057qib7	5650	4	analysis	analysis	NN
cord-005453-4057qib7	5650	5	was	be	VBD
cord-005453-4057qib7	5650	6	performed	perform	VBN
cord-005453-4057qib7	5650	7	on	on	IN
cord-005453-4057qib7	5650	8	55	55	CD
cord-005453-4057qib7	5650	9	patients	patient	NNS
cord-005453-4057qib7	5650	10	.	.	.
cord-005453-4057qib7	5651	1	Stem	stem	NN
cord-005453-4057qib7	5651	2	cells	cell	NNS
cord-005453-4057qib7	5651	3	source	source	NN
cord-005453-4057qib7	5651	4	was	be	VBD
cord-005453-4057qib7	5651	5	peripheral	peripheral	JJ
cord-005453-4057qib7	5651	6	blood	blood	NN
cord-005453-4057qib7	5651	7	(	(	-LRB-
cord-005453-4057qib7	5651	8	PB	PB	NNP
cord-005453-4057qib7	5651	9	)	)	-RRB-
cord-005453-4057qib7	5651	10	in	in	IN
cord-005453-4057qib7	5651	11	27	27	CD
cord-005453-4057qib7	5651	12	cases	case	NNS
cord-005453-4057qib7	5651	13	and	and	CC
cord-005453-4057qib7	5651	14	bone	bone	NN
cord-005453-4057qib7	5651	15	marrow	marrow	NN
cord-005453-4057qib7	5651	16	(	(	-LRB-
cord-005453-4057qib7	5651	17	BM	BM	NNP
cord-005453-4057qib7	5651	18	)	)	-RRB-
cord-005453-4057qib7	5651	19	in	in	IN
cord-005453-4057qib7	5651	20	the	the	DT
cord-005453-4057qib7	5651	21	others	other	NNS
cord-005453-4057qib7	5651	22	28	28	CD
cord-005453-4057qib7	5651	23	.	.	.
cord-005453-4057qib7	5652	1	The	the	DT
cord-005453-4057qib7	5652	2	conditioning	conditioning	NN
cord-005453-4057qib7	5652	3	regimen	regimen	NN
cord-005453-4057qib7	5652	4	was	be	VBD
cord-005453-4057qib7	5652	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	5652	6	in	in	IN
cord-005453-4057qib7	5652	7	26	26	CD
cord-005453-4057qib7	5652	8	patients	patient	NNS
cord-005453-4057qib7	5652	9	and	and	CC
cord-005453-4057qib7	5652	10	RIC	RIC	NNP
cord-005453-4057qib7	5652	11	in	in	IN
cord-005453-4057qib7	5652	12	29	29	CD
cord-005453-4057qib7	5652	13	patients	patient	NNS
cord-005453-4057qib7	5652	14	.	.	.
cord-005453-4057qib7	5653	1	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5653	2	was	be	VBD
cord-005453-4057qib7	5653	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	5653	4	in	in	IN
cord-005453-4057qib7	5653	5	22	22	CD
cord-005453-4057qib7	5653	6	patients	patient	NNS
cord-005453-4057qib7	5653	7	(	(	-LRB-
cord-005453-4057qib7	5653	8	40	40	CD
cord-005453-4057qib7	5653	9	%	%	NN
cord-005453-4057qib7	5653	10	)	)	-RRB-
cord-005453-4057qib7	5653	11	.	.	.
cord-005453-4057qib7	5654	1	No	no	DT
cord-005453-4057qib7	5654	2	associations	association	NNS
cord-005453-4057qib7	5654	3	were	be	VBD
cord-005453-4057qib7	5654	4	found	find	VBN
cord-005453-4057qib7	5654	5	between	between	IN
cord-005453-4057qib7	5654	6	B	b	NN
cord-005453-4057qib7	5654	7	cell	cell	NN
cord-005453-4057qib7	5654	8	subsets	subset	NNS
cord-005453-4057qib7	5654	9	in	in	IN
cord-005453-4057qib7	5654	10	donors	donor	NNS
cord-005453-4057qib7	5654	11	and	and	CC
cord-005453-4057qib7	5654	12	patients	patient	NNS
cord-005453-4057qib7	5654	13	at	at	IN
cord-005453-4057qib7	5654	14	baseline	baseline	NN
cord-005453-4057qib7	5654	15	and	and	CC
cord-005453-4057qib7	5654	16	the	the	DT
cord-005453-4057qib7	5654	17	occurrence	occurrence	NN
cord-005453-4057qib7	5654	18	of	of	IN
cord-005453-4057qib7	5654	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5654	20	.	.	.
cord-005453-4057qib7	5655	1	However	however	RB
cord-005453-4057qib7	5655	2	we	-PRON-	PRP
cord-005453-4057qib7	5655	3	found	find	VBD
cord-005453-4057qib7	5655	4	a	a	DT
cord-005453-4057qib7	5655	5	higher	high	JJR
cord-005453-4057qib7	5655	6	median	median	JJ
cord-005453-4057qib7	5655	7	percentage	percentage	NN
cord-005453-4057qib7	5655	8	of	of	IN
cord-005453-4057qib7	5655	9	transitional	transitional	JJ
cord-005453-4057qib7	5655	10	B	b	NN
cord-005453-4057qib7	5655	11	cells	cell	NNS
cord-005453-4057qib7	5655	12	in	in	IN
cord-005453-4057qib7	5655	13	graft	graft	NN
cord-005453-4057qib7	5655	14	products	product	NNS
cord-005453-4057qib7	5655	15	in	in	IN
cord-005453-4057qib7	5655	16	patients	patient	NNS
cord-005453-4057qib7	5655	17	without	without	IN
cord-005453-4057qib7	5655	18	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5655	19	(	(	-LRB-
cord-005453-4057qib7	5655	20	9.6	9.6	CD
cord-005453-4057qib7	5655	21	%	%	NN
cord-005453-4057qib7	5655	22	,	,	,
cord-005453-4057qib7	5655	23	4.5	4.5	CD
cord-005453-4057qib7	5655	24	-	-	SYM
cord-005453-4057qib7	5655	25	26.7	26.7	CD
cord-005453-4057qib7	5655	26	)	)	-RRB-
cord-005453-4057qib7	5655	27	compared	compare	VBN
cord-005453-4057qib7	5655	28	to	to	IN
cord-005453-4057qib7	5655	29	patients	patient	NNS
cord-005453-4057qib7	5655	30	with	with	IN
cord-005453-4057qib7	5655	31	aGvHD	agvhd	NN
cord-005453-4057qib7	5655	32	(	(	-LRB-
cord-005453-4057qib7	5655	33	6.9	6.9	CD
cord-005453-4057qib7	5655	34	%	%	NN
cord-005453-4057qib7	5655	35	,	,	,
cord-005453-4057qib7	5655	36	1.5	1.5	CD
cord-005453-4057qib7	5655	37	-	-	SYM
cord-005453-4057qib7	5655	38	21.1	21.1	CD
cord-005453-4057qib7	5655	39	)	)	-RRB-
cord-005453-4057qib7	5656	1	(	(	-LRB-
cord-005453-4057qib7	5656	2	p=0.02	p=0.02	NNP
cord-005453-4057qib7	5656	3	,	,	,
cord-005453-4057qib7	5656	4	Fig	Fig	NNP
cord-005453-4057qib7	5656	5	1A	1a	NN
cord-005453-4057qib7	5656	6	)	)	-RRB-
cord-005453-4057qib7	5656	7	.	.	.
cord-005453-4057qib7	5657	1	In	in	IN
cord-005453-4057qib7	5657	2	addition	addition	NN
cord-005453-4057qib7	5657	3	,	,	,
cord-005453-4057qib7	5657	4	patients	patient	NNS
cord-005453-4057qib7	5657	5	without	without	IN
cord-005453-4057qib7	5657	6	aGvHD	aGvHD	NNP
cord-005453-4057qib7	5657	7	showed	show	VBD
cord-005453-4057qib7	5657	8	a	a	DT
cord-005453-4057qib7	5657	9	lower	low	JJR
cord-005453-4057qib7	5657	10	median	median	JJ
cord-005453-4057qib7	5657	11	percentage	percentage	NN
cord-005453-4057qib7	5657	12	of	of	IN
cord-005453-4057qib7	5657	13	memory	memory	NN
cord-005453-4057qib7	5657	14	B	b	NN
cord-005453-4057qib7	5657	15	cells	cell	NNS
cord-005453-4057qib7	5657	16	(	(	-LRB-
cord-005453-4057qib7	5657	17	24.2	24.2	CD
cord-005453-4057qib7	5657	18	%	%	NN
cord-005453-4057qib7	5657	19	,	,	,
cord-005453-4057qib7	5657	20	range	range	VBP
cord-005453-4057qib7	5657	21	11.6	11.6	CD
cord-005453-4057qib7	5657	22	-	-	SYM
cord-005453-4057qib7	5657	23	49	49	CD
cord-005453-4057qib7	5657	24	)	)	-RRB-
cord-005453-4057qib7	5657	25	in	in	IN
cord-005453-4057qib7	5657	26	graft	graft	NN
cord-005453-4057qib7	5657	27	product	product	NN
cord-005453-4057qib7	5657	28	as	as	IN
cord-005453-4057qib7	5657	29	compared	compare	VBN
cord-005453-4057qib7	5657	30	to	to	IN
cord-005453-4057qib7	5657	31	patients	patient	NNS
cord-005453-4057qib7	5657	32	with	with	IN
cord-005453-4057qib7	5657	33	aGvHD	agvhd	NN
cord-005453-4057qib7	5657	34	(	(	-LRB-
cord-005453-4057qib7	5657	35	34.2	34.2	CD
cord-005453-4057qib7	5657	36	%	%	NN
cord-005453-4057qib7	5657	37	,	,	,
cord-005453-4057qib7	5657	38	range	range	NN
cord-005453-4057qib7	5657	39	10.3	10.3	CD
cord-005453-4057qib7	5657	40	-	-	HYPH
cord-005453-4057qib7	5657	41	68.15	68.15	CD
cord-005453-4057qib7	5657	42	)	)	-RRB-
cord-005453-4057qib7	5658	1	(	(	-LRB-
cord-005453-4057qib7	5658	2	p	p	NN
cord-005453-4057qib7	5658	3	=	=	SYM
cord-005453-4057qib7	5658	4	0.03	0.03	CD
cord-005453-4057qib7	5658	5	,	,	,
cord-005453-4057qib7	5658	6	Fig.1B	Fig.1B	NNP
cord-005453-4057qib7	5658	7	)	)	-RRB-
cord-005453-4057qib7	5658	8	.	.	.
cord-005453-4057qib7	5659	1	Finally	finally	RB
cord-005453-4057qib7	5659	2	in	in	IN
cord-005453-4057qib7	5659	3	the	the	DT
cord-005453-4057qib7	5659	4	subgroup	subgroup	NN
cord-005453-4057qib7	5659	5	of	of	IN
cord-005453-4057qib7	5659	6	patients	patient	NNS
cord-005453-4057qib7	5659	7	receiving	receive	VBG
cord-005453-4057qib7	5659	8	PB	PB	NNP
cord-005453-4057qib7	5659	9	as	as	IN
cord-005453-4057qib7	5659	10	stem	stem	NN
cord-005453-4057qib7	5659	11	cell	cell	NN
cord-005453-4057qib7	5659	12	source	source	NN
cord-005453-4057qib7	5659	13	we	-PRON-	PRP
cord-005453-4057qib7	5659	14	observed	observe	VBD
cord-005453-4057qib7	5659	15	a	a	DT
cord-005453-4057qib7	5659	16	higher	high	JJR
cord-005453-4057qib7	5659	17	percentage	percentage	NN
cord-005453-4057qib7	5659	18	of	of	IN
cord-005453-4057qib7	5659	19	CD3	CD3	NNP
cord-005453-4057qib7	5659	20	+	+	CC
cord-005453-4057qib7	5659	21	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	5659	22	in	in	IN
cord-005453-4057qib7	5659	23	graft	graft	NN
cord-005453-4057qib7	5659	24	product	product	NN
cord-005453-4057qib7	5659	25	in	in	IN
cord-005453-4057qib7	5659	26	patients	patient	NNS
cord-005453-4057qib7	5659	27	with	with	IN
cord-005453-4057qib7	5659	28	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5659	29	(	(	-LRB-
cord-005453-4057qib7	5659	30	75	75	CD
cord-005453-4057qib7	5659	31	%	%	NN
cord-005453-4057qib7	5659	32	;	;	:
cord-005453-4057qib7	5659	33	range	range	VBP
cord-005453-4057qib7	5659	34	68	68	CD
cord-005453-4057qib7	5659	35	-	-	SYM
cord-005453-4057qib7	5659	36	80	80	CD
cord-005453-4057qib7	5659	37	)	)	-RRB-
cord-005453-4057qib7	5659	38	compared	compare	VBN
cord-005453-4057qib7	5659	39	to	to	IN
cord-005453-4057qib7	5659	40	patients	patient	NNS
cord-005453-4057qib7	5659	41	without	without	IN
cord-005453-4057qib7	5659	42	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5659	43	(	(	-LRB-
cord-005453-4057qib7	5659	44	71	71	CD
cord-005453-4057qib7	5659	45	%	%	NN
cord-005453-4057qib7	5659	46	;	;	:
cord-005453-4057qib7	5659	47	range	range	VBP
cord-005453-4057qib7	5659	48	62	62	CD
cord-005453-4057qib7	5659	49	-	-	SYM
cord-005453-4057qib7	5659	50	78	78	CD
cord-005453-4057qib7	5659	51	)	)	-RRB-
cord-005453-4057qib7	5659	52	(	(	-LRB-
cord-005453-4057qib7	5659	53	p=0.01	p=0.01	NNP
cord-005453-4057qib7	5659	54	)	)	-RRB-
cord-005453-4057qib7	5659	55	.	.	.
cord-005453-4057qib7	5660	1	In	in	IN
cord-005453-4057qib7	5660	2	the	the	DT
cord-005453-4057qib7	5660	3	monitoring	monitoring	NN
cord-005453-4057qib7	5660	4	of	of	IN
cord-005453-4057qib7	5660	5	B	b	NN
cord-005453-4057qib7	5660	6	cells	cell	NNS
cord-005453-4057qib7	5660	7	reconstitution	reconstitution	NN
cord-005453-4057qib7	5660	8	we	-PRON-	PRP
cord-005453-4057qib7	5660	9	observed	observe	VBD
cord-005453-4057qib7	5660	10	that	that	IN
cord-005453-4057qib7	5660	11	CD19	CD19	NNP
cord-005453-4057qib7	5660	12	+	+	SYM
cord-005453-4057qib7	5660	13	events	event	NNS
cord-005453-4057qib7	5660	14	did	do	VBD
cord-005453-4057qib7	5660	15	not	not	RB
cord-005453-4057qib7	5660	16	appear	appear	VB
cord-005453-4057qib7	5660	17	before	before	IN
cord-005453-4057qib7	5660	18	day	day	NN
cord-005453-4057qib7	5660	19	+90	+90	CD
cord-005453-4057qib7	5660	20	after	after	IN
cord-005453-4057qib7	5660	21	HSCT	HSCT	NNP
cord-005453-4057qib7	5660	22	and	and	CC
cord-005453-4057qib7	5660	23	these	these	DT
cord-005453-4057qib7	5660	24	were	be	VBD
cord-005453-4057qib7	5660	25	B	b	NN
cord-005453-4057qib7	5660	26	transitional	transitional	JJ
cord-005453-4057qib7	5660	27	immature	immature	JJ
cord-005453-4057qib7	5660	28	events	event	NNS
cord-005453-4057qib7	5660	29	predominantly	predominantly	RB
cord-005453-4057qib7	5660	30	.	.	.
cord-005453-4057qib7	5661	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5661	2	:	:	:
cord-005453-4057qib7	5662	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5662	2	data	datum	NNS
cord-005453-4057qib7	5662	3	suggest	suggest	VBP
cord-005453-4057qib7	5662	4	a	a	DT
cord-005453-4057qib7	5662	5	possible	possible	JJ
cord-005453-4057qib7	5662	6	protective	protective	JJ
cord-005453-4057qib7	5662	7	link	link	NN
cord-005453-4057qib7	5662	8	between	between	IN
cord-005453-4057qib7	5662	9	transitional	transitional	JJ
cord-005453-4057qib7	5662	10	B	b	NN
cord-005453-4057qib7	5662	11	cells	cell	NNS
cord-005453-4057qib7	5662	12	and	and	CC
cord-005453-4057qib7	5662	13	aGvHD	agvhd	NN
cord-005453-4057qib7	5662	14	development	development	NN
cord-005453-4057qib7	5662	15	.	.	.
cord-005453-4057qib7	5663	1	These	these	DT
cord-005453-4057qib7	5663	2	results	result	NNS
cord-005453-4057qib7	5663	3	data	datum	NNS
cord-005453-4057qib7	5663	4	need	need	VBP
cord-005453-4057qib7	5663	5	to	to	TO
cord-005453-4057qib7	5663	6	be	be	VB
cord-005453-4057qib7	5663	7	confirmed	confirm	VBN
cord-005453-4057qib7	5663	8	in	in	IN
cord-005453-4057qib7	5663	9	a	a	DT
cord-005453-4057qib7	5663	10	larger	large	JJR
cord-005453-4057qib7	5663	11	cohort	cohort	NN
cord-005453-4057qib7	5663	12	of	of	IN
cord-005453-4057qib7	5663	13	patients	patient	NNS
cord-005453-4057qib7	5663	14	.	.	.
cord-005453-4057qib7	5664	1	Moreover	moreover	RB
cord-005453-4057qib7	5664	2	,	,	,
cord-005453-4057qib7	5664	3	it	-PRON-	PRP
cord-005453-4057qib7	5664	4	will	will	MD
cord-005453-4057qib7	5664	5	be	be	VB
cord-005453-4057qib7	5664	6	interesting	interesting	JJ
cord-005453-4057qib7	5664	7	to	to	TO
cord-005453-4057qib7	5664	8	evaluate	evaluate	VB
cord-005453-4057qib7	5664	9	the	the	DT
cord-005453-4057qib7	5664	10	relationship	relationship	NN
cord-005453-4057qib7	5664	11	between	between	IN
cord-005453-4057qib7	5664	12	transitional	transitional	JJ
cord-005453-4057qib7	5664	13	B	B	NNP
cord-005453-4057qib7	5664	14	cells	cell	NNS
cord-005453-4057qib7	5664	15	at	at	IN
cord-005453-4057qib7	5664	16	day	day	NN
cord-005453-4057qib7	5664	17	+90	+90	CD
cord-005453-4057qib7	5664	18	and	and	CC
cord-005453-4057qib7	5664	19	the	the	DT
cord-005453-4057qib7	5664	20	occurrence	occurrence	NN
cord-005453-4057qib7	5664	21	of	of	IN
cord-005453-4057qib7	5664	22	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5664	23	.	.	.
cord-005453-4057qib7	5665	1	Clinical	clinical	JJ
cord-005453-4057qib7	5665	2	Background	background	NN
cord-005453-4057qib7	5665	3	:	:	:
cord-005453-4057qib7	5666	1	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5666	2	is	be	VBZ
cord-005453-4057qib7	5666	3	a	a	DT
cord-005453-4057qib7	5666	4	major	major	JJ
cord-005453-4057qib7	5666	5	complication	complication	NN
cord-005453-4057qib7	5666	6	of	of	IN
cord-005453-4057qib7	5666	7	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5666	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5666	9	stem	stem	NN
cord-005453-4057qib7	5666	10	cell	cell	NN
cord-005453-4057qib7	5666	11	transplant	transplant	NN
cord-005453-4057qib7	5666	12	(	(	-LRB-
cord-005453-4057qib7	5666	13	HSCT	HSCT	NNP
cord-005453-4057qib7	5666	14	)	)	-RRB-
cord-005453-4057qib7	5666	15	and	and	CC
cord-005453-4057qib7	5666	16	a	a	DT
cord-005453-4057qib7	5666	17	risk	risk	NN
cord-005453-4057qib7	5666	18	factor	factor	NN
cord-005453-4057qib7	5666	19	for	for	IN
cord-005453-4057qib7	5666	20	post	post	JJ
cord-005453-4057qib7	5666	21	-	-	JJ
cord-005453-4057qib7	5666	22	HSCT	hsct	JJ
cord-005453-4057qib7	5666	23	mortality	mortality	NN
cord-005453-4057qib7	5666	24	.	.	.
cord-005453-4057qib7	5667	1	The	the	DT
cord-005453-4057qib7	5667	2	objective	objective	NN
cord-005453-4057qib7	5667	3	of	of	IN
cord-005453-4057qib7	5667	4	this	this	DT
cord-005453-4057qib7	5667	5	analysis	analysis	NN
cord-005453-4057qib7	5667	6	is	be	VBZ
cord-005453-4057qib7	5667	7	to	to	TO
cord-005453-4057qib7	5667	8	describe	describe	VB
cord-005453-4057qib7	5667	9	patients	patient	NNS
cord-005453-4057qib7	5667	10	with	with	IN
cord-005453-4057qib7	5667	11	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5667	12	who	who	WP
cord-005453-4057qib7	5667	13	had	have	VBD
cord-005453-4057qib7	5667	14	a	a	DT
cord-005453-4057qib7	5667	15	suboptimal	suboptimal	JJ
cord-005453-4057qib7	5667	16	response	response	NN
cord-005453-4057qib7	5667	17	to	to	IN
cord-005453-4057qib7	5667	18	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5667	19	.	.	.
cord-005453-4057qib7	5668	1	Methods	method	NNS
cord-005453-4057qib7	5668	2	:	:	:
cord-005453-4057qib7	5668	3	Patients	patient	NNS
cord-005453-4057qib7	5668	4	who	who	WP
cord-005453-4057qib7	5668	5	developed	develop	VBD
cord-005453-4057qib7	5668	6	IBMTR	IBMTR	NNP
cord-005453-4057qib7	5668	7	Severity	Severity	NNP
cord-005453-4057qib7	5668	8	Index	Index	NNP
cord-005453-4057qib7	5668	9	II	II	NNP
cord-005453-4057qib7	5668	10	-	-	HYPH
cord-005453-4057qib7	5668	11	IV	IV	NNP
cord-005453-4057qib7	5668	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5669	1	after	after	IN
cord-005453-4057qib7	5669	2	first	first	JJ
cord-005453-4057qib7	5669	3	HSCT	HSCT	NNP
cord-005453-4057qib7	5669	4	between	between	IN
cord-005453-4057qib7	5669	5	1/1/14	1/1/14	CD
cord-005453-4057qib7	5669	6	to	to	IN
cord-005453-4057qib7	5669	7	6/	6/	CD
cord-005453-4057qib7	5669	8	30/16	30/16	CD
cord-005453-4057qib7	5669	9	were	be	VBD
cord-005453-4057qib7	5669	10	included	include	VBN
cord-005453-4057qib7	5669	11	in	in	IN
cord-005453-4057qib7	5669	12	an	an	DT
cord-005453-4057qib7	5669	13	ongoing	ongoing	JJ
cord-005453-4057qib7	5669	14	chart	chart	NN
cord-005453-4057qib7	5669	15	review	review	NN
cord-005453-4057qib7	5669	16	at	at	IN
cord-005453-4057qib7	5669	17	centers	center	NNS
cord-005453-4057qib7	5669	18	in	in	IN
cord-005453-4057qib7	5669	19	the	the	DT
cord-005453-4057qib7	5669	20	United	United	NNP
cord-005453-4057qib7	5669	21	States	States	NNP
cord-005453-4057qib7	5669	22	.	.	.
cord-005453-4057qib7	5670	1	Patients	patient	NNS
cord-005453-4057qib7	5670	2	who	who	WP
cord-005453-4057qib7	5670	3	had	have	VBD
cord-005453-4057qib7	5670	4	ever	ever	RB
cord-005453-4057qib7	5670	5	participated	participate	VBN
cord-005453-4057qib7	5670	6	in	in	IN
cord-005453-4057qib7	5670	7	a	a	DT
cord-005453-4057qib7	5670	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5670	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5670	10	trial	trial	NN
cord-005453-4057qib7	5670	11	or	or	CC
cord-005453-4057qib7	5670	12	used	use	VBD
cord-005453-4057qib7	5670	13	JAK	JAK	NNP
cord-005453-4057qib7	5670	14	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5670	15	were	be	VBD
cord-005453-4057qib7	5670	16	excluded	exclude	VBN
cord-005453-4057qib7	5670	17	from	from	IN
cord-005453-4057qib7	5670	18	the	the	DT
cord-005453-4057qib7	5670	19	study	study	NN
cord-005453-4057qib7	5670	20	.	.	.
cord-005453-4057qib7	5671	1	Suboptimal	suboptimal	JJ
cord-005453-4057qib7	5671	2	response	response	NN
cord-005453-4057qib7	5671	3	to	to	IN
cord-005453-4057qib7	5671	4	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5671	5	was	be	VBD
cord-005453-4057qib7	5671	6	defined	define	VBN
cord-005453-4057qib7	5671	7	as	as	IN
cord-005453-4057qib7	5671	8	use	use	NN
cord-005453-4057qib7	5671	9	of	of	IN
cord-005453-4057qib7	5671	10	additional	additional	JJ
cord-005453-4057qib7	5671	11	systemic	systemic	JJ
cord-005453-4057qib7	5671	12	anti	anti	JJ
cord-005453-4057qib7	5671	13	-	-	JJ
cord-005453-4057qib7	5671	14	GVHD	gvhd	JJ
cord-005453-4057qib7	5671	15	therapy	therapy	NN
cord-005453-4057qib7	5671	16	,	,	,
cord-005453-4057qib7	5671	17	inability	inability	NN
cord-005453-4057qib7	5671	18	to	to	TO
cord-005453-4057qib7	5671	19	taper	taper	VB
cord-005453-4057qib7	5671	20	high	high	JJ
cord-005453-4057qib7	5671	21	-	-	HYPH
cord-005453-4057qib7	5671	22	dose	dose	NN
cord-005453-4057qib7	5671	23	steroids	steroid	NNS
cord-005453-4057qib7	5671	24	(	(	-LRB-
cord-005453-4057qib7	5671	25	≥1	≥1	NNP
cord-005453-4057qib7	5671	26	mg/	mg/	NNP
cord-005453-4057qib7	5671	27	kg	kg	NNP
cord-005453-4057qib7	5671	28	)	)	-RRB-
cord-005453-4057qib7	5671	29	by	by	IN
cord-005453-4057qib7	5671	30	≥25	≥25	NNP
cord-005453-4057qib7	5671	31	%	%	NN
cord-005453-4057qib7	5671	32	,	,	,
cord-005453-4057qib7	5671	33	or	or	CC
cord-005453-4057qib7	5671	34	tapered	tapered	JJ
cord-005453-4057qib7	5671	35	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5671	36	by	by	IN
cord-005453-4057qib7	5671	37	≥25	≥25	NNP
cord-005453-4057qib7	5671	38	%	%	NN
cord-005453-4057qib7	5671	39	but	but	CC
cord-005453-4057qib7	5671	40	not	not	RB
cord-005453-4057qib7	5671	41	to	to	IN
cord-005453-4057qib7	5671	42	<	<	XX
cord-005453-4057qib7	5671	43	10	10	CD
cord-005453-4057qib7	5671	44	mg	mg	NNP
cord-005453-4057qib7	5671	45	/	/	SYM
cord-005453-4057qib7	5671	46	day	day	NN
cord-005453-4057qib7	5671	47	.	.	.
cord-005453-4057qib7	5672	1	Results	result	NNS
cord-005453-4057qib7	5672	2	:	:	:
cord-005453-4057qib7	5673	1	The	the	DT
cord-005453-4057qib7	5673	2	analysis	analysis	NN
cord-005453-4057qib7	5673	3	included	include	VBD
cord-005453-4057qib7	5673	4	64	64	CD
cord-005453-4057qib7	5673	5	patients	patient	NNS
cord-005453-4057qib7	5673	6	with	with	IN
cord-005453-4057qib7	5673	7	suboptimal	suboptimal	JJ
cord-005453-4057qib7	5673	8	response	response	NN
cord-005453-4057qib7	5673	9	to	to	IN
cord-005453-4057qib7	5673	10	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5673	11	.	.	.
cord-005453-4057qib7	5674	1	Mean	mean	JJ
cord-005453-4057qib7	5674	2	age	age	NN
cord-005453-4057qib7	5674	3	was	be	VBD
cord-005453-4057qib7	5674	4	55	55	CD
cord-005453-4057qib7	5674	5	years	year	NNS
cord-005453-4057qib7	5674	6	;	;	:
cord-005453-4057qib7	5674	7	66	66	CD
cord-005453-4057qib7	5674	8	%	%	NN
cord-005453-4057qib7	5674	9	were	be	VBD
cord-005453-4057qib7	5674	10	male	male	JJ
cord-005453-4057qib7	5674	11	.	.	.
cord-005453-4057qib7	5675	1	Median	median	JJ
cord-005453-4057qib7	5675	2	time	time	NN
cord-005453-4057qib7	5675	3	from	from	IN
cord-005453-4057qib7	5675	4	transplant	transplant	NN
cord-005453-4057qib7	5675	5	to	to	IN
cord-005453-4057qib7	5675	6	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5675	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	5675	8	was	be	VBD
cord-005453-4057qib7	5675	9	33	33	CD
cord-005453-4057qib7	5675	10	days	day	NNS
cord-005453-4057qib7	5675	11	.	.	.
cord-005453-4057qib7	5676	1	At	at	IN
cord-005453-4057qib7	5676	2	the	the	DT
cord-005453-4057qib7	5676	3	time	time	NN
cord-005453-4057qib7	5676	4	of	of	IN
cord-005453-4057qib7	5676	5	maximum	maximum	JJ
cord-005453-4057qib7	5676	6	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5676	7	grade	grade	NN
cord-005453-4057qib7	5676	8	,	,	,
cord-005453-4057qib7	5676	9	33	33	CD
cord-005453-4057qib7	5676	10	%	%	NN
cord-005453-4057qib7	5676	11	of	of	IN
cord-005453-4057qib7	5676	12	patients	patient	NNS
cord-005453-4057qib7	5676	13	were	be	VBD
cord-005453-4057qib7	5676	14	grade	grade	NN
cord-005453-4057qib7	5676	15	II	II	NNP
cord-005453-4057qib7	5676	16	and	and	CC
cord-005453-4057qib7	5676	17	66	66	CD
cord-005453-4057qib7	5676	18	%	%	NN
cord-005453-4057qib7	5676	19	were	be	VBD
cord-005453-4057qib7	5676	20	grade	grade	NN
cord-005453-4057qib7	5676	21	III	III	NNP
cord-005453-4057qib7	5676	22	-	-	HYPH
cord-005453-4057qib7	5676	23	IV	IV	NNP
cord-005453-4057qib7	5676	24	;	;	:
cord-005453-4057qib7	5676	25	58	58	CD
cord-005453-4057qib7	5676	26	%	%	NN
cord-005453-4057qib7	5676	27	had	have	VBD
cord-005453-4057qib7	5676	28	lower	low	JJR
cord-005453-4057qib7	5676	29	GI	GI	NNP
cord-005453-4057qib7	5676	30	involvement	involvement	NN
cord-005453-4057qib7	5676	31	,	,	,
cord-005453-4057qib7	5676	32	and	and	CC
cord-005453-4057qib7	5676	33	59	59	CD
cord-005453-4057qib7	5676	34	%	%	NN
cord-005453-4057qib7	5676	35	had	have	VBD
cord-005453-4057qib7	5676	36	≥2	≥2	NNP
cord-005453-4057qib7	5676	37	organs	organ	NNS
cord-005453-4057qib7	5676	38	involved	involve	VBN
cord-005453-4057qib7	5676	39	.	.	.
cord-005453-4057qib7	5677	1	From	from	IN
cord-005453-4057qib7	5677	2	time	time	NN
cord-005453-4057qib7	5677	3	of	of	IN
cord-005453-4057qib7	5677	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	5677	5	to	to	TO
cord-005453-4057qib7	5677	6	maximum	maximum	VB
cord-005453-4057qib7	5677	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5677	8	grade	grade	NN
cord-005453-4057qib7	5677	9	,	,	,
cord-005453-4057qib7	5677	10	52	52	CD
cord-005453-4057qib7	5677	11	%	%	NN
cord-005453-4057qib7	5677	12	of	of	IN
cord-005453-4057qib7	5677	13	patients	patient	NNS
cord-005453-4057qib7	5677	14	had	have	VBD
cord-005453-4057qib7	5677	15	new	new	JJ
cord-005453-4057qib7	5677	16	organ	organ	NN
cord-005453-4057qib7	5677	17	involvement	involvement	NN
cord-005453-4057qib7	5677	18	or	or	CC
cord-005453-4057qib7	5677	19	an	an	DT
cord-005453-4057qib7	5677	20	increase	increase	NN
cord-005453-4057qib7	5677	21	in	in	IN
cord-005453-4057qib7	5677	22	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5677	23	grade	grade	NN
cord-005453-4057qib7	5677	24	.	.	.
cord-005453-4057qib7	5678	1	Median	median	JJ
cord-005453-4057qib7	5678	2	time	time	NN
cord-005453-4057qib7	5678	3	from	from	IN
cord-005453-4057qib7	5678	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	5678	5	to	to	IN
cord-005453-4057qib7	5678	6	maximum	maximum	JJ
cord-005453-4057qib7	5678	7	grade	grade	NN
cord-005453-4057qib7	5678	8	was	be	VBD
cord-005453-4057qib7	5678	9	5.5	5.5	CD
cord-005453-4057qib7	5678	10	days	day	NNS
cord-005453-4057qib7	5678	11	,	,	,
cord-005453-4057qib7	5678	12	and	and	CC
cord-005453-4057qib7	5678	13	was	be	VBD
cord-005453-4057qib7	5678	14	2.5	2.5	CD
cord-005453-4057qib7	5678	15	days	day	NNS
cord-005453-4057qib7	5678	16	for	for	IN
cord-005453-4057qib7	5678	17	patients	patient	NNS
cord-005453-4057qib7	5678	18	with	with	IN
cord-005453-4057qib7	5678	19	lower	low	JJR
cord-005453-4057qib7	5678	20	GI	GI	NNP
cord-005453-4057qib7	5678	21	involvement	involvement	NN
cord-005453-4057qib7	5678	22	.	.	.
cord-005453-4057qib7	5679	1	Systemic	systemic	JJ
cord-005453-4057qib7	5679	2	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5679	3	were	be	VBD
cord-005453-4057qib7	5679	4	initiated	initiate	VBN
cord-005453-4057qib7	5679	5	on	on	IN
cord-005453-4057qib7	5679	6	the	the	DT
cord-005453-4057qib7	5679	7	day	day	NN
cord-005453-4057qib7	5679	8	of	of	IN
cord-005453-4057qib7	5679	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	5679	10	for	for	IN
cord-005453-4057qib7	5679	11	73	73	CD
cord-005453-4057qib7	5679	12	%	%	NN
cord-005453-4057qib7	5679	13	of	of	IN
cord-005453-4057qib7	5679	14	patients	patient	NNS
cord-005453-4057qib7	5679	15	.	.	.
cord-005453-4057qib7	5680	1	Average	average	JJ
cord-005453-4057qib7	5680	2	starting	start	VBG
cord-005453-4057qib7	5680	3	daily	daily	RB
cord-005453-4057qib7	5680	4	dose	dose	NN
cord-005453-4057qib7	5680	5	was	be	VBD
cord-005453-4057qib7	5680	6	93	93	CD
cord-005453-4057qib7	5680	7	mg	mg	NN
cord-005453-4057qib7	5680	8	(	(	-LRB-
cord-005453-4057qib7	5680	9	1.1	1.1	CD
cord-005453-4057qib7	5680	10	mg	mg	NNP
cord-005453-4057qib7	5680	11	/	/	SYM
cord-005453-4057qib7	5680	12	kg	kg	NNP
cord-005453-4057qib7	5680	13	)	)	-RRB-
cord-005453-4057qib7	5680	14	for	for	IN
cord-005453-4057qib7	5680	15	prednisone	prednisone	NNP
cord-005453-4057qib7	5680	16	and	and	CC
cord-005453-4057qib7	5680	17	136	136	CD
cord-005453-4057qib7	5680	18	mg	mg	NNS
cord-005453-4057qib7	5680	19	(	(	-LRB-
cord-005453-4057qib7	5680	20	1.6	1.6	CD
cord-005453-4057qib7	5680	21	mg	mg	NNP
cord-005453-4057qib7	5680	22	/	/	SYM
cord-005453-4057qib7	5680	23	kg	kg	NNP
cord-005453-4057qib7	5680	24	)	)	-RRB-
cord-005453-4057qib7	5680	25	for	for	IN
cord-005453-4057qib7	5680	26	methylprednisolone	methylprednisolone	NNP
cord-005453-4057qib7	5680	27	.	.	.
cord-005453-4057qib7	5681	1	Steroid	steroid	NN
cord-005453-4057qib7	5681	2	dose	dose	NN
cord-005453-4057qib7	5681	3	was	be	VBD
cord-005453-4057qib7	5681	4	increased	increase	VBN
cord-005453-4057qib7	5681	5	for	for	IN
cord-005453-4057qib7	5681	6	44	44	CD
cord-005453-4057qib7	5681	7	%	%	NN
cord-005453-4057qib7	5681	8	of	of	IN
cord-005453-4057qib7	5681	9	patients	patient	NNS
cord-005453-4057qib7	5681	10	during	during	IN
cord-005453-4057qib7	5681	11	follow	follow	NN
cord-005453-4057qib7	5681	12	-	-	HYPH
cord-005453-4057qib7	5681	13	up	up	NN
cord-005453-4057qib7	5681	14	;	;	:
cord-005453-4057qib7	5681	15	80	80	CD
cord-005453-4057qib7	5681	16	%	%	NN
cord-005453-4057qib7	5681	17	were	be	VBD
cord-005453-4057qib7	5681	18	unable	unable	JJ
cord-005453-4057qib7	5681	19	to	to	TO
cord-005453-4057qib7	5681	20	taper	taper	VB
cord-005453-4057qib7	5681	21	below	below	IN
cord-005453-4057qib7	5681	22	10	10	CD
cord-005453-4057qib7	5681	23	mg	mg	NNP
cord-005453-4057qib7	5681	24	/	/	SYM
cord-005453-4057qib7	5681	25	day	day	NN
cord-005453-4057qib7	5681	26	.	.	.
cord-005453-4057qib7	5682	1	Among	among	IN
cord-005453-4057qib7	5682	2	patients	patient	NNS
cord-005453-4057qib7	5682	3	who	who	WP
cord-005453-4057qib7	5682	4	received	receive	VBD
cord-005453-4057qib7	5682	5	additional	additional	JJ
cord-005453-4057qib7	5682	6	systemic	systemic	JJ
cord-005453-4057qib7	5682	7	anti	anti	JJ
cord-005453-4057qib7	5682	8	-	-	JJ
cord-005453-4057qib7	5682	9	GVHD	gvhd	JJ
cord-005453-4057qib7	5682	10	therapy	therapy	NN
cord-005453-4057qib7	5682	11	(	(	-LRB-
cord-005453-4057qib7	5682	12	n=32	n=32	NNP
cord-005453-4057qib7	5682	13	)	)	-RRB-
cord-005453-4057qib7	5682	14	,	,	,
cord-005453-4057qib7	5682	15	41	41	CD
cord-005453-4057qib7	5682	16	%	%	NN
cord-005453-4057qib7	5682	17	increased	increase	VBD
cord-005453-4057qib7	5682	18	their	-PRON-	PRP$
cord-005453-4057qib7	5682	19	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	5682	20	dose	dose	NN
cord-005453-4057qib7	5682	21	before	before	IN
cord-005453-4057qib7	5682	22	initiation	initiation	NN
cord-005453-4057qib7	5682	23	of	of	IN
cord-005453-4057qib7	5682	24	additional	additional	JJ
cord-005453-4057qib7	5682	25	anti	anti	JJ
cord-005453-4057qib7	5682	26	-	-	JJ
cord-005453-4057qib7	5682	27	GVHD	gvhd	JJ
cord-005453-4057qib7	5682	28	therapy	therapy	NN
cord-005453-4057qib7	5682	29	.	.	.
cord-005453-4057qib7	5683	1	Median	median	JJ
cord-005453-4057qib7	5683	2	time	time	NN
cord-005453-4057qib7	5683	3	from	from	IN
cord-005453-4057qib7	5683	4	initiation	initiation	NN
cord-005453-4057qib7	5683	5	of	of	IN
cord-005453-4057qib7	5683	6	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5683	7	to	to	IN
cord-005453-4057qib7	5683	8	additional	additional	JJ
cord-005453-4057qib7	5683	9	therapy	therapy	NN
cord-005453-4057qib7	5683	10	was	be	VBD
cord-005453-4057qib7	5683	11	16.5	16.5	CD
cord-005453-4057qib7	5683	12	days	day	NNS
cord-005453-4057qib7	5683	13	.	.	.
cord-005453-4057qib7	5684	1	Frequently	frequently	RB
cord-005453-4057qib7	5684	2	used	use	VBN
cord-005453-4057qib7	5684	3	therapies	therapy	NNS
cord-005453-4057qib7	5684	4	were	be	VBD
cord-005453-4057qib7	5685	1	mycophenyalate	mycophenyalate	NNP
cord-005453-4057qib7	5685	2	mofetil	mofetil	NNP
cord-005453-4057qib7	5685	3	(	(	-LRB-
cord-005453-4057qib7	5685	4	25	25	CD
cord-005453-4057qib7	5685	5	%	%	NN
cord-005453-4057qib7	5685	6	)	)	-RRB-
cord-005453-4057qib7	5685	7	,	,	,
cord-005453-4057qib7	5685	8	ATG	ATG	NNP
cord-005453-4057qib7	5685	9	(	(	-LRB-
cord-005453-4057qib7	5685	10	16	16	CD
cord-005453-4057qib7	5685	11	%	%	NN
cord-005453-4057qib7	5685	12	)	)	-RRB-
cord-005453-4057qib7	5685	13	,	,	,
cord-005453-4057qib7	5685	14	extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5685	15	photophoresis	photophoresis	NN
cord-005453-4057qib7	5685	16	(	(	-LRB-
cord-005453-4057qib7	5685	17	13	13	CD
cord-005453-4057qib7	5685	18	%	%	NN
cord-005453-4057qib7	5685	19	)	)	-RRB-
cord-005453-4057qib7	5685	20	,	,	,
cord-005453-4057qib7	5685	21	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5685	22	(	(	-LRB-
cord-005453-4057qib7	5685	23	13	13	CD
cord-005453-4057qib7	5685	24	%	%	NN
cord-005453-4057qib7	5685	25	)	)	-RRB-
cord-005453-4057qib7	5685	26	,	,	,
cord-005453-4057qib7	5685	27	etanercept	etanercept	NNP
cord-005453-4057qib7	5685	28	(	(	-LRB-
cord-005453-4057qib7	5685	29	9	9	CD
cord-005453-4057qib7	5685	30	%	%	NN
cord-005453-4057qib7	5685	31	)	)	-RRB-
cord-005453-4057qib7	5685	32	,	,	,
cord-005453-4057qib7	5685	33	and	and	CC
cord-005453-4057qib7	5685	34	sirolimus	sirolimus	NNP
cord-005453-4057qib7	5685	35	(	(	-LRB-
cord-005453-4057qib7	5685	36	9	9	CD
cord-005453-4057qib7	5685	37	%	%	NN
cord-005453-4057qib7	5685	38	)	)	-RRB-
cord-005453-4057qib7	5685	39	.	.	.
cord-005453-4057qib7	5686	1	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5686	2	recurred	recur	VBD
cord-005453-4057qib7	5686	3	in	in	IN
cord-005453-4057qib7	5686	4	31	31	CD
cord-005453-4057qib7	5686	5	%	%	NN
cord-005453-4057qib7	5686	6	of	of	IN
cord-005453-4057qib7	5686	7	patients	patient	NNS
cord-005453-4057qib7	5686	8	and	and	CC
cord-005453-4057qib7	5686	9	was	be	VBD
cord-005453-4057qib7	5686	10	managed	manage	VBN
cord-005453-4057qib7	5686	11	by	by	IN
cord-005453-4057qib7	5686	12	increasing	increase	VBG
cord-005453-4057qib7	5686	13	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	5686	14	dose	dose	NN
cord-005453-4057qib7	5686	15	in	in	IN
cord-005453-4057qib7	5686	16	70	70	CD
cord-005453-4057qib7	5686	17	%	%	NN
cord-005453-4057qib7	5686	18	of	of	IN
cord-005453-4057qib7	5686	19	patients	patient	NNS
cord-005453-4057qib7	5686	20	.	.	.
cord-005453-4057qib7	5687	1	44	44	CD
cord-005453-4057qib7	5687	2	%	%	NN
cord-005453-4057qib7	5687	3	had	have	VBD
cord-005453-4057qib7	5687	4	any	any	DT
cord-005453-4057qib7	5687	5	infection	infection	NN
cord-005453-4057qib7	5687	6	within	within	IN
cord-005453-4057qib7	5687	7	first	first	JJ
cord-005453-4057qib7	5687	8	100	100	CD
cord-005453-4057qib7	5687	9	days	day	NNS
cord-005453-4057qib7	5687	10	post	post	NN
cord-005453-4057qib7	5687	11	-	-	JJ
cord-005453-4057qib7	5687	12	HSCT	HSCT	NNP
cord-005453-4057qib7	5687	13	.	.	.
cord-005453-4057qib7	5688	1	Forty	forty	CD
cord-005453-4057qib7	5688	2	patients	patient	NNS
cord-005453-4057qib7	5688	3	(	(	-LRB-
cord-005453-4057qib7	5688	4	63	63	CD
cord-005453-4057qib7	5688	5	%	%	NN
cord-005453-4057qib7	5688	6	)	)	-RRB-
cord-005453-4057qib7	5688	7	required	require	VBN
cord-005453-4057qib7	5688	8	hospital	hospital	NN
cord-005453-4057qib7	5688	9	readmission(s	readmission(s	NNP
cord-005453-4057qib7	5688	10	)	)	-RRB-
cord-005453-4057qib7	5688	11	;	;	:
cord-005453-4057qib7	5688	12	40	40	CD
cord-005453-4057qib7	5688	13	%	%	NN
cord-005453-4057qib7	5688	14	had	have	VBD
cord-005453-4057qib7	5689	1	≥2	≥2	NNP
cord-005453-4057qib7	5689	2	readmissions	readmission	NNS
cord-005453-4057qib7	5689	3	within	within	IN
cord-005453-4057qib7	5689	4	100	100	CD
cord-005453-4057qib7	5689	5	days	day	NNS
cord-005453-4057qib7	5689	6	post	post	NN
cord-005453-4057qib7	5689	7	-	-	JJ
cord-005453-4057qib7	5689	8	HSCT	HSCT	NNP
cord-005453-4057qib7	5689	9	,	,	,
cord-005453-4057qib7	5689	10	with	with	IN
cord-005453-4057qib7	5689	11	a	a	DT
cord-005453-4057qib7	5689	12	mean	mean	JJ
cord-005453-4057qib7	5689	13	inpatient	inpatient	JJ
cord-005453-4057qib7	5689	14	lengthof	lengthof	NN
cord-005453-4057qib7	5689	15	-	-	HYPH
cord-005453-4057qib7	5689	16	stay	stay	NN
cord-005453-4057qib7	5689	17	of	of	IN
cord-005453-4057qib7	5689	18	28	28	CD
cord-005453-4057qib7	5689	19	days	day	NNS
cord-005453-4057qib7	5689	20	.	.	.
cord-005453-4057qib7	5690	1	Relapse	relapse	NN
cord-005453-4057qib7	5690	2	of	of	IN
cord-005453-4057qib7	5690	3	underlying	underlie	VBG
cord-005453-4057qib7	5690	4	malignancy	malignancy	NN
cord-005453-4057qib7	5690	5	was	be	VBD
cord-005453-4057qib7	5690	6	reported	report	VBN
cord-005453-4057qib7	5690	7	for	for	IN
cord-005453-4057qib7	5690	8	13	13	CD
cord-005453-4057qib7	5690	9	(	(	-LRB-
cord-005453-4057qib7	5690	10	20	20	CD
cord-005453-4057qib7	5690	11	%	%	NN
cord-005453-4057qib7	5690	12	)	)	-RRB-
cord-005453-4057qib7	5690	13	patients	patient	NNS
cord-005453-4057qib7	5690	14	.	.	.
cord-005453-4057qib7	5691	1	Two	two	CD
cord-005453-4057qib7	5691	2	-	-	HYPH
cord-005453-4057qib7	5691	3	thirds	third	NNS
cord-005453-4057qib7	5691	4	(	(	-LRB-
cord-005453-4057qib7	5691	5	66	66	CD
cord-005453-4057qib7	5691	6	%	%	NN
cord-005453-4057qib7	5691	7	,	,	,
cord-005453-4057qib7	5691	8	n=40	n=40	JJ
cord-005453-4057qib7	5691	9	)	)	-RRB-
cord-005453-4057qib7	5691	10	patients	patient	NNS
cord-005453-4057qib7	5691	11	died	die	VBD
cord-005453-4057qib7	5691	12	at	at	IN
cord-005453-4057qib7	5691	13	a	a	DT
cord-005453-4057qib7	5691	14	median	median	NN
cord-005453-4057qib7	5691	15	of	of	IN
cord-005453-4057qib7	5691	16	87	87	CD
cord-005453-4057qib7	5691	17	(	(	-LRB-
cord-005453-4057qib7	5691	18	interquartile	interquartile	JJ
cord-005453-4057qib7	5691	19	range	range	NN
cord-005453-4057qib7	5691	20	(	(	-LRB-
cord-005453-4057qib7	5691	21	IQR	IQR	NNP
cord-005453-4057qib7	5691	22	)	)	-RRB-
cord-005453-4057qib7	5691	23	:	:	:
cord-005453-4057qib7	5691	24	44	44	CD
cord-005453-4057qib7	5691	25	-	-	SYM
cord-005453-4057qib7	5691	26	180	180	CD
cord-005453-4057qib7	5691	27	)	)	-RRB-
cord-005453-4057qib7	5691	28	days	day	NNS
cord-005453-4057qib7	5691	29	from	from	IN
cord-005453-4057qib7	5691	30	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5691	31	diagnosis	diagnosis	NN
cord-005453-4057qib7	5691	32	;	;	:
cord-005453-4057qib7	5691	33	a	a	DT
cord-005453-4057qib7	5691	34	higher	high	JJR
cord-005453-4057qib7	5691	35	proportion	proportion	NN
cord-005453-4057qib7	5691	36	(	(	-LRB-
cord-005453-4057qib7	5691	37	76	76	CD
cord-005453-4057qib7	5691	38	%	%	NN
cord-005453-4057qib7	5691	39	)	)	-RRB-
cord-005453-4057qib7	5691	40	of	of	IN
cord-005453-4057qib7	5691	41	patients	patient	NNS
cord-005453-4057qib7	5691	42	with	with	IN
cord-005453-4057qib7	5691	43	maximum	maximum	JJ
cord-005453-4057qib7	5691	44	grade	grade	NN
cord-005453-4057qib7	5691	45	III	III	NNP
cord-005453-4057qib7	5691	46	-	-	HYPH
cord-005453-4057qib7	5691	47	IV	IV	NNP
cord-005453-4057qib7	5691	48	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5691	49	died	die	VBD
cord-005453-4057qib7	5691	50	at	at	IN
cord-005453-4057qib7	5691	51	a	a	DT
cord-005453-4057qib7	5691	52	median	median	NN
cord-005453-4057qib7	5691	53	of	of	IN
cord-005453-4057qib7	5691	54	63	63	CD
cord-005453-4057qib7	5691	55	(	(	-LRB-
cord-005453-4057qib7	5691	56	IQR	iqr	NN
cord-005453-4057qib7	5691	57	:	:	:
cord-005453-4057qib7	5691	58	41.5	41.5	CD
cord-005453-4057qib7	5691	59	-	-	SYM
cord-005453-4057qib7	5691	60	186.5	186.5	CD
cord-005453-4057qib7	5691	61	)	)	-RRB-
cord-005453-4057qib7	5691	62	days	day	NNS
cord-005453-4057qib7	5691	63	;	;	:
cord-005453-4057qib7	5691	64	majority	majority	NN
cord-005453-4057qib7	5691	65	(	(	-LRB-
cord-005453-4057qib7	5691	66	81	81	CD
cord-005453-4057qib7	5691	67	%	%	NN
cord-005453-4057qib7	5691	68	)	)	-RRB-
cord-005453-4057qib7	5691	69	of	of	IN
cord-005453-4057qib7	5691	70	patients	patient	NNS
cord-005453-4057qib7	5691	71	with	with	IN
cord-005453-4057qib7	5691	72	lower	low	JJR
cord-005453-4057qib7	5691	73	GI	GI	NNP
cord-005453-4057qib7	5691	74	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5691	75	died	die	VBD
cord-005453-4057qib7	5691	76	at	at	IN
cord-005453-4057qib7	5691	77	a	a	DT
cord-005453-4057qib7	5691	78	median	median	NN
cord-005453-4057qib7	5691	79	of	of	IN
cord-005453-4057qib7	5691	80	68.5	68.5	CD
cord-005453-4057qib7	5691	81	(	(	-LRB-
cord-005453-4057qib7	5691	82	IQR	IQR	NNP
cord-005453-4057qib7	5691	83	:	:	:
cord-005453-4057qib7	5691	84	44	44	CD
cord-005453-4057qib7	5691	85	-	-	SYM
cord-005453-4057qib7	5691	86	137	137	CD
cord-005453-4057qib7	5691	87	)	)	-RRB-
cord-005453-4057qib7	5691	88	days	day	NNS
cord-005453-4057qib7	5691	89	.	.	.
cord-005453-4057qib7	5692	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5692	2	:	:	:
cord-005453-4057qib7	5693	1	A	a	DT
cord-005453-4057qib7	5693	2	majority	majority	NN
cord-005453-4057qib7	5693	3	of	of	IN
cord-005453-4057qib7	5693	4	patients	patient	NNS
cord-005453-4057qib7	5693	5	with	with	IN
cord-005453-4057qib7	5693	6	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5693	7	who	who	WP
cord-005453-4057qib7	5693	8	had	have	VBD
cord-005453-4057qib7	5693	9	suboptimal	suboptimal	JJ
cord-005453-4057qib7	5693	10	response	response	NN
cord-005453-4057qib7	5693	11	to	to	IN
cord-005453-4057qib7	5693	12	systemic	systemic	JJ
cord-005453-4057qib7	5693	13	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5693	14	had	have	VBD
cord-005453-4057qib7	5693	15	severe	severe	JJ
cord-005453-4057qib7	5693	16	and	and	CC
cord-005453-4057qib7	5693	17	rapidly	rapidly	RB
cord-005453-4057qib7	5693	18	progressing	progress	VBG
cord-005453-4057qib7	5693	19	disease	disease	NN
cord-005453-4057qib7	5693	20	and	and	CC
cord-005453-4057qib7	5693	21	resulted	result	VBD
cord-005453-4057qib7	5693	22	in	in	IN
cord-005453-4057qib7	5693	23	a	a	DT
cord-005453-4057qib7	5693	24	high	high	JJ
cord-005453-4057qib7	5693	25	mortality	mortality	NN
cord-005453-4057qib7	5693	26	rate	rate	NN
cord-005453-4057qib7	5693	27	(	(	-LRB-
cord-005453-4057qib7	5693	28	66	66	CD
cord-005453-4057qib7	5693	29	%	%	NN
cord-005453-4057qib7	5693	30	)	)	-RRB-
cord-005453-4057qib7	5693	31	;	;	:
cord-005453-4057qib7	5693	32	progression	progression	NN
cord-005453-4057qib7	5693	33	was	be	VBD
cord-005453-4057qib7	5693	34	more	more	RBR
cord-005453-4057qib7	5693	35	rapid	rapid	JJ
cord-005453-4057qib7	5693	36	and	and	CC
cord-005453-4057qib7	5693	37	mortality	mortality	NN
cord-005453-4057qib7	5693	38	increased	increase	VBD
cord-005453-4057qib7	5693	39	for	for	IN
cord-005453-4057qib7	5693	40	patients	patient	NNS
cord-005453-4057qib7	5693	41	with	with	IN
cord-005453-4057qib7	5693	42	lower	low	JJR
cord-005453-4057qib7	5693	43	GI	GI	NNP
cord-005453-4057qib7	5693	44	involvement	involvement	NN
cord-005453-4057qib7	5693	45	.	.	.
cord-005453-4057qib7	5694	1	Most	Most	JJS
cord-005453-4057qib7	5694	2	patients	patient	NNS
cord-005453-4057qib7	5694	3	required	require	VBD
cord-005453-4057qib7	5694	4	readmission	readmission	NN
cord-005453-4057qib7	5694	5	to	to	IN
cord-005453-4057qib7	5694	6	the	the	DT
cord-005453-4057qib7	5694	7	hospital	hospital	NN
cord-005453-4057qib7	5694	8	with	with	IN
cord-005453-4057qib7	5694	9	extended	extended	JJ
cord-005453-4057qib7	5694	10	length	length	NN
cord-005453-4057qib7	5694	11	-	-	HYPH
cord-005453-4057qib7	5694	12	of	of	IN
cord-005453-4057qib7	5694	13	-	-	HYPH
cord-005453-4057qib7	5694	14	stay	stay	NN
cord-005453-4057qib7	5694	15	.	.	.
cord-005453-4057qib7	5695	1	An	an	DT
cord-005453-4057qib7	5695	2	urgent	urgent	JJ
cord-005453-4057qib7	5695	3	need	need	NN
cord-005453-4057qib7	5695	4	exists	exist	VBZ
cord-005453-4057qib7	5695	5	for	for	IN
cord-005453-4057qib7	5695	6	effective	effective	JJ
cord-005453-4057qib7	5695	7	and	and	CC
cord-005453-4057qib7	5695	8	tolerable	tolerable	JJ
cord-005453-4057qib7	5695	9	therapies	therapy	NNS
cord-005453-4057qib7	5695	10	that	that	WDT
cord-005453-4057qib7	5695	11	quickly	quickly	RB
cord-005453-4057qib7	5695	12	resolve	resolve	VB
cord-005453-4057qib7	5695	13	life	life	NN
cord-005453-4057qib7	5695	14	-	-	HYPH
cord-005453-4057qib7	5695	15	threatening	threaten	VBG
cord-005453-4057qib7	5695	16	aGVHD	agvhd	NN
cord-005453-4057qib7	5695	17	in	in	IN
cord-005453-4057qib7	5695	18	early	early	JJ
cord-005453-4057qib7	5695	19	stages	stage	NNS
cord-005453-4057qib7	5695	20	of	of	IN
cord-005453-4057qib7	5695	21	disease	disease	NN
cord-005453-4057qib7	5695	22	.	.	.
cord-005453-4057qib7	5696	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5696	2	Results	result	NNS
cord-005453-4057qib7	5696	3	:	:	:
cord-005453-4057qib7	5697	1	Median	median	JJ
cord-005453-4057qib7	5697	2	time	time	NN
cord-005453-4057qib7	5697	3	to	to	IN
cord-005453-4057qib7	5697	4	onset	onset	NN
cord-005453-4057qib7	5697	5	of	of	IN
cord-005453-4057qib7	5697	6	BO	BO	NNP
cord-005453-4057qib7	5697	7	from	from	IN
cord-005453-4057qib7	5697	8	alloHCT	alloHCT	NNP
cord-005453-4057qib7	5697	9	was	be	VBD
cord-005453-4057qib7	5697	10	6.9	6.9	CD
cord-005453-4057qib7	5697	11	months	month	NNS
cord-005453-4057qib7	5698	1	(	(	-LRB-
cord-005453-4057qib7	5698	2	range	range	VBP
cord-005453-4057qib7	5698	3	0.6	0.6	CD
cord-005453-4057qib7	5698	4	-	-	HYPH
cord-005453-4057qib7	5698	5	31.2	31.2	CD
cord-005453-4057qib7	5698	6	)	)	-RRB-
cord-005453-4057qib7	5698	7	.	.	.
cord-005453-4057qib7	5699	1	Previous	previous	JJ
cord-005453-4057qib7	5699	2	acute	acute	JJ
cord-005453-4057qib7	5699	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5699	4	in	in	IN
cord-005453-4057qib7	5699	5	52.2	52.2	CD
cord-005453-4057qib7	5699	6	%	%	NN
cord-005453-4057qib7	5700	1	(	(	-LRB-
cord-005453-4057qib7	5700	2	n	n	NN
cord-005453-4057qib7	5700	3	=	=	SYM
cord-005453-4057qib7	5700	4	24	24	CD
cord-005453-4057qib7	5700	5	)	)	-RRB-
cord-005453-4057qib7	5700	6	[	[	-LRB-
cord-005453-4057qib7	5700	7	grades	grade	NNS
cord-005453-4057qib7	5700	8	III	III	NNP
cord-005453-4057qib7	5700	9	-	-	HYPH
cord-005453-4057qib7	5700	10	IV	IV	NNP
cord-005453-4057qib7	5700	11	29.2	29.2	CD
cord-005453-4057qib7	5700	12	%	%	NN
cord-005453-4057qib7	5700	13	(	(	-LRB-
cord-005453-4057qib7	5700	14	n	n	NN
cord-005453-4057qib7	5700	15	=	=	SYM
cord-005453-4057qib7	5700	16	7	7	CD
cord-005453-4057qib7	5700	17	)	)	-RRB-
cord-005453-4057qib7	5700	18	]	]	-RRB-
cord-005453-4057qib7	5700	19	.	.	.
cord-005453-4057qib7	5701	1	In	in	IN
cord-005453-4057qib7	5701	2	23.9	23.9	CD
cord-005453-4057qib7	5701	3	%	%	NN
cord-005453-4057qib7	5701	4	(	(	-LRB-
cord-005453-4057qib7	5701	5	n	n	NN
cord-005453-4057qib7	5701	6	=	=	SYM
cord-005453-4057qib7	5701	7	11	11	CD
cord-005453-4057qib7	5701	8	)	)	-RRB-
cord-005453-4057qib7	5701	9	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5701	10	had	have	VBD
cord-005453-4057qib7	5701	11	exclusive	exclusive	JJ
cord-005453-4057qib7	5701	12	lung	lung	NN
cord-005453-4057qib7	5701	13	involvement	involvement	NN
cord-005453-4057qib7	5701	14	,	,	,
cord-005453-4057qib7	5701	15	while	while	IN
cord-005453-4057qib7	5701	16	the	the	DT
cord-005453-4057qib7	5701	17	other	other	JJ
cord-005453-4057qib7	5701	18	35	35	CD
cord-005453-4057qib7	5701	19	patients	patient	NNS
cord-005453-4057qib7	5701	20	(	(	-LRB-
cord-005453-4057qib7	5701	21	76	76	CD
cord-005453-4057qib7	5701	22	%	%	NN
cord-005453-4057qib7	5701	23	)	)	-RRB-
cord-005453-4057qib7	5701	24	had	have	VBD
cord-005453-4057qib7	5701	25	other	other	JJ
cord-005453-4057qib7	5701	26	organs	organ	NNS
cord-005453-4057qib7	5701	27	affected	affect	VBN
cord-005453-4057qib7	5701	28	.	.	.
cord-005453-4057qib7	5702	1	At	at	IN
cord-005453-4057qib7	5702	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	5702	3	of	of	IN
cord-005453-4057qib7	5702	4	BO	BO	NNP
cord-005453-4057qib7	5702	5	,	,	,
cord-005453-4057qib7	5702	6	69.6	69.6	CD
cord-005453-4057qib7	5702	7	%	%	NN
cord-005453-4057qib7	5702	8	(	(	-LRB-
cord-005453-4057qib7	5702	9	n	n	NN
cord-005453-4057qib7	5702	10	=	=	SYM
cord-005453-4057qib7	5702	11	32	32	CD
cord-005453-4057qib7	5702	12	)	)	-RRB-
cord-005453-4057qib7	5702	13	were	be	VBD
cord-005453-4057qib7	5702	14	under	under	IN
cord-005453-4057qib7	5702	15	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5702	16	treatment	treatment	NN
cord-005453-4057qib7	5702	17	.	.	.
cord-005453-4057qib7	5703	1	32.6	32.6	CD
cord-005453-4057qib7	5703	2	%	%	NN
cord-005453-4057qib7	5703	3	(	(	-LRB-
cord-005453-4057qib7	5703	4	n=15	n=15	NNP
cord-005453-4057qib7	5703	5	)	)	-RRB-
cord-005453-4057qib7	5703	6	of	of	IN
cord-005453-4057qib7	5703	7	patients	patient	NNS
cord-005453-4057qib7	5703	8	with	with	IN
cord-005453-4057qib7	5703	9	BO	BO	NNP
cord-005453-4057qib7	5703	10	received	receive	VBD
cord-005453-4057qib7	5703	11	ECP	ECP	NNP
cord-005453-4057qib7	5703	12	as	as	IN
cord-005453-4057qib7	5703	13	second	second	JJ
cord-005453-4057qib7	5703	14	-	-	HYPH
cord-005453-4057qib7	5703	15	line	line	NN
cord-005453-4057qib7	5703	16	treatment	treatment	NN
cord-005453-4057qib7	5703	17	.	.	.
cord-005453-4057qib7	5704	1	Median	median	JJ
cord-005453-4057qib7	5704	2	duration	duration	NN
cord-005453-4057qib7	5704	3	of	of	IN
cord-005453-4057qib7	5704	4	treatment	treatment	NN
cord-005453-4057qib7	5704	5	was	be	VBD
cord-005453-4057qib7	5704	6	22	22	CD
cord-005453-4057qib7	5704	7	months	month	NNS
cord-005453-4057qib7	5704	8	(	(	-LRB-
cord-005453-4057qib7	5704	9	1.5	1.5	CD
cord-005453-4057qib7	5704	10	-	-	SYM
cord-005453-4057qib7	5704	11	36.8	36.8	CD
cord-005453-4057qib7	5704	12	)	)	-RRB-
cord-005453-4057qib7	5704	13	and	and	CC
cord-005453-4057qib7	5704	14	time	time	NN
cord-005453-4057qib7	5704	15	to	to	TO
cord-005453-4057qib7	5704	16	response	response	VB
cord-005453-4057qib7	5704	17	9.9	9.9	CD
cord-005453-4057qib7	5704	18	months	month	NNS
cord-005453-4057qib7	5704	19	(	(	-LRB-
cord-005453-4057qib7	5704	20	1.9	1.9	CD
cord-005453-4057qib7	5704	21	-	-	SYM
cord-005453-4057qib7	5704	22	30.2	30.2	CD
cord-005453-4057qib7	5704	23	)	)	-RRB-
cord-005453-4057qib7	5704	24	.	.	.
cord-005453-4057qib7	5705	1	Median	median	NN
cord-005453-4057qib7	5705	2	of	of	IN
cord-005453-4057qib7	5705	3	sessions	session	NNS
cord-005453-4057qib7	5705	4	was	be	VBD
cord-005453-4057qib7	5705	5	40	40	CD
cord-005453-4057qib7	5705	6	(	(	-LRB-
cord-005453-4057qib7	5705	7	4	4	CD
cord-005453-4057qib7	5705	8	-	-	SYM
cord-005453-4057qib7	5705	9	108	108	CD
cord-005453-4057qib7	5705	10	)	)	-RRB-
cord-005453-4057qib7	5705	11	.	.	.
cord-005453-4057qib7	5706	1	Evaluation	evaluation	NN
cord-005453-4057qib7	5706	2	of	of	IN
cord-005453-4057qib7	5706	3	response	response	NN
cord-005453-4057qib7	5706	4	was	be	VBD
cord-005453-4057qib7	5706	5	based	base	VBN
cord-005453-4057qib7	5706	6	on	on	IN
cord-005453-4057qib7	5706	7	the	the	DT
cord-005453-4057qib7	5706	8	evolution	evolution	NN
cord-005453-4057qib7	5706	9	of	of	IN
cord-005453-4057qib7	5706	10	FEV1	FEV1	NNP
cord-005453-4057qib7	5706	11	measurement	measurement	NN
cord-005453-4057qib7	5706	12	:	:	:
cord-005453-4057qib7	5706	13	26.6	26.6	CD
cord-005453-4057qib7	5706	14	%	%	NN
cord-005453-4057qib7	5706	15	(	(	-LRB-
cord-005453-4057qib7	5706	16	n	n	NN
cord-005453-4057qib7	5706	17	=	=	SYM
cord-005453-4057qib7	5706	18	4	4	CD
cord-005453-4057qib7	5706	19	)	)	-RRB-
cord-005453-4057qib7	5706	20	complete	complete	JJ
cord-005453-4057qib7	5706	21	response	response	NN
cord-005453-4057qib7	5706	22	;	;	:
cord-005453-4057qib7	5706	23	40	40	CD
cord-005453-4057qib7	5706	24	%	%	NN
cord-005453-4057qib7	5706	25	(	(	-LRB-
cord-005453-4057qib7	5706	26	n	n	NN
cord-005453-4057qib7	5706	27	=	=	SYM
cord-005453-4057qib7	5706	28	6	6	CD
cord-005453-4057qib7	5706	29	)	)	-RRB-
cord-005453-4057qib7	5706	30	partial	partial	JJ
cord-005453-4057qib7	5706	31	response	response	NN
cord-005453-4057qib7	5706	32	and	and	CC
cord-005453-4057qib7	5706	33	20	20	CD
cord-005453-4057qib7	5706	34	%	%	NN
cord-005453-4057qib7	5706	35	(	(	-LRB-
cord-005453-4057qib7	5706	36	n	n	NN
cord-005453-4057qib7	5706	37	=	=	SYM
cord-005453-4057qib7	5706	38	3	3	CD
cord-005453-4057qib7	5706	39	)	)	-RRB-
cord-005453-4057qib7	5706	40	stable	stable	JJ
cord-005453-4057qib7	5706	41	disease	disease	NN
cord-005453-4057qib7	5706	42	.	.	.
cord-005453-4057qib7	5707	1	One	one	CD
cord-005453-4057qib7	5707	2	patient	patient	NN
cord-005453-4057qib7	5707	3	did	do	VBD
cord-005453-4057qib7	5707	4	not	not	RB
cord-005453-4057qib7	5707	5	get	get	VB
cord-005453-4057qib7	5707	6	any	any	DT
cord-005453-4057qib7	5707	7	response	response	NN
cord-005453-4057qib7	5707	8	and	and	CC
cord-005453-4057qib7	5707	9	another	another	DT
cord-005453-4057qib7	5707	10	was	be	VBD
cord-005453-4057qib7	5707	11	not	not	RB
cord-005453-4057qib7	5707	12	evaluable	evaluable	JJ
cord-005453-4057qib7	5707	13	.	.	.
cord-005453-4057qib7	5708	1	66.6	66.6	CD
cord-005453-4057qib7	5708	2	%	%	NN
cord-005453-4057qib7	5708	3	of	of	IN
cord-005453-4057qib7	5708	4	patients	patient	NNS
cord-005453-4057qib7	5708	5	(	(	-LRB-
cord-005453-4057qib7	5708	6	n	n	NN
cord-005453-4057qib7	5708	7	=	=	SYM
cord-005453-4057qib7	5708	8	10	10	CD
cord-005453-4057qib7	5708	9	)	)	-RRB-
cord-005453-4057qib7	5708	10	could	could	MD
cord-005453-4057qib7	5708	11	reduce	reduce	VB
cord-005453-4057qib7	5708	12	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	5708	13	,	,	,
cord-005453-4057qib7	5708	14	and	and	CC
cord-005453-4057qib7	5708	15	in	in	IN
cord-005453-4057qib7	5708	16	one	one	CD
cord-005453-4057qib7	5708	17	case	case	NN
cord-005453-4057qib7	5708	18	it	-PRON-	PRP
cord-005453-4057qib7	5708	19	was	be	VBD
cord-005453-4057qib7	5708	20	completely	completely	RB
cord-005453-4057qib7	5708	21	discontinued	discontinue	VBN
cord-005453-4057qib7	5708	22	.	.	.
cord-005453-4057qib7	5709	1	There	there	EX
cord-005453-4057qib7	5709	2	is	be	VBZ
cord-005453-4057qib7	5709	3	a	a	DT
cord-005453-4057qib7	5709	4	trend	trend	NN
cord-005453-4057qib7	5709	5	for	for	IN
cord-005453-4057qib7	5709	6	early	early	JJ
cord-005453-4057qib7	5709	7	separation	separation	NN
cord-005453-4057qib7	5709	8	between	between	IN
cord-005453-4057qib7	5709	9	survival	survival	NN
cord-005453-4057qib7	5709	10	curves	curve	NNS
cord-005453-4057qib7	5709	11	in	in	IN
cord-005453-4057qib7	5709	12	favor	favor	NN
cord-005453-4057qib7	5709	13	of	of	IN
cord-005453-4057qib7	5709	14	ECP	ECP	NNP
cord-005453-4057qib7	5709	15	(	(	-LRB-
cord-005453-4057qib7	5709	16	Figure	figure	NN
cord-005453-4057qib7	5709	17	1	1	CD
cord-005453-4057qib7	5709	18	)	)	-RRB-
cord-005453-4057qib7	5709	19	.	.	.
cord-005453-4057qib7	5710	1	One	one	CD
cord-005453-4057qib7	5710	2	patient	patient	NN
cord-005453-4057qib7	5710	3	had	have	VBD
cord-005453-4057qib7	5710	4	sepsis	sepsis	NN
cord-005453-4057qib7	5710	5	secondary	secondary	JJ
cord-005453-4057qib7	5710	6	to	to	IN
cord-005453-4057qib7	5710	7	central	central	JJ
cord-005453-4057qib7	5710	8	venous	venous	JJ
cord-005453-4057qib7	5710	9	catheter	catheter	NN
cord-005453-4057qib7	5710	10	infection	infection	NN
cord-005453-4057qib7	5710	11	as	as	IN
cord-005453-4057qib7	5710	12	complication	complication	NN
cord-005453-4057qib7	5710	13	related	relate	VBN
cord-005453-4057qib7	5710	14	to	to	IN
cord-005453-4057qib7	5710	15	ECP	ECP	NNP
cord-005453-4057qib7	5710	16	.	.	.
cord-005453-4057qib7	5711	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5711	2	:	:	:
cord-005453-4057qib7	5712	1	ECP	ECP	NNP
cord-005453-4057qib7	5712	2	has	have	VBZ
cord-005453-4057qib7	5712	3	emerged	emerge	VBN
cord-005453-4057qib7	5712	4	as	as	IN
cord-005453-4057qib7	5712	5	a	a	DT
cord-005453-4057qib7	5712	6	promising	promising	JJ
cord-005453-4057qib7	5712	7	treatment	treatment	NN
cord-005453-4057qib7	5712	8	for	for	IN
cord-005453-4057qib7	5712	9	BO	BO	NNP
cord-005453-4057qib7	5712	10	after	after	IN
cord-005453-4057qib7	5712	11	alloHCT	alloHCT	NNP
cord-005453-4057qib7	5712	12	.	.	.
cord-005453-4057qib7	5713	1	In	in	IN
cord-005453-4057qib7	5713	2	our	-PRON-	PRP$
cord-005453-4057qib7	5713	3	experience	experience	NN
cord-005453-4057qib7	5713	4	,	,	,
cord-005453-4057qib7	5713	5	ECP	ECP	NNP
cord-005453-4057qib7	5713	6	was	be	VBD
cord-005453-4057qib7	5713	7	effective	effective	JJ
cord-005453-4057qib7	5713	8	to	to	TO
cord-005453-4057qib7	5713	9	stabilize	stabilize	VB
cord-005453-4057qib7	5713	10	or	or	CC
cord-005453-4057qib7	5713	11	improve	improve	VB
cord-005453-4057qib7	5713	12	the	the	DT
cord-005453-4057qib7	5713	13	disease	disease	NN
cord-005453-4057qib7	5713	14	in	in	IN
cord-005453-4057qib7	5713	15	many	many	JJ
cord-005453-4057qib7	5713	16	patients	patient	NNS
cord-005453-4057qib7	5713	17	and	and	CC
cord-005453-4057qib7	5713	18	allowed	allow	VBN
cord-005453-4057qib7	5713	19	to	to	TO
cord-005453-4057qib7	5713	20	taper	taper	VB
cord-005453-4057qib7	5713	21	esteroids	esteroid	NNS
cord-005453-4057qib7	5713	22	with	with	IN
cord-005453-4057qib7	5713	23	minimal	minimal	JJ
cord-005453-4057qib7	5713	24	associated	associate	VBN
cord-005453-4057qib7	5713	25	complications	complication	NNS
cord-005453-4057qib7	5713	26	.	.	.
cord-005453-4057qib7	5714	1	However	however	RB
cord-005453-4057qib7	5714	2	,	,	,
cord-005453-4057qib7	5714	3	prospective	prospective	JJ
cord-005453-4057qib7	5714	4	studies	study	NNS
cord-005453-4057qib7	5714	5	and	and	CC
cord-005453-4057qib7	5714	6	longer	long	RBR
cord-005453-4057qib7	5714	7	follow	follow	VB
cord-005453-4057qib7	5714	8	-	-	HYPH
cord-005453-4057qib7	5714	9	up	up	NN
cord-005453-4057qib7	5714	10	are	be	VBP
cord-005453-4057qib7	5714	11	needed	need	VBN
cord-005453-4057qib7	5714	12	to	to	TO
cord-005453-4057qib7	5714	13	support	support	VB
cord-005453-4057qib7	5714	14	these	these	DT
cord-005453-4057qib7	5714	15	findings	finding	NNS
cord-005453-4057qib7	5714	16	.	.	.
cord-005453-4057qib7	5715	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5715	2	:	:	:
cord-005453-4057qib7	5715	3	Nothing	nothing	NN
cord-005453-4057qib7	5715	4	to	to	TO
cord-005453-4057qib7	5715	5	declare	declare	VB
cord-005453-4057qib7	5715	6	Background	background	NN
cord-005453-4057qib7	5715	7	:	:	:
cord-005453-4057qib7	5716	1	The	the	DT
cord-005453-4057qib7	5716	2	key	key	JJ
cord-005453-4057qib7	5716	3	role	role	NN
cord-005453-4057qib7	5716	4	of	of	IN
cord-005453-4057qib7	5716	5	IL-6	IL-6	NNP
cord-005453-4057qib7	5716	6	signaling	signal	VBG
cord-005453-4057qib7	5716	7	in	in	IN
cord-005453-4057qib7	5716	8	acute	acute	JJ
cord-005453-4057qib7	5716	9	graft	graft	NN
cord-005453-4057qib7	5716	10	vs.	vs.	IN
cord-005453-4057qib7	5716	11	host	host	NN
cord-005453-4057qib7	5716	12	disease	disease	NN
cord-005453-4057qib7	5716	13	(	(	-LRB-
cord-005453-4057qib7	5716	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5716	15	)	)	-RRB-
cord-005453-4057qib7	5716	16	and	and	CC
cord-005453-4057qib7	5716	17	cytokine	cytokine	NN
cord-005453-4057qib7	5716	18	release	release	NN
cord-005453-4057qib7	5716	19	syndrome	syndrome	NN
cord-005453-4057qib7	5716	20	(	(	-LRB-
cord-005453-4057qib7	5716	21	CRS	CRS	NNP
cord-005453-4057qib7	5716	22	)	)	-RRB-
cord-005453-4057qib7	5716	23	has	have	VBZ
cord-005453-4057qib7	5716	24	evoked	evoke	VBN
cord-005453-4057qib7	5716	25	growing	grow	VBG
cord-005453-4057qib7	5716	26	use	use	NN
cord-005453-4057qib7	5716	27	of	of	IN
cord-005453-4057qib7	5716	28	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5716	29	,	,	,
cord-005453-4057qib7	5716	30	an	an	DT
cord-005453-4057qib7	5716	31	anti	anti	JJ
cord-005453-4057qib7	5716	32	-	-	JJ
cord-005453-4057qib7	5716	33	IL6	il6	JJ
cord-005453-4057qib7	5716	34	receptor	receptor	NN
cord-005453-4057qib7	5716	35	(	(	-LRB-
cord-005453-4057qib7	5716	36	IL6-R	il6-r	NN
cord-005453-4057qib7	5716	37	)	)	-RRB-
cord-005453-4057qib7	5716	38	antibody	antibody	NN
cord-005453-4057qib7	5716	39	,	,	,
cord-005453-4057qib7	5716	40	in	in	IN
cord-005453-4057qib7	5716	41	these	these	DT
cord-005453-4057qib7	5716	42	settings	setting	NNS
cord-005453-4057qib7	5716	43	.	.	.
cord-005453-4057qib7	5717	1	Apart	apart	RB
cord-005453-4057qib7	5717	2	from	from	IN
cord-005453-4057qib7	5717	3	regulation	regulation	NN
cord-005453-4057qib7	5717	4	of	of	IN
cord-005453-4057qib7	5717	5	T	T	NNP
cord-005453-4057qib7	5717	6	-	-	HYPH
cord-005453-4057qib7	5717	7	and	and	CC
cord-005453-4057qib7	5717	8	B	b	NN
cord-005453-4057qib7	5717	9	-	-	HYPH
cord-005453-4057qib7	5717	10	cell	cell	NN
cord-005453-4057qib7	5717	11	differentiation	differentiation	NN
cord-005453-4057qib7	5717	12	,	,	,
cord-005453-4057qib7	5717	13	immune	immune	JJ
cord-005453-4057qib7	5717	14	cells	cell	NNS
cord-005453-4057qib7	5717	15	migration	migration	NN
cord-005453-4057qib7	5717	16	to	to	IN
cord-005453-4057qib7	5717	17	inflammatory	inflammatory	JJ
cord-005453-4057qib7	5717	18	sites	site	NNS
cord-005453-4057qib7	5717	19	and	and	CC
cord-005453-4057qib7	5717	20	T	t	NN
cord-005453-4057qib7	5717	21	-	-	HYPH
cord-005453-4057qib7	5717	22	cell	cell	NN
cord-005453-4057qib7	5717	23	recruitment	recruitment	NN
cord-005453-4057qib7	5717	24	,	,	,
cord-005453-4057qib7	5717	25	IL-6	IL-6	NNP
cord-005453-4057qib7	5717	26	complex	complex	NN
cord-005453-4057qib7	5717	27	with	with	IN
cord-005453-4057qib7	5717	28	IL6-R	il6-r	NN
cord-005453-4057qib7	5718	1	through	through	IN
cord-005453-4057qib7	5718	2	gp130	gp130	NNS
cord-005453-4057qib7	5719	1	upregulates	upregulate	VBZ
cord-005453-4057qib7	5719	2	production	production	NN
cord-005453-4057qib7	5719	3	of	of	IN
cord-005453-4057qib7	5719	4	fibrinogen	fibrinogen	NN
cord-005453-4057qib7	5719	5	(	(	-LRB-
cord-005453-4057qib7	5719	6	Fg	Fg	NNP
cord-005453-4057qib7	5719	7	)	)	-RRB-
cord-005453-4057qib7	5719	8	and	and	CC
cord-005453-4057qib7	5719	9	other	other	JJ
cord-005453-4057qib7	5719	10	acute	acute	JJ
cord-005453-4057qib7	5719	11	phase	phase	NN
cord-005453-4057qib7	5719	12	proteins	protein	NNS
cord-005453-4057qib7	5719	13	,	,	,
cord-005453-4057qib7	5719	14	including	include	VBG
cord-005453-4057qib7	5719	15	C	c	NN
cord-005453-4057qib7	5719	16	-	-	HYPH
cord-005453-4057qib7	5719	17	reactive	reactive	JJ
cord-005453-4057qib7	5719	18	protein	protein	NN
cord-005453-4057qib7	5719	19	(	(	-LRB-
cord-005453-4057qib7	5719	20	CRP	CRP	NNP
cord-005453-4057qib7	5719	21	)	)	-RRB-
cord-005453-4057qib7	5719	22	.	.	.
cord-005453-4057qib7	5720	1	Methods	method	NNS
cord-005453-4057qib7	5720	2	:	:	:
cord-005453-4057qib7	5721	1	We	-PRON-	PRP
cord-005453-4057qib7	5721	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	5721	3	analyzed	analyze	VBD
cord-005453-4057qib7	5721	4	data	datum	NNS
cord-005453-4057qib7	5721	5	of	of	IN
cord-005453-4057qib7	5721	6	7	7	CD
cord-005453-4057qib7	5721	7	patients	patient	NNS
cord-005453-4057qib7	5721	8	treated	treat	VBN
cord-005453-4057qib7	5721	9	with	with	IN
cord-005453-4057qib7	5721	10	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5721	11	(	(	-LRB-
cord-005453-4057qib7	5721	12	8mg	8mg	NNP
cord-005453-4057qib7	5721	13	/	/	SYM
cord-005453-4057qib7	5721	14	kg	kg	NN
cord-005453-4057qib7	5721	15	)	)	-RRB-
cord-005453-4057qib7	5721	16	due	due	IN
cord-005453-4057qib7	5721	17	to	to	IN
cord-005453-4057qib7	5721	18	steroid	steroid	NN
cord-005453-4057qib7	5721	19	-	-	HYPH
cord-005453-4057qib7	5721	20	refractory	refractory	JJ
cord-005453-4057qib7	5721	21	(	(	-LRB-
cord-005453-4057qib7	5721	22	SR	SR	NNP
cord-005453-4057qib7	5721	23	)	)	-RRB-
cord-005453-4057qib7	5721	24	aGvHD	agvhd	NN
cord-005453-4057qib7	5721	25	and	and	CC
cord-005453-4057qib7	5721	26	4	4	CD
cord-005453-4057qib7	5721	27	patients	patient	NNS
cord-005453-4057qib7	5721	28	because	because	IN
cord-005453-4057qib7	5721	29	of	of	IN
cord-005453-4057qib7	5721	30	CRS	CRS	NNP
cord-005453-4057qib7	5721	31	.	.	.
cord-005453-4057qib7	5722	1	Median	median	JJ
cord-005453-4057qib7	5722	2	age	age	NN
cord-005453-4057qib7	5722	3	was	be	VBD
cord-005453-4057qib7	5722	4	37	37	CD
cord-005453-4057qib7	5722	5	and	and	CC
cord-005453-4057qib7	5722	6	47	47	CD
cord-005453-4057qib7	5722	7	years	year	NNS
cord-005453-4057qib7	5722	8	,	,	,
cord-005453-4057qib7	5722	9	respectively	respectively	RB
cord-005453-4057qib7	5722	10	.	.	.
cord-005453-4057qib7	5723	1	Seven	seven	CD
cord-005453-4057qib7	5723	2	patients	patient	NNS
cord-005453-4057qib7	5723	3	were	be	VBD
cord-005453-4057qib7	5723	4	transplanted	transplant	VBN
cord-005453-4057qib7	5723	5	from	from	IN
cord-005453-4057qib7	5723	6	unrelated	unrelated	JJ
cord-005453-4057qib7	5723	7	donors	donor	NNS
cord-005453-4057qib7	5723	8	(	(	-LRB-
cord-005453-4057qib7	5723	9	MUD	mud	NN
cord-005453-4057qib7	5723	10	/	/	SYM
cord-005453-4057qib7	5723	11	MMUD	MMUD	NNP
cord-005453-4057qib7	5723	12	)	)	-RRB-
cord-005453-4057qib7	5723	13	and	and	CC
cord-005453-4057qib7	5723	14	4	4	CD
cord-005453-4057qib7	5723	15	from	from	IN
cord-005453-4057qib7	5723	16	sibling	sibling	NN
cord-005453-4057qib7	5723	17	donors	donor	NNS
cord-005453-4057qib7	5723	18	.	.	.
cord-005453-4057qib7	5724	1	Eight	eight	CD
cord-005453-4057qib7	5724	2	patients	patient	NNS
cord-005453-4057qib7	5724	3	received	receive	VBD
cord-005453-4057qib7	5724	4	myeloablative	myeloablative	NNP
cord-005453-4057qib7	5724	5	and	and	CC
cord-005453-4057qib7	5724	6	3	3	CD
cord-005453-4057qib7	5724	7	reduced	reduced	JJ
cord-005453-4057qib7	5724	8	intensity	intensity	NN
cord-005453-4057qib7	5724	9	conditioning	conditioning	NN
cord-005453-4057qib7	5724	10	regimen	regimen	NN
cord-005453-4057qib7	5724	11	.	.	.
cord-005453-4057qib7	5725	1	Analyzed	analyze	VBN
cord-005453-4057qib7	5725	2	data	datum	NNS
cord-005453-4057qib7	5725	3	included	include	VBD
cord-005453-4057qib7	5725	4	concentrations	concentration	NNS
cord-005453-4057qib7	5725	5	of	of	IN
cord-005453-4057qib7	5725	6	Fg	Fg	NNP
cord-005453-4057qib7	5725	7	,	,	,
cord-005453-4057qib7	5725	8	CRP	CRP	NNP
cord-005453-4057qib7	5725	9	,	,	,
cord-005453-4057qib7	5725	10	an	an	DT
cord-005453-4057qib7	5725	11	incidence	incidence	NN
cord-005453-4057qib7	5725	12	of	of	IN
cord-005453-4057qib7	5725	13	infections	infection	NNS
cord-005453-4057qib7	5725	14	at	at	IN
cord-005453-4057qib7	5725	15	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5725	16	administration	administration	NN
cord-005453-4057qib7	5725	17	and	and	CC
cord-005453-4057qib7	5725	18	in	in	IN
cord-005453-4057qib7	5725	19	weeks	week	NNS
cord-005453-4057qib7	5725	20	following	follow	VBG
cord-005453-4057qib7	5725	21	the	the	DT
cord-005453-4057qib7	5725	22	infusion	infusion	NN
cord-005453-4057qib7	5725	23	.	.	.
cord-005453-4057qib7	5726	1	Results	result	NNS
cord-005453-4057qib7	5726	2	:	:	:
cord-005453-4057qib7	5727	1	Stage	stage	NN
cord-005453-4057qib7	5727	2	II	II	NNP
cord-005453-4057qib7	5727	3	aGvHD	agvhd	NN
cord-005453-4057qib7	5727	4	was	be	VBD
cord-005453-4057qib7	5727	5	diagnosed	diagnose	VBN
cord-005453-4057qib7	5727	6	in	in	IN
cord-005453-4057qib7	5727	7	1	1	CD
cord-005453-4057qib7	5727	8	patient	patient	NN
cord-005453-4057qib7	5727	9	,	,	,
cord-005453-4057qib7	5727	10	stage	stage	NN
cord-005453-4057qib7	5727	11	III	iii	CD
cord-005453-4057qib7	5727	12	in	in	IN
cord-005453-4057qib7	5727	13	4	4	CD
cord-005453-4057qib7	5727	14	,	,	,
cord-005453-4057qib7	5727	15	and	and	CC
cord-005453-4057qib7	5727	16	stage	stage	NN
cord-005453-4057qib7	5727	17	IV	IV	NNP
cord-005453-4057qib7	5727	18	in	in	IN
cord-005453-4057qib7	5727	19	2	2	CD
cord-005453-4057qib7	5727	20	patients	patient	NNS
cord-005453-4057qib7	5727	21	.	.	.
cord-005453-4057qib7	5728	1	Involvement	involvement	NN
cord-005453-4057qib7	5728	2	of	of	IN
cord-005453-4057qib7	5728	3	the	the	DT
cord-005453-4057qib7	5728	4	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	5728	5	tract	tract	NN
cord-005453-4057qib7	5728	6	(	(	-LRB-
cord-005453-4057qib7	5728	7	GI	GI	NNP
cord-005453-4057qib7	5728	8	)	)	-RRB-
cord-005453-4057qib7	5728	9	was	be	VBD
cord-005453-4057qib7	5728	10	observed	observe	VBN
cord-005453-4057qib7	5728	11	in	in	IN
cord-005453-4057qib7	5728	12	85	85	CD
cord-005453-4057qib7	5728	13	%	%	NN
cord-005453-4057qib7	5728	14	of	of	IN
cord-005453-4057qib7	5728	15	cases	case	NNS
cord-005453-4057qib7	5728	16	.	.	.
cord-005453-4057qib7	5729	1	The	the	DT
cord-005453-4057qib7	5729	2	median	median	JJ
cord-005453-4057qib7	5729	3	Fg	Fg	NNP
cord-005453-4057qib7	5729	4	concentration	concentration	NN
cord-005453-4057qib7	5729	5	before	before	IN
cord-005453-4057qib7	5729	6	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5729	7	administration	administration	NN
cord-005453-4057qib7	5729	8	was	be	VBD
cord-005453-4057qib7	5729	9	2.56	2.56	CD
cord-005453-4057qib7	5729	10	g	g	NN
cord-005453-4057qib7	5729	11	/	/	SYM
cord-005453-4057qib7	5729	12	l	l	NN
cord-005453-4057qib7	5729	13	(	(	-LRB-
cord-005453-4057qib7	5729	14	range	range	NN
cord-005453-4057qib7	5729	15	,	,	,
cord-005453-4057qib7	5729	16	1.4	1.4	CD
cord-005453-4057qib7	5729	17	-	-	SYM
cord-005453-4057qib7	5729	18	7	7	CD
cord-005453-4057qib7	5729	19	)	)	-RRB-
cord-005453-4057qib7	5729	20	and	and	CC
cord-005453-4057qib7	5729	21	CRP	CRP	NNP
cord-005453-4057qib7	5729	22	21	21	CD
cord-005453-4057qib7	5729	23	mg	mg	NNP
cord-005453-4057qib7	5729	24	/	/	SYM
cord-005453-4057qib7	5729	25	dl	dl	NNP
cord-005453-4057qib7	5729	26	(	(	-LRB-
cord-005453-4057qib7	5729	27	range	range	NN
cord-005453-4057qib7	5729	28	,	,	,
cord-005453-4057qib7	5729	29	1	1	CD
cord-005453-4057qib7	5729	30	-	-	SYM
cord-005453-4057qib7	5729	31	260	260	CD
cord-005453-4057qib7	5729	32	)	)	-RRB-
cord-005453-4057qib7	5729	33	and	and	CC
cord-005453-4057qib7	5729	34	60	60	CD
cord-005453-4057qib7	5729	35	%	%	NN
cord-005453-4057qib7	5729	36	of	of	IN
cord-005453-4057qib7	5729	37	patients	patient	NNS
cord-005453-4057qib7	5729	38	had	have	VBD
cord-005453-4057qib7	5729	39	an	an	DT
cord-005453-4057qib7	5729	40	active	active	JJ
cord-005453-4057qib7	5729	41	infection	infection	NN
cord-005453-4057qib7	5729	42	.	.	.
cord-005453-4057qib7	5730	1	After	after	IN
cord-005453-4057qib7	5730	2	infusion	infusion	NN
cord-005453-4057qib7	5730	3	of	of	IN
cord-005453-4057qib7	5730	4	the	the	DT
cord-005453-4057qib7	5730	5	antibody	antibody	NN
cord-005453-4057qib7	5730	6	,	,	,
cord-005453-4057qib7	5730	7	we	-PRON-	PRP
cord-005453-4057qib7	5730	8	observed	observe	VBD
cord-005453-4057qib7	5730	9	a	a	DT
cord-005453-4057qib7	5730	10	decline	decline	NN
cord-005453-4057qib7	5730	11	of	of	IN
cord-005453-4057qib7	5730	12	Fg	Fg	NNP
cord-005453-4057qib7	5730	13	and	and	CC
cord-005453-4057qib7	5730	14	CRP	CRP	NNP
cord-005453-4057qib7	5730	15	levels	level	NNS
cord-005453-4057qib7	5730	16	.	.	.
cord-005453-4057qib7	5731	1	The	the	DT
cord-005453-4057qib7	5731	2	median	median	JJ
cord-005453-4057qib7	5731	3	level	level	NN
cord-005453-4057qib7	5731	4	of	of	IN
cord-005453-4057qib7	5731	5	Fg	Fg	NNP
cord-005453-4057qib7	5731	6	was	be	VBD
cord-005453-4057qib7	5731	7	1.02	1.02	CD
cord-005453-4057qib7	5731	8	g	g	NN
cord-005453-4057qib7	5731	9	/	/	SYM
cord-005453-4057qib7	5731	10	l	l	NN
cord-005453-4057qib7	5731	11	(	(	-LRB-
cord-005453-4057qib7	5731	12	range	range	NN
cord-005453-4057qib7	5731	13	,	,	,
cord-005453-4057qib7	5731	14	0.46	0.46	CD
cord-005453-4057qib7	5731	15	-	-	SYM
cord-005453-4057qib7	5731	16	1.7	1.7	CD
cord-005453-4057qib7	5731	17	)	)	-RRB-
cord-005453-4057qib7	5731	18	7	7	CD
cord-005453-4057qib7	5731	19	-14	-14	CD
cord-005453-4057qib7	5731	20	days	day	NNS
cord-005453-4057qib7	5731	21	after	after	IN
cord-005453-4057qib7	5731	22	the	the	DT
cord-005453-4057qib7	5731	23	tocilizumab	tocilizumab	JJ
cord-005453-4057qib7	5731	24	infusion	infusion	NN
cord-005453-4057qib7	5731	25	with	with	IN
cord-005453-4057qib7	5731	26	no	no	DT
cord-005453-4057qib7	5731	27	severe	severe	JJ
cord-005453-4057qib7	5731	28	bleeding	bleeding	JJ
cord-005453-4057qib7	5731	29	complications	complication	NNS
cord-005453-4057qib7	5731	30	.	.	.
cord-005453-4057qib7	5732	1	A	a	DT
cord-005453-4057qib7	5732	2	median	median	JJ
cord-005453-4057qib7	5732	3	CRP	crp	NN
cord-005453-4057qib7	5732	4	value	value	NN
cord-005453-4057qib7	5732	5	was	be	VBD
cord-005453-4057qib7	5732	6	1.82	1.82	CD
cord-005453-4057qib7	5732	7	mg	mg	NNP
cord-005453-4057qib7	5732	8	/	/	SYM
cord-005453-4057qib7	5732	9	dl	dl	NN
cord-005453-4057qib7	5732	10	(	(	-LRB-
cord-005453-4057qib7	5732	11	range	range	NN
cord-005453-4057qib7	5732	12	,	,	,
cord-005453-4057qib7	5732	13	0.1	0.1	CD
cord-005453-4057qib7	5732	14	-	-	SYM
cord-005453-4057qib7	5732	15	36	36	CD
cord-005453-4057qib7	5732	16	)	)	-RRB-
cord-005453-4057qib7	5732	17	despite	despite	IN
cord-005453-4057qib7	5732	18	confirmed	confirm	VBD
cord-005453-4057qib7	5732	19	infectious	infectious	JJ
cord-005453-4057qib7	5732	20	complications	complication	NNS
cord-005453-4057qib7	5732	21	.	.	.
cord-005453-4057qib7	5733	1	Three	three	CD
cord-005453-4057qib7	5733	2	weeks	week	NNS
cord-005453-4057qib7	5733	3	after	after	IN
cord-005453-4057qib7	5733	4	infusion	infusion	NN
cord-005453-4057qib7	5733	5	of	of	IN
cord-005453-4057qib7	5733	6	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5733	7	Fg	Fg	NNP
cord-005453-4057qib7	5733	8	raised	raise	VBD
cord-005453-4057qib7	5733	9	to	to	IN
cord-005453-4057qib7	5733	10	the	the	DT
cord-005453-4057qib7	5733	11	normal	normal	JJ
cord-005453-4057qib7	5733	12	range	range	NN
cord-005453-4057qib7	5733	13	in	in	IN
cord-005453-4057qib7	5733	14	85	85	CD
cord-005453-4057qib7	5733	15	%	%	NN
cord-005453-4057qib7	5733	16	of	of	IN
cord-005453-4057qib7	5733	17	patients	patient	NNS
cord-005453-4057qib7	5733	18	(	(	-LRB-
cord-005453-4057qib7	5733	19	Fig	Fig	NNP
cord-005453-4057qib7	5733	20	1	1	CD
cord-005453-4057qib7	5733	21	)	)	-RRB-
cord-005453-4057qib7	5733	22	.	.	.
cord-005453-4057qib7	5734	1	Five	five	CD
cord-005453-4057qib7	5734	2	patients	patient	NNS
cord-005453-4057qib7	5734	3	with	with	IN
cord-005453-4057qib7	5734	4	SR	SR	NNP
cord-005453-4057qib7	5734	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5734	6	achieved	achieve	VBD
cord-005453-4057qib7	5734	7	a	a	DT
cord-005453-4057qib7	5734	8	complete	complete	JJ
cord-005453-4057qib7	5734	9	response	response	NN
cord-005453-4057qib7	5734	10	,	,	,
cord-005453-4057qib7	5734	11	and	and	CC
cord-005453-4057qib7	5734	12	2	2	CD
cord-005453-4057qib7	5734	13	had	have	VBD
cord-005453-4057qib7	5734	14	a	a	DT
cord-005453-4057qib7	5734	15	partial	partial	JJ
cord-005453-4057qib7	5734	16	response	response	NN
cord-005453-4057qib7	5734	17	after	after	IN
cord-005453-4057qib7	5734	18	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5734	19	therapy	therapy	NN
cord-005453-4057qib7	5734	20	.	.	.
cord-005453-4057qib7	5735	1	[	[	-LRB-
cord-005453-4057qib7	5735	2	[	[	-LRB-
cord-005453-4057qib7	5735	3	P265	p265	CD
cord-005453-4057qib7	5735	4	Image	image	NN
cord-005453-4057qib7	5735	5	]	]	-RRB-
cord-005453-4057qib7	5735	6	1	1	CD
cord-005453-4057qib7	5735	7	.	.	.
cord-005453-4057qib7	5736	1	Fibrinogen	fibrinogen	NN
cord-005453-4057qib7	5736	2	levels	level	NNS
cord-005453-4057qib7	5736	3	in	in	IN
cord-005453-4057qib7	5736	4	GvHD	gvhd	NN
cord-005453-4057qib7	5736	5	patients	patient	NNS
cord-005453-4057qib7	5736	6	following	follow	VBG
cord-005453-4057qib7	5736	7	tocilizumab	tocilizumab	JJ
cord-005453-4057qib7	5736	8	infusion	infusion	NN
cord-005453-4057qib7	5736	9	.	.	.
cord-005453-4057qib7	5736	10	]	]	-RRB-
cord-005453-4057qib7	5737	1	A	a	DT
cord-005453-4057qib7	5737	2	group	group	NN
cord-005453-4057qib7	5737	3	treated	treat	VBN
cord-005453-4057qib7	5737	4	with	with	IN
cord-005453-4057qib7	5737	5	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5737	6	due	due	IN
cord-005453-4057qib7	5737	7	to	to	IN
cord-005453-4057qib7	5737	8	CRS	CRS	NNP
cord-005453-4057qib7	5737	9	had	have	VBD
cord-005453-4057qib7	5737	10	higher	high	JJR
cord-005453-4057qib7	5737	11	initial	initial	JJ
cord-005453-4057qib7	5737	12	levels	level	NNS
cord-005453-4057qib7	5737	13	of	of	IN
cord-005453-4057qib7	5737	14	Fg	Fg	NNP
cord-005453-4057qib7	5737	15	5.1	5.1	CD
cord-005453-4057qib7	5737	16	g	g	NN
cord-005453-4057qib7	5737	17	/	/	SYM
cord-005453-4057qib7	5737	18	l	l	NN
cord-005453-4057qib7	5737	19	(	(	-LRB-
cord-005453-4057qib7	5737	20	range	range	NN
cord-005453-4057qib7	5737	21	,	,	,
cord-005453-4057qib7	5737	22	4.1	4.1	CD
cord-005453-4057qib7	5737	23	-	-	SYM
cord-005453-4057qib7	5737	24	6.6	6.6	CD
cord-005453-4057qib7	5737	25	)	)	-RRB-
cord-005453-4057qib7	5737	26	and	and	CC
cord-005453-4057qib7	5737	27	CRP	CRP	NNP
cord-005453-4057qib7	5737	28	143	143	CD
cord-005453-4057qib7	5737	29	mg/	mg/	NN
cord-005453-4057qib7	5737	30	dl	dl	NN
cord-005453-4057qib7	5737	31	(	(	-LRB-
cord-005453-4057qib7	5737	32	range	range	NN
cord-005453-4057qib7	5737	33	,	,	,
cord-005453-4057qib7	5737	34	80	80	CD
cord-005453-4057qib7	5737	35	-	-	SYM
cord-005453-4057qib7	5737	36	227	227	CD
cord-005453-4057qib7	5737	37	)	)	-RRB-
cord-005453-4057qib7	5738	1	before	before	IN
cord-005453-4057qib7	5738	2	administration	administration	NN
cord-005453-4057qib7	5738	3	of	of	IN
cord-005453-4057qib7	5738	4	the	the	DT
cord-005453-4057qib7	5738	5	drug	drug	NN
cord-005453-4057qib7	5738	6	.	.	.
cord-005453-4057qib7	5739	1	Reduced	reduced	JJ
cord-005453-4057qib7	5739	2	Fg	Fg	NNP
cord-005453-4057qib7	5739	3	and	and	CC
cord-005453-4057qib7	5739	4	CRP	CRP	NNP
cord-005453-4057qib7	5739	5	levels	level	NNS
cord-005453-4057qib7	5739	6	from	from	IN
cord-005453-4057qib7	5739	7	a	a	DT
cord-005453-4057qib7	5739	8	baseline	baseline	JJ
cord-005453-4057qib7	5739	9	value	value	NN
cord-005453-4057qib7	5739	10	were	be	VBD
cord-005453-4057qib7	5739	11	also	also	RB
cord-005453-4057qib7	5739	12	observed	observe	VBN
cord-005453-4057qib7	5739	13	in	in	IN
cord-005453-4057qib7	5739	14	this	this	DT
cord-005453-4057qib7	5739	15	group	group	NN
cord-005453-4057qib7	5739	16	.	.	.
cord-005453-4057qib7	5740	1	However	however	RB
cord-005453-4057qib7	5740	2	,	,	,
cord-005453-4057qib7	5740	3	concentrations	concentration	NNS
cord-005453-4057qib7	5740	4	were	be	VBD
cord-005453-4057qib7	5740	5	higher	high	JJR
cord-005453-4057qib7	5740	6	than	than	IN
cord-005453-4057qib7	5740	7	in	in	IN
cord-005453-4057qib7	5740	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5740	9	patients	patient	NNS
cord-005453-4057qib7	5740	10	:	:	:
cord-005453-4057qib7	5741	1	Fg	Fg	NNP
cord-005453-4057qib7	5741	2	2.02	2.02	CD
cord-005453-4057qib7	5741	3	g	g	NN
cord-005453-4057qib7	5741	4	/	/	SYM
cord-005453-4057qib7	5741	5	l	l	NN
cord-005453-4057qib7	5741	6	(	(	-LRB-
cord-005453-4057qib7	5741	7	range	range	NNP
cord-005453-4057qib7	5741	8	1.2	1.2	CD
cord-005453-4057qib7	5741	9	-	-	SYM
cord-005453-4057qib7	5741	10	3.4	3.4	CD
cord-005453-4057qib7	5741	11	)	)	-RRB-
cord-005453-4057qib7	5741	12	and	and	CC
cord-005453-4057qib7	5741	13	CRP	CRP	NNP
cord-005453-4057qib7	5741	14	3.2	3.2	CD
cord-005453-4057qib7	5741	15	mg	mg	NNP
cord-005453-4057qib7	5741	16	/	/	SYM
cord-005453-4057qib7	5741	17	dl	dl	NNP
cord-005453-4057qib7	5741	18	(	(	-LRB-
cord-005453-4057qib7	5741	19	range	range	NNP
cord-005453-4057qib7	5741	20	2.7	2.7	CD
cord-005453-4057qib7	5741	21	-	-	SYM
cord-005453-4057qib7	5741	22	11	11	CD
cord-005453-4057qib7	5741	23	)	)	-RRB-
cord-005453-4057qib7	5741	24	.	.	.
cord-005453-4057qib7	5742	1	In	in	IN
cord-005453-4057qib7	5742	2	all	all	DT
cord-005453-4057qib7	5742	3	patients	patient	NNS
cord-005453-4057qib7	5742	4	,	,	,
cord-005453-4057qib7	5742	5	a	a	DT
cord-005453-4057qib7	5742	6	differential	differential	JJ
cord-005453-4057qib7	5742	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	5742	8	of	of	IN
cord-005453-4057qib7	5742	9	disseminated	disseminate	VBN
cord-005453-4057qib7	5742	10	intravascular	intravascular	JJ
cord-005453-4057qib7	5742	11	coagulation	coagulation	NN
cord-005453-4057qib7	5742	12	was	be	VBD
cord-005453-4057qib7	5742	13	excluded	exclude	VBN
cord-005453-4057qib7	5742	14	.	.	.
cord-005453-4057qib7	5743	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5743	2	:	:	:
cord-005453-4057qib7	5743	3	1	1	CD
cord-005453-4057qib7	5743	4	.	.	.
cord-005453-4057qib7	5744	1	Fibrinogen	fibrinogen	NN
cord-005453-4057qib7	5744	2	declines	decline	VBZ
cord-005453-4057qib7	5744	3	after	after	IN
cord-005453-4057qib7	5744	4	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5744	5	therapy	therapy	NN
cord-005453-4057qib7	5744	6	due	due	IN
cord-005453-4057qib7	5744	7	to	to	IN
cord-005453-4057qib7	5744	8	its	-PRON-	PRP$
cord-005453-4057qib7	5744	9	cytokine	cytokine	NN
cord-005453-4057qib7	5744	10	-	-	HYPH
cord-005453-4057qib7	5744	11	regulated	regulate	VBN
cord-005453-4057qib7	5744	12	production	production	NN
cord-005453-4057qib7	5744	13	in	in	IN
cord-005453-4057qib7	5744	14	the	the	DT
cord-005453-4057qib7	5744	15	liver	liver	NN
cord-005453-4057qib7	5744	16	.	.	.
cord-005453-4057qib7	5745	1	Coagulation	coagulation	NN
cord-005453-4057qib7	5745	2	monitoring	monitoring	NN
cord-005453-4057qib7	5745	3	should	should	MD
cord-005453-4057qib7	5745	4	be	be	VB
cord-005453-4057qib7	5745	5	performed	perform	VBN
cord-005453-4057qib7	5745	6	during	during	IN
cord-005453-4057qib7	5745	7	the	the	DT
cord-005453-4057qib7	5745	8	first	first	JJ
cord-005453-4057qib7	5745	9	3	3	CD
cord-005453-4057qib7	5745	10	weeks	week	NNS
cord-005453-4057qib7	5745	11	after	after	IN
cord-005453-4057qib7	5745	12	administration	administration	NN
cord-005453-4057qib7	5745	13	of	of	IN
cord-005453-4057qib7	5745	14	the	the	DT
cord-005453-4057qib7	5745	15	antibody	antibody	NN
cord-005453-4057qib7	5745	16	to	to	TO
cord-005453-4057qib7	5745	17	avoid	avoid	VB
cord-005453-4057qib7	5745	18	serious	serious	JJ
cord-005453-4057qib7	5745	19	bleeding	bleeding	JJ
cord-005453-4057qib7	5745	20	complications	complication	NNS
cord-005453-4057qib7	5745	21	.	.	.
cord-005453-4057qib7	5746	1	2	2	LS
cord-005453-4057qib7	5746	2	.	.	.
cord-005453-4057qib7	5747	1	CRP	CRP	NNP
cord-005453-4057qib7	5747	2	concentrations	concentration	NNS
cord-005453-4057qib7	5747	3	remain	remain	VBP
cord-005453-4057qib7	5747	4	low	low	JJ
cord-005453-4057qib7	5747	5	despite	despite	IN
cord-005453-4057qib7	5747	6	the	the	DT
cord-005453-4057qib7	5747	7	presence	presence	NN
cord-005453-4057qib7	5747	8	of	of	IN
cord-005453-4057qib7	5747	9	active	active	JJ
cord-005453-4057qib7	5747	10	infections	infection	NNS
cord-005453-4057qib7	5747	11	following	follow	VBG
cord-005453-4057qib7	5747	12	infusion	infusion	NN
cord-005453-4057qib7	5747	13	of	of	IN
cord-005453-4057qib7	5747	14	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	5747	15	.	.	.
cord-005453-4057qib7	5748	1	CRP	CRP	NNP
cord-005453-4057qib7	5748	2	fails	fail	VBZ
cord-005453-4057qib7	5748	3	as	as	IN
cord-005453-4057qib7	5748	4	a	a	DT
cord-005453-4057qib7	5748	5	marker	marker	NN
cord-005453-4057qib7	5748	6	of	of	IN
cord-005453-4057qib7	5748	7	infection	infection	NN
cord-005453-4057qib7	5748	8	during	during	IN
cord-005453-4057qib7	5748	9	3	3	CD
cord-005453-4057qib7	5748	10	weeks	week	NNS
cord-005453-4057qib7	5748	11	following	follow	VBG
cord-005453-4057qib7	5748	12	the	the	DT
cord-005453-4057qib7	5748	13	therapy	therapy	NN
cord-005453-4057qib7	5748	14	.	.	.
cord-005453-4057qib7	5749	1	3	3	LS
cord-005453-4057qib7	5749	2	.	.	.
cord-005453-4057qib7	5750	1	Tocilizumab	Tocilizumab	NNP
cord-005453-4057qib7	5750	2	is	be	VBZ
cord-005453-4057qib7	5750	3	an	an	DT
cord-005453-4057qib7	5750	4	effective	effective	JJ
cord-005453-4057qib7	5750	5	therapy	therapy	NN
cord-005453-4057qib7	5750	6	in	in	IN
cord-005453-4057qib7	5750	7	patients	patient	NNS
cord-005453-4057qib7	5750	8	with	with	IN
cord-005453-4057qib7	5750	9	aGvHD	agvhd	NN
cord-005453-4057qib7	5750	10	,	,	,
cord-005453-4057qib7	5750	11	especially	especially	RB
cord-005453-4057qib7	5750	12	with	with	IN
cord-005453-4057qib7	5750	13	the	the	DT
cord-005453-4057qib7	5750	14	GI	GI	NNP
cord-005453-4057qib7	5750	15	involvement	involvement	NN
cord-005453-4057qib7	5750	16	.	.	.
cord-005453-4057qib7	5751	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5751	2	:	:	:
cord-005453-4057qib7	5751	3	Nothing	nothing	NN
cord-005453-4057qib7	5751	4	to	to	TO
cord-005453-4057qib7	5751	5	declare	declare	VB
cord-005453-4057qib7	5751	6	Vanishing	vanish	VBG
cord-005453-4057qib7	5751	7	bile	bile	NN
cord-005453-4057qib7	5751	8	ducts	duct	NNS
cord-005453-4057qib7	5751	9	after	after	IN
cord-005453-4057qib7	5751	10	allogenic	allogenic	JJ
cord-005453-4057qib7	5751	11	HSCT	HSCT	NNP
cord-005453-4057qib7	5751	12	:	:	:
cord-005453-4057qib7	5752	1	Is	be	VBZ
cord-005453-4057qib7	5752	2	it	-PRON-	PRP
cord-005453-4057qib7	5752	3	really	really	RB
cord-005453-4057qib7	5752	4	GVHD	gvhd	JJ
cord-005453-4057qib7	5752	5	?	?	.
cord-005453-4057qib7	5753	1	Antonio	Antonio	NNP
cord-005453-4057qib7	5753	2	Grasso	Grasso	NNP
cord-005453-4057qib7	5753	3	1	1	CD
cord-005453-4057qib7	5753	4	,	,	,
cord-005453-4057qib7	5753	5	Lorenzo	Lorenzo	NNP
cord-005453-4057qib7	5753	6	D'Antiga	D'Antiga	NNP
cord-005453-4057qib7	5753	7	2	2	CD
cord-005453-4057qib7	5753	8	,	,	,
cord-005453-4057qib7	5753	9	Aurelio	Aurelio	NNP
cord-005453-4057qib7	5753	10	Sonzogni	Sonzogni	NNP
cord-005453-4057qib7	5753	11	2	2	CD
cord-005453-4057qib7	5753	12	,	,	,
cord-005453-4057qib7	5753	13	Massimo	Massimo	NNP
cord-005453-4057qib7	5753	14	Gregori	Gregori	NNP
cord-005453-4057qib7	5753	15	3	3	CD
cord-005453-4057qib7	5753	16	,	,	,
cord-005453-4057qib7	5753	17	Alessandra	Alessandra	NNP
cord-005453-4057qib7	5753	18	Maestro	Maestro	NNP
cord-005453-4057qib7	5753	19	3	3	CD
cord-005453-4057qib7	5753	20	,	,	,
cord-005453-4057qib7	5753	21	Roberto	Roberto	NNP
cord-005453-4057qib7	5753	22	Simeone	Simeone	NNP
cord-005453-4057qib7	5753	23	3	3	CD
cord-005453-4057qib7	5753	24	,	,	,
cord-005453-4057qib7	5753	25	Natalia	Natalia	NNP
cord-005453-4057qib7	5753	26	Maximova	Maximova	NNP
cord-005453-4057qib7	5753	27	3	3	CD
cord-005453-4057qib7	5753	28	Background	Background	NNP
cord-005453-4057qib7	5753	29	:	:	:
cord-005453-4057qib7	5754	1	Evaluation	evaluation	NN
cord-005453-4057qib7	5754	2	of	of	IN
cord-005453-4057qib7	5754	3	liver	liver	NN
cord-005453-4057qib7	5754	4	GVHD	GVHD	NNP
cord-005453-4057qib7	5754	5	was	be	VBD
cord-005453-4057qib7	5754	6	historically	historically	RB
cord-005453-4057qib7	5754	7	based	base	VBN
cord-005453-4057qib7	5754	8	by	by	IN
cord-005453-4057qib7	5754	9	elevation	elevation	NN
cord-005453-4057qib7	5754	10	of	of	IN
cord-005453-4057qib7	5754	11	bilirubin	bilirubin	JJ
cord-005453-4057qib7	5754	12	levels	level	NNS
cord-005453-4057qib7	5754	13	and	and	CC
cord-005453-4057qib7	5754	14	by	by	IN
cord-005453-4057qib7	5754	15	reduction	reduction	NN
cord-005453-4057qib7	5754	16	and	and	CC
cord-005453-4057qib7	5754	17	degeneration	degeneration	NN
cord-005453-4057qib7	5754	18	of	of	IN
cord-005453-4057qib7	5754	19	small	small	JJ
cord-005453-4057qib7	5754	20	bile	bile	NN
cord-005453-4057qib7	5754	21	ducts	duct	NNS
cord-005453-4057qib7	5754	22	on	on	IN
cord-005453-4057qib7	5754	23	histological	histological	JJ
cord-005453-4057qib7	5754	24	samples	sample	NNS
cord-005453-4057qib7	5754	25	of	of	IN
cord-005453-4057qib7	5754	26	post	post	JJ
cord-005453-4057qib7	5754	27	-	-	JJ
cord-005453-4057qib7	5754	28	transplant	transplant	JJ
cord-005453-4057qib7	5754	29	liver	liver	NN
cord-005453-4057qib7	5754	30	biopsy	biopsy	NN
cord-005453-4057qib7	5754	31	.	.	.
cord-005453-4057qib7	5755	1	However	however	RB
cord-005453-4057qib7	5755	2	,	,	,
cord-005453-4057qib7	5755	3	there	there	EX
cord-005453-4057qib7	5755	4	is	be	VBZ
cord-005453-4057qib7	5755	5	a	a	DT
cord-005453-4057qib7	5755	6	lack	lack	NN
cord-005453-4057qib7	5755	7	of	of	IN
cord-005453-4057qib7	5755	8	studies	study	NNS
cord-005453-4057qib7	5755	9	that	that	WDT
cord-005453-4057qib7	5755	10	compared	compare	VBD
cord-005453-4057qib7	5755	11	histological	histological	JJ
cord-005453-4057qib7	5755	12	finding	finding	NN
cord-005453-4057qib7	5755	13	of	of	IN
cord-005453-4057qib7	5755	14	ductopenia	ductopenia	NN
cord-005453-4057qib7	5755	15	between	between	IN
cord-005453-4057qib7	5755	16	post	post	JJ
cord-005453-4057qib7	5755	17	-	-	JJ
cord-005453-4057qib7	5755	18	autologous	autologous	JJ
cord-005453-4057qib7	5755	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5755	20	and	and	CC
cord-005453-4057qib7	5755	21	post	post	JJ
cord-005453-4057qib7	5755	22	-	-	JJ
cord-005453-4057qib7	5755	23	allogenic	allogenic	JJ
cord-005453-4057qib7	5755	24	HSCT	HSCT	NNP
cord-005453-4057qib7	5755	25	.	.	.
cord-005453-4057qib7	5756	1	Studying	study	VBG
cord-005453-4057qib7	5756	2	severity	severity	NN
cord-005453-4057qib7	5756	3	of	of	IN
cord-005453-4057qib7	5756	4	ductopenia	ductopenia	NN
cord-005453-4057qib7	5756	5	following	follow	VBG
cord-005453-4057qib7	5756	6	allogenic	allogenic	JJ
cord-005453-4057qib7	5756	7	HSCT	HSCT	NNP
cord-005453-4057qib7	5756	8	,	,	,
cord-005453-4057qib7	5756	9	we	-PRON-	PRP
cord-005453-4057qib7	5756	10	aimed	aim	VBD
cord-005453-4057qib7	5756	11	to	to	TO
cord-005453-4057qib7	5756	12	demonstrate	demonstrate	VB
cord-005453-4057qib7	5756	13	lack	lack	NN
cord-005453-4057qib7	5756	14	of	of	IN
cord-005453-4057qib7	5756	15	correlation	correlation	NN
cord-005453-4057qib7	5756	16	between	between	IN
cord-005453-4057qib7	5756	17	ductopenia	ductopenia	NN
cord-005453-4057qib7	5756	18	and	and	CC
cord-005453-4057qib7	5756	19	clinical	clinical	JJ
cord-005453-4057qib7	5756	20	signs	sign	NNS
cord-005453-4057qib7	5756	21	of	of	IN
cord-005453-4057qib7	5756	22	liver	liver	NN
cord-005453-4057qib7	5756	23	GVHD	GVHD	NNP
cord-005453-4057qib7	5756	24	.	.	.
cord-005453-4057qib7	5757	1	Methods	method	NNS
cord-005453-4057qib7	5757	2	:	:	:
cord-005453-4057qib7	5757	3	We	-PRON-	PRP
cord-005453-4057qib7	5757	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	5757	5	collected	collect	VBD
cord-005453-4057qib7	5757	6	a	a	DT
cord-005453-4057qib7	5757	7	series	series	NN
cord-005453-4057qib7	5757	8	of	of	IN
cord-005453-4057qib7	5757	9	72	72	CD
cord-005453-4057qib7	5757	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	5757	11	HSCT	HSCT	NNP
cord-005453-4057qib7	5757	12	performed	perform	VBN
cord-005453-4057qib7	5757	13	from	from	IN
cord-005453-4057qib7	5757	14	2005	2005	CD
cord-005453-4057qib7	5757	15	to	to	IN
cord-005453-4057qib7	5757	16	2017	2017	CD
cord-005453-4057qib7	5757	17	in	in	IN
cord-005453-4057qib7	5757	18	the	the	DT
cord-005453-4057qib7	5757	19	Institute	Institute	NNP
cord-005453-4057qib7	5757	20	Burlo	Burlo	NNP
cord-005453-4057qib7	5757	21	Garofolo	Garofolo	NNP
cord-005453-4057qib7	5757	22	.	.	.
cord-005453-4057qib7	5758	1	All	all	DT
cord-005453-4057qib7	5758	2	patients	patient	NNS
cord-005453-4057qib7	5758	3	undergo	undergo	VBP
cord-005453-4057qib7	5758	4	percutaneous	percutaneous	JJ
cord-005453-4057qib7	5758	5	liver	liver	NN
cord-005453-4057qib7	5758	6	biopsy	biopsy	NN
cord-005453-4057qib7	5758	7	in	in	IN
cord-005453-4057qib7	5758	8	most	most	JJS
cord-005453-4057qib7	5758	9	cases	case	NNS
cord-005453-4057qib7	5758	10	at	at	IN
cord-005453-4057qib7	5758	11	three	three	CD
cord-005453-4057qib7	5758	12	months	month	NNS
cord-005453-4057qib7	5758	13	,	,	,
cord-005453-4057qib7	5758	14	one	one	CD
cord-005453-4057qib7	5758	15	year	year	NN
cord-005453-4057qib7	5758	16	and	and	CC
cord-005453-4057qib7	5758	17	three	three	CD
cord-005453-4057qib7	5758	18	or	or	CC
cord-005453-4057qib7	5758	19	more	more	JJR
cord-005453-4057qib7	5758	20	years	year	NNS
cord-005453-4057qib7	5758	21	after	after	IN
cord-005453-4057qib7	5758	22	HSCT	HSCT	NNP
cord-005453-4057qib7	5758	23	.	.	.
cord-005453-4057qib7	5759	1	Indications	indication	NNS
cord-005453-4057qib7	5759	2	for	for	IN
cord-005453-4057qib7	5759	3	biopsy	biopsy	NN
cord-005453-4057qib7	5759	4	were	be	VBD
cord-005453-4057qib7	5759	5	alteration	alteration	NN
cord-005453-4057qib7	5759	6	noted	note	VBN
cord-005453-4057qib7	5759	7	at	at	IN
cord-005453-4057qib7	5759	8	2	2	CD
cord-005453-4057qib7	5759	9	weekly	weekly	JJ
cord-005453-4057qib7	5759	10	follow	follow	NN
cord-005453-4057qib7	5759	11	-	-	HYPH
cord-005453-4057qib7	5759	12	up	up	RP
cord-005453-4057qib7	5759	13	assessments	assessment	NNS
cord-005453-4057qib7	5759	14	of	of	IN
cord-005453-4057qib7	5759	15	at	at	RB
cord-005453-4057qib7	5759	16	least	least	RBS
cord-005453-4057qib7	5759	17	one	one	CD
cord-005453-4057qib7	5759	18	clinical	clinical	JJ
cord-005453-4057qib7	5759	19	or	or	CC
cord-005453-4057qib7	5759	20	laboratory	laboratory	NN
cord-005453-4057qib7	5759	21	marker	marker	NN
cord-005453-4057qib7	5759	22	of	of	IN
cord-005453-4057qib7	5759	23	liver	liver	NN
cord-005453-4057qib7	5759	24	impairment	impairment	NN
cord-005453-4057qib7	5759	25	or	or	CC
cord-005453-4057qib7	5759	26	cholestasis	cholestasis	NN
cord-005453-4057qib7	5759	27	.	.	.
cord-005453-4057qib7	5760	1	Ductopenia	Ductopenia	NNP
cord-005453-4057qib7	5760	2	was	be	VBD
cord-005453-4057qib7	5760	3	defined	define	VBN
cord-005453-4057qib7	5760	4	by	by	IN
cord-005453-4057qib7	5760	5	number	number	NN
cord-005453-4057qib7	5760	6	of	of	IN
cord-005453-4057qib7	5760	7	portal	portal	JJ
cord-005453-4057qib7	5760	8	tracts	tract	NNS
cord-005453-4057qib7	5760	9	with	with	IN
cord-005453-4057qib7	5760	10	no	no	DT
cord-005453-4057qib7	5760	11	interlobular	interlobular	JJ
cord-005453-4057qib7	5760	12	bile	bile	NN
cord-005453-4057qib7	5760	13	duct	duct	NN
cord-005453-4057qib7	5760	14	divided	divide	VBN
cord-005453-4057qib7	5760	15	by	by	IN
cord-005453-4057qib7	5760	16	the	the	DT
cord-005453-4057qib7	5760	17	total	total	JJ
cord-005453-4057qib7	5760	18	number	number	NN
cord-005453-4057qib7	5760	19	(	(	-LRB-
cord-005453-4057qib7	5760	20	severe	severe	JJ
cord-005453-4057qib7	5760	21	if	if	IN
cord-005453-4057qib7	5760	22	the	the	DT
cord-005453-4057qib7	5760	23	ratio	ratio	NN
cord-005453-4057qib7	5760	24	was	be	VBD
cord-005453-4057qib7	5760	25	less	less	JJR
cord-005453-4057qib7	5760	26	than	than	IN
cord-005453-4057qib7	5760	27	0.2	0.2	CD
cord-005453-4057qib7	5760	28	)	)	-RRB-
cord-005453-4057qib7	5760	29	.	.	.
cord-005453-4057qib7	5761	1	Clinical	clinical	JJ
cord-005453-4057qib7	5761	2	GVHD	GVHD	NNP
cord-005453-4057qib7	5761	3	was	be	VBD
cord-005453-4057qib7	5761	4	defined	define	VBN
cord-005453-4057qib7	5761	5	by	by	IN
cord-005453-4057qib7	5761	6	NIH	NIH	NNP
cord-005453-4057qib7	5761	7	consensus	consensus	NN
cord-005453-4057qib7	5761	8	criteria	criterion	NNS
cord-005453-4057qib7	5761	9	Results	result	NNS
cord-005453-4057qib7	5761	10	:	:	:
cord-005453-4057qib7	5762	1	Our	-PRON-	PRP$
cord-005453-4057qib7	5762	2	population	population	NN
cord-005453-4057qib7	5762	3	involved	involve	VBD
cord-005453-4057qib7	5762	4	64	64	CD
cord-005453-4057qib7	5762	5	%	%	NN
cord-005453-4057qib7	5762	6	males	male	NNS
cord-005453-4057qib7	5762	7	and	and	CC
cord-005453-4057qib7	5762	8	36	36	CD
cord-005453-4057qib7	5762	9	%	%	NN
cord-005453-4057qib7	5762	10	females	female	NNS
cord-005453-4057qib7	5762	11	with	with	IN
cord-005453-4057qib7	5762	12	oncological	oncological	JJ
cord-005453-4057qib7	5762	13	(	(	-LRB-
cord-005453-4057qib7	5762	14	70	70	CD
cord-005453-4057qib7	5762	15	%	%	NN
cord-005453-4057qib7	5762	16	)	)	-RRB-
cord-005453-4057qib7	5762	17	and	and	CC
cord-005453-4057qib7	5762	18	non	non	JJ
cord-005453-4057qib7	5762	19	-	-	JJ
cord-005453-4057qib7	5762	20	oncological	oncological	JJ
cord-005453-4057qib7	5762	21	underlying	underlie	VBG
cord-005453-4057qib7	5762	22	disease	disease	NN
cord-005453-4057qib7	5762	23	(	(	-LRB-
cord-005453-4057qib7	5762	24	30	30	CD
cord-005453-4057qib7	5762	25	%	%	NN
cord-005453-4057qib7	5762	26	)	)	-RRB-
cord-005453-4057qib7	5762	27	.	.	.
cord-005453-4057qib7	5763	1	Clinical	clinical	JJ
cord-005453-4057qib7	5763	2	signs	sign	NNS
cord-005453-4057qib7	5763	3	of	of	IN
cord-005453-4057qib7	5763	4	liver	liver	NN
cord-005453-4057qib7	5763	5	GVHD	GVHD	NNP
cord-005453-4057qib7	5763	6	were	be	VBD
cord-005453-4057qib7	5763	7	present	present	JJ
cord-005453-4057qib7	5763	8	in	in	IN
cord-005453-4057qib7	5763	9	18	18	CD
cord-005453-4057qib7	5763	10	%	%	NN
cord-005453-4057qib7	5763	11	of	of	IN
cord-005453-4057qib7	5763	12	the	the	DT
cord-005453-4057qib7	5763	13	patients	patient	NNS
cord-005453-4057qib7	5763	14	(	(	-LRB-
cord-005453-4057qib7	5763	15	n=13	n=13	NNP
cord-005453-4057qib7	5763	16	)	)	-RRB-
cord-005453-4057qib7	5763	17	,	,	,
cord-005453-4057qib7	5763	18	8	8	CD
cord-005453-4057qib7	5763	19	%	%	NN
cord-005453-4057qib7	5763	20	with	with	IN
cord-005453-4057qib7	5763	21	contextual	contextual	JJ
cord-005453-4057qib7	5763	22	intestinal	intestinal	JJ
cord-005453-4057qib7	5763	23	involvement	involvement	NN
cord-005453-4057qib7	5763	24	,	,	,
cord-005453-4057qib7	5763	25	8	8	CD
cord-005453-4057qib7	5763	26	%	%	NN
cord-005453-4057qib7	5763	27	with	with	IN
cord-005453-4057qib7	5763	28	cutaneous	cutaneous	JJ
cord-005453-4057qib7	5763	29	and	and	CC
cord-005453-4057qib7	5763	30	intestinal	intestinal	JJ
cord-005453-4057qib7	5763	31	involvement	involvement	NN
cord-005453-4057qib7	5763	32	.	.	.
cord-005453-4057qib7	5764	1	71	71	CD
cord-005453-4057qib7	5764	2	patients	patient	NNS
cord-005453-4057qib7	5764	3	underwent	undergo	VBD
cord-005453-4057qib7	5764	4	biopsy	biopsy	JJ
cord-005453-4057qib7	5764	5	at	at	IN
cord-005453-4057qib7	5764	6	a	a	DT
cord-005453-4057qib7	5764	7	mean	mean	JJ
cord-005453-4057qib7	5764	8	time	time	NN
cord-005453-4057qib7	5764	9	of	of	IN
cord-005453-4057qib7	5764	10	110	110	CD
cord-005453-4057qib7	5765	1	+	+	CC
cord-005453-4057qib7	5765	2	/-32	/-32	CD
cord-005453-4057qib7	5765	3	days	day	NNS
cord-005453-4057qib7	5765	4	after	after	IN
cord-005453-4057qib7	5765	5	HSCT	HSCT	NNP
cord-005453-4057qib7	5765	6	,	,	,
cord-005453-4057qib7	5765	7	45	45	CD
cord-005453-4057qib7	5765	8	patients	patient	NNS
cord-005453-4057qib7	5765	9	underwent	undergo	VBD
cord-005453-4057qib7	5765	10	a	a	DT
cord-005453-4057qib7	5765	11	biopsy	biopsy	NN
cord-005453-4057qib7	5765	12	at	at	IN
cord-005453-4057qib7	5765	13	12	12	CD
cord-005453-4057qib7	5765	14	months	month	NNS
cord-005453-4057qib7	5765	15	after	after	IN
cord-005453-4057qib7	5765	16	HSCT	HSCT	NNP
cord-005453-4057qib7	5765	17	and	and	CC
cord-005453-4057qib7	5765	18	35	35	CD
cord-005453-4057qib7	5765	19	patients	patient	NNS
cord-005453-4057qib7	5765	20	after	after	IN
cord-005453-4057qib7	5765	21	three	three	CD
cord-005453-4057qib7	5765	22	or	or	CC
cord-005453-4057qib7	5765	23	more	more	JJR
cord-005453-4057qib7	5765	24	years	year	NNS
cord-005453-4057qib7	5765	25	from	from	IN
cord-005453-4057qib7	5765	26	HSCT	HSCT	NNP
cord-005453-4057qib7	5765	27	.	.	.
cord-005453-4057qib7	5766	1	Results	result	NNS
cord-005453-4057qib7	5766	2	of	of	IN
cord-005453-4057qib7	5766	3	biopsies	biopsy	NNS
cord-005453-4057qib7	5766	4	are	be	VBP
cord-005453-4057qib7	5766	5	showed	show	VBN
cord-005453-4057qib7	5766	6	in	in	IN
cord-005453-4057qib7	5766	7	table	table	NN
cord-005453-4057qib7	5766	8	1	1	CD
cord-005453-4057qib7	5766	9	.	.	.
cord-005453-4057qib7	5767	1	No	no	DT
cord-005453-4057qib7	5767	2	difference	difference	NN
cord-005453-4057qib7	5767	3	in	in	IN
cord-005453-4057qib7	5767	4	incidence	incidence	NN
cord-005453-4057qib7	5767	5	of	of	IN
cord-005453-4057qib7	5767	6	ductopenia	ductopenia	NNP
cord-005453-4057qib7	5767	7	were	be	VBD
cord-005453-4057qib7	5767	8	found	find	VBN
cord-005453-4057qib7	5767	9	between	between	IN
cord-005453-4057qib7	5767	10	liver	liver	NN
cord-005453-4057qib7	5767	11	GVHD	GVHD	NNP
cord-005453-4057qib7	5767	12	group	group	NN
cord-005453-4057qib7	5767	13	and	and	CC
cord-005453-4057qib7	5767	14	no	no	DT
cord-005453-4057qib7	5767	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5767	16	.	.	.
cord-005453-4057qib7	5768	1	Table	table	NN
cord-005453-4057qib7	5768	2	]	]	-RRB-
cord-005453-4057qib7	5768	3	1	1	CD
cord-005453-4057qib7	5768	4	.	.	.
cord-005453-4057qib7	5769	1	Table	table	NN
cord-005453-4057qib7	5769	2	1	1	CD
cord-005453-4057qib7	5769	3	:	:	:
cord-005453-4057qib7	5769	4	Incidence	incidence	NN
cord-005453-4057qib7	5769	5	of	of	IN
cord-005453-4057qib7	5769	6	ductopenia	ductopenia	NNP
cord-005453-4057qib7	5769	7	3	3	CD
cord-005453-4057qib7	5769	8	-	-	SYM
cord-005453-4057qib7	5769	9	6	6	CD
cord-005453-4057qib7	5769	10	months	month	NNS
cord-005453-4057qib7	5769	11	,	,	,
cord-005453-4057qib7	5769	12	12	12	CD
cord-005453-4057qib7	5769	13	months	month	NNS
cord-005453-4057qib7	5769	14	and	and	CC
cord-005453-4057qib7	5769	15	3	3	CD
cord-005453-4057qib7	5769	16	or	or	CC
cord-005453-4057qib7	5769	17	more	more	JJR
cord-005453-4057qib7	5769	18	years	year	NNS
cord-005453-4057qib7	5769	19	after	after	IN
cord-005453-4057qib7	5769	20	HSCT	HSCT	NNP
cord-005453-4057qib7	5769	21	in	in	IN
cord-005453-4057qib7	5769	22	total	total	JJ
cord-005453-4057qib7	5769	23	population	population	NN
cord-005453-4057qib7	5769	24	,	,	,
cord-005453-4057qib7	5769	25	GVHD	GVHD	NNP
cord-005453-4057qib7	5769	26	group	group	NN
cord-005453-4057qib7	5769	27	and	and	CC
cord-005453-4057qib7	5769	28	no	no	DT
cord-005453-4057qib7	5769	29	-	-	HYPH
cord-005453-4057qib7	5769	30	GVHD	GVHD	NNP
cord-005453-4057qib7	5769	31	group	group	NN
cord-005453-4057qib7	5769	32	]	]	-RRB-
cord-005453-4057qib7	5770	1	The	the	DT
cord-005453-4057qib7	5770	2	group	group	NN
cord-005453-4057qib7	5770	3	that	that	WDT
cord-005453-4057qib7	5770	4	not	not	RB
cord-005453-4057qib7	5770	5	received	receive	VBD
cord-005453-4057qib7	5770	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	5770	7	prior	prior	IN
cord-005453-4057qib7	5770	8	the	the	DT
cord-005453-4057qib7	5770	9	HSCT	HSCT	NNP
cord-005453-4057qib7	5770	10	had	have	VBD
cord-005453-4057qib7	5770	11	an	an	DT
cord-005453-4057qib7	5770	12	overall	overall	JJ
cord-005453-4057qib7	5770	13	incidence	incidence	NN
cord-005453-4057qib7	5770	14	of	of	IN
cord-005453-4057qib7	5770	15	ductopenia	ductopenia	NN
cord-005453-4057qib7	5770	16	of	of	IN
cord-005453-4057qib7	5770	17	77	77	CD
cord-005453-4057qib7	5770	18	%	%	NN
cord-005453-4057qib7	5770	19	(	(	-LRB-
cord-005453-4057qib7	5770	20	severe	severe	JJ
cord-005453-4057qib7	5770	21	ductopenia	ductopenia	NN
cord-005453-4057qib7	5770	22	of	of	IN
cord-005453-4057qib7	5770	23	42	42	CD
cord-005453-4057qib7	5770	24	%	%	NN
cord-005453-4057qib7	5770	25	)	)	-RRB-
cord-005453-4057qib7	5770	26	statistically	statistically	RB
cord-005453-4057qib7	5770	27	significative	significative	JJ
cord-005453-4057qib7	5770	28	in	in	IN
cord-005453-4057qib7	5770	29	comparison	comparison	NN
cord-005453-4057qib7	5770	30	with	with	IN
cord-005453-4057qib7	5770	31	the	the	DT
cord-005453-4057qib7	5770	32	oncological	oncological	JJ
cord-005453-4057qib7	5770	33	underlying	underlie	VBG
cord-005453-4057qib7	5770	34	disease	disease	NN
cord-005453-4057qib7	5770	35	group	group	NN
cord-005453-4057qib7	5770	36	(	(	-LRB-
cord-005453-4057qib7	5770	37	94	94	CD
cord-005453-4057qib7	5770	38	%	%	NN
cord-005453-4057qib7	5770	39	of	of	IN
cord-005453-4057qib7	5770	40	ductopenia	ductopenia	NN
cord-005453-4057qib7	5770	41	and	and	CC
cord-005453-4057qib7	5770	42	64	64	CD
cord-005453-4057qib7	5770	43	%	%	NN
cord-005453-4057qib7	5770	44	of	of	IN
cord-005453-4057qib7	5770	45	severe	severe	JJ
cord-005453-4057qib7	5770	46	ductopenia	ductopenia	NN
cord-005453-4057qib7	5770	47	)	)	-RRB-
cord-005453-4057qib7	5770	48	.	.	.
cord-005453-4057qib7	5771	1	Furthermore	furthermore	RB
cord-005453-4057qib7	5771	2	,	,	,
cord-005453-4057qib7	5771	3	a	a	DT
cord-005453-4057qib7	5771	4	little	little	JJ
cord-005453-4057qib7	5771	5	sub	sub	NN
cord-005453-4057qib7	5771	6	-	-	JJ
cord-005453-4057qib7	5771	7	group	group	NN
cord-005453-4057qib7	5771	8	of	of	IN
cord-005453-4057qib7	5771	9	16	16	CD
cord-005453-4057qib7	5771	10	patients	patient	NNS
cord-005453-4057qib7	5771	11	extrapolated	extrapolate	VBN
cord-005453-4057qib7	5771	12	from	from	IN
cord-005453-4057qib7	5771	13	our	-PRON-	PRP$
cord-005453-4057qib7	5771	14	population	population	NN
cord-005453-4057qib7	5771	15	received	receive	VBD
cord-005453-4057qib7	5771	16	liver	liver	NN
cord-005453-4057qib7	5771	17	biopsy	biopsy	NN
cord-005453-4057qib7	5771	18	before	before	IN
cord-005453-4057qib7	5771	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5771	20	for	for	IN
cord-005453-4057qib7	5771	21	diagnostic	diagnostic	JJ
cord-005453-4057qib7	5771	22	assessments	assessment	NNS
cord-005453-4057qib7	5771	23	:	:	:
cord-005453-4057qib7	5771	24	of	of	IN
cord-005453-4057qib7	5771	25	the	the	DT
cord-005453-4057qib7	5771	26	10	10	CD
cord-005453-4057qib7	5771	27	with	with	IN
cord-005453-4057qib7	5771	28	an	an	DT
cord-005453-4057qib7	5771	29	oncological	oncological	JJ
cord-005453-4057qib7	5771	30	underlying	underlie	VBG
cord-005453-4057qib7	5771	31	disease	disease	NN
cord-005453-4057qib7	5771	32	70	70	CD
cord-005453-4057qib7	5771	33	%	%	NN
cord-005453-4057qib7	5771	34	already	already	RB
cord-005453-4057qib7	5771	35	showed	show	VBD
cord-005453-4057qib7	5771	36	ductopenia	ductopenia	NNP
cord-005453-4057qib7	5771	37	,	,	,
cord-005453-4057qib7	5771	38	while	while	IN
cord-005453-4057qib7	5771	39	no	no	DT
cord-005453-4057qib7	5771	40	signs	sign	NNS
cord-005453-4057qib7	5771	41	of	of	IN
cord-005453-4057qib7	5771	42	ductopenia	ductopenia	NNP
cord-005453-4057qib7	5771	43	were	be	VBD
cord-005453-4057qib7	5771	44	found	find	VBN
cord-005453-4057qib7	5771	45	in	in	IN
cord-005453-4057qib7	5771	46	the	the	DT
cord-005453-4057qib7	5771	47	others	other	NNS
cord-005453-4057qib7	5771	48	with	with	IN
cord-005453-4057qib7	5771	49	a	a	DT
cord-005453-4057qib7	5771	50	nononcological	nononcological	JJ
cord-005453-4057qib7	5771	51	disease	disease	NN
cord-005453-4057qib7	5771	52	.	.	.
cord-005453-4057qib7	5772	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5772	2	:	:	:
cord-005453-4057qib7	5773	1	There	there	EX
cord-005453-4057qib7	5773	2	is	be	VBZ
cord-005453-4057qib7	5773	3	no	no	DT
cord-005453-4057qib7	5773	4	correlation	correlation	NN
cord-005453-4057qib7	5773	5	between	between	IN
cord-005453-4057qib7	5773	6	incidence	incidence	NN
cord-005453-4057qib7	5773	7	of	of	IN
cord-005453-4057qib7	5773	8	GVHD	GVHD	NNP
cord-005453-4057qib7	5773	9	and	and	CC
cord-005453-4057qib7	5773	10	histologically	histologically	RB
cord-005453-4057qib7	5773	11	finding	find	VBG
cord-005453-4057qib7	5773	12	of	of	IN
cord-005453-4057qib7	5773	13	ductopenia	ductopenia	NNP
cord-005453-4057qib7	5773	14	on	on	IN
cord-005453-4057qib7	5773	15	liver	liver	NN
cord-005453-4057qib7	5773	16	biopsy	biopsy	NN
cord-005453-4057qib7	5773	17	.	.	.
cord-005453-4057qib7	5774	1	Ductopenia	Ductopenia	NNP
cord-005453-4057qib7	5774	2	may	may	MD
cord-005453-4057qib7	5774	3	be	be	VB
cord-005453-4057qib7	5774	4	caused	cause	VBN
cord-005453-4057qib7	5774	5	in	in	IN
cord-005453-4057qib7	5774	6	the	the	DT
cord-005453-4057qib7	5774	7	first	first	JJ
cord-005453-4057qib7	5774	8	place	place	NN
cord-005453-4057qib7	5774	9	by	by	IN
cord-005453-4057qib7	5774	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	5774	11	treatment	treatment	NN
cord-005453-4057qib7	5774	12	received	receive	VBN
cord-005453-4057qib7	5774	13	before	before	IN
cord-005453-4057qib7	5774	14	HSCT	HSCT	NNP
cord-005453-4057qib7	5774	15	and	and	CC
cord-005453-4057qib7	5774	16	myeloablative	myeloablative	JJ
cord-005453-4057qib7	5774	17	conditioning	conditioning	NN
cord-005453-4057qib7	5774	18	for	for	IN
cord-005453-4057qib7	5774	19	HSCT	HSCT	NNP
cord-005453-4057qib7	5775	1	and	and	CC
cord-005453-4057qib7	5775	2	it	-PRON-	PRP
cord-005453-4057qib7	5775	3	's	be	VBZ
cord-005453-4057qib7	5775	4	not	not	RB
cord-005453-4057qib7	5775	5	related	relate	VBN
cord-005453-4057qib7	5775	6	with	with	IN
cord-005453-4057qib7	5775	7	GVHD	GVHD	NNP
cord-005453-4057qib7	5775	8	.	.	.
cord-005453-4057qib7	5776	1	This	this	DT
cord-005453-4057qib7	5776	2	hypothesis	hypothesis	NN
cord-005453-4057qib7	5776	3	is	be	VBZ
cord-005453-4057qib7	5776	4	strengthened	strengthen	VBN
cord-005453-4057qib7	5776	5	by	by	IN
cord-005453-4057qib7	5776	6	the	the	DT
cord-005453-4057qib7	5776	7	subgroup	subgroup	NN
cord-005453-4057qib7	5776	8	analysis	analysis	NN
cord-005453-4057qib7	5776	9	of	of	IN
cord-005453-4057qib7	5776	10	pre	pre	JJ
cord-005453-4057qib7	5776	11	-	-	JJ
cord-005453-4057qib7	5776	12	HSCT	hsct	JJ
cord-005453-4057qib7	5776	13	biopsy	biopsy	NN
cord-005453-4057qib7	5776	14	.	.	.
cord-005453-4057qib7	5777	1	Background	background	NN
cord-005453-4057qib7	5777	2	:	:	:
cord-005453-4057qib7	5778	1	Second	second	JJ
cord-005453-4057qib7	5778	2	and	and	CC
cord-005453-4057qib7	5778	3	third	third	JJ
cord-005453-4057qib7	5778	4	line	line	NN
cord-005453-4057qib7	5778	5	therapies	therapy	NNS
cord-005453-4057qib7	5778	6	for	for	IN
cord-005453-4057qib7	5778	7	steroid	steroid	NN
cord-005453-4057qib7	5778	8	refractory	refractory	JJ
cord-005453-4057qib7	5778	9	acute	acute	JJ
cord-005453-4057qib7	5778	10	Graft	graft	NN
cord-005453-4057qib7	5778	11	versus	versus	IN
cord-005453-4057qib7	5778	12	Host	Host	NNP
cord-005453-4057qib7	5778	13	disease	disease	NN
cord-005453-4057qib7	5778	14	(	(	-LRB-
cord-005453-4057qib7	5778	15	aGvHD	agvhd	NN
cord-005453-4057qib7	5778	16	)	)	-RRB-
cord-005453-4057qib7	5778	17	after	after	IN
cord-005453-4057qib7	5778	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	5778	19	stem	stem	NN
cord-005453-4057qib7	5778	20	cell	cell	NN
cord-005453-4057qib7	5778	21	transplantation	transplantation	NN
cord-005453-4057qib7	5778	22	(	(	-LRB-
cord-005453-4057qib7	5778	23	ASCT	ASCT	NNP
cord-005453-4057qib7	5778	24	)	)	-RRB-
cord-005453-4057qib7	5778	25	are	be	VBP
cord-005453-4057qib7	5778	26	still	still	RB
cord-005453-4057qib7	5778	27	lacking	lack	VBG
cord-005453-4057qib7	5778	28	.	.	.
cord-005453-4057qib7	5779	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5779	2	,	,	,
cord-005453-4057qib7	5779	3	a	a	DT
cord-005453-4057qib7	5779	4	selective	selective	JJ
cord-005453-4057qib7	5779	5	Januskinase	Januskinase	NNP
cord-005453-4057qib7	5779	6	1/2	1/2	CD
cord-005453-4057qib7	5779	7	inhibitor	inhibitor	NN
cord-005453-4057qib7	5779	8	could	could	MD
cord-005453-4057qib7	5779	9	show	show	VB
cord-005453-4057qib7	5779	10	high	high	JJ
cord-005453-4057qib7	5779	11	efficacy	efficacy	NN
cord-005453-4057qib7	5779	12	in	in	IN
cord-005453-4057qib7	5779	13	aGvHD	agvhd	NN
cord-005453-4057qib7	5779	14	,	,	,
cord-005453-4057qib7	5779	15	as	as	RB
cord-005453-4057qib7	5779	16	well	well	RB
cord-005453-4057qib7	5779	17	as	as	IN
cord-005453-4057qib7	5779	18	Extracorporeal	Extracorporeal	NNP
cord-005453-4057qib7	5779	19	Photopheresis	Photopheresis	NNP
cord-005453-4057qib7	5779	20	(	(	-LRB-
cord-005453-4057qib7	5779	21	ECP	ECP	NNP
cord-005453-4057qib7	5779	22	)	)	-RRB-
cord-005453-4057qib7	5779	23	.	.	.
cord-005453-4057qib7	5780	1	Here	here	RB
cord-005453-4057qib7	5780	2	we	-PRON-	PRP
cord-005453-4057qib7	5780	3	report	report	VBP
cord-005453-4057qib7	5780	4	a	a	DT
cord-005453-4057qib7	5780	5	single	single	JJ
cord-005453-4057qib7	5780	6	center	center	NN
cord-005453-4057qib7	5780	7	experience	experience	NN
cord-005453-4057qib7	5780	8	of	of	IN
cord-005453-4057qib7	5780	9	combining	combine	VBG
cord-005453-4057qib7	5780	10	both	both	DT
cord-005453-4057qib7	5780	11	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5780	12	approaches	approach	NNS
cord-005453-4057qib7	5780	13	in	in	IN
cord-005453-4057qib7	5780	14	severe	severe	JJ
cord-005453-4057qib7	5780	15	steroid	steroid	NN
cord-005453-4057qib7	5780	16	refractory	refractory	JJ
cord-005453-4057qib7	5780	17	aGvHD	agvhd	NN
cord-005453-4057qib7	5780	18	with	with	IN
cord-005453-4057qib7	5780	19	additional	additional	JJ
cord-005453-4057qib7	5780	20	analysis	analysis	NN
cord-005453-4057qib7	5780	21	of	of	IN
cord-005453-4057qib7	5780	22	immune	immune	JJ
cord-005453-4057qib7	5780	23	status	status	NN
cord-005453-4057qib7	5780	24	of	of	IN
cord-005453-4057qib7	5780	25	these	these	DT
cord-005453-4057qib7	5780	26	patients	patient	NNS
cord-005453-4057qib7	5780	27	to	to	TO
cord-005453-4057qib7	5780	28	elucidate	elucidate	VB
cord-005453-4057qib7	5780	29	direct	direct	JJ
cord-005453-4057qib7	5780	30	effects	effect	NNS
cord-005453-4057qib7	5780	31	of	of	IN
cord-005453-4057qib7	5780	32	this	this	DT
cord-005453-4057qib7	5780	33	treatment	treatment	NN
cord-005453-4057qib7	5780	34	on	on	IN
cord-005453-4057qib7	5780	35	immune	immune	JJ
cord-005453-4057qib7	5780	36	response	response	NN
cord-005453-4057qib7	5780	37	.	.	.
cord-005453-4057qib7	5781	1	Methods	method	NNS
cord-005453-4057qib7	5781	2	:	:	:
cord-005453-4057qib7	5781	3	From	from	IN
cord-005453-4057qib7	5781	4	June	June	NNP
cord-005453-4057qib7	5781	5	2015	2015	CD
cord-005453-4057qib7	5781	6	to	to	IN
cord-005453-4057qib7	5781	7	February	February	NNP
cord-005453-4057qib7	5781	8	2017	2017	CD
cord-005453-4057qib7	5781	9	,	,	,
cord-005453-4057qib7	5781	10	18	18	CD
cord-005453-4057qib7	5781	11	patients	patient	NNS
cord-005453-4057qib7	5781	12	(	(	-LRB-
cord-005453-4057qib7	5781	13	77.8	77.8	CD
cord-005453-4057qib7	5781	14	%	%	NN
cord-005453-4057qib7	5781	15	male	male	NN
cord-005453-4057qib7	5781	16	,	,	,
cord-005453-4057qib7	5781	17	22.2	22.2	CD
cord-005453-4057qib7	5781	18	%	%	NN
cord-005453-4057qib7	5781	19	female	female	JJ
cord-005453-4057qib7	5781	20	,	,	,
cord-005453-4057qib7	5781	21	median	median	JJ
cord-005453-4057qib7	5781	22	age	age	NN
cord-005453-4057qib7	5781	23	:	:	:
cord-005453-4057qib7	5781	24	58.5	58.5	CD
cord-005453-4057qib7	5781	25	years	year	NNS
cord-005453-4057qib7	5781	26	,	,	,
cord-005453-4057qib7	5781	27	r	r	NN
cord-005453-4057qib7	5781	28	:	:	:
cord-005453-4057qib7	5781	29	21	21	CD
cord-005453-4057qib7	5781	30	-	-	SYM
cord-005453-4057qib7	5781	31	73	73	CD
cord-005453-4057qib7	5781	32	)	)	-RRB-
cord-005453-4057qib7	5781	33	with	with	IN
cord-005453-4057qib7	5781	34	steroid	steroid	NN
cord-005453-4057qib7	5781	35	refractory	refractory	JJ
cord-005453-4057qib7	5781	36	aGvHD	agvhd	NN
cord-005453-4057qib7	5781	37	of	of	IN
cord-005453-4057qib7	5781	38	lower	low	JJR
cord-005453-4057qib7	5781	39	GI	gi	NN
cord-005453-4057qib7	5781	40	-	-	HYPH
cord-005453-4057qib7	5781	41	tract	tract	NN
cord-005453-4057qib7	5781	42	after	after	IN
cord-005453-4057qib7	5781	43	ASCT	ASCT	NNP
cord-005453-4057qib7	5781	44	were	be	VBD
cord-005453-4057qib7	5781	45	treated	treat	VBN
cord-005453-4057qib7	5781	46	with	with	IN
cord-005453-4057qib7	5781	47	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5781	48	and	and	CC
cord-005453-4057qib7	5781	49	Extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5781	50	photopheresis	photopheresis	NN
cord-005453-4057qib7	5781	51	as	as	IN
cord-005453-4057qib7	5781	52	third	third	JJ
cord-005453-4057qib7	5781	53	,	,	,
cord-005453-4057qib7	5781	54	fourth	fourth	JJ
cord-005453-4057qib7	5781	55	or	or	CC
cord-005453-4057qib7	5781	56	fifth	fifth	JJ
cord-005453-4057qib7	5781	57	line	line	NN
cord-005453-4057qib7	5781	58	therapy	therapy	NN
cord-005453-4057qib7	5781	59	.	.	.
cord-005453-4057qib7	5782	1	Some	some	DT
cord-005453-4057qib7	5782	2	patients	patient	NNS
cord-005453-4057qib7	5782	3	showed	show	VBD
cord-005453-4057qib7	5782	4	additional	additional	JJ
cord-005453-4057qib7	5782	5	aGvHD	agvhd	NN
cord-005453-4057qib7	5782	6	of	of	IN
cord-005453-4057qib7	5782	7	skin	skin	NN
cord-005453-4057qib7	5782	8	(	(	-LRB-
cord-005453-4057qib7	5782	9	n=7	n=7	NNS
cord-005453-4057qib7	5782	10	)	)	-RRB-
cord-005453-4057qib7	5782	11	,	,	,
cord-005453-4057qib7	5782	12	liver	liver	NN
cord-005453-4057qib7	5782	13	(	(	-LRB-
cord-005453-4057qib7	5782	14	n=6	n=6	NNP
cord-005453-4057qib7	5782	15	)	)	-RRB-
cord-005453-4057qib7	5782	16	or	or	CC
cord-005453-4057qib7	5782	17	upper	upper	JJ
cord-005453-4057qib7	5782	18	GI	gi	NN
cord-005453-4057qib7	5782	19	-	-	HYPH
cord-005453-4057qib7	5782	20	tract	tract	NN
cord-005453-4057qib7	5782	21	(	(	-LRB-
cord-005453-4057qib7	5782	22	n=2	n=2	NNS
cord-005453-4057qib7	5782	23	)	)	-RRB-
cord-005453-4057qib7	5782	24	.	.	.
cord-005453-4057qib7	5783	1	All	all	DT
cord-005453-4057qib7	5783	2	patients	patient	NNS
cord-005453-4057qib7	5783	3	had	have	VBD
cord-005453-4057qib7	5783	4	an	an	DT
cord-005453-4057qib7	5783	5	overall	overall	JJ
cord-005453-4057qib7	5783	6	grade	grade	NN
cord-005453-4057qib7	5783	7	III	III	NNP
cord-005453-4057qib7	5783	8	(	(	-LRB-
cord-005453-4057qib7	5783	9	50	50	CD
cord-005453-4057qib7	5783	10	%	%	NN
cord-005453-4057qib7	5783	11	)	)	-RRB-
cord-005453-4057qib7	5783	12	or	or	CC
cord-005453-4057qib7	5783	13	IV	IV	NNP
cord-005453-4057qib7	5783	14	aGvHD	aGvHD	.
cord-005453-4057qib7	5783	15	(	(	-LRB-
cord-005453-4057qib7	5783	16	50	50	CD
cord-005453-4057qib7	5783	17	%	%	NN
cord-005453-4057qib7	5783	18	)	)	-RRB-
cord-005453-4057qib7	5783	19	.	.	.
cord-005453-4057qib7	5784	1	Steroid	steroid	JJ
cord-005453-4057qib7	5784	2	refractoriness	refractoriness	NN
cord-005453-4057qib7	5784	3	was	be	VBD
cord-005453-4057qib7	5784	4	defined	define	VBN
cord-005453-4057qib7	5784	5	as	as	IN
cord-005453-4057qib7	5784	6	no	no	DT
cord-005453-4057qib7	5784	7	improvement	improvement	NN
cord-005453-4057qib7	5784	8	in	in	IN
cord-005453-4057qib7	5784	9	7	7	CD
cord-005453-4057qib7	5784	10	days	day	NNS
cord-005453-4057qib7	5784	11	or	or	CC
cord-005453-4057qib7	5784	12	aggravation	aggravation	NN
cord-005453-4057qib7	5784	13	after	after	IN
cord-005453-4057qib7	5784	14	5	5	CD
cord-005453-4057qib7	5784	15	days	day	NNS
cord-005453-4057qib7	5784	16	of	of	IN
cord-005453-4057qib7	5784	17	steroid	steroid	NN
cord-005453-4057qib7	5784	18	treatment	treatment	NN
cord-005453-4057qib7	5784	19	.	.	.
cord-005453-4057qib7	5785	1	Median	median	JJ
cord-005453-4057qib7	5785	2	start	start	NN
cord-005453-4057qib7	5785	3	of	of	IN
cord-005453-4057qib7	5785	4	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5785	5	or	or	CC
cord-005453-4057qib7	5785	6	ECP	ECP	NNP
cord-005453-4057qib7	5785	7	was	be	VBD
cord-005453-4057qib7	5785	8	day	day	NN
cord-005453-4057qib7	5785	9	86.5	86.5	CD
cord-005453-4057qib7	5785	10	after	after	IN
cord-005453-4057qib7	5785	11	ASCT	ASCT	NNP
cord-005453-4057qib7	5786	1	(	(	-LRB-
cord-005453-4057qib7	5786	2	r	r	NN
cord-005453-4057qib7	5786	3	:	:	:
cord-005453-4057qib7	5786	4	35	35	CD
cord-005453-4057qib7	5786	5	-	-	SYM
cord-005453-4057qib7	5786	6	257	257	CD
cord-005453-4057qib7	5786	7	)	)	-RRB-
cord-005453-4057qib7	5786	8	.	.	.
cord-005453-4057qib7	5787	1	Medianduration	Medianduration	NNP
cord-005453-4057qib7	5787	2	of	of	IN
cord-005453-4057qib7	5787	3	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5787	4	therapy	therapy	NN
cord-005453-4057qib7	5787	5	was	be	VBD
cord-005453-4057qib7	5787	6	59.8	59.8	CD
cord-005453-4057qib7	5787	7	days	day	NNS
cord-005453-4057qib7	5788	1	(	(	-LRB-
cord-005453-4057qib7	5788	2	r	r	NN
cord-005453-4057qib7	5788	3	:	:	:
cord-005453-4057qib7	5788	4	14	14	CD
cord-005453-4057qib7	5788	5	-	-	SYM
cord-005453-4057qib7	5788	6	192	192	CD
cord-005453-4057qib7	5788	7	)	)	-RRB-
cord-005453-4057qib7	5788	8	with	with	IN
cord-005453-4057qib7	5788	9	a	a	DT
cord-005453-4057qib7	5788	10	median	median	JJ
cord-005453-4057qib7	5788	11	start	start	NN
cord-005453-4057qib7	5788	12	dosage	dosage	NN
cord-005453-4057qib7	5788	13	of	of	IN
cord-005453-4057qib7	5788	14	20	20	CD
cord-005453-4057qib7	5788	15	mg	mg	NN
cord-005453-4057qib7	5788	16	per	per	IN
cord-005453-4057qib7	5788	17	day	day	NN
cord-005453-4057qib7	5788	18	(	(	-LRB-
cord-005453-4057qib7	5788	19	2	2	CD
cord-005453-4057qib7	5788	20	x	x	SYM
cord-005453-4057qib7	5788	21	10	10	CD
cord-005453-4057qib7	5788	22	mg	mg	NN
cord-005453-4057qib7	5788	23	;	;	:
cord-005453-4057qib7	5788	24	r	r	NN
cord-005453-4057qib7	5788	25	:	:	:
cord-005453-4057qib7	5788	26	10	10	CD
cord-005453-4057qib7	5788	27	-	-	SYM
cord-005453-4057qib7	5788	28	20	20	CD
cord-005453-4057qib7	5788	29	mg	mg	NNP
cord-005453-4057qib7	5788	30	)	)	-RRB-
cord-005453-4057qib7	5788	31	.	.	.
cord-005453-4057qib7	5789	1	All	all	DT
cord-005453-4057qib7	5789	2	patients	patient	NNS
cord-005453-4057qib7	5789	3	started	start	VBD
cord-005453-4057qib7	5789	4	with	with	IN
cord-005453-4057qib7	5789	5	2	2	CD
cord-005453-4057qib7	5789	6	ECP	ECP	NNP
cord-005453-4057qib7	5789	7	treatments	treatment	NNS
cord-005453-4057qib7	5789	8	per	per	IN
cord-005453-4057qib7	5789	9	week	week	NN
cord-005453-4057qib7	5789	10	with	with	IN
cord-005453-4057qib7	5789	11	an	an	DT
cord-005453-4057qib7	5789	12	individual	individual	JJ
cord-005453-4057qib7	5789	13	reduction	reduction	NN
cord-005453-4057qib7	5789	14	of	of	IN
cord-005453-4057qib7	5789	15	treatment	treatment	NN
cord-005453-4057qib7	5789	16	frequency	frequency	NN
cord-005453-4057qib7	5789	17	.	.	.
cord-005453-4057qib7	5790	1	Median	median	JJ
cord-005453-4057qib7	5790	2	number	number	NN
cord-005453-4057qib7	5790	3	of	of	IN
cord-005453-4057qib7	5790	4	ECP	ECP	NNP
cord-005453-4057qib7	5790	5	treatments	treatment	NNS
cord-005453-4057qib7	5790	6	was	be	VBD
cord-005453-4057qib7	5790	7	20.5	20.5	CD
cord-005453-4057qib7	5790	8	(	(	-LRB-
cord-005453-4057qib7	5790	9	r	r	NN
cord-005453-4057qib7	5790	10	:	:	:
cord-005453-4057qib7	5790	11	2	2	CD
cord-005453-4057qib7	5790	12	-	-	SYM
cord-005453-4057qib7	5790	13	71	71	CD
cord-005453-4057qib7	5790	14	)	)	-RRB-
cord-005453-4057qib7	5790	15	with	with	IN
cord-005453-4057qib7	5790	16	a	a	DT
cord-005453-4057qib7	5790	17	median	median	JJ
cord-005453-4057qib7	5790	18	frequency	frequency	NN
cord-005453-4057qib7	5790	19	of	of	IN
cord-005453-4057qib7	5790	20	ECP	ECP	NNP
cord-005453-4057qib7	5790	21	therapy	therapy	NN
cord-005453-4057qib7	5791	1	once	once	RB
cord-005453-4057qib7	5791	2	a	a	DT
cord-005453-4057qib7	5791	3	week	week	NN
cord-005453-4057qib7	5792	1	(	(	-LRB-
cord-005453-4057qib7	5792	2	r	r	NN
cord-005453-4057qib7	5792	3	:	:	:
cord-005453-4057qib7	5792	4	0.5	0.5	CD
cord-005453-4057qib7	5792	5	-	-	HYPH
cord-005453-4057qib7	5792	6	2.1	2.1	CD
cord-005453-4057qib7	5792	7	)	)	-RRB-
cord-005453-4057qib7	5792	8	.	.	.
cord-005453-4057qib7	5793	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	5793	2	(	(	-LRB-
cord-005453-4057qib7	5793	3	CMV	CMV	NNP
cord-005453-4057qib7	5793	4	)	)	-RRB-
cord-005453-4057qib7	5793	5	status	status	NN
cord-005453-4057qib7	5793	6	of	of	IN
cord-005453-4057qib7	5793	7	all	all	DT
cord-005453-4057qib7	5793	8	patients	patient	NNS
cord-005453-4057qib7	5793	9	and	and	CC
cord-005453-4057qib7	5793	10	immune	immune	JJ
cord-005453-4057qib7	5793	11	status	status	NN
cord-005453-4057qib7	5793	12	of	of	IN
cord-005453-4057qib7	5793	13	ten	ten	CD
cord-005453-4057qib7	5793	14	patients	patient	NNS
cord-005453-4057qib7	5793	15	(	(	-LRB-
cord-005453-4057qib7	5793	16	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5793	17	count	count	NN
cord-005453-4057qib7	5793	18	with	with	IN
cord-005453-4057qib7	5793	19	CD4	CD4	NNP
cord-005453-4057qib7	5793	20	+	+	CC
cord-005453-4057qib7	5793	21	T	t	NN
cord-005453-4057qib7	5793	22	helper	helper	NN
cord-005453-4057qib7	5793	23	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5793	24	and	and	CC
cord-005453-4057qib7	5793	25	regulatory	regulatory	JJ
cord-005453-4057qib7	5793	26	T	T	NNP
cord-005453-4057qib7	5793	27	cell	cell	NN
cord-005453-4057qib7	5793	28	count	count	NN
cord-005453-4057qib7	5793	29	)	)	-RRB-
cord-005453-4057qib7	5793	30	were	be	VBD
cord-005453-4057qib7	5793	31	collected	collect	VBN
cord-005453-4057qib7	5793	32	previously	previously	RB
cord-005453-4057qib7	5793	33	,	,	,
cord-005453-4057qib7	5793	34	after	after	IN
cord-005453-4057qib7	5793	35	four	four	CD
cord-005453-4057qib7	5793	36	weeks	week	NNS
cord-005453-4057qib7	5793	37	of	of	IN
cord-005453-4057qib7	5793	38	starting	start	VBG
cord-005453-4057qib7	5793	39	combined	combine	VBN
cord-005453-4057qib7	5793	40	treatment	treatment	NN
cord-005453-4057qib7	5793	41	and	and	CC
cord-005453-4057qib7	5793	42	four	four	CD
cord-005453-4057qib7	5793	43	weeks	week	NNS
cord-005453-4057qib7	5793	44	after	after	IN
cord-005453-4057qib7	5793	45	stopping	stop	VBG
cord-005453-4057qib7	5793	46	the	the	DT
cord-005453-4057qib7	5793	47	treatment	treatment	NN
cord-005453-4057qib7	5793	48	.	.	.
cord-005453-4057qib7	5794	1	Results	result	NNS
cord-005453-4057qib7	5794	2	:	:	:
cord-005453-4057qib7	5795	1	One	one	CD
cord-005453-4057qib7	5795	2	-	-	HYPH
cord-005453-4057qib7	5795	3	year	year	NN
cord-005453-4057qib7	5795	4	estimated	estimate	VBN
cord-005453-4057qib7	5795	5	overall	overall	JJ
cord-005453-4057qib7	5795	6	survival	survival	NN
cord-005453-4057qib7	5795	7	(	(	-LRB-
cord-005453-4057qib7	5795	8	OS	OS	NNP
cord-005453-4057qib7	5795	9	)	)	-RRB-
cord-005453-4057qib7	5795	10	of	of	IN
cord-005453-4057qib7	5795	11	all	all	DT
cord-005453-4057qib7	5795	12	patients	patient	NNS
cord-005453-4057qib7	5795	13	was	be	VBD
cord-005453-4057qib7	5795	14	50	50	CD
cord-005453-4057qib7	5795	15	%	%	NN
cord-005453-4057qib7	5795	16	with	with	IN
cord-005453-4057qib7	5795	17	a	a	DT
cord-005453-4057qib7	5795	18	median	median	JJ
cord-005453-4057qib7	5795	19	estimated	estimate	VBN
cord-005453-4057qib7	5795	20	OS	os	NN
cord-005453-4057qib7	5795	21	of	of	IN
cord-005453-4057qib7	5795	22	314	314	CD
cord-005453-4057qib7	5795	23	days	day	NNS
cord-005453-4057qib7	5795	24	.	.	.
cord-005453-4057qib7	5796	1	3	3	CD
cord-005453-4057qib7	5796	2	patients	patient	NNS
cord-005453-4057qib7	5796	3	died	die	VBD
cord-005453-4057qib7	5796	4	because	because	IN
cord-005453-4057qib7	5796	5	of	of	IN
cord-005453-4057qib7	5796	6	relapse	relapse	NN
cord-005453-4057qib7	5796	7	of	of	IN
cord-005453-4057qib7	5796	8	underlying	underlie	VBG
cord-005453-4057qib7	5796	9	disease	disease	NN
cord-005453-4057qib7	5796	10	,	,	,
cord-005453-4057qib7	5796	11	one	one	CD
cord-005453-4057qib7	5796	12	of	of	IN
cord-005453-4057qib7	5796	13	severe	severe	JJ
cord-005453-4057qib7	5796	14	therapy	therapy	NN
cord-005453-4057qib7	5796	15	refractory	refractory	JJ
cord-005453-4057qib7	5796	16	aGvHD	agvhd	NN
cord-005453-4057qib7	5796	17	of	of	IN
cord-005453-4057qib7	5796	18	lower	low	JJR
cord-005453-4057qib7	5796	19	GI	GI	NNP
cord-005453-4057qib7	5796	20	tract	tract	NN
cord-005453-4057qib7	5796	21	and	and	CC
cord-005453-4057qib7	5796	22	5	5	CD
cord-005453-4057qib7	5796	23	due	due	IN
cord-005453-4057qib7	5796	24	to	to	IN
cord-005453-4057qib7	5796	25	infection	infection	NN
cord-005453-4057qib7	5796	26	complications	complication	NNS
cord-005453-4057qib7	5796	27	in	in	IN
cord-005453-4057qib7	5796	28	aGvHD	agvhd	NN
cord-005453-4057qib7	5796	29	refractory	refractory	JJ
cord-005453-4057qib7	5796	30	setting	setting	NN
cord-005453-4057qib7	5796	31	.	.	.
cord-005453-4057qib7	5797	1	Overall	overall	JJ
cord-005453-4057qib7	5797	2	response	response	NN
cord-005453-4057qib7	5797	3	was	be	VBD
cord-005453-4057qib7	5797	4	55.5	55.5	CD
cord-005453-4057qib7	5797	5	%	%	NN
cord-005453-4057qib7	5797	6	(	(	-LRB-
cord-005453-4057qib7	5797	7	complete	complete	JJ
cord-005453-4057qib7	5797	8	remission	remission	NN
cord-005453-4057qib7	5797	9	rate	rate	NN
cord-005453-4057qib7	5797	10	:	:	:
cord-005453-4057qib7	5797	11	44.4	44.4	CD
cord-005453-4057qib7	5797	12	%	%	NN
cord-005453-4057qib7	5797	13	,	,	,
cord-005453-4057qib7	5797	14	partial	partial	JJ
cord-005453-4057qib7	5797	15	remission	remission	NN
cord-005453-4057qib7	5797	16	rate	rate	NN
cord-005453-4057qib7	5797	17	:	:	:
cord-005453-4057qib7	5797	18	11.1	11.1	CD
cord-005453-4057qib7	5797	19	%	%	NN
cord-005453-4057qib7	5797	20	)	)	-RRB-
cord-005453-4057qib7	5797	21	.	.	.
cord-005453-4057qib7	5798	1	72.2	72.2	CD
cord-005453-4057qib7	5798	2	%	%	NN
cord-005453-4057qib7	5798	3	(	(	-LRB-
cord-005453-4057qib7	5798	4	n=13	n=13	NNP
cord-005453-4057qib7	5798	5	)	)	-RRB-
cord-005453-4057qib7	5798	6	of	of	IN
cord-005453-4057qib7	5798	7	the	the	DT
cord-005453-4057qib7	5798	8	patients	patient	NNS
cord-005453-4057qib7	5798	9	had	have	VBD
cord-005453-4057qib7	5798	10	cytopenia	cytopenia	VBN
cord-005453-4057qib7	5798	11	CTC	CTC	NNP
cord-005453-4057qib7	5798	12	I	I	NNP
cord-005453-4057qib7	5798	13	-	-	HYPH
cord-005453-4057qib7	5798	14	III	III	NNP
cord-005453-4057qib7	5798	15	during	during	IN
cord-005453-4057qib7	5798	16	the	the	DT
cord-005453-4057qib7	5798	17	treatment	treatment	NN
cord-005453-4057qib7	5798	18	,	,	,
cord-005453-4057qib7	5798	19	no	no	DT
cord-005453-4057qib7	5798	20	grade	grade	NN
cord-005453-4057qib7	5798	21	IV	IV	NNP
cord-005453-4057qib7	5798	22	cytopenia	cytopenia	NNP
cord-005453-4057qib7	5798	23	was	be	VBD
cord-005453-4057qib7	5798	24	reported	report	VBN
cord-005453-4057qib7	5798	25	.	.	.
cord-005453-4057qib7	5799	1	CMV	CMV	NNP
cord-005453-4057qib7	5799	2	reactivation	reactivation	NN
cord-005453-4057qib7	5799	3	during	during	IN
cord-005453-4057qib7	5799	4	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5799	5	occured	occur	VBD
cord-005453-4057qib7	5799	6	in	in	IN
cord-005453-4057qib7	5799	7	66.7	66.7	CD
cord-005453-4057qib7	5799	8	%	%	NN
cord-005453-4057qib7	5799	9	of	of	IN
cord-005453-4057qib7	5799	10	cases	case	NNS
cord-005453-4057qib7	5799	11	(	(	-LRB-
cord-005453-4057qib7	5799	12	n=12	n=12	NNP
cord-005453-4057qib7	5799	13	)	)	-RRB-
cord-005453-4057qib7	5799	14	.	.	.
cord-005453-4057qib7	5800	1	Tapering	taper	VBG
cord-005453-4057qib7	5800	2	of	of	IN
cord-005453-4057qib7	5800	3	steroids	steroid	NNS
cord-005453-4057qib7	5800	4	could	could	MD
cord-005453-4057qib7	5800	5	be	be	VB
cord-005453-4057qib7	5800	6	performed	perform	VBN
cord-005453-4057qib7	5800	7	rapidly	rapidly	RB
cord-005453-4057qib7	5800	8	with	with	IN
cord-005453-4057qib7	5800	9	a	a	DT
cord-005453-4057qib7	5800	10	medium	medium	JJ
cord-005453-4057qib7	5800	11	reduction	reduction	NN
cord-005453-4057qib7	5800	12	time	time	NN
cord-005453-4057qib7	5800	13	of	of	IN
cord-005453-4057qib7	5800	14	1.75	1.75	CD
cord-005453-4057qib7	5800	15	days	day	NNS
cord-005453-4057qib7	5800	16	for	for	IN
cord-005453-4057qib7	5800	17	reducing	reduce	VBG
cord-005453-4057qib7	5800	18	to	to	IN
cord-005453-4057qib7	5800	19	half	half	NN
cord-005453-4057qib7	5800	20	of	of	IN
cord-005453-4057qib7	5800	21	the	the	DT
cord-005453-4057qib7	5800	22	dosage	dosage	NN
cord-005453-4057qib7	5800	23	.	.	.
cord-005453-4057qib7	5801	1	Remarkably	remarkably	RB
cord-005453-4057qib7	5801	2	,	,	,
cord-005453-4057qib7	5801	3	regulatory	regulatory	JJ
cord-005453-4057qib7	5801	4	T	t	NN
cord-005453-4057qib7	5801	5	cells	cell	NNS
cord-005453-4057qib7	5801	6	significantly	significantly	RB
cord-005453-4057qib7	5801	7	increased	increase	VBD
cord-005453-4057qib7	5801	8	during	during	IN
cord-005453-4057qib7	5801	9	combined	combine	VBN
cord-005453-4057qib7	5801	10	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5801	11	/	/	SYM
cord-005453-4057qib7	5801	12	ECP	ECP	NNP
cord-005453-4057qib7	5801	13	treatment	treatment	NN
cord-005453-4057qib7	5801	14	compared	compare	VBN
cord-005453-4057qib7	5801	15	to	to	IN
cord-005453-4057qib7	5801	16	regulatory	regulatory	JJ
cord-005453-4057qib7	5801	17	T	t	NN
cord-005453-4057qib7	5801	18	cell	cell	NN
cord-005453-4057qib7	5801	19	count	count	NN
cord-005453-4057qib7	5801	20	before	before	IN
cord-005453-4057qib7	5801	21	treatment	treatment	NN
cord-005453-4057qib7	5801	22	(	(	-LRB-
cord-005453-4057qib7	5801	23	p=0.02	p=0.02	NN
cord-005453-4057qib7	5801	24	)	)	-RRB-
cord-005453-4057qib7	5801	25	and	and	CC
cord-005453-4057qib7	5801	26	after	after	IN
cord-005453-4057qib7	5801	27	stopping	stop	VBG
cord-005453-4057qib7	5801	28	treatment	treatment	NN
cord-005453-4057qib7	5801	29	,	,	,
cord-005453-4057qib7	5801	30	regulatory	regulatory	JJ
cord-005453-4057qib7	5801	31	T	t	NN
cord-005453-4057qib7	5801	32	cell	cell	NN
cord-005453-4057qib7	5801	33	count	count	NN
cord-005453-4057qib7	5801	34	decreased	decrease	VBD
cord-005453-4057qib7	5801	35	again	again	RB
cord-005453-4057qib7	5802	1	(	(	-LRB-
cord-005453-4057qib7	5802	2	p=0.02	p=0.02	JJ
cord-005453-4057qib7	5802	3	,	,	,
cord-005453-4057qib7	5802	4	see	see	VB
cord-005453-4057qib7	5802	5	figure	figure	NN
cord-005453-4057qib7	5802	6	)	)	-RRB-
cord-005453-4057qib7	5802	7	.	.	.
cord-005453-4057qib7	5803	1	Significant	significant	JJ
cord-005453-4057qib7	5803	2	changes	change	NNS
cord-005453-4057qib7	5803	3	in	in	IN
cord-005453-4057qib7	5803	4	whole	whole	JJ
cord-005453-4057qib7	5803	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	5803	6	count	count	NN
cord-005453-4057qib7	5803	7	or	or	CC
cord-005453-4057qib7	5803	8	in	in	IN
cord-005453-4057qib7	5803	9	CD4	CD4	NNP
cord-005453-4057qib7	5803	10	+	+	CC
cord-005453-4057qib7	5803	11	T	T	NNP
cord-005453-4057qib7	5803	12	helper	helper	NN
cord-005453-4057qib7	5803	13	cell	cell	NN
cord-005453-4057qib7	5803	14	count	count	NN
cord-005453-4057qib7	5803	15	were	be	VBD
cord-005453-4057qib7	5803	16	not	not	RB
cord-005453-4057qib7	5803	17	observed	observe	VBN
cord-005453-4057qib7	5803	18	.	.	.
cord-005453-4057qib7	5804	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5804	2	:	:	:
cord-005453-4057qib7	5805	1	Treatment	treatment	NN
cord-005453-4057qib7	5805	2	of	of	IN
cord-005453-4057qib7	5805	3	severe	severe	JJ
cord-005453-4057qib7	5805	4	steroid	steroid	NN
cord-005453-4057qib7	5805	5	refractory	refractory	JJ
cord-005453-4057qib7	5805	6	aGvHD	agvhd	NN
cord-005453-4057qib7	5805	7	with	with	IN
cord-005453-4057qib7	5805	8	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5805	9	plus	plus	CC
cord-005453-4057qib7	5805	10	ECP	ECP	NNP
cord-005453-4057qib7	5805	11	could	could	MD
cord-005453-4057qib7	5805	12	show	show	VB
cord-005453-4057qib7	5805	13	a	a	DT
cord-005453-4057qib7	5805	14	high	high	JJ
cord-005453-4057qib7	5805	15	complete	complete	JJ
cord-005453-4057qib7	5805	16	remission	remission	NN
cord-005453-4057qib7	5805	17	rate	rate	NN
cord-005453-4057qib7	5805	18	of	of	IN
cord-005453-4057qib7	5805	19	44.4	44.4	CD
cord-005453-4057qib7	5805	20	%	%	NN
cord-005453-4057qib7	5805	21	with	with	IN
cord-005453-4057qib7	5805	22	an	an	DT
cord-005453-4057qib7	5805	23	one	one	CD
cord-005453-4057qib7	5805	24	year	year	NN
cord-005453-4057qib7	5805	25	OS	os	NN
cord-005453-4057qib7	5805	26	of	of	IN
cord-005453-4057qib7	5805	27	50	50	CD
cord-005453-4057qib7	5805	28	%	%	NN
cord-005453-4057qib7	5805	29	.	.	.
cord-005453-4057qib7	5806	1	Detecting	detect	VBG
cord-005453-4057qib7	5806	2	increased	increase	VBN
cord-005453-4057qib7	5806	3	regulatory	regulatory	JJ
cord-005453-4057qib7	5806	4	T	t	NN
cord-005453-4057qib7	5806	5	cell	cell	NN
cord-005453-4057qib7	5806	6	count	count	NN
cord-005453-4057qib7	5806	7	during	during	IN
cord-005453-4057qib7	5806	8	the	the	DT
cord-005453-4057qib7	5806	9	treatment	treatment	NN
cord-005453-4057qib7	5806	10	underlines	underline	VBZ
cord-005453-4057qib7	5806	11	its	-PRON-	PRP$
cord-005453-4057qib7	5806	12	direct	direct	JJ
cord-005453-4057qib7	5806	13	effects	effect	NNS
cord-005453-4057qib7	5806	14	on	on	IN
cord-005453-4057qib7	5806	15	immune	immune	JJ
cord-005453-4057qib7	5806	16	response	response	NN
cord-005453-4057qib7	5806	17	and	and	CC
cord-005453-4057qib7	5806	18	encourages	encourage	VBZ
cord-005453-4057qib7	5806	19	to	to	TO
cord-005453-4057qib7	5806	20	pursue	pursue	VB
cord-005453-4057qib7	5806	21	this	this	DT
cord-005453-4057qib7	5806	22	promising	promising	JJ
cord-005453-4057qib7	5806	23	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5806	24	approach	approach	NN
cord-005453-4057qib7	5806	25	.	.	.
cord-005453-4057qib7	5807	1	[	[	-LRB-
cord-005453-4057qib7	5807	2	Background	background	NN
cord-005453-4057qib7	5807	3	:	:	:
cord-005453-4057qib7	5807	4	Due	due	IN
cord-005453-4057qib7	5807	5	to	to	IN
cord-005453-4057qib7	5807	6	increased	increase	VBN
cord-005453-4057qib7	5807	7	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	5807	8	infections	infection	NNS
cord-005453-4057qib7	5807	9	remain	remain	VBP
cord-005453-4057qib7	5807	10	the	the	DT
cord-005453-4057qib7	5807	11	main	main	JJ
cord-005453-4057qib7	5807	12	cause	cause	NN
cord-005453-4057qib7	5807	13	of	of	IN
cord-005453-4057qib7	5807	14	death	death	NN
cord-005453-4057qib7	5807	15	followed	follow	VBN
cord-005453-4057qib7	5807	16	by	by	IN
cord-005453-4057qib7	5807	17	higher	high	JJR
cord-005453-4057qib7	5807	18	risk	risk	NN
cord-005453-4057qib7	5807	19	of	of	IN
cord-005453-4057qib7	5807	20	relapse	relapse	NN
cord-005453-4057qib7	5807	21	in	in	IN
cord-005453-4057qib7	5807	22	patients	patient	NNS
cord-005453-4057qib7	5807	23	treated	treat	VBN
cord-005453-4057qib7	5807	24	for	for	IN
cord-005453-4057qib7	5807	25	acute	acute	JJ
cord-005453-4057qib7	5807	26	graft	graft	NN
cord-005453-4057qib7	5807	27	versus	versus	IN
cord-005453-4057qib7	5807	28	host	host	NN
cord-005453-4057qib7	5807	29	disease	disease	NN
cord-005453-4057qib7	5807	30	(	(	-LRB-
cord-005453-4057qib7	5807	31	aGvHD	agvhd	NN
cord-005453-4057qib7	5807	32	)	)	-RRB-
cord-005453-4057qib7	5807	33	after	after	IN
cord-005453-4057qib7	5807	34	allogeneic	allogeneic	NN
cord-005453-4057qib7	5807	35	stem	stem	NN
cord-005453-4057qib7	5807	36	cell	cell	NN
cord-005453-4057qib7	5807	37	transplant	transplant	NN
cord-005453-4057qib7	5807	38	(	(	-LRB-
cord-005453-4057qib7	5807	39	SCT	SCT	NNP
cord-005453-4057qib7	5807	40	)	)	-RRB-
cord-005453-4057qib7	5807	41	.	.	.
cord-005453-4057qib7	5808	1	Here	here	RB
cord-005453-4057qib7	5808	2	we	-PRON-	PRP
cord-005453-4057qib7	5808	3	report	report	VBP
cord-005453-4057qib7	5808	4	a	a	DT
cord-005453-4057qib7	5808	5	single	single	JJ
cord-005453-4057qib7	5808	6	-	-	HYPH
cord-005453-4057qib7	5808	7	centre	centre	NN
cord-005453-4057qib7	5808	8	experience	experience	NN
cord-005453-4057qib7	5808	9	with	with	IN
cord-005453-4057qib7	5808	10	extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5808	11	photopheresis	photopheresis	NN
cord-005453-4057qib7	5808	12	(	(	-LRB-
cord-005453-4057qib7	5808	13	ECP	ECP	NNP
cord-005453-4057qib7	5808	14	)	)	-RRB-
cord-005453-4057qib7	5808	15	for	for	IN
cord-005453-4057qib7	5808	16	acute	acute	JJ
cord-005453-4057qib7	5808	17	GvHD	GvHD	NNP
cord-005453-4057qib7	5808	18	that	that	WDT
cord-005453-4057qib7	5808	19	was	be	VBD
cord-005453-4057qib7	5808	20	introduced	introduce	VBN
cord-005453-4057qib7	5808	21	in	in	IN
cord-005453-4057qib7	5808	22	order	order	NN
cord-005453-4057qib7	5808	23	to	to	TO
cord-005453-4057qib7	5808	24	reduce	reduce	VB
cord-005453-4057qib7	5808	25	steroid	steroid	NN
cord-005453-4057qib7	5808	26	treatment	treatment	NN
cord-005453-4057qib7	5808	27	.	.	.
cord-005453-4057qib7	5809	1	Comparison	comparison	NN
cord-005453-4057qib7	5809	2	of	of	IN
cord-005453-4057qib7	5809	3	overall	overall	JJ
cord-005453-4057qib7	5809	4	survival	survival	NN
cord-005453-4057qib7	5809	5	(	(	-LRB-
cord-005453-4057qib7	5809	6	OS	OS	NNP
cord-005453-4057qib7	5809	7	)	)	-RRB-
cord-005453-4057qib7	5809	8	for	for	IN
cord-005453-4057qib7	5809	9	patients	patient	NNS
cord-005453-4057qib7	5809	10	on	on	IN
cord-005453-4057qib7	5809	11	ECP	ECP	NNP
cord-005453-4057qib7	5809	12	and	and	CC
cord-005453-4057qib7	5809	13	patients	patient	NNS
cord-005453-4057qib7	5809	14	that	that	WDT
cord-005453-4057qib7	5809	15	received	receive	VBD
cord-005453-4057qib7	5809	16	standard	standard	JJ
cord-005453-4057qib7	5809	17	first	first	JJ
cord-005453-4057qib7	5809	18	line	line	NN
cord-005453-4057qib7	5809	19	therapy	therapy	NN
cord-005453-4057qib7	5809	20	for	for	IN
cord-005453-4057qib7	5809	21	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5809	22	was	be	VBD
cord-005453-4057qib7	5809	23	performed	perform	VBN
cord-005453-4057qib7	5809	24	.	.	.
cord-005453-4057qib7	5810	1	Methods	method	NNS
cord-005453-4057qib7	5810	2	:	:	:
cord-005453-4057qib7	5810	3	We	-PRON-	PRP
cord-005453-4057qib7	5810	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	5810	5	analysed	analyse	VBD
cord-005453-4057qib7	5810	6	62	62	CD
cord-005453-4057qib7	5810	7	patients	patient	NNS
cord-005453-4057qib7	5810	8	(	(	-LRB-
cord-005453-4057qib7	5810	9	28	28	CD
cord-005453-4057qib7	5810	10	%	%	NN
cord-005453-4057qib7	5810	11	)	)	-RRB-
cord-005453-4057qib7	5810	12	with	with	IN
cord-005453-4057qib7	5810	13	acute	acute	JJ
cord-005453-4057qib7	5810	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5810	15	grade	grade	NN
cord-005453-4057qib7	5810	16	II	II	NNP
cord-005453-4057qib7	5810	17	-	-	HYPH
cord-005453-4057qib7	5810	18	IV	IV	NNP
cord-005453-4057qib7	5810	19	treated	treat	VBN
cord-005453-4057qib7	5810	20	from	from	IN
cord-005453-4057qib7	5810	21	January	January	NNP
cord-005453-4057qib7	5810	22	2010	2010	CD
cord-005453-4057qib7	5810	23	to	to	IN
cord-005453-4057qib7	5810	24	October	October	NNP
cord-005453-4057qib7	5810	25	2018	2018	CD
cord-005453-4057qib7	5810	26	out	out	IN
cord-005453-4057qib7	5810	27	of	of	IN
cord-005453-4057qib7	5810	28	total	total	JJ
cord-005453-4057qib7	5810	29	221	221	CD
cord-005453-4057qib7	5810	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	5810	31	SCT	SCT	NNP
cord-005453-4057qib7	5810	32	in	in	IN
cord-005453-4057qib7	5810	33	that	that	DT
cord-005453-4057qib7	5810	34	period	period	NN
cord-005453-4057qib7	5810	35	.	.	.
cord-005453-4057qib7	5811	1	All	all	DT
cord-005453-4057qib7	5811	2	patients	patient	NNS
cord-005453-4057qib7	5811	3	received	receive	VBD
cord-005453-4057qib7	5811	4	calcineurin	calcineurin	NNP
cord-005453-4057qib7	5811	5	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5811	6	or	or	CC
cord-005453-4057qib7	5811	7	sirolimus	sirolimus	NN
cord-005453-4057qib7	5811	8	while	while	IN
cord-005453-4057qib7	5811	9	receiving	receive	VBG
cord-005453-4057qib7	5811	10	steroid	steroid	NN
cord-005453-4057qib7	5811	11	treatment	treatment	NN
cord-005453-4057qib7	5811	12	for	for	IN
cord-005453-4057qib7	5811	13	aGvHD	agvhd	NN
cord-005453-4057qib7	5811	14	.	.	.
cord-005453-4057qib7	5812	1	Twenty	twenty	CD
cord-005453-4057qib7	5812	2	-	-	HYPH
cord-005453-4057qib7	5812	3	five	five	CD
cord-005453-4057qib7	5812	4	patients	patient	NNS
cord-005453-4057qib7	5812	5	(	(	-LRB-
cord-005453-4057qib7	5812	6	40	40	CD
cord-005453-4057qib7	5812	7	%	%	NN
cord-005453-4057qib7	5812	8	)	)	-RRB-
cord-005453-4057qib7	5812	9	received	receive	VBD
cord-005453-4057qib7	5812	10	ECP	ECP	NNP
cord-005453-4057qib7	5812	11	with	with	IN
cord-005453-4057qib7	5812	12	steroid	steroid	NN
cord-005453-4057qib7	5812	13	lowering	lower	VBG
cord-005453-4057qib7	5812	14	intent	intent	NN
cord-005453-4057qib7	5812	15	.	.	.
cord-005453-4057qib7	5813	1	We	-PRON-	PRP
cord-005453-4057qib7	5813	2	defined	define	VBD
cord-005453-4057qib7	5813	3	response	response	NN
cord-005453-4057qib7	5813	4	as	as	IN
cord-005453-4057qib7	5813	5	(	(	-LRB-
cord-005453-4057qib7	5813	6	1	1	CD
cord-005453-4057qib7	5813	7	)	)	-RRB-
cord-005453-4057qib7	5813	8	reduction	reduction	NN
cord-005453-4057qib7	5813	9	of	of	IN
cord-005453-4057qib7	5813	10	steroid	steroid	NN
cord-005453-4057qib7	5813	11	dose	dose	NN
cord-005453-4057qib7	5813	12	for	for	IN
cord-005453-4057qib7	5813	13	at	at	RB
cord-005453-4057qib7	5813	14	least	least	JJS
cord-005453-4057qib7	5813	15	50	50	CD
cord-005453-4057qib7	5813	16	%	%	NN
cord-005453-4057qib7	5813	17	from	from	IN
cord-005453-4057qib7	5813	18	baseline	baseline	NN
cord-005453-4057qib7	5813	19	while	while	IN
cord-005453-4057qib7	5813	20	not	not	RB
cord-005453-4057qib7	5813	21	adding	add	VBG
cord-005453-4057qib7	5813	22	another	another	DT
cord-005453-4057qib7	5813	23	immunosuppresive	immunosuppresive	JJ
cord-005453-4057qib7	5813	24	agent	agent	NN
cord-005453-4057qib7	5813	25	and	and	CC
cord-005453-4057qib7	5813	26	(	(	-LRB-
cord-005453-4057qib7	5813	27	2	2	LS
cord-005453-4057qib7	5813	28	)	)	-RRB-
cord-005453-4057qib7	5813	29	not	not	RB
cord-005453-4057qib7	5813	30	repeating	repeat	VBG
cord-005453-4057qib7	5813	31	second	second	JJ
cord-005453-4057qib7	5813	32	steroid	steroid	JJ
cord-005453-4057qib7	5813	33	treatment	treatment	NN
cord-005453-4057qib7	5813	34	if	if	IN
cord-005453-4057qib7	5813	35	the	the	DT
cord-005453-4057qib7	5813	36	ECP	ECP	NNP
cord-005453-4057qib7	5813	37	was	be	VBD
cord-005453-4057qib7	5813	38	started	start	VBN
cord-005453-4057qib7	5813	39	after	after	IN
cord-005453-4057qib7	5813	40	lowering	lower	VBG
cord-005453-4057qib7	5813	41	of	of	IN
cord-005453-4057qib7	5813	42	steroids	steroid	NNS
cord-005453-4057qib7	5813	43	to	to	TO
cord-005453-4057qib7	5813	44	prevent	prevent	VB
cord-005453-4057qib7	5813	45	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5813	46	flare	flare	NN
cord-005453-4057qib7	5813	47	.	.	.
cord-005453-4057qib7	5814	1	We	-PRON-	PRP
cord-005453-4057qib7	5814	2	checked	check	VBD
cord-005453-4057qib7	5814	3	separately	separately	RB
cord-005453-4057qib7	5814	4	patient	patient	JJ
cord-005453-4057qib7	5814	5	responsive	responsive	JJ
cord-005453-4057qib7	5814	6	and	and	CC
cord-005453-4057qib7	5814	7	refractory	refractory	JJ
cord-005453-4057qib7	5814	8	/	/	SYM
cord-005453-4057qib7	5814	9	dependent	dependent	JJ
cord-005453-4057qib7	5814	10	to	to	IN
cord-005453-4057qib7	5814	11	steroids	steroid	NNS
cord-005453-4057qib7	5814	12	.	.	.
cord-005453-4057qib7	5815	1	On	on	IN
cord-005453-4057qib7	5815	2	average	average	JJ
cord-005453-4057qib7	5815	3	patients	patient	NNS
cord-005453-4057qib7	5815	4	received	receive	VBD
cord-005453-4057qib7	5815	5	ECP	ECP	NNP
cord-005453-4057qib7	5815	6	procedure	procedure	NN
cord-005453-4057qib7	5815	7	once	once	RB
cord-005453-4057qib7	5815	8	weekly	weekly	RB
cord-005453-4057qib7	5815	9	.	.	.
cord-005453-4057qib7	5816	1	Results	result	NNS
cord-005453-4057qib7	5816	2	:	:	:
cord-005453-4057qib7	5817	1	Tapering	taper	VBG
cord-005453-4057qib7	5817	2	of	of	IN
cord-005453-4057qib7	5817	3	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5817	4	therapy	therapy	NN
cord-005453-4057qib7	5817	5	as	as	IN
cord-005453-4057qib7	5817	6	defined	define	VBN
cord-005453-4057qib7	5817	7	was	be	VBD
cord-005453-4057qib7	5817	8	successful	successful	JJ
cord-005453-4057qib7	5817	9	in	in	IN
cord-005453-4057qib7	5817	10	13	13	CD
cord-005453-4057qib7	5817	11	(	(	-LRB-
cord-005453-4057qib7	5817	12	52	52	CD
cord-005453-4057qib7	5817	13	%	%	NN
cord-005453-4057qib7	5817	14	)	)	-RRB-
cord-005453-4057qib7	5817	15	out	out	IN
cord-005453-4057qib7	5817	16	of	of	IN
cord-005453-4057qib7	5817	17	25	25	CD
cord-005453-4057qib7	5817	18	patients	patient	NNS
cord-005453-4057qib7	5817	19	in	in	IN
cord-005453-4057qib7	5817	20	ECP	ECP	NNP
cord-005453-4057qib7	5817	21	group	group	NN
cord-005453-4057qib7	5817	22	.	.	.
cord-005453-4057qib7	5818	1	In	in	IN
cord-005453-4057qib7	5818	2	a	a	DT
cord-005453-4057qib7	5818	3	group	group	NN
cord-005453-4057qib7	5818	4	of	of	IN
cord-005453-4057qib7	5818	5	patients	patient	NNS
cord-005453-4057qib7	5818	6	without	without	IN
cord-005453-4057qib7	5818	7	ECP	ECP	NNP
cord-005453-4057qib7	5818	8	14	14	CD
cord-005453-4057qib7	5818	9	(	(	-LRB-
cord-005453-4057qib7	5818	10	37	37	CD
cord-005453-4057qib7	5818	11	%	%	NN
cord-005453-4057qib7	5818	12	)	)	-RRB-
cord-005453-4057qib7	5818	13	patients	patient	NNS
cord-005453-4057qib7	5818	14	had	have	VBD
cord-005453-4057qib7	5818	15	steroid	steroid	NN
cord-005453-4057qib7	5818	16	refractory	refractory	JJ
cord-005453-4057qib7	5818	17	or	or	CC
cord-005453-4057qib7	5818	18	steroid	steroid	NN
cord-005453-4057qib7	5818	19	dependent	dependent	JJ
cord-005453-4057qib7	5818	20	aGVHD	agvhd	NN
cord-005453-4057qib7	5818	21	compared	compare	VBN
cord-005453-4057qib7	5818	22	to	to	IN
cord-005453-4057qib7	5818	23	11	11	CD
cord-005453-4057qib7	5818	24	(	(	-LRB-
cord-005453-4057qib7	5818	25	44	44	CD
cord-005453-4057qib7	5818	26	%	%	NN
cord-005453-4057qib7	5818	27	)	)	-RRB-
cord-005453-4057qib7	5818	28	patients	patient	NNS
cord-005453-4057qib7	5818	29	in	in	IN
cord-005453-4057qib7	5818	30	ECP	ECP	NNP
cord-005453-4057qib7	5818	31	group	group	NN
cord-005453-4057qib7	5818	32	.	.	.
cord-005453-4057qib7	5819	1	Four	four	CD
cord-005453-4057qib7	5819	2	(	(	-LRB-
cord-005453-4057qib7	5819	3	16	16	CD
cord-005453-4057qib7	5819	4	%	%	NN
cord-005453-4057qib7	5819	5	)	)	-RRB-
cord-005453-4057qib7	5819	6	patients	patient	NNS
cord-005453-4057qib7	5819	7	with	with	IN
cord-005453-4057qib7	5819	8	steroid	steroid	NN
cord-005453-4057qib7	5819	9	refractory	refractory	JJ
cord-005453-4057qib7	5819	10	or	or	CC
cord-005453-4057qib7	5819	11	dependent	dependent	JJ
cord-005453-4057qib7	5819	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5819	13	showed	show	VBD
cord-005453-4057qib7	5819	14	improvement	improvement	NN
cord-005453-4057qib7	5819	15	in	in	IN
cord-005453-4057qib7	5819	16	ECP	ECP	NNP
cord-005453-4057qib7	5819	17	group	group	NN
cord-005453-4057qib7	5819	18	compared	compare	VBN
cord-005453-4057qib7	5819	19	to	to	IN
cord-005453-4057qib7	5819	20	only	only	RB
cord-005453-4057qib7	5819	21	one	one	CD
cord-005453-4057qib7	5819	22	(	(	-LRB-
cord-005453-4057qib7	5819	23	2,7	2,7	CD
cord-005453-4057qib7	5819	24	%	%	NN
cord-005453-4057qib7	5819	25	)	)	-RRB-
cord-005453-4057qib7	5819	26	in	in	IN
cord-005453-4057qib7	5819	27	non	non	JJ
cord-005453-4057qib7	5819	28	ECP	ECP	NNP
cord-005453-4057qib7	5819	29	group	group	NN
cord-005453-4057qib7	5819	30	.	.	.
cord-005453-4057qib7	5820	1	Twenty	twenty	CD
cord-005453-4057qib7	5820	2	(	(	-LRB-
cord-005453-4057qib7	5820	3	74	74	CD
cord-005453-4057qib7	5820	4	%	%	NN
cord-005453-4057qib7	5820	5	)	)	-RRB-
cord-005453-4057qib7	5820	6	patients	patient	NNS
cord-005453-4057qib7	5820	7	died	die	VBD
cord-005453-4057qib7	5820	8	due	due	JJ
cord-005453-4057qib7	5820	9	to	to	IN
cord-005453-4057qib7	5820	10	infectious	infectious	JJ
cord-005453-4057qib7	5820	11	complication	complication	NN
cord-005453-4057qib7	5820	12	and	and	CC
cord-005453-4057qib7	5820	13	7	7	CD
cord-005453-4057qib7	5820	14	(	(	-LRB-
cord-005453-4057qib7	5820	15	26	26	CD
cord-005453-4057qib7	5820	16	%	%	NN
cord-005453-4057qib7	5820	17	)	)	-RRB-
cord-005453-4057qib7	5820	18	due	due	IN
cord-005453-4057qib7	5820	19	to	to	IN
cord-005453-4057qib7	5820	20	relapse	relapse	NN
cord-005453-4057qib7	5820	21	in	in	IN
cord-005453-4057qib7	5820	22	non	non	JJ
cord-005453-4057qib7	5820	23	ECP	ECP	NNP
cord-005453-4057qib7	5820	24	cohort	cohort	NN
cord-005453-4057qib7	5820	25	.	.	.
cord-005453-4057qib7	5821	1	In	in	IN
cord-005453-4057qib7	5821	2	ECP	ECP	NNP
cord-005453-4057qib7	5821	3	cohort	cohort	NN
cord-005453-4057qib7	5821	4	10	10	CD
cord-005453-4057qib7	5821	5	(	(	-LRB-
cord-005453-4057qib7	5821	6	77	77	CD
cord-005453-4057qib7	5821	7	%	%	NN
cord-005453-4057qib7	5821	8	)	)	-RRB-
cord-005453-4057qib7	5821	9	patients	patient	NNS
cord-005453-4057qib7	5821	10	died	die	VBD
cord-005453-4057qib7	5821	11	due	due	IN
cord-005453-4057qib7	5821	12	to	to	IN
cord-005453-4057qib7	5821	13	infection	infection	NN
cord-005453-4057qib7	5821	14	and	and	CC
cord-005453-4057qib7	5821	15	3	3	CD
cord-005453-4057qib7	5821	16	(	(	-LRB-
cord-005453-4057qib7	5821	17	23	23	CD
cord-005453-4057qib7	5821	18	%	%	NN
cord-005453-4057qib7	5821	19	)	)	-RRB-
cord-005453-4057qib7	5821	20	due	due	IN
cord-005453-4057qib7	5821	21	to	to	IN
cord-005453-4057qib7	5821	22	relapse	relapse	NN
cord-005453-4057qib7	5821	23	.	.	.
cord-005453-4057qib7	5822	1	Median	median	JJ
cord-005453-4057qib7	5822	2	OS	OS	NNP
cord-005453-4057qib7	5822	3	was	be	VBD
cord-005453-4057qib7	5822	4	5	5	CD
cord-005453-4057qib7	5822	5	months	month	NNS
cord-005453-4057qib7	5822	6	in	in	IN
cord-005453-4057qib7	5822	7	non	non	JJ
cord-005453-4057qib7	5822	8	ECP	ECP	NNP
cord-005453-4057qib7	5822	9	group	group	NN
cord-005453-4057qib7	5822	10	(	(	-LRB-
cord-005453-4057qib7	5822	11	r.	r.	NNP
cord-005453-4057qib7	5822	12	,	,	,
cord-005453-4057qib7	5822	13	1	1	CD
cord-005453-4057qib7	5822	14	-	-	SYM
cord-005453-4057qib7	5822	15	99	99	CD
cord-005453-4057qib7	5822	16	)	)	-RRB-
cord-005453-4057qib7	5822	17	compared	compare	VBN
cord-005453-4057qib7	5822	18	to	to	IN
cord-005453-4057qib7	5822	19	21	21	CD
cord-005453-4057qib7	5822	20	months	month	NNS
cord-005453-4057qib7	5823	1	(	(	-LRB-
cord-005453-4057qib7	5823	2	r.	r.	NNP
cord-005453-4057qib7	5823	3	,	,	,
cord-005453-4057qib7	5823	4	2	2	CD
cord-005453-4057qib7	5823	5	-	-	SYM
cord-005453-4057qib7	5823	6	76	76	CD
cord-005453-4057qib7	5823	7	)	)	-RRB-
cord-005453-4057qib7	5823	8	in	in	IN
cord-005453-4057qib7	5823	9	ECP	ECP	NNP
cord-005453-4057qib7	5823	10	group	group	NN
cord-005453-4057qib7	5823	11	and	and	CC
cord-005453-4057qib7	5823	12	OS	os	NN
cord-005453-4057qib7	5823	13	of	of	IN
cord-005453-4057qib7	5823	14	20	20	CD
cord-005453-4057qib7	5823	15	%	%	NN
cord-005453-4057qib7	5823	16	at	at	IN
cord-005453-4057qib7	5823	17	5	5	CD
cord-005453-4057qib7	5823	18	years	year	NNS
cord-005453-4057qib7	5823	19	in	in	IN
cord-005453-4057qib7	5823	20	non	non	JJ
cord-005453-4057qib7	5823	21	ECP	ECP	NNP
cord-005453-4057qib7	5823	22	compared	compare	VBN
cord-005453-4057qib7	5823	23	to	to	IN
cord-005453-4057qib7	5823	24	35	35	CD
cord-005453-4057qib7	5823	25	%	%	NN
cord-005453-4057qib7	5823	26	in	in	IN
cord-005453-4057qib7	5823	27	ECP	ECP	NNP
cord-005453-4057qib7	5823	28	cohort	cohort	NN
cord-005453-4057qib7	5823	29	was	be	VBD
cord-005453-4057qib7	5823	30	observed	observe	VBN
cord-005453-4057qib7	5823	31	.	.	.
cord-005453-4057qib7	5824	1	Patients	patient	NNS
cord-005453-4057qib7	5824	2	with	with	IN
cord-005453-4057qib7	5824	3	aGvHD	agvhd	NN
cord-005453-4057qib7	5824	4	treated	treat	VBN
cord-005453-4057qib7	5824	5	with	with	IN
cord-005453-4057qib7	5824	6	ECP	ECP	NNP
cord-005453-4057qib7	5824	7	and	and	CC
cord-005453-4057qib7	5824	8	faster	fast	JJR
cord-005453-4057qib7	5824	9	steroid	steroid	NN
cord-005453-4057qib7	5824	10	tapering	tapering	NN
cord-005453-4057qib7	5824	11	had	have	VBD
cord-005453-4057qib7	5824	12	longer	long	JJR
cord-005453-4057qib7	5824	13	OS	os	NN
cord-005453-4057qib7	5824	14	compared	compare	VBN
cord-005453-4057qib7	5824	15	to	to	IN
cord-005453-4057qib7	5824	16	patients	patient	NNS
cord-005453-4057qib7	5824	17	without	without	IN
cord-005453-4057qib7	5824	18	ECP	ECP	NNP
cord-005453-4057qib7	5824	19	(	(	-LRB-
cord-005453-4057qib7	5824	20	p=0,03	p=0,03	NN
cord-005453-4057qib7	5824	21	)	)	-RRB-
cord-005453-4057qib7	5824	22	.	.	.
cord-005453-4057qib7	5825	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5825	2	:	:	:
cord-005453-4057qib7	5826	1	ECP	ECP	NNP
cord-005453-4057qib7	5826	2	enables	enable	VBZ
cord-005453-4057qib7	5826	3	successful	successful	JJ
cord-005453-4057qib7	5826	4	tapering	tapering	NN
cord-005453-4057qib7	5826	5	or	or	CC
cord-005453-4057qib7	5826	6	withdrawal	withdrawal	NN
cord-005453-4057qib7	5826	7	of	of	IN
cord-005453-4057qib7	5826	8	steroid	steroid	NN
cord-005453-4057qib7	5826	9	therapy	therapy	NN
cord-005453-4057qib7	5826	10	in	in	IN
cord-005453-4057qib7	5826	11	many	many	JJ
cord-005453-4057qib7	5826	12	patients	patient	NNS
cord-005453-4057qib7	5826	13	,	,	,
cord-005453-4057qib7	5826	14	even	even	RB
cord-005453-4057qib7	5826	15	in	in	IN
cord-005453-4057qib7	5826	16	those	those	DT
cord-005453-4057qib7	5826	17	who	who	WP
cord-005453-4057qib7	5826	18	are	be	VBP
cord-005453-4057qib7	5826	19	steroid	steroid	NN
cord-005453-4057qib7	5826	20	refractory	refractory	JJ
cord-005453-4057qib7	5826	21	or	or	CC
cord-005453-4057qib7	5826	22	steroid	steroid	NN
cord-005453-4057qib7	5826	23	dependent	dependent	JJ
cord-005453-4057qib7	5826	24	.	.	.
cord-005453-4057qib7	5827	1	Reduction	reduction	NN
cord-005453-4057qib7	5827	2	of	of	IN
cord-005453-4057qib7	5827	3	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	5827	4	leads	lead	VBZ
cord-005453-4057qib7	5827	5	to	to	IN
cord-005453-4057qib7	5827	6	reduced	reduce	VBN
cord-005453-4057qib7	5827	7	incidence	incidence	NN
cord-005453-4057qib7	5827	8	of	of	IN
cord-005453-4057qib7	5827	9	infection	infection	NN
cord-005453-4057qib7	5827	10	and	and	CC
cord-005453-4057qib7	5827	11	relapse	relapse	NN
cord-005453-4057qib7	5827	12	which	which	WDT
cord-005453-4057qib7	5827	13	translates	translate	VBZ
cord-005453-4057qib7	5827	14	into	into	IN
cord-005453-4057qib7	5827	15	a	a	DT
cord-005453-4057qib7	5827	16	better	well	JJR
cord-005453-4057qib7	5827	17	overall	overall	JJ
cord-005453-4057qib7	5827	18	survival	survival	NN
cord-005453-4057qib7	5827	19	.	.	.
cord-005453-4057qib7	5828	1	Background	background	NN
cord-005453-4057qib7	5828	2	:	:	:
cord-005453-4057qib7	5829	1	The	the	DT
cord-005453-4057qib7	5829	2	curative	curative	JJ
cord-005453-4057qib7	5829	3	potential	potential	NN
cord-005453-4057qib7	5829	4	of	of	IN
cord-005453-4057qib7	5829	5	allogenic	allogenic	JJ
cord-005453-4057qib7	5829	6	stem	stem	NN
cord-005453-4057qib7	5829	7	cell	cell	NN
cord-005453-4057qib7	5829	8	transplantation	transplantation	NN
cord-005453-4057qib7	5829	9	is	be	VBZ
cord-005453-4057qib7	5829	10	hampered	hamper	VBN
cord-005453-4057qib7	5829	11	by	by	IN
cord-005453-4057qib7	5829	12	Graft	graft	NN
cord-005453-4057qib7	5829	13	-	-	HYPH
cord-005453-4057qib7	5829	14	Versus	Versus	NNP
cord-005453-4057qib7	5829	15	-	-	HYPH
cord-005453-4057qib7	5829	16	Host	host	NN
cord-005453-4057qib7	5829	17	disease	disease	NN
cord-005453-4057qib7	5829	18	(	(	-LRB-
cord-005453-4057qib7	5829	19	GVHD	GVHD	NNP
cord-005453-4057qib7	5829	20	)	)	-RRB-
cord-005453-4057qib7	5829	21	.	.	.
cord-005453-4057qib7	5830	1	Pre	pre	JJ
cord-005453-4057qib7	5830	2	-	-	JJ
cord-005453-4057qib7	5830	3	clinical	clinical	JJ
cord-005453-4057qib7	5830	4	study	study	NN
cord-005453-4057qib7	5830	5	showed	show	VBD
cord-005453-4057qib7	5830	6	an	an	DT
cord-005453-4057qib7	5830	7	efficacity	efficacity	NN
cord-005453-4057qib7	5830	8	of	of	IN
cord-005453-4057qib7	5830	9	JAK1/2	JAK1/2	NNP
cord-005453-4057qib7	5831	1	inhibitor	inhibitor	NN
cord-005453-4057qib7	5831	2	,	,	,
cord-005453-4057qib7	5831	3	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5831	4	,	,	,
cord-005453-4057qib7	5831	5	in	in	IN
cord-005453-4057qib7	5831	6	treatment	treatment	NN
cord-005453-4057qib7	5831	7	of	of	IN
cord-005453-4057qib7	5831	8	steroidrefractory	steroidrefractory	NNP
cord-005453-4057qib7	5831	9	GVHD	GVHD	NNP
cord-005453-4057qib7	5831	10	.	.	.
cord-005453-4057qib7	5832	1	Methods	method	NNS
cord-005453-4057qib7	5832	2	:	:	:
cord-005453-4057qib7	5833	1	We	-PRON-	PRP
cord-005453-4057qib7	5833	2	reported	report	VBD
cord-005453-4057qib7	5833	3	in	in	IN
cord-005453-4057qib7	5833	4	this	this	DT
cord-005453-4057qib7	5833	5	monocentric	monocentric	JJ
cord-005453-4057qib7	5833	6	retrospective	retrospective	JJ
cord-005453-4057qib7	5833	7	study	study	NN
cord-005453-4057qib7	5833	8	,	,	,
cord-005453-4057qib7	5833	9	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	5833	10	response	response	NN
cord-005453-4057qib7	5833	11	and	and	CC
cord-005453-4057qib7	5833	12	follow	follow	VB
cord-005453-4057qib7	5833	13	up	up	IN
cord-005453-4057qib7	5833	14	of	of	IN
cord-005453-4057qib7	5833	15	44	44	CD
cord-005453-4057qib7	5833	16	cases	case	NNS
cord-005453-4057qib7	5833	17	of	of	IN
cord-005453-4057qib7	5833	18	chronic	chronic	JJ
cord-005453-4057qib7	5833	19	GVHD	GVHD	NNP
cord-005453-4057qib7	5833	20	(	(	-LRB-
cord-005453-4057qib7	5833	21	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5833	22	)	)	-RRB-
cord-005453-4057qib7	5833	23	not	not	RB
cord-005453-4057qib7	5833	24	improved	improve	VBN
cord-005453-4057qib7	5833	25	with	with	IN
cord-005453-4057qib7	5833	26	standard	standard	JJ
cord-005453-4057qib7	5833	27	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5833	28	therapy	therapy	NN
cord-005453-4057qib7	5833	29	.	.	.
cord-005453-4057qib7	5834	1	Complete	complete	JJ
cord-005453-4057qib7	5834	2	organ	organ	NN
cord-005453-4057qib7	5834	3	response	response	NN
cord-005453-4057qib7	5834	4	(	(	-LRB-
cord-005453-4057qib7	5834	5	CR	CR	NNP
cord-005453-4057qib7	5834	6	)	)	-RRB-
cord-005453-4057qib7	5834	7	was	be	VBD
cord-005453-4057qib7	5834	8	defined	define	VBN
cord-005453-4057qib7	5834	9	as	as	IN
cord-005453-4057qib7	5834	10	the	the	DT
cord-005453-4057qib7	5834	11	resolution	resolution	NN
cord-005453-4057qib7	5834	12	of	of	IN
cord-005453-4057qib7	5834	13	clinical	clinical	JJ
cord-005453-4057qib7	5834	14	manifestations	manifestation	NNS
cord-005453-4057qib7	5834	15	of	of	IN
cord-005453-4057qib7	5834	16	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5834	17	in	in	IN
cord-005453-4057qib7	5834	18	a	a	DT
cord-005453-4057qib7	5834	19	specific	specific	JJ
cord-005453-4057qib7	5834	20	organ	organ	NN
cord-005453-4057qib7	5834	21	.	.	.
cord-005453-4057qib7	5835	1	Very	very	RB
cord-005453-4057qib7	5835	2	good	good	JJ
cord-005453-4057qib7	5835	3	response	response	NN
cord-005453-4057qib7	5835	4	partial	partial	JJ
cord-005453-4057qib7	5835	5	(	(	-LRB-
cord-005453-4057qib7	5835	6	VGPR	VGPR	NNP
cord-005453-4057qib7	5835	7	)	)	-RRB-
cord-005453-4057qib7	5835	8	was	be	VBD
cord-005453-4057qib7	5835	9	defined	define	VBN
cord-005453-4057qib7	5835	10	as	as	IN
cord-005453-4057qib7	5835	11	an	an	DT
cord-005453-4057qib7	5835	12	improvement	improvement	NN
cord-005453-4057qib7	5835	13	of	of	IN
cord-005453-4057qib7	5835	14	clinical	clinical	JJ
cord-005453-4057qib7	5835	15	manifestations	manifestation	NNS
cord-005453-4057qib7	5835	16	of	of	IN
cord-005453-4057qib7	5835	17	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5835	18	with	with	IN
cord-005453-4057qib7	5835	19	more	more	JJR
cord-005453-4057qib7	5835	20	than	than	IN
cord-005453-4057qib7	5835	21	50	50	CD
cord-005453-4057qib7	5835	22	%	%	NN
cord-005453-4057qib7	5835	23	decrease	decrease	NN
cord-005453-4057qib7	5835	24	of	of	IN
cord-005453-4057qib7	5835	25	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	5835	26	,	,	,
cord-005453-4057qib7	5835	27	while	while	IN
cord-005453-4057qib7	5835	28	a	a	DT
cord-005453-4057qib7	5835	29	partial	partial	JJ
cord-005453-4057qib7	5835	30	response	response	NN
cord-005453-4057qib7	5835	31	(	(	-LRB-
cord-005453-4057qib7	5835	32	PR	PR	NNP
cord-005453-4057qib7	5835	33	)	)	-RRB-
cord-005453-4057qib7	5835	34	was	be	VBD
cord-005453-4057qib7	5835	35	associated	associate	VBN
cord-005453-4057qib7	5835	36	with	with	IN
cord-005453-4057qib7	5835	37	less	less	JJR
cord-005453-4057qib7	5835	38	than	than	IN
cord-005453-4057qib7	5835	39	50	50	CD
cord-005453-4057qib7	5835	40	%	%	NN
cord-005453-4057qib7	5835	41	decrease	decrease	NN
cord-005453-4057qib7	5835	42	of	of	IN
cord-005453-4057qib7	5835	43	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	5835	44	.	.	.
cord-005453-4057qib7	5836	1	Treatment	treatment	NN
cord-005453-4057qib7	5836	2	failure	failure	NN
cord-005453-4057qib7	5836	3	was	be	VBD
cord-005453-4057qib7	5836	4	defined	define	VBN
cord-005453-4057qib7	5836	5	by	by	IN
cord-005453-4057qib7	5836	6	the	the	DT
cord-005453-4057qib7	5836	7	absence	absence	NN
cord-005453-4057qib7	5836	8	of	of	IN
cord-005453-4057qib7	5836	9	improvement	improvement	NN
cord-005453-4057qib7	5836	10	of	of	IN
cord-005453-4057qib7	5836	11	cGVHD	cgvhd	NN
cord-005453-4057qib7	5836	12	,	,	,
cord-005453-4057qib7	5836	13	deterioration	deterioration	NN
cord-005453-4057qib7	5836	14	of	of	IN
cord-005453-4057qib7	5836	15	cGVHD	cgvhd	NN
cord-005453-4057qib7	5836	16	in	in	IN
cord-005453-4057qib7	5836	17	any	any	DT
cord-005453-4057qib7	5836	18	organ	organ	NN
cord-005453-4057qib7	5836	19	by	by	IN
cord-005453-4057qib7	5836	20	at	at	RB
cord-005453-4057qib7	5836	21	least	least	RBS
cord-005453-4057qib7	5836	22	one	one	CD
cord-005453-4057qib7	5836	23	stage	stage	NN
cord-005453-4057qib7	5836	24	,	,	,
cord-005453-4057qib7	5836	25	the	the	DT
cord-005453-4057qib7	5836	26	development	development	NN
cord-005453-4057qib7	5836	27	of	of	IN
cord-005453-4057qib7	5836	28	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5836	29	manifestations	manifestation	NNS
cord-005453-4057qib7	5836	30	in	in	IN
cord-005453-4057qib7	5836	31	a	a	DT
cord-005453-4057qib7	5836	32	previously	previously	RB
cord-005453-4057qib7	5836	33	unaffected	unaffected	JJ
cord-005453-4057qib7	5836	34	organ	organ	NN
cord-005453-4057qib7	5836	35	,	,	,
cord-005453-4057qib7	5836	36	and	and	CC
cord-005453-4057qib7	5836	37	the	the	DT
cord-005453-4057qib7	5836	38	use	use	NN
cord-005453-4057qib7	5836	39	of	of	IN
cord-005453-4057qib7	5836	40	any	any	DT
cord-005453-4057qib7	5836	41	additional	additional	JJ
cord-005453-4057qib7	5836	42	agents	agent	NNS
cord-005453-4057qib7	5836	43	to	to	TO
cord-005453-4057qib7	5836	44	control	control	VB
cord-005453-4057qib7	5836	45	the	the	DT
cord-005453-4057qib7	5836	46	disease	disease	NN
cord-005453-4057qib7	5836	47	.	.	.
cord-005453-4057qib7	5837	1	Results	result	NNS
cord-005453-4057qib7	5837	2	:	:	:
cord-005453-4057qib7	5838	1	Median	median	JJ
cord-005453-4057qib7	5838	2	age	age	NN
cord-005453-4057qib7	5838	3	at	at	IN
cord-005453-4057qib7	5838	4	transplant	transplant	NN
cord-005453-4057qib7	5838	5	was	be	VBD
cord-005453-4057qib7	5838	6	52	52	CD
cord-005453-4057qib7	5838	7	years	year	NNS
cord-005453-4057qib7	5839	1	(	(	-LRB-
cord-005453-4057qib7	5839	2	range	range	NN
cord-005453-4057qib7	5839	3	,	,	,
cord-005453-4057qib7	5839	4	19	19	CD
cord-005453-4057qib7	5839	5	-	-	SYM
cord-005453-4057qib7	5839	6	66	66	CD
cord-005453-4057qib7	5839	7	)	)	-RRB-
cord-005453-4057qib7	5839	8	.	.	.
cord-005453-4057qib7	5840	1	59	59	CD
cord-005453-4057qib7	5840	2	%	%	NN
cord-005453-4057qib7	5840	3	of	of	IN
cord-005453-4057qib7	5840	4	patients	patient	NNS
cord-005453-4057qib7	5840	5	presented	present	VBD
cord-005453-4057qib7	5840	6	an	an	DT
cord-005453-4057qib7	5840	7	acute	acute	JJ
cord-005453-4057qib7	5840	8	myeloid	myeloid	NN
cord-005453-4057qib7	5840	9	leukemia	leukemia	NN
cord-005453-4057qib7	5840	10	.	.	.
cord-005453-4057qib7	5841	1	Donor	donor	NN
cord-005453-4057qib7	5841	2	type	type	NN
cord-005453-4057qib7	5841	3	was	be	VBD
cord-005453-4057qib7	5841	4	sibling	sible	VBG
cord-005453-4057qib7	5841	5	(	(	-LRB-
cord-005453-4057qib7	5841	6	n=12	n=12	NNP
cord-005453-4057qib7	5841	7	)	)	-RRB-
cord-005453-4057qib7	5841	8	,	,	,
cord-005453-4057qib7	5841	9	unrelated	unrelated	JJ
cord-005453-4057qib7	5841	10	(	(	-LRB-
cord-005453-4057qib7	5841	11	n=24	n=24	NNP
cord-005453-4057qib7	5841	12	)	)	-RRB-
cord-005453-4057qib7	5841	13	or	or	CC
cord-005453-4057qib7	5841	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	5841	15	(	(	-LRB-
cord-005453-4057qib7	5841	16	n=6).Two	n=6).Two	NNP
cord-005453-4057qib7	5841	17	patients	patient	NNS
cord-005453-4057qib7	5841	18	benefited	benefit	VBD
cord-005453-4057qib7	5841	19	a	a	DT
cord-005453-4057qib7	5841	20	cord	cord	NN
cord-005453-4057qib7	5841	21	blood	blood	NN
cord-005453-4057qib7	5841	22	transplant	transplant	NN
cord-005453-4057qib7	5841	23	.	.	.
cord-005453-4057qib7	5842	1	Patients	patient	NNS
cord-005453-4057qib7	5842	2	received	receive	VBD
cord-005453-4057qib7	5842	3	either	either	CC
cord-005453-4057qib7	5842	4	myeloablative	myeloablative	NNP
cord-005453-4057qib7	5842	5	(	(	-LRB-
cord-005453-4057qib7	5842	6	64	64	CD
cord-005453-4057qib7	5842	7	%	%	NN
cord-005453-4057qib7	5842	8	)	)	-RRB-
cord-005453-4057qib7	5842	9	or	or	CC
cord-005453-4057qib7	5842	10	reduced	reduce	VBN
cord-005453-4057qib7	5842	11	intensity	intensity	NN
cord-005453-4057qib7	5842	12	(	(	-LRB-
cord-005453-4057qib7	5842	13	36	36	CD
cord-005453-4057qib7	5842	14	%	%	NN
cord-005453-4057qib7	5842	15	)	)	-RRB-
cord-005453-4057qib7	5842	16	conditioning	conditioning	NN
cord-005453-4057qib7	5842	17	regimens	regimen	NNS
cord-005453-4057qib7	5842	18	.	.	.
cord-005453-4057qib7	5843	1	Stem	stem	JJ
cord-005453-4057qib7	5843	2	cell	cell	NN
cord-005453-4057qib7	5843	3	source	source	NN
cord-005453-4057qib7	5843	4	was	be	VBD
cord-005453-4057qib7	5843	5	peripheral	peripheral	JJ
cord-005453-4057qib7	5843	6	blood	blood	NN
cord-005453-4057qib7	5843	7	for	for	IN
cord-005453-4057qib7	5843	8	75	75	CD
cord-005453-4057qib7	5843	9	%	%	NN
cord-005453-4057qib7	5843	10	of	of	IN
cord-005453-4057qib7	5843	11	patients	patient	NNS
cord-005453-4057qib7	5843	12	.	.	.
cord-005453-4057qib7	5844	1	Patients	patient	NNS
cord-005453-4057qib7	5844	2	presented	present	VBD
cord-005453-4057qib7	5844	3	mild	mild	JJ
cord-005453-4057qib7	5844	4	(	(	-LRB-
cord-005453-4057qib7	5844	5	n=11	n=11	FW
cord-005453-4057qib7	5844	6	)	)	-RRB-
cord-005453-4057qib7	5844	7	,	,	,
cord-005453-4057qib7	5844	8	moderate	moderate	JJ
cord-005453-4057qib7	5844	9	(	(	-LRB-
cord-005453-4057qib7	5844	10	n=21	n=21	JJ
cord-005453-4057qib7	5844	11	)	)	-RRB-
cord-005453-4057qib7	5844	12	or	or	CC
cord-005453-4057qib7	5844	13	severe	severe	JJ
cord-005453-4057qib7	5844	14	(	(	-LRB-
cord-005453-4057qib7	5844	15	n=12	n=12	NNP
cord-005453-4057qib7	5844	16	)	)	-RRB-
cord-005453-4057qib7	5844	17	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5845	1	according	accord	VBG
cord-005453-4057qib7	5845	2	to	to	IN
cord-005453-4057qib7	5845	3	NIH	NIH	NNP
cord-005453-4057qib7	5845	4	score	score	NN
cord-005453-4057qib7	5845	5	.	.	.
cord-005453-4057qib7	5846	1	Median	median	JJ
cord-005453-4057qib7	5846	2	number	number	NN
cord-005453-4057qib7	5846	3	of	of	IN
cord-005453-4057qib7	5846	4	regimens	regimen	NNS
cord-005453-4057qib7	5846	5	prior	prior	RB
cord-005453-4057qib7	5846	6	to	to	IN
cord-005453-4057qib7	5846	7	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5846	8	was	be	VBD
cord-005453-4057qib7	5846	9	1	1	CD
cord-005453-4057qib7	5847	1	(	(	-LRB-
cord-005453-4057qib7	5847	2	range	range	NN
cord-005453-4057qib7	5847	3	,	,	,
cord-005453-4057qib7	5847	4	0	0	CD
cord-005453-4057qib7	5847	5	-	-	SYM
cord-005453-4057qib7	5847	6	6	6	CD
cord-005453-4057qib7	5847	7	)	)	-RRB-
cord-005453-4057qib7	5847	8	,	,	,
cord-005453-4057qib7	5847	9	among	among	IN
cord-005453-4057qib7	5847	10	those	those	DT
cord-005453-4057qib7	5847	11	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5847	12	(	(	-LRB-
cord-005453-4057qib7	5847	13	n=36	n=36	NNS
cord-005453-4057qib7	5847	14	)	)	-RRB-
cord-005453-4057qib7	5847	15	.	.	.
cord-005453-4057qib7	5848	1	Median	median	JJ
cord-005453-4057qib7	5848	2	follow	follow	NN
cord-005453-4057qib7	5848	3	-	-	HYPH
cord-005453-4057qib7	5848	4	up	up	NN
cord-005453-4057qib7	5848	5	after	after	IN
cord-005453-4057qib7	5848	6	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5848	7	was	be	VBD
cord-005453-4057qib7	5848	8	18	18	CD
cord-005453-4057qib7	5848	9	months	month	NNS
cord-005453-4057qib7	5848	10	(	(	-LRB-
cord-005453-4057qib7	5848	11	range	range	NN
cord-005453-4057qib7	5848	12	,	,	,
cord-005453-4057qib7	5848	13	4	4	CD
cord-005453-4057qib7	5848	14	-	-	SYM
cord-005453-4057qib7	5848	15	32	32	CD
cord-005453-4057qib7	5848	16	)	)	-RRB-
cord-005453-4057qib7	5848	17	.	.	.
cord-005453-4057qib7	5849	1	Overall	overall	JJ
cord-005453-4057qib7	5849	2	responses	response	NNS
cord-005453-4057qib7	5849	3	rate	rate	NN
cord-005453-4057qib7	5849	4	(	(	-LRB-
cord-005453-4057qib7	5849	5	ORR	ORR	NNP
cord-005453-4057qib7	5849	6	)	)	-RRB-
cord-005453-4057qib7	5849	7	at	at	IN
cord-005453-4057qib7	5849	8	1	1	CD
cord-005453-4057qib7	5849	9	month	month	NN
cord-005453-4057qib7	5849	10	was	be	VBD
cord-005453-4057qib7	5849	11	84	84	CD
cord-005453-4057qib7	5849	12	%	%	NN
cord-005453-4057qib7	5849	13	with	with	IN
cord-005453-4057qib7	5849	14	34	34	CD
cord-005453-4057qib7	5849	15	%	%	NN
cord-005453-4057qib7	5849	16	CR	cr	NN
cord-005453-4057qib7	5849	17	,	,	,
cord-005453-4057qib7	5849	18	6	6	CD
cord-005453-4057qib7	5849	19	%	%	NN
cord-005453-4057qib7	5849	20	VGPR	vgpr	NN
cord-005453-4057qib7	5849	21	and	and	CC
cord-005453-4057qib7	5849	22	43	43	CD
cord-005453-4057qib7	5849	23	%	%	NN
cord-005453-4057qib7	5849	24	PR	pr	NN
cord-005453-4057qib7	5849	25	(	(	-LRB-
cord-005453-4057qib7	5849	26	Figure	figure	NN
cord-005453-4057qib7	5849	27	1	1	CD
cord-005453-4057qib7	5849	28	)	)	-RRB-
cord-005453-4057qib7	5849	29	.	.	.
cord-005453-4057qib7	5850	1	13	13	CD
cord-005453-4057qib7	5850	2	%	%	NN
cord-005453-4057qib7	5850	3	of	of	IN
cord-005453-4057qib7	5850	4	patients	patient	NNS
cord-005453-4057qib7	5850	5	failed	fail	VBD
cord-005453-4057qib7	5850	6	at	at	IN
cord-005453-4057qib7	5850	7	1	1	CD
cord-005453-4057qib7	5850	8	month	month	NN
cord-005453-4057qib7	5850	9	after	after	IN
cord-005453-4057qib7	5850	10	introduction	introduction	NN
cord-005453-4057qib7	5850	11	of	of	IN
cord-005453-4057qib7	5850	12	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5850	13	.	.	.
cord-005453-4057qib7	5851	1	The	the	DT
cord-005453-4057qib7	5851	2	rate	rate	NN
cord-005453-4057qib7	5851	3	of	of	IN
cord-005453-4057qib7	5851	4	CR	cr	NN
cord-005453-4057qib7	5851	5	increased	increase	VBD
cord-005453-4057qib7	5851	6	with	with	IN
cord-005453-4057qib7	5851	7	time	time	NN
cord-005453-4057qib7	5851	8	:	:	:
cord-005453-4057qib7	5851	9	45	45	CD
cord-005453-4057qib7	5851	10	%	%	NN
cord-005453-4057qib7	5851	11	at	at	IN
cord-005453-4057qib7	5851	12	3	3	CD
cord-005453-4057qib7	5851	13	months	month	NNS
cord-005453-4057qib7	5851	14	(	(	-LRB-
cord-005453-4057qib7	5851	15	n=38	n=38	NNP
cord-005453-4057qib7	5851	16	)	)	-RRB-
cord-005453-4057qib7	5851	17	,	,	,
cord-005453-4057qib7	5851	18	53	53	CD
cord-005453-4057qib7	5851	19	%	%	NN
cord-005453-4057qib7	5851	20	at	at	IN
cord-005453-4057qib7	5851	21	6	6	CD
cord-005453-4057qib7	5851	22	months	month	NNS
cord-005453-4057qib7	5851	23	(	(	-LRB-
cord-005453-4057qib7	5851	24	n=30	n=30	NNP
cord-005453-4057qib7	5851	25	)	)	-RRB-
cord-005453-4057qib7	5851	26	and	and	CC
cord-005453-4057qib7	5851	27	65	65	CD
cord-005453-4057qib7	5851	28	%	%	NN
cord-005453-4057qib7	5851	29	at	at	IN
cord-005453-4057qib7	5851	30	12	12	CD
cord-005453-4057qib7	5851	31	months	month	NNS
cord-005453-4057qib7	5851	32	(	(	-LRB-
cord-005453-4057qib7	5851	33	n=23	n=23	NN
cord-005453-4057qib7	5851	34	)	)	-RRB-
cord-005453-4057qib7	5851	35	.	.	.
cord-005453-4057qib7	5852	1	But	but	CC
cord-005453-4057qib7	5852	2	VGPR	VGPR	NNP
cord-005453-4057qib7	5852	3	rate	rate	NN
cord-005453-4057qib7	5852	4	was	be	VBD
cord-005453-4057qib7	5852	5	rather	rather	RB
cord-005453-4057qib7	5852	6	stable	stable	JJ
cord-005453-4057qib7	5852	7	at	at	IN
cord-005453-4057qib7	5852	8	3	3	CD
cord-005453-4057qib7	5852	9	months	month	NNS
cord-005453-4057qib7	5852	10	(	(	-LRB-
cord-005453-4057qib7	5852	11	24	24	CD
cord-005453-4057qib7	5852	12	%	%	NN
cord-005453-4057qib7	5852	13	)	)	-RRB-
cord-005453-4057qib7	5852	14	,	,	,
cord-005453-4057qib7	5852	15	at	at	IN
cord-005453-4057qib7	5852	16	6	6	CD
cord-005453-4057qib7	5852	17	months	month	NNS
cord-005453-4057qib7	5852	18	(	(	-LRB-
cord-005453-4057qib7	5852	19	33	33	CD
cord-005453-4057qib7	5852	20	%	%	NN
cord-005453-4057qib7	5852	21	)	)	-RRB-
cord-005453-4057qib7	5852	22	and	and	CC
cord-005453-4057qib7	5852	23	at	at	IN
cord-005453-4057qib7	5852	24	12	12	CD
cord-005453-4057qib7	5852	25	months	month	NNS
cord-005453-4057qib7	5852	26	(	(	-LRB-
cord-005453-4057qib7	5852	27	22	22	CD
cord-005453-4057qib7	5852	28	%	%	NN
cord-005453-4057qib7	5852	29	)	)	-RRB-
cord-005453-4057qib7	5852	30	vs	vs	IN
cord-005453-4057qib7	5852	31	6	6	CD
cord-005453-4057qib7	5852	32	%	%	NN
cord-005453-4057qib7	5852	33	at	at	IN
cord-005453-4057qib7	5852	34	1	1	CD
cord-005453-4057qib7	5852	35	month	month	NN
cord-005453-4057qib7	5852	36	.	.	.
cord-005453-4057qib7	5853	1	Among	among	IN
cord-005453-4057qib7	5853	2	the	the	DT
cord-005453-4057qib7	5853	3	patients	patient	NNS
cord-005453-4057qib7	5853	4	under	under	IN
cord-005453-4057qib7	5853	5	steroids	steroid	NNS
cord-005453-4057qib7	5853	6	,	,	,
cord-005453-4057qib7	5853	7	21	21	CD
cord-005453-4057qib7	5853	8	(	(	-LRB-
cord-005453-4057qib7	5853	9	58	58	CD
cord-005453-4057qib7	5853	10	%	%	NN
cord-005453-4057qib7	5853	11	)	)	-RRB-
cord-005453-4057qib7	5853	12	patients	patient	NNS
cord-005453-4057qib7	5853	13	discontinued	discontinue	VBD
cord-005453-4057qib7	5853	14	steroids	steroid	NNS
cord-005453-4057qib7	5853	15	.	.	.
cord-005453-4057qib7	5854	1	The	the	DT
cord-005453-4057qib7	5854	2	12-months	12-months	CD
cord-005453-4057qib7	5854	3	overall	overall	JJ
cord-005453-4057qib7	5854	4	survival	survival	NN
cord-005453-4057qib7	5854	5	(	(	-LRB-
cord-005453-4057qib7	5854	6	OS	OS	NNP
cord-005453-4057qib7	5854	7	)	)	-RRB-
cord-005453-4057qib7	5854	8	and	and	CC
cord-005453-4057qib7	5854	9	diseasefree	diseasefree	NNP
cord-005453-4057qib7	5854	10	survival	survival	NNP
cord-005453-4057qib7	5854	11	(	(	-LRB-
cord-005453-4057qib7	5854	12	DFS	DFS	NNP
cord-005453-4057qib7	5854	13	)	)	-RRB-
cord-005453-4057qib7	5855	1	after	after	IN
cord-005453-4057qib7	5855	2	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5855	3	was	be	VBD
cord-005453-4057qib7	5855	4	89	89	CD
cord-005453-4057qib7	5855	5	%	%	NN
cord-005453-4057qib7	5855	6	(	(	-LRB-
cord-005453-4057qib7	5855	7	80%-99	80%-99	CD
cord-005453-4057qib7	5855	8	%	%	NN
cord-005453-4057qib7	5855	9	,	,	,
cord-005453-4057qib7	5855	10	95	95	CD
cord-005453-4057qib7	5855	11	%	%	NN
cord-005453-4057qib7	5855	12	CI	CI	NNP
cord-005453-4057qib7	5855	13	)	)	-RRB-
cord-005453-4057qib7	5855	14	and	and	CC
cord-005453-4057qib7	5855	15	86	86	CD
cord-005453-4057qib7	5855	16	%	%	NN
cord-005453-4057qib7	5855	17	(	(	-LRB-
cord-005453-4057qib7	5855	18	76%-96	76%-96	CD
cord-005453-4057qib7	5855	19	%	%	NN
cord-005453-4057qib7	5855	20	,	,	,
cord-005453-4057qib7	5855	21	95	95	CD
cord-005453-4057qib7	5855	22	%	%	NN
cord-005453-4057qib7	5855	23	CI	CI	NNP
cord-005453-4057qib7	5855	24	)	)	-RRB-
cord-005453-4057qib7	5855	25	,	,	,
cord-005453-4057qib7	5855	26	respectively	respectively	RB
cord-005453-4057qib7	5855	27	.	.	.
cord-005453-4057qib7	5856	1	Severe	severe	JJ
cord-005453-4057qib7	5856	2	cytopenia	cytopenia	NNS
cord-005453-4057qib7	5856	3	(	(	-LRB-
cord-005453-4057qib7	5856	4	grade	grade	NN
cord-005453-4057qib7	5856	5	3	3	CD
cord-005453-4057qib7	5856	6	and	and	CC
cord-005453-4057qib7	5856	7	4	4	CD
cord-005453-4057qib7	5856	8	)	)	-RRB-
cord-005453-4057qib7	5856	9	was	be	VBD
cord-005453-4057qib7	5856	10	observed	observe	VBN
cord-005453-4057qib7	5856	11	in	in	IN
cord-005453-4057qib7	5856	12	12	12	CD
cord-005453-4057qib7	5856	13	patients	patient	NNS
cord-005453-4057qib7	5856	14	.	.	.
cord-005453-4057qib7	5857	1	After	after	IN
cord-005453-4057qib7	5857	2	introduction	introduction	NN
cord-005453-4057qib7	5857	3	of	of	IN
cord-005453-4057qib7	5857	4	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5857	5	,	,	,
cord-005453-4057qib7	5857	6	4	4	CD
cord-005453-4057qib7	5857	7	patients	patient	NNS
cord-005453-4057qib7	5857	8	presented	present	VBD
cord-005453-4057qib7	5857	9	bacterial	bacterial	JJ
cord-005453-4057qib7	5857	10	infections	infection	NNS
cord-005453-4057qib7	5857	11	,	,	,
cord-005453-4057qib7	5857	12	3	3	CD
cord-005453-4057qib7	5857	13	patients	patient	NNS
cord-005453-4057qib7	5857	14	presented	present	VBD
cord-005453-4057qib7	5857	15	an	an	DT
cord-005453-4057qib7	5857	16	invasive	invasive	JJ
cord-005453-4057qib7	5857	17	pulmonary	pulmonary	JJ
cord-005453-4057qib7	5857	18	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	5857	19	and	and	CC
cord-005453-4057qib7	5857	20	1	1	CD
cord-005453-4057qib7	5857	21	patient	patient	NN
cord-005453-4057qib7	5857	22	developped	developpe	VBD
cord-005453-4057qib7	5857	23	a	a	DT
cord-005453-4057qib7	5857	24	pneumocystis	pneumocystis	NN
cord-005453-4057qib7	5857	25	.	.	.
cord-005453-4057qib7	5858	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	5858	2	reactivation	reactivation	NN
cord-005453-4057qib7	5858	3	requiring	require	VBG
cord-005453-4057qib7	5858	4	preemptive	preemptive	JJ
cord-005453-4057qib7	5858	5	treatment	treatment	NN
cord-005453-4057qib7	5858	6	was	be	VBD
cord-005453-4057qib7	5858	7	observed	observe	VBN
cord-005453-4057qib7	5858	8	in	in	IN
cord-005453-4057qib7	5858	9	7	7	CD
cord-005453-4057qib7	5858	10	patients	patient	NNS
cord-005453-4057qib7	5858	11	.	.	.
cord-005453-4057qib7	5859	1	No	no	DT
cord-005453-4057qib7	5859	2	toxicities	toxicity	NNS
cord-005453-4057qib7	5859	3	required	require	VBD
cord-005453-4057qib7	5859	4	withdrawal	withdrawal	NN
cord-005453-4057qib7	5859	5	of	of	IN
cord-005453-4057qib7	5859	6	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	5859	7	.	.	.
cord-005453-4057qib7	5860	1	[	[	-LRB-
cord-005453-4057qib7	5860	2	[	[	-LRB-
cord-005453-4057qib7	5860	3	P269	P269	``
cord-005453-4057qib7	5860	4	Image	image	NN
cord-005453-4057qib7	5860	5	]	]	-RRB-
cord-005453-4057qib7	5860	6	1	1	CD
cord-005453-4057qib7	5860	7	.	.	.
cord-005453-4057qib7	5861	1	Figure	figure	NN
cord-005453-4057qib7	5861	2	1	1	CD
cord-005453-4057qib7	5861	3	and	and	CC
cord-005453-4057qib7	5861	4	partial	partial	JJ
cord-005453-4057qib7	5861	5	response	response	NN
cord-005453-4057qib7	5861	6	to	to	IN
cord-005453-4057qib7	5861	7	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	5861	8	stem	stem	NN
cord-005453-4057qib7	5861	9	cells	cell	NNS
cord-005453-4057qib7	5861	10	(	(	-LRB-
cord-005453-4057qib7	5861	11	MSC	MSC	NNP
cord-005453-4057qib7	5861	12	)	)	-RRB-
cord-005453-4057qib7	5861	13	,	,	,
cord-005453-4057qib7	5861	14	as	as	IN
cord-005453-4057qib7	5861	15	second	second	JJ
cord-005453-4057qib7	5861	16	-	-	HYPH
cord-005453-4057qib7	5861	17	line	line	NN
cord-005453-4057qib7	5861	18	therapy	therapy	NN
cord-005453-4057qib7	5861	19	,	,	,
cord-005453-4057qib7	5861	20	varies	vary	VBZ
cord-005453-4057qib7	5861	21	from	from	IN
cord-005453-4057qib7	5861	22	15	15	CD
cord-005453-4057qib7	5861	23	%	%	NN
cord-005453-4057qib7	5861	24	to	to	IN
cord-005453-4057qib7	5861	25	82	82	CD
cord-005453-4057qib7	5861	26	%	%	NN
cord-005453-4057qib7	5861	27	in	in	IN
cord-005453-4057qib7	5861	28	acute	acute	JJ
cord-005453-4057qib7	5861	29	GVHD	GVHD	NNP
cord-005453-4057qib7	5861	30	patients	patient	NNS
cord-005453-4057qib7	5861	31	.	.	.
cord-005453-4057qib7	5862	1	We	-PRON-	PRP
cord-005453-4057qib7	5862	2	report	report	VBP
cord-005453-4057qib7	5862	3	our	-PRON-	PRP$
cord-005453-4057qib7	5862	4	experience	experience	NN
cord-005453-4057qib7	5862	5	using	use	VBG
cord-005453-4057qib7	5862	6	MSCs	msc	NNS
cord-005453-4057qib7	5862	7	to	to	TO
cord-005453-4057qib7	5862	8	treat	treat	VB
cord-005453-4057qib7	5862	9	refractory	refractory	JJ
cord-005453-4057qib7	5862	10	aGVHD	agvhd	NN
cord-005453-4057qib7	5862	11	.	.	.
cord-005453-4057qib7	5863	1	Methods	method	NNS
cord-005453-4057qib7	5863	2	:	:	:
cord-005453-4057qib7	5864	1	The	the	DT
cord-005453-4057qib7	5864	2	study	study	NN
cord-005453-4057qib7	5864	3	was	be	VBD
cord-005453-4057qib7	5864	4	a	a	DT
cord-005453-4057qib7	5864	5	retrospective	retrospective	JJ
cord-005453-4057qib7	5864	6	single	single	JJ
cord-005453-4057qib7	5864	7	center	center	NN
cord-005453-4057qib7	5864	8	study	study	NN
cord-005453-4057qib7	5864	9	.	.	.
cord-005453-4057qib7	5865	1	All	all	DT
cord-005453-4057qib7	5865	2	data	datum	NNS
cord-005453-4057qib7	5865	3	were	be	VBD
cord-005453-4057qib7	5865	4	collected	collect	VBN
cord-005453-4057qib7	5865	5	from	from	IN
cord-005453-4057qib7	5865	6	patients	patient	NNS
cord-005453-4057qib7	5865	7	'	'	POS
cord-005453-4057qib7	5865	8	files	file	NNS
cord-005453-4057qib7	5865	9	.	.	.
cord-005453-4057qib7	5866	1	Twenty	twenty	CD
cord-005453-4057qib7	5866	2	patients	patient	NNS
cord-005453-4057qib7	5866	3	were	be	VBD
cord-005453-4057qib7	5866	4	enrolled	enrol	VBN
cord-005453-4057qib7	5866	5	(	(	-LRB-
cord-005453-4057qib7	5866	6	age	age	NN
cord-005453-4057qib7	5866	7	ranging	range	VBG
cord-005453-4057qib7	5866	8	from	from	IN
cord-005453-4057qib7	5866	9	7	7	CD
cord-005453-4057qib7	5866	10	months	month	NNS
cord-005453-4057qib7	5866	11	to	to	IN
cord-005453-4057qib7	5866	12	19	19	CD
cord-005453-4057qib7	5866	13	years	year	NNS
cord-005453-4057qib7	5866	14	)	)	-RRB-
cord-005453-4057qib7	5866	15	between	between	IN
cord-005453-4057qib7	5866	16	April	April	NNP
cord-005453-4057qib7	5866	17	2014	2014	CD
cord-005453-4057qib7	5866	18	and	and	CC
cord-005453-4057qib7	5866	19	April	April	NNP
cord-005453-4057qib7	5866	20	2018	2018	CD
cord-005453-4057qib7	5866	21	.	.	.
cord-005453-4057qib7	5867	1	Results	result	NNS
cord-005453-4057qib7	5867	2	:	:	:
cord-005453-4057qib7	5868	1	Five	five	CD
cord-005453-4057qib7	5868	2	of	of	IN
cord-005453-4057qib7	5868	3	these	these	DT
cord-005453-4057qib7	5868	4	patients	patient	NNS
cord-005453-4057qib7	5868	5	received	receive	VBD
cord-005453-4057qib7	5868	6	reduced	reduced	JJ
cord-005453-4057qib7	5868	7	intensity	intensity	NN
cord-005453-4057qib7	5868	8	conditioning	conditioning	NN
cord-005453-4057qib7	5868	9	and	and	CC
cord-005453-4057qib7	5868	10	15	15	CD
cord-005453-4057qib7	5868	11	patients	patient	NNS
cord-005453-4057qib7	5868	12	received	receive	VBD
cord-005453-4057qib7	5868	13	myeloablative	myeloablative	NNP
cord-005453-4057qib7	5868	14	regimens	regimen	NNS
cord-005453-4057qib7	5868	15	before	before	IN
cord-005453-4057qib7	5868	16	HSCT	HSCT	NNP
cord-005453-4057qib7	5868	17	.	.	.
cord-005453-4057qib7	5869	1	One	one	CD
cord-005453-4057qib7	5869	2	haploidentical	haploidentical	JJ
cord-005453-4057qib7	5869	3	,	,	,
cord-005453-4057qib7	5869	4	1	1	CD
cord-005453-4057qib7	5869	5	autologous	autologous	JJ
cord-005453-4057qib7	5869	6	,	,	,
cord-005453-4057qib7	5869	7	1	1	CD
cord-005453-4057qib7	5869	8	cord	cord	NN
cord-005453-4057qib7	5869	9	blood	blood	NN
cord-005453-4057qib7	5869	10	,	,	,
cord-005453-4057qib7	5869	11	14	14	CD
cord-005453-4057qib7	5869	12	MUD	mud	NN
cord-005453-4057qib7	5869	13	,	,	,
cord-005453-4057qib7	5869	14	3	3	CD
cord-005453-4057qib7	5869	15	MSD	MSD	NNP
cord-005453-4057qib7	5869	16	transplantations	transplantation	NNS
cord-005453-4057qib7	5869	17	were	be	VBD
cord-005453-4057qib7	5869	18	performed	perform	VBN
cord-005453-4057qib7	5869	19	.	.	.
cord-005453-4057qib7	5870	1	The	the	DT
cord-005453-4057qib7	5870	2	patients	patient	NNS
cord-005453-4057qib7	5870	3	were	be	VBD
cord-005453-4057qib7	5870	4	eligible	eligible	JJ
cord-005453-4057qib7	5870	5	if	if	IN
cord-005453-4057qib7	5870	6	they	-PRON-	PRP
cord-005453-4057qib7	5870	7	developed	develop	VBD
cord-005453-4057qib7	5870	8	grades	grade	NNS
cord-005453-4057qib7	5870	9	II	II	NNP
cord-005453-4057qib7	5870	10	-	-	HYPH
cord-005453-4057qib7	5870	11	IV	IV	NNP
cord-005453-4057qib7	5870	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5870	13	.	.	.
cord-005453-4057qib7	5871	1	All	all	DT
cord-005453-4057qib7	5871	2	patients	patient	NNS
cord-005453-4057qib7	5871	3	were	be	VBD
cord-005453-4057qib7	5871	4	treated	treat	VBN
cord-005453-4057qib7	5871	5	with	with	IN
cord-005453-4057qib7	5871	6	standard	standard	JJ
cord-005453-4057qib7	5871	7	first	first	JJ
cord-005453-4057qib7	5871	8	-	-	HYPH
cord-005453-4057qib7	5871	9	line	line	NN
cord-005453-4057qib7	5871	10	treatment	treatment	NN
cord-005453-4057qib7	5871	11	with	with	IN
cord-005453-4057qib7	5871	12	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5871	13	and	and	CC
cord-005453-4057qib7	5871	14	at	at	RB
cord-005453-4057qib7	5871	15	least	least	RBS
cord-005453-4057qib7	5871	16	one	one	CD
cord-005453-4057qib7	5871	17	second	second	JJ
cord-005453-4057qib7	5871	18	-	-	HYPH
cord-005453-4057qib7	5871	19	line	line	NN
cord-005453-4057qib7	5871	20	therapy	therapy	NN
cord-005453-4057qib7	5871	21	.	.	.
cord-005453-4057qib7	5872	1	The	the	DT
cord-005453-4057qib7	5872	2	definition	definition	NN
cord-005453-4057qib7	5872	3	of	of	IN
cord-005453-4057qib7	5872	4	steroid	steroid	NN
cord-005453-4057qib7	5872	5	resistant	resistant	JJ
cord-005453-4057qib7	5872	6	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5872	7	considered	consider	VBN
cord-005453-4057qib7	5872	8	as	as	IN
cord-005453-4057qib7	5872	9	either	either	CC
cord-005453-4057qib7	5872	10	no	no	DT
cord-005453-4057qib7	5872	11	response	response	NN
cord-005453-4057qib7	5872	12	to	to	IN
cord-005453-4057qib7	5872	13	steroid	steroid	NN
cord-005453-4057qib7	5872	14	treatment	treatment	NN
cord-005453-4057qib7	5872	15	lasting	last	VBG
cord-005453-4057qib7	5872	16	at	at	RB
cord-005453-4057qib7	5872	17	least	least	JJS
cord-005453-4057qib7	5872	18	7	7	CD
cord-005453-4057qib7	5872	19	days	day	NNS
cord-005453-4057qib7	5872	20	or	or	CC
cord-005453-4057qib7	5872	21	progression	progression	NN
cord-005453-4057qib7	5872	22	during	during	IN
cord-005453-4057qib7	5872	23	treatment	treatment	NN
cord-005453-4057qib7	5872	24	of	of	IN
cord-005453-4057qib7	5872	25	at	at	RB
cord-005453-4057qib7	5872	26	least	least	RBS
cord-005453-4057qib7	5872	27	one	one	CD
cord-005453-4057qib7	5872	28	grade	grade	NN
cord-005453-4057qib7	5872	29	within	within	IN
cord-005453-4057qib7	5872	30	the	the	DT
cord-005453-4057qib7	5872	31	first	first	JJ
cord-005453-4057qib7	5872	32	72	72	CD
cord-005453-4057qib7	5872	33	hours	hour	NNS
cord-005453-4057qib7	5872	34	.	.	.
cord-005453-4057qib7	5873	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	5873	2	treatment	treatment	NN
cord-005453-4057qib7	5873	3	with	with	IN
cord-005453-4057qib7	5873	4	calcineurin	calcineurin	NNP
cord-005453-4057qib7	5873	5	inhibitors	inhibitor	NNS
cord-005453-4057qib7	5873	6	continued	continue	VBD
cord-005453-4057qib7	5873	7	at	at	IN
cord-005453-4057qib7	5873	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	5873	9	dose	dose	JJ
cord-005453-4057qib7	5873	10	level	level	NN
cord-005453-4057qib7	5873	11	.	.	.
cord-005453-4057qib7	5874	1	Totally	totally	RB
cord-005453-4057qib7	5874	2	,	,	,
cord-005453-4057qib7	5874	3	77	77	CD
cord-005453-4057qib7	5874	4	doses	dose	NNS
cord-005453-4057qib7	5874	5	of	of	IN
cord-005453-4057qib7	5874	6	MSCs	msc	NNS
cord-005453-4057qib7	5874	7	were	be	VBD
cord-005453-4057qib7	5874	8	infused	infuse	VBN
cord-005453-4057qib7	5874	9	.	.	.
cord-005453-4057qib7	5875	1	The	the	DT
cord-005453-4057qib7	5875	2	median	median	JJ
cord-005453-4057qib7	5875	3	dose	dose	NN
cord-005453-4057qib7	5875	4	of	of	IN
cord-005453-4057qib7	5875	5	MSC	MSC	NNP
cord-005453-4057qib7	5875	6	was	be	VBD
cord-005453-4057qib7	5875	7	1.02	1.02	CD
cord-005453-4057qib7	5875	8	×	×	NN
cord-005453-4057qib7	5875	9	10	10	CD
cord-005453-4057qib7	5875	10	6	6	CD
cord-005453-4057qib7	5875	11	cells	cell	NNS
cord-005453-4057qib7	5875	12	per	per	IN
cord-005453-4057qib7	5875	13	kg	kg	NN
cord-005453-4057qib7	5875	14	body	body	NN
cord-005453-4057qib7	5875	15	weight	weight	NN
cord-005453-4057qib7	5875	16	.	.	.
cord-005453-4057qib7	5876	1	The	the	DT
cord-005453-4057qib7	5876	2	median	median	JJ
cord-005453-4057qib7	5876	3	duration	duration	NN
cord-005453-4057qib7	5876	4	between	between	IN
cord-005453-4057qib7	5876	5	the	the	DT
cord-005453-4057qib7	5876	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	5876	7	of	of	IN
cord-005453-4057qib7	5876	8	aGVHD	agvhd	NN
cord-005453-4057qib7	5876	9	and	and	CC
cord-005453-4057qib7	5876	10	initiation	initiation	NN
cord-005453-4057qib7	5876	11	of	of	IN
cord-005453-4057qib7	5876	12	MSCs	mscs	NN
cord-005453-4057qib7	5876	13	therapy	therapy	NN
cord-005453-4057qib7	5876	14	was	be	VBD
cord-005453-4057qib7	5876	15	16	16	CD
cord-005453-4057qib7	5876	16	days	day	NNS
cord-005453-4057qib7	5876	17	(	(	-LRB-
cord-005453-4057qib7	5876	18	range	range	NN
cord-005453-4057qib7	5876	19	:	:	:
cord-005453-4057qib7	5876	20	4	4	CD
cord-005453-4057qib7	5876	21	-	-	SYM
cord-005453-4057qib7	5876	22	241	241	CD
cord-005453-4057qib7	5876	23	)	)	-RRB-
cord-005453-4057qib7	5876	24	.	.	.
cord-005453-4057qib7	5877	1	The	the	DT
cord-005453-4057qib7	5877	2	received	receive	VBN
cord-005453-4057qib7	5877	3	MSC	MSC	NNP
cord-005453-4057qib7	5877	4	doses	dose	NNS
cord-005453-4057qib7	5877	5	ranged	range	VBD
cord-005453-4057qib7	5877	6	from	from	IN
cord-005453-4057qib7	5877	7	one	one	CD
cord-005453-4057qib7	5877	8	to	to	IN
cord-005453-4057qib7	5877	9	seven	seven	CD
cord-005453-4057qib7	5877	10	.	.	.
cord-005453-4057qib7	5878	1	None	none	NN
cord-005453-4057qib7	5878	2	of	of	IN
cord-005453-4057qib7	5878	3	our	-PRON-	PRP$
cord-005453-4057qib7	5878	4	patients	patient	NNS
cord-005453-4057qib7	5878	5	had	have	VBD
cord-005453-4057qib7	5878	6	severe	severe	JJ
cord-005453-4057qib7	5878	7	side	side	NN
cord-005453-4057qib7	5878	8	-	-	HYPH
cord-005453-4057qib7	5878	9	effects	effect	NNS
cord-005453-4057qib7	5878	10	during	during	IN
cord-005453-4057qib7	5878	11	infusions	infusion	NNS
cord-005453-4057qib7	5878	12	of	of	IN
cord-005453-4057qib7	5878	13	MSCs	msc	NNS
cord-005453-4057qib7	5878	14	.	.	.
cord-005453-4057qib7	5879	1	Overall	overall	RB
cord-005453-4057qib7	5879	2	,	,	,
cord-005453-4057qib7	5879	3	complete	complete	JJ
cord-005453-4057qib7	5879	4	response	response	NN
cord-005453-4057qib7	5879	5	(	(	-LRB-
cord-005453-4057qib7	5879	6	OCR	OCR	NNP
cord-005453-4057qib7	5879	7	)	)	-RRB-
cord-005453-4057qib7	5879	8	was	be	VBD
cord-005453-4057qib7	5879	9	obtained	obtain	VBN
cord-005453-4057qib7	5879	10	in	in	IN
cord-005453-4057qib7	5879	11	10	10	CD
cord-005453-4057qib7	5879	12	patients	patient	NNS
cord-005453-4057qib7	5879	13	,	,	,
cord-005453-4057qib7	5879	14	partial	partial	JJ
cord-005453-4057qib7	5879	15	response	response	NN
cord-005453-4057qib7	5879	16	in	in	IN
cord-005453-4057qib7	5879	17	7	7	CD
cord-005453-4057qib7	5879	18	patients	patient	NNS
cord-005453-4057qib7	5879	19	and	and	CC
cord-005453-4057qib7	5879	20	no	no	DT
cord-005453-4057qib7	5879	21	response	response	NN
cord-005453-4057qib7	5879	22	(	(	-LRB-
cord-005453-4057qib7	5879	23	NR	NR	NNP
cord-005453-4057qib7	5879	24	)	)	-RRB-
cord-005453-4057qib7	5879	25	was	be	VBD
cord-005453-4057qib7	5879	26	documented	document	VBN
cord-005453-4057qib7	5879	27	in	in	IN
cord-005453-4057qib7	5879	28	3	3	CD
cord-005453-4057qib7	5879	29	patients	patient	NNS
cord-005453-4057qib7	5879	30	.	.	.
cord-005453-4057qib7	5880	1	In	in	IN
cord-005453-4057qib7	5880	2	our	-PRON-	PRP$
cord-005453-4057qib7	5880	3	study	study	NN
cord-005453-4057qib7	5880	4	group	group	NN
cord-005453-4057qib7	5880	5	,	,	,
cord-005453-4057qib7	5880	6	the	the	DT
cord-005453-4057qib7	5880	7	complete	complete	JJ
cord-005453-4057qib7	5880	8	response	response	NN
cord-005453-4057qib7	5880	9	rates	rate	NNS
cord-005453-4057qib7	5880	10	in	in	IN
cord-005453-4057qib7	5880	11	liver	liver	NN
cord-005453-4057qib7	5880	12	,	,	,
cord-005453-4057qib7	5880	13	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	5880	14	,	,	,
cord-005453-4057qib7	5880	15	skin	skin	NN
cord-005453-4057qib7	5880	16	aGVHD	agvhd	NN
cord-005453-4057qib7	5880	17	were	be	VBD
cord-005453-4057qib7	5880	18	20	20	CD
cord-005453-4057qib7	5880	19	%	%	NN
cord-005453-4057qib7	5880	20	,	,	,
cord-005453-4057qib7	5880	21	35	35	CD
cord-005453-4057qib7	5880	22	%	%	NN
cord-005453-4057qib7	5880	23	,	,	,
cord-005453-4057qib7	5880	24	72	72	CD
cord-005453-4057qib7	5880	25	%	%	NN
cord-005453-4057qib7	5880	26	respectively	respectively	RB
cord-005453-4057qib7	5880	27	.	.	.
cord-005453-4057qib7	5881	1	Four	four	CD
cord-005453-4057qib7	5881	2	patients	patient	NNS
cord-005453-4057qib7	5881	3	(	(	-LRB-
cord-005453-4057qib7	5881	4	20	20	CD
cord-005453-4057qib7	5881	5	%	%	NN
cord-005453-4057qib7	5881	6	)	)	-RRB-
cord-005453-4057qib7	5881	7	died	die	VBD
cord-005453-4057qib7	5881	8	in	in	IN
cord-005453-4057qib7	5881	9	90	90	CD
cord-005453-4057qib7	5881	10	days	day	NNS
cord-005453-4057qib7	5881	11	after	after	IN
cord-005453-4057qib7	5881	12	using	use	VBG
cord-005453-4057qib7	5881	13	MSCs	msc	NNS
cord-005453-4057qib7	5881	14	from	from	IN
cord-005453-4057qib7	5881	15	complications	complication	NNS
cord-005453-4057qib7	5881	16	of	of	IN
cord-005453-4057qib7	5881	17	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5881	18	.	.	.
cord-005453-4057qib7	5882	1	Eleven	eleven	CD
cord-005453-4057qib7	5882	2	of	of	IN
cord-005453-4057qib7	5882	3	20	20	CD
cord-005453-4057qib7	5882	4	patients	patient	NNS
cord-005453-4057qib7	5882	5	(	(	-LRB-
cord-005453-4057qib7	5882	6	55	55	CD
cord-005453-4057qib7	5882	7	%	%	NN
cord-005453-4057qib7	5882	8	)	)	-RRB-
cord-005453-4057qib7	5882	9	were	be	VBD
cord-005453-4057qib7	5882	10	still	still	RB
cord-005453-4057qib7	5882	11	alive	alive	JJ
cord-005453-4057qib7	5882	12	with	with	IN
cord-005453-4057qib7	5882	13	a	a	DT
cord-005453-4057qib7	5882	14	median	median	JJ
cord-005453-4057qib7	5882	15	follow	follow	NN
cord-005453-4057qib7	5882	16	-	-	HYPH
cord-005453-4057qib7	5882	17	up	up	NN
cord-005453-4057qib7	5882	18	of	of	IN
cord-005453-4057qib7	5882	19	558	558	CD
cord-005453-4057qib7	5882	20	days	day	NNS
cord-005453-4057qib7	5882	21	(	(	-LRB-
cord-005453-4057qib7	5882	22	range:171	range:171	NNP
cord-005453-4057qib7	5882	23	-	-	HYPH
cord-005453-4057qib7	5882	24	989	989	CD
cord-005453-4057qib7	5882	25	days	day	NNS
cord-005453-4057qib7	5882	26	)	)	-RRB-
cord-005453-4057qib7	5882	27	after	after	IN
cord-005453-4057qib7	5882	28	first	first	JJ
cord-005453-4057qib7	5882	29	MSCs	mscs	NN
cord-005453-4057qib7	5882	30	infusion	infusion	NN
cord-005453-4057qib7	5882	31	.	.	.
cord-005453-4057qib7	5883	1	One	one	CD
cord-005453-4057qib7	5883	2	year	year	NN
cord-005453-4057qib7	5883	3	estimated	estimate	VBD
cord-005453-4057qib7	5883	4	probability	probability	NN
cord-005453-4057qib7	5883	5	of	of	IN
cord-005453-4057qib7	5883	6	overall	overall	JJ
cord-005453-4057qib7	5883	7	survival	survival	NN
cord-005453-4057qib7	5883	8	for	for	IN
cord-005453-4057qib7	5883	9	patients	patient	NNS
cord-005453-4057qib7	5883	10	achieving	achieve	VBG
cord-005453-4057qib7	5883	11	OCR	OCR	NNP
cord-005453-4057qib7	5883	12	and	and	CC
cord-005453-4057qib7	5883	13	partial	partial	JJ
cord-005453-4057qib7	5883	14	remission/	remission/	ADD
cord-005453-4057qib7	5884	1	no	no	DT
cord-005453-4057qib7	5884	2	remission	remission	NN
cord-005453-4057qib7	5884	3	in	in	IN
cord-005453-4057qib7	5884	4	90th	90th	JJ
cord-005453-4057qib7	5884	5	day	day	NN
cord-005453-4057qib7	5884	6	of	of	IN
cord-005453-4057qib7	5884	7	MSCs	msc	NNS
cord-005453-4057qib7	5884	8	were	be	VBD
cord-005453-4057qib7	5884	9	87.5	87.5	CD
cord-005453-4057qib7	5884	10	%	%	NN
cord-005453-4057qib7	5884	11	and	and	CC
cord-005453-4057qib7	5884	12	20	20	CD
cord-005453-4057qib7	5884	13	%	%	NN
cord-005453-4057qib7	5884	14	,	,	,
cord-005453-4057qib7	5884	15	respectively	respectively	RB
cord-005453-4057qib7	5884	16	.	.	.
cord-005453-4057qib7	5885	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5885	2	:	:	:
cord-005453-4057qib7	5886	1	In	in	IN
cord-005453-4057qib7	5886	2	conclusion	conclusion	NN
cord-005453-4057qib7	5886	3	,	,	,
cord-005453-4057qib7	5886	4	MSCs	MSCs	NNP
cord-005453-4057qib7	5886	5	appears	appear	VBZ
cord-005453-4057qib7	5886	6	to	to	TO
cord-005453-4057qib7	5886	7	be	be	VB
cord-005453-4057qib7	5886	8	a	a	DT
cord-005453-4057qib7	5886	9	safe	safe	JJ
cord-005453-4057qib7	5886	10	and	and	CC
cord-005453-4057qib7	5886	11	effective	effective	JJ
cord-005453-4057qib7	5886	12	treatment	treatment	NN
cord-005453-4057qib7	5886	13	option	option	NN
cord-005453-4057qib7	5886	14	for	for	IN
cord-005453-4057qib7	5886	15	pediatric	pediatric	JJ
cord-005453-4057qib7	5886	16	patients	patient	NNS
cord-005453-4057qib7	5886	17	with	with	IN
cord-005453-4057qib7	5886	18	steroid	steroid	NN
cord-005453-4057qib7	5886	19	refractory	refractory	JJ
cord-005453-4057qib7	5886	20	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5886	21	.	.	.
cord-005453-4057qib7	5887	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5887	2	:	:	:
cord-005453-4057qib7	5887	3	Nothing	nothing	NN
cord-005453-4057qib7	5887	4	to	to	TO
cord-005453-4057qib7	5887	5	declare	declare	VB
cord-005453-4057qib7	5887	6	Effect	effect	NN
cord-005453-4057qib7	5887	7	of	of	IN
cord-005453-4057qib7	5887	8	extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5887	9	photopheresis	photopheresis	NN
cord-005453-4057qib7	5887	10	on	on	IN
cord-005453-4057qib7	5887	11	production	production	NN
cord-005453-4057qib7	5887	12	of	of	IN
cord-005453-4057qib7	5887	13	serum	serum	NN
cord-005453-4057qib7	5887	14	elafin	elafin	NN
cord-005453-4057qib7	5887	15	in	in	IN
cord-005453-4057qib7	5887	16	chronic	chronic	JJ
cord-005453-4057qib7	5887	17	graft	graft	NN
cord-005453-4057qib7	5887	18	versus	versus	IN
cord-005453-4057qib7	5887	19	host	host	NN
cord-005453-4057qib7	5887	20	disease	disease	NN
cord-005453-4057qib7	5887	21	Arun	Arun	NNP
cord-005453-4057qib7	5887	22	Alfred	Alfred	NNP
cord-005453-4057qib7	5887	23	1	1	CD
cord-005453-4057qib7	5887	24	,	,	,
cord-005453-4057qib7	5887	25	Charlotte	Charlotte	NNP
cord-005453-4057qib7	5887	26	Burton	Burton	NNP
cord-005453-4057qib7	5887	27	1	1	CD
cord-005453-4057qib7	5887	28	,	,	,
cord-005453-4057qib7	5887	29	Kathryn	Kathryn	NNP
cord-005453-4057qib7	5887	30	Goddard	Goddard	NNP
cord-005453-4057qib7	5887	31	1	1	CD
cord-005453-4057qib7	5887	32	,	,	,
cord-005453-4057qib7	5887	33	Nichloas	Nichloas	NNP
cord-005453-4057qib7	5887	34	Matthews	Matthews	NNP
cord-005453-4057qib7	5887	35	1	1	CD
cord-005453-4057qib7	5887	36	Background	Background	NNP
cord-005453-4057qib7	5887	37	:	:	:
cord-005453-4057qib7	5888	1	Extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5888	2	photopheresis	photopheresis	NN
cord-005453-4057qib7	5888	3	(	(	-LRB-
cord-005453-4057qib7	5888	4	ECP	ECP	NNP
cord-005453-4057qib7	5888	5	)	)	-RRB-
cord-005453-4057qib7	5888	6	is	be	VBZ
cord-005453-4057qib7	5888	7	a	a	DT
cord-005453-4057qib7	5888	8	second	second	JJ
cord-005453-4057qib7	5888	9	line	line	NN
cord-005453-4057qib7	5888	10	therapy	therapy	NN
cord-005453-4057qib7	5888	11	for	for	IN
cord-005453-4057qib7	5888	12	steroid	steroid	NN
cord-005453-4057qib7	5888	13	refractory	refractory	JJ
cord-005453-4057qib7	5888	14	,	,	,
cord-005453-4057qib7	5888	15	dependent	dependent	JJ
cord-005453-4057qib7	5888	16	or	or	CC
cord-005453-4057qib7	5888	17	intolerant	intolerant	JJ
cord-005453-4057qib7	5888	18	chronic	chronic	JJ
cord-005453-4057qib7	5888	19	GVHD	GVHD	NNP
cord-005453-4057qib7	5888	20	(	(	-LRB-
cord-005453-4057qib7	5888	21	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5888	22	)	)	-RRB-
cord-005453-4057qib7	5888	23	.	.	.
cord-005453-4057qib7	5889	1	In	in	IN
cord-005453-4057qib7	5889	2	order	order	NN
cord-005453-4057qib7	5889	3	to	to	TO
cord-005453-4057qib7	5889	4	guide	guide	VB
cord-005453-4057qib7	5889	5	ECP	ECP	NNP
cord-005453-4057qib7	5889	6	there	there	EX
cord-005453-4057qib7	5889	7	is	be	VBZ
cord-005453-4057qib7	5889	8	an	an	DT
cord-005453-4057qib7	5889	9	unmet	unmet	JJ
cord-005453-4057qib7	5889	10	need	need	NN
cord-005453-4057qib7	5889	11	for	for	IN
cord-005453-4057qib7	5889	12	predictive	predictive	JJ
cord-005453-4057qib7	5889	13	and	and	CC
cord-005453-4057qib7	5889	14	diagnostic	diagnostic	JJ
cord-005453-4057qib7	5889	15	biomarkers	biomarker	NNS
cord-005453-4057qib7	5889	16	.	.	.
cord-005453-4057qib7	5890	1	Elafin	Elafin	NNP
cord-005453-4057qib7	5890	2	is	be	VBZ
cord-005453-4057qib7	5890	3	a	a	DT
cord-005453-4057qib7	5890	4	serine	serine	NN
cord-005453-4057qib7	5890	5	-	-	HYPH
cord-005453-4057qib7	5890	6	protease	protease	NN
cord-005453-4057qib7	5890	7	inhibitor	inhibitor	NN
cord-005453-4057qib7	5890	8	primarily	primarily	RB
cord-005453-4057qib7	5890	9	produced	produce	VBN
cord-005453-4057qib7	5890	10	by	by	IN
cord-005453-4057qib7	5890	11	epithelial	epithelial	JJ
cord-005453-4057qib7	5890	12	cells	cell	NNS
cord-005453-4057qib7	5890	13	,	,	,
cord-005453-4057qib7	5890	14	particularly	particularly	RB
cord-005453-4057qib7	5890	15	keratinocytes	keratinocyte	VBZ
cord-005453-4057qib7	5890	16	in	in	IN
cord-005453-4057qib7	5890	17	inflammatory	inflammatory	JJ
cord-005453-4057qib7	5890	18	skin	skin	NN
cord-005453-4057qib7	5890	19	diseases	disease	NNS
cord-005453-4057qib7	5890	20	and	and	CC
cord-005453-4057qib7	5890	21	plasma	plasma	NN
cord-005453-4057qib7	5890	22	and	and	CC
cord-005453-4057qib7	5890	23	epidermal	epidermal	JJ
cord-005453-4057qib7	5890	24	elafin	elafin	NN
cord-005453-4057qib7	5890	25	have	have	VBP
cord-005453-4057qib7	5890	26	been	be	VBN
cord-005453-4057qib7	5890	27	identified	identify	VBN
cord-005453-4057qib7	5890	28	as	as	IN
cord-005453-4057qib7	5890	29	biomarkers	biomarker	NNS
cord-005453-4057qib7	5890	30	of	of	IN
cord-005453-4057qib7	5890	31	skin	skin	NN
cord-005453-4057qib7	5890	32	GVHD	GVHD	NNP
cord-005453-4057qib7	5890	33	(	(	-LRB-
cord-005453-4057qib7	5890	34	1	1	CD
cord-005453-4057qib7	5890	35	,	,	,
cord-005453-4057qib7	5890	36	2	2	CD
cord-005453-4057qib7	5890	37	)	)	-RRB-
cord-005453-4057qib7	5890	38	.	.	.
cord-005453-4057qib7	5891	1	Since	since	IN
cord-005453-4057qib7	5891	2	Skin	Skin	NNP
cord-005453-4057qib7	5891	3	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5891	4	is	be	VBZ
cord-005453-4057qib7	5891	5	noted	note	VBN
cord-005453-4057qib7	5891	6	for	for	IN
cord-005453-4057qib7	5891	7	a	a	DT
cord-005453-4057qib7	5891	8	particularly	particularly	RB
cord-005453-4057qib7	5891	9	high	high	JJ
cord-005453-4057qib7	5891	10	response	response	NN
cord-005453-4057qib7	5891	11	rate	rate	NN
cord-005453-4057qib7	5891	12	to	to	IN
cord-005453-4057qib7	5891	13	ECP	ECP	NNP
cord-005453-4057qib7	5891	14	,	,	,
cord-005453-4057qib7	5891	15	we	-PRON-	PRP
cord-005453-4057qib7	5891	16	conducted	conduct	VBD
cord-005453-4057qib7	5891	17	a	a	DT
cord-005453-4057qib7	5891	18	study	study	NN
cord-005453-4057qib7	5891	19	to	to	TO
cord-005453-4057qib7	5891	20	investigate	investigate	VB
cord-005453-4057qib7	5891	21	whether	whether	IN
cord-005453-4057qib7	5891	22	ECP	ECP	NNP
cord-005453-4057qib7	5891	23	affects	affect	VBZ
cord-005453-4057qib7	5891	24	the	the	DT
cord-005453-4057qib7	5891	25	production	production	NN
cord-005453-4057qib7	5891	26	of	of	IN
cord-005453-4057qib7	5891	27	elafin	elafin	NNP
cord-005453-4057qib7	5891	28	.	.	.
cord-005453-4057qib7	5892	1	Methods	method	NNS
cord-005453-4057qib7	5892	2	:	:	:
cord-005453-4057qib7	5892	3	Serum	serum	NN
cord-005453-4057qib7	5892	4	samples	sample	NNS
cord-005453-4057qib7	5892	5	were	be	VBD
cord-005453-4057qib7	5892	6	collected	collect	VBN
cord-005453-4057qib7	5892	7	from	from	IN
cord-005453-4057qib7	5892	8	72	72	CD
cord-005453-4057qib7	5892	9	cGVHD	cgvhd	NN
cord-005453-4057qib7	5892	10	patients	patient	NNS
cord-005453-4057qib7	5892	11	(	(	-LRB-
cord-005453-4057qib7	5893	1	39	39	CD
cord-005453-4057qib7	5893	2	male	male	NN
cord-005453-4057qib7	5893	3	/33	/33	.
cord-005453-4057qib7	5893	4	female	female	JJ
cord-005453-4057qib7	5894	1	;	;	:
cord-005453-4057qib7	5894	2	age	age	NN
cord-005453-4057qib7	5894	3	range	range	NN
cord-005453-4057qib7	5894	4	:	:	:
cord-005453-4057qib7	5894	5	25	25	CD
cord-005453-4057qib7	5894	6	-	-	SYM
cord-005453-4057qib7	5894	7	74	74	CD
cord-005453-4057qib7	5894	8	)	)	-RRB-
cord-005453-4057qib7	5894	9	and	and	CC
cord-005453-4057qib7	5894	10	17	17	CD
cord-005453-4057qib7	5894	11	age	age	NN
cord-005453-4057qib7	5894	12	-	-	HYPH
cord-005453-4057qib7	5894	13	matched	match	VBN
cord-005453-4057qib7	5894	14	healthy	healthy	JJ
cord-005453-4057qib7	5894	15	controls	control	NNS
cord-005453-4057qib7	5894	16	(	(	-LRB-
cord-005453-4057qib7	5894	17	10	10	CD
cord-005453-4057qib7	5894	18	male	male	JJ
cord-005453-4057qib7	5894	19	/	/	SYM
cord-005453-4057qib7	5894	20	7	7	CD
cord-005453-4057qib7	5894	21	female	female	NN
cord-005453-4057qib7	5894	22	)	)	-RRB-
cord-005453-4057qib7	5894	23	before	before	IN
cord-005453-4057qib7	5894	24	ECP	ECP	NNP
cord-005453-4057qib7	5894	25	and	and	CC
cord-005453-4057qib7	5894	26	at	at	IN
cord-005453-4057qib7	5894	27	3	3	CD
cord-005453-4057qib7	5894	28	month	month	NN
cord-005453-4057qib7	5894	29	intervals	interval	NNS
cord-005453-4057qib7	5894	30	up	up	IN
cord-005453-4057qib7	5894	31	to	to	IN
cord-005453-4057qib7	5894	32	1	1	CD
cord-005453-4057qib7	5894	33	year	year	NN
cord-005453-4057qib7	5894	34	.	.	.
cord-005453-4057qib7	5895	1	Patients	patient	NNS
cord-005453-4057qib7	5895	2	had	have	VBD
cord-005453-4057qib7	5895	3	GVHD	GVHD	NNP
cord-005453-4057qib7	5895	4	affecting	affect	VBG
cord-005453-4057qib7	5895	5	skin	skin	NN
cord-005453-4057qib7	5895	6	(	(	-LRB-
cord-005453-4057qib7	5895	7	61/72	61/72	CD
cord-005453-4057qib7	5895	8	)	)	-RRB-
cord-005453-4057qib7	5895	9	,	,	,
cord-005453-4057qib7	5895	10	mucosal	mucosal	JJ
cord-005453-4057qib7	5895	11	membranes	membrane	NNS
cord-005453-4057qib7	5895	12	(	(	-LRB-
cord-005453-4057qib7	5895	13	16/	16/	CD
cord-005453-4057qib7	5895	14	72	72	CD
cord-005453-4057qib7	5895	15	)	)	-RRB-
cord-005453-4057qib7	5895	16	,	,	,
cord-005453-4057qib7	5895	17	liver	liver	NN
cord-005453-4057qib7	5895	18	(	(	-LRB-
cord-005453-4057qib7	5895	19	14/72	14/72	CD
cord-005453-4057qib7	5895	20	)	)	-RRB-
cord-005453-4057qib7	5895	21	,	,	,
cord-005453-4057qib7	5895	22	joints	joint	NNS
cord-005453-4057qib7	5895	23	(	(	-LRB-
cord-005453-4057qib7	5895	24	8/72	8/72	CD
cord-005453-4057qib7	5895	25	)	)	-RRB-
cord-005453-4057qib7	5895	26	,	,	,
cord-005453-4057qib7	5895	27	gut	gut	NNP
cord-005453-4057qib7	5895	28	(	(	-LRB-
cord-005453-4057qib7	5895	29	17/72	17/72	CD
cord-005453-4057qib7	5895	30	)	)	-RRB-
cord-005453-4057qib7	5895	31	,	,	,
cord-005453-4057qib7	5895	32	eye	eye	NN
cord-005453-4057qib7	5895	33	(	(	-LRB-
cord-005453-4057qib7	5895	34	8/72	8/72	CD
cord-005453-4057qib7	5895	35	)	)	-RRB-
cord-005453-4057qib7	5895	36	,	,	,
cord-005453-4057qib7	5895	37	genital	genital	JJ
cord-005453-4057qib7	5895	38	(	(	-LRB-
cord-005453-4057qib7	5895	39	4/72	4/72	CD
cord-005453-4057qib7	5895	40	)	)	-RRB-
cord-005453-4057qib7	5895	41	,	,	,
cord-005453-4057qib7	5895	42	and	and	CC
cord-005453-4057qib7	5895	43	respiratory	respiratory	JJ
cord-005453-4057qib7	5895	44	involvement	involvement	NN
cord-005453-4057qib7	5895	45	(	(	-LRB-
cord-005453-4057qib7	5895	46	4/72	4/72	CD
cord-005453-4057qib7	5895	47	)	)	-RRB-
cord-005453-4057qib7	5895	48	.	.	.
cord-005453-4057qib7	5896	1	Serum	serum	NN
cord-005453-4057qib7	5896	2	elafin	elafin	NN
cord-005453-4057qib7	5896	3	was	be	VBD
cord-005453-4057qib7	5896	4	assessed	assess	VBN
cord-005453-4057qib7	5896	5	by	by	IN
cord-005453-4057qib7	5896	6	ELISA	ELISA	NNP
cord-005453-4057qib7	5896	7	(	(	-LRB-
cord-005453-4057qib7	5896	8	R&D	R&D	NNP
cord-005453-4057qib7	5896	9	Systems	Systems	NNP
cord-005453-4057qib7	5896	10	)	)	-RRB-
cord-005453-4057qib7	5896	11	.	.	.
cord-005453-4057qib7	5897	1	Data	datum	NNS
cord-005453-4057qib7	5897	2	were	be	VBD
cord-005453-4057qib7	5897	3	analysed	analyse	VBN
cord-005453-4057qib7	5897	4	using	use	VBG
cord-005453-4057qib7	5897	5	GraphPad	GraphPad	NNP
cord-005453-4057qib7	5897	6	Prism	Prism	NNP
cord-005453-4057qib7	5897	7	6	6	CD
cord-005453-4057qib7	5897	8	.	.	.
cord-005453-4057qib7	5898	1	Statistical	statistical	JJ
cord-005453-4057qib7	5898	2	tests	test	NNS
cord-005453-4057qib7	5898	3	performed	perform	VBN
cord-005453-4057qib7	5898	4	include	include	VBP
cord-005453-4057qib7	5898	5	2-tailed	2-tailed	CD
cord-005453-4057qib7	5898	6	Mann	Mann	NNP
cord-005453-4057qib7	5898	7	-	-	HYPH
cord-005453-4057qib7	5898	8	Whitney	Whitney	NNP
cord-005453-4057qib7	5898	9	,	,	,
cord-005453-4057qib7	5898	10	Pearson	Pearson	NNP
cord-005453-4057qib7	5898	11	's	's	POS
cord-005453-4057qib7	5898	12	correlation	correlation	NN
cord-005453-4057qib7	5898	13	test	test	NN
cord-005453-4057qib7	5898	14	,	,	,
cord-005453-4057qib7	5898	15	and	and	CC
cord-005453-4057qib7	5898	16	2-way	2-way	JJ
cord-005453-4057qib7	5898	17	ANOVA	ANOVA	NNP
cord-005453-4057qib7	5898	18	with	with	IN
cord-005453-4057qib7	5898	19	repeat	repeat	NN
cord-005453-4057qib7	5898	20	measures	measure	NNS
cord-005453-4057qib7	5898	21	,	,	,
cord-005453-4057qib7	5898	22	as	as	IN
cord-005453-4057qib7	5898	23	appropriate	appropriate	JJ
cord-005453-4057qib7	5898	24	.	.	.
cord-005453-4057qib7	5899	1	Results	result	NNS
cord-005453-4057qib7	5899	2	:	:	:
cord-005453-4057qib7	5899	3	Chronic	chronic	JJ
cord-005453-4057qib7	5899	4	GVHD	GVHD	NNP
cord-005453-4057qib7	5899	5	patients	patient	NNS
cord-005453-4057qib7	5899	6	presenting	present	VBG
cord-005453-4057qib7	5899	7	for	for	IN
cord-005453-4057qib7	5899	8	ECP	ECP	NNP
cord-005453-4057qib7	5899	9	had	have	VBD
cord-005453-4057qib7	5899	10	significantly	significantly	RB
cord-005453-4057qib7	5899	11	elevated	elevate	VBN
cord-005453-4057qib7	5899	12	serum	serum	NN
cord-005453-4057qib7	5899	13	levels	level	NNS
cord-005453-4057qib7	5899	14	of	of	IN
cord-005453-4057qib7	5899	15	elafin	elafin	NNP
cord-005453-4057qib7	5900	1	(	(	-LRB-
cord-005453-4057qib7	5900	2	P=0.0029	P=0.0029	NNS
cord-005453-4057qib7	5900	3	;	;	:
cord-005453-4057qib7	5900	4	median	median	NN
cord-005453-4057qib7	5900	5	of	of	IN
cord-005453-4057qib7	5900	6	22ng	22ng	JJ
cord-005453-4057qib7	5900	7	/	/	SYM
cord-005453-4057qib7	5900	8	ml	ml	XX
cord-005453-4057qib7	5900	9	,	,	,
cord-005453-4057qib7	5900	10	IQR	IQR	NNP
cord-005453-4057qib7	5900	11	15	15	CD
cord-005453-4057qib7	5900	12	-	-	HYPH
cord-005453-4057qib7	5900	13	45ng	45ng	NN
cord-005453-4057qib7	5900	14	/	/	SYM
cord-005453-4057qib7	5900	15	ml	ml	NN
cord-005453-4057qib7	5900	16	)	)	-RRB-
cord-005453-4057qib7	5900	17	compared	compare	VBN
cord-005453-4057qib7	5900	18	to	to	IN
cord-005453-4057qib7	5900	19	healthy	healthy	JJ
cord-005453-4057qib7	5900	20	controls	control	NNS
cord-005453-4057qib7	5900	21	(	(	-LRB-
cord-005453-4057qib7	5900	22	median	median	NN
cord-005453-4057qib7	5900	23	of	of	IN
cord-005453-4057qib7	5900	24	14	14	CD
cord-005453-4057qib7	5900	25	ng	ng	NN
cord-005453-4057qib7	5900	26	/	/	SYM
cord-005453-4057qib7	5900	27	ml	ml	XX
cord-005453-4057qib7	5900	28	,	,	,
cord-005453-4057qib7	5900	29	IQR	IQR	NNP
cord-005453-4057qib7	5900	30	9.6	9.6	CD
cord-005453-4057qib7	5900	31	-	-	HYPH
cord-005453-4057qib7	5900	32	18ng	18ng	NNP
cord-005453-4057qib7	5900	33	/	/	SYM
cord-005453-4057qib7	5900	34	ml).While	ml).While	NNP
cord-005453-4057qib7	5900	35	85	85	CD
cord-005453-4057qib7	5900	36	%	%	NN
cord-005453-4057qib7	5900	37	of	of	IN
cord-005453-4057qib7	5900	38	patients	patient	NNS
cord-005453-4057qib7	5900	39	had	have	VBD
cord-005453-4057qib7	5900	40	skin	skin	NN
cord-005453-4057qib7	5900	41	involvement	involvement	NN
cord-005453-4057qib7	5900	42	,	,	,
cord-005453-4057qib7	5900	43	only	only	RB
cord-005453-4057qib7	5900	44	40	40	CD
cord-005453-4057qib7	5900	45	%	%	NN
cord-005453-4057qib7	5900	46	had	have	VBD
cord-005453-4057qib7	5900	47	elafin	elafin	NN
cord-005453-4057qib7	5900	48	levels	level	NNS
cord-005453-4057qib7	5900	49	above	above	IN
cord-005453-4057qib7	5900	50	the	the	DT
cord-005453-4057qib7	5900	51	IQR	IQR	NNP
cord-005453-4057qib7	5900	52	of	of	IN
cord-005453-4057qib7	5900	53	healthy	healthy	JJ
cord-005453-4057qib7	5900	54	controls	control	NNS
cord-005453-4057qib7	5900	55	.	.	.
cord-005453-4057qib7	5901	1	Where	where	WRB
cord-005453-4057qib7	5901	2	disease	disease	NN
cord-005453-4057qib7	5901	3	scores	score	NNS
cord-005453-4057qib7	5901	4	were	be	VBD
cord-005453-4057qib7	5901	5	available	available	JJ
cord-005453-4057qib7	5901	6	(	(	-LRB-
cord-005453-4057qib7	5901	7	n=25	n=25	NN
cord-005453-4057qib7	5901	8	)	)	-RRB-
cord-005453-4057qib7	5902	1	there	there	EX
cord-005453-4057qib7	5902	2	were	be	VBD
cord-005453-4057qib7	5902	3	no	no	DT
cord-005453-4057qib7	5902	4	significant	significant	JJ
cord-005453-4057qib7	5902	5	correlations	correlation	NNS
cord-005453-4057qib7	5902	6	with	with	IN
cord-005453-4057qib7	5902	7	Modified	Modified	NNP
cord-005453-4057qib7	5902	8	Rodnans	Rodnans	NNP
cord-005453-4057qib7	5902	9	(	(	-LRB-
cord-005453-4057qib7	5902	10	r=0.19	r=0.19	NNP
cord-005453-4057qib7	5902	11	)	)	-RRB-
cord-005453-4057qib7	5902	12	or	or	CC
cord-005453-4057qib7	5902	13	NIH	NIH	NNP
cord-005453-4057qib7	5902	14	BSA	BSA	NNP
cord-005453-4057qib7	5902	15	scores	score	NNS
cord-005453-4057qib7	5902	16	(	(	-LRB-
cord-005453-4057qib7	5902	17	r=0.37).Sub	r=0.37).sub	NN
cord-005453-4057qib7	5902	18	-	-	HYPH
cord-005453-4057qib7	5902	19	analysis	analysis	NN
cord-005453-4057qib7	5902	20	was	be	VBD
cord-005453-4057qib7	5902	21	performed	perform	VBN
cord-005453-4057qib7	5902	22	by	by	IN
cord-005453-4057qib7	5902	23	grouping	group	VBG
cord-005453-4057qib7	5902	24	cGVHD	cGVHD	NNP
cord-005453-4057qib7	5902	25	patients	patient	NNS
cord-005453-4057qib7	5902	26	according	accord	VBG
cord-005453-4057qib7	5902	27	to	to	IN
cord-005453-4057qib7	5902	28	quartiles	quartile	NNS
cord-005453-4057qib7	5902	29	of	of	IN
cord-005453-4057qib7	5902	30	serum	serum	NN
cord-005453-4057qib7	5902	31	elafin	elafin	NN
cord-005453-4057qib7	5902	32	at	at	IN
cord-005453-4057qib7	5902	33	pre	pre	JJ
cord-005453-4057qib7	5902	34	-	-	JJ
cord-005453-4057qib7	5902	35	ECP	ecp	JJ
cord-005453-4057qib7	5902	36	baseline	baseline	NN
cord-005453-4057qib7	5902	37	.	.	.
cord-005453-4057qib7	5903	1	Retrospective	retrospective	JJ
cord-005453-4057qib7	5903	2	analysis	analysis	NN
cord-005453-4057qib7	5903	3	of	of	IN
cord-005453-4057qib7	5903	4	patients	patient	NNS
cord-005453-4057qib7	5903	5	after	after	IN
cord-005453-4057qib7	5903	6	12	12	CD
cord-005453-4057qib7	5903	7	months	month	NNS
cord-005453-4057qib7	5903	8	of	of	IN
cord-005453-4057qib7	5903	9	ECP	ECP	NNP
cord-005453-4057qib7	5903	10	(	(	-LRB-
cord-005453-4057qib7	5904	1	n=66	n=66	NNP
cord-005453-4057qib7	5904	2	)	)	-RRB-
cord-005453-4057qib7	5904	3	revealed	reveal	VBD
cord-005453-4057qib7	5904	4	that	that	IN
cord-005453-4057qib7	5904	5	those	those	DT
cord-005453-4057qib7	5904	6	with	with	IN
cord-005453-4057qib7	5904	7	serum	serum	NN
cord-005453-4057qib7	5904	8	elafin	elafin	NN
cord-005453-4057qib7	5904	9	levels	level	NNS
cord-005453-4057qib7	5904	10	in	in	IN
cord-005453-4057qib7	5904	11	the	the	DT
cord-005453-4057qib7	5904	12	upper	upper	JJ
cord-005453-4057qib7	5904	13	quartile	quartile	NN
cord-005453-4057qib7	5905	1	(	(	-LRB-
cord-005453-4057qib7	5905	2	elafin	elafin	NNP
cord-005453-4057qib7	5905	3	hi	hi	UH
cord-005453-4057qib7	5905	4	)	)	-RRB-
cord-005453-4057qib7	5906	1	pre	pre	JJ
cord-005453-4057qib7	5906	2	-	-	JJ
cord-005453-4057qib7	5906	3	ECP	ECP	NNP
cord-005453-4057qib7	5907	1	(	(	-LRB-
cord-005453-4057qib7	5907	2	min	min	NNP
cord-005453-4057qib7	5907	3	-	-	HYPH
cord-005453-4057qib7	5907	4	max	max	NN
cord-005453-4057qib7	5907	5	:	:	:
cord-005453-4057qib7	5908	1	46	46	CD
cord-005453-4057qib7	5908	2	-	-	HYPH
cord-005453-4057qib7	5908	3	117ng	117ng	NNP
cord-005453-4057qib7	5908	4	/	/	SYM
cord-005453-4057qib7	5908	5	ml	ml	NN
cord-005453-4057qib7	5908	6	)	)	-RRB-
cord-005453-4057qib7	5908	7	,	,	,
cord-005453-4057qib7	5908	8	showed	show	VBD
cord-005453-4057qib7	5908	9	a	a	DT
cord-005453-4057qib7	5908	10	significant	significant	JJ
cord-005453-4057qib7	5908	11	reduction	reduction	NN
cord-005453-4057qib7	5908	12	after	after	IN
cord-005453-4057qib7	5908	13	3	3	CD
cord-005453-4057qib7	5908	14	months	month	NNS
cord-005453-4057qib7	5908	15	of	of	IN
cord-005453-4057qib7	5908	16	therapy	therapy	NN
cord-005453-4057qib7	5908	17	(	(	-LRB-
cord-005453-4057qib7	5908	18	p	p	NN
cord-005453-4057qib7	5908	19	<	<	XX
cord-005453-4057qib7	5908	20	0.05	0.05	CD
cord-005453-4057qib7	5908	21	;	;	:
cord-005453-4057qib7	5908	22	mean	mean	VB
cord-005453-4057qib7	5908	23	+	+	CC
cord-005453-4057qib7	5909	1	/-SD	/-SD	NNP
cord-005453-4057qib7	5909	2	:	:	:
cord-005453-4057qib7	5910	1	72ng	72ng	NNP
cord-005453-4057qib7	5910	2	/	/	SYM
cord-005453-4057qib7	5910	3	ml	ml	NN
cord-005453-4057qib7	5911	1	+	+	CC
cord-005453-4057qib7	5912	1	/-26	/-26	.
cord-005453-4057qib7	5913	1	ng	ng	NNP
cord-005453-4057qib7	5913	2	/	/	SYM
cord-005453-4057qib7	5913	3	ml	ml	NN
cord-005453-4057qib7	5914	1	vs	vs	IN
cord-005453-4057qib7	5914	2	53ng	53ng	CD
cord-005453-4057qib7	5915	1	/ml	/ml	.
cord-005453-4057qib7	5916	1	+	+	CC
cord-005453-4057qib7	5916	2	/-23ng	/-23ng	.
cord-005453-4057qib7	5917	1	/ml	/ml	NFP
cord-005453-4057qib7	5917	2	,	,	,
cord-005453-4057qib7	5917	3	respectively	respectively	RB
cord-005453-4057qib7	5917	4	)	)	-RRB-
cord-005453-4057qib7	5917	5	,	,	,
cord-005453-4057qib7	5917	6	which	which	WDT
cord-005453-4057qib7	5917	7	was	be	VBD
cord-005453-4057qib7	5917	8	sustained	sustain	VBN
cord-005453-4057qib7	5917	9	up	up	RP
cord-005453-4057qib7	5917	10	to	to	TO
cord-005453-4057qib7	5917	11	12	12	CD
cord-005453-4057qib7	5917	12	months	month	NNS
cord-005453-4057qib7	5917	13	of	of	IN
cord-005453-4057qib7	5917	14	ECP	ECP	NNP
cord-005453-4057qib7	5917	15	(	(	-LRB-
cord-005453-4057qib7	5917	16	P	p	NN
cord-005453-4057qib7	5917	17	<	<	XX
cord-005453-4057qib7	5917	18	0.0001	0.0001	CD
cord-005453-4057qib7	5918	1	;	;	:
cord-005453-4057qib7	5918	2	mean	mean	VB
cord-005453-4057qib7	5918	3	+	+	CC
cord-005453-4057qib7	5919	1	/-SD	/-SD	NNP
cord-005453-4057qib7	5919	2	:	:	:
cord-005453-4057qib7	5920	1	37	37	CD
cord-005453-4057qib7	5920	2	ng/	ng/	NN
cord-005453-4057qib7	5920	3	ml	ml	NNP
cord-005453-4057qib7	5921	1	+	+	CC
cord-005453-4057qib7	5922	1	/-20ng	/-20ng	NNP
cord-005453-4057qib7	5922	2	/	/	SYM
cord-005453-4057qib7	5922	3	ml	ml	NN
cord-005453-4057qib7	5922	4	)	)	-RRB-
cord-005453-4057qib7	5922	5	.	.	.
cord-005453-4057qib7	5923	1	In	in	IN
cord-005453-4057qib7	5923	2	contrast	contrast	NN
cord-005453-4057qib7	5923	3	,	,	,
cord-005453-4057qib7	5923	4	patients	patient	NNS
cord-005453-4057qib7	5923	5	with	with	IN
cord-005453-4057qib7	5923	6	elafin	elafin	NNP
cord-005453-4057qib7	5923	7	levels	level	NNS
cord-005453-4057qib7	5923	8	below	below	IN
cord-005453-4057qib7	5923	9	the	the	DT
cord-005453-4057qib7	5923	10	upper	upper	JJ
cord-005453-4057qib7	5923	11	quartile	quartile	NNP
cord-005453-4057qib7	5923	12	(	(	-LRB-
cord-005453-4057qib7	5923	13	elafin	elafin	NNP
cord-005453-4057qib7	5923	14	lo	lo	NNP
cord-005453-4057qib7	5923	15	)	)	-RRB-
cord-005453-4057qib7	5923	16	showed	show	VBD
cord-005453-4057qib7	5923	17	no	no	DT
cord-005453-4057qib7	5923	18	significant	significant	JJ
cord-005453-4057qib7	5923	19	change	change	NN
cord-005453-4057qib7	5923	20	(	(	-LRB-
cord-005453-4057qib7	5924	1	mean	mean	VB
cord-005453-4057qib7	5925	1	+	+	CC
cord-005453-4057qib7	5926	1	/-SD	/-SD	NNP
cord-005453-4057qib7	5926	2	:	:	:
cord-005453-4057qib7	5927	1	21ng	21ng	NNP
cord-005453-4057qib7	5928	1	/ml	/ml	.
cord-005453-4057qib7	5929	1	+	+	CC
cord-005453-4057qib7	5930	1	/-11ng	/-11ng	NNP
cord-005453-4057qib7	5930	2	/	/	SYM
cord-005453-4057qib7	5930	3	ml	ml	XX
cord-005453-4057qib7	5931	1	vs	vs	IN
cord-005453-4057qib7	5931	2	26ng	26ng	NNP
cord-005453-4057qib7	5932	1	/ml	/ml	.
cord-005453-4057qib7	5933	1	+	+	CC
cord-005453-4057qib7	5933	2	/-20	/-20	.
cord-005453-4057qib7	5934	1	ng	ng	NNP
cord-005453-4057qib7	5934	2	/	/	SYM
cord-005453-4057qib7	5934	3	ml	ml	XX
cord-005453-4057qib7	5934	4	,	,	,
cord-005453-4057qib7	5934	5	respectively	respectively	RB
cord-005453-4057qib7	5934	6	)	)	-RRB-
cord-005453-4057qib7	5934	7	.	.	.
cord-005453-4057qib7	5935	1	Of	of	IN
cord-005453-4057qib7	5935	2	note	note	VB
cord-005453-4057qib7	5935	3	,	,	,
cord-005453-4057qib7	5935	4	pre	pre	JJ
cord-005453-4057qib7	5935	5	-	-	JJ
cord-005453-4057qib7	5935	6	ECP	ecp	JJ
cord-005453-4057qib7	5935	7	patients	patient	NNS
cord-005453-4057qib7	5935	8	with	with	IN
cord-005453-4057qib7	5935	9	elafin	elafin	NNP
cord-005453-4057qib7	5935	10	below	below	IN
cord-005453-4057qib7	5935	11	the	the	DT
cord-005453-4057qib7	5935	12	median	median	NN
cord-005453-4057qib7	5935	13	received	receive	VBD
cord-005453-4057qib7	5935	14	significantly	significantly	RB
cord-005453-4057qib7	5935	15	more	more	JJR
cord-005453-4057qib7	5935	16	corticosteroid	corticosteroid	JJ
cord-005453-4057qib7	5935	17	(	(	-LRB-
cord-005453-4057qib7	5935	18	CS	CS	NNP
cord-005453-4057qib7	5935	19	)	)	-RRB-
cord-005453-4057qib7	5935	20	than	than	IN
cord-005453-4057qib7	5935	21	those	those	DT
cord-005453-4057qib7	5935	22	above	above	RB
cord-005453-4057qib7	5935	23	,	,	,
cord-005453-4057qib7	5935	24	(	(	-LRB-
cord-005453-4057qib7	5935	25	P	p	NN
cord-005453-4057qib7	5935	26	<	<	XX
cord-005453-4057qib7	5935	27	0.05	0.05	CD
cord-005453-4057qib7	5935	28	;	;	:
cord-005453-4057qib7	5935	29	mean	mean	VB
cord-005453-4057qib7	5935	30	+	+	CC
cord-005453-4057qib7	5935	31	-SD	-sd	NN
cord-005453-4057qib7	5935	32	:	:	:
cord-005453-4057qib7	5936	1	27+/-18mg	27+/-18mg	CD
cord-005453-4057qib7	5936	2	/	/	SYM
cord-005453-4057qib7	5936	3	d	d	NN
cord-005453-4057qib7	5936	4	vs	vs	IN
cord-005453-4057qib7	5936	5	16+/-16mg	16+/-16mg	CD
cord-005453-4057qib7	5936	6	/	/	SYM
cord-005453-4057qib7	5936	7	d	d	NN
cord-005453-4057qib7	5936	8	,	,	,
cord-005453-4057qib7	5936	9	respectively	respectively	RB
cord-005453-4057qib7	5936	10	)	)	-RRB-
cord-005453-4057qib7	5936	11	,	,	,
cord-005453-4057qib7	5936	12	which	which	WDT
cord-005453-4057qib7	5936	13	was	be	VBD
cord-005453-4057qib7	5936	14	significantly	significantly	RB
cord-005453-4057qib7	5936	15	reduced	reduce	VBN
cord-005453-4057qib7	5936	16	after	after	IN
cord-005453-4057qib7	5936	17	3	3	CD
cord-005453-4057qib7	5936	18	months	month	NNS
cord-005453-4057qib7	5936	19	of	of	IN
cord-005453-4057qib7	5936	20	ECP	ECP	NNP
cord-005453-4057qib7	5936	21	(	(	-LRB-
cord-005453-4057qib7	5936	22	P	p	NN
cord-005453-4057qib7	5936	23	<	<	XX
cord-005453-4057qib7	5936	24	0.001	0.001	XX
cord-005453-4057qib7	5936	25	;	;	:
cord-005453-4057qib7	5936	26	to	to	IN
cord-005453-4057qib7	5936	27	13+/-10	13+/-10	CD
cord-005453-4057qib7	5936	28	mg	mg	NNP
cord-005453-4057qib7	5936	29	/	/	SYM
cord-005453-4057qib7	5936	30	d	d	NNP
cord-005453-4057qib7	5936	31	)	)	-RRB-
cord-005453-4057qib7	5936	32	,	,	,
cord-005453-4057qib7	5936	33	while	while	IN
cord-005453-4057qib7	5936	34	CS	CS	NNP
cord-005453-4057qib7	5936	35	dose	dose	NN
cord-005453-4057qib7	5936	36	was	be	VBD
cord-005453-4057qib7	5936	37	not	not	RB
cord-005453-4057qib7	5936	38	significantly	significantly	RB
cord-005453-4057qib7	5936	39	changed	change	VBN
cord-005453-4057qib7	5936	40	in	in	IN
cord-005453-4057qib7	5936	41	elafin	elafin	NNP
cord-005453-4057qib7	5936	42	hi	hi	CD
cord-005453-4057qib7	5936	43	patients	patient	NNS
cord-005453-4057qib7	5936	44	until	until	IN
cord-005453-4057qib7	5936	45	6	6	CD
cord-005453-4057qib7	5936	46	months	month	NNS
cord-005453-4057qib7	5936	47	(	(	-LRB-
cord-005453-4057qib7	5936	48	P	p	NN
cord-005453-4057qib7	5936	49	<	<	XX
cord-005453-4057qib7	5936	50	0.05	0.05	CD
cord-005453-4057qib7	5937	1	;	;	:
cord-005453-4057qib7	5937	2	mean	mean	VB
cord-005453-4057qib7	5937	3	+	+	CC
cord-005453-4057qib7	5937	4	/-SD	/-SD	.
cord-005453-4057qib7	5937	5	:	:	:
cord-005453-4057qib7	5938	1	16mg	16mg	NNP
cord-005453-4057qib7	5938	2	/	/	SYM
cord-005453-4057qib7	5938	3	d	d	NN
cord-005453-4057qib7	5939	1	+	+	CC
cord-005453-4057qib7	5939	2	/-16mg	/-16mg	NNS
cord-005453-4057qib7	5939	3	/	/	NFP
cord-005453-4057qib7	5939	4	d	d	XX
cord-005453-4057qib7	5939	5	vs	vs	IN
cord-005453-4057qib7	5939	6	6mg/	6mg/	CD
cord-005453-4057qib7	5940	1	d	d	LS
cord-005453-4057qib7	5940	2	+	+	CC
cord-005453-4057qib7	5940	3	/-5.5mg	/-5.5mg	NN
cord-005453-4057qib7	5940	4	/	/	SYM
cord-005453-4057qib7	5940	5	d	d	NN
cord-005453-4057qib7	5940	6	,	,	,
cord-005453-4057qib7	5940	7	respectively	respectively	RB
cord-005453-4057qib7	5940	8	)	)	-RRB-
cord-005453-4057qib7	5940	9	.	.	.
cord-005453-4057qib7	5941	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5941	2	:	:	:
cord-005453-4057qib7	5942	1	Consistent	consistent	JJ
cord-005453-4057qib7	5942	2	with	with	IN
cord-005453-4057qib7	5942	3	recent	recent	JJ
cord-005453-4057qib7	5942	4	data	datum	NNS
cord-005453-4057qib7	5942	5	,	,	,
cord-005453-4057qib7	5942	6	we	-PRON-	PRP
cord-005453-4057qib7	5942	7	found	find	VBD
cord-005453-4057qib7	5942	8	that	that	IN
cord-005453-4057qib7	5942	9	serum	serum	NN
cord-005453-4057qib7	5942	10	elafin	elafin	NN
cord-005453-4057qib7	5942	11	is	be	VBZ
cord-005453-4057qib7	5942	12	significantly	significantly	RB
cord-005453-4057qib7	5942	13	elevated	elevate	VBN
cord-005453-4057qib7	5942	14	in	in	IN
cord-005453-4057qib7	5942	15	a	a	DT
cord-005453-4057qib7	5942	16	subset	subset	NN
cord-005453-4057qib7	5942	17	of	of	IN
cord-005453-4057qib7	5942	18	cGVHD	cgvhd	NN
cord-005453-4057qib7	5942	19	patients	patient	NNS
cord-005453-4057qib7	5942	20	compared	compare	VBN
cord-005453-4057qib7	5942	21	to	to	IN
cord-005453-4057qib7	5942	22	healthy	healthy	JJ
cord-005453-4057qib7	5942	23	controls	control	NNS
cord-005453-4057qib7	5942	24	,	,	,
cord-005453-4057qib7	5942	25	but	but	CC
cord-005453-4057qib7	5942	26	did	do	VBD
cord-005453-4057qib7	5942	27	not	not	RB
cord-005453-4057qib7	5942	28	correlate	correlate	VB
cord-005453-4057qib7	5942	29	with	with	IN
cord-005453-4057qib7	5942	30	skin	skin	NN
cord-005453-4057qib7	5942	31	disease	disease	NN
cord-005453-4057qib7	5942	32	scores	score	NNS
cord-005453-4057qib7	5942	33	.	.	.
cord-005453-4057qib7	5943	1	ECP	ECP	NNP
cord-005453-4057qib7	5943	2	administration	administration	NN
cord-005453-4057qib7	5943	3	was	be	VBD
cord-005453-4057qib7	5943	4	associated	associate	VBN
cord-005453-4057qib7	5943	5	with	with	IN
cord-005453-4057qib7	5943	6	a	a	DT
cord-005453-4057qib7	5943	7	reduction	reduction	NN
cord-005453-4057qib7	5943	8	in	in	IN
cord-005453-4057qib7	5943	9	serum	serum	NN
cord-005453-4057qib7	5943	10	elafin	elafin	NN
cord-005453-4057qib7	5943	11	in	in	IN
cord-005453-4057qib7	5943	12	the	the	DT
cord-005453-4057qib7	5943	13	Elafin	Elafin	NNP
cord-005453-4057qib7	5943	14	hi	hi	UH
cord-005453-4057qib7	5943	15	subset	subset	JJ
cord-005453-4057qib7	5943	16	.	.	.
cord-005453-4057qib7	5944	1	Further	further	RB
cord-005453-4057qib7	5944	2	,	,	,
cord-005453-4057qib7	5944	3	elafin	elafin	NNP
cord-005453-4057qib7	5944	4	lo	lo	NNP
cord-005453-4057qib7	5944	5	and	and	CC
cord-005453-4057qib7	5944	6	elafin	elafin	NNP
cord-005453-4057qib7	5944	7	hi	hi	UH
cord-005453-4057qib7	5944	8	patients	patient	NNS
cord-005453-4057qib7	5944	9	tolerated	tolerate	VBD
cord-005453-4057qib7	5944	10	different	different	JJ
cord-005453-4057qib7	5944	11	rates	rate	NNS
cord-005453-4057qib7	5944	12	of	of	IN
cord-005453-4057qib7	5944	13	ECP	ECP	NNP
cord-005453-4057qib7	5944	14	-	-	HYPH
cord-005453-4057qib7	5944	15	mediated	mediate	VBN
cord-005453-4057qib7	5944	16	tapering	tapering	NN
cord-005453-4057qib7	5944	17	of	of	IN
cord-005453-4057qib7	5944	18	CS	CS	NNP
cord-005453-4057qib7	5944	19	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	5945	1	suggests	suggest	VBZ
cord-005453-4057qib7	5945	2	pre	pre	JJ
cord-005453-4057qib7	5945	3	-	-	JJ
cord-005453-4057qib7	5945	4	ECP	ecp	JJ
cord-005453-4057qib7	5945	5	elafin	elafin	NN
cord-005453-4057qib7	5945	6	measurements	measurement	NNS
cord-005453-4057qib7	5945	7	may	may	MD
cord-005453-4057qib7	5945	8	have	have	VB
cord-005453-4057qib7	5945	9	predictive	predictive	JJ
cord-005453-4057qib7	5945	10	value	value	NN
cord-005453-4057qib7	5945	11	.	.	.
cord-005453-4057qib7	5946	1	References	reference	NNS
cord-005453-4057qib7	5946	2	:	:	:
cord-005453-4057qib7	5946	3	Background	background	NN
cord-005453-4057qib7	5946	4	:	:	:
cord-005453-4057qib7	5947	1	Allogenic	allogenic	JJ
cord-005453-4057qib7	5947	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5947	3	stem	stem	NN
cord-005453-4057qib7	5947	4	cell	cell	NN
cord-005453-4057qib7	5947	5	transplantation	transplantation	NN
cord-005453-4057qib7	5947	6	(	(	-LRB-
cord-005453-4057qib7	5947	7	HSCT	HSCT	NNP
cord-005453-4057qib7	5947	8	)	)	-RRB-
cord-005453-4057qib7	5947	9	is	be	VBZ
cord-005453-4057qib7	5947	10	a	a	DT
cord-005453-4057qib7	5947	11	potential	potential	JJ
cord-005453-4057qib7	5947	12	curative	curative	JJ
cord-005453-4057qib7	5947	13	treatment	treatment	NN
cord-005453-4057qib7	5947	14	for	for	IN
cord-005453-4057qib7	5947	15	many	many	JJ
cord-005453-4057qib7	5947	16	malignant	malignant	JJ
cord-005453-4057qib7	5947	17	and	and	CC
cord-005453-4057qib7	5947	18	no	no	DT
cord-005453-4057qib7	5947	19	malignant	malignant	JJ
cord-005453-4057qib7	5947	20	hematologic	hematologic	JJ
cord-005453-4057qib7	5947	21	diseases	disease	NNS
cord-005453-4057qib7	5947	22	,	,	,
cord-005453-4057qib7	5947	23	primary	primary	JJ
cord-005453-4057qib7	5947	24	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	5947	25	and	and	CC
cord-005453-4057qib7	5947	26	some	some	DT
cord-005453-4057qib7	5947	27	metabolic	metabolic	JJ
cord-005453-4057qib7	5947	28	and	and	CC
cord-005453-4057qib7	5947	29	deposit	deposit	NN
cord-005453-4057qib7	5947	30	diseases	disease	NNS
cord-005453-4057qib7	5947	31	in	in	IN
cord-005453-4057qib7	5947	32	children	child	NNS
cord-005453-4057qib7	5947	33	.	.	.
cord-005453-4057qib7	5948	1	Graft	graft	NN
cord-005453-4057qib7	5948	2	versus	versus	IN
cord-005453-4057qib7	5948	3	host	host	NN
cord-005453-4057qib7	5948	4	disease	disease	NN
cord-005453-4057qib7	5948	5	(	(	-LRB-
cord-005453-4057qib7	5948	6	GVHD	GVHD	NNP
cord-005453-4057qib7	5948	7	)	)	-RRB-
cord-005453-4057qib7	5948	8	is	be	VBZ
cord-005453-4057qib7	5948	9	a	a	DT
cord-005453-4057qib7	5948	10	major	major	JJ
cord-005453-4057qib7	5948	11	cause	cause	NN
cord-005453-4057qib7	5948	12	of	of	IN
cord-005453-4057qib7	5948	13	morbidity	morbidity	NN
cord-005453-4057qib7	5948	14	and	and	CC
cord-005453-4057qib7	5948	15	a	a	DT
cord-005453-4057qib7	5948	16	leading	leading	JJ
cord-005453-4057qib7	5948	17	cause	cause	NN
cord-005453-4057qib7	5948	18	of	of	IN
cord-005453-4057qib7	5948	19	non	non	JJ
cord-005453-4057qib7	5948	20	-	-	JJ
cord-005453-4057qib7	5948	21	relapse	relapse	JJ
cord-005453-4057qib7	5948	22	mortality	mortality	NN
cord-005453-4057qib7	5948	23	.	.	.
cord-005453-4057qib7	5949	1	Corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5949	2	are	be	VBP
cord-005453-4057qib7	5949	3	the	the	DT
cord-005453-4057qib7	5949	4	standard	standard	JJ
cord-005453-4057qib7	5949	5	first	first	JJ
cord-005453-4057qib7	5949	6	-	-	HYPH
cord-005453-4057qib7	5949	7	line	line	NN
cord-005453-4057qib7	5949	8	systemic	systemic	JJ
cord-005453-4057qib7	5949	9	treatment	treatment	NN
cord-005453-4057qib7	5949	10	for	for	IN
cord-005453-4057qib7	5949	11	both	both	CC
cord-005453-4057qib7	5949	12	acute	acute	JJ
cord-005453-4057qib7	5949	13	and	and	CC
cord-005453-4057qib7	5949	14	chronic	chronic	JJ
cord-005453-4057qib7	5949	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5949	16	,	,	,
cord-005453-4057qib7	5949	17	whereas	whereas	IN
cord-005453-4057qib7	5949	18	no	no	DT
cord-005453-4057qib7	5949	19	second	second	JJ
cord-005453-4057qib7	5949	20	line	line	NN
cord-005453-4057qib7	5949	21	option	option	NN
cord-005453-4057qib7	5949	22	for	for	IN
cord-005453-4057qib7	5949	23	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	5949	24	-	-	HYPH
cord-005453-4057qib7	5949	25	refractory	refractory	JJ
cord-005453-4057qib7	5949	26	patients	patient	NNS
cord-005453-4057qib7	5949	27	is	be	VBZ
cord-005453-4057qib7	5949	28	standardised	standardised	JJ
cord-005453-4057qib7	5949	29	.	.	.
cord-005453-4057qib7	5950	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5950	2	is	be	VBZ
cord-005453-4057qib7	5950	3	a	a	DT
cord-005453-4057qib7	5950	4	potent	potent	JJ
cord-005453-4057qib7	5950	5	inhibitor	inhibitor	NN
cord-005453-4057qib7	5950	6	of	of	IN
cord-005453-4057qib7	5950	7	JAK	JAK	NNP
cord-005453-4057qib7	5950	8	1/	1/	CD
cord-005453-4057qib7	5950	9	2	2	CD
cord-005453-4057qib7	5950	10	showing	show	VBG
cord-005453-4057qib7	5950	11	significant	significant	JJ
cord-005453-4057qib7	5950	12	responses	response	NNS
cord-005453-4057qib7	5950	13	in	in	IN
cord-005453-4057qib7	5950	14	refractory	refractory	JJ
cord-005453-4057qib7	5950	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5950	16	patients	patient	NNS
cord-005453-4057qib7	5950	17	in	in	IN
cord-005453-4057qib7	5950	18	recent	recent	JJ
cord-005453-4057qib7	5950	19	reports	report	NNS
cord-005453-4057qib7	5950	20	.	.	.
cord-005453-4057qib7	5951	1	Methods	method	NNS
cord-005453-4057qib7	5951	2	:	:	:
cord-005453-4057qib7	5951	3	We	-PRON-	PRP
cord-005453-4057qib7	5951	4	present	present	VBP
cord-005453-4057qib7	5951	5	two	two	CD
cord-005453-4057qib7	5951	6	centres	centre	NNS
cord-005453-4057qib7	5951	7	experience	experience	NN
cord-005453-4057qib7	5951	8	with	with	IN
cord-005453-4057qib7	5951	9	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5951	10	for	for	IN
cord-005453-4057qib7	5951	11	GVHD	GVHD	NNP
cord-005453-4057qib7	5951	12	treatment	treatment	NN
cord-005453-4057qib7	5951	13	in	in	IN
cord-005453-4057qib7	5951	14	pediatric	pediatric	JJ
cord-005453-4057qib7	5951	15	patients	patient	NNS
cord-005453-4057qib7	5951	16	.	.	.
cord-005453-4057qib7	5952	1	The	the	DT
cord-005453-4057qib7	5952	2	study	study	NN
cord-005453-4057qib7	5952	3	was	be	VBD
cord-005453-4057qib7	5952	4	conducted	conduct	VBN
cord-005453-4057qib7	5952	5	in	in	IN
cord-005453-4057qib7	5952	6	two	two	CD
cord-005453-4057qib7	5952	7	spanish	spanish	JJ
cord-005453-4057qib7	5952	8	pediatric	pediatric	JJ
cord-005453-4057qib7	5952	9	HSCT	HSCT	NNP
cord-005453-4057qib7	5952	10	centres	centre	NNS
cord-005453-4057qib7	5952	11	,	,	,
cord-005453-4057qib7	5952	12	Hospital	Hospital	NNP
cord-005453-4057qib7	5952	13	Vall	Vall	NNP
cord-005453-4057qib7	5952	14	d'Hebron	d'Hebron	NNP
cord-005453-4057qib7	5952	15	(	(	-LRB-
cord-005453-4057qib7	5952	16	Barcelona	Barcelona	NNP
cord-005453-4057qib7	5952	17	)	)	-RRB-
cord-005453-4057qib7	5952	18	and	and	CC
cord-005453-4057qib7	5952	19	Hospital	Hospital	NNP
cord-005453-4057qib7	5952	20	Universitario	Universitario	NNP
cord-005453-4057qib7	5952	21	La	La	NNP
cord-005453-4057qib7	5952	22	Paz	Paz	NNP
cord-005453-4057qib7	5952	23	(	(	-LRB-
cord-005453-4057qib7	5952	24	Madrid	Madrid	NNP
cord-005453-4057qib7	5952	25	)	)	-RRB-
cord-005453-4057qib7	5952	26	.	.	.
cord-005453-4057qib7	5953	1	All	all	DT
cord-005453-4057qib7	5953	2	patients	patient	NNS
cord-005453-4057qib7	5953	3	receiving	receive	VBG
cord-005453-4057qib7	5953	4	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5953	5	since	since	IN
cord-005453-4057qib7	5953	6	the	the	DT
cord-005453-4057qib7	5953	7	drug	drug	NN
cord-005453-4057qib7	5953	8	was	be	VBD
cord-005453-4057qib7	5953	9	available	available	JJ
cord-005453-4057qib7	5953	10	were	be	VBD
cord-005453-4057qib7	5953	11	included	include	VBN
cord-005453-4057qib7	5953	12	for	for	IN
cord-005453-4057qib7	5953	13	retrospective	retrospective	JJ
cord-005453-4057qib7	5953	14	analysis	analysis	NN
cord-005453-4057qib7	5953	15	.	.	.
cord-005453-4057qib7	5954	1	Results	result	NNS
cord-005453-4057qib7	5954	2	:	:	:
cord-005453-4057qib7	5955	1	Between	between	IN
cord-005453-4057qib7	5955	2	March	March	NNP
cord-005453-4057qib7	5955	3	2017	2017	CD
cord-005453-4057qib7	5955	4	and	and	CC
cord-005453-4057qib7	5955	5	December	December	NNP
cord-005453-4057qib7	5955	6	2018	2018	CD
cord-005453-4057qib7	5955	7	19	19	CD
cord-005453-4057qib7	5955	8	pediatric	pediatric	JJ
cord-005453-4057qib7	5955	9	patients	patient	NNS
cord-005453-4057qib7	5955	10	with	with	IN
cord-005453-4057qib7	5955	11	acute	acute	JJ
cord-005453-4057qib7	5955	12	or	or	CC
cord-005453-4057qib7	5955	13	chronic	chronic	JJ
cord-005453-4057qib7	5955	14	GVHD	GVHD	NNP
cord-005453-4057qib7	5955	15	with	with	IN
cord-005453-4057qib7	5955	16	refractoriness	refractoriness	NN
cord-005453-4057qib7	5955	17	to	to	IN
cord-005453-4057qib7	5955	18	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5955	19	were	be	VBD
cord-005453-4057qib7	5955	20	treated	treat	VBN
cord-005453-4057qib7	5955	21	with	with	IN
cord-005453-4057qib7	5955	22	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5955	23	,	,	,
cord-005453-4057qib7	5955	24	in	in	IN
cord-005453-4057qib7	5955	25	22	22	CD
cord-005453-4057qib7	5955	26	different	different	JJ
cord-005453-4057qib7	5955	27	episodes	episode	NNS
cord-005453-4057qib7	5955	28	(	(	-LRB-
cord-005453-4057qib7	5955	29	one	one	CD
cord-005453-4057qib7	5955	30	patient	patient	NN
cord-005453-4057qib7	5955	31	received	receive	VBD
cord-005453-4057qib7	5955	32	it	-PRON-	PRP
cord-005453-4057qib7	5955	33	in	in	IN
cord-005453-4057qib7	5955	34	3	3	CD
cord-005453-4057qib7	5955	35	different	different	JJ
cord-005453-4057qib7	5955	36	moments	moment	NNS
cord-005453-4057qib7	5955	37	,	,	,
cord-005453-4057qib7	5955	38	and	and	CC
cord-005453-4057qib7	5955	39	one	one	CD
cord-005453-4057qib7	5955	40	patient	patient	NN
cord-005453-4057qib7	5955	41	received	receive	VBD
cord-005453-4057qib7	5955	42	it	-PRON-	PRP
cord-005453-4057qib7	5955	43	in	in	IN
cord-005453-4057qib7	5955	44	2	2	CD
cord-005453-4057qib7	5955	45	)	)	-RRB-
cord-005453-4057qib7	5955	46	.	.	.
cord-005453-4057qib7	5956	1	Patient	Patient	NNP
cord-005453-4057qib7	5956	2	's	's	POS
cord-005453-4057qib7	5956	3	sex	sex	NN
cord-005453-4057qib7	5956	4	at	at	IN
cord-005453-4057qib7	5956	5	birth	birth	NN
cord-005453-4057qib7	5956	6	was	be	VBD
cord-005453-4057qib7	5956	7	female	female	JJ
cord-005453-4057qib7	5956	8	in	in	IN
cord-005453-4057qib7	5956	9	11	11	CD
cord-005453-4057qib7	5956	10	and	and	CC
cord-005453-4057qib7	5956	11	male	male	NN
cord-005453-4057qib7	5956	12	in	in	IN
cord-005453-4057qib7	5956	13	8	8	CD
cord-005453-4057qib7	5956	14	cases	case	NNS
cord-005453-4057qib7	5956	15	.	.	.
cord-005453-4057qib7	5957	1	Median	median	JJ
cord-005453-4057qib7	5957	2	age	age	NN
cord-005453-4057qib7	5957	3	at	at	IN
cord-005453-4057qib7	5957	4	HSCT	HSCT	NNP
cord-005453-4057qib7	5957	5	was	be	VBD
cord-005453-4057qib7	5957	6	10,94	10,94	CD
cord-005453-4057qib7	5957	7	years	year	NNS
cord-005453-4057qib7	5957	8	(	(	-LRB-
cord-005453-4057qib7	5957	9	0,79	0,79	CD
cord-005453-4057qib7	5957	10	-	-	SYM
cord-005453-4057qib7	5957	11	18,11	18,11	CD
cord-005453-4057qib7	5957	12	)	)	-RRB-
cord-005453-4057qib7	5957	13	.	.	.
cord-005453-4057qib7	5958	1	Primary	primary	JJ
cord-005453-4057qib7	5958	2	disease	disease	NN
cord-005453-4057qib7	5958	3	was	be	VBD
cord-005453-4057qib7	5958	4	malignant	malignant	JJ
cord-005453-4057qib7	5958	5	in	in	IN
cord-005453-4057qib7	5958	6	11	11	CD
cord-005453-4057qib7	5958	7	patients	patient	NNS
cord-005453-4057qib7	5958	8	and	and	CC
cord-005453-4057qib7	5958	9	non	non	AFX
cord-005453-4057qib7	5958	10	malignant	malignant	JJ
cord-005453-4057qib7	5958	11	in	in	IN
cord-005453-4057qib7	5958	12	8	8	CD
cord-005453-4057qib7	5958	13	.	.	.
cord-005453-4057qib7	5959	1	Median	median	JJ
cord-005453-4057qib7	5959	2	time	time	NN
cord-005453-4057qib7	5959	3	of	of	IN
cord-005453-4057qib7	5959	4	GVHD	GVHD	NNP
cord-005453-4057qib7	5959	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	5959	6	was	be	VBD
cord-005453-4057qib7	5959	7	47,5	47,5	CD
cord-005453-4057qib7	5959	8	days	day	NNS
cord-005453-4057qib7	5959	9	(	(	-LRB-
cord-005453-4057qib7	5959	10	6	6	CD
cord-005453-4057qib7	5959	11	-	-	SYM
cord-005453-4057qib7	5959	12	525	525	CD
cord-005453-4057qib7	5959	13	)	)	-RRB-
cord-005453-4057qib7	5959	14	.	.	.
cord-005453-4057qib7	5960	1	All	all	DT
cord-005453-4057qib7	5960	2	GVHD	GVHD	NNP
cord-005453-4057qib7	5960	3	episodes	episode	NNS
cord-005453-4057qib7	5960	4	were	be	VBD
cord-005453-4057qib7	5960	5	treated	treat	VBN
cord-005453-4057qib7	5960	6	with	with	IN
cord-005453-4057qib7	5960	7	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5960	8	as	as	IN
cord-005453-4057qib7	5960	9	first	first	JJ
cord-005453-4057qib7	5960	10	line	line	NN
cord-005453-4057qib7	5960	11	,	,	,
cord-005453-4057qib7	5960	12	with	with	IN
cord-005453-4057qib7	5960	13	maximum	maximum	JJ
cord-005453-4057qib7	5960	14	doses	dose	NNS
cord-005453-4057qib7	5960	15	between	between	IN
cord-005453-4057qib7	5960	16	1	1	CD
cord-005453-4057qib7	5960	17	-	-	SYM
cord-005453-4057qib7	5960	18	5	5	CD
cord-005453-4057qib7	5960	19	mg	mg	NNP
cord-005453-4057qib7	5960	20	/	/	SYM
cord-005453-4057qib7	5960	21	kg	kg	NNP
cord-005453-4057qib7	5960	22	/	/	SYM
cord-005453-4057qib7	5960	23	day	day	NN
cord-005453-4057qib7	5960	24	(	(	-LRB-
cord-005453-4057qib7	5960	25	the	the	DT
cord-005453-4057qib7	5960	26	main	main	JJ
cord-005453-4057qib7	5960	27	dose	dose	NN
cord-005453-4057qib7	5960	28	used	use	VBN
cord-005453-4057qib7	5960	29	was	be	VBD
cord-005453-4057qib7	5960	30	2	2	CD
cord-005453-4057qib7	5960	31	mg	mg	NNP
cord-005453-4057qib7	5960	32	/	/	SYM
cord-005453-4057qib7	5960	33	kg	kg	NNP
cord-005453-4057qib7	5960	34	/	/	SYM
cord-005453-4057qib7	5960	35	day	day	NN
cord-005453-4057qib7	5960	36	,	,	,
cord-005453-4057qib7	5960	37	15/22	15/22	CD
cord-005453-4057qib7	5960	38	episodes	episode	NNS
cord-005453-4057qib7	5960	39	)	)	-RRB-
cord-005453-4057qib7	5960	40	.	.	.
cord-005453-4057qib7	5961	1	Patients	patient	NNS
cord-005453-4057qib7	5961	2	received	receive	VBD
cord-005453-4057qib7	5961	3	a	a	DT
cord-005453-4057qib7	5961	4	median	median	JJ
cord-005453-4057qib7	5961	5	number	number	NN
cord-005453-4057qib7	5961	6	of	of	IN
cord-005453-4057qib7	5961	7	3,5	3,5	CD
cord-005453-4057qib7	5961	8	(	(	-LRB-
cord-005453-4057qib7	5961	9	2	2	CD
cord-005453-4057qib7	5961	10	-	-	SYM
cord-005453-4057qib7	5961	11	7	7	CD
cord-005453-4057qib7	5961	12	)	)	-RRB-
cord-005453-4057qib7	5961	13	previous	previous	JJ
cord-005453-4057qib7	5961	14	lines	line	NNS
cord-005453-4057qib7	5961	15	of	of	IN
cord-005453-4057qib7	5961	16	treatment	treatment	NN
cord-005453-4057qib7	5961	17	including	include	VBG
cord-005453-4057qib7	5961	18	steroids	steroid	NNS
cord-005453-4057qib7	5961	19	before	before	IN
cord-005453-4057qib7	5961	20	starting	start	VBG
cord-005453-4057qib7	5961	21	Ruxolinib	Ruxolinib	NNP
cord-005453-4057qib7	5961	22	;	;	:
cord-005453-4057qib7	5961	23	they	-PRON-	PRP
cord-005453-4057qib7	5961	24	were	be	VBD
cord-005453-4057qib7	5961	25	extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	5961	26	photopheresis	photopheresis	NN
cord-005453-4057qib7	5961	27	(	(	-LRB-
cord-005453-4057qib7	5961	28	19/22	19/22	CD
cord-005453-4057qib7	5961	29	episodes	episode	NNS
cord-005453-4057qib7	5961	30	)	)	-RRB-
cord-005453-4057qib7	5961	31	,	,	,
cord-005453-4057qib7	5961	32	sirolimus	sirolimus	NNP
cord-005453-4057qib7	5961	33	(	(	-LRB-
cord-005453-4057qib7	5961	34	7/22	7/22	CD
cord-005453-4057qib7	5961	35	)	)	-RRB-
cord-005453-4057qib7	5961	36	,	,	,
cord-005453-4057qib7	5961	37	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	5961	38	cells	cell	NNS
cord-005453-4057qib7	5961	39	(	(	-LRB-
cord-005453-4057qib7	5961	40	5/22	5/22	CD
cord-005453-4057qib7	5961	41	)	)	-RRB-
cord-005453-4057qib7	5962	1	Ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	5962	2	initiation	initiation	NN
cord-005453-4057qib7	5962	3	was	be	VBD
cord-005453-4057qib7	5962	4	indicated	indicate	VBN
cord-005453-4057qib7	5962	5	for	for	IN
cord-005453-4057qib7	5962	6	acute	acute	JJ
cord-005453-4057qib7	5962	7	gut	gut	NN
cord-005453-4057qib7	5962	8	refractory	refractory	JJ
cord-005453-4057qib7	5962	9	/	/	SYM
cord-005453-4057qib7	5962	10	steroid	steroid	NN
cord-005453-4057qib7	5962	11	dependant	dependant	JJ
cord-005453-4057qib7	5962	12	GVHD	GVHD	NNP
cord-005453-4057qib7	5962	13	in	in	IN
cord-005453-4057qib7	5962	14	9	9	CD
cord-005453-4057qib7	5962	15	episodes	episode	NNS
cord-005453-4057qib7	5962	16	and	and	CC
cord-005453-4057qib7	5962	17	chronic	chronic	JJ
cord-005453-4057qib7	5962	18	multisystemic	multisystemic	NN
cord-005453-4057qib7	5962	19	in	in	IN
cord-005453-4057qib7	5962	20	7	7	CD
cord-005453-4057qib7	5962	21	episodes	episode	NNS
cord-005453-4057qib7	5962	22	.	.	.
cord-005453-4057qib7	5963	1	Other	other	JJ
cord-005453-4057qib7	5963	2	indications	indication	NNS
cord-005453-4057qib7	5963	3	were	be	VBD
cord-005453-4057qib7	5963	4	chronic	chronic	JJ
cord-005453-4057qib7	5963	5	lung	lung	NN
cord-005453-4057qib7	5963	6	(	(	-LRB-
cord-005453-4057qib7	5963	7	3/22	3/22	CD
cord-005453-4057qib7	5963	8	episodes	episode	NNS
cord-005453-4057qib7	5963	9	)	)	-RRB-
cord-005453-4057qib7	5963	10	,	,	,
cord-005453-4057qib7	5963	11	chronic	chronic	JJ
cord-005453-4057qib7	5963	12	skin	skin	NN
cord-005453-4057qib7	5963	13	(	(	-LRB-
cord-005453-4057qib7	5963	14	2/22	2/22	CD
cord-005453-4057qib7	5963	15	)	)	-RRB-
cord-005453-4057qib7	5963	16	and	and	CC
cord-005453-4057qib7	5963	17	acute	acute	JJ
cord-005453-4057qib7	5963	18	skin	skin	NN
cord-005453-4057qib7	5963	19	GVHD	GVHD	NNP
cord-005453-4057qib7	5963	20	(	(	-LRB-
cord-005453-4057qib7	5963	21	1/22	1/22	CD
cord-005453-4057qib7	5963	22	)	)	-RRB-
cord-005453-4057qib7	5963	23	.	.	.
cord-005453-4057qib7	5964	1	Median	median	JJ
cord-005453-4057qib7	5964	2	post	post	JJ
cord-005453-4057qib7	5964	3	-	-	JJ
cord-005453-4057qib7	5964	4	HSCT	hsct	JJ
cord-005453-4057qib7	5964	5	time	time	NN
cord-005453-4057qib7	5964	6	of	of	IN
cord-005453-4057qib7	5964	7	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5964	8	start	start	NN
cord-005453-4057qib7	5964	9	was	be	VBD
cord-005453-4057qib7	5964	10	300	300	CD
cord-005453-4057qib7	5964	11	days	day	NNS
cord-005453-4057qib7	5964	12	.	.	.
cord-005453-4057qib7	5965	1	Doses	dose	NNS
cord-005453-4057qib7	5965	2	ranged	range	VBD
cord-005453-4057qib7	5965	3	between	between	IN
cord-005453-4057qib7	5965	4	2,5	2,5	CD
cord-005453-4057qib7	5965	5	-	-	SYM
cord-005453-4057qib7	5965	6	10	10	CD
cord-005453-4057qib7	5965	7	mg/12h	mg/12h	NN
cord-005453-4057qib7	5965	8	depending	depend	VBG
cord-005453-4057qib7	5965	9	on	on	IN
cord-005453-4057qib7	5965	10	age	age	NN
cord-005453-4057qib7	5965	11	,	,	,
cord-005453-4057qib7	5965	12	weight	weight	NN
cord-005453-4057qib7	5965	13	,	,	,
cord-005453-4057qib7	5965	14	and	and	CC
cord-005453-4057qib7	5965	15	tolerance	tolerance	NN
cord-005453-4057qib7	5965	16	(	(	-LRB-
cord-005453-4057qib7	5965	17	hematologic	hematologic	JJ
cord-005453-4057qib7	5965	18	and	and	CC
cord-005453-4057qib7	5965	19	liver	liver	NN
cord-005453-4057qib7	5965	20	toxicities	toxicity	NNS
cord-005453-4057qib7	5965	21	)	)	-RRB-
cord-005453-4057qib7	5965	22	.	.	.
cord-005453-4057qib7	5966	1	Average	average	JJ
cord-005453-4057qib7	5966	2	duration	duration	NN
cord-005453-4057qib7	5966	3	of	of	IN
cord-005453-4057qib7	5966	4	treatment	treatment	NN
cord-005453-4057qib7	5966	5	was	be	VBD
cord-005453-4057qib7	5966	6	186	186	CD
cord-005453-4057qib7	5966	7	days	day	NNS
cord-005453-4057qib7	5966	8	(	(	-LRB-
cord-005453-4057qib7	5966	9	11	11	CD
cord-005453-4057qib7	5966	10	-	-	SYM
cord-005453-4057qib7	5966	11	616	616	CD
cord-005453-4057qib7	5966	12	)	)	-RRB-
cord-005453-4057qib7	5966	13	.	.	.
cord-005453-4057qib7	5967	1	Complete	complete	JJ
cord-005453-4057qib7	5967	2	response	response	NN
cord-005453-4057qib7	5967	3	(	(	-LRB-
cord-005453-4057qib7	5967	4	CR	cr	NN
cord-005453-4057qib7	5967	5	)	)	-RRB-
cord-005453-4057qib7	5967	6	rate	rate	NN
cord-005453-4057qib7	5967	7	was	be	VBD
cord-005453-4057qib7	5967	8	18,1	18,1	CD
cord-005453-4057qib7	5967	9	%	%	NN
cord-005453-4057qib7	5967	10	,	,	,
cord-005453-4057qib7	5967	11	global	global	JJ
cord-005453-4057qib7	5967	12	partial	partial	JJ
cord-005453-4057qib7	5967	13	response	response	NN
cord-005453-4057qib7	5967	14	(	(	-LRB-
cord-005453-4057qib7	5967	15	PR	pr	NN
cord-005453-4057qib7	5967	16	)	)	-RRB-
cord-005453-4057qib7	5968	1	72,7	72,7	CD
cord-005453-4057qib7	5968	2	%	%	NN
cord-005453-4057qib7	5968	3	,	,	,
cord-005453-4057qib7	5968	4	and	and	CC
cord-005453-4057qib7	5968	5	no	no	DT
cord-005453-4057qib7	5968	6	response	response	NN
cord-005453-4057qib7	5968	7	(	(	-LRB-
cord-005453-4057qib7	5968	8	NR	nr	NN
cord-005453-4057qib7	5968	9	)	)	-RRB-
cord-005453-4057qib7	5968	10	9	9	CD
cord-005453-4057qib7	5968	11	%	%	NN
cord-005453-4057qib7	5968	12	(	(	-LRB-
cord-005453-4057qib7	5968	13	progression	progression	NN
cord-005453-4057qib7	5968	14	in	in	IN
cord-005453-4057qib7	5968	15	one	one	CD
cord-005453-4057qib7	5968	16	patient	patient	NN
cord-005453-4057qib7	5968	17	and	and	CC
cord-005453-4057qib7	5968	18	recent	recent	JJ
cord-005453-4057qib7	5968	19	treatment	treatment	NN
cord-005453-4057qib7	5968	20	start	start	NN
cord-005453-4057qib7	5968	21	in	in	IN
cord-005453-4057qib7	5968	22	other	other	JJ
cord-005453-4057qib7	5968	23	patient	patient	NN
cord-005453-4057qib7	5968	24	)	)	-RRB-
cord-005453-4057qib7	5968	25	.	.	.
cord-005453-4057qib7	5969	1	Mean	mean	JJ
cord-005453-4057qib7	5969	2	time	time	NN
cord-005453-4057qib7	5969	3	to	to	TO
cord-005453-4057qib7	5969	4	maximum	maximum	VB
cord-005453-4057qib7	5969	5	response	response	NN
cord-005453-4057qib7	5969	6	was	be	VBD
cord-005453-4057qib7	5969	7	4	4	CD
cord-005453-4057qib7	5969	8	weeks	week	NNS
cord-005453-4057qib7	5969	9	.	.	.
cord-005453-4057qib7	5970	1	Treatment	treatment	NN
cord-005453-4057qib7	5970	2	stop	stop	NN
cord-005453-4057qib7	5970	3	cause	cause	NN
cord-005453-4057qib7	5970	4	was	be	VBD
cord-005453-4057qib7	5970	5	CR	cr	NN
cord-005453-4057qib7	5970	6	in	in	IN
cord-005453-4057qib7	5970	7	2	2	CD
cord-005453-4057qib7	5970	8	cases	case	NNS
cord-005453-4057qib7	5970	9	,	,	,
cord-005453-4057qib7	5970	10	infection	infection	NN
cord-005453-4057qib7	5970	11	in	in	IN
cord-005453-4057qib7	5970	12	4	4	CD
cord-005453-4057qib7	5970	13	,	,	,
cord-005453-4057qib7	5970	14	liver	liver	NN
cord-005453-4057qib7	5970	15	toxicity	toxicity	NN
cord-005453-4057qib7	5970	16	in	in	IN
cord-005453-4057qib7	5970	17	1	1	CD
cord-005453-4057qib7	5970	18	.	.	.
cord-005453-4057qib7	5971	1	No	no	DT
cord-005453-4057qib7	5971	2	severe	severe	JJ
cord-005453-4057qib7	5971	3	side	side	NN
cord-005453-4057qib7	5971	4	effects	effect	NNS
cord-005453-4057qib7	5971	5	directly	directly	RB
cord-005453-4057qib7	5971	6	related	relate	VBN
cord-005453-4057qib7	5971	7	to	to	IN
cord-005453-4057qib7	5971	8	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5971	9	treatment	treatment	NN
cord-005453-4057qib7	5971	10	were	be	VBD
cord-005453-4057qib7	5971	11	described	describe	VBN
cord-005453-4057qib7	5971	12	.	.	.
cord-005453-4057qib7	5972	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	5972	2	:	:	:
cord-005453-4057qib7	5973	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	5973	2	has	have	VBZ
cord-005453-4057qib7	5973	3	been	be	VBN
cord-005453-4057qib7	5973	4	recently	recently	RB
cord-005453-4057qib7	5973	5	introduced	introduce	VBN
cord-005453-4057qib7	5973	6	as	as	IN
cord-005453-4057qib7	5973	7	second	second	JJ
cord-005453-4057qib7	5973	8	line	line	NN
cord-005453-4057qib7	5973	9	strategy	strategy	NN
cord-005453-4057qib7	5973	10	for	for	IN
cord-005453-4057qib7	5973	11	rescuing	rescue	VBG
cord-005453-4057qib7	5973	12	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	5973	13	-	-	HYPH
cord-005453-4057qib7	5973	14	refractory	refractory	JJ
cord-005453-4057qib7	5973	15	GVHD	GVHD	NNP
cord-005453-4057qib7	5973	16	in	in	IN
cord-005453-4057qib7	5973	17	pediatric	pediatric	JJ
cord-005453-4057qib7	5973	18	patients	patient	NNS
cord-005453-4057qib7	5973	19	.	.	.
cord-005453-4057qib7	5974	1	While	while	IN
cord-005453-4057qib7	5974	2	results	result	NNS
cord-005453-4057qib7	5974	3	of	of	IN
cord-005453-4057qib7	5974	4	randomized	randomized	JJ
cord-005453-4057qib7	5974	5	trials	trial	NNS
cord-005453-4057qib7	5974	6	are	be	VBP
cord-005453-4057qib7	5974	7	lacking	lack	VBG
cord-005453-4057qib7	5974	8	,	,	,
cord-005453-4057qib7	5974	9	we	-PRON-	PRP
cord-005453-4057qib7	5974	10	present	present	VBP
cord-005453-4057qib7	5974	11	our	-PRON-	PRP$
cord-005453-4057qib7	5974	12	experience	experience	NN
cord-005453-4057qib7	5974	13	(	(	-LRB-
cord-005453-4057qib7	5974	14	two	two	CD
cord-005453-4057qib7	5974	15	centres	centre	NNS
cord-005453-4057qib7	5974	16	)	)	-RRB-
cord-005453-4057qib7	5974	17	.	.	.
cord-005453-4057qib7	5975	1	The	the	DT
cord-005453-4057qib7	5975	2	main	main	JJ
cord-005453-4057qib7	5975	3	indications	indication	NNS
cord-005453-4057qib7	5975	4	for	for	IN
cord-005453-4057qib7	5975	5	starting	start	VBG
cord-005453-4057qib7	5975	6	treatment	treatment	NN
cord-005453-4057qib7	5975	7	were	be	VBD
cord-005453-4057qib7	5975	8	acute	acute	JJ
cord-005453-4057qib7	5975	9	gut	gut	NN
cord-005453-4057qib7	5975	10	and	and	CC
cord-005453-4057qib7	5975	11	chronic	chronic	JJ
cord-005453-4057qib7	5975	12	multisystemic	multisystemic	JJ
cord-005453-4057qib7	5975	13	GVHD	GVHD	NNP
cord-005453-4057qib7	5975	14	.	.	.
cord-005453-4057qib7	5976	1	Most	Most	JJS
cord-005453-4057qib7	5976	2	patients	patient	NNS
cord-005453-4057qib7	5976	3	achieved	achieve	VBD
cord-005453-4057qib7	5976	4	some	some	DT
cord-005453-4057qib7	5976	5	grade	grade	NN
cord-005453-4057qib7	5976	6	of	of	IN
cord-005453-4057qib7	5976	7	response	response	NN
cord-005453-4057qib7	5976	8	(	(	-LRB-
cord-005453-4057qib7	5976	9	partial	partial	JJ
cord-005453-4057qib7	5976	10	or	or	CC
cord-005453-4057qib7	5976	11	complete	complete	JJ
cord-005453-4057qib7	5976	12	)	)	-RRB-
cord-005453-4057qib7	5976	13	,	,	,
cord-005453-4057qib7	5976	14	allowing	allow	VBG
cord-005453-4057qib7	5976	15	stopping	stop	VBG
cord-005453-4057qib7	5976	16	or	or	CC
cord-005453-4057qib7	5976	17	tapering	taper	VBG
cord-005453-4057qib7	5976	18	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	5976	19	.	.	.
cord-005453-4057qib7	5977	1	Toxicity	toxicity	NN
cord-005453-4057qib7	5977	2	profile	profile	NN
cord-005453-4057qib7	5977	3	appears	appear	VBZ
cord-005453-4057qib7	5977	4	to	to	TO
cord-005453-4057qib7	5977	5	be	be	VB
cord-005453-4057qib7	5977	6	acceptable	acceptable	JJ
cord-005453-4057qib7	5977	7	.	.	.
cord-005453-4057qib7	5978	1	Disclosure	disclosure	NN
cord-005453-4057qib7	5978	2	:	:	:
cord-005453-4057qib7	5978	3	Nothing	nothing	NN
cord-005453-4057qib7	5978	4	to	to	TO
cord-005453-4057qib7	5978	5	declare	declare	VB
cord-005453-4057qib7	5978	6	.	.	.
cord-005453-4057qib7	5979	1	Stability	stability	NN
cord-005453-4057qib7	5979	2	of	of	IN
cord-005453-4057qib7	5979	3	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5979	4	concentration	concentration	NN
cord-005453-4057qib7	5979	5	early	early	RB
cord-005453-4057qib7	5979	6	after	after	IN
cord-005453-4057qib7	5979	7	allogeneic	allogeneic	JJ
cord-005453-4057qib7	5979	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5979	9	stem	stem	NN
cord-005453-4057qib7	5979	10	cell	cell	NN
cord-005453-4057qib7	5979	11	transplantation	transplantation	NN
cord-005453-4057qib7	5979	12	reduces	reduce	VBZ
cord-005453-4057qib7	5979	13	the	the	DT
cord-005453-4057qib7	5979	14	risk	risk	NN
cord-005453-4057qib7	5979	15	of	of	IN
cord-005453-4057qib7	5979	16	acute	acute	JJ
cord-005453-4057qib7	5979	17	GVHD	GVHD	NNP
cord-005453-4057qib7	5979	18	Background	background	NN
cord-005453-4057qib7	5979	19	:	:	:
cord-005453-4057qib7	5980	1	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	5980	2	is	be	VBZ
cord-005453-4057qib7	5980	3	used	use	VBN
cord-005453-4057qib7	5980	4	as	as	IN
cord-005453-4057qib7	5980	5	an	an	DT
cord-005453-4057qib7	5980	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	5980	7	drug	drug	NN
cord-005453-4057qib7	5980	8	after	after	IN
cord-005453-4057qib7	5980	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	5980	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	5980	11	stem	stem	NN
cord-005453-4057qib7	5980	12	cell	cell	NN
cord-005453-4057qib7	5980	13	transplantation	transplantation	NN
cord-005453-4057qib7	5980	14	(	(	-LRB-
cord-005453-4057qib7	5980	15	allo	allo	NN
cord-005453-4057qib7	5980	16	-	-	HYPH
cord-005453-4057qib7	5980	17	HSCT	HSCT	NNP
cord-005453-4057qib7	5980	18	)	)	-RRB-
cord-005453-4057qib7	5980	19	.	.	.
cord-005453-4057qib7	5981	1	It	-PRON-	PRP
cord-005453-4057qib7	5981	2	is	be	VBZ
cord-005453-4057qib7	5981	3	well	well	RB
cord-005453-4057qib7	5981	4	known	know	VBN
cord-005453-4057qib7	5981	5	that	that	IN
cord-005453-4057qib7	5981	6	early	early	JJ
cord-005453-4057qib7	5981	7	concentration	concentration	NN
cord-005453-4057qib7	5981	8	level	level	NN
cord-005453-4057qib7	5981	9	of	of	IN
cord-005453-4057qib7	5981	10	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5981	11	is	be	VBZ
cord-005453-4057qib7	5981	12	correlated	correlate	VBN
cord-005453-4057qib7	5981	13	with	with	IN
cord-005453-4057qib7	5981	14	the	the	DT
cord-005453-4057qib7	5981	15	risk	risk	NN
cord-005453-4057qib7	5981	16	of	of	IN
cord-005453-4057qib7	5981	17	acute	acute	JJ
cord-005453-4057qib7	5981	18	graft	graft	NN
cord-005453-4057qib7	5981	19	versus	versus	IN
cord-005453-4057qib7	5981	20	host	host	NN
cord-005453-4057qib7	5981	21	disease	disease	NN
cord-005453-4057qib7	5981	22	(	(	-LRB-
cord-005453-4057qib7	5981	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5981	24	)	)	-RRB-
cord-005453-4057qib7	5981	25	,	,	,
cord-005453-4057qib7	5981	26	however	however	RB
cord-005453-4057qib7	5981	27	,	,	,
cord-005453-4057qib7	5981	28	whether	whether	IN
cord-005453-4057qib7	5981	29	range	range	NN
cord-005453-4057qib7	5981	30	of	of	IN
cord-005453-4057qib7	5981	31	standard	standard	JJ
cord-005453-4057qib7	5981	32	derivation	derivation	NN
cord-005453-4057qib7	5981	33	(	(	-LRB-
cord-005453-4057qib7	5981	34	SD	SD	NNP
cord-005453-4057qib7	5981	35	)	)	-RRB-
cord-005453-4057qib7	5981	36	of	of	IN
cord-005453-4057qib7	5981	37	early	early	JJ
cord-005453-4057qib7	5981	38	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5981	39	concentration	concentration	NN
cord-005453-4057qib7	5981	40	after	after	IN
cord-005453-4057qib7	5981	41	allo	allo	NN
cord-005453-4057qib7	5981	42	-	-	HYPH
cord-005453-4057qib7	5981	43	HSCT	HSCT	NNP
cord-005453-4057qib7	5981	44	also	also	RB
cord-005453-4057qib7	5981	45	affect	affect	VBP
cord-005453-4057qib7	5981	46	to	to	IN
cord-005453-4057qib7	5981	47	the	the	DT
cord-005453-4057qib7	5981	48	risk	risk	NN
cord-005453-4057qib7	5981	49	of	of	IN
cord-005453-4057qib7	5981	50	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5981	51	still	still	RB
cord-005453-4057qib7	5981	52	remains	remain	VBZ
cord-005453-4057qib7	5981	53	unknown	unknown	JJ
cord-005453-4057qib7	5981	54	.	.	.
cord-005453-4057qib7	5982	1	Here	here	RB
cord-005453-4057qib7	5982	2	,	,	,
cord-005453-4057qib7	5982	3	we	-PRON-	PRP
cord-005453-4057qib7	5982	4	investigate	investigate	VBP
cord-005453-4057qib7	5982	5	the	the	DT
cord-005453-4057qib7	5982	6	correlation	correlation	NN
cord-005453-4057qib7	5982	7	between	between	IN
cord-005453-4057qib7	5982	8	the	the	DT
cord-005453-4057qib7	5982	9	range	range	NN
cord-005453-4057qib7	5982	10	of	of	IN
cord-005453-4057qib7	5982	11	SD	SD	NNP
cord-005453-4057qib7	5982	12	of	of	IN
cord-005453-4057qib7	5982	13	early	early	JJ
cord-005453-4057qib7	5982	14	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5982	15	concentration	concentration	NN
cord-005453-4057qib7	5982	16	after	after	IN
cord-005453-4057qib7	5982	17	donor	donor	NN
cord-005453-4057qib7	5982	18	hematopoietic	hematopoietic	NN
cord-005453-4057qib7	5982	19	cells	cell	NNS
cord-005453-4057qib7	5982	20	engraftment	engraftment	NN
cord-005453-4057qib7	5982	21	and	and	CC
cord-005453-4057qib7	5982	22	the	the	DT
cord-005453-4057qib7	5982	23	development	development	NN
cord-005453-4057qib7	5982	24	of	of	IN
cord-005453-4057qib7	5982	25	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5982	26	.	.	.
cord-005453-4057qib7	5983	1	Methods	method	NNS
cord-005453-4057qib7	5983	2	:	:	:
cord-005453-4057qib7	5983	3	We	-PRON-	PRP
cord-005453-4057qib7	5983	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	5983	5	assessed	assess	VBD
cord-005453-4057qib7	5983	6	207	207	CD
cord-005453-4057qib7	5983	7	patients	patient	NNS
cord-005453-4057qib7	5983	8	who	who	WP
cord-005453-4057qib7	5983	9	underwent	undergo	VBD
cord-005453-4057qib7	5983	10	allo	allo	NN
cord-005453-4057qib7	5983	11	-	-	HYPH
cord-005453-4057qib7	5983	12	HSCT	HSCT	NNP
cord-005453-4057qib7	5983	13	in	in	IN
cord-005453-4057qib7	5983	14	our	-PRON-	PRP$
cord-005453-4057qib7	5983	15	hospital	hospital	NN
cord-005453-4057qib7	5983	16	from	from	IN
cord-005453-4057qib7	5983	17	2010	2010	CD
cord-005453-4057qib7	5983	18	-	-	SYM
cord-005453-4057qib7	5983	19	2017	2017	CD
cord-005453-4057qib7	5983	20	.	.	.
cord-005453-4057qib7	5984	1	All	all	DT
cord-005453-4057qib7	5984	2	patients	patient	NNS
cord-005453-4057qib7	5984	3	received	receive	VBD
cord-005453-4057qib7	5984	4	standard	standard	JJ
cord-005453-4057qib7	5984	5	GVHD	GVHD	NNP
cord-005453-4057qib7	5984	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	5984	7	by	by	IN
cord-005453-4057qib7	5984	8	continuous	continuous	JJ
cord-005453-4057qib7	5984	9	intravenous	intravenous	NN
cord-005453-4057qib7	5984	10	(	(	-LRB-
cord-005453-4057qib7	5984	11	iv	iv	LS
cord-005453-4057qib7	5984	12	)	)	-RRB-
cord-005453-4057qib7	5984	13	TAC	TAC	NNP
cord-005453-4057qib7	5984	14	with	with	IN
cord-005453-4057qib7	5984	15	starting	start	VBG
cord-005453-4057qib7	5984	16	dose	dose	NN
cord-005453-4057qib7	5984	17	of	of	IN
cord-005453-4057qib7	5984	18	0.02	0.02	CD
cord-005453-4057qib7	5984	19	mg/	mg/	NNP
cord-005453-4057qib7	5984	20	kg	kg	NNP
cord-005453-4057qib7	5984	21	/	/	SYM
cord-005453-4057qib7	5984	22	day	day	NN
cord-005453-4057qib7	5984	23	from	from	IN
cord-005453-4057qib7	5984	24	1	1	CD
cord-005453-4057qib7	5984	25	day	day	NN
cord-005453-4057qib7	5984	26	before	before	IN
cord-005453-4057qib7	5984	27	allo	allo	NN
cord-005453-4057qib7	5984	28	-	-	HYPH
cord-005453-4057qib7	5984	29	HSCT	HSCT	NNP
cord-005453-4057qib7	5984	30	(	(	-LRB-
cord-005453-4057qib7	5984	31	day	day	NN
cord-005453-4057qib7	5984	32	-1	-1	NNP
cord-005453-4057qib7	5984	33	)	)	-RRB-
cord-005453-4057qib7	5984	34	and	and	CC
cord-005453-4057qib7	5984	35	iv	iv	NNP
cord-005453-4057qib7	5984	36	methotrexate	methotrexate	NNP
cord-005453-4057qib7	5984	37	on	on	IN
cord-005453-4057qib7	5984	38	day	day	NN
cord-005453-4057qib7	5984	39	1	1	CD
cord-005453-4057qib7	5984	40	,	,	,
cord-005453-4057qib7	5984	41	3	3	CD
cord-005453-4057qib7	5984	42	,	,	,
cord-005453-4057qib7	5984	43	6	6	CD
cord-005453-4057qib7	5984	44	at	at	IN
cord-005453-4057qib7	5984	45	dose	dose	NN
cord-005453-4057qib7	5984	46	of	of	IN
cord-005453-4057qib7	5984	47	10	10	CD
cord-005453-4057qib7	5984	48	mg	mg	NNP
cord-005453-4057qib7	5984	49	/	/	SYM
cord-005453-4057qib7	5984	50	m	m	NN
cord-005453-4057qib7	5984	51	2	2	CD
cord-005453-4057qib7	5985	1	,	,	,
cord-005453-4057qib7	5985	2	7	7	CD
cord-005453-4057qib7	5985	3	mg	mg	NNP
cord-005453-4057qib7	5985	4	/	/	SYM
cord-005453-4057qib7	5985	5	m	m	NNP
cord-005453-4057qib7	5985	6	2	2	CD
cord-005453-4057qib7	5985	7	,	,	,
cord-005453-4057qib7	5985	8	7	7	CD
cord-005453-4057qib7	5985	9	mg	mg	NNP
cord-005453-4057qib7	5985	10	/	/	SYM
cord-005453-4057qib7	5985	11	m	m	NNP
cord-005453-4057qib7	5985	12	2	2	CD
cord-005453-4057qib7	5985	13	,	,	,
cord-005453-4057qib7	5985	14	respectively	respectively	RB
cord-005453-4057qib7	5985	15	.	.	.
cord-005453-4057qib7	5986	1	TAC	TAC	NNP
cord-005453-4057qib7	5986	2	dosage	dosage	NN
cord-005453-4057qib7	5986	3	was	be	VBD
cord-005453-4057qib7	5986	4	adjusted	adjust	VBN
cord-005453-4057qib7	5986	5	to	to	TO
cord-005453-4057qib7	5986	6	target	target	VB
cord-005453-4057qib7	5986	7	the	the	DT
cord-005453-4057qib7	5986	8	serum	serum	NN
cord-005453-4057qib7	5986	9	concentration	concentration	NN
cord-005453-4057qib7	5986	10	of	of	IN
cord-005453-4057qib7	5986	11	8	8	CD
cord-005453-4057qib7	5986	12	-	-	SYM
cord-005453-4057qib7	5986	13	12	12	CD
cord-005453-4057qib7	5986	14	ng	ng	NN
cord-005453-4057qib7	5986	15	/	/	SYM
cord-005453-4057qib7	5986	16	ml	ml	NN
cord-005453-4057qib7	5986	17	until	until	IN
cord-005453-4057qib7	5986	18	at	at	IN
cord-005453-4057qib7	5986	19	least	least	JJS
cord-005453-4057qib7	5986	20	day	day	NN
cord-005453-4057qib7	5986	21	30	30	CD
cord-005453-4057qib7	5986	22	and	and	CC
cord-005453-4057qib7	5986	23	then	then	RB
cord-005453-4057qib7	5986	24	tapered	tapered	JJ
cord-005453-4057qib7	5986	25	.	.	.
cord-005453-4057qib7	5987	1	To	to	TO
cord-005453-4057qib7	5987	2	evaluate	evaluate	VB
cord-005453-4057qib7	5987	3	the	the	DT
cord-005453-4057qib7	5987	4	SD	SD	NNP
cord-005453-4057qib7	5987	5	of	of	IN
cord-005453-4057qib7	5987	6	weekly	weekly	JJ
cord-005453-4057qib7	5987	7	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5987	8	concentration	concentration	NN
cord-005453-4057qib7	5987	9	,	,	,
cord-005453-4057qib7	5987	10	the	the	DT
cord-005453-4057qib7	5987	11	range	range	NN
cord-005453-4057qib7	5987	12	of	of	IN
cord-005453-4057qib7	5987	13	SD	SD	NNP
cord-005453-4057qib7	5987	14	of	of	IN
cord-005453-4057qib7	5987	15	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5987	16	concentration	concentration	NN
cord-005453-4057qib7	5987	17	at	at	IN
cord-005453-4057qib7	5987	18	day1	day1	NNP
cord-005453-4057qib7	5987	19	-	-	HYPH
cord-005453-4057qib7	5987	20	7	7	NNP
cord-005453-4057qib7	5987	21	(	(	-LRB-
cord-005453-4057qib7	5987	22	week-1	week-1	NNP
cord-005453-4057qib7	5987	23	)	)	-RRB-
cord-005453-4057qib7	5987	24	,	,	,
cord-005453-4057qib7	5987	25	day8	day8	VBN
cord-005453-4057qib7	5987	26	-	-	HYPH
cord-005453-4057qib7	5987	27	14(week-2	14(week-2	NNP
cord-005453-4057qib7	5987	28	)	)	-RRB-
cord-005453-4057qib7	5987	29	,	,	,
cord-005453-4057qib7	5987	30	day15	day15	JJS
cord-005453-4057qib7	5987	31	-	-	HYPH
cord-005453-4057qib7	5987	32	21(week-3	21(week-3	NNP
cord-005453-4057qib7	5987	33	)	)	-RRB-
cord-005453-4057qib7	5987	34	and	and	CC
cord-005453-4057qib7	5987	35	day22	day22	NNP
cord-005453-4057qib7	5987	36	-	-	HYPH
cord-005453-4057qib7	5987	37	28(week-4	28(week-4	CD
cord-005453-4057qib7	5987	38	)	)	-RRB-
cord-005453-4057qib7	5987	39	were	be	VBD
cord-005453-4057qib7	5987	40	calculated	calculate	VBN
cord-005453-4057qib7	5987	41	.	.	.
cord-005453-4057qib7	5988	1	The	the	DT
cord-005453-4057qib7	5988	2	difference	difference	NN
cord-005453-4057qib7	5988	3	of	of	IN
cord-005453-4057qib7	5988	4	the	the	DT
cord-005453-4057qib7	5988	5	range	range	NN
cord-005453-4057qib7	5988	6	of	of	IN
cord-005453-4057qib7	5988	7	SD	sd	NN
cord-005453-4057qib7	5988	8	between	between	IN
cord-005453-4057qib7	5988	9	the	the	DT
cord-005453-4057qib7	5988	10	2	2	CD
cord-005453-4057qib7	5988	11	groups	group	NNS
cord-005453-4057qib7	5988	12	that	that	WDT
cord-005453-4057qib7	5988	13	develop	develop	VBP
cord-005453-4057qib7	5988	14	or	or	CC
cord-005453-4057qib7	5988	15	did	do	VBD
cord-005453-4057qib7	5988	16	not	not	RB
cord-005453-4057qib7	5988	17	develop	develop	VB
cord-005453-4057qib7	5988	18	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5988	19	was	be	VBD
cord-005453-4057qib7	5988	20	compared	compare	VBN
cord-005453-4057qib7	5988	21	by	by	IN
cord-005453-4057qib7	5988	22	using	use	VBG
cord-005453-4057qib7	5988	23	Mann	Mann	NNP
cord-005453-4057qib7	5988	24	-	-	HYPH
cord-005453-4057qib7	5988	25	Whitney	Whitney	NNP
cord-005453-4057qib7	5988	26	U	U	NNP
cord-005453-4057qib7	5988	27	test	test	NN
cord-005453-4057qib7	5988	28	.	.	.
cord-005453-4057qib7	5989	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	5989	2	analysis	analysis	NN
cord-005453-4057qib7	5989	3	was	be	VBD
cord-005453-4057qib7	5989	4	performed	perform	VBN
cord-005453-4057qib7	5989	5	by	by	IN
cord-005453-4057qib7	5989	6	using	use	VBG
cord-005453-4057qib7	5989	7	multiple	multiple	JJ
cord-005453-4057qib7	5989	8	logistic	logistic	JJ
cord-005453-4057qib7	5989	9	regression	regression	NN
cord-005453-4057qib7	5989	10	analysis	analysis	NN
cord-005453-4057qib7	5989	11	.	.	.
cord-005453-4057qib7	5990	1	Patients	patient	NNS
cord-005453-4057qib7	5990	2	had	have	VBD
cord-005453-4057qib7	5990	3	given	give	VBN
cord-005453-4057qib7	5990	4	written	write	VBN
cord-005453-4057qib7	5990	5	consent	consent	NN
cord-005453-4057qib7	5990	6	allowing	allow	VBG
cord-005453-4057qib7	5990	7	the	the	DT
cord-005453-4057qib7	5990	8	use	use	NN
cord-005453-4057qib7	5990	9	of	of	IN
cord-005453-4057qib7	5990	10	medical	medical	JJ
cord-005453-4057qib7	5990	11	records	record	NNS
cord-005453-4057qib7	5990	12	for	for	IN
cord-005453-4057qib7	5990	13	research	research	NN
cord-005453-4057qib7	5990	14	,	,	,
cord-005453-4057qib7	5990	15	in	in	IN
cord-005453-4057qib7	5990	16	accordance	accordance	NN
cord-005453-4057qib7	5990	17	with	with	IN
cord-005453-4057qib7	5990	18	the	the	DT
cord-005453-4057qib7	5990	19	Declaration	Declaration	NNP
cord-005453-4057qib7	5990	20	of	of	IN
cord-005453-4057qib7	5990	21	Helsinki	Helsinki	NNP
cord-005453-4057qib7	5990	22	,	,	,
cord-005453-4057qib7	5990	23	and	and	CC
cord-005453-4057qib7	5990	24	the	the	DT
cord-005453-4057qib7	5990	25	Institutional	Institutional	NNP
cord-005453-4057qib7	5990	26	Review	Review	NNP
cord-005453-4057qib7	5990	27	Board	Board	NNP
cord-005453-4057qib7	5990	28	approved	approve	VBD
cord-005453-4057qib7	5990	29	the	the	DT
cord-005453-4057qib7	5990	30	study	study	NN
cord-005453-4057qib7	5990	31	.	.	.
cord-005453-4057qib7	5991	1	Results	result	NNS
cord-005453-4057qib7	5991	2	:	:	:
cord-005453-4057qib7	5992	1	There	there	EX
cord-005453-4057qib7	5992	2	were	be	VBD
cord-005453-4057qib7	5992	3	114	114	CD
cord-005453-4057qib7	5992	4	males	male	NNS
cord-005453-4057qib7	5992	5	and	and	CC
cord-005453-4057qib7	5992	6	93	93	CD
cord-005453-4057qib7	5992	7	females	female	NNS
cord-005453-4057qib7	5992	8	and	and	CC
cord-005453-4057qib7	5992	9	the	the	DT
cord-005453-4057qib7	5992	10	median	median	JJ
cord-005453-4057qib7	5992	11	age	age	NN
cord-005453-4057qib7	5992	12	was	be	VBD
cord-005453-4057qib7	5992	13	45	45	CD
cord-005453-4057qib7	5992	14	years	year	NNS
cord-005453-4057qib7	5992	15	(	(	-LRB-
cord-005453-4057qib7	5992	16	range	range	NN
cord-005453-4057qib7	5992	17	,	,	,
cord-005453-4057qib7	5992	18	16	16	CD
cord-005453-4057qib7	5992	19	to	to	TO
cord-005453-4057qib7	5992	20	68	68	CD
cord-005453-4057qib7	5992	21	years	year	NNS
cord-005453-4057qib7	5992	22	)	)	-RRB-
cord-005453-4057qib7	5992	23	.	.	.
cord-005453-4057qib7	5993	1	The	the	DT
cord-005453-4057qib7	5993	2	risks	risk	NNS
cord-005453-4057qib7	5993	3	of	of	IN
cord-005453-4057qib7	5993	4	disease	disease	NN
cord-005453-4057qib7	5993	5	were	be	VBD
cord-005453-4057qib7	5993	6	low	low	JJ
cord-005453-4057qib7	5993	7	-	-	HYPH
cord-005453-4057qib7	5993	8	standard	standard	NN
cord-005453-4057qib7	5993	9	in	in	IN
cord-005453-4057qib7	5993	10	141	141	CD
cord-005453-4057qib7	5993	11	and	and	CC
cord-005453-4057qib7	5993	12	high	high	JJ
cord-005453-4057qib7	5993	13	in	in	IN
cord-005453-4057qib7	5993	14	66	66	CD
cord-005453-4057qib7	5993	15	pts	pt	NNS
cord-005453-4057qib7	5993	16	.	.	.
cord-005453-4057qib7	5994	1	The	the	DT
cord-005453-4057qib7	5994	2	number	number	NN
cord-005453-4057qib7	5994	3	of	of	IN
cord-005453-4057qib7	5994	4	donors	donor	NNS
cord-005453-4057qib7	5994	5	were	be	VBD
cord-005453-4057qib7	5994	6	in	in	IN
cord-005453-4057qib7	5994	7	6	6	CD
cord-005453-4057qib7	5994	8	HLA	HLA	NNP
cord-005453-4057qib7	5994	9	-	-	HYPH
cord-005453-4057qib7	5994	10	identical	identical	JJ
cord-005453-4057qib7	5994	11	sibling	sibling	NN
cord-005453-4057qib7	5994	12	,	,	,
cord-005453-4057qib7	5994	13	13	13	CD
cord-005453-4057qib7	5994	14	in	in	IN
cord-005453-4057qib7	5994	15	HLA	HLA	NNP
cord-005453-4057qib7	5994	16	-	-	HYPH
cord-005453-4057qib7	5994	17	mismatched	mismatch	VBN
cord-005453-4057qib7	5994	18	related	related	JJ
cord-005453-4057qib7	5994	19	donor	donor	NN
cord-005453-4057qib7	5994	20	,	,	,
cord-005453-4057qib7	5994	21	81	81	CD
cord-005453-4057qib7	5994	22	in	in	IN
cord-005453-4057qib7	5994	23	HLA	HLA	NNP
cord-005453-4057qib7	5994	24	-	-	HYPH
cord-005453-4057qib7	5994	25	matched	match	VBN
cord-005453-4057qib7	5994	26	unrelated	unrelated	JJ
cord-005453-4057qib7	5994	27	donor	donor	NN
cord-005453-4057qib7	5994	28	and	and	CC
cord-005453-4057qib7	5994	29	107	107	CD
cord-005453-4057qib7	5994	30	in	in	IN
cord-005453-4057qib7	5994	31	HLA	HLA	NNP
cord-005453-4057qib7	5994	32	-	-	HYPH
cord-005453-4057qib7	5994	33	mismatched	mismatch	VBN
cord-005453-4057qib7	5994	34	unrelated	unrelated	JJ
cord-005453-4057qib7	5994	35	donor	donor	NN
cord-005453-4057qib7	5994	36	.	.	.
cord-005453-4057qib7	5995	1	Thirty	thirty	CD
cord-005453-4057qib7	5995	2	-	-	HYPH
cord-005453-4057qib7	5995	3	seven	seven	CD
cord-005453-4057qib7	5995	4	patients	patient	NNS
cord-005453-4057qib7	5995	5	developed	develop	VBD
cord-005453-4057qib7	5995	6	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5995	7	(	(	-LRB-
cord-005453-4057qib7	5995	8	Grade	Grade	NNP
cord-005453-4057qib7	5995	9	I	I	NNP
cord-005453-4057qib7	5995	10	-	-	HYPH
cord-005453-4057qib7	5995	11	II	II	NNP
cord-005453-4057qib7	5995	12	;	;	:
cord-005453-4057qib7	5995	13	28	28	CD
cord-005453-4057qib7	5995	14	,	,	,
cord-005453-4057qib7	5995	15	GradeIII	GradeIII	NNP
cord-005453-4057qib7	5995	16	-	-	HYPH
cord-005453-4057qib7	5995	17	IV	IV	NNP
cord-005453-4057qib7	5995	18	;	;	:
cord-005453-4057qib7	5995	19	9	9	CD
cord-005453-4057qib7	5995	20	patients	patient	NNS
cord-005453-4057qib7	5995	21	)	)	-RRB-
cord-005453-4057qib7	5995	22	.	.	.
cord-005453-4057qib7	5996	1	As	as	IN
cord-005453-4057qib7	5996	2	a	a	DT
cord-005453-4057qib7	5996	3	result	result	NN
cord-005453-4057qib7	5996	4	,	,	,
cord-005453-4057qib7	5996	5	the	the	DT
cord-005453-4057qib7	5996	6	wide	wide	JJ
cord-005453-4057qib7	5996	7	range	range	NN
cord-005453-4057qib7	5996	8	of	of	IN
cord-005453-4057qib7	5996	9	SD	sd	NN
cord-005453-4057qib7	5996	10	at	at	IN
cord-005453-4057qib7	5996	11	week-3	week-3	NNP
cord-005453-4057qib7	5996	12	significantly	significantly	RB
cord-005453-4057qib7	5996	13	increased	increase	VBD
cord-005453-4057qib7	5996	14	the	the	DT
cord-005453-4057qib7	5996	15	risk	risk	NN
cord-005453-4057qib7	5996	16	of	of	IN
cord-005453-4057qib7	5996	17	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5996	18	(	(	-LRB-
cord-005453-4057qib7	5996	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5996	20	-	-	HYPH
cord-005453-4057qib7	5996	21	group	group	NN
cord-005453-4057qib7	5996	22	;	;	:
cord-005453-4057qib7	5996	23	1.178±0.8159	1.178±0.8159	NNP
cord-005453-4057qib7	5996	24	ng	ng	NNP
cord-005453-4057qib7	5996	25	/	/	SYM
cord-005453-4057qib7	5996	26	ml	ml	XX
cord-005453-4057qib7	5996	27	,	,	,
cord-005453-4057qib7	5996	28	aGVHD+	aGVHD+	NNP
cord-005453-4057qib7	5996	29	group	group	NN
cord-005453-4057qib7	5996	30	;	;	:
cord-005453-4057qib7	5996	31	1.447±0.7359	1.447±0.7359	CD
cord-005453-4057qib7	5996	32	ng	ng	NN
cord-005453-4057qib7	5996	33	/	/	SYM
cord-005453-4057qib7	5996	34	ml	ml	NN
cord-005453-4057qib7	5996	35	,	,	,
cord-005453-4057qib7	5996	36	p=0.02	p=0.02	NNP
cord-005453-4057qib7	5996	37	)	)	-RRB-
cord-005453-4057qib7	5996	38	.	.	.
cord-005453-4057qib7	5997	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	5997	2	analysis	analysis	NN
cord-005453-4057qib7	5997	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	5997	4	that	that	IN
cord-005453-4057qib7	5997	5	narrow	narrow	JJ
cord-005453-4057qib7	5997	6	range	range	NN
cord-005453-4057qib7	5997	7	of	of	IN
cord-005453-4057qib7	5997	8	SD	sd	NN
cord-005453-4057qib7	5997	9	of	of	IN
cord-005453-4057qib7	5997	10	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	5997	11	concentration	concentration	NN
cord-005453-4057qib7	5997	12	at	at	IN
cord-005453-4057qib7	5997	13	week-3	week-3	NNP
cord-005453-4057qib7	5997	14	reduce	reduce	VB
cord-005453-4057qib7	5997	15	the	the	DT
cord-005453-4057qib7	5997	16	risk	risk	NN
cord-005453-4057qib7	5997	17	of	of	IN
cord-005453-4057qib7	5997	18	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5997	19	(	(	-LRB-
cord-005453-4057qib7	5997	20	OR=4.19	or=4.19	XX
cord-005453-4057qib7	5998	1	;	;	:
cord-005453-4057qib7	5998	2	95	95	CD
cord-005453-4057qib7	5998	3	%	%	NN
cord-005453-4057qib7	5998	4	CI	ci	NN
cord-005453-4057qib7	5998	5	:	:	:
cord-005453-4057qib7	5998	6	1.59	1.59	CD
cord-005453-4057qib7	5998	7	-	-	SYM
cord-005453-4057qib7	5998	8	14.80	14.80	CD
cord-005453-4057qib7	5998	9	;	;	:
cord-005453-4057qib7	5998	10	p=0.005	p=0.005	NNP
cord-005453-4057qib7	5998	11	)	)	-RRB-
cord-005453-4057qib7	5998	12	.	.	.
cord-005453-4057qib7	5999	1	There	there	EX
cord-005453-4057qib7	5999	2	were	be	VBD
cord-005453-4057qib7	5999	3	no	no	DT
cord-005453-4057qib7	5999	4	correlation	correlation	NN
cord-005453-4057qib7	5999	5	between	between	IN
cord-005453-4057qib7	5999	6	gender	gender	NN
cord-005453-4057qib7	5999	7	,	,	,
cord-005453-4057qib7	5999	8	age	age	NN
cord-005453-4057qib7	5999	9	,	,	,
cord-005453-4057qib7	5999	10	disease	disease	NN
cord-005453-4057qib7	5999	11	status	status	NN
cord-005453-4057qib7	5999	12	,	,	,
cord-005453-4057qib7	5999	13	HLA	HLA	NNP
cord-005453-4057qib7	5999	14	with	with	IN
cord-005453-4057qib7	5999	15	the	the	DT
cord-005453-4057qib7	5999	16	development	development	NN
cord-005453-4057qib7	5999	17	of	of	IN
cord-005453-4057qib7	5999	18	aGVHD	aGVHD	NNP
cord-005453-4057qib7	5999	19	.	.	.
cord-005453-4057qib7	6000	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6000	2	:	:	:
cord-005453-4057qib7	6001	1	The	the	DT
cord-005453-4057qib7	6001	2	range	range	NN
cord-005453-4057qib7	6001	3	of	of	IN
cord-005453-4057qib7	6001	4	SD	sd	NN
cord-005453-4057qib7	6001	5	at	at	IN
cord-005453-4057qib7	6001	6	week-3	week-3	NNP
cord-005453-4057qib7	6001	7	,	,	,
cord-005453-4057qib7	6001	8	an	an	DT
cord-005453-4057qib7	6001	9	engraftment	engraftment	NN
cord-005453-4057qib7	6001	10	phase	phase	NN
cord-005453-4057qib7	6001	11	of	of	IN
cord-005453-4057qib7	6001	12	donor	donor	NN
cord-005453-4057qib7	6001	13	hematopoietic	hematopoietic	NN
cord-005453-4057qib7	6001	14	cells	cell	NNS
cord-005453-4057qib7	6001	15	,	,	,
cord-005453-4057qib7	6001	16	was	be	VBD
cord-005453-4057qib7	6001	17	significantly	significantly	RB
cord-005453-4057qib7	6001	18	correlated	correlate	VBN
cord-005453-4057qib7	6001	19	with	with	IN
cord-005453-4057qib7	6001	20	the	the	DT
cord-005453-4057qib7	6001	21	development	development	NN
cord-005453-4057qib7	6001	22	of	of	IN
cord-005453-4057qib7	6001	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6001	24	.	.	.
cord-005453-4057qib7	6002	1	Fine	fine	JJ
cord-005453-4057qib7	6002	2	tuning	tuning	NN
cord-005453-4057qib7	6002	3	of	of	IN
cord-005453-4057qib7	6002	4	early	early	JJ
cord-005453-4057qib7	6002	5	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	6002	6	concentration	concentration	NN
cord-005453-4057qib7	6002	7	with	with	IN
cord-005453-4057qib7	6002	8	narrow	narrow	JJ
cord-005453-4057qib7	6002	9	range	range	NN
cord-005453-4057qib7	6002	10	of	of	IN
cord-005453-4057qib7	6002	11	SD	sd	NN
cord-005453-4057qib7	6002	12	reduces	reduce	VBZ
cord-005453-4057qib7	6002	13	the	the	DT
cord-005453-4057qib7	6002	14	risk	risk	NN
cord-005453-4057qib7	6002	15	of	of	IN
cord-005453-4057qib7	6002	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6002	17	,	,	,
cord-005453-4057qib7	6002	18	resulting	result	VBG
cord-005453-4057qib7	6002	19	in	in	IN
cord-005453-4057qib7	6002	20	improvement	improvement	NN
cord-005453-4057qib7	6002	21	of	of	IN
cord-005453-4057qib7	6002	22	the	the	DT
cord-005453-4057qib7	6002	23	overall	overall	JJ
cord-005453-4057qib7	6002	24	survival	survival	NN
cord-005453-4057qib7	6002	25	after	after	IN
cord-005453-4057qib7	6002	26	allo	allo	NN
cord-005453-4057qib7	6002	27	-	-	HYPH
cord-005453-4057qib7	6002	28	HSCT	HSCT	NNP
cord-005453-4057qib7	6002	29	.	.	.
cord-005453-4057qib7	6003	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6003	2	:	:	:
cord-005453-4057qib7	6003	3	Nothing	nothing	NN
cord-005453-4057qib7	6003	4	to	to	TO
cord-005453-4057qib7	6003	5	declair	declair	VB
cord-005453-4057qib7	6003	6	P274	P274	NNP
cord-005453-4057qib7	6003	7	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	6003	8	treatment	treatment	NN
cord-005453-4057qib7	6003	9	for	for	IN
cord-005453-4057qib7	6003	10	steroid	steroid	NN
cord-005453-4057qib7	6003	11	-	-	HYPH
cord-005453-4057qib7	6003	12	refractory	refractory	JJ
cord-005453-4057qib7	6003	13	graftversus	graftversus	NN
cord-005453-4057qib7	6003	14	-	-	HYPH
cord-005453-4057qib7	6003	15	host	host	NN
cord-005453-4057qib7	6003	16	disease	disease	NN
cord-005453-4057qib7	6003	17	Han	Han	NNP
cord-005453-4057qib7	6003	18	-	-	HYPH
cord-005453-4057qib7	6003	19	Seung	Seung	NNP
cord-005453-4057qib7	6003	20	Park	Park	NNP
cord-005453-4057qib7	6003	21	1	1	CD
cord-005453-4057qib7	6003	22	,	,	,
cord-005453-4057qib7	6003	23	Je	Je	NNP
cord-005453-4057qib7	6003	24	-	-	HYPH
cord-005453-4057qib7	6003	25	Hwan	Hwan	NNP
cord-005453-4057qib7	6003	26	Lee	Lee	NNP
cord-005453-4057qib7	6003	27	1	1	CD
cord-005453-4057qib7	6003	28	,	,	,
cord-005453-4057qib7	6004	1	Jung	Jung	NNP
cord-005453-4057qib7	6004	2	-	-	HYPH
cord-005453-4057qib7	6004	3	Hee	Hee	NNP
cord-005453-4057qib7	6004	4	Lee	Lee	NNP
cord-005453-4057qib7	6004	5	1	1	CD
cord-005453-4057qib7	6004	6	,	,	,
cord-005453-4057qib7	6004	7	Eun	Eun	NNP
cord-005453-4057qib7	6004	8	-	-	HYPH
cord-005453-4057qib7	6004	9	Ji	Ji	NNP
cord-005453-4057qib7	6004	10	Choi	Choi	NNP
cord-005453-4057qib7	6004	11	1	1	CD
cord-005453-4057qib7	6004	12	,	,	,
cord-005453-4057qib7	6004	13	Miee	Miee	NNP
cord-005453-4057qib7	6004	14	Seol	Seol	NNP
cord-005453-4057qib7	6004	15	1	1	CD
cord-005453-4057qib7	6004	16	,	,	,
cord-005453-4057qib7	6004	17	Young	Young	NNP
cord-005453-4057qib7	6004	18	-	-	HYPH
cord-005453-4057qib7	6004	19	Shin	Shin	NNP
cord-005453-4057qib7	6004	20	Lee	Lee	NNP
cord-005453-4057qib7	6004	21	1	1	CD
cord-005453-4057qib7	6004	22	,	,	,
cord-005453-4057qib7	6004	23	Young	Young	NNP
cord-005453-4057qib7	6004	24	-	-	HYPH
cord-005453-4057qib7	6004	25	Ah	Ah	NNP
cord-005453-4057qib7	6004	26	Kang	Kang	NNP
cord-005453-4057qib7	6004	27	1	1	CD
cord-005453-4057qib7	6004	28	,	,	,
cord-005453-4057qib7	6004	29	Mijin	Mijin	NNP
cord-005453-4057qib7	6004	30	Jeon	Jeon	NNP
cord-005453-4057qib7	6004	31	1	1	CD
cord-005453-4057qib7	6005	1	,	,	,
cord-005453-4057qib7	6005	2	Kyoo	Kyoo	NNP
cord-005453-4057qib7	6005	3	-	-	HYPH
cord-005453-4057qib7	6005	4	Hyung	Hyung	NNP
cord-005453-4057qib7	6005	5	Lee	Lee	NNP
cord-005453-4057qib7	6005	6	1	1	CD
cord-005453-4057qib7	6005	7	Background	Background	NNP
cord-005453-4057qib7	6005	8	:	:	:
cord-005453-4057qib7	6005	9	Steroid	steroid	JJ
cord-005453-4057qib7	6005	10	-	-	HYPH
cord-005453-4057qib7	6005	11	refractory	refractory	JJ
cord-005453-4057qib7	6005	12	graft	graft	NN
cord-005453-4057qib7	6005	13	versus	versus	IN
cord-005453-4057qib7	6005	14	-	-	HYPH
cord-005453-4057qib7	6005	15	host	host	NN
cord-005453-4057qib7	6005	16	disease	disease	NN
cord-005453-4057qib7	6005	17	(	(	-LRB-
cord-005453-4057qib7	6005	18	GVHD	GVHD	NNP
cord-005453-4057qib7	6005	19	)	)	-RRB-
cord-005453-4057qib7	6005	20	is	be	VBZ
cord-005453-4057qib7	6005	21	one	one	CD
cord-005453-4057qib7	6005	22	of	of	IN
cord-005453-4057qib7	6005	23	the	the	DT
cord-005453-4057qib7	6005	24	most	most	RBS
cord-005453-4057qib7	6005	25	lethal	lethal	JJ
cord-005453-4057qib7	6005	26	complications	complication	NNS
cord-005453-4057qib7	6005	27	after	after	IN
cord-005453-4057qib7	6005	28	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6005	29	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6005	30	cell	cell	NN
cord-005453-4057qib7	6005	31	transplantation	transplantation	NN
cord-005453-4057qib7	6005	32	.	.	.
cord-005453-4057qib7	6006	1	Recent	recent	JJ
cord-005453-4057qib7	6006	2	studies	study	NNS
cord-005453-4057qib7	6006	3	have	have	VBP
cord-005453-4057qib7	6006	4	shown	show	VBN
cord-005453-4057qib7	6006	5	that	that	IN
cord-005453-4057qib7	6006	6	ruxolitinib	ruxolitinib	NN
cord-005453-4057qib7	6006	7	,	,	,
cord-005453-4057qib7	6006	8	a	a	DT
cord-005453-4057qib7	6006	9	Janus	Janus	NNP
cord-005453-4057qib7	6006	10	kinase	kinase	NN
cord-005453-4057qib7	6006	11	1/2	1/2	CD
cord-005453-4057qib7	6006	12	inhibitor	inhibitor	NN
cord-005453-4057qib7	6006	13	,	,	,
cord-005453-4057qib7	6006	14	is	be	VBZ
cord-005453-4057qib7	6006	15	effective	effective	JJ
cord-005453-4057qib7	6006	16	in	in	IN
cord-005453-4057qib7	6006	17	patients	patient	NNS
cord-005453-4057qib7	6006	18	suffering	suffer	VBG
cord-005453-4057qib7	6006	19	from	from	IN
cord-005453-4057qib7	6006	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6006	21	.	.	.
cord-005453-4057qib7	6007	1	Here	here	RB
cord-005453-4057qib7	6007	2	,	,	,
cord-005453-4057qib7	6007	3	we	-PRON-	PRP
cord-005453-4057qib7	6007	4	report	report	VBP
cord-005453-4057qib7	6007	5	a	a	DT
cord-005453-4057qib7	6007	6	retrospective	retrospective	JJ
cord-005453-4057qib7	6007	7	result	result	NN
cord-005453-4057qib7	6007	8	of	of	IN
cord-005453-4057qib7	6007	9	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	6007	10	treatment	treatment	NN
cord-005453-4057qib7	6007	11	for	for	IN
cord-005453-4057qib7	6007	12	steroid	steroid	NN
cord-005453-4057qib7	6007	13	-	-	HYPH
cord-005453-4057qib7	6007	14	refractory	refractory	JJ
cord-005453-4057qib7	6007	15	GVHD	GVHD	NNP
cord-005453-4057qib7	6007	16	.	.	.
cord-005453-4057qib7	6008	1	Methods	method	NNS
cord-005453-4057qib7	6008	2	:	:	:
cord-005453-4057qib7	6009	1	All	all	DT
cord-005453-4057qib7	6009	2	patients	patient	NNS
cord-005453-4057qib7	6009	3	had	have	VBD
cord-005453-4057qib7	6009	4	received	receive	VBN
cord-005453-4057qib7	6009	5	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	6009	6	and	and	CC
cord-005453-4057qib7	6009	7	a	a	DT
cord-005453-4057qib7	6009	8	short	short	JJ
cord-005453-4057qib7	6009	9	course	course	NN
cord-005453-4057qib7	6009	10	of	of	IN
cord-005453-4057qib7	6009	11	methotrexate	methotrexate	NNP
cord-005453-4057qib7	6009	12	as	as	IN
cord-005453-4057qib7	6009	13	GVHD	GVHD	NNP
cord-005453-4057qib7	6009	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6009	15	.	.	.
cord-005453-4057qib7	6010	1	Antithymocyte	Antithymocyte	NNP
cord-005453-4057qib7	6010	2	globulin	globulin	NN
cord-005453-4057qib7	6010	3	was	be	VBD
cord-005453-4057qib7	6010	4	added	add	VBN
cord-005453-4057qib7	6010	5	for	for	IN
cord-005453-4057qib7	6010	6	unrelated	unrelated	JJ
cord-005453-4057qib7	6010	7	or	or	CC
cord-005453-4057qib7	6010	8	mismatched	mismatched	JJ
cord-005453-4057qib7	6010	9	familial	familial	JJ
cord-005453-4057qib7	6010	10	donor	donor	NN
cord-005453-4057qib7	6010	11	HCT	hct	NN
cord-005453-4057qib7	6010	12	.	.	.
cord-005453-4057qib7	6011	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	6011	2	5	5	CD
cord-005453-4057qib7	6011	3	mg	mg	NN
cord-005453-4057qib7	6011	4	twice	twice	RB
cord-005453-4057qib7	6011	5	daily	daily	RB
cord-005453-4057qib7	6011	6	was	be	VBD
cord-005453-4057qib7	6011	7	added	add	VBN
cord-005453-4057qib7	6011	8	to	to	IN
cord-005453-4057qib7	6011	9	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6011	10	treatment	treatment	NN
cord-005453-4057qib7	6011	11	in	in	IN
cord-005453-4057qib7	6011	12	patients	patient	NNS
cord-005453-4057qib7	6011	13	with	with	IN
cord-005453-4057qib7	6011	14	steroid	steroid	JJ
cord-005453-4057qib7	6011	15	-	-	HYPH
cord-005453-4057qib7	6011	16	refractory	refractory	JJ
cord-005453-4057qib7	6011	17	GVHD	GVHD	NNP
cord-005453-4057qib7	6011	18	.	.	.
cord-005453-4057qib7	6012	1	Results	result	NNS
cord-005453-4057qib7	6012	2	:	:	:
cord-005453-4057qib7	6013	1	A	a	DT
cord-005453-4057qib7	6013	2	total	total	NN
cord-005453-4057qib7	6013	3	of	of	IN
cord-005453-4057qib7	6013	4	27	27	CD
cord-005453-4057qib7	6013	5	patients	patient	NNS
cord-005453-4057qib7	6013	6	with	with	IN
cord-005453-4057qib7	6013	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6013	8	(	(	-LRB-
cord-005453-4057qib7	6013	9	acute	acute	JJ
cord-005453-4057qib7	6013	10	,	,	,
cord-005453-4057qib7	6013	11	8	8	CD
cord-005453-4057qib7	6013	12	,	,	,
cord-005453-4057qib7	6013	13	including	include	VBG
cord-005453-4057qib7	6013	14	3	3	CD
cord-005453-4057qib7	6013	15	patients	patient	NNS
cord-005453-4057qib7	6013	16	with	with	IN
cord-005453-4057qib7	6013	17	donor	donor	NN
cord-005453-4057qib7	6013	18	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6013	19	infusion	infusion	NN
cord-005453-4057qib7	6013	20	[	[	-LRB-
cord-005453-4057qib7	6013	21	DLI]related	dli]related	XX
cord-005453-4057qib7	6013	22	;	;	:
cord-005453-4057qib7	6013	23	and	and	CC
cord-005453-4057qib7	6013	24	chronic	chronic	NN
cord-005453-4057qib7	6013	25	,	,	,
cord-005453-4057qib7	6013	26	19	19	CD
cord-005453-4057qib7	6013	27	)	)	-RRB-
cord-005453-4057qib7	6013	28	were	be	VBD
cord-005453-4057qib7	6013	29	included	include	VBN
cord-005453-4057qib7	6013	30	in	in	IN
cord-005453-4057qib7	6013	31	the	the	DT
cord-005453-4057qib7	6013	32	analysis	analysis	NN
cord-005453-4057qib7	6013	33	.	.	.
cord-005453-4057qib7	6014	1	All	all	DT
cord-005453-4057qib7	6014	2	patients	patient	NNS
cord-005453-4057qib7	6014	3	had	have	VBD
cord-005453-4057qib7	6014	4	grade	grade	NN
cord-005453-4057qib7	6014	5	3/4	3/4	CD
cord-005453-4057qib7	6014	6	acute	acute	JJ
cord-005453-4057qib7	6014	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6014	8	or	or	CC
cord-005453-4057qib7	6014	9	severe	severe	JJ
cord-005453-4057qib7	6014	10	chronic	chronic	JJ
cord-005453-4057qib7	6014	11	GVHD	GVHD	NNP
cord-005453-4057qib7	6014	12	at	at	IN
cord-005453-4057qib7	6014	13	the	the	DT
cord-005453-4057qib7	6014	14	time	time	NN
cord-005453-4057qib7	6014	15	of	of	IN
cord-005453-4057qib7	6014	16	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	6014	17	treatment	treatment	NN
cord-005453-4057qib7	6014	18	.	.	.
cord-005453-4057qib7	6015	1	Six	six	CD
cord-005453-4057qib7	6015	2	(	(	-LRB-
cord-005453-4057qib7	6015	3	75.0	75.0	CD
cord-005453-4057qib7	6015	4	%	%	NN
cord-005453-4057qib7	6015	5	)	)	-RRB-
cord-005453-4057qib7	6015	6	of	of	IN
cord-005453-4057qib7	6015	7	8	8	CD
cord-005453-4057qib7	6015	8	patients	patient	NNS
cord-005453-4057qib7	6015	9	with	with	IN
cord-005453-4057qib7	6015	10	acute	acute	JJ
cord-005453-4057qib7	6015	11	GVHD	GVHD	NNP
cord-005453-4057qib7	6015	12	responded	respond	VBD
cord-005453-4057qib7	6015	13	to	to	IN
cord-005453-4057qib7	6015	14	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6015	15	,	,	,
cord-005453-4057qib7	6015	16	including	include	VBG
cord-005453-4057qib7	6015	17	3	3	CD
cord-005453-4057qib7	6015	18	with	with	IN
cord-005453-4057qib7	6015	19	complete	complete	JJ
cord-005453-4057qib7	6015	20	response	response	NN
cord-005453-4057qib7	6015	21	(	(	-LRB-
cord-005453-4057qib7	6015	22	CR	CR	NNP
cord-005453-4057qib7	6015	23	)	)	-RRB-
cord-005453-4057qib7	6015	24	.	.	.
cord-005453-4057qib7	6016	1	The	the	DT
cord-005453-4057qib7	6016	2	median	median	JJ
cord-005453-4057qib7	6016	3	time	time	NN
cord-005453-4057qib7	6016	4	to	to	IN
cord-005453-4057qib7	6016	5	response	response	NN
cord-005453-4057qib7	6016	6	was	be	VBD
cord-005453-4057qib7	6016	7	13.5	13.5	CD
cord-005453-4057qib7	6016	8	days	day	NNS
cord-005453-4057qib7	6016	9	(	(	-LRB-
cord-005453-4057qib7	6016	10	range	range	NN
cord-005453-4057qib7	6016	11	,	,	,
cord-005453-4057qib7	6016	12	8	8	CD
cord-005453-4057qib7	6016	13	-	-	SYM
cord-005453-4057qib7	6016	14	25	25	CD
cord-005453-4057qib7	6016	15	)	)	-RRB-
cord-005453-4057qib7	6016	16	.	.	.
cord-005453-4057qib7	6017	1	Nineteen	nineteen	CD
cord-005453-4057qib7	6017	2	patients	patient	NNS
cord-005453-4057qib7	6017	3	received	receive	VBD
cord-005453-4057qib7	6017	4	ruxolitinib	ruxolitinib	NN
cord-005453-4057qib7	6017	5	for	for	IN
cord-005453-4057qib7	6017	6	severe	severe	JJ
cord-005453-4057qib7	6017	7	chronic	chronic	JJ
cord-005453-4057qib7	6017	8	GVHD	GVHD	NNP
cord-005453-4057qib7	6017	9	,	,	,
cord-005453-4057qib7	6017	10	with	with	IN
cord-005453-4057qib7	6017	11	the	the	DT
cord-005453-4057qib7	6017	12	median	median	NN
cord-005453-4057qib7	6017	13	of	of	IN
cord-005453-4057qib7	6017	14	3	3	CD
cord-005453-4057qib7	6017	15	involved	involved	JJ
cord-005453-4057qib7	6017	16	organs	organ	NNS
cord-005453-4057qib7	6017	17	(	(	-LRB-
cord-005453-4057qib7	6017	18	range	range	VBP
cord-005453-4057qib7	6017	19	2	2	CD
cord-005453-4057qib7	6017	20	-	-	SYM
cord-005453-4057qib7	6017	21	5	5	CD
cord-005453-4057qib7	6017	22	)	)	-RRB-
cord-005453-4057qib7	6017	23	.	.	.
cord-005453-4057qib7	6018	1	Fourteen	fourteen	CD
cord-005453-4057qib7	6018	2	patients	patient	NNS
cord-005453-4057qib7	6018	3	(	(	-LRB-
cord-005453-4057qib7	6018	4	73.7	73.7	CD
cord-005453-4057qib7	6018	5	%	%	NN
cord-005453-4057qib7	6018	6	)	)	-RRB-
cord-005453-4057qib7	6018	7	showed	show	VBD
cord-005453-4057qib7	6018	8	response	response	NN
cord-005453-4057qib7	6018	9	to	to	IN
cord-005453-4057qib7	6018	10	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6018	11	,	,	,
cord-005453-4057qib7	6018	12	including	include	VBG
cord-005453-4057qib7	6018	13	4	4	CD
cord-005453-4057qib7	6018	14	CRs	cr	NNS
cord-005453-4057qib7	6018	15	.	.	.
cord-005453-4057qib7	6019	1	The	the	DT
cord-005453-4057qib7	6019	2	median	median	JJ
cord-005453-4057qib7	6019	3	time	time	NN
cord-005453-4057qib7	6019	4	to	to	IN
cord-005453-4057qib7	6019	5	response	response	NN
cord-005453-4057qib7	6019	6	was	be	VBD
cord-005453-4057qib7	6019	7	24	24	CD
cord-005453-4057qib7	6019	8	days	day	NNS
cord-005453-4057qib7	6019	9	(	(	-LRB-
cord-005453-4057qib7	6019	10	range	range	NN
cord-005453-4057qib7	6019	11	,	,	,
cord-005453-4057qib7	6019	12	12	12	CD
cord-005453-4057qib7	6019	13	-	-	SYM
cord-005453-4057qib7	6019	14	138	138	CD
cord-005453-4057qib7	6019	15	)	)	-RRB-
cord-005453-4057qib7	6019	16	.	.	.
cord-005453-4057qib7	6020	1	Five	five	CD
cord-005453-4057qib7	6020	2	responders	responder	NNS
cord-005453-4057qib7	6020	3	discontinued	discontinue	VBD
cord-005453-4057qib7	6020	4	ruxolitinib	ruxolitinib	NN
cord-005453-4057qib7	6020	5	and	and	CC
cord-005453-4057qib7	6020	6	9	9	CD
cord-005453-4057qib7	6020	7	patients	patient	NNS
cord-005453-4057qib7	6020	8	are	be	VBP
cord-005453-4057qib7	6020	9	still	still	RB
cord-005453-4057qib7	6020	10	on	on	IN
cord-005453-4057qib7	6020	11	the	the	DT
cord-005453-4057qib7	6020	12	agent	agent	NN
cord-005453-4057qib7	6020	13	.	.	.
cord-005453-4057qib7	6021	1	After	after	IN
cord-005453-4057qib7	6021	2	a	a	DT
cord-005453-4057qib7	6021	3	median	median	JJ
cord-005453-4057qib7	6021	4	follow	follow	NN
cord-005453-4057qib7	6021	5	-	-	HYPH
cord-005453-4057qib7	6021	6	up	up	NN
cord-005453-4057qib7	6021	7	duration	duration	NN
cord-005453-4057qib7	6021	8	of	of	IN
cord-005453-4057qib7	6021	9	8.7	8.7	CD
cord-005453-4057qib7	6021	10	months	month	NNS
cord-005453-4057qib7	6021	11	,	,	,
cord-005453-4057qib7	6021	12	5	5	CD
cord-005453-4057qib7	6021	13	died	die	VBD
cord-005453-4057qib7	6021	14	(	(	-LRB-
cord-005453-4057qib7	6021	15	2	2	CD
cord-005453-4057qib7	6021	16	from	from	IN
cord-005453-4057qib7	6021	17	relapse	relapse	NN
cord-005453-4057qib7	6021	18	of	of	IN
cord-005453-4057qib7	6021	19	disease	disease	NN
cord-005453-4057qib7	6021	20	,	,	,
cord-005453-4057qib7	6021	21	3	3	CD
cord-005453-4057qib7	6021	22	from	from	IN
cord-005453-4057qib7	6021	23	infection	infection	NN
cord-005453-4057qib7	6021	24	)	)	-RRB-
cord-005453-4057qib7	6021	25	.	.	.
cord-005453-4057qib7	6022	1	The	the	DT
cord-005453-4057qib7	6022	2	1-year	1-year	CD
cord-005453-4057qib7	6022	3	survival	survival	NN
cord-005453-4057qib7	6022	4	probability	probability	NN
cord-005453-4057qib7	6022	5	was	be	VBD
cord-005453-4057qib7	6022	6	70.1	70.1	CD
cord-005453-4057qib7	6022	7	%	%	NN
cord-005453-4057qib7	6022	8	.	.	.
cord-005453-4057qib7	6023	1	Eleven	eleven	CD
cord-005453-4057qib7	6023	2	of	of	IN
cord-005453-4057qib7	6023	3	20	20	CD
cord-005453-4057qib7	6023	4	responders	responder	NNS
cord-005453-4057qib7	6023	5	discontinued	discontinue	VBD
cord-005453-4057qib7	6023	6	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6023	7	.	.	.
cord-005453-4057qib7	6024	1	GVHD	GVHD	NNP
cord-005453-4057qib7	6024	2	relapsed	relapse	VBD
cord-005453-4057qib7	6024	3	in	in	IN
cord-005453-4057qib7	6024	4	3	3	CD
cord-005453-4057qib7	6024	5	of	of	IN
cord-005453-4057qib7	6024	6	11	11	CD
cord-005453-4057qib7	6024	7	patients	patient	NNS
cord-005453-4057qib7	6024	8	at	at	IN
cord-005453-4057qib7	6024	9	14	14	CD
cord-005453-4057qib7	6024	10	,	,	,
cord-005453-4057qib7	6024	11	35	35	CD
cord-005453-4057qib7	6024	12	,	,	,
cord-005453-4057qib7	6024	13	and	and	CC
cord-005453-4057qib7	6024	14	149	149	CD
cord-005453-4057qib7	6024	15	days	day	NNS
cord-005453-4057qib7	6024	16	after	after	IN
cord-005453-4057qib7	6024	17	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	6024	18	discontinuation	discontinuation	NN
cord-005453-4057qib7	6024	19	.	.	.
cord-005453-4057qib7	6025	1	Thrombocytopenia	Thrombocytopenia	NNP
cord-005453-4057qib7	6025	2	(	(	-LRB-
cord-005453-4057qib7	6025	3	12/27	12/27	CD
cord-005453-4057qib7	6025	4	,	,	,
cord-005453-4057qib7	6025	5	Grade3/4	Grade3/4	NNP
cord-005453-4057qib7	6025	6	;	;	:
cord-005453-4057qib7	6025	7	4	4	LS
cord-005453-4057qib7	6025	8	)	)	-RRB-
cord-005453-4057qib7	6025	9	was	be	VBD
cord-005453-4057qib7	6025	10	the	the	DT
cord-005453-4057qib7	6025	11	most	most	RBS
cord-005453-4057qib7	6025	12	common	common	JJ
cord-005453-4057qib7	6025	13	adverse	adverse	JJ
cord-005453-4057qib7	6025	14	event	event	NN
cord-005453-4057qib7	6025	15	of	of	IN
cord-005453-4057qib7	6025	16	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6025	17	.	.	.
cord-005453-4057qib7	6026	1	During	during	IN
cord-005453-4057qib7	6026	2	treatment	treatment	NN
cord-005453-4057qib7	6026	3	,	,	,
cord-005453-4057qib7	6026	4	4	4	CD
cord-005453-4057qib7	6026	5	with	with	IN
cord-005453-4057qib7	6026	6	grade	grade	NN
cord-005453-4057qib7	6026	7	3/4	3/4	CD
cord-005453-4057qib7	6026	8	infectious	infectious	JJ
cord-005453-4057qib7	6026	9	adverse	adverse	JJ
cord-005453-4057qib7	6026	10	events	event	NNS
cord-005453-4057qib7	6026	11	occurred	occur	VBD
cord-005453-4057qib7	6026	12	;	;	:
cord-005453-4057qib7	6026	13	2	2	CD
cord-005453-4057qib7	6026	14	pneumonias	pneumonia	NNS
cord-005453-4057qib7	6026	15	,	,	,
cord-005453-4057qib7	6026	16	1	1	CD
cord-005453-4057qib7	6026	17	brain	brain	NN
cord-005453-4057qib7	6026	18	abscess	abscess	NN
cord-005453-4057qib7	6026	19	,	,	,
cord-005453-4057qib7	6026	20	and	and	CC
cord-005453-4057qib7	6026	21	1	1	CD
cord-005453-4057qib7	6026	22	liver	liver	NN
cord-005453-4057qib7	6026	23	abscess	abscess	NN
cord-005453-4057qib7	6026	24	.	.	.
cord-005453-4057qib7	6027	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6027	2	:	:	:
cord-005453-4057qib7	6028	1	Ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	6028	2	treatment	treatment	NN
cord-005453-4057qib7	6028	3	seems	seem	VBZ
cord-005453-4057qib7	6028	4	to	to	TO
cord-005453-4057qib7	6028	5	be	be	VB
cord-005453-4057qib7	6028	6	effective	effective	JJ
cord-005453-4057qib7	6028	7	for	for	IN
cord-005453-4057qib7	6028	8	the	the	DT
cord-005453-4057qib7	6028	9	treatment	treatment	NN
cord-005453-4057qib7	6028	10	of	of	IN
cord-005453-4057qib7	6028	11	steroid	steroid	NN
cord-005453-4057qib7	6028	12	-	-	HYPH
cord-005453-4057qib7	6028	13	refractory	refractory	JJ
cord-005453-4057qib7	6028	14	GVHD	GVHD	NNP
cord-005453-4057qib7	6028	15	including	include	VBG
cord-005453-4057qib7	6028	16	long	long	RB
cord-005453-4057qib7	6028	17	-	-	HYPH
cord-005453-4057qib7	6028	18	standing	stand	VBG
cord-005453-4057qib7	6028	19	chronic	chronic	JJ
cord-005453-4057qib7	6028	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6028	21	.	.	.
cord-005453-4057qib7	6029	1	The	the	DT
cord-005453-4057qib7	6029	2	agent	agent	NN
cord-005453-4057qib7	6029	3	was	be	VBD
cord-005453-4057qib7	6029	4	well	well	RB
cord-005453-4057qib7	6029	5	tolerated	tolerate	VBN
cord-005453-4057qib7	6029	6	and	and	CC
cord-005453-4057qib7	6029	7	relatively	relatively	RB
cord-005453-4057qib7	6029	8	safe	safe	JJ
cord-005453-4057qib7	6029	9	.	.	.
cord-005453-4057qib7	6030	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6030	2	:	:	:
cord-005453-4057qib7	6030	3	Nothing	nothing	NN
cord-005453-4057qib7	6030	4	to	to	TO
cord-005453-4057qib7	6030	5	declare	declare	VB
cord-005453-4057qib7	6030	6	.	.	.
cord-005453-4057qib7	6031	1	IL6-receptor	IL6-receptor	NNP
cord-005453-4057qib7	6031	2	antibody	antibody	NNP
cord-005453-4057qib7	6031	3	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6031	4	as	as	IN
cord-005453-4057qib7	6031	5	salvage	salvage	NN
cord-005453-4057qib7	6031	6	therapy	therapy	NN
cord-005453-4057qib7	6031	7	in	in	IN
cord-005453-4057qib7	6031	8	the	the	DT
cord-005453-4057qib7	6031	9	treatment	treatment	NN
cord-005453-4057qib7	6031	10	of	of	IN
cord-005453-4057qib7	6031	11	severe	severe	JJ
cord-005453-4057qib7	6031	12	chronic	chronic	JJ
cord-005453-4057qib7	6031	13	gvhd	gvhd	NN
cord-005453-4057qib7	6031	14	after	after	IN
cord-005453-4057qib7	6031	15	stem	stem	NN
cord-005453-4057qib7	6031	16	cell	cell	NN
cord-005453-4057qib7	6031	17	transplantation	transplantation	NN
cord-005453-4057qib7	6031	18	:	:	:
cord-005453-4057qib7	6032	1	A	a	DT
cord-005453-4057qib7	6032	2	retrospective	retrospective	JJ
cord-005453-4057qib7	6032	3	analysis	analysis	NN
cord-005453-4057qib7	6033	1	Background	background	NN
cord-005453-4057qib7	6033	2	:	:	:
cord-005453-4057qib7	6034	1	Severe	severe	JJ
cord-005453-4057qib7	6034	2	chronic	chronic	JJ
cord-005453-4057qib7	6034	3	graft	graft	NN
cord-005453-4057qib7	6034	4	-	-	HYPH
cord-005453-4057qib7	6034	5	versus	versus	IN
cord-005453-4057qib7	6034	6	-	-	HYPH
cord-005453-4057qib7	6034	7	host	host	NN
cord-005453-4057qib7	6034	8	disease	disease	NN
cord-005453-4057qib7	6034	9	(	(	-LRB-
cord-005453-4057qib7	6034	10	cGvHD	cGvHD	NNP
cord-005453-4057qib7	6034	11	)	)	-RRB-
cord-005453-4057qib7	6034	12	remains	remain	VBZ
cord-005453-4057qib7	6034	13	the	the	DT
cord-005453-4057qib7	6034	14	most	most	RBS
cord-005453-4057qib7	6034	15	relevant	relevant	JJ
cord-005453-4057qib7	6034	16	factor	factor	NN
cord-005453-4057qib7	6034	17	affecting	affect	VBG
cord-005453-4057qib7	6034	18	survival	survival	NN
cord-005453-4057qib7	6034	19	and	and	CC
cord-005453-4057qib7	6034	20	long	long	JJ
cord-005453-4057qib7	6034	21	-	-	HYPH
cord-005453-4057qib7	6034	22	term	term	NN
cord-005453-4057qib7	6034	23	quality	quality	NN
cord-005453-4057qib7	6034	24	of	of	IN
cord-005453-4057qib7	6034	25	life	life	NN
cord-005453-4057qib7	6034	26	after	after	IN
cord-005453-4057qib7	6034	27	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6034	28	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6034	29	stem	stem	NN
cord-005453-4057qib7	6034	30	cell	cell	NN
cord-005453-4057qib7	6034	31	transplantation	transplantation	NN
cord-005453-4057qib7	6034	32	(	(	-LRB-
cord-005453-4057qib7	6034	33	HCT	HCT	NNP
cord-005453-4057qib7	6034	34	)	)	-RRB-
cord-005453-4057qib7	6034	35	.	.	.
cord-005453-4057qib7	6035	1	Besides	besides	IN
cord-005453-4057qib7	6035	2	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	6035	3	there	there	EX
cord-005453-4057qib7	6035	4	is	be	VBZ
cord-005453-4057qib7	6035	5	no	no	DT
cord-005453-4057qib7	6035	6	established	establish	VBN
cord-005453-4057qib7	6035	7	therapy	therapy	NN
cord-005453-4057qib7	6035	8	for	for	IN
cord-005453-4057qib7	6035	9	cGvHD	cGvHD	NNP
cord-005453-4057qib7	6035	10	and	and	CC
cord-005453-4057qib7	6035	11	many	many	JJ
cord-005453-4057qib7	6035	12	of	of	IN
cord-005453-4057qib7	6035	13	the	the	DT
cord-005453-4057qib7	6035	14	used	use	VBN
cord-005453-4057qib7	6035	15	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6035	16	agents	agent	NNS
cord-005453-4057qib7	6035	17	may	may	MD
cord-005453-4057qib7	6035	18	lead	lead	VB
cord-005453-4057qib7	6035	19	to	to	IN
cord-005453-4057qib7	6035	20	significant	significant	JJ
cord-005453-4057qib7	6035	21	toxicity	toxicity	NN
cord-005453-4057qib7	6035	22	incl	incl	NNS
cord-005453-4057qib7	6035	23	.	.	.
cord-005453-4057qib7	6036	1	infectious	infectious	JJ
cord-005453-4057qib7	6036	2	complications	complication	NNS
cord-005453-4057qib7	6036	3	.	.	.
cord-005453-4057qib7	6037	1	Tocilizumab	Tocilizumab	NNP
cord-005453-4057qib7	6037	2	(	(	-LRB-
cord-005453-4057qib7	6037	3	an	an	DT
cord-005453-4057qib7	6037	4	IL6-receptor	il6-receptor	NN
cord-005453-4057qib7	6037	5	antibody	antibody	NN
cord-005453-4057qib7	6037	6	)	)	-RRB-
cord-005453-4057qib7	6037	7	has	have	VBZ
cord-005453-4057qib7	6037	8	shown	show	VBN
cord-005453-4057qib7	6037	9	efficacy	efficacy	NN
cord-005453-4057qib7	6037	10	in	in	IN
cord-005453-4057qib7	6037	11	acute	acute	JJ
cord-005453-4057qib7	6037	12	GvHD	gvhd	NN
cord-005453-4057qib7	6037	13	and	and	CC
cord-005453-4057qib7	6037	14	cGvHD	cgvhd	NN
cord-005453-4057qib7	6037	15	.	.	.
cord-005453-4057qib7	6038	1	We	-PRON-	PRP
cord-005453-4057qib7	6038	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	6038	3	analyzed	analyze	VBD
cord-005453-4057qib7	6038	4	the	the	DT
cord-005453-4057qib7	6038	5	efficacy	efficacy	NN
cord-005453-4057qib7	6038	6	and	and	CC
cord-005453-4057qib7	6038	7	safety	safety	NN
cord-005453-4057qib7	6038	8	of	of	IN
cord-005453-4057qib7	6038	9	patients	patient	NNS
cord-005453-4057qib7	6038	10	having	have	VBG
cord-005453-4057qib7	6038	11	received	receive	VBN
cord-005453-4057qib7	6038	12	tocilizumab	tocilizumab	NN
cord-005453-4057qib7	6038	13	for	for	IN
cord-005453-4057qib7	6038	14	treatment	treatment	NN
cord-005453-4057qib7	6038	15	of	of	IN
cord-005453-4057qib7	6038	16	advanced	advanced	JJ
cord-005453-4057qib7	6038	17	cGvHD	cgvhd	NN
cord-005453-4057qib7	6038	18	at	at	IN
cord-005453-4057qib7	6038	19	our	-PRON-	PRP$
cord-005453-4057qib7	6038	20	center	center	NN
cord-005453-4057qib7	6038	21	between	between	IN
cord-005453-4057qib7	6038	22	the	the	DT
cord-005453-4057qib7	6038	23	years	year	NNS
cord-005453-4057qib7	6038	24	2015	2015	CD
cord-005453-4057qib7	6038	25	and	and	CC
cord-005453-4057qib7	6038	26	2018	2018	CD
cord-005453-4057qib7	6038	27	.	.	.
cord-005453-4057qib7	6039	1	Methods	method	NNS
cord-005453-4057qib7	6039	2	:	:	:
cord-005453-4057qib7	6039	3	9	9	CD
cord-005453-4057qib7	6039	4	patients	patient	NNS
cord-005453-4057qib7	6039	5	with	with	IN
cord-005453-4057qib7	6039	6	severe	severe	JJ
cord-005453-4057qib7	6039	7	steroid	steroid	NN
cord-005453-4057qib7	6039	8	refractory	refractory	JJ
cord-005453-4057qib7	6039	9	cGvHD	cgvhd	NN
cord-005453-4057qib7	6039	10	and	and	CC
cord-005453-4057qib7	6039	11	a	a	DT
cord-005453-4057qib7	6039	12	median	median	JJ
cord-005453-4057qib7	6039	13	age	age	NN
cord-005453-4057qib7	6039	14	of	of	IN
cord-005453-4057qib7	6039	15	50	50	CD
cord-005453-4057qib7	6039	16	years	year	NNS
cord-005453-4057qib7	6040	1	(	(	-LRB-
cord-005453-4057qib7	6040	2	range	range	NN
cord-005453-4057qib7	6040	3	:	:	:
cord-005453-4057qib7	6040	4	21	21	CD
cord-005453-4057qib7	6040	5	-	-	SYM
cord-005453-4057qib7	6040	6	62	62	CD
cord-005453-4057qib7	6040	7	yrs	yrs	NN
cord-005453-4057qib7	6040	8	)	)	-RRB-
cord-005453-4057qib7	6040	9	having	have	VBG
cord-005453-4057qib7	6040	10	received	receive	VBN
cord-005453-4057qib7	6040	11	at	at	RB
cord-005453-4057qib7	6040	12	least	least	RBS
cord-005453-4057qib7	6040	13	two	two	CD
cord-005453-4057qib7	6040	14	prior	prior	JJ
cord-005453-4057qib7	6040	15	lines	line	NNS
cord-005453-4057qib7	6040	16	of	of	IN
cord-005453-4057qib7	6040	17	therapy	therapy	NN
cord-005453-4057qib7	6040	18	for	for	IN
cord-005453-4057qib7	6040	19	cGvHD	cGvHD	NNP
cord-005453-4057qib7	6040	20	(	(	-LRB-
cord-005453-4057qib7	6040	21	range	range	NN
cord-005453-4057qib7	6040	22	:	:	:
cord-005453-4057qib7	6040	23	2	2	CD
cord-005453-4057qib7	6040	24	-	-	SYM
cord-005453-4057qib7	6040	25	8	8	CD
cord-005453-4057qib7	6040	26	regimens	regimen	NNS
cord-005453-4057qib7	6040	27	)	)	-RRB-
cord-005453-4057qib7	6040	28	were	be	VBD
cord-005453-4057qib7	6040	29	treated	treat	VBN
cord-005453-4057qib7	6040	30	with	with	IN
cord-005453-4057qib7	6040	31	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6040	32	for	for	IN
cord-005453-4057qib7	6040	33	at	at	RB
cord-005453-4057qib7	6040	34	least	least	RBS
cord-005453-4057qib7	6040	35	one	one	CD
cord-005453-4057qib7	6040	36	cycle	cycle	NN
cord-005453-4057qib7	6040	37	(	(	-LRB-
cord-005453-4057qib7	6040	38	q4w	q4w	UH
cord-005453-4057qib7	6040	39	,	,	,
cord-005453-4057qib7	6040	40	dosage	dosage	NN
cord-005453-4057qib7	6040	41	:	:	:
cord-005453-4057qib7	6040	42	8	8	CD
cord-005453-4057qib7	6040	43	mg	mg	NNP
cord-005453-4057qib7	6040	44	/	/	SYM
cord-005453-4057qib7	6040	45	kg	kg	NN
cord-005453-4057qib7	6041	1	iv	iv	LS
cord-005453-4057qib7	6041	2	,	,	,
cord-005453-4057qib7	6041	3	maximum	maximum	NNP
cord-005453-4057qib7	6041	4	:	:	:
cord-005453-4057qib7	6041	5	800	800	CD
cord-005453-4057qib7	6041	6	mg	mg	NNP
cord-005453-4057qib7	6041	7	)	)	-RRB-
cord-005453-4057qib7	6041	8	with	with	IN
cord-005453-4057qib7	6041	9	a	a	DT
cord-005453-4057qib7	6041	10	median	median	JJ
cord-005453-4057qib7	6041	11	number	number	NN
cord-005453-4057qib7	6041	12	of	of	IN
cord-005453-4057qib7	6041	13	4	4	CD
cord-005453-4057qib7	6041	14	cycles	cycle	NNS
cord-005453-4057qib7	6041	15	(	(	-LRB-
cord-005453-4057qib7	6041	16	range	range	NN
cord-005453-4057qib7	6041	17	:	:	:
cord-005453-4057qib7	6041	18	.	.	.
cord-005453-4057qib7	6042	1	NIH	NIH	NNP
cord-005453-4057qib7	6042	2	consensus	consensus	NN
cord-005453-4057qib7	6042	3	criteria	criterion	NNS
cord-005453-4057qib7	6042	4	grading	grade	VBG
cord-005453-4057qib7	6042	5	for	for	IN
cord-005453-4057qib7	6042	6	cGvHD	cgvhd	NN
cord-005453-4057qib7	6042	7	and	and	CC
cord-005453-4057qib7	6043	1	the	the	DT
cord-005453-4057qib7	6043	2	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6043	3	regimen	regimen	NN
cord-005453-4057qib7	6043	4	were	be	VBD
cord-005453-4057qib7	6043	5	noted	note	VBN
cord-005453-4057qib7	6043	6	at	at	IN
cord-005453-4057qib7	6043	7	the	the	DT
cord-005453-4057qib7	6043	8	time	time	NN
cord-005453-4057qib7	6043	9	of	of	IN
cord-005453-4057qib7	6043	10	the	the	DT
cord-005453-4057qib7	6043	11	first	first	JJ
cord-005453-4057qib7	6043	12	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6043	13	administration	administration	NN
cord-005453-4057qib7	6043	14	and	and	CC
cord-005453-4057qib7	6043	15	after	after	IN
cord-005453-4057qib7	6043	16	3	3	CD
cord-005453-4057qib7	6043	17	,	,	,
cord-005453-4057qib7	6043	18	6	6	CD
cord-005453-4057qib7	6043	19	and	and	CC
cord-005453-4057qib7	6043	20	12	12	CD
cord-005453-4057qib7	6043	21	months	month	NNS
cord-005453-4057qib7	6043	22	of	of	IN
cord-005453-4057qib7	6043	23	therapy	therapy	NN
cord-005453-4057qib7	6043	24	.	.	.
cord-005453-4057qib7	6044	1	All	all	DT
cord-005453-4057qib7	6044	2	patients	patient	NNS
cord-005453-4057qib7	6044	3	received	receive	VBD
cord-005453-4057qib7	6044	4	additional	additional	JJ
cord-005453-4057qib7	6044	5	concomitant	concomitant	JJ
cord-005453-4057qib7	6044	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6044	7	agents	agent	NNS
cord-005453-4057qib7	6044	8	already	already	RB
cord-005453-4057qib7	6044	9	given	give	VBN
cord-005453-4057qib7	6044	10	at	at	IN
cord-005453-4057qib7	6044	11	least	least	JJS
cord-005453-4057qib7	6044	12	4	4	CD
cord-005453-4057qib7	6044	13	weeks	week	NNS
cord-005453-4057qib7	6044	14	without	without	IN
cord-005453-4057qib7	6044	15	response	response	NN
cord-005453-4057qib7	6044	16	before	before	IN
cord-005453-4057qib7	6044	17	start	start	NN
cord-005453-4057qib7	6044	18	of	of	IN
cord-005453-4057qib7	6044	19	tocilizumab	tocilizumab	NN
cord-005453-4057qib7	6044	20	.	.	.
cord-005453-4057qib7	6045	1	No	no	DT
cord-005453-4057qib7	6045	2	new	new	JJ
cord-005453-4057qib7	6045	3	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	6045	4	(	(	-LRB-
cord-005453-4057qib7	6045	5	IS	is	NN
cord-005453-4057qib7	6045	6	)	)	-RRB-
cord-005453-4057qib7	6045	7	was	be	VBD
cord-005453-4057qib7	6045	8	added	add	VBN
cord-005453-4057qib7	6045	9	in	in	IN
cord-005453-4057qib7	6045	10	parallel	parallel	NN
cord-005453-4057qib7	6045	11	to	to	IN
cord-005453-4057qib7	6045	12	tocilizumab	tocilizumab	NN
cord-005453-4057qib7	6045	13	and	and	CC
cord-005453-4057qib7	6045	14	response	response	NN
cord-005453-4057qib7	6045	15	assessment	assessment	NN
cord-005453-4057qib7	6045	16	was	be	VBD
cord-005453-4057qib7	6045	17	stopped	stop	VBN
cord-005453-4057qib7	6045	18	at	at	IN
cord-005453-4057qib7	6045	19	start	start	NN
cord-005453-4057qib7	6045	20	of	of	IN
cord-005453-4057qib7	6045	21	any	any	DT
cord-005453-4057qib7	6045	22	additional	additional	JJ
cord-005453-4057qib7	6045	23	new	new	JJ
cord-005453-4057qib7	6045	24	IS	is	NN
cord-005453-4057qib7	6045	25	.	.	.
cord-005453-4057qib7	6046	1	All	all	DT
cord-005453-4057qib7	6046	2	patients	patient	NNS
cord-005453-4057qib7	6046	3	had	have	VBD
cord-005453-4057qib7	6046	4	received	receive	VBN
cord-005453-4057qib7	6046	5	peripheral	peripheral	JJ
cord-005453-4057qib7	6046	6	stem	stem	NN
cord-005453-4057qib7	6046	7	cell	cell	NN
cord-005453-4057qib7	6046	8	allografts	allograft	NNS
cord-005453-4057qib7	6046	9	.	.	.
cord-005453-4057qib7	6047	1	GvHD	GvHD	NNP
cord-005453-4057qib7	6047	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6047	3	consisted	consist	VBD
cord-005453-4057qib7	6047	4	of	of	IN
cord-005453-4057qib7	6047	5	a	a	DT
cord-005453-4057qib7	6047	6	calcineurin	calcineurin	JJ
cord-005453-4057qib7	6047	7	inhibitor	inhibitor	NN
cord-005453-4057qib7	6047	8	in	in	IN
cord-005453-4057qib7	6047	9	combination	combination	NN
cord-005453-4057qib7	6047	10	with	with	IN
cord-005453-4057qib7	6047	11	methotrexate	methotrexate	NNP
cord-005453-4057qib7	6047	12	or	or	CC
cord-005453-4057qib7	6047	13	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	6047	14	and	and	CC
cord-005453-4057qib7	6047	15	in	in	IN
cord-005453-4057qib7	6047	16	case	case	NN
cord-005453-4057qib7	6047	17	of	of	IN
cord-005453-4057qib7	6047	18	unrelated	unrelated	JJ
cord-005453-4057qib7	6047	19	donors	donor	NNS
cord-005453-4057qib7	6047	20	ATG	ATG	NNP
cord-005453-4057qib7	6047	21	was	be	VBD
cord-005453-4057qib7	6047	22	added	add	VBN
cord-005453-4057qib7	6047	23	.	.	.
cord-005453-4057qib7	6048	1	8/9	8/9	CD
cord-005453-4057qib7	6048	2	patients	patient	NNS
cord-005453-4057qib7	6048	3	had	have	VBD
cord-005453-4057qib7	6048	4	quiescent	quiescent	JJ
cord-005453-4057qib7	6048	5	onset	onset	NN
cord-005453-4057qib7	6048	6	of	of	IN
cord-005453-4057qib7	6048	7	cGvHD	cgvhd	NN
cord-005453-4057qib7	6048	8	,	,	,
cord-005453-4057qib7	6048	9	one	one	CD
cord-005453-4057qib7	6048	10	patient	patient	NN
cord-005453-4057qib7	6048	11	developed	develop	VBN
cord-005453-4057qib7	6048	12	de	de	IN
cord-005453-4057qib7	6048	13	novo	novo	NNP
cord-005453-4057qib7	6048	14	cGvHD	cGvHD	NNP
cord-005453-4057qib7	6048	15	.	.	.
cord-005453-4057qib7	6049	1	The	the	DT
cord-005453-4057qib7	6049	2	median	median	JJ
cord-005453-4057qib7	6049	3	number	number	NN
cord-005453-4057qib7	6049	4	of	of	IN
cord-005453-4057qib7	6049	5	days	day	NNS
cord-005453-4057qib7	6049	6	between	between	IN
cord-005453-4057qib7	6049	7	HCT	hct	NN
cord-005453-4057qib7	6049	8	and	and	CC
cord-005453-4057qib7	6049	9	onset	onset	NN
cord-005453-4057qib7	6049	10	of	of	IN
cord-005453-4057qib7	6049	11	cGvHD	cgvhd	NN
cord-005453-4057qib7	6049	12	was	be	VBD
cord-005453-4057qib7	6049	13	215	215	CD
cord-005453-4057qib7	6049	14	(	(	-LRB-
cord-005453-4057qib7	6049	15	89	89	CD
cord-005453-4057qib7	6049	16	-	-	SYM
cord-005453-4057qib7	6049	17	545	545	CD
cord-005453-4057qib7	6049	18	)	)	-RRB-
cord-005453-4057qib7	6049	19	.	.	.
cord-005453-4057qib7	6050	1	The	the	DT
cord-005453-4057qib7	6050	2	median	median	JJ
cord-005453-4057qib7	6050	3	number	number	NN
cord-005453-4057qib7	6050	4	of	of	IN
cord-005453-4057qib7	6050	5	days	day	NNS
cord-005453-4057qib7	6050	6	between	between	IN
cord-005453-4057qib7	6050	7	HCT	hct	NN
cord-005453-4057qib7	6050	8	and	and	CC
cord-005453-4057qib7	6050	9	initiation	initiation	NN
cord-005453-4057qib7	6050	10	of	of	IN
cord-005453-4057qib7	6050	11	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6050	12	therapy	therapy	NN
cord-005453-4057qib7	6050	13	was	be	VBD
cord-005453-4057qib7	6050	14	1033	1033	CD
cord-005453-4057qib7	6050	15	(	(	-LRB-
cord-005453-4057qib7	6050	16	510	510	CD
cord-005453-4057qib7	6050	17	-	-	HYPH
cord-005453-4057qib7	6050	18	1749	1749	CD
cord-005453-4057qib7	6050	19	)	)	-RRB-
cord-005453-4057qib7	6050	20	days	day	NNS
cord-005453-4057qib7	6050	21	.	.	.
cord-005453-4057qib7	6051	1	At	at	IN
cord-005453-4057qib7	6051	2	cGvHD	cGvHD	NNP
cord-005453-4057qib7	6051	3	onset	onset	NN
cord-005453-4057qib7	6051	4	,	,	,
cord-005453-4057qib7	6051	5	7/9	7/9	CD
cord-005453-4057qib7	6051	6	patients	patient	NNS
cord-005453-4057qib7	6051	7	had	have	VBD
cord-005453-4057qib7	6051	8	mild	mild	JJ
cord-005453-4057qib7	6051	9	cGvHD	cgvhd	NN
cord-005453-4057qib7	6051	10	and	and	CC
cord-005453-4057qib7	6051	11	2/9	2/9	CD
cord-005453-4057qib7	6051	12	patients	patient	NNS
cord-005453-4057qib7	6051	13	had	have	VBD
cord-005453-4057qib7	6051	14	moderate	moderate	JJ
cord-005453-4057qib7	6051	15	cGvHD	cgvhd	NN
cord-005453-4057qib7	6051	16	.	.	.
cord-005453-4057qib7	6052	1	The	the	DT
cord-005453-4057qib7	6052	2	thrombocyte	thrombocyte	NN
cord-005453-4057qib7	6052	3	count	count	NN
cord-005453-4057qib7	6052	4	was	be	VBD
cord-005453-4057qib7	6052	5	<	<	NNP
cord-005453-4057qib7	6052	6	100	100	CD
cord-005453-4057qib7	6052	7	/	/	SYM
cord-005453-4057qib7	6052	8	nl	nl	NNP
cord-005453-4057qib7	6052	9	in	in	IN
cord-005453-4057qib7	6052	10	5/9	5/9	CD
cord-005453-4057qib7	6052	11	patients	patient	NNS
cord-005453-4057qib7	6052	12	.	.	.
cord-005453-4057qib7	6053	1	Organs	organ	NNS
cord-005453-4057qib7	6053	2	involved	involve	VBN
cord-005453-4057qib7	6053	3	at	at	IN
cord-005453-4057qib7	6053	4	initiation	initiation	NN
cord-005453-4057qib7	6053	5	of	of	IN
cord-005453-4057qib7	6053	6	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6053	7	therapy	therapy	NN
cord-005453-4057qib7	6053	8	were	be	VBD
cord-005453-4057qib7	6053	9	skin	skin	NN
cord-005453-4057qib7	6053	10	(	(	-LRB-
cord-005453-4057qib7	6053	11	100	100	CD
cord-005453-4057qib7	6053	12	%	%	NN
cord-005453-4057qib7	6053	13	,	,	,
cord-005453-4057qib7	6053	14	all	all	DT
cord-005453-4057qib7	6053	15	grade	grade	NN
cord-005453-4057qib7	6053	16	3	3	CD
cord-005453-4057qib7	6053	17	)	)	-RRB-
cord-005453-4057qib7	6053	18	,	,	,
cord-005453-4057qib7	6053	19	eyes	eye	NNS
cord-005453-4057qib7	6053	20	(	(	-LRB-
cord-005453-4057qib7	6053	21	78	78	CD
cord-005453-4057qib7	6053	22	%	%	NN
cord-005453-4057qib7	6053	23	)	)	-RRB-
cord-005453-4057qib7	6053	24	,	,	,
cord-005453-4057qib7	6053	25	mouth	mouth	NN
cord-005453-4057qib7	6053	26	(	(	-LRB-
cord-005453-4057qib7	6053	27	67	67	CD
cord-005453-4057qib7	6053	28	%	%	NN
cord-005453-4057qib7	6053	29	)	)	-RRB-
cord-005453-4057qib7	6053	30	,	,	,
cord-005453-4057qib7	6053	31	fascia	fascia	NN
cord-005453-4057qib7	6053	32	(	(	-LRB-
cord-005453-4057qib7	6053	33	67	67	CD
cord-005453-4057qib7	6053	34	%	%	NN
cord-005453-4057qib7	6053	35	)	)	-RRB-
cord-005453-4057qib7	6053	36	,	,	,
cord-005453-4057qib7	6053	37	lungs	lung	NNS
cord-005453-4057qib7	6053	38	(	(	-LRB-
cord-005453-4057qib7	6053	39	44	44	CD
cord-005453-4057qib7	6053	40	%	%	NN
cord-005453-4057qib7	6053	41	)	)	-RRB-
cord-005453-4057qib7	6053	42	and	and	CC
cord-005453-4057qib7	6053	43	genitals	genital	NNS
cord-005453-4057qib7	6053	44	(	(	-LRB-
cord-005453-4057qib7	6053	45	22	22	CD
cord-005453-4057qib7	6053	46	%	%	NN
cord-005453-4057qib7	6053	47	)	)	-RRB-
cord-005453-4057qib7	6053	48	.	.	.
cord-005453-4057qib7	6054	1	5/9	5/9	CD
cord-005453-4057qib7	6054	2	patients	patient	NNS
cord-005453-4057qib7	6054	3	are	be	VBP
cord-005453-4057qib7	6054	4	still	still	RB
cord-005453-4057qib7	6054	5	receiving	receive	VBG
cord-005453-4057qib7	6054	6	tocilizumab	tocilizumab	NN
cord-005453-4057qib7	6054	7	at	at	IN
cord-005453-4057qib7	6054	8	the	the	DT
cord-005453-4057qib7	6054	9	time	time	NN
cord-005453-4057qib7	6054	10	of	of	IN
cord-005453-4057qib7	6054	11	analysis	analysis	NN
cord-005453-4057qib7	6054	12	.	.	.
cord-005453-4057qib7	6055	1	Results	result	NNS
cord-005453-4057qib7	6055	2	:	:	:
cord-005453-4057qib7	6056	1	As	as	IN
cord-005453-4057qib7	6056	2	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6056	3	was	be	VBD
cord-005453-4057qib7	6056	4	given	give	VBN
cord-005453-4057qib7	6056	5	fairly	fairly	RB
cord-005453-4057qib7	6056	6	recently	recently	RB
cord-005453-4057qib7	6056	7	in	in	IN
cord-005453-4057qib7	6056	8	most	most	JJS
cord-005453-4057qib7	6056	9	patients	patient	NNS
cord-005453-4057qib7	6056	10	,	,	,
cord-005453-4057qib7	6056	11	6-and	6-and	CD
cord-005453-4057qib7	6056	12	12-month	12-month	JJ
cord-005453-4057qib7	6056	13	follow	follow	NN
cord-005453-4057qib7	6056	14	-	-	HYPH
cord-005453-4057qib7	6056	15	up	up	NN
cord-005453-4057qib7	6056	16	was	be	VBD
cord-005453-4057qib7	6056	17	only	only	RB
cord-005453-4057qib7	6056	18	reached	reach	VBN
cord-005453-4057qib7	6056	19	in	in	IN
cord-005453-4057qib7	6056	20	3/	3/	CD
cord-005453-4057qib7	6056	21	9	9	CD
cord-005453-4057qib7	6056	22	patients	patient	NNS
cord-005453-4057qib7	6056	23	(	(	-LRB-
cord-005453-4057qib7	6056	24	33	33	CD
cord-005453-4057qib7	6056	25	%	%	NN
cord-005453-4057qib7	6056	26	)	)	-RRB-
cord-005453-4057qib7	6056	27	.	.	.
cord-005453-4057qib7	6057	1	At	at	IN
cord-005453-4057qib7	6057	2	three	three	CD
cord-005453-4057qib7	6057	3	-	-	HYPH
cord-005453-4057qib7	6057	4	month	month	NN
cord-005453-4057qib7	6057	5	follow	follow	NN
cord-005453-4057qib7	6057	6	-	-	HYPH
cord-005453-4057qib7	6057	7	up	up	NN
cord-005453-4057qib7	6057	8	after	after	IN
cord-005453-4057qib7	6057	9	initiation	initiation	NN
cord-005453-4057qib7	6057	10	of	of	IN
cord-005453-4057qib7	6057	11	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6057	12	therapy	therapy	NN
cord-005453-4057qib7	6057	13	,	,	,
cord-005453-4057qib7	6057	14	4/9	4/9	CD
cord-005453-4057qib7	6057	15	patients	patient	NNS
cord-005453-4057qib7	6057	16	(	(	-LRB-
cord-005453-4057qib7	6057	17	44	44	CD
cord-005453-4057qib7	6057	18	%	%	NN
cord-005453-4057qib7	6057	19	)	)	-RRB-
cord-005453-4057qib7	6057	20	showed	show	VBD
cord-005453-4057qib7	6057	21	partial	partial	JJ
cord-005453-4057qib7	6057	22	remission	remission	NN
cord-005453-4057qib7	6057	23	,	,	,
cord-005453-4057qib7	6057	24	2/9	2/9	CD
cord-005453-4057qib7	6057	25	patients	patient	NNS
cord-005453-4057qib7	6057	26	stable	stable	JJ
cord-005453-4057qib7	6057	27	disease	disease	NN
cord-005453-4057qib7	6057	28	(	(	-LRB-
cord-005453-4057qib7	6057	29	22	22	CD
cord-005453-4057qib7	6057	30	%	%	NN
cord-005453-4057qib7	6057	31	)	)	-RRB-
cord-005453-4057qib7	6057	32	,	,	,
cord-005453-4057qib7	6057	33	and	and	CC
cord-005453-4057qib7	6057	34	2/9	2/9	CD
cord-005453-4057qib7	6057	35	patients	patient	NNS
cord-005453-4057qib7	6057	36	progressive	progressive	JJ
cord-005453-4057qib7	6057	37	disease	disease	NN
cord-005453-4057qib7	6057	38	(	(	-LRB-
cord-005453-4057qib7	6057	39	22	22	CD
cord-005453-4057qib7	6057	40	%	%	NN
cord-005453-4057qib7	6057	41	)	)	-RRB-
cord-005453-4057qib7	6057	42	of	of	IN
cord-005453-4057qib7	6057	43	cGvHD	cGvHD	NNP
cord-005453-4057qib7	6057	44	.	.	.
cord-005453-4057qib7	6058	1	Maximal	maximal	JJ
cord-005453-4057qib7	6058	2	response	response	NN
cord-005453-4057qib7	6058	3	was	be	VBD
cord-005453-4057qib7	6058	4	partial	partial	JJ
cord-005453-4057qib7	6058	5	remission	remission	NN
cord-005453-4057qib7	6058	6	(	(	-LRB-
cord-005453-4057qib7	6058	7	56	56	CD
cord-005453-4057qib7	6058	8	%	%	NN
cord-005453-4057qib7	6058	9	)	)	-RRB-
cord-005453-4057qib7	6058	10	,	,	,
cord-005453-4057qib7	6058	11	stable	stable	JJ
cord-005453-4057qib7	6058	12	disease	disease	NN
cord-005453-4057qib7	6058	13	(	(	-LRB-
cord-005453-4057qib7	6058	14	11	11	CD
cord-005453-4057qib7	6058	15	%	%	NN
cord-005453-4057qib7	6058	16	)	)	-RRB-
cord-005453-4057qib7	6058	17	and	and	CC
cord-005453-4057qib7	6058	18	progressive	progressive	JJ
cord-005453-4057qib7	6058	19	disease	disease	NN
cord-005453-4057qib7	6058	20	(	(	-LRB-
cord-005453-4057qib7	6058	21	22	22	CD
cord-005453-4057qib7	6058	22	%	%	NN
cord-005453-4057qib7	6058	23	)	)	-RRB-
cord-005453-4057qib7	6058	24	.	.	.
cord-005453-4057qib7	6059	1	3	3	CD
cord-005453-4057qib7	6059	2	patients	patient	NNS
cord-005453-4057qib7	6059	3	required	require	VBD
cord-005453-4057qib7	6059	4	subsequent	subsequent	JJ
cord-005453-4057qib7	6059	5	new	new	JJ
cord-005453-4057qib7	6059	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6059	7	treatment	treatment	NN
cord-005453-4057qib7	6059	8	.	.	.
cord-005453-4057qib7	6060	1	One	one	CD
cord-005453-4057qib7	6060	2	patient	patient	NN
cord-005453-4057qib7	6060	3	has	have	VBZ
cord-005453-4057qib7	6060	4	not	not	RB
cord-005453-4057qib7	6060	5	yet	yet	RB
cord-005453-4057qib7	6060	6	reached	reach	VBN
cord-005453-4057qib7	6060	7	3-month	3-month	CD
cord-005453-4057qib7	6060	8	follow	follow	NN
cord-005453-4057qib7	6060	9	-	-	HYPH
cord-005453-4057qib7	6060	10	up	up	NN
cord-005453-4057qib7	6060	11	.	.	.
cord-005453-4057qib7	6061	1	During	during	IN
cord-005453-4057qib7	6061	2	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6061	3	therapy	therapy	NN
cord-005453-4057qib7	6061	4	none	none	NN
cord-005453-4057qib7	6061	5	of	of	IN
cord-005453-4057qib7	6061	6	the	the	DT
cord-005453-4057qib7	6061	7	patients	patient	NNS
cord-005453-4057qib7	6061	8	suffered	suffer	VBD
cord-005453-4057qib7	6061	9	recurrence	recurrence	NN
cord-005453-4057qib7	6061	10	of	of	IN
cord-005453-4057qib7	6061	11	underlying	underlie	VBG
cord-005453-4057qib7	6061	12	malignancy	malignancy	NN
cord-005453-4057qib7	6061	13	.	.	.
cord-005453-4057qib7	6062	1	Two	two	CD
cord-005453-4057qib7	6062	2	patients	patient	NNS
cord-005453-4057qib7	6062	3	developed	develop	VBD
cord-005453-4057qib7	6062	4	significant	significant	JJ
cord-005453-4057qib7	6062	5	respiratory	respiratory	JJ
cord-005453-4057qib7	6062	6	infection	infection	NN
cord-005453-4057qib7	6062	7	and	and	CC
cord-005453-4057qib7	6062	8	one	one	CD
cord-005453-4057qib7	6062	9	patient	patient	NN
cord-005453-4057qib7	6062	10	developed	develop	VBD
cord-005453-4057qib7	6062	11	soft	soft	JJ
cord-005453-4057qib7	6062	12	tissue	tissue	NN
cord-005453-4057qib7	6062	13	infection	infection	NN
cord-005453-4057qib7	6062	14	,	,	,
cord-005453-4057qib7	6062	15	all	all	DT
cord-005453-4057qib7	6062	16	requiring	require	VBG
cord-005453-4057qib7	6062	17	antibiotic	antibiotic	JJ
cord-005453-4057qib7	6062	18	treatment	treatment	NN
cord-005453-4057qib7	6062	19	and	and	CC
cord-005453-4057qib7	6062	20	pausing	pausing	NN
cord-005453-4057qib7	6062	21	of	of	IN
cord-005453-4057qib7	6062	22	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	6062	23	administration	administration	NN
cord-005453-4057qib7	6062	24	,	,	,
cord-005453-4057qib7	6062	25	hospital	hospital	NN
cord-005453-4057qib7	6062	26	admission	admission	NN
cord-005453-4057qib7	6062	27	was	be	VBD
cord-005453-4057qib7	6062	28	not	not	RB
cord-005453-4057qib7	6062	29	required	require	VBN
cord-005453-4057qib7	6062	30	.	.	.
cord-005453-4057qib7	6063	1	The	the	DT
cord-005453-4057qib7	6063	2	OS	OS	NNP
cord-005453-4057qib7	6063	3	and	and	CC
cord-005453-4057qib7	6063	4	RFS	RFS	NNP
cord-005453-4057qib7	6063	5	was	be	VBD
cord-005453-4057qib7	6063	6	100	100	CD
cord-005453-4057qib7	6063	7	%	%	NN
cord-005453-4057qib7	6063	8	with	with	IN
cord-005453-4057qib7	6063	9	median	median	NN
cord-005453-4057qib7	6063	10	follow	follow	NN
cord-005453-4057qib7	6063	11	up	up	IN
cord-005453-4057qib7	6063	12	of	of	IN
cord-005453-4057qib7	6063	13	8.5	8.5	CD
cord-005453-4057qib7	6063	14	months	month	NNS
cord-005453-4057qib7	6063	15	(	(	-LRB-
cord-005453-4057qib7	6063	16	range	range	VBP
cord-005453-4057qib7	6063	17	2	2	CD
cord-005453-4057qib7	6063	18	-	-	SYM
cord-005453-4057qib7	6063	19	12	12	CD
cord-005453-4057qib7	6063	20	months	month	NNS
cord-005453-4057qib7	6063	21	)	)	-RRB-
cord-005453-4057qib7	6063	22	.	.	.
cord-005453-4057qib7	6064	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6064	2	:	:	:
cord-005453-4057qib7	6065	1	Tocilizumab	Tocilizumab	NNP
cord-005453-4057qib7	6065	2	appears	appear	VBZ
cord-005453-4057qib7	6065	3	to	to	TO
cord-005453-4057qib7	6065	4	be	be	VB
cord-005453-4057qib7	6065	5	a	a	DT
cord-005453-4057qib7	6065	6	promising	promising	JJ
cord-005453-4057qib7	6065	7	treatment	treatment	NN
cord-005453-4057qib7	6065	8	option	option	NN
cord-005453-4057qib7	6065	9	in	in	IN
cord-005453-4057qib7	6065	10	advanced	advanced	JJ
cord-005453-4057qib7	6065	11	cGvHD	cgvhd	NN
cord-005453-4057qib7	6065	12	but	but	CC
cord-005453-4057qib7	6065	13	further	further	JJ
cord-005453-4057qib7	6065	14	evaluation	evaluation	NN
cord-005453-4057qib7	6065	15	within	within	IN
cord-005453-4057qib7	6065	16	a	a	DT
cord-005453-4057qib7	6065	17	phase	phase	NN
cord-005453-4057qib7	6065	18	II	II	NNP
cord-005453-4057qib7	6065	19	trial	trial	NN
cord-005453-4057qib7	6065	20	is	be	VBZ
cord-005453-4057qib7	6065	21	required	require	VBN
cord-005453-4057qib7	6065	22	.	.	.
cord-005453-4057qib7	6066	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6066	2	:	:	:
cord-005453-4057qib7	6066	3	Nothing	nothing	NN
cord-005453-4057qib7	6066	4	to	to	TO
cord-005453-4057qib7	6066	5	declare	declare	VB
cord-005453-4057qib7	6066	6	Background	background	NN
cord-005453-4057qib7	6066	7	:	:	:
cord-005453-4057qib7	6066	8	Allogeneic	allogeneic	NN
cord-005453-4057qib7	6066	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6066	10	stem	stem	NN
cord-005453-4057qib7	6066	11	cell	cell	NN
cord-005453-4057qib7	6066	12	transplantation	transplantation	NN
cord-005453-4057qib7	6066	13	(	(	-LRB-
cord-005453-4057qib7	6066	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6066	15	)	)	-RRB-
cord-005453-4057qib7	6066	16	is	be	VBZ
cord-005453-4057qib7	6066	17	for	for	IN
cord-005453-4057qib7	6066	18	many	many	JJ
cord-005453-4057qib7	6066	19	patients	patient	NNS
cord-005453-4057qib7	6066	20	suffering	suffer	VBG
cord-005453-4057qib7	6066	21	from	from	IN
cord-005453-4057qib7	6066	22	AML	AML	NNP
cord-005453-4057qib7	6066	23	the	the	DT
cord-005453-4057qib7	6066	24	only	only	JJ
cord-005453-4057qib7	6066	25	curative	curative	JJ
cord-005453-4057qib7	6066	26	treatment	treatment	NN
cord-005453-4057qib7	6066	27	option	option	NN
cord-005453-4057qib7	6066	28	.	.	.
cord-005453-4057qib7	6067	1	One	one	CD
cord-005453-4057qib7	6067	2	major	major	JJ
cord-005453-4057qib7	6067	3	complication	complication	NN
cord-005453-4057qib7	6067	4	is	be	VBZ
cord-005453-4057qib7	6067	5	graft	graft	NN
cord-005453-4057qib7	6067	6	versus	versus	IN
cord-005453-4057qib7	6067	7	host	host	NN
cord-005453-4057qib7	6067	8	disease	disease	NN
cord-005453-4057qib7	6067	9	(	(	-LRB-
cord-005453-4057qib7	6067	10	GvHD	GvHD	NNP
cord-005453-4057qib7	6067	11	)	)	-RRB-
cord-005453-4057qib7	6067	12	,	,	,
cord-005453-4057qib7	6067	13	caused	cause	VBN
cord-005453-4057qib7	6067	14	by	by	IN
cord-005453-4057qib7	6067	15	donor	donor	NN
cord-005453-4057qib7	6067	16	immune	immune	NN
cord-005453-4057qib7	6067	17	cells	cell	NNS
cord-005453-4057qib7	6067	18	attacking	attack	VBG
cord-005453-4057qib7	6067	19	healthy	healthy	JJ
cord-005453-4057qib7	6067	20	tissue	tissue	NN
cord-005453-4057qib7	6067	21	.	.	.
cord-005453-4057qib7	6068	1	Regulatory	regulatory	JJ
cord-005453-4057qib7	6068	2	T	t	NN
cord-005453-4057qib7	6068	3	cells	cell	NNS
cord-005453-4057qib7	6068	4	(	(	-LRB-
cord-005453-4057qib7	6068	5	Treg	Treg	NNP
cord-005453-4057qib7	6068	6	)	)	-RRB-
cord-005453-4057qib7	6068	7	have	have	VBP
cord-005453-4057qib7	6068	8	been	be	VBN
cord-005453-4057qib7	6068	9	getting	get	VBG
cord-005453-4057qib7	6068	10	huge	huge	JJ
cord-005453-4057qib7	6068	11	attention	attention	NN
cord-005453-4057qib7	6068	12	during	during	IN
cord-005453-4057qib7	6068	13	the	the	DT
cord-005453-4057qib7	6068	14	past	past	JJ
cord-005453-4057qib7	6068	15	years	year	NNS
cord-005453-4057qib7	6068	16	because	because	IN
cord-005453-4057qib7	6068	17	of	of	IN
cord-005453-4057qib7	6068	18	their	-PRON-	PRP$
cord-005453-4057qib7	6068	19	important	important	JJ
cord-005453-4057qib7	6068	20	role	role	NN
cord-005453-4057qib7	6068	21	in	in	IN
cord-005453-4057qib7	6068	22	maintaining	maintain	VBG
cord-005453-4057qib7	6068	23	immune	immune	JJ
cord-005453-4057qib7	6068	24	balance	balance	NN
cord-005453-4057qib7	6068	25	.	.	.
cord-005453-4057qib7	6069	1	Here	here	RB
cord-005453-4057qib7	6069	2	we	-PRON-	PRP
cord-005453-4057qib7	6069	3	collected	collect	VBD
cord-005453-4057qib7	6069	4	peripheral	peripheral	JJ
cord-005453-4057qib7	6069	5	blood	blood	NN
cord-005453-4057qib7	6069	6	samples	sample	NNS
cord-005453-4057qib7	6069	7	from	from	IN
cord-005453-4057qib7	6069	8	11	11	CD
cord-005453-4057qib7	6069	9	patients	patient	NNS
cord-005453-4057qib7	6069	10	at	at	IN
cord-005453-4057qib7	6069	11	different	different	JJ
cord-005453-4057qib7	6069	12	time	time	NN
cord-005453-4057qib7	6069	13	points	point	NNS
cord-005453-4057qib7	6069	14	after	after	IN
cord-005453-4057qib7	6069	15	HSCT	HSCT	NNP
cord-005453-4057qib7	6069	16	to	to	TO
cord-005453-4057qib7	6069	17	investigate	investigate	VB
cord-005453-4057qib7	6069	18	immune	immune	JJ
cord-005453-4057qib7	6069	19	-	-	HYPH
cord-005453-4057qib7	6069	20	reconstitution	reconstitution	NN
cord-005453-4057qib7	6069	21	of	of	IN
cord-005453-4057qib7	6069	22	Treg	Treg	NNP
cord-005453-4057qib7	6069	23	as	as	IN
cord-005453-4057qib7	6069	24	predictive	predictive	JJ
cord-005453-4057qib7	6069	25	marker	marker	NN
cord-005453-4057qib7	6069	26	for	for	IN
cord-005453-4057qib7	6069	27	the	the	DT
cord-005453-4057qib7	6069	28	development	development	NN
cord-005453-4057qib7	6069	29	of	of	IN
cord-005453-4057qib7	6069	30	GvHD	GvHD	NNP
cord-005453-4057qib7	6069	31	.	.	.
cord-005453-4057qib7	6070	1	Methods	method	NNS
cord-005453-4057qib7	6070	2	:	:	:
cord-005453-4057qib7	6070	3	We	-PRON-	PRP
cord-005453-4057qib7	6070	4	collected	collect	VBD
cord-005453-4057qib7	6070	5	blood	blood	NN
cord-005453-4057qib7	6070	6	samples	sample	NNS
cord-005453-4057qib7	6070	7	from	from	IN
cord-005453-4057qib7	6070	8	11	11	CD
cord-005453-4057qib7	6070	9	patients	patient	NNS
cord-005453-4057qib7	6070	10	in	in	IN
cord-005453-4057qib7	6070	11	the	the	DT
cord-005453-4057qib7	6070	12	course	course	NN
cord-005453-4057qib7	6070	13	of	of	IN
cord-005453-4057qib7	6070	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	6070	15	HSCT	HSCT	NNP
cord-005453-4057qib7	6070	16	prospectively	prospectively	RB
cord-005453-4057qib7	6070	17	once	once	RB
cord-005453-4057qib7	6070	18	a	a	DT
cord-005453-4057qib7	6070	19	week	week	NN
cord-005453-4057qib7	6070	20	from	from	IN
cord-005453-4057qib7	6070	21	d+7	d+7	NNP
cord-005453-4057qib7	6070	22	up	up	IN
cord-005453-4057qib7	6070	23	to	to	IN
cord-005453-4057qib7	6070	24	d+200	d+200	NNP
cord-005453-4057qib7	6070	25	.	.	.
cord-005453-4057qib7	6071	1	All	all	DT
cord-005453-4057qib7	6071	2	patients	patient	NNS
cord-005453-4057qib7	6071	3	received	receive	VBD
cord-005453-4057qib7	6071	4	conditioning	conditioning	NN
cord-005453-4057qib7	6071	5	regimen	regimen	NN
cord-005453-4057qib7	6071	6	with	with	IN
cord-005453-4057qib7	6071	7	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	6071	8	and	and	CC
cord-005453-4057qib7	6071	9	Melphalan	Melphalan	NNP
cord-005453-4057qib7	6071	10	,	,	,
cord-005453-4057qib7	6071	11	combined	combine	VBN
cord-005453-4057qib7	6071	12	with	with	IN
cord-005453-4057qib7	6071	13	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	6071	14	for	for	IN
cord-005453-4057qib7	6071	15	T	T	NNP
cord-005453-4057qib7	6071	16	cell	cell	NN
cord-005453-4057qib7	6071	17	depletion	depletion	NN
cord-005453-4057qib7	6071	18	.	.	.
cord-005453-4057qib7	6072	1	9	9	CD
cord-005453-4057qib7	6072	2	patients	patient	NNS
cord-005453-4057qib7	6072	3	developed	develop	VBD
cord-005453-4057qib7	6072	4	acute	acute	JJ
cord-005453-4057qib7	6072	5	GVHD	GVHD	NNP
cord-005453-4057qib7	6072	6	in	in	IN
cord-005453-4057qib7	6072	7	the	the	DT
cord-005453-4057qib7	6072	8	later	later	JJ
cord-005453-4057qib7	6072	9	course	course	NN
cord-005453-4057qib7	6072	10	.	.	.
cord-005453-4057qib7	6073	1	After	after	IN
cord-005453-4057qib7	6073	2	isolation	isolation	NN
cord-005453-4057qib7	6073	3	of	of	IN
cord-005453-4057qib7	6073	4	PBMC`s	pbmc`s	NN
cord-005453-4057qib7	6074	1	we	-PRON-	PRP
cord-005453-4057qib7	6074	2	performed	perform	VBD
cord-005453-4057qib7	6074	3	FACS	FACS	NNP
cord-005453-4057qib7	6074	4	multicolor	multicolor	NN
cord-005453-4057qib7	6074	5	staining	staining	NN
cord-005453-4057qib7	6074	6	of	of	IN
cord-005453-4057qib7	6074	7	T	T	NNP
cord-005453-4057qib7	6074	8	cell	cell	NN
cord-005453-4057qib7	6074	9	and	and	CC
cord-005453-4057qib7	6074	10	NK	NK	NNP
cord-005453-4057qib7	6074	11	cells	cell	NNS
cord-005453-4057qib7	6074	12	.	.	.
cord-005453-4057qib7	6075	1	Treg	Treg	NNP
cord-005453-4057qib7	6075	2	were	be	VBD
cord-005453-4057qib7	6075	3	identified	identify	VBN
cord-005453-4057qib7	6075	4	as	as	IN
cord-005453-4057qib7	6075	5	CD3	CD3	NNP
cord-005453-4057qib7	6075	6	+	+	SYM
cord-005453-4057qib7	6075	7	CD4	CD4	NNP
cord-005453-4057qib7	6075	8	+	+	CC
cord-005453-4057qib7	6075	9	CD25	CD25	NNP
cord-005453-4057qib7	6076	1	+	+	CC
cord-005453-4057qib7	6077	1	+	+	CC
cord-005453-4057qib7	6077	2	Foxp3	Foxp3	VBN
cord-005453-4057qib7	6078	1	+	+	UH
cord-005453-4057qib7	6078	2	,	,	,
cord-005453-4057qib7	6078	3	NK	NK	NNP
cord-005453-4057qib7	6078	4	cells	cell	NNS
cord-005453-4057qib7	6078	5	were	be	VBD
cord-005453-4057qib7	6078	6	characterized	characterize	VBN
cord-005453-4057qib7	6078	7	as	as	IN
cord-005453-4057qib7	6078	8	CD3	CD3	NNP
cord-005453-4057qib7	6078	9	neg	neg	NNP
cord-005453-4057qib7	6078	10	CD56	CD56	NNP
cord-005453-4057qib7	6078	11	+	+	CC
cord-005453-4057qib7	6078	12	CD16	CD16	NNP
cord-005453-4057qib7	6078	13	+	+	CC
cord-005453-4057qib7	6078	14	and	and	CC
cord-005453-4057qib7	6078	15	divided	divide	VBN
cord-005453-4057qib7	6078	16	in	in	IN
cord-005453-4057qib7	6078	17	NK	NK	NNP
cord-005453-4057qib7	6078	18	cell	cell	NN
cord-005453-4057qib7	6078	19	subpopulation	subpopulation	NN
cord-005453-4057qib7	6078	20	due	due	IN
cord-005453-4057qib7	6078	21	to	to	IN
cord-005453-4057qib7	6078	22	their	-PRON-	PRP$
cord-005453-4057qib7	6078	23	expression	expression	NN
cord-005453-4057qib7	6078	24	of	of	IN
cord-005453-4057qib7	6078	25	CD56	cd56	NN
cord-005453-4057qib7	6078	26	dim	dim	NN
cord-005453-4057qib7	6078	27	or	or	CC
cord-005453-4057qib7	6078	28	CD56	CD56	NNP
cord-005453-4057qib7	6078	29	high	high	JJ
cord-005453-4057qib7	6078	30	.	.	.
cord-005453-4057qib7	6079	1	Results	result	NNS
cord-005453-4057qib7	6079	2	:	:	:
cord-005453-4057qib7	6079	3	1	1	CD
cord-005453-4057qib7	6079	4	.	.	.
cord-005453-4057qib7	6080	1	CD52	CD52	NNP
cord-005453-4057qib7	6080	2	neg	neg	NN
cord-005453-4057qib7	6080	3	T	T	NNP
cord-005453-4057qib7	6080	4	cells	cell	NNS
cord-005453-4057qib7	6080	5	:	:	:
cord-005453-4057qib7	6080	6	all	all	DT
cord-005453-4057qib7	6080	7	patients	patient	NNS
cord-005453-4057qib7	6080	8	developing	develop	VBG
cord-005453-4057qib7	6080	9	acute	acute	JJ
cord-005453-4057qib7	6080	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6080	11	in	in	IN
cord-005453-4057qib7	6080	12	the	the	DT
cord-005453-4057qib7	6080	13	later	later	JJ
cord-005453-4057qib7	6080	14	course	course	NN
cord-005453-4057qib7	6080	15	showed	show	VBD
cord-005453-4057qib7	6080	16	significant	significant	JJ
cord-005453-4057qib7	6080	17	elevated	elevated	JJ
cord-005453-4057qib7	6080	18	levels	level	NNS
cord-005453-4057qib7	6080	19	of	of	IN
cord-005453-4057qib7	6080	20	CD4	CD4	NNP
cord-005453-4057qib7	6080	21	+	+	CC
cord-005453-4057qib7	6080	22	CD52	CD52	NNP
cord-005453-4057qib7	6080	23	neg	neg	NN
cord-005453-4057qib7	6080	24	T	t	NN
cord-005453-4057qib7	6080	25	cells	cell	NNS
cord-005453-4057qib7	6080	26	,	,	,
cord-005453-4057qib7	6080	27	especially	especially	RB
cord-005453-4057qib7	6080	28	CD52	CD52	NNP
cord-005453-4057qib7	6080	29	neg	neg	NNP
cord-005453-4057qib7	6080	30	Treg	Treg	NNP
cord-005453-4057qib7	6080	31	at	at	IN
cord-005453-4057qib7	6080	32	d+50	d+50	NNP
cord-005453-4057qib7	6080	33	.	.	.
cord-005453-4057qib7	6080	34	2	2	CD
cord-005453-4057qib7	6080	35	.	.	.
cord-005453-4057qib7	6081	1	CD52	CD52	NNP
cord-005453-4057qib7	6081	2	neg	neg	NNP
cord-005453-4057qib7	6081	3	Treg	Treg	NNP
cord-005453-4057qib7	6081	4	/	/	SYM
cord-005453-4057qib7	6081	5	CD8	CD8	NNP
cord-005453-4057qib7	6081	6	+	+	CC
cord-005453-4057qib7	6081	7	CD52	CD52	NNP
cord-005453-4057qib7	6081	8	+	+	CC
cord-005453-4057qib7	6081	9	T	t	NN
cord-005453-4057qib7	6081	10	cells	cell	NNS
cord-005453-4057qib7	6081	11	:	:	:
cord-005453-4057qib7	6081	12	one	one	CD
cord-005453-4057qib7	6081	13	patient	patient	NN
cord-005453-4057qib7	6081	14	not	not	RB
cord-005453-4057qib7	6081	15	developing	develop	VBG
cord-005453-4057qib7	6081	16	acute	acute	JJ
cord-005453-4057qib7	6081	17	GVHD	GVHD	NNP
cord-005453-4057qib7	6081	18	showed	show	VBD
cord-005453-4057qib7	6081	19	lots	lot	NNS
cord-005453-4057qib7	6081	20	of	of	IN
cord-005453-4057qib7	6081	21	CD52	CD52	NNP
cord-005453-4057qib7	6081	22	neg	neg	NNP
cord-005453-4057qib7	6081	23	Treg	Treg	NNP
cord-005453-4057qib7	6081	24	but	but	CC
cord-005453-4057qib7	6081	25	missed	miss	VBD
cord-005453-4057qib7	6081	26	CD8	CD8	NNP
cord-005453-4057qib7	6081	27	+	+	CC
cord-005453-4057qib7	6081	28	CD52	CD52	NNP
cord-005453-4057qib7	6081	29	+	+	CC
cord-005453-4057qib7	6081	30	effector	effector	VB
cord-005453-4057qib7	6081	31	T	t	NN
cord-005453-4057qib7	6081	32	cells	cell	NNS
cord-005453-4057qib7	6081	33	.	.	.
cord-005453-4057qib7	6082	1	We	-PRON-	PRP
cord-005453-4057qib7	6082	2	recently	recently	RB
cord-005453-4057qib7	6082	3	showed	show	VBD
cord-005453-4057qib7	6082	4	that	that	IN
cord-005453-4057qib7	6082	5	CD8	CD8	NNP
cord-005453-4057qib7	6082	6	+	+	SYM
cord-005453-4057qib7	6082	7	CD52	CD52	NNP
cord-005453-4057qib7	6082	8	neg	neg	NN
cord-005453-4057qib7	6082	9	effector	effector	NN
cord-005453-4057qib7	6082	10	T	t	NN
cord-005453-4057qib7	6082	11	cells	cell	NNS
cord-005453-4057qib7	6082	12	are	be	VBP
cord-005453-4057qib7	6082	13	of	of	IN
cord-005453-4057qib7	6082	14	impaired	impair	VBN
cord-005453-4057qib7	6082	15	effector	effector	NN
cord-005453-4057qib7	6082	16	function	function	NN
cord-005453-4057qib7	6082	17	.	.	.
cord-005453-4057qib7	6083	1	These	these	DT
cord-005453-4057qib7	6083	2	data	datum	NNS
cord-005453-4057qib7	6083	3	suggest	suggest	VBP
cord-005453-4057qib7	6083	4	that	that	IN
cord-005453-4057qib7	6083	5	CD52	CD52	NNP
cord-005453-4057qib7	6083	6	neg	neg	NNP
cord-005453-4057qib7	6083	7	Treg	Treg	NNP
cord-005453-4057qib7	6083	8	are	be	VBP
cord-005453-4057qib7	6083	9	only	only	RB
cord-005453-4057qib7	6083	10	of	of	IN
cord-005453-4057qib7	6083	11	relevance	relevance	NN
cord-005453-4057qib7	6083	12	combined	combine	VBN
cord-005453-4057qib7	6083	13	with	with	IN
cord-005453-4057qib7	6083	14	functional	functional	JJ
cord-005453-4057qib7	6083	15	CD8	CD8	NNS
cord-005453-4057qib7	6083	16	+	+	CC
cord-005453-4057qib7	6083	17	CD52	CD52	NNP
cord-005453-4057qib7	6083	18	+	+	CC
cord-005453-4057qib7	6083	19	effector	effector	VB
cord-005453-4057qib7	6083	20	T	t	NN
cord-005453-4057qib7	6083	21	cells	cell	NNS
cord-005453-4057qib7	6083	22	in	in	IN
cord-005453-4057qib7	6083	23	the	the	DT
cord-005453-4057qib7	6083	24	development	development	NN
cord-005453-4057qib7	6083	25	of	of	IN
cord-005453-4057qib7	6083	26	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6083	27	.	.	.
cord-005453-4057qib7	6084	1	3	3	LS
cord-005453-4057qib7	6084	2	.	.	.
cord-005453-4057qib7	6085	1	T	T	NNP
cord-005453-4057qib7	6085	2	cell	cell	NN
cord-005453-4057qib7	6085	3	marker	marker	NN
cord-005453-4057qib7	6085	4	:	:	:
cord-005453-4057qib7	6085	5	Patients	patient	NNS
cord-005453-4057qib7	6085	6	without	without	IN
cord-005453-4057qib7	6085	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6085	8	showed	show	VBD
cord-005453-4057qib7	6085	9	elevated	elevated	JJ
cord-005453-4057qib7	6085	10	expression	expression	NN
cord-005453-4057qib7	6085	11	of	of	IN
cord-005453-4057qib7	6085	12	Garp	Garp	NNP
cord-005453-4057qib7	6085	13	on	on	IN
cord-005453-4057qib7	6085	14	Treg	Treg	NNP
cord-005453-4057qib7	6085	15	.	.	.
cord-005453-4057qib7	6086	1	Garp	Garp	NNP
cord-005453-4057qib7	6086	2	was	be	VBD
cord-005453-4057qib7	6086	3	significantly	significantly	RB
cord-005453-4057qib7	6086	4	higher	high	JJR
cord-005453-4057qib7	6086	5	expressed	express	VBN
cord-005453-4057qib7	6086	6	on	on	IN
cord-005453-4057qib7	6086	7	CD52	CD52	NNP
cord-005453-4057qib7	6086	8	+	+	CC
cord-005453-4057qib7	6086	9	Treg	Treg	NNP
cord-005453-4057qib7	6086	10	,	,	,
cord-005453-4057qib7	6086	11	indicating	indicate	VBG
cord-005453-4057qib7	6086	12	a	a	DT
cord-005453-4057qib7	6086	13	better	well	JJR
cord-005453-4057qib7	6086	14	suppressive	suppressive	JJ
cord-005453-4057qib7	6086	15	capacity	capacity	NN
cord-005453-4057qib7	6086	16	of	of	IN
cord-005453-4057qib7	6086	17	CD52	CD52	NNP
cord-005453-4057qib7	6086	18	+	+	CC
cord-005453-4057qib7	6086	19	Treg	Treg	NNP
cord-005453-4057qib7	6086	20	.	.	.
cord-005453-4057qib7	6087	1	This	this	DT
cord-005453-4057qib7	6087	2	was	be	VBD
cord-005453-4057qib7	6087	3	detected	detect	VBN
cord-005453-4057qib7	6087	4	throughout	throughout	IN
cord-005453-4057qib7	6087	5	from	from	IN
cord-005453-4057qib7	6087	6	d+50	d+50	NNP
cord-005453-4057qib7	6087	7	until	until	IN
cord-005453-4057qib7	6087	8	d+200	d+200	NNP
cord-005453-4057qib7	6087	9	.	.	.
cord-005453-4057qib7	6088	1	Tigit	Tigit	NNP
cord-005453-4057qib7	6088	2	and	and	CC
cord-005453-4057qib7	6088	3	ILT3	ILT3	NNP
cord-005453-4057qib7	6088	4	showed	show	VBD
cord-005453-4057qib7	6088	5	a	a	DT
cord-005453-4057qib7	6088	6	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	6088	7	expression	expression	NN
cord-005453-4057qib7	6088	8	profile	profile	NN
cord-005453-4057qib7	6088	9	without	without	IN
cord-005453-4057qib7	6088	10	significant	significant	JJ
cord-005453-4057qib7	6088	11	differences	difference	NNS
cord-005453-4057qib7	6088	12	between	between	IN
cord-005453-4057qib7	6088	13	the	the	DT
cord-005453-4057qib7	6088	14	two	two	CD
cord-005453-4057qib7	6088	15	groups	group	NNS
cord-005453-4057qib7	6088	16	.	.	.
cord-005453-4057qib7	6089	1	4	4	LS
cord-005453-4057qib7	6089	2	.	.	.
cord-005453-4057qib7	6090	1	NK	NK	NNP
cord-005453-4057qib7	6090	2	cells	cell	NNS
cord-005453-4057qib7	6091	1	:	:	:
cord-005453-4057qib7	6091	2	We	-PRON-	PRP
cord-005453-4057qib7	6091	3	detected	detect	VBD
cord-005453-4057qib7	6091	4	a	a	DT
cord-005453-4057qib7	6091	5	higher	high	JJR
cord-005453-4057qib7	6091	6	ratio	ratio	NN
cord-005453-4057qib7	6091	7	of	of	IN
cord-005453-4057qib7	6091	8	CD65	CD65	NNP
cord-005453-4057qib7	6091	9	+	+	.
cord-005453-4057qib7	6092	1	+	+	CC
cord-005453-4057qib7	6092	2	/CD56	/CD56	NNP
cord-005453-4057qib7	6092	3	dim	dim	JJ
cord-005453-4057qib7	6092	4	NK	nk	NN
cord-005453-4057qib7	6092	5	-	-	HYPH
cord-005453-4057qib7	6092	6	cell	cell	NN
cord-005453-4057qib7	6092	7	population	population	NN
cord-005453-4057qib7	6092	8	in	in	IN
cord-005453-4057qib7	6092	9	patients	patient	NNS
cord-005453-4057qib7	6092	10	without	without	IN
cord-005453-4057qib7	6092	11	.	.	.
cord-005453-4057qib7	6093	1	We	-PRON-	PRP
cord-005453-4057qib7	6093	2	could	could	MD
cord-005453-4057qib7	6093	3	also	also	RB
cord-005453-4057qib7	6093	4	show	show	VB
cord-005453-4057qib7	6093	5	that	that	IN
cord-005453-4057qib7	6093	6	Tigit	Tigit	NNP
cord-005453-4057qib7	6093	7	is	be	VBZ
cord-005453-4057qib7	6093	8	mainly	mainly	RB
cord-005453-4057qib7	6093	9	expressed	express	VBN
cord-005453-4057qib7	6093	10	on	on	IN
cord-005453-4057qib7	6093	11	CD56	CD56	NNP
cord-005453-4057qib7	6093	12	dim	dim	NN
cord-005453-4057qib7	6093	13	NK	NK	NNP
cord-005453-4057qib7	6093	14	cells	cell	NNS
cord-005453-4057qib7	6093	15	.	.	.
cord-005453-4057qib7	6094	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6094	2	:	:	:
cord-005453-4057qib7	6095	1	We	-PRON-	PRP
cord-005453-4057qib7	6095	2	and	and	CC
cord-005453-4057qib7	6095	3	others	other	NNS
cord-005453-4057qib7	6095	4	showed	show	VBD
cord-005453-4057qib7	6095	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	6095	6	of	of	IN
cord-005453-4057qib7	6095	7	CD52	CD52	NNP
cord-005453-4057qib7	6095	8	neg	neg	JJ
cord-005453-4057qib7	6095	9	T	t	NN
cord-005453-4057qib7	6095	10	cell	cell	NN
cord-005453-4057qib7	6095	11	subsets	subset	NNS
cord-005453-4057qib7	6095	12	after	after	IN
cord-005453-4057qib7	6095	13	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	6095	14	mediated	mediate	VBD
cord-005453-4057qib7	6095	15	T	t	NN
cord-005453-4057qib7	6095	16	cell	cell	NN
cord-005453-4057qib7	6095	17	depletion	depletion	NN
cord-005453-4057qib7	6095	18	-our	-our	:
cord-005453-4057qib7	6095	19	data	datum	NNS
cord-005453-4057qib7	6095	20	on	on	IN
cord-005453-4057qib7	6095	21	effector	effector	NN
cord-005453-4057qib7	6095	22	T	T	NNP
cord-005453-4057qib7	6095	23	cells	cell	NNS
cord-005453-4057qib7	6095	24	showed	show	VBD
cord-005453-4057qib7	6095	25	an	an	DT
cord-005453-4057qib7	6095	26	impaired	impaired	JJ
cord-005453-4057qib7	6095	27	effector	effector	NN
cord-005453-4057qib7	6095	28	function	function	NN
cord-005453-4057qib7	6095	29	for	for	IN
cord-005453-4057qib7	6095	30	CD52	CD52	NNP
cord-005453-4057qib7	6095	31	neg	neg	NN
cord-005453-4057qib7	6095	32	CD4	CD4	NNP
cord-005453-4057qib7	6095	33	and	and	CC
cord-005453-4057qib7	6095	34	CD8	CD8	NNP
cord-005453-4057qib7	6095	35	T	T	NNP
cord-005453-4057qib7	6095	36	cells	cell	NNS
cord-005453-4057qib7	6095	37	.	.	.
cord-005453-4057qib7	6096	1	Recently	recently	RB
cord-005453-4057qib7	6096	2	we	-PRON-	PRP
cord-005453-4057qib7	6096	3	presented	present	VBD
cord-005453-4057qib7	6096	4	Data	Data	NNP
cord-005453-4057qib7	6096	5	on	on	IN
cord-005453-4057qib7	6096	6	impaired	impaired	JJ
cord-005453-4057qib7	6096	7	suppressive	suppressive	JJ
cord-005453-4057qib7	6096	8	capacity	capacity	NN
cord-005453-4057qib7	6096	9	of	of	IN
cord-005453-4057qib7	6096	10	CD52	CD52	NNP
cord-005453-4057qib7	6096	11	neg	neg	NNP
cord-005453-4057qib7	6096	12	Treg	Treg	NNP
cord-005453-4057qib7	6096	13	and	and	CC
cord-005453-4057qib7	6096	14	the	the	DT
cord-005453-4057qib7	6096	15	association	association	NN
cord-005453-4057qib7	6096	16	with	with	IN
cord-005453-4057qib7	6096	17	acute	acute	JJ
cord-005453-4057qib7	6096	18	GVHD	GVHD	NNP
cord-005453-4057qib7	6096	19	retrospectively	retrospectively	RB
cord-005453-4057qib7	6096	20	(	(	-LRB-
cord-005453-4057qib7	6096	21	Wölfinger	Wölfinger	NNP
cord-005453-4057qib7	6096	22	EBMT	EBMT	NNP
cord-005453-4057qib7	6096	23	2018	2018	CD
cord-005453-4057qib7	6096	24	,	,	,
cord-005453-4057qib7	6096	25	ASH	ASH	NNP
cord-005453-4057qib7	6096	26	2017	2017	CD
cord-005453-4057qib7	6096	27	)	)	-RRB-
cord-005453-4057qib7	6096	28	.	.	.
cord-005453-4057qib7	6097	1	Here	here	RB
cord-005453-4057qib7	6097	2	we	-PRON-	PRP
cord-005453-4057qib7	6097	3	provide	provide	VBP
cord-005453-4057qib7	6097	4	prospective	prospective	JJ
cord-005453-4057qib7	6097	5	Data	datum	NNS
cord-005453-4057qib7	6097	6	on	on	IN
cord-005453-4057qib7	6097	7	patients	patient	NNS
cord-005453-4057qib7	6097	8	after	after	IN
cord-005453-4057qib7	6097	9	the	the	DT
cord-005453-4057qib7	6097	10	use	use	NN
cord-005453-4057qib7	6097	11	of	of	IN
cord-005453-4057qib7	6097	12	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	6097	13	in	in	IN
cord-005453-4057qib7	6097	14	the	the	DT
cord-005453-4057qib7	6097	15	context	context	NN
cord-005453-4057qib7	6097	16	of	of	IN
cord-005453-4057qib7	6097	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6097	18	:	:	:
cord-005453-4057qib7	6098	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6098	2	preliminary	preliminary	JJ
cord-005453-4057qib7	6098	3	data	datum	NNS
cord-005453-4057qib7	6098	4	suggest	suggest	VBP
cord-005453-4057qib7	6098	5	that	that	IN
cord-005453-4057qib7	6098	6	the	the	DT
cord-005453-4057qib7	6098	7	total	total	JJ
cord-005453-4057qib7	6098	8	amount	amount	NN
cord-005453-4057qib7	6098	9	of	of	IN
cord-005453-4057qib7	6098	10	CD52	CD52	NNP
cord-005453-4057qib7	6098	11	neg	neg	NNP
cord-005453-4057qib7	6098	12	-	-	NNP
cord-005453-4057qib7	6098	13	Treg	Treg	NNP
cord-005453-4057qib7	6098	14	and	and	CC
cord-005453-4057qib7	6098	15	the	the	DT
cord-005453-4057qib7	6098	16	ratio	ratio	NN
cord-005453-4057qib7	6098	17	of	of	IN
cord-005453-4057qib7	6098	18	CD52	CD52	NNP
cord-005453-4057qib7	6098	19	neg	neg	NNP
cord-005453-4057qib7	6098	20	Treg	Treg	NNP
cord-005453-4057qib7	6098	21	to	to	IN
cord-005453-4057qib7	6098	22	CD8	CD8	NNP
cord-005453-4057qib7	6098	23	+	+	CC
cord-005453-4057qib7	6098	24	CD52	CD52	NNP
cord-005453-4057qib7	6099	1	+	+	CC
cord-005453-4057qib7	6100	1	Treg	Treg	NNP
cord-005453-4057qib7	6100	2	on	on	IN
cord-005453-4057qib7	6100	3	d+50	d+50	NN
cord-005453-4057qib7	6100	4	after	after	IN
cord-005453-4057qib7	6100	5	allogenic	allogenic	JJ
cord-005453-4057qib7	6100	6	HSCT	HSCT	NNP
cord-005453-4057qib7	6100	7	could	could	MD
cord-005453-4057qib7	6100	8	predict	predict	VB
cord-005453-4057qib7	6100	9	aGvHD	agvhd	NN
cord-005453-4057qib7	6100	10	.	.	.
cord-005453-4057qib7	6101	1	This	this	DT
cord-005453-4057qib7	6101	2	data	datum	NNS
cord-005453-4057qib7	6101	3	may	may	MD
cord-005453-4057qib7	6101	4	be	be	VB
cord-005453-4057qib7	6101	5	a	a	DT
cord-005453-4057qib7	6101	6	basis	basis	NN
cord-005453-4057qib7	6101	7	for	for	IN
cord-005453-4057qib7	6101	8	immune	immune	JJ
cord-005453-4057qib7	6101	9	monitoring	monitoring	NN
cord-005453-4057qib7	6101	10	of	of	IN
cord-005453-4057qib7	6101	11	patients	patient	NNS
cord-005453-4057qib7	6101	12	at	at	IN
cord-005453-4057qib7	6101	13	d+50	d+50	NNP
cord-005453-4057qib7	6101	14	to	to	TO
cord-005453-4057qib7	6101	15	evaluate	evaluate	VB
cord-005453-4057qib7	6101	16	their	-PRON-	PRP$
cord-005453-4057qib7	6101	17	risk	risk	NN
cord-005453-4057qib7	6101	18	for	for	IN
cord-005453-4057qib7	6101	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6101	20	and	and	CC
cord-005453-4057qib7	6101	21	could	could	MD
cord-005453-4057qib7	6101	22	lead	lead	VB
cord-005453-4057qib7	6101	23	to	to	IN
cord-005453-4057qib7	6101	24	the	the	DT
cord-005453-4057qib7	6101	25	use	use	NN
cord-005453-4057qib7	6101	26	of	of	IN
cord-005453-4057qib7	6101	27	prophylactic	prophylactic	JJ
cord-005453-4057qib7	6101	28	Treg	Treg	NNP
cord-005453-4057qib7	6101	29	DLI	DLI	NNP
cord-005453-4057qib7	6101	30	in	in	IN
cord-005453-4057qib7	6101	31	the	the	DT
cord-005453-4057qib7	6101	32	context	context	NN
cord-005453-4057qib7	6101	33	of	of	IN
cord-005453-4057qib7	6101	34	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	6101	35	mediated	mediate	VBD
cord-005453-4057qib7	6101	36	T	t	NN
cord-005453-4057qib7	6101	37	cell	cell	NN
cord-005453-4057qib7	6101	38	depletion	depletion	NN
cord-005453-4057qib7	6101	39	.	.	.
cord-005453-4057qib7	6102	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6102	2	:	:	:
cord-005453-4057qib7	6103	1	Medac	Medac	NNP
cord-005453-4057qib7	6103	2	-travel	-travel	NNP
cord-005453-4057qib7	6103	3	support	support	NN
cord-005453-4057qib7	6103	4	,	,	,
cord-005453-4057qib7	6103	5	Novartis	Novartis	NNP
cord-005453-4057qib7	6103	6	-consultancy	-consultancy	NNP
cord-005453-4057qib7	6103	7	fee	fee	NN
cord-005453-4057qib7	6103	8	,	,	,
cord-005453-4057qib7	6103	9	Pfizer	Pfizer	NNP
cord-005453-4057qib7	6103	10	-consultancy	-consultancy	NNP
cord-005453-4057qib7	6103	11	fee	fee	NN
cord-005453-4057qib7	6104	1	,	,	,
cord-005453-4057qib7	6104	2	Shireconsultancy	Shireconsultancy	NNP
cord-005453-4057qib7	6104	3	fee	fee	NN
cord-005453-4057qib7	6104	4	Background	Background	NNP
cord-005453-4057qib7	6104	5	:	:	:
cord-005453-4057qib7	6105	1	Multiple	multiple	JJ
cord-005453-4057qib7	6105	2	factors	factor	NNS
cord-005453-4057qib7	6105	3	such	such	JJ
cord-005453-4057qib7	6105	4	as	as	IN
cord-005453-4057qib7	6105	5	disease	disease	NN
cord-005453-4057qib7	6105	6	activity	activity	NN
cord-005453-4057qib7	6105	7	and	and	CC
cord-005453-4057qib7	6105	8	severity	severity	NN
cord-005453-4057qib7	6105	9	,	,	,
cord-005453-4057qib7	6105	10	therapy	therapy	NN
cord-005453-4057qib7	6105	11	and/or	and/or	CC
cord-005453-4057qib7	6105	12	dietary	dietary	JJ
cord-005453-4057qib7	6105	13	habits	habit	NNS
cord-005453-4057qib7	6105	14	can	can	MD
cord-005453-4057qib7	6105	15	cause	cause	VB
cord-005453-4057qib7	6105	16	changes	change	NNS
cord-005453-4057qib7	6105	17	in	in	IN
cord-005453-4057qib7	6105	18	nutritional	nutritional	JJ
cord-005453-4057qib7	6105	19	status	status	NN
cord-005453-4057qib7	6105	20	independently	independently	RB
cord-005453-4057qib7	6105	21	or	or	CC
cord-005453-4057qib7	6105	22	by	by	IN
cord-005453-4057qib7	6105	23	interacting	interact	VBG
cord-005453-4057qib7	6105	24	with	with	IN
cord-005453-4057qib7	6105	25	each	each	DT
cord-005453-4057qib7	6105	26	other	other	JJ
cord-005453-4057qib7	6105	27	.	.	.
cord-005453-4057qib7	6106	1	Presence	presence	NN
cord-005453-4057qib7	6106	2	of	of	IN
cord-005453-4057qib7	6106	3	malnutrition	malnutrition	NN
cord-005453-4057qib7	6106	4	or	or	CC
cord-005453-4057qib7	6106	5	significant	significant	JJ
cord-005453-4057qib7	6106	6	weight	weight	NN
cord-005453-4057qib7	6106	7	loss	loss	NN
cord-005453-4057qib7	6106	8	in	in	IN
cord-005453-4057qib7	6106	9	chronic	chronic	JJ
cord-005453-4057qib7	6106	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6106	11	(	(	-LRB-
cord-005453-4057qib7	6106	12	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6106	13	)	)	-RRB-
cord-005453-4057qib7	6106	14	patients	patient	NNS
cord-005453-4057qib7	6106	15	was	be	VBD
cord-005453-4057qib7	6106	16	reported	report	VBN
cord-005453-4057qib7	6106	17	in	in	IN
cord-005453-4057qib7	6106	18	literature	literature	NN
cord-005453-4057qib7	6106	19	up	up	IN
cord-005453-4057qib7	6106	20	to	to	TO
cord-005453-4057qib7	6106	21	43	43	CD
cord-005453-4057qib7	6106	22	%	%	NN
cord-005453-4057qib7	6106	23	.	.	.
cord-005453-4057qib7	6107	1	The	the	DT
cord-005453-4057qib7	6107	2	aim	aim	NN
cord-005453-4057qib7	6107	3	of	of	IN
cord-005453-4057qib7	6107	4	this	this	DT
cord-005453-4057qib7	6107	5	cross	cross	JJ
cord-005453-4057qib7	6107	6	-	-	JJ
cord-005453-4057qib7	6107	7	sectional	sectional	JJ
cord-005453-4057qib7	6107	8	study	study	NN
cord-005453-4057qib7	6107	9	was	be	VBD
cord-005453-4057qib7	6107	10	to	to	TO
cord-005453-4057qib7	6107	11	identify	identify	VB
cord-005453-4057qib7	6107	12	factors	factor	NNS
cord-005453-4057qib7	6107	13	that	that	WDT
cord-005453-4057qib7	6107	14	affect	affect	VBP
cord-005453-4057qib7	6107	15	nutritional	nutritional	JJ
cord-005453-4057qib7	6107	16	status	status	NN
cord-005453-4057qib7	6107	17	in	in	IN
cord-005453-4057qib7	6107	18	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6107	19	patients	patient	NNS
cord-005453-4057qib7	6107	20	.	.	.
cord-005453-4057qib7	6108	1	Methods	method	NNS
cord-005453-4057qib7	6108	2	:	:	:
cord-005453-4057qib7	6108	3	Nutritional	nutritional	JJ
cord-005453-4057qib7	6108	4	status	status	NN
cord-005453-4057qib7	6108	5	in	in	IN
cord-005453-4057qib7	6108	6	patients	patient	NNS
cord-005453-4057qib7	6108	7	with	with	IN
cord-005453-4057qib7	6108	8	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6108	9	treated	treat	VBN
cord-005453-4057qib7	6108	10	at	at	IN
cord-005453-4057qib7	6108	11	the	the	DT
cord-005453-4057qib7	6108	12	University	University	NNP
cord-005453-4057qib7	6108	13	Hospital	Hospital	NNP
cord-005453-4057qib7	6108	14	Center	Center	NNP
cord-005453-4057qib7	6108	15	Zagreb	Zagreb	NNP
cord-005453-4057qib7	6108	16	,	,	,
cord-005453-4057qib7	6109	1	Croatia	Croatia	NNP
cord-005453-4057qib7	6109	2	from	from	IN
cord-005453-4057qib7	6109	3	2015	2015	CD
cord-005453-4057qib7	6109	4	to	to	IN
cord-005453-4057qib7	6109	5	2018	2018	CD
cord-005453-4057qib7	6109	6	was	be	VBD
cord-005453-4057qib7	6109	7	assessed	assess	VBN
cord-005453-4057qib7	6109	8	.	.	.
cord-005453-4057qib7	6110	1	Anthropometric	anthropometric	JJ
cord-005453-4057qib7	6110	2	measurements	measurement	NNS
cord-005453-4057qib7	6110	3	(	(	-LRB-
cord-005453-4057qib7	6110	4	height	height	NN
cord-005453-4057qib7	6110	5	,	,	,
cord-005453-4057qib7	6110	6	body	body	NN
cord-005453-4057qib7	6110	7	weight	weight	NN
cord-005453-4057qib7	6110	8	(	(	-LRB-
cord-005453-4057qib7	6110	9	BW	BW	NNP
cord-005453-4057qib7	6110	10	)	)	-RRB-
cord-005453-4057qib7	6110	11	,	,	,
cord-005453-4057qib7	6110	12	body	body	NN
cord-005453-4057qib7	6110	13	mass	mass	NN
cord-005453-4057qib7	6110	14	index	index	NN
cord-005453-4057qib7	6110	15	(	(	-LRB-
cord-005453-4057qib7	6110	16	BMI	BMI	NNP
cord-005453-4057qib7	6110	17	)	)	-RRB-
cord-005453-4057qib7	6110	18	)	)	-RRB-
cord-005453-4057qib7	6110	19	and	and	CC
cord-005453-4057qib7	6110	20	clinical	clinical	JJ
cord-005453-4057qib7	6110	21	validated	validate	VBN
cord-005453-4057qib7	6110	22	tool	tool	NN
cord-005453-4057qib7	6110	23	patient	patient	NN
cord-005453-4057qib7	6110	24	-	-	HYPH
cord-005453-4057qib7	6110	25	generated	generate	VBN
cord-005453-4057qib7	6110	26	subjective	subjective	JJ
cord-005453-4057qib7	6110	27	global	global	JJ
cord-005453-4057qib7	6110	28	assessment	assessment	NN
cord-005453-4057qib7	6110	29	(	(	-LRB-
cord-005453-4057qib7	6110	30	PG	PG	NNP
cord-005453-4057qib7	6110	31	-	-	HYPH
cord-005453-4057qib7	6110	32	SGA	SGA	NNP
cord-005453-4057qib7	6110	33	)	)	-RRB-
cord-005453-4057qib7	6110	34	(	(	-LRB-
cord-005453-4057qib7	6110	35	where	where	WRB
cord-005453-4057qib7	6110	36	patients	patient	NNS
cord-005453-4057qib7	6110	37	were	be	VBD
cord-005453-4057qib7	6110	38	categorized	categorize	VBN
cord-005453-4057qib7	6110	39	as	as	RB
cord-005453-4057qib7	6110	40	well	well	RB
cord-005453-4057qib7	6110	41	-	-	HYPH
cord-005453-4057qib7	6110	42	nourished	nourish	VBN
cord-005453-4057qib7	6110	43	(	(	-LRB-
cord-005453-4057qib7	6110	44	PG	PG	NNP
cord-005453-4057qib7	6110	45	-	-	HYPH
cord-005453-4057qib7	6110	46	SGA	SGA	NNP
cord-005453-4057qib7	6110	47	A	A	NNP
cord-005453-4057qib7	6110	48	)	)	-RRB-
cord-005453-4057qib7	6110	49	,	,	,
cord-005453-4057qib7	6110	50	moderately	moderately	RB
cord-005453-4057qib7	6110	51	malnourished	malnourished	JJ
cord-005453-4057qib7	6110	52	(	(	-LRB-
cord-005453-4057qib7	6110	53	PG	PG	NNP
cord-005453-4057qib7	6110	54	-	-	HYPH
cord-005453-4057qib7	6110	55	SGA	SGA	NNP
cord-005453-4057qib7	6110	56	B	B	NNP
cord-005453-4057qib7	6110	57	)	)	-RRB-
cord-005453-4057qib7	6110	58	or	or	CC
cord-005453-4057qib7	6110	59	severely	severely	RB
cord-005453-4057qib7	6110	60	malnourished	malnourished	JJ
cord-005453-4057qib7	6110	61	(	(	-LRB-
cord-005453-4057qib7	6110	62	PG	PG	NNP
cord-005453-4057qib7	6110	63	-	-	HYPH
cord-005453-4057qib7	6110	64	SGA	SGA	NNP
cord-005453-4057qib7	6110	65	C	C	NNP
cord-005453-4057qib7	6110	66	)	)	-RRB-
cord-005453-4057qib7	6110	67	)	)	-RRB-
cord-005453-4057qib7	6110	68	were	be	VBD
cord-005453-4057qib7	6110	69	used	use	VBN
cord-005453-4057qib7	6110	70	.	.	.
cord-005453-4057qib7	6111	1	All	all	DT
cord-005453-4057qib7	6111	2	patients	patient	NNS
cord-005453-4057qib7	6111	3	were	be	VBD
cord-005453-4057qib7	6111	4	evaluated	evaluate	VBN
cord-005453-4057qib7	6111	5	according	accord	VBG
cord-005453-4057qib7	6111	6	to	to	IN
cord-005453-4057qib7	6111	7	2005	2005	CD
cord-005453-4057qib7	6111	8	NIH	NIH	NNP
cord-005453-4057qib7	6111	9	criteria	criterion	NNS
cord-005453-4057qib7	6111	10	for	for	IN
cord-005453-4057qib7	6111	11	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6111	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	6111	13	.	.	.
cord-005453-4057qib7	6112	1	Descriptive	descriptive	JJ
cord-005453-4057qib7	6112	2	and	and	CC
cord-005453-4057qib7	6112	3	correlation	correlation	NN
cord-005453-4057qib7	6112	4	analysis	analysis	NN
cord-005453-4057qib7	6112	5	were	be	VBD
cord-005453-4057qib7	6112	6	preformed	preform	VBN
cord-005453-4057qib7	6112	7	.	.	.
cord-005453-4057qib7	6113	1	Results	result	NNS
cord-005453-4057qib7	6113	2	:	:	:
cord-005453-4057qib7	6114	1	In	in	IN
cord-005453-4057qib7	6114	2	total	total	NN
cord-005453-4057qib7	6114	3	,	,	,
cord-005453-4057qib7	6114	4	44	44	CD
cord-005453-4057qib7	6114	5	adult	adult	NN
cord-005453-4057qib7	6114	6	cGVHD	cgvhd	NN
cord-005453-4057qib7	6114	7	patients	patient	NNS
cord-005453-4057qib7	6114	8	were	be	VBD
cord-005453-4057qib7	6114	9	included	include	VBN
cord-005453-4057qib7	6114	10	in	in	IN
cord-005453-4057qib7	6114	11	the	the	DT
cord-005453-4057qib7	6114	12	study	study	NN
cord-005453-4057qib7	6114	13	,	,	,
cord-005453-4057qib7	6114	14	23	23	CD
cord-005453-4057qib7	6114	15	women	woman	NNS
cord-005453-4057qib7	6114	16	(	(	-LRB-
cord-005453-4057qib7	6114	17	52.3	52.3	CD
cord-005453-4057qib7	6114	18	%	%	NN
cord-005453-4057qib7	6114	19	)	)	-RRB-
cord-005453-4057qib7	6114	20	,	,	,
cord-005453-4057qib7	6114	21	median	median	JJ
cord-005453-4057qib7	6114	22	age	age	NN
cord-005453-4057qib7	6114	23	47	47	CD
cord-005453-4057qib7	6114	24	(	(	-LRB-
cord-005453-4057qib7	6114	25	18	18	CD
cord-005453-4057qib7	6114	26	-	-	SYM
cord-005453-4057qib7	6114	27	65	65	CD
cord-005453-4057qib7	6114	28	)	)	-RRB-
cord-005453-4057qib7	6114	29	years	year	NNS
cord-005453-4057qib7	6114	30	,	,	,
cord-005453-4057qib7	6114	31	with	with	IN
cord-005453-4057qib7	6114	32	mild	mild	JJ
cord-005453-4057qib7	6114	33	cGVHD	cgvhd	NN
cord-005453-4057qib7	6114	34	in	in	IN
cord-005453-4057qib7	6114	35	6	6	CD
cord-005453-4057qib7	6114	36	(	(	-LRB-
cord-005453-4057qib7	6114	37	13.64	13.64	CD
cord-005453-4057qib7	6114	38	%	%	NN
cord-005453-4057qib7	6114	39	)	)	-RRB-
cord-005453-4057qib7	6114	40	,	,	,
cord-005453-4057qib7	6114	41	moderate	moderate	JJ
cord-005453-4057qib7	6114	42	in	in	IN
cord-005453-4057qib7	6114	43	24	24	CD
cord-005453-4057qib7	6114	44	(	(	-LRB-
cord-005453-4057qib7	6114	45	54.55	54.55	CD
cord-005453-4057qib7	6114	46	%	%	NN
cord-005453-4057qib7	6114	47	)	)	-RRB-
cord-005453-4057qib7	6114	48	and	and	CC
cord-005453-4057qib7	6114	49	severe	severe	JJ
cord-005453-4057qib7	6114	50	in	in	IN
cord-005453-4057qib7	6114	51	13	13	CD
cord-005453-4057qib7	6114	52	(	(	-LRB-
cord-005453-4057qib7	6114	53	29.55	29.55	CD
cord-005453-4057qib7	6114	54	%	%	NN
cord-005453-4057qib7	6114	55	)	)	-RRB-
cord-005453-4057qib7	6114	56	patients	patient	NNS
cord-005453-4057qib7	6114	57	.	.	.
cord-005453-4057qib7	6115	1	According	accord	VBG
cord-005453-4057qib7	6115	2	to	to	IN
cord-005453-4057qib7	6115	3	the	the	DT
cord-005453-4057qib7	6115	4	PG	PG	NNP
cord-005453-4057qib7	6115	5	-	-	HYPH
cord-005453-4057qib7	6115	6	SGA	SGA	NNP
cord-005453-4057qib7	6115	7	rating	rating	NN
cord-005453-4057qib7	6115	8	19	19	CD
cord-005453-4057qib7	6115	9	(	(	-LRB-
cord-005453-4057qib7	6115	10	43.18	43.18	CD
cord-005453-4057qib7	6115	11	%	%	NN
cord-005453-4057qib7	6115	12	)	)	-RRB-
cord-005453-4057qib7	6115	13	patients	patient	NNS
cord-005453-4057qib7	6115	14	had	have	VBD
cord-005453-4057qib7	6115	15	PG	PG	NNP
cord-005453-4057qib7	6115	16	-	-	HYPH
cord-005453-4057qib7	6115	17	SGA	SGA	NNP
cord-005453-4057qib7	6115	18	A	A	NNP
cord-005453-4057qib7	6115	19	,	,	,
cord-005453-4057qib7	6115	20	19	19	CD
cord-005453-4057qib7	6115	21	(	(	-LRB-
cord-005453-4057qib7	6115	22	43.18	43.18	CD
cord-005453-4057qib7	6115	23	%	%	NN
cord-005453-4057qib7	6115	24	)	)	-RRB-
cord-005453-4057qib7	6116	1	PG	PG	NNP
cord-005453-4057qib7	6116	2	-	-	HYPH
cord-005453-4057qib7	6116	3	SGA	SGA	NNP
cord-005453-4057qib7	6116	4	B	B	NNP
cord-005453-4057qib7	6116	5	and	and	CC
cord-005453-4057qib7	6116	6	6	6	CD
cord-005453-4057qib7	6116	7	(	(	-LRB-
cord-005453-4057qib7	6116	8	13.64	13.64	CD
cord-005453-4057qib7	6116	9	%	%	NN
cord-005453-4057qib7	6116	10	)	)	-RRB-
cord-005453-4057qib7	6116	11	had	have	VBD
cord-005453-4057qib7	6116	12	PG	PG	NNP
cord-005453-4057qib7	6116	13	-	-	HYPH
cord-005453-4057qib7	6116	14	SGA	SGA	NNP
cord-005453-4057qib7	6116	15	C	C	NNP
cord-005453-4057qib7	6116	16	,	,	,
cord-005453-4057qib7	6116	17	giving	give	VBG
cord-005453-4057qib7	6116	18	a	a	DT
cord-005453-4057qib7	6116	19	total	total	JJ
cord-005453-4057qib7	6116	20	malnutrition	malnutrition	NN
cord-005453-4057qib7	6116	21	or	or	CC
cord-005453-4057qib7	6116	22	risk	risk	NN
cord-005453-4057qib7	6116	23	of	of	IN
cord-005453-4057qib7	6116	24	malnutrition	malnutrition	NN
cord-005453-4057qib7	6116	25	prevalence	prevalence	NN
cord-005453-4057qib7	6116	26	of	of	IN
cord-005453-4057qib7	6116	27	56.82	56.82	CD
cord-005453-4057qib7	6116	28	%	%	NN
cord-005453-4057qib7	6116	29	.	.	.
cord-005453-4057qib7	6117	1	The	the	DT
cord-005453-4057qib7	6117	2	mean	mean	JJ
cord-005453-4057qib7	6117	3	BMI	BMI	NNP
cord-005453-4057qib7	6117	4	was	be	VBD
cord-005453-4057qib7	6117	5	23.83±4.3	23.83±4.3	CD
cord-005453-4057qib7	6117	6	kg	kg	NNP
cord-005453-4057qib7	6117	7	/	/	SYM
cord-005453-4057qib7	6117	8	m	m	NN
cord-005453-4057qib7	6117	9	2	2	CD
cord-005453-4057qib7	6117	10	with	with	IN
cord-005453-4057qib7	6117	11	correlation	correlation	NN
cord-005453-4057qib7	6117	12	to	to	IN
cord-005453-4057qib7	6117	13	PG	PG	NNP
cord-005453-4057qib7	6117	14	-	-	HYPH
cord-005453-4057qib7	6117	15	SGA	SGA	NNP
cord-005453-4057qib7	6117	16	rating	rating	NN
cord-005453-4057qib7	6117	17	(	(	-LRB-
cord-005453-4057qib7	6117	18	r=0.446	r=0.446	NNP
cord-005453-4057qib7	6117	19	,	,	,
cord-005453-4057qib7	6117	20	p=0.0024	p=0.0024	NNP
cord-005453-4057qib7	6117	21	)	)	-RRB-
cord-005453-4057qib7	6117	22	.	.	.
cord-005453-4057qib7	6118	1	Malnutrition	malnutrition	NN
cord-005453-4057qib7	6118	2	according	accord	VBG
cord-005453-4057qib7	6118	3	to	to	IN
cord-005453-4057qib7	6118	4	the	the	DT
cord-005453-4057qib7	6118	5	BMI	BMI	NNP
cord-005453-4057qib7	6118	6	(	(	-LRB-
cord-005453-4057qib7	6118	7	defined	define	VBN
cord-005453-4057qib7	6118	8	as	as	IN
cord-005453-4057qib7	6118	9	BMI	BMI	NNP
cord-005453-4057qib7	6118	10	<	<	XX
cord-005453-4057qib7	6118	11	21	21	CD
cord-005453-4057qib7	6118	12	kg	kg	NNS
cord-005453-4057qib7	6119	1	/m	/m	NNP
cord-005453-4057qib7	6119	2	2	2	LS
cord-005453-4057qib7	6119	3	)	)	-RRB-
cord-005453-4057qib7	6119	4	was	be	VBD
cord-005453-4057qib7	6119	5	found	find	VBN
cord-005453-4057qib7	6119	6	in	in	IN
cord-005453-4057qib7	6119	7	8	8	CD
cord-005453-4057qib7	6119	8	patients	patient	NNS
cord-005453-4057qib7	6119	9	(	(	-LRB-
cord-005453-4057qib7	6119	10	18.18	18.18	CD
cord-005453-4057qib7	6119	11	%	%	NN
cord-005453-4057qib7	6119	12	)	)	-RRB-
cord-005453-4057qib7	6119	13	.	.	.
cord-005453-4057qib7	6120	1	BW	BW	NNP
cord-005453-4057qib7	6120	2	changes	change	NNS
cord-005453-4057qib7	6120	3	(	(	-LRB-
cord-005453-4057qib7	6120	4	10	10	CD
cord-005453-4057qib7	6120	5	%	%	NN
cord-005453-4057qib7	6120	6	or	or	CC
cord-005453-4057qib7	6120	7	more	more	JJR
cord-005453-4057qib7	6120	8	in	in	IN
cord-005453-4057qib7	6120	9	6	6	CD
cord-005453-4057qib7	6120	10	months	month	NNS
cord-005453-4057qib7	6120	11	)	)	-RRB-
cord-005453-4057qib7	6120	12	were	be	VBD
cord-005453-4057qib7	6120	13	significant	significant	JJ
cord-005453-4057qib7	6120	14	in	in	IN
cord-005453-4057qib7	6120	15	14	14	CD
cord-005453-4057qib7	6120	16	patients	patient	NNS
cord-005453-4057qib7	6120	17	(	(	-LRB-
cord-005453-4057qib7	6120	18	31.82	31.82	CD
cord-005453-4057qib7	6120	19	%	%	NN
cord-005453-4057qib7	6120	20	)	)	-RRB-
cord-005453-4057qib7	6120	21	.	.	.
cord-005453-4057qib7	6121	1	According	accord	VBG
cord-005453-4057qib7	6121	2	to	to	IN
cord-005453-4057qib7	6121	3	the	the	DT
cord-005453-4057qib7	6121	4	PG	PG	NNP
cord-005453-4057qib7	6121	5	-	-	HYPH
cord-005453-4057qib7	6121	6	SGA	SGA	NNP
cord-005453-4057qib7	6121	7	assessment	assessment	NN
cord-005453-4057qib7	6121	8	tool	tool	NN
cord-005453-4057qib7	6121	9	,	,	,
cord-005453-4057qib7	6121	10	oral	oral	JJ
cord-005453-4057qib7	6121	11	symptoms	symptom	NNS
cord-005453-4057qib7	6121	12	reported	report	VBN
cord-005453-4057qib7	6121	13	by	by	IN
cord-005453-4057qib7	6121	14	31	31	CD
cord-005453-4057qib7	6121	15	patient	patient	NN
cord-005453-4057qib7	6121	16	(	(	-LRB-
cord-005453-4057qib7	6121	17	70.45	70.45	CD
cord-005453-4057qib7	6121	18	%	%	NN
cord-005453-4057qib7	6121	19	)	)	-RRB-
cord-005453-4057qib7	6121	20	and	and	CC
cord-005453-4057qib7	6121	21	decreased	decrease	VBD
cord-005453-4057qib7	6121	22	appetite	appetite	NN
cord-005453-4057qib7	6121	23	reported	report	VBN
cord-005453-4057qib7	6121	24	by	by	IN
cord-005453-4057qib7	6121	25	12	12	CD
cord-005453-4057qib7	6121	26	patients	patient	NNS
cord-005453-4057qib7	6121	27	(	(	-LRB-
cord-005453-4057qib7	6121	28	27.27	27.27	CD
cord-005453-4057qib7	6121	29	%	%	NN
cord-005453-4057qib7	6121	30	)	)	-RRB-
cord-005453-4057qib7	6121	31	were	be	VBD
cord-005453-4057qib7	6121	32	associated	associate	VBN
cord-005453-4057qib7	6121	33	with	with	IN
cord-005453-4057qib7	6121	34	oral	oral	JJ
cord-005453-4057qib7	6121	35	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6121	36	NIH	NIH	NNP
cord-005453-4057qib7	6121	37	score	score	NN
cord-005453-4057qib7	6121	38	(	(	-LRB-
cord-005453-4057qib7	6121	39	r=0.536	r=0.536	NN
cord-005453-4057qib7	6121	40	,	,	,
cord-005453-4057qib7	6121	41	p=0.0002	p=0.0002	UH
cord-005453-4057qib7	6121	42	;	;	:
cord-005453-4057qib7	6121	43	r=0.441	r=0.441	NNP
cord-005453-4057qib7	6121	44	,	,	,
cord-005453-4057qib7	6121	45	p=0.0027	p=0.0027	NNP
cord-005453-4057qib7	6121	46	)	)	-RRB-
cord-005453-4057qib7	6121	47	but	but	CC
cord-005453-4057qib7	6121	48	not	not	RB
cord-005453-4057qib7	6121	49	with	with	IN
cord-005453-4057qib7	6121	50	BW	BW	NNP
cord-005453-4057qib7	6121	51	or	or	CC
cord-005453-4057qib7	6121	52	BMI	BMI	NNP
cord-005453-4057qib7	6121	53	.	.	.
cord-005453-4057qib7	6122	1	Gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	6122	2	(	(	-LRB-
cord-005453-4057qib7	6122	3	GI	GI	NNP
cord-005453-4057qib7	6122	4	)	)	-RRB-
cord-005453-4057qib7	6122	5	symptoms	symptom	NNS
cord-005453-4057qib7	6122	6	assessed	assess	VBN
cord-005453-4057qib7	6122	7	with	with	IN
cord-005453-4057qib7	6122	8	SGA	SGA	NNP
cord-005453-4057qib7	6122	9	,	,	,
cord-005453-4057qib7	6122	10	were	be	VBD
cord-005453-4057qib7	6122	11	generally	generally	RB
cord-005453-4057qib7	6122	12	mild	mild	JJ
cord-005453-4057qib7	6122	13	with	with	IN
cord-005453-4057qib7	6122	14	no	no	DT
cord-005453-4057qib7	6122	15	correlation	correlation	NN
cord-005453-4057qib7	6122	16	to	to	IN
cord-005453-4057qib7	6122	17	GI	GI	NNP
cord-005453-4057qib7	6122	18	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6122	19	NIH	NIH	NNP
cord-005453-4057qib7	6122	20	score	score	NN
cord-005453-4057qib7	6122	21	.	.	.
cord-005453-4057qib7	6123	1	No	no	DT
cord-005453-4057qib7	6123	2	significant	significant	JJ
cord-005453-4057qib7	6123	3	association	association	NN
cord-005453-4057qib7	6123	4	was	be	VBD
cord-005453-4057qib7	6123	5	found	find	VBN
cord-005453-4057qib7	6123	6	between	between	IN
cord-005453-4057qib7	6123	7	nutritional	nutritional	JJ
cord-005453-4057qib7	6123	8	status	status	NN
cord-005453-4057qib7	6123	9	and	and	CC
cord-005453-4057qib7	6123	10	other	other	JJ
cord-005453-4057qib7	6123	11	NIH	NIH	NNP
cord-005453-4057qib7	6123	12	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6123	13	scores	score	NNS
cord-005453-4057qib7	6123	14	.	.	.
cord-005453-4057qib7	6124	1	Corticosteroid	Corticosteroid	NNP
cord-005453-4057qib7	6124	2	therapy	therapy	NN
cord-005453-4057qib7	6124	3	present	present	NN
cord-005453-4057qib7	6124	4	in	in	IN
cord-005453-4057qib7	6124	5	12	12	CD
cord-005453-4057qib7	6124	6	(	(	-LRB-
cord-005453-4057qib7	6124	7	27.27	27.27	CD
cord-005453-4057qib7	6124	8	%	%	NN
cord-005453-4057qib7	6124	9	)	)	-RRB-
cord-005453-4057qib7	6124	10	correlated	correlate	VBN
cord-005453-4057qib7	6124	11	with	with	IN
cord-005453-4057qib7	6124	12	PG	PG	NNP
cord-005453-4057qib7	6124	13	-	-	HYPH
cord-005453-4057qib7	6124	14	SGA	SGA	NNP
cord-005453-4057qib7	6124	15	rating	rating	NN
cord-005453-4057qib7	6124	16	(	(	-LRB-
cord-005453-4057qib7	6124	17	r=0.494	r=0.494	NNS
cord-005453-4057qib7	6124	18	,	,	,
cord-005453-4057qib7	6124	19	p=0.0006	p=0.0006	NNP
cord-005453-4057qib7	6124	20	)	)	-RRB-
cord-005453-4057qib7	6124	21	but	but	CC
cord-005453-4057qib7	6124	22	not	not	RB
cord-005453-4057qib7	6124	23	with	with	IN
cord-005453-4057qib7	6124	24	BW	BW	NNP
cord-005453-4057qib7	6124	25	,	,	,
cord-005453-4057qib7	6124	26	BMI	BMI	NNP
cord-005453-4057qib7	6124	27	or	or	CC
cord-005453-4057qib7	6124	28	appetite	appetite	NN
cord-005453-4057qib7	6124	29	changes	change	NNS
cord-005453-4057qib7	6124	30	.	.	.
cord-005453-4057qib7	6125	1	In	in	IN
cord-005453-4057qib7	6125	2	23	23	CD
cord-005453-4057qib7	6125	3	patients	patient	NNS
cord-005453-4057qib7	6125	4	(	(	-LRB-
cord-005453-4057qib7	6125	5	52.7	52.7	CD
cord-005453-4057qib7	6125	6	%	%	NN
cord-005453-4057qib7	6125	7	)	)	-RRB-
cord-005453-4057qib7	6125	8	with	with	IN
cord-005453-4057qib7	6125	9	altered	alter	VBN
cord-005453-4057qib7	6125	10	PG	PG	NNP
cord-005453-4057qib7	6125	11	-	-	HYPH
cord-005453-4057qib7	6125	12	SGA	SGA	NNP
cord-005453-4057qib7	6125	13	rating	rating	NN
cord-005453-4057qib7	6125	14	,	,	,
cord-005453-4057qib7	6125	15	BMI	BMI	NNP
cord-005453-4057qib7	6125	16	,	,	,
cord-005453-4057qib7	6125	17	appetite	appetite	NN
cord-005453-4057qib7	6125	18	and	and	CC
cord-005453-4057qib7	6125	19	body	body	NN
cord-005453-4057qib7	6125	20	weight	weight	NN
cord-005453-4057qib7	6125	21	changes	change	NNS
cord-005453-4057qib7	6125	22	,	,	,
cord-005453-4057qib7	6125	23	dietary	dietary	JJ
cord-005453-4057qib7	6125	24	counseling	counseling	NN
cord-005453-4057qib7	6125	25	and	and	CC
cord-005453-4057qib7	6125	26	oral	oral	JJ
cord-005453-4057qib7	6125	27	nutritional	nutritional	JJ
cord-005453-4057qib7	6125	28	supplementation	supplementation	NN
cord-005453-4057qib7	6125	29	were	be	VBD
cord-005453-4057qib7	6125	30	initiated	initiate	VBN
cord-005453-4057qib7	6125	31	.	.	.
cord-005453-4057qib7	6126	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6126	2	:	:	:
cord-005453-4057qib7	6127	1	Oral	oral	JJ
cord-005453-4057qib7	6127	2	symptoms	symptom	NNS
cord-005453-4057qib7	6127	3	,	,	,
cord-005453-4057qib7	6127	4	decreased	decrease	VBD
cord-005453-4057qib7	6127	5	appetite	appetite	NN
cord-005453-4057qib7	6127	6	and	and	CC
cord-005453-4057qib7	6127	7	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	6127	8	therapy	therapy	NN
cord-005453-4057qib7	6127	9	in	in	IN
cord-005453-4057qib7	6127	10	our	-PRON-	PRP$
cord-005453-4057qib7	6127	11	cGVHD	cgvhd	NN
cord-005453-4057qib7	6127	12	patients	patient	NNS
cord-005453-4057qib7	6127	13	were	be	VBD
cord-005453-4057qib7	6127	14	associated	associate	VBN
cord-005453-4057qib7	6127	15	with	with	IN
cord-005453-4057qib7	6127	16	altered	altered	JJ
cord-005453-4057qib7	6127	17	nutritional	nutritional	JJ
cord-005453-4057qib7	6127	18	status	status	NN
cord-005453-4057qib7	6127	19	according	accord	VBG
cord-005453-4057qib7	6127	20	to	to	IN
cord-005453-4057qib7	6127	21	the	the	DT
cord-005453-4057qib7	6127	22	PG	PG	NNP
cord-005453-4057qib7	6127	23	-	-	HYPH
cord-005453-4057qib7	6127	24	SGA	SGA	NNP
cord-005453-4057qib7	6127	25	,	,	,
cord-005453-4057qib7	6127	26	but	but	CC
cord-005453-4057qib7	6127	27	not	not	RB
cord-005453-4057qib7	6127	28	with	with	IN
cord-005453-4057qib7	6127	29	BMI	BMI	NNP
cord-005453-4057qib7	6127	30	.	.	.
cord-005453-4057qib7	6128	1	Therefore	therefore	RB
cord-005453-4057qib7	6128	2	,	,	,
cord-005453-4057qib7	6128	3	PG	PG	NNP
cord-005453-4057qib7	6128	4	-	-	HYPH
cord-005453-4057qib7	6128	5	SGA	SGA	NNP
cord-005453-4057qib7	6128	6	might	may	MD
cord-005453-4057qib7	6128	7	be	be	VB
cord-005453-4057qib7	6128	8	a	a	DT
cord-005453-4057qib7	6128	9	more	more	RBR
cord-005453-4057qib7	6128	10	sensitive	sensitive	JJ
cord-005453-4057qib7	6128	11	tool	tool	NN
cord-005453-4057qib7	6128	12	in	in	IN
cord-005453-4057qib7	6128	13	assessment	assessment	NN
cord-005453-4057qib7	6128	14	of	of	IN
cord-005453-4057qib7	6128	15	changes	change	NNS
cord-005453-4057qib7	6128	16	of	of	IN
cord-005453-4057qib7	6128	17	the	the	DT
cord-005453-4057qib7	6128	18	nutritional	nutritional	JJ
cord-005453-4057qib7	6128	19	status	status	NN
cord-005453-4057qib7	6128	20	and	and	CC
cord-005453-4057qib7	6128	21	detection	detection	NN
cord-005453-4057qib7	6128	22	of	of	IN
cord-005453-4057qib7	6128	23	patients	patient	NNS
cord-005453-4057qib7	6128	24	at	at	IN
cord-005453-4057qib7	6128	25	risk	risk	NN
cord-005453-4057qib7	6128	26	of	of	IN
cord-005453-4057qib7	6128	27	malnutrition	malnutrition	NN
cord-005453-4057qib7	6128	28	than	than	IN
cord-005453-4057qib7	6128	29	BMI	BMI	NNP
cord-005453-4057qib7	6128	30	since	since	IN
cord-005453-4057qib7	6128	31	it	-PRON-	PRP
cord-005453-4057qib7	6128	32	includes	include	VBZ
cord-005453-4057qib7	6128	33	different	different	JJ
cord-005453-4057qib7	6128	34	factors	factor	NNS
cord-005453-4057qib7	6128	35	like	like	IN
cord-005453-4057qib7	6128	36	physical	physical	JJ
cord-005453-4057qib7	6128	37	examination	examination	NN
cord-005453-4057qib7	6128	38	,	,	,
cord-005453-4057qib7	6128	39	presence	presence	NN
cord-005453-4057qib7	6128	40	of	of	IN
cord-005453-4057qib7	6128	41	GI	GI	NNP
cord-005453-4057qib7	6128	42	symptoms	symptom	NNS
cord-005453-4057qib7	6128	43	and	and	CC
cord-005453-4057qib7	6128	44	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	6128	45	therapy	therapy	NN
cord-005453-4057qib7	6128	46	in	in	IN
cord-005453-4057qib7	6128	47	its	-PRON-	PRP$
cord-005453-4057qib7	6128	48	scoring	scoring	NN
cord-005453-4057qib7	6128	49	system	system	NN
cord-005453-4057qib7	6128	50	.	.	.
cord-005453-4057qib7	6129	1	Nutritional	nutritional	JJ
cord-005453-4057qib7	6129	2	counseling	counseling	NN
cord-005453-4057qib7	6129	3	and	and	CC
cord-005453-4057qib7	6129	4	support	support	NN
cord-005453-4057qib7	6129	5	are	be	VBP
cord-005453-4057qib7	6129	6	important	important	JJ
cord-005453-4057qib7	6129	7	in	in	IN
cord-005453-4057qib7	6129	8	cGVHD	cgvhd	NN
cord-005453-4057qib7	6129	9	patients	patient	NNS
cord-005453-4057qib7	6129	10	especially	especially	RB
cord-005453-4057qib7	6129	11	in	in	IN
cord-005453-4057qib7	6129	12	presence	presence	NN
cord-005453-4057qib7	6129	13	of	of	IN
cord-005453-4057qib7	6129	14	oral	oral	JJ
cord-005453-4057qib7	6129	15	symptoms	symptom	NNS
cord-005453-4057qib7	6129	16	.	.	.
cord-005453-4057qib7	6130	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6130	2	:	:	:
cord-005453-4057qib7	6130	3	Nothing	nothing	NN
cord-005453-4057qib7	6130	4	to	to	TO
cord-005453-4057qib7	6130	5	declare	declare	VB
cord-005453-4057qib7	6130	6	.	.	.
cord-005453-4057qib7	6131	1	Background	background	NN
cord-005453-4057qib7	6131	2	:	:	:
cord-005453-4057qib7	6132	1	Sclerotic	sclerotic	JJ
cord-005453-4057qib7	6132	2	skin	skin	NN
cord-005453-4057qib7	6132	3	changes	change	NNS
cord-005453-4057qib7	6132	4	are	be	VBP
cord-005453-4057qib7	6132	5	common	common	JJ
cord-005453-4057qib7	6132	6	features	feature	NNS
cord-005453-4057qib7	6132	7	in	in	IN
cord-005453-4057qib7	6132	8	chronic	chronic	JJ
cord-005453-4057qib7	6132	9	graft	graft	NN
cord-005453-4057qib7	6132	10	versus	versus	IN
cord-005453-4057qib7	6132	11	host	host	NN
cord-005453-4057qib7	6132	12	disease	disease	NN
cord-005453-4057qib7	6132	13	(	(	-LRB-
cord-005453-4057qib7	6132	14	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6132	15	)	)	-RRB-
cord-005453-4057qib7	6132	16	.	.	.
cord-005453-4057qib7	6133	1	One	one	CD
cord-005453-4057qib7	6133	2	of	of	IN
cord-005453-4057qib7	6133	3	the	the	DT
cord-005453-4057qib7	6133	4	most	most	RBS
cord-005453-4057qib7	6133	5	challenging	challenging	JJ
cord-005453-4057qib7	6133	6	aspects	aspect	NNS
cord-005453-4057qib7	6133	7	in	in	IN
cord-005453-4057qib7	6133	8	the	the	DT
cord-005453-4057qib7	6133	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	6133	10	and	and	CC
cord-005453-4057qib7	6133	11	management	management	NN
cord-005453-4057qib7	6133	12	of	of	IN
cord-005453-4057qib7	6133	13	sclerodermoid	sclerodermoid	NNP
cord-005453-4057qib7	6133	14	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6134	1	(	(	-LRB-
cord-005453-4057qib7	6134	2	scGVHD	scGVHD	NNP
cord-005453-4057qib7	6134	3	)	)	-RRB-
cord-005453-4057qib7	6134	4	is	be	VBZ
cord-005453-4057qib7	6134	5	the	the	DT
cord-005453-4057qib7	6134	6	differentiation	differentiation	NN
cord-005453-4057qib7	6134	7	between	between	IN
cord-005453-4057qib7	6134	8	reversible	reversible	JJ
cord-005453-4057qib7	6134	9	symptoms	symptom	NNS
cord-005453-4057qib7	6134	10	related	relate	VBN
cord-005453-4057qib7	6134	11	to	to	IN
cord-005453-4057qib7	6134	12	active	active	JJ
cord-005453-4057qib7	6134	13	cGVHD	cgvhd	NN
cord-005453-4057qib7	6134	14	and	and	CC
cord-005453-4057qib7	6134	15	nonreversible	nonreversible	JJ
cord-005453-4057qib7	6134	16	symptoms	symptom	NNS
cord-005453-4057qib7	6134	17	related	relate	VBN
cord-005453-4057qib7	6134	18	to	to	IN
cord-005453-4057qib7	6134	19	residual	residual	JJ
cord-005453-4057qib7	6134	20	permanent	permanent	JJ
cord-005453-4057qib7	6134	21	damage	damage	NN
cord-005453-4057qib7	6134	22	such	such	JJ
cord-005453-4057qib7	6134	23	as	as	IN
cord-005453-4057qib7	6134	24	long	long	RB
cord-005453-4057qib7	6134	25	-	-	HYPH
cord-005453-4057qib7	6134	26	standing	stand	VBG
cord-005453-4057qib7	6134	27	fibrosis	fibrosis	NN
cord-005453-4057qib7	6134	28	.	.	.
cord-005453-4057qib7	6135	1	Although	although	IN
cord-005453-4057qib7	6135	2	several	several	JJ
cord-005453-4057qib7	6135	3	candidate	candidate	NN
cord-005453-4057qib7	6135	4	biomarkers	biomarker	NNS
cord-005453-4057qib7	6135	5	of	of	IN
cord-005453-4057qib7	6135	6	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6135	7	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6135	8	activity	activity	NN
cord-005453-4057qib7	6135	9	have	have	VBP
cord-005453-4057qib7	6135	10	been	be	VBN
cord-005453-4057qib7	6135	11	proposed	propose	VBN
cord-005453-4057qib7	6135	12	,	,	,
cord-005453-4057qib7	6135	13	none	none	NN
cord-005453-4057qib7	6135	14	of	of	IN
cord-005453-4057qib7	6135	15	them	-PRON-	PRP
cord-005453-4057qib7	6135	16	are	be	VBP
cord-005453-4057qib7	6135	17	currently	currently	RB
cord-005453-4057qib7	6135	18	validated	validate	VBN
cord-005453-4057qib7	6135	19	.	.	.
cord-005453-4057qib7	6136	1	Therefore	therefore	RB
cord-005453-4057qib7	6136	2	,	,	,
cord-005453-4057qib7	6136	3	there	there	EX
cord-005453-4057qib7	6136	4	is	be	VBZ
cord-005453-4057qib7	6136	5	a	a	DT
cord-005453-4057qib7	6136	6	need	need	NN
cord-005453-4057qib7	6136	7	for	for	IN
cord-005453-4057qib7	6136	8	the	the	DT
cord-005453-4057qib7	6136	9	development	development	NN
cord-005453-4057qib7	6136	10	of	of	IN
cord-005453-4057qib7	6136	11	more	more	RBR
cord-005453-4057qib7	6136	12	quantifiable	quantifiable	JJ
cord-005453-4057qib7	6136	13	and	and	CC
cord-005453-4057qib7	6136	14	reproducible	reproducible	JJ
cord-005453-4057qib7	6136	15	measurements	measurement	NNS
cord-005453-4057qib7	6136	16	tools	tool	NNS
cord-005453-4057qib7	6136	17	to	to	TO
cord-005453-4057qib7	6136	18	guide	guide	VB
cord-005453-4057qib7	6136	19	clinical	clinical	JJ
cord-005453-4057qib7	6136	20	decisions	decision	NNS
cord-005453-4057qib7	6136	21	.	.	.
cord-005453-4057qib7	6137	1	We	-PRON-	PRP
cord-005453-4057qib7	6137	2	report	report	VBP
cord-005453-4057qib7	6137	3	our	-PRON-	PRP$
cord-005453-4057qib7	6137	4	experience	experience	NN
cord-005453-4057qib7	6137	5	evaluating	evaluate	VBG
cord-005453-4057qib7	6137	6	the	the	DT
cord-005453-4057qib7	6137	7	usefulness	usefulness	NN
cord-005453-4057qib7	6137	8	of	of	IN
cord-005453-4057qib7	6137	9	high	high	JJ
cord-005453-4057qib7	6137	10	-	-	HYPH
cord-005453-4057qib7	6137	11	frequency	frequency	NN
cord-005453-4057qib7	6137	12	ultrasonography	ultrasonography	NN
cord-005453-4057qib7	6137	13	(	(	-LRB-
cord-005453-4057qib7	6137	14	HFUS	HFUS	NNP
cord-005453-4057qib7	6137	15	)	)	-RRB-
cord-005453-4057qib7	6137	16	plus	plus	CC
cord-005453-4057qib7	6137	17	Doppler	Doppler	NNP
cord-005453-4057qib7	6137	18	ultrasound	ultrasound	NN
cord-005453-4057qib7	6137	19	(	(	-LRB-
cord-005453-4057qib7	6137	20	Doppler	Doppler	NNP
cord-005453-4057qib7	6137	21	-	-	HYPH
cord-005453-4057qib7	6137	22	US	US	NNP
cord-005453-4057qib7	6137	23	)	)	-RRB-
cord-005453-4057qib7	6137	24	and	and	CC
cord-005453-4057qib7	6137	25	serum	serum	NN
cord-005453-4057qib7	6137	26	fibrosis	fibrosis	NN
cord-005453-4057qib7	6137	27	biomarkers	biomarker	NNS
cord-005453-4057qib7	6137	28	to	to	TO
cord-005453-4057qib7	6137	29	determine	determine	VB
cord-005453-4057qib7	6137	30	the	the	DT
cord-005453-4057qib7	6137	31	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6137	32	activity	activity	NN
cord-005453-4057qib7	6137	33	of	of	IN
cord-005453-4057qib7	6137	34	scGVHD	scgvhd	ADD
cord-005453-4057qib7	6137	35	.	.	.
cord-005453-4057qib7	6138	1	Methods	method	NNS
cord-005453-4057qib7	6138	2	:	:	:
cord-005453-4057qib7	6139	1	We	-PRON-	PRP
cord-005453-4057qib7	6139	2	report	report	VBP
cord-005453-4057qib7	6139	3	6	6	CD
cord-005453-4057qib7	6139	4	patients	patient	NNS
cord-005453-4057qib7	6139	5	with	with	IN
cord-005453-4057qib7	6139	6	scGVHD	scgvhd	ADD
cord-005453-4057qib7	6139	7	.	.	.
cord-005453-4057qib7	6140	1	HFUS	HFUS	NNP
cord-005453-4057qib7	6140	2	plus	plus	CC
cord-005453-4057qib7	6140	3	Doppler	Doppler	NNP
cord-005453-4057qib7	6140	4	-	-	HYPH
cord-005453-4057qib7	6140	5	US	US	NNP
cord-005453-4057qib7	6140	6	were	be	VBD
cord-005453-4057qib7	6140	7	performed	perform	VBN
cord-005453-4057qib7	6140	8	at	at	IN
cord-005453-4057qib7	6140	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	6140	10	of	of	IN
cord-005453-4057qib7	6140	11	scGVHD	scGVHD	NNP
cord-005453-4057qib7	6140	12	and	and	CC
cord-005453-4057qib7	6140	13	at	at	IN
cord-005453-4057qib7	6140	14	different	different	JJ
cord-005453-4057qib7	6140	15	time	time	NN
cord-005453-4057qib7	6140	16	-	-	HYPH
cord-005453-4057qib7	6140	17	points	point	NNS
cord-005453-4057qib7	6140	18	after	after	IN
cord-005453-4057qib7	6140	19	treatment	treatment	NN
cord-005453-4057qib7	6140	20	initiation	initiation	NN
cord-005453-4057qib7	6140	21	.	.	.
cord-005453-4057qib7	6141	1	Serum	serum	NN
cord-005453-4057qib7	6141	2	hyaluronic	hyaluronic	NN
cord-005453-4057qib7	6141	3	acid	acid	NN
cord-005453-4057qib7	6141	4	and	and	CC
cord-005453-4057qib7	6141	5	pro	pro	JJ
cord-005453-4057qib7	6141	6	-	-	JJ
cord-005453-4057qib7	6141	7	colagen	colagen	JJ
cord-005453-4057qib7	6141	8	-	-	HYPH
cord-005453-4057qib7	6141	9	III	III	NNP
cord-005453-4057qib7	6141	10	were	be	VBD
cord-005453-4057qib7	6141	11	measured	measure	VBN
cord-005453-4057qib7	6141	12	as	as	IN
cord-005453-4057qib7	6141	13	fibrosis	fibrosis	NN
cord-005453-4057qib7	6141	14	biomarkers	biomarker	NNS
cord-005453-4057qib7	6141	15	simultaneously	simultaneously	RB
cord-005453-4057qib7	6141	16	with	with	IN
cord-005453-4057qib7	6141	17	HFUS	HFUS	NNP
cord-005453-4057qib7	6141	18	and	and	CC
cord-005453-4057qib7	6141	19	Doppler	Doppler	NNP
cord-005453-4057qib7	6141	20	-	-	HYPH
cord-005453-4057qib7	6141	21	US	US	NNP
cord-005453-4057qib7	6141	22	.	.	.
cord-005453-4057qib7	6142	1	NIH	NIH	NNP
cord-005453-4057qib7	6142	2	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6142	3	2014	2014	CD
cord-005453-4057qib7	6142	4	Consensus	Consensus	NNP
cord-005453-4057qib7	6142	5	Conference	Conference	NNP
cord-005453-4057qib7	6142	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	6142	7	criteria	criterion	NNS
cord-005453-4057qib7	6142	8	,	,	,
cord-005453-4057qib7	6142	9	scoring	score	VBG
cord-005453-4057qib7	6142	10	system	system	NN
cord-005453-4057qib7	6142	11	,	,	,
cord-005453-4057qib7	6142	12	and	and	CC
cord-005453-4057qib7	6142	13	response	response	NN
cord-005453-4057qib7	6142	14	criteria	criterion	NNS
cord-005453-4057qib7	6142	15	were	be	VBD
cord-005453-4057qib7	6142	16	used	use	VBN
cord-005453-4057qib7	6142	17	to	to	TO
cord-005453-4057qib7	6142	18	assess	assess	VB
cord-005453-4057qib7	6142	19	global	global	JJ
cord-005453-4057qib7	6142	20	and	and	CC
cord-005453-4057qib7	6142	21	organ	organ	NN
cord-005453-4057qib7	6142	22	-	-	HYPH
cord-005453-4057qib7	6142	23	specific	specific	JJ
cord-005453-4057qib7	6142	24	cGVHD	cgvhd	NN
cord-005453-4057qib7	6142	25	,	,	,
cord-005453-4057qib7	6142	26	and	and	CC
cord-005453-4057qib7	6142	27	to	to	TO
cord-005453-4057qib7	6142	28	measure	measure	VB
cord-005453-4057qib7	6142	29	overall	overall	JJ
cord-005453-4057qib7	6142	30	response	response	NN
cord-005453-4057qib7	6142	31	to	to	IN
cord-005453-4057qib7	6142	32	therapy	therapy	NN
cord-005453-4057qib7	6142	33	.	.	.
cord-005453-4057qib7	6143	1	Abnormal	abnormal	JJ
cord-005453-4057qib7	6143	2	ultrasound	ultrasound	NN
cord-005453-4057qib7	6143	3	findings	finding	NNS
cord-005453-4057qib7	6143	4	were	be	VBD
cord-005453-4057qib7	6143	5	defined	define	VBN
cord-005453-4057qib7	6143	6	as	as	IN
cord-005453-4057qib7	6143	7	the	the	DT
cord-005453-4057qib7	6143	8	presence	presence	NN
cord-005453-4057qib7	6143	9	of	of	IN
cord-005453-4057qib7	6143	10	≥	≥	CD
cord-005453-4057qib7	6143	11	1	1	CD
cord-005453-4057qib7	6143	12	of	of	IN
cord-005453-4057qib7	6143	13	the	the	DT
cord-005453-4057qib7	6143	14	following	follow	VBG
cord-005453-4057qib7	6143	15	:	:	:
cord-005453-4057qib7	6143	16	hypoechogenic	hypoechogenic	NNP
cord-005453-4057qib7	6143	17	dermis	dermis	NN
cord-005453-4057qib7	6143	18	,	,	,
cord-005453-4057qib7	6143	19	dermo	dermo	NN
cord-005453-4057qib7	6143	20	-	-	HYPH
cord-005453-4057qib7	6143	21	epidermal	epidermal	JJ
cord-005453-4057qib7	6143	22	junction	junction	NN
cord-005453-4057qib7	6143	23	effacement	effacement	NN
cord-005453-4057qib7	6143	24	,	,	,
cord-005453-4057qib7	6143	25	hypoechogenicity	hypoechogenicity	NN
cord-005453-4057qib7	6143	26	of	of	IN
cord-005453-4057qib7	6143	27	septa	septa	NNP
cord-005453-4057qib7	6143	28	and/or	and/or	CC
cord-005453-4057qib7	6143	29	hyperechogenicity	hyperechogenicity	NN
cord-005453-4057qib7	6143	30	of	of	IN
cord-005453-4057qib7	6143	31	lobules	lobule	NNS
cord-005453-4057qib7	6143	32	in	in	IN
cord-005453-4057qib7	6143	33	hypodermis	hypodermis	NNP
cord-005453-4057qib7	6143	34	,	,	,
cord-005453-4057qib7	6143	35	hypoechogenic	hypoechogenic	NNP
cord-005453-4057qib7	6143	36	fascia	fascia	NN
cord-005453-4057qib7	6143	37	,	,	,
cord-005453-4057qib7	6143	38	or	or	CC
cord-005453-4057qib7	6143	39	myositis	myositis	NN
cord-005453-4057qib7	6143	40	,	,	,
cord-005453-4057qib7	6143	41	for	for	IN
cord-005453-4057qib7	6143	42	HFUS	HFUS	NNP
cord-005453-4057qib7	6143	43	;	;	:
cord-005453-4057qib7	6143	44	and	and	CC
cord-005453-4057qib7	6143	45	,	,	,
cord-005453-4057qib7	6143	46	vessels	vessel	NNS
cord-005453-4057qib7	6143	47	thicker	thick	JJR
cord-005453-4057qib7	6143	48	than	than	IN
cord-005453-4057qib7	6143	49	1	1	CD
cord-005453-4057qib7	6143	50	mm	mm	NNS
cord-005453-4057qib7	6143	51	in	in	IN
cord-005453-4057qib7	6143	52	dermis	dermis	NN
cord-005453-4057qib7	6143	53	and/or	and/or	CC
cord-005453-4057qib7	6143	54	hypodermis	hypodermis	NNP
cord-005453-4057qib7	6143	55	,	,	,
cord-005453-4057qib7	6143	56	systolic	systolic	JJ
cord-005453-4057qib7	6143	57	pressure	pressure	NN
cord-005453-4057qib7	6143	58	>	>	XX
cord-005453-4057qib7	6143	59	10	10	CD
cord-005453-4057qib7	6143	60	cm	cm	NNS
cord-005453-4057qib7	6143	61	/	/	SYM
cord-005453-4057qib7	6143	62	sec	sec	NNP
cord-005453-4057qib7	6143	63	,	,	,
cord-005453-4057qib7	6143	64	and	and	CC
cord-005453-4057qib7	6143	65	index	index	NN
cord-005453-4057qib7	6143	66	of	of	IN
cord-005453-4057qib7	6143	67	vascular	vascular	JJ
cord-005453-4057qib7	6143	68	resistance	resistance	NN
cord-005453-4057qib7	6143	69	>	>	XX
cord-005453-4057qib7	6143	70	0.75	0.75	CD
cord-005453-4057qib7	6143	71	,	,	,
cord-005453-4057qib7	6143	72	for	for	IN
cord-005453-4057qib7	6143	73	Doppler	Doppler	NNP
cord-005453-4057qib7	6143	74	-	-	HYPH
cord-005453-4057qib7	6143	75	US	US	NNP
cord-005453-4057qib7	6143	76	.	.	.
cord-005453-4057qib7	6144	1	Inflammatory	inflammatory	JJ
cord-005453-4057qib7	6144	2	activity	activity	NN
cord-005453-4057qib7	6144	3	was	be	VBD
cord-005453-4057qib7	6144	4	classified	classify	VBN
cord-005453-4057qib7	6144	5	as	as	IN
cord-005453-4057qib7	6144	6	mild	mild	JJ
cord-005453-4057qib7	6144	7	,	,	,
cord-005453-4057qib7	6144	8	moderate	moderate	JJ
cord-005453-4057qib7	6144	9	and	and	CC
cord-005453-4057qib7	6144	10	severe	severe	JJ
cord-005453-4057qib7	6144	11	according	accord	VBG
cord-005453-4057qib7	6144	12	to	to	IN
cord-005453-4057qib7	6144	13	the	the	DT
cord-005453-4057qib7	6144	14	severity	severity	NN
cord-005453-4057qib7	6144	15	of	of	IN
cord-005453-4057qib7	6144	16	Doppler	Doppler	NNP
cord-005453-4057qib7	6144	17	-	-	HYPH
cord-005453-4057qib7	6144	18	US	US	NNP
cord-005453-4057qib7	6144	19	findings	finding	NNS
cord-005453-4057qib7	6144	20	.	.	.
cord-005453-4057qib7	6145	1	Results	result	NNS
cord-005453-4057qib7	6145	2	:	:	:
cord-005453-4057qib7	6146	1	HFSU	HFSU	NNP
cord-005453-4057qib7	6146	2	showed	show	VBD
cord-005453-4057qib7	6146	3	abnormal	abnormal	JJ
cord-005453-4057qib7	6146	4	findings	finding	NNS
cord-005453-4057qib7	6146	5	in	in	IN
cord-005453-4057qib7	6146	6	all	all	DT
cord-005453-4057qib7	6146	7	patients	patient	NNS
cord-005453-4057qib7	6146	8	at	at	IN
cord-005453-4057qib7	6146	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	6146	10	with	with	IN
cord-005453-4057qib7	6146	11	no	no	DT
cord-005453-4057qib7	6146	12	changes	change	NNS
cord-005453-4057qib7	6146	13	except	except	IN
cord-005453-4057qib7	6146	14	in	in	IN
cord-005453-4057qib7	6146	15	two	two	CD
cord-005453-4057qib7	6146	16	patients	patient	NNS
cord-005453-4057qib7	6146	17	along	along	IN
cord-005453-4057qib7	6146	18	the	the	DT
cord-005453-4057qib7	6146	19	treatment	treatment	NN
cord-005453-4057qib7	6146	20	follow	follow	NN
cord-005453-4057qib7	6146	21	-	-	HYPH
cord-005453-4057qib7	6146	22	up	up	NN
cord-005453-4057qib7	6146	23	.	.	.
cord-005453-4057qib7	6147	1	Inflammatory	inflammatory	JJ
cord-005453-4057qib7	6147	2	activity	activity	NN
cord-005453-4057qib7	6147	3	by	by	IN
cord-005453-4057qib7	6147	4	Doppler	Doppler	NNP
cord-005453-4057qib7	6147	5	-	-	HYPH
cord-005453-4057qib7	6147	6	US	US	NNP
cord-005453-4057qib7	6147	7	was	be	VBD
cord-005453-4057qib7	6147	8	observed	observe	VBN
cord-005453-4057qib7	6147	9	in	in	IN
cord-005453-4057qib7	6147	10	5/6	5/6	CD
cord-005453-4057qib7	6147	11	patients	patient	NNS
cord-005453-4057qib7	6147	12	at	at	IN
cord-005453-4057qib7	6147	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	6147	14	(	(	-LRB-
cord-005453-4057qib7	6147	15	1	1	CD
cord-005453-4057qib7	6147	16	mild	mild	JJ
cord-005453-4057qib7	6147	17	,	,	,
cord-005453-4057qib7	6147	18	3	3	CD
cord-005453-4057qib7	6147	19	moderate	moderate	JJ
cord-005453-4057qib7	6147	20	,	,	,
cord-005453-4057qib7	6147	21	1	1	CD
cord-005453-4057qib7	6147	22	severe	severe	NN
cord-005453-4057qib7	6147	23	)	)	-RRB-
cord-005453-4057qib7	6147	24	.	.	.
cord-005453-4057qib7	6148	1	Four	four	CD
cord-005453-4057qib7	6148	2	patients	patient	NNS
cord-005453-4057qib7	6148	3	responded	respond	VBD
cord-005453-4057qib7	6148	4	to	to	IN
cord-005453-4057qib7	6148	5	treatment	treatment	NN
cord-005453-4057qib7	6148	6	(	(	-LRB-
cord-005453-4057qib7	6148	7	2	2	CD
cord-005453-4057qib7	6148	8	complete	complete	JJ
cord-005453-4057qib7	6148	9	responses	response	NNS
cord-005453-4057qib7	6148	10	,	,	,
cord-005453-4057qib7	6148	11	CR	CR	NNP
cord-005453-4057qib7	6148	12	,	,	,
cord-005453-4057qib7	6148	13	and	and	CC
cord-005453-4057qib7	6148	14	2	2	CD
cord-005453-4057qib7	6148	15	partial	partial	JJ
cord-005453-4057qib7	6148	16	responses	response	NNS
cord-005453-4057qib7	6148	17	,	,	,
cord-005453-4057qib7	6148	18	PR	PR	NNP
cord-005453-4057qib7	6148	19	)	)	-RRB-
cord-005453-4057qib7	6148	20	,	,	,
cord-005453-4057qib7	6148	21	one	one	CD
cord-005453-4057qib7	6148	22	presented	present	VBD
cord-005453-4057qib7	6148	23	clinical	clinical	JJ
cord-005453-4057qib7	6148	24	improvement	improvement	NN
cord-005453-4057qib7	6148	25	less	less	JJR
cord-005453-4057qib7	6148	26	than	than	IN
cord-005453-4057qib7	6148	27	PR	PR	NNP
cord-005453-4057qib7	6148	28	,	,	,
cord-005453-4057qib7	6148	29	and	and	CC
cord-005453-4057qib7	6148	30	one	one	CD
cord-005453-4057qib7	6148	31	,	,	,
cord-005453-4057qib7	6148	32	progressive	progressive	JJ
cord-005453-4057qib7	6148	33	disease	disease	NN
cord-005453-4057qib7	6148	34	.	.	.
cord-005453-4057qib7	6149	1	All	all	DT
cord-005453-4057qib7	6149	2	patients	patient	NNS
cord-005453-4057qib7	6149	3	with	with	IN
cord-005453-4057qib7	6149	4	clinical	clinical	JJ
cord-005453-4057qib7	6149	5	response	response	NN
cord-005453-4057qib7	6149	6	had	have	VBD
cord-005453-4057qib7	6149	7	also	also	RB
cord-005453-4057qib7	6149	8	a	a	DT
cord-005453-4057qib7	6149	9	P	p	NN
cord-005453-4057qib7	6149	10	-	-	HYPH
cord-005453-4057qib7	6149	11	ROM	rom	NN
cord-005453-4057qib7	6149	12	improvement	improvement	NN
cord-005453-4057qib7	6149	13	or	or	CC
cord-005453-4057qib7	6149	14	normalization	normalization	NN
cord-005453-4057qib7	6149	15	.	.	.
cord-005453-4057qib7	6150	1	All	all	DT
cord-005453-4057qib7	6150	2	patients	patient	NNS
cord-005453-4057qib7	6150	3	achieving	achieve	VBG
cord-005453-4057qib7	6150	4	a	a	DT
cord-005453-4057qib7	6150	5	response	response	NN
cord-005453-4057qib7	6150	6	showed	show	VBD
cord-005453-4057qib7	6150	7	normalization	normalization	NN
cord-005453-4057qib7	6150	8	(	(	-LRB-
cord-005453-4057qib7	6150	9	n=2	n=2	NNS
cord-005453-4057qib7	6150	10	)	)	-RRB-
cord-005453-4057qib7	6150	11	or	or	CC
cord-005453-4057qib7	6150	12	improvement	improvement	NN
cord-005453-4057qib7	6150	13	(	(	-LRB-
cord-005453-4057qib7	6150	14	n=2	n=2	NNS
cord-005453-4057qib7	6150	15	)	)	-RRB-
cord-005453-4057qib7	6150	16	of	of	IN
cord-005453-4057qib7	6150	17	Doppler	Doppler	NNP
cord-005453-4057qib7	6150	18	-	-	HYPH
cord-005453-4057qib7	6150	19	US	US	NNP
cord-005453-4057qib7	6150	20	findings	finding	NNS
cord-005453-4057qib7	6150	21	.	.	.
cord-005453-4057qib7	6151	1	The	the	DT
cord-005453-4057qib7	6151	2	patient	patient	NN
cord-005453-4057qib7	6151	3	with	with	IN
cord-005453-4057qib7	6151	4	clinical	clinical	JJ
cord-005453-4057qib7	6151	5	improvement	improvement	NN
cord-005453-4057qib7	6151	6	less	less	JJR
cord-005453-4057qib7	6151	7	than	than	IN
cord-005453-4057qib7	6151	8	PR	PR	NNP
cord-005453-4057qib7	6151	9	and	and	CC
cord-005453-4057qib7	6151	10	the	the	DT
cord-005453-4057qib7	6151	11	patient	patient	NN
cord-005453-4057qib7	6151	12	with	with	IN
cord-005453-4057qib7	6151	13	progressive	progressive	JJ
cord-005453-4057qib7	6151	14	disease	disease	NN
cord-005453-4057qib7	6151	15	showed	show	VBD
cord-005453-4057qib7	6151	16	persistence	persistence	NN
cord-005453-4057qib7	6151	17	of	of	IN
cord-005453-4057qib7	6151	18	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6151	19	Doppler	Doppler	NNP
cord-005453-4057qib7	6151	20	-	-	HYPH
cord-005453-4057qib7	6151	21	US	US	NNP
cord-005453-4057qib7	6151	22	findings	finding	NNS
cord-005453-4057qib7	6151	23	.	.	.
cord-005453-4057qib7	6152	1	Most	Most	JJS
cord-005453-4057qib7	6152	2	patients	patient	NNS
cord-005453-4057qib7	6152	3	had	have	VBD
cord-005453-4057qib7	6152	4	normal	normal	JJ
cord-005453-4057qib7	6152	5	or	or	CC
cord-005453-4057qib7	6152	6	light	light	JJ
cord-005453-4057qib7	6152	7	increase	increase	NN
cord-005453-4057qib7	6152	8	of	of	IN
cord-005453-4057qib7	6152	9	pro	pro	JJ
cord-005453-4057qib7	6152	10	-	-	JJ
cord-005453-4057qib7	6152	11	collagen	collagen	JJ
cord-005453-4057qib7	6152	12	levels	level	NNS
cord-005453-4057qib7	6152	13	at	at	IN
cord-005453-4057qib7	6152	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	6152	15	and	and	CC
cord-005453-4057qib7	6152	16	no	no	DT
cord-005453-4057qib7	6152	17	significant	significant	JJ
cord-005453-4057qib7	6152	18	changes	change	NNS
cord-005453-4057qib7	6152	19	were	be	VBD
cord-005453-4057qib7	6152	20	observed	observe	VBN
cord-005453-4057qib7	6152	21	during	during	IN
cord-005453-4057qib7	6152	22	follow	follow	NN
cord-005453-4057qib7	6152	23	-	-	HYPH
cord-005453-4057qib7	6152	24	up	up	NN
cord-005453-4057qib7	6152	25	.	.	.
cord-005453-4057qib7	6153	1	Levels	level	NNS
cord-005453-4057qib7	6153	2	of	of	IN
cord-005453-4057qib7	6153	3	hyaluronic	hyaluronic	NN
cord-005453-4057qib7	6153	4	acid	acid	NN
cord-005453-4057qib7	6153	5	tended	tend	VBD
cord-005453-4057qib7	6153	6	to	to	TO
cord-005453-4057qib7	6153	7	be	be	VB
cord-005453-4057qib7	6153	8	very	very	RB
cord-005453-4057qib7	6153	9	high	high	JJ
cord-005453-4057qib7	6153	10	in	in	IN
cord-005453-4057qib7	6153	11	patients	patient	NNS
cord-005453-4057qib7	6153	12	with	with	IN
cord-005453-4057qib7	6153	13	progressive	progressive	JJ
cord-005453-4057qib7	6153	14	scGVHD	scGVHD	NNP
cord-005453-4057qib7	6153	15	(	(	-LRB-
cord-005453-4057qib7	6153	16	patients	patient	NNS
cord-005453-4057qib7	6153	17	2	2	CD
cord-005453-4057qib7	6153	18	and	and	CC
cord-005453-4057qib7	6153	19	5	5	CD
cord-005453-4057qib7	6153	20	)	)	-RRB-
cord-005453-4057qib7	6153	21	and	and	CC
cord-005453-4057qib7	6153	22	tended	tend	VBD
cord-005453-4057qib7	6153	23	to	to	TO
cord-005453-4057qib7	6153	24	decrease	decrease	VB
cord-005453-4057qib7	6153	25	or	or	CC
cord-005453-4057qib7	6153	26	normalize	normalize	VB
cord-005453-4057qib7	6153	27	in	in	IN
cord-005453-4057qib7	6153	28	those	those	DT
cord-005453-4057qib7	6153	29	who	who	WP
cord-005453-4057qib7	6153	30	responded	respond	VBD
cord-005453-4057qib7	6153	31	to	to	IN
cord-005453-4057qib7	6153	32	therapy	therapy	NN
cord-005453-4057qib7	6153	33	(	(	-LRB-
cord-005453-4057qib7	6153	34	patients	patient	NNS
cord-005453-4057qib7	6153	35	1	1	CD
cord-005453-4057qib7	6153	36	,	,	,
cord-005453-4057qib7	6153	37	2	2	CD
cord-005453-4057qib7	6153	38	,	,	,
cord-005453-4057qib7	6153	39	and	and	CC
cord-005453-4057qib7	6153	40	3	3	CD
cord-005453-4057qib7	6153	41	)	)	-RRB-
cord-005453-4057qib7	6153	42	.	.	.
cord-005453-4057qib7	6154	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6154	2	:	:	:
cord-005453-4057qib7	6155	1	In	in	IN
cord-005453-4057qib7	6155	2	this	this	DT
cord-005453-4057qib7	6155	3	exploratory	exploratory	JJ
cord-005453-4057qib7	6155	4	study	study	NN
cord-005453-4057qib7	6155	5	,	,	,
cord-005453-4057qib7	6155	6	HFSU	HFSU	NNP
cord-005453-4057qib7	6155	7	was	be	VBD
cord-005453-4057qib7	6155	8	a	a	DT
cord-005453-4057qib7	6155	9	reliable	reliable	JJ
cord-005453-4057qib7	6155	10	method	method	NN
cord-005453-4057qib7	6155	11	for	for	IN
cord-005453-4057qib7	6155	12	evaluating	evaluate	VBG
cord-005453-4057qib7	6155	13	sclerotic	sclerotic	JJ
cord-005453-4057qib7	6155	14	skin	skin	NN
cord-005453-4057qib7	6155	15	changes	change	NNS
cord-005453-4057qib7	6155	16	in	in	IN
cord-005453-4057qib7	6155	17	scGVHD	scgvhd	ADD
cord-005453-4057qib7	6155	18	.	.	.
cord-005453-4057qib7	6156	1	Doppler	Doppler	NNP
cord-005453-4057qib7	6156	2	-	-	HYPH
cord-005453-4057qib7	6156	3	US	US	NNP
cord-005453-4057qib7	6156	4	showed	show	VBD
cord-005453-4057qib7	6156	5	a	a	DT
cord-005453-4057qib7	6156	6	good	good	JJ
cord-005453-4057qib7	6156	7	correlation	correlation	NN
cord-005453-4057qib7	6156	8	with	with	IN
cord-005453-4057qib7	6156	9	disease	disease	NN
cord-005453-4057qib7	6156	10	activity	activity	NN
cord-005453-4057qib7	6156	11	and	and	CC
cord-005453-4057qib7	6156	12	response	response	NN
cord-005453-4057qib7	6156	13	to	to	IN
cord-005453-4057qib7	6156	14	treatment	treatment	NN
cord-005453-4057qib7	6156	15	.	.	.
cord-005453-4057qib7	6157	1	Serum	serum	NN
cord-005453-4057qib7	6157	2	hyaluronic	hyaluronic	NN
cord-005453-4057qib7	6157	3	acid	acid	NN
cord-005453-4057qib7	6157	4	levels	level	NNS
cord-005453-4057qib7	6157	5	might	may	MD
cord-005453-4057qib7	6157	6	be	be	VB
cord-005453-4057qib7	6157	7	a	a	DT
cord-005453-4057qib7	6157	8	biomarker	biomarker	NN
cord-005453-4057qib7	6157	9	of	of	IN
cord-005453-4057qib7	6157	10	disease	disease	NN
cord-005453-4057qib7	6157	11	activity	activity	NN
cord-005453-4057qib7	6157	12	that	that	WDT
cord-005453-4057qib7	6157	13	deserves	deserve	VBZ
cord-005453-4057qib7	6157	14	further	further	JJ
cord-005453-4057qib7	6157	15	investigation	investigation	NN
cord-005453-4057qib7	6157	16	.	.	.
cord-005453-4057qib7	6158	1	HFSU	HFSU	NNP
cord-005453-4057qib7	6158	2	plus	plus	CC
cord-005453-4057qib7	6158	3	Doppler	Doppler	NNP
cord-005453-4057qib7	6158	4	-	-	HYPH
cord-005453-4057qib7	6158	5	US	US	NNP
cord-005453-4057qib7	6158	6	is	be	VBZ
cord-005453-4057qib7	6158	7	a	a	DT
cord-005453-4057qib7	6158	8	useful	useful	JJ
cord-005453-4057qib7	6158	9	,	,	,
cord-005453-4057qib7	6158	10	non	non	JJ
cord-005453-4057qib7	6158	11	-	-	JJ
cord-005453-4057qib7	6158	12	invasive	invasive	JJ
cord-005453-4057qib7	6158	13	,	,	,
cord-005453-4057qib7	6158	14	repeatable	repeatable	JJ
cord-005453-4057qib7	6158	15	device	device	NN
cord-005453-4057qib7	6158	16	in	in	IN
cord-005453-4057qib7	6158	17	monitoring	monitor	VBG
cord-005453-4057qib7	6158	18	patients	patient	NNS
cord-005453-4057qib7	6158	19	suffering	suffer	VBG
cord-005453-4057qib7	6158	20	from	from	IN
cord-005453-4057qib7	6158	21	scGVHD	scgvhd	ADD
cord-005453-4057qib7	6158	22	.	.	.
cord-005453-4057qib7	6159	1	According	accord	VBG
cord-005453-4057qib7	6159	2	to	to	IN
cord-005453-4057qib7	6159	3	our	-PRON-	PRP$
cord-005453-4057qib7	6159	4	results	result	NNS
cord-005453-4057qib7	6159	5	,	,	,
cord-005453-4057qib7	6159	6	Doppler	Doppler	NNP
cord-005453-4057qib7	6159	7	-	-	HYPH
cord-005453-4057qib7	6159	8	US	US	NNP
cord-005453-4057qib7	6159	9	may	may	MD
cord-005453-4057qib7	6159	10	be	be	VB
cord-005453-4057qib7	6159	11	a	a	DT
cord-005453-4057qib7	6159	12	more	more	RBR
cord-005453-4057qib7	6159	13	sensitive	sensitive	JJ
cord-005453-4057qib7	6159	14	parameter	parameter	NN
cord-005453-4057qib7	6159	15	than	than	IN
cord-005453-4057qib7	6159	16	HFSU	HFSU	NNP
cord-005453-4057qib7	6159	17	in	in	IN
cord-005453-4057qib7	6159	18	assessment	assessment	NN
cord-005453-4057qib7	6159	19	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6159	20	activity	activity	NN
cord-005453-4057qib7	6159	21	of	of	IN
cord-005453-4057qib7	6159	22	scGVHD	scgvhd	ADD
cord-005453-4057qib7	6159	23	.	.	.
cord-005453-4057qib7	6160	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6160	2	:	:	:
cord-005453-4057qib7	6161	1	María	María	NNP
cord-005453-4057qib7	6161	2	Suárez	Suárez	NNP
cord-005453-4057qib7	6161	3	-	-	HYPH
cord-005453-4057qib7	6161	4	Lledó	Lledó	NNP
cord-005453-4057qib7	6161	5	received	receive	VBD
cord-005453-4057qib7	6161	6	a	a	DT
cord-005453-4057qib7	6161	7	grant	grant	NN
cord-005453-4057qib7	6161	8	from	from	IN
cord-005453-4057qib7	6161	9	DKMS	DKMS	NNP
cord-005453-4057qib7	6161	10	-	-	HYPH
cord-005453-4057qib7	6161	11	Spain	Spain	NNP
cord-005453-4057qib7	6161	12	Foundation	Foundation	NNP
cord-005453-4057qib7	6161	13	.	.	.
cord-005453-4057qib7	6162	1	Other	other	JJ
cord-005453-4057qib7	6162	2	authors	author	NNS
cord-005453-4057qib7	6162	3	have	have	VBP
cord-005453-4057qib7	6162	4	Nothing	nothing	NN
cord-005453-4057qib7	6162	5	to	to	TO
cord-005453-4057qib7	6162	6	declare	declare	VB
cord-005453-4057qib7	6162	7	Post	Post	NNP
cord-005453-4057qib7	6162	8	-	-	JJ
cord-005453-4057qib7	6162	9	transplant	transplant	NN
cord-005453-4057qib7	6162	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	6162	11	versus	versus	IN
cord-005453-4057qib7	6162	12	antithymocyte	antithymocyte	NN
cord-005453-4057qib7	6162	13	-	-	HYPH
cord-005453-4057qib7	6162	14	globulin	globulin	NN
cord-005453-4057qib7	6162	15	in	in	IN
cord-005453-4057qib7	6162	16	HLA	HLA	NNP
cord-005453-4057qib7	6162	17	-	-	HYPH
cord-005453-4057qib7	6162	18	matched	match	VBN
cord-005453-4057qib7	6162	19	unrelated	unrelated	JJ
cord-005453-4057qib7	6162	20	and	and	CC
cord-005453-4057qib7	6162	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6162	22	transplantation	transplantation	NN
cord-005453-4057qib7	6162	23	for	for	IN
cord-005453-4057qib7	6162	24	hematologic	hematologic	JJ
cord-005453-4057qib7	6162	25	malignancies	malignancy	NNS
cord-005453-4057qib7	6162	26	Background	background	NN
cord-005453-4057qib7	6162	27	:	:	:
cord-005453-4057qib7	6162	28	Post	post	JJ
cord-005453-4057qib7	6162	29	-	-	NN
cord-005453-4057qib7	6162	30	transplant	transplant	NN
cord-005453-4057qib7	6162	31	cyclophosphamide(PTCy	cyclophosphamide(ptcy	NN
cord-005453-4057qib7	6162	32	)	)	-RRB-
cord-005453-4057qib7	6162	33	and	and	CC
cord-005453-4057qib7	6162	34	antithymocyte	antithymocyte	RB
cord-005453-4057qib7	6162	35	-	-	HYPH
cord-005453-4057qib7	6162	36	globulin(ATG	globulin(ATG	NNP
cord-005453-4057qib7	6162	37	)	)	-RRB-
cord-005453-4057qib7	6162	38	are	be	VBP
cord-005453-4057qib7	6162	39	the	the	DT
cord-005453-4057qib7	6162	40	most	most	RBS
cord-005453-4057qib7	6162	41	commonly	commonly	RB
cord-005453-4057qib7	6162	42	used	use	VBN
cord-005453-4057qib7	6162	43	regimens	regimen	NNS
cord-005453-4057qib7	6162	44	for	for	IN
cord-005453-4057qib7	6162	45	the	the	DT
cord-005453-4057qib7	6162	46	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6162	47	of	of	IN
cord-005453-4057qib7	6162	48	graft	graft	NN
cord-005453-4057qib7	6162	49	-	-	HYPH
cord-005453-4057qib7	6162	50	versus	versus	NN
cord-005453-4057qib7	6162	51	host	host	NN
cord-005453-4057qib7	6162	52	disease(GVHD	disease(gvhd	ADD
cord-005453-4057qib7	6162	53	)	)	-RRB-
cord-005453-4057qib7	6162	54	.	.	.
cord-005453-4057qib7	6163	1	We	-PRON-	PRP
cord-005453-4057qib7	6163	2	compared	compare	VBD
cord-005453-4057qib7	6163	3	these	these	DT
cord-005453-4057qib7	6163	4	two	two	CD
cord-005453-4057qib7	6163	5	regimens	regimen	NNS
cord-005453-4057qib7	6163	6	in	in	IN
cord-005453-4057qib7	6163	7	HLAmatched	hlamatched	JJ
cord-005453-4057qib7	6163	8	unrelated	unrelated	JJ
cord-005453-4057qib7	6163	9	(	(	-LRB-
cord-005453-4057qib7	6163	10	MUD	mud	NN
cord-005453-4057qib7	6163	11	)	)	-RRB-
cord-005453-4057qib7	6163	12	and	and	CC
cord-005453-4057qib7	6163	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6163	14	transplantation	transplantation	NN
cord-005453-4057qib7	6163	15	for	for	IN
cord-005453-4057qib7	6163	16	hematologic	hematologic	JJ
cord-005453-4057qib7	6163	17	malignancies	malignancy	NNS
cord-005453-4057qib7	6163	18	.	.	.
cord-005453-4057qib7	6164	1	Methods	method	NNS
cord-005453-4057qib7	6164	2	:	:	:
cord-005453-4057qib7	6164	3	We	-PRON-	PRP
cord-005453-4057qib7	6164	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	6164	5	analyzed	analyze	VBD
cord-005453-4057qib7	6164	6	the	the	DT
cord-005453-4057qib7	6164	7	consecutive	consecutive	JJ
cord-005453-4057qib7	6164	8	adult	adult	NN
cord-005453-4057qib7	6164	9	patients	patient	NNS
cord-005453-4057qib7	6164	10	with	with	IN
cord-005453-4057qib7	6164	11	hematologic	hematologic	JJ
cord-005453-4057qib7	6164	12	malignancies	malignancy	NNS
cord-005453-4057qib7	6164	13	who	who	WP
cord-005453-4057qib7	6164	14	received	receive	VBD
cord-005453-4057qib7	6164	15	MUD	MUD	NNP
cord-005453-4057qib7	6164	16	and	and	CC
cord-005453-4057qib7	6164	17	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6164	18	transplantation	transplantation	NN
cord-005453-4057qib7	6164	19	at	at	IN
cord-005453-4057qib7	6164	20	Chungnam	Chungnam	NNP
cord-005453-4057qib7	6164	21	National	National	NNP
cord-005453-4057qib7	6164	22	University	University	NNP
cord-005453-4057qib7	6164	23	Hospital	Hospital	NNP
cord-005453-4057qib7	6164	24	between	between	IN
cord-005453-4057qib7	6164	25	January	January	NNP
cord-005453-4057qib7	6164	26	2013	2013	CD
cord-005453-4057qib7	6164	27	and	and	CC
cord-005453-4057qib7	6164	28	January	January	NNP
cord-005453-4057qib7	6164	29	2018	2018	CD
cord-005453-4057qib7	6164	30	.	.	.
cord-005453-4057qib7	6165	1	Patients	patient	NNS
cord-005453-4057qib7	6165	2	who	who	WP
cord-005453-4057qib7	6165	3	received	receive	VBD
cord-005453-4057qib7	6165	4	second	second	JJ
cord-005453-4057qib7	6165	5	transplantation	transplantation	NN
cord-005453-4057qib7	6165	6	and	and	CC
cord-005453-4057qib7	6165	7	had	have	VBD
cord-005453-4057qib7	6165	8	refractory	refractory	JJ
cord-005453-4057qib7	6165	9	disease	disease	NN
cord-005453-4057qib7	6165	10	were	be	VBD
cord-005453-4057qib7	6165	11	excluded	exclude	VBN
cord-005453-4057qib7	6165	12	.	.	.
cord-005453-4057qib7	6166	1	Results	result	NNS
cord-005453-4057qib7	6166	2	:	:	:
cord-005453-4057qib7	6167	1	This	this	DT
cord-005453-4057qib7	6167	2	study	study	NN
cord-005453-4057qib7	6167	3	included	include	VBD
cord-005453-4057qib7	6167	4	45	45	CD
cord-005453-4057qib7	6167	5	patients	patient	NNS
cord-005453-4057qib7	6167	6	with	with	IN
cord-005453-4057qib7	6167	7	median	median	JJ
cord-005453-4057qib7	6167	8	age	age	NN
cord-005453-4057qib7	6167	9	of	of	IN
cord-005453-4057qib7	6167	10	54	54	CD
cord-005453-4057qib7	6168	1	(	(	-LRB-
cord-005453-4057qib7	6168	2	range	range	NN
cord-005453-4057qib7	6168	3	,	,	,
cord-005453-4057qib7	6168	4	18	18	CD
cord-005453-4057qib7	6168	5	-	-	SYM
cord-005453-4057qib7	6168	6	71	71	CD
cord-005453-4057qib7	6168	7	)	)	-RRB-
cord-005453-4057qib7	6168	8	years	year	NNS
cord-005453-4057qib7	6168	9	:	:	:
cord-005453-4057qib7	6168	10	29	29	CD
cord-005453-4057qib7	6168	11	(	(	-LRB-
cord-005453-4057qib7	6168	12	64.4	64.4	CD
cord-005453-4057qib7	6168	13	%	%	NN
cord-005453-4057qib7	6168	14	)	)	-RRB-
cord-005453-4057qib7	6169	1	patients	patient	NNS
cord-005453-4057qib7	6169	2	received	receive	VBD
cord-005453-4057qib7	6169	3	MUD	mud	NN
cord-005453-4057qib7	6169	4	transplant	transplant	NN
cord-005453-4057qib7	6169	5	(	(	-LRB-
cord-005453-4057qib7	6169	6	8	8	CD
cord-005453-4057qib7	6169	7	and	and	CC
cord-005453-4057qib7	6169	8	21	21	CD
cord-005453-4057qib7	6169	9	patients	patient	NNS
cord-005453-4057qib7	6169	10	in	in	IN
cord-005453-4057qib7	6169	11	PTCy	PTCy	NNS
cord-005453-4057qib7	6169	12	and	and	CC
cord-005453-4057qib7	6169	13	ATG	ATG	NNP
cord-005453-4057qib7	6169	14	group	group	NN
cord-005453-4057qib7	6169	15	,	,	,
cord-005453-4057qib7	6169	16	respectively	respectively	RB
cord-005453-4057qib7	6169	17	)	)	-RRB-
cord-005453-4057qib7	6169	18	,	,	,
cord-005453-4057qib7	6169	19	and	and	CC
cord-005453-4057qib7	6169	20	16	16	CD
cord-005453-4057qib7	6169	21	(	(	-LRB-
cord-005453-4057qib7	6169	22	35.6	35.6	CD
cord-005453-4057qib7	6169	23	%	%	NN
cord-005453-4057qib7	6169	24	)	)	-RRB-
cord-005453-4057qib7	6170	1	patients	patient	NNS
cord-005453-4057qib7	6170	2	received	receive	VBD
cord-005453-4057qib7	6170	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6170	4	transplant	transplant	NN
cord-005453-4057qib7	6170	5	(	(	-LRB-
cord-005453-4057qib7	6170	6	11	11	CD
cord-005453-4057qib7	6170	7	and	and	CC
cord-005453-4057qib7	6170	8	5	5	CD
cord-005453-4057qib7	6170	9	patients	patient	NNS
cord-005453-4057qib7	6170	10	in	in	IN
cord-005453-4057qib7	6170	11	PTCy	PTCy	NNS
cord-005453-4057qib7	6170	12	and	and	CC
cord-005453-4057qib7	6170	13	ATG	ATG	NNP
cord-005453-4057qib7	6170	14	group	group	NN
cord-005453-4057qib7	6170	15	)	)	-RRB-
cord-005453-4057qib7	6170	16	.	.	.
cord-005453-4057qib7	6171	1	Graft	graft	NN
cord-005453-4057qib7	6171	2	source	source	NN
cord-005453-4057qib7	6171	3	was	be	VBD
cord-005453-4057qib7	6171	4	peripheral	peripheral	JJ
cord-005453-4057qib7	6171	5	blood	blood	NN
cord-005453-4057qib7	6171	6	stem	stem	NN
cord-005453-4057qib7	6171	7	cell	cell	NN
cord-005453-4057qib7	6171	8	in	in	IN
cord-005453-4057qib7	6171	9	all	all	DT
cord-005453-4057qib7	6171	10	patients	patient	NNS
cord-005453-4057qib7	6171	11	.	.	.
cord-005453-4057qib7	6172	1	Median	median	JJ
cord-005453-4057qib7	6172	2	follow	follow	NN
cord-005453-4057qib7	6172	3	-	-	HYPH
cord-005453-4057qib7	6172	4	up	up	RP
cord-005453-4057qib7	6172	5	duration	duration	NN
cord-005453-4057qib7	6172	6	was	be	VBD
cord-005453-4057qib7	6172	7	15.5	15.5	CD
cord-005453-4057qib7	6172	8	months	month	NNS
cord-005453-4057qib7	6173	1	(	(	-LRB-
cord-005453-4057qib7	6173	2	range	range	NN
cord-005453-4057qib7	6173	3	,	,	,
cord-005453-4057qib7	6173	4	0.5	0.5	CD
cord-005453-4057qib7	6173	5	-	-	HYPH
cord-005453-4057qib7	6173	6	58.0	58.0	CD
cord-005453-4057qib7	6173	7	)	)	-RRB-
cord-005453-4057qib7	6173	8	.	.	.
cord-005453-4057qib7	6174	1	In	in	IN
cord-005453-4057qib7	6174	2	MUD	mud	NN
cord-005453-4057qib7	6174	3	transplant	transplant	NN
cord-005453-4057qib7	6174	4	,	,	,
cord-005453-4057qib7	6174	5	the	the	DT
cord-005453-4057qib7	6174	6	estimated	estimate	VBN
cord-005453-4057qib7	6174	7	20-months	20-months	CD
cord-005453-4057qib7	6174	8	survival	survival	NN
cord-005453-4057qib7	6174	9	rate	rate	NN
cord-005453-4057qib7	6174	10	were	be	VBD
cord-005453-4057qib7	6174	11	85.7	85.7	CD
cord-005453-4057qib7	6174	12	%	%	NN
cord-005453-4057qib7	6174	13	in	in	IN
cord-005453-4057qib7	6174	14	PTCy	PTCy	NNS
cord-005453-4057qib7	6174	15	vs.	vs.	CC
cord-005453-4057qib7	6174	16	80.7	80.7	CD
cord-005453-4057qib7	6174	17	%	%	NN
cord-005453-4057qib7	6174	18	in	in	IN
cord-005453-4057qib7	6174	19	ATG	ATG	NNP
cord-005453-4057qib7	6174	20	(	(	-LRB-
cord-005453-4057qib7	6174	21	p=0.835	p=0.835	NNP
cord-005453-4057qib7	6174	22	)	)	-RRB-
cord-005453-4057qib7	6174	23	,	,	,
cord-005453-4057qib7	6174	24	the	the	DT
cord-005453-4057qib7	6174	25	20-months	20-months	CD
cord-005453-4057qib7	6174	26	relapse	relapse	NN
cord-005453-4057qib7	6174	27	rate	rate	NN
cord-005453-4057qib7	6174	28	were	be	VBD
cord-005453-4057qib7	6174	29	37.5	37.5	CD
cord-005453-4057qib7	6174	30	%	%	NN
cord-005453-4057qib7	6174	31	in	in	IN
cord-005453-4057qib7	6174	32	PTCy	PTCy	NNS
cord-005453-4057qib7	6174	33	vs.	vs.	CC
cord-005453-4057qib7	6174	34	35.0	35.0	CD
cord-005453-4057qib7	6174	35	%	%	NN
cord-005453-4057qib7	6174	36	in	in	IN
cord-005453-4057qib7	6174	37	ATG	ATG	NNP
cord-005453-4057qib7	6174	38	(	(	-LRB-
cord-005453-4057qib7	6174	39	p=0.663	p=0.663	NNP
cord-005453-4057qib7	6174	40	)	)	-RRB-
cord-005453-4057qib7	6174	41	,	,	,
cord-005453-4057qib7	6174	42	the	the	DT
cord-005453-4057qib7	6174	43	cumulative	cumulative	JJ
cord-005453-4057qib7	6174	44	incidence	incidence	NN
cord-005453-4057qib7	6174	45	of	of	IN
cord-005453-4057qib7	6174	46	grade	grade	NN
cord-005453-4057qib7	6174	47	2	2	CD
cord-005453-4057qib7	6174	48	to	to	TO
cord-005453-4057qib7	6174	49	4	4	CD
cord-005453-4057qib7	6174	50	acute	acute	JJ
cord-005453-4057qib7	6174	51	GVHD	GVHD	NNP
cord-005453-4057qib7	6174	52	were	be	VBD
cord-005453-4057qib7	6174	53	25.0	25.0	CD
cord-005453-4057qib7	6174	54	%	%	NN
cord-005453-4057qib7	6174	55	in	in	IN
cord-005453-4057qib7	6174	56	PTCy	PTCy	NNS
cord-005453-4057qib7	6174	57	vs.	vs.	CC
cord-005453-4057qib7	6174	58	22.2	22.2	CD
cord-005453-4057qib7	6174	59	%	%	NN
cord-005453-4057qib7	6174	60	in	in	IN
cord-005453-4057qib7	6174	61	ATG	ATG	NNP
cord-005453-4057qib7	6174	62	(	(	-LRB-
cord-005453-4057qib7	6174	63	p=0.706	p=0.706	NNP
cord-005453-4057qib7	6174	64	)	)	-RRB-
cord-005453-4057qib7	6174	65	,	,	,
cord-005453-4057qib7	6174	66	and	and	CC
cord-005453-4057qib7	6174	67	the	the	DT
cord-005453-4057qib7	6174	68	estimated	estimate	VBN
cord-005453-4057qib7	6174	69	20-month	20-month	JJ
cord-005453-4057qib7	6174	70	extensive	extensive	JJ
cord-005453-4057qib7	6174	71	chronic	chronic	JJ
cord-005453-4057qib7	6174	72	GVHD	GVHD	NNP
cord-005453-4057qib7	6174	73	rate	rate	NN
cord-005453-4057qib7	6174	74	were	be	VBD
cord-005453-4057qib7	6174	75	25.0	25.0	CD
cord-005453-4057qib7	6174	76	%	%	NN
cord-005453-4057qib7	6174	77	in	in	IN
cord-005453-4057qib7	6174	78	PTCy	PTCy	NNS
cord-005453-4057qib7	6174	79	vs.	vs.	CC
cord-005453-4057qib7	6174	80	16.7	16.7	CD
cord-005453-4057qib7	6174	81	%	%	NN
cord-005453-4057qib7	6174	82	in	in	IN
cord-005453-4057qib7	6174	83	ATG	ATG	NNP
cord-005453-4057qib7	6174	84	(	(	-LRB-
cord-005453-4057qib7	6174	85	p=0.902	p=0.902	NNP
cord-005453-4057qib7	6174	86	)	)	-RRB-
cord-005453-4057qib7	6174	87	.	.	.
cord-005453-4057qib7	6175	1	In	in	IN
cord-005453-4057qib7	6175	2	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6175	3	transplant	transplant	NN
cord-005453-4057qib7	6175	4	,	,	,
cord-005453-4057qib7	6175	5	the	the	DT
cord-005453-4057qib7	6175	6	estimated	estimate	VBN
cord-005453-4057qib7	6175	7	20-months	20-months	CD
cord-005453-4057qib7	6175	8	survival	survival	NN
cord-005453-4057qib7	6175	9	rate	rate	NN
cord-005453-4057qib7	6175	10	were	be	VBD
cord-005453-4057qib7	6175	11	55.4	55.4	CD
cord-005453-4057qib7	6175	12	%	%	NN
cord-005453-4057qib7	6175	13	in	in	IN
cord-005453-4057qib7	6175	14	PTCy	PTCy	NNS
cord-005453-4057qib7	6175	15	vs.	vs.	IN
cord-005453-4057qib7	6175	16	40.0	40.0	CD
cord-005453-4057qib7	6175	17	%	%	NN
cord-005453-4057qib7	6175	18	in	in	IN
cord-005453-4057qib7	6175	19	ATG	ATG	NNP
cord-005453-4057qib7	6175	20	(	(	-LRB-
cord-005453-4057qib7	6175	21	p=0.936	p=0.936	NNP
cord-005453-4057qib7	6175	22	)	)	-RRB-
cord-005453-4057qib7	6175	23	,	,	,
cord-005453-4057qib7	6175	24	the	the	DT
cord-005453-4057qib7	6175	25	20-months	20-months	CD
cord-005453-4057qib7	6175	26	relapse	relapse	NN
cord-005453-4057qib7	6175	27	rate	rate	NN
cord-005453-4057qib7	6175	28	were	be	VBD
cord-005453-4057qib7	6175	29	42.9	42.9	CD
cord-005453-4057qib7	6175	30	%	%	NN
cord-005453-4057qib7	6175	31	in	in	IN
cord-005453-4057qib7	6175	32	PTCy	PTCy	NNS
cord-005453-4057qib7	6175	33	vs.	vs.	CC
cord-005453-4057qib7	6175	34	33.3	33.3	CD
cord-005453-4057qib7	6175	35	%	%	NN
cord-005453-4057qib7	6175	36	in	in	IN
cord-005453-4057qib7	6175	37	ATG	ATG	NNP
cord-005453-4057qib7	6175	38	(	(	-LRB-
cord-005453-4057qib7	6175	39	p=0.328	p=0.328	NNP
cord-005453-4057qib7	6175	40	)	)	-RRB-
cord-005453-4057qib7	6175	41	,	,	,
cord-005453-4057qib7	6175	42	the	the	DT
cord-005453-4057qib7	6175	43	cumulative	cumulative	JJ
cord-005453-4057qib7	6175	44	incidence	incidence	NN
cord-005453-4057qib7	6175	45	of	of	IN
cord-005453-4057qib7	6175	46	grade	grade	NN
cord-005453-4057qib7	6175	47	3	3	CD
cord-005453-4057qib7	6175	48	to	to	TO
cord-005453-4057qib7	6175	49	4	4	CD
cord-005453-4057qib7	6175	50	acute	acute	JJ
cord-005453-4057qib7	6175	51	GVHD	GVHD	NNP
cord-005453-4057qib7	6175	52	rate	rate	NN
cord-005453-4057qib7	6175	53	were	be	VBD
cord-005453-4057qib7	6175	54	29.9	29.9	CD
cord-005453-4057qib7	6175	55	%	%	NN
cord-005453-4057qib7	6175	56	in	in	IN
cord-005453-4057qib7	6175	57	PTCy	PTCy	NNS
cord-005453-4057qib7	6175	58	vs.	vs.	CC
cord-005453-4057qib7	6175	59	33.3	33.3	CD
cord-005453-4057qib7	6175	60	%	%	NN
cord-005453-4057qib7	6175	61	in	in	IN
cord-005453-4057qib7	6175	62	ATG	ATG	NNP
cord-005453-4057qib7	6175	63	(	(	-LRB-
cord-005453-4057qib7	6175	64	p=0.686	p=0.686	NNP
cord-005453-4057qib7	6175	65	)	)	-RRB-
cord-005453-4057qib7	6175	66	,	,	,
cord-005453-4057qib7	6175	67	and	and	CC
cord-005453-4057qib7	6175	68	the	the	DT
cord-005453-4057qib7	6175	69	estimated	estimate	VBN
cord-005453-4057qib7	6175	70	12	12	CD
cord-005453-4057qib7	6175	71	month	month	NN
cord-005453-4057qib7	6175	72	extensive	extensive	JJ
cord-005453-4057qib7	6175	73	chronic	chronic	JJ
cord-005453-4057qib7	6175	74	GVHD	GVHD	NNP
cord-005453-4057qib7	6175	75	rate	rate	NN
cord-005453-4057qib7	6175	76	were	be	VBD
cord-005453-4057qib7	6175	77	25.0	25.0	CD
cord-005453-4057qib7	6175	78	%	%	NN
cord-005453-4057qib7	6175	79	in	in	IN
cord-005453-4057qib7	6175	80	PTCy	PTCy	NNS
cord-005453-4057qib7	6175	81	vs.	vs.	IN
cord-005453-4057qib7	6175	82	50.0	50.0	CD
cord-005453-4057qib7	6175	83	%	%	NN
cord-005453-4057qib7	6175	84	in	in	IN
cord-005453-4057qib7	6175	85	ATG	ATG	NNP
cord-005453-4057qib7	6175	86	(	(	-LRB-
cord-005453-4057qib7	6175	87	p=0.575	p=0.575	VBG
cord-005453-4057qib7	6175	88	)	)	-RRB-
cord-005453-4057qib7	6175	89	.	.	.
cord-005453-4057qib7	6176	1	Patients	patient	NNS
cord-005453-4057qib7	6176	2	receiving	receive	VBG
cord-005453-4057qib7	6176	3	PTCy	PTCy	NNS
cord-005453-4057qib7	6176	4	had	have	VBD
cord-005453-4057qib7	6176	5	significantly	significantly	RB
cord-005453-4057qib7	6176	6	longer	long	JJR
cord-005453-4057qib7	6176	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	6176	8	engraftment	engraftment	NN
cord-005453-4057qib7	6176	9	time	time	NN
cord-005453-4057qib7	6176	10	than	than	IN
cord-005453-4057qib7	6176	11	those	those	DT
cord-005453-4057qib7	6176	12	receiving	receive	VBG
cord-005453-4057qib7	6176	13	ATG	ATG	NNP
cord-005453-4057qib7	6176	14	in	in	IN
cord-005453-4057qib7	6176	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6176	16	transplant	transplant	NN
cord-005453-4057qib7	6176	17	[	[	-LRB-
cord-005453-4057qib7	6176	18	median(range	median(range	NN
cord-005453-4057qib7	6176	19	)	)	-RRB-
cord-005453-4057qib7	6177	1	;	;	:
cord-005453-4057qib7	6177	2	17.0(14.0	17.0(14.0	NNP
cord-005453-4057qib7	6177	3	-	-	HYPH
cord-005453-4057qib7	6177	4	21.0	21.0	CD
cord-005453-4057qib7	6177	5	)	)	-RRB-
cord-005453-4057qib7	6177	6	days	day	NNS
cord-005453-4057qib7	6177	7	vs.	vs.	IN
cord-005453-4057qib7	6177	8	14.0(13.0	14.0(13.0	NNP
cord-005453-4057qib7	6177	9	-	-	HYPH
cord-005453-4057qib7	6177	10	16.0	16.0	CD
cord-005453-4057qib7	6177	11	)	)	-RRB-
cord-005453-4057qib7	6177	12	days	day	NNS
cord-005453-4057qib7	6177	13	,	,	,
cord-005453-4057qib7	6177	14	p=0.005	p=0.005	NNP
cord-005453-4057qib7	6177	15	]	]	-RRB-
cord-005453-4057qib7	6177	16	.	.	.
cord-005453-4057qib7	6178	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6178	2	:	:	:
cord-005453-4057qib7	6179	1	PTCy	PTCy	NNS
cord-005453-4057qib7	6179	2	might	may	MD
cord-005453-4057qib7	6179	3	be	be	VB
cord-005453-4057qib7	6179	4	a	a	DT
cord-005453-4057qib7	6179	5	good	good	JJ
cord-005453-4057qib7	6179	6	option	option	NN
cord-005453-4057qib7	6179	7	for	for	IN
cord-005453-4057qib7	6179	8	the	the	DT
cord-005453-4057qib7	6179	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6179	10	of	of	IN
cord-005453-4057qib7	6179	11	GVHD	GVHD	NNP
cord-005453-4057qib7	6179	12	in	in	IN
cord-005453-4057qib7	6179	13	HLA	HLA	NNP
cord-005453-4057qib7	6179	14	-	-	HYPH
cord-005453-4057qib7	6179	15	matched	match	VBN
cord-005453-4057qib7	6179	16	unrelated	unrelated	JJ
cord-005453-4057qib7	6179	17	transplant	transplant	NN
cord-005453-4057qib7	6179	18	as	as	RB
cord-005453-4057qib7	6179	19	well	well	RB
cord-005453-4057qib7	6179	20	as	as	IN
cord-005453-4057qib7	6179	21	haplo	haplo	NN
cord-005453-4057qib7	6179	22	-	-	HYPH
cord-005453-4057qib7	6179	23	identical	identical	JJ
cord-005453-4057qib7	6179	24	transplant	transplant	NN
cord-005453-4057qib7	6179	25	.	.	.
cord-005453-4057qib7	6180	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6180	2	:	:	:
cord-005453-4057qib7	6180	3	Nothing	nothing	NN
cord-005453-4057qib7	6180	4	to	to	TO
cord-005453-4057qib7	6180	5	declare	declare	VB
cord-005453-4057qib7	6180	6	Early	early	JJ
cord-005453-4057qib7	6180	7	fam	fam	JJ
cord-005453-4057qib7	6180	8	therapy	therapy	NN
cord-005453-4057qib7	6180	9	for	for	IN
cord-005453-4057qib7	6180	10	post	post	FW
cord-005453-4057qib7	6180	11	allo	allo	NNP
cord-005453-4057qib7	6180	12	-	-	HYPH
cord-005453-4057qib7	6180	13	HSCT	HSCT	NNP
cord-005453-4057qib7	6180	14	bronchiolitis	bronchiolitis	NN
cord-005453-4057qib7	6180	15	obliterans	obliterans	NNP
cord-005453-4057qib7	6181	1	syndrome	syndrome	NN
cord-005453-4057qib7	6181	2	Background	Background	NNP
cord-005453-4057qib7	6181	3	:	:	:
cord-005453-4057qib7	6182	1	bronchiolitis	bronchiolitis	NNP
cord-005453-4057qib7	6182	2	obliterans	obliterans	NNP
cord-005453-4057qib7	6182	3	syndrome	syndrome	NNP
cord-005453-4057qib7	6182	4	(	(	-LRB-
cord-005453-4057qib7	6182	5	BOS	BOS	NNP
cord-005453-4057qib7	6182	6	)	)	-RRB-
cord-005453-4057qib7	6182	7	is	be	VBZ
cord-005453-4057qib7	6182	8	a	a	DT
cord-005453-4057qib7	6182	9	potential	potential	JJ
cord-005453-4057qib7	6182	10	major	major	JJ
cord-005453-4057qib7	6182	11	complication	complication	NN
cord-005453-4057qib7	6182	12	after	after	IN
cord-005453-4057qib7	6182	13	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6182	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6182	15	stem	stem	NN
cord-005453-4057qib7	6182	16	cell	cell	NN
cord-005453-4057qib7	6182	17	transplantation	transplantation	NN
cord-005453-4057qib7	6182	18	(	(	-LRB-
cord-005453-4057qib7	6182	19	HSCT	HSCT	NNP
cord-005453-4057qib7	6182	20	)	)	-RRB-
cord-005453-4057qib7	6182	21	.	.	.
cord-005453-4057qib7	6183	1	Attributed	attribute	VBN
cord-005453-4057qib7	6183	2	to	to	IN
cord-005453-4057qib7	6183	3	an	an	DT
cord-005453-4057qib7	6183	4	allo	allo	NN
cord-005453-4057qib7	6183	5	-	-	HYPH
cord-005453-4057qib7	6183	6	immune	immune	JJ
cord-005453-4057qib7	6183	7	reaction	reaction	NN
cord-005453-4057qib7	6183	8	against	against	IN
cord-005453-4057qib7	6183	9	the	the	DT
cord-005453-4057qib7	6183	10	small	small	JJ
cord-005453-4057qib7	6183	11	airways	airway	NNS
cord-005453-4057qib7	6183	12	,	,	,
cord-005453-4057qib7	6183	13	BO	BO	NNP
cord-005453-4057qib7	6183	14	is	be	VBZ
cord-005453-4057qib7	6183	15	considered	consider	VBN
cord-005453-4057qib7	6183	16	a	a	DT
cord-005453-4057qib7	6183	17	pulmonary	pulmonary	JJ
cord-005453-4057qib7	6183	18	manifestation	manifestation	NN
cord-005453-4057qib7	6183	19	of	of	IN
cord-005453-4057qib7	6183	20	chronic	chronic	JJ
cord-005453-4057qib7	6183	21	GVHD	GVHD	NNP
cord-005453-4057qib7	6183	22	.	.	.
cord-005453-4057qib7	6184	1	Reported	report	VBN
cord-005453-4057qib7	6184	2	incidence	incidence	NN
cord-005453-4057qib7	6184	3	of	of	IN
cord-005453-4057qib7	6184	4	BOS	BOS	NNP
cord-005453-4057qib7	6184	5	ranges	range	VBZ
cord-005453-4057qib7	6184	6	from	from	IN
cord-005453-4057qib7	6184	7	5	5	CD
cord-005453-4057qib7	6184	8	to	to	TO
cord-005453-4057qib7	6184	9	12	12	CD
cord-005453-4057qib7	6184	10	%	%	NN
cord-005453-4057qib7	6184	11	,	,	,
cord-005453-4057qib7	6184	12	and	and	CC
cord-005453-4057qib7	6184	13	BOS	BOS	NNP
cord-005453-4057qib7	6184	14	-	-	HYPH
cord-005453-4057qib7	6184	15	attributed	attribute	VBN
cord-005453-4057qib7	6184	16	mortality	mortality	NN
cord-005453-4057qib7	6184	17	as	as	RB
cord-005453-4057qib7	6184	18	high	high	JJ
cord-005453-4057qib7	6184	19	as	as	IN
cord-005453-4057qib7	6184	20	30%-80	30%-80	CD
cord-005453-4057qib7	6184	21	%	%	NN
cord-005453-4057qib7	6184	22	.	.	.
cord-005453-4057qib7	6185	1	A	a	DT
cord-005453-4057qib7	6185	2	few	few	JJ
cord-005453-4057qib7	6185	3	years	year	NNS
cord-005453-4057qib7	6185	4	ago	ago	RB
cord-005453-4057qib7	6185	5	,	,	,
cord-005453-4057qib7	6185	6	a	a	DT
cord-005453-4057qib7	6185	7	new	new	JJ
cord-005453-4057qib7	6185	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	6185	9	approach	approach	NN
cord-005453-4057qib7	6185	10	with	with	IN
cord-005453-4057qib7	6185	11	Fluticasone	Fluticasone	NNP
cord-005453-4057qib7	6185	12	,	,	,
cord-005453-4057qib7	6185	13	Azithromycin	Azithromycin	NNP
cord-005453-4057qib7	6185	14	,	,	,
cord-005453-4057qib7	6185	15	and	and	CC
cord-005453-4057qib7	6185	16	Montelukast	Montelukast	NNP
cord-005453-4057qib7	6185	17	(	(	-LRB-
cord-005453-4057qib7	6185	18	FAM	FAM	NNP
cord-005453-4057qib7	6185	19	)	)	-RRB-
cord-005453-4057qib7	6185	20	was	be	VBD
cord-005453-4057qib7	6185	21	described	describe	VBN
cord-005453-4057qib7	6185	22	(	(	-LRB-
cord-005453-4057qib7	6185	23	Norman	Norman	NNP
cord-005453-4057qib7	6185	24	BC	BC	NNP
cord-005453-4057qib7	6185	25	,	,	,
cord-005453-4057qib7	6185	26	et	et	NNP
cord-005453-4057qib7	6185	27	al	al	NNP
cord-005453-4057qib7	6185	28	.	.	.
cord-005453-4057qib7	6186	1	BMT	BMT	NNP
cord-005453-4057qib7	6186	2	2011	2011	CD
cord-005453-4057qib7	6186	3	)	)	-RRB-
cord-005453-4057qib7	6186	4	.	.	.
cord-005453-4057qib7	6187	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6187	2	aim	aim	NN
cord-005453-4057qib7	6187	3	was	be	VBD
cord-005453-4057qib7	6187	4	to	to	TO
cord-005453-4057qib7	6187	5	analyze	analyze	VB
cord-005453-4057qib7	6187	6	the	the	DT
cord-005453-4057qib7	6187	7	outcomes	outcome	NNS
cord-005453-4057qib7	6187	8	of	of	IN
cord-005453-4057qib7	6187	9	pts	pt	NNS
cord-005453-4057qib7	6187	10	who	who	WP
cord-005453-4057qib7	6187	11	developed	develop	VBD
cord-005453-4057qib7	6187	12	BOS	BOS	NNP
cord-005453-4057qib7	6187	13	and	and	CC
cord-005453-4057qib7	6187	14	were	be	VBD
cord-005453-4057qib7	6187	15	precociously	precociously	RB
cord-005453-4057qib7	6187	16	treated	treat	VBN
cord-005453-4057qib7	6187	17	with	with	IN
cord-005453-4057qib7	6187	18	the	the	DT
cord-005453-4057qib7	6187	19	FAM	FAM	NNP
cord-005453-4057qib7	6187	20	scheme	scheme	NN
cord-005453-4057qib7	6187	21	.	.	.
cord-005453-4057qib7	6188	1	Methods	method	NNS
cord-005453-4057qib7	6188	2	:	:	:
cord-005453-4057qib7	6188	3	all	all	PDT
cord-005453-4057qib7	6188	4	the	the	DT
cord-005453-4057qib7	6188	5	209	209	CD
cord-005453-4057qib7	6188	6	allo	allo	NN
cord-005453-4057qib7	6188	7	-	-	HYPH
cord-005453-4057qib7	6188	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6188	9	performed	perform	VBD
cord-005453-4057qib7	6188	10	in	in	IN
cord-005453-4057qib7	6188	11	our	-PRON-	PRP$
cord-005453-4057qib7	6188	12	center	center	NN
cord-005453-4057qib7	6188	13	from	from	IN
cord-005453-4057qib7	6188	14	January	January	NNP
cord-005453-4057qib7	6188	15	2015	2015	CD
cord-005453-4057qib7	6188	16	and	and	CC
cord-005453-4057qib7	6188	17	July	July	NNP
cord-005453-4057qib7	6188	18	2018	2018	CD
cord-005453-4057qib7	6188	19	were	be	VBD
cord-005453-4057qib7	6188	20	included	include	VBN
cord-005453-4057qib7	6188	21	in	in	IN
cord-005453-4057qib7	6188	22	the	the	DT
cord-005453-4057qib7	6188	23	analysis	analysis	NN
cord-005453-4057qib7	6188	24	.	.	.
cord-005453-4057qib7	6189	1	Baseline	baseline	JJ
cord-005453-4057qib7	6189	2	diseases	disease	NNS
cord-005453-4057qib7	6189	3	were	be	VBD
cord-005453-4057qib7	6189	4	:	:	:
cord-005453-4057qib7	6189	5	69	69	CD
cord-005453-4057qib7	6189	6	AML	AML	NNP
cord-005453-4057qib7	6189	7	,	,	,
cord-005453-4057qib7	6189	8	49	49	CD
cord-005453-4057qib7	6189	9	LPD	LPD	NNP
cord-005453-4057qib7	6189	10	,	,	,
cord-005453-4057qib7	6189	11	31	31	CD
cord-005453-4057qib7	6189	12	MDS	MDS	NNP
cord-005453-4057qib7	6189	13	,	,	,
cord-005453-4057qib7	6189	14	28	28	CD
cord-005453-4057qib7	6189	15	ALL	all	DT
cord-005453-4057qib7	6189	16	,	,	,
cord-005453-4057qib7	6189	17	16	16	CD
cord-005453-4057qib7	6189	18	MPD	MPD	NNP
cord-005453-4057qib7	6189	19	,	,	,
cord-005453-4057qib7	6189	20	10	10	CD
cord-005453-4057qib7	6189	21	MM	mm	NN
cord-005453-4057qib7	6189	22	,	,	,
cord-005453-4057qib7	6189	23	and	and	CC
cord-005453-4057qib7	6189	24	6	6	CD
cord-005453-4057qib7	6189	25	BMF	bmf	NN
cord-005453-4057qib7	6189	26	.	.	.
cord-005453-4057qib7	6190	1	Day	day	NN
cord-005453-4057qib7	6190	2	+100	+100	NNS
cord-005453-4057qib7	6190	3	and	and	CC
cord-005453-4057qib7	6190	4	day	day	NN
cord-005453-4057qib7	6190	5	+365	+365	NNP
cord-005453-4057qib7	6190	6	overall	overall	JJ
cord-005453-4057qib7	6190	7	mortality	mortality	NN
cord-005453-4057qib7	6190	8	were	be	VBD
cord-005453-4057qib7	6190	9	9,1	9,1	CD
cord-005453-4057qib7	6190	10	%	%	NN
cord-005453-4057qib7	6190	11	and	and	CC
cord-005453-4057qib7	6190	12	24,4	24,4	CD
cord-005453-4057qib7	6190	13	%	%	NN
cord-005453-4057qib7	6190	14	,	,	,
cord-005453-4057qib7	6190	15	respectively	respectively	RB
cord-005453-4057qib7	6190	16	.	.	.
cord-005453-4057qib7	6191	1	Rest	rest	NN
cord-005453-4057qib7	6191	2	of	of	IN
cord-005453-4057qib7	6191	3	characteristics	characteristic	NNS
cord-005453-4057qib7	6191	4	of	of	IN
cord-005453-4057qib7	6191	5	the	the	DT
cord-005453-4057qib7	6191	6	series	series	NN
cord-005453-4057qib7	6191	7	are	be	VBP
cord-005453-4057qib7	6191	8	shown	show	VBN
cord-005453-4057qib7	6191	9	in	in	IN
cord-005453-4057qib7	6191	10	table	table	NN
cord-005453-4057qib7	6191	11	.	.	.
cord-005453-4057qib7	6192	1	FAM	FAM	NNP
cord-005453-4057qib7	6192	2	therapy	therapy	NN
cord-005453-4057qib7	6192	3	was	be	VBD
cord-005453-4057qib7	6192	4	systematically	systematically	RB
cord-005453-4057qib7	6192	5	started	start	VBN
cord-005453-4057qib7	6192	6	when	when	WRB
cord-005453-4057qib7	6192	7	any	any	DT
cord-005453-4057qib7	6192	8	patient	patient	NN
cord-005453-4057qib7	6192	9	was	be	VBD
cord-005453-4057qib7	6192	10	first	first	RB
cord-005453-4057qib7	6192	11	diagnosed	diagnose	VBN
cord-005453-4057qib7	6192	12	with	with	IN
cord-005453-4057qib7	6192	13	BO	BO	NNP
cord-005453-4057qib7	6192	14	.	.	.
cord-005453-4057qib7	6193	1	Results	result	NNS
cord-005453-4057qib7	6193	2	:	:	:
cord-005453-4057qib7	6194	1	eleven	eleven	CD
cord-005453-4057qib7	6194	2	patients	patient	NNS
cord-005453-4057qib7	6194	3	(	(	-LRB-
cord-005453-4057qib7	6194	4	5,3	5,3	CD
cord-005453-4057qib7	6194	5	%	%	NN
cord-005453-4057qib7	6194	6	)	)	-RRB-
cord-005453-4057qib7	6194	7	were	be	VBD
cord-005453-4057qib7	6194	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	6194	9	with	with	IN
cord-005453-4057qib7	6194	10	BOS	BOS	NNP
cord-005453-4057qib7	6194	11	.	.	.
cord-005453-4057qib7	6195	1	At	at	IN
cord-005453-4057qib7	6195	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	6195	3	of	of	IN
cord-005453-4057qib7	6195	4	BOS	BOS	NNP
cord-005453-4057qib7	6195	5	,	,	,
cord-005453-4057qib7	6195	6	the	the	DT
cord-005453-4057qib7	6195	7	pts	pts	NN
cord-005453-4057qib7	6195	8	exhibited	exhibit	VBD
cord-005453-4057qib7	6195	9	a	a	DT
cord-005453-4057qib7	6195	10	FEV1	FEV1	NNP
cord-005453-4057qib7	6195	11	80	80	CD
cord-005453-4057qib7	6195	12	%	%	NN
cord-005453-4057qib7	6195	13	of	of	IN
cord-005453-4057qib7	6195	14	predicted	predict	VBN
cord-005453-4057qib7	6195	15	(	(	-LRB-
cord-005453-4057qib7	6195	16	median	median	JJ
cord-005453-4057qib7	6195	17	FEV1	FEV1	NNP
cord-005453-4057qib7	6195	18	:	:	:
cord-005453-4057qib7	6195	19	74	74	CD
cord-005453-4057qib7	6195	20	%	%	NN
cord-005453-4057qib7	6195	21	;	;	:
cord-005453-4057qib7	6195	22	range	range	NN
cord-005453-4057qib7	6195	23	;	;	:
cord-005453-4057qib7	6195	24	54	54	CD
cord-005453-4057qib7	6195	25	-	-	SYM
cord-005453-4057qib7	6195	26	86	86	CD
cord-005453-4057qib7	6195	27	%	%	NN
cord-005453-4057qib7	6195	28	)	)	-RRB-
cord-005453-4057qib7	6196	1	and/or	and/or	CC
cord-005453-4057qib7	6197	1	a	a	DT
cord-005453-4057qib7	6197	2	decline	decline	NN
cord-005453-4057qib7	6197	3	>	>	SYM
cord-005453-4057qib7	6197	4	10	10	CD
cord-005453-4057qib7	6197	5	%	%	NN
cord-005453-4057qib7	6197	6	from	from	IN
cord-005453-4057qib7	6197	7	pre	pre	JJ
cord-005453-4057qib7	6197	8	-	-	JJ
cord-005453-4057qib7	6197	9	HSCT	HSCT	NNP
cord-005453-4057qib7	6197	10	.	.	.
cord-005453-4057qib7	6198	1	At	at	IN
cord-005453-4057qib7	6198	2	day	day	NN
cord-005453-4057qib7	6198	3	+100	+100	NNS
cord-005453-4057qib7	6198	4	,	,	,
cord-005453-4057qib7	6198	5	6	6	CD
cord-005453-4057qib7	6198	6	pts	pt	NNS
cord-005453-4057qib7	6198	7	had	have	VBD
cord-005453-4057qib7	6198	8	already	already	RB
cord-005453-4057qib7	6198	9	the	the	DT
cord-005453-4057qib7	6198	10	syndrome	syndrome	NN
cord-005453-4057qib7	6198	11	.	.	.
cord-005453-4057qib7	6199	1	Two	two	CD
cord-005453-4057qib7	6199	2	of	of	IN
cord-005453-4057qib7	6199	3	them	-PRON-	PRP
cord-005453-4057qib7	6199	4	died	die	VBD
cord-005453-4057qib7	6199	5	before	before	IN
cord-005453-4057qib7	6199	6	the	the	DT
cord-005453-4057qib7	6199	7	end	end	NN
cord-005453-4057qib7	6199	8	of	of	IN
cord-005453-4057qib7	6199	9	the	the	DT
cord-005453-4057qib7	6199	10	first	first	JJ
cord-005453-4057qib7	6199	11	year	year	NN
cord-005453-4057qib7	6199	12	:	:	:
cord-005453-4057qib7	6199	13	one	one	CD
cord-005453-4057qib7	6199	14	due	due	IN
cord-005453-4057qib7	6199	15	to	to	IN
cord-005453-4057qib7	6199	16	invasive	invasive	JJ
cord-005453-4057qib7	6199	17	zygomycosis	zygomycosis	NN
cord-005453-4057qib7	6199	18	(	(	-LRB-
cord-005453-4057qib7	6199	19	CNS	CNS	NNP
cord-005453-4057qib7	6199	20	plus	plus	CC
cord-005453-4057qib7	6199	21	pulmonary	pulmonary	JJ
cord-005453-4057qib7	6199	22	)	)	-RRB-
cord-005453-4057qib7	6199	23	and	and	CC
cord-005453-4057qib7	6199	24	the	the	DT
cord-005453-4057qib7	6199	25	other	other	JJ
cord-005453-4057qib7	6199	26	to	to	IN
cord-005453-4057qib7	6199	27	baseline	baseline	JJ
cord-005453-4057qib7	6199	28	disease	disease	NN
cord-005453-4057qib7	6199	29	progression	progression	NN
cord-005453-4057qib7	6199	30	.	.	.
cord-005453-4057qib7	6200	1	At	at	IN
cord-005453-4057qib7	6200	2	day	day	NN
cord-005453-4057qib7	6200	3	+365	+365	NNP
cord-005453-4057qib7	6200	4	,	,	,
cord-005453-4057qib7	6200	5	5	5	CD
cord-005453-4057qib7	6200	6	more	more	JJR
cord-005453-4057qib7	6200	7	pts	pt	NNS
cord-005453-4057qib7	6200	8	had	have	VBD
cord-005453-4057qib7	6200	9	BOS	BOS	NNP
cord-005453-4057qib7	6200	10	.	.	.
cord-005453-4057qib7	6201	1	Two	two	CD
cord-005453-4057qib7	6201	2	more	more	JJR
cord-005453-4057qib7	6201	3	pts	pts	NN
cord-005453-4057qib7	6201	4	with	with	IN
cord-005453-4057qib7	6201	5	BOS	BOS	NNP
cord-005453-4057qib7	6201	6	died	die	VBD
cord-005453-4057qib7	6201	7	at	at	IN
cord-005453-4057qib7	6201	8	15	15	CD
cord-005453-4057qib7	6201	9	and	and	CC
cord-005453-4057qib7	6201	10	17	17	CD
cord-005453-4057qib7	6201	11	months	month	NNS
cord-005453-4057qib7	6201	12	post	post	JJ
cord-005453-4057qib7	6201	13	-	-	JJ
cord-005453-4057qib7	6201	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6201	15	due	due	IN
cord-005453-4057qib7	6201	16	to	to	IN
cord-005453-4057qib7	6201	17	baseline	baseline	JJ
cord-005453-4057qib7	6201	18	disease	disease	NN
cord-005453-4057qib7	6201	19	progression	progression	NN
cord-005453-4057qib7	6201	20	.	.	.
cord-005453-4057qib7	6202	1	At	at	IN
cord-005453-4057qib7	6202	2	the	the	DT
cord-005453-4057qib7	6202	3	close	close	NN
cord-005453-4057qib7	6202	4	of	of	IN
cord-005453-4057qib7	6202	5	the	the	DT
cord-005453-4057qib7	6202	6	analysis	analysis	NN
cord-005453-4057qib7	6202	7	,	,	,
cord-005453-4057qib7	6202	8	7	7	CD
cord-005453-4057qib7	6202	9	of	of	IN
cord-005453-4057qib7	6202	10	the	the	DT
cord-005453-4057qib7	6202	11	11	11	CD
cord-005453-4057qib7	6202	12	pts	pt	NNS
cord-005453-4057qib7	6202	13	were	be	VBD
cord-005453-4057qib7	6202	14	alive	alive	JJ
cord-005453-4057qib7	6202	15	.	.	.
cord-005453-4057qib7	6203	1	So	so	RB
cord-005453-4057qib7	6203	2	,	,	,
cord-005453-4057qib7	6203	3	with	with	IN
cord-005453-4057qib7	6203	4	a	a	DT
cord-005453-4057qib7	6203	5	median	median	JJ
cord-005453-4057qib7	6203	6	follow	follow	NN
cord-005453-4057qib7	6203	7	-	-	HYPH
cord-005453-4057qib7	6203	8	up	up	NN
cord-005453-4057qib7	6203	9	of	of	IN
cord-005453-4057qib7	6203	10	29	29	CD
cord-005453-4057qib7	6203	11	months	month	NNS
cord-005453-4057qib7	6203	12	(	(	-LRB-
cord-005453-4057qib7	6203	13	range	range	NN
cord-005453-4057qib7	6203	14	:	:	:
cord-005453-4057qib7	6203	15	8	8	CD
cord-005453-4057qib7	6203	16	-	-	SYM
cord-005453-4057qib7	6203	17	44	44	CD
cord-005453-4057qib7	6203	18	)	)	-RRB-
cord-005453-4057qib7	6203	19	,	,	,
cord-005453-4057qib7	6203	20	mortality	mortality	NN
cord-005453-4057qib7	6203	21	and	and	CC
cord-005453-4057qib7	6203	22	BOS	BOS	NNP
cord-005453-4057qib7	6203	23	-	-	HYPH
cord-005453-4057qib7	6203	24	attributable	attributable	JJ
cord-005453-4057qib7	6203	25	mortality	mortality	NN
cord-005453-4057qib7	6203	26	of	of	IN
cord-005453-4057qib7	6203	27	the	the	DT
cord-005453-4057qib7	6203	28	pts	pts	NN
cord-005453-4057qib7	6203	29	with	with	IN
cord-005453-4057qib7	6203	30	the	the	DT
cord-005453-4057qib7	6203	31	complication	complication	NN
cord-005453-4057qib7	6203	32	were	be	VBD
cord-005453-4057qib7	6203	33	36,4	36,4	CD
cord-005453-4057qib7	6203	34	%	%	NN
cord-005453-4057qib7	6203	35	and	and	CC
cord-005453-4057qib7	6203	36	9,1	9,1	CD
cord-005453-4057qib7	6203	37	%	%	NN
cord-005453-4057qib7	6203	38	,	,	,
cord-005453-4057qib7	6203	39	respectively	respectively	RB
cord-005453-4057qib7	6203	40	.	.	.
cord-005453-4057qib7	6204	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6204	2	:	:	:
cord-005453-4057qib7	6205	1	1	1	LS
cord-005453-4057qib7	6205	2	)	)	-RRB-
cord-005453-4057qib7	6205	3	BOS	BOS	NNP
cord-005453-4057qib7	6205	4	is	be	VBZ
cord-005453-4057qib7	6205	5	an	an	DT
cord-005453-4057qib7	6205	6	infrequent	infrequent	JJ
cord-005453-4057qib7	6205	7	but	but	CC
cord-005453-4057qib7	6205	8	very	very	RB
cord-005453-4057qib7	6205	9	severe	severe	JJ
cord-005453-4057qib7	6205	10	complication	complication	NN
cord-005453-4057qib7	6205	11	of	of	IN
cord-005453-4057qib7	6205	12	allo	allo	NN
cord-005453-4057qib7	6205	13	-	-	HYPH
cord-005453-4057qib7	6205	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6205	15	;	;	:
cord-005453-4057qib7	6205	16	2	2	LS
cord-005453-4057qib7	6205	17	)	)	-RRB-
cord-005453-4057qib7	6205	18	BOS	BOS	NNP
cord-005453-4057qib7	6205	19	seems	seem	VBZ
cord-005453-4057qib7	6205	20	to	to	TO
cord-005453-4057qib7	6205	21	be	be	VB
cord-005453-4057qib7	6205	22	less	less	RBR
cord-005453-4057qib7	6205	23	frequent	frequent	JJ
cord-005453-4057qib7	6205	24	in	in	IN
cord-005453-4057qib7	6205	25	pts	pts	NN
cord-005453-4057qib7	6205	26	with	with	IN
cord-005453-4057qib7	6205	27	prophylactic	prophylactic	JJ
cord-005453-4057qib7	6205	28	pre	pre	JJ
cord-005453-4057qib7	6205	29	-	-	JJ
cord-005453-4057qib7	6205	30	transplant	transplant	JJ
cord-005453-4057qib7	6205	31	rATG	ratg	JJ
cord-005453-4057qib7	6205	32	or	or	CC
cord-005453-4057qib7	6205	33	post	post	JJ
cord-005453-4057qib7	6205	34	-	-	JJ
cord-005453-4057qib7	6205	35	transplant	transplant	NN
cord-005453-4057qib7	6205	36	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	6205	37	,	,	,
cord-005453-4057qib7	6205	38	as	as	RB
cord-005453-4057qib7	6205	39	well	well	RB
cord-005453-4057qib7	6205	40	as	as	IN
cord-005453-4057qib7	6205	41	in	in	IN
cord-005453-4057qib7	6205	42	pts	pts	NN
cord-005453-4057qib7	6205	43	undergoing	undergo	VBG
cord-005453-4057qib7	6205	44	transplantation	transplantation	NN
cord-005453-4057qib7	6205	45	with	with	IN
cord-005453-4057qib7	6205	46	BM	BM	NNP
cord-005453-4057qib7	6205	47	(	(	-LRB-
cord-005453-4057qib7	6205	48	compared	compare	VBN
cord-005453-4057qib7	6205	49	to	to	IN
cord-005453-4057qib7	6205	50	PBSC	PBSC	NNP
cord-005453-4057qib7	6205	51	)	)	-RRB-
cord-005453-4057qib7	6205	52	.	.	.
cord-005453-4057qib7	6206	1	3	3	LS
cord-005453-4057qib7	6206	2	)	)	-RRB-
cord-005453-4057qib7	6207	1	Early	early	JJ
cord-005453-4057qib7	6207	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	6207	3	and	and	CC
cord-005453-4057qib7	6207	4	therapy	therapy	NN
cord-005453-4057qib7	6207	5	are	be	VBP
cord-005453-4057qib7	6207	6	critical	critical	JJ
cord-005453-4057qib7	6207	7	to	to	TO
cord-005453-4057qib7	6207	8	minimize	minimize	VB
cord-005453-4057qib7	6207	9	the	the	DT
cord-005453-4057qib7	6207	10	BOS	BOS	NNP
cord-005453-4057qib7	6207	11	-	-	HYPH
cord-005453-4057qib7	6207	12	attributable	attributable	JJ
cord-005453-4057qib7	6207	13	mortality	mortality	NN
cord-005453-4057qib7	6207	14	.	.	.
cord-005453-4057qib7	6208	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6208	2	Background	background	NN
cord-005453-4057qib7	6208	3	:	:	:
cord-005453-4057qib7	6208	4	Donor	donor	NN
cord-005453-4057qib7	6208	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6208	6	infusion	infusion	NN
cord-005453-4057qib7	6208	7	(	(	-LRB-
cord-005453-4057qib7	6208	8	DLI	DLI	NNP
cord-005453-4057qib7	6208	9	)	)	-RRB-
cord-005453-4057qib7	6208	10	is	be	VBZ
cord-005453-4057qib7	6208	11	an	an	DT
cord-005453-4057qib7	6208	12	established	establish	VBN
cord-005453-4057qib7	6208	13	treatment	treatment	NN
cord-005453-4057qib7	6208	14	for	for	IN
cord-005453-4057qib7	6208	15	patients	patient	NNS
cord-005453-4057qib7	6208	16	with	with	IN
cord-005453-4057qib7	6208	17	hematological	hematological	JJ
cord-005453-4057qib7	6208	18	malignancies	malignancy	NNS
cord-005453-4057qib7	6208	19	relapsed	relapse	VBN
cord-005453-4057qib7	6208	20	after	after	IN
cord-005453-4057qib7	6208	21	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6208	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6208	23	stem	stem	NN
cord-005453-4057qib7	6208	24	cell	cell	NN
cord-005453-4057qib7	6208	25	transplantation	transplantation	NN
cord-005453-4057qib7	6208	26	(	(	-LRB-
cord-005453-4057qib7	6208	27	HSCT	HSCT	NNP
cord-005453-4057qib7	6208	28	)	)	-RRB-
cord-005453-4057qib7	6208	29	.	.	.
cord-005453-4057qib7	6209	1	However	however	RB
cord-005453-4057qib7	6209	2	,	,	,
cord-005453-4057qib7	6209	3	it	-PRON-	PRP
cord-005453-4057qib7	6209	4	is	be	VBZ
cord-005453-4057qib7	6209	5	associated	associate	VBN
cord-005453-4057qib7	6209	6	with	with	IN
cord-005453-4057qib7	6209	7	an	an	DT
cord-005453-4057qib7	6209	8	increased	increase	VBN
cord-005453-4057qib7	6209	9	risk	risk	NN
cord-005453-4057qib7	6209	10	of	of	IN
cord-005453-4057qib7	6209	11	graft	graft	NN
cord-005453-4057qib7	6209	12	-	-	HYPH
cord-005453-4057qib7	6209	13	versus	versus	IN
cord-005453-4057qib7	6209	14	-	-	HYPH
cord-005453-4057qib7	6209	15	host	host	NN
cord-005453-4057qib7	6209	16	disease	disease	NN
cord-005453-4057qib7	6209	17	(	(	-LRB-
cord-005453-4057qib7	6209	18	GVHD	GVHD	NNP
cord-005453-4057qib7	6209	19	)	)	-RRB-
cord-005453-4057qib7	6209	20	and	and	CC
cord-005453-4057qib7	6209	21	modest	modest	JJ
cord-005453-4057qib7	6209	22	anti	anti	JJ
cord-005453-4057qib7	6209	23	-	-	JJ
cord-005453-4057qib7	6209	24	tumor	tumor	JJ
cord-005453-4057qib7	6209	25	activity	activity	NN
cord-005453-4057qib7	6209	26	.	.	.
cord-005453-4057qib7	6210	1	Compared	compare	VBN
cord-005453-4057qib7	6210	2	to	to	IN
cord-005453-4057qib7	6210	3	the	the	DT
cord-005453-4057qib7	6210	4	infusion	infusion	NN
cord-005453-4057qib7	6210	5	of	of	IN
cord-005453-4057qib7	6210	6	nonmobilized	nonmobilized	JJ
cord-005453-4057qib7	6210	7	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6210	8	,	,	,
cord-005453-4057qib7	6210	9	granulocyte	granulocyte	NN
cord-005453-4057qib7	6210	10	colony	colony	NN
cord-005453-4057qib7	6210	11	-	-	HYPH
cord-005453-4057qib7	6210	12	stimulating	stimulate	VBG
cord-005453-4057qib7	6210	13	factor	factor	NN
cord-005453-4057qib7	6210	14	(	(	-LRB-
cord-005453-4057qib7	6210	15	G	g	NN
cord-005453-4057qib7	6210	16	-	-	HYPH
cord-005453-4057qib7	6210	17	CSF)-primed	csf)-primed	NN
cord-005453-4057qib7	6210	18	DLI	DLI	NNP
cord-005453-4057qib7	6210	19	might	may	MD
cord-005453-4057qib7	6210	20	induce	induce	VB
cord-005453-4057qib7	6210	21	a	a	DT
cord-005453-4057qib7	6210	22	stronger	strong	JJR
cord-005453-4057qib7	6210	23	anti	anti	JJ
cord-005453-4057qib7	6210	24	-	-	JJ
cord-005453-4057qib7	6210	25	tumor	tumor	JJ
cord-005453-4057qib7	6210	26	effect	effect	NN
cord-005453-4057qib7	6210	27	and	and	CC
cord-005453-4057qib7	6210	28	reduce	reduce	VB
cord-005453-4057qib7	6210	29	the	the	DT
cord-005453-4057qib7	6210	30	risk	risk	NN
cord-005453-4057qib7	6210	31	of	of	IN
cord-005453-4057qib7	6210	32	infusion	infusion	NN
cord-005453-4057qib7	6210	33	-	-	HYPH
cord-005453-4057qib7	6210	34	induced	induce	VBN
cord-005453-4057qib7	6210	35	GVHD	GVHD	NNP
cord-005453-4057qib7	6210	36	.	.	.
cord-005453-4057qib7	6211	1	Due	due	IN
cord-005453-4057qib7	6211	2	to	to	IN
cord-005453-4057qib7	6211	3	the	the	DT
cord-005453-4057qib7	6211	4	limited	limited	JJ
cord-005453-4057qib7	6211	5	experience	experience	NN
cord-005453-4057qib7	6211	6	of	of	IN
cord-005453-4057qib7	6211	7	G	G	NNP
cord-005453-4057qib7	6211	8	-	-	HYPH
cord-005453-4057qib7	6211	9	CSF	CSF	NNP
cord-005453-4057qib7	6211	10	primed	prime	VBD
cord-005453-4057qib7	6211	11	DLI	DLI	NNP
cord-005453-4057qib7	6211	12	in	in	IN
cord-005453-4057qib7	6211	13	patients	patient	NNS
cord-005453-4057qib7	6211	14	relapsed	relapse	VBN
cord-005453-4057qib7	6211	15	after	after	IN
cord-005453-4057qib7	6211	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6211	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6211	18	,	,	,
cord-005453-4057qib7	6211	19	we	-PRON-	PRP
cord-005453-4057qib7	6211	20	conducted	conduct	VBD
cord-005453-4057qib7	6211	21	a	a	DT
cord-005453-4057qib7	6211	22	retrospective	retrospective	JJ
cord-005453-4057qib7	6211	23	study	study	NN
cord-005453-4057qib7	6211	24	of	of	IN
cord-005453-4057qib7	6211	25	all	all	DT
cord-005453-4057qib7	6211	26	patients	patient	NNS
cord-005453-4057qib7	6211	27	at	at	IN
cord-005453-4057qib7	6211	28	our	-PRON-	PRP$
cord-005453-4057qib7	6211	29	hospital	hospital	NN
cord-005453-4057qib7	6211	30	who	who	WP
cord-005453-4057qib7	6211	31	received	receive	VBD
cord-005453-4057qib7	6211	32	DLI	DLI	NNP
cord-005453-4057qib7	6211	33	for	for	IN
cord-005453-4057qib7	6211	34	the	the	DT
cord-005453-4057qib7	6211	35	relapsed	relapse	VBN
cord-005453-4057qib7	6211	36	hematological	hematological	JJ
cord-005453-4057qib7	6211	37	diseases	disease	NNS
cord-005453-4057qib7	6211	38	following	follow	VBG
cord-005453-4057qib7	6211	39	related	relate	VBN
cord-005453-4057qib7	6211	40	HLA	HLA	NNP
cord-005453-4057qib7	6211	41	-	-	HYPH
cord-005453-4057qib7	6211	42	matched	match	VBN
cord-005453-4057qib7	6211	43	or	or	CC
cord-005453-4057qib7	6211	44	HLA	HLA	NNP
cord-005453-4057qib7	6211	45	-	-	HYPH
cord-005453-4057qib7	6211	46	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6211	47	HSCT	HSCT	NNP
cord-005453-4057qib7	6211	48	.	.	.
cord-005453-4057qib7	6212	1	Methods	method	NNS
cord-005453-4057qib7	6212	2	:	:	:
cord-005453-4057qib7	6213	1	The	the	DT
cord-005453-4057qib7	6213	2	Institutional	Institutional	NNP
cord-005453-4057qib7	6213	3	Research	Research	NNP
cord-005453-4057qib7	6213	4	Board	Board	NNP
cord-005453-4057qib7	6213	5	approved	approve	VBD
cord-005453-4057qib7	6213	6	the	the	DT
cord-005453-4057qib7	6213	7	study	study	NN
cord-005453-4057qib7	6213	8	.	.	.
cord-005453-4057qib7	6214	1	We	-PRON-	PRP
cord-005453-4057qib7	6214	2	identified	identify	VBD
cord-005453-4057qib7	6214	3	94	94	CD
cord-005453-4057qib7	6214	4	patients	patient	NNS
cord-005453-4057qib7	6214	5	with	with	IN
cord-005453-4057qib7	6214	6	hematological	hematological	JJ
cord-005453-4057qib7	6214	7	malignancies	malignancy	NNS
cord-005453-4057qib7	6214	8	receiving	receive	VBG
cord-005453-4057qib7	6214	9	DLI	DLI	NNP
cord-005453-4057qib7	6214	10	following	follow	VBG
cord-005453-4057qib7	6214	11	related	relate	VBN
cord-005453-4057qib7	6214	12	allo	allo	NN
cord-005453-4057qib7	6214	13	-	-	HYPH
cord-005453-4057qib7	6214	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6214	15	at	at	IN
cord-005453-4057qib7	6214	16	National	National	NNP
cord-005453-4057qib7	6214	17	Taiwan	Taiwan	NNP
cord-005453-4057qib7	6214	18	University	University	NNP
cord-005453-4057qib7	6214	19	Hospital	Hospital	NNP
cord-005453-4057qib7	6214	20	between	between	IN
cord-005453-4057qib7	6214	21	1999	1999	CD
cord-005453-4057qib7	6214	22	and	and	CC
cord-005453-4057qib7	6214	23	2018	2018	CD
cord-005453-4057qib7	6214	24	Aug.	August	NNP
cord-005453-4057qib7	6215	1	The	the	DT
cord-005453-4057qib7	6215	2	infusate	infusate	NN
cord-005453-4057qib7	6215	3	was	be	VBD
cord-005453-4057qib7	6215	4	obtained	obtain	VBN
cord-005453-4057qib7	6215	5	from	from	IN
cord-005453-4057qib7	6215	6	the	the	DT
cord-005453-4057qib7	6215	7	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	6215	8	specimen	specimen	NN
cord-005453-4057qib7	6215	9	,	,	,
cord-005453-4057qib7	6215	10	which	which	WDT
cord-005453-4057qib7	6215	11	had	have	VBD
cord-005453-4057qib7	6215	12	been	be	VBN
cord-005453-4057qib7	6215	13	collected	collect	VBN
cord-005453-4057qib7	6215	14	and	and	CC
cord-005453-4057qib7	6215	15	stored	store	VBN
cord-005453-4057qib7	6215	16	at	at	IN
cord-005453-4057qib7	6215	17	multiple	multiple	JJ
cord-005453-4057qib7	6215	18	aliquots	aliquot	NNS
cord-005453-4057qib7	6215	19	at	at	IN
cord-005453-4057qib7	6215	20	the	the	DT
cord-005453-4057qib7	6215	21	same	same	JJ
cord-005453-4057qib7	6215	22	time	time	NN
cord-005453-4057qib7	6215	23	as	as	IN
cord-005453-4057qib7	6215	24	the	the	DT
cord-005453-4057qib7	6215	25	initial	initial	JJ
cord-005453-4057qib7	6215	26	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6215	27	peripheral	peripheral	JJ
cord-005453-4057qib7	6215	28	stem	stem	NN
cord-005453-4057qib7	6215	29	cell	cell	NN
cord-005453-4057qib7	6215	30	graft	graft	NN
cord-005453-4057qib7	6215	31	.	.	.
cord-005453-4057qib7	6216	1	Patients	patient	NNS
cord-005453-4057qib7	6216	2	received	receive	VBD
cord-005453-4057qib7	6216	3	DLI	DLI	NNP
cord-005453-4057qib7	6216	4	for	for	IN
cord-005453-4057qib7	6216	5	either	either	DT
cord-005453-4057qib7	6216	6	hematological	hematological	JJ
cord-005453-4057qib7	6216	7	relapse	relapse	NN
cord-005453-4057qib7	6216	8	,	,	,
cord-005453-4057qib7	6216	9	preemptive	preemptive	JJ
cord-005453-4057qib7	6216	10	or	or	CC
cord-005453-4057qib7	6216	11	prophylactic	prophylactic	JJ
cord-005453-4057qib7	6216	12	treatment	treatment	NN
cord-005453-4057qib7	6216	13	.	.	.
cord-005453-4057qib7	6217	1	Univariate	univariate	JJ
cord-005453-4057qib7	6217	2	and	and	CC
cord-005453-4057qib7	6217	3	multivariate	multivariate	JJ
cord-005453-4057qib7	6217	4	analysis	analysis	NN
cord-005453-4057qib7	6217	5	was	be	VBD
cord-005453-4057qib7	6217	6	performed	perform	VBN
cord-005453-4057qib7	6217	7	using	use	VBG
cord-005453-4057qib7	6217	8	Cox	Cox	NNP
cord-005453-4057qib7	6217	9	proportional	proportional	JJ
cord-005453-4057qib7	6217	10	hazard	hazard	NN
cord-005453-4057qib7	6217	11	regression	regression	NN
cord-005453-4057qib7	6217	12	model	model	NN
cord-005453-4057qib7	6217	13	.	.	.
cord-005453-4057qib7	6218	1	Results	result	NNS
cord-005453-4057qib7	6218	2	:	:	:
cord-005453-4057qib7	6219	1	For	for	IN
cord-005453-4057qib7	6219	2	the	the	DT
cord-005453-4057qib7	6219	3	61	61	CD
cord-005453-4057qib7	6219	4	patients	patient	NNS
cord-005453-4057qib7	6219	5	following	follow	VBG
cord-005453-4057qib7	6219	6	related	related	JJ
cord-005453-4057qib7	6219	7	HLAmatched	HLAmatched	NNP
cord-005453-4057qib7	6219	8	and	and	CC
cord-005453-4057qib7	6219	9	the	the	DT
cord-005453-4057qib7	6219	10	33	33	CD
cord-005453-4057qib7	6219	11	patients	patient	NNS
cord-005453-4057qib7	6219	12	following	follow	VBG
cord-005453-4057qib7	6219	13	HLA	HLA	NNP
cord-005453-4057qib7	6219	14	-	-	HYPH
cord-005453-4057qib7	6219	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6219	16	HSCT	HSCT	NNP
cord-005453-4057qib7	6219	17	received	receive	VBD
cord-005453-4057qib7	6219	18	119	119	CD
cord-005453-4057qib7	6219	19	and	and	CC
cord-005453-4057qib7	6219	20	72	72	CD
cord-005453-4057qib7	6219	21	doses	dose	NNS
cord-005453-4057qib7	6219	22	of	of	IN
cord-005453-4057qib7	6219	23	DLI	DLI	NNP
cord-005453-4057qib7	6219	24	,	,	,
cord-005453-4057qib7	6219	25	respectively	respectively	RB
cord-005453-4057qib7	6219	26	.	.	.
cord-005453-4057qib7	6220	1	In	in	IN
cord-005453-4057qib7	6220	2	comparison	comparison	NN
cord-005453-4057qib7	6220	3	,	,	,
cord-005453-4057qib7	6220	4	the	the	DT
cord-005453-4057qib7	6220	5	median	median	JJ
cord-005453-4057qib7	6220	6	CD3	CD3	NNP
cord-005453-4057qib7	6220	7	+	+	CC
cord-005453-4057qib7	6220	8	cell	cell	NN
cord-005453-4057qib7	6220	9	dosage	dosage	NN
cord-005453-4057qib7	6220	10	of	of	IN
cord-005453-4057qib7	6220	11	haplo	haplo	NNP
cord-005453-4057qib7	6220	12	-	-	HYPH
cord-005453-4057qib7	6220	13	DLI	DLI	NNP
cord-005453-4057qib7	6220	14	is	be	VBZ
cord-005453-4057qib7	6220	15	significantly	significantly	RB
cord-005453-4057qib7	6220	16	lower	low	JJR
cord-005453-4057qib7	6220	17	(	(	-LRB-
cord-005453-4057qib7	6220	18	P	p	NN
cord-005453-4057qib7	6220	19	=	=	SYM
cord-005453-4057qib7	6220	20	0.0224	0.0224	CD
cord-005453-4057qib7	6220	21	)	)	-RRB-
cord-005453-4057qib7	6220	22	than	than	IN
cord-005453-4057qib7	6220	23	that	that	DT
cord-005453-4057qib7	6220	24	of	of	IN
cord-005453-4057qib7	6220	25	DLI	DLI	NNP
cord-005453-4057qib7	6220	26	from	from	IN
cord-005453-4057qib7	6220	27	sibling	sibling	NN
cord-005453-4057qib7	6220	28	donors	donor	NNS
cord-005453-4057qib7	6220	29	,	,	,
cord-005453-4057qib7	6220	30	with	with	IN
cord-005453-4057qib7	6220	31	median	median	JJ
cord-005453-4057qib7	6220	32	cell	cell	NN
cord-005453-4057qib7	6220	33	dosage	dosage	NN
cord-005453-4057qib7	6220	34	0.45	0.45	CD
cord-005453-4057qib7	6220	35	×	×	NNP
cord-005453-4057qib7	6220	36	10	10	CD
cord-005453-4057qib7	6220	37	7	7	CD
cord-005453-4057qib7	6221	1	/kg	/kg	.
cord-005453-4057qib7	6222	1	(	(	-LRB-
cord-005453-4057qib7	6222	2	range	range	NN
cord-005453-4057qib7	6222	3	,	,	,
cord-005453-4057qib7	6222	4	0.05	0.05	CD
cord-005453-4057qib7	6222	5	-	-	SYM
cord-005453-4057qib7	6222	6	12	12	CD
cord-005453-4057qib7	6222	7	×	×	NN
cord-005453-4057qib7	6222	8	10	10	CD
cord-005453-4057qib7	6222	9	7	7	CD
cord-005453-4057qib7	6222	10	/kg	/kg	CD
cord-005453-4057qib7	6222	11	)	)	-RRB-
cord-005453-4057qib7	6222	12	and	and	CC
cord-005453-4057qib7	6222	13	1.1	1.1	CD
cord-005453-4057qib7	6222	14	×	×	NN
cord-005453-4057qib7	6222	15	10	10	CD
cord-005453-4057qib7	6222	16	7	7	CD
cord-005453-4057qib7	6222	17	/kg	/kg	.
cord-005453-4057qib7	6222	18	(	(	-LRB-
cord-005453-4057qib7	6222	19	range	range	NN
cord-005453-4057qib7	6222	20	,	,	,
cord-005453-4057qib7	6222	21	0.04	0.04	CD
cord-005453-4057qib7	6222	22	-	-	SYM
cord-005453-4057qib7	6222	23	9.78	9.78	CD
cord-005453-4057qib7	6222	24	×	×	NN
cord-005453-4057qib7	6222	25	10	10	CD
cord-005453-4057qib7	6222	26	7	7	CD
cord-005453-4057qib7	6222	27	/kg	/kg	CD
cord-005453-4057qib7	6222	28	)	)	-RRB-
cord-005453-4057qib7	6222	29	,	,	,
cord-005453-4057qib7	6222	30	respectively	respectively	RB
cord-005453-4057qib7	6222	31	.	.	.
cord-005453-4057qib7	6223	1	The	the	DT
cord-005453-4057qib7	6223	2	median	median	JJ
cord-005453-4057qib7	6223	3	time	time	NN
cord-005453-4057qib7	6223	4	to	to	IN
cord-005453-4057qib7	6223	5	DLI	DLI	NNP
cord-005453-4057qib7	6223	6	from	from	IN
cord-005453-4057qib7	6223	7	initial	initial	JJ
cord-005453-4057qib7	6223	8	sibling	sibling	NN
cord-005453-4057qib7	6223	9	HSCT	HSCT	NNP
cord-005453-4057qib7	6223	10	and	and	CC
cord-005453-4057qib7	6223	11	haplo	haplo	NNP
cord-005453-4057qib7	6223	12	-	-	HYPH
cord-005453-4057qib7	6223	13	HSCT	HSCT	NNP
cord-005453-4057qib7	6223	14	was	be	VBD
cord-005453-4057qib7	6223	15	152	152	CD
cord-005453-4057qib7	6223	16	days	day	NNS
cord-005453-4057qib7	6223	17	(	(	-LRB-
cord-005453-4057qib7	6223	18	range	range	NN
cord-005453-4057qib7	6223	19	,	,	,
cord-005453-4057qib7	6223	20	13	13	CD
cord-005453-4057qib7	6223	21	-	-	SYM
cord-005453-4057qib7	6223	22	3357	3357	CD
cord-005453-4057qib7	6223	23	days	day	NNS
cord-005453-4057qib7	6223	24	)	)	-RRB-
cord-005453-4057qib7	6223	25	and	and	CC
cord-005453-4057qib7	6223	26	155	155	CD
cord-005453-4057qib7	6223	27	days	day	NNS
cord-005453-4057qib7	6223	28	(	(	-LRB-
cord-005453-4057qib7	6223	29	range	range	NN
cord-005453-4057qib7	6223	30	,	,	,
cord-005453-4057qib7	6223	31	13	13	CD
cord-005453-4057qib7	6223	32	-	-	SYM
cord-005453-4057qib7	6223	33	946	946	CD
cord-005453-4057qib7	6223	34	days	day	NNS
cord-005453-4057qib7	6223	35	)	)	-RRB-
cord-005453-4057qib7	6223	36	,	,	,
cord-005453-4057qib7	6223	37	respectively	respectively	RB
cord-005453-4057qib7	6223	38	.	.	.
cord-005453-4057qib7	6224	1	Overall	overall	RB
cord-005453-4057qib7	6224	2	,	,	,
cord-005453-4057qib7	6224	3	12	12	CD
cord-005453-4057qib7	6224	4	(	(	-LRB-
cord-005453-4057qib7	6224	5	20	20	CD
cord-005453-4057qib7	6224	6	%	%	NN
cord-005453-4057qib7	6224	7	)	)	-RRB-
cord-005453-4057qib7	6224	8	of	of	IN
cord-005453-4057qib7	6224	9	the	the	DT
cord-005453-4057qib7	6224	10	61	61	CD
cord-005453-4057qib7	6224	11	patients	patient	NNS
cord-005453-4057qib7	6224	12	following	follow	VBG
cord-005453-4057qib7	6224	13	sibling	sibling	NN
cord-005453-4057qib7	6224	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6224	15	developed	develop	VBD
cord-005453-4057qib7	6224	16	grade	grade	NN
cord-005453-4057qib7	6224	17	2	2	CD
cord-005453-4057qib7	6224	18	-	-	SYM
cord-005453-4057qib7	6224	19	4	4	CD
cord-005453-4057qib7	6224	20	acute	acute	JJ
cord-005453-4057qib7	6224	21	GVHD	GVHD	NNP
cord-005453-4057qib7	6224	22	after	after	IN
cord-005453-4057qib7	6224	23	DLI	DLI	NNP
cord-005453-4057qib7	6224	24	,	,	,
cord-005453-4057qib7	6224	25	whereas	whereas	IN
cord-005453-4057qib7	6224	26	12	12	CD
cord-005453-4057qib7	6224	27	(	(	-LRB-
cord-005453-4057qib7	6224	28	36	36	CD
cord-005453-4057qib7	6224	29	%	%	NN
cord-005453-4057qib7	6224	30	)	)	-RRB-
cord-005453-4057qib7	6224	31	of	of	IN
cord-005453-4057qib7	6224	32	the	the	DT
cord-005453-4057qib7	6224	33	33	33	CD
cord-005453-4057qib7	6224	34	patients	patient	NNS
cord-005453-4057qib7	6224	35	receiving	receive	VBG
cord-005453-4057qib7	6224	36	haplo	haplo	NNP
cord-005453-4057qib7	6224	37	-	-	HYPH
cord-005453-4057qib7	6224	38	HSCT	HSCT	NNP
cord-005453-4057qib7	6224	39	developed	develop	VBD
cord-005453-4057qib7	6224	40	grade	grade	NN
cord-005453-4057qib7	6224	41	2	2	CD
cord-005453-4057qib7	6224	42	-	-	SYM
cord-005453-4057qib7	6224	43	4	4	CD
cord-005453-4057qib7	6224	44	acute	acute	JJ
cord-005453-4057qib7	6224	45	GVHD	GVHD	NNP
cord-005453-4057qib7	6224	46	after	after	IN
cord-005453-4057qib7	6224	47	DLI	DLI	NNP
cord-005453-4057qib7	6224	48	(	(	-LRB-
cord-005453-4057qib7	6224	49	p=0.1460	p=0.1460	NNP
cord-005453-4057qib7	6224	50	)	)	-RRB-
cord-005453-4057qib7	6224	51	.	.	.
cord-005453-4057qib7	6225	1	Importantly	importantly	RB
cord-005453-4057qib7	6225	2	,	,	,
cord-005453-4057qib7	6225	3	for	for	IN
cord-005453-4057qib7	6225	4	patients	patient	NNS
cord-005453-4057qib7	6225	5	receiving	receive	VBG
cord-005453-4057qib7	6225	6	DLI	DLI	NNP
cord-005453-4057qib7	6225	7	with	with	IN
cord-005453-4057qib7	6225	8	CD3	CD3	NNP
cord-005453-4057qib7	6225	9	+	+	CC
cord-005453-4057qib7	6225	10	cell	cell	NN
cord-005453-4057qib7	6225	11	dosage	dosage	NN
cord-005453-4057qib7	6225	12	less	less	JJR
cord-005453-4057qib7	6225	13	than	than	IN
cord-005453-4057qib7	6225	14	1	1	CD
cord-005453-4057qib7	6225	15	×	×	CD
cord-005453-4057qib7	6225	16	10	10	CD
cord-005453-4057qib7	6225	17	7	7	CD
cord-005453-4057qib7	6226	1	/kg	/kg	NFP
cord-005453-4057qib7	6226	2	,	,	,
cord-005453-4057qib7	6226	3	there	there	EX
cord-005453-4057qib7	6226	4	is	be	VBZ
cord-005453-4057qib7	6226	5	no	no	DT
cord-005453-4057qib7	6226	6	difference	difference	NN
cord-005453-4057qib7	6226	7	in	in	IN
cord-005453-4057qib7	6226	8	the	the	DT
cord-005453-4057qib7	6226	9	risk	risk	NN
cord-005453-4057qib7	6226	10	of	of	IN
cord-005453-4057qib7	6226	11	developing	develop	VBG
cord-005453-4057qib7	6226	12	grade	grade	NN
cord-005453-4057qib7	6226	13	2	2	CD
cord-005453-4057qib7	6226	14	-	-	SYM
cord-005453-4057qib7	6226	15	4	4	CD
cord-005453-4057qib7	6226	16	acute	acute	JJ
cord-005453-4057qib7	6226	17	GVHD	GVHD	NNP
cord-005453-4057qib7	6226	18	between	between	IN
cord-005453-4057qib7	6226	19	patients	patient	NNS
cord-005453-4057qib7	6226	20	receiving	receive	VBG
cord-005453-4057qib7	6226	21	DLI	DLI	NNP
cord-005453-4057qib7	6226	22	from	from	IN
cord-005453-4057qib7	6226	23	sibling	sibling	NN
cord-005453-4057qib7	6226	24	or	or	CC
cord-005453-4057qib7	6226	25	haplo	haplo	NN
cord-005453-4057qib7	6226	26	donors	donor	NNS
cord-005453-4057qib7	6226	27	(	(	-LRB-
cord-005453-4057qib7	6226	28	Figure	figure	NN
cord-005453-4057qib7	6226	29	1A	1a	NN
cord-005453-4057qib7	6226	30	)	)	-RRB-
cord-005453-4057qib7	6226	31	.	.	.
cord-005453-4057qib7	6227	1	Interestingly	interestingly	RB
cord-005453-4057qib7	6227	2	,	,	,
cord-005453-4057qib7	6227	3	for	for	IN
cord-005453-4057qib7	6227	4	patients	patient	NNS
cord-005453-4057qib7	6227	5	receiving	receive	VBG
cord-005453-4057qib7	6227	6	DLI	DLI	NNP
cord-005453-4057qib7	6227	7	with	with	IN
cord-005453-4057qib7	6227	8	CD3	CD3	NNP
cord-005453-4057qib7	6227	9	+	+	CC
cord-005453-4057qib7	6227	10	cell	cell	NN
cord-005453-4057qib7	6227	11	dosage	dosage	NN
cord-005453-4057qib7	6227	12	more	more	JJR
cord-005453-4057qib7	6227	13	than	than	IN
cord-005453-4057qib7	6227	14	or	or	CC
cord-005453-4057qib7	6227	15	equal	equal	JJ
cord-005453-4057qib7	6227	16	to	to	IN
cord-005453-4057qib7	6227	17	1×	1×	CD
cord-005453-4057qib7	6227	18	10	10	CD
cord-005453-4057qib7	6227	19	7	7	CD
cord-005453-4057qib7	6228	1	/kg	/kg	NFP
cord-005453-4057qib7	6228	2	,	,	,
cord-005453-4057qib7	6228	3	4	4	CD
cord-005453-4057qib7	6228	4	(	(	-LRB-
cord-005453-4057qib7	6228	5	50	50	CD
cord-005453-4057qib7	6228	6	%	%	NN
cord-005453-4057qib7	6228	7	)	)	-RRB-
cord-005453-4057qib7	6228	8	of	of	IN
cord-005453-4057qib7	6228	9	the	the	DT
cord-005453-4057qib7	6228	10	8	8	CD
cord-005453-4057qib7	6228	11	patients	patient	NNS
cord-005453-4057qib7	6228	12	following	follow	VBG
cord-005453-4057qib7	6228	13	haplo	haplo	NNP
cord-005453-4057qib7	6228	14	-	-	HYPH
cord-005453-4057qib7	6228	15	HSCT	HSCT	NNP
cord-005453-4057qib7	6228	16	developed	develop	VBD
cord-005453-4057qib7	6228	17	grade	grade	NN
cord-005453-4057qib7	6228	18	2	2	CD
cord-005453-4057qib7	6228	19	-	-	SYM
cord-005453-4057qib7	6228	20	4	4	CD
cord-005453-4057qib7	6228	21	acute	acute	JJ
cord-005453-4057qib7	6228	22	GVHD	GVHD	NNP
cord-005453-4057qib7	6228	23	after	after	IN
cord-005453-4057qib7	6228	24	DLI	DLI	NNP
cord-005453-4057qib7	6228	25	,	,	,
cord-005453-4057qib7	6228	26	significantly	significantly	RB
cord-005453-4057qib7	6228	27	more	more	JJR
cord-005453-4057qib7	6228	28	than	than	IN
cord-005453-4057qib7	6228	29	5	5	CD
cord-005453-4057qib7	6228	30	(	(	-LRB-
cord-005453-4057qib7	6228	31	14	14	CD
cord-005453-4057qib7	6228	32	%	%	NN
cord-005453-4057qib7	6228	33	)	)	-RRB-
cord-005453-4057qib7	6228	34	of	of	IN
cord-005453-4057qib7	6228	35	the	the	DT
cord-005453-4057qib7	6228	36	37	37	CD
cord-005453-4057qib7	6228	37	patients	patient	NNS
cord-005453-4057qib7	6228	38	following	follow	VBG
cord-005453-4057qib7	6228	39	sibling	sibling	NN
cord-005453-4057qib7	6228	40	HSCT	HSCT	NNP
cord-005453-4057qib7	6228	41	developed	develop	VBD
cord-005453-4057qib7	6228	42	grade	grade	NN
cord-005453-4057qib7	6228	43	2	2	CD
cord-005453-4057qib7	6228	44	-	-	SYM
cord-005453-4057qib7	6228	45	4	4	CD
cord-005453-4057qib7	6228	46	acute	acute	JJ
cord-005453-4057qib7	6228	47	GVHD	GVHD	NNP
cord-005453-4057qib7	6228	48	after	after	IN
cord-005453-4057qib7	6228	49	DLI	DLI	NNP
cord-005453-4057qib7	6228	50	(	(	-LRB-
cord-005453-4057qib7	6228	51	Figure	figure	NN
cord-005453-4057qib7	6228	52	1B	1b	CD
cord-005453-4057qib7	6228	53	)	)	-RRB-
cord-005453-4057qib7	6228	54	.	.	.
cord-005453-4057qib7	6229	1	The	the	DT
cord-005453-4057qib7	6229	2	cumulative	cumulative	JJ
cord-005453-4057qib7	6229	3	incidence	incidence	NN
cord-005453-4057qib7	6229	4	of	of	IN
cord-005453-4057qib7	6229	5	grade	grade	NN
cord-005453-4057qib7	6229	6	2	2	CD
cord-005453-4057qib7	6229	7	-	-	SYM
cord-005453-4057qib7	6229	8	4	4	CD
cord-005453-4057qib7	6229	9	acute	acute	JJ
cord-005453-4057qib7	6229	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6229	11	at	at	IN
cord-005453-4057qib7	6229	12	day	day	NN
cord-005453-4057qib7	6229	13	100	100	CD
cord-005453-4057qib7	6229	14	after	after	IN
cord-005453-4057qib7	6229	15	haplo	haplo	NN
cord-005453-4057qib7	6229	16	-	-	HYPH
cord-005453-4057qib7	6229	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6229	18	and	and	CC
cord-005453-4057qib7	6229	19	sibling	sibling	NN
cord-005453-4057qib7	6229	20	HSCT	HSCT	NNP
cord-005453-4057qib7	6229	21	were	be	VBD
cord-005453-4057qib7	6229	22	50	50	CD
cord-005453-4057qib7	6229	23	%	%	NN
cord-005453-4057qib7	6229	24	(	(	-LRB-
cord-005453-4057qib7	6229	25	95	95	CD
cord-005453-4057qib7	6229	26	%	%	NN
cord-005453-4057qib7	6229	27	CI	ci	NN
cord-005453-4057qib7	6229	28	:	:	:
cord-005453-4057qib7	6229	29	0.13	0.13	CD
cord-005453-4057qib7	6229	30	-0.79	-0.79	NFP
cord-005453-4057qib7	6229	31	)	)	-RRB-
cord-005453-4057qib7	6229	32	and	and	CC
cord-005453-4057qib7	6229	33	13.5	13.5	CD
cord-005453-4057qib7	6229	34	%	%	NN
cord-005453-4057qib7	6229	35	(	(	-LRB-
cord-005453-4057qib7	6229	36	95	95	CD
cord-005453-4057qib7	6229	37	%	%	NN
cord-005453-4057qib7	6229	38	CI	ci	NN
cord-005453-4057qib7	6229	39	:	:	:
cord-005453-4057qib7	6229	40	0.05	0.05	CD
cord-005453-4057qib7	6229	41	-	-	HYPH
cord-005453-4057qib7	6229	42	0.27	0.27	CD
cord-005453-4057qib7	6229	43	)	)	-RRB-
cord-005453-4057qib7	6229	44	,	,	,
cord-005453-4057qib7	6229	45	respectively	respectively	RB
cord-005453-4057qib7	6229	46	(	(	-LRB-
cord-005453-4057qib7	6229	47	Figure	figure	NN
cord-005453-4057qib7	6229	48	1B	1b	NN
cord-005453-4057qib7	6229	49	,	,	,
cord-005453-4057qib7	6229	50	P	p	NN
cord-005453-4057qib7	6229	51	=	=	SYM
cord-005453-4057qib7	6229	52	0.0146	0.0146	CD
cord-005453-4057qib7	6229	53	)	)	-RRB-
cord-005453-4057qib7	6229	54	.	.	.
cord-005453-4057qib7	6230	1	[	[	-LRB-
cord-005453-4057qib7	6230	2	[	[	-LRB-
cord-005453-4057qib7	6230	3	P282	P282	NNP
cord-005453-4057qib7	6230	4	Image	image	NN
cord-005453-4057qib7	6230	5	]	]	-RRB-
cord-005453-4057qib7	6230	6	1	1	CD
cord-005453-4057qib7	6230	7	.	.	.
cord-005453-4057qib7	6231	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6231	2	:	:	:
cord-005453-4057qib7	6232	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6232	2	study	study	NN
cord-005453-4057qib7	6232	3	shows	show	VBZ
cord-005453-4057qib7	6232	4	that	that	IN
cord-005453-4057qib7	6232	5	the	the	DT
cord-005453-4057qib7	6232	6	administration	administration	NN
cord-005453-4057qib7	6232	7	of	of	IN
cord-005453-4057qib7	6232	8	G	G	NNP
cord-005453-4057qib7	6232	9	-	-	HYPH
cord-005453-4057qib7	6232	10	CSF	CSF	NNP
cord-005453-4057qib7	6232	11	mobilized	mobilize	VBD
cord-005453-4057qib7	6232	12	DLI	DLI	NNP
cord-005453-4057qib7	6232	13	is	be	VBZ
cord-005453-4057qib7	6232	14	feasible	feasible	JJ
cord-005453-4057qib7	6232	15	after	after	IN
cord-005453-4057qib7	6232	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6232	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6232	18	for	for	IN
cord-005453-4057qib7	6232	19	relapsed	relapse	VBN
cord-005453-4057qib7	6232	20	hematological	hematological	JJ
cord-005453-4057qib7	6232	21	malignancies	malignancy	NNS
cord-005453-4057qib7	6232	22	.	.	.
cord-005453-4057qib7	6233	1	However	however	RB
cord-005453-4057qib7	6233	2	,	,	,
cord-005453-4057qib7	6233	3	DLI	DLI	NNP
cord-005453-4057qib7	6233	4	with	with	IN
cord-005453-4057qib7	6233	5	CD3	CD3	NNP
cord-005453-4057qib7	6233	6	+	+	CC
cord-005453-4057qib7	6233	7	cell	cell	NN
cord-005453-4057qib7	6233	8	dosage	dosage	NN
cord-005453-4057qib7	6233	9	more	more	JJR
cord-005453-4057qib7	6233	10	than	than	IN
cord-005453-4057qib7	6233	11	or	or	CC
cord-005453-4057qib7	6233	12	equal	equal	JJ
cord-005453-4057qib7	6233	13	to	to	IN
cord-005453-4057qib7	6233	14	1×	1×	CD
cord-005453-4057qib7	6233	15	10	10	CD
cord-005453-4057qib7	6233	16	7	7	CD
cord-005453-4057qib7	6234	1	/kg	/kg	NFP
cord-005453-4057qib7	6234	2	in	in	IN
cord-005453-4057qib7	6234	3	patients	patient	NNS
cord-005453-4057qib7	6234	4	receiving	receive	VBG
cord-005453-4057qib7	6234	5	haplo	haplo	NNP
cord-005453-4057qib7	6234	6	-	-	HYPH
cord-005453-4057qib7	6234	7	HSCT	HSCT	NNP
cord-005453-4057qib7	6235	1	is	be	VBZ
cord-005453-4057qib7	6235	2	associated	associate	VBN
cord-005453-4057qib7	6235	3	with	with	IN
cord-005453-4057qib7	6235	4	significantly	significantly	RB
cord-005453-4057qib7	6235	5	higher	high	JJR
cord-005453-4057qib7	6235	6	risk	risk	NN
cord-005453-4057qib7	6235	7	of	of	IN
cord-005453-4057qib7	6235	8	developing	develop	VBG
cord-005453-4057qib7	6235	9	acute	acute	JJ
cord-005453-4057qib7	6235	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6235	11	than	than	IN
cord-005453-4057qib7	6235	12	DLI	DLI	NNP
cord-005453-4057qib7	6235	13	from	from	IN
cord-005453-4057qib7	6235	14	the	the	DT
cord-005453-4057qib7	6235	15	sibling	sibling	NN
cord-005453-4057qib7	6235	16	donors	donor	NNS
cord-005453-4057qib7	6235	17	.	.	.
cord-005453-4057qib7	6236	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6236	2	:	:	:
cord-005453-4057qib7	6237	1	The	the	DT
cord-005453-4057qib7	6237	2	authors	author	NNS
cord-005453-4057qib7	6237	3	declare	declare	VBP
cord-005453-4057qib7	6237	4	no	no	DT
cord-005453-4057qib7	6237	5	competing	compete	VBG
cord-005453-4057qib7	6237	6	financial	financial	JJ
cord-005453-4057qib7	6237	7	interests	interest	NNS
cord-005453-4057qib7	6237	8	.	.	.
cord-005453-4057qib7	6238	1	Background	background	NN
cord-005453-4057qib7	6238	2	:	:	:
cord-005453-4057qib7	6239	1	The	the	DT
cord-005453-4057qib7	6239	2	Fresenius	Fresenius	NNP
cord-005453-4057qib7	6239	3	Phelix	Phelix	NNP
cord-005453-4057qib7	6239	4	is	be	VBZ
cord-005453-4057qib7	6239	5	a	a	DT
cord-005453-4057qib7	6239	6	UVA	UVA	NNP
cord-005453-4057qib7	6239	7	irradiation	irradiation	NN
cord-005453-4057qib7	6239	8	device	device	NN
cord-005453-4057qib7	6239	9	used	use	VBN
cord-005453-4057qib7	6239	10	to	to	TO
cord-005453-4057qib7	6239	11	photoactivate	photoactivate	VB
cord-005453-4057qib7	6239	12	MNC	MNC	NNP
cord-005453-4057qib7	6239	13	collected	collect	VBN
cord-005453-4057qib7	6239	14	on	on	IN
cord-005453-4057qib7	6239	15	the	the	DT
cord-005453-4057qib7	6239	16	Amicus	Amicus	NNP
cord-005453-4057qib7	6239	17	.	.	.
cord-005453-4057qib7	6240	1	The	the	DT
cord-005453-4057qib7	6240	2	system	system	NN
cord-005453-4057qib7	6240	3	is	be	VBZ
cord-005453-4057qib7	6240	4	closed	close	VBN
cord-005453-4057qib7	6240	5	,	,	,
cord-005453-4057qib7	6240	6	utilizing	utilize	VBG
cord-005453-4057qib7	6240	7	a	a	DT
cord-005453-4057qib7	6240	8	special	special	JJ
cord-005453-4057qib7	6240	9	MNC	MNC	NNP
cord-005453-4057qib7	6240	10	kit	kit	NN
cord-005453-4057qib7	6240	11	and	and	CC
cord-005453-4057qib7	6240	12	modified	modify	VBN
cord-005453-4057qib7	6240	13	instrument	instrument	NN
cord-005453-4057qib7	6240	14	software	software	NN
cord-005453-4057qib7	6240	15	.	.	.
cord-005453-4057qib7	6241	1	The	the	DT
cord-005453-4057qib7	6241	2	preliminary	preliminary	JJ
cord-005453-4057qib7	6241	3	results	result	NNS
cord-005453-4057qib7	6241	4	of	of	IN
cord-005453-4057qib7	6241	5	a	a	DT
cord-005453-4057qib7	6241	6	phase	phase	NN
cord-005453-4057qib7	6241	7	I	-PRON-	PRP
cord-005453-4057qib7	6241	8	safety	safety	NN
cord-005453-4057qib7	6241	9	trial	trial	NN
cord-005453-4057qib7	6241	10	involving	involve	VBG
cord-005453-4057qib7	6241	11	three	three	CD
cord-005453-4057qib7	6241	12	patients	patient	NNS
cord-005453-4057qib7	6241	13	(	(	-LRB-
cord-005453-4057qib7	6241	14	12	12	CD
cord-005453-4057qib7	6241	15	treatments	treatment	NNS
cord-005453-4057qib7	6241	16	)	)	-RRB-
cord-005453-4057qib7	6241	17	with	with	IN
cord-005453-4057qib7	6241	18	chronic	chronic	JJ
cord-005453-4057qib7	6241	19	graft	graft	NN
cord-005453-4057qib7	6241	20	vs.	vs.	IN
cord-005453-4057qib7	6241	21	host	host	NN
cord-005453-4057qib7	6241	22	disease	disease	NN
cord-005453-4057qib7	6241	23	are	be	VBP
cord-005453-4057qib7	6241	24	presented	present	VBN
cord-005453-4057qib7	6241	25	.	.	.
cord-005453-4057qib7	6242	1	Methods	method	NNS
cord-005453-4057qib7	6242	2	:	:	:
cord-005453-4057qib7	6242	3	Reasons	reason	NNS
cord-005453-4057qib7	6242	4	for	for	IN
cord-005453-4057qib7	6242	5	transplantation	transplantation	NN
cord-005453-4057qib7	6242	6	for	for	IN
cord-005453-4057qib7	6242	7	the	the	DT
cord-005453-4057qib7	6242	8	patients	patient	NNS
cord-005453-4057qib7	6242	9	ages	age	NNS
cord-005453-4057qib7	6242	10	37	37	CD
cord-005453-4057qib7	6242	11	,	,	,
cord-005453-4057qib7	6242	12	61	61	CD
cord-005453-4057qib7	6242	13	and	and	CC
cord-005453-4057qib7	6242	14	62	62	CD
cord-005453-4057qib7	6242	15	years	year	NNS
cord-005453-4057qib7	6243	1	were	be	VBD
cord-005453-4057qib7	6243	2	:	:	:
cord-005453-4057qib7	6243	3	Acute	acute	JJ
cord-005453-4057qib7	6243	4	myelogenous	myelogenous	NN
cord-005453-4057qib7	6243	5	leukemia	leukemia	NN
cord-005453-4057qib7	6243	6	,	,	,
cord-005453-4057qib7	6243	7	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	6243	8	syndrome	syndrome	NN
cord-005453-4057qib7	6243	9	,	,	,
cord-005453-4057qib7	6243	10	and	and	CC
cord-005453-4057qib7	6243	11	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	6243	12	syndrome	syndrome	NN
cord-005453-4057qib7	6243	13	with	with	IN
cord-005453-4057qib7	6243	14	PNH	PNH	NNP
cord-005453-4057qib7	6243	15	.	.	.
cord-005453-4057qib7	6244	1	Stem	stem	JJ
cord-005453-4057qib7	6244	2	cell	cell	NN
cord-005453-4057qib7	6244	3	source	source	NN
cord-005453-4057qib7	6244	4	was	be	VBD
cord-005453-4057qib7	6244	5	peripheral	peripheral	JJ
cord-005453-4057qib7	6244	6	blood	blood	NN
cord-005453-4057qib7	6244	7	with	with	IN
cord-005453-4057qib7	6244	8	a	a	DT
cord-005453-4057qib7	6244	9	10/10	10/10	CD
cord-005453-4057qib7	6244	10	match	match	NN
cord-005453-4057qib7	6244	11	for	for	IN
cord-005453-4057qib7	6244	12	all	all	DT
cord-005453-4057qib7	6244	13	.	.	.
cord-005453-4057qib7	6245	1	Each	each	DT
cord-005453-4057qib7	6245	2	developed	develop	VBD
cord-005453-4057qib7	6245	3	chronic	chronic	NN
cord-005453-4057qib7	6245	4	skin	skin	NN
cord-005453-4057qib7	6245	5	GVHD	GVHD	NNP
cord-005453-4057qib7	6245	6	.	.	.
cord-005453-4057qib7	6246	1	Inclusion	inclusion	NN
cord-005453-4057qib7	6246	2	criteria	criterion	NNS
cord-005453-4057qib7	6246	3	included	include	VBD
cord-005453-4057qib7	6246	4	WBC	WBC	NNP
cord-005453-4057qib7	6246	5	and	and	CC
cord-005453-4057qib7	6246	6	PLT	PLT	NNP
cord-005453-4057qib7	6246	7	counts	count	VBZ
cord-005453-4057qib7	6246	8	>	>	XX
cord-005453-4057qib7	6247	1	1000	1000	CD
cord-005453-4057qib7	6247	2	and	and	CC
cord-005453-4057qib7	6247	3	25x10	25x10	CD
cord-005453-4057qib7	6247	4	9	9	CD
cord-005453-4057qib7	6247	5	/L	/l	NN
cord-005453-4057qib7	6247	6	,	,	,
cord-005453-4057qib7	6247	7	GFR	GFR	NNP
cord-005453-4057qib7	6247	8	>	>	XX
cord-005453-4057qib7	6247	9	30	30	CD
cord-005453-4057qib7	6247	10	ml	ml	NN
cord-005453-4057qib7	6247	11	/	/	SYM
cord-005453-4057qib7	6247	12	min	min	NNP
cord-005453-4057qib7	6247	13	/	/	SYM
cord-005453-4057qib7	6247	14	BSA	BSA	NNP
cord-005453-4057qib7	6247	15	,	,	,
cord-005453-4057qib7	6247	16	and	and	CC
cord-005453-4057qib7	6247	17	AST	AST	NNP
cord-005453-4057qib7	6247	18	10	10	CD
cord-005453-4057qib7	6247	19	-	-	SYM
cord-005453-4057qib7	6247	20	120	120	CD
cord-005453-4057qib7	6247	21	unit	unit	NN
cord-005453-4057qib7	6247	22	/	/	SYM
cord-005453-4057qib7	6247	23	L.	L.	NNP
cord-005453-4057qib7	6247	24	Exclusion	Exclusion	NNP
cord-005453-4057qib7	6247	25	criteria	criterion	NNS
cord-005453-4057qib7	6247	26	included	include	VBD
cord-005453-4057qib7	6247	27	active	active	JJ
cord-005453-4057qib7	6247	28	GI	GI	NNP
cord-005453-4057qib7	6247	29	bleeding	bleeding	NN
cord-005453-4057qib7	6247	30	,	,	,
cord-005453-4057qib7	6247	31	NYHA	NYHA	NNP
cord-005453-4057qib7	6247	32	cardiac	cardiac	JJ
cord-005453-4057qib7	6247	33	disease	disease	NN
cord-005453-4057qib7	6247	34	greater	great	JJR
cord-005453-4057qib7	6247	35	than	than	IN
cord-005453-4057qib7	6247	36	grade	grade	NN
cord-005453-4057qib7	6247	37	III	III	NNP
cord-005453-4057qib7	6247	38	,	,	,
cord-005453-4057qib7	6247	39	and	and	CC
cord-005453-4057qib7	6247	40	the	the	DT
cord-005453-4057qib7	6247	41	presence	presence	NN
cord-005453-4057qib7	6247	42	of	of	IN
cord-005453-4057qib7	6247	43	light	light	JJ
cord-005453-4057qib7	6247	44	-	-	HYPH
cord-005453-4057qib7	6247	45	sensitive	sensitive	JJ
cord-005453-4057qib7	6247	46	diseases	disease	NNS
cord-005453-4057qib7	6247	47	.	.	.
cord-005453-4057qib7	6248	1	Amicus	Amicus	NNP
cord-005453-4057qib7	6248	2	software	software	NN
cord-005453-4057qib7	6248	3	4.51	4.51	CD
cord-005453-4057qib7	6248	4	and	and	CC
cord-005453-4057qib7	6248	5	Phelix	Phelix	NNP
cord-005453-4057qib7	6248	6	software	software	NN
cord-005453-4057qib7	6248	7	1.0	1.0	CD
cord-005453-4057qib7	6248	8	were	be	VBD
cord-005453-4057qib7	6248	9	used	use	VBN
cord-005453-4057qib7	6248	10	.	.	.
cord-005453-4057qib7	6249	1	Settings	setting	NNS
cord-005453-4057qib7	6249	2	included	include	VBD
cord-005453-4057qib7	6249	3	:	:	:
cord-005453-4057qib7	6249	4	80	80	CD
cord-005453-4057qib7	6250	1	ml	ml	NNP
cord-005453-4057qib7	6250	2	/	/	SYM
cord-005453-4057qib7	6250	3	min	min	NNP
cord-005453-4057qib7	6250	4	max	max	NNP
cord-005453-4057qib7	6250	5	draw	draw	NN
cord-005453-4057qib7	6250	6	rate	rate	NN
cord-005453-4057qib7	6250	7	,	,	,
cord-005453-4057qib7	6250	8	2000	2000	CD
cord-005453-4057qib7	6250	9	ml	ml	XX
cord-005453-4057qib7	6250	10	fixed	fix	VBN
cord-005453-4057qib7	6250	11	cycle	cycle	NN
cord-005453-4057qib7	6250	12	volume	volume	NN
cord-005453-4057qib7	6250	13	,	,	,
cord-005453-4057qib7	6250	14	1.25	1.25	CD
cord-005453-4057qib7	6250	15	mg	mg	NNP
cord-005453-4057qib7	6250	16	/	/	SYM
cord-005453-4057qib7	6250	17	kg	kg	NNP
cord-005453-4057qib7	6250	18	/	/	SYM
cord-005453-4057qib7	6250	19	min	min	NNP
cord-005453-4057qib7	6250	20	citrate	citrate	NNP
cord-005453-4057qib7	6250	21	infusion	infusion	NN
cord-005453-4057qib7	6250	22	rate	rate	NN
cord-005453-4057qib7	6250	23	,	,	,
cord-005453-4057qib7	6250	24	and	and	CC
cord-005453-4057qib7	6250	25	12:1	12:1	CD
cord-005453-4057qib7	6250	26	ACD	ACD	NNP
cord-005453-4057qib7	6250	27	-	-	HYPH
cord-005453-4057qib7	6250	28	A	a	NN
cord-005453-4057qib7	6250	29	ratio	ratio	NN
cord-005453-4057qib7	6250	30	.	.	.
cord-005453-4057qib7	6251	1	Venous	venous	JJ
cord-005453-4057qib7	6251	2	access	access	NN
cord-005453-4057qib7	6251	3	was	be	VBD
cord-005453-4057qib7	6251	4	peripheral	peripheral	JJ
cord-005453-4057qib7	6251	5	or	or	CC
cord-005453-4057qib7	6251	6	subcutaneous	subcutaneous	JJ
cord-005453-4057qib7	6251	7	port	port	NN
cord-005453-4057qib7	6251	8	.	.	.
cord-005453-4057qib7	6252	1	Target	Target	NNP
cord-005453-4057qib7	6252	2	UVA	UVA	NNP
cord-005453-4057qib7	6252	3	dose	dose	NN
cord-005453-4057qib7	6252	4	was	be	VBD
cord-005453-4057qib7	6252	5	1.5	1.5	CD
cord-005453-4057qib7	6252	6	J	J	NNP
cord-005453-4057qib7	6252	7	/	/	SYM
cord-005453-4057qib7	6252	8	CM	CM	NNP
cord-005453-4057qib7	6252	9	2	2	CD
cord-005453-4057qib7	6252	10	and	and	CC
cord-005453-4057qib7	6252	11	8-methoxypsoralen	8-methoxypsoralen	CD
cord-005453-4057qib7	6252	12	dose	dose	NN
cord-005453-4057qib7	6252	13	was	be	VBD
cord-005453-4057qib7	6252	14	3.4	3.4	CD
cord-005453-4057qib7	6252	15	ml	ml	NN
cord-005453-4057qib7	6252	16	.	.	.
cord-005453-4057qib7	6253	1	Results	result	NNS
cord-005453-4057qib7	6253	2	:	:	:
cord-005453-4057qib7	6254	1	The	the	DT
cord-005453-4057qib7	6254	2	following	following	JJ
cord-005453-4057qib7	6254	3	mean	mean	NN
cord-005453-4057qib7	6254	4	+	+	CC
cord-005453-4057qib7	6255	1	SD	sd	NN
cord-005453-4057qib7	6255	2	procedure	procedure	NN
cord-005453-4057qib7	6255	3	results	result	NNS
cord-005453-4057qib7	6255	4	were	be	VBD
cord-005453-4057qib7	6255	5	obtained	obtain	VBN
cord-005453-4057qib7	6255	6	:	:	:
cord-005453-4057qib7	6255	7	2,341	2,341	CD
cord-005453-4057qib7	6255	8	+	+	SYM
cord-005453-4057qib7	6255	9	14	14	CD
cord-005453-4057qib7	6255	10	ml	ml	NN
cord-005453-4057qib7	6255	11	whole	whole	JJ
cord-005453-4057qib7	6255	12	blood	blood	NN
cord-005453-4057qib7	6255	13	with	with	IN
cord-005453-4057qib7	6255	14	ACD	ACD	NNP
cord-005453-4057qib7	6255	15	-	-	HYPH
cord-005453-4057qib7	6255	16	A	a	NN
cord-005453-4057qib7	6255	17	drawn	draw	VBN
cord-005453-4057qib7	6255	18	,	,	,
cord-005453-4057qib7	6255	19	191	191	CD
cord-005453-4057qib7	6255	20	+	+	CC
cord-005453-4057qib7	6256	1	3	3	CD
cord-005453-4057qib7	6256	2	ml	ml	NN
cord-005453-4057qib7	6256	3	ACD	ACD	NNP
cord-005453-4057qib7	6256	4	-	-	HYPH
cord-005453-4057qib7	6256	5	A	A	NNP
cord-005453-4057qib7	6256	6	used	use	VBN
cord-005453-4057qib7	6256	7	,	,	,
cord-005453-4057qib7	6257	1	691	691	CD
cord-005453-4057qib7	6257	2	+	+	SYM
cord-005453-4057qib7	6257	3	127	127	CD
cord-005453-4057qib7	6257	4	ml	ml	NN
cord-005453-4057qib7	6257	5	saline	saline	NN
cord-005453-4057qib7	6257	6	used	use	VBN
cord-005453-4057qib7	6257	7	,	,	,
cord-005453-4057qib7	6257	8	91	91	CD
cord-005453-4057qib7	6257	9	+	+	SYM
cord-005453-4057qib7	6257	10	5	5	CD
cord-005453-4057qib7	6257	11	minutes	minute	NNS
cord-005453-4057qib7	6257	12	procedure	procedure	NN
cord-005453-4057qib7	6257	13	time	time	NN
cord-005453-4057qib7	6257	14	,	,	,
cord-005453-4057qib7	6257	15	and	and	CC
cord-005453-4057qib7	6257	16	4,881	4,881	CD
cord-005453-4057qib7	6257	17	+	+	SYM
cord-005453-4057qib7	6257	18	419	419	CD
cord-005453-4057qib7	6257	19	ml	ml	NNS
cord-005453-4057qib7	6257	20	total	total	JJ
cord-005453-4057qib7	6257	21	blood	blood	NN
cord-005453-4057qib7	6257	22	volume	volume	NN
cord-005453-4057qib7	6257	23	.	.	.
cord-005453-4057qib7	6258	1	Minor	minor	JJ
cord-005453-4057qib7	6258	2	alarms	alarm	NNS
cord-005453-4057qib7	6258	3	(	(	-LRB-
cord-005453-4057qib7	6258	4	N=4	N=4	NNP
cord-005453-4057qib7	6258	5	)	)	-RRB-
cord-005453-4057qib7	6258	6	on	on	IN
cord-005453-4057qib7	6258	7	the	the	DT
cord-005453-4057qib7	6258	8	Amicus	Amicus	NNP
cord-005453-4057qib7	6258	9	and	and	CC
cord-005453-4057qib7	6258	10	no	no	DT
cord-005453-4057qib7	6258	11	alarms	alarm	NNS
cord-005453-4057qib7	6258	12	on	on	IN
cord-005453-4057qib7	6258	13	the	the	DT
cord-005453-4057qib7	6258	14	Phelix	Phelix	NNP
cord-005453-4057qib7	6258	15	were	be	VBD
cord-005453-4057qib7	6258	16	encountered	encounter	VBN
cord-005453-4057qib7	6258	17	.	.	.
cord-005453-4057qib7	6259	1	All	all	DT
cord-005453-4057qib7	6259	2	14-day	14-day	CD
cord-005453-4057qib7	6259	3	aerobic	aerobic	JJ
cord-005453-4057qib7	6259	4	and	and	CC
cord-005453-4057qib7	6259	5	anaerobic	anaerobic	JJ
cord-005453-4057qib7	6259	6	cultures	culture	NNS
cord-005453-4057qib7	6259	7	were	be	VBD
cord-005453-4057qib7	6259	8	negative	negative	JJ
cord-005453-4057qib7	6259	9	and	and	CC
cord-005453-4057qib7	6259	10	mean	mean	JJ
cord-005453-4057qib7	6259	11	endotoxin	endotoxin	NN
cord-005453-4057qib7	6259	12	levels	level	NNS
cord-005453-4057qib7	6259	13	were	be	VBD
cord-005453-4057qib7	6259	14	0.425	0.425	CD
cord-005453-4057qib7	6259	15	+	+	CD
cord-005453-4057qib7	6260	1	0.1752	0.1752	CD
cord-005453-4057qib7	6260	2	EU	EU	NNP
cord-005453-4057qib7	6260	3	/	/	SYM
cord-005453-4057qib7	6260	4	ml	ml	NN
cord-005453-4057qib7	6260	5	.	.	.
cord-005453-4057qib7	6261	1	Mean	mean	JJ
cord-005453-4057qib7	6262	1	pre	pre	NNP
cord-005453-4057qib7	6262	2	/	/	SYM
cord-005453-4057qib7	6262	3	post	post	VB
cord-005453-4057qib7	6262	4	CBC	CBC	NNP
cord-005453-4057qib7	6262	5	and	and	CC
cord-005453-4057qib7	6262	6	plasma	plasma	NN
cord-005453-4057qib7	6262	7	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	6262	8	levels	level	NNS
cord-005453-4057qib7	6262	9	were	be	VBD
cord-005453-4057qib7	6262	10	:	:	:
cord-005453-4057qib7	6263	1	12.5/11.8	12.5/11.8	CD
cord-005453-4057qib7	6263	2	WBC	WBC	NNP
cord-005453-4057qib7	6263	3	,	,	,
cord-005453-4057qib7	6263	4	9.9/9.5	9.9/9.5	CD
cord-005453-4057qib7	6263	5	neutrophils	neutrophil	NNS
cord-005453-4057qib7	6263	6	,	,	,
cord-005453-4057qib7	6263	7	0.06/0.05	0.06/0.05	CD
cord-005453-4057qib7	6263	8	basophils	basophil	NNS
cord-005453-4057qib7	6263	9	,	,	,
cord-005453-4057qib7	6263	10	0.21/0.15	0.21/0.15	CD
cord-005453-4057qib7	6263	11	eosinophils	eosinophil	NNS
cord-005453-4057qib7	6263	12	,	,	,
cord-005453-4057qib7	6263	13	1.06/1.03	1.06/1.03	CD
cord-005453-4057qib7	6263	14	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6263	15	,	,	,
cord-005453-4057qib7	6263	16	1.23/1.06	1.23/1.06	NNP
cord-005453-4057qib7	6263	17	monocytes	monocyte	NNS
cord-005453-4057qib7	6263	18	,	,	,
cord-005453-4057qib7	6263	19	314/293	314/293	CD
cord-005453-4057qib7	6263	20	platelets	platelet	NNS
cord-005453-4057qib7	6263	21	x	x	SYM
cord-005453-4057qib7	6263	22	10	10	CD
cord-005453-4057qib7	6263	23	9	9	CD
cord-005453-4057qib7	6263	24	/L	/l	CD
cord-005453-4057qib7	6263	25	,	,	,
cord-005453-4057qib7	6263	26	40/	40/	CD
cord-005453-4057qib7	6263	27	37	37	CD
cord-005453-4057qib7	6263	28	%	%	NN
cord-005453-4057qib7	6263	29	HCT	hct	NN
cord-005453-4057qib7	6263	30	,	,	,
cord-005453-4057qib7	6263	31	13.3/12.2	13.3/12.2	NNP
cord-005453-4057qib7	6263	32	g	g	NN
cord-005453-4057qib7	6263	33	/	/	SYM
cord-005453-4057qib7	6263	34	dl	dl	NNP
cord-005453-4057qib7	6263	35	Hgb	Hgb	NNP
cord-005453-4057qib7	6263	36	,	,	,
cord-005453-4057qib7	6263	37	and	and	CC
cord-005453-4057qib7	6263	38	26.8/23.4	26.8/23.4	CD
cord-005453-4057qib7	6263	39	mg	mg	NNP
cord-005453-4057qib7	6263	40	/	/	SYM
cord-005453-4057qib7	6263	41	dl	dl	NN
cord-005453-4057qib7	6263	42	plasma	plasma	NN
cord-005453-4057qib7	6263	43	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	6263	44	.	.	.
cord-005453-4057qib7	6264	1	Plasma	plasma	NN
cord-005453-4057qib7	6264	2	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	6264	3	delta	delta	NN
cord-005453-4057qib7	6264	4	in	in	IN
cord-005453-4057qib7	6264	5	the	the	DT
cord-005453-4057qib7	6264	6	product	product	NN
cord-005453-4057qib7	6264	7	was	be	VBD
cord-005453-4057qib7	6265	1	0.00	0.00	CD
cord-005453-4057qib7	6265	2	+	+	SYM
cord-005453-4057qib7	6265	3	0.001	0.001	CD
cord-005453-4057qib7	6265	4	grams	gram	NNS
cord-005453-4057qib7	6265	5	and	and	CC
cord-005453-4057qib7	6265	6	the	the	DT
cord-005453-4057qib7	6265	7	subject	subject	NN
cord-005453-4057qib7	6265	8	was	be	VBD
cord-005453-4057qib7	6265	9	-0.15	-0.15	CD
cord-005453-4057qib7	6265	10	+	+	SYM
cord-005453-4057qib7	6265	11	0.70	0.70	CD
cord-005453-4057qib7	6265	12	grams	gram	NNS
cord-005453-4057qib7	6265	13	.	.	.
cord-005453-4057qib7	6266	1	Collected	collect	VBN
cord-005453-4057qib7	6266	2	product	product	NN
cord-005453-4057qib7	6267	1	Hct	Hct	NNP
cord-005453-4057qib7	6267	2	.	.	.
cord-005453-4057qib7	6268	1	Mean	mean	JJ
cord-005453-4057qib7	6268	2	1.95	1.95	CD
cord-005453-4057qib7	6268	3	+	+	SYM
cord-005453-4057qib7	6268	4	0.255	0.255	CD
cord-005453-4057qib7	6268	5	%	%	NN
cord-005453-4057qib7	6268	6	.	.	.
cord-005453-4057qib7	6269	1	Yields	yield	NNS
cord-005453-4057qib7	6269	2	are	be	VBP
cord-005453-4057qib7	6269	3	in	in	IN
cord-005453-4057qib7	6269	4	the	the	DT
cord-005453-4057qib7	6269	5	table	table	NN
cord-005453-4057qib7	6269	6	.	.	.
cord-005453-4057qib7	6270	1	Adverse	adverse	JJ
cord-005453-4057qib7	6270	2	events	event	NNS
cord-005453-4057qib7	6270	3	included	include	VBD
cord-005453-4057qib7	6270	4	one	one	CD
cord-005453-4057qib7	6270	5	each	each	DT
cord-005453-4057qib7	6270	6	:	:	:
cord-005453-4057qib7	6270	7	Acute	acute	JJ
cord-005453-4057qib7	6270	8	respiratory	respiratory	JJ
cord-005453-4057qib7	6270	9	failure	failure	NN
cord-005453-4057qib7	6270	10	,	,	,
cord-005453-4057qib7	6270	11	respiratory	respiratory	JJ
cord-005453-4057qib7	6270	12	failure	failure	NN
cord-005453-4057qib7	6270	13	,	,	,
cord-005453-4057qib7	6270	14	muscular	muscular	JJ
cord-005453-4057qib7	6270	15	weakness	weakness	NN
cord-005453-4057qib7	6270	16	,	,	,
cord-005453-4057qib7	6270	17	musculoskeletal	musculoskeletal	JJ
cord-005453-4057qib7	6270	18	discomfort	discomfort	NN
cord-005453-4057qib7	6270	19	,	,	,
cord-005453-4057qib7	6270	20	and	and	CC
cord-005453-4057qib7	6270	21	peripheral	peripheral	JJ
cord-005453-4057qib7	6270	22	swelling	swelling	NN
cord-005453-4057qib7	6270	23	.	.	.
cord-005453-4057qib7	6271	1	Three	three	CD
cord-005453-4057qib7	6271	2	of	of	IN
cord-005453-4057qib7	6271	3	four	four	CD
cord-005453-4057qib7	6271	4	events	event	NNS
cord-005453-4057qib7	6271	5	occurred	occur	VBD
cord-005453-4057qib7	6271	6	in	in	IN
cord-005453-4057qib7	6271	7	one	one	CD
cord-005453-4057qib7	6271	8	patient	patient	NN
cord-005453-4057qib7	6271	9	two	two	CD
cord-005453-4057qib7	6271	10	weeks	week	NNS
cord-005453-4057qib7	6271	11	after	after	IN
cord-005453-4057qib7	6271	12	the	the	DT
cord-005453-4057qib7	6271	13	study	study	NN
cord-005453-4057qib7	6271	14	procedure	procedure	NN
cord-005453-4057qib7	6271	15	.	.	.
cord-005453-4057qib7	6272	1	None	none	NN
cord-005453-4057qib7	6272	2	of	of	IN
cord-005453-4057qib7	6272	3	the	the	DT
cord-005453-4057qib7	6272	4	adverse	adverse	JJ
cord-005453-4057qib7	6272	5	events	event	NNS
cord-005453-4057qib7	6272	6	were	be	VBD
cord-005453-4057qib7	6272	7	considered	consider	VBN
cord-005453-4057qib7	6272	8	related	related	JJ
cord-005453-4057qib7	6272	9	to	to	IN
cord-005453-4057qib7	6272	10	the	the	DT
cord-005453-4057qib7	6272	11	procedure	procedure	NN
cord-005453-4057qib7	6272	12	or	or	CC
cord-005453-4057qib7	6272	13	investigational	investigational	JJ
cord-005453-4057qib7	6272	14	product	product	NN
cord-005453-4057qib7	6272	15	.	.	.
cord-005453-4057qib7	6273	1	The	the	DT
cord-005453-4057qib7	6273	2	patient	patient	NN
cord-005453-4057qib7	6273	3	who	who	WP
cord-005453-4057qib7	6273	4	experienced	experience	VBD
cord-005453-4057qib7	6273	5	acute	acute	JJ
cord-005453-4057qib7	6273	6	respiratory	respiratory	JJ
cord-005453-4057qib7	6273	7	failure	failure	NN
cord-005453-4057qib7	6273	8	was	be	VBD
cord-005453-4057qib7	6273	9	removed	remove	VBN
cord-005453-4057qib7	6273	10	from	from	IN
cord-005453-4057qib7	6273	11	the	the	DT
cord-005453-4057qib7	6273	12	study	study	NN
cord-005453-4057qib7	6273	13	because	because	IN
cord-005453-4057qib7	6273	14	of	of	IN
cord-005453-4057qib7	6273	15	death	death	NN
cord-005453-4057qib7	6273	16	due	due	IN
cord-005453-4057qib7	6273	17	to	to	IN
cord-005453-4057qib7	6273	18	pneumonia	pneumonia	NN
cord-005453-4057qib7	6273	19	,	,	,
cord-005453-4057qib7	6273	20	felt	feel	VBD
cord-005453-4057qib7	6273	21	to	to	TO
cord-005453-4057qib7	6273	22	be	be	VB
cord-005453-4057qib7	6273	23	unrelated	unrelated	JJ
cord-005453-4057qib7	6273	24	to	to	IN
cord-005453-4057qib7	6273	25	the	the	DT
cord-005453-4057qib7	6273	26	procedure	procedure	NN
cord-005453-4057qib7	6273	27	.	.	.
cord-005453-4057qib7	6274	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6274	2	:	:	:
cord-005453-4057qib7	6275	1	Results	result	NNS
cord-005453-4057qib7	6275	2	indicate	indicate	VBP
cord-005453-4057qib7	6275	3	the	the	DT
cord-005453-4057qib7	6275	4	new	new	JJ
cord-005453-4057qib7	6275	5	closed	closed	JJ
cord-005453-4057qib7	6275	6	photopheresis	photopheresis	NN
cord-005453-4057qib7	6275	7	system	system	NN
cord-005453-4057qib7	6275	8	is	be	VBZ
cord-005453-4057qib7	6275	9	capable	capable	JJ
cord-005453-4057qib7	6275	10	of	of	IN
cord-005453-4057qib7	6275	11	collecting	collect	VBG
cord-005453-4057qib7	6275	12	sufficient	sufficient	JJ
cord-005453-4057qib7	6275	13	MNC	MNC	NNP
cord-005453-4057qib7	6275	14	and	and	CC
cord-005453-4057qib7	6275	15	irradiating	irradiate	VBG
cord-005453-4057qib7	6275	16	the	the	DT
cord-005453-4057qib7	6275	17	cells	cell	NNS
cord-005453-4057qib7	6275	18	producing	produce	VBG
cord-005453-4057qib7	6275	19	high	high	JJ
cord-005453-4057qib7	6275	20	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6275	21	apoptosis	apoptosis	NN
cord-005453-4057qib7	6275	22	,	,	,
cord-005453-4057qib7	6275	23	with	with	IN
cord-005453-4057qib7	6275	24	minimal	minimal	JJ
cord-005453-4057qib7	6275	25	alarms	alarm	NNS
cord-005453-4057qib7	6275	26	and	and	CC
cord-005453-4057qib7	6275	27	adverse	adverse	JJ
cord-005453-4057qib7	6275	28	reactions	reaction	NNS
cord-005453-4057qib7	6275	29	.	.	.
cord-005453-4057qib7	6276	1	(	(	-LRB-
cord-005453-4057qib7	6276	2	21.4	21.4	CD
cord-005453-4057qib7	6276	3	%	%	NN
cord-005453-4057qib7	6276	4	)	)	-RRB-
cord-005453-4057qib7	6276	5	)	)	-RRB-
cord-005453-4057qib7	6276	6	.	.	.
cord-005453-4057qib7	6277	1	10	10	CD
cord-005453-4057qib7	6277	2	(	(	-LRB-
cord-005453-4057qib7	6277	3	23.8	23.8	CD
cord-005453-4057qib7	6277	4	%	%	NN
cord-005453-4057qib7	6277	5	)	)	-RRB-
cord-005453-4057qib7	6277	6	of	of	IN
cord-005453-4057qib7	6277	7	the	the	DT
cord-005453-4057qib7	6277	8	42	42	CD
cord-005453-4057qib7	6277	9	patients	patient	NNS
cord-005453-4057qib7	6277	10	also	also	RB
cord-005453-4057qib7	6277	11	had	have	VBD
cord-005453-4057qib7	6277	12	acute	acute	JJ
cord-005453-4057qib7	6277	13	GVHD	GVHD	NNP
cord-005453-4057qib7	6277	14	of	of	IN
cord-005453-4057qib7	6277	15	the	the	DT
cord-005453-4057qib7	6277	16	skin	skin	NN
cord-005453-4057qib7	6277	17	or	or	CC
cord-005453-4057qib7	6277	18	Liver	liver	NN
cord-005453-4057qib7	6277	19	.	.	.
cord-005453-4057qib7	6278	1	37	37	CD
cord-005453-4057qib7	6278	2	patients	patient	NNS
cord-005453-4057qib7	6278	3	(	(	-LRB-
cord-005453-4057qib7	6278	4	88.09	88.09	CD
cord-005453-4057qib7	6278	5	%	%	NN
cord-005453-4057qib7	6278	6	)	)	-RRB-
cord-005453-4057qib7	6278	7	could	could	MD
cord-005453-4057qib7	6278	8	be	be	VB
cord-005453-4057qib7	6278	9	treated	treat	VBN
cord-005453-4057qib7	6278	10	and	and	CC
cord-005453-4057qib7	6278	11	controlled	control	VBN
cord-005453-4057qib7	6278	12	with	with	IN
cord-005453-4057qib7	6278	13	Methyl	methyl	NN
cord-005453-4057qib7	6278	14	-	-	HYPH
cord-005453-4057qib7	6278	15	prednislone	prednislone	NN
cord-005453-4057qib7	6278	16	monotherapy	monotherapy	NN
cord-005453-4057qib7	6278	17	,	,	,
cord-005453-4057qib7	6278	18	5	5	CD
cord-005453-4057qib7	6278	19	patients	patient	NNS
cord-005453-4057qib7	6278	20	had	have	VBD
cord-005453-4057qib7	6278	21	steroid	steroid	JJ
cord-005453-4057qib7	6278	22	refractory	refractory	JJ
cord-005453-4057qib7	6278	23	GVHD	GVHD	NNP
cord-005453-4057qib7	6278	24	of	of	IN
cord-005453-4057qib7	6278	25	whom	whom	WP
cord-005453-4057qib7	6278	26	3	3	CD
cord-005453-4057qib7	6278	27	patients	patient	NNS
cord-005453-4057qib7	6278	28	(	(	-LRB-
cord-005453-4057qib7	6278	29	7.14	7.14	CD
cord-005453-4057qib7	6278	30	%	%	NN
cord-005453-4057qib7	6278	31	)	)	-RRB-
cord-005453-4057qib7	6278	32	could	could	MD
cord-005453-4057qib7	6278	33	be	be	VB
cord-005453-4057qib7	6278	34	salvaged	salvage	VBN
cord-005453-4057qib7	6278	35	with	with	IN
cord-005453-4057qib7	6278	36	additional	additional	JJ
cord-005453-4057qib7	6278	37	drugs	drug	NNS
cord-005453-4057qib7	6278	38	(	(	-LRB-
cord-005453-4057qib7	6278	39	Infliximab:2	infliximab:2	NN
cord-005453-4057qib7	6278	40	;	;	:
cord-005453-4057qib7	6278	41	Tacrolimus:1	Tacrolimus:1	NNP
cord-005453-4057qib7	6278	42	)	)	-RRB-
cord-005453-4057qib7	6278	43	;	;	:
cord-005453-4057qib7	6278	44	2	2	CD
cord-005453-4057qib7	6278	45	patients	patient	NNS
cord-005453-4057qib7	6278	46	(	(	-LRB-
cord-005453-4057qib7	6278	47	4.77	4.77	CD
cord-005453-4057qib7	6278	48	%	%	NN
cord-005453-4057qib7	6278	49	)	)	-RRB-
cord-005453-4057qib7	6278	50	had	have	VBD
cord-005453-4057qib7	6278	51	refractory	refractory	JJ
cord-005453-4057qib7	6278	52	acute	acute	JJ
cord-005453-4057qib7	6278	53	Gut	Gut	NNP
cord-005453-4057qib7	6278	54	GVHD	GVHD	NNP
cord-005453-4057qib7	6278	55	and	and	CC
cord-005453-4057qib7	6278	56	could	could	MD
cord-005453-4057qib7	6278	57	not	not	RB
cord-005453-4057qib7	6278	58	be	be	VB
cord-005453-4057qib7	6278	59	salvaged	salvage	VBN
cord-005453-4057qib7	6278	60	despite	despite	IN
cord-005453-4057qib7	6278	61	more	more	JJR
cord-005453-4057qib7	6278	62	than	than	IN
cord-005453-4057qib7	6278	63	three	three	CD
cord-005453-4057qib7	6278	64	lines	line	NNS
cord-005453-4057qib7	6278	65	of	of	IN
cord-005453-4057qib7	6278	66	therapy	therapy	NN
cord-005453-4057qib7	6278	67	.	.	.
cord-005453-4057qib7	6279	1	At	at	IN
cord-005453-4057qib7	6279	2	the	the	DT
cord-005453-4057qib7	6279	3	time	time	NN
cord-005453-4057qib7	6279	4	of	of	IN
cord-005453-4057qib7	6279	5	reporting	reporting	NN
cord-005453-4057qib7	6279	6	,	,	,
cord-005453-4057qib7	6279	7	26	26	CD
cord-005453-4057qib7	6279	8	patients	patient	NNS
cord-005453-4057qib7	6279	9	(	(	-LRB-
cord-005453-4057qib7	6279	10	61.9	61.9	CD
cord-005453-4057qib7	6279	11	%	%	NN
cord-005453-4057qib7	6279	12	)	)	-RRB-
cord-005453-4057qib7	6279	13	of	of	IN
cord-005453-4057qib7	6279	14	the	the	DT
cord-005453-4057qib7	6279	15	42	42	CD
cord-005453-4057qib7	6279	16	are	be	VBP
cord-005453-4057qib7	6279	17	alive	alive	JJ
cord-005453-4057qib7	6279	18	.	.	.
cord-005453-4057qib7	6280	1	11	11	CD
cord-005453-4057qib7	6280	2	patients	patient	NNS
cord-005453-4057qib7	6280	3	died	die	VBD
cord-005453-4057qib7	6280	4	due	due	JJ
cord-005453-4057qib7	6280	5	to	to	IN
cord-005453-4057qib7	6280	6	transplant	transplant	NN
cord-005453-4057qib7	6280	7	related	relate	VBN
cord-005453-4057qib7	6280	8	mortality	mortality	NN
cord-005453-4057qib7	6280	9	,	,	,
cord-005453-4057qib7	6280	10	while	while	IN
cord-005453-4057qib7	6280	11	5	5	CD
cord-005453-4057qib7	6280	12	patients	patient	NNS
cord-005453-4057qib7	6280	13	developed	develop	VBD
cord-005453-4057qib7	6280	14	relapsed	relapsed	JJ
cord-005453-4057qib7	6280	15	disease	disease	NN
cord-005453-4057qib7	6280	16	.	.	.
cord-005453-4057qib7	6281	1	On	on	IN
cord-005453-4057qib7	6281	2	binary	binary	JJ
cord-005453-4057qib7	6281	3	logistic	logistic	JJ
cord-005453-4057qib7	6281	4	regression	regression	NN
cord-005453-4057qib7	6281	5	analysis	analysis	NN
cord-005453-4057qib7	6281	6	,	,	,
cord-005453-4057qib7	6281	7	no	no	DT
cord-005453-4057qib7	6281	8	baseline	baseline	JJ
cord-005453-4057qib7	6281	9	clinical	clinical	JJ
cord-005453-4057qib7	6281	10	or	or	CC
cord-005453-4057qib7	6281	11	treatment	treatment	NN
cord-005453-4057qib7	6281	12	related	related	JJ
cord-005453-4057qib7	6281	13	predictor	predictor	NN
cord-005453-4057qib7	6281	14	(	(	-LRB-
cord-005453-4057qib7	6281	15	Disease	Disease	NNP
cord-005453-4057qib7	6281	16	indication	indication	NN
cord-005453-4057qib7	6281	17	,	,	,
cord-005453-4057qib7	6281	18	Disease	Disease	NNP
cord-005453-4057qib7	6281	19	status	status	NN
cord-005453-4057qib7	6281	20	at	at	IN
cord-005453-4057qib7	6281	21	transplant	transplant	NN
cord-005453-4057qib7	6281	22	,	,	,
cord-005453-4057qib7	6281	23	Transplant	Transplant	NNP
cord-005453-4057qib7	6281	24	Type	type	NN
cord-005453-4057qib7	6281	25	,	,	,
cord-005453-4057qib7	6281	26	Graft	Graft	NNP
cord-005453-4057qib7	6281	27	Source	source	NN
cord-005453-4057qib7	6281	28	,	,	,
cord-005453-4057qib7	6281	29	Type	type	NN
cord-005453-4057qib7	6281	30	of	of	IN
cord-005453-4057qib7	6281	31	conditioning	conditioning	NN
cord-005453-4057qib7	6281	32	)	)	-RRB-
cord-005453-4057qib7	6281	33	could	could	MD
cord-005453-4057qib7	6281	34	be	be	VB
cord-005453-4057qib7	6281	35	identified	identify	VBN
cord-005453-4057qib7	6281	36	for	for	IN
cord-005453-4057qib7	6281	37	developing	develop	VBG
cord-005453-4057qib7	6281	38	acute	acute	JJ
cord-005453-4057qib7	6281	39	GVHD	GVHD	NNP
cord-005453-4057qib7	6281	40	of	of	IN
cord-005453-4057qib7	6281	41	the	the	DT
cord-005453-4057qib7	6281	42	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	6281	43	system	system	NN
cord-005453-4057qib7	6281	44	.	.	.
cord-005453-4057qib7	6282	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6282	2	:	:	:
cord-005453-4057qib7	6283	1	Acute	acute	JJ
cord-005453-4057qib7	6283	2	GVHD	GVHD	NNP
cord-005453-4057qib7	6283	3	of	of	IN
cord-005453-4057qib7	6283	4	the	the	DT
cord-005453-4057qib7	6283	5	Gastro	gastro	JJ
cord-005453-4057qib7	6283	6	-	-	HYPH
cord-005453-4057qib7	6283	7	intestinal	intestinal	JJ
cord-005453-4057qib7	6283	8	system	system	NN
cord-005453-4057qib7	6283	9	is	be	VBZ
cord-005453-4057qib7	6283	10	a	a	DT
cord-005453-4057qib7	6283	11	significant	significant	JJ
cord-005453-4057qib7	6283	12	cause	cause	NN
cord-005453-4057qib7	6283	13	for	for	IN
cord-005453-4057qib7	6283	14	morbidity	morbidity	NN
cord-005453-4057qib7	6283	15	in	in	IN
cord-005453-4057qib7	6283	16	Allo	Allo	NNP
cord-005453-4057qib7	6283	17	-	-	HYPH
cord-005453-4057qib7	6283	18	HCT	hct	NN
cord-005453-4057qib7	6283	19	patients	patient	NNS
cord-005453-4057qib7	6283	20	at	at	IN
cord-005453-4057qib7	6283	21	our	-PRON-	PRP$
cord-005453-4057qib7	6283	22	centre	centre	NN
cord-005453-4057qib7	6283	23	.	.	.
cord-005453-4057qib7	6284	1	Further	further	JJ
cord-005453-4057qib7	6284	2	studies	study	NNS
cord-005453-4057qib7	6284	3	are	be	VBP
cord-005453-4057qib7	6284	4	warranted	warrant	VBN
cord-005453-4057qib7	6284	5	in	in	IN
cord-005453-4057qib7	6284	6	our	-PRON-	PRP$
cord-005453-4057qib7	6284	7	cohort	cohort	NN
cord-005453-4057qib7	6284	8	,	,	,
cord-005453-4057qib7	6284	9	and	and	CC
cord-005453-4057qib7	6284	10	a	a	DT
cord-005453-4057qib7	6284	11	prospective	prospective	JJ
cord-005453-4057qib7	6284	12	analysis	analysis	NN
cord-005453-4057qib7	6284	13	of	of	IN
cord-005453-4057qib7	6284	14	gut	gut	NN
cord-005453-4057qib7	6284	15	microbiome	microbiome	NN
cord-005453-4057qib7	6284	16	analysis	analysis	NN
cord-005453-4057qib7	6284	17	,	,	,
cord-005453-4057qib7	6284	18	faecal	faecal	JJ
cord-005453-4057qib7	6284	19	multi	multi	JJ
cord-005453-4057qib7	6284	20	-	-	JJ
cord-005453-4057qib7	6284	21	drug	drug	JJ
cord-005453-4057qib7	6284	22	resistance	resistance	NN
cord-005453-4057qib7	6284	23	organism	organism	NN
cord-005453-4057qib7	6284	24	surveillance	surveillance	NN
cord-005453-4057qib7	6284	25	,	,	,
cord-005453-4057qib7	6284	26	conditioning	conditioning	NN
cord-005453-4057qib7	6284	27	related	relate	VBN
cord-005453-4057qib7	6284	28	toxicity	toxicity	NN
cord-005453-4057qib7	6284	29	and	and	CC
cord-005453-4057qib7	6284	30	antibiotic	antibiotic	JJ
cord-005453-4057qib7	6284	31	usage	usage	NN
cord-005453-4057qib7	6284	32	is	be	VBZ
cord-005453-4057qib7	6284	33	ongoing	ongoing	JJ
cord-005453-4057qib7	6284	34	.	.	.
cord-005453-4057qib7	6285	1	Clinical	clinical	JJ
cord-005453-4057qib7	6285	2	Trial	Trial	NNP
cord-005453-4057qib7	6285	3	Registry	Registry	NNP
cord-005453-4057qib7	6285	4	:	:	:
cord-005453-4057qib7	6286	1	Not	not	RB
cord-005453-4057qib7	6286	2	applicable	applicable	JJ
cord-005453-4057qib7	6286	3	Disclosure	disclosure	NN
cord-005453-4057qib7	6286	4	:	:	:
cord-005453-4057qib7	6287	1	The	the	DT
cord-005453-4057qib7	6287	2	authors	author	NNS
cord-005453-4057qib7	6287	3	declare	declare	VBP
cord-005453-4057qib7	6287	4	no	no	DT
cord-005453-4057qib7	6287	5	potential	potential	JJ
cord-005453-4057qib7	6287	6	conflicts	conflict	NNS
cord-005453-4057qib7	6287	7	of	of	IN
cord-005453-4057qib7	6287	8	interest	interest	NN
cord-005453-4057qib7	6287	9	Benefits	benefit	NNS
cord-005453-4057qib7	6287	10	and	and	CC
cord-005453-4057qib7	6287	11	precautions	precaution	NNS
cord-005453-4057qib7	6287	12	of	of	IN
cord-005453-4057qib7	6287	13	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6287	14	in	in	IN
cord-005453-4057qib7	6287	15	steroidrefractory	steroidrefractory	NNP
cord-005453-4057qib7	6287	16	acute	acute	JJ
cord-005453-4057qib7	6287	17	GVHD	GVHD	NNP
cord-005453-4057qib7	6287	18	Background	Background	NNP
cord-005453-4057qib7	6287	19	:	:	:
cord-005453-4057qib7	6288	1	Corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	6288	2	are	be	VBP
cord-005453-4057qib7	6288	3	the	the	DT
cord-005453-4057qib7	6288	4	standard	standard	JJ
cord-005453-4057qib7	6288	5	first	first	JJ
cord-005453-4057qib7	6288	6	-	-	HYPH
cord-005453-4057qib7	6288	7	line	line	NN
cord-005453-4057qib7	6288	8	treatment	treatment	NN
cord-005453-4057qib7	6288	9	option	option	NN
cord-005453-4057qib7	6288	10	for	for	IN
cord-005453-4057qib7	6288	11	patients	patient	NNS
cord-005453-4057qib7	6288	12	with	with	IN
cord-005453-4057qib7	6288	13	acute	acute	JJ
cord-005453-4057qib7	6288	14	graft	graft	NN
cord-005453-4057qib7	6288	15	-	-	HYPH
cord-005453-4057qib7	6288	16	versus	versus	IN
cord-005453-4057qib7	6288	17	host	host	NN
cord-005453-4057qib7	6288	18	disease	disease	NN
cord-005453-4057qib7	6288	19	(	(	-LRB-
cord-005453-4057qib7	6288	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6288	21	)	)	-RRB-
cord-005453-4057qib7	6288	22	,	,	,
cord-005453-4057qib7	6288	23	but	but	CC
cord-005453-4057qib7	6288	24	approximately	approximately	RB
cord-005453-4057qib7	6288	25	half	half	NN
cord-005453-4057qib7	6288	26	of	of	IN
cord-005453-4057qib7	6288	27	patients	patient	NNS
cord-005453-4057qib7	6288	28	become	become	VBP
cord-005453-4057qib7	6288	29	refractory	refractory	JJ
cord-005453-4057qib7	6288	30	to	to	IN
cord-005453-4057qib7	6288	31	steroids	steroid	NNS
cord-005453-4057qib7	6288	32	and	and	CC
cord-005453-4057qib7	6288	33	require	require	VB
cord-005453-4057qib7	6288	34	second	second	JJ
cord-005453-4057qib7	6288	35	-	-	HYPH
cord-005453-4057qib7	6288	36	line	line	NN
cord-005453-4057qib7	6288	37	treatment	treatment	NN
cord-005453-4057qib7	6288	38	.	.	.
cord-005453-4057qib7	6289	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	6289	2	has	have	VBZ
cord-005453-4057qib7	6289	3	the	the	DT
cord-005453-4057qib7	6289	4	potential	potential	NN
cord-005453-4057qib7	6289	5	to	to	TO
cord-005453-4057qib7	6289	6	treat	treat	VB
cord-005453-4057qib7	6289	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6289	8	in	in	IN
cord-005453-4057qib7	6289	9	steroidrefractory	steroidrefractory	NNP
cord-005453-4057qib7	6289	10	(	(	-LRB-
cord-005453-4057qib7	6289	11	SR	SR	NNP
cord-005453-4057qib7	6289	12	)	)	-RRB-
cord-005453-4057qib7	6289	13	patients	patient	NNS
cord-005453-4057qib7	6289	14	based	base	VBN
cord-005453-4057qib7	6289	15	on	on	IN
cord-005453-4057qib7	6289	16	retrospective	retrospective	JJ
cord-005453-4057qib7	6289	17	clinical	clinical	JJ
cord-005453-4057qib7	6289	18	data	datum	NNS
cord-005453-4057qib7	6289	19	.	.	.
cord-005453-4057qib7	6290	1	The	the	DT
cord-005453-4057qib7	6290	2	ongoing	ongoing	JJ
cord-005453-4057qib7	6290	3	prospective	prospective	JJ
cord-005453-4057qib7	6290	4	trials	trial	NNS
cord-005453-4057qib7	6290	5	are	be	VBP
cord-005453-4057qib7	6290	6	currently	currently	RB
cord-005453-4057qib7	6290	7	enrolling	enrol	VBG
cord-005453-4057qib7	6290	8	patients	patient	NNS
cord-005453-4057qib7	6290	9	to	to	TO
cord-005453-4057qib7	6290	10	evaluate	evaluate	VB
cord-005453-4057qib7	6290	11	the	the	DT
cord-005453-4057qib7	6290	12	therapeutic	therapeutic	JJ
cord-005453-4057qib7	6290	13	potential	potential	NN
cord-005453-4057qib7	6290	14	of	of	IN
cord-005453-4057qib7	6290	15	ruxolitinib	ruxolitinib	NN
cord-005453-4057qib7	6290	16	for	for	IN
cord-005453-4057qib7	6290	17	GVHD	GVHD	NNP
cord-005453-4057qib7	6290	18	.	.	.
cord-005453-4057qib7	6291	1	Methods	method	NNS
cord-005453-4057qib7	6291	2	:	:	:
cord-005453-4057qib7	6292	1	We	-PRON-	PRP
cord-005453-4057qib7	6292	2	analyzed	analyze	VBD
cord-005453-4057qib7	6292	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	6292	4	clinical	clinical	JJ
cord-005453-4057qib7	6292	5	experience	experience	NN
cord-005453-4057qib7	6292	6	with	with	IN
cord-005453-4057qib7	6292	7	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6292	8	in	in	IN
cord-005453-4057qib7	6292	9	patients	patient	NNS
cord-005453-4057qib7	6292	10	(	(	-LRB-
cord-005453-4057qib7	6292	11	n=15	n=15	NNP
cord-005453-4057qib7	6292	12	)	)	-RRB-
cord-005453-4057qib7	6292	13	with	with	IN
cord-005453-4057qib7	6292	14	grade	grade	NN
cord-005453-4057qib7	6292	15	2~4	2~4	CD
cord-005453-4057qib7	6292	16	steroid	steroid	JJ
cord-005453-4057qib7	6292	17	-	-	HYPH
cord-005453-4057qib7	6292	18	refractory	refractory	JJ
cord-005453-4057qib7	6292	19	acute	acute	JJ
cord-005453-4057qib7	6292	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6292	21	patients	patient	NNS
cord-005453-4057qib7	6292	22	compared	compare	VBN
cord-005453-4057qib7	6292	23	with	with	IN
cord-005453-4057qib7	6292	24	the	the	DT
cord-005453-4057qib7	6292	25	control	control	NN
cord-005453-4057qib7	6292	26	group	group	NN
cord-005453-4057qib7	6292	27	not	not	RB
cord-005453-4057qib7	6292	28	receiving	receive	VBG
cord-005453-4057qib7	6292	29	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6292	30	.	.	.
cord-005453-4057qib7	6293	1	In	in	IN
cord-005453-4057qib7	6293	2	addition	addition	NN
cord-005453-4057qib7	6293	3	,	,	,
cord-005453-4057qib7	6293	4	immune	immune	JJ
cord-005453-4057qib7	6293	5	status	status	NN
cord-005453-4057qib7	6293	6	was	be	VBD
cord-005453-4057qib7	6293	7	evaluated	evaluate	VBN
cord-005453-4057qib7	6293	8	about	about	IN
cord-005453-4057qib7	6293	9	6	6	CD
cord-005453-4057qib7	6293	10	weeks~8	weeks~8	NNP
cord-005453-4057qib7	6293	11	weeks	week	NNS
cord-005453-4057qib7	6293	12	after	after	IN
cord-005453-4057qib7	6293	13	the	the	DT
cord-005453-4057qib7	6293	14	administration	administration	NN
cord-005453-4057qib7	6293	15	of	of	IN
cord-005453-4057qib7	6293	16	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6293	17	using	use	VBG
cord-005453-4057qib7	6293	18	flow	flow	NN
cord-005453-4057qib7	6293	19	-	-	HYPH
cord-005453-4057qib7	6293	20	cytometry	cytometry	NN
cord-005453-4057qib7	6293	21	.	.	.
cord-005453-4057qib7	6294	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	6294	2	was	be	VBD
cord-005453-4057qib7	6294	3	used	use	VBN
cord-005453-4057qib7	6294	4	as	as	IN
cord-005453-4057qib7	6294	5	a	a	DT
cord-005453-4057qib7	6294	6	third	third	JJ
cord-005453-4057qib7	6294	7	option	option	NN
cord-005453-4057qib7	6294	8	for	for	IN
cord-005453-4057qib7	6294	9	SR	SR	NNP
cord-005453-4057qib7	6294	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6294	11	,	,	,
cord-005453-4057qib7	6294	12	combined	combine	VBN
cord-005453-4057qib7	6294	13	with	with	IN
cord-005453-4057qib7	6294	14	previously	previously	RB
cord-005453-4057qib7	6294	15	used	use	VBN
cord-005453-4057qib7	6294	16	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6294	17	drugs	drug	NNS
cord-005453-4057qib7	6294	18	.	.	.
cord-005453-4057qib7	6295	1	And	and	CC
cord-005453-4057qib7	6295	2	steroids	steroid	NNS
cord-005453-4057qib7	6295	3	were	be	VBD
cord-005453-4057qib7	6295	4	gradually	gradually	RB
cord-005453-4057qib7	6295	5	decreased	decrease	VBN
cord-005453-4057qib7	6295	6	according	accord	VBG
cord-005453-4057qib7	6295	7	to	to	IN
cord-005453-4057qib7	6295	8	the	the	DT
cord-005453-4057qib7	6295	9	symptoms	symptom	NNS
cord-005453-4057qib7	6295	10	and	and	CC
cord-005453-4057qib7	6295	11	discontinued	discontinue	VBD
cord-005453-4057qib7	6295	12	.	.	.
cord-005453-4057qib7	6296	1	Patients	patient	NNS
cord-005453-4057qib7	6296	2	received	receive	VBD
cord-005453-4057qib7	6296	3	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6296	4	5	5	CD
cord-005453-4057qib7	6296	5	mg	mg	NNP
cord-005453-4057qib7	6296	6	twice	twice	RB
cord-005453-4057qib7	6296	7	daily	daily	RB
cord-005453-4057qib7	6296	8	(	(	-LRB-
cord-005453-4057qib7	6296	9	BID	BID	NNP
cord-005453-4057qib7	6296	10	)	)	-RRB-
cord-005453-4057qib7	6296	11	,	,	,
cord-005453-4057qib7	6296	12	with	with	IN
cord-005453-4057qib7	6296	13	increase	increase	NN
cord-005453-4057qib7	6296	14	to	to	IN
cord-005453-4057qib7	6296	15	10	10	CD
cord-005453-4057qib7	6296	16	mg	mg	NN
cord-005453-4057qib7	6296	17	BID	BID	NNP
cord-005453-4057qib7	6296	18	if	if	IN
cord-005453-4057qib7	6296	19	hematologic	hematologic	JJ
cord-005453-4057qib7	6296	20	parameters	parameter	NNS
cord-005453-4057qib7	6296	21	are	be	VBP
cord-005453-4057qib7	6296	22	stable	stable	JJ
cord-005453-4057qib7	6296	23	and	and	CC
cord-005453-4057qib7	6296	24	no	no	DT
cord-005453-4057qib7	6296	25	treatmentrelated	treatmentrelate	VBN
cord-005453-4057qib7	6296	26	toxicities	toxicity	NNS
cord-005453-4057qib7	6296	27	.	.	.
cord-005453-4057qib7	6297	1	Results	result	NNS
cord-005453-4057qib7	6297	2	:	:	:
cord-005453-4057qib7	6298	1	Fifteen	fifteen	CD
cord-005453-4057qib7	6298	2	patients	patient	NNS
cord-005453-4057qib7	6298	3	all	all	DT
cord-005453-4057qib7	6298	4	were	be	VBD
cord-005453-4057qib7	6298	5	assessable	assessable	JJ
cord-005453-4057qib7	6298	6	for	for	IN
cord-005453-4057qib7	6298	7	response	response	NN
cord-005453-4057qib7	6298	8	.	.	.
cord-005453-4057qib7	6299	1	Seven	seven	CD
cord-005453-4057qib7	6299	2	patients	patient	NNS
cord-005453-4057qib7	6299	3	achieved	achieve	VBD
cord-005453-4057qib7	6299	4	a	a	DT
cord-005453-4057qib7	6299	5	complete	complete	JJ
cord-005453-4057qib7	6299	6	response	response	NN
cord-005453-4057qib7	6299	7	,	,	,
cord-005453-4057qib7	6299	8	5	5	CD
cord-005453-4057qib7	6299	9	had	have	VBD
cord-005453-4057qib7	6299	10	a	a	DT
cord-005453-4057qib7	6299	11	partial	partial	JJ
cord-005453-4057qib7	6299	12	response	response	NN
cord-005453-4057qib7	6299	13	,	,	,
cord-005453-4057qib7	6299	14	and	and	CC
cord-005453-4057qib7	6299	15	3	3	CD
cord-005453-4057qib7	6299	16	had	have	VBD
cord-005453-4057qib7	6299	17	no	no	DT
cord-005453-4057qib7	6299	18	response	response	NN
cord-005453-4057qib7	6299	19	at	at	IN
cord-005453-4057qib7	6299	20	8	8	CD
cord-005453-4057qib7	6299	21	weeks	week	NNS
cord-005453-4057qib7	6299	22	after	after	IN
cord-005453-4057qib7	6299	23	the	the	DT
cord-005453-4057qib7	6299	24	first	first	JJ
cord-005453-4057qib7	6299	25	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6299	26	dose	dose	NN
cord-005453-4057qib7	6299	27	.	.	.
cord-005453-4057qib7	6300	1	Overall	overall	JJ
cord-005453-4057qib7	6300	2	response	response	NN
cord-005453-4057qib7	6300	3	rate	rate	NN
cord-005453-4057qib7	6300	4	was	be	VBD
cord-005453-4057qib7	6300	5	75	75	CD
cord-005453-4057qib7	6300	6	%	%	NN
cord-005453-4057qib7	6300	7	.	.	.
cord-005453-4057qib7	6301	1	Three	three	CD
cord-005453-4057qib7	6301	2	were	be	VBD
cord-005453-4057qib7	6301	3	treatment	treatment	NN
cord-005453-4057qib7	6301	4	failures	failure	NNS
cord-005453-4057qib7	6301	5	.	.	.
cord-005453-4057qib7	6302	1	Most	Most	JJS
cord-005453-4057qib7	6302	2	adverse	adverse	JJ
cord-005453-4057qib7	6302	3	effects	effect	NNS
cord-005453-4057qib7	6302	4	were	be	VBD
cord-005453-4057qib7	6302	5	manageable	manageable	JJ
cord-005453-4057qib7	6302	6	,	,	,
cord-005453-4057qib7	6302	7	except	except	IN
cord-005453-4057qib7	6302	8	infectious	infectious	JJ
cord-005453-4057qib7	6302	9	complications	complication	NNS
cord-005453-4057qib7	6302	10	.	.	.
cord-005453-4057qib7	6303	1	Infectious	infectious	JJ
cord-005453-4057qib7	6303	2	complications	complication	NNS
cord-005453-4057qib7	6303	3	were	be	VBD
cord-005453-4057qib7	6303	4	occurred	occur	VBN
cord-005453-4057qib7	6303	5	in	in	IN
cord-005453-4057qib7	6303	6	about	about	RB
cord-005453-4057qib7	6303	7	73	73	CD
cord-005453-4057qib7	6303	8	%	%	NN
cord-005453-4057qib7	6303	9	patients	patient	NNS
cord-005453-4057qib7	6303	10	(	(	-LRB-
cord-005453-4057qib7	6303	11	n	n	NN
cord-005453-4057qib7	6303	12	=	=	SYM
cord-005453-4057qib7	6303	13	11	11	CD
cord-005453-4057qib7	6303	14	)	)	-RRB-
cord-005453-4057qib7	6303	15	,	,	,
cord-005453-4057qib7	6303	16	resulting	result	VBG
cord-005453-4057qib7	6303	17	in	in	IN
cord-005453-4057qib7	6303	18	two	two	CD
cord-005453-4057qib7	6303	19	deaths	death	NNS
cord-005453-4057qib7	6303	20	.	.	.
cord-005453-4057qib7	6304	1	Common	common	JJ
cord-005453-4057qib7	6304	2	cause	cause	NN
cord-005453-4057qib7	6304	3	of	of	IN
cord-005453-4057qib7	6304	4	infectious	infectious	JJ
cord-005453-4057qib7	6304	5	events	event	NNS
cord-005453-4057qib7	6304	6	included	include	VBD
cord-005453-4057qib7	6304	7	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	6304	8	(	(	-LRB-
cord-005453-4057qib7	6304	9	n	n	NN
cord-005453-4057qib7	6304	10	=	=	SYM
cord-005453-4057qib7	6304	11	5	5	CD
cord-005453-4057qib7	6304	12	)	)	-RRB-
cord-005453-4057qib7	6304	13	,	,	,
cord-005453-4057qib7	6304	14	herpes	herpes	NN
cord-005453-4057qib7	6304	15	-	-	HYPH
cord-005453-4057qib7	6304	16	zoster	zoster	NN
cord-005453-4057qib7	6304	17	(	(	-LRB-
cord-005453-4057qib7	6304	18	n=2	n=2	NNS
cord-005453-4057qib7	6304	19	)	)	-RRB-
cord-005453-4057qib7	6304	20	,	,	,
cord-005453-4057qib7	6304	21	Epstein	Epstein	NNP
cord-005453-4057qib7	6304	22	-	-	HYPH
cord-005453-4057qib7	6304	23	Barr	Barr	NNP
cord-005453-4057qib7	6304	24	virus	virus	NN
cord-005453-4057qib7	6304	25	(	(	-LRB-
cord-005453-4057qib7	6304	26	n=2	n=2	NNS
cord-005453-4057qib7	6304	27	)	)	-RRB-
cord-005453-4057qib7	6304	28	,	,	,
cord-005453-4057qib7	6304	29	fungal	fungal	JJ
cord-005453-4057qib7	6304	30	infection	infection	NN
cord-005453-4057qib7	6305	1	(	(	-LRB-
cord-005453-4057qib7	6305	2	n	n	NN
cord-005453-4057qib7	6305	3	=	=	SYM
cord-005453-4057qib7	6305	4	2	2	CD
cord-005453-4057qib7	6305	5	)	)	-RRB-
cord-005453-4057qib7	6305	6	,	,	,
cord-005453-4057qib7	6305	7	pneumocystis	pneumocystis	NNP
cord-005453-4057qib7	6305	8	jiroveci	jiroveci	NNP
cord-005453-4057qib7	6305	9	(	(	-LRB-
cord-005453-4057qib7	6305	10	n	n	NN
cord-005453-4057qib7	6305	11	=	=	SYM
cord-005453-4057qib7	6305	12	2	2	CD
cord-005453-4057qib7	6305	13	)	)	-RRB-
cord-005453-4057qib7	6305	14	,	,	,
cord-005453-4057qib7	6305	15	bacterial	bacterial	JJ
cord-005453-4057qib7	6305	16	infections	infection	NNS
cord-005453-4057qib7	6305	17	(	(	-LRB-
cord-005453-4057qib7	6305	18	n	n	NN
cord-005453-4057qib7	6305	19	=	=	SYM
cord-005453-4057qib7	6305	20	1	1	CD
cord-005453-4057qib7	6305	21	)	)	-RRB-
cord-005453-4057qib7	6305	22	,	,	,
cord-005453-4057qib7	6305	23	and	and	CC
cord-005453-4057qib7	6305	24	pneumonia	pneumonia	NN
cord-005453-4057qib7	6305	25	of	of	IN
cord-005453-4057qib7	6305	26	unknown	unknown	JJ
cord-005453-4057qib7	6305	27	origin	origin	NN
cord-005453-4057qib7	6305	28	(	(	-LRB-
cord-005453-4057qib7	6305	29	n	n	NN
cord-005453-4057qib7	6305	30	=	=	SYM
cord-005453-4057qib7	6305	31	1	1	CD
cord-005453-4057qib7	6305	32	)	)	-RRB-
cord-005453-4057qib7	6305	33	.	.	.
cord-005453-4057qib7	6306	1	T	T	NNP
cord-005453-4057qib7	6306	2	cell	cell	NN
cord-005453-4057qib7	6306	3	counts	count	NNS
cord-005453-4057qib7	6306	4	tended	tend	VBD
cord-005453-4057qib7	6306	5	to	to	TO
cord-005453-4057qib7	6306	6	decreased	decrease	VBD
cord-005453-4057qib7	6306	7	in	in	IN
cord-005453-4057qib7	6306	8	the	the	DT
cord-005453-4057qib7	6306	9	group	group	NN
cord-005453-4057qib7	6306	10	with	with	IN
cord-005453-4057qib7	6306	11	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6306	12	compared	compare	VBN
cord-005453-4057qib7	6306	13	with	with	IN
cord-005453-4057qib7	6306	14	the	the	DT
cord-005453-4057qib7	6306	15	control	control	NN
cord-005453-4057qib7	6306	16	group	group	NN
cord-005453-4057qib7	6306	17	,	,	,
cord-005453-4057qib7	6306	18	especially	especially	RB
cord-005453-4057qib7	6306	19	CD4	CD4	NNP
cord-005453-4057qib7	6306	20	cell	cell	NN
cord-005453-4057qib7	6306	21	counts	count	VBZ
cord-005453-4057qib7	6306	22	.	.	.
cord-005453-4057qib7	6307	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6307	2	:	:	:
cord-005453-4057qib7	6308	1	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	6308	2	is	be	VBZ
cord-005453-4057qib7	6308	3	effective	effective	JJ
cord-005453-4057qib7	6308	4	in	in	IN
cord-005453-4057qib7	6308	5	controlling	control	VBG
cord-005453-4057qib7	6308	6	SR	SR	NNP
cord-005453-4057qib7	6308	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6308	8	and	and	CC
cord-005453-4057qib7	6308	9	can	can	MD
cord-005453-4057qib7	6308	10	lead	lead	VB
cord-005453-4057qib7	6308	11	to	to	IN
cord-005453-4057qib7	6308	12	clinical	clinical	JJ
cord-005453-4057qib7	6308	13	benefits	benefit	NNS
cord-005453-4057qib7	6308	14	.	.	.
cord-005453-4057qib7	6309	1	However	however	RB
cord-005453-4057qib7	6309	2	,	,	,
cord-005453-4057qib7	6309	3	we	-PRON-	PRP
cord-005453-4057qib7	6309	4	need	need	VBP
cord-005453-4057qib7	6309	5	to	to	TO
cord-005453-4057qib7	6309	6	be	be	VB
cord-005453-4057qib7	6309	7	aware	aware	JJ
cord-005453-4057qib7	6309	8	of	of	IN
cord-005453-4057qib7	6309	9	the	the	DT
cord-005453-4057qib7	6309	10	infectious	infectious	JJ
cord-005453-4057qib7	6309	11	complications	complication	NNS
cord-005453-4057qib7	6309	12	because	because	IN
cord-005453-4057qib7	6309	13	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6309	14	may	may	MD
cord-005453-4057qib7	6309	15	lead	lead	VB
cord-005453-4057qib7	6309	16	to	to	IN
cord-005453-4057qib7	6309	17	increased	increase	VBN
cord-005453-4057qib7	6309	18	risk	risk	NN
cord-005453-4057qib7	6309	19	of	of	IN
cord-005453-4057qib7	6309	20	opportunistic	opportunistic	JJ
cord-005453-4057qib7	6309	21	infections	infection	NNS
cord-005453-4057qib7	6309	22	or	or	CC
cord-005453-4057qib7	6309	23	reactivation	reactivation	NN
cord-005453-4057qib7	6309	24	of	of	IN
cord-005453-4057qib7	6309	25	latent	latent	JJ
cord-005453-4057qib7	6309	26	infections	infection	NNS
cord-005453-4057qib7	6309	27	.	.	.
cord-005453-4057qib7	6310	1	In	in	IN
cord-005453-4057qib7	6310	2	addition	addition	NN
cord-005453-4057qib7	6310	3	,	,	,
cord-005453-4057qib7	6310	4	common	common	JJ
cord-005453-4057qib7	6310	5	infectious	infectious	JJ
cord-005453-4057qib7	6310	6	complications	complication	NNS
cord-005453-4057qib7	6310	7	are	be	VBP
cord-005453-4057qib7	6310	8	presumed	presume	VBN
cord-005453-4057qib7	6310	9	to	to	TO
cord-005453-4057qib7	6310	10	involve	involve	VB
cord-005453-4057qib7	6310	11	T	T	NNP
cord-005453-4057qib7	6310	12	cell	cell	NN
cord-005453-4057qib7	6310	13	dysfunction	dysfunction	NN
cord-005453-4057qib7	6310	14	.	.	.
cord-005453-4057qib7	6311	1	Clinical	clinical	JJ
cord-005453-4057qib7	6311	2	Background	background	NN
cord-005453-4057qib7	6311	3	:	:	:
cord-005453-4057qib7	6311	4	Graft	graft	NN
cord-005453-4057qib7	6311	5	versus	versus	IN
cord-005453-4057qib7	6311	6	host	host	NN
cord-005453-4057qib7	6311	7	disease	disease	NN
cord-005453-4057qib7	6311	8	(	(	-LRB-
cord-005453-4057qib7	6311	9	GvHD	GvHD	NNP
cord-005453-4057qib7	6311	10	)	)	-RRB-
cord-005453-4057qib7	6311	11	,	,	,
cord-005453-4057qib7	6311	12	being	be	VBG
cord-005453-4057qib7	6311	13	one	one	CD
cord-005453-4057qib7	6311	14	of	of	IN
cord-005453-4057qib7	6311	15	most	most	JJS
cord-005453-4057qib7	6311	16	common	common	JJ
cord-005453-4057qib7	6311	17	life	life	NN
cord-005453-4057qib7	6311	18	-	-	HYPH
cord-005453-4057qib7	6311	19	threatening	threaten	VBG
cord-005453-4057qib7	6311	20	complication	complication	NN
cord-005453-4057qib7	6311	21	post	post	NN
cord-005453-4057qib7	6311	22	HSCT	HSCT	NNP
cord-005453-4057qib7	6311	23	,	,	,
cord-005453-4057qib7	6311	24	contributes	contribute	VBZ
cord-005453-4057qib7	6311	25	significantly	significantly	RB
cord-005453-4057qib7	6311	26	to	to	IN
cord-005453-4057qib7	6311	27	morbidity	morbidity	NN
cord-005453-4057qib7	6311	28	and	and	CC
cord-005453-4057qib7	6311	29	mortality	mortality	NN
cord-005453-4057qib7	6311	30	.	.	.
cord-005453-4057qib7	6312	1	When	when	WRB
cord-005453-4057qib7	6312	2	affecting	affect	VBG
cord-005453-4057qib7	6312	3	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	6312	4	tract	tract	NN
cord-005453-4057qib7	6312	5	(	(	-LRB-
cord-005453-4057qib7	6312	6	GI	GI	NNP
cord-005453-4057qib7	6312	7	)	)	-RRB-
cord-005453-4057qib7	6313	1	it	-PRON-	PRP
cord-005453-4057qib7	6313	2	is	be	VBZ
cord-005453-4057qib7	6313	3	the	the	DT
cord-005453-4057qib7	6313	4	major	major	JJ
cord-005453-4057qib7	6313	5	cause	cause	NN
cord-005453-4057qib7	6313	6	of	of	IN
cord-005453-4057qib7	6313	7	death	death	NN
cord-005453-4057qib7	6313	8	in	in	IN
cord-005453-4057qib7	6313	9	early	early	JJ
cord-005453-4057qib7	6313	10	period	period	NN
cord-005453-4057qib7	6313	11	post	post	NN
cord-005453-4057qib7	6313	12	HSCT	HSCT	NNP
cord-005453-4057qib7	6313	13	.	.	.
cord-005453-4057qib7	6314	1	Due	due	IN
cord-005453-4057qib7	6314	2	to	to	IN
cord-005453-4057qib7	6314	3	widespread	widespread	JJ
cord-005453-4057qib7	6314	4	tissue	tissue	NN
cord-005453-4057qib7	6314	5	involvement	involvement	NN
cord-005453-4057qib7	6314	6	in	in	IN
cord-005453-4057qib7	6314	7	most	most	JJS
cord-005453-4057qib7	6314	8	patients	patient	NNS
cord-005453-4057qib7	6314	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	6314	10	with	with	IN
cord-005453-4057qib7	6314	11	GI	GI	NNP
cord-005453-4057qib7	6314	12	GvHD	GvHD	NNP
cord-005453-4057qib7	6314	13	,	,	,
cord-005453-4057qib7	6314	14	surgical	surgical	JJ
cord-005453-4057qib7	6314	15	treatment	treatment	NN
cord-005453-4057qib7	6314	16	is	be	VBZ
cord-005453-4057qib7	6314	17	rarely	rarely	RB
cord-005453-4057qib7	6314	18	considered	consider	VBN
cord-005453-4057qib7	6314	19	.	.	.
cord-005453-4057qib7	6315	1	Methods	method	NNS
cord-005453-4057qib7	6315	2	:	:	:
cord-005453-4057qib7	6316	1	Among	among	IN
cord-005453-4057qib7	6316	2	972	972	CD
cord-005453-4057qib7	6316	3	allo	allo	NN
cord-005453-4057qib7	6316	4	-	-	HYPH
cord-005453-4057qib7	6316	5	HSCT	HSCT	NNP
cord-005453-4057qib7	6316	6	performed	perform	VBD
cord-005453-4057qib7	6316	7	in	in	IN
cord-005453-4057qib7	6316	8	Department	Department	NNP
cord-005453-4057qib7	6316	9	of	of	IN
cord-005453-4057qib7	6316	10	Pediatric	Pediatric	NNP
cord-005453-4057qib7	6316	11	Hematology	Hematology	NNP
cord-005453-4057qib7	6316	12	,	,	,
cord-005453-4057qib7	6316	13	Oncology	Oncology	NNP
cord-005453-4057qib7	6316	14	and	and	CC
cord-005453-4057qib7	6316	15	Bone	Bone	NNP
cord-005453-4057qib7	6316	16	Marrow	Marrow	NNP
cord-005453-4057qib7	6316	17	Transplantation	transplantation	NN
cord-005453-4057qib7	6316	18	in	in	IN
cord-005453-4057qib7	6316	19	Wroclaw	Wroclaw	NNP
cord-005453-4057qib7	6316	20	,	,	,
cord-005453-4057qib7	6316	21	Poland	Poland	NNP
cord-005453-4057qib7	6316	22	during	during	IN
cord-005453-4057qib7	6316	23	years	year	NNS
cord-005453-4057qib7	6316	24	1996	1996	CD
cord-005453-4057qib7	6316	25	-	-	SYM
cord-005453-4057qib7	6316	26	2018	2018	CD
cord-005453-4057qib7	6316	27	,	,	,
cord-005453-4057qib7	6316	28	291	291	CD
cord-005453-4057qib7	6316	29	(	(	-LRB-
cord-005453-4057qib7	6316	30	29,9	29,9	CD
cord-005453-4057qib7	6316	31	%	%	NN
cord-005453-4057qib7	6316	32	)	)	-RRB-
cord-005453-4057qib7	6316	33	cases	case	NNS
cord-005453-4057qib7	6316	34	were	be	VBD
cord-005453-4057qib7	6316	35	diagnosed	diagnose	VBN
cord-005453-4057qib7	6316	36	with	with	IN
cord-005453-4057qib7	6316	37	GI	GI	NNP
cord-005453-4057qib7	6316	38	GvHD	GvHD	NNP
cord-005453-4057qib7	6316	39	.	.	.
cord-005453-4057qib7	6317	1	In	in	IN
cord-005453-4057qib7	6317	2	this	this	DT
cord-005453-4057qib7	6317	3	study	study	NN
cord-005453-4057qib7	6317	4	we	-PRON-	PRP
cord-005453-4057qib7	6317	5	present	present	VBP
cord-005453-4057qib7	6317	6	3	3	CD
cord-005453-4057qib7	6317	7	cases	case	NNS
cord-005453-4057qib7	6317	8	(	(	-LRB-
cord-005453-4057qib7	6317	9	1	1	CD
cord-005453-4057qib7	6317	10	%	%	NN
cord-005453-4057qib7	6317	11	)	)	-RRB-
cord-005453-4057qib7	6317	12	which	which	WDT
cord-005453-4057qib7	6317	13	were	be	VBD
cord-005453-4057qib7	6317	14	referred	refer	VBN
cord-005453-4057qib7	6317	15	to	to	IN
cord-005453-4057qib7	6317	16	and	and	CC
cord-005453-4057qib7	6317	17	benefit	benefit	VB
cord-005453-4057qib7	6317	18	from	from	IN
cord-005453-4057qib7	6317	19	surgical	surgical	JJ
cord-005453-4057qib7	6317	20	approach	approach	NN
cord-005453-4057qib7	6317	21	.	.	.
cord-005453-4057qib7	6318	1	Results	result	NNS
cord-005453-4057qib7	6318	2	:	:	:
cord-005453-4057qib7	6318	3	1	1	CD
cord-005453-4057qib7	6318	4	.	.	.
cord-005453-4057qib7	6319	1	Male	male	JJ
cord-005453-4057qib7	6319	2	,	,	,
cord-005453-4057qib7	6319	3	4	4	CD
cord-005453-4057qib7	6319	4	years	year	NNS
cord-005453-4057qib7	6319	5	old	old	JJ
cord-005453-4057qib7	6319	6	underwent	undergo	VBD
cord-005453-4057qib7	6319	7	HSCT	HSCT	NNP
cord-005453-4057qib7	6319	8	from	from	IN
cord-005453-4057qib7	6319	9	matched	matched	JJ
cord-005453-4057qib7	6319	10	unrelated	unrelated	JJ
cord-005453-4057qib7	6319	11	donor	donor	NN
cord-005453-4057qib7	6319	12	(	(	-LRB-
cord-005453-4057qib7	6319	13	MUD	mud	NN
cord-005453-4057qib7	6319	14	)	)	-RRB-
cord-005453-4057qib7	6319	15	due	due	IN
cord-005453-4057qib7	6319	16	to	to	IN
cord-005453-4057qib7	6319	17	chronic	chronic	JJ
cord-005453-4057qib7	6319	18	myelogenous	myelogenous	NN
cord-005453-4057qib7	6319	19	leukemia	leukemia	NN
cord-005453-4057qib7	6319	20	(	(	-LRB-
cord-005453-4057qib7	6319	21	CML	CML	NNP
cord-005453-4057qib7	6319	22	)	)	-RRB-
cord-005453-4057qib7	6319	23	and	and	CC
cord-005453-4057qib7	6319	24	subsequent	subsequent	JJ
cord-005453-4057qib7	6319	25	molecular	molecular	JJ
cord-005453-4057qib7	6319	26	relapse	relapse	NN
cord-005453-4057qib7	6319	27	succesfully	succesfully	RB
cord-005453-4057qib7	6319	28	treated	treat	VBD
cord-005453-4057qib7	6319	29	with	with	IN
cord-005453-4057qib7	6319	30	donor	donor	NN
cord-005453-4057qib7	6319	31	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6319	32	infusion	infusion	NN
cord-005453-4057qib7	6319	33	,	,	,
cord-005453-4057qib7	6319	34	followed	follow	VBN
cord-005453-4057qib7	6319	35	by	by	IN
cord-005453-4057qib7	6319	36	aGvHD	agvhd	NN
cord-005453-4057qib7	6319	37	(	(	-LRB-
cord-005453-4057qib7	6319	38	skin	skin	NN
cord-005453-4057qib7	6319	39	and	and	CC
cord-005453-4057qib7	6319	40	gut	gut	NN
cord-005453-4057qib7	6319	41	involvement	involvement	NN
cord-005453-4057qib7	6319	42	,	,	,
cord-005453-4057qib7	6319	43	grade	grade	NN
cord-005453-4057qib7	6319	44	IV	IV	NNP
cord-005453-4057qib7	6319	45	)	)	-RRB-
cord-005453-4057qib7	6319	46	.	.	.
cord-005453-4057qib7	6320	1	Extensive	extensive	JJ
cord-005453-4057qib7	6320	2	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	6320	3	(	(	-LRB-
cord-005453-4057qib7	6320	4	steroids	steroid	NNS
cord-005453-4057qib7	6320	5	,	,	,
cord-005453-4057qib7	6320	6	mycofenolate	mycofenolate	NNP
cord-005453-4057qib7	6320	7	mofetile	mofetile	NNP
cord-005453-4057qib7	6320	8	,	,	,
cord-005453-4057qib7	6320	9	ATG	ATG	NNP
cord-005453-4057qib7	6320	10	,	,	,
cord-005453-4057qib7	6320	11	OKT3	OKT3	NNP
cord-005453-4057qib7	6320	12	)	)	-RRB-
cord-005453-4057qib7	6320	13	resulted	result	VBD
cord-005453-4057qib7	6320	14	in	in	IN
cord-005453-4057qib7	6320	15	significant	significant	JJ
cord-005453-4057qib7	6320	16	resolution	resolution	NN
cord-005453-4057qib7	6320	17	of	of	IN
cord-005453-4057qib7	6320	18	aGvHD	agvhd	NN
cord-005453-4057qib7	6320	19	symptoms	symptom	NNS
cord-005453-4057qib7	6320	20	.	.	.
cord-005453-4057qib7	6321	1	However	however	RB
cord-005453-4057qib7	6321	2	aggravating	aggravating	JJ
cord-005453-4057qib7	6321	3	severe	severe	JJ
cord-005453-4057qib7	6321	4	abdominal	abdominal	JJ
cord-005453-4057qib7	6321	5	pain	pain	NN
cord-005453-4057qib7	6321	6	and	and	CC
cord-005453-4057qib7	6321	7	lack	lack	NN
cord-005453-4057qib7	6321	8	of	of	IN
cord-005453-4057qib7	6321	9	gut	gut	NN
cord-005453-4057qib7	6321	10	movement	movement	NN
cord-005453-4057qib7	6321	11	suggesting	suggest	VBG
cord-005453-4057qib7	6321	12	bowel	bowel	JJ
cord-005453-4057qib7	6321	13	obstruction	obstruction	NN
cord-005453-4057qib7	6321	14	.	.	.
cord-005453-4057qib7	6322	1	Due	due	IN
cord-005453-4057qib7	6322	2	to	to	IN
cord-005453-4057qib7	6322	3	presence	presence	NN
cord-005453-4057qib7	6322	4	of	of	IN
cord-005453-4057qib7	6322	5	acute	acute	JJ
cord-005453-4057qib7	6322	6	abdomen	abdomen	NN
cord-005453-4057qib7	6322	7	patient	patient	NN
cord-005453-4057qib7	6322	8	was	be	VBD
cord-005453-4057qib7	6322	9	immediately	immediately	RB
cord-005453-4057qib7	6322	10	directed	direct	VBN
cord-005453-4057qib7	6322	11	for	for	IN
cord-005453-4057qib7	6322	12	laparotomy	laparotomy	NN
cord-005453-4057qib7	6322	13	.	.	.
cord-005453-4057qib7	6323	1	Resection	resection	NN
cord-005453-4057qib7	6323	2	of	of	IN
cord-005453-4057qib7	6323	3	constricted	constricted	JJ
cord-005453-4057qib7	6323	4	bowel	bowel	NN
cord-005453-4057qib7	6323	5	segment	segment	NN
cord-005453-4057qib7	6323	6	followed	follow	VBN
cord-005453-4057qib7	6323	7	by	by	IN
cord-005453-4057qib7	6323	8	2	2	CD
cord-005453-4057qib7	6323	9	subsequent	subsequent	JJ
cord-005453-4057qib7	6323	10	laparotomies	laparotomy	NNS
cord-005453-4057qib7	6323	11	for	for	IN
cord-005453-4057qib7	6323	12	secondary	secondary	JJ
cord-005453-4057qib7	6323	13	obstruction	obstruction	NN
cord-005453-4057qib7	6323	14	provided	provide	VBD
cord-005453-4057qib7	6323	15	complete	complete	JJ
cord-005453-4057qib7	6323	16	resolution	resolution	NN
cord-005453-4057qib7	6323	17	of	of	IN
cord-005453-4057qib7	6323	18	abdominal	abdominal	JJ
cord-005453-4057qib7	6323	19	symptoms	symptom	NNS
cord-005453-4057qib7	6323	20	.	.	.
cord-005453-4057qib7	6324	1	After	after	IN
cord-005453-4057qib7	6324	2	16	16	CD
cord-005453-4057qib7	6324	3	years	year	NNS
cord-005453-4057qib7	6324	4	of	of	IN
cord-005453-4057qib7	6324	5	follow	follow	VB
cord-005453-4057qib7	6324	6	-	-	HYPH
cord-005453-4057qib7	6324	7	up	up	NN
cord-005453-4057qib7	6324	8	patient	patient	NN
cord-005453-4057qib7	6324	9	is	be	VBZ
cord-005453-4057qib7	6324	10	alive	alive	JJ
cord-005453-4057qib7	6324	11	and	and	CC
cord-005453-4057qib7	6324	12	well	well	RB
cord-005453-4057qib7	6324	13	.	.	.
cord-005453-4057qib7	6325	1	2	2	LS
cord-005453-4057qib7	6325	2	.	.	.
cord-005453-4057qib7	6326	1	Eleven	eleven	CD
cord-005453-4057qib7	6326	2	years	year	NNS
cord-005453-4057qib7	6326	3	old	old	JJ
cord-005453-4057qib7	6326	4	male	male	NN
cord-005453-4057qib7	6326	5	was	be	VBD
cord-005453-4057qib7	6326	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	6326	7	with	with	IN
cord-005453-4057qib7	6326	8	skin	skin	NN
cord-005453-4057qib7	6326	9	and	and	CC
cord-005453-4057qib7	6326	10	gut	gut	NN
cord-005453-4057qib7	6326	11	grade	grade	NN
cord-005453-4057qib7	6326	12	IV	IV	NNP
cord-005453-4057qib7	6326	13	aGvHD	agvhd	NN
cord-005453-4057qib7	6326	14	on	on	IN
cord-005453-4057qib7	6326	15	day	day	NN
cord-005453-4057qib7	6326	16	+84	+84	NNP
cord-005453-4057qib7	6327	1	post	post	NNP
cord-005453-4057qib7	6327	2	MUD	MUD	NNP
cord-005453-4057qib7	6327	3	-	-	HYPH
cord-005453-4057qib7	6327	4	HSCT	HSCT	NNP
cord-005453-4057qib7	6327	5	performed	perform	VBD
cord-005453-4057qib7	6327	6	due	due	IN
cord-005453-4057qib7	6327	7	to	to	IN
cord-005453-4057qib7	6327	8	acute	acute	JJ
cord-005453-4057qib7	6327	9	myelogenous	myelogenous	NN
cord-005453-4057qib7	6327	10	leukemia	leukemia	NN
cord-005453-4057qib7	6327	11	(	(	-LRB-
cord-005453-4057qib7	6327	12	AML	AML	NNP
cord-005453-4057qib7	6327	13	)	)	-RRB-
cord-005453-4057qib7	6327	14	.	.	.
cord-005453-4057qib7	6328	1	He	-PRON-	PRP
cord-005453-4057qib7	6328	2	received	receive	VBD
cord-005453-4057qib7	6328	3	pronlonged	pronlonged	JJ
cord-005453-4057qib7	6328	4	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6328	5	treatment	treatment	NN
cord-005453-4057qib7	6328	6	including	include	VBG
cord-005453-4057qib7	6328	7	steroids	steroid	NNS
cord-005453-4057qib7	6328	8	,	,	,
cord-005453-4057qib7	6328	9	antibodies	antibody	NNS
cord-005453-4057qib7	6328	10	,	,	,
cord-005453-4057qib7	6328	11	MSC	MSC	NNP
cord-005453-4057qib7	6328	12	and	and	CC
cord-005453-4057qib7	6328	13	ECP	ECP	NNP
cord-005453-4057qib7	6328	14	which	which	WDT
cord-005453-4057qib7	6328	15	led	lead	VBD
cord-005453-4057qib7	6328	16	to	to	IN
cord-005453-4057qib7	6328	17	resolving	resolve	VBG
cord-005453-4057qib7	6328	18	of	of	IN
cord-005453-4057qib7	6328	19	skin	skin	NN
cord-005453-4057qib7	6328	20	leasions	leasion	NNS
cord-005453-4057qib7	6328	21	and	and	CC
cord-005453-4057qib7	6328	22	diarhoea	diarhoea	NN
cord-005453-4057qib7	6328	23	.	.	.
cord-005453-4057qib7	6329	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	6329	2	patient	patient	JJ
cord-005453-4057qib7	6329	3	was	be	VBD
cord-005453-4057qib7	6329	4	suffering	suffer	VBG
cord-005453-4057qib7	6329	5	from	from	IN
cord-005453-4057qib7	6329	6	severe	severe	JJ
cord-005453-4057qib7	6329	7	paroxysmal	paroxysmal	JJ
cord-005453-4057qib7	6329	8	abdominal	abdominal	JJ
cord-005453-4057qib7	6329	9	pain	pain	NN
cord-005453-4057qib7	6329	10	and	and	CC
cord-005453-4057qib7	6329	11	incidentally	incidentally	RB
cord-005453-4057qib7	6329	12	vomiting	vomit	VBG
cord-005453-4057qib7	6329	13	.	.	.
cord-005453-4057qib7	6330	1	CT	CT	NNP
cord-005453-4057qib7	6330	2	enterography	enterography	NN
cord-005453-4057qib7	6330	3	showed	show	VBD
cord-005453-4057qib7	6330	4	partial	partial	JJ
cord-005453-4057qib7	6330	5	small	small	JJ
cord-005453-4057qib7	6330	6	bowel	bowel	NN
cord-005453-4057qib7	6330	7	constriction	constriction	NN
cord-005453-4057qib7	6330	8	.	.	.
cord-005453-4057qib7	6331	1	After	after	IN
cord-005453-4057qib7	6331	2	numerous	numerous	JJ
cord-005453-4057qib7	6331	3	surgical	surgical	JJ
cord-005453-4057qib7	6331	4	consultations	consultation	NNS
cord-005453-4057qib7	6331	5	,	,	,
cord-005453-4057qib7	6331	6	eventually	eventually	RB
cord-005453-4057qib7	6331	7	on	on	IN
cord-005453-4057qib7	6331	8	day+	day+	NNP
cord-005453-4057qib7	6331	9	503	503	CD
cord-005453-4057qib7	6331	10	patient	patient	NN
cord-005453-4057qib7	6331	11	underwent	undergo	VBD
cord-005453-4057qib7	6331	12	laparotomy	laparotomy	NN
cord-005453-4057qib7	6331	13	with	with	IN
cord-005453-4057qib7	6331	14	constricted	constricted	JJ
cord-005453-4057qib7	6331	15	bowel	bowel	NN
cord-005453-4057qib7	6331	16	resection	resection	NN
cord-005453-4057qib7	6331	17	.	.	.
cord-005453-4057qib7	6332	1	Histopatological	histopatological	JJ
cord-005453-4057qib7	6332	2	examination	examination	NN
cord-005453-4057qib7	6332	3	of	of	IN
cord-005453-4057qib7	6332	4	resected	resected	JJ
cord-005453-4057qib7	6332	5	tissue	tissue	NN
cord-005453-4057qib7	6332	6	revealed	reveal	VBD
cord-005453-4057qib7	6332	7	moderate	moderate	JJ
cord-005453-4057qib7	6332	8	GvHD	GvHD	NNP
cord-005453-4057qib7	6332	9	.	.	.
cord-005453-4057qib7	6333	1	Immunosuppersion	Immunosuppersion	NNP
cord-005453-4057qib7	6333	2	was	be	VBD
cord-005453-4057qib7	6333	3	tapered	taper	VBN
cord-005453-4057qib7	6333	4	to	to	IN
cord-005453-4057qib7	6333	5	low	low	JJ
cord-005453-4057qib7	6333	6	dose	dose	NN
cord-005453-4057qib7	6333	7	of	of	IN
cord-005453-4057qib7	6333	8	steroids	steroid	NNS
cord-005453-4057qib7	6333	9	with	with	IN
cord-005453-4057qib7	6333	10	ECP	ECP	NNP
cord-005453-4057qib7	6333	11	.	.	.
cord-005453-4057qib7	6334	1	For	for	IN
cord-005453-4057qib7	6334	2	now	now	RB
cord-005453-4057qib7	6334	3	,	,	,
cord-005453-4057qib7	6334	4	2	2	CD
cord-005453-4057qib7	6334	5	years	year	NNS
cord-005453-4057qib7	6334	6	post	post	NN
cord-005453-4057qib7	6334	7	HSCT	HSCT	NNP
cord-005453-4057qib7	6334	8	patient	patient	NN
cord-005453-4057qib7	6334	9	is	be	VBZ
cord-005453-4057qib7	6334	10	alive	alive	JJ
cord-005453-4057qib7	6334	11	,	,	,
cord-005453-4057qib7	6334	12	rarely	rarely	RB
cord-005453-4057qib7	6334	13	experiencing	experience	VBG
cord-005453-4057qib7	6334	14	mild	mild	JJ
cord-005453-4057qib7	6334	15	abdominal	abdominal	JJ
cord-005453-4057qib7	6334	16	cramps	cramp	NNS
cord-005453-4057qib7	6334	17	3	3	CD
cord-005453-4057qib7	6334	18	.	.	.
cord-005453-4057qib7	6335	1	Fourteen	fourteen	CD
cord-005453-4057qib7	6335	2	years	year	NNS
cord-005453-4057qib7	6335	3	old	old	JJ
cord-005453-4057qib7	6335	4	female	female	NN
cord-005453-4057qib7	6335	5	developed	develop	VBD
cord-005453-4057qib7	6335	6	severe	severe	JJ
cord-005453-4057qib7	6335	7	abdominal	abdominal	JJ
cord-005453-4057qib7	6335	8	pain	pain	NN
cord-005453-4057qib7	6335	9	and	and	CC
cord-005453-4057qib7	6335	10	high	high	JJ
cord-005453-4057qib7	6335	11	volume	volume	NN
cord-005453-4057qib7	6335	12	diarhoea	diarhoea	NN
cord-005453-4057qib7	6335	13	on	on	IN
cord-005453-4057qib7	6335	14	day	day	NN
cord-005453-4057qib7	6335	15	+24	+24	CD
cord-005453-4057qib7	6335	16	post	post	NNP
cord-005453-4057qib7	6335	17	MUD	MUD	NNP
cord-005453-4057qib7	6335	18	-	-	HYPH
cord-005453-4057qib7	6335	19	HSCT	HSCT	NNP
cord-005453-4057qib7	6336	1	performed	perform	VBN
cord-005453-4057qib7	6336	2	for	for	IN
cord-005453-4057qib7	6336	3	severe	severe	JJ
cord-005453-4057qib7	6336	4	anaplastic	anaplastic	JJ
cord-005453-4057qib7	6336	5	anemia	anemia	NN
cord-005453-4057qib7	6336	6	(	(	-LRB-
cord-005453-4057qib7	6336	7	SAA	SAA	NNP
cord-005453-4057qib7	6336	8	)	)	-RRB-
cord-005453-4057qib7	6336	9	.	.	.
cord-005453-4057qib7	6337	1	Despite	despite	IN
cord-005453-4057qib7	6337	2	extensive	extensive	JJ
cord-005453-4057qib7	6337	3	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	6337	4	(	(	-LRB-
cord-005453-4057qib7	6337	5	steroids	steroid	NNS
cord-005453-4057qib7	6337	6	,	,	,
cord-005453-4057qib7	6337	7	anti	anti	NNP
cord-005453-4057qib7	6337	8	-	-	NNP
cord-005453-4057qib7	6337	9	TNF	TNF	NNP
cord-005453-4057qib7	6337	10	,	,	,
cord-005453-4057qib7	6337	11	anti	anti	JJ
cord-005453-4057qib7	6337	12	-	-	JJ
cord-005453-4057qib7	6337	13	IL2	il2	JJ
cord-005453-4057qib7	6337	14	antibodies	antibody	NNS
cord-005453-4057qib7	6337	15	)	)	-RRB-
cord-005453-4057qib7	6338	1	patient	patient	JJ
cord-005453-4057qib7	6338	2	condition	condition	NN
cord-005453-4057qib7	6338	3	did	do	VBD
cord-005453-4057qib7	6338	4	not	not	RB
cord-005453-4057qib7	6338	5	improved	improve	VBN
cord-005453-4057qib7	6338	6	.	.	.
cord-005453-4057qib7	6339	1	Through	through	IN
cord-005453-4057qib7	6339	2	consistent	consistent	JJ
cord-005453-4057qib7	6339	3	stomach	stomach	NN
cord-005453-4057qib7	6339	4	pain	pain	NN
cord-005453-4057qib7	6339	5	,	,	,
cord-005453-4057qib7	6339	6	suspected	suspect	VBN
cord-005453-4057qib7	6339	7	subileus	subileu	NNS
cord-005453-4057qib7	6339	8	confirmed	confirm	VBN
cord-005453-4057qib7	6339	9	by	by	IN
cord-005453-4057qib7	6339	10	CT	CT	NNP
cord-005453-4057qib7	6339	11	enterography	enterography	NN
cord-005453-4057qib7	6339	12	,	,	,
cord-005453-4057qib7	6339	13	laparotomy	laparotomy	NN
cord-005453-4057qib7	6339	14	was	be	VBD
cord-005453-4057qib7	6339	15	performed	perform	VBN
cord-005453-4057qib7	6339	16	(	(	-LRB-
cord-005453-4057qib7	6339	17	day+158	day+158	NNP
cord-005453-4057qib7	6339	18	)	)	-RRB-
cord-005453-4057qib7	6339	19	.	.	.
cord-005453-4057qib7	6340	1	Resection	resection	NN
cord-005453-4057qib7	6340	2	of	of	IN
cord-005453-4057qib7	6340	3	inflamated	inflamated	JJ
cord-005453-4057qib7	6340	4	and	and	CC
cord-005453-4057qib7	6340	5	obstructed	obstructed	JJ
cord-005453-4057qib7	6340	6	bowel	bowel	NN
cord-005453-4057qib7	6340	7	was	be	VBD
cord-005453-4057qib7	6340	8	made	make	VBN
cord-005453-4057qib7	6340	9	.	.	.
cord-005453-4057qib7	6341	1	Microscopic	microscopic	JJ
cord-005453-4057qib7	6341	2	evaluation	evaluation	NN
cord-005453-4057qib7	6341	3	confirmed	confirm	VBD
cord-005453-4057qib7	6341	4	prior	prior	JJ
cord-005453-4057qib7	6341	5	GvHD	GvHD	NNP
cord-005453-4057qib7	6341	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	6341	7	therefore	therefore	RB
cord-005453-4057qib7	6341	8	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	6341	9	including	include	VBG
cord-005453-4057qib7	6341	10	CsA	csa	NN
cord-005453-4057qib7	6341	11	and	and	CC
cord-005453-4057qib7	6341	12	tapered	tapered	JJ
cord-005453-4057qib7	6341	13	doses	dose	NNS
cord-005453-4057qib7	6341	14	of	of	IN
cord-005453-4057qib7	6341	15	steroids	steroid	NNS
cord-005453-4057qib7	6341	16	was	be	VBD
cord-005453-4057qib7	6341	17	continued	continue	VBN
cord-005453-4057qib7	6341	18	.	.	.
cord-005453-4057qib7	6342	1	Complete	complete	JJ
cord-005453-4057qib7	6342	2	resolution	resolution	NN
cord-005453-4057qib7	6342	3	of	of	IN
cord-005453-4057qib7	6342	4	abdominal	abdominal	JJ
cord-005453-4057qib7	6342	5	symptoms	symptom	NNS
cord-005453-4057qib7	6342	6	was	be	VBD
cord-005453-4057qib7	6342	7	almost	almost	RB
cord-005453-4057qib7	6342	8	immediately	immediately	RB
cord-005453-4057qib7	6342	9	achieved	achieve	VBN
cord-005453-4057qib7	6342	10	post	post	NN
cord-005453-4057qib7	6342	11	-	-	NN
cord-005453-4057qib7	6342	12	surgery	surgery	JJ
cord-005453-4057qib7	6342	13	,	,	,
cord-005453-4057qib7	6342	14	however	however	RB
cord-005453-4057qib7	6342	15	2	2	CD
cord-005453-4057qib7	6342	16	months	month	NNS
cord-005453-4057qib7	6342	17	after	after	IN
cord-005453-4057qib7	6342	18	recurrent	recurrent	JJ
cord-005453-4057qib7	6342	19	abdominal	abdominal	JJ
cord-005453-4057qib7	6342	20	cramps	cramp	NNS
cord-005453-4057qib7	6342	21	were	be	VBD
cord-005453-4057qib7	6342	22	observed	observe	VBN
cord-005453-4057qib7	6342	23	and	and	CC
cord-005453-4057qib7	6342	24	are	be	VBP
cord-005453-4057qib7	6342	25	now	now	RB
cord-005453-4057qib7	6342	26	well	well	RB
cord-005453-4057qib7	6342	27	controlled	control	VBN
cord-005453-4057qib7	6342	28	by	by	IN
cord-005453-4057qib7	6342	29	pain	pain	NN
cord-005453-4057qib7	6342	30	killers	killer	NNS
cord-005453-4057qib7	6342	31	.	.	.
cord-005453-4057qib7	6343	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6343	2	:	:	:
cord-005453-4057qib7	6344	1	Commonly	commonly	RB
cord-005453-4057qib7	6344	2	GI	GI	NNP
cord-005453-4057qib7	6344	3	GvHD	GvHD	NNP
cord-005453-4057qib7	6344	4	is	be	VBZ
cord-005453-4057qib7	6344	5	diffused	diffuse	VBN
cord-005453-4057qib7	6344	6	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6344	7	process	process	NN
cord-005453-4057qib7	6344	8	.	.	.
cord-005453-4057qib7	6345	1	However	however	RB
cord-005453-4057qib7	6345	2	in	in	IN
cord-005453-4057qib7	6345	3	some	some	DT
cord-005453-4057qib7	6345	4	cases	case	NNS
cord-005453-4057qib7	6345	5	it	-PRON-	PRP
cord-005453-4057qib7	6345	6	may	may	MD
cord-005453-4057qib7	6345	7	be	be	VB
cord-005453-4057qib7	6345	8	localized	localize	VBN
cord-005453-4057qib7	6345	9	and	and	CC
cord-005453-4057qib7	6345	10	may	may	MD
cord-005453-4057qib7	6345	11	lead	lead	VB
cord-005453-4057qib7	6345	12	to	to	IN
cord-005453-4057qib7	6345	13	partial	partial	JJ
cord-005453-4057qib7	6345	14	bowel	bowel	NN
cord-005453-4057qib7	6345	15	constriction	constriction	NN
cord-005453-4057qib7	6345	16	.	.	.
cord-005453-4057qib7	6346	1	In	in	IN
cord-005453-4057qib7	6346	2	case	case	NN
cord-005453-4057qib7	6346	3	of	of	IN
cord-005453-4057qib7	6346	4	severe	severe	JJ
cord-005453-4057qib7	6346	5	and	and	CC
cord-005453-4057qib7	6346	6	prolonged	prolonged	JJ
cord-005453-4057qib7	6346	7	stomach	stomach	NN
cord-005453-4057qib7	6346	8	pain	pain	NN
cord-005453-4057qib7	6346	9	,	,	,
cord-005453-4057qib7	6346	10	despite	despite	IN
cord-005453-4057qib7	6346	11	of	of	IN
cord-005453-4057qib7	6346	12	partial	partial	JJ
cord-005453-4057qib7	6346	13	resolving	resolving	NN
cord-005453-4057qib7	6346	14	of	of	IN
cord-005453-4057qib7	6346	15	other	other	JJ
cord-005453-4057qib7	6346	16	GvHD	gvhd	NN
cord-005453-4057qib7	6346	17	symptoms	symptom	NNS
cord-005453-4057qib7	6346	18	,	,	,
cord-005453-4057qib7	6346	19	ileus	ileus	NNP
cord-005453-4057qib7	6346	20	should	should	MD
cord-005453-4057qib7	6346	21	be	be	VB
cord-005453-4057qib7	6346	22	considered	consider	VBN
cord-005453-4057qib7	6346	23	.	.	.
cord-005453-4057qib7	6347	1	CT	CT	NNP
cord-005453-4057qib7	6347	2	enterography	enterography	NN
cord-005453-4057qib7	6347	3	may	may	MD
cord-005453-4057qib7	6347	4	be	be	VB
cord-005453-4057qib7	6347	5	useful	useful	JJ
cord-005453-4057qib7	6347	6	for	for	IN
cord-005453-4057qib7	6347	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	6347	8	confirmation	confirmation	NN
cord-005453-4057qib7	6347	9	.	.	.
cord-005453-4057qib7	6348	1	In	in	IN
cord-005453-4057qib7	6348	2	those	those	DT
cord-005453-4057qib7	6348	3	patients	patient	NNS
cord-005453-4057qib7	6348	4	,	,	,
cord-005453-4057qib7	6348	5	surgical	surgical	JJ
cord-005453-4057qib7	6348	6	intervention	intervention	NN
cord-005453-4057qib7	6348	7	may	may	MD
cord-005453-4057qib7	6348	8	improve	improve	VB
cord-005453-4057qib7	6348	9	quality	quality	NN
cord-005453-4057qib7	6348	10	of	of	IN
cord-005453-4057qib7	6348	11	life	life	NN
cord-005453-4057qib7	6348	12	or	or	CC
cord-005453-4057qib7	6348	13	even	even	RB
cord-005453-4057qib7	6348	14	be	be	VB
cord-005453-4057qib7	6348	15	a	a	DT
cord-005453-4057qib7	6348	16	salvage	salvage	NN
cord-005453-4057qib7	6348	17	approach	approach	NN
cord-005453-4057qib7	6348	18	.	.	.
cord-005453-4057qib7	6349	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6349	2	:	:	:
cord-005453-4057qib7	6349	3	Nothing	nothing	NN
cord-005453-4057qib7	6349	4	to	to	TO
cord-005453-4057qib7	6349	5	disclose	disclose	VB
cord-005453-4057qib7	6349	6	Is	be	VBZ
cord-005453-4057qib7	6349	7	there	there	EX
cord-005453-4057qib7	6349	8	any	any	DT
cord-005453-4057qib7	6349	9	impact	impact	NN
cord-005453-4057qib7	6349	10	of	of	IN
cord-005453-4057qib7	6349	11	the	the	DT
cord-005453-4057qib7	6349	12	uric	uric	JJ
cord-005453-4057qib7	6349	13	acid	acid	NN
cord-005453-4057qib7	6349	14	levels	level	NNS
cord-005453-4057qib7	6349	15	during	during	IN
cord-005453-4057qib7	6349	16	the	the	DT
cord-005453-4057qib7	6349	17	preand	preand	NN
cord-005453-4057qib7	6349	18	early	early	JJ
cord-005453-4057qib7	6349	19	post	post	JJ
cord-005453-4057qib7	6349	20	-	-	JJ
cord-005453-4057qib7	6349	21	graft	graft	NN
cord-005453-4057qib7	6349	22	infusion	infusion	NN
cord-005453-4057qib7	6349	23	period	period	NN
cord-005453-4057qib7	6349	24	,	,	,
cord-005453-4057qib7	6349	25	on	on	IN
cord-005453-4057qib7	6349	26	the	the	DT
cord-005453-4057qib7	6349	27	GVHD	GVHD	NNP
cord-005453-4057qib7	6349	28	occurence	occurence	NN
cord-005453-4057qib7	6349	29	and	and	CC
cord-005453-4057qib7	6349	30	allotransplant	allotransplant	JJ
cord-005453-4057qib7	6349	31	outcome	outcome	NN
cord-005453-4057qib7	6349	32	?	?	.
cord-005453-4057qib7	6350	1	36.8(16.7	36.8(16.7	CD
cord-005453-4057qib7	6350	2	-	-	SYM
cord-005453-4057qib7	6350	3	61.6	61.6	CD
cord-005453-4057qib7	6350	4	)	)	-RRB-
cord-005453-4057qib7	6350	5	years	year	NNS
cord-005453-4057qib7	6350	6	,	,	,
cord-005453-4057qib7	6350	7	who	who	WP
cord-005453-4057qib7	6350	8	underwent	undergo	VBD
cord-005453-4057qib7	6350	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6350	10	stem	stem	NN
cord-005453-4057qib7	6350	11	cell	cell	NN
cord-005453-4057qib7	6350	12	transplantation	transplantation	NN
cord-005453-4057qib7	6350	13	(	(	-LRB-
cord-005453-4057qib7	6350	14	alloSCT	alloSCT	NNP
cord-005453-4057qib7	6350	15	)	)	-RRB-
cord-005453-4057qib7	6350	16	from	from	IN
cord-005453-4057qib7	6350	17	full	full	RB
cord-005453-4057qib7	6350	18	-	-	HYPH
cord-005453-4057qib7	6350	19	matched	match	VBN
cord-005453-4057qib7	6350	20	sibling	sibling	NN
cord-005453-4057qib7	6350	21	donors	donor	NNS
cord-005453-4057qib7	6350	22	for	for	IN
cord-005453-4057qib7	6350	23	acute	acute	JJ
cord-005453-4057qib7	6350	24	leukemia	leukemia	NN
cord-005453-4057qib7	6350	25	(	(	-LRB-
cord-005453-4057qib7	6350	26	n=31	n=31	NNP
cord-005453-4057qib7	6350	27	)	)	-RRB-
cord-005453-4057qib7	6350	28	,	,	,
cord-005453-4057qib7	6350	29	very	very	RB
cord-005453-4057qib7	6350	30	severe	severe	JJ
cord-005453-4057qib7	6350	31	aplastic	aplastic	JJ
cord-005453-4057qib7	6350	32	anemia	anemia	NN
cord-005453-4057qib7	6350	33	/	/	,
cord-005453-4057qib7	6350	34	PNH	PNH	NNP
cord-005453-4057qib7	6350	35	(	(	-LRB-
cord-005453-4057qib7	6350	36	n=5	n=5	NNP
cord-005453-4057qib7	6350	37	)	)	-RRB-
cord-005453-4057qib7	6350	38	,	,	,
cord-005453-4057qib7	6350	39	lymphoma	lymphoma	NN
cord-005453-4057qib7	6350	40	(	(	-LRB-
cord-005453-4057qib7	6350	41	n=3	n=3	NN
cord-005453-4057qib7	6350	42	)	)	-RRB-
cord-005453-4057qib7	6350	43	,	,	,
cord-005453-4057qib7	6350	44	myelodysplastic/	myelodysplastic/	JJ
cord-005453-4057qib7	6350	45	myeloproliferative	myeloproliferative	NNP
cord-005453-4057qib7	6350	46	syndrome	syndrome	NN
cord-005453-4057qib7	6350	47	(	(	-LRB-
cord-005453-4057qib7	6350	48	n=3	n=3	NN
cord-005453-4057qib7	6350	49	)	)	-RRB-
cord-005453-4057qib7	6350	50	.	.	.
cord-005453-4057qib7	6351	1	Thirty	thirty	CD
cord-005453-4057qib7	6351	2	-	-	HYPH
cord-005453-4057qib7	6351	3	two	two	CD
cord-005453-4057qib7	6351	4	patients	patient	NNS
cord-005453-4057qib7	6351	5	were	be	VBD
cord-005453-4057qib7	6351	6	in	in	IN
cord-005453-4057qib7	6351	7	remission	remission	NN
cord-005453-4057qib7	6351	8	at	at	IN
cord-005453-4057qib7	6351	9	the	the	DT
cord-005453-4057qib7	6351	10	time	time	NN
cord-005453-4057qib7	6351	11	of	of	IN
cord-005453-4057qib7	6351	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	6352	1	(	(	-LRB-
cord-005453-4057qib7	6352	2	CR1	CR1	NNP
cord-005453-4057qib7	6352	3	:	:	:
cord-005453-4057qib7	6352	4	23	23	CD
cord-005453-4057qib7	6352	5	,	,	,
cord-005453-4057qib7	6352	6	CR2	CR2	NNP
cord-005453-4057qib7	6352	7	:	:	:
cord-005453-4057qib7	6352	8	7	7	CD
cord-005453-4057qib7	6352	9	,	,	,
cord-005453-4057qib7	6352	10	beyond	beyond	IN
cord-005453-4057qib7	6352	11	CR2	CR2	NNP
cord-005453-4057qib7	6352	12	:	:	:
cord-005453-4057qib7	6352	13	2	2	CD
cord-005453-4057qib7	6352	14	)	)	-RRB-
cord-005453-4057qib7	6352	15	.	.	.
cord-005453-4057qib7	6353	1	For	for	IN
cord-005453-4057qib7	6353	2	a	a	DT
cord-005453-4057qib7	6353	3	better	well	JJR
cord-005453-4057qib7	6353	4	and	and	CC
cord-005453-4057qib7	6353	5	more	more	RBR
cord-005453-4057qib7	6353	6	accurate	accurate	JJ
cord-005453-4057qib7	6353	7	assessment	assessment	NN
cord-005453-4057qib7	6353	8	of	of	IN
cord-005453-4057qib7	6353	9	the	the	DT
cord-005453-4057qib7	6353	10	UA	UA	NNP
cord-005453-4057qib7	6353	11	levels	level	NNS
cord-005453-4057qib7	6353	12	on	on	IN
cord-005453-4057qib7	6353	13	the	the	DT
cord-005453-4057qib7	6353	14	aGvHD	agvhd	NN
cord-005453-4057qib7	6353	15	incidence	incidence	NN
cord-005453-4057qib7	6353	16	,	,	,
cord-005453-4057qib7	6353	17	unlike	unlike	IN
cord-005453-4057qib7	6353	18	to	to	IN
cord-005453-4057qib7	6353	19	the	the	DT
cord-005453-4057qib7	6353	20	other	other	JJ
cord-005453-4057qib7	6353	21	published	publish	VBN
cord-005453-4057qib7	6353	22	studies	study	NNS
cord-005453-4057qib7	6353	23	which	which	WDT
cord-005453-4057qib7	6353	24	evaluated	evaluate	VBD
cord-005453-4057qib7	6353	25	the	the	DT
cord-005453-4057qib7	6353	26	UA	UA	NNP
cord-005453-4057qib7	6353	27	levels	level	NNS
cord-005453-4057qib7	6353	28	only	only	RB
cord-005453-4057qib7	6353	29	at	at	IN
cord-005453-4057qib7	6353	30	day	day	NN
cord-005453-4057qib7	6353	31	0	0	NFP
cord-005453-4057qib7	6353	32	,	,	,
cord-005453-4057qib7	6353	33	we	-PRON-	PRP
cord-005453-4057qib7	6353	34	evaluated	evaluate	VBD
cord-005453-4057qib7	6353	35	the	the	DT
cord-005453-4057qib7	6353	36	UA	UA	NNP
cord-005453-4057qib7	6353	37	levels	level	NNS
cord-005453-4057qib7	6353	38	in	in	IN
cord-005453-4057qib7	6353	39	different	different	JJ
cord-005453-4057qib7	6353	40	time	time	NN
cord-005453-4057qib7	6353	41	points	point	NNS
cord-005453-4057qib7	6353	42	during	during	IN
cord-005453-4057qib7	6353	43	the	the	DT
cord-005453-4057qib7	6353	44	the	the	DT
cord-005453-4057qib7	6353	45	peri	peri	NN
cord-005453-4057qib7	6353	46	-	-	HYPH
cord-005453-4057qib7	6353	47	transplant	transplant	NN
cord-005453-4057qib7	6353	48	period	period	NN
cord-005453-4057qib7	6353	49	(	(	-LRB-
cord-005453-4057qib7	6353	50	at	at	IN
cord-005453-4057qib7	6353	51	the	the	DT
cord-005453-4057qib7	6353	52	conditioning	conditioning	NN
cord-005453-4057qib7	6353	53	regimen	regimen	NN
cord-005453-4057qib7	6353	54	initiation	initiation	NN
cord-005453-4057qib7	6353	55	,	,	,
cord-005453-4057qib7	6353	56	and	and	CC
cord-005453-4057qib7	6353	57	at	at	IN
cord-005453-4057qib7	6353	58	days	day	NNS
cord-005453-4057qib7	6353	59	0	0	CD
cord-005453-4057qib7	6353	60	,	,	,
cord-005453-4057qib7	6353	61	+7	+7	NN
cord-005453-4057qib7	6353	62	and	and	CC
cord-005453-4057qib7	6353	63	+14	+14	CD
cord-005453-4057qib7	6353	64	)	)	-RRB-
cord-005453-4057qib7	6353	65	.	.	.
cord-005453-4057qib7	6354	1	Because	because	IN
cord-005453-4057qib7	6354	2	the	the	DT
cord-005453-4057qib7	6354	3	majority	majority	NN
cord-005453-4057qib7	6354	4	of	of	IN
cord-005453-4057qib7	6354	5	our	-PRON-	PRP$
cord-005453-4057qib7	6354	6	patients	patient	NNS
cord-005453-4057qib7	6354	7	developed	develop	VBN
cord-005453-4057qib7	6354	8	aGvHD	agvhd	NN
cord-005453-4057qib7	6354	9	within	within	IN
cord-005453-4057qib7	6354	10	the	the	DT
cord-005453-4057qib7	6354	11	15	15	CD
cord-005453-4057qib7	6354	12	-	-	SYM
cord-005453-4057qib7	6354	13	30	30	CD
cord-005453-4057qib7	6354	14	days	day	NNS
cord-005453-4057qib7	6354	15	post	post	NN
cord-005453-4057qib7	6354	16	-	-	NN
cord-005453-4057qib7	6354	17	transplant	transplant	NN
cord-005453-4057qib7	6354	18	,	,	,
cord-005453-4057qib7	6354	19	we	-PRON-	PRP
cord-005453-4057qib7	6354	20	did	do	VBD
cord-005453-4057qib7	6354	21	not	not	RB
cord-005453-4057qib7	6354	22	incorporated	incorporate	VBN
cord-005453-4057qib7	6354	23	in	in	IN
cord-005453-4057qib7	6354	24	the	the	DT
cord-005453-4057qib7	6354	25	study	study	NN
cord-005453-4057qib7	6354	26	the	the	DT
cord-005453-4057qib7	6354	27	of	of	IN
cord-005453-4057qib7	6354	28	UA	UA	NNP
cord-005453-4057qib7	6354	29	levels	level	NNS
cord-005453-4057qib7	6354	30	beyond	beyond	IN
cord-005453-4057qib7	6354	31	the	the	DT
cord-005453-4057qib7	6354	32	+14	+14	CD
cord-005453-4057qib7	6354	33	day	day	NN
cord-005453-4057qib7	6354	34	.	.	.
cord-005453-4057qib7	6355	1	We	-PRON-	PRP
cord-005453-4057qib7	6355	2	also	also	RB
cord-005453-4057qib7	6355	3	investigated	investigate	VBD
cord-005453-4057qib7	6355	4	the	the	DT
cord-005453-4057qib7	6355	5	effect	effect	NN
cord-005453-4057qib7	6355	6	of	of	IN
cord-005453-4057qib7	6355	7	the	the	DT
cord-005453-4057qib7	6355	8	UA	UA	NNP
cord-005453-4057qib7	6355	9	on	on	IN
cord-005453-4057qib7	6355	10	survival	survival	NN
cord-005453-4057qib7	6355	11	and	and	CC
cord-005453-4057qib7	6355	12	the	the	DT
cord-005453-4057qib7	6355	13	non	non	JJ
cord-005453-4057qib7	6355	14	-	-	JJ
cord-005453-4057qib7	6355	15	relapse	relapse	JJ
cord-005453-4057qib7	6355	16	mortality	mortality	NN
cord-005453-4057qib7	6355	17	(	(	-LRB-
cord-005453-4057qib7	6355	18	NRM	NRM	NNP
cord-005453-4057qib7	6355	19	)	)	-RRB-
cord-005453-4057qib7	6355	20	.	.	.
cord-005453-4057qib7	6356	1	The	the	DT
cord-005453-4057qib7	6356	2	vast	vast	JJ
cord-005453-4057qib7	6356	3	majority	majority	NN
cord-005453-4057qib7	6356	4	of	of	IN
cord-005453-4057qib7	6356	5	patients	patient	NNS
cord-005453-4057qib7	6356	6	received	receive	VBD
cord-005453-4057qib7	6356	7	allopurinol	allopurinol	NN
cord-005453-4057qib7	6356	8	from	from	IN
cord-005453-4057qib7	6356	9	the	the	DT
cord-005453-4057qib7	6356	10	1	1	CD
cord-005453-4057qib7	6356	11	st	st	NNP
cord-005453-4057qib7	6356	12	day	day	NN
cord-005453-4057qib7	6356	13	of	of	IN
cord-005453-4057qib7	6356	14	conditioning	conditioning	NN
cord-005453-4057qib7	6356	15	regimen	regimen	NN
cord-005453-4057qib7	6356	16	till	till	IN
cord-005453-4057qib7	6356	17	day	day	NN
cord-005453-4057qib7	6356	18	-1	-1	CD
cord-005453-4057qib7	6356	19	.	.	.
cord-005453-4057qib7	6357	1	The	the	DT
cord-005453-4057qib7	6357	2	independent	independent	JJ
cord-005453-4057qib7	6357	3	T	t	NN
cord-005453-4057qib7	6357	4	-	-	HYPH
cord-005453-4057qib7	6357	5	test	test	NN
cord-005453-4057qib7	6357	6	,	,	,
cord-005453-4057qib7	6357	7	Kaplan	Kaplan	NNP
cord-005453-4057qib7	6357	8	-	-	HYPH
cord-005453-4057qib7	6357	9	Meir	Meir	NNP
cord-005453-4057qib7	6357	10	method	method	NN
cord-005453-4057qib7	6357	11	and	and	CC
cord-005453-4057qib7	6357	12	logrank	logrank	NN
cord-005453-4057qib7	6357	13	test	test	NN
cord-005453-4057qib7	6357	14	were	be	VBD
cord-005453-4057qib7	6357	15	used	use	VBN
cord-005453-4057qib7	6357	16	in	in	IN
cord-005453-4057qib7	6357	17	the	the	DT
cord-005453-4057qib7	6357	18	statistical	statistical	JJ
cord-005453-4057qib7	6357	19	analysis	analysis	NN
cord-005453-4057qib7	6357	20	.	.	.
cord-005453-4057qib7	6358	1	Results	result	NNS
cord-005453-4057qib7	6358	2	:	:	:
cord-005453-4057qib7	6359	1	The	the	DT
cord-005453-4057qib7	6359	2	median	median	JJ
cord-005453-4057qib7	6359	3	UA	UA	NNP
cord-005453-4057qib7	6359	4	levels	level	NNS
cord-005453-4057qib7	6359	5	were	be	VBD
cord-005453-4057qib7	6359	6	4.2	4.2	CD
cord-005453-4057qib7	6359	7	,	,	,
cord-005453-4057qib7	6359	8	2.5	2.5	CD
cord-005453-4057qib7	6359	9	,	,	,
cord-005453-4057qib7	6359	10	2.7	2.7	CD
cord-005453-4057qib7	6359	11	and	and	CC
cord-005453-4057qib7	6359	12	3.2	3.2	CD
cord-005453-4057qib7	6359	13	mg	mg	NNP
cord-005453-4057qib7	6359	14	/	/	SYM
cord-005453-4057qib7	6359	15	dl	dl	NN
cord-005453-4057qib7	6359	16	at	at	IN
cord-005453-4057qib7	6359	17	days	day	NNS
cord-005453-4057qib7	6359	18	-7	-7	NNP
cord-005453-4057qib7	6359	19	,	,	,
cord-005453-4057qib7	6359	20	0	0	CD
cord-005453-4057qib7	6359	21	,	,	,
cord-005453-4057qib7	6359	22	+7	+7	NN
cord-005453-4057qib7	6359	23	and	and	CC
cord-005453-4057qib7	6359	24	+14	+14	CD
cord-005453-4057qib7	6359	25	respectively	respectively	RB
cord-005453-4057qib7	6359	26	.	.	.
cord-005453-4057qib7	6360	1	For	for	IN
cord-005453-4057qib7	6360	2	the	the	DT
cord-005453-4057qib7	6360	3	statistical	statistical	JJ
cord-005453-4057qib7	6360	4	analysis	analysis	NN
cord-005453-4057qib7	6360	5	purposes	purpose	NNS
cord-005453-4057qib7	6360	6	,	,	,
cord-005453-4057qib7	6360	7	we	-PRON-	PRP
cord-005453-4057qib7	6360	8	grouped	group	VBD
cord-005453-4057qib7	6360	9	our	-PRON-	PRP$
cord-005453-4057qib7	6360	10	patients	patient	NNS
cord-005453-4057qib7	6360	11	as	as	IN
cord-005453-4057qib7	6360	12	low	low	JJ
cord-005453-4057qib7	6360	13	-	-	HYPH
cord-005453-4057qib7	6360	14	UA	ua	NN
cord-005453-4057qib7	6360	15	if	if	IN
cord-005453-4057qib7	6360	16	they	-PRON-	PRP
cord-005453-4057qib7	6360	17	had	have	VBD
cord-005453-4057qib7	6360	18	values	value	NNS
cord-005453-4057qib7	6360	19	<	<	XX
cord-005453-4057qib7	6360	20	3	3	CD
cord-005453-4057qib7	6360	21	mg	mg	NNP
cord-005453-4057qib7	6360	22	/	/	SYM
cord-005453-4057qib7	6360	23	dl	dl	NN
cord-005453-4057qib7	6360	24	or	or	CC
cord-005453-4057qib7	6360	25	high	high	JJ
cord-005453-4057qib7	6360	26	-	-	HYPH
cord-005453-4057qib7	6360	27	UA	ua	NN
cord-005453-4057qib7	6360	28	if	if	IN
cord-005453-4057qib7	6360	29	they	-PRON-	PRP
cord-005453-4057qib7	6360	30	had	have	VBD
cord-005453-4057qib7	6360	31	>	>	XX
cord-005453-4057qib7	6361	1	3	3	CD
cord-005453-4057qib7	6361	2	mg	mg	NNP
cord-005453-4057qib7	6361	3	/	/	SYM
cord-005453-4057qib7	6361	4	dl	dl	NN
cord-005453-4057qib7	6361	5	.	.	.
cord-005453-4057qib7	6362	1	This	this	DT
cord-005453-4057qib7	6362	2	threshold	threshold	NN
cord-005453-4057qib7	6362	3	was	be	VBD
cord-005453-4057qib7	6362	4	chosen	choose	VBN
cord-005453-4057qib7	6362	5	based	base	VBN
cord-005453-4057qib7	6362	6	on	on	IN
cord-005453-4057qib7	6362	7	the	the	DT
cord-005453-4057qib7	6362	8	UA	UA	NNP
cord-005453-4057qib7	6362	9	values	value	NNS
cord-005453-4057qib7	6362	10	from	from	IN
cord-005453-4057qib7	6362	11	all	all	PDT
cord-005453-4057qib7	6362	12	the	the	DT
cord-005453-4057qib7	6362	13	collected	collect	VBN
cord-005453-4057qib7	6362	14	samples	sample	NNS
cord-005453-4057qib7	6362	15	(	(	-LRB-
cord-005453-4057qib7	6362	16	n=175	n=175	RB
cord-005453-4057qib7	6362	17	)	)	-RRB-
cord-005453-4057qib7	6362	18	.	.	.
cord-005453-4057qib7	6363	1	Finally	finally	RB
cord-005453-4057qib7	6363	2	16/	16/	CD
cord-005453-4057qib7	6363	3	42	42	CD
cord-005453-4057qib7	6363	4	(	(	-LRB-
cord-005453-4057qib7	6363	5	38	38	CD
cord-005453-4057qib7	6363	6	%	%	NN
cord-005453-4057qib7	6363	7	)	)	-RRB-
cord-005453-4057qib7	6364	1	patients	patient	NNS
cord-005453-4057qib7	6364	2	developed	develop	VBD
cord-005453-4057qib7	6364	3	aGvHD	agvhd	NN
cord-005453-4057qib7	6364	4	;	;	:
cord-005453-4057qib7	6364	5	14(33	14(33	CD
cord-005453-4057qib7	6364	6	%	%	NN
cord-005453-4057qib7	6364	7	)	)	-RRB-
cord-005453-4057qib7	6364	8	were	be	VBD
cord-005453-4057qib7	6364	9	assessed	assess	VBN
cord-005453-4057qib7	6364	10	as	as	IN
cord-005453-4057qib7	6364	11	gr	gr	NNP
cord-005453-4057qib7	6365	1	≥II	≥ii	UH
cord-005453-4057qib7	6365	2	,	,	,
cord-005453-4057qib7	6365	3	while	while	IN
cord-005453-4057qib7	6365	4	7(16	7(16	CD
cord-005453-4057qib7	6365	5	%	%	NN
cord-005453-4057qib7	6365	6	)	)	-RRB-
cord-005453-4057qib7	6365	7	as	as	IN
cord-005453-4057qib7	6365	8	gr	gr	NNP
cord-005453-4057qib7	6365	9	III	III	NNP
cord-005453-4057qib7	6365	10	-	-	HYPH
cord-005453-4057qib7	6365	11	IV	IV	NNP
cord-005453-4057qib7	6365	12	.	.	.
cord-005453-4057qib7	6366	1	The	the	DT
cord-005453-4057qib7	6366	2	incidence	incidence	NN
cord-005453-4057qib7	6366	3	of	of	IN
cord-005453-4057qib7	6366	4	the	the	DT
cord-005453-4057qib7	6366	5	aGvHD	agvhd	NN
cord-005453-4057qib7	6366	6	gr	gr	NNP
cord-005453-4057qib7	6366	7	≥II	≥II	NNP
cord-005453-4057qib7	6366	8	was	be	VBD
cord-005453-4057qib7	6366	9	similar	similar	JJ
cord-005453-4057qib7	6366	10	(	(	-LRB-
cord-005453-4057qib7	6366	11	ranged	range	VBN
cord-005453-4057qib7	6366	12	from	from	IN
cord-005453-4057qib7	6366	13	30	30	CD
cord-005453-4057qib7	6366	14	-	-	SYM
cord-005453-4057qib7	6366	15	35	35	CD
cord-005453-4057qib7	6366	16	%	%	NN
cord-005453-4057qib7	6366	17	)	)	-RRB-
cord-005453-4057qib7	6366	18	in	in	IN
cord-005453-4057qib7	6366	19	both	both	DT
cord-005453-4057qib7	6366	20	groups	group	NNS
cord-005453-4057qib7	6366	21	of	of	IN
cord-005453-4057qib7	6366	22	patients	patient	NNS
cord-005453-4057qib7	6366	23	(	(	-LRB-
cord-005453-4057qib7	6366	24	low	low	JJ
cord-005453-4057qib7	6366	25	-	-	HYPH
cord-005453-4057qib7	6366	26	UA	ua	NN
cord-005453-4057qib7	6366	27	and	and	CC
cord-005453-4057qib7	6366	28	high	high	JJ
cord-005453-4057qib7	6366	29	-	-	HYPH
cord-005453-4057qib7	6366	30	UA	ua	NN
cord-005453-4057qib7	6366	31	)	)	-RRB-
cord-005453-4057qib7	6366	32	and	and	CC
cord-005453-4057qib7	6366	33	for	for	IN
cord-005453-4057qib7	6366	34	all	all	PDT
cord-005453-4057qib7	6366	35	the	the	DT
cord-005453-4057qib7	6366	36	estimated	estimate	VBN
cord-005453-4057qib7	6366	37	time	time	NN
cord-005453-4057qib7	6366	38	points	point	NNS
cord-005453-4057qib7	6366	39	(	(	-LRB-
cord-005453-4057qib7	6366	40	days	day	NNS
cord-005453-4057qib7	6366	41	-7	-7	NNP
cord-005453-4057qib7	6366	42	,	,	,
cord-005453-4057qib7	6366	43	0	0	CD
cord-005453-4057qib7	6366	44	,	,	,
cord-005453-4057qib7	6366	45	+7	+7	NN
cord-005453-4057qib7	6366	46	,	,	,
cord-005453-4057qib7	6366	47	+14	+14	CD
cord-005453-4057qib7	6366	48	)	)	-RRB-
cord-005453-4057qib7	6366	49	.	.	.
cord-005453-4057qib7	6367	1	We	-PRON-	PRP
cord-005453-4057qib7	6367	2	noticed	notice	VBD
cord-005453-4057qib7	6367	3	a	a	DT
cord-005453-4057qib7	6367	4	better	well	JJR
cord-005453-4057qib7	6367	5	2-years	2-years	CD
cord-005453-4057qib7	6367	6	overall	overall	JJ
cord-005453-4057qib7	6367	7	survival	survival	NN
cord-005453-4057qib7	6367	8	for	for	IN
cord-005453-4057qib7	6367	9	patients	patient	NNS
cord-005453-4057qib7	6367	10	with	with	IN
cord-005453-4057qib7	6367	11	low	low	JJ
cord-005453-4057qib7	6367	12	-	-	HYPH
cord-005453-4057qib7	6367	13	UA	ua	NN
cord-005453-4057qib7	6367	14	(	(	-LRB-
cord-005453-4057qib7	6367	15	75	75	CD
cord-005453-4057qib7	6367	16	%	%	NN
cord-005453-4057qib7	6367	17	vs.	vs.	CC
cord-005453-4057qib7	6367	18	63	63	CD
cord-005453-4057qib7	6367	19	%	%	NN
cord-005453-4057qib7	6367	20	)	)	-RRB-
cord-005453-4057qib7	6367	21	however	however	RB
cord-005453-4057qib7	6367	22	without	without	IN
cord-005453-4057qib7	6367	23	any	any	DT
cord-005453-4057qib7	6367	24	statistical	statistical	JJ
cord-005453-4057qib7	6367	25	significance	significance	NN
cord-005453-4057qib7	6367	26	.	.	.
cord-005453-4057qib7	6368	1	Ten	ten	CD
cord-005453-4057qib7	6368	2	patients	patient	NNS
cord-005453-4057qib7	6368	3	succumbed	succumb	VBD
cord-005453-4057qib7	6368	4	to	to	IN
cord-005453-4057qib7	6368	5	NRM	NRM	NNP
cord-005453-4057qib7	6368	6	causes	cause	NNS
cord-005453-4057qib7	6368	7	;	;	:
cord-005453-4057qib7	6368	8	6/10	6/10	CD
cord-005453-4057qib7	6368	9	deaths	death	NNS
cord-005453-4057qib7	6368	10	attributed	attribute	VBN
cord-005453-4057qib7	6368	11	to	to	IN
cord-005453-4057qib7	6368	12	GvHD	GvHD	NNP
cord-005453-4057qib7	6368	13	complications	complication	NNS
cord-005453-4057qib7	6368	14	.	.	.
cord-005453-4057qib7	6369	1	The	the	DT
cord-005453-4057qib7	6369	2	NRM	NRM	NNP
cord-005453-4057qib7	6369	3	was	be	VBD
cord-005453-4057qib7	6369	4	assessed	assess	VBN
cord-005453-4057qib7	6369	5	higher	high	JJR
cord-005453-4057qib7	6369	6	in	in	IN
cord-005453-4057qib7	6369	7	the	the	DT
cord-005453-4057qib7	6369	8	high	high	JJ
cord-005453-4057qib7	6369	9	-	-	HYPH
cord-005453-4057qib7	6369	10	UA	ua	NN
cord-005453-4057qib7	6369	11	group	group	NN
cord-005453-4057qib7	6369	12	(	(	-LRB-
cord-005453-4057qib7	6369	13	38	38	CD
cord-005453-4057qib7	6369	14	%	%	NN
cord-005453-4057qib7	6369	15	vs.	vs.	IN
cord-005453-4057qib7	6369	16	18	18	CD
cord-005453-4057qib7	6369	17	%	%	NN
cord-005453-4057qib7	6369	18	)	)	-RRB-
cord-005453-4057qib7	6369	19	but	but	CC
cord-005453-4057qib7	6369	20	also	also	RB
cord-005453-4057qib7	6369	21	this	this	DT
cord-005453-4057qib7	6369	22	difference	difference	NN
cord-005453-4057qib7	6369	23	was	be	VBD
cord-005453-4057qib7	6369	24	not	not	RB
cord-005453-4057qib7	6369	25	statistically	statistically	RB
cord-005453-4057qib7	6369	26	significant	significant	JJ
cord-005453-4057qib7	6369	27	.	.	.
cord-005453-4057qib7	6370	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6370	2	:	:	:
cord-005453-4057qib7	6371	1	Though	though	IN
cord-005453-4057qib7	6371	2	our	-PRON-	PRP$
cord-005453-4057qib7	6371	3	study	study	NN
cord-005453-4057qib7	6371	4	bears	bear	VBZ
cord-005453-4057qib7	6371	5	the	the	DT
cord-005453-4057qib7	6371	6	limitations	limitation	NNS
cord-005453-4057qib7	6371	7	of	of	IN
cord-005453-4057qib7	6371	8	the	the	DT
cord-005453-4057qib7	6371	9	small	small	JJ
cord-005453-4057qib7	6371	10	number	number	NN
cord-005453-4057qib7	6371	11	of	of	IN
cord-005453-4057qib7	6371	12	patients	patient	NNS
cord-005453-4057qib7	6371	13	and	and	CC
cord-005453-4057qib7	6371	14	the	the	DT
cord-005453-4057qib7	6371	15	retrospective	retrospective	JJ
cord-005453-4057qib7	6371	16	origin	origin	NN
cord-005453-4057qib7	6371	17	,	,	,
cord-005453-4057qib7	6371	18	at	at	IN
cord-005453-4057qib7	6371	19	least	least	JJS
cord-005453-4057qib7	6371	20	to	to	IN
cord-005453-4057qib7	6371	21	our	-PRON-	PRP$
cord-005453-4057qib7	6371	22	knowledge	knowledge	NN
cord-005453-4057qib7	6371	23	is	be	VBZ
cord-005453-4057qib7	6371	24	the	the	DT
cord-005453-4057qib7	6371	25	first	first	JJ
cord-005453-4057qib7	6371	26	which	which	WDT
cord-005453-4057qib7	6371	27	evaluates	evaluate	VBZ
cord-005453-4057qib7	6371	28	the	the	DT
cord-005453-4057qib7	6371	29	impact	impact	NN
cord-005453-4057qib7	6371	30	of	of	IN
cord-005453-4057qib7	6371	31	UA	UA	NNP
cord-005453-4057qib7	6371	32	levels	level	NNS
cord-005453-4057qib7	6371	33	at	at	IN
cord-005453-4057qib7	6371	34	different	different	JJ
cord-005453-4057qib7	6371	35	time	time	NN
cord-005453-4057qib7	6371	36	points	point	NNS
cord-005453-4057qib7	6371	37	in	in	IN
cord-005453-4057qib7	6371	38	the	the	DT
cord-005453-4057qib7	6371	39	peritransplant	peritransplant	JJ
cord-005453-4057qib7	6371	40	period	period	NN
cord-005453-4057qib7	6371	41	,	,	,
cord-005453-4057qib7	6371	42	on	on	IN
cord-005453-4057qib7	6371	43	the	the	DT
cord-005453-4057qib7	6371	44	aGvHD	agvhd	NN
cord-005453-4057qib7	6371	45	incidence	incidence	NN
cord-005453-4057qib7	6371	46	.	.	.
cord-005453-4057qib7	6372	1	In	in	IN
cord-005453-4057qib7	6372	2	our	-PRON-	PRP$
cord-005453-4057qib7	6372	3	study	study	NN
cord-005453-4057qib7	6372	4	the	the	DT
cord-005453-4057qib7	6372	5	UA	UA	NNP
cord-005453-4057qib7	6372	6	levels	level	NNS
cord-005453-4057qib7	6372	7	did	do	VBD
cord-005453-4057qib7	6372	8	not	not	RB
cord-005453-4057qib7	6372	9	influence	influence	VB
cord-005453-4057qib7	6372	10	the	the	DT
cord-005453-4057qib7	6372	11	incidence	incidence	NN
cord-005453-4057qib7	6372	12	or	or	CC
cord-005453-4057qib7	6372	13	the	the	DT
cord-005453-4057qib7	6372	14	severity	severity	NN
cord-005453-4057qib7	6372	15	of	of	IN
cord-005453-4057qib7	6372	16	aGvHD	agvhd	NN
cord-005453-4057qib7	6372	17	.	.	.
cord-005453-4057qib7	6373	1	The	the	DT
cord-005453-4057qib7	6373	2	higher	high	JJR
cord-005453-4057qib7	6373	3	NRM	NRM	NNP
cord-005453-4057qib7	6373	4	rates	rate	NNS
cord-005453-4057qib7	6373	5	for	for	IN
cord-005453-4057qib7	6373	6	patients	patient	NNS
cord-005453-4057qib7	6373	7	with	with	IN
cord-005453-4057qib7	6374	1	UA>3.0	UA>3.0	NNP
cord-005453-4057qib7	6374	2	mg	mg	NNP
cord-005453-4057qib7	6374	3	/	/	SYM
cord-005453-4057qib7	6374	4	dl	dl	NNP
cord-005453-4057qib7	6374	5	merits	merit	VBZ
cord-005453-4057qib7	6374	6	further	further	JJ
cord-005453-4057qib7	6374	7	evaluation	evaluation	NN
cord-005453-4057qib7	6374	8	.	.	.
cord-005453-4057qib7	6375	1	Definitely	definitely	RB
cord-005453-4057qib7	6375	2	,	,	,
cord-005453-4057qib7	6375	3	the	the	DT
cord-005453-4057qib7	6375	4	role	role	NN
cord-005453-4057qib7	6375	5	of	of	IN
cord-005453-4057qib7	6375	6	UA	UA	NNP
cord-005453-4057qib7	6375	7	on	on	IN
cord-005453-4057qib7	6375	8	the	the	DT
cord-005453-4057qib7	6375	9	alloSCT	alloSCT	NNP
cord-005453-4057qib7	6375	10	outcome	outcome	NN
cord-005453-4057qib7	6375	11	will	will	MD
cord-005453-4057qib7	6375	12	be	be	VB
cord-005453-4057qib7	6375	13	clarified	clarify	VBN
cord-005453-4057qib7	6375	14	through	through	IN
cord-005453-4057qib7	6375	15	well	well	RB
cord-005453-4057qib7	6375	16	designed	design	VBN
cord-005453-4057qib7	6375	17	prospective	prospective	JJ
cord-005453-4057qib7	6375	18	trials	trial	NNS
cord-005453-4057qib7	6375	19	.	.	.
cord-005453-4057qib7	6376	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6376	2	Results	result	NNS
cord-005453-4057qib7	6376	3	:	:	:
cord-005453-4057qib7	6377	1	Five	five	CD
cord-005453-4057qib7	6377	2	male	male	JJ
cord-005453-4057qib7	6377	3	patients	patient	NNS
cord-005453-4057qib7	6377	4	(	(	-LRB-
cord-005453-4057qib7	6377	5	12	12	CD
cord-005453-4057qib7	6377	6	%	%	NN
cord-005453-4057qib7	6377	7	)	)	-RRB-
cord-005453-4057qib7	6377	8	had	have	VBD
cord-005453-4057qib7	6377	9	genital	genital	JJ
cord-005453-4057qib7	6377	10	cGVHD	cgvhd	JJ
cord-005453-4057qib7	6377	11	manifestations	manifestation	NNS
cord-005453-4057qib7	6377	12	presented	present	VBN
cord-005453-4057qib7	6377	13	by	by	IN
cord-005453-4057qib7	6377	14	urethral	urethral	JJ
cord-005453-4057qib7	6377	15	stricture	stricture	NN
cord-005453-4057qib7	6377	16	in	in	IN
cord-005453-4057qib7	6377	17	4/5	4/5	CD
cord-005453-4057qib7	6377	18	patients	patient	NNS
cord-005453-4057qib7	6377	19	and	and	CC
cord-005453-4057qib7	6377	20	phimosis	phimosis	NN
cord-005453-4057qib7	6377	21	requiring	require	VBG
cord-005453-4057qib7	6377	22	surgical	surgical	JJ
cord-005453-4057qib7	6377	23	treatment	treatment	NN
cord-005453-4057qib7	6377	24	in	in	IN
cord-005453-4057qib7	6377	25	one	one	CD
cord-005453-4057qib7	6377	26	patient	patient	NN
cord-005453-4057qib7	6377	27	.	.	.
cord-005453-4057qib7	6378	1	All	all	DT
cord-005453-4057qib7	6378	2	five	five	CD
cord-005453-4057qib7	6378	3	patients	patient	NNS
cord-005453-4057qib7	6378	4	had	have	VBD
cord-005453-4057qib7	6378	5	simultaneously	simultaneously	RB
cord-005453-4057qib7	6378	6	cutaneous	cutaneous	JJ
cord-005453-4057qib7	6378	7	,	,	,
cord-005453-4057qib7	6378	8	oral	oral	JJ
cord-005453-4057qib7	6378	9	,	,	,
cord-005453-4057qib7	6378	10	and/or	and/or	CC
cord-005453-4057qib7	6378	11	ocular	ocular	JJ
cord-005453-4057qib7	6378	12	cGVHD	cgvhd	NN
cord-005453-4057qib7	6378	13	manifestations	manifestation	NNS
cord-005453-4057qib7	6378	14	.	.	.
cord-005453-4057qib7	6379	1	The	the	DT
cord-005453-4057qib7	6379	2	first	first	JJ
cord-005453-4057qib7	6379	3	patient	patient	NN
cord-005453-4057qib7	6379	4	underwent	undergo	VBD
cord-005453-4057qib7	6379	5	urethroplasty	urethroplasty	NNP
cord-005453-4057qib7	6379	6	of	of	IN
cord-005453-4057qib7	6379	7	bulbomembranous	bulbomembranous	JJ
cord-005453-4057qib7	6379	8	part	part	NN
cord-005453-4057qib7	6379	9	of	of	IN
cord-005453-4057qib7	6379	10	urethra	urethra	NN
cord-005453-4057qib7	6379	11	with	with	IN
cord-005453-4057qib7	6379	12	termino	termino	JJ
cord-005453-4057qib7	6379	13	-	-	JJ
cord-005453-4057qib7	6379	14	terminal	terminal	JJ
cord-005453-4057qib7	6379	15	anastomosis	anastomosis	NN
cord-005453-4057qib7	6379	16	and	and	CC
cord-005453-4057qib7	6379	17	urethroplasty	urethroplasty	NN
cord-005453-4057qib7	6379	18	of	of	IN
cord-005453-4057qib7	6379	19	penile	penile	JJ
cord-005453-4057qib7	6379	20	part	part	NN
cord-005453-4057qib7	6379	21	of	of	IN
cord-005453-4057qib7	6379	22	urethra	urethra	NN
cord-005453-4057qib7	6379	23	with	with	IN
cord-005453-4057qib7	6379	24	buccal	buccal	JJ
cord-005453-4057qib7	6379	25	mucosa	mucosa	JJ
cord-005453-4057qib7	6379	26	autograft	autograft	NN
cord-005453-4057qib7	6379	27	-BMG	-BMG	-RRB-
cord-005453-4057qib7	6379	28	(	(	-LRB-
cord-005453-4057qib7	6379	29	dorsal	dorsal	JJ
cord-005453-4057qib7	6379	30	onlay	onlay	NN
cord-005453-4057qib7	6379	31	)	)	-RRB-
cord-005453-4057qib7	6379	32	that	that	WDT
cord-005453-4057qib7	6379	33	resulted	result	VBD
cord-005453-4057qib7	6379	34	in	in	IN
cord-005453-4057qib7	6379	35	significant	significant	JJ
cord-005453-4057qib7	6379	36	improvement	improvement	NN
cord-005453-4057qib7	6379	37	of	of	IN
cord-005453-4057qib7	6379	38	symptoms	symptom	NNS
cord-005453-4057qib7	6379	39	and	and	CC
cord-005453-4057qib7	6379	40	normal	normal	JJ
cord-005453-4057qib7	6379	41	miction	miction	NN
cord-005453-4057qib7	6379	42	afterwards	afterwards	RB
cord-005453-4057qib7	6379	43	.	.	.
cord-005453-4057qib7	6380	1	Biopsy	biopsy	NN
cord-005453-4057qib7	6380	2	of	of	IN
cord-005453-4057qib7	6380	3	the	the	DT
cord-005453-4057qib7	6380	4	urethra	urethra	NN
cord-005453-4057qib7	6380	5	showed	show	VBD
cord-005453-4057qib7	6380	6	mononuclear	mononuclear	JJ
cord-005453-4057qib7	6380	7	infiltration	infiltration	NN
cord-005453-4057qib7	6380	8	in	in	IN
cord-005453-4057qib7	6380	9	lamina	lamina	NNP
cord-005453-4057qib7	6380	10	propria	propria	FW
cord-005453-4057qib7	6380	11	consistent	consistent	JJ
cord-005453-4057qib7	6380	12	with	with	IN
cord-005453-4057qib7	6380	13	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6380	14	.	.	.
cord-005453-4057qib7	6381	1	Biopsy	biopsy	NN
cord-005453-4057qib7	6381	2	of	of	IN
cord-005453-4057qib7	6381	3	the	the	DT
cord-005453-4057qib7	6381	4	buccal	buccal	JJ
cord-005453-4057qib7	6381	5	mucosa	mucosa	NN
cord-005453-4057qib7	6381	6	was	be	VBD
cord-005453-4057qib7	6381	7	done	do	VBN
cord-005453-4057qib7	6381	8	prior	prior	RB
cord-005453-4057qib7	6381	9	to	to	IN
cord-005453-4057qib7	6381	10	surgery	surgery	NN
cord-005453-4057qib7	6381	11	and	and	CC
cord-005453-4057qib7	6381	12	was	be	VBD
cord-005453-4057qib7	6381	13	negative	negative	JJ
cord-005453-4057qib7	6381	14	for	for	IN
cord-005453-4057qib7	6381	15	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6381	16	involvement	involvement	NN
cord-005453-4057qib7	6381	17	.	.	.
cord-005453-4057qib7	6382	1	The	the	DT
cord-005453-4057qib7	6382	2	second	second	JJ
cord-005453-4057qib7	6382	3	patient	patient	NN
cord-005453-4057qib7	6382	4	underwent	undergo	VBD
cord-005453-4057qib7	6382	5	urethrotomy	urethrotomy	NN
cord-005453-4057qib7	6382	6	due	due	IN
cord-005453-4057qib7	6382	7	to	to	IN
cord-005453-4057qib7	6382	8	circular	circular	JJ
cord-005453-4057qib7	6382	9	strictures	stricture	NNS
cord-005453-4057qib7	6382	10	,	,	,
cord-005453-4057qib7	6382	11	but	but	CC
cord-005453-4057qib7	6382	12	symptoms	symptom	NNS
cord-005453-4057qib7	6382	13	reappeared	reappear	VBD
cord-005453-4057qib7	6382	14	again	again	RB
cord-005453-4057qib7	6382	15	and	and	CC
cord-005453-4057qib7	6382	16	he	-PRON-	PRP
cord-005453-4057qib7	6382	17	is	be	VBZ
cord-005453-4057qib7	6382	18	now	now	RB
cord-005453-4057qib7	6382	19	candidate	candidate	NN
cord-005453-4057qib7	6382	20	for	for	IN
cord-005453-4057qib7	6382	21	BMG	BMG	NNP
cord-005453-4057qib7	6382	22	.	.	.
cord-005453-4057qib7	6383	1	In	in	IN
cord-005453-4057qib7	6383	2	two	two	CD
cord-005453-4057qib7	6383	3	patients	patient	NNS
cord-005453-4057qib7	6383	4	urethral	urethral	JJ
cord-005453-4057qib7	6383	5	dilatation	dilatation	NN
cord-005453-4057qib7	6383	6	was	be	VBD
cord-005453-4057qib7	6383	7	done	do	VBN
cord-005453-4057qib7	6383	8	,	,	,
cord-005453-4057qib7	6383	9	and	and	CC
cord-005453-4057qib7	6383	10	the	the	DT
cord-005453-4057qib7	6383	11	fifth	fifth	JJ
cord-005453-4057qib7	6383	12	patient	patient	NN
cord-005453-4057qib7	6383	13	presented	present	VBN
cord-005453-4057qib7	6383	14	with	with	IN
cord-005453-4057qib7	6383	15	phimosis	phimosis	NN
cord-005453-4057qib7	6383	16	requiring	require	VBG
cord-005453-4057qib7	6383	17	circumcision	circumcision	NN
cord-005453-4057qib7	6383	18	,	,	,
cord-005453-4057qib7	6383	19	resulted	result	VBD
cord-005453-4057qib7	6383	20	in	in	IN
cord-005453-4057qib7	6383	21	significant	significant	JJ
cord-005453-4057qib7	6383	22	improvement	improvement	NN
cord-005453-4057qib7	6383	23	of	of	IN
cord-005453-4057qib7	6383	24	symptoms	symptom	NNS
cord-005453-4057qib7	6383	25	.	.	.
cord-005453-4057qib7	6384	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6384	2	:	:	:
cord-005453-4057qib7	6385	1	Male	male	JJ
cord-005453-4057qib7	6385	2	genital	genital	JJ
cord-005453-4057qib7	6385	3	cGVHD	cgvhd	NN
cord-005453-4057qib7	6385	4	is	be	VBZ
cord-005453-4057qib7	6385	5	an	an	DT
cord-005453-4057qib7	6385	6	underrecognized	underrecognized	JJ
cord-005453-4057qib7	6385	7	and	and	CC
cord-005453-4057qib7	6385	8	under	under	RB
cord-005453-4057qib7	6385	9	-	-	HYPH
cord-005453-4057qib7	6385	10	reported	report	VBN
cord-005453-4057qib7	6385	11	manifestation	manifestation	NN
cord-005453-4057qib7	6385	12	.	.	.
cord-005453-4057qib7	6386	1	Patients	patient	NNS
cord-005453-4057qib7	6386	2	after	after	IN
cord-005453-4057qib7	6386	3	allo	allo	NN
cord-005453-4057qib7	6386	4	-	-	HYPH
cord-005453-4057qib7	6386	5	HSCT	HSCT	NNP
cord-005453-4057qib7	6386	6	need	need	VBP
cord-005453-4057qib7	6386	7	to	to	TO
cord-005453-4057qib7	6386	8	be	be	VB
cord-005453-4057qib7	6386	9	actively	actively	RB
cord-005453-4057qib7	6386	10	asked	ask	VBN
cord-005453-4057qib7	6386	11	about	about	IN
cord-005453-4057qib7	6386	12	their	-PRON-	PRP$
cord-005453-4057qib7	6386	13	genital	genital	JJ
cord-005453-4057qib7	6386	14	symptoms	symptom	NNS
cord-005453-4057qib7	6386	15	and	and	CC
cord-005453-4057qib7	6386	16	sexual	sexual	JJ
cord-005453-4057qib7	6386	17	function	function	NN
cord-005453-4057qib7	6386	18	,	,	,
cord-005453-4057qib7	6386	19	especially	especially	RB
cord-005453-4057qib7	6386	20	if	if	IN
cord-005453-4057qib7	6386	21	they	-PRON-	PRP
cord-005453-4057qib7	6386	22	are	be	VBP
cord-005453-4057qib7	6386	23	diagnosed	diagnose	VBN
cord-005453-4057qib7	6386	24	with	with	IN
cord-005453-4057qib7	6386	25	other	other	JJ
cord-005453-4057qib7	6386	26	mucocutaneous	mucocutaneous	JJ
cord-005453-4057qib7	6386	27	or	or	CC
cord-005453-4057qib7	6386	28	ocular	ocular	JJ
cord-005453-4057qib7	6386	29	cGVHD	cgvhd	NN
cord-005453-4057qib7	6386	30	.	.	.
cord-005453-4057qib7	6387	1	Multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	6387	2	approach	approach	NN
cord-005453-4057qib7	6387	3	,	,	,
cord-005453-4057qib7	6387	4	early	early	JJ
cord-005453-4057qib7	6387	5	recognition	recognition	NN
cord-005453-4057qib7	6387	6	and	and	CC
cord-005453-4057qib7	6387	7	frequent	frequent	JJ
cord-005453-4057qib7	6387	8	follow	follow	NN
cord-005453-4057qib7	6387	9	-	-	HYPH
cord-005453-4057qib7	6387	10	up	up	NN
cord-005453-4057qib7	6387	11	is	be	VBZ
cord-005453-4057qib7	6387	12	necessary	necessary	JJ
cord-005453-4057qib7	6387	13	for	for	IN
cord-005453-4057qib7	6387	14	timely	timely	JJ
cord-005453-4057qib7	6387	15	start	start	NN
cord-005453-4057qib7	6387	16	of	of	IN
cord-005453-4057qib7	6387	17	treatment	treatment	NN
cord-005453-4057qib7	6387	18	.	.	.
cord-005453-4057qib7	6388	1	New	new	JJ
cord-005453-4057qib7	6388	2	methods	method	NNS
cord-005453-4057qib7	6388	3	,	,	,
cord-005453-4057qib7	6388	4	such	such	JJ
cord-005453-4057qib7	6388	5	as	as	IN
cord-005453-4057qib7	6388	6	BMG	BMG	NNP
cord-005453-4057qib7	6388	7	for	for	IN
cord-005453-4057qib7	6388	8	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6388	9	patients	patient	NNS
cord-005453-4057qib7	6388	10	with	with	IN
cord-005453-4057qib7	6388	11	urethral	urethral	JJ
cord-005453-4057qib7	6388	12	stricture	stricture	NN
cord-005453-4057qib7	6388	13	seem	seem	VBP
cord-005453-4057qib7	6388	14	promising	promise	VBG
cord-005453-4057qib7	6388	15	and	and	CC
cord-005453-4057qib7	6388	16	should	should	MD
cord-005453-4057qib7	6388	17	be	be	VB
cord-005453-4057qib7	6388	18	further	further	RB
cord-005453-4057qib7	6388	19	investigated	investigate	VBN
cord-005453-4057qib7	6388	20	.	.	.
cord-005453-4057qib7	6389	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6389	2	:	:	:
cord-005453-4057qib7	6389	3	Nothing	nothing	NN
cord-005453-4057qib7	6389	4	to	to	TO
cord-005453-4057qib7	6389	5	declare	declare	VB
cord-005453-4057qib7	6389	6	.	.	.
cord-005453-4057qib7	6390	1	P289	P289	NNP
cord-005453-4057qib7	6390	2	Abstract	Abstract	NNP
cord-005453-4057qib7	6390	3	withdrawn	withdraw	VBN
cord-005453-4057qib7	6390	4	.	.	.
cord-005453-4057qib7	6391	1	Heracles	Heracles	NNP
cord-005453-4057qib7	6391	2	:	:	:
cord-005453-4057qib7	6392	1	A	a	DT
cord-005453-4057qib7	6392	2	phase	phase	NN
cord-005453-4057qib7	6392	3	II	ii	CD
cord-005453-4057qib7	6392	4	single	single	JJ
cord-005453-4057qib7	6392	5	-	-	HYPH
cord-005453-4057qib7	6392	6	arm	arm	NN
cord-005453-4057qib7	6392	7	prospective	prospective	JJ
cord-005453-4057qib7	6392	8	study	study	NN
cord-005453-4057qib7	6392	9	to	to	TO
cord-005453-4057qib7	6392	10	assess	assess	VB
cord-005453-4057qib7	6392	11	the	the	DT
cord-005453-4057qib7	6392	12	efficacy	efficacy	NN
cord-005453-4057qib7	6392	13	of	of	IN
cord-005453-4057qib7	6392	14	fecal	fecal	JJ
cord-005453-4057qib7	6392	15	microbiota	microbiota	NN
cord-005453-4057qib7	6392	16	transfer	transfer	NN
cord-005453-4057qib7	6392	17	in	in	IN
cord-005453-4057qib7	6392	18	the	the	DT
cord-005453-4057qib7	6392	19	treatment	treatment	NN
cord-005453-4057qib7	6392	20	of	of	IN
cord-005453-4057qib7	6392	21	steroid	steroid	NN
cord-005453-4057qib7	6392	22	refractory	refractory	JJ
cord-005453-4057qib7	6392	23	gastro	gastro	JJ
cord-005453-4057qib7	6392	24	-	-	HYPH
cord-005453-4057qib7	6392	25	intestinal	intestinal	JJ
cord-005453-4057qib7	6392	26	AGVHD	AGVHD	NNP
cord-005453-4057qib7	6392	27	post	post	AFX
cord-005453-4057qib7	6392	28	allo	allo	NN
cord-005453-4057qib7	6392	29	-	-	HYPH
cord-005453-4057qib7	6392	30	HSCT	HSCT	NNP
cord-005453-4057qib7	6392	31	Background	Background	NNP
cord-005453-4057qib7	6392	32	:	:	:
cord-005453-4057qib7	6392	33	Steroid	steroid	JJ
cord-005453-4057qib7	6392	34	-	-	HYPH
cord-005453-4057qib7	6392	35	refractory	refractory	JJ
cord-005453-4057qib7	6392	36	acute	acute	JJ
cord-005453-4057qib7	6392	37	graft	graft	NN
cord-005453-4057qib7	6392	38	-	-	HYPH
cord-005453-4057qib7	6392	39	versus	versus	IN
cord-005453-4057qib7	6392	40	-	-	HYPH
cord-005453-4057qib7	6392	41	host	host	NN
cord-005453-4057qib7	6392	42	disease	disease	NN
cord-005453-4057qib7	6392	43	(	(	-LRB-
cord-005453-4057qib7	6392	44	SR	SR	NNP
cord-005453-4057qib7	6392	45	-	-	HYPH
cord-005453-4057qib7	6392	46	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6392	47	)	)	-RRB-
cord-005453-4057qib7	6392	48	is	be	VBZ
cord-005453-4057qib7	6392	49	associated	associate	VBN
cord-005453-4057qib7	6392	50	with	with	IN
cord-005453-4057qib7	6392	51	an	an	DT
cord-005453-4057qib7	6392	52	80	80	CD
cord-005453-4057qib7	6392	53	%	%	NN
cord-005453-4057qib7	6392	54	mortality	mortality	NN
cord-005453-4057qib7	6392	55	rate	rate	NN
cord-005453-4057qib7	6392	56	and	and	CC
cord-005453-4057qib7	6392	57	reduced	reduced	JJ
cord-005453-4057qib7	6392	58	quality	quality	NN
cord-005453-4057qib7	6392	59	of	of	IN
cord-005453-4057qib7	6392	60	life	life	NN
cord-005453-4057qib7	6392	61	(	(	-LRB-
cord-005453-4057qib7	6392	62	QoL	qol	NN
cord-005453-4057qib7	6392	63	)	)	-RRB-
cord-005453-4057qib7	6392	64	.	.	.
cord-005453-4057qib7	6393	1	So	so	RB
cord-005453-4057qib7	6393	2	far	far	RB
cord-005453-4057qib7	6393	3	,	,	,
cord-005453-4057qib7	6393	4	there	there	EX
cord-005453-4057qib7	6393	5	is	be	VBZ
cord-005453-4057qib7	6393	6	no	no	DT
cord-005453-4057qib7	6393	7	approved	approve	VBN
cord-005453-4057qib7	6393	8	standard	standard	NN
cord-005453-4057qib7	6393	9	of	of	IN
cord-005453-4057qib7	6393	10	care	care	NN
cord-005453-4057qib7	6393	11	for	for	IN
cord-005453-4057qib7	6393	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6393	13	second	second	JJ
cord-005453-4057qib7	6393	14	-	-	HYPH
cord-005453-4057qib7	6393	15	line	line	NN
cord-005453-4057qib7	6393	16	treatment	treatment	NN
cord-005453-4057qib7	6393	17	.	.	.
cord-005453-4057qib7	6394	1	There	there	EX
cord-005453-4057qib7	6394	2	is	be	VBZ
cord-005453-4057qib7	6394	3	an	an	DT
cord-005453-4057qib7	6394	4	urgent	urgent	JJ
cord-005453-4057qib7	6394	5	need	need	NN
cord-005453-4057qib7	6394	6	to	to	TO
cord-005453-4057qib7	6394	7	identify	identify	VB
cord-005453-4057qib7	6394	8	effective	effective	JJ
cord-005453-4057qib7	6394	9	therapy	therapy	NN
cord-005453-4057qib7	6394	10	for	for	IN
cord-005453-4057qib7	6394	11	SR	SR	NNP
cord-005453-4057qib7	6394	12	-	-	HYPH
cord-005453-4057qib7	6394	13	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6394	14	to	to	TO
cord-005453-4057qib7	6394	15	improve	improve	VB
cord-005453-4057qib7	6394	16	patients	patient	NNS
cord-005453-4057qib7	6394	17	'	'	POS
cord-005453-4057qib7	6394	18	outcomes	outcome	NNS
cord-005453-4057qib7	6394	19	.	.	.
cord-005453-4057qib7	6395	1	Fecal	Fecal	NNP
cord-005453-4057qib7	6395	2	Microbiota	Microbiota	NNP
cord-005453-4057qib7	6395	3	Transfer	Transfer	NNP
cord-005453-4057qib7	6395	4	(	(	-LRB-
cord-005453-4057qib7	6395	5	FMT	fmt	NN
cord-005453-4057qib7	6395	6	)	)	-RRB-
cord-005453-4057qib7	6395	7	might	may	MD
cord-005453-4057qib7	6395	8	be	be	VB
cord-005453-4057qib7	6395	9	beneficial	beneficial	JJ
cord-005453-4057qib7	6395	10	to	to	TO
cord-005453-4057qib7	6395	11	substantially	substantially	RB
cord-005453-4057qib7	6395	12	improve	improve	VB
cord-005453-4057qib7	6395	13	the	the	DT
cord-005453-4057qib7	6395	14	prognosis	prognosis	NN
cord-005453-4057qib7	6395	15	.	.	.
cord-005453-4057qib7	6396	1	Higher	high	JJR
cord-005453-4057qib7	6396	2	gut	gut	NN
cord-005453-4057qib7	6396	3	microbial	microbial	JJ
cord-005453-4057qib7	6396	4	diversity	diversity	NN
cord-005453-4057qib7	6396	5	is	be	VBZ
cord-005453-4057qib7	6396	6	strongly	strongly	RB
cord-005453-4057qib7	6396	7	associated	associate	VBN
cord-005453-4057qib7	6396	8	with	with	IN
cord-005453-4057qib7	6396	9	increased	increase	VBN
cord-005453-4057qib7	6396	10	survival	survival	NN
cord-005453-4057qib7	6396	11	in	in	IN
cord-005453-4057qib7	6396	12	GvHD	gvhd	NN
cord-005453-4057qib7	6396	13	patients	patient	NNS
cord-005453-4057qib7	6396	14	.	.	.
cord-005453-4057qib7	6397	1	Recent	recent	JJ
cord-005453-4057qib7	6397	2	studies	study	NNS
cord-005453-4057qib7	6397	3	reported	report	VBD
cord-005453-4057qib7	6397	4	promising	promising	JJ
cord-005453-4057qib7	6397	5	results	result	NNS
cord-005453-4057qib7	6397	6	of	of	IN
cord-005453-4057qib7	6397	7	SR	SR	NNP
cord-005453-4057qib7	6397	8	-	-	HYPH
cord-005453-4057qib7	6397	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6397	10	patients	patient	NNS
cord-005453-4057qib7	6397	11	treated	treat	VBN
cord-005453-4057qib7	6397	12	with	with	IN
cord-005453-4057qib7	6397	13	FMT	FMT	NNP
cord-005453-4057qib7	6397	14	.	.	.
cord-005453-4057qib7	6398	1	Further	further	JJ
cord-005453-4057qib7	6398	2	evaluation	evaluation	NN
cord-005453-4057qib7	6398	3	to	to	TO
cord-005453-4057qib7	6398	4	confirm	confirm	VB
cord-005453-4057qib7	6398	5	the	the	DT
cord-005453-4057qib7	6398	6	efficacy	efficacy	NN
cord-005453-4057qib7	6398	7	and	and	CC
cord-005453-4057qib7	6398	8	safety	safety	NN
cord-005453-4057qib7	6398	9	of	of	IN
cord-005453-4057qib7	6398	10	FMT	fmt	NN
cord-005453-4057qib7	6398	11	for	for	IN
cord-005453-4057qib7	6398	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6398	13	is	be	VBZ
cord-005453-4057qib7	6398	14	warranted	warrant	VBN
cord-005453-4057qib7	6398	15	.	.	.
cord-005453-4057qib7	6399	1	The	the	DT
cord-005453-4057qib7	6399	2	ongoing	ongoing	JJ
cord-005453-4057qib7	6399	3	phase	phase	NN
cord-005453-4057qib7	6399	4	2	2	CD
cord-005453-4057qib7	6399	5	study	study	NN
cord-005453-4057qib7	6399	6	(	(	-LRB-
cord-005453-4057qib7	6399	7	HERACLES	HERACLES	NNP
cord-005453-4057qib7	6399	8	)	)	-RRB-
cord-005453-4057qib7	6399	9	investigates	investigate	VBZ
cord-005453-4057qib7	6399	10	the	the	DT
cord-005453-4057qib7	6399	11	efficacy	efficacy	NN
cord-005453-4057qib7	6399	12	of	of	IN
cord-005453-4057qib7	6399	13	allogeneic	allogeneic	NN
cord-005453-4057qib7	6399	14	FMT	fmt	NN
cord-005453-4057qib7	6399	15	in	in	IN
cord-005453-4057qib7	6399	16	the	the	DT
cord-005453-4057qib7	6399	17	treatment	treatment	NN
cord-005453-4057qib7	6399	18	of	of	IN
cord-005453-4057qib7	6399	19	patients	patient	NNS
cord-005453-4057qib7	6399	20	with	with	IN
cord-005453-4057qib7	6399	21	SR	SR	NNP
cord-005453-4057qib7	6399	22	-	-	HYPH
cord-005453-4057qib7	6399	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6399	24	.	.	.
cord-005453-4057qib7	6400	1	HERACLES	HERACLES	NNP
cord-005453-4057qib7	6400	2	was	be	VBD
cord-005453-4057qib7	6400	3	launched	launch	VBN
cord-005453-4057qib7	6400	4	after	after	IN
cord-005453-4057qib7	6400	5	the	the	DT
cord-005453-4057qib7	6400	6	ODYSSEE	ODYSSEE	NNP
cord-005453-4057qib7	6400	7	study	study	NN
cord-005453-4057qib7	6400	8	showed	show	VBD
cord-005453-4057qib7	6400	9	promising	promising	JJ
cord-005453-4057qib7	6400	10	results	result	NNS
cord-005453-4057qib7	6400	11	in	in	IN
cord-005453-4057qib7	6400	12	the	the	DT
cord-005453-4057qib7	6400	13	reconstruction	reconstruction	NN
cord-005453-4057qib7	6400	14	of	of	IN
cord-005453-4057qib7	6400	15	gut	gut	NN
cord-005453-4057qib7	6400	16	microbiota	microbiota	NN
cord-005453-4057qib7	6400	17	diversity	diversity	NN
cord-005453-4057qib7	6400	18	after	after	IN
cord-005453-4057qib7	6400	19	induction	induction	NN
cord-005453-4057qib7	6400	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	6400	21	with	with	IN
cord-005453-4057qib7	6400	22	FMT	fmt	NN
cord-005453-4057qib7	6400	23	in	in	IN
cord-005453-4057qib7	6400	24	Acute	Acute	NNP
cord-005453-4057qib7	6400	25	Myeloid	Myeloid	NNP
cord-005453-4057qib7	6400	26	Leukemia	Leukemia	NNP
cord-005453-4057qib7	6400	27	patients	patient	NNS
cord-005453-4057qib7	6400	28	.	.	.
cord-005453-4057qib7	6401	1	We	-PRON-	PRP
cord-005453-4057qib7	6401	2	expect	expect	VBP
cord-005453-4057qib7	6401	3	that	that	IN
cord-005453-4057qib7	6401	4	FMT	fmt	NN
cord-005453-4057qib7	6401	5	-	-	HYPH
cord-005453-4057qib7	6401	6	based	base	VBN
cord-005453-4057qib7	6401	7	biotherapeutic	biotherapeutic	JJ
cord-005453-4057qib7	6401	8	drugs	drug	NNS
cord-005453-4057qib7	6401	9	could	could	MD
cord-005453-4057qib7	6401	10	be	be	VB
cord-005453-4057qib7	6401	11	effective	effective	JJ
cord-005453-4057qib7	6401	12	treatments	treatment	NNS
cord-005453-4057qib7	6401	13	to	to	TO
cord-005453-4057qib7	6401	14	contain	contain	VB
cord-005453-4057qib7	6401	15	SR	SR	NNP
cord-005453-4057qib7	6401	16	-	-	HYPH
cord-005453-4057qib7	6401	17	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6401	18	,	,	,
cord-005453-4057qib7	6401	19	and	and	CC
cord-005453-4057qib7	6401	20	thereby	thereby	RB
cord-005453-4057qib7	6401	21	reduce	reduce	VB
cord-005453-4057qib7	6401	22	the	the	DT
cord-005453-4057qib7	6401	23	risk	risk	NN
cord-005453-4057qib7	6401	24	of	of	IN
cord-005453-4057qib7	6401	25	life	life	NN
cord-005453-4057qib7	6401	26	-	-	HYPH
cord-005453-4057qib7	6401	27	threatening	threaten	VBG
cord-005453-4057qib7	6401	28	complications	complication	NNS
cord-005453-4057qib7	6401	29	after	after	IN
cord-005453-4057qib7	6401	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	6401	31	HSCT	HSCT	NNP
cord-005453-4057qib7	6401	32	.	.	.
cord-005453-4057qib7	6402	1	Methods	method	NNS
cord-005453-4057qib7	6402	2	:	:	:
cord-005453-4057qib7	6402	3	HERACLES	HERACLES	NNP
cord-005453-4057qib7	6402	4	is	be	VBZ
cord-005453-4057qib7	6402	5	a	a	DT
cord-005453-4057qib7	6402	6	single	single	JJ
cord-005453-4057qib7	6402	7	-	-	HYPH
cord-005453-4057qib7	6402	8	arm	arm	NN
cord-005453-4057qib7	6402	9	,	,	,
cord-005453-4057qib7	6402	10	multicenter	multicenter	JJ
cord-005453-4057qib7	6402	11	prospective	prospective	JJ
cord-005453-4057qib7	6402	12	trial	trial	NN
cord-005453-4057qib7	6402	13	in	in	IN
cord-005453-4057qib7	6402	14	5	5	CD
cord-005453-4057qib7	6402	15	European	european	JJ
cord-005453-4057qib7	6402	16	countries	country	NNS
cord-005453-4057qib7	6402	17	.	.	.
cord-005453-4057qib7	6403	1	Patients	patient	NNS
cord-005453-4057qib7	6403	2	aged	aged	JJ
cord-005453-4057qib7	6404	1	≥18	≥18	NNP
cord-005453-4057qib7	6404	2	years	year	NNS
cord-005453-4057qib7	6404	3	-	-	HYPH
cord-005453-4057qib7	6404	4	old	old	JJ
cord-005453-4057qib7	6404	5	,	,	,
cord-005453-4057qib7	6404	6	who	who	WP
cord-005453-4057qib7	6404	7	underwent	undergo	VBD
cord-005453-4057qib7	6404	8	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6404	9	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	6404	10	Stem	Stem	NNP
cord-005453-4057qib7	6404	11	Cell	cell	NN
cord-005453-4057qib7	6404	12	Transplantation	transplantation	NN
cord-005453-4057qib7	6404	13	(	(	-LRB-
cord-005453-4057qib7	6404	14	allo	allo	NN
cord-005453-4057qib7	6404	15	-	-	HYPH
cord-005453-4057qib7	6404	16	HSCT	HSCT	NNP
cord-005453-4057qib7	6404	17	)	)	-RRB-
cord-005453-4057qib7	6404	18	and	and	CC
cord-005453-4057qib7	6404	19	developed	develop	VBD
cord-005453-4057qib7	6404	20	a	a	DT
cord-005453-4057qib7	6404	21	first	first	JJ
cord-005453-4057qib7	6404	22	episode	episode	NN
cord-005453-4057qib7	6404	23	of	of	IN
cord-005453-4057qib7	6404	24	Stage	Stage	NNP
cord-005453-4057qib7	6404	25	3	3	CD
cord-005453-4057qib7	6404	26	or	or	CC
cord-005453-4057qib7	6404	27	4	4	CD
cord-005453-4057qib7	6404	28	aGVHD	agvhd	NN
cord-005453-4057qib7	6404	29	with	with	IN
cord-005453-4057qib7	6404	30	gut	gut	NN
cord-005453-4057qib7	6404	31	predominance	predominance	NN
cord-005453-4057qib7	6404	32	resistant	resistant	JJ
cord-005453-4057qib7	6404	33	to	to	IN
cord-005453-4057qib7	6404	34	a	a	DT
cord-005453-4057qib7	6404	35	first	first	JJ
cord-005453-4057qib7	6404	36	-	-	HYPH
cord-005453-4057qib7	6404	37	line	line	NN
cord-005453-4057qib7	6404	38	steroid	steroid	NN
cord-005453-4057qib7	6404	39	therapy	therapy	NN
cord-005453-4057qib7	6404	40	are	be	VBP
cord-005453-4057qib7	6404	41	eligible	eligible	JJ
cord-005453-4057qib7	6404	42	for	for	IN
cord-005453-4057qib7	6404	43	inclusion	inclusion	NN
cord-005453-4057qib7	6404	44	.	.	.
cord-005453-4057qib7	6405	1	Main	main	JJ
cord-005453-4057qib7	6405	2	exclusion	exclusion	NN
cord-005453-4057qib7	6405	3	criteria	criterion	NNS
cord-005453-4057qib7	6405	4	comprise	comprise	VBP
cord-005453-4057qib7	6405	5	the	the	DT
cord-005453-4057qib7	6405	6	use	use	NN
cord-005453-4057qib7	6405	7	of	of	IN
cord-005453-4057qib7	6405	8	other	other	JJ
cord-005453-4057qib7	6405	9	second	second	JJ
cord-005453-4057qib7	6405	10	-	-	HYPH
cord-005453-4057qib7	6405	11	line	line	NN
cord-005453-4057qib7	6405	12	GVHD	GVHD	NNP
cord-005453-4057qib7	6405	13	therapy	therapy	NN
cord-005453-4057qib7	6405	14	,	,	,
cord-005453-4057qib7	6405	15	patients	patient	NNS
cord-005453-4057qib7	6405	16	with	with	IN
cord-005453-4057qib7	6405	17	grade	grade	NN
cord-005453-4057qib7	6405	18	IV	IV	NNP
cord-005453-4057qib7	6405	19	hyperacute	hyperacute	JJ
cord-005453-4057qib7	6405	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6405	21	,	,	,
cord-005453-4057qib7	6405	22	late	late	JJ
cord-005453-4057qib7	6405	23	onset	onset	NN
cord-005453-4057qib7	6405	24	aGVHD	agvhd	NN
cord-005453-4057qib7	6405	25	,	,	,
cord-005453-4057qib7	6405	26	and	and	CC
cord-005453-4057qib7	6405	27	overlap	overlap	VBP
cord-005453-4057qib7	6405	28	chronic	chronic	JJ
cord-005453-4057qib7	6405	29	GVHD	GVHD	NNP
cord-005453-4057qib7	6405	30	and	and	CC
cord-005453-4057qib7	6405	31	aGVHD	agvhd	NN
cord-005453-4057qib7	6405	32	after	after	IN
cord-005453-4057qib7	6405	33	donor	donor	NN
cord-005453-4057qib7	6405	34	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6405	35	infusion	infusion	NN
cord-005453-4057qib7	6405	36	.	.	.
cord-005453-4057qib7	6406	1	Patients	patient	NNS
cord-005453-4057qib7	6406	2	receive	receive	VBP
cord-005453-4057qib7	6406	3	a	a	DT
cord-005453-4057qib7	6406	4	first	first	JJ
cord-005453-4057qib7	6406	5	MaaT013	MaaT013	NNP
cord-005453-4057qib7	6406	6	enema	enema	NN
cord-005453-4057qib7	6406	7	within	within	IN
cord-005453-4057qib7	6406	8	5	5	CD
cord-005453-4057qib7	6406	9	days	day	NNS
cord-005453-4057qib7	6406	10	after	after	IN
cord-005453-4057qib7	6406	11	SR	SR	NNP
cord-005453-4057qib7	6406	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	6406	13	(	(	-LRB-
cord-005453-4057qib7	6406	14	V1	V1	NNS
cord-005453-4057qib7	6406	15	)	)	-RRB-
cord-005453-4057qib7	6406	16	and	and	CC
cord-005453-4057qib7	6406	17	2	2	CD
cord-005453-4057qib7	6406	18	additional	additional	JJ
cord-005453-4057qib7	6406	19	ones	one	NNS
cord-005453-4057qib7	6406	20	1	1	CD
cord-005453-4057qib7	6406	21	week	week	NN
cord-005453-4057qib7	6406	22	apart	apart	RB
cord-005453-4057qib7	6406	23	(	(	-LRB-
cord-005453-4057qib7	6406	24	V2/	V2/	NNP
cord-005453-4057qib7	6406	25	V3	V3	NNP
cord-005453-4057qib7	6406	26	)	)	-RRB-
cord-005453-4057qib7	6406	27	from	from	IN
cord-005453-4057qib7	6406	28	each	each	DT
cord-005453-4057qib7	6406	29	other	other	JJ
cord-005453-4057qib7	6406	30	.	.	.
cord-005453-4057qib7	6407	1	MaaT013	MaaT013	NNP
cord-005453-4057qib7	6407	2	is	be	VBZ
cord-005453-4057qib7	6407	3	a	a	DT
cord-005453-4057qib7	6407	4	highly	highly	RB
cord-005453-4057qib7	6407	5	-	-	HYPH
cord-005453-4057qib7	6407	6	diverse	diverse	JJ
cord-005453-4057qib7	6407	7	,	,	,
cord-005453-4057qib7	6407	8	microbiome	microbiome	NN
cord-005453-4057qib7	6407	9	-	-	HYPH
cord-005453-4057qib7	6407	10	rich	rich	JJ
cord-005453-4057qib7	6407	11	enema	enema	NN
cord-005453-4057qib7	6407	12	formulation	formulation	NN
cord-005453-4057qib7	6407	13	obtained	obtain	VBN
cord-005453-4057qib7	6407	14	from	from	IN
cord-005453-4057qib7	6407	15	pooled	pool	VBN
cord-005453-4057qib7	6407	16	,	,	,
cord-005453-4057qib7	6407	17	rigorously	rigorously	RB
cord-005453-4057qib7	6407	18	screened	screen	VBD
cord-005453-4057qib7	6407	19	faeces	faece	NNS
cord-005453-4057qib7	6407	20	from	from	IN
cord-005453-4057qib7	6407	21	healthy	healthy	JJ
cord-005453-4057qib7	6407	22	donors	donor	NNS
cord-005453-4057qib7	6407	23	,	,	,
cord-005453-4057qib7	6407	24	manufactured	manufacture	VBN
cord-005453-4057qib7	6407	25	with	with	IN
cord-005453-4057qib7	6407	26	a	a	DT
cord-005453-4057qib7	6407	27	standardized	standardized	JJ
cord-005453-4057qib7	6407	28	process	process	NN
cord-005453-4057qib7	6407	29	using	use	VBG
cord-005453-4057qib7	6407	30	the	the	DT
cord-005453-4057qib7	6407	31	signature	signature	NN
cord-005453-4057qib7	6407	32	MaaT	MaaT	NNP
cord-005453-4057qib7	6407	33	Microbiome	microbiome	NN
cord-005453-4057qib7	6407	34	Restoration	Restoration	NNP
cord-005453-4057qib7	6407	35	Biotherapeutic	Biotherapeutic	NNP
cord-005453-4057qib7	6407	36	(	(	-LRB-
cord-005453-4057qib7	6407	37	MMRB	MMRB	NNP
cord-005453-4057qib7	6407	38	)	)	-RRB-
cord-005453-4057qib7	6407	39	platform	platform	NN
cord-005453-4057qib7	6407	40	.	.	.
cord-005453-4057qib7	6408	1	At	at	IN
cord-005453-4057qib7	6408	2	inclusion	inclusion	NN
cord-005453-4057qib7	6408	3	(	(	-LRB-
cord-005453-4057qib7	6408	4	V1	V1	NNS
cord-005453-4057qib7	6408	5	)	)	-RRB-
cord-005453-4057qib7	6408	6	,	,	,
cord-005453-4057qib7	6408	7	before	before	IN
cord-005453-4057qib7	6408	8	each	each	DT
cord-005453-4057qib7	6408	9	dosing	dosing	NN
cord-005453-4057qib7	6408	10	(	(	-LRB-
cord-005453-4057qib7	6408	11	V2,3	V2,3	NNP
cord-005453-4057qib7	6408	12	)	)	-RRB-
cord-005453-4057qib7	6408	13	,	,	,
cord-005453-4057qib7	6408	14	and	and	CC
cord-005453-4057qib7	6408	15	28	28	CD
cord-005453-4057qib7	6408	16	days	day	NNS
cord-005453-4057qib7	6408	17	post	post	NN
cord-005453-4057qib7	6408	18	inclusion	inclusion	NN
cord-005453-4057qib7	6408	19	(	(	-LRB-
cord-005453-4057qib7	6408	20	V4	V4	NNP
cord-005453-4057qib7	6408	21	)	)	-RRB-
cord-005453-4057qib7	6408	22	,	,	,
cord-005453-4057qib7	6408	23	patients	patient	NNS
cord-005453-4057qib7	6408	24	'	'	POS
cord-005453-4057qib7	6408	25	faeces	faece	NNS
cord-005453-4057qib7	6408	26	and	and	CC
cord-005453-4057qib7	6408	27	blood	blood	NN
cord-005453-4057qib7	6408	28	are	be	VBP
cord-005453-4057qib7	6408	29	collected	collect	VBN
cord-005453-4057qib7	6408	30	.	.	.
cord-005453-4057qib7	6409	1	Safety	safety	NN
cord-005453-4057qib7	6409	2	monitoring	monitoring	NN
cord-005453-4057qib7	6409	3	will	will	MD
cord-005453-4057qib7	6409	4	be	be	VB
cord-005453-4057qib7	6409	5	performed	perform	VBN
cord-005453-4057qib7	6409	6	with	with	IN
cord-005453-4057qib7	6409	7	corresponding	correspond	VBG
cord-005453-4057qib7	6409	8	blood	blood	NN
cord-005453-4057qib7	6409	9	analyses	analysis	NNS
cord-005453-4057qib7	6409	10	.	.	.
cord-005453-4057qib7	6410	1	Exploratory	exploratory	JJ
cord-005453-4057qib7	6410	2	measures	measure	NNS
cord-005453-4057qib7	6410	3	on	on	IN
cord-005453-4057qib7	6410	4	faeces	faece	NNS
cord-005453-4057qib7	6410	5	include	include	VBP
cord-005453-4057qib7	6410	6	characterization	characterization	NN
cord-005453-4057qib7	6410	7	of	of	IN
cord-005453-4057qib7	6410	8	gut	gut	NN
cord-005453-4057qib7	6410	9	microbiota	microbiota	NN
cord-005453-4057qib7	6410	10	composition	composition	NN
cord-005453-4057qib7	6410	11	and	and	CC
cord-005453-4057qib7	6410	12	evolution	evolution	NN
cord-005453-4057qib7	6410	13	,	,	,
cord-005453-4057qib7	6410	14	impact	impact	NN
cord-005453-4057qib7	6410	15	of	of	IN
cord-005453-4057qib7	6410	16	MaaT013	MaaT013	NNP
cord-005453-4057qib7	6410	17	on	on	IN
cord-005453-4057qib7	6410	18	metabolism	metabolism	NN
cord-005453-4057qib7	6410	19	,	,	,
cord-005453-4057qib7	6410	20	and	and	CC
cord-005453-4057qib7	6410	21	gut	gut	VB
cord-005453-4057qib7	6410	22	inflammation	inflammation	NN
cord-005453-4057qib7	6410	23	.	.	.
cord-005453-4057qib7	6411	1	Immune	immune	JJ
cord-005453-4057qib7	6411	2	system	system	NN
cord-005453-4057qib7	6411	3	phenotyping	phenotyping	NN
cord-005453-4057qib7	6411	4	will	will	MD
cord-005453-4057qib7	6411	5	be	be	VB
cord-005453-4057qib7	6411	6	performed	perform	VBN
cord-005453-4057qib7	6411	7	by	by	IN
cord-005453-4057qib7	6411	8	flow	flow	NN
cord-005453-4057qib7	6411	9	cytometry	cytometry	NN
cord-005453-4057qib7	6411	10	on	on	IN
cord-005453-4057qib7	6411	11	peripheral	peripheral	JJ
cord-005453-4057qib7	6411	12	blood	blood	NN
cord-005453-4057qib7	6411	13	mononuclear	mononuclear	NN
cord-005453-4057qib7	6411	14	cells	cell	NNS
cord-005453-4057qib7	6411	15	,	,	,
cord-005453-4057qib7	6411	16	and	and	CC
cord-005453-4057qib7	6411	17	by	by	IN
cord-005453-4057qib7	6411	18	ELISA	ELISA	NNP
cord-005453-4057qib7	6411	19	assay	assay	NN
cord-005453-4057qib7	6411	20	on	on	IN
cord-005453-4057qib7	6411	21	plasma	plasma	NN
cord-005453-4057qib7	6411	22	.	.	.
cord-005453-4057qib7	6412	1	Patients	patient	NNS
cord-005453-4057qib7	6412	2	'	'	POS
cord-005453-4057qib7	6412	3	QoL	qol	NN
cord-005453-4057qib7	6412	4	will	will	MD
cord-005453-4057qib7	6412	5	be	be	VB
cord-005453-4057qib7	6412	6	assessed	assess	VBN
cord-005453-4057qib7	6412	7	using	use	VBG
cord-005453-4057qib7	6412	8	a	a	DT
cord-005453-4057qib7	6412	9	standard	standard	NN
cord-005453-4057qib7	6412	10	,	,	,
cord-005453-4057qib7	6412	11	EQ-5D-5L	EQ-5D-5L	NNP
cord-005453-4057qib7	6412	12	questionnaire	questionnaire	NN
cord-005453-4057qib7	6412	13	.	.	.
cord-005453-4057qib7	6413	1	The	the	DT
cord-005453-4057qib7	6413	2	primary	primary	JJ
cord-005453-4057qib7	6413	3	objective	objective	NN
cord-005453-4057qib7	6413	4	is	be	VBZ
cord-005453-4057qib7	6413	5	to	to	TO
cord-005453-4057qib7	6413	6	assess	assess	VB
cord-005453-4057qib7	6413	7	the	the	DT
cord-005453-4057qib7	6413	8	efficacy	efficacy	NN
cord-005453-4057qib7	6413	9	of	of	IN
cord-005453-4057qib7	6413	10	MaaT013	MaaT013	NNP
cord-005453-4057qib7	6413	11	by	by	IN
cord-005453-4057qib7	6413	12	evaluating	evaluate	VBG
cord-005453-4057qib7	6413	13	complete	complete	JJ
cord-005453-4057qib7	6413	14	response	response	NN
cord-005453-4057qib7	6413	15	(	(	-LRB-
cord-005453-4057qib7	6413	16	CR	cr	NN
cord-005453-4057qib7	6413	17	,	,	,
cord-005453-4057qib7	6413	18	according	accord	VBG
cord-005453-4057qib7	6413	19	to	to	IN
cord-005453-4057qib7	6413	20	modified	modify	VBN
cord-005453-4057qib7	6413	21	Glucksberg	Glucksberg	NNP
cord-005453-4057qib7	6413	22	criteria	criterion	NNS
cord-005453-4057qib7	6413	23	)	)	-RRB-
cord-005453-4057qib7	6413	24	and	and	CC
cord-005453-4057qib7	6413	25	Very	very	RB
cord-005453-4057qib7	6413	26	Good	Good	NNP
cord-005453-4057qib7	6413	27	Partial	partial	JJ
cord-005453-4057qib7	6413	28	Response	response	NN
cord-005453-4057qib7	6413	29	(	(	-LRB-
cord-005453-4057qib7	6413	30	VGPR	VGPR	NNP
cord-005453-4057qib7	6413	31	,	,	,
cord-005453-4057qib7	6413	32	defined	define	VBN
cord-005453-4057qib7	6413	33	by	by	IN
cord-005453-4057qib7	6413	34	Martin	Martin	NNP
cord-005453-4057qib7	6413	35	et	et	NNP
cord-005453-4057qib7	6413	36	al	al	NNP
cord-005453-4057qib7	6413	37	.	.	.
cord-005453-4057qib7	6414	1	,	,	,
cord-005453-4057qib7	6414	2	BBMT	BBMT	NNP
cord-005453-4057qib7	6414	3	,	,	,
cord-005453-4057qib7	6414	4	2009	2009	CD
cord-005453-4057qib7	6414	5	)	)	-RRB-
cord-005453-4057qib7	6415	1	28	28	CD
cord-005453-4057qib7	6415	2	days	day	NNS
cord-005453-4057qib7	6415	3	post	post	NN
cord-005453-4057qib7	6415	4	-	-	NN
cord-005453-4057qib7	6415	5	inclusion	inclusion	JJ
cord-005453-4057qib7	6415	6	(	(	-LRB-
cord-005453-4057qib7	6415	7	Primary	primary	JJ
cord-005453-4057qib7	6415	8	follow	follow	NN
cord-005453-4057qib7	6415	9	-	-	HYPH
cord-005453-4057qib7	6415	10	up	up	NN
cord-005453-4057qib7	6415	11	)	)	-RRB-
cord-005453-4057qib7	6415	12	.	.	.
cord-005453-4057qib7	6416	1	Secondary	secondary	JJ
cord-005453-4057qib7	6416	2	objectives	objective	NNS
cord-005453-4057qib7	6416	3	include	include	VBP
cord-005453-4057qib7	6416	4	FMT	fmt	NN
cord-005453-4057qib7	6416	5	safety	safety	NN
cord-005453-4057qib7	6416	6	assessment	assessment	NN
cord-005453-4057qib7	6416	7	and	and	CC
cord-005453-4057qib7	6416	8	evaluation	evaluation	NN
cord-005453-4057qib7	6416	9	of	of	IN
cord-005453-4057qib7	6416	10	FMT	fmt	NN
cord-005453-4057qib7	6416	11	impact	impact	NN
cord-005453-4057qib7	6416	12	on	on	IN
cord-005453-4057qib7	6416	13	several	several	JJ
cord-005453-4057qib7	6416	14	endpoints	endpoint	NNS
cord-005453-4057qib7	6416	15	,	,	,
cord-005453-4057qib7	6416	16	such	such	JJ
cord-005453-4057qib7	6416	17	as	as	IN
cord-005453-4057qib7	6416	18	overall	overall	JJ
cord-005453-4057qib7	6416	19	,	,	,
cord-005453-4057qib7	6416	20	relapsefree	relapsefree	JJ
cord-005453-4057qib7	6416	21	or	or	CC
cord-005453-4057qib7	6416	22	GVHD	GVHD	NNP
cord-005453-4057qib7	6416	23	-	-	HYPH
cord-005453-4057qib7	6416	24	free	free	JJ
cord-005453-4057qib7	6416	25	survival	survival	NN
cord-005453-4057qib7	6416	26	and	and	CC
cord-005453-4057qib7	6416	27	chronic	chronic	JJ
cord-005453-4057qib7	6416	28	GVHD	GVHD	NNP
cord-005453-4057qib7	6416	29	evaluation	evaluation	NN
cord-005453-4057qib7	6416	30	,	,	,
cord-005453-4057qib7	6416	31	as	as	RB
cord-005453-4057qib7	6416	32	well	well	RB
cord-005453-4057qib7	6416	33	as	as	IN
cord-005453-4057qib7	6416	34	multi	multi	JJ
cord-005453-4057qib7	6416	35	-	-	JJ
cord-005453-4057qib7	6416	36	drug	drug	JJ
cord-005453-4057qib7	6416	37	resistant	resistant	JJ
cord-005453-4057qib7	6416	38	bacteria	bacteria	NNS
cord-005453-4057qib7	6416	39	carriage	carriage	NN
cord-005453-4057qib7	6416	40	.	.	.
cord-005453-4057qib7	6417	1	Patients	patient	NNS
cord-005453-4057qib7	6417	2	will	will	MD
cord-005453-4057qib7	6417	3	be	be	VB
cord-005453-4057qib7	6417	4	followed	follow	VBN
cord-005453-4057qib7	6417	5	-	-	HYPH
cord-005453-4057qib7	6417	6	up	up	RP
cord-005453-4057qib7	6417	7	until1	until1	NN
cord-005453-4057qib7	6417	8	year	year	NN
cord-005453-4057qib7	6417	9	after	after	IN
cord-005453-4057qib7	6417	10	inclusion	inclusion	NN
cord-005453-4057qib7	6417	11	.	.	.
cord-005453-4057qib7	6418	1	Overall	overall	RB
cord-005453-4057qib7	6418	2	,	,	,
cord-005453-4057qib7	6418	3	32	32	CD
cord-005453-4057qib7	6418	4	patients	patient	NNS
cord-005453-4057qib7	6418	5	are	be	VBP
cord-005453-4057qib7	6418	6	planned	plan	VBN
cord-005453-4057qib7	6418	7	to	to	TO
cord-005453-4057qib7	6418	8	be	be	VB
cord-005453-4057qib7	6418	9	enrolled	enrol	VBN
cord-005453-4057qib7	6418	10	and	and	CC
cord-005453-4057qib7	6418	11	treated	treat	VBN
cord-005453-4057qib7	6418	12	,	,	,
cord-005453-4057qib7	6418	13	to	to	TO
cord-005453-4057qib7	6418	14	assess	assess	VB
cord-005453-4057qib7	6418	15	overall	overall	JJ
cord-005453-4057qib7	6418	16	response	response	NN
cord-005453-4057qib7	6418	17	rates	rate	NNS
cord-005453-4057qib7	6418	18	and	and	CC
cord-005453-4057qib7	6418	19	MaaT013	MaaT013	NNP
cord-005453-4057qib7	6418	20	's	's	POS
cord-005453-4057qib7	6418	21	safety	safety	NN
cord-005453-4057qib7	6418	22	profile	profile	NN
cord-005453-4057qib7	6418	23	.	.	.
cord-005453-4057qib7	6419	1	Results	result	NNS
cord-005453-4057qib7	6419	2	Background	Background	NNP
cord-005453-4057qib7	6419	3	:	:	:
cord-005453-4057qib7	6419	4	Anti	anti	JJ
cord-005453-4057qib7	6419	5	-	-	JJ
cord-005453-4057qib7	6419	6	programmed	programmed	JJ
cord-005453-4057qib7	6419	7	cell	cell	NN
cord-005453-4057qib7	6419	8	death	death	NN
cord-005453-4057qib7	6419	9	protein	protein	NN
cord-005453-4057qib7	6419	10	1	1	CD
cord-005453-4057qib7	6420	1	(	(	-LRB-
cord-005453-4057qib7	6420	2	PD1	pd1	NN
cord-005453-4057qib7	6420	3	)	)	-RRB-
cord-005453-4057qib7	6420	4	monoclonal	monoclonal	JJ
cord-005453-4057qib7	6420	5	antibodies	antibody	NNS
cord-005453-4057qib7	6420	6	can	can	MD
cord-005453-4057qib7	6420	7	be	be	VB
cord-005453-4057qib7	6420	8	used	use	VBN
cord-005453-4057qib7	6420	9	as	as	IN
cord-005453-4057qib7	6420	10	"	"	``
cord-005453-4057qib7	6420	11	bridge	bridge	NN
cord-005453-4057qib7	6420	12	to	to	IN
cord-005453-4057qib7	6420	13	"	"	''
cord-005453-4057qib7	6420	14	a	a	DT
cord-005453-4057qib7	6420	15	subsequent	subsequent	JJ
cord-005453-4057qib7	6420	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	6420	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6420	18	stem	stem	NN
cord-005453-4057qib7	6420	19	cell	cell	NN
cord-005453-4057qib7	6420	20	transplantation	transplantation	NN
cord-005453-4057qib7	6420	21	(	(	-LRB-
cord-005453-4057qib7	6420	22	HSCT	HSCT	NNP
cord-005453-4057qib7	6420	23	)	)	-RRB-
cord-005453-4057qib7	6420	24	in	in	IN
cord-005453-4057qib7	6420	25	patients	patient	NNS
cord-005453-4057qib7	6420	26	with	with	IN
cord-005453-4057qib7	6420	27	relapsed	relapse	VBN
cord-005453-4057qib7	6420	28	/	/	SYM
cord-005453-4057qib7	6420	29	refractory	refractory	JJ
cord-005453-4057qib7	6420	30	Hodgkin´s	hodgkin´	NNS
cord-005453-4057qib7	6421	1	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	6421	2	(	(	-LRB-
cord-005453-4057qib7	6421	3	HL	HL	NNP
cord-005453-4057qib7	6421	4	)	)	-RRB-
cord-005453-4057qib7	6421	5	.	.	.
cord-005453-4057qib7	6422	1	This	this	DT
cord-005453-4057qib7	6422	2	strategy	strategy	NN
cord-005453-4057qib7	6422	3	has	have	VBZ
cord-005453-4057qib7	6422	4	been	be	VBN
cord-005453-4057qib7	6422	5	reported	report	VBN
cord-005453-4057qib7	6422	6	to	to	TO
cord-005453-4057qib7	6422	7	be	be	VB
cord-005453-4057qib7	6422	8	effective	effective	JJ
cord-005453-4057qib7	6422	9	,	,	,
cord-005453-4057qib7	6422	10	but	but	CC
cord-005453-4057qib7	6422	11	a	a	DT
cord-005453-4057qib7	6422	12	frequent	frequent	JJ
cord-005453-4057qib7	6422	13	onset	onset	NN
cord-005453-4057qib7	6422	14	of	of	IN
cord-005453-4057qib7	6422	15	steroid	steroid	JJ
cord-005453-4057qib7	6422	16	-	-	HYPH
cord-005453-4057qib7	6422	17	refractory	refractory	JJ
cord-005453-4057qib7	6422	18	Graft	graft	NN
cord-005453-4057qib7	6422	19	versus	versus	IN
cord-005453-4057qib7	6422	20	Host	Host	NNP
cord-005453-4057qib7	6422	21	Disease	Disease	NNP
cord-005453-4057qib7	6422	22	(	(	-LRB-
cord-005453-4057qib7	6422	23	GVHD	GVHD	NNP
cord-005453-4057qib7	6422	24	)	)	-RRB-
cord-005453-4057qib7	6422	25	was	be	VBD
cord-005453-4057qib7	6422	26	also	also	RB
cord-005453-4057qib7	6422	27	reported	report	VBN
cord-005453-4057qib7	6422	28	.	.	.
cord-005453-4057qib7	6423	1	We	-PRON-	PRP
cord-005453-4057qib7	6423	2	report	report	VBP
cord-005453-4057qib7	6423	3	3	3	CD
cord-005453-4057qib7	6423	4	clinical	clinical	JJ
cord-005453-4057qib7	6423	5	cases	case	NNS
cord-005453-4057qib7	6423	6	of	of	IN
cord-005453-4057qib7	6423	7	patients	patient	NNS
cord-005453-4057qib7	6423	8	affected	affect	VBN
cord-005453-4057qib7	6423	9	by	by	IN
cord-005453-4057qib7	6423	10	HL	HL	NNP
cord-005453-4057qib7	6423	11	undergoing	undergo	VBG
cord-005453-4057qib7	6423	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	6423	13	HSCT	HSCT	NNP
cord-005453-4057qib7	6423	14	after	after	IN
cord-005453-4057qib7	6423	15	having	have	VBG
cord-005453-4057qib7	6423	16	been	be	VBN
cord-005453-4057qib7	6423	17	treated	treat	VBN
cord-005453-4057qib7	6423	18	with	with	IN
cord-005453-4057qib7	6423	19	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	6423	20	.	.	.
cord-005453-4057qib7	6424	1	Methods	method	NNS
cord-005453-4057qib7	6424	2	:	:	:
cord-005453-4057qib7	6425	1	The	the	DT
cord-005453-4057qib7	6425	2	3	3	CD
cord-005453-4057qib7	6425	3	patients	patient	NNS
cord-005453-4057qib7	6425	4	of	of	IN
cord-005453-4057qib7	6425	5	48	48	CD
cord-005453-4057qib7	6425	6	,	,	,
cord-005453-4057qib7	6425	7	18	18	CD
cord-005453-4057qib7	6425	8	and	and	CC
cord-005453-4057qib7	6425	9	42	42	CD
cord-005453-4057qib7	6425	10	years	year	NNS
cord-005453-4057qib7	6425	11	respectively	respectively	RB
cord-005453-4057qib7	6425	12	had	have	VBD
cord-005453-4057qib7	6425	13	advanced	advance	VBN
cord-005453-4057qib7	6425	14	HL	HL	NNP
cord-005453-4057qib7	6425	15	and	and	CC
cord-005453-4057qib7	6425	16	had	have	VBD
cord-005453-4057qib7	6425	17	relapsed	relapse	VBN
cord-005453-4057qib7	6425	18	after	after	IN
cord-005453-4057qib7	6425	19	a	a	DT
cord-005453-4057qib7	6425	20	previous	previous	JJ
cord-005453-4057qib7	6425	21	autologous	autologous	NN
cord-005453-4057qib7	6425	22	(	(	-LRB-
cord-005453-4057qib7	6425	23	2	2	CD
cord-005453-4057qib7	6425	24	)	)	-RRB-
cord-005453-4057qib7	6425	25	or	or	CC
cord-005453-4057qib7	6426	1	allogeneic	allogeneic	NNP
cord-005453-4057qib7	6426	2	(	(	-LRB-
cord-005453-4057qib7	6426	3	1	1	CD
cord-005453-4057qib7	6426	4	)	)	-RRB-
cord-005453-4057qib7	6426	5	HSCT	HSCT	NNP
cord-005453-4057qib7	6426	6	.	.	.
cord-005453-4057qib7	6427	1	They	-PRON-	PRP
cord-005453-4057qib7	6427	2	underwent	undergo	VBD
cord-005453-4057qib7	6427	3	a	a	DT
cord-005453-4057qib7	6427	4	rescue	rescue	NN
cord-005453-4057qib7	6427	5	therapy	therapy	NN
cord-005453-4057qib7	6427	6	with	with	IN
cord-005453-4057qib7	6427	7	18	18	CD
cord-005453-4057qib7	6427	8	,	,	,
cord-005453-4057qib7	6427	9	12	12	CD
cord-005453-4057qib7	6427	10	,	,	,
cord-005453-4057qib7	6427	11	16	16	CD
cord-005453-4057qib7	6427	12	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	6427	13	cycles	cycle	NNS
cord-005453-4057qib7	6427	14	respectively	respectively	RB
cord-005453-4057qib7	6427	15	,	,	,
cord-005453-4057qib7	6427	16	depending	depend	VBG
cord-005453-4057qib7	6427	17	on	on	IN
cord-005453-4057qib7	6427	18	the	the	DT
cord-005453-4057qib7	6427	19	time	time	NN
cord-005453-4057qib7	6427	20	of	of	IN
cord-005453-4057qib7	6427	21	partial	partial	JJ
cord-005453-4057qib7	6427	22	response	response	NN
cord-005453-4057qib7	6427	23	achievement	achievement	NN
cord-005453-4057qib7	6427	24	and	and	CC
cord-005453-4057qib7	6427	25	the	the	DT
cord-005453-4057qib7	6427	26	availability	availability	NN
cord-005453-4057qib7	6427	27	of	of	IN
cord-005453-4057qib7	6427	28	a	a	DT
cord-005453-4057qib7	6427	29	donor	donor	NN
cord-005453-4057qib7	6427	30	.	.	.
cord-005453-4057qib7	6428	1	Two	two	CD
cord-005453-4057qib7	6428	2	patients	patient	NNS
cord-005453-4057qib7	6428	3	received	receive	VBD
cord-005453-4057qib7	6428	4	a	a	DT
cord-005453-4057qib7	6428	5	thiotepa	thiotepa	JJ
cord-005453-4057qib7	6428	6	-	-	HYPH
cord-005453-4057qib7	6428	7	fludarabinecyclophosphamide	fludarabinecyclophosphamide	NN
cord-005453-4057qib7	6428	8	conditioning	conditioning	NN
cord-005453-4057qib7	6428	9	,	,	,
cord-005453-4057qib7	6428	10	ATG	ATG	NNP
cord-005453-4057qib7	6428	11	-	-	HYPH
cord-005453-4057qib7	6428	12	based	base	VBN
cord-005453-4057qib7	6428	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6428	14	and	and	CC
cord-005453-4057qib7	6428	15	PB	PB	NNP
cord-005453-4057qib7	6428	16	cells	cell	NNS
cord-005453-4057qib7	6428	17	from	from	IN
cord-005453-4057qib7	6428	18	unrelated	unrelated	JJ
cord-005453-4057qib7	6428	19	donors	donor	NNS
cord-005453-4057qib7	6428	20	.	.	.
cord-005453-4057qib7	6429	1	The	the	DT
cord-005453-4057qib7	6429	2	third	third	JJ
cord-005453-4057qib7	6429	3	patient	patient	NN
cord-005453-4057qib7	6429	4	received	receive	VBD
cord-005453-4057qib7	6429	5	BM	BM	NNP
cord-005453-4057qib7	6429	6	cells	cell	NNS
cord-005453-4057qib7	6429	7	from	from	IN
cord-005453-4057qib7	6429	8	an	an	DT
cord-005453-4057qib7	6429	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6429	10	donor	donor	NN
cord-005453-4057qib7	6429	11	using	use	VBG
cord-005453-4057qib7	6429	12	the	the	DT
cord-005453-4057qib7	6429	13	"	"	``
cord-005453-4057qib7	6429	14	Baltimora	Baltimora	NNP
cord-005453-4057qib7	6429	15	"	"	''
cord-005453-4057qib7	6429	16	nonmieloablative	nonmieloablative	JJ
cord-005453-4057qib7	6429	17	platform	platform	NN
cord-005453-4057qib7	6429	18	.	.	.
cord-005453-4057qib7	6430	1	Results	result	NNS
cord-005453-4057qib7	6430	2	:	:	:
cord-005453-4057qib7	6431	1	At	at	IN
cord-005453-4057qib7	6431	2	a	a	DT
cord-005453-4057qib7	6431	3	follow	follow	NN
cord-005453-4057qib7	6431	4	-	-	HYPH
cord-005453-4057qib7	6431	5	up	up	NN
cord-005453-4057qib7	6431	6	of	of	IN
cord-005453-4057qib7	6431	7	11	11	CD
cord-005453-4057qib7	6431	8	,	,	,
cord-005453-4057qib7	6431	9	12	12	CD
cord-005453-4057qib7	6431	10	,	,	,
cord-005453-4057qib7	6431	11	15	15	CD
cord-005453-4057qib7	6431	12	months	month	NNS
cord-005453-4057qib7	6431	13	after	after	IN
cord-005453-4057qib7	6431	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6431	15	,	,	,
cord-005453-4057qib7	6431	16	respectively	respectively	RB
cord-005453-4057qib7	6431	17	,	,	,
cord-005453-4057qib7	6431	18	all	all	DT
cord-005453-4057qib7	6431	19	patients	patient	NNS
cord-005453-4057qib7	6431	20	achieved	achieve	VBN
cord-005453-4057qib7	6431	21	and	and	CC
cord-005453-4057qib7	6431	22	maintained	maintain	VBD
cord-005453-4057qib7	6431	23	a	a	DT
cord-005453-4057qib7	6431	24	complete	complete	JJ
cord-005453-4057qib7	6431	25	remission	remission	NN
cord-005453-4057qib7	6431	26	by	by	IN
cord-005453-4057qib7	6431	27	PET	PET	NNP
cord-005453-4057qib7	6431	28	-	-	HYPH
cord-005453-4057qib7	6431	29	CT	CT	NNP
cord-005453-4057qib7	6431	30	scans	scan	NNS
cord-005453-4057qib7	6431	31	.	.	.
cord-005453-4057qib7	6432	1	All	all	PDT
cord-005453-4057qib7	6432	2	the	the	DT
cord-005453-4057qib7	6432	3	3	3	CD
cord-005453-4057qib7	6432	4	patients	patient	NNS
cord-005453-4057qib7	6432	5	developed	develop	VBD
cord-005453-4057qib7	6432	6	acute	acute	JJ
cord-005453-4057qib7	6432	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6432	8	on	on	IN
cord-005453-4057qib7	6432	9	day	day	NN
cord-005453-4057qib7	6432	10	+32	+32	NNP
cord-005453-4057qib7	6432	11	,	,	,
cord-005453-4057qib7	6432	12	+54	+54	NNP
cord-005453-4057qib7	6432	13	and	and	CC
cord-005453-4057qib7	6432	14	+107	+107	NNP
cord-005453-4057qib7	6432	15	,	,	,
cord-005453-4057qib7	6432	16	respectively	respectively	RB
cord-005453-4057qib7	6432	17	.	.	.
cord-005453-4057qib7	6433	1	Patient	patient	NN
cord-005453-4057qib7	6433	2	1	1	CD
cord-005453-4057qib7	6433	3	progressed	progress	VBD
cord-005453-4057qib7	6433	4	to	to	IN
cord-005453-4057qib7	6433	5	grade	grade	NN
cord-005453-4057qib7	6433	6	IV	IV	NNP
cord-005453-4057qib7	6433	7	acute	acute	JJ
cord-005453-4057qib7	6433	8	GVHD	GVHD	NNP
cord-005453-4057qib7	6433	9	with	with	IN
cord-005453-4057qib7	6433	10	hepatic	hepatic	JJ
cord-005453-4057qib7	6433	11	and	and	CC
cord-005453-4057qib7	6433	12	intestinal	intestinal	JJ
cord-005453-4057qib7	6433	13	involvement	involvement	NN
cord-005453-4057qib7	6433	14	unresponsive	unresponsive	JJ
cord-005453-4057qib7	6433	15	to	to	IN
cord-005453-4057qib7	6433	16	first	first	JJ
cord-005453-4057qib7	6433	17	line	line	NN
cord-005453-4057qib7	6433	18	2	2	CD
cord-005453-4057qib7	6433	19	mg	mg	NNP
cord-005453-4057qib7	6433	20	/	/	SYM
cord-005453-4057qib7	6433	21	kg	kg	NNP
cord-005453-4057qib7	6433	22	steroid	steroid	NN
cord-005453-4057qib7	6433	23	therapy	therapy	NN
cord-005453-4057qib7	6433	24	and	and	CC
cord-005453-4057qib7	6433	25	second	second	JJ
cord-005453-4057qib7	6433	26	line	line	NN
cord-005453-4057qib7	6433	27	etanercept	etanercept	NN
cord-005453-4057qib7	6433	28	plus	plus	CC
cord-005453-4057qib7	6433	29	extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	6433	30	photopheresis	photopheresis	NN
cord-005453-4057qib7	6433	31	(	(	-LRB-
cord-005453-4057qib7	6433	32	ECP	ECP	NNP
cord-005453-4057qib7	6433	33	)	)	-RRB-
cord-005453-4057qib7	6433	34	.	.	.
cord-005453-4057qib7	6434	1	Third	third	JJ
cord-005453-4057qib7	6434	2	line	line	NN
cord-005453-4057qib7	6434	3	therapy	therapy	NN
cord-005453-4057qib7	6434	4	with	with	IN
cord-005453-4057qib7	6434	5	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6434	6	partially	partially	RB
cord-005453-4057qib7	6434	7	controlled	control	VBD
cord-005453-4057qib7	6434	8	the	the	DT
cord-005453-4057qib7	6434	9	GVHD	GVHD	NNP
cord-005453-4057qib7	6434	10	.	.	.
cord-005453-4057qib7	6435	1	GVHD	GVHD	NNP
cord-005453-4057qib7	6435	2	onset	onset	NN
cord-005453-4057qib7	6435	3	in	in	IN
cord-005453-4057qib7	6435	4	patients	patient	NNS
cord-005453-4057qib7	6435	5	2	2	CD
cord-005453-4057qib7	6435	6	and	and	CC
cord-005453-4057qib7	6435	7	3	3	CD
cord-005453-4057qib7	6435	8	was	be	VBD
cord-005453-4057qib7	6435	9	preceeded	preceede	VBN
cord-005453-4057qib7	6435	10	by	by	IN
cord-005453-4057qib7	6435	11	a	a	DT
cord-005453-4057qib7	6435	12	prolonged	prolonged	JJ
cord-005453-4057qib7	6435	13	fever	fever	NN
cord-005453-4057qib7	6435	14	without	without	IN
cord-005453-4057qib7	6435	15	microbiological	microbiological	JJ
cord-005453-4057qib7	6435	16	findings	finding	NNS
cord-005453-4057qib7	6435	17	.	.	.
cord-005453-4057qib7	6436	1	Patient	patient	NN
cord-005453-4057qib7	6436	2	2	2	CD
cord-005453-4057qib7	6436	3	developed	develop	VBD
cord-005453-4057qib7	6436	4	hepatic	hepatic	JJ
cord-005453-4057qib7	6436	5	grade	grade	NN
cord-005453-4057qib7	6436	6	II	II	NNP
cord-005453-4057qib7	6436	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6436	8	with	with	IN
cord-005453-4057qib7	6436	9	high	high	JJ
cord-005453-4057qib7	6436	10	transaminase	transaminase	NN
cord-005453-4057qib7	6436	11	levels	level	NNS
cord-005453-4057qib7	6436	12	,	,	,
cord-005453-4057qib7	6436	13	initially	initially	RB
cord-005453-4057qib7	6436	14	responsive	responsive	JJ
cord-005453-4057qib7	6436	15	to	to	IN
cord-005453-4057qib7	6436	16	steroid	steroid	NN
cord-005453-4057qib7	6436	17	therapy	therapy	NN
cord-005453-4057qib7	6436	18	,	,	,
cord-005453-4057qib7	6436	19	then	then	RB
cord-005453-4057qib7	6436	20	it	-PRON-	PRP
cord-005453-4057qib7	6436	21	progressed	progress	VBD
cord-005453-4057qib7	6436	22	to	to	TO
cord-005453-4057qib7	6436	23	gut	gut	VB
cord-005453-4057qib7	6436	24	requiring	require	VBG
cord-005453-4057qib7	6436	25	second	second	JJ
cord-005453-4057qib7	6436	26	line	line	NN
cord-005453-4057qib7	6436	27	therapy	therapy	NN
cord-005453-4057qib7	6436	28	with	with	IN
cord-005453-4057qib7	6436	29	etanercept	etanercept	NNP
cord-005453-4057qib7	6436	30	.	.	.
cord-005453-4057qib7	6437	1	Patient	patient	NN
cord-005453-4057qib7	6437	2	3	3	CD
cord-005453-4057qib7	6437	3	progressed	progress	VBD
cord-005453-4057qib7	6437	4	to	to	IN
cord-005453-4057qib7	6437	5	severe	severe	JJ
cord-005453-4057qib7	6437	6	chronic	chronic	JJ
cord-005453-4057qib7	6437	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6437	8	with	with	IN
cord-005453-4057qib7	6437	9	skin	skin	NN
cord-005453-4057qib7	6437	10	involvement	involvement	NN
cord-005453-4057qib7	6437	11	and	and	CC
cord-005453-4057qib7	6437	12	resulted	result	VBD
cord-005453-4057qib7	6437	13	unresponsive	unresponsive	JJ
cord-005453-4057qib7	6437	14	to	to	IN
cord-005453-4057qib7	6437	15	steroids	steroid	NNS
cord-005453-4057qib7	6437	16	and	and	CC
cord-005453-4057qib7	6437	17	ECP	ECP	NNP
cord-005453-4057qib7	6438	1	and	and	CC
cord-005453-4057qib7	6438	2	it	-PRON-	PRP
cord-005453-4057qib7	6438	3	was	be	VBD
cord-005453-4057qib7	6438	4	partially	partially	RB
cord-005453-4057qib7	6438	5	controlled	control	VBN
cord-005453-4057qib7	6438	6	by	by	IN
cord-005453-4057qib7	6438	7	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	6438	8	.	.	.
cord-005453-4057qib7	6439	1	Immune	immune	JJ
cord-005453-4057qib7	6439	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	6439	3	was	be	VBD
cord-005453-4057qib7	6439	4	delayed	delay	VBN
cord-005453-4057qib7	6439	5	in	in	IN
cord-005453-4057qib7	6439	6	all	all	DT
cord-005453-4057qib7	6439	7	3	3	CD
cord-005453-4057qib7	6439	8	patients	patient	NNS
cord-005453-4057qib7	6439	9	:	:	:
cord-005453-4057qib7	6439	10	at	at	IN
cord-005453-4057qib7	6439	11	6	6	CD
cord-005453-4057qib7	6439	12	months	month	NNS
cord-005453-4057qib7	6439	13	post	post	NN
cord-005453-4057qib7	6439	14	transplantation	transplantation	NN
cord-005453-4057qib7	6439	15	CD3	cd3	NN
cord-005453-4057qib7	6439	16	levels	level	NNS
cord-005453-4057qib7	6439	17	were	be	VBD
cord-005453-4057qib7	6439	18	80	80	CD
cord-005453-4057qib7	6440	1	/μL	/μL	NFP
cord-005453-4057qib7	6440	2	,	,	,
cord-005453-4057qib7	6441	1	17/	17/	CD
cord-005453-4057qib7	6441	2	μL	μl	ADD
cord-005453-4057qib7	6441	3	and	and	CC
cord-005453-4057qib7	6442	1	127	127	CD
cord-005453-4057qib7	6442	2	/	/	SYM
cord-005453-4057qib7	6442	3	μL	μL	NNP
cord-005453-4057qib7	6442	4	and	and	CC
cord-005453-4057qib7	6442	5	CD4	CD4	NNP
cord-005453-4057qib7	6442	6	levels	level	NNS
cord-005453-4057qib7	6442	7	were	be	VBD
cord-005453-4057qib7	6442	8	36	36	CD
cord-005453-4057qib7	6442	9	/	/	SYM
cord-005453-4057qib7	6442	10	μL	μL	NNP
cord-005453-4057qib7	6442	11	,	,	,
cord-005453-4057qib7	6442	12	16	16	CD
cord-005453-4057qib7	6442	13	/	/	SYM
cord-005453-4057qib7	6442	14	μL	μl	NN
cord-005453-4057qib7	6442	15	and	and	CC
cord-005453-4057qib7	6442	16	65/	65/	CD
cord-005453-4057qib7	6442	17	μL	μl	NN
cord-005453-4057qib7	6442	18	respectively	respectively	RB
cord-005453-4057qib7	6442	19	.	.	.
cord-005453-4057qib7	6443	1	Only	only	RB
cord-005453-4057qib7	6443	2	patient	patient	JJ
cord-005453-4057qib7	6443	3	2	2	CD
cord-005453-4057qib7	6443	4	,	,	,
cord-005453-4057qib7	6443	5	that	that	WDT
cord-005453-4057qib7	6443	6	underwent	undergo	VBD
cord-005453-4057qib7	6443	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6443	8	transplant	transplant	NN
cord-005453-4057qib7	6443	9	and	and	CC
cord-005453-4057qib7	6443	10	received	receive	VBD
cord-005453-4057qib7	6443	11	post	post	JJ
cord-005453-4057qib7	6443	12	-	-	JJ
cord-005453-4057qib7	6443	13	trasplant	trasplant	JJ
cord-005453-4057qib7	6443	14	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	6443	15	(	(	-LRB-
cord-005453-4057qib7	6443	16	PT	PT	NNP
cord-005453-4057qib7	6443	17	-	-	HYPH
cord-005453-4057qib7	6443	18	Cy	Cy	NNP
cord-005453-4057qib7	6443	19	)	)	-RRB-
cord-005453-4057qib7	6443	20	,	,	,
cord-005453-4057qib7	6443	21	is	be	VBZ
cord-005453-4057qib7	6443	22	off	off	IN
cord-005453-4057qib7	6443	23	of	of	IN
cord-005453-4057qib7	6443	24	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6443	25	treatment	treatment	NN
cord-005453-4057qib7	6443	26	at	at	IN
cord-005453-4057qib7	6443	27	11	11	CD
cord-005453-4057qib7	6443	28	months	month	NNS
cord-005453-4057qib7	6443	29	after	after	IN
cord-005453-4057qib7	6443	30	HSCT	HSCT	NNP
cord-005453-4057qib7	6443	31	,	,	,
cord-005453-4057qib7	6443	32	without	without	IN
cord-005453-4057qib7	6443	33	evidence	evidence	NN
cord-005453-4057qib7	6443	34	of	of	IN
cord-005453-4057qib7	6443	35	GVHD	GVHD	NNP
cord-005453-4057qib7	6443	36	and	and	CC
cord-005453-4057qib7	6443	37	no	no	DT
cord-005453-4057qib7	6443	38	history	history	NN
cord-005453-4057qib7	6443	39	of	of	IN
cord-005453-4057qib7	6443	40	infections	infection	NNS
cord-005453-4057qib7	6443	41	.	.	.
cord-005453-4057qib7	6444	1	Out	out	IN
cord-005453-4057qib7	6444	2	of	of	IN
cord-005453-4057qib7	6444	3	the	the	DT
cord-005453-4057qib7	6444	4	2	2	CD
cord-005453-4057qib7	6444	5	patients	patient	NNS
cord-005453-4057qib7	6444	6	receiving	receive	VBG
cord-005453-4057qib7	6444	7	PBSC	PBSC	NNS
cord-005453-4057qib7	6444	8	from	from	IN
cord-005453-4057qib7	6444	9	unrelated	unrelated	JJ
cord-005453-4057qib7	6444	10	donors	donor	NNS
cord-005453-4057qib7	6444	11	and	and	CC
cord-005453-4057qib7	6444	12	ATG	ATG	NNP
cord-005453-4057qib7	6444	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6444	14	,	,	,
cord-005453-4057qib7	6444	15	patient	patient	NN
cord-005453-4057qib7	6444	16	1	1	CD
cord-005453-4057qib7	6444	17	developed	develop	VBD
cord-005453-4057qib7	6444	18	a	a	DT
cord-005453-4057qib7	6444	19	disseminated	disseminate	VBN
cord-005453-4057qib7	6444	20	fusariosis	fusariosis	NN
cord-005453-4057qib7	6444	21	on	on	IN
cord-005453-4057qib7	6444	22	day	day	NN
cord-005453-4057qib7	6444	23	+	+	SYM
cord-005453-4057qib7	6444	24	180	180	CD
cord-005453-4057qib7	6444	25	and	and	CC
cord-005453-4057qib7	6444	26	died	die	VBD
cord-005453-4057qib7	6444	27	of	of	IN
cord-005453-4057qib7	6444	28	CNS	CNS	NNP
cord-005453-4057qib7	6444	29	fusarium	fusarium	NN
cord-005453-4057qib7	6444	30	localization	localization	NN
cord-005453-4057qib7	6444	31	1	1	CD
cord-005453-4057qib7	6444	32	year	year	NN
cord-005453-4057qib7	6444	33	after	after	IN
cord-005453-4057qib7	6444	34	HSCT	HSCT	NNP
cord-005453-4057qib7	6444	35	,	,	,
cord-005453-4057qib7	6444	36	despite	despite	IN
cord-005453-4057qib7	6444	37	targeted	target	VBN
cord-005453-4057qib7	6444	38	antifungal	antifungal	NN
cord-005453-4057qib7	6444	39	therapy	therapy	NN
cord-005453-4057qib7	6444	40	.	.	.
cord-005453-4057qib7	6445	1	Patient	Patient	NNP
cord-005453-4057qib7	6445	2	3	3	CD
cord-005453-4057qib7	6445	3	had	have	VBD
cord-005453-4057qib7	6445	4	pulmonary	pulmonary	JJ
cord-005453-4057qib7	6445	5	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	6445	6	,	,	,
cord-005453-4057qib7	6445	7	sepsis	sepsis	NN
cord-005453-4057qib7	6445	8	by	by	IN
cord-005453-4057qib7	6445	9	multidrug	multidrug	NN
cord-005453-4057qib7	6445	10	resistant	resistant	JJ
cord-005453-4057qib7	6445	11	Psuedomonas	Psuedomonas	NNP
cord-005453-4057qib7	6445	12	Aeruginosa	Aeruginosa	NNP
cord-005453-4057qib7	6445	13	and	and	CC
cord-005453-4057qib7	6445	14	otomastoiditis	otomastoiditis	NN
cord-005453-4057qib7	6445	15	:	:	:
cord-005453-4057qib7	6445	16	at	at	IN
cord-005453-4057qib7	6445	17	+15	+15	CD
cord-005453-4057qib7	6445	18	months	month	NNS
cord-005453-4057qib7	6445	19	after	after	IN
cord-005453-4057qib7	6445	20	HSCT	HSCT	NNP
cord-005453-4057qib7	6445	21	,	,	,
cord-005453-4057qib7	6445	22	he	-PRON-	PRP
cord-005453-4057qib7	6445	23	is	be	VBZ
cord-005453-4057qib7	6445	24	on	on	IN
cord-005453-4057qib7	6445	25	ruxolitinib	ruxolitinib	JJ
cord-005453-4057qib7	6445	26	treatment	treatment	NN
cord-005453-4057qib7	6445	27	with	with	IN
cord-005453-4057qib7	6445	28	skin	skin	NN
cord-005453-4057qib7	6445	29	clinical	clinical	JJ
cord-005453-4057qib7	6445	30	partial	partial	JJ
cord-005453-4057qib7	6445	31	response	response	NN
cord-005453-4057qib7	6445	32	.	.	.
cord-005453-4057qib7	6446	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6446	2	:	:	:
cord-005453-4057qib7	6447	1	This	this	DT
cord-005453-4057qib7	6447	2	case	case	NN
cord-005453-4057qib7	6447	3	series	series	NN
cord-005453-4057qib7	6447	4	confirms	confirm	VBZ
cord-005453-4057qib7	6447	5	that	that	IN
cord-005453-4057qib7	6447	6	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	6447	7	as	as	IN
cord-005453-4057qib7	6447	8	"	"	``
cord-005453-4057qib7	6447	9	bridge	bridge	NN
cord-005453-4057qib7	6447	10	to	to	IN
cord-005453-4057qib7	6447	11	transplant	transplant	NN
cord-005453-4057qib7	6447	12	"	"	``
cord-005453-4057qib7	6447	13	is	be	VBZ
cord-005453-4057qib7	6447	14	effective	effective	JJ
cord-005453-4057qib7	6447	15	in	in	IN
cord-005453-4057qib7	6447	16	appropriately	appropriately	RB
cord-005453-4057qib7	6447	17	selected	select	VBN
cord-005453-4057qib7	6447	18	patients	patient	NNS
cord-005453-4057qib7	6447	19	.	.	.
cord-005453-4057qib7	6448	1	However	however	RB
cord-005453-4057qib7	6448	2	,	,	,
cord-005453-4057qib7	6448	3	risk	risk	NN
cord-005453-4057qib7	6448	4	of	of	IN
cord-005453-4057qib7	6448	5	acute	acute	JJ
cord-005453-4057qib7	6448	6	GVHD	GVHD	NNP
cord-005453-4057qib7	6448	7	and	and	CC
cord-005453-4057qib7	6448	8	delayed	delay	VBN
cord-005453-4057qib7	6448	9	immune	immune	JJ
cord-005453-4057qib7	6448	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	6448	11	may	may	MD
cord-005453-4057qib7	6448	12	require	require	VB
cord-005453-4057qib7	6448	13	a	a	DT
cord-005453-4057qib7	6448	14	careful	careful	JJ
cord-005453-4057qib7	6448	15	consideration	consideration	NN
cord-005453-4057qib7	6448	16	at	at	IN
cord-005453-4057qib7	6448	17	the	the	DT
cord-005453-4057qib7	6448	18	moment	moment	NN
cord-005453-4057qib7	6448	19	of	of	IN
cord-005453-4057qib7	6448	20	planning	plan	VBG
cord-005453-4057qib7	6448	21	the	the	DT
cord-005453-4057qib7	6448	22	transplant	transplant	NN
cord-005453-4057qib7	6448	23	.	.	.
cord-005453-4057qib7	6449	1	A	a	DT
cord-005453-4057qib7	6449	2	possible	possible	JJ
cord-005453-4057qib7	6449	3	advantage	advantage	NN
cord-005453-4057qib7	6449	4	of	of	IN
cord-005453-4057qib7	6449	5	PT	PT	NNP
cord-005453-4057qib7	6449	6	-	-	HYPH
cord-005453-4057qib7	6449	7	Cy	Cy	NNP
cord-005453-4057qib7	6449	8	GVHD	GVHD	NNP
cord-005453-4057qib7	6449	9	platform	platform	NN
cord-005453-4057qib7	6449	10	and	and	CC
cord-005453-4057qib7	6449	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6449	12	donors	donor	NNS
cord-005453-4057qib7	6449	13	should	should	MD
cord-005453-4057qib7	6449	14	be	be	VB
cord-005453-4057qib7	6449	15	addressed	address	VBN
cord-005453-4057qib7	6449	16	in	in	IN
cord-005453-4057qib7	6449	17	larger	large	JJR
cord-005453-4057qib7	6449	18	studies	study	NNS
cord-005453-4057qib7	6449	19	.	.	.
cord-005453-4057qib7	6450	1	Background	background	NN
cord-005453-4057qib7	6450	2	:	:	:
cord-005453-4057qib7	6451	1	Acute	acute	JJ
cord-005453-4057qib7	6451	2	graft	graft	NN
cord-005453-4057qib7	6451	3	-	-	HYPH
cord-005453-4057qib7	6451	4	versus	versus	IN
cord-005453-4057qib7	6451	5	-	-	HYPH
cord-005453-4057qib7	6451	6	host	host	NN
cord-005453-4057qib7	6451	7	disease	disease	NN
cord-005453-4057qib7	6451	8	(	(	-LRB-
cord-005453-4057qib7	6451	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6451	10	)	)	-RRB-
cord-005453-4057qib7	6451	11	is	be	VBZ
cord-005453-4057qib7	6451	12	the	the	DT
cord-005453-4057qib7	6451	13	most	most	RBS
cord-005453-4057qib7	6451	14	important	important	JJ
cord-005453-4057qib7	6451	15	complication	complication	NN
cord-005453-4057qib7	6451	16	after	after	IN
cord-005453-4057qib7	6451	17	an	an	DT
cord-005453-4057qib7	6451	18	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6451	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6451	20	stem	stem	NN
cord-005453-4057qib7	6451	21	cell	cell	NN
cord-005453-4057qib7	6451	22	transplant	transplant	NN
cord-005453-4057qib7	6451	23	(	(	-LRB-
cord-005453-4057qib7	6451	24	HSCT	HSCT	NNP
cord-005453-4057qib7	6451	25	)	)	-RRB-
cord-005453-4057qib7	6451	26	.	.	.
cord-005453-4057qib7	6452	1	No	no	DT
cord-005453-4057qib7	6452	2	standard	standard	JJ
cord-005453-4057qib7	6452	3	secondline	secondline	NN
cord-005453-4057qib7	6452	4	treatment	treatment	NN
cord-005453-4057qib7	6452	5	has	have	VBZ
cord-005453-4057qib7	6452	6	been	be	VBN
cord-005453-4057qib7	6452	7	established	establish	VBN
cord-005453-4057qib7	6452	8	for	for	IN
cord-005453-4057qib7	6452	9	the	the	DT
cord-005453-4057qib7	6452	10	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	6452	11	refractory	refractory	JJ
cord-005453-4057qib7	6452	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6452	13	.	.	.
cord-005453-4057qib7	6453	1	The	the	DT
cord-005453-4057qib7	6453	2	anti	anti	JJ
cord-005453-4057qib7	6453	3	-	-	JJ
cord-005453-4057qib7	6453	4	TNFα	tnfα	JJ
cord-005453-4057qib7	6453	5	agents	agent	NNS
cord-005453-4057qib7	6453	6	are	be	VBP
cord-005453-4057qib7	6453	7	a	a	DT
cord-005453-4057qib7	6453	8	good	good	JJ
cord-005453-4057qib7	6453	9	option	option	NN
cord-005453-4057qib7	6453	10	of	of	IN
cord-005453-4057qib7	6453	11	treatment	treatment	NN
cord-005453-4057qib7	6453	12	for	for	IN
cord-005453-4057qib7	6453	13	these	these	DT
cord-005453-4057qib7	6453	14	patients	patient	NNS
cord-005453-4057qib7	6453	15	,	,	,
cord-005453-4057qib7	6453	16	especially	especially	RB
cord-005453-4057qib7	6453	17	when	when	WRB
cord-005453-4057qib7	6453	18	lower	low	JJR
cord-005453-4057qib7	6453	19	GI	GI	NNP
cord-005453-4057qib7	6453	20	tract	tract	NN
cord-005453-4057qib7	6453	21	is	be	VBZ
cord-005453-4057qib7	6453	22	involved	involve	VBN
cord-005453-4057qib7	6453	23	.	.	.
cord-005453-4057qib7	6454	1	Methods	method	NNS
cord-005453-4057qib7	6454	2	:	:	:
cord-005453-4057qib7	6455	1	From	from	IN
cord-005453-4057qib7	6455	2	April	April	NNP
cord-005453-4057qib7	6455	3	2010	2010	CD
cord-005453-4057qib7	6455	4	to	to	IN
cord-005453-4057qib7	6455	5	July	July	NNP
cord-005453-4057qib7	6455	6	2017	2017	CD
cord-005453-4057qib7	6455	7	we	-PRON-	PRP
cord-005453-4057qib7	6455	8	reviewed	review	VBD
cord-005453-4057qib7	6455	9	the	the	DT
cord-005453-4057qib7	6455	10	outcome	outcome	NN
cord-005453-4057qib7	6455	11	of	of	IN
cord-005453-4057qib7	6455	12	19	19	CD
cord-005453-4057qib7	6455	13	patients	patient	NNS
cord-005453-4057qib7	6455	14	with	with	IN
cord-005453-4057qib7	6455	15	steroid	steroid	NN
cord-005453-4057qib7	6455	16	-	-	HYPH
cord-005453-4057qib7	6455	17	refractory	refractory	JJ
cord-005453-4057qib7	6455	18	(	(	-LRB-
cord-005453-4057qib7	6455	19	SR	SR	NNP
cord-005453-4057qib7	6455	20	)	)	-RRB-
cord-005453-4057qib7	6455	21	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6455	22	treated	treat	VBN
cord-005453-4057qib7	6455	23	with	with	IN
cord-005453-4057qib7	6455	24	etanercept	etanercept	NNP
cord-005453-4057qib7	6455	25	as	as	IN
cord-005453-4057qib7	6455	26	at	at	IN
cord-005453-4057qib7	6455	27	least	least	JJS
cord-005453-4057qib7	6455	28	,	,	,
cord-005453-4057qib7	6455	29	second	second	JJ
cord-005453-4057qib7	6455	30	line	line	NN
cord-005453-4057qib7	6455	31	treatment	treatment	NN
cord-005453-4057qib7	6455	32	.	.	.
cord-005453-4057qib7	6456	1	Etanercept	Etanercept	NNP
cord-005453-4057qib7	6456	2	dose	dose	NN
cord-005453-4057qib7	6456	3	was	be	VBD
cord-005453-4057qib7	6456	4	25	25	CD
cord-005453-4057qib7	6456	5	mg	mg	NNS
cord-005453-4057qib7	6456	6	twice	twice	PDT
cord-005453-4057qib7	6456	7	a	a	DT
cord-005453-4057qib7	6456	8	week	week	NN
cord-005453-4057qib7	6456	9	for	for	IN
cord-005453-4057qib7	6456	10	the	the	DT
cord-005453-4057qib7	6456	11	first	first	JJ
cord-005453-4057qib7	6456	12	4	4	CD
cord-005453-4057qib7	6456	13	weeks	week	NNS
cord-005453-4057qib7	6456	14	,	,	,
cord-005453-4057qib7	6456	15	followed	follow	VBN
cord-005453-4057qib7	6456	16	by	by	IN
cord-005453-4057qib7	6456	17	4	4	CD
cord-005453-4057qib7	6456	18	weekly	weekly	JJ
cord-005453-4057qib7	6456	19	doses	dose	NNS
cord-005453-4057qib7	6456	20	.	.	.
cord-005453-4057qib7	6457	1	Results	result	NNS
cord-005453-4057qib7	6457	2	:	:	:
cord-005453-4057qib7	6458	1	Median	median	JJ
cord-005453-4057qib7	6458	2	age	age	NN
cord-005453-4057qib7	6458	3	was	be	VBD
cord-005453-4057qib7	6458	4	52	52	CD
cord-005453-4057qib7	6458	5	years	year	NNS
cord-005453-4057qib7	6459	1	(	(	-LRB-
cord-005453-4057qib7	6459	2	range	range	NNP
cord-005453-4057qib7	6459	3	15	15	CD
cord-005453-4057qib7	6459	4	-	-	SYM
cord-005453-4057qib7	6459	5	69	69	CD
cord-005453-4057qib7	6459	6	years	year	NNS
cord-005453-4057qib7	6459	7	)	)	-RRB-
cord-005453-4057qib7	6459	8	,	,	,
cord-005453-4057qib7	6459	9	and	and	CC
cord-005453-4057qib7	6459	10	12	12	CD
cord-005453-4057qib7	6459	11	patients	patient	NNS
cord-005453-4057qib7	6459	12	(	(	-LRB-
cord-005453-4057qib7	6459	13	63	63	CD
cord-005453-4057qib7	6459	14	%	%	NN
cord-005453-4057qib7	6459	15	)	)	-RRB-
cord-005453-4057qib7	6459	16	were	be	VBD
cord-005453-4057qib7	6459	17	male	male	JJ
cord-005453-4057qib7	6459	18	.	.	.
cord-005453-4057qib7	6460	1	Fourteen	fourteen	CD
cord-005453-4057qib7	6460	2	patients	patient	NNS
cord-005453-4057qib7	6460	3	(	(	-LRB-
cord-005453-4057qib7	6460	4	74	74	CD
cord-005453-4057qib7	6460	5	%	%	NN
cord-005453-4057qib7	6460	6	)	)	-RRB-
cord-005453-4057qib7	6460	7	had	have	VBD
cord-005453-4057qib7	6460	8	a	a	DT
cord-005453-4057qib7	6460	9	non	non	JJ
cord-005453-4057qib7	6460	10	-	-	JJ
cord-005453-4057qib7	6460	11	advanced	advanced	JJ
cord-005453-4057qib7	6460	12	disease	disease	NN
cord-005453-4057qib7	6460	13	status	status	NN
cord-005453-4057qib7	6460	14	at	at	IN
cord-005453-4057qib7	6460	15	HSTC	HSTC	NNP
cord-005453-4057qib7	6460	16	.	.	.
cord-005453-4057qib7	6461	1	Eleven	eleven	CD
cord-005453-4057qib7	6461	2	patients	patient	NNS
cord-005453-4057qib7	6461	3	(	(	-LRB-
cord-005453-4057qib7	6461	4	59	59	CD
cord-005453-4057qib7	6461	5	%	%	NN
cord-005453-4057qib7	6461	6	)	)	-RRB-
cord-005453-4057qib7	6461	7	received	receive	VBD
cord-005453-4057qib7	6461	8	a	a	DT
cord-005453-4057qib7	6461	9	myeloablative	myeloablative	JJ
cord-005453-4057qib7	6461	10	conditioning	conditioning	NN
cord-005453-4057qib7	6461	11	,	,	,
cord-005453-4057qib7	6461	12	and	and	CC
cord-005453-4057qib7	6461	13	the	the	DT
cord-005453-4057qib7	6461	14	stem	stem	NN
cord-005453-4057qib7	6461	15	cell	cell	NN
cord-005453-4057qib7	6461	16	source	source	NN
cord-005453-4057qib7	6461	17	was	be	VBD
cord-005453-4057qib7	6461	18	peripheral	peripheral	JJ
cord-005453-4057qib7	6461	19	blood	blood	NN
cord-005453-4057qib7	6461	20	in	in	IN
cord-005453-4057qib7	6461	21	18	18	CD
cord-005453-4057qib7	6461	22	patients	patient	NNS
cord-005453-4057qib7	6461	23	(	(	-LRB-
cord-005453-4057qib7	6461	24	95	95	CD
cord-005453-4057qib7	6461	25	%	%	NN
cord-005453-4057qib7	6461	26	)	)	-RRB-
cord-005453-4057qib7	6461	27	.	.	.
cord-005453-4057qib7	6462	1	Sixteen	sixteen	CD
cord-005453-4057qib7	6462	2	patients	patient	NNS
cord-005453-4057qib7	6462	3	(	(	-LRB-
cord-005453-4057qib7	6462	4	84	84	CD
cord-005453-4057qib7	6462	5	%	%	NN
cord-005453-4057qib7	6462	6	)	)	-RRB-
cord-005453-4057qib7	6462	7	were	be	VBD
cord-005453-4057qib7	6462	8	8/8	8/8	CD
cord-005453-4057qib7	6462	9	HLA	HLA	NNP
cord-005453-4057qib7	6462	10	matched	match	VBN
cord-005453-4057qib7	6462	11	.	.	.
cord-005453-4057qib7	6463	1	The	the	DT
cord-005453-4057qib7	6463	2	characteristics	characteristic	NNS
cord-005453-4057qib7	6463	3	of	of	IN
cord-005453-4057qib7	6463	4	the	the	DT
cord-005453-4057qib7	6463	5	19	19	CD
cord-005453-4057qib7	6463	6	patients	patient	NNS
cord-005453-4057qib7	6463	7	,	,	,
cord-005453-4057qib7	6463	8	their	-PRON-	PRP$
cord-005453-4057qib7	6463	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6463	10	stage	stage	NN
cord-005453-4057qib7	6463	11	previous	previous	JJ
cord-005453-4057qib7	6463	12	to	to	TO
cord-005453-4057qib7	6463	13	rescue	rescue	VB
cord-005453-4057qib7	6463	14	treatment	treatment	NN
cord-005453-4057qib7	6463	15	with	with	IN
cord-005453-4057qib7	6463	16	etanercept	etanercept	NNP
cord-005453-4057qib7	6463	17	and	and	CC
cord-005453-4057qib7	6463	18	their	-PRON-	PRP$
cord-005453-4057qib7	6463	19	outcome	outcome	NN
cord-005453-4057qib7	6463	20	are	be	VBP
cord-005453-4057qib7	6463	21	shown	show	VBN
cord-005453-4057qib7	6463	22	in	in	IN
cord-005453-4057qib7	6463	23	Table	Table	NNP
cord-005453-4057qib7	6463	24	1	1	CD
cord-005453-4057qib7	6463	25	.	.	.
cord-005453-4057qib7	6464	1	Seventeen	seventeen	CD
cord-005453-4057qib7	6464	2	patients	patient	NNS
cord-005453-4057qib7	6464	3	(	(	-LRB-
cord-005453-4057qib7	6464	4	89	89	CD
cord-005453-4057qib7	6464	5	%	%	NN
cord-005453-4057qib7	6464	6	)	)	-RRB-
cord-005453-4057qib7	6464	7	had	have	VBD
cord-005453-4057qib7	6464	8	a	a	DT
cord-005453-4057qib7	6464	9	classic	classic	JJ
cord-005453-4057qib7	6464	10	aGVHD	agvhd	NN
cord-005453-4057qib7	6465	1	while	while	IN
cord-005453-4057qib7	6465	2	2	2	CD
cord-005453-4057qib7	6465	3	had	have	VBD
cord-005453-4057qib7	6465	4	a	a	DT
cord-005453-4057qib7	6465	5	late	late	JJ
cord-005453-4057qib7	6465	6	-	-	HYPH
cord-005453-4057qib7	6465	7	onset	onset	NN
cord-005453-4057qib7	6465	8	aGVHD	agvhd	NN
cord-005453-4057qib7	6465	9	.	.	.
cord-005453-4057qib7	6466	1	Etanercept	Etanercept	NNP
cord-005453-4057qib7	6466	2	was	be	VBD
cord-005453-4057qib7	6466	3	given	give	VBN
cord-005453-4057qib7	6466	4	as	as	IN
cord-005453-4057qib7	6466	5	a	a	DT
cord-005453-4057qib7	6466	6	2	2	CD
cord-005453-4057qib7	6466	7	nd	nd	NNP
cord-005453-4057qib7	6466	8	,	,	,
cord-005453-4057qib7	6466	9	3	3	CD
cord-005453-4057qib7	6466	10	rd	rd	NNP
cord-005453-4057qib7	6466	11	and	and	CC
cord-005453-4057qib7	6466	12	4	4	CD
cord-005453-4057qib7	6466	13	th	th	XX
cord-005453-4057qib7	6466	14	line	line	NN
cord-005453-4057qib7	6466	15	in	in	IN
cord-005453-4057qib7	6466	16	3	3	CD
cord-005453-4057qib7	6466	17	(	(	-LRB-
cord-005453-4057qib7	6466	18	16	16	CD
cord-005453-4057qib7	6466	19	%	%	NN
cord-005453-4057qib7	6466	20	)	)	-RRB-
cord-005453-4057qib7	6466	21	,	,	,
cord-005453-4057qib7	6466	22	10	10	CD
cord-005453-4057qib7	6466	23	(	(	-LRB-
cord-005453-4057qib7	6466	24	53	53	CD
cord-005453-4057qib7	6466	25	%	%	NN
cord-005453-4057qib7	6466	26	)	)	-RRB-
cord-005453-4057qib7	6466	27	and	and	CC
cord-005453-4057qib7	6466	28	6	6	CD
cord-005453-4057qib7	6466	29	(	(	-LRB-
cord-005453-4057qib7	6466	30	31	31	CD
cord-005453-4057qib7	6466	31	%	%	NN
cord-005453-4057qib7	6466	32	)	)	-RRB-
cord-005453-4057qib7	6466	33	patients	patient	NNS
cord-005453-4057qib7	6466	34	respectively	respectively	RB
cord-005453-4057qib7	6466	35	.	.	.
cord-005453-4057qib7	6467	1	The	the	DT
cord-005453-4057qib7	6467	2	median	median	JJ
cord-005453-4057qib7	6467	3	doses	dose	NNS
cord-005453-4057qib7	6467	4	of	of	IN
cord-005453-4057qib7	6467	5	etanercept	etanercept	NNP
cord-005453-4057qib7	6467	6	administered	administer	VBN
cord-005453-4057qib7	6467	7	were	be	VBD
cord-005453-4057qib7	6467	8	7	7	CD
cord-005453-4057qib7	6468	1	(	(	-LRB-
cord-005453-4057qib7	6468	2	range	range	NNP
cord-005453-4057qib7	6468	3	1	1	CD
cord-005453-4057qib7	6468	4	-	-	SYM
cord-005453-4057qib7	6468	5	12	12	CD
cord-005453-4057qib7	6468	6	)	)	-RRB-
cord-005453-4057qib7	6468	7	,	,	,
cord-005453-4057qib7	6468	8	and	and	CC
cord-005453-4057qib7	6468	9	just	just	RB
cord-005453-4057qib7	6468	10	4	4	CD
cord-005453-4057qib7	6468	11	patients	patient	NNS
cord-005453-4057qib7	6468	12	(	(	-LRB-
cord-005453-4057qib7	6468	13	20	20	CD
cord-005453-4057qib7	6468	14	%	%	NN
cord-005453-4057qib7	6468	15	)	)	-RRB-
cord-005453-4057qib7	6468	16	completed	complete	VBD
cord-005453-4057qib7	6468	17	the	the	DT
cord-005453-4057qib7	6468	18	12	12	CD
cord-005453-4057qib7	6468	19	doses	dose	NNS
cord-005453-4057qib7	6468	20	planned	plan	VBN
cord-005453-4057qib7	6468	21	treatment	treatment	NN
cord-005453-4057qib7	6468	22	,	,	,
cord-005453-4057qib7	6468	23	of	of	IN
cord-005453-4057qib7	6468	24	whom	whom	WP
cord-005453-4057qib7	6468	25	3	3	CD
cord-005453-4057qib7	6468	26	were	be	VBD
cord-005453-4057qib7	6468	27	alive	alive	JJ
cord-005453-4057qib7	6468	28	at	at	IN
cord-005453-4057qib7	6468	29	38	38	CD
cord-005453-4057qib7	6468	30	,	,	,
cord-005453-4057qib7	6468	31	24	24	CD
cord-005453-4057qib7	6468	32	and	and	CC
cord-005453-4057qib7	6468	33	18	18	CD
cord-005453-4057qib7	6468	34	months	month	NNS
cord-005453-4057qib7	6468	35	from	from	IN
cord-005453-4057qib7	6468	36	the	the	DT
cord-005453-4057qib7	6468	37	onset	onset	NN
cord-005453-4057qib7	6468	38	of	of	IN
cord-005453-4057qib7	6468	39	rescue	rescue	NN
cord-005453-4057qib7	6468	40	treatment	treatment	NN
cord-005453-4057qib7	6468	41	.	.	.
cord-005453-4057qib7	6469	1	Complications	complication	NNS
cord-005453-4057qib7	6469	2	during	during	IN
cord-005453-4057qib7	6469	3	etanercept	etanercept	NNP
cord-005453-4057qib7	6469	4	treatment	treatment	NN
cord-005453-4057qib7	6469	5	were	be	VBD
cord-005453-4057qib7	6469	6	:	:	:
cord-005453-4057qib7	6469	7	infection	infection	NN
cord-005453-4057qib7	6469	8	(	(	-LRB-
cord-005453-4057qib7	6469	9	n=9	n=9	NN
cord-005453-4057qib7	6469	10	[	[	-LRB-
cord-005453-4057qib7	6469	11	47	47	CD
cord-005453-4057qib7	6469	12	%	%	NN
cord-005453-4057qib7	6469	13	]	]	-RRB-
cord-005453-4057qib7	6469	14	:	:	:
cord-005453-4057qib7	6469	15	gram	gram	NN
cord-005453-4057qib7	6469	16	negative	negative	JJ
cord-005453-4057qib7	6469	17	bacilli	bacilli	NN
cord-005453-4057qib7	6469	18	[	[	-LRB-
cord-005453-4057qib7	6469	19	n=6	n=6	NN
cord-005453-4057qib7	6469	20	]	]	-RRB-
cord-005453-4057qib7	6469	21	)	)	-RRB-
cord-005453-4057qib7	6469	22	,	,	,
cord-005453-4057qib7	6469	23	grade	grade	NN
cord-005453-4057qib7	6469	24	2	2	CD
cord-005453-4057qib7	6469	25	-	-	SYM
cord-005453-4057qib7	6469	26	4	4	CD
cord-005453-4057qib7	6469	27	neutropenia	neutropenia	NN
cord-005453-4057qib7	6469	28	(	(	-LRB-
cord-005453-4057qib7	6469	29	n=8	n=8	NN
cord-005453-4057qib7	6469	30	)	)	-RRB-
cord-005453-4057qib7	6469	31	and	and	CC
cord-005453-4057qib7	6469	32	grade	grade	NN
cord-005453-4057qib7	6469	33	3	3	CD
cord-005453-4057qib7	6469	34	-	-	SYM
cord-005453-4057qib7	6469	35	4	4	CD
cord-005453-4057qib7	6469	36	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	6469	37	(	(	-LRB-
cord-005453-4057qib7	6469	38	n=6	n=6	NNP
cord-005453-4057qib7	6469	39	)	)	-RRB-
cord-005453-4057qib7	6469	40	.	.	.
cord-005453-4057qib7	6470	1	Etanercept	Etanercept	NNP
cord-005453-4057qib7	6470	2	was	be	VBD
cord-005453-4057qib7	6470	3	indicated	indicate	VBN
cord-005453-4057qib7	6470	4	as	as	IN
cord-005453-4057qib7	6470	5	a	a	DT
cord-005453-4057qib7	6470	6	rescue	rescue	NN
cord-005453-4057qib7	6470	7	treatment	treatment	NN
cord-005453-4057qib7	6470	8	due	due	IN
cord-005453-4057qib7	6470	9	to	to	IN
cord-005453-4057qib7	6470	10	:	:	:
cord-005453-4057qib7	6470	11	progression	progression	NN
cord-005453-4057qib7	6470	12	after	after	IN
cord-005453-4057qib7	6470	13	3	3	CD
cord-005453-4057qib7	6470	14	days	day	NNS
cord-005453-4057qib7	6470	15	of	of	IN
cord-005453-4057qib7	6470	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6470	17	treatment	treatment	NN
cord-005453-4057qib7	6470	18	(	(	-LRB-
cord-005453-4057qib7	6470	19	n=1	n=1	CD
cord-005453-4057qib7	6470	20	)	)	-RRB-
cord-005453-4057qib7	6470	21	,	,	,
cord-005453-4057qib7	6470	22	no	no	DT
cord-005453-4057qib7	6470	23	response	response	NN
cord-005453-4057qib7	6470	24	after	after	IN
cord-005453-4057qib7	6470	25	7	7	CD
cord-005453-4057qib7	6470	26	days	day	NNS
cord-005453-4057qib7	6470	27	of	of	IN
cord-005453-4057qib7	6470	28	treatment	treatment	NN
cord-005453-4057qib7	6470	29	(	(	-LRB-
cord-005453-4057qib7	6470	30	n=11	n=11	NNP
cord-005453-4057qib7	6470	31	)	)	-RRB-
cord-005453-4057qib7	6470	32	,	,	,
cord-005453-4057qib7	6470	33	no	no	DT
cord-005453-4057qib7	6470	34	complete	complete	JJ
cord-005453-4057qib7	6470	35	remission	remission	NN
cord-005453-4057qib7	6470	36	after	after	IN
cord-005453-4057qib7	6470	37	14	14	CD
cord-005453-4057qib7	6470	38	days	day	NNS
cord-005453-4057qib7	6470	39	of	of	IN
cord-005453-4057qib7	6470	40	treatment	treatment	NN
cord-005453-4057qib7	6470	41	(	(	-LRB-
cord-005453-4057qib7	6470	42	n=3	n=3	NN
cord-005453-4057qib7	6470	43	)	)	-RRB-
cord-005453-4057qib7	6470	44	and	and	CC
cord-005453-4057qib7	6470	45	relapse	relapse	VB
cord-005453-4057qib7	6470	46	due	due	IN
cord-005453-4057qib7	6470	47	to	to	TO
cord-005453-4057qib7	6470	48	decrease	decrease	VB
cord-005453-4057qib7	6470	49	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	6470	50	doses	dose	NNS
cord-005453-4057qib7	6470	51	(	(	-LRB-
cord-005453-4057qib7	6470	52	n=4	n=4	NNS
cord-005453-4057qib7	6470	53	)	)	-RRB-
cord-005453-4057qib7	6470	54	.	.	.
cord-005453-4057qib7	6471	1	At	at	IN
cord-005453-4057qib7	6471	2	the	the	DT
cord-005453-4057qib7	6471	3	end	end	NN
cord-005453-4057qib7	6471	4	of	of	IN
cord-005453-4057qib7	6471	5	treatment	treatment	NN
cord-005453-4057qib7	6471	6	1	1	CD
cord-005453-4057qib7	6471	7	patient	patient	NN
cord-005453-4057qib7	6471	8	achieved	achieve	VBD
cord-005453-4057qib7	6471	9	a	a	DT
cord-005453-4057qib7	6471	10	complete	complete	JJ
cord-005453-4057qib7	6471	11	response	response	NN
cord-005453-4057qib7	6471	12	and	and	CC
cord-005453-4057qib7	6471	13	3	3	CD
cord-005453-4057qib7	6471	14	patients	patient	NNS
cord-005453-4057qib7	6471	15	a	a	DT
cord-005453-4057qib7	6471	16	partial	partial	JJ
cord-005453-4057qib7	6471	17	response	response	NN
cord-005453-4057qib7	6471	18	,	,	,
cord-005453-4057qib7	6471	19	all	all	DT
cord-005453-4057qib7	6471	20	of	of	IN
cord-005453-4057qib7	6471	21	them	-PRON-	PRP
cord-005453-4057qib7	6471	22	are	be	VBP
cord-005453-4057qib7	6471	23	alive	alive	JJ
cord-005453-4057qib7	6471	24	.	.	.
cord-005453-4057qib7	6472	1	These	these	DT
cord-005453-4057qib7	6472	2	4	4	CD
cord-005453-4057qib7	6472	3	patients	patient	NNS
cord-005453-4057qib7	6472	4	received	receive	VBD
cord-005453-4057qib7	6472	5	etanercept	etanercept	NNP
cord-005453-4057qib7	6472	6	as	as	IN
cord-005453-4057qib7	6472	7	a	a	DT
cord-005453-4057qib7	6472	8	2	2	CD
cord-005453-4057qib7	6472	9	nd	nd	NNP
cord-005453-4057qib7	6472	10	(	(	-LRB-
cord-005453-4057qib7	6472	11	n=3	n=3	NN
cord-005453-4057qib7	6472	12	)	)	-RRB-
cord-005453-4057qib7	6472	13	and	and	CC
cord-005453-4057qib7	6472	14	3th	3th	JJ
cord-005453-4057qib7	6472	15	line	line	NN
cord-005453-4057qib7	6472	16	(	(	-LRB-
cord-005453-4057qib7	6472	17	n=1	n=1	CD
cord-005453-4057qib7	6472	18	)	)	-RRB-
cord-005453-4057qib7	6472	19	treatment	treatment	NN
cord-005453-4057qib7	6472	20	,	,	,
cord-005453-4057qib7	6472	21	all	all	DT
cord-005453-4057qib7	6472	22	of	of	IN
cord-005453-4057qib7	6472	23	them	-PRON-	PRP
cord-005453-4057qib7	6472	24	had	have	VBD
cord-005453-4057qib7	6472	25	lower	low	JJR
cord-005453-4057qib7	6472	26	GI	GI	NNP
cord-005453-4057qib7	6472	27	aGVHD	agvhd	NN
cord-005453-4057qib7	6473	1	without	without	IN
cord-005453-4057qib7	6473	2	any	any	DT
cord-005453-4057qib7	6473	3	other	other	JJ
cord-005453-4057qib7	6473	4	organ	organ	NN
cord-005453-4057qib7	6473	5	significantly	significantly	RB
cord-005453-4057qib7	6473	6	involved	involve	VBN
cord-005453-4057qib7	6473	7	.	.	.
cord-005453-4057qib7	6474	1	Causes	cause	NNS
cord-005453-4057qib7	6474	2	of	of	IN
cord-005453-4057qib7	6474	3	death	death	NN
cord-005453-4057qib7	6474	4	were	be	VBD
cord-005453-4057qib7	6474	5	:	:	:
cord-005453-4057qib7	6474	6	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6474	7	with	with	IN
cord-005453-4057qib7	6474	8	or	or	CC
cord-005453-4057qib7	6474	9	without	without	IN
cord-005453-4057qib7	6474	10	infection	infection	NN
cord-005453-4057qib7	6474	11	in	in	IN
cord-005453-4057qib7	6474	12	15	15	CD
cord-005453-4057qib7	6474	13	patients	patient	NNS
cord-005453-4057qib7	6474	14	(	(	-LRB-
cord-005453-4057qib7	6474	15	78	78	CD
cord-005453-4057qib7	6474	16	%	%	NN
cord-005453-4057qib7	6474	17	)	)	-RRB-
cord-005453-4057qib7	6474	18	and	and	CC
cord-005453-4057qib7	6474	19	leukemia	leukemia	NN
cord-005453-4057qib7	6474	20	relapse	relapse	NN
cord-005453-4057qib7	6474	21	in	in	IN
cord-005453-4057qib7	6474	22	1	1	CD
cord-005453-4057qib7	6474	23	patient	patient	NN
cord-005453-4057qib7	6474	24	.	.	.
cord-005453-4057qib7	6475	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6475	2	:	:	:
cord-005453-4057qib7	6476	1	Although	although	IN
cord-005453-4057qib7	6476	2	if	if	IN
cord-005453-4057qib7	6476	3	etanercept	etanercept	NNP
cord-005453-4057qib7	6476	4	is	be	VBZ
cord-005453-4057qib7	6476	5	an	an	DT
cord-005453-4057qib7	6476	6	option	option	NN
cord-005453-4057qib7	6476	7	for	for	IN
cord-005453-4057qib7	6476	8	treatment	treatment	NN
cord-005453-4057qib7	6476	9	of	of	IN
cord-005453-4057qib7	6476	10	SR	SR	NNP
cord-005453-4057qib7	6476	11	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6476	12	in	in	IN
cord-005453-4057qib7	6476	13	some	some	DT
cord-005453-4057qib7	6476	14	patients	patient	NNS
cord-005453-4057qib7	6476	15	,	,	,
cord-005453-4057qib7	6476	16	their	-PRON-	PRP$
cord-005453-4057qib7	6476	17	prognostic	prognostic	JJ
cord-005453-4057qib7	6476	18	remains	remain	VBZ
cord-005453-4057qib7	6476	19	poor	poor	JJ
cord-005453-4057qib7	6476	20	and	and	CC
cord-005453-4057qib7	6476	21	more	more	RBR
cord-005453-4057qib7	6476	22	effective	effective	JJ
cord-005453-4057qib7	6476	23	alternative	alternative	JJ
cord-005453-4057qib7	6476	24	strategies	strategy	NNS
cord-005453-4057qib7	6476	25	are	be	VBP
cord-005453-4057qib7	6476	26	needed	need	VBN
cord-005453-4057qib7	6476	27	.	.	.
cord-005453-4057qib7	6477	1	A	a	DT
cord-005453-4057qib7	6477	2	prompt	prompt	JJ
cord-005453-4057qib7	6477	3	initiation	initiation	NN
cord-005453-4057qib7	6477	4	of	of	IN
cord-005453-4057qib7	6477	5	etanercept	etanercept	NNP
cord-005453-4057qib7	6477	6	as	as	IN
cord-005453-4057qib7	6477	7	a	a	DT
cord-005453-4057qib7	6477	8	rescue	rescue	NN
cord-005453-4057qib7	6477	9	treatment	treatment	NN
cord-005453-4057qib7	6477	10	for	for	IN
cord-005453-4057qib7	6477	11	SR	SR	NNP
cord-005453-4057qib7	6477	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6477	13	is	be	VBZ
cord-005453-4057qib7	6477	14	crucial	crucial	JJ
cord-005453-4057qib7	6477	15	to	to	TO
cord-005453-4057qib7	6477	16	improve	improve	VB
cord-005453-4057qib7	6477	17	the	the	DT
cord-005453-4057qib7	6477	18	prognosis	prognosis	NN
cord-005453-4057qib7	6477	19	.	.	.
cord-005453-4057qib7	6478	1	(	(	-LRB-
cord-005453-4057qib7	6478	2	58	58	CD
cord-005453-4057qib7	6478	3	)	)	-RRB-
cord-005453-4057qib7	6478	4	5(26	5(26	CD
cord-005453-4057qib7	6478	5	)	)	-RRB-
cord-005453-4057qib7	6479	1	Background	background	NN
cord-005453-4057qib7	6479	2	:	:	:
cord-005453-4057qib7	6480	1	Although	although	IN
cord-005453-4057qib7	6480	2	both	both	CC
cord-005453-4057qib7	6480	3	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	6480	4	(	(	-LRB-
cord-005453-4057qib7	6480	5	CSA	CSA	NNP
cord-005453-4057qib7	6480	6	)	)	-RRB-
cord-005453-4057qib7	6480	7	and	and	CC
cord-005453-4057qib7	6480	8	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	6480	9	are	be	VBP
cord-005453-4057qib7	6480	10	calcineurin	calcineurin	NNP
cord-005453-4057qib7	6480	11	inhibitors	inhibitor	NNS
cord-005453-4057qib7	6480	12	,	,	,
cord-005453-4057qib7	6480	13	CSA	CSA	NNP
cord-005453-4057qib7	6480	14	is	be	VBZ
cord-005453-4057qib7	6480	15	more	more	RBR
cord-005453-4057qib7	6480	16	widely	widely	RB
cord-005453-4057qib7	6480	17	used	use	VBN
cord-005453-4057qib7	6480	18	in	in	IN
cord-005453-4057qib7	6480	19	pediatric	pediatric	JJ
cord-005453-4057qib7	6480	20	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	6480	21	stem	stem	NN
cord-005453-4057qib7	6480	22	cell	cell	NN
cord-005453-4057qib7	6480	23	transplantation	transplantation	NN
cord-005453-4057qib7	6480	24	(	(	-LRB-
cord-005453-4057qib7	6480	25	HSCT	HSCT	NNP
cord-005453-4057qib7	6480	26	)	)	-RRB-
cord-005453-4057qib7	6480	27	as	as	IN
cord-005453-4057qib7	6480	28	a	a	DT
cord-005453-4057qib7	6480	29	prophylactic	prophylactic	JJ
cord-005453-4057qib7	6480	30	drug	drug	NN
cord-005453-4057qib7	6480	31	for	for	IN
cord-005453-4057qib7	6480	32	acute	acute	JJ
cord-005453-4057qib7	6480	33	graft	graft	NN
cord-005453-4057qib7	6480	34	versus	versus	IN
cord-005453-4057qib7	6480	35	host	host	NN
cord-005453-4057qib7	6480	36	disease	disease	NN
cord-005453-4057qib7	6480	37	(	(	-LRB-
cord-005453-4057qib7	6480	38	aGvHD	agvhd	NN
cord-005453-4057qib7	6480	39	)	)	-RRB-
cord-005453-4057qib7	6480	40	.	.	.
cord-005453-4057qib7	6481	1	There	there	EX
cord-005453-4057qib7	6481	2	are	be	VBP
cord-005453-4057qib7	6481	3	some	some	DT
cord-005453-4057qib7	6481	4	clinical	clinical	JJ
cord-005453-4057qib7	6481	5	experience	experience	NN
cord-005453-4057qib7	6481	6	but	but	CC
cord-005453-4057qib7	6481	7	very	very	RB
cord-005453-4057qib7	6481	8	few	few	JJ
cord-005453-4057qib7	6481	9	data	datum	NNS
cord-005453-4057qib7	6481	10	about	about	IN
cord-005453-4057qib7	6481	11	the	the	DT
cord-005453-4057qib7	6481	12	clinical	clinical	JJ
cord-005453-4057qib7	6481	13	efficacy	efficacy	NN
cord-005453-4057qib7	6481	14	of	of	IN
cord-005453-4057qib7	6481	15	conversion	conversion	NN
cord-005453-4057qib7	6481	16	to	to	IN
cord-005453-4057qib7	6481	17	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	6481	18	.	.	.
cord-005453-4057qib7	6482	1	Here	here	RB
cord-005453-4057qib7	6482	2	,	,	,
cord-005453-4057qib7	6482	3	we	-PRON-	PRP
cord-005453-4057qib7	6482	4	present	present	VBP
cord-005453-4057qib7	6482	5	our	-PRON-	PRP$
cord-005453-4057qib7	6482	6	single	single	JJ
cord-005453-4057qib7	6482	7	center	center	NN
cord-005453-4057qib7	6482	8	data	datum	NNS
cord-005453-4057qib7	6482	9	on	on	IN
cord-005453-4057qib7	6482	10	this	this	DT
cord-005453-4057qib7	6482	11	arguable	arguable	JJ
cord-005453-4057qib7	6482	12	topic	topic	NN
cord-005453-4057qib7	6482	13	.	.	.
cord-005453-4057qib7	6483	1	Methods	method	NNS
cord-005453-4057qib7	6483	2	:	:	:
cord-005453-4057qib7	6483	3	This	this	DT
cord-005453-4057qib7	6483	4	study	study	NN
cord-005453-4057qib7	6483	5	involves	involve	VBZ
cord-005453-4057qib7	6483	6	the	the	DT
cord-005453-4057qib7	6483	7	data	datum	NNS
cord-005453-4057qib7	6483	8	of	of	IN
cord-005453-4057qib7	6483	9	71	71	CD
cord-005453-4057qib7	6483	10	pediatric	pediatric	JJ
cord-005453-4057qib7	6483	11	HSCT	HSCT	NNP
cord-005453-4057qib7	6483	12	patients	patient	NNS
cord-005453-4057qib7	6483	13	in	in	IN
cord-005453-4057qib7	6483	14	Medical	Medical	NNP
cord-005453-4057qib7	6483	15	Park	Park	NNP
cord-005453-4057qib7	6483	16	Göztepe	Göztepe	NNP
cord-005453-4057qib7	6483	17	Hospital	Hospital	NNP
cord-005453-4057qib7	6483	18	between	between	IN
cord-005453-4057qib7	6483	19	2014	2014	CD
cord-005453-4057qib7	6483	20	-	-	SYM
cord-005453-4057qib7	6483	21	2018	2018	CD
cord-005453-4057qib7	6483	22	.	.	.
cord-005453-4057qib7	6484	1	All	all	DT
cord-005453-4057qib7	6484	2	71	71	CD
cord-005453-4057qib7	6484	3	patients	patient	NNS
cord-005453-4057qib7	6484	4	had	have	VBD
cord-005453-4057qib7	6484	5	prophylactic	prophylactic	JJ
cord-005453-4057qib7	6484	6	CSA	CSA	NNP
cord-005453-4057qib7	6484	7	therapy	therapy	NN
cord-005453-4057qib7	6484	8	and	and	CC
cord-005453-4057qib7	6484	9	for	for	IN
cord-005453-4057qib7	6484	10	various	various	JJ
cord-005453-4057qib7	6484	11	reasons	reason	NNS
cord-005453-4057qib7	6484	12	CSA	CSA	NNP
cord-005453-4057qib7	6484	13	was	be	VBD
cord-005453-4057qib7	6484	14	converted	convert	VBN
cord-005453-4057qib7	6484	15	to	to	IN
cord-005453-4057qib7	6484	16	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	6484	17	therapy	therapy	NN
cord-005453-4057qib7	6484	18	.	.	.
cord-005453-4057qib7	6485	1	Most	Most	JJS
cord-005453-4057qib7	6485	2	of	of	IN
cord-005453-4057qib7	6485	3	the	the	DT
cord-005453-4057qib7	6485	4	patients	patient	NNS
cord-005453-4057qib7	6485	5	had	have	VBD
cord-005453-4057qib7	6485	6	this	this	DT
cord-005453-4057qib7	6485	7	conversion	conversion	NN
cord-005453-4057qib7	6485	8	due	due	IN
cord-005453-4057qib7	6485	9	to	to	IN
cord-005453-4057qib7	6485	10	aGvHD	agvhd	NN
cord-005453-4057qib7	6485	11	.	.	.
cord-005453-4057qib7	6486	1	As	as	IN
cord-005453-4057qib7	6486	2	steroid	steroid	NN
cord-005453-4057qib7	6486	3	is	be	VBZ
cord-005453-4057qib7	6486	4	the	the	DT
cord-005453-4057qib7	6486	5	first	first	JJ
cord-005453-4057qib7	6486	6	line	line	NN
cord-005453-4057qib7	6486	7	therapy	therapy	NN
cord-005453-4057qib7	6486	8	for	for	IN
cord-005453-4057qib7	6486	9	aGvHD	agvhd	NN
cord-005453-4057qib7	6486	10	,	,	,
cord-005453-4057qib7	6486	11	conversion	conversion	NN
cord-005453-4057qib7	6486	12	to	to	IN
cord-005453-4057qib7	6486	13	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	6486	14	is	be	VBZ
cord-005453-4057qib7	6486	15	done	do	VBN
cord-005453-4057qib7	6486	16	concurrently	concurrently	RB
cord-005453-4057qib7	6486	17	at	at	IN
cord-005453-4057qib7	6486	18	the	the	DT
cord-005453-4057qib7	6486	19	start	start	NN
cord-005453-4057qib7	6486	20	of	of	IN
cord-005453-4057qib7	6486	21	steroid	steroid	NN
cord-005453-4057qib7	6486	22	therapy	therapy	NN
cord-005453-4057qib7	6486	23	(	(	-LRB-
cord-005453-4057qib7	6486	24	within	within	IN
cord-005453-4057qib7	6486	25	72	72	CD
cord-005453-4057qib7	6486	26	hours	hour	NNS
cord-005453-4057qib7	6486	27	after	after	IN
cord-005453-4057qib7	6486	28	the	the	DT
cord-005453-4057qib7	6486	29	start	start	NN
cord-005453-4057qib7	6486	30	of	of	IN
cord-005453-4057qib7	6486	31	steroid	steroid	NN
cord-005453-4057qib7	6486	32	)	)	-RRB-
cord-005453-4057qib7	6486	33	.	.	.
cord-005453-4057qib7	6487	1	And	and	CC
cord-005453-4057qib7	6487	2	also	also	RB
cord-005453-4057qib7	6487	3	,	,	,
cord-005453-4057qib7	6487	4	patients	patient	NNS
cord-005453-4057qib7	6487	5	who	who	WP
cord-005453-4057qib7	6487	6	had	have	VBD
cord-005453-4057qib7	6487	7	any	any	DT
cord-005453-4057qib7	6487	8	other	other	JJ
cord-005453-4057qib7	6487	9	immunosupressive	immunosupressive	JJ
cord-005453-4057qib7	6487	10	therapy	therapy	NN
cord-005453-4057qib7	6487	11	for	for	IN
cord-005453-4057qib7	6487	12	aGvHD	aGvHD	NNP
cord-005453-4057qib7	6487	13	are	be	VBP
cord-005453-4057qib7	6487	14	excluded	exclude	VBN
cord-005453-4057qib7	6487	15	.	.	.
cord-005453-4057qib7	6488	1	Response	response	NN
cord-005453-4057qib7	6488	2	is	be	VBZ
cord-005453-4057qib7	6488	3	defined	define	VBN
cord-005453-4057qib7	6488	4	as	as	IN
cord-005453-4057qib7	6488	5	resolution	resolution	NN
cord-005453-4057qib7	6488	6	of	of	IN
cord-005453-4057qib7	6488	7	symptoms	symptom	NNS
cord-005453-4057qib7	6488	8	within	within	IN
cord-005453-4057qib7	6488	9	7	7	CD
cord-005453-4057qib7	6488	10	days	day	NNS
cord-005453-4057qib7	6488	11	after	after	IN
cord-005453-4057qib7	6488	12	conversion	conversion	NN
cord-005453-4057qib7	6488	13	.	.	.
cord-005453-4057qib7	6489	1	Results	result	NNS
cord-005453-4057qib7	6489	2	:	:	:
cord-005453-4057qib7	6490	1	Mean	mean	JJ
cord-005453-4057qib7	6490	2	age	age	NN
cord-005453-4057qib7	6490	3	of	of	IN
cord-005453-4057qib7	6490	4	the	the	DT
cord-005453-4057qib7	6490	5	study	study	NN
cord-005453-4057qib7	6490	6	population	population	NN
cord-005453-4057qib7	6490	7	is	be	VBZ
cord-005453-4057qib7	6490	8	130	130	CD
cord-005453-4057qib7	6490	9	months	month	NNS
cord-005453-4057qib7	6490	10	(	(	-LRB-
cord-005453-4057qib7	6490	11	5	5	CD
cord-005453-4057qib7	6490	12	-	-	SYM
cord-005453-4057qib7	6490	13	266	266	CD
cord-005453-4057qib7	6490	14	months	month	NNS
cord-005453-4057qib7	6490	15	)	)	-RRB-
cord-005453-4057qib7	6490	16	,	,	,
cord-005453-4057qib7	6490	17	male	male	JJ
cord-005453-4057qib7	6490	18	/	/	SYM
cord-005453-4057qib7	6490	19	female	female	JJ
cord-005453-4057qib7	6490	20	ratio	ratio	NN
cord-005453-4057qib7	6490	21	is	be	VBZ
cord-005453-4057qib7	6490	22	1,3	1,3	CD
cord-005453-4057qib7	6490	23	(	(	-LRB-
cord-005453-4057qib7	6490	24	40/31	40/31	CD
cord-005453-4057qib7	6490	25	)	)	-RRB-
cord-005453-4057qib7	6490	26	,	,	,
cord-005453-4057qib7	6490	27	donor	donor	NN
cord-005453-4057qib7	6490	28	types	type	NNS
cord-005453-4057qib7	6490	29	are	be	VBP
cord-005453-4057qib7	6490	30	MUD	mud	NN
cord-005453-4057qib7	6490	31	48	48	CD
cord-005453-4057qib7	6490	32	patients	patient	NNS
cord-005453-4057qib7	6490	33	(	(	-LRB-
cord-005453-4057qib7	6490	34	67	67	CD
cord-005453-4057qib7	6490	35	%	%	NN
cord-005453-4057qib7	6490	36	)	)	-RRB-
cord-005453-4057qib7	6490	37	,	,	,
cord-005453-4057qib7	6490	38	MFD	MFD	NNP
cord-005453-4057qib7	6490	39	18	18	CD
cord-005453-4057qib7	6490	40	patients	patient	NNS
cord-005453-4057qib7	6490	41	(	(	-LRB-
cord-005453-4057qib7	6490	42	26	26	CD
cord-005453-4057qib7	6490	43	%	%	NN
cord-005453-4057qib7	6490	44	)	)	-RRB-
cord-005453-4057qib7	6490	45	,	,	,
cord-005453-4057qib7	6490	46	haplo	haplo	NNP
cord-005453-4057qib7	6491	1	5	5	CD
cord-005453-4057qib7	6491	2	patients	patient	NNS
cord-005453-4057qib7	6491	3	(	(	-LRB-
cord-005453-4057qib7	6491	4	7	7	CD
cord-005453-4057qib7	6491	5	%	%	NN
cord-005453-4057qib7	6491	6	)	)	-RRB-
cord-005453-4057qib7	6491	7	and	and	CC
cord-005453-4057qib7	6491	8	mean	mean	VB
cord-005453-4057qib7	6491	9	conversion	conversion	NN
cord-005453-4057qib7	6491	10	time	time	NN
cord-005453-4057qib7	6491	11	is	be	VBZ
cord-005453-4057qib7	6491	12	32	32	CD
cord-005453-4057qib7	6491	13	days	day	NNS
cord-005453-4057qib7	6491	14	(	(	-LRB-
cord-005453-4057qib7	6491	15	1	1	CD
cord-005453-4057qib7	6491	16	-	-	SYM
cord-005453-4057qib7	6491	17	142	142	CD
cord-005453-4057qib7	6491	18	days	day	NNS
cord-005453-4057qib7	6491	19	)	)	-RRB-
cord-005453-4057qib7	6491	20	.	.	.
cord-005453-4057qib7	6492	1	The	the	DT
cord-005453-4057qib7	6492	2	rationales	rationale	NNS
cord-005453-4057qib7	6492	3	for	for	IN
cord-005453-4057qib7	6492	4	conversion	conversion	NN
cord-005453-4057qib7	6492	5	are	be	VBP
cord-005453-4057qib7	6492	6	aGvHD	agvhd	NN
cord-005453-4057qib7	6492	7	for	for	IN
cord-005453-4057qib7	6492	8	40	40	CD
cord-005453-4057qib7	6492	9	patients	patient	NNS
cord-005453-4057qib7	6492	10	,	,	,
cord-005453-4057qib7	6492	11	unproper	unproper	JJ
cord-005453-4057qib7	6492	12	CSA	CSA	NNP
cord-005453-4057qib7	6492	13	plasma	plasma	NN
cord-005453-4057qib7	6492	14	levels	level	NNS
cord-005453-4057qib7	6492	15	for	for	IN
cord-005453-4057qib7	6492	16	7	7	CD
cord-005453-4057qib7	6492	17	patients	patient	NNS
cord-005453-4057qib7	6492	18	,	,	,
cord-005453-4057qib7	6492	19	allergic	allergic	JJ
cord-005453-4057qib7	6492	20	reaction	reaction	NN
cord-005453-4057qib7	6492	21	for	for	IN
cord-005453-4057qib7	6492	22	6	6	CD
cord-005453-4057qib7	6492	23	patients	patient	NNS
cord-005453-4057qib7	6492	24	,	,	,
cord-005453-4057qib7	6492	25	nephrotoxicity	nephrotoxicity	NN
cord-005453-4057qib7	6492	26	for	for	IN
cord-005453-4057qib7	6492	27	6	6	CD
cord-005453-4057qib7	6492	28	patients	patient	NNS
cord-005453-4057qib7	6492	29	,	,	,
cord-005453-4057qib7	6492	30	hepatotoxicity	hepatotoxicity	NN
cord-005453-4057qib7	6492	31	for	for	IN
cord-005453-4057qib7	6492	32	5	5	CD
cord-005453-4057qib7	6492	33	patients	patient	NNS
cord-005453-4057qib7	6492	34	,	,	,
cord-005453-4057qib7	6492	35	severe	severe	JJ
cord-005453-4057qib7	6492	36	headache	headache	NN
cord-005453-4057qib7	6492	37	for	for	IN
cord-005453-4057qib7	6492	38	2	2	CD
cord-005453-4057qib7	6492	39	patients	patient	NNS
cord-005453-4057qib7	6492	40	,	,	,
cord-005453-4057qib7	6492	41	high	high	JJ
cord-005453-4057qib7	6492	42	arterial	arterial	JJ
cord-005453-4057qib7	6492	43	blood	blood	NN
cord-005453-4057qib7	6492	44	pressure	pressure	NN
cord-005453-4057qib7	6492	45	for	for	IN
cord-005453-4057qib7	6492	46	2	2	CD
cord-005453-4057qib7	6492	47	patients	patient	NNS
cord-005453-4057qib7	6492	48	and	and	CC
cord-005453-4057qib7	6492	49	one	one	CD
cord-005453-4057qib7	6492	50	each	each	DT
cord-005453-4057qib7	6492	51	for	for	IN
cord-005453-4057qib7	6492	52	refractory	refractory	JJ
cord-005453-4057qib7	6492	53	vomiting	vomiting	NN
cord-005453-4057qib7	6492	54	,	,	,
cord-005453-4057qib7	6492	55	autoimmune	autoimmune	JJ
cord-005453-4057qib7	6492	56	thyroiditis	thyroiditis	NN
cord-005453-4057qib7	6492	57	and	and	CC
cord-005453-4057qib7	6492	58	visual	visual	JJ
cord-005453-4057qib7	6492	59	disturbance	disturbance	NN
cord-005453-4057qib7	6492	60	.	.	.
cord-005453-4057qib7	6493	1	The	the	DT
cord-005453-4057qib7	6493	2	subgroup	subgroup	NN
cord-005453-4057qib7	6493	3	analysis	analysis	NN
cord-005453-4057qib7	6493	4	of	of	IN
cord-005453-4057qib7	6493	5	aGvHD	agvhd	NN
cord-005453-4057qib7	6493	6	patients	patient	NNS
cord-005453-4057qib7	6493	7	reveals	reveal	VBZ
cord-005453-4057qib7	6493	8	that	that	IN
cord-005453-4057qib7	6493	9	mean	mean	VBP
cord-005453-4057qib7	6493	10	conversion	conversion	NN
cord-005453-4057qib7	6493	11	time	time	NN
cord-005453-4057qib7	6493	12	for	for	IN
cord-005453-4057qib7	6493	13	aGvHD	agvhd	NN
cord-005453-4057qib7	6493	14	is	be	VBZ
cord-005453-4057qib7	6493	15	41	41	CD
cord-005453-4057qib7	6493	16	days	day	NNS
cord-005453-4057qib7	6493	17	(	(	-LRB-
cord-005453-4057qib7	6493	18	8	8	CD
cord-005453-4057qib7	6493	19	-	-	SYM
cord-005453-4057qib7	6493	20	142	142	CD
cord-005453-4057qib7	6493	21	days	day	NNS
cord-005453-4057qib7	6493	22	)	)	-RRB-
cord-005453-4057qib7	6493	23	and	and	CC
cord-005453-4057qib7	6493	24	there	there	EX
cord-005453-4057qib7	6493	25	are	be	VBP
cord-005453-4057qib7	6493	26	only	only	RB
cord-005453-4057qib7	6493	27	11	11	CD
cord-005453-4057qib7	6493	28	responders	responder	NNS
cord-005453-4057qib7	6493	29	whose	whose	WP$
cord-005453-4057qib7	6493	30	aGvHD	aGvHD	.
cord-005453-4057qib7	6493	31	resolve	resolve	VB
cord-005453-4057qib7	6493	32	completely	completely	RB
cord-005453-4057qib7	6493	33	(	(	-LRB-
cord-005453-4057qib7	6493	34	%	%	NN
cord-005453-4057qib7	6493	35	27	27	CD
cord-005453-4057qib7	6493	36	)	)	-RRB-
cord-005453-4057qib7	6493	37	after	after	IN
cord-005453-4057qib7	6493	38	conversion	conversion	NN
cord-005453-4057qib7	6493	39	.	.	.
cord-005453-4057qib7	6494	1	All	all	DT
cord-005453-4057qib7	6494	2	of	of	IN
cord-005453-4057qib7	6494	3	the	the	DT
cord-005453-4057qib7	6494	4	patients	patient	NNS
cord-005453-4057qib7	6494	5	had	have	VBD
cord-005453-4057qib7	6494	6	proper	proper	JJ
cord-005453-4057qib7	6494	7	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	6494	8	levels	level	NNS
cord-005453-4057qib7	6494	9	after	after	IN
cord-005453-4057qib7	6494	10	conversion	conversion	NN
cord-005453-4057qib7	6494	11	due	due	IN
cord-005453-4057qib7	6494	12	to	to	IN
cord-005453-4057qib7	6494	13	unproper	unproper	JJ
cord-005453-4057qib7	6494	14	CSA	CSA	NNP
cord-005453-4057qib7	6494	15	levels	level	NNS
cord-005453-4057qib7	6494	16	and	and	CC
cord-005453-4057qib7	6494	17	also	also	RB
cord-005453-4057qib7	6494	18	patients	patient	NNS
cord-005453-4057qib7	6494	19	in	in	IN
cord-005453-4057qib7	6494	20	allegic	allegic	JJ
cord-005453-4057qib7	6494	21	reaction	reaction	NN
cord-005453-4057qib7	6494	22	,	,	,
cord-005453-4057qib7	6494	23	severe	severe	JJ
cord-005453-4057qib7	6494	24	headache	headache	NN
cord-005453-4057qib7	6494	25	,	,	,
cord-005453-4057qib7	6494	26	visiual	visiual	JJ
cord-005453-4057qib7	6494	27	disturbance	disturbance	NN
cord-005453-4057qib7	6494	28	and	and	CC
cord-005453-4057qib7	6494	29	refractory	refractory	JJ
cord-005453-4057qib7	6494	30	vomiting	vomiting	NN
cord-005453-4057qib7	6494	31	group	group	NN
cord-005453-4057qib7	6494	32	responded	respond	VBD
cord-005453-4057qib7	6494	33	to	to	IN
cord-005453-4057qib7	6494	34	conversion	conversion	NN
cord-005453-4057qib7	6494	35	completely	completely	RB
cord-005453-4057qib7	6494	36	but	but	CC
cord-005453-4057qib7	6494	37	only	only	RB
cord-005453-4057qib7	6494	38	one	one	CD
cord-005453-4057qib7	6494	39	of	of	IN
cord-005453-4057qib7	6494	40	the	the	DT
cord-005453-4057qib7	6494	41	6	6	CD
cord-005453-4057qib7	6494	42	patients	patient	NNS
cord-005453-4057qib7	6494	43	in	in	IN
cord-005453-4057qib7	6494	44	nephrotoxicity	nephrotoxicity	NNP
cord-005453-4057qib7	6494	45	group	group	NN
cord-005453-4057qib7	6494	46	responded	respond	VBD
cord-005453-4057qib7	6494	47	and	and	CC
cord-005453-4057qib7	6494	48	also	also	RB
cord-005453-4057qib7	6494	49	3	3	CD
cord-005453-4057qib7	6494	50	of	of	IN
cord-005453-4057qib7	6494	51	the	the	DT
cord-005453-4057qib7	6494	52	5	5	CD
cord-005453-4057qib7	6494	53	patients	patient	NNS
cord-005453-4057qib7	6494	54	in	in	IN
cord-005453-4057qib7	6494	55	hepatoxicity	hepatoxicity	NNP
cord-005453-4057qib7	6494	56	group	group	NN
cord-005453-4057qib7	6494	57	responded	respond	VBD
cord-005453-4057qib7	6494	58	.	.	.
cord-005453-4057qib7	6495	1	The	the	DT
cord-005453-4057qib7	6495	2	only	only	JJ
cord-005453-4057qib7	6495	3	one	one	CD
cord-005453-4057qib7	6495	4	patient	patient	NN
cord-005453-4057qib7	6495	5	suffered	suffer	VBD
cord-005453-4057qib7	6495	6	from	from	IN
cord-005453-4057qib7	6495	7	autoimmune	autoimmune	JJ
cord-005453-4057qib7	6495	8	thyroiditis	thyroiditis	NN
cord-005453-4057qib7	6495	9	did	do	VBD
cord-005453-4057qib7	6495	10	not	not	RB
cord-005453-4057qib7	6495	11	respond	respond	VB
cord-005453-4057qib7	6495	12	to	to	IN
cord-005453-4057qib7	6495	13	conversion	conversion	NN
cord-005453-4057qib7	6495	14	.	.	.
cord-005453-4057qib7	6496	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6496	2	:	:	:
cord-005453-4057qib7	6497	1	In	in	IN
cord-005453-4057qib7	6497	2	this	this	DT
cord-005453-4057qib7	6497	3	study	study	NN
cord-005453-4057qib7	6497	4	,	,	,
cord-005453-4057qib7	6497	5	it	-PRON-	PRP
cord-005453-4057qib7	6497	6	is	be	VBZ
cord-005453-4057qib7	6497	7	obvious	obvious	JJ
cord-005453-4057qib7	6497	8	that	that	IN
cord-005453-4057qib7	6497	9	there	there	EX
cord-005453-4057qib7	6497	10	are	be	VBP
cord-005453-4057qib7	6497	11	response	response	NN
cord-005453-4057qib7	6497	12	to	to	IN
cord-005453-4057qib7	6497	13	conversion	conversion	NN
cord-005453-4057qib7	6497	14	for	for	IN
cord-005453-4057qib7	6497	15	some	some	DT
cord-005453-4057qib7	6497	16	specific	specific	JJ
cord-005453-4057qib7	6497	17	adverse	adverse	JJ
cord-005453-4057qib7	6497	18	effects	effect	NNS
cord-005453-4057qib7	6497	19	of	of	IN
cord-005453-4057qib7	6497	20	CSA	CSA	NNP
cord-005453-4057qib7	6497	21	and	and	CC
cord-005453-4057qib7	6497	22	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	6497	23	is	be	VBZ
cord-005453-4057qib7	6497	24	a	a	DT
cord-005453-4057qib7	6497	25	good	good	JJ
cord-005453-4057qib7	6497	26	alternative	alternative	NN
cord-005453-4057qib7	6497	27	for	for	IN
cord-005453-4057qib7	6497	28	the	the	DT
cord-005453-4057qib7	6497	29	patients	patient	NNS
cord-005453-4057qib7	6497	30	who	who	WP
cord-005453-4057qib7	6497	31	have	have	VBP
cord-005453-4057qib7	6497	32	unproper	unproper	JJ
cord-005453-4057qib7	6497	33	CSA	CSA	NNP
cord-005453-4057qib7	6497	34	levels	level	NNS
cord-005453-4057qib7	6497	35	.	.	.
cord-005453-4057qib7	6498	1	Conversely	conversely	RB
cord-005453-4057qib7	6498	2	,	,	,
cord-005453-4057qib7	6498	3	the	the	DT
cord-005453-4057qib7	6498	4	high	high	JJ
cord-005453-4057qib7	6498	5	percentage	percentage	NN
cord-005453-4057qib7	6498	6	(	(	-LRB-
cord-005453-4057qib7	6498	7	%	%	NN
cord-005453-4057qib7	6498	8	73	73	CD
cord-005453-4057qib7	6498	9	)	)	-RRB-
cord-005453-4057qib7	6498	10	of	of	IN
cord-005453-4057qib7	6498	11	non	non	NNS
cord-005453-4057qib7	6498	12	-	-	NNS
cord-005453-4057qib7	6498	13	responders	responder	NNS
cord-005453-4057qib7	6498	14	shows	show	VBZ
cord-005453-4057qib7	6498	15	that	that	IN
cord-005453-4057qib7	6498	16	it	-PRON-	PRP
cord-005453-4057qib7	6498	17	is	be	VBZ
cord-005453-4057qib7	6498	18	not	not	RB
cord-005453-4057qib7	6498	19	feasible	feasible	JJ
cord-005453-4057qib7	6498	20	to	to	TO
cord-005453-4057qib7	6498	21	make	make	VB
cord-005453-4057qib7	6498	22	a	a	DT
cord-005453-4057qib7	6498	23	conversion	conversion	NN
cord-005453-4057qib7	6498	24	to	to	TO
cord-005453-4057qib7	6498	25	tacrolimus	tacrolimus	VB
cord-005453-4057qib7	6498	26	for	for	IN
cord-005453-4057qib7	6498	27	acute	acute	JJ
cord-005453-4057qib7	6498	28	GvHD	GvHD	NNP
cord-005453-4057qib7	6498	29	.	.	.
cord-005453-4057qib7	6499	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6499	2	:	:	:
cord-005453-4057qib7	6499	3	Nothing	nothing	NN
cord-005453-4057qib7	6499	4	to	to	TO
cord-005453-4057qib7	6499	5	declare	declare	VB
cord-005453-4057qib7	6499	6	Background	background	NN
cord-005453-4057qib7	6499	7	:	:	:
cord-005453-4057qib7	6500	1	Capillary	capillary	JJ
cord-005453-4057qib7	6500	2	leak	leak	NN
cord-005453-4057qib7	6500	3	syndrome	syndrome	NN
cord-005453-4057qib7	6500	4	is	be	VBZ
cord-005453-4057qib7	6500	5	caused	cause	VBN
cord-005453-4057qib7	6500	6	by	by	IN
cord-005453-4057qib7	6500	7	the	the	DT
cord-005453-4057qib7	6500	8	dysfunction	dysfunction	NN
cord-005453-4057qib7	6500	9	of	of	IN
cord-005453-4057qib7	6500	10	the	the	DT
cord-005453-4057qib7	6500	11	vascular	vascular	JJ
cord-005453-4057qib7	6500	12	endothelial	endothelial	JJ
cord-005453-4057qib7	6500	13	cells	cell	NNS
cord-005453-4057qib7	6500	14	,	,	,
cord-005453-4057qib7	6500	15	and	and	CC
cord-005453-4057qib7	6500	16	is	be	VBZ
cord-005453-4057qib7	6500	17	characterized	characterize	VBN
cord-005453-4057qib7	6500	18	by	by	IN
cord-005453-4057qib7	6500	19	weight	weight	NN
cord-005453-4057qib7	6500	20	gain	gain	NN
cord-005453-4057qib7	6500	21	,	,	,
cord-005453-4057qib7	6500	22	generalized	generalize	VBN
cord-005453-4057qib7	6500	23	edemas	edemas	NN
cord-005453-4057qib7	6500	24	,	,	,
cord-005453-4057qib7	6500	25	unresponsive	unresponsive	JJ
cord-005453-4057qib7	6500	26	to	to	IN
cord-005453-4057qib7	6500	27	diuretic	diuretic	JJ
cord-005453-4057qib7	6500	28	treatment	treatment	NN
cord-005453-4057qib7	6500	29	,	,	,
cord-005453-4057qib7	6500	30	and	and	CC
cord-005453-4057qib7	6500	31	hypotension	hypotension	NN
cord-005453-4057qib7	6500	32	.	.	.
cord-005453-4057qib7	6501	1	It	-PRON-	PRP
cord-005453-4057qib7	6501	2	usually	usually	RB
cord-005453-4057qib7	6501	3	develops	develop	VBZ
cord-005453-4057qib7	6501	4	in	in	IN
cord-005453-4057qib7	6501	5	the	the	DT
cord-005453-4057qib7	6501	6	first	first	JJ
cord-005453-4057qib7	6501	7	15	15	CD
cord-005453-4057qib7	6501	8	days	day	NNS
cord-005453-4057qib7	6501	9	post	post	NN
cord-005453-4057qib7	6502	1	HSCT.And	HSCT.And	NNP
cord-005453-4057qib7	6503	1	it	-PRON-	PRP
cord-005453-4057qib7	6503	2	is	be	VBZ
cord-005453-4057qib7	6503	3	of	of	IN
cord-005453-4057qib7	6503	4	great	great	JJ
cord-005453-4057qib7	6503	5	difficuty	difficuty	NNS
cord-005453-4057qib7	6503	6	to	to	TO
cord-005453-4057qib7	6503	7	distinguish	distinguish	VB
cord-005453-4057qib7	6503	8	from	from	IN
cord-005453-4057qib7	6503	9	other	other	JJ
cord-005453-4057qib7	6503	10	complications	complication	NNS
cord-005453-4057qib7	6503	11	which	which	WDT
cord-005453-4057qib7	6503	12	are	be	VBP
cord-005453-4057qib7	6503	13	occured	occur	VBN
cord-005453-4057qib7	6503	14	post	post	VB
cord-005453-4057qib7	6503	15	the	the	DT
cord-005453-4057qib7	6503	16	allo	allo	NN
cord-005453-4057qib7	6503	17	-	-	HYPH
cord-005453-4057qib7	6503	18	HSCT	HSCT	NNP
cord-005453-4057qib7	6503	19	.	.	.
cord-005453-4057qib7	6504	1	To	to	TO
cord-005453-4057qib7	6504	2	diagnose	diagnose	VB
cord-005453-4057qib7	6504	3	this	this	DT
cord-005453-4057qib7	6504	4	complication	complication	NN
cord-005453-4057qib7	6504	5	at	at	IN
cord-005453-4057qib7	6504	6	the	the	DT
cord-005453-4057qib7	6504	7	early	early	JJ
cord-005453-4057qib7	6504	8	stage	stage	NN
cord-005453-4057qib7	6504	9	,	,	,
cord-005453-4057qib7	6504	10	it	-PRON-	PRP
cord-005453-4057qib7	6504	11	is	be	VBZ
cord-005453-4057qib7	6504	12	very	very	RB
cord-005453-4057qib7	6504	13	difficulty	difficulty	NN
cord-005453-4057qib7	6504	14	.	.	.
cord-005453-4057qib7	6505	1	Methods	method	NNS
cord-005453-4057qib7	6505	2	:	:	:
cord-005453-4057qib7	6506	1	A	a	DT
cord-005453-4057qib7	6506	2	34-year	34-year	JJ
cord-005453-4057qib7	6506	3	-	-	HYPH
cord-005453-4057qib7	6506	4	old	old	JJ
cord-005453-4057qib7	6506	5	man	man	NN
cord-005453-4057qib7	6506	6	was	be	VBD
cord-005453-4057qib7	6506	7	admitted	admit	VBN
cord-005453-4057qib7	6506	8	to	to	IN
cord-005453-4057qib7	6506	9	Ningbo	Ningbo	NNP
cord-005453-4057qib7	6506	10	first	first	JJ
cord-005453-4057qib7	6506	11	hospital	hospital	NN
cord-005453-4057qib7	6506	12	for	for	IN
cord-005453-4057qib7	6506	13	its	-PRON-	PRP$
cord-005453-4057qib7	6506	14	abnormal	abnormal	JJ
cord-005453-4057qib7	6506	15	in	in	IN
cord-005453-4057qib7	6506	16	the	the	DT
cord-005453-4057qib7	6506	17	peripheral	peripheral	JJ
cord-005453-4057qib7	6506	18	blood	blood	NN
cord-005453-4057qib7	6506	19	.He	.He	.
cord-005453-4057qib7	6506	20	was	be	VBD
cord-005453-4057qib7	6506	21	diagnosed	diagnose	VBN
cord-005453-4057qib7	6506	22	with	with	IN
cord-005453-4057qib7	6506	23	AML	AML	NNP
cord-005453-4057qib7	6506	24	-	-	HYPH
cord-005453-4057qib7	6506	25	M5	M5	NNP
cord-005453-4057qib7	6506	26	by	by	IN
cord-005453-4057qib7	6506	27	the	the	DT
cord-005453-4057qib7	6506	28	classical	classical	JJ
cord-005453-4057qib7	6506	29	morphology	morphology	NN
cord-005453-4057qib7	6506	30	and	and	CC
cord-005453-4057qib7	6506	31	immunophenotype	immunophenotype	NN
cord-005453-4057qib7	6506	32	.	.	.
cord-005453-4057qib7	6507	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	6507	2	evaluation	evaluation	NN
cord-005453-4057qib7	6507	3	showed	show	VBD
cord-005453-4057qib7	6507	4	a	a	DT
cord-005453-4057qib7	6507	5	normal	normal	JJ
cord-005453-4057qib7	6507	6	46	46	CD
cord-005453-4057qib7	6507	7	,	,	,
cord-005453-4057qib7	6507	8	XY(20).The	XY(20).The	NNP
cord-005453-4057qib7	6507	9	patient	patient	NN
cord-005453-4057qib7	6507	10	achieved	achieve	VBD
cord-005453-4057qib7	6507	11	CR	CR	NNP
cord-005453-4057qib7	6507	12	with	with	IN
cord-005453-4057qib7	6507	13	induction	induction	NN
cord-005453-4057qib7	6507	14	therapy	therapy	NN
cord-005453-4057qib7	6507	15	including	include	VBG
cord-005453-4057qib7	6507	16	Idarubicin	Idarubicin	NNP
cord-005453-4057qib7	6507	17	,	,	,
cord-005453-4057qib7	6507	18	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	6507	19	and	and	CC
cord-005453-4057qib7	6507	20	Etoposide	Etoposide	NNP
cord-005453-4057qib7	6507	21	.	.	.
cord-005453-4057qib7	6508	1	After	after	IN
cord-005453-4057qib7	6508	2	consolidation	consolidation	NN
cord-005453-4057qib7	6508	3	therapy	therapy	NN
cord-005453-4057qib7	6508	4	,	,	,
cord-005453-4057qib7	6508	5	an	an	DT
cord-005453-4057qib7	6508	6	allo	allo	NN
cord-005453-4057qib7	6508	7	-	-	HYPH
cord-005453-4057qib7	6508	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6508	9	from	from	IN
cord-005453-4057qib7	6508	10	HLA	HLA	NNP
cord-005453-4057qib7	6508	11	identical	identical	JJ
cord-005453-4057qib7	6508	12	related	relate	VBN
cord-005453-4057qib7	6508	13	dornor(33-year	dornor(33-year	JJ
cord-005453-4057qib7	6508	14	-	-	HYPH
cord-005453-4057qib7	6508	15	old	old	JJ
cord-005453-4057qib7	6508	16	male	male	NN
cord-005453-4057qib7	6508	17	,	,	,
cord-005453-4057qib7	6508	18	donorrecipient	donorrecipient	NN
cord-005453-4057qib7	6508	19	matched	match	VBN
cord-005453-4057qib7	6508	20	by	by	IN
cord-005453-4057qib7	6508	21	high	high	JJ
cord-005453-4057qib7	6508	22	resolution	resolution	NN
cord-005453-4057qib7	6508	23	HLA	HLA	NNP
cord-005453-4057qib7	6508	24	typing	type	VBG
cord-005453-4057qib7	6508	25	at	at	IN
cord-005453-4057qib7	6508	26	HLAA	HLAA	NNP
cord-005453-4057qib7	6508	27	,	,	,
cord-005453-4057qib7	6508	28	-B	-b	ADD
cord-005453-4057qib7	6508	29	,	,	,
cord-005453-4057qib7	6508	30	-C	-C	VBZ
cord-005453-4057qib7	6508	31	,	,	,
cord-005453-4057qib7	6508	32	DRB1	DRB1	NNP
cord-005453-4057qib7	6508	33	,	,	,
cord-005453-4057qib7	6508	34	and	and	CC
cord-005453-4057qib7	6508	35	DQB1	DQB1	NNP
cord-005453-4057qib7	6508	36	,	,	,
cord-005453-4057qib7	6508	37	10/10	10/10	CD
cord-005453-4057qib7	6508	38	matches	match	NNS
cord-005453-4057qib7	6508	39	)	)	-RRB-
cord-005453-4057qib7	6508	40	was	be	VBD
cord-005453-4057qib7	6508	41	performed	perform	VBN
cord-005453-4057qib7	6508	42	.	.	.
cord-005453-4057qib7	6509	1	The	the	DT
cord-005453-4057qib7	6509	2	recipient	recipient	NN
cord-005453-4057qib7	6509	3	received	receive	VBD
cord-005453-4057qib7	6509	4	conditioning	conditioning	NN
cord-005453-4057qib7	6509	5	with	with	IN
cord-005453-4057qib7	6509	6	busulfan	busulfan	NN
cord-005453-4057qib7	6509	7	,	,	,
cord-005453-4057qib7	6509	8	4	4	CD
cord-005453-4057qib7	6509	9	mg	mg	NNP
cord-005453-4057qib7	6509	10	/	/	SYM
cord-005453-4057qib7	6509	11	kg	kg	NNP
cord-005453-4057qib7	6509	12	/	/	SYM
cord-005453-4057qib7	6509	13	day	day	NN
cord-005453-4057qib7	6509	14	injection	injection	NN
cord-005453-4057qib7	6509	15	for	for	IN
cord-005453-4057qib7	6509	16	3	3	CD
cord-005453-4057qib7	6509	17	days	day	NNS
cord-005453-4057qib7	6509	18	;	;	:
cord-005453-4057qib7	6509	19	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	6509	20	,	,	,
cord-005453-4057qib7	6509	21	50	50	CD
cord-005453-4057qib7	6509	22	mg	mg	NNP
cord-005453-4057qib7	6509	23	/	/	SYM
cord-005453-4057qib7	6509	24	kg	kg	NNP
cord-005453-4057qib7	6509	25	/	/	SYM
cord-005453-4057qib7	6509	26	day	day	NN
cord-005453-4057qib7	6509	27	injection	injection	NN
cord-005453-4057qib7	6509	28	for	for	IN
cord-005453-4057qib7	6509	29	2	2	CD
cord-005453-4057qib7	6509	30	days	day	NNS
cord-005453-4057qib7	6509	31	;	;	:
cord-005453-4057qib7	6509	32	cytarabine	cytarabine	RB
cord-005453-4057qib7	6509	33	,	,	,
cord-005453-4057qib7	6509	34	2	2	CD
cord-005453-4057qib7	6509	35	g	g	NN
cord-005453-4057qib7	6509	36	/	/	SYM
cord-005453-4057qib7	6509	37	m2	m2	NNP
cord-005453-4057qib7	6509	38	/	/	SYM
cord-005453-4057qib7	6509	39	day	day	NN
cord-005453-4057qib7	6509	40	injection	injection	NN
cord-005453-4057qib7	6509	41	for	for	IN
cord-005453-4057qib7	6509	42	1	1	CD
cord-005453-4057qib7	6509	43	day	day	NN
cord-005453-4057qib7	6509	44	;	;	:
cord-005453-4057qib7	6509	45	semustine	semustine	NNP
cord-005453-4057qib7	6509	46	,	,	,
cord-005453-4057qib7	6510	1	250	250	CD
cord-005453-4057qib7	6510	2	mg	mg	NNP
cord-005453-4057qib7	6510	3	/	/	SYM
cord-005453-4057qib7	6510	4	m2	m2	NNP
cord-005453-4057qib7	6510	5	/	/	SYM
cord-005453-4057qib7	6510	6	day	day	NN
cord-005453-4057qib7	6510	7	orally	orally	RB
cord-005453-4057qib7	6510	8	for	for	IN
cord-005453-4057qib7	6510	9	1day	1day	CD
cord-005453-4057qib7	6510	10	;	;	:
cord-005453-4057qib7	6510	11	Donor	donor	NN
cord-005453-4057qib7	6510	12	peripheral	peripheral	JJ
cord-005453-4057qib7	6510	13	blood	blood	NN
cord-005453-4057qib7	6510	14	stem	stem	NN
cord-005453-4057qib7	6510	15	cells	cell	NNS
cord-005453-4057qib7	6510	16	(	(	-LRB-
cord-005453-4057qib7	6510	17	PBSC	PBSC	NNP
cord-005453-4057qib7	6510	18	:	:	:
cord-005453-4057qib7	6510	19	MNC	MNC	NNP
cord-005453-4057qib7	6510	20	:	:	:
cord-005453-4057qib7	6511	1	6.43×109	6.43×109	LS
cord-005453-4057qib7	6511	2	/	/	SYM
cord-005453-4057qib7	6511	3	L	L	NNP
cord-005453-4057qib7	6511	4	,	,	,
cord-005453-4057qib7	6511	5	CD34+:4.05×106	CD34+:4.05×106	NNP
cord-005453-4057qib7	6511	6	/	/	SYM
cord-005453-4057qib7	6511	7	L	L	NNP
cord-005453-4057qib7	6511	8	)	)	-RRB-
cord-005453-4057qib7	6511	9	were	be	VBD
cord-005453-4057qib7	6511	10	mobilized	mobilize	VBN
cord-005453-4057qib7	6511	11	,	,	,
cord-005453-4057qib7	6511	12	pheresed	pheresed	JJ
cord-005453-4057qib7	6511	13	and	and	CC
cord-005453-4057qib7	6511	14	administered	administer	VBN
cord-005453-4057qib7	6511	15	to	to	IN
cord-005453-4057qib7	6511	16	the	the	DT
cord-005453-4057qib7	6511	17	recipient	recipient	NN
cord-005453-4057qib7	6511	18	.	.	.
cord-005453-4057qib7	6512	1	GVHD	GVHD	NNP
cord-005453-4057qib7	6512	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6512	3	consisted	consist	VBD
cord-005453-4057qib7	6512	4	of	of	IN
cord-005453-4057qib7	6512	5	traditional	traditional	JJ
cord-005453-4057qib7	6512	6	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	6512	7	,	,	,
cord-005453-4057qib7	6512	8	short	short	JJ
cord-005453-4057qib7	6512	9	-	-	HYPH
cord-005453-4057qib7	6512	10	course	course	NN
cord-005453-4057qib7	6512	11	methotrexate	methotrexate	NNP
cord-005453-4057qib7	6512	12	(	(	-LRB-
cord-005453-4057qib7	6512	13	15	15	CD
cord-005453-4057qib7	6512	14	mg/	mg/	NN
cord-005453-4057qib7	6512	15	m2	m2	NNP
cord-005453-4057qib7	6512	16	at	at	IN
cord-005453-4057qib7	6512	17	day	day	NN
cord-005453-4057qib7	6512	18	+1	+1	NFP
cord-005453-4057qib7	6512	19	,	,	,
cord-005453-4057qib7	6512	20	10	10	CD
cord-005453-4057qib7	6512	21	mg	mg	NNP
cord-005453-4057qib7	6512	22	/	/	SYM
cord-005453-4057qib7	6512	23	m2	m2	NNP
cord-005453-4057qib7	6512	24	at	at	IN
cord-005453-4057qib7	6512	25	days	day	NNS
cord-005453-4057qib7	6512	26	+3	+3	NNP
cord-005453-4057qib7	6512	27	,	,	,
cord-005453-4057qib7	6512	28	+6	+6	NNP
cord-005453-4057qib7	6512	29	,	,	,
cord-005453-4057qib7	6512	30	and	and	CC
cord-005453-4057qib7	6512	31	+11	+11	CD
cord-005453-4057qib7	6512	32	)	)	-RRB-
cord-005453-4057qib7	6512	33	and	and	CC
cord-005453-4057qib7	6512	34	Cyclosporin	Cyclosporin	NNP
cord-005453-4057qib7	6512	35	A	a	DT
cord-005453-4057qib7	6512	36	injection	injection	NN
cord-005453-4057qib7	6512	37	5mg	5mg	NN
cord-005453-4057qib7	6512	38	/	/	SYM
cord-005453-4057qib7	6512	39	kg	kg	NNP
cord-005453-4057qib7	6512	40	qer	qer	NNP
cord-005453-4057qib7	6512	41	day	day	NNP
cord-005453-4057qib7	6513	1	was	be	VBD
cord-005453-4057qib7	6513	2	mot	mot	NNP
cord-005453-4057qib7	6513	3	reduced	reduce	VBN
cord-005453-4057qib7	6513	4	untill	untill	IN
cord-005453-4057qib7	6513	5	the	the	DT
cord-005453-4057qib7	6513	6	hematopoietic	hematopoietic	NN
cord-005453-4057qib7	6513	7	reconstitute	reconstitute	VBP
cord-005453-4057qib7	6513	8	sucessfully	sucessfully	RB
cord-005453-4057qib7	6513	9	.	.	.
cord-005453-4057qib7	6514	1	On	on	IN
cord-005453-4057qib7	6514	2	day	day	NN
cord-005453-4057qib7	6514	3	+19	+19	CD
cord-005453-4057qib7	6514	4	,	,	,
cord-005453-4057qib7	6514	5	complete	complete	JJ
cord-005453-4057qib7	6514	6	donor	donor	NN
cord-005453-4057qib7	6514	7	chimerism	chimerism	NN
cord-005453-4057qib7	6514	8	was	be	VBD
cord-005453-4057qib7	6514	9	acheieved	acheieved	JJ
cord-005453-4057qib7	6514	10	.	.	.
cord-005453-4057qib7	6515	1	The	the	DT
cord-005453-4057qib7	6515	2	CsA	csa	NN
cord-005453-4057qib7	6515	3	was	be	VBD
cord-005453-4057qib7	6515	4	gradually	gradually	RB
cord-005453-4057qib7	6515	5	reduced	reduce	VBN
cord-005453-4057qib7	6515	6	and	and	CC
cord-005453-4057qib7	6515	7	tapered	tapered	JJ
cord-005453-4057qib7	6515	8	.	.	.
cord-005453-4057qib7	6516	1	On	on	IN
cord-005453-4057qib7	6516	2	day	day	NN
cord-005453-4057qib7	6516	3	+150,the	+150,the	JJS
cord-005453-4057qib7	6516	4	patients	patient	NNS
cord-005453-4057qib7	6516	5	was	be	VBD
cord-005453-4057qib7	6516	6	manifested	manifest	VBN
cord-005453-4057qib7	6516	7	with	with	IN
cord-005453-4057qib7	6516	8	increasing	increase	VBG
cord-005453-4057qib7	6516	9	in	in	IN
cord-005453-4057qib7	6516	10	the	the	DT
cord-005453-4057qib7	6516	11	time	time	NN
cord-005453-4057qib7	6516	12	and	and	CC
cord-005453-4057qib7	6516	13	volume	volume	NN
cord-005453-4057qib7	6516	14	of	of	IN
cord-005453-4057qib7	6516	15	the	the	DT
cord-005453-4057qib7	6516	16	faeces	faece	NNS
cord-005453-4057qib7	6516	17	,	,	,
cord-005453-4057qib7	6516	18	he	-PRON-	PRP
cord-005453-4057qib7	6516	19	was	be	VBD
cord-005453-4057qib7	6516	20	diagnosed	diagnose	VBN
cord-005453-4057qib7	6516	21	with	with	IN
cord-005453-4057qib7	6516	22	II	ii	CD
cord-005453-4057qib7	6516	23	°	°	NN
cord-005453-4057qib7	6516	24	GVHD	GVHD	NNP
cord-005453-4057qib7	6517	1	(	(	-LRB-
cord-005453-4057qib7	6517	2	gut).The	gut).The	NNP
cord-005453-4057qib7	6517	3	standarded	standarde	VBD
cord-005453-4057qib7	6517	4	does	do	VBZ
cord-005453-4057qib7	6517	5	of	of	IN
cord-005453-4057qib7	6517	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6517	7	drug	drug	NN
cord-005453-4057qib7	6517	8	including	include	VBG
cord-005453-4057qib7	6517	9	methylprednisolone	methylprednisolone	NN
cord-005453-4057qib7	6517	10	and	and	CC
cord-005453-4057qib7	6517	11	Cyclosporin	Cyclosporin	NNP
cord-005453-4057qib7	6517	12	A	A	NNP
cord-005453-4057qib7	6517	13	was	be	VBD
cord-005453-4057qib7	6517	14	administrated	administrate	VBN
cord-005453-4057qib7	6517	15	.	.	.
cord-005453-4057qib7	6518	1	The	the	DT
cord-005453-4057qib7	6518	2	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6518	3	drug	drug	NN
cord-005453-4057qib7	6518	4	was	be	VBD
cord-005453-4057qib7	6518	5	gradually	gradually	RB
cord-005453-4057qib7	6518	6	reduced	reduce	VBN
cord-005453-4057qib7	6518	7	when	when	WRB
cord-005453-4057qib7	6518	8	the	the	DT
cord-005453-4057qib7	6518	9	GVHD	GVHD	NNP
cord-005453-4057qib7	6518	10	was	be	VBD
cord-005453-4057qib7	6518	11	controlled	control	VBN
cord-005453-4057qib7	6518	12	.	.	.
cord-005453-4057qib7	6519	1	On	on	IN
cord-005453-4057qib7	6519	2	day+271,the	day+271,the	DT
cord-005453-4057qib7	6519	3	patient	patient	NN
cord-005453-4057qib7	6519	4	felt	feel	VBD
cord-005453-4057qib7	6519	5	distress	distress	NN
cord-005453-4057qib7	6519	6	and	and	CC
cord-005453-4057qib7	6519	7	the	the	DT
cord-005453-4057qib7	6519	8	distress	distress	NN
cord-005453-4057qib7	6519	9	was	be	VBD
cord-005453-4057qib7	6519	10	not	not	RB
cord-005453-4057qib7	6519	11	related	relate	VBN
cord-005453-4057qib7	6519	12	to	to	IN
cord-005453-4057qib7	6519	13	with	with	IN
cord-005453-4057qib7	6519	14	the	the	DT
cord-005453-4057qib7	6519	15	exercise	exercise	NN
cord-005453-4057qib7	6519	16	,	,	,
cord-005453-4057qib7	6519	17	the	the	DT
cord-005453-4057qib7	6519	18	temperature	temperature	NN
cord-005453-4057qib7	6519	19	was	be	VBD
cord-005453-4057qib7	6519	20	normal	normal	JJ
cord-005453-4057qib7	6519	21	,	,	,
cord-005453-4057qib7	6519	22	and	and	CC
cord-005453-4057qib7	6519	23	he	-PRON-	PRP
cord-005453-4057qib7	6519	24	did	do	VBD
cord-005453-4057qib7	6519	25	not	not	RB
cord-005453-4057qib7	6519	26	gain	gain	VB
cord-005453-4057qib7	6519	27	weight	weight	NN
cord-005453-4057qib7	6519	28	.	.	.
cord-005453-4057qib7	6520	1	There	there	EX
cord-005453-4057qib7	6520	2	was	be	VBD
cord-005453-4057qib7	6520	3	no	no	DT
cord-005453-4057qib7	6520	4	edema	edema	NN
cord-005453-4057qib7	6520	5	in	in	IN
cord-005453-4057qib7	6520	6	the	the	DT
cord-005453-4057qib7	6520	7	body	body	NN
cord-005453-4057qib7	6520	8	.	.	.
cord-005453-4057qib7	6521	1	Laboratory	laboratory	NN
cord-005453-4057qib7	6521	2	test	test	NN
cord-005453-4057qib7	6521	3	including	include	VBG
cord-005453-4057qib7	6521	4	routine	routine	JJ
cord-005453-4057qib7	6521	5	blood	blood	NN
cord-005453-4057qib7	6521	6	test	test	NN
cord-005453-4057qib7	6521	7	,	,	,
cord-005453-4057qib7	6521	8	C	c	NN
cord-005453-4057qib7	6521	9	-	-	HYPH
cord-005453-4057qib7	6521	10	reactive	reactive	JJ
cord-005453-4057qib7	6521	11	protein	protein	NN
cord-005453-4057qib7	6521	12	,	,	,
cord-005453-4057qib7	6521	13	procalcitonin	procalcitonin	NNS
cord-005453-4057qib7	6521	14	,	,	,
cord-005453-4057qib7	6521	15	blood	blood	NN
cord-005453-4057qib7	6521	16	gas	gas	NN
cord-005453-4057qib7	6521	17	analysis	analysis	NN
cord-005453-4057qib7	6521	18	,	,	,
cord-005453-4057qib7	6521	19	CMVDNA	CMVDNA	NNP
cord-005453-4057qib7	6521	20	,	,	,
cord-005453-4057qib7	6521	21	EBVDNA	EBVDNA	NNP
cord-005453-4057qib7	6521	22	was	be	VBD
cord-005453-4057qib7	6521	23	normal	normal	JJ
cord-005453-4057qib7	6521	24	.	.	.
cord-005453-4057qib7	6522	1	The	the	DT
cord-005453-4057qib7	6522	2	CT	CT	NNP
cord-005453-4057qib7	6522	3	scan	scan	NN
cord-005453-4057qib7	6522	4	shows	show	VBZ
cord-005453-4057qib7	6522	5	that	that	IN
cord-005453-4057qib7	6522	6	1the	1the	DT
cord-005453-4057qib7	6522	7	pleural	pleural	NN
cord-005453-4057qib7	6522	8	is	be	VBZ
cord-005453-4057qib7	6522	9	filled	fill	VBN
cord-005453-4057qib7	6522	10	up	up	RP
cord-005453-4057qib7	6522	11	with	with	IN
cord-005453-4057qib7	6522	12	water	water	NN
cord-005453-4057qib7	6522	13	,	,	,
cord-005453-4057qib7	6522	14	and	and	CC
cord-005453-4057qib7	6522	15	could	could	MD
cord-005453-4057qib7	6522	16	not	not	RB
cord-005453-4057qib7	6522	17	be	be	VB
cord-005453-4057qib7	6522	18	enlarged	enlarge	VBN
cord-005453-4057qib7	6522	19	promptly,2There	promptly,2there	NN
cord-005453-4057qib7	6522	20	is	be	VBZ
cord-005453-4057qib7	6522	21	pericardial	pericardial	JJ
cord-005453-4057qib7	6522	22	effusion	effusion	NN
cord-005453-4057qib7	6522	23	in	in	IN
cord-005453-4057qib7	6522	24	the	the	DT
cord-005453-4057qib7	6522	25	body	body	NN
cord-005453-4057qib7	6522	26	.	.	.
cord-005453-4057qib7	6523	1	Pulmonary	pulmonary	JJ
cord-005453-4057qib7	6523	2	function	function	NN
cord-005453-4057qib7	6523	3	test	test	NN
cord-005453-4057qib7	6523	4	shows	show	VBZ
cord-005453-4057qib7	6523	5	that	that	IN
cord-005453-4057qib7	6523	6	1	1	CD
cord-005453-4057qib7	6523	7	reduced	reduce	VBN
cord-005453-4057qib7	6523	8	function	function	NN
cord-005453-4057qib7	6523	9	in	in	IN
cord-005453-4057qib7	6523	10	ventilation	ventilation	NN
cord-005453-4057qib7	6523	11	and	and	CC
cord-005453-4057qib7	6523	12	diffusion	diffusion	NN
cord-005453-4057qib7	6523	13	fuction	fuction	NN
cord-005453-4057qib7	6523	14	.	.	.
cord-005453-4057qib7	6524	1	The	the	DT
cord-005453-4057qib7	6524	2	laboratory	laboratory	NN
cord-005453-4057qib7	6524	3	test	test	NN
cord-005453-4057qib7	6524	4	of	of	IN
cord-005453-4057qib7	6524	5	the	the	DT
cord-005453-4057qib7	6524	6	pleural	pleural	JJ
cord-005453-4057qib7	6524	7	effusion	effusion	NN
cord-005453-4057qib7	6524	8	was	be	VBD
cord-005453-4057qib7	6524	9	normal	normal	JJ
cord-005453-4057qib7	6524	10	,	,	,
cord-005453-4057qib7	6524	11	the	the	DT
cord-005453-4057qib7	6524	12	blast	blast	NN
cord-005453-4057qib7	6524	13	cell	cell	NN
cord-005453-4057qib7	6524	14	was	be	VBD
cord-005453-4057qib7	6524	15	not	not	RB
cord-005453-4057qib7	6524	16	detected	detect	VBN
cord-005453-4057qib7	6524	17	in	in	IN
cord-005453-4057qib7	6524	18	the	the	DT
cord-005453-4057qib7	6524	19	pleural	pleural	JJ
cord-005453-4057qib7	6524	20	effusion	effusion	NN
cord-005453-4057qib7	6524	21	,	,	.
cord-005453-4057qib7	6525	1	the	the	DT
cord-005453-4057qib7	6525	2	CD34	CD34	NNP
cord-005453-4057qib7	6525	3	+	+	CC
cord-005453-4057qib7	6525	4	cell	cell	NN
cord-005453-4057qib7	6525	5	count	count	NN
cord-005453-4057qib7	6525	6	was	be	VBD
cord-005453-4057qib7	6525	7	below	below	IN
cord-005453-4057qib7	6525	8	the	the	DT
cord-005453-4057qib7	6525	9	dectable	dectable	JJ
cord-005453-4057qib7	6525	10	level	level	NN
cord-005453-4057qib7	6525	11	,	,	,
cord-005453-4057qib7	6525	12	the	the	DT
cord-005453-4057qib7	6525	13	next	next	JJ
cord-005453-4057qib7	6525	14	generation	generation	NN
cord-005453-4057qib7	6525	15	sequencing	sequence	VBG
cord-005453-4057qib7	6525	16	for	for	IN
cord-005453-4057qib7	6525	17	minimal	minimal	JJ
cord-005453-4057qib7	6525	18	residual	residual	JJ
cord-005453-4057qib7	6525	19	disease	disease	NN
cord-005453-4057qib7	6525	20	shows	show	VBZ
cord-005453-4057qib7	6525	21	that	that	IN
cord-005453-4057qib7	6525	22	there	there	EX
cord-005453-4057qib7	6525	23	was	be	VBD
cord-005453-4057qib7	6525	24	no	no	DT
cord-005453-4057qib7	6525	25	gene	gene	NN
cord-005453-4057qib7	6525	26	mutation	mutation	NN
cord-005453-4057qib7	6525	27	.Thus	.Thus	.
cord-005453-4057qib7	6526	1	,	,	,
cord-005453-4057qib7	6526	2	post	post	JJ
cord-005453-4057qib7	6526	3	capillary	capillary	JJ
cord-005453-4057qib7	6526	4	leak	leak	NN
cord-005453-4057qib7	6526	5	syndrome	syndrome	NN
cord-005453-4057qib7	6526	6	was	be	VBD
cord-005453-4057qib7	6526	7	considered	consider	VBN
cord-005453-4057qib7	6526	8	.Sirolimus	.sirolimus	NN
cord-005453-4057qib7	6526	9	was	be	VBD
cord-005453-4057qib7	6526	10	adopted	adopt	VBN
cord-005453-4057qib7	6526	11	and	and	CC
cord-005453-4057qib7	6526	12	taken	take	VBN
cord-005453-4057qib7	6526	13	the	the	DT
cord-005453-4057qib7	6526	14	place	place	NN
cord-005453-4057qib7	6526	15	of	of	IN
cord-005453-4057qib7	6526	16	Cyclosporin	Cyclosporin	NNP
cord-005453-4057qib7	6526	17	A	A	NNP
cord-005453-4057qib7	6526	18	,	,	,
cord-005453-4057qib7	6526	19	Immunoglobulin	Immunoglobulin	NNP
cord-005453-4057qib7	6526	20	was	be	VBD
cord-005453-4057qib7	6526	21	adminstrated	adminstrate	VBN
cord-005453-4057qib7	6526	22	to	to	TO
cord-005453-4057qib7	6526	23	reduce	reduce	VB
cord-005453-4057qib7	6526	24	the	the	DT
cord-005453-4057qib7	6526	25	edema	edema	NN
cord-005453-4057qib7	6526	26	.	.	.
cord-005453-4057qib7	6527	1	Results	result	NNS
cord-005453-4057qib7	6527	2	:	:	:
cord-005453-4057qib7	6528	1	Taking	take	VBG
cord-005453-4057qib7	6528	2	together	together	RB
cord-005453-4057qib7	6528	3	comprehensively	comprehensively	RB
cord-005453-4057qib7	6528	4	,	,	,
cord-005453-4057qib7	6528	5	the	the	DT
cord-005453-4057qib7	6528	6	effusion	effusion	NN
cord-005453-4057qib7	6528	7	in	in	IN
cord-005453-4057qib7	6528	8	the	the	DT
cord-005453-4057qib7	6528	9	pleural	pleural	JJ
cord-005453-4057qib7	6528	10	and	and	CC
cord-005453-4057qib7	6528	11	cardiac	cardiac	NN
cord-005453-4057qib7	6528	12	was	be	VBD
cord-005453-4057qib7	6528	13	absorbed	absorb	VBN
cord-005453-4057qib7	6528	14	well	well	RB
cord-005453-4057qib7	6528	15	.	.	.
cord-005453-4057qib7	6529	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6529	2	:	:	:
cord-005453-4057qib7	6530	1	Occurance	occurance	IN
cord-005453-4057qib7	6530	2	of	of	IN
cord-005453-4057qib7	6530	3	capillary	capillary	JJ
cord-005453-4057qib7	6530	4	leak	leak	NN
cord-005453-4057qib7	6530	5	syndrome	syndrome	NN
cord-005453-4057qib7	6530	6	is	be	VBZ
cord-005453-4057qib7	6530	7	rare	rare	JJ
cord-005453-4057qib7	6530	8	,	,	,
cord-005453-4057qib7	6530	9	there	there	EX
cord-005453-4057qib7	6530	10	is	be	VBZ
cord-005453-4057qib7	6530	11	limited	limited	JJ
cord-005453-4057qib7	6530	12	data	datum	NNS
cord-005453-4057qib7	6530	13	about	about	IN
cord-005453-4057qib7	6530	14	capillary	capillary	JJ
cord-005453-4057qib7	6530	15	leak	leak	NN
cord-005453-4057qib7	6530	16	syndrome	syndrome	NN
cord-005453-4057qib7	6530	17	.	.	.
cord-005453-4057qib7	6531	1	Comprehensively	comprehensively	RB
cord-005453-4057qib7	6531	2	,	,	,
cord-005453-4057qib7	6531	3	the	the	DT
cord-005453-4057qib7	6531	4	mechanism	mechanism	NN
cord-005453-4057qib7	6531	5	of	of	IN
cord-005453-4057qib7	6531	6	CLS	CLS	NNP
cord-005453-4057qib7	6531	7	has	have	VBZ
cord-005453-4057qib7	6531	8	not	not	RB
cord-005453-4057qib7	6531	9	been	be	VBN
cord-005453-4057qib7	6531	10	totally	totally	RB
cord-005453-4057qib7	6531	11	identified	identify	VBN
cord-005453-4057qib7	6531	12	.	.	.
cord-005453-4057qib7	6532	1	And	and	CC
cord-005453-4057qib7	6532	2	there	there	EX
cord-005453-4057qib7	6532	3	is	be	VBZ
cord-005453-4057qib7	6532	4	no	no	DT
cord-005453-4057qib7	6532	5	standard	standard	JJ
cord-005453-4057qib7	6532	6	treatment	treatment	NN
cord-005453-4057qib7	6532	7	to	to	TO
cord-005453-4057qib7	6532	8	treat	treat	VB
cord-005453-4057qib7	6532	9	the	the	DT
cord-005453-4057qib7	6532	10	complication	complication	NN
cord-005453-4057qib7	6532	11	.	.	.
cord-005453-4057qib7	6533	1	At	at	IN
cord-005453-4057qib7	6533	2	present	present	NN
cord-005453-4057qib7	6533	3	,	,	,
cord-005453-4057qib7	6533	4	the	the	DT
cord-005453-4057qib7	6533	5	CLS	CLS	NNP
cord-005453-4057qib7	6533	6	of	of	IN
cord-005453-4057qib7	6533	7	this	this	DT
cord-005453-4057qib7	6533	8	patient	patient	NN
cord-005453-4057qib7	6533	9	was	be	VBD
cord-005453-4057qib7	6533	10	absorbed	absorb	VBN
cord-005453-4057qib7	6533	11	well	well	RB
cord-005453-4057qib7	6533	12	by	by	IN
cord-005453-4057qib7	6533	13	administrating	administrate	VBG
cord-005453-4057qib7	6533	14	Sirolimus	Sirolimus	NNP
cord-005453-4057qib7	6533	15	,	,	,
cord-005453-4057qib7	6533	16	closely	closely	RB
cord-005453-4057qib7	6533	17	followup	followup	NN
cord-005453-4057qib7	6533	18	is	be	VBZ
cord-005453-4057qib7	6533	19	needed	need	VBN
cord-005453-4057qib7	6533	20	.	.	.
cord-005453-4057qib7	6534	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6534	2	:	:	:
cord-005453-4057qib7	6534	3	Nothing	nothing	NN
cord-005453-4057qib7	6534	4	to	to	TO
cord-005453-4057qib7	6534	5	declare	declare	VB
cord-005453-4057qib7	6534	6	Graft	graft	NN
cord-005453-4057qib7	6534	7	-	-	HYPH
cord-005453-4057qib7	6534	8	versus	versus	IN
cord-005453-4057qib7	6534	9	-	-	HYPH
cord-005453-4057qib7	6534	10	host	host	NN
cord-005453-4057qib7	6534	11	diseasepreclinical	diseasepreclinical	JJ
cord-005453-4057qib7	6534	12	and	and	CC
cord-005453-4057qib7	6534	13	animal	animal	NN
cord-005453-4057qib7	6534	14	models	model	NNS
cord-005453-4057qib7	6535	1	P295	P295	``
cord-005453-4057qib7	6535	2	Short	short	JJ
cord-005453-4057qib7	6535	3	-	-	HYPH
cord-005453-4057qib7	6535	4	term	term	NN
cord-005453-4057qib7	6535	5	KRP203	krp203	NN
cord-005453-4057qib7	6535	6	and	and	CC
cord-005453-4057qib7	6535	7	posttransplant	posttransplant	JJ
cord-005453-4057qib7	6535	8	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	6535	9	for	for	IN
cord-005453-4057qib7	6535	10	graft	graft	NN
cord-005453-4057qib7	6535	11	-	-	HYPH
cord-005453-4057qib7	6535	12	versus	versus	IN
cord-005453-4057qib7	6535	13	-	-	HYPH
cord-005453-4057qib7	6535	14	host	host	NN
cord-005453-4057qib7	6535	15	disease	disease	NN
cord-005453-4057qib7	6535	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6535	17	Emi	Emi	NNP
cord-005453-4057qib7	6535	18	Yokoyama	Yokoyama	NNP
cord-005453-4057qib7	6535	19	1	1	CD
cord-005453-4057qib7	6535	20	,	,	,
cord-005453-4057qib7	6535	21	Daigo	Daigo	NNP
cord-005453-4057qib7	6535	22	Hashimoto	Hashimoto	NNP
cord-005453-4057qib7	6535	23	1	1	CD
cord-005453-4057qib7	6535	24	,	,	,
cord-005453-4057qib7	6535	25	Takahide	Takahide	NNP
cord-005453-4057qib7	6535	26	Ara	Ara	NNP
cord-005453-4057qib7	6535	27	1	1	CD
cord-005453-4057qib7	6535	28	,	,	,
cord-005453-4057qib7	6535	29	Eko	Eko	NNP
cord-005453-4057qib7	6535	30	Hayase	Hayase	NNP
cord-005453-4057qib7	6535	31	1	1	CD
cord-005453-4057qib7	6535	32	,	,	,
cord-005453-4057qib7	6536	1	Takanori	Takanori	NNP
cord-005453-4057qib7	6536	2	Teshima	Teshima	NNP
cord-005453-4057qib7	6536	3	1	1	CD
cord-005453-4057qib7	6536	4	1	1	CD
cord-005453-4057qib7	6536	5	Hokkaido	Hokkaido	NNP
cord-005453-4057qib7	6536	6	University	University	NNP
cord-005453-4057qib7	6536	7	Faculty	Faculty	NNP
cord-005453-4057qib7	6536	8	of	of	IN
cord-005453-4057qib7	6536	9	Medicine	Medicine	NNP
cord-005453-4057qib7	6536	10	,	,	,
cord-005453-4057qib7	6536	11	Hematology	Hematology	NNP
cord-005453-4057qib7	6536	12	,	,	,
cord-005453-4057qib7	6536	13	Sapporo	Sapporo	NNP
cord-005453-4057qib7	6536	14	,	,	,
cord-005453-4057qib7	6536	15	Japan	Japan	NNP
cord-005453-4057qib7	6536	16	Background	Background	NNP
cord-005453-4057qib7	6536	17	:	:	:
cord-005453-4057qib7	6536	18	Post	post	JJ
cord-005453-4057qib7	6536	19	-	-	JJ
cord-005453-4057qib7	6536	20	transplant	transplant	JJ
cord-005453-4057qib7	6536	21	high	high	JJ
cord-005453-4057qib7	6536	22	-	-	HYPH
cord-005453-4057qib7	6536	23	dose	dose	NN
cord-005453-4057qib7	6536	24	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	6536	25	(	(	-LRB-
cord-005453-4057qib7	6536	26	PTCY	PTCY	NNP
cord-005453-4057qib7	6536	27	)	)	-RRB-
cord-005453-4057qib7	6536	28	in	in	IN
cord-005453-4057qib7	6536	29	combination	combination	NN
cord-005453-4057qib7	6536	30	with	with	IN
cord-005453-4057qib7	6536	31	other	other	JJ
cord-005453-4057qib7	6536	32	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	6536	33	such	such	JJ
cord-005453-4057qib7	6536	34	as	as	IN
cord-005453-4057qib7	6536	35	calcineurin	calcineurin	NN
cord-005453-4057qib7	6536	36	-	-	HYPH
cord-005453-4057qib7	6536	37	inhibitors	inhibitor	NNS
cord-005453-4057qib7	6536	38	(	(	-LRB-
cord-005453-4057qib7	6536	39	CIs	CIs	NNP
cord-005453-4057qib7	6536	40	)	)	-RRB-
cord-005453-4057qib7	6536	41	has	have	VBZ
cord-005453-4057qib7	6536	42	been	be	VBN
cord-005453-4057qib7	6536	43	increasingly	increasingly	RB
cord-005453-4057qib7	6536	44	used	use	VBN
cord-005453-4057qib7	6536	45	as	as	IN
cord-005453-4057qib7	6536	46	GVHD	GVHD	NNP
cord-005453-4057qib7	6536	47	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6536	48	after	after	IN
cord-005453-4057qib7	6536	49	HLA	HLA	NNP
cord-005453-4057qib7	6536	50	-	-	HYPH
cord-005453-4057qib7	6536	51	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6536	52	or	or	CC
cord-005453-4057qib7	6536	53	matched	match	VBN
cord-005453-4057qib7	6536	54	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6536	55	stem	stem	NN
cord-005453-4057qib7	6536	56	cell	cell	NN
cord-005453-4057qib7	6536	57	transplantation	transplantation	NN
cord-005453-4057qib7	6536	58	(	(	-LRB-
cord-005453-4057qib7	6536	59	HSCT	HSCT	NNP
cord-005453-4057qib7	6536	60	)	)	-RRB-
cord-005453-4057qib7	6536	61	.	.	.
cord-005453-4057qib7	6537	1	However	however	RB
cord-005453-4057qib7	6537	2	,	,	,
cord-005453-4057qib7	6537	3	CIs	CIs	NNP
cord-005453-4057qib7	6537	4	could	could	MD
cord-005453-4057qib7	6537	5	hamper	hamper	VB
cord-005453-4057qib7	6537	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	6537	7	of	of	IN
cord-005453-4057qib7	6537	8	regulatory	regulatory	JJ
cord-005453-4057qib7	6537	9	T	t	NN
cord-005453-4057qib7	6537	10	cells	cell	NNS
cord-005453-4057qib7	6537	11	(	(	-LRB-
cord-005453-4057qib7	6537	12	Tregs	Tregs	NNP
cord-005453-4057qib7	6537	13	)	)	-RRB-
cord-005453-4057qib7	6537	14	and	and	CC
cord-005453-4057qib7	6537	15	tolerance	tolerance	NN
cord-005453-4057qib7	6537	16	induction	induction	NN
cord-005453-4057qib7	6537	17	after	after	IN
cord-005453-4057qib7	6537	18	HSCT	HSCT	NNP
cord-005453-4057qib7	6537	19	,	,	,
cord-005453-4057qib7	6537	20	facilitating	facilitate	VBG
cord-005453-4057qib7	6537	21	us	-PRON-	PRP
cord-005453-4057qib7	6537	22	to	to	TO
cord-005453-4057qib7	6537	23	develop	develop	VB
cord-005453-4057qib7	6537	24	novel	novel	JJ
cord-005453-4057qib7	6537	25	CI	ci	NN
cord-005453-4057qib7	6537	26	-	-	HYPH
cord-005453-4057qib7	6537	27	free	free	JJ
cord-005453-4057qib7	6537	28	/	/	SYM
cord-005453-4057qib7	6537	29	PTCY	ptcy	NN
cord-005453-4057qib7	6537	30	-	-	HYPH
cord-005453-4057qib7	6537	31	based	base	VBN
cord-005453-4057qib7	6537	32	GVHD	GVHD	NNP
cord-005453-4057qib7	6537	33	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6537	34	.	.	.
cord-005453-4057qib7	6538	1	In	in	IN
cord-005453-4057qib7	6538	2	the	the	DT
cord-005453-4057qib7	6538	3	current	current	JJ
cord-005453-4057qib7	6538	4	study	study	NN
cord-005453-4057qib7	6538	5	,	,	,
cord-005453-4057qib7	6538	6	we	-PRON-	PRP
cord-005453-4057qib7	6538	7	developed	develop	VBD
cord-005453-4057qib7	6538	8	a	a	DT
cord-005453-4057qib7	6538	9	novel	novel	JJ
cord-005453-4057qib7	6538	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6538	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6538	12	in	in	IN
cord-005453-4057qib7	6538	13	which	which	WDT
cord-005453-4057qib7	6538	14	PTCY	PTCY	NNP
cord-005453-4057qib7	6538	15	was	be	VBD
cord-005453-4057qib7	6538	16	combined	combine	VBN
cord-005453-4057qib7	6538	17	with	with	IN
cord-005453-4057qib7	6538	18	short	short	JJ
cord-005453-4057qib7	6538	19	-	-	HYPH
cord-005453-4057qib7	6538	20	term	term	NN
cord-005453-4057qib7	6538	21	administration	administration	NN
cord-005453-4057qib7	6538	22	of	of	IN
cord-005453-4057qib7	6538	23	KRP203	KRP203	NNP
cord-005453-4057qib7	6538	24	,	,	,
cord-005453-4057qib7	6538	25	a	a	DT
cord-005453-4057qib7	6538	26	selective	selective	JJ
cord-005453-4057qib7	6538	27	agonist	agonist	NN
cord-005453-4057qib7	6538	28	of	of	IN
cord-005453-4057qib7	6538	29	sphingosine-1-phosphate	sphingosine-1-phosphate	NNP
cord-005453-4057qib7	6538	30	receptor	receptor	NN
cord-005453-4057qib7	6538	31	type	type	NN
cord-005453-4057qib7	6538	32	1	1	CD
cord-005453-4057qib7	6538	33	(	(	-LRB-
cord-005453-4057qib7	6538	34	S1PR1	S1PR1	NNP
cord-005453-4057qib7	6538	35	)	)	-RRB-
cord-005453-4057qib7	6538	36	,	,	,
cord-005453-4057qib7	6538	37	using	use	VBG
cord-005453-4057qib7	6538	38	murine	murine	JJ
cord-005453-4057qib7	6538	39	models	model	NNS
cord-005453-4057qib7	6538	40	of	of	IN
cord-005453-4057qib7	6538	41	MHC	MHC	NNP
cord-005453-4057qib7	6538	42	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6538	43	bone	bone	NN
cord-005453-4057qib7	6538	44	marrow	marrow	NN
cord-005453-4057qib7	6538	45	transplantation	transplantation	NN
cord-005453-4057qib7	6538	46	(	(	-LRB-
cord-005453-4057qib7	6538	47	BMT	BMT	NNP
cord-005453-4057qib7	6538	48	)	)	-RRB-
cord-005453-4057qib7	6538	49	.	.	.
cord-005453-4057qib7	6539	1	Methods	method	NNS
cord-005453-4057qib7	6539	2	:	:	:
cord-005453-4057qib7	6539	3	B6D2F1	b6d2f1	NN
cord-005453-4057qib7	6539	4	(	(	-LRB-
cord-005453-4057qib7	6539	5	H-2	H-2	NNP
cord-005453-4057qib7	6539	6	b	b	NN
cord-005453-4057qib7	6539	7	/	/	SYM
cord-005453-4057qib7	6539	8	d	d	NN
cord-005453-4057qib7	6539	9	)	)	-RRB-
cord-005453-4057qib7	6540	1	recipients	recipient	NNS
cord-005453-4057qib7	6540	2	were	be	VBD
cord-005453-4057qib7	6540	3	lethally	lethally	RB
cord-005453-4057qib7	6540	4	irradiated	irradiate	VBN
cord-005453-4057qib7	6540	5	and	and	CC
cord-005453-4057qib7	6540	6	transplanted	transplant	VBN
cord-005453-4057qib7	6540	7	with	with	IN
cord-005453-4057qib7	6540	8	bone	bone	NN
cord-005453-4057qib7	6540	9	marrow	marrow	NN
cord-005453-4057qib7	6540	10	cells	cell	NNS
cord-005453-4057qib7	6540	11	and	and	CC
cord-005453-4057qib7	6540	12	splenocytes	splenocyte	NNS
cord-005453-4057qib7	6540	13	from	from	IN
cord-005453-4057qib7	6540	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	6540	15	B6	b6	NN
cord-005453-4057qib7	6540	16	(	(	-LRB-
cord-005453-4057qib7	6540	17	H-2	H-2	NNP
cord-005453-4057qib7	6540	18	b	b	NN
cord-005453-4057qib7	6540	19	)	)	-RRB-
cord-005453-4057qib7	6540	20	donors	donor	NNS
cord-005453-4057qib7	6540	21	.	.	.
cord-005453-4057qib7	6541	1	CY	CY	NNP
cord-005453-4057qib7	6541	2	at	at	IN
cord-005453-4057qib7	6541	3	a	a	DT
cord-005453-4057qib7	6541	4	dose	dose	NN
cord-005453-4057qib7	6541	5	of	of	IN
cord-005453-4057qib7	6541	6	50	50	CD
cord-005453-4057qib7	6541	7	mg	mg	NNP
cord-005453-4057qib7	6541	8	/	/	SYM
cord-005453-4057qib7	6541	9	kg	kg	NNP
cord-005453-4057qib7	6541	10	was	be	VBD
cord-005453-4057qib7	6541	11	intraperitoneally	intraperitoneally	RB
cord-005453-4057qib7	6541	12	injected	inject	VBN
cord-005453-4057qib7	6541	13	into	into	IN
cord-005453-4057qib7	6541	14	the	the	DT
cord-005453-4057qib7	6541	15	recipients	recipient	NNS
cord-005453-4057qib7	6541	16	on	on	IN
cord-005453-4057qib7	6541	17	day	day	NN
cord-005453-4057qib7	6541	18	+3	+3	NN
cord-005453-4057qib7	6541	19	,	,	,
cord-005453-4057qib7	6541	20	and	and	CC
cord-005453-4057qib7	6541	21	KRP	KRP	NNP
cord-005453-4057qib7	6541	22	at	at	IN
cord-005453-4057qib7	6541	23	a	a	DT
cord-005453-4057qib7	6541	24	dose	dose	NN
cord-005453-4057qib7	6541	25	of	of	IN
cord-005453-4057qib7	6541	26	1.0	1.0	CD
cord-005453-4057qib7	6541	27	mg	mg	NNP
cord-005453-4057qib7	6541	28	/	/	SYM
cord-005453-4057qib7	6541	29	kg	kg	NNP
cord-005453-4057qib7	6541	30	was	be	VBD
cord-005453-4057qib7	6541	31	orally	orally	RB
cord-005453-4057qib7	6541	32	administrated	administrate	VBN
cord-005453-4057qib7	6541	33	daily	daily	RB
cord-005453-4057qib7	6541	34	from	from	IN
cord-005453-4057qib7	6541	35	day	day	NN
cord-005453-4057qib7	6541	36	0	0	CD
cord-005453-4057qib7	6541	37	to	to	IN
cord-005453-4057qib7	6541	38	day	day	NN
cord-005453-4057qib7	6541	39	+4	+4	NN
cord-005453-4057qib7	6541	40	after	after	IN
cord-005453-4057qib7	6541	41	BMT	BMT	NNP
cord-005453-4057qib7	6541	42	.	.	.
cord-005453-4057qib7	6542	1	Donor	donor	NN
cord-005453-4057qib7	6542	2	T	t	NN
cord-005453-4057qib7	6542	3	cells	cell	NNS
cord-005453-4057qib7	6542	4	in	in	IN
cord-005453-4057qib7	6542	5	the	the	DT
cord-005453-4057qib7	6542	6	target	target	NN
cord-005453-4057qib7	6542	7	organs	organ	NNS
cord-005453-4057qib7	6542	8	and	and	CC
cord-005453-4057qib7	6542	9	secondary	secondary	JJ
cord-005453-4057qib7	6542	10	lymphoid	lymphoid	JJ
cord-005453-4057qib7	6542	11	organs	organ	NNS
cord-005453-4057qib7	6542	12	were	be	VBD
cord-005453-4057qib7	6542	13	evaluated	evaluate	VBN
cord-005453-4057qib7	6542	14	by	by	IN
cord-005453-4057qib7	6542	15	flow	flow	NN
cord-005453-4057qib7	6542	16	cytometric	cytometric	NNP
cord-005453-4057qib7	6542	17	analysis	analysis	NN
cord-005453-4057qib7	6542	18	.	.	.
cord-005453-4057qib7	6543	1	Plasma	plasma	NN
cord-005453-4057qib7	6543	2	levels	level	NNS
cord-005453-4057qib7	6543	3	of	of	IN
cord-005453-4057qib7	6543	4	TNF	TNF	NNP
cord-005453-4057qib7	6543	5	-	-	HYPH
cord-005453-4057qib7	6543	6	α	α	NNP
cord-005453-4057qib7	6543	7	were	be	VBD
cord-005453-4057qib7	6543	8	determined	determine	VBN
cord-005453-4057qib7	6543	9	using	use	VBG
cord-005453-4057qib7	6543	10	cytometric	cytometric	NN
cord-005453-4057qib7	6543	11	beads	bead	NNS
cord-005453-4057qib7	6543	12	array	array	NN
cord-005453-4057qib7	6543	13	.	.	.
cord-005453-4057qib7	6544	1	To	to	TO
cord-005453-4057qib7	6544	2	evaluate	evaluate	VB
cord-005453-4057qib7	6544	3	graft	graft	NN
cord-005453-4057qib7	6544	4	-	-	HYPH
cord-005453-4057qib7	6544	5	versus	versus	IN
cord-005453-4057qib7	6544	6	-	-	HYPH
cord-005453-4057qib7	6544	7	leukemia	leukemia	NN
cord-005453-4057qib7	6544	8	(	(	-LRB-
cord-005453-4057qib7	6544	9	GVL	gvl	NN
cord-005453-4057qib7	6544	10	)	)	-RRB-
cord-005453-4057qib7	6544	11	effects	effect	NNS
cord-005453-4057qib7	6544	12	,	,	,
cord-005453-4057qib7	6544	13	recipient	recipient	NN
cord-005453-4057qib7	6544	14	mice	mouse	NNS
cord-005453-4057qib7	6544	15	were	be	VBD
cord-005453-4057qib7	6544	16	intravenously	intravenously	RB
cord-005453-4057qib7	6544	17	injected	inject	VBN
cord-005453-4057qib7	6544	18	with	with	IN
cord-005453-4057qib7	6544	19	luciferase	luciferase	NN
cord-005453-4057qib7	6544	20	-	-	HYPH
cord-005453-4057qib7	6544	21	transduced	transduce	VBN
cord-005453-4057qib7	6544	22	P815	P815	NNP
cord-005453-4057qib7	6544	23	cells	cell	NNS
cord-005453-4057qib7	6544	24	(	(	-LRB-
cord-005453-4057qib7	6544	25	P815-luc	P815-luc	NNP
cord-005453-4057qib7	6544	26	)	)	-RRB-
cord-005453-4057qib7	6544	27	on	on	IN
cord-005453-4057qib7	6544	28	day	day	NN
cord-005453-4057qib7	6544	29	0	0	CD
cord-005453-4057qib7	6544	30	,	,	,
cord-005453-4057qib7	6544	31	and	and	CC
cord-005453-4057qib7	6544	32	in	in	IN
cord-005453-4057qib7	6544	33	vivo	vivo	NNP
cord-005453-4057qib7	6544	34	bioluminescence	bioluminescence	NN
cord-005453-4057qib7	6544	35	imagingwas	imagingwas	NNP
cord-005453-4057qib7	6544	36	conducted	conduct	VBN
cord-005453-4057qib7	6544	37	weekly	weekly	RB
cord-005453-4057qib7	6544	38	after	after	IN
cord-005453-4057qib7	6544	39	BMT	BMT	NNP
cord-005453-4057qib7	6544	40	.	.	.
cord-005453-4057qib7	6545	1	Results	result	NNS
cord-005453-4057qib7	6545	2	:	:	:
cord-005453-4057qib7	6546	1	Severe	severe	JJ
cord-005453-4057qib7	6546	2	GVHD	GVHD	NNP
cord-005453-4057qib7	6546	3	was	be	VBD
cord-005453-4057qib7	6546	4	developed	develop	VBN
cord-005453-4057qib7	6546	5	in	in	IN
cord-005453-4057qib7	6546	6	allogeneic	allogeneic	NN
cord-005453-4057qib7	6546	7	recipients	recipient	NNS
cord-005453-4057qib7	6546	8	and	and	CC
cord-005453-4057qib7	6546	9	all	all	DT
cord-005453-4057qib7	6546	10	mice	mouse	NNS
cord-005453-4057qib7	6546	11	died	die	VBD
cord-005453-4057qib7	6546	12	by	by	IN
cord-005453-4057qib7	6546	13	day	day	NN
cord-005453-4057qib7	6546	14	50	50	CD
cord-005453-4057qib7	6546	15	after	after	IN
cord-005453-4057qib7	6546	16	BMT.PTCY	bmt.ptcy	NN
cord-005453-4057qib7	6546	17	alone	alone	RB
cord-005453-4057qib7	6546	18	at	at	IN
cord-005453-4057qib7	6546	19	a	a	DT
cord-005453-4057qib7	6546	20	dose	dose	NN
cord-005453-4057qib7	6546	21	of	of	IN
cord-005453-4057qib7	6546	22	50	50	CD
cord-005453-4057qib7	6546	23	mg	mg	NNP
cord-005453-4057qib7	6546	24	/	/	SYM
cord-005453-4057qib7	6546	25	kg	kg	NNP
cord-005453-4057qib7	6546	26	significantly	significantly	RB
cord-005453-4057qib7	6546	27	ameliorated	ameliorate	VBD
cord-005453-4057qib7	6546	28	GVHD	GVHD	NNP
cord-005453-4057qib7	6546	29	and	and	CC
cord-005453-4057qib7	6546	30	30	30	CD
cord-005453-4057qib7	6546	31	%	%	NN
cord-005453-4057qib7	6546	32	of	of	IN
cord-005453-4057qib7	6546	33	PTCY	PTCY	NNP
cord-005453-4057qib7	6546	34	-	-	HYPH
cord-005453-4057qib7	6546	35	treated	treat	VBN
cord-005453-4057qib7	6546	36	allogeneic	allogeneic	IN
cord-005453-4057qib7	6546	37	recipients	recipient	NNS
cord-005453-4057qib7	6546	38	survived	survive	VBD
cord-005453-4057qib7	6546	39	.	.	.
cord-005453-4057qib7	6547	1	Oral	oral	JJ
cord-005453-4057qib7	6547	2	administration	administration	NN
cord-005453-4057qib7	6547	3	of	of	IN
cord-005453-4057qib7	6547	4	KRP203	KRP203	NNP
cord-005453-4057qib7	6547	5	alone	alone	RB
cord-005453-4057qib7	6547	6	enhanced	enhance	VBN
cord-005453-4057qib7	6547	7	contraction	contraction	NN
cord-005453-4057qib7	6547	8	of	of	IN
cord-005453-4057qib7	6547	9	donor	donor	NN
cord-005453-4057qib7	6547	10	T	t	NN
cord-005453-4057qib7	6547	11	cells	cell	NNS
cord-005453-4057qib7	6547	12	in	in	IN
cord-005453-4057qib7	6547	13	the	the	DT
cord-005453-4057qib7	6547	14	lymph	lymph	NN
cord-005453-4057qib7	6547	15	nodes	node	NNS
cord-005453-4057qib7	6547	16	and	and	CC
cord-005453-4057qib7	6547	17	also	also	RB
cord-005453-4057qib7	6547	18	ameliorated	ameliorate	VBD
cord-005453-4057qib7	6547	19	GVHD	GVHD	NNP
cord-005453-4057qib7	6547	20	as	as	IN
cord-005453-4057qib7	6547	21	has	have	VBZ
cord-005453-4057qib7	6547	22	been	be	VBN
cord-005453-4057qib7	6547	23	previously	previously	RB
cord-005453-4057qib7	6547	24	shown	show	VBN
cord-005453-4057qib7	6547	25	with	with	IN
cord-005453-4057qib7	6547	26	multi	multi	JJ
cord-005453-4057qib7	6547	27	-	-	JJ
cord-005453-4057qib7	6547	28	S1PR	s1pr	JJ
cord-005453-4057qib7	6547	29	agonist	agonist	NN
cord-005453-4057qib7	6547	30	,	,	,
cord-005453-4057qib7	6547	31	fingolimod	fingolimod	NNP
cord-005453-4057qib7	6547	32	.	.	.
cord-005453-4057qib7	6548	1	Next	next	RB
cord-005453-4057qib7	6548	2	,	,	,
cord-005453-4057qib7	6548	3	we	-PRON-	PRP
cord-005453-4057qib7	6548	4	tested	test	VBD
cord-005453-4057qib7	6548	5	if	if	IN
cord-005453-4057qib7	6548	6	shortterm	shortterm	JJ
cord-005453-4057qib7	6548	7	KRP203	krp203	NN
cord-005453-4057qib7	6548	8	on	on	IN
cord-005453-4057qib7	6548	9	days	day	NNS
cord-005453-4057qib7	6548	10	0	0	CD
cord-005453-4057qib7	6548	11	to	to	IN
cord-005453-4057qib7	6548	12	+4	+4	ADD
cord-005453-4057qib7	6548	13	added	add	VBN
cord-005453-4057qib7	6548	14	to	to	IN
cord-005453-4057qib7	6548	15	PTCY	PTCY	NNP
cord-005453-4057qib7	6548	16	enhances	enhance	VBZ
cord-005453-4057qib7	6548	17	anti	anti	JJ
cord-005453-4057qib7	6548	18	-	-	JJ
cord-005453-4057qib7	6548	19	GVHD	gvhd	JJ
cord-005453-4057qib7	6548	20	effects	effect	NNS
cord-005453-4057qib7	6548	21	of	of	IN
cord-005453-4057qib7	6548	22	PTCY	PTCY	NNP
cord-005453-4057qib7	6548	23	.	.	.
cord-005453-4057qib7	6549	1	We	-PRON-	PRP
cord-005453-4057qib7	6549	2	found	find	VBD
cord-005453-4057qib7	6549	3	that	that	IN
cord-005453-4057qib7	6549	4	survivals	survival	NNS
cord-005453-4057qib7	6549	5	of	of	IN
cord-005453-4057qib7	6549	6	PTCY+KRP203	ptcy+krp203	JJ
cord-005453-4057qib7	6549	7	group	group	NN
cord-005453-4057qib7	6549	8	were	be	VBD
cord-005453-4057qib7	6549	9	significantly	significantly	RB
cord-005453-4057qib7	6549	10	prolonged	prolong	VBN
cord-005453-4057qib7	6549	11	compared	compare	VBN
cord-005453-4057qib7	6549	12	to	to	IN
cord-005453-4057qib7	6549	13	those	those	DT
cord-005453-4057qib7	6549	14	of	of	IN
cord-005453-4057qib7	6549	15	PTCY	PTCY	NNP
cord-005453-4057qib7	6549	16	-	-	HYPH
cord-005453-4057qib7	6549	17	alone	alone	RB
cord-005453-4057qib7	6549	18	group	group	NN
cord-005453-4057qib7	6549	19	(	(	-LRB-
cord-005453-4057qib7	6549	20	Figure	figure	NN
cord-005453-4057qib7	6549	21	A	A	NNP
cord-005453-4057qib7	6549	22	)	)	-RRB-
cord-005453-4057qib7	6549	23	.	.	.
cord-005453-4057qib7	6550	1	Plasma	plasma	NN
cord-005453-4057qib7	6550	2	levels	level	NNS
cord-005453-4057qib7	6550	3	of	of	IN
cord-005453-4057qib7	6550	4	TNF	TNF	NNP
cord-005453-4057qib7	6550	5	-	-	HYPH
cord-005453-4057qib7	6550	6	a	a	NNP
cord-005453-4057qib7	6550	7	,	,	,
cord-005453-4057qib7	6550	8	clinical	clinical	JJ
cord-005453-4057qib7	6550	9	GVHD	gvhd	NN
cord-005453-4057qib7	6550	10	scores	score	NNS
cord-005453-4057qib7	6550	11	(	(	-LRB-
cord-005453-4057qib7	6550	12	Figure	figure	NN
cord-005453-4057qib7	6550	13	B	B	NNP
cord-005453-4057qib7	6550	14	)	)	-RRB-
cord-005453-4057qib7	6550	15	,	,	,
cord-005453-4057qib7	6550	16	and	and	CC
cord-005453-4057qib7	6550	17	donor	donor	NN
cord-005453-4057qib7	6550	18	T	t	NN
cord-005453-4057qib7	6550	19	-	-	HYPH
cord-005453-4057qib7	6550	20	cell	cell	NN
cord-005453-4057qib7	6550	21	infiltration	infiltration	NN
cord-005453-4057qib7	6550	22	into	into	IN
cord-005453-4057qib7	6550	23	the	the	DT
cord-005453-4057qib7	6550	24	target	target	NN
cord-005453-4057qib7	6550	25	organs	organ	NNS
cord-005453-4057qib7	6550	26	such	such	JJ
cord-005453-4057qib7	6550	27	as	as	IN
cord-005453-4057qib7	6550	28	the	the	DT
cord-005453-4057qib7	6550	29	gut	gut	NN
cord-005453-4057qib7	6550	30	and	and	CC
cord-005453-4057qib7	6550	31	skin	skin	NN
cord-005453-4057qib7	6550	32	were	be	VBD
cord-005453-4057qib7	6550	33	also	also	RB
cord-005453-4057qib7	6550	34	significantly	significantly	RB
cord-005453-4057qib7	6550	35	reduced	reduce	VBN
cord-005453-4057qib7	6550	36	in	in	IN
cord-005453-4057qib7	6550	37	PTCY	PTCY	NNP
cord-005453-4057qib7	6550	38	+	+	CC
cord-005453-4057qib7	6550	39	KRP203	krp203	NN
cord-005453-4057qib7	6550	40	group	group	NN
cord-005453-4057qib7	6550	41	compared	compare	VBN
cord-005453-4057qib7	6550	42	to	to	IN
cord-005453-4057qib7	6550	43	PTCY	PTCY	NNP
cord-005453-4057qib7	6550	44	-	-	HYPH
cord-005453-4057qib7	6550	45	alone	alone	RB
cord-005453-4057qib7	6550	46	group	group	NN
cord-005453-4057qib7	6550	47	(	(	-LRB-
cord-005453-4057qib7	6550	48	Figure	figure	NN
cord-005453-4057qib7	6550	49	C	c	NN
cord-005453-4057qib7	6550	50	and	and	CC
cord-005453-4057qib7	6550	51	D	D	NNP
cord-005453-4057qib7	6550	52	)	)	-RRB-
cord-005453-4057qib7	6550	53	.	.	.
cord-005453-4057qib7	6551	1	Unlike	unlike	IN
cord-005453-4057qib7	6551	2	CIs	CIs	NNP
cord-005453-4057qib7	6551	3	,	,	,
cord-005453-4057qib7	6551	4	addition	addition	NN
cord-005453-4057qib7	6551	5	of	of	IN
cord-005453-4057qib7	6551	6	KRP203	krp203	NN
cord-005453-4057qib7	6551	7	to	to	IN
cord-005453-4057qib7	6551	8	PTCY	PTCY	NNP
cord-005453-4057qib7	6551	9	promoted	promote	VBD
cord-005453-4057qib7	6551	10	Treg	Treg	NNP
cord-005453-4057qib7	6551	11	reconstitution	reconstitution	NN
cord-005453-4057qib7	6551	12	after	after	IN
cord-005453-4057qib7	6551	13	BMT	BMT	NNP
cord-005453-4057qib7	6551	14	.	.	.
cord-005453-4057qib7	6552	1	Finally	finally	RB
cord-005453-4057qib7	6552	2	,	,	,
cord-005453-4057qib7	6552	3	bioluminescence	bioluminescence	NN
cord-005453-4057qib7	6552	4	imaging	imaging	NN
cord-005453-4057qib7	6552	5	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6552	6	that	that	IN
cord-005453-4057qib7	6552	7	proliferation	proliferation	NN
cord-005453-4057qib7	6552	8	of	of	IN
cord-005453-4057qib7	6552	9	P815-luc	P815-luc	NNP
cord-005453-4057qib7	6552	10	injected	inject	VBD
cord-005453-4057qib7	6552	11	on	on	IN
cord-005453-4057qib7	6552	12	day	day	NN
cord-005453-4057qib7	6552	13	0	0	NFP
cord-005453-4057qib7	6552	14	was	be	VBD
cord-005453-4057qib7	6552	15	significantly	significantly	RB
cord-005453-4057qib7	6552	16	delayed	delay	VBN
cord-005453-4057qib7	6552	17	in	in	IN
cord-005453-4057qib7	6552	18	PTCY	PTCY	NNP
cord-005453-4057qib7	6552	19	+	+	CC
cord-005453-4057qib7	6553	1	KRP203-treated	krp203-treated	JJ
cord-005453-4057qib7	6553	2	allogeneic	allogeneic	IN
cord-005453-4057qib7	6553	3	recipients	recipient	NNS
cord-005453-4057qib7	6553	4	compared	compare	VBN
cord-005453-4057qib7	6553	5	to	to	TO
cord-005453-4057qib7	6553	6	control	control	NN
cord-005453-4057qib7	6553	7	mice	mouse	NNS
cord-005453-4057qib7	6553	8	transplanted	transplant	VBN
cord-005453-4057qib7	6553	9	only	only	RB
cord-005453-4057qib7	6553	10	with	with	IN
cord-005453-4057qib7	6553	11	T	t	NN
cord-005453-4057qib7	6553	12	-	-	HYPH
cord-005453-4057qib7	6553	13	cell	cell	NN
cord-005453-4057qib7	6553	14	depleted	deplete	VBN
cord-005453-4057qib7	6553	15	bone	bone	NN
cord-005453-4057qib7	6553	16	marrow	marrow	NN
cord-005453-4057qib7	6553	17	cells	cell	NNS
cord-005453-4057qib7	6553	18	,	,	,
cord-005453-4057qib7	6553	19	suggesting	suggest	VBG
cord-005453-4057qib7	6553	20	that	that	IN
cord-005453-4057qib7	6553	21	significant	significant	JJ
cord-005453-4057qib7	6553	22	GVL	GVL	NNP
cord-005453-4057qib7	6553	23	effects	effect	NNS
cord-005453-4057qib7	6553	24	persisted	persist	VBD
cord-005453-4057qib7	6553	25	in	in	IN
cord-005453-4057qib7	6553	26	PTCY+KRP203-treated	PTCY+KRP203-treated	NNP
cord-005453-4057qib7	6553	27	recipients	recipient	NNS
cord-005453-4057qib7	6553	28	.	.	.
cord-005453-4057qib7	6554	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6554	2	:	:	:
cord-005453-4057qib7	6555	1	A	a	DT
cord-005453-4057qib7	6555	2	combination	combination	NN
cord-005453-4057qib7	6555	3	of	of	IN
cord-005453-4057qib7	6555	4	short	short	JJ
cord-005453-4057qib7	6555	5	-	-	HYPH
cord-005453-4057qib7	6555	6	term	term	NN
cord-005453-4057qib7	6555	7	KRP203	KRP203	NNP
cord-005453-4057qib7	6555	8	and	and	CC
cord-005453-4057qib7	6555	9	PTCY	PTCY	NNP
cord-005453-4057qib7	6555	10	is	be	VBZ
cord-005453-4057qib7	6555	11	a	a	DT
cord-005453-4057qib7	6555	12	promising	promising	JJ
cord-005453-4057qib7	6555	13	novel	novel	JJ
cord-005453-4057qib7	6555	14	calcineurin	calcineurin	NN
cord-005453-4057qib7	6555	15	-	-	HYPH
cord-005453-4057qib7	6555	16	free	free	JJ
cord-005453-4057qib7	6555	17	GVHD	GVHD	NNP
cord-005453-4057qib7	6555	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6555	19	in	in	IN
cord-005453-4057qib7	6555	20	MHC	MHC	NNP
cord-005453-4057qib7	6555	21	-	-	HYPH
cord-005453-4057qib7	6555	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6555	23	SCT	SCT	NNP
cord-005453-4057qib7	6555	24	.	.	.
cord-005453-4057qib7	6556	1	We	-PRON-	PRP
cord-005453-4057qib7	6556	2	recently	recently	RB
cord-005453-4057qib7	6556	3	showed	show	VBD
cord-005453-4057qib7	6556	4	that	that	IN
cord-005453-4057qib7	6556	5	donor	donor	NN
cord-005453-4057qib7	6556	6	iNKT	inkt	NN
cord-005453-4057qib7	6556	7	cells	cell	NNS
cord-005453-4057qib7	6556	8	can	can	MD
cord-005453-4057qib7	6556	9	be	be	VB
cord-005453-4057qib7	6556	10	expanded	expand	VBN
cord-005453-4057qib7	6556	11	ex	ex	FW
cord-005453-4057qib7	6556	12	vivo	vivo	NN
cord-005453-4057qib7	6556	13	and	and	CC
cord-005453-4057qib7	6556	14	that	that	IN
cord-005453-4057qib7	6556	15	they	-PRON-	PRP
cord-005453-4057qib7	6556	16	are	be	VBP
cord-005453-4057qib7	6556	17	able	able	JJ
cord-005453-4057qib7	6556	18	to	to	TO
cord-005453-4057qib7	6556	19	prevent	prevent	VB
cord-005453-4057qib7	6556	20	activation	activation	NN
cord-005453-4057qib7	6556	21	and	and	CC
cord-005453-4057qib7	6556	22	proliferation	proliferation	NN
cord-005453-4057qib7	6556	23	of	of	IN
cord-005453-4057qib7	6556	24	alloreactive	alloreactive	JJ
cord-005453-4057qib7	6556	25	donor	donor	NN
cord-005453-4057qib7	6556	26	T	t	NN
cord-005453-4057qib7	6556	27	cells	cell	NNS
cord-005453-4057qib7	6556	28	while	while	IN
cord-005453-4057qib7	6556	29	promoting	promote	VBG
cord-005453-4057qib7	6556	30	efficient	efficient	JJ
cord-005453-4057qib7	6556	31	graft	graft	NN
cord-005453-4057qib7	6556	32	-	-	HYPH
cord-005453-4057qib7	6556	33	versus	versus	IN
cord-005453-4057qib7	6556	34	-	-	HYPH
cord-005453-4057qib7	6556	35	leukemia	leukemia	NN
cord-005453-4057qib7	6556	36	effects	effect	NNS
cord-005453-4057qib7	6556	37	(	(	-LRB-
cord-005453-4057qib7	6556	38	Schmid	Schmid	NNP
cord-005453-4057qib7	6556	39	et	et	NNP
cord-005453-4057qib7	6556	40	al	al	NNP
cord-005453-4057qib7	6556	41	.	.	.
cord-005453-4057qib7	6556	42	2018	2018	CD
cord-005453-4057qib7	6556	43	)	)	-RRB-
cord-005453-4057qib7	6556	44	.	.	.
cord-005453-4057qib7	6557	1	However	however	RB
cord-005453-4057qib7	6557	2	,	,	,
cord-005453-4057qib7	6557	3	the	the	DT
cord-005453-4057qib7	6557	4	underlying	underlie	VBG
cord-005453-4057qib7	6557	5	mechanisms	mechanism	NNS
cord-005453-4057qib7	6557	6	how	how	WRB
cord-005453-4057qib7	6557	7	human	human	JJ
cord-005453-4057qib7	6557	8	iNKT	inkt	JJ
cord-005453-4057qib7	6557	9	cells	cell	NNS
cord-005453-4057qib7	6557	10	induce	induce	VBP
cord-005453-4057qib7	6557	11	immune	immune	JJ
cord-005453-4057qib7	6557	12	tolerance	tolerance	NN
cord-005453-4057qib7	6557	13	after	after	IN
cord-005453-4057qib7	6557	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	6557	15	HCT	hct	NN
cord-005453-4057qib7	6557	16	are	be	VBP
cord-005453-4057qib7	6557	17	not	not	RB
cord-005453-4057qib7	6557	18	fully	fully	RB
cord-005453-4057qib7	6557	19	understood	understand	VBN
cord-005453-4057qib7	6557	20	.	.	.
cord-005453-4057qib7	6558	1	Methods	method	NNS
cord-005453-4057qib7	6558	2	:	:	:
cord-005453-4057qib7	6558	3	Monocyte	Monocyte	NNP
cord-005453-4057qib7	6558	4	-	-	HYPH
cord-005453-4057qib7	6558	5	derived	derive	VBN
cord-005453-4057qib7	6558	6	dendritic	dendritic	JJ
cord-005453-4057qib7	6558	7	cells	cell	NNS
cord-005453-4057qib7	6558	8	(	(	-LRB-
cord-005453-4057qib7	6558	9	DCs	DCs	NNP
cord-005453-4057qib7	6558	10	)	)	-RRB-
cord-005453-4057qib7	6558	11	were	be	VBD
cord-005453-4057qib7	6558	12	cultured	culture	VBN
cord-005453-4057qib7	6558	13	in	in	IN
cord-005453-4057qib7	6558	14	a	a	DT
cord-005453-4057qib7	6558	15	mixed	mixed	JJ
cord-005453-4057qib7	6558	16	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6558	17	reaction	reaction	NN
cord-005453-4057qib7	6558	18	with	with	IN
cord-005453-4057qib7	6558	19	MHCmismatched	MHCmismatched	NNP
cord-005453-4057qib7	6558	20	T	T	NNP
cord-005453-4057qib7	6558	21	cells	cell	NNS
cord-005453-4057qib7	6558	22	and	and	CC
cord-005453-4057qib7	6558	23	culture	culture	NN
cord-005453-4057qib7	6558	24	-	-	HYPH
cord-005453-4057qib7	6558	25	expanded	expand	VBN
cord-005453-4057qib7	6558	26	iNKT	inkt	JJ
cord-005453-4057qib7	6558	27	cells	cell	NNS
cord-005453-4057qib7	6558	28	.	.	.
cord-005453-4057qib7	6559	1	Tcell	Tcell	NNP
cord-005453-4057qib7	6559	2	activation	activation	NN
cord-005453-4057qib7	6559	3	and	and	CC
cord-005453-4057qib7	6559	4	proliferation	proliferation	NN
cord-005453-4057qib7	6559	5	was	be	VBD
cord-005453-4057qib7	6559	6	analyzed	analyze	VBN
cord-005453-4057qib7	6559	7	by	by	IN
cord-005453-4057qib7	6559	8	multiparametric	multiparametric	JJ
cord-005453-4057qib7	6559	9	flow	flow	NN
cord-005453-4057qib7	6559	10	cytometry	cytometry	NN
cord-005453-4057qib7	6559	11	and	and	CC
cord-005453-4057qib7	6559	12	released	release	VBN
cord-005453-4057qib7	6559	13	cytokines	cytokine	NNS
cord-005453-4057qib7	6559	14	were	be	VBD
cord-005453-4057qib7	6559	15	measured	measure	VBN
cord-005453-4057qib7	6559	16	via	via	IN
cord-005453-4057qib7	6559	17	multiplex	multiplex	NN
cord-005453-4057qib7	6559	18	analysis	analysis	NN
cord-005453-4057qib7	6559	19	.	.	.
cord-005453-4057qib7	6560	1	Transwell	Transwell	NNP
cord-005453-4057qib7	6560	2	assays	assay	NNS
cord-005453-4057qib7	6560	3	and	and	CC
cord-005453-4057qib7	6560	4	imaging	image	VBG
cord-005453-4057qib7	6560	5	flow	flow	NN
cord-005453-4057qib7	6560	6	cytometry	cytometry	NN
cord-005453-4057qib7	6560	7	were	be	VBD
cord-005453-4057qib7	6560	8	performed	perform	VBN
cord-005453-4057qib7	6560	9	to	to	TO
cord-005453-4057qib7	6560	10	elucidate	elucidate	VB
cord-005453-4057qib7	6560	11	cellcell	cellcell	NN
cord-005453-4057qib7	6560	12	interactions	interaction	NNS
cord-005453-4057qib7	6560	13	.	.	.
cord-005453-4057qib7	6561	1	Bead	bead	NN
cord-005453-4057qib7	6561	2	-	-	HYPH
cord-005453-4057qib7	6561	3	controlled	control	VBN
cord-005453-4057qib7	6561	4	flow	flow	NN
cord-005453-4057qib7	6561	5	cytometry	cytometry	NN
cord-005453-4057qib7	6561	6	-	-	HYPH
cord-005453-4057qib7	6561	7	based	base	VBN
cord-005453-4057qib7	6561	8	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	6561	9	assays	assay	NNS
cord-005453-4057qib7	6561	10	were	be	VBD
cord-005453-4057qib7	6561	11	used	use	VBN
cord-005453-4057qib7	6561	12	to	to	TO
cord-005453-4057qib7	6561	13	evaluate	evaluate	VB
cord-005453-4057qib7	6561	14	DC	DC	NNP
cord-005453-4057qib7	6561	15	apoptosis	apoptosis	NN
cord-005453-4057qib7	6561	16	.	.	.
cord-005453-4057qib7	6562	1	Apoptotic	apoptotic	JJ
cord-005453-4057qib7	6562	2	DCs	dc	NNS
cord-005453-4057qib7	6562	3	were	be	VBD
cord-005453-4057qib7	6562	4	then	then	RB
cord-005453-4057qib7	6562	5	purified	purify	VBN
cord-005453-4057qib7	6562	6	by	by	IN
cord-005453-4057qib7	6562	7	fluorescence	fluorescence	NN
cord-005453-4057qib7	6562	8	-	-	HYPH
cord-005453-4057qib7	6562	9	activated	activate	VBN
cord-005453-4057qib7	6562	10	cell	cell	NN
cord-005453-4057qib7	6562	11	sorting	sorting	NN
cord-005453-4057qib7	6562	12	to	to	TO
cord-005453-4057qib7	6562	13	investigate	investigate	VB
cord-005453-4057qib7	6562	14	their	-PRON-	PRP$
cord-005453-4057qib7	6562	15	tolerogenic	tolerogenic	NN
cord-005453-4057qib7	6562	16	potential	potential	NN
cord-005453-4057qib7	6562	17	to	to	IN
cord-005453-4057qib7	6562	18	prime	prime	JJ
cord-005453-4057qib7	6562	19	regulatory	regulatory	JJ
cord-005453-4057qib7	6562	20	T	t	NN
cord-005453-4057qib7	6562	21	cells	cell	NNS
cord-005453-4057qib7	6562	22	(	(	-LRB-
cord-005453-4057qib7	6562	23	Tregs	Tregs	NNP
cord-005453-4057qib7	6562	24	)	)	-RRB-
cord-005453-4057qib7	6562	25	.	.	.
cord-005453-4057qib7	6563	1	Results	result	NNS
cord-005453-4057qib7	6563	2	:	:	:
cord-005453-4057qib7	6564	1	The	the	DT
cord-005453-4057qib7	6564	2	addition	addition	NN
cord-005453-4057qib7	6564	3	of	of	IN
cord-005453-4057qib7	6564	4	iNKT	inkt	JJ
cord-005453-4057qib7	6564	5	cells	cell	NNS
cord-005453-4057qib7	6564	6	to	to	IN
cord-005453-4057qib7	6564	7	mixed	mixed	JJ
cord-005453-4057qib7	6564	8	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6564	9	reactions	reaction	NNS
cord-005453-4057qib7	6564	10	resulted	result	VBD
cord-005453-4057qib7	6564	11	in	in	IN
cord-005453-4057qib7	6564	12	a	a	DT
cord-005453-4057qib7	6564	13	significantly	significantly	RB
cord-005453-4057qib7	6564	14	reduced	reduce	VBN
cord-005453-4057qib7	6564	15	activation	activation	NN
cord-005453-4057qib7	6564	16	and	and	CC
cord-005453-4057qib7	6564	17	proliferation	proliferation	NN
cord-005453-4057qib7	6564	18	of	of	IN
cord-005453-4057qib7	6564	19	MHC	MHC	NNP
cord-005453-4057qib7	6564	20	-	-	HYPH
cord-005453-4057qib7	6564	21	mismatched	mismatch	VBN
cord-005453-4057qib7	6564	22	T	t	NN
cord-005453-4057qib7	6564	23	cells	cell	NNS
cord-005453-4057qib7	6564	24	.	.	.
cord-005453-4057qib7	6565	1	Transwell	Transwell	NNP
cord-005453-4057qib7	6565	2	assays	assay	NNS
cord-005453-4057qib7	6565	3	and	and	CC
cord-005453-4057qib7	6565	4	imaging	image	VBG
cord-005453-4057qib7	6565	5	flow	flow	NN
cord-005453-4057qib7	6565	6	cytometry	cytometry	NN
cord-005453-4057qib7	6565	7	revealed	reveal	VBD
cord-005453-4057qib7	6565	8	a	a	DT
cord-005453-4057qib7	6565	9	cell	cell	NN
cord-005453-4057qib7	6565	10	contactdependent	contactdependent	NN
cord-005453-4057qib7	6565	11	mechanism	mechanism	NN
cord-005453-4057qib7	6565	12	between	between	IN
cord-005453-4057qib7	6565	13	iNKT	inkt	JJ
cord-005453-4057qib7	6565	14	cells	cell	NNS
cord-005453-4057qib7	6565	15	and	and	CC
cord-005453-4057qib7	6565	16	DCs	dc	NNS
cord-005453-4057qib7	6565	17	leading	lead	VBG
cord-005453-4057qib7	6565	18	to	to	IN
cord-005453-4057qib7	6565	19	apoptosis	apoptosis	NN
cord-005453-4057qib7	6565	20	with	with	IN
cord-005453-4057qib7	6565	21	increasing	increase	VBG
cord-005453-4057qib7	6565	22	DNA	dna	NN
cord-005453-4057qib7	6565	23	fragmentation	fragmentation	NN
cord-005453-4057qib7	6565	24	of	of	IN
cord-005453-4057qib7	6565	25	DCs	DCs	NNP
cord-005453-4057qib7	6565	26	over	over	IN
cord-005453-4057qib7	6565	27	time	time	NN
cord-005453-4057qib7	6565	28	.	.	.
cord-005453-4057qib7	6566	1	Interestingly	interestingly	RB
cord-005453-4057qib7	6566	2	,	,	,
cord-005453-4057qib7	6566	3	various	various	JJ
cord-005453-4057qib7	6566	4	fluorescence	fluorescence	NN
cord-005453-4057qib7	6566	5	-	-	HYPH
cord-005453-4057qib7	6566	6	activated	activate	VBN
cord-005453-4057qib7	6566	7	single	single	JJ
cord-005453-4057qib7	6566	8	cell	cell	NN
cord-005453-4057qib7	6566	9	sorted	sort	VBN
cord-005453-4057qib7	6566	10	iNKT	inkt	JJ
cord-005453-4057qib7	6566	11	-	-	HYPH
cord-005453-4057qib7	6566	12	cell	cell	NN
cord-005453-4057qib7	6566	13	subsets	subset	NNS
cord-005453-4057qib7	6566	14	were	be	VBD
cord-005453-4057qib7	6566	15	all	all	RB
cord-005453-4057qib7	6566	16	able	able	JJ
cord-005453-4057qib7	6566	17	to	to	TO
cord-005453-4057qib7	6566	18	induce	induce	VB
cord-005453-4057qib7	6566	19	apoptosis	apoptosis	NN
cord-005453-4057qib7	6566	20	of	of	IN
cord-005453-4057qib7	6566	21	host	host	NN
cord-005453-4057qib7	6566	22	DCs	DCs	NNP
cord-005453-4057qib7	6566	23	.	.	.
cord-005453-4057qib7	6567	1	Multiplex	multiplex	NN
cord-005453-4057qib7	6567	2	analysis	analysis	NN
cord-005453-4057qib7	6567	3	revealed	reveal	VBD
cord-005453-4057qib7	6567	4	that	that	IN
cord-005453-4057qib7	6567	5	DCs	DCs	NNP
cord-005453-4057qib7	6567	6	triggered	trigger	VBD
cord-005453-4057qib7	6567	7	iNKT	inkt	JJ
cord-005453-4057qib7	6567	8	-	-	HYPH
cord-005453-4057qib7	6567	9	cell	cell	NN
cord-005453-4057qib7	6567	10	release	release	NN
cord-005453-4057qib7	6567	11	of	of	IN
cord-005453-4057qib7	6567	12	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	6567	13	factors	factor	NNS
cord-005453-4057qib7	6567	14	like	like	IN
cord-005453-4057qib7	6567	15	perforin	perforin	NNP
cord-005453-4057qib7	6567	16	,	,	,
cord-005453-4057qib7	6567	17	granzyme	granzyme	NNP
cord-005453-4057qib7	6567	18	B	B	NNP
cord-005453-4057qib7	6567	19	and	and	CC
cord-005453-4057qib7	6567	20	granulysin	granulysin	NNP
cord-005453-4057qib7	6567	21	.	.	.
cord-005453-4057qib7	6568	1	Blocking	block	VBG
cord-005453-4057qib7	6568	2	the	the	DT
cord-005453-4057qib7	6568	3	iNKTcell	iNKTcell	NNP
cord-005453-4057qib7	6568	4	receptor	receptor	NN
cord-005453-4057qib7	6568	5	engagement	engagement	NN
cord-005453-4057qib7	6568	6	with	with	IN
cord-005453-4057qib7	6568	7	a	a	DT
cord-005453-4057qib7	6568	8	CD1d	CD1d	NNP
cord-005453-4057qib7	6568	9	antibody	antibody	NN
cord-005453-4057qib7	6568	10	prevented	prevent	VBD
cord-005453-4057qib7	6568	11	iNKT	inkt	JJ
cord-005453-4057qib7	6568	12	-	-	HYPH
cord-005453-4057qib7	6568	13	cell	cell	NN
cord-005453-4057qib7	6568	14	degranulation	degranulation	NN
cord-005453-4057qib7	6568	15	as	as	RB
cord-005453-4057qib7	6568	16	well	well	RB
cord-005453-4057qib7	6568	17	as	as	IN
cord-005453-4057qib7	6568	18	the	the	DT
cord-005453-4057qib7	6568	19	subsequent	subsequent	JJ
cord-005453-4057qib7	6568	20	induction	induction	NN
cord-005453-4057qib7	6568	21	of	of	IN
cord-005453-4057qib7	6568	22	host	host	NN
cord-005453-4057qib7	6568	23	DC	DC	NNP
cord-005453-4057qib7	6568	24	apoptosis	apoptosis	NN
cord-005453-4057qib7	6568	25	.	.	.
cord-005453-4057qib7	6569	1	Inhibition	inhibition	NN
cord-005453-4057qib7	6569	2	of	of	IN
cord-005453-4057qib7	6569	3	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	6569	4	factors	factor	NNS
cord-005453-4057qib7	6569	5	also	also	RB
cord-005453-4057qib7	6569	6	abrogated	abrogate	VBD
cord-005453-4057qib7	6569	7	apoptosis	apoptosis	NN
cord-005453-4057qib7	6569	8	of	of	IN
cord-005453-4057qib7	6569	9	DCs	dc	NNS
cord-005453-4057qib7	6569	10	.	.	.
cord-005453-4057qib7	6570	1	In	in	IN
cord-005453-4057qib7	6570	2	turn	turn	NN
cord-005453-4057qib7	6570	3	,	,	,
cord-005453-4057qib7	6570	4	sorted	sort	VBD
cord-005453-4057qib7	6570	5	apoptotic	apoptotic	JJ
cord-005453-4057qib7	6570	6	DCs	dc	NNS
cord-005453-4057qib7	6570	7	induced	induce	VBD
cord-005453-4057qib7	6570	8	tolerogenic	tolerogenic	NNP
cord-005453-4057qib7	6570	9	DCs	DCs	NNP
cord-005453-4057qib7	6570	10	characterized	characterize	VBN
cord-005453-4057qib7	6570	11	by	by	IN
cord-005453-4057qib7	6570	12	a	a	DT
cord-005453-4057qib7	6570	13	high	high	JJ
cord-005453-4057qib7	6570	14	expression	expression	NN
cord-005453-4057qib7	6570	15	of	of	IN
cord-005453-4057qib7	6570	16	PD	PD	NNP
cord-005453-4057qib7	6570	17	-	-	HYPH
cord-005453-4057qib7	6570	18	L1	L1	NNP
cord-005453-4057qib7	6570	19	in	in	IN
cord-005453-4057qib7	6570	20	mixed	mixed	JJ
cord-005453-4057qib7	6570	21	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6570	22	reactions	reaction	NNS
cord-005453-4057qib7	6570	23	.	.	.
cord-005453-4057qib7	6571	1	Such	such	JJ
cord-005453-4057qib7	6571	2	tolerogenic	tolerogenic	JJ
cord-005453-4057qib7	6571	3	DCs	dc	NNS
cord-005453-4057qib7	6571	4	promoted	promote	VBD
cord-005453-4057qib7	6571	5	the	the	DT
cord-005453-4057qib7	6571	6	expansion	expansion	NN
cord-005453-4057qib7	6571	7	of	of	IN
cord-005453-4057qib7	6571	8	CD4	CD4	NNP
cord-005453-4057qib7	6571	9	+	+	CC
cord-005453-4057qib7	6571	10	CD25	CD25	NNP
cord-005453-4057qib7	6571	11	+	+	CC
cord-005453-4057qib7	6571	12	FoxP3	FoxP3	NNP
cord-005453-4057qib7	6571	13	+	+	CC
cord-005453-4057qib7	6571	14	Tregs	Tregs	NNP
cord-005453-4057qib7	6571	15	and	and	CC
cord-005453-4057qib7	6571	16	prevented	prevent	VBD
cord-005453-4057qib7	6571	17	activation	activation	NN
cord-005453-4057qib7	6571	18	and	and	CC
cord-005453-4057qib7	6571	19	proliferation	proliferation	NN
cord-005453-4057qib7	6571	20	of	of	IN
cord-005453-4057qib7	6571	21	MHCmismatched	mhcmismatched	JJ
cord-005453-4057qib7	6571	22	T	t	NN
cord-005453-4057qib7	6571	23	cells	cell	NNS
cord-005453-4057qib7	6571	24	.	.	.
cord-005453-4057qib7	6572	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6572	2	:	:	:
cord-005453-4057qib7	6573	1	We	-PRON-	PRP
cord-005453-4057qib7	6573	2	propose	propose	VBP
cord-005453-4057qib7	6573	3	a	a	DT
cord-005453-4057qib7	6573	4	novel	novel	JJ
cord-005453-4057qib7	6573	5	mechanism	mechanism	NN
cord-005453-4057qib7	6573	6	how	how	WRB
cord-005453-4057qib7	6573	7	culture	culture	NN
cord-005453-4057qib7	6573	8	-	-	HYPH
cord-005453-4057qib7	6573	9	expanded	expand	VBN
cord-005453-4057qib7	6573	10	human	human	JJ
cord-005453-4057qib7	6573	11	iNKT	inkt	JJ
cord-005453-4057qib7	6573	12	cells	cell	NNS
cord-005453-4057qib7	6573	13	prevent	prevent	VBP
cord-005453-4057qib7	6573	14	GVHD	GVHD	NNP
cord-005453-4057qib7	6573	15	after	after	IN
cord-005453-4057qib7	6573	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	6573	17	HCT	hct	NN
cord-005453-4057qib7	6573	18	.	.	.
cord-005453-4057qib7	6574	1	Host	host	NN
cord-005453-4057qib7	6574	2	DC	DC	NNP
cord-005453-4057qib7	6574	3	apoptosis	apoptosis	NN
cord-005453-4057qib7	6574	4	through	through	IN
cord-005453-4057qib7	6574	5	donor	donor	NN
cord-005453-4057qib7	6574	6	iNKT	inkt	NN
cord-005453-4057qib7	6574	7	cells	cell	NNS
cord-005453-4057qib7	6574	8	induces	induce	VBZ
cord-005453-4057qib7	6574	9	a	a	DT
cord-005453-4057qib7	6574	10	tolerogenic	tolerogenic	NNP
cord-005453-4057qib7	6574	11	immunoenvironment	immunoenvironment	NN
cord-005453-4057qib7	6574	12	characterized	characterize	VBN
cord-005453-4057qib7	6574	13	by	by	IN
cord-005453-4057qib7	6574	14	PD	PD	NNP
cord-005453-4057qib7	6574	15	-	-	HYPH
cord-005453-4057qib7	6574	16	L1	L1	NNP
cord-005453-4057qib7	6574	17	high	high	JJ
cord-005453-4057qib7	6574	18	DCs	dc	NNS
cord-005453-4057qib7	6574	19	and	and	CC
cord-005453-4057qib7	6574	20	expanding	expand	VBG
cord-005453-4057qib7	6574	21	donor	donor	NN
cord-005453-4057qib7	6574	22	Tregs	Tregs	NNP
cord-005453-4057qib7	6574	23	inhibiting	inhibit	VBG
cord-005453-4057qib7	6574	24	activation	activation	NN
cord-005453-4057qib7	6574	25	and	and	CC
cord-005453-4057qib7	6574	26	expansion	expansion	NN
cord-005453-4057qib7	6574	27	of	of	IN
cord-005453-4057qib7	6574	28	alloreactive	alloreactive	JJ
cord-005453-4057qib7	6574	29	donor	donor	NN
cord-005453-4057qib7	6574	30	T	t	NN
cord-005453-4057qib7	6574	31	cells	cell	NNS
cord-005453-4057qib7	6574	32	.	.	.
cord-005453-4057qib7	6575	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6575	2	findings	finding	NNS
cord-005453-4057qib7	6575	3	pave	pave	VBP
cord-005453-4057qib7	6575	4	the	the	DT
cord-005453-4057qib7	6575	5	avenue	avenue	NN
cord-005453-4057qib7	6575	6	for	for	IN
cord-005453-4057qib7	6575	7	clinical	clinical	JJ
cord-005453-4057qib7	6575	8	translation	translation	NN
cord-005453-4057qib7	6575	9	of	of	IN
cord-005453-4057qib7	6575	10	adoptively	adoptively	RB
cord-005453-4057qib7	6575	11	transferred	transfer	VBN
cord-005453-4057qib7	6575	12	culture	culture	NN
cord-005453-4057qib7	6575	13	-	-	HYPH
cord-005453-4057qib7	6575	14	expanded	expand	VBN
cord-005453-4057qib7	6575	15	iNKT	inkt	JJ
cord-005453-4057qib7	6575	16	cells	cell	NNS
cord-005453-4057qib7	6575	17	in	in	IN
cord-005453-4057qib7	6575	18	humans	human	NNS
cord-005453-4057qib7	6575	19	.	.	.
cord-005453-4057qib7	6576	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6576	2	:	:	:
cord-005453-4057qib7	6576	3	Nothing	nothing	NN
cord-005453-4057qib7	6576	4	to	to	TO
cord-005453-4057qib7	6576	5	declare	declare	VB
cord-005453-4057qib7	6576	6	Results	result	NNS
cord-005453-4057qib7	6576	7	:	:	:
cord-005453-4057qib7	6576	8	VIP	VIP	NNP
cord-005453-4057qib7	6576	9	-	-	HYPH
cord-005453-4057qib7	6576	10	KO	KO	NNP
cord-005453-4057qib7	6576	11	mice	mouse	NNS
cord-005453-4057qib7	6576	12	transplanted	transplant	VBN
cord-005453-4057qib7	6576	13	with	with	IN
cord-005453-4057qib7	6576	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	6576	15	TCD	TCD	NNP
cord-005453-4057qib7	6576	16	BM	BM	NNP
cord-005453-4057qib7	6576	17	alone	alone	RB
cord-005453-4057qib7	6576	18	had	have	VBD
cord-005453-4057qib7	6576	19	increased	increase	VBN
cord-005453-4057qib7	6576	20	graft	graft	NN
cord-005453-4057qib7	6576	21	rejection	rejection	NN
cord-005453-4057qib7	6576	22	with	with	IN
cord-005453-4057qib7	6576	23	lower	low	JJR
cord-005453-4057qib7	6576	24	levels	level	NNS
cord-005453-4057qib7	6576	25	of	of	IN
cord-005453-4057qib7	6576	26	donor	donor	NN
cord-005453-4057qib7	6576	27	chimerism	chimerism	NN
cord-005453-4057qib7	6576	28	and	and	CC
cord-005453-4057qib7	6576	29	33	33	CD
cord-005453-4057qib7	6576	30	%	%	NN
cord-005453-4057qib7	6576	31	day	day	NN
cord-005453-4057qib7	6576	32	75	75	CD
cord-005453-4057qib7	6576	33	survival	survival	NN
cord-005453-4057qib7	6576	34	compared	compare	VBN
cord-005453-4057qib7	6576	35	with	with	IN
cord-005453-4057qib7	6576	36	73	73	CD
cord-005453-4057qib7	6576	37	%	%	NN
cord-005453-4057qib7	6576	38	survival	survival	NN
cord-005453-4057qib7	6576	39	of	of	IN
cord-005453-4057qib7	6576	40	WT	WT	NNP
cord-005453-4057qib7	6576	41	recipients	recipient	NNS
cord-005453-4057qib7	6576	42	.	.	.
cord-005453-4057qib7	6577	1	Transplanting	transplant	VBG
cord-005453-4057qib7	6577	2	TCD	TCD	NNP
cord-005453-4057qib7	6577	3	BM	BM	NNP
cord-005453-4057qib7	6577	4	plus	plus	CC
cord-005453-4057qib7	6577	5	3	3	CD
cord-005453-4057qib7	6577	6	×	×	NN
cord-005453-4057qib7	6577	7	10E6	10e6	CD
cord-005453-4057qib7	6577	8	donor	donor	NN
cord-005453-4057qib7	6577	9	T	t	NN
cord-005453-4057qib7	6577	10	cells	cell	NNS
cord-005453-4057qib7	6577	11	from	from	IN
cord-005453-4057qib7	6577	12	B10.BR	B10.BR	NNS
cord-005453-4057qib7	6578	1	or	or	CC
cord-005453-4057qib7	6578	2	Balb	Balb	NNP
cord-005453-4057qib7	6578	3	/	/	SYM
cord-005453-4057qib7	6578	4	c	c	NN
cord-005453-4057qib7	6578	5	donors	donor	NNS
cord-005453-4057qib7	6578	6	in	in	IN
cord-005453-4057qib7	6578	7	VIP	VIP	NNP
cord-005453-4057qib7	6578	8	KIO	KIO	NNP
cord-005453-4057qib7	6578	9	mice	mouse	NNS
cord-005453-4057qib7	6578	10	led	lead	VBD
cord-005453-4057qib7	6578	11	to	to	IN
cord-005453-4057qib7	6578	12	>	>	XX
cord-005453-4057qib7	6578	13	95	95	CD
cord-005453-4057qib7	6578	14	%	%	NN
cord-005453-4057qib7	6578	15	donor	donor	NN
cord-005453-4057qib7	6578	16	chimerism	chimerism	NN
cord-005453-4057qib7	6578	17	and	and	CC
cord-005453-4057qib7	6578	18	significantly	significantly	RB
cord-005453-4057qib7	6578	19	increased	increase	VBN
cord-005453-4057qib7	6578	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6578	21	-	-	HYPH
cord-005453-4057qib7	6578	22	mortality	mortality	NN
cord-005453-4057qib7	6578	23	compared	compare	VBN
cord-005453-4057qib7	6578	24	with	with	IN
cord-005453-4057qib7	6578	25	WT	WT	NNP
cord-005453-4057qib7	6578	26	recipients	recipient	NNS
cord-005453-4057qib7	6578	27	,	,	,
cord-005453-4057qib7	6578	28	with	with	IN
cord-005453-4057qib7	6578	29	0	0	CD
cord-005453-4057qib7	6578	30	%	%	NN
cord-005453-4057qib7	6578	31	vs	vs	IN
cord-005453-4057qib7	6578	32	40	40	CD
cord-005453-4057qib7	6578	33	%	%	NN
cord-005453-4057qib7	6578	34	survival	survival	NN
cord-005453-4057qib7	6578	35	in	in	IN
cord-005453-4057qib7	6578	36	the	the	DT
cord-005453-4057qib7	6578	37	B10.BR-->B6	b10.br-->b6	JJ
cord-005453-4057qib7	6578	38	model	model	NN
cord-005453-4057qib7	6578	39	(	(	-LRB-
cord-005453-4057qib7	6578	40	p	p	NN
cord-005453-4057qib7	6578	41	<	<	XX
cord-005453-4057qib7	6578	42	0.01	0.01	CD
cord-005453-4057qib7	6578	43	)	)	-RRB-
cord-005453-4057qib7	6578	44	,	,	,
cord-005453-4057qib7	6578	45	and	and	CC
cord-005453-4057qib7	6578	46	0	0	CD
cord-005453-4057qib7	6578	47	%	%	NN
cord-005453-4057qib7	6578	48	vs	vs	IN
cord-005453-4057qib7	6578	49	73	73	CD
cord-005453-4057qib7	6578	50	%	%	NN
cord-005453-4057qib7	6578	51	survival	survival	NN
cord-005453-4057qib7	6578	52	in	in	IN
cord-005453-4057qib7	6578	53	the	the	DT
cord-005453-4057qib7	6578	54	Balb	Balb	NNP
cord-005453-4057qib7	6578	55	/	/	SYM
cord-005453-4057qib7	6578	56	c-->B6	c-->b6	NN
cord-005453-4057qib7	6578	57	model	model	NN
cord-005453-4057qib7	6578	58	(	(	-LRB-
cord-005453-4057qib7	6578	59	P	p	NN
cord-005453-4057qib7	6578	60	<	<	XX
cord-005453-4057qib7	6578	61	0.01	0.01	CD
cord-005453-4057qib7	6578	62	)	)	-RRB-
cord-005453-4057qib7	6578	63	.	.	.
cord-005453-4057qib7	6579	1	Donor	donor	NN
cord-005453-4057qib7	6579	2	-	-	HYPH
cord-005453-4057qib7	6579	3	derived	derive	VBN
cord-005453-4057qib7	6579	4	T	t	NN
cord-005453-4057qib7	6579	5	cells	cell	NNS
cord-005453-4057qib7	6579	6	in	in	IN
cord-005453-4057qib7	6579	7	VIP	VIP	NNP
cord-005453-4057qib7	6579	8	-	-	HYPH
cord-005453-4057qib7	6579	9	KO	KO	NNP
cord-005453-4057qib7	6579	10	recipients	recipient	NNS
cord-005453-4057qib7	6579	11	had	have	VBD
cord-005453-4057qib7	6579	12	significantly	significantly	RB
cord-005453-4057qib7	6579	13	higher	high	JJR
cord-005453-4057qib7	6579	14	Th1	th1	NN
cord-005453-4057qib7	6579	15	and	and	CC
cord-005453-4057qib7	6579	16	Th17	th17	CD
cord-005453-4057qib7	6579	17	polarization	polarization	NN
cord-005453-4057qib7	6579	18	,	,	,
cord-005453-4057qib7	6579	19	with	with	IN
cord-005453-4057qib7	6579	20	higher	high	JJR
cord-005453-4057qib7	6579	21	RORγt	RORγt	NNP
cord-005453-4057qib7	6579	22	in	in	IN
cord-005453-4057qib7	6579	23	both	both	DT
cord-005453-4057qib7	6579	24	CD4	CD4	NNP
cord-005453-4057qib7	6579	25	+	+	CC
cord-005453-4057qib7	6579	26	(	(	-LRB-
cord-005453-4057qib7	6579	27	p	p	NN
cord-005453-4057qib7	6579	28	<	<	XX
cord-005453-4057qib7	6579	29	0.0001	0.0001	CD
cord-005453-4057qib7	6579	30	)	)	-RRB-
cord-005453-4057qib7	6579	31	and	and	CC
cord-005453-4057qib7	6579	32	CD8	CD8	NNP
cord-005453-4057qib7	6579	33	+	+	CC
cord-005453-4057qib7	6579	34	(	(	-LRB-
cord-005453-4057qib7	6579	35	p	p	NN
cord-005453-4057qib7	6579	36	<	<	XX
cord-005453-4057qib7	6579	37	0.0001	0.0001	CD
cord-005453-4057qib7	6579	38	)	)	-RRB-
cord-005453-4057qib7	6579	39	T	t	NN
cord-005453-4057qib7	6579	40	cells	cell	NNS
cord-005453-4057qib7	6579	41	,	,	,
cord-005453-4057qib7	6579	42	and	and	CC
cord-005453-4057qib7	6579	43	higher	high	JJR
cord-005453-4057qib7	6579	44	frequencies	frequency	NNS
cord-005453-4057qib7	6579	45	of	of	IN
cord-005453-4057qib7	6579	46	IFN	IFN	NNP
cord-005453-4057qib7	6579	47	-	-	HYPH
cord-005453-4057qib7	6579	48	γ	γ	NNP
cord-005453-4057qib7	6579	49	(	(	-LRB-
cord-005453-4057qib7	6579	50	p	p	NN
cord-005453-4057qib7	6579	51	<	<	XX
cord-005453-4057qib7	6579	52	0.001	0.001	CD
cord-005453-4057qib7	6579	53	)	)	-RRB-
cord-005453-4057qib7	6579	54	,	,	,
cord-005453-4057qib7	6579	55	TNF	TNF	NNP
cord-005453-4057qib7	6579	56	-	-	HYPH
cord-005453-4057qib7	6579	57	α	α	NNP
cord-005453-4057qib7	6579	58	(	(	-LRB-
cord-005453-4057qib7	6579	59	p	p	NN
cord-005453-4057qib7	6579	60	<	<	XX
cord-005453-4057qib7	6579	61	0.05	0.05	CD
cord-005453-4057qib7	6579	62	)	)	-RRB-
cord-005453-4057qib7	6579	63	,	,	,
cord-005453-4057qib7	6579	64	and	and	CC
cord-005453-4057qib7	6579	65	IL2	IL2	NNP
cord-005453-4057qib7	6579	66	(	(	-LRB-
cord-005453-4057qib7	6579	67	p	p	NN
cord-005453-4057qib7	6579	68	<	<	XX
cord-005453-4057qib7	6579	69	0.01	0.01	CD
cord-005453-4057qib7	6579	70	)	)	-RRB-
cord-005453-4057qib7	6579	71	in	in	IN
cord-005453-4057qib7	6579	72	CD4	CD4	NNP
cord-005453-4057qib7	6579	73	+	+	CC
cord-005453-4057qib7	6579	74	and	and	CC
cord-005453-4057qib7	6579	75	CD8	CD8	NNP
cord-005453-4057qib7	6579	76	+	+	CC
cord-005453-4057qib7	6579	77	T	t	NN
cord-005453-4057qib7	6579	78	cells	cell	NNS
cord-005453-4057qib7	6579	79	compared	compare	VBN
cord-005453-4057qib7	6579	80	to	to	IN
cord-005453-4057qib7	6579	81	WT	WT	NNP
cord-005453-4057qib7	6579	82	recipients	recipient	NNS
cord-005453-4057qib7	6579	83	.	.	.
cord-005453-4057qib7	6580	1	B10.BR-->B6	b10.br-->b6	JJ
cord-005453-4057qib7	6580	2	second	second	JJ
cord-005453-4057qib7	6580	3	allogeneic	allogeneic	NN
cord-005453-4057qib7	6580	4	transplantation	transplantation	NN
cord-005453-4057qib7	6580	5	of	of	IN
cord-005453-4057qib7	6580	6	radiation	radiation	NN
cord-005453-4057qib7	6580	7	chimeras	chimera	NNS
cord-005453-4057qib7	6580	8	caused	cause	VBD
cord-005453-4057qib7	6580	9	lethal	lethal	JJ
cord-005453-4057qib7	6580	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6580	11	mortality	mortality	NN
cord-005453-4057qib7	6580	12	in	in	IN
cord-005453-4057qib7	6580	13	VIP	vip	NN
cord-005453-4057qib7	6580	14	-	-	HYPH
cord-005453-4057qib7	6580	15	KO-->VIP	ko-->vip	NN
cord-005453-4057qib7	6580	16	-	-	HYPH
cord-005453-4057qib7	6580	17	KO	KO	NNP
cord-005453-4057qib7	6580	18	and	and	CC
cord-005453-4057qib7	6580	19	WT-->VIP	WT-->VIP	NNP
cord-005453-4057qib7	6580	20	-	-	HYPH
cord-005453-4057qib7	6580	21	KO	KO	NNP
cord-005453-4057qib7	6580	22	mice	mouse	NNS
cord-005453-4057qib7	6580	23	,	,	,
cord-005453-4057qib7	6580	24	but	but	CC
cord-005453-4057qib7	6580	25	not	not	RB
cord-005453-4057qib7	6580	26	in	in	IN
cord-005453-4057qib7	6580	27	WT-->WT	wt-->wt	CD
cord-005453-4057qib7	6580	28	or	or	CC
cord-005453-4057qib7	6580	29	VIP	vip	NN
cord-005453-4057qib7	6580	30	-	-	HYPH
cord-005453-4057qib7	6580	31	KO-->WT	ko-->wt	CD
cord-005453-4057qib7	6580	32	B6	b6	NN
cord-005453-4057qib7	6580	33	mice	mouse	NNS
cord-005453-4057qib7	6580	34	,	,	,
cord-005453-4057qib7	6580	35	demonstrating	demonstrate	VBG
cord-005453-4057qib7	6580	36	the	the	DT
cord-005453-4057qib7	6580	37	protective	protective	JJ
cord-005453-4057qib7	6580	38	effect	effect	NN
cord-005453-4057qib7	6580	39	of	of	IN
cord-005453-4057qib7	6580	40	VIP	VIP	NNP
cord-005453-4057qib7	6580	41	was	be	VBD
cord-005453-4057qib7	6580	42	due	due	JJ
cord-005453-4057qib7	6580	43	to	to	IN
cord-005453-4057qib7	6580	44	synthesis	synthesis	NN
cord-005453-4057qib7	6580	45	by	by	IN
cord-005453-4057qib7	6580	46	non	non	JJ
cord-005453-4057qib7	6580	47	-	-	JJ
cord-005453-4057qib7	6580	48	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6580	49	recipient	recipient	NN
cord-005453-4057qib7	6580	50	cells	cell	NNS
cord-005453-4057qib7	6580	51	.	.	.
cord-005453-4057qib7	6581	1	Immunofluorescent	Immunofluorescent	NNP
cord-005453-4057qib7	6581	2	imaging	imaging	NN
cord-005453-4057qib7	6581	3	of	of	IN
cord-005453-4057qib7	6581	4	allo	allo	NN
cord-005453-4057qib7	6581	5	-	-	HYPH
cord-005453-4057qib7	6581	6	BMT	BMT	NNP
cord-005453-4057qib7	6581	7	recipients	recipient	NNS
cord-005453-4057qib7	6581	8	showed	show	VBD
cord-005453-4057qib7	6581	9	marked	mark	VBN
cord-005453-4057qib7	6581	10	up	up	JJ
cord-005453-4057qib7	6581	11	-	-	HYPH
cord-005453-4057qib7	6581	12	regulation	regulation	NN
cord-005453-4057qib7	6581	13	of	of	IN
cord-005453-4057qib7	6581	14	VIP	vip	NN
cord-005453-4057qib7	6581	15	in	in	IN
cord-005453-4057qib7	6581	16	lungs	lung	NNS
cord-005453-4057qib7	6581	17	post	post	JJ
cord-005453-4057qib7	6581	18	-	-	JJ
cord-005453-4057qib7	6581	19	transplant	transplant	JJ
cord-005453-4057qib7	6581	20	and	and	CC
cord-005453-4057qib7	6581	21	high	high	JJ
cord-005453-4057qib7	6581	22	VIP	vip	NN
cord-005453-4057qib7	6581	23	production	production	NN
cord-005453-4057qib7	6581	24	within	within	IN
cord-005453-4057qib7	6581	25	neurons	neuron	NNS
cord-005453-4057qib7	6581	26	innervating	innervate	VBG
cord-005453-4057qib7	6581	27	the	the	DT
cord-005453-4057qib7	6581	28	lungs	lung	NNS
cord-005453-4057qib7	6581	29	.	.	.
cord-005453-4057qib7	6582	1	Finally	finally	RB
cord-005453-4057qib7	6582	2	,	,	,
cord-005453-4057qib7	6582	3	we	-PRON-	PRP
cord-005453-4057qib7	6582	4	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6582	5	that	that	IN
cord-005453-4057qib7	6582	6	short	short	JJ
cord-005453-4057qib7	6582	7	-	-	HYPH
cord-005453-4057qib7	6582	8	term	term	NN
cord-005453-4057qib7	6582	9	administration	administration	NN
cord-005453-4057qib7	6582	10	of	of	IN
cord-005453-4057qib7	6582	11	VIP	VIP	NNP
cord-005453-4057qib7	6582	12	(	(	-LRB-
cord-005453-4057qib7	6582	13	10mcg	10mcg	NNP
cord-005453-4057qib7	6582	14	/	/	SYM
cord-005453-4057qib7	6582	15	day	day	NN
cord-005453-4057qib7	6582	16	)	)	-RRB-
cord-005453-4057qib7	6582	17	from	from	IN
cord-005453-4057qib7	6582	18	day	day	NN
cord-005453-4057qib7	6582	19	0	0	CD
cord-005453-4057qib7	6582	20	to	to	IN
cord-005453-4057qib7	6582	21	day	day	NN
cord-005453-4057qib7	6582	22	10	10	CD
cord-005453-4057qib7	6582	23	prevented	prevent	VBD
cord-005453-4057qib7	6582	24	GvHDmortality	GvHDmortality	NNP
cord-005453-4057qib7	6582	25	in	in	IN
cord-005453-4057qib7	6582	26	VIP	VIP	NNP
cord-005453-4057qib7	6582	27	-	-	HYPH
cord-005453-4057qib7	6582	28	KO	KO	NNP
cord-005453-4057qib7	6582	29	recipients	recipient	NNS
cord-005453-4057qib7	6582	30	transplanted	transplant	VBN
cord-005453-4057qib7	6582	31	with	with	IN
cord-005453-4057qib7	6582	32	B10.BR-->B6	B10.BR-->B6	NNP
cord-005453-4057qib7	6582	33	MHC	MHC	NNP
cord-005453-4057qib7	6582	34	donor	donor	NN
cord-005453-4057qib7	6582	35	BM	BM	NNP
cord-005453-4057qib7	6582	36	&	&	CC
cord-005453-4057qib7	6582	37	T	T	NNP
cord-005453-4057qib7	6582	38	cells	cell	NNS
cord-005453-4057qib7	6582	39	.	.	.
cord-005453-4057qib7	6583	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6583	2	:	:	:
cord-005453-4057qib7	6584	1	The	the	DT
cord-005453-4057qib7	6584	2	absence	absence	NN
cord-005453-4057qib7	6584	3	of	of	IN
cord-005453-4057qib7	6584	4	VIP	vip	NN
cord-005453-4057qib7	6584	5	in	in	IN
cord-005453-4057qib7	6584	6	recipient	recipient	NN
cord-005453-4057qib7	6584	7	cells	cell	NNS
cord-005453-4057qib7	6584	8	led	lead	VBD
cord-005453-4057qib7	6584	9	to	to	IN
cord-005453-4057qib7	6584	10	increased	increase	VBN
cord-005453-4057qib7	6584	11	graft	graft	NN
cord-005453-4057qib7	6584	12	rejection	rejection	NN
cord-005453-4057qib7	6584	13	in	in	IN
cord-005453-4057qib7	6584	14	the	the	DT
cord-005453-4057qib7	6584	15	absence	absence	NN
cord-005453-4057qib7	6584	16	of	of	IN
cord-005453-4057qib7	6584	17	donor	donor	NN
cord-005453-4057qib7	6584	18	T	t	NN
cord-005453-4057qib7	6584	19	cells	cell	NNS
cord-005453-4057qib7	6584	20	and	and	CC
cord-005453-4057qib7	6584	21	increased	increase	VBN
cord-005453-4057qib7	6584	22	lethal	lethal	JJ
cord-005453-4057qib7	6584	23	GVHD	gvhd	NN
cord-005453-4057qib7	6584	24	when	when	WRB
cord-005453-4057qib7	6584	25	donor	donor	NN
cord-005453-4057qib7	6584	26	T	t	NN
cord-005453-4057qib7	6584	27	cells	cell	NNS
cord-005453-4057qib7	6584	28	were	be	VBD
cord-005453-4057qib7	6584	29	transplanted	transplant	VBN
cord-005453-4057qib7	6584	30	,	,	,
cord-005453-4057qib7	6584	31	indicating	indicate	VBG
cord-005453-4057qib7	6584	32	VIP	vip	NN
cord-005453-4057qib7	6584	33	induced	induce	VBN
cord-005453-4057qib7	6584	34	post	post	JJ
cord-005453-4057qib7	6584	35	-	-	JJ
cord-005453-4057qib7	6584	36	transplant	transplant	JJ
cord-005453-4057qib7	6584	37	regulates	regulate	VBZ
cord-005453-4057qib7	6584	38	allo	allo	NN
cord-005453-4057qib7	6584	39	-	-	HYPH
cord-005453-4057qib7	6584	40	reactivity	reactivity	NN
cord-005453-4057qib7	6584	41	of	of	IN
cord-005453-4057qib7	6584	42	host	host	NN
cord-005453-4057qib7	6584	43	graft	graft	NN
cord-005453-4057qib7	6584	44	-	-	HYPH
cord-005453-4057qib7	6584	45	rejecting	reject	VBG
cord-005453-4057qib7	6584	46	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6584	47	and	and	CC
cord-005453-4057qib7	6584	48	donor	donor	NN
cord-005453-4057qib7	6585	1	GVHD	GVHD	NNP
cord-005453-4057qib7	6585	2	-	-	HYPH
cord-005453-4057qib7	6585	3	causing	cause	VBG
cord-005453-4057qib7	6585	4	T	t	NN
cord-005453-4057qib7	6585	5	cells	cell	NNS
cord-005453-4057qib7	6585	6	.	.	.
cord-005453-4057qib7	6586	1	The	the	DT
cord-005453-4057qib7	6586	2	protective	protective	JJ
cord-005453-4057qib7	6586	3	effect	effect	NN
cord-005453-4057qib7	6586	4	of	of	IN
cord-005453-4057qib7	6586	5	parenteral	parenteral	JJ
cord-005453-4057qib7	6586	6	VIP	VIP	NNP
cord-005453-4057qib7	6586	7	administration	administration	NN
cord-005453-4057qib7	6586	8	suggests	suggest	VBZ
cord-005453-4057qib7	6586	9	VIP	vip	NN
cord-005453-4057qib7	6586	10	-	-	HYPH
cord-005453-4057qib7	6586	11	mimetics	mimetic	NNS
cord-005453-4057qib7	6586	12	represent	represent	VBP
cord-005453-4057qib7	6586	13	a	a	DT
cord-005453-4057qib7	6586	14	novel	novel	JJ
cord-005453-4057qib7	6586	15	approach	approach	NN
cord-005453-4057qib7	6586	16	to	to	TO
cord-005453-4057qib7	6586	17	prevent	prevent	VB
cord-005453-4057qib7	6586	18	and	and	CC
cord-005453-4057qib7	6586	19	treat	treat	VB
cord-005453-4057qib7	6586	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6586	21	.	.	.
cord-005453-4057qib7	6587	1	These	these	DT
cord-005453-4057qib7	6587	2	data	datum	NNS
cord-005453-4057qib7	6587	3	also	also	RB
cord-005453-4057qib7	6587	4	suggest	suggest	VBP
cord-005453-4057qib7	6587	5	a	a	DT
cord-005453-4057qib7	6587	6	mechanism	mechanism	NN
cord-005453-4057qib7	6587	7	of	of	IN
cord-005453-4057qib7	6587	8	action	action	NN
cord-005453-4057qib7	6587	9	for	for	IN
cord-005453-4057qib7	6587	10	the	the	DT
cord-005453-4057qib7	6587	11	mitigation	mitigation	NN
cord-005453-4057qib7	6587	12	of	of	IN
cord-005453-4057qib7	6587	13	GvHD	GvHD	NNP
cord-005453-4057qib7	6587	14	by	by	IN
cord-005453-4057qib7	6587	15	alpha-1	alpha-1	NNP
cord-005453-4057qib7	6587	16	anti	anti	JJ
cord-005453-4057qib7	6587	17	-	-	JJ
cord-005453-4057qib7	6587	18	trypsin	trypsin	JJ
cord-005453-4057qib7	6587	19	(	(	-LRB-
cord-005453-4057qib7	6587	20	AAT	AAT	NNP
cord-005453-4057qib7	6587	21	)	)	-RRB-
cord-005453-4057qib7	6587	22	whereby	whereby	WRB
cord-005453-4057qib7	6587	23	AAT	AAT	NNP
cord-005453-4057qib7	6587	24	inhibits	inhibit	VBZ
cord-005453-4057qib7	6587	25	the	the	DT
cord-005453-4057qib7	6587	26	proteolytic	proteolytic	JJ
cord-005453-4057qib7	6587	27	inactivation	inactivation	NN
cord-005453-4057qib7	6587	28	of	of	IN
cord-005453-4057qib7	6587	29	endogenous	endogenous	JJ
cord-005453-4057qib7	6587	30	VIP	vip	NN
cord-005453-4057qib7	6587	31	.	.	.
cord-005453-4057qib7	6588	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6588	2	:	:	:
cord-005453-4057qib7	6588	3	Dr.	Dr.	NNP
cord-005453-4057qib7	6588	4	Waller	Waller	NNP
cord-005453-4057qib7	6588	5	reports	report	VBZ
cord-005453-4057qib7	6588	6	personal	personal	JJ
cord-005453-4057qib7	6588	7	fees	fee	NNS
cord-005453-4057qib7	6588	8	and	and	CC
cord-005453-4057qib7	6588	9	other	other	JJ
cord-005453-4057qib7	6588	10	support	support	NN
cord-005453-4057qib7	6588	11	from	from	IN
cord-005453-4057qib7	6588	12	Cambium	Cambium	NNP
cord-005453-4057qib7	6588	13	Medical	Medical	NNP
cord-005453-4057qib7	6588	14	Technologies	Technologies	NNPS
cord-005453-4057qib7	6588	15	,	,	,
cord-005453-4057qib7	6588	16	grants	grant	NNS
cord-005453-4057qib7	6588	17	from	from	IN
cord-005453-4057qib7	6588	18	Celldex	Celldex	NNP
cord-005453-4057qib7	6588	19	,	,	,
cord-005453-4057qib7	6588	20	personal	personal	JJ
cord-005453-4057qib7	6588	21	fees	fee	NNS
cord-005453-4057qib7	6588	22	from	from	IN
cord-005453-4057qib7	6588	23	Kalytera	Kalytera	NNP
cord-005453-4057qib7	6588	24	,	,	,
cord-005453-4057qib7	6588	25	grants	grant	NNS
cord-005453-4057qib7	6588	26	and	and	CC
cord-005453-4057qib7	6588	27	personal	personal	JJ
cord-005453-4057qib7	6588	28	fees	fee	NNS
cord-005453-4057qib7	6588	29	from	from	IN
cord-005453-4057qib7	6588	30	Novartis	Novartis	NNP
cord-005453-4057qib7	6588	31	,	,	,
cord-005453-4057qib7	6588	32	grants	grant	NNS
cord-005453-4057qib7	6588	33	and	and	CC
cord-005453-4057qib7	6588	34	non	non	JJ
cord-005453-4057qib7	6588	35	-	-	JJ
cord-005453-4057qib7	6588	36	financial	financial	JJ
cord-005453-4057qib7	6588	37	support	support	NN
cord-005453-4057qib7	6588	38	from	from	IN
cord-005453-4057qib7	6588	39	Pharmacyclics	Pharmacyclics	NNP
cord-005453-4057qib7	6588	40	,	,	,
cord-005453-4057qib7	6588	41	and	and	CC
cord-005453-4057qib7	6588	42	equity	equity	NN
cord-005453-4057qib7	6588	43	ownership	ownership	NN
cord-005453-4057qib7	6588	44	in	in	IN
cord-005453-4057qib7	6588	45	Cerus	Cerus	NNP
cord-005453-4057qib7	6588	46	Corporation	Corporation	NNP
cord-005453-4057qib7	6588	47	and	and	CC
cord-005453-4057qib7	6588	48	Chimerix	Chimerix	NNP
cord-005453-4057qib7	6588	49	outside	outside	IN
cord-005453-4057qib7	6588	50	the	the	DT
cord-005453-4057qib7	6588	51	submitted	submit	VBN
cord-005453-4057qib7	6588	52	work	work	NN
cord-005453-4057qib7	6588	53	.	.	.
cord-005453-4057qib7	6589	1	In	in	IN
cord-005453-4057qib7	6589	2	addition	addition	NN
cord-005453-4057qib7	6589	3	,	,	,
cord-005453-4057qib7	6589	4	Dr.	Dr.	NNP
cord-005453-4057qib7	6589	5	Waller	Waller	NNP
cord-005453-4057qib7	6589	6	has	have	VBZ
cord-005453-4057qib7	6589	7	intellectual	intellectual	JJ
cord-005453-4057qib7	6589	8	property	property	NN
cord-005453-4057qib7	6589	9	related	relate	VBN
cord-005453-4057qib7	6589	10	to	to	IN
cord-005453-4057qib7	6589	11	VIP	vip	NN
cord-005453-4057qib7	6589	12	signaling	signaling	NN
cord-005453-4057qib7	6589	13	that	that	WDT
cord-005453-4057qib7	6589	14	has	have	VBZ
cord-005453-4057qib7	6589	15	been	be	VBN
cord-005453-4057qib7	6589	16	licensed	license	VBN
cord-005453-4057qib7	6589	17	to	to	IN
cord-005453-4057qib7	6589	18	Cambium	Cambium	NNP
cord-005453-4057qib7	6589	19	Oncology	Oncology	NNP
cord-005453-4057qib7	6589	20	in	in	IN
cord-005453-4057qib7	6589	21	which	which	WDT
cord-005453-4057qib7	6589	22	he	-PRON-	PRP
cord-005453-4057qib7	6589	23	holds	hold	VBZ
cord-005453-4057qib7	6589	24	equity	equity	NN
cord-005453-4057qib7	6589	25	.	.	.
cord-005453-4057qib7	6590	1	Low	low	JJ
cord-005453-4057qib7	6590	2	-	-	HYPH
cord-005453-4057qib7	6590	3	density	density	NN
cord-005453-4057qib7	6590	4	neutrophils	neutrophil	NNS
cord-005453-4057qib7	6590	5	expansion	expansion	NN
cord-005453-4057qib7	6590	6	is	be	VBZ
cord-005453-4057qib7	6590	7	associated	associate	VBN
cord-005453-4057qib7	6590	8	with	with	IN
cord-005453-4057qib7	6590	9	acute	acute	JJ
cord-005453-4057qib7	6590	10	graft	graft	NN
cord-005453-4057qib7	6590	11	versus	versus	IN
cord-005453-4057qib7	6590	12	host	host	NN
cord-005453-4057qib7	6590	13	disease	disease	NN
cord-005453-4057qib7	6590	14	in	in	IN
cord-005453-4057qib7	6590	15	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6590	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6590	17	stem	stem	NN
cord-005453-4057qib7	6590	18	cell	cell	NN
cord-005453-4057qib7	6590	19	transplant	transplant	NN
cord-005453-4057qib7	6590	20	patients	patient	NNS
cord-005453-4057qib7	6591	1	Background	background	NN
cord-005453-4057qib7	6591	2	:	:	:
cord-005453-4057qib7	6591	3	Low	low	JJ
cord-005453-4057qib7	6591	4	-	-	HYPH
cord-005453-4057qib7	6591	5	density	density	NN
cord-005453-4057qib7	6591	6	neutrophils	neutrophil	NNS
cord-005453-4057qib7	6591	7	(	(	-LRB-
cord-005453-4057qib7	6591	8	LDNs	LDNs	NNP
cord-005453-4057qib7	6591	9	)	)	-RRB-
cord-005453-4057qib7	6591	10	are	be	VBP
cord-005453-4057qib7	6591	11	distinguished	distinguish	VBN
cord-005453-4057qib7	6591	12	from	from	IN
cord-005453-4057qib7	6591	13	normal	normal	JJ
cord-005453-4057qib7	6591	14	-	-	HYPH
cord-005453-4057qib7	6591	15	density	density	NN
cord-005453-4057qib7	6591	16	neutrophils	neutrophil	NNS
cord-005453-4057qib7	6591	17	(	(	-LRB-
cord-005453-4057qib7	6591	18	NDNs	ndn	NNS
cord-005453-4057qib7	6591	19	)	)	-RRB-
cord-005453-4057qib7	6591	20	by	by	IN
cord-005453-4057qib7	6591	21	their	-PRON-	PRP$
cord-005453-4057qib7	6591	22	anomalous	anomalous	JJ
cord-005453-4057qib7	6591	23	sedimentation	sedimentation	NN
cord-005453-4057qib7	6591	24	within	within	IN
cord-005453-4057qib7	6591	25	the	the	DT
cord-005453-4057qib7	6591	26	mononuclear	mononuclear	JJ
cord-005453-4057qib7	6591	27	cell	cell	NN
cord-005453-4057qib7	6591	28	fraction	fraction	NN
cord-005453-4057qib7	6591	29	after	after	IN
cord-005453-4057qib7	6591	30	density	density	NN
cord-005453-4057qib7	6591	31	gradient	gradient	NN
cord-005453-4057qib7	6591	32	centrifugation	centrifugation	NN
cord-005453-4057qib7	6591	33	of	of	IN
cord-005453-4057qib7	6591	34	peripheral	peripheral	JJ
cord-005453-4057qib7	6591	35	blood	blood	NN
cord-005453-4057qib7	6591	36	(	(	-LRB-
cord-005453-4057qib7	6591	37	PB	PB	NNP
cord-005453-4057qib7	6591	38	)	)	-RRB-
cord-005453-4057qib7	6591	39	.	.	.
cord-005453-4057qib7	6592	1	By	by	IN
cord-005453-4057qib7	6592	2	analysing	analyse	VBG
cord-005453-4057qib7	6592	3	LDNs	ldn	NNS
cord-005453-4057qib7	6592	4	and	and	CC
cord-005453-4057qib7	6592	5	NDNs	ndn	NNS
cord-005453-4057qib7	6592	6	from	from	IN
cord-005453-4057qib7	6592	7	G	g	NN
cord-005453-4057qib7	6592	8	-	-	HYPH
cord-005453-4057qib7	6592	9	CSFstimulated	csfstimulate	VBN
cord-005453-4057qib7	6592	10	donors	donor	NNS
cord-005453-4057qib7	6592	11	or	or	CC
cord-005453-4057qib7	6592	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	6592	13	patients	patient	NNS
cord-005453-4057qib7	6592	14	,	,	,
cord-005453-4057qib7	6592	15	we	-PRON-	PRP
cord-005453-4057qib7	6592	16	have	have	VBP
cord-005453-4057qib7	6592	17	previously	previously	RB
cord-005453-4057qib7	6592	18	demonstrated	demonstrate	VBN
cord-005453-4057qib7	6592	19	that	that	IN
cord-005453-4057qib7	6592	20	,	,	,
cord-005453-4057qib7	6592	21	depending	depend	VBG
cord-005453-4057qib7	6592	22	on	on	IN
cord-005453-4057qib7	6592	23	physiopathological	physiopathological	JJ
cord-005453-4057qib7	6592	24	conditions	condition	NNS
cord-005453-4057qib7	6592	25	,	,	,
cord-005453-4057qib7	6592	26	immature	immature	JJ
cord-005453-4057qib7	6592	27	CD66b	CD66b	NNS
cord-005453-4057qib7	6592	28	+	+	CC
cord-005453-4057qib7	6592	29	CD10	CD10	NNP
cord-005453-4057qib7	6592	30	-LDNs	-ldns	TO
cord-005453-4057qib7	6592	31	can	can	MD
cord-005453-4057qib7	6592	32	promote	promote	VB
cord-005453-4057qib7	6592	33	T	T	NNP
cord-005453-4057qib7	6592	34	cell	cell	NN
cord-005453-4057qib7	6592	35	survival	survival	NN
cord-005453-4057qib7	6592	36	and	and	CC
cord-005453-4057qib7	6592	37	IFN	IFN	NNP
cord-005453-4057qib7	6592	38	-	-	HYPH
cord-005453-4057qib7	6592	39	γ	γ	NN
cord-005453-4057qib7	6592	40	production	production	NN
cord-005453-4057qib7	6592	41	,	,	,
cord-005453-4057qib7	6592	42	while	while	IN
cord-005453-4057qib7	6592	43	mature	mature	JJ
cord-005453-4057qib7	6592	44	CD66b	CD66b	NNP
cord-005453-4057qib7	6592	45	+	+	CC
cord-005453-4057qib7	6592	46	CD10	CD10	NNP
cord-005453-4057qib7	6592	47	+	+	CC
cord-005453-4057qib7	6592	48	LDNs	ldn	NNS
cord-005453-4057qib7	6592	49	can	can	MD
cord-005453-4057qib7	6592	50	exert	exert	VB
cord-005453-4057qib7	6592	51	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6592	52	proprieties	propriety	NNS
cord-005453-4057qib7	6592	53	.	.	.
cord-005453-4057qib7	6593	1	Aim	aim	VB
cord-005453-4057qib7	6593	2	of	of	IN
cord-005453-4057qib7	6593	3	this	this	DT
cord-005453-4057qib7	6593	4	study	study	NN
cord-005453-4057qib7	6593	5	was	be	VBD
cord-005453-4057qib7	6593	6	to	to	TO
cord-005453-4057qib7	6593	7	establish	establish	VB
cord-005453-4057qib7	6593	8	the	the	DT
cord-005453-4057qib7	6593	9	frequency	frequency	NN
cord-005453-4057qib7	6593	10	of	of	IN
cord-005453-4057qib7	6593	11	CD66b	cd66b	NN
cord-005453-4057qib7	6593	12	+	+	CC
cord-005453-4057qib7	6593	13	CD10and	cd10and	NN
cord-005453-4057qib7	6593	14	/	/	,
cord-005453-4057qib7	6593	15	or	or	CC
cord-005453-4057qib7	6593	16	CD66b	cd66b	NN
cord-005453-4057qib7	6593	17	+	+	CC
cord-005453-4057qib7	6593	18	CD10	CD10	NNP
cord-005453-4057qib7	6593	19	+	+	CC
cord-005453-4057qib7	6593	20	LDNs	ldn	NNS
cord-005453-4057qib7	6593	21	in	in	IN
cord-005453-4057qib7	6593	22	PB	PB	NNP
cord-005453-4057qib7	6593	23	of	of	IN
cord-005453-4057qib7	6593	24	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6593	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6593	26	stem	stem	NN
cord-005453-4057qib7	6593	27	cell	cell	NN
cord-005453-4057qib7	6593	28	transplant	transplant	NN
cord-005453-4057qib7	6593	29	(	(	-LRB-
cord-005453-4057qib7	6593	30	HSCT	HSCT	NNP
cord-005453-4057qib7	6593	31	)	)	-RRB-
cord-005453-4057qib7	6593	32	patients	patient	NNS
cord-005453-4057qib7	6593	33	throughout	throughout	IN
cord-005453-4057qib7	6593	34	immune	immune	JJ
cord-005453-4057qib7	6593	35	reconstitution	reconstitution	NN
cord-005453-4057qib7	6593	36	,	,	,
cord-005453-4057qib7	6593	37	and	and	CC
cord-005453-4057qib7	6593	38	verify	verify	VB
cord-005453-4057qib7	6593	39	their	-PRON-	PRP$
cord-005453-4057qib7	6593	40	potential	potential	JJ
cord-005453-4057qib7	6593	41	correlation	correlation	NN
cord-005453-4057qib7	6593	42	with	with	IN
cord-005453-4057qib7	6593	43	acute	acute	JJ
cord-005453-4057qib7	6593	44	graft	graft	NN
cord-005453-4057qib7	6593	45	versus	versus	IN
cord-005453-4057qib7	6593	46	host	host	NN
cord-005453-4057qib7	6593	47	disease	disease	NN
cord-005453-4057qib7	6593	48	(	(	-LRB-
cord-005453-4057qib7	6593	49	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6593	50	)	)	-RRB-
cord-005453-4057qib7	6593	51	.	.	.
cord-005453-4057qib7	6594	1	Methods	method	NNS
cord-005453-4057qib7	6594	2	:	:	:
cord-005453-4057qib7	6594	3	Patients	patient	NNS
cord-005453-4057qib7	6594	4	undergoing	undergo	VBG
cord-005453-4057qib7	6594	5	HSCT	HSCT	NNP
cord-005453-4057qib7	6594	6	in	in	IN
cord-005453-4057qib7	6594	7	our	-PRON-	PRP$
cord-005453-4057qib7	6594	8	Institution	Institution	NNP
cord-005453-4057qib7	6594	9	between	between	IN
cord-005453-4057qib7	6594	10	December	December	NNP
cord-005453-4057qib7	6594	11	2015	2015	CD
cord-005453-4057qib7	6594	12	and	and	CC
cord-005453-4057qib7	6594	13	June	June	NNP
cord-005453-4057qib7	6594	14	2018	2018	CD
cord-005453-4057qib7	6594	15	were	be	VBD
cord-005453-4057qib7	6594	16	prospectively	prospectively	RB
cord-005453-4057qib7	6594	17	enrolled	enrol	VBN
cord-005453-4057qib7	6594	18	in	in	IN
cord-005453-4057qib7	6594	19	the	the	DT
cord-005453-4057qib7	6594	20	study	study	NN
cord-005453-4057qib7	6594	21	upon	upon	IN
cord-005453-4057qib7	6594	22	informed	informed	JJ
cord-005453-4057qib7	6594	23	consent	consent	NN
cord-005453-4057qib7	6594	24	and	and	CC
cord-005453-4057qib7	6594	25	after	after	IN
cord-005453-4057qib7	6594	26	Institutional	Institutional	NNP
cord-005453-4057qib7	6594	27	Board	Board	NNP
cord-005453-4057qib7	6594	28	approval	approval	NN
cord-005453-4057qib7	6594	29	.	.	.
cord-005453-4057qib7	6595	1	Criteria	criterion	NNS
cord-005453-4057qib7	6595	2	of	of	IN
cord-005453-4057qib7	6595	3	inclusion	inclusion	NN
cord-005453-4057qib7	6595	4	were	be	VBD
cord-005453-4057qib7	6595	5	age	age	NN
cord-005453-4057qib7	6595	6	≥	≥	CD
cord-005453-4057qib7	6595	7	18	18	CD
cord-005453-4057qib7	6595	8	years	year	NNS
cord-005453-4057qib7	6595	9	and	and	CC
cord-005453-4057qib7	6595	10	absence	absence	NN
cord-005453-4057qib7	6595	11	of	of	IN
cord-005453-4057qib7	6595	12	rheumatologic	rheumatologic	JJ
cord-005453-4057qib7	6595	13	or	or	CC
cord-005453-4057qib7	6595	14	viral	viral	JJ
cord-005453-4057qib7	6595	15	diseases	disease	NNS
cord-005453-4057qib7	6595	16	.	.	.
cord-005453-4057qib7	6596	1	PB	PB	NNP
cord-005453-4057qib7	6596	2	samples	sample	NNS
cord-005453-4057qib7	6596	3	were	be	VBD
cord-005453-4057qib7	6596	4	collected	collect	VBN
cord-005453-4057qib7	6596	5	at	at	IN
cord-005453-4057qib7	6596	6	day	day	NN
cord-005453-4057qib7	6596	7	+21	+21	NNS
cord-005453-4057qib7	6596	8	,	,	,
cord-005453-4057qib7	6596	9	+42	+42	NN
cord-005453-4057qib7	6596	10	,	,	,
cord-005453-4057qib7	6596	11	+60	+60	NNP
cord-005453-4057qib7	6596	12	,	,	,
cord-005453-4057qib7	6596	13	+90	+90	NN
cord-005453-4057qib7	6596	14	and	and	CC
cord-005453-4057qib7	6596	15	+180	+180	NNP
cord-005453-4057qib7	6596	16	after	after	IN
cord-005453-4057qib7	6596	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6596	18	and	and	CC
cord-005453-4057qib7	6596	19	any	any	DT
cord-005453-4057qib7	6596	20	time	time	NN
cord-005453-4057qib7	6596	21	within	within	IN
cord-005453-4057qib7	6596	22	day	day	NN
cord-005453-4057qib7	6596	23	+180	+180	NNP
cord-005453-4057qib7	6596	24	in	in	IN
cord-005453-4057qib7	6596	25	case	case	NN
cord-005453-4057qib7	6596	26	of	of	IN
cord-005453-4057qib7	6596	27	GVHD	GVHD	NNP
cord-005453-4057qib7	6596	28	,	,	,
cord-005453-4057qib7	6596	29	before	before	IN
cord-005453-4057qib7	6596	30	first	first	JJ
cord-005453-4057qib7	6596	31	-	-	HYPH
cord-005453-4057qib7	6596	32	line	line	NN
cord-005453-4057qib7	6596	33	therapy	therapy	NN
cord-005453-4057qib7	6596	34	.	.	.
cord-005453-4057qib7	6597	1	Eight	eight	CD
cord-005453-4057qib7	6597	2	healthy	healthy	JJ
cord-005453-4057qib7	6597	3	donors	donor	NNS
cord-005453-4057qib7	6597	4	(	(	-LRB-
cord-005453-4057qib7	6597	5	HDs	hd	NNS
cord-005453-4057qib7	6597	6	)	)	-RRB-
cord-005453-4057qib7	6597	7	were	be	VBD
cord-005453-4057qib7	6597	8	enrolled	enrol	VBN
cord-005453-4057qib7	6597	9	as	as	IN
cord-005453-4057qib7	6597	10	control	control	NN
cord-005453-4057qib7	6597	11	.	.	.
cord-005453-4057qib7	6598	1	Mononuclear	Mononuclear	NNP
cord-005453-4057qib7	6598	2	,	,	,
cord-005453-4057qib7	6598	3	polymorphonuclear	polymorphonuclear	NN
cord-005453-4057qib7	6598	4	,	,	,
cord-005453-4057qib7	6598	5	and	and	CC
cord-005453-4057qib7	6598	6	whole	whole	JJ
cord-005453-4057qib7	6598	7	blood	blood	NN
cord-005453-4057qib7	6598	8	cells	cell	NNS
cord-005453-4057qib7	6598	9	were	be	VBD
cord-005453-4057qib7	6598	10	analysed	analyse	VBN
cord-005453-4057qib7	6598	11	by	by	IN
cord-005453-4057qib7	6598	12	flow	flow	NN
cord-005453-4057qib7	6598	13	cytometry	cytometry	NN
cord-005453-4057qib7	6598	14	after	after	IN
cord-005453-4057qib7	6598	15	CD45	CD45	NNP
cord-005453-4057qib7	6598	16	Vioblue	Vioblue	NNP
cord-005453-4057qib7	6598	17	,	,	,
cord-005453-4057qib7	6598	18	CD16	CD16	NNP
cord-005453-4057qib7	6598	19	APC	APC	NNP
cord-005453-4057qib7	6598	20	-	-	HYPH
cord-005453-4057qib7	6598	21	Cy7	Cy7	NNP
cord-005453-4057qib7	6598	22	,	,	,
cord-005453-4057qib7	6598	23	CD11b	CD11b	VBZ
cord-005453-4057qib7	6598	24	PE	pe	NN
cord-005453-4057qib7	6598	25	-	-	HYPH
cord-005453-4057qib7	6598	26	Cy7	Cy7	NNP
cord-005453-4057qib7	6598	27	,	,	,
cord-005453-4057qib7	6599	1	CD10	CD10	NNP
cord-005453-4057qib7	6599	2	PE	PE	NNP
cord-005453-4057qib7	6599	3	,	,	,
cord-005453-4057qib7	6599	4	CD66b	cd66b	NN
cord-005453-4057qib7	6599	5	FITC	FITC	NNP
cord-005453-4057qib7	6599	6	staining	stain	VBG
cord-005453-4057qib7	6599	7	.	.	.
cord-005453-4057qib7	6600	1	CD66b	cd66b	NN
cord-005453-4057qib7	6600	2	+	+	CC
cord-005453-4057qib7	6600	3	LDNs	ldn	NNS
cord-005453-4057qib7	6600	4	were	be	VBD
cord-005453-4057qib7	6600	5	expressed	express	VBN
cord-005453-4057qib7	6600	6	as	as	IN
cord-005453-4057qib7	6600	7	percentage	percentage	NN
cord-005453-4057qib7	6600	8	of	of	IN
cord-005453-4057qib7	6600	9	CD45	CD45	NNP
cord-005453-4057qib7	6600	10	+	+	SYM
cord-005453-4057qib7	6600	11	PB	PB	NNP
cord-005453-4057qib7	6600	12	mononuclear	mononuclear	NN
cord-005453-4057qib7	6600	13	cells	cell	NNS
cord-005453-4057qib7	6600	14	(	(	-LRB-
cord-005453-4057qib7	6600	15	PBMCs	pbmc	NNS
cord-005453-4057qib7	6600	16	)	)	-RRB-
cord-005453-4057qib7	6600	17	or	or	CC
cord-005453-4057qib7	6600	18	CD45	CD45	NNP
cord-005453-4057qib7	6600	19	+	+	CC
cord-005453-4057qib7	6600	20	whole	whole	JJ
cord-005453-4057qib7	6600	21	blood	blood	NN
cord-005453-4057qib7	6600	22	cells	cell	NNS
cord-005453-4057qib7	6600	23	and	and	CC
cord-005453-4057qib7	6600	24	were	be	VBD
cord-005453-4057qib7	6600	25	further	further	RB
cord-005453-4057qib7	6600	26	characterized	characterize	VBN
cord-005453-4057qib7	6600	27	based	base	VBN
cord-005453-4057qib7	6600	28	on	on	IN
cord-005453-4057qib7	6600	29	CD10	CD10	NNP
cord-005453-4057qib7	6600	30	expression	expression	NN
cord-005453-4057qib7	6600	31	.	.	.
cord-005453-4057qib7	6601	1	CD66b	CD66b	NNS
cord-005453-4057qib7	6601	2	+	+	CC
cord-005453-4057qib7	6601	3	NDNs	ndn	NNS
cord-005453-4057qib7	6601	4	,	,	,
cord-005453-4057qib7	6601	5	expressed	express	VBN
cord-005453-4057qib7	6601	6	as	as	IN
cord-005453-4057qib7	6601	7	percentage	percentage	NN
cord-005453-4057qib7	6601	8	of	of	IN
cord-005453-4057qib7	6601	9	CD45	CD45	NNP
cord-005453-4057qib7	6601	10	+	+	CC
cord-005453-4057qib7	6601	11	whole	whole	JJ
cord-005453-4057qib7	6601	12	blood	blood	NN
cord-005453-4057qib7	6601	13	cells	cell	NNS
cord-005453-4057qib7	6601	14	,	,	,
cord-005453-4057qib7	6601	15	were	be	VBD
cord-005453-4057qib7	6601	16	also	also	RB
cord-005453-4057qib7	6601	17	analysed	analyse	VBN
cord-005453-4057qib7	6601	18	for	for	IN
cord-005453-4057qib7	6601	19	CD10	CD10	NNP
cord-005453-4057qib7	6601	20	staining	staining	NN
cord-005453-4057qib7	6601	21	.	.	.
cord-005453-4057qib7	6602	1	Results	result	NNS
cord-005453-4057qib7	6602	2	:	:	:
cord-005453-4057qib7	6602	3	39	39	CD
cord-005453-4057qib7	6602	4	patients	patient	NNS
cord-005453-4057qib7	6602	5	(	(	-LRB-
cord-005453-4057qib7	6602	6	M	M	NNP
cord-005453-4057qib7	6602	7	/	/	SYM
cord-005453-4057qib7	6602	8	F	F	NNP
cord-005453-4057qib7	6602	9	25/14	25/14	CD
cord-005453-4057qib7	6602	10	,	,	,
cord-005453-4057qib7	6602	11	median	median	JJ
cord-005453-4057qib7	6602	12	age	age	NN
cord-005453-4057qib7	6602	13	47	47	CD
cord-005453-4057qib7	6602	14	)	)	-RRB-
cord-005453-4057qib7	6602	15	were	be	VBD
cord-005453-4057qib7	6602	16	enrolled	enrol	VBN
cord-005453-4057qib7	6602	17	in	in	IN
cord-005453-4057qib7	6602	18	the	the	DT
cord-005453-4057qib7	6602	19	study	study	NN
cord-005453-4057qib7	6602	20	.	.	.
cord-005453-4057qib7	6603	1	Patients	patient	NNS
cord-005453-4057qib7	6603	2	received	receive	VBD
cord-005453-4057qib7	6603	3	HSCT	HSCT	NNP
cord-005453-4057qib7	6603	4	from	from	IN
cord-005453-4057qib7	6603	5	HLAidentical	HLAidentical	NNP
cord-005453-4057qib7	6603	6	(	(	-LRB-
cord-005453-4057qib7	6603	7	13	13	CD
cord-005453-4057qib7	6603	8	)	)	-RRB-
cord-005453-4057qib7	6603	9	or	or	CC
cord-005453-4057qib7	6603	10	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6603	11	(	(	-LRB-
cord-005453-4057qib7	6603	12	6	6	CD
cord-005453-4057qib7	6603	13	)	)	-RRB-
cord-005453-4057qib7	6603	14	related	relate	VBN
cord-005453-4057qib7	6603	15	and	and	CC
cord-005453-4057qib7	6603	16	from	from	IN
cord-005453-4057qib7	6603	17	HLAidentical	hlaidentical	JJ
cord-005453-4057qib7	6603	18	unrelated	unrelated	JJ
cord-005453-4057qib7	6603	19	(	(	-LRB-
cord-005453-4057qib7	6603	20	20	20	CD
cord-005453-4057qib7	6603	21	)	)	-RRB-
cord-005453-4057qib7	6603	22	donors	donor	NNS
cord-005453-4057qib7	6603	23	.	.	.
cord-005453-4057qib7	6604	1	After	after	IN
cord-005453-4057qib7	6604	2	a	a	DT
cord-005453-4057qib7	6604	3	median	median	JJ
cord-005453-4057qib7	6604	4	time	time	NN
cord-005453-4057qib7	6604	5	of	of	IN
cord-005453-4057qib7	6604	6	33	33	CD
cord-005453-4057qib7	6604	7	(	(	-LRB-
cord-005453-4057qib7	6604	8	15	15	CD
cord-005453-4057qib7	6604	9	-	-	SYM
cord-005453-4057qib7	6604	10	95	95	CD
cord-005453-4057qib7	6604	11	)	)	-RRB-
cord-005453-4057qib7	6604	12	days	day	NNS
cord-005453-4057qib7	6604	13	,	,	,
cord-005453-4057qib7	6604	14	13	13	CD
cord-005453-4057qib7	6604	15	patients	patient	NNS
cord-005453-4057qib7	6604	16	developed	develop	VBD
cord-005453-4057qib7	6604	17	grade	grade	NN
cord-005453-4057qib7	6604	18	II	II	NNP
cord-005453-4057qib7	6604	19	-	-	HYPH
cord-005453-4057qib7	6604	20	IV	IV	NNP
cord-005453-4057qib7	6604	21	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6604	22	.	.	.
cord-005453-4057qib7	6605	1	No	no	DT
cord-005453-4057qib7	6605	2	patients	patient	NNS
cord-005453-4057qib7	6605	3	were	be	VBD
cord-005453-4057qib7	6605	4	receiving	receive	VBG
cord-005453-4057qib7	6605	5	G	G	NNP
cord-005453-4057qib7	6605	6	-	-	HYPH
cord-005453-4057qib7	6605	7	CSF	CSF	NNP
cord-005453-4057qib7	6605	8	at	at	IN
cord-005453-4057qib7	6605	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6605	10	onset	onset	NN
cord-005453-4057qib7	6605	11	.	.	.
cord-005453-4057qib7	6606	1	The	the	DT
cord-005453-4057qib7	6606	2	scheduled	schedule	VBN
cord-005453-4057qib7	6606	3	assessments	assessment	NNS
cord-005453-4057qib7	6606	4	were	be	VBD
cord-005453-4057qib7	6606	5	interrupted	interrupt	VBN
cord-005453-4057qib7	6606	6	in	in	IN
cord-005453-4057qib7	6606	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6606	8	patients	patient	NNS
cord-005453-4057qib7	6606	9	at	at	IN
cord-005453-4057qib7	6606	10	the	the	DT
cord-005453-4057qib7	6606	11	beginning	beginning	NN
cord-005453-4057qib7	6606	12	of	of	IN
cord-005453-4057qib7	6606	13	first	first	JJ
cord-005453-4057qib7	6606	14	-	-	HYPH
cord-005453-4057qib7	6606	15	line	line	NN
cord-005453-4057qib7	6606	16	treatment	treatment	NN
cord-005453-4057qib7	6606	17	and	and	CC
cord-005453-4057qib7	6606	18	in	in	IN
cord-005453-4057qib7	6606	19	4	4	CD
cord-005453-4057qib7	6606	20	patients	patient	NNS
cord-005453-4057qib7	6606	21	relapsed	relapse	VBN
cord-005453-4057qib7	6606	22	of	of	IN
cord-005453-4057qib7	6606	23	their	-PRON-	PRP$
cord-005453-4057qib7	6606	24	primary	primary	JJ
cord-005453-4057qib7	6606	25	malignancy	malignancy	NN
cord-005453-4057qib7	6606	26	.	.	.
cord-005453-4057qib7	6607	1	No	no	DT
cord-005453-4057qib7	6607	2	patients	patient	NNS
cord-005453-4057qib7	6607	3	developed	develop	VBD
cord-005453-4057qib7	6607	4	de	de	IN
cord-005453-4057qib7	6607	5	novo	novo	NNP
cord-005453-4057qib7	6607	6	late	late	JJ
cord-005453-4057qib7	6607	7	-	-	HYPH
cord-005453-4057qib7	6607	8	acute	acute	JJ
cord-005453-4057qib7	6607	9	or	or	CC
cord-005453-4057qib7	6607	10	chronic	chronic	JJ
cord-005453-4057qib7	6607	11	GVHD	GVHD	NNP
cord-005453-4057qib7	6607	12	.	.	.
cord-005453-4057qib7	6608	1	Starting	start	VBG
cord-005453-4057qib7	6608	2	from	from	IN
cord-005453-4057qib7	6608	3	day	day	NN
cord-005453-4057qib7	6608	4	+21	+21	VBZ
cord-005453-4057qib7	6608	5	the	the	DT
cord-005453-4057qib7	6608	6	frequency	frequency	NN
cord-005453-4057qib7	6608	7	of	of	IN
cord-005453-4057qib7	6608	8	LDNs	ldns	NN
cord-005453-4057qib7	6608	9	within	within	IN
cord-005453-4057qib7	6608	10	CD45	CD45	NNP
cord-005453-4057qib7	6608	11	+	+	CC
cord-005453-4057qib7	6608	12	PBMCs	pbmc	NNS
cord-005453-4057qib7	6608	13	was	be	VBD
cord-005453-4057qib7	6608	14	higher	high	JJR
cord-005453-4057qib7	6608	15	in	in	IN
cord-005453-4057qib7	6608	16	all	all	DT
cord-005453-4057qib7	6608	17	patients	patient	NNS
cord-005453-4057qib7	6608	18	as	as	IN
cord-005453-4057qib7	6608	19	compared	compare	VBN
cord-005453-4057qib7	6608	20	to	to	IN
cord-005453-4057qib7	6608	21	HDs	hd	NNS
cord-005453-4057qib7	6608	22	.	.	.
cord-005453-4057qib7	6609	1	The	the	DT
cord-005453-4057qib7	6609	2	25	25	CD
cord-005453-4057qib7	6609	3	patients	patient	NNS
cord-005453-4057qib7	6609	4	that	that	WDT
cord-005453-4057qib7	6609	5	did	do	VBD
cord-005453-4057qib7	6609	6	not	not	RB
cord-005453-4057qib7	6609	7	develop	develop	VB
cord-005453-4057qib7	6609	8	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6609	9	showed	show	VBD
cord-005453-4057qib7	6609	10	a	a	DT
cord-005453-4057qib7	6609	11	decreasing	decrease	VBG
cord-005453-4057qib7	6609	12	frequency	frequency	NN
cord-005453-4057qib7	6609	13	of	of	IN
cord-005453-4057qib7	6609	14	CD66b	cd66b	NN
cord-005453-4057qib7	6609	15	+	+	CC
cord-005453-4057qib7	6609	16	CD10	CD10	NNP
cord-005453-4057qib7	6609	17	-LDNs	-ldns	CD
cord-005453-4057qib7	6609	18	,	,	,
cord-005453-4057qib7	6609	19	with	with	IN
cord-005453-4057qib7	6609	20	a	a	DT
cord-005453-4057qib7	6609	21	progressive	progressive	JJ
cord-005453-4057qib7	6609	22	increase	increase	NN
cord-005453-4057qib7	6609	23	of	of	IN
cord-005453-4057qib7	6609	24	CD66b	cd66b	NN
cord-005453-4057qib7	6609	25	+	+	CC
cord-005453-4057qib7	6609	26	CD10	CD10	NNP
cord-005453-4057qib7	6609	27	+	+	CC
cord-005453-4057qib7	6609	28	LDNs	ldn	NNS
cord-005453-4057qib7	6609	29	,	,	,
cord-005453-4057qib7	6609	30	from	from	IN
cord-005453-4057qib7	6609	31	day	day	NN
cord-005453-4057qib7	6609	32	+21	+21	CD
cord-005453-4057qib7	6610	1	to	to	IN
cord-005453-4057qib7	6610	2	+180	+180	NNP
cord-005453-4057qib7	6610	3	.	.	.
cord-005453-4057qib7	6611	1	Interestingly	interestingly	RB
cord-005453-4057qib7	6611	2	,	,	,
cord-005453-4057qib7	6611	3	patients	patient	NNS
cord-005453-4057qib7	6611	4	with	with	IN
cord-005453-4057qib7	6611	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6611	6	showed	show	VBD
cord-005453-4057qib7	6611	7	a	a	DT
cord-005453-4057qib7	6611	8	significantly	significantly	RB
cord-005453-4057qib7	6611	9	higher	high	JJR
cord-005453-4057qib7	6611	10	frequency	frequency	NN
cord-005453-4057qib7	6611	11	of	of	IN
cord-005453-4057qib7	6611	12	CD66b	cd66b	NN
cord-005453-4057qib7	6612	1	+	+	CC
cord-005453-4057qib7	6612	2	CD10	CD10	NNP
cord-005453-4057qib7	6612	3	-LDNs	-ldns	CD
cord-005453-4057qib7	6612	4	as	as	IN
cord-005453-4057qib7	6612	5	compared	compare	VBN
cord-005453-4057qib7	6612	6	to	to	IN
cord-005453-4057qib7	6612	7	patients	patient	NNS
cord-005453-4057qib7	6612	8	without	without	IN
cord-005453-4057qib7	6612	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6612	10	throughout	throughout	IN
cord-005453-4057qib7	6612	11	the	the	DT
cord-005453-4057qib7	6612	12	same	same	JJ
cord-005453-4057qib7	6612	13	time	time	NN
cord-005453-4057qib7	6612	14	lapse	lapse	NN
cord-005453-4057qib7	6612	15	(	(	-LRB-
cord-005453-4057qib7	6612	16	i.e.	i.e.	FW
cord-005453-4057qib7	6612	17	from	from	IN
cord-005453-4057qib7	6612	18	day	day	NN
cord-005453-4057qib7	6612	19	+21	+21	CD
cord-005453-4057qib7	6612	20	to	to	IN
cord-005453-4057qib7	6612	21	+90	+90	CD
cord-005453-4057qib7	6612	22	)	)	-RRB-
cord-005453-4057qib7	6612	23	(	(	-LRB-
cord-005453-4057qib7	6612	24	83.15	83.15	CD
cord-005453-4057qib7	6612	25	vs	vs	IN
cord-005453-4057qib7	6612	26	50.8	50.8	CD
cord-005453-4057qib7	6612	27	,	,	,
cord-005453-4057qib7	6612	28	p=0.027	p=0.027	NNP
cord-005453-4057qib7	6612	29	)	)	-RRB-
cord-005453-4057qib7	6612	30	.	.	.
cord-005453-4057qib7	6613	1	Consistently	consistently	RB
cord-005453-4057qib7	6613	2	,	,	,
cord-005453-4057qib7	6613	3	patients	patient	NNS
cord-005453-4057qib7	6613	4	with	with	IN
cord-005453-4057qib7	6613	5	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6613	6	had	have	VBD
cord-005453-4057qib7	6613	7	a	a	DT
cord-005453-4057qib7	6613	8	significantly	significantly	RB
cord-005453-4057qib7	6613	9	lower	low	JJR
cord-005453-4057qib7	6613	10	frequency	frequency	NN
cord-005453-4057qib7	6613	11	of	of	IN
cord-005453-4057qib7	6613	12	CD66b	cd66b	NN
cord-005453-4057qib7	6613	13	+	+	CC
cord-005453-4057qib7	6613	14	CD10	CD10	NNP
cord-005453-4057qib7	6613	15	+	+	CC
cord-005453-4057qib7	6613	16	LDNs	LDNs	NNP
cord-005453-4057qib7	6613	17	(	(	-LRB-
cord-005453-4057qib7	6613	18	12.1	12.1	CD
cord-005453-4057qib7	6613	19	vs	vs	IN
cord-005453-4057qib7	6613	20	50.05	50.05	CD
cord-005453-4057qib7	6613	21	,	,	,
cord-005453-4057qib7	6613	22	p=0.0014	p=0.0014	NNPS
cord-005453-4057qib7	6613	23	)	)	-RRB-
cord-005453-4057qib7	6613	24	.	.	.
cord-005453-4057qib7	6614	1	The	the	DT
cord-005453-4057qib7	6614	2	frequency	frequency	NN
cord-005453-4057qib7	6614	3	of	of	IN
cord-005453-4057qib7	6614	4	mature	mature	JJ
cord-005453-4057qib7	6614	5	CD66b	CD66b	NNP
cord-005453-4057qib7	6614	6	+	+	CC
cord-005453-4057qib7	6614	7	CD10	CD10	NNP
cord-005453-4057qib7	6614	8	+	+	CC
cord-005453-4057qib7	6614	9	NDNs	ndn	NNS
cord-005453-4057qib7	6614	10	was	be	VBD
cord-005453-4057qib7	6614	11	normal	normal	JJ
cord-005453-4057qib7	6614	12	in	in	IN
cord-005453-4057qib7	6614	13	all	all	DT
cord-005453-4057qib7	6614	14	patients	patient	NNS
cord-005453-4057qib7	6614	15	since	since	IN
cord-005453-4057qib7	6614	16	day	day	NN
cord-005453-4057qib7	6614	17	+21	+21	CD
cord-005453-4057qib7	6614	18	.	.	.
cord-005453-4057qib7	6615	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6615	2	:	:	:
cord-005453-4057qib7	6616	1	LDNs	LDNs	NNP
cord-005453-4057qib7	6616	2	are	be	VBP
cord-005453-4057qib7	6616	3	more	more	RBR
cord-005453-4057qib7	6616	4	represented	represent	VBN
cord-005453-4057qib7	6616	5	in	in	IN
cord-005453-4057qib7	6616	6	HSCT	HSCT	NNP
cord-005453-4057qib7	6616	7	patients	patient	NNS
cord-005453-4057qib7	6616	8	than	than	IN
cord-005453-4057qib7	6616	9	in	in	IN
cord-005453-4057qib7	6616	10	HDs	HDs	NNP
cord-005453-4057qib7	6616	11	,	,	,
cord-005453-4057qib7	6616	12	with	with	IN
cord-005453-4057qib7	6616	13	a	a	DT
cord-005453-4057qib7	6616	14	significant	significant	JJ
cord-005453-4057qib7	6616	15	expansion	expansion	NN
cord-005453-4057qib7	6616	16	of	of	IN
cord-005453-4057qib7	6616	17	the	the	DT
cord-005453-4057qib7	6616	18	CD66b	CD66b	NNS
cord-005453-4057qib7	6616	19	+	+	CC
cord-005453-4057qib7	6616	20	CD10subpopulation	cd10subpopulation	NN
cord-005453-4057qib7	6617	1	(	(	-LRB-
cord-005453-4057qib7	6617	2	with	with	IN
cord-005453-4057qib7	6617	3	a	a	DT
cord-005453-4057qib7	6617	4	parallel	parallel	JJ
cord-005453-4057qib7	6617	5	decrease	decrease	NN
cord-005453-4057qib7	6617	6	of	of	IN
cord-005453-4057qib7	6617	7	the	the	DT
cord-005453-4057qib7	6617	8	CD66b	CD66b	NNS
cord-005453-4057qib7	6617	9	+	+	CC
cord-005453-4057qib7	6617	10	CD10	CD10	NNP
cord-005453-4057qib7	6617	11	+	+	CC
cord-005453-4057qib7	6617	12	subpopulation	subpopulation	NN
cord-005453-4057qib7	6617	13	)	)	-RRB-
cord-005453-4057qib7	6617	14	in	in	IN
cord-005453-4057qib7	6617	15	patients	patient	NNS
cord-005453-4057qib7	6617	16	with	with	IN
cord-005453-4057qib7	6617	17	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6617	18	as	as	IN
cord-005453-4057qib7	6617	19	compared	compare	VBN
cord-005453-4057qib7	6617	20	to	to	IN
cord-005453-4057qib7	6617	21	those	those	DT
cord-005453-4057qib7	6617	22	without	without	IN
cord-005453-4057qib7	6617	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6617	24	.	.	.
cord-005453-4057qib7	6618	1	According	accord	VBG
cord-005453-4057qib7	6618	2	to	to	IN
cord-005453-4057qib7	6618	3	the	the	DT
cord-005453-4057qib7	6618	4	previously	previously	RB
cord-005453-4057qib7	6618	5	demonstrated	demonstrate	VBN
cord-005453-4057qib7	6618	6	T	t	NN
cord-005453-4057qib7	6618	7	cell	cell	NN
cord-005453-4057qib7	6618	8	activating	activate	VBG
cord-005453-4057qib7	6618	9	function	function	NN
cord-005453-4057qib7	6618	10	of	of	IN
cord-005453-4057qib7	6618	11	CD66b	CD66b	NNS
cord-005453-4057qib7	6618	12	+	+	CC
cord-005453-4057qib7	6618	13	CD10	CD10	NNP
cord-005453-4057qib7	6618	14	-LDNs	-ldns	XX
cord-005453-4057qib7	6618	15	,	,	,
cord-005453-4057qib7	6618	16	it	-PRON-	PRP
cord-005453-4057qib7	6618	17	is	be	VBZ
cord-005453-4057qib7	6618	18	tempting	tempt	VBG
cord-005453-4057qib7	6618	19	to	to	TO
cord-005453-4057qib7	6618	20	speculate	speculate	VB
cord-005453-4057qib7	6618	21	that	that	IN
cord-005453-4057qib7	6618	22	the	the	DT
cord-005453-4057qib7	6618	23	expansion	expansion	NN
cord-005453-4057qib7	6618	24	of	of	IN
cord-005453-4057qib7	6618	25	this	this	DT
cord-005453-4057qib7	6618	26	subpopulation	subpopulation	NN
cord-005453-4057qib7	6618	27	may	may	MD
cord-005453-4057qib7	6618	28	contribute	contribute	VB
cord-005453-4057qib7	6618	29	to	to	IN
cord-005453-4057qib7	6618	30	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6618	31	development	development	NN
cord-005453-4057qib7	6618	32	.	.	.
cord-005453-4057qib7	6619	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6619	2	:	:	:
cord-005453-4057qib7	6619	3	Nothing	nothing	NN
cord-005453-4057qib7	6619	4	to	to	TO
cord-005453-4057qib7	6619	5	declare	declare	VB
cord-005453-4057qib7	6619	6	Background	background	NN
cord-005453-4057qib7	6619	7	:	:	:
cord-005453-4057qib7	6620	1	Acute	acute	JJ
cord-005453-4057qib7	6620	2	graft	graft	NN
cord-005453-4057qib7	6620	3	-	-	HYPH
cord-005453-4057qib7	6620	4	versus	versus	IN
cord-005453-4057qib7	6620	5	-	-	HYPH
cord-005453-4057qib7	6620	6	host	host	NN
cord-005453-4057qib7	6620	7	disease	disease	NN
cord-005453-4057qib7	6620	8	(	(	-LRB-
cord-005453-4057qib7	6620	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6620	10	)	)	-RRB-
cord-005453-4057qib7	6620	11	is	be	VBZ
cord-005453-4057qib7	6620	12	a	a	DT
cord-005453-4057qib7	6620	13	major	major	JJ
cord-005453-4057qib7	6620	14	complication	complication	NN
cord-005453-4057qib7	6620	15	after	after	IN
cord-005453-4057qib7	6620	16	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6620	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6620	18	stem	stem	NN
cord-005453-4057qib7	6620	19	cell	cell	NN
cord-005453-4057qib7	6620	20	transplantation	transplantation	NN
cord-005453-4057qib7	6620	21	(	(	-LRB-
cord-005453-4057qib7	6620	22	allo	allo	NN
cord-005453-4057qib7	6620	23	-	-	HYPH
cord-005453-4057qib7	6620	24	HSCT	HSCT	NNP
cord-005453-4057qib7	6620	25	)	)	-RRB-
cord-005453-4057qib7	6620	26	which	which	WDT
cord-005453-4057qib7	6620	27	has	have	VBZ
cord-005453-4057qib7	6620	28	negative	negative	JJ
cord-005453-4057qib7	6620	29	impact	impact	NN
cord-005453-4057qib7	6620	30	on	on	IN
cord-005453-4057qib7	6620	31	the	the	DT
cord-005453-4057qib7	6620	32	morbidity	morbidity	NN
cord-005453-4057qib7	6620	33	and	and	CC
cord-005453-4057qib7	6620	34	mortality	mortality	NN
cord-005453-4057qib7	6620	35	of	of	IN
cord-005453-4057qib7	6620	36	the	the	DT
cord-005453-4057qib7	6620	37	patients	patient	NNS
cord-005453-4057qib7	6620	38	.	.	.
cord-005453-4057qib7	6621	1	Accumulating	accumulate	VBG
cord-005453-4057qib7	6621	2	evidences	evidence	NNS
cord-005453-4057qib7	6621	3	suggest	suggest	VBP
cord-005453-4057qib7	6621	4	that	that	IN
cord-005453-4057qib7	6621	5	abnormalities	abnormality	NNS
cord-005453-4057qib7	6621	6	of	of	IN
cord-005453-4057qib7	6621	7	Foxp3	foxp3	JJ
cord-005453-4057qib7	6621	8	+	+	CC
cord-005453-4057qib7	6621	9	Regulatory	Regulatory	NNP
cord-005453-4057qib7	6621	10	T	T	NNP
cord-005453-4057qib7	6621	11	(	(	-LRB-
cord-005453-4057qib7	6621	12	Treg	Treg	NNP
cord-005453-4057qib7	6621	13	)	)	-RRB-
cord-005453-4057qib7	6621	14	cells	cell	NNS
cord-005453-4057qib7	6621	15	contributed	contribute	VBD
cord-005453-4057qib7	6621	16	to	to	IN
cord-005453-4057qib7	6621	17	the	the	DT
cord-005453-4057qib7	6621	18	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	6621	19	of	of	IN
cord-005453-4057qib7	6621	20	GVHD	GVHD	NNP
cord-005453-4057qib7	6621	21	,	,	,
cord-005453-4057qib7	6621	22	but	but	CC
cord-005453-4057qib7	6621	23	the	the	DT
cord-005453-4057qib7	6621	24	underlying	underlying	JJ
cord-005453-4057qib7	6621	25	molecular	molecular	JJ
cord-005453-4057qib7	6621	26	mechanisms	mechanism	NNS
cord-005453-4057qib7	6621	27	still	still	RB
cord-005453-4057qib7	6621	28	remain	remain	VBP
cord-005453-4057qib7	6621	29	largely	largely	RB
cord-005453-4057qib7	6621	30	unknown	unknown	JJ
cord-005453-4057qib7	6621	31	.	.	.
cord-005453-4057qib7	6622	1	Methods	method	NNS
cord-005453-4057qib7	6622	2	:	:	:
cord-005453-4057qib7	6622	3	In	in	IN
cord-005453-4057qib7	6622	4	this	this	DT
cord-005453-4057qib7	6622	5	study	study	NN
cord-005453-4057qib7	6622	6	,	,	,
cord-005453-4057qib7	6622	7	we	-PRON-	PRP
cord-005453-4057qib7	6622	8	enrolled	enrol	VBD
cord-005453-4057qib7	6622	9	all	all	PDT
cord-005453-4057qib7	6622	10	the	the	DT
cord-005453-4057qib7	6622	11	40	40	CD
cord-005453-4057qib7	6622	12	patients	patient	NNS
cord-005453-4057qib7	6622	13	treated	treat	VBN
cord-005453-4057qib7	6622	14	with	with	IN
cord-005453-4057qib7	6622	15	allogeneic	allogeneic	IN
cord-005453-4057qib7	6622	16	HSCT	HSCT	NNP
cord-005453-4057qib7	6622	17	at	at	IN
cord-005453-4057qib7	6622	18	the	the	DT
cord-005453-4057qib7	6622	19	Institute	Institute	NNP
cord-005453-4057qib7	6622	20	of	of	IN
cord-005453-4057qib7	6622	21	Hematology	Hematology	NNP
cord-005453-4057qib7	6622	22	,	,	,
cord-005453-4057qib7	6622	23	Chinese	Chinese	NNP
cord-005453-4057qib7	6622	24	Academy	Academy	NNP
cord-005453-4057qib7	6622	25	of	of	IN
cord-005453-4057qib7	6622	26	Medical	Medical	NNP
cord-005453-4057qib7	6622	27	Sciences	Sciences	NNPS
cord-005453-4057qib7	6622	28	between	between	IN
cord-005453-4057qib7	6622	29	2016	2016	CD
cord-005453-4057qib7	6622	30	and	and	CC
cord-005453-4057qib7	6622	31	2018,as	2018,as	CD
cord-005453-4057qib7	6622	32	well	well	RB
cord-005453-4057qib7	6622	33	as	as	IN
cord-005453-4057qib7	6622	34	10	10	CD
cord-005453-4057qib7	6622	35	age	age	NN
cord-005453-4057qib7	6622	36	-	-	HYPH
cord-005453-4057qib7	6622	37	matched	match	VBN
cord-005453-4057qib7	6622	38	healthy	healthy	JJ
cord-005453-4057qib7	6622	39	adults	adult	NNS
cord-005453-4057qib7	6622	40	as	as	IN
cord-005453-4057qib7	6622	41	control	control	NN
cord-005453-4057qib7	6622	42	samples	sample	NNS
cord-005453-4057qib7	6622	43	.	.	.
cord-005453-4057qib7	6623	1	The	the	DT
cord-005453-4057qib7	6623	2	ratio	ratio	NN
cord-005453-4057qib7	6623	3	of	of	IN
cord-005453-4057qib7	6623	4	Tregs	Tregs	NNP
cord-005453-4057qib7	6623	5	in	in	IN
cord-005453-4057qib7	6623	6	PB	PB	NNP
cord-005453-4057qib7	6623	7	and	and	CC
cord-005453-4057qib7	6623	8	BM	BM	NNP
cord-005453-4057qib7	6623	9	of	of	IN
cord-005453-4057qib7	6623	10	healthy	healthy	JJ
cord-005453-4057qib7	6623	11	controls	control	NNS
cord-005453-4057qib7	6623	12	(	(	-LRB-
cord-005453-4057qib7	6623	13	HCs	HCs	NNP
cord-005453-4057qib7	6623	14	)	)	-RRB-
cord-005453-4057qib7	6623	15	and	and	CC
cord-005453-4057qib7	6623	16	patients	patient	NNS
cord-005453-4057qib7	6623	17	with	with	IN
cord-005453-4057qib7	6623	18	and	and	CC
cord-005453-4057qib7	6623	19	without	without	IN
cord-005453-4057qib7	6623	20	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6623	21	was	be	VBD
cord-005453-4057qib7	6623	22	determined	determine	VBN
cord-005453-4057qib7	6623	23	by	by	IN
cord-005453-4057qib7	6623	24	flow	flow	NN
cord-005453-4057qib7	6623	25	cytometry	cytometry	NN
cord-005453-4057qib7	6623	26	.	.	.
cord-005453-4057qib7	6624	1	The	the	DT
cord-005453-4057qib7	6624	2	transcription	transcription	NN
cord-005453-4057qib7	6624	3	profile	profile	NN
cord-005453-4057qib7	6624	4	between	between	IN
cord-005453-4057qib7	6624	5	Tregs	Tregs	NNP
cord-005453-4057qib7	6624	6	from	from	IN
cord-005453-4057qib7	6624	7	patients	patient	NNS
cord-005453-4057qib7	6624	8	with	with	IN
cord-005453-4057qib7	6624	9	or	or	CC
cord-005453-4057qib7	6624	10	without	without	IN
cord-005453-4057qib7	6624	11	acute	acute	JJ
cord-005453-4057qib7	6624	12	GVHD	GVHD	NNP
cord-005453-4057qib7	6624	13	was	be	VBD
cord-005453-4057qib7	6624	14	measured	measure	VBN
cord-005453-4057qib7	6624	15	,	,	,
cord-005453-4057qib7	6624	16	the	the	DT
cord-005453-4057qib7	6624	17	pathway	pathway	NN
cord-005453-4057qib7	6624	18	enrichment	enrichment	NN
cord-005453-4057qib7	6624	19	analyses	analysis	NNS
cord-005453-4057qib7	6624	20	were	be	VBD
cord-005453-4057qib7	6624	21	performed	perform	VBN
cord-005453-4057qib7	6624	22	by	by	IN
cord-005453-4057qib7	6624	23	the	the	DT
cord-005453-4057qib7	6624	24	Kyoto	Kyoto	NNP
cord-005453-4057qib7	6624	25	Encyclopedia	Encyclopedia	NNP
cord-005453-4057qib7	6624	26	of	of	IN
cord-005453-4057qib7	6624	27	Genes	Genes	NNPS
cord-005453-4057qib7	6624	28	and	and	CC
cord-005453-4057qib7	6624	29	Genomes	Genomes	NNPS
cord-005453-4057qib7	6624	30	(	(	-LRB-
cord-005453-4057qib7	6624	31	KEGG	KEGG	NNP
cord-005453-4057qib7	6624	32	)	)	-RRB-
cord-005453-4057qib7	6624	33	pathway	pathway	NN
cord-005453-4057qib7	6624	34	database	database	NN
cord-005453-4057qib7	6624	35	and	and	CC
cord-005453-4057qib7	6624	36	geneset	geneset	NNP
cord-005453-4057qib7	6624	37	enrichment	enrichment	NNP
cord-005453-4057qib7	6624	38	analysis	analysis	NNP
cord-005453-4057qib7	6625	1	(	(	-LRB-
cord-005453-4057qib7	6625	2	GSEA).The	gsea).the	JJ
cord-005453-4057qib7	6625	3	expression	expression	NN
cord-005453-4057qib7	6625	4	of	of	IN
cord-005453-4057qib7	6625	5	Lkb1	Lkb1	NNP
cord-005453-4057qib7	6625	6	at	at	IN
cord-005453-4057qib7	6625	7	transcript	transcript	NN
cord-005453-4057qib7	6625	8	levels	level	NNS
cord-005453-4057qib7	6625	9	and	and	CC
cord-005453-4057qib7	6625	10	protein	protein	NN
cord-005453-4057qib7	6625	11	levels	level	NNS
cord-005453-4057qib7	6625	12	was	be	VBD
cord-005453-4057qib7	6625	13	measured	measure	VBN
cord-005453-4057qib7	6625	14	by	by	IN
cord-005453-4057qib7	6625	15	realtime	realtime	NNP
cord-005453-4057qib7	6625	16	PCR	PCR	NNP
cord-005453-4057qib7	6625	17	and	and	CC
cord-005453-4057qib7	6625	18	analyzed	analyze	VBN
cord-005453-4057qib7	6625	19	by	by	IN
cord-005453-4057qib7	6625	20	the	the	DT
cord-005453-4057qib7	6625	21	NanoPro1000TM	NanoPro1000TM	NNP
cord-005453-4057qib7	6625	22	system	system	NN
cord-005453-4057qib7	6625	23	.	.	.
cord-005453-4057qib7	6626	1	A	a	DT
cord-005453-4057qib7	6626	2	series	series	NN
cord-005453-4057qib7	6626	3	of	of	IN
cord-005453-4057qib7	6626	4	functional	functional	JJ
cord-005453-4057qib7	6626	5	assays	assay	NNS
cord-005453-4057qib7	6626	6	in	in	IN
cord-005453-4057qib7	6626	7	vitro	vitro	FW
cord-005453-4057qib7	6626	8	were	be	VBD
cord-005453-4057qib7	6626	9	performed	perform	VBN
cord-005453-4057qib7	6626	10	to	to	TO
cord-005453-4057qib7	6626	11	assess	assess	VB
cord-005453-4057qib7	6626	12	the	the	DT
cord-005453-4057qib7	6626	13	function	function	NN
cord-005453-4057qib7	6626	14	and	and	CC
cord-005453-4057qib7	6626	15	stability	stability	NN
cord-005453-4057qib7	6626	16	of	of	IN
cord-005453-4057qib7	6626	17	Tregs	Tregs	NNP
cord-005453-4057qib7	6626	18	from	from	IN
cord-005453-4057qib7	6626	19	patients	patient	NNS
cord-005453-4057qib7	6626	20	with	with	IN
cord-005453-4057qib7	6626	21	and	and	CC
cord-005453-4057qib7	6626	22	without	without	IN
cord-005453-4057qib7	6626	23	aGVHD.Meanwhile	aGVHD.Meanwhile	NNP
cord-005453-4057qib7	6626	24	,	,	,
cord-005453-4057qib7	6626	25	to	to	TO
cord-005453-4057qib7	6626	26	assume	assume	VB
cord-005453-4057qib7	6626	27	the	the	DT
cord-005453-4057qib7	6626	28	affect	affect	NN
cord-005453-4057qib7	6626	29	of	of	IN
cord-005453-4057qib7	6626	30	Lkb1	Lkb1	NNP
cord-005453-4057qib7	6626	31	on	on	IN
cord-005453-4057qib7	6626	32	GVHD	GVHD	NNP
cord-005453-4057qib7	6626	33	outcome	outcome	NN
cord-005453-4057qib7	6626	34	,	,	,
cord-005453-4057qib7	6626	35	we	-PRON-	PRP
cord-005453-4057qib7	6626	36	established	establish	VBD
cord-005453-4057qib7	6626	37	a	a	DT
cord-005453-4057qib7	6626	38	murine	murine	JJ
cord-005453-4057qib7	6626	39	transplant	transplant	NN
cord-005453-4057qib7	6626	40	model	model	NN
cord-005453-4057qib7	6626	41	,	,	,
cord-005453-4057qib7	6626	42	which	which	WDT
cord-005453-4057qib7	6626	43	recipient	recipient	NN
cord-005453-4057qib7	6626	44	Balb	Balb	NNP
cord-005453-4057qib7	6626	45	/	/	SYM
cord-005453-4057qib7	6626	46	c	c	NN
cord-005453-4057qib7	6626	47	animals	animal	NNS
cord-005453-4057qib7	6626	48	were	be	VBD
cord-005453-4057qib7	6626	49	transplanted	transplant	VBN
cord-005453-4057qib7	6626	50	with	with	IN
cord-005453-4057qib7	6626	51	the	the	DT
cord-005453-4057qib7	6626	52	same	same	JJ
cord-005453-4057qib7	6626	53	amount	amount	NN
cord-005453-4057qib7	6626	54	of	of	IN
cord-005453-4057qib7	6626	55	mixture	mixture	NN
cord-005453-4057qib7	6626	56	made	make	VBN
cord-005453-4057qib7	6626	57	by	by	IN
cord-005453-4057qib7	6626	58	BM	BM	NNP
cord-005453-4057qib7	6626	59	,	,	,
cord-005453-4057qib7	6626	60	CD4	CD4	NNP
cord-005453-4057qib7	6626	61	+	+	CC
cord-005453-4057qib7	6626	62	CD25-Tcon	CD25-Tcon	NNP
cord-005453-4057qib7	6626	63	cells	cell	NNS
cord-005453-4057qib7	6626	64	from	from	IN
cord-005453-4057qib7	6626	65	C57BL/6	C57BL/6	NNP
cord-005453-4057qib7	6626	66	and	and	CC
cord-005453-4057qib7	6626	67	CD4	CD4	NNP
cord-005453-4057qib7	6627	1	+	+	CC
cord-005453-4057qib7	6627	2	Foxp3	Foxp3	VBN
cord-005453-4057qib7	6628	1	YFP+	YFP+	NNP
cord-005453-4057qib7	6628	2	Tregs	Tregs	NNP
cord-005453-4057qib7	6628	3	from	from	IN
cord-005453-4057qib7	6628	4	either	either	DT
cord-005453-4057qib7	6628	5	Foxp3CreLkb1f	foxp3crelkb1f	NN
cord-005453-4057qib7	6628	6	/	/	SYM
cord-005453-4057qib7	6628	7	f	f	NN
cord-005453-4057qib7	6628	8	or	or	CC
cord-005453-4057qib7	6628	9	Foxp3Cre	foxp3cre	JJ
cord-005453-4057qib7	6628	10	mice	mouse	NNS
cord-005453-4057qib7	6628	11	.	.	.
cord-005453-4057qib7	6629	1	Results	result	NNS
cord-005453-4057qib7	6629	2	:	:	:
cord-005453-4057qib7	6630	1	In	in	IN
cord-005453-4057qib7	6630	2	this	this	DT
cord-005453-4057qib7	6630	3	study	study	NN
cord-005453-4057qib7	6630	4	,	,	,
cord-005453-4057qib7	6630	5	we	-PRON-	PRP
cord-005453-4057qib7	6630	6	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6630	7	that	that	IN
cord-005453-4057qib7	6630	8	BM	BM	NNP
cord-005453-4057qib7	6630	9	had	have	VBD
cord-005453-4057qib7	6630	10	decreased	decrease	VBN
cord-005453-4057qib7	6630	11	frequencies	frequency	NNS
cord-005453-4057qib7	6630	12	of	of	IN
cord-005453-4057qib7	6630	13	Tregs	Tregs	NNP
cord-005453-4057qib7	6630	14	,	,	,
cord-005453-4057qib7	6630	15	accompanied	accompany	VBN
cord-005453-4057qib7	6630	16	with	with	IN
cord-005453-4057qib7	6630	17	a	a	DT
cord-005453-4057qib7	6630	18	reversed	reverse	VBN
cord-005453-4057qib7	6630	19	lower	low	JJR
cord-005453-4057qib7	6630	20	ratio	ratio	NN
cord-005453-4057qib7	6630	21	of	of	IN
cord-005453-4057qib7	6630	22	Tregs	Tregs	NNP
cord-005453-4057qib7	6630	23	frequencies	frequency	NNS
cord-005453-4057qib7	6630	24	between	between	IN
cord-005453-4057qib7	6630	25	BM	BM	NNP
cord-005453-4057qib7	6630	26	and	and	CC
cord-005453-4057qib7	6630	27	PB	PB	NNP
cord-005453-4057qib7	6630	28	in	in	IN
cord-005453-4057qib7	6630	29	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6630	30	patients	patient	NNS
cord-005453-4057qib7	6630	31	.	.	.
cord-005453-4057qib7	6631	1	Meanwhile	meanwhile	RB
cord-005453-4057qib7	6631	2	,	,	,
cord-005453-4057qib7	6631	3	the	the	DT
cord-005453-4057qib7	6631	4	number	number	NN
cord-005453-4057qib7	6631	5	and	and	CC
cord-005453-4057qib7	6631	6	function	function	NN
cord-005453-4057qib7	6631	7	of	of	IN
cord-005453-4057qib7	6631	8	Tregs	Tregs	NNP
cord-005453-4057qib7	6631	9	in	in	IN
cord-005453-4057qib7	6631	10	bone	bone	NN
cord-005453-4057qib7	6631	11	marrow	marrow	NN
cord-005453-4057qib7	6631	12	also	also	RB
cord-005453-4057qib7	6631	13	affected	affect	VBD
cord-005453-4057qib7	6631	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6631	15	reconstitution	reconstitution	NN
cord-005453-4057qib7	6631	16	.	.	.
cord-005453-4057qib7	6632	1	Futhermore	futhermore	RB
cord-005453-4057qib7	6632	2	,	,	,
cord-005453-4057qib7	6632	3	to	to	TO
cord-005453-4057qib7	6632	4	elucidate	elucidate	VB
cord-005453-4057qib7	6632	5	these	these	DT
cord-005453-4057qib7	6632	6	mechanisms	mechanism	NNS
cord-005453-4057qib7	6632	7	which	which	WDT
cord-005453-4057qib7	6632	8	regulate	regulate	VBP
cord-005453-4057qib7	6632	9	Tregs	Tregs	NNP
cord-005453-4057qib7	6632	10	homeostasis	homeostasis	NN
cord-005453-4057qib7	6632	11	,	,	,
cord-005453-4057qib7	6632	12	we	-PRON-	PRP
cord-005453-4057qib7	6632	13	examined	examine	VBD
cord-005453-4057qib7	6632	14	the	the	DT
cord-005453-4057qib7	6632	15	role	role	NN
cord-005453-4057qib7	6632	16	of	of	IN
cord-005453-4057qib7	6632	17	Lkb1	Lkb1	NNP
cord-005453-4057qib7	6632	18	on	on	IN
cord-005453-4057qib7	6632	19	Tregs	Tregs	NNP
cord-005453-4057qib7	6632	20	in	in	IN
cord-005453-4057qib7	6632	21	patients	patient	NNS
cord-005453-4057qib7	6632	22	with	with	IN
cord-005453-4057qib7	6632	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6632	24	and	and	CC
cord-005453-4057qib7	6632	25	in	in	IN
cord-005453-4057qib7	6632	26	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6632	27	murine	murine	JJ
cord-005453-4057qib7	6632	28	model	model	NN
cord-005453-4057qib7	6632	29	.	.	.
cord-005453-4057qib7	6633	1	Studies	study	NNS
cord-005453-4057qib7	6633	2	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6633	3	that	that	IN
cord-005453-4057qib7	6633	4	Lkb1deficient	Lkb1deficient	NNP
cord-005453-4057qib7	6633	5	Tregs	Tregs	NNP
cord-005453-4057qib7	6633	6	lost	lose	VBD
cord-005453-4057qib7	6633	7	Foxp3	foxp3	JJ
cord-005453-4057qib7	6633	8	expression	expression	NN
cord-005453-4057qib7	6633	9	and	and	CC
cord-005453-4057qib7	6633	10	weaken	weaken	VB
cord-005453-4057qib7	6633	11	suppressor	suppressor	NN
cord-005453-4057qib7	6633	12	function	function	NN
cord-005453-4057qib7	6633	13	during	during	IN
cord-005453-4057qib7	6633	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6633	15	.	.	.
cord-005453-4057qib7	6634	1	Transcriptional	transcriptional	JJ
cord-005453-4057qib7	6634	2	profiling	profiling	NN
cord-005453-4057qib7	6634	3	and	and	CC
cord-005453-4057qib7	6634	4	pathway	pathway	NN
cord-005453-4057qib7	6634	5	analysis	analysis	NN
cord-005453-4057qib7	6634	6	revealed	reveal	VBD
cord-005453-4057qib7	6634	7	that	that	IN
cord-005453-4057qib7	6634	8	NF	NF	NNP
cord-005453-4057qib7	6634	9	-	-	HYPH
cord-005453-4057qib7	6634	10	kB	kB	NNP
cord-005453-4057qib7	6634	11	signaling	signal	VBG
cord-005453-4057qib7	6634	12	activation	activation	NN
cord-005453-4057qib7	6634	13	and	and	CC
cord-005453-4057qib7	6634	14	the	the	DT
cord-005453-4057qib7	6634	15	impairment	impairment	NN
cord-005453-4057qib7	6634	16	of	of	IN
cord-005453-4057qib7	6634	17	a	a	DT
cord-005453-4057qib7	6634	18	wide	wide	JJ
cord-005453-4057qib7	6634	19	spectrum	spectrum	NN
cord-005453-4057qib7	6634	20	of	of	IN
cord-005453-4057qib7	6634	21	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6634	22	genes	gene	NNS
cord-005453-4057qib7	6634	23	in	in	IN
cord-005453-4057qib7	6634	24	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6634	25	Tregs	Tregs	NNP
cord-005453-4057qib7	6634	26	.	.	.
cord-005453-4057qib7	6635	1	Further	further	JJ
cord-005453-4057qib7	6635	2	mice	mice	NN
cord-005453-4057qib7	6635	3	experiments	experiment	NNS
cord-005453-4057qib7	6635	4	suggested	suggest	VBD
cord-005453-4057qib7	6635	5	that	that	IN
cord-005453-4057qib7	6635	6	CNS2	CNS2	NNP
cord-005453-4057qib7	6635	7	methylation	methylation	NN
cord-005453-4057qib7	6635	8	might	may	MD
cord-005453-4057qib7	6635	9	lead	lead	VB
cord-005453-4057qib7	6635	10	to	to	IN
cord-005453-4057qib7	6635	11	the	the	DT
cord-005453-4057qib7	6635	12	instability	instability	NN
cord-005453-4057qib7	6635	13	of	of	IN
cord-005453-4057qib7	6635	14	Tregs	Tregs	NNP
cord-005453-4057qib7	6635	15	in	in	IN
cord-005453-4057qib7	6635	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6635	17	group	group	NN
cord-005453-4057qib7	6635	18	.	.	.
cord-005453-4057qib7	6636	1	Transplantation	transplantation	NN
cord-005453-4057qib7	6636	2	with	with	IN
cord-005453-4057qib7	6636	3	marrow	marrow	NN
cord-005453-4057qib7	6636	4	grafts	graft	NNS
cord-005453-4057qib7	6636	5	from	from	IN
cord-005453-4057qib7	6636	6	Foxp3CreLkb1f	foxp3crelkb1f	NN
cord-005453-4057qib7	6636	7	/	/	SYM
cord-005453-4057qib7	6636	8	fmice	fmice	NN
cord-005453-4057qib7	6636	9	exacerbates	exacerbate	VBZ
cord-005453-4057qib7	6636	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6636	11	lethality	lethality	NN
cord-005453-4057qib7	6636	12	.	.	.
cord-005453-4057qib7	6637	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6637	2	:	:	:
cord-005453-4057qib7	6638	1	These	these	DT
cord-005453-4057qib7	6638	2	studies	study	NNS
cord-005453-4057qib7	6638	3	indicate	indicate	VBP
cord-005453-4057qib7	6638	4	that	that	IN
cord-005453-4057qib7	6638	5	Lkb1	Lkb1	NNP
cord-005453-4057qib7	6638	6	is	be	VBZ
cord-005453-4057qib7	6638	7	a	a	DT
cord-005453-4057qib7	6638	8	critical	critical	JJ
cord-005453-4057qib7	6638	9	homeostatic	homeostatic	JJ
cord-005453-4057qib7	6638	10	regulator	regulator	NN
cord-005453-4057qib7	6638	11	for	for	IN
cord-005453-4057qib7	6638	12	Tregs	Tregs	NNP
cord-005453-4057qib7	6638	13	during	during	IN
cord-005453-4057qib7	6638	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6638	15	.	.	.
cord-005453-4057qib7	6639	1	Targeting	target	VBG
cord-005453-4057qib7	6639	2	of	of	IN
cord-005453-4057qib7	6639	3	Lkb1	Lkb1	NNP
cord-005453-4057qib7	6639	4	therefore	therefore	RB
cord-005453-4057qib7	6639	5	represents	represent	VBZ
cord-005453-4057qib7	6639	6	a	a	DT
cord-005453-4057qib7	6639	7	novel	novel	JJ
cord-005453-4057qib7	6639	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	6639	9	strategy	strategy	NN
cord-005453-4057qib7	6639	10	that	that	WDT
cord-005453-4057qib7	6639	11	promote	promote	VBP
cord-005453-4057qib7	6639	12	immune	immune	JJ
cord-005453-4057qib7	6639	13	tolerance	tolerance	NN
cord-005453-4057qib7	6639	14	to	to	TO
cord-005453-4057qib7	6639	15	mitigates	mitigate	VBZ
cord-005453-4057qib7	6639	16	the	the	DT
cord-005453-4057qib7	6639	17	severity	severity	NN
cord-005453-4057qib7	6639	18	of	of	IN
cord-005453-4057qib7	6639	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6639	20	.	.	.
cord-005453-4057qib7	6640	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6640	2	:	:	:
cord-005453-4057qib7	6640	3	National	National	NNP
cord-005453-4057qib7	6640	4	Program	Program	NNP
cord-005453-4057qib7	6640	5	on	on	IN
cord-005453-4057qib7	6640	6	Key	Key	NNP
cord-005453-4057qib7	6640	7	Basic	Basic	NNP
cord-005453-4057qib7	6640	8	Research	Research	NNP
cord-005453-4057qib7	6640	9	Project	Project	NNP
cord-005453-4057qib7	6640	10	(	(	-LRB-
cord-005453-4057qib7	6640	11	973	973	CD
cord-005453-4057qib7	6640	12	Program	Program	NNP
cord-005453-4057qib7	6640	13	)	)	-RRB-
cord-005453-4057qib7	6640	14	Role	role	NN
cord-005453-4057qib7	6640	15	of	of	IN
cord-005453-4057qib7	6640	16	aryl	aryl	NN
cord-005453-4057qib7	6640	17	hydrocarbon	hydrocarbon	NN
cord-005453-4057qib7	6640	18	receptor	receptor	NN
cord-005453-4057qib7	6640	19	in	in	IN
cord-005453-4057qib7	6640	20	intestine	intestine	NN
cord-005453-4057qib7	6640	21	after	after	IN
cord-005453-4057qib7	6640	22	allogeneic	allogeneic	NN
cord-005453-4057qib7	6640	23	HSCT	HSCT	NNP
cord-005453-4057qib7	6640	24	in	in	IN
cord-005453-4057qib7	6640	25	mice	mouse	NNS
cord-005453-4057qib7	6641	1	Won	Won	NNP
cord-005453-4057qib7	6641	2	-	-	HYPH
cord-005453-4057qib7	6641	3	Sik	Sik	NNP
cord-005453-4057qib7	6641	4	Lee	Lee	NNP
cord-005453-4057qib7	6641	5	1	1	CD
cord-005453-4057qib7	6641	6	,	,	,
cord-005453-4057qib7	6641	7	Soung	Soung	NNP
cord-005453-4057qib7	6641	8	-	-	HYPH
cord-005453-4057qib7	6641	9	Min	Min	NNP
cord-005453-4057qib7	6641	10	Lee	Lee	NNP
cord-005453-4057qib7	6641	11	1	1	CD
cord-005453-4057qib7	6642	1	,	,	,
cord-005453-4057qib7	6642	2	Sj	Sj	NNP
cord-005453-4057qib7	6642	3	-	-	HYPH
cord-005453-4057qib7	6642	4	Kil	Kil	NNP
cord-005453-4057qib7	6642	5	Seo	Seo	NNP
cord-005453-4057qib7	6643	1	1	1	CD
cord-005453-4057qib7	6643	2	1	1	CD
cord-005453-4057qib7	6643	3	Inje	Inje	NNP
cord-005453-4057qib7	6643	4	University	University	NNP
cord-005453-4057qib7	6643	5	,	,	,
cord-005453-4057qib7	6643	6	Busan	Busan	NNP
cord-005453-4057qib7	6643	7	Paik	Paik	NNP
cord-005453-4057qib7	6643	8	Hospital	Hospital	NNP
cord-005453-4057qib7	6643	9	,	,	,
cord-005453-4057qib7	6643	10	Hemato	Hemato	NNP
cord-005453-4057qib7	6643	11	-	-	HYPH
cord-005453-4057qib7	6643	12	Oncology	Oncology	NNP
cord-005453-4057qib7	6643	13	,	,	,
cord-005453-4057qib7	6643	14	Busan	Busan	NNP
cord-005453-4057qib7	6643	15	,	,	,
cord-005453-4057qib7	6643	16	Korea	Korea	NNP
cord-005453-4057qib7	6643	17	,	,	,
cord-005453-4057qib7	6643	18	Republic	Republic	NNP
cord-005453-4057qib7	6643	19	of	of	IN
cord-005453-4057qib7	6643	20	Background	Background	NNP
cord-005453-4057qib7	6643	21	:	:	:
cord-005453-4057qib7	6643	22	Aryl	Aryl	NNP
cord-005453-4057qib7	6643	23	hydrocarbon	hydrocarbon	NN
cord-005453-4057qib7	6643	24	receptor	receptor	NN
cord-005453-4057qib7	6643	25	(	(	-LRB-
cord-005453-4057qib7	6643	26	AhR	AhR	NNP
cord-005453-4057qib7	6643	27	)	)	-RRB-
cord-005453-4057qib7	6643	28	is	be	VBZ
cord-005453-4057qib7	6643	29	a	a	DT
cord-005453-4057qib7	6643	30	ligandactivated	ligandactivated	JJ
cord-005453-4057qib7	6643	31	transcription	transcription	NN
cord-005453-4057qib7	6643	32	factor	factor	NN
cord-005453-4057qib7	6643	33	that	that	WDT
cord-005453-4057qib7	6643	34	is	be	VBZ
cord-005453-4057qib7	6643	35	activated	activate	VBN
cord-005453-4057qib7	6643	36	by	by	IN
cord-005453-4057qib7	6643	37	various	various	JJ
cord-005453-4057qib7	6643	38	small	small	JJ
cord-005453-4057qib7	6643	39	molecules	molecule	NNS
cord-005453-4057qib7	6643	40	from	from	IN
cord-005453-4057qib7	6643	41	the	the	DT
cord-005453-4057qib7	6643	42	diet	diet	NN
cord-005453-4057qib7	6643	43	,	,	,
cord-005453-4057qib7	6643	44	microorganisms	microorganism	NNS
cord-005453-4057qib7	6643	45	,	,	,
cord-005453-4057qib7	6643	46	host	host	NN
cord-005453-4057qib7	6643	47	metabolism	metabolism	NN
cord-005453-4057qib7	6643	48	,	,	,
cord-005453-4057qib7	6643	49	and	and	CC
cord-005453-4057qib7	6643	50	xenobiotic	xenobiotic	JJ
cord-005453-4057qib7	6643	51	toxic	toxic	JJ
cord-005453-4057qib7	6643	52	chemicals	chemical	NNS
cord-005453-4057qib7	6643	53	.	.	.
cord-005453-4057qib7	6644	1	The	the	DT
cord-005453-4057qib7	6644	2	function	function	NN
cord-005453-4057qib7	6644	3	of	of	IN
cord-005453-4057qib7	6644	4	AhR	AhR	NNP
cord-005453-4057qib7	6644	5	has	have	VBZ
cord-005453-4057qib7	6644	6	been	be	VBN
cord-005453-4057qib7	6644	7	demonstrated	demonstrate	VBN
cord-005453-4057qib7	6644	8	as	as	IN
cord-005453-4057qib7	6644	9	a	a	DT
cord-005453-4057qib7	6644	10	crucial	crucial	JJ
cord-005453-4057qib7	6644	11	regulator	regulator	NN
cord-005453-4057qib7	6644	12	in	in	IN
cord-005453-4057qib7	6644	13	intestinal	intestinal	JJ
cord-005453-4057qib7	6644	14	homeostasis	homeostasis	NN
cord-005453-4057qib7	6644	15	.	.	.
cord-005453-4057qib7	6645	1	Here	here	RB
cord-005453-4057qib7	6645	2	,	,	,
cord-005453-4057qib7	6645	3	we	-PRON-	PRP
cord-005453-4057qib7	6645	4	investigated	investigate	VBD
cord-005453-4057qib7	6645	5	the	the	DT
cord-005453-4057qib7	6645	6	regulatory	regulatory	JJ
cord-005453-4057qib7	6645	7	role	role	NN
cord-005453-4057qib7	6645	8	of	of	IN
cord-005453-4057qib7	6645	9	AhR	ahr	NN
cord-005453-4057qib7	6645	10	in	in	IN
cord-005453-4057qib7	6645	11	intestine	intestine	NN
cord-005453-4057qib7	6645	12	of	of	IN
cord-005453-4057qib7	6645	13	recipients	recipient	NNS
cord-005453-4057qib7	6645	14	after	after	IN
cord-005453-4057qib7	6645	15	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6645	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6645	17	cell	cell	NN
cord-005453-4057qib7	6645	18	transplantation	transplantation	NN
cord-005453-4057qib7	6645	19	in	in	IN
cord-005453-4057qib7	6645	20	mice	mouse	NNS
cord-005453-4057qib7	6645	21	.	.	.
cord-005453-4057qib7	6646	1	Methods	method	NNS
cord-005453-4057qib7	6646	2	:	:	:
cord-005453-4057qib7	6647	1	Wild	wild	JJ
cord-005453-4057qib7	6647	2	-	-	HYPH
cord-005453-4057qib7	6647	3	type	type	NN
cord-005453-4057qib7	6647	4	(	(	-LRB-
cord-005453-4057qib7	6647	5	WT	WT	NNP
cord-005453-4057qib7	6647	6	)	)	-RRB-
cord-005453-4057qib7	6647	7	B6	b6	NN
cord-005453-4057qib7	6647	8	(	(	-LRB-
cord-005453-4057qib7	6647	9	H-2	H-2	NNP
cord-005453-4057qib7	6647	10	b	b	NN
cord-005453-4057qib7	6647	11	)	)	-RRB-
cord-005453-4057qib7	6647	12	,	,	,
cord-005453-4057qib7	6647	13	IDO	IDO	NNP
cord-005453-4057qib7	6647	14	-/-(H-2	-/-(H-2	NNP
cord-005453-4057qib7	6647	15	b	b	NN
cord-005453-4057qib7	6647	16	)	)	-RRB-
cord-005453-4057qib7	6647	17	and	and	CC
cord-005453-4057qib7	6648	1	AhR	AhR	NNP
cord-005453-4057qib7	6648	2	-/-(H-2	-/-(H-2	NNP
cord-005453-4057qib7	6648	3	b	b	NN
cord-005453-4057qib7	6648	4	)	)	-RRB-
cord-005453-4057qib7	6648	5	mice	mouse	NNS
cord-005453-4057qib7	6648	6	were	be	VBD
cord-005453-4057qib7	6648	7	lethally	lethally	RB
cord-005453-4057qib7	6648	8	irradiated	irradiate	VBN
cord-005453-4057qib7	6648	9	and	and	CC
cord-005453-4057qib7	6648	10	transplanted	transplant	VBN
cord-005453-4057qib7	6648	11	with	with	IN
cord-005453-4057qib7	6648	12	5	5	CD
cord-005453-4057qib7	6648	13	x	x	SYM
cord-005453-4057qib7	6648	14	10	10	CD
cord-005453-4057qib7	6648	15	6	6	CD
cord-005453-4057qib7	6648	16	TCD	TCD	NNP
cord-005453-4057qib7	6648	17	-	-	HYPH
cord-005453-4057qib7	6648	18	BM	BM	NNP
cord-005453-4057qib7	6648	19	plus	plus	CC
cord-005453-4057qib7	6648	20	2	2	CD
cord-005453-4057qib7	6648	21	x	x	SYM
cord-005453-4057qib7	6648	22	10	10	CD
cord-005453-4057qib7	6648	23	6	6	CD
cord-005453-4057qib7	6648	24	T	t	NN
cord-005453-4057qib7	6648	25	cells	cell	NNS
cord-005453-4057qib7	6648	26	from	from	IN
cord-005453-4057qib7	6648	27	BALB	BALB	NNP
cord-005453-4057qib7	6648	28	/	/	SYM
cord-005453-4057qib7	6648	29	c	c	NNP
cord-005453-4057qib7	6648	30	donor	donor	NN
cord-005453-4057qib7	6648	31	mice	mouse	NNS
cord-005453-4057qib7	6648	32	.	.	.
cord-005453-4057qib7	6649	1	AhR	AhR	NNP
cord-005453-4057qib7	6649	2	activation	activation	NN
cord-005453-4057qib7	6649	3	in	in	IN
cord-005453-4057qib7	6649	4	colon	colon	NN
cord-005453-4057qib7	6649	5	tissue	tissue	NN
cord-005453-4057qib7	6649	6	of	of	IN
cord-005453-4057qib7	6649	7	recipients	recipient	NNS
cord-005453-4057qib7	6649	8	was	be	VBD
cord-005453-4057qib7	6649	9	determined	determine	VBN
cord-005453-4057qib7	6649	10	by	by	IN
cord-005453-4057qib7	6649	11	the	the	DT
cord-005453-4057qib7	6649	12	AhR	AhR	NNP
cord-005453-4057qib7	6649	13	target	target	NN
cord-005453-4057qib7	6649	14	genes	gene	NNS
cord-005453-4057qib7	6649	15	CYP1A1	CYP1A1	NNP
cord-005453-4057qib7	6649	16	and	and	CC
cord-005453-4057qib7	6649	17	CYP1B1	CYP1B1	NNP
cord-005453-4057qib7	6649	18	expression	expression	NN
cord-005453-4057qib7	6649	19	using	use	VBG
cord-005453-4057qib7	6649	20	real	real	JJ
cord-005453-4057qib7	6649	21	-	-	HYPH
cord-005453-4057qib7	6649	22	time	time	NN
cord-005453-4057qib7	6649	23	PCR	PCR	NNP
cord-005453-4057qib7	6649	24	.	.	.
cord-005453-4057qib7	6650	1	The	the	DT
cord-005453-4057qib7	6650	2	recipient	recipient	NN
cord-005453-4057qib7	6650	3	mice	mouse	NNS
cord-005453-4057qib7	6650	4	were	be	VBD
cord-005453-4057qib7	6650	5	monitored	monitor	VBN
cord-005453-4057qib7	6650	6	every	every	DT
cord-005453-4057qib7	6650	7	other	other	JJ
cord-005453-4057qib7	6650	8	day	day	NN
cord-005453-4057qib7	6650	9	for	for	IN
cord-005453-4057qib7	6650	10	survival	survival	NN
cord-005453-4057qib7	6650	11	and	and	CC
cord-005453-4057qib7	6650	12	clinical	clinical	JJ
cord-005453-4057qib7	6650	13	score	score	NN
cord-005453-4057qib7	6650	14	.	.	.
cord-005453-4057qib7	6651	1	Histopathology	Histopathology	NNP
cord-005453-4057qib7	6651	2	and	and	CC
cord-005453-4057qib7	6651	3	pathogenic	pathogenic	JJ
cord-005453-4057qib7	6651	4	effector	effector	NN
cord-005453-4057qib7	6651	5	cytokine	cytokine	NN
cord-005453-4057qib7	6651	6	levels	level	NNS
cord-005453-4057qib7	6651	7	in	in	IN
cord-005453-4057qib7	6651	8	colon	colon	NN
cord-005453-4057qib7	6651	9	tissue	tissue	NN
cord-005453-4057qib7	6651	10	were	be	VBD
cord-005453-4057qib7	6651	11	analyzed	analyze	VBN
cord-005453-4057qib7	6651	12	for	for	IN
cord-005453-4057qib7	6651	13	evaluating	evaluate	VBG
cord-005453-4057qib7	6651	14	AhR	ahr	JJ
cord-005453-4057qib7	6651	15	function	function	NN
cord-005453-4057qib7	6651	16	.	.	.
cord-005453-4057qib7	6652	1	Results	result	NNS
cord-005453-4057qib7	6652	2	:	:	:
cord-005453-4057qib7	6653	1	We	-PRON-	PRP
cord-005453-4057qib7	6653	2	observed	observe	VBD
cord-005453-4057qib7	6653	3	that	that	IN
cord-005453-4057qib7	6653	4	CYP1A1	CYP1A1	NNP
cord-005453-4057qib7	6653	5	was	be	VBD
cord-005453-4057qib7	6653	6	constitutively	constitutively	RB
cord-005453-4057qib7	6653	7	expressed	express	VBN
cord-005453-4057qib7	6653	8	in	in	IN
cord-005453-4057qib7	6653	9	the	the	DT
cord-005453-4057qib7	6653	10	colon	colon	NN
cord-005453-4057qib7	6653	11	tissue	tissue	NN
cord-005453-4057qib7	6653	12	of	of	IN
cord-005453-4057qib7	6653	13	naïve	naïve	JJ
cord-005453-4057qib7	6653	14	recipient	recipient	NN
cord-005453-4057qib7	6653	15	mice	mouse	NNS
cord-005453-4057qib7	6653	16	.	.	.
cord-005453-4057qib7	6654	1	Although	although	IN
cord-005453-4057qib7	6654	2	the	the	DT
cord-005453-4057qib7	6654	3	expression	expression	NN
cord-005453-4057qib7	6654	4	levels	level	NNS
cord-005453-4057qib7	6654	5	were	be	VBD
cord-005453-4057qib7	6654	6	increased	increase	VBN
cord-005453-4057qib7	6654	7	by	by	IN
cord-005453-4057qib7	6654	8	TBI	TBI	NNP
cord-005453-4057qib7	6654	9	conditioning	conditioning	NN
cord-005453-4057qib7	6654	10	,	,	,
cord-005453-4057qib7	6654	11	the	the	DT
cord-005453-4057qib7	6654	12	additive	additive	NN
cord-005453-4057qib7	6654	13	up	up	IN
cord-005453-4057qib7	6654	14	-	-	HYPH
cord-005453-4057qib7	6654	15	regulation	regulation	NN
cord-005453-4057qib7	6654	16	of	of	IN
cord-005453-4057qib7	6654	17	its	-PRON-	PRP$
cord-005453-4057qib7	6654	18	levels	level	NNS
cord-005453-4057qib7	6654	19	with	with	IN
cord-005453-4057qib7	6654	20	donor	donor	NN
cord-005453-4057qib7	6654	21	T	t	NN
cord-005453-4057qib7	6654	22	cell	cell	NN
cord-005453-4057qib7	6654	23	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	6654	24	was	be	VBD
cord-005453-4057qib7	6654	25	not	not	RB
cord-005453-4057qib7	6654	26	observed	observe	VBN
cord-005453-4057qib7	6654	27	.	.	.
cord-005453-4057qib7	6655	1	In	in	IN
cord-005453-4057qib7	6655	2	contrast	contrast	NN
cord-005453-4057qib7	6655	3	,	,	,
cord-005453-4057qib7	6655	4	CYP1B1	CYP1B1	NNP
cord-005453-4057qib7	6655	5	expression	expression	NN
cord-005453-4057qib7	6655	6	was	be	VBD
cord-005453-4057qib7	6655	7	markedly	markedly	RB
cord-005453-4057qib7	6655	8	induced	induce	VBN
cord-005453-4057qib7	6655	9	in	in	IN
cord-005453-4057qib7	6655	10	the	the	DT
cord-005453-4057qib7	6655	11	colon	colon	NN
cord-005453-4057qib7	6655	12	tissue	tissue	NN
cord-005453-4057qib7	6655	13	by	by	IN
cord-005453-4057qib7	6655	14	donor	donor	NN
cord-005453-4057qib7	6655	15	T	t	NN
cord-005453-4057qib7	6655	16	cell	cell	NN
cord-005453-4057qib7	6655	17	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	6655	18	.	.	.
cord-005453-4057qib7	6656	1	We	-PRON-	PRP
cord-005453-4057qib7	6656	2	further	further	RB
cord-005453-4057qib7	6656	3	observed	observe	VBD
cord-005453-4057qib7	6656	4	that	that	IN
cord-005453-4057qib7	6656	5	the	the	DT
cord-005453-4057qib7	6656	6	CYP1B1	CYP1B1	NNP
cord-005453-4057qib7	6656	7	expression	expression	NN
cord-005453-4057qib7	6656	8	was	be	VBD
cord-005453-4057qib7	6656	9	significantly	significantly	RB
cord-005453-4057qib7	6656	10	decreased	decrease	VBN
cord-005453-4057qib7	6656	11	in	in	IN
cord-005453-4057qib7	6656	12	the	the	DT
cord-005453-4057qib7	6656	13	colon	colon	NN
cord-005453-4057qib7	6656	14	of	of	IN
cord-005453-4057qib7	6656	15	IDO-/-recipients	ido-/-recipient	NNS
cord-005453-4057qib7	6656	16	with	with	IN
cord-005453-4057qib7	6656	17	donor	donor	NN
cord-005453-4057qib7	6656	18	T	t	NN
cord-005453-4057qib7	6656	19	cell	cell	NN
cord-005453-4057qib7	6656	20	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	6656	21	,	,	,
cord-005453-4057qib7	6656	22	but	but	CC
cord-005453-4057qib7	6656	23	CYP1A1	CYP1A1	NNP
cord-005453-4057qib7	6656	24	was	be	VBD
cord-005453-4057qib7	6656	25	not	not	RB
cord-005453-4057qib7	6656	26	changed	change	VBN
cord-005453-4057qib7	6656	27	.	.	.
cord-005453-4057qib7	6657	1	IDO-/-and	ido-/-and	NN
cord-005453-4057qib7	6657	2	AhR-/recipient	ahr-/recipient	CD
cord-005453-4057qib7	6657	3	mice	mouse	NNS
cord-005453-4057qib7	6657	4	showed	show	VBD
cord-005453-4057qib7	6657	5	higher	high	JJR
cord-005453-4057qib7	6657	6	histopathological	histopathological	JJ
cord-005453-4057qib7	6657	7	score	score	NN
cord-005453-4057qib7	6657	8	for	for	IN
cord-005453-4057qib7	6657	9	intestinal	intestinal	JJ
cord-005453-4057qib7	6657	10	GVHD	GVHD	NNP
cord-005453-4057qib7	6657	11	and	and	CC
cord-005453-4057qib7	6657	12	increasing	increase	VBG
cord-005453-4057qib7	6657	13	pathogenic	pathogenic	JJ
cord-005453-4057qib7	6657	14	cytokine	cytokine	NN
cord-005453-4057qib7	6657	15	levels	level	NNS
cord-005453-4057qib7	6657	16	in	in	IN
cord-005453-4057qib7	6657	17	the	the	DT
cord-005453-4057qib7	6657	18	colon	colon	NN
cord-005453-4057qib7	6657	19	compared	compare	VBN
cord-005453-4057qib7	6657	20	with	with	IN
cord-005453-4057qib7	6657	21	WT	WT	NNP
cord-005453-4057qib7	6657	22	mice	mouse	NNS
cord-005453-4057qib7	6657	23	.	.	.
cord-005453-4057qib7	6658	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6658	2	:	:	:
cord-005453-4057qib7	6659	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6659	2	results	result	NNS
cord-005453-4057qib7	6659	3	demonstrate	demonstrate	VBP
cord-005453-4057qib7	6659	4	that	that	IN
cord-005453-4057qib7	6659	5	AhR	ahr	NN
cord-005453-4057qib7	6659	6	-	-	HYPH
cord-005453-4057qib7	6659	7	induced	induce	VBN
cord-005453-4057qib7	6659	8	target	target	NN
cord-005453-4057qib7	6659	9	gene	gene	NN
cord-005453-4057qib7	6659	10	profiles	profile	NNS
cord-005453-4057qib7	6659	11	might	may	MD
cord-005453-4057qib7	6659	12	be	be	VB
cord-005453-4057qib7	6659	13	differently	differently	RB
cord-005453-4057qib7	6659	14	induced	induce	VBN
cord-005453-4057qib7	6659	15	in	in	IN
cord-005453-4057qib7	6659	16	intestine	intestine	NN
cord-005453-4057qib7	6659	17	by	by	IN
cord-005453-4057qib7	6659	18	ligand	ligand	NN
cord-005453-4057qib7	6659	19	dependent	dependent	JJ
cord-005453-4057qib7	6659	20	manner	manner	NN
cord-005453-4057qib7	6659	21	after	after	IN
cord-005453-4057qib7	6659	22	HSCT	HSCT	NNP
cord-005453-4057qib7	6659	23	,	,	,
cord-005453-4057qib7	6659	24	which	which	WDT
cord-005453-4057qib7	6659	25	affect	affect	VBP
cord-005453-4057qib7	6659	26	intestinal	intestinal	JJ
cord-005453-4057qib7	6659	27	GVHD	GVHD	NNP
cord-005453-4057qib7	6659	28	.	.	.
cord-005453-4057qib7	6660	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6660	2	:	:	:
cord-005453-4057qib7	6660	3	Nothing	nothing	NN
cord-005453-4057qib7	6660	4	to	to	TO
cord-005453-4057qib7	6660	5	declare	declare	VB
cord-005453-4057qib7	6660	6	.	.	.
cord-005453-4057qib7	6661	1	Abstract	Abstract	NNP
cord-005453-4057qib7	6661	2	already	already	RB
cord-005453-4057qib7	6661	3	published	publish	VBN
cord-005453-4057qib7	6661	4	.	.	.
cord-005453-4057qib7	6662	1	Abstract	Abstract	NNP
cord-005453-4057qib7	6662	2	withdrawn	withdraw	VBN
cord-005453-4057qib7	6662	3	.	.	.
cord-005453-4057qib7	6663	1	In	in	IN
cord-005453-4057qib7	6663	2	vitro	vitro	FW
cord-005453-4057qib7	6663	3	platelet	platelet	NN
cord-005453-4057qib7	6663	4	activation	activation	NN
cord-005453-4057qib7	6663	5	evaluation	evaluation	NN
cord-005453-4057qib7	6663	6	in	in	IN
cord-005453-4057qib7	6663	7	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6663	8	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	6663	9	stem	stem	NN
cord-005453-4057qib7	6663	10	cell	cell	NN
cord-005453-4057qib7	6663	11	transplanted	transplant	VBN
cord-005453-4057qib7	6663	12	patients	patient	NNS
cord-005453-4057qib7	6663	13	in	in	IN
cord-005453-4057qib7	6663	14	response	response	NN
cord-005453-4057qib7	6663	15	to	to	IN
cord-005453-4057qib7	6663	16	haemostatic	haemostatic	JJ
cord-005453-4057qib7	6663	17	stimulation	stimulation	NN
cord-005453-4057qib7	6663	18	and	and	CC
cord-005453-4057qib7	6663	19	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	6663	20	stimulation	stimulation	NN
cord-005453-4057qib7	6663	21	(	(	-LRB-
cord-005453-4057qib7	6663	22	GvHD	GvHD	NNP
cord-005453-4057qib7	6663	23	)	)	-RRB-
cord-005453-4057qib7	6663	24	,	,	,
cord-005453-4057qib7	6663	25	complication	complication	NN
cord-005453-4057qib7	6663	26	of	of	IN
cord-005453-4057qib7	6663	27	which	which	WDT
cord-005453-4057qib7	6663	28	one	one	CD
cord-005453-4057qib7	6663	29	of	of	IN
cord-005453-4057qib7	6663	30	the	the	DT
cord-005453-4057qib7	6663	31	risk	risk	NN
cord-005453-4057qib7	6663	32	factor	factor	NN
cord-005453-4057qib7	6663	33	is	be	VBZ
cord-005453-4057qib7	6663	34	CMV	CMV	NNP
cord-005453-4057qib7	6663	35	reactivation	reactivation	NN
cord-005453-4057qib7	6663	36	.	.	.
cord-005453-4057qib7	6664	1	The	the	DT
cord-005453-4057qib7	6664	2	resultant	resultant	JJ
cord-005453-4057qib7	6664	3	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6664	4	platelet	platelet	NN
cord-005453-4057qib7	6664	5	response	response	NN
cord-005453-4057qib7	6664	6	during	during	IN
cord-005453-4057qib7	6664	7	the	the	DT
cord-005453-4057qib7	6664	8	high	high	JJ
cord-005453-4057qib7	6664	9	-	-	HYPH
cord-005453-4057qib7	6664	10	risk	risk	NN
cord-005453-4057qib7	6664	11	period	period	NN
cord-005453-4057qib7	6664	12	of	of	IN
cord-005453-4057qib7	6664	13	GvHD	GvHD	NNP
cord-005453-4057qib7	6664	14	after	after	IN
cord-005453-4057qib7	6664	15	allogeneic	allogeneic	NN
cord-005453-4057qib7	6664	16	HSCT	HSCT	NNP
cord-005453-4057qib7	6664	17	remains	remain	VBZ
cord-005453-4057qib7	6664	18	unknown	unknown	JJ
cord-005453-4057qib7	6664	19	.	.	.
cord-005453-4057qib7	6665	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6665	2	study	study	NN
cord-005453-4057qib7	6665	3	aimed	aim	VBD
cord-005453-4057qib7	6665	4	to	to	TO
cord-005453-4057qib7	6665	5	characterize	characterize	VB
cord-005453-4057qib7	6665	6	spontaneous	spontaneous	JJ
cord-005453-4057qib7	6665	7	platelet	platelet	NN
cord-005453-4057qib7	6665	8	activation	activation	NN
cord-005453-4057qib7	6665	9	during	during	IN
cord-005453-4057qib7	6665	10	the	the	DT
cord-005453-4057qib7	6665	11	2d	2d	NNP
cord-005453-4057qib7	6665	12	and	and	CC
cord-005453-4057qib7	6665	13	3d	3d	JJ
cord-005453-4057qib7	6665	14	months	month	NNS
cord-005453-4057qib7	6665	15	after	after	IN
cord-005453-4057qib7	6665	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	6665	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6665	18	,	,	,
cord-005453-4057qib7	6665	19	and	and	CC
cord-005453-4057qib7	6665	20	in	in	IN
cord-005453-4057qib7	6665	21	response	response	NN
cord-005453-4057qib7	6665	22	to	to	IN
cord-005453-4057qib7	6665	23	haemostatic	haemostatic	JJ
cord-005453-4057qib7	6665	24	stimulation	stimulation	NN
cord-005453-4057qib7	6665	25	and	and	CC
cord-005453-4057qib7	6665	26	CMV	CMV	NNP
cord-005453-4057qib7	6665	27	stimulation	stimulation	NN
cord-005453-4057qib7	6665	28	.	.	.
cord-005453-4057qib7	6666	1	Methods	method	NNS
cord-005453-4057qib7	6666	2	:	:	:
cord-005453-4057qib7	6667	1	We	-PRON-	PRP
cord-005453-4057qib7	6667	2	compared	compare	VBD
cord-005453-4057qib7	6667	3	a	a	DT
cord-005453-4057qib7	6667	4	group	group	NN
cord-005453-4057qib7	6667	5	of	of	IN
cord-005453-4057qib7	6667	6	healthy	healthy	JJ
cord-005453-4057qib7	6667	7	volunteers	volunteer	NNS
cord-005453-4057qib7	6667	8	to	to	IN
cord-005453-4057qib7	6667	9	a	a	DT
cord-005453-4057qib7	6667	10	group	group	NN
cord-005453-4057qib7	6667	11	of	of	IN
cord-005453-4057qib7	6667	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6667	13	HSCT	HSCT	NNP
cord-005453-4057qib7	6667	14	patients	patient	NNS
cord-005453-4057qib7	6667	15	followed	follow	VBD
cord-005453-4057qib7	6667	16	between	between	IN
cord-005453-4057qib7	6667	17	the	the	DT
cord-005453-4057qib7	6667	18	30	30	CD
cord-005453-4057qib7	6667	19	th	th	XX
cord-005453-4057qib7	6667	20	and	and	CC
cord-005453-4057qib7	6667	21	the	the	DT
cord-005453-4057qib7	6667	22	90	90	CD
cord-005453-4057qib7	6667	23	th	th	XX
cord-005453-4057qib7	6667	24	days	day	NNS
cord-005453-4057qib7	6667	25	after	after	IN
cord-005453-4057qib7	6667	26	HSCT	HSCT	NNP
cord-005453-4057qib7	6667	27	.	.	.
cord-005453-4057qib7	6668	1	Platelet	platelet	NN
cord-005453-4057qib7	6668	2	activation	activation	NN
cord-005453-4057qib7	6668	3	was	be	VBD
cord-005453-4057qib7	6668	4	determined	determine	VBN
cord-005453-4057qib7	6668	5	by	by	IN
cord-005453-4057qib7	6668	6	the	the	DT
cord-005453-4057qib7	6668	7	platelet	platelet	NN
cord-005453-4057qib7	6668	8	surface	surface	NN
cord-005453-4057qib7	6668	9	expression	expression	NN
cord-005453-4057qib7	6668	10	of	of	IN
cord-005453-4057qib7	6668	11	CD62P	cd62p	NN
cord-005453-4057qib7	6668	12	and	and	CC
cord-005453-4057qib7	6668	13	CD63	CD63	NNP
cord-005453-4057qib7	6668	14	using	use	VBG
cord-005453-4057qib7	6668	15	flow	flow	NN
cord-005453-4057qib7	6668	16	cytometer	cytometer	NN
cord-005453-4057qib7	6668	17	after	after	IN
cord-005453-4057qib7	6668	18	stimulation	stimulation	NN
cord-005453-4057qib7	6668	19	by	by	IN
cord-005453-4057qib7	6668	20	an	an	DT
cord-005453-4057qib7	6668	21	haemostatic	haemostatic	JJ
cord-005453-4057qib7	6668	22	agent	agent	NN
cord-005453-4057qib7	6668	23	,	,	,
cord-005453-4057qib7	6668	24	Thrombin	Thrombin	NNP
cord-005453-4057qib7	6668	25	-	-	HYPH
cord-005453-4057qib7	6668	26	receptor	receptor	NN
cord-005453-4057qib7	6668	27	activating	activate	VBG
cord-005453-4057qib7	6668	28	Peptid	Peptid	NNP
cord-005453-4057qib7	6668	29	(	(	-LRB-
cord-005453-4057qib7	6668	30	TRAP	TRAP	NNP
cord-005453-4057qib7	6668	31	)	)	-RRB-
cord-005453-4057qib7	6668	32	and	and	CC
cord-005453-4057qib7	6668	33	after	after	IN
cord-005453-4057qib7	6668	34	stimulation	stimulation	NN
cord-005453-4057qib7	6668	35	by	by	IN
cord-005453-4057qib7	6668	36	CMV	CMV	NNP
cord-005453-4057qib7	6668	37	glycoprotein	glycoprotein	NN
cord-005453-4057qib7	6669	1	B.	B.	NNP
cord-005453-4057qib7	6670	1	The	the	DT
cord-005453-4057qib7	6670	2	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6670	3	response	response	NN
cord-005453-4057qib7	6670	4	was	be	VBD
cord-005453-4057qib7	6670	5	determined	determine	VBN
cord-005453-4057qib7	6670	6	by	by	IN
cord-005453-4057qib7	6670	7	the	the	DT
cord-005453-4057qib7	6670	8	detection	detection	NN
cord-005453-4057qib7	6670	9	of	of	IN
cord-005453-4057qib7	6670	10	immune	immune	JJ
cord-005453-4057qib7	6670	11	mediators	mediator	NNS
cord-005453-4057qib7	6670	12	,	,	,
cord-005453-4057qib7	6670	13	RANTES	rante	NNS
cord-005453-4057qib7	6670	14	,	,	,
cord-005453-4057qib7	6670	15	CD62Ps	cd62ps	UH
cord-005453-4057qib7	6670	16	,	,	,
cord-005453-4057qib7	6670	17	PF4	pf4	UH
cord-005453-4057qib7	6670	18	,	,	,
cord-005453-4057qib7	6670	19	CD40L	cd40l	NN
cord-005453-4057qib7	6670	20	and	and	CC
cord-005453-4057qib7	6670	21	CCL3	CCL3	NNP
cord-005453-4057qib7	6670	22	,	,	,
cord-005453-4057qib7	6670	23	using	use	VBG
cord-005453-4057qib7	6670	24	the	the	DT
cord-005453-4057qib7	6670	25	ELISA	ELISA	NNP
cord-005453-4057qib7	6670	26	technique	technique	NN
cord-005453-4057qib7	6670	27	in	in	IN
cord-005453-4057qib7	6670	28	the	the	DT
cord-005453-4057qib7	6670	29	stimulated	stimulated	JJ
cord-005453-4057qib7	6670	30	platelet	platelet	NN
cord-005453-4057qib7	6670	31	supernatants	supernatant	NNS
cord-005453-4057qib7	6670	32	.	.	.
cord-005453-4057qib7	6671	1	Results	result	NNS
cord-005453-4057qib7	6671	2	:	:	:
cord-005453-4057qib7	6672	1	No	no	DT
cord-005453-4057qib7	6672	2	platelet	platelet	NN
cord-005453-4057qib7	6672	3	activation	activation	NN
cord-005453-4057qib7	6672	4	or	or	CC
cord-005453-4057qib7	6672	5	molecules	molecule	NNS
cord-005453-4057qib7	6672	6	release	release	NN
cord-005453-4057qib7	6672	7	were	be	VBD
cord-005453-4057qib7	6672	8	observed	observe	VBN
cord-005453-4057qib7	6672	9	after	after	IN
cord-005453-4057qib7	6672	10	stimulation	stimulation	NN
cord-005453-4057qib7	6672	11	by	by	IN
cord-005453-4057qib7	6672	12	CMV	CMV	NNP
cord-005453-4057qib7	6672	13	glycoprotein	glycoprotein	NN
cord-005453-4057qib7	6672	14	B	b	NN
cord-005453-4057qib7	6672	15	in	in	IN
cord-005453-4057qib7	6672	16	both	both	DT
cord-005453-4057qib7	6672	17	groups	group	NNS
cord-005453-4057qib7	6672	18	.	.	.
cord-005453-4057qib7	6673	1	RANTES	RANTES	NNPS
cord-005453-4057qib7	6673	2	and	and	CC
cord-005453-4057qib7	6673	3	CD62Ps	cd62ps	VB
cord-005453-4057qib7	6673	4	baseline	baseline	JJ
cord-005453-4057qib7	6673	5	levels	level	NNS
cord-005453-4057qib7	6673	6	are	be	VBP
cord-005453-4057qib7	6673	7	spontaneously	spontaneously	RB
cord-005453-4057qib7	6673	8	higher	high	JJR
cord-005453-4057qib7	6673	9	in	in	IN
cord-005453-4057qib7	6673	10	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6673	11	HSC	HSC	NNP
cord-005453-4057qib7	6673	12	patients	patient	NNS
cord-005453-4057qib7	6673	13	than	than	IN
cord-005453-4057qib7	6673	14	in	in	IN
cord-005453-4057qib7	6673	15	healthy	healthy	JJ
cord-005453-4057qib7	6673	16	volunteers	volunteer	NNS
cord-005453-4057qib7	6673	17	.	.	.
cord-005453-4057qib7	6674	1	Platelets	platelet	NNS
cord-005453-4057qib7	6674	2	from	from	IN
cord-005453-4057qib7	6674	3	allogeneic	allogeneic	VBG
cord-005453-4057qib7	6674	4	HSCT	HSCT	NNP
cord-005453-4057qib7	6674	5	patients	patient	NNS
cord-005453-4057qib7	6674	6	can	can	MD
cord-005453-4057qib7	6674	7	be	be	VB
cord-005453-4057qib7	6674	8	activated	activate	VBN
cord-005453-4057qib7	6674	9	after	after	IN
cord-005453-4057qib7	6674	10	haemostatic	haemostatic	JJ
cord-005453-4057qib7	6674	11	stimulation	stimulation	NN
cord-005453-4057qib7	6674	12	and	and	CC
cord-005453-4057qib7	6674	13	release	release	NN
cord-005453-4057qib7	6674	14	CD62Ps	cd62ps	NN
cord-005453-4057qib7	6674	15	and	and	CC
cord-005453-4057qib7	6674	16	RANTES	RANTES	NNPS
cord-005453-4057qib7	6674	17	.	.	.
cord-005453-4057qib7	6675	1	In	in	IN
cord-005453-4057qib7	6675	2	this	this	DT
cord-005453-4057qib7	6675	3	situation	situation	NN
cord-005453-4057qib7	6675	4	,	,	,
cord-005453-4057qib7	6675	5	platelets	platelet	NNS
cord-005453-4057qib7	6675	6	release	release	VBP
cord-005453-4057qib7	6675	7	more	more	JJR
cord-005453-4057qib7	6675	8	CD62PS	CD62PS	NNP
cord-005453-4057qib7	6675	9	,	,	,
cord-005453-4057qib7	6675	10	RANTES	rante	NNS
cord-005453-4057qib7	6675	11	and	and	CC
cord-005453-4057qib7	6675	12	PF4	pf4	NN
cord-005453-4057qib7	6675	13	than	than	IN
cord-005453-4057qib7	6675	14	platelets	platelet	NNS
cord-005453-4057qib7	6675	15	from	from	IN
cord-005453-4057qib7	6675	16	healthy	healthy	JJ
cord-005453-4057qib7	6675	17	volunteers	volunteer	NNS
cord-005453-4057qib7	6675	18	.	.	.
cord-005453-4057qib7	6676	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6676	2	:	:	:
cord-005453-4057qib7	6677	1	Although	although	IN
cord-005453-4057qib7	6677	2	no	no	DT
cord-005453-4057qib7	6677	3	platelet	platelet	NN
cord-005453-4057qib7	6677	4	activation	activation	NN
cord-005453-4057qib7	6677	5	was	be	VBD
cord-005453-4057qib7	6677	6	detected	detect	VBN
cord-005453-4057qib7	6677	7	in	in	IN
cord-005453-4057qib7	6677	8	response	response	NN
cord-005453-4057qib7	6677	9	to	to	IN
cord-005453-4057qib7	6677	10	CMV	CMV	NNP
cord-005453-4057qib7	6677	11	glycoprotein	glycoprotein	NN
cord-005453-4057qib7	6677	12	B	b	NN
cord-005453-4057qib7	6677	13	stimulation	stimulation	NN
cord-005453-4057qib7	6677	14	,	,	,
cord-005453-4057qib7	6677	15	our	-PRON-	PRP$
cord-005453-4057qib7	6677	16	study	study	NN
cord-005453-4057qib7	6677	17	revealed	reveal	VBD
cord-005453-4057qib7	6677	18	a	a	DT
cord-005453-4057qib7	6677	19	chronic	chronic	JJ
cord-005453-4057qib7	6677	20	platelet	platelet	NN
cord-005453-4057qib7	6677	21	activation	activation	NN
cord-005453-4057qib7	6677	22	condition	condition	NN
cord-005453-4057qib7	6677	23	during	during	IN
cord-005453-4057qib7	6677	24	the	the	DT
cord-005453-4057qib7	6677	25	2d	2d	NNP
cord-005453-4057qib7	6677	26	and	and	CC
cord-005453-4057qib7	6677	27	3d	3d	JJ
cord-005453-4057qib7	6677	28	months	month	NNS
cord-005453-4057qib7	6677	29	after	after	IN
cord-005453-4057qib7	6677	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	6677	31	HSCT	HSCT	NNP
cord-005453-4057qib7	6677	32	with	with	IN
cord-005453-4057qib7	6677	33	an	an	DT
cord-005453-4057qib7	6677	34	haemostatic	haemostatic	JJ
cord-005453-4057qib7	6677	35	inducible	inducible	JJ
cord-005453-4057qib7	6677	36	hyper	hyper	NN
cord-005453-4057qib7	6677	37	-	-	NN
cord-005453-4057qib7	6677	38	responsiveness	responsiveness	NN
cord-005453-4057qib7	6677	39	.	.	.
cord-005453-4057qib7	6678	1	This	this	DT
cord-005453-4057qib7	6678	2	leads	lead	VBZ
cord-005453-4057qib7	6678	3	to	to	IN
cord-005453-4057qib7	6678	4	the	the	DT
cord-005453-4057qib7	6678	5	release	release	NN
cord-005453-4057qib7	6678	6	of	of	IN
cord-005453-4057qib7	6678	7	molecules	molecule	NNS
cord-005453-4057qib7	6678	8	with	with	IN
cord-005453-4057qib7	6678	9	immune	immune	NN
cord-005453-4057qib7	6678	10	-	-	HYPH
cord-005453-4057qib7	6678	11	modulating	modulate	VBG
cord-005453-4057qib7	6678	12	properties	property	NNS
cord-005453-4057qib7	6678	13	involved	involve	VBN
cord-005453-4057qib7	6678	14	in	in	IN
cord-005453-4057qib7	6678	15	the	the	DT
cord-005453-4057qib7	6678	16	pathophysiology	pathophysiology	NN
cord-005453-4057qib7	6678	17	of	of	IN
cord-005453-4057qib7	6678	18	GvHD	GvHD	NNP
cord-005453-4057qib7	6678	19	.	.	.
cord-005453-4057qib7	6679	1	As	as	IN
cord-005453-4057qib7	6679	2	we	-PRON-	PRP
cord-005453-4057qib7	6679	3	move	move	VBP
cord-005453-4057qib7	6679	4	further	further	RB
cord-005453-4057qib7	6679	5	away	away	RB
cord-005453-4057qib7	6679	6	from	from	IN
cord-005453-4057qib7	6679	7	the	the	DT
cord-005453-4057qib7	6679	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6679	9	,	,	,
cord-005453-4057qib7	6679	10	that	that	DT
cord-005453-4057qib7	6679	11	phenomenon	phenomenon	NN
cord-005453-4057qib7	6679	12	seems	seem	VBZ
cord-005453-4057qib7	6679	13	to	to	TO
cord-005453-4057qib7	6679	14	gradually	gradually	RB
cord-005453-4057qib7	6679	15	weaken	weaken	VB
cord-005453-4057qib7	6679	16	.	.	.
cord-005453-4057qib7	6680	1	Clinical	clinical	JJ
cord-005453-4057qib7	6680	2	Trial	Trial	NNP
cord-005453-4057qib7	6680	3	Registry	Registry	NNP
cord-005453-4057qib7	6680	4	:	:	:
cord-005453-4057qib7	6681	1	NCT03009708	NCT03009708	NNP
cord-005453-4057qib7	6681	2	,	,	,
cord-005453-4057qib7	6681	3	FIPALLOC	FIPALLOC	NNP
cord-005453-4057qib7	6681	4	https://clinicaltrials.gov/ct2/show/NCT03009708	https://clinicaltrials.gov/ct2/show/NCT03009708	NNP
cord-005453-4057qib7	6681	5	Disclosure	Disclosure	NNP
cord-005453-4057qib7	6681	6	:	:	:
cord-005453-4057qib7	6681	7	Nothing	nothing	NN
cord-005453-4057qib7	6681	8	to	to	TO
cord-005453-4057qib7	6681	9	declare	declare	VB
cord-005453-4057qib7	6681	10	P305	P305	NNP
cord-005453-4057qib7	6681	11	Efficient	efficient	JJ
cord-005453-4057qib7	6681	12	process	process	NN
cord-005453-4057qib7	6681	13	and	and	CC
cord-005453-4057qib7	6681	14	characteristics	characteristic	NNS
cord-005453-4057qib7	6681	15	of	of	IN
cord-005453-4057qib7	6681	16	umbilical	umbilical	JJ
cord-005453-4057qib7	6681	17	cordderived	cordderived	JJ
cord-005453-4057qib7	6681	18	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	6681	19	stromal	stromal	JJ
cord-005453-4057qib7	6681	20	cells	cell	NNS
cord-005453-4057qib7	6681	21	as	as	IN
cord-005453-4057qib7	6681	22	a	a	DT
cord-005453-4057qib7	6681	23	feasible	feasible	JJ
cord-005453-4057qib7	6681	24	source	source	NN
cord-005453-4057qib7	6681	25	for	for	IN
cord-005453-4057qib7	6681	26	anti	anti	JJ
cord-005453-4057qib7	6681	27	-	-	JJ
cord-005453-4057qib7	6681	28	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6681	29	therapy	therapy	NN
cord-005453-4057qib7	6681	30	Background	background	NN
cord-005453-4057qib7	6681	31	:	:	:
cord-005453-4057qib7	6682	1	Recently	recently	RB
cord-005453-4057qib7	6682	2	,	,	,
cord-005453-4057qib7	6682	3	umbilical	umbilical	JJ
cord-005453-4057qib7	6682	4	cord	cord	NN
cord-005453-4057qib7	6682	5	(	(	-LRB-
cord-005453-4057qib7	6682	6	UC	UC	NNP
cord-005453-4057qib7	6682	7	)	)	-RRB-
cord-005453-4057qib7	6682	8	has	have	VBZ
cord-005453-4057qib7	6682	9	become	become	VBN
cord-005453-4057qib7	6682	10	attracted	attract	VBN
cord-005453-4057qib7	6682	11	source	source	NN
cord-005453-4057qib7	6682	12	of	of	IN
cord-005453-4057qib7	6682	13	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	6682	14	stromal	stromal	JJ
cord-005453-4057qib7	6682	15	cells	cell	NNS
cord-005453-4057qib7	6682	16	(	(	-LRB-
cord-005453-4057qib7	6682	17	MSC	MSC	NNP
cord-005453-4057qib7	6682	18	)	)	-RRB-
cord-005453-4057qib7	6682	19	,	,	,
cord-005453-4057qib7	6682	20	because	because	IN
cord-005453-4057qib7	6682	21	of	of	IN
cord-005453-4057qib7	6682	22	abundant	abundant	JJ
cord-005453-4057qib7	6682	23	sources	source	NNS
cord-005453-4057qib7	6682	24	and	and	CC
cord-005453-4057qib7	6682	25	ease	ease	NN
cord-005453-4057qib7	6682	26	of	of	IN
cord-005453-4057qib7	6682	27	collection	collection	NN
cord-005453-4057qib7	6682	28	of	of	IN
cord-005453-4057qib7	6682	29	fetal	fetal	JJ
cord-005453-4057qib7	6682	30	origin	origin	NN
cord-005453-4057qib7	6682	31	without	without	IN
cord-005453-4057qib7	6682	32	invasive	invasive	JJ
cord-005453-4057qib7	6682	33	process	process	NN
cord-005453-4057qib7	6682	34	for	for	IN
cord-005453-4057qib7	6682	35	the	the	DT
cord-005453-4057qib7	6682	36	donor	donor	NN
cord-005453-4057qib7	6682	37	and	and	CC
cord-005453-4057qib7	6682	38	low	low	JJ
cord-005453-4057qib7	6682	39	immunogenicity	immunogenicity	NN
cord-005453-4057qib7	6682	40	with	with	IN
cord-005453-4057qib7	6682	41	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6682	42	ability	ability	NN
cord-005453-4057qib7	6682	43	and	and	CC
cord-005453-4057qib7	6682	44	tissue	tissue	NN
cord-005453-4057qib7	6682	45	repair	repair	NN
cord-005453-4057qib7	6682	46	potency	potency	NN
cord-005453-4057qib7	6682	47	.	.	.
cord-005453-4057qib7	6683	1	Objectives	objective	NNS
cord-005453-4057qib7	6683	2	of	of	IN
cord-005453-4057qib7	6683	3	this	this	DT
cord-005453-4057qib7	6683	4	study	study	NN
cord-005453-4057qib7	6683	5	were	be	VBD
cord-005453-4057qib7	6683	6	to	to	TO
cord-005453-4057qib7	6683	7	explorer	explorer	VB
cord-005453-4057qib7	6683	8	the	the	DT
cord-005453-4057qib7	6683	9	efficient	efficient	JJ
cord-005453-4057qib7	6683	10	and	and	CC
cord-005453-4057qib7	6683	11	safe	safe	JJ
cord-005453-4057qib7	6683	12	products	product	NNS
cord-005453-4057qib7	6683	13	and	and	CC
cord-005453-4057qib7	6683	14	to	to	TO
cord-005453-4057qib7	6683	15	evaluate	evaluate	VB
cord-005453-4057qib7	6683	16	the	the	DT
cord-005453-4057qib7	6683	17	antiinflammatory	antiinflammatory	JJ
cord-005453-4057qib7	6683	18	potency	potency	NN
cord-005453-4057qib7	6683	19	of	of	IN
cord-005453-4057qib7	6683	20	UC	UC	NNP
cord-005453-4057qib7	6683	21	-	-	HYPH
cord-005453-4057qib7	6683	22	MSCs	MSCs	NNP
cord-005453-4057qib7	6683	23	for	for	IN
cord-005453-4057qib7	6683	24	the	the	DT
cord-005453-4057qib7	6683	25	application	application	NN
cord-005453-4057qib7	6683	26	of	of	IN
cord-005453-4057qib7	6683	27	acute	acute	JJ
cord-005453-4057qib7	6683	28	graft	graft	NN
cord-005453-4057qib7	6683	29	versus	versus	IN
cord-005453-4057qib7	6683	30	host	host	NN
cord-005453-4057qib7	6683	31	disease	disease	NN
cord-005453-4057qib7	6683	32	(	(	-LRB-
cord-005453-4057qib7	6683	33	GVHD	GVHD	NNP
cord-005453-4057qib7	6683	34	)	)	-RRB-
cord-005453-4057qib7	6683	35	.	.	.
cord-005453-4057qib7	6684	1	Methods	method	NNS
cord-005453-4057qib7	6684	2	:	:	:
cord-005453-4057qib7	6685	1	Informed	informed	JJ
cord-005453-4057qib7	6685	2	consent	consent	NN
cord-005453-4057qib7	6685	3	was	be	VBD
cord-005453-4057qib7	6685	4	obtained	obtain	VBN
cord-005453-4057qib7	6685	5	from	from	IN
cord-005453-4057qib7	6685	6	mothers	mother	NNS
cord-005453-4057qib7	6685	7	planning	plan	VBG
cord-005453-4057qib7	6685	8	to	to	TO
cord-005453-4057qib7	6685	9	have	have	VB
cord-005453-4057qib7	6685	10	cesarean	cesarean	NN
cord-005453-4057qib7	6685	11	sections	section	NNS
cord-005453-4057qib7	6685	12	.	.	.
cord-005453-4057qib7	6686	1	UC	UC	NNP
cord-005453-4057qib7	6686	2	tissue	tissue	NN
cord-005453-4057qib7	6686	3	was	be	VBD
cord-005453-4057qib7	6686	4	cut	cut	VBN
cord-005453-4057qib7	6686	5	and	and	CC
cord-005453-4057qib7	6686	6	once	once	RB
cord-005453-4057qib7	6686	7	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	6686	8	.	.	.
cord-005453-4057qib7	6687	1	The	the	DT
cord-005453-4057qib7	6687	2	safety	safety	NN
cord-005453-4057qib7	6687	3	assessment	assessment	NN
cord-005453-4057qib7	6687	4	including	include	VBG
cord-005453-4057qib7	6687	5	infections	infection	NNS
cord-005453-4057qib7	6687	6	and	and	CC
cord-005453-4057qib7	6687	7	baby	baby	NN
cord-005453-4057qib7	6687	8	's	's	POS
cord-005453-4057qib7	6687	9	health	health	NN
cord-005453-4057qib7	6687	10	and	and	CC
cord-005453-4057qib7	6687	11	development	development	NN
cord-005453-4057qib7	6687	12	were	be	VBD
cord-005453-4057qib7	6687	13	done	do	VBN
cord-005453-4057qib7	6687	14	after	after	IN
cord-005453-4057qib7	6687	15	6	6	CD
cord-005453-4057qib7	6687	16	months	month	NNS
cord-005453-4057qib7	6687	17	of	of	IN
cord-005453-4057qib7	6687	18	birth	birth	NN
cord-005453-4057qib7	6687	19	,	,	,
cord-005453-4057qib7	6687	20	and	and	CC
cord-005453-4057qib7	6687	21	performed	perform	VBD
cord-005453-4057qib7	6687	22	small	small	JJ
cord-005453-4057qib7	6687	23	-	-	HYPH
cord-005453-4057qib7	6687	24	scale	scale	NN
cord-005453-4057qib7	6687	25	quality	quality	NN
cord-005453-4057qib7	6687	26	test	test	NN
cord-005453-4057qib7	6687	27	of	of	IN
cord-005453-4057qib7	6687	28	the	the	DT
cord-005453-4057qib7	6687	29	frozen	frozen	JJ
cord-005453-4057qib7	6687	30	UC	UC	NNP
cord-005453-4057qib7	6687	31	.	.	.
cord-005453-4057qib7	6688	1	Then	then	RB
cord-005453-4057qib7	6688	2	we	-PRON-	PRP
cord-005453-4057qib7	6688	3	initiated	initiate	VBD
cord-005453-4057qib7	6688	4	to	to	TO
cord-005453-4057qib7	6688	5	isolate	isolate	VB
cord-005453-4057qib7	6688	6	master	master	NN
cord-005453-4057qib7	6688	7	UC	UC	NNP
cord-005453-4057qib7	6688	8	-	-	HYPH
cord-005453-4057qib7	6688	9	MSCs	msc	NNS
cord-005453-4057qib7	6688	10	from	from	IN
cord-005453-4057qib7	6688	11	frozen	frozen	JJ
cord-005453-4057qib7	6688	12	-	-	HYPH
cord-005453-4057qib7	6688	13	thawed	thaw	VBN
cord-005453-4057qib7	6688	14	UC	UC	NNP
cord-005453-4057qib7	6688	15	by	by	IN
cord-005453-4057qib7	6688	16	an	an	DT
cord-005453-4057qib7	6688	17	improved	improve	VBN
cord-005453-4057qib7	6688	18	explant	explant	NN
cord-005453-4057qib7	6688	19	method	method	NN
cord-005453-4057qib7	6688	20	,	,	,
cord-005453-4057qib7	6688	21	which	which	WDT
cord-005453-4057qib7	6688	22	was	be	VBD
cord-005453-4057qib7	6688	23	passed	pass	VBN
cord-005453-4057qib7	6688	24	for	for	IN
cord-005453-4057qib7	6688	25	quality	quality	NN
cord-005453-4057qib7	6688	26	test	test	NN
cord-005453-4057qib7	6688	27	.	.	.
cord-005453-4057qib7	6689	1	The	the	DT
cord-005453-4057qib7	6689	2	master	master	NN
cord-005453-4057qib7	6689	3	UC	UC	NNP
cord-005453-4057qib7	6689	4	-	-	HYPH
cord-005453-4057qib7	6689	5	MSCs	MSCs	NNP
cord-005453-4057qib7	6689	6	were	be	VBD
cord-005453-4057qib7	6689	7	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	6689	8	once	once	RB
cord-005453-4057qib7	6689	9	and	and	CC
cord-005453-4057qib7	6689	10	thawed	thaw	VBN
cord-005453-4057qib7	6689	11	and	and	CC
cord-005453-4057qib7	6689	12	expanded	expand	VBN
cord-005453-4057qib7	6689	13	until	until	IN
cord-005453-4057qib7	6689	14	P4	P4	NNP
cord-005453-4057qib7	6689	15	.	.	.
cord-005453-4057qib7	6690	1	Product	product	NN
cord-005453-4057qib7	6690	2	cells	cell	NNS
cord-005453-4057qib7	6690	3	were	be	VBD
cord-005453-4057qib7	6690	4	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	6690	5	in	in	IN
cord-005453-4057qib7	6690	6	original	original	JJ
cord-005453-4057qib7	6690	7	serum	serum	NN
cord-005453-4057qib7	6690	8	-	-	HYPH
cord-005453-4057qib7	6690	9	free	free	JJ
cord-005453-4057qib7	6690	10	cryoprotectant	cryoprotectant	NN
cord-005453-4057qib7	6690	11	DBA	dba	NN
cord-005453-4057qib7	6690	12	-	-	HYPH
cord-005453-4057qib7	6690	13	D	d	NN
cord-005453-4057qib7	6690	14	solution	solution	NN
cord-005453-4057qib7	6690	15	.	.	.
cord-005453-4057qib7	6691	1	Mixed	mixed	JJ
cord-005453-4057qib7	6691	2	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6691	3	reaction	reaction	NN
cord-005453-4057qib7	6692	1	(	(	-LRB-
cord-005453-4057qib7	6692	2	MLR	MLR	NNP
cord-005453-4057qib7	6692	3	)	)	-RRB-
cord-005453-4057qib7	6692	4	assay	assay	NN
cord-005453-4057qib7	6692	5	co	co	NN
cord-005453-4057qib7	6692	6	-	-	JJ
cord-005453-4057qib7	6692	7	cultured	cultured	JJ
cord-005453-4057qib7	6692	8	with	with	IN
cord-005453-4057qib7	6692	9	UC	UC	NNP
cord-005453-4057qib7	6692	10	-	-	HYPH
cord-005453-4057qib7	6692	11	MSCs	MSCs	NNP
cord-005453-4057qib7	6692	12	was	be	VBD
cord-005453-4057qib7	6692	13	carried	carry	VBN
cord-005453-4057qib7	6692	14	out	out	RP
cord-005453-4057qib7	6692	15	using	use	VBG
cord-005453-4057qib7	6692	16	responder	responder	NN
cord-005453-4057qib7	6692	17	mononuclear	mononuclear	NN
cord-005453-4057qib7	6692	18	cells	cell	NNS
cord-005453-4057qib7	6692	19	(	(	-LRB-
cord-005453-4057qib7	6692	20	MNC	MNC	NNP
cord-005453-4057qib7	6692	21	)	)	-RRB-
cord-005453-4057qib7	6692	22	stained	stain	VBN
cord-005453-4057qib7	6692	23	with	with	IN
cord-005453-4057qib7	6692	24	CFSE	CFSE	NNP
cord-005453-4057qib7	6692	25	,	,	,
cord-005453-4057qib7	6692	26	and	and	CC
cord-005453-4057qib7	6692	27	proliferation	proliferation	NN
cord-005453-4057qib7	6692	28	and	and	CC
cord-005453-4057qib7	6692	29	cytokine	cytokine	JJ
cord-005453-4057qib7	6692	30	secretion	secretion	NN
cord-005453-4057qib7	6692	31	were	be	VBD
cord-005453-4057qib7	6692	32	analyzed	analyze	VBN
cord-005453-4057qib7	6692	33	by	by	IN
cord-005453-4057qib7	6692	34	flowcytometry	flowcytometry	NN
cord-005453-4057qib7	6692	35	.	.	.
cord-005453-4057qib7	6693	1	Results	result	NNS
cord-005453-4057qib7	6693	2	:	:	:
cord-005453-4057qib7	6694	1	UC	UC	NNP
cord-005453-4057qib7	6694	2	-	-	HYPH
cord-005453-4057qib7	6694	3	MSC	MSC	NNP
cord-005453-4057qib7	6694	4	cultured	culture	VBN
cord-005453-4057qib7	6694	5	showed	show	VBD
cord-005453-4057qib7	6694	6	significantly	significantly	RB
cord-005453-4057qib7	6694	7	higher	high	JJR
cord-005453-4057qib7	6694	8	proliferation	proliferation	NN
cord-005453-4057qib7	6694	9	ability	ability	NN
cord-005453-4057qib7	6694	10	compared	compare	VBN
cord-005453-4057qib7	6694	11	with	with	IN
cord-005453-4057qib7	6694	12	those	those	DT
cord-005453-4057qib7	6694	13	from	from	IN
cord-005453-4057qib7	6694	14	bone	bone	NN
cord-005453-4057qib7	6694	15	marrow	marrow	NN
cord-005453-4057qib7	6694	16	-	-	HYPH
cord-005453-4057qib7	6694	17	derived	derive	VBN
cord-005453-4057qib7	6694	18	MSCs	mscs	NN
cord-005453-4057qib7	6694	19	,	,	,
cord-005453-4057qib7	6694	20	and	and	CC
cord-005453-4057qib7	6694	21	positive	positive	JJ
cord-005453-4057qib7	6694	22	for	for	IN
cord-005453-4057qib7	6694	23	CD105	CD105	NNP
cord-005453-4057qib7	6694	24	,	,	,
cord-005453-4057qib7	6694	25	CD73	CD73	NNP
cord-005453-4057qib7	6694	26	,	,	,
cord-005453-4057qib7	6694	27	CD90	CD90	NNP
cord-005453-4057qib7	6694	28	,	,	,
cord-005453-4057qib7	6694	29	and	and	CC
cord-005453-4057qib7	6694	30	negative	negative	JJ
cord-005453-4057qib7	6694	31	for	for	IN
cord-005453-4057qib7	6694	32	CD45	CD45	NNP
cord-005453-4057qib7	6694	33	,	,	,
cord-005453-4057qib7	6694	34	HLA	HLA	NNP
cord-005453-4057qib7	6694	35	-	-	HYPH
cord-005453-4057qib7	6694	36	DR	DR	NNP
cord-005453-4057qib7	6694	37	.	.	.
cord-005453-4057qib7	6695	1	CD80	CD80	NNP
cord-005453-4057qib7	6695	2	,	,	,
cord-005453-4057qib7	6695	3	and	and	CC
cord-005453-4057qib7	6695	4	CD86	CD86	NNP
cord-005453-4057qib7	6695	5	were	be	VBD
cord-005453-4057qib7	6695	6	negative	negative	JJ
cord-005453-4057qib7	6695	7	even	even	RB
cord-005453-4057qib7	6695	8	in	in	IN
cord-005453-4057qib7	6695	9	the	the	DT
cord-005453-4057qib7	6695	10	high	high	JJ
cord-005453-4057qib7	6695	11	concentration	concentration	NN
cord-005453-4057qib7	6695	12	of	of	IN
cord-005453-4057qib7	6695	13	IFN	IFN	NNP
cord-005453-4057qib7	6695	14	-	-	HYPH
cord-005453-4057qib7	6695	15	γ	γ	NNP
cord-005453-4057qib7	6695	16	,	,	,
cord-005453-4057qib7	6695	17	while	while	IN
cord-005453-4057qib7	6695	18	BM	BM	NNP
cord-005453-4057qib7	6695	19	-	-	HYPH
cord-005453-4057qib7	6695	20	MSCs	MSCs	NNP
cord-005453-4057qib7	6695	21	became	become	VBD
cord-005453-4057qib7	6695	22	positive	positive	JJ
cord-005453-4057qib7	6695	23	for	for	IN
cord-005453-4057qib7	6695	24	HLA	HLA	NNP
cord-005453-4057qib7	6695	25	-	-	HYPH
cord-005453-4057qib7	6695	26	DR	DR	NNP
cord-005453-4057qib7	6695	27	.	.	.
cord-005453-4057qib7	6696	1	PD	PD	NNP
cord-005453-4057qib7	6696	2	-	-	HYPH
cord-005453-4057qib7	6696	3	L2	L2	NNP
cord-005453-4057qib7	6696	4	was	be	VBD
cord-005453-4057qib7	6696	5	constitutively	constitutively	RB
cord-005453-4057qib7	6696	6	expressed	express	VBN
cord-005453-4057qib7	6696	7	in	in	IN
cord-005453-4057qib7	6696	8	UC	UC	NNP
cord-005453-4057qib7	6696	9	-	-	HYPH
cord-005453-4057qib7	6696	10	MSC	MSC	NNP
cord-005453-4057qib7	6696	11	,	,	,
cord-005453-4057qib7	6696	12	while	while	IN
cord-005453-4057qib7	6696	13	PD	PD	NNP
cord-005453-4057qib7	6696	14	-	-	HYPH
cord-005453-4057qib7	6696	15	L1	L1	NNP
cord-005453-4057qib7	6696	16	was	be	VBD
cord-005453-4057qib7	6696	17	induced	induce	VBN
cord-005453-4057qib7	6696	18	by	by	IN
cord-005453-4057qib7	6696	19	the	the	DT
cord-005453-4057qib7	6696	20	addition	addition	NN
cord-005453-4057qib7	6696	21	of	of	IN
cord-005453-4057qib7	6696	22	IFN	IFN	NNP
cord-005453-4057qib7	6696	23	-	-	HYPH
cord-005453-4057qib7	6696	24	γ	γ	NNP
cord-005453-4057qib7	6696	25	.	.	.
cord-005453-4057qib7	6697	1	In	in	IN
cord-005453-4057qib7	6697	2	MLR	MLR	NNP
cord-005453-4057qib7	6697	3	,	,	,
cord-005453-4057qib7	6697	4	responder	responder	NN
cord-005453-4057qib7	6697	5	T	t	NN
cord-005453-4057qib7	6697	6	cell	cell	NN
cord-005453-4057qib7	6697	7	proliferation	proliferation	NN
cord-005453-4057qib7	6697	8	triggered	trigger	VBN
cord-005453-4057qib7	6697	9	by	by	IN
cord-005453-4057qib7	6697	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	6697	11	dendritic	dendritic	JJ
cord-005453-4057qib7	6697	12	cells	cell	NNS
cord-005453-4057qib7	6697	13	was	be	VBD
cord-005453-4057qib7	6697	14	inhibited	inhibit	VBN
cord-005453-4057qib7	6697	15	efficiently	efficiently	RB
cord-005453-4057qib7	6697	16	by	by	IN
cord-005453-4057qib7	6697	17	3rd	3rd	NNP
cord-005453-4057qib7	6697	18	party	party	NNP
cord-005453-4057qib7	6697	19	derived	derive	VBD
cord-005453-4057qib7	6697	20	UC	UC	NNP
cord-005453-4057qib7	6697	21	-	-	HYPH
cord-005453-4057qib7	6697	22	MSCs	MSCs	NNP
cord-005453-4057qib7	6697	23	,	,	,
cord-005453-4057qib7	6697	24	in	in	IN
cord-005453-4057qib7	6697	25	which	which	WDT
cord-005453-4057qib7	6697	26	was	be	VBD
cord-005453-4057qib7	6697	27	induced	induce	VBN
cord-005453-4057qib7	6697	28	IDO	IDO	NNP
cord-005453-4057qib7	6697	29	,	,	,
cord-005453-4057qib7	6697	30	PGE2	PGE2	NNP
cord-005453-4057qib7	6697	31	,	,	,
cord-005453-4057qib7	6697	32	HGF	HGF	NNP
cord-005453-4057qib7	6697	33	,	,	,
cord-005453-4057qib7	6697	34	and	and	CC
cord-005453-4057qib7	6697	35	TGF	TGF	NNP
cord-005453-4057qib7	6697	36	-	-	HYPH
cord-005453-4057qib7	6697	37	β	β	NNP
cord-005453-4057qib7	6697	38	analyzed	analyze	VBN
cord-005453-4057qib7	6697	39	by	by	IN
cord-005453-4057qib7	6697	40	RT	RT	NNP
cord-005453-4057qib7	6697	41	-	-	HYPH
cord-005453-4057qib7	6697	42	PCR	PCR	NNP
cord-005453-4057qib7	6697	43	,	,	,
cord-005453-4057qib7	6697	44	and	and	CC
cord-005453-4057qib7	6697	45	inhibited	inhibit	VBN
cord-005453-4057qib7	6697	46	IFN	IFN	NNP
cord-005453-4057qib7	6697	47	-	-	HYPH
cord-005453-4057qib7	6697	48	γ	γ	NNP
cord-005453-4057qib7	6697	49	and	and	CC
cord-005453-4057qib7	6697	50	TNF	TNF	NNP
cord-005453-4057qib7	6697	51	-	-	HYPH
cord-005453-4057qib7	6697	52	α	α	NN
cord-005453-4057qib7	6697	53	in	in	IN
cord-005453-4057qib7	6697	54	the	the	DT
cord-005453-4057qib7	6697	55	supernatant	supernatant	NN
cord-005453-4057qib7	6697	56	by	by	IN
cord-005453-4057qib7	6697	57	cytokine	cytokine	JJ
cord-005453-4057qib7	6697	58	beads	bead	NNS
cord-005453-4057qib7	6697	59	array	array	NN
cord-005453-4057qib7	6697	60	.	.	.
cord-005453-4057qib7	6698	1	UC	UC	NNP
cord-005453-4057qib7	6698	2	-	-	HYPH
cord-005453-4057qib7	6698	3	MSCs	MSCs	NNP
cord-005453-4057qib7	6698	4	migrated	migrate	VBD
cord-005453-4057qib7	6698	5	toward	toward	IN
cord-005453-4057qib7	6698	6	the	the	DT
cord-005453-4057qib7	6698	7	TNF	TNF	NNP
cord-005453-4057qib7	6698	8	-	-	HYPH
cord-005453-4057qib7	6698	9	α	α	NNP
cord-005453-4057qib7	6698	10	treated	treat	VBN
cord-005453-4057qib7	6698	11	MNC	MNC	NNP
cord-005453-4057qib7	6698	12	and	and	CC
cord-005453-4057qib7	6698	13	increased	increase	VBN
cord-005453-4057qib7	6698	14	regulatory	regulatory	JJ
cord-005453-4057qib7	6698	15	T	t	NN
cord-005453-4057qib7	6698	16	cells	cell	NNS
cord-005453-4057qib7	6698	17	incidence	incidence	NN
cord-005453-4057qib7	6698	18	in	in	IN
cord-005453-4057qib7	6698	19	peripheral	peripheral	JJ
cord-005453-4057qib7	6698	20	mononuclear	mononuclear	JJ
cord-005453-4057qib7	6698	21	cells	cell	NNS
cord-005453-4057qib7	6698	22	by	by	IN
cord-005453-4057qib7	6698	23	the	the	DT
cord-005453-4057qib7	6698	24	coculture	coculture	NN
cord-005453-4057qib7	6698	25	.	.	.
cord-005453-4057qib7	6699	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6699	2	:	:	:
cord-005453-4057qib7	6700	1	These	these	DT
cord-005453-4057qib7	6700	2	results	result	NNS
cord-005453-4057qib7	6700	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6700	4	that	that	IN
cord-005453-4057qib7	6700	5	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	6700	6	UC	UC	NNP
cord-005453-4057qib7	6700	7	are	be	VBP
cord-005453-4057qib7	6700	8	feasible	feasible	JJ
cord-005453-4057qib7	6700	9	and	and	CC
cord-005453-4057qib7	6700	10	efficient	efficient	JJ
cord-005453-4057qib7	6700	11	source	source	NN
cord-005453-4057qib7	6700	12	of	of	IN
cord-005453-4057qib7	6700	13	MSCs	mscs	NN
cord-005453-4057qib7	6700	14	and	and	CC
cord-005453-4057qib7	6700	15	frozen	frozen	NNS
cord-005453-4057qib7	6700	16	-	-	HYPH
cord-005453-4057qib7	6700	17	thawed	thaw	VBN
cord-005453-4057qib7	6700	18	UC	UC	NNP
cord-005453-4057qib7	6700	19	-	-	HYPH
cord-005453-4057qib7	6700	20	MSCs	MSCs	NNP
cord-005453-4057qib7	6700	21	have	have	VBP
cord-005453-4057qib7	6700	22	high	high	JJ
cord-005453-4057qib7	6700	23	anti	anti	JJ
cord-005453-4057qib7	6700	24	-	-	JJ
cord-005453-4057qib7	6700	25	inflammatory	inflammatory	JJ
cord-005453-4057qib7	6700	26	Background	background	NN
cord-005453-4057qib7	6700	27	:	:	:
cord-005453-4057qib7	6700	28	A	a	DT
cord-005453-4057qib7	6700	29	new	new	JJ
cord-005453-4057qib7	6700	30	protocol	protocol	NN
cord-005453-4057qib7	6700	31	is	be	VBZ
cord-005453-4057qib7	6700	32	under	under	IN
cord-005453-4057qib7	6700	33	development	development	NN
cord-005453-4057qib7	6700	34	on	on	IN
cord-005453-4057qib7	6700	35	the	the	DT
cord-005453-4057qib7	6700	36	AMICUS	AMICUS	NNP
cord-005453-4057qib7	6700	37	Separator	Separator	NNP
cord-005453-4057qib7	6700	38	that	that	WDT
cord-005453-4057qib7	6700	39	enables	enable	VBZ
cord-005453-4057qib7	6700	40	the	the	DT
cord-005453-4057qib7	6700	41	device	device	NN
cord-005453-4057qib7	6700	42	to	to	TO
cord-005453-4057qib7	6700	43	perform	perform	VB
cord-005453-4057qib7	6700	44	ECP	ECP	NNP
cord-005453-4057qib7	6700	45	procedures	procedure	NNS
cord-005453-4057qib7	6700	46	.	.	.
cord-005453-4057qib7	6701	1	The	the	DT
cord-005453-4057qib7	6701	2	AMICUS	AMICUS	NNP
cord-005453-4057qib7	6701	3	Separator	Separator	NNP
cord-005453-4057qib7	6701	4	is	be	VBZ
cord-005453-4057qib7	6701	5	used	use	VBN
cord-005453-4057qib7	6701	6	with	with	IN
cord-005453-4057qib7	6701	7	a	a	DT
cord-005453-4057qib7	6701	8	photoactivation	photoactivation	NN
cord-005453-4057qib7	6701	9	device	device	NN
cord-005453-4057qib7	6701	10	,	,	,
cord-005453-4057qib7	6701	11	disposable	disposable	JJ
cord-005453-4057qib7	6701	12	kit	kit	NN
cord-005453-4057qib7	6701	13	and	and	CC
cord-005453-4057qib7	6701	14	8-MOP	8-mop	CD
cord-005453-4057qib7	6701	15	to	to	TO
cord-005453-4057qib7	6701	16	provide	provide	VB
cord-005453-4057qib7	6701	17	ECP	ECP	NNP
cord-005453-4057qib7	6701	18	therapy	therapy	NN
cord-005453-4057qib7	6701	19	in	in	IN
cord-005453-4057qib7	6701	20	a	a	DT
cord-005453-4057qib7	6701	21	closed	closed	JJ
cord-005453-4057qib7	6701	22	system	system	NN
cord-005453-4057qib7	6701	23	.	.	.
cord-005453-4057qib7	6702	1	The	the	DT
cord-005453-4057qib7	6702	2	objective	objective	NN
cord-005453-4057qib7	6702	3	of	of	IN
cord-005453-4057qib7	6702	4	this	this	DT
cord-005453-4057qib7	6702	5	study	study	NN
cord-005453-4057qib7	6702	6	was	be	VBD
cord-005453-4057qib7	6702	7	to	to	TO
cord-005453-4057qib7	6702	8	evaluate	evaluate	VB
cord-005453-4057qib7	6702	9	the	the	DT
cord-005453-4057qib7	6702	10	safety	safety	NN
cord-005453-4057qib7	6702	11	and	and	CC
cord-005453-4057qib7	6702	12	performance	performance	NN
cord-005453-4057qib7	6702	13	of	of	IN
cord-005453-4057qib7	6702	14	the	the	DT
cord-005453-4057qib7	6702	15	investigational	investigational	JJ
cord-005453-4057qib7	6702	16	AMICUS	AMICUS	NNP
cord-005453-4057qib7	6702	17	ECP	ECP	NNP
cord-005453-4057qib7	6702	18	System	System	NNP
cord-005453-4057qib7	6702	19	in	in	IN
cord-005453-4057qib7	6702	20	healthy	healthy	JJ
cord-005453-4057qib7	6702	21	human	human	JJ
cord-005453-4057qib7	6702	22	subjects	subject	NNS
cord-005453-4057qib7	6702	23	.	.	.
cord-005453-4057qib7	6703	1	Methods	method	NNS
cord-005453-4057qib7	6703	2	:	:	:
cord-005453-4057qib7	6704	1	An	an	DT
cord-005453-4057qib7	6704	2	IRB	IRB	NNP
cord-005453-4057qib7	6704	3	-	-	HYPH
cord-005453-4057qib7	6704	4	approved	approve	VBN
cord-005453-4057qib7	6704	5	written	write	VBN
cord-005453-4057qib7	6704	6	informed	informed	JJ
cord-005453-4057qib7	6704	7	consent	consent	NN
cord-005453-4057qib7	6704	8	was	be	VBD
cord-005453-4057qib7	6704	9	obtained	obtain	VBN
cord-005453-4057qib7	6704	10	from	from	IN
cord-005453-4057qib7	6704	11	17	17	CD
cord-005453-4057qib7	6704	12	subjects	subject	NNS
cord-005453-4057qib7	6704	13	(	(	-LRB-
cord-005453-4057qib7	6704	14	12	12	CD
cord-005453-4057qib7	6704	15	male	male	NN
cord-005453-4057qib7	6704	16	,	,	,
cord-005453-4057qib7	6704	17	5	5	CD
cord-005453-4057qib7	6704	18	female	female	NN
cord-005453-4057qib7	6704	19	)	)	-RRB-
cord-005453-4057qib7	6704	20	.	.	.
cord-005453-4057qib7	6705	1	The	the	DT
cord-005453-4057qib7	6705	2	AMICUS	AMICUS	NNP
cord-005453-4057qib7	6705	3	ECP	ECP	NNP
cord-005453-4057qib7	6705	4	System	System	NNP
cord-005453-4057qib7	6705	5	processed	process	VBD
cord-005453-4057qib7	6705	6	either	either	CC
cord-005453-4057qib7	6705	7	500	500	CD
cord-005453-4057qib7	6705	8	,	,	,
cord-005453-4057qib7	6705	9	2000	2000	CD
cord-005453-4057qib7	6705	10	or	or	CC
cord-005453-4057qib7	6705	11	4000	4000	CD
cord-005453-4057qib7	6705	12	mL	ml	NN
cord-005453-4057qib7	6705	13	whole	whole	JJ
cord-005453-4057qib7	6705	14	blood	blood	NN
cord-005453-4057qib7	6705	15	(	(	-LRB-
cord-005453-4057qib7	6705	16	n	n	NN
cord-005453-4057qib7	6705	17	≥	≥	CD
cord-005453-4057qib7	6705	18	5	5	CD
cord-005453-4057qib7	6705	19	per	per	IN
cord-005453-4057qib7	6705	20	arm	arm	NN
cord-005453-4057qib7	6705	21	)	)	-RRB-
cord-005453-4057qib7	6705	22	using	use	VBG
cord-005453-4057qib7	6705	23	double	double	JJ
cord-005453-4057qib7	6705	24	-	-	HYPH
cord-005453-4057qib7	6705	25	needle	needle	NN
cord-005453-4057qib7	6705	26	access	access	NN
cord-005453-4057qib7	6705	27	and	and	CC
cord-005453-4057qib7	6705	28	ACD	acd	NN
cord-005453-4057qib7	6705	29	-	-	HYPH
cord-005453-4057qib7	6705	30	A	a	DT
cord-005453-4057qib7	6705	31	anticoagulation	anticoagulation	NN
cord-005453-4057qib7	6705	32	at	at	IN
cord-005453-4057qib7	6705	33	a	a	DT
cord-005453-4057qib7	6705	34	12:1	12:1	CD
cord-005453-4057qib7	6705	35	WB	WB	NNP
cord-005453-4057qib7	6705	36	:	:	:
cord-005453-4057qib7	6705	37	AC	ac	NN
cord-005453-4057qib7	6705	38	ratio	ratio	NN
cord-005453-4057qib7	6705	39	.	.	.
cord-005453-4057qib7	6706	1	After	after	IN
cord-005453-4057qib7	6706	2	MNC	MNC	NNP
cord-005453-4057qib7	6706	3	collection	collection	NN
cord-005453-4057qib7	6706	4	was	be	VBD
cord-005453-4057qib7	6706	5	completed	complete	VBN
cord-005453-4057qib7	6706	6	,	,	,
cord-005453-4057qib7	6706	7	the	the	DT
cord-005453-4057qib7	6706	8	subject	subject	NN
cord-005453-4057qib7	6706	9	was	be	VBD
cord-005453-4057qib7	6706	10	disconnected	disconnect	VBN
cord-005453-4057qib7	6706	11	from	from	IN
cord-005453-4057qib7	6706	12	the	the	DT
cord-005453-4057qib7	6706	13	device	device	NN
cord-005453-4057qib7	6706	14	.	.	.
cord-005453-4057qib7	6707	1	8-MOP	8-mop	CD
cord-005453-4057qib7	6708	1	(	(	-LRB-
cord-005453-4057qib7	6708	2	3.4	3.4	CD
cord-005453-4057qib7	6708	3	mL	ml	NN
cord-005453-4057qib7	6708	4	,	,	,
cord-005453-4057qib7	6708	5	20	20	CD
cord-005453-4057qib7	6708	6	μg	μg	NN
cord-005453-4057qib7	6708	7	/	/	SYM
cord-005453-4057qib7	6708	8	mL	mL	NNP
cord-005453-4057qib7	6708	9	)	)	-RRB-
cord-005453-4057qib7	6708	10	was	be	VBD
cord-005453-4057qib7	6708	11	injected	inject	VBN
cord-005453-4057qib7	6708	12	directly	directly	RB
cord-005453-4057qib7	6708	13	into	into	IN
cord-005453-4057qib7	6708	14	the	the	DT
cord-005453-4057qib7	6708	15	collected	collect	VBN
cord-005453-4057qib7	6708	16	MNC	MNC	NNP
cord-005453-4057qib7	6708	17	product	product	NN
cord-005453-4057qib7	6708	18	and	and	CC
cord-005453-4057qib7	6708	19	saline	saline	NN
cord-005453-4057qib7	6708	20	(	(	-LRB-
cord-005453-4057qib7	6708	21	approximately	approximately	RB
cord-005453-4057qib7	6708	22	200	200	CD
cord-005453-4057qib7	6708	23	mL	ml	NN
cord-005453-4057qib7	6708	24	total	total	NN
cord-005453-4057qib7	6708	25	)	)	-RRB-
cord-005453-4057qib7	6708	26	,	,	,
cord-005453-4057qib7	6708	27	which	which	WDT
cord-005453-4057qib7	6708	28	was	be	VBD
cord-005453-4057qib7	6708	29	photoactivated	photoactivate	VBN
cord-005453-4057qib7	6708	30	with	with	IN
cord-005453-4057qib7	6708	31	1	1	CD
cord-005453-4057qib7	6708	32	-	-	SYM
cord-005453-4057qib7	6708	33	2	2	CD
cord-005453-4057qib7	6708	34	J	J	NNP
cord-005453-4057qib7	6708	35	/	/	SYM
cord-005453-4057qib7	6708	36	cm	cm	NNP
cord-005453-4057qib7	6708	37	2	2	CD
cord-005453-4057qib7	6708	38	UVA	UVA	NNP
cord-005453-4057qib7	6708	39	light	light	NN
cord-005453-4057qib7	6708	40	.	.	.
cord-005453-4057qib7	6709	1	Post	post	JJ
cord-005453-4057qib7	6709	2	photoactivation	photoactivation	NN
cord-005453-4057qib7	6709	3	,	,	,
cord-005453-4057qib7	6709	4	the	the	DT
cord-005453-4057qib7	6709	5	AMICUS	AMICUS	NNP
cord-005453-4057qib7	6709	6	Separator	Separator	NNP
cord-005453-4057qib7	6709	7	reinfused	reinfuse	VBD
cord-005453-4057qib7	6709	8	the	the	DT
cord-005453-4057qib7	6709	9	treated	treat	VBN
cord-005453-4057qib7	6709	10	MNCs	mnc	NNS
cord-005453-4057qib7	6709	11	into	into	IN
cord-005453-4057qib7	6709	12	a	a	DT
cord-005453-4057qib7	6709	13	transfer	transfer	NN
cord-005453-4057qib7	6709	14	pack	pack	NN
cord-005453-4057qib7	6709	15	.	.	.
cord-005453-4057qib7	6710	1	Subject	subject	JJ
cord-005453-4057qib7	6710	2	laboratory	laboratory	NN
cord-005453-4057qib7	6710	3	and	and	CC
cord-005453-4057qib7	6710	4	safety	safety	NN
cord-005453-4057qib7	6710	5	parameters	parameter	NNS
cord-005453-4057qib7	6710	6	were	be	VBD
cord-005453-4057qib7	6710	7	evaluated	evaluate	VBN
cord-005453-4057qib7	6710	8	;	;	:
cord-005453-4057qib7	6710	9	in	in	FW
cord-005453-4057qib7	6710	10	vitro	vitro	FW
cord-005453-4057qib7	6710	11	evaluations	evaluation	NNS
cord-005453-4057qib7	6710	12	were	be	VBD
cord-005453-4057qib7	6710	13	performed	perform	VBN
cord-005453-4057qib7	6710	14	on	on	IN
cord-005453-4057qib7	6710	15	subject	subject	JJ
cord-005453-4057qib7	6710	16	whole	whole	JJ
cord-005453-4057qib7	6710	17	blood	blood	NN
cord-005453-4057qib7	6710	18	,	,	,
cord-005453-4057qib7	6710	19	collected	collect	VBN
cord-005453-4057qib7	6710	20	MNCs	mnc	NNS
cord-005453-4057qib7	6710	21	,	,	,
cord-005453-4057qib7	6710	22	treated	treat	VBN
cord-005453-4057qib7	6710	23	MNCs	mnc	NNS
cord-005453-4057qib7	6710	24	,	,	,
cord-005453-4057qib7	6710	25	and	and	CC
cord-005453-4057qib7	6710	26	reinfused	reinfuse	VBD
cord-005453-4057qib7	6710	27	cells	cell	NNS
cord-005453-4057qib7	6710	28	.	.	.
cord-005453-4057qib7	6711	1	Lymphocyte	lymphocyte	NN
cord-005453-4057qib7	6711	2	and	and	CC
cord-005453-4057qib7	6711	3	monocyte	monocyte	NNP
cord-005453-4057qib7	6711	4	analysis	analysis	NN
cord-005453-4057qib7	6711	5	were	be	VBD
cord-005453-4057qib7	6711	6	performed	perform	VBN
cord-005453-4057qib7	6711	7	on	on	IN
cord-005453-4057qib7	6711	8	samples	sample	NNS
cord-005453-4057qib7	6711	9	purified	purify	VBN
cord-005453-4057qib7	6711	10	using	use	VBG
cord-005453-4057qib7	6711	11	density	density	NN
cord-005453-4057qib7	6711	12	gradient	gradient	NN
cord-005453-4057qib7	6711	13	separation	separation	NN
cord-005453-4057qib7	6711	14	and	and	CC
cord-005453-4057qib7	6711	15	cultured	culture	VBN
cord-005453-4057qib7	6711	16	for	for	IN
cord-005453-4057qib7	6711	17	up	up	IN
cord-005453-4057qib7	6711	18	to	to	TO
cord-005453-4057qib7	6711	19	3	3	CD
cord-005453-4057qib7	6711	20	days	day	NNS
cord-005453-4057qib7	6711	21	post	post	NN
cord-005453-4057qib7	6711	22	treatment	treatment	NN
cord-005453-4057qib7	6711	23	.	.	.
cord-005453-4057qib7	6712	1	Results	result	NNS
cord-005453-4057qib7	6712	2	:	:	:
cord-005453-4057qib7	6713	1	In	in	IN
cord-005453-4057qib7	6713	2	17	17	CD
cord-005453-4057qib7	6713	3	procedures	procedure	NNS
cord-005453-4057qib7	6713	4	,	,	,
cord-005453-4057qib7	6713	5	median	median	JJ
cord-005453-4057qib7	6713	6	(	(	-LRB-
cord-005453-4057qib7	6713	7	range	range	NN
cord-005453-4057qib7	6713	8	)	)	-RRB-
cord-005453-4057qib7	6713	9	WB	WB	NNP
cord-005453-4057qib7	6713	10	processed	process	VBN
cord-005453-4057qib7	6713	11	was	be	VBD
cord-005453-4057qib7	6713	12	2016.0	2016.0	CD
cord-005453-4057qib7	6714	1	(	(	-LRB-
cord-005453-4057qib7	6714	2	509	509	CD
cord-005453-4057qib7	6714	3	-4024	-4024	JJS
cord-005453-4057qib7	6714	4	)	)	-RRB-
cord-005453-4057qib7	6714	5	mL	ml	NN
cord-005453-4057qib7	6714	6	using	use	VBG
cord-005453-4057qib7	6714	7	172.0	172.0	CD
cord-005453-4057qib7	6715	1	(	(	-LRB-
cord-005453-4057qib7	6715	2	51	51	CD
cord-005453-4057qib7	6715	3	-333	-333	NN
cord-005453-4057qib7	6715	4	)	)	-RRB-
cord-005453-4057qib7	6715	5	mL	mL	NNP
cord-005453-4057qib7	6715	6	of	of	IN
cord-005453-4057qib7	6715	7	ACD	ACD	NNP
cord-005453-4057qib7	6715	8	-	-	HYPH
cord-005453-4057qib7	6715	9	A.	A.	NNP
cord-005453-4057qib7	6715	10	Procedure	Procedure	NNP
cord-005453-4057qib7	6715	11	time	time	NN
cord-005453-4057qib7	6715	12	was	be	VBD
cord-005453-4057qib7	6715	13	93.0	93.0	CD
cord-005453-4057qib7	6715	14	(	(	-LRB-
cord-005453-4057qib7	6715	15	66	66	CD
cord-005453-4057qib7	6715	16	-119	-119	NN
cord-005453-4057qib7	6715	17	)	)	-RRB-
cord-005453-4057qib7	6715	18	minutes	minute	NNS
cord-005453-4057qib7	6715	19	,	,	,
cord-005453-4057qib7	6715	20	including	include	VBG
cord-005453-4057qib7	6715	21	photoactivation	photoactivation	NN
cord-005453-4057qib7	6715	22	.	.	.
cord-005453-4057qib7	6716	1	No	no	DT
cord-005453-4057qib7	6716	2	adverse	adverse	JJ
cord-005453-4057qib7	6716	3	events	event	NNS
cord-005453-4057qib7	6716	4	were	be	VBD
cord-005453-4057qib7	6716	5	reported	report	VBN
cord-005453-4057qib7	6716	6	.	.	.
cord-005453-4057qib7	6717	1	Subjects	subject	NNS
cord-005453-4057qib7	6717	2	'	'	POS
cord-005453-4057qib7	6717	3	vital	vital	JJ
cord-005453-4057qib7	6717	4	signs	sign	NNS
cord-005453-4057qib7	6717	5	and	and	CC
cord-005453-4057qib7	6717	6	hematology	hematology	NN
cord-005453-4057qib7	6717	7	values	value	NNS
cord-005453-4057qib7	6717	8	were	be	VBD
cord-005453-4057qib7	6717	9	unremarkable	unremarkable	JJ
cord-005453-4057qib7	6717	10	and	and	CC
cord-005453-4057qib7	6717	11	within	within	IN
cord-005453-4057qib7	6717	12	expected	expect	VBN
cord-005453-4057qib7	6717	13	values	value	NNS
cord-005453-4057qib7	6717	14	.	.	.
cord-005453-4057qib7	6718	1	The	the	DT
cord-005453-4057qib7	6718	2	WBC	WBC	NNP
cord-005453-4057qib7	6718	3	count	count	NN
cord-005453-4057qib7	6718	4	of	of	IN
cord-005453-4057qib7	6718	5	the	the	DT
cord-005453-4057qib7	6718	6	collected	collect	VBN
cord-005453-4057qib7	6718	7	MNCs	mnc	NNS
cord-005453-4057qib7	6718	8	was	be	VBD
cord-005453-4057qib7	6718	9	13.50	13.50	CD
cord-005453-4057qib7	6718	10	(	(	-LRB-
cord-005453-4057qib7	6718	11	3.3	3.3	CD
cord-005453-4057qib7	6718	12	-30	-30	NN
cord-005453-4057qib7	6718	13	.	.	.
cord-005453-4057qib7	6718	14	2	2	LS
cord-005453-4057qib7	6718	15	)	)	-RRB-
cord-005453-4057qib7	6718	16	x10	x10	CD
cord-005453-4057qib7	6718	17	3	3	CD
cord-005453-4057qib7	6718	18	/μL	/μl	CD
cord-005453-4057qib7	6718	19	,	,	,
cord-005453-4057qib7	6718	20	comprised	comprise	VBN
cord-005453-4057qib7	6718	21	of	of	IN
cord-005453-4057qib7	6718	22	77.10	77.10	CD
cord-005453-4057qib7	6718	23	(	(	-LRB-
cord-005453-4057qib7	6718	24	47.9	47.9	CD
cord-005453-4057qib7	6718	25	-87.0	-87.0	NFP
cord-005453-4057qib7	6718	26	)	)	-RRB-
cord-005453-4057qib7	6718	27	%	%	NN
cord-005453-4057qib7	6718	28	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6718	29	,	,	,
cord-005453-4057qib7	6718	30	15.50	15.50	CD
cord-005453-4057qib7	6718	31	(	(	-LRB-
cord-005453-4057qib7	6718	32	7.0	7.0	CD
cord-005453-4057qib7	6718	33	-36.8	-36.8	CD
cord-005453-4057qib7	6718	34	)	)	-RRB-
cord-005453-4057qib7	6718	35	%	%	NN
cord-005453-4057qib7	6718	36	monocytes	monocyte	NNS
cord-005453-4057qib7	6718	37	and	and	CC
cord-005453-4057qib7	6718	38	5.70	5.70	CD
cord-005453-4057qib7	6718	39	(	(	-LRB-
cord-005453-4057qib7	6718	40	2.9	2.9	CD
cord-005453-4057qib7	6718	41	-25.5	-25.5	CD
cord-005453-4057qib7	6718	42	)	)	-RRB-
cord-005453-4057qib7	6718	43	%	%	NN
cord-005453-4057qib7	6718	44	granulocytes	granulocyte	NNS
cord-005453-4057qib7	6718	45	and	and	CC
cord-005453-4057qib7	6718	46	platelet	platelet	NN
cord-005453-4057qib7	6718	47	count	count	NN
cord-005453-4057qib7	6718	48	was	be	VBD
cord-005453-4057qib7	6718	49	94.0	94.0	CD
cord-005453-4057qib7	6718	50	(	(	-LRB-
cord-005453-4057qib7	6718	51	70	70	CD
cord-005453-4057qib7	6718	52	-169	-169	NNS
cord-005453-4057qib7	6718	53	)	)	-RRB-
cord-005453-4057qib7	6719	1	Background	background	NN
cord-005453-4057qib7	6719	2	:	:	:
cord-005453-4057qib7	6719	3	Transfusion	transfusion	NN
cord-005453-4057qib7	6719	4	of	of	IN
cord-005453-4057qib7	6719	5	white	white	JJ
cord-005453-4057qib7	6719	6	blood	blood	NN
cord-005453-4057qib7	6719	7	cells	cell	NNS
cord-005453-4057qib7	6719	8	(	(	-LRB-
cord-005453-4057qib7	6719	9	WBC	WBC	NNP
cord-005453-4057qib7	6719	10	)	)	-RRB-
cord-005453-4057qib7	6719	11	causes	cause	VBZ
cord-005453-4057qib7	6719	12	a	a	DT
cord-005453-4057qib7	6719	13	number	number	NN
cord-005453-4057qib7	6719	14	of	of	IN
cord-005453-4057qib7	6719	15	transfusion	transfusion	NN
cord-005453-4057qib7	6719	16	reactions	reaction	NNS
cord-005453-4057qib7	6719	17	and	and	CC
cord-005453-4057qib7	6719	18	complications	complication	NNS
cord-005453-4057qib7	6719	19	,	,	,
cord-005453-4057qib7	6719	20	for	for	IN
cord-005453-4057qib7	6719	21	example	example	NN
cord-005453-4057qib7	6719	22	transfusion	transfusion	NN
cord-005453-4057qib7	6719	23	-	-	HYPH
cord-005453-4057qib7	6719	24	associated	associate	VBN
cord-005453-4057qib7	6719	25	graft	graft	NN
cord-005453-4057qib7	6719	26	versus	versus	IN
cord-005453-4057qib7	6719	27	host	host	NN
cord-005453-4057qib7	6719	28	disease	disease	NN
cord-005453-4057qib7	6719	29	(	(	-LRB-
cord-005453-4057qib7	6719	30	taGVHT	taGVHT	NNP
cord-005453-4057qib7	6719	31	)	)	-RRB-
cord-005453-4057qib7	6719	32	,	,	,
cord-005453-4057qib7	6719	33	which	which	WDT
cord-005453-4057qib7	6719	34	still	still	RB
cord-005453-4057qib7	6719	35	does	do	VBZ
cord-005453-4057qib7	6719	36	not	not	RB
cord-005453-4057qib7	6719	37	have	have	VB
cord-005453-4057qib7	6719	38	effective	effective	JJ
cord-005453-4057qib7	6719	39	treatment	treatment	NN
cord-005453-4057qib7	6719	40	and	and	CC
cord-005453-4057qib7	6719	41	is	be	VBZ
cord-005453-4057qib7	6719	42	a	a	DT
cord-005453-4057qib7	6719	43	fatal	fatal	JJ
cord-005453-4057qib7	6719	44	complication	complication	NN
cord-005453-4057qib7	6719	45	of	of	IN
cord-005453-4057qib7	6719	46	transfusions	transfusion	NNS
cord-005453-4057qib7	6719	47	.	.	.
cord-005453-4057qib7	6720	1	The	the	DT
cord-005453-4057qib7	6720	2	only	only	JJ
cord-005453-4057qib7	6720	3	effective	effective	JJ
cord-005453-4057qib7	6720	4	method	method	NN
cord-005453-4057qib7	6720	5	of	of	IN
cord-005453-4057qib7	6720	6	preventing	prevent	VBG
cord-005453-4057qib7	6720	7	taGVHT	taGVHT	NNP
cord-005453-4057qib7	6720	8	is	be	VBZ
cord-005453-4057qib7	6720	9	irradiation	irradiation	NN
cord-005453-4057qib7	6720	10	of	of	IN
cord-005453-4057qib7	6720	11	blood	blood	NN
cord-005453-4057qib7	6720	12	components	component	NNS
cord-005453-4057qib7	6720	13	with	with	IN
cord-005453-4057qib7	6720	14	ionizing	ionize	VBG
cord-005453-4057qib7	6720	15	radiation	radiation	NN
cord-005453-4057qib7	6720	16	(	(	-LRB-
cord-005453-4057qib7	6720	17	X	x	NN
cord-005453-4057qib7	6720	18	-	-	NN
cord-005453-4057qib7	6720	19	ray	ray	NN
cord-005453-4057qib7	6720	20	or	or	CC
cord-005453-4057qib7	6720	21	gamma	gamma	NN
cord-005453-4057qib7	6720	22	radiation	radiation	NN
cord-005453-4057qib7	6720	23	)	)	-RRB-
cord-005453-4057qib7	6720	24	.	.	.
cord-005453-4057qib7	6721	1	But	but	CC
cord-005453-4057qib7	6721	2	the	the	DT
cord-005453-4057qib7	6721	3	use	use	NN
cord-005453-4057qib7	6721	4	of	of	IN
cord-005453-4057qib7	6721	5	ionizing	ionize	VBG
cord-005453-4057qib7	6721	6	radiation	radiation	NN
cord-005453-4057qib7	6721	7	sources	source	NNS
cord-005453-4057qib7	6721	8	has	have	VBZ
cord-005453-4057qib7	6721	9	a	a	DT
cord-005453-4057qib7	6721	10	number	number	NN
cord-005453-4057qib7	6721	11	of	of	IN
cord-005453-4057qib7	6721	12	technical	technical	JJ
cord-005453-4057qib7	6721	13	and	and	CC
cord-005453-4057qib7	6721	14	material	material	JJ
cord-005453-4057qib7	6721	15	difficulties	difficulty	NNS
cord-005453-4057qib7	6721	16	.	.	.
cord-005453-4057qib7	6722	1	The	the	DT
cord-005453-4057qib7	6722	2	emergence	emergence	NN
cord-005453-4057qib7	6722	3	of	of	IN
cord-005453-4057qib7	6722	4	pathogen	pathogen	NN
cord-005453-4057qib7	6722	5	reduction	reduction	NN
cord-005453-4057qib7	6722	6	technologies	technology	NNS
cord-005453-4057qib7	6722	7	(	(	-LRB-
cord-005453-4057qib7	6722	8	PRT	PRT	NNP
cord-005453-4057qib7	6722	9	)	)	-RRB-
cord-005453-4057qib7	6722	10	in	in	IN
cord-005453-4057qib7	6722	11	blood	blood	NN
cord-005453-4057qib7	6722	12	components	component	NNS
cord-005453-4057qib7	6722	13	targeted	target	VBN
cord-005453-4057qib7	6722	14	by	by	IN
cord-005453-4057qib7	6722	15	nucleic	nucleic	JJ
cord-005453-4057qib7	6722	16	acids	acid	NNS
cord-005453-4057qib7	6722	17	has	have	VBZ
cord-005453-4057qib7	6722	18	opened	open	VBN
cord-005453-4057qib7	6722	19	the	the	DT
cord-005453-4057qib7	6722	20	possibility	possibility	NN
cord-005453-4057qib7	6722	21	of	of	IN
cord-005453-4057qib7	6722	22	using	use	VBG
cord-005453-4057qib7	6722	23	these	these	DT
cord-005453-4057qib7	6722	24	technologies	technology	NNS
cord-005453-4057qib7	6722	25	as	as	IN
cord-005453-4057qib7	6722	26	an	an	DT
cord-005453-4057qib7	6722	27	alternative	alternative	NN
cord-005453-4057qib7	6722	28	to	to	IN
cord-005453-4057qib7	6722	29	irradiating	irradiate	VBG
cord-005453-4057qib7	6722	30	of	of	IN
cord-005453-4057qib7	6722	31	blood	blood	NN
cord-005453-4057qib7	6722	32	components	component	NNS
cord-005453-4057qib7	6722	33	.	.	.
cord-005453-4057qib7	6723	1	Several	several	JJ
cord-005453-4057qib7	6723	2	PRT	PRT	NNP
cord-005453-4057qib7	6723	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6723	4	effective	effective	JJ
cord-005453-4057qib7	6723	5	inactivation	inactivation	NN
cord-005453-4057qib7	6723	6	of	of	IN
cord-005453-4057qib7	6723	7	WBC	WBC	NNP
cord-005453-4057qib7	6723	8	in	in	IN
cord-005453-4057qib7	6723	9	platelet	platelet	NN
cord-005453-4057qib7	6723	10	concentrates	concentrate	NNS
cord-005453-4057qib7	6723	11	and	and	CC
cord-005453-4057qib7	6723	12	blood	blood	NN
cord-005453-4057qib7	6723	13	plasma	plasma	NN
cord-005453-4057qib7	6723	14	.	.	.
cord-005453-4057qib7	6724	1	So	so	RB
cord-005453-4057qib7	6724	2	,	,	,
cord-005453-4057qib7	6724	3	determination	determination	NN
cord-005453-4057qib7	6724	4	of	of	IN
cord-005453-4057qib7	6724	5	the	the	DT
cord-005453-4057qib7	6724	6	influence	influence	NN
cord-005453-4057qib7	6724	7	of	of	IN
cord-005453-4057qib7	6724	8	PRT	PRT	NNP
cord-005453-4057qib7	6724	9	based	base	VBN
cord-005453-4057qib7	6724	10	on	on	IN
cord-005453-4057qib7	6724	11	the	the	DT
cord-005453-4057qib7	6724	12	combined	combined	JJ
cord-005453-4057qib7	6724	13	effect	effect	NN
cord-005453-4057qib7	6724	14	of	of	IN
cord-005453-4057qib7	6724	15	riboflavin	riboflavin	NN
cord-005453-4057qib7	6724	16	(	(	-LRB-
cord-005453-4057qib7	6724	17	RF	rf	NN
cord-005453-4057qib7	6724	18	)	)	-RRB-
cord-005453-4057qib7	6724	19	and	and	CC
cord-005453-4057qib7	6724	20	ultraviolet	ultraviolet	NN
cord-005453-4057qib7	6724	21	(	(	-LRB-
cord-005453-4057qib7	6724	22	UV	uv	NN
cord-005453-4057qib7	6724	23	)	)	-RRB-
cord-005453-4057qib7	6724	24	on	on	IN
cord-005453-4057qib7	6724	25	the	the	DT
cord-005453-4057qib7	6724	26	viability	viability	NN
cord-005453-4057qib7	6724	27	and	and	CC
cord-005453-4057qib7	6724	28	proliferating	proliferate	VBG
cord-005453-4057qib7	6724	29	potential	potential	NN
cord-005453-4057qib7	6724	30	of	of	IN
cord-005453-4057qib7	6724	31	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6724	32	in	in	IN
cord-005453-4057qib7	6724	33	whole	whole	JJ
cord-005453-4057qib7	6724	34	blood	blood	NN
cord-005453-4057qib7	6724	35	is	be	VBZ
cord-005453-4057qib7	6724	36	important	important	JJ
cord-005453-4057qib7	6724	37	.	.	.
cord-005453-4057qib7	6725	1	Methods	method	NNS
cord-005453-4057qib7	6725	2	:	:	:
cord-005453-4057qib7	6725	3	Samples	sample	NNS
cord-005453-4057qib7	6725	4	of	of	IN
cord-005453-4057qib7	6725	5	whole	whole	JJ
cord-005453-4057qib7	6725	6	blood	blood	NN
cord-005453-4057qib7	6725	7	were	be	VBD
cord-005453-4057qib7	6725	8	obtained	obtain	VBN
cord-005453-4057qib7	6725	9	in	in	IN
cord-005453-4057qib7	6725	10	35	35	CD
cord-005453-4057qib7	6725	11	healthy	healthy	JJ
cord-005453-4057qib7	6725	12	volunteers	volunteer	NNS
cord-005453-4057qib7	6725	13	.	.	.
cord-005453-4057qib7	6726	1	Each	each	DT
cord-005453-4057qib7	6726	2	sample	sample	NN
cord-005453-4057qib7	6726	3	was	be	VBD
cord-005453-4057qib7	6726	4	divided	divide	VBN
cord-005453-4057qib7	6726	5	into	into	IN
cord-005453-4057qib7	6726	6	three	three	CD
cord-005453-4057qib7	6726	7	unequal	unequal	JJ
cord-005453-4057qib7	6726	8	parts	part	NNS
cord-005453-4057qib7	6726	9	:	:	:
cord-005453-4057qib7	6726	10	untreated	untreated	JJ
cord-005453-4057qib7	6726	11	control	control	NN
cord-005453-4057qib7	6726	12	,	,	,
cord-005453-4057qib7	6726	13	gamma	gamma	NN
cord-005453-4057qib7	6726	14	irradiated	irradiate	VBD
cord-005453-4057qib7	6726	15	,	,	,
cord-005453-4057qib7	6726	16	and	and	CC
cord-005453-4057qib7	6726	17	treated	treat	VBN
cord-005453-4057qib7	6726	18	by	by	IN
cord-005453-4057qib7	6726	19	RF	RF	NNP
cord-005453-4057qib7	6726	20	and	and	CC
cord-005453-4057qib7	6726	21	UV	UV	NNP
cord-005453-4057qib7	6726	22	PRT	PRT	NNP
cord-005453-4057qib7	6726	23	(	(	-LRB-
cord-005453-4057qib7	6726	24	Mirasol	Mirasol	NNP
cord-005453-4057qib7	6726	25	,	,	,
cord-005453-4057qib7	6726	26	Terumo	Terumo	NNP
cord-005453-4057qib7	6726	27	BCT	BCT	NNP
cord-005453-4057qib7	6726	28	Inc.	Inc.	NNP
cord-005453-4057qib7	6726	29	)	)	-RRB-
cord-005453-4057qib7	6726	30	.	.	.
cord-005453-4057qib7	6727	1	Mononuclear	Mononuclear	NNP
cord-005453-4057qib7	6727	2	cells	cell	NNS
cord-005453-4057qib7	6727	3	(	(	-LRB-
cord-005453-4057qib7	6727	4	MNC	MNC	NNP
cord-005453-4057qib7	6727	5	)	)	-RRB-
cord-005453-4057qib7	6727	6	were	be	VBD
cord-005453-4057qib7	6727	7	CFSE	CFSE	NNP
cord-005453-4057qib7	6727	8	stained	stain	VBN
cord-005453-4057qib7	6727	9	,	,	,
cord-005453-4057qib7	6727	10	viability	viability	NN
cord-005453-4057qib7	6727	11	and	and	CC
cord-005453-4057qib7	6727	12	proliferating	proliferate	VBG
cord-005453-4057qib7	6727	13	activity	activity	NN
cord-005453-4057qib7	6727	14	were	be	VBD
cord-005453-4057qib7	6727	15	tested	test	VBN
cord-005453-4057qib7	6727	16	at	at	IN
cord-005453-4057qib7	6727	17	intervals	interval	NNS
cord-005453-4057qib7	6727	18	of	of	IN
cord-005453-4057qib7	6727	19	24	24	CD
cord-005453-4057qib7	6727	20	hours	hour	NNS
cord-005453-4057qib7	6727	21	for	for	IN
cord-005453-4057qib7	6727	22	3	3	CD
cord-005453-4057qib7	6727	23	consecutive	consecutive	JJ
cord-005453-4057qib7	6727	24	days	day	NNS
cord-005453-4057qib7	6727	25	by	by	IN
cord-005453-4057qib7	6727	26	flow	flow	NN
cord-005453-4057qib7	6727	27	cytometry	cytometry	NN
cord-005453-4057qib7	6727	28	.	.	.
cord-005453-4057qib7	6728	1	Statistical	statistical	JJ
cord-005453-4057qib7	6728	2	analysis	analysis	NN
cord-005453-4057qib7	6728	3	was	be	VBD
cord-005453-4057qib7	6728	4	performed	perform	VBN
cord-005453-4057qib7	6728	5	with	with	IN
cord-005453-4057qib7	6728	6	XLStat	XLStat	NNP
cord-005453-4057qib7	6728	7	7.0	7.0	CD
cord-005453-4057qib7	6728	8	.	.	.
cord-005453-4057qib7	6729	1	Levels	level	NNS
cord-005453-4057qib7	6729	2	of	of	IN
cord-005453-4057qib7	6729	3	significance	significance	NN
cord-005453-4057qib7	6729	4	were	be	VBD
cord-005453-4057qib7	6729	5	calculated	calculate	VBN
cord-005453-4057qib7	6729	6	by	by	IN
cord-005453-4057qib7	6729	7	Mann	Mann	NNP
cord-005453-4057qib7	6729	8	-	-	HYPH
cord-005453-4057qib7	6729	9	Whitney	Whitney	NNP
cord-005453-4057qib7	6729	10	test	test	NN
cord-005453-4057qib7	6729	11	,	,	,
cord-005453-4057qib7	6729	12	expressed	express	VBD
cord-005453-4057qib7	6729	13	as	as	IN
cord-005453-4057qib7	6729	14	P	p	NN
cord-005453-4057qib7	6729	15	-	-	HYPH
cord-005453-4057qib7	6729	16	values	value	NNS
cord-005453-4057qib7	6729	17	(	(	-LRB-
cord-005453-4057qib7	6729	18	P	p	NN
cord-005453-4057qib7	6729	19	<	<	XX
cord-005453-4057qib7	6729	20	0,05	0,05	NN
cord-005453-4057qib7	6729	21	)	)	-RRB-
cord-005453-4057qib7	6729	22	.	.	.
cord-005453-4057qib7	6730	1	Results	result	NNS
cord-005453-4057qib7	6730	2	:	:	:
cord-005453-4057qib7	6731	1	The	the	DT
cord-005453-4057qib7	6731	2	median	median	JJ
cord-005453-4057qib7	6731	3	viability	viability	NN
cord-005453-4057qib7	6731	4	of	of	IN
cord-005453-4057qib7	6731	5	MNC	MNC	NNP
cord-005453-4057qib7	6731	6	after	after	IN
cord-005453-4057qib7	6731	7	application	application	NN
cord-005453-4057qib7	6731	8	of	of	IN
cord-005453-4057qib7	6731	9	both	both	DT
cord-005453-4057qib7	6731	10	methods	method	NNS
cord-005453-4057qib7	6731	11	of	of	IN
cord-005453-4057qib7	6731	12	treatment	treatment	NN
cord-005453-4057qib7	6731	13	was	be	VBD
cord-005453-4057qib7	6731	14	over	over	IN
cord-005453-4057qib7	6731	15	85,0	85,0	CD
cord-005453-4057qib7	6731	16	%	%	NN
cord-005453-4057qib7	6731	17	on	on	IN
cord-005453-4057qib7	6731	18	day	day	NN
cord-005453-4057qib7	6731	19	0	0	CD
cord-005453-4057qib7	6731	20	and	and	CC
cord-005453-4057qib7	6731	21	decreased	decrease	VBD
cord-005453-4057qib7	6731	22	to	to	IN
cord-005453-4057qib7	6731	23	day	day	NN
cord-005453-4057qib7	6731	24	3	3	CD
cord-005453-4057qib7	6731	25	-median	-median	JJ
cord-005453-4057qib7	6731	26	percentage	percentage	NN
cord-005453-4057qib7	6731	27	of	of	IN
cord-005453-4057qib7	6731	28	viable	viable	JJ
cord-005453-4057qib7	6731	29	MNC	MNC	NNP
cord-005453-4057qib7	6731	30	were	be	VBD
cord-005453-4057qib7	6731	31	84,0	84,0	CD
cord-005453-4057qib7	6731	32	%	%	NN
cord-005453-4057qib7	6731	33	(	(	-LRB-
cord-005453-4057qib7	6731	34	control	control	NNP
cord-005453-4057qib7	6731	35	group	group	NN
cord-005453-4057qib7	6731	36	)	)	-RRB-
cord-005453-4057qib7	6731	37	,	,	,
cord-005453-4057qib7	6731	38	69,0	69,0	CD
cord-005453-4057qib7	6731	39	%	%	NN
cord-005453-4057qib7	6731	40	(	(	-LRB-
cord-005453-4057qib7	6731	41	after	after	IN
cord-005453-4057qib7	6731	42	gamma	gamma	NN
cord-005453-4057qib7	6731	43	irradiation	irradiation	NN
cord-005453-4057qib7	6731	44	)	)	-RRB-
cord-005453-4057qib7	6731	45	and	and	CC
cord-005453-4057qib7	6731	46	63,0	63,0	CD
cord-005453-4057qib7	6731	47	%	%	NN
cord-005453-4057qib7	6731	48	(	(	-LRB-
cord-005453-4057qib7	6731	49	RF	rf	NN
cord-005453-4057qib7	6731	50	/	/	SYM
cord-005453-4057qib7	6731	51	UV	UV	NNP
cord-005453-4057qib7	6731	52	PRT	PRT	NNP
cord-005453-4057qib7	6731	53	)	)	-RRB-
cord-005453-4057qib7	6731	54	.	.	.
cord-005453-4057qib7	6732	1	The	the	DT
cord-005453-4057qib7	6732	2	median	median	NN
cord-005453-4057qib7	6732	3	of	of	IN
cord-005453-4057qib7	6732	4	spontaneous	spontaneous	JJ
cord-005453-4057qib7	6732	5	proliferative	proliferative	JJ
cord-005453-4057qib7	6732	6	activity	activity	NN
cord-005453-4057qib7	6732	7	on	on	IN
cord-005453-4057qib7	6732	8	day	day	NN
cord-005453-4057qib7	6732	9	3	3	CD
cord-005453-4057qib7	6732	10	of	of	IN
cord-005453-4057qib7	6732	11	untreated	untreated	JJ
cord-005453-4057qib7	6732	12	and	and	CC
cord-005453-4057qib7	6732	13	gamma	gamma	NN
cord-005453-4057qib7	6732	14	irradiated	irradiate	VBD
cord-005453-4057qib7	6733	1	MNC	MNC	NNP
cord-005453-4057qib7	6733	2	did	do	VBD
cord-005453-4057qib7	6733	3	not	not	RB
cord-005453-4057qib7	6733	4	differ	differ	VB
cord-005453-4057qib7	6733	5	(	(	-LRB-
cord-005453-4057qib7	6733	6	1,8	1,8	CD
cord-005453-4057qib7	6733	7	%	%	NN
cord-005453-4057qib7	6733	8	and	and	CC
cord-005453-4057qib7	6733	9	2,1	2,1	CD
cord-005453-4057qib7	6733	10	%	%	NN
cord-005453-4057qib7	6733	11	respectively	respectively	RB
cord-005453-4057qib7	6733	12	,	,	,
cord-005453-4057qib7	6733	13	p	p	NN
cord-005453-4057qib7	6733	14	<	<	XX
cord-005453-4057qib7	6733	15	0,05	0,05	NNP
cord-005453-4057qib7	6733	16	)	)	-RRB-
cord-005453-4057qib7	6733	17	.	.	.
cord-005453-4057qib7	6734	1	Phytohemaglutenin	Phytohemaglutenin	NNP
cord-005453-4057qib7	6734	2	(	(	-LRB-
cord-005453-4057qib7	6734	3	PHA	PHA	NNP
cord-005453-4057qib7	6734	4	)	)	-RRB-
cord-005453-4057qib7	6734	5	induced	induce	VBD
cord-005453-4057qib7	6734	6	proliferation	proliferation	NN
cord-005453-4057qib7	6734	7	on	on	IN
cord-005453-4057qib7	6734	8	day	day	NN
cord-005453-4057qib7	6734	9	3	3	CD
cord-005453-4057qib7	6734	10	in	in	IN
cord-005453-4057qib7	6734	11	gamma	gamma	NN
cord-005453-4057qib7	6734	12	-	-	HYPH
cord-005453-4057qib7	6734	13	irradiated	irradiate	VBN
cord-005453-4057qib7	6734	14	samples	sample	NNS
cord-005453-4057qib7	6734	15	was	be	VBD
cord-005453-4057qib7	6734	16	significantly	significantly	RB
cord-005453-4057qib7	6734	17	lower	low	JJR
cord-005453-4057qib7	6734	18	in	in	IN
cord-005453-4057qib7	6734	19	comparison	comparison	NN
cord-005453-4057qib7	6734	20	with	with	IN
cord-005453-4057qib7	6734	21	control	control	NN
cord-005453-4057qib7	6734	22	group	group	NN
cord-005453-4057qib7	6734	23	(	(	-LRB-
cord-005453-4057qib7	6734	24	4,0	4,0	CD
cord-005453-4057qib7	6734	25	%	%	NN
cord-005453-4057qib7	6734	26	and	and	CC
cord-005453-4057qib7	6734	27	45,0	45,0	CD
cord-005453-4057qib7	6734	28	%	%	NN
cord-005453-4057qib7	6734	29	respectively	respectively	RB
cord-005453-4057qib7	6734	30	,	,	,
cord-005453-4057qib7	6734	31	p	p	NN
cord-005453-4057qib7	6734	32	<	<	XX
cord-005453-4057qib7	6734	33	0,01	0,01	NN
cord-005453-4057qib7	6734	34	)	)	-RRB-
cord-005453-4057qib7	6734	35	.	.	.
cord-005453-4057qib7	6735	1	In	in	IN
cord-005453-4057qib7	6735	2	samples	sample	NNS
cord-005453-4057qib7	6735	3	treated	treat	VBN
cord-005453-4057qib7	6735	4	with	with	IN
cord-005453-4057qib7	6735	5	RF	RF	NNP
cord-005453-4057qib7	6735	6	/	/	SYM
cord-005453-4057qib7	6735	7	UV	uv	NN
cord-005453-4057qib7	6735	8	,	,	,
cord-005453-4057qib7	6735	9	spontaneous	spontaneous	JJ
cord-005453-4057qib7	6735	10	and	and	CC
cord-005453-4057qib7	6735	11	stimulated	stimulate	VBN
cord-005453-4057qib7	6735	12	proliferating	proliferate	VBG
cord-005453-4057qib7	6735	13	cells	cell	NNS
cord-005453-4057qib7	6735	14	was	be	VBD
cord-005453-4057qib7	6735	15	not	not	RB
cord-005453-4057qib7	6735	16	detected	detect	VBN
cord-005453-4057qib7	6735	17	.	.	.
cord-005453-4057qib7	6736	1	Median	median	JJ
cord-005453-4057qib7	6736	2	percentage	percentage	NN
cord-005453-4057qib7	6736	3	of	of	IN
cord-005453-4057qib7	6736	4	proliferating	proliferate	VBG
cord-005453-4057qib7	6736	5	MNC	MNC	NNP
cord-005453-4057qib7	6736	6	was	be	VBD
cord-005453-4057qib7	6737	1	less	less	JJR
cord-005453-4057qib7	6737	2	than	than	IN
cord-005453-4057qib7	6737	3	0,2	0,2	CD
cord-005453-4057qib7	6737	4	%	%	NN
cord-005453-4057qib7	6737	5	.	.	.
cord-005453-4057qib7	6738	1	The	the	DT
cord-005453-4057qib7	6738	2	use	use	NN
cord-005453-4057qib7	6738	3	of	of	IN
cord-005453-4057qib7	6738	4	this	this	DT
cord-005453-4057qib7	6738	5	PRT	PRT	NNP
cord-005453-4057qib7	6738	6	on	on	IN
cord-005453-4057qib7	6738	7	whole	whole	JJ
cord-005453-4057qib7	6738	8	blood	blood	NN
cord-005453-4057qib7	6738	9	,	,	,
cord-005453-4057qib7	6738	10	as	as	RB
cord-005453-4057qib7	6738	11	well	well	RB
cord-005453-4057qib7	6738	12	as	as	IN
cord-005453-4057qib7	6738	13	gamma	gamma	NN
cord-005453-4057qib7	6738	14	irradiation	irradiation	NN
cord-005453-4057qib7	6738	15	,	,	,
cord-005453-4057qib7	6738	16	significantly	significantly	RB
cord-005453-4057qib7	6738	17	reduces	reduce	VBZ
cord-005453-4057qib7	6738	18	the	the	DT
cord-005453-4057qib7	6738	19	viability	viability	NN
cord-005453-4057qib7	6738	20	of	of	IN
cord-005453-4057qib7	6738	21	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6738	22	during	during	IN
cord-005453-4057qib7	6738	23	storage	storage	NN
cord-005453-4057qib7	6738	24	for	for	IN
cord-005453-4057qib7	6738	25	3	3	CD
cord-005453-4057qib7	6738	26	days	day	NNS
cord-005453-4057qib7	6738	27	.	.	.
cord-005453-4057qib7	6739	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6739	2	:	:	:
cord-005453-4057qib7	6740	1	Inactivation	Inactivation	NNP
cord-005453-4057qib7	6740	2	of	of	IN
cord-005453-4057qib7	6740	3	WBC	WBC	NNP
cord-005453-4057qib7	6740	4	using	use	VBG
cord-005453-4057qib7	6740	5	RF	RF	NNP
cord-005453-4057qib7	6740	6	/	/	SYM
cord-005453-4057qib7	6740	7	UV	UV	NNP
cord-005453-4057qib7	6740	8	PRT	PRT	NNP
cord-005453-4057qib7	6740	9	is	be	VBZ
cord-005453-4057qib7	6740	10	a	a	DT
cord-005453-4057qib7	6740	11	useful	useful	JJ
cord-005453-4057qib7	6740	12	and	and	CC
cord-005453-4057qib7	6740	13	very	very	RB
cord-005453-4057qib7	6740	14	necessary	necessary	JJ
cord-005453-4057qib7	6740	15	bonus	bonus	NN
cord-005453-4057qib7	6740	16	for	for	IN
cord-005453-4057qib7	6740	17	a	a	DT
cord-005453-4057qib7	6740	18	number	number	NN
cord-005453-4057qib7	6740	19	of	of	IN
cord-005453-4057qib7	6740	20	reasons	reason	NNS
cord-005453-4057qib7	6740	21	.	.	.
cord-005453-4057qib7	6741	1	In	in	IN
cord-005453-4057qib7	6741	2	one	one	CD
cord-005453-4057qib7	6741	3	procedure	procedure	NN
cord-005453-4057qib7	6741	4	two	two	CD
cord-005453-4057qib7	6741	5	effects	effect	NNS
cord-005453-4057qib7	6741	6	are	be	VBP
cord-005453-4057qib7	6741	7	achieved	achieve	VBN
cord-005453-4057qib7	6741	8	:	:	:
cord-005453-4057qib7	6741	9	infectious	infectious	JJ
cord-005453-4057qib7	6741	10	and	and	CC
cord-005453-4057qib7	6741	11	immunological	immunological	JJ
cord-005453-4057qib7	6741	12	safety	safety	NN
cord-005453-4057qib7	6741	13	.	.	.
cord-005453-4057qib7	6742	1	The	the	DT
cord-005453-4057qib7	6742	2	use	use	NN
cord-005453-4057qib7	6742	3	of	of	IN
cord-005453-4057qib7	6742	4	PRT	PRT	NNP
cord-005453-4057qib7	6742	5	on	on	IN
cord-005453-4057qib7	6742	6	whole	whole	JJ
cord-005453-4057qib7	6742	7	blood	blood	NN
cord-005453-4057qib7	6742	8	gives	give	VBZ
cord-005453-4057qib7	6742	9	the	the	DT
cord-005453-4057qib7	6742	10	potential	potential	NN
cord-005453-4057qib7	6742	11	for	for	IN
cord-005453-4057qib7	6742	12	obtaining	obtain	VBG
cord-005453-4057qib7	6742	13	pathogen	pathogen	NN
cord-005453-4057qib7	6742	14	-	-	HYPH
cord-005453-4057qib7	6742	15	reduced	reduce	VBN
cord-005453-4057qib7	6742	16	and	and	CC
cord-005453-4057qib7	6742	17	immunological	immunological	JJ
cord-005453-4057qib7	6742	18	safety	safety	NN
cord-005453-4057qib7	6742	19	components	component	NNS
cord-005453-4057qib7	6742	20	of	of	IN
cord-005453-4057qib7	6742	21	blood	blood	NN
cord-005453-4057qib7	6742	22	,	,	,
cord-005453-4057qib7	6742	23	which	which	WDT
cord-005453-4057qib7	6742	24	reduces	reduce	VBZ
cord-005453-4057qib7	6742	25	their	-PRON-	PRP$
cord-005453-4057qib7	6742	26	material	material	NN
cord-005453-4057qib7	6742	27	cost	cost	NN
cord-005453-4057qib7	6742	28	and	and	CC
cord-005453-4057qib7	6742	29	staff	staff	NN
cord-005453-4057qib7	6742	30	loading	loading	NN
cord-005453-4057qib7	6742	31	.	.	.
cord-005453-4057qib7	6743	1	The	the	DT
cord-005453-4057qib7	6743	2	use	use	NN
cord-005453-4057qib7	6743	3	of	of	IN
cord-005453-4057qib7	6743	4	RF	rf	NN
cord-005453-4057qib7	6743	5	/	/	SYM
cord-005453-4057qib7	6743	6	UV	uv	NN
cord-005453-4057qib7	6743	7	system	system	NN
cord-005453-4057qib7	6743	8	does	do	VBZ
cord-005453-4057qib7	6743	9	not	not	RB
cord-005453-4057qib7	6743	10	have	have	VB
cord-005453-4057qib7	6743	11	such	such	JJ
cord-005453-4057qib7	6743	12	complex	complex	JJ
cord-005453-4057qib7	6743	13	security	security	NN
cord-005453-4057qib7	6743	14	requirements	requirement	NNS
cord-005453-4057qib7	6743	15	and	and	CC
cord-005453-4057qib7	6743	16	difficulties	difficulty	NNS
cord-005453-4057qib7	6743	17	in	in	IN
cord-005453-4057qib7	6743	18	servicing	service	VBG
cord-005453-4057qib7	6743	19	as	as	IN
cord-005453-4057qib7	6743	20	the	the	DT
cord-005453-4057qib7	6743	21	use	use	NN
cord-005453-4057qib7	6743	22	of	of	IN
cord-005453-4057qib7	6743	23	sources	source	NNS
cord-005453-4057qib7	6743	24	of	of	IN
cord-005453-4057qib7	6743	25	ionizing	ionize	VBG
cord-005453-4057qib7	6743	26	radiation	radiation	NN
cord-005453-4057qib7	6743	27	.	.	.
cord-005453-4057qib7	6744	1	The	the	DT
cord-005453-4057qib7	6744	2	results	result	NNS
cord-005453-4057qib7	6744	3	demonstrate	demonstrate	VBP
cord-005453-4057qib7	6744	4	a	a	DT
cord-005453-4057qib7	6744	5	promising	promising	JJ
cord-005453-4057qib7	6744	6	potential	potential	NN
cord-005453-4057qib7	6744	7	for	for	IN
cord-005453-4057qib7	6744	8	using	use	VBG
cord-005453-4057qib7	6744	9	this	this	DT
cord-005453-4057qib7	6744	10	technology	technology	NN
cord-005453-4057qib7	6744	11	as	as	IN
cord-005453-4057qib7	6744	12	an	an	DT
cord-005453-4057qib7	6744	13	alternative	alternative	NN
cord-005453-4057qib7	6744	14	to	to	IN
cord-005453-4057qib7	6744	15	irradiation	irradiation	NN
cord-005453-4057qib7	6744	16	Disclosure	disclosure	NN
cord-005453-4057qib7	6744	17	:	:	:
cord-005453-4057qib7	6745	1	Nothing	nothing	NN
cord-005453-4057qib7	6745	2	to	to	TO
cord-005453-4057qib7	6745	3	declare	declare	VB
cord-005453-4057qib7	6745	4	P308	P308	NNP
cord-005453-4057qib7	6745	5	Influence	influence	NN
cord-005453-4057qib7	6745	6	of	of	IN
cord-005453-4057qib7	6745	7	patients´serum	patients´serum	NNP
cord-005453-4057qib7	6745	8	after	after	IN
cord-005453-4057qib7	6745	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	6745	10	stem	stem	NN
cord-005453-4057qib7	6745	11	cell	cell	NN
cord-005453-4057qib7	6745	12	transplantation	transplantation	NN
cord-005453-4057qib7	6745	13	on	on	IN
cord-005453-4057qib7	6745	14	T	t	NN
cord-005453-4057qib7	6745	15	cell	cell	NN
cord-005453-4057qib7	6745	16	proliferation	proliferation	NN
cord-005453-4057qib7	6745	17	and	and	CC
cord-005453-4057qib7	6745	18	TREG	TREG	NNP
cord-005453-4057qib7	6745	19	function	function	NN
cord-005453-4057qib7	6745	20	Background	background	NN
cord-005453-4057qib7	6745	21	:	:	:
cord-005453-4057qib7	6746	1	Acute	acute	JJ
cord-005453-4057qib7	6746	2	or	or	CC
cord-005453-4057qib7	6746	3	chronic	chronic	JJ
cord-005453-4057qib7	6746	4	graft	graft	NN
cord-005453-4057qib7	6746	5	versus	versus	IN
cord-005453-4057qib7	6746	6	host	host	NN
cord-005453-4057qib7	6746	7	disease	disease	NN
cord-005453-4057qib7	6746	8	(	(	-LRB-
cord-005453-4057qib7	6746	9	a/	a/	NNP
cord-005453-4057qib7	6746	10	cGVHD	cGVHD	NNP
cord-005453-4057qib7	6746	11	)	)	-RRB-
cord-005453-4057qib7	6746	12	is	be	VBZ
cord-005453-4057qib7	6746	13	one	one	CD
cord-005453-4057qib7	6746	14	of	of	IN
cord-005453-4057qib7	6746	15	the	the	DT
cord-005453-4057qib7	6746	16	major	major	JJ
cord-005453-4057qib7	6746	17	complications	complication	NNS
cord-005453-4057qib7	6746	18	after	after	IN
cord-005453-4057qib7	6746	19	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6746	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6746	21	stem	stem	NN
cord-005453-4057qib7	6746	22	cell	cell	NN
cord-005453-4057qib7	6746	23	transplantation	transplantation	NN
cord-005453-4057qib7	6746	24	(	(	-LRB-
cord-005453-4057qib7	6746	25	aHSCT	aHSCT	NNP
cord-005453-4057qib7	6746	26	)	)	-RRB-
cord-005453-4057qib7	6746	27	.	.	.
cord-005453-4057qib7	6747	1	Application	application	NN
cord-005453-4057qib7	6747	2	of	of	IN
cord-005453-4057qib7	6747	3	regulatory	regulatory	JJ
cord-005453-4057qib7	6747	4	T	t	NN
cord-005453-4057qib7	6747	5	cells	cell	NNS
cord-005453-4057qib7	6747	6	(	(	-LRB-
cord-005453-4057qib7	6747	7	Treg	Treg	NNP
cord-005453-4057qib7	6747	8	)	)	-RRB-
cord-005453-4057qib7	6747	9	as	as	IN
cord-005453-4057qib7	6747	10	"	"	``
cord-005453-4057qib7	6747	11	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6747	12	DLI	DLI	NNP
cord-005453-4057qib7	6747	13	"	"	''
cord-005453-4057qib7	6747	14	to	to	TO
cord-005453-4057qib7	6747	15	prevent	prevent	VB
cord-005453-4057qib7	6747	16	or	or	CC
cord-005453-4057qib7	6747	17	treat	treat	VB
cord-005453-4057qib7	6747	18	GVHD	GVHD	NNP
cord-005453-4057qib7	6747	19	is	be	VBZ
cord-005453-4057qib7	6747	20	investigated	investigate	VBN
cord-005453-4057qib7	6747	21	in	in	IN
cord-005453-4057qib7	6747	22	clinical	clinical	JJ
cord-005453-4057qib7	6747	23	trials	trial	NNS
cord-005453-4057qib7	6747	24	.	.	.
cord-005453-4057qib7	6748	1	Here	here	RB
cord-005453-4057qib7	6748	2	we	-PRON-	PRP
cord-005453-4057qib7	6748	3	ask	ask	VBP
cord-005453-4057qib7	6748	4	the	the	DT
cord-005453-4057qib7	6748	5	question	question	NN
cord-005453-4057qib7	6748	6	,	,	,
cord-005453-4057qib7	6748	7	if	if	IN
cord-005453-4057qib7	6748	8	there	there	EX
cord-005453-4057qib7	6748	9	could	could	MD
cord-005453-4057qib7	6748	10	be	be	VB
cord-005453-4057qib7	6748	11	clinical	clinical	JJ
cord-005453-4057qib7	6748	12	conditions	condition	NNS
cord-005453-4057qib7	6748	13	(	(	-LRB-
cord-005453-4057qib7	6748	14	e.g.	e.g.	IN
cord-005453-4057qib7	6748	15	cytokines	cytokine	NNS
cord-005453-4057qib7	6748	16	or	or	CC
cord-005453-4057qib7	6748	17	drug	drug	NN
cord-005453-4057qib7	6748	18	effects	effect	NNS
cord-005453-4057qib7	6748	19	)	)	-RRB-
cord-005453-4057qib7	6748	20	limiting	limit	VBG
cord-005453-4057qib7	6748	21	the	the	DT
cord-005453-4057qib7	6748	22	efficacy	efficacy	NN
cord-005453-4057qib7	6748	23	of	of	IN
cord-005453-4057qib7	6748	24	this	this	DT
cord-005453-4057qib7	6748	25	approach	approach	NN
cord-005453-4057qib7	6748	26	.	.	.
cord-005453-4057qib7	6749	1	To	to	TO
cord-005453-4057qib7	6749	2	face	face	VB
cord-005453-4057qib7	6749	3	this	this	DT
cord-005453-4057qib7	6749	4	problem	problem	NN
cord-005453-4057qib7	6749	5	we	-PRON-	PRP
cord-005453-4057qib7	6749	6	tested	test	VBD
cord-005453-4057qib7	6749	7	the	the	DT
cord-005453-4057qib7	6749	8	influence	influence	NN
cord-005453-4057qib7	6749	9	of	of	IN
cord-005453-4057qib7	6749	10	patients´serum	patients´serum	NNP
cord-005453-4057qib7	6749	11	on	on	IN
cord-005453-4057qib7	6749	12	T	T	NNP
cord-005453-4057qib7	6749	13	cell	cell	NN
cord-005453-4057qib7	6749	14	proliferation	proliferation	NN
cord-005453-4057qib7	6749	15	and	and	CC
cord-005453-4057qib7	6749	16	Treg	Treg	NNP
cord-005453-4057qib7	6749	17	function	function	NN
cord-005453-4057qib7	6749	18	.	.	.
cord-005453-4057qib7	6750	1	Methods	method	NNS
cord-005453-4057qib7	6750	2	:	:	:
cord-005453-4057qib7	6750	3	Lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6750	4	from	from	IN
cord-005453-4057qib7	6750	5	healthy	healthy	JJ
cord-005453-4057qib7	6750	6	donors	donor	NNS
cord-005453-4057qib7	6750	7	were	be	VBD
cord-005453-4057qib7	6750	8	incubated	incubate	VBN
cord-005453-4057qib7	6750	9	with	with	IN
cord-005453-4057qib7	6750	10	T	T	NNP
cord-005453-4057qib7	6750	11	cell	cell	NN
cord-005453-4057qib7	6750	12	medium	medium	NN
cord-005453-4057qib7	6750	13	(	(	-LRB-
cord-005453-4057qib7	6750	14	90	90	CD
cord-005453-4057qib7	6750	15	%	%	NN
cord-005453-4057qib7	6750	16	AIM	aim	NN
cord-005453-4057qib7	6750	17	V	v	NN
cord-005453-4057qib7	6750	18	+	+	CC
cord-005453-4057qib7	6751	1	10	10	CD
cord-005453-4057qib7	6751	2	%	%	NN
cord-005453-4057qib7	6751	3	serum	serum	NN
cord-005453-4057qib7	6751	4	+	+	CC
cord-005453-4057qib7	6751	5	IL2	IL2	NNP
cord-005453-4057qib7	6751	6	/	/	SYM
cord-005453-4057qib7	6751	7	OKT3	OKT3	NNP
cord-005453-4057qib7	6751	8	)	)	-RRB-
cord-005453-4057qib7	6751	9	containing	contain	VBG
cord-005453-4057qib7	6751	10	serum	serum	NN
cord-005453-4057qib7	6751	11	from	from	IN
cord-005453-4057qib7	6751	12	healthy	healthy	JJ
cord-005453-4057qib7	6751	13	donors	donor	NNS
cord-005453-4057qib7	6751	14	or	or	CC
cord-005453-4057qib7	6751	15	serum	serum	NN
cord-005453-4057qib7	6751	16	derived	derive	VBN
cord-005453-4057qib7	6751	17	from	from	IN
cord-005453-4057qib7	6751	18	patients	patient	NNS
cord-005453-4057qib7	6751	19	after	after	IN
cord-005453-4057qib7	6751	20	aHSCT	ahsct	NN
cord-005453-4057qib7	6751	21	with	with	IN
cord-005453-4057qib7	6751	22	or	or	CC
cord-005453-4057qib7	6751	23	without	without	IN
cord-005453-4057qib7	6751	24	GVHD	GVHD	NNP
cord-005453-4057qib7	6751	25	(	(	-LRB-
cord-005453-4057qib7	6751	26	n=10	n=10	NNP
cord-005453-4057qib7	6751	27	)	)	-RRB-
cord-005453-4057qib7	6751	28	.	.	.
cord-005453-4057qib7	6752	1	Next	next	RB
cord-005453-4057qib7	6752	2	we	-PRON-	PRP
cord-005453-4057qib7	6752	3	evaluated	evaluate	VBD
cord-005453-4057qib7	6752	4	the	the	DT
cord-005453-4057qib7	6752	5	suppressive	suppressive	JJ
cord-005453-4057qib7	6752	6	function	function	NN
cord-005453-4057qib7	6752	7	of	of	IN
cord-005453-4057qib7	6752	8	Treg	Treg	NNP
cord-005453-4057qib7	6752	9	by	by	IN
cord-005453-4057qib7	6752	10	performing	perform	VBG
cord-005453-4057qib7	6752	11	Treg	Treg	NNP
cord-005453-4057qib7	6752	12	suppression	suppression	NN
cord-005453-4057qib7	6752	13	assays	assay	NNS
cord-005453-4057qib7	6752	14	,	,	,
cord-005453-4057qib7	6752	15	also	also	RB
cord-005453-4057qib7	6752	16	comparing	compare	VBG
cord-005453-4057qib7	6752	17	serum	serum	NN
cord-005453-4057qib7	6752	18	from	from	IN
cord-005453-4057qib7	6752	19	patients	patient	NNS
cord-005453-4057qib7	6752	20	suffering	suffer	VBG
cord-005453-4057qib7	6752	21	from	from	IN
cord-005453-4057qib7	6752	22	GVHD	GVHD	NNP
cord-005453-4057qib7	6752	23	versus	versus	IN
cord-005453-4057qib7	6752	24	serum	serum	NN
cord-005453-4057qib7	6752	25	obtained	obtain	VBN
cord-005453-4057qib7	6752	26	from	from	IN
cord-005453-4057qib7	6752	27	healthy	healthy	JJ
cord-005453-4057qib7	6752	28	donors	donor	NNS
cord-005453-4057qib7	6752	29	(	(	-LRB-
cord-005453-4057qib7	6752	30	n=8	n=8	NN
cord-005453-4057qib7	6752	31	)	)	-RRB-
cord-005453-4057qib7	6752	32	.	.	.
cord-005453-4057qib7	6753	1	Proliferation	proliferation	NN
cord-005453-4057qib7	6753	2	of	of	IN
cord-005453-4057qib7	6753	3	CFSE	CFSE	NNP
cord-005453-4057qib7	6753	4	stained	stain	VBN
cord-005453-4057qib7	6753	5	T	t	NN
cord-005453-4057qib7	6753	6	cells	cell	NNS
cord-005453-4057qib7	6753	7	was	be	VBD
cord-005453-4057qib7	6753	8	measured	measure	VBN
cord-005453-4057qib7	6753	9	after	after	IN
cord-005453-4057qib7	6753	10	5	5	CD
cord-005453-4057qib7	6753	11	days	day	NNS
cord-005453-4057qib7	6753	12	.	.	.
cord-005453-4057qib7	6754	1	To	to	TO
cord-005453-4057qib7	6754	2	test	test	VB
cord-005453-4057qib7	6754	3	the	the	DT
cord-005453-4057qib7	6754	4	effect	effect	NN
cord-005453-4057qib7	6754	5	of	of	IN
cord-005453-4057qib7	6754	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6754	7	drugs	drug	NNS
cord-005453-4057qib7	6754	8	on	on	IN
cord-005453-4057qib7	6754	9	Treg	Treg	NNP
cord-005453-4057qib7	6754	10	we	-PRON-	PRP
cord-005453-4057qib7	6754	11	performed	perform	VBD
cord-005453-4057qib7	6754	12	Treg	Treg	NNP
cord-005453-4057qib7	6754	13	suppression	suppression	NN
cord-005453-4057qib7	6754	14	assays	assay	NNS
cord-005453-4057qib7	6754	15	after	after	IN
cord-005453-4057qib7	6754	16	incubation	incubation	NN
cord-005453-4057qib7	6754	17	of	of	IN
cord-005453-4057qib7	6754	18	Treg	Treg	NNP
cord-005453-4057qib7	6754	19	with	with	IN
cord-005453-4057qib7	6754	20	Corticosteroids	Corticosteroids	NNPS
cord-005453-4057qib7	6754	21	or	or	CC
cord-005453-4057qib7	6754	22	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	6754	23	or	or	CC
cord-005453-4057qib7	6754	24	the	the	DT
cord-005453-4057qib7	6754	25	combination	combination	NN
cord-005453-4057qib7	6754	26	of	of	IN
cord-005453-4057qib7	6754	27	both	both	DT
cord-005453-4057qib7	6754	28	drugs	drug	NNS
cord-005453-4057qib7	6754	29	.	.	.
cord-005453-4057qib7	6755	1	Results	result	NNS
cord-005453-4057qib7	6755	2	:	:	:
cord-005453-4057qib7	6756	1	Serum	serum	NN
cord-005453-4057qib7	6756	2	of	of	IN
cord-005453-4057qib7	6756	3	patients	patient	NNS
cord-005453-4057qib7	6756	4	with	with	IN
cord-005453-4057qib7	6756	5	acute	acute	JJ
cord-005453-4057qib7	6756	6	or	or	CC
cord-005453-4057qib7	6756	7	chronic	chronic	JJ
cord-005453-4057qib7	6756	8	GVHD	GVHD	NNP
cord-005453-4057qib7	6756	9	had	have	VBD
cord-005453-4057qib7	6756	10	a	a	DT
cord-005453-4057qib7	6756	11	negative	negative	JJ
cord-005453-4057qib7	6756	12	effect	effect	NN
cord-005453-4057qib7	6756	13	on	on	IN
cord-005453-4057qib7	6756	14	T	t	NN
cord-005453-4057qib7	6756	15	cell	cell	NN
cord-005453-4057qib7	6756	16	proliferation	proliferation	NN
cord-005453-4057qib7	6756	17	.	.	.
cord-005453-4057qib7	6757	1	To	to	TO
cord-005453-4057qib7	6757	2	avoid	avoid	VB
cord-005453-4057qib7	6757	3	bias	bias	NN
cord-005453-4057qib7	6757	4	tests	test	NNS
cord-005453-4057qib7	6757	5	were	be	VBD
cord-005453-4057qib7	6757	6	performed	perform	VBN
cord-005453-4057qib7	6757	7	with	with	IN
cord-005453-4057qib7	6757	8	samples	sample	NNS
cord-005453-4057qib7	6757	9	from	from	IN
cord-005453-4057qib7	6757	10	patients	patient	NNS
cord-005453-4057qib7	6757	11	without	without	IN
cord-005453-4057qib7	6757	12	or	or	CC
cord-005453-4057qib7	6757	13	only	only	RB
cord-005453-4057qib7	6757	14	with	with	IN
cord-005453-4057qib7	6757	15	low	low	JJ
cord-005453-4057qib7	6757	16	levels	level	NNS
cord-005453-4057qib7	6757	17	of	of	IN
cord-005453-4057qib7	6757	18	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6757	19	drugs	drug	NNS
cord-005453-4057qib7	6757	20	.	.	.
cord-005453-4057qib7	6758	1	Incubation	incubation	NN
cord-005453-4057qib7	6758	2	with	with	IN
cord-005453-4057qib7	6758	3	serum	serum	NN
cord-005453-4057qib7	6758	4	of	of	IN
cord-005453-4057qib7	6758	5	patients	patient	NNS
cord-005453-4057qib7	6758	6	without	without	IN
cord-005453-4057qib7	6758	7	GVHD	GVHD	NNP
cord-005453-4057qib7	6758	8	or	or	CC
cord-005453-4057qib7	6758	9	with	with	IN
cord-005453-4057qib7	6758	10	serum	serum	NN
cord-005453-4057qib7	6758	11	of	of	IN
cord-005453-4057qib7	6758	12	healthy	healthy	JJ
cord-005453-4057qib7	6758	13	individuals	individual	NNS
cord-005453-4057qib7	6758	14	showed	show	VBD
cord-005453-4057qib7	6758	15	no	no	DT
cord-005453-4057qib7	6758	16	differences	difference	NNS
cord-005453-4057qib7	6758	17	in	in	IN
cord-005453-4057qib7	6758	18	T	t	NN
cord-005453-4057qib7	6758	19	cell	cell	NN
cord-005453-4057qib7	6758	20	proliferation	proliferation	NN
cord-005453-4057qib7	6758	21	.	.	.
cord-005453-4057qib7	6759	1	Treg	Treg	NNP
cord-005453-4057qib7	6759	2	from	from	IN
cord-005453-4057qib7	6759	3	healthy	healthy	JJ
cord-005453-4057qib7	6759	4	donors	donor	NNS
cord-005453-4057qib7	6759	5	showed	show	VBD
cord-005453-4057qib7	6759	6	a	a	DT
cord-005453-4057qib7	6759	7	stronger	strong	JJR
cord-005453-4057qib7	6759	8	antiproliferative	antiproliferative	JJ
cord-005453-4057qib7	6759	9	capacity	capacity	NN
cord-005453-4057qib7	6759	10	when	when	WRB
cord-005453-4057qib7	6759	11	incubated	incubate	VBN
cord-005453-4057qib7	6759	12	with	with	IN
cord-005453-4057qib7	6759	13	serum	serum	NN
cord-005453-4057qib7	6759	14	derived	derive	VBN
cord-005453-4057qib7	6759	15	from	from	IN
cord-005453-4057qib7	6759	16	patients	patient	NNS
cord-005453-4057qib7	6759	17	with	with	IN
cord-005453-4057qib7	6759	18	GVHD	GVHD	NNP
cord-005453-4057qib7	6759	19	.	.	.
cord-005453-4057qib7	6760	1	Treg	Treg	NNP
cord-005453-4057qib7	6760	2	previously	previously	RB
cord-005453-4057qib7	6760	3	incubated	incubate	VBD
cord-005453-4057qib7	6760	4	with	with	IN
cord-005453-4057qib7	6760	5	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6760	6	drugs	drug	NNS
cord-005453-4057qib7	6760	7	showed	show	VBD
cord-005453-4057qib7	6760	8	no	no	DT
cord-005453-4057qib7	6760	9	decreased	decrease	VBN
cord-005453-4057qib7	6760	10	suppressive	suppressive	JJ
cord-005453-4057qib7	6760	11	capacity	capacity	NN
cord-005453-4057qib7	6760	12	.	.	.
cord-005453-4057qib7	6761	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6761	2	:	:	:
cord-005453-4057qib7	6762	1	Components	component	NNS
cord-005453-4057qib7	6762	2	of	of	IN
cord-005453-4057qib7	6762	3	serum	serum	NN
cord-005453-4057qib7	6762	4	from	from	IN
cord-005453-4057qib7	6762	5	GVHD	GVHD	NNP
cord-005453-4057qib7	6762	6	patients	patient	NNS
cord-005453-4057qib7	6762	7	seem	seem	VBP
cord-005453-4057qib7	6762	8	to	to	TO
cord-005453-4057qib7	6762	9	have	have	VB
cord-005453-4057qib7	6762	10	an	an	DT
cord-005453-4057qib7	6762	11	antiproliferative	antiproliferative	JJ
cord-005453-4057qib7	6762	12	effect	effect	NN
cord-005453-4057qib7	6762	13	on	on	IN
cord-005453-4057qib7	6762	14	T	t	NN
cord-005453-4057qib7	6762	15	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	6762	16	itself	-PRON-	PRP
cord-005453-4057qib7	6762	17	.	.	.
cord-005453-4057qib7	6763	1	This	this	DT
cord-005453-4057qib7	6763	2	fact	fact	NN
cord-005453-4057qib7	6763	3	might	may	MD
cord-005453-4057qib7	6763	4	influence	influence	VB
cord-005453-4057qib7	6763	5	the	the	DT
cord-005453-4057qib7	6763	6	clinical	clinical	JJ
cord-005453-4057qib7	6763	7	course	course	NN
cord-005453-4057qib7	6763	8	of	of	IN
cord-005453-4057qib7	6763	9	GVHD	GVHD	NNP
cord-005453-4057qib7	6763	10	,	,	,
cord-005453-4057qib7	6763	11	but	but	CC
cord-005453-4057qib7	6763	12	should	should	MD
cord-005453-4057qib7	6763	13	not	not	RB
cord-005453-4057qib7	6763	14	be	be	VB
cord-005453-4057qib7	6763	15	a	a	DT
cord-005453-4057qib7	6763	16	limiting	limit	VBG
cord-005453-4057qib7	6763	17	factor	factor	NN
cord-005453-4057qib7	6763	18	for	for	IN
cord-005453-4057qib7	6763	19	therapeutic	therapeutic	JJ
cord-005453-4057qib7	6763	20	application	application	NN
cord-005453-4057qib7	6763	21	of	of	IN
cord-005453-4057qib7	6763	22	Treg	Treg	NNP
cord-005453-4057qib7	6763	23	DLI	DLI	NNP
cord-005453-4057qib7	6763	24	.	.	.
cord-005453-4057qib7	6764	1	Even	even	RB
cord-005453-4057qib7	6764	2	the	the	DT
cord-005453-4057qib7	6764	3	systemic	systemic	JJ
cord-005453-4057qib7	6764	4	treatment	treatment	NN
cord-005453-4057qib7	6764	5	with	with	IN
cord-005453-4057qib7	6764	6	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6764	7	drugs	drug	NNS
cord-005453-4057qib7	6765	1	e.g.	e.g.	IN
cord-005453-4057qib7	6765	2	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	6765	3	or	or	CC
cord-005453-4057qib7	6765	4	calcineurin	calcineurin	NN
cord-005453-4057qib7	6765	5	-	-	HYPH
cord-005453-4057qib7	6765	6	inhibitors	inhibitor	NNS
cord-005453-4057qib7	6765	7	should	should	MD
cord-005453-4057qib7	6765	8	not	not	RB
cord-005453-4057qib7	6765	9	diminish	diminish	VB
cord-005453-4057qib7	6765	10	the	the	DT
cord-005453-4057qib7	6765	11	Treg	Treg	NNP
cord-005453-4057qib7	6765	12	application	application	NN
cord-005453-4057qib7	6765	13	.	.	.
cord-005453-4057qib7	6766	1	In	in	IN
cord-005453-4057qib7	6766	2	a	a	DT
cord-005453-4057qib7	6766	3	next	next	JJ
cord-005453-4057qib7	6766	4	step	step	NN
cord-005453-4057qib7	6766	5	we	-PRON-	PRP
cord-005453-4057qib7	6766	6	will	will	MD
cord-005453-4057qib7	6766	7	analyze	analyze	VB
cord-005453-4057qib7	6766	8	serum	serum	NN
cord-005453-4057qib7	6766	9	components	component	NNS
cord-005453-4057qib7	6766	10	responsible	responsible	JJ
cord-005453-4057qib7	6766	11	for	for	IN
cord-005453-4057qib7	6766	12	this	this	DT
cord-005453-4057qib7	6766	13	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	6766	14	effect	effect	NN
cord-005453-4057qib7	6766	15	with	with	IN
cord-005453-4057qib7	6766	16	multi	multi	JJ
cord-005453-4057qib7	6766	17	cytokine	cytokine	NN
cord-005453-4057qib7	6766	18	assays	assay	NNS
cord-005453-4057qib7	6766	19	and	and	CC
cord-005453-4057qib7	6766	20	proteomic	proteomic	JJ
cord-005453-4057qib7	6766	21	analysis	analysis	NN
cord-005453-4057qib7	6766	22	.	.	.
cord-005453-4057qib7	6767	1	The	the	DT
cord-005453-4057qib7	6767	2	aim	aim	NN
cord-005453-4057qib7	6767	3	of	of	IN
cord-005453-4057qib7	6767	4	our	-PRON-	PRP$
cord-005453-4057qib7	6767	5	project	project	NN
cord-005453-4057qib7	6767	6	is	be	VBZ
cord-005453-4057qib7	6767	7	to	to	TO
cord-005453-4057qib7	6767	8	develop	develop	VB
cord-005453-4057qib7	6767	9	new	new	JJ
cord-005453-4057qib7	6767	10	strategies	strategy	NNS
cord-005453-4057qib7	6767	11	to	to	TO
cord-005453-4057qib7	6767	12	avoid	avoid	VB
cord-005453-4057qib7	6767	13	GVHD	GVHD	NNP
cord-005453-4057qib7	6767	14	and	and	CC
cord-005453-4057qib7	6767	15	to	to	TO
cord-005453-4057qib7	6767	16	optimize	optimize	VB
cord-005453-4057qib7	6767	17	clinical	clinical	JJ
cord-005453-4057qib7	6767	18	settings	setting	NNS
cord-005453-4057qib7	6767	19	for	for	IN
cord-005453-4057qib7	6767	20	Treg	Treg	NNP
cord-005453-4057qib7	6767	21	DLI	DLI	NNP
cord-005453-4057qib7	6767	22	.	.	.
cord-005453-4057qib7	6768	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6768	2	Background	background	NN
cord-005453-4057qib7	6768	3	:	:	:
cord-005453-4057qib7	6768	4	Hypercalcaemia	Hypercalcaemia	NNP
cord-005453-4057qib7	6768	5	can	can	MD
cord-005453-4057qib7	6768	6	be	be	VB
cord-005453-4057qib7	6768	7	very	very	RB
cord-005453-4057qib7	6768	8	severe	severe	JJ
cord-005453-4057qib7	6768	9	following	follow	VBG
cord-005453-4057qib7	6768	10	stem	stem	NN
cord-005453-4057qib7	6768	11	cell	cell	NN
cord-005453-4057qib7	6768	12	transplant	transplant	NN
cord-005453-4057qib7	6768	13	(	(	-LRB-
cord-005453-4057qib7	6768	14	SCT	SCT	NNP
cord-005453-4057qib7	6768	15	)	)	-RRB-
cord-005453-4057qib7	6768	16	in	in	IN
cord-005453-4057qib7	6768	17	some	some	DT
cord-005453-4057qib7	6768	18	osteopetrosis	osteopetrosis	NN
cord-005453-4057qib7	6768	19	patients	patient	NNS
cord-005453-4057qib7	6768	20	.	.	.
cord-005453-4057qib7	6769	1	Denosumab	Denosumab	NNP
cord-005453-4057qib7	6769	2	is	be	VBZ
cord-005453-4057qib7	6769	3	a	a	DT
cord-005453-4057qib7	6769	4	fully	fully	RB
cord-005453-4057qib7	6769	5	human	human	JJ
cord-005453-4057qib7	6769	6	monoclonal	monoclonal	JJ
cord-005453-4057qib7	6769	7	antibody	antibody	NN
cord-005453-4057qib7	6769	8	that	that	WDT
cord-005453-4057qib7	6769	9	binds	bind	VBZ
cord-005453-4057qib7	6769	10	the	the	DT
cord-005453-4057qib7	6769	11	cytokine	cytokine	NN
cord-005453-4057qib7	6769	12	RANKL	RANKL	NNP
cord-005453-4057qib7	6769	13	(	(	-LRB-
cord-005453-4057qib7	6769	14	receptor	receptor	NN
cord-005453-4057qib7	6769	15	activator	activator	NN
cord-005453-4057qib7	6769	16	of	of	IN
cord-005453-4057qib7	6769	17	NFκB	NFκB	NNP
cord-005453-4057qib7	6769	18	ligand	ligand	NN
cord-005453-4057qib7	6769	19	)	)	-RRB-
cord-005453-4057qib7	6769	20	,	,	,
cord-005453-4057qib7	6769	21	an	an	DT
cord-005453-4057qib7	6769	22	essential	essential	JJ
cord-005453-4057qib7	6769	23	factor	factor	NN
cord-005453-4057qib7	6769	24	initiating	initiate	VBG
cord-005453-4057qib7	6769	25	bone	bone	NN
cord-005453-4057qib7	6769	26	turnover	turnover	NN
cord-005453-4057qib7	6769	27	.	.	.
cord-005453-4057qib7	6770	1	RANKL	RANKL	NNP
cord-005453-4057qib7	6770	2	inhibition	inhibition	NN
cord-005453-4057qib7	6770	3	blocks	block	VBZ
cord-005453-4057qib7	6770	4	osteoclast	osteoclast	NN
cord-005453-4057qib7	6770	5	maturation	maturation	NN
cord-005453-4057qib7	6770	6	,	,	,
cord-005453-4057qib7	6770	7	function	function	NN
cord-005453-4057qib7	6770	8	and	and	CC
cord-005453-4057qib7	6770	9	survival	survival	NN
cord-005453-4057qib7	6770	10	,	,	,
cord-005453-4057qib7	6770	11	thus	thus	RB
cord-005453-4057qib7	6770	12	reducing	reduce	VBG
cord-005453-4057qib7	6770	13	bone	bone	NN
cord-005453-4057qib7	6770	14	resorption	resorption	NN
cord-005453-4057qib7	6770	15	.	.	.
cord-005453-4057qib7	6771	1	We	-PRON-	PRP
cord-005453-4057qib7	6771	2	describe	describe	VBP
cord-005453-4057qib7	6771	3	the	the	DT
cord-005453-4057qib7	6771	4	effective	effective	JJ
cord-005453-4057qib7	6771	5	management	management	NN
cord-005453-4057qib7	6771	6	of	of	IN
cord-005453-4057qib7	6771	7	hypercalcaemia	hypercalcaemia	NNP
cord-005453-4057qib7	6771	8	in	in	IN
cord-005453-4057qib7	6771	9	a	a	DT
cord-005453-4057qib7	6771	10	patient	patient	NN
cord-005453-4057qib7	6771	11	with	with	IN
cord-005453-4057qib7	6771	12	RANK	RANK	NNP
cord-005453-4057qib7	6771	13	mutation	mutation	NN
cord-005453-4057qib7	6771	14	osteopetrosis	osteopetrosis	NN
cord-005453-4057qib7	6771	15	who	who	WP
cord-005453-4057qib7	6771	16	received	receive	VBD
cord-005453-4057qib7	6771	17	a	a	DT
cord-005453-4057qib7	6771	18	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6771	19	SCT	SCT	NNP
cord-005453-4057qib7	6771	20	.	.	.
cord-005453-4057qib7	6772	1	Methods	method	NNS
cord-005453-4057qib7	6772	2	:	:	:
cord-005453-4057qib7	6773	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6773	2	patient	patient	NN
cord-005453-4057qib7	6773	3	was	be	VBD
cord-005453-4057qib7	6773	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	6773	5	with	with	IN
cord-005453-4057qib7	6773	6	osteopetrosis	osteopetrosis	NNP
cord-005453-4057qib7	6773	7	at	at	IN
cord-005453-4057qib7	6773	8	2	2	CD
cord-005453-4057qib7	6773	9	year	year	NN
cord-005453-4057qib7	6773	10	of	of	IN
cord-005453-4057qib7	6773	11	age	age	NN
cord-005453-4057qib7	6773	12	with	with	IN
cord-005453-4057qib7	6773	13	a	a	DT
cord-005453-4057qib7	6773	14	defect	defect	NN
cord-005453-4057qib7	6773	15	in	in	IN
cord-005453-4057qib7	6773	16	the	the	DT
cord-005453-4057qib7	6773	17	TNFRSF11A	TNFRSF11A	NNP
cord-005453-4057qib7	6773	18	gene	gene	NN
cord-005453-4057qib7	6773	19	which	which	WDT
cord-005453-4057qib7	6773	20	codes	code	VBZ
cord-005453-4057qib7	6773	21	for	for	IN
cord-005453-4057qib7	6773	22	RANK	rank	NN
cord-005453-4057qib7	6773	23	and	and	CC
cord-005453-4057qib7	6773	24	received	receive	VBD
cord-005453-4057qib7	6773	25	a	a	DT
cord-005453-4057qib7	6773	26	maternal	maternal	JJ
cord-005453-4057qib7	6773	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6773	28	SCT	SCT	NNP
cord-005453-4057qib7	6773	29	aged	age	VBN
cord-005453-4057qib7	6773	30	4	4	CD
cord-005453-4057qib7	6773	31	years	year	NNS
cord-005453-4057qib7	6773	32	.	.	.
cord-005453-4057qib7	6774	1	The	the	DT
cord-005453-4057qib7	6774	2	patients	patient	NNS
cord-005453-4057qib7	6774	3	calcium	calcium	NN
cord-005453-4057qib7	6774	4	levels	level	NNS
cord-005453-4057qib7	6774	5	were	be	VBD
cord-005453-4057qib7	6774	6	monitored	monitor	VBN
cord-005453-4057qib7	6774	7	regularly	regularly	RB
cord-005453-4057qib7	6774	8	post	post	VB
cord-005453-4057qib7	6774	9	SCT	SCT	NNP
cord-005453-4057qib7	6774	10	.	.	.
cord-005453-4057qib7	6775	1	Denosumab	Denosumab	NNP
cord-005453-4057qib7	6775	2	was	be	VBD
cord-005453-4057qib7	6775	3	administered	administer	VBN
cord-005453-4057qib7	6775	4	for	for	IN
cord-005453-4057qib7	6775	5	hypercalcaemia	hypercalcaemia	NN
cord-005453-4057qib7	6775	6	as	as	IN
cord-005453-4057qib7	6775	7	per	per	IN
cord-005453-4057qib7	6775	8	laboratory	laboratory	NN
cord-005453-4057qib7	6775	9	reports	report	NNS
cord-005453-4057qib7	6775	10	or	or	CC
cord-005453-4057qib7	6775	11	clinical	clinical	JJ
cord-005453-4057qib7	6775	12	symptoms	symptom	NNS
cord-005453-4057qib7	6775	13	.	.	.
cord-005453-4057qib7	6776	1	The	the	DT
cord-005453-4057qib7	6776	2	drug	drug	NN
cord-005453-4057qib7	6776	3	was	be	VBD
cord-005453-4057qib7	6776	4	diluted	dilute	VBN
cord-005453-4057qib7	6776	5	with	with	IN
cord-005453-4057qib7	6776	6	water	water	NN
cord-005453-4057qib7	6776	7	for	for	IN
cord-005453-4057qib7	6776	8	injection	injection	NN
cord-005453-4057qib7	6776	9	to	to	TO
cord-005453-4057qib7	6776	10	make	make	VB
cord-005453-4057qib7	6776	11	6mg	6mg	NN
cord-005453-4057qib7	6776	12	/	/	SYM
cord-005453-4057qib7	6776	13	ml	ml	NN
cord-005453-4057qib7	6776	14	solution	solution	NN
cord-005453-4057qib7	6776	15	to	to	TO
cord-005453-4057qib7	6776	16	facilitate	facilitate	VB
cord-005453-4057qib7	6776	17	subcutaneous	subcutaneous	JJ
cord-005453-4057qib7	6776	18	administration	administration	NN
cord-005453-4057qib7	6776	19	.	.	.
cord-005453-4057qib7	6777	1	Results	result	NNS
cord-005453-4057qib7	6777	2	:	:	:
cord-005453-4057qib7	6778	1	Significant	significant	JJ
cord-005453-4057qib7	6778	2	hypercalcaemia	hypercalcaemia	NN
cord-005453-4057qib7	6778	3	emerged	emerge	VBD
cord-005453-4057qib7	6778	4	on	on	IN
cord-005453-4057qib7	6778	5	day	day	NN
cord-005453-4057qib7	6778	6	+18	+18	CD
cord-005453-4057qib7	6778	7	with	with	IN
cord-005453-4057qib7	6778	8	a	a	DT
cord-005453-4057qib7	6778	9	level	level	NN
cord-005453-4057qib7	6778	10	of	of	IN
cord-005453-4057qib7	6778	11	3mmol	3mmol	CD
cord-005453-4057qib7	6778	12	/	/	SYM
cord-005453-4057qib7	6778	13	L	l	NN
cord-005453-4057qib7	6778	14	and	and	CC
cord-005453-4057qib7	6778	15	treated	treat	VBN
cord-005453-4057qib7	6778	16	with	with	IN
cord-005453-4057qib7	6778	17	hyper	hyper	JJ
cord-005453-4057qib7	6778	18	-	-	NN
cord-005453-4057qib7	6778	19	hydration	hydration	NN
cord-005453-4057qib7	6778	20	and	and	CC
cord-005453-4057qib7	6778	21	diuretics	diuretic	NNS
cord-005453-4057qib7	6778	22	.	.	.
cord-005453-4057qib7	6779	1	This	this	DT
cord-005453-4057qib7	6779	2	was	be	VBD
cord-005453-4057qib7	6779	3	ineffective	ineffective	JJ
cord-005453-4057qib7	6779	4	in	in	IN
cord-005453-4057qib7	6779	5	reducing	reduce	VBG
cord-005453-4057qib7	6779	6	the	the	DT
cord-005453-4057qib7	6779	7	hypercalcaemia	hypercalcaemia	NN
cord-005453-4057qib7	6779	8	;	;	:
cord-005453-4057qib7	6779	9	therefore	therefore	RB
cord-005453-4057qib7	6779	10	denosumab	denosumab	NNP
cord-005453-4057qib7	6779	11	was	be	VBD
cord-005453-4057qib7	6779	12	initiated	initiate	VBN
cord-005453-4057qib7	6779	13	on	on	IN
cord-005453-4057qib7	6779	14	day	day	NN
cord-005453-4057qib7	6779	15	+20	+20	CD
cord-005453-4057qib7	6779	16	post	post	NN
cord-005453-4057qib7	6779	17	-	-	NN
cord-005453-4057qib7	6779	18	transplant	transplant	NN
cord-005453-4057qib7	6779	19	.	.	.
cord-005453-4057qib7	6780	1	Initial	initial	JJ
cord-005453-4057qib7	6780	2	dosing	dosing	NN
cord-005453-4057qib7	6780	3	was	be	VBD
cord-005453-4057qib7	6780	4	determined	determine	VBN
cord-005453-4057qib7	6780	5	using	use	VBG
cord-005453-4057qib7	6780	6	the	the	DT
cord-005453-4057qib7	6780	7	only	only	RB
cord-005453-4057qib7	6780	8	available	available	JJ
cord-005453-4057qib7	6780	9	paediatric	paediatric	JJ
cord-005453-4057qib7	6780	10	case	case	NN
cord-005453-4057qib7	6780	11	report	report	NN
cord-005453-4057qib7	6780	12	at	at	IN
cord-005453-4057qib7	6780	13	0.13	0.13	CD
cord-005453-4057qib7	6780	14	mg	mg	NNP
cord-005453-4057qib7	6780	15	/	/	SYM
cord-005453-4057qib7	6780	16	kg	kg	NNP
cord-005453-4057qib7	6780	17	.	.	.
cord-005453-4057qib7	6781	1	A	a	DT
cord-005453-4057qib7	6781	2	repeated	repeated	JJ
cord-005453-4057qib7	6781	3	larger	large	JJR
cord-005453-4057qib7	6781	4	dose	dose	NN
cord-005453-4057qib7	6781	5	of	of	IN
cord-005453-4057qib7	6781	6	0.19mg	0.19mg	CD
cord-005453-4057qib7	6781	7	/	/	SYM
cord-005453-4057qib7	6781	8	kg	kg	NNS
cord-005453-4057qib7	6781	9	was	be	VBD
cord-005453-4057qib7	6781	10	given	give	VBN
cord-005453-4057qib7	6781	11	4	4	CD
cord-005453-4057qib7	6781	12	days	day	NNS
cord-005453-4057qib7	6781	13	later	later	RB
cord-005453-4057qib7	6781	14	due	due	IN
cord-005453-4057qib7	6781	15	to	to	IN
cord-005453-4057qib7	6781	16	an	an	DT
cord-005453-4057qib7	6781	17	inadequate	inadequate	JJ
cord-005453-4057qib7	6781	18	response	response	NN
cord-005453-4057qib7	6781	19	(	(	-LRB-
cord-005453-4057qib7	6781	20	calcium	calcium	NN
cord-005453-4057qib7	6781	21	decreased	decrease	VBD
cord-005453-4057qib7	6781	22	from	from	IN
cord-005453-4057qib7	6781	23	3.9mmol	3.9mmol	CD
cord-005453-4057qib7	6781	24	/	/	SYM
cord-005453-4057qib7	6781	25	L	l	NN
cord-005453-4057qib7	6781	26	to	to	IN
cord-005453-4057qib7	6781	27	3.80mmol	3.80mmol	CD
cord-005453-4057qib7	6781	28	/	/	SYM
cord-005453-4057qib7	6781	29	L	l	NN
cord-005453-4057qib7	6781	30	)	)	-RRB-
cord-005453-4057qib7	6781	31	.	.	.
cord-005453-4057qib7	6782	1	The	the	DT
cord-005453-4057qib7	6782	2	calcium	calcium	NN
cord-005453-4057qib7	6782	3	decreased	decrease	VBD
cord-005453-4057qib7	6782	4	to	to	IN
cord-005453-4057qib7	6782	5	1.93mmol	1.93mmol	CD
cord-005453-4057qib7	6782	6	/	/	SYM
cord-005453-4057qib7	6782	7	L	l	NN
cord-005453-4057qib7	6782	8	after	after	IN
cord-005453-4057qib7	6782	9	this	this	DT
cord-005453-4057qib7	6782	10	dose	dose	NN
cord-005453-4057qib7	6782	11	.	.	.
cord-005453-4057qib7	6783	1	Four	four	CD
cord-005453-4057qib7	6783	2	weeks	week	NNS
cord-005453-4057qib7	6783	3	later	later	RB
cord-005453-4057qib7	6783	4	a	a	DT
cord-005453-4057qib7	6783	5	third	third	JJ
cord-005453-4057qib7	6783	6	dose	dose	NN
cord-005453-4057qib7	6783	7	was	be	VBD
cord-005453-4057qib7	6783	8	required	require	VBN
cord-005453-4057qib7	6783	9	at	at	IN
cord-005453-4057qib7	6783	10	0.26mg	0.26mg	CD
cord-005453-4057qib7	6783	11	/	/	SYM
cord-005453-4057qib7	6783	12	kg	kg	NNS
cord-005453-4057qib7	6783	13	as	as	IN
cord-005453-4057qib7	6783	14	the	the	DT
cord-005453-4057qib7	6783	15	calcium	calcium	NN
cord-005453-4057qib7	6783	16	level	level	NN
cord-005453-4057qib7	6783	17	had	have	VBD
cord-005453-4057qib7	6783	18	increased	increase	VBN
cord-005453-4057qib7	6783	19	to	to	IN
cord-005453-4057qib7	6783	20	4.1mmol	4.1mmol	CD
cord-005453-4057qib7	6783	21	/	/	SYM
cord-005453-4057qib7	6783	22	L.	L.	NNP
cord-005453-4057qib7	6784	1	The	the	DT
cord-005453-4057qib7	6784	2	dose	dose	NN
cord-005453-4057qib7	6784	3	was	be	VBD
cord-005453-4057qib7	6784	4	further	further	RB
cord-005453-4057qib7	6784	5	increased	increase	VBN
cord-005453-4057qib7	6784	6	to	to	IN
cord-005453-4057qib7	6784	7	0.32mg	0.32mg	CD
cord-005453-4057qib7	6784	8	/	/	SYM
cord-005453-4057qib7	6784	9	kg	kg	NNS
cord-005453-4057qib7	6784	10	for	for	IN
cord-005453-4057qib7	6784	11	another	another	DT
cord-005453-4057qib7	6784	12	four	four	CD
cord-005453-4057qib7	6784	13	doses	dose	NNS
cord-005453-4057qib7	6784	14	and	and	CC
cord-005453-4057qib7	6784	15	then	then	RB
cord-005453-4057qib7	6784	16	further	further	RB
cord-005453-4057qib7	6784	17	increased	increase	VBD
cord-005453-4057qib7	6784	18	to	to	IN
cord-005453-4057qib7	6784	19	0.65mg	0.65mg	CD
cord-005453-4057qib7	6784	20	/	/	SYM
cord-005453-4057qib7	6784	21	kg	kg	NNS
cord-005453-4057qib7	6784	22	for	for	IN
cord-005453-4057qib7	6784	23	another	another	DT
cord-005453-4057qib7	6784	24	3	3	CD
cord-005453-4057qib7	6784	25	doses	dose	NNS
cord-005453-4057qib7	6784	26	and	and	CC
cord-005453-4057qib7	6784	27	repeated	repeat	VBD
cord-005453-4057qib7	6784	28	every	every	DT
cord-005453-4057qib7	6784	29	7	7	CD
cord-005453-4057qib7	6784	30	weeks	week	NNS
cord-005453-4057qib7	6784	31	.	.	.
cord-005453-4057qib7	6785	1	Normalisation	Normalisation	NNP
cord-005453-4057qib7	6785	2	,	,	,
cord-005453-4057qib7	6785	3	but	but	CC
cord-005453-4057qib7	6785	4	not	not	RB
cord-005453-4057qib7	6785	5	excessive	excessive	JJ
cord-005453-4057qib7	6785	6	drop	drop	NN
cord-005453-4057qib7	6785	7	in	in	IN
cord-005453-4057qib7	6785	8	calcium	calcium	NN
cord-005453-4057qib7	6785	9	was	be	VBD
cord-005453-4057qib7	6785	10	achieved	achieve	VBN
cord-005453-4057qib7	6785	11	with	with	IN
cord-005453-4057qib7	6785	12	these	these	DT
cord-005453-4057qib7	6785	13	larger	large	JJR
cord-005453-4057qib7	6785	14	doses	dose	NNS
cord-005453-4057qib7	6785	15	.	.	.
cord-005453-4057qib7	6786	1	Over	over	IN
cord-005453-4057qib7	6786	2	the	the	DT
cord-005453-4057qib7	6786	3	9	9	CD
cord-005453-4057qib7	6786	4	month	month	NN
cord-005453-4057qib7	6786	5	follow	follow	VB
cord-005453-4057qib7	6786	6	up	up	RP
cord-005453-4057qib7	6786	7	post	post	JJ
cord-005453-4057qib7	6786	8	-	-	JJ
cord-005453-4057qib7	6786	9	transplant	transplant	NN
cord-005453-4057qib7	6786	10	there	there	EX
cord-005453-4057qib7	6786	11	were	be	VBD
cord-005453-4057qib7	6786	12	three	three	CD
cord-005453-4057qib7	6786	13	admissions	admission	NNS
cord-005453-4057qib7	6786	14	lasting	last	VBG
cord-005453-4057qib7	6786	15	less	less	JJR
cord-005453-4057qib7	6786	16	than	than	IN
cord-005453-4057qib7	6786	17	24	24	CD
cord-005453-4057qib7	6786	18	hours	hour	NNS
cord-005453-4057qib7	6786	19	for	for	IN
cord-005453-4057qib7	6786	20	symptoms	symptom	NNS
cord-005453-4057qib7	6786	21	of	of	IN
cord-005453-4057qib7	6786	22	hypercalcaemia	hypercalcaemia	NN
cord-005453-4057qib7	6786	23	.	.	.
cord-005453-4057qib7	6787	1	These	these	DT
cord-005453-4057qib7	6787	2	were	be	VBD
cord-005453-4057qib7	6787	3	managed	manage	VBN
cord-005453-4057qib7	6787	4	with	with	IN
cord-005453-4057qib7	6787	5	denosumab	denosumab	NNP
cord-005453-4057qib7	6787	6	administration	administration	NN
cord-005453-4057qib7	6787	7	and	and	CC
cord-005453-4057qib7	6787	8	hyper	hyper	JJ
cord-005453-4057qib7	6787	9	-	-	NN
cord-005453-4057qib7	6787	10	hydration	hydration	NN
cord-005453-4057qib7	6787	11	.	.	.
cord-005453-4057qib7	6788	1	The	the	DT
cord-005453-4057qib7	6788	2	remaining	remain	VBG
cord-005453-4057qib7	6788	3	doses	dose	NNS
cord-005453-4057qib7	6788	4	were	be	VBD
cord-005453-4057qib7	6788	5	given	give	VBN
cord-005453-4057qib7	6788	6	in	in	IN
cord-005453-4057qib7	6788	7	an	an	DT
cord-005453-4057qib7	6788	8	outpatient	outpatient	NN
cord-005453-4057qib7	6788	9	setting	setting	NN
cord-005453-4057qib7	6788	10	.	.	.
cord-005453-4057qib7	6789	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6789	2	:	:	:
cord-005453-4057qib7	6790	1	Denosumab	Denosumab	NNP
cord-005453-4057qib7	6790	2	can	can	MD
cord-005453-4057qib7	6790	3	be	be	VB
cord-005453-4057qib7	6790	4	safely	safely	RB
cord-005453-4057qib7	6790	5	used	use	VBN
cord-005453-4057qib7	6790	6	as	as	IN
cord-005453-4057qib7	6790	7	a	a	DT
cord-005453-4057qib7	6790	8	first	first	JJ
cord-005453-4057qib7	6790	9	line	line	NN
cord-005453-4057qib7	6790	10	agent	agent	NN
cord-005453-4057qib7	6790	11	in	in	IN
cord-005453-4057qib7	6790	12	treating	treat	VBG
cord-005453-4057qib7	6790	13	post	post	JJ
cord-005453-4057qib7	6790	14	stem	stem	NN
cord-005453-4057qib7	6790	15	cell	cell	NN
cord-005453-4057qib7	6790	16	transplant	transplant	NN
cord-005453-4057qib7	6790	17	hypercalcemia	hypercalcemia	NN
cord-005453-4057qib7	6790	18	in	in	IN
cord-005453-4057qib7	6790	19	patients	patient	NNS
cord-005453-4057qib7	6790	20	with	with	IN
cord-005453-4057qib7	6790	21	osteopetrosis	osteopetrosis	NN
cord-005453-4057qib7	6790	22	.	.	.
cord-005453-4057qib7	6791	1	A	a	DT
cord-005453-4057qib7	6791	2	dose	dose	NN
cord-005453-4057qib7	6791	3	of	of	IN
cord-005453-4057qib7	6791	4	0.3mg	0.3mg	CD
cord-005453-4057qib7	6791	5	/	/	SYM
cord-005453-4057qib7	6791	6	kg	kg	NN
cord-005453-4057qib7	6791	7	is	be	VBZ
cord-005453-4057qib7	6791	8	required	require	VBN
cord-005453-4057qib7	6791	9	as	as	IN
cord-005453-4057qib7	6791	10	an	an	DT
cord-005453-4057qib7	6791	11	initial	initial	JJ
cord-005453-4057qib7	6791	12	starting	starting	NN
cord-005453-4057qib7	6791	13	dose	dose	NN
cord-005453-4057qib7	6791	14	in	in	IN
cord-005453-4057qib7	6791	15	order	order	NN
cord-005453-4057qib7	6791	16	to	to	TO
cord-005453-4057qib7	6791	17	control	control	VB
cord-005453-4057qib7	6791	18	hypercalcemia	hypercalcemia	NN
cord-005453-4057qib7	6791	19	.	.	.
cord-005453-4057qib7	6792	1	This	this	DT
cord-005453-4057qib7	6792	2	is	be	VBZ
cord-005453-4057qib7	6792	3	a	a	DT
cord-005453-4057qib7	6792	4	new	new	JJ
cord-005453-4057qib7	6792	5	higher	high	JJR
cord-005453-4057qib7	6792	6	dose	dose	NN
cord-005453-4057qib7	6792	7	than	than	IN
cord-005453-4057qib7	6792	8	previously	previously	RB
cord-005453-4057qib7	6792	9	suggested	suggest	VBN
cord-005453-4057qib7	6792	10	by	by	IN
cord-005453-4057qib7	6792	11	the	the	DT
cord-005453-4057qib7	6792	12	original	original	JJ
cord-005453-4057qib7	6792	13	report	report	NN
cord-005453-4057qib7	6792	14	.	.	.
cord-005453-4057qib7	6793	1	Denosumab	Denosumab	NNP
cord-005453-4057qib7	6793	2	can	can	MD
cord-005453-4057qib7	6793	3	be	be	VB
cord-005453-4057qib7	6793	4	effective	effective	JJ
cord-005453-4057qib7	6793	5	even	even	RB
cord-005453-4057qib7	6793	6	after	after	IN
cord-005453-4057qib7	6793	7	dilution	dilution	NN
cord-005453-4057qib7	6793	8	and	and	CC
cord-005453-4057qib7	6793	9	safely	safely	RB
cord-005453-4057qib7	6793	10	given	give	VBN
cord-005453-4057qib7	6793	11	in	in	IN
cord-005453-4057qib7	6793	12	children	child	NNS
cord-005453-4057qib7	6793	13	weighing	weigh	VBG
cord-005453-4057qib7	6793	14	less	less	JJR
cord-005453-4057qib7	6793	15	than	than	IN
cord-005453-4057qib7	6793	16	10	10	CD
cord-005453-4057qib7	6793	17	kg	kg	NNS
cord-005453-4057qib7	6793	18	.	.	.
cord-005453-4057qib7	6794	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6794	2	:	:	:
cord-005453-4057qib7	6794	3	Nothing	nothing	NN
cord-005453-4057qib7	6794	4	to	to	TO
cord-005453-4057qib7	6794	5	Declare	declare	VB
cord-005453-4057qib7	6794	6	Methods	method	NNS
cord-005453-4057qib7	6794	7	:	:	:
cord-005453-4057qib7	6794	8	The	the	DT
cord-005453-4057qib7	6794	9	clinical	clinical	JJ
cord-005453-4057qib7	6794	10	,	,	,
cord-005453-4057qib7	6794	11	laboratory	laboratory	NN
cord-005453-4057qib7	6794	12	and	and	CC
cord-005453-4057qib7	6794	13	molecular	molecular	JJ
cord-005453-4057qib7	6794	14	aspects	aspect	NNS
cord-005453-4057qib7	6794	15	of	of	IN
cord-005453-4057qib7	6794	16	this	this	DT
cord-005453-4057qib7	6794	17	Italian	italian	JJ
cord-005453-4057qib7	6794	18	male	male	JJ
cord-005453-4057qib7	6794	19	patient	patient	NN
cord-005453-4057qib7	6794	20	who	who	WP
cord-005453-4057qib7	6794	21	developed	develop	VBD
cord-005453-4057qib7	6794	22	such	such	PDT
cord-005453-4057qib7	6794	23	a	a	DT
cord-005453-4057qib7	6794	24	complication	complication	NN
cord-005453-4057qib7	6794	25	were	be	VBD
cord-005453-4057qib7	6794	26	collected	collect	VBN
cord-005453-4057qib7	6794	27	and	and	CC
cord-005453-4057qib7	6794	28	presented	present	VBN
cord-005453-4057qib7	6794	29	in	in	IN
cord-005453-4057qib7	6794	30	order	order	NN
cord-005453-4057qib7	6794	31	to	to	TO
cord-005453-4057qib7	6794	32	discuss	discuss	VB
cord-005453-4057qib7	6794	33	the	the	DT
cord-005453-4057qib7	6794	34	origin	origin	NN
cord-005453-4057qib7	6794	35	,	,	,
cord-005453-4057qib7	6794	36	clinical	clinical	JJ
cord-005453-4057qib7	6794	37	outcome	outcome	NN
cord-005453-4057qib7	6794	38	and	and	CC
cord-005453-4057qib7	6794	39	management	management	NN
cord-005453-4057qib7	6794	40	of	of	IN
cord-005453-4057qib7	6794	41	this	this	DT
cord-005453-4057qib7	6794	42	very	very	RB
cord-005453-4057qib7	6794	43	rare	rare	JJ
cord-005453-4057qib7	6794	44	post	post	JJ
cord-005453-4057qib7	6794	45	-	-	JJ
cord-005453-4057qib7	6794	46	transplant	transplant	JJ
cord-005453-4057qib7	6794	47	event	event	NN
cord-005453-4057qib7	6794	48	.	.	.
cord-005453-4057qib7	6795	1	Results	result	NNS
cord-005453-4057qib7	6795	2	:	:	:
cord-005453-4057qib7	6796	1	A	a	DT
cord-005453-4057qib7	6796	2	68-years	68-years	CD
cord-005453-4057qib7	6796	3	-	-	HYPH
cord-005453-4057qib7	6796	4	old	old	JJ
cord-005453-4057qib7	6796	5	man	man	NN
cord-005453-4057qib7	6796	6	affected	affect	VBN
cord-005453-4057qib7	6796	7	by	by	IN
cord-005453-4057qib7	6796	8	a	a	DT
cord-005453-4057qib7	6796	9	high	high	JJ
cord-005453-4057qib7	6796	10	-	-	HYPH
cord-005453-4057qib7	6796	11	risk	risk	NN
cord-005453-4057qib7	6796	12	chromosomally	chromosomally	RB
cord-005453-4057qib7	6796	13	abnormal	abnormal	JJ
cord-005453-4057qib7	6796	14	,	,	,
cord-005453-4057qib7	6796	15	Ph1-	Ph1-	NNP
cord-005453-4057qib7	6796	16	,	,	,
cord-005453-4057qib7	6796	17	MLL	MLL	NNP
cord-005453-4057qib7	6796	18	-	-	HYPH
cord-005453-4057qib7	6796	19	pro	pro	NN
cord-005453-4057qib7	6796	20	-	-	JJ
cord-005453-4057qib7	6796	21	B	b	JJ
cord-005453-4057qib7	6796	22	(	(	-LRB-
cord-005453-4057qib7	6796	23	EGIL	EGIL	NNP
cord-005453-4057qib7	6796	24	B	B	NNP
cord-005453-4057qib7	6796	25	-	-	:
cord-005453-4057qib7	6796	26	I	I	NNP
cord-005453-4057qib7	6796	27	)	)	-RRB-
cord-005453-4057qib7	6796	28	ALL	all	DT
cord-005453-4057qib7	6796	29	relapsed	relapse	VBD
cord-005453-4057qib7	6796	30	during	during	IN
cord-005453-4057qib7	6796	31	maintenance	maintenance	NN
cord-005453-4057qib7	6796	32	treatment	treatment	NN
cord-005453-4057qib7	6796	33	,	,	,
cord-005453-4057qib7	6796	34	nonresponsive	nonresponsive	JJ
cord-005453-4057qib7	6796	35	to	to	TO
cord-005453-4057qib7	6796	36	re	re	VB
cord-005453-4057qib7	6796	37	-	-	NN
cord-005453-4057qib7	6796	38	induction	induction	JJ
cord-005453-4057qib7	6796	39	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	6796	40	,	,	,
cord-005453-4057qib7	6796	41	in	in	IN
cord-005453-4057qib7	6796	42	second	second	JJ
cord-005453-4057qib7	6796	43	complete	complete	JJ
cord-005453-4057qib7	6796	44	remission	remission	NN
cord-005453-4057qib7	6796	45	(	(	-LRB-
cord-005453-4057qib7	6796	46	II	II	NNP
cord-005453-4057qib7	6796	47	CR	CR	NNP
cord-005453-4057qib7	6796	48	)	)	-RRB-
cord-005453-4057qib7	6796	49	after	after	IN
cord-005453-4057qib7	6796	50	Blinatumumab	Blinatumumab	NNP
cord-005453-4057qib7	6796	51	treatment	treatment	NN
cord-005453-4057qib7	6796	52	received	receive	VBD
cord-005453-4057qib7	6796	53	a	a	DT
cord-005453-4057qib7	6796	54	female	female	JJ
cord-005453-4057qib7	6796	55	CB	CB	NNP
cord-005453-4057qib7	6796	56	transplant	transplant	NN
cord-005453-4057qib7	6796	57	.	.	.
cord-005453-4057qib7	6797	1	According	accord	VBG
cord-005453-4057qib7	6797	2	to	to	IN
cord-005453-4057qib7	6797	3	Sorror	Sorror	NNP
cord-005453-4057qib7	6797	4	's	's	POS
cord-005453-4057qib7	6797	5	and	and	CC
cord-005453-4057qib7	6797	6	EBMT	EBMT	NNP
cord-005453-4057qib7	6797	7	scores	score	NNS
cord-005453-4057qib7	6797	8	he	-PRON-	PRP
cord-005453-4057qib7	6797	9	was	be	VBD
cord-005453-4057qib7	6797	10	considered	consider	VBN
cord-005453-4057qib7	6797	11	a	a	DT
cord-005453-4057qib7	6797	12	high	high	JJ
cord-005453-4057qib7	6797	13	-	-	HYPH
cord-005453-4057qib7	6797	14	risk	risk	NN
cord-005453-4057qib7	6797	15	transplant	transplant	NN
cord-005453-4057qib7	6797	16	.	.	.
cord-005453-4057qib7	6798	1	The	the	DT
cord-005453-4057qib7	6798	2	patient	patient	NN
cord-005453-4057qib7	6798	3	and	and	CC
cord-005453-4057qib7	6798	4	the	the	DT
cord-005453-4057qib7	6798	5	CB	CB	NNP
cord-005453-4057qib7	6798	6	unit	unit	NN
cord-005453-4057qib7	6798	7	were	be	VBD
cord-005453-4057qib7	6798	8	sex	sex	NN
cord-005453-4057qib7	6798	9	-	-	HYPH
cord-005453-4057qib7	6798	10	mismatched	mismatched	JJ
cord-005453-4057qib7	6798	11	,	,	,
cord-005453-4057qib7	6798	12	shared	share	VBD
cord-005453-4057qib7	6798	13	the	the	DT
cord-005453-4057qib7	6798	14	same	same	JJ
cord-005453-4057qib7	6798	15	blood	blood	NN
cord-005453-4057qib7	6798	16	groups	group	NNS
cord-005453-4057qib7	6798	17	and	and	CC
cord-005453-4057qib7	6798	18	were	be	VBD
cord-005453-4057qib7	6798	19	both	both	DT
cord-005453-4057qib7	6798	20	CMV+/EBV+	CMV+/EBV+	NNS
cord-005453-4057qib7	6798	21	.	.	.
cord-005453-4057qib7	6799	1	He	-PRON-	PRP
cord-005453-4057qib7	6799	2	received	receive	VBD
cord-005453-4057qib7	6799	3	a	a	DT
cord-005453-4057qib7	6799	4	TBF	tbf	NN
cord-005453-4057qib7	6799	5	conditioning	conditioning	NN
cord-005453-4057qib7	6799	6	regimen	regimen	NN
cord-005453-4057qib7	6799	7	that	that	WDT
cord-005453-4057qib7	6799	8	was	be	VBD
cord-005453-4057qib7	6799	9	followed	follow	VBN
cord-005453-4057qib7	6799	10	by	by	IN
cord-005453-4057qib7	6799	11	the	the	DT
cord-005453-4057qib7	6799	12	infusion	infusion	NN
cord-005453-4057qib7	6799	13	of	of	IN
cord-005453-4057qib7	6799	14	0.54x10	0.54x10	CD
cord-005453-4057qib7	6799	15	5	5	CD
cord-005453-4057qib7	6799	16	/kg	/kg	.
cord-005453-4057qib7	6799	17	CD34	CD34	NNP
cord-005453-4057qib7	6799	18	+	+	CC
cord-005453-4057qib7	6799	19	CB	CB	NNP
cord-005453-4057qib7	6799	20	cells	cell	NNS
cord-005453-4057qib7	6799	21	.	.	.
cord-005453-4057qib7	6800	1	GVHD	GVHD	NNP
cord-005453-4057qib7	6800	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6800	3	consisted	consist	VBD
cord-005453-4057qib7	6800	4	of	of	IN
cord-005453-4057qib7	6800	5	rabbit	rabbit	NN
cord-005453-4057qib7	6800	6	ATG	ATG	NNP
cord-005453-4057qib7	6800	7	,	,	,
cord-005453-4057qib7	6800	8	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	6800	9	A	A	NNP
cord-005453-4057qib7	6800	10	(	(	-LRB-
cord-005453-4057qib7	6800	11	CsA	csa	NN
cord-005453-4057qib7	6800	12	)	)	-RRB-
cord-005453-4057qib7	6800	13	and	and	CC
cord-005453-4057qib7	6800	14	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	6800	15	mophetyl	mophetyl	NNP
cord-005453-4057qib7	6800	16	(	(	-LRB-
cord-005453-4057qib7	6800	17	MMF	MMF	NNP
cord-005453-4057qib7	6800	18	)	)	-RRB-
cord-005453-4057qib7	6800	19	.	.	.
cord-005453-4057qib7	6801	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	6801	2	engraftment	engraftment	NN
cord-005453-4057qib7	6801	3	occurred	occur	VBD
cord-005453-4057qib7	6801	4	on	on	IN
cord-005453-4057qib7	6801	5	day	day	NN
cord-005453-4057qib7	6801	6	+28	+28	NNS
cord-005453-4057qib7	6801	7	,	,	,
cord-005453-4057qib7	6801	8	whereas	whereas	IN
cord-005453-4057qib7	6801	9	platelets	platelet	NNS
cord-005453-4057qib7	6801	10	were	be	VBD
cord-005453-4057qib7	6801	11	never	never	RB
cord-005453-4057qib7	6801	12	>	>	XX
cord-005453-4057qib7	6802	1	20.000	20.000	CD
cord-005453-4057qib7	6802	2	/	/	SYM
cord-005453-4057qib7	6802	3	μl	μl	NN
cord-005453-4057qib7	6802	4	.	.	.
cord-005453-4057qib7	6803	1	On	on	IN
cord-005453-4057qib7	6803	2	day	day	NN
cord-005453-4057qib7	6803	3	+67	+67	NNP
cord-005453-4057qib7	6803	4	a	a	DT
cord-005453-4057qib7	6803	5	2	2	CD
cord-005453-4057qib7	6803	6	cm	cm	NN
cord-005453-4057qib7	6803	7	bulged	bulge	VBN
cord-005453-4057qib7	6803	8	area	area	NN
cord-005453-4057qib7	6803	9	became	become	VBD
cord-005453-4057qib7	6803	10	apparent	apparent	JJ
cord-005453-4057qib7	6803	11	on	on	IN
cord-005453-4057qib7	6803	12	the	the	DT
cord-005453-4057qib7	6803	13	left	left	JJ
cord-005453-4057qib7	6803	14	parietal	parietal	JJ
cord-005453-4057qib7	6803	15	region	region	NN
cord-005453-4057qib7	6803	16	of	of	IN
cord-005453-4057qib7	6803	17	the	the	DT
cord-005453-4057qib7	6803	18	skull	skull	NN
cord-005453-4057qib7	6803	19	.	.	.
cord-005453-4057qib7	6804	1	An	an	DT
cord-005453-4057qib7	6804	2	echotomography	echotomography	NN
cord-005453-4057qib7	6804	3	showed	show	VBD
cord-005453-4057qib7	6804	4	that	that	IN
cord-005453-4057qib7	6804	5	the	the	DT
cord-005453-4057qib7	6804	6	lesion	lesion	NN
cord-005453-4057qib7	6804	7	adhered	adhere	VBN
cord-005453-4057qib7	6804	8	to	to	IN
cord-005453-4057qib7	6804	9	the	the	DT
cord-005453-4057qib7	6804	10	bone	bone	NN
cord-005453-4057qib7	6804	11	without	without	IN
cord-005453-4057qib7	6804	12	infiltrating	infiltrate	VBG
cord-005453-4057qib7	6804	13	it	-PRON-	PRP
cord-005453-4057qib7	6804	14	and	and	CC
cord-005453-4057qib7	6804	15	lacked	lack	VBD
cord-005453-4057qib7	6804	16	blood	blood	NN
cord-005453-4057qib7	6804	17	vessels	vessel	NNS
cord-005453-4057qib7	6804	18	and	and	CC
cord-005453-4057qib7	6804	19	suggested	suggest	VBD
cord-005453-4057qib7	6804	20	that	that	IN
cord-005453-4057qib7	6804	21	it	-PRON-	PRP
cord-005453-4057qib7	6804	22	may	may	MD
cord-005453-4057qib7	6804	23	be	be	VB
cord-005453-4057qib7	6804	24	either	either	CC
cord-005453-4057qib7	6804	25	a	a	DT
cord-005453-4057qib7	6804	26	site	site	NN
cord-005453-4057qib7	6804	27	of	of	IN
cord-005453-4057qib7	6804	28	disease	disease	NN
cord-005453-4057qib7	6804	29	relapse	relapse	NN
cord-005453-4057qib7	6804	30	or	or	CC
cord-005453-4057qib7	6804	31	an	an	DT
cord-005453-4057qib7	6804	32	area	area	NN
cord-005453-4057qib7	6804	33	of	of	IN
cord-005453-4057qib7	6804	34	infection	infection	NN
cord-005453-4057qib7	6804	35	.	.	.
cord-005453-4057qib7	6805	1	At	at	IN
cord-005453-4057qib7	6805	2	the	the	DT
cord-005453-4057qib7	6805	3	same	same	JJ
cord-005453-4057qib7	6805	4	time	time	NN
cord-005453-4057qib7	6805	5	a	a	DT
cord-005453-4057qib7	6805	6	bone	bone	NN
cord-005453-4057qib7	6805	7	marrow	marrow	NN
cord-005453-4057qib7	6805	8	(	(	-LRB-
cord-005453-4057qib7	6805	9	BM	BM	NNP
cord-005453-4057qib7	6805	10	)	)	-RRB-
cord-005453-4057qib7	6805	11	aspiration	aspiration	NN
cord-005453-4057qib7	6805	12	showed	show	VBD
cord-005453-4057qib7	6805	13	morphological	morphological	JJ
cord-005453-4057qib7	6805	14	CR	CR	NNP
cord-005453-4057qib7	6805	15	confirmed	confirm	VBN
cord-005453-4057qib7	6805	16	by	by	IN
cord-005453-4057qib7	6805	17	immune	immune	JJ
cord-005453-4057qib7	6805	18	-	-	HYPH
cord-005453-4057qib7	6805	19	phenotypic	phenotypic	JJ
cord-005453-4057qib7	6805	20	studies	study	NNS
cord-005453-4057qib7	6805	21	and	and	CC
cord-005453-4057qib7	6805	22	X	x	NN
cord-005453-4057qib7	6805	23	-	-	NN
cord-005453-4057qib7	6805	24	Y	Y	NNP
cord-005453-4057qib7	6805	25	FISH	fish	NN
cord-005453-4057qib7	6805	26	a	a	DT
cord-005453-4057qib7	6805	27	complete	complete	JJ
cord-005453-4057qib7	6805	28	chimera	chimera	NN
cord-005453-4057qib7	6805	29	.	.	.
cord-005453-4057qib7	6806	1	Since	since	IN
cord-005453-4057qib7	6806	2	the	the	DT
cord-005453-4057qib7	6806	3	patient	patient	NN
cord-005453-4057qib7	6806	4	was	be	VBD
cord-005453-4057qib7	6806	5	still	still	RB
cord-005453-4057qib7	6806	6	febrile	febrile	JJ
cord-005453-4057qib7	6806	7	no	no	DT
cord-005453-4057qib7	6806	8	biopsy	biopsy	NN
cord-005453-4057qib7	6806	9	was	be	VBD
cord-005453-4057qib7	6806	10	performed	perform	VBN
cord-005453-4057qib7	6806	11	,	,	,
cord-005453-4057qib7	6806	12	but	but	CC
cord-005453-4057qib7	6806	13	on	on	IN
cord-005453-4057qib7	6806	14	day	day	NN
cord-005453-4057qib7	6806	15	+94	+94	NN
cord-005453-4057qib7	6806	16	the	the	DT
cord-005453-4057qib7	6806	17	axial	axial	JJ
cord-005453-4057qib7	6806	18	diameter	diameter	NN
cord-005453-4057qib7	6806	19	of	of	IN
cord-005453-4057qib7	6806	20	the	the	DT
cord-005453-4057qib7	6806	21	lesion	lesion	NN
cord-005453-4057qib7	6806	22	that	that	IN
cord-005453-4057qib7	6806	23	on	on	IN
cord-005453-4057qib7	6806	24	a	a	DT
cord-005453-4057qib7	6806	25	CT	CT	NNP
cord-005453-4057qib7	6806	26	scan	scan	NN
cord-005453-4057qib7	6806	27	showed	show	VBD
cord-005453-4057qib7	6806	28	the	the	DT
cord-005453-4057qib7	6806	29	same	same	JJ
cord-005453-4057qib7	6806	30	appearance	appearance	NN
cord-005453-4057qib7	6806	31	revealed	reveal	VBN
cord-005453-4057qib7	6806	32	by	by	IN
cord-005453-4057qib7	6806	33	the	the	DT
cord-005453-4057qib7	6806	34	previous	previous	JJ
cord-005453-4057qib7	6806	35	echo	echo	NN
cord-005453-4057qib7	6806	36	-	-	HYPH
cord-005453-4057qib7	6806	37	tomography	tomography	NN
cord-005453-4057qib7	6806	38	increased	increase	VBD
cord-005453-4057qib7	6806	39	to	to	IN
cord-005453-4057qib7	6806	40	4	4	CD
cord-005453-4057qib7	6806	41	cm	cm	NNS
cord-005453-4057qib7	6806	42	.	.	.
cord-005453-4057qib7	6807	1	Thus	thus	RB
cord-005453-4057qib7	6807	2	,	,	,
cord-005453-4057qib7	6807	3	the	the	DT
cord-005453-4057qib7	6807	4	lesion	lesion	NN
cord-005453-4057qib7	6807	5	was	be	VBD
cord-005453-4057qib7	6807	6	surgically	surgically	RB
cord-005453-4057qib7	6807	7	removed	remove	VBN
cord-005453-4057qib7	6807	8	and	and	CC
cord-005453-4057qib7	6807	9	histological	histological	JJ
cord-005453-4057qib7	6807	10	examination	examination	NN
cord-005453-4057qib7	6807	11	showed	show	VBD
cord-005453-4057qib7	6807	12	CD33	CD33	NNP
cord-005453-4057qib7	6807	13	+	+	CC
cord-005453-4057qib7	6807	14	,	,	,
cord-005453-4057qib7	6807	15	CD14+/-	CD14+/-	NNP
cord-005453-4057qib7	6807	16	,	,	,
cord-005453-4057qib7	6808	1	CD163+/-	CD163+/-	NNP
cord-005453-4057qib7	6808	2	,	,	,
cord-005453-4057qib7	6808	3	CD45	CD45	NNP
cord-005453-4057qib7	6808	4	/	/	SYM
cord-005453-4057qib7	6808	5	LCA+/-	LCA+/-	NNP
cord-005453-4057qib7	6808	6	,	,	,
cord-005453-4057qib7	6808	7	CD21-	CD21-	NNP
cord-005453-4057qib7	6808	8	,	,	,
cord-005453-4057qib7	6808	9	CD23-	CD23-	NNP
cord-005453-4057qib7	6808	10	,	,	,
cord-005453-4057qib7	6808	11	CD35-	CD35-	NNP
cord-005453-4057qib7	6808	12	,	,	,
cord-005453-4057qib7	6808	13	CD207-	CD207-	NNP
cord-005453-4057qib7	6808	14	,	,	,
cord-005453-4057qib7	6808	15	and	and	CC
cord-005453-4057qib7	6808	16	S100-neoplastic	s100-neoplastic	JJ
cord-005453-4057qib7	6808	17	cells	cell	NNS
cord-005453-4057qib7	6808	18	whose	whose	WP$
cord-005453-4057qib7	6808	19	phenotype	phenotype	NN
cord-005453-4057qib7	6808	20	suggested	suggest	VBD
cord-005453-4057qib7	6808	21	a	a	DT
cord-005453-4057qib7	6808	22	granulocytic	granulocytic	JJ
cord-005453-4057qib7	6808	23	sarcoma	sarcoma	NN
cord-005453-4057qib7	6808	24	rather	rather	RB
cord-005453-4057qib7	6808	25	than	than	IN
cord-005453-4057qib7	6808	26	a	a	DT
cord-005453-4057qib7	6808	27	histiocytic	histiocytic	JJ
cord-005453-4057qib7	6808	28	sarcoma	sarcoma	NN
cord-005453-4057qib7	6808	29	.	.	.
cord-005453-4057qib7	6809	1	Immuno	immuno	JJ
cord-005453-4057qib7	6809	2	-	-	HYPH
cord-005453-4057qib7	6809	3	chemistry	chemistry	NN
cord-005453-4057qib7	6809	4	confirmed	confirm	VBD
cord-005453-4057qib7	6809	5	this	this	DT
cord-005453-4057qib7	6809	6	suggestion	suggestion	NN
cord-005453-4057qib7	6809	7	by	by	IN
cord-005453-4057qib7	6809	8	showing	show	VBG
cord-005453-4057qib7	6809	9	a	a	DT
cord-005453-4057qib7	6809	10	nuclear	nuclear	JJ
cord-005453-4057qib7	6809	11	NPM1	NPM1	NNP
cord-005453-4057qib7	6809	12	positivity	positivity	NN
cord-005453-4057qib7	6809	13	.	.	.
cord-005453-4057qib7	6810	1	FISH	FISH	NNP
cord-005453-4057qib7	6810	2	studies	study	NNS
cord-005453-4057qib7	6810	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	6810	4	that	that	IN
cord-005453-4057qib7	6810	5	these	these	DT
cord-005453-4057qib7	6810	6	neoplastic	neoplastic	JJ
cord-005453-4057qib7	6810	7	cells	cell	NNS
cord-005453-4057qib7	6810	8	were	be	VBD
cord-005453-4057qib7	6810	9	of	of	IN
cord-005453-4057qib7	6810	10	recipient	recipient	NN
cord-005453-4057qib7	6810	11	's	's	POS
cord-005453-4057qib7	6810	12	origin	origin	NN
cord-005453-4057qib7	6810	13	.	.	.
cord-005453-4057qib7	6811	1	A	a	DT
cord-005453-4057qib7	6811	2	novel	novel	JJ
cord-005453-4057qib7	6811	3	BM	BM	NNP
cord-005453-4057qib7	6811	4	aspiration	aspiration	NN
cord-005453-4057qib7	6811	5	showed	show	VBD
cord-005453-4057qib7	6811	6	CR	CR	NNP
cord-005453-4057qib7	6811	7	confirmed	confirm	VBN
cord-005453-4057qib7	6811	8	by	by	IN
cord-005453-4057qib7	6811	9	immune	immune	JJ
cord-005453-4057qib7	6811	10	-	-	HYPH
cord-005453-4057qib7	6811	11	phenotypic	phenotypic	JJ
cord-005453-4057qib7	6811	12	studies	study	NNS
cord-005453-4057qib7	6811	13	and	and	CC
cord-005453-4057qib7	6811	14	FISH	FISH	NNP
cord-005453-4057qib7	6811	15	revealed	reveal	VBD
cord-005453-4057qib7	6811	16	a	a	DT
cord-005453-4057qib7	6811	17	complete	complete	JJ
cord-005453-4057qib7	6811	18	chimera	chimera	NN
cord-005453-4057qib7	6811	19	.	.	.
cord-005453-4057qib7	6812	1	Since	since	IN
cord-005453-4057qib7	6812	2	the	the	DT
cord-005453-4057qib7	6812	3	patient	patient	NN
cord-005453-4057qib7	6812	4	was	be	VBD
cord-005453-4057qib7	6812	5	still	still	RB
cord-005453-4057qib7	6812	6	pancytopenic	pancytopenic	JJ
cord-005453-4057qib7	6812	7	due	due	JJ
cord-005453-4057qib7	6812	8	to	to	IN
cord-005453-4057qib7	6812	9	anti	anti	JJ
cord-005453-4057qib7	6812	10	-	-	JJ
cord-005453-4057qib7	6812	11	CMV	CMV	NNP
cord-005453-4057qib7	6812	12	treatment	treatment	NN
cord-005453-4057qib7	6812	13	,	,	,
cord-005453-4057qib7	6812	14	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	6812	15	with	with	IN
cord-005453-4057qib7	6812	16	18Gy	18gy	CD
cord-005453-4057qib7	6812	17	in	in	IN
cord-005453-4057qib7	6812	18	nine	nine	CD
cord-005453-4057qib7	6812	19	fractions	fraction	NNS
cord-005453-4057qib7	6812	20	were	be	VBD
cord-005453-4057qib7	6812	21	given	give	VBN
cord-005453-4057qib7	6812	22	and	and	CC
cord-005453-4057qib7	6812	23	the	the	DT
cord-005453-4057qib7	6812	24	lesion	lesion	NN
cord-005453-4057qib7	6812	25	completely	completely	RB
cord-005453-4057qib7	6812	26	resolved	resolve	VBD
cord-005453-4057qib7	6812	27	.	.	.
cord-005453-4057qib7	6813	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6813	2	:	:	:
cord-005453-4057qib7	6814	1	A	a	DT
cord-005453-4057qib7	6814	2	granulocytic	granulocytic	JJ
cord-005453-4057qib7	6814	3	sarcoma	sarcoma	NN
cord-005453-4057qib7	6814	4	of	of	IN
cord-005453-4057qib7	6814	5	recipient	recipient	NN
cord-005453-4057qib7	6814	6	's	's	POS
cord-005453-4057qib7	6814	7	origin	origin	NN
cord-005453-4057qib7	6814	8	occurring	occur	VBG
cord-005453-4057qib7	6814	9	three	three	CD
cord-005453-4057qib7	6814	10	months	month	NNS
cord-005453-4057qib7	6814	11	after	after	IN
cord-005453-4057qib7	6814	12	a	a	DT
cord-005453-4057qib7	6814	13	CB	CB	NNP
cord-005453-4057qib7	6814	14	transplant	transplant	NN
cord-005453-4057qib7	6814	15	is	be	VBZ
cord-005453-4057qib7	6814	16	a	a	DT
cord-005453-4057qib7	6814	17	very	very	RB
cord-005453-4057qib7	6814	18	rare	rare	JJ
cord-005453-4057qib7	6814	19	and	and	CC
cord-005453-4057qib7	6814	20	unusual	unusual	JJ
cord-005453-4057qib7	6814	21	event	event	NN
cord-005453-4057qib7	6814	22	.	.	.
cord-005453-4057qib7	6815	1	In	in	IN
cord-005453-4057qib7	6815	2	order	order	NN
cord-005453-4057qib7	6815	3	to	to	TO
cord-005453-4057qib7	6815	4	explain	explain	VB
cord-005453-4057qib7	6815	5	such	such	PDT
cord-005453-4057qib7	6815	6	a	a	DT
cord-005453-4057qib7	6815	7	complication	complication	NN
cord-005453-4057qib7	6815	8	we	-PRON-	PRP
cord-005453-4057qib7	6815	9	suggest	suggest	VBP
cord-005453-4057qib7	6815	10	that	that	IN
cord-005453-4057qib7	6815	11	granulocytic	granulocytic	JJ
cord-005453-4057qib7	6815	12	sarcoma	sarcoma	NN
cord-005453-4057qib7	6815	13	cells	cell	NNS
cord-005453-4057qib7	6815	14	were	be	VBD
cord-005453-4057qib7	6815	15	dormant	dormant	JJ
cord-005453-4057qib7	6815	16	but	but	CC
cord-005453-4057qib7	6815	17	already	already	RB
cord-005453-4057qib7	6815	18	present	present	JJ
cord-005453-4057qib7	6815	19	at	at	IN
cord-005453-4057qib7	6815	20	the	the	DT
cord-005453-4057qib7	6815	21	time	time	NN
cord-005453-4057qib7	6815	22	of	of	IN
cord-005453-4057qib7	6815	23	pro	pro	JJ
cord-005453-4057qib7	6815	24	-	-	JJ
cord-005453-4057qib7	6815	25	B	b	JJ
cord-005453-4057qib7	6815	26	ALL	all	DT
cord-005453-4057qib7	6815	27	diagnosis	diagnosis	NN
cord-005453-4057qib7	6815	28	and	and	CC
cord-005453-4057qib7	6815	29	survived	survive	VBD
cord-005453-4057qib7	6815	30	not	not	RB
cord-005453-4057qib7	6815	31	only	only	RB
cord-005453-4057qib7	6815	32	the	the	DT
cord-005453-4057qib7	6815	33	initial	initial	JJ
cord-005453-4057qib7	6815	34	ALL	all	DT
cord-005453-4057qib7	6815	35	treatment	treatment	NN
cord-005453-4057qib7	6815	36	but	but	CC
cord-005453-4057qib7	6815	37	also	also	RB
cord-005453-4057qib7	6815	38	the	the	DT
cord-005453-4057qib7	6815	39	CB	CB	NNP
cord-005453-4057qib7	6815	40	transplant	transplant	NN
cord-005453-4057qib7	6815	41	conditioning	conditioning	NN
cord-005453-4057qib7	6815	42	regimen	regimen	NN
cord-005453-4057qib7	6815	43	.	.	.
cord-005453-4057qib7	6816	1	We	-PRON-	PRP
cord-005453-4057qib7	6816	2	ca	can	MD
cord-005453-4057qib7	6816	3	n't	not	RB
cord-005453-4057qib7	6816	4	exclude	exclude	VB
cord-005453-4057qib7	6816	5	that	that	IN
cord-005453-4057qib7	6816	6	immune	immune	JJ
cord-005453-4057qib7	6816	7	-	-	HYPH
cord-005453-4057qib7	6816	8	suppressive	suppressive	JJ
cord-005453-4057qib7	6816	9	treatments	treatment	NNS
cord-005453-4057qib7	6816	10	given	give	VBN
cord-005453-4057qib7	6816	11	early	early	JJ
cord-005453-4057qib7	6816	12	post	post	JJ
cord-005453-4057qib7	6816	13	-	-	NN
cord-005453-4057qib7	6816	14	transplant	transplant	NN
cord-005453-4057qib7	6816	15	might	may	MD
cord-005453-4057qib7	6816	16	have	have	VB
cord-005453-4057qib7	6816	17	promoted	promote	VBN
cord-005453-4057qib7	6816	18	the	the	DT
cord-005453-4057qib7	6816	19	outgrowth	outgrowth	NN
cord-005453-4057qib7	6816	20	of	of	IN
cord-005453-4057qib7	6816	21	these	these	DT
cord-005453-4057qib7	6816	22	neoplastic	neoplastic	JJ
cord-005453-4057qib7	6816	23	cell	cell	NN
cord-005453-4057qib7	6816	24	population	population	NN
cord-005453-4057qib7	6816	25	.	.	.
cord-005453-4057qib7	6817	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6817	2	:	:	:
cord-005453-4057qib7	6817	3	Nothing	nothing	NN
cord-005453-4057qib7	6817	4	to	to	TO
cord-005453-4057qib7	6817	5	declare	declare	VB
cord-005453-4057qib7	6817	6	Haemoglobinopathy	Haemoglobinopathy	NNP
cord-005453-4057qib7	6817	7	and	and	CC
cord-005453-4057qib7	6817	8	inborn	inborn	JJ
cord-005453-4057qib7	6817	9	errors	error	NNS
cord-005453-4057qib7	6817	10	of	of	IN
cord-005453-4057qib7	6817	11	metabolism	metabolism	NN
cord-005453-4057qib7	6817	12	P311	P311	NNP
cord-005453-4057qib7	6817	13	Abstract	Abstract	NNP
cord-005453-4057qib7	6817	14	already	already	RB
cord-005453-4057qib7	6817	15	published	publish	VBN
cord-005453-4057qib7	6817	16	.	.	.
cord-005453-4057qib7	6818	1	Addition	addition	NN
cord-005453-4057qib7	6818	2	of	of	IN
cord-005453-4057qib7	6818	3	fludarabine	fludarabine	NN
cord-005453-4057qib7	6818	4	on	on	IN
cord-005453-4057qib7	6818	5	to	to	IN
cord-005453-4057qib7	6818	6	anti	anti	JJ
cord-005453-4057qib7	6818	7	-	-	JJ
cord-005453-4057qib7	6818	8	thymocyte	thymocyte	JJ
cord-005453-4057qib7	6818	9	globulin	globulin	NN
cord-005453-4057qib7	6818	10	,	,	,
cord-005453-4057qib7	6818	11	busulfan	busulfan	NN
cord-005453-4057qib7	6818	12	and	and	CC
cord-005453-4057qib7	6818	13	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	6818	14	conditioning	conditioning	NN
cord-005453-4057qib7	6818	15	improves	improve	VBZ
cord-005453-4057qib7	6818	16	outcomes	outcome	NNS
cord-005453-4057qib7	6818	17	in	in	IN
cord-005453-4057qib7	6818	18	low	low	JJ
cord-005453-4057qib7	6818	19	-	-	HYPH
cord-005453-4057qib7	6818	20	risk	risk	NN
cord-005453-4057qib7	6818	21	matched	match	VBN
cord-005453-4057qib7	6818	22	-	-	HYPH
cord-005453-4057qib7	6818	23	related	relate	VBN
cord-005453-4057qib7	6818	24	bone	bone	NN
cord-005453-4057qib7	6818	25	marrow	marrow	NN
cord-005453-4057qib7	6818	26	transplantation	transplantation	NN
cord-005453-4057qib7	6818	27	in	in	IN
cord-005453-4057qib7	6818	28	children	child	NNS
cord-005453-4057qib7	6818	29	with	with	IN
cord-005453-4057qib7	6818	30	severe	severe	JJ
cord-005453-4057qib7	6818	31	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	6818	32	Flu	Flu	NNP
cord-005453-4057qib7	6818	33	-	-	HYPH
cord-005453-4057qib7	6818	34	ATG	ATG	NNP
cord-005453-4057qib7	6818	35	-	-	HYPH
cord-005453-4057qib7	6818	36	BuCy	BuCy	NNP
cord-005453-4057qib7	6818	37	.	.	.
cord-005453-4057qib7	6819	1	ATG	ATG	NNP
cord-005453-4057qib7	6819	2	dose	dose	NN
cord-005453-4057qib7	6819	3	was	be	VBD
cord-005453-4057qib7	6819	4	4	4	CD
cord-005453-4057qib7	6819	5	mg	mg	NNP
cord-005453-4057qib7	6819	6	/	/	SYM
cord-005453-4057qib7	6819	7	kg	kg	NNS
cord-005453-4057qib7	6819	8	in	in	IN
cord-005453-4057qib7	6819	9	all	all	DT
cord-005453-4057qib7	6819	10	patients	patient	NNS
cord-005453-4057qib7	6819	11	except	except	IN
cord-005453-4057qib7	6819	12	patients	patient	NNS
cord-005453-4057qib7	6819	13	with	with	IN
cord-005453-4057qib7	6819	14	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	6819	15	>	>	XX
cord-005453-4057qib7	6819	16	3	3	CD
cord-005453-4057qib7	6819	17	cm	cm	NNS
cord-005453-4057qib7	6819	18	from	from	IN
cord-005453-4057qib7	6819	19	costal	costal	JJ
cord-005453-4057qib7	6819	20	margin	margin	NNP
cord-005453-4057qib7	6819	21	and/or	and/or	CC
cord-005453-4057qib7	6819	22	sex	sex	NN
cord-005453-4057qib7	6819	23	-	-	HYPH
cord-005453-4057qib7	6819	24	mismatched	mismatched	JJ
cord-005453-4057qib7	6819	25	/	/	SYM
cord-005453-4057qib7	6819	26	maternal	maternal	JJ
cord-005453-4057qib7	6819	27	donor	donor	NN
cord-005453-4057qib7	6819	28	in	in	IN
cord-005453-4057qib7	6819	29	whom	whom	WP
cord-005453-4057qib7	6819	30	ATG	ATG	NNP
cord-005453-4057qib7	6819	31	was	be	VBD
cord-005453-4057qib7	6819	32	increased	increase	VBN
cord-005453-4057qib7	6819	33	to	to	IN
cord-005453-4057qib7	6819	34	7	7	CD
cord-005453-4057qib7	6819	35	mg	mg	NNP
cord-005453-4057qib7	6819	36	/	/	SYM
cord-005453-4057qib7	6819	37	kg	kg	NNS
cord-005453-4057qib7	6819	38	.	.	.
cord-005453-4057qib7	6820	1	All	all	DT
cord-005453-4057qib7	6820	2	patients	patient	NNS
cord-005453-4057qib7	6820	3	were	be	VBD
cord-005453-4057qib7	6820	4	younger	young	JJR
cord-005453-4057qib7	6820	5	than	than	IN
cord-005453-4057qib7	6820	6	15	15	CD
cord-005453-4057qib7	6820	7	years	year	NNS
cord-005453-4057qib7	6820	8	and	and	CC
cord-005453-4057qib7	6820	9	had	have	VBD
cord-005453-4057qib7	6820	10	no	no	DT
cord-005453-4057qib7	6820	11	hepatomegaly	hepatomegaly	NNP
cord-005453-4057qib7	6820	12	(	(	-LRB-
cord-005453-4057qib7	6820	13	liver	liver	NNP
cord-005453-4057qib7	6820	14	≤	≤	NNP
cord-005453-4057qib7	6820	15	2	2	CD
cord-005453-4057qib7	6820	16	cm	cm	NNP
cord-005453-4057qib7	6820	17	from	from	IN
cord-005453-4057qib7	6820	18	costal	costal	JJ
cord-005453-4057qib7	6820	19	margin	margin	NNP
cord-005453-4057qib7	6820	20	)	)	-RRB-
cord-005453-4057qib7	6820	21	at	at	IN
cord-005453-4057qib7	6820	22	BMT	BMT	NNP
cord-005453-4057qib7	6820	23	.	.	.
cord-005453-4057qib7	6821	1	Results	result	NNS
cord-005453-4057qib7	6821	2	:	:	:
cord-005453-4057qib7	6822	1	Actuarial	actuarial	JJ
cord-005453-4057qib7	6822	2	overall	overall	JJ
cord-005453-4057qib7	6822	3	survival	survival	NN
cord-005453-4057qib7	6822	4	(	(	-LRB-
cord-005453-4057qib7	6822	5	OS	OS	NNP
cord-005453-4057qib7	6822	6	)	)	-RRB-
cord-005453-4057qib7	6822	7	in	in	IN
cord-005453-4057qib7	6822	8	the	the	DT
cord-005453-4057qib7	6822	9	ATG	ATG	NNP
cord-005453-4057qib7	6822	10	-	-	HYPH
cord-005453-4057qib7	6822	11	BuCy	BuCy	NNP
cord-005453-4057qib7	6822	12	and	and	CC
cord-005453-4057qib7	6822	13	Flu	Flu	NNP
cord-005453-4057qib7	6822	14	-	-	HYPH
cord-005453-4057qib7	6822	15	ATG	ATG	NNP
cord-005453-4057qib7	6822	16	-	-	HYPH
cord-005453-4057qib7	6822	17	BuCy	BuCy	NNP
cord-005453-4057qib7	6822	18	groups	group	NNS
cord-005453-4057qib7	6822	19	is	be	VBZ
cord-005453-4057qib7	6822	20	89	89	CD
cord-005453-4057qib7	6822	21	%	%	NN
cord-005453-4057qib7	6822	22	and	and	CC
cord-005453-4057qib7	6822	23	98	98	CD
cord-005453-4057qib7	6822	24	%	%	NN
cord-005453-4057qib7	6822	25	,	,	,
cord-005453-4057qib7	6822	26	thalassemia	thalassemia	NN
cord-005453-4057qib7	6822	27	-	-	HYPH
cord-005453-4057qib7	6822	28	free	free	JJ
cord-005453-4057qib7	6822	29	survival	survival	NN
cord-005453-4057qib7	6822	30	(	(	-LRB-
cord-005453-4057qib7	6822	31	TFS	TFS	NNP
cord-005453-4057qib7	6822	32	)	)	-RRB-
cord-005453-4057qib7	6822	33	75	75	CD
cord-005453-4057qib7	6822	34	%	%	NN
cord-005453-4057qib7	6822	35	and	and	CC
cord-005453-4057qib7	6822	36	93	93	CD
cord-005453-4057qib7	6822	37	%	%	NN
cord-005453-4057qib7	6822	38	,	,	,
cord-005453-4057qib7	6822	39	GVHDfree	GVHDfree	NNP
cord-005453-4057qib7	6822	40	and	and	CC
cord-005453-4057qib7	6822	41	Thalassaemia	Thalassaemia	NNP
cord-005453-4057qib7	6822	42	-	-	HYPH
cord-005453-4057qib7	6822	43	free	free	JJ
cord-005453-4057qib7	6822	44	survival	survival	NN
cord-005453-4057qib7	6822	45	(	(	-LRB-
cord-005453-4057qib7	6822	46	GTFS	GTFS	NNP
cord-005453-4057qib7	6822	47	)	)	-RRB-
cord-005453-4057qib7	6822	48	at	at	IN
cord-005453-4057qib7	6822	49	a	a	DT
cord-005453-4057qib7	6822	50	median	median	NN
cord-005453-4057qib7	6822	51	follow	follow	NN
cord-005453-4057qib7	6822	52	up	up	IN
cord-005453-4057qib7	6822	53	of	of	IN
cord-005453-4057qib7	6822	54	23.5	23.5	CD
cord-005453-4057qib7	6822	55	and	and	CC
cord-005453-4057qib7	6822	56	10.6	10.6	CD
cord-005453-4057qib7	6822	57	months	month	NNS
cord-005453-4057qib7	6822	58	was	be	VBD
cord-005453-4057qib7	6822	59	72.6	72.6	CD
cord-005453-4057qib7	6822	60	%	%	NN
cord-005453-4057qib7	6822	61	and	and	CC
cord-005453-4057qib7	6822	62	93.3	93.3	CD
cord-005453-4057qib7	6822	63	%	%	NN
cord-005453-4057qib7	6822	64	months	month	NNS
cord-005453-4057qib7	6822	65	respectively	respectively	RB
cord-005453-4057qib7	6822	66	,	,	,
cord-005453-4057qib7	6822	67	which	which	WDT
cord-005453-4057qib7	6822	68	is	be	VBZ
cord-005453-4057qib7	6822	69	a	a	DT
cord-005453-4057qib7	6822	70	significantly	significantly	RB
cord-005453-4057qib7	6822	71	improved	improve	VBN
cord-005453-4057qib7	6822	72	outcome	outcome	NN
cord-005453-4057qib7	6822	73	by	by	IN
cord-005453-4057qib7	6822	74	log	log	NN
cord-005453-4057qib7	6822	75	-	-	HYPH
cord-005453-4057qib7	6822	76	rank	rank	NN
cord-005453-4057qib7	6822	77	statistics	statistic	NNS
cord-005453-4057qib7	6822	78	(	(	-LRB-
cord-005453-4057qib7	6822	79	p=0.002	p=0.002	NNP
cord-005453-4057qib7	6822	80	)	)	-RRB-
cord-005453-4057qib7	6823	1	in	in	IN
cord-005453-4057qib7	6823	2	the	the	DT
cord-005453-4057qib7	6823	3	Flu	Flu	NNP
cord-005453-4057qib7	6823	4	-	-	HYPH
cord-005453-4057qib7	6823	5	ATG	ATG	NNP
cord-005453-4057qib7	6823	6	-	-	HYPH
cord-005453-4057qib7	6823	7	BuCy	BuCy	NNP
cord-005453-4057qib7	6823	8	group	group	NN
cord-005453-4057qib7	6823	9	.	.	.
cord-005453-4057qib7	6824	1	There	there	EX
cord-005453-4057qib7	6824	2	was	be	VBD
cord-005453-4057qib7	6824	3	no	no	DT
cord-005453-4057qib7	6824	4	significant	significant	JJ
cord-005453-4057qib7	6824	5	difference	difference	NN
cord-005453-4057qib7	6824	6	between	between	IN
cord-005453-4057qib7	6824	7	the	the	DT
cord-005453-4057qib7	6824	8	groups	group	NNS
cord-005453-4057qib7	6824	9	in	in	IN
cord-005453-4057qib7	6824	10	pre	pre	JJ
cord-005453-4057qib7	6824	11	-	-	JJ
cord-005453-4057qib7	6824	12	transplant	transplant	JJ
cord-005453-4057qib7	6824	13	characteristics	characteristic	NNS
cord-005453-4057qib7	6824	14	and	and	CC
cord-005453-4057qib7	6824	15	posttransplant	posttransplant	NN
cord-005453-4057qib7	6824	16	complications	complication	NNS
cord-005453-4057qib7	6824	17	except	except	IN
cord-005453-4057qib7	6824	18	for	for	IN
cord-005453-4057qib7	6824	19	the	the	DT
cord-005453-4057qib7	6824	20	following	follow	VBG
cord-005453-4057qib7	6824	21	:	:	:
cord-005453-4057qib7	6824	22	Median	median	JJ
cord-005453-4057qib7	6824	23	cell	cell	NN
cord-005453-4057qib7	6824	24	dose	dose	NN
cord-005453-4057qib7	6824	25	more	more	JJR
cord-005453-4057qib7	6824	26	in	in	IN
cord-005453-4057qib7	6824	27	2	2	CD
cord-005453-4057qib7	6824	28	nd	nd	NNP
cord-005453-4057qib7	6824	29	group	group	NN
cord-005453-4057qib7	6824	30	with	with	IN
cord-005453-4057qib7	6824	31	total	total	JJ
cord-005453-4057qib7	6824	32	nucleated	nucleated	JJ
cord-005453-4057qib7	6824	33	cell	cell	NN
cord-005453-4057qib7	6824	34	dose	dose	NN
cord-005453-4057qib7	6824	35	of	of	IN
cord-005453-4057qib7	6824	36	8.7	8.7	CD
cord-005453-4057qib7	6824	37	vs	vs	IN
cord-005453-4057qib7	6824	38	6.4	6.4	CD
cord-005453-4057qib7	6824	39	x	x	SYM
cord-005453-4057qib7	6824	40	10	10	CD
cord-005453-4057qib7	6824	41	8	8	CD
cord-005453-4057qib7	6824	42	cell	cell	NN
cord-005453-4057qib7	6824	43	/	/	SYM
cord-005453-4057qib7	6824	44	kg	kg	NN
cord-005453-4057qib7	6824	45	with	with	IN
cord-005453-4057qib7	6824	46	p	p	NN
cord-005453-4057qib7	6824	47	<	<	XX
cord-005453-4057qib7	6824	48	0.0001	0.0001	CD
cord-005453-4057qib7	6824	49	;	;	:
cord-005453-4057qib7	6824	50	CSA	CSA	NNP
cord-005453-4057qib7	6824	51	taper	taper	NN
cord-005453-4057qib7	6824	52	started	start	VBD
cord-005453-4057qib7	6824	53	later	later	RB
cord-005453-4057qib7	6824	54	in	in	IN
cord-005453-4057qib7	6824	55	the	the	DT
cord-005453-4057qib7	6824	56	new	new	JJ
cord-005453-4057qib7	6824	57	protocol	protocol	NN
cord-005453-4057qib7	6824	58	(	(	-LRB-
cord-005453-4057qib7	6824	59	184	184	CD
cord-005453-4057qib7	6824	60	day	day	NN
cord-005453-4057qib7	6824	61	vs.	vs.	IN
cord-005453-4057qib7	6824	62	152	152	CD
cord-005453-4057qib7	6824	63	p=0.0005	p=0.0005	NNS
cord-005453-4057qib7	6824	64	)	)	-RRB-
cord-005453-4057qib7	6824	65	;	;	:
cord-005453-4057qib7	6824	66	Median	median	JJ
cord-005453-4057qib7	6824	67	age	age	NN
cord-005453-4057qib7	6824	68	at	at	IN
cord-005453-4057qib7	6824	69	BMT	BMT	NNP
cord-005453-4057qib7	6824	70	(	(	-LRB-
cord-005453-4057qib7	6824	71	7.2	7.2	CD
cord-005453-4057qib7	6824	72	vs.	vs.	IN
cord-005453-4057qib7	6824	73	4.6	4.6	CD
cord-005453-4057qib7	6824	74	years	year	NNS
cord-005453-4057qib7	6824	75	,	,	,
cord-005453-4057qib7	6824	76	p=0.001	p=0.001	NNP
cord-005453-4057qib7	6824	77	)	)	-RRB-
cord-005453-4057qib7	6824	78	;	;	:
cord-005453-4057qib7	6825	1	Number	number	NN
cord-005453-4057qib7	6825	2	of	of	IN
cord-005453-4057qib7	6825	3	Pre	Pre	NNP
cord-005453-4057qib7	6825	4	-	-	JJ
cord-005453-4057qib7	6825	5	BMT	BMT	NNP
cord-005453-4057qib7	6825	6	transfusions	transfusion	NNS
cord-005453-4057qib7	6825	7	(	(	-LRB-
cord-005453-4057qib7	6825	8	p=0.01	p=0.01	NNP
cord-005453-4057qib7	6825	9	)	)	-RRB-
cord-005453-4057qib7	6825	10	and	and	CC
cord-005453-4057qib7	6825	11	Ferritin	ferritin	NN
cord-005453-4057qib7	6825	12	at	at	IN
cord-005453-4057qib7	6825	13	BMT	BMT	NNP
cord-005453-4057qib7	6825	14	(	(	-LRB-
cord-005453-4057qib7	6825	15	2.214	2.214	CD
cord-005453-4057qib7	6825	16	vs.	vs.	NN
cord-005453-4057qib7	6825	17	1.599	1.599	CD
cord-005453-4057qib7	6825	18	ng	ng	NNP
cord-005453-4057qib7	6825	19	/	/	SYM
cord-005453-4057qib7	6825	20	mL	mL	NNP
cord-005453-4057qib7	6825	21	,	,	,
cord-005453-4057qib7	6825	22	p=0.002	p=0.002	NNP
cord-005453-4057qib7	6825	23	)	)	-RRB-
cord-005453-4057qib7	6825	24	were	be	VBD
cord-005453-4057qib7	6825	25	higher	high	JJR
cord-005453-4057qib7	6825	26	in	in	IN
cord-005453-4057qib7	6825	27	the	the	DT
cord-005453-4057qib7	6825	28	second	second	JJ
cord-005453-4057qib7	6825	29	group	group	NN
cord-005453-4057qib7	6825	30	;	;	:
cord-005453-4057qib7	6825	31	Day	day	NN
cord-005453-4057qib7	6825	32	30	30	CD
cord-005453-4057qib7	6825	33	and	and	CC
cord-005453-4057qib7	6825	34	60	60	CD
cord-005453-4057qib7	6825	35	chimerisms	chimerism	NNS
cord-005453-4057qib7	6825	36	were	be	VBD
cord-005453-4057qib7	6825	37	also	also	RB
cord-005453-4057qib7	6825	38	significantly	significantly	RB
cord-005453-4057qib7	6825	39	higher	high	JJR
cord-005453-4057qib7	6825	40	in	in	IN
cord-005453-4057qib7	6825	41	new	new	JJ
cord-005453-4057qib7	6825	42	protocol	protocol	NN
cord-005453-4057qib7	6825	43	(	(	-LRB-
cord-005453-4057qib7	6825	44	p=0.02	p=0.02	NN
cord-005453-4057qib7	6825	45	and	and	CC
cord-005453-4057qib7	6825	46	0.03	0.03	CD
cord-005453-4057qib7	6825	47	respectively	respectively	RB
cord-005453-4057qib7	6825	48	)	)	-RRB-
cord-005453-4057qib7	6825	49	.	.	.
cord-005453-4057qib7	6826	1	There	there	EX
cord-005453-4057qib7	6826	2	was	be	VBD
cord-005453-4057qib7	6826	3	a	a	DT
cord-005453-4057qib7	6826	4	trend	trend	NN
cord-005453-4057qib7	6826	5	towards	towards	IN
cord-005453-4057qib7	6826	6	increased	increase	VBN
cord-005453-4057qib7	6826	7	incidence	incidence	NN
cord-005453-4057qib7	6826	8	of	of	IN
cord-005453-4057qib7	6826	9	Veno	Veno	NNP
cord-005453-4057qib7	6826	10	-	-	HYPH
cord-005453-4057qib7	6826	11	Occulsive	Occulsive	NNP
cord-005453-4057qib7	6826	12	Disease	Disease	NNP
cord-005453-4057qib7	6826	13	(	(	-LRB-
cord-005453-4057qib7	6826	14	VOD	VOD	NNP
cord-005453-4057qib7	6826	15	)	)	-RRB-
cord-005453-4057qib7	6826	16	and	and	CC
cord-005453-4057qib7	6826	17	Posterior	Posterior	NNP
cord-005453-4057qib7	6826	18	Reversible	Reversible	NNP
cord-005453-4057qib7	6826	19	Encephalopathy	Encephalopathy	NNP
cord-005453-4057qib7	6826	20	Syndrome	Syndrome	NNP
cord-005453-4057qib7	6826	21	(	(	-LRB-
cord-005453-4057qib7	6826	22	PRES	PRES	NNP
cord-005453-4057qib7	6826	23	)	)	-RRB-
cord-005453-4057qib7	6826	24	on	on	IN
cord-005453-4057qib7	6826	25	the	the	DT
cord-005453-4057qib7	6826	26	second	second	JJ
cord-005453-4057qib7	6826	27	group	group	NN
cord-005453-4057qib7	6827	1	but	but	CC
cord-005453-4057qib7	6827	2	this	this	DT
cord-005453-4057qib7	6827	3	difference	difference	NN
cord-005453-4057qib7	6827	4	did	do	VBD
cord-005453-4057qib7	6827	5	not	not	RB
cord-005453-4057qib7	6827	6	reach	reach	VB
cord-005453-4057qib7	6827	7	statistical	statistical	JJ
cord-005453-4057qib7	6827	8	significance	significance	NN
cord-005453-4057qib7	6827	9	.	.	.
cord-005453-4057qib7	6828	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6828	2	:	:	:
cord-005453-4057qib7	6829	1	Adding	add	VBG
cord-005453-4057qib7	6829	2	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	6829	3	and	and	CC
cord-005453-4057qib7	6829	4	targeted	target	VBN
cord-005453-4057qib7	6829	5	dose	dose	JJ
cord-005453-4057qib7	6829	6	increase	increase	NN
cord-005453-4057qib7	6829	7	of	of	IN
cord-005453-4057qib7	6829	8	ATG	ATG	NNP
cord-005453-4057qib7	6829	9	in	in	IN
cord-005453-4057qib7	6829	10	the	the	DT
cord-005453-4057qib7	6829	11	standard	standard	JJ
cord-005453-4057qib7	6829	12	BuCy	BuCy	NNP
cord-005453-4057qib7	6829	13	context	context	NN
cord-005453-4057qib7	6829	14	seems	seem	VBZ
cord-005453-4057qib7	6829	15	to	to	TO
cord-005453-4057qib7	6829	16	significantly	significantly	RB
cord-005453-4057qib7	6829	17	improve	improve	VB
cord-005453-4057qib7	6829	18	outcomes	outcome	NNS
cord-005453-4057qib7	6829	19	of	of	IN
cord-005453-4057qib7	6829	20	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	6829	21	transplants	transplant	NNS
cord-005453-4057qib7	6829	22	without	without	IN
cord-005453-4057qib7	6829	23	contributing	contribute	VBG
cord-005453-4057qib7	6829	24	to	to	IN
cord-005453-4057qib7	6829	25	excessive	excessive	JJ
cord-005453-4057qib7	6829	26	GVHD	GVHD	NNP
cord-005453-4057qib7	6829	27	or	or	CC
cord-005453-4057qib7	6829	28	infectious	infectious	JJ
cord-005453-4057qib7	6829	29	complications	complication	NNS
cord-005453-4057qib7	6829	30	.	.	.
cord-005453-4057qib7	6830	1	This	this	DT
cord-005453-4057qib7	6830	2	protocol	protocol	NN
cord-005453-4057qib7	6830	3	can	can	MD
cord-005453-4057qib7	6830	4	be	be	VB
cord-005453-4057qib7	6830	5	easily	easily	RB
cord-005453-4057qib7	6830	6	administered	administer	VBN
cord-005453-4057qib7	6830	7	in	in	IN
cord-005453-4057qib7	6830	8	low	low	JJ
cord-005453-4057qib7	6830	9	resource	resource	NN
cord-005453-4057qib7	6830	10	setting	set	VBG
cord-005453-4057qib7	6830	11	without	without	IN
cord-005453-4057qib7	6830	12	major	major	JJ
cord-005453-4057qib7	6830	13	additional	additional	JJ
cord-005453-4057qib7	6830	14	costs	cost	NNS
cord-005453-4057qib7	6830	15	.	.	.
cord-005453-4057qib7	6831	1	Clinical	clinical	JJ
cord-005453-4057qib7	6831	2	is	be	VBZ
cord-005453-4057qib7	6831	3	an	an	DT
cord-005453-4057qib7	6831	4	acquired	acquire	VBN
cord-005453-4057qib7	6831	5	clonal	clonal	JJ
cord-005453-4057qib7	6831	6	disorder	disorder	NN
cord-005453-4057qib7	6831	7	of	of	IN
cord-005453-4057qib7	6831	8	the	the	DT
cord-005453-4057qib7	6831	9	hemopoietic	hemopoietic	JJ
cord-005453-4057qib7	6831	10	stem	stem	NN
cord-005453-4057qib7	6831	11	cells	cell	NNS
cord-005453-4057qib7	6831	12	for	for	IN
cord-005453-4057qib7	6831	13	which	which	WDT
cord-005453-4057qib7	6831	14	the	the	DT
cord-005453-4057qib7	6831	15	only	only	JJ
cord-005453-4057qib7	6831	16	curative	curative	JJ
cord-005453-4057qib7	6831	17	treatment	treatment	NN
cord-005453-4057qib7	6831	18	is	be	VBZ
cord-005453-4057qib7	6831	19	allogeneic	allogeneic	VBG
cord-005453-4057qib7	6831	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6831	21	stem	stem	NN
cord-005453-4057qib7	6831	22	cell	cell	NN
cord-005453-4057qib7	6831	23	transplantation	transplantation	NN
cord-005453-4057qib7	6831	24	.	.	.
cord-005453-4057qib7	6832	1	However	however	RB
cord-005453-4057qib7	6832	2	,	,	,
cord-005453-4057qib7	6832	3	there	there	EX
cord-005453-4057qib7	6832	4	are	be	VBP
cord-005453-4057qib7	6832	5	still	still	RB
cord-005453-4057qib7	6832	6	few	few	JJ
cord-005453-4057qib7	6832	7	reports	report	NNS
cord-005453-4057qib7	6832	8	on	on	IN
cord-005453-4057qib7	6832	9	the	the	DT
cord-005453-4057qib7	6832	10	outcomes	outcome	NNS
cord-005453-4057qib7	6832	11	of	of	IN
cord-005453-4057qib7	6832	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	6832	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6832	14	stem	stem	NN
cord-005453-4057qib7	6832	15	cell	cell	NN
cord-005453-4057qib7	6832	16	transplantation	transplantation	NN
cord-005453-4057qib7	6832	17	(	(	-LRB-
cord-005453-4057qib7	6832	18	allo	allo	NN
cord-005453-4057qib7	6832	19	-	-	HYPH
cord-005453-4057qib7	6832	20	HSCT	HSCT	NNP
cord-005453-4057qib7	6832	21	)	)	-RRB-
cord-005453-4057qib7	6832	22	in	in	IN
cord-005453-4057qib7	6832	23	patients	patient	NNS
cord-005453-4057qib7	6832	24	with	with	IN
cord-005453-4057qib7	6832	25	PNH	PNH	NNP
cord-005453-4057qib7	6832	26	compared	compare	VBN
cord-005453-4057qib7	6832	27	to	to	IN
cord-005453-4057qib7	6832	28	paroxysmal	paroxysmal	JJ
cord-005453-4057qib7	6832	29	nocturnal	nocturnal	JJ
cord-005453-4057qib7	6832	30	hemoglobinuria	hemoglobinuria	NN
cord-005453-4057qib7	6832	31	-	-	HYPH
cord-005453-4057qib7	6832	32	aplastic	aplastic	JJ
cord-005453-4057qib7	6832	33	anemia	anemia	NN
cord-005453-4057qib7	6832	34	(	(	-LRB-
cord-005453-4057qib7	6832	35	PNH	PNH	NNP
cord-005453-4057qib7	6832	36	-	-	HYPH
cord-005453-4057qib7	6832	37	AA	AA	NNP
cord-005453-4057qib7	6832	38	)	)	-RRB-
cord-005453-4057qib7	6832	39	syndrome	syndrome	NN
cord-005453-4057qib7	6832	40	.	.	.
cord-005453-4057qib7	6833	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6833	2	study	study	NN
cord-005453-4057qib7	6833	3	aimed	aim	VBD
cord-005453-4057qib7	6833	4	to	to	TO
cord-005453-4057qib7	6833	5	compare	compare	VB
cord-005453-4057qib7	6833	6	the	the	DT
cord-005453-4057qib7	6833	7	outcomes	outcome	NNS
cord-005453-4057qib7	6833	8	of	of	IN
cord-005453-4057qib7	6833	9	allo	allo	NN
cord-005453-4057qib7	6833	10	-	-	HYPH
cord-005453-4057qib7	6833	11	HSCT	HSCT	NNP
cord-005453-4057qib7	6833	12	for	for	IN
cord-005453-4057qib7	6833	13	PNH	PNH	NNP
cord-005453-4057qib7	6833	14	with	with	IN
cord-005453-4057qib7	6833	15	PNH	PNH	NNP
cord-005453-4057qib7	6833	16	-	-	HYPH
cord-005453-4057qib7	6833	17	AA	AA	NNP
cord-005453-4057qib7	6833	18	syndrome	syndrome	NN
cord-005453-4057qib7	6833	19	.	.	.
cord-005453-4057qib7	6834	1	Methods	method	NNS
cord-005453-4057qib7	6834	2	:	:	:
cord-005453-4057qib7	6835	1	The	the	DT
cord-005453-4057qib7	6835	2	clinical	clinical	JJ
cord-005453-4057qib7	6835	3	data	datum	NNS
cord-005453-4057qib7	6835	4	of	of	IN
cord-005453-4057qib7	6835	5	46	46	CD
cord-005453-4057qib7	6835	6	PNH	PNH	NNP
cord-005453-4057qib7	6835	7	patients	patient	NNS
cord-005453-4057qib7	6835	8	received	receive	VBD
cord-005453-4057qib7	6835	9	allo	allo	NN
cord-005453-4057qib7	6835	10	-	-	HYPH
cord-005453-4057qib7	6835	11	HSCT	HSCT	NNP
cord-005453-4057qib7	6835	12	(	(	-LRB-
cord-005453-4057qib7	6835	13	PNH	PNH	NNP
cord-005453-4057qib7	6835	14	=	=	SYM
cord-005453-4057qib7	6835	15	16	16	CD
cord-005453-4057qib7	6835	16	,	,	,
cord-005453-4057qib7	6835	17	PNH	PNH	NNP
cord-005453-4057qib7	6835	18	-	-	HYPH
cord-005453-4057qib7	6835	19	AA	AA	NNP
cord-005453-4057qib7	6835	20	=	=	SYM
cord-005453-4057qib7	6835	21	30	30	CD
cord-005453-4057qib7	6835	22	)	)	-RRB-
cord-005453-4057qib7	6835	23	in	in	IN
cord-005453-4057qib7	6835	24	our	-PRON-	PRP$
cord-005453-4057qib7	6835	25	center	center	NN
cord-005453-4057qib7	6835	26	from	from	IN
cord-005453-4057qib7	6835	27	July	July	NNP
cord-005453-4057qib7	6835	28	2007	2007	CD
cord-005453-4057qib7	6835	29	to	to	IN
cord-005453-4057qib7	6835	30	June	June	NNP
cord-005453-4057qib7	6835	31	2018	2018	CD
cord-005453-4057qib7	6835	32	were	be	VBD
cord-005453-4057qib7	6835	33	analyzed	analyze	VBN
cord-005453-4057qib7	6835	34	retrospectively	retrospectively	RB
cord-005453-4057qib7	6835	35	to	to	TO
cord-005453-4057qib7	6835	36	compare	compare	VB
cord-005453-4057qib7	6835	37	the	the	DT
cord-005453-4057qib7	6835	38	outcomes	outcome	NNS
cord-005453-4057qib7	6835	39	of	of	IN
cord-005453-4057qib7	6835	40	PNH	PNH	NNP
cord-005453-4057qib7	6835	41	group	group	NN
cord-005453-4057qib7	6835	42	with	with	IN
cord-005453-4057qib7	6835	43	PNH	PNH	NNP
cord-005453-4057qib7	6835	44	-	-	HYPH
cord-005453-4057qib7	6835	45	AA	AA	NNP
cord-005453-4057qib7	6835	46	group	group	NN
cord-005453-4057qib7	6835	47	.	.	.
cord-005453-4057qib7	6836	1	The	the	DT
cord-005453-4057qib7	6836	2	clinical	clinical	JJ
cord-005453-4057qib7	6836	3	data	datum	NNS
cord-005453-4057qib7	6836	4	including	include	VBG
cord-005453-4057qib7	6836	5	28	28	CD
cord-005453-4057qib7	6836	6	male	male	JJ
cord-005453-4057qib7	6836	7	patients	patient	NNS
cord-005453-4057qib7	6836	8	and	and	CC
cord-005453-4057qib7	6836	9	18	18	CD
cord-005453-4057qib7	6836	10	female	female	JJ
cord-005453-4057qib7	6836	11	patients	patient	NNS
cord-005453-4057qib7	6836	12	,	,	,
cord-005453-4057qib7	6836	13	the	the	DT
cord-005453-4057qib7	6836	14	median	median	JJ
cord-005453-4057qib7	6836	15	age	age	NN
cord-005453-4057qib7	6836	16	was	be	VBD
cord-005453-4057qib7	6836	17	29	29	CD
cord-005453-4057qib7	6836	18	years	year	NNS
cord-005453-4057qib7	6837	1	(	(	-LRB-
cord-005453-4057qib7	6837	2	range	range	NNP
cord-005453-4057qib7	6837	3	6	6	CD
cord-005453-4057qib7	6837	4	-	-	SYM
cord-005453-4057qib7	6837	5	54	54	CD
cord-005453-4057qib7	6837	6	)	)	-RRB-
cord-005453-4057qib7	6837	7	.	.	.
cord-005453-4057qib7	6838	1	All	all	DT
cord-005453-4057qib7	6838	2	patients	patient	NNS
cord-005453-4057qib7	6838	3	had	have	VBD
cord-005453-4057qib7	6838	4	received	receive	VBN
cord-005453-4057qib7	6838	5	various	various	JJ
cord-005453-4057qib7	6838	6	treatments	treatment	NNS
cord-005453-4057qib7	6838	7	before	before	IN
cord-005453-4057qib7	6838	8	transplantation	transplantation	NN
cord-005453-4057qib7	6838	9	such	such	JJ
cord-005453-4057qib7	6838	10	as	as	IN
cord-005453-4057qib7	6838	11	steroids	steroid	NNS
cord-005453-4057qib7	6838	12	,	,	,
cord-005453-4057qib7	6838	13	androgens	androgen	NNS
cord-005453-4057qib7	6838	14	,	,	,
cord-005453-4057qib7	6838	15	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	6838	16	(	(	-LRB-
cord-005453-4057qib7	6838	17	CsA	CsA	NNP
cord-005453-4057qib7	6838	18	)	)	-RRB-
cord-005453-4057qib7	6838	19	,	,	,
cord-005453-4057qib7	6838	20	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	6838	21	globulin	globulin	NN
cord-005453-4057qib7	6838	22	,	,	,
cord-005453-4057qib7	6838	23	and	and	CC
cord-005453-4057qib7	6838	24	growth	growth	NN
cord-005453-4057qib7	6838	25	factors	factor	NNS
cord-005453-4057qib7	6838	26	.	.	.
cord-005453-4057qib7	6839	1	The	the	DT
cord-005453-4057qib7	6839	2	median	median	JJ
cord-005453-4057qib7	6839	3	interval	interval	NN
cord-005453-4057qib7	6839	4	from	from	IN
cord-005453-4057qib7	6839	5	PNH	PNH	NNP
cord-005453-4057qib7	6839	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	6839	7	to	to	IN
cord-005453-4057qib7	6839	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6839	9	was	be	VBD
cord-005453-4057qib7	6839	10	6	6	CD
cord-005453-4057qib7	6839	11	months	month	NNS
cord-005453-4057qib7	6840	1	(	(	-LRB-
cord-005453-4057qib7	6840	2	range	range	NNP
cord-005453-4057qib7	6840	3	3	3	CD
cord-005453-4057qib7	6840	4	-	-	SYM
cord-005453-4057qib7	6840	5	240	240	CD
cord-005453-4057qib7	6840	6	)	)	-RRB-
cord-005453-4057qib7	6840	7	.	.	.
cord-005453-4057qib7	6841	1	The	the	DT
cord-005453-4057qib7	6841	2	conditioning	conditioning	NN
cord-005453-4057qib7	6841	3	regimen	regimen	NN
cord-005453-4057qib7	6841	4	was	be	VBD
cord-005453-4057qib7	6841	5	modified	modify	VBN
cord-005453-4057qib7	6841	6	BU	BU	NNP
cord-005453-4057qib7	6841	7	/	/	SYM
cord-005453-4057qib7	6841	8	CYbased	cybase	VBN
cord-005453-4057qib7	6841	9	regimen	regimen	NN
cord-005453-4057qib7	6841	10	in	in	IN
cord-005453-4057qib7	6841	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6841	12	donors	donor	NNS
cord-005453-4057qib7	6841	13	and	and	CC
cord-005453-4057qib7	6841	14	unrelated	unrelated	JJ
cord-005453-4057qib7	6841	15	donors	donor	NNS
cord-005453-4057qib7	6841	16	,	,	,
cord-005453-4057qib7	6841	17	CsA	CsA	NNP
cord-005453-4057qib7	6841	18	,	,	,
cord-005453-4057qib7	6841	19	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	6841	20	mofetil	mofetil	NNP
cord-005453-4057qib7	6841	21	(	(	-LRB-
cord-005453-4057qib7	6841	22	MMF	MMF	NNP
cord-005453-4057qib7	6841	23	)	)	-RRB-
cord-005453-4057qib7	6841	24	and	and	CC
cord-005453-4057qib7	6841	25	shortterm	shortterm	JJ
cord-005453-4057qib7	6841	26	methotrexate	methotrexate	NNP
cord-005453-4057qib7	6841	27	(	(	-LRB-
cord-005453-4057qib7	6841	28	MTX	MTX	NNP
cord-005453-4057qib7	6841	29	)	)	-RRB-
cord-005453-4057qib7	6841	30	were	be	VBD
cord-005453-4057qib7	6841	31	administered	administer	VBN
cord-005453-4057qib7	6841	32	for	for	IN
cord-005453-4057qib7	6841	33	graftversus	graftversus	NNP
cord-005453-4057qib7	6841	34	host	host	NN
cord-005453-4057qib7	6841	35	disease	disease	NN
cord-005453-4057qib7	6841	36	(	(	-LRB-
cord-005453-4057qib7	6841	37	GVHD	GVHD	NNP
cord-005453-4057qib7	6841	38	)	)	-RRB-
cord-005453-4057qib7	6841	39	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6841	40	.	.	.
cord-005453-4057qib7	6842	1	Patients	patient	NNS
cord-005453-4057qib7	6842	2	with	with	IN
cord-005453-4057qib7	6842	3	matched	match	VBN
cord-005453-4057qib7	6842	4	sibling	sibling	NN
cord-005453-4057qib7	6842	5	donors	donor	NNS
cord-005453-4057qib7	6842	6	were	be	VBD
cord-005453-4057qib7	6842	7	treated	treat	VBN
cord-005453-4057qib7	6842	8	with	with	IN
cord-005453-4057qib7	6842	9	the	the	DT
cord-005453-4057qib7	6842	10	FLU	FLU	NNP
cord-005453-4057qib7	6842	11	/	/	SYM
cord-005453-4057qib7	6842	12	CYbased	cybase	VBN
cord-005453-4057qib7	6842	13	regimen	regimen	NN
cord-005453-4057qib7	6842	14	and	and	CC
cord-005453-4057qib7	6842	15	CsA	CsA	NNP
cord-005453-4057qib7	6842	16	were	be	VBD
cord-005453-4057qib7	6842	17	administered	administer	VBN
cord-005453-4057qib7	6842	18	for	for	IN
cord-005453-4057qib7	6842	19	GVHD	GVHD	NNP
cord-005453-4057qib7	6842	20	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6842	21	.	.	.
cord-005453-4057qib7	6843	1	Results	result	NNS
cord-005453-4057qib7	6843	2	:	:	:
cord-005453-4057qib7	6844	1	There	there	EX
cord-005453-4057qib7	6844	2	were	be	VBD
cord-005453-4057qib7	6844	3	no	no	DT
cord-005453-4057qib7	6844	4	differences	difference	NNS
cord-005453-4057qib7	6844	5	of	of	IN
cord-005453-4057qib7	6844	6	baseline	baseline	NN
cord-005453-4057qib7	6844	7	between	between	IN
cord-005453-4057qib7	6844	8	the	the	DT
cord-005453-4057qib7	6844	9	2	2	CD
cord-005453-4057qib7	6844	10	groups	group	NNS
cord-005453-4057qib7	6844	11	(	(	-LRB-
cord-005453-4057qib7	6844	12	P>0.05	P>0.05	NNP
cord-005453-4057qib7	6844	13	)	)	-RRB-
cord-005453-4057qib7	6844	14	except	except	IN
cord-005453-4057qib7	6844	15	gender	gender	NN
cord-005453-4057qib7	6844	16	and	and	CC
cord-005453-4057qib7	6844	17	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6844	18	donors	donor	NNS
cord-005453-4057qib7	6844	19	.	.	.
cord-005453-4057qib7	6845	1	The	the	DT
cord-005453-4057qib7	6845	2	median	median	JJ
cord-005453-4057qib7	6845	3	values	value	NNS
cord-005453-4057qib7	6845	4	of	of	IN
cord-005453-4057qib7	6845	5	absolute	absolute	JJ
cord-005453-4057qib7	6845	6	nucleated	nucleated	JJ
cord-005453-4057qib7	6845	7	cell	cell	NN
cord-005453-4057qib7	6845	8	counts	count	NNS
cord-005453-4057qib7	6845	9	were	be	VBD
cord-005453-4057qib7	6845	10	10.58	10.58	CD
cord-005453-4057qib7	6845	11	(	(	-LRB-
cord-005453-4057qib7	6845	12	3.83	3.83	CD
cord-005453-4057qib7	6845	13	-	-	SYM
cord-005453-4057qib7	6845	14	13.83	13.83	CD
cord-005453-4057qib7	6845	15	)	)	-RRB-
cord-005453-4057qib7	6846	1	×10	×10	NNS
cord-005453-4057qib7	6846	2	8	8	CD
cord-005453-4057qib7	6847	1	/kg	/kg	NFP
cord-005453-4057qib7	6847	2	in	in	IN
cord-005453-4057qib7	6847	3	the	the	DT
cord-005453-4057qib7	6847	4	PNH	PNH	NNP
cord-005453-4057qib7	6847	5	group	group	NN
cord-005453-4057qib7	6847	6	and	and	CC
cord-005453-4057qib7	6847	7	10.81	10.81	CD
cord-005453-4057qib7	6847	8	(	(	-LRB-
cord-005453-4057qib7	6847	9	3.96	3.96	CD
cord-005453-4057qib7	6847	10	-	-	SYM
cord-005453-4057qib7	6847	11	33.40	33.40	CD
cord-005453-4057qib7	6847	12	)	)	-RRB-
cord-005453-4057qib7	6848	1	×10	×10	NNS
cord-005453-4057qib7	6848	2	8	8	CD
cord-005453-4057qib7	6849	1	/kg	/kg	NFP
cord-005453-4057qib7	6849	2	in	in	IN
cord-005453-4057qib7	6849	3	the	the	DT
cord-005453-4057qib7	6849	4	PNH	PNH	NNP
cord-005453-4057qib7	6849	5	-	-	HYPH
cord-005453-4057qib7	6849	6	AA	AA	NNP
cord-005453-4057qib7	6849	7	group	group	NN
cord-005453-4057qib7	6849	8	(	(	-LRB-
cord-005453-4057qib7	6849	9	P	p	NN
cord-005453-4057qib7	6849	10	=	=	SYM
cord-005453-4057qib7	6849	11	0.668	0.668	CD
cord-005453-4057qib7	6849	12	)	)	-RRB-
cord-005453-4057qib7	6849	13	.	.	.
cord-005453-4057qib7	6850	1	The	the	DT
cord-005453-4057qib7	6850	2	median	median	JJ
cord-005453-4057qib7	6850	3	doses	dose	NNS
cord-005453-4057qib7	6850	4	of	of	IN
cord-005453-4057qib7	6850	5	CD34	CD34	NNP
cord-005453-4057qib7	6850	6	+	+	CC
cord-005453-4057qib7	6850	7	cells	cell	NNS
cord-005453-4057qib7	6850	8	infused	infuse	VBN
cord-005453-4057qib7	6850	9	were	be	VBD
cord-005453-4057qib7	6850	10	5.00	5.00	CD
cord-005453-4057qib7	6850	11	(	(	-LRB-
cord-005453-4057qib7	6850	12	3.14	3.14	CD
cord-005453-4057qib7	6850	13	-	-	SYM
cord-005453-4057qib7	6850	14	8.42)×10	8.42)×10	CD
cord-005453-4057qib7	6850	15	6	6	CD
cord-005453-4057qib7	6850	16	/kg	/kg	NFP
cord-005453-4057qib7	6850	17	and	and	CC
cord-005453-4057qib7	6850	18	3.57	3.57	CD
cord-005453-4057qib7	6850	19	(	(	-LRB-
cord-005453-4057qib7	6850	20	1.97	1.97	CD
cord-005453-4057qib7	6850	21	-	-	SYM
cord-005453-4057qib7	6850	22	6.17)×10	6.17)×10	CD
cord-005453-4057qib7	6850	23	6	6	CD
cord-005453-4057qib7	6851	1	/kg	/kg	NFP
cord-005453-4057qib7	6851	2	(	(	-LRB-
cord-005453-4057qib7	6851	3	P	p	NN
cord-005453-4057qib7	6851	4	=	=	SYM
cord-005453-4057qib7	6851	5	0.002	0.002	CD
cord-005453-4057qib7	6851	6	)	)	-RRB-
cord-005453-4057qib7	6851	7	,	,	,
cord-005453-4057qib7	6851	8	respectively	respectively	RB
cord-005453-4057qib7	6851	9	.	.	.
cord-005453-4057qib7	6852	1	All	all	DT
cord-005453-4057qib7	6852	2	patients	patient	NNS
cord-005453-4057qib7	6852	3	attained	attain	VBD
cord-005453-4057qib7	6852	4	complete	complete	JJ
cord-005453-4057qib7	6852	5	engraftment	engraftment	NN
cord-005453-4057qib7	6852	6	,	,	,
cord-005453-4057qib7	6852	7	no	no	DT
cord-005453-4057qib7	6852	8	patient	patient	NN
cord-005453-4057qib7	6852	9	occurred	occur	VBD
cord-005453-4057qib7	6852	10	graft	graft	NN
cord-005453-4057qib7	6852	11	failure	failure	NN
cord-005453-4057qib7	6852	12	.	.	.
cord-005453-4057qib7	6853	1	The	the	DT
cord-005453-4057qib7	6853	2	median	median	JJ
cord-005453-4057qib7	6853	3	time	time	NN
cord-005453-4057qib7	6853	4	for	for	IN
cord-005453-4057qib7	6853	5	myeloid	myeloid	NN
cord-005453-4057qib7	6853	6	engraftment	engraftment	NN
cord-005453-4057qib7	6853	7	were	be	VBD
cord-005453-4057qib7	6853	8	11	11	CD
cord-005453-4057qib7	6854	1	(	(	-LRB-
cord-005453-4057qib7	6854	2	range	range	NN
cord-005453-4057qib7	6854	3	,	,	,
cord-005453-4057qib7	6854	4	7	7	CD
cord-005453-4057qib7	6854	5	-	-	SYM
cord-005453-4057qib7	6854	6	14	14	CD
cord-005453-4057qib7	6854	7	)	)	-RRB-
cord-005453-4057qib7	6854	8	days	day	NNS
cord-005453-4057qib7	6854	9	in	in	IN
cord-005453-4057qib7	6854	10	the	the	DT
cord-005453-4057qib7	6854	11	PNH	PNH	NNP
cord-005453-4057qib7	6854	12	group	group	NN
cord-005453-4057qib7	6854	13	and	and	CC
cord-005453-4057qib7	6854	14	12	12	CD
cord-005453-4057qib7	6854	15	(	(	-LRB-
cord-005453-4057qib7	6854	16	range	range	NN
cord-005453-4057qib7	6854	17	,	,	,
cord-005453-4057qib7	6854	18	10	10	CD
cord-005453-4057qib7	6854	19	-	-	SYM
cord-005453-4057qib7	6854	20	26	26	CD
cord-005453-4057qib7	6854	21	)	)	-RRB-
cord-005453-4057qib7	6854	22	days	day	NNS
cord-005453-4057qib7	6854	23	in	in	IN
cord-005453-4057qib7	6854	24	the	the	DT
cord-005453-4057qib7	6854	25	PNH	PNH	NNP
cord-005453-4057qib7	6854	26	-	-	HYPH
cord-005453-4057qib7	6854	27	AA	AA	NNP
cord-005453-4057qib7	6854	28	group	group	NN
cord-005453-4057qib7	6854	29	(	(	-LRB-
cord-005453-4057qib7	6854	30	P	p	NN
cord-005453-4057qib7	6854	31	=	=	SYM
cord-005453-4057qib7	6854	32	0.003	0.003	CD
cord-005453-4057qib7	6854	33	)	)	-RRB-
cord-005453-4057qib7	6854	34	.	.	.
cord-005453-4057qib7	6855	1	The	the	DT
cord-005453-4057qib7	6855	2	median	median	JJ
cord-005453-4057qib7	6855	3	time	time	NN
cord-005453-4057qib7	6855	4	for	for	IN
cord-005453-4057qib7	6855	5	platelet	platelet	NN
cord-005453-4057qib7	6855	6	engraftment	engraftment	NN
cord-005453-4057qib7	6855	7	were	be	VBD
cord-005453-4057qib7	6855	8	13	13	CD
cord-005453-4057qib7	6856	1	(	(	-LRB-
cord-005453-4057qib7	6856	2	range	range	NN
cord-005453-4057qib7	6856	3	,	,	,
cord-005453-4057qib7	6856	4	11	11	CD
cord-005453-4057qib7	6856	5	-	-	SYM
cord-005453-4057qib7	6856	6	16	16	CD
cord-005453-4057qib7	6856	7	)	)	-RRB-
cord-005453-4057qib7	6856	8	days	day	NNS
cord-005453-4057qib7	6856	9	and	and	CC
cord-005453-4057qib7	6856	10	18	18	CD
cord-005453-4057qib7	6857	1	(	(	-LRB-
cord-005453-4057qib7	6857	2	range	range	NN
cord-005453-4057qib7	6857	3	,	,	,
cord-005453-4057qib7	6857	4	12	12	CD
cord-005453-4057qib7	6857	5	-	-	SYM
cord-005453-4057qib7	6857	6	75	75	CD
cord-005453-4057qib7	6857	7	)	)	-RRB-
cord-005453-4057qib7	6857	8	days	day	NNS
cord-005453-4057qib7	6857	9	(	(	-LRB-
cord-005453-4057qib7	6857	10	P	p	NN
cord-005453-4057qib7	6857	11	=	=	SYM
cord-005453-4057qib7	6857	12	0.002	0.002	CD
cord-005453-4057qib7	6857	13	)	)	-RRB-
cord-005453-4057qib7	6857	14	,	,	,
cord-005453-4057qib7	6857	15	respectively	respectively	RB
cord-005453-4057qib7	6857	16	.	.	.
cord-005453-4057qib7	6858	1	With	with	IN
cord-005453-4057qib7	6858	2	a	a	DT
cord-005453-4057qib7	6858	3	median	median	JJ
cord-005453-4057qib7	6858	4	follow	follow	NN
cord-005453-4057qib7	6858	5	-	-	HYPH
cord-005453-4057qib7	6858	6	up	up	NN
cord-005453-4057qib7	6858	7	of	of	IN
cord-005453-4057qib7	6858	8	36	36	CD
cord-005453-4057qib7	6858	9	(	(	-LRB-
cord-005453-4057qib7	6858	10	4	4	CD
cord-005453-4057qib7	6858	11	-	-	SYM
cord-005453-4057qib7	6858	12	132	132	CD
cord-005453-4057qib7	6858	13	)	)	-RRB-
cord-005453-4057qib7	6858	14	months	month	NNS
cord-005453-4057qib7	6858	15	in	in	IN
cord-005453-4057qib7	6858	16	the	the	DT
cord-005453-4057qib7	6858	17	PNH	PNH	NNP
cord-005453-4057qib7	6858	18	group	group	NN
cord-005453-4057qib7	6858	19	and	and	CC
cord-005453-4057qib7	6858	20	26	26	CD
cord-005453-4057qib7	6858	21	(	(	-LRB-
cord-005453-4057qib7	6858	22	4	4	CD
cord-005453-4057qib7	6858	23	-	-	SYM
cord-005453-4057qib7	6858	24	75	75	CD
cord-005453-4057qib7	6858	25	)	)	-RRB-
cord-005453-4057qib7	6858	26	months	month	NNS
cord-005453-4057qib7	6858	27	in	in	IN
cord-005453-4057qib7	6858	28	the	the	DT
cord-005453-4057qib7	6858	29	PNH	PNH	NNP
cord-005453-4057qib7	6858	30	-	-	HYPH
cord-005453-4057qib7	6858	31	AA	AA	NNP
cord-005453-4057qib7	6858	32	group	group	NN
cord-005453-4057qib7	6858	33	(	(	-LRB-
cord-005453-4057qib7	6858	34	P	p	NN
cord-005453-4057qib7	6858	35	=	=	SYM
cord-005453-4057qib7	6858	36	0.428	0.428	CD
cord-005453-4057qib7	6858	37	)	)	-RRB-
cord-005453-4057qib7	6858	38	.	.	.
cord-005453-4057qib7	6859	1	In	in	IN
cord-005453-4057qib7	6859	2	PNH	PNH	NNP
cord-005453-4057qib7	6859	3	and	and	CC
cord-005453-4057qib7	6859	4	PNH	PNH	NNP
cord-005453-4057qib7	6859	5	-	-	HYPH
cord-005453-4057qib7	6859	6	AA	AA	NNP
cord-005453-4057qib7	6859	7	groups	group	NNS
cord-005453-4057qib7	6859	8	the	the	DT
cord-005453-4057qib7	6859	9	incidences	incidence	NNS
cord-005453-4057qib7	6859	10	of	of	IN
cord-005453-4057qib7	6859	11	grade	grade	NN
cord-005453-4057qib7	6859	12	I	I	NNP
cord-005453-4057qib7	6859	13	-	-	HYPH
cord-005453-4057qib7	6859	14	IV	IV	NNP
cord-005453-4057qib7	6859	15	acute	acute	JJ
cord-005453-4057qib7	6859	16	graft	graft	NN
cord-005453-4057qib7	6859	17	-	-	HYPH
cord-005453-4057qib7	6859	18	versus	versus	IN
cord-005453-4057qib7	6859	19	-	-	HYPH
cord-005453-4057qib7	6859	20	host	host	NN
cord-005453-4057qib7	6859	21	disease	disease	NN
cord-005453-4057qib7	6859	22	(	(	-LRB-
cord-005453-4057qib7	6859	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6859	24	)	)	-RRB-
cord-005453-4057qib7	6859	25	were	be	VBD
cord-005453-4057qib7	6859	26	12.50	12.50	CD
cord-005453-4057qib7	6859	27	%	%	NN
cord-005453-4057qib7	6859	28	and	and	CC
cord-005453-4057qib7	6859	29	33.30	33.30	CD
cord-005453-4057qib7	6859	30	%	%	NN
cord-005453-4057qib7	6859	31	(	(	-LRB-
cord-005453-4057qib7	6859	32	P	p	NN
cord-005453-4057qib7	6859	33	=	=	SYM
cord-005453-4057qib7	6859	34	0.121	0.121	CD
cord-005453-4057qib7	6859	35	)	)	-RRB-
cord-005453-4057qib7	6859	36	,	,	,
cord-005453-4057qib7	6859	37	grade	grade	NN
cord-005453-4057qib7	6859	38	II	II	NNP
cord-005453-4057qib7	6859	39	-	-	HYPH
cord-005453-4057qib7	6859	40	IV	IV	NNP
cord-005453-4057qib7	6859	41	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6859	42	were	be	VBD
cord-005453-4057qib7	6859	43	6.25	6.25	CD
cord-005453-4057qib7	6859	44	%	%	NN
cord-005453-4057qib7	6859	45	and	and	CC
cord-005453-4057qib7	6859	46	20.00	20.00	CD
cord-005453-4057qib7	6859	47	%	%	NN
cord-005453-4057qib7	6859	48	(	(	-LRB-
cord-005453-4057qib7	6859	49	P	p	NN
cord-005453-4057qib7	6859	50	=	=	SYM
cord-005453-4057qib7	6859	51	0.209	0.209	CD
cord-005453-4057qib7	6859	52	)	)	-RRB-
cord-005453-4057qib7	6859	53	;	;	,
cord-005453-4057qib7	6859	54	chronic	chronic	JJ
cord-005453-4057qib7	6859	55	GVHD	GVHD	NNP
cord-005453-4057qib7	6859	56	were	be	VBD
cord-005453-4057qib7	6859	57	12.50	12.50	CD
cord-005453-4057qib7	6859	58	%	%	NN
cord-005453-4057qib7	6859	59	and	and	CC
cord-005453-4057qib7	6859	60	35.67	35.67	CD
cord-005453-4057qib7	6859	61	%	%	NN
cord-005453-4057qib7	6859	62	(	(	-LRB-
cord-005453-4057qib7	6859	63	P	p	NN
cord-005453-4057qib7	6859	64	=	=	SYM
cord-005453-4057qib7	6859	65	0.274	0.274	CD
cord-005453-4057qib7	6859	66	)	)	-RRB-
cord-005453-4057qib7	6859	67	,	,	,
cord-005453-4057qib7	6859	68	moderatesevere	moderatesevere	NN
cord-005453-4057qib7	6859	69	chronic	chronic	JJ
cord-005453-4057qib7	6859	70	GVHD	GVHD	NNP
cord-005453-4057qib7	6859	71	were	be	VBD
cord-005453-4057qib7	6859	72	0.00	0.00	CD
cord-005453-4057qib7	6859	73	%	%	NN
cord-005453-4057qib7	6859	74	and	and	CC
cord-005453-4057qib7	6859	75	14.39	14.39	CD
cord-005453-4057qib7	6859	76	%	%	NN
cord-005453-4057qib7	6859	77	(	(	-LRB-
cord-005453-4057qib7	6859	78	P	p	NN
cord-005453-4057qib7	6859	79	=	=	SYM
cord-005453-4057qib7	6859	80	0.146	0.146	CD
cord-005453-4057qib7	6859	81	)	)	-RRB-
cord-005453-4057qib7	6859	82	.	.	.
cord-005453-4057qib7	6860	1	In	in	IN
cord-005453-4057qib7	6860	2	haplo	haplo	NNP
cord-005453-4057qib7	6860	3	-	-	HYPH
cord-005453-4057qib7	6860	4	HSCT	HSCT	NNP
cord-005453-4057qib7	6860	5	and	and	CC
cord-005453-4057qib7	6860	6	MSD	MSD	NNP
cord-005453-4057qib7	6860	7	groups	group	NNS
cord-005453-4057qib7	6860	8	the	the	DT
cord-005453-4057qib7	6860	9	incidences	incidence	NNS
cord-005453-4057qib7	6860	10	of	of	IN
cord-005453-4057qib7	6860	11	infection	infection	NN
cord-005453-4057qib7	6860	12	were	be	VBD
cord-005453-4057qib7	6860	13	37.50	37.50	CD
cord-005453-4057qib7	6860	14	%	%	NN
cord-005453-4057qib7	6860	15	(	(	-LRB-
cord-005453-4057qib7	6860	16	6/16	6/16	CD
cord-005453-4057qib7	6860	17	)	)	-RRB-
cord-005453-4057qib7	6860	18	and	and	CC
cord-005453-4057qib7	6860	19	33.33	33.33	CD
cord-005453-4057qib7	6860	20	%	%	NN
cord-005453-4057qib7	6860	21	(	(	-LRB-
cord-005453-4057qib7	6860	22	10/30	10/30	CD
cord-005453-4057qib7	6860	23	)	)	-RRB-
cord-005453-4057qib7	6861	1	(	(	-LRB-
cord-005453-4057qib7	6861	2	P	p	NN
cord-005453-4057qib7	6861	3	=	=	SYM
cord-005453-4057qib7	6861	4	0.777	0.777	CD
cord-005453-4057qib7	6861	5	)	)	-RRB-
cord-005453-4057qib7	6861	6	.	.	.
cord-005453-4057qib7	6862	1	No	no	DT
cord-005453-4057qib7	6862	2	patient	patient	NN
cord-005453-4057qib7	6862	3	occurred	occur	VBD
cord-005453-4057qib7	6862	4	early	early	JJ
cord-005453-4057qib7	6862	5	death	death	NN
cord-005453-4057qib7	6862	6	and	and	CC
cord-005453-4057qib7	6862	7	relapse	relapse	NN
cord-005453-4057qib7	6862	8	.	.	.
cord-005453-4057qib7	6863	1	3-year	3-year	CD
cord-005453-4057qib7	6863	2	estimated	estimate	VBN
cord-005453-4057qib7	6863	3	overall	overall	JJ
cord-005453-4057qib7	6863	4	survival	survival	NN
cord-005453-4057qib7	6863	5	(	(	-LRB-
cord-005453-4057qib7	6863	6	OS	OS	NNP
cord-005453-4057qib7	6863	7	)	)	-RRB-
cord-005453-4057qib7	6863	8	of	of	IN
cord-005453-4057qib7	6863	9	PNH	PNH	NNP
cord-005453-4057qib7	6863	10	and	and	CC
cord-005453-4057qib7	6863	11	PNH	PNH	NNP
cord-005453-4057qib7	6863	12	-	-	HYPH
cord-005453-4057qib7	6863	13	AA	AA	NNP
cord-005453-4057qib7	6863	14	groups	group	NNS
cord-005453-4057qib7	6863	15	were	be	VBD
cord-005453-4057qib7	6863	16	100.0	100.0	CD
cord-005453-4057qib7	6863	17	%	%	NN
cord-005453-4057qib7	6863	18	±	±	NNP
cord-005453-4057qib7	6863	19	0.0	0.0	CD
cord-005453-4057qib7	6863	20	%	%	NN
cord-005453-4057qib7	6863	21	and	and	CC
cord-005453-4057qib7	6863	22	85.7	85.7	CD
cord-005453-4057qib7	6863	23	%	%	NN
cord-005453-4057qib7	6863	24	±	±	NNP
cord-005453-4057qib7	6863	25	6.6	6.6	CD
cord-005453-4057qib7	6863	26	%	%	NN
cord-005453-4057qib7	6863	27	(	(	-LRB-
cord-005453-4057qib7	6863	28	P	p	NN
cord-005453-4057qib7	6863	29	=	=	SYM
cord-005453-4057qib7	6863	30	0.141	0.141	CD
cord-005453-4057qib7	6863	31	)	)	-RRB-
cord-005453-4057qib7	6863	32	,	,	,
cord-005453-4057qib7	6863	33	GVHD	GVHD	NNP
cord-005453-4057qib7	6863	34	-	-	HYPH
cord-005453-4057qib7	6863	35	free	free	JJ
cord-005453-4057qib7	6863	36	and	and	CC
cord-005453-4057qib7	6863	37	failure	failure	NN
cord-005453-4057qib7	6863	38	-	-	HYPH
cord-005453-4057qib7	6863	39	free	free	JJ
cord-005453-4057qib7	6863	40	survival	survival	NN
cord-005453-4057qib7	6863	41	(	(	-LRB-
cord-005453-4057qib7	6863	42	GFFS	GFFS	NNP
cord-005453-4057qib7	6863	43	)	)	-RRB-
cord-005453-4057qib7	6863	44	were	be	VBD
cord-005453-4057qib7	6863	45	100.0	100.0	CD
cord-005453-4057qib7	6863	46	%	%	NN
cord-005453-4057qib7	6863	47	±	±	NNP
cord-005453-4057qib7	6863	48	0.0%、78.7	0.0%、78.7	CD
cord-005453-4057qib7	6863	49	%	%	NN
cord-005453-4057qib7	6863	50	±	±	CD
cord-005453-4057qib7	6863	51	7.7	7.7	CD
cord-005453-4057qib7	6863	52	%	%	NN
cord-005453-4057qib7	6863	53	(	(	-LRB-
cord-005453-4057qib7	6863	54	P	p	NN
cord-005453-4057qib7	6863	55	=	=	SYM
cord-005453-4057qib7	6863	56	0.067	0.067	CD
cord-005453-4057qib7	6863	57	)	)	-RRB-
cord-005453-4057qib7	6863	58	.	.	.
cord-005453-4057qib7	6864	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6864	2	:	:	:
cord-005453-4057qib7	6865	1	The	the	DT
cord-005453-4057qib7	6865	2	preliminary	preliminary	JJ
cord-005453-4057qib7	6865	3	results	result	NNS
cord-005453-4057qib7	6865	4	indicated	indicate	VBD
cord-005453-4057qib7	6865	5	that	that	IN
cord-005453-4057qib7	6865	6	allo	allo	NN
cord-005453-4057qib7	6865	7	-	-	HYPH
cord-005453-4057qib7	6865	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6865	9	is	be	VBZ
cord-005453-4057qib7	6865	10	a	a	DT
cord-005453-4057qib7	6865	11	feasible	feasible	JJ
cord-005453-4057qib7	6865	12	choice	choice	NN
cord-005453-4057qib7	6865	13	for	for	IN
cord-005453-4057qib7	6865	14	PNH	PNH	NNP
cord-005453-4057qib7	6865	15	with	with	IN
cord-005453-4057qib7	6865	16	favorable	favorable	JJ
cord-005453-4057qib7	6865	17	outcomes	outcome	NNS
cord-005453-4057qib7	6865	18	,	,	,
cord-005453-4057qib7	6865	19	time	time	NN
cord-005453-4057qib7	6865	20	for	for	IN
cord-005453-4057qib7	6865	21	myeloid	myeloid	NN
cord-005453-4057qib7	6865	22	and	and	CC
cord-005453-4057qib7	6865	23	platelet	platelet	NN
cord-005453-4057qib7	6865	24	engraftment	engraftment	NN
cord-005453-4057qib7	6865	25	in	in	IN
cord-005453-4057qib7	6865	26	PNH	PNH	NNP
cord-005453-4057qib7	6865	27	group	group	NN
cord-005453-4057qib7	6865	28	were	be	VBD
cord-005453-4057qib7	6865	29	faster	fast	JJR
cord-005453-4057qib7	6865	30	than	than	IN
cord-005453-4057qib7	6865	31	PNH	PNH	NNP
cord-005453-4057qib7	6865	32	-	-	HYPH
cord-005453-4057qib7	6865	33	AA	AA	NNP
cord-005453-4057qib7	6865	34	group	group	NN
cord-005453-4057qib7	6865	35	.	.	.
cord-005453-4057qib7	6866	1	There	there	EX
cord-005453-4057qib7	6866	2	were	be	VBD
cord-005453-4057qib7	6866	3	no	no	DT
cord-005453-4057qib7	6866	4	differences	difference	NNS
cord-005453-4057qib7	6866	5	in	in	IN
cord-005453-4057qib7	6866	6	OS	OS	NNP
cord-005453-4057qib7	6866	7	and	and	CC
cord-005453-4057qib7	6866	8	GFFS	GFFS	NNP
cord-005453-4057qib7	6866	9	between	between	IN
cord-005453-4057qib7	6866	10	PNH	PNH	NNP
cord-005453-4057qib7	6866	11	group	group	NN
cord-005453-4057qib7	6866	12	and	and	CC
cord-005453-4057qib7	6866	13	PNH	PNH	NNP
cord-005453-4057qib7	6866	14	-	-	HYPH
cord-005453-4057qib7	6866	15	AA	AA	NNP
cord-005453-4057qib7	6866	16	group	group	NN
cord-005453-4057qib7	6866	17	.	.	.
cord-005453-4057qib7	6867	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6867	2	:	:	:
cord-005453-4057qib7	6867	3	no	no	DT
cord-005453-4057qib7	6867	4	disclosure	disclosure	NN
cord-005453-4057qib7	6867	5	Pattern	pattern	NN
cord-005453-4057qib7	6867	6	of	of	IN
cord-005453-4057qib7	6867	7	calcineurin	calcineurin	JJ
cord-005453-4057qib7	6867	8	inhibitor	inhibitor	NN
cord-005453-4057qib7	6867	9	-	-	HYPH
cord-005453-4057qib7	6867	10	associated	associate	VBN
cord-005453-4057qib7	6867	11	neurotoxicity	neurotoxicity	NN
cord-005453-4057qib7	6867	12	in	in	IN
cord-005453-4057qib7	6867	13	sickle	sickle	NN
cord-005453-4057qib7	6867	14	cell	cell	NN
cord-005453-4057qib7	6867	15	disease	disease	NN
cord-005453-4057qib7	6867	16	patients	patient	NNS
cord-005453-4057qib7	6867	17	receiving	receive	VBG
cord-005453-4057qib7	6867	18	a	a	DT
cord-005453-4057qib7	6867	19	stem	stem	NN
cord-005453-4057qib7	6867	20	cell	cell	NN
cord-005453-4057qib7	6867	21	transplantation	transplantation	NN
cord-005453-4057qib7	6867	22	Background	background	NN
cord-005453-4057qib7	6867	23	:	:	:
cord-005453-4057qib7	6868	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	6868	2	HSCT	HSCT	NNP
cord-005453-4057qib7	6868	3	with	with	IN
cord-005453-4057qib7	6868	4	a	a	DT
cord-005453-4057qib7	6868	5	MSD	MSD	NNP
cord-005453-4057qib7	6868	6	represents	represent	VBZ
cord-005453-4057qib7	6868	7	currently	currently	RB
cord-005453-4057qib7	6868	8	the	the	DT
cord-005453-4057qib7	6868	9	only	only	JJ
cord-005453-4057qib7	6868	10	curative	curative	JJ
cord-005453-4057qib7	6868	11	option	option	NN
cord-005453-4057qib7	6868	12	for	for	IN
cord-005453-4057qib7	6868	13	sickle	sickle	NN
cord-005453-4057qib7	6868	14	cell	cell	NN
cord-005453-4057qib7	6868	15	disease	disease	NN
cord-005453-4057qib7	6868	16	(	(	-LRB-
cord-005453-4057qib7	6868	17	SCD	SCD	NNP
cord-005453-4057qib7	6868	18	)	)	-RRB-
cord-005453-4057qib7	6868	19	,	,	,
cord-005453-4057qib7	6868	20	limited	limit	VBN
cord-005453-4057qib7	6868	21	by	by	IN
cord-005453-4057qib7	6868	22	a	a	DT
cord-005453-4057qib7	6868	23	donor	donor	NN
cord-005453-4057qib7	6868	24	availability	availability	NN
cord-005453-4057qib7	6868	25	<	<	XX
cord-005453-4057qib7	6868	26	20	20	CD
cord-005453-4057qib7	6868	27	%	%	NN
cord-005453-4057qib7	6868	28	.	.	.
cord-005453-4057qib7	6869	1	Neurotoxicity	neurotoxicity	NN
cord-005453-4057qib7	6869	2	(	(	-LRB-
cord-005453-4057qib7	6869	3	NT	NT	NNP
cord-005453-4057qib7	6869	4	)	)	-RRB-
cord-005453-4057qib7	6869	5	contributes	contribute	VBZ
cord-005453-4057qib7	6869	6	significantly	significantly	RB
cord-005453-4057qib7	6869	7	to	to	IN
cord-005453-4057qib7	6869	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6869	9	-	-	HYPH
cord-005453-4057qib7	6869	10	associated	associate	VBN
cord-005453-4057qib7	6869	11	morbidity	morbidity	NN
cord-005453-4057qib7	6869	12	and	and	CC
cord-005453-4057qib7	6869	13	mortality	mortality	NN
cord-005453-4057qib7	6869	14	.	.	.
cord-005453-4057qib7	6870	1	Calcineurin	Calcineurin	NNP
cord-005453-4057qib7	6870	2	-	-	HYPH
cord-005453-4057qib7	6870	3	inhibitor	inhibitor	NN
cord-005453-4057qib7	6870	4	(	(	-LRB-
cord-005453-4057qib7	6870	5	CNI	CNI	NNP
cord-005453-4057qib7	6870	6	)	)	-RRB-
cord-005453-4057qib7	6870	7	associated	associate	VBD
cord-005453-4057qib7	6870	8	NT	NT	NNP
cord-005453-4057qib7	6870	9	ranges	range	VBZ
cord-005453-4057qib7	6870	10	from	from	IN
cord-005453-4057qib7	6870	11	4.2%-28.8	4.2%-28.8	CD
cord-005453-4057qib7	6870	12	%	%	NN
cord-005453-4057qib7	6870	13	(	(	-LRB-
cord-005453-4057qib7	6870	14	severe	severe	JJ
cord-005453-4057qib7	6870	15	NT	NT	NNP
cord-005453-4057qib7	6870	16	4%-11	4%-11	CD
cord-005453-4057qib7	6870	17	%	%	NN
cord-005453-4057qib7	6870	18	)	)	-RRB-
cord-005453-4057qib7	6870	19	.	.	.
cord-005453-4057qib7	6871	1	The	the	DT
cord-005453-4057qib7	6871	2	elevated	elevated	JJ
cord-005453-4057qib7	6871	3	incidence	incidence	NN
cord-005453-4057qib7	6871	4	of	of	IN
cord-005453-4057qib7	6871	5	NT	NT	NNP
cord-005453-4057qib7	6871	6	in	in	IN
cord-005453-4057qib7	6871	7	SCD	SCD	NNP
cord-005453-4057qib7	6871	8	(	(	-LRB-
cord-005453-4057qib7	6871	9	around	around	IN
cord-005453-4057qib7	6871	10	30	30	CD
cord-005453-4057qib7	6871	11	%	%	NN
cord-005453-4057qib7	6871	12	)	)	-RRB-
cord-005453-4057qib7	6871	13	might	may	MD
cord-005453-4057qib7	6871	14	be	be	VB
cord-005453-4057qib7	6871	15	triggered	trigger	VBN
cord-005453-4057qib7	6871	16	by	by	IN
cord-005453-4057qib7	6871	17	the	the	DT
cord-005453-4057qib7	6871	18	systemic	systemic	JJ
cord-005453-4057qib7	6871	19	vasculopathy	vasculopathy	NN
cord-005453-4057qib7	6871	20	of	of	IN
cord-005453-4057qib7	6871	21	SCD	SCD	NNP
cord-005453-4057qib7	6871	22	,	,	,
cord-005453-4057qib7	6871	23	with	with	IN
cord-005453-4057qib7	6871	24	the	the	DT
cord-005453-4057qib7	6871	25	brain	brain	NN
cord-005453-4057qib7	6871	26	being	be	VBG
cord-005453-4057qib7	6871	27	the	the	DT
cord-005453-4057qib7	6871	28	primary	primary	JJ
cord-005453-4057qib7	6871	29	target	target	NN
cord-005453-4057qib7	6871	30	.	.	.
cord-005453-4057qib7	6872	1	Although	although	IN
cord-005453-4057qib7	6872	2	both	both	DT
cord-005453-4057qib7	6872	3	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	6872	4	A	a	NN
cord-005453-4057qib7	6872	5	(	(	-LRB-
cord-005453-4057qib7	6872	6	CsA	csa	NN
cord-005453-4057qib7	6872	7	)	)	-RRB-
cord-005453-4057qib7	6872	8	and	and	CC
cord-005453-4057qib7	6872	9	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	6872	10	(	(	-LRB-
cord-005453-4057qib7	6872	11	FK506	FK506	NNP
cord-005453-4057qib7	6872	12	)	)	-RRB-
cord-005453-4057qib7	6872	13	have	have	VB
cord-005453-4057qib7	6872	14	a	a	DT
cord-005453-4057qib7	6872	15	proinflammatory	proinflammatory	JJ
cord-005453-4057qib7	6872	16	effect	effect	NN
cord-005453-4057qib7	6872	17	,	,	,
cord-005453-4057qib7	6872	18	it	-PRON-	PRP
cord-005453-4057qib7	6872	19	is	be	VBZ
cord-005453-4057qib7	6872	20	more	more	RBR
cord-005453-4057qib7	6872	21	pronounced	pronounced	JJ
cord-005453-4057qib7	6872	22	in	in	IN
cord-005453-4057qib7	6872	23	CsA.	CsA.	NNP
cord-005453-4057qib7	6873	1	Infusion	infusion	NN
cord-005453-4057qib7	6873	2	modalities	modality	NNS
cord-005453-4057qib7	6873	3	also	also	RB
cord-005453-4057qib7	6873	4	might	may	MD
cord-005453-4057qib7	6873	5	impact	impact	VB
cord-005453-4057qib7	6873	6	(	(	-LRB-
cord-005453-4057qib7	6873	7	10.3	10.3	CD
cord-005453-4057qib7	6873	8	%	%	NN
cord-005453-4057qib7	6873	9	after	after	IN
cord-005453-4057qib7	6873	10	bolus	bolus	NN
cord-005453-4057qib7	6873	11	injections	injection	NNS
cord-005453-4057qib7	6873	12	versus	versus	IN
cord-005453-4057qib7	6873	13	3.3	3.3	CD
cord-005453-4057qib7	6873	14	%	%	NN
cord-005453-4057qib7	6873	15	after	after	IN
cord-005453-4057qib7	6873	16	continuous	continuous	JJ
cord-005453-4057qib7	6873	17	infusion	infusion	NN
cord-005453-4057qib7	6873	18	)	)	-RRB-
cord-005453-4057qib7	6873	19	.	.	.
cord-005453-4057qib7	6874	1	Methods	method	NNS
cord-005453-4057qib7	6874	2	:	:	:
cord-005453-4057qib7	6874	3	In	in	IN
cord-005453-4057qib7	6874	4	a	a	DT
cord-005453-4057qib7	6874	5	pilot	pilot	NN
cord-005453-4057qib7	6874	6	study	study	NN
cord-005453-4057qib7	6874	7	,	,	,
cord-005453-4057qib7	6874	8	we	-PRON-	PRP
cord-005453-4057qib7	6874	9	compared	compare	VBD
cord-005453-4057qib7	6874	10	T	t	NN
cord-005453-4057qib7	6874	11	-	-	HYPH
cord-005453-4057qib7	6874	12	cell	cell	NN
cord-005453-4057qib7	6874	13	depleted	deplete	VBN
cord-005453-4057qib7	6874	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	6874	15	HSCT	HSCT	NNP
cord-005453-4057qib7	6874	16	(	(	-LRB-
cord-005453-4057qib7	6874	17	T	T	NNP
cord-005453-4057qib7	6874	18	-	-	HYPH
cord-005453-4057qib7	6874	19	haplo	haplo	NNP
cord-005453-4057qib7	6874	20	HSCT	HSCT	NNP
cord-005453-4057qib7	6874	21	)	)	-RRB-
cord-005453-4057qib7	6874	22	with	with	IN
cord-005453-4057qib7	6874	23	MSD	MSD	NNP
cord-005453-4057qib7	6874	24	HSCT	HSCT	NNP
cord-005453-4057qib7	6874	25	in	in	IN
cord-005453-4057qib7	6874	26	patients	patient	NNS
cord-005453-4057qib7	6874	27	(	(	-LRB-
cord-005453-4057qib7	6874	28	pts	pt	NNS
cord-005453-4057qib7	6874	29	)	)	-RRB-
cord-005453-4057qib7	6874	30	with	with	IN
cord-005453-4057qib7	6874	31	advanced	advanced	JJ
cord-005453-4057qib7	6874	32	stage	stage	NN
cord-005453-4057qib7	6874	33	SCD	SCD	NNP
cord-005453-4057qib7	6874	34	,	,	,
cord-005453-4057qib7	6874	35	using	use	VBG
cord-005453-4057qib7	6874	36	almost	almost	RB
cord-005453-4057qib7	6874	37	identical	identical	JJ
cord-005453-4057qib7	6874	38	conditioning	conditioning	NN
cord-005453-4057qib7	6874	39	regimens	regimen	NNS
cord-005453-4057qib7	6874	40	.	.	.
cord-005453-4057qib7	6875	1	32	32	CD
cord-005453-4057qib7	6875	2	pts	pts	NN
cord-005453-4057qib7	6875	3	(	(	-LRB-
cord-005453-4057qib7	6875	4	3	3	CD
cord-005453-4057qib7	6875	5	-	-	SYM
cord-005453-4057qib7	6875	6	31	31	CD
cord-005453-4057qib7	6875	7	years	year	NNS
cord-005453-4057qib7	6875	8	;	;	:
cord-005453-4057qib7	6875	9	yrs	yr	NNS
cord-005453-4057qib7	6875	10	)	)	-RRB-
cord-005453-4057qib7	6875	11	with	with	IN
cord-005453-4057qib7	6875	12	homozygous	homozygous	JJ
cord-005453-4057qib7	6875	13	SCD	SCD	NNP
cord-005453-4057qib7	6875	14	or	or	CC
cord-005453-4057qib7	6875	15	HbS	hbs	NN
cord-005453-4057qib7	6875	16	0/+	0/+	.
cord-005453-4057qib7	6876	1	ß	ß	LS
cord-005453-4057qib7	6876	2	-	-	:
cord-005453-4057qib7	6876	3	Thal	Thal	NNP
cord-005453-4057qib7	6876	4	were	be	VBD
cord-005453-4057qib7	6876	5	treated	treat	VBN
cord-005453-4057qib7	6876	6	between	between	IN
cord-005453-4057qib7	6876	7	2012	2012	CD
cord-005453-4057qib7	6876	8	and	and	CC
cord-005453-4057qib7	6876	9	2018	2018	CD
cord-005453-4057qib7	6876	10	.	.	.
cord-005453-4057qib7	6877	1	Nine	nine	CD
cord-005453-4057qib7	6877	2	pts	pt	NNS
cord-005453-4057qib7	6877	3	received	receive	VBD
cord-005453-4057qib7	6877	4	a	a	DT
cord-005453-4057qib7	6877	5	MSD	MSD	NNP
cord-005453-4057qib7	6877	6	bone	bone	NN
cord-005453-4057qib7	6877	7	marrow	marrow	NN
cord-005453-4057qib7	6877	8	graft	graft	NN
cord-005453-4057qib7	6877	9	,	,	,
cord-005453-4057qib7	6877	10	23	23	CD
cord-005453-4057qib7	6877	11	pts	pt	NNS
cord-005453-4057qib7	6877	12	received	receive	VBD
cord-005453-4057qib7	6877	13	24	24	CD
cord-005453-4057qib7	6877	14	T	T	NNP
cord-005453-4057qib7	6877	15	-	-	HYPH
cord-005453-4057qib7	6877	16	haplo	haplo	NNP
cord-005453-4057qib7	6877	17	-	-	HYPH
cord-005453-4057qib7	6877	18	HSCT	HSCT	NNP
cord-005453-4057qib7	6877	19	(	(	-LRB-
cord-005453-4057qib7	6877	20	1	1	CD
cord-005453-4057qib7	6877	21	second	second	JJ
cord-005453-4057qib7	6877	22	T	T	NNP
cord-005453-4057qib7	6877	23	-	-	HYPH
cord-005453-4057qib7	6877	24	haplo	haplo	NNP
cord-005453-4057qib7	6877	25	due	due	IN
cord-005453-4057qib7	6877	26	to	to	IN
cord-005453-4057qib7	6877	27	graft	graft	NN
cord-005453-4057qib7	6877	28	rejection	rejection	NN
cord-005453-4057qib7	6877	29	)	)	-RRB-
cord-005453-4057qib7	6877	30	.	.	.
cord-005453-4057qib7	6878	1	Immunosuppression	Immunosuppression	NNP
cord-005453-4057qib7	6878	2	consisted	consist	VBD
cord-005453-4057qib7	6878	3	of	of	IN
cord-005453-4057qib7	6878	4	either	either	DT
cord-005453-4057qib7	6878	5	CsA	CsA	NNP
cord-005453-4057qib7	6878	6	(	(	-LRB-
cord-005453-4057qib7	6878	7	6	6	CD
cord-005453-4057qib7	6878	8	MSD	MSD	NNP
cord-005453-4057qib7	6878	9	,	,	,
cord-005453-4057qib7	6878	10	16	16	CD
cord-005453-4057qib7	6878	11	T	t	NN
cord-005453-4057qib7	6878	12	-	-	HYPH
cord-005453-4057qib7	6878	13	haplo	haplo	NNP
cord-005453-4057qib7	6878	14	)	)	-RRB-
cord-005453-4057qib7	6878	15	or	or	CC
cord-005453-4057qib7	6879	1	FK506	FK506	NNP
cord-005453-4057qib7	6879	2	(	(	-LRB-
cord-005453-4057qib7	6879	3	3	3	CD
cord-005453-4057qib7	6879	4	MSD	MSD	NNP
cord-005453-4057qib7	6879	5	,	,	,
cord-005453-4057qib7	6879	6	,	,	,
cord-005453-4057qib7	6879	7	in	in	IN
cord-005453-4057qib7	6879	8	combination	combination	NN
cord-005453-4057qib7	6879	9	with	with	IN
cord-005453-4057qib7	6879	10	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	6879	11	mofetil	mofetil	NNP
cord-005453-4057qib7	6879	12	(	(	-LRB-
cord-005453-4057qib7	6879	13	MMF	MMF	NNP
cord-005453-4057qib7	6879	14	)	)	-RRB-
cord-005453-4057qib7	6879	15	.	.	.
cord-005453-4057qib7	6880	1	FK506	FK506	NNP
cord-005453-4057qib7	6880	2	was	be	VBD
cord-005453-4057qib7	6880	3	administered	administer	VBN
cord-005453-4057qib7	6880	4	as	as	IN
cord-005453-4057qib7	6880	5	a	a	DT
cord-005453-4057qib7	6880	6	20-hours	20-hours	CD
cord-005453-4057qib7	6880	7	continuous	continuous	JJ
cord-005453-4057qib7	6880	8	infusion	infusion	NN
cord-005453-4057qib7	6880	9	,	,	,
cord-005453-4057qib7	6880	10	CsA	csa	NN
cord-005453-4057qib7	6880	11	as	as	IN
cord-005453-4057qib7	6880	12	4-hours	4-hours	CD
cord-005453-4057qib7	6880	13	bolus	bolus	NN
cord-005453-4057qib7	6880	14	injections	injection	NNS
cord-005453-4057qib7	6880	15	;	;	.
cord-005453-4057qib7	6881	1	both	both	DT
cord-005453-4057qib7	6881	2	target	target	NN
cord-005453-4057qib7	6881	3	level	level	NN
cord-005453-4057qib7	6881	4	adjusted	adjust	VBN
cord-005453-4057qib7	6881	5	(	(	-LRB-
cord-005453-4057qib7	6881	6	CsA	CsA	NNP
cord-005453-4057qib7	6881	7	:	:	:
cord-005453-4057qib7	6881	8	100	100	CD
cord-005453-4057qib7	6881	9	-	-	SYM
cord-005453-4057qib7	6881	10	120	120	CD
cord-005453-4057qib7	6881	11	ng	ng	NN
cord-005453-4057qib7	6881	12	/	/	SYM
cord-005453-4057qib7	6881	13	ml	ml	XX
cord-005453-4057qib7	6881	14	;	;	:
cord-005453-4057qib7	6881	15	FK506	fk506	NN
cord-005453-4057qib7	6881	16	:	:	:
cord-005453-4057qib7	6881	17	5	5	CD
cord-005453-4057qib7	6881	18	-	-	SYM
cord-005453-4057qib7	6881	19	8	8	CD
cord-005453-4057qib7	6881	20	ng/	ng/	NN
cord-005453-4057qib7	6881	21	ml	ml	NNP
cord-005453-4057qib7	6881	22	)	)	-RRB-
cord-005453-4057qib7	6881	23	.	.	.
cord-005453-4057qib7	6882	1	Duration	duration	NN
cord-005453-4057qib7	6882	2	of	of	IN
cord-005453-4057qib7	6882	3	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	6882	4	was	be	VBD
cord-005453-4057qib7	6882	5	>	>	NFP
cord-005453-4057qib7	6882	6	6	6	CD
cord-005453-4057qib7	6882	7	months	month	NNS
cord-005453-4057qib7	6882	8	in	in	IN
cord-005453-4057qib7	6882	9	Thaplo	Thaplo	NNP
cord-005453-4057qib7	6882	10	-	-	HYPH
cord-005453-4057qib7	6882	11	SCT	SCT	NNP
cord-005453-4057qib7	6882	12	and	and	CC
cord-005453-4057qib7	6882	13	<	<	NNP
cord-005453-4057qib7	6882	14	6	6	CD
cord-005453-4057qib7	6882	15	months	month	NNS
cord-005453-4057qib7	6882	16	in	in	IN
cord-005453-4057qib7	6882	17	MSD	MSD	NNP
cord-005453-4057qib7	6882	18	,	,	,
cord-005453-4057qib7	6882	19	depending	depend	VBG
cord-005453-4057qib7	6882	20	on	on	IN
cord-005453-4057qib7	6882	21	chimerism	chimerism	NN
cord-005453-4057qib7	6882	22	.	.	.
cord-005453-4057qib7	6883	1	Results	result	NNS
cord-005453-4057qib7	6883	2	:	:	:
cord-005453-4057qib7	6884	1	CNI	CNI	NNP
cord-005453-4057qib7	6884	2	-	-	HYPH
cord-005453-4057qib7	6884	3	related	relate	VBN
cord-005453-4057qib7	6884	4	NT	NT	NNP
cord-005453-4057qib7	6884	5	was	be	VBD
cord-005453-4057qib7	6884	6	observed	observe	VBN
cord-005453-4057qib7	6884	7	in	in	IN
cord-005453-4057qib7	6884	8	36.4	36.4	CD
cord-005453-4057qib7	6884	9	%	%	NN
cord-005453-4057qib7	6884	10	,	,	,
cord-005453-4057qib7	6884	11	severe	severe	JJ
cord-005453-4057qib7	6884	12	NT	NT	NNP
cord-005453-4057qib7	6884	13	(	(	-LRB-
cord-005453-4057qib7	6884	14	PRES	PRES	NNP
cord-005453-4057qib7	6884	15	,	,	,
cord-005453-4057qib7	6884	16	visual	visual	JJ
cord-005453-4057qib7	6884	17	disturbance	disturbance	NN
cord-005453-4057qib7	6884	18	,	,	,
cord-005453-4057qib7	6884	19	aphasia	aphasia	NN
cord-005453-4057qib7	6884	20	)	)	-RRB-
cord-005453-4057qib7	6884	21	in	in	IN
cord-005453-4057qib7	6884	22	21.2	21.2	CD
cord-005453-4057qib7	6884	23	%	%	NN
cord-005453-4057qib7	6884	24	.	.	.
cord-005453-4057qib7	6885	1	NT	NT	NNP
cord-005453-4057qib7	6885	2	was	be	VBD
cord-005453-4057qib7	6885	3	more	more	RBR
cord-005453-4057qib7	6885	4	prevalent	prevalent	JJ
cord-005453-4057qib7	6885	5	in	in	IN
cord-005453-4057qib7	6885	6	MSD	MSD	NNP
cord-005453-4057qib7	6885	7	(	(	-LRB-
cord-005453-4057qib7	6885	8	n=5	n=5	JJ
cord-005453-4057qib7	6885	9	,	,	,
cord-005453-4057qib7	6885	10	55.5	55.5	CD
cord-005453-4057qib7	6885	11	%	%	NN
cord-005453-4057qib7	6885	12	)	)	-RRB-
cord-005453-4057qib7	6885	13	than	than	IN
cord-005453-4057qib7	6885	14	in	in	IN
cord-005453-4057qib7	6885	15	T	T	NNP
cord-005453-4057qib7	6885	16	-	-	HYPH
cord-005453-4057qib7	6885	17	haplo	haplo	NNP
cord-005453-4057qib7	6885	18	(	(	-LRB-
cord-005453-4057qib7	6885	19	n=7	n=7	NNS
cord-005453-4057qib7	6885	20	,	,	,
cord-005453-4057qib7	6885	21	29.2	29.2	CD
cord-005453-4057qib7	6885	22	%	%	NN
cord-005453-4057qib7	6885	23	)	)	-RRB-
cord-005453-4057qib7	6885	24	.	.	.
cord-005453-4057qib7	6886	1	The	the	DT
cord-005453-4057qib7	6886	2	incidence	incidence	NN
cord-005453-4057qib7	6886	3	of	of	IN
cord-005453-4057qib7	6886	4	NT	NT	NNP
cord-005453-4057qib7	6886	5	was	be	VBD
cord-005453-4057qib7	6886	6	identical	identical	JJ
cord-005453-4057qib7	6886	7	under	under	IN
cord-005453-4057qib7	6886	8	CsA	csa	NN
cord-005453-4057qib7	6886	9	(	(	-LRB-
cord-005453-4057qib7	6886	10	8/22	8/22	CD
cord-005453-4057qib7	6886	11	;	;	:
cord-005453-4057qib7	6886	12	36.4	36.4	CD
cord-005453-4057qib7	6886	13	%	%	NN
cord-005453-4057qib7	6886	14	)	)	-RRB-
cord-005453-4057qib7	6886	15	and	and	CC
cord-005453-4057qib7	6886	16	FK506	fk506	JJ
cord-005453-4057qib7	6886	17	(	(	-LRB-
cord-005453-4057qib7	6886	18	4/11	4/11	CD
cord-005453-4057qib7	6886	19	;	;	:
cord-005453-4057qib7	6886	20	36.4	36.4	CD
cord-005453-4057qib7	6886	21	%	%	NN
cord-005453-4057qib7	6886	22	)	)	-RRB-
cord-005453-4057qib7	6886	23	,	,	,
cord-005453-4057qib7	6886	24	however	however	RB
cord-005453-4057qib7	6886	25	the	the	DT
cord-005453-4057qib7	6886	26	majority	majority	NN
cord-005453-4057qib7	6886	27	of	of	IN
cord-005453-4057qib7	6886	28	severe	severe	JJ
cord-005453-4057qib7	6886	29	NT	NT	NNP
cord-005453-4057qib7	6886	30	(	(	-LRB-
cord-005453-4057qib7	6886	31	all	all	DT
cord-005453-4057qib7	6886	32	PRES	PRES	NNP
cord-005453-4057qib7	6886	33	)	)	-RRB-
cord-005453-4057qib7	6886	34	occurred	occur	VBD
cord-005453-4057qib7	6886	35	with	with	IN
cord-005453-4057qib7	6886	36	CsA.	CsA.	NNP
cord-005453-4057qib7	6887	1	Complete	complete	JJ
cord-005453-4057qib7	6887	2	recovery	recovery	NN
cord-005453-4057qib7	6887	3	of	of	IN
cord-005453-4057qib7	6887	4	NT	NT	NNP
cord-005453-4057qib7	6887	5	was	be	VBD
cord-005453-4057qib7	6887	6	achieved	achieve	VBN
cord-005453-4057qib7	6887	7	in	in	IN
cord-005453-4057qib7	6887	8	all	all	DT
cord-005453-4057qib7	6887	9	pts	pt	NNS
cord-005453-4057qib7	6887	10	either	either	CC
cord-005453-4057qib7	6887	11	spontaneously	spontaneously	RB
cord-005453-4057qib7	6887	12	or	or	CC
cord-005453-4057qib7	6887	13	after	after	IN
cord-005453-4057qib7	6887	14	switching	switch	VBG
cord-005453-4057qib7	6887	15	to	to	IN
cord-005453-4057qib7	6887	16	FK506	FK506	NNP
cord-005453-4057qib7	6887	17	/	/	SYM
cord-005453-4057qib7	6887	18	everolimus	everolimus	NN
cord-005453-4057qib7	6887	19	or	or	CC
cord-005453-4057qib7	6887	20	withdrawal	withdrawal	NN
cord-005453-4057qib7	6887	21	of	of	IN
cord-005453-4057qib7	6887	22	FK506	fk506	NN
cord-005453-4057qib7	6887	23	.	.	.
cord-005453-4057qib7	6888	1	Moreover	moreover	RB
cord-005453-4057qib7	6888	2	,	,	,
cord-005453-4057qib7	6888	3	66.6	66.6	CD
cord-005453-4057qib7	6888	4	%	%	NN
cord-005453-4057qib7	6888	5	of	of	IN
cord-005453-4057qib7	6888	6	pts	pt	NNS
cord-005453-4057qib7	6888	7	with	with	IN
cord-005453-4057qib7	6888	8	NT	NT	NNP
cord-005453-4057qib7	6888	9	were	be	VBD
cord-005453-4057qib7	6888	10	>	>	NNS
cord-005453-4057qib7	6888	11	18	18	CD
cord-005453-4057qib7	6888	12	yrs	yr	NNS
cord-005453-4057qib7	6888	13	,	,	,
cord-005453-4057qib7	6888	14	and	and	CC
cord-005453-4057qib7	6888	15	91.6	91.6	CD
cord-005453-4057qib7	6888	16	%	%	NN
cord-005453-4057qib7	6888	17	>	>	SYM
cord-005453-4057qib7	6888	18	12	12	CD
cord-005453-4057qib7	6888	19	yrs	yr	NNS
cord-005453-4057qib7	6888	20	,	,	,
cord-005453-4057qib7	6888	21	suggesting	suggest	VBG
cord-005453-4057qib7	6888	22	an	an	DT
cord-005453-4057qib7	6888	23	increased	increase	VBN
cord-005453-4057qib7	6888	24	risk	risk	NN
cord-005453-4057qib7	6888	25	with	with	IN
cord-005453-4057qib7	6888	26	age	age	NN
cord-005453-4057qib7	6888	27	.	.	.
cord-005453-4057qib7	6889	1	Only	only	RB
cord-005453-4057qib7	6889	2	37.5	37.5	CD
cord-005453-4057qib7	6889	3	%	%	NN
cord-005453-4057qib7	6889	4	of	of	IN
cord-005453-4057qib7	6889	5	pts	pt	NNS
cord-005453-4057qib7	6889	6	with	with	IN
cord-005453-4057qib7	6889	7	pre	pre	JJ
cord-005453-4057qib7	6889	8	-	-	JJ
cord-005453-4057qib7	6889	9	existing	existing	JJ
cord-005453-4057qib7	6889	10	cerebrovascular	cerebrovascular	JJ
cord-005453-4057qib7	6889	11	disease	disease	NN
cord-005453-4057qib7	6889	12	experienced	experience	VBD
cord-005453-4057qib7	6889	13	post	post	JJ
cord-005453-4057qib7	6889	14	-	-	JJ
cord-005453-4057qib7	6889	15	HSCT	HSCT	NNP
cord-005453-4057qib7	6889	16	NT	NT	NNP
cord-005453-4057qib7	6889	17	.	.	.
cord-005453-4057qib7	6890	1	Of	of	IN
cord-005453-4057qib7	6890	2	note	note	NN
cord-005453-4057qib7	6890	3	,	,	,
cord-005453-4057qib7	6890	4	57.1	57.1	CD
cord-005453-4057qib7	6890	5	%	%	NN
cord-005453-4057qib7	6890	6	of	of	IN
cord-005453-4057qib7	6890	7	pts	pts	NN
cord-005453-4057qib7	6890	8	with	with	IN
cord-005453-4057qib7	6890	9	severe	severe	JJ
cord-005453-4057qib7	6890	10	NT	NT	NNP
cord-005453-4057qib7	6890	11	also	also	RB
cord-005453-4057qib7	6890	12	developed	develop	VBD
cord-005453-4057qib7	6890	13	mild	mild	JJ
cord-005453-4057qib7	6890	14	acute	acute	JJ
cord-005453-4057qib7	6890	15	GvHD	gvhd	NN
cord-005453-4057qib7	6890	16	.	.	.
cord-005453-4057qib7	6891	1	The	the	DT
cord-005453-4057qib7	6891	2	overall	overall	JJ
cord-005453-4057qib7	6891	3	(	(	-LRB-
cord-005453-4057qib7	6891	4	OS	OS	NNP
cord-005453-4057qib7	6891	5	)	)	-RRB-
cord-005453-4057qib7	6891	6	and	and	CC
cord-005453-4057qib7	6891	7	disease	disease	NN
cord-005453-4057qib7	6891	8	-	-	HYPH
cord-005453-4057qib7	6891	9	free	free	JJ
cord-005453-4057qib7	6891	10	survival	survival	NN
cord-005453-4057qib7	6891	11	(	(	-LRB-
cord-005453-4057qib7	6891	12	DFS	DFS	NNP
cord-005453-4057qib7	6891	13	)	)	-RRB-
cord-005453-4057qib7	6891	14	with	with	IN
cord-005453-4057qib7	6891	15	a	a	DT
cord-005453-4057qib7	6891	16	median	median	JJ
cord-005453-4057qib7	6891	17	follow	follow	NN
cord-005453-4057qib7	6891	18	-	-	HYPH
cord-005453-4057qib7	6891	19	up	up	NN
cord-005453-4057qib7	6891	20	of	of	IN
cord-005453-4057qib7	6891	21	17	17	CD
cord-005453-4057qib7	6891	22	months	month	NNS
cord-005453-4057qib7	6891	23	in	in	IN
cord-005453-4057qib7	6891	24	T	t	NN
cord-005453-4057qib7	6891	25	-	-	HYPH
cord-005453-4057qib7	6891	26	haplo	haplo	NNP
cord-005453-4057qib7	6891	27	-	-	HYPH
cord-005453-4057qib7	6891	28	HSCT	HSCT	NNP
cord-005453-4057qib7	6891	29	and	and	CC
cord-005453-4057qib7	6891	30	22	22	CD
cord-005453-4057qib7	6891	31	months	month	NNS
cord-005453-4057qib7	6891	32	in	in	IN
cord-005453-4057qib7	6891	33	MSD	MSD	NNP
cord-005453-4057qib7	6891	34	HSCT	HSCT	NNP
cord-005453-4057qib7	6891	35	was	be	VBD
cord-005453-4057qib7	6891	36	91	91	CD
cord-005453-4057qib7	6891	37	%	%	NN
cord-005453-4057qib7	6891	38	vs.	vs.	CC
cord-005453-4057qib7	6891	39	100	100	CD
cord-005453-4057qib7	6891	40	%	%	NN
cord-005453-4057qib7	6891	41	,	,	,
cord-005453-4057qib7	6891	42	respectively	respectively	RB
cord-005453-4057qib7	6891	43	.	.	.
cord-005453-4057qib7	6892	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6892	2	:	:	:
cord-005453-4057qib7	6893	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6893	2	data	datum	NNS
cord-005453-4057qib7	6893	3	confirm	confirm	VBP
cord-005453-4057qib7	6893	4	an	an	DT
cord-005453-4057qib7	6893	5	elevated	elevated	JJ
cord-005453-4057qib7	6893	6	NT	NT	NNP
cord-005453-4057qib7	6893	7	risk	risk	NN
cord-005453-4057qib7	6893	8	in	in	IN
cord-005453-4057qib7	6893	9	SCD	SCD	NNP
cord-005453-4057qib7	6893	10	pts	pts	NN
cord-005453-4057qib7	6893	11	following	follow	VBG
cord-005453-4057qib7	6893	12	allo	allo	NN
cord-005453-4057qib7	6893	13	-	-	HYPH
cord-005453-4057qib7	6893	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6893	15	.	.	.
cord-005453-4057qib7	6894	1	Importantly	importantly	RB
cord-005453-4057qib7	6894	2	,	,	,
cord-005453-4057qib7	6894	3	the	the	DT
cord-005453-4057qib7	6894	4	incidence	incidence	NN
cord-005453-4057qib7	6894	5	of	of	IN
cord-005453-4057qib7	6894	6	NT	NT	NNP
cord-005453-4057qib7	6894	7	seems	seem	VBZ
cord-005453-4057qib7	6894	8	to	to	TO
cord-005453-4057qib7	6894	9	be	be	VB
cord-005453-4057qib7	6894	10	related	relate	VBN
cord-005453-4057qib7	6894	11	to	to	IN
cord-005453-4057qib7	6894	12	age	age	NN
cord-005453-4057qib7	6894	13	(	(	-LRB-
cord-005453-4057qib7	6894	14	91	91	CD
cord-005453-4057qib7	6894	15	%	%	NN
cord-005453-4057qib7	6894	16	of	of	IN
cord-005453-4057qib7	6894	17	pts	pt	NNS
cord-005453-4057qib7	6894	18	with	with	IN
cord-005453-4057qib7	6894	19	NT	NT	NNP
cord-005453-4057qib7	6894	20	were	be	VBD
cord-005453-4057qib7	6894	21	>	>	NNS
cord-005453-4057qib7	6894	22	10	10	CD
cord-005453-4057qib7	6894	23	yrs	yr	NNS
cord-005453-4057qib7	6894	24	)	)	-RRB-
cord-005453-4057qib7	6894	25	,	,	,
cord-005453-4057qib7	6894	26	donor	donor	NN
cord-005453-4057qib7	6894	27	source	source	NN
cord-005453-4057qib7	6894	28	(	(	-LRB-
cord-005453-4057qib7	6894	29	MSD	MSD	NNP
cord-005453-4057qib7	6894	30	55.5	55.5	CD
cord-005453-4057qib7	6894	31	%	%	NN
cord-005453-4057qib7	6894	32	vs.	vs.	FW
cord-005453-4057qib7	6894	33	T	t	NN
cord-005453-4057qib7	6894	34	-	-	HYPH
cord-005453-4057qib7	6894	35	haplo	haplo	NNP
cord-005453-4057qib7	6894	36	29.2	29.2	CD
cord-005453-4057qib7	6894	37	%	%	NN
cord-005453-4057qib7	6894	38	)	)	-RRB-
cord-005453-4057qib7	6894	39	and	and	CC
cord-005453-4057qib7	6894	40	type	type	NN
cord-005453-4057qib7	6894	41	of	of	IN
cord-005453-4057qib7	6894	42	CNI	CNI	NNP
cord-005453-4057qib7	6894	43	inhibitor	inhibitor	NN
cord-005453-4057qib7	6894	44	where	where	WRB
cord-005453-4057qib7	6894	45	almost	almost	RB
cord-005453-4057qib7	6894	46	all	all	DT
cord-005453-4057qib7	6894	47	severe	severe	JJ
cord-005453-4057qib7	6894	48	NT	NT	NNP
cord-005453-4057qib7	6894	49	(	(	-LRB-
cord-005453-4057qib7	6894	50	71.4	71.4	CD
cord-005453-4057qib7	6894	51	%	%	NN
cord-005453-4057qib7	6894	52	,	,	,
cord-005453-4057qib7	6894	53	particularly	particularly	RB
cord-005453-4057qib7	6894	54	all	all	DT
cord-005453-4057qib7	6894	55	PRES	PRES	NNP
cord-005453-4057qib7	6894	56	)	)	-RRB-
cord-005453-4057qib7	6894	57	was	be	VBD
cord-005453-4057qib7	6894	58	observed	observe	VBN
cord-005453-4057qib7	6894	59	under	under	IN
cord-005453-4057qib7	6894	60	CsA.	CsA.	NNP
cord-005453-4057qib7	6894	61	Continuous	continuous	JJ
cord-005453-4057qib7	6894	62	infusion	infusion	NN
cord-005453-4057qib7	6894	63	of	of	IN
cord-005453-4057qib7	6894	64	FK506	fk506	NN
cord-005453-4057qib7	6894	65	vs.	vs.	FW
cord-005453-4057qib7	6894	66	bolus	bolus	NN
cord-005453-4057qib7	6894	67	injections	injection	NNS
cord-005453-4057qib7	6894	68	of	of	IN
cord-005453-4057qib7	6894	69	CsA	CsA	NNP
cord-005453-4057qib7	6894	70	might	may	MD
cord-005453-4057qib7	6894	71	have	have	VB
cord-005453-4057qib7	6894	72	levelled	level	VBN
cord-005453-4057qib7	6894	73	concentration	concentration	NN
cord-005453-4057qib7	6894	74	peaks	peak	NNS
cord-005453-4057qib7	6894	75	.	.	.
cord-005453-4057qib7	6895	1	The	the	DT
cord-005453-4057qib7	6895	2	NT	NT	NNP
cord-005453-4057qib7	6895	3	observed	observe	VBD
cord-005453-4057qib7	6895	4	with	with	IN
cord-005453-4057qib7	6895	5	CsA	CsA	NNP
cord-005453-4057qib7	6895	6	could	could	MD
cord-005453-4057qib7	6895	7	be	be	VB
cord-005453-4057qib7	6895	8	the	the	DT
cord-005453-4057qib7	6895	9	consequence	consequence	NN
cord-005453-4057qib7	6895	10	of	of	IN
cord-005453-4057qib7	6895	11	predominantly	predominantly	RB
cord-005453-4057qib7	6895	12	CsArelated	csarelated	JJ
cord-005453-4057qib7	6895	13	vascular	vascular	JJ
cord-005453-4057qib7	6895	14	toxicity	toxicity	NN
cord-005453-4057qib7	6895	15	inflicting	inflict	VBG
cord-005453-4057qib7	6895	16	pre	pre	JJ
cord-005453-4057qib7	6895	17	-	-	JJ
cord-005453-4057qib7	6895	18	damaged	damaged	JJ
cord-005453-4057qib7	6895	19	vessels	vessel	NNS
cord-005453-4057qib7	6895	20	in	in	IN
cord-005453-4057qib7	6895	21	SCD	SCD	NNP
cord-005453-4057qib7	6895	22	.	.	.
cord-005453-4057qib7	6896	1	The	the	DT
cord-005453-4057qib7	6896	2	mechanism	mechanism	NN
cord-005453-4057qib7	6896	3	of	of	IN
cord-005453-4057qib7	6896	4	action	action	NN
cord-005453-4057qib7	6896	5	could	could	MD
cord-005453-4057qib7	6896	6	be	be	VB
cord-005453-4057qib7	6896	7	related	relate	VBN
cord-005453-4057qib7	6896	8	to	to	IN
cord-005453-4057qib7	6896	9	other	other	JJ
cord-005453-4057qib7	6896	10	systemic	systemic	JJ
cord-005453-4057qib7	6896	11	endotheliopathies	endotheliopathie	NNS
cord-005453-4057qib7	6896	12	such	such	JJ
cord-005453-4057qib7	6896	13	as	as	IN
cord-005453-4057qib7	6896	14	VOD	VOD	NNP
cord-005453-4057qib7	6896	15	,	,	,
cord-005453-4057qib7	6896	16	TAM	TAM	NNP
cord-005453-4057qib7	6896	17	and	and	CC
cord-005453-4057qib7	6896	18	aGvHD	aGvHD	NNP
cord-005453-4057qib7	6896	19	,	,	,
cord-005453-4057qib7	6896	20	which	which	WDT
cord-005453-4057qib7	6896	21	was	be	VBD
cord-005453-4057qib7	6896	22	observed	observe	VBN
cord-005453-4057qib7	6896	23	in	in	IN
cord-005453-4057qib7	6896	24	57.1	57.1	CD
cord-005453-4057qib7	6896	25	%	%	NN
cord-005453-4057qib7	6896	26	of	of	IN
cord-005453-4057qib7	6896	27	pts	pts	NN
cord-005453-4057qib7	6896	28	with	with	IN
cord-005453-4057qib7	6896	29	severe	severe	JJ
cord-005453-4057qib7	6896	30	NT	NT	NNP
cord-005453-4057qib7	6896	31	,	,	,
cord-005453-4057qib7	6896	32	compared	compare	VBN
cord-005453-4057qib7	6896	33	to	to	IN
cord-005453-4057qib7	6896	34	an	an	DT
cord-005453-4057qib7	6896	35	overall	overall	JJ
cord-005453-4057qib7	6896	36	aGvHD	agvhd	NN
cord-005453-4057qib7	6896	37	rate	rate	NN
cord-005453-4057qib7	6896	38	of	of	IN
cord-005453-4057qib7	6896	39	30	30	CD
cord-005453-4057qib7	6896	40	%	%	NN
cord-005453-4057qib7	6896	41	.	.	.
cord-005453-4057qib7	6897	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6897	2	:	:	:
cord-005453-4057qib7	6897	3	Nothing	nothing	NN
cord-005453-4057qib7	6897	4	to	to	TO
cord-005453-4057qib7	6897	5	declare	declare	VB
cord-005453-4057qib7	6897	6	Background	background	NN
cord-005453-4057qib7	6897	7	:	:	:
cord-005453-4057qib7	6897	8	Matched	match	VBN
cord-005453-4057qib7	6897	9	-	-	HYPH
cord-005453-4057qib7	6897	10	related	relate	VBN
cord-005453-4057qib7	6897	11	bone	bone	NN
cord-005453-4057qib7	6897	12	marrow	marrow	NN
cord-005453-4057qib7	6897	13	transplantation	transplantation	NN
cord-005453-4057qib7	6897	14	(	(	-LRB-
cord-005453-4057qib7	6897	15	BMT	BMT	NNP
cord-005453-4057qib7	6897	16	)	)	-RRB-
cord-005453-4057qib7	6897	17	may	may	MD
cord-005453-4057qib7	6897	18	cure	cure	VB
cord-005453-4057qib7	6897	19	over	over	IN
cord-005453-4057qib7	6897	20	80	80	CD
cord-005453-4057qib7	6897	21	%	%	NN
cord-005453-4057qib7	6897	22	of	of	IN
cord-005453-4057qib7	6897	23	low	low	JJ
cord-005453-4057qib7	6897	24	-	-	HYPH
cord-005453-4057qib7	6897	25	riskchildren	riskchildren	NN
cord-005453-4057qib7	6897	26	with	with	IN
cord-005453-4057qib7	6897	27	severe	severe	JJ
cord-005453-4057qib7	6897	28	thalassemia	thalassemia	NN
cord-005453-4057qib7	6897	29	(	(	-LRB-
cord-005453-4057qib7	6897	30	ST	ST	NNP
cord-005453-4057qib7	6897	31	)	)	-RRB-
cord-005453-4057qib7	6897	32	defined	define	VBD
cord-005453-4057qib7	6897	33	as	as	IN
cord-005453-4057qib7	6897	34	a	a	DT
cord-005453-4057qib7	6897	35	thalassemia	thalassemia	NN
cord-005453-4057qib7	6897	36	syndrome	syndrome	NN
cord-005453-4057qib7	6897	37	with	with	IN
cord-005453-4057qib7	6897	38	inability	inability	NN
cord-005453-4057qib7	6897	39	to	to	TO
cord-005453-4057qib7	6897	40	keep	keep	VB
cord-005453-4057qib7	6897	41	a	a	DT
cord-005453-4057qib7	6897	42	spontaneous	spontaneous	JJ
cord-005453-4057qib7	6897	43	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	6897	44	>	>	SYM
cord-005453-4057qib7	6897	45	7	7	CD
cord-005453-4057qib7	6897	46	g	g	NN
cord-005453-4057qib7	6897	47	/	/	SYM
cord-005453-4057qib7	6897	48	dL.	dL.	NNS
cord-005453-4057qib7	6898	1	It	-PRON-	PRP
cord-005453-4057qib7	6898	2	is	be	VBZ
cord-005453-4057qib7	6898	3	well	well	RB
cord-005453-4057qib7	6898	4	known	know	VBN
cord-005453-4057qib7	6898	5	that	that	DT
cord-005453-4057qib7	6898	6	patient	patient	JJ
cord-005453-4057qib7	6898	7	status	status	NN
cord-005453-4057qib7	6898	8	at	at	IN
cord-005453-4057qib7	6898	9	the	the	DT
cord-005453-4057qib7	6898	10	time	time	NN
cord-005453-4057qib7	6898	11	of	of	IN
cord-005453-4057qib7	6898	12	transplant	transplant	NN
cord-005453-4057qib7	6898	13	is	be	VBZ
cord-005453-4057qib7	6898	14	critical	critical	JJ
cord-005453-4057qib7	6898	15	in	in	IN
cord-005453-4057qib7	6898	16	predicting	predict	VBG
cord-005453-4057qib7	6898	17	transplant	transplant	NN
cord-005453-4057qib7	6898	18	outcome	outcome	NN
cord-005453-4057qib7	6898	19	.	.	.
cord-005453-4057qib7	6899	1	Liver	liver	NN
cord-005453-4057qib7	6899	2	size	size	NN
cord-005453-4057qib7	6899	3	>	>	XX
cord-005453-4057qib7	6899	4	2	2	CD
cord-005453-4057qib7	6899	5	cm	cm	NN
cord-005453-4057qib7	6899	6	is	be	VBZ
cord-005453-4057qib7	6899	7	an	an	DT
cord-005453-4057qib7	6899	8	established	establish	VBN
cord-005453-4057qib7	6899	9	adverse	adverse	JJ
cord-005453-4057qib7	6899	10	prognostic	prognostic	JJ
cord-005453-4057qib7	6899	11	factor	factor	NN
cord-005453-4057qib7	6899	12	in	in	IN
cord-005453-4057qib7	6899	13	terms	term	NNS
cord-005453-4057qib7	6899	14	of	of	IN
cord-005453-4057qib7	6899	15	transplant	transplant	NN
cord-005453-4057qib7	6899	16	-	-	HYPH
cord-005453-4057qib7	6899	17	related	relate	VBN
cord-005453-4057qib7	6899	18	mortality	mortality	NN
cord-005453-4057qib7	6899	19	and	and	CC
cord-005453-4057qib7	6899	20	,	,	,
cord-005453-4057qib7	6899	21	in	in	IN
cord-005453-4057qib7	6899	22	our	-PRON-	PRP$
cord-005453-4057qib7	6899	23	own	own	JJ
cord-005453-4057qib7	6899	24	experience	experience	NN
cord-005453-4057qib7	6899	25	,	,	,
cord-005453-4057qib7	6899	26	a	a	DT
cord-005453-4057qib7	6899	27	spleen	spleen	NN
cord-005453-4057qib7	6899	28	size	size	NN
cord-005453-4057qib7	6899	29	>	>	XX
cord-005453-4057qib7	6899	30	3	3	CD
cord-005453-4057qib7	6899	31	cm	cm	NN
cord-005453-4057qib7	6899	32	from	from	IN
cord-005453-4057qib7	6899	33	costal	costal	JJ
cord-005453-4057qib7	6899	34	marginis	marginis	NNP
cord-005453-4057qib7	6899	35	associated	associate	VBN
cord-005453-4057qib7	6899	36	with	with	IN
cord-005453-4057qib7	6899	37	increase	increase	NN
cord-005453-4057qib7	6899	38	rejection	rejection	NN
cord-005453-4057qib7	6899	39	rates	rate	NNS
cord-005453-4057qib7	6899	40	(	(	-LRB-
cord-005453-4057qib7	6899	41	Blood	blood	NN
cord-005453-4057qib7	6899	42	2017	2017	CD
cord-005453-4057qib7	6899	43	vol	vol	NN
cord-005453-4057qib7	6899	44	.	.	.
cord-005453-4057qib7	6900	1	130	130	CD
cord-005453-4057qib7	6900	2	no	no	UH
cord-005453-4057qib7	6900	3	.	.	.
cord-005453-4057qib7	6901	1	Suppl	Suppl	NNP
cord-005453-4057qib7	6901	2	1	1	CD
cord-005453-4057qib7	6901	3	1944	1944	CD
cord-005453-4057qib7	6901	4	)	)	-RRB-
cord-005453-4057qib7	6901	5	.	.	.
cord-005453-4057qib7	6902	1	Optimising	optimise	VBG
cord-005453-4057qib7	6902	2	liver	liver	NN
cord-005453-4057qib7	6902	3	and	and	CC
cord-005453-4057qib7	6902	4	spleen	spleen	NN
cord-005453-4057qib7	6902	5	size	size	NN
cord-005453-4057qib7	6902	6	prior	prior	RB
cord-005453-4057qib7	6902	7	to	to	IN
cord-005453-4057qib7	6902	8	transplant	transplant	NN
cord-005453-4057qib7	6902	9	is	be	VBZ
cord-005453-4057qib7	6902	10	likely	likely	JJ
cord-005453-4057qib7	6902	11	to	to	TO
cord-005453-4057qib7	6902	12	improve	improve	VB
cord-005453-4057qib7	6902	13	transplant	transplant	NN
cord-005453-4057qib7	6902	14	outcomes	outcome	NNS
cord-005453-4057qib7	6902	15	.	.	.
cord-005453-4057qib7	6903	1	Methods	method	NNS
cord-005453-4057qib7	6903	2	:	:	:
cord-005453-4057qib7	6903	3	We	-PRON-	PRP
cord-005453-4057qib7	6903	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	6903	5	reviewed	review	VBD
cord-005453-4057qib7	6903	6	the	the	DT
cord-005453-4057qib7	6903	7	effectiveness	effectiveness	NN
cord-005453-4057qib7	6903	8	of	of	IN
cord-005453-4057qib7	6903	9	our	-PRON-	PRP$
cord-005453-4057qib7	6903	10	strategy	strategy	NN
cord-005453-4057qib7	6903	11	to	to	TO
cord-005453-4057qib7	6903	12	reduce	reduce	VB
cord-005453-4057qib7	6903	13	liver	liver	NN
cord-005453-4057qib7	6903	14	and	and	CC
cord-005453-4057qib7	6903	15	spleen	spleen	NN
cord-005453-4057qib7	6903	16	size	size	NN
cord-005453-4057qib7	6903	17	pre	pre	NN
cord-005453-4057qib7	6903	18	-	-	NN
cord-005453-4057qib7	6903	19	transplant	transplant	JJ
cord-005453-4057qib7	6903	20	using	use	VBG
cord-005453-4057qib7	6903	21	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	6903	22	,	,	,
cord-005453-4057qib7	6903	23	super	super	JJ
cord-005453-4057qib7	6903	24	-	-	JJ
cord-005453-4057qib7	6903	25	transfusion	transfusion	NN
cord-005453-4057qib7	6903	26	and	and	CC
cord-005453-4057qib7	6903	27	intensive	intensive	JJ
cord-005453-4057qib7	6903	28	iron	iron	NN
cord-005453-4057qib7	6903	29	chelation	chelation	NN
cord-005453-4057qib7	6903	30	.	.	.
cord-005453-4057qib7	6904	1	We	-PRON-	PRP
cord-005453-4057qib7	6904	2	considered	consider	VBD
cord-005453-4057qib7	6904	3	liver	liver	NN
cord-005453-4057qib7	6904	4	size	size	NN
cord-005453-4057qib7	6904	5	<	<	XX
cord-005453-4057qib7	6904	6	2	2	CD
cord-005453-4057qib7	6904	7	cm	cm	NNS
cord-005453-4057qib7	6904	8	and	and	CC
cord-005453-4057qib7	6904	9	spleen	spleen	NN
cord-005453-4057qib7	6904	10	size	size	NN
cord-005453-4057qib7	6904	11	less	less	JJR
cord-005453-4057qib7	6904	12	than	than	IN
cord-005453-4057qib7	6904	13	3	3	CD
cord-005453-4057qib7	6904	14	cm	cm	NNS
cord-005453-4057qib7	6904	15	below	below	IN
cord-005453-4057qib7	6904	16	costal	costal	JJ
cord-005453-4057qib7	6904	17	margins	margin	NNS
cord-005453-4057qib7	6904	18	as	as	IN
cord-005453-4057qib7	6904	19	good	good	JJ
cord-005453-4057qib7	6904	20	risk	risk	NN
cord-005453-4057qib7	6904	21	features	feature	NNS
cord-005453-4057qib7	6904	22	.	.	.
cord-005453-4057qib7	6905	1	Liver	liver	NN
cord-005453-4057qib7	6905	2	biopsies	biopsy	NNS
cord-005453-4057qib7	6905	3	were	be	VBD
cord-005453-4057qib7	6905	4	not	not	RB
cord-005453-4057qib7	6905	5	performed	perform	VBN
cord-005453-4057qib7	6905	6	thus	thus	RB
cord-005453-4057qib7	6905	7	Pesaro	Pesaro	NNP
cord-005453-4057qib7	6905	8	risk	risk	NN
cord-005453-4057qib7	6905	9	classification	classification	NN
cord-005453-4057qib7	6905	10	could	could	MD
cord-005453-4057qib7	6905	11	not	not	RB
cord-005453-4057qib7	6905	12	be	be	VB
cord-005453-4057qib7	6905	13	assigned	assign	VBN
cord-005453-4057qib7	6905	14	.	.	.
cord-005453-4057qib7	6906	1	All	all	DT
cord-005453-4057qib7	6906	2	transplant	transplant	NN
cord-005453-4057qib7	6906	3	candidates	candidate	NNS
cord-005453-4057qib7	6906	4	were	be	VBD
cord-005453-4057qib7	6906	5	started	start	VBN
cord-005453-4057qib7	6906	6	on	on	IN
cord-005453-4057qib7	6906	7	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	6906	8	for	for	IN
cord-005453-4057qib7	6906	9	a	a	DT
cord-005453-4057qib7	6906	10	minimum	minimum	NN
cord-005453-4057qib7	6906	11	of	of	IN
cord-005453-4057qib7	6906	12	3	3	CD
cord-005453-4057qib7	6906	13	months	month	NNS
cord-005453-4057qib7	6906	14	and	and	CC
cord-005453-4057qib7	6906	15	pre	pre	JJ
cord-005453-4057qib7	6906	16	-	-	JJ
cord-005453-4057qib7	6906	17	transfusion	transfusion	JJ
cord-005453-4057qib7	6906	18	haemoglobin	haemoglobin	NN
cord-005453-4057qib7	6906	19	was	be	VBD
cord-005453-4057qib7	6906	20	maintained	maintain	VBN
cord-005453-4057qib7	6906	21	>	>	XX
cord-005453-4057qib7	6907	1	7	7	CD
cord-005453-4057qib7	6907	2	gm	gm	NNP
cord-005453-4057qib7	6907	3	/	/	SYM
cord-005453-4057qib7	6907	4	dl	dl	NN
cord-005453-4057qib7	6908	1	while	while	IN
cord-005453-4057qib7	6908	2	on	on	IN
cord-005453-4057qib7	6908	3	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	6908	4	.	.	.
cord-005453-4057qib7	6909	1	If	if	IN
cord-005453-4057qib7	6909	2	the	the	DT
cord-005453-4057qib7	6909	3	child	child	NN
cord-005453-4057qib7	6909	4	had	have	VBD
cord-005453-4057qib7	6909	5	hepatospenomegaly	hepatospenomegaly	NNP
cord-005453-4057qib7	6909	6	at	at	IN
cord-005453-4057qib7	6909	7	enrollmentand	enrollmentand	,
cord-005453-4057qib7	6909	8	no	no	DT
cord-005453-4057qib7	6909	9	improvement	improvement	NN
cord-005453-4057qib7	6909	10	in	in	IN
cord-005453-4057qib7	6909	11	liver	liver	NN
cord-005453-4057qib7	6909	12	and	and	CC
cord-005453-4057qib7	6909	13	spleen	spleen	NN
cord-005453-4057qib7	6909	14	size	size	NN
cord-005453-4057qib7	6909	15	after	after	IN
cord-005453-4057qib7	6909	16	an	an	DT
cord-005453-4057qib7	6909	17	adequate	adequate	JJ
cord-005453-4057qib7	6909	18	trial	trial	NN
cord-005453-4057qib7	6909	19	of	of	IN
cord-005453-4057qib7	6909	20	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	6909	21	(	(	-LRB-
cord-005453-4057qib7	6909	22	minimum	minimum	NN
cord-005453-4057qib7	6909	23	of	of	IN
cord-005453-4057qib7	6909	24	3	3	CD
cord-005453-4057qib7	6909	25	months	month	NNS
cord-005453-4057qib7	6909	26	of	of	IN
cord-005453-4057qib7	6909	27	treatment	treatment	NN
cord-005453-4057qib7	6909	28	achieving	achieve	VBG
cord-005453-4057qib7	6909	29	maximum	maximum	JJ
cord-005453-4057qib7	6909	30	dose	dose	NN
cord-005453-4057qib7	6909	31	of	of	IN
cord-005453-4057qib7	6909	32	50	50	CD
cord-005453-4057qib7	6909	33	mg	mg	NNP
cord-005453-4057qib7	6909	34	/	/	SYM
cord-005453-4057qib7	6909	35	kg	kg	NNP
cord-005453-4057qib7	6909	36	day	day	NN
cord-005453-4057qib7	6909	37	or	or	CC
cord-005453-4057qib7	6909	38	tolerable	tolerable	JJ
cord-005453-4057qib7	6909	39	haematological	haematological	JJ
cord-005453-4057qib7	6909	40	toxicity	toxicity	NN
cord-005453-4057qib7	6909	41	,	,	,
cord-005453-4057qib7	6909	42	i.e.	i.e.	FW
cord-005453-4057qib7	6909	43	neutrophil	neutrophil	NN
cord-005453-4057qib7	6909	44	count	count	NN
cord-005453-4057qib7	6909	45	between	between	IN
cord-005453-4057qib7	6909	46	1000	1000	CD
cord-005453-4057qib7	6909	47	and	and	CC
cord-005453-4057qib7	6909	48	1500/	1500/	CD
cord-005453-4057qib7	6910	1	μL	μL	.
cord-005453-4057qib7	6911	1	and/or	and/or	CC
cord-005453-4057qib7	6911	2	platelet	platelet	NN
cord-005453-4057qib7	6911	3	count	count	NN
cord-005453-4057qib7	6911	4	between	between	IN
cord-005453-4057qib7	6911	5	100.000	100.000	CD
cord-005453-4057qib7	6911	6	and	and	CC
cord-005453-4057qib7	6911	7	150.000	150.000	CD
cord-005453-4057qib7	6912	1	/μL	/μL	NFP
cord-005453-4057qib7	6912	2	)	)	-RRB-
cord-005453-4057qib7	6912	3	patients	patient	NNS
cord-005453-4057qib7	6912	4	were	be	VBD
cord-005453-4057qib7	6912	5	given	give	VBN
cord-005453-4057qib7	6912	6	a	a	DT
cord-005453-4057qib7	6912	7	trial	trial	NN
cord-005453-4057qib7	6912	8	of	of	IN
cord-005453-4057qib7	6912	9	supertransfusion	supertransfusion	NN
cord-005453-4057qib7	6912	10	maintaining	maintain	VBG
cord-005453-4057qib7	6912	11	haemoglobin	haemoglobin	NN
cord-005453-4057qib7	6912	12	above	above	IN
cord-005453-4057qib7	6912	13	12	12	CD
cord-005453-4057qib7	6912	14	g	g	NN
cord-005453-4057qib7	6912	15	/	/	SYM
cord-005453-4057qib7	6912	16	dL	dl	NN
cord-005453-4057qib7	6912	17	)	)	-RRB-
cord-005453-4057qib7	6912	18	for	for	IN
cord-005453-4057qib7	6912	19	a	a	DT
cord-005453-4057qib7	6912	20	minimum	minimum	NN
cord-005453-4057qib7	6912	21	of	of	IN
cord-005453-4057qib7	6912	22	3	3	CD
cord-005453-4057qib7	6912	23	months	month	NNS
cord-005453-4057qib7	6912	24	prior	prior	RB
cord-005453-4057qib7	6912	25	to	to	IN
cord-005453-4057qib7	6912	26	declaring	declare	VBG
cord-005453-4057qib7	6912	27	the	the	DT
cord-005453-4057qib7	6912	28	patient	patient	NN
cord-005453-4057qib7	6912	29	as	as	IN
cord-005453-4057qib7	6912	30	having	have	VBG
cord-005453-4057qib7	6912	31	failed	fail	VBN
cord-005453-4057qib7	6912	32	downstaging	downstage	VBG
cord-005453-4057qib7	6912	33	.	.	.
cord-005453-4057qib7	6913	1	Results	result	NNS
cord-005453-4057qib7	6913	2	:	:	:
cord-005453-4057qib7	6914	1	Out	out	IN
cord-005453-4057qib7	6914	2	of	of	IN
cord-005453-4057qib7	6914	3	119	119	CD
cord-005453-4057qib7	6914	4	transplants	transplant	NNS
cord-005453-4057qib7	6914	5	across	across	IN
cord-005453-4057qib7	6914	6	3	3	CD
cord-005453-4057qib7	6914	7	collaborating	collaborate	VBG
cord-005453-4057qib7	6914	8	centers	center	NNS
cord-005453-4057qib7	6914	9	in	in	IN
cord-005453-4057qib7	6914	10	India	India	NNP
cord-005453-4057qib7	6914	11	,	,	,
cord-005453-4057qib7	6914	12	85	85	CD
cord-005453-4057qib7	6914	13	patients	patient	NNS
cord-005453-4057qib7	6914	14	had	have	VBD
cord-005453-4057qib7	6914	15	no	no	DT
cord-005453-4057qib7	6914	16	hepatosplenomegaly	hepatosplenomegaly	NNS
cord-005453-4057qib7	6914	17	at	at	IN
cord-005453-4057qib7	6914	18	enrolment	enrolment	NN
cord-005453-4057qib7	6914	19	and	and	CC
cord-005453-4057qib7	6914	20	hence	hence	RB
cord-005453-4057qib7	6914	21	were	be	VBD
cord-005453-4057qib7	6914	22	not	not	RB
cord-005453-4057qib7	6914	23	actively	actively	RB
cord-005453-4057qib7	6914	24	downstaged	downstage	VBN
cord-005453-4057qib7	6914	25	.	.	.
cord-005453-4057qib7	6915	1	Twelve	twelve	CD
cord-005453-4057qib7	6915	2	patients	patient	NNS
cord-005453-4057qib7	6915	3	were	be	VBD
cord-005453-4057qib7	6915	4	excluded	exclude	VBN
cord-005453-4057qib7	6915	5	due	due	IN
cord-005453-4057qib7	6915	6	to	to	IN
cord-005453-4057qib7	6915	7	inadequate	inadequate	JJ
cord-005453-4057qib7	6915	8	information	information	NN
cord-005453-4057qib7	6915	9	on	on	IN
cord-005453-4057qib7	6915	10	their	-PRON-	PRP$
cord-005453-4057qib7	6915	11	records	record	NNS
cord-005453-4057qib7	6915	12	.	.	.
cord-005453-4057qib7	6916	1	All	all	DT
cord-005453-4057qib7	6916	2	of	of	IN
cord-005453-4057qib7	6916	3	the	the	DT
cord-005453-4057qib7	6916	4	remaining	remain	VBG
cord-005453-4057qib7	6916	5	22	22	CD
cord-005453-4057qib7	6916	6	patients	patient	NNS
cord-005453-4057qib7	6916	7	with	with	IN
cord-005453-4057qib7	6916	8	enlarged	enlarged	JJ
cord-005453-4057qib7	6916	9	liver	liver	NN
cord-005453-4057qib7	6916	10	and/or	and/or	CC
cord-005453-4057qib7	6916	11	spleen	spleen	NNS
cord-005453-4057qib7	6916	12	were	be	VBD
cord-005453-4057qib7	6916	13	downstaged	downstage	VBN
cord-005453-4057qib7	6916	14	to	to	IN
cord-005453-4057qib7	6916	15	low	low	JJ
cord-005453-4057qib7	6916	16	-	-	HYPH
cord-005453-4057qib7	6916	17	risk	risk	NN
cord-005453-4057qib7	6916	18	features	feature	NNS
cord-005453-4057qib7	6916	19	.	.	.
cord-005453-4057qib7	6917	1	All	all	DT
cord-005453-4057qib7	6917	2	patients	patient	NNS
cord-005453-4057qib7	6917	3	received	receive	VBD
cord-005453-4057qib7	6917	4	adequate	adequate	JJ
cord-005453-4057qib7	6917	5	hydroxyurea	hydroxyurea	NN
cord-005453-4057qib7	6917	6	trial	trial	NN
cord-005453-4057qib7	6917	7	among	among	IN
cord-005453-4057qib7	6917	8	which	which	WDT
cord-005453-4057qib7	6917	9	seven	seven	CD
cord-005453-4057qib7	6917	10	(	(	-LRB-
cord-005453-4057qib7	6917	11	32	32	CD
cord-005453-4057qib7	6917	12	%	%	NN
cord-005453-4057qib7	6917	13	)	)	-RRB-
cord-005453-4057qib7	6917	14	patients	patient	NNS
cord-005453-4057qib7	6917	15	required	require	VBD
cord-005453-4057qib7	6917	16	super	super	JJ
cord-005453-4057qib7	6917	17	transfusion	transfusion	NN
cord-005453-4057qib7	6917	18	in	in	IN
cord-005453-4057qib7	6917	19	addition	addition	NN
cord-005453-4057qib7	6917	20	to	to	IN
cord-005453-4057qib7	6917	21	maximal	maximal	JJ
cord-005453-4057qib7	6917	22	hydroxyurea	hydroxyurea	NN
cord-005453-4057qib7	6917	23	.	.	.
cord-005453-4057qib7	6918	1	Out	out	IN
cord-005453-4057qib7	6918	2	of	of	IN
cord-005453-4057qib7	6918	3	the	the	DT
cord-005453-4057qib7	6918	4	22	22	CD
cord-005453-4057qib7	6918	5	patients	patient	NNS
cord-005453-4057qib7	6918	6	18	18	CD
cord-005453-4057qib7	6918	7	(	(	-LRB-
cord-005453-4057qib7	6918	8	82	82	CD
cord-005453-4057qib7	6918	9	%	%	NN
cord-005453-4057qib7	6918	10	)	)	-RRB-
cord-005453-4057qib7	6918	11	were	be	VBD
cord-005453-4057qib7	6918	12	successfully	successfully	RB
cord-005453-4057qib7	6918	13	down	down	RB
cord-005453-4057qib7	6918	14	-	-	HYPH
cord-005453-4057qib7	6918	15	staged	stage	VBN
cord-005453-4057qib7	6918	16	with	with	IN
cord-005453-4057qib7	6918	17	the	the	DT
cord-005453-4057qib7	6918	18	above	above	JJ
cord-005453-4057qib7	6918	19	strategy	strategy	NN
cord-005453-4057qib7	6918	20	and	and	CC
cord-005453-4057qib7	6918	21	proceeded	proceed	VBD
cord-005453-4057qib7	6918	22	to	to	TO
cord-005453-4057qib7	6918	23	transplant	transplant	VB
cord-005453-4057qib7	6918	24	as	as	RB
cord-005453-4057qib7	6918	25	low	low	JJ
cord-005453-4057qib7	6918	26	-	-	HYPH
cord-005453-4057qib7	6918	27	risk	risk	NN
cord-005453-4057qib7	6918	28	patients	patient	NNS
cord-005453-4057qib7	6918	29	.	.	.
cord-005453-4057qib7	6919	1	Among	among	IN
cord-005453-4057qib7	6919	2	the	the	DT
cord-005453-4057qib7	6919	3	remaining	remain	VBG
cord-005453-4057qib7	6919	4	4	4	CD
cord-005453-4057qib7	6919	5	(	(	-LRB-
cord-005453-4057qib7	6919	6	25	25	CD
cord-005453-4057qib7	6919	7	%	%	NN
cord-005453-4057qib7	6919	8	)	)	-RRB-
cord-005453-4057qib7	6919	9	patients	patient	NNS
cord-005453-4057qib7	6919	10	3	3	CD
cord-005453-4057qib7	6919	11	had	have	VBD
cord-005453-4057qib7	6919	12	liver	liver	NN
cord-005453-4057qib7	6919	13	>	>	XX
cord-005453-4057qib7	6919	14	2	2	CD
cord-005453-4057qib7	6919	15	cm	cm	NNS
cord-005453-4057qib7	6919	16	and	and	CC
cord-005453-4057qib7	6919	17	one	one	CD
cord-005453-4057qib7	6919	18	had	have	VBD
cord-005453-4057qib7	6919	19	a	a	DT
cord-005453-4057qib7	6919	20	spleen	spleen	NN
cord-005453-4057qib7	6919	21	>	>	XX
cord-005453-4057qib7	6920	1	3	3	CD
cord-005453-4057qib7	6920	2	cm	cm	NNS
cord-005453-4057qib7	6920	3	only	only	RB
cord-005453-4057qib7	6920	4	.	.	.
cord-005453-4057qib7	6921	1	There	there	EX
cord-005453-4057qib7	6921	2	was	be	VBD
cord-005453-4057qib7	6921	3	significant	significant	JJ
cord-005453-4057qib7	6921	4	improvement	improvement	NN
cord-005453-4057qib7	6921	5	in	in	IN
cord-005453-4057qib7	6921	6	liver	liver	NN
cord-005453-4057qib7	6921	7	and	and	CC
cord-005453-4057qib7	6921	8	spleen	spleen	NN
cord-005453-4057qib7	6921	9	size	size	NN
cord-005453-4057qib7	6921	10	from	from	IN
cord-005453-4057qib7	6921	11	the	the	DT
cord-005453-4057qib7	6921	12	time	time	NN
cord-005453-4057qib7	6921	13	of	of	IN
cord-005453-4057qib7	6921	14	enrollment	enrollment	NN
cord-005453-4057qib7	6921	15	to	to	IN
cord-005453-4057qib7	6921	16	transplant	transplant	NN
cord-005453-4057qib7	6921	17	(	(	-LRB-
cord-005453-4057qib7	6921	18	p	p	IN
cord-005453-4057qib7	6921	19	value	value	NN
cord-005453-4057qib7	6921	20	0.0004	0.0004	CD
cord-005453-4057qib7	6921	21	and	and	CC
cord-005453-4057qib7	6921	22	0.0002	0.0002	CD
cord-005453-4057qib7	6921	23	respectively	respectively	RB
cord-005453-4057qib7	6921	24	by	by	IN
cord-005453-4057qib7	6921	25	Wilcoxon	Wilcoxon	NNP
cord-005453-4057qib7	6921	26	test	test	NN
cord-005453-4057qib7	6921	27	for	for	IN
cord-005453-4057qib7	6921	28	paired	pair	VBN
cord-005453-4057qib7	6921	29	samples	sample	NNS
cord-005453-4057qib7	6921	30	-two	-two	ADD
cord-005453-4057qib7	6921	31	tailed	tail	VBN
cord-005453-4057qib7	6921	32	)	)	-RRB-
cord-005453-4057qib7	6921	33	with	with	IN
cord-005453-4057qib7	6921	34	median	median	JJ
cord-005453-4057qib7	6921	35	duration	duration	NN
cord-005453-4057qib7	6921	36	of	of	IN
cord-005453-4057qib7	6921	37	downstaging	downstaging	NN
cord-005453-4057qib7	6921	38	of	of	IN
cord-005453-4057qib7	6921	39	9	9	CD
cord-005453-4057qib7	6921	40	months	month	NNS
cord-005453-4057qib7	6922	1	(	(	-LRB-
cord-005453-4057qib7	6922	2	range	range	NNP
cord-005453-4057qib7	6922	3	2	2	CD
cord-005453-4057qib7	6922	4	-	-	SYM
cord-005453-4057qib7	6922	5	27	27	CD
cord-005453-4057qib7	6922	6	months	month	NNS
cord-005453-4057qib7	6922	7	)	)	-RRB-
cord-005453-4057qib7	6922	8	.	.	.
cord-005453-4057qib7	6923	1	There	there	EX
cord-005453-4057qib7	6923	2	was	be	VBD
cord-005453-4057qib7	6923	3	no	no	DT
cord-005453-4057qib7	6923	4	significant	significant	JJ
cord-005453-4057qib7	6923	5	difference	difference	NN
cord-005453-4057qib7	6923	6	in	in	IN
cord-005453-4057qib7	6923	7	Overall	overall	JJ
cord-005453-4057qib7	6923	8	survival	survival	NN
cord-005453-4057qib7	6923	9	(	(	-LRB-
cord-005453-4057qib7	6923	10	OS	OS	NNP
cord-005453-4057qib7	6923	11	)	)	-RRB-
cord-005453-4057qib7	6923	12	and	and	CC
cord-005453-4057qib7	6923	13	Disease	Disease	NNP
cord-005453-4057qib7	6923	14	-	-	HYPH
cord-005453-4057qib7	6923	15	Free	Free	NNP
cord-005453-4057qib7	6923	16	Survival	Survival	NNP
cord-005453-4057qib7	6923	17	(	(	-LRB-
cord-005453-4057qib7	6923	18	DFS	DFS	NNP
cord-005453-4057qib7	6923	19	)	)	-RRB-
cord-005453-4057qib7	6923	20	by	by	IN
cord-005453-4057qib7	6923	21	log	log	NN
cord-005453-4057qib7	6923	22	rank	rank	NN
cord-005453-4057qib7	6923	23	test	test	NN
cord-005453-4057qib7	6923	24	between	between	IN
cord-005453-4057qib7	6923	25	the	the	DT
cord-005453-4057qib7	6923	26	downstaged	downstaged	JJ
cord-005453-4057qib7	6923	27	group	group	NN
cord-005453-4057qib7	6923	28	and	and	CC
cord-005453-4057qib7	6923	29	those	those	DT
cord-005453-4057qib7	6923	30	who	who	WP
cord-005453-4057qib7	6923	31	did	do	VBD
cord-005453-4057qib7	6923	32	not	not	RB
cord-005453-4057qib7	6923	33	have	have	VB
cord-005453-4057qib7	6923	34	hepatosplenomegaly	hepatosplenomegaly	NNS
cord-005453-4057qib7	6923	35	at	at	IN
cord-005453-4057qib7	6923	36	enrollment	enrollment	NN
cord-005453-4057qib7	6923	37	(	(	-LRB-
cord-005453-4057qib7	6923	38	p	p	NN
cord-005453-4057qib7	6923	39	value	value	NN
cord-005453-4057qib7	6923	40	0.59	0.59	CD
cord-005453-4057qib7	6923	41	0.64	0.64	CD
cord-005453-4057qib7	6923	42	respectively	respectively	RB
cord-005453-4057qib7	6923	43	)	)	-RRB-
cord-005453-4057qib7	6923	44	.	.	.
cord-005453-4057qib7	6924	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6924	2	:	:	:
cord-005453-4057qib7	6925	1	In	in	IN
cord-005453-4057qib7	6925	2	the	the	DT
cord-005453-4057qib7	6925	3	majority	majority	NN
cord-005453-4057qib7	6925	4	of	of	IN
cord-005453-4057qib7	6925	5	children	child	NNS
cord-005453-4057qib7	6925	6	with	with	IN
cord-005453-4057qib7	6925	7	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	6925	8	and	and	CC
cord-005453-4057qib7	6925	9	high	high	JJ
cord-005453-4057qib7	6925	10	transplant	transplant	NN
cord-005453-4057qib7	6925	11	risk	risk	NN
cord-005453-4057qib7	6925	12	features	feature	VBZ
cord-005453-4057qib7	6926	1	liver	liver	NN
cord-005453-4057qib7	6926	2	and	and	CC
cord-005453-4057qib7	6926	3	spleen	spleen	NN
cord-005453-4057qib7	6926	4	size	size	NN
cord-005453-4057qib7	6926	5	can	can	MD
cord-005453-4057qib7	6926	6	be	be	VB
cord-005453-4057qib7	6926	7	reduced	reduce	VBN
cord-005453-4057qib7	6927	1	pre	pre	JJ
cord-005453-4057qib7	6927	2	-	-	NN
cord-005453-4057qib7	6927	3	transplant	transplant	JJ
cord-005453-4057qib7	6927	4	using	use	VBG
cord-005453-4057qib7	6927	5	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	6927	6	and	and	CC
cord-005453-4057qib7	6927	7	supertransfusions	supertransfusion	NNS
cord-005453-4057qib7	6927	8	thereby	thereby	RB
cord-005453-4057qib7	6927	9	decreasing	decrease	VBG
cord-005453-4057qib7	6927	10	transplant	transplant	NN
cord-005453-4057qib7	6927	11	risk	risk	NN
cord-005453-4057qib7	6927	12	.	.	.
cord-005453-4057qib7	6928	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6928	2	:	:	:
cord-005453-4057qib7	6928	3	Nothing	nothing	NN
cord-005453-4057qib7	6928	4	to	to	TO
cord-005453-4057qib7	6928	5	Declare	declare	VB
cord-005453-4057qib7	6928	6	P316	p316	CD
cord-005453-4057qib7	6928	7	Abstract	Abstract	NNP
cord-005453-4057qib7	6928	8	already	already	RB
cord-005453-4057qib7	6928	9	published	publish	VBN
cord-005453-4057qib7	6928	10	.	.	.
cord-005453-4057qib7	6929	1	Abstract	Abstract	NNP
cord-005453-4057qib7	6929	2	withdrawn	withdraw	VBN
cord-005453-4057qib7	6929	3	.	.	.
cord-005453-4057qib7	6930	1	Longitudinal	longitudinal	JJ
cord-005453-4057qib7	6930	2	analysis	analysis	NN
cord-005453-4057qib7	6930	3	of	of	IN
cord-005453-4057qib7	6930	4	the	the	DT
cord-005453-4057qib7	6930	5	effect	effect	NN
cord-005453-4057qib7	6930	6	of	of	IN
cord-005453-4057qib7	6930	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6930	8	cell	cell	NN
cord-005453-4057qib7	6930	9	transplantation	transplantation	NN
cord-005453-4057qib7	6930	10	on	on	IN
cord-005453-4057qib7	6930	11	ocular	ocular	JJ
cord-005453-4057qib7	6930	12	disease	disease	NN
cord-005453-4057qib7	6930	13	in	in	IN
cord-005453-4057qib7	6930	14	children	child	NNS
cord-005453-4057qib7	6930	15	with	with	IN
cord-005453-4057qib7	6930	16	mucopolysaccharidosis	mucopolysaccharidosis	NNP
cord-005453-4057qib7	6931	1	i	i	PRP
cord-005453-4057qib7	6931	2	shows	show	VBZ
cord-005453-4057qib7	6931	3	ongoing	ongoing	JJ
cord-005453-4057qib7	6931	4	disease	disease	NN
cord-005453-4057qib7	6931	5	progression	progression	NN
cord-005453-4057qib7	6931	6	Background	background	NN
cord-005453-4057qib7	6931	7	:	:	:
cord-005453-4057qib7	6931	8	Corneal	corneal	JJ
cord-005453-4057qib7	6931	9	clouding	clouding	NN
cord-005453-4057qib7	6931	10	is	be	VBZ
cord-005453-4057qib7	6931	11	seen	see	VBN
cord-005453-4057qib7	6931	12	in	in	IN
cord-005453-4057qib7	6931	13	nearly	nearly	RB
cord-005453-4057qib7	6931	14	all	all	DT
cord-005453-4057qib7	6931	15	patients	patient	NNS
cord-005453-4057qib7	6931	16	with	with	IN
cord-005453-4057qib7	6931	17	Mucopolysaccharidosis-1	Mucopolysaccharidosis-1	NNP
cord-005453-4057qib7	6931	18	(	(	-LRB-
cord-005453-4057qib7	6931	19	MPS-1	MPS-1	NNP
cord-005453-4057qib7	6931	20	)	)	-RRB-
cord-005453-4057qib7	6931	21	causing	cause	VBG
cord-005453-4057qib7	6931	22	visual	visual	JJ
cord-005453-4057qib7	6931	23	impairment	impairment	NN
cord-005453-4057qib7	6931	24	.	.	.
cord-005453-4057qib7	6932	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6932	2	cell	cell	NN
cord-005453-4057qib7	6932	3	transplantation	transplantation	NN
cord-005453-4057qib7	6932	4	(	(	-LRB-
cord-005453-4057qib7	6932	5	HCT	HCT	NNP
cord-005453-4057qib7	6932	6	)	)	-RRB-
cord-005453-4057qib7	6932	7	is	be	VBZ
cord-005453-4057qib7	6932	8	able	able	JJ
cord-005453-4057qib7	6932	9	to	to	TO
cord-005453-4057qib7	6932	10	stabilize	stabilize	VB
cord-005453-4057qib7	6932	11	disease	disease	NN
cord-005453-4057qib7	6932	12	in	in	IN
cord-005453-4057qib7	6932	13	many	many	JJ
cord-005453-4057qib7	6932	14	organs	organ	NNS
cord-005453-4057qib7	6932	15	including	include	VBG
cord-005453-4057qib7	6932	16	the	the	DT
cord-005453-4057qib7	6932	17	brain	brain	NN
cord-005453-4057qib7	6932	18	.	.	.
cord-005453-4057qib7	6933	1	However	however	RB
cord-005453-4057qib7	6933	2	,	,	,
cord-005453-4057qib7	6933	3	residual	residual	JJ
cord-005453-4057qib7	6933	4	disease	disease	NN
cord-005453-4057qib7	6933	5	in	in	IN
cord-005453-4057qib7	6933	6	peripheral	peripheral	JJ
cord-005453-4057qib7	6933	7	tissues	tissue	NNS
cord-005453-4057qib7	6933	8	is	be	VBZ
cord-005453-4057qib7	6933	9	often	often	RB
cord-005453-4057qib7	6933	10	described	describe	VBN
cord-005453-4057qib7	6933	11	.	.	.
cord-005453-4057qib7	6934	1	Therefore	therefore	RB
cord-005453-4057qib7	6934	2	,	,	,
cord-005453-4057qib7	6934	3	the	the	DT
cord-005453-4057qib7	6934	4	aim	aim	NN
cord-005453-4057qib7	6934	5	of	of	IN
cord-005453-4057qib7	6934	6	this	this	DT
cord-005453-4057qib7	6934	7	study	study	NN
cord-005453-4057qib7	6934	8	was	be	VBD
cord-005453-4057qib7	6934	9	to	to	TO
cord-005453-4057qib7	6934	10	determine	determine	VB
cord-005453-4057qib7	6934	11	the	the	DT
cord-005453-4057qib7	6934	12	long	long	JJ
cord-005453-4057qib7	6934	13	-	-	HYPH
cord-005453-4057qib7	6934	14	term	term	NN
cord-005453-4057qib7	6934	15	effect	effect	NN
cord-005453-4057qib7	6934	16	of	of	IN
cord-005453-4057qib7	6934	17	HCT	hct	NN
cord-005453-4057qib7	6934	18	on	on	IN
cord-005453-4057qib7	6934	19	ocular	ocular	JJ
cord-005453-4057qib7	6934	20	disease	disease	NN
cord-005453-4057qib7	6934	21	in	in	IN
cord-005453-4057qib7	6934	22	MPS-1	MPS-1	NNP
cord-005453-4057qib7	6934	23	patients	patient	NNS
cord-005453-4057qib7	6934	24	.	.	.
cord-005453-4057qib7	6935	1	Methods	method	NNS
cord-005453-4057qib7	6935	2	:	:	:
cord-005453-4057qib7	6935	3	Corneal	corneal	JJ
cord-005453-4057qib7	6935	4	clouding	clouding	NN
cord-005453-4057qib7	6935	5	(	(	-LRB-
cord-005453-4057qib7	6935	6	grade	grade	NN
cord-005453-4057qib7	6935	7	0	0	CD
cord-005453-4057qib7	6935	8	-	-	SYM
cord-005453-4057qib7	6935	9	4	4	CD
cord-005453-4057qib7	6935	10	)	)	-RRB-
cord-005453-4057qib7	6935	11	and	and	CC
cord-005453-4057qib7	6935	12	visual	visual	JJ
cord-005453-4057qib7	6935	13	acuity	acuity	NN
cord-005453-4057qib7	6935	14	(	(	-LRB-
cord-005453-4057qib7	6935	15	Decimal	decimal	JJ
cord-005453-4057qib7	6935	16	scale	scale	NN
cord-005453-4057qib7	6935	17	)	)	-RRB-
cord-005453-4057qib7	6935	18	were	be	VBD
cord-005453-4057qib7	6935	19	prospectively	prospectively	RB
cord-005453-4057qib7	6935	20	collected	collect	VBN
cord-005453-4057qib7	6935	21	from	from	IN
cord-005453-4057qib7	6935	22	all	all	DT
cord-005453-4057qib7	6935	23	consecutive	consecutive	JJ
cord-005453-4057qib7	6935	24	MPS-1	MPS-1	NNP
cord-005453-4057qib7	6935	25	patients	patient	NNS
cord-005453-4057qib7	6935	26	treated	treat	VBN
cord-005453-4057qib7	6935	27	with	with	IN
cord-005453-4057qib7	6935	28	HCT	hct	NN
cord-005453-4057qib7	6935	29	between	between	IN
cord-005453-4057qib7	6935	30	2003	2003	CD
cord-005453-4057qib7	6935	31	and	and	CC
cord-005453-4057qib7	6935	32	2018	2018	CD
cord-005453-4057qib7	6935	33	at	at	IN
cord-005453-4057qib7	6935	34	the	the	DT
cord-005453-4057qib7	6935	35	UMC	UMC	NNP
cord-005453-4057qib7	6935	36	Utrecht	Utrecht	NNP
cord-005453-4057qib7	6935	37	.	.	.
cord-005453-4057qib7	6936	1	The	the	DT
cord-005453-4057qib7	6936	2	primary	primary	JJ
cord-005453-4057qib7	6936	3	outcomes	outcome	NNS
cord-005453-4057qib7	6936	4	of	of	IN
cord-005453-4057qib7	6936	5	interest	interest	NN
cord-005453-4057qib7	6936	6	,	,	,
cord-005453-4057qib7	6936	7	the	the	DT
cord-005453-4057qib7	6936	8	effect	effect	NN
cord-005453-4057qib7	6936	9	of	of	IN
cord-005453-4057qib7	6936	10	time	time	NN
cord-005453-4057qib7	6936	11	on	on	IN
cord-005453-4057qib7	6936	12	corneal	corneal	JJ
cord-005453-4057qib7	6936	13	clouding	clouding	NN
cord-005453-4057qib7	6936	14	and	and	CC
cord-005453-4057qib7	6936	15	visual	visual	JJ
cord-005453-4057qib7	6936	16	acuity	acuity	NN
cord-005453-4057qib7	6936	17	,	,	,
cord-005453-4057qib7	6936	18	were	be	VBD
cord-005453-4057qib7	6936	19	analyzed	analyze	VBN
cord-005453-4057qib7	6936	20	using	use	VBG
cord-005453-4057qib7	6936	21	a	a	DT
cord-005453-4057qib7	6936	22	linear	linear	JJ
cord-005453-4057qib7	6936	23	mixed	mixed	JJ
cord-005453-4057qib7	6936	24	model	model	NN
cord-005453-4057qib7	6936	25	.	.	.
cord-005453-4057qib7	6937	1	The	the	DT
cord-005453-4057qib7	6937	2	correlation	correlation	NN
cord-005453-4057qib7	6937	3	between	between	IN
cord-005453-4057qib7	6937	4	corneal	corneal	JJ
cord-005453-4057qib7	6937	5	clouding	clouding	NN
cord-005453-4057qib7	6937	6	and	and	CC
cord-005453-4057qib7	6937	7	visual	visual	JJ
cord-005453-4057qib7	6937	8	acuity	acuity	NN
cord-005453-4057qib7	6937	9	was	be	VBD
cord-005453-4057qib7	6937	10	analyzed	analyze	VBN
cord-005453-4057qib7	6937	11	with	with	IN
cord-005453-4057qib7	6937	12	Pearson	Pearson	NNP
cord-005453-4057qib7	6937	13	's	's	POS
cord-005453-4057qib7	6937	14	rho	rho	NN
cord-005453-4057qib7	6937	15	.	.	.
cord-005453-4057qib7	6938	1	Other	other	JJ
cord-005453-4057qib7	6938	2	parameters	parameter	NNS
cord-005453-4057qib7	6938	3	studied	study	VBD
cord-005453-4057qib7	6938	4	were	be	VBD
cord-005453-4057qib7	6938	5	clinical	clinical	JJ
cord-005453-4057qib7	6938	6	phenotype	phenotype	NN
cord-005453-4057qib7	6938	7	,	,	,
cord-005453-4057qib7	6938	8	age	age	NN
cord-005453-4057qib7	6938	9	at	at	IN
cord-005453-4057qib7	6938	10	time	time	NN
cord-005453-4057qib7	6938	11	of	of	IN
cord-005453-4057qib7	6939	1	transplantation	transplantation	NN
cord-005453-4057qib7	6939	2	and	and	CC
cord-005453-4057qib7	6939	3	hematological	hematological	JJ
cord-005453-4057qib7	6939	4	enzyme	enzyme	NN
cord-005453-4057qib7	6939	5	level	level	NN
cord-005453-4057qib7	6939	6	after	after	IN
cord-005453-4057qib7	6939	7	transplantation	transplantation	NN
cord-005453-4057qib7	6939	8	.	.	.
cord-005453-4057qib7	6940	1	Other	other	JJ
cord-005453-4057qib7	6940	2	outcomes	outcome	NNS
cord-005453-4057qib7	6940	3	of	of	IN
cord-005453-4057qib7	6940	4	interest	interest	NN
cord-005453-4057qib7	6940	5	analyzed	analyze	VBD
cord-005453-4057qib7	6940	6	included	include	VBD
cord-005453-4057qib7	6940	7	intra	intra	JJ
cord-005453-4057qib7	6940	8	-	-	JJ
cord-005453-4057qib7	6940	9	ocular	ocular	JJ
cord-005453-4057qib7	6940	10	pressure	pressure	NN
cord-005453-4057qib7	6940	11	,	,	,
cord-005453-4057qib7	6940	12	refraction	refraction	NN
cord-005453-4057qib7	6940	13	,	,	,
cord-005453-4057qib7	6940	14	and	and	CC
cord-005453-4057qib7	6940	15	macula	macula	NN
cord-005453-4057qib7	6940	16	and	and	CC
cord-005453-4057qib7	6940	17	lens	lens	NN
cord-005453-4057qib7	6940	18	abnormalities	abnormality	NNS
cord-005453-4057qib7	6940	19	.	.	.
cord-005453-4057qib7	6941	1	[	[	-LRB-
cord-005453-4057qib7	6941	2	[	[	-LRB-
cord-005453-4057qib7	6941	3	P318	p318	CD
cord-005453-4057qib7	6941	4	Image	image	NN
cord-005453-4057qib7	6941	5	]	]	-RRB-
cord-005453-4057qib7	6941	6	1	1	CD
cord-005453-4057qib7	6941	7	.	.	.
cord-005453-4057qib7	6942	1	Results	result	NNS
cord-005453-4057qib7	6942	2	:	:	:
cord-005453-4057qib7	6942	3	24	24	CD
cord-005453-4057qib7	6942	4	successfully	successfully	RB
cord-005453-4057qib7	6942	5	engrafted	engraft	VBN
cord-005453-4057qib7	6942	6	MPS-1	MPS-1	NNP
cord-005453-4057qib7	6942	7	patients	patient	NNS
cord-005453-4057qib7	6942	8	were	be	VBD
cord-005453-4057qib7	6942	9	included	include	VBN
cord-005453-4057qib7	6942	10	(	(	-LRB-
cord-005453-4057qib7	6942	11	92	92	CD
cord-005453-4057qib7	6942	12	%	%	NN
cord-005453-4057qib7	6942	13	with	with	IN
cord-005453-4057qib7	6942	14	>	>	XX
cord-005453-4057qib7	6942	15	95	95	CD
cord-005453-4057qib7	6942	16	%	%	NN
cord-005453-4057qib7	6942	17	chimerism	chimerism	NN
cord-005453-4057qib7	6942	18	and	and	CC
cord-005453-4057qib7	6942	19	normal	normal	JJ
cord-005453-4057qib7	6942	20	enzyme	enzyme	NN
cord-005453-4057qib7	6942	21	levels	level	NNS
cord-005453-4057qib7	6942	22	after	after	IN
cord-005453-4057qib7	6942	23	HCT	HCT	NNP
cord-005453-4057qib7	6942	24	)	)	-RRB-
cord-005453-4057qib7	6942	25	.	.	.
cord-005453-4057qib7	6943	1	Corneal	corneal	JJ
cord-005453-4057qib7	6943	2	clouding	clouding	NN
cord-005453-4057qib7	6943	3	stabilized	stabilize	VBD
cord-005453-4057qib7	6943	4	during	during	IN
cord-005453-4057qib7	6943	5	the	the	DT
cord-005453-4057qib7	6943	6	first	first	JJ
cord-005453-4057qib7	6943	7	years	year	NNS
cord-005453-4057qib7	6943	8	after	after	IN
cord-005453-4057qib7	6943	9	HCT	hct	NN
cord-005453-4057qib7	6943	10	,	,	,
cord-005453-4057qib7	6943	11	but	but	CC
cord-005453-4057qib7	6943	12	increased	increase	VBD
cord-005453-4057qib7	6943	13	rapidly	rapidly	RB
cord-005453-4057qib7	6943	14	beyond	beyond	IN
cord-005453-4057qib7	6943	15	three	three	CD
cord-005453-4057qib7	6943	16	years	year	NNS
cord-005453-4057qib7	6943	17	(	(	-LRB-
cord-005453-4057qib7	6943	18	figure	figure	NN
cord-005453-4057qib7	6943	19	1	1	CD
cord-005453-4057qib7	6943	20	)	)	-RRB-
cord-005453-4057qib7	6943	21	.	.	.
cord-005453-4057qib7	6944	1	Other	other	JJ
cord-005453-4057qib7	6944	2	predictors	predictor	NNS
cord-005453-4057qib7	6944	3	for	for	IN
cord-005453-4057qib7	6944	4	increased	increase	VBN
cord-005453-4057qib7	6944	5	corneal	corneal	JJ
cord-005453-4057qib7	6944	6	clouding	clouding	NN
cord-005453-4057qib7	6944	7	were	be	VBD
cord-005453-4057qib7	6944	8	age	age	NN
cord-005453-4057qib7	6944	9	at	at	IN
cord-005453-4057qib7	6944	10	time	time	NN
cord-005453-4057qib7	6944	11	of	of	IN
cord-005453-4057qib7	6944	12	transplantation	transplantation	NN
cord-005453-4057qib7	6944	13	(	(	-LRB-
cord-005453-4057qib7	6944	14	0.74	0.74	CD
cord-005453-4057qib7	6944	15	,	,	,
cord-005453-4057qib7	6944	16	95%CI	95%ci	CD
cord-005453-4057qib7	6944	17	0.34:1.15	0.34:1.15	CD
cord-005453-4057qib7	6944	18	;	;	:
cord-005453-4057qib7	6944	19	p=0.0026	p=0.0026	VB
cord-005453-4057qib7	6944	20	)	)	-RRB-
cord-005453-4057qib7	6944	21	and	and	CC
cord-005453-4057qib7	6944	22	clinical	clinical	JJ
cord-005453-4057qib7	6944	23	phenotype	phenotype	NN
cord-005453-4057qib7	6944	24	(	(	-LRB-
cord-005453-4057qib7	6944	25	-1.02	-1.02	NFP
cord-005453-4057qib7	6944	26	,	,	,
cord-005453-4057qib7	6944	27	95%CI	95%ci	CD
cord-005453-4057qib7	6944	28	-0.18:-1.86	-0.18:-1.86	VBD
cord-005453-4057qib7	6944	29	;	;	:
cord-005453-4057qib7	6944	30	p=0.0335	p=0.0335	ADD
cord-005453-4057qib7	6944	31	)	)	-RRB-
cord-005453-4057qib7	6944	32	.	.	.
cord-005453-4057qib7	6945	1	Visual	visual	JJ
cord-005453-4057qib7	6945	2	acuity	acuity	NN
cord-005453-4057qib7	6945	3	also	also	RB
cord-005453-4057qib7	6945	4	worsened	worsen	VBD
cord-005453-4057qib7	6945	5	significantly	significantly	RB
cord-005453-4057qib7	6945	6	over	over	IN
cord-005453-4057qib7	6945	7	time	time	NN
cord-005453-4057qib7	6945	8	(	(	-LRB-
cord-005453-4057qib7	6945	9	-0.03	-0.03	CD
cord-005453-4057qib7	6945	10	,	,	,
cord-005453-4057qib7	6945	11	95%CI	95%ci	CD
cord-005453-4057qib7	6945	12	-0.06:-0.007	-0.06:-0.007	NN
cord-005453-4057qib7	6945	13	;	;	:
cord-005453-4057qib7	6945	14	p=0.01	p=0.01	NNP
cord-005453-4057qib7	6945	15	)	)	-RRB-
cord-005453-4057qib7	6945	16	.	.	.
cord-005453-4057qib7	6946	1	Corneal	corneal	JJ
cord-005453-4057qib7	6946	2	clouding	clouding	NN
cord-005453-4057qib7	6946	3	was	be	VBD
cord-005453-4057qib7	6946	4	strongly	strongly	RB
cord-005453-4057qib7	6946	5	negatively	negatively	RB
cord-005453-4057qib7	6946	6	correlated	correlate	VBN
cord-005453-4057qib7	6946	7	with	with	IN
cord-005453-4057qib7	6946	8	visual	visual	JJ
cord-005453-4057qib7	6946	9	acuity	acuity	NN
cord-005453-4057qib7	6946	10	(	(	-LRB-
cord-005453-4057qib7	6946	11	ρ	ρ	CD
cord-005453-4057qib7	6946	12	-0.60	-0.60	CD
cord-005453-4057qib7	6946	13	,	,	,
cord-005453-4057qib7	6946	14	p	p	NN
cord-005453-4057qib7	6946	15	=	=	SYM
cord-005453-4057qib7	6946	16	7.12e-11	7.12e-11	CD
cord-005453-4057qib7	6946	17	)	)	-RRB-
cord-005453-4057qib7	6946	18	.	.	.
cord-005453-4057qib7	6947	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6947	2	:	:	:
cord-005453-4057qib7	6948	1	After	after	IN
cord-005453-4057qib7	6948	2	initial	initial	JJ
cord-005453-4057qib7	6948	3	stabilization	stabilization	NN
cord-005453-4057qib7	6948	4	,	,	,
cord-005453-4057qib7	6948	5	ongoing	ongoing	JJ
cord-005453-4057qib7	6948	6	ocular	ocular	JJ
cord-005453-4057qib7	6948	7	disease	disease	NN
cord-005453-4057qib7	6948	8	is	be	VBZ
cord-005453-4057qib7	6948	9	seen	see	VBN
cord-005453-4057qib7	6948	10	in	in	IN
cord-005453-4057qib7	6948	11	MPS-1	MPS-1	NNP
cord-005453-4057qib7	6948	12	patients	patient	NNS
cord-005453-4057qib7	6948	13	despite	despite	IN
cord-005453-4057qib7	6948	14	successful	successful	JJ
cord-005453-4057qib7	6948	15	HCT	hct	NN
cord-005453-4057qib7	6948	16	.	.	.
cord-005453-4057qib7	6949	1	This	this	DT
cord-005453-4057qib7	6949	2	hallmarks	hallmark	VBD
cord-005453-4057qib7	6949	3	the	the	DT
cord-005453-4057qib7	6949	4	shortcomings	shortcoming	NNS
cord-005453-4057qib7	6949	5	of	of	IN
cord-005453-4057qib7	6949	6	current	current	JJ
cord-005453-4057qib7	6949	7	standard	standard	JJ
cord-005453-4057qib7	6949	8	therapies	therapy	NNS
cord-005453-4057qib7	6949	9	.	.	.
cord-005453-4057qib7	6950	1	New	new	JJ
cord-005453-4057qib7	6950	2	therapies	therapy	NNS
cord-005453-4057qib7	6950	3	that	that	WDT
cord-005453-4057qib7	6950	4	overcome	overcome	VBP
cord-005453-4057qib7	6950	5	the	the	DT
cord-005453-4057qib7	6950	6	weak	weak	JJ
cord-005453-4057qib7	6950	7	spots	spot	NNS
cord-005453-4057qib7	6950	8	of	of	IN
cord-005453-4057qib7	6950	9	current	current	JJ
cord-005453-4057qib7	6950	10	therapies	therapy	NNS
cord-005453-4057qib7	6950	11	are	be	VBP
cord-005453-4057qib7	6950	12	necessary	necessary	JJ
cord-005453-4057qib7	6950	13	to	to	TO
cord-005453-4057qib7	6950	14	improve	improve	VB
cord-005453-4057qib7	6950	15	the	the	DT
cord-005453-4057qib7	6950	16	late	late	JJ
cord-005453-4057qib7	6950	17	outcomes	outcome	NNS
cord-005453-4057qib7	6950	18	of	of	IN
cord-005453-4057qib7	6950	19	these	these	DT
cord-005453-4057qib7	6950	20	patients	patient	NNS
cord-005453-4057qib7	6950	21	.	.	.
cord-005453-4057qib7	6951	1	Clinical	clinical	JJ
cord-005453-4057qib7	6951	2	Trial	Trial	NNP
cord-005453-4057qib7	6951	3	Registry	Registry	NNP
cord-005453-4057qib7	6951	4	:	:	:
cord-005453-4057qib7	6952	1	N.A.	N.A.	NNP
cord-005453-4057qib7	6952	2	Disclosure	Disclosure	NNP
cord-005453-4057qib7	6952	3	:	:	:
cord-005453-4057qib7	6953	1	B.T.A.v.d	b.t.a.v.d	RB
cord-005453-4057qib7	6953	2	.	.	.
cord-005453-4057qib7	6954	1	B.	B.	NNP
cord-005453-4057qib7	6954	2	was	be	VBD
cord-005453-4057qib7	6954	3	supported	support	VBN
cord-005453-4057qib7	6954	4	by	by	IN
cord-005453-4057qib7	6954	5	a	a	DT
cord-005453-4057qib7	6954	6	research	research	NN
cord-005453-4057qib7	6954	7	grant	grant	NN
cord-005453-4057qib7	6954	8	from	from	IN
cord-005453-4057qib7	6954	9	the	the	DT
cord-005453-4057qib7	6954	10	Sylvia	Sylvia	NNP
cord-005453-4057qib7	6954	11	Toth	Toth	NNP
cord-005453-4057qib7	6954	12	Charity	Charity	NNP
cord-005453-4057qib7	6954	13	Foundation	Foundation	NNP
cord-005453-4057qib7	6954	14	,	,	,
cord-005453-4057qib7	6954	15	the	the	DT
cord-005453-4057qib7	6954	16	Hague	Hague	NNP
cord-005453-4057qib7	6954	17	,	,	,
cord-005453-4057qib7	6954	18	the	the	DT
cord-005453-4057qib7	6954	19	Netherlands	Netherlands	NNP
cord-005453-4057qib7	6954	20	,	,	,
cord-005453-4057qib7	6954	21	while	while	IN
cord-005453-4057qib7	6954	22	working	work	VBG
cord-005453-4057qib7	6954	23	on	on	IN
cord-005453-4057qib7	6954	24	this	this	DT
cord-005453-4057qib7	6954	25	study	study	NN
cord-005453-4057qib7	6954	26	.	.	.
cord-005453-4057qib7	6955	1	The	the	DT
cord-005453-4057qib7	6955	2	sponsors	sponsor	NNS
cord-005453-4057qib7	6955	3	of	of	IN
cord-005453-4057qib7	6955	4	this	this	DT
cord-005453-4057qib7	6955	5	study	study	NN
cord-005453-4057qib7	6955	6	are	be	VBP
cord-005453-4057qib7	6955	7	public	public	JJ
cord-005453-4057qib7	6955	8	or	or	CC
cord-005453-4057qib7	6955	9	nonprofit	nonprofit	JJ
cord-005453-4057qib7	6955	10	organizations	organization	NNS
cord-005453-4057qib7	6955	11	that	that	WDT
cord-005453-4057qib7	6955	12	support	support	VBP
cord-005453-4057qib7	6955	13	science	science	NN
cord-005453-4057qib7	6955	14	in	in	IN
cord-005453-4057qib7	6955	15	general	general	JJ
cord-005453-4057qib7	6955	16	.	.	.
cord-005453-4057qib7	6956	1	They	-PRON-	PRP
cord-005453-4057qib7	6956	2	had	have	VBD
cord-005453-4057qib7	6956	3	no	no	DT
cord-005453-4057qib7	6956	4	role	role	NN
cord-005453-4057qib7	6956	5	in	in	IN
cord-005453-4057qib7	6956	6	gathering	gathering	NN
cord-005453-4057qib7	6956	7	,	,	,
cord-005453-4057qib7	6956	8	analyzing	analyze	VBG
cord-005453-4057qib7	6956	9	,	,	,
cord-005453-4057qib7	6956	10	or	or	CC
cord-005453-4057qib7	6956	11	interpreting	interpret	VBG
cord-005453-4057qib7	6956	12	the	the	DT
cord-005453-4057qib7	6956	13	data	datum	NNS
cord-005453-4057qib7	6956	14	.	.	.
cord-005453-4057qib7	6957	1	All	all	DT
cord-005453-4057qib7	6957	2	authors	author	NNS
cord-005453-4057qib7	6957	3	would	would	MD
cord-005453-4057qib7	6957	4	like	like	VB
cord-005453-4057qib7	6957	5	to	to	TO
cord-005453-4057qib7	6957	6	thank	thank	VB
cord-005453-4057qib7	6957	7	all	all	DT
cord-005453-4057qib7	6957	8	parents	parent	NNS
cord-005453-4057qib7	6957	9	and	and	CC
cord-005453-4057qib7	6957	10	patients	patient	NNS
cord-005453-4057qib7	6957	11	for	for	IN
cord-005453-4057qib7	6957	12	participating	participate	VBG
cord-005453-4057qib7	6957	13	in	in	IN
cord-005453-4057qib7	6957	14	this	this	DT
cord-005453-4057qib7	6957	15	study	study	NN
cord-005453-4057qib7	6957	16	.	.	.
cord-005453-4057qib7	6958	1	All	all	DT
cord-005453-4057qib7	6958	2	authors	author	NNS
cord-005453-4057qib7	6958	3	state	state	VBP
cord-005453-4057qib7	6959	1	they	-PRON-	PRP
cord-005453-4057qib7	6959	2	have	have	VBP
cord-005453-4057qib7	6959	3	no	no	DT
cord-005453-4057qib7	6959	4	competitive	competitive	JJ
cord-005453-4057qib7	6959	5	(	(	-LRB-
cord-005453-4057qib7	6959	6	financial	financial	JJ
cord-005453-4057qib7	6959	7	)	)	-RRB-
cord-005453-4057qib7	6959	8	interests	interest	NNS
cord-005453-4057qib7	6959	9	in	in	IN
cord-005453-4057qib7	6959	10	this	this	DT
cord-005453-4057qib7	6959	11	study	study	NN
cord-005453-4057qib7	6959	12	.	.	.
cord-005453-4057qib7	6960	1	Background	background	NN
cord-005453-4057qib7	6960	2	:	:	:
cord-005453-4057qib7	6961	1	Paroxysmal	Paroxysmal	NNP
cord-005453-4057qib7	6961	2	nocturnal	nocturnal	JJ
cord-005453-4057qib7	6961	3	hemoglobinuria	hemoglobinuria	NN
cord-005453-4057qib7	6961	4	(	(	-LRB-
cord-005453-4057qib7	6961	5	PNH	PNH	NNP
cord-005453-4057qib7	6961	6	)	)	-RRB-
cord-005453-4057qib7	6961	7	is	be	VBZ
cord-005453-4057qib7	6961	8	an	an	DT
cord-005453-4057qib7	6961	9	acquired	acquire	VBN
cord-005453-4057qib7	6961	10	clonal	clonal	JJ
cord-005453-4057qib7	6961	11	disorder	disorder	NN
cord-005453-4057qib7	6961	12	of	of	IN
cord-005453-4057qib7	6961	13	the	the	DT
cord-005453-4057qib7	6961	14	hemopoietic	hemopoietic	JJ
cord-005453-4057qib7	6961	15	stem	stem	NN
cord-005453-4057qib7	6961	16	cells	cell	NNS
cord-005453-4057qib7	6961	17	for	for	IN
cord-005453-4057qib7	6961	18	which	which	WDT
cord-005453-4057qib7	6961	19	the	the	DT
cord-005453-4057qib7	6961	20	only	only	JJ
cord-005453-4057qib7	6961	21	curative	curative	JJ
cord-005453-4057qib7	6961	22	treatment	treatment	NN
cord-005453-4057qib7	6961	23	is	be	VBZ
cord-005453-4057qib7	6961	24	allogeneic	allogeneic	VBG
cord-005453-4057qib7	6961	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6961	26	stem	stem	NN
cord-005453-4057qib7	6961	27	cell	cell	NN
cord-005453-4057qib7	6961	28	transplantation	transplantation	NN
cord-005453-4057qib7	6961	29	.	.	.
cord-005453-4057qib7	6962	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	6962	2	donor	donor	NN
cord-005453-4057qib7	6962	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	6962	4	stem	stem	NN
cord-005453-4057qib7	6962	5	cell	cell	NN
cord-005453-4057qib7	6962	6	transplantation	transplantation	NN
cord-005453-4057qib7	6962	7	(	(	-LRB-
cord-005453-4057qib7	6962	8	haplo	haplo	NNP
cord-005453-4057qib7	6962	9	-	-	HYPH
cord-005453-4057qib7	6962	10	HSCT	HSCT	NNP
cord-005453-4057qib7	6962	11	)	)	-RRB-
cord-005453-4057qib7	6962	12	is	be	VBZ
cord-005453-4057qib7	6962	13	now	now	RB
cord-005453-4057qib7	6962	14	increasingly	increasingly	RB
cord-005453-4057qib7	6962	15	applied	apply	VBN
cord-005453-4057qib7	6962	16	as	as	IN
cord-005453-4057qib7	6962	17	a	a	DT
cord-005453-4057qib7	6962	18	curative	curative	JJ
cord-005453-4057qib7	6962	19	therapy	therapy	NN
cord-005453-4057qib7	6962	20	for	for	IN
cord-005453-4057qib7	6962	21	patients	patient	NNS
cord-005453-4057qib7	6962	22	with	with	IN
cord-005453-4057qib7	6962	23	hematologic	hematologic	JJ
cord-005453-4057qib7	6962	24	diseases	disease	NNS
cord-005453-4057qib7	6962	25	.	.	.
cord-005453-4057qib7	6963	1	However	however	RB
cord-005453-4057qib7	6963	2	,	,	,
cord-005453-4057qib7	6963	3	there	there	EX
cord-005453-4057qib7	6963	4	are	be	VBP
cord-005453-4057qib7	6963	5	still	still	RB
cord-005453-4057qib7	6963	6	few	few	JJ
cord-005453-4057qib7	6963	7	reports	report	NNS
cord-005453-4057qib7	6963	8	on	on	IN
cord-005453-4057qib7	6963	9	the	the	DT
cord-005453-4057qib7	6963	10	use	use	NN
cord-005453-4057qib7	6963	11	of	of	IN
cord-005453-4057qib7	6963	12	haplo	haplo	NNP
cord-005453-4057qib7	6963	13	-	-	HYPH
cord-005453-4057qib7	6963	14	HSCT	HSCT	NNP
cord-005453-4057qib7	6963	15	for	for	IN
cord-005453-4057qib7	6963	16	the	the	DT
cord-005453-4057qib7	6963	17	treatment	treatment	NN
cord-005453-4057qib7	6963	18	of	of	IN
cord-005453-4057qib7	6963	19	PNH	PNH	NNP
cord-005453-4057qib7	6963	20	.	.	.
cord-005453-4057qib7	6964	1	Our	-PRON-	PRP$
cord-005453-4057qib7	6964	2	study	study	NN
cord-005453-4057qib7	6964	3	aimed	aim	VBD
cord-005453-4057qib7	6964	4	to	to	TO
cord-005453-4057qib7	6964	5	compare	compare	VB
cord-005453-4057qib7	6964	6	the	the	DT
cord-005453-4057qib7	6964	7	outcomes	outcome	NNS
cord-005453-4057qib7	6964	8	of	of	IN
cord-005453-4057qib7	6964	9	haplo	haplo	NN
cord-005453-4057qib7	6964	10	-	-	HYPH
cord-005453-4057qib7	6964	11	HSCT	HSCT	NNP
cord-005453-4057qib7	6964	12	with	with	IN
cord-005453-4057qib7	6964	13	matched	match	VBN
cord-005453-4057qib7	6964	14	-	-	HYPH
cord-005453-4057qib7	6964	15	sibling	sibling	NN
cord-005453-4057qib7	6964	16	donor	donor	NN
cord-005453-4057qib7	6964	17	transplantation	transplantation	NN
cord-005453-4057qib7	6964	18	(	(	-LRB-
cord-005453-4057qib7	6964	19	MSD	MSD	NNP
cord-005453-4057qib7	6964	20	-	-	HYPH
cord-005453-4057qib7	6964	21	HSCT	HSCT	NNP
cord-005453-4057qib7	6964	22	)	)	-RRB-
cord-005453-4057qib7	6964	23	for	for	IN
cord-005453-4057qib7	6964	24	PNH	PNH	NNP
cord-005453-4057qib7	6964	25	.	.	.
cord-005453-4057qib7	6965	1	Methods	method	NNS
cord-005453-4057qib7	6965	2	:	:	:
cord-005453-4057qib7	6966	1	The	the	DT
cord-005453-4057qib7	6966	2	clinical	clinical	JJ
cord-005453-4057qib7	6966	3	data	datum	NNS
cord-005453-4057qib7	6966	4	of	of	IN
cord-005453-4057qib7	6966	5	40	40	CD
cord-005453-4057qib7	6966	6	PNH	PNH	NNP
cord-005453-4057qib7	6966	7	patients	patient	NNS
cord-005453-4057qib7	6966	8	received	receive	VBD
cord-005453-4057qib7	6966	9	HSCT	HSCT	NNP
cord-005453-4057qib7	6966	10	(	(	-LRB-
cord-005453-4057qib7	6966	11	haplo	haplo	NNP
cord-005453-4057qib7	6966	12	-	-	HYPH
cord-005453-4057qib7	6966	13	HSCT	HSCT	NNP
cord-005453-4057qib7	6966	14	=	=	NFP
cord-005453-4057qib7	6967	1	25	25	CD
cord-005453-4057qib7	6967	2	,	,	,
cord-005453-4057qib7	6967	3	MSD	MSD	NNP
cord-005453-4057qib7	6967	4	-	-	HYPH
cord-005453-4057qib7	6967	5	HSCT	HSCT	NNP
cord-005453-4057qib7	6967	6	=	=	SYM
cord-005453-4057qib7	6967	7	15	15	CD
cord-005453-4057qib7	6967	8	)	)	-RRB-
cord-005453-4057qib7	6967	9	in	in	IN
cord-005453-4057qib7	6967	10	our	-PRON-	PRP$
cord-005453-4057qib7	6967	11	center	center	NN
cord-005453-4057qib7	6967	12	from	from	IN
cord-005453-4057qib7	6967	13	July	July	NNP
cord-005453-4057qib7	6967	14	2007	2007	CD
cord-005453-4057qib7	6967	15	to	to	IN
cord-005453-4057qib7	6967	16	May	May	NNP
cord-005453-4057qib7	6967	17	2018	2018	CD
cord-005453-4057qib7	6967	18	were	be	VBD
cord-005453-4057qib7	6967	19	analyzed	analyze	VBN
cord-005453-4057qib7	6967	20	retrospectively	retrospectively	RB
cord-005453-4057qib7	6967	21	to	to	TO
cord-005453-4057qib7	6967	22	compare	compare	VB
cord-005453-4057qib7	6967	23	the	the	DT
cord-005453-4057qib7	6967	24	outcomes	outcome	NNS
cord-005453-4057qib7	6967	25	of	of	IN
cord-005453-4057qib7	6967	26	haplo	haplo	NNP
cord-005453-4057qib7	6967	27	-	-	HYPH
cord-005453-4057qib7	6967	28	HSCT	HSCT	NNP
cord-005453-4057qib7	6967	29	group	group	NN
cord-005453-4057qib7	6967	30	with	with	IN
cord-005453-4057qib7	6967	31	MSD	MSD	NNP
cord-005453-4057qib7	6967	32	-	-	HYPH
cord-005453-4057qib7	6967	33	HSCT	HSCT	NNP
cord-005453-4057qib7	6967	34	group	group	NN
cord-005453-4057qib7	6967	35	.	.	.
cord-005453-4057qib7	6968	1	The	the	DT
cord-005453-4057qib7	6968	2	clinical	clinical	JJ
cord-005453-4057qib7	6968	3	data	datum	NNS
cord-005453-4057qib7	6968	4	including	include	VBG
cord-005453-4057qib7	6968	5	23	23	CD
cord-005453-4057qib7	6968	6	male	male	JJ
cord-005453-4057qib7	6968	7	patients	patient	NNS
cord-005453-4057qib7	6968	8	and	and	CC
cord-005453-4057qib7	6968	9	17	17	CD
cord-005453-4057qib7	6968	10	female	female	JJ
cord-005453-4057qib7	6968	11	patients	patient	NNS
cord-005453-4057qib7	6968	12	,	,	,
cord-005453-4057qib7	6968	13	13	13	CD
cord-005453-4057qib7	6968	14	classical	classical	JJ
cord-005453-4057qib7	6968	15	PNH	PNH	NNP
cord-005453-4057qib7	6968	16	and	and	CC
cord-005453-4057qib7	6968	17	27	27	CD
cord-005453-4057qib7	6968	18	PNH	PNH	NNP
cord-005453-4057qib7	6968	19	-	-	HYPH
cord-005453-4057qib7	6968	20	AA	AA	NNP
cord-005453-4057qib7	6968	21	syndrome	syndrome	NN
cord-005453-4057qib7	6968	22	,	,	,
cord-005453-4057qib7	6968	23	the	the	DT
cord-005453-4057qib7	6968	24	median	median	JJ
cord-005453-4057qib7	6968	25	age	age	NN
cord-005453-4057qib7	6968	26	was	be	VBD
cord-005453-4057qib7	6968	27	29	29	CD
cord-005453-4057qib7	6968	28	years	year	NNS
cord-005453-4057qib7	6969	1	(	(	-LRB-
cord-005453-4057qib7	6969	2	range	range	NNP
cord-005453-4057qib7	6969	3	6	6	CD
cord-005453-4057qib7	6969	4	-	-	SYM
cord-005453-4057qib7	6969	5	54	54	CD
cord-005453-4057qib7	6969	6	)	)	-RRB-
cord-005453-4057qib7	6969	7	.	.	.
cord-005453-4057qib7	6970	1	All	all	DT
cord-005453-4057qib7	6970	2	patients	patient	NNS
cord-005453-4057qib7	6970	3	had	have	VBD
cord-005453-4057qib7	6970	4	received	receive	VBN
cord-005453-4057qib7	6970	5	various	various	JJ
cord-005453-4057qib7	6970	6	treatments	treatment	NNS
cord-005453-4057qib7	6970	7	before	before	IN
cord-005453-4057qib7	6970	8	transplantation	transplantation	NN
cord-005453-4057qib7	6970	9	such	such	JJ
cord-005453-4057qib7	6970	10	as	as	IN
cord-005453-4057qib7	6970	11	steroids	steroid	NNS
cord-005453-4057qib7	6970	12	,	,	,
cord-005453-4057qib7	6970	13	androgens	androgen	NNS
cord-005453-4057qib7	6970	14	,	,	,
cord-005453-4057qib7	6970	15	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	6970	16	(	(	-LRB-
cord-005453-4057qib7	6970	17	CsA	CsA	NNP
cord-005453-4057qib7	6970	18	)	)	-RRB-
cord-005453-4057qib7	6970	19	,	,	,
cord-005453-4057qib7	6970	20	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	6970	21	globulin	globulin	NN
cord-005453-4057qib7	6970	22	,	,	,
cord-005453-4057qib7	6970	23	and	and	CC
cord-005453-4057qib7	6970	24	growth	growth	NN
cord-005453-4057qib7	6970	25	factors	factor	NNS
cord-005453-4057qib7	6970	26	.	.	.
cord-005453-4057qib7	6971	1	The	the	DT
cord-005453-4057qib7	6971	2	median	median	JJ
cord-005453-4057qib7	6971	3	interval	interval	NN
cord-005453-4057qib7	6971	4	from	from	IN
cord-005453-4057qib7	6971	5	PNH	PNH	NNP
cord-005453-4057qib7	6971	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	6971	7	to	to	IN
cord-005453-4057qib7	6971	8	SCT	SCT	NNP
cord-005453-4057qib7	6971	9	was	be	VBD
cord-005453-4057qib7	6971	10	6	6	CD
cord-005453-4057qib7	6971	11	months	month	NNS
cord-005453-4057qib7	6972	1	(	(	-LRB-
cord-005453-4057qib7	6972	2	range	range	NNP
cord-005453-4057qib7	6972	3	3	3	CD
cord-005453-4057qib7	6972	4	-	-	SYM
cord-005453-4057qib7	6972	5	240	240	CD
cord-005453-4057qib7	6972	6	)	)	-RRB-
cord-005453-4057qib7	6972	7	.	.	.
cord-005453-4057qib7	6973	1	The	the	DT
cord-005453-4057qib7	6973	2	conditioning	conditioning	NN
cord-005453-4057qib7	6973	3	regimen	regimen	NN
cord-005453-4057qib7	6973	4	was	be	VBD
cord-005453-4057qib7	6973	5	modified	modify	VBN
cord-005453-4057qib7	6973	6	BuCybased	BuCybased	NNP
cord-005453-4057qib7	6973	7	regimen	regimen	NN
cord-005453-4057qib7	6973	8	in	in	IN
cord-005453-4057qib7	6973	9	haplo	haplo	NNP
cord-005453-4057qib7	6973	10	-	-	HYPH
cord-005453-4057qib7	6973	11	HSCT	HSCT	NNP
cord-005453-4057qib7	6973	12	group	group	NN
cord-005453-4057qib7	6973	13	,	,	,
cord-005453-4057qib7	6973	14	CsA	CsA	NNP
cord-005453-4057qib7	6973	15	,	,	,
cord-005453-4057qib7	6973	16	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	6973	17	mofetil	mofetil	NNP
cord-005453-4057qib7	6973	18	(	(	-LRB-
cord-005453-4057qib7	6973	19	MMF	MMF	NNP
cord-005453-4057qib7	6973	20	)	)	-RRB-
cord-005453-4057qib7	6973	21	and	and	CC
cord-005453-4057qib7	6973	22	short	short	JJ
cord-005453-4057qib7	6973	23	-	-	HYPH
cord-005453-4057qib7	6973	24	term	term	NN
cord-005453-4057qib7	6973	25	methotrexate	methotrexate	NNP
cord-005453-4057qib7	6973	26	(	(	-LRB-
cord-005453-4057qib7	6973	27	MTX	MTX	NNP
cord-005453-4057qib7	6973	28	)	)	-RRB-
cord-005453-4057qib7	6973	29	were	be	VBD
cord-005453-4057qib7	6973	30	administered	administer	VBN
cord-005453-4057qib7	6973	31	for	for	IN
cord-005453-4057qib7	6973	32	graft	graft	NN
cord-005453-4057qib7	6973	33	-	-	HYPH
cord-005453-4057qib7	6973	34	versus	versus	IN
cord-005453-4057qib7	6973	35	host	host	NN
cord-005453-4057qib7	6973	36	disease	disease	NN
cord-005453-4057qib7	6973	37	(	(	-LRB-
cord-005453-4057qib7	6973	38	GVHD	GVHD	NNP
cord-005453-4057qib7	6973	39	)	)	-RRB-
cord-005453-4057qib7	6973	40	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6973	41	.	.	.
cord-005453-4057qib7	6974	1	Patients	patient	NNS
cord-005453-4057qib7	6974	2	with	with	IN
cord-005453-4057qib7	6974	3	MSD	MSD	NNP
cord-005453-4057qib7	6974	4	-	-	HYPH
cord-005453-4057qib7	6974	5	HSCT	HSCT	NNP
cord-005453-4057qib7	6974	6	were	be	VBD
cord-005453-4057qib7	6974	7	treated	treat	VBN
cord-005453-4057qib7	6974	8	with	with	IN
cord-005453-4057qib7	6974	9	the	the	DT
cord-005453-4057qib7	6974	10	FluCy	flucy	NN
cord-005453-4057qib7	6974	11	-	-	HYPH
cord-005453-4057qib7	6974	12	based	base	VBN
cord-005453-4057qib7	6974	13	regimen	regimen	NN
cord-005453-4057qib7	6974	14	and	and	CC
cord-005453-4057qib7	6974	15	CsA	CsA	NNP
cord-005453-4057qib7	6974	16	were	be	VBD
cord-005453-4057qib7	6974	17	administered	administer	VBN
cord-005453-4057qib7	6974	18	for	for	IN
cord-005453-4057qib7	6974	19	GVHD	GVHD	NNP
cord-005453-4057qib7	6974	20	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	6974	21	.	.	.
cord-005453-4057qib7	6975	1	Results	result	NNS
cord-005453-4057qib7	6975	2	:	:	:
cord-005453-4057qib7	6976	1	There	there	EX
cord-005453-4057qib7	6976	2	were	be	VBD
cord-005453-4057qib7	6976	3	no	no	DT
cord-005453-4057qib7	6976	4	differences	difference	NNS
cord-005453-4057qib7	6976	5	of	of	IN
cord-005453-4057qib7	6976	6	gender	gender	NN
cord-005453-4057qib7	6976	7	,	,	,
cord-005453-4057qib7	6976	8	age	age	NN
cord-005453-4057qib7	6976	9	,	,	,
cord-005453-4057qib7	6976	10	patients	patient	NNS
cord-005453-4057qib7	6976	11	of	of	IN
cord-005453-4057qib7	6976	12	PNH	PNH	NNP
cord-005453-4057qib7	6976	13	-	-	HYPH
cord-005453-4057qib7	6976	14	AA	AA	NNP
cord-005453-4057qib7	6976	15	and	and	CC
cord-005453-4057qib7	6976	16	median	median	JJ
cord-005453-4057qib7	6976	17	time	time	NN
cord-005453-4057qib7	6976	18	from	from	IN
cord-005453-4057qib7	6976	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	6976	20	to	to	IN
cord-005453-4057qib7	6976	21	transplantation	transplantation	NN
cord-005453-4057qib7	6976	22	between	between	IN
cord-005453-4057qib7	6976	23	the	the	DT
cord-005453-4057qib7	6976	24	2	2	CD
cord-005453-4057qib7	6976	25	groups	group	NNS
cord-005453-4057qib7	6976	26	(	(	-LRB-
cord-005453-4057qib7	6976	27	På	På	NNP
cord-005453-4057qib7	6976	28	0.05	0.05	CD
cord-005453-4057qib7	6976	29	)	)	-RRB-
cord-005453-4057qib7	6976	30	.	.	.
cord-005453-4057qib7	6977	1	The	the	DT
cord-005453-4057qib7	6977	2	median	median	JJ
cord-005453-4057qib7	6977	3	values	value	NNS
cord-005453-4057qib7	6977	4	of	of	IN
cord-005453-4057qib7	6977	5	absolute	absolute	JJ
cord-005453-4057qib7	6977	6	nucleated	nucleated	JJ
cord-005453-4057qib7	6977	7	cell	cell	NN
cord-005453-4057qib7	6977	8	counts	count	NNS
cord-005453-4057qib7	6977	9	were	be	VBD
cord-005453-4057qib7	6977	10	10.74	10.74	CD
cord-005453-4057qib7	6977	11	(	(	-LRB-
cord-005453-4057qib7	6977	12	4.80	4.80	CD
cord-005453-4057qib7	6977	13	-	-	SYM
cord-005453-4057qib7	6977	14	22.86	22.86	CD
cord-005453-4057qib7	6977	15	)	)	-RRB-
cord-005453-4057qib7	6978	1	×10	×10	NNS
cord-005453-4057qib7	6978	2	8	8	CD
cord-005453-4057qib7	6979	1	/kg	/kg	NFP
cord-005453-4057qib7	6979	2	in	in	IN
cord-005453-4057qib7	6979	3	the	the	DT
cord-005453-4057qib7	6979	4	haplo	haplo	NNP
cord-005453-4057qib7	6979	5	-	-	HYPH
cord-005453-4057qib7	6979	6	HSCT	HSCT	NNP
cord-005453-4057qib7	6979	7	group	group	NN
cord-005453-4057qib7	6979	8	and	and	CC
cord-005453-4057qib7	6979	9	12.19	12.19	CD
cord-005453-4057qib7	6979	10	(	(	-LRB-
cord-005453-4057qib7	6979	11	5.14	5.14	CD
cord-005453-4057qib7	6979	12	-	-	SYM
cord-005453-4057qib7	6979	13	17.25	17.25	CD
cord-005453-4057qib7	6979	14	)	)	-RRB-
cord-005453-4057qib7	6980	1	×10	×10	NFP
cord-005453-4057qib7	6980	2	8	8	CD
cord-005453-4057qib7	6980	3	/kg	/kg	NFP
cord-005453-4057qib7	6980	4	in	in	IN
cord-005453-4057qib7	6980	5	the	the	DT
cord-005453-4057qib7	6980	6	MSD	MSD	NNP
cord-005453-4057qib7	6980	7	-	-	HYPH
cord-005453-4057qib7	6980	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6980	9	group	group	NN
cord-005453-4057qib7	6980	10	(	(	-LRB-
cord-005453-4057qib7	6980	11	P	p	NN
cord-005453-4057qib7	6980	12	=	=	SYM
cord-005453-4057qib7	6980	13	0.866	0.866	CD
cord-005453-4057qib7	6980	14	)	)	-RRB-
cord-005453-4057qib7	6980	15	.	.	.
cord-005453-4057qib7	6981	1	The	the	DT
cord-005453-4057qib7	6981	2	median	median	JJ
cord-005453-4057qib7	6981	3	doses	dose	NNS
cord-005453-4057qib7	6981	4	of	of	IN
cord-005453-4057qib7	6981	5	CD34	CD34	NNP
cord-005453-4057qib7	6981	6	+	+	CC
cord-005453-4057qib7	6981	7	cells	cell	NNS
cord-005453-4057qib7	6981	8	infused	infuse	VBN
cord-005453-4057qib7	6981	9	were	be	VBD
cord-005453-4057qib7	6981	10	3.57	3.57	CD
cord-005453-4057qib7	6981	11	(	(	-LRB-
cord-005453-4057qib7	6981	12	0.68	0.68	CD
cord-005453-4057qib7	6981	13	-	-	SYM
cord-005453-4057qib7	6981	14	7.80	7.80	CD
cord-005453-4057qib7	6981	15	)	)	-RRB-
cord-005453-4057qib7	6981	16	×10	×10	NFP
cord-005453-4057qib7	6981	17	6	6	CD
cord-005453-4057qib7	6981	18	/kg	/kg	NFP
cord-005453-4057qib7	6981	19	and	and	CC
cord-005453-4057qib7	6981	20	4.00	4.00	CD
cord-005453-4057qib7	6981	21	(	(	-LRB-
cord-005453-4057qib7	6981	22	3.02	3.02	CD
cord-005453-4057qib7	6981	23	-	-	HYPH
cord-005453-4057qib7	6981	24	8.42	8.42	CD
cord-005453-4057qib7	6981	25	)	)	-RRB-
cord-005453-4057qib7	6982	1	×10	×10	NFP
cord-005453-4057qib7	6982	2	6	6	CD
cord-005453-4057qib7	6983	1	/kg	/kg	NFP
cord-005453-4057qib7	6983	2	(	(	-LRB-
cord-005453-4057qib7	6983	3	P	p	NN
cord-005453-4057qib7	6983	4	=	=	SYM
cord-005453-4057qib7	6983	5	0.151	0.151	CD
cord-005453-4057qib7	6983	6	)	)	-RRB-
cord-005453-4057qib7	6983	7	,	,	,
cord-005453-4057qib7	6983	8	respectively	respectively	RB
cord-005453-4057qib7	6983	9	.	.	.
cord-005453-4057qib7	6984	1	All	all	DT
cord-005453-4057qib7	6984	2	patients	patient	NNS
cord-005453-4057qib7	6984	3	attained	attain	VBD
cord-005453-4057qib7	6984	4	complete	complete	JJ
cord-005453-4057qib7	6984	5	engraftment	engraftment	NN
cord-005453-4057qib7	6984	6	,	,	,
cord-005453-4057qib7	6984	7	no	no	DT
cord-005453-4057qib7	6984	8	patient	patient	NN
cord-005453-4057qib7	6984	9	occurred	occur	VBD
cord-005453-4057qib7	6984	10	graft	graft	NN
cord-005453-4057qib7	6984	11	failure	failure	NN
cord-005453-4057qib7	6984	12	.	.	.
cord-005453-4057qib7	6985	1	The	the	DT
cord-005453-4057qib7	6985	2	median	median	JJ
cord-005453-4057qib7	6985	3	time	time	NN
cord-005453-4057qib7	6985	4	for	for	IN
cord-005453-4057qib7	6985	5	myeloid	myeloid	NN
cord-005453-4057qib7	6985	6	engraftment	engraftment	NN
cord-005453-4057qib7	6985	7	were	be	VBD
cord-005453-4057qib7	6985	8	12	12	CD
cord-005453-4057qib7	6986	1	(	(	-LRB-
cord-005453-4057qib7	6986	2	range	range	NN
cord-005453-4057qib7	6986	3	,	,	,
cord-005453-4057qib7	6986	4	9	9	CD
cord-005453-4057qib7	6986	5	-	-	SYM
cord-005453-4057qib7	6986	6	26	26	CD
cord-005453-4057qib7	6986	7	)	)	-RRB-
cord-005453-4057qib7	6986	8	days	day	NNS
cord-005453-4057qib7	6986	9	in	in	IN
cord-005453-4057qib7	6986	10	the	the	DT
cord-005453-4057qib7	6986	11	haplo	haplo	NNP
cord-005453-4057qib7	6986	12	-	-	HYPH
cord-005453-4057qib7	6986	13	HSCT	HSCT	NNP
cord-005453-4057qib7	6986	14	group	group	NN
cord-005453-4057qib7	6986	15	and	and	CC
cord-005453-4057qib7	6986	16	11	11	CD
cord-005453-4057qib7	6986	17	(	(	-LRB-
cord-005453-4057qib7	6986	18	range	range	NN
cord-005453-4057qib7	6986	19	,	,	,
cord-005453-4057qib7	6986	20	7	7	CD
cord-005453-4057qib7	6986	21	-	-	SYM
cord-005453-4057qib7	6986	22	15	15	CD
cord-005453-4057qib7	6986	23	)	)	-RRB-
cord-005453-4057qib7	6986	24	days	day	NNS
cord-005453-4057qib7	6986	25	in	in	IN
cord-005453-4057qib7	6986	26	the	the	DT
cord-005453-4057qib7	6986	27	MSD	MSD	NNP
cord-005453-4057qib7	6986	28	-	-	HYPH
cord-005453-4057qib7	6986	29	HSCT	HSCT	NNP
cord-005453-4057qib7	6986	30	group	group	NN
cord-005453-4057qib7	6986	31	(	(	-LRB-
cord-005453-4057qib7	6986	32	P	p	NN
cord-005453-4057qib7	6986	33	=	=	SYM
cord-005453-4057qib7	6986	34	0.065	0.065	CD
cord-005453-4057qib7	6986	35	)	)	-RRB-
cord-005453-4057qib7	6986	36	.	.	.
cord-005453-4057qib7	6987	1	The	the	DT
cord-005453-4057qib7	6987	2	median	median	JJ
cord-005453-4057qib7	6987	3	time	time	NN
cord-005453-4057qib7	6987	4	for	for	IN
cord-005453-4057qib7	6987	5	platelet	platelet	NN
cord-005453-4057qib7	6987	6	engraftment	engraftment	NN
cord-005453-4057qib7	6987	7	were	be	VBD
cord-005453-4057qib7	6987	8	19	19	CD
cord-005453-4057qib7	6988	1	(	(	-LRB-
cord-005453-4057qib7	6988	2	range	range	NN
cord-005453-4057qib7	6988	3	,	,	,
cord-005453-4057qib7	6988	4	11	11	CD
cord-005453-4057qib7	6988	5	-	-	SYM
cord-005453-4057qib7	6988	6	75	75	CD
cord-005453-4057qib7	6988	7	)	)	-RRB-
cord-005453-4057qib7	6988	8	days	day	NNS
cord-005453-4057qib7	6988	9	and	and	CC
cord-005453-4057qib7	6988	10	13	13	CD
cord-005453-4057qib7	6989	1	(	(	-LRB-
cord-005453-4057qib7	6989	2	range	range	NN
cord-005453-4057qib7	6989	3	,	,	,
cord-005453-4057qib7	6989	4	11	11	CD
cord-005453-4057qib7	6989	5	-	-	SYM
cord-005453-4057qib7	6989	6	25	25	CD
cord-005453-4057qib7	6989	7	)	)	-RRB-
cord-005453-4057qib7	6989	8	days	day	NNS
cord-005453-4057qib7	6989	9	(	(	-LRB-
cord-005453-4057qib7	6989	10	P	p	NN
cord-005453-4057qib7	6989	11	=	=	SYM
cord-005453-4057qib7	6989	12	0.027	0.027	CD
cord-005453-4057qib7	6989	13	)	)	-RRB-
cord-005453-4057qib7	6989	14	,	,	,
cord-005453-4057qib7	6989	15	respectively	respectively	RB
cord-005453-4057qib7	6989	16	.	.	.
cord-005453-4057qib7	6990	1	With	with	IN
cord-005453-4057qib7	6990	2	a	a	DT
cord-005453-4057qib7	6990	3	median	median	JJ
cord-005453-4057qib7	6990	4	followup	followup	NN
cord-005453-4057qib7	6990	5	of	of	IN
cord-005453-4057qib7	6990	6	26	26	CD
cord-005453-4057qib7	6990	7	(	(	-LRB-
cord-005453-4057qib7	6990	8	4	4	CD
cord-005453-4057qib7	6990	9	-	-	SYM
cord-005453-4057qib7	6990	10	65	65	CD
cord-005453-4057qib7	6990	11	)	)	-RRB-
cord-005453-4057qib7	6990	12	months	month	NNS
cord-005453-4057qib7	6990	13	in	in	IN
cord-005453-4057qib7	6990	14	the	the	DT
cord-005453-4057qib7	6990	15	haplo	haplo	NNP
cord-005453-4057qib7	6990	16	-	-	HYPH
cord-005453-4057qib7	6990	17	HSCT	HSCT	NNP
cord-005453-4057qib7	6990	18	group	group	NN
cord-005453-4057qib7	6990	19	and	and	CC
cord-005453-4057qib7	6990	20	36	36	CD
cord-005453-4057qib7	6990	21	(	(	-LRB-
cord-005453-4057qib7	6990	22	4	4	CD
cord-005453-4057qib7	6990	23	-	-	SYM
cord-005453-4057qib7	6990	24	132	132	CD
cord-005453-4057qib7	6990	25	)	)	-RRB-
cord-005453-4057qib7	6990	26	months	month	NNS
cord-005453-4057qib7	6990	27	in	in	IN
cord-005453-4057qib7	6990	28	the	the	DT
cord-005453-4057qib7	6990	29	MSD	MSD	NNP
cord-005453-4057qib7	6990	30	-	-	HYPH
cord-005453-4057qib7	6990	31	HSCT	HSCT	NNP
cord-005453-4057qib7	6990	32	group	group	NN
cord-005453-4057qib7	6990	33	(	(	-LRB-
cord-005453-4057qib7	6990	34	P	p	NN
cord-005453-4057qib7	6990	35	=	=	SYM
cord-005453-4057qib7	6990	36	0.294	0.294	CD
cord-005453-4057qib7	6990	37	)	)	-RRB-
cord-005453-4057qib7	6990	38	.	.	.
cord-005453-4057qib7	6991	1	In	in	IN
cord-005453-4057qib7	6991	2	haplo	haplo	NNP
cord-005453-4057qib7	6991	3	-	-	HYPH
cord-005453-4057qib7	6991	4	HSCT	HSCT	NNP
cord-005453-4057qib7	6991	5	and	and	CC
cord-005453-4057qib7	6991	6	MSD	MSD	NNP
cord-005453-4057qib7	6991	7	-	-	HYPH
cord-005453-4057qib7	6991	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6991	9	groups	group	NNS
cord-005453-4057qib7	6991	10	the	the	DT
cord-005453-4057qib7	6991	11	incidences	incidence	NNS
cord-005453-4057qib7	6991	12	of	of	IN
cord-005453-4057qib7	6991	13	grade	grade	NN
cord-005453-4057qib7	6991	14	I	I	NNP
cord-005453-4057qib7	6991	15	-	-	HYPH
cord-005453-4057qib7	6991	16	IV	IV	NNP
cord-005453-4057qib7	6991	17	acute	acute	JJ
cord-005453-4057qib7	6991	18	graft	graft	NN
cord-005453-4057qib7	6991	19	-	-	HYPH
cord-005453-4057qib7	6991	20	versus	versus	IN
cord-005453-4057qib7	6991	21	-	-	HYPH
cord-005453-4057qib7	6991	22	host	host	NN
cord-005453-4057qib7	6991	23	disease	disease	NN
cord-005453-4057qib7	6991	24	(	(	-LRB-
cord-005453-4057qib7	6991	25	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6991	26	)	)	-RRB-
cord-005453-4057qib7	6991	27	were	be	VBD
cord-005453-4057qib7	6991	28	32.00	32.00	CD
cord-005453-4057qib7	6991	29	%	%	NN
cord-005453-4057qib7	6991	30	and	and	CC
cord-005453-4057qib7	6991	31	20.00	20.00	CD
cord-005453-4057qib7	6991	32	%	%	NN
cord-005453-4057qib7	6991	33	(	(	-LRB-
cord-005453-4057qib7	6991	34	P	p	NN
cord-005453-4057qib7	6991	35	=	=	SYM
cord-005453-4057qib7	6991	36	0.343	0.343	CD
cord-005453-4057qib7	6991	37	)	)	-RRB-
cord-005453-4057qib7	6991	38	,	,	,
cord-005453-4057qib7	6991	39	grade	grade	NN
cord-005453-4057qib7	6991	40	II	II	NNP
cord-005453-4057qib7	6991	41	-	-	HYPH
cord-005453-4057qib7	6991	42	IV	IV	NNP
cord-005453-4057qib7	6991	43	aGVHD	aGVHD	NNP
cord-005453-4057qib7	6991	44	were	be	VBD
cord-005453-4057qib7	6991	45	16.00%、13.33	16.00%、13.33	CD
cord-005453-4057qib7	6991	46	%	%	NN
cord-005453-4057qib7	6991	47	(	(	-LRB-
cord-005453-4057qib7	6991	48	P	p	NN
cord-005453-4057qib7	6991	49	=	=	SYM
cord-005453-4057qib7	6991	50	0.759	0.759	CD
cord-005453-4057qib7	6991	51	)	)	-RRB-
cord-005453-4057qib7	6991	52	.	.	.
cord-005453-4057qib7	6992	1	chronic	chronic	JJ
cord-005453-4057qib7	6992	2	GVHD	GVHD	NNP
cord-005453-4057qib7	6992	3	were	be	VBD
cord-005453-4057qib7	6992	4	30.69	30.69	CD
cord-005453-4057qib7	6992	5	%	%	NN
cord-005453-4057qib7	6992	6	and	and	CC
cord-005453-4057qib7	6992	7	24.62	24.62	CD
cord-005453-4057qib7	6992	8	%	%	NN
cord-005453-4057qib7	6992	9	(	(	-LRB-
cord-005453-4057qib7	6992	10	P	p	NN
cord-005453-4057qib7	6992	11	=	=	SYM
cord-005453-4057qib7	6992	12	0.418	0.418	CD
cord-005453-4057qib7	6992	13	)	)	-RRB-
cord-005453-4057qib7	6992	14	,	,	,
cord-005453-4057qib7	6992	15	moderate	moderate	JJ
cord-005453-4057qib7	6992	16	-	-	HYPH
cord-005453-4057qib7	6992	17	severe	severe	JJ
cord-005453-4057qib7	6992	18	chronic	chronic	JJ
cord-005453-4057qib7	6992	19	GVHD	GVHD	NNP
cord-005453-4057qib7	6992	20	were	be	VBD
cord-005453-4057qib7	6992	21	12.73	12.73	CD
cord-005453-4057qib7	6992	22	%	%	NN
cord-005453-4057qib7	6992	23	and	and	CC
cord-005453-4057qib7	6992	24	7.14	7.14	CD
cord-005453-4057qib7	6992	25	%	%	NN
cord-005453-4057qib7	6992	26	(	(	-LRB-
cord-005453-4057qib7	6992	27	P	p	NN
cord-005453-4057qib7	6992	28	=	=	SYM
cord-005453-4057qib7	6992	29	0.522	0.522	CD
cord-005453-4057qib7	6992	30	)	)	-RRB-
cord-005453-4057qib7	6992	31	.	.	.
cord-005453-4057qib7	6993	1	In	in	IN
cord-005453-4057qib7	6993	2	haplo	haplo	NNP
cord-005453-4057qib7	6993	3	-	-	HYPH
cord-005453-4057qib7	6993	4	HSCT	HSCT	NNP
cord-005453-4057qib7	6993	5	and	and	CC
cord-005453-4057qib7	6993	6	MSD	MSD	NNP
cord-005453-4057qib7	6993	7	groups	group	NNS
cord-005453-4057qib7	6993	8	the	the	DT
cord-005453-4057qib7	6993	9	incidences	incidence	NNS
cord-005453-4057qib7	6993	10	of	of	IN
cord-005453-4057qib7	6993	11	infection	infection	NN
cord-005453-4057qib7	6993	12	were	be	VBD
cord-005453-4057qib7	6993	13	32.00	32.00	CD
cord-005453-4057qib7	6993	14	%	%	NN
cord-005453-4057qib7	6993	15	(	(	-LRB-
cord-005453-4057qib7	6993	16	8/25	8/25	CD
cord-005453-4057qib7	6993	17	)	)	-RRB-
cord-005453-4057qib7	6993	18	and	and	CC
cord-005453-4057qib7	6993	19	26.67	26.67	CD
cord-005453-4057qib7	6993	20	%	%	NN
cord-005453-4057qib7	6993	21	(	(	-LRB-
cord-005453-4057qib7	6993	22	4/15	4/15	CD
cord-005453-4057qib7	6993	23	)	)	-RRB-
cord-005453-4057qib7	6993	24	(	(	-LRB-
cord-005453-4057qib7	6993	25	P	p	NN
cord-005453-4057qib7	6993	26	=	=	SYM
cord-005453-4057qib7	6993	27	1.000	1.000	CD
cord-005453-4057qib7	6993	28	)	)	-RRB-
cord-005453-4057qib7	6993	29	.	.	.
cord-005453-4057qib7	6994	1	No	no	DT
cord-005453-4057qib7	6994	2	patient	patient	NN
cord-005453-4057qib7	6994	3	occurred	occur	VBD
cord-005453-4057qib7	6994	4	early	early	JJ
cord-005453-4057qib7	6994	5	death	death	NN
cord-005453-4057qib7	6994	6	and	and	CC
cord-005453-4057qib7	6994	7	relapse	relapse	NN
cord-005453-4057qib7	6994	8	.	.	.
cord-005453-4057qib7	6995	1	3-year	3-year	CD
cord-005453-4057qib7	6995	2	estimated	estimate	VBN
cord-005453-4057qib7	6995	3	overall	overall	JJ
cord-005453-4057qib7	6995	4	survival	survival	NN
cord-005453-4057qib7	6995	5	(	(	-LRB-
cord-005453-4057qib7	6995	6	OS	OS	NNP
cord-005453-4057qib7	6995	7	)	)	-RRB-
cord-005453-4057qib7	6995	8	of	of	IN
cord-005453-4057qib7	6995	9	haplo	haplo	NNP
cord-005453-4057qib7	6995	10	-	-	HYPH
cord-005453-4057qib7	6995	11	HSCT	HSCT	NNP
cord-005453-4057qib7	6995	12	and	and	CC
cord-005453-4057qib7	6995	13	MSD	MSD	NNP
cord-005453-4057qib7	6995	14	-	-	HYPH
cord-005453-4057qib7	6995	15	HSCT	HSCT	NNP
cord-005453-4057qib7	6995	16	groups	group	NNS
cord-005453-4057qib7	6995	17	were	be	VBD
cord-005453-4057qib7	6995	18	86.5	86.5	CD
cord-005453-4057qib7	6995	19	%	%	NN
cord-005453-4057qib7	6995	20	±	±	NNP
cord-005453-4057qib7	6995	21	7.3	7.3	CD
cord-005453-4057qib7	6995	22	%	%	NN
cord-005453-4057qib7	6995	23	and	and	CC
cord-005453-4057qib7	6995	24	93.3	93.3	CD
cord-005453-4057qib7	6995	25	%	%	NN
cord-005453-4057qib7	6995	26	±	±	NNP
cord-005453-4057qib7	6995	27	6.4	6.4	CD
cord-005453-4057qib7	6995	28	%	%	NN
cord-005453-4057qib7	6995	29	(	(	-LRB-
cord-005453-4057qib7	6995	30	P	p	NN
cord-005453-4057qib7	6995	31	=	=	SYM
cord-005453-4057qib7	6995	32	0.520	0.520	CD
cord-005453-4057qib7	6995	33	)	)	-RRB-
cord-005453-4057qib7	6995	34	,	,	,
cord-005453-4057qib7	6995	35	GVHD	GVHD	NNP
cord-005453-4057qib7	6995	36	-	-	HYPH
cord-005453-4057qib7	6995	37	free	free	JJ
cord-005453-4057qib7	6995	38	and	and	CC
cord-005453-4057qib7	6995	39	failure	failure	NN
cord-005453-4057qib7	6995	40	-	-	HYPH
cord-005453-4057qib7	6995	41	free	free	JJ
cord-005453-4057qib7	6995	42	survival	survival	NN
cord-005453-4057qib7	6995	43	(	(	-LRB-
cord-005453-4057qib7	6995	44	GFFS	GFFS	NNP
cord-005453-4057qib7	6995	45	)	)	-RRB-
cord-005453-4057qib7	6995	46	were	be	VBD
cord-005453-4057qib7	6995	47	78.3	78.3	CD
cord-005453-4057qib7	6995	48	%	%	NN
cord-005453-4057qib7	6995	49	±	±	NNP
cord-005453-4057qib7	6995	50	8.6	8.6	CD
cord-005453-4057qib7	6995	51	%	%	NN
cord-005453-4057qib7	6995	52	and	and	CC
cord-005453-4057qib7	6995	53	92.9	92.9	CD
cord-005453-4057qib7	6995	54	%	%	NN
cord-005453-4057qib7	6995	55	±	±	NNP
cord-005453-4057qib7	6995	56	6.9	6.9	CD
cord-005453-4057qib7	6995	57	%	%	NN
cord-005453-4057qib7	6995	58	(	(	-LRB-
cord-005453-4057qib7	6995	59	P	p	NN
cord-005453-4057qib7	6995	60	=	=	SYM
cord-005453-4057qib7	6995	61	0.250	0.250	CD
cord-005453-4057qib7	6995	62	)	)	-RRB-
cord-005453-4057qib7	6995	63	.	.	.
cord-005453-4057qib7	6996	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	6996	2	:	:	:
cord-005453-4057qib7	6997	1	The	the	DT
cord-005453-4057qib7	6997	2	preliminary	preliminary	JJ
cord-005453-4057qib7	6997	3	results	result	NNS
cord-005453-4057qib7	6997	4	indicated	indicate	VBD
cord-005453-4057qib7	6997	5	that	that	IN
cord-005453-4057qib7	6997	6	haplo	haplo	NNP
cord-005453-4057qib7	6997	7	-	-	HYPH
cord-005453-4057qib7	6997	8	HSCT	HSCT	NNP
cord-005453-4057qib7	6997	9	is	be	VBZ
cord-005453-4057qib7	6997	10	a	a	DT
cord-005453-4057qib7	6997	11	feasible	feasible	JJ
cord-005453-4057qib7	6997	12	choice	choice	NN
cord-005453-4057qib7	6997	13	for	for	IN
cord-005453-4057qib7	6997	14	PNH	PNH	NNP
cord-005453-4057qib7	6997	15	with	with	IN
cord-005453-4057qib7	6997	16	favorable	favorable	JJ
cord-005453-4057qib7	6997	17	outcomes	outcome	NNS
cord-005453-4057qib7	6997	18	,	,	,
cord-005453-4057qib7	6997	19	haplo	haplo	NN
cord-005453-4057qib7	6997	20	-	-	HYPH
cord-005453-4057qib7	6997	21	HSCT	HSCT	NNP
cord-005453-4057qib7	6997	22	and	and	CC
cord-005453-4057qib7	6997	23	MSD	MSD	NNP
cord-005453-4057qib7	6997	24	-	-	HYPH
cord-005453-4057qib7	6997	25	HSCT	HSCT	NNP
cord-005453-4057qib7	6997	26	had	have	VBD
cord-005453-4057qib7	6997	27	similar	similar	JJ
cord-005453-4057qib7	6997	28	therapeutic	therapeutic	JJ
cord-005453-4057qib7	6997	29	efficacy	efficacy	NN
cord-005453-4057qib7	6997	30	.	.	.
cord-005453-4057qib7	6998	1	Disclosure	disclosure	NN
cord-005453-4057qib7	6998	2	:	:	:
cord-005453-4057qib7	6998	3	no	no	DT
cord-005453-4057qib7	6998	4	disclosure	disclosure	NN
cord-005453-4057qib7	6998	5	P320	p320	NN
cord-005453-4057qib7	6998	6	Pres	Pres	NNP
cord-005453-4057qib7	6998	7	in	in	IN
cord-005453-4057qib7	6998	8	BMT	BMT	NNP
cord-005453-4057qib7	6998	9	for	for	IN
cord-005453-4057qib7	6998	10	thalassemia	thalassemia	NN
cord-005453-4057qib7	6998	11	major	major	NN
cord-005453-4057qib7	6998	12	in	in	IN
cord-005453-4057qib7	6998	13	India	India	NNP
cord-005453-4057qib7	6998	14	:	:	:
cord-005453-4057qib7	6999	1	Lower	low	JJR
cord-005453-4057qib7	6999	2	incidence	incidence	NN
cord-005453-4057qib7	6999	3	and	and	CC
cord-005453-4057qib7	6999	4	limited	limited	JJ
cord-005453-4057qib7	6999	5	impact	impact	NN
cord-005453-4057qib7	7000	1	Background	background	NN
cord-005453-4057qib7	7000	2	:	:	:
cord-005453-4057qib7	7000	3	Posterior	posterior	JJ
cord-005453-4057qib7	7000	4	reversible	reversible	JJ
cord-005453-4057qib7	7000	5	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	7000	6	syndrome	syndrome	NN
cord-005453-4057qib7	7000	7	(	(	-LRB-
cord-005453-4057qib7	7000	8	PRES	PRES	NNP
cord-005453-4057qib7	7000	9	)	)	-RRB-
cord-005453-4057qib7	7000	10	is	be	VBZ
cord-005453-4057qib7	7000	11	a	a	DT
cord-005453-4057qib7	7000	12	relatively	relatively	RB
cord-005453-4057qib7	7000	13	common	common	JJ
cord-005453-4057qib7	7000	14	complication	complication	NN
cord-005453-4057qib7	7000	15	seen	see	VBN
cord-005453-4057qib7	7000	16	after	after	IN
cord-005453-4057qib7	7000	17	blood	blood	NN
cord-005453-4057qib7	7000	18	or	or	CC
cord-005453-4057qib7	7000	19	marrow	marrow	NN
cord-005453-4057qib7	7000	20	transplantation	transplantation	NN
cord-005453-4057qib7	7000	21	(	(	-LRB-
cord-005453-4057qib7	7000	22	BMT	BMT	NNP
cord-005453-4057qib7	7000	23	)	)	-RRB-
cord-005453-4057qib7	7000	24	for	for	IN
cord-005453-4057qib7	7000	25	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	7000	26	with	with	IN
cord-005453-4057qib7	7000	27	a	a	DT
cord-005453-4057qib7	7000	28	reported	report	VBN
cord-005453-4057qib7	7000	29	frequency	frequency	NN
cord-005453-4057qib7	7000	30	of	of	IN
cord-005453-4057qib7	7000	31	10	10	CD
cord-005453-4057qib7	7000	32	-	-	SYM
cord-005453-4057qib7	7000	33	19	19	CD
cord-005453-4057qib7	7000	34	%	%	NN
cord-005453-4057qib7	7000	35	.	.	.
cord-005453-4057qib7	7001	1	PRES	PRES	NNP
cord-005453-4057qib7	7001	2	has	have	VBZ
cord-005453-4057qib7	7001	3	also	also	RB
cord-005453-4057qib7	7001	4	been	be	VBN
cord-005453-4057qib7	7001	5	associated	associate	VBN
cord-005453-4057qib7	7001	6	with	with	IN
cord-005453-4057qib7	7001	7	poorer	poor	JJR
cord-005453-4057qib7	7001	8	survival	survival	NN
cord-005453-4057qib7	7001	9	rates	rate	NNS
cord-005453-4057qib7	7001	10	.	.	.
cord-005453-4057qib7	7002	1	Severe	severe	JJ
cord-005453-4057qib7	7002	2	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	7002	3	are	be	VBP
cord-005453-4057qib7	7002	4	one	one	CD
cord-005453-4057qib7	7002	5	of	of	IN
cord-005453-4057qib7	7002	6	the	the	DT
cord-005453-4057qib7	7002	7	most	most	RBS
cord-005453-4057qib7	7002	8	frequent	frequent	JJ
cord-005453-4057qib7	7002	9	indications	indication	NNS
cord-005453-4057qib7	7002	10	for	for	IN
cord-005453-4057qib7	7002	11	BMT	BMT	NNP
cord-005453-4057qib7	7002	12	in	in	IN
cord-005453-4057qib7	7002	13	the	the	DT
cord-005453-4057qib7	7002	14	developing	develop	VBG
cord-005453-4057qib7	7002	15	world	world	NN
cord-005453-4057qib7	7002	16	,	,	,
cord-005453-4057qib7	7002	17	particularly	particularly	RB
cord-005453-4057qib7	7002	18	in	in	IN
cord-005453-4057qib7	7002	19	India	India	NNP
cord-005453-4057qib7	7002	20	.	.	.
cord-005453-4057qib7	7003	1	Given	give	VBN
cord-005453-4057qib7	7003	2	the	the	DT
cord-005453-4057qib7	7003	3	risk	risk	NN
cord-005453-4057qib7	7003	4	of	of	IN
cord-005453-4057qib7	7003	5	rejection	rejection	NN
cord-005453-4057qib7	7003	6	in	in	IN
cord-005453-4057qib7	7003	7	multiply	multiply	NN
cord-005453-4057qib7	7003	8	transfused	transfuse	VBN
cord-005453-4057qib7	7003	9	patients	patient	NNS
cord-005453-4057qib7	7003	10	and	and	CC
cord-005453-4057qib7	7003	11	the	the	DT
cord-005453-4057qib7	7003	12	need	need	NN
cord-005453-4057qib7	7003	13	to	to	TO
cord-005453-4057qib7	7003	14	minimize	minimize	VB
cord-005453-4057qib7	7003	15	GVHD	GVHD	NNP
cord-005453-4057qib7	7003	16	risk	risk	NN
cord-005453-4057qib7	7003	17	,	,	,
cord-005453-4057qib7	7003	18	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7003	19	post	post	NN
cord-005453-4057qib7	7003	20	-	-	NN
cord-005453-4057qib7	7003	21	BMT	BMT	NNP
cord-005453-4057qib7	7003	22	for	for	IN
cord-005453-4057qib7	7003	23	these	these	DT
cord-005453-4057qib7	7003	24	non	non	JJ
cord-005453-4057qib7	7003	25	-	-	JJ
cord-005453-4057qib7	7003	26	malignant	malignant	JJ
cord-005453-4057qib7	7003	27	conditions	condition	NNS
cord-005453-4057qib7	7003	28	can	can	MD
cord-005453-4057qib7	7003	29	be	be	VB
cord-005453-4057qib7	7003	30	particularly	particularly	RB
cord-005453-4057qib7	7003	31	intense	intense	JJ
cord-005453-4057qib7	7003	32	and	and	CC
cord-005453-4057qib7	7003	33	prolonged	prolonged	JJ
cord-005453-4057qib7	7003	34	.	.	.
cord-005453-4057qib7	7004	1	We	-PRON-	PRP
cord-005453-4057qib7	7004	2	sought	seek	VBD
cord-005453-4057qib7	7004	3	to	to	TO
cord-005453-4057qib7	7004	4	measure	measure	VB
cord-005453-4057qib7	7004	5	the	the	DT
cord-005453-4057qib7	7004	6	incidence	incidence	NN
cord-005453-4057qib7	7004	7	and	and	CC
cord-005453-4057qib7	7004	8	impact	impact	NN
cord-005453-4057qib7	7004	9	of	of	IN
cord-005453-4057qib7	7004	10	PRES	PRES	NNP
cord-005453-4057qib7	7004	11	in	in	IN
cord-005453-4057qib7	7004	12	developing	develop	VBG
cord-005453-4057qib7	7004	13	countries	country	NNS
cord-005453-4057qib7	7004	14	.	.	.
cord-005453-4057qib7	7005	1	Methods	method	NNS
cord-005453-4057qib7	7005	2	:	:	:
cord-005453-4057qib7	7005	3	We	-PRON-	PRP
cord-005453-4057qib7	7005	4	analysed	analyse	VBD
cord-005453-4057qib7	7005	5	194	194	CD
cord-005453-4057qib7	7005	6	successive	successive	JJ
cord-005453-4057qib7	7005	7	transplants	transplant	NNS
cord-005453-4057qib7	7005	8	for	for	IN
cord-005453-4057qib7	7005	9	thalassemia	thalassemia	NN
cord-005453-4057qib7	7005	10	using	use	VBG
cord-005453-4057qib7	7005	11	Protocol	Protocol	NNP
cord-005453-4057qib7	7005	12	1	1	CD
cord-005453-4057qib7	7005	13	(	(	-LRB-
cord-005453-4057qib7	7005	14	ATG	ATG	NNP
cord-005453-4057qib7	7005	15	-	-	HYPH
cord-005453-4057qib7	7005	16	BuCy+CSA	BuCy+CSA	NNP
cord-005453-4057qib7	7005	17	/	/	SYM
cord-005453-4057qib7	7005	18	MMF	mmf	NN
cord-005453-4057qib7	7005	19	or	or	CC
cord-005453-4057qib7	7005	20	CSA	CSA	NNP
cord-005453-4057qib7	7005	21	/	/	SYM
cord-005453-4057qib7	7005	22	MTX	MTX	NNP
cord-005453-4057qib7	7005	23	)	)	-RRB-
cord-005453-4057qib7	7005	24	maintaining	maintain	VBG
cord-005453-4057qib7	7005	25	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	7005	26	A	a	NN
cord-005453-4057qib7	7005	27	(	(	-LRB-
cord-005453-4057qib7	7005	28	CSA	CSA	NNP
cord-005453-4057qib7	7005	29	)	)	-RRB-
cord-005453-4057qib7	7005	30	blood	blood	NN
cord-005453-4057qib7	7005	31	levels	level	NNS
cord-005453-4057qib7	7005	32	100	100	CD
cord-005453-4057qib7	7005	33	-	-	SYM
cord-005453-4057qib7	7005	34	150	150	CD
cord-005453-4057qib7	7005	35	ng	ng	NN
cord-005453-4057qib7	7005	36	/	/	SYM
cord-005453-4057qib7	7005	37	mL	ml	NN
cord-005453-4057qib7	7005	38	for	for	IN
cord-005453-4057qib7	7005	39	74	74	CD
cord-005453-4057qib7	7005	40	patients	patient	NNS
cord-005453-4057qib7	7005	41	and	and	CC
cord-005453-4057qib7	7005	42	Protocol	Protocol	NNP
cord-005453-4057qib7	7005	43	2	2	CD
cord-005453-4057qib7	7005	44	(	(	-LRB-
cord-005453-4057qib7	7005	45	FLU	FLU	NNP
cord-005453-4057qib7	7005	46	-	-	HYPH
cord-005453-4057qib7	7005	47	ATG	ATG	NNP
cord-005453-4057qib7	7005	48	-	-	HYPH
cord-005453-4057qib7	7005	49	BuCy+CSA	BuCy+CSA	NNP
cord-005453-4057qib7	7005	50	/	/	SYM
cord-005453-4057qib7	7005	51	MTX	MTX	NNP
cord-005453-4057qib7	7005	52	)	)	-RRB-
cord-005453-4057qib7	7005	53	maintaining	maintain	VBG
cord-005453-4057qib7	7005	54	higher	high	JJR
cord-005453-4057qib7	7005	55	CSA	CSA	NNP
cord-005453-4057qib7	7005	56	levels	level	NNS
cord-005453-4057qib7	7005	57	post	post	NN
cord-005453-4057qib7	7005	58	,	,	,
cord-005453-4057qib7	7005	59	i.e.	i.e.	FW
cord-005453-4057qib7	7005	60	150	150	CD
cord-005453-4057qib7	7005	61	-	-	SYM
cord-005453-4057qib7	7005	62	250	250	CD
cord-005453-4057qib7	7005	63	ng	ng	NN
cord-005453-4057qib7	7005	64	/	/	SYM
cord-005453-4057qib7	7005	65	mL	ml	NN
cord-005453-4057qib7	7005	66	for	for	IN
cord-005453-4057qib7	7005	67	120	120	CD
cord-005453-4057qib7	7005	68	patients	patient	NNS
cord-005453-4057qib7	7005	69	from	from	IN
cord-005453-4057qib7	7005	70	fully	fully	RB
cord-005453-4057qib7	7005	71	matched	match	VBN
cord-005453-4057qib7	7005	72	donors	donor	NNS
cord-005453-4057qib7	7005	73	with	with	IN
cord-005453-4057qib7	7005	74	G	G	NNP
cord-005453-4057qib7	7005	75	-	-	HYPH
cord-005453-4057qib7	7005	76	CSF	csf	NN
cord-005453-4057qib7	7005	77	-	-	HYPH
cord-005453-4057qib7	7005	78	primed	prime	VBN
cord-005453-4057qib7	7005	79	bone	bone	NN
cord-005453-4057qib7	7005	80	marrow	marrow	NN
cord-005453-4057qib7	7005	81	.	.	.
cord-005453-4057qib7	7006	1	For	for	IN
cord-005453-4057qib7	7006	2	3	3	CD
cord-005453-4057qib7	7006	3	patients	patient	NNS
cord-005453-4057qib7	7006	4	this	this	DT
cord-005453-4057qib7	7006	5	was	be	VBD
cord-005453-4057qib7	7006	6	the	the	DT
cord-005453-4057qib7	7006	7	second	second	JJ
cord-005453-4057qib7	7006	8	transplant	transplant	NN
cord-005453-4057qib7	7006	9	from	from	IN
cord-005453-4057qib7	7006	10	a	a	DT
cord-005453-4057qib7	7006	11	different	different	JJ
cord-005453-4057qib7	7006	12	matched	match	VBN
cord-005453-4057qib7	7006	13	related	related	JJ
cord-005453-4057qib7	7006	14	donor	donor	NN
cord-005453-4057qib7	7006	15	.	.	.
cord-005453-4057qib7	7007	1	PRES	PRES	NNP
cord-005453-4057qib7	7007	2	was	be	VBD
cord-005453-4057qib7	7007	3	confirmed	confirm	VBN
cord-005453-4057qib7	7007	4	with	with	IN
cord-005453-4057qib7	7007	5	brain	brain	NN
cord-005453-4057qib7	7007	6	CT	CT	NNP
cord-005453-4057qib7	7007	7	/	/	SYM
cord-005453-4057qib7	7007	8	MRI	MRI	NNP
cord-005453-4057qib7	7007	9	for	for	IN
cord-005453-4057qib7	7007	10	all	all	DT
cord-005453-4057qib7	7007	11	patients	patient	NNS
cord-005453-4057qib7	7007	12	.	.	.
cord-005453-4057qib7	7008	1	Results	result	NNS
cord-005453-4057qib7	7008	2	:	:	:
cord-005453-4057qib7	7009	1	All	all	DT
cord-005453-4057qib7	7009	2	recipients	recipient	NNS
cord-005453-4057qib7	7009	3	who	who	WP
cord-005453-4057qib7	7009	4	had	have	VBD
cord-005453-4057qib7	7009	5	PRES	PRES	NNP
cord-005453-4057qib7	7009	6	had	have	VBD
cord-005453-4057qib7	7009	7	sibling	sibling	NN
cord-005453-4057qib7	7009	8	donors	donor	NNS
cord-005453-4057qib7	7009	9	,	,	,
cord-005453-4057qib7	7009	10	5	5	CD
cord-005453-4057qib7	7009	11	males	male	NNS
cord-005453-4057qib7	7009	12	and	and	CC
cord-005453-4057qib7	7009	13	2	2	CD
cord-005453-4057qib7	7009	14	females	female	NNS
cord-005453-4057qib7	7009	15	.	.	.
cord-005453-4057qib7	7010	1	Age	age	NN
cord-005453-4057qib7	7010	2	median	median	NN
cord-005453-4057qib7	7010	3	7.4	7.4	CD
cord-005453-4057qib7	7010	4	(	(	-LRB-
cord-005453-4057qib7	7010	5	IQR	IQR	NNP
cord-005453-4057qib7	7010	6	5.6	5.6	CD
cord-005453-4057qib7	7010	7	-	-	SYM
cord-005453-4057qib7	7010	8	8	8	CD
cord-005453-4057qib7	7010	9	years	year	NNS
cord-005453-4057qib7	7010	10	)	)	-RRB-
cord-005453-4057qib7	7010	11	.	.	.
cord-005453-4057qib7	7011	1	The	the	DT
cord-005453-4057qib7	7011	2	frequency	frequency	NN
cord-005453-4057qib7	7011	3	of	of	IN
cord-005453-4057qib7	7011	4	PRES	PRES	NNP
cord-005453-4057qib7	7011	5	was	be	VBD
cord-005453-4057qib7	7011	6	3.6	3.6	CD
cord-005453-4057qib7	7011	7	%	%	NN
cord-005453-4057qib7	7011	8	;	;	:
cord-005453-4057qib7	7011	9	disease	disease	NNP
cord-005453-4057qib7	7011	10	free	free	JJ
cord-005453-4057qib7	7011	11	survival	survival	NN
cord-005453-4057qib7	7011	12	for	for	IN
cord-005453-4057qib7	7011	13	patients	patient	NNS
cord-005453-4057qib7	7011	14	who	who	WP
cord-005453-4057qib7	7011	15	had	have	VBD
cord-005453-4057qib7	7011	16	PRES	PRES	NNP
cord-005453-4057qib7	7011	17	was	be	VBD
cord-005453-4057qib7	7011	18	100	100	CD
cord-005453-4057qib7	7011	19	%	%	NN
cord-005453-4057qib7	7011	20	.	.	.
cord-005453-4057qib7	7012	1	PRES	PRES	NNP
cord-005453-4057qib7	7012	2	resolved	resolve	VBD
cord-005453-4057qib7	7012	3	completely	completely	RB
cord-005453-4057qib7	7012	4	in	in	RB
cord-005453-4057qib7	7012	5	all	all	RB
cord-005453-4057qib7	7012	6	.	.	.
cord-005453-4057qib7	7013	1	CSA	CSA	NNP
cord-005453-4057qib7	7013	2	was	be	VBD
cord-005453-4057qib7	7013	3	switched	switch	VBN
cord-005453-4057qib7	7013	4	to	to	IN
cord-005453-4057qib7	7013	5	MMF	MMF	NNP
cord-005453-4057qib7	7013	6	in	in	IN
cord-005453-4057qib7	7013	7	5	5	CD
cord-005453-4057qib7	7013	8	patients	patient	NNS
cord-005453-4057qib7	7013	9	who	who	WP
cord-005453-4057qib7	7013	10	had	have	VBD
cord-005453-4057qib7	7013	11	received	receive	VBN
cord-005453-4057qib7	7013	12	MTX	MTX	NNP
cord-005453-4057qib7	7013	13	and	and	CC
cord-005453-4057qib7	7013	14	were	be	VBD
cord-005453-4057qib7	7013	15	on	on	IN
cord-005453-4057qib7	7013	16	CSA	CSA	NNP
cord-005453-4057qib7	7013	17	only	only	RB
cord-005453-4057qib7	7013	18	at	at	IN
cord-005453-4057qib7	7013	19	the	the	DT
cord-005453-4057qib7	7013	20	time	time	NN
cord-005453-4057qib7	7013	21	of	of	IN
cord-005453-4057qib7	7013	22	PRES	PRES	NNP
cord-005453-4057qib7	7013	23	occurrence	occurrence	NN
cord-005453-4057qib7	7013	24	,	,	,
cord-005453-4057qib7	7013	25	while	while	IN
cord-005453-4057qib7	7013	26	CSA	CSA	NNP
cord-005453-4057qib7	7013	27	was	be	VBD
cord-005453-4057qib7	7013	28	stopped	stop	VBN
cord-005453-4057qib7	7013	29	but	but	CC
cord-005453-4057qib7	7013	30	MMF	MMF	NNP
cord-005453-4057qib7	7013	31	continued	continue	VBD
cord-005453-4057qib7	7013	32	in	in	IN
cord-005453-4057qib7	7013	33	1	1	CD
cord-005453-4057qib7	7013	34	patients	patient	NNS
cord-005453-4057qib7	7013	35	taking	take	VBG
cord-005453-4057qib7	7013	36	CSA	CSA	NNP
cord-005453-4057qib7	7013	37	/	/	SYM
cord-005453-4057qib7	7013	38	MMF	MMF	NNP
cord-005453-4057qib7	7013	39	combination	combination	NN
cord-005453-4057qib7	7013	40	and	and	CC
cord-005453-4057qib7	7013	41	CSA	CSA	NNP
cord-005453-4057qib7	7013	42	was	be	VBD
cord-005453-4057qib7	7013	43	continued	continue	VBN
cord-005453-4057qib7	7013	44	for	for	IN
cord-005453-4057qib7	7013	45	1	1	CD
cord-005453-4057qib7	7013	46	patient	patient	NN
cord-005453-4057qib7	7013	47	.	.	.
cord-005453-4057qib7	7014	1	Three	three	CD
cord-005453-4057qib7	7014	2	patients	patient	NNS
cord-005453-4057qib7	7014	3	with	with	IN
cord-005453-4057qib7	7014	4	PRES	PRES	NNP
cord-005453-4057qib7	7014	5	had	have	VBD
cord-005453-4057qib7	7014	6	grade	grade	NN
cord-005453-4057qib7	7014	7	2	2	CD
cord-005453-4057qib7	7014	8	acute	acute	JJ
cord-005453-4057qib7	7014	9	GVHD	GVHD	NNP
cord-005453-4057qib7	7014	10	,	,	,
cord-005453-4057qib7	7014	11	1	1	CD
cord-005453-4057qib7	7014	12	had	have	VBD
cord-005453-4057qib7	7014	13	grade	grade	NN
cord-005453-4057qib7	7014	14	1	1	CD
cord-005453-4057qib7	7014	15	GVHD	GVHD	NNP
cord-005453-4057qib7	7014	16	and	and	CC
cord-005453-4057qib7	7014	17	none	none	NN
cord-005453-4057qib7	7014	18	developed	develop	VBD
cord-005453-4057qib7	7014	19	chronic	chronic	JJ
cord-005453-4057qib7	7014	20	GVHD	GVHD	NNP
cord-005453-4057qib7	7014	21	.	.	.
cord-005453-4057qib7	7015	1	CSA	CSA	NNP
cord-005453-4057qib7	7015	2	levels	level	NNS
cord-005453-4057qib7	7015	3	at	at	IN
cord-005453-4057qib7	7015	4	the	the	DT
cord-005453-4057qib7	7015	5	time	time	NN
cord-005453-4057qib7	7015	6	of	of	IN
cord-005453-4057qib7	7015	7	PRES	PRES	NNP
cord-005453-4057qib7	7015	8	were	be	VBD
cord-005453-4057qib7	7015	9	a	a	DT
cord-005453-4057qib7	7015	10	median	median	NN
cord-005453-4057qib7	7015	11	of	of	IN
cord-005453-4057qib7	7015	12	133	133	CD
cord-005453-4057qib7	7015	13	ng	ng	NN
cord-005453-4057qib7	7015	14	/	/	SYM
cord-005453-4057qib7	7015	15	mL	ml	NN
cord-005453-4057qib7	7015	16	(	(	-LRB-
cord-005453-4057qib7	7015	17	IQR	iqr	NN
cord-005453-4057qib7	7015	18	:	:	:
cord-005453-4057qib7	7015	19	89	89	CD
cord-005453-4057qib7	7015	20	to194	to194	CD
cord-005453-4057qib7	7015	21	)	)	-RRB-
cord-005453-4057qib7	7015	22	with	with	IN
cord-005453-4057qib7	7015	23	1	1	CD
cord-005453-4057qib7	7015	24	patient	patient	NN
cord-005453-4057qib7	7015	25	having	have	VBG
cord-005453-4057qib7	7015	26	419	419	CD
cord-005453-4057qib7	7015	27	ng	ng	NNP
cord-005453-4057qib7	7015	28	/	/	SYM
cord-005453-4057qib7	7015	29	mL.	mL.	NNP
cord-005453-4057qib7	7015	30	Three	three	CD
cord-005453-4057qib7	7015	31	patients	patient	NNS
cord-005453-4057qib7	7015	32	had	have	VBD
cord-005453-4057qib7	7015	33	PRES	PRES	NNP
cord-005453-4057qib7	7015	34	while	while	IN
cord-005453-4057qib7	7015	35	they	-PRON-	PRP
cord-005453-4057qib7	7015	36	were	be	VBD
cord-005453-4057qib7	7015	37	thrombocytopenic	thrombocytopenic	JJ
cord-005453-4057qib7	7015	38	.	.	.
cord-005453-4057qib7	7016	1	Hypertension	hypertension	NN
cord-005453-4057qib7	7016	2	stage	stage	NN
cord-005453-4057qib7	7016	3	2	2	CD
cord-005453-4057qib7	7016	4	was	be	VBD
cord-005453-4057qib7	7016	5	observed	observe	VBN
cord-005453-4057qib7	7016	6	in	in	IN
cord-005453-4057qib7	7016	7	four	four	CD
cord-005453-4057qib7	7016	8	patients	patient	NNS
cord-005453-4057qib7	7016	9	,	,	,
cord-005453-4057qib7	7016	10	stage	stage	NN
cord-005453-4057qib7	7016	11	1	1	CD
cord-005453-4057qib7	7016	12	in	in	IN
cord-005453-4057qib7	7016	13	one	one	CD
cord-005453-4057qib7	7016	14	patient	patient	NN
cord-005453-4057qib7	7016	15	,	,	,
cord-005453-4057qib7	7016	16	one	one	CD
cord-005453-4057qib7	7016	17	patient	patient	NN
cord-005453-4057qib7	7016	18	was	be	VBD
cord-005453-4057qib7	7016	19	not	not	RB
cord-005453-4057qib7	7016	20	hypertensive	hypertensive	JJ
cord-005453-4057qib7	7016	21	and	and	CC
cord-005453-4057qib7	7016	22	in	in	IN
cord-005453-4057qib7	7016	23	one	one	CD
cord-005453-4057qib7	7016	24	patient	patient	JJ
cord-005453-4057qib7	7016	25	blood	blood	NN
cord-005453-4057qib7	7016	26	pressure	pressure	NN
cord-005453-4057qib7	7016	27	values	value	NNS
cord-005453-4057qib7	7016	28	were	be	VBD
cord-005453-4057qib7	7016	29	not	not	RB
cord-005453-4057qib7	7016	30	available	available	JJ
cord-005453-4057qib7	7016	31	.	.	.
cord-005453-4057qib7	7017	1	Two	two	CD
cord-005453-4057qib7	7017	2	patients	patient	NNS
cord-005453-4057qib7	7017	3	were	be	VBD
cord-005453-4057qib7	7017	4	on	on	IN
cord-005453-4057qib7	7017	5	methylprednisolone	methylprednisolone	NNP
cord-005453-4057qib7	7017	6	1	1	CD
cord-005453-4057qib7	7017	7	and	and	CC
cord-005453-4057qib7	7017	8	1.3	1.3	CD
cord-005453-4057qib7	7017	9	mg	mg	NNP
cord-005453-4057qib7	7017	10	/	/	SYM
cord-005453-4057qib7	7017	11	kg	kg	NNP
cord-005453-4057qib7	7017	12	/	/	SYM
cord-005453-4057qib7	7017	13	day	day	NN
cord-005453-4057qib7	7017	14	and	and	CC
cord-005453-4057qib7	7017	15	one	one	CD
cord-005453-4057qib7	7017	16	was	be	VBD
cord-005453-4057qib7	7017	17	on	on	IN
cord-005453-4057qib7	7017	18	dexamethasone	dexamethasone	NNP
cord-005453-4057qib7	7017	19	10	10	CD
cord-005453-4057qib7	7017	20	mg	mg	NNP
cord-005453-4057qib7	7017	21	/	/	SYM
cord-005453-4057qib7	7017	22	m2	m2	NNP
cord-005453-4057qib7	7017	23	/	/	SYM
cord-005453-4057qib7	7017	24	day	day	NN
cord-005453-4057qib7	7017	25	.	.	.
cord-005453-4057qib7	7018	1	One	one	CD
cord-005453-4057qib7	7018	2	patient	patient	NN
cord-005453-4057qib7	7018	3	was	be	VBD
cord-005453-4057qib7	7018	4	started	start	VBN
cord-005453-4057qib7	7018	5	on	on	IN
cord-005453-4057qib7	7018	6	CSA	CSA	NNP
cord-005453-4057qib7	7018	7	again	again	RB
cord-005453-4057qib7	7018	8	after	after	IN
cord-005453-4057qib7	7018	9	the	the	DT
cord-005453-4057qib7	7018	10	PRES	PRES	NNP
cord-005453-4057qib7	7018	11	episode	episode	NN
cord-005453-4057qib7	7018	12	and	and	CC
cord-005453-4057qib7	7018	13	within	within	IN
cord-005453-4057qib7	7018	14	2	2	CD
cord-005453-4057qib7	7018	15	weeks	week	NNS
cord-005453-4057qib7	7018	16	had	have	VBD
cord-005453-4057qib7	7018	17	another	another	DT
cord-005453-4057qib7	7018	18	one	one	NN
cord-005453-4057qib7	7018	19	while	while	NN
cord-005453-4057qib7	7018	20	on	on	IN
cord-005453-4057qib7	7018	21	CSA	CSA	NNP
cord-005453-4057qib7	7018	22	(	(	-LRB-
cord-005453-4057qib7	7018	23	level	level	NN
cord-005453-4057qib7	7018	24	30	30	CD
cord-005453-4057qib7	7018	25	ng(mL	ng(ml	CD
cord-005453-4057qib7	7018	26	)	)	-RRB-
cord-005453-4057qib7	7018	27	,	,	,
cord-005453-4057qib7	7018	28	methylprednisolone	methylprednisolone	NNP
cord-005453-4057qib7	7018	29	1.5	1.5	CD
cord-005453-4057qib7	7018	30	mg	mg	NNP
cord-005453-4057qib7	7018	31	/	/	SYM
cord-005453-4057qib7	7018	32	kg	kg	NNP
cord-005453-4057qib7	7018	33	/	/	SYM
cord-005453-4057qib7	7018	34	day	day	NN
cord-005453-4057qib7	7018	35	and	and	CC
cord-005453-4057qib7	7018	36	Ruxolitinib	Ruxolitinib	NNP
cord-005453-4057qib7	7018	37	for	for	IN
cord-005453-4057qib7	7018	38	GVHD	GVHD	NNP
cord-005453-4057qib7	7018	39	.	.	.
cord-005453-4057qib7	7019	1	Protocol	protocol	NN
cord-005453-4057qib7	7019	2	2	2	CD
cord-005453-4057qib7	7019	3	had	have	VBD
cord-005453-4057qib7	7019	4	statistically	statistically	RB
cord-005453-4057qib7	7019	5	significant	significant	JJ
cord-005453-4057qib7	7019	6	improvement	improvement	NN
cord-005453-4057qib7	7019	7	in	in	IN
cord-005453-4057qib7	7019	8	disease	disease	NN
cord-005453-4057qib7	7019	9	free	free	JJ
cord-005453-4057qib7	7019	10	survival	survival	NN
cord-005453-4057qib7	7019	11	from	from	IN
cord-005453-4057qib7	7019	12	67	67	CD
cord-005453-4057qib7	7019	13	%	%	NN
cord-005453-4057qib7	7019	14	to	to	IN
cord-005453-4057qib7	7019	15	91	91	CD
cord-005453-4057qib7	7019	16	%	%	NN
cord-005453-4057qib7	7019	17	(	(	-LRB-
cord-005453-4057qib7	7019	18	p	p	NN
cord-005453-4057qib7	7019	19	<	<	XX
cord-005453-4057qib7	7019	20	0.001	0.001	CD
cord-005453-4057qib7	7019	21	)	)	-RRB-
cord-005453-4057qib7	7019	22	with	with	IN
cord-005453-4057qib7	7019	23	probability	probability	NN
cord-005453-4057qib7	7019	24	of	of	IN
cord-005453-4057qib7	7019	25	occurrence	occurrence	NN
cord-005453-4057qib7	7019	26	of	of	IN
cord-005453-4057qib7	7019	27	PRES	PRES	NNP
cord-005453-4057qib7	7019	28	increasing	increase	VBG
cord-005453-4057qib7	7019	29	from	from	IN
cord-005453-4057qib7	7019	30	1.4	1.4	CD
cord-005453-4057qib7	7019	31	%	%	NN
cord-005453-4057qib7	7019	32	to	to	IN
cord-005453-4057qib7	7019	33	5.0	5.0	CD
cord-005453-4057qib7	7019	34	%	%	NN
cord-005453-4057qib7	7019	35	(	(	-LRB-
cord-005453-4057qib7	7019	36	P	p	NN
cord-005453-4057qib7	7019	37	=	=	SYM
cord-005453-4057qib7	7019	38	0.17	0.17	CD
cord-005453-4057qib7	7019	39	,	,	,
cord-005453-4057qib7	7019	40	see	see	VB
cord-005453-4057qib7	7019	41	Figure	figure	NN
cord-005453-4057qib7	7019	42	1	1	CD
cord-005453-4057qib7	7019	43	)	)	-RRB-
cord-005453-4057qib7	7019	44	,	,	,
cord-005453-4057qib7	7019	45	yet	yet	CC
cord-005453-4057qib7	7019	46	had	have	VBD
cord-005453-4057qib7	7019	47	a	a	DT
cord-005453-4057qib7	7019	48	benign	benign	JJ
cord-005453-4057qib7	7019	49	course	course	NN
cord-005453-4057qib7	7019	50	in	in	IN
cord-005453-4057qib7	7019	51	all	all	DT
cord-005453-4057qib7	7019	52	patients	patient	NNS
cord-005453-4057qib7	7019	53	.	.	.
cord-005453-4057qib7	7020	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7020	2	:	:	:
cord-005453-4057qib7	7021	1	Not	not	RB
cord-005453-4057qib7	7021	2	stopping	stop	VBG
cord-005453-4057qib7	7021	3	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7021	4	may	may	MD
cord-005453-4057qib7	7021	5	have	have	VB
cord-005453-4057qib7	7021	6	been	be	VBN
cord-005453-4057qib7	7021	7	the	the	DT
cord-005453-4057qib7	7021	8	key	key	JJ
cord-005453-4057qib7	7021	9	factor	factor	NN
cord-005453-4057qib7	7021	10	which	which	WDT
cord-005453-4057qib7	7021	11	could	could	MD
cord-005453-4057qib7	7021	12	explain	explain	VB
cord-005453-4057qib7	7021	13	why	why	WRB
cord-005453-4057qib7	7021	14	we	-PRON-	PRP
cord-005453-4057qib7	7021	15	have	have	VBP
cord-005453-4057qib7	7021	16	better	well	JJR
cord-005453-4057qib7	7021	17	outcomes	outcome	NNS
cord-005453-4057qib7	7021	18	with	with	IN
cord-005453-4057qib7	7021	19	PRES	PRES	NNP
cord-005453-4057qib7	7021	20	than	than	IN
cord-005453-4057qib7	7021	21	what	what	WP
cord-005453-4057qib7	7021	22	is	be	VBZ
cord-005453-4057qib7	7021	23	reported	report	VBN
cord-005453-4057qib7	7021	24	.	.	.
cord-005453-4057qib7	7022	1	Intensifying	intensify	VBG
cord-005453-4057qib7	7022	2	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7022	3	pre	pre	JJ
cord-005453-4057qib7	7022	4	-	-	NN
cord-005453-4057qib7	7022	5	BMT	BMT	NNP
cord-005453-4057qib7	7022	6	did	do	VBD
cord-005453-4057qib7	7022	7	lead	lead	VB
cord-005453-4057qib7	7022	8	to	to	IN
cord-005453-4057qib7	7022	9	more	more	JJR
cord-005453-4057qib7	7022	10	PRES	PRES	NNP
cord-005453-4057qib7	7022	11	,	,	,
cord-005453-4057qib7	7022	12	albeit	albeit	IN
cord-005453-4057qib7	7022	13	not	not	RB
cord-005453-4057qib7	7022	14	significantly	significantly	RB
cord-005453-4057qib7	7022	15	,	,	,
cord-005453-4057qib7	7022	16	and	and	CC
cord-005453-4057qib7	7022	17	yet	yet	RB
cord-005453-4057qib7	7022	18	it	-PRON-	PRP
cord-005453-4057qib7	7022	19	was	be	VBD
cord-005453-4057qib7	7022	20	quite	quite	RB
cord-005453-4057qib7	7022	21	manageable	manageable	JJ
cord-005453-4057qib7	7022	22	.	.	.
cord-005453-4057qib7	7023	1	Even	even	RB
cord-005453-4057qib7	7023	2	with	with	IN
cord-005453-4057qib7	7023	3	addition	addition	NN
cord-005453-4057qib7	7023	4	of	of	IN
cord-005453-4057qib7	7023	5	fludarabine	fludarabine	NN
cord-005453-4057qib7	7023	6	our	-PRON-	PRP$
cord-005453-4057qib7	7023	7	PRES	PRES	NNP
cord-005453-4057qib7	7023	8	incidence	incidence	NN
cord-005453-4057qib7	7023	9	is	be	VBZ
cord-005453-4057qib7	7023	10	lower	low	JJR
cord-005453-4057qib7	7023	11	than	than	IN
cord-005453-4057qib7	7023	12	previously	previously	RB
cord-005453-4057qib7	7023	13	reported	report	VBN
cord-005453-4057qib7	7023	14	.	.	.
cord-005453-4057qib7	7024	1	[	[	-LRB-
cord-005453-4057qib7	7024	2	[	[	-LRB-
cord-005453-4057qib7	7024	3	P320	P320	NNP
cord-005453-4057qib7	7024	4	Image	image	NN
cord-005453-4057qib7	7024	5	]	]	-RRB-
cord-005453-4057qib7	7024	6	1	1	CD
cord-005453-4057qib7	7024	7	.	.	.
cord-005453-4057qib7	7025	1	Background	background	NN
cord-005453-4057qib7	7025	2	:	:	:
cord-005453-4057qib7	7026	1	Sickle	sickle	NN
cord-005453-4057qib7	7026	2	-	-	HYPH
cord-005453-4057qib7	7026	3	cell	cell	NN
cord-005453-4057qib7	7026	4	diseases	disease	NNS
cord-005453-4057qib7	7026	5	(	(	-LRB-
cord-005453-4057qib7	7026	6	SCD	SCD	NNP
cord-005453-4057qib7	7026	7	)	)	-RRB-
cord-005453-4057qib7	7026	8	are	be	VBP
cord-005453-4057qib7	7026	9	a	a	DT
cord-005453-4057qib7	7026	10	group	group	NN
cord-005453-4057qib7	7026	11	of	of	IN
cord-005453-4057qib7	7026	12	genetic	genetic	JJ
cord-005453-4057qib7	7026	13	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	7026	14	disorders	disorder	NNS
cord-005453-4057qib7	7026	15	marked	mark	VBN
cord-005453-4057qib7	7026	16	by	by	IN
cord-005453-4057qib7	7026	17	brain	brain	NN
cord-005453-4057qib7	7026	18	vasculopathy	vasculopathy	NNP
cord-005453-4057qib7	7026	19	.	.	.
cord-005453-4057qib7	7027	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	7027	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7027	3	stem	stem	NN
cord-005453-4057qib7	7027	4	cell	cell	NN
cord-005453-4057qib7	7027	5	transplantation	transplantation	NN
cord-005453-4057qib7	7027	6	(	(	-LRB-
cord-005453-4057qib7	7027	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7027	8	)	)	-RRB-
cord-005453-4057qib7	7027	9	is	be	VBZ
cord-005453-4057qib7	7027	10	a	a	DT
cord-005453-4057qib7	7027	11	curative	curative	JJ
cord-005453-4057qib7	7027	12	option	option	NN
cord-005453-4057qib7	7027	13	able	able	JJ
cord-005453-4057qib7	7027	14	to	to	TO
cord-005453-4057qib7	7027	15	stop	stop	VB
cord-005453-4057qib7	7027	16	vascular	vascular	JJ
cord-005453-4057qib7	7027	17	disease	disease	NN
cord-005453-4057qib7	7027	18	progression	progression	NN
cord-005453-4057qib7	7027	19	.	.	.
cord-005453-4057qib7	7028	1	Diffusion	diffusion	NN
cord-005453-4057qib7	7028	2	-	-	HYPH
cord-005453-4057qib7	7028	3	tensor	tensor	NN
cord-005453-4057qib7	7028	4	imaging	imaging	NN
cord-005453-4057qib7	7028	5	(	(	-LRB-
cord-005453-4057qib7	7028	6	DTI	DTI	NNP
cord-005453-4057qib7	7028	7	)	)	-RRB-
cord-005453-4057qib7	7028	8	is	be	VBZ
cord-005453-4057qib7	7028	9	a	a	DT
cord-005453-4057qib7	7028	10	magnetic	magnetic	JJ
cord-005453-4057qib7	7028	11	resonance	resonance	NN
cord-005453-4057qib7	7028	12	imaging	imaging	NN
cord-005453-4057qib7	7028	13	(	(	-LRB-
cord-005453-4057qib7	7028	14	MRI	MRI	NNP
cord-005453-4057qib7	7028	15	)	)	-RRB-
cord-005453-4057qib7	7028	16	technique	technique	NN
cord-005453-4057qib7	7028	17	sensitive	sensitive	JJ
cord-005453-4057qib7	7028	18	to	to	IN
cord-005453-4057qib7	7028	19	the	the	DT
cord-005453-4057qib7	7028	20	Brownian	Brownian	NNP
cord-005453-4057qib7	7028	21	motion	motion	NN
cord-005453-4057qib7	7028	22	of	of	IN
cord-005453-4057qib7	7028	23	water	water	NN
cord-005453-4057qib7	7028	24	molecules	molecule	NNS
cord-005453-4057qib7	7028	25	and	and	CC
cord-005453-4057qib7	7028	26	cellular	cellular	JJ
cord-005453-4057qib7	7028	27	environment	environment	NN
cord-005453-4057qib7	7028	28	.	.	.
cord-005453-4057qib7	7029	1	This	this	DT
cord-005453-4057qib7	7029	2	microscopic	microscopic	JJ
cord-005453-4057qib7	7029	3	quantitative	quantitative	JJ
cord-005453-4057qib7	7029	4	technique	technique	NN
cord-005453-4057qib7	7029	5	is	be	VBZ
cord-005453-4057qib7	7029	6	able	able	JJ
cord-005453-4057qib7	7029	7	to	to	TO
cord-005453-4057qib7	7029	8	detect	detect	VB
cord-005453-4057qib7	7029	9	white	white	JJ
cord-005453-4057qib7	7029	10	matter	matter	NN
cord-005453-4057qib7	7029	11	(	(	-LRB-
cord-005453-4057qib7	7029	12	WM	WM	NNP
cord-005453-4057qib7	7029	13	)	)	-RRB-
cord-005453-4057qib7	7029	14	alterations	alteration	NNS
cord-005453-4057qib7	7029	15	before	before	IN
cord-005453-4057qib7	7029	16	a	a	DT
cord-005453-4057qib7	7029	17	conventional	conventional	JJ
cord-005453-4057qib7	7029	18	MRI	mri	NN
cord-005453-4057qib7	7029	19	.	.	.
cord-005453-4057qib7	7030	1	The	the	DT
cord-005453-4057qib7	7030	2	aim	aim	NN
cord-005453-4057qib7	7030	3	of	of	IN
cord-005453-4057qib7	7030	4	this	this	DT
cord-005453-4057qib7	7030	5	study	study	NN
cord-005453-4057qib7	7030	6	was	be	VBD
cord-005453-4057qib7	7030	7	to	to	TO
cord-005453-4057qib7	7030	8	use	use	VB
cord-005453-4057qib7	7030	9	DTI	DTI	NNP
cord-005453-4057qib7	7030	10	to	to	TO
cord-005453-4057qib7	7030	11	evaluate	evaluate	VB
cord-005453-4057qib7	7030	12	axonal	axonal	JJ
cord-005453-4057qib7	7030	13	damage	damage	NN
cord-005453-4057qib7	7030	14	and	and	CC
cord-005453-4057qib7	7030	15	structural	structural	JJ
cord-005453-4057qib7	7030	16	connectivity	connectivity	NN
cord-005453-4057qib7	7030	17	in	in	IN
cord-005453-4057qib7	7030	18	the	the	DT
cord-005453-4057qib7	7030	19	brain	brain	NN
cord-005453-4057qib7	7030	20	of	of	IN
cord-005453-4057qib7	7030	21	patients	patient	NNS
cord-005453-4057qib7	7030	22	with	with	IN
cord-005453-4057qib7	7030	23	SCD	SCD	NNP
cord-005453-4057qib7	7030	24	submitted	submit	VBN
cord-005453-4057qib7	7030	25	to	to	IN
cord-005453-4057qib7	7030	26	HLA	HLA	NNP
cord-005453-4057qib7	7030	27	-	-	HYPH
cord-005453-4057qib7	7030	28	identical	identical	JJ
cord-005453-4057qib7	7030	29	sibling	sibling	NN
cord-005453-4057qib7	7030	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	7030	31	HSCT	HSCT	NNP
cord-005453-4057qib7	7030	32	.	.	.
cord-005453-4057qib7	7031	1	Methods	method	NNS
cord-005453-4057qib7	7031	2	:	:	:
cord-005453-4057qib7	7032	1	Sixteen	sixteen	JJ
cord-005453-4057qib7	7032	2	SCD	SCD	NNP
cord-005453-4057qib7	7032	3	patients	patient	NNS
cord-005453-4057qib7	7032	4	with	with	IN
cord-005453-4057qib7	7032	5	no	no	DT
cord-005453-4057qib7	7032	6	extensive	extensive	JJ
cord-005453-4057qib7	7032	7	vasculopathy	vasculopathy	NN
cord-005453-4057qib7	7032	8	detected	detect	VBN
cord-005453-4057qib7	7032	9	by	by	IN
cord-005453-4057qib7	7032	10	conventional	conventional	JJ
cord-005453-4057qib7	7032	11	MRI	MRI	NNP
cord-005453-4057qib7	7032	12	(	(	-LRB-
cord-005453-4057qib7	7032	13	11	11	CD
cord-005453-4057qib7	7032	14	male	male	NN
cord-005453-4057qib7	7032	15	,	,	,
cord-005453-4057qib7	7032	16	age	age	NN
cord-005453-4057qib7	7032	17	range	range	NN
cord-005453-4057qib7	7032	18	:	:	:
cord-005453-4057qib7	7032	19	9	9	CD
cord-005453-4057qib7	7032	20	-33	-33	NNS
cord-005453-4057qib7	7032	21	years	year	NNS
cord-005453-4057qib7	7032	22	)	)	-RRB-
cord-005453-4057qib7	7032	23	and	and	CC
cord-005453-4057qib7	7032	24	17	17	CD
cord-005453-4057qib7	7032	25	age	age	NN
cord-005453-4057qib7	7032	26	-	-	HYPH
cord-005453-4057qib7	7032	27	matched	match	VBN
cord-005453-4057qib7	7032	28	healthy	healthy	JJ
cord-005453-4057qib7	7032	29	controls	control	NNS
cord-005453-4057qib7	7032	30	(	(	-LRB-
cord-005453-4057qib7	7032	31	10	10	CD
cord-005453-4057qib7	7032	32	male	male	NN
cord-005453-4057qib7	7032	33	,	,	,
cord-005453-4057qib7	7032	34	age	age	NN
cord-005453-4057qib7	7032	35	range	range	NN
cord-005453-4057qib7	7032	36	:	:	:
cord-005453-4057qib7	7032	37	6	6	CD
cord-005453-4057qib7	7032	38	-31	-31	CD
cord-005453-4057qib7	7032	39	years	year	NNS
cord-005453-4057qib7	7032	40	)	)	-RRB-
cord-005453-4057qib7	7032	41	participated	participate	VBD
cord-005453-4057qib7	7032	42	in	in	IN
cord-005453-4057qib7	7032	43	this	this	DT
cord-005453-4057qib7	7032	44	prospective	prospective	JJ
cord-005453-4057qib7	7032	45	study	study	NN
cord-005453-4057qib7	7032	46	.	.	.
cord-005453-4057qib7	7033	1	MRI	MRI	NNP
cord-005453-4057qib7	7033	2	acquisitions	acquisition	NNS
cord-005453-4057qib7	7033	3	were	be	VBD
cord-005453-4057qib7	7033	4	performed	perform	VBN
cord-005453-4057qib7	7033	5	in	in	IN
cord-005453-4057qib7	7033	6	a	a	DT
cord-005453-4057qib7	7033	7	3	3	CD
cord-005453-4057qib7	7033	8	T	t	NN
cord-005453-4057qib7	7033	9	scanner	scanner	NN
cord-005453-4057qib7	7033	10	two	two	CD
cord-005453-4057qib7	7033	11	times	time	NNS
cord-005453-4057qib7	7033	12	for	for	IN
cord-005453-4057qib7	7033	13	patients	patient	NNS
cord-005453-4057qib7	7033	14	(	(	-LRB-
cord-005453-4057qib7	7033	15	before	before	IN
cord-005453-4057qib7	7033	16	and	and	CC
cord-005453-4057qib7	7033	17	1	1	CD
cord-005453-4057qib7	7033	18	-	-	SYM
cord-005453-4057qib7	7033	19	5	5	CD
cord-005453-4057qib7	7033	20	years	year	NNS
cord-005453-4057qib7	7033	21	after	after	IN
cord-005453-4057qib7	7033	22	HSCT	HSCT	NNP
cord-005453-4057qib7	7033	23	)	)	-RRB-
cord-005453-4057qib7	7033	24	and	and	CC
cord-005453-4057qib7	7033	25	at	at	IN
cord-005453-4057qib7	7033	26	a	a	DT
cord-005453-4057qib7	7033	27	single	single	JJ
cord-005453-4057qib7	7033	28	moment	moment	NN
cord-005453-4057qib7	7033	29	for	for	IN
cord-005453-4057qib7	7033	30	controls	control	NNS
cord-005453-4057qib7	7033	31	.	.	.
cord-005453-4057qib7	7034	1	From	from	IN
cord-005453-4057qib7	7034	2	DTI	DTI	NNP
cord-005453-4057qib7	7034	3	acquisitions	acquisition	NNS
cord-005453-4057qib7	7034	4	,	,	,
cord-005453-4057qib7	7034	5	fractional	fractional	JJ
cord-005453-4057qib7	7034	6	anisotropy	anisotropy	NN
cord-005453-4057qib7	7034	7	(	(	-LRB-
cord-005453-4057qib7	7034	8	FA	FA	NNP
cord-005453-4057qib7	7034	9	)	)	-RRB-
cord-005453-4057qib7	7034	10	,	,	,
cord-005453-4057qib7	7034	11	mean	mean	JJ
cord-005453-4057qib7	7034	12	(	(	-LRB-
cord-005453-4057qib7	7034	13	MD	MD	NNP
cord-005453-4057qib7	7034	14	)	)	-RRB-
cord-005453-4057qib7	7034	15	,	,	,
cord-005453-4057qib7	7034	16	radial	radial	JJ
cord-005453-4057qib7	7034	17	(	(	-LRB-
cord-005453-4057qib7	7034	18	RD	RD	NNP
cord-005453-4057qib7	7034	19	)	)	-RRB-
cord-005453-4057qib7	7034	20	and	and	CC
cord-005453-4057qib7	7034	21	axial	axial	JJ
cord-005453-4057qib7	7034	22	diffusibility	diffusibility	NN
cord-005453-4057qib7	7034	23	(	(	-LRB-
cord-005453-4057qib7	7034	24	AD	ad	NN
cord-005453-4057qib7	7034	25	)	)	-RRB-
cord-005453-4057qib7	7034	26	were	be	VBD
cord-005453-4057qib7	7034	27	calculated	calculate	VBN
cord-005453-4057qib7	7034	28	in	in	IN
cord-005453-4057qib7	7034	29	the	the	DT
cord-005453-4057qib7	7034	30	WM	WM	NNP
cord-005453-4057qib7	7034	31	of	of	IN
cord-005453-4057qib7	7034	32	the	the	DT
cord-005453-4057qib7	7034	33	whole	whole	JJ
cord-005453-4057qib7	7034	34	brain	brain	NN
cord-005453-4057qib7	7034	35	.	.	.
cord-005453-4057qib7	7035	1	Structural	structural	JJ
cord-005453-4057qib7	7035	2	connectivity	connectivity	NN
cord-005453-4057qib7	7035	3	was	be	VBD
cord-005453-4057qib7	7035	4	also	also	RB
cord-005453-4057qib7	7035	5	analyzed	analyze	VBN
cord-005453-4057qib7	7035	6	,	,	,
cord-005453-4057qib7	7035	7	based	base	VBN
cord-005453-4057qib7	7035	8	on	on	IN
cord-005453-4057qib7	7035	9	graph	graph	NN
cord-005453-4057qib7	7035	10	theory	theory	NN
cord-005453-4057qib7	7035	11	,	,	,
cord-005453-4057qib7	7035	12	obtaining	obtain	VBG
cord-005453-4057qib7	7035	13	efficiency	efficiency	NN
cord-005453-4057qib7	7035	14	,	,	,
cord-005453-4057qib7	7035	15	length	length	NN
cord-005453-4057qib7	7035	16	path	path	NN
cord-005453-4057qib7	7035	17	and	and	CC
cord-005453-4057qib7	7035	18	clustering	clustering	NN
cord-005453-4057qib7	7035	19	coefficients	coefficient	NNS
cord-005453-4057qib7	7035	20	of	of	IN
cord-005453-4057qib7	7035	21	the	the	DT
cord-005453-4057qib7	7035	22	brain	brain	NN
cord-005453-4057qib7	7035	23	network	network	NN
cord-005453-4057qib7	7035	24	.	.	.
cord-005453-4057qib7	7036	1	An	an	DT
cord-005453-4057qib7	7036	2	ANOVA	anova	NN
cord-005453-4057qib7	7036	3	test	test	NN
cord-005453-4057qib7	7036	4	was	be	VBD
cord-005453-4057qib7	7036	5	applied	apply	VBN
cord-005453-4057qib7	7036	6	to	to	TO
cord-005453-4057qib7	7036	7	analyze	analyze	VB
cord-005453-4057qib7	7036	8	FA	FA	NNP
cord-005453-4057qib7	7036	9	differences	difference	NNS
cord-005453-4057qib7	7036	10	among	among	IN
cord-005453-4057qib7	7036	11	controls	control	NNS
cord-005453-4057qib7	7036	12	and	and	CC
cord-005453-4057qib7	7036	13	patients	patient	NNS
cord-005453-4057qib7	7036	14	,	,	,
cord-005453-4057qib7	7036	15	before	before	IN
cord-005453-4057qib7	7036	16	and	and	CC
cord-005453-4057qib7	7036	17	after	after	IN
cord-005453-4057qib7	7036	18	HSCT	HSCT	NNP
cord-005453-4057qib7	7036	19	.	.	.
cord-005453-4057qib7	7037	1	A	a	DT
cord-005453-4057qib7	7037	2	paired	paired	JJ
cord-005453-4057qib7	7037	3	two	two	CD
cord-005453-4057qib7	7037	4	-	-	HYPH
cord-005453-4057qib7	7037	5	tailed	tailed	JJ
cord-005453-4057qib7	7037	6	t	t	NN
cord-005453-4057qib7	7037	7	-	-	HYPH
cord-005453-4057qib7	7037	8	test	test	NN
cord-005453-4057qib7	7037	9	was	be	VBD
cord-005453-4057qib7	7037	10	used	use	VBN
cord-005453-4057qib7	7037	11	to	to	TO
cord-005453-4057qib7	7037	12	determine	determine	VB
cord-005453-4057qib7	7037	13	statistical	statistical	JJ
cord-005453-4057qib7	7037	14	significance	significance	NN
cord-005453-4057qib7	7037	15	of	of	IN
cord-005453-4057qib7	7037	16	changes	change	NNS
cord-005453-4057qib7	7037	17	in	in	IN
cord-005453-4057qib7	7037	18	the	the	DT
cord-005453-4057qib7	7037	19	FA	fa	NN
cord-005453-4057qib7	7037	20	,	,	,
cord-005453-4057qib7	7037	21	diffusivity	diffusivity	NN
cord-005453-4057qib7	7037	22	mean	mean	VB
cord-005453-4057qib7	7037	23	values	value	NNS
cord-005453-4057qib7	7037	24	and	and	CC
cord-005453-4057qib7	7037	25	network	network	NN
cord-005453-4057qib7	7037	26	parameters	parameter	NNS
cord-005453-4057qib7	7037	27	before	before	IN
cord-005453-4057qib7	7037	28	and	and	CC
cord-005453-4057qib7	7037	29	after	after	IN
cord-005453-4057qib7	7037	30	HSCT	HSCT	NNP
cord-005453-4057qib7	7037	31	.	.	.
cord-005453-4057qib7	7038	1	Results	result	NNS
cord-005453-4057qib7	7038	2	:	:	:
cord-005453-4057qib7	7039	1	Mean	mean	JJ
cord-005453-4057qib7	7039	2	FA	FA	NNP
cord-005453-4057qib7	7039	3	was	be	VBD
cord-005453-4057qib7	7039	4	lower	low	JJR
cord-005453-4057qib7	7039	5	in	in	IN
cord-005453-4057qib7	7039	6	patients	patient	NNS
cord-005453-4057qib7	7039	7	before	before	IN
cord-005453-4057qib7	7039	8	HSCT	HSCT	NNP
cord-005453-4057qib7	7039	9	than	than	IN
cord-005453-4057qib7	7039	10	controls	control	NNS
cord-005453-4057qib7	7040	1	(	(	-LRB-
cord-005453-4057qib7	7040	2	p	p	NN
cord-005453-4057qib7	7040	3	=	=	SYM
cord-005453-4057qib7	7040	4	0,038	0,038	CD
cord-005453-4057qib7	7040	5	)	)	-RRB-
cord-005453-4057qib7	7040	6	and	and	CC
cord-005453-4057qib7	7040	7	increased	increase	VBD
cord-005453-4057qib7	7040	8	after	after	IN
cord-005453-4057qib7	7040	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7040	10	being	be	VBG
cord-005453-4057qib7	7040	11	not	not	RB
cord-005453-4057qib7	7040	12	statistically	statistically	RB
cord-005453-4057qib7	7040	13	different	different	JJ
cord-005453-4057qib7	7040	14	when	when	WRB
cord-005453-4057qib7	7040	15	compared	compare	VBN
cord-005453-4057qib7	7040	16	to	to	IN
cord-005453-4057qib7	7040	17	controls	control	NNS
cord-005453-4057qib7	7040	18	(	(	-LRB-
cord-005453-4057qib7	7040	19	controls	control	NNS
cord-005453-4057qib7	7040	20	=	=	NNP
cord-005453-4057qib7	7040	21	0,3504	0,3504	NNP
cord-005453-4057qib7	7040	22	;	;	:
cord-005453-4057qib7	7040	23	patients	patient	NNS
cord-005453-4057qib7	7040	24	before	before	IN
cord-005453-4057qib7	7040	25	HSCT	HSCT	NNP
cord-005453-4057qib7	7040	26	=	=	SYM
cord-005453-4057qib7	7040	27	0,3328	0,3328	NNP
cord-005453-4057qib7	7040	28	;	;	:
cord-005453-4057qib7	7040	29	patients	patient	NNS
cord-005453-4057qib7	7040	30	after	after	IN
cord-005453-4057qib7	7040	31	HSCT	HSCT	NNP
cord-005453-4057qib7	7040	32	=	=	NFP
cord-005453-4057qib7	7041	1	0,3422	0,3422	LS
cord-005453-4057qib7	7041	2	;	;	:
cord-005453-4057qib7	7041	3	Post	Post	NNP
cord-005453-4057qib7	7041	4	hoc	hoc	FW
cord-005453-4057qib7	7041	5	Dunnett	Dunnett	NNP
cord-005453-4057qib7	7041	6	's	's	POS
cord-005453-4057qib7	7041	7	test	test	NN
cord-005453-4057qib7	7041	8	-Error	-Error	.
cord-005453-4057qib7	7041	9	0,03	0,03	XX
cord-005453-4057qib7	7041	10	;	;	:
cord-005453-4057qib7	7041	11	ANOVA	ANOVA	NNP
cord-005453-4057qib7	7041	12	test	test	NN
cord-005453-4057qib7	7041	13	)	)	-RRB-
cord-005453-4057qib7	7041	14	.	.	.
cord-005453-4057qib7	7042	1	When	when	WRB
cord-005453-4057qib7	7042	2	patients	patient	NNS
cord-005453-4057qib7	7042	3	were	be	VBD
cord-005453-4057qib7	7042	4	compared	compare	VBN
cord-005453-4057qib7	7042	5	before	before	IN
cord-005453-4057qib7	7042	6	and	and	CC
cord-005453-4057qib7	7042	7	after	after	IN
cord-005453-4057qib7	7042	8	HSCT	HSCT	NNP
cord-005453-4057qib7	7042	9	,	,	,
cord-005453-4057qib7	7042	10	MD	MD	NNP
cord-005453-4057qib7	7042	11	and	and	CC
cord-005453-4057qib7	7042	12	RD	RD	NNP
cord-005453-4057qib7	7042	13	decrease	decrease	NN
cord-005453-4057qib7	7042	14	after	after	IN
cord-005453-4057qib7	7042	15	HSCT	HSCT	NNP
cord-005453-4057qib7	7042	16	(	(	-LRB-
cord-005453-4057qib7	7042	17	p	p	NN
cord-005453-4057qib7	7043	1	=	=	LS
cord-005453-4057qib7	7043	2	0,038	0,038	CD
cord-005453-4057qib7	7043	3	and	and	CC
cord-005453-4057qib7	7043	4	0,047	0,047	CD
cord-005453-4057qib7	7043	5	,	,	,
cord-005453-4057qib7	7043	6	respectively	respectively	RB
cord-005453-4057qib7	7043	7	)	)	-RRB-
cord-005453-4057qib7	7043	8	.	.	.
cord-005453-4057qib7	7044	1	On	on	IN
cord-005453-4057qib7	7044	2	the	the	DT
cord-005453-4057qib7	7044	3	other	other	JJ
cord-005453-4057qib7	7044	4	hand	hand	NN
cord-005453-4057qib7	7044	5	,	,	,
cord-005453-4057qib7	7044	6	FA	FA	NNP
cord-005453-4057qib7	7044	7	increased	increase	VBD
cord-005453-4057qib7	7044	8	(	(	-LRB-
cord-005453-4057qib7	7044	9	p	p	NN
cord-005453-4057qib7	7044	10	=	=	SYM
cord-005453-4057qib7	7044	11	0,044	0,044	CD
cord-005453-4057qib7	7044	12	)	)	-RRB-
cord-005453-4057qib7	7044	13	.	.	.
cord-005453-4057qib7	7045	1	After	after	IN
cord-005453-4057qib7	7045	2	HSCT	HSCT	NNP
cord-005453-4057qib7	7045	3	,	,	,
cord-005453-4057qib7	7045	4	efficiency	efficiency	NN
cord-005453-4057qib7	7045	5	was	be	VBD
cord-005453-4057qib7	7045	6	higher	high	JJR
cord-005453-4057qib7	7045	7	(	(	-LRB-
cord-005453-4057qib7	7045	8	p	p	NN
cord-005453-4057qib7	7045	9	=	=	SYM
cord-005453-4057qib7	7045	10	0,023	0,023	CD
cord-005453-4057qib7	7045	11	)	)	-RRB-
cord-005453-4057qib7	7045	12	and	and	CC
cord-005453-4057qib7	7045	13	path	path	NN
cord-005453-4057qib7	7045	14	length	length	NN
cord-005453-4057qib7	7045	15	index	index	NN
cord-005453-4057qib7	7045	16	was	be	VBD
cord-005453-4057qib7	7045	17	lower	low	JJR
cord-005453-4057qib7	7045	18	(	(	-LRB-
cord-005453-4057qib7	7045	19	p=0,027	p=0,027	NNP
cord-005453-4057qib7	7045	20	)	)	-RRB-
cord-005453-4057qib7	7045	21	than	than	IN
cord-005453-4057qib7	7045	22	at	at	IN
cord-005453-4057qib7	7045	23	study	study	NN
cord-005453-4057qib7	7045	24	entry	entry	NN
cord-005453-4057qib7	7045	25	(	(	-LRB-
cord-005453-4057qib7	7045	26	table	table	NN
cord-005453-4057qib7	7045	27	1	1	CD
cord-005453-4057qib7	7045	28	)	)	-RRB-
cord-005453-4057qib7	7045	29	.	.	.
cord-005453-4057qib7	7046	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7046	2	:	:	:
cord-005453-4057qib7	7047	1	This	this	DT
cord-005453-4057qib7	7047	2	study	study	NN
cord-005453-4057qib7	7047	3	indicates	indicate	VBZ
cord-005453-4057qib7	7047	4	that	that	IN
cord-005453-4057qib7	7047	5	,	,	,
cord-005453-4057qib7	7047	6	before	before	IN
cord-005453-4057qib7	7047	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7047	8	,	,	,
cord-005453-4057qib7	7047	9	patients	patient	NNS
cord-005453-4057qib7	7047	10	with	with	IN
cord-005453-4057qib7	7047	11	SCD	SCD	NNP
cord-005453-4057qib7	7047	12	present	present	JJ
cord-005453-4057qib7	7047	13	axonal	axonal	JJ
cord-005453-4057qib7	7047	14	damage	damage	NN
cord-005453-4057qib7	7047	15	not	not	RB
cord-005453-4057qib7	7047	16	detectable	detectable	JJ
cord-005453-4057qib7	7047	17	by	by	IN
cord-005453-4057qib7	7047	18	conventional	conventional	JJ
cord-005453-4057qib7	7047	19	MRI	mri	NN
cord-005453-4057qib7	7047	20	,	,	,
cord-005453-4057qib7	7047	21	when	when	WRB
cord-005453-4057qib7	7047	22	compared	compare	VBN
cord-005453-4057qib7	7047	23	to	to	IN
cord-005453-4057qib7	7047	24	healthy	healthy	JJ
cord-005453-4057qib7	7047	25	controls	control	NNS
cord-005453-4057qib7	7047	26	.	.	.
cord-005453-4057qib7	7048	1	We	-PRON-	PRP
cord-005453-4057qib7	7048	2	also	also	RB
cord-005453-4057qib7	7048	3	suggest	suggest	VBP
cord-005453-4057qib7	7048	4	that	that	IN
cord-005453-4057qib7	7048	5	HSCT	HSCT	NNP
cord-005453-4057qib7	7048	6	is	be	VBZ
cord-005453-4057qib7	7048	7	able	able	JJ
cord-005453-4057qib7	7048	8	to	to	TO
cord-005453-4057qib7	7048	9	promote	promote	VB
cord-005453-4057qib7	7048	10	axonal	axonal	JJ
cord-005453-4057qib7	7048	11	recovery	recovery	NN
cord-005453-4057qib7	7048	12	and	and	CC
cord-005453-4057qib7	7048	13	reorganization	reorganization	NN
cord-005453-4057qib7	7048	14	.	.	.
cord-005453-4057qib7	7049	1	Partial	partial	JJ
cord-005453-4057qib7	7049	2	diffusivity	diffusivity	NN
cord-005453-4057qib7	7049	3	recovery	recovery	NN
cord-005453-4057qib7	7049	4	could	could	MD
cord-005453-4057qib7	7049	5	be	be	VB
cord-005453-4057qib7	7049	6	associate	associate	JJ
cord-005453-4057qib7	7049	7	to	to	IN
cord-005453-4057qib7	7049	8	a	a	DT
cord-005453-4057qib7	7049	9	still	still	RB
cord-005453-4057qib7	7049	10	unidentified	unidentified	JJ
cord-005453-4057qib7	7049	11	mechanism	mechanism	NN
cord-005453-4057qib7	7049	12	of	of	IN
cord-005453-4057qib7	7049	13	myelin	myelin	JJ
cord-005453-4057qib7	7049	14	regeneration	regeneration	NN
cord-005453-4057qib7	7049	15	.	.	.
cord-005453-4057qib7	7050	1	In	in	IN
cord-005453-4057qib7	7050	2	the	the	DT
cord-005453-4057qib7	7050	3	future	future	NN
cord-005453-4057qib7	7050	4	,	,	,
cord-005453-4057qib7	7050	5	longer	longer	RB
cord-005453-4057qib7	7050	6	follow	follow	VB
cord-005453-4057qib7	7050	7	up	up	RP
cord-005453-4057qib7	7050	8	and	and	CC
cord-005453-4057qib7	7050	9	comparisons	comparison	NNS
cord-005453-4057qib7	7050	10	with	with	IN
cord-005453-4057qib7	7050	11	other	other	JJ
cord-005453-4057qib7	7050	12	forms	form	NNS
cord-005453-4057qib7	7050	13	of	of	IN
cord-005453-4057qib7	7050	14	treatment	treatment	NN
cord-005453-4057qib7	7050	15	are	be	VBP
cord-005453-4057qib7	7050	16	required	require	VBN
cord-005453-4057qib7	7050	17	.	.	.
cord-005453-4057qib7	7051	1	Background	background	NN
cord-005453-4057qib7	7051	2	:	:	:
cord-005453-4057qib7	7052	1	BMT	BMT	NNP
cord-005453-4057qib7	7052	2	is	be	VBZ
cord-005453-4057qib7	7052	3	a	a	DT
cord-005453-4057qib7	7052	4	well	well	RB
cord-005453-4057qib7	7052	5	-	-	HYPH
cord-005453-4057qib7	7052	6	established	establish	VBN
cord-005453-4057qib7	7052	7	treatment	treatment	NN
cord-005453-4057qib7	7052	8	modality	modality	NN
cord-005453-4057qib7	7052	9	for	for	IN
cord-005453-4057qib7	7052	10	haemoglobinopathies	haemoglobinopathy	NNS
cord-005453-4057qib7	7052	11	,	,	,
cord-005453-4057qib7	7052	12	limited	limit	VBN
cord-005453-4057qib7	7052	13	by	by	IN
cord-005453-4057qib7	7052	14	the	the	DT
cord-005453-4057qib7	7052	15	availability	availability	NN
cord-005453-4057qib7	7052	16	of	of	IN
cord-005453-4057qib7	7052	17	related	related	JJ
cord-005453-4057qib7	7052	18	donors	donor	NNS
cord-005453-4057qib7	7052	19	.	.	.
cord-005453-4057qib7	7053	1	Unrelated	unrelated	JJ
cord-005453-4057qib7	7053	2	transplantation	transplantation	NN
cord-005453-4057qib7	7053	3	has	have	VBZ
cord-005453-4057qib7	7053	4	historically	historically	RB
cord-005453-4057qib7	7053	5	shown	show	VBN
cord-005453-4057qib7	7053	6	variable	variable	JJ
cord-005453-4057qib7	7053	7	outcomes	outcome	NNS
cord-005453-4057qib7	7053	8	driven	drive	VBN
cord-005453-4057qib7	7053	9	by	by	IN
cord-005453-4057qib7	7053	10	GvHD	gvhd	NN
cord-005453-4057qib7	7053	11	and	and	CC
cord-005453-4057qib7	7053	12	toxicity	toxicity	NN
cord-005453-4057qib7	7053	13	,	,	,
cord-005453-4057qib7	7053	14	and	and	CC
cord-005453-4057qib7	7053	15	usually	usually	RB
cord-005453-4057qib7	7053	16	restricted	restrict	VBN
cord-005453-4057qib7	7053	17	to	to	IN
cord-005453-4057qib7	7053	18	10/10	10/10	CD
cord-005453-4057qib7	7053	19	matches	match	NNS
cord-005453-4057qib7	7053	20	,	,	,
cord-005453-4057qib7	7053	21	but	but	CC
cord-005453-4057qib7	7053	22	the	the	DT
cord-005453-4057qib7	7053	23	impact	impact	NN
cord-005453-4057qib7	7053	24	of	of	IN
cord-005453-4057qib7	7053	25	reduced	reduce	VBN
cord-005453-4057qib7	7053	26	toxicity	toxicity	NN
cord-005453-4057qib7	7053	27	conditioning	conditioning	NN
cord-005453-4057qib7	7053	28	regimens	regimen	NNS
cord-005453-4057qib7	7053	29	is	be	VBZ
cord-005453-4057qib7	7053	30	yet	yet	RB
cord-005453-4057qib7	7053	31	to	to	TO
cord-005453-4057qib7	7053	32	be	be	VB
cord-005453-4057qib7	7053	33	known	know	VBN
cord-005453-4057qib7	7053	34	.	.	.
cord-005453-4057qib7	7054	1	Methods	method	NNS
cord-005453-4057qib7	7054	2	:	:	:
cord-005453-4057qib7	7055	1	From	from	IN
cord-005453-4057qib7	7055	2	2011	2011	CD
cord-005453-4057qib7	7055	3	to	to	IN
cord-005453-4057qib7	7055	4	2018	2018	CD
cord-005453-4057qib7	7055	5	twenty	twenty	CD
cord-005453-4057qib7	7055	6	-	-	HYPH
cord-005453-4057qib7	7055	7	five	five	CD
cord-005453-4057qib7	7055	8	consecutive	consecutive	JJ
cord-005453-4057qib7	7055	9	unrelated	unrelated	JJ
cord-005453-4057qib7	7055	10	bone	bone	NN
cord-005453-4057qib7	7055	11	marrow	marrow	NN
cord-005453-4057qib7	7055	12	transplants	transplant	NNS
cord-005453-4057qib7	7055	13	were	be	VBD
cord-005453-4057qib7	7055	14	conditioned	condition	VBN
cord-005453-4057qib7	7055	15	with	with	IN
cord-005453-4057qib7	7055	16	fludarabine	fludarabine	NN
cord-005453-4057qib7	7055	17	160	160	CD
cord-005453-4057qib7	7055	18	mg	mg	NNP
cord-005453-4057qib7	7055	19	/	/	SYM
cord-005453-4057qib7	7055	20	m	m	NNP
cord-005453-4057qib7	7055	21	2	2	CD
cord-005453-4057qib7	7055	22	,	,	,
cord-005453-4057qib7	7055	23	treosulfan	treosulfan	NN
cord-005453-4057qib7	7055	24	42	42	CD
cord-005453-4057qib7	7055	25	g	g	NN
cord-005453-4057qib7	7055	26	/	/	SYM
cord-005453-4057qib7	7055	27	m	m	NNP
cord-005453-4057qib7	7055	28	2	2	CD
cord-005453-4057qib7	7055	29	,	,	,
cord-005453-4057qib7	7055	30	thiotepa	thiotepa	VBZ
cord-005453-4057qib7	7055	31	10	10	CD
cord-005453-4057qib7	7055	32	mg/	mg/	NN
cord-005453-4057qib7	7055	33	kg	kg	NNP
cord-005453-4057qib7	7055	34	and	and	CC
cord-005453-4057qib7	7055	35	ATG	ATG	NNP
cord-005453-4057qib7	7055	36	(	(	-LRB-
cord-005453-4057qib7	7055	37	Thymoglobulin	Thymoglobulin	NNP
cord-005453-4057qib7	7055	38	)	)	-RRB-
cord-005453-4057qib7	7056	1	11.25	11.25	CD
cord-005453-4057qib7	7056	2	mg	mg	NNP
cord-005453-4057qib7	7056	3	/	/	SYM
cord-005453-4057qib7	7056	4	kg	kg	NNP
cord-005453-4057qib7	7057	1	if	if	IN
cord-005453-4057qib7	7057	2	the	the	DT
cord-005453-4057qib7	7057	3	source	source	NN
cord-005453-4057qib7	7057	4	of	of	IN
cord-005453-4057qib7	7057	5	stem	stem	NN
cord-005453-4057qib7	7057	6	cells	cell	NNS
cord-005453-4057qib7	7057	7	was	be	VBD
cord-005453-4057qib7	7057	8	marrow	marrow	NN
cord-005453-4057qib7	7057	9	(	(	-LRB-
cord-005453-4057qib7	7057	10	n	n	NN
cord-005453-4057qib7	7057	11	=	=	SYM
cord-005453-4057qib7	7057	12	21	21	CD
cord-005453-4057qib7	7057	13	)	)	-RRB-
cord-005453-4057qib7	7057	14	or	or	CC
cord-005453-4057qib7	7057	15	PTCy	PTCy	NNS
cord-005453-4057qib7	7057	16	if	if	IN
cord-005453-4057qib7	7057	17	PBSC	PBSC	NNP
cord-005453-4057qib7	7057	18	(	(	-LRB-
cord-005453-4057qib7	7057	19	n	n	NN
cord-005453-4057qib7	7057	20	=	=	SYM
cord-005453-4057qib7	7057	21	4	4	CD
cord-005453-4057qib7	7057	22	)	)	-RRB-
cord-005453-4057qib7	7057	23	.	.	.
cord-005453-4057qib7	7058	1	Endogenous	endogenous	JJ
cord-005453-4057qib7	7058	2	haemopoiesis	haemopoiesis	NN
cord-005453-4057qib7	7058	3	was	be	VBD
cord-005453-4057qib7	7058	4	suppressed	suppress	VBN
cord-005453-4057qib7	7058	5	pretransplantation	pretransplantation	NN
cord-005453-4057qib7	7058	6	for	for	IN
cord-005453-4057qib7	7058	7	a	a	DT
cord-005453-4057qib7	7058	8	minimum	minimum	NN
cord-005453-4057qib7	7058	9	of	of	IN
cord-005453-4057qib7	7058	10	8	8	CD
cord-005453-4057qib7	7058	11	weeks	week	NNS
cord-005453-4057qib7	7058	12	.	.	.
cord-005453-4057qib7	7059	1	GvHD	GvHD	NNP
cord-005453-4057qib7	7059	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7059	3	was	be	VBD
cord-005453-4057qib7	7059	4	provided	provide	VBN
cord-005453-4057qib7	7059	5	with	with	IN
cord-005453-4057qib7	7059	6	ciclosporin	ciclosporin	NN
cord-005453-4057qib7	7059	7	/	/	SYM
cord-005453-4057qib7	7059	8	sirolimus	sirolimus	NN
cord-005453-4057qib7	7059	9	and	and	CC
cord-005453-4057qib7	7059	10	MMF	mmf	NN
cord-005453-4057qib7	7059	11	.	.	.
cord-005453-4057qib7	7060	1	Thirteen	thirteen	CD
cord-005453-4057qib7	7060	2	patients	patient	NNS
cord-005453-4057qib7	7060	3	were	be	VBD
cord-005453-4057qib7	7060	4	transplanted	transplant	VBN
cord-005453-4057qib7	7060	5	for	for	IN
cord-005453-4057qib7	7060	6	b	b	NNP
cord-005453-4057qib7	7060	7	thalassaemia	thalassaemia	NNP
cord-005453-4057qib7	7060	8	major	major	NNP
cord-005453-4057qib7	7060	9	,	,	,
cord-005453-4057qib7	7060	10	one	one	CD
cord-005453-4057qib7	7060	11	of	of	IN
cord-005453-4057qib7	7060	12	a	a	DT
cord-005453-4057qib7	7060	13	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	7060	14	major	major	NN
cord-005453-4057qib7	7060	15	and	and	CC
cord-005453-4057qib7	7060	16	11	11	CD
cord-005453-4057qib7	7060	17	sickle	sickle	NN
cord-005453-4057qib7	7060	18	cell	cell	NN
cord-005453-4057qib7	7060	19	disease	disease	NN
cord-005453-4057qib7	7060	20	.	.	.
cord-005453-4057qib7	7061	1	The	the	DT
cord-005453-4057qib7	7061	2	median	median	JJ
cord-005453-4057qib7	7061	3	age	age	NN
cord-005453-4057qib7	7061	4	was	be	VBD
cord-005453-4057qib7	7061	5	8	8	CD
cord-005453-4057qib7	7061	6	years	year	NNS
cord-005453-4057qib7	7061	7	(	(	-LRB-
cord-005453-4057qib7	7061	8	2	2	CD
cord-005453-4057qib7	7061	9	-19	-19	CD
cord-005453-4057qib7	7061	10	)	)	-RRB-
cord-005453-4057qib7	7061	11	.	.	.
cord-005453-4057qib7	7062	1	Ten	ten	CD
cord-005453-4057qib7	7062	2	patients	patient	NNS
cord-005453-4057qib7	7062	3	were	be	VBD
cord-005453-4057qib7	7062	4	10/10	10/10	CD
cord-005453-4057qib7	7062	5	matched	match	VBN
cord-005453-4057qib7	7062	6	(	(	-LRB-
cord-005453-4057qib7	7062	7	7	7	CD
cord-005453-4057qib7	7062	8	thalassemia	thalassemia	NN
cord-005453-4057qib7	7062	9	and	and	CC
cord-005453-4057qib7	7062	10	3	3	CD
cord-005453-4057qib7	7062	11	sickle	sickle	NN
cord-005453-4057qib7	7062	12	)	)	-RRB-
cord-005453-4057qib7	7062	13	and	and	CC
cord-005453-4057qib7	7062	14	15	15	CD
cord-005453-4057qib7	7062	15	patients	patient	NNS
cord-005453-4057qib7	7062	16	had	have	VBD
cord-005453-4057qib7	7062	17	a	a	DT
cord-005453-4057qib7	7062	18	9/10	9/10	CD
cord-005453-4057qib7	7062	19	match	match	NN
cord-005453-4057qib7	7062	20	(	(	-LRB-
cord-005453-4057qib7	7062	21	7	7	CD
cord-005453-4057qib7	7062	22	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	7062	23	and	and	CC
cord-005453-4057qib7	7062	24	8	8	CD
cord-005453-4057qib7	7062	25	sickle	sickle	NN
cord-005453-4057qib7	7062	26	)	)	-RRB-
cord-005453-4057qib7	7062	27	.	.	.
cord-005453-4057qib7	7063	1	The	the	DT
cord-005453-4057qib7	7063	2	median	median	JJ
cord-005453-4057qib7	7063	3	cell	cell	NN
cord-005453-4057qib7	7063	4	dose	dose	NN
cord-005453-4057qib7	7063	5	was	be	VBD
cord-005453-4057qib7	7063	6	3.88	3.88	CD
cord-005453-4057qib7	7063	7	x	x	SYM
cord-005453-4057qib7	7063	8	10	10	CD
cord-005453-4057qib7	7063	9	8	8	CD
cord-005453-4057qib7	7063	10	TNC	TNC	NNP
cord-005453-4057qib7	7063	11	/	/	SYM
cord-005453-4057qib7	7063	12	kg	kg	NN
cord-005453-4057qib7	7064	1	(	(	-LRB-
cord-005453-4057qib7	7064	2	range	range	VBP
cord-005453-4057qib7	7064	3	1.38	1.38	CD
cord-005453-4057qib7	7064	4	-13.3	-13.3	CD
cord-005453-4057qib7	7064	5	)	)	-RRB-
cord-005453-4057qib7	7064	6	and	and	CC
cord-005453-4057qib7	7065	1	5.22	5.22	CD
cord-005453-4057qib7	7065	2	x	x	SYM
cord-005453-4057qib7	7065	3	10	10	CD
cord-005453-4057qib7	7065	4	6	6	CD
cord-005453-4057qib7	7065	5	CD34+/kg	CD34+/kg	NNP
cord-005453-4057qib7	7065	6	(	(	-LRB-
cord-005453-4057qib7	7065	7	range	range	NN
cord-005453-4057qib7	7065	8	1.10	1.10	CD
cord-005453-4057qib7	7065	9	-27.41	-27.41	NN
cord-005453-4057qib7	7065	10	)	)	-RRB-
cord-005453-4057qib7	7065	11	.	.	.
cord-005453-4057qib7	7066	1	The	the	DT
cord-005453-4057qib7	7066	2	median	median	JJ
cord-005453-4057qib7	7066	3	survival	survival	NN
cord-005453-4057qib7	7066	4	was	be	VBD
cord-005453-4057qib7	7066	5	13.4	13.4	CD
cord-005453-4057qib7	7066	6	months	month	NNS
cord-005453-4057qib7	7066	7	(	(	-LRB-
cord-005453-4057qib7	7066	8	0.7	0.7	CD
cord-005453-4057qib7	7066	9	-68.3	-68.3	NNP
cord-005453-4057qib7	7066	10	)	)	-RRB-
cord-005453-4057qib7	7066	11	.	.	.
cord-005453-4057qib7	7067	1	Patients	patient	NNS
cord-005453-4057qib7	7067	2	with	with	IN
cord-005453-4057qib7	7067	3	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	7067	4	were	be	VBD
cord-005453-4057qib7	7067	5	Pesaro	Pesaro	NNP
cord-005453-4057qib7	7067	6	class	class	NN
cord-005453-4057qib7	7067	7	I	i	NN
cord-005453-4057qib7	7067	8	or	or	CC
cord-005453-4057qib7	7067	9	II	II	NNP
cord-005453-4057qib7	7067	10	(	(	-LRB-
cord-005453-4057qib7	7067	11	Pesaro	Pesaro	NNP
cord-005453-4057qib7	7067	12	class	class	NN
cord-005453-4057qib7	7067	13	III	iii	CD
cord-005453-4057qib7	7067	14	patients	patient	NNS
cord-005453-4057qib7	7067	15	were	be	VBD
cord-005453-4057qib7	7067	16	intensively	intensively	RB
cord-005453-4057qib7	7067	17	chelated	chelated	JJ
cord-005453-4057qib7	7067	18	pretransplantation	pretransplantation	NN
cord-005453-4057qib7	7067	19	to	to	TO
cord-005453-4057qib7	7067	20	return	return	VB
cord-005453-4057qib7	7067	21	to	to	IN
cord-005453-4057qib7	7067	22	class	class	NN
cord-005453-4057qib7	7067	23	I	i	NN
cord-005453-4057qib7	7067	24	or	or	CC
cord-005453-4057qib7	7067	25	II	II	NNP
cord-005453-4057qib7	7067	26	)	)	-RRB-
cord-005453-4057qib7	7067	27	.	.	.
cord-005453-4057qib7	7068	1	Patients	patient	NNS
cord-005453-4057qib7	7068	2	with	with	IN
cord-005453-4057qib7	7068	3	sickle	sickle	NN
cord-005453-4057qib7	7068	4	cell	cell	NN
cord-005453-4057qib7	7068	5	disease	disease	NN
cord-005453-4057qib7	7068	6	were	be	VBD
cord-005453-4057qib7	7068	7	transplanted	transplant	VBN
cord-005453-4057qib7	7068	8	for	for	IN
cord-005453-4057qib7	7068	9	stroke	stroke	NN
cord-005453-4057qib7	7068	10	or	or	CC
cord-005453-4057qib7	7068	11	recurrent	recurrent	JJ
cord-005453-4057qib7	7068	12	vaso	vaso	JJ
cord-005453-4057qib7	7068	13	-	-	HYPH
cord-005453-4057qib7	7068	14	oclusive	oclusive	JJ
cord-005453-4057qib7	7068	15	crises	crisis	NNS
cord-005453-4057qib7	7068	16	and/or	and/or	CC
cord-005453-4057qib7	7068	17	acute	acute	JJ
cord-005453-4057qib7	7068	18	chest	chest	NN
cord-005453-4057qib7	7068	19	syndrome	syndrome	NN
cord-005453-4057qib7	7068	20	not	not	RB
cord-005453-4057qib7	7068	21	responding	respond	VBG
cord-005453-4057qib7	7068	22	to	to	IN
cord-005453-4057qib7	7068	23	hydroxycarbamide	hydroxycarbamide	VB
cord-005453-4057qib7	7068	24	.	.	.
cord-005453-4057qib7	7069	1	Results	result	NNS
cord-005453-4057qib7	7069	2	:	:	:
cord-005453-4057qib7	7070	1	All	all	DT
cord-005453-4057qib7	7070	2	patients	patient	NNS
cord-005453-4057qib7	7070	3	engrafted	engraft	VBD
cord-005453-4057qib7	7070	4	and	and	CC
cord-005453-4057qib7	7070	5	achieved	achieve	VBD
cord-005453-4057qib7	7070	6	evidence	evidence	NN
cord-005453-4057qib7	7070	7	of	of	IN
cord-005453-4057qib7	7070	8	donor	donor	NN
cord-005453-4057qib7	7070	9	haemopoiesis	haemopoiesis	NN
cord-005453-4057qib7	7070	10	on	on	IN
cord-005453-4057qib7	7070	11	day	day	NN
cord-005453-4057qib7	7070	12	+28	+28	CD
cord-005453-4057qib7	7070	13	and	and	CC
cord-005453-4057qib7	7070	14	achieved	achieve	VBD
cord-005453-4057qib7	7070	15	transfusionindependence	transfusionindependence	NNP
cord-005453-4057qib7	7070	16	and	and	CC
cord-005453-4057qib7	7070	17	donor	donor	NN
cord-005453-4057qib7	7070	18	haematological	haematological	JJ
cord-005453-4057qib7	7070	19	values	value	NNS
cord-005453-4057qib7	7070	20	,	,	,
cord-005453-4057qib7	7070	21	but	but	CC
cord-005453-4057qib7	7070	22	subsequently	subsequently	RB
cord-005453-4057qib7	7070	23	one	one	CD
cord-005453-4057qib7	7070	24	9/10	9/10	CD
cord-005453-4057qib7	7070	25	patient	patient	NN
cord-005453-4057qib7	7070	26	with	with	IN
cord-005453-4057qib7	7070	27	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	7070	28	suffered	suffer	VBD
cord-005453-4057qib7	7070	29	secondary	secondary	JJ
cord-005453-4057qib7	7070	30	graft	graft	NN
cord-005453-4057qib7	7070	31	failure	failure	NN
cord-005453-4057qib7	7070	32	on	on	IN
cord-005453-4057qib7	7070	33	day	day	NN
cord-005453-4057qib7	7070	34	+75	+75	CD
cord-005453-4057qib7	7070	35	after	after	IN
cord-005453-4057qib7	7070	36	macrophage	macrophage	NN
cord-005453-4057qib7	7070	37	activation	activation	NN
cord-005453-4057qib7	7070	38	syndrome	syndrome	NN
cord-005453-4057qib7	7070	39	.	.	.
cord-005453-4057qib7	7071	1	Median	median	JJ
cord-005453-4057qib7	7071	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	7071	3	engraftment	engraftment	NN
cord-005453-4057qib7	7071	4	was	be	VBD
cord-005453-4057qib7	7071	5	13	13	CD
cord-005453-4057qib7	7071	6	days	day	NNS
cord-005453-4057qib7	7071	7	(	(	-LRB-
cord-005453-4057qib7	7071	8	range	range	VBP
cord-005453-4057qib7	7071	9	9	9	CD
cord-005453-4057qib7	7071	10	to	to	IN
cord-005453-4057qib7	7071	11	19	19	CD
cord-005453-4057qib7	7071	12	)	)	-RRB-
cord-005453-4057qib7	7071	13	and	and	CC
cord-005453-4057qib7	7071	14	12	12	CD
cord-005453-4057qib7	7071	15	days	day	NNS
cord-005453-4057qib7	7071	16	(	(	-LRB-
cord-005453-4057qib7	7071	17	9	9	CD
cord-005453-4057qib7	7071	18	-22	-22	CD
cord-005453-4057qib7	7071	19	)	)	-RRB-
cord-005453-4057qib7	7071	20	for	for	IN
cord-005453-4057qib7	7071	21	10/10	10/10	CD
cord-005453-4057qib7	7071	22	and	and	CC
cord-005453-4057qib7	7071	23	9/	9/	CD
cord-005453-4057qib7	7071	24	10	10	CD
cord-005453-4057qib7	7071	25	patients	patient	NNS
cord-005453-4057qib7	7071	26	respectively	respectively	RB
cord-005453-4057qib7	7071	27	.	.	.
cord-005453-4057qib7	7072	1	Patient	patient	JJ
cord-005453-4057qib7	7072	2	with	with	IN
cord-005453-4057qib7	7072	3	sickle	sickle	NN
cord-005453-4057qib7	7072	4	cell	cell	NN
cord-005453-4057qib7	7072	5	disease	disease	NN
cord-005453-4057qib7	7072	6	had	have	VBD
cord-005453-4057qib7	7072	7	the	the	DT
cord-005453-4057qib7	7072	8	platelet	platelet	NN
cord-005453-4057qib7	7072	9	count	count	NN
cord-005453-4057qib7	7072	10	maintained	maintain	VBD
cord-005453-4057qib7	7073	1	>	>	XX
cord-005453-4057qib7	7074	1	50	50	CD
cord-005453-4057qib7	7074	2	x	x	SYM
cord-005453-4057qib7	7074	3	10	10	CD
cord-005453-4057qib7	7074	4	9	9	CD
cord-005453-4057qib7	7074	5	/L	/L	.
cord-005453-4057qib7	7074	6	at	at	RB
cord-005453-4057qib7	7074	7	all	all	DT
cord-005453-4057qib7	7074	8	times	time	NNS
cord-005453-4057qib7	7074	9	.	.	.
cord-005453-4057qib7	7075	1	The	the	DT
cord-005453-4057qib7	7075	2	median	median	JJ
cord-005453-4057qib7	7075	3	platelet	platelet	NN
cord-005453-4057qib7	7075	4	engraftment	engraftment	NN
cord-005453-4057qib7	7075	5	>	>	XX
cord-005453-4057qib7	7076	1	50	50	CD
cord-005453-4057qib7	7076	2	x	x	SYM
cord-005453-4057qib7	7076	3	10	10	CD
cord-005453-4057qib7	7076	4	9	9	CD
cord-005453-4057qib7	7076	5	/L	/L	,
cord-005453-4057qib7	7076	6	was	be	VBD
cord-005453-4057qib7	7076	7	31	31	CD
cord-005453-4057qib7	7076	8	days	day	NNS
cord-005453-4057qib7	7076	9	(	(	-LRB-
cord-005453-4057qib7	7076	10	range	range	VBP
cord-005453-4057qib7	7076	11	21	21	CD
cord-005453-4057qib7	7076	12	to	to	IN
cord-005453-4057qib7	7076	13	53	53	CD
cord-005453-4057qib7	7076	14	)	)	-RRB-
cord-005453-4057qib7	7076	15	and	and	CC
cord-005453-4057qib7	7076	16	40	40	CD
cord-005453-4057qib7	7076	17	days	day	NNS
cord-005453-4057qib7	7076	18	(	(	-LRB-
cord-005453-4057qib7	7076	19	range	range	VB
cord-005453-4057qib7	7076	20	15	15	CD
cord-005453-4057qib7	7076	21	to	to	IN
cord-005453-4057qib7	7076	22	86	86	CD
cord-005453-4057qib7	7076	23	)	)	-RRB-
cord-005453-4057qib7	7076	24	10/10	10/10	CD
cord-005453-4057qib7	7076	25	and	and	CC
cord-005453-4057qib7	7076	26	9/10	9/10	CD
cord-005453-4057qib7	7076	27	patients	patient	NNS
cord-005453-4057qib7	7076	28	respectively	respectively	RB
cord-005453-4057qib7	7076	29	.	.	.
cord-005453-4057qib7	7077	1	There	there	EX
cord-005453-4057qib7	7077	2	were	be	VBD
cord-005453-4057qib7	7077	3	three	three	CD
cord-005453-4057qib7	7077	4	deaths	death	NNS
cord-005453-4057qib7	7077	5	,	,	,
cord-005453-4057qib7	7077	6	all	all	DT
cord-005453-4057qib7	7077	7	in	in	IN
cord-005453-4057qib7	7077	8	the	the	DT
cord-005453-4057qib7	7077	9	9/10	9/10	CD
cord-005453-4057qib7	7077	10	matched	match	VBN
cord-005453-4057qib7	7077	11	group	group	NN
cord-005453-4057qib7	7077	12	:	:	:
cord-005453-4057qib7	7077	13	two	two	CD
cord-005453-4057qib7	7077	14	with	with	IN
cord-005453-4057qib7	7077	15	thalassaemia	thalassaemia	NN
cord-005453-4057qib7	7077	16	(	(	-LRB-
cord-005453-4057qib7	7077	17	day	day	NN
cord-005453-4057qib7	7077	18	+257	+257	NNP
cord-005453-4057qib7	7077	19	due	due	JJ
cord-005453-4057qib7	7077	20	to	to	IN
cord-005453-4057qib7	7077	21	idiopathic	idiopathic	JJ
cord-005453-4057qib7	7077	22	pneumonia	pneumonia	NN
cord-005453-4057qib7	7077	23	syndrome	syndrome	NN
cord-005453-4057qib7	7077	24	and	and	CC
cord-005453-4057qib7	7077	25	day	day	NN
cord-005453-4057qib7	7077	26	+102	+102	NNS
cord-005453-4057qib7	7077	27	due	due	JJ
cord-005453-4057qib7	7077	28	to	to	IN
cord-005453-4057qib7	7077	29	MAS	MAS	NNP
cord-005453-4057qib7	7077	30	)	)	-RRB-
cord-005453-4057qib7	7077	31	and	and	CC
cord-005453-4057qib7	7077	32	one	one	CD
cord-005453-4057qib7	7077	33	with	with	IN
cord-005453-4057qib7	7077	34	SCD	SCD	NNP
cord-005453-4057qib7	7077	35	(	(	-LRB-
cord-005453-4057qib7	7077	36	day	day	NN
cord-005453-4057qib7	7077	37	+43	+43	CD
cord-005453-4057qib7	7077	38	due	due	IN
cord-005453-4057qib7	7077	39	to	to	IN
cord-005453-4057qib7	7077	40	IPS	IPS	NNP
cord-005453-4057qib7	7077	41	)	)	-RRB-
cord-005453-4057qib7	7077	42	.	.	.
cord-005453-4057qib7	7078	1	There	there	EX
cord-005453-4057qib7	7078	2	were	be	VBD
cord-005453-4057qib7	7078	3	different	different	JJ
cord-005453-4057qib7	7078	4	trends	trend	NNS
cord-005453-4057qib7	7078	5	of	of	IN
cord-005453-4057qib7	7078	6	complications	complication	NNS
cord-005453-4057qib7	7078	7	seen	see	VBN
cord-005453-4057qib7	7078	8	by	by	IN
cord-005453-4057qib7	7078	9	degree	degree	NN
cord-005453-4057qib7	7078	10	of	of	IN
cord-005453-4057qib7	7078	11	matching	matching	NN
cord-005453-4057qib7	7078	12	that	that	WDT
cord-005453-4057qib7	7078	13	did	do	VBD
cord-005453-4057qib7	7078	14	not	not	RB
cord-005453-4057qib7	7078	15	segregate	segregate	VB
cord-005453-4057qib7	7078	16	otherwise	otherwise	RB
cord-005453-4057qib7	7078	17	by	by	IN
cord-005453-4057qib7	7078	18	disease	disease	NN
cord-005453-4057qib7	7078	19	.	.	.
cord-005453-4057qib7	7079	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7079	2	:	:	:
cord-005453-4057qib7	7080	1	In	in	IN
cord-005453-4057qib7	7080	2	conclusion	conclusion	NN
cord-005453-4057qib7	7080	3	,	,	,
cord-005453-4057qib7	7080	4	unrelated	unrelated	JJ
cord-005453-4057qib7	7080	5	BMT	BMT	NNP
cord-005453-4057qib7	7080	6	for	for	IN
cord-005453-4057qib7	7080	7	haemoglobinopathies	haemoglobinopathy	NNS
cord-005453-4057qib7	7080	8	with	with	IN
cord-005453-4057qib7	7080	9	reduced	reduce	VBN
cord-005453-4057qib7	7080	10	toxicity	toxicity	NN
cord-005453-4057qib7	7080	11	regimens	regimen	NNS
cord-005453-4057qib7	7080	12	is	be	VBZ
cord-005453-4057qib7	7080	13	feasible	feasible	JJ
cord-005453-4057qib7	7080	14	.	.	.
cord-005453-4057qib7	7081	1	Whilst	whilst	IN
cord-005453-4057qib7	7081	2	GvHD	GvHD	NNP
cord-005453-4057qib7	7081	3	caused	cause	VBD
cord-005453-4057qib7	7081	4	significant	significant	JJ
cord-005453-4057qib7	7081	5	morbidity	morbidity	NN
cord-005453-4057qib7	7081	6	during	during	IN
cord-005453-4057qib7	7081	7	the	the	DT
cord-005453-4057qib7	7081	8	transplant	transplant	NN
cord-005453-4057qib7	7081	9	period	period	NN
cord-005453-4057qib7	7081	10	,	,	,
cord-005453-4057qib7	7081	11	other	other	JJ
cord-005453-4057qib7	7081	12	alloreactive	alloreactive	JJ
cord-005453-4057qib7	7081	13	/	/	SYM
cord-005453-4057qib7	7081	14	endothelial	endothelial	JJ
cord-005453-4057qib7	7081	15	complications	complication	NNS
cord-005453-4057qib7	7081	16	(	(	-LRB-
cord-005453-4057qib7	7081	17	VOD	VOD	NNP
cord-005453-4057qib7	7081	18	,	,	,
cord-005453-4057qib7	7081	19	macrophage	macrophage	NN
cord-005453-4057qib7	7081	20	activation	activation	NN
cord-005453-4057qib7	7081	21	syndrome	syndrome	NN
cord-005453-4057qib7	7081	22	,	,	,
cord-005453-4057qib7	7081	23	idiopathic	idiopathic	JJ
cord-005453-4057qib7	7081	24	pneumonia	pneumonia	NN
cord-005453-4057qib7	7081	25	syndrome	syndrome	NN
cord-005453-4057qib7	7081	26	)	)	-RRB-
cord-005453-4057qib7	7081	27	were	be	VBD
cord-005453-4057qib7	7081	28	only	only	RB
cord-005453-4057qib7	7081	29	seen	see	VBN
cord-005453-4057qib7	7081	30	in	in	IN
cord-005453-4057qib7	7081	31	the	the	DT
cord-005453-4057qib7	7081	32	9/10	9/10	CD
cord-005453-4057qib7	7081	33	transplants	transplant	NNS
cord-005453-4057qib7	7081	34	.	.	.
cord-005453-4057qib7	7082	1	Disease	disease	NN
cord-005453-4057qib7	7082	2	-	-	HYPH
cord-005453-4057qib7	7082	3	free	free	JJ
cord-005453-4057qib7	7082	4	survival	survival	NN
cord-005453-4057qib7	7082	5	,	,	,
cord-005453-4057qib7	7082	6	dependent	dependent	JJ
cord-005453-4057qib7	7082	7	on	on	IN
cord-005453-4057qib7	7082	8	transplantrelated	transplantrelated	JJ
cord-005453-4057qib7	7082	9	mortality	mortality	NN
cord-005453-4057qib7	7082	10	,	,	,
cord-005453-4057qib7	7082	11	and	and	CC
cord-005453-4057qib7	7082	12	lack	lack	NN
cord-005453-4057qib7	7082	13	of	of	IN
cord-005453-4057qib7	7082	14	long	long	JJ
cord-005453-4057qib7	7082	15	-	-	HYPH
cord-005453-4057qib7	7082	16	term	term	NN
cord-005453-4057qib7	7082	17	toxicity	toxicity	NN
cord-005453-4057qib7	7082	18	,	,	,
cord-005453-4057qib7	7082	19	including	include	VBG
cord-005453-4057qib7	7082	20	chronic	chronic	JJ
cord-005453-4057qib7	7082	21	GvHD	GvHD	NNP
cord-005453-4057qib7	7082	22	,	,	,
cord-005453-4057qib7	7082	23	are	be	VBP
cord-005453-4057qib7	7082	24	determined	determine	VBN
cord-005453-4057qib7	7082	25	by	by	IN
cord-005453-4057qib7	7082	26	the	the	DT
cord-005453-4057qib7	7082	27	degree	degree	NN
cord-005453-4057qib7	7082	28	of	of	IN
cord-005453-4057qib7	7082	29	matching	matching	NN
cord-005453-4057qib7	7082	30	.	.	.
cord-005453-4057qib7	7083	1	10/10	10/10	CD
cord-005453-4057qib7	7083	2	matched	match	VBN
cord-005453-4057qib7	7083	3	transplants	transplant	NNS
cord-005453-4057qib7	7083	4	have	have	VBP
cord-005453-4057qib7	7083	5	excellent	excellent	JJ
cord-005453-4057qib7	7083	6	long	long	JJ
cord-005453-4057qib7	7083	7	-	-	HYPH
cord-005453-4057qib7	7083	8	term	term	NN
cord-005453-4057qib7	7083	9	outcomes	outcome	NNS
cord-005453-4057qib7	7083	10	with	with	IN
cord-005453-4057qib7	7083	11	no	no	DT
cord-005453-4057qib7	7083	12	chronic	chronic	JJ
cord-005453-4057qib7	7083	13	GvHD	gvhd	NN
cord-005453-4057qib7	7083	14	>	>	NFP
cord-005453-4057qib7	7083	15	18	18	CD
cord-005453-4057qib7	7083	16	months	month	NNS
cord-005453-4057qib7	7083	17	and	and	CC
cord-005453-4057qib7	7083	18	can	can	MD
cord-005453-4057qib7	7083	19	be	be	VB
cord-005453-4057qib7	7083	20	considered	consider	VBN
cord-005453-4057qib7	7083	21	for	for	IN
cord-005453-4057qib7	7083	22	patients	patient	NNS
cord-005453-4057qib7	7083	23	without	without	IN
cord-005453-4057qib7	7083	24	a	a	DT
cord-005453-4057qib7	7083	25	related	related	JJ
cord-005453-4057qib7	7083	26	donor	donor	NN
cord-005453-4057qib7	7083	27	;	;	:
cord-005453-4057qib7	7083	28	whereas	whereas	IN
cord-005453-4057qib7	7083	29	9/	9/	CD
cord-005453-4057qib7	7083	30	10	10	CD
cord-005453-4057qib7	7083	31	transplant	transplant	NN
cord-005453-4057qib7	7083	32	have	have	VBP
cord-005453-4057qib7	7083	33	significant	significant	JJ
cord-005453-4057qib7	7083	34	toxicity	toxicity	NN
cord-005453-4057qib7	7083	35	and	and	CC
cord-005453-4057qib7	7083	36	mortality	mortality	NN
cord-005453-4057qib7	7083	37	,	,	,
cord-005453-4057qib7	7083	38	warranting	warrant	VBG
cord-005453-4057qib7	7083	39	a	a	DT
cord-005453-4057qib7	7083	40	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7083	41	approach	approach	NN
cord-005453-4057qib7	7083	42	.	.	.
cord-005453-4057qib7	7084	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7084	2	:	:	:
cord-005453-4057qib7	7084	3	No	no	DT
cord-005453-4057qib7	7084	4	conflict	conflict	NN
cord-005453-4057qib7	7084	5	.	.	.
cord-005453-4057qib7	7085	1	Long	long	JJ
cord-005453-4057qib7	7085	2	-	-	HYPH
cord-005453-4057qib7	7085	3	term	term	NN
cord-005453-4057qib7	7085	4	safety	safety	NN
cord-005453-4057qib7	7085	5	and	and	CC
cord-005453-4057qib7	7085	6	efficacy	efficacy	NN
cord-005453-4057qib7	7085	7	of	of	IN
cord-005453-4057qib7	7085	8	lentiglobin	lentiglobin	NNP
cord-005453-4057qib7	7085	9	gene	gene	NNP
cord-005453-4057qib7	7085	10	therapy	therapy	NN
cord-005453-4057qib7	7085	11	in	in	IN
cord-005453-4057qib7	7085	12	patients	patient	NNS
cord-005453-4057qib7	7085	13	with	with	IN
cord-005453-4057qib7	7085	14	transfusion	transfusion	NN
cord-005453-4057qib7	7085	15	-	-	HYPH
cord-005453-4057qib7	7085	16	dependent	dependent	JJ
cord-005453-4057qib7	7085	17	β	β	NN
cord-005453-4057qib7	7085	18	-	-	HYPH
cord-005453-4057qib7	7085	19	thalassemia	thalassemia	NN
cord-005453-4057qib7	7085	20	following	follow	VBG
cord-005453-4057qib7	7085	21	completion	completion	NN
cord-005453-4057qib7	7085	22	of	of	IN
cord-005453-4057qib7	7085	23	the	the	DT
cord-005453-4057qib7	7085	24	phase	phase	NN
cord-005453-4057qib7	7085	25	1/2	1/2	CD
cord-005453-4057qib7	7085	26	northstar	northstar	NNP
cord-005453-4057qib7	7085	27	study	study	NN
cord-005453-4057qib7	7085	28	 	 	_SP
cord-005453-4057qib7	7085	29	Patients	Patients	NNP
cord-005453-4057qib7	7085	30	with	with	IN
cord-005453-4057qib7	7085	31	transfusion	transfusion	NN
cord-005453-4057qib7	7085	32	-	-	HYPH
cord-005453-4057qib7	7085	33	dependent	dependent	JJ
cord-005453-4057qib7	7085	34	β	β	NN
cord-005453-4057qib7	7085	35	-	-	HYPH
cord-005453-4057qib7	7085	36	thalassemia	thalassemia	NN
cord-005453-4057qib7	7085	37	(	(	-LRB-
cord-005453-4057qib7	7085	38	TDT	TDT	NNP
cord-005453-4057qib7	7085	39	)	)	-RRB-
cord-005453-4057qib7	7085	40	may	may	MD
cord-005453-4057qib7	7085	41	benefit	benefit	VB
cord-005453-4057qib7	7085	42	from	from	IN
cord-005453-4057qib7	7085	43	gene	gene	NN
cord-005453-4057qib7	7085	44	therapy	therapy	NN
cord-005453-4057qib7	7085	45	involving	involve	VBG
cord-005453-4057qib7	7085	46	β	β	NNP
cord-005453-4057qib7	7085	47	-	-	HYPH
cord-005453-4057qib7	7085	48	globin	globin	NN
cord-005453-4057qib7	7085	49	gene	gene	NN
cord-005453-4057qib7	7085	50	addition	addition	NN
cord-005453-4057qib7	7085	51	to	to	IN
cord-005453-4057qib7	7085	52	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7085	53	stem	stem	NN
cord-005453-4057qib7	7085	54	cells	cell	NNS
cord-005453-4057qib7	7085	55	(	(	-LRB-
cord-005453-4057qib7	7085	56	HSCs	hscs	NN
cord-005453-4057qib7	7085	57	)	)	-RRB-
cord-005453-4057qib7	7085	58	enabling	enable	VBG
cord-005453-4057qib7	7085	59	production	production	NN
cord-005453-4057qib7	7085	60	of	of	IN
cord-005453-4057qib7	7085	61	functional	functional	JJ
cord-005453-4057qib7	7085	62	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	7085	63	(	(	-LRB-
cord-005453-4057qib7	7085	64	Hb	Hb	NNP
cord-005453-4057qib7	7085	65	)	)	-RRB-
cord-005453-4057qib7	7085	66	.	.	.
cord-005453-4057qib7	7086	1	LentiGlobin	LentiGlobin	NNP
cord-005453-4057qib7	7086	2	gene	gene	NN
cord-005453-4057qib7	7086	3	therapy	therapy	NN
cord-005453-4057qib7	7086	4	contains	contain	VBZ
cord-005453-4057qib7	7086	5	autologous	autologous	JJ
cord-005453-4057qib7	7086	6	CD34	CD34	NNP
cord-005453-4057qib7	7087	1	+	+	CC
cord-005453-4057qib7	7087	2	HSCs	hscs	NN
cord-005453-4057qib7	7087	3	transduced	transduce	VBD
cord-005453-4057qib7	7087	4	ex	ex	NN
cord-005453-4057qib7	7087	5	vivo	vivo	NN
cord-005453-4057qib7	7087	6	with	with	IN
cord-005453-4057qib7	7087	7	the	the	DT
cord-005453-4057qib7	7087	8	BB305	BB305	NNP
cord-005453-4057qib7	7087	9	lentiviral	lentiviral	NN
cord-005453-4057qib7	7087	10	vector	vector	NN
cord-005453-4057qib7	7087	11	encoding	encode	VBG
cord-005453-4057qib7	7087	12	β	β	NN
cord-005453-4057qib7	7087	13	-	-	HYPH
cord-005453-4057qib7	7087	14	globin	globin	NN
cord-005453-4057qib7	7087	15	with	with	IN
cord-005453-4057qib7	7087	16	a	a	DT
cord-005453-4057qib7	7087	17	T87Q	t87q	JJ
cord-005453-4057qib7	7087	18	substitution	substitution	NN
cord-005453-4057qib7	7087	19	under	under	IN
cord-005453-4057qib7	7087	20	transcriptional	transcriptional	JJ
cord-005453-4057qib7	7087	21	control	control	NN
cord-005453-4057qib7	7087	22	of	of	IN
cord-005453-4057qib7	7087	23	the	the	DT
cord-005453-4057qib7	7087	24	encoding	encoding	NN
cord-005453-4057qib7	7087	25	β	β	NN
cord-005453-4057qib7	7087	26	-	-	HYPH
cord-005453-4057qib7	7087	27	globin	globin	NN
cord-005453-4057qib7	7087	28	locus	locus	NN
cord-005453-4057qib7	7087	29	control	control	NN
cord-005453-4057qib7	7087	30	region	region	NN
cord-005453-4057qib7	7087	31	.	.	.
cord-005453-4057qib7	7088	1	The	the	DT
cord-005453-4057qib7	7088	2	safety	safety	NN
cord-005453-4057qib7	7088	3	and	and	CC
cord-005453-4057qib7	7088	4	efficacy	efficacy	NN
cord-005453-4057qib7	7088	5	of	of	IN
cord-005453-4057qib7	7088	6	LentiGlobin	LentiGlobin	NNP
cord-005453-4057qib7	7088	7	was	be	VBD
cord-005453-4057qib7	7088	8	evaluated	evaluate	VBN
cord-005453-4057qib7	7088	9	in	in	IN
cord-005453-4057qib7	7088	10	adults	adult	NNS
cord-005453-4057qib7	7088	11	and	and	CC
cord-005453-4057qib7	7088	12	adolescents	adolescent	NNS
cord-005453-4057qib7	7088	13	with	with	IN
cord-005453-4057qib7	7088	14	TDT	TDT	NNP
cord-005453-4057qib7	7088	15	in	in	IN
cord-005453-4057qib7	7088	16	the	the	DT
cord-005453-4057qib7	7088	17	2-year	2-year	CD
cord-005453-4057qib7	7088	18	phase	phase	NN
cord-005453-4057qib7	7088	19	1/2	1/2	CD
cord-005453-4057qib7	7088	20	Northstar	Northstar	NNP
cord-005453-4057qib7	7088	21	study	study	NN
cord-005453-4057qib7	7088	22	(	(	-LRB-
cord-005453-4057qib7	7088	23	HGB-204	HGB-204	NNP
cord-005453-4057qib7	7088	24	;	;	:
cord-005453-4057qib7	7088	25	NCT01745120	NCT01745120	NNP
cord-005453-4057qib7	7088	26	)	)	-RRB-
cord-005453-4057qib7	7088	27	.	.	.
cord-005453-4057qib7	7089	1	Methods	method	NNS
cord-005453-4057qib7	7089	2	:	:	:
cord-005453-4057qib7	7090	1	Patients	patient	NNS
cord-005453-4057qib7	7090	2	with	with	IN
cord-005453-4057qib7	7090	3	TDT	TDT	NNP
cord-005453-4057qib7	7090	4	(	(	-LRB-
cord-005453-4057qib7	7090	5	≥	≥	NNP
cord-005453-4057qib7	7090	6	100	100	CD
cord-005453-4057qib7	7090	7	mL	ml	NN
cord-005453-4057qib7	7090	8	/	/	SYM
cord-005453-4057qib7	7090	9	kg	kg	NN
cord-005453-4057qib7	7090	10	/	/	SYM
cord-005453-4057qib7	7090	11	year	year	NN
cord-005453-4057qib7	7090	12	of	of	IN
cord-005453-4057qib7	7090	13	red	red	JJ
cord-005453-4057qib7	7090	14	blood	blood	NN
cord-005453-4057qib7	7090	15	cells	cell	NNS
cord-005453-4057qib7	7090	16	[	[	-LRB-
cord-005453-4057qib7	7090	17	RBCs	rbc	NNS
cord-005453-4057qib7	7090	18	]	]	-RRB-
cord-005453-4057qib7	7090	19	or	or	CC
cord-005453-4057qib7	7090	20	≥	≥	CD
cord-005453-4057qib7	7090	21	8	8	CD
cord-005453-4057qib7	7090	22	RBC	RBC	NNP
cord-005453-4057qib7	7090	23	transfusions	transfusion	NNS
cord-005453-4057qib7	7090	24	/	/	SYM
cord-005453-4057qib7	7090	25	year	year	NN
cord-005453-4057qib7	7090	26	)	)	-RRB-
cord-005453-4057qib7	7090	27	received	receive	VBD
cord-005453-4057qib7	7090	28	G	G	NNP
cord-005453-4057qib7	7090	29	-	-	HYPH
cord-005453-4057qib7	7090	30	CSF	csf	NN
cord-005453-4057qib7	7090	31	and	and	CC
cord-005453-4057qib7	7090	32	plerixafor	plerixafor	NN
cord-005453-4057qib7	7090	33	for	for	IN
cord-005453-4057qib7	7090	34	HSC	HSC	NNP
cord-005453-4057qib7	7090	35	mobilization	mobilization	NN
cord-005453-4057qib7	7090	36	.	.	.
cord-005453-4057qib7	7091	1	To	to	TO
cord-005453-4057qib7	7091	2	generate	generate	VB
cord-005453-4057qib7	7091	3	drug	drug	NN
cord-005453-4057qib7	7091	4	product	product	NN
cord-005453-4057qib7	7091	5	(	(	-LRB-
cord-005453-4057qib7	7091	6	DP	DP	NNP
cord-005453-4057qib7	7091	7	)	)	-RRB-
cord-005453-4057qib7	7091	8	,	,	,
cord-005453-4057qib7	7091	9	CD34	CD34	NNP
cord-005453-4057qib7	7091	10	+	+	CC
cord-005453-4057qib7	7091	11	HSCs	hsc	NNS
cord-005453-4057qib7	7091	12	were	be	VBD
cord-005453-4057qib7	7091	13	transduced	transduce	VBN
cord-005453-4057qib7	7091	14	with	with	IN
cord-005453-4057qib7	7091	15	the	the	DT
cord-005453-4057qib7	7091	16	BB305	BB305	NNP
cord-005453-4057qib7	7091	17	lentiviral	lentiviral	JJ
cord-005453-4057qib7	7091	18	vector	vector	NN
cord-005453-4057qib7	7091	19	.	.	.
cord-005453-4057qib7	7092	1	Patients	patient	NNS
cord-005453-4057qib7	7092	2	underwent	undergo	VBD
cord-005453-4057qib7	7092	3	single	single	JJ
cord-005453-4057qib7	7092	4	-	-	HYPH
cord-005453-4057qib7	7092	5	agent	agent	NN
cord-005453-4057qib7	7092	6	,	,	,
cord-005453-4057qib7	7092	7	myeloablative	myeloablative	NNP
cord-005453-4057qib7	7092	8	busulfan	busulfan	NNP
cord-005453-4057qib7	7092	9	conditioning	conditioning	NN
cord-005453-4057qib7	7092	10	,	,	,
cord-005453-4057qib7	7092	11	were	be	VBD
cord-005453-4057qib7	7092	12	infused	infuse	VBN
cord-005453-4057qib7	7092	13	with	with	IN
cord-005453-4057qib7	7092	14	the	the	DT
cord-005453-4057qib7	7092	15	DP	dp	NN
cord-005453-4057qib7	7092	16	,	,	,
cord-005453-4057qib7	7092	17	and	and	CC
cord-005453-4057qib7	7092	18	were	be	VBD
cord-005453-4057qib7	7092	19	followed	follow	VBN
cord-005453-4057qib7	7092	20	for	for	IN
cord-005453-4057qib7	7092	21	safety	safety	NN
cord-005453-4057qib7	7092	22	and	and	CC
cord-005453-4057qib7	7092	23	efficacy	efficacy	NN
cord-005453-4057qib7	7092	24	.	.	.
cord-005453-4057qib7	7093	1	Results	result	NNS
cord-005453-4057qib7	7093	2	:	:	:
cord-005453-4057qib7	7094	1	Eighteen	eighteen	CD
cord-005453-4057qib7	7094	2	patients	patient	NNS
cord-005453-4057qib7	7094	3	have	have	VBP
cord-005453-4057qib7	7094	4	been	be	VBN
cord-005453-4057qib7	7094	5	treated	treat	VBN
cord-005453-4057qib7	7094	6	in	in	IN
cord-005453-4057qib7	7094	7	the	the	DT
cord-005453-4057qib7	7094	8	completed	complete	VBN
cord-005453-4057qib7	7094	9	Northstar	Northstar	NNP
cord-005453-4057qib7	7094	10	study	study	NN
cord-005453-4057qib7	7094	11	.	.	.
cord-005453-4057qib7	7095	1	As	as	IN
cord-005453-4057qib7	7095	2	of	of	IN
cord-005453-4057qib7	7095	3	14	14	CD
cord-005453-4057qib7	7095	4	September	September	NNP
cord-005453-4057qib7	7095	5	2018	2018	CD
cord-005453-4057qib7	7095	6	,	,	,
cord-005453-4057qib7	7095	7	patients	patient	NNS
cord-005453-4057qib7	7095	8	had	have	VBD
cord-005453-4057qib7	7095	9	a	a	DT
cord-005453-4057qib7	7095	10	median	median	JJ
cord-005453-4057qib7	7095	11	follow	follow	NN
cord-005453-4057qib7	7095	12	-	-	HYPH
cord-005453-4057qib7	7095	13	up	up	NN
cord-005453-4057qib7	7095	14	of	of	IN
cord-005453-4057qib7	7095	15	38.9	38.9	CD
cord-005453-4057qib7	7095	16	(	(	-LRB-
cord-005453-4057qib7	7095	17	min	min	NN
cord-005453-4057qib7	7095	18	-max	-max	ADD
cord-005453-4057qib7	7095	19	:	:	:
cord-005453-4057qib7	7096	1	29.3	29.3	CD
cord-005453-4057qib7	7096	2	-48.1	-48.1	NNP
cord-005453-4057qib7	7096	3	)	)	-RRB-
cord-005453-4057qib7	7096	4	months	month	NNS
cord-005453-4057qib7	7096	5	.	.	.
cord-005453-4057qib7	7097	1	The	the	DT
cord-005453-4057qib7	7097	2	median	median	JJ
cord-005453-4057qib7	7097	3	age	age	NN
cord-005453-4057qib7	7097	4	at	at	IN
cord-005453-4057qib7	7097	5	consent	consent	NN
cord-005453-4057qib7	7097	6	was	be	VBD
cord-005453-4057qib7	7097	7	20	20	CD
cord-005453-4057qib7	7097	8	(	(	-LRB-
cord-005453-4057qib7	7097	9	min	min	NN
cord-005453-4057qib7	7097	10	-max	-max	-RRB-
cord-005453-4057qib7	7097	11	:	:	:
cord-005453-4057qib7	7097	12	12	12	CD
cord-005453-4057qib7	7097	13	-35	-35	CD
cord-005453-4057qib7	7097	14	)	)	-RRB-
cord-005453-4057qib7	7097	15	years	year	NNS
cord-005453-4057qib7	7097	16	including	include	VBG
cord-005453-4057qib7	7097	17	15	15	CD
cord-005453-4057qib7	7097	18	patients	patient	NNS
cord-005453-4057qib7	7097	19	≥	≥	CD
cord-005453-4057qib7	7097	20	18	18	CD
cord-005453-4057qib7	7097	21	years	year	NNS
cord-005453-4057qib7	7097	22	old	old	JJ
cord-005453-4057qib7	7097	23	.	.	.
cord-005453-4057qib7	7098	1	Patients	patient	NNS
cord-005453-4057qib7	7098	2	received	receive	VBD
cord-005453-4057qib7	7098	3	a	a	DT
cord-005453-4057qib7	7098	4	median	median	JJ
cord-005453-4057qib7	7098	5	cell	cell	NN
cord-005453-4057qib7	7098	6	dose	dose	NN
cord-005453-4057qib7	7098	7	of	of	IN
cord-005453-4057qib7	7098	8	8.1	8.1	CD
cord-005453-4057qib7	7098	9	(	(	-LRB-
cord-005453-4057qib7	7098	10	min	min	NN
cord-005453-4057qib7	7098	11	-max	-max	ADD
cord-005453-4057qib7	7098	12	:	:	:
cord-005453-4057qib7	7099	1	5.2	5.2	CD
cord-005453-4057qib7	7099	2	-18.1	-18.1	CD
cord-005453-4057qib7	7099	3	)	)	-RRB-
cord-005453-4057qib7	7100	1	CD34	CD34	NNP
cord-005453-4057qib7	7100	2	+	+	CC
cord-005453-4057qib7	7100	3	cells	cell	NNS
cord-005453-4057qib7	7100	4	x10	x10	CD
cord-005453-4057qib7	7100	5	6	6	CD
cord-005453-4057qib7	7101	1	/kg	/kg	NFP
cord-005453-4057qib7	7101	2	with	with	IN
cord-005453-4057qib7	7101	3	a	a	DT
cord-005453-4057qib7	7101	4	median	median	JJ
cord-005453-4057qib7	7101	5	DP	dp	NN
cord-005453-4057qib7	7101	6	vector	vector	NN
cord-005453-4057qib7	7101	7	copy	copy	NN
cord-005453-4057qib7	7101	8	number	number	NN
cord-005453-4057qib7	7101	9	(	(	-LRB-
cord-005453-4057qib7	7101	10	VCN	VCN	NNP
cord-005453-4057qib7	7101	11	)	)	-RRB-
cord-005453-4057qib7	7101	12	of	of	IN
cord-005453-4057qib7	7101	13	0.7	0.7	CD
cord-005453-4057qib7	7101	14	(	(	-LRB-
cord-005453-4057qib7	7101	15	min	min	NN
cord-005453-4057qib7	7101	16	-max	-max	-RRB-
cord-005453-4057qib7	7101	17	:	:	:
cord-005453-4057qib7	7101	18	0.3	0.3	CD
cord-005453-4057qib7	7101	19	-1.5	-1.5	NFP
cord-005453-4057qib7	7101	20	)	)	-RRB-
cord-005453-4057qib7	7101	21	vector	vector	NN
cord-005453-4057qib7	7101	22	copies/	copies/	NN
cord-005453-4057qib7	7101	23	diploid	diploid	JJ
cord-005453-4057qib7	7101	24	genome	genome	NN
cord-005453-4057qib7	7101	25	.	.	.
cord-005453-4057qib7	7102	1	The	the	DT
cord-005453-4057qib7	7102	2	median	median	JJ
cord-005453-4057qib7	7102	3	liver	liver	NN
cord-005453-4057qib7	7102	4	iron	iron	NN
cord-005453-4057qib7	7102	5	content	content	NN
cord-005453-4057qib7	7102	6	(	(	-LRB-
cord-005453-4057qib7	7102	7	LIC	LIC	NNP
cord-005453-4057qib7	7102	8	)	)	-RRB-
cord-005453-4057qib7	7102	9	at	at	IN
cord-005453-4057qib7	7102	10	baseline	baseline	NN
cord-005453-4057qib7	7102	11	was	be	VBD
cord-005453-4057qib7	7102	12	5.7	5.7	CD
cord-005453-4057qib7	7102	13	(	(	-LRB-
cord-005453-4057qib7	7102	14	min	min	NN
cord-005453-4057qib7	7102	15	-max	-max	-RRB-
cord-005453-4057qib7	7102	16	:	:	:
cord-005453-4057qib7	7102	17	0.4	0.4	CD
cord-005453-4057qib7	7102	18	-26.4	-26.4	CD
cord-005453-4057qib7	7102	19	)	)	-RRB-
cord-005453-4057qib7	7103	1	mg	mg	NNP
cord-005453-4057qib7	7104	1	Fe	Fe	NNP
cord-005453-4057qib7	7104	2	/	/	SYM
cord-005453-4057qib7	7104	3	g	g	NN
cord-005453-4057qib7	7104	4	dw	dw	NNP
cord-005453-4057qib7	7104	5	.	.	.
cord-005453-4057qib7	7105	1	Outcomes	outcome	NNS
cord-005453-4057qib7	7105	2	by	by	IN
cord-005453-4057qib7	7105	3	age	age	NN
cord-005453-4057qib7	7105	4	and	and	CC
cord-005453-4057qib7	7105	5	baseline	baseline	JJ
cord-005453-4057qib7	7105	6	iron	iron	NN
cord-005453-4057qib7	7105	7	status	status	NN
cord-005453-4057qib7	7105	8	will	will	MD
cord-005453-4057qib7	7105	9	be	be	VB
cord-005453-4057qib7	7105	10	presented	present	VBN
cord-005453-4057qib7	7105	11	.	.	.
cord-005453-4057qib7	7106	1	The	the	DT
cord-005453-4057qib7	7106	2	median	median	JJ
cord-005453-4057qib7	7106	3	time	time	NN
cord-005453-4057qib7	7106	4	to	to	IN
cord-005453-4057qib7	7106	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	7106	6	and	and	CC
cord-005453-4057qib7	7106	7	platelet	platelet	NN
cord-005453-4057qib7	7106	8	engraftment	engraftment	NN
cord-005453-4057qib7	7106	9	was	be	VBD
cord-005453-4057qib7	7106	10	18.5	18.5	CD
cord-005453-4057qib7	7106	11	(	(	-LRB-
cord-005453-4057qib7	7106	12	min	min	NN
cord-005453-4057qib7	7106	13	-max	-max	-RRB-
cord-005453-4057qib7	7106	14	:	:	:
cord-005453-4057qib7	7106	15	14	14	CD
cord-005453-4057qib7	7106	16	-30	-30	CD
cord-005453-4057qib7	7106	17	)	)	-RRB-
cord-005453-4057qib7	7106	18	and	and	CC
cord-005453-4057qib7	7106	19	39.5	39.5	CD
cord-005453-4057qib7	7106	20	(	(	-LRB-
cord-005453-4057qib7	7106	21	min	min	NN
cord-005453-4057qib7	7106	22	-max	-max	-RRB-
cord-005453-4057qib7	7106	23	:	:	:
cord-005453-4057qib7	7106	24	19	19	CD
cord-005453-4057qib7	7106	25	-191	-191	NN
cord-005453-4057qib7	7106	26	)	)	-RRB-
cord-005453-4057qib7	7106	27	days	day	NNS
cord-005453-4057qib7	7106	28	,	,	,
cord-005453-4057qib7	7106	29	respectively	respectively	RB
cord-005453-4057qib7	7106	30	.	.	.
cord-005453-4057qib7	7107	1	Four	four	CD
cord-005453-4057qib7	7107	2	patients	patient	NNS
cord-005453-4057qib7	7107	3	had	have	VBD
cord-005453-4057qib7	7107	4	platelet	platelet	NN
cord-005453-4057qib7	7107	5	engraftment	engraftment	NN
cord-005453-4057qib7	7107	6	≥	≥	NNP
cord-005453-4057qib7	7107	7	Day	Day	NNP
cord-005453-4057qib7	7107	8	60	60	CD
cord-005453-4057qib7	7107	9	and	and	CC
cord-005453-4057qib7	7107	10	four	four	CD
cord-005453-4057qib7	7107	11	patients	patient	NNS
cord-005453-4057qib7	7107	12	had	have	VBD
cord-005453-4057qib7	7107	13	platelet	platelet	NN
cord-005453-4057qib7	7107	14	counts	count	NNS
cord-005453-4057qib7	7107	15	of	of	IN
cord-005453-4057qib7	7107	16	≤	≤	NNS
cord-005453-4057qib7	7107	17	100x10	100x10	CD
cord-005453-4057qib7	7107	18	9	9	CD
cord-005453-4057qib7	7107	19	/L	/L	.
cord-005453-4057qib7	7107	20	at	at	IN
cord-005453-4057qib7	7107	21	Month	month	NN
cord-005453-4057qib7	7107	22	12	12	CD
cord-005453-4057qib7	7107	23	.	.	.
cord-005453-4057qib7	7108	1	None	none	NN
cord-005453-4057qib7	7108	2	of	of	IN
cord-005453-4057qib7	7108	3	these	these	DT
cord-005453-4057qib7	7108	4	patients	patient	NNS
cord-005453-4057qib7	7108	5	had	have	VBD
cord-005453-4057qib7	7108	6	≥	≥	CD
cord-005453-4057qib7	7108	7	grade	grade	NN
cord-005453-4057qib7	7108	8	3	3	CD
cord-005453-4057qib7	7108	9	bleeding	bleed	VBG
cord-005453-4057qib7	7108	10	events	event	NNS
cord-005453-4057qib7	7108	11	post	post	VBP
cord-005453-4057qib7	7108	12	-	-	JJ
cord-005453-4057qib7	7108	13	LentiGlobin	LentiGlobin	NNP
cord-005453-4057qib7	7108	14	infusion	infusion	NN
cord-005453-4057qib7	7108	15	.	.	.
cord-005453-4057qib7	7109	1	Transfusion	transfusion	NN
cord-005453-4057qib7	7109	2	independence	independence	NN
cord-005453-4057qib7	7109	3	(	(	-LRB-
cord-005453-4057qib7	7109	4	TI	TI	NNP
cord-005453-4057qib7	7109	5	,	,	,
cord-005453-4057qib7	7109	6	defined	define	VBN
cord-005453-4057qib7	7109	7	as	as	IN
cord-005453-4057qib7	7109	8	weighted	weighted	JJ
cord-005453-4057qib7	7109	9	average	average	JJ
cord-005453-4057qib7	7109	10	Hb	Hb	NNP
cord-005453-4057qib7	7109	11	≥	≥	CD
cord-005453-4057qib7	7109	12	9	9	CD
cord-005453-4057qib7	7109	13	g	g	NN
cord-005453-4057qib7	7109	14	/	/	SYM
cord-005453-4057qib7	7109	15	dL	dl	NN
cord-005453-4057qib7	7109	16	without	without	IN
cord-005453-4057qib7	7109	17	RBC	RBC	NNP
cord-005453-4057qib7	7109	18	transfusions	transfusion	NNS
cord-005453-4057qib7	7109	19	for	for	IN
cord-005453-4057qib7	7109	20	≥	≥	CD
cord-005453-4057qib7	7109	21	12	12	CD
cord-005453-4057qib7	7109	22	months	month	NNS
cord-005453-4057qib7	7109	23	)	)	-RRB-
cord-005453-4057qib7	7109	24	was	be	VBD
cord-005453-4057qib7	7109	25	achieved	achieve	VBN
cord-005453-4057qib7	7109	26	in	in	IN
cord-005453-4057qib7	7109	27	8/10	8/10	CD
cord-005453-4057qib7	7109	28	patients	patient	NNS
cord-005453-4057qib7	7109	29	with	with	IN
cord-005453-4057qib7	7109	30	non	non	AFX
cord-005453-4057qib7	7109	31	-	-	JJ
cord-005453-4057qib7	7109	32	β	β	JJ
cord-005453-4057qib7	7109	33	0	0	CD
cord-005453-4057qib7	7109	34	/β	/β	NN
cord-005453-4057qib7	7109	35	0	0	NFP
cord-005453-4057qib7	7109	36	genotypes	genotype	NNS
cord-005453-4057qib7	7109	37	and	and	CC
cord-005453-4057qib7	7109	38	3/8	3/8	CD
cord-005453-4057qib7	7109	39	patients	patient	NNS
cord-005453-4057qib7	7109	40	with	with	IN
cord-005453-4057qib7	7109	41	β	β	NN
cord-005453-4057qib7	7109	42	0	0	CD
cord-005453-4057qib7	7109	43	/β	/β	NN
cord-005453-4057qib7	7109	44	0	0	NFP
cord-005453-4057qib7	7109	45	genotypes	genotype	NNS
cord-005453-4057qib7	7109	46	.	.	.
cord-005453-4057qib7	7110	1	In	in	IN
cord-005453-4057qib7	7110	2	patients	patient	NNS
cord-005453-4057qib7	7110	3	who	who	WP
cord-005453-4057qib7	7110	4	achieved	achieve	VBD
cord-005453-4057qib7	7110	5	TI	TI	NNP
cord-005453-4057qib7	7110	6	,	,	,
cord-005453-4057qib7	7110	7	total	total	JJ
cord-005453-4057qib7	7110	8	Hb	Hb	NNP
cord-005453-4057qib7	7110	9	at	at	IN
cord-005453-4057qib7	7110	10	last	last	JJ
cord-005453-4057qib7	7110	11	visit	visit	NN
cord-005453-4057qib7	7110	12	was	be	VBD
cord-005453-4057qib7	7110	13	9.1	9.1	CD
cord-005453-4057qib7	7110	14	-14.1	-14.1	CD
cord-005453-4057qib7	7111	1	g	g	NNP
cord-005453-4057qib7	7111	2	/	/	SYM
cord-005453-4057qib7	7111	3	dL.	dL.	NNP
cord-005453-4057qib7	7111	4	LIC	LIC	NNP
cord-005453-4057qib7	7111	5	increased	increase	VBD
cord-005453-4057qib7	7111	6	from	from	IN
cord-005453-4057qib7	7111	7	baseline	baseline	NN
cord-005453-4057qib7	7111	8	in	in	IN
cord-005453-4057qib7	7111	9	patients	patient	NNS
cord-005453-4057qib7	7111	10	who	who	WP
cord-005453-4057qib7	7111	11	achieved	achieve	VBD
cord-005453-4057qib7	7111	12	TI	TI	NNP
cord-005453-4057qib7	7111	13	by	by	IN
cord-005453-4057qib7	7111	14	a	a	DT
cord-005453-4057qib7	7111	15	median	median	NN
cord-005453-4057qib7	7111	16	of	of	IN
cord-005453-4057qib7	7111	17	55.6	55.6	CD
cord-005453-4057qib7	7111	18	%	%	NN
cord-005453-4057qib7	7111	19	and	and	CC
cord-005453-4057qib7	7111	20	12.5	12.5	CD
cord-005453-4057qib7	7111	21	%	%	NN
cord-005453-4057qib7	7111	22	at	at	IN
cord-005453-4057qib7	7111	23	Month	month	NN
cord-005453-4057qib7	7111	24	12	12	CD
cord-005453-4057qib7	7111	25	and	and	CC
cord-005453-4057qib7	7111	26	24	24	CD
cord-005453-4057qib7	7111	27	then	then	RB
cord-005453-4057qib7	7111	28	decreased	decrease	VBD
cord-005453-4057qib7	7111	29	from	from	IN
cord-005453-4057qib7	7111	30	baseline	baseline	NN
cord-005453-4057qib7	7111	31	by	by	IN
cord-005453-4057qib7	7111	32	a	a	DT
cord-005453-4057qib7	7111	33	median	median	NN
cord-005453-4057qib7	7111	34	of	of	IN
cord-005453-4057qib7	7111	35	9.2	9.2	CD
cord-005453-4057qib7	7111	36	%	%	NN
cord-005453-4057qib7	7111	37	and	and	CC
cord-005453-4057qib7	7111	38	44.4	44.4	CD
cord-005453-4057qib7	7111	39	%	%	NN
cord-005453-4057qib7	7111	40	at	at	IN
cord-005453-4057qib7	7111	41	Month	Month	NNP
cord-005453-4057qib7	7111	42	36	36	CD
cord-005453-4057qib7	7111	43	and	and	CC
cord-005453-4057qib7	7111	44	48	48	CD
cord-005453-4057qib7	7111	45	,	,	,
cord-005453-4057qib7	7111	46	respectively	respectively	RB
cord-005453-4057qib7	7111	47	.	.	.
cord-005453-4057qib7	7112	1	Non	non	JJ
cord-005453-4057qib7	7112	2	-	-	JJ
cord-005453-4057qib7	7112	3	hematologic	hematologic	JJ
cord-005453-4057qib7	7112	4	grade	grade	NN
cord-005453-4057qib7	7113	1	≥	≥	CD
cord-005453-4057qib7	7113	2	3	3	CD
cord-005453-4057qib7	7113	3	adverse	adverse	JJ
cord-005453-4057qib7	7113	4	events	event	NNS
cord-005453-4057qib7	7113	5	post	post	NN
cord-005453-4057qib7	7113	6	-	-	NN
cord-005453-4057qib7	7113	7	infusion	infusion	NN
cord-005453-4057qib7	7113	8	in	in	IN
cord-005453-4057qib7	7113	9	≥	≥	CD
cord-005453-4057qib7	7113	10	3	3	CD
cord-005453-4057qib7	7113	11	patients	patient	NNS
cord-005453-4057qib7	7113	12	included	include	VBD
cord-005453-4057qib7	7113	13	stomatitis	stomatitis	NN
cord-005453-4057qib7	7113	14	,	,	,
cord-005453-4057qib7	7113	15	febrile	febrile	JJ
cord-005453-4057qib7	7113	16	neutropenia	neutropenia	NN
cord-005453-4057qib7	7113	17	,	,	,
cord-005453-4057qib7	7113	18	pharyngeal	pharyngeal	JJ
cord-005453-4057qib7	7113	19	inflammation	inflammation	NN
cord-005453-4057qib7	7113	20	,	,	,
cord-005453-4057qib7	7113	21	and	and	CC
cord-005453-4057qib7	7113	22	irregular	irregular	JJ
cord-005453-4057qib7	7113	23	menstruation	menstruation	NN
cord-005453-4057qib7	7113	24	.	.	.
cord-005453-4057qib7	7114	1	There	there	EX
cord-005453-4057qib7	7114	2	was	be	VBD
cord-005453-4057qib7	7114	3	no	no	DT
cord-005453-4057qib7	7114	4	transplant	transplant	NN
cord-005453-4057qib7	7114	5	-	-	HYPH
cord-005453-4057qib7	7114	6	related	relate	VBN
cord-005453-4057qib7	7114	7	mortality	mortality	NN
cord-005453-4057qib7	7114	8	,	,	,
cord-005453-4057qib7	7114	9	vector	vector	NN
cord-005453-4057qib7	7114	10	-	-	HYPH
cord-005453-4057qib7	7114	11	mediated	mediate	VBN
cord-005453-4057qib7	7114	12	replication	replication	NN
cord-005453-4057qib7	7114	13	competent	competent	JJ
cord-005453-4057qib7	7114	14	lentivirus	lentivirus	NN
cord-005453-4057qib7	7114	15	,	,	,
cord-005453-4057qib7	7114	16	or	or	CC
cord-005453-4057qib7	7114	17	clonal	clonal	JJ
cord-005453-4057qib7	7114	18	dominance	dominance	NN
cord-005453-4057qib7	7114	19	.	.	.
cord-005453-4057qib7	7115	1	Two	two	CD
cord-005453-4057qib7	7115	2	patients	patient	NNS
cord-005453-4057qib7	7115	3	experienced	experience	VBD
cord-005453-4057qib7	7115	4	grade	grade	NN
cord-005453-4057qib7	7115	5	3	3	CD
cord-005453-4057qib7	7115	6	serious	serious	JJ
cord-005453-4057qib7	7115	7	veno	veno	NN
cord-005453-4057qib7	7115	8	-	-	HYPH
cord-005453-4057qib7	7115	9	occlusive	occlusive	JJ
cord-005453-4057qib7	7115	10	liver	liver	NN
cord-005453-4057qib7	7115	11	disease	disease	NN
cord-005453-4057qib7	7115	12	(	(	-LRB-
cord-005453-4057qib7	7115	13	Table	table	NN
cord-005453-4057qib7	7115	14	1	1	CD
cord-005453-4057qib7	7115	15	)	)	-RRB-
cord-005453-4057qib7	7115	16	.	.	.
cord-005453-4057qib7	7116	1	Events	event	NNS
cord-005453-4057qib7	7116	2	resolved	resolve	VBD
cord-005453-4057qib7	7116	3	following	follow	VBG
cord-005453-4057qib7	7116	4	treatment	treatment	NN
cord-005453-4057qib7	7116	5	with	with	IN
cord-005453-4057qib7	7116	6	defibrotide	defibrotide	NN
cord-005453-4057qib7	7116	7	and	and	CC
cord-005453-4057qib7	7116	8	were	be	VBD
cord-005453-4057qib7	7116	9	attributed	attribute	VBN
cord-005453-4057qib7	7116	10	to	to	IN
cord-005453-4057qib7	7116	11	myeloablative	myeloablative	NNP
cord-005453-4057qib7	7116	12	conditioning	conditioning	NN
cord-005453-4057qib7	7116	13	.	.	.
cord-005453-4057qib7	7117	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7117	2	:	:	:
cord-005453-4057qib7	7118	1	In	in	IN
cord-005453-4057qib7	7118	2	the	the	DT
cord-005453-4057qib7	7118	3	Northstar	Northstar	NNP
cord-005453-4057qib7	7118	4	study	study	NN
cord-005453-4057qib7	7118	5	,	,	,
cord-005453-4057qib7	7118	6	80	80	CD
cord-005453-4057qib7	7118	7	%	%	NN
cord-005453-4057qib7	7118	8	of	of	IN
cord-005453-4057qib7	7118	9	patients	patient	NNS
cord-005453-4057qib7	7118	10	with	with	IN
cord-005453-4057qib7	7118	11	TDT	TDT	NNP
cord-005453-4057qib7	7118	12	and	and	CC
cord-005453-4057qib7	7118	13	non	non	NNS
cord-005453-4057qib7	7118	14	-	-	JJ
cord-005453-4057qib7	7118	15	β	β	JJ
cord-005453-4057qib7	7118	16	0	0	CD
cord-005453-4057qib7	7118	17	/β	/β	NN
cord-005453-4057qib7	7118	18	0	0	NFP
cord-005453-4057qib7	7118	19	genotypes	genotype	NNS
cord-005453-4057qib7	7118	20	and	and	CC
cord-005453-4057qib7	7118	21	38	38	CD
cord-005453-4057qib7	7118	22	%	%	NN
cord-005453-4057qib7	7118	23	of	of	IN
cord-005453-4057qib7	7118	24	patients	patient	NNS
cord-005453-4057qib7	7118	25	with	with	IN
cord-005453-4057qib7	7118	26	β	β	NN
cord-005453-4057qib7	7118	27	0	0	CD
cord-005453-4057qib7	7118	28	/	/	NFP
cord-005453-4057qib7	7119	1	β	β	NN
cord-005453-4057qib7	7119	2	0	0	CD
cord-005453-4057qib7	7119	3	genotypes	genotype	NNS
cord-005453-4057qib7	7119	4	achieved	achieve	VBD
cord-005453-4057qib7	7119	5	transfusion	transfusion	NN
cord-005453-4057qib7	7119	6	independence	independence	NN
cord-005453-4057qib7	7119	7	.	.	.
cord-005453-4057qib7	7120	1	The	the	DT
cord-005453-4057qib7	7120	2	safety	safety	NN
cord-005453-4057qib7	7120	3	profile	profile	NN
cord-005453-4057qib7	7120	4	of	of	IN
cord-005453-4057qib7	7120	5	LentiGlobin	LentiGlobin	NNP
cord-005453-4057qib7	7120	6	remains	remain	VBZ
cord-005453-4057qib7	7120	7	consistent	consistent	JJ
cord-005453-4057qib7	7120	8	with	with	IN
cord-005453-4057qib7	7120	9	myeloablative	myeloablative	NNP
cord-005453-4057qib7	7120	10	busulfan	busulfan	NNP
cord-005453-4057qib7	7120	11	conditioning	conditioning	NN
cord-005453-4057qib7	7120	12	.	.	.
cord-005453-4057qib7	7121	1	Longer	long	JJR
cord-005453-4057qib7	7121	2	time	time	NN
cord-005453-4057qib7	7121	3	to	to	IN
cord-005453-4057qib7	7121	4	platelet	platelet	NN
cord-005453-4057qib7	7121	5	engraftment	engraftment	NN
cord-005453-4057qib7	7121	6	was	be	VBD
cord-005453-4057qib7	7121	7	observed	observe	VBN
cord-005453-4057qib7	7121	8	in	in	IN
cord-005453-4057qib7	7121	9	some	some	DT
cord-005453-4057qib7	7121	10	patients	patient	NNS
cord-005453-4057qib7	7121	11	,	,	,
cord-005453-4057qib7	7121	12	but	but	CC
cord-005453-4057qib7	7121	13	no	no	DT
cord-005453-4057qib7	7121	14	graft	graft	NN
cord-005453-4057qib7	7121	15	failure	failure	NN
cord-005453-4057qib7	7121	16	was	be	VBD
cord-005453-4057qib7	7121	17	reported	report	VBN
cord-005453-4057qib7	7121	18	.	.	.
cord-005453-4057qib7	7122	1	Clinical	clinical	JJ
cord-005453-4057qib7	7122	2	Background	Background	NNP
cord-005453-4057qib7	7122	3	:	:	:
cord-005453-4057qib7	7122	4	Sickle	Sickle	NNP
cord-005453-4057qib7	7122	5	Cell	Cell	NNP
cord-005453-4057qib7	7122	6	Disease	Disease	NNP
cord-005453-4057qib7	7122	7	(	(	-LRB-
cord-005453-4057qib7	7122	8	SCD	SCD	NNP
cord-005453-4057qib7	7122	9	)	)	-RRB-
cord-005453-4057qib7	7122	10	is	be	VBZ
cord-005453-4057qib7	7122	11	an	an	DT
cord-005453-4057qib7	7122	12	inherited	inherit	VBN
cord-005453-4057qib7	7122	13	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	7122	14	disorder	disorder	NN
cord-005453-4057qib7	7122	15	associated	associate	VBN
cord-005453-4057qib7	7122	16	with	with	IN
cord-005453-4057qib7	7122	17	high	high	JJ
cord-005453-4057qib7	7122	18	morbidity	morbidity	NN
cord-005453-4057qib7	7122	19	and	and	CC
cord-005453-4057qib7	7122	20	mortality	mortality	NN
cord-005453-4057qib7	7122	21	.	.	.
cord-005453-4057qib7	7123	1	Currently	currently	RB
cord-005453-4057qib7	7123	2	,	,	,
cord-005453-4057qib7	7123	3	allogeneic	allogeneic	IN
cord-005453-4057qib7	7123	4	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	7123	5	Stem	Stem	NNP
cord-005453-4057qib7	7123	6	Cell	cell	NN
cord-005453-4057qib7	7123	7	Transplantation	transplantation	NN
cord-005453-4057qib7	7123	8	(	(	-LRB-
cord-005453-4057qib7	7123	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7123	10	)	)	-RRB-
cord-005453-4057qib7	7123	11	is	be	VBZ
cord-005453-4057qib7	7123	12	the	the	DT
cord-005453-4057qib7	7123	13	only	only	JJ
cord-005453-4057qib7	7123	14	curative	curative	JJ
cord-005453-4057qib7	7123	15	therapy	therapy	NN
cord-005453-4057qib7	7123	16	for	for	IN
cord-005453-4057qib7	7123	17	SCD	SCD	NNP
cord-005453-4057qib7	7123	18	.	.	.
cord-005453-4057qib7	7124	1	Transplant	transplant	NN
cord-005453-4057qib7	7124	2	outcomes	outcome	NNS
cord-005453-4057qib7	7124	3	with	with	IN
cord-005453-4057qib7	7124	4	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	7124	5	,	,	,
cord-005453-4057qib7	7124	6	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	7124	7	and	and	CC
cord-005453-4057qib7	7124	8	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	7124	9	(	(	-LRB-
cord-005453-4057qib7	7124	10	TTF	TTF	NNP
cord-005453-4057qib7	7124	11	)	)	-RRB-
cord-005453-4057qib7	7125	1	preparative	preparative	JJ
cord-005453-4057qib7	7125	2	regimen	regimen	NN
cord-005453-4057qib7	7125	3	are	be	VBP
cord-005453-4057qib7	7125	4	encouraging	encourage	VBG
cord-005453-4057qib7	7125	5	but	but	CC
cord-005453-4057qib7	7125	6	this	this	DT
cord-005453-4057qib7	7125	7	regimen	regimen	NN
cord-005453-4057qib7	7125	8	has	have	VBZ
cord-005453-4057qib7	7125	9	not	not	RB
cord-005453-4057qib7	7125	10	been	be	VBN
cord-005453-4057qib7	7125	11	directly	directly	RB
cord-005453-4057qib7	7125	12	compared	compare	VBN
cord-005453-4057qib7	7125	13	to	to	IN
cord-005453-4057qib7	7125	14	other	other	JJ
cord-005453-4057qib7	7125	15	preparative	preparative	JJ
cord-005453-4057qib7	7125	16	regimens	regimen	NNS
cord-005453-4057qib7	7125	17	in	in	IN
cord-005453-4057qib7	7125	18	SCD	SCD	NNP
cord-005453-4057qib7	7125	19	.	.	.
cord-005453-4057qib7	7126	1	We	-PRON-	PRP
cord-005453-4057qib7	7126	2	therefore	therefore	RB
cord-005453-4057qib7	7126	3	planned	plan	VBD
cord-005453-4057qib7	7126	4	to	to	TO
cord-005453-4057qib7	7126	5	compare	compare	VB
cord-005453-4057qib7	7126	6	the	the	DT
cord-005453-4057qib7	7126	7	event	event	NN
cord-005453-4057qib7	7126	8	free	free	JJ
cord-005453-4057qib7	7126	9	probability	probability	NN
cord-005453-4057qib7	7126	10	for	for	IN
cord-005453-4057qib7	7126	11	death	death	NN
cord-005453-4057qib7	7126	12	,	,	,
cord-005453-4057qib7	7126	13	rejection	rejection	NN
cord-005453-4057qib7	7126	14	and	and	CC
cord-005453-4057qib7	7126	15	high	high	JJ
cord-005453-4057qib7	7126	16	grade	grade	NN
cord-005453-4057qib7	7126	17	acute	acute	JJ
cord-005453-4057qib7	7126	18	Graft	graft	NN
cord-005453-4057qib7	7126	19	versus	versus	IN
cord-005453-4057qib7	7126	20	Host	Host	NNP
cord-005453-4057qib7	7126	21	Disease	Disease	NNP
cord-005453-4057qib7	7126	22	(	(	-LRB-
cord-005453-4057qib7	7126	23	aGvHD	agvhd	NN
cord-005453-4057qib7	7126	24	)	)	-RRB-
cord-005453-4057qib7	7126	25	between	between	IN
cord-005453-4057qib7	7126	26	TTF	TTF	NNP
cord-005453-4057qib7	7126	27	and	and	CC
cord-005453-4057qib7	7126	28	Busulfan	Busulfan	NNP
cord-005453-4057qib7	7126	29	and	and	CC
cord-005453-4057qib7	7126	30	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	7126	31	(	(	-LRB-
cord-005453-4057qib7	7126	32	BF	BF	NNP
cord-005453-4057qib7	7126	33	)	)	-RRB-
cord-005453-4057qib7	7126	34	regimens	regimen	NNS
cord-005453-4057qib7	7126	35	.	.	.
cord-005453-4057qib7	7127	1	Methods	method	NNS
cord-005453-4057qib7	7127	2	:	:	:
cord-005453-4057qib7	7127	3	In	in	IN
cord-005453-4057qib7	7127	4	this	this	DT
cord-005453-4057qib7	7127	5	retrospectively	retrospectively	RB
cord-005453-4057qib7	7127	6	cohort	cohort	JJ
cord-005453-4057qib7	7127	7	study	study	NN
cord-005453-4057qib7	7127	8	,	,	,
cord-005453-4057qib7	7127	9	we	-PRON-	PRP
cord-005453-4057qib7	7127	10	included	include	VBD
cord-005453-4057qib7	7127	11	all	all	DT
cord-005453-4057qib7	7127	12	patients	patient	NNS
cord-005453-4057qib7	7127	13	with	with	IN
cord-005453-4057qib7	7127	14	SCD	SCD	NNP
cord-005453-4057qib7	7127	15	who	who	WP
cord-005453-4057qib7	7127	16	received	receive	VBD
cord-005453-4057qib7	7127	17	allogeneic	allogeneic	IN
cord-005453-4057qib7	7127	18	HSCT	HSCT	NNP
cord-005453-4057qib7	7127	19	at	at	IN
cord-005453-4057qib7	7127	20	our	-PRON-	PRP$
cord-005453-4057qib7	7127	21	center	center	NN
cord-005453-4057qib7	7127	22	or	or	CC
cord-005453-4057qib7	7127	23	who	who	WP
cord-005453-4057qib7	7127	24	were	be	VBD
cord-005453-4057qib7	7127	25	transplanted	transplant	VBN
cord-005453-4057qib7	7127	26	in	in	IN
cord-005453-4057qib7	7127	27	other	other	JJ
cord-005453-4057qib7	7127	28	centers	center	NNS
cord-005453-4057qib7	7127	29	and	and	CC
cord-005453-4057qib7	7127	30	referred	refer	VBD
cord-005453-4057qib7	7127	31	to	to	IN
cord-005453-4057qib7	7127	32	ours	-PRON-	PRP
cord-005453-4057qib7	7127	33	for	for	IN
cord-005453-4057qib7	7127	34	follow	follow	NN
cord-005453-4057qib7	7127	35	up	up	RP
cord-005453-4057qib7	7127	36	before	before	IN
cord-005453-4057qib7	7127	37	day	day	NN
cord-005453-4057qib7	7127	38	100	100	CD
cord-005453-4057qib7	7127	39	.	.	.
cord-005453-4057qib7	7128	1	Patients	patient	NNS
cord-005453-4057qib7	7128	2	were	be	VBD
cord-005453-4057qib7	7128	3	transplanted	transplant	VBN
cord-005453-4057qib7	7128	4	between	between	IN
cord-005453-4057qib7	7128	5	July	July	NNP
cord-005453-4057qib7	7128	6	2007	2007	CD
cord-005453-4057qib7	7128	7	and	and	CC
cord-005453-4057qib7	7128	8	December	December	NNP
cord-005453-4057qib7	7128	9	2017	2017	CD
cord-005453-4057qib7	7128	10	.	.	.
cord-005453-4057qib7	7129	1	We	-PRON-	PRP
cord-005453-4057qib7	7129	2	used	use	VBD
cord-005453-4057qib7	7129	3	Kaplan	Kaplan	NNP
cord-005453-4057qib7	7129	4	-	-	HYPH
cord-005453-4057qib7	7129	5	Meier	Meier	NNP
cord-005453-4057qib7	7129	6	curve	curve	NN
cord-005453-4057qib7	7129	7	to	to	TO
cord-005453-4057qib7	7129	8	estimate	estimate	VB
cord-005453-4057qib7	7129	9	the	the	DT
cord-005453-4057qib7	7129	10	event	event	NN
cord-005453-4057qib7	7129	11	free	free	JJ
cord-005453-4057qib7	7129	12	probability	probability	NN
cord-005453-4057qib7	7129	13	for	for	IN
cord-005453-4057qib7	7129	14	death	death	NN
cord-005453-4057qib7	7129	15	,	,	,
cord-005453-4057qib7	7129	16	rejection	rejection	NN
cord-005453-4057qib7	7129	17	and	and	CC
cord-005453-4057qib7	7129	18	high	high	JJ
cord-005453-4057qib7	7129	19	grade	grade	NN
cord-005453-4057qib7	7129	20	aGvHD	agvhd	NN
cord-005453-4057qib7	7129	21	(	(	-LRB-
cord-005453-4057qib7	7129	22	Grades	grade	NNS
cord-005453-4057qib7	7129	23	3	3	CD
cord-005453-4057qib7	7129	24	-	-	SYM
cord-005453-4057qib7	7129	25	4	4	CD
cord-005453-4057qib7	7129	26	)	)	-RRB-
cord-005453-4057qib7	7129	27	.	.	.
cord-005453-4057qib7	7130	1	Cox	Cox	NNP
cord-005453-4057qib7	7130	2	regression	regression	NN
cord-005453-4057qib7	7130	3	was	be	VBD
cord-005453-4057qib7	7130	4	used	use	VBN
cord-005453-4057qib7	7130	5	to	to	TO
cord-005453-4057qib7	7130	6	assess	assess	VB
cord-005453-4057qib7	7130	7	the	the	DT
cord-005453-4057qib7	7130	8	impact	impact	NN
cord-005453-4057qib7	7130	9	of	of	IN
cord-005453-4057qib7	7130	10	the	the	DT
cord-005453-4057qib7	7130	11	preparative	preparative	JJ
cord-005453-4057qib7	7130	12	regimen	regimen	NN
cord-005453-4057qib7	7130	13	on	on	IN
cord-005453-4057qib7	7130	14	these	these	DT
cord-005453-4057qib7	7130	15	outcomes	outcome	NNS
cord-005453-4057qib7	7130	16	.	.	.
cord-005453-4057qib7	7131	1	Results	result	NNS
cord-005453-4057qib7	7131	2	:	:	:
cord-005453-4057qib7	7132	1	A	a	DT
cord-005453-4057qib7	7132	2	total	total	NN
cord-005453-4057qib7	7132	3	of	of	IN
cord-005453-4057qib7	7132	4	61	61	CD
cord-005453-4057qib7	7132	5	patients	patient	NNS
cord-005453-4057qib7	7132	6	were	be	VBD
cord-005453-4057qib7	7132	7	included	include	VBN
cord-005453-4057qib7	7132	8	with	with	IN
cord-005453-4057qib7	7132	9	a	a	DT
cord-005453-4057qib7	7132	10	median	median	JJ
cord-005453-4057qib7	7132	11	age	age	NN
cord-005453-4057qib7	7132	12	of	of	IN
cord-005453-4057qib7	7132	13	20	20	CD
cord-005453-4057qib7	7132	14	years	year	NNS
cord-005453-4057qib7	7133	1	(	(	-LRB-
cord-005453-4057qib7	7133	2	Interquartile	Interquartile	NNP
cord-005453-4057qib7	7133	3	Range	Range	NNP
cord-005453-4057qib7	7133	4	[	[	-LRB-
cord-005453-4057qib7	7133	5	IQR	IQR	NNP
cord-005453-4057qib7	7133	6	]	]	-RRB-
cord-005453-4057qib7	7133	7	:	:	:
cord-005453-4057qib7	7133	8	14	14	CD
cord-005453-4057qib7	7133	9	-	-	SYM
cord-005453-4057qib7	7133	10	26	26	CD
cord-005453-4057qib7	7133	11	)	)	-RRB-
cord-005453-4057qib7	7133	12	and	and	CC
cord-005453-4057qib7	7133	13	a	a	DT
cord-005453-4057qib7	7133	14	median	median	JJ
cord-005453-4057qib7	7133	15	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	7133	16	of	of	IN
cord-005453-4057qib7	7133	17	10	10	CD
cord-005453-4057qib7	7133	18	g	g	NN
cord-005453-4057qib7	7133	19	/	/	SYM
cord-005453-4057qib7	7133	20	dL	dl	NN
cord-005453-4057qib7	7133	21	(	(	-LRB-
cord-005453-4057qib7	7133	22	IQR	iqr	NN
cord-005453-4057qib7	7133	23	:	:	:
cord-005453-4057qib7	7133	24	9	9	CD
cord-005453-4057qib7	7133	25	-	-	SYM
cord-005453-4057qib7	7133	26	10	10	CD
cord-005453-4057qib7	7133	27	)	)	-RRB-
cord-005453-4057qib7	7133	28	.	.	.
cord-005453-4057qib7	7134	1	Sixtytwo	Sixtytwo	NNP
cord-005453-4057qib7	7134	2	percent	percent	NN
cord-005453-4057qib7	7134	3	were	be	VBD
cord-005453-4057qib7	7134	4	males	male	NNS
cord-005453-4057qib7	7134	5	.	.	.
cord-005453-4057qib7	7135	1	The	the	DT
cord-005453-4057qib7	7135	2	proportion	proportion	NN
cord-005453-4057qib7	7135	3	of	of	IN
cord-005453-4057qib7	7135	4	patients	patient	NNS
cord-005453-4057qib7	7135	5	who	who	WP
cord-005453-4057qib7	7135	6	had	have	VBD
cord-005453-4057qib7	7135	7	splenectomy	splenectomy	NN
cord-005453-4057qib7	7135	8	,	,	,
cord-005453-4057qib7	7135	9	stroke	stroke	NN
cord-005453-4057qib7	7135	10	and	and	CC
cord-005453-4057qib7	7135	11	acute	acute	JJ
cord-005453-4057qib7	7135	12	chest	chest	NN
cord-005453-4057qib7	7135	13	syndrome	syndrome	NN
cord-005453-4057qib7	7135	14	was	be	VBD
cord-005453-4057qib7	7135	15	34	34	CD
cord-005453-4057qib7	7135	16	%	%	NN
cord-005453-4057qib7	7135	17	,	,	,
cord-005453-4057qib7	7135	18	23	23	CD
cord-005453-4057qib7	7135	19	%	%	NN
cord-005453-4057qib7	7135	20	and	and	CC
cord-005453-4057qib7	7135	21	57	57	CD
cord-005453-4057qib7	7135	22	%	%	NN
cord-005453-4057qib7	7135	23	respectively	respectively	RB
cord-005453-4057qib7	7135	24	.	.	.
cord-005453-4057qib7	7136	1	All	all	DT
cord-005453-4057qib7	7136	2	patients	patient	NNS
cord-005453-4057qib7	7136	3	received	receive	VBD
cord-005453-4057qib7	7136	4	peripherally	peripherally	RB
cord-005453-4057qib7	7136	5	collected	collect	VBN
cord-005453-4057qib7	7136	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7136	7	stem	stem	NN
cord-005453-4057qib7	7136	8	cells	cell	NNS
cord-005453-4057qib7	7136	9	from	from	IN
cord-005453-4057qib7	7136	10	a	a	DT
cord-005453-4057qib7	7136	11	matched	match	VBN
cord-005453-4057qib7	7136	12	sibling	sibling	NN
cord-005453-4057qib7	7136	13	donor	donor	NN
cord-005453-4057qib7	7136	14	with	with	IN
cord-005453-4057qib7	7136	15	a	a	DT
cord-005453-4057qib7	7136	16	median	median	JJ
cord-005453-4057qib7	7136	17	stem	stem	NN
cord-005453-4057qib7	7136	18	cell	cell	NN
cord-005453-4057qib7	7136	19	dose	dose	NN
cord-005453-4057qib7	7136	20	of	of	IN
cord-005453-4057qib7	7136	21	6	6	CD
cord-005453-4057qib7	7136	22	x	x	SYM
cord-005453-4057qib7	7136	23	10	10	CD
cord-005453-4057qib7	7136	24	6	6	CD
cord-005453-4057qib7	7137	1	/Kg	/Kg	.
cord-005453-4057qib7	7138	1	(	(	-LRB-
cord-005453-4057qib7	7138	2	IQR	IQR	NNP
cord-005453-4057qib7	7138	3	:	:	:
cord-005453-4057qib7	7138	4	5	5	CD
cord-005453-4057qib7	7138	5	.	.	.
cord-005453-4057qib7	7138	6	1	1	CD
cord-005453-4057qib7	7138	7	-	-	SYM
cord-005453-4057qib7	7138	8	8.8	8.8	CD
cord-005453-4057qib7	7138	9	)	)	-RRB-
cord-005453-4057qib7	7138	10	.	.	.
cord-005453-4057qib7	7139	1	Most	Most	JJS
cord-005453-4057qib7	7139	2	patients	patient	NNS
cord-005453-4057qib7	7139	3	,	,	,
cord-005453-4057qib7	7139	4	95	95	CD
cord-005453-4057qib7	7139	5	%	%	NN
cord-005453-4057qib7	7139	6	,	,	,
cord-005453-4057qib7	7139	7	received	receive	VBD
cord-005453-4057qib7	7139	8	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	7139	9	or	or	CC
cord-005453-4057qib7	7139	10	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	7139	11	based	base	VBN
cord-005453-4057qib7	7139	12	aGvHD	aGvHD	NNP
cord-005453-4057qib7	7139	13	prophylaxis	prophylaxis	NNP
cord-005453-4057qib7	7139	14	.	.	.
cord-005453-4057qib7	7140	1	Most	Most	JJS
cord-005453-4057qib7	7140	2	patients	patient	NNS
cord-005453-4057qib7	7140	3	received	receive	VBD
cord-005453-4057qib7	7140	4	TTF	TTF	NNP
cord-005453-4057qib7	7140	5	(	(	-LRB-
cord-005453-4057qib7	7140	6	41	41	CD
cord-005453-4057qib7	7140	7	%	%	NN
cord-005453-4057qib7	7140	8	)	)	-RRB-
cord-005453-4057qib7	7140	9	or	or	CC
cord-005453-4057qib7	7140	10	BF	BF	NNP
cord-005453-4057qib7	7140	11	(	(	-LRB-
cord-005453-4057qib7	7140	12	53	53	CD
cord-005453-4057qib7	7140	13	%	%	NN
cord-005453-4057qib7	7140	14	)	)	-RRB-
cord-005453-4057qib7	7140	15	preparative	preparative	JJ
cord-005453-4057qib7	7140	16	regimens	regimen	NNS
cord-005453-4057qib7	7140	17	.	.	.
cord-005453-4057qib7	7141	1	All	all	DT
cord-005453-4057qib7	7141	2	patients	patient	NNS
cord-005453-4057qib7	7141	3	in	in	IN
cord-005453-4057qib7	7141	4	the	the	DT
cord-005453-4057qib7	7141	5	BF	BF	NNP
cord-005453-4057qib7	7141	6	group	group	NN
cord-005453-4057qib7	7141	7	received	receive	VBD
cord-005453-4057qib7	7141	8	ATG	ATG	NNP
cord-005453-4057qib7	7141	9	.	.	.
cord-005453-4057qib7	7142	1	The	the	DT
cord-005453-4057qib7	7142	2	median	median	JJ
cord-005453-4057qib7	7142	3	follow	follow	NN
cord-005453-4057qib7	7142	4	-	-	HYPH
cord-005453-4057qib7	7142	5	up	up	RP
cord-005453-4057qib7	7142	6	time	time	NN
cord-005453-4057qib7	7142	7	was	be	VBD
cord-005453-4057qib7	7142	8	44	44	CD
cord-005453-4057qib7	7142	9	months	month	NNS
cord-005453-4057qib7	7143	1	(	(	-LRB-
cord-005453-4057qib7	7143	2	Range	range	NN
cord-005453-4057qib7	7143	3	:	:	:
cord-005453-4057qib7	7143	4	2	2	CD
cord-005453-4057qib7	7143	5	-	-	SYM
cord-005453-4057qib7	7143	6	127	127	CD
cord-005453-4057qib7	7143	7	)	)	-RRB-
cord-005453-4057qib7	7143	8	.	.	.
cord-005453-4057qib7	7144	1	Four	four	CD
cord-005453-4057qib7	7144	2	patients	patient	NNS
cord-005453-4057qib7	7144	3	died	die	VBD
cord-005453-4057qib7	7144	4	during	during	IN
cord-005453-4057qib7	7144	5	the	the	DT
cord-005453-4057qib7	7144	6	follow	follow	NN
cord-005453-4057qib7	7144	7	-	-	HYPH
cord-005453-4057qib7	7144	8	up	up	NN
cord-005453-4057qib7	7144	9	period	period	NN
cord-005453-4057qib7	7144	10	with	with	IN
cord-005453-4057qib7	7144	11	an	an	DT
cord-005453-4057qib7	7144	12	OS	os	NN
cord-005453-4057qib7	7144	13	of	of	IN
cord-005453-4057qib7	7144	14	93	93	CD
cord-005453-4057qib7	7144	15	%	%	NN
cord-005453-4057qib7	7144	16	(	(	-LRB-
cord-005453-4057qib7	7144	17	95	95	CD
cord-005453-4057qib7	7144	18	%	%	NN
cord-005453-4057qib7	7144	19	Confidence	confidence	NN
cord-005453-4057qib7	7144	20	Interval	interval	NN
cord-005453-4057qib7	7144	21	[	[	-LRB-
cord-005453-4057qib7	7144	22	CI	CI	NNP
cord-005453-4057qib7	7144	23	]	]	-RRB-
cord-005453-4057qib7	7144	24	:	:	:
cord-005453-4057qib7	7144	25	87%-100	87%-100	CD
cord-005453-4057qib7	7144	26	%	%	NN
cord-005453-4057qib7	7144	27	)	)	-RRB-
cord-005453-4057qib7	7144	28	at	at	IN
cord-005453-4057qib7	7144	29	5	5	CD
cord-005453-4057qib7	7144	30	years	year	NNS
cord-005453-4057qib7	7144	31	.	.	.
cord-005453-4057qib7	7145	1	The	the	DT
cord-005453-4057qib7	7145	2	OS	OS	NNP
cord-005453-4057qib7	7145	3	was	be	VBD
cord-005453-4057qib7	7145	4	not	not	RB
cord-005453-4057qib7	7145	5	different	different	JJ
cord-005453-4057qib7	7145	6	(	(	-LRB-
cord-005453-4057qib7	7145	7	HR	HR	NNP
cord-005453-4057qib7	7145	8	1.3	1.3	CD
cord-005453-4057qib7	7145	9	,	,	,
cord-005453-4057qib7	7145	10	p	p	NN
cord-005453-4057qib7	7145	11	=	=	SYM
cord-005453-4057qib7	7145	12	0.82	0.82	CD
cord-005453-4057qib7	7145	13	)	)	-RRB-
cord-005453-4057qib7	7145	14	between	between	IN
cord-005453-4057qib7	7145	15	the	the	DT
cord-005453-4057qib7	7145	16	TTF	TTF	NNP
cord-005453-4057qib7	7145	17	(	(	-LRB-
cord-005453-4057qib7	7145	18	91	91	CD
cord-005453-4057qib7	7145	19	%	%	NN
cord-005453-4057qib7	7145	20	)	)	-RRB-
cord-005453-4057qib7	7145	21	and	and	CC
cord-005453-4057qib7	7145	22	the	the	DT
cord-005453-4057qib7	7145	23	BF	BF	NNP
cord-005453-4057qib7	7145	24	(	(	-LRB-
cord-005453-4057qib7	7145	25	94	94	CD
cord-005453-4057qib7	7145	26	%	%	NN
cord-005453-4057qib7	7145	27	)	)	-RRB-
cord-005453-4057qib7	7145	28	regimens	regimen	NNS
cord-005453-4057qib7	7145	29	.	.	.
cord-005453-4057qib7	7146	1	The	the	DT
cord-005453-4057qib7	7146	2	probability	probability	NN
cord-005453-4057qib7	7146	3	of	of	IN
cord-005453-4057qib7	7146	4	high	high	JJ
cord-005453-4057qib7	7146	5	grade	grade	NN
cord-005453-4057qib7	7146	6	aGvHD	aGvHD	.
cord-005453-4057qib7	7146	7	free	free	JJ
cord-005453-4057qib7	7146	8	survival	survival	NN
cord-005453-4057qib7	7146	9	at	at	IN
cord-005453-4057qib7	7146	10	day	day	NN
cord-005453-4057qib7	7146	11	100	100	CD
cord-005453-4057qib7	7146	12	was	be	VBD
cord-005453-4057qib7	7146	13	91	91	CD
cord-005453-4057qib7	7146	14	%	%	NN
cord-005453-4057qib7	7146	15	(	(	-LRB-
cord-005453-4057qib7	7146	16	95	95	CD
cord-005453-4057qib7	7146	17	%	%	NN
cord-005453-4057qib7	7146	18	CI	ci	NN
cord-005453-4057qib7	7146	19	:	:	:
cord-005453-4057qib7	7146	20	84	84	CD
cord-005453-4057qib7	7146	21	-	-	SYM
cord-005453-4057qib7	7146	22	99	99	CD
cord-005453-4057qib7	7146	23	)	)	-RRB-
cord-005453-4057qib7	7146	24	for	for	IN
cord-005453-4057qib7	7146	25	all	all	DT
cord-005453-4057qib7	7146	26	patients	patient	NNS
cord-005453-4057qib7	7146	27	.	.	.
cord-005453-4057qib7	7147	1	This	this	DT
cord-005453-4057qib7	7147	2	probability	probability	NN
cord-005453-4057qib7	7147	3	was	be	VBD
cord-005453-4057qib7	7147	4	85	85	CD
cord-005453-4057qib7	7147	5	%	%	NN
cord-005453-4057qib7	7147	6	in	in	IN
cord-005453-4057qib7	7147	7	the	the	DT
cord-005453-4057qib7	7147	8	TTF	TTF	NNP
cord-005453-4057qib7	7147	9	group	group	NN
cord-005453-4057qib7	7147	10	and	and	CC
cord-005453-4057qib7	7147	11	93	93	CD
cord-005453-4057qib7	7147	12	%	%	NN
cord-005453-4057qib7	7147	13	in	in	IN
cord-005453-4057qib7	7147	14	the	the	DT
cord-005453-4057qib7	7147	15	BF	BF	NNP
cord-005453-4057qib7	7147	16	group	group	NN
cord-005453-4057qib7	7147	17	and	and	CC
cord-005453-4057qib7	7147	18	the	the	DT
cord-005453-4057qib7	7147	19	difference	difference	NN
cord-005453-4057qib7	7147	20	was	be	VBD
cord-005453-4057qib7	7147	21	not	not	RB
cord-005453-4057qib7	7147	22	statistically	statistically	RB
cord-005453-4057qib7	7147	23	significant	significant	JJ
cord-005453-4057qib7	7147	24	(	(	-LRB-
cord-005453-4057qib7	7147	25	HR	HR	NNP
cord-005453-4057qib7	7147	26	2.2	2.2	CD
cord-005453-4057qib7	7147	27	,	,	,
cord-005453-4057qib7	7147	28	p	p	NN
cord-005453-4057qib7	7147	29	=	=	SYM
cord-005453-4057qib7	7147	30	0.39	0.39	CD
cord-005453-4057qib7	7147	31	)	)	-RRB-
cord-005453-4057qib7	7147	32	.	.	.
cord-005453-4057qib7	7148	1	The	the	DT
cord-005453-4057qib7	7148	2	rejection	rejection	NN
cord-005453-4057qib7	7148	3	free	free	JJ
cord-005453-4057qib7	7148	4	survival	survival	NN
cord-005453-4057qib7	7148	5	at	at	IN
cord-005453-4057qib7	7148	6	12	12	CD
cord-005453-4057qib7	7148	7	months	month	NNS
cord-005453-4057qib7	7148	8	was	be	VBD
cord-005453-4057qib7	7148	9	93	93	CD
cord-005453-4057qib7	7148	10	%	%	NN
cord-005453-4057qib7	7148	11	(	(	-LRB-
cord-005453-4057qib7	7148	12	95	95	CD
cord-005453-4057qib7	7148	13	%	%	NN
cord-005453-4057qib7	7148	14	CI	ci	NN
cord-005453-4057qib7	7148	15	:	:	:
cord-005453-4057qib7	7148	16	87	87	CD
cord-005453-4057qib7	7148	17	-	-	SYM
cord-005453-4057qib7	7148	18	100	100	CD
cord-005453-4057qib7	7148	19	)	)	-RRB-
cord-005453-4057qib7	7148	20	for	for	IN
cord-005453-4057qib7	7148	21	all	all	DT
cord-005453-4057qib7	7148	22	patients	patient	NNS
cord-005453-4057qib7	7148	23	.	.	.
cord-005453-4057qib7	7149	1	No	no	DT
cord-005453-4057qib7	7149	2	patients	patient	NNS
cord-005453-4057qib7	7149	3	in	in	IN
cord-005453-4057qib7	7149	4	the	the	DT
cord-005453-4057qib7	7149	5	TTF	TTF	NNP
cord-005453-4057qib7	7149	6	group	group	NN
cord-005453-4057qib7	7149	7	rejected	reject	VBD
cord-005453-4057qib7	7149	8	while	while	IN
cord-005453-4057qib7	7149	9	the	the	DT
cord-005453-4057qib7	7149	10	rejection	rejection	NN
cord-005453-4057qib7	7149	11	free	free	JJ
cord-005453-4057qib7	7149	12	survival	survival	NN
cord-005453-4057qib7	7149	13	at	at	IN
cord-005453-4057qib7	7149	14	12	12	CD
cord-005453-4057qib7	7149	15	months	month	NNS
cord-005453-4057qib7	7149	16	for	for	IN
cord-005453-4057qib7	7149	17	the	the	DT
cord-005453-4057qib7	7149	18	BF	BF	NNP
cord-005453-4057qib7	7149	19	group	group	NN
cord-005453-4057qib7	7149	20	was	be	VBD
cord-005453-4057qib7	7149	21	90	90	CD
cord-005453-4057qib7	7149	22	%	%	NN
cord-005453-4057qib7	7149	23	.	.	.
cord-005453-4057qib7	7150	1	This	this	DT
cord-005453-4057qib7	7150	2	was	be	VBD
cord-005453-4057qib7	7150	3	not	not	RB
cord-005453-4057qib7	7150	4	statistically	statistically	RB
cord-005453-4057qib7	7150	5	significant	significant	JJ
cord-005453-4057qib7	7150	6	(	(	-LRB-
cord-005453-4057qib7	7150	7	p	p	NN
cord-005453-4057qib7	7150	8	=	=	SYM
cord-005453-4057qib7	7150	9	0.07	0.07	CD
cord-005453-4057qib7	7150	10	)	)	-RRB-
cord-005453-4057qib7	7150	11	.	.	.
cord-005453-4057qib7	7151	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7151	2	:	:	:
cord-005453-4057qib7	7152	1	In	in	IN
cord-005453-4057qib7	7152	2	patients	patient	NNS
cord-005453-4057qib7	7152	3	with	with	IN
cord-005453-4057qib7	7152	4	SCD	SCD	NNP
cord-005453-4057qib7	7152	5	undergoing	undergoing	NN
cord-005453-4057qib7	7152	6	allogeneic	allogeneic	IN
cord-005453-4057qib7	7152	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7152	8	from	from	IN
cord-005453-4057qib7	7152	9	a	a	DT
cord-005453-4057qib7	7152	10	matched	match	VBN
cord-005453-4057qib7	7152	11	sibling	sibling	NN
cord-005453-4057qib7	7152	12	donor	donor	NN
cord-005453-4057qib7	7152	13	,	,	,
cord-005453-4057qib7	7152	14	the	the	DT
cord-005453-4057qib7	7152	15	TTF	TTF	NNP
cord-005453-4057qib7	7152	16	preparative	preparative	JJ
cord-005453-4057qib7	7152	17	regimen	regimen	NN
cord-005453-4057qib7	7152	18	is	be	VBZ
cord-005453-4057qib7	7152	19	not	not	RB
cord-005453-4057qib7	7152	20	associated	associate	VBN
cord-005453-4057qib7	7152	21	with	with	IN
cord-005453-4057qib7	7152	22	improved	improved	JJ
cord-005453-4057qib7	7152	23	OS	OS	NNP
cord-005453-4057qib7	7152	24	,	,	,
cord-005453-4057qib7	7152	25	rejection	rejection	NN
cord-005453-4057qib7	7152	26	free	free	JJ
cord-005453-4057qib7	7152	27	or	or	CC
cord-005453-4057qib7	7152	28	high	high	JJ
cord-005453-4057qib7	7152	29	grade	grade	NN
cord-005453-4057qib7	7152	30	free	free	JJ
cord-005453-4057qib7	7152	31	aGvHD	aGvHD	.
cord-005453-4057qib7	7152	32	survival	survival	NN
cord-005453-4057qib7	7152	33	when	when	WRB
cord-005453-4057qib7	7152	34	compared	compare	VBN
cord-005453-4057qib7	7152	35	to	to	IN
cord-005453-4057qib7	7152	36	the	the	DT
cord-005453-4057qib7	7152	37	BF	BF	NNP
cord-005453-4057qib7	7152	38	preparative	preparative	JJ
cord-005453-4057qib7	7152	39	regimen	regimen	NN
cord-005453-4057qib7	7152	40	.	.	.
cord-005453-4057qib7	7153	1	Larger	large	JJR
cord-005453-4057qib7	7153	2	studies	study	NNS
cord-005453-4057qib7	7153	3	are	be	VBP
cord-005453-4057qib7	7153	4	needed	need	VBN
cord-005453-4057qib7	7153	5	to	to	TO
cord-005453-4057qib7	7153	6	confirm	confirm	VB
cord-005453-4057qib7	7153	7	these	these	DT
cord-005453-4057qib7	7153	8	findings	finding	NNS
cord-005453-4057qib7	7153	9	.	.	.
cord-005453-4057qib7	7154	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7154	2	:	:	:
cord-005453-4057qib7	7154	3	Nothing	nothing	NN
cord-005453-4057qib7	7154	4	to	to	TO
cord-005453-4057qib7	7154	5	declare	declare	VB
cord-005453-4057qib7	7154	6	.	.	.
cord-005453-4057qib7	7155	1	Novel	novel	JJ
cord-005453-4057qib7	7155	2	strategy	strategy	NN
cord-005453-4057qib7	7155	3	for	for	IN
cord-005453-4057qib7	7155	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7155	5	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7155	6	stem	stem	NN
cord-005453-4057qib7	7155	7	cell	cell	NN
cord-005453-4057qib7	7155	8	transplant	transplant	NN
cord-005453-4057qib7	7155	9	in	in	IN
cord-005453-4057qib7	7155	10	sickle	sickle	NN
cord-005453-4057qib7	7155	11	cell	cell	NN
cord-005453-4057qib7	7155	12	disease	disease	NN
cord-005453-4057qib7	7155	13	Methods	method	NNS
cord-005453-4057qib7	7155	14	:	:	:
cord-005453-4057qib7	7155	15	9	9	CD
cord-005453-4057qib7	7155	16	consecutive	consecutive	JJ
cord-005453-4057qib7	7155	17	patients	patient	NNS
cord-005453-4057qib7	7155	18	suffering	suffer	VBG
cord-005453-4057qib7	7155	19	from	from	IN
cord-005453-4057qib7	7155	20	SCD	SCD	NNP
cord-005453-4057qib7	7155	21	who	who	WP
cord-005453-4057qib7	7155	22	underwent	undergo	VBD
cord-005453-4057qib7	7155	23	HHSCT	HHSCT	NNP
cord-005453-4057qib7	7155	24	between	between	IN
cord-005453-4057qib7	7155	25	Jan	Jan	NNP
cord-005453-4057qib7	7155	26	2018	2018	CD
cord-005453-4057qib7	7155	27	till	till	IN
cord-005453-4057qib7	7155	28	date	date	NN
cord-005453-4057qib7	7155	29	were	be	VBD
cord-005453-4057qib7	7155	30	enrolled	enrol	VBN
cord-005453-4057qib7	7155	31	in	in	IN
cord-005453-4057qib7	7155	32	the	the	DT
cord-005453-4057qib7	7155	33	study	study	NN
cord-005453-4057qib7	7155	34	.	.	.
cord-005453-4057qib7	7156	1	All	all	DT
cord-005453-4057qib7	7156	2	9	9	CD
cord-005453-4057qib7	7156	3	underwent	undergo	VBD
cord-005453-4057qib7	7156	4	autologous	autologous	JJ
cord-005453-4057qib7	7156	5	backup	backup	NN
cord-005453-4057qib7	7156	6	(	(	-LRB-
cord-005453-4057qib7	7156	7	target	target	NN
cord-005453-4057qib7	7156	8	dose>5x10	dose>5x10	NNP
cord-005453-4057qib7	7156	9	6	6	CD
cord-005453-4057qib7	7156	10	/kg	/kg	NFP
cord-005453-4057qib7	7156	11	)	)	-RRB-
cord-005453-4057qib7	7156	12	followed	follow	VBN
cord-005453-4057qib7	7156	13	by	by	IN
cord-005453-4057qib7	7156	14	pre	pre	JJ
cord-005453-4057qib7	7156	15	-	-	JJ
cord-005453-4057qib7	7156	16	transplant	transplant	JJ
cord-005453-4057qib7	7156	17	immune	immune	JJ
cord-005453-4057qib7	7156	18	suppression	suppression	NN
cord-005453-4057qib7	7156	19	(	(	-LRB-
cord-005453-4057qib7	7156	20	PTIS	PTIS	NNP
cord-005453-4057qib7	7156	21	)	)	-RRB-
cord-005453-4057qib7	7156	22	2	2	CD
cord-005453-4057qib7	7156	23	cycles	cycle	NNS
cord-005453-4057qib7	7156	24	at	at	IN
cord-005453-4057qib7	7156	25	3	3	CD
cord-005453-4057qib7	7156	26	weekly	weekly	JJ
cord-005453-4057qib7	7156	27	intervals	interval	NNS
cord-005453-4057qib7	7156	28	using	use	VBG
cord-005453-4057qib7	7156	29	fludarabine	fludarabine	NN
cord-005453-4057qib7	7156	30	@30mg	@30mg	NNP
cord-005453-4057qib7	7156	31	/	/	SYM
cord-005453-4057qib7	7156	32	m2	m2	NNP
cord-005453-4057qib7	7156	33	/	/	SYM
cord-005453-4057qib7	7156	34	day(D1-D5	day(d1-d5	NN
cord-005453-4057qib7	7156	35	)	)	-RRB-
cord-005453-4057qib7	7157	1	+	+	CC
cord-005453-4057qib7	7157	2	cyclophosphami	cyclophosphami	NN
cord-005453-4057qib7	7157	3	-	-	HYPH
cord-005453-4057qib7	7157	4	de@1000mg	de@1000mg	VBN
cord-005453-4057qib7	7157	5	/	/	SYM
cord-005453-4057qib7	7157	6	m2	m2	NNP
cord-005453-4057qib7	7157	7	/	/	SYM
cord-005453-4057qib7	7157	8	day(D1	day(D1	NNP
cord-005453-4057qib7	7157	9	)	)	-RRB-
cord-005453-4057qib7	7158	1	+	+	CC
cord-005453-4057qib7	7159	1	dexamethasone@20mg	dexamethasone@20mg	NNS
cord-005453-4057qib7	7159	2	/	/	SYM
cord-005453-4057qib7	7159	3	m2/	m2/	NNS
cord-005453-4057qib7	7160	1	day(D1-D5	day(d1-d5	NN
cord-005453-4057qib7	7160	2	)	)	-RRB-
cord-005453-4057qib7	7161	1	along	along	IN
cord-005453-4057qib7	7161	2	with	with	IN
cord-005453-4057qib7	7161	3	hypertransfusion	hypertransfusion	NN
cord-005453-4057qib7	7161	4	(	(	-LRB-
cord-005453-4057qib7	7161	5	target	target	NN
cord-005453-4057qib7	7161	6	Hb	Hb	NNP
cord-005453-4057qib7	7161	7	11	11	CD
cord-005453-4057qib7	7161	8	-	-	HYPH
cord-005453-4057qib7	7161	9	13gm	13gm	NN
cord-005453-4057qib7	7161	10	/	/	SYM
cord-005453-4057qib7	7161	11	dl	dl	NNP
cord-005453-4057qib7	7161	12	)	)	-RRB-
cord-005453-4057qib7	7161	13	,	,	,
cord-005453-4057qib7	7161	14	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	7161	15	(	(	-LRB-
cord-005453-4057qib7	7161	16	20mg	20mg	NNP
cord-005453-4057qib7	7161	17	/	/	SYM
cord-005453-4057qib7	7161	18	kg	kg	NN
cord-005453-4057qib7	7161	19	/	/	SYM
cord-005453-4057qib7	7161	20	day	day	NN
cord-005453-4057qib7	7161	21	)	)	-RRB-
cord-005453-4057qib7	7161	22	and	and	CC
cord-005453-4057qib7	7161	23	azathioprine	azathioprine	JJ
cord-005453-4057qib7	7161	24	(	(	-LRB-
cord-005453-4057qib7	7161	25	2mg	2mg	NNP
cord-005453-4057qib7	7161	26	/	/	SYM
cord-005453-4057qib7	7161	27	kg	kg	NN
cord-005453-4057qib7	7161	28	/	/	SYM
cord-005453-4057qib7	7161	29	day	day	NN
cord-005453-4057qib7	7161	30	)	)	-RRB-
cord-005453-4057qib7	7161	31	from	from	IN
cord-005453-4057qib7	7161	32	day	day	NN
cord-005453-4057qib7	7161	33	-60	-60	NNS
cord-005453-4057qib7	7161	34	.	.	.
cord-005453-4057qib7	7162	1	The	the	DT
cord-005453-4057qib7	7162	2	graft	graft	NN
cord-005453-4057qib7	7162	3	was	be	VBD
cord-005453-4057qib7	7162	4	mobilized	mobilize	VBN
cord-005453-4057qib7	7162	5	using	use	VBG
cord-005453-4057qib7	7162	6	GCSF@10mcg	GCSF@10mcg	NNP
cord-005453-4057qib7	7162	7	/	/	SYM
cord-005453-4057qib7	7162	8	kg	kg	NN
cord-005453-4057qib7	7162	9	/	/	SYM
cord-005453-4057qib7	7162	10	day(D1-D5	day(d1-d5	NN
cord-005453-4057qib7	7162	11	)	)	-RRB-
cord-005453-4057qib7	7162	12	+	+	CC
cord-005453-4057qib7	7162	13	Plerixafor@0.24	Plerixafor@0.24	NNP
cord-005453-4057qib7	7162	14	mg	mg	NN
cord-005453-4057qib7	7163	1	/kg	/kg	NFP
cord-005453-4057qib7	7163	2	s/	s/	NNP
cord-005453-4057qib7	7163	3	c	c	NN
cord-005453-4057qib7	7163	4	on	on	IN
cord-005453-4057qib7	7163	5	D5	D5	NNP
cord-005453-4057qib7	7163	6	6	6	CD
cord-005453-4057qib7	7163	7	-	-	SYM
cord-005453-4057qib7	7163	8	8	8	CD
cord-005453-4057qib7	7163	9	hours	hour	NNS
cord-005453-4057qib7	7163	10	before	before	IN
cord-005453-4057qib7	7163	11	the	the	DT
cord-005453-4057qib7	7163	12	PBSCH	PBSCH	NNP
cord-005453-4057qib7	7163	13	.	.	.
cord-005453-4057qib7	7164	1	Conditioning	conditioning	NN
cord-005453-4057qib7	7164	2	included	include	VBD
cord-005453-4057qib7	7164	3	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	7164	4	10mg	10mg	NNP
cord-005453-4057qib7	7164	5	/	/	SYM
cord-005453-4057qib7	7164	6	kg	kg	NN
cord-005453-4057qib7	7164	7	in	in	IN
cord-005453-4057qib7	7164	8	two	two	CD
cord-005453-4057qib7	7164	9	divided	divide	VBN
cord-005453-4057qib7	7164	10	doses	dose	NNS
cord-005453-4057qib7	7164	11	(	(	-LRB-
cord-005453-4057qib7	7164	12	D-7	D-7	NNP
cord-005453-4057qib7	7164	13	)	)	-RRB-
cord-005453-4057qib7	7164	14	,	,	,
cord-005453-4057qib7	7164	15	fludarabine	fludarabine	NNP
cord-005453-4057qib7	7164	16	30mg	30mg	NNP
cord-005453-4057qib7	7164	17	/	/	SYM
cord-005453-4057qib7	7164	18	m2	m2	NNP
cord-005453-4057qib7	7164	19	(	(	-LRB-
cord-005453-4057qib7	7164	20	D-6	D-6	NNP
cord-005453-4057qib7	7164	21	to	to	IN
cord-005453-4057qib7	7164	22	D-2	D-2	NNP
cord-005453-4057qib7	7164	23	)	)	-RRB-
cord-005453-4057qib7	7164	24	,	,	,
cord-005453-4057qib7	7164	25	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	7164	26	14.5	14.5	CD
cord-005453-4057qib7	7164	27	mg	mg	NNP
cord-005453-4057qib7	7164	28	/	/	SYM
cord-005453-4057qib7	7164	29	kg	kg	NNP
cord-005453-4057qib7	7164	30	(	(	-LRB-
cord-005453-4057qib7	7164	31	D-5	D-5	NNP
cord-005453-4057qib7	7164	32	,	,	,
cord-005453-4057qib7	7164	33	D-4	D-4	NNP
cord-005453-4057qib7	7164	34	)	)	-RRB-
cord-005453-4057qib7	7164	35	,	,	,
cord-005453-4057qib7	7164	36	TBI	TBI	NNP
cord-005453-4057qib7	7164	37	2Gy	2gy	NN
cord-005453-4057qib7	7164	38	with	with	IN
cord-005453-4057qib7	7164	39	thymic	thymic	JJ
cord-005453-4057qib7	7164	40	shielding	shielding	NN
cord-005453-4057qib7	7164	41	(	(	-LRB-
cord-005453-4057qib7	7165	1	D-1	D-1	NNP
cord-005453-4057qib7	7165	2	)	)	-RRB-
cord-005453-4057qib7	7165	3	,	,	,
cord-005453-4057qib7	7165	4	rATG	rATG	NNP
cord-005453-4057qib7	7165	5	(	(	-LRB-
cord-005453-4057qib7	7165	6	Genzyme	Genzyme	NNP
cord-005453-4057qib7	7165	7	Thymoglobulin	Thymoglobulin	NNP
cord-005453-4057qib7	7165	8	1.5	1.5	CD
cord-005453-4057qib7	7165	9	mg	mg	NNP
cord-005453-4057qib7	7165	10	/	/	SYM
cord-005453-4057qib7	7165	11	kg	kg	NNP
cord-005453-4057qib7	7165	12	(	(	-LRB-
cord-005453-4057qib7	7165	13	D-9	D-9	NNP
cord-005453-4057qib7	7165	14	to	to	IN
cord-005453-4057qib7	7165	15	D-7	D-7	NNP
cord-005453-4057qib7	7165	16	)	)	-RRB-
cord-005453-4057qib7	7165	17	.	.	.
cord-005453-4057qib7	7166	1	GVHD	GVHD	NNP
cord-005453-4057qib7	7166	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7166	3	included	include	VBD
cord-005453-4057qib7	7166	4	PTCy	PTCy	NNS
cord-005453-4057qib7	7167	1	50	50	CD
cord-005453-4057qib7	7167	2	mg	mg	NNP
cord-005453-4057qib7	7167	3	/	/	SYM
cord-005453-4057qib7	7167	4	kg	kg	NNP
cord-005453-4057qib7	7167	5	/	/	SYM
cord-005453-4057qib7	7167	6	day	day	NN
cord-005453-4057qib7	7167	7	on	on	IN
cord-005453-4057qib7	7167	8	D3	D3	NNP
cord-005453-4057qib7	7167	9	and	and	CC
cord-005453-4057qib7	7167	10	4	4	CD
cord-005453-4057qib7	7168	1	,	,	,
cord-005453-4057qib7	7168	2	sirolimus	sirolimus	NNP
cord-005453-4057qib7	7168	3	(	(	-LRB-
cord-005453-4057qib7	7168	4	target	target	NN
cord-005453-4057qib7	7168	5	levels	level	NNS
cord-005453-4057qib7	7168	6	10	10	CD
cord-005453-4057qib7	7168	7	-	-	HYPH
cord-005453-4057qib7	7168	8	15ng	15ng	NN
cord-005453-4057qib7	7168	9	/	/	SYM
cord-005453-4057qib7	7168	10	ml	ml	NN
cord-005453-4057qib7	7168	11	)	)	-RRB-
cord-005453-4057qib7	7168	12	(	(	-LRB-
cord-005453-4057qib7	7168	13	till	till	IN
cord-005453-4057qib7	7168	14	9	9	CD
cord-005453-4057qib7	7168	15	-	-	SYM
cord-005453-4057qib7	7168	16	12	12	CD
cord-005453-4057qib7	7168	17	months	month	NNS
cord-005453-4057qib7	7168	18	post	post	NN
cord-005453-4057qib7	7168	19	HSCT	HSCT	NNP
cord-005453-4057qib7	7168	20	)	)	-RRB-
cord-005453-4057qib7	7168	21	and	and	CC
cord-005453-4057qib7	7168	22	MMF	mmf	NN
cord-005453-4057qib7	7168	23	(	(	-LRB-
cord-005453-4057qib7	7168	24	till	till	IN
cord-005453-4057qib7	7168	25	D35	D35	NNP
cord-005453-4057qib7	7168	26	)	)	-RRB-
cord-005453-4057qib7	7169	1	starting	start	VBG
cord-005453-4057qib7	7169	2	from	from	IN
cord-005453-4057qib7	7169	3	D5	D5	NNP
cord-005453-4057qib7	7169	4	.	.	.
cord-005453-4057qib7	7170	1	Results	result	NNS
cord-005453-4057qib7	7170	2	:	:	:
cord-005453-4057qib7	7171	1	The	the	DT
cord-005453-4057qib7	7171	2	median	median	JJ
cord-005453-4057qib7	7171	3	age	age	NN
cord-005453-4057qib7	7171	4	of	of	IN
cord-005453-4057qib7	7171	5	patient	patient	NN
cord-005453-4057qib7	7171	6	's	's	POS
cord-005453-4057qib7	7171	7	was	be	VBD
cord-005453-4057qib7	7171	8	7	7	CD
cord-005453-4057qib7	7171	9	years	year	NNS
cord-005453-4057qib7	7172	1	(	(	-LRB-
cord-005453-4057qib7	7172	2	range	range	NNP
cord-005453-4057qib7	7172	3	3	3	CD
cord-005453-4057qib7	7172	4	-	-	SYM
cord-005453-4057qib7	7172	5	22	22	CD
cord-005453-4057qib7	7172	6	years	year	NNS
cord-005453-4057qib7	7172	7	)	)	-RRB-
cord-005453-4057qib7	7172	8	.	.	.
cord-005453-4057qib7	7173	1	Before	before	IN
cord-005453-4057qib7	7173	2	transplantation	transplantation	NN
cord-005453-4057qib7	7173	3	all	all	DT
cord-005453-4057qib7	7173	4	patients	patient	NNS
cord-005453-4057qib7	7173	5	had	have	VBD
cord-005453-4057qib7	7173	6	repeated	repeat	VBN
cord-005453-4057qib7	7173	7	episodes	episode	NNS
cord-005453-4057qib7	7173	8	of	of	IN
cord-005453-4057qib7	7173	9	one	one	CD
cord-005453-4057qib7	7173	10	or	or	CC
cord-005453-4057qib7	7173	11	other	other	JJ
cord-005453-4057qib7	7173	12	complication	complication	NN
cord-005453-4057qib7	7173	13	warranting	warrant	VBG
cord-005453-4057qib7	7173	14	a	a	DT
cord-005453-4057qib7	7173	15	transplant	transplant	NN
cord-005453-4057qib7	7173	16	,	,	,
cord-005453-4057qib7	7173	17	non	non	JJ
cord-005453-4057qib7	7173	18	-	-	JJ
cord-005453-4057qib7	7173	19	responsive	responsive	JJ
cord-005453-4057qib7	7173	20	to	to	IN
cord-005453-4057qib7	7173	21	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	7173	22	.	.	.
cord-005453-4057qib7	7174	1	Six	six	CD
cord-005453-4057qib7	7174	2	had	have	VBD
cord-005453-4057qib7	7174	3	maternal	maternal	JJ
cord-005453-4057qib7	7174	4	donors	donor	NNS
cord-005453-4057qib7	7174	5	,	,	,
cord-005453-4057qib7	7174	6	2	2	CD
cord-005453-4057qib7	7174	7	paternal	paternal	JJ
cord-005453-4057qib7	7174	8	and	and	CC
cord-005453-4057qib7	7174	9	1	1	CD
cord-005453-4057qib7	7174	10	sibling	sibling	NN
cord-005453-4057qib7	7174	11	.	.	.
cord-005453-4057qib7	7175	1	Median	median	JJ
cord-005453-4057qib7	7175	2	age	age	NN
cord-005453-4057qib7	7175	3	of	of	IN
cord-005453-4057qib7	7175	4	the	the	DT
cord-005453-4057qib7	7175	5	donor	donor	NN
cord-005453-4057qib7	7175	6	was	be	VBD
cord-005453-4057qib7	7175	7	41	41	CD
cord-005453-4057qib7	7175	8	years	year	NNS
cord-005453-4057qib7	7176	1	(	(	-LRB-
cord-005453-4057qib7	7176	2	range	range	NNP
cord-005453-4057qib7	7176	3	19	19	CD
cord-005453-4057qib7	7176	4	-	-	SYM
cord-005453-4057qib7	7176	5	51	51	CD
cord-005453-4057qib7	7176	6	years	year	NNS
cord-005453-4057qib7	7176	7	)	)	-RRB-
cord-005453-4057qib7	7176	8	.	.	.
cord-005453-4057qib7	7177	1	All	all	DT
cord-005453-4057qib7	7177	2	were	be	VBD
cord-005453-4057qib7	7177	3	DSA	DSA	NNP
cord-005453-4057qib7	7177	4	negative	negative	JJ
cord-005453-4057qib7	7177	5	with	with	IN
cord-005453-4057qib7	7177	6	a	a	DT
cord-005453-4057qib7	7177	7	cutoff	cutoff	NN
cord-005453-4057qib7	7177	8	MFI	MFI	NNP
cord-005453-4057qib7	7177	9	of	of	IN
cord-005453-4057qib7	7177	10	>	>	XX
cord-005453-4057qib7	7177	11	2000	2000	CD
cord-005453-4057qib7	7177	12	IU	IU	NNP
cord-005453-4057qib7	7177	13	.	.	.
cord-005453-4057qib7	7178	1	All	all	DT
cord-005453-4057qib7	7178	2	patients	patient	NNS
cord-005453-4057qib7	7178	3	received	receive	VBD
cord-005453-4057qib7	7178	4	10x10	10x10	CD
cord-005453-4057qib7	7178	5	6	6	CD
cord-005453-4057qib7	7178	6	/kg	/kg	.
cord-005453-4057qib7	7178	7	CD34	CD34	NNP
cord-005453-4057qib7	7178	8	cells	cell	NNS
cord-005453-4057qib7	7178	9	irrespective	irrespective	RB
cord-005453-4057qib7	7178	10	of	of	IN
cord-005453-4057qib7	7178	11	harvested	harvest	VBN
cord-005453-4057qib7	7178	12	dose	dose	NN
cord-005453-4057qib7	7178	13	which	which	WDT
cord-005453-4057qib7	7178	14	ranged	range	VBD
cord-005453-4057qib7	7178	15	from	from	IN
cord-005453-4057qib7	7178	16	(	(	-LRB-
cord-005453-4057qib7	7178	17	10.13	10.13	CD
cord-005453-4057qib7	7178	18	-	-	SYM
cord-005453-4057qib7	7178	19	34.82	34.82	CD
cord-005453-4057qib7	7178	20	x10	x10	CD
cord-005453-4057qib7	7178	21	6	6	CD
cord-005453-4057qib7	7178	22	/kg	/kg	.
cord-005453-4057qib7	7178	23	)	)	-RRB-
cord-005453-4057qib7	7178	24	.	.	.
cord-005453-4057qib7	7179	1	Median	median	JJ
cord-005453-4057qib7	7179	2	CD3	CD3	NNP
cord-005453-4057qib7	7179	3	dose	dose	NN
cord-005453-4057qib7	7179	4	was	be	VBD
cord-005453-4057qib7	7179	5	16.59	16.59	CD
cord-005453-4057qib7	7179	6	x10	x10	CD
cord-005453-4057qib7	7179	7	7	7	CD
cord-005453-4057qib7	7180	1	/kg	/kg	NFP
cord-005453-4057qib7	7180	2	(	(	-LRB-
cord-005453-4057qib7	7180	3	range	range	NN
cord-005453-4057qib7	7180	4	10.44	10.44	CD
cord-005453-4057qib7	7180	5	-	-	HYPH
cord-005453-4057qib7	7180	6	41.9	41.9	CD
cord-005453-4057qib7	7180	7	x10	x10	CD
cord-005453-4057qib7	7180	8	7	7	CD
cord-005453-4057qib7	7180	9	/kg	/kg	.
cord-005453-4057qib7	7180	10	)	)	-RRB-
cord-005453-4057qib7	7180	11	.	.	.
cord-005453-4057qib7	7181	1	All	all	DT
cord-005453-4057qib7	7181	2	patients	patient	NNS
cord-005453-4057qib7	7181	3	engrafted	engraft	VBN
cord-005453-4057qib7	7181	4	with	with	IN
cord-005453-4057qib7	7181	5	median	median	JJ
cord-005453-4057qib7	7181	6	time	time	NN
cord-005453-4057qib7	7181	7	to	to	IN
cord-005453-4057qib7	7181	8	neutrophil	neutrophil	NN
cord-005453-4057qib7	7181	9	engraftment	engraftment	NN
cord-005453-4057qib7	7181	10	13	13	CD
cord-005453-4057qib7	7181	11	days	day	NNS
cord-005453-4057qib7	7181	12	(	(	-LRB-
cord-005453-4057qib7	7181	13	range	range	VBP
cord-005453-4057qib7	7181	14	12	12	CD
cord-005453-4057qib7	7181	15	-	-	SYM
cord-005453-4057qib7	7181	16	15	15	CD
cord-005453-4057qib7	7181	17	days	day	NNS
cord-005453-4057qib7	7181	18	)	)	-RRB-
cord-005453-4057qib7	7181	19	and	and	CC
cord-005453-4057qib7	7181	20	median	median	JJ
cord-005453-4057qib7	7181	21	time	time	NN
cord-005453-4057qib7	7181	22	to	to	IN
cord-005453-4057qib7	7181	23	platelet	platelet	NN
cord-005453-4057qib7	7181	24	engraftment	engraftment	NN
cord-005453-4057qib7	7181	25	13	13	CD
cord-005453-4057qib7	7181	26	days	day	NNS
cord-005453-4057qib7	7181	27	(	(	-LRB-
cord-005453-4057qib7	7181	28	range	range	VBP
cord-005453-4057qib7	7181	29	11	11	CD
cord-005453-4057qib7	7181	30	-	-	SYM
cord-005453-4057qib7	7181	31	16	16	CD
cord-005453-4057qib7	7181	32	days	day	NNS
cord-005453-4057qib7	7181	33	)	)	-RRB-
cord-005453-4057qib7	7181	34	.	.	.
cord-005453-4057qib7	7182	1	Median	median	JJ
cord-005453-4057qib7	7182	2	duration	duration	NN
cord-005453-4057qib7	7182	3	of	of	IN
cord-005453-4057qib7	7182	4	hospital	hospital	NN
cord-005453-4057qib7	7182	5	stay	stay	NN
cord-005453-4057qib7	7182	6	was	be	VBD
cord-005453-4057qib7	7182	7	30	30	CD
cord-005453-4057qib7	7182	8	days	day	NNS
cord-005453-4057qib7	7182	9	(	(	-LRB-
cord-005453-4057qib7	7182	10	range	range	VBP
cord-005453-4057qib7	7182	11	24	24	CD
cord-005453-4057qib7	7182	12	-	-	SYM
cord-005453-4057qib7	7182	13	35	35	CD
cord-005453-4057qib7	7182	14	days	day	NNS
cord-005453-4057qib7	7182	15	)	)	-RRB-
cord-005453-4057qib7	7182	16	.	.	.
cord-005453-4057qib7	7183	1	One	one	CD
cord-005453-4057qib7	7183	2	patient	patient	NN
cord-005453-4057qib7	7183	3	had	have	VBD
cord-005453-4057qib7	7183	4	cytokine	cytokine	NN
cord-005453-4057qib7	7183	5	release	release	NN
cord-005453-4057qib7	7183	6	syndrome	syndrome	NN
cord-005453-4057qib7	7183	7	needing	need	VBG
cord-005453-4057qib7	7183	8	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	7183	9	.	.	.
cord-005453-4057qib7	7184	1	Five	five	CD
cord-005453-4057qib7	7184	2	had	have	VBD
cord-005453-4057qib7	7184	3	engraftment	engraftment	NN
cord-005453-4057qib7	7184	4	syndrome	syndrome	NN
cord-005453-4057qib7	7184	5	treated	treat	VBN
cord-005453-4057qib7	7184	6	with	with	IN
cord-005453-4057qib7	7184	7	short	short	JJ
cord-005453-4057qib7	7184	8	course	course	NN
cord-005453-4057qib7	7184	9	of	of	IN
cord-005453-4057qib7	7184	10	steroids	steroid	NNS
cord-005453-4057qib7	7184	11	.	.	.
cord-005453-4057qib7	7185	1	Two	two	CD
cord-005453-4057qib7	7185	2	had	have	VBD
cord-005453-4057qib7	7185	3	CMV	CMV	NNP
cord-005453-4057qib7	7185	4	reactivation	reactivation	NN
cord-005453-4057qib7	7185	5	needing	need	VBG
cord-005453-4057qib7	7185	6	treatment	treatment	NN
cord-005453-4057qib7	7185	7	with	with	IN
cord-005453-4057qib7	7185	8	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	7185	9	/	/	SYM
cord-005453-4057qib7	7185	10	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	7185	11	.	.	.
cord-005453-4057qib7	7186	1	Acute	acute	JJ
cord-005453-4057qib7	7186	2	GVHD	GVHD	NNP
cord-005453-4057qib7	7186	3	grade	grade	NN
cord-005453-4057qib7	7186	4	II	II	NNP
cord-005453-4057qib7	7186	5	was	be	VBD
cord-005453-4057qib7	7186	6	seen	see	VBN
cord-005453-4057qib7	7186	7	in	in	IN
cord-005453-4057qib7	7186	8	one	one	CD
cord-005453-4057qib7	7186	9	patient	patient	NN
cord-005453-4057qib7	7186	10	.	.	.
cord-005453-4057qib7	7187	1	Till	till	IN
cord-005453-4057qib7	7187	2	date	date	NN
cord-005453-4057qib7	7187	3	of	of	IN
cord-005453-4057qib7	7187	4	analysis	analysis	NN
cord-005453-4057qib7	7187	5	none	none	NN
cord-005453-4057qib7	7187	6	had	have	VBD
cord-005453-4057qib7	7187	7	features	feature	NNS
cord-005453-4057qib7	7187	8	compatible	compatible	JJ
cord-005453-4057qib7	7187	9	with	with	IN
cord-005453-4057qib7	7187	10	chronic	chronic	JJ
cord-005453-4057qib7	7187	11	GVHD	GVHD	NNP
cord-005453-4057qib7	7187	12	.	.	.
cord-005453-4057qib7	7188	1	Of	of	IN
cord-005453-4057qib7	7188	2	the	the	DT
cord-005453-4057qib7	7188	3	9	9	CD
cord-005453-4057qib7	7188	4	patients	patient	NNS
cord-005453-4057qib7	7188	5	,	,	,
cord-005453-4057qib7	7188	6	8	8	CD
cord-005453-4057qib7	7188	7	are	be	VBP
cord-005453-4057qib7	7188	8	alive	alive	JJ
cord-005453-4057qib7	7188	9	without	without	IN
cord-005453-4057qib7	7188	10	sickle	sickle	NN
cord-005453-4057qib7	7188	11	cell	cell	NN
cord-005453-4057qib7	7188	12	disease	disease	NN
cord-005453-4057qib7	7188	13	with	with	IN
cord-005453-4057qib7	7188	14	Lansky/	Lansky/	NNP
cord-005453-4057qib7	7188	15	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	7188	16	scores	score	NNS
cord-005453-4057qib7	7188	17	of	of	IN
cord-005453-4057qib7	7188	18	100	100	CD
cord-005453-4057qib7	7188	19	.	.	.
cord-005453-4057qib7	7189	1	At	at	IN
cord-005453-4057qib7	7189	2	median	median	NN
cord-005453-4057qib7	7189	3	follow	follow	VB
cord-005453-4057qib7	7189	4	up	up	IN
cord-005453-4057qib7	7189	5	of	of	IN
cord-005453-4057qib7	7189	6	164	164	CD
cord-005453-4057qib7	7189	7	days	day	NNS
cord-005453-4057qib7	7189	8	(	(	-LRB-
cord-005453-4057qib7	7189	9	range	range	VBP
cord-005453-4057qib7	7189	10	61	61	CD
cord-005453-4057qib7	7189	11	-	-	SYM
cord-005453-4057qib7	7189	12	271	271	CD
cord-005453-4057qib7	7189	13	)	)	-RRB-
cord-005453-4057qib7	7190	1	the	the	DT
cord-005453-4057qib7	7190	2	probabilities	probability	NNS
cord-005453-4057qib7	7190	3	of	of	IN
cord-005453-4057qib7	7190	4	survival	survival	NN
cord-005453-4057qib7	7190	5	,	,	,
cord-005453-4057qib7	7190	6	SCA	SCA	NNP
cord-005453-4057qib7	7190	7	-	-	HYPH
cord-005453-4057qib7	7190	8	free	free	JJ
cord-005453-4057qib7	7190	9	survival	survival	NN
cord-005453-4057qib7	7190	10	,	,	,
cord-005453-4057qib7	7190	11	and	and	CC
cord-005453-4057qib7	7190	12	transplant	transplant	NN
cord-005453-4057qib7	7190	13	-	-	HYPH
cord-005453-4057qib7	7190	14	related	relate	VBN
cord-005453-4057qib7	7190	15	mortality	mortality	NN
cord-005453-4057qib7	7190	16	after	after	IN
cord-005453-4057qib7	7190	17	transplant	transplant	NN
cord-005453-4057qib7	7190	18	were	be	VBD
cord-005453-4057qib7	7190	19	88.9	88.9	CD
cord-005453-4057qib7	7190	20	%	%	NN
cord-005453-4057qib7	7190	21	,	,	,
cord-005453-4057qib7	7190	22	88.9	88.9	CD
cord-005453-4057qib7	7190	23	%	%	NN
cord-005453-4057qib7	7190	24	,	,	,
cord-005453-4057qib7	7190	25	and	and	CC
cord-005453-4057qib7	7190	26	11.1	11.1	CD
cord-005453-4057qib7	7190	27	%	%	NN
cord-005453-4057qib7	7190	28	,	,	,
cord-005453-4057qib7	7190	29	respectively	respectively	RB
cord-005453-4057qib7	7190	30	.	.	.
cord-005453-4057qib7	7191	1	One	one	CD
cord-005453-4057qib7	7191	2	patient	patient	NN
cord-005453-4057qib7	7191	3	died	die	VBD
cord-005453-4057qib7	7191	4	due	due	IN
cord-005453-4057qib7	7191	5	to	to	IN
cord-005453-4057qib7	7191	6	MDR	MDR	NNP
cord-005453-4057qib7	7191	7	Klebsiella	Klebsiella	NNP
cord-005453-4057qib7	7191	8	sepsis	sepsis	NN
cord-005453-4057qib7	7191	9	after	after	IN
cord-005453-4057qib7	7191	10	being	be	VBG
cord-005453-4057qib7	7191	11	discharged	discharge	VBN
cord-005453-4057qib7	7191	12	initially	initially	RB
cord-005453-4057qib7	7191	13	while	while	IN
cord-005453-4057qib7	7191	14	he	-PRON-	PRP
cord-005453-4057qib7	7191	15	was	be	VBD
cord-005453-4057qib7	7191	16	receiving	receive	VBG
cord-005453-4057qib7	7191	17	IV	IV	NNP
cord-005453-4057qib7	7191	18	ganciclovir	ganciclovir	NN
cord-005453-4057qib7	7191	19	on	on	IN
cord-005453-4057qib7	7191	20	day	day	NN
cord-005453-4057qib7	7191	21	care	care	NN
cord-005453-4057qib7	7191	22	basis	basis	NN
cord-005453-4057qib7	7191	23	.	.	.
cord-005453-4057qib7	7192	1	He	-PRON-	PRP
cord-005453-4057qib7	7192	2	had	have	VBD
cord-005453-4057qib7	7192	3	full	full	JJ
cord-005453-4057qib7	7192	4	donor	donor	NN
cord-005453-4057qib7	7192	5	chimerism	chimerism	NN
cord-005453-4057qib7	7192	6	.	.	.
cord-005453-4057qib7	7193	1	None	none	NN
cord-005453-4057qib7	7193	2	of	of	IN
cord-005453-4057qib7	7193	3	the	the	DT
cord-005453-4057qib7	7193	4	patient	patient	NN
cord-005453-4057qib7	7193	5	had	have	VBD
cord-005453-4057qib7	7193	6	primary	primary	JJ
cord-005453-4057qib7	7193	7	or	or	CC
cord-005453-4057qib7	7193	8	secondary	secondary	JJ
cord-005453-4057qib7	7193	9	graft	graft	NN
cord-005453-4057qib7	7193	10	failure	failure	NN
cord-005453-4057qib7	7193	11	.	.	.
cord-005453-4057qib7	7194	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7194	2	:	:	:
cord-005453-4057qib7	7195	1	Pre	pre	JJ
cord-005453-4057qib7	7195	2	-	-	JJ
cord-005453-4057qib7	7195	3	transplant	transplant	JJ
cord-005453-4057qib7	7195	4	immune	immune	JJ
cord-005453-4057qib7	7195	5	suppression	suppression	NN
cord-005453-4057qib7	7195	6	and	and	CC
cord-005453-4057qib7	7195	7	upfront	upfront	JJ
cord-005453-4057qib7	7195	8	use	use	NN
cord-005453-4057qib7	7195	9	of	of	IN
cord-005453-4057qib7	7195	10	plerixafor	plerixafor	NN
cord-005453-4057qib7	7195	11	for	for	IN
cord-005453-4057qib7	7195	12	graft	graft	NN
cord-005453-4057qib7	7195	13	mobilization	mobilization	NN
cord-005453-4057qib7	7195	14	decreases	decrease	VBZ
cord-005453-4057qib7	7195	15	the	the	DT
cord-005453-4057qib7	7195	16	risk	risk	NN
cord-005453-4057qib7	7195	17	of	of	IN
cord-005453-4057qib7	7195	18	graft	graft	NN
cord-005453-4057qib7	7195	19	failure	failure	NN
cord-005453-4057qib7	7195	20	and	and	CC
cord-005453-4057qib7	7195	21	graft	graft	NN
cord-005453-4057qib7	7195	22	versus	versus	IN
cord-005453-4057qib7	7195	23	host	host	NN
cord-005453-4057qib7	7195	24	disease	disease	NN
cord-005453-4057qib7	7195	25	leading	lead	VBG
cord-005453-4057qib7	7195	26	to	to	IN
cord-005453-4057qib7	7195	27	overall	overall	JJ
cord-005453-4057qib7	7195	28	better	well	JJR
cord-005453-4057qib7	7195	29	survival	survival	NN
cord-005453-4057qib7	7195	30	in	in	IN
cord-005453-4057qib7	7195	31	HHSCT	HHSCT	NNP
cord-005453-4057qib7	7195	32	for	for	IN
cord-005453-4057qib7	7195	33	sickle	sickle	NN
cord-005453-4057qib7	7195	34	cell	cell	NN
cord-005453-4057qib7	7195	35	disease	disease	NN
cord-005453-4057qib7	7195	36	.	.	.
cord-005453-4057qib7	7196	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7196	2	:	:	:
cord-005453-4057qib7	7196	3	None	none	NN
cord-005453-4057qib7	7196	4	.	.	.
cord-005453-4057qib7	7197	1	Combined	combine	VBN
cord-005453-4057qib7	7197	2	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	7197	3	stem	stem	NN
cord-005453-4057qib7	7197	4	cell	cell	NN
cord-005453-4057qib7	7197	5	transplant	transplant	NN
cord-005453-4057qib7	7197	6	and	and	CC
cord-005453-4057qib7	7197	7	enzyme	enzyme	NN
cord-005453-4057qib7	7197	8	replacement	replacement	NN
cord-005453-4057qib7	7197	9	therapy	therapy	NN
cord-005453-4057qib7	7197	10	in	in	IN
cord-005453-4057qib7	7197	11	wolman	wolman	NNP
cord-005453-4057qib7	7197	12	disease	disease	NN
cord-005453-4057qib7	7197	13	:	:	:
cord-005453-4057qib7	7198	1	Outcomes	outcome	NNS
cord-005453-4057qib7	7198	2	and	and	CC
cord-005453-4057qib7	7198	3	challenges	challenge	VBZ
cord-005453-4057qib7	7198	4	Jane	Jane	NNP
cord-005453-4057qib7	7198	5	Kinsella	Kinsella	NNP
cord-005453-4057qib7	7198	6	1	1	CD
cord-005453-4057qib7	7198	7	,	,	,
cord-005453-4057qib7	7198	8	Denise	Denise	NNP
cord-005453-4057qib7	7198	9	Bonney	Bonney	NNP
cord-005453-4057qib7	7198	10	1	1	CD
cord-005453-4057qib7	7198	11	,	,	,
cord-005453-4057qib7	7198	12	Helen	Helen	NNP
cord-005453-4057qib7	7198	13	Campbell	Campbell	NNP
cord-005453-4057qib7	7198	14	1	1	CD
cord-005453-4057qib7	7198	15	,	,	,
cord-005453-4057qib7	7198	16	Robert	Robert	NNP
cord-005453-4057qib7	7198	17	Wynn	Wynn	NNP
cord-005453-4057qib7	7198	18	1	1	CD
cord-005453-4057qib7	7199	1	,	,	,
cord-005453-4057qib7	7199	2	Simon	Simon	NNP
cord-005453-4057qib7	7199	3	Jones	Jones	NNP
cord-005453-4057qib7	7199	4	1	1	CD
cord-005453-4057qib7	7199	5	Background	Background	NNP
cord-005453-4057qib7	7199	6	:	:	:
cord-005453-4057qib7	7200	1	Infantile	infantile	JJ
cord-005453-4057qib7	7200	2	lysosomal	lysosomal	JJ
cord-005453-4057qib7	7200	3	acid	acid	NN
cord-005453-4057qib7	7200	4	lipase	lipase	NN
cord-005453-4057qib7	7200	5	deficiencymore	deficiencymore	NN
cord-005453-4057qib7	7200	6	commonly	commonly	RB
cord-005453-4057qib7	7200	7	known	know	VBN
cord-005453-4057qib7	7200	8	as	as	IN
cord-005453-4057qib7	7200	9	Wolman	Wolman	NNP
cord-005453-4057qib7	7200	10	disease	disease	NN
cord-005453-4057qib7	7200	11	-is	-i	VBZ
cord-005453-4057qib7	7200	12	an	an	DT
cord-005453-4057qib7	7200	13	autosomal	autosomal	JJ
cord-005453-4057qib7	7200	14	recessive	recessive	JJ
cord-005453-4057qib7	7200	15	lysosomal	lysosomal	JJ
cord-005453-4057qib7	7200	16	storage	storage	NN
cord-005453-4057qib7	7200	17	disease	disease	NN
cord-005453-4057qib7	7200	18	,	,	,
cord-005453-4057qib7	7200	19	characterised	characterise	VBN
cord-005453-4057qib7	7200	20	by	by	IN
cord-005453-4057qib7	7200	21	storage	storage	NN
cord-005453-4057qib7	7200	22	of	of	IN
cord-005453-4057qib7	7200	23	cholesterol	cholesterol	NN
cord-005453-4057qib7	7200	24	esters	ester	NNS
cord-005453-4057qib7	7200	25	in	in	IN
cord-005453-4057qib7	7200	26	the	the	DT
cord-005453-4057qib7	7200	27	liver	liver	NN
cord-005453-4057qib7	7200	28	,	,	,
cord-005453-4057qib7	7200	29	spleen	spleen	NN
cord-005453-4057qib7	7200	30	and	and	CC
cord-005453-4057qib7	7200	31	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	7200	32	tract	tract	NN
cord-005453-4057qib7	7200	33	.	.	.
cord-005453-4057qib7	7201	1	These	these	DT
cord-005453-4057qib7	7201	2	children	child	NNS
cord-005453-4057qib7	7201	3	present	present	JJ
cord-005453-4057qib7	7201	4	under	under	IN
cord-005453-4057qib7	7201	5	the	the	DT
cord-005453-4057qib7	7201	6	age	age	NN
cord-005453-4057qib7	7201	7	of	of	IN
cord-005453-4057qib7	7201	8	6	6	CD
cord-005453-4057qib7	7201	9	months	month	NNS
cord-005453-4057qib7	7201	10	and	and	CC
cord-005453-4057qib7	7201	11	traditionally	traditionally	RB
cord-005453-4057qib7	7201	12	had	have	VBD
cord-005453-4057qib7	7201	13	a	a	DT
cord-005453-4057qib7	7201	14	poor	poor	JJ
cord-005453-4057qib7	7201	15	prognosis	prognosis	NN
cord-005453-4057qib7	7201	16	,	,	,
cord-005453-4057qib7	7201	17	with	with	IN
cord-005453-4057qib7	7201	18	almost	almost	RB
cord-005453-4057qib7	7201	19	all	all	DT
cord-005453-4057qib7	7201	20	being	be	VBG
cord-005453-4057qib7	7201	21	dead	dead	JJ
cord-005453-4057qib7	7201	22	by	by	IN
cord-005453-4057qib7	7201	23	the	the	DT
cord-005453-4057qib7	7201	24	age	age	NN
cord-005453-4057qib7	7201	25	of	of	IN
cord-005453-4057qib7	7201	26	12	12	CD
cord-005453-4057qib7	7201	27	months	month	NNS
cord-005453-4057qib7	7201	28	.	.	.
cord-005453-4057qib7	7202	1	Bone	bone	NN
cord-005453-4057qib7	7202	2	marrow	marrow	NN
cord-005453-4057qib7	7202	3	transplant	transplant	NN
cord-005453-4057qib7	7202	4	has	have	VBZ
cord-005453-4057qib7	7202	5	been	be	VBN
cord-005453-4057qib7	7202	6	used	use	VBN
cord-005453-4057qib7	7202	7	to	to	TO
cord-005453-4057qib7	7202	8	correct	correct	VB
cord-005453-4057qib7	7202	9	disease	disease	NN
cord-005453-4057qib7	7202	10	manifestations	manifestation	NNS
cord-005453-4057qib7	7202	11	,	,	,
cord-005453-4057qib7	7202	12	but	but	CC
cord-005453-4057qib7	7202	13	limited	limit	VBN
cord-005453-4057qib7	7202	14	by	by	IN
cord-005453-4057qib7	7202	15	high	high	JJ
cord-005453-4057qib7	7202	16	procedure	procedure	NN
cord-005453-4057qib7	7202	17	-	-	HYPH
cord-005453-4057qib7	7202	18	related	relate	VBN
cord-005453-4057qib7	7202	19	mortality	mortality	NN
cord-005453-4057qib7	7202	20	with	with	IN
cord-005453-4057qib7	7202	21	the	the	DT
cord-005453-4057qib7	7202	22	significant	significant	JJ
cord-005453-4057qib7	7202	23	co	co	NNS
cord-005453-4057qib7	7202	24	-	-	NNS
cord-005453-4057qib7	7202	25	morbidities	morbidity	NNS
cord-005453-4057qib7	7202	26	.	.	.
cord-005453-4057qib7	7203	1	The	the	DT
cord-005453-4057qib7	7203	2	survival	survival	NN
cord-005453-4057qib7	7203	3	has	have	VBZ
cord-005453-4057qib7	7203	4	changed	change	VBN
cord-005453-4057qib7	7203	5	over	over	IN
cord-005453-4057qib7	7203	6	the	the	DT
cord-005453-4057qib7	7203	7	past	past	JJ
cord-005453-4057qib7	7203	8	few	few	JJ
cord-005453-4057qib7	7203	9	years	year	NNS
cord-005453-4057qib7	7203	10	due	due	JJ
cord-005453-4057qib7	7203	11	to	to	IN
cord-005453-4057qib7	7203	12	pharmacological	pharmacological	JJ
cord-005453-4057qib7	7203	13	enzyme	enzyme	NN
cord-005453-4057qib7	7203	14	replacement	replacement	NN
cord-005453-4057qib7	7203	15	therapy	therapy	NN
cord-005453-4057qib7	7203	16	but	but	CC
cord-005453-4057qib7	7203	17	still	still	RB
cord-005453-4057qib7	7203	18	presents	present	VBZ
cord-005453-4057qib7	7203	19	challenges	challenge	NNS
cord-005453-4057qib7	7203	20	for	for	IN
cord-005453-4057qib7	7203	21	these	these	DT
cord-005453-4057qib7	7203	22	patients	patient	NNS
cord-005453-4057qib7	7203	23	and	and	CC
cord-005453-4057qib7	7203	24	their	-PRON-	PRP$
cord-005453-4057qib7	7203	25	clinicians	clinician	NNS
cord-005453-4057qib7	7203	26	.	.	.
cord-005453-4057qib7	7204	1	In	in	IN
cord-005453-4057qib7	7204	2	these	these	DT
cord-005453-4057qib7	7204	3	children	child	NNS
cord-005453-4057qib7	7204	4	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	7204	5	stem	stem	NN
cord-005453-4057qib7	7204	6	cell	cell	NN
cord-005453-4057qib7	7204	7	transplant	transplant	NN
cord-005453-4057qib7	7204	8	we	-PRON-	PRP
cord-005453-4057qib7	7204	9	have	have	VBP
cord-005453-4057qib7	7204	10	offered	offer	VBN
cord-005453-4057qib7	7204	11	BMT	BMT	NNP
cord-005453-4057qib7	7204	12	with	with	IN
cord-005453-4057qib7	7204	13	enzyme	enzyme	NN
cord-005453-4057qib7	7204	14	replacement	replacement	NN
cord-005453-4057qib7	7204	15	therapy	therapy	NN
cord-005453-4057qib7	7204	16	,	,	,
cord-005453-4057qib7	7204	17	in	in	IN
cord-005453-4057qib7	7204	18	certain	certain	JJ
cord-005453-4057qib7	7204	19	specific	specific	JJ
cord-005453-4057qib7	7204	20	circumstances	circumstance	NNS
cord-005453-4057qib7	7204	21	.	.	.
cord-005453-4057qib7	7205	1	Methods	method	NNS
cord-005453-4057qib7	7205	2	:	:	:
cord-005453-4057qib7	7205	3	Four	four	CD
cord-005453-4057qib7	7205	4	children	child	NNS
cord-005453-4057qib7	7205	5	with	with	IN
cord-005453-4057qib7	7205	6	Wolman	Wolman	NNP
cord-005453-4057qib7	7205	7	disease	disease	NN
cord-005453-4057qib7	7205	8	being	be	VBG
cord-005453-4057qib7	7205	9	treated	treat	VBN
cord-005453-4057qib7	7205	10	with	with	IN
cord-005453-4057qib7	7205	11	enzyme	enzyme	NN
cord-005453-4057qib7	7205	12	replacement	replacement	NN
cord-005453-4057qib7	7205	13	therapy	therapy	NN
cord-005453-4057qib7	7205	14	,	,	,
cord-005453-4057qib7	7205	15	limited	limit	VBN
cord-005453-4057qib7	7205	16	by	by	IN
cord-005453-4057qib7	7205	17	alloantibody	alloantibody	NN
cord-005453-4057qib7	7205	18	,	,	,
cord-005453-4057qib7	7205	19	or	or	CC
cord-005453-4057qib7	7205	20	poor	poor	JJ
cord-005453-4057qib7	7205	21	venous	venous	JJ
cord-005453-4057qib7	7205	22	access	access	NN
cord-005453-4057qib7	7205	23	,	,	,
cord-005453-4057qib7	7205	24	received	receive	VBD
cord-005453-4057qib7	7205	25	treosulfan	treosulfan	NNP
cord-005453-4057qib7	7205	26	-	-	HYPH
cord-005453-4057qib7	7205	27	based	base	VBN
cord-005453-4057qib7	7205	28	,	,	,
cord-005453-4057qib7	7205	29	myeloablative	myeloablative	NNP
cord-005453-4057qib7	7205	30	conditioning	conditioning	NN
cord-005453-4057qib7	7205	31	with	with	IN
cord-005453-4057qib7	7205	32	serotherapy	serotherapy	NN
cord-005453-4057qib7	7205	33	followed	follow	VBN
cord-005453-4057qib7	7205	34	by	by	IN
cord-005453-4057qib7	7205	35	a	a	DT
cord-005453-4057qib7	7205	36	matched	match	VBN
cord-005453-4057qib7	7205	37	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	7205	38	stem	stem	NN
cord-005453-4057qib7	7205	39	cell	cell	NN
cord-005453-4057qib7	7205	40	transplant	transplant	NN
cord-005453-4057qib7	7205	41	:	:	:
cord-005453-4057qib7	7205	42	two	two	CD
cord-005453-4057qib7	7205	43	family	family	NN
cord-005453-4057qib7	7205	44	donors	donor	NNS
cord-005453-4057qib7	7205	45	,	,	,
cord-005453-4057qib7	7205	46	one	one	CD
cord-005453-4057qib7	7205	47	sibling	sibling	NN
cord-005453-4057qib7	7205	48	donor	donor	NN
cord-005453-4057qib7	7205	49	and	and	CC
cord-005453-4057qib7	7205	50	one	one	CD
cord-005453-4057qib7	7205	51	unrelated	unrelated	JJ
cord-005453-4057qib7	7205	52	donor	donor	NN
cord-005453-4057qib7	7205	53	.	.	.
cord-005453-4057qib7	7206	1	Results	result	NNS
cord-005453-4057qib7	7206	2	:	:	:
cord-005453-4057qib7	7207	1	Three	three	CD
cord-005453-4057qib7	7207	2	of	of	IN
cord-005453-4057qib7	7207	3	the	the	DT
cord-005453-4057qib7	7207	4	four	four	CD
cord-005453-4057qib7	7207	5	children	child	NNS
cord-005453-4057qib7	7207	6	survived	survive	VBD
cord-005453-4057qib7	7207	7	transplant	transplant	NN
cord-005453-4057qib7	7207	8	.	.	.
cord-005453-4057qib7	7208	1	They	-PRON-	PRP
cord-005453-4057qib7	7208	2	have	have	VBP
cord-005453-4057qib7	7208	3	continued	continue	VBN
cord-005453-4057qib7	7208	4	to	to	TO
cord-005453-4057qib7	7208	5	receive	receive	VB
cord-005453-4057qib7	7208	6	enzyme	enzyme	NN
cord-005453-4057qib7	7208	7	replacement	replacement	NN
cord-005453-4057qib7	7208	8	therapy	therapy	NN
cord-005453-4057qib7	7208	9	but	but	CC
cord-005453-4057qib7	7208	10	at	at	IN
cord-005453-4057qib7	7208	11	reduced	reduce	VBN
cord-005453-4057qib7	7208	12	dose	dose	NN
cord-005453-4057qib7	7208	13	and	and	CC
cord-005453-4057qib7	7208	14	frequency	frequency	NN
cord-005453-4057qib7	7208	15	with	with	IN
cord-005453-4057qib7	7208	16	improved	improved	JJ
cord-005453-4057qib7	7208	17	tolerability	tolerability	NN
cord-005453-4057qib7	7208	18	.	.	.
cord-005453-4057qib7	7209	1	They	-PRON-	PRP
cord-005453-4057qib7	7209	2	have	have	VBP
cord-005453-4057qib7	7209	3	continues	continue	VBZ
cord-005453-4057qib7	7209	4	to	to	TO
cord-005453-4057qib7	7209	5	grow	grow	VB
cord-005453-4057qib7	7209	6	and	and	CC
cord-005453-4057qib7	7209	7	develop	develop	VB
cord-005453-4057qib7	7209	8	.	.	.
cord-005453-4057qib7	7210	1	Growth	growth	NN
cord-005453-4057qib7	7210	2	and	and	CC
cord-005453-4057qib7	7210	3	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	7210	4	histology	histology	NN
cord-005453-4057qib7	7210	5	is	be	VBZ
cord-005453-4057qib7	7210	6	improved	improve	VBN
cord-005453-4057qib7	7210	7	for	for	IN
cord-005453-4057qib7	7210	8	children	child	NNS
cord-005453-4057qib7	7210	9	having	have	VBG
cord-005453-4057qib7	7210	10	received	receive	VBN
cord-005453-4057qib7	7210	11	transplant	transplant	NN
cord-005453-4057qib7	7210	12	compared	compare	VBN
cord-005453-4057qib7	7210	13	to	to	IN
cord-005453-4057qib7	7210	14	those	those	DT
cord-005453-4057qib7	7210	15	receiving	receive	VBG
cord-005453-4057qib7	7210	16	enzyme	enzyme	NN
cord-005453-4057qib7	7210	17	replacement	replacement	NN
cord-005453-4057qib7	7210	18	alone	alone	RB
cord-005453-4057qib7	7210	19	.	.	.
cord-005453-4057qib7	7211	1	Monitoring	monitoring	NN
cord-005453-4057qib7	7211	2	of	of	IN
cord-005453-4057qib7	7211	3	peripheral	peripheral	JJ
cord-005453-4057qib7	7211	4	blood	blood	NN
cord-005453-4057qib7	7211	5	chimerism	chimerism	NN
cord-005453-4057qib7	7211	6	has	have	VBZ
cord-005453-4057qib7	7211	7	shown	show	VBN
cord-005453-4057qib7	7211	8	a	a	DT
cord-005453-4057qib7	7211	9	disease	disease	NN
cord-005453-4057qib7	7211	10	-	-	HYPH
cord-005453-4057qib7	7211	11	associated	associate	VBN
cord-005453-4057qib7	7211	12	engraftment	engraftment	NN
cord-005453-4057qib7	7211	13	defect	defect	NN
cord-005453-4057qib7	7211	14	,	,	,
cord-005453-4057qib7	7211	15	with	with	IN
cord-005453-4057qib7	7211	16	mixed	mixed	JJ
cord-005453-4057qib7	7211	17	chimerism	chimerism	NN
cord-005453-4057qib7	7211	18	in	in	IN
cord-005453-4057qib7	7211	19	the	the	DT
cord-005453-4057qib7	7211	20	3	3	CD
cord-005453-4057qib7	7211	21	surviving	survive	VBG
cord-005453-4057qib7	7211	22	patient	patient	NN
cord-005453-4057qib7	7211	23	.	.	.
cord-005453-4057qib7	7212	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7212	2	:	:	:
cord-005453-4057qib7	7213	1	Haemopoietic	haemopoietic	JJ
cord-005453-4057qib7	7213	2	stem	stem	NN
cord-005453-4057qib7	7213	3	cell	cell	NN
cord-005453-4057qib7	7213	4	transplant	transplant	NN
cord-005453-4057qib7	7213	5	is	be	VBZ
cord-005453-4057qib7	7213	6	a	a	DT
cord-005453-4057qib7	7213	7	suitable	suitable	JJ
cord-005453-4057qib7	7213	8	treatment	treatment	NN
cord-005453-4057qib7	7213	9	option	option	NN
cord-005453-4057qib7	7213	10	in	in	IN
cord-005453-4057qib7	7213	11	children	child	NNS
cord-005453-4057qib7	7213	12	with	with	IN
cord-005453-4057qib7	7213	13	Wolman	Wolman	NNP
cord-005453-4057qib7	7213	14	disease	disease	NN
cord-005453-4057qib7	7213	15	in	in	IN
cord-005453-4057qib7	7213	16	whom	whom	WP
cord-005453-4057qib7	7213	17	receiving	receive	VBG
cord-005453-4057qib7	7213	18	enzyme	enzyme	NN
cord-005453-4057qib7	7213	19	replacement	replacement	NN
cord-005453-4057qib7	7213	20	therapy	therapy	NN
cord-005453-4057qib7	7213	21	is	be	VBZ
cord-005453-4057qib7	7213	22	not	not	RB
cord-005453-4057qib7	7213	23	possible	possible	JJ
cord-005453-4057qib7	7213	24	because	because	IN
cord-005453-4057qib7	7213	25	of	of	IN
cord-005453-4057qib7	7213	26	venous	venous	JJ
cord-005453-4057qib7	7213	27	access	access	NN
cord-005453-4057qib7	7213	28	,	,	,
cord-005453-4057qib7	7213	29	sensitisation	sensitisation	NN
cord-005453-4057qib7	7213	30	or	or	CC
cord-005453-4057qib7	7213	31	cost	cost	NN
cord-005453-4057qib7	7213	32	reasons	reason	NNS
cord-005453-4057qib7	7213	33	.	.	.
cord-005453-4057qib7	7214	1	It	-PRON-	PRP
cord-005453-4057qib7	7214	2	improves	improve	VBZ
cord-005453-4057qib7	7214	3	their	-PRON-	PRP$
cord-005453-4057qib7	7214	4	tolerability	tolerability	NN
cord-005453-4057qib7	7214	5	of	of	IN
cord-005453-4057qib7	7214	6	the	the	DT
cord-005453-4057qib7	7214	7	enzyme	enzyme	NN
cord-005453-4057qib7	7214	8	treatment	treatment	NN
cord-005453-4057qib7	7214	9	and	and	CC
cord-005453-4057qib7	7214	10	allows	allow	VBZ
cord-005453-4057qib7	7214	11	for	for	IN
cord-005453-4057qib7	7214	12	a	a	DT
cord-005453-4057qib7	7214	13	reduction	reduction	NN
cord-005453-4057qib7	7214	14	in	in	IN
cord-005453-4057qib7	7214	15	enzyme	enzyme	NN
cord-005453-4057qib7	7214	16	dose	dose	NN
cord-005453-4057qib7	7214	17	and	and	CC
cord-005453-4057qib7	7214	18	frequency	frequency	NN
cord-005453-4057qib7	7214	19	.	.	.
cord-005453-4057qib7	7215	1	However	however	RB
cord-005453-4057qib7	7215	2	,	,	,
cord-005453-4057qib7	7215	3	the	the	DT
cord-005453-4057qib7	7215	4	results	result	NNS
cord-005453-4057qib7	7215	5	of	of	IN
cord-005453-4057qib7	7215	6	engraftment	engraftment	NN
cord-005453-4057qib7	7215	7	are	be	VBP
cord-005453-4057qib7	7215	8	not	not	RB
cord-005453-4057qib7	7215	9	as	as	RB
cord-005453-4057qib7	7215	10	good	good	JJ
cord-005453-4057qib7	7215	11	as	as	IN
cord-005453-4057qib7	7215	12	expected	expect	VBN
cord-005453-4057qib7	7215	13	for	for	IN
cord-005453-4057qib7	7215	14	a	a	DT
cord-005453-4057qib7	7215	15	transplant	transplant	NN
cord-005453-4057qib7	7215	16	with	with	IN
cord-005453-4057qib7	7215	17	myeloablative	myeloablative	JJ
cord-005453-4057qib7	7215	18	conditioning	conditioning	NN
cord-005453-4057qib7	7215	19	and	and	CC
cord-005453-4057qib7	7215	20	a	a	DT
cord-005453-4057qib7	7215	21	matched	match	VBN
cord-005453-4057qib7	7215	22	donor	donor	NN
cord-005453-4057qib7	7215	23	.	.	.
cord-005453-4057qib7	7216	1	An	an	DT
cord-005453-4057qib7	7216	2	engraftment	engraftment	NN
cord-005453-4057qib7	7216	3	defect	defect	NN
cord-005453-4057qib7	7216	4	has	have	VBZ
cord-005453-4057qib7	7216	5	been	be	VBN
cord-005453-4057qib7	7216	6	observed	observe	VBN
cord-005453-4057qib7	7216	7	in	in	IN
cord-005453-4057qib7	7216	8	lysosomal	lysosomal	JJ
cord-005453-4057qib7	7216	9	acid	acid	NN
cord-005453-4057qib7	7216	10	lipase	lipase	NN
cord-005453-4057qib7	7216	11	deficient	deficient	JJ
cord-005453-4057qib7	7216	12	animal	animal	NN
cord-005453-4057qib7	7216	13	models	model	NNS
cord-005453-4057qib7	7216	14	.	.	.
cord-005453-4057qib7	7217	1	A	a	DT
cord-005453-4057qib7	7217	2	further	further	JJ
cord-005453-4057qib7	7217	3	understanding	understanding	NN
cord-005453-4057qib7	7217	4	of	of	IN
cord-005453-4057qib7	7217	5	this	this	DT
cord-005453-4057qib7	7217	6	poor	poor	JJ
cord-005453-4057qib7	7217	7	engraftment	engraftment	NN
cord-005453-4057qib7	7217	8	in	in	IN
cord-005453-4057qib7	7217	9	children	child	NNS
cord-005453-4057qib7	7217	10	with	with	IN
cord-005453-4057qib7	7217	11	Wolman	Wolman	NNP
cord-005453-4057qib7	7217	12	disease	disease	NN
cord-005453-4057qib7	7217	13	is	be	VBZ
cord-005453-4057qib7	7217	14	required	require	VBN
cord-005453-4057qib7	7217	15	as	as	IN
cord-005453-4057qib7	7217	16	to	to	TO
cord-005453-4057qib7	7217	17	determine	determine	VB
cord-005453-4057qib7	7217	18	whether	whether	IN
cord-005453-4057qib7	7217	19	the	the	DT
cord-005453-4057qib7	7217	20	risks	risk	NNS
cord-005453-4057qib7	7217	21	of	of	IN
cord-005453-4057qib7	7217	22	transplant	transplant	NN
cord-005453-4057qib7	7217	23	is	be	VBZ
cord-005453-4057qib7	7217	24	beneficial	beneficial	JJ
cord-005453-4057qib7	7217	25	in	in	IN
cord-005453-4057qib7	7217	26	these	these	DT
cord-005453-4057qib7	7217	27	patients	patient	NNS
cord-005453-4057qib7	7217	28	and	and	CC
cord-005453-4057qib7	7217	29	for	for	IN
cord-005453-4057qib7	7217	30	the	the	DT
cord-005453-4057qib7	7217	31	consideration	consideration	NN
cord-005453-4057qib7	7217	32	of	of	IN
cord-005453-4057qib7	7217	33	future	future	JJ
cord-005453-4057qib7	7217	34	treatment	treatment	NN
cord-005453-4057qib7	7217	35	options	option	NNS
cord-005453-4057qib7	7217	36	including	include	VBG
cord-005453-4057qib7	7217	37	gene	gene	NN
cord-005453-4057qib7	7217	38	therapy	therapy	NN
cord-005453-4057qib7	7217	39	.	.	.
cord-005453-4057qib7	7218	1	Background	background	NN
cord-005453-4057qib7	7218	2	:	:	:
cord-005453-4057qib7	7219	1	Thalassemia	thalassemia	NN
cord-005453-4057qib7	7219	2	major	major	NN
cord-005453-4057qib7	7219	3	is	be	VBZ
cord-005453-4057qib7	7219	4	the	the	DT
cord-005453-4057qib7	7219	5	most	most	RBS
cord-005453-4057qib7	7219	6	common	common	JJ
cord-005453-4057qib7	7219	7	transfusion	transfusion	NN
cord-005453-4057qib7	7219	8	dependent	dependent	JJ
cord-005453-4057qib7	7219	9	hemolytic	hemolytic	JJ
cord-005453-4057qib7	7219	10	anemia	anemia	NN
cord-005453-4057qib7	7219	11	in	in	IN
cord-005453-4057qib7	7219	12	the	the	DT
cord-005453-4057qib7	7219	13	world	world	NN
cord-005453-4057qib7	7219	14	.	.	.
cord-005453-4057qib7	7220	1	The	the	DT
cord-005453-4057qib7	7220	2	absent	absent	JJ
cord-005453-4057qib7	7220	3	or	or	CC
cord-005453-4057qib7	7220	4	reduced	reduced	JJ
cord-005453-4057qib7	7220	5	production	production	NN
cord-005453-4057qib7	7220	6	of	of	IN
cord-005453-4057qib7	7220	7	the	the	DT
cord-005453-4057qib7	7220	8	β	β	NN
cord-005453-4057qib7	7220	9	-	-	HYPH
cord-005453-4057qib7	7220	10	chain	chain	NN
cord-005453-4057qib7	7220	11	of	of	IN
cord-005453-4057qib7	7220	12	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	7220	13	causes	cause	VBZ
cord-005453-4057qib7	7220	14	severe	severe	JJ
cord-005453-4057qib7	7220	15	ineffective	ineffective	JJ
cord-005453-4057qib7	7220	16	erythropoiesis	erythropoiesis	NN
cord-005453-4057qib7	7220	17	,	,	,
cord-005453-4057qib7	7220	18	massive	massive	JJ
cord-005453-4057qib7	7220	19	erythroid	erythroid	JJ
cord-005453-4057qib7	7220	20	hyperplasia	hyperplasia	NN
cord-005453-4057qib7	7220	21	in	in	IN
cord-005453-4057qib7	7220	22	the	the	DT
cord-005453-4057qib7	7220	23	bone	bone	NN
cord-005453-4057qib7	7220	24	marrow	marrow	NN
cord-005453-4057qib7	7220	25	and	and	CC
cord-005453-4057qib7	7220	26	extramedullary	extramedullary	NNP
cord-005453-4057qib7	7220	27	hematopoesis	hematopoesis	NNP
cord-005453-4057qib7	7220	28	occurs	occur	VBZ
cord-005453-4057qib7	7220	29	.	.	.
cord-005453-4057qib7	7221	1	Patients	patient	NNS
cord-005453-4057qib7	7221	2	require	require	VBP
cord-005453-4057qib7	7221	3	regular	regular	JJ
cord-005453-4057qib7	7221	4	transfusion	transfusion	NN
cord-005453-4057qib7	7221	5	therapy	therapy	NN
cord-005453-4057qib7	7221	6	lifelong	lifelong	NN
cord-005453-4057qib7	7221	7	.	.	.
cord-005453-4057qib7	7222	1	Currently	currently	RB
cord-005453-4057qib7	7222	2	,	,	,
cord-005453-4057qib7	7222	3	the	the	DT
cord-005453-4057qib7	7222	4	only	only	JJ
cord-005453-4057qib7	7222	5	proven	prove	VBN
cord-005453-4057qib7	7222	6	curative	curative	JJ
cord-005453-4057qib7	7222	7	treatment	treatment	NN
cord-005453-4057qib7	7222	8	of	of	IN
cord-005453-4057qib7	7222	9	thalassemia	thalassemia	NN
cord-005453-4057qib7	7222	10	is	be	VBZ
cord-005453-4057qib7	7222	11	allogeneic	allogeneic	IN
cord-005453-4057qib7	7222	12	stem	stem	NN
cord-005453-4057qib7	7222	13	cell	cell	NN
cord-005453-4057qib7	7222	14	transplantation	transplantation	NN
cord-005453-4057qib7	7222	15	(	(	-LRB-
cord-005453-4057qib7	7222	16	SCT	SCT	NNP
cord-005453-4057qib7	7222	17	)	)	-RRB-
cord-005453-4057qib7	7222	18	.	.	.
cord-005453-4057qib7	7223	1	Methods	method	NNS
cord-005453-4057qib7	7223	2	:	:	:
cord-005453-4057qib7	7223	3	We	-PRON-	PRP
cord-005453-4057qib7	7223	4	evaluated	evaluate	VBD
cord-005453-4057qib7	7223	5	the	the	DT
cord-005453-4057qib7	7223	6	immune	immune	JJ
cord-005453-4057qib7	7223	7	reconstitution	reconstitution	NN
cord-005453-4057qib7	7223	8	results	result	NNS
cord-005453-4057qib7	7223	9	of	of	IN
cord-005453-4057qib7	7223	10	23	23	CD
cord-005453-4057qib7	7223	11	patients	patient	NNS
cord-005453-4057qib7	7223	12	at	at	IN
cord-005453-4057qib7	7223	13	1	1	CD
cord-005453-4057qib7	7223	14	year	year	NN
cord-005453-4057qib7	7223	15	after	after	IN
cord-005453-4057qib7	7223	16	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	7223	17	stem	stem	NN
cord-005453-4057qib7	7223	18	cell	cell	NN
cord-005453-4057qib7	7223	19	transplantation	transplantation	NN
cord-005453-4057qib7	7223	20	at	at	IN
cord-005453-4057qib7	7223	21	our	-PRON-	PRP$
cord-005453-4057qib7	7223	22	pediatric	pediatric	JJ
cord-005453-4057qib7	7223	23	bone	bone	NN
cord-005453-4057qib7	7223	24	marrow	marrow	NN
cord-005453-4057qib7	7223	25	transplantation	transplantation	NN
cord-005453-4057qib7	7223	26	center	center	NN
cord-005453-4057qib7	7223	27	between	between	IN
cord-005453-4057qib7	7223	28	January	January	NNP
cord-005453-4057qib7	7223	29	2015	2015	CD
cord-005453-4057qib7	7223	30	and	and	CC
cord-005453-4057qib7	7223	31	December	December	NNP
cord-005453-4057qib7	7223	32	2018	2018	CD
cord-005453-4057qib7	7223	33	.	.	.
cord-005453-4057qib7	7224	1	All	all	DT
cord-005453-4057qib7	7224	2	patients	patient	NNS
cord-005453-4057qib7	7224	3	were	be	VBD
cord-005453-4057qib7	7224	4	not	not	RB
cord-005453-4057qib7	7224	5	receiving	receive	VBG
cord-005453-4057qib7	7224	6	any	any	DT
cord-005453-4057qib7	7224	7	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	7224	8	treatment	treatment	NN
cord-005453-4057qib7	7224	9	at	at	IN
cord-005453-4057qib7	7224	10	least	least	JJS
cord-005453-4057qib7	7224	11	for	for	IN
cord-005453-4057qib7	7224	12	3	3	CD
cord-005453-4057qib7	7224	13	months	month	NNS
cord-005453-4057qib7	7224	14	and	and	CC
cord-005453-4057qib7	7224	15	they	-PRON-	PRP
cord-005453-4057qib7	7224	16	have	have	VBP
cord-005453-4057qib7	7224	17	normal	normal	JJ
cord-005453-4057qib7	7224	18	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7224	19	counts	count	NNS
cord-005453-4057qib7	7224	20	,	,	,
cord-005453-4057qib7	7224	21	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	7224	22	levels	level	NNS
cord-005453-4057qib7	7224	23	and	and	CC
cord-005453-4057qib7	7224	24	transfusion	transfusion	NN
cord-005453-4057qib7	7224	25	independent	independent	JJ
cord-005453-4057qib7	7224	26	.	.	.
cord-005453-4057qib7	7225	1	Lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7225	2	subtypes	subtype	NNS
cord-005453-4057qib7	7225	3	and	and	CC
cord-005453-4057qib7	7225	4	chimerism	chimerism	NN
cord-005453-4057qib7	7225	5	percentages	percentage	NNS
cord-005453-4057qib7	7225	6	and	and	CC
cord-005453-4057qib7	7225	7	the	the	DT
cord-005453-4057qib7	7225	8	relationship	relationship	NN
cord-005453-4057qib7	7225	9	with	with	IN
cord-005453-4057qib7	7225	10	the	the	DT
cord-005453-4057qib7	7225	11	donor	donor	NN
cord-005453-4057qib7	7225	12	type	type	NN
cord-005453-4057qib7	7225	13	were	be	VBD
cord-005453-4057qib7	7225	14	evaluated	evaluate	VBN
cord-005453-4057qib7	7225	15	at	at	IN
cord-005453-4057qib7	7225	16	1	1	CD
cord-005453-4057qib7	7225	17	year	year	NN
cord-005453-4057qib7	7225	18	of	of	IN
cord-005453-4057qib7	7225	19	transplantation	transplantation	NN
cord-005453-4057qib7	7225	20	.	.	.
cord-005453-4057qib7	7226	1	Results	result	NNS
cord-005453-4057qib7	7226	2	:	:	:
cord-005453-4057qib7	7227	1	Ages	age	NNS
cord-005453-4057qib7	7227	2	of	of	IN
cord-005453-4057qib7	7227	3	transplantation	transplantation	NN
cord-005453-4057qib7	7227	4	was	be	VBD
cord-005453-4057qib7	7227	5	ranged	range	VBN
cord-005453-4057qib7	7227	6	between	between	IN
cord-005453-4057qib7	7227	7	1	1	CD
cord-005453-4057qib7	7227	8	-	-	SYM
cord-005453-4057qib7	7227	9	17	17	CD
cord-005453-4057qib7	7227	10	years	year	NNS
cord-005453-4057qib7	7227	11	(	(	-LRB-
cord-005453-4057qib7	7227	12	Median	median	NN
cord-005453-4057qib7	7227	13	:	:	:
cord-005453-4057qib7	7227	14	5	5	CD
cord-005453-4057qib7	7227	15	years	year	NNS
cord-005453-4057qib7	7227	16	)	)	-RRB-
cord-005453-4057qib7	7227	17	.	.	.
cord-005453-4057qib7	7228	1	Seven	seven	CD
cord-005453-4057qib7	7228	2	(	(	-LRB-
cord-005453-4057qib7	7228	3	30	30	CD
cord-005453-4057qib7	7228	4	%	%	NN
cord-005453-4057qib7	7228	5	)	)	-RRB-
cord-005453-4057qib7	7228	6	of	of	IN
cord-005453-4057qib7	7228	7	them	-PRON-	PRP
cord-005453-4057qib7	7228	8	was	be	VBD
cord-005453-4057qib7	7228	9	male	male	JJ
cord-005453-4057qib7	7228	10	.	.	.
cord-005453-4057qib7	7229	1	Matched	matched	JJ
cord-005453-4057qib7	7229	2	unrelated	unrelated	JJ
cord-005453-4057qib7	7229	3	donor	donor	NN
cord-005453-4057qib7	7229	4	type	type	NN
cord-005453-4057qib7	7229	5	was	be	VBD
cord-005453-4057qib7	7229	6	chosen	choose	VBN
cord-005453-4057qib7	7229	7	in	in	IN
cord-005453-4057qib7	7229	8	7	7	CD
cord-005453-4057qib7	7229	9	patients	patient	NNS
cord-005453-4057qib7	7229	10	while	while	IN
cord-005453-4057qib7	7229	11	others	other	NNS
cord-005453-4057qib7	7229	12	(	(	-LRB-
cord-005453-4057qib7	7229	13	16	16	CD
cord-005453-4057qib7	7229	14	patients	patient	NNS
cord-005453-4057qib7	7229	15	)	)	-RRB-
cord-005453-4057qib7	7229	16	were	be	VBD
cord-005453-4057qib7	7229	17	transplanted	transplant	VBN
cord-005453-4057qib7	7229	18	from	from	IN
cord-005453-4057qib7	7229	19	family	family	NN
cord-005453-4057qib7	7229	20	matched	match	VBN
cord-005453-4057qib7	7229	21	donor	donor	NN
cord-005453-4057qib7	7229	22	(	(	-LRB-
cord-005453-4057qib7	7229	23	Matched	match	VBN
cord-005453-4057qib7	7229	24	sibling	sibling	NN
cord-005453-4057qib7	7229	25	:	:	:
cord-005453-4057qib7	7229	26	9	9	CD
cord-005453-4057qib7	7229	27	patients	patient	NNS
cord-005453-4057qib7	7229	28	,	,	,
cord-005453-4057qib7	7229	29	Matched	match	VBN
cord-005453-4057qib7	7229	30	family	family	NN
cord-005453-4057qib7	7229	31	:	:	:
cord-005453-4057qib7	7229	32	7	7	CD
cord-005453-4057qib7	7229	33	patients	patient	NNS
cord-005453-4057qib7	7229	34	)	)	-RRB-
cord-005453-4057qib7	7229	35	.	.	.
cord-005453-4057qib7	7230	1	All	all	DT
cord-005453-4057qib7	7230	2	patients	patient	NNS
cord-005453-4057qib7	7230	3	received	receive	VBD
cord-005453-4057qib7	7230	4	myeloablative	myeloablative	NNP
cord-005453-4057qib7	7230	5	conditioning	conditioning	NN
cord-005453-4057qib7	7230	6	regimen	regimen	NN
cord-005453-4057qib7	7230	7	containing	contain	VBG
cord-005453-4057qib7	7230	8	busulfan	busulfan	NN
cord-005453-4057qib7	7230	9	/	/	SYM
cord-005453-4057qib7	7230	10	treosulfan	treosulfan	NNP
cord-005453-4057qib7	7230	11	,	,	,
cord-005453-4057qib7	7230	12	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	7230	13	,	,	,
cord-005453-4057qib7	7230	14	thiotepa	thiotepa	NN
cord-005453-4057qib7	7230	15	and	and	CC
cord-005453-4057qib7	7230	16	fludarabine	fludarabine	NN
cord-005453-4057qib7	7230	17	.	.	.
cord-005453-4057qib7	7231	1	Follow	follow	VB
cord-005453-4057qib7	7231	2	up	up	RP
cord-005453-4057qib7	7231	3	time	time	NN
cord-005453-4057qib7	7231	4	was	be	VBD
cord-005453-4057qib7	7231	5	between	between	IN
cord-005453-4057qib7	7231	6	12	12	CD
cord-005453-4057qib7	7231	7	-	-	SYM
cord-005453-4057qib7	7231	8	47	47	CD
cord-005453-4057qib7	7231	9	months	month	NNS
cord-005453-4057qib7	7232	1	(	(	-LRB-
cord-005453-4057qib7	7232	2	Mean	mean	JJ
cord-005453-4057qib7	7232	3	:	:	:
cord-005453-4057qib7	7232	4	24	24	CD
cord-005453-4057qib7	7232	5	±	±	CD
cord-005453-4057qib7	7232	6	10	10	CD
cord-005453-4057qib7	7232	7	months	month	NNS
cord-005453-4057qib7	7232	8	)	)	-RRB-
cord-005453-4057qib7	7232	9	.	.	.
cord-005453-4057qib7	7233	1	In	in	IN
cord-005453-4057qib7	7233	2	9	9	CD
cord-005453-4057qib7	7233	3	patients	patient	NNS
cord-005453-4057qib7	7233	4	,	,	,
cord-005453-4057qib7	7233	5	whole	whole	JJ
cord-005453-4057qib7	7233	6	bone	bone	NN
cord-005453-4057qib7	7233	7	marrow	marrow	NN
cord-005453-4057qib7	7233	8	product	product	NN
cord-005453-4057qib7	7233	9	was	be	VBD
cord-005453-4057qib7	7233	10	used	use	VBN
cord-005453-4057qib7	7233	11	while	while	IN
cord-005453-4057qib7	7233	12	peripheral	peripheral	JJ
cord-005453-4057qib7	7233	13	stem	stem	NN
cord-005453-4057qib7	7233	14	cell	cell	NN
cord-005453-4057qib7	7233	15	harvest	harvest	NN
cord-005453-4057qib7	7233	16	in	in	IN
cord-005453-4057qib7	7233	17	remaining	remain	VBG
cord-005453-4057qib7	7233	18	patients	patient	NNS
cord-005453-4057qib7	7233	19	.	.	.
cord-005453-4057qib7	7234	1	CD3	CD3	NNP
cord-005453-4057qib7	7234	2	levels	level	NNS
cord-005453-4057qib7	7234	3	were	be	VBD
cord-005453-4057qib7	7234	4	found	find	VBN
cord-005453-4057qib7	7234	5	low	low	JJ
cord-005453-4057qib7	7234	6	in	in	IN
cord-005453-4057qib7	7234	7	only	only	RB
cord-005453-4057qib7	7234	8	4	4	CD
cord-005453-4057qib7	7234	9	patients	patient	NNS
cord-005453-4057qib7	7234	10	,	,	,
cord-005453-4057qib7	7234	11	in	in	IN
cord-005453-4057qib7	7234	12	normal	normal	JJ
cord-005453-4057qib7	7234	13	patients	patient	NNS
cord-005453-4057qib7	7234	14	mean	mean	JJ
cord-005453-4057qib7	7234	15	was	be	VBD
cord-005453-4057qib7	7234	16	59	59	CD
cord-005453-4057qib7	7234	17	%	%	NN
cord-005453-4057qib7	7234	18	±	±	CD
cord-005453-4057qib7	7234	19	14	14	CD
cord-005453-4057qib7	7234	20	%	%	NN
cord-005453-4057qib7	7234	21	.	.	.
cord-005453-4057qib7	7235	1	CD4	CD4	NNP
cord-005453-4057qib7	7235	2	levels	level	NNS
cord-005453-4057qib7	7235	3	were	be	VBD
cord-005453-4057qib7	7235	4	severely	severely	RB
cord-005453-4057qib7	7235	5	low	low	JJ
cord-005453-4057qib7	7235	6	in	in	IN
cord-005453-4057qib7	7235	7	18	18	CD
cord-005453-4057qib7	7235	8	patients	patient	NNS
cord-005453-4057qib7	7235	9	while	while	IN
cord-005453-4057qib7	7235	10	CD8	CD8	NNP
cord-005453-4057qib7	7235	11	in	in	IN
cord-005453-4057qib7	7235	12	only	only	RB
cord-005453-4057qib7	7235	13	1	1	CD
cord-005453-4057qib7	7235	14	patient	patient	NN
cord-005453-4057qib7	7235	15	.	.	.
cord-005453-4057qib7	7236	1	CD8	CD8	NNP
cord-005453-4057qib7	7236	2	levels	level	NNS
cord-005453-4057qib7	7236	3	were	be	VBD
cord-005453-4057qib7	7236	4	increased	increase	VBN
cord-005453-4057qib7	7236	5	in	in	IN
cord-005453-4057qib7	7236	6	total	total	JJ
cord-005453-4057qib7	7236	7	13	13	CD
cord-005453-4057qib7	7236	8	patients	patient	NNS
cord-005453-4057qib7	7236	9	in	in	IN
cord-005453-4057qib7	7236	10	as	as	RB
cord-005453-4057qib7	7236	11	compensatory	compensatory	JJ
cord-005453-4057qib7	7236	12	.	.	.
cord-005453-4057qib7	7237	1	CD4	CD4	NNP
cord-005453-4057qib7	7237	2	/	/	SYM
cord-005453-4057qib7	7237	3	CD8	CD8	NNP
cord-005453-4057qib7	7237	4	ratios	ratio	NNS
cord-005453-4057qib7	7237	5	were	be	VBD
cord-005453-4057qib7	7237	6	very	very	RB
cord-005453-4057qib7	7237	7	low	low	JJ
cord-005453-4057qib7	7237	8	in	in	IN
cord-005453-4057qib7	7237	9	all	all	DT
cord-005453-4057qib7	7237	10	patients	patient	NNS
cord-005453-4057qib7	7237	11	(	(	-LRB-
cord-005453-4057qib7	7237	12	Range	range	NN
cord-005453-4057qib7	7237	13	:	:	:
cord-005453-4057qib7	7237	14	0.2	0.2	CD
cord-005453-4057qib7	7237	15	-	-	SYM
cord-005453-4057qib7	7237	16	0.7	0.7	CD
cord-005453-4057qib7	7237	17	)	)	-RRB-
cord-005453-4057qib7	7237	18	.	.	.
cord-005453-4057qib7	7238	1	B	b	NN
cord-005453-4057qib7	7238	2	cells	cell	NNS
cord-005453-4057qib7	7238	3	(	(	-LRB-
cord-005453-4057qib7	7238	4	CD19	CD19	NNP
cord-005453-4057qib7	7238	5	+	+	CC
cord-005453-4057qib7	7238	6	)	)	-RRB-
cord-005453-4057qib7	7238	7	were	be	VBD
cord-005453-4057qib7	7238	8	low	low	JJ
cord-005453-4057qib7	7238	9	in	in	IN
cord-005453-4057qib7	7238	10	3	3	CD
cord-005453-4057qib7	7238	11	patients	patient	NNS
cord-005453-4057qib7	7238	12	while	while	IN
cord-005453-4057qib7	7238	13	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	7238	14	levels	level	NNS
cord-005453-4057qib7	7238	15	were	be	VBD
cord-005453-4057qib7	7238	16	normal	normal	JJ
cord-005453-4057qib7	7238	17	.	.	.
cord-005453-4057qib7	7239	1	Chimerism	chimerism	NN
cord-005453-4057qib7	7239	2	values	value	NNS
cord-005453-4057qib7	7239	3	between	between	IN
cord-005453-4057qib7	7239	4	55	55	CD
cord-005453-4057qib7	7239	5	-	-	SYM
cord-005453-4057qib7	7239	6	99	99	CD
cord-005453-4057qib7	7239	7	%	%	NN
cord-005453-4057qib7	7240	1	(	(	-LRB-
cord-005453-4057qib7	7240	2	Mean	mean	JJ
cord-005453-4057qib7	7240	3	:	:	:
cord-005453-4057qib7	7240	4	93	93	CD
cord-005453-4057qib7	7240	5	±	±	CD
cord-005453-4057qib7	7240	6	11	11	CD
cord-005453-4057qib7	7240	7	%	%	NN
cord-005453-4057qib7	7240	8	)	)	-RRB-
cord-005453-4057qib7	7240	9	.	.	.
cord-005453-4057qib7	7241	1	Donor	donor	NN
cord-005453-4057qib7	7241	2	and	and	CC
cord-005453-4057qib7	7241	3	product	product	NN
cord-005453-4057qib7	7241	4	types	type	NNS
cord-005453-4057qib7	7241	5	did	do	VBD
cord-005453-4057qib7	7241	6	not	not	RB
cord-005453-4057qib7	7241	7	differ	differ	VB
cord-005453-4057qib7	7241	8	in	in	IN
cord-005453-4057qib7	7241	9	CD3	CD3	NNP
cord-005453-4057qib7	7241	10	+	+	CC
cord-005453-4057qib7	7241	11	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7241	12	reconstitution	reconstitution	NN
cord-005453-4057qib7	7241	13	at	at	IN
cord-005453-4057qib7	7241	14	1	1	CD
cord-005453-4057qib7	7241	15	year	year	NN
cord-005453-4057qib7	7242	1	(	(	-LRB-
cord-005453-4057qib7	7242	2	p=0.15	p=0.15	NNP
cord-005453-4057qib7	7242	3	,	,	,
cord-005453-4057qib7	7242	4	P=042	p=042	NN
cord-005453-4057qib7	7242	5	respectively	respectively	RB
cord-005453-4057qib7	7242	6	)	)	-RRB-
cord-005453-4057qib7	7242	7	.	.	.
cord-005453-4057qib7	7243	1	All	all	DT
cord-005453-4057qib7	7243	2	patients	patient	NNS
cord-005453-4057qib7	7243	3	were	be	VBD
cord-005453-4057qib7	7243	4	alive	alive	JJ
cord-005453-4057qib7	7243	5	and	and	CC
cord-005453-4057qib7	7243	6	well	well	RB
cord-005453-4057qib7	7243	7	at	at	IN
cord-005453-4057qib7	7243	8	1	1	CD
cord-005453-4057qib7	7243	9	year	year	NN
cord-005453-4057qib7	7243	10	after	after	IN
cord-005453-4057qib7	7243	11	transplantation	transplantation	NN
cord-005453-4057qib7	7243	12	.	.	.
cord-005453-4057qib7	7244	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7244	2	:	:	:
cord-005453-4057qib7	7245	1	After	after	IN
cord-005453-4057qib7	7245	2	1	1	CD
cord-005453-4057qib7	7245	3	year	year	NN
cord-005453-4057qib7	7245	4	of	of	IN
cord-005453-4057qib7	7245	5	transplantation	transplantation	NN
cord-005453-4057qib7	7245	6	,	,	,
cord-005453-4057qib7	7245	7	although	although	IN
cord-005453-4057qib7	7245	8	patients	patient	NNS
cord-005453-4057qib7	7245	9	are	be	VBP
cord-005453-4057qib7	7245	10	in	in	IN
cord-005453-4057qib7	7245	11	well	well	JJ
cord-005453-4057qib7	7245	12	condition	condition	NN
cord-005453-4057qib7	7245	13	regarding	regard	VBG
cord-005453-4057qib7	7245	14	to	to	IN
cord-005453-4057qib7	7245	15	infection	infection	NN
cord-005453-4057qib7	7245	16	frequency	frequency	NN
cord-005453-4057qib7	7245	17	and	and	CC
cord-005453-4057qib7	7245	18	transfussion	transfussion	NN
cord-005453-4057qib7	7245	19	dependency	dependency	NN
cord-005453-4057qib7	7245	20	,	,	,
cord-005453-4057qib7	7245	21	it	-PRON-	PRP
cord-005453-4057qib7	7245	22	was	be	VBD
cord-005453-4057qib7	7245	23	seen	see	VBN
cord-005453-4057qib7	7245	24	that	that	IN
cord-005453-4057qib7	7245	25	their	-PRON-	PRP$
cord-005453-4057qib7	7245	26	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7245	27	subtypes	subtype	NNS
cord-005453-4057qib7	7245	28	reconstitution	reconstitution	NN
cord-005453-4057qib7	7245	29	could	could	MD
cord-005453-4057qib7	7245	30	not	not	RB
cord-005453-4057qib7	7245	31	be	be	VB
cord-005453-4057qib7	7245	32	achieved	achieve	VBN
cord-005453-4057qib7	7245	33	enough	enough	RB
cord-005453-4057qib7	7245	34	as	as	IN
cord-005453-4057qib7	7245	35	in	in	IN
cord-005453-4057qib7	7245	36	normal	normal	JJ
cord-005453-4057qib7	7245	37	children	child	NNS
cord-005453-4057qib7	7245	38	.	.	.
cord-005453-4057qib7	7246	1	We	-PRON-	PRP
cord-005453-4057qib7	7246	2	can	can	MD
cord-005453-4057qib7	7246	3	conclude	conclude	VB
cord-005453-4057qib7	7246	4	that	that	IN
cord-005453-4057qib7	7246	5	low	low	JJ
cord-005453-4057qib7	7246	6	CD4	CD4	NNP
cord-005453-4057qib7	7246	7	+	+	CC
cord-005453-4057qib7	7246	8	cell	cell	NN
cord-005453-4057qib7	7246	9	levels	level	NNS
cord-005453-4057qib7	7246	10	were	be	VBD
cord-005453-4057qib7	7246	11	an	an	DT
cord-005453-4057qib7	7246	12	expected	expect	VBN
cord-005453-4057qib7	7246	13	finding	finding	NN
cord-005453-4057qib7	7246	14	in	in	IN
cord-005453-4057qib7	7246	15	almost	almost	RB
cord-005453-4057qib7	7246	16	all	all	DT
cord-005453-4057qib7	7246	17	patients	patient	NNS
cord-005453-4057qib7	7246	18	.	.	.
cord-005453-4057qib7	7247	1	So	so	RB
cord-005453-4057qib7	7247	2	,	,	,
cord-005453-4057qib7	7247	3	these	these	DT
cord-005453-4057qib7	7247	4	patients	patient	NNS
cord-005453-4057qib7	7247	5	may	may	MD
cord-005453-4057qib7	7247	6	have	have	VB
cord-005453-4057qib7	7247	7	a	a	DT
cord-005453-4057qib7	7247	8	tendency	tendency	NN
cord-005453-4057qib7	7247	9	to	to	TO
cord-005453-4057qib7	7247	10	suffer	suffer	VB
cord-005453-4057qib7	7247	11	serious	serious	JJ
cord-005453-4057qib7	7247	12	bacterial	bacterial	JJ
cord-005453-4057qib7	7247	13	and	and	CC
cord-005453-4057qib7	7247	14	viral	viral	JJ
cord-005453-4057qib7	7247	15	infections	infection	NNS
cord-005453-4057qib7	7247	16	,	,	,
cord-005453-4057qib7	7247	17	and	and	CC
cord-005453-4057qib7	7247	18	close	close	VB
cord-005453-4057qib7	7247	19	follow	follow	NN
cord-005453-4057qib7	7247	20	up	up	RP
cord-005453-4057qib7	7247	21	be	be	VB
cord-005453-4057qib7	7247	22	required	require	VBN
cord-005453-4057qib7	7247	23	in	in	IN
cord-005453-4057qib7	7247	24	terms	term	NNS
cord-005453-4057qib7	7247	25	of	of	IN
cord-005453-4057qib7	7247	26	infections	infection	NNS
cord-005453-4057qib7	7247	27	as	as	RB
cord-005453-4057qib7	7247	28	long	long	RB
cord-005453-4057qib7	7247	29	as	as	IN
cord-005453-4057qib7	7247	30	CD4	CD4	NNP
cord-005453-4057qib7	7247	31	levels	level	NNS
cord-005453-4057qib7	7247	32	continue	continue	VBP
cord-005453-4057qib7	7247	33	to	to	TO
cord-005453-4057qib7	7247	34	be	be	VB
cord-005453-4057qib7	7247	35	low	low	JJ
cord-005453-4057qib7	7247	36	.	.	.
cord-005453-4057qib7	7248	1	Immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	7248	2	replacement	replacement	NN
cord-005453-4057qib7	7248	3	therapy	therapy	NN
cord-005453-4057qib7	7248	4	did	do	VBD
cord-005453-4057qib7	7248	5	not	not	RB
cord-005453-4057qib7	7248	6	required	require	VBN
cord-005453-4057qib7	7248	7	even	even	RB
cord-005453-4057qib7	7248	8	in	in	IN
cord-005453-4057qib7	7248	9	patients	patient	NNS
cord-005453-4057qib7	7248	10	with	with	IN
cord-005453-4057qib7	7248	11	low	low	JJ
cord-005453-4057qib7	7248	12	B	b	NN
cord-005453-4057qib7	7248	13	cell	cell	NN
cord-005453-4057qib7	7248	14	levels	level	NNS
cord-005453-4057qib7	7248	15	.	.	.
cord-005453-4057qib7	7249	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7249	2	:	:	:
cord-005453-4057qib7	7249	3	Nothing	nothing	NN
cord-005453-4057qib7	7249	4	to	to	TO
cord-005453-4057qib7	7249	5	declare	declare	VB
cord-005453-4057qib7	7249	6	P328	P328	NNP
cord-005453-4057qib7	7249	7	Phase	phase	NN
cord-005453-4057qib7	7249	8	2	2	CD
cord-005453-4057qib7	7249	9	international	international	JJ
cord-005453-4057qib7	7249	10	,	,	,
cord-005453-4057qib7	7249	11	multicentre	multicentre	NNP
cord-005453-4057qib7	7249	12	trial	trial	NN
cord-005453-4057qib7	7249	13	to	to	TO
cord-005453-4057qib7	7249	14	assess	assess	VB
cord-005453-4057qib7	7249	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7249	16	Aß	Aß	NNP
cord-005453-4057qib7	7249	17	T	t	NN
cord-005453-4057qib7	7249	18	-	-	HYPH
cord-005453-4057qib7	7249	19	cell	cell	NN
cord-005453-4057qib7	7249	20	depleted	deplete	VBN
cord-005453-4057qib7	7249	21	stem	stem	NN
cord-005453-4057qib7	7249	22	cell	cell	NN
cord-005453-4057qib7	7249	23	transplantation	transplantation	NN
cord-005453-4057qib7	7249	24	in	in	IN
cord-005453-4057qib7	7249	25	patients	patient	NNS
cord-005453-4057qib7	7249	26	with	with	IN
cord-005453-4057qib7	7249	27	sickle	sickle	NN
cord-005453-4057qib7	7249	28	cell	cell	NN
cord-005453-4057qib7	7249	29	disease	disease	NN
cord-005453-4057qib7	7249	30	with	with	IN
cord-005453-4057qib7	7249	31	no	no	DT
cord-005453-4057qib7	7249	32	available	available	JJ
cord-005453-4057qib7	7249	33	sibling	sibling	NN
cord-005453-4057qib7	7249	34	donor	donor	NN
cord-005453-4057qib7	7249	35	Background	background	NN
cord-005453-4057qib7	7249	36	:	:	:
cord-005453-4057qib7	7250	1	Sickle	sickle	NN
cord-005453-4057qib7	7250	2	cell	cell	NN
cord-005453-4057qib7	7250	3	disease	disease	NN
cord-005453-4057qib7	7250	4	(	(	-LRB-
cord-005453-4057qib7	7250	5	SCD	SCD	NNP
cord-005453-4057qib7	7250	6	)	)	-RRB-
cord-005453-4057qib7	7250	7	is	be	VBZ
cord-005453-4057qib7	7250	8	an	an	DT
cord-005453-4057qib7	7250	9	inherited	inherit	VBN
cord-005453-4057qib7	7250	10	disorder	disorder	NN
cord-005453-4057qib7	7250	11	with	with	IN
cord-005453-4057qib7	7250	12	an	an	DT
cord-005453-4057qib7	7250	13	estimate	estimate	NN
cord-005453-4057qib7	7250	14	of	of	IN
cord-005453-4057qib7	7250	15	300,000	300,000	CD
cord-005453-4057qib7	7250	16	affected	affect	VBN
cord-005453-4057qib7	7250	17	newborns	newborn	NNS
cord-005453-4057qib7	7250	18	per	per	IN
cord-005453-4057qib7	7250	19	year	year	NN
cord-005453-4057qib7	7250	20	worldwide	worldwide	RB
cord-005453-4057qib7	7250	21	.	.	.
cord-005453-4057qib7	7251	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	7251	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7251	3	stem	stem	NN
cord-005453-4057qib7	7251	4	cell	cell	NN
cord-005453-4057qib7	7251	5	transplantation	transplantation	NN
cord-005453-4057qib7	7251	6	(	(	-LRB-
cord-005453-4057qib7	7251	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7251	8	)	)	-RRB-
cord-005453-4057qib7	7251	9	with	with	IN
cord-005453-4057qib7	7251	10	a	a	DT
cord-005453-4057qib7	7251	11	matched	match	VBN
cord-005453-4057qib7	7251	12	sibling	sibling	NN
cord-005453-4057qib7	7251	13	donor	donor	NN
cord-005453-4057qib7	7251	14	(	(	-LRB-
cord-005453-4057qib7	7251	15	MSD	MSD	NNP
cord-005453-4057qib7	7251	16	)	)	-RRB-
cord-005453-4057qib7	7251	17	is	be	VBZ
cord-005453-4057qib7	7251	18	currently	currently	RB
cord-005453-4057qib7	7251	19	the	the	DT
cord-005453-4057qib7	7251	20	curative	curative	JJ
cord-005453-4057qib7	7251	21	standard	standard	NN
cord-005453-4057qib7	7251	22	of	of	IN
cord-005453-4057qib7	7251	23	care	care	NN
cord-005453-4057qib7	7251	24	for	for	IN
cord-005453-4057qib7	7251	25	SCD	SCD	NNP
cord-005453-4057qib7	7251	26	patients	patient	NNS
cord-005453-4057qib7	7251	27	(	(	-LRB-
cord-005453-4057qib7	7251	28	pts	pts	NNP
cord-005453-4057qib7	7251	29	)	)	-RRB-
cord-005453-4057qib7	7251	30	.	.	.
cord-005453-4057qib7	7252	1	However	however	RB
cord-005453-4057qib7	7252	2	,	,	,
cord-005453-4057qib7	7252	3	MSD	MSD	NNP
cord-005453-4057qib7	7252	4	availability	availability	NN
cord-005453-4057qib7	7252	5	is	be	VBZ
cord-005453-4057qib7	7252	6	<	<	XX
cord-005453-4057qib7	7252	7	20	20	CD
cord-005453-4057qib7	7252	8	%	%	NN
cord-005453-4057qib7	7252	9	.	.	.
cord-005453-4057qib7	7253	1	A	a	DT
cord-005453-4057qib7	7253	2	T	t	NN
cord-005453-4057qib7	7253	3	-	-	HYPH
cord-005453-4057qib7	7253	4	cell	cell	NN
cord-005453-4057qib7	7253	5	depleted	deplete	VBN
cord-005453-4057qib7	7253	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7253	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7254	1	(	(	-LRB-
cord-005453-4057qib7	7254	2	T	t	NN
cord-005453-4057qib7	7254	3	-	-	HYPH
cord-005453-4057qib7	7254	4	haplo	haplo	NNP
cord-005453-4057qib7	7254	5	-	-	HYPH
cord-005453-4057qib7	7254	6	HSCT	HSCT	NNP
cord-005453-4057qib7	7254	7	)	)	-RRB-
cord-005453-4057qib7	7254	8	from	from	IN
cord-005453-4057qib7	7254	9	a	a	DT
cord-005453-4057qib7	7254	10	relative	relative	NN
cord-005453-4057qib7	7254	11	,	,	,
cord-005453-4057qib7	7254	12	mostly	mostly	RB
cord-005453-4057qib7	7254	13	a	a	DT
cord-005453-4057qib7	7254	14	parent	parent	NN
cord-005453-4057qib7	7254	15	,	,	,
cord-005453-4057qib7	7254	16	expands	expand	VBZ
cord-005453-4057qib7	7254	17	the	the	DT
cord-005453-4057qib7	7254	18	donor	donor	NN
cord-005453-4057qib7	7254	19	availability	availability	NN
cord-005453-4057qib7	7254	20	while	while	IN
cord-005453-4057qib7	7254	21	exhibiting	exhibit	VBG
cord-005453-4057qib7	7254	22	low	low	JJ
cord-005453-4057qib7	7254	23	GvHD	gvhd	NN
cord-005453-4057qib7	7254	24	rates	rate	NNS
cord-005453-4057qib7	7254	25	and	and	CC
cord-005453-4057qib7	7254	26	thus	thus	RB
cord-005453-4057qib7	7254	27	could	could	MD
cord-005453-4057qib7	7254	28	offer	offer	VB
cord-005453-4057qib7	7254	29	cure	cure	NN
cord-005453-4057qib7	7254	30	to	to	IN
cord-005453-4057qib7	7254	31	the	the	DT
cord-005453-4057qib7	7254	32	remaining	remain	VBG
cord-005453-4057qib7	7254	33	80	80	CD
cord-005453-4057qib7	7254	34	%	%	NN
cord-005453-4057qib7	7254	35	of	of	IN
cord-005453-4057qib7	7254	36	SCD	SCD	NNP
cord-005453-4057qib7	7254	37	patients	patient	NNS
cord-005453-4057qib7	7254	38	.	.	.
cord-005453-4057qib7	7255	1	In	in	IN
cord-005453-4057qib7	7255	2	a	a	DT
cord-005453-4057qib7	7255	3	pilot	pilot	NN
cord-005453-4057qib7	7255	4	study	study	NN
cord-005453-4057qib7	7255	5	,	,	,
cord-005453-4057qib7	7255	6	comparing	compare	VBG
cord-005453-4057qib7	7255	7	T	t	NN
cord-005453-4057qib7	7255	8	-	-	HYPH
cord-005453-4057qib7	7255	9	haplo	haplo	NNP
cord-005453-4057qib7	7255	10	-	-	HYPH
cord-005453-4057qib7	7255	11	HSCT	HSCT	NNP
cord-005453-4057qib7	7255	12	with	with	IN
cord-005453-4057qib7	7255	13	MSD	MSD	NNP
cord-005453-4057qib7	7255	14	HSCT	HSCT	NNP
cord-005453-4057qib7	7255	15	in	in	IN
cord-005453-4057qib7	7255	16	advanced	advanced	JJ
cord-005453-4057qib7	7255	17	stage	stage	NN
cord-005453-4057qib7	7255	18	SCD	SCD	NNP
cord-005453-4057qib7	7255	19	,	,	,
cord-005453-4057qib7	7255	20	using	use	VBG
cord-005453-4057qib7	7255	21	almost	almost	RB
cord-005453-4057qib7	7255	22	identical	identical	JJ
cord-005453-4057qib7	7255	23	transplant	transplant	NN
cord-005453-4057qib7	7255	24	regimens	regimen	NNS
cord-005453-4057qib7	7255	25	for	for	IN
cord-005453-4057qib7	7255	26	both	both	DT
cord-005453-4057qib7	7255	27	.	.	.
cord-005453-4057qib7	7256	1	The	the	DT
cord-005453-4057qib7	7256	2	overall	overall	JJ
cord-005453-4057qib7	7256	3	(	(	-LRB-
cord-005453-4057qib7	7256	4	OS	OS	NNP
cord-005453-4057qib7	7256	5	)	)	-RRB-
cord-005453-4057qib7	7256	6	and	and	CC
cord-005453-4057qib7	7256	7	disease	disease	NN
cord-005453-4057qib7	7256	8	-	-	HYPH
cord-005453-4057qib7	7256	9	free	free	JJ
cord-005453-4057qib7	7256	10	survival	survival	NN
cord-005453-4057qib7	7256	11	(	(	-LRB-
cord-005453-4057qib7	7256	12	DFS	DFS	NNP
cord-005453-4057qib7	7256	13	)	)	-RRB-
cord-005453-4057qib7	7256	14	was	be	VBD
cord-005453-4057qib7	7256	15	90	90	CD
cord-005453-4057qib7	7256	16	%	%	NN
cord-005453-4057qib7	7256	17	vs.	vs.	CC
cord-005453-4057qib7	7256	18	100	100	CD
cord-005453-4057qib7	7256	19	%	%	NN
cord-005453-4057qib7	7256	20	,	,	,
cord-005453-4057qib7	7256	21	respectively	respectively	RB
cord-005453-4057qib7	7256	22	.	.	.
cord-005453-4057qib7	7257	1	Methods	method	NNS
cord-005453-4057qib7	7257	2	:	:	:
cord-005453-4057qib7	7258	1	These	these	DT
cord-005453-4057qib7	7258	2	results	result	NNS
cord-005453-4057qib7	7258	3	led	lead	VBD
cord-005453-4057qib7	7258	4	to	to	IN
cord-005453-4057qib7	7258	5	the	the	DT
cord-005453-4057qib7	7258	6	design	design	NN
cord-005453-4057qib7	7258	7	of	of	IN
cord-005453-4057qib7	7258	8	a	a	DT
cord-005453-4057qib7	7258	9	clinical	clinical	JJ
cord-005453-4057qib7	7258	10	trial	trial	NN
cord-005453-4057qib7	7258	11	to	to	TO
cord-005453-4057qib7	7258	12	assess	assess	VB
cord-005453-4057qib7	7258	13	TCD	TCD	NNP
cord-005453-4057qib7	7258	14	-	-	HYPH
cord-005453-4057qib7	7258	15	haplo	haplo	NNP
cord-005453-4057qib7	7258	16	-	-	HYPH
cord-005453-4057qib7	7258	17	HSCT	HSCT	NNP
cord-005453-4057qib7	7258	18	prospectively	prospectively	RB
cord-005453-4057qib7	7258	19	which	which	WDT
cord-005453-4057qib7	7258	20	aims	aim	VBZ
cord-005453-4057qib7	7258	21	to	to	TO
cord-005453-4057qib7	7258	22	demonstrate	demonstrate	VB
cord-005453-4057qib7	7258	23	that	that	IN
cord-005453-4057qib7	7258	24	a	a	DT
cord-005453-4057qib7	7258	25	HSCT	HSCT	NNP
cord-005453-4057qib7	7258	26	from	from	IN
cord-005453-4057qib7	7258	27	a	a	DT
cord-005453-4057qib7	7258	28	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7258	29	relative	relative	NN
cord-005453-4057qib7	7258	30	is	be	VBZ
cord-005453-4057qib7	7258	31	not	not	RB
cord-005453-4057qib7	7258	32	inferior	inferior	JJ
cord-005453-4057qib7	7258	33	to	to	IN
cord-005453-4057qib7	7258	34	a	a	DT
cord-005453-4057qib7	7258	35	MSD	MSD	NNP
cord-005453-4057qib7	7258	36	HSCT	HSCT	NNP
cord-005453-4057qib7	7258	37	with	with	IN
cord-005453-4057qib7	7258	38	regard	regard	NN
cord-005453-4057qib7	7258	39	to	to	IN
cord-005453-4057qib7	7258	40	major	major	JJ
cord-005453-4057qib7	7258	41	outcome	outcome	NN
cord-005453-4057qib7	7258	42	parameter	parameter	NN
cord-005453-4057qib7	7258	43	.	.	.
cord-005453-4057qib7	7259	1	This	this	DT
cord-005453-4057qib7	7259	2	phase	phase	NN
cord-005453-4057qib7	7259	3	2	2	CD
cord-005453-4057qib7	7259	4	,	,	,
cord-005453-4057qib7	7259	5	prospective	prospective	JJ
cord-005453-4057qib7	7259	6	,	,	,
cord-005453-4057qib7	7259	7	stratified	stratified	JJ
cord-005453-4057qib7	7259	8	,	,	,
cord-005453-4057qib7	7259	9	open	open	JJ
cord-005453-4057qib7	7259	10	-	-	HYPH
cord-005453-4057qib7	7259	11	label	label	NN
cord-005453-4057qib7	7259	12	study	study	NN
cord-005453-4057qib7	7259	13	is	be	VBZ
cord-005453-4057qib7	7259	14	targeting	target	VBG
cord-005453-4057qib7	7259	15	enrollment	enrollment	NN
cord-005453-4057qib7	7259	16	of	of	IN
cord-005453-4057qib7	7259	17	212	212	CD
cord-005453-4057qib7	7259	18	patients	patient	NNS
cord-005453-4057qib7	7259	19	aged	age	VBN
cord-005453-4057qib7	7259	20	1	1	CD
cord-005453-4057qib7	7259	21	-	-	SYM
cord-005453-4057qib7	7259	22	35	35	CD
cord-005453-4057qib7	7259	23	years	year	NNS
cord-005453-4057qib7	7259	24	with	with	IN
cord-005453-4057qib7	7259	25	homozygous	homozygous	JJ
cord-005453-4057qib7	7259	26	HbS	hbs	JJ
cord-005453-4057qib7	7259	27	disease	disease	NN
cord-005453-4057qib7	7259	28	or	or	CC
cord-005453-4057qib7	7259	29	heterozygous	heterozygous	JJ
cord-005453-4057qib7	7259	30	HbSC	HbSC	NNP
cord-005453-4057qib7	7259	31	or	or	CC
cord-005453-4057qib7	7259	32	HbS	hbs	NN
cord-005453-4057qib7	7259	33	0/+	0/+	.
cord-005453-4057qib7	7260	1	ß	ß	LS
cord-005453-4057qib7	7260	2	-	-	:
cord-005453-4057qib7	7260	3	Thal	Thal	NNP
cord-005453-4057qib7	7260	4	suffering	suffer	VBG
cord-005453-4057qib7	7260	5	from	from	IN
cord-005453-4057qib7	7260	6	severe	severe	JJ
cord-005453-4057qib7	7260	7	or	or	CC
cord-005453-4057qib7	7260	8	moderate	moderate	JJ
cord-005453-4057qib7	7260	9	SCD	SCD	NNP
cord-005453-4057qib7	7260	10	related	relate	VBN
cord-005453-4057qib7	7260	11	complications	complication	NNS
cord-005453-4057qib7	7260	12	.	.	.
cord-005453-4057qib7	7261	1	Inclusion	inclusion	NN
cord-005453-4057qib7	7261	2	criteria	criterion	NNS
cord-005453-4057qib7	7261	3	are	be	VBP
cord-005453-4057qib7	7261	4	clinically	clinically	RB
cord-005453-4057qib7	7261	5	significant	significant	JJ
cord-005453-4057qib7	7261	6	SCD	SCD	NNP
cord-005453-4057qib7	7261	7	related	relate	VBN
cord-005453-4057qib7	7261	8	complications	complication	NNS
cord-005453-4057qib7	7261	9	such	such	JJ
cord-005453-4057qib7	7261	10	as	as	IN
cord-005453-4057qib7	7261	11	stroke	stroke	NN
cord-005453-4057qib7	7261	12	,	,	,
cord-005453-4057qib7	7261	13	silent	silent	JJ
cord-005453-4057qib7	7261	14	crisis	crisis	NN
cord-005453-4057qib7	7261	15	,	,	,
cord-005453-4057qib7	7261	16	pathological	pathological	JJ
cord-005453-4057qib7	7261	17	angio	angio	NN
cord-005453-4057qib7	7261	18	-	-	HYPH
cord-005453-4057qib7	7261	19	MRI	MRI	NNP
cord-005453-4057qib7	7261	20	,	,	,
cord-005453-4057qib7	7261	21	transcranial	transcranial	JJ
cord-005453-4057qib7	7261	22	doppler	doppler	NN
cord-005453-4057qib7	7261	23	(	(	-LRB-
cord-005453-4057qib7	7261	24	TCD	TCD	NNP
cord-005453-4057qib7	7261	25	)	)	-RRB-
cord-005453-4057qib7	7261	26	velocity	velocity	NN
cord-005453-4057qib7	7261	27	>	>	XX
cord-005453-4057qib7	7261	28	200	200	CD
cord-005453-4057qib7	7261	29	cm	cm	NNS
cord-005453-4057qib7	7261	30	/	/	SYM
cord-005453-4057qib7	7261	31	s	s	NN
cord-005453-4057qib7	7261	32	,	,	,
cord-005453-4057qib7	7261	33	2	2	CD
cord-005453-4057qib7	7261	34	or	or	CC
cord-005453-4057qib7	7261	35	more	more	JJR
cord-005453-4057qib7	7261	36	episodes	episode	NNS
cord-005453-4057qib7	7261	37	of	of	IN
cord-005453-4057qib7	7261	38	acute	acute	JJ
cord-005453-4057qib7	7261	39	chest	chest	NN
cord-005453-4057qib7	7261	40	syndrome	syndrome	NN
cord-005453-4057qib7	7261	41	(	(	-LRB-
cord-005453-4057qib7	7261	42	ACS	ACS	NNP
cord-005453-4057qib7	7261	43	)	)	-RRB-
cord-005453-4057qib7	7261	44	in	in	IN
cord-005453-4057qib7	7261	45	a	a	DT
cord-005453-4057qib7	7261	46	lifetime	lifetime	NN
cord-005453-4057qib7	7261	47	,	,	,
cord-005453-4057qib7	7261	48	chronic	chronic	JJ
cord-005453-4057qib7	7261	49	transfusion	transfusion	NN
cord-005453-4057qib7	7261	50	dependency	dependency	NN
cord-005453-4057qib7	7261	51	,	,	,
cord-005453-4057qib7	7261	52	transfusion	transfusion	NN
cord-005453-4057qib7	7261	53	-	-	HYPH
cord-005453-4057qib7	7261	54	refractory	refractory	JJ
cord-005453-4057qib7	7261	55	allo	allo	NN
cord-005453-4057qib7	7261	56	-	-	HYPH
cord-005453-4057qib7	7261	57	immunization	immunization	NN
cord-005453-4057qib7	7261	58	and	and	CC
cord-005453-4057qib7	7261	59	others	other	NNS
cord-005453-4057qib7	7261	60	.	.	.
cord-005453-4057qib7	7262	1	Pts	Pts	NNP
cord-005453-4057qib7	7262	2	fulfilling	fulfil	VBG
cord-005453-4057qib7	7262	3	inclusion	inclusion	NN
cord-005453-4057qib7	7262	4	criteria	criterion	NNS
cord-005453-4057qib7	7262	5	will	will	MD
cord-005453-4057qib7	7262	6	be	be	VB
cord-005453-4057qib7	7262	7	stratified	stratify	VBN
cord-005453-4057qib7	7262	8	according	accord	VBG
cord-005453-4057qib7	7262	9	to	to	IN
cord-005453-4057qib7	7262	10	donor	donor	NN
cord-005453-4057qib7	7262	11	availability	availability	NN
cord-005453-4057qib7	7262	12	.	.	.
cord-005453-4057qib7	7263	1	Pts	Pts	NNP
cord-005453-4057qib7	7263	2	with	with	IN
cord-005453-4057qib7	7263	3	a	a	DT
cord-005453-4057qib7	7263	4	MSD	MSD	NNP
cord-005453-4057qib7	7263	5	will	will	MD
cord-005453-4057qib7	7263	6	receive	receive	VB
cord-005453-4057qib7	7263	7	a	a	DT
cord-005453-4057qib7	7263	8	bone	bone	NN
cord-005453-4057qib7	7263	9	marrow	marrow	NN
cord-005453-4057qib7	7263	10	graft	graft	NN
cord-005453-4057qib7	7263	11	,	,	,
cord-005453-4057qib7	7263	12	pts	pts	IN
cord-005453-4057qib7	7263	13	requiring	require	VBG
cord-005453-4057qib7	7263	14	an	an	DT
cord-005453-4057qib7	7263	15	alternative	alternative	JJ
cord-005453-4057qib7	7263	16	donor	donor	NN
cord-005453-4057qib7	7263	17	will	will	MD
cord-005453-4057qib7	7263	18	be	be	VB
cord-005453-4057qib7	7263	19	transplanted	transplant	VBN
cord-005453-4057qib7	7263	20	with	with	IN
cord-005453-4057qib7	7263	21	an	an	DT
cord-005453-4057qib7	7263	22	aß/	aß/	NN
cord-005453-4057qib7	7264	1	CD19	CD19	NNP
cord-005453-4057qib7	7264	2	depleted	deplete	VBD
cord-005453-4057qib7	7264	3	graft	graft	NN
cord-005453-4057qib7	7264	4	from	from	IN
cord-005453-4057qib7	7264	5	a	a	DT
cord-005453-4057qib7	7264	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7264	7	family	family	NN
cord-005453-4057qib7	7264	8	donor	donor	NN
cord-005453-4057qib7	7264	9	.	.	.
cord-005453-4057qib7	7265	1	The	the	DT
cord-005453-4057qib7	7265	2	conditioning	conditioning	NN
cord-005453-4057qib7	7265	3	regimen	regimen	NN
cord-005453-4057qib7	7265	4	for	for	IN
cord-005453-4057qib7	7265	5	both	both	DT
cord-005453-4057qib7	7265	6	groups	group	NNS
cord-005453-4057qib7	7265	7	will	will	MD
cord-005453-4057qib7	7265	8	be	be	VB
cord-005453-4057qib7	7265	9	identical	identical	JJ
cord-005453-4057qib7	7265	10	with	with	IN
cord-005453-4057qib7	7265	11	the	the	DT
cord-005453-4057qib7	7265	12	exception	exception	NN
cord-005453-4057qib7	7265	13	that	that	IN
cord-005453-4057qib7	7265	14	antithymoglobulin	antithymoglobulin	NNP
cord-005453-4057qib7	7265	15	(	(	-LRB-
cord-005453-4057qib7	7265	16	ATG	ATG	NNP
cord-005453-4057qib7	7265	17	-	-	HYPH
cord-005453-4057qib7	7265	18	Neovii	Neovii	NNP
cord-005453-4057qib7	7265	19	®	®	.
cord-005453-4057qib7	7265	20	)	)	-RRB-
cord-005453-4057qib7	7265	21	is	be	VBZ
cord-005453-4057qib7	7265	22	given	give	VBN
cord-005453-4057qib7	7265	23	upfront	upfront	NN
cord-005453-4057qib7	7265	24	in	in	IN
cord-005453-4057qib7	7265	25	Thaplo	Thaplo	NNP
cord-005453-4057qib7	7265	26	-	-	HYPH
cord-005453-4057qib7	7265	27	HSCT	HSCT	NNP
cord-005453-4057qib7	7265	28	versus	versus	IN
cord-005453-4057qib7	7265	29	day	day	NN
cord-005453-4057qib7	7265	30	-3	-3	NNP
cord-005453-4057qib7	7265	31	to	to	IN
cord-005453-4057qib7	7265	32	-1	-1	NN
cord-005453-4057qib7	7265	33	in	in	IN
cord-005453-4057qib7	7265	34	MSD	MSD	NNP
cord-005453-4057qib7	7265	35	.	.	.
cord-005453-4057qib7	7266	1	Chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7266	2	consists	consist	VBZ
cord-005453-4057qib7	7266	3	of	of	IN
cord-005453-4057qib7	7266	4	thiotepa	thiotepa	JJ
cord-005453-4057qib7	7266	5	,	,	,
cord-005453-4057qib7	7266	6	fludarabine	fludarabine	NN
cord-005453-4057qib7	7266	7	and	and	CC
cord-005453-4057qib7	7266	8	treosulfan	treosulfan	NNP
cord-005453-4057qib7	7266	9	.	.	.
cord-005453-4057qib7	7267	1	Posttransplant	Posttransplant	NNP
cord-005453-4057qib7	7267	2	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7267	3	will	will	MD
cord-005453-4057qib7	7267	4	consist	consist	VB
cord-005453-4057qib7	7267	5	of	of	IN
cord-005453-4057qib7	7267	6	mofetil	mofetil	NNP
cord-005453-4057qib7	7267	7	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	7267	8	and	and	CC
cord-005453-4057qib7	7267	9	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	7267	10	for	for	IN
cord-005453-4057qib7	7267	11	a	a	DT
cord-005453-4057qib7	7267	12	duration	duration	NN
cord-005453-4057qib7	7267	13	>	>	XX
cord-005453-4057qib7	7267	14	6	6	CD
cord-005453-4057qib7	7267	15	months	month	NNS
cord-005453-4057qib7	7267	16	in	in	IN
cord-005453-4057qib7	7267	17	T	t	NN
cord-005453-4057qib7	7267	18	-	-	HYPH
cord-005453-4057qib7	7267	19	haplo	haplo	NNP
cord-005453-4057qib7	7267	20	-	-	HYPH
cord-005453-4057qib7	7267	21	HSCT	HSCT	NNP
cord-005453-4057qib7	7267	22	and	and	CC
cord-005453-4057qib7	7267	23	<	<	NNP
cord-005453-4057qib7	7267	24	6	6	CD
cord-005453-4057qib7	7267	25	months	month	NNS
cord-005453-4057qib7	7267	26	in	in	IN
cord-005453-4057qib7	7267	27	MSD	MSD	NNP
cord-005453-4057qib7	7267	28	,	,	,
cord-005453-4057qib7	7267	29	depending	depend	VBG
cord-005453-4057qib7	7267	30	on	on	IN
cord-005453-4057qib7	7267	31	chimerism	chimerism	NN
cord-005453-4057qib7	7267	32	.	.	.
cord-005453-4057qib7	7268	1	(	(	-LRB-
cord-005453-4057qib7	7268	2	EudraCT	eudract	JJ
cord-005453-4057qib7	7268	3	number	number	NN
cord-005453-4057qib7	7268	4	:	:	:
cord-005453-4057qib7	7268	5	2018	2018	CD
cord-005453-4057qib7	7268	6	-	-	HYPH
cord-005453-4057qib7	7268	7	002652	002652	CD
cord-005453-4057qib7	7268	8	-	-	SYM
cord-005453-4057qib7	7268	9	33	33	CD
cord-005453-4057qib7	7268	10	)	)	-RRB-
cord-005453-4057qib7	7268	11	Results	result	NNS
cord-005453-4057qib7	7268	12	:	:	:
cord-005453-4057qib7	7268	13	Primary	primary	JJ
cord-005453-4057qib7	7268	14	efficacy	efficacy	NN
cord-005453-4057qib7	7268	15	endpoint	endpoint	NN
cord-005453-4057qib7	7268	16	:	:	:
cord-005453-4057qib7	7269	1	Event	event	NN
cord-005453-4057qib7	7269	2	free	free	JJ
cord-005453-4057qib7	7269	3	survival	survival	NN
cord-005453-4057qib7	7269	4	(	(	-LRB-
cord-005453-4057qib7	7269	5	EFS	EFS	NNP
cord-005453-4057qib7	7269	6	)	)	-RRB-
cord-005453-4057qib7	7269	7	.	.	.
cord-005453-4057qib7	7270	1	Event	event	NN
cord-005453-4057qib7	7270	2	is	be	VBZ
cord-005453-4057qib7	7270	3	defined	define	VBN
cord-005453-4057qib7	7270	4	as	as	IN
cord-005453-4057qib7	7270	5	incidence	incidence	NN
cord-005453-4057qib7	7270	6	of	of	IN
cord-005453-4057qib7	7270	7	acute	acute	JJ
cord-005453-4057qib7	7270	8	GvHD	gvhd	NN
cord-005453-4057qib7	7270	9	,	,	,
cord-005453-4057qib7	7270	10	grade	grade	NN
cord-005453-4057qib7	7270	11	III	III	NNP
cord-005453-4057qib7	7270	12	-IV	-iv	NN
cord-005453-4057qib7	7270	13	,	,	,
cord-005453-4057qib7	7270	14	chronic	chronic	JJ
cord-005453-4057qib7	7270	15	GvHD	gvhd	NN
cord-005453-4057qib7	7270	16	,	,	,
cord-005453-4057qib7	7270	17	rejection	rejection	NN
cord-005453-4057qib7	7270	18	(	(	-LRB-
cord-005453-4057qib7	7270	19	graft	graft	NN
cord-005453-4057qib7	7270	20	failure	failure	NN
cord-005453-4057qib7	7270	21	)	)	-RRB-
cord-005453-4057qib7	7270	22	or	or	CC
cord-005453-4057qib7	7270	23	death	death	NN
cord-005453-4057qib7	7270	24	(	(	-LRB-
cord-005453-4057qib7	7270	25	for	for	IN
cord-005453-4057qib7	7270	26	any	any	DT
cord-005453-4057qib7	7270	27	reason	reason	NN
cord-005453-4057qib7	7270	28	)	)	-RRB-
cord-005453-4057qib7	7270	29	.	.	.
cord-005453-4057qib7	7271	1	Key	key	JJ
cord-005453-4057qib7	7271	2	secondary	secondary	JJ
cord-005453-4057qib7	7271	3	endpoint(s	endpoint(s	NNP
cord-005453-4057qib7	7271	4	)	)	-RRB-
cord-005453-4057qib7	7271	5	are	be	VBP
cord-005453-4057qib7	7271	6	OS	OS	NNP
cord-005453-4057qib7	7271	7	,	,	,
cord-005453-4057qib7	7271	8	DFS	DFS	NNP
cord-005453-4057qib7	7271	9	,	,	,
cord-005453-4057qib7	7271	10	graft	graft	NN
cord-005453-4057qib7	7271	11	failure	failure	NN
cord-005453-4057qib7	7271	12	,	,	,
cord-005453-4057qib7	7271	13	hematological	hematological	JJ
cord-005453-4057qib7	7271	14	and	and	CC
cord-005453-4057qib7	7271	15	immunological	immunological	JJ
cord-005453-4057qib7	7271	16	reconstitution	reconstitution	NN
cord-005453-4057qib7	7271	17	,	,	,
cord-005453-4057qib7	7271	18	quality	quality	NN
cord-005453-4057qib7	7271	19	of	of	IN
cord-005453-4057qib7	7271	20	life	life	NN
cord-005453-4057qib7	7271	21	(	(	-LRB-
cord-005453-4057qib7	7271	22	QOL	QOL	NNP
cord-005453-4057qib7	7271	23	)	)	-RRB-
cord-005453-4057qib7	7271	24	assessment	assessment	NN
cord-005453-4057qib7	7271	25	and	and	CC
cord-005453-4057qib7	7271	26	fertility	fertility	NN
cord-005453-4057qib7	7271	27	.	.	.
cord-005453-4057qib7	7272	1	The	the	DT
cord-005453-4057qib7	7272	2	primary	primary	JJ
cord-005453-4057qib7	7272	3	null	null	JJ
cord-005453-4057qib7	7272	4	hypothesis	hypothesis	NN
cord-005453-4057qib7	7272	5	is	be	VBZ
cord-005453-4057qib7	7272	6	:	:	:
cord-005453-4057qib7	7272	7	EFS	EFS	NNP
cord-005453-4057qib7	7272	8	of	of	IN
cord-005453-4057qib7	7272	9	SCD	SCD	NNP
cord-005453-4057qib7	7272	10	patients	patient	NNS
cord-005453-4057qib7	7272	11	treated	treat	VBN
cord-005453-4057qib7	7272	12	with	with	IN
cord-005453-4057qib7	7272	13	T	T	NNP
cord-005453-4057qib7	7272	14	-	-	HYPH
cord-005453-4057qib7	7272	15	Haplo	Haplo	NNP
cord-005453-4057qib7	7272	16	-	-	HYPH
cord-005453-4057qib7	7272	17	HSCT	HSCT	NNP
cord-005453-4057qib7	7273	1	is	be	VBZ
cord-005453-4057qib7	7273	2	non	non	JJ
cord-005453-4057qib7	7273	3	-	-	JJ
cord-005453-4057qib7	7273	4	relevantly	relevantly	RB
cord-005453-4057qib7	7273	5	inferior	inferior	JJ
cord-005453-4057qib7	7273	6	to	to	IN
cord-005453-4057qib7	7273	7	EFS	EFS	NNP
cord-005453-4057qib7	7273	8	in	in	IN
cord-005453-4057qib7	7273	9	the	the	DT
cord-005453-4057qib7	7273	10	MSD	MSD	NNP
cord-005453-4057qib7	7273	11	arm	arm	NN
cord-005453-4057qib7	7273	12	.	.	.
cord-005453-4057qib7	7274	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7274	2	:	:	:
cord-005453-4057qib7	7275	1	Results	result	NNS
cord-005453-4057qib7	7275	2	will	will	MD
cord-005453-4057qib7	7275	3	help	help	VB
cord-005453-4057qib7	7275	4	to	to	TO
cord-005453-4057qib7	7275	5	determine	determine	VB
cord-005453-4057qib7	7275	6	if	if	IN
cord-005453-4057qib7	7275	7	an	an	DT
cord-005453-4057qib7	7275	8	a	a	NN
cord-005453-4057qib7	7275	9	/	/	SYM
cord-005453-4057qib7	7275	10	ß	ß	NN
cord-005453-4057qib7	7275	11	depleted	deplete	VBD
cord-005453-4057qib7	7275	12	T	T	NNP
cord-005453-4057qib7	7275	13	-	-	HYPH
cord-005453-4057qib7	7275	14	haplo	haplo	NNP
cord-005453-4057qib7	7275	15	-	-	HYPH
cord-005453-4057qib7	7275	16	HSCT	HSCT	NNP
cord-005453-4057qib7	7275	17	can	can	MD
cord-005453-4057qib7	7275	18	be	be	VB
cord-005453-4057qib7	7275	19	considered	consider	VBN
cord-005453-4057qib7	7275	20	equivalent	equivalent	JJ
cord-005453-4057qib7	7275	21	to	to	IN
cord-005453-4057qib7	7275	22	MSD	MSD	NNP
cord-005453-4057qib7	7275	23	HSCT	HSCT	NNP
cord-005453-4057qib7	7275	24	with	with	IN
cord-005453-4057qib7	7275	25	regard	regard	NN
cord-005453-4057qib7	7275	26	to	to	IN
cord-005453-4057qib7	7275	27	DFS	DFS	NNP
cord-005453-4057qib7	7275	28	,	,	,
cord-005453-4057qib7	7275	29	adverse	adverse	JJ
cord-005453-4057qib7	7275	30	events	event	NNS
cord-005453-4057qib7	7275	31	and	and	CC
cord-005453-4057qib7	7275	32	safety	safety	NN
cord-005453-4057qib7	7275	33	,	,	,
cord-005453-4057qib7	7275	34	in	in	IN
cord-005453-4057qib7	7275	35	order	order	NN
cord-005453-4057qib7	7275	36	to	to	TO
cord-005453-4057qib7	7275	37	offer	offer	VB
cord-005453-4057qib7	7275	38	this	this	DT
cord-005453-4057qib7	7275	39	form	form	NN
cord-005453-4057qib7	7275	40	of	of	IN
cord-005453-4057qib7	7275	41	cure	cure	NN
cord-005453-4057qib7	7275	42	to	to	IN
cord-005453-4057qib7	7275	43	the	the	DT
cord-005453-4057qib7	7275	44	majority	majority	NN
cord-005453-4057qib7	7275	45	of	of	IN
cord-005453-4057qib7	7275	46	patients	patient	NNS
cord-005453-4057qib7	7275	47	with	with	IN
cord-005453-4057qib7	7275	48	SCD	SCD	NNP
cord-005453-4057qib7	7275	49	.	.	.
cord-005453-4057qib7	7276	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7276	2	:	:	:
cord-005453-4057qib7	7276	3	Nothing	nothing	NN
cord-005453-4057qib7	7276	4	to	to	TO
cord-005453-4057qib7	7276	5	declare	declare	VB
cord-005453-4057qib7	7276	6	Hit	Hit	VBN
cord-005453-4057qib7	7276	7	three	three	CD
cord-005453-4057qib7	7276	8	birds	bird	NNS
cord-005453-4057qib7	7276	9	with	with	IN
cord-005453-4057qib7	7276	10	one	one	CD
cord-005453-4057qib7	7276	11	stone	stone	NN
cord-005453-4057qib7	7276	12	:	:	:
cord-005453-4057qib7	7276	13	Successful	successful	JJ
cord-005453-4057qib7	7276	14	stem	stem	NN
cord-005453-4057qib7	7276	15	cell	cell	NN
cord-005453-4057qib7	7276	16	transplantation	transplantation	NN
cord-005453-4057qib7	7276	17	from	from	IN
cord-005453-4057qib7	7276	18	one	one	CD
cord-005453-4057qib7	7276	19	family	family	NN
cord-005453-4057qib7	7276	20	donor	donor	NN
cord-005453-4057qib7	7276	21	to	to	IN
cord-005453-4057qib7	7276	22	three	three	CD
cord-005453-4057qib7	7276	23	siblings	sibling	NNS
cord-005453-4057qib7	7276	24	Methods	method	NNS
cord-005453-4057qib7	7276	25	:	:	:
cord-005453-4057qib7	7276	26	In	in	IN
cord-005453-4057qib7	7276	27	August	August	NNP
cord-005453-4057qib7	7276	28	2016	2016	CD
cord-005453-4057qib7	7276	29	,	,	,
cord-005453-4057qib7	7276	30	three	three	CD
cord-005453-4057qib7	7276	31	thalassemic	thalassemic	NNP
cord-005453-4057qib7	7276	32	siblings	sibling	NNS
cord-005453-4057qib7	7276	33	were	be	VBD
cord-005453-4057qib7	7276	34	admitted	admit	VBN
cord-005453-4057qib7	7276	35	to	to	IN
cord-005453-4057qib7	7276	36	hospital	hospital	NN
cord-005453-4057qib7	7276	37	for	for	IN
cord-005453-4057qib7	7276	38	stem	stem	NN
cord-005453-4057qib7	7276	39	cell	cell	NN
cord-005453-4057qib7	7276	40	transplantation	transplantation	NN
cord-005453-4057qib7	7276	41	from	from	IN
cord-005453-4057qib7	7276	42	a	a	DT
cord-005453-4057qib7	7276	43	full	full	JJ
cord-005453-4057qib7	7276	44	match	match	NN
cord-005453-4057qib7	7276	45	donor	donor	NN
cord-005453-4057qib7	7276	46	,	,	,
cord-005453-4057qib7	7276	47	their	-PRON-	PRP$
cord-005453-4057qib7	7276	48	17	17	CD
cord-005453-4057qib7	7276	49	years	year	NNS
cord-005453-4057qib7	7276	50	old	old	JJ
cord-005453-4057qib7	7276	51	sister	sister	NN
cord-005453-4057qib7	7276	52	.	.	.
cord-005453-4057qib7	7277	1	The	the	DT
cord-005453-4057qib7	7277	2	patients	patient	NNS
cord-005453-4057qib7	7277	3	'	'	POS
cord-005453-4057qib7	7277	4	general	general	JJ
cord-005453-4057qib7	7277	5	health	health	NN
cord-005453-4057qib7	7277	6	conditions	condition	NNS
cord-005453-4057qib7	7277	7	and	and	CC
cord-005453-4057qib7	7277	8	specific	specific	JJ
cord-005453-4057qib7	7277	9	health	health	NN
cord-005453-4057qib7	7277	10	issues	issue	NNS
cord-005453-4057qib7	7277	11	due	due	JJ
cord-005453-4057qib7	7277	12	to	to	IN
cord-005453-4057qib7	7277	13	thalassemia	thalassemia	NN
cord-005453-4057qib7	7277	14	were	be	VBD
cord-005453-4057qib7	7277	15	checked	check	VBN
cord-005453-4057qib7	7277	16	extensively	extensively	RB
cord-005453-4057qib7	7277	17	.	.	.
cord-005453-4057qib7	7278	1	It	-PRON-	PRP
cord-005453-4057qib7	7278	2	was	be	VBD
cord-005453-4057qib7	7278	3	decided	decide	VBN
cord-005453-4057qib7	7278	4	to	to	TO
cord-005453-4057qib7	7278	5	perform	perform	VB
cord-005453-4057qib7	7278	6	first	first	JJ
cord-005453-4057qib7	7278	7	transplant	transplant	NN
cord-005453-4057qib7	7278	8	to	to	IN
cord-005453-4057qib7	7278	9	older	old	JJR
cord-005453-4057qib7	7278	10	sister	sister	NN
cord-005453-4057qib7	7278	11	whom	whom	WP
cord-005453-4057qib7	7278	12	the	the	DT
cord-005453-4057qib7	7278	13	disease	disease	NN
cord-005453-4057qib7	7278	14	and	and	CC
cord-005453-4057qib7	7278	15	transplant	transplant	NN
cord-005453-4057qib7	7278	16	complications	complication	NNS
cord-005453-4057qib7	7278	17	are	be	VBP
cord-005453-4057qib7	7278	18	expected	expect	VBN
cord-005453-4057qib7	7278	19	more	more	RBR
cord-005453-4057qib7	7278	20	intense	intense	JJ
cord-005453-4057qib7	7278	21	due	due	IN
cord-005453-4057qib7	7278	22	to	to	IN
cord-005453-4057qib7	7278	23	prolonged	prolong	VBN
cord-005453-4057qib7	7278	24	transfusion	transfusion	NN
cord-005453-4057qib7	7278	25	and	and	CC
cord-005453-4057qib7	7278	26	chelation	chelation	NN
cord-005453-4057qib7	7278	27	therapy	therapy	NN
cord-005453-4057qib7	7278	28	.	.	.
cord-005453-4057qib7	7279	1	The	the	DT
cord-005453-4057qib7	7279	2	oldest	old	JJS
cord-005453-4057qib7	7279	3	daughter	daughter	NN
cord-005453-4057qib7	7279	4	of	of	IN
cord-005453-4057qib7	7279	5	family	family	NN
cord-005453-4057qib7	7279	6	,	,	,
cord-005453-4057qib7	7279	7	healthy	healthy	JJ
cord-005453-4057qib7	7279	8	,	,	,
cord-005453-4057qib7	7279	9	was	be	VBD
cord-005453-4057qib7	7279	10	planned	plan	VBN
cord-005453-4057qib7	7279	11	to	to	TO
cord-005453-4057qib7	7279	12	accompany	accompany	VB
cord-005453-4057qib7	7279	13	her	-PRON-	PRP$
cord-005453-4057qib7	7279	14	sisters	sister	NNS
cord-005453-4057qib7	7279	15	in	in	IN
cord-005453-4057qib7	7279	16	transplantation	transplantation	NN
cord-005453-4057qib7	7279	17	unit	unit	NN
cord-005453-4057qib7	7279	18	so	so	IN
cord-005453-4057qib7	7279	19	parents	parent	NNS
cord-005453-4057qib7	7279	20	can	can	MD
cord-005453-4057qib7	7279	21	take	take	VB
cord-005453-4057qib7	7279	22	care	care	VB
cord-005453-4057qib7	7279	23	the	the	DT
cord-005453-4057qib7	7279	24	others	other	NNS
cord-005453-4057qib7	7279	25	and	and	CC
cord-005453-4057qib7	7279	26	organize	organize	VB
cord-005453-4057qib7	7279	27	this	this	DT
cord-005453-4057qib7	7279	28	period	period	NN
cord-005453-4057qib7	7279	29	for	for	IN
cord-005453-4057qib7	7279	30	whole	whole	JJ
cord-005453-4057qib7	7279	31	family	family	NN
cord-005453-4057qib7	7279	32	.	.	.
cord-005453-4057qib7	7280	1	Results	result	NNS
cord-005453-4057qib7	7280	2	:	:	:
cord-005453-4057qib7	7281	1	The	the	DT
cord-005453-4057qib7	7281	2	13	13	CD
cord-005453-4057qib7	7281	3	years	year	NNS
cord-005453-4057qib7	7281	4	old	old	JJ
cord-005453-4057qib7	7281	5	sibling	sibling	NN
cord-005453-4057qib7	7281	6	was	be	VBD
cord-005453-4057qib7	7281	7	first	first	RB
cord-005453-4057qib7	7281	8	admitted	admit	VBN
cord-005453-4057qib7	7281	9	to	to	IN
cord-005453-4057qib7	7281	10	bone	bone	NN
cord-005453-4057qib7	7281	11	marrow	marrow	NN
cord-005453-4057qib7	7281	12	transplantation	transplantation	NN
cord-005453-4057qib7	7281	13	unit	unit	NN
cord-005453-4057qib7	7281	14	in	in	IN
cord-005453-4057qib7	7281	15	July	July	NNP
cord-005453-4057qib7	7281	16	2017	2017	CD
cord-005453-4057qib7	7281	17	.	.	.
cord-005453-4057qib7	7282	1	The	the	DT
cord-005453-4057qib7	7282	2	conditioning	conditioning	NN
cord-005453-4057qib7	7282	3	regimen	regimen	NN
cord-005453-4057qib7	7282	4	was	be	VBD
cord-005453-4057qib7	7282	5	busulfan	busulfan	NN
cord-005453-4057qib7	7282	6	,	,	,
cord-005453-4057qib7	7282	7	fludarabine	fludarabine	NN
cord-005453-4057qib7	7282	8	,	,	,
cord-005453-4057qib7	7282	9	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7282	10	and	and	CC
cord-005453-4057qib7	7282	11	thiotepa	thiotepa	NNS
cord-005453-4057qib7	7282	12	with	with	IN
cord-005453-4057qib7	7282	13	Antithymocyteglobulin(ATG	Antithymocyteglobulin(ATG	NNP
cord-005453-4057qib7	7282	14	)	)	-RRB-
cord-005453-4057qib7	7282	15	and	and	CC
cord-005453-4057qib7	7282	16	defibrotide	defibrotide	NNP
cord-005453-4057qib7	7282	17	prophylaxis	prophylaxis	NNP
cord-005453-4057qib7	7282	18	was	be	VBD
cord-005453-4057qib7	7282	19	given	give	VBN
cord-005453-4057qib7	7282	20	.	.	.
cord-005453-4057qib7	7283	1	The	the	DT
cord-005453-4057qib7	7283	2	healthy	healthy	JJ
cord-005453-4057qib7	7283	3	donor	donor	NN
cord-005453-4057qib7	7283	4	was	be	VBD
cord-005453-4057qib7	7283	5	admitted	admit	VBN
cord-005453-4057qib7	7283	6	to	to	IN
cord-005453-4057qib7	7283	7	hospital	hospital	NN
cord-005453-4057qib7	7283	8	and	and	CC
cord-005453-4057qib7	7283	9	received	receive	VBD
cord-005453-4057qib7	7283	10	G	G	NNP
cord-005453-4057qib7	7283	11	-	-	HYPH
cord-005453-4057qib7	7283	12	CSF	CSF	NNP
cord-005453-4057qib7	7283	13	for	for	IN
cord-005453-4057qib7	7283	14	5	5	CD
cord-005453-4057qib7	7283	15	continuous	continuous	JJ
cord-005453-4057qib7	7283	16	days	day	NNS
cord-005453-4057qib7	7283	17	before	before	IN
cord-005453-4057qib7	7283	18	harvesting	harvest	VBG
cord-005453-4057qib7	7283	19	.	.	.
cord-005453-4057qib7	7284	1	Stem	stem	NN
cord-005453-4057qib7	7284	2	cells	cell	NNS
cord-005453-4057qib7	7284	3	were	be	VBD
cord-005453-4057qib7	7284	4	collected	collect	VBN
cord-005453-4057qib7	7284	5	peripherally	peripherally	RB
cord-005453-4057qib7	7284	6	on	on	IN
cord-005453-4057qib7	7284	7	day	day	NN
cord-005453-4057qib7	7284	8	0	0	CD
cord-005453-4057qib7	7284	9	and	and	CC
cord-005453-4057qib7	7284	10	viable	viable	JJ
cord-005453-4057qib7	7284	11	CD34	CD34	NNP
cord-005453-4057qib7	7285	1	+	+	CC
cord-005453-4057qib7	7285	2	cells	cell	NNS
cord-005453-4057qib7	7285	3	were	be	VBD
cord-005453-4057qib7	7286	1	2211	2211	CD
cord-005453-4057qib7	7286	2	/	/	SYM
cord-005453-4057qib7	7286	3	uL.	ul.	JJ
cord-005453-4057qib7	7286	4	Patient	Patient	NNP
cord-005453-4057qib7	7286	5	received	receive	VBD
cord-005453-4057qib7	7286	6	5,5	5,5	CD
cord-005453-4057qib7	7286	7	x10e6	x10e6	NNP
cord-005453-4057qib7	7286	8	/	/	SYM
cord-005453-4057qib7	7286	9	kg	kg	CD
cord-005453-4057qib7	7286	10	stem	stem	NN
cord-005453-4057qib7	7286	11	cell	cell	NN
cord-005453-4057qib7	7286	12	and	and	CC
cord-005453-4057qib7	7286	13	the	the	DT
cord-005453-4057qib7	7286	14	other	other	JJ
cord-005453-4057qib7	7286	15	cell	cell	NN
cord-005453-4057qib7	7286	16	products	product	NNS
cord-005453-4057qib7	7286	17	were	be	VBD
cord-005453-4057qib7	7286	18	divided	divide	VBN
cord-005453-4057qib7	7286	19	into	into	IN
cord-005453-4057qib7	7286	20	4	4	CD
cord-005453-4057qib7	7286	21	parts	part	NNS
cord-005453-4057qib7	7286	22	according	accord	VBG
cord-005453-4057qib7	7286	23	to	to	IN
cord-005453-4057qib7	7286	24	other	other	JJ
cord-005453-4057qib7	7286	25	recipients´weight	recipients´weight	CD
cord-005453-4057qib7	7286	26	.	.	.
cord-005453-4057qib7	7287	1	No	no	DT
cord-005453-4057qib7	7287	2	infusion	infusion	NN
cord-005453-4057qib7	7287	3	problems	problem	NNS
cord-005453-4057qib7	7287	4	were	be	VBD
cord-005453-4057qib7	7287	5	recorded	record	VBN
cord-005453-4057qib7	7287	6	in	in	IN
cord-005453-4057qib7	7287	7	stem	stem	NN
cord-005453-4057qib7	7287	8	cell	cell	NN
cord-005453-4057qib7	7287	9	transfusion	transfusion	NN
cord-005453-4057qib7	7287	10	.	.	.
cord-005453-4057qib7	7288	1	GVHD	GVHD	NNP
cord-005453-4057qib7	7288	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7288	3	was	be	VBD
cord-005453-4057qib7	7288	4	given	give	VBN
cord-005453-4057qib7	7288	5	with	with	IN
cord-005453-4057qib7	7288	6	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	7288	7	and	and	CC
cord-005453-4057qib7	7288	8	methotrexate	methotrexate	NNP
cord-005453-4057qib7	7288	9	.	.	.
cord-005453-4057qib7	7289	1	Severe	severe	JJ
cord-005453-4057qib7	7289	2	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	7289	3	obstruction	obstruction	NN
cord-005453-4057qib7	7289	4	syndrome	syndrome	NN
cord-005453-4057qib7	7289	5	was	be	VBD
cord-005453-4057qib7	7289	6	observed	observe	VBN
cord-005453-4057qib7	7289	7	and	and	CC
cord-005453-4057qib7	7289	8	successfully	successfully	RB
cord-005453-4057qib7	7289	9	managed	manage	VBN
cord-005453-4057qib7	7289	10	with	with	IN
cord-005453-4057qib7	7289	11	supportive	supportive	JJ
cord-005453-4057qib7	7289	12	therapy	therapy	NN
cord-005453-4057qib7	7289	13	.	.	.
cord-005453-4057qib7	7290	1	Neutrophils	neutrophil	NNS
cord-005453-4057qib7	7290	2	were	be	VBD
cord-005453-4057qib7	7290	3	engrafted	engraft	VBN
cord-005453-4057qib7	7290	4	+11	+11	CD
cord-005453-4057qib7	7290	5	.	.	.
cord-005453-4057qib7	7291	1	day	day	NN
cord-005453-4057qib7	7291	2	,	,	,
cord-005453-4057qib7	7291	3	and	and	CC
cord-005453-4057qib7	7291	4	platelets	platelet	NNS
cord-005453-4057qib7	7291	5	were	be	VBD
cord-005453-4057qib7	7291	6	on	on	IN
cord-005453-4057qib7	7291	7	day	day	NN
cord-005453-4057qib7	7291	8	64	64	CD
cord-005453-4057qib7	7291	9	.	.	.
cord-005453-4057qib7	7292	1	Full	full	JJ
cord-005453-4057qib7	7292	2	blood	blood	NN
cord-005453-4057qib7	7292	3	chimerism	chimerism	NN
cord-005453-4057qib7	7292	4	results	result	NNS
cord-005453-4057qib7	7292	5	were	be	VBD
cord-005453-4057qib7	7292	6	%	%	NN
cord-005453-4057qib7	7292	7	98	98	CD
cord-005453-4057qib7	7292	8	in	in	IN
cord-005453-4057qib7	7292	9	day	day	NN
cord-005453-4057qib7	7292	10	30	30	CD
cord-005453-4057qib7	7292	11	,	,	,
cord-005453-4057qib7	7292	12	%	%	NN
cord-005453-4057qib7	7292	13	99	99	CD
cord-005453-4057qib7	7292	14	in	in	IN
cord-005453-4057qib7	7292	15	day	day	NN
cord-005453-4057qib7	7292	16	60	60	CD
cord-005453-4057qib7	7292	17	and	and	CC
cord-005453-4057qib7	7292	18	%	%	NN
cord-005453-4057qib7	7292	19	98	98	CD
cord-005453-4057qib7	7292	20	in	in	IN
cord-005453-4057qib7	7292	21	day	day	NN
cord-005453-4057qib7	7292	22	180	180	CD
cord-005453-4057qib7	7292	23	consecutively	consecutively	RB
cord-005453-4057qib7	7292	24	.	.	.
cord-005453-4057qib7	7293	1	After	after	IN
cord-005453-4057qib7	7293	2	3	3	CD
cord-005453-4057qib7	7293	3	months	month	NNS
cord-005453-4057qib7	7293	4	from	from	IN
cord-005453-4057qib7	7293	5	first	first	JJ
cord-005453-4057qib7	7293	6	transplant	transplant	NN
cord-005453-4057qib7	7293	7	the	the	DT
cord-005453-4057qib7	7293	8	4	4	CD
cord-005453-4057qib7	7293	9	years	year	NNS
cord-005453-4057qib7	7293	10	old	old	JJ
cord-005453-4057qib7	7293	11	sister	sister	NN
cord-005453-4057qib7	7293	12	was	be	VBD
cord-005453-4057qib7	7293	13	admitted	admit	VBN
cord-005453-4057qib7	7293	14	to	to	IN
cord-005453-4057qib7	7293	15	hospital	hospital	NN
cord-005453-4057qib7	7293	16	on	on	IN
cord-005453-4057qib7	7293	17	October	October	NNP
cord-005453-4057qib7	7293	18	2017	2017	CD
cord-005453-4057qib7	7293	19	.	.	.
cord-005453-4057qib7	7294	1	Same	same	JJ
cord-005453-4057qib7	7294	2	conditioning	conditioning	NN
cord-005453-4057qib7	7294	3	with	with	IN
cord-005453-4057qib7	7294	4	defibrotide	defibrotide	NN
cord-005453-4057qib7	7294	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7294	6	and	and	CC
cord-005453-4057qib7	7294	7	GVHD	GVHD	NNP
cord-005453-4057qib7	7294	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7294	9	were	be	VBD
cord-005453-4057qib7	7294	10	given	give	VBN
cord-005453-4057qib7	7294	11	and	and	CC
cord-005453-4057qib7	7294	12	6,8	6,8	CD
cord-005453-4057qib7	7295	1	x10e6	x10e6	NNP
cord-005453-4057qib7	7295	2	/	/	SYM
cord-005453-4057qib7	7295	3	kg	kg	NNS
cord-005453-4057qib7	7295	4	peripherally	peripherally	RB
cord-005453-4057qib7	7295	5	derived	derive	VBN
cord-005453-4057qib7	7295	6	and	and	CC
cord-005453-4057qib7	7295	7	previously	previously	RB
cord-005453-4057qib7	7295	8	frost	frost	VB
cord-005453-4057qib7	7295	9	stem	stem	NN
cord-005453-4057qib7	7295	10	cell	cell	NN
cord-005453-4057qib7	7295	11	was	be	VBD
cord-005453-4057qib7	7295	12	infused	infuse	VBN
cord-005453-4057qib7	7295	13	without	without	IN
cord-005453-4057qib7	7295	14	any	any	DT
cord-005453-4057qib7	7295	15	complications	complication	NNS
cord-005453-4057qib7	7295	16	.	.	.
cord-005453-4057qib7	7296	1	Mild	mild	JJ
cord-005453-4057qib7	7296	2	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	7296	3	obstruction	obstruction	NN
cord-005453-4057qib7	7296	4	syndrome	syndrome	NN
cord-005453-4057qib7	7296	5	was	be	VBD
cord-005453-4057qib7	7296	6	observed	observe	VBN
cord-005453-4057qib7	7296	7	and	and	CC
cord-005453-4057qib7	7296	8	managed	manage	VBN
cord-005453-4057qib7	7296	9	with	with	IN
cord-005453-4057qib7	7296	10	supportive	supportive	JJ
cord-005453-4057qib7	7296	11	therapy	therapy	NN
cord-005453-4057qib7	7296	12	successfully	successfully	RB
cord-005453-4057qib7	7296	13	.	.	.
cord-005453-4057qib7	7297	1	Neutrophils	neutrophil	NNS
cord-005453-4057qib7	7297	2	were	be	VBD
cord-005453-4057qib7	7297	3	engrafted	engraft	VBN
cord-005453-4057qib7	7297	4	+11	+11	CD
cord-005453-4057qib7	7297	5	.	.	.
cord-005453-4057qib7	7298	1	day	day	NN
cord-005453-4057qib7	7298	2	,	,	,
cord-005453-4057qib7	7298	3	and	and	CC
cord-005453-4057qib7	7298	4	platelets	platelet	NNS
cord-005453-4057qib7	7298	5	were	be	VBD
cord-005453-4057qib7	7298	6	on	on	IN
cord-005453-4057qib7	7298	7	day	day	NN
cord-005453-4057qib7	7298	8	16	16	CD
cord-005453-4057qib7	7298	9	.	.	.
cord-005453-4057qib7	7299	1	Full	full	JJ
cord-005453-4057qib7	7299	2	blood	blood	NN
cord-005453-4057qib7	7299	3	chimerism	chimerism	NN
cord-005453-4057qib7	7299	4	results	result	NNS
cord-005453-4057qib7	7299	5	were	be	VBD
cord-005453-4057qib7	7299	6	%	%	NN
cord-005453-4057qib7	7299	7	99	99	CD
cord-005453-4057qib7	7299	8	in	in	IN
cord-005453-4057qib7	7299	9	day	day	NN
cord-005453-4057qib7	7299	10	30	30	CD
cord-005453-4057qib7	7299	11	,	,	,
cord-005453-4057qib7	7299	12	%	%	NN
cord-005453-4057qib7	7299	13	99	99	CD
cord-005453-4057qib7	7299	14	in	in	IN
cord-005453-4057qib7	7299	15	day	day	NN
cord-005453-4057qib7	7299	16	60	60	CD
cord-005453-4057qib7	7299	17	and	and	CC
cord-005453-4057qib7	7299	18	%	%	NN
cord-005453-4057qib7	7299	19	99	99	CD
cord-005453-4057qib7	7299	20	in	in	IN
cord-005453-4057qib7	7299	21	day	day	NN
cord-005453-4057qib7	7299	22	180	180	CD
cord-005453-4057qib7	7299	23	consecutively	consecutively	RB
cord-005453-4057qib7	7299	24	.	.	.
cord-005453-4057qib7	7300	1	The	the	DT
cord-005453-4057qib7	7300	2	third	third	JJ
cord-005453-4057qib7	7300	3	transplant	transplant	NN
cord-005453-4057qib7	7300	4	was	be	VBD
cord-005453-4057qib7	7300	5	performed	perform	VBN
cord-005453-4057qib7	7300	6	on	on	IN
cord-005453-4057qib7	7300	7	January	January	NNP
cord-005453-4057qib7	7300	8	2018	2018	CD
cord-005453-4057qib7	7300	9	with	with	IN
cord-005453-4057qib7	7300	10	the	the	DT
cord-005453-4057qib7	7300	11	same	same	JJ
cord-005453-4057qib7	7300	12	conditioning	conditioning	NN
cord-005453-4057qib7	7300	13	and	and	CC
cord-005453-4057qib7	7300	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7300	15	regimen	regimen	NN
cord-005453-4057qib7	7300	16	.	.	.
cord-005453-4057qib7	7301	1	Although	although	IN
cord-005453-4057qib7	7301	2	defibrotide	defibrotide	NN
cord-005453-4057qib7	7301	3	was	be	VBD
cord-005453-4057qib7	7301	4	used	use	VBN
cord-005453-4057qib7	7301	5	mild	mild	JJ
cord-005453-4057qib7	7301	6	SOS	SOS	NNP
cord-005453-4057qib7	7301	7	was	be	VBD
cord-005453-4057qib7	7301	8	observed	observe	VBN
cord-005453-4057qib7	7301	9	and	and	CC
cord-005453-4057qib7	7301	10	treated	treat	VBN
cord-005453-4057qib7	7301	11	with	with	IN
cord-005453-4057qib7	7301	12	supportive	supportive	JJ
cord-005453-4057qib7	7301	13	therapy	therapy	NN
cord-005453-4057qib7	7301	14	with	with	IN
cord-005453-4057qib7	7301	15	success	success	NN
cord-005453-4057qib7	7301	16	.	.	.
cord-005453-4057qib7	7302	1	Neutrophils	neutrophil	NNS
cord-005453-4057qib7	7302	2	were	be	VBD
cord-005453-4057qib7	7302	3	engrafted	engraft	VBN
cord-005453-4057qib7	7302	4	+10	+10	CD
cord-005453-4057qib7	7302	5	.	.	.
cord-005453-4057qib7	7303	1	Day	day	NN
cord-005453-4057qib7	7303	2	,	,	,
cord-005453-4057qib7	7303	3	and	and	CC
cord-005453-4057qib7	7303	4	platelets	platelet	NNS
cord-005453-4057qib7	7303	5	were	be	VBD
cord-005453-4057qib7	7303	6	on	on	IN
cord-005453-4057qib7	7303	7	day	day	NN
cord-005453-4057qib7	7303	8	27	27	CD
cord-005453-4057qib7	7303	9	.	.	.
cord-005453-4057qib7	7304	1	Full	full	JJ
cord-005453-4057qib7	7304	2	blood	blood	NN
cord-005453-4057qib7	7304	3	chimerism	chimerism	NN
cord-005453-4057qib7	7304	4	results	result	NNS
cord-005453-4057qib7	7304	5	were	be	VBD
cord-005453-4057qib7	7304	6	%	%	NN
cord-005453-4057qib7	7304	7	99	99	CD
cord-005453-4057qib7	7304	8	in	in	IN
cord-005453-4057qib7	7304	9	day	day	NN
cord-005453-4057qib7	7304	10	30	30	CD
cord-005453-4057qib7	7304	11	,	,	,
cord-005453-4057qib7	7304	12	%	%	NN
cord-005453-4057qib7	7304	13	99	99	CD
cord-005453-4057qib7	7304	14	in	in	IN
cord-005453-4057qib7	7304	15	day	day	NN
cord-005453-4057qib7	7304	16	60	60	CD
cord-005453-4057qib7	7304	17	and	and	CC
cord-005453-4057qib7	7304	18	%	%	NN
cord-005453-4057qib7	7304	19	99	99	CD
cord-005453-4057qib7	7304	20	in	in	IN
cord-005453-4057qib7	7304	21	day	day	NN
cord-005453-4057qib7	7304	22	180	180	CD
cord-005453-4057qib7	7304	23	consecutively	consecutively	RB
cord-005453-4057qib7	7304	24	.	.	.
cord-005453-4057qib7	7305	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7305	2	:	:	:
cord-005453-4057qib7	7306	1	The	the	DT
cord-005453-4057qib7	7306	2	patients	patient	NNS
cord-005453-4057qib7	7306	3	are	be	VBP
cord-005453-4057qib7	7306	4	being	be	VBG
cord-005453-4057qib7	7306	5	followed	follow	VBN
cord-005453-4057qib7	7306	6	for	for	IN
cord-005453-4057qib7	7306	7	over	over	IN
cord-005453-4057qib7	7306	8	a	a	DT
cord-005453-4057qib7	7306	9	year	year	NN
cord-005453-4057qib7	7306	10	after	after	IN
cord-005453-4057qib7	7306	11	first	first	JJ
cord-005453-4057qib7	7306	12	transplat	transplat	NNP
cord-005453-4057qib7	7306	13	,	,	,
cord-005453-4057qib7	7306	14	neither	neither	CC
cord-005453-4057qib7	7306	15	adverse	adverse	JJ
cord-005453-4057qib7	7306	16	nor	nor	CC
cord-005453-4057qib7	7306	17	GVHD	gvhd	JJ
cord-005453-4057qib7	7306	18	symptoms	symptom	NNS
cord-005453-4057qib7	7306	19	were	be	VBD
cord-005453-4057qib7	7306	20	observed	observe	VBN
cord-005453-4057qib7	7306	21	.	.	.
cord-005453-4057qib7	7307	1	We	-PRON-	PRP
cord-005453-4057qib7	7307	2	presented	present	VBD
cord-005453-4057qib7	7307	3	this	this	DT
cord-005453-4057qib7	7307	4	case	case	NN
cord-005453-4057qib7	7307	5	for	for	IN
cord-005453-4057qib7	7307	6	being	be	VBG
cord-005453-4057qib7	7307	7	a	a	DT
cord-005453-4057qib7	7307	8	unique	unique	JJ
cord-005453-4057qib7	7307	9	example	example	NN
cord-005453-4057qib7	7307	10	for	for	IN
cord-005453-4057qib7	7307	11	match	match	NN
cord-005453-4057qib7	7307	12	family	family	NN
cord-005453-4057qib7	7307	13	donor	donor	NN
cord-005453-4057qib7	7307	14	transplant	transplant	NN
cord-005453-4057qib7	7307	15	and	and	CC
cord-005453-4057qib7	7307	16	the	the	DT
cord-005453-4057qib7	7307	17	first	first	JJ
cord-005453-4057qib7	7307	18	successful	successful	JJ
cord-005453-4057qib7	7307	19	example	example	NN
cord-005453-4057qib7	7307	20	from	from	IN
cord-005453-4057qib7	7307	21	one	one	CD
cord-005453-4057qib7	7307	22	donor	donor	NN
cord-005453-4057qib7	7307	23	to	to	IN
cord-005453-4057qib7	7307	24	three	three	CD
cord-005453-4057qib7	7307	25	recipients	recipient	NNS
cord-005453-4057qib7	7307	26	.	.	.
cord-005453-4057qib7	7308	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7308	2	:	:	:
cord-005453-4057qib7	7308	3	Nothing	nothing	NN
cord-005453-4057qib7	7308	4	to	to	TO
cord-005453-4057qib7	7308	5	declare	declare	VB
cord-005453-4057qib7	7308	6	Results	result	NNS
cord-005453-4057qib7	7308	7	:	:	:
cord-005453-4057qib7	7309	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7309	2	female	female	JJ
cord-005453-4057qib7	7309	3	patient	patient	NN
cord-005453-4057qib7	7309	4	admitted	admit	VBN
cord-005453-4057qib7	7309	5	for	for	IN
cord-005453-4057qib7	7309	6	anemia	anemia	NN
cord-005453-4057qib7	7309	7	at	at	IN
cord-005453-4057qib7	7309	8	3	3	CD
cord-005453-4057qib7	7309	9	rd	rd	NNP
cord-005453-4057qib7	7309	10	month	month	NN
cord-005453-4057qib7	7309	11	of	of	IN
cord-005453-4057qib7	7309	12	birth	birth	NN
cord-005453-4057qib7	7309	13	and	and	CC
cord-005453-4057qib7	7309	14	was	be	VBD
cord-005453-4057qib7	7309	15	transfused	transfuse	VBN
cord-005453-4057qib7	7309	16	every	every	DT
cord-005453-4057qib7	7309	17	4	4	CD
cord-005453-4057qib7	7309	18	-	-	SYM
cord-005453-4057qib7	7309	19	5	5	CD
cord-005453-4057qib7	7309	20	months	month	NNS
cord-005453-4057qib7	7309	21	from	from	IN
cord-005453-4057qib7	7309	22	6	6	CD
cord-005453-4057qib7	7309	23	th	th	CD
cord-005453-4057qib7	7309	24	months	month	NNS
cord-005453-4057qib7	7309	25	to	to	IN
cord-005453-4057qib7	7309	26	3.5	3.5	CD
cord-005453-4057qib7	7309	27	years	year	NNS
cord-005453-4057qib7	7309	28	of	of	IN
cord-005453-4057qib7	7309	29	age	age	NN
cord-005453-4057qib7	7309	30	.	.	.
cord-005453-4057qib7	7310	1	Since	since	IN
cord-005453-4057qib7	7310	2	investigations	investigation	NNS
cord-005453-4057qib7	7310	3	directed	direct	VBN
cord-005453-4057qib7	7310	4	towards	towards	IN
cord-005453-4057qib7	7310	5	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	7310	6	or	or	CC
cord-005453-4057qib7	7310	7	membrane	membrane	NN
cord-005453-4057qib7	7310	8	defects	defect	NNS
cord-005453-4057qib7	7310	9	like	like	IN
cord-005453-4057qib7	7310	10	hereditary	hereditary	JJ
cord-005453-4057qib7	7310	11	spherocytosis	spherocytosis	NN
cord-005453-4057qib7	7310	12	were	be	VBD
cord-005453-4057qib7	7310	13	unremarkable	unremarkable	JJ
cord-005453-4057qib7	7310	14	,	,	,
cord-005453-4057qib7	7310	15	she	-PRON-	PRP
cord-005453-4057qib7	7310	16	was	be	VBD
cord-005453-4057qib7	7310	17	not	not	RB
cord-005453-4057qib7	7310	18	transfused	transfuse	VBN
cord-005453-4057qib7	7310	19	for	for	IN
cord-005453-4057qib7	7310	20	6	6	CD
cord-005453-4057qib7	7310	21	years	year	NNS
cord-005453-4057qib7	7310	22	after	after	IN
cord-005453-4057qib7	7310	23	the	the	DT
cord-005453-4057qib7	7310	24	age	age	NN
cord-005453-4057qib7	7310	25	of	of	IN
cord-005453-4057qib7	7310	26	3.5-years	3.5-years	CD
cord-005453-4057qib7	7310	27	because	because	IN
cord-005453-4057qib7	7310	28	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	7310	29	level	level	NN
cord-005453-4057qib7	7310	30	was	be	VBD
cord-005453-4057qib7	7310	31	constant	constant	JJ
cord-005453-4057qib7	7310	32	over	over	IN
cord-005453-4057qib7	7310	33	7	7	CD
cord-005453-4057qib7	7310	34	g	g	NN
cord-005453-4057qib7	7310	35	/	/	SYM
cord-005453-4057qib7	7310	36	dl	dl	NN
cord-005453-4057qib7	7310	37	.	.	.
cord-005453-4057qib7	7311	1	Her	-PRON-	PRP$
cord-005453-4057qib7	7311	2	BM	BM	NNP
cord-005453-4057qib7	7311	3	examination	examination	NN
cord-005453-4057qib7	7311	4	showed	show	VBD
cord-005453-4057qib7	7311	5	erythroid	erythroid	JJ
cord-005453-4057qib7	7311	6	hyperplasia	hyperplasia	NN
cord-005453-4057qib7	7311	7	and	and	CC
cord-005453-4057qib7	7311	8	feature	feature	NN
cord-005453-4057qib7	7311	9	of	of	IN
cord-005453-4057qib7	7311	10	dyserythropoiesis	dyserythropoiesis	NN
cord-005453-4057qib7	7311	11	with	with	IN
cord-005453-4057qib7	7311	12	a	a	DT
cord-005453-4057qib7	7311	13	few	few	JJ
cord-005453-4057qib7	7311	14	binucleated	binucleate	VBN
cord-005453-4057qib7	7311	15	erythroblasts	erythroblast	NNS
cord-005453-4057qib7	7311	16	.	.	.
cord-005453-4057qib7	7312	1	It	-PRON-	PRP
cord-005453-4057qib7	7312	2	was	be	VBD
cord-005453-4057qib7	7312	3	decided	decide	VBN
cord-005453-4057qib7	7312	4	to	to	TO
cord-005453-4057qib7	7312	5	follow	follow	VB
cord-005453-4057qib7	7312	6	-	-	HYPH
cord-005453-4057qib7	7312	7	up	up	NN
cord-005453-4057qib7	7312	8	the	the	DT
cord-005453-4057qib7	7312	9	patient	patient	NN
cord-005453-4057qib7	7312	10	with	with	IN
cord-005453-4057qib7	7312	11	a	a	DT
cord-005453-4057qib7	7312	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	7312	13	of	of	IN
cord-005453-4057qib7	7312	14	CDA	CDA	NNP
cord-005453-4057qib7	7312	15	II	II	NNP
cord-005453-4057qib7	7312	16	.	.	.
cord-005453-4057qib7	7313	1	After	after	IN
cord-005453-4057qib7	7313	2	the	the	DT
cord-005453-4057qib7	7313	3	age	age	NN
cord-005453-4057qib7	7313	4	of	of	IN
cord-005453-4057qib7	7313	5	10-years	10-years	CD
cord-005453-4057qib7	7313	6	,	,	,
cord-005453-4057qib7	7313	7	the	the	DT
cord-005453-4057qib7	7313	8	need	need	NN
cord-005453-4057qib7	7313	9	for	for	IN
cord-005453-4057qib7	7313	10	transfusion	transfusion	NN
cord-005453-4057qib7	7313	11	started	start	VBD
cord-005453-4057qib7	7313	12	again	again	RB
cord-005453-4057qib7	7313	13	for	for	IN
cord-005453-4057qib7	7313	14	every	every	DT
cord-005453-4057qib7	7313	15	4	4	CD
cord-005453-4057qib7	7313	16	to	to	TO
cord-005453-4057qib7	7313	17	5	5	CD
cord-005453-4057qib7	7313	18	months	month	NNS
cord-005453-4057qib7	7313	19	which	which	WDT
cord-005453-4057qib7	7313	20	led	lead	VBD
cord-005453-4057qib7	7313	21	the	the	DT
cord-005453-4057qib7	7313	22	parents	parent	NNS
cord-005453-4057qib7	7313	23	of	of	IN
cord-005453-4057qib7	7313	24	our	-PRON-	PRP$
cord-005453-4057qib7	7313	25	patient	patient	NN
cord-005453-4057qib7	7313	26	to	to	TO
cord-005453-4057qib7	7313	27	request	request	VB
cord-005453-4057qib7	7313	28	for	for	IN
cord-005453-4057qib7	7313	29	bone	bone	NN
cord-005453-4057qib7	7313	30	marrow	marrow	NN
cord-005453-4057qib7	7313	31	transplantation	transplantation	NN
cord-005453-4057qib7	7313	32	,	,	,
cord-005453-4057qib7	7313	33	however	however	RB
cord-005453-4057qib7	7313	34	,	,	,
cord-005453-4057qib7	7313	35	the	the	DT
cord-005453-4057qib7	7313	36	diagnosis	diagnosis	NN
cord-005453-4057qib7	7313	37	was	be	VBD
cord-005453-4057qib7	7313	38	not	not	RB
cord-005453-4057qib7	7313	39	definite	definite	JJ
cord-005453-4057qib7	7313	40	,	,	,
cord-005453-4057qib7	7313	41	and	and	CC
cord-005453-4057qib7	7313	42	because	because	IN
cord-005453-4057qib7	7313	43	of	of	IN
cord-005453-4057qib7	7313	44	the	the	DT
cord-005453-4057qib7	7313	45	insufficient	insufficient	JJ
cord-005453-4057qib7	7313	46	data	datum	NNS
cord-005453-4057qib7	7313	47	for	for	IN
cord-005453-4057qib7	7313	48	the	the	DT
cord-005453-4057qib7	7313	49	transplantations	transplantation	NNS
cord-005453-4057qib7	7313	50	for	for	IN
cord-005453-4057qib7	7313	51	CDA	CDA	NNP
cord-005453-4057qib7	7313	52	II	II	NNP
cord-005453-4057qib7	7313	53	patients	patient	NNS
cord-005453-4057qib7	7313	54	,	,	,
cord-005453-4057qib7	7313	55	it	-PRON-	PRP
cord-005453-4057qib7	7313	56	was	be	VBD
cord-005453-4057qib7	7313	57	decided	decide	VBN
cord-005453-4057qib7	7313	58	to	to	TO
cord-005453-4057qib7	7313	59	go	go	VB
cord-005453-4057qib7	7313	60	on	on	RP
cord-005453-4057qib7	7313	61	to	to	TO
cord-005453-4057qib7	7313	62	follow	follow	VB
cord-005453-4057qib7	7313	63	-	-	HYPH
cord-005453-4057qib7	7313	64	up	up	NN
cord-005453-4057qib7	7313	65	.	.	.
cord-005453-4057qib7	7314	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	7314	2	,	,	,
cord-005453-4057qib7	7314	3	after	after	IN
cord-005453-4057qib7	7314	4	2	2	CD
cord-005453-4057qib7	7314	5	years	year	NNS
cord-005453-4057qib7	7314	6	,	,	,
cord-005453-4057qib7	7314	7	the	the	DT
cord-005453-4057qib7	7314	8	frequency	frequency	NN
cord-005453-4057qib7	7314	9	of	of	IN
cord-005453-4057qib7	7314	10	transfusion	transfusion	NN
cord-005453-4057qib7	7314	11	gradually	gradually	RB
cord-005453-4057qib7	7314	12	increased	increase	VBD
cord-005453-4057qib7	7314	13	to	to	IN
cord-005453-4057qib7	7314	14	every	every	DT
cord-005453-4057qib7	7314	15	2	2	CD
cord-005453-4057qib7	7314	16	-	-	SYM
cord-005453-4057qib7	7314	17	3	3	CD
cord-005453-4057qib7	7314	18	weeks	week	NNS
cord-005453-4057qib7	7314	19	,	,	,
cord-005453-4057qib7	7314	20	and	and	CC
cord-005453-4057qib7	7314	21	bone	bone	NN
cord-005453-4057qib7	7314	22	marrow	marrow	NN
cord-005453-4057qib7	7314	23	transplantation	transplantation	NN
cord-005453-4057qib7	7314	24	was	be	VBD
cord-005453-4057qib7	7314	25	brought	bring	VBN
cord-005453-4057qib7	7314	26	into	into	IN
cord-005453-4057qib7	7314	27	question	question	NN
cord-005453-4057qib7	7314	28	again	again	RB
cord-005453-4057qib7	7314	29	.	.	.
cord-005453-4057qib7	7315	1	At	at	IN
cord-005453-4057qib7	7315	2	that	that	DT
cord-005453-4057qib7	7315	3	time	time	NN
cord-005453-4057qib7	7315	4	,	,	,
cord-005453-4057qib7	7315	5	genetic	genetic	JJ
cord-005453-4057qib7	7315	6	examination	examination	NN
cord-005453-4057qib7	7315	7	was	be	VBD
cord-005453-4057qib7	7315	8	started	start	VBN
cord-005453-4057qib7	7315	9	and	and	CC
cord-005453-4057qib7	7315	10	SEC23B	sec23b	NN
cord-005453-4057qib7	7315	11	gene	gene	NN
cord-005453-4057qib7	7315	12	was	be	VBD
cord-005453-4057qib7	7315	13	analyzed	analyze	VBN
cord-005453-4057qib7	7315	14	by	by	IN
cord-005453-4057qib7	7315	15	direct	direct	JJ
cord-005453-4057qib7	7315	16	sequencing	sequencing	NN
cord-005453-4057qib7	7315	17	.	.	.
cord-005453-4057qib7	7316	1	HSCT	HSCT	NNP
cord-005453-4057qib7	7316	2	decision	decision	NN
cord-005453-4057qib7	7316	3	from	from	IN
cord-005453-4057qib7	7316	4	her	-PRON-	PRP$
cord-005453-4057qib7	7316	5	HLA	HLA	NNP
cord-005453-4057qib7	7316	6	10/10	10/10	CD
cord-005453-4057qib7	7316	7	matched	match	VBN
cord-005453-4057qib7	7316	8	brother	brother	NN
cord-005453-4057qib7	7316	9	,	,	,
cord-005453-4057qib7	7316	10	carrying	carry	VBG
cord-005453-4057qib7	7316	11	SEC23B	SEC23B	NNP
cord-005453-4057qib7	7316	12	mutation	mutation	NN
cord-005453-4057qib7	7316	13	in	in	IN
cord-005453-4057qib7	7316	14	heterozygous	heterozygous	JJ
cord-005453-4057qib7	7316	15	state	state	NN
cord-005453-4057qib7	7316	16	,	,	,
cord-005453-4057qib7	7316	17	was	be	VBD
cord-005453-4057qib7	7316	18	taken	take	VBN
cord-005453-4057qib7	7316	19	.	.	.
cord-005453-4057qib7	7317	1	In	in	IN
cord-005453-4057qib7	7317	2	the	the	DT
cord-005453-4057qib7	7317	3	preparation	preparation	NN
cord-005453-4057qib7	7317	4	regimen	regimen	NN
cord-005453-4057qib7	7317	5	,	,	,
cord-005453-4057qib7	7317	6	busulfan	busulfan	FW
cord-005453-4057qib7	7317	7	(	(	-LRB-
cord-005453-4057qib7	7317	8	Bu	Bu	NNP
cord-005453-4057qib7	7317	9	)	)	-RRB-
cord-005453-4057qib7	7317	10	at	at	IN
cord-005453-4057qib7	7317	11	a	a	DT
cord-005453-4057qib7	7317	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	7317	13	weight	weight	NN
cord-005453-4057qib7	7317	14	adjusted	adjust	VBN
cord-005453-4057qib7	7317	15	dose	dose	NN
cord-005453-4057qib7	7317	16	(	(	-LRB-
cord-005453-4057qib7	7317	17	4	4	CD
cord-005453-4057qib7	7317	18	days	day	NNS
cord-005453-4057qib7	7317	19	)	)	-RRB-
cord-005453-4057qib7	7317	20	,	,	,
cord-005453-4057qib7	7317	21	200	200	CD
cord-005453-4057qib7	7317	22	mg	mg	NNP
cord-005453-4057qib7	7317	23	/	/	SYM
cord-005453-4057qib7	7317	24	kg	kg	NNS
cord-005453-4057qib7	7317	25	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7317	26	(	(	-LRB-
cord-005453-4057qib7	7317	27	Cy	Cy	NNP
cord-005453-4057qib7	7317	28	)	)	-RRB-
cord-005453-4057qib7	7317	29	(	(	-LRB-
cord-005453-4057qib7	7317	30	4	4	CD
cord-005453-4057qib7	7317	31	days	day	NNS
cord-005453-4057qib7	7317	32	)	)	-RRB-
cord-005453-4057qib7	7317	33	,	,	,
cord-005453-4057qib7	7317	34	and	and	CC
cord-005453-4057qib7	7317	35	30	30	CD
cord-005453-4057qib7	7317	36	mg	mg	NNP
cord-005453-4057qib7	7317	37	/	/	SYM
cord-005453-4057qib7	7317	38	kg	kg	NNP
cord-005453-4057qib7	7317	39	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	7317	40	globulin	globulin	NNP
cord-005453-4057qib7	7317	41	(	(	-LRB-
cord-005453-4057qib7	7317	42	ATG	ATG	NNP
cord-005453-4057qib7	7317	43	fresenius	fresenius	NNP
cord-005453-4057qib7	7317	44	)	)	-RRB-
cord-005453-4057qib7	7317	45	were	be	VBD
cord-005453-4057qib7	7317	46	used	use	VBN
cord-005453-4057qib7	7317	47	.	.	.
cord-005453-4057qib7	7318	1	Graftversus	Graftversus	NNP
cord-005453-4057qib7	7318	2	-	-	HYPH
cord-005453-4057qib7	7318	3	host	host	NN
cord-005453-4057qib7	7318	4	disease	disease	NN
cord-005453-4057qib7	7318	5	(	(	-LRB-
cord-005453-4057qib7	7318	6	GVHD	GVHD	NNP
cord-005453-4057qib7	7318	7	)	)	-RRB-
cord-005453-4057qib7	7318	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7318	9	was	be	VBD
cord-005453-4057qib7	7318	10	with	with	IN
cord-005453-4057qib7	7318	11	cyclosporin	cyclosporin	NNP
cord-005453-4057qib7	7318	12	A	A	NNP
cord-005453-4057qib7	7318	13	started	start	VBD
cord-005453-4057qib7	7318	14	on	on	IN
cord-005453-4057qib7	7318	15	day	day	NN
cord-005453-4057qib7	7318	16	-1	-1	NN
cord-005453-4057qib7	7318	17	and	and	CC
cord-005453-4057qib7	7318	18	short	short	JJ
cord-005453-4057qib7	7318	19	-	-	HYPH
cord-005453-4057qib7	7318	20	term	term	NN
cord-005453-4057qib7	7318	21	methotrexate	methotrexate	NNP
cord-005453-4057qib7	7318	22	on	on	IN
cord-005453-4057qib7	7318	23	day	day	NN
cord-005453-4057qib7	7319	1	+1,+3	+1,+3	NNP
cord-005453-4057qib7	7319	2	and	and	CC
cord-005453-4057qib7	7320	1	+6	+6	XX
cord-005453-4057qib7	7320	2	.	.	.
cord-005453-4057qib7	7321	1	She	-PRON-	PRP
cord-005453-4057qib7	7321	2	was	be	VBD
cord-005453-4057qib7	7321	3	transplanted	transplant	VBN
cord-005453-4057qib7	7321	4	with	with	IN
cord-005453-4057qib7	7321	5	BM	BM	NNP
cord-005453-4057qib7	7321	6	with	with	IN
cord-005453-4057qib7	7321	7	a	a	DT
cord-005453-4057qib7	7321	8	dose	dose	NN
cord-005453-4057qib7	7321	9	of	of	IN
cord-005453-4057qib7	7321	10	total	total	JJ
cord-005453-4057qib7	7321	11	nucleated	nucleated	JJ
cord-005453-4057qib7	7321	12	cells=7.1x10	cells=7.1x10	NNP
cord-005453-4057qib7	7321	13	8	8	CD
cord-005453-4057qib7	7321	14	/kg	/kg	NFP
cord-005453-4057qib7	7321	15	and	and	CC
cord-005453-4057qib7	7321	16	CD34=3x10	CD34=3x10	NNP
cord-005453-4057qib7	7321	17	6	6	CD
cord-005453-4057qib7	7321	18	/	/	SYM
cord-005453-4057qib7	7321	19	kg	kg	NNS
cord-005453-4057qib7	7321	20	.	.	.
cord-005453-4057qib7	7322	1	Neutrophile	neutrophile	JJ
cord-005453-4057qib7	7322	2	and	and	CC
cord-005453-4057qib7	7322	3	platelet	platelet	NN
cord-005453-4057qib7	7322	4	engraftment	engraftment	NN
cord-005453-4057qib7	7322	5	were	be	VBD
cord-005453-4057qib7	7322	6	achieved	achieve	VBN
cord-005453-4057qib7	7322	7	at	at	IN
cord-005453-4057qib7	7322	8	+20	+20	CD
cord-005453-4057qib7	7322	9	and	and	CC
cord-005453-4057qib7	7322	10	+38	+38	NNS
cord-005453-4057qib7	7322	11	,	,	,
cord-005453-4057qib7	7322	12	respectively	respectively	RB
cord-005453-4057qib7	7322	13	.	.	.
cord-005453-4057qib7	7323	1	Indeed	indeed	RB
cord-005453-4057qib7	7323	2	,	,	,
cord-005453-4057qib7	7323	3	grade	grade	NN
cord-005453-4057qib7	7323	4	4	4	CD
cord-005453-4057qib7	7323	5	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	7323	6	cystitis	cystitis	NN
cord-005453-4057qib7	7323	7	due	due	JJ
cord-005453-4057qib7	7323	8	to	to	IN
cord-005453-4057qib7	7323	9	BK	BK	NNP
cord-005453-4057qib7	7323	10	virus	virus	NN
cord-005453-4057qib7	7323	11	and	and	CC
cord-005453-4057qib7	7323	12	a	a	DT
cord-005453-4057qib7	7323	13	moderate	moderate	JJ
cord-005453-4057qib7	7323	14	veno	veno	NNP
cord-005453-4057qib7	7323	15	-	-	HYPH
cord-005453-4057qib7	7323	16	occlusive	occlusive	JJ
cord-005453-4057qib7	7323	17	disease	disease	NN
cord-005453-4057qib7	7323	18	prolonged	prolong	VBD
cord-005453-4057qib7	7323	19	platelet	platelet	NN
cord-005453-4057qib7	7323	20	transfusion	transfusion	NN
cord-005453-4057qib7	7323	21	days	day	NNS
cord-005453-4057qib7	7323	22	which	which	WDT
cord-005453-4057qib7	7323	23	concealed	conceal	VBD
cord-005453-4057qib7	7323	24	the	the	DT
cord-005453-4057qib7	7323	25	exact	exact	JJ
cord-005453-4057qib7	7323	26	engraftment	engraftment	NNP
cord-005453-4057qib7	7323	27	day	day	NN
cord-005453-4057qib7	7323	28	of	of	IN
cord-005453-4057qib7	7323	29	platelet	platelet	NN
cord-005453-4057qib7	7323	30	.	.	.
cord-005453-4057qib7	7324	1	The	the	DT
cord-005453-4057qib7	7324	2	patient	patient	NN
cord-005453-4057qib7	7324	3	was	be	VBD
cord-005453-4057qib7	7324	4	discharged	discharge	VBN
cord-005453-4057qib7	7324	5	on	on	IN
cord-005453-4057qib7	7324	6	day	day	NN
cord-005453-4057qib7	7324	7	45	45	CD
cord-005453-4057qib7	7324	8	with	with	IN
cord-005453-4057qib7	7324	9	no	no	DT
cord-005453-4057qib7	7324	10	more	more	JJR
cord-005453-4057qib7	7324	11	need	need	NN
cord-005453-4057qib7	7324	12	for	for	IN
cord-005453-4057qib7	7324	13	any	any	DT
cord-005453-4057qib7	7324	14	transfusion	transfusion	NN
cord-005453-4057qib7	7324	15	and	and	CC
cord-005453-4057qib7	7324	16	followed	follow	VBD
cord-005453-4057qib7	7324	17	up	up	RP
cord-005453-4057qib7	7324	18	as	as	IN
cord-005453-4057qib7	7324	19	a	a	DT
cord-005453-4057qib7	7324	20	complete	complete	JJ
cord-005453-4057qib7	7324	21	chimeric	chimeric	JJ
cord-005453-4057qib7	7324	22	with	with	IN
cord-005453-4057qib7	7324	23	no	no	DT
cord-005453-4057qib7	7324	24	type	type	NN
cord-005453-4057qib7	7324	25	of	of	IN
cord-005453-4057qib7	7324	26	GVHD	GVHD	NNP
cord-005453-4057qib7	7324	27	since	since	IN
cord-005453-4057qib7	7324	28	then	then	RB
cord-005453-4057qib7	7324	29	.	.	.
cord-005453-4057qib7	7325	1	Now	now	RB
cord-005453-4057qib7	7325	2	,	,	,
cord-005453-4057qib7	7325	3	she	-PRON-	PRP
cord-005453-4057qib7	7325	4	is	be	VBZ
cord-005453-4057qib7	7325	5	20	20	CD
cord-005453-4057qib7	7325	6	years	year	NNS
cord-005453-4057qib7	7325	7	old	old	JJ
cord-005453-4057qib7	7325	8	,	,	,
cord-005453-4057qib7	7325	9	under	under	IN
cord-005453-4057qib7	7325	10	regular	regular	JJ
cord-005453-4057qib7	7325	11	surveillance	surveillance	NN
cord-005453-4057qib7	7325	12	at	at	IN
cord-005453-4057qib7	7325	13	our	-PRON-	PRP$
cord-005453-4057qib7	7325	14	transplant	transplant	NN
cord-005453-4057qib7	7325	15	centre	centre	NN
cord-005453-4057qib7	7325	16	without	without	IN
cord-005453-4057qib7	7325	17	any	any	DT
cord-005453-4057qib7	7325	18	symptoms	symptom	NNS
cord-005453-4057qib7	7325	19	.	.	.
cord-005453-4057qib7	7326	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7326	2	:	:	:
cord-005453-4057qib7	7326	3	HSCT	HSCT	NNP
cord-005453-4057qib7	7326	4	data	datum	NNS
cord-005453-4057qib7	7326	5	in	in	IN
cord-005453-4057qib7	7326	6	CDA	CDA	NNP
cord-005453-4057qib7	7326	7	II	II	NNP
cord-005453-4057qib7	7326	8	patients	patient	NNS
cord-005453-4057qib7	7326	9	is	be	VBZ
cord-005453-4057qib7	7326	10	still	still	RB
cord-005453-4057qib7	7326	11	insufficient	insufficient	JJ
cord-005453-4057qib7	7326	12	,	,	,
cord-005453-4057qib7	7326	13	however	however	RB
cord-005453-4057qib7	7326	14	based	base	VBN
cord-005453-4057qib7	7326	15	on	on	IN
cord-005453-4057qib7	7326	16	data	datum	NNS
cord-005453-4057qib7	7326	17	from	from	IN
cord-005453-4057qib7	7326	18	TM	TM	NNP
cord-005453-4057qib7	7326	19	patients	patient	NNS
cord-005453-4057qib7	7326	20	with	with	IN
cord-005453-4057qib7	7326	21	similar	similar	JJ
cord-005453-4057qib7	7326	22	treatment	treatment	NN
cord-005453-4057qib7	7326	23	approaches	approach	NNS
cord-005453-4057qib7	7326	24	in	in	IN
cord-005453-4057qib7	7326	25	TD	TD	NNP
cord-005453-4057qib7	7326	26	CDA	CDA	NNP
cord-005453-4057qib7	7326	27	II	II	NNP
cord-005453-4057qib7	7326	28	patients	patient	NNS
cord-005453-4057qib7	7327	1	,	,	,
cord-005453-4057qib7	7327	2	it	-PRON-	PRP
cord-005453-4057qib7	7327	3	is	be	VBZ
cord-005453-4057qib7	7327	4	seen	see	VBN
cord-005453-4057qib7	7327	5	that	that	IN
cord-005453-4057qib7	7327	6	the	the	DT
cord-005453-4057qib7	7327	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7327	8	is	be	VBZ
cord-005453-4057qib7	7327	9	reliable	reliable	JJ
cord-005453-4057qib7	7327	10	and	and	CC
cord-005453-4057qib7	7327	11	effective	effective	JJ
cord-005453-4057qib7	7327	12	.	.	.
cord-005453-4057qib7	7328	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7328	2	:	:	:
cord-005453-4057qib7	7328	3	Nothing	nothing	NN
cord-005453-4057qib7	7328	4	to	to	TO
cord-005453-4057qib7	7328	5	declare	declare	VB
cord-005453-4057qib7	7328	6	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	7328	7	stem	stem	NN
cord-005453-4057qib7	7328	8	cells	cell	NNS
cord-005453-4057qib7	7329	1	Background	background	NN
cord-005453-4057qib7	7329	2	:	:	:
cord-005453-4057qib7	7330	1	The	the	DT
cord-005453-4057qib7	7330	2	prognosis	prognosis	NN
cord-005453-4057qib7	7330	3	after	after	IN
cord-005453-4057qib7	7330	4	frontline	frontline	JJ
cord-005453-4057qib7	7330	5	therapy	therapy	NN
cord-005453-4057qib7	7330	6	in	in	IN
cord-005453-4057qib7	7330	7	B	B	NNP
cord-005453-4057qib7	7331	1	-ALL	-ALL	:
cord-005453-4057qib7	7331	2	patients	patient	NNS
cord-005453-4057qib7	7331	3	have	have	VBP
cord-005453-4057qib7	7331	4	improved	improve	VBN
cord-005453-4057qib7	7331	5	due	due	IN
cord-005453-4057qib7	7331	6	to	to	IN
cord-005453-4057qib7	7331	7	monoclonal	monoclonal	JJ
cord-005453-4057qib7	7331	8	antibodies	antibody	NNS
cord-005453-4057qib7	7331	9	(	(	-LRB-
cord-005453-4057qib7	7331	10	CD20	CD20	NNP
cord-005453-4057qib7	7331	11	,	,	,
cord-005453-4057qib7	7331	12	CD19	CD19	NNP
cord-005453-4057qib7	7331	13	,	,	,
cord-005453-4057qib7	7331	14	CD22	CD22	NNP
cord-005453-4057qib7	7331	15	)	)	-RRB-
cord-005453-4057qib7	7331	16	and	and	CC
cord-005453-4057qib7	7331	17	approximately	approximately	RB
cord-005453-4057qib7	7331	18	90	90	CD
cord-005453-4057qib7	7331	19	%	%	NN
cord-005453-4057qib7	7331	20	of	of	IN
cord-005453-4057qib7	7331	21	patients	patient	NNS
cord-005453-4057qib7	7331	22	achieve	achieve	VB
cord-005453-4057qib7	7331	23	complete	complete	JJ
cord-005453-4057qib7	7331	24	remission	remission	NN
cord-005453-4057qib7	7331	25	.	.	.
cord-005453-4057qib7	7332	1	In	in	IN
cord-005453-4057qib7	7332	2	relapsed	relapsed	JJ
cord-005453-4057qib7	7332	3	and	and	CC
cord-005453-4057qib7	7332	4	refractory	refractory	JJ
cord-005453-4057qib7	7332	5	(	(	-LRB-
cord-005453-4057qib7	7332	6	R/	R/	NNP
cord-005453-4057qib7	7332	7	R	r	NN
cord-005453-4057qib7	7332	8	)	)	-RRB-
cord-005453-4057qib7	7332	9	B	b	NN
cord-005453-4057qib7	7332	10	-	-	:
cord-005453-4057qib7	7332	11	ALL	all	DT
cord-005453-4057qib7	7332	12	and	and	CC
cord-005453-4057qib7	7332	13	also	also	RB
cord-005453-4057qib7	7332	14	in	in	IN
cord-005453-4057qib7	7332	15	MRD	MRD	NNP
cord-005453-4057qib7	7332	16	+	+	SYM
cord-005453-4057qib7	7332	17	outcomes	outcome	NNS
cord-005453-4057qib7	7332	18	are	be	VBP
cord-005453-4057qib7	7332	19	relatively	relatively	RB
cord-005453-4057qib7	7332	20	poor	poor	JJ
cord-005453-4057qib7	7332	21	.	.	.
cord-005453-4057qib7	7333	1	Disease	disease	NN
cord-005453-4057qib7	7333	2	-	-	HYPH
cord-005453-4057qib7	7333	3	free	free	JJ
cord-005453-4057qib7	7333	4	survival	survival	NN
cord-005453-4057qib7	7333	5	(	(	-LRB-
cord-005453-4057qib7	7333	6	DFS	DFS	NNP
cord-005453-4057qib7	7333	7	)	)	-RRB-
cord-005453-4057qib7	7333	8	in	in	IN
cord-005453-4057qib7	7333	9	this	this	DT
cord-005453-4057qib7	7333	10	cohort	cohort	NN
cord-005453-4057qib7	7333	11	is	be	VBZ
cord-005453-4057qib7	7333	12	10	10	CD
cord-005453-4057qib7	7333	13	-	-	SYM
cord-005453-4057qib7	7333	14	20	20	CD
cord-005453-4057qib7	7333	15	%	%	NN
cord-005453-4057qib7	7333	16	.	.	.
cord-005453-4057qib7	7334	1	In	in	IN
cord-005453-4057qib7	7334	2	this	this	DT
cord-005453-4057qib7	7334	3	cohort	cohort	NN
cord-005453-4057qib7	7334	4	allo	allo	NN
cord-005453-4057qib7	7334	5	-	-	HYPH
cord-005453-4057qib7	7334	6	HSCT	HSCT	NNP
cord-005453-4057qib7	7334	7	is	be	VBZ
cord-005453-4057qib7	7334	8	indicated	indicate	VBN
cord-005453-4057qib7	7334	9	and	and	CC
cord-005453-4057qib7	7334	10	complete	complete	JJ
cord-005453-4057qib7	7334	11	remission	remission	NN
cord-005453-4057qib7	7334	12	before	before	IN
cord-005453-4057qib7	7334	13	transplantation	transplantation	NN
cord-005453-4057qib7	7334	14	is	be	VBZ
cord-005453-4057qib7	7334	15	crucial	crucial	JJ
cord-005453-4057qib7	7334	16	for	for	IN
cord-005453-4057qib7	7334	17	prognosis	prognosis	NN
cord-005453-4057qib7	7334	18	.	.	.
cord-005453-4057qib7	7335	1	Conventional	conventional	JJ
cord-005453-4057qib7	7335	2	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7335	3	is	be	VBZ
cord-005453-4057qib7	7335	4	associated	associate	VBN
cord-005453-4057qib7	7335	5	with	with	IN
cord-005453-4057qib7	7335	6	high	high	JJ
cord-005453-4057qib7	7335	7	failure	failure	NN
cord-005453-4057qib7	7335	8	rate	rate	NN
cord-005453-4057qib7	7335	9	and	and	CC
cord-005453-4057qib7	7335	10	significant	significant	JJ
cord-005453-4057qib7	7335	11	toxicity	toxicity	NN
cord-005453-4057qib7	7335	12	.	.	.
cord-005453-4057qib7	7336	1	Immunotherapy	immunotherapy	NN
cord-005453-4057qib7	7336	2	with	with	IN
cord-005453-4057qib7	7336	3	monoclonal	monoclonal	JJ
cord-005453-4057qib7	7336	4	antibodies	antibody	NNS
cord-005453-4057qib7	7336	5	and	and	CC
cord-005453-4057qib7	7336	6	CAR	CAR	NNP
cord-005453-4057qib7	7336	7	-	-	HYPH
cord-005453-4057qib7	7336	8	T	T	NNP
cord-005453-4057qib7	7336	9	are	be	VBP
cord-005453-4057qib7	7336	10	more	more	RBR
cord-005453-4057qib7	7336	11	promising	promising	JJ
cord-005453-4057qib7	7336	12	approaches	approach	NNS
cord-005453-4057qib7	7336	13	.	.	.
cord-005453-4057qib7	7337	1	The	the	DT
cord-005453-4057qib7	7337	2	aim	aim	NN
cord-005453-4057qib7	7337	3	was	be	VBD
cord-005453-4057qib7	7337	4	to	to	TO
cord-005453-4057qib7	7337	5	evaluate	evaluate	VB
cord-005453-4057qib7	7337	6	the	the	DT
cord-005453-4057qib7	7337	7	efficacy	efficacy	NN
cord-005453-4057qib7	7337	8	(	(	-LRB-
cord-005453-4057qib7	7337	9	frequency	frequency	NN
cord-005453-4057qib7	7337	10	of	of	IN
cord-005453-4057qib7	7337	11	responses	response	NNS
cord-005453-4057qib7	7337	12	,	,	,
cord-005453-4057qib7	7337	13	OS	OS	NNP
cord-005453-4057qib7	7337	14	,	,	,
cord-005453-4057qib7	7337	15	DFS	DFS	NNP
cord-005453-4057qib7	7337	16	)	)	-RRB-
cord-005453-4057qib7	7337	17	and	and	CC
cord-005453-4057qib7	7337	18	toxicity	toxicity	NN
cord-005453-4057qib7	7337	19	,	,	,
cord-005453-4057qib7	7337	20	especially	especially	RB
cord-005453-4057qib7	7337	21	neurotoxicity	neurotoxicity	NN
cord-005453-4057qib7	7337	22	and	and	CC
cord-005453-4057qib7	7337	23	cytokinerelease	cytokinerelease	NN
cord-005453-4057qib7	7337	24	syndrome	syndrome	NN
cord-005453-4057qib7	7337	25	,	,	,
cord-005453-4057qib7	7337	26	of	of	IN
cord-005453-4057qib7	7337	27	a	a	DT
cord-005453-4057qib7	7337	28	bispecific	bispecific	NN
cord-005453-4057qib7	7337	29	monoclonal	monoclonal	JJ
cord-005453-4057qib7	7337	30	antibody	antibody	NN
cord-005453-4057qib7	7337	31	blinatumomab	blinatumomab	NN
cord-005453-4057qib7	7337	32	in	in	IN
cord-005453-4057qib7	7337	33	patients	patient	NNS
cord-005453-4057qib7	7337	34	both	both	CC
cord-005453-4057qib7	7337	35	children	child	NNS
cord-005453-4057qib7	7337	36	and	and	CC
cord-005453-4057qib7	7337	37	adults	adult	NNS
cord-005453-4057qib7	7337	38	with	with	IN
cord-005453-4057qib7	7337	39	persistence	persistence	NN
cord-005453-4057qib7	7337	40	of	of	IN
cord-005453-4057qib7	7337	41	minimal	minimal	JJ
cord-005453-4057qib7	7337	42	residual	residual	JJ
cord-005453-4057qib7	7337	43	disease	disease	NN
cord-005453-4057qib7	7337	44	(	(	-LRB-
cord-005453-4057qib7	7337	45	MRD	MRD	NNP
cord-005453-4057qib7	7337	46	+	+	SYM
cord-005453-4057qib7	7337	47	)	)	-RRB-
cord-005453-4057qib7	7337	48	or	or	CC
cord-005453-4057qib7	7337	49	R	r	NN
cord-005453-4057qib7	7337	50	/	/	SYM
cord-005453-4057qib7	7337	51	R	r	NN
cord-005453-4057qib7	7337	52	B	b	NN
cord-005453-4057qib7	7337	53	-	-	,
cord-005453-4057qib7	7337	54	ALL	all	DT
cord-005453-4057qib7	7337	55	as	as	IN
cord-005453-4057qib7	7337	56	a	a	DT
cord-005453-4057qib7	7337	57	bridge	bridge	NN
cord-005453-4057qib7	7337	58	to	to	IN
cord-005453-4057qib7	7337	59	allo	allo	NN
cord-005453-4057qib7	7337	60	-	-	HYPH
cord-005453-4057qib7	7337	61	HSCT	HSCT	NNP
cord-005453-4057qib7	7337	62	.	.	.
cord-005453-4057qib7	7338	1	Methods	method	NNS
cord-005453-4057qib7	7338	2	:	:	:
cord-005453-4057qib7	7339	1	This	this	DT
cord-005453-4057qib7	7339	2	study	study	NN
cord-005453-4057qib7	7339	3	included	include	VBD
cord-005453-4057qib7	7339	4	120	120	CD
cord-005453-4057qib7	7339	5	patients	patient	NNS
cord-005453-4057qib7	7339	6	with	with	IN
cord-005453-4057qib7	7339	7	high	high	JJ
cord-005453-4057qib7	7339	8	risk	risk	NN
cord-005453-4057qib7	7339	9	B-	b-	NN
cord-005453-4057qib7	7340	1	ALL	all	DT
cord-005453-4057qib7	7340	2	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	7340	3	treated	treat	VBN
cord-005453-4057qib7	7340	4	in	in	IN
cord-005453-4057qib7	7340	5	2013	2013	CD
cord-005453-4057qib7	7340	6	-	-	SYM
cord-005453-4057qib7	7340	7	2018	2018	CD
cord-005453-4057qib7	7340	8	,	,	,
cord-005453-4057qib7	7340	9	among	among	IN
cord-005453-4057qib7	7340	10	them	-PRON-	PRP
cord-005453-4057qib7	7340	11	14	14	CD
cord-005453-4057qib7	7340	12	pts	pt	NNS
cord-005453-4057qib7	7340	13	(	(	-LRB-
cord-005453-4057qib7	7340	14	12	12	CD
cord-005453-4057qib7	7340	15	%	%	NN
cord-005453-4057qib7	7340	16	)	)	-RRB-
cord-005453-4057qib7	7340	17	with	with	IN
cord-005453-4057qib7	7340	18	t(9;22	t(9;22	NNP
cord-005453-4057qib7	7340	19	)	)	-RRB-
cord-005453-4057qib7	7340	20	,	,	,
cord-005453-4057qib7	7340	21	10	10	CD
cord-005453-4057qib7	7340	22	(	(	-LRB-
cord-005453-4057qib7	7340	23	8	8	CD
cord-005453-4057qib7	7340	24	%	%	NN
cord-005453-4057qib7	7340	25	)	)	-RRB-
cord-005453-4057qib7	7340	26	with	with	IN
cord-005453-4057qib7	7340	27	t(4;11	t(4;11	NNP
cord-005453-4057qib7	7340	28	)	)	-RRB-
cord-005453-4057qib7	7340	29	,	,	,
cord-005453-4057qib7	7340	30	with	with	IN
cord-005453-4057qib7	7340	31	MLL	MLL	NNP
cord-005453-4057qib7	7340	32	11(9	11(9	CD
cord-005453-4057qib7	7340	33	%	%	NN
cord-005453-4057qib7	7340	34	)	)	-RRB-
cord-005453-4057qib7	7340	35	,	,	,
cord-005453-4057qib7	7340	36	84	84	CD
cord-005453-4057qib7	7340	37	pts	pt	NNS
cord-005453-4057qib7	7340	38	(	(	-LRB-
cord-005453-4057qib7	7340	39	70	70	CD
cord-005453-4057qib7	7340	40	%	%	NN
cord-005453-4057qib7	7340	41	)	)	-RRB-
cord-005453-4057qib7	7340	42	who	who	WP
cord-005453-4057qib7	7340	43	were	be	VBD
cord-005453-4057qib7	7340	44	refractory	refractory	JJ
cord-005453-4057qib7	7340	45	to	to	IN
cord-005453-4057qib7	7340	46	previous	previous	JJ
cord-005453-4057qib7	7340	47	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7340	48	,	,	,
cord-005453-4057qib7	7340	49	66	66	CD
cord-005453-4057qib7	7340	50	(	(	-LRB-
cord-005453-4057qib7	7340	51	30	30	CD
cord-005453-4057qib7	7340	52	%	%	NN
cord-005453-4057qib7	7340	53	)	)	-RRB-
cord-005453-4057qib7	7340	54	after	after	IN
cord-005453-4057qib7	7340	55	allo	allo	NN
cord-005453-4057qib7	7340	56	-	-	HYPH
cord-005453-4057qib7	7340	57	HSCT	HSCT	NNP
cord-005453-4057qib7	7340	58	from	from	IN
cord-005453-4057qib7	7340	59	deferent	deferent	JJ
cord-005453-4057qib7	7340	60	type	type	NN
cord-005453-4057qib7	7340	61	of	of	IN
cord-005453-4057qib7	7340	62	donors	donor	NNS
cord-005453-4057qib7	7340	63	.	.	.
cord-005453-4057qib7	7341	1	Median	median	JJ
cord-005453-4057qib7	7341	2	age	age	NN
cord-005453-4057qib7	7341	3	was	be	VBD
cord-005453-4057qib7	7341	4	21	21	CD
cord-005453-4057qib7	7341	5	y.o	y.o	NNP
cord-005453-4057qib7	7341	6	.	.	.
cord-005453-4057qib7	7342	1	(	(	-LRB-
cord-005453-4057qib7	7342	2	range	range	NNP
cord-005453-4057qib7	7342	3	5m-71y.o	5m-71y.o	CD
cord-005453-4057qib7	7342	4	)	)	-RRB-
cord-005453-4057qib7	7343	1	,	,	,
cord-005453-4057qib7	7343	2	55	55	CD
cord-005453-4057qib7	7343	3	children	child	NNS
cord-005453-4057qib7	7343	4	0	0	CD
cord-005453-4057qib7	7343	5	-	-	SYM
cord-005453-4057qib7	7343	6	18	18	CD
cord-005453-4057qib7	7343	7	y.o	y.o	NNP
cord-005453-4057qib7	7343	8	.	.	NNP
cord-005453-4057qib7	7343	9	(	(	-LRB-
cord-005453-4057qib7	7343	10	46	46	CD
cord-005453-4057qib7	7343	11	%	%	NN
cord-005453-4057qib7	7343	12	)	)	-RRB-
cord-005453-4057qib7	7343	13	and	and	CC
cord-005453-4057qib7	7343	14	65	65	CD
cord-005453-4057qib7	7343	15	adults	adult	NNS
cord-005453-4057qib7	7343	16	>	>	NFP
cord-005453-4057qib7	7343	17	18	18	CD
cord-005453-4057qib7	7343	18	y.o	y.o	NNP
cord-005453-4057qib7	7343	19	.	.	NNP
cord-005453-4057qib7	7343	20	(	(	-LRB-
cord-005453-4057qib7	7343	21	54	54	CD
cord-005453-4057qib7	7343	22	%	%	NN
cord-005453-4057qib7	7343	23	)	)	-RRB-
cord-005453-4057qib7	7343	24	.	.	.
cord-005453-4057qib7	7344	1	R	r	NN
cord-005453-4057qib7	7344	2	/	/	SYM
cord-005453-4057qib7	7344	3	R	r	NN
cord-005453-4057qib7	7344	4	ALL	all	DT
cord-005453-4057qib7	7344	5	had	have	VBD
cord-005453-4057qib7	7344	6	63	63	CD
cord-005453-4057qib7	7344	7	pts	pt	NNS
cord-005453-4057qib7	7344	8	(	(	-LRB-
cord-005453-4057qib7	7344	9	52	52	CD
cord-005453-4057qib7	7344	10	%	%	NN
cord-005453-4057qib7	7344	11	)	)	-RRB-
cord-005453-4057qib7	7344	12	,	,	,
cord-005453-4057qib7	7344	13	MRD	MRD	NNP
cord-005453-4057qib7	7344	14	+	+	CC
cord-005453-4057qib7	7344	15	-57	-57	NNP
cord-005453-4057qib7	7344	16	pts	pts	NNP
cord-005453-4057qib7	7344	17	(	(	-LRB-
cord-005453-4057qib7	7344	18	48	48	CD
cord-005453-4057qib7	7344	19	%	%	NN
cord-005453-4057qib7	7344	20	)	)	-RRB-
cord-005453-4057qib7	7344	21	,	,	,
cord-005453-4057qib7	7344	22	median	median	JJ
cord-005453-4057qib7	7344	23	days	day	NNS
cord-005453-4057qib7	7344	24	of	of	IN
cord-005453-4057qib7	7344	25	follow	follow	VBP
cord-005453-4057qib7	7344	26	up	up	RP
cord-005453-4057qib7	7344	27	were	be	VBD
cord-005453-4057qib7	7344	28	227	227	CD
cord-005453-4057qib7	7344	29	(	(	-LRB-
cord-005453-4057qib7	7344	30	18	18	CD
cord-005453-4057qib7	7344	31	-	-	SYM
cord-005453-4057qib7	7344	32	720	720	CD
cord-005453-4057qib7	7344	33	)	)	-RRB-
cord-005453-4057qib7	7344	34	.	.	.
cord-005453-4057qib7	7345	1	Blinatumomab	Blinatumomab	NNP
cord-005453-4057qib7	7345	2	was	be	VBD
cord-005453-4057qib7	7345	3	applied	apply	VBN
cord-005453-4057qib7	7345	4	as	as	IN
cord-005453-4057qib7	7345	5	28-day	28-day	CD
cord-005453-4057qib7	7345	6	cycles	cycle	NNS
cord-005453-4057qib7	7345	7	followed	follow	VBN
cord-005453-4057qib7	7345	8	by	by	IN
cord-005453-4057qib7	7345	9	a	a	DT
cord-005453-4057qib7	7345	10	14-day	14-day	CD
cord-005453-4057qib7	7345	11	off	off	NN
cord-005453-4057qib7	7345	12	-	-	HYPH
cord-005453-4057qib7	7345	13	period	period	NN
cord-005453-4057qib7	7345	14	before	before	IN
cord-005453-4057qib7	7345	15	the	the	DT
cord-005453-4057qib7	7345	16	start	start	NN
cord-005453-4057qib7	7345	17	of	of	IN
cord-005453-4057qib7	7345	18	the	the	DT
cord-005453-4057qib7	7345	19	following	follow	VBG
cord-005453-4057qib7	7345	20	cycle	cycle	NN
cord-005453-4057qib7	7345	21	.	.	.
cord-005453-4057qib7	7346	1	Majority	majority	NN
cord-005453-4057qib7	7346	2	pts	pts	CD
cord-005453-4057qib7	7346	3	received	receive	VBD
cord-005453-4057qib7	7346	4	one	one	CD
cord-005453-4057qib7	7346	5	cycle	cycle	NN
cord-005453-4057qib7	7346	6	(	(	-LRB-
cord-005453-4057qib7	7346	7	N=94	N=94	NNP
cord-005453-4057qib7	7346	8	,	,	,
cord-005453-4057qib7	7346	9	78	78	CD
cord-005453-4057qib7	7346	10	%	%	NN
cord-005453-4057qib7	7346	11	)	)	-RRB-
cord-005453-4057qib7	7346	12	.	.	.
cord-005453-4057qib7	7347	1	In	in	IN
cord-005453-4057qib7	7347	2	R	r	NN
cord-005453-4057qib7	7347	3	/	/	SYM
cord-005453-4057qib7	7347	4	R	r	NN
cord-005453-4057qib7	7347	5	ALL	all	DT
cord-005453-4057qib7	7347	6	group	group	NN
cord-005453-4057qib7	7347	7	dose	dose	NN
cord-005453-4057qib7	7347	8	was	be	VBD
cord-005453-4057qib7	7347	9	of	of	IN
cord-005453-4057qib7	7347	10	9	9	CD
cord-005453-4057qib7	7347	11	mcg	mcg	NN
cord-005453-4057qib7	7347	12	/	/	SYM
cord-005453-4057qib7	7347	13	d	d	NN
cord-005453-4057qib7	7347	14	during	during	IN
cord-005453-4057qib7	7347	15	the	the	DT
cord-005453-4057qib7	7347	16	first	first	JJ
cord-005453-4057qib7	7347	17	7	7	CD
cord-005453-4057qib7	7347	18	days	day	NNS
cord-005453-4057qib7	7347	19	and	and	CC
cord-005453-4057qib7	7347	20	afterwards	afterwards	RB
cord-005453-4057qib7	7347	21	28mcg	28mcg	CD
cord-005453-4057qib7	7347	22	/	/	SYM
cord-005453-4057qib7	7347	23	d	d	NN
cord-005453-4057qib7	7347	24	.	.	.
cord-005453-4057qib7	7348	1	Patients	patient	NNS
cord-005453-4057qib7	7348	2	with	with	IN
cord-005453-4057qib7	7348	3	weight	weight	NN
cord-005453-4057qib7	7348	4	less	less	JJR
cord-005453-4057qib7	7348	5	than	than	IN
cord-005453-4057qib7	7348	6	45	45	CD
cord-005453-4057qib7	7348	7	kg	kg	NNS
cord-005453-4057qib7	7348	8	received	receive	VBD
cord-005453-4057qib7	7348	9	5	5	CD
cord-005453-4057qib7	7348	10	mcg	mcg	NNP
cord-005453-4057qib7	7348	11	/	/	SYM
cord-005453-4057qib7	7348	12	m	m	NN
cord-005453-4057qib7	7348	13	2	2	CD
cord-005453-4057qib7	7348	14	/d	/d	NNP
cord-005453-4057qib7	7348	15	and	and	CC
cord-005453-4057qib7	7348	16	15mkg	15mkg	NNP
cord-005453-4057qib7	7348	17	/	/	SYM
cord-005453-4057qib7	7348	18	m	m	NN
cord-005453-4057qib7	7349	1	2	2	LS
cord-005453-4057qib7	7349	2	/d	/d	NNP
cord-005453-4057qib7	7349	3	accordingly	accordingly	RB
cord-005453-4057qib7	7349	4	.	.	.
cord-005453-4057qib7	7350	1	In	in	IN
cord-005453-4057qib7	7350	2	MRD	MRD	NNP
cord-005453-4057qib7	7350	3	group	group	NN
cord-005453-4057qib7	7350	4	dose	dose	NN
cord-005453-4057qib7	7350	5	was	be	VBD
cord-005453-4057qib7	7350	6	15	15	CD
cord-005453-4057qib7	7350	7	mcg	mcg	NN
cord-005453-4057qib7	7350	8	/	/	SYM
cord-005453-4057qib7	7350	9	m	m	NN
cord-005453-4057qib7	7350	10	2	2	CD
cord-005453-4057qib7	7351	1	/d	/d	NNP
cord-005453-4057qib7	7351	2	.	.	.
cord-005453-4057qib7	7352	1	Results	result	NNS
cord-005453-4057qib7	7352	2	:	:	:
cord-005453-4057qib7	7353	1	The	the	DT
cord-005453-4057qib7	7353	2	frequency	frequency	NN
cord-005453-4057qib7	7353	3	of	of	IN
cord-005453-4057qib7	7353	4	responses	response	NNS
cord-005453-4057qib7	7353	5	to	to	IN
cord-005453-4057qib7	7353	6	blinatumomab	blinatumomab	NNP
cord-005453-4057qib7	7353	7	was	be	VBD
cord-005453-4057qib7	7353	8	higher	high	JJR
cord-005453-4057qib7	7353	9	in	in	IN
cord-005453-4057qib7	7353	10	MRD	MRD	NNP
cord-005453-4057qib7	7353	11	+	+	CC
cord-005453-4057qib7	7353	12	pts	pt	NNS
cord-005453-4057qib7	7353	13	in	in	IN
cord-005453-4057qib7	7353	14	comparison	comparison	NN
cord-005453-4057qib7	7353	15	R	r	NN
cord-005453-4057qib7	7353	16	/	/	SYM
cord-005453-4057qib7	7353	17	R	r	NN
cord-005453-4057qib7	7354	1	ALL	all	DT
cord-005453-4057qib7	7354	2	pts	pt	NNS
cord-005453-4057qib7	7354	3	(	(	-LRB-
cord-005453-4057qib7	7354	4	85	85	CD
cord-005453-4057qib7	7354	5	%	%	NN
cord-005453-4057qib7	7354	6	vs	vs	IN
cord-005453-4057qib7	7354	7	62	62	CD
cord-005453-4057qib7	7354	8	%	%	NN
cord-005453-4057qib7	7354	9	p=0.007	p=0.007	NN
cord-005453-4057qib7	7354	10	)	)	-RRB-
cord-005453-4057qib7	7354	11	.	.	.
cord-005453-4057qib7	7355	1	In	in	IN
cord-005453-4057qib7	7355	2	MRD	MRD	NNP
cord-005453-4057qib7	7355	3	+	+	CC
cord-005453-4057qib7	7355	4	pts	pts	NN
cord-005453-4057qib7	7355	5	CR	CR	NNP
cord-005453-4057qib7	7355	6	MRDwas	MRDwas	NNP
cord-005453-4057qib7	7355	7	achieved	achieve	VBN
cord-005453-4057qib7	7355	8	in	in	IN
cord-005453-4057qib7	7355	9	47	47	CD
cord-005453-4057qib7	7355	10	pts	pt	NNS
cord-005453-4057qib7	7355	11	(	(	-LRB-
cord-005453-4057qib7	7355	12	82.5	82.5	CD
cord-005453-4057qib7	7355	13	%	%	NN
cord-005453-4057qib7	7355	14	)	)	-RRB-
cord-005453-4057qib7	7355	15	,	,	,
cord-005453-4057qib7	7355	16	10	10	CD
cord-005453-4057qib7	7355	17	pts	pt	NNS
cord-005453-4057qib7	7355	18	(	(	-LRB-
cord-005453-4057qib7	7355	19	17.5	17.5	CD
cord-005453-4057qib7	7355	20	%	%	NN
cord-005453-4057qib7	7355	21	)	)	-RRB-
cord-005453-4057qib7	7355	22	were	be	VBD
cord-005453-4057qib7	7355	23	MRD+	MRD+	NNP
cord-005453-4057qib7	7355	24	after	after	IN
cord-005453-4057qib7	7355	25	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	7355	26	.	.	.
cord-005453-4057qib7	7356	1	Two	two	CD
cord-005453-4057qib7	7356	2	-	-	HYPH
cord-005453-4057qib7	7356	3	year	year	NN
cord-005453-4057qib7	7356	4	OS	os	NN
cord-005453-4057qib7	7356	5	in	in	IN
cord-005453-4057qib7	7356	6	this	this	DT
cord-005453-4057qib7	7356	7	group	group	NN
cord-005453-4057qib7	7356	8	was	be	VBD
cord-005453-4057qib7	7356	9	61	61	CD
cord-005453-4057qib7	7356	10	%	%	NN
cord-005453-4057qib7	7356	11	.	.	.
cord-005453-4057qib7	7357	1	Twenty	twenty	CD
cord-005453-4057qib7	7357	2	pts	pts	NN
cord-005453-4057qib7	7357	3	(	(	-LRB-
cord-005453-4057qib7	7357	4	34	34	CD
cord-005453-4057qib7	7357	5	%	%	NN
cord-005453-4057qib7	7357	6	)	)	-RRB-
cord-005453-4057qib7	7357	7	received	receive	VBD
cord-005453-4057qib7	7357	8	allo	allo	NN
cord-005453-4057qib7	7357	9	-	-	HYPH
cord-005453-4057qib7	7357	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7357	11	.	.	.
cord-005453-4057qib7	7358	1	In	in	IN
cord-005453-4057qib7	7358	2	RR	RR	NNP
cord-005453-4057qib7	7358	3	ALL	all	DT
cord-005453-4057qib7	7358	4	pts	pts	NN
cord-005453-4057qib7	7358	5	CR	CR	NNP
cord-005453-4057qib7	7358	6	MRDwas	MRDwas	NNP
cord-005453-4057qib7	7358	7	achieved	achieve	VBN
cord-005453-4057qib7	7358	8	in	in	IN
cord-005453-4057qib7	7358	9	30	30	CD
cord-005453-4057qib7	7358	10	pts	pt	NNS
cord-005453-4057qib7	7358	11	(	(	-LRB-
cord-005453-4057qib7	7358	12	48	48	CD
cord-005453-4057qib7	7358	13	%	%	NN
cord-005453-4057qib7	7358	14	)	)	-RRB-
cord-005453-4057qib7	7358	15	,	,	,
cord-005453-4057qib7	7358	16	9	9	CD
cord-005453-4057qib7	7358	17	pts	pt	NNS
cord-005453-4057qib7	7358	18	(	(	-LRB-
cord-005453-4057qib7	7358	19	14	14	CD
cord-005453-4057qib7	7358	20	%	%	NN
cord-005453-4057qib7	7358	21	)	)	-RRB-
cord-005453-4057qib7	7358	22	were	be	VBD
cord-005453-4057qib7	7358	23	MRD+	MRD+	NNP
cord-005453-4057qib7	7358	24	after	after	IN
cord-005453-4057qib7	7358	25	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	7358	26	,	,	,
cord-005453-4057qib7	7358	27	24	24	CD
cord-005453-4057qib7	7358	28	pts	pt	NNS
cord-005453-4057qib7	7358	29	(	(	-LRB-
cord-005453-4057qib7	7358	30	38	38	CD
cord-005453-4057qib7	7358	31	%	%	NN
cord-005453-4057qib7	7358	32	)	)	-RRB-
cord-005453-4057qib7	7358	33	had	have	VBD
cord-005453-4057qib7	7358	34	no	no	DT
cord-005453-4057qib7	7358	35	hematological	hematological	JJ
cord-005453-4057qib7	7358	36	response	response	NN
cord-005453-4057qib7	7358	37	.	.	.
cord-005453-4057qib7	7359	1	Two	two	CD
cord-005453-4057qib7	7359	2	-	-	HYPH
cord-005453-4057qib7	7359	3	year	year	NN
cord-005453-4057qib7	7359	4	OS	os	NN
cord-005453-4057qib7	7359	5	in	in	IN
cord-005453-4057qib7	7359	6	R	r	NN
cord-005453-4057qib7	7359	7	/	/	SYM
cord-005453-4057qib7	7359	8	R	r	NN
cord-005453-4057qib7	7359	9	ALL	all	DT
cord-005453-4057qib7	7359	10	was	be	VBD
cord-005453-4057qib7	7359	11	43	43	CD
cord-005453-4057qib7	7359	12	%	%	NN
cord-005453-4057qib7	7359	13	.	.	.
cord-005453-4057qib7	7360	1	Fifteen	fifteen	CD
cord-005453-4057qib7	7360	2	pts	pts	NN
cord-005453-4057qib7	7360	3	(	(	-LRB-
cord-005453-4057qib7	7360	4	24	24	CD
cord-005453-4057qib7	7360	5	%	%	NN
cord-005453-4057qib7	7360	6	)	)	-RRB-
cord-005453-4057qib7	7360	7	received	receive	VBD
cord-005453-4057qib7	7360	8	allo	allo	NN
cord-005453-4057qib7	7360	9	-	-	HYPH
cord-005453-4057qib7	7360	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7360	11	.	.	.
cord-005453-4057qib7	7361	1	OS	OS	NNP
cord-005453-4057qib7	7361	2	in	in	IN
cord-005453-4057qib7	7361	3	CR	CR	NNP
cord-005453-4057qib7	7361	4	MRDpatients	mrdpatient	NNS
cord-005453-4057qib7	7361	5	who	who	WP
cord-005453-4057qib7	7361	6	received	receive	VBD
cord-005453-4057qib7	7361	7	allo	allo	NN
cord-005453-4057qib7	7361	8	-	-	HYPH
cord-005453-4057qib7	7361	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7361	10	was	be	VBD
cord-005453-4057qib7	7361	11	not	not	RB
cord-005453-4057qib7	7361	12	significantly	significantly	RB
cord-005453-4057qib7	7361	13	different	different	JJ
cord-005453-4057qib7	7361	14	in	in	IN
cord-005453-4057qib7	7361	15	comparison	comparison	NN
cord-005453-4057qib7	7361	16	with	with	IN
cord-005453-4057qib7	7361	17	patients	patient	NNS
cord-005453-4057qib7	7361	18	who	who	WP
cord-005453-4057qib7	7361	19	received	receive	VBD
cord-005453-4057qib7	7361	20	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	7361	21	as	as	IN
cord-005453-4057qib7	7361	22	a	a	DT
cord-005453-4057qib7	7361	23	monotherapy	monotherapy	NN
cord-005453-4057qib7	7361	24	(	(	-LRB-
cord-005453-4057qib7	7361	25	84	84	CD
cord-005453-4057qib7	7361	26	%	%	NN
cord-005453-4057qib7	7361	27	vs	vs	IN
cord-005453-4057qib7	7361	28	71	71	CD
cord-005453-4057qib7	7361	29	%	%	NN
cord-005453-4057qib7	7361	30	,	,	,
cord-005453-4057qib7	7361	31	p=0.08	p=0.08	NNP
cord-005453-4057qib7	7361	32	)	)	-RRB-
cord-005453-4057qib7	7361	33	.	.	.
cord-005453-4057qib7	7362	1	No	no	DT
cord-005453-4057qib7	7362	2	significant	significant	JJ
cord-005453-4057qib7	7362	3	differences	difference	NNS
cord-005453-4057qib7	7362	4	in	in	IN
cord-005453-4057qib7	7362	5	DFS	DFS	NNP
cord-005453-4057qib7	7362	6	were	be	VBD
cord-005453-4057qib7	7362	7	observed	observe	VBN
cord-005453-4057qib7	7362	8	at	at	IN
cord-005453-4057qib7	7362	9	two	two	CD
cord-005453-4057qib7	7362	10	years	year	NNS
cord-005453-4057qib7	7362	11	in	in	IN
cord-005453-4057qib7	7362	12	CR	cr	NN
cord-005453-4057qib7	7362	13	MRDpts	MRDpts	NNP
cord-005453-4057qib7	7362	14	depending	depend	VBG
cord-005453-4057qib7	7362	15	status	status	NN
cord-005453-4057qib7	7362	16	of	of	IN
cord-005453-4057qib7	7362	17	the	the	DT
cord-005453-4057qib7	7362	18	disease	disease	NN
cord-005453-4057qib7	7362	19	before	before	IN
cord-005453-4057qib7	7362	20	therapy	therapy	NN
cord-005453-4057qib7	7362	21	-	-	HYPH
cord-005453-4057qib7	7362	22	MRD	MRD	NNP
cord-005453-4057qib7	7362	23	vs	vs	IN
cord-005453-4057qib7	7362	24	R	R	NNP
cord-005453-4057qib7	7362	25	/	/	SYM
cord-005453-4057qib7	7362	26	R	r	NN
cord-005453-4057qib7	7362	27	(	(	-LRB-
cord-005453-4057qib7	7362	28	66	66	CD
cord-005453-4057qib7	7362	29	%	%	NN
cord-005453-4057qib7	7362	30	vs	vs	IN
cord-005453-4057qib7	7362	31	59	59	CD
cord-005453-4057qib7	7362	32	%	%	NN
cord-005453-4057qib7	7362	33	)	)	-RRB-
cord-005453-4057qib7	7362	34	.	.	.
cord-005453-4057qib7	7363	1	Of	of	IN
cord-005453-4057qib7	7363	2	the	the	DT
cord-005453-4057qib7	7363	3	reported	report	VBN
cord-005453-4057qib7	7363	4	adverse	adverse	JJ
cord-005453-4057qib7	7363	5	events	event	NNS
cord-005453-4057qib7	7363	6	,	,	,
cord-005453-4057qib7	7363	7	febrile	febrile	JJ
cord-005453-4057qib7	7363	8	fever	fever	NN
cord-005453-4057qib7	7363	9	was	be	VBD
cord-005453-4057qib7	7363	10	the	the	DT
cord-005453-4057qib7	7363	11	most	most	RBS
cord-005453-4057qib7	7363	12	common	common	JJ
cord-005453-4057qib7	7363	13	91pts	91pts	XX
cord-005453-4057qib7	7363	14	(	(	-LRB-
cord-005453-4057qib7	7363	15	76	76	CD
cord-005453-4057qib7	7363	16	%	%	NN
cord-005453-4057qib7	7363	17	)	)	-RRB-
cord-005453-4057qib7	7363	18	,	,	,
cord-005453-4057qib7	7363	19	neutropenia	neutropenia	NN
cord-005453-4057qib7	7363	20	43	43	CD
cord-005453-4057qib7	7363	21	(	(	-LRB-
cord-005453-4057qib7	7363	22	35	35	CD
cord-005453-4057qib7	7363	23	%	%	NN
cord-005453-4057qib7	7363	24	)	)	-RRB-
cord-005453-4057qib7	7363	25	,	,	,
cord-005453-4057qib7	7363	26	thrombocytopenia	thrombocytopenia	VBD
cord-005453-4057qib7	7363	27	46	46	CD
cord-005453-4057qib7	7363	28	(	(	-LRB-
cord-005453-4057qib7	7363	29	38	38	CD
cord-005453-4057qib7	7363	30	%	%	NN
cord-005453-4057qib7	7363	31	)	)	-RRB-
cord-005453-4057qib7	7363	32	,	,	,
cord-005453-4057qib7	7363	33	infection	infection	NN
cord-005453-4057qib7	7363	34	32	32	CD
cord-005453-4057qib7	7363	35	(	(	-LRB-
cord-005453-4057qib7	7363	36	26	26	CD
cord-005453-4057qib7	7363	37	%	%	NN
cord-005453-4057qib7	7363	38	)	)	-RRB-
cord-005453-4057qib7	7363	39	,	,	,
cord-005453-4057qib7	7363	40	neurotoxicity	neurotoxicity	NN
cord-005453-4057qib7	7363	41	29	29	CD
cord-005453-4057qib7	7363	42	(	(	-LRB-
cord-005453-4057qib7	7363	43	24	24	CD
cord-005453-4057qib7	7363	44	%	%	NN
cord-005453-4057qib7	7363	45	)	)	-RRB-
cord-005453-4057qib7	7363	46	,	,	,
cord-005453-4057qib7	7363	47	cytokine	cytokine	NN
cord-005453-4057qib7	7363	48	-	-	HYPH
cord-005453-4057qib7	7363	49	release	release	NN
cord-005453-4057qib7	7363	50	syndrome	syndrome	NN
cord-005453-4057qib7	7363	51	8	8	CD
cord-005453-4057qib7	7363	52	(	(	-LRB-
cord-005453-4057qib7	7363	53	7	7	CD
cord-005453-4057qib7	7363	54	%	%	NN
cord-005453-4057qib7	7363	55	)	)	-RRB-
cord-005453-4057qib7	7363	56	.	.	.
cord-005453-4057qib7	7364	1	All	all	DT
cord-005453-4057qib7	7364	2	complications	complication	NNS
cord-005453-4057qib7	7364	3	were	be	VBD
cord-005453-4057qib7	7364	4	reversible	reversible	JJ
cord-005453-4057qib7	7364	5	.	.	.
cord-005453-4057qib7	7365	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7365	2	:	:	:
cord-005453-4057qib7	7366	1	Blinatumomab	Blinatumomab	NNP
cord-005453-4057qib7	7366	2	is	be	VBZ
cord-005453-4057qib7	7366	3	effective	effective	JJ
cord-005453-4057qib7	7366	4	option	option	NN
cord-005453-4057qib7	7366	5	in	in	IN
cord-005453-4057qib7	7366	6	patients	patient	NNS
cord-005453-4057qib7	7366	7	with	with	IN
cord-005453-4057qib7	7366	8	high	high	JJ
cord-005453-4057qib7	7366	9	risk	risk	NN
cord-005453-4057qib7	7366	10	B	b	NN
cord-005453-4057qib7	7366	11	-	-	:
cord-005453-4057qib7	7366	12	ALL	all	DT
cord-005453-4057qib7	7366	13	especially	especially	RB
cord-005453-4057qib7	7366	14	in	in	IN
cord-005453-4057qib7	7366	15	the	the	DT
cord-005453-4057qib7	7366	16	group	group	NN
cord-005453-4057qib7	7366	17	with	with	IN
cord-005453-4057qib7	7366	18	MRD	MRD	NNP
cord-005453-4057qib7	7366	19	persistence	persistence	NN
cord-005453-4057qib7	7366	20	after	after	IN
cord-005453-4057qib7	7366	21	previous	previous	JJ
cord-005453-4057qib7	7366	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7366	23	and	and	CC
cord-005453-4057qib7	7366	24	facilitates	facilitate	VBZ
cord-005453-4057qib7	7366	25	effective	effective	JJ
cord-005453-4057qib7	7366	26	bridging	bridging	NN
cord-005453-4057qib7	7366	27	to	to	IN
cord-005453-4057qib7	7366	28	HSCT	HSCT	NNP
cord-005453-4057qib7	7366	29	.	.	.
cord-005453-4057qib7	7367	1	Blinatumomab	blinatumomab	JJ
cord-005453-4057qib7	7367	2	therapy	therapy	NN
cord-005453-4057qib7	7367	3	is	be	VBZ
cord-005453-4057qib7	7367	4	generally	generally	RB
cord-005453-4057qib7	7367	5	well	well	RB
cord-005453-4057qib7	7367	6	tolerated	tolerate	VBN
cord-005453-4057qib7	7367	7	.	.	.
cord-005453-4057qib7	7368	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7368	2	Here	here	RB
cord-005453-4057qib7	7369	1	we	-PRON-	PRP
cord-005453-4057qib7	7369	2	address	address	VBP
cord-005453-4057qib7	7369	3	the	the	DT
cord-005453-4057qib7	7369	4	transcriptional	transcriptional	JJ
cord-005453-4057qib7	7369	5	regulation	regulation	NN
cord-005453-4057qib7	7369	6	of	of	IN
cord-005453-4057qib7	7369	7	differentiated	differentiated	JJ
cord-005453-4057qib7	7369	8	cells	cell	NNS
cord-005453-4057qib7	7369	9	from	from	IN
cord-005453-4057qib7	7369	10	human	human	JJ
cord-005453-4057qib7	7369	11	embryonic	embryonic	JJ
cord-005453-4057qib7	7369	12	stem	stem	NN
cord-005453-4057qib7	7369	13	cells	cell	NNS
cord-005453-4057qib7	7369	14	(	(	-LRB-
cord-005453-4057qib7	7369	15	ESCs	esc	NNS
cord-005453-4057qib7	7369	16	)	)	-RRB-
cord-005453-4057qib7	7369	17	using	use	VBG
cord-005453-4057qib7	7369	18	self	self	NN
cord-005453-4057qib7	7369	19	-	-	HYPH
cord-005453-4057qib7	7369	20	assembling	assemble	VBG
cord-005453-4057qib7	7369	21	peptide	peptide	JJ
cord-005453-4057qib7	7369	22	hydrogel	hydrogel	NN
cord-005453-4057qib7	7369	23	without	without	IN
cord-005453-4057qib7	7369	24	stromal	stromal	JJ
cord-005453-4057qib7	7369	25	cells	cell	NNS
cord-005453-4057qib7	7369	26	,	,	,
cord-005453-4057qib7	7369	27	and	and	CC
cord-005453-4057qib7	7369	28	compare	compare	VBP
cord-005453-4057qib7	7369	29	with	with	IN
cord-005453-4057qib7	7369	30	embryoid	embryoid	JJ
cord-005453-4057qib7	7369	31	body	body	NN
cord-005453-4057qib7	7369	32	(	(	-LRB-
cord-005453-4057qib7	7369	33	EB	EB	NNP
cord-005453-4057qib7	7369	34	)	)	-RRB-
cord-005453-4057qib7	7369	35	culture	culture	NN
cord-005453-4057qib7	7369	36	system	system	NN
cord-005453-4057qib7	7369	37	.	.	.
cord-005453-4057qib7	7370	1	Methods	method	NNS
cord-005453-4057qib7	7370	2	:	:	:
cord-005453-4057qib7	7370	3	ESC	esc	NN
cord-005453-4057qib7	7370	4	differentiation	differentiation	NN
cord-005453-4057qib7	7370	5	was	be	VBD
cord-005453-4057qib7	7370	6	induced	induce	VBN
cord-005453-4057qib7	7370	7	in	in	IN
cord-005453-4057qib7	7370	8	EB	EB	NNP
cord-005453-4057qib7	7370	9	culture	culture	NN
cord-005453-4057qib7	7370	10	system	system	NN
cord-005453-4057qib7	7370	11	or	or	CC
cord-005453-4057qib7	7370	12	three	three	CD
cord-005453-4057qib7	7370	13	-	-	HYPH
cord-005453-4057qib7	7370	14	dimensional	dimensional	JJ
cord-005453-4057qib7	7370	15	(	(	-LRB-
cord-005453-4057qib7	7370	16	3D	3D	NNP
cord-005453-4057qib7	7370	17	)	)	-RRB-
cord-005453-4057qib7	7370	18	hydrogel	hydrogel	NN
cord-005453-4057qib7	7370	19	culture	culture	NN
cord-005453-4057qib7	7370	20	system	system	NN
cord-005453-4057qib7	7370	21	.	.	.
cord-005453-4057qib7	7371	1	The	the	DT
cord-005453-4057qib7	7371	2	engraftment	engraftment	NN
cord-005453-4057qib7	7371	3	potential	potential	NN
cord-005453-4057qib7	7371	4	of	of	IN
cord-005453-4057qib7	7371	5	differentiated	differentiated	JJ
cord-005453-4057qib7	7371	6	cells	cell	NNS
cord-005453-4057qib7	7371	7	was	be	VBD
cord-005453-4057qib7	7371	8	evaluated	evaluate	VBN
cord-005453-4057qib7	7371	9	by	by	IN
cord-005453-4057qib7	7371	10	flow	flow	NN
cord-005453-4057qib7	7371	11	cytometry	cytometry	NN
cord-005453-4057qib7	7371	12	.	.	.
cord-005453-4057qib7	7372	1	CD34	CD34	NNP
cord-005453-4057qib7	7372	2	+	+	CC
cord-005453-4057qib7	7372	3	cells	cell	NNS
cord-005453-4057qib7	7372	4	from	from	IN
cord-005453-4057qib7	7372	5	mobilized	mobilize	VBN
cord-005453-4057qib7	7372	6	peripheral	peripheral	JJ
cord-005453-4057qib7	7372	7	mononuclear	mononuclear	JJ
cord-005453-4057qib7	7372	8	blood	blood	NN
cord-005453-4057qib7	7372	9	cells	cell	NNS
cord-005453-4057qib7	7372	10	(	(	-LRB-
cord-005453-4057qib7	7372	11	mPBMCs	mpbmcs	CD
cord-005453-4057qib7	7372	12	)	)	-RRB-
cord-005453-4057qib7	7372	13	or	or	CC
cord-005453-4057qib7	7372	14	differentiated	differentiate	VBN
cord-005453-4057qib7	7372	15	from	from	IN
cord-005453-4057qib7	7372	16	ESCs	esc	NNS
cord-005453-4057qib7	7372	17	at	at	IN
cord-005453-4057qib7	7372	18	different	different	JJ
cord-005453-4057qib7	7372	19	times	time	NNS
cord-005453-4057qib7	7372	20	(	(	-LRB-
cord-005453-4057qib7	7372	21	day	day	NN
cord-005453-4057qib7	7372	22	7	7	CD
cord-005453-4057qib7	7372	23	,	,	,
cord-005453-4057qib7	7372	24	day	day	NN
cord-005453-4057qib7	7372	25	10	10	CD
cord-005453-4057qib7	7372	26	,	,	,
cord-005453-4057qib7	7372	27	day	day	NN
cord-005453-4057qib7	7372	28	14	14	CD
cord-005453-4057qib7	7372	29	)	)	-RRB-
cord-005453-4057qib7	7372	30	were	be	VBD
cord-005453-4057qib7	7372	31	purified	purify	VBN
cord-005453-4057qib7	7372	32	by	by	IN
cord-005453-4057qib7	7372	33	fluorescent	fluorescent	NN
cord-005453-4057qib7	7372	34	-	-	HYPH
cord-005453-4057qib7	7372	35	activated	activate	VBN
cord-005453-4057qib7	7372	36	cell	cell	NN
cord-005453-4057qib7	7372	37	sorting	sorting	NN
cord-005453-4057qib7	7372	38	.	.	.
cord-005453-4057qib7	7373	1	Sorted	sorted	JJ
cord-005453-4057qib7	7373	2	cells	cell	NNS
cord-005453-4057qib7	7373	3	were	be	VBD
cord-005453-4057qib7	7373	4	captured	capture	VBN
cord-005453-4057qib7	7373	5	on	on	IN
cord-005453-4057qib7	7373	6	medium	medium	JJ
cord-005453-4057qib7	7373	7	-	-	HYPH
cord-005453-4057qib7	7373	8	sized	sized	JJ
cord-005453-4057qib7	7373	9	microfluidic	microfluidic	JJ
cord-005453-4057qib7	7373	10	chips	chip	NNS
cord-005453-4057qib7	7373	11	using	use	VBG
cord-005453-4057qib7	7373	12	the	the	DT
cord-005453-4057qib7	7373	13	Fluidigm	Fluidigm	NNP
cord-005453-4057qib7	7373	14	C1	C1	NNP
cord-005453-4057qib7	7373	15	Single	Single	NNP
cord-005453-4057qib7	7373	16	Cell	Cell	NNP
cord-005453-4057qib7	7373	17	Auto	Auto	NNP
cord-005453-4057qib7	7373	18	Prep	Prep	NNP
cord-005453-4057qib7	7373	19	System	System	NNP
cord-005453-4057qib7	7373	20	.	.	.
cord-005453-4057qib7	7374	1	Sequencing	sequencing	NN
cord-005453-4057qib7	7374	2	was	be	VBD
cord-005453-4057qib7	7374	3	performed	perform	VBN
cord-005453-4057qib7	7374	4	by	by	IN
cord-005453-4057qib7	7374	5	HiSeq	HiSeq	NNP
cord-005453-4057qib7	7374	6	X	X	NNP
cord-005453-4057qib7	7374	7	Ten	Ten	NNP
cord-005453-4057qib7	7374	8	.	.	.
cord-005453-4057qib7	7375	1	Results	result	NNS
cord-005453-4057qib7	7375	2	:	:	:
cord-005453-4057qib7	7376	1	Self	self	NN
cord-005453-4057qib7	7376	2	-	-	HYPH
cord-005453-4057qib7	7376	3	assembling	assemble	VBG
cord-005453-4057qib7	7376	4	peptide	peptide	JJ
cord-005453-4057qib7	7376	5	hydrogel	hydrogel	NN
cord-005453-4057qib7	7376	6	formed	form	VBD
cord-005453-4057qib7	7376	7	a	a	DT
cord-005453-4057qib7	7376	8	3D	3d	JJ
cord-005453-4057qib7	7376	9	scaffold	scaffold	NN
cord-005453-4057qib7	7376	10	for	for	IN
cord-005453-4057qib7	7376	11	cell	cell	NN
cord-005453-4057qib7	7376	12	culture	culture	NN
cord-005453-4057qib7	7376	13	,	,	,
cord-005453-4057qib7	7376	14	the	the	DT
cord-005453-4057qib7	7376	15	pore	pore	NN
cord-005453-4057qib7	7376	16	diameter	diameter	NN
cord-005453-4057qib7	7376	17	of	of	IN
cord-005453-4057qib7	7376	18	which	which	WDT
cord-005453-4057qib7	7376	19	ranged	range	VBD
cord-005453-4057qib7	7376	20	from	from	IN
cord-005453-4057qib7	7376	21	50	50	CD
cord-005453-4057qib7	7376	22	to	to	IN
cord-005453-4057qib7	7376	23	200	200	CD
cord-005453-4057qib7	7376	24	nm	nm	NN
cord-005453-4057qib7	7376	25	.	.	.
cord-005453-4057qib7	7377	1	Compared	compare	VBN
cord-005453-4057qib7	7377	2	to	to	IN
cord-005453-4057qib7	7377	3	EB	eb	NN
cord-005453-4057qib7	7377	4	culture	culture	NN
cord-005453-4057qib7	7377	5	system	system	NN
cord-005453-4057qib7	7377	6	,	,	,
cord-005453-4057qib7	7377	7	ESCs	esc	NNS
cord-005453-4057qib7	7377	8	in	in	IN
cord-005453-4057qib7	7377	9	3D	3d	JJ
cord-005453-4057qib7	7377	10	culture	culture	NN
cord-005453-4057qib7	7377	11	system	system	NN
cord-005453-4057qib7	7377	12	differentiated	differentiate	VBD
cord-005453-4057qib7	7377	13	more	more	RBR
cord-005453-4057qib7	7377	14	potently	potently	RB
cord-005453-4057qib7	7377	15	.	.	.
cord-005453-4057qib7	7378	1	The	the	DT
cord-005453-4057qib7	7378	2	differentiated	differentiated	JJ
cord-005453-4057qib7	7378	3	cells	cell	NNS
cord-005453-4057qib7	7378	4	from	from	IN
cord-005453-4057qib7	7378	5	3D	3d	JJ
cord-005453-4057qib7	7378	6	system	system	NN
cord-005453-4057qib7	7378	7	were	be	VBD
cord-005453-4057qib7	7378	8	short	short	JJ
cord-005453-4057qib7	7378	9	-	-	HYPH
cord-005453-4057qib7	7378	10	term	term	NN
cord-005453-4057qib7	7378	11	engrafted	engraft	VBN
cord-005453-4057qib7	7378	12	in	in	IN
cord-005453-4057qib7	7378	13	the	the	DT
cord-005453-4057qib7	7378	14	NOG	NOG	NNP
cord-005453-4057qib7	7378	15	mice	mouse	NNS
cord-005453-4057qib7	7378	16	,	,	,
cord-005453-4057qib7	7378	17	and	and	CC
cord-005453-4057qib7	7378	18	myeloid	myeloid	NN
cord-005453-4057qib7	7378	19	cells	cell	NNS
cord-005453-4057qib7	7378	20	,	,	,
cord-005453-4057qib7	7378	21	B	b	NN
cord-005453-4057qib7	7378	22	cells	cell	NNS
cord-005453-4057qib7	7378	23	and	and	CC
cord-005453-4057qib7	7378	24	T	t	NN
cord-005453-4057qib7	7378	25	cells	cell	NNS
cord-005453-4057qib7	7378	26	could	could	MD
cord-005453-4057qib7	7378	27	all	all	DT
cord-005453-4057qib7	7378	28	be	be	VB
cord-005453-4057qib7	7378	29	detected	detect	VBN
cord-005453-4057qib7	7378	30	in	in	IN
cord-005453-4057qib7	7378	31	peripheral	peripheral	JJ
cord-005453-4057qib7	7378	32	blood	blood	NN
cord-005453-4057qib7	7378	33	after	after	IN
cord-005453-4057qib7	7378	34	transplantation	transplantation	NN
cord-005453-4057qib7	7378	35	.	.	.
cord-005453-4057qib7	7379	1	However	however	RB
cord-005453-4057qib7	7379	2	,	,	,
cord-005453-4057qib7	7379	3	the	the	DT
cord-005453-4057qib7	7379	4	engraftment	engraftment	NN
cord-005453-4057qib7	7379	5	was	be	VBD
cord-005453-4057qib7	7379	6	not	not	RB
cord-005453-4057qib7	7379	7	obtained	obtain	VBN
cord-005453-4057qib7	7379	8	in	in	IN
cord-005453-4057qib7	7379	9	differentiated	differentiated	JJ
cord-005453-4057qib7	7379	10	cells	cell	NNS
cord-005453-4057qib7	7379	11	from	from	IN
cord-005453-4057qib7	7379	12	EB	eb	NN
cord-005453-4057qib7	7379	13	culture	culture	NN
cord-005453-4057qib7	7379	14	system	system	NN
cord-005453-4057qib7	7379	15	.	.	.
cord-005453-4057qib7	7380	1	We	-PRON-	PRP
cord-005453-4057qib7	7380	2	obtained	obtain	VBD
cord-005453-4057qib7	7380	3	and	and	CC
cord-005453-4057qib7	7380	4	analyzed	analyze	VBD
cord-005453-4057qib7	7380	5	301	301	CD
cord-005453-4057qib7	7380	6	ESCs	esc	NNS
cord-005453-4057qib7	7380	7	,	,	,
cord-005453-4057qib7	7380	8	554	554	CD
cord-005453-4057qib7	7380	9	CD34	CD34	NNP
cord-005453-4057qib7	7380	10	+	+	CC
cord-005453-4057qib7	7380	11	cells	cell	NNS
cord-005453-4057qib7	7380	12	from	from	IN
cord-005453-4057qib7	7380	13	EB	eb	NN
cord-005453-4057qib7	7380	14	culture	culture	NN
cord-005453-4057qib7	7380	15	system	system	NN
cord-005453-4057qib7	7380	16	,	,	,
cord-005453-4057qib7	7380	17	440	440	CD
cord-005453-4057qib7	7380	18	CD34	CD34	NNP
cord-005453-4057qib7	7380	19	+	+	CC
cord-005453-4057qib7	7380	20	cells	cell	NNS
cord-005453-4057qib7	7380	21	from	from	IN
cord-005453-4057qib7	7380	22	3D	3d	JJ
cord-005453-4057qib7	7380	23	culture	culture	NN
cord-005453-4057qib7	7380	24	system	system	NN
cord-005453-4057qib7	7380	25	,	,	,
cord-005453-4057qib7	7380	26	and	and	CC
cord-005453-4057qib7	7380	27	218	218	CD
cord-005453-4057qib7	7380	28	CD34	CD34	NNP
cord-005453-4057qib7	7380	29	+	+	CC
cord-005453-4057qib7	7380	30	cells	cell	NNS
cord-005453-4057qib7	7380	31	from	from	IN
cord-005453-4057qib7	7380	32	mPBMCs	mpbmcs	CD
cord-005453-4057qib7	7380	33	.	.	.
cord-005453-4057qib7	7381	1	The	the	DT
cord-005453-4057qib7	7381	2	cells	cell	NNS
cord-005453-4057qib7	7381	3	were	be	VBD
cord-005453-4057qib7	7381	4	divided	divide	VBN
cord-005453-4057qib7	7381	5	into	into	IN
cord-005453-4057qib7	7381	6	11	11	CD
cord-005453-4057qib7	7381	7	cluters	cluter	NNS
cord-005453-4057qib7	7381	8	(	(	-LRB-
cord-005453-4057qib7	7381	9	Figure	figure	NN
cord-005453-4057qib7	7381	10	1A	1a	NN
cord-005453-4057qib7	7381	11	)	)	-RRB-
cord-005453-4057qib7	7381	12	.	.	.
cord-005453-4057qib7	7382	1	In	in	IN
cord-005453-4057qib7	7382	2	both	both	DT
cord-005453-4057qib7	7382	3	differentiation	differentiation	NN
cord-005453-4057qib7	7382	4	systems	system	NNS
cord-005453-4057qib7	7382	5	,	,	,
cord-005453-4057qib7	7382	6	the	the	DT
cord-005453-4057qib7	7382	7	CD34	CD34	NNP
cord-005453-4057qib7	7382	8	+	+	CC
cord-005453-4057qib7	7382	9	cells	cell	NNS
cord-005453-4057qib7	7382	10	from	from	IN
cord-005453-4057qib7	7382	11	day	day	NN
cord-005453-4057qib7	7382	12	7	7	CD
cord-005453-4057qib7	7382	13	were	be	VBD
cord-005453-4057qib7	7382	14	more	more	RBR
cord-005453-4057qib7	7382	15	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	7382	16	than	than	IN
cord-005453-4057qib7	7382	17	CD34	CD34	NNP
cord-005453-4057qib7	7382	18	+	+	CC
cord-005453-4057qib7	7382	19	cells	cell	NNS
cord-005453-4057qib7	7382	20	from	from	IN
cord-005453-4057qib7	7382	21	day	day	NN
cord-005453-4057qib7	7382	22	10	10	CD
cord-005453-4057qib7	7382	23	and	and	CC
cord-005453-4057qib7	7382	24	day	day	NN
cord-005453-4057qib7	7382	25	14	14	CD
cord-005453-4057qib7	7382	26	(	(	-LRB-
cord-005453-4057qib7	7382	27	Figure	figure	NN
cord-005453-4057qib7	7382	28	1B	1b	CD
cord-005453-4057qib7	7382	29	)	)	-RRB-
cord-005453-4057qib7	7382	30	.	.	.
cord-005453-4057qib7	7383	1	However	however	RB
cord-005453-4057qib7	7383	2	,	,	,
cord-005453-4057qib7	7383	3	CD34	CD34	NNP
cord-005453-4057qib7	7383	4	+	+	CC
cord-005453-4057qib7	7383	5	cells	cell	NNS
cord-005453-4057qib7	7383	6	from	from	IN
cord-005453-4057qib7	7383	7	mPBMCs	mPBMCs	NNP
cord-005453-4057qib7	7383	8	were	be	VBD
cord-005453-4057qib7	7383	9	more	more	RBR
cord-005453-4057qib7	7383	10	homogeneous	homogeneous	JJ
cord-005453-4057qib7	7383	11	,	,	,
cord-005453-4057qib7	7383	12	probably	probably	RB
cord-005453-4057qib7	7383	13	because	because	IN
cord-005453-4057qib7	7383	14	the	the	DT
cord-005453-4057qib7	7383	15	differentiated	differentiated	JJ
cord-005453-4057qib7	7383	16	CD34	CD34	NNP
cord-005453-4057qib7	7383	17	+	+	CC
cord-005453-4057qib7	7383	18	cells	cell	NNS
cord-005453-4057qib7	7383	19	contained	contain	VBD
cord-005453-4057qib7	7383	20	several	several	JJ
cord-005453-4057qib7	7383	21	cell	cell	NN
cord-005453-4057qib7	7383	22	lineages	lineage	NNS
cord-005453-4057qib7	7383	23	,	,	,
cord-005453-4057qib7	7383	24	including	include	VBG
cord-005453-4057qib7	7383	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7383	26	cells	cell	NNS
cord-005453-4057qib7	7383	27	,	,	,
cord-005453-4057qib7	7383	28	endothelial	endothelial	JJ
cord-005453-4057qib7	7383	29	cells	cell	NNS
cord-005453-4057qib7	7383	30	and	and	CC
cord-005453-4057qib7	7383	31	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	7383	32	cells	cell	NNS
cord-005453-4057qib7	7383	33	.	.	.
cord-005453-4057qib7	7384	1	There	there	EX
cord-005453-4057qib7	7384	2	is	be	VBZ
cord-005453-4057qib7	7384	3	transcriptional	transcriptional	JJ
cord-005453-4057qib7	7384	4	overlap	overlap	NN
cord-005453-4057qib7	7384	5	between	between	IN
cord-005453-4057qib7	7384	6	individual	individual	JJ
cord-005453-4057qib7	7384	7	CD34	CD34	NNP
cord-005453-4057qib7	7384	8	+	+	CC
cord-005453-4057qib7	7384	9	cells	cell	NNS
cord-005453-4057qib7	7384	10	from	from	IN
cord-005453-4057qib7	7384	11	EB	EB	NNP
cord-005453-4057qib7	7384	12	and	and	CC
cord-005453-4057qib7	7384	13	3D	3D	NNP
cord-005453-4057qib7	7384	14	culture	culture	NN
cord-005453-4057qib7	7384	15	systems	system	NNS
cord-005453-4057qib7	7384	16	.	.	.
cord-005453-4057qib7	7385	1	However	however	RB
cord-005453-4057qib7	7385	2	,	,	,
cord-005453-4057qib7	7385	3	we	-PRON-	PRP
cord-005453-4057qib7	7385	4	found	find	VBD
cord-005453-4057qib7	7385	5	that	that	IN
cord-005453-4057qib7	7385	6	cluster	cluster	NN
cord-005453-4057qib7	7385	7	3	3	CD
cord-005453-4057qib7	7385	8	,	,	,
cord-005453-4057qib7	7385	9	which	which	WDT
cord-005453-4057qib7	7385	10	is	be	VBZ
cord-005453-4057qib7	7385	11	composed	compose	VBN
cord-005453-4057qib7	7385	12	mainly	mainly	RB
cord-005453-4057qib7	7385	13	of	of	IN
cord-005453-4057qib7	7385	14	CD34	CD34	NNP
cord-005453-4057qib7	7385	15	+	+	CC
cord-005453-4057qib7	7385	16	cells	cell	NNS
cord-005453-4057qib7	7385	17	from	from	IN
cord-005453-4057qib7	7385	18	3D	3D	NNP
cord-005453-4057qib7	7385	19	at	at	IN
cord-005453-4057qib7	7385	20	day	day	NN
cord-005453-4057qib7	7385	21	14	14	CD
cord-005453-4057qib7	7385	22	and	and	CC
cord-005453-4057qib7	7385	23	day	day	NN
cord-005453-4057qib7	7385	24	10	10	CD
cord-005453-4057qib7	7385	25	,	,	,
cord-005453-4057qib7	7385	26	expressed	express	VBD
cord-005453-4057qib7	7385	27	similar	similar	JJ
cord-005453-4057qib7	7385	28	level	level	NN
cord-005453-4057qib7	7385	29	of	of	IN
cord-005453-4057qib7	7385	30	several	several	JJ
cord-005453-4057qib7	7385	31	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7385	32	regulator	regulator	NN
cord-005453-4057qib7	7385	33	as	as	IN
cord-005453-4057qib7	7385	34	HSC	HSC	NNP
cord-005453-4057qib7	7385	35	,	,	,
cord-005453-4057qib7	7385	36	such	such	JJ
cord-005453-4057qib7	7385	37	as	as	IN
cord-005453-4057qib7	7385	38	TAL1	TAL1	NNP
cord-005453-4057qib7	7385	39	,	,	,
cord-005453-4057qib7	7385	40	LMO2	LMO2	NNP
cord-005453-4057qib7	7385	41	,	,	,
cord-005453-4057qib7	7385	42	ERG	ERG	NNP
cord-005453-4057qib7	7385	43	(	(	-LRB-
cord-005453-4057qib7	7385	44	Figure	Figure	NNP
cord-005453-4057qib7	7385	45	1C	1c	NN
cord-005453-4057qib7	7385	46	)	)	-RRB-
cord-005453-4057qib7	7385	47	.	.	.
cord-005453-4057qib7	7386	1	The	the	DT
cord-005453-4057qib7	7386	2	cluster	cluster	NN
cord-005453-4057qib7	7386	3	6	6	CD
cord-005453-4057qib7	7386	4	,	,	,
cord-005453-4057qib7	7386	5	which	which	WDT
cord-005453-4057qib7	7386	6	is	be	VBZ
cord-005453-4057qib7	7386	7	almost	almost	RB
cord-005453-4057qib7	7386	8	the	the	DT
cord-005453-4057qib7	7386	9	CD34	CD34	NNP
cord-005453-4057qib7	7386	10	+	+	CC
cord-005453-4057qib7	7386	11	cells	cell	NNS
cord-005453-4057qib7	7386	12	from	from	IN
cord-005453-4057qib7	7386	13	3D	3D	NNP
cord-005453-4057qib7	7386	14	at	at	IN
cord-005453-4057qib7	7386	15	day	day	NN
cord-005453-4057qib7	7386	16	7	7	CD
cord-005453-4057qib7	7386	17	,	,	,
cord-005453-4057qib7	7386	18	also	also	RB
cord-005453-4057qib7	7386	19	expressed	express	VBD
cord-005453-4057qib7	7386	20	the	the	DT
cord-005453-4057qib7	7386	21	highest	high	JJS
cord-005453-4057qib7	7386	22	GATA2	GATA2	NNS
cord-005453-4057qib7	7386	23	among	among	IN
cord-005453-4057qib7	7386	24	the	the	DT
cord-005453-4057qib7	7386	25	clusters	cluster	NNS
cord-005453-4057qib7	7386	26	from	from	IN
cord-005453-4057qib7	7386	27	differentiated	differentiated	JJ
cord-005453-4057qib7	7386	28	cells	cell	NNS
cord-005453-4057qib7	7386	29	(	(	-LRB-
cord-005453-4057qib7	7386	30	Figure	figure	NN
cord-005453-4057qib7	7386	31	1C	1c	NN
cord-005453-4057qib7	7386	32	)	)	-RRB-
cord-005453-4057qib7	7386	33	.	.	.
cord-005453-4057qib7	7387	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7387	2	:	:	:
cord-005453-4057qib7	7388	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7388	2	study	study	NN
cord-005453-4057qib7	7388	3	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	7388	4	that	that	IN
cord-005453-4057qib7	7388	5	3D	3d	JJ
cord-005453-4057qib7	7388	6	hydrogel	hydrogel	NN
cord-005453-4057qib7	7388	7	culture	culture	NN
cord-005453-4057qib7	7388	8	system	system	NN
cord-005453-4057qib7	7388	9	facilitates	facilitate	VBZ
cord-005453-4057qib7	7388	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7388	11	specification	specification	NN
cord-005453-4057qib7	7388	12	of	of	IN
cord-005453-4057qib7	7388	13	ESCs	esc	NNS
cord-005453-4057qib7	7388	14	.	.	.
cord-005453-4057qib7	7389	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7389	2	:	:	:
cord-005453-4057qib7	7389	3	Nothing	nothing	NN
cord-005453-4057qib7	7389	4	to	to	TO
cord-005453-4057qib7	7389	5	declare	declare	VB
cord-005453-4057qib7	7389	6	Higher	high	JJR
cord-005453-4057qib7	7389	7	CD34	CD34	NNP
cord-005453-4057qib7	7389	8	+	+	CC
cord-005453-4057qib7	7389	9	cell	cell	NN
cord-005453-4057qib7	7389	10	dose	dose	NN
cord-005453-4057qib7	7389	11	increases	increase	VBZ
cord-005453-4057qib7	7389	12	overall	overall	JJ
cord-005453-4057qib7	7389	13	survival	survival	NN
cord-005453-4057qib7	7389	14	in	in	IN
cord-005453-4057qib7	7389	15	the	the	DT
cord-005453-4057qib7	7389	16	setting	setting	NN
cord-005453-4057qib7	7389	17	of	of	IN
cord-005453-4057qib7	7389	18	dual	dual	JJ
cord-005453-4057qib7	7389	19	T	t	NN
cord-005453-4057qib7	7389	20	-	-	HYPH
cord-005453-4057qib7	7389	21	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7389	22	suppression	suppression	NN
cord-005453-4057qib7	7389	23	with	with	IN
cord-005453-4057qib7	7389	24	ATG	ATG	NNP
cord-005453-4057qib7	7389	25	and	and	CC
cord-005453-4057qib7	7389	26	PTCY	PTCY	NNP
cord-005453-4057qib7	7389	27	in	in	IN
cord-005453-4057qib7	7389	28	matched	match	VBN
cord-005453-4057qib7	7389	29	related	related	JJ
cord-005453-4057qib7	7389	30	and	and	CC
cord-005453-4057qib7	7389	31	unrelated	unrelated	JJ
cord-005453-4057qib7	7389	32	donor	donor	NN
cord-005453-4057qib7	7390	1	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7390	2	Background	Background	NNP
cord-005453-4057qib7	7390	3	:	:	:
cord-005453-4057qib7	7391	1	There	there	EX
cord-005453-4057qib7	7391	2	is	be	VBZ
cord-005453-4057qib7	7391	3	no	no	DT
cord-005453-4057qib7	7391	4	consensus	consensus	NN
cord-005453-4057qib7	7391	5	on	on	IN
cord-005453-4057qib7	7391	6	the	the	DT
cord-005453-4057qib7	7391	7	CD34	CD34	NNP
cord-005453-4057qib7	7391	8	+	+	CC
cord-005453-4057qib7	7391	9	donor	donor	NN
cord-005453-4057qib7	7391	10	cell	cell	NN
cord-005453-4057qib7	7391	11	numbers	number	NNS
cord-005453-4057qib7	7391	12	required	require	VBN
cord-005453-4057qib7	7391	13	for	for	IN
cord-005453-4057qib7	7391	14	optimal	optimal	JJ
cord-005453-4057qib7	7391	15	outcomes	outcome	NNS
cord-005453-4057qib7	7391	16	in	in	IN
cord-005453-4057qib7	7391	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	7391	18	stem	stem	NN
cord-005453-4057qib7	7391	19	cell	cell	NN
cord-005453-4057qib7	7391	20	transplant	transplant	NN
cord-005453-4057qib7	7391	21	(	(	-LRB-
cord-005453-4057qib7	7391	22	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7391	23	)	)	-RRB-
cord-005453-4057qib7	7391	24	.	.	.
cord-005453-4057qib7	7392	1	There	there	EX
cord-005453-4057qib7	7392	2	is	be	VBZ
cord-005453-4057qib7	7392	3	controversy	controversy	NN
cord-005453-4057qib7	7392	4	on	on	IN
cord-005453-4057qib7	7392	5	the	the	DT
cord-005453-4057qib7	7392	6	benefits	benefit	NNS
cord-005453-4057qib7	7392	7	or	or	CC
cord-005453-4057qib7	7392	8	harm	harm	NN
cord-005453-4057qib7	7392	9	in	in	IN
cord-005453-4057qib7	7392	10	higher	high	JJR
cord-005453-4057qib7	7392	11	cell	cell	NN
cord-005453-4057qib7	7392	12	dose	dose	NN
cord-005453-4057qib7	7392	13	for	for	IN
cord-005453-4057qib7	7392	14	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7392	15	.	.	.
cord-005453-4057qib7	7393	1	This	this	DT
cord-005453-4057qib7	7393	2	study	study	NN
cord-005453-4057qib7	7393	3	aims	aim	VBZ
cord-005453-4057qib7	7393	4	to	to	TO
cord-005453-4057qib7	7393	5	evaluate	evaluate	VB
cord-005453-4057qib7	7393	6	the	the	DT
cord-005453-4057qib7	7393	7	impact	impact	NN
cord-005453-4057qib7	7393	8	of	of	IN
cord-005453-4057qib7	7393	9	CD34	CD34	NNP
cord-005453-4057qib7	7393	10	+	+	CC
cord-005453-4057qib7	7393	11	cell	cell	NN
cord-005453-4057qib7	7393	12	dose	dose	NN
cord-005453-4057qib7	7393	13	in	in	IN
cord-005453-4057qib7	7393	14	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7393	15	patients	patient	NNS
cord-005453-4057qib7	7393	16	receiving	receive	VBG
cord-005453-4057qib7	7393	17	reduced	reduced	JJ
cord-005453-4057qib7	7393	18	intensity	intensity	NN
cord-005453-4057qib7	7393	19	conditioning	conditioning	NN
cord-005453-4057qib7	7393	20	(	(	-LRB-
cord-005453-4057qib7	7393	21	RIC	RIC	NNP
cord-005453-4057qib7	7393	22	)	)	-RRB-
cord-005453-4057qib7	7393	23	combined	combine	VBN
cord-005453-4057qib7	7393	24	with	with	IN
cord-005453-4057qib7	7393	25	anti	anti	JJ
cord-005453-4057qib7	7393	26	-	-	JJ
cord-005453-4057qib7	7393	27	thymoglobulin	thymoglobulin	JJ
cord-005453-4057qib7	7393	28	(	(	-LRB-
cord-005453-4057qib7	7393	29	ATG	ATG	NNP
cord-005453-4057qib7	7393	30	)	)	-RRB-
cord-005453-4057qib7	7393	31	and	and	CC
cord-005453-4057qib7	7393	32	posttransplant	posttransplant	NNP
cord-005453-4057qib7	7393	33	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7393	34	(	(	-LRB-
cord-005453-4057qib7	7393	35	PTCy	PTCy	NNP
cord-005453-4057qib7	7393	36	)	)	-RRB-
cord-005453-4057qib7	7393	37	using	use	VBG
cord-005453-4057qib7	7393	38	related	relate	VBN
cord-005453-4057qib7	7393	39	(	(	-LRB-
cord-005453-4057qib7	7393	40	MRD	MRD	NNP
cord-005453-4057qib7	7393	41	)	)	-RRB-
cord-005453-4057qib7	7393	42	and	and	CC
cord-005453-4057qib7	7393	43	10/10	10/10	CD
cord-005453-4057qib7	7393	44	and	and	CC
cord-005453-4057qib7	7393	45	9/10	9/10	CD
cord-005453-4057qib7	7393	46	matched	match	VBN
cord-005453-4057qib7	7393	47	unrelated	unrelated	JJ
cord-005453-4057qib7	7393	48	donors	donor	NNS
cord-005453-4057qib7	7393	49	(	(	-LRB-
cord-005453-4057qib7	7393	50	MUD	mud	NN
cord-005453-4057qib7	7393	51	)	)	-RRB-
cord-005453-4057qib7	7393	52	.	.	.
cord-005453-4057qib7	7394	1	Methods	method	NNS
cord-005453-4057qib7	7394	2	:	:	:
cord-005453-4057qib7	7394	3	This	this	DT
cord-005453-4057qib7	7394	4	is	be	VBZ
cord-005453-4057qib7	7394	5	a	a	DT
cord-005453-4057qib7	7394	6	single	single	JJ
cord-005453-4057qib7	7394	7	-	-	HYPH
cord-005453-4057qib7	7394	8	centre	centre	NN
cord-005453-4057qib7	7394	9	retrospective	retrospective	JJ
cord-005453-4057qib7	7394	10	analysis	analysis	NN
cord-005453-4057qib7	7394	11	of	of	IN
cord-005453-4057qib7	7394	12	140	140	CD
cord-005453-4057qib7	7394	13	adult	adult	NN
cord-005453-4057qib7	7394	14	patients	patient	NNS
cord-005453-4057qib7	7394	15	who	who	WP
cord-005453-4057qib7	7394	16	received	receive	VBD
cord-005453-4057qib7	7394	17	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7394	18	for	for	IN
cord-005453-4057qib7	7394	19	hematologic	hematologic	JJ
cord-005453-4057qib7	7394	20	malignancies	malignancy	NNS
cord-005453-4057qib7	7394	21	between	between	IN
cord-005453-4057qib7	7394	22	October	October	NNP
cord-005453-4057qib7	7394	23	2015	2015	CD
cord-005453-4057qib7	7394	24	and	and	CC
cord-005453-4057qib7	7394	25	May	May	NNP
cord-005453-4057qib7	7394	26	2018	2018	CD
cord-005453-4057qib7	7394	27	.	.	.
cord-005453-4057qib7	7395	1	All	all	DT
cord-005453-4057qib7	7395	2	received	receive	VBD
cord-005453-4057qib7	7395	3	RIC	RIC	NNP
cord-005453-4057qib7	7395	4	using	use	VBG
cord-005453-4057qib7	7395	5	fludarabine	fludarabine	NN
cord-005453-4057qib7	7395	6	(	(	-LRB-
cord-005453-4057qib7	7395	7	30mg	30mg	NNP
cord-005453-4057qib7	7395	8	/	/	SYM
cord-005453-4057qib7	7395	9	m	m	NN
cord-005453-4057qib7	7395	10	2	2	CD
cord-005453-4057qib7	7395	11	/day	/day	CD
cord-005453-4057qib7	7395	12	:	:	:
cord-005453-4057qib7	7395	13	day	day	NN
cord-005453-4057qib7	7395	14	-5	-5	JJ
cord-005453-4057qib7	7395	15	to	to	IN
cord-005453-4057qib7	7395	16	-2	-2	NNP
cord-005453-4057qib7	7395	17	)	)	-RRB-
cord-005453-4057qib7	7395	18	,	,	,
cord-005453-4057qib7	7395	19	busulfan	busulfan	NNP
cord-005453-4057qib7	7395	20	(	(	-LRB-
cord-005453-4057qib7	7395	21	3.2kg	3.2kg	NNP
cord-005453-4057qib7	7395	22	/	/	SYM
cord-005453-4057qib7	7395	23	m	m	NN
cord-005453-4057qib7	7395	24	2	2	CD
cord-005453-4057qib7	7395	25	/day	/day	CD
cord-005453-4057qib7	7395	26	:	:	:
cord-005453-4057qib7	7395	27	day	day	NN
cord-005453-4057qib7	7395	28	-3	-3	NNP
cord-005453-4057qib7	7395	29	and	and	CC
cord-005453-4057qib7	7395	30	-2	-2	LS
cord-005453-4057qib7	7395	31	)	)	-RRB-
cord-005453-4057qib7	7395	32	and	and	CC
cord-005453-4057qib7	7395	33	total	total	JJ
cord-005453-4057qib7	7395	34	body	body	NN
cord-005453-4057qib7	7395	35	irradiation	irradiation	NN
cord-005453-4057qib7	7395	36	(	(	-LRB-
cord-005453-4057qib7	7395	37	200	200	CD
cord-005453-4057qib7	7395	38	cGy	cGy	NNS
cord-005453-4057qib7	7395	39	:	:	:
cord-005453-4057qib7	7395	40	day	day	NN
cord-005453-4057qib7	7395	41	-1	-1	NN
cord-005453-4057qib7	7395	42	)	)	-RRB-
cord-005453-4057qib7	7395	43	.	.	.
cord-005453-4057qib7	7396	1	All	all	DT
cord-005453-4057qib7	7396	2	patients	patient	NNS
cord-005453-4057qib7	7396	3	also	also	RB
cord-005453-4057qib7	7396	4	received	receive	VBD
cord-005453-4057qib7	7396	5	rabbit	rabbit	NN
cord-005453-4057qib7	7396	6	-	-	HYPH
cord-005453-4057qib7	7396	7	ATG	ATG	NNP
cord-005453-4057qib7	7396	8	(	(	-LRB-
cord-005453-4057qib7	7396	9	4.5	4.5	CD
cord-005453-4057qib7	7396	10	mg	mg	NNP
cord-005453-4057qib7	7396	11	/	/	SYM
cord-005453-4057qib7	7396	12	kg	kg	NNP
cord-005453-4057qib7	7396	13	:	:	:
cord-005453-4057qib7	7396	14	day	day	NN
cord-005453-4057qib7	7396	15	-3	-3	NNP
cord-005453-4057qib7	7396	16	to	to	IN
cord-005453-4057qib7	7396	17	-1	-1	NN
cord-005453-4057qib7	7396	18	)	)	-RRB-
cord-005453-4057qib7	7396	19	,	,	,
cord-005453-4057qib7	7396	20	PTCy	PTCy	NNPS
cord-005453-4057qib7	7396	21	(	(	-LRB-
cord-005453-4057qib7	7396	22	50mg	50mg	NNP
cord-005453-4057qib7	7396	23	/	/	SYM
cord-005453-4057qib7	7396	24	kg	kg	NN
cord-005453-4057qib7	7396	25	/	/	SYM
cord-005453-4057qib7	7396	26	day	day	NN
cord-005453-4057qib7	7396	27	:	:	:
cord-005453-4057qib7	7396	28	day	day	NN
cord-005453-4057qib7	7396	29	+3,+4	+3,+4	NNS
cord-005453-4057qib7	7396	30	)	)	-RRB-
cord-005453-4057qib7	7396	31	and	and	CC
cord-005453-4057qib7	7396	32	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	7396	33	(	(	-LRB-
cord-005453-4057qib7	7396	34	from	from	IN
cord-005453-4057qib7	7396	35	day	day	NN
cord-005453-4057qib7	7396	36	+5	+5	NN
cord-005453-4057qib7	7396	37	)	)	-RRB-
cord-005453-4057qib7	7396	38	.	.	.
cord-005453-4057qib7	7397	1	Unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	7397	2	peripheral	peripheral	JJ
cord-005453-4057qib7	7397	3	blood	blood	NN
cord-005453-4057qib7	7397	4	stem	stem	NN
cord-005453-4057qib7	7397	5	cells	cell	NNS
cord-005453-4057qib7	7397	6	were	be	VBD
cord-005453-4057qib7	7397	7	infused	infuse	VBN
cord-005453-4057qib7	7397	8	on	on	IN
cord-005453-4057qib7	7397	9	day	day	NN
cord-005453-4057qib7	7397	10	0	0	CD
cord-005453-4057qib7	7397	11	.	.	.
cord-005453-4057qib7	7398	1	Analyses	analysis	NNS
cord-005453-4057qib7	7398	2	were	be	VBD
cord-005453-4057qib7	7398	3	done	do	VBN
cord-005453-4057qib7	7398	4	using	use	VBG
cord-005453-4057qib7	7398	5	2	2	CD
cord-005453-4057qib7	7398	6	thresholds	threshold	NNS
cord-005453-4057qib7	7398	7	:	:	:
cord-005453-4057qib7	7398	8	(	(	-LRB-
cord-005453-4057qib7	7398	9	1	1	LS
cord-005453-4057qib7	7398	10	)	)	-RRB-
cord-005453-4057qib7	7398	11	an	an	DT
cord-005453-4057qib7	7398	12	arbitrary	arbitrary	JJ
cord-005453-4057qib7	7398	13	CD34	CD34	NNP
cord-005453-4057qib7	7398	14	+	+	CC
cord-005453-4057qib7	7398	15	cell	cell	NN
cord-005453-4057qib7	7398	16	dose	dose	NN
cord-005453-4057qib7	7398	17	of	of	IN
cord-005453-4057qib7	7398	18	6	6	CD
cord-005453-4057qib7	7398	19	x10	x10	CD
cord-005453-4057qib7	7398	20	6	6	CD
cord-005453-4057qib7	7399	1	/kg	/kg	.
cord-005453-4057qib7	7400	1	(	(	-LRB-
cord-005453-4057qib7	7400	2	as	as	IN
cord-005453-4057qib7	7400	3	this	this	DT
cord-005453-4057qib7	7400	4	was	be	VBD
cord-005453-4057qib7	7400	5	our	-PRON-	PRP$
cord-005453-4057qib7	7400	6	target	target	NN
cord-005453-4057qib7	7400	7	dose	dose	NN
cord-005453-4057qib7	7400	8	)	)	-RRB-
cord-005453-4057qib7	7400	9	and	and	CC
cord-005453-4057qib7	7400	10	(	(	-LRB-
cord-005453-4057qib7	7400	11	2	2	LS
cord-005453-4057qib7	7400	12	)	)	-RRB-
cord-005453-4057qib7	7400	13	cell	cell	NN
cord-005453-4057qib7	7400	14	dose	dose	NN
cord-005453-4057qib7	7400	15	according	accord	VBG
cord-005453-4057qib7	7400	16	to	to	IN
cord-005453-4057qib7	7400	17	quartiles	quartile	NNS
cord-005453-4057qib7	7400	18	(	(	-LRB-
cord-005453-4057qib7	7400	19	<	<	NNP
cord-005453-4057qib7	7400	20	5.67	5.67	CD
cord-005453-4057qib7	7400	21	,	,	,
cord-005453-4057qib7	7400	22	5.67	5.67	CD
cord-005453-4057qib7	7400	23	-	-	SYM
cord-005453-4057qib7	7400	24	7.98	7.98	CD
cord-005453-4057qib7	7400	25	,	,	,
cord-005453-4057qib7	7400	26	7.99	7.99	CD
cord-005453-4057qib7	7400	27	-	-	SYM
cord-005453-4057qib7	7400	28	11.34	11.34	CD
cord-005453-4057qib7	7400	29	and	and	CC
cord-005453-4057qib7	7400	30	≥	≥	CD
cord-005453-4057qib7	7400	31	11.35	11.35	CD
cord-005453-4057qib7	7400	32	x10	x10	NN
cord-005453-4057qib7	7400	33	6	6	CD
cord-005453-4057qib7	7400	34	/kg	/kg	.
cord-005453-4057qib7	7400	35	)	)	-RRB-
cord-005453-4057qib7	7400	36	.	.	.
cord-005453-4057qib7	7401	1	Results	result	NNS
cord-005453-4057qib7	7401	2	:	:	:
cord-005453-4057qib7	7402	1	Median	median	JJ
cord-005453-4057qib7	7402	2	CD34	CD34	NNP
cord-005453-4057qib7	7402	3	+	+	CC
cord-005453-4057qib7	7402	4	cell	cell	NN
cord-005453-4057qib7	7402	5	dose	dose	NN
cord-005453-4057qib7	7402	6	was	be	VBD
cord-005453-4057qib7	7402	7	7.98	7.98	CD
cord-005453-4057qib7	7402	8	x10	x10	CD
cord-005453-4057qib7	7402	9	6	6	CD
cord-005453-4057qib7	7403	1	/kg	/kg	NFP
cord-005453-4057qib7	7403	2	.	.	.
cord-005453-4057qib7	7404	1	Median	median	JJ
cord-005453-4057qib7	7404	2	follow	follow	VBP
cord-005453-4057qib7	7404	3	up	up	RP
cord-005453-4057qib7	7404	4	was	be	VBD
cord-005453-4057qib7	7404	5	19	19	CD
cord-005453-4057qib7	7404	6	months	month	NNS
cord-005453-4057qib7	7404	7	(	(	-LRB-
cord-005453-4057qib7	7404	8	range	range	VBP
cord-005453-4057qib7	7404	9	5	5	CD
cord-005453-4057qib7	7404	10	-	-	SYM
cord-005453-4057qib7	7404	11	35	35	CD
cord-005453-4057qib7	7404	12	)	)	-RRB-
cord-005453-4057qib7	7404	13	.	.	.
cord-005453-4057qib7	7405	1	Median	median	JJ
cord-005453-4057qib7	7405	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	7405	3	engraftment	engraftment	NN
cord-005453-4057qib7	7405	4	was	be	VBD
cord-005453-4057qib7	7405	5	16	16	CD
cord-005453-4057qib7	7406	1	(	(	-LRB-
cord-005453-4057qib7	7406	2	range	range	NNP
cord-005453-4057qib7	7406	3	13	13	CD
cord-005453-4057qib7	7406	4	-	-	SYM
cord-005453-4057qib7	7406	5	31	31	CD
cord-005453-4057qib7	7406	6	)	)	-RRB-
cord-005453-4057qib7	7406	7	days	day	NNS
cord-005453-4057qib7	7406	8	and	and	CC
cord-005453-4057qib7	7406	9	platelet	platelet	NN
cord-005453-4057qib7	7406	10	engraftment	engraftment	NN
cord-005453-4057qib7	7406	11	was	be	VBD
cord-005453-4057qib7	7406	12	21	21	CD
cord-005453-4057qib7	7407	1	(	(	-LRB-
cord-005453-4057qib7	7407	2	range	range	NNP
cord-005453-4057qib7	7407	3	11	11	CD
cord-005453-4057qib7	7407	4	-	-	SYM
cord-005453-4057qib7	7407	5	83	83	CD
cord-005453-4057qib7	7407	6	)	)	-RRB-
cord-005453-4057qib7	7407	7	days	day	NNS
cord-005453-4057qib7	7407	8	.	.	.
cord-005453-4057qib7	7408	1	A	a	DT
cord-005453-4057qib7	7408	2	cell	cell	NN
cord-005453-4057qib7	7408	3	dose	dose	NN
cord-005453-4057qib7	7408	4	greater	great	JJR
cord-005453-4057qib7	7408	5	than	than	IN
cord-005453-4057qib7	7408	6	6	6	CD
cord-005453-4057qib7	7408	7	x10	x10	CD
cord-005453-4057qib7	7408	8	6	6	CD
cord-005453-4057qib7	7409	1	/kg	/kg	NNP
cord-005453-4057qib7	7409	2	was	be	VBD
cord-005453-4057qib7	7409	3	associated	associate	VBN
cord-005453-4057qib7	7409	4	with	with	IN
cord-005453-4057qib7	7409	5	an	an	DT
cord-005453-4057qib7	7409	6	increased	increased	JJ
cord-005453-4057qib7	7409	7	overall	overall	JJ
cord-005453-4057qib7	7409	8	survival	survival	NN
cord-005453-4057qib7	7409	9	(	(	-LRB-
cord-005453-4057qib7	7409	10	OS	OS	NNP
cord-005453-4057qib7	7409	11	)	)	-RRB-
cord-005453-4057qib7	7409	12	at	at	IN
cord-005453-4057qib7	7409	13	1	1	CD
cord-005453-4057qib7	7409	14	year	year	NN
cord-005453-4057qib7	7409	15	(	(	-LRB-
cord-005453-4057qib7	7409	16	71.3	71.3	CD
cord-005453-4057qib7	7409	17	%	%	NN
cord-005453-4057qib7	7409	18	;	;	:
cord-005453-4057qib7	7409	19	95	95	CD
cord-005453-4057qib7	7409	20	%	%	NN
cord-005453-4057qib7	7409	21	CI	CI	NNP
cord-005453-4057qib7	7409	22	,	,	,
cord-005453-4057qib7	7409	23	62.3	62.3	CD
cord-005453-4057qib7	7409	24	-	-	HYPH
cord-005453-4057qib7	7409	25	80.3	80.3	CD
cord-005453-4057qib7	7409	26	vs	vs	IN
cord-005453-4057qib7	7409	27	46.7	46.7	CD
cord-005453-4057qib7	7409	28	%	%	NN
cord-005453-4057qib7	7409	29	;	;	:
cord-005453-4057qib7	7409	30	95	95	CD
cord-005453-4057qib7	7409	31	%	%	NN
cord-005453-4057qib7	7409	32	CI	CI	NNP
cord-005453-4057qib7	7409	33	30.3	30.3	CD
cord-005453-4057qib7	7409	34	-	-	HYPH
cord-005453-4057qib7	7409	35	63.1	63.1	CD
cord-005453-4057qib7	7409	36	;	;	:
cord-005453-4057qib7	7409	37	p=0.018	p=0.018	ADD
cord-005453-4057qib7	7410	1	,	,	,
cord-005453-4057qib7	7410	2	Figure	figure	NN
cord-005453-4057qib7	7410	3	1	1	CD
cord-005453-4057qib7	7410	4	)	)	-RRB-
cord-005453-4057qib7	7410	5	.	.	.
cord-005453-4057qib7	7411	1	The	the	DT
cord-005453-4057qib7	7411	2	higher	high	JJR
cord-005453-4057qib7	7411	3	dose	dose	NN
cord-005453-4057qib7	7411	4	was	be	VBD
cord-005453-4057qib7	7411	5	also	also	RB
cord-005453-4057qib7	7411	6	associated	associate	VBN
cord-005453-4057qib7	7411	7	with	with	IN
cord-005453-4057qib7	7411	8	shorter	short	JJR
cord-005453-4057qib7	7411	9	platelet	platelet	NN
cord-005453-4057qib7	7411	10	engraftment	engraftment	NN
cord-005453-4057qib7	7411	11	time	time	NN
cord-005453-4057qib7	7411	12	(	(	-LRB-
cord-005453-4057qib7	7411	13	p=0.016	p=0.016	RB
cord-005453-4057qib7	7411	14	,	,	,
cord-005453-4057qib7	7411	15	Figure	figure	NN
cord-005453-4057qib7	7411	16	2	2	CD
cord-005453-4057qib7	7411	17	)	)	-RRB-
cord-005453-4057qib7	7411	18	.	.	.
cord-005453-4057qib7	7412	1	There	there	EX
cord-005453-4057qib7	7412	2	was	be	VBD
cord-005453-4057qib7	7412	3	no	no	DT
cord-005453-4057qib7	7412	4	significant	significant	JJ
cord-005453-4057qib7	7412	5	difference	difference	NN
cord-005453-4057qib7	7412	6	in	in	IN
cord-005453-4057qib7	7412	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	7412	8	engraftment	engraftment	NN
cord-005453-4057qib7	7412	9	,	,	,
cord-005453-4057qib7	7412	10	nonrelapse	nonrelapse	JJ
cord-005453-4057qib7	7412	11	mortality	mortality	NN
cord-005453-4057qib7	7412	12	(	(	-LRB-
cord-005453-4057qib7	7412	13	NRM	NRM	NNP
cord-005453-4057qib7	7412	14	)	)	-RRB-
cord-005453-4057qib7	7412	15	,	,	,
cord-005453-4057qib7	7412	16	relapse	relapse	VB
cord-005453-4057qib7	7412	17	free	free	JJ
cord-005453-4057qib7	7412	18	survival	survival	NN
cord-005453-4057qib7	7412	19	(	(	-LRB-
cord-005453-4057qib7	7412	20	RFS	RFS	NNP
cord-005453-4057qib7	7412	21	)	)	-RRB-
cord-005453-4057qib7	7412	22	,	,	,
cord-005453-4057qib7	7412	23	Grade	Grade	NNP
cord-005453-4057qib7	7412	24	II	II	NNP
cord-005453-4057qib7	7412	25	-	-	HYPH
cord-005453-4057qib7	7412	26	IV	IV	NNP
cord-005453-4057qib7	7412	27	acute	acute	JJ
cord-005453-4057qib7	7412	28	graft	graft	NN
cord-005453-4057qib7	7412	29	versus	versus	IN
cord-005453-4057qib7	7412	30	host	host	NN
cord-005453-4057qib7	7412	31	disease	disease	NN
cord-005453-4057qib7	7412	32	(	(	-LRB-
cord-005453-4057qib7	7412	33	aGVHD	aGVHD	NNP
cord-005453-4057qib7	7412	34	)	)	-RRB-
cord-005453-4057qib7	7412	35	and	and	CC
cord-005453-4057qib7	7412	36	moderate	moderate	JJ
cord-005453-4057qib7	7412	37	to	to	IN
cord-005453-4057qib7	7412	38	severe	severe	JJ
cord-005453-4057qib7	7412	39	chronic	chronic	JJ
cord-005453-4057qib7	7412	40	graft	graft	NN
cord-005453-4057qib7	7412	41	versus	versus	IN
cord-005453-4057qib7	7412	42	host	host	NN
cord-005453-4057qib7	7412	43	disease	disease	NN
cord-005453-4057qib7	7412	44	(	(	-LRB-
cord-005453-4057qib7	7412	45	cGVHD	cGVHD	NNP
cord-005453-4057qib7	7412	46	)	)	-RRB-
cord-005453-4057qib7	7412	47	,	,	.
cord-005453-4057qib7	7413	1	(	(	-LRB-
cord-005453-4057qib7	7413	2	Table	table	NN
cord-005453-4057qib7	7413	3	1	1	CD
cord-005453-4057qib7	7413	4	)	)	-RRB-
cord-005453-4057qib7	7413	5	.	.	.
cord-005453-4057qib7	7414	1	Analyses	analysis	NNS
cord-005453-4057qib7	7414	2	using	use	VBG
cord-005453-4057qib7	7414	3	quartile	quartile	NN
cord-005453-4057qib7	7414	4	cell	cell	NN
cord-005453-4057qib7	7414	5	dose	dose	NN
cord-005453-4057qib7	7414	6	thresholds	threshold	NNS
cord-005453-4057qib7	7414	7	showed	show	VBD
cord-005453-4057qib7	7414	8	a	a	DT
cord-005453-4057qib7	7414	9	trend	trend	NN
cord-005453-4057qib7	7414	10	towards	towards	IN
cord-005453-4057qib7	7414	11	decreased	decrease	VBN
cord-005453-4057qib7	7414	12	OS	OS	NNP
cord-005453-4057qib7	7414	13	with	with	IN
cord-005453-4057qib7	7414	14	a	a	DT
cord-005453-4057qib7	7414	15	cell	cell	NN
cord-005453-4057qib7	7414	16	dose	dose	NN
cord-005453-4057qib7	7414	17	of	of	IN
cord-005453-4057qib7	7414	18	<	<	NNP
cord-005453-4057qib7	7414	19	5.67x10	5.67x10	CD
cord-005453-4057qib7	7414	20	^	^	SYM
cord-005453-4057qib7	7414	21	6	6	CD
cord-005453-4057qib7	7414	22	/	/	SYM
cord-005453-4057qib7	7414	23	kg	kg	NNS
cord-005453-4057qib7	7414	24	,	,	,
cord-005453-4057qib7	7414	25	however	however	RB
cord-005453-4057qib7	7414	26	this	this	DT
cord-005453-4057qib7	7414	27	was	be	VBD
cord-005453-4057qib7	7414	28	not	not	RB
cord-005453-4057qib7	7414	29	statistically	statistically	RB
cord-005453-4057qib7	7414	30	significant	significant	JJ
cord-005453-4057qib7	7415	1	(	(	-LRB-
cord-005453-4057qib7	7415	2	Figure	figure	NN
cord-005453-4057qib7	7415	3	1	1	CD
cord-005453-4057qib7	7415	4	)	)	-RRB-
cord-005453-4057qib7	7415	5	.	.	.
cord-005453-4057qib7	7416	1	Higher	high	JJR
cord-005453-4057qib7	7416	2	CD34	CD34	NNP
cord-005453-4057qib7	7416	3	+	+	CC
cord-005453-4057qib7	7416	4	cell	cell	NN
cord-005453-4057qib7	7416	5	doses	dose	NNS
cord-005453-4057qib7	7416	6	were	be	VBD
cord-005453-4057qib7	7416	7	associated	associate	VBN
cord-005453-4057qib7	7416	8	with	with	IN
cord-005453-4057qib7	7416	9	shorter	short	JJR
cord-005453-4057qib7	7416	10	platelet	platelet	NN
cord-005453-4057qib7	7416	11	engraftment	engraftment	NN
cord-005453-4057qib7	7416	12	time	time	NN
cord-005453-4057qib7	7416	13	(	(	-LRB-
cord-005453-4057qib7	7416	14	p=0.005	p=0.005	NNP
cord-005453-4057qib7	7417	1	,	,	,
cord-005453-4057qib7	7417	2	Figure	figure	NN
cord-005453-4057qib7	7417	3	2	2	CD
cord-005453-4057qib7	7417	4	)	)	-RRB-
cord-005453-4057qib7	7417	5	.	.	.
cord-005453-4057qib7	7418	1	There	there	EX
cord-005453-4057qib7	7418	2	was	be	VBD
cord-005453-4057qib7	7418	3	no	no	DT
cord-005453-4057qib7	7418	4	significant	significant	JJ
cord-005453-4057qib7	7418	5	difference	difference	NN
cord-005453-4057qib7	7418	6	in	in	IN
cord-005453-4057qib7	7418	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	7418	8	engraftment	engraftment	NN
cord-005453-4057qib7	7418	9	,	,	,
cord-005453-4057qib7	7418	10	NRM	NRM	NNP
cord-005453-4057qib7	7418	11	,	,	,
cord-005453-4057qib7	7418	12	RFS	RFS	NNP
cord-005453-4057qib7	7418	13	,	,	,
cord-005453-4057qib7	7418	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	7418	15	and	and	CC
cord-005453-4057qib7	7418	16	cGVHD	cGVHD	NNP
cord-005453-4057qib7	7418	17	(	(	-LRB-
cord-005453-4057qib7	7418	18	Table	Table	NNP
cord-005453-4057qib7	7418	19	2	2	CD
cord-005453-4057qib7	7418	20	)	)	-RRB-
cord-005453-4057qib7	7418	21	.	.	.
cord-005453-4057qib7	7419	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7419	2	:	:	:
cord-005453-4057qib7	7420	1	CD34	CD34	NNP
cord-005453-4057qib7	7420	2	+	+	CC
cord-005453-4057qib7	7420	3	cell	cell	NN
cord-005453-4057qib7	7420	4	dose	dose	NN
cord-005453-4057qib7	7420	5	greater	great	JJR
cord-005453-4057qib7	7420	6	than	than	IN
cord-005453-4057qib7	7420	7	6	6	CD
cord-005453-4057qib7	7420	8	x10	x10	CD
cord-005453-4057qib7	7420	9	6	6	CD
cord-005453-4057qib7	7420	10	/kg	/kg	NFP
cord-005453-4057qib7	7420	11	significantly	significantly	RB
cord-005453-4057qib7	7420	12	increases	increase	VBZ
cord-005453-4057qib7	7420	13	overall	overall	JJ
cord-005453-4057qib7	7420	14	survival	survival	NN
cord-005453-4057qib7	7420	15	in	in	IN
cord-005453-4057qib7	7420	16	the	the	DT
cord-005453-4057qib7	7420	17	setting	setting	NN
cord-005453-4057qib7	7420	18	of	of	IN
cord-005453-4057qib7	7420	19	RIC	RIC	NNP
cord-005453-4057qib7	7420	20	and	and	CC
cord-005453-4057qib7	7420	21	dual	dual	JJ
cord-005453-4057qib7	7420	22	T	t	NN
cord-005453-4057qib7	7420	23	-	-	HYPH
cord-005453-4057qib7	7420	24	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7420	25	suppression	suppression	NN
cord-005453-4057qib7	7420	26	with	with	IN
cord-005453-4057qib7	7420	27	ATG	ATG	NNP
cord-005453-4057qib7	7420	28	and	and	CC
cord-005453-4057qib7	7420	29	PTCy	PTCy	NNPS
cord-005453-4057qib7	7420	30	in	in	IN
cord-005453-4057qib7	7420	31	MRD	MRD	NNP
cord-005453-4057qib7	7420	32	and	and	CC
cord-005453-4057qib7	7420	33	MUD	MUD	NNP
cord-005453-4057qib7	7420	34	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	7420	35	.	.	.
cord-005453-4057qib7	7421	1	Further	further	JJ
cord-005453-4057qib7	7421	2	studies	study	NNS
cord-005453-4057qib7	7421	3	in	in	IN
cord-005453-4057qib7	7421	4	a	a	DT
cord-005453-4057qib7	7421	5	larger	large	JJR
cord-005453-4057qib7	7421	6	number	number	NN
cord-005453-4057qib7	7421	7	of	of	IN
cord-005453-4057qib7	7421	8	patients	patient	NNS
cord-005453-4057qib7	7421	9	and	and	CC
cord-005453-4057qib7	7421	10	longer	long	RBR
cord-005453-4057qib7	7421	11	follow	follow	VB
cord-005453-4057qib7	7421	12	up	up	RP
cord-005453-4057qib7	7421	13	are	be	VBP
cord-005453-4057qib7	7421	14	recommended	recommend	VBN
cord-005453-4057qib7	7421	15	to	to	TO
cord-005453-4057qib7	7421	16	validate	validate	VB
cord-005453-4057qib7	7421	17	these	these	DT
cord-005453-4057qib7	7421	18	findings	finding	NNS
cord-005453-4057qib7	7421	19	.	.	.
cord-005453-4057qib7	7422	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7422	2	Methods	method	NNS
cord-005453-4057qib7	7422	3	:	:	:
cord-005453-4057qib7	7422	4	Fifty	fifty	CD
cord-005453-4057qib7	7422	5	two	two	CD
cord-005453-4057qib7	7422	6	adult	adult	NN
cord-005453-4057qib7	7422	7	patients	patient	NNS
cord-005453-4057qib7	7422	8	were	be	VBD
cord-005453-4057qib7	7422	9	included	include	VBN
cord-005453-4057qib7	7422	10	.	.	.
cord-005453-4057qib7	7423	1	Median	median	JJ
cord-005453-4057qib7	7423	2	CD34	CD34	NNP
cord-005453-4057qib7	7423	3	+	+	CC
cord-005453-4057qib7	7423	4	cells	cell	NNS
cord-005453-4057qib7	7423	5	requested	request	VBN
cord-005453-4057qib7	7423	6	for	for	IN
cord-005453-4057qib7	7423	7	infusion	infusion	NN
cord-005453-4057qib7	7423	8	were	be	VBD
cord-005453-4057qib7	7423	9	6x10	6x10	CD
cord-005453-4057qib7	7423	10	^	^	SYM
cord-005453-4057qib7	7423	11	6	6	CD
cord-005453-4057qib7	7423	12	/	/	SYM
cord-005453-4057qib7	7423	13	Kg	Kg	NNP
cord-005453-4057qib7	7423	14	.	.	.
cord-005453-4057qib7	7424	1	All	all	DT
cord-005453-4057qib7	7424	2	patients	patient	NNS
cord-005453-4057qib7	7424	3	received	receive	VBD
cord-005453-4057qib7	7424	4	the	the	DT
cord-005453-4057qib7	7424	5	same	same	JJ
cord-005453-4057qib7	7424	6	RIC	RIC	NNP
cord-005453-4057qib7	7424	7	regimen	regimen	NN
cord-005453-4057qib7	7424	8	including	include	VBG
cord-005453-4057qib7	7424	9	fludarabine	fludarabine	NN
cord-005453-4057qib7	7424	10	(	(	-LRB-
cord-005453-4057qib7	7424	11	30mg	30mg	NNP
cord-005453-4057qib7	7424	12	/	/	SYM
cord-005453-4057qib7	7424	13	m2	m2	NNP
cord-005453-4057qib7	7424	14	/	/	SYM
cord-005453-4057qib7	7424	15	day	day	NN
cord-005453-4057qib7	7424	16	day	day	NN
cord-005453-4057qib7	7424	17	-5	-5	JJ
cord-005453-4057qib7	7424	18	to	to	IN
cord-005453-4057qib7	7424	19	-2	-2	NNP
cord-005453-4057qib7	7424	20	)	)	-RRB-
cord-005453-4057qib7	7424	21	,	,	,
cord-005453-4057qib7	7424	22	busulfan	busulfan	NNP
cord-005453-4057qib7	7424	23	(	(	-LRB-
cord-005453-4057qib7	7424	24	3.2kg	3.2kg	NNP
cord-005453-4057qib7	7424	25	/	/	SYM
cord-005453-4057qib7	7424	26	m2	m2	NNP
cord-005453-4057qib7	7424	27	/	/	SYM
cord-005453-4057qib7	7424	28	day	day	NN
cord-005453-4057qib7	7424	29	day	day	NN
cord-005453-4057qib7	7424	30	-3	-3	.
cord-005453-4057qib7	7425	1	and	and	CC
cord-005453-4057qib7	7425	2	-2	-2	LS
cord-005453-4057qib7	7425	3	)	)	-RRB-
cord-005453-4057qib7	7425	4	,	,	,
cord-005453-4057qib7	7425	5	and	and	CC
cord-005453-4057qib7	7425	6	total	total	JJ
cord-005453-4057qib7	7425	7	body	body	NN
cord-005453-4057qib7	7425	8	irradiation	irradiation	NN
cord-005453-4057qib7	7425	9	(	(	-LRB-
cord-005453-4057qib7	7425	10	200	200	CD
cord-005453-4057qib7	7425	11	cGy	cGy	NNS
cord-005453-4057qib7	7425	12	)	)	-RRB-
cord-005453-4057qib7	7425	13	(	(	-LRB-
cord-005453-4057qib7	7425	14	day	day	NN
cord-005453-4057qib7	7425	15	-1	-1	NN
cord-005453-4057qib7	7425	16	)	)	-RRB-
cord-005453-4057qib7	7425	17	combined	combine	VBN
cord-005453-4057qib7	7425	18	with	with	IN
cord-005453-4057qib7	7425	19	rabbit	rabbit	NN
cord-005453-4057qib7	7425	20	-	-	HYPH
cord-005453-4057qib7	7425	21	ATG	ATG	NNP
cord-005453-4057qib7	7425	22	(	(	-LRB-
cord-005453-4057qib7	7425	23	4.5	4.5	CD
cord-005453-4057qib7	7425	24	mg	mg	NNP
cord-005453-4057qib7	7425	25	/	/	SYM
cord-005453-4057qib7	7425	26	kg	kg	NNP
cord-005453-4057qib7	7425	27	:	:	:
cord-005453-4057qib7	7425	28	day	day	NN
cord-005453-4057qib7	7425	29	-3	-3	NNP
cord-005453-4057qib7	7425	30	to	to	IN
cord-005453-4057qib7	7425	31	-1	-1	NN
cord-005453-4057qib7	7425	32	)	)	-RRB-
cord-005453-4057qib7	7425	33	,	,	,
cord-005453-4057qib7	7425	34	PTCy	PTCy	NNPS
cord-005453-4057qib7	7425	35	(	(	-LRB-
cord-005453-4057qib7	7425	36	50mg	50mg	NNP
cord-005453-4057qib7	7425	37	/	/	SYM
cord-005453-4057qib7	7425	38	kg	kg	NN
cord-005453-4057qib7	7425	39	/	/	SYM
cord-005453-4057qib7	7425	40	day	day	NN
cord-005453-4057qib7	7425	41	:	:	:
cord-005453-4057qib7	7425	42	day	day	NN
cord-005453-4057qib7	7425	43	+3,+4	+3,+4	NNP
cord-005453-4057qib7	7425	44	)	)	-RRB-
cord-005453-4057qib7	7425	45	,	,	,
cord-005453-4057qib7	7425	46	and	and	CC
cord-005453-4057qib7	7425	47	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	7425	48	.	.	.
cord-005453-4057qib7	7426	1	Unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	7426	2	peripheral	peripheral	JJ
cord-005453-4057qib7	7426	3	blood	blood	NN
cord-005453-4057qib7	7426	4	stem	stem	NN
cord-005453-4057qib7	7426	5	cells	cell	NNS
cord-005453-4057qib7	7426	6	were	be	VBD
cord-005453-4057qib7	7426	7	infused	infuse	VBN
cord-005453-4057qib7	7426	8	.	.	.
cord-005453-4057qib7	7427	1	Last	last	JJ
cord-005453-4057qib7	7427	2	followup	followup	NN
cord-005453-4057qib7	7427	3	was	be	VBD
cord-005453-4057qib7	7427	4	November	November	NNP
cord-005453-4057qib7	7427	5	2018	2018	CD
cord-005453-4057qib7	7427	6	.	.	.
cord-005453-4057qib7	7428	1	Median	median	JJ
cord-005453-4057qib7	7428	2	follow	follow	NN
cord-005453-4057qib7	7428	3	-	-	HYPH
cord-005453-4057qib7	7428	4	up	up	NN
cord-005453-4057qib7	7428	5	was	be	VBD
cord-005453-4057qib7	7428	6	13	13	CD
cord-005453-4057qib7	7428	7	months	month	NNS
cord-005453-4057qib7	7429	1	(	(	-LRB-
cord-005453-4057qib7	7429	2	range	range	NNP
cord-005453-4057qib7	7429	3	5	5	CD
cord-005453-4057qib7	7429	4	-	-	SYM
cord-005453-4057qib7	7429	5	26	26	CD
cord-005453-4057qib7	7429	6	)	)	-RRB-
cord-005453-4057qib7	7429	7	.	.	.
cord-005453-4057qib7	7430	1	Median	median	JJ
cord-005453-4057qib7	7430	2	cell	cell	NN
cord-005453-4057qib7	7430	3	dose	dose	NN
cord-005453-4057qib7	7430	4	count	count	NN
cord-005453-4057qib7	7430	5	infused	infuse	VBN
cord-005453-4057qib7	7430	6	was	be	VBD
cord-005453-4057qib7	7430	7	9.83	9.83	CD
cord-005453-4057qib7	7430	8	CD34+/Kg	CD34+/Kg	NNP
cord-005453-4057qib7	7430	9	.	.	.
cord-005453-4057qib7	7431	1	We	-PRON-	PRP
cord-005453-4057qib7	7431	2	arbitrarily	arbitrarily	RB
cord-005453-4057qib7	7431	3	divided	divide	VBD
cord-005453-4057qib7	7431	4	the	the	DT
cord-005453-4057qib7	7431	5	cohort	cohort	NN
cord-005453-4057qib7	7431	6	in	in	IN
cord-005453-4057qib7	7431	7	two	two	CD
cord-005453-4057qib7	7431	8	groups	group	NNS
cord-005453-4057qib7	7431	9	with	with	IN
cord-005453-4057qib7	7431	10	CD34	CD34	NNP
cord-005453-4057qib7	7431	11	+	+	CC
cord-005453-4057qib7	7431	12	dose	dose	NN
cord-005453-4057qib7	7431	13	of	of	IN
cord-005453-4057qib7	7431	14	>	>	XX
cord-005453-4057qib7	7431	15	8x10	8x10	CD
cord-005453-4057qib7	7431	16	^	^	SYM
cord-005453-4057qib7	7431	17	6	6	CD
cord-005453-4057qib7	7431	18	CD34	CD34	NNP
cord-005453-4057qib7	7431	19	/	/	SYM
cord-005453-4057qib7	7431	20	Kg	Kg	NNP
cord-005453-4057qib7	7431	21	as	as	IN
cord-005453-4057qib7	7431	22	cut	cut	VBN
cord-005453-4057qib7	7431	23	-	-	HYPH
cord-005453-4057qib7	7431	24	off	off	RP
cord-005453-4057qib7	7431	25	point	point	NN
cord-005453-4057qib7	7431	26	.	.	.
cord-005453-4057qib7	7432	1	Results	result	NNS
cord-005453-4057qib7	7432	2	:	:	:
cord-005453-4057qib7	7433	1	Findings	finding	NNS
cord-005453-4057qib7	7433	2	are	be	VBP
cord-005453-4057qib7	7433	3	summarized	summarize	VBN
cord-005453-4057qib7	7433	4	in	in	IN
cord-005453-4057qib7	7433	5	Figure1	Figure1	NNP
cord-005453-4057qib7	7433	6	.	.	.
cord-005453-4057qib7	7434	1	The	the	DT
cord-005453-4057qib7	7434	2	infusion	infusion	NN
cord-005453-4057qib7	7434	3	of	of	IN
cord-005453-4057qib7	7434	4	more	more	JJR
cord-005453-4057qib7	7434	5	than	than	IN
cord-005453-4057qib7	7434	6	8x10	8x10	CD
cord-005453-4057qib7	7434	7	^	^	SYM
cord-005453-4057qib7	7434	8	6	6	CD
cord-005453-4057qib7	7434	9	CD34	CD34	NNP
cord-005453-4057qib7	7434	10	/	/	SYM
cord-005453-4057qib7	7434	11	Kg	Kg	NNP
cord-005453-4057qib7	7434	12	dose	dose	NN
cord-005453-4057qib7	7434	13	had	have	VBD
cord-005453-4057qib7	7434	14	a	a	DT
cord-005453-4057qib7	7434	15	significant	significant	JJ
cord-005453-4057qib7	7434	16	worse	bad	JJR
cord-005453-4057qib7	7434	17	impact	impact	NN
cord-005453-4057qib7	7434	18	on	on	IN
cord-005453-4057qib7	7434	19	overall	overall	JJ
cord-005453-4057qib7	7434	20	survival	survival	NN
cord-005453-4057qib7	7434	21	(	(	-LRB-
cord-005453-4057qib7	7434	22	OS	OS	NNP
cord-005453-4057qib7	7434	23	)	)	-RRB-
cord-005453-4057qib7	7434	24	(	(	-LRB-
cord-005453-4057qib7	7434	25	P=0.022	P=0.022	NNP
cord-005453-4057qib7	7434	26	)	)	-RRB-
cord-005453-4057qib7	7434	27	,	,	,
cord-005453-4057qib7	7434	28	relapse	relapse	NN
cord-005453-4057qib7	7434	29	-	-	HYPH
cord-005453-4057qib7	7434	30	free	free	JJ
cord-005453-4057qib7	7434	31	survival	survival	NN
cord-005453-4057qib7	7434	32	(	(	-LRB-
cord-005453-4057qib7	7434	33	RFS	RFS	NNP
cord-005453-4057qib7	7434	34	)	)	-RRB-
cord-005453-4057qib7	7434	35	(	(	-LRB-
cord-005453-4057qib7	7434	36	P=0.042	P=0.042	NNP
cord-005453-4057qib7	7434	37	)	)	-RRB-
cord-005453-4057qib7	7434	38	and	and	CC
cord-005453-4057qib7	7434	39	cumulative	cumulative	JJ
cord-005453-4057qib7	7434	40	incidence	incidence	NN
cord-005453-4057qib7	7434	41	of	of	IN
cord-005453-4057qib7	7434	42	acute	acute	JJ
cord-005453-4057qib7	7434	43	GVHD	GVHD	NNP
cord-005453-4057qib7	7434	44	(	(	-LRB-
cord-005453-4057qib7	7434	45	P=0.000	P=0.000	NNP
cord-005453-4057qib7	7434	46	)	)	-RRB-
cord-005453-4057qib7	7434	47	.	.	.
cord-005453-4057qib7	7435	1	Chronic	chronic	JJ
cord-005453-4057qib7	7435	2	GVHD	GVHD	NNP
cord-005453-4057qib7	7435	3	could	could	MD
cord-005453-4057qib7	7435	4	not	not	RB
cord-005453-4057qib7	7435	5	be	be	VB
cord-005453-4057qib7	7435	6	compared	compare	VBN
cord-005453-4057qib7	7435	7	between	between	IN
cord-005453-4057qib7	7435	8	the	the	DT
cord-005453-4057qib7	7435	9	two	two	CD
cord-005453-4057qib7	7435	10	cohorts	cohort	NNS
cord-005453-4057qib7	7435	11	due	due	JJ
cord-005453-4057qib7	7435	12	to	to	IN
cord-005453-4057qib7	7435	13	the	the	DT
cord-005453-4057qib7	7435	14	different	different	JJ
cord-005453-4057qib7	7435	15	median	median	JJ
cord-005453-4057qib7	7435	16	follow	follow	NN
cord-005453-4057qib7	7435	17	-	-	HYPH
cord-005453-4057qib7	7435	18	up	up	NN
cord-005453-4057qib7	7435	19	.	.	.
cord-005453-4057qib7	7436	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7436	2	:	:	:
cord-005453-4057qib7	7437	1	The	the	DT
cord-005453-4057qib7	7437	2	infusion	infusion	NN
cord-005453-4057qib7	7437	3	of	of	IN
cord-005453-4057qib7	7437	4	a	a	DT
cord-005453-4057qib7	7437	5	CD34	CD34	NNP
cord-005453-4057qib7	7437	6	+	+	CC
cord-005453-4057qib7	7437	7	cell	cell	NN
cord-005453-4057qib7	7437	8	dose	dose	NN
cord-005453-4057qib7	7437	9	count	count	NN
cord-005453-4057qib7	7437	10	higher	high	JJR
cord-005453-4057qib7	7437	11	than	than	IN
cord-005453-4057qib7	7437	12	8x10	8x10	CD
cord-005453-4057qib7	7437	13	^	^	SYM
cord-005453-4057qib7	7437	14	6	6	CD
cord-005453-4057qib7	7437	15	cells	cell	NNS
cord-005453-4057qib7	7437	16	/	/	SYM
cord-005453-4057qib7	7437	17	kg	kg	NNS
cord-005453-4057qib7	7437	18	had	have	VBD
cord-005453-4057qib7	7437	19	a	a	DT
cord-005453-4057qib7	7437	20	significant	significant	JJ
cord-005453-4057qib7	7437	21	adverse	adverse	JJ
cord-005453-4057qib7	7437	22	impact	impact	NN
cord-005453-4057qib7	7437	23	in	in	IN
cord-005453-4057qib7	7437	24	overall	overall	JJ
cord-005453-4057qib7	7437	25	survival	survival	NN
cord-005453-4057qib7	7437	26	and	and	CC
cord-005453-4057qib7	7437	27	grade	grade	NN
cord-005453-4057qib7	7437	28	II	II	NNP
cord-005453-4057qib7	7437	29	-	-	HYPH
cord-005453-4057qib7	7437	30	IV	IV	NNP
cord-005453-4057qib7	7437	31	acute	acute	JJ
cord-005453-4057qib7	7437	32	GVHD	GVHD	NNP
cord-005453-4057qib7	7437	33	in	in	IN
cord-005453-4057qib7	7437	34	the	the	DT
cord-005453-4057qib7	7437	35	setting	setting	NN
cord-005453-4057qib7	7437	36	of	of	IN
cord-005453-4057qib7	7437	37	RIC	RIC	NNP
cord-005453-4057qib7	7437	38	and	and	CC
cord-005453-4057qib7	7437	39	dual	dual	JJ
cord-005453-4057qib7	7437	40	T	t	NN
cord-005453-4057qib7	7437	41	-	-	HYPH
cord-005453-4057qib7	7437	42	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7437	43	suppression	suppression	NN
cord-005453-4057qib7	7437	44	with	with	IN
cord-005453-4057qib7	7437	45	ATG	ATG	NNP
cord-005453-4057qib7	7437	46	and	and	CC
cord-005453-4057qib7	7437	47	PTCy	PTCy	NNPS
cord-005453-4057qib7	7437	48	for	for	IN
cord-005453-4057qib7	7437	49	haploHSCT	haploHSCT	NNP
cord-005453-4057qib7	7437	50	.	.	.
cord-005453-4057qib7	7438	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7438	2	:	:	:
cord-005453-4057qib7	7438	3	Nothing	nothing	NN
cord-005453-4057qib7	7438	4	to	to	TO
cord-005453-4057qib7	7438	5	declare	declare	VB
cord-005453-4057qib7	7438	6	P335	p335	CD
cord-005453-4057qib7	7438	7	Long	long	JJ
cord-005453-4057qib7	7438	8	-	-	HYPH
cord-005453-4057qib7	7438	9	term	term	NN
cord-005453-4057qib7	7438	10	thymic	thymic	JJ
cord-005453-4057qib7	7438	11	activity	activity	NN
cord-005453-4057qib7	7438	12	and	and	CC
cord-005453-4057qib7	7438	13	immune	immune	JJ
cord-005453-4057qib7	7438	14	-	-	HYPH
cord-005453-4057qib7	7438	15	reconstitution	reconstitution	NN
cord-005453-4057qib7	7438	16	after	after	IN
cord-005453-4057qib7	7438	17	haplo	haplo	NN
cord-005453-4057qib7	7438	18	-	-	HYPH
cord-005453-4057qib7	7438	19	identical	identical	JJ
cord-005453-4057qib7	7438	20	allografting	allografting	NN
cord-005453-4057qib7	7438	21	with	with	IN
cord-005453-4057qib7	7438	22	post	post	JJ
cord-005453-4057qib7	7438	23	-	-	JJ
cord-005453-4057qib7	7438	24	transplant	transplant	NN
cord-005453-4057qib7	7438	25	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7438	26	Background	background	NN
cord-005453-4057qib7	7438	27	:	:	:
cord-005453-4057qib7	7439	1	The	the	DT
cord-005453-4057qib7	7439	2	use	use	NN
cord-005453-4057qib7	7439	3	of	of	IN
cord-005453-4057qib7	7439	4	post	post	JJ
cord-005453-4057qib7	7439	5	-	-	JJ
cord-005453-4057qib7	7439	6	transplant	transplant	NN
cord-005453-4057qib7	7439	7	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	7439	8	(	(	-LRB-
cord-005453-4057qib7	7439	9	PTCY	PTCY	NNP
cord-005453-4057qib7	7439	10	)	)	-RRB-
cord-005453-4057qib7	7439	11	has	have	VBZ
cord-005453-4057qib7	7439	12	expanded	expand	VBN
cord-005453-4057qib7	7439	13	the	the	DT
cord-005453-4057qib7	7439	14	application	application	NN
cord-005453-4057qib7	7439	15	of	of	IN
cord-005453-4057qib7	7439	16	T	T	NNP
cord-005453-4057qib7	7439	17	repleted	replete	VBD
cord-005453-4057qib7	7439	18	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7439	19	stem	stem	NN
cord-005453-4057qib7	7439	20	cell	cell	NN
cord-005453-4057qib7	7439	21	transplantation	transplantation	NN
cord-005453-4057qib7	7439	22	(	(	-LRB-
cord-005453-4057qib7	7439	23	haplo	haplo	NNP
cord-005453-4057qib7	7439	24	-	-	HYPH
cord-005453-4057qib7	7439	25	HSCT	HSCT	NNP
cord-005453-4057qib7	7439	26	)	)	-RRB-
cord-005453-4057qib7	7439	27	.	.	.
cord-005453-4057qib7	7440	1	In	in	IN
cord-005453-4057qib7	7440	2	this	this	DT
cord-005453-4057qib7	7440	3	setting	setting	NN
cord-005453-4057qib7	7440	4	,	,	,
cord-005453-4057qib7	7440	5	to	to	TO
cord-005453-4057qib7	7440	6	investigate	investigate	VB
cord-005453-4057qib7	7440	7	thymus	thymus	NN
cord-005453-4057qib7	7440	8	role	role	NN
cord-005453-4057qib7	7440	9	in	in	IN
cord-005453-4057qib7	7440	10	longterm	longterm	JJ
cord-005453-4057qib7	7440	11	clinical	clinical	JJ
cord-005453-4057qib7	7440	12	outcomes	outcome	NNS
cord-005453-4057qib7	7440	13	,	,	,
cord-005453-4057qib7	7440	14	evaluation	evaluation	NN
cord-005453-4057qib7	7440	15	of	of	IN
cord-005453-4057qib7	7440	16	immune	immune	JJ
cord-005453-4057qib7	7440	17	reconstitution	reconstitution	NN
cord-005453-4057qib7	7440	18	kinetics	kinetics	NN
cord-005453-4057qib7	7440	19	was	be	VBD
cord-005453-4057qib7	7440	20	performed	perform	VBN
cord-005453-4057qib7	7440	21	.	.	.
cord-005453-4057qib7	7441	1	Methods	method	NNS
cord-005453-4057qib7	7441	2	:	:	:
cord-005453-4057qib7	7441	3	Twenty	twenty	CD
cord-005453-4057qib7	7441	4	-	-	HYPH
cord-005453-4057qib7	7441	5	nine	nine	CD
cord-005453-4057qib7	7441	6	patients	patient	NNS
cord-005453-4057qib7	7441	7	(	(	-LRB-
cord-005453-4057qib7	7441	8	median	median	JJ
cord-005453-4057qib7	7441	9	age	age	NN
cord-005453-4057qib7	7441	10	53	53	CD
cord-005453-4057qib7	7441	11	)	)	-RRB-
cord-005453-4057qib7	7441	12	were	be	VBD
cord-005453-4057qib7	7441	13	enrolled	enrol	VBN
cord-005453-4057qib7	7441	14	.	.	.
cord-005453-4057qib7	7442	1	Blood	blood	NN
cord-005453-4057qib7	7442	2	samples	sample	NNS
cord-005453-4057qib7	7442	3	were	be	VBD
cord-005453-4057qib7	7442	4	collected	collect	VBN
cord-005453-4057qib7	7442	5	before	before	IN
cord-005453-4057qib7	7442	6	conditioning	conditioning	NN
cord-005453-4057qib7	7442	7	and	and	CC
cord-005453-4057qib7	7442	8	at	at	IN
cord-005453-4057qib7	7442	9	1	1	CD
cord-005453-4057qib7	7442	10	,	,	,
cord-005453-4057qib7	7442	11	3	3	CD
cord-005453-4057qib7	7442	12	,	,	,
cord-005453-4057qib7	7442	13	6	6	CD
cord-005453-4057qib7	7442	14	,	,	,
cord-005453-4057qib7	7442	15	12	12	CD
cord-005453-4057qib7	7442	16	,	,	,
cord-005453-4057qib7	7442	17	18	18	CD
cord-005453-4057qib7	7442	18	,	,	,
cord-005453-4057qib7	7442	19	24	24	CD
cord-005453-4057qib7	7442	20	months	month	NNS
cord-005453-4057qib7	7442	21	after	after	IN
cord-005453-4057qib7	7442	22	Haplo	Haplo	NNP
cord-005453-4057qib7	7442	23	-	-	HYPH
cord-005453-4057qib7	7442	24	HSCT	HSCT	NNP
cord-005453-4057qib7	7442	25	.	.	.
cord-005453-4057qib7	7443	1	Analyses	analysis	NNS
cord-005453-4057qib7	7443	2	of	of	IN
cord-005453-4057qib7	7443	3	CD4	CD4	NNP
cord-005453-4057qib7	7443	4	and	and	CC
cord-005453-4057qib7	7443	5	CD8	CD8	NNP
cord-005453-4057qib7	7443	6	T	T	NNP
cord-005453-4057qib7	7443	7	-	-	HYPH
cord-005453-4057qib7	7443	8	cell	cell	NN
cord-005453-4057qib7	7443	9	subsets	subset	NNS
cord-005453-4057qib7	7443	10	by	by	IN
cord-005453-4057qib7	7443	11	flow	flow	NN
cord-005453-4057qib7	7443	12	-	-	HYPH
cord-005453-4057qib7	7443	13	cytometry	cytometry	NN
cord-005453-4057qib7	7443	14	were	be	VBD
cord-005453-4057qib7	7443	15	correlated	correlate	VBN
cord-005453-4057qib7	7443	16	by	by	IN
cord-005453-4057qib7	7443	17	generalized	generalized	JJ
cord-005453-4057qib7	7443	18	linear	linear	JJ
cord-005453-4057qib7	7443	19	models	model	NNS
cord-005453-4057qib7	7443	20	with	with	IN
cord-005453-4057qib7	7443	21	Real	real	JJ
cord-005453-4057qib7	7443	22	-	-	HYPH
cord-005453-4057qib7	7443	23	Time	time	NN
cord-005453-4057qib7	7443	24	PCR	PCR	NNP
cord-005453-4057qib7	7443	25	(	(	-LRB-
cord-005453-4057qib7	7443	26	RT	RT	NNP
cord-005453-4057qib7	7443	27	-	-	HYPH
cord-005453-4057qib7	7443	28	PCR	PCR	NNP
cord-005453-4057qib7	7443	29	)	)	-RRB-
cord-005453-4057qib7	7443	30	quantification	quantification	NN
cord-005453-4057qib7	7443	31	of	of	IN
cord-005453-4057qib7	7443	32	signal	signal	NN
cord-005453-4057qib7	7443	33	joint	joint	JJ
cord-005453-4057qib7	7443	34	T	t	NN
cord-005453-4057qib7	7443	35	-	-	HYPH
cord-005453-4057qib7	7443	36	cell	cell	NN
cord-005453-4057qib7	7443	37	receptor	receptor	NN
cord-005453-4057qib7	7443	38	excision	excision	NN
cord-005453-4057qib7	7443	39	DNA	dna	NN
cord-005453-4057qib7	7443	40	circles	circle	NNS
cord-005453-4057qib7	7443	41	(	(	-LRB-
cord-005453-4057qib7	7443	42	sjTRECs	sjtrecs	NN
cord-005453-4057qib7	7443	43	)	)	-RRB-
cord-005453-4057qib7	7443	44	,	,	,
cord-005453-4057qib7	7443	45	specific	specific	JJ
cord-005453-4057qib7	7443	46	marker	marker	NN
cord-005453-4057qib7	7443	47	of	of	IN
cord-005453-4057qib7	7443	48	naive	naive	JJ
cord-005453-4057qib7	7443	49	T	T	NNP
cord-005453-4057qib7	7443	50	-	-	HYPH
cord-005453-4057qib7	7443	51	cells	cell	NNS
cord-005453-4057qib7	7443	52	thymopoiesis	thymopoiesis	NN
cord-005453-4057qib7	7443	53	.	.	.
cord-005453-4057qib7	7444	1	A	a	LS
cord-005453-4057qib7	7444	2	)	)	-RRB-
cord-005453-4057qib7	7444	3	Naive	naive	JJ
cord-005453-4057qib7	7444	4	;	;	:
cord-005453-4057qib7	7444	5	b	b	LS
cord-005453-4057qib7	7444	6	)	)	-RRB-
cord-005453-4057qib7	7444	7	central	central	JJ
cord-005453-4057qib7	7444	8	;	;	:
cord-005453-4057qib7	7444	9	c	c	NN
cord-005453-4057qib7	7444	10	)	)	-RRB-
cord-005453-4057qib7	7444	11	memory	memory	NN
cord-005453-4057qib7	7444	12	;	;	:
cord-005453-4057qib7	7444	13	and	and	CC
cord-005453-4057qib7	7444	14	d	d	LS
cord-005453-4057qib7	7444	15	)	)	-RRB-
cord-005453-4057qib7	7445	1	revertant	revertant	NNP
cord-005453-4057qib7	7445	2	CD4	CD4	NNP
cord-005453-4057qib7	7445	3	and	and	CC
cord-005453-4057qib7	7445	4	CD8	CD8	NNP
cord-005453-4057qib7	7445	5	T	T	NNP
cord-005453-4057qib7	7445	6	-	-	HYPH
cord-005453-4057qib7	7445	7	cells	cell	NNS
cord-005453-4057qib7	7445	8	were	be	VBD
cord-005453-4057qib7	7445	9	defined	define	VBN
cord-005453-4057qib7	7445	10	as	as	IN
cord-005453-4057qib7	7445	11	follows	follow	VBZ
cord-005453-4057qib7	7445	12	:	:	:
cord-005453-4057qib7	7445	13	a	a	LS
cord-005453-4057qib7	7445	14	)	)	-RRB-
cord-005453-4057qib7	7445	15	CD45RA+CD62L+	CD45RA+CD62L+	NNS
cord-005453-4057qib7	7445	16	;	;	:
cord-005453-4057qib7	7446	1	b	b	LS
cord-005453-4057qib7	7446	2	)	)	-RRB-
cord-005453-4057qib7	7446	3	CD45RO	cd45ro	VB
cord-005453-4057qib7	7446	4	+	+	SYM
cord-005453-4057qib7	7446	5	CD62L+	CD62L+	NNS
cord-005453-4057qib7	7446	6	;	;	:
cord-005453-4057qib7	7446	7	c	c	LS
cord-005453-4057qib7	7446	8	)	)	-RRB-
cord-005453-4057qib7	7446	9	CD45RO+CD27-	CD45RO+CD27-	NNP
cord-005453-4057qib7	7446	10	;	;	:
cord-005453-4057qib7	7446	11	and	and	CC
cord-005453-4057qib7	7446	12	d	d	LS
cord-005453-4057qib7	7446	13	)	)	-RRB-
cord-005453-4057qib7	7446	14	CD45RA+/45RO	cd45ra+/45ro	NN
cord-005453-4057qib7	7446	15	+	+	CC
cord-005453-4057qib7	7446	16	,	,	,
cord-005453-4057qib7	7446	17	respectively	respectively	RB
cord-005453-4057qib7	7446	18	.	.	.
cord-005453-4057qib7	7447	1	SjTRECs	SjTRECs	NNP
cord-005453-4057qib7	7447	2	RT.PCR	RT.PCR	NNP
cord-005453-4057qib7	7447	3	was	be	VBD
cord-005453-4057qib7	7447	4	performed	perform	VBN
cord-005453-4057qib7	7447	5	on	on	IN
cord-005453-4057qib7	7447	6	genomic	genomic	JJ
cord-005453-4057qib7	7447	7	DNA	dna	NN
cord-005453-4057qib7	7447	8	(	(	-LRB-
cord-005453-4057qib7	7447	9	100	100	CD
cord-005453-4057qib7	7447	10	ng	ng	NN
cord-005453-4057qib7	7447	11	)	)	-RRB-
cord-005453-4057qib7	7447	12	extracted	extract	VBN
cord-005453-4057qib7	7447	13	from	from	IN
cord-005453-4057qib7	7447	14	sorted	sort	VBN
cord-005453-4057qib7	7447	15	CD4	CD4	NNP
cord-005453-4057qib7	7447	16	and	and	CC
cord-005453-4057qib7	7447	17	CD8	CD8	NNP
cord-005453-4057qib7	7447	18	T	T	NNP
cord-005453-4057qib7	7447	19	-	-	HYPH
cord-005453-4057qib7	7447	20	cells	cell	NNS
cord-005453-4057qib7	7447	21	.	.	.
cord-005453-4057qib7	7448	1	Results	result	NNS
cord-005453-4057qib7	7448	2	:	:	:
cord-005453-4057qib7	7449	1	A	a	DT
cord-005453-4057qib7	7449	2	gradual	gradual	JJ
cord-005453-4057qib7	7449	3	increase	increase	NN
cord-005453-4057qib7	7449	4	in	in	IN
cord-005453-4057qib7	7449	5	absolute	absolute	JJ
cord-005453-4057qib7	7449	6	numbers	number	NNS
cord-005453-4057qib7	7449	7	of	of	IN
cord-005453-4057qib7	7449	8	all	all	DT
cord-005453-4057qib7	7449	9	CD4	CD4	NNP
cord-005453-4057qib7	7449	10	and	and	CC
cord-005453-4057qib7	7449	11	CD8	CD8	NNP
cord-005453-4057qib7	7449	12	T	T	NNP
cord-005453-4057qib7	7449	13	cell	cell	NN
cord-005453-4057qib7	7449	14	subsets	subset	NNS
cord-005453-4057qib7	7449	15	and	and	CC
cord-005453-4057qib7	7449	16	of	of	IN
cord-005453-4057qib7	7449	17	sjTRECs	sjtrecs	NN
cord-005453-4057qib7	7449	18	copies	copy	NNS
cord-005453-4057qib7	7449	19	from	from	IN
cord-005453-4057qib7	7449	20	the	the	DT
cord-005453-4057qib7	7449	21	first	first	JJ
cord-005453-4057qib7	7449	22	month	month	NN
cord-005453-4057qib7	7449	23	up	up	IN
cord-005453-4057qib7	7449	24	to	to	TO
cord-005453-4057qib7	7449	25	2	2	CD
cord-005453-4057qib7	7449	26	years	year	NNS
cord-005453-4057qib7	7449	27	post	post	JJ
cord-005453-4057qib7	7449	28	-	-	NN
cord-005453-4057qib7	7449	29	transplant	transplant	NN
cord-005453-4057qib7	7449	30	was	be	VBD
cord-005453-4057qib7	7449	31	observed	observe	VBN
cord-005453-4057qib7	7449	32	(	(	-LRB-
cord-005453-4057qib7	7449	33	Figure	figure	NN
cord-005453-4057qib7	7449	34	1	1	CD
cord-005453-4057qib7	7449	35	)	)	-RRB-
cord-005453-4057qib7	7449	36	.	.	.
cord-005453-4057qib7	7450	1	However	however	RB
cord-005453-4057qib7	7450	2	,	,	,
cord-005453-4057qib7	7450	3	at	at	IN
cord-005453-4057qib7	7450	4	2	2	CD
cord-005453-4057qib7	7450	5	years	year	NNS
cord-005453-4057qib7	7450	6	,	,	,
cord-005453-4057qib7	7450	7	CD4	CD4	NNP
cord-005453-4057qib7	7450	8	and	and	CC
cord-005453-4057qib7	7450	9	CD8	CD8	NNP
cord-005453-4057qib7	7450	10	T	T	NNP
cord-005453-4057qib7	7450	11	-	-	HYPH
cord-005453-4057qib7	7450	12	cell	cell	NN
cord-005453-4057qib7	7450	13	levels	level	NNS
cord-005453-4057qib7	7450	14	and	and	CC
cord-005453-4057qib7	7450	15	sjTRECs	sjtrecs	NN
cord-005453-4057qib7	7450	16	levels	level	NNS
cord-005453-4057qib7	7450	17	were	be	VBD
cord-005453-4057qib7	7450	18	lower	low	JJR
cord-005453-4057qib7	7450	19	than	than	IN
cord-005453-4057qib7	7450	20	those	those	DT
cord-005453-4057qib7	7450	21	observed	observe	VBN
cord-005453-4057qib7	7450	22	in	in	IN
cord-005453-4057qib7	7450	23	healthy	healthy	JJ
cord-005453-4057qib7	7450	24	donors	donor	NNS
cord-005453-4057qib7	7450	25	.	.	.
cord-005453-4057qib7	7451	1	sjTRECs	sjTRECs	NNP
cord-005453-4057qib7	7451	2	kinetics	kinetics	NNP
cord-005453-4057qib7	7451	3	was	be	VBD
cord-005453-4057qib7	7451	4	associated	associate	VBN
cord-005453-4057qib7	7451	5	with	with	IN
cord-005453-4057qib7	7451	6	the	the	DT
cord-005453-4057qib7	7451	7	increase	increase	NN
cord-005453-4057qib7	7451	8	in	in	IN
cord-005453-4057qib7	7451	9	CD4	CD4	NNP
cord-005453-4057qib7	7451	10	naive	naive	JJ
cord-005453-4057qib7	7451	11	T	T	NNP
cord-005453-4057qib7	7451	12	-	-	HYPH
cord-005453-4057qib7	7451	13	cells	cell	NNS
cord-005453-4057qib7	7451	14	(	(	-LRB-
cord-005453-4057qib7	7451	15	overall	overall	RB
cord-005453-4057qib7	7451	16	,	,	,
cord-005453-4057qib7	7451	17	p	p	NN
cord-005453-4057qib7	7451	18	<	<	XX
cord-005453-4057qib7	7451	19	0.002	0.002	CD
cord-005453-4057qib7	7451	20	)	)	-RRB-
cord-005453-4057qib7	7451	21	.	.	.
cord-005453-4057qib7	7452	1	This	this	DT
cord-005453-4057qib7	7452	2	correlation	correlation	NN
cord-005453-4057qib7	7452	3	suggests	suggest	VBZ
cord-005453-4057qib7	7452	4	that	that	IN
cord-005453-4057qib7	7452	5	most	most	JJS
cord-005453-4057qib7	7452	6	of	of	IN
cord-005453-4057qib7	7452	7	CD4	CD4	NNP
cord-005453-4057qib7	7452	8	naive	naive	JJ
cord-005453-4057qib7	7452	9	T	T	NNP
cord-005453-4057qib7	7452	10	-	-	HYPH
cord-005453-4057qib7	7452	11	cells	cell	NNS
cord-005453-4057qib7	7452	12	derives	derive	VBZ
cord-005453-4057qib7	7452	13	from	from	IN
cord-005453-4057qib7	7452	14	thymic	thymic	JJ
cord-005453-4057qib7	7452	15	re	re	NN
cord-005453-4057qib7	7452	16	-	-	NN
cord-005453-4057qib7	7452	17	education	education	NN
cord-005453-4057qib7	7452	18	of	of	IN
cord-005453-4057qib7	7452	19	donor	donor	NN
cord-005453-4057qib7	7452	20	precursor	precursor	NN
cord-005453-4057qib7	7452	21	stem	stem	NN
cord-005453-4057qib7	7452	22	cells	cell	NNS
cord-005453-4057qib7	7452	23	,	,	,
cord-005453-4057qib7	7452	24	whereas	whereas	IN
cord-005453-4057qib7	7452	25	CD8	CD8	NNP
cord-005453-4057qib7	7452	26	naive	naive	JJ
cord-005453-4057qib7	7452	27	T	T	NNP
cord-005453-4057qib7	7452	28	-	-	HYPH
cord-005453-4057qib7	7452	29	cells	cell	NNS
cord-005453-4057qib7	7452	30	undergo	undergo	VBP
cord-005453-4057qib7	7452	31	peripheral	peripheral	JJ
cord-005453-4057qib7	7452	32	expansion	expansion	NN
cord-005453-4057qib7	7452	33	after	after	IN
cord-005453-4057qib7	7452	34	thymic	thymic	JJ
cord-005453-4057qib7	7452	35	production	production	NN
cord-005453-4057qib7	7452	36	.	.	.
cord-005453-4057qib7	7453	1	Furthermore	furthermore	RB
cord-005453-4057qib7	7453	2	,	,	,
cord-005453-4057qib7	7453	3	an	an	DT
cord-005453-4057qib7	7453	4	increase	increase	NN
cord-005453-4057qib7	7453	5	in	in	IN
cord-005453-4057qib7	7453	6	CD4	CD4	NNP
cord-005453-4057qib7	7453	7	revertant	revertant	NNP
cord-005453-4057qib7	7453	8	memory	memory	NN
cord-005453-4057qib7	7453	9	T	T	NNP
cord-005453-4057qib7	7453	10	-	-	HYPH
cord-005453-4057qib7	7453	11	cells	cell	NNS
cord-005453-4057qib7	7453	12	was	be	VBD
cord-005453-4057qib7	7453	13	also	also	RB
cord-005453-4057qib7	7453	14	significantly	significantly	RB
cord-005453-4057qib7	7453	15	correlated	correlate	VBN
cord-005453-4057qib7	7453	16	with	with	IN
cord-005453-4057qib7	7453	17	sjTRECs	sjtrecs	NN
cord-005453-4057qib7	7453	18	kinetic	kinetic	NNP
cord-005453-4057qib7	7453	19	(	(	-LRB-
cord-005453-4057qib7	7453	20	p	p	NN
cord-005453-4057qib7	7453	21	0,041	0,041	CD
cord-005453-4057qib7	7453	22	)	)	-RRB-
cord-005453-4057qib7	7453	23	.	.	.
cord-005453-4057qib7	7454	1	Central	central	JJ
cord-005453-4057qib7	7454	2	and	and	CC
cord-005453-4057qib7	7454	3	effector	effector	JJ
cord-005453-4057qib7	7454	4	memory	memory	NN
cord-005453-4057qib7	7454	5	T	t	NN
cord-005453-4057qib7	7454	6	-	-	HYPH
cord-005453-4057qib7	7454	7	cells	cell	NNS
cord-005453-4057qib7	7454	8	showed	show	VBD
cord-005453-4057qib7	7454	9	a	a	DT
cord-005453-4057qib7	7454	10	faster	fast	RBR
cord-005453-4057qib7	7454	11	thymic	thymic	JJ
cord-005453-4057qib7	7454	12	-	-	HYPH
cord-005453-4057qib7	7454	13	independent	independent	JJ
cord-005453-4057qib7	7454	14	expansion	expansion	NN
cord-005453-4057qib7	7454	15	in	in	IN
cord-005453-4057qib7	7454	16	both	both	CC
cord-005453-4057qib7	7454	17	CD4	CD4	NNP
cord-005453-4057qib7	7454	18	and	and	CC
cord-005453-4057qib7	7454	19	CD8	CD8	NNP
cord-005453-4057qib7	7454	20	Tcells	Tcells	NNP
cord-005453-4057qib7	7454	21	.	.	.
cord-005453-4057qib7	7455	1	Interestingly	interestingly	RB
cord-005453-4057qib7	7455	2	,	,	,
cord-005453-4057qib7	7455	3	sjTRECs	sjtrecs	NN
cord-005453-4057qib7	7455	4	levels	level	NNS
cord-005453-4057qib7	7455	5	and	and	CC
cord-005453-4057qib7	7455	6	thymic	thymic	JJ
cord-005453-4057qib7	7455	7	dependent	dependent	JJ
cord-005453-4057qib7	7455	8	immune	immune	NN
cord-005453-4057qib7	7455	9	-	-	HYPH
cord-005453-4057qib7	7455	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	7455	11	were	be	VBD
cord-005453-4057qib7	7455	12	higher	high	JJR
cord-005453-4057qib7	7455	13	in	in	IN
cord-005453-4057qib7	7455	14	a	a	DT
cord-005453-4057qib7	7455	15	cohort	cohort	NN
cord-005453-4057qib7	7455	16	of	of	IN
cord-005453-4057qib7	7455	17	63	63	CD
cord-005453-4057qib7	7455	18	patients	patient	NNS
cord-005453-4057qib7	7455	19	undergoing	undergo	VBG
cord-005453-4057qib7	7455	20	HSCT	HSCT	NNP
cord-005453-4057qib7	7455	21	from	from	IN
cord-005453-4057qib7	7455	22	HLA	HLA	NNP
cord-005453-4057qib7	7455	23	identical	identical	JJ
cord-005453-4057qib7	7455	24	donors	donor	NNS
cord-005453-4057qib7	7455	25	(	(	-LRB-
cord-005453-4057qib7	7455	26	manuscript	manuscript	NN
cord-005453-4057qib7	7455	27	in	in	IN
cord-005453-4057qib7	7455	28	preparation	preparation	NN
cord-005453-4057qib7	7455	29	)	)	-RRB-
cord-005453-4057qib7	7455	30	.	.	.
cord-005453-4057qib7	7456	1	Clinical	clinical	JJ
cord-005453-4057qib7	7456	2	outcomes	outcome	NNS
cord-005453-4057qib7	7456	3	and	and	CC
cord-005453-4057qib7	7456	4	thymic	thymic	JJ
cord-005453-4057qib7	7456	5	function	function	NN
cord-005453-4057qib7	7456	6	were	be	VBD
cord-005453-4057qib7	7456	7	correlated	correlate	VBN
cord-005453-4057qib7	7456	8	starting	start	VBG
cord-005453-4057qib7	7456	9	at	at	IN
cord-005453-4057qib7	7456	10	6	6	CD
cord-005453-4057qib7	7456	11	months	month	NNS
cord-005453-4057qib7	7456	12	after	after	IN
cord-005453-4057qib7	7456	13	HSCT	HSCT	NNP
cord-005453-4057qib7	7456	14	.	.	.
cord-005453-4057qib7	7457	1	Lower	low	JJR
cord-005453-4057qib7	7457	2	thymic	thymic	JJ
cord-005453-4057qib7	7457	3	output	output	NN
cord-005453-4057qib7	7457	4	was	be	VBD
cord-005453-4057qib7	7457	5	significantly	significantly	RB
cord-005453-4057qib7	7457	6	associated	associate	VBN
cord-005453-4057qib7	7457	7	by	by	IN
cord-005453-4057qib7	7457	8	multivariate	multivariate	JJ
cord-005453-4057qib7	7457	9	analysis	analysis	NN
cord-005453-4057qib7	7457	10	with	with	IN
cord-005453-4057qib7	7457	11	low	low	JJ
cord-005453-4057qib7	7457	12	pre	pre	JJ
cord-005453-4057qib7	7457	13	-	-	JJ
cord-005453-4057qib7	7457	14	transplant	transplant	JJ
cord-005453-4057qib7	7457	15	TRECs	trec	NNS
cord-005453-4057qib7	7457	16	values	value	NNS
cord-005453-4057qib7	7457	17	(	(	-LRB-
cord-005453-4057qib7	7457	18	p	p	NN
cord-005453-4057qib7	7457	19	0,002	0,002	CD
cord-005453-4057qib7	7457	20	and	and	CC
cord-005453-4057qib7	7457	21	p	p	NN
cord-005453-4057qib7	7457	22	<	<	XX
cord-005453-4057qib7	7457	23	0,001	0,001	CD
cord-005453-4057qib7	7457	24	in	in	IN
cord-005453-4057qib7	7457	25	CD4	CD4	NNP
cord-005453-4057qib7	7457	26	and	and	CC
cord-005453-4057qib7	7457	27	CD8	CD8	NNP
cord-005453-4057qib7	7457	28	,	,	,
cord-005453-4057qib7	7457	29	respectively	respectively	RB
cord-005453-4057qib7	7457	30	)	)	-RRB-
cord-005453-4057qib7	7457	31	,	,	,
cord-005453-4057qib7	7457	32	moderate	moderate	JJ
cord-005453-4057qib7	7457	33	-	-	HYPH
cord-005453-4057qib7	7457	34	severe	severe	JJ
cord-005453-4057qib7	7457	35	chronic	chronic	JJ
cord-005453-4057qib7	7457	36	graft	graft	NN
cord-005453-4057qib7	7457	37	-	-	HYPH
cord-005453-4057qib7	7457	38	versus	versus	IN
cord-005453-4057qib7	7457	39	-	-	HYPH
cord-005453-4057qib7	7457	40	host	host	NN
cord-005453-4057qib7	7457	41	disease	disease	NN
cord-005453-4057qib7	7457	42	(	(	-LRB-
cord-005453-4057qib7	7457	43	GVHD	GVHD	NNP
cord-005453-4057qib7	7457	44	;	;	.
cord-005453-4057qib7	7458	1	p	p	LS
cord-005453-4057qib7	7458	2	<	<	XX
cord-005453-4057qib7	7458	3	0,001	0,001	CD
cord-005453-4057qib7	7458	4	in	in	IN
cord-005453-4057qib7	7458	5	CD8	CD8	NNP
cord-005453-4057qib7	7458	6	)	)	-RRB-
cord-005453-4057qib7	7458	7	,	,	,
cord-005453-4057qib7	7458	8	and	and	CC
cord-005453-4057qib7	7458	9	age	age	NN
cord-005453-4057qib7	7458	10	(	(	-LRB-
cord-005453-4057qib7	7458	11	≥50	≥50	NNP
cord-005453-4057qib7	7458	12	years	year	NNS
cord-005453-4057qib7	7458	13	,	,	,
cord-005453-4057qib7	7458	14	p	p	NN
cord-005453-4057qib7	7458	15	0,006	0,006	CD
cord-005453-4057qib7	7458	16	in	in	IN
cord-005453-4057qib7	7458	17	CD8	CD8	NNP
cord-005453-4057qib7	7458	18	)	)	-RRB-
cord-005453-4057qib7	7458	19	.	.	.
cord-005453-4057qib7	7459	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7459	2	:	:	:
cord-005453-4057qib7	7460	1	The	the	DT
cord-005453-4057qib7	7460	2	thymus	thymus	NN
cord-005453-4057qib7	7460	3	,	,	,
cord-005453-4057qib7	7460	4	despite	despite	IN
cord-005453-4057qib7	7460	5	age	age	NN
cord-005453-4057qib7	7460	6	-	-	HYPH
cord-005453-4057qib7	7460	7	dependent	dependent	JJ
cord-005453-4057qib7	7460	8	involution	involution	NN
cord-005453-4057qib7	7460	9	,	,	,
cord-005453-4057qib7	7460	10	substantially	substantially	RB
cord-005453-4057qib7	7460	11	contributes	contribute	VBZ
cord-005453-4057qib7	7460	12	to	to	IN
cord-005453-4057qib7	7460	13	T	t	NN
cord-005453-4057qib7	7460	14	-	-	HYPH
cord-005453-4057qib7	7460	15	cell	cell	NN
cord-005453-4057qib7	7460	16	reconstitution	reconstitution	NN
cord-005453-4057qib7	7460	17	after	after	IN
cord-005453-4057qib7	7460	18	haplo	haplo	NNP
cord-005453-4057qib7	7460	19	-	-	HYPH
cord-005453-4057qib7	7460	20	HSCT	HSCT	NNP
cord-005453-4057qib7	7460	21	.	.	.
cord-005453-4057qib7	7461	1	Chronic	chronic	JJ
cord-005453-4057qib7	7461	2	GVHD	GVHD	NNP
cord-005453-4057qib7	7461	3	and	and	CC
cord-005453-4057qib7	7461	4	older	old	JJR
cord-005453-4057qib7	7461	5	age	age	NN
cord-005453-4057qib7	7461	6	were	be	VBD
cord-005453-4057qib7	7461	7	significantly	significantly	RB
cord-005453-4057qib7	7461	8	correlated	correlate	VBN
cord-005453-4057qib7	7461	9	with	with	IN
cord-005453-4057qib7	7461	10	reduced	reduced	JJ
cord-005453-4057qib7	7461	11	thymic	thymic	JJ
cord-005453-4057qib7	7461	12	function	function	NN
cord-005453-4057qib7	7461	13	.	.	.
cord-005453-4057qib7	7462	1	Overall	overall	RB
cord-005453-4057qib7	7462	2	,	,	,
cord-005453-4057qib7	7462	3	lower	low	JJR
cord-005453-4057qib7	7462	4	production	production	NN
cord-005453-4057qib7	7462	5	of	of	IN
cord-005453-4057qib7	7462	6	sjTRECs	sjtrecs	NN
cord-005453-4057qib7	7462	7	after	after	IN
cord-005453-4057qib7	7462	8	haplo	haplo	NNP
cord-005453-4057qib7	7462	9	-	-	HYPH
cord-005453-4057qib7	7462	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7462	11	as	as	IN
cord-005453-4057qib7	7462	12	compared	compare	VBN
cord-005453-4057qib7	7462	13	after	after	IN
cord-005453-4057qib7	7462	14	HLA	HLA	NNP
cord-005453-4057qib7	7462	15	identical	identical	JJ
cord-005453-4057qib7	7462	16	sibling	sibling	NN
cord-005453-4057qib7	7462	17	HSCT	HSCT	NNP
cord-005453-4057qib7	7462	18	may	may	MD
cord-005453-4057qib7	7462	19	partly	partly	RB
cord-005453-4057qib7	7462	20	be	be	VB
cord-005453-4057qib7	7462	21	due	due	JJ
cord-005453-4057qib7	7462	22	to	to	IN
cord-005453-4057qib7	7462	23	a	a	DT
cord-005453-4057qib7	7462	24	higher	high	JJR
cord-005453-4057qib7	7462	25	degree	degree	NN
cord-005453-4057qib7	7462	26	of	of	IN
cord-005453-4057qib7	7462	27	"	"	``
cord-005453-4057qib7	7462	28	mismatching	mismatching	NN
cord-005453-4057qib7	7462	29	"	"	''
cord-005453-4057qib7	7462	30	of	of	IN
cord-005453-4057qib7	7462	31	MHC	MHC	NNP
cord-005453-4057qib7	7462	32	molecules	molecule	NNS
cord-005453-4057qib7	7462	33	during	during	IN
cord-005453-4057qib7	7462	34	thymic	thymic	JJ
cord-005453-4057qib7	7462	35	re	re	NN
cord-005453-4057qib7	7462	36	-	-	NN
cord-005453-4057qib7	7462	37	education	education	NN
cord-005453-4057qib7	7462	38	.	.	.
cord-005453-4057qib7	7463	1	[	[	-LRB-
cord-005453-4057qib7	7463	2	[	[	-LRB-
cord-005453-4057qib7	7463	3	P335	p335	CD
cord-005453-4057qib7	7463	4	Image	image	NN
cord-005453-4057qib7	7463	5	]	]	-RRB-
cord-005453-4057qib7	7463	6	1	1	CD
cord-005453-4057qib7	7463	7	.	.	.
cord-005453-4057qib7	7464	1	Figure	figure	NN
cord-005453-4057qib7	7464	2	1	1	CD
cord-005453-4057qib7	7464	3	]	]	-RRB-
cord-005453-4057qib7	7465	1	Background	background	NN
cord-005453-4057qib7	7465	2	:	:	:
cord-005453-4057qib7	7466	1	The	the	DT
cord-005453-4057qib7	7466	2	use	use	NN
cord-005453-4057qib7	7466	3	of	of	IN
cord-005453-4057qib7	7466	4	Allogenic	Allogenic	NNP
cord-005453-4057qib7	7466	5	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	7466	6	Stem	Stem	NNP
cord-005453-4057qib7	7466	7	Cell	Cell	NNP
cord-005453-4057qib7	7466	8	Transplantation	transplantation	NN
cord-005453-4057qib7	7466	9	(	(	-LRB-
cord-005453-4057qib7	7466	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7466	11	)	)	-RRB-
cord-005453-4057qib7	7466	12	in	in	IN
cord-005453-4057qib7	7466	13	the	the	DT
cord-005453-4057qib7	7466	14	treatment	treatment	NN
cord-005453-4057qib7	7466	15	of	of	IN
cord-005453-4057qib7	7466	16	Adolescents	Adolescents	NNPS
cord-005453-4057qib7	7466	17	and	and	CC
cord-005453-4057qib7	7466	18	Young	Young	NNP
cord-005453-4057qib7	7466	19	Adults	Adults	NNPS
cord-005453-4057qib7	7466	20	(	(	-LRB-
cord-005453-4057qib7	7466	21	AYA	AYA	NNP
cord-005453-4057qib7	7466	22	)	)	-RRB-
cord-005453-4057qib7	7466	23	with	with	IN
cord-005453-4057qib7	7466	24	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	7466	25	negative	negative	JJ
cord-005453-4057qib7	7466	26	ALL	all	DT
cord-005453-4057qib7	7466	27	is	be	VBZ
cord-005453-4057qib7	7466	28	decreasing	decrease	VBG
cord-005453-4057qib7	7466	29	with	with	IN
cord-005453-4057qib7	7466	30	the	the	DT
cord-005453-4057qib7	7466	31	adoption	adoption	NN
cord-005453-4057qib7	7466	32	of	of	IN
cord-005453-4057qib7	7466	33	pediatric	pediatric	JJ
cord-005453-4057qib7	7466	34	inspired	inspire	VBN
cord-005453-4057qib7	7466	35	protocols	protocol	NNS
cord-005453-4057qib7	7466	36	to	to	TO
cord-005453-4057qib7	7466	37	treat	treat	VB
cord-005453-4057qib7	7466	38	this	this	DT
cord-005453-4057qib7	7466	39	age	age	NN
cord-005453-4057qib7	7466	40	group	group	NN
cord-005453-4057qib7	7466	41	and	and	CC
cord-005453-4057qib7	7466	42	the	the	DT
cord-005453-4057qib7	7466	43	incorporation	incorporation	NN
cord-005453-4057qib7	7466	44	of	of	IN
cord-005453-4057qib7	7466	45	minimal	minimal	JJ
cord-005453-4057qib7	7466	46	residual	residual	JJ
cord-005453-4057qib7	7466	47	disease	disease	NN
cord-005453-4057qib7	7466	48	assessment	assessment	NN
cord-005453-4057qib7	7466	49	in	in	IN
cord-005453-4057qib7	7466	50	the	the	DT
cord-005453-4057qib7	7466	51	routine	routine	JJ
cord-005453-4057qib7	7466	52	care	care	NN
cord-005453-4057qib7	7466	53	of	of	IN
cord-005453-4057qib7	7466	54	ALL	all	DT
cord-005453-4057qib7	7466	55	patients	patient	NNS
cord-005453-4057qib7	7466	56	.	.	.
cord-005453-4057qib7	7467	1	Previously	previously	RB
cord-005453-4057qib7	7467	2	,	,	,
cord-005453-4057qib7	7467	3	its	-PRON-	PRP$
cord-005453-4057qib7	7467	4	use	use	NN
cord-005453-4057qib7	7467	5	was	be	VBD
cord-005453-4057qib7	7467	6	defined	define	VBN
cord-005453-4057qib7	7467	7	mainly	mainly	RB
cord-005453-4057qib7	7467	8	by	by	IN
cord-005453-4057qib7	7467	9	disease	disease	NN
cord-005453-4057qib7	7467	10	risk	risk	NN
cord-005453-4057qib7	7467	11	features	feature	VBZ
cord-005453-4057qib7	7467	12	at	at	IN
cord-005453-4057qib7	7467	13	presentation	presentation	NN
cord-005453-4057qib7	7467	14	.	.	.
cord-005453-4057qib7	7468	1	Methods	method	NNS
cord-005453-4057qib7	7468	2	:	:	:
cord-005453-4057qib7	7469	1	A	a	DT
cord-005453-4057qib7	7469	2	study	study	NN
cord-005453-4057qib7	7469	3	on	on	IN
cord-005453-4057qib7	7469	4	209	209	CD
cord-005453-4057qib7	7469	5	AYA	AYA	NNP
cord-005453-4057qib7	7469	6	(	(	-LRB-
cord-005453-4057qib7	7469	7	age	age	NN
cord-005453-4057qib7	7469	8	14	14	CD
cord-005453-4057qib7	7469	9	-	-	SYM
cord-005453-4057qib7	7469	10	39	39	CD
cord-005453-4057qib7	7469	11	years	year	NNS
cord-005453-4057qib7	7469	12	)	)	-RRB-
cord-005453-4057qib7	7469	13	,	,	,
cord-005453-4057qib7	7469	14	who	who	WP
cord-005453-4057qib7	7469	15	underwent	undergo	VBD
cord-005453-4057qib7	7469	16	Allogenic	Allogenic	NNP
cord-005453-4057qib7	7469	17	HSCT	HSCT	NNP
cord-005453-4057qib7	7469	18	at	at	IN
cord-005453-4057qib7	7469	19	our	-PRON-	PRP$
cord-005453-4057qib7	7469	20	institute	institute	NN
cord-005453-4057qib7	7469	21	for	for	IN
cord-005453-4057qib7	7469	22	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	7469	23	negative	negative	JJ
cord-005453-4057qib7	7469	24	ALL	all	DT
cord-005453-4057qib7	7469	25	,	,	,
cord-005453-4057qib7	7469	26	between	between	IN
cord-005453-4057qib7	7469	27	February	February	NNP
cord-005453-4057qib7	7469	28	2005	2005	CD
cord-005453-4057qib7	7469	29	and	and	CC
cord-005453-4057qib7	7469	30	December	December	NNP
cord-005453-4057qib7	7469	31	2015	2015	CD
cord-005453-4057qib7	7469	32	.	.	.
cord-005453-4057qib7	7470	1	All	all	PDT
cord-005453-4057qib7	7470	2	the	the	DT
cord-005453-4057qib7	7470	3	studied	study	VBN
cord-005453-4057qib7	7470	4	patients	patient	NNS
cord-005453-4057qib7	7470	5	received	receive	VBD
cord-005453-4057qib7	7470	6	CALGB	CALGB	NNP
cord-005453-4057qib7	7470	7	based	base	VBN
cord-005453-4057qib7	7470	8	adult	adult	NN
cord-005453-4057qib7	7470	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7470	10	protocol	protocol	NN
cord-005453-4057qib7	7470	11	for	for	IN
cord-005453-4057qib7	7470	12	induction	induction	NN
cord-005453-4057qib7	7470	13	,	,	,
cord-005453-4057qib7	7470	14	and	and	CC
cord-005453-4057qib7	7470	15	underwent	undergo	VBD
cord-005453-4057qib7	7470	16	a	a	DT
cord-005453-4057qib7	7470	17	Matched	match	VBN
cord-005453-4057qib7	7470	18	Related	Related	NNP
cord-005453-4057qib7	7470	19	Donor	Donor	NNP
cord-005453-4057qib7	7470	20	(	(	-LRB-
cord-005453-4057qib7	7470	21	MRD	MRD	NNP
cord-005453-4057qib7	7470	22	)	)	-RRB-
cord-005453-4057qib7	7470	23	transplant	transplant	NN
cord-005453-4057qib7	7470	24	with	with	IN
cord-005453-4057qib7	7470	25	CY	CY	NNP
cord-005453-4057qib7	7470	26	/	/	SYM
cord-005453-4057qib7	7470	27	TBI	TBI	NNP
cord-005453-4057qib7	7470	28	conditioning	conditioning	NN
cord-005453-4057qib7	7470	29	and	and	CC
cord-005453-4057qib7	7470	30	MTX	MTX	NNP
cord-005453-4057qib7	7470	31	/	/	SYM
cord-005453-4057qib7	7470	32	CSA	CSA	NNP
cord-005453-4057qib7	7470	33	as	as	IN
cord-005453-4057qib7	7470	34	GVHD	GVHD	NNP
cord-005453-4057qib7	7470	35	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7470	36	.	.	.
cord-005453-4057qib7	7471	1	The	the	DT
cord-005453-4057qib7	7471	2	patients	patient	NNS
cord-005453-4057qib7	7471	3	were	be	VBD
cord-005453-4057qib7	7471	4	eligible	eligible	JJ
cord-005453-4057qib7	7471	5	for	for	IN
cord-005453-4057qib7	7471	6	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	7471	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7471	8	,	,	,
cord-005453-4057qib7	7471	9	if	if	IN
cord-005453-4057qib7	7471	10	they	-PRON-	PRP
cord-005453-4057qib7	7471	11	have	have	VBP
cord-005453-4057qib7	7471	12	a	a	DT
cord-005453-4057qib7	7471	13	MRD	MRD	NNP
cord-005453-4057qib7	7471	14	plus	plus	CC
cord-005453-4057qib7	7471	15	one	one	CD
cord-005453-4057qib7	7471	16	or	or	CC
cord-005453-4057qib7	7471	17	more	more	JJR
cord-005453-4057qib7	7471	18	of	of	IN
cord-005453-4057qib7	7471	19	the	the	DT
cord-005453-4057qib7	7471	20	following	follow	VBG
cord-005453-4057qib7	7471	21	risk	risk	NN
cord-005453-4057qib7	7471	22	factors	factor	NNS
cord-005453-4057qib7	7471	23	:	:	:
cord-005453-4057qib7	7471	24	(	(	-LRB-
cord-005453-4057qib7	7471	25	1	1	LS
cord-005453-4057qib7	7471	26	)	)	-RRB-
cord-005453-4057qib7	7472	1	Age	age	NN
cord-005453-4057qib7	7472	2	˃	˃	.
cord-005453-4057qib7	7473	1	30	30	CD
cord-005453-4057qib7	7473	2	years	year	NNS
cord-005453-4057qib7	7473	3	,	,	,
cord-005453-4057qib7	7474	1	(	(	-LRB-
cord-005453-4057qib7	7474	2	2	2	LS
cord-005453-4057qib7	7474	3	)	)	-RRB-
cord-005453-4057qib7	7474	4	High	high	JJ
cord-005453-4057qib7	7474	5	presenting	present	VBG
cord-005453-4057qib7	7474	6	WBC	WBC	NNP
cord-005453-4057qib7	7474	7	count	count	NN
cord-005453-4057qib7	7474	8	(	(	-LRB-
cord-005453-4057qib7	7474	9	>	>	NFP
cord-005453-4057qib7	7474	10	30	30	CD
cord-005453-4057qib7	7474	11	for	for	IN
cord-005453-4057qib7	7474	12	B	b	NN
cord-005453-4057qib7	7474	13	-	-	HYPH
cord-005453-4057qib7	7474	14	ALL	all	DT
cord-005453-4057qib7	7474	15	,	,	,
cord-005453-4057qib7	7474	16	>	>	XX
cord-005453-4057qib7	7474	17	100	100	CD
cord-005453-4057qib7	7474	18	for	for	IN
cord-005453-4057qib7	7474	19	T	T	NNP
cord-005453-4057qib7	7474	20	-	-	HYPH
cord-005453-4057qib7	7474	21	ALL	ALL	NNP
cord-005453-4057qib7	7474	22	)	)	-RRB-
cord-005453-4057qib7	7474	23	,	,	,
cord-005453-4057qib7	7474	24	(	(	-LRB-
cord-005453-4057qib7	7474	25	3	3	LS
cord-005453-4057qib7	7474	26	)	)	-RRB-
cord-005453-4057qib7	7474	27	High	high	JJ
cord-005453-4057qib7	7474	28	risk	risk	NN
cord-005453-4057qib7	7475	1	Immuno	immuno	JJ
cord-005453-4057qib7	7475	2	-	-	HYPH
cord-005453-4057qib7	7475	3	phenotyping	phenotyping	JJ
cord-005453-4057qib7	7475	4	(	(	-LRB-
cord-005453-4057qib7	7475	5	Pro	pro	JJ
cord-005453-4057qib7	7475	6	-	-	NN
cord-005453-4057qib7	7475	7	B	b	JJ
cord-005453-4057qib7	7475	8	,	,	,
cord-005453-4057qib7	7475	9	Pro	Pro	NNP
cord-005453-4057qib7	7475	10	-	-	HYPH
cord-005453-4057qib7	7475	11	T	t	JJ
cord-005453-4057qib7	7475	12	,	,	,
cord-005453-4057qib7	7475	13	Early	Early	NNP
cord-005453-4057qib7	7475	14	T	T	NNP
cord-005453-4057qib7	7475	15	,	,	,
cord-005453-4057qib7	7475	16	and	and	CC
cord-005453-4057qib7	7475	17	Mature	Mature	NNP
cord-005453-4057qib7	7475	18	T	T	NNP
cord-005453-4057qib7	7475	19	)	)	-RRB-
cord-005453-4057qib7	7475	20	,	,	.
cord-005453-4057qib7	7476	1	(	(	-LRB-
cord-005453-4057qib7	7476	2	4	4	LS
cord-005453-4057qib7	7476	3	)	)	-RRB-
cord-005453-4057qib7	7476	4	Bulky	bulky	JJ
cord-005453-4057qib7	7476	5	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	7476	6	or	or	CC
cord-005453-4057qib7	7476	7	bulky	bulky	JJ
cord-005453-4057qib7	7476	8	lymphadenopathy	lymphadenopathy	NN
cord-005453-4057qib7	7476	9	,	,	,
cord-005453-4057qib7	7476	10	(	(	-LRB-
cord-005453-4057qib7	7476	11	5	5	LS
cord-005453-4057qib7	7476	12	)	)	-RRB-
cord-005453-4057qib7	7476	13	High	high	JJ
cord-005453-4057qib7	7476	14	risk	risk	NN
cord-005453-4057qib7	7476	15	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	7476	16	(	(	-LRB-
cord-005453-4057qib7	7476	17	4;11	4;11	CD
cord-005453-4057qib7	7476	18	,	,	,
cord-005453-4057qib7	7476	19	1;19	1;19	CD
cord-005453-4057qib7	7476	20	,	,	,
cord-005453-4057qib7	7476	21	low	low	JJ
cord-005453-4057qib7	7476	22	hypodiploidy	hypodiploidy	NNP
cord-005453-4057qib7	7476	23	/	/	,
cord-005453-4057qib7	7476	24	near	near	IN
cord-005453-4057qib7	7476	25	triploidy	triploidy	NNP
cord-005453-4057qib7	7476	26	,	,	,
cord-005453-4057qib7	7476	27	complex	complex	NNP
cord-005453-4057qib7	7476	28	)	)	-RRB-
cord-005453-4057qib7	7476	29	,	,	,
cord-005453-4057qib7	7476	30	(	(	-LRB-
cord-005453-4057qib7	7476	31	6	6	CD
cord-005453-4057qib7	7476	32	)	)	-RRB-
cord-005453-4057qib7	7476	33	CNS	CNS	NNP
cord-005453-4057qib7	7476	34	involvement	involvement	NN
cord-005453-4057qib7	7476	35	,	,	,
cord-005453-4057qib7	7476	36	(	(	-LRB-
cord-005453-4057qib7	7476	37	7	7	LS
cord-005453-4057qib7	7476	38	)	)	-RRB-
cord-005453-4057qib7	7476	39	Relapsed	relapsed	JJ
cord-005453-4057qib7	7476	40	or	or	CC
cord-005453-4057qib7	7476	41	refractory	refractory	JJ
cord-005453-4057qib7	7476	42	disease	disease	NN
cord-005453-4057qib7	7476	43	at	at	IN
cord-005453-4057qib7	7476	44	D28	D28	NNP
cord-005453-4057qib7	7476	45	of	of	IN
cord-005453-4057qib7	7476	46	induction	induction	NN
cord-005453-4057qib7	7476	47	.	.	.
cord-005453-4057qib7	7477	1	In	in	IN
cord-005453-4057qib7	7477	2	this	this	DT
cord-005453-4057qib7	7477	3	study	study	NN
cord-005453-4057qib7	7477	4	,	,	,
cord-005453-4057qib7	7477	5	we	-PRON-	PRP
cord-005453-4057qib7	7477	6	investigated	investigate	VBD
cord-005453-4057qib7	7477	7	the	the	DT
cord-005453-4057qib7	7477	8	impact	impact	NN
cord-005453-4057qib7	7477	9	of	of	IN
cord-005453-4057qib7	7477	10	those	those	DT
cord-005453-4057qib7	7477	11	different	different	JJ
cord-005453-4057qib7	7477	12	risk	risk	NN
cord-005453-4057qib7	7477	13	factors	factor	NNS
cord-005453-4057qib7	7477	14	on	on	IN
cord-005453-4057qib7	7477	15	the	the	DT
cord-005453-4057qib7	7477	16	long	long	JJ
cord-005453-4057qib7	7477	17	term	term	NN
cord-005453-4057qib7	7477	18	outcome	outcome	NN
cord-005453-4057qib7	7477	19	of	of	IN
cord-005453-4057qib7	7477	20	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	7477	21	HSCT	HSCT	NNP
cord-005453-4057qib7	7477	22	.	.	.
cord-005453-4057qib7	7478	1	Results	result	NNS
cord-005453-4057qib7	7478	2	:	:	:
cord-005453-4057qib7	7479	1	The	the	DT
cord-005453-4057qib7	7479	2	median	median	JJ
cord-005453-4057qib7	7479	3	OS	os	NN
cord-005453-4057qib7	7479	4	of	of	IN
cord-005453-4057qib7	7479	5	our	-PRON-	PRP$
cord-005453-4057qib7	7479	6	studied	study	VBN
cord-005453-4057qib7	7479	7	patients	patient	NNS
cord-005453-4057qib7	7479	8	was	be	VBD
cord-005453-4057qib7	7479	9	not	not	RB
cord-005453-4057qib7	7479	10	reached	reach	VBN
cord-005453-4057qib7	7479	11	at	at	IN
cord-005453-4057qib7	7479	12	12.5	12.5	CD
cord-005453-4057qib7	7479	13	years	year	NNS
cord-005453-4057qib7	7479	14	,	,	,
cord-005453-4057qib7	7479	15	with	with	IN
cord-005453-4057qib7	7479	16	a	a	DT
cord-005453-4057qib7	7479	17	median	median	JJ
cord-005453-4057qib7	7479	18	DFS	DFS	NNP
cord-005453-4057qib7	7479	19	of	of	IN
cord-005453-4057qib7	7479	20	8.3	8.3	CD
cord-005453-4057qib7	7479	21	years	year	NNS
cord-005453-4057qib7	7480	1	(	(	-LRB-
cord-005453-4057qib7	7480	2	Figure	figure	NN
cord-005453-4057qib7	7480	3	1	1	CD
cord-005453-4057qib7	7480	4	)	)	-RRB-
cord-005453-4057qib7	7480	5	.	.	.
cord-005453-4057qib7	7481	1	In	in	IN
cord-005453-4057qib7	7481	2	a	a	DT
cord-005453-4057qib7	7481	3	univariate	univariate	JJ
cord-005453-4057qib7	7481	4	analysis	analysis	NN
cord-005453-4057qib7	7481	5	,	,	,
cord-005453-4057qib7	7481	6	relapsed	relapsed	JJ
cord-005453-4057qib7	7481	7	or	or	CC
cord-005453-4057qib7	7481	8	refractory	refractory	JJ
cord-005453-4057qib7	7481	9	disease	disease	NN
cord-005453-4057qib7	7481	10	prior	prior	RB
cord-005453-4057qib7	7481	11	to	to	IN
cord-005453-4057qib7	7481	12	transplant	transplant	NN
cord-005453-4057qib7	7481	13	was	be	VBD
cord-005453-4057qib7	7481	14	the	the	DT
cord-005453-4057qib7	7481	15	only	only	JJ
cord-005453-4057qib7	7481	16	independent	independent	JJ
cord-005453-4057qib7	7481	17	risk	risk	NN
cord-005453-4057qib7	7481	18	factor	factor	NN
cord-005453-4057qib7	7481	19	for	for	IN
cord-005453-4057qib7	7481	20	OS	OS	NNP
cord-005453-4057qib7	7481	21	and	and	CC
cord-005453-4057qib7	7481	22	DFS	DFS	NNP
cord-005453-4057qib7	7481	23	(	(	-LRB-
cord-005453-4057qib7	7481	24	p	p	NN
cord-005453-4057qib7	7481	25	-	-	HYPH
cord-005453-4057qib7	7481	26	value=	value=	NN
cord-005453-4057qib7	7481	27	0.36	0.36	CD
cord-005453-4057qib7	7481	28	,	,	,
cord-005453-4057qib7	7481	29	and	and	CC
cord-005453-4057qib7	7481	30	0.01	0.01	CD
cord-005453-4057qib7	7481	31	respectively	respectively	RB
cord-005453-4057qib7	7481	32	)	)	-RRB-
cord-005453-4057qib7	7482	1	(	(	-LRB-
cord-005453-4057qib7	7482	2	Figure	figure	NN
cord-005453-4057qib7	7482	3	2	2	CD
cord-005453-4057qib7	7482	4	)	)	-RRB-
cord-005453-4057qib7	7482	5	.	.	.
cord-005453-4057qib7	7483	1	In	in	IN
cord-005453-4057qib7	7483	2	addition	addition	NN
cord-005453-4057qib7	7483	3	,	,	,
cord-005453-4057qib7	7483	4	patients	patient	NNS
cord-005453-4057qib7	7483	5	who	who	WP
cord-005453-4057qib7	7483	6	had	have	VBD
cord-005453-4057qib7	7483	7	3	3	CD
cord-005453-4057qib7	7483	8	or	or	CC
cord-005453-4057qib7	7483	9	more	more	JJR
cord-005453-4057qib7	7483	10	risk	risk	NN
cord-005453-4057qib7	7483	11	factors	factor	NNS
cord-005453-4057qib7	7483	12	(	(	-LRB-
cord-005453-4057qib7	7483	13	41	41	CD
cord-005453-4057qib7	7483	14	,	,	,
cord-005453-4057qib7	7483	15	19.6	19.6	CD
cord-005453-4057qib7	7483	16	%	%	NN
cord-005453-4057qib7	7483	17	)	)	-RRB-
cord-005453-4057qib7	7483	18	prior	prior	RB
cord-005453-4057qib7	7483	19	to	to	IN
cord-005453-4057qib7	7483	20	transplant	transplant	NN
cord-005453-4057qib7	7483	21	had	have	VBD
cord-005453-4057qib7	7483	22	a	a	DT
cord-005453-4057qib7	7483	23	significantly	significantly	RB
cord-005453-4057qib7	7483	24	lower	low	JJR
cord-005453-4057qib7	7483	25	long	long	JJ
cord-005453-4057qib7	7483	26	term	term	NN
cord-005453-4057qib7	7483	27	outcome	outcome	NN
cord-005453-4057qib7	7483	28	compared	compare	VBN
cord-005453-4057qib7	7483	29	to	to	IN
cord-005453-4057qib7	7483	30	patients	patient	NNS
cord-005453-4057qib7	7483	31	,	,	,
cord-005453-4057qib7	7483	32	who	who	WP
cord-005453-4057qib7	7483	33	had	have	VBD
cord-005453-4057qib7	7483	34	one	one	CD
cord-005453-4057qib7	7483	35	(	(	-LRB-
cord-005453-4057qib7	7483	36	100	100	CD
cord-005453-4057qib7	7483	37	,	,	,
cord-005453-4057qib7	7483	38	47.9	47.9	CD
cord-005453-4057qib7	7483	39	%	%	NN
cord-005453-4057qib7	7483	40	)	)	-RRB-
cord-005453-4057qib7	7483	41	or	or	CC
cord-005453-4057qib7	7483	42	two	two	CD
cord-005453-4057qib7	7483	43	risk	risk	NN
cord-005453-4057qib7	7483	44	factors	factor	NNS
cord-005453-4057qib7	7483	45	(	(	-LRB-
cord-005453-4057qib7	7483	46	68	68	CD
cord-005453-4057qib7	7483	47	,	,	,
cord-005453-4057qib7	7483	48	32.5	32.5	CD
cord-005453-4057qib7	7483	49	%	%	NN
cord-005453-4057qib7	7483	50	)	)	-RRB-
cord-005453-4057qib7	7483	51	with	with	IN
cord-005453-4057qib7	7483	52	a	a	DT
cord-005453-4057qib7	7483	53	median	median	JJ
cord-005453-4057qib7	7483	54	OS	os	NN
cord-005453-4057qib7	7483	55	of	of	IN
cord-005453-4057qib7	7483	56	23	23	CD
cord-005453-4057qib7	7483	57	months	month	NNS
cord-005453-4057qib7	7483	58	,	,	,
cord-005453-4057qib7	7483	59	and	and	CC
cord-005453-4057qib7	7483	60	a	a	DT
cord-005453-4057qib7	7483	61	median	median	JJ
cord-005453-4057qib7	7483	62	DFS	DFS	NNP
cord-005453-4057qib7	7483	63	of	of	IN
cord-005453-4057qib7	7483	64	only	only	RB
cord-005453-4057qib7	7483	65	11	11	CD
cord-005453-4057qib7	7483	66	months	month	NNS
cord-005453-4057qib7	7483	67	(	(	-LRB-
cord-005453-4057qib7	7483	68	p	p	NN
cord-005453-4057qib7	7483	69	-	-	:
cord-005453-4057qib7	7483	70	value=0.32	value=0.32	NNP
cord-005453-4057qib7	7483	71	,	,	,
cord-005453-4057qib7	7483	72	and	and	CC
cord-005453-4057qib7	7483	73	0.009	0.009	CD
cord-005453-4057qib7	7483	74	respectively	respectively	RB
cord-005453-4057qib7	7483	75	)	)	-RRB-
cord-005453-4057qib7	7484	1	(	(	-LRB-
cord-005453-4057qib7	7484	2	Figure	figure	NN
cord-005453-4057qib7	7484	3	3	3	CD
cord-005453-4057qib7	7484	4	)	)	-RRB-
cord-005453-4057qib7	7484	5	.	.	.
cord-005453-4057qib7	7485	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7485	2	:	:	:
cord-005453-4057qib7	7486	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7486	2	results	result	NNS
cord-005453-4057qib7	7486	3	show	show	VBP
cord-005453-4057qib7	7486	4	that	that	IN
cord-005453-4057qib7	7486	5	the	the	DT
cord-005453-4057qib7	7486	6	long	long	JJ
cord-005453-4057qib7	7486	7	term	term	NN
cord-005453-4057qib7	7486	8	outcomes	outcome	NNS
cord-005453-4057qib7	7486	9	of	of	IN
cord-005453-4057qib7	7486	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7486	11	in	in	IN
cord-005453-4057qib7	7486	12	AYA	AYA	NNP
cord-005453-4057qib7	7486	13	with	with	IN
cord-005453-4057qib7	7486	14	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	7486	15	negative	negative	NN
cord-005453-4057qib7	7486	16	ALL	all	DT
cord-005453-4057qib7	7486	17	treated	treat	VBN
cord-005453-4057qib7	7486	18	on	on	IN
cord-005453-4057qib7	7486	19	an	an	DT
cord-005453-4057qib7	7486	20	adult	adult	NN
cord-005453-4057qib7	7486	21	type	type	NN
cord-005453-4057qib7	7486	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7486	23	regimen	regimen	NN
cord-005453-4057qib7	7486	24	,	,	,
cord-005453-4057qib7	7486	25	were	be	VBD
cord-005453-4057qib7	7486	26	significantly	significantly	RB
cord-005453-4057qib7	7486	27	better	well	JJR
cord-005453-4057qib7	7486	28	in	in	IN
cord-005453-4057qib7	7486	29	patients	patient	NNS
cord-005453-4057qib7	7486	30	who	who	WP
cord-005453-4057qib7	7486	31	showed	show	VBD
cord-005453-4057qib7	7486	32	a	a	DT
cord-005453-4057qib7	7486	33	good	good	JJ
cord-005453-4057qib7	7486	34	response	response	NN
cord-005453-4057qib7	7486	35	to	to	IN
cord-005453-4057qib7	7486	36	initial	initial	JJ
cord-005453-4057qib7	7486	37	therapy	therapy	NN
cord-005453-4057qib7	7486	38	and	and	CC
cord-005453-4057qib7	7486	39	a	a	DT
cord-005453-4057qib7	7486	40	limited	limited	JJ
cord-005453-4057qib7	7486	41	poor	poor	JJ
cord-005453-4057qib7	7486	42	prognostic	prognostic	JJ
cord-005453-4057qib7	7486	43	factors	factor	NNS
cord-005453-4057qib7	7486	44	at	at	IN
cord-005453-4057qib7	7486	45	presentation	presentation	NN
cord-005453-4057qib7	7486	46	,	,	,
cord-005453-4057qib7	7486	47	with	with	IN
cord-005453-4057qib7	7486	48	worsening	worsen	VBG
cord-005453-4057qib7	7486	49	of	of	IN
cord-005453-4057qib7	7486	50	DFS	DFS	NNP
cord-005453-4057qib7	7486	51	as	as	IN
cord-005453-4057qib7	7486	52	the	the	DT
cord-005453-4057qib7	7486	53	number	number	NN
cord-005453-4057qib7	7486	54	of	of	IN
cord-005453-4057qib7	7486	55	poor	poor	JJ
cord-005453-4057qib7	7486	56	prognostic	prognostic	JJ
cord-005453-4057qib7	7486	57	features	feature	NNS
cord-005453-4057qib7	7486	58	increase	increase	NN
cord-005453-4057qib7	7486	59	.	.	.
cord-005453-4057qib7	7487	1	We	-PRON-	PRP
cord-005453-4057qib7	7487	2	can	can	MD
cord-005453-4057qib7	7487	3	conclude	conclude	VB
cord-005453-4057qib7	7487	4	that	that	IN
cord-005453-4057qib7	7487	5	,	,	,
cord-005453-4057qib7	7487	6	using	use	VBG
cord-005453-4057qib7	7487	7	this	this	DT
cord-005453-4057qib7	7487	8	risk	risk	NN
cord-005453-4057qib7	7487	9	score	score	NN
cord-005453-4057qib7	7487	10	can	can	MD
cord-005453-4057qib7	7487	11	be	be	VB
cord-005453-4057qib7	7487	12	helpful	helpful	JJ
cord-005453-4057qib7	7487	13	in	in	IN
cord-005453-4057qib7	7487	14	predicting	predict	VBG
cord-005453-4057qib7	7487	15	the	the	DT
cord-005453-4057qib7	7487	16	outcome	outcome	NN
cord-005453-4057qib7	7487	17	of	of	IN
cord-005453-4057qib7	7487	18	Allogenic	Allogenic	NNP
cord-005453-4057qib7	7487	19	HSCT	HSCT	NNP
cord-005453-4057qib7	7487	20	in	in	IN
cord-005453-4057qib7	7487	21	AYA	AYA	NNP
cord-005453-4057qib7	7487	22	with	with	IN
cord-005453-4057qib7	7487	23	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	7487	24	negative	negative	NN
cord-005453-4057qib7	7487	25	ALL	all	DT
cord-005453-4057qib7	7487	26	treated	treat	VBN
cord-005453-4057qib7	7487	27	with	with	IN
cord-005453-4057qib7	7487	28	adult	adult	NN
cord-005453-4057qib7	7487	29	type	type	NN
cord-005453-4057qib7	7487	30	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7487	31	protocol	protocol	NN
cord-005453-4057qib7	7487	32	.	.	.
cord-005453-4057qib7	7488	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7488	2	:	:	:
cord-005453-4057qib7	7488	3	No	no	DT
cord-005453-4057qib7	7488	4	conflict	conflict	NN
cord-005453-4057qib7	7488	5	of	of	IN
cord-005453-4057qib7	7488	6	interest	interest	NN
cord-005453-4057qib7	7489	1	A	a	DT
cord-005453-4057qib7	7489	2	prospective	prospective	JJ
cord-005453-4057qib7	7489	3	single	single	JJ
cord-005453-4057qib7	7489	4	center	center	NN
cord-005453-4057qib7	7489	5	survey	survey	NN
cord-005453-4057qib7	7489	6	on	on	IN
cord-005453-4057qib7	7489	7	donor	donor	NN
cord-005453-4057qib7	7489	8	-	-	HYPH
cord-005453-4057qib7	7489	9	specific	specific	JJ
cord-005453-4057qib7	7489	10	anti	anti	JJ
cord-005453-4057qib7	7489	11	-	-	JJ
cord-005453-4057qib7	7489	12	HLA	HLA	NNP
cord-005453-4057qib7	7489	13	antibodies	antibody	NNS
cord-005453-4057qib7	7489	14	and	and	CC
cord-005453-4057qib7	7489	15	desensitization	desensitization	NN
cord-005453-4057qib7	7489	16	strategy	strategy	NN
cord-005453-4057qib7	7489	17	in	in	IN
cord-005453-4057qib7	7489	18	patients	patient	NNS
cord-005453-4057qib7	7489	19	undergoing	undergo	VBG
cord-005453-4057qib7	7489	20	an	an	DT
cord-005453-4057qib7	7489	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	7489	22	stem	stem	NN
cord-005453-4057qib7	7489	23	cell	cell	NN
cord-005453-4057qib7	7489	24	transplant	transplant	NN
cord-005453-4057qib7	7489	25	Background	background	NN
cord-005453-4057qib7	7489	26	:	:	:
cord-005453-4057qib7	7490	1	In	in	IN
cord-005453-4057qib7	7490	2	the	the	DT
cord-005453-4057qib7	7490	3	setting	setting	NN
cord-005453-4057qib7	7490	4	of	of	IN
cord-005453-4057qib7	7490	5	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7490	6	stem	stem	NN
cord-005453-4057qib7	7490	7	cell	cell	NN
cord-005453-4057qib7	7490	8	transplantation	transplantation	NN
cord-005453-4057qib7	7490	9	(	(	-LRB-
cord-005453-4057qib7	7490	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7490	11	)	)	-RRB-
cord-005453-4057qib7	7490	12	,	,	,
cord-005453-4057qib7	7490	13	considering	consider	VBG
cord-005453-4057qib7	7490	14	the	the	DT
cord-005453-4057qib7	7490	15	risk	risk	NN
cord-005453-4057qib7	7490	16	of	of	IN
cord-005453-4057qib7	7490	17	poor	poor	JJ
cord-005453-4057qib7	7490	18	engraftment	engraftment	NN
cord-005453-4057qib7	7490	19	or	or	CC
cord-005453-4057qib7	7490	20	graft	graft	NN
cord-005453-4057qib7	7490	21	failure	failure	NN
cord-005453-4057qib7	7490	22	(	(	-LRB-
cord-005453-4057qib7	7490	23	GF	GF	NNP
cord-005453-4057qib7	7490	24	)	)	-RRB-
cord-005453-4057qib7	7490	25	,	,	,
cord-005453-4057qib7	7490	26	the	the	DT
cord-005453-4057qib7	7490	27	detection	detection	NN
cord-005453-4057qib7	7490	28	of	of	IN
cord-005453-4057qib7	7490	29	antibodies	antibody	NNS
cord-005453-4057qib7	7490	30	(	(	-LRB-
cord-005453-4057qib7	7490	31	Ab	Ab	NNP
cord-005453-4057qib7	7490	32	)	)	-RRB-
cord-005453-4057qib7	7490	33	directed	direct	VBN
cord-005453-4057qib7	7490	34	against	against	IN
cord-005453-4057qib7	7490	35	donor	donor	NN
cord-005453-4057qib7	7490	36	specific	specific	JJ
cord-005453-4057qib7	7490	37	HLA	HLA	NNP
cord-005453-4057qib7	7490	38	loci	locus	NNS
cord-005453-4057qib7	7490	39	(	(	-LRB-
cord-005453-4057qib7	7490	40	DSA	DSA	NNP
cord-005453-4057qib7	7490	41	)	)	-RRB-
cord-005453-4057qib7	7490	42	represents	represent	VBZ
cord-005453-4057qib7	7490	43	a	a	DT
cord-005453-4057qib7	7490	44	contraindication	contraindication	NN
cord-005453-4057qib7	7490	45	to	to	TO
cord-005453-4057qib7	7490	46	proceed	proceed	VB
cord-005453-4057qib7	7490	47	with	with	IN
cord-005453-4057qib7	7490	48	the	the	DT
cord-005453-4057qib7	7490	49	same	same	JJ
cord-005453-4057qib7	7490	50	donor	donor	NN
cord-005453-4057qib7	7490	51	,	,	,
cord-005453-4057qib7	7490	52	suggesting	suggest	VBG
cord-005453-4057qib7	7490	53	the	the	DT
cord-005453-4057qib7	7490	54	search	search	NN
cord-005453-4057qib7	7490	55	of	of	IN
cord-005453-4057qib7	7490	56	other	other	JJ
cord-005453-4057qib7	7490	57	donors	donor	NNS
cord-005453-4057qib7	7490	58	.	.	.
cord-005453-4057qib7	7491	1	In	in	IN
cord-005453-4057qib7	7491	2	many	many	JJ
cord-005453-4057qib7	7491	3	cases	case	NNS
cord-005453-4057qib7	7491	4	,	,	,
cord-005453-4057qib7	7491	5	there	there	EX
cord-005453-4057qib7	7491	6	is	be	VBZ
cord-005453-4057qib7	7491	7	not	not	RB
cord-005453-4057qib7	7491	8	sufficient	sufficient	JJ
cord-005453-4057qib7	7491	9	time	time	NN
cord-005453-4057qib7	7491	10	to	to	TO
cord-005453-4057qib7	7491	11	search	search	VB
cord-005453-4057qib7	7491	12	for	for	IN
cord-005453-4057qib7	7491	13	alternative	alternative	JJ
cord-005453-4057qib7	7491	14	donors	donor	NNS
cord-005453-4057qib7	7491	15	and	and	CC
cord-005453-4057qib7	7491	16	it	-PRON-	PRP
cord-005453-4057qib7	7491	17	is	be	VBZ
cord-005453-4057qib7	7491	18	necessary	necessary	JJ
cord-005453-4057qib7	7491	19	to	to	TO
cord-005453-4057qib7	7491	20	plan	plan	VB
cord-005453-4057qib7	7491	21	an	an	DT
cord-005453-4057qib7	7491	22	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	7491	23	strategy	strategy	NN
cord-005453-4057qib7	7491	24	to	to	TO
cord-005453-4057qib7	7491	25	decrease	decrease	VB
cord-005453-4057qib7	7491	26	the	the	DT
cord-005453-4057qib7	7491	27	DSA	DSA	NNP
cord-005453-4057qib7	7491	28	level	level	NN
cord-005453-4057qib7	7491	29	,	,	,
cord-005453-4057qib7	7491	30	thus	thus	RB
cord-005453-4057qib7	7491	31	reducing	reduce	VBG
cord-005453-4057qib7	7491	32	the	the	DT
cord-005453-4057qib7	7491	33	risk	risk	NN
cord-005453-4057qib7	7491	34	of	of	IN
cord-005453-4057qib7	7491	35	GF	GF	NNP
cord-005453-4057qib7	7491	36	.	.	.
cord-005453-4057qib7	7492	1	To	to	IN
cord-005453-4057qib7	7492	2	date	date	NN
cord-005453-4057qib7	7492	3	,	,	,
cord-005453-4057qib7	7492	4	there	there	EX
cord-005453-4057qib7	7492	5	is	be	VBZ
cord-005453-4057qib7	7492	6	no	no	DT
cord-005453-4057qib7	7492	7	consensus	consensus	NN
cord-005453-4057qib7	7492	8	on	on	IN
cord-005453-4057qib7	7492	9	desensitization	desensitization	NN
cord-005453-4057qib7	7492	10	standards	standard	NNS
cord-005453-4057qib7	7492	11	to	to	TO
cord-005453-4057qib7	7492	12	manage	manage	VB
cord-005453-4057qib7	7492	13	DSAs	dsa	NNS
cord-005453-4057qib7	7492	14	in	in	IN
cord-005453-4057qib7	7492	15	HSCT	HSCT	NNP
cord-005453-4057qib7	7492	16	.	.	.
cord-005453-4057qib7	7493	1	The	the	DT
cord-005453-4057qib7	7493	2	aim	aim	NN
cord-005453-4057qib7	7493	3	of	of	IN
cord-005453-4057qib7	7493	4	this	this	DT
cord-005453-4057qib7	7493	5	study	study	NN
cord-005453-4057qib7	7493	6	was	be	VBD
cord-005453-4057qib7	7493	7	to	to	TO
cord-005453-4057qib7	7493	8	determine	determine	VB
cord-005453-4057qib7	7493	9	the	the	DT
cord-005453-4057qib7	7493	10	incidence	incidence	NN
cord-005453-4057qib7	7493	11	of	of	IN
cord-005453-4057qib7	7493	12	anti	anti	JJ
cord-005453-4057qib7	7493	13	-	-	JJ
cord-005453-4057qib7	7493	14	HLA	HLA	NNP
cord-005453-4057qib7	7493	15	Ab	Ab	NNP
cord-005453-4057qib7	7493	16	and	and	CC
cord-005453-4057qib7	7493	17	DSAs	dsa	NNS
cord-005453-4057qib7	7493	18	in	in	IN
cord-005453-4057qib7	7493	19	hematologic	hematologic	JJ
cord-005453-4057qib7	7493	20	patients	patient	NNS
cord-005453-4057qib7	7493	21	candidate	candidate	NN
cord-005453-4057qib7	7493	22	to	to	IN
cord-005453-4057qib7	7493	23	an	an	DT
cord-005453-4057qib7	7493	24	allogeneic	allogeneic	JJ
cord-005453-4057qib7	7493	25	HSCT	HSCT	NNP
cord-005453-4057qib7	7493	26	,	,	,
cord-005453-4057qib7	7493	27	and	and	CC
cord-005453-4057qib7	7493	28	the	the	DT
cord-005453-4057qib7	7493	29	efficacy	efficacy	NN
cord-005453-4057qib7	7493	30	of	of	IN
cord-005453-4057qib7	7493	31	our	-PRON-	PRP$
cord-005453-4057qib7	7493	32	desensitization	desensitization	NN
cord-005453-4057qib7	7493	33	protocol	protocol	NN
cord-005453-4057qib7	7493	34	.	.	.
cord-005453-4057qib7	7494	1	Here	here	RB
cord-005453-4057qib7	7494	2	,	,	,
cord-005453-4057qib7	7494	3	we	-PRON-	PRP
cord-005453-4057qib7	7494	4	present	present	VBP
cord-005453-4057qib7	7494	5	an	an	DT
cord-005453-4057qib7	7494	6	update	update	NN
cord-005453-4057qib7	7494	7	of	of	IN
cord-005453-4057qib7	7494	8	the	the	DT
cord-005453-4057qib7	7494	9	results	result	NNS
cord-005453-4057qib7	7494	10	obtained	obtain	VBN
cord-005453-4057qib7	7494	11	with	with	IN
cord-005453-4057qib7	7494	12	our	-PRON-	PRP$
cord-005453-4057qib7	7494	13	strategy	strategy	NN
cord-005453-4057qib7	7494	14	.	.	.
cord-005453-4057qib7	7495	1	Methods	method	NNS
cord-005453-4057qib7	7495	2	:	:	:
cord-005453-4057qib7	7496	1	Between	between	IN
cord-005453-4057qib7	7496	2	August	August	NNP
cord-005453-4057qib7	7496	3	2014	2014	CD
cord-005453-4057qib7	7496	4	and	and	CC
cord-005453-4057qib7	7496	5	September	September	NNP
cord-005453-4057qib7	7496	6	2018	2018	CD
cord-005453-4057qib7	7496	7	,	,	,
cord-005453-4057qib7	7496	8	we	-PRON-	PRP
cord-005453-4057qib7	7496	9	prospectively	prospectively	RB
cord-005453-4057qib7	7496	10	screened	screen	VBD
cord-005453-4057qib7	7496	11	for	for	IN
cord-005453-4057qib7	7496	12	DSA	DSA	NNP
cord-005453-4057qib7	7496	13	140	140	CD
cord-005453-4057qib7	7496	14	consecutive	consecutive	JJ
cord-005453-4057qib7	7496	15	patients	patient	NNS
cord-005453-4057qib7	7496	16	candidates	candidate	NNS
cord-005453-4057qib7	7496	17	to	to	IN
cord-005453-4057qib7	7496	18	an	an	DT
cord-005453-4057qib7	7496	19	allogeneic	allogeneic	JJ
cord-005453-4057qib7	7496	20	HSCT	HSCT	NNP
cord-005453-4057qib7	7496	21	.	.	.
cord-005453-4057qib7	7497	1	Anti	Anti	NNP
cord-005453-4057qib7	7497	2	-	-	NNP
cord-005453-4057qib7	7497	3	HLA	HLA	NNP
cord-005453-4057qib7	7497	4	Ab	Ab	NNP
cord-005453-4057qib7	7497	5	research	research	NN
cord-005453-4057qib7	7497	6	was	be	VBD
cord-005453-4057qib7	7497	7	carried	carry	VBN
cord-005453-4057qib7	7497	8	out	out	RP
cord-005453-4057qib7	7497	9	using	use	VBG
cord-005453-4057qib7	7497	10	the	the	DT
cord-005453-4057qib7	7497	11	Luminex	Luminex	NNP
cord-005453-4057qib7	7497	12	bead	bead	NN
cord-005453-4057qib7	7497	13	assay	assay	NN
cord-005453-4057qib7	7497	14	(	(	-LRB-
cord-005453-4057qib7	7497	15	Lifecode	Lifecode	NNP
cord-005453-4057qib7	7497	16	Screen	Screen	NNP
cord-005453-4057qib7	7497	17	and	and	CC
cord-005453-4057qib7	7497	18	LSA	LSA	NNP
cord-005453-4057qib7	7497	19	I	I	NNP
cord-005453-4057qib7	7497	20	/	/	SYM
cord-005453-4057qib7	7497	21	II	II	NNP
cord-005453-4057qib7	7497	22	-	-	HYPH
cord-005453-4057qib7	7497	23	Immucor	Immucor	NNP
cord-005453-4057qib7	7497	24	)	)	-RRB-
cord-005453-4057qib7	7497	25	.	.	.
cord-005453-4057qib7	7498	1	The	the	DT
cord-005453-4057qib7	7498	2	results	result	NNS
cord-005453-4057qib7	7498	3	were	be	VBD
cord-005453-4057qib7	7498	4	expressed	express	VBN
cord-005453-4057qib7	7498	5	as	as	IN
cord-005453-4057qib7	7498	6	mean	mean	JJ
cord-005453-4057qib7	7498	7	fluorescence	fluorescence	NN
cord-005453-4057qib7	7498	8	intensity	intensity	NN
cord-005453-4057qib7	7498	9	(	(	-LRB-
cord-005453-4057qib7	7498	10	MFI	MFI	NNP
cord-005453-4057qib7	7498	11	)	)	-RRB-
cord-005453-4057qib7	7498	12	;	;	:
cord-005453-4057qib7	7498	13	MFI	MFI	NNP
cord-005453-4057qib7	7498	14	>	>	XX
cord-005453-4057qib7	7498	15	1000	1000	CD
cord-005453-4057qib7	7498	16	was	be	VBD
cord-005453-4057qib7	7498	17	considered	consider	VBN
cord-005453-4057qib7	7498	18	positive	positive	JJ
cord-005453-4057qib7	7498	19	.	.	.
cord-005453-4057qib7	7499	1	In	in	IN
cord-005453-4057qib7	7499	2	case	case	NN
cord-005453-4057qib7	7499	3	of	of	IN
cord-005453-4057qib7	7499	4	a	a	DT
cord-005453-4057qib7	7499	5	mismatched	mismatched	JJ
cord-005453-4057qib7	7499	6	related	related	JJ
cord-005453-4057qib7	7499	7	donor	donor	NN
cord-005453-4057qib7	7499	8	,	,	,
cord-005453-4057qib7	7499	9	a	a	DT
cord-005453-4057qib7	7499	10	flow	flow	NN
cord-005453-4057qib7	7499	11	cytometric	cytometric	NNP
cord-005453-4057qib7	7499	12	crossmatch	crossmatch	NN
cord-005453-4057qib7	7499	13	test	test	NN
cord-005453-4057qib7	7499	14	(	(	-LRB-
cord-005453-4057qib7	7499	15	FCXM	FCXM	NNP
cord-005453-4057qib7	7499	16	)	)	-RRB-
cord-005453-4057qib7	7499	17	was	be	VBD
cord-005453-4057qib7	7499	18	performed	perform	VBN
cord-005453-4057qib7	7499	19	.	.	.
cord-005453-4057qib7	7500	1	If	if	IN
cord-005453-4057qib7	7500	2	the	the	DT
cord-005453-4057qib7	7500	3	patient	patient	NN
cord-005453-4057qib7	7500	4	had	have	VBD
cord-005453-4057qib7	7500	5	DSAs	dsa	NNS
cord-005453-4057qib7	7500	6	and	and	CC
cord-005453-4057qib7	7500	7	only	only	RB
cord-005453-4057qib7	7500	8	one	one	CD
cord-005453-4057qib7	7500	9	available	available	JJ
cord-005453-4057qib7	7500	10	donor	donor	NN
cord-005453-4057qib7	7500	11	,	,	,
cord-005453-4057qib7	7500	12	a	a	DT
cord-005453-4057qib7	7500	13	desensitization	desensitization	NN
cord-005453-4057qib7	7500	14	strategy	strategy	NN
cord-005453-4057qib7	7500	15	was	be	VBD
cord-005453-4057qib7	7500	16	employed	employ	VBN
cord-005453-4057qib7	7500	17	,	,	,
cord-005453-4057qib7	7500	18	scheduled	schedule	VBN
cord-005453-4057qib7	7500	19	with	with	IN
cord-005453-4057qib7	7500	20	Rituximab	Rituximab	NNP
cord-005453-4057qib7	7500	21	on	on	IN
cord-005453-4057qib7	7500	22	day	day	NN
cord-005453-4057qib7	7500	23	-15	-15	CD
cord-005453-4057qib7	7500	24	,	,	,
cord-005453-4057qib7	7500	25	single	single	JJ
cord-005453-4057qib7	7500	26	-	-	HYPH
cord-005453-4057qib7	7500	27	volume	volume	NN
cord-005453-4057qib7	7500	28	plasmapheresis	plasmapheresis	NN
cord-005453-4057qib7	7500	29	procedures	procedure	NNS
cord-005453-4057qib7	7500	30	(	(	-LRB-
cord-005453-4057qib7	7500	31	PP	PP	NNP
cord-005453-4057qib7	7500	32	)	)	-RRB-
cord-005453-4057qib7	7500	33	,	,	,
cord-005453-4057qib7	7500	34	usually	usually	RB
cord-005453-4057qib7	7500	35	on	on	IN
cord-005453-4057qib7	7500	36	day	day	NN
cord-005453-4057qib7	7500	37	-9	-9	NN
cord-005453-4057qib7	7500	38	and	and	CC
cord-005453-4057qib7	7500	39	-8	-8	NNP
cord-005453-4057qib7	7500	40	,	,	,
cord-005453-4057qib7	7500	41	intravenous	intravenous	JJ
cord-005453-4057qib7	7500	42	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	7500	43	on	on	IN
cord-005453-4057qib7	7500	44	day	day	NN
cord-005453-4057qib7	7500	45	-7	-7	NNP
cord-005453-4057qib7	7500	46	,	,	,
cord-005453-4057qib7	7500	47	infusion	infusion	NN
cord-005453-4057qib7	7500	48	of	of	IN
cord-005453-4057qib7	7500	49	HLA	HLA	NNP
cord-005453-4057qib7	7500	50	selected	select	VBN
cord-005453-4057qib7	7500	51	platelets	platelet	NNS
cord-005453-4057qib7	7500	52	for	for	IN
cord-005453-4057qib7	7500	53	DSA	DSA	NNP
cord-005453-4057qib7	7500	54	absorption	absorption	NN
cord-005453-4057qib7	7500	55	in	in	IN
cord-005453-4057qib7	7500	56	case	case	NN
cord-005453-4057qib7	7500	57	of	of	IN
cord-005453-4057qib7	7500	58	persistent	persistent	JJ
cord-005453-4057qib7	7500	59	antibodies	antibody	NNS
cord-005453-4057qib7	7500	60	directed	direct	VBN
cord-005453-4057qib7	7500	61	against	against	IN
cord-005453-4057qib7	7500	62	class	class	NN
cord-005453-4057qib7	7500	63	I	-PRON-	PRP
cord-005453-4057qib7	7500	64	HLA	HLA	NNP
cord-005453-4057qib7	7500	65	antigens	antigen	NNS
cord-005453-4057qib7	7500	66	.	.	.
cord-005453-4057qib7	7501	1	The	the	DT
cord-005453-4057qib7	7501	2	aim	aim	NN
cord-005453-4057qib7	7501	3	of	of	IN
cord-005453-4057qib7	7501	4	this	this	DT
cord-005453-4057qib7	7501	5	schedule	schedule	NN
cord-005453-4057qib7	7501	6	was	be	VBD
cord-005453-4057qib7	7501	7	to	to	TO
cord-005453-4057qib7	7501	8	avoid	avoid	VB
cord-005453-4057qib7	7501	9	interferences	interference	NNS
cord-005453-4057qib7	7501	10	with	with	IN
cord-005453-4057qib7	7501	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7501	12	and	and	CC
cord-005453-4057qib7	7501	13	anti	anti	JJ
cord-005453-4057qib7	7501	14	-	-	JJ
cord-005453-4057qib7	7501	15	T	t	JJ
cord-005453-4057qib7	7501	16	-	-	HYPH
cord-005453-4057qib7	7501	17	cell	cell	NN
cord-005453-4057qib7	7501	18	globulins	globulin	NNS
cord-005453-4057qib7	7501	19	,	,	,
cord-005453-4057qib7	7501	20	infused	infuse	VBN
cord-005453-4057qib7	7501	21	during	during	IN
cord-005453-4057qib7	7501	22	condition	condition	NN
cord-005453-4057qib7	7501	23	regimen	regimen	NN
cord-005453-4057qib7	7501	24	Results	result	NNS
cord-005453-4057qib7	7501	25	:	:	:
cord-005453-4057qib7	7501	26	Since	since	IN
cord-005453-4057qib7	7501	27	August	August	NNP
cord-005453-4057qib7	7501	28	2014	2014	CD
cord-005453-4057qib7	7501	29	,	,	,
cord-005453-4057qib7	7501	30	140	140	CD
cord-005453-4057qib7	7501	31	patients	patient	NNS
cord-005453-4057qib7	7501	32	have	have	VBP
cord-005453-4057qib7	7501	33	been	be	VBN
cord-005453-4057qib7	7501	34	prospectively	prospectively	RB
cord-005453-4057qib7	7501	35	screened	screen	VBN
cord-005453-4057qib7	7501	36	.	.	.
cord-005453-4057qib7	7502	1	Thirty	thirty	CD
cord-005453-4057qib7	7502	2	-	-	HYPH
cord-005453-4057qib7	7502	3	three	three	CD
cord-005453-4057qib7	7502	4	patients	patient	NNS
cord-005453-4057qib7	7502	5	(	(	-LRB-
cord-005453-4057qib7	7502	6	23.6	23.6	CD
cord-005453-4057qib7	7502	7	%	%	NN
cord-005453-4057qib7	7502	8	)	)	-RRB-
cord-005453-4057qib7	7502	9	showed	show	VBD
cord-005453-4057qib7	7502	10	anti	anti	JJ
cord-005453-4057qib7	7502	11	-	-	JJ
cord-005453-4057qib7	7502	12	HLA	HLA	NNP
cord-005453-4057qib7	7502	13	Ab	Ab	NNP
cord-005453-4057qib7	7502	14	and	and	CC
cord-005453-4057qib7	7502	15	9	9	CD
cord-005453-4057qib7	7502	16	of	of	IN
cord-005453-4057qib7	7502	17	them	-PRON-	PRP
cord-005453-4057qib7	7502	18	(	(	-LRB-
cord-005453-4057qib7	7502	19	6.4	6.4	CD
cord-005453-4057qib7	7502	20	%	%	NN
cord-005453-4057qib7	7502	21	)	)	-RRB-
cord-005453-4057qib7	7502	22	had	have	VBD
cord-005453-4057qib7	7502	23	DSAs	dsa	NNS
cord-005453-4057qib7	7502	24	:	:	:
cord-005453-4057qib7	7502	25	6	6	CD
cord-005453-4057qib7	7502	26	were	be	VBD
cord-005453-4057qib7	7502	27	treated	treat	VBN
cord-005453-4057qib7	7502	28	with	with	IN
cord-005453-4057qib7	7502	29	the	the	DT
cord-005453-4057qib7	7502	30	desensitization	desensitization	NN
cord-005453-4057qib7	7502	31	strategy	strategy	NN
cord-005453-4057qib7	7502	32	,	,	,
cord-005453-4057qib7	7502	33	applied	apply	VBD
cord-005453-4057qib7	7502	34	according	accord	VBG
cord-005453-4057qib7	7502	35	to	to	IN
cord-005453-4057qib7	7502	36	the	the	DT
cord-005453-4057qib7	7502	37	MFI	MFI	NNP
cord-005453-4057qib7	7502	38	score	score	NN
cord-005453-4057qib7	7502	39	and	and	CC
cord-005453-4057qib7	7502	40	the	the	DT
cord-005453-4057qib7	7502	41	FCXM	FCXM	NNP
cord-005453-4057qib7	7502	42	result	result	NN
cord-005453-4057qib7	7502	43	,	,	,
cord-005453-4057qib7	7502	44	and	and	CC
cord-005453-4057qib7	7502	45	all	all	DT
cord-005453-4057qib7	7502	46	of	of	IN
cord-005453-4057qib7	7502	47	them	-PRON-	PRP
cord-005453-4057qib7	7502	48	obtained	obtain	VBD
cord-005453-4057qib7	7502	49	an	an	DT
cord-005453-4057qib7	7502	50	engraftment	engraftment	NN
cord-005453-4057qib7	7502	51	;	;	:
cord-005453-4057qib7	7502	52	in	in	IN
cord-005453-4057qib7	7502	53	2	2	CD
cord-005453-4057qib7	7502	54	cases	case	NNS
cord-005453-4057qib7	7502	55	,	,	,
cord-005453-4057qib7	7502	56	an	an	DT
cord-005453-4057qib7	7502	57	alternative	alternative	JJ
cord-005453-4057qib7	7502	58	donor	donor	NN
cord-005453-4057qib7	7502	59	was	be	VBD
cord-005453-4057qib7	7502	60	selected	select	VBN
cord-005453-4057qib7	7502	61	and	and	CC
cord-005453-4057qib7	7502	62	in	in	IN
cord-005453-4057qib7	7502	63	1	1	CD
cord-005453-4057qib7	7502	64	case	case	NN
cord-005453-4057qib7	7502	65	the	the	DT
cord-005453-4057qib7	7502	66	research	research	NN
cord-005453-4057qib7	7502	67	for	for	IN
cord-005453-4057qib7	7502	68	an	an	DT
cord-005453-4057qib7	7502	69	alternative	alternative	JJ
cord-005453-4057qib7	7502	70	donor	donor	NN
cord-005453-4057qib7	7502	71	is	be	VBZ
cord-005453-4057qib7	7502	72	still	still	RB
cord-005453-4057qib7	7502	73	underway	underway	JJ
cord-005453-4057qib7	7502	74	.	.	.
cord-005453-4057qib7	7503	1	DSA	DSA	NNP
cord-005453-4057qib7	7503	2	detection	detection	NN
cord-005453-4057qib7	7503	3	was	be	VBD
cord-005453-4057qib7	7503	4	performed	perform	VBN
cord-005453-4057qib7	7503	5	every	every	DT
cord-005453-4057qib7	7503	6	7	7	CD
cord-005453-4057qib7	7503	7	days	day	NNS
cord-005453-4057qib7	7503	8	after	after	IN
cord-005453-4057qib7	7503	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7503	10	for	for	IN
cord-005453-4057qib7	7503	11	the	the	DT
cord-005453-4057qib7	7503	12	first	first	JJ
cord-005453-4057qib7	7503	13	month	month	NN
cord-005453-4057qib7	7503	14	and	and	CC
cord-005453-4057qib7	7503	15	60	60	CD
cord-005453-4057qib7	7503	16	,	,	,
cord-005453-4057qib7	7503	17	180	180	CD
cord-005453-4057qib7	7503	18	and	and	CC
cord-005453-4057qib7	7503	19	365	365	CD
cord-005453-4057qib7	7503	20	days	day	NNS
cord-005453-4057qib7	7503	21	following	follow	VBG
cord-005453-4057qib7	7503	22	HSCT	HSCT	NNP
cord-005453-4057qib7	7503	23	.	.	.
cord-005453-4057qib7	7504	1	Neither	neither	CC
cord-005453-4057qib7	7504	2	a	a	DT
cord-005453-4057qib7	7504	3	DSA	DSA	NNP
cord-005453-4057qib7	7504	4	rebound	rebound	NN
cord-005453-4057qib7	7504	5	nor	nor	CC
cord-005453-4057qib7	7504	6	other	other	JJ
cord-005453-4057qib7	7504	7	complications	complication	NNS
cord-005453-4057qib7	7504	8	were	be	VBD
cord-005453-4057qib7	7504	9	observed	observe	VBN
cord-005453-4057qib7	7504	10	during	during	IN
cord-005453-4057qib7	7504	11	the	the	DT
cord-005453-4057qib7	7504	12	follow	follow	NN
cord-005453-4057qib7	7504	13	-	-	HYPH
cord-005453-4057qib7	7504	14	up	up	NN
cord-005453-4057qib7	7504	15	.	.	.
cord-005453-4057qib7	7505	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7505	2	:	:	:
cord-005453-4057qib7	7506	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7506	2	prospective	prospective	JJ
cord-005453-4057qib7	7506	3	analysis	analysis	NN
cord-005453-4057qib7	7506	4	underlines	underline	VBZ
cord-005453-4057qib7	7506	5	the	the	DT
cord-005453-4057qib7	7506	6	high	high	JJ
cord-005453-4057qib7	7506	7	frequency	frequency	NN
cord-005453-4057qib7	7506	8	of	of	IN
cord-005453-4057qib7	7506	9	anti	anti	JJ
cord-005453-4057qib7	7506	10	-	-	JJ
cord-005453-4057qib7	7506	11	HLA	HLA	NNP
cord-005453-4057qib7	7506	12	antibodies	antibody	NNS
cord-005453-4057qib7	7506	13	detection	detection	NN
cord-005453-4057qib7	7506	14	in	in	IN
cord-005453-4057qib7	7506	15	hematologic	hematologic	JJ
cord-005453-4057qib7	7506	16	patients	patient	NNS
cord-005453-4057qib7	7506	17	,	,	,
cord-005453-4057qib7	7506	18	confirming	confirm	VBG
cord-005453-4057qib7	7506	19	the	the	DT
cord-005453-4057qib7	7506	20	necessity	necessity	NN
cord-005453-4057qib7	7506	21	to	to	TO
cord-005453-4057qib7	7506	22	routinely	routinely	RB
cord-005453-4057qib7	7506	23	evaluate	evaluate	VB
cord-005453-4057qib7	7506	24	the	the	DT
cord-005453-4057qib7	7506	25	presence	presence	NN
cord-005453-4057qib7	7506	26	of	of	IN
cord-005453-4057qib7	7506	27	DSAs	dsa	NNS
cord-005453-4057qib7	7506	28	before	before	IN
cord-005453-4057qib7	7506	29	an	an	DT
cord-005453-4057qib7	7506	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	7506	31	mismatched	mismatch	VBN
cord-005453-4057qib7	7506	32	HSCT	HSCT	NNP
cord-005453-4057qib7	7506	33	.	.	.
cord-005453-4057qib7	7507	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7507	2	desensitization	desensitization	NN
cord-005453-4057qib7	7507	3	schedules	schedule	NNS
cord-005453-4057qib7	7507	4	based	base	VBN
cord-005453-4057qib7	7507	5	on	on	IN
cord-005453-4057qib7	7507	6	the	the	DT
cord-005453-4057qib7	7507	7	combination	combination	NN
cord-005453-4057qib7	7507	8	of	of	IN
cord-005453-4057qib7	7507	9	PP	PP	NNP
cord-005453-4057qib7	7507	10	,	,	,
cord-005453-4057qib7	7507	11	rituximab	rituximab	NN
cord-005453-4057qib7	7507	12	,	,	,
cord-005453-4057qib7	7507	13	IVIG	IVIG	NNP
cord-005453-4057qib7	7507	14	and	and	CC
cord-005453-4057qib7	7507	15	platelet	platelet	NN
cord-005453-4057qib7	7507	16	absorption	absorption	NN
cord-005453-4057qib7	7507	17	proved	prove	VBD
cord-005453-4057qib7	7507	18	successful	successful	JJ
cord-005453-4057qib7	7507	19	in	in	IN
cord-005453-4057qib7	7507	20	reducing	reduce	VBG
cord-005453-4057qib7	7507	21	DSAs	dsa	NNS
cord-005453-4057qib7	7507	22	.	.	.
cord-005453-4057qib7	7508	1	We	-PRON-	PRP
cord-005453-4057qib7	7508	2	confirm	confirm	VBP
cord-005453-4057qib7	7508	3	the	the	DT
cord-005453-4057qib7	7508	4	necessity	necessity	NN
cord-005453-4057qib7	7508	5	of	of	IN
cord-005453-4057qib7	7508	6	a	a	DT
cord-005453-4057qib7	7508	7	prospective	prospective	JJ
cord-005453-4057qib7	7508	8	multicenter	multicenter	JJ
cord-005453-4057qib7	7508	9	collaboration	collaboration	NN
cord-005453-4057qib7	7508	10	to	to	TO
cord-005453-4057qib7	7508	11	better	better	RB
cord-005453-4057qib7	7508	12	define	define	VB
cord-005453-4057qib7	7508	13	the	the	DT
cord-005453-4057qib7	7508	14	role	role	NN
cord-005453-4057qib7	7508	15	of	of	IN
cord-005453-4057qib7	7508	16	DSAs	dsa	NNS
cord-005453-4057qib7	7508	17	against	against	IN
cord-005453-4057qib7	7508	18	each	each	DT
cord-005453-4057qib7	7508	19	HLA	HLA	NNP
cord-005453-4057qib7	7508	20	locus	locus	NN
cord-005453-4057qib7	7508	21	and	and	CC
cord-005453-4057qib7	7508	22	the	the	DT
cord-005453-4057qib7	7508	23	critical	critical	JJ
cord-005453-4057qib7	7508	24	MFI	MFI	NNP
cord-005453-4057qib7	7508	25	cut	cut	VBN
cord-005453-4057qib7	7508	26	-	-	HYPH
cord-005453-4057qib7	7508	27	off	off	RP
cord-005453-4057qib7	7508	28	level	level	NN
cord-005453-4057qib7	7508	29	associated	associate	VBN
cord-005453-4057qib7	7508	30	with	with	IN
cord-005453-4057qib7	7508	31	a	a	DT
cord-005453-4057qib7	7508	32	higher	high	JJR
cord-005453-4057qib7	7508	33	risk	risk	NN
cord-005453-4057qib7	7508	34	of	of	IN
cord-005453-4057qib7	7508	35	GF	GF	NNP
cord-005453-4057qib7	7508	36	.	.	.
cord-005453-4057qib7	7509	1	Transplant	transplant	NN
cord-005453-4057qib7	7509	2	and	and	CC
cord-005453-4057qib7	7509	3	transfusion	transfusion	NN
cord-005453-4057qib7	7509	4	specialists	specialist	NNS
cord-005453-4057qib7	7509	5	should	should	MD
cord-005453-4057qib7	7509	6	joint	joint	VB
cord-005453-4057qib7	7509	7	to	to	TO
cord-005453-4057qib7	7509	8	define	define	VB
cord-005453-4057qib7	7509	9	a	a	DT
cord-005453-4057qib7	7509	10	consensus	consensus	NN
cord-005453-4057qib7	7509	11	for	for	IN
cord-005453-4057qib7	7509	12	a	a	DT
cord-005453-4057qib7	7509	13	standard	standard	JJ
cord-005453-4057qib7	7509	14	desensitization	desensitization	NN
cord-005453-4057qib7	7509	15	strategy	strategy	NN
cord-005453-4057qib7	7509	16	.	.	.
cord-005453-4057qib7	7510	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7510	2	The	the	DT
cord-005453-4057qib7	7510	3	most	most	RBS
cord-005453-4057qib7	7510	4	frequent	frequent	JJ
cord-005453-4057qib7	7510	5	technique	technique	NN
cord-005453-4057qib7	7510	6	used	use	VBN
cord-005453-4057qib7	7510	7	for	for	IN
cord-005453-4057qib7	7510	8	counterbalance	counterbalance	JJ
cord-005453-4057qib7	7510	9	partial	partial	JJ
cord-005453-4057qib7	7510	10	incompatible	incompatible	JJ
cord-005453-4057qib7	7510	11	HSCT	HSCT	NNP
cord-005453-4057qib7	7510	12	is	be	VBZ
cord-005453-4057qib7	7510	13	CD34	CD34	NNP
cord-005453-4057qib7	7511	1	+	+	CC
cord-005453-4057qib7	7512	1	selection	selection	NN
cord-005453-4057qib7	7512	2	that	that	WDT
cord-005453-4057qib7	7512	3	is	be	VBZ
cord-005453-4057qib7	7512	4	associated	associate	VBN
cord-005453-4057qib7	7512	5	with	with	IN
cord-005453-4057qib7	7512	6	sustained	sustained	JJ
cord-005453-4057qib7	7512	7	engraftment	engraftment	NN
cord-005453-4057qib7	7512	8	and	and	CC
cord-005453-4057qib7	7512	9	effective	effective	JJ
cord-005453-4057qib7	7512	10	reduction	reduction	NN
cord-005453-4057qib7	7512	11	of	of	IN
cord-005453-4057qib7	7512	12	T	t	NN
cord-005453-4057qib7	7512	13	cells	cell	NNS
cord-005453-4057qib7	7512	14	that	that	WDT
cord-005453-4057qib7	7512	15	minimizes	minimize	VBZ
cord-005453-4057qib7	7512	16	GvHD	GvHD	NNP
cord-005453-4057qib7	7512	17	.	.	.
cord-005453-4057qib7	7513	1	On	on	IN
cord-005453-4057qib7	7513	2	the	the	DT
cord-005453-4057qib7	7513	3	other	other	JJ
cord-005453-4057qib7	7513	4	hand	hand	NN
cord-005453-4057qib7	7513	5	,	,	,
cord-005453-4057qib7	7513	6	this	this	DT
cord-005453-4057qib7	7513	7	approach	approach	NN
cord-005453-4057qib7	7513	8	could	could	MD
cord-005453-4057qib7	7513	9	delay	delay	VB
cord-005453-4057qib7	7513	10	immune	immune	JJ
cord-005453-4057qib7	7513	11	reconstitution	reconstitution	NN
cord-005453-4057qib7	7513	12	and	and	CC
cord-005453-4057qib7	7513	13	increase	increase	VB
cord-005453-4057qib7	7513	14	risk	risk	NN
cord-005453-4057qib7	7513	15	of	of	IN
cord-005453-4057qib7	7513	16	viral	viral	JJ
cord-005453-4057qib7	7513	17	and	and	CC
cord-005453-4057qib7	7513	18	fungal	fungal	JJ
cord-005453-4057qib7	7513	19	infection	infection	NN
cord-005453-4057qib7	7513	20	.	.	.
cord-005453-4057qib7	7514	1	In	in	IN
cord-005453-4057qib7	7514	2	MUD	mud	NN
cord-005453-4057qib7	7514	3	setting	set	VBG
cord-005453-4057qib7	7514	4	the	the	DT
cord-005453-4057qib7	7514	5	use	use	NN
cord-005453-4057qib7	7514	6	of	of	IN
cord-005453-4057qib7	7514	7	PBSC	PBSC	NNP
cord-005453-4057qib7	7514	8	is	be	VBZ
cord-005453-4057qib7	7514	9	the	the	DT
cord-005453-4057qib7	7514	10	procedure	procedure	NN
cord-005453-4057qib7	7514	11	that	that	IN
cord-005453-4057qib7	7514	12	most	most	JJS
cord-005453-4057qib7	7514	13	centers	center	NNS
cord-005453-4057qib7	7514	14	have	have	VBP
cord-005453-4057qib7	7514	15	recently	recently	RB
cord-005453-4057qib7	7514	16	adopted	adopt	VBN
cord-005453-4057qib7	7514	17	.	.	.
cord-005453-4057qib7	7515	1	This	this	DT
cord-005453-4057qib7	7515	2	implies	imply	VBZ
cord-005453-4057qib7	7515	3	the	the	DT
cord-005453-4057qib7	7515	4	infusion	infusion	NN
cord-005453-4057qib7	7515	5	of	of	IN
cord-005453-4057qib7	7515	6	a	a	DT
cord-005453-4057qib7	7515	7	relevant	relevant	JJ
cord-005453-4057qib7	7515	8	higher	high	JJR
cord-005453-4057qib7	7515	9	number	number	NN
cord-005453-4057qib7	7515	10	of	of	IN
cord-005453-4057qib7	7515	11	T	t	NN
cord-005453-4057qib7	7515	12	cells	cell	NNS
cord-005453-4057qib7	7515	13	5	5	CD
cord-005453-4057qib7	7515	14	to	to	TO
cord-005453-4057qib7	7515	15	10	10	CD
cord-005453-4057qib7	7515	16	times	time	NNS
cord-005453-4057qib7	7515	17	more	more	JJR
cord-005453-4057qib7	7515	18	as	as	IN
cord-005453-4057qib7	7515	19	compared	compare	VBN
cord-005453-4057qib7	7515	20	with	with	IN
cord-005453-4057qib7	7515	21	Bone	Bone	NNP
cord-005453-4057qib7	7515	22	Marrow	Marrow	NNP
cord-005453-4057qib7	7515	23	(	(	-LRB-
cord-005453-4057qib7	7515	24	BM	BM	NNP
cord-005453-4057qib7	7515	25	)	)	-RRB-
cord-005453-4057qib7	7515	26	.	.	.
cord-005453-4057qib7	7516	1	Since	since	IN
cord-005453-4057qib7	7516	2	in	in	IN
cord-005453-4057qib7	7516	3	our	-PRON-	PRP$
cord-005453-4057qib7	7516	4	centre	centre	NN
cord-005453-4057qib7	7516	5	most	most	JJS
cord-005453-4057qib7	7516	6	part	part	NN
cord-005453-4057qib7	7516	7	of	of	IN
cord-005453-4057qib7	7516	8	our	-PRON-	PRP$
cord-005453-4057qib7	7516	9	patients	patient	NNS
cord-005453-4057qib7	7516	10	are	be	VBP
cord-005453-4057qib7	7516	11	primary	primary	JJ
cord-005453-4057qib7	7516	12	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	7516	13	,	,	,
cord-005453-4057qib7	7516	14	we	-PRON-	PRP
cord-005453-4057qib7	7516	15	applied	apply	VBD
cord-005453-4057qib7	7516	16	a	a	DT
cord-005453-4057qib7	7516	17	procedure	procedure	NN
cord-005453-4057qib7	7516	18	to	to	TO
cord-005453-4057qib7	7516	19	minimize	minimize	VB
cord-005453-4057qib7	7516	20	the	the	DT
cord-005453-4057qib7	7516	21	risk	risk	NN
cord-005453-4057qib7	7516	22	of	of	IN
cord-005453-4057qib7	7516	23	severe	severe	JJ
cord-005453-4057qib7	7516	24	GvHD	gvhd	NN
cord-005453-4057qib7	7516	25	infusing	infuse	VBG
cord-005453-4057qib7	7516	26	a	a	DT
cord-005453-4057qib7	7516	27	controlled	control	VBN
cord-005453-4057qib7	7516	28	number	number	NN
cord-005453-4057qib7	7516	29	of	of	IN
cord-005453-4057qib7	7516	30	CD3	CD3	NNP
cord-005453-4057qib7	7516	31	positive	positive	JJ
cord-005453-4057qib7	7516	32	cells	cell	NNS
cord-005453-4057qib7	7516	33	.	.	.
cord-005453-4057qib7	7517	1	Methods	method	NNS
cord-005453-4057qib7	7517	2	:	:	:
cord-005453-4057qib7	7517	3	We	-PRON-	PRP
cord-005453-4057qib7	7517	4	report	report	VBP
cord-005453-4057qib7	7517	5	data	datum	NNS
cord-005453-4057qib7	7517	6	about	about	RB
cord-005453-4057qib7	7517	7	91	91	CD
cord-005453-4057qib7	7517	8	paediatric	paediatric	JJ
cord-005453-4057qib7	7517	9	patients	patient	NNS
cord-005453-4057qib7	7517	10	who	who	WP
cord-005453-4057qib7	7517	11	received	receive	VBD
cord-005453-4057qib7	7517	12	92	92	CD
cord-005453-4057qib7	7517	13	MUD	mud	NN
cord-005453-4057qib7	7517	14	HSCT	HSCT	NNP
cord-005453-4057qib7	7517	15	(	(	-LRB-
cord-005453-4057qib7	7517	16	1	1	CD
cord-005453-4057qib7	7517	17	patient	patient	NN
cord-005453-4057qib7	7517	18	received	receive	VBD
cord-005453-4057qib7	7517	19	2	2	CD
cord-005453-4057qib7	7517	20	HSCT	HSCT	NNP
cord-005453-4057qib7	7517	21	)	)	-RRB-
cord-005453-4057qib7	7517	22	between	between	IN
cord-005453-4057qib7	7517	23	2001	2001	CD
cord-005453-4057qib7	7517	24	and	and	CC
cord-005453-4057qib7	7517	25	2018	2018	CD
cord-005453-4057qib7	7517	26	in	in	IN
cord-005453-4057qib7	7517	27	the	the	DT
cord-005453-4057qib7	7517	28	BMT	BMT	NNP
cord-005453-4057qib7	7517	29	Unit	Unit	NNP
cord-005453-4057qib7	7517	30	of	of	IN
cord-005453-4057qib7	7517	31	the	the	DT
cord-005453-4057qib7	7517	32	Children	Children	NNPS
cord-005453-4057qib7	7517	33	's	's	POS
cord-005453-4057qib7	7517	34	Hospital	Hospital	NNP
cord-005453-4057qib7	7517	35	of	of	IN
cord-005453-4057qib7	7517	36	Brescia	Brescia	NNP
cord-005453-4057qib7	7517	37	.	.	.
cord-005453-4057qib7	7518	1	Patients	patient	NNS
cord-005453-4057qib7	7518	2	received	receive	VBD
cord-005453-4057qib7	7518	3	conditioning	conditioning	NN
cord-005453-4057qib7	7518	4	,	,	,
cord-005453-4057qib7	7518	5	according	accord	VBG
cord-005453-4057qib7	7518	6	to	to	IN
cord-005453-4057qib7	7518	7	the	the	DT
cord-005453-4057qib7	7518	8	European	European	NNP
cord-005453-4057qib7	7518	9	Group	Group	NNP
cord-005453-4057qib7	7518	10	for	for	IN
cord-005453-4057qib7	7518	11	Bone	Bone	NNP
cord-005453-4057qib7	7518	12	Marrow	Marrow	NNP
cord-005453-4057qib7	7518	13	Transplantation	transplantation	NN
cord-005453-4057qib7	7518	14	(	(	-LRB-
cord-005453-4057qib7	7518	15	EBMT	EBMT	NNP
cord-005453-4057qib7	7518	16	)	)	-RRB-
cord-005453-4057qib7	7518	17	and	and	CC
cord-005453-4057qib7	7518	18	the	the	DT
cord-005453-4057qib7	7518	19	European	European	NNP
cord-005453-4057qib7	7518	20	Society	Society	NNP
cord-005453-4057qib7	7518	21	for	for	IN
cord-005453-4057qib7	7518	22	Immunodeficiencies	Immunodeficiencies	NNP
cord-005453-4057qib7	7518	23	(	(	-LRB-
cord-005453-4057qib7	7518	24	ESID	ESID	NNP
cord-005453-4057qib7	7518	25	)	)	-RRB-
cord-005453-4057qib7	7518	26	Guidelines	Guidelines	NNPS
cord-005453-4057qib7	7518	27	.	.	.
cord-005453-4057qib7	7519	1	CD34	CD34	NNP
cord-005453-4057qib7	7519	2	+	+	CC
cord-005453-4057qib7	7519	3	selection	selection	NN
cord-005453-4057qib7	7519	4	has	have	VBZ
cord-005453-4057qib7	7519	5	been	be	VBN
cord-005453-4057qib7	7519	6	realized	realize	VBN
cord-005453-4057qib7	7519	7	by	by	IN
cord-005453-4057qib7	7519	8	a	a	DT
cord-005453-4057qib7	7519	9	Milteny	Milteny	NNP
cord-005453-4057qib7	7519	10	column	column	NN
cord-005453-4057qib7	7519	11	with	with	IN
cord-005453-4057qib7	7519	12	an	an	DT
cord-005453-4057qib7	7519	13	ideal	ideal	JJ
cord-005453-4057qib7	7519	14	addback	addback	NN
cord-005453-4057qib7	7519	15	of	of	IN
cord-005453-4057qib7	7519	16	CD3	CD3	NNP
cord-005453-4057qib7	7519	17	positive	positive	JJ
cord-005453-4057qib7	7519	18	cells	cell	NNS
cord-005453-4057qib7	7519	19	of	of	IN
cord-005453-4057qib7	7519	20	30x10	30x10	CD
cord-005453-4057qib7	7519	21	6	6	CD
cord-005453-4057qib7	7520	1	/Kg	/Kg	NNP
cord-005453-4057qib7	7520	2	.	.	.
cord-005453-4057qib7	7521	1	Stem	stem	JJ
cord-005453-4057qib7	7521	2	cell	cell	NN
cord-005453-4057qib7	7521	3	source	source	NN
cord-005453-4057qib7	7521	4	was	be	VBD
cord-005453-4057qib7	7521	5	BM	BM	NNP
cord-005453-4057qib7	7521	6	in	in	IN
cord-005453-4057qib7	7521	7	62	62	CD
cord-005453-4057qib7	7521	8	cases	case	NNS
cord-005453-4057qib7	7521	9	and	and	CC
cord-005453-4057qib7	7521	10	PBSC	PBSC	NNP
cord-005453-4057qib7	7521	11	in	in	IN
cord-005453-4057qib7	7521	12	30	30	CD
cord-005453-4057qib7	7521	13	cases	case	NNS
cord-005453-4057qib7	7521	14	.	.	.
cord-005453-4057qib7	7522	1	Results	result	NNS
cord-005453-4057qib7	7522	2	:	:	:
cord-005453-4057qib7	7523	1	Median	median	JJ
cord-005453-4057qib7	7523	2	patients	patient	NNS
cord-005453-4057qib7	7523	3	age	age	NN
cord-005453-4057qib7	7523	4	at	at	IN
cord-005453-4057qib7	7523	5	transplant	transplant	NN
cord-005453-4057qib7	7523	6	was	be	VBD
cord-005453-4057qib7	7523	7	2	2	CD
cord-005453-4057qib7	7523	8	years	year	NNS
cord-005453-4057qib7	7523	9	(	(	-LRB-
cord-005453-4057qib7	7523	10	range	range	VBP
cord-005453-4057qib7	7523	11	2.6	2.6	CD
cord-005453-4057qib7	7523	12	months-17	months-17	CD
cord-005453-4057qib7	7523	13	years	year	NNS
cord-005453-4057qib7	7523	14	)	)	-RRB-
cord-005453-4057qib7	7523	15	.	.	.
cord-005453-4057qib7	7524	1	The	the	DT
cord-005453-4057qib7	7524	2	mean	mean	JJ
cord-005453-4057qib7	7524	3	number	number	NN
cord-005453-4057qib7	7524	4	of	of	IN
cord-005453-4057qib7	7524	5	infused	infuse	VBN
cord-005453-4057qib7	7524	6	cells	cell	NNS
cord-005453-4057qib7	7524	7	were	be	VBD
cord-005453-4057qib7	7524	8	:	:	:
cord-005453-4057qib7	7524	9	12x10	12x10	CD
cord-005453-4057qib7	7524	10	6	6	CD
cord-005453-4057qib7	7524	11	/Kg	/kg	NN
cord-005453-4057qib7	7524	12	CD34	CD34	NNP
cord-005453-4057qib7	7524	13	+	+	CC
cord-005453-4057qib7	7524	14	and	and	CC
cord-005453-4057qib7	7524	15	36x10	36x10	CD
cord-005453-4057qib7	7524	16	6	6	CD
cord-005453-4057qib7	7525	1	/Kg	/Kg	.
cord-005453-4057qib7	7526	1	CD3	CD3	NNP
cord-005453-4057qib7	7526	2	+	+	CC
cord-005453-4057qib7	7526	3	in	in	IN
cord-005453-4057qib7	7526	4	BM	BM	NNP
cord-005453-4057qib7	7526	5	product	product	NN
cord-005453-4057qib7	7526	6	,	,	,
cord-005453-4057qib7	7526	7	while	while	IN
cord-005453-4057qib7	7526	8	20x10	20x10	CD
cord-005453-4057qib7	7526	9	6	6	CD
cord-005453-4057qib7	7526	10	/Kg	/kg	NN
cord-005453-4057qib7	7526	11	CD34	CD34	NNP
cord-005453-4057qib7	7526	12	+	+	CC
cord-005453-4057qib7	7526	13	and	and	CC
cord-005453-4057qib7	7526	14	39x10	39x10	CD
cord-005453-4057qib7	7526	15	6	6	CD
cord-005453-4057qib7	7527	1	/Kg	/Kg	NNP
cord-005453-4057qib7	7527	2	CD3	CD3	NNP
cord-005453-4057qib7	7527	3	+	+	CC
cord-005453-4057qib7	7527	4	in	in	IN
cord-005453-4057qib7	7527	5	PBSC	PBSC	NNP
cord-005453-4057qib7	7527	6	.	.	.
cord-005453-4057qib7	7528	1	Mean	mean	JJ
cord-005453-4057qib7	7528	2	time	time	NN
cord-005453-4057qib7	7528	3	for	for	IN
cord-005453-4057qib7	7528	4	engraftment	engraftment	NN
cord-005453-4057qib7	7528	5	was	be	VBD
cord-005453-4057qib7	7528	6	day	day	NN
cord-005453-4057qib7	7528	7	15	15	CD
cord-005453-4057qib7	7528	8	post	post	NN
cord-005453-4057qib7	7528	9	-	-	JJ
cord-005453-4057qib7	7528	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7528	11	.	.	.
cord-005453-4057qib7	7529	1	As	as	IN
cord-005453-4057qib7	7529	2	concerns	concern	NNS
cord-005453-4057qib7	7529	3	acute	acute	JJ
cord-005453-4057qib7	7529	4	GvHD	gvhd	JJ
cord-005453-4057qib7	7529	5	overall	overall	JJ
cord-005453-4057qib7	7529	6	incidence	incidence	NN
cord-005453-4057qib7	7530	1	64.1	64.1	CD
cord-005453-4057qib7	7530	2	%	%	NN
cord-005453-4057qib7	7530	3	(	(	-LRB-
cord-005453-4057qib7	7530	4	59/92	59/92	CD
cord-005453-4057qib7	7530	5	)	)	-RRB-
cord-005453-4057qib7	7530	6	of	of	IN
cord-005453-4057qib7	7530	7	the	the	DT
cord-005453-4057qib7	7530	8	children	child	NNS
cord-005453-4057qib7	7530	9	presented	present	VBD
cord-005453-4057qib7	7530	10	this	this	DT
cord-005453-4057qib7	7530	11	complication	complication	NN
cord-005453-4057qib7	7530	12	,	,	,
cord-005453-4057qib7	7530	13	but	but	CC
cord-005453-4057qib7	7530	14	only	only	RB
cord-005453-4057qib7	7530	15	11	11	CD
cord-005453-4057qib7	7530	16	%	%	NN
cord-005453-4057qib7	7530	17	(	(	-LRB-
cord-005453-4057qib7	7530	18	7/	7/	CD
cord-005453-4057qib7	7530	19	59	59	CD
cord-005453-4057qib7	7530	20	)	)	-RRB-
cord-005453-4057qib7	7530	21	presented	present	VBD
cord-005453-4057qib7	7530	22	GvHD	GvHD	NNP
cord-005453-4057qib7	7530	23	grade	grade	NN
cord-005453-4057qib7	7530	24	III	III	NNP
cord-005453-4057qib7	7530	25	and	and	CC
cord-005453-4057qib7	7530	26	none	none	NN
cord-005453-4057qib7	7530	27	GvHD	GvHD	NNP
cord-005453-4057qib7	7530	28	grade	grade	NN
cord-005453-4057qib7	7530	29	IV	IV	NNP
cord-005453-4057qib7	7530	30	,	,	,
cord-005453-4057qib7	7530	31	while	while	IN
cord-005453-4057qib7	7530	32	chronic	chronic	JJ
cord-005453-4057qib7	7530	33	GvHD	GvHD	NNP
cord-005453-4057qib7	7530	34	presented	present	VBN
cord-005453-4057qib7	7530	35	in	in	IN
cord-005453-4057qib7	7530	36	7.6	7.6	CD
cord-005453-4057qib7	7530	37	%	%	NN
cord-005453-4057qib7	7530	38	(	(	-LRB-
cord-005453-4057qib7	7530	39	6	6	CD
cord-005453-4057qib7	7530	40	limited	limited	JJ
cord-005453-4057qib7	7530	41	,	,	,
cord-005453-4057qib7	7530	42	1	1	CD
cord-005453-4057qib7	7530	43	extensive/92	extensive/92	NNP
cord-005453-4057qib7	7530	44	)	)	-RRB-
cord-005453-4057qib7	7530	45	.	.	.
cord-005453-4057qib7	7531	1	While	while	IN
cord-005453-4057qib7	7531	2	acute	acute	JJ
cord-005453-4057qib7	7531	3	GvHD	gvhd	NN
cord-005453-4057qib7	7531	4	incidence	incidence	NN
cord-005453-4057qib7	7531	5	and	and	CC
cord-005453-4057qib7	7531	6	severity	severity	NN
cord-005453-4057qib7	7531	7	were	be	VBD
cord-005453-4057qib7	7531	8	n't	not	RB
cord-005453-4057qib7	7531	9	significantly	significantly	RB
cord-005453-4057qib7	7531	10	different	different	JJ
cord-005453-4057qib7	7531	11	between	between	IN
cord-005453-4057qib7	7531	12	BM	BM	NNP
cord-005453-4057qib7	7531	13	recipients	recipient	NNS
cord-005453-4057qib7	7531	14	and	and	CC
cord-005453-4057qib7	7531	15	PBSC	PBSC	NNP
cord-005453-4057qib7	7531	16	recipients	recipient	NNS
cord-005453-4057qib7	7531	17	,	,	,
cord-005453-4057qib7	7531	18	the	the	DT
cord-005453-4057qib7	7531	19	cases	case	NNS
cord-005453-4057qib7	7531	20	of	of	IN
cord-005453-4057qib7	7531	21	chronic	chronic	JJ
cord-005453-4057qib7	7531	22	GvHD	gvhd	NN
cord-005453-4057qib7	7531	23	were	be	VBD
cord-005453-4057qib7	7531	24	prevalently	prevalently	RB
cord-005453-4057qib7	7531	25	in	in	IN
cord-005453-4057qib7	7531	26	the	the	DT
cord-005453-4057qib7	7531	27	latters	latter	NNS
cord-005453-4057qib7	7531	28	.	.	.
cord-005453-4057qib7	7532	1	No	no	DT
cord-005453-4057qib7	7532	2	major	major	JJ
cord-005453-4057qib7	7532	3	infections	infection	NNS
cord-005453-4057qib7	7532	4	presented	present	VBN
cord-005453-4057qib7	7532	5	in	in	IN
cord-005453-4057qib7	7532	6	the	the	DT
cord-005453-4057qib7	7532	7	post	post	JJ
cord-005453-4057qib7	7532	8	-	-	JJ
cord-005453-4057qib7	7532	9	transplant	transplant	JJ
cord-005453-4057qib7	7532	10	period	period	NN
cord-005453-4057qib7	7532	11	and	and	CC
cord-005453-4057qib7	7532	12	immunological	immunological	JJ
cord-005453-4057qib7	7532	13	reconstitution	reconstitution	NN
cord-005453-4057qib7	7532	14	both	both	CC
cord-005453-4057qib7	7532	15	cellular	cellular	JJ
cord-005453-4057qib7	7532	16	and	and	CC
cord-005453-4057qib7	7532	17	humoral	humoral	JJ
cord-005453-4057qib7	7532	18	was	be	VBD
cord-005453-4057qib7	7532	19	completed	complete	VBN
cord-005453-4057qib7	7532	20	by	by	IN
cord-005453-4057qib7	7532	21	12	12	CD
cord-005453-4057qib7	7532	22	months	month	NNS
cord-005453-4057qib7	7532	23	.	.	.
cord-005453-4057qib7	7533	1	Overall	overall	JJ
cord-005453-4057qib7	7533	2	survival	survival	NN
cord-005453-4057qib7	7533	3	at	at	IN
cord-005453-4057qib7	7533	4	10	10	CD
cord-005453-4057qib7	7533	5	years	year	NNS
cord-005453-4057qib7	7533	6	is	be	VBZ
cord-005453-4057qib7	7533	7	75	75	CD
cord-005453-4057qib7	7533	8	%	%	NN
cord-005453-4057qib7	7533	9	(	(	-LRB-
cord-005453-4057qib7	7533	10	23/92	23/92	CD
cord-005453-4057qib7	7533	11	)	)	-RRB-
cord-005453-4057qib7	7533	12	.	.	.
cord-005453-4057qib7	7534	1	The	the	DT
cord-005453-4057qib7	7534	2	results	result	NNS
cord-005453-4057qib7	7534	3	obtained	obtain	VBD
cord-005453-4057qib7	7534	4	show	show	NN
cord-005453-4057qib7	7534	5	how	how	WRB
cord-005453-4057qib7	7534	6	it	-PRON-	PRP
cord-005453-4057qib7	7534	7	is	be	VBZ
cord-005453-4057qib7	7534	8	possible	possible	JJ
cord-005453-4057qib7	7534	9	control	control	NN
cord-005453-4057qib7	7534	10	severity	severity	NN
cord-005453-4057qib7	7534	11	of	of	IN
cord-005453-4057qib7	7534	12	GvHD	GvHD	NNP
cord-005453-4057qib7	7534	13	if	if	IN
cord-005453-4057qib7	7534	14	an	an	DT
cord-005453-4057qib7	7534	15	addback	addback	NN
cord-005453-4057qib7	7534	16	of	of	IN
cord-005453-4057qib7	7534	17	a	a	DT
cord-005453-4057qib7	7534	18	controlled	control	VBN
cord-005453-4057qib7	7534	19	number	number	NN
cord-005453-4057qib7	7534	20	of	of	IN
cord-005453-4057qib7	7534	21	CD3	CD3	NNP
cord-005453-4057qib7	7534	22	+	+	CC
cord-005453-4057qib7	7534	23	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	7534	24	.	.	.
cord-005453-4057qib7	7535	1	Acute	acute	JJ
cord-005453-4057qib7	7535	2	GvHD	GvHD	NNP
cord-005453-4057qib7	7535	3	was	be	VBD
cord-005453-4057qib7	7535	4	n't	not	RB
cord-005453-4057qib7	7535	5	severe	severe	JJ
cord-005453-4057qib7	7535	6	and	and	CC
cord-005453-4057qib7	7535	7	only	only	RB
cord-005453-4057qib7	7535	8	few	few	JJ
cord-005453-4057qib7	7535	9	children	child	NNS
cord-005453-4057qib7	7535	10	presented	present	VBN
cord-005453-4057qib7	7535	11	with	with	IN
cord-005453-4057qib7	7535	12	limited	limited	JJ
cord-005453-4057qib7	7535	13	chronic	chronic	JJ
cord-005453-4057qib7	7535	14	GvHD	GvHD	NNP
cord-005453-4057qib7	7535	15	.	.	.
cord-005453-4057qib7	7536	1	The	the	DT
cord-005453-4057qib7	7536	2	method	method	NN
cord-005453-4057qib7	7536	3	allows	allow	VBZ
cord-005453-4057qib7	7536	4	to	to	TO
cord-005453-4057qib7	7536	5	graft	graft	VB
cord-005453-4057qib7	7536	6	primary	primary	JJ
cord-005453-4057qib7	7536	7	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	7536	8	patients	patient	NNS
cord-005453-4057qib7	7536	9	even	even	RB
cord-005453-4057qib7	7536	10	with	with	IN
cord-005453-4057qib7	7536	11	PBSC	PBSC	NNP
cord-005453-4057qib7	7536	12	without	without	IN
cord-005453-4057qib7	7536	13	infusing	infuse	VBG
cord-005453-4057qib7	7536	14	too	too	RB
cord-005453-4057qib7	7536	15	many	many	JJ
cord-005453-4057qib7	7536	16	T	t	NN
cord-005453-4057qib7	7536	17	cells	cell	NNS
cord-005453-4057qib7	7536	18	.	.	.
cord-005453-4057qib7	7537	1	In	in	IN
cord-005453-4057qib7	7537	2	fact	fact	NN
cord-005453-4057qib7	7537	3	,	,	,
cord-005453-4057qib7	7537	4	especially	especially	RB
cord-005453-4057qib7	7537	5	in	in	IN
cord-005453-4057qib7	7537	6	very	very	RB
cord-005453-4057qib7	7537	7	young	young	JJ
cord-005453-4057qib7	7537	8	children	child	NNS
cord-005453-4057qib7	7537	9	,	,	,
cord-005453-4057qib7	7537	10	the	the	DT
cord-005453-4057qib7	7537	11	number	number	NN
cord-005453-4057qib7	7537	12	could	could	MD
cord-005453-4057qib7	7537	13	be	be	VB
cord-005453-4057qib7	7537	14	excessive	excessive	JJ
cord-005453-4057qib7	7537	15	and	and	CC
cord-005453-4057qib7	7537	16	risky	risky	JJ
cord-005453-4057qib7	7537	17	.	.	.
cord-005453-4057qib7	7538	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	7538	2	in	in	IN
cord-005453-4057qib7	7538	3	case	case	NN
cord-005453-4057qib7	7538	4	of	of	IN
cord-005453-4057qib7	7538	5	an	an	DT
cord-005453-4057qib7	7538	6	oncohaematological	oncohaematological	JJ
cord-005453-4057qib7	7538	7	patient	patient	NN
cord-005453-4057qib7	7538	8	,	,	,
cord-005453-4057qib7	7538	9	GvL	gvl	NN
cord-005453-4057qib7	7538	10	effect	effect	NN
cord-005453-4057qib7	7538	11	is	be	VBZ
cord-005453-4057qib7	7538	12	preserved	preserve	VBN
cord-005453-4057qib7	7538	13	.	.	.
cord-005453-4057qib7	7539	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7539	2	Background	background	NN
cord-005453-4057qib7	7539	3	:	:	:
cord-005453-4057qib7	7539	4	DC	DC	NNP
cord-005453-4057qib7	7539	5	is	be	VBZ
cord-005453-4057qib7	7539	6	a	a	DT
cord-005453-4057qib7	7539	7	rare	rare	JJ
cord-005453-4057qib7	7539	8	genetic	genetic	JJ
cord-005453-4057qib7	7539	9	disorder	disorder	NN
cord-005453-4057qib7	7539	10	that	that	WDT
cord-005453-4057qib7	7539	11	results	result	VBZ
cord-005453-4057qib7	7539	12	from	from	IN
cord-005453-4057qib7	7539	13	a	a	DT
cord-005453-4057qib7	7539	14	defective	defective	JJ
cord-005453-4057qib7	7539	15	telomere	telomere	NN
cord-005453-4057qib7	7539	16	length	length	NN
cord-005453-4057qib7	7539	17	maintenance	maintenance	NN
cord-005453-4057qib7	7539	18	and	and	CC
cord-005453-4057qib7	7539	19	is	be	VBZ
cord-005453-4057qib7	7539	20	characterized	characterize	VBN
cord-005453-4057qib7	7539	21	by	by	IN
cord-005453-4057qib7	7539	22	mucocutaneous	mucocutaneous	JJ
cord-005453-4057qib7	7539	23	features	feature	NNS
cord-005453-4057qib7	7539	24	,	,	,
cord-005453-4057qib7	7539	25	bone	bone	NN
cord-005453-4057qib7	7539	26	marrow	marrow	NN
cord-005453-4057qib7	7539	27	failure	failure	NN
cord-005453-4057qib7	7539	28	(	(	-LRB-
cord-005453-4057qib7	7539	29	BMF	BMF	NNP
cord-005453-4057qib7	7539	30	)	)	-RRB-
cord-005453-4057qib7	7539	31	and	and	CC
cord-005453-4057qib7	7539	32	a	a	DT
cord-005453-4057qib7	7539	33	high	high	JJ
cord-005453-4057qib7	7539	34	predisposition	predisposition	NN
cord-005453-4057qib7	7539	35	to	to	IN
cord-005453-4057qib7	7539	36	cancer	cancer	NN
cord-005453-4057qib7	7539	37	and	and	CC
cord-005453-4057qib7	7539	38	pulmonary	pulmonary	JJ
cord-005453-4057qib7	7539	39	fibrosis	fibrosis	NN
cord-005453-4057qib7	7539	40	.	.	.
cord-005453-4057qib7	7540	1	BMF	BMF	NNP
cord-005453-4057qib7	7540	2	remains	remain	VBZ
cord-005453-4057qib7	7540	3	the	the	DT
cord-005453-4057qib7	7540	4	major	major	JJ
cord-005453-4057qib7	7540	5	cause	cause	NN
cord-005453-4057qib7	7540	6	of	of	IN
cord-005453-4057qib7	7540	7	mortality	mortality	NN
cord-005453-4057qib7	7540	8	and	and	CC
cord-005453-4057qib7	7540	9	the	the	DT
cord-005453-4057qib7	7540	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7540	11	is	be	VBZ
cord-005453-4057qib7	7540	12	the	the	DT
cord-005453-4057qib7	7540	13	only	only	JJ
cord-005453-4057qib7	7540	14	definitive	definitive	JJ
cord-005453-4057qib7	7540	15	treatment	treatment	NN
cord-005453-4057qib7	7540	16	to	to	TO
cord-005453-4057qib7	7540	17	restore	restore	VB
cord-005453-4057qib7	7540	18	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	7540	19	but	but	CC
cord-005453-4057qib7	7540	20	is	be	VBZ
cord-005453-4057qib7	7540	21	limited	limit	VBN
cord-005453-4057qib7	7540	22	by	by	IN
cord-005453-4057qib7	7540	23	a	a	DT
cord-005453-4057qib7	7540	24	high	high	JJ
cord-005453-4057qib7	7540	25	incidence	incidence	NN
cord-005453-4057qib7	7540	26	of	of	IN
cord-005453-4057qib7	7540	27	treatmentrelated	treatmentrelated	JJ
cord-005453-4057qib7	7540	28	mortality	mortality	NN
cord-005453-4057qib7	7540	29	.	.	.
cord-005453-4057qib7	7541	1	Methods	method	NNS
cord-005453-4057qib7	7541	2	:	:	:
cord-005453-4057qib7	7542	1	A	a	DT
cord-005453-4057qib7	7542	2	retrospective	retrospective	JJ
cord-005453-4057qib7	7542	3	analysis	analysis	NN
cord-005453-4057qib7	7542	4	of	of	IN
cord-005453-4057qib7	7542	5	28	28	CD
cord-005453-4057qib7	7542	6	patients	patient	NNS
cord-005453-4057qib7	7542	7	(	(	-LRB-
cord-005453-4057qib7	7542	8	pts	pt	NNS
cord-005453-4057qib7	7542	9	)	)	-RRB-
cord-005453-4057qib7	7542	10	with	with	IN
cord-005453-4057qib7	7542	11	DC	DC	NNP
cord-005453-4057qib7	7542	12	who	who	WP
cord-005453-4057qib7	7542	13	underwent	undergo	VBD
cord-005453-4057qib7	7542	14	HSCT	HSCT	NNP
cord-005453-4057qib7	7542	15	at	at	IN
cord-005453-4057qib7	7542	16	the	the	DT
cord-005453-4057qib7	7542	17	Bone	Bone	NNP
cord-005453-4057qib7	7542	18	Marrow	Marrow	NNP
cord-005453-4057qib7	7542	19	Transplantation	Transplantation	NNP
cord-005453-4057qib7	7542	20	Unit	Unit	NNP
cord-005453-4057qib7	7542	21	in	in	IN
cord-005453-4057qib7	7542	22	the	the	DT
cord-005453-4057qib7	7542	23	Clinical	Clinical	NNP
cord-005453-4057qib7	7542	24	Hospital	Hospital	NNP
cord-005453-4057qib7	7542	25	of	of	IN
cord-005453-4057qib7	7542	26	Federal	Federal	NNP
cord-005453-4057qib7	7542	27	University	University	NNP
cord-005453-4057qib7	7542	28	of	of	IN
cord-005453-4057qib7	7542	29	Paraná	Paraná	NNP
cord-005453-4057qib7	7542	30	,	,	,
cord-005453-4057qib7	7542	31	Brazil	Brazil	NNP
cord-005453-4057qib7	7542	32	,	,	,
cord-005453-4057qib7	7542	33	between	between	IN
cord-005453-4057qib7	7542	34	July-1993	july-1993	XX
cord-005453-4057qib7	7542	35	and	and	CC
cord-005453-4057qib7	7542	36	November-2017	November-2017	NNP
cord-005453-4057qib7	7542	37	.	.	.
cord-005453-4057qib7	7543	1	Results	result	NNS
cord-005453-4057qib7	7543	2	:	:	:
cord-005453-4057qib7	7544	1	15	15	CD
cord-005453-4057qib7	7544	2	boys	boy	NNS
cord-005453-4057qib7	7544	3	and	and	CC
cord-005453-4057qib7	7544	4	13	13	CD
cord-005453-4057qib7	7544	5	girls	girl	NNS
cord-005453-4057qib7	7544	6	,	,	,
cord-005453-4057qib7	7544	7	with	with	IN
cord-005453-4057qib7	7544	8	a	a	DT
cord-005453-4057qib7	7544	9	median	median	JJ
cord-005453-4057qib7	7544	10	age	age	NN
cord-005453-4057qib7	7544	11	of	of	IN
cord-005453-4057qib7	7544	12	14y	14y	NNS
cord-005453-4057qib7	7544	13	(	(	-LRB-
cord-005453-4057qib7	7544	14	3	3	CD
cord-005453-4057qib7	7544	15	-30y	-30y	JJS
cord-005453-4057qib7	7544	16	)	)	-RRB-
cord-005453-4057qib7	7544	17	received	receive	VBD
cord-005453-4057qib7	7544	18	a	a	DT
cord-005453-4057qib7	7544	19	HSCT	HSCT	NNP
cord-005453-4057qib7	7544	20	from	from	IN
cord-005453-4057qib7	7544	21	a	a	DT
cord-005453-4057qib7	7544	22	MDS	MDS	NNP
cord-005453-4057qib7	7544	23	(	(	-LRB-
cord-005453-4057qib7	7544	24	n=7	n=7	NNS
cord-005453-4057qib7	7544	25	)	)	-RRB-
cord-005453-4057qib7	7544	26	,	,	,
cord-005453-4057qib7	7544	27	MUD	MUD	NNP
cord-005453-4057qib7	7544	28	(	(	-LRB-
cord-005453-4057qib7	7544	29	n=17	n=17	NNP
cord-005453-4057qib7	7544	30	)	)	-RRB-
cord-005453-4057qib7	7544	31	or	or	CC
cord-005453-4057qib7	7544	32	MMRD	MMRD	NNP
cord-005453-4057qib7	7544	33	(	(	-LRB-
cord-005453-4057qib7	7544	34	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7544	35	,	,	,
cord-005453-4057qib7	7544	36	n=4	n=4	JJ
cord-005453-4057qib7	7544	37	)	)	-RRB-
cord-005453-4057qib7	7544	38	.	.	.
cord-005453-4057qib7	7545	1	27pts	27pts	NNP
cord-005453-4057qib7	7545	2	received	receive	VBD
cord-005453-4057qib7	7545	3	bone	bone	NN
cord-005453-4057qib7	7545	4	marrow	marrow	NN
cord-005453-4057qib7	7545	5	(	(	-LRB-
cord-005453-4057qib7	7545	6	BM	BM	NNP
cord-005453-4057qib7	7545	7	)	)	-RRB-
cord-005453-4057qib7	7545	8	and	and	CC
cord-005453-4057qib7	7545	9	1pt	1pt	NNP
cord-005453-4057qib7	7545	10	received	receive	VBD
cord-005453-4057qib7	7545	11	a	a	DT
cord-005453-4057qib7	7545	12	cord	cord	NN
cord-005453-4057qib7	7545	13	blood	blood	NN
cord-005453-4057qib7	7545	14	unit	unit	NN
cord-005453-4057qib7	7545	15	(	(	-LRB-
cord-005453-4057qib7	7545	16	CBU	CBU	NNP
cord-005453-4057qib7	7545	17	)	)	-RRB-
cord-005453-4057qib7	7545	18	.	.	.
cord-005453-4057qib7	7546	1	The	the	DT
cord-005453-4057qib7	7546	2	median	median	NN
cord-005453-4057qib7	7546	3	of	of	IN
cord-005453-4057qib7	7546	4	TNC	TNC	NNP
cord-005453-4057qib7	7546	5	infused	infuse	VBN
cord-005453-4057qib7	7546	6	was	be	VBD
cord-005453-4057qib7	7546	7	4,76x10	4,76x10	CD
cord-005453-4057qib7	7546	8	8	8	CD
cord-005453-4057qib7	7547	1	/Kg	/Kg	.
cord-005453-4057qib7	7548	1	(	(	-LRB-
cord-005453-4057qib7	7548	2	range	range	NN
cord-005453-4057qib7	7548	3	2,26	2,26	CD
cord-005453-4057qib7	7548	4	-	-	HYPH
cord-005453-4057qib7	7548	5	10,12x10	10,12x10	CD
cord-005453-4057qib7	7548	6	8	8	CD
cord-005453-4057qib7	7549	1	/Kg	/kg	LS
cord-005453-4057qib7	7549	2	)	)	-RRB-
cord-005453-4057qib7	7550	1	and	and	CC
cord-005453-4057qib7	7550	2	in	in	IN
cord-005453-4057qib7	7550	3	the	the	DT
cord-005453-4057qib7	7550	4	CBU	CBU	NNP
cord-005453-4057qib7	7550	5	was	be	VBD
cord-005453-4057qib7	7550	6	6,5x10	6,5x10	NNP
cord-005453-4057qib7	7550	7	7	7	CD
cord-005453-4057qib7	7550	8	/	/	SYM
cord-005453-4057qib7	7550	9	Kg	Kg	NNP
cord-005453-4057qib7	7550	10	.	.	.
cord-005453-4057qib7	7551	1	Two	two	CD
cord-005453-4057qib7	7551	2	pts	pt	NNS
cord-005453-4057qib7	7551	3	received	receive	VBD
cord-005453-4057qib7	7551	4	a	a	DT
cord-005453-4057qib7	7551	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	7551	6	preparatory	preparatory	JJ
cord-005453-4057qib7	7551	7	regimen	regimen	NN
cord-005453-4057qib7	7551	8	with	with	IN
cord-005453-4057qib7	7551	9	busulfan	busulfan	NN
cord-005453-4057qib7	7551	10	(	(	-LRB-
cord-005453-4057qib7	7551	11	Bu	Bu	NNP
cord-005453-4057qib7	7551	12	)	)	-RRB-
cord-005453-4057qib7	7551	13	12mg	12mg	NN
cord-005453-4057qib7	7551	14	/	/	SYM
cord-005453-4057qib7	7551	15	Kg	kg	NN
cord-005453-4057qib7	7551	16	+	+	CC
cord-005453-4057qib7	7551	17	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7551	18	(	(	-LRB-
cord-005453-4057qib7	7551	19	Cy	Cy	NNP
cord-005453-4057qib7	7551	20	)	)	-RRB-
cord-005453-4057qib7	7551	21	120mg	120mg	NNP
cord-005453-4057qib7	7551	22	/	/	SYM
cord-005453-4057qib7	7551	23	Kg	Kg	NNP
cord-005453-4057qib7	7551	24	or	or	CC
cord-005453-4057qib7	7551	25	fludarabine	fludarabine	NN
cord-005453-4057qib7	7551	26	(	(	-LRB-
cord-005453-4057qib7	7551	27	Flu	flu	NN
cord-005453-4057qib7	7551	28	)	)	-RRB-
cord-005453-4057qib7	7552	1	150mg	150mg	NNP
cord-005453-4057qib7	7552	2	/	/	SYM
cord-005453-4057qib7	7552	3	m	m	NN
cord-005453-4057qib7	7552	4	2	2	CD
cord-005453-4057qib7	7552	5	+	+	SYM
cord-005453-4057qib7	7552	6	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	7552	7	globulin	globulin	NN
cord-005453-4057qib7	7552	8	(	(	-LRB-
cord-005453-4057qib7	7552	9	ATG	ATG	NNP
cord-005453-4057qib7	7552	10	)	)	-RRB-
cord-005453-4057qib7	7552	11	.	.	.
cord-005453-4057qib7	7553	1	The	the	DT
cord-005453-4057qib7	7553	2	remaining	remain	VBG
cord-005453-4057qib7	7553	3	pts	pt	NNS
cord-005453-4057qib7	7553	4	received	receive	VBD
cord-005453-4057qib7	7553	5	a	a	DT
cord-005453-4057qib7	7553	6	RIC	RIC	NNP
cord-005453-4057qib7	7553	7	regimen	regimen	NN
cord-005453-4057qib7	7553	8	with	with	IN
cord-005453-4057qib7	7553	9	Cy200mg	Cy200mg	NNPS
cord-005453-4057qib7	7553	10	/	/	SYM
cord-005453-4057qib7	7553	11	Kg	Kg	NNP
cord-005453-4057qib7	7553	12	(	(	-LRB-
cord-005453-4057qib7	7553	13	n=5	n=5	NNP
cord-005453-4057qib7	7553	14	)	)	-RRB-
cord-005453-4057qib7	7553	15	,	,	,
cord-005453-4057qib7	7553	16	Flu150mg	Flu150mg	NNP
cord-005453-4057qib7	7553	17	/	/	SYM
cord-005453-4057qib7	7553	18	m	m	NN
cord-005453-4057qib7	7553	19	2	2	CD
cord-005453-4057qib7	7554	1	+	+	CC
cord-005453-4057qib7	7555	1	Cy60mg	Cy60mg	NNP
cord-005453-4057qib7	7555	2	/	/	SYM
cord-005453-4057qib7	7555	3	Kg	Kg	NNP
cord-005453-4057qib7	7555	4	+	+	CC
cord-005453-4057qib7	7556	1	ATG5mg	ATG5mg	NNP
cord-005453-4057qib7	7556	2	/	/	SYM
cord-005453-4057qib7	7556	3	Kg	Kg	NNP
cord-005453-4057qib7	7556	4	(	(	-LRB-
cord-005453-4057qib7	7556	5	n=17	n=17	NNP
cord-005453-4057qib7	7556	6	)	)	-RRB-
cord-005453-4057qib7	7556	7	,	,	,
cord-005453-4057qib7	7556	8	and	and	CC
cord-005453-4057qib7	7556	9	Flu150mg	Flu150mg	NNP
cord-005453-4057qib7	7556	10	/	/	SYM
cord-005453-4057qib7	7556	11	m	m	NN
cord-005453-4057qib7	7556	12	2	2	CD
cord-005453-4057qib7	7557	1	+	+	CC
cord-005453-4057qib7	7557	2	Cy30	cy30	NN
cord-005453-4057qib7	7557	3	+	+	CC
cord-005453-4057qib7	7557	4	TBI200rads	TBI200rads	NNP
cord-005453-4057qib7	7557	5	(	(	-LRB-
cord-005453-4057qib7	7557	6	n=4	n=4	NNS
cord-005453-4057qib7	7557	7	,	,	,
cord-005453-4057qib7	7557	8	haplo	haplo	NNP
cord-005453-4057qib7	7557	9	)	)	-RRB-
cord-005453-4057qib7	7557	10	.	.	.
cord-005453-4057qib7	7558	1	Graft	graft	NN
cord-005453-4057qib7	7558	2	versus	versus	IN
cord-005453-4057qib7	7558	3	Host	Host	NNP
cord-005453-4057qib7	7558	4	Disease	Disease	NNP
cord-005453-4057qib7	7558	5	(	(	-LRB-
cord-005453-4057qib7	7558	6	GVHD	GVHD	NNP
cord-005453-4057qib7	7558	7	)	)	-RRB-
cord-005453-4057qib7	7558	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7558	9	consisted	consist	VBD
cord-005453-4057qib7	7558	10	of	of	IN
cord-005453-4057qib7	7558	11	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	7558	12	(	(	-LRB-
cord-005453-4057qib7	7558	13	CSA	CSA	NNP
cord-005453-4057qib7	7558	14	)	)	-RRB-
cord-005453-4057qib7	7558	15	and	and	CC
cord-005453-4057qib7	7558	16	methotrexate	methotrexate	NNP
cord-005453-4057qib7	7558	17	or	or	CC
cord-005453-4057qib7	7558	18	steroids	steroid	NNS
cord-005453-4057qib7	7558	19	(	(	-LRB-
cord-005453-4057qib7	7558	20	CBU	CBU	NNP
cord-005453-4057qib7	7558	21	)	)	-RRB-
cord-005453-4057qib7	7558	22	and	and	CC
cord-005453-4057qib7	7558	23	post	post	JJ
cord-005453-4057qib7	7558	24	-	-	JJ
cord-005453-4057qib7	7558	25	transplant	transplant	NN
cord-005453-4057qib7	7558	26	Cy	Cy	NNP
cord-005453-4057qib7	7558	27	+	+	CC
cord-005453-4057qib7	7558	28	CSA	CSA	NNP
cord-005453-4057qib7	7558	29	+	+	CC
cord-005453-4057qib7	7558	30	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	7558	31	mofetil	mofetil	NNP
cord-005453-4057qib7	7558	32	in	in	IN
cord-005453-4057qib7	7558	33	the	the	DT
cord-005453-4057qib7	7558	34	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7558	35	transplants	transplant	NNS
cord-005453-4057qib7	7558	36	.	.	.
cord-005453-4057qib7	7559	1	26	26	CD
cord-005453-4057qib7	7559	2	of	of	IN
cord-005453-4057qib7	7559	3	27	27	CD
cord-005453-4057qib7	7559	4	evaluable	evaluable	JJ
cord-005453-4057qib7	7559	5	pts	pt	NNS
cord-005453-4057qib7	7559	6	engrafted	engraft	VBN
cord-005453-4057qib7	7559	7	with	with	IN
cord-005453-4057qib7	7559	8	a	a	DT
cord-005453-4057qib7	7559	9	median	median	JJ
cord-005453-4057qib7	7559	10	time	time	NN
cord-005453-4057qib7	7559	11	to	to	IN
cord-005453-4057qib7	7559	12	neutrophil	neutrophil	NN
cord-005453-4057qib7	7559	13	recovery	recovery	NN
cord-005453-4057qib7	7559	14	of	of	IN
cord-005453-4057qib7	7559	15	20	20	CD
cord-005453-4057qib7	7559	16	days	day	NNS
cord-005453-4057qib7	7559	17	(	(	-LRB-
cord-005453-4057qib7	7559	18	range:13	range:13	NNS
cord-005453-4057qib7	7559	19	-	-	:
cord-005453-4057qib7	7559	20	36	36	CD
cord-005453-4057qib7	7559	21	days	day	NNS
cord-005453-4057qib7	7559	22	)	)	-RRB-
cord-005453-4057qib7	7559	23	.	.	.
cord-005453-4057qib7	7560	1	One	one	CD
cord-005453-4057qib7	7560	2	patient	patient	NN
cord-005453-4057qib7	7560	3	experienced	experience	VBD
cord-005453-4057qib7	7560	4	primary	primary	JJ
cord-005453-4057qib7	7560	5	graft	graft	NN
cord-005453-4057qib7	7560	6	failure	failure	NN
cord-005453-4057qib7	7560	7	(	(	-LRB-
cord-005453-4057qib7	7560	8	haplo	haplo	NNP
cord-005453-4057qib7	7560	9	)	)	-RRB-
cord-005453-4057qib7	7560	10	while	while	IN
cord-005453-4057qib7	7560	11	second	second	JJ
cord-005453-4057qib7	7560	12	graft	graft	NN
cord-005453-4057qib7	7560	13	failure	failure	NN
cord-005453-4057qib7	7560	14	occurred	occur	VBD
cord-005453-4057qib7	7560	15	in	in	IN
cord-005453-4057qib7	7560	16	other	other	JJ
cord-005453-4057qib7	7560	17	3pts	3pt	NNS
cord-005453-4057qib7	7560	18	.	.	.
cord-005453-4057qib7	7561	1	All	all	PDT
cord-005453-4057qib7	7561	2	these	these	DT
cord-005453-4057qib7	7561	3	4pts	4pt	NNS
cord-005453-4057qib7	7561	4	went	go	VBD
cord-005453-4057qib7	7561	5	a	a	DT
cord-005453-4057qib7	7561	6	second	second	JJ
cord-005453-4057qib7	7561	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7561	8	and	and	CC
cord-005453-4057qib7	7561	9	3	3	CD
cord-005453-4057qib7	7561	10	survived	survive	VBD
cord-005453-4057qib7	7561	11	.	.	.
cord-005453-4057qib7	7562	1	Acute	acute	JJ
cord-005453-4057qib7	7562	2	GVHD	GVHD	NNP
cord-005453-4057qib7	7562	3	grade	grade	NN
cord-005453-4057qib7	7562	4	II	II	NNP
cord-005453-4057qib7	7562	5	-	-	HYPH
cord-005453-4057qib7	7562	6	IV	IV	NNP
cord-005453-4057qib7	7562	7	occurred	occur	VBD
cord-005453-4057qib7	7562	8	in	in	IN
cord-005453-4057qib7	7562	9	6	6	CD
cord-005453-4057qib7	7562	10	of	of	IN
cord-005453-4057qib7	7562	11	26	26	CD
cord-005453-4057qib7	7562	12	pts	pt	NNS
cord-005453-4057qib7	7562	13	at	at	IN
cord-005453-4057qib7	7562	14	risk	risk	NN
cord-005453-4057qib7	7562	15	.	.	.
cord-005453-4057qib7	7563	1	Moderate	moderate	JJ
cord-005453-4057qib7	7563	2	to	to	IN
cord-005453-4057qib7	7563	3	severe	severe	JJ
cord-005453-4057qib7	7563	4	chronic	chronic	JJ
cord-005453-4057qib7	7563	5	GVHD	GVHD	NNP
cord-005453-4057qib7	7563	6	occurred	occur	VBD
cord-005453-4057qib7	7563	7	in	in	IN
cord-005453-4057qib7	7563	8	6	6	CD
cord-005453-4057qib7	7563	9	pts	pt	NNS
cord-005453-4057qib7	7563	10	with	with	IN
cord-005453-4057qib7	7563	11	5	5	CD
cord-005453-4057qib7	7563	12	cases	case	NNS
cord-005453-4057qib7	7563	13	occurring	occur	VBG
cord-005453-4057qib7	7563	14	in	in	IN
cord-005453-4057qib7	7563	15	pts	pts	NN
cord-005453-4057qib7	7563	16	who	who	WP
cord-005453-4057qib7	7563	17	had	have	VBD
cord-005453-4057qib7	7563	18	previously	previously	RB
cord-005453-4057qib7	7563	19	presented	present	VBN
cord-005453-4057qib7	7563	20	acute	acute	JJ
cord-005453-4057qib7	7563	21	GVHD	GVHD	NNP
cord-005453-4057qib7	7563	22	.	.	.
cord-005453-4057qib7	7564	1	Overall	overall	JJ
cord-005453-4057qib7	7564	2	survival	survival	NN
cord-005453-4057qib7	7564	3	(	(	-LRB-
cord-005453-4057qib7	7564	4	OS	OS	NNP
cord-005453-4057qib7	7564	5	)	)	-RRB-
cord-005453-4057qib7	7564	6	was	be	VBD
cord-005453-4057qib7	7564	7	53,6	53,6	CD
cord-005453-4057qib7	7564	8	%	%	NN
cord-005453-4057qib7	7564	9	at	at	IN
cord-005453-4057qib7	7564	10	a	a	DT
cord-005453-4057qib7	7564	11	median	median	JJ
cord-005453-4057qib7	7564	12	follow	follow	NN
cord-005453-4057qib7	7564	13	-	-	HYPH
cord-005453-4057qib7	7564	14	up	up	NN
cord-005453-4057qib7	7564	15	of	of	IN
cord-005453-4057qib7	7564	16	6y	6y	CD
cord-005453-4057qib7	7564	17	.	.	.
cord-005453-4057qib7	7565	1	The	the	DT
cord-005453-4057qib7	7565	2	5y	5y	NN
cord-005453-4057qib7	7565	3	OS	OS	NNP
cord-005453-4057qib7	7565	4	was	be	VBD
cord-005453-4057qib7	7565	5	slightly	slightly	RB
cord-005453-4057qib7	7565	6	better	well	JJR
cord-005453-4057qib7	7565	7	in	in	IN
cord-005453-4057qib7	7565	8	MSD	MSD	NNP
cord-005453-4057qib7	7565	9	transplants	transplant	NNS
cord-005453-4057qib7	7565	10	compared	compare	VBN
cord-005453-4057qib7	7565	11	to	to	IN
cord-005453-4057qib7	7565	12	the	the	DT
cord-005453-4057qib7	7565	13	others	other	NNS
cord-005453-4057qib7	7565	14	(	(	-LRB-
cord-005453-4057qib7	7565	15	54,5	54,5	CD
cord-005453-4057qib7	7565	16	%	%	NN
cord-005453-4057qib7	7566	1	x	x	VBP
cord-005453-4057qib7	7566	2	52,9	52,9	CD
cord-005453-4057qib7	7566	3	%	%	NN
cord-005453-4057qib7	7566	4	p=0,053	p=0,053	NN
cord-005453-4057qib7	7566	5	)	)	-RRB-
cord-005453-4057qib7	7566	6	.	.	.
cord-005453-4057qib7	7567	1	Causes	cause	NNS
cord-005453-4057qib7	7567	2	of	of	IN
cord-005453-4057qib7	7567	3	early	early	JJ
cord-005453-4057qib7	7567	4	death	death	NN
cord-005453-4057qib7	7567	5	include	include	VBP
cord-005453-4057qib7	7567	6	adenovirus	adenovirus	NN
cord-005453-4057qib7	7567	7	sepsis	sepsis	NN
cord-005453-4057qib7	7567	8	(	(	-LRB-
cord-005453-4057qib7	7567	9	n=1	n=1	NNS
cord-005453-4057qib7	7567	10	)	)	-RRB-
cord-005453-4057qib7	7567	11	,	,	,
cord-005453-4057qib7	7567	12	toxicity	toxicity	NN
cord-005453-4057qib7	7567	13	to	to	IN
cord-005453-4057qib7	7567	14	preparatory	preparatory	JJ
cord-005453-4057qib7	7567	15	regimen	regimen	NN
cord-005453-4057qib7	7567	16	and	and	CC
cord-005453-4057qib7	7567	17	sepsis	sepsis	NN
cord-005453-4057qib7	7567	18	(	(	-LRB-
cord-005453-4057qib7	7567	19	n=2	n=2	NNS
cord-005453-4057qib7	7567	20	)	)	-RRB-
cord-005453-4057qib7	7567	21	,	,	,
cord-005453-4057qib7	7567	22	primary	primary	JJ
cord-005453-4057qib7	7567	23	graft	graft	NN
cord-005453-4057qib7	7567	24	failure	failure	NN
cord-005453-4057qib7	7567	25	(	(	-LRB-
cord-005453-4057qib7	7567	26	n=1	n=1	FW
cord-005453-4057qib7	7567	27	)	)	-RRB-
cord-005453-4057qib7	7567	28	.	.	.
cord-005453-4057qib7	7568	1	13pts	13pts	NNP
cord-005453-4057qib7	7568	2	remain	remain	VBP
cord-005453-4057qib7	7568	3	alive	alive	JJ
cord-005453-4057qib7	7568	4	between	between	IN
cord-005453-4057qib7	7568	5	1	1	CD
cord-005453-4057qib7	7568	6	-	-	SYM
cord-005453-4057qib7	7568	7	16y	16y	CD
cord-005453-4057qib7	7568	8	after	after	IN
cord-005453-4057qib7	7568	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7568	10	with	with	IN
cord-005453-4057qib7	7568	11	a	a	DT
cord-005453-4057qib7	7568	12	median	median	JJ
cord-005453-4057qib7	7568	13	FU	FU	NNP
cord-005453-4057qib7	7568	14	of	of	IN
cord-005453-4057qib7	7568	15	8y	8y	CD
cord-005453-4057qib7	7568	16	.	.	.
cord-005453-4057qib7	7569	1	Among	among	IN
cord-005453-4057qib7	7569	2	them	-PRON-	PRP
cord-005453-4057qib7	7569	3	only	only	RB
cord-005453-4057qib7	7569	4	1pt	1pt	NNP
cord-005453-4057qib7	7569	5	has	have	VBZ
cord-005453-4057qib7	7569	6	developed	develop	VBN
cord-005453-4057qib7	7569	7	organ	organ	NN
cord-005453-4057qib7	7569	8	involvement	involvement	NN
cord-005453-4057qib7	7569	9	by	by	IN
cord-005453-4057qib7	7569	10	the	the	DT
cord-005453-4057qib7	7569	11	underlying	underlie	VBG
cord-005453-4057qib7	7569	12	disease	disease	NN
cord-005453-4057qib7	7569	13	:	:	:
cord-005453-4057qib7	7569	14	hepatopulmonary	hepatopulmonary	NNP
cord-005453-4057qib7	7569	15	syndrome	syndrome	NN
cord-005453-4057qib7	7569	16	(	(	-LRB-
cord-005453-4057qib7	7569	17	HPS	HPS	NNP
cord-005453-4057qib7	7569	18	)	)	-RRB-
cord-005453-4057qib7	7569	19	.	.	.
cord-005453-4057qib7	7570	1	7pts	7pts	NNP
cord-005453-4057qib7	7570	2	died	die	VBD
cord-005453-4057qib7	7570	3	due	due	JJ
cord-005453-4057qib7	7570	4	to	to	IN
cord-005453-4057qib7	7570	5	pulmonary	pulmonary	JJ
cord-005453-4057qib7	7570	6	fibrosis	fibrosis	NN
cord-005453-4057qib7	7570	7	(	(	-LRB-
cord-005453-4057qib7	7570	8	n=1	n=1	CD
cord-005453-4057qib7	7570	9	)	)	-RRB-
cord-005453-4057qib7	7570	10	,	,	,
cord-005453-4057qib7	7570	11	liver	liver	NN
cord-005453-4057qib7	7570	12	fibrosis(n=1	fibrosis(n=1	NNP
cord-005453-4057qib7	7570	13	)	)	-RRB-
cord-005453-4057qib7	7570	14	,	,	,
cord-005453-4057qib7	7570	15	GI	GI	NNP
cord-005453-4057qib7	7570	16	bleeding(n=1	bleeding(n=1	CD
cord-005453-4057qib7	7570	17	)	)	-RRB-
cord-005453-4057qib7	7570	18	,	,	,
cord-005453-4057qib7	7570	19	HPS	HPS	NNP
cord-005453-4057qib7	7570	20	(	(	-LRB-
cord-005453-4057qib7	7570	21	n=2	n=2	NNS
cord-005453-4057qib7	7570	22	)	)	-RRB-
cord-005453-4057qib7	7570	23	;	;	:
cord-005453-4057qib7	7570	24	cGVHD	cGVHD	NNP
cord-005453-4057qib7	7570	25	and	and	CC
cord-005453-4057qib7	7570	26	sepsis(n=1	sepsis(n=1	ADD
cord-005453-4057qib7	7570	27	)	)	-RRB-
cord-005453-4057qib7	7570	28	,	,	,
cord-005453-4057qib7	7570	29	infection	infection	NN
cord-005453-4057qib7	7570	30	(	(	-LRB-
cord-005453-4057qib7	7570	31	n=1	n=1	CD
cord-005453-4057qib7	7570	32	)	)	-RRB-
cord-005453-4057qib7	7570	33	,	,	,
cord-005453-4057qib7	7570	34	and	and	CC
cord-005453-4057qib7	7570	35	2pts	2pts	CD
cord-005453-4057qib7	7570	36	were	be	VBD
cord-005453-4057qib7	7570	37	lost	lose	VBN
cord-005453-4057qib7	7570	38	to	to	IN
cord-005453-4057qib7	7570	39	FU	FU	NNP
cord-005453-4057qib7	7570	40	.	.	.
cord-005453-4057qib7	7571	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7571	2	:	:	:
cord-005453-4057qib7	7572	1	Early	early	JJ
cord-005453-4057qib7	7572	2	mortality	mortality	NN
cord-005453-4057qib7	7572	3	from	from	IN
cord-005453-4057qib7	7572	4	BMF	BMF	NNP
cord-005453-4057qib7	7572	5	can	can	MD
cord-005453-4057qib7	7572	6	be	be	VB
cord-005453-4057qib7	7572	7	reduced	reduce	VBN
cord-005453-4057qib7	7572	8	by	by	IN
cord-005453-4057qib7	7572	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7572	10	,	,	,
cord-005453-4057qib7	7572	11	but	but	CC
cord-005453-4057qib7	7572	12	late	late	JJ
cord-005453-4057qib7	7572	13	outcomes	outcome	NNS
cord-005453-4057qib7	7572	14	remain	remain	VBP
cord-005453-4057qib7	7572	15	a	a	DT
cord-005453-4057qib7	7572	16	consequence	consequence	NN
cord-005453-4057qib7	7572	17	of	of	IN
cord-005453-4057qib7	7572	18	the	the	DT
cord-005453-4057qib7	7572	19	underlying	underlie	VBG
cord-005453-4057qib7	7572	20	disease	disease	NN
cord-005453-4057qib7	7572	21	.	.	.
cord-005453-4057qib7	7573	1	Long	long	JJ
cord-005453-4057qib7	7573	2	term	term	NN
cord-005453-4057qib7	7573	3	FU	FU	NNP
cord-005453-4057qib7	7573	4	is	be	VBZ
cord-005453-4057qib7	7573	5	essential	essential	JJ
cord-005453-4057qib7	7573	6	in	in	IN
cord-005453-4057qib7	7573	7	order	order	NN
cord-005453-4057qib7	7573	8	to	to	TO
cord-005453-4057qib7	7573	9	detect	detect	VB
cord-005453-4057qib7	7573	10	late	late	JJ
cord-005453-4057qib7	7573	11	complications	complication	NNS
cord-005453-4057qib7	7573	12	related	relate	VBN
cord-005453-4057qib7	7573	13	to	to	IN
cord-005453-4057qib7	7573	14	the	the	DT
cord-005453-4057qib7	7573	15	HSCT	HSCT	NNP
cord-005453-4057qib7	7573	16	procedure	procedure	NN
cord-005453-4057qib7	7573	17	or	or	CC
cord-005453-4057qib7	7573	18	the	the	DT
cord-005453-4057qib7	7573	19	underlying	underlie	VBG
cord-005453-4057qib7	7573	20	disease	disease	NN
cord-005453-4057qib7	7573	21	.	.	.
cord-005453-4057qib7	7574	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7574	2	:	:	:
cord-005453-4057qib7	7574	3	Nothing	nothing	NN
cord-005453-4057qib7	7574	4	to	to	TO
cord-005453-4057qib7	7574	5	declare	declare	VB
cord-005453-4057qib7	7574	6	Single	single	JJ
cord-005453-4057qib7	7574	7	intra	intra	JJ
cord-005453-4057qib7	7574	8	-	-	JJ
cord-005453-4057qib7	7574	9	bone	bone	JJ
cord-005453-4057qib7	7574	10	cord	cord	NN
cord-005453-4057qib7	7574	11	-	-	HYPH
cord-005453-4057qib7	7574	12	blood	blood	NN
cord-005453-4057qib7	7574	13	transplantation	transplantation	NN
cord-005453-4057qib7	7574	14	with	with	IN
cord-005453-4057qib7	7574	15	a	a	DT
cord-005453-4057qib7	7574	16	treosulfan	treosulfan	NN
cord-005453-4057qib7	7574	17	-	-	HYPH
cord-005453-4057qib7	7574	18	based	base	VBN
cord-005453-4057qib7	7574	19	regimen	regimen	NN
cord-005453-4057qib7	7574	20	,	,	,
cord-005453-4057qib7	7574	21	ATG	ATG	NNP
cord-005453-4057qib7	7574	22	-	-	HYPH
cord-005453-4057qib7	7574	23	free	free	JJ
cord-005453-4057qib7	7574	24	and	and	CC
cord-005453-4057qib7	7574	25	sirolimusbased	sirolimusbase	VBD
cord-005453-4057qib7	7574	26	gvhd	gvhd	NNP
cord-005453-4057qib7	7574	27	prophylaxis	prophylaxis	NNP
cord-005453-4057qib7	7574	28	:	:	:
cord-005453-4057qib7	7574	29	fast	fast	JJ
cord-005453-4057qib7	7574	30	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7574	31	engraftment	engraftment	NN
cord-005453-4057qib7	7574	32	and	and	CC
cord-005453-4057qib7	7574	33	immune	immune	JJ
cord-005453-4057qib7	7574	34	-	-	HYPH
cord-005453-4057qib7	7574	35	reconstitution	reconstitution	NN
cord-005453-4057qib7	7574	36	in	in	IN
cord-005453-4057qib7	7574	37	20	20	CD
cord-005453-4057qib7	7574	38	patients	patient	NNS
cord-005453-4057qib7	7575	1	Background	background	NN
cord-005453-4057qib7	7575	2	:	:	:
cord-005453-4057qib7	7576	1	Cord	cord	NN
cord-005453-4057qib7	7576	2	Blood	blood	NN
cord-005453-4057qib7	7576	3	Transplants	transplant	NNS
cord-005453-4057qib7	7576	4	(	(	-LRB-
cord-005453-4057qib7	7576	5	CBT	CBT	NNP
cord-005453-4057qib7	7576	6	)	)	-RRB-
cord-005453-4057qib7	7576	7	require	require	VBP
cord-005453-4057qib7	7576	8	less	less	RBR
cord-005453-4057qib7	7576	9	stringent	stringent	JJ
cord-005453-4057qib7	7576	10	HLA	HLA	NNP
cord-005453-4057qib7	7576	11	-	-	HYPH
cord-005453-4057qib7	7576	12	matching	matching	NN
cord-005453-4057qib7	7576	13	,	,	,
cord-005453-4057qib7	7576	14	compared	compare	VBN
cord-005453-4057qib7	7576	15	to	to	IN
cord-005453-4057qib7	7576	16	peripheral	peripheral	JJ
cord-005453-4057qib7	7576	17	blood	blood	NN
cord-005453-4057qib7	7576	18	stem	stem	NN
cord-005453-4057qib7	7576	19	cell	cell	NN
cord-005453-4057qib7	7576	20	or	or	CC
cord-005453-4057qib7	7576	21	bone	bone	NN
cord-005453-4057qib7	7576	22	marrow	marrow	NN
cord-005453-4057qib7	7576	23	.	.	.
cord-005453-4057qib7	7577	1	However	however	RB
cord-005453-4057qib7	7577	2	,	,	,
cord-005453-4057qib7	7577	3	CBT	CBT	NNP
cord-005453-4057qib7	7577	4	has	have	VBZ
cord-005453-4057qib7	7577	5	been	be	VBN
cord-005453-4057qib7	7577	6	associated	associate	VBN
cord-005453-4057qib7	7577	7	with	with	IN
cord-005453-4057qib7	7577	8	delayed	delay	VBN
cord-005453-4057qib7	7577	9	engraftment	engraftment	NN
cord-005453-4057qib7	7577	10	and	and	CC
cord-005453-4057qib7	7577	11	immune	immune	JJ
cord-005453-4057qib7	7577	12	reconstitution	reconstitution	NN
cord-005453-4057qib7	7577	13	,	,	,
cord-005453-4057qib7	7577	14	especially	especially	RB
cord-005453-4057qib7	7577	15	if	if	IN
cord-005453-4057qib7	7577	16	in	in	IN
cord-005453-4057qib7	7577	17	vivo	vivo	NNP
cord-005453-4057qib7	7577	18	T	t	NN
cord-005453-4057qib7	7577	19	-	-	HYPH
cord-005453-4057qib7	7577	20	cell	cell	NN
cord-005453-4057qib7	7577	21	depletion	depletion	NN
cord-005453-4057qib7	7577	22	,	,	,
cord-005453-4057qib7	7577	23	such	such	JJ
cord-005453-4057qib7	7577	24	as	as	IN
cord-005453-4057qib7	7577	25	antithymoglobulin	antithymoglobulin	NNP
cord-005453-4057qib7	7577	26	(	(	-LRB-
cord-005453-4057qib7	7577	27	ATG	ATG	NNP
cord-005453-4057qib7	7577	28	)	)	-RRB-
cord-005453-4057qib7	7577	29	,	,	,
cord-005453-4057qib7	7577	30	is	be	VBZ
cord-005453-4057qib7	7577	31	used	use	VBN
cord-005453-4057qib7	7577	32	.	.	.
cord-005453-4057qib7	7578	1	Methods	method	NNS
cord-005453-4057qib7	7578	2	:	:	:
cord-005453-4057qib7	7579	1	From	from	IN
cord-005453-4057qib7	7579	2	2010	2010	CD
cord-005453-4057qib7	7579	3	to	to	IN
cord-005453-4057qib7	7579	4	2018	2018	CD
cord-005453-4057qib7	7579	5	,	,	,
cord-005453-4057qib7	7579	6	20	20	CD
cord-005453-4057qib7	7579	7	patients	patient	NNS
cord-005453-4057qib7	7579	8	with	with	IN
cord-005453-4057qib7	7579	9	high	high	JJ
cord-005453-4057qib7	7579	10	-	-	HYPH
cord-005453-4057qib7	7579	11	risk	risk	NN
cord-005453-4057qib7	7579	12	diseases	disease	NNS
cord-005453-4057qib7	7579	13	received	receive	VBD
cord-005453-4057qib7	7579	14	intra	intra	JJ
cord-005453-4057qib7	7579	15	-	-	JJ
cord-005453-4057qib7	7579	16	bone	bone	JJ
cord-005453-4057qib7	7579	17	infusion	infusion	NN
cord-005453-4057qib7	7579	18	of	of	IN
cord-005453-4057qib7	7579	19	unwashed	unwashed	JJ
cord-005453-4057qib7	7579	20	single	single	JJ
cord-005453-4057qib7	7579	21	CB	CB	NNP
cord-005453-4057qib7	7579	22	unit	unit	NN
cord-005453-4057qib7	7579	23	with	with	IN
cord-005453-4057qib7	7579	24	an	an	DT
cord-005453-4057qib7	7579	25	ATG	ATG	NNP
cord-005453-4057qib7	7579	26	-	-	HYPH
cord-005453-4057qib7	7579	27	free	free	JJ
cord-005453-4057qib7	7579	28	GvHD	GvHD	NNP
cord-005453-4057qib7	7579	29	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7579	30	;	;	:
cord-005453-4057qib7	7579	31	7	7	CD
cord-005453-4057qib7	7579	32	were	be	VBD
cord-005453-4057qib7	7579	33	in	in	IN
cord-005453-4057qib7	7579	34	active	active	JJ
cord-005453-4057qib7	7579	35	disease	disease	NN
cord-005453-4057qib7	7579	36	at	at	IN
cord-005453-4057qib7	7579	37	CBT	CBT	NNP
cord-005453-4057qib7	7579	38	and	and	CC
cord-005453-4057qib7	7579	39	8	8	CD
cord-005453-4057qib7	7579	40	had	have	VBD
cord-005453-4057qib7	7579	41	received	receive	VBN
cord-005453-4057qib7	7579	42	prior	prior	JJ
cord-005453-4057qib7	7579	43	allogeneic	allogeneic	NN
cord-005453-4057qib7	7579	44	stem	stem	NN
cord-005453-4057qib7	7579	45	cell	cell	NN
cord-005453-4057qib7	7579	46	transplantation	transplantation	NN
cord-005453-4057qib7	7579	47	.	.	.
cord-005453-4057qib7	7580	1	Median	median	JJ
cord-005453-4057qib7	7580	2	age	age	NN
cord-005453-4057qib7	7580	3	was	be	VBD
cord-005453-4057qib7	7580	4	44	44	CD
cord-005453-4057qib7	7580	5	y	y	NN
cord-005453-4057qib7	7580	6	[	[	-LRB-
cord-005453-4057qib7	7580	7	range	range	NN
cord-005453-4057qib7	7580	8	(	(	-LRB-
cord-005453-4057qib7	7580	9	r	r	NN
cord-005453-4057qib7	7580	10	)	)	-RRB-
cord-005453-4057qib7	7580	11	.	.	.
cord-005453-4057qib7	7581	1	Conditioning	conditioning	NN
cord-005453-4057qib7	7581	2	regimen	regimen	NN
cord-005453-4057qib7	7581	3	was	be	VBD
cord-005453-4057qib7	7581	4	myeloablative	myeloablative	JJ
cord-005453-4057qib7	7581	5	,	,	,
cord-005453-4057qib7	7581	6	with	with	IN
cord-005453-4057qib7	7581	7	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	7581	8	and	and	CC
cord-005453-4057qib7	7581	9	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	7581	10	in	in	IN
cord-005453-4057qib7	7581	11	all	all	DT
cord-005453-4057qib7	7581	12	,	,	,
cord-005453-4057qib7	7581	13	intensified	intensify	VBN
cord-005453-4057qib7	7581	14	with	with	IN
cord-005453-4057qib7	7581	15	Melphalan	Melphalan	NNP
cord-005453-4057qib7	7581	16	in	in	IN
cord-005453-4057qib7	7581	17	15	15	CD
cord-005453-4057qib7	7581	18	or	or	CC
cord-005453-4057qib7	7581	19	with	with	IN
cord-005453-4057qib7	7581	20	4Gy	4gy	JJ
cord-005453-4057qib7	7581	21	TBI	TBI	NNP
cord-005453-4057qib7	7581	22	in	in	IN
cord-005453-4057qib7	7581	23	4	4	CD
cord-005453-4057qib7	7581	24	.	.	.
cord-005453-4057qib7	7582	1	HLA	HLA	NNP
cord-005453-4057qib7	7582	2	matches	match	NNS
cord-005453-4057qib7	7582	3	was	be	VBD
cord-005453-4057qib7	7582	4	4/6	4/6	CD
cord-005453-4057qib7	7582	5	,	,	,
cord-005453-4057qib7	7582	6	5/6	5/6	CD
cord-005453-4057qib7	7582	7	,	,	,
cord-005453-4057qib7	7582	8	6/6	6/6	CD
cord-005453-4057qib7	7582	9	in	in	IN
cord-005453-4057qib7	7582	10	12	12	CD
cord-005453-4057qib7	7582	11	,	,	,
cord-005453-4057qib7	7582	12	5	5	CD
cord-005453-4057qib7	7582	13	and	and	CC
cord-005453-4057qib7	7582	14	3	3	CD
cord-005453-4057qib7	7582	15	cases	case	NNS
cord-005453-4057qib7	7582	16	,	,	,
cord-005453-4057qib7	7582	17	respectively	respectively	RB
cord-005453-4057qib7	7582	18	.	.	.
cord-005453-4057qib7	7583	1	GvHD	GvHD	NNP
cord-005453-4057qib7	7583	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7583	3	included	include	VBD
cord-005453-4057qib7	7583	4	Sirolimus	Sirolimus	NNP
cord-005453-4057qib7	7583	5	and	and	CC
cord-005453-4057qib7	7583	6	Mycophenolic	Mycophenolic	NNP
cord-005453-4057qib7	7583	7	acid	acid	NN
cord-005453-4057qib7	7583	8	(	(	-LRB-
cord-005453-4057qib7	7583	9	MMF	MMF	NNP
cord-005453-4057qib7	7583	10	)	)	-RRB-
cord-005453-4057qib7	7583	11	.	.	.
cord-005453-4057qib7	7584	1	Results	result	NNS
cord-005453-4057qib7	7584	2	:	:	:
cord-005453-4057qib7	7585	1	After	after	IN
cord-005453-4057qib7	7585	2	thawing	thawing	NN
cord-005453-4057qib7	7585	3	,	,	,
cord-005453-4057qib7	7585	4	median	median	JJ
cord-005453-4057qib7	7585	5	CD45	CD45	NNP
cord-005453-4057qib7	7585	6	+	+	CC
cord-005453-4057qib7	7585	7	cells	cell	NNS
cord-005453-4057qib7	7585	8	was	be	VBD
cord-005453-4057qib7	7585	9	1.39	1.39	CD
cord-005453-4057qib7	7585	10	x	x	SYM
cord-005453-4057qib7	7585	11	10	10	CD
cord-005453-4057qib7	7585	12	7	7	CD
cord-005453-4057qib7	7586	1	/kg	/kg	.
cord-005453-4057qib7	7587	1	[	[	-LRB-
cord-005453-4057qib7	7587	2	r	r	NN
cord-005453-4057qib7	7587	3	0.69	0.69	CD
cord-005453-4057qib7	7587	4	-	-	SYM
cord-005453-4057qib7	7587	5	5.9	5.9	CD
cord-005453-4057qib7	7587	6	]	]	-RRB-
cord-005453-4057qib7	7587	7	,	,	,
cord-005453-4057qib7	7587	8	median	median	JJ
cord-005453-4057qib7	7587	9	CD34	CD34	NNP
cord-005453-4057qib7	7587	10	+	+	CC
cord-005453-4057qib7	7587	11	cells	cell	NNS
cord-005453-4057qib7	7587	12	0.08	0.08	CD
cord-005453-4057qib7	7587	13	x	x	SYM
cord-005453-4057qib7	7587	14	10	10	CD
cord-005453-4057qib7	7587	15	6	6	CD
cord-005453-4057qib7	7588	1	/kg	/kg	.
cord-005453-4057qib7	7589	1	[	[	-LRB-
cord-005453-4057qib7	7589	2	r	r	NN
cord-005453-4057qib7	7589	3	0.04	0.04	CD
cord-005453-4057qib7	7589	4	-	-	SYM
cord-005453-4057qib7	7589	5	0.23	0.23	CD
cord-005453-4057qib7	7589	6	]	]	-RRB-
cord-005453-4057qib7	7589	7	,	,	,
cord-005453-4057qib7	7589	8	and	and	CC
cord-005453-4057qib7	7589	9	median	median	NN
cord-005453-4057qib7	7589	10	CD3	cd3	NN
cord-005453-4057qib7	7590	1	+	+	CC
cord-005453-4057qib7	7590	2	cells	cell	NNS
cord-005453-4057qib7	7590	3	3.05	3.05	CD
cord-005453-4057qib7	7590	4	x	x	SYM
cord-005453-4057qib7	7590	5	10	10	CD
cord-005453-4057qib7	7590	6	6	6	CD
cord-005453-4057qib7	7591	1	/kg	/kg	.
cord-005453-4057qib7	7592	1	[	[	-LRB-
cord-005453-4057qib7	7592	2	r	r	NN
cord-005453-4057qib7	7592	3	1.29	1.29	CD
cord-005453-4057qib7	7592	4	-	-	SYM
cord-005453-4057qib7	7592	5	5.9	5.9	CD
cord-005453-4057qib7	7592	6	]	]	-RRB-
cord-005453-4057qib7	7592	7	.	.	.
cord-005453-4057qib7	7593	1	Of	of	IN
cord-005453-4057qib7	7593	2	the	the	DT
cord-005453-4057qib7	7593	3	16	16	CD
cord-005453-4057qib7	7593	4	evaluable	evaluable	JJ
cord-005453-4057qib7	7593	5	patients	patient	NNS
cord-005453-4057qib7	7593	6	all	all	DT
cord-005453-4057qib7	7593	7	engrafted	engraft	VBD
cord-005453-4057qib7	7593	8	with	with	IN
cord-005453-4057qib7	7593	9	a	a	DT
cord-005453-4057qib7	7593	10	sustained	sustained	JJ
cord-005453-4057qib7	7593	11	full	full	JJ
cord-005453-4057qib7	7593	12	donor	donor	NN
cord-005453-4057qib7	7593	13	chimerism	chimerism	NN
cord-005453-4057qib7	7593	14	at	at	IN
cord-005453-4057qib7	7593	15	day	day	NN
cord-005453-4057qib7	7593	16	100	100	CD
cord-005453-4057qib7	7593	17	.	.	.
cord-005453-4057qib7	7594	1	Median	median	JJ
cord-005453-4057qib7	7594	2	time	time	NN
cord-005453-4057qib7	7594	3	to	to	IN
cord-005453-4057qib7	7594	4	neutrophils	neutrophil	NNS
cord-005453-4057qib7	7594	5	(	(	-LRB-
cord-005453-4057qib7	7594	6	16/16	16/16	CD
cord-005453-4057qib7	7594	7	,	,	,
cord-005453-4057qib7	7594	8	ANC	ANC	NNP
cord-005453-4057qib7	7594	9	>	>	XX
cord-005453-4057qib7	7595	1	500	500	CD
cord-005453-4057qib7	7595	2	/	/	SYM
cord-005453-4057qib7	7595	3	μL	μL	.
cord-005453-4057qib7	7596	1	for	for	IN
cord-005453-4057qib7	7596	2	3	3	CD
cord-005453-4057qib7	7596	3	consecutive	consecutive	JJ
cord-005453-4057qib7	7596	4	days	day	NNS
cord-005453-4057qib7	7596	5	)	)	-RRB-
cord-005453-4057qib7	7596	6	and	and	CC
cord-005453-4057qib7	7596	7	platelet	platelet	NN
cord-005453-4057qib7	7596	8	engraftment	engraftment	NN
cord-005453-4057qib7	7596	9	(	(	-LRB-
cord-005453-4057qib7	7596	10	14/	14/	CD
cord-005453-4057qib7	7596	11	Immune	immune	NN
cord-005453-4057qib7	7596	12	-	-	HYPH
cord-005453-4057qib7	7596	13	reconstitution	reconstitution	NN
cord-005453-4057qib7	7596	14	of	of	IN
cord-005453-4057qib7	7596	15	CBT	CBT	NNP
cord-005453-4057qib7	7596	16	patients	patient	NNS
cord-005453-4057qib7	7596	17	(	(	-LRB-
cord-005453-4057qib7	7596	18	Tables	table	NNS
cord-005453-4057qib7	7596	19	1a	1a	NNP
cord-005453-4057qib7	7596	20	-	-	HYPH
cord-005453-4057qib7	7596	21	b	b	LS
cord-005453-4057qib7	7596	22	)	)	-RRB-
cord-005453-4057qib7	7596	23	was	be	VBD
cord-005453-4057qib7	7596	24	compared	compare	VBN
cord-005453-4057qib7	7596	25	with	with	IN
cord-005453-4057qib7	7596	26	two	two	CD
cord-005453-4057qib7	7596	27	cohorts	cohort	NNS
cord-005453-4057qib7	7596	28	of	of	IN
cord-005453-4057qib7	7596	29	patients	patient	NNS
cord-005453-4057qib7	7596	30	transplanted	transplant	VBN
cord-005453-4057qib7	7596	31	at	at	IN
cord-005453-4057qib7	7596	32	our	-PRON-	PRP$
cord-005453-4057qib7	7596	33	Center	Center	NNP
cord-005453-4057qib7	7596	34	from	from	IN
cord-005453-4057qib7	7596	35	any	any	DT
cord-005453-4057qib7	7596	36	adult	adult	NN
cord-005453-4057qib7	7596	37	donor	donor	NN
cord-005453-4057qib7	7596	38	with	with	IN
cord-005453-4057qib7	7596	39	(	(	-LRB-
cord-005453-4057qib7	7596	40	81	81	CD
cord-005453-4057qib7	7596	41	)	)	-RRB-
cord-005453-4057qib7	7596	42	or	or	CC
cord-005453-4057qib7	7596	43	without	without	IN
cord-005453-4057qib7	7596	44	(	(	-LRB-
cord-005453-4057qib7	7596	45	126	126	CD
cord-005453-4057qib7	7596	46	patients	patient	NNS
cord-005453-4057qib7	7596	47	,	,	,
cord-005453-4057qib7	7596	48	including	include	VBG
cord-005453-4057qib7	7596	49	post	post	JJ
cord-005453-4057qib7	7596	50	-	-	JJ
cord-005453-4057qib7	7596	51	transplant	transplant	NN
cord-005453-4057qib7	7596	52	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7596	53	cohort	cohort	NN
cord-005453-4057qib7	7596	54	)	)	-RRB-
cord-005453-4057qib7	7596	55	ATG	ATG	NNP
cord-005453-4057qib7	7596	56	in	in	IN
cord-005453-4057qib7	7596	57	association	association	NN
cord-005453-4057qib7	7596	58	with	with	IN
cord-005453-4057qib7	7596	59	Sirolimus	Sirolimus	NNP
cord-005453-4057qib7	7596	60	and	and	CC
cord-005453-4057qib7	7596	61	MMF	MMF	NNP
cord-005453-4057qib7	7596	62	.	.	.
cord-005453-4057qib7	7597	1	Profiles	profile	NNS
cord-005453-4057qib7	7597	2	of	of	IN
cord-005453-4057qib7	7597	3	immune	immune	JJ
cord-005453-4057qib7	7597	4	-	-	HYPH
cord-005453-4057qib7	7597	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	7597	6	at	at	IN
cord-005453-4057qib7	7597	7	day	day	NN
cord-005453-4057qib7	7597	8	90	90	CD
cord-005453-4057qib7	7598	1	-180	-180	NNP
cord-005453-4057qib7	7599	1	-365	-365	NNP
cord-005453-4057qib7	7599	2	showed	show	VBD
cord-005453-4057qib7	7599	3	a	a	DT
cord-005453-4057qib7	7599	4	better	well	JJR
cord-005453-4057qib7	7599	5	CD4	CD4	NNP
cord-005453-4057qib7	7599	6	+	+	CC
cord-005453-4057qib7	7599	7	recovery	recovery	NN
cord-005453-4057qib7	7599	8	at	at	IN
cord-005453-4057qib7	7599	9	any	any	DT
cord-005453-4057qib7	7599	10	time	time	NN
cord-005453-4057qib7	7599	11	-	-	HYPH
cord-005453-4057qib7	7599	12	point	point	NN
cord-005453-4057qib7	7599	13	in	in	IN
cord-005453-4057qib7	7599	14	both	both	CC
cord-005453-4057qib7	7599	15	CBT	CBT	NNP
cord-005453-4057qib7	7599	16	and	and	CC
cord-005453-4057qib7	7599	17	no	no	DT
cord-005453-4057qib7	7599	18	-	-	HYPH
cord-005453-4057qib7	7599	19	ATG	ATG	NNP
cord-005453-4057qib7	7599	20	versus	versus	IN
cord-005453-4057qib7	7599	21	ATG	ATG	NNP
cord-005453-4057qib7	7599	22	cohort	cohort	NN
cord-005453-4057qib7	7599	23	,	,	,
cord-005453-4057qib7	7599	24	with	with	IN
cord-005453-4057qib7	7599	25	no	no	DT
cord-005453-4057qib7	7599	26	statistic	statistic	JJ
cord-005453-4057qib7	7599	27	significant	significant	JJ
cord-005453-4057qib7	7599	28	difference	difference	NN
cord-005453-4057qib7	7599	29	in	in	IN
cord-005453-4057qib7	7599	30	the	the	DT
cord-005453-4057qib7	7599	31	first	first	JJ
cord-005453-4057qib7	7599	32	2	2	CD
cord-005453-4057qib7	7599	33	cohorts	cohort	NNS
cord-005453-4057qib7	7599	34	.	.	.
cord-005453-4057qib7	7600	1	Moreover	moreover	RB
cord-005453-4057qib7	7600	2	,	,	,
cord-005453-4057qib7	7600	3	CD4	CD4	NNP
cord-005453-4057qib7	7600	4	+	+	CC
cord-005453-4057qib7	7600	5	/CD8	/CD8	,
cord-005453-4057qib7	7600	6	+	+	CC
cord-005453-4057qib7	7600	7	ratio	ratio	NN
cord-005453-4057qib7	7600	8	at	at	IN
cord-005453-4057qib7	7600	9	any	any	DT
cord-005453-4057qib7	7600	10	time	time	NN
cord-005453-4057qib7	7600	11	point	point	NN
cord-005453-4057qib7	7600	12	was	be	VBD
cord-005453-4057qib7	7600	13	better	well	JJR
cord-005453-4057qib7	7600	14	in	in	IN
cord-005453-4057qib7	7600	15	the	the	DT
cord-005453-4057qib7	7600	16	CBT	CBT	NNP
cord-005453-4057qib7	7600	17	cohort	cohort	NN
cord-005453-4057qib7	7600	18	vs	vs	IN
cord-005453-4057qib7	7600	19	the	the	DT
cord-005453-4057qib7	7600	20	no	no	DT
cord-005453-4057qib7	7600	21	-	-	HYPH
cord-005453-4057qib7	7600	22	ATG	ATG	NNP
cord-005453-4057qib7	7600	23	cohort	cohort	NN
cord-005453-4057qib7	7600	24	.	.	.
cord-005453-4057qib7	7601	1	B	b	NN
cord-005453-4057qib7	7601	2	cell	cell	NN
cord-005453-4057qib7	7601	3	recovery	recovery	NN
cord-005453-4057qib7	7601	4	was	be	VBD
cord-005453-4057qib7	7601	5	faster	fast	JJR
cord-005453-4057qib7	7601	6	in	in	IN
cord-005453-4057qib7	7601	7	the	the	DT
cord-005453-4057qib7	7601	8	CBT	CBT	NNP
cord-005453-4057qib7	7601	9	cohort	cohort	NN
cord-005453-4057qib7	7601	10	;	;	:
cord-005453-4057qib7	7601	11	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	7601	12	recovery	recovery	NN
cord-005453-4057qib7	7601	13	was	be	VBD
cord-005453-4057qib7	7601	14	superimposable	superimposable	JJ
cord-005453-4057qib7	7601	15	across	across	IN
cord-005453-4057qib7	7601	16	different	different	JJ
cord-005453-4057qib7	7601	17	platforms	platform	NNS
cord-005453-4057qib7	7601	18	.	.	.
cord-005453-4057qib7	7602	1	Focusing	focus	VBG
cord-005453-4057qib7	7602	2	on	on	IN
cord-005453-4057qib7	7602	3	late	late	JJ
cord-005453-4057qib7	7602	4	events	event	NNS
cord-005453-4057qib7	7602	5	(	(	-LRB-
cord-005453-4057qib7	7602	6	>	>	NFP
cord-005453-4057qib7	7602	7	180	180	CD
cord-005453-4057qib7	7602	8	days	day	NNS
cord-005453-4057qib7	7602	9	from	from	IN
cord-005453-4057qib7	7602	10	CBT	CBT	NNP
cord-005453-4057qib7	7602	11	)	)	-RRB-
cord-005453-4057qib7	7602	12	,	,	,
cord-005453-4057qib7	7602	13	3/12	3/12	CD
cord-005453-4057qib7	7602	14	pts	pts	NN
cord-005453-4057qib7	7602	15	experienced	experience	VBN
cord-005453-4057qib7	7602	16	EBV	EBV	NNP
cord-005453-4057qib7	7602	17	reactivation	reactivation	NN
cord-005453-4057qib7	7602	18	,	,	,
cord-005453-4057qib7	7602	19	median	median	JJ
cord-005453-4057qib7	7602	20	time	time	NN
cord-005453-4057qib7	7602	21	586	586	CD
cord-005453-4057qib7	7602	22	days	day	NNS
cord-005453-4057qib7	7602	23	[	[	-LRB-
cord-005453-4057qib7	7602	24	362	362	CD
cord-005453-4057qib7	7602	25	-	-	SYM
cord-005453-4057qib7	7602	26	655	655	CD
cord-005453-4057qib7	7602	27	]	]	-RRB-
cord-005453-4057qib7	7602	28	treated	treat	VBN
cord-005453-4057qib7	7602	29	with	with	IN
cord-005453-4057qib7	7602	30	rituximab	rituximab	NN
cord-005453-4057qib7	7602	31	,	,	,
cord-005453-4057qib7	7602	32	and	and	CC
cord-005453-4057qib7	7602	33	1	1	CD
cord-005453-4057qib7	7602	34	experienced	experience	VBD
cord-005453-4057qib7	7602	35	late	late	JJ
cord-005453-4057qib7	7602	36	HHV6	HHV6	NNP
cord-005453-4057qib7	7602	37	and	and	CC
cord-005453-4057qib7	7602	38	CMV	CMV	NNP
cord-005453-4057qib7	7602	39	reactivation	reactivation	NN
cord-005453-4057qib7	7602	40	,	,	,
cord-005453-4057qib7	7602	41	both	both	DT
cord-005453-4057qib7	7602	42	solved	solve	VBD
cord-005453-4057qib7	7602	43	at	at	IN
cord-005453-4057qib7	7602	44	last	last	JJ
cord-005453-4057qib7	7602	45	visit	visit	NN
cord-005453-4057qib7	7602	46	.	.	.
cord-005453-4057qib7	7603	1	Sirolimus	Sirolimus	NNP
cord-005453-4057qib7	7603	2	was	be	VBD
cord-005453-4057qib7	7603	3	withdrawn	withdraw	VBN
cord-005453-4057qib7	7603	4	after	after	IN
cord-005453-4057qib7	7603	5	a	a	DT
cord-005453-4057qib7	7603	6	median	median	NN
cord-005453-4057qib7	7603	7	of	of	IN
cord-005453-4057qib7	7603	8	188	188	CD
cord-005453-4057qib7	7603	9	days	day	NNS
cord-005453-4057qib7	7604	1	[	[	-LRB-
cord-005453-4057qib7	7604	2	r	r	NNP
cord-005453-4057qib7	7604	3	64	64	CD
cord-005453-4057qib7	7604	4	-	-	SYM
cord-005453-4057qib7	7604	5	394	394	CD
cord-005453-4057qib7	7604	6	]	]	-RRB-
cord-005453-4057qib7	7604	7	.	.	.
cord-005453-4057qib7	7605	1	Only	only	RB
cord-005453-4057qib7	7605	2	1	1	CD
cord-005453-4057qib7	7605	3	patient	patient	NN
cord-005453-4057qib7	7605	4	developed	develop	VBD
cord-005453-4057qib7	7605	5	severe	severe	JJ
cord-005453-4057qib7	7605	6	chronic	chronic	JJ
cord-005453-4057qib7	7605	7	GvHD	GvHD	NNP
cord-005453-4057qib7	7605	8	,	,	,
cord-005453-4057qib7	7605	9	solved	solve	VBD
cord-005453-4057qib7	7605	10	at	at	IN
cord-005453-4057qib7	7605	11	last	last	JJ
cord-005453-4057qib7	7605	12	visit	visit	NN
cord-005453-4057qib7	7605	13	.	.	.
cord-005453-4057qib7	7606	1	Overall	overall	RB
cord-005453-4057qib7	7606	2	,	,	,
cord-005453-4057qib7	7606	3	after	after	IN
cord-005453-4057qib7	7606	4	a	a	DT
cord-005453-4057qib7	7606	5	median	median	JJ
cord-005453-4057qib7	7606	6	follow	follow	NN
cord-005453-4057qib7	7606	7	-	-	HYPH
cord-005453-4057qib7	7606	8	up	up	NN
cord-005453-4057qib7	7606	9	of	of	IN
cord-005453-4057qib7	7606	10	330	330	CD
cord-005453-4057qib7	7606	11	days	day	NNS
cord-005453-4057qib7	7606	12	[	[	-LRB-
cord-005453-4057qib7	7606	13	r	r	NNP
cord-005453-4057qib7	7606	14	9	9	CD
cord-005453-4057qib7	7606	15	-	-	SYM
cord-005453-4057qib7	7606	16	1311	1311	CD
cord-005453-4057qib7	7606	17	]	]	-RRB-
cord-005453-4057qib7	7606	18	,	,	,
cord-005453-4057qib7	7606	19	11	11	CD
cord-005453-4057qib7	7606	20	pts	pt	NNS
cord-005453-4057qib7	7606	21	are	be	VBP
cord-005453-4057qib7	7606	22	alive	alive	JJ
cord-005453-4057qib7	7606	23	and	and	CC
cord-005453-4057qib7	7606	24	well	well	RB
cord-005453-4057qib7	7606	25	.	.	.
cord-005453-4057qib7	7607	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7607	2	:	:	:
cord-005453-4057qib7	7608	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7608	2	data	datum	NNS
cord-005453-4057qib7	7608	3	confirm	confirm	VBP
cord-005453-4057qib7	7608	4	that	that	IN
cord-005453-4057qib7	7608	5	intra	intra	JJ
cord-005453-4057qib7	7608	6	-	-	JJ
cord-005453-4057qib7	7608	7	bone	bone	JJ
cord-005453-4057qib7	7608	8	CBT	CBT	NNP
cord-005453-4057qib7	7608	9	without	without	IN
cord-005453-4057qib7	7608	10	in	in	IN
cord-005453-4057qib7	7608	11	-	-	HYPH
cord-005453-4057qib7	7608	12	vivo	vivo	NN
cord-005453-4057qib7	7608	13	T	t	NN
cord-005453-4057qib7	7608	14	-	-	HYPH
cord-005453-4057qib7	7608	15	cell	cell	NN
cord-005453-4057qib7	7608	16	depletion	depletion	NN
cord-005453-4057qib7	7608	17	is	be	VBZ
cord-005453-4057qib7	7608	18	associated	associate	VBN
cord-005453-4057qib7	7608	19	with	with	IN
cord-005453-4057qib7	7608	20	fast	fast	JJ
cord-005453-4057qib7	7608	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7608	22	engraftment	engraftment	NN
cord-005453-4057qib7	7608	23	and	and	CC
cord-005453-4057qib7	7608	24	immune	immune	JJ
cord-005453-4057qib7	7608	25	-	-	HYPH
cord-005453-4057qib7	7608	26	reconstitution	reconstitution	NN
cord-005453-4057qib7	7608	27	,	,	,
cord-005453-4057qib7	7608	28	with	with	IN
cord-005453-4057qib7	7608	29	very	very	RB
cord-005453-4057qib7	7608	30	low	low	JJ
cord-005453-4057qib7	7608	31	rate	rate	NN
cord-005453-4057qib7	7608	32	of	of	IN
cord-005453-4057qib7	7608	33	chronic	chronic	JJ
cord-005453-4057qib7	7608	34	GvHD	gvhd	NN
cord-005453-4057qib7	7608	35	and	and	CC
cord-005453-4057qib7	7608	36	late	late	JJ
cord-005453-4057qib7	7608	37	infective	infective	JJ
cord-005453-4057qib7	7608	38	events	event	NNS
cord-005453-4057qib7	7608	39	.	.	.
cord-005453-4057qib7	7609	1	Background	background	NN
cord-005453-4057qib7	7609	2	:	:	:
cord-005453-4057qib7	7610	1	A	a	DT
cord-005453-4057qib7	7610	2	promising	promising	JJ
cord-005453-4057qib7	7610	3	improvement	improvement	NN
cord-005453-4057qib7	7610	4	of	of	IN
cord-005453-4057qib7	7610	5	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7610	6	stem	stem	NN
cord-005453-4057qib7	7610	7	cell	cell	NN
cord-005453-4057qib7	7610	8	transplantation	transplantation	NN
cord-005453-4057qib7	7610	9	(	(	-LRB-
cord-005453-4057qib7	7610	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7610	11	)	)	-RRB-
cord-005453-4057qib7	7610	12	may	may	MD
cord-005453-4057qib7	7610	13	lie	lie	VB
cord-005453-4057qib7	7610	14	in	in	IN
cord-005453-4057qib7	7610	15	the	the	DT
cord-005453-4057qib7	7610	16	transplantation	transplantation	NN
cord-005453-4057qib7	7610	17	of	of	IN
cord-005453-4057qib7	7610	18	high	high	JJ
cord-005453-4057qib7	7610	19	numbers	number	NNS
cord-005453-4057qib7	7610	20	of	of	IN
cord-005453-4057qib7	7610	21	pluripotent	pluripotent	JJ
cord-005453-4057qib7	7610	22	stem	stem	NN
cord-005453-4057qib7	7610	23	cells	cell	NNS
cord-005453-4057qib7	7610	24	to	to	TO
cord-005453-4057qib7	7610	25	minimize	minimize	VB
cord-005453-4057qib7	7610	26	the	the	DT
cord-005453-4057qib7	7610	27	time	time	NN
cord-005453-4057qib7	7610	28	span	span	NN
cord-005453-4057qib7	7610	29	between	between	IN
cord-005453-4057qib7	7610	30	transplantation	transplantation	NN
cord-005453-4057qib7	7610	31	and	and	CC
cord-005453-4057qib7	7610	32	immunological	immunological	JJ
cord-005453-4057qib7	7610	33	reconstitution	reconstitution	NN
cord-005453-4057qib7	7610	34	.	.	.
cord-005453-4057qib7	7611	1	Hence	hence	RB
cord-005453-4057qib7	7611	2	,	,	,
cord-005453-4057qib7	7611	3	an	an	DT
cord-005453-4057qib7	7611	4	ex	ex	FW
cord-005453-4057qib7	7611	5	vivo	vivo	NN
cord-005453-4057qib7	7611	6	platform	platform	NN
cord-005453-4057qib7	7611	7	is	be	VBZ
cord-005453-4057qib7	7611	8	needed	need	VBN
cord-005453-4057qib7	7611	9	that	that	WDT
cord-005453-4057qib7	7611	10	supports	support	VBZ
cord-005453-4057qib7	7611	11	HSC	HSC	NNP
cord-005453-4057qib7	7611	12	proliferation	proliferation	NN
cord-005453-4057qib7	7611	13	before	before	IN
cord-005453-4057qib7	7611	14	application	application	NN
cord-005453-4057qib7	7611	15	and	and	CC
cord-005453-4057qib7	7611	16	,	,	,
cord-005453-4057qib7	7611	17	at	at	IN
cord-005453-4057qib7	7611	18	the	the	DT
cord-005453-4057qib7	7611	19	same	same	JJ
cord-005453-4057qib7	7611	20	time	time	NN
cord-005453-4057qib7	7611	21	,	,	,
cord-005453-4057qib7	7611	22	the	the	DT
cord-005453-4057qib7	7611	23	maintenance	maintenance	NN
cord-005453-4057qib7	7611	24	of	of	IN
cord-005453-4057qib7	7611	25	pluripotency	pluripotency	NN
cord-005453-4057qib7	7611	26	by	by	IN
cord-005453-4057qib7	7611	27	diminishing	diminish	VBG
cord-005453-4057qib7	7611	28	HSC	HSC	NNP
cord-005453-4057qib7	7611	29	differentiation	differentiation	NN
cord-005453-4057qib7	7611	30	into	into	IN
cord-005453-4057qib7	7611	31	lineage	lineage	NN
cord-005453-4057qib7	7611	32	-	-	HYPH
cord-005453-4057qib7	7611	33	specific	specific	JJ
cord-005453-4057qib7	7611	34	progenitor	progenitor	NN
cord-005453-4057qib7	7611	35	cells	cell	NNS
cord-005453-4057qib7	7611	36	.	.	.
cord-005453-4057qib7	7612	1	Methods	method	NNS
cord-005453-4057qib7	7612	2	:	:	:
cord-005453-4057qib7	7612	3	To	to	TO
cord-005453-4057qib7	7612	4	artificially	artificially	RB
cord-005453-4057qib7	7612	5	model	model	VB
cord-005453-4057qib7	7612	6	the	the	DT
cord-005453-4057qib7	7612	7	natural	natural	JJ
cord-005453-4057qib7	7612	8	HSC	HSC	NNP
cord-005453-4057qib7	7612	9	niche	niche	NN
cord-005453-4057qib7	7612	10	in	in	IN
cord-005453-4057qib7	7612	11	vitro	vitro	FW
cord-005453-4057qib7	7612	12	,	,	,
cord-005453-4057qib7	7612	13	we	-PRON-	PRP
cord-005453-4057qib7	7612	14	used	use	VBD
cord-005453-4057qib7	7612	15	3D	3d	JJ
cord-005453-4057qib7	7612	16	bone	bone	NN
cord-005453-4057qib7	7612	17	marrow	marrow	NN
cord-005453-4057qib7	7612	18	(	(	-LRB-
cord-005453-4057qib7	7612	19	BM)-like	bm)-like	IN
cord-005453-4057qib7	7612	20	scaffolds	scaffold	NNS
cord-005453-4057qib7	7612	21	made	make	VBN
cord-005453-4057qib7	7612	22	of	of	IN
cord-005453-4057qib7	7612	23	polydimethylsiloxane	polydimethylsiloxane	NNP
cord-005453-4057qib7	7612	24	(	(	-LRB-
cord-005453-4057qib7	7612	25	PDMS	PDMS	NNP
cord-005453-4057qib7	7612	26	)	)	-RRB-
cord-005453-4057qib7	7612	27	.	.	.
cord-005453-4057qib7	7613	1	These	these	DT
cord-005453-4057qib7	7613	2	structures	structure	NNS
cord-005453-4057qib7	7613	3	are	be	VBP
cord-005453-4057qib7	7613	4	based	base	VBN
cord-005453-4057qib7	7613	5	on	on	IN
cord-005453-4057qib7	7613	6	a	a	DT
cord-005453-4057qib7	7613	7	human	human	JJ
cord-005453-4057qib7	7613	8	long	long	JJ
cord-005453-4057qib7	7613	9	bone	bone	NN
cord-005453-4057qib7	7613	10	cross	cross	NN
cord-005453-4057qib7	7613	11	section	section	NN
cord-005453-4057qib7	7613	12	as	as	IN
cord-005453-4057qib7	7613	13	a	a	DT
cord-005453-4057qib7	7613	14	representative	representative	NN
cord-005453-4057qib7	7613	15	of	of	IN
cord-005453-4057qib7	7613	16	the	the	DT
cord-005453-4057qib7	7613	17	BM	BM	NNP
cord-005453-4057qib7	7613	18	.	.	.
cord-005453-4057qib7	7614	1	Human	human	JJ
cord-005453-4057qib7	7614	2	cryoconserved	cryoconserve	VBN
cord-005453-4057qib7	7614	3	HSCs	HSCs	NNP
cord-005453-4057qib7	7614	4	were	be	VBD
cord-005453-4057qib7	7614	5	cultured	culture	VBN
cord-005453-4057qib7	7614	6	in	in	IN
cord-005453-4057qib7	7614	7	distinct	distinct	JJ
cord-005453-4057qib7	7614	8	cultivation	cultivation	NN
cord-005453-4057qib7	7614	9	systems	system	NNS
cord-005453-4057qib7	7614	10	for	for	IN
cord-005453-4057qib7	7614	11	14	14	CD
cord-005453-4057qib7	7614	12	days	day	NNS
cord-005453-4057qib7	7614	13	under	under	IN
cord-005453-4057qib7	7614	14	different	different	JJ
cord-005453-4057qib7	7614	15	conditions	condition	NNS
cord-005453-4057qib7	7614	16	.	.	.
cord-005453-4057qib7	7615	1	Cell	cell	NN
cord-005453-4057qib7	7615	2	counting	counting	NN
cord-005453-4057qib7	7615	3	and	and	CC
cord-005453-4057qib7	7615	4	FACS	FACS	NNP
cord-005453-4057qib7	7615	5	analyses	analysis	NNS
cord-005453-4057qib7	7615	6	at	at	IN
cord-005453-4057qib7	7615	7	day	day	NN
cord-005453-4057qib7	7615	8	14	14	CD
cord-005453-4057qib7	7615	9	were	be	VBD
cord-005453-4057qib7	7615	10	conducted	conduct	VBN
cord-005453-4057qib7	7615	11	.	.	.
cord-005453-4057qib7	7616	1	For	for	IN
cord-005453-4057qib7	7616	2	characterization	characterization	NN
cord-005453-4057qib7	7616	3	of	of	IN
cord-005453-4057qib7	7616	4	the	the	DT
cord-005453-4057qib7	7616	5	cultivated	cultivate	VBN
cord-005453-4057qib7	7616	6	HSCs	hscs	NN
cord-005453-4057qib7	7616	7	,	,	,
cord-005453-4057qib7	7616	8	we	-PRON-	PRP
cord-005453-4057qib7	7616	9	used	use	VBD
cord-005453-4057qib7	7616	10	antibodies	antibody	NNS
cord-005453-4057qib7	7616	11	against	against	IN
cord-005453-4057qib7	7616	12	CD34	CD34	NNP
cord-005453-4057qib7	7616	13	alone	alone	RB
cord-005453-4057qib7	7616	14	or	or	CC
cord-005453-4057qib7	7616	15	in	in	IN
cord-005453-4057qib7	7616	16	combination	combination	NN
cord-005453-4057qib7	7616	17	with	with	IN
cord-005453-4057qib7	7616	18	antibodies	antibody	NNS
cord-005453-4057qib7	7616	19	against	against	IN
cord-005453-4057qib7	7616	20	CD38	CD38	NNP
cord-005453-4057qib7	7616	21	,	,	,
cord-005453-4057qib7	7616	22	CD90	CD90	NNP
cord-005453-4057qib7	7616	23	,	,	,
cord-005453-4057qib7	7616	24	CD45RA	cd45ra	NN
cord-005453-4057qib7	7616	25	and	and	CC
cord-005453-4057qib7	7616	26	CD49f	cd49f	NN
cord-005453-4057qib7	7616	27	.	.	.
cord-005453-4057qib7	7617	1	Results	result	NNS
cord-005453-4057qib7	7617	2	:	:	:
cord-005453-4057qib7	7618	1	For	for	IN
cord-005453-4057qib7	7618	2	optimization	optimization	NN
cord-005453-4057qib7	7618	3	of	of	IN
cord-005453-4057qib7	7618	4	culture	culture	NN
cord-005453-4057qib7	7618	5	conditions	condition	NNS
cord-005453-4057qib7	7618	6	for	for	IN
cord-005453-4057qib7	7618	7	human	human	JJ
cord-005453-4057qib7	7618	8	HSCs	hscs	NN
cord-005453-4057qib7	7618	9	,	,	,
cord-005453-4057qib7	7618	10	a	a	DT
cord-005453-4057qib7	7618	11	commercially	commercially	RB
cord-005453-4057qib7	7618	12	available	available	JJ
cord-005453-4057qib7	7618	13	medium	medium	NN
cord-005453-4057qib7	7618	14	was	be	VBD
cord-005453-4057qib7	7618	15	supplemented	supplement	VBN
cord-005453-4057qib7	7618	16	with	with	IN
cord-005453-4057qib7	7618	17	a	a	DT
cord-005453-4057qib7	7618	18	panel	panel	NN
cord-005453-4057qib7	7618	19	of	of	IN
cord-005453-4057qib7	7618	20	cytokines	cytokine	NNS
cord-005453-4057qib7	7618	21	and	and	CC
cord-005453-4057qib7	7618	22	valproic	valproic	NN
cord-005453-4057qib7	7618	23	acid	acid	NN
cord-005453-4057qib7	7618	24	.	.	.
cord-005453-4057qib7	7619	1	We	-PRON-	PRP
cord-005453-4057qib7	7619	2	found	find	VBD
cord-005453-4057qib7	7619	3	a	a	DT
cord-005453-4057qib7	7619	4	significant	significant	JJ
cord-005453-4057qib7	7619	5	increase	increase	NN
cord-005453-4057qib7	7619	6	in	in	IN
cord-005453-4057qib7	7619	7	the	the	DT
cord-005453-4057qib7	7619	8	number	number	NN
cord-005453-4057qib7	7619	9	of	of	IN
cord-005453-4057qib7	7619	10	CD34	CD34	NNP
cord-005453-4057qib7	7619	11	+	+	CC
cord-005453-4057qib7	7619	12	HSCs	hscs	NN
cord-005453-4057qib7	7619	13	by	by	IN
cord-005453-4057qib7	7619	14	simultaneously	simultaneously	RB
cord-005453-4057qib7	7619	15	increasing	increase	VBG
cord-005453-4057qib7	7619	16	their	-PRON-	PRP$
cord-005453-4057qib7	7619	17	vitality	vitality	NN
cord-005453-4057qib7	7619	18	using	use	VBG
cord-005453-4057qib7	7619	19	the	the	DT
cord-005453-4057qib7	7619	20	3D	3d	JJ
cord-005453-4057qib7	7619	21	system	system	NN
cord-005453-4057qib7	7619	22	compared	compare	VBN
cord-005453-4057qib7	7619	23	with	with	IN
cord-005453-4057qib7	7619	24	conventional	conventional	JJ
cord-005453-4057qib7	7619	25	2D	2d	NN
cord-005453-4057qib7	7619	26	culturing	culturing	NN
cord-005453-4057qib7	7619	27	.	.	.
cord-005453-4057qib7	7620	1	A	a	DT
cord-005453-4057qib7	7620	2	further	further	JJ
cord-005453-4057qib7	7620	3	improvement	improvement	NN
cord-005453-4057qib7	7620	4	was	be	VBD
cord-005453-4057qib7	7620	5	achieved	achieve	VBN
cord-005453-4057qib7	7620	6	by	by	IN
cord-005453-4057qib7	7620	7	introducing	introduce	VBG
cord-005453-4057qib7	7620	8	a	a	DT
cord-005453-4057qib7	7620	9	silicon	silicon	NN
cord-005453-4057qib7	7620	10	oxidecovering	oxidecovering	NN
cord-005453-4057qib7	7620	11	of	of	IN
cord-005453-4057qib7	7620	12	the	the	DT
cord-005453-4057qib7	7620	13	3D	3d	JJ
cord-005453-4057qib7	7620	14	PDMS	PDMS	NNP
cord-005453-4057qib7	7620	15	structures	structure	NNS
cord-005453-4057qib7	7620	16	,	,	,
cord-005453-4057qib7	7620	17	suggesting	suggest	VBG
cord-005453-4057qib7	7620	18	that	that	IN
cord-005453-4057qib7	7620	19	hydrophilic	hydrophilic	JJ
cord-005453-4057qib7	7620	20	surface	surface	NN
cord-005453-4057qib7	7620	21	properties	property	NNS
cord-005453-4057qib7	7620	22	offer	offer	VBP
cord-005453-4057qib7	7620	23	superior	superior	JJ
cord-005453-4057qib7	7620	24	attachment	attachment	NN
cord-005453-4057qib7	7620	25	for	for	IN
cord-005453-4057qib7	7620	26	semi	semi	JJ
cord-005453-4057qib7	7620	27	-	-	JJ
cord-005453-4057qib7	7620	28	adherent	adherent	JJ
cord-005453-4057qib7	7620	29	HSCs	hscs	NN
cord-005453-4057qib7	7620	30	.	.	.
cord-005453-4057qib7	7621	1	For	for	IN
cord-005453-4057qib7	7621	2	a	a	DT
cord-005453-4057qib7	7621	3	more	more	RBR
cord-005453-4057qib7	7621	4	precise	precise	JJ
cord-005453-4057qib7	7621	5	characterization	characterization	NN
cord-005453-4057qib7	7621	6	of	of	IN
cord-005453-4057qib7	7621	7	the	the	DT
cord-005453-4057qib7	7621	8	cultivated	cultivate	VBN
cord-005453-4057qib7	7621	9	HSCs	hscs	NN
cord-005453-4057qib7	7621	10	,	,	,
cord-005453-4057qib7	7621	11	we	-PRON-	PRP
cord-005453-4057qib7	7621	12	introduced	introduce	VBD
cord-005453-4057qib7	7621	13	a	a	DT
cord-005453-4057qib7	7621	14	panel	panel	NN
cord-005453-4057qib7	7621	15	of	of	IN
cord-005453-4057qib7	7621	16	FACS	FACS	NNP
cord-005453-4057qib7	7621	17	markers	marker	NNS
cord-005453-4057qib7	7621	18	reflecting	reflect	VBG
cord-005453-4057qib7	7621	19	the	the	DT
cord-005453-4057qib7	7621	20	immaturity	immaturity	NN
cord-005453-4057qib7	7621	21	of	of	IN
cord-005453-4057qib7	7621	22	the	the	DT
cord-005453-4057qib7	7621	23	amplified	amplify	VBN
cord-005453-4057qib7	7621	24	HSC	HSC	NNP
cord-005453-4057qib7	7621	25	.	.	.
cord-005453-4057qib7	7622	1	Surprisingly	surprisingly	RB
cord-005453-4057qib7	7622	2	,	,	,
cord-005453-4057qib7	7622	3	with	with	IN
cord-005453-4057qib7	7622	4	increasing	increase	VBG
cord-005453-4057qib7	7622	5	immaturity	immaturity	NN
cord-005453-4057qib7	7622	6	of	of	IN
cord-005453-4057qib7	7622	7	the	the	DT
cord-005453-4057qib7	7622	8	cultivated	cultivate	VBN
cord-005453-4057qib7	7622	9	HSC	HSC	NNP
cord-005453-4057qib7	7622	10	,	,	,
cord-005453-4057qib7	7622	11	non	non	JJ
cord-005453-4057qib7	7622	12	-	-	JJ
cord-005453-4057qib7	7622	13	covered	covered	JJ
cord-005453-4057qib7	7622	14	3D	3d	JJ
cord-005453-4057qib7	7622	15	PDMS	PDMS	NNP
cord-005453-4057qib7	7622	16	revealed	reveal	VBD
cord-005453-4057qib7	7622	17	to	to	TO
cord-005453-4057qib7	7622	18	be	be	VB
cord-005453-4057qib7	7622	19	best	well	RBS
cord-005453-4057qib7	7622	20	suited	suit	VBN
cord-005453-4057qib7	7622	21	for	for	IN
cord-005453-4057qib7	7622	22	amplification	amplification	NN
cord-005453-4057qib7	7622	23	:	:	:
cord-005453-4057qib7	7622	24	Cell	cell	NN
cord-005453-4057qib7	7622	25	number	number	NN
cord-005453-4057qib7	7622	26	of	of	IN
cord-005453-4057qib7	7622	27	vital	vital	JJ
cord-005453-4057qib7	7622	28	immature	immature	JJ
cord-005453-4057qib7	7622	29	HSCs	hscs	NN
cord-005453-4057qib7	7622	30	was	be	VBD
cord-005453-4057qib7	7622	31	increased	increase	VBN
cord-005453-4057qib7	7622	32	after	after	IN
cord-005453-4057qib7	7622	33	cultivation	cultivation	NN
cord-005453-4057qib7	7622	34	on	on	IN
cord-005453-4057qib7	7622	35	non	non	JJ
cord-005453-4057qib7	7622	36	-	-	JJ
cord-005453-4057qib7	7622	37	covered	covered	JJ
cord-005453-4057qib7	7622	38	3D	3d	JJ
cord-005453-4057qib7	7622	39	PDMS	PDMS	NNP
cord-005453-4057qib7	7622	40	compared	compare	VBN
cord-005453-4057qib7	7622	41	with	with	IN
cord-005453-4057qib7	7622	42	silicon	silicon	NN
cord-005453-4057qib7	7622	43	oxide	oxide	NN
cord-005453-4057qib7	7622	44	-	-	HYPH
cord-005453-4057qib7	7622	45	covered	cover	VBN
cord-005453-4057qib7	7622	46	3D	3d	JJ
cord-005453-4057qib7	7622	47	PDMS	PDMS	NNP
cord-005453-4057qib7	7622	48	and	and	CC
cord-005453-4057qib7	7622	49	the	the	DT
cord-005453-4057qib7	7622	50	2D	2d	NN
cord-005453-4057qib7	7622	51	system	system	NN
cord-005453-4057qib7	7622	52	.	.	.
cord-005453-4057qib7	7623	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7623	2	:	:	:
cord-005453-4057qib7	7624	1	By	by	IN
cord-005453-4057qib7	7624	2	establishing	establish	VBG
cord-005453-4057qib7	7624	3	a	a	DT
cord-005453-4057qib7	7624	4	3D	3d	JJ
cord-005453-4057qib7	7624	5	scaffold	scaffold	NN
cord-005453-4057qib7	7624	6	according	accord	VBG
cord-005453-4057qib7	7624	7	to	to	IN
cord-005453-4057qib7	7624	8	the	the	DT
cord-005453-4057qib7	7624	9	human	human	JJ
cord-005453-4057qib7	7624	10	BM	bm	NN
cord-005453-4057qib7	7624	11	,	,	,
cord-005453-4057qib7	7624	12	we	-PRON-	PRP
cord-005453-4057qib7	7624	13	found	find	VBD
cord-005453-4057qib7	7624	14	a	a	DT
cord-005453-4057qib7	7624	15	platform	platform	NN
cord-005453-4057qib7	7624	16	mimicking	mimic	VBG
cord-005453-4057qib7	7624	17	the	the	DT
cord-005453-4057qib7	7624	18	natural	natural	JJ
cord-005453-4057qib7	7624	19	niche	niche	NN
cord-005453-4057qib7	7624	20	of	of	IN
cord-005453-4057qib7	7624	21	human	human	JJ
cord-005453-4057qib7	7624	22	HSC	HSC	NNP
cord-005453-4057qib7	7624	23	which	which	WDT
cord-005453-4057qib7	7624	24	is	be	VBZ
cord-005453-4057qib7	7624	25	suitable	suitable	JJ
cord-005453-4057qib7	7624	26	to	to	TO
cord-005453-4057qib7	7624	27	amplify	amplify	VB
cord-005453-4057qib7	7624	28	human	human	JJ
cord-005453-4057qib7	7624	29	HSCs	hscs	NN
cord-005453-4057qib7	7624	30	in	in	IN
cord-005453-4057qib7	7624	31	vitro	vitro	FW
cord-005453-4057qib7	7624	32	and	and	CC
cord-005453-4057qib7	7624	33	support	support	VB
cord-005453-4057qib7	7624	34	their	-PRON-	PRP$
cord-005453-4057qib7	7624	35	vitality	vitality	NN
cord-005453-4057qib7	7624	36	,	,	,
cord-005453-4057qib7	7624	37	pluripotency	pluripotency	NN
cord-005453-4057qib7	7624	38	and	and	CC
cord-005453-4057qib7	7624	39	ability	ability	NN
cord-005453-4057qib7	7624	40	for	for	IN
cord-005453-4057qib7	7624	41	self	self	NN
cord-005453-4057qib7	7624	42	-	-	HYPH
cord-005453-4057qib7	7624	43	renewal	renewal	NN
cord-005453-4057qib7	7624	44	.	.	.
cord-005453-4057qib7	7625	1	[	[	-LRB-
cord-005453-4057qib7	7625	2	[	[	-LRB-
cord-005453-4057qib7	7625	3	P341	p341	NN
cord-005453-4057qib7	7625	4	Image	image	NN
cord-005453-4057qib7	7625	5	]	]	-RRB-
cord-005453-4057qib7	7625	6	1	1	CD
cord-005453-4057qib7	7625	7	.	.	.
cord-005453-4057qib7	7626	1	With	with	IN
cord-005453-4057qib7	7626	2	the	the	DT
cord-005453-4057qib7	7626	3	introduction	introduction	NN
cord-005453-4057qib7	7626	4	of	of	IN
cord-005453-4057qib7	7626	5	SiOn	SiOn	NNP
cord-005453-4057qib7	7626	6	covering	cover	VBG
cord-005453-4057qib7	7626	7	of	of	IN
cord-005453-4057qib7	7626	8	3D	3d	JJ
cord-005453-4057qib7	7626	9	PDMS	PDMS	NNP
cord-005453-4057qib7	7626	10	structures	structure	NNS
cord-005453-4057qib7	7626	11	the	the	DT
cord-005453-4057qib7	7626	12	maintenance	maintenance	NN
cord-005453-4057qib7	7626	13	of	of	IN
cord-005453-4057qib7	7626	14	CD34	CD34	NNP
cord-005453-4057qib7	7626	15	+	+	CC
cord-005453-4057qib7	7626	16	HSCs	hscs	NN
cord-005453-4057qib7	7626	17	could	could	MD
cord-005453-4057qib7	7626	18	be	be	VB
cord-005453-4057qib7	7626	19	further	further	RB
cord-005453-4057qib7	7626	20	improved	improve	VBN
cord-005453-4057qib7	7626	21	.	.	.
cord-005453-4057qib7	7627	1	Despite	despite	IN
cord-005453-4057qib7	7627	2	the	the	DT
cord-005453-4057qib7	7627	3	better	well	JJR
cord-005453-4057qib7	7627	4	conservation	conservation	NN
cord-005453-4057qib7	7627	5	of	of	IN
cord-005453-4057qib7	7627	6	CD34	CD34	NNP
cord-005453-4057qib7	7627	7	+	+	CC
cord-005453-4057qib7	7627	8	HSCs	hscs	NN
cord-005453-4057qib7	7627	9	by	by	IN
cord-005453-4057qib7	7627	10	using	use	VBG
cord-005453-4057qib7	7627	11	silicon	silicon	NN
cord-005453-4057qib7	7627	12	oxide	oxide	NN
cord-005453-4057qib7	7627	13	-	-	HYPH
cord-005453-4057qib7	7627	14	covered	cover	VBN
cord-005453-4057qib7	7627	15	3D	3d	JJ
cord-005453-4057qib7	7627	16	PDMS	PDMS	NNP
cord-005453-4057qib7	7627	17	,	,	,
cord-005453-4057qib7	7627	18	we	-PRON-	PRP
cord-005453-4057qib7	7627	19	found	find	VBD
cord-005453-4057qib7	7627	20	that	that	IN
cord-005453-4057qib7	7627	21	immature	immature	JJ
cord-005453-4057qib7	7627	22	human	human	JJ
cord-005453-4057qib7	7627	23	HSCs	hsc	NNS
cord-005453-4057qib7	7627	24	obviously	obviously	RB
cord-005453-4057qib7	7627	25	prefer	prefer	VBP
cord-005453-4057qib7	7627	26	more	more	JJR
cord-005453-4057qib7	7627	27	hydrophobic	hydrophobic	JJ
cord-005453-4057qib7	7627	28	conditions	condition	NNS
cord-005453-4057qib7	7627	29	found	find	VBN
cord-005453-4057qib7	7627	30	on	on	IN
cord-005453-4057qib7	7627	31	non	non	JJ
cord-005453-4057qib7	7627	32	-	-	JJ
cord-005453-4057qib7	7627	33	covered	covered	JJ
cord-005453-4057qib7	7627	34	3D	3d	JJ
cord-005453-4057qib7	7627	35	PDMS	PDMS	NNP
cord-005453-4057qib7	7627	36	.	.	.
cord-005453-4057qib7	7628	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7628	2	:	:	:
cord-005453-4057qib7	7628	3	Nothing	nothing	NN
cord-005453-4057qib7	7628	4	to	to	TO
cord-005453-4057qib7	7628	5	declare	declare	VB
cord-005453-4057qib7	7628	6	.	.	.
cord-005453-4057qib7	7629	1	Abstract	Abstract	NNP
cord-005453-4057qib7	7629	2	already	already	RB
cord-005453-4057qib7	7629	3	published	publish	VBN
cord-005453-4057qib7	7629	4	.	.	.
cord-005453-4057qib7	7630	1	Improvements	improvement	NNS
cord-005453-4057qib7	7630	2	in	in	IN
cord-005453-4057qib7	7630	3	neutrophil	neutrophil	NN
cord-005453-4057qib7	7630	4	engraftment	engraftment	NN
cord-005453-4057qib7	7630	5	following	follow	VBG
cord-005453-4057qib7	7630	6	changes	change	NNS
cord-005453-4057qib7	7630	7	in	in	IN
cord-005453-4057qib7	7630	8	freezing	freezing	NN
cord-005453-4057qib7	7630	9	method	method	NN
cord-005453-4057qib7	7630	10	Background	background	NN
cord-005453-4057qib7	7630	11	:	:	:
cord-005453-4057qib7	7630	12	In	in	IN
cord-005453-4057qib7	7630	13	the	the	DT
cord-005453-4057qib7	7630	14	setting	setting	NN
cord-005453-4057qib7	7630	15	of	of	IN
cord-005453-4057qib7	7630	16	autologous	autologous	JJ
cord-005453-4057qib7	7630	17	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	7630	18	progenitor	progenitor	NN
cord-005453-4057qib7	7630	19	cell	cell	NN
cord-005453-4057qib7	7630	20	(	(	-LRB-
cord-005453-4057qib7	7630	21	HPC	HPC	NNP
cord-005453-4057qib7	7630	22	)	)	-RRB-
cord-005453-4057qib7	7630	23	transplants	transplant	NNS
cord-005453-4057qib7	7630	24	for	for	IN
cord-005453-4057qib7	7630	25	haematological	haematological	JJ
cord-005453-4057qib7	7630	26	disorders	disorder	NNS
cord-005453-4057qib7	7630	27	,	,	,
cord-005453-4057qib7	7630	28	peripheral	peripheral	JJ
cord-005453-4057qib7	7630	29	blood	blood	NN
cord-005453-4057qib7	7630	30	stem	stem	NN
cord-005453-4057qib7	7630	31	cells	cell	NNS
cord-005453-4057qib7	7630	32	are	be	VBP
cord-005453-4057qib7	7630	33	routinely	routinely	RB
cord-005453-4057qib7	7630	34	collected	collect	VBN
cord-005453-4057qib7	7630	35	via	via	IN
cord-005453-4057qib7	7630	36	apheresis	apheresis	NN
cord-005453-4057qib7	7630	37	and	and	CC
cord-005453-4057qib7	7630	38	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	7630	39	.	.	.
cord-005453-4057qib7	7631	1	Leicester	Leicester	NNP
cord-005453-4057qib7	7631	2	Royal	Royal	NNP
cord-005453-4057qib7	7631	3	Infirmary	Infirmary	NNP
cord-005453-4057qib7	7631	4	had	have	VBD
cord-005453-4057qib7	7631	5	been	be	VBN
cord-005453-4057qib7	7631	6	using	use	VBG
cord-005453-4057qib7	7631	7	a	a	DT
cord-005453-4057qib7	7631	8	controlled	control	VBN
cord-005453-4057qib7	7631	9	rate	rate	NN
cord-005453-4057qib7	7631	10	freezer	freezer	NN
cord-005453-4057qib7	7631	11	(	(	-LRB-
cord-005453-4057qib7	7631	12	CRF	CRF	NNP
cord-005453-4057qib7	7631	13	)	)	-RRB-
cord-005453-4057qib7	7631	14	to	to	TO
cord-005453-4057qib7	7631	15	cryopreserve	cryopreserve	VB
cord-005453-4057qib7	7631	16	cellular	cellular	JJ
cord-005453-4057qib7	7631	17	therapy	therapy	NN
cord-005453-4057qib7	7631	18	products	product	NNS
cord-005453-4057qib7	7631	19	up	up	IN
cord-005453-4057qib7	7631	20	until	until	IN
cord-005453-4057qib7	7631	21	2017	2017	CD
cord-005453-4057qib7	7631	22	.	.	.
cord-005453-4057qib7	7632	1	In	in	IN
cord-005453-4057qib7	7632	2	2017	2017	CD
cord-005453-4057qib7	7632	3	a	a	DT
cord-005453-4057qib7	7632	4	literature	literature	NN
cord-005453-4057qib7	7632	5	review	review	NN
cord-005453-4057qib7	7632	6	of	of	IN
cord-005453-4057qib7	7632	7	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	7632	8	techniques	technique	NNS
cord-005453-4057qib7	7632	9	was	be	VBD
cord-005453-4057qib7	7632	10	undertaken	undertake	VBN
cord-005453-4057qib7	7632	11	,	,	,
cord-005453-4057qib7	7632	12	since	since	IN
cord-005453-4057qib7	7632	13	the	the	DT
cord-005453-4057qib7	7632	14	CRF	CRF	NNP
cord-005453-4057qib7	7632	15	required	require	VBN
cord-005453-4057qib7	7632	16	replacement	replacement	NN
cord-005453-4057qib7	7632	17	.	.	.
cord-005453-4057qib7	7633	1	This	this	DT
cord-005453-4057qib7	7633	2	review	review	NN
cord-005453-4057qib7	7633	3	found	find	VBD
cord-005453-4057qib7	7633	4	consistent	consistent	JJ
cord-005453-4057qib7	7633	5	evidence	evidence	NN
cord-005453-4057qib7	7633	6	that	that	IN
cord-005453-4057qib7	7633	7	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	7633	8	using	use	VBG
cord-005453-4057qib7	7633	9	minus	minus	NN
cord-005453-4057qib7	7633	10	80	80	CD
cord-005453-4057qib7	7633	11	o	o	NN
cord-005453-4057qib7	7633	12	C	c	NN
cord-005453-4057qib7	7633	13	is	be	VBZ
cord-005453-4057qib7	7633	14	comparable	comparable	JJ
cord-005453-4057qib7	7633	15	to	to	IN
cord-005453-4057qib7	7633	16	CRF	CRF	NNP
cord-005453-4057qib7	7633	17	,	,	,
cord-005453-4057qib7	7633	18	and	and	CC
cord-005453-4057qib7	7633	19	engraftment	engraftment	NN
cord-005453-4057qib7	7633	20	times	time	NNS
cord-005453-4057qib7	7633	21	should	should	MD
cord-005453-4057qib7	7633	22	not	not	RB
cord-005453-4057qib7	7633	23	be	be	VB
cord-005453-4057qib7	7633	24	negatively	negatively	RB
cord-005453-4057qib7	7633	25	affected	affect	VBN
cord-005453-4057qib7	7633	26	by	by	IN
cord-005453-4057qib7	7633	27	changing	change	VBG
cord-005453-4057qib7	7633	28	to	to	IN
cord-005453-4057qib7	7633	29	a	a	DT
cord-005453-4057qib7	7633	30	more	more	RBR
cord-005453-4057qib7	7633	31	simplified	simplified	JJ
cord-005453-4057qib7	7633	32	method	method	NN
cord-005453-4057qib7	7633	33	of	of	IN
cord-005453-4057qib7	7633	34	freezing	freezing	NN
cord-005453-4057qib7	7633	35	.	.	.
cord-005453-4057qib7	7634	1	There	there	EX
cord-005453-4057qib7	7634	2	would	would	MD
cord-005453-4057qib7	7634	3	also	also	RB
cord-005453-4057qib7	7634	4	be	be	VB
cord-005453-4057qib7	7634	5	cost	cost	NN
cord-005453-4057qib7	7634	6	saving	saving	NN
cord-005453-4057qib7	7634	7	benefits	benefit	NNS
cord-005453-4057qib7	7634	8	from	from	IN
cord-005453-4057qib7	7634	9	switching	switch	VBG
cord-005453-4057qib7	7634	10	from	from	IN
cord-005453-4057qib7	7634	11	a	a	DT
cord-005453-4057qib7	7634	12	CRF	crf	NN
cord-005453-4057qib7	7634	13	to	to	IN
cord-005453-4057qib7	7634	14	minus	minus	NN
cord-005453-4057qib7	7634	15	80	80	CD
cord-005453-4057qib7	7634	16	o	o	NN
cord-005453-4057qib7	7634	17	C	c	NN
cord-005453-4057qib7	7634	18	freezers	freezer	NNS
cord-005453-4057qib7	7634	19	.	.	.
cord-005453-4057qib7	7635	1	Methods	method	NNS
cord-005453-4057qib7	7635	2	:	:	:
cord-005453-4057qib7	7636	1	As	as	IN
cord-005453-4057qib7	7636	2	a	a	DT
cord-005453-4057qib7	7636	3	result	result	NN
cord-005453-4057qib7	7636	4	two	two	CD
cord-005453-4057qib7	7636	5	minus	minus	CC
cord-005453-4057qib7	7636	6	80	80	CD
cord-005453-4057qib7	7636	7	o	o	NN
cord-005453-4057qib7	7636	8	C	c	NN
cord-005453-4057qib7	7636	9	freezers	freezer	NNS
cord-005453-4057qib7	7636	10	were	be	VBD
cord-005453-4057qib7	7636	11	purchased	purchase	VBN
cord-005453-4057qib7	7636	12	following	follow	VBG
cord-005453-4057qib7	7636	13	the	the	DT
cord-005453-4057qib7	7636	14	acceptance	acceptance	NN
cord-005453-4057qib7	7636	15	of	of	IN
cord-005453-4057qib7	7636	16	a	a	DT
cord-005453-4057qib7	7636	17	Preparation	Preparation	NNP
cord-005453-4057qib7	7636	18	Process	process	NN
cord-005453-4057qib7	7636	19	Dosier	Dosier	NNP
cord-005453-4057qib7	7636	20	(	(	-LRB-
cord-005453-4057qib7	7636	21	PPD	PPD	NNP
cord-005453-4057qib7	7636	22	)	)	-RRB-
cord-005453-4057qib7	7636	23	which	which	WDT
cord-005453-4057qib7	7636	24	was	be	VBD
cord-005453-4057qib7	7636	25	prepared	prepare	VBN
cord-005453-4057qib7	7636	26	for	for	IN
cord-005453-4057qib7	7636	27	the	the	DT
cord-005453-4057qib7	7636	28	Human	Human	NNP
cord-005453-4057qib7	7636	29	Tissue	Tissue	NNP
cord-005453-4057qib7	7636	30	Authority	Authority	NNP
cord-005453-4057qib7	7636	31	.	.	.
cord-005453-4057qib7	7637	1	Validation	validation	NN
cord-005453-4057qib7	7637	2	was	be	VBD
cord-005453-4057qib7	7637	3	carried	carry	VBN
cord-005453-4057qib7	7637	4	out	out	RP
cord-005453-4057qib7	7637	5	,	,	,
cord-005453-4057qib7	7637	6	and	and	CC
cord-005453-4057qib7	7637	7	from	from	IN
cord-005453-4057qib7	7637	8	January	January	NNP
cord-005453-4057qib7	7637	9	2018	2018	CD
cord-005453-4057qib7	7637	10	stem	stem	NN
cord-005453-4057qib7	7637	11	cell	cell	NN
cord-005453-4057qib7	7637	12	laboratory	laboratory	NN
cord-005453-4057qib7	7637	13	at	at	IN
cord-005453-4057qib7	7637	14	the	the	DT
cord-005453-4057qib7	7637	15	LRI	LRI	NNP
cord-005453-4057qib7	7637	16	switched	switch	VBD
cord-005453-4057qib7	7637	17	from	from	IN
cord-005453-4057qib7	7637	18	the	the	DT
cord-005453-4057qib7	7637	19	CRF	CRF	NNP
cord-005453-4057qib7	7637	20	method	method	NN
cord-005453-4057qib7	7637	21	to	to	IN
cord-005453-4057qib7	7637	22	minus	minus	IN
cord-005453-4057qib7	7637	23	80	80	CD
cord-005453-4057qib7	7637	24	o	o	NN
cord-005453-4057qib7	7637	25	C	c	NN
cord-005453-4057qib7	7637	26	for	for	IN
cord-005453-4057qib7	7637	27	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	7637	28	of	of	IN
cord-005453-4057qib7	7637	29	cellular	cellular	JJ
cord-005453-4057qib7	7637	30	therapy	therapy	NN
cord-005453-4057qib7	7637	31	products	product	NNS
cord-005453-4057qib7	7637	32	.	.	.
cord-005453-4057qib7	7638	1	Briefly	briefly	RB
cord-005453-4057qib7	7638	2	,	,	,
cord-005453-4057qib7	7638	3	cells	cell	NNS
cord-005453-4057qib7	7638	4	are	be	VBP
cord-005453-4057qib7	7638	5	frozen	freeze	VBN
cord-005453-4057qib7	7638	6	using	use	VBG
cord-005453-4057qib7	7638	7	10	10	CD
cord-005453-4057qib7	7638	8	%	%	NN
cord-005453-4057qib7	7638	9	DMSO	DMSO	NNP
cord-005453-4057qib7	7638	10	(	(	-LRB-
cord-005453-4057qib7	7638	11	Wak	Wak	NNP
cord-005453-4057qib7	7638	12	-	-	HYPH
cord-005453-4057qib7	7638	13	Chemie	Chemie	NNP
cord-005453-4057qib7	7638	14	)	)	-RRB-
cord-005453-4057qib7	7638	15	in	in	IN
cord-005453-4057qib7	7638	16	20g	20g	NNPS
cord-005453-4057qib7	7638	17	/	/	SYM
cord-005453-4057qib7	7638	18	l	l	NNP
cord-005453-4057qib7	7638	19	Human	Human	NNP
cord-005453-4057qib7	7638	20	Albumin	Albumin	NNP
cord-005453-4057qib7	7638	21	Solution	Solution	NNP
cord-005453-4057qib7	7638	22	(	(	-LRB-
cord-005453-4057qib7	7638	23	Grifols	Grifols	NNP
cord-005453-4057qib7	7638	24	)	)	-RRB-
cord-005453-4057qib7	7638	25	in	in	IN
cord-005453-4057qib7	7638	26	Cyrobags	Cyrobags	NNP
cord-005453-4057qib7	7638	27	(	(	-LRB-
cord-005453-4057qib7	7638	28	Origen	Origen	NNP
cord-005453-4057qib7	7638	29	Biomedical	Biomedical	NNP
cord-005453-4057qib7	7638	30	,	,	,
cord-005453-4057qib7	7638	31	Inc	Inc	NNP
cord-005453-4057qib7	7638	32	)	)	-RRB-
cord-005453-4057qib7	7638	33	.	.	.
cord-005453-4057qib7	7639	1	The	the	DT
cord-005453-4057qib7	7639	2	cells	cell	NNS
cord-005453-4057qib7	7639	3	are	be	VBP
cord-005453-4057qib7	7639	4	transferred	transfer	VBN
cord-005453-4057qib7	7639	5	on	on	IN
cord-005453-4057qib7	7639	6	cold	cold	JJ
cord-005453-4057qib7	7639	7	packs	pack	NNS
cord-005453-4057qib7	7639	8	to	to	IN
cord-005453-4057qib7	7639	9	the	the	DT
cord-005453-4057qib7	7639	10	minus	minus	NN
cord-005453-4057qib7	7639	11	80	80	CD
cord-005453-4057qib7	7639	12	o	o	NN
cord-005453-4057qib7	7639	13	C	c	NN
cord-005453-4057qib7	7639	14	freezer	freezer	NN
cord-005453-4057qib7	7639	15	.	.	.
cord-005453-4057qib7	7640	1	Cells	cell	NNS
cord-005453-4057qib7	7640	2	are	be	VBP
cord-005453-4057qib7	7640	3	packaged	package	VBN
cord-005453-4057qib7	7640	4	in	in	IN
cord-005453-4057qib7	7640	5	between	between	IN
cord-005453-4057qib7	7640	6	stainless	stainless	JJ
cord-005453-4057qib7	7640	7	steel	steel	NN
cord-005453-4057qib7	7640	8	heattransfer	heattransfer	NN
cord-005453-4057qib7	7640	9	plates	plate	NNS
cord-005453-4057qib7	7640	10	.	.	.
cord-005453-4057qib7	7641	1	The	the	DT
cord-005453-4057qib7	7641	2	plates	plate	NNS
cord-005453-4057qib7	7641	3	are	be	VBP
cord-005453-4057qib7	7641	4	placed	place	VBN
cord-005453-4057qib7	7641	5	within	within	IN
cord-005453-4057qib7	7641	6	a	a	DT
cord-005453-4057qib7	7641	7	bubble	bubble	NN
cord-005453-4057qib7	7641	8	wrap	wrap	NN
cord-005453-4057qib7	7641	9	bag	bag	NN
cord-005453-4057qib7	7641	10	,	,	,
cord-005453-4057qib7	7641	11	and	and	CC
cord-005453-4057qib7	7641	12	are	be	VBP
cord-005453-4057qib7	7641	13	placed	place	VBN
cord-005453-4057qib7	7641	14	in	in	IN
cord-005453-4057qib7	7641	15	a	a	DT
cord-005453-4057qib7	7641	16	rack	rack	NN
cord-005453-4057qib7	7641	17	within	within	IN
cord-005453-4057qib7	7641	18	the	the	DT
cord-005453-4057qib7	7641	19	minus	minus	NN
cord-005453-4057qib7	7641	20	80	80	CD
cord-005453-4057qib7	7641	21	o	o	NN
cord-005453-4057qib7	7641	22	C	c	NN
cord-005453-4057qib7	7641	23	freezer	freezer	NN
cord-005453-4057qib7	7641	24	,	,	,
cord-005453-4057qib7	7641	25	which	which	WDT
cord-005453-4057qib7	7641	26	allows	allow	VBZ
cord-005453-4057qib7	7641	27	air	air	NN
cord-005453-4057qib7	7641	28	to	to	TO
cord-005453-4057qib7	7641	29	circulate	circulate	VB
cord-005453-4057qib7	7641	30	freely	freely	RB
cord-005453-4057qib7	7641	31	around	around	IN
cord-005453-4057qib7	7641	32	each	each	DT
cord-005453-4057qib7	7641	33	bag	bag	NN
cord-005453-4057qib7	7641	34	.	.	.
cord-005453-4057qib7	7642	1	In	in	IN
cord-005453-4057qib7	7642	2	one	one	CD
cord-005453-4057qib7	7642	3	plate	plate	NN
cord-005453-4057qib7	7642	4	a	a	DT
cord-005453-4057qib7	7642	5	EL	EL	NNP
cord-005453-4057qib7	7642	6	-	-	HYPH
cord-005453-4057qib7	7642	7	USB	usb	NN
cord-005453-4057qib7	7642	8	-	-	HYPH
cord-005453-4057qib7	7642	9	TC	tc	NN
cord-005453-4057qib7	7642	10	thermocouple	thermocouple	NN
cord-005453-4057qib7	7642	11	data	datum	NNS
cord-005453-4057qib7	7642	12	logger	logger	NN
cord-005453-4057qib7	7642	13	(	(	-LRB-
cord-005453-4057qib7	7642	14	Thermosense	Thermosense	NNP
cord-005453-4057qib7	7642	15	)	)	-RRB-
cord-005453-4057qib7	7642	16	is	be	VBZ
cord-005453-4057qib7	7642	17	inserted	insert	VBN
cord-005453-4057qib7	7642	18	between	between	IN
cord-005453-4057qib7	7642	19	the	the	DT
cord-005453-4057qib7	7642	20	bag	bag	NN
cord-005453-4057qib7	7642	21	and	and	CC
cord-005453-4057qib7	7642	22	stainless	stainless	JJ
cord-005453-4057qib7	7642	23	steel	steel	NN
cord-005453-4057qib7	7642	24	plate	plate	NN
cord-005453-4057qib7	7642	25	,	,	,
cord-005453-4057qib7	7642	26	to	to	TO
cord-005453-4057qib7	7642	27	record	record	VB
cord-005453-4057qib7	7642	28	the	the	DT
cord-005453-4057qib7	7642	29	freezing	freeze	VBG
cord-005453-4057qib7	7642	30	profile	profile	NN
cord-005453-4057qib7	7642	31	.	.	.
cord-005453-4057qib7	7643	1	This	this	DT
cord-005453-4057qib7	7643	2	data	data	NN
cord-005453-4057qib7	7643	3	is	be	VBZ
cord-005453-4057qib7	7643	4	downloaded	download	VBN
cord-005453-4057qib7	7643	5	after	after	IN
cord-005453-4057qib7	7643	6	each	each	DT
cord-005453-4057qib7	7643	7	run	run	NN
cord-005453-4057qib7	7643	8	.	.	.
cord-005453-4057qib7	7644	1	After	after	IN
cord-005453-4057qib7	7644	2	an	an	DT
cord-005453-4057qib7	7644	3	overnight	overnight	JJ
cord-005453-4057qib7	7644	4	freeze	freeze	NN
cord-005453-4057qib7	7644	5	at	at	IN
cord-005453-4057qib7	7644	6	minus	minus	NN
cord-005453-4057qib7	7644	7	80	80	CD
cord-005453-4057qib7	7644	8	o	o	NN
cord-005453-4057qib7	7644	9	C	c	NN
cord-005453-4057qib7	7644	10	,	,	,
cord-005453-4057qib7	7644	11	the	the	DT
cord-005453-4057qib7	7644	12	cells	cell	NNS
cord-005453-4057qib7	7644	13	are	be	VBP
cord-005453-4057qib7	7644	14	subsequently	subsequently	RB
cord-005453-4057qib7	7644	15	removed	remove	VBN
cord-005453-4057qib7	7644	16	from	from	IN
cord-005453-4057qib7	7644	17	the	the	DT
cord-005453-4057qib7	7644	18	bubble	bubble	NN
cord-005453-4057qib7	7644	19	wrap	wrap	NN
cord-005453-4057qib7	7644	20	and	and	CC
cord-005453-4057qib7	7644	21	plates	plate	NNS
cord-005453-4057qib7	7644	22	,	,	,
cord-005453-4057qib7	7644	23	and	and	CC
cord-005453-4057qib7	7644	24	are	be	VBP
cord-005453-4057qib7	7644	25	transferred	transfer	VBN
cord-005453-4057qib7	7644	26	to	to	IN
cord-005453-4057qib7	7644	27	minus	minus	NN
cord-005453-4057qib7	7644	28	150	150	CD
cord-005453-4057qib7	7644	29	o	o	NN
cord-005453-4057qib7	7644	30	C	c	NN
cord-005453-4057qib7	7644	31	freezers	freezer	NNS
cord-005453-4057qib7	7644	32	the	the	DT
cord-005453-4057qib7	7644	33	following	following	JJ
cord-005453-4057qib7	7644	34	morning	morning	NN
cord-005453-4057qib7	7644	35	.	.	.
cord-005453-4057qib7	7645	1	Results	result	NNS
cord-005453-4057qib7	7645	2	:	:	:
cord-005453-4057qib7	7646	1	A	a	DT
cord-005453-4057qib7	7646	2	total	total	NN
cord-005453-4057qib7	7646	3	of	of	IN
cord-005453-4057qib7	7646	4	40	40	CD
cord-005453-4057qib7	7646	5	patients	patient	NNS
cord-005453-4057qib7	7646	6	have	have	VBP
cord-005453-4057qib7	7646	7	had	have	VBN
cord-005453-4057qib7	7646	8	autologous	autologous	JJ
cord-005453-4057qib7	7646	9	stem	stem	NN
cord-005453-4057qib7	7646	10	cells	cell	NNS
cord-005453-4057qib7	7646	11	frozen	freeze	VBN
cord-005453-4057qib7	7646	12	using	use	VBG
cord-005453-4057qib7	7646	13	this	this	DT
cord-005453-4057qib7	7646	14	method	method	NN
cord-005453-4057qib7	7646	15	so	so	RB
cord-005453-4057qib7	7646	16	far	far	RB
cord-005453-4057qib7	7646	17	this	this	DT
cord-005453-4057qib7	7646	18	year	year	NN
cord-005453-4057qib7	7646	19	.	.	.
cord-005453-4057qib7	7647	1	In	in	IN
cord-005453-4057qib7	7647	2	addition	addition	NN
cord-005453-4057qib7	7647	3	to	to	IN
cord-005453-4057qib7	7647	4	engraftment	engraftment	NNP
cord-005453-4057qib7	7647	5	data	datum	NNS
cord-005453-4057qib7	7647	6	for	for	IN
cord-005453-4057qib7	7647	7	neutrophils	neutrophil	NNS
cord-005453-4057qib7	7647	8	,	,	,
cord-005453-4057qib7	7647	9	post	post	JJ
cord-005453-4057qib7	7647	10	-	-	JJ
cord-005453-4057qib7	7647	11	freeze	freeze	JJ
cord-005453-4057qib7	7647	12	trypan	trypan	NNP
cord-005453-4057qib7	7647	13	blue	blue	JJ
cord-005453-4057qib7	7647	14	viabilities	viability	NNS
cord-005453-4057qib7	7647	15	were	be	VBD
cord-005453-4057qib7	7647	16	also	also	RB
cord-005453-4057qib7	7647	17	compared	compare	VBN
cord-005453-4057qib7	7647	18	to	to	IN
cord-005453-4057qib7	7647	19	the	the	DT
cord-005453-4057qib7	7647	20	previous	previous	JJ
cord-005453-4057qib7	7647	21	year	year	NN
cord-005453-4057qib7	7647	22	.	.	.
cord-005453-4057qib7	7648	1	During	during	IN
cord-005453-4057qib7	7648	2	2017	2017	CD
cord-005453-4057qib7	7648	3	a	a	DT
cord-005453-4057qib7	7648	4	total	total	NN
cord-005453-4057qib7	7648	5	of	of	IN
cord-005453-4057qib7	7648	6	51	51	CD
cord-005453-4057qib7	7648	7	patients	patient	NNS
cord-005453-4057qib7	7648	8	,	,	,
cord-005453-4057qib7	7648	9	who	who	WP
cord-005453-4057qib7	7648	10	had	have	VBD
cord-005453-4057qib7	7648	11	all	all	PDT
cord-005453-4057qib7	7648	12	their	-PRON-	PRP$
cord-005453-4057qib7	7648	13	cells	cell	NNS
cord-005453-4057qib7	7648	14	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	7648	15	,	,	,
cord-005453-4057qib7	7648	16	underwent	undergo	VBD
cord-005453-4057qib7	7648	17	72	72	CD
cord-005453-4057qib7	7648	18	collections	collection	NNS
cord-005453-4057qib7	7648	19	.	.	.
cord-005453-4057qib7	7649	1	The	the	DT
cord-005453-4057qib7	7649	2	post	post	NN
cord-005453-4057qib7	7649	3	freeze	freeze	NN
cord-005453-4057qib7	7649	4	median	median	JJ
cord-005453-4057qib7	7649	5	viability	viability	NN
cord-005453-4057qib7	7649	6	was	be	VBD
cord-005453-4057qib7	7649	7	90	90	CD
cord-005453-4057qib7	7649	8	%	%	NN
cord-005453-4057qib7	7649	9	(	(	-LRB-
cord-005453-4057qib7	7649	10	75	75	CD
cord-005453-4057qib7	7649	11	-	-	SYM
cord-005453-4057qib7	7649	12	98	98	CD
cord-005453-4057qib7	7649	13	%	%	NN
cord-005453-4057qib7	7649	14	)	)	-RRB-
cord-005453-4057qib7	7649	15	.	.	.
cord-005453-4057qib7	7650	1	A	a	DT
cord-005453-4057qib7	7650	2	total	total	NN
cord-005453-4057qib7	7650	3	of	of	IN
cord-005453-4057qib7	7650	4	median	median	JJ
cord-005453-4057qib7	7650	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	7650	6	engraftment	engraftment	NN
cord-005453-4057qib7	7650	7	was	be	VBD
cord-005453-4057qib7	7650	8	12.0	12.0	CD
cord-005453-4057qib7	7650	9	days	day	NNS
cord-005453-4057qib7	7650	10	,	,	,
cord-005453-4057qib7	7650	11	with	with	IN
cord-005453-4057qib7	7650	12	a	a	DT
cord-005453-4057qib7	7650	13	median	median	JJ
cord-005453-4057qib7	7650	14	CD34	CD34	NNP
cord-005453-4057qib7	7650	15	dose	dose	NN
cord-005453-4057qib7	7650	16	infused	infuse	VBN
cord-005453-4057qib7	7650	17	of	of	IN
cord-005453-4057qib7	7650	18	4.0	4.0	CD
cord-005453-4057qib7	7650	19	x	x	SYM
cord-005453-4057qib7	7650	20	10	10	CD
cord-005453-4057qib7	7650	21	6	6	CD
cord-005453-4057qib7	7650	22	/kg	/kg	.
cord-005453-4057qib7	7650	23	.	.	.
cord-005453-4057qib7	7651	1	During	during	IN
cord-005453-4057qib7	7651	2	2018	2018	CD
cord-005453-4057qib7	7651	3	so	so	RB
cord-005453-4057qib7	7651	4	far	far	RB
cord-005453-4057qib7	7651	5	,	,	,
cord-005453-4057qib7	7651	6	40	40	CD
cord-005453-4057qib7	7651	7	patients	patient	NNS
cord-005453-4057qib7	7651	8	have	have	VBP
cord-005453-4057qib7	7651	9	undergone	undergo	VBN
cord-005453-4057qib7	7651	10	57	57	CD
cord-005453-4057qib7	7651	11	collections	collection	NNS
cord-005453-4057qib7	7651	12	.	.	.
cord-005453-4057qib7	7652	1	Median	median	JJ
cord-005453-4057qib7	7652	2	viability	viability	NN
cord-005453-4057qib7	7652	3	is	be	VBZ
cord-005453-4057qib7	7652	4	95.5	95.5	CD
cord-005453-4057qib7	7652	5	%	%	NN
cord-005453-4057qib7	7652	6	(	(	-LRB-
cord-005453-4057qib7	7652	7	82	82	CD
cord-005453-4057qib7	7652	8	-	-	SYM
cord-005453-4057qib7	7652	9	98	98	CD
cord-005453-4057qib7	7652	10	%	%	NN
cord-005453-4057qib7	7652	11	)	)	-RRB-
cord-005453-4057qib7	7652	12	.	.	.
cord-005453-4057qib7	7653	1	Subsequent	subsequent	JJ
cord-005453-4057qib7	7653	2	median	median	JJ
cord-005453-4057qib7	7653	3	neutrophil	neutrophil	NN
cord-005453-4057qib7	7653	4	engraftment	engraftment	NN
cord-005453-4057qib7	7653	5	is	be	VBZ
cord-005453-4057qib7	7653	6	11	11	CD
cord-005453-4057qib7	7653	7	days	day	NNS
cord-005453-4057qib7	7653	8	,	,	,
cord-005453-4057qib7	7653	9	with	with	IN
cord-005453-4057qib7	7653	10	a	a	DT
cord-005453-4057qib7	7653	11	median	median	JJ
cord-005453-4057qib7	7653	12	CD34	CD34	NNP
cord-005453-4057qib7	7653	13	dose	dose	NN
cord-005453-4057qib7	7653	14	infused	infuse	VBN
cord-005453-4057qib7	7653	15	of	of	IN
cord-005453-4057qib7	7653	16	4.1	4.1	CD
cord-005453-4057qib7	7653	17	x	x	SYM
cord-005453-4057qib7	7653	18	10	10	CD
cord-005453-4057qib7	7653	19	6	6	CD
cord-005453-4057qib7	7653	20	/kg	/kg	.
cord-005453-4057qib7	7653	21	.	.	.
cord-005453-4057qib7	7654	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7654	2	:	:	:
cord-005453-4057qib7	7655	1	Ongoing	ongoing	JJ
cord-005453-4057qib7	7655	2	savings	saving	NNS
cord-005453-4057qib7	7655	3	of	of	IN
cord-005453-4057qib7	7655	4	approximately	approximately	RB
cord-005453-4057qib7	7655	5	£	£	$
cord-005453-4057qib7	7655	6	6400	6400	CD
cord-005453-4057qib7	7655	7	per	per	IN
cord-005453-4057qib7	7655	8	annum	annum	NN
cord-005453-4057qib7	7655	9	have	have	VBP
cord-005453-4057qib7	7655	10	been	be	VBN
cord-005453-4057qib7	7655	11	made	make	VBN
cord-005453-4057qib7	7655	12	by	by	IN
cord-005453-4057qib7	7655	13	changing	change	VBG
cord-005453-4057qib7	7655	14	our	-PRON-	PRP$
cord-005453-4057qib7	7655	15	procedure	procedure	NN
cord-005453-4057qib7	7655	16	.	.	.
cord-005453-4057qib7	7656	1	The	the	DT
cord-005453-4057qib7	7656	2	benefit	benefit	NN
cord-005453-4057qib7	7656	3	of	of	IN
cord-005453-4057qib7	7656	4	changing	change	VBG
cord-005453-4057qib7	7656	5	to	to	IN
cord-005453-4057qib7	7656	6	a	a	DT
cord-005453-4057qib7	7656	7	simplified	simplified	JJ
cord-005453-4057qib7	7656	8	method	method	NN
cord-005453-4057qib7	7656	9	of	of	IN
cord-005453-4057qib7	7656	10	freezing	freezing	NN
cord-005453-4057qib7	7656	11	has	have	VBZ
cord-005453-4057qib7	7656	12	also	also	RB
cord-005453-4057qib7	7656	13	resulted	result	VBN
cord-005453-4057qib7	7656	14	in	in	IN
cord-005453-4057qib7	7656	15	a	a	DT
cord-005453-4057qib7	7656	16	reduction	reduction	NN
cord-005453-4057qib7	7656	17	in	in	IN
cord-005453-4057qib7	7656	18	staff	staff	NN
cord-005453-4057qib7	7656	19	working	work	VBG
cord-005453-4057qib7	7656	20	overtime	overtime	NN
cord-005453-4057qib7	7656	21	.	.	.
cord-005453-4057qib7	7657	1	More	more	RBR
cord-005453-4057qib7	7657	2	importantly	importantly	RB
cord-005453-4057qib7	7657	3	,	,	,
cord-005453-4057qib7	7657	4	this	this	DT
cord-005453-4057qib7	7657	5	simplified	simplified	JJ
cord-005453-4057qib7	7657	6	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	7657	7	method	method	NN
cord-005453-4057qib7	7657	8	has	have	VBZ
cord-005453-4057qib7	7657	9	resulted	result	VBN
cord-005453-4057qib7	7657	10	in	in	IN
cord-005453-4057qib7	7657	11	an	an	DT
cord-005453-4057qib7	7657	12	improvement	improvement	NN
cord-005453-4057qib7	7657	13	in	in	IN
cord-005453-4057qib7	7657	14	neutrophil	neutrophil	NN
cord-005453-4057qib7	7657	15	engraftment	engraftment	NN
cord-005453-4057qib7	7657	16	times	time	NNS
cord-005453-4057qib7	7657	17	since	since	IN
cord-005453-4057qib7	7657	18	changing	change	VBG
cord-005453-4057qib7	7657	19	the	the	DT
cord-005453-4057qib7	7657	20	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	7657	21	technique	technique	NN
cord-005453-4057qib7	7657	22	from	from	IN
cord-005453-4057qib7	7657	23	the	the	DT
cord-005453-4057qib7	7657	24	previous	previous	JJ
cord-005453-4057qib7	7657	25	method	method	NN
cord-005453-4057qib7	7657	26	using	use	VBG
cord-005453-4057qib7	7657	27	CRF	CRF	NNP
cord-005453-4057qib7	7657	28	to	to	IN
cord-005453-4057qib7	7657	29	mechanical	mechanical	JJ
cord-005453-4057qib7	7657	30	freezing	freezing	NN
cord-005453-4057qib7	7657	31	using	use	VBG
cord-005453-4057qib7	7657	32	a	a	DT
cord-005453-4057qib7	7657	33	minus	minus	NN
cord-005453-4057qib7	7657	34	80	80	CD
cord-005453-4057qib7	7657	35	o	o	NN
cord-005453-4057qib7	7657	36	C	c	NN
cord-005453-4057qib7	7657	37	freezer	freezer	NN
cord-005453-4057qib7	7657	38	.	.	.
cord-005453-4057qib7	7658	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7658	2	:	:	:
cord-005453-4057qib7	7659	1	Nothing	nothing	NN
cord-005453-4057qib7	7659	2	to	to	TO
cord-005453-4057qib7	7659	3	declare	declare	VB
cord-005453-4057qib7	7659	4	Low	low	JJ
cord-005453-4057qib7	7659	5	doses	dose	NNS
cord-005453-4057qib7	7659	6	of	of	IN
cord-005453-4057qib7	7659	7	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7659	8	in	in	IN
cord-005453-4057qib7	7659	9	the	the	DT
cord-005453-4057qib7	7659	10	apheresis	apheresis	NN
cord-005453-4057qib7	7659	11	product	product	NN
cord-005453-4057qib7	7659	12	predict	predict	VBP
cord-005453-4057qib7	7659	13	a	a	DT
cord-005453-4057qib7	7659	14	better	well	JJR
cord-005453-4057qib7	7659	15	outcome	outcome	NN
cord-005453-4057qib7	7659	16	of	of	IN
cord-005453-4057qib7	7659	17	autologous	autologous	JJ
cord-005453-4057qib7	7659	18	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7659	19	stem	stem	NN
cord-005453-4057qib7	7659	20	cell	cell	NN
cord-005453-4057qib7	7659	21	transplantation	transplantation	NN
cord-005453-4057qib7	7659	22	in	in	IN
cord-005453-4057qib7	7659	23	multiple	multiple	JJ
cord-005453-4057qib7	7659	24	myeloma	myeloma	NN
cord-005453-4057qib7	7659	25	patients	patient	NNS
cord-005453-4057qib7	7660	1	Background	background	NN
cord-005453-4057qib7	7660	2	:	:	:
cord-005453-4057qib7	7661	1	High	high	JJ
cord-005453-4057qib7	7661	2	-	-	HYPH
cord-005453-4057qib7	7661	3	dose	dose	NN
cord-005453-4057qib7	7661	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7661	5	with	with	IN
cord-005453-4057qib7	7661	6	autologous	autologous	JJ
cord-005453-4057qib7	7661	7	stem	stem	NN
cord-005453-4057qib7	7661	8	-	-	HYPH
cord-005453-4057qib7	7661	9	cell	cell	NN
cord-005453-4057qib7	7661	10	transplantation	transplantation	NN
cord-005453-4057qib7	7661	11	(	(	-LRB-
cord-005453-4057qib7	7661	12	ASCT	ASCT	NNP
cord-005453-4057qib7	7661	13	)	)	-RRB-
cord-005453-4057qib7	7661	14	remains	remain	VBZ
cord-005453-4057qib7	7661	15	the	the	DT
cord-005453-4057qib7	7661	16	standard	standard	JJ
cord-005453-4057qib7	7661	17	consolidation	consolidation	NN
cord-005453-4057qib7	7661	18	therapy	therapy	NN
cord-005453-4057qib7	7661	19	for	for	IN
cord-005453-4057qib7	7661	20	multiple	multiple	JJ
cord-005453-4057qib7	7661	21	myeloma	myeloma	NN
cord-005453-4057qib7	7661	22	(	(	-LRB-
cord-005453-4057qib7	7661	23	MM	MM	NNP
cord-005453-4057qib7	7661	24	)	)	-RRB-
cord-005453-4057qib7	7661	25	.	.	.
cord-005453-4057qib7	7662	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	7662	2	blood	blood	NN
cord-005453-4057qib7	7662	3	stem	stem	NN
cord-005453-4057qib7	7662	4	cell	cell	NN
cord-005453-4057qib7	7662	5	collection	collection	NN
cord-005453-4057qib7	7662	6	may	may	MD
cord-005453-4057qib7	7662	7	be	be	VB
cord-005453-4057qib7	7662	8	contaminated	contaminate	VBN
cord-005453-4057qib7	7662	9	with	with	IN
cord-005453-4057qib7	7662	10	large	large	JJ
cord-005453-4057qib7	7662	11	quantities	quantity	NNS
cord-005453-4057qib7	7662	12	of	of	IN
cord-005453-4057qib7	7662	13	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7662	14	and	and	CC
cord-005453-4057qib7	7662	15	its	-PRON-	PRP$
cord-005453-4057qib7	7662	16	consequences	consequence	NNS
cord-005453-4057qib7	7662	17	on	on	IN
cord-005453-4057qib7	7662	18	the	the	DT
cord-005453-4057qib7	7662	19	outcome	outcome	NN
cord-005453-4057qib7	7662	20	of	of	IN
cord-005453-4057qib7	7662	21	ASCT	ASCT	NNP
cord-005453-4057qib7	7662	22	are	be	VBP
cord-005453-4057qib7	7662	23	still	still	RB
cord-005453-4057qib7	7662	24	unclear	unclear	JJ
cord-005453-4057qib7	7662	25	.	.	.
cord-005453-4057qib7	7663	1	On	on	IN
cord-005453-4057qib7	7663	2	the	the	DT
cord-005453-4057qib7	7663	3	other	other	JJ
cord-005453-4057qib7	7663	4	hand	hand	NN
cord-005453-4057qib7	7663	5	,	,	,
cord-005453-4057qib7	7663	6	the	the	DT
cord-005453-4057qib7	7663	7	effect	effect	NN
cord-005453-4057qib7	7663	8	of	of	IN
cord-005453-4057qib7	7663	9	performing	perform	VBG
cord-005453-4057qib7	7663	10	apheresis	apheresis	NN
cord-005453-4057qib7	7663	11	with	with	IN
cord-005453-4057qib7	7663	12	high	high	JJ
cord-005453-4057qib7	7663	13	levels	level	NNS
cord-005453-4057qib7	7663	14	of	of	IN
cord-005453-4057qib7	7663	15	monoclonal	monoclonal	JJ
cord-005453-4057qib7	7663	16	component	component	NN
cord-005453-4057qib7	7663	17	(	(	-LRB-
cord-005453-4057qib7	7663	18	MC	MC	NNP
cord-005453-4057qib7	7663	19	)	)	-RRB-
cord-005453-4057qib7	7663	20	on	on	IN
cord-005453-4057qib7	7663	21	outcome	outcome	NN
cord-005453-4057qib7	7663	22	is	be	VBZ
cord-005453-4057qib7	7663	23	unknown	unknown	JJ
cord-005453-4057qib7	7663	24	.	.	.
cord-005453-4057qib7	7664	1	The	the	DT
cord-005453-4057qib7	7664	2	objective	objective	NN
cord-005453-4057qib7	7664	3	of	of	IN
cord-005453-4057qib7	7664	4	this	this	DT
cord-005453-4057qib7	7664	5	study	study	NN
cord-005453-4057qib7	7664	6	was	be	VBD
cord-005453-4057qib7	7664	7	to	to	TO
cord-005453-4057qib7	7664	8	analyze	analyze	VB
cord-005453-4057qib7	7664	9	the	the	DT
cord-005453-4057qib7	7664	10	effect	effect	NN
cord-005453-4057qib7	7664	11	of	of	IN
cord-005453-4057qib7	7664	12	total	total	JJ
cord-005453-4057qib7	7664	13	nucleated	nucleated	JJ
cord-005453-4057qib7	7664	14	cells	cell	NNS
cord-005453-4057qib7	7664	15	(	(	-LRB-
cord-005453-4057qib7	7664	16	TNC	TNC	NNP
cord-005453-4057qib7	7664	17	)	)	-RRB-
cord-005453-4057qib7	7664	18	and	and	CC
cord-005453-4057qib7	7664	19	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7664	20	count	count	VBP
cord-005453-4057qib7	7664	21	(	(	-LRB-
cord-005453-4057qib7	7664	22	considered	consider	VBN
cord-005453-4057qib7	7664	23	as	as	IN
cord-005453-4057qib7	7664	24	contaminating	contaminate	VBG
cord-005453-4057qib7	7664	25	components	component	NNS
cord-005453-4057qib7	7664	26	of	of	IN
cord-005453-4057qib7	7664	27	apheresis	apheresis	NN
cord-005453-4057qib7	7664	28	products	product	NNS
cord-005453-4057qib7	7664	29	)	)	-RRB-
cord-005453-4057qib7	7664	30	as	as	RB
cord-005453-4057qib7	7664	31	well	well	RB
cord-005453-4057qib7	7664	32	as	as	IN
cord-005453-4057qib7	7664	33	the	the	DT
cord-005453-4057qib7	7664	34	influence	influence	NN
cord-005453-4057qib7	7664	35	of	of	IN
cord-005453-4057qib7	7664	36	MC	MC	NNP
cord-005453-4057qib7	7664	37	in	in	IN
cord-005453-4057qib7	7664	38	the	the	DT
cord-005453-4057qib7	7664	39	apheresis	apheresis	NN
cord-005453-4057qib7	7664	40	product	product	NN
cord-005453-4057qib7	7664	41	on	on	IN
cord-005453-4057qib7	7664	42	outcome	outcome	NN
cord-005453-4057qib7	7664	43	of	of	IN
cord-005453-4057qib7	7664	44	ASCT	ASCT	NNP
cord-005453-4057qib7	7664	45	in	in	IN
cord-005453-4057qib7	7664	46	MM	MM	NNP
cord-005453-4057qib7	7664	47	.	.	.
cord-005453-4057qib7	7665	1	Methods	method	NNS
cord-005453-4057qib7	7665	2	:	:	:
cord-005453-4057qib7	7666	1	Eighty	eighty	CD
cord-005453-4057qib7	7666	2	-	-	HYPH
cord-005453-4057qib7	7666	3	two	two	CD
cord-005453-4057qib7	7666	4	patients	patient	NNS
cord-005453-4057qib7	7666	5	diagnosed	diagnose	VBN
cord-005453-4057qib7	7666	6	with	with	IN
cord-005453-4057qib7	7666	7	MM	MM	NNP
cord-005453-4057qib7	7666	8	were	be	VBD
cord-005453-4057qib7	7666	9	mobilized	mobilize	VBN
cord-005453-4057qib7	7666	10	with	with	IN
cord-005453-4057qib7	7666	11	filgrastim	filgrastim	NN
cord-005453-4057qib7	7666	12	10	10	CD
cord-005453-4057qib7	7666	13	μg	μg	NNP
cord-005453-4057qib7	7666	14	/	/	SYM
cord-005453-4057qib7	7666	15	kg	kg	NNP
cord-005453-4057qib7	7666	16	/	/	SYM
cord-005453-4057qib7	7666	17	day	day	NN
cord-005453-4057qib7	7666	18	(	(	-LRB-
cord-005453-4057qib7	7666	19	plus	plus	CC
cord-005453-4057qib7	7666	20	plerixafor	plerixafor	NN
cord-005453-4057qib7	7666	21	if	if	IN
cord-005453-4057qib7	7666	22	insufficient	insufficient	JJ
cord-005453-4057qib7	7666	23	mobilization	mobilization	NN
cord-005453-4057qib7	7666	24	of	of	IN
cord-005453-4057qib7	7666	25	CD34	CD34	NNP
cord-005453-4057qib7	7666	26	+	+	CC
cord-005453-4057qib7	7666	27	cells	cell	NNS
cord-005453-4057qib7	7666	28	on	on	IN
cord-005453-4057qib7	7666	29	day	day	NN
cord-005453-4057qib7	7666	30	4	4	CD
cord-005453-4057qib7	7666	31	)	)	-RRB-
cord-005453-4057qib7	7666	32	.	.	.
cord-005453-4057qib7	7667	1	Apheresis	Apheresis	NNP
cord-005453-4057qib7	7667	2	collection	collection	NN
cord-005453-4057qib7	7667	3	was	be	VBD
cord-005453-4057qib7	7667	4	performed	perform	VBN
cord-005453-4057qib7	7667	5	with	with	IN
cord-005453-4057qib7	7667	6	CMNc	CMNc	NNS
cord-005453-4057qib7	7667	7	program	program	NN
cord-005453-4057qib7	7667	8	by	by	IN
cord-005453-4057qib7	7667	9	Spectra	Spectra	NNP
cord-005453-4057qib7	7667	10	Optia	Optia	NNP
cord-005453-4057qib7	7667	11	cell	cell	NN
cord-005453-4057qib7	7667	12	separator	separator	NN
cord-005453-4057qib7	7667	13	.	.	.
cord-005453-4057qib7	7668	1	CD34	CD34	NNP
cord-005453-4057qib7	7668	2	+	+	CC
cord-005453-4057qib7	7668	3	count	count	NN
cord-005453-4057qib7	7668	4	was	be	VBD
cord-005453-4057qib7	7668	5	carried	carry	VBN
cord-005453-4057qib7	7668	6	out	out	RP
cord-005453-4057qib7	7668	7	according	accord	VBG
cord-005453-4057qib7	7668	8	to	to	IN
cord-005453-4057qib7	7668	9	ISHAGE	ISHAGE	NNP
cord-005453-4057qib7	7668	10	protocol	protocol	NN
cord-005453-4057qib7	7668	11	(	(	-LRB-
cord-005453-4057qib7	7668	12	target	target	NN
cord-005453-4057qib7	7668	13	:	:	:
cord-005453-4057qib7	7668	14	≥2x10E6	≥2x10E6	NNP
cord-005453-4057qib7	7668	15	CD34	CD34	NNP
cord-005453-4057qib7	7668	16	+	+	CC
cord-005453-4057qib7	7669	1	/Kg	/Kg	NNP
cord-005453-4057qib7	7669	2	)	)	-RRB-
cord-005453-4057qib7	7669	3	.	.	.
cord-005453-4057qib7	7670	1	Subsequent	subsequent	JJ
cord-005453-4057qib7	7670	2	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	7670	3	were	be	VBD
cord-005453-4057qib7	7670	4	performed	perform	VBN
cord-005453-4057qib7	7670	5	according	accord	VBG
cord-005453-4057qib7	7670	6	to	to	IN
cord-005453-4057qib7	7670	7	the	the	DT
cord-005453-4057qib7	7670	8	local	local	JJ
cord-005453-4057qib7	7670	9	protocol	protocol	NN
cord-005453-4057qib7	7670	10	.	.	.
cord-005453-4057qib7	7671	1	Results	result	NNS
cord-005453-4057qib7	7671	2	:	:	:
cord-005453-4057qib7	7672	1	The	the	DT
cord-005453-4057qib7	7672	2	medians	median	NNS
cord-005453-4057qib7	7672	3	(	(	-LRB-
cord-005453-4057qib7	7672	4	range	range	NN
cord-005453-4057qib7	7672	5	)	)	-RRB-
cord-005453-4057qib7	7672	6	of	of	IN
cord-005453-4057qib7	7672	7	collected	collect	VBN
cord-005453-4057qib7	7672	8	CD34	CD34	NNP
cord-005453-4057qib7	7672	9	+	+	SYM
cord-005453-4057qib7	7672	10	,	,	,
cord-005453-4057qib7	7672	11	TNC	TNC	NNP
cord-005453-4057qib7	7672	12	and	and	CC
cord-005453-4057qib7	7672	13	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7672	14	were	be	VBD
cord-005453-4057qib7	7672	15	4.69x10	4.69x10	CD
cord-005453-4057qib7	7672	16	6	6	CD
cord-005453-4057qib7	7673	1	/Kg	/Kg	.
cord-005453-4057qib7	7674	1	(	(	-LRB-
cord-005453-4057qib7	7674	2	1.69	1.69	CD
cord-005453-4057qib7	7674	3	-	-	SYM
cord-005453-4057qib7	7674	4	15.54	15.54	CD
cord-005453-4057qib7	7674	5	)	)	-RRB-
cord-005453-4057qib7	7674	6	,	,	,
cord-005453-4057qib7	7674	7	9.35x10	9.35x10	CD
cord-005453-4057qib7	7674	8	8	8	CD
cord-005453-4057qib7	7674	9	/	/	SYM
cord-005453-4057qib7	7674	10	Kg	Kg	NNP
cord-005453-4057qib7	7674	11	(	(	-LRB-
cord-005453-4057qib7	7674	12	2.16	2.16	CD
cord-005453-4057qib7	7674	13	-	-	SYM
cord-005453-4057qib7	7674	14	19.66	19.66	CD
cord-005453-4057qib7	7674	15	)	)	-RRB-
cord-005453-4057qib7	7674	16	and	and	CC
cord-005453-4057qib7	7674	17	13.7x10	13.7x10	CD
cord-005453-4057qib7	7674	18	9	9	CD
cord-005453-4057qib7	7675	1	/Kg	/Kg	.
cord-005453-4057qib7	7676	1	(	(	-LRB-
cord-005453-4057qib7	7676	2	1.4	1.4	CD
cord-005453-4057qib7	7676	3	-	-	SYM
cord-005453-4057qib7	7676	4	90.6	90.6	CD
cord-005453-4057qib7	7676	5	)	)	-RRB-
cord-005453-4057qib7	7676	6	,	,	,
cord-005453-4057qib7	7676	7	respectively	respectively	RB
cord-005453-4057qib7	7676	8	.	.	.
cord-005453-4057qib7	7677	1	The	the	DT
cord-005453-4057qib7	7677	2	medians	median	NNS
cord-005453-4057qib7	7677	3	(	(	-LRB-
cord-005453-4057qib7	7677	4	range	range	NN
cord-005453-4057qib7	7677	5	)	)	-RRB-
cord-005453-4057qib7	7677	6	of	of	IN
cord-005453-4057qib7	7677	7	infused	infuse	VBN
cord-005453-4057qib7	7677	8	CD34	CD34	NNP
cord-005453-4057qib7	7677	9	+	+	SYM
cord-005453-4057qib7	7677	10	,	,	,
cord-005453-4057qib7	7677	11	TNC	TNC	NNP
cord-005453-4057qib7	7677	12	and	and	CC
cord-005453-4057qib7	7677	13	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7677	14	were	be	VBD
cord-005453-4057qib7	7677	15	2.99x10	2.99x10	CD
cord-005453-4057qib7	7677	16	6	6	CD
cord-005453-4057qib7	7678	1	/Kg	/Kg	.
cord-005453-4057qib7	7679	1	(	(	-LRB-
cord-005453-4057qib7	7679	2	0.89	0.89	CD
cord-005453-4057qib7	7679	3	-	-	SYM
cord-005453-4057qib7	7679	4	10.93	10.93	CD
cord-005453-4057qib7	7679	5	)	)	-RRB-
cord-005453-4057qib7	7679	6	,	,	.
cord-005453-4057qib7	7680	1	6.46x10	6.46x10	CD
cord-005453-4057qib7	7681	1	8	8	CD
cord-005453-4057qib7	7681	2	/Kg	/kg	JJ
cord-005453-4057qib7	7681	3	(	(	-LRB-
cord-005453-4057qib7	7681	4	1.93	1.93	CD
cord-005453-4057qib7	7681	5	-	-	SYM
cord-005453-4057qib7	7681	6	18.60	18.60	CD
cord-005453-4057qib7	7681	7	)	)	-RRB-
cord-005453-4057qib7	7681	8	and	and	CC
cord-005453-4057qib7	7681	9	8.30x10	8.30x10	CD
cord-005453-4057qib7	7681	10	9	9	CD
cord-005453-4057qib7	7681	11	/Kg	/kg	NN
cord-005453-4057qib7	7681	12	(	(	-LRB-
cord-005453-4057qib7	7681	13	1.1	1.1	CD
cord-005453-4057qib7	7681	14	-	-	HYPH
cord-005453-4057qib7	7681	15	86.0	86.0	CD
cord-005453-4057qib7	7681	16	)	)	-RRB-
cord-005453-4057qib7	7681	17	,	,	,
cord-005453-4057qib7	7681	18	respectively	respectively	RB
cord-005453-4057qib7	7681	19	.	.	.
cord-005453-4057qib7	7682	1	A	a	DT
cord-005453-4057qib7	7682	2	successful	successful	JJ
cord-005453-4057qib7	7682	3	collection	collection	NN
cord-005453-4057qib7	7682	4	after	after	IN
cord-005453-4057qib7	7682	5	first	first	JJ
cord-005453-4057qib7	7682	6	line	line	NN
cord-005453-4057qib7	7682	7	therapy	therapy	NN
cord-005453-4057qib7	7682	8	was	be	VBD
cord-005453-4057qib7	7682	9	performed	perform	VBN
cord-005453-4057qib7	7682	10	in	in	IN
cord-005453-4057qib7	7682	11	94	94	CD
cord-005453-4057qib7	7682	12	%	%	NN
cord-005453-4057qib7	7682	13	of	of	IN
cord-005453-4057qib7	7682	14	patients	patient	NNS
cord-005453-4057qib7	7682	15	.	.	.
cord-005453-4057qib7	7683	1	Treatment	treatment	NN
cord-005453-4057qib7	7683	2	for	for	IN
cord-005453-4057qib7	7683	3	MM	MM	NNP
cord-005453-4057qib7	7683	4	was	be	VBD
cord-005453-4057qib7	7683	5	continued	continue	VBN
cord-005453-4057qib7	7683	6	after	after	IN
cord-005453-4057qib7	7683	7	carrying	carry	VBG
cord-005453-4057qib7	7683	8	out	out	RP
cord-005453-4057qib7	7683	9	apheresis	apheresis	NN
cord-005453-4057qib7	7683	10	in	in	IN
cord-005453-4057qib7	7683	11	40	40	CD
cord-005453-4057qib7	7683	12	%	%	NN
cord-005453-4057qib7	7683	13	of	of	IN
cord-005453-4057qib7	7683	14	patients	patient	NNS
cord-005453-4057qib7	7683	15	,	,	,
cord-005453-4057qib7	7683	16	as	as	IN
cord-005453-4057qib7	7683	17	per	per	IN
cord-005453-4057qib7	7683	18	protocol	protocol	NN
cord-005453-4057qib7	7683	19	.	.	.
cord-005453-4057qib7	7684	1	A	a	DT
cord-005453-4057qib7	7684	2	significant	significant	JJ
cord-005453-4057qib7	7684	3	reduction	reduction	NN
cord-005453-4057qib7	7684	4	of	of	IN
cord-005453-4057qib7	7684	5	MC	MC	NNP
cord-005453-4057qib7	7684	6	was	be	VBD
cord-005453-4057qib7	7684	7	observed	observe	VBN
cord-005453-4057qib7	7684	8	prior	prior	RB
cord-005453-4057qib7	7684	9	to	to	IN
cord-005453-4057qib7	7684	10	ASCT	ASCT	NNP
cord-005453-4057qib7	7684	11	,	,	,
cord-005453-4057qib7	7684	12	indicating	indicate	VBG
cord-005453-4057qib7	7684	13	a	a	DT
cord-005453-4057qib7	7684	14	further	further	JJ
cord-005453-4057qib7	7684	15	improvement	improvement	NN
cord-005453-4057qib7	7684	16	in	in	IN
cord-005453-4057qib7	7684	17	responses	response	NNS
cord-005453-4057qib7	7684	18	after	after	IN
cord-005453-4057qib7	7684	19	apheresis	apheresis	NN
cord-005453-4057qib7	7684	20	(	(	-LRB-
cord-005453-4057qib7	7684	21	p=0.005	p=0.005	NNP
cord-005453-4057qib7	7684	22	)	)	-RRB-
cord-005453-4057qib7	7684	23	.	.	.
cord-005453-4057qib7	7685	1	An	an	DT
cord-005453-4057qib7	7685	2	optimal	optimal	JJ
cord-005453-4057qib7	7685	3	response	response	NN
cord-005453-4057qib7	7685	4	(	(	-LRB-
cord-005453-4057qib7	7685	5	CR	CR	NNP
cord-005453-4057qib7	7685	6	or	or	CC
cord-005453-4057qib7	7685	7	VGPR	VGPR	NNP
cord-005453-4057qib7	7685	8	)	)	-RRB-
cord-005453-4057qib7	7685	9	at	at	IN
cord-005453-4057qib7	7685	10	the	the	DT
cord-005453-4057qib7	7685	11	time	time	NN
cord-005453-4057qib7	7685	12	of	of	IN
cord-005453-4057qib7	7685	13	apheresis	apheresis	NN
cord-005453-4057qib7	7685	14	was	be	VBD
cord-005453-4057qib7	7685	15	achieved	achieve	VBN
cord-005453-4057qib7	7685	16	in	in	IN
cord-005453-4057qib7	7685	17	45	45	CD
cord-005453-4057qib7	7685	18	%	%	NN
cord-005453-4057qib7	7685	19	of	of	IN
cord-005453-4057qib7	7685	20	patients	patient	NNS
cord-005453-4057qib7	7685	21	and	and	CC
cord-005453-4057qib7	7685	22	a	a	DT
cord-005453-4057qib7	7685	23	suboptimal	suboptimal	JJ
cord-005453-4057qib7	7685	24	response	response	NN
cord-005453-4057qib7	7685	25	(	(	-LRB-
cord-005453-4057qib7	7685	26	partial	partial	JJ
cord-005453-4057qib7	7685	27	or	or	CC
cord-005453-4057qib7	7685	28	minimal	minimal	JJ
cord-005453-4057qib7	7685	29	response	response	NN
cord-005453-4057qib7	7685	30	)	)	-RRB-
cord-005453-4057qib7	7685	31	was	be	VBD
cord-005453-4057qib7	7685	32	observed	observe	VBN
cord-005453-4057qib7	7685	33	in	in	IN
cord-005453-4057qib7	7685	34	the	the	DT
cord-005453-4057qib7	7685	35	remaining	remain	VBG
cord-005453-4057qib7	7685	36	55	55	CD
cord-005453-4057qib7	7685	37	%	%	NN
cord-005453-4057qib7	7685	38	.	.	.
cord-005453-4057qib7	7686	1	Undergoing	undergo	VBG
cord-005453-4057qib7	7686	2	apheresis	apheresis	NN
cord-005453-4057qib7	7686	3	in	in	IN
cord-005453-4057qib7	7686	4	optimal	optimal	JJ
cord-005453-4057qib7	7686	5	response	response	NN
cord-005453-4057qib7	7686	6	did	do	VBD
cord-005453-4057qib7	7686	7	not	not	RB
cord-005453-4057qib7	7686	8	result	result	VB
cord-005453-4057qib7	7686	9	in	in	IN
cord-005453-4057qib7	7686	10	lower	low	JJR
cord-005453-4057qib7	7686	11	number	number	NN
cord-005453-4057qib7	7686	12	of	of	IN
cord-005453-4057qib7	7686	13	TNC	TNC	NNP
cord-005453-4057qib7	7686	14	or	or	CC
cord-005453-4057qib7	7686	15	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7686	16	in	in	IN
cord-005453-4057qib7	7686	17	the	the	DT
cord-005453-4057qib7	7686	18	harvest	harvest	NN
cord-005453-4057qib7	7686	19	.	.	.
cord-005453-4057qib7	7687	1	The	the	DT
cord-005453-4057qib7	7687	2	subtype	subtype	NN
cord-005453-4057qib7	7687	3	of	of	IN
cord-005453-4057qib7	7687	4	MC	MC	NNP
cord-005453-4057qib7	7687	5	did	do	VBD
cord-005453-4057qib7	7687	6	not	not	RB
cord-005453-4057qib7	7687	7	influence	influence	VB
cord-005453-4057qib7	7687	8	on	on	IN
cord-005453-4057qib7	7687	9	the	the	DT
cord-005453-4057qib7	7687	10	number	number	NN
cord-005453-4057qib7	7687	11	of	of	IN
cord-005453-4057qib7	7687	12	TNC	TNC	NNP
cord-005453-4057qib7	7687	13	and	and	CC
cord-005453-4057qib7	7687	14	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7687	15	in	in	IN
cord-005453-4057qib7	7687	16	the	the	DT
cord-005453-4057qib7	7687	17	product	product	NN
cord-005453-4057qib7	7687	18	of	of	IN
cord-005453-4057qib7	7687	19	apheresis	apheresis	NN
cord-005453-4057qib7	7687	20	.	.	.
cord-005453-4057qib7	7688	1	No	no	DT
cord-005453-4057qib7	7688	2	differences	difference	NNS
cord-005453-4057qib7	7688	3	in	in	IN
cord-005453-4057qib7	7688	4	collected	collect	VBN
cord-005453-4057qib7	7688	5	TNC	TNC	NNP
cord-005453-4057qib7	7688	6	and	and	CC
cord-005453-4057qib7	7688	7	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7688	8	were	be	VBD
cord-005453-4057qib7	7688	9	observed	observe	VBN
cord-005453-4057qib7	7688	10	when	when	WRB
cord-005453-4057qib7	7688	11	plerixafor	plerixafor	NN
cord-005453-4057qib7	7688	12	was	be	VBD
cord-005453-4057qib7	7688	13	used	use	VBN
cord-005453-4057qib7	7688	14	as	as	IN
cord-005453-4057qib7	7688	15	mobilizing	mobilize	VBG
cord-005453-4057qib7	7688	16	agent	agent	NN
cord-005453-4057qib7	7688	17	.	.	.
cord-005453-4057qib7	7689	1	The	the	DT
cord-005453-4057qib7	7689	2	type	type	NN
cord-005453-4057qib7	7689	3	of	of	IN
cord-005453-4057qib7	7689	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7689	5	given	give	VBN
cord-005453-4057qib7	7689	6	prior	prior	RB
cord-005453-4057qib7	7689	7	the	the	DT
cord-005453-4057qib7	7689	8	apheresis	apheresis	NN
cord-005453-4057qib7	7689	9	did	do	VBD
cord-005453-4057qib7	7689	10	not	not	RB
cord-005453-4057qib7	7689	11	have	have	VB
cord-005453-4057qib7	7689	12	influence	influence	NN
cord-005453-4057qib7	7689	13	on	on	IN
cord-005453-4057qib7	7689	14	the	the	DT
cord-005453-4057qib7	7689	15	characteristics	characteristic	NNS
cord-005453-4057qib7	7689	16	of	of	IN
cord-005453-4057qib7	7689	17	the	the	DT
cord-005453-4057qib7	7689	18	apheresis	apheresis	NN
cord-005453-4057qib7	7689	19	product	product	NN
cord-005453-4057qib7	7689	20	.	.	.
cord-005453-4057qib7	7690	1	A	a	DT
cord-005453-4057qib7	7690	2	significant	significant	JJ
cord-005453-4057qib7	7690	3	improvement	improvement	NN
cord-005453-4057qib7	7690	4	in	in	IN
cord-005453-4057qib7	7690	5	overall	overall	JJ
cord-005453-4057qib7	7690	6	survival	survival	NN
cord-005453-4057qib7	7690	7	(	(	-LRB-
cord-005453-4057qib7	7690	8	OS	os	NN
cord-005453-4057qib7	7690	9	)	)	-RRB-
cord-005453-4057qib7	7690	10	probability	probability	NN
cord-005453-4057qib7	7690	11	(	(	-LRB-
cord-005453-4057qib7	7690	12	95%CI	95%ci	CD
cord-005453-4057qib7	7690	13	)	)	-RRB-
cord-005453-4057qib7	7690	14	was	be	VBD
cord-005453-4057qib7	7690	15	observed	observe	VBN
cord-005453-4057qib7	7690	16	when	when	WRB
cord-005453-4057qib7	7690	17	low	low	JJ
cord-005453-4057qib7	7690	18	TNC	TNC	NNP
cord-005453-4057qib7	7690	19	(	(	-LRB-
cord-005453-4057qib7	7690	20	<	<	NNP
cord-005453-4057qib7	7690	21	6.46x10	6.46x10	CD
cord-005453-4057qib7	7690	22	8	8	CD
cord-005453-4057qib7	7690	23	Figure	figure	NN
cord-005453-4057qib7	7690	24	1A	1a	NN
cord-005453-4057qib7	7690	25	)	)	-RRB-
cord-005453-4057qib7	7690	26	.	.	.
cord-005453-4057qib7	7691	1	Lower	low	JJR
cord-005453-4057qib7	7691	2	incidence	incidence	NN
cord-005453-4057qib7	7691	3	of	of	IN
cord-005453-4057qib7	7691	4	relapse	relapse	NN
cord-005453-4057qib7	7691	5	(	(	-LRB-
cord-005453-4057qib7	7691	6	p=0.044	p=0.044	NNS
cord-005453-4057qib7	7691	7	)	)	-RRB-
cord-005453-4057qib7	7692	1	(	(	-LRB-
cord-005453-4057qib7	7692	2	Figure	figure	NN
cord-005453-4057qib7	7692	3	1B	1b	CD
cord-005453-4057qib7	7692	4	)	)	-RRB-
cord-005453-4057qib7	7692	5	and	and	CC
cord-005453-4057qib7	7692	6	non	non	JJ
cord-005453-4057qib7	7692	7	-	-	JJ
cord-005453-4057qib7	7692	8	relapse	relapse	JJ
cord-005453-4057qib7	7692	9	mortality	mortality	NN
cord-005453-4057qib7	7692	10	(	(	-LRB-
cord-005453-4057qib7	7692	11	p=0.040	p=0.040	NNP
cord-005453-4057qib7	7692	12	)	)	-RRB-
cord-005453-4057qib7	7692	13	was	be	VBD
cord-005453-4057qib7	7692	14	observed	observe	VBN
cord-005453-4057qib7	7692	15	in	in	IN
cord-005453-4057qib7	7692	16	patients	patient	NNS
cord-005453-4057qib7	7692	17	who	who	WP
cord-005453-4057qib7	7692	18	received	receive	VBD
cord-005453-4057qib7	7692	19	low	low	JJ
cord-005453-4057qib7	7692	20	granulocyte	granulocyte	NN
cord-005453-4057qib7	7692	21	count	count	NN
cord-005453-4057qib7	7692	22	in	in	IN
cord-005453-4057qib7	7692	23	the	the	DT
cord-005453-4057qib7	7692	24	graft	graft	NN
cord-005453-4057qib7	7692	25	.	.	.
cord-005453-4057qib7	7693	1	No	no	DT
cord-005453-4057qib7	7693	2	significant	significant	JJ
cord-005453-4057qib7	7693	3	correlation	correlation	NN
cord-005453-4057qib7	7693	4	was	be	VBD
cord-005453-4057qib7	7693	5	observed	observe	VBN
cord-005453-4057qib7	7693	6	between	between	IN
cord-005453-4057qib7	7693	7	the	the	DT
cord-005453-4057qib7	7693	8	time	time	NN
cord-005453-4057qib7	7693	9	of	of	IN
cord-005453-4057qib7	7693	10	engraftment	engraftment	NN
cord-005453-4057qib7	7693	11	and	and	CC
cord-005453-4057qib7	7693	12	the	the	DT
cord-005453-4057qib7	7693	13	number	number	NN
cord-005453-4057qib7	7693	14	of	of	IN
cord-005453-4057qib7	7693	15	TNC	TNC	NNP
cord-005453-4057qib7	7693	16	or	or	CC
cord-005453-4057qib7	7693	17	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7693	18	infused	infuse	VBN
cord-005453-4057qib7	7693	19	.	.	.
cord-005453-4057qib7	7694	1	Similarly	similarly	RB
cord-005453-4057qib7	7694	2	,	,	,
cord-005453-4057qib7	7694	3	no	no	DT
cord-005453-4057qib7	7694	4	increase	increase	NN
cord-005453-4057qib7	7694	5	in	in	IN
cord-005453-4057qib7	7694	6	the	the	DT
cord-005453-4057qib7	7694	7	frequency	frequency	NN
cord-005453-4057qib7	7694	8	of	of	IN
cord-005453-4057qib7	7694	9	the	the	DT
cord-005453-4057qib7	7694	10	engraftment	engraftment	NNP
cord-005453-4057qib7	7694	11	syndrome	syndrome	NNP
cord-005453-4057qib7	7694	12	was	be	VBD
cord-005453-4057qib7	7694	13	observed	observe	VBN
cord-005453-4057qib7	7694	14	when	when	WRB
cord-005453-4057qib7	7694	15	higher	high	JJR
cord-005453-4057qib7	7694	16	number	number	NN
cord-005453-4057qib7	7694	17	of	of	IN
cord-005453-4057qib7	7694	18	TNC	TNC	NNP
cord-005453-4057qib7	7694	19	or	or	CC
cord-005453-4057qib7	7694	20	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7694	21	were	be	VBD
cord-005453-4057qib7	7694	22	infused	infuse	VBN
cord-005453-4057qib7	7694	23	.	.	.
cord-005453-4057qib7	7695	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7695	2	:	:	:
cord-005453-4057qib7	7696	1	In	in	IN
cord-005453-4057qib7	7696	2	our	-PRON-	PRP$
cord-005453-4057qib7	7696	3	series	series	NN
cord-005453-4057qib7	7696	4	,	,	,
cord-005453-4057qib7	7696	5	low	low	JJ
cord-005453-4057qib7	7696	6	doses	dose	NNS
cord-005453-4057qib7	7696	7	of	of	IN
cord-005453-4057qib7	7696	8	granulocytes	granulocyte	NNS
cord-005453-4057qib7	7696	9	in	in	IN
cord-005453-4057qib7	7696	10	the	the	DT
cord-005453-4057qib7	7696	11	product	product	NN
cord-005453-4057qib7	7696	12	of	of	IN
cord-005453-4057qib7	7696	13	apheresis	apheresis	NN
cord-005453-4057qib7	7696	14	predicted	predict	VBD
cord-005453-4057qib7	7696	15	a	a	DT
cord-005453-4057qib7	7696	16	better	well	JJR
cord-005453-4057qib7	7696	17	outcome	outcome	NN
cord-005453-4057qib7	7696	18	of	of	IN
cord-005453-4057qib7	7696	19	ASCT	ASCT	NNP
cord-005453-4057qib7	7696	20	in	in	IN
cord-005453-4057qib7	7696	21	MM	MM	NNP
cord-005453-4057qib7	7696	22	patients	patient	NNS
cord-005453-4057qib7	7696	23	.	.	.
cord-005453-4057qib7	7697	1	The	the	DT
cord-005453-4057qib7	7697	2	amount	amount	NN
cord-005453-4057qib7	7697	3	of	of	IN
cord-005453-4057qib7	7697	4	MC	MC	NNP
cord-005453-4057qib7	7697	5	at	at	IN
cord-005453-4057qib7	7697	6	the	the	DT
cord-005453-4057qib7	7697	7	time	time	NN
cord-005453-4057qib7	7697	8	of	of	IN
cord-005453-4057qib7	7697	9	apheresis	apheresis	NN
cord-005453-4057qib7	7697	10	did	do	VBD
cord-005453-4057qib7	7697	11	not	not	RB
cord-005453-4057qib7	7697	12	have	have	VB
cord-005453-4057qib7	7697	13	influence	influence	NN
cord-005453-4057qib7	7697	14	in	in	IN
cord-005453-4057qib7	7697	15	the	the	DT
cord-005453-4057qib7	7697	16	characteristics	characteristic	NNS
cord-005453-4057qib7	7697	17	of	of	IN
cord-005453-4057qib7	7697	18	the	the	DT
cord-005453-4057qib7	7697	19	harvest	harvest	NN
cord-005453-4057qib7	7697	20	.	.	.
cord-005453-4057qib7	7698	1	Efforts	effort	NNS
cord-005453-4057qib7	7698	2	for	for	IN
cord-005453-4057qib7	7698	3	avoiding	avoid	VBG
cord-005453-4057qib7	7698	4	contamination	contamination	NN
cord-005453-4057qib7	7698	5	in	in	IN
cord-005453-4057qib7	7698	6	grafts	graft	NNS
cord-005453-4057qib7	7698	7	are	be	VBP
cord-005453-4057qib7	7698	8	important	important	JJ
cord-005453-4057qib7	7698	9	for	for	IN
cord-005453-4057qib7	7698	10	its	-PRON-	PRP$
cord-005453-4057qib7	7698	11	impact	impact	NN
cord-005453-4057qib7	7698	12	on	on	IN
cord-005453-4057qib7	7698	13	outcome	outcome	NN
cord-005453-4057qib7	7698	14	of	of	IN
cord-005453-4057qib7	7698	15	ASCT	ASCT	NNP
cord-005453-4057qib7	7698	16	in	in	IN
cord-005453-4057qib7	7698	17	MM	MM	NNP
cord-005453-4057qib7	7698	18	patients	patient	NNS
cord-005453-4057qib7	7698	19	.	.	.
cord-005453-4057qib7	7699	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7699	2	:	:	:
cord-005453-4057qib7	7699	3	DKMS	DKMS	NNP
cord-005453-4057qib7	7699	4	Foundation	Foundation	NNP
cord-005453-4057qib7	7699	5	,	,	,
cord-005453-4057qib7	7699	6	PI14/01971	PI14/01971	NNP
cord-005453-4057qib7	7700	1	(	(	-LRB-
cord-005453-4057qib7	7700	2	Instituto	Instituto	NNP
cord-005453-4057qib7	7700	3	Carlos	Carlos	NNP
cord-005453-4057qib7	7700	4	III	III	NNP
cord-005453-4057qib7	7700	5	)	)	-RRB-
cord-005453-4057qib7	7701	1	and	and	CC
cord-005453-4057qib7	7701	2	SGR288	SGR288	NNP
cord-005453-4057qib7	7701	3	(	(	-LRB-
cord-005453-4057qib7	7701	4	GRC	GRC	NNP
cord-005453-4057qib7	7701	5	)	)	-RRB-
cord-005453-4057qib7	7701	6	,	,	,
cord-005453-4057qib7	7701	7	Generalitat	Generalitat	NNP
cord-005453-4057qib7	7701	8	de	de	NNP
cord-005453-4057qib7	7701	9	Catalunya	Catalunya	NNP
cord-005453-4057qib7	7701	10	.	.	.
cord-005453-4057qib7	7702	1	Background	background	NN
cord-005453-4057qib7	7702	2	:	:	:
cord-005453-4057qib7	7703	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7703	2	initial	initial	JJ
cord-005453-4057qib7	7703	3	experience	experience	NN
cord-005453-4057qib7	7703	4	(	(	-LRB-
cord-005453-4057qib7	7703	5	from	from	IN
cord-005453-4057qib7	7703	6	2012	2012	CD
cord-005453-4057qib7	7703	7	to	to	IN
cord-005453-4057qib7	7703	8	2017	2017	CD
cord-005453-4057qib7	7703	9	years	year	NNS
cord-005453-4057qib7	7703	10	)	)	-RRB-
cord-005453-4057qib7	7703	11	with	with	IN
cord-005453-4057qib7	7703	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7703	13	stem	stem	NN
cord-005453-4057qib7	7703	14	cell	cell	NN
cord-005453-4057qib7	7703	15	transplantation	transplantation	NN
cord-005453-4057qib7	7703	16	(	(	-LRB-
cord-005453-4057qib7	7703	17	HSCT	HSCT	NNP
cord-005453-4057qib7	7703	18	)	)	-RRB-
cord-005453-4057qib7	7703	19	from	from	IN
cord-005453-4057qib7	7703	20	MUD	mud	NN
cord-005453-4057qib7	7703	21	with	with	IN
cord-005453-4057qib7	7703	22	TCRαβ+/CD19	tcrαβ+/cd19	NN
cord-005453-4057qib7	7703	23	+	+	CC
cord-005453-4057qib7	7703	24	graft	graft	NN
cord-005453-4057qib7	7703	25	depletion	depletion	NN
cord-005453-4057qib7	7703	26	in	in	IN
cord-005453-4057qib7	7703	27	patients	patient	NNS
cord-005453-4057qib7	7703	28	with	with	IN
cord-005453-4057qib7	7703	29	CGD	CGD	NNP
cord-005453-4057qib7	7703	30	showed	show	VBD
cord-005453-4057qib7	7703	31	high	high	JJ
cord-005453-4057qib7	7703	32	rate	rate	NN
cord-005453-4057qib7	7703	33	of	of	IN
cord-005453-4057qib7	7703	34	secondary	secondary	JJ
cord-005453-4057qib7	7703	35	graft	graft	NN
cord-005453-4057qib7	7703	36	dysfunction	dysfunction	NN
cord-005453-4057qib7	7703	37	,	,	,
cord-005453-4057qib7	7703	38	the	the	DT
cord-005453-4057qib7	7703	39	incident	incident	NN
cord-005453-4057qib7	7703	40	of	of	IN
cord-005453-4057qib7	7703	41	graft	graft	NN
cord-005453-4057qib7	7703	42	rejection	rejection	NN
cord-005453-4057qib7	7703	43	was	be	VBD
cord-005453-4057qib7	7703	44	29	29	CD
cord-005453-4057qib7	7703	45	%	%	NN
cord-005453-4057qib7	7703	46	.	.	.
cord-005453-4057qib7	7704	1	To	to	TO
cord-005453-4057qib7	7704	2	improve	improve	VB
cord-005453-4057qib7	7704	3	the	the	DT
cord-005453-4057qib7	7704	4	outcome	outcome	NN
cord-005453-4057qib7	7704	5	,	,	,
cord-005453-4057qib7	7704	6	we	-PRON-	PRP
cord-005453-4057qib7	7704	7	hypothesized	hypothesize	VBD
cord-005453-4057qib7	7704	8	that	that	IN
cord-005453-4057qib7	7704	9	the	the	DT
cord-005453-4057qib7	7704	10	use	use	NN
cord-005453-4057qib7	7704	11	of	of	IN
cord-005453-4057qib7	7704	12	plerixafor	plerixafor	NN
cord-005453-4057qib7	7704	13	and	and	CC
cord-005453-4057qib7	7704	14	G	G	NNP
cord-005453-4057qib7	7704	15	-	-	HYPH
cord-005453-4057qib7	7704	16	CSF	CSF	NNP
cord-005453-4057qib7	7704	17	as	as	IN
cord-005453-4057qib7	7704	18	additional	additional	JJ
cord-005453-4057qib7	7704	19	agents	agent	NNS
cord-005453-4057qib7	7704	20	in	in	IN
cord-005453-4057qib7	7704	21	conditioning	conditioning	NN
cord-005453-4057qib7	7704	22	regimen	regimen	NN
cord-005453-4057qib7	7704	23	would	would	MD
cord-005453-4057qib7	7704	24	offers	offer	VBZ
cord-005453-4057qib7	7704	25	advantages	advantage	NNS
cord-005453-4057qib7	7704	26	and	and	CC
cord-005453-4057qib7	7704	27	better	well	JJR
cord-005453-4057qib7	7704	28	outcomes	outcome	NNS
cord-005453-4057qib7	7704	29	.	.	.
cord-005453-4057qib7	7705	1	This	this	DT
cord-005453-4057qib7	7705	2	trial	trial	NN
cord-005453-4057qib7	7705	3	was	be	VBD
cord-005453-4057qib7	7705	4	registered	register	VBN
cord-005453-4057qib7	7705	5	at	at	IN
cord-005453-4057qib7	7705	6	www.clinicaltrials.gov	www.clinicaltrials.gov	NNP
cord-005453-4057qib7	7705	7	(	(	-LRB-
cord-005453-4057qib7	7705	8	NCT03547830	NCT03547830	NNP
cord-005453-4057qib7	7705	9	)	)	-RRB-
cord-005453-4057qib7	7705	10	Methods	method	NNS
cord-005453-4057qib7	7705	11	:	:	:
cord-005453-4057qib7	7705	12	Between	between	IN
cord-005453-4057qib7	7705	13	April	April	NNP
cord-005453-4057qib7	7705	14	2018	2018	CD
cord-005453-4057qib7	7705	15	and	and	CC
cord-005453-4057qib7	7705	16	September	September	NNP
cord-005453-4057qib7	7705	17	2018	2018	CD
cord-005453-4057qib7	7705	18	,	,	,
cord-005453-4057qib7	7705	19	5	5	CD
cord-005453-4057qib7	7705	20	patients	patient	NNS
cord-005453-4057qib7	7705	21	with	with	IN
cord-005453-4057qib7	7705	22	CGD	CGD	NNP
cord-005453-4057qib7	7705	23	underwent	undergo	VBD
cord-005453-4057qib7	7705	24	allogeneic	allogeneic	JJ
cord-005453-4057qib7	7705	25	HSCTs	hsct	NNS
cord-005453-4057qib7	7705	26	from	from	IN
cord-005453-4057qib7	7705	27	mached	mached	JJ
cord-005453-4057qib7	7705	28	unrelated	unrelated	JJ
cord-005453-4057qib7	7705	29	donors	donor	NNS
cord-005453-4057qib7	7705	30	with	with	IN
cord-005453-4057qib7	7705	31	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	7705	32	+	+	CC
cord-005453-4057qib7	7705	33	/	/	.
cord-005453-4057qib7	7706	1	CD19	CD19	NNP
cord-005453-4057qib7	7706	2	+	+	CC
cord-005453-4057qib7	7706	3	graft	graft	NN
cord-005453-4057qib7	7706	4	.	.	.
cord-005453-4057qib7	7707	1	The	the	DT
cord-005453-4057qib7	7707	2	conditioning	conditioning	NN
cord-005453-4057qib7	7707	3	regimen	regimen	NN
cord-005453-4057qib7	7707	4	included	include	VBD
cord-005453-4057qib7	7707	5	-treosulfan	-treosulfan	NN
cord-005453-4057qib7	7707	6	42	42	CD
cord-005453-4057qib7	7707	7	g	g	NN
cord-005453-4057qib7	7707	8	/	/	SYM
cord-005453-4057qib7	7707	9	m2	m2	NNP
cord-005453-4057qib7	7707	10	,	,	,
cord-005453-4057qib7	7707	11	fludarabine	fludarabine	JJ
cord-005453-4057qib7	7707	12	150	150	CD
cord-005453-4057qib7	7707	13	mg	mg	NNP
cord-005453-4057qib7	7707	14	/	/	SYM
cord-005453-4057qib7	7707	15	m2	m2	NNP
cord-005453-4057qib7	7707	16	,	,	,
cord-005453-4057qib7	7707	17	thiotepa	thiotepa	JJ
cord-005453-4057qib7	7707	18	10	10	CD
cord-005453-4057qib7	7707	19	mg	mg	NNP
cord-005453-4057qib7	7707	20	/	/	SYM
cord-005453-4057qib7	7707	21	kg	kg	NNP
cord-005453-4057qib7	7707	22	,	,	,
cord-005453-4057qib7	7707	23	G	G	NNP
cord-005453-4057qib7	7707	24	-	-	HYPH
cord-005453-4057qib7	7707	25	CSF	CSF	NNP
cord-005453-4057qib7	7707	26	50	50	CD
cord-005453-4057qib7	7707	27	mcg	mcg	NNP
cord-005453-4057qib7	7707	28	/	/	SYM
cord-005453-4057qib7	7707	29	kg	kg	NN
cord-005453-4057qib7	7707	30	and	and	CC
cord-005453-4057qib7	7707	31	plerixafor	plerixafor	NN
cord-005453-4057qib7	7707	32	720	720	CD
cord-005453-4057qib7	7707	33	mcg	mcg	NN
cord-005453-4057qib7	7707	34	/	/	SYM
cord-005453-4057qib7	7707	35	kg	kg	NNP
cord-005453-4057qib7	7707	36	.	.	.
cord-005453-4057qib7	7708	1	All	all	DT
cord-005453-4057qib7	7708	2	patients	patient	NNS
cord-005453-4057qib7	7708	3	received	receive	VBD
cord-005453-4057qib7	7708	4	rabbit	rabbit	NN
cord-005453-4057qib7	7708	5	ATG	ATG	NNP
cord-005453-4057qib7	7708	6	-Timoglobulin	-Timoglobulin	.
cord-005453-4057qib7	7709	1	®	®	VB
cord-005453-4057qib7	7709	2	(	(	-LRB-
cord-005453-4057qib7	7709	3	"	"	``
cord-005453-4057qib7	7709	4	Genzyme	Genzyme	NNP
cord-005453-4057qib7	7709	5	Europe	Europe	NNP
cord-005453-4057qib7	7709	6	B.V.	B.V.	NNP
cord-005453-4057qib7	7709	7	"	"	''
cord-005453-4057qib7	7709	8	,	,	,
cord-005453-4057qib7	7709	9	The	the	DT
cord-005453-4057qib7	7709	10	Netherlands	Netherlands	NNP
cord-005453-4057qib7	7709	11	)	)	-RRB-
cord-005453-4057qib7	7710	1	5	5	CD
cord-005453-4057qib7	7710	2	mg	mg	NNP
cord-005453-4057qib7	7710	3	/	/	SYM
cord-005453-4057qib7	7710	4	kg	kg	NNP
cord-005453-4057qib7	7710	5	for	for	IN
cord-005453-4057qib7	7710	6	serotherapy	serotherapy	NNP
cord-005453-4057qib7	7710	7	.	.	.
cord-005453-4057qib7	7711	1	In	in	IN
cord-005453-4057qib7	7711	2	all	all	DT
cord-005453-4057qib7	7711	3	cases	case	NNS
cord-005453-4057qib7	7711	4	,	,	,
cord-005453-4057qib7	7711	5	TCRab	TCRab	NNP
cord-005453-4057qib7	7711	6	+	+	CC
cord-005453-4057qib7	7711	7	/CD19	/cd19	NN
cord-005453-4057qib7	7711	8	+	+	CC
cord-005453-4057qib7	7711	9	graft	graft	NN
cord-005453-4057qib7	7711	10	depletion	depletion	NN
cord-005453-4057qib7	7711	11	was	be	VBD
cord-005453-4057qib7	7711	12	used	use	VBN
cord-005453-4057qib7	7711	13	with	with	IN
cord-005453-4057qib7	7711	14	the	the	DT
cord-005453-4057qib7	7711	15	immunemagnetic	immunemagnetic	JJ
cord-005453-4057qib7	7711	16	method	method	NN
cord-005453-4057qib7	7711	17	(	(	-LRB-
cord-005453-4057qib7	7711	18	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	7711	19	Biotec	Biotec	NNP
cord-005453-4057qib7	7711	20	,	,	,
cord-005453-4057qib7	7711	21	Bergisch	Bergisch	NNP
cord-005453-4057qib7	7711	22	Gladbach	Gladbach	NNP
cord-005453-4057qib7	7711	23	,	,	,
cord-005453-4057qib7	7711	24	Germany	Germany	NNP
cord-005453-4057qib7	7711	25	)	)	-RRB-
cord-005453-4057qib7	7711	26	according	accord	VBG
cord-005453-4057qib7	7711	27	to	to	IN
cord-005453-4057qib7	7711	28	the	the	DT
cord-005453-4057qib7	7711	29	manufacturer	manufacturer	NN
cord-005453-4057qib7	7711	30	's	's	POS
cord-005453-4057qib7	7711	31	instructions	instruction	NNS
cord-005453-4057qib7	7711	32	.	.	.
cord-005453-4057qib7	7712	1	Stem	stem	JJ
cord-005453-4057qib7	7712	2	cell	cell	NN
cord-005453-4057qib7	7712	3	source	source	NN
cord-005453-4057qib7	7712	4	was	be	VBD
cord-005453-4057qib7	7712	5	G	G	NNP
cord-005453-4057qib7	7712	6	-	-	HYPH
cord-005453-4057qib7	7712	7	CSF	CSF	NNP
cord-005453-4057qib7	7712	8	mobilized	mobilize	VBD
cord-005453-4057qib7	7712	9	peripheral	peripheral	JJ
cord-005453-4057qib7	7712	10	blood	blood	NN
cord-005453-4057qib7	7712	11	stem	stem	NN
cord-005453-4057qib7	7712	12	cells	cell	NNS
cord-005453-4057qib7	7712	13	in	in	IN
cord-005453-4057qib7	7712	14	all	all	DT
cord-005453-4057qib7	7712	15	cases	case	NNS
cord-005453-4057qib7	7712	16	.	.	.
cord-005453-4057qib7	7713	1	Posttransplant	Posttransplant	NNP
cord-005453-4057qib7	7713	2	GVHD	GVHD	NNP
cord-005453-4057qib7	7713	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7713	4	was	be	VBD
cord-005453-4057qib7	7713	5	not	not	RB
cord-005453-4057qib7	7713	6	performed	perform	VBN
cord-005453-4057qib7	7713	7	.	.	.
cord-005453-4057qib7	7714	1	Minimal	minimal	JJ
cord-005453-4057qib7	7714	2	follow	follow	NN
cord-005453-4057qib7	7714	3	up	up	RP
cord-005453-4057qib7	7714	4	was	be	VBD
cord-005453-4057qib7	7714	5	90	90	CD
cord-005453-4057qib7	7714	6	days	day	NNS
cord-005453-4057qib7	7714	7	after	after	IN
cord-005453-4057qib7	7714	8	HSCT	HSCT	NNP
cord-005453-4057qib7	7714	9	.	.	.
cord-005453-4057qib7	7715	1	Results	result	NNS
cord-005453-4057qib7	7715	2	:	:	:
cord-005453-4057qib7	7716	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	7716	2	and	and	CC
cord-005453-4057qib7	7716	3	platelet	platelet	NN
cord-005453-4057qib7	7716	4	engraftment	engraftment	NN
cord-005453-4057qib7	7716	5	occurred	occur	VBD
cord-005453-4057qib7	7716	6	at	at	IN
cord-005453-4057qib7	7716	7	12	12	CD
cord-005453-4057qib7	7716	8	-	-	SYM
cord-005453-4057qib7	7716	9	17	17	CD
cord-005453-4057qib7	7716	10	days	day	NNS
cord-005453-4057qib7	7716	11	post	post	NN
cord-005453-4057qib7	7716	12	-	-	JJ
cord-005453-4057qib7	7716	13	HSCT	HSCT	NNP
cord-005453-4057qib7	7716	14	in	in	IN
cord-005453-4057qib7	7716	15	all	all	DT
cord-005453-4057qib7	7716	16	patients	patient	NNS
cord-005453-4057qib7	7716	17	.	.	.
cord-005453-4057qib7	7717	1	3	3	CD
cord-005453-4057qib7	7717	2	patients	patient	NNS
cord-005453-4057qib7	7717	3	had	have	VBD
cord-005453-4057qib7	7717	4	full	full	JJ
cord-005453-4057qib7	7717	5	donor	donor	NN
cord-005453-4057qib7	7717	6	chimerism	chimerism	NN
cord-005453-4057qib7	7717	7	in	in	IN
cord-005453-4057qib7	7717	8	whole	whole	JJ
cord-005453-4057qib7	7717	9	blood	blood	NN
cord-005453-4057qib7	7717	10	and	and	CC
cord-005453-4057qib7	7717	11	in	in	IN
cord-005453-4057qib7	7717	12	2	2	CD
cord-005453-4057qib7	7717	13	cases	case	NNS
cord-005453-4057qib7	7717	14	we	-PRON-	PRP
cord-005453-4057qib7	7717	15	observed	observe	VBD
cord-005453-4057qib7	7717	16	predominantly	predominantly	RB
cord-005453-4057qib7	7717	17	donor	donor	NN
cord-005453-4057qib7	7717	18	mixed	mix	VBN
cord-005453-4057qib7	7717	19	chimerism	chimerism	NN
cord-005453-4057qib7	7717	20	at	at	IN
cord-005453-4057qib7	7717	21	last	last	JJ
cord-005453-4057qib7	7717	22	follow	follow	VB
cord-005453-4057qib7	7717	23	up	up	RP
cord-005453-4057qib7	7717	24	.	.	.
cord-005453-4057qib7	7718	1	All	all	DT
cord-005453-4057qib7	7718	2	patients	patient	NNS
cord-005453-4057qib7	7718	3	had	have	VBD
cord-005453-4057qib7	7718	4	full	full	JJ
cord-005453-4057qib7	7718	5	donor	donor	NN
cord-005453-4057qib7	7718	6	chimerism	chimerism	NN
cord-005453-4057qib7	7718	7	in	in	IN
cord-005453-4057qib7	7718	8	CD15	CD15	NNP
cord-005453-4057qib7	7718	9	+	+	CC
cord-005453-4057qib7	7718	10	compartment	compartment	NN
cord-005453-4057qib7	7718	11	and	and	CC
cord-005453-4057qib7	7718	12	mixed	mixed	JJ
cord-005453-4057qib7	7718	13	chimerism	chimerism	NN
cord-005453-4057qib7	7718	14	in	in	IN
cord-005453-4057qib7	7718	15	CD3	CD3	NNP
cord-005453-4057qib7	7718	16	+	+	CC
cord-005453-4057qib7	7718	17	lineage	lineage	NN
cord-005453-4057qib7	7718	18	,	,	,
cord-005453-4057qib7	7718	19	but	but	CC
cord-005453-4057qib7	7718	20	it	-PRON-	PRP
cord-005453-4057qib7	7718	21	stable	stable	JJ
cord-005453-4057qib7	7718	22	without	without	IN
cord-005453-4057qib7	7718	23	any	any	DT
cord-005453-4057qib7	7718	24	sign	sign	NN
cord-005453-4057qib7	7718	25	of	of	IN
cord-005453-4057qib7	7718	26	graft	graft	NN
cord-005453-4057qib7	7718	27	dysfunction	dysfunction	NN
cord-005453-4057qib7	7718	28	.	.	.
cord-005453-4057qib7	7719	1	Acute	acute	JJ
cord-005453-4057qib7	7719	2	GVHD	GVHD	NNP
cord-005453-4057qib7	7719	3	is	be	VBZ
cord-005453-4057qib7	7719	4	verified	verify	VBN
cord-005453-4057qib7	7719	5	in	in	IN
cord-005453-4057qib7	7719	6	1	1	CD
cord-005453-4057qib7	7719	7	of	of	IN
cord-005453-4057qib7	7719	8	5	5	CD
cord-005453-4057qib7	7719	9	cases	case	NNS
cord-005453-4057qib7	7719	10	and	and	CC
cord-005453-4057qib7	7719	11	was	be	VBD
cord-005453-4057qib7	7719	12	limited	limit	VBN
cord-005453-4057qib7	7719	13	to	to	TO
cord-005453-4057qib7	7719	14	skin	skin	VB
cord-005453-4057qib7	7719	15	grade	grade	NN
cord-005453-4057qib7	7719	16	2	2	CD
cord-005453-4057qib7	7719	17	.	.	.
cord-005453-4057qib7	7720	1	All	all	DT
cord-005453-4057qib7	7720	2	patients	patient	NNS
cord-005453-4057qib7	7720	3	are	be	VBP
cord-005453-4057qib7	7720	4	alive	alive	JJ
cord-005453-4057qib7	7720	5	for	for	IN
cord-005453-4057qib7	7720	6	periods	period	NNS
cord-005453-4057qib7	7720	7	from	from	IN
cord-005453-4057qib7	7720	8	3	3	CD
cord-005453-4057qib7	7720	9	to	to	TO
cord-005453-4057qib7	7720	10	8	8	CD
cord-005453-4057qib7	7720	11	months	month	NNS
cord-005453-4057qib7	7720	12	post	post	NN
cord-005453-4057qib7	7720	13	-	-	JJ
cord-005453-4057qib7	7720	14	HSCT	HSCT	NNP
cord-005453-4057qib7	7720	15	with	with	IN
cord-005453-4057qib7	7720	16	good	good	JJ
cord-005453-4057qib7	7720	17	graft	graft	NN
cord-005453-4057qib7	7720	18	function	function	NN
cord-005453-4057qib7	7720	19	without	without	IN
cord-005453-4057qib7	7720	20	severe	severe	JJ
cord-005453-4057qib7	7720	21	clinical	clinical	JJ
cord-005453-4057qib7	7720	22	problems	problem	NNS
cord-005453-4057qib7	7720	23	.	.	.
cord-005453-4057qib7	7721	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7721	2	:	:	:
cord-005453-4057qib7	7722	1	We	-PRON-	PRP
cord-005453-4057qib7	7722	2	presented	present	VBD
cord-005453-4057qib7	7722	3	first	first	JJ
cord-005453-4057qib7	7722	4	experience	experience	NN
cord-005453-4057qib7	7722	5	of	of	IN
cord-005453-4057qib7	7722	6	G	G	NNP
cord-005453-4057qib7	7722	7	-	-	HYPH
cord-005453-4057qib7	7722	8	CSF	CSF	NNP
cord-005453-4057qib7	7722	9	and	and	CC
cord-005453-4057qib7	7722	10	plerixafor	plerixafor	NN
cord-005453-4057qib7	7722	11	addition	addition	NN
cord-005453-4057qib7	7722	12	to	to	IN
cord-005453-4057qib7	7722	13	conditioning	conditioning	NN
cord-005453-4057qib7	7722	14	regimen	regimen	NN
cord-005453-4057qib7	7722	15	before	before	IN
cord-005453-4057qib7	7722	16	HSCT	HSCT	NNP
cord-005453-4057qib7	7722	17	with	with	IN
cord-005453-4057qib7	7722	18	TCRαβ+/CD19	tcrαβ+/cd19	NN
cord-005453-4057qib7	7722	19	+	+	CC
cord-005453-4057qib7	7722	20	graft	graft	NN
cord-005453-4057qib7	7722	21	depletion	depletion	NN
cord-005453-4057qib7	7722	22	in	in	IN
cord-005453-4057qib7	7722	23	CGD	CGD	NNP
cord-005453-4057qib7	7722	24	patients	patient	NNS
cord-005453-4057qib7	7722	25	.	.	.
cord-005453-4057qib7	7723	1	We	-PRON-	PRP
cord-005453-4057qib7	7723	2	suppose	suppose	VBP
cord-005453-4057qib7	7723	3	,	,	,
cord-005453-4057qib7	7723	4	the	the	DT
cord-005453-4057qib7	7723	5	preliminary	preliminary	JJ
cord-005453-4057qib7	7723	6	results	result	NNS
cord-005453-4057qib7	7723	7	are	be	VBP
cord-005453-4057qib7	7723	8	encouraging	encouraging	JJ
cord-005453-4057qib7	7723	9	,	,	,
cord-005453-4057qib7	7723	10	as	as	IN
cord-005453-4057qib7	7723	11	the	the	DT
cord-005453-4057qib7	7723	12	frequency	frequency	NN
cord-005453-4057qib7	7723	13	of	of	IN
cord-005453-4057qib7	7723	14	primary	primary	JJ
cord-005453-4057qib7	7723	15	and	and	CC
cord-005453-4057qib7	7723	16	secondary	secondary	JJ
cord-005453-4057qib7	7723	17	graft	graft	NN
cord-005453-4057qib7	7723	18	dysfunction	dysfunction	NN
cord-005453-4057qib7	7723	19	in	in	IN
cord-005453-4057qib7	7723	20	patients	patient	NNS
cord-005453-4057qib7	7723	21	from	from	IN
cord-005453-4057qib7	7723	22	this	this	DT
cord-005453-4057qib7	7723	23	group	group	NN
cord-005453-4057qib7	7723	24	is	be	VBZ
cord-005453-4057qib7	7723	25	not	not	RB
cord-005453-4057qib7	7723	26	observed	observe	VBN
cord-005453-4057qib7	7723	27	today	today	NN
cord-005453-4057qib7	7723	28	,	,	,
cord-005453-4057qib7	7723	29	there	there	EX
cord-005453-4057qib7	7723	30	are	be	VBP
cord-005453-4057qib7	7723	31	no	no	DT
cord-005453-4057qib7	7723	32	significant	significant	JJ
cord-005453-4057qib7	7723	33	toxic	toxic	JJ
cord-005453-4057qib7	7723	34	complications	complication	NNS
cord-005453-4057qib7	7723	35	,	,	,
cord-005453-4057qib7	7723	36	as	as	RB
cord-005453-4057qib7	7723	37	well	well	RB
cord-005453-4057qib7	7723	38	as	as	IN
cord-005453-4057qib7	7723	39	clinically	clinically	RB
cord-005453-4057qib7	7723	40	severe	severe	JJ
cord-005453-4057qib7	7723	41	manifestations	manifestation	NNS
cord-005453-4057qib7	7723	42	of	of	IN
cord-005453-4057qib7	7723	43	GVHD	GVHD	NNP
cord-005453-4057qib7	7723	44	.	.	.
cord-005453-4057qib7	7724	1	Currently	currently	RB
cord-005453-4057qib7	7724	2	,	,	,
cord-005453-4057qib7	7724	3	the	the	DT
cord-005453-4057qib7	7724	4	recruitment	recruitment	NN
cord-005453-4057qib7	7724	5	of	of	IN
cord-005453-4057qib7	7724	6	patients	patient	NNS
cord-005453-4057qib7	7724	7	is	be	VBZ
cord-005453-4057qib7	7724	8	continuing	continue	VBG
cord-005453-4057qib7	7724	9	,	,	,
cord-005453-4057qib7	7724	10	and	and	CC
cord-005453-4057qib7	7724	11	estimation	estimation	NN
cord-005453-4057qib7	7724	12	of	of	IN
cord-005453-4057qib7	7724	13	the	the	DT
cord-005453-4057qib7	7724	14	rates	rate	NNS
cord-005453-4057qib7	7724	15	of	of	IN
cord-005453-4057qib7	7724	16	immune	immune	JJ
cord-005453-4057qib7	7724	17	reconstitution	reconstitution	NN
cord-005453-4057qib7	7724	18	and	and	CC
cord-005453-4057qib7	7724	19	a	a	DT
cord-005453-4057qib7	7724	20	more	more	JJR
cord-005453-4057qib7	7724	21	detail	detail	NN
cord-005453-4057qib7	7724	22	analyses	analysis	NNS
cord-005453-4057qib7	7724	23	will	will	MD
cord-005453-4057qib7	7724	24	be	be	VB
cord-005453-4057qib7	7724	25	evaluated	evaluate	VBN
cord-005453-4057qib7	7724	26	later	later	RB
cord-005453-4057qib7	7724	27	.	.	.
cord-005453-4057qib7	7725	1	Background	background	NN
cord-005453-4057qib7	7725	2	:	:	:
cord-005453-4057qib7	7726	1	Introduction	introduction	NN
cord-005453-4057qib7	7726	2	-It	-It	:
cord-005453-4057qib7	7726	3	is	be	VBZ
cord-005453-4057qib7	7726	4	believed	believe	VBN
cord-005453-4057qib7	7726	5	that	that	IN
cord-005453-4057qib7	7726	6	ABOincompatibility	aboincompatibility	NN
cord-005453-4057qib7	7726	7	is	be	VBZ
cord-005453-4057qib7	7726	8	of	of	IN
cord-005453-4057qib7	7726	9	minor	minor	JJ
cord-005453-4057qib7	7726	10	importance	importance	NN
cord-005453-4057qib7	7726	11	in	in	IN
cord-005453-4057qib7	7726	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	7726	13	stem	stem	NN
cord-005453-4057qib7	7726	14	cell	cell	NN
cord-005453-4057qib7	7726	15	transplantation	transplantation	NN
cord-005453-4057qib7	7726	16	(	(	-LRB-
cord-005453-4057qib7	7726	17	allo	allo	FW
cord-005453-4057qib7	7726	18	-	-	HYPH
cord-005453-4057qib7	7726	19	SCT	SCT	NNP
cord-005453-4057qib7	7726	20	)	)	-RRB-
cord-005453-4057qib7	7726	21	and	and	CC
cord-005453-4057qib7	7726	22	that	that	IN
cord-005453-4057qib7	7726	23	the	the	DT
cord-005453-4057qib7	7726	24	clinical	clinical	JJ
cord-005453-4057qib7	7726	25	outcome	outcome	NN
cord-005453-4057qib7	7726	26	is	be	VBZ
cord-005453-4057qib7	7726	27	equivalent	equivalent	JJ
cord-005453-4057qib7	7726	28	to	to	IN
cord-005453-4057qib7	7726	29	ABO	ABO	NNP
cord-005453-4057qib7	7726	30	-	-	HYPH
cord-005453-4057qib7	7726	31	compatible	compatible	JJ
cord-005453-4057qib7	7726	32	SCT	SCT	NNP
cord-005453-4057qib7	7726	33	.	.	.
cord-005453-4057qib7	7727	1	Therefore	therefore	RB
cord-005453-4057qib7	7727	2	,	,	,
cord-005453-4057qib7	7727	3	we	-PRON-	PRP
cord-005453-4057qib7	7727	4	performed	perform	VBD
cord-005453-4057qib7	7727	5	a	a	DT
cord-005453-4057qib7	7727	6	single	single	JJ
cord-005453-4057qib7	7727	7	center	center	NN
cord-005453-4057qib7	7727	8	retrospective	retrospective	JJ
cord-005453-4057qib7	7727	9	study	study	NN
cord-005453-4057qib7	7727	10	to	to	TO
cord-005453-4057qib7	7727	11	characterize	characterize	VB
cord-005453-4057qib7	7727	12	the	the	DT
cord-005453-4057qib7	7727	13	impact	impact	NN
cord-005453-4057qib7	7727	14	of	of	IN
cord-005453-4057qib7	7727	15	ABO	ABO	NNP
cord-005453-4057qib7	7727	16	-	-	HYPH
cord-005453-4057qib7	7727	17	incompatibility	incompatibility	NN
cord-005453-4057qib7	7727	18	on	on	IN
cord-005453-4057qib7	7727	19	the	the	DT
cord-005453-4057qib7	7727	20	outcome	outcome	NN
cord-005453-4057qib7	7727	21	of	of	IN
cord-005453-4057qib7	7727	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7727	23	stem	stem	NN
cord-005453-4057qib7	7727	24	cell	cell	NN
cord-005453-4057qib7	7727	25	transplantation	transplantation	NN
cord-005453-4057qib7	7727	26	(	(	-LRB-
cord-005453-4057qib7	7727	27	Haplo	Haplo	NNP
cord-005453-4057qib7	7727	28	-	-	HYPH
cord-005453-4057qib7	7727	29	SCT	SCT	NNP
cord-005453-4057qib7	7727	30	)	)	-RRB-
cord-005453-4057qib7	7727	31	.	.	.
cord-005453-4057qib7	7728	1	Methods	method	NNS
cord-005453-4057qib7	7728	2	:	:	:
cord-005453-4057qib7	7729	1	This	this	DT
cord-005453-4057qib7	7729	2	analysis	analysis	NN
cord-005453-4057qib7	7729	3	included	include	VBD
cord-005453-4057qib7	7729	4	27	27	CD
cord-005453-4057qib7	7729	5	consecutive	consecutive	JJ
cord-005453-4057qib7	7729	6	patients	patient	NNS
cord-005453-4057qib7	7729	7	who	who	WP
cord-005453-4057qib7	7729	8	underwent	undergo	VBD
cord-005453-4057qib7	7729	9	haplo	haplo	NNP
cord-005453-4057qib7	7729	10	-	-	HYPH
cord-005453-4057qib7	7729	11	SCT	SCT	NNP
cord-005453-4057qib7	7729	12	for	for	IN
cord-005453-4057qib7	7729	13	various	various	JJ
cord-005453-4057qib7	7729	14	hematological	hematological	JJ
cord-005453-4057qib7	7729	15	malignancies	malignancy	NNS
cord-005453-4057qib7	7729	16	at	at	IN
cord-005453-4057qib7	7729	17	our	-PRON-	PRP$
cord-005453-4057qib7	7729	18	center	center	NN
cord-005453-4057qib7	7729	19	between	between	IN
cord-005453-4057qib7	7729	20	October	October	NNP
cord-005453-4057qib7	7729	21	2010	2010	CD
cord-005453-4057qib7	7729	22	and	and	CC
cord-005453-4057qib7	7729	23	May	May	NNP
cord-005453-4057qib7	7729	24	2018	2018	CD
cord-005453-4057qib7	7729	25	.	.	.
cord-005453-4057qib7	7730	1	We	-PRON-	PRP
cord-005453-4057qib7	7730	2	used	use	VBD
cord-005453-4057qib7	7730	3	our	-PRON-	PRP$
cord-005453-4057qib7	7730	4	institutional	institutional	JJ
cord-005453-4057qib7	7730	5	database	database	NN
cord-005453-4057qib7	7730	6	to	to	TO
cord-005453-4057qib7	7730	7	evaluate	evaluate	VB
cord-005453-4057qib7	7730	8	details	detail	NNS
cord-005453-4057qib7	7730	9	and	and	CC
cord-005453-4057qib7	7730	10	characteristics	characteristic	NNS
cord-005453-4057qib7	7730	11	of	of	IN
cord-005453-4057qib7	7730	12	patients	patient	NNS
cord-005453-4057qib7	7730	13	and	and	CC
cord-005453-4057qib7	7730	14	transplant	transplant	NN
cord-005453-4057qib7	7730	15	outcomes	outcome	NNS
cord-005453-4057qib7	7730	16	.	.	.
cord-005453-4057qib7	7731	1	Results	result	NNS
cord-005453-4057qib7	7731	2	:	:	:
cord-005453-4057qib7	7732	1	Demographic	demographic	JJ
cord-005453-4057qib7	7732	2	features	feature	NNS
cord-005453-4057qib7	7732	3	of	of	IN
cord-005453-4057qib7	7732	4	the	the	DT
cord-005453-4057qib7	7732	5	patients	patient	NNS
cord-005453-4057qib7	7732	6	and	and	CC
cord-005453-4057qib7	7732	7	donors	donor	NNS
cord-005453-4057qib7	7732	8	have	have	VBP
cord-005453-4057qib7	7732	9	been	be	VBN
cord-005453-4057qib7	7732	10	summarized	summarize	VBN
cord-005453-4057qib7	7732	11	in	in	IN
cord-005453-4057qib7	7732	12	Table	Table	NNP
cord-005453-4057qib7	7732	13	1	1	CD
cord-005453-4057qib7	7732	14	.	.	.
cord-005453-4057qib7	7733	1	All	all	DT
cord-005453-4057qib7	7733	2	of	of	IN
cord-005453-4057qib7	7733	3	the	the	DT
cord-005453-4057qib7	7733	4	patients	patient	NNS
cord-005453-4057qib7	7733	5	had	have	VBD
cord-005453-4057qib7	7733	6	advanced	advanced	JJ
cord-005453-4057qib7	7733	7	hematological	hematological	JJ
cord-005453-4057qib7	7733	8	disease	disease	NN
cord-005453-4057qib7	7733	9	with	with	IN
cord-005453-4057qib7	7733	10	a	a	DT
cord-005453-4057qib7	7733	11	high	high	JJ
cord-005453-4057qib7	7733	12	risk	risk	NN
cord-005453-4057qib7	7733	13	of	of	IN
cord-005453-4057qib7	7733	14	relapse	relapse	NN
cord-005453-4057qib7	7733	15	(	(	-LRB-
cord-005453-4057qib7	7733	16	22	22	CD
cord-005453-4057qib7	7733	17	patients	patient	NNS
cord-005453-4057qib7	7733	18	with	with	IN
cord-005453-4057qib7	7733	19	acute	acute	JJ
cord-005453-4057qib7	7733	20	leukemia	leukemia	NN
cord-005453-4057qib7	7733	21	)	)	-RRB-
cord-005453-4057qib7	7733	22	.	.	.
cord-005453-4057qib7	7734	1	Out	out	IN
cord-005453-4057qib7	7734	2	of	of	IN
cord-005453-4057qib7	7734	3	24	24	CD
cord-005453-4057qib7	7734	4	patients	patient	NNS
cord-005453-4057qib7	7734	5	,	,	,
cord-005453-4057qib7	7734	6	early	early	JJ
cord-005453-4057qib7	7734	7	transplant	transplant	NN
cord-005453-4057qib7	7734	8	-	-	HYPH
cord-005453-4057qib7	7734	9	related	relate	VBN
cord-005453-4057qib7	7734	10	mortality	mortality	NN
cord-005453-4057qib7	7734	11	was	be	VBD
cord-005453-4057qib7	7734	12	seen	see	VBN
cord-005453-4057qib7	7734	13	in	in	IN
cord-005453-4057qib7	7734	14	this	this	DT
cord-005453-4057qib7	7734	15	cohort	cohort	NN
cord-005453-4057qib7	7734	16	of	of	IN
cord-005453-4057qib7	7734	17	5	5	CD
cord-005453-4057qib7	7734	18	patients	patient	NNS
cord-005453-4057qib7	7734	19	.	.	.
cord-005453-4057qib7	7735	1	The	the	DT
cord-005453-4057qib7	7735	2	remaining	remain	VBG
cord-005453-4057qib7	7735	3	19	19	CD
cord-005453-4057qib7	7735	4	patients	patient	NNS
cord-005453-4057qib7	7735	5	were	be	VBD
cord-005453-4057qib7	7735	6	followed	follow	VBN
cord-005453-4057qib7	7735	7	in	in	IN
cord-005453-4057qib7	7735	8	1	1	CD
cord-005453-4057qib7	7735	9	and	and	CC
cord-005453-4057qib7	7735	10	42	42	CD
cord-005453-4057qib7	7735	11	months	month	NNS
cord-005453-4057qib7	7735	12	.	.	.
cord-005453-4057qib7	7736	1	Donor	donor	NN
cord-005453-4057qib7	7736	2	type	type	NN
cord-005453-4057qib7	7736	3	ABO	ABO	NNP
cord-005453-4057qib7	7736	4	group	group	NN
cord-005453-4057qib7	7736	5	switch	switch	NN
cord-005453-4057qib7	7736	6	was	be	VBD
cord-005453-4057qib7	7736	7	observed	observe	VBN
cord-005453-4057qib7	7736	8	in	in	IN
cord-005453-4057qib7	7736	9	a	a	DT
cord-005453-4057qib7	7736	10	median	median	NN
cord-005453-4057qib7	7736	11	of	of	IN
cord-005453-4057qib7	7736	12	45	45	CD
cord-005453-4057qib7	7736	13	days	day	NNS
cord-005453-4057qib7	7736	14	(	(	-LRB-
cord-005453-4057qib7	7736	15	30	30	CD
cord-005453-4057qib7	7736	16	-	-	SYM
cord-005453-4057qib7	7736	17	60	60	CD
cord-005453-4057qib7	7736	18	days	day	NNS
cord-005453-4057qib7	7736	19	)	)	-RRB-
cord-005453-4057qib7	7736	20	after	after	IN
cord-005453-4057qib7	7736	21	transplant	transplant	NN
cord-005453-4057qib7	7736	22	.	.	.
cord-005453-4057qib7	7737	1	We	-PRON-	PRP
cord-005453-4057qib7	7737	2	were	be	VBD
cord-005453-4057qib7	7737	3	not	not	RB
cord-005453-4057qib7	7737	4	able	able	JJ
cord-005453-4057qib7	7737	5	to	to	TO
cord-005453-4057qib7	7737	6	show	show	VB
cord-005453-4057qib7	7737	7	any	any	DT
cord-005453-4057qib7	7737	8	statistical	statistical	JJ
cord-005453-4057qib7	7737	9	difference	difference	NN
cord-005453-4057qib7	7737	10	in	in	IN
cord-005453-4057qib7	7737	11	terms	term	NNS
cord-005453-4057qib7	7737	12	of	of	IN
cord-005453-4057qib7	7737	13	blood	blood	NN
cord-005453-4057qib7	7737	14	group	group	NN
cord-005453-4057qib7	7737	15	switch	switch	NN
cord-005453-4057qib7	7737	16	between	between	IN
cord-005453-4057qib7	7737	17	minor	minor	JJ
cord-005453-4057qib7	7737	18	and	and	CC
cord-005453-4057qib7	7737	19	major	major	JJ
cord-005453-4057qib7	7737	20	ABO	ABO	NNP
cord-005453-4057qib7	7737	21	incompatible	incompatible	JJ
cord-005453-4057qib7	7737	22	transplant	transplant	NN
cord-005453-4057qib7	7737	23	.	.	.
cord-005453-4057qib7	7738	1	The	the	DT
cord-005453-4057qib7	7738	2	median	median	JJ
cord-005453-4057qib7	7738	3	red	red	JJ
cord-005453-4057qib7	7738	4	blood	blood	NN
cord-005453-4057qib7	7738	5	cell	cell	NN
cord-005453-4057qib7	7738	6	(	(	-LRB-
cord-005453-4057qib7	7738	7	RBC	RBC	NNP
cord-005453-4057qib7	7738	8	)	)	-RRB-
cord-005453-4057qib7	7738	9	transfusions	transfusion	NNS
cord-005453-4057qib7	7738	10	in	in	IN
cord-005453-4057qib7	7738	11	the	the	DT
cord-005453-4057qib7	7738	12	first	first	JJ
cord-005453-4057qib7	7738	13	30	30	CD
cord-005453-4057qib7	7738	14	days	day	NNS
cord-005453-4057qib7	7738	15	for	for	IN
cord-005453-4057qib7	7738	16	the	the	DT
cord-005453-4057qib7	7738	17	ABO	ABO	NNP
cord-005453-4057qib7	7738	18	compatible	compatible	JJ
cord-005453-4057qib7	7738	19	and	and	CC
cord-005453-4057qib7	7738	20	incompatible	incompatible	JJ
cord-005453-4057qib7	7738	21	transplants	transplant	NNS
cord-005453-4057qib7	7738	22	were	be	VBD
cord-005453-4057qib7	7738	23	median	median	JJ
cord-005453-4057qib7	7738	24	4	4	CD
cord-005453-4057qib7	7738	25	units	unit	NNS
cord-005453-4057qib7	7738	26	(	(	-LRB-
cord-005453-4057qib7	7738	27	range	range	NN
cord-005453-4057qib7	7738	28	,	,	,
cord-005453-4057qib7	7738	29	0	0	CD
cord-005453-4057qib7	7738	30	-	-	SYM
cord-005453-4057qib7	7738	31	11	11	CD
cord-005453-4057qib7	7738	32	)	)	-RRB-
cord-005453-4057qib7	7738	33	and	and	CC
cord-005453-4057qib7	7738	34	median	median	JJ
cord-005453-4057qib7	7738	35	4	4	CD
cord-005453-4057qib7	7738	36	units	unit	NNS
cord-005453-4057qib7	7738	37	(	(	-LRB-
cord-005453-4057qib7	7738	38	range	range	VBP
cord-005453-4057qib7	7738	39	,	,	,
cord-005453-4057qib7	7738	40	3	3	CD
cord-005453-4057qib7	7738	41	-	-	SYM
cord-005453-4057qib7	7738	42	12	12	CD
cord-005453-4057qib7	7738	43	)	)	-RRB-
cord-005453-4057qib7	7738	44	(	(	-LRB-
cord-005453-4057qib7	7738	45	p=0.6	p=0.6	NN
cord-005453-4057qib7	7738	46	)	)	-RRB-
cord-005453-4057qib7	7738	47	.	.	.
cord-005453-4057qib7	7739	1	No	no	DT
cord-005453-4057qib7	7739	2	statistical	statistical	JJ
cord-005453-4057qib7	7739	3	difference	difference	NN
cord-005453-4057qib7	7739	4	was	be	VBD
cord-005453-4057qib7	7739	5	also	also	RB
cord-005453-4057qib7	7739	6	encountered	encounter	VBN
cord-005453-4057qib7	7739	7	for	for	IN
cord-005453-4057qib7	7739	8	the	the	DT
cord-005453-4057qib7	7739	9	RBC	RBC	NNP
cord-005453-4057qib7	7739	10	transfusion	transfusion	NN
cord-005453-4057qib7	7739	11	need	need	NN
cord-005453-4057qib7	7739	12	for	for	IN
cord-005453-4057qib7	7739	13	stem	stem	NN
cord-005453-4057qib7	7739	14	cell	cell	NN
cord-005453-4057qib7	7739	15	source	source	NN
cord-005453-4057qib7	7739	16	,	,	,
cord-005453-4057qib7	7739	17	peripheral	peripheral	JJ
cord-005453-4057qib7	7739	18	blood	blood	NN
cord-005453-4057qib7	7739	19	vs	vs	IN
cord-005453-4057qib7	7739	20	bone	bone	NN
cord-005453-4057qib7	7739	21	marrow	marrow	NN
cord-005453-4057qib7	7739	22	.	.	.
cord-005453-4057qib7	7740	1	A	a	DT
cord-005453-4057qib7	7740	2	total	total	NN
cord-005453-4057qib7	7740	3	of	of	IN
cord-005453-4057qib7	7740	4	15	15	CD
cord-005453-4057qib7	7740	5	patients	patient	NNS
cord-005453-4057qib7	7740	6	were	be	VBD
cord-005453-4057qib7	7740	7	followed	follow	VBN
cord-005453-4057qib7	7740	8	up	up	RP
cord-005453-4057qib7	7740	9	for	for	IN
cord-005453-4057qib7	7740	10	reticulocyte	reticulocyte	NNP
cord-005453-4057qib7	7740	11	engraftment	engraftment	NNP
cord-005453-4057qib7	7740	12	.	.	.
cord-005453-4057qib7	7741	1	The	the	DT
cord-005453-4057qib7	7741	2	median	median	JJ
cord-005453-4057qib7	7741	3	time	time	NN
cord-005453-4057qib7	7741	4	for	for	IN
cord-005453-4057qib7	7741	5	reticulocyte	reticulocyte	NNP
cord-005453-4057qib7	7741	6	engraftment	engraftment	NNP
cord-005453-4057qib7	7741	7	was	be	VBD
cord-005453-4057qib7	7741	8	19	19	CD
cord-005453-4057qib7	7741	9	days	day	NNS
cord-005453-4057qib7	7741	10	(	(	-LRB-
cord-005453-4057qib7	7741	11	range	range	NN
cord-005453-4057qib7	7741	12	,	,	,
cord-005453-4057qib7	7741	13	15	15	CD
cord-005453-4057qib7	7741	14	-	-	SYM
cord-005453-4057qib7	7741	15	60	60	CD
cord-005453-4057qib7	7741	16	)	)	-RRB-
cord-005453-4057qib7	7741	17	for	for	IN
cord-005453-4057qib7	7741	18	all	all	DT
cord-005453-4057qib7	7741	19	patients	patient	NNS
cord-005453-4057qib7	7741	20	.	.	.
cord-005453-4057qib7	7742	1	Reticulocyte	Reticulocyte	NNP
cord-005453-4057qib7	7742	2	engraftment	engraftment	NNP
cord-005453-4057qib7	7742	3	was	be	VBD
cord-005453-4057qib7	7742	4	tended	tend	VBN
cord-005453-4057qib7	7742	5	to	to	TO
cord-005453-4057qib7	7742	6	be	be	VB
cord-005453-4057qib7	7742	7	faster	fast	JJR
cord-005453-4057qib7	7742	8	in	in	IN
cord-005453-4057qib7	7742	9	minor	minor	JJ
cord-005453-4057qib7	7742	10	ABO	abo	NN
cord-005453-4057qib7	7742	11	-	-	HYPH
cord-005453-4057qib7	7742	12	mismatched	mismatch	VBN
cord-005453-4057qib7	7742	13	group	group	NN
cord-005453-4057qib7	7742	14	(	(	-LRB-
cord-005453-4057qib7	7742	15	p=0.05	p=0.05	NNP
cord-005453-4057qib7	7742	16	)	)	-RRB-
cord-005453-4057qib7	7742	17	than	than	IN
cord-005453-4057qib7	7742	18	major	major	JJ
cord-005453-4057qib7	7742	19	or	or	CC
cord-005453-4057qib7	7742	20	ABO	ABO	NNP
cord-005453-4057qib7	7742	21	-	-	HYPH
cord-005453-4057qib7	7742	22	compatible	compatible	JJ
cord-005453-4057qib7	7742	23	ones	one	NNS
cord-005453-4057qib7	7742	24	.	.	.
cord-005453-4057qib7	7743	1	Nineteen	nineteen	CD
cord-005453-4057qib7	7743	2	patients	patient	NNS
cord-005453-4057qib7	7743	3	achieved	achieve	VBD
cord-005453-4057qib7	7743	4	independence	independence	NN
cord-005453-4057qib7	7743	5	from	from	IN
cord-005453-4057qib7	7743	6	RBC	RBC	NNP
cord-005453-4057qib7	7743	7	support	support	NN
cord-005453-4057qib7	7743	8	after	after	IN
cord-005453-4057qib7	7743	9	a	a	DT
cord-005453-4057qib7	7743	10	median	median	JJ
cord-005453-4057qib7	7743	11	time	time	NN
cord-005453-4057qib7	7743	12	of	of	IN
cord-005453-4057qib7	7743	13	44	44	CD
cord-005453-4057qib7	7743	14	days	day	NNS
cord-005453-4057qib7	7743	15	(	(	-LRB-
cord-005453-4057qib7	7743	16	range	range	NN
cord-005453-4057qib7	7743	17	,	,	,
cord-005453-4057qib7	7743	18	11	11	CD
cord-005453-4057qib7	7743	19	-	-	SYM
cord-005453-4057qib7	7743	20	61	61	CD
cord-005453-4057qib7	7743	21	days	day	NNS
cord-005453-4057qib7	7743	22	)	)	-RRB-
cord-005453-4057qib7	7743	23	in	in	IN
cord-005453-4057qib7	7743	24	ABOcompatible	abocompatible	JJ
cord-005453-4057qib7	7743	25	patients	patient	NNS
cord-005453-4057qib7	7743	26	,	,	,
cord-005453-4057qib7	7743	27	25	25	CD
cord-005453-4057qib7	7743	28	days	day	NNS
cord-005453-4057qib7	7743	29	(	(	-LRB-
cord-005453-4057qib7	7743	30	range	range	NN
cord-005453-4057qib7	7743	31	,	,	,
cord-005453-4057qib7	7743	32	7	7	CD
cord-005453-4057qib7	7743	33	-	-	SYM
cord-005453-4057qib7	7743	34	52	52	CD
cord-005453-4057qib7	7743	35	days	day	NNS
cord-005453-4057qib7	7743	36	)	)	-RRB-
cord-005453-4057qib7	7743	37	in	in	IN
cord-005453-4057qib7	7743	38	minor	minor	JJ
cord-005453-4057qib7	7743	39	ABO	ABO	NNP
cord-005453-4057qib7	7743	40	-	-	HYPH
cord-005453-4057qib7	7743	41	incompatibilityand	incompatibilityand	NNP
cord-005453-4057qib7	7743	42	34	34	CD
cord-005453-4057qib7	7743	43	days	day	NNS
cord-005453-4057qib7	7743	44	(	(	-LRB-
cord-005453-4057qib7	7743	45	range	range	NN
cord-005453-4057qib7	7743	46	,	,	,
cord-005453-4057qib7	7743	47	20	20	CD
cord-005453-4057qib7	7743	48	-	-	SYM
cord-005453-4057qib7	7743	49	57	57	CD
cord-005453-4057qib7	7743	50	days	day	NNS
cord-005453-4057qib7	7743	51	)	)	-RRB-
cord-005453-4057qib7	7743	52	in	in	IN
cord-005453-4057qib7	7743	53	major	major	JJ
cord-005453-4057qib7	7743	54	ABO	ABO	NNP
cord-005453-4057qib7	7743	55	-	-	HYPH
cord-005453-4057qib7	7743	56	incompatibilitygroup	incompatibilitygroup	NNP
cord-005453-4057qib7	7743	57	,	,	,
cord-005453-4057qib7	7743	58	respectively	respectively	RB
cord-005453-4057qib7	7743	59	(	(	-LRB-
cord-005453-4057qib7	7743	60	p>0.5	p>0.5	NNP
cord-005453-4057qib7	7743	61	)	)	-RRB-
cord-005453-4057qib7	7743	62	.	.	.
cord-005453-4057qib7	7744	1	The	the	DT
cord-005453-4057qib7	7744	2	engraftman	engraftman	NN
cord-005453-4057qib7	7744	3	kinetics	kinetic	NNS
cord-005453-4057qib7	7744	4	due	due	JJ
cord-005453-4057qib7	7744	5	to	to	IN
cord-005453-4057qib7	7744	6	major	major	JJ
cord-005453-4057qib7	7744	7	and	and	CC
cord-005453-4057qib7	7744	8	minor	minor	JJ
cord-005453-4057qib7	7744	9	ABOincompatibilitytransplants	aboincompatibilitytransplant	NNS
cord-005453-4057qib7	7744	10	were	be	VBD
cord-005453-4057qib7	7744	11	presented	present	VBN
cord-005453-4057qib7	7744	12	in	in	IN
cord-005453-4057qib7	7744	13	Table-	Table-	NNP
cord-005453-4057qib7	7744	14	2	2	CD
cord-005453-4057qib7	7744	15	.	.	.
cord-005453-4057qib7	7745	1	Pure	pure	JJ
cord-005453-4057qib7	7745	2	red	red	JJ
cord-005453-4057qib7	7745	3	cell	cell	NN
cord-005453-4057qib7	7745	4	aplasia	aplasia	NNP
cord-005453-4057qib7	7745	5	was	be	VBD
cord-005453-4057qib7	7745	6	not	not	RB
cord-005453-4057qib7	7745	7	developed	develop	VBN
cord-005453-4057qib7	7745	8	in	in	IN
cord-005453-4057qib7	7745	9	our	-PRON-	PRP$
cord-005453-4057qib7	7745	10	cohort	cohort	NN
cord-005453-4057qib7	7745	11	.	.	.
cord-005453-4057qib7	7746	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7746	2	:	:	:
cord-005453-4057qib7	7747	1	The	the	DT
cord-005453-4057qib7	7747	2	present	present	JJ
cord-005453-4057qib7	7747	3	single	single	JJ
cord-005453-4057qib7	7747	4	center	center	NN
cord-005453-4057qib7	7747	5	study	study	NN
cord-005453-4057qib7	7747	6	provides	provide	VBZ
cord-005453-4057qib7	7747	7	new	new	JJ
cord-005453-4057qib7	7747	8	evidence	evidence	NN
cord-005453-4057qib7	7747	9	for	for	IN
cord-005453-4057qib7	7747	10	the	the	DT
cord-005453-4057qib7	7747	11	importance	importance	NN
cord-005453-4057qib7	7747	12	of	of	IN
cord-005453-4057qib7	7747	13	the	the	DT
cord-005453-4057qib7	7747	14	ABO	ABO	NNP
cord-005453-4057qib7	7747	15	system	system	NN
cord-005453-4057qib7	7747	16	for	for	IN
cord-005453-4057qib7	7747	17	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	7747	18	recovery	recovery	NN
cord-005453-4057qib7	7747	19	in	in	IN
cord-005453-4057qib7	7747	20	haploidentic	haploidentic	JJ
cord-005453-4057qib7	7747	21	stem	stem	NN
cord-005453-4057qib7	7747	22	cell	cell	NN
cord-005453-4057qib7	7747	23	transplantation	transplantation	NN
cord-005453-4057qib7	7747	24	.	.	.
cord-005453-4057qib7	7748	1	It	-PRON-	PRP
cord-005453-4057qib7	7748	2	's	be	VBZ
cord-005453-4057qib7	7748	3	important	important	JJ
cord-005453-4057qib7	7748	4	to	to	TO
cord-005453-4057qib7	7748	5	note	note	VB
cord-005453-4057qib7	7748	6	that	that	IN
cord-005453-4057qib7	7748	7	,	,	,
cord-005453-4057qib7	7748	8	randomize	randomize	VB
cord-005453-4057qib7	7748	9	prospective	prospective	JJ
cord-005453-4057qib7	7748	10	and	and	CC
cord-005453-4057qib7	7748	11	larger	large	JJR
cord-005453-4057qib7	7748	12	studies	study	NNS
cord-005453-4057qib7	7748	13	are	be	VBP
cord-005453-4057qib7	7748	14	warranted	warrant	VBN
cord-005453-4057qib7	7748	15	.	.	.
cord-005453-4057qib7	7749	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7749	2	:	:	:
cord-005453-4057qib7	7749	3	Nothing	nothing	NN
cord-005453-4057qib7	7749	4	to	to	TO
cord-005453-4057qib7	7749	5	declare	declare	VB
cord-005453-4057qib7	7749	6	Low	Low	NNP
cord-005453-4057qib7	7749	7	dose	dose	NN
cord-005453-4057qib7	7749	8	of	of	IN
cord-005453-4057qib7	7749	9	anti	anti	JJ
cord-005453-4057qib7	7749	10	-	-	JJ
cord-005453-4057qib7	7749	11	T	t	JJ
cord-005453-4057qib7	7749	12	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7749	13	globulin	globulin	NN
cord-005453-4057qib7	7749	14	protects	protect	VBZ
cord-005453-4057qib7	7749	15	against	against	IN
cord-005453-4057qib7	7749	16	severe	severe	JJ
cord-005453-4057qib7	7749	17	forms	form	NNS
cord-005453-4057qib7	7749	18	of	of	IN
cord-005453-4057qib7	7749	19	graft	graft	NN
cord-005453-4057qib7	7749	20	versus	versus	IN
cord-005453-4057qib7	7749	21	host	host	NN
cord-005453-4057qib7	7749	22	disease	disease	NN
cord-005453-4057qib7	7749	23	in	in	IN
cord-005453-4057qib7	7749	24	patients	patient	NNS
cord-005453-4057qib7	7749	25	undergoing	undergo	VBG
cord-005453-4057qib7	7749	26	allogenic	allogenic	JJ
cord-005453-4057qib7	7749	27	stem	stem	NN
cord-005453-4057qib7	7749	28	cell	cell	NN
cord-005453-4057qib7	7749	29	transplantation	transplantation	NN
cord-005453-4057qib7	7749	30	Background	background	NN
cord-005453-4057qib7	7749	31	:	:	:
cord-005453-4057qib7	7750	1	Graft	graft	NN
cord-005453-4057qib7	7750	2	versus	versus	IN
cord-005453-4057qib7	7750	3	host	host	NN
cord-005453-4057qib7	7750	4	disease	disease	NN
cord-005453-4057qib7	7750	5	(	(	-LRB-
cord-005453-4057qib7	7750	6	GvHD	GvHD	NNP
cord-005453-4057qib7	7750	7	)	)	-RRB-
cord-005453-4057qib7	7750	8	is	be	VBZ
cord-005453-4057qib7	7750	9	the	the	DT
cord-005453-4057qib7	7750	10	most	most	RBS
cord-005453-4057qib7	7750	11	important	important	JJ
cord-005453-4057qib7	7750	12	complication	complication	NN
cord-005453-4057qib7	7750	13	after	after	IN
cord-005453-4057qib7	7750	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	7750	15	stem	stem	NN
cord-005453-4057qib7	7750	16	cell	cell	NN
cord-005453-4057qib7	7750	17	transplantation	transplantation	NN
cord-005453-4057qib7	7750	18	(	(	-LRB-
cord-005453-4057qib7	7750	19	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7750	20	)	)	-RRB-
cord-005453-4057qib7	7750	21	.	.	.
cord-005453-4057qib7	7751	1	Optimal	optimal	JJ
cord-005453-4057qib7	7751	2	dose	dose	NN
cord-005453-4057qib7	7751	3	of	of	IN
cord-005453-4057qib7	7751	4	different	different	JJ
cord-005453-4057qib7	7751	5	anti	anti	JJ
cord-005453-4057qib7	7751	6	-	-	JJ
cord-005453-4057qib7	7751	7	Tlymphocyte	tlymphocyte	JJ
cord-005453-4057qib7	7751	8	globulin	globulin	NN
cord-005453-4057qib7	7751	9	(	(	-LRB-
cord-005453-4057qib7	7751	10	ATG	ATG	NNP
cord-005453-4057qib7	7751	11	)	)	-RRB-
cord-005453-4057qib7	7751	12	formulations	formulation	NNS
cord-005453-4057qib7	7751	13	in	in	IN
cord-005453-4057qib7	7751	14	this	this	DT
cord-005453-4057qib7	7751	15	setting	setting	NN
cord-005453-4057qib7	7751	16	has	have	VBZ
cord-005453-4057qib7	7751	17	not	not	RB
cord-005453-4057qib7	7751	18	been	be	VBN
cord-005453-4057qib7	7751	19	established	establish	VBN
cord-005453-4057qib7	7751	20	yet	yet	RB
cord-005453-4057qib7	7751	21	.	.	.
cord-005453-4057qib7	7752	1	The	the	DT
cord-005453-4057qib7	7752	2	aim	aim	NN
cord-005453-4057qib7	7752	3	of	of	IN
cord-005453-4057qib7	7752	4	this	this	DT
cord-005453-4057qib7	7752	5	study	study	NN
cord-005453-4057qib7	7752	6	was	be	VBD
cord-005453-4057qib7	7752	7	to	to	TO
cord-005453-4057qib7	7752	8	analyze	analyze	VB
cord-005453-4057qib7	7752	9	the	the	DT
cord-005453-4057qib7	7752	10	impact	impact	NN
cord-005453-4057qib7	7752	11	of	of	IN
cord-005453-4057qib7	7752	12	a	a	DT
cord-005453-4057qib7	7752	13	low	low	JJ
cord-005453-4057qib7	7752	14	dose	dose	NN
cord-005453-4057qib7	7752	15	of	of	IN
cord-005453-4057qib7	7752	16	ATG	ATG	NNP
cord-005453-4057qib7	7752	17	-	-	HYPH
cord-005453-4057qib7	7752	18	Fresenius	Fresenius	NNP
cord-005453-4057qib7	7752	19	(	(	-LRB-
cord-005453-4057qib7	7752	20	ATG	ATG	NNP
cord-005453-4057qib7	7752	21	-	-	HYPH
cord-005453-4057qib7	7752	22	F	F	NNP
cord-005453-4057qib7	7752	23	)	)	-RRB-
cord-005453-4057qib7	7752	24	in	in	IN
cord-005453-4057qib7	7752	25	alloSCT	alloSCT	NNP
cord-005453-4057qib7	7752	26	outcomes	outcome	NNS
cord-005453-4057qib7	7752	27	.	.	.
cord-005453-4057qib7	7753	1	Methods	method	NNS
cord-005453-4057qib7	7753	2	:	:	:
cord-005453-4057qib7	7753	3	We	-PRON-	PRP
cord-005453-4057qib7	7753	4	analyzed	analyze	VBD
cord-005453-4057qib7	7753	5	57	57	CD
cord-005453-4057qib7	7753	6	adult	adult	NN
cord-005453-4057qib7	7753	7	patients	patient	NNS
cord-005453-4057qib7	7753	8	who	who	WP
cord-005453-4057qib7	7753	9	received	receive	VBD
cord-005453-4057qib7	7753	10	an	an	DT
cord-005453-4057qib7	7753	11	alloSCT	allosct	NN
cord-005453-4057qib7	7753	12	for	for	IN
cord-005453-4057qib7	7753	13	hematologic	hematologic	JJ
cord-005453-4057qib7	7753	14	malignancies	malignancy	NNS
cord-005453-4057qib7	7753	15	from	from	IN
cord-005453-4057qib7	7753	16	October	October	NNP
cord-005453-4057qib7	7753	17	2012	2012	CD
cord-005453-4057qib7	7753	18	to	to	IN
cord-005453-4057qib7	7753	19	March	March	NNP
cord-005453-4057qib7	7753	20	2018	2018	CD
cord-005453-4057qib7	7753	21	.	.	.
cord-005453-4057qib7	7754	1	The	the	DT
cord-005453-4057qib7	7754	2	GvHD	GvHD	NNP
cord-005453-4057qib7	7754	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7754	4	included	include	VBD
cord-005453-4057qib7	7754	5	a	a	DT
cord-005453-4057qib7	7754	6	total	total	JJ
cord-005453-4057qib7	7754	7	dose	dose	NN
cord-005453-4057qib7	7754	8	of	of	IN
cord-005453-4057qib7	7754	9	21	21	CD
cord-005453-4057qib7	7754	10	mg	mg	NNP
cord-005453-4057qib7	7754	11	/	/	SYM
cord-005453-4057qib7	7754	12	kg	kg	NNP
cord-005453-4057qib7	7754	13	(	(	-LRB-
cord-005453-4057qib7	7754	14	7	7	CD
cord-005453-4057qib7	7754	15	mg	mg	NNP
cord-005453-4057qib7	7754	16	/	/	SYM
cord-005453-4057qib7	7754	17	kg	kg	NNS
cord-005453-4057qib7	7754	18	on	on	IN
cord-005453-4057qib7	7754	19	day	day	NN
cord-005453-4057qib7	7754	20	-3	-3	NNP
cord-005453-4057qib7	7754	21	,	,	,
cord-005453-4057qib7	7754	22	-2	-2	NNP
cord-005453-4057qib7	7754	23	and	and	CC
cord-005453-4057qib7	7754	24	-1	-1	NN
cord-005453-4057qib7	7754	25	)	)	-RRB-
cord-005453-4057qib7	7754	26	of	of	IN
cord-005453-4057qib7	7754	27	ATG	ATG	NNP
cord-005453-4057qib7	7754	28	-	-	HYPH
cord-005453-4057qib7	7754	29	F	F	NNP
cord-005453-4057qib7	7754	30	for	for	IN
cord-005453-4057qib7	7754	31	patients	patient	NNS
cord-005453-4057qib7	7754	32	who	who	WP
cord-005453-4057qib7	7754	33	received	receive	VBD
cord-005453-4057qib7	7754	34	a	a	DT
cord-005453-4057qib7	7754	35	graft	graft	NN
cord-005453-4057qib7	7754	36	from	from	IN
cord-005453-4057qib7	7754	37	peripheral	peripheral	JJ
cord-005453-4057qib7	7754	38	blood	blood	NN
cord-005453-4057qib7	7754	39	,	,	,
cord-005453-4057qib7	7754	40	an	an	DT
cord-005453-4057qib7	7754	41	unrelated	unrelated	JJ
cord-005453-4057qib7	7754	42	donor	donor	NN
cord-005453-4057qib7	7754	43	;	;	:
cord-005453-4057qib7	7754	44	with	with	IN
cord-005453-4057qib7	7754	45	a	a	DT
cord-005453-4057qib7	7754	46	mismatch	mismatch	NN
cord-005453-4057qib7	7754	47	,	,	,
cord-005453-4057qib7	7754	48	and/or	and/or	CC
cord-005453-4057qib7	7754	49	were	be	VBD
cord-005453-4057qib7	7754	50	older	old	JJR
cord-005453-4057qib7	7754	51	than	than	IN
cord-005453-4057qib7	7754	52	55	55	CD
cord-005453-4057qib7	7754	53	years	year	NNS
cord-005453-4057qib7	7754	54	;	;	,
cord-005453-4057qib7	7754	55	associated	associate	VBN
cord-005453-4057qib7	7754	56	to	to	IN
cord-005453-4057qib7	7754	57	a	a	DT
cord-005453-4057qib7	7754	58	calcineurin	calcineurin	JJ
cord-005453-4057qib7	7754	59	inhibitor	inhibitor	NN
cord-005453-4057qib7	7754	60	and	and	CC
cord-005453-4057qib7	7754	61	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	7754	62	mofetil	mofetil	NNP
cord-005453-4057qib7	7754	63	/	/	SYM
cord-005453-4057qib7	7754	64	short	short	JJ
cord-005453-4057qib7	7754	65	course	course	NN
cord-005453-4057qib7	7754	66	-	-	HYPH
cord-005453-4057qib7	7754	67	methotrexate	methotrexate	NN
cord-005453-4057qib7	7754	68	.	.	.
cord-005453-4057qib7	7755	1	Statistical	statistical	JJ
cord-005453-4057qib7	7755	2	analysis	analysis	NN
cord-005453-4057qib7	7755	3	was	be	VBD
cord-005453-4057qib7	7755	4	performed	perform	VBN
cord-005453-4057qib7	7755	5	using	use	VBG
cord-005453-4057qib7	7755	6	SPSS	SPSS	NNP
cord-005453-4057qib7	7755	7	v.22	v.22	NNP
cord-005453-4057qib7	7755	8	and	and	CC
cord-005453-4057qib7	7755	9	R	r	NN
cord-005453-4057qib7	7755	10	software	software	NN
cord-005453-4057qib7	7755	11	.	.	.
cord-005453-4057qib7	7756	1	Results	result	NNS
cord-005453-4057qib7	7756	2	:	:	:
cord-005453-4057qib7	7757	1	Median	median	JJ
cord-005453-4057qib7	7757	2	age	age	NN
cord-005453-4057qib7	7757	3	was	be	VBD
cord-005453-4057qib7	7757	4	57	57	CD
cord-005453-4057qib7	7757	5	years	year	NNS
cord-005453-4057qib7	7757	6	(	(	-LRB-
cord-005453-4057qib7	7757	7	18	18	CD
cord-005453-4057qib7	7757	8	-	-	SYM
cord-005453-4057qib7	7757	9	70	70	CD
cord-005453-4057qib7	7757	10	)	)	-RRB-
cord-005453-4057qib7	7757	11	and	and	CC
cord-005453-4057qib7	7757	12	66.7	66.7	CD
cord-005453-4057qib7	7757	13	%	%	NN
cord-005453-4057qib7	7757	14	of	of	IN
cord-005453-4057qib7	7757	15	patients	patient	NNS
cord-005453-4057qib7	7757	16	were	be	VBD
cord-005453-4057qib7	7757	17	males	male	NNS
cord-005453-4057qib7	7757	18	.	.	.
cord-005453-4057qib7	7758	1	Seventy	seventy	CD
cord-005453-4057qib7	7758	2	-	-	HYPH
cord-005453-4057qib7	7758	3	four	four	CD
cord-005453-4057qib7	7758	4	percent	percent	NN
cord-005453-4057qib7	7758	5	of	of	IN
cord-005453-4057qib7	7758	6	patients	patient	NNS
cord-005453-4057qib7	7758	7	underwent	undergo	VBD
cord-005453-4057qib7	7758	8	myeloablative	myeloablative	JJ
cord-005453-4057qib7	7758	9	conditioning	conditioning	NN
cord-005453-4057qib7	7758	10	.	.	.
cord-005453-4057qib7	7759	1	The	the	DT
cord-005453-4057qib7	7759	2	stem	stem	NN
cord-005453-4057qib7	7759	3	cell	cell	NN
cord-005453-4057qib7	7759	4	source	source	NN
cord-005453-4057qib7	7759	5	was	be	VBD
cord-005453-4057qib7	7759	6	peripheral	peripheral	JJ
cord-005453-4057qib7	7759	7	blood	blood	NN
cord-005453-4057qib7	7759	8	in	in	IN
cord-005453-4057qib7	7759	9	51	51	CD
cord-005453-4057qib7	7759	10	patients	patient	NNS
cord-005453-4057qib7	7759	11	(	(	-LRB-
cord-005453-4057qib7	7759	12	89.5	89.5	CD
cord-005453-4057qib7	7759	13	%	%	NN
cord-005453-4057qib7	7759	14	)	)	-RRB-
cord-005453-4057qib7	7759	15	,	,	,
cord-005453-4057qib7	7759	16	80	80	CD
cord-005453-4057qib7	7759	17	%	%	NN
cord-005453-4057qib7	7759	18	were	be	VBD
cord-005453-4057qib7	7759	19	from	from	IN
cord-005453-4057qib7	7759	20	unrelated	unrelated	JJ
cord-005453-4057qib7	7759	21	donors	donor	NNS
cord-005453-4057qib7	7759	22	(	(	-LRB-
cord-005453-4057qib7	7759	23	28	28	CD
cord-005453-4057qib7	7759	24	%	%	NN
cord-005453-4057qib7	7759	25	mismatched	mismatched	JJ
cord-005453-4057qib7	7759	26	)	)	-RRB-
cord-005453-4057qib7	7759	27	.	.	.
cord-005453-4057qib7	7760	1	Seventeen	seventeen	CD
cord-005453-4057qib7	7760	2	(	(	-LRB-
cord-005453-4057qib7	7760	3	29.8	29.8	CD
cord-005453-4057qib7	7760	4	%	%	NN
cord-005453-4057qib7	7760	5	)	)	-RRB-
cord-005453-4057qib7	7761	1	patients	patient	NNS
cord-005453-4057qib7	7761	2	had	have	VBD
cord-005453-4057qib7	7761	3	high	high	JJ
cord-005453-4057qib7	7761	4	risk	risk	NN
cord-005453-4057qib7	7761	5	CMV	CMV	NNP
cord-005453-4057qib7	7761	6	status	status	NN
cord-005453-4057qib7	7761	7	(	(	-LRB-
cord-005453-4057qib7	7761	8	D-/R+	D-/R+	NNP
cord-005453-4057qib7	7761	9	)	)	-RRB-
cord-005453-4057qib7	7761	10	(	(	-LRB-
cord-005453-4057qib7	7761	11	see	see	VB
cord-005453-4057qib7	7761	12	image	image	NN
cord-005453-4057qib7	7761	13	1B	1b	CD
cord-005453-4057qib7	7761	14	)	)	-RRB-
cord-005453-4057qib7	7761	15	.	.	.
cord-005453-4057qib7	7762	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	7762	2	was	be	VBD
cord-005453-4057qib7	7762	3	observed	observe	VBN
cord-005453-4057qib7	7762	4	in	in	IN
cord-005453-4057qib7	7762	5	54	54	CD
cord-005453-4057qib7	7762	6	patients	patient	NNS
cord-005453-4057qib7	7762	7	(	(	-LRB-
cord-005453-4057qib7	7762	8	94.7	94.7	CD
cord-005453-4057qib7	7762	9	%	%	NN
cord-005453-4057qib7	7762	10	)	)	-RRB-
cord-005453-4057qib7	7762	11	.	.	.
cord-005453-4057qib7	7763	1	Primary	primary	JJ
cord-005453-4057qib7	7763	2	graft	graft	NN
cord-005453-4057qib7	7763	3	failure	failure	NN
cord-005453-4057qib7	7763	4	occurred	occur	VBD
cord-005453-4057qib7	7763	5	in	in	IN
cord-005453-4057qib7	7763	6	3	3	CD
cord-005453-4057qib7	7763	7	patients	patient	NNS
cord-005453-4057qib7	7763	8	(	(	-LRB-
cord-005453-4057qib7	7763	9	2	2	CD
cord-005453-4057qib7	7763	10	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	7763	11	,	,	,
cord-005453-4057qib7	7763	12	1	1	CD
cord-005453-4057qib7	7763	13	AML	AML	NNP
cord-005453-4057qib7	7763	14	)	)	-RRB-
cord-005453-4057qib7	7763	15	.	.	.
cord-005453-4057qib7	7764	1	Twenty	twenty	CD
cord-005453-4057qib7	7764	2	(	(	-LRB-
cord-005453-4057qib7	7764	3	39.2	39.2	CD
cord-005453-4057qib7	7764	4	%	%	NN
cord-005453-4057qib7	7764	5	)	)	-RRB-
cord-005453-4057qib7	7764	6	out	out	IN
cord-005453-4057qib7	7764	7	of	of	IN
cord-005453-4057qib7	7764	8	51	51	CD
cord-005453-4057qib7	7764	9	evaluable	evaluable	JJ
cord-005453-4057qib7	7764	10	patients	patient	NNS
cord-005453-4057qib7	7764	11	developed	develop	VBD
cord-005453-4057qib7	7764	12	grade	grade	NN
cord-005453-4057qib7	7764	13	2	2	CD
cord-005453-4057qib7	7764	14	-	-	SYM
cord-005453-4057qib7	7764	15	4	4	CD
cord-005453-4057qib7	7764	16	acute	acute	JJ
cord-005453-4057qib7	7764	17	GvHD	GvHD	NNP
cord-005453-4057qib7	7764	18	.	.	.
cord-005453-4057qib7	7765	1	The	the	DT
cord-005453-4057qib7	7765	2	cumulative	cumulative	JJ
cord-005453-4057qib7	7765	3	incidence	incidence	NN
cord-005453-4057qib7	7765	4	of	of	IN
cord-005453-4057qib7	7765	5	severe	severe	JJ
cord-005453-4057qib7	7765	6	aGvHD	agvhd	NN
cord-005453-4057qib7	7765	7	and	and	CC
cord-005453-4057qib7	7765	8	moderatesevere	moderatesevere	NN
cord-005453-4057qib7	7765	9	chronic	chronic	JJ
cord-005453-4057qib7	7765	10	GvHD	GvHD	NNP
cord-005453-4057qib7	7765	11	were	be	VBD
cord-005453-4057qib7	7765	12	8.8	8.8	CD
cord-005453-4057qib7	7765	13	%	%	NN
cord-005453-4057qib7	7765	14	(	(	-LRB-
cord-005453-4057qib7	7765	15	95	95	CD
cord-005453-4057qib7	7765	16	%	%	NN
cord-005453-4057qib7	7765	17	CI	CI	NNP
cord-005453-4057qib7	7765	18	,	,	,
cord-005453-4057qib7	7765	19	3.2	3.2	CD
cord-005453-4057qib7	7765	20	-	-	SYM
cord-005453-4057qib7	7765	21	17.9	17.9	CD
cord-005453-4057qib7	7765	22	%	%	NN
cord-005453-4057qib7	7765	23	)	)	-RRB-
cord-005453-4057qib7	7765	24	and	and	CC
cord-005453-4057qib7	7765	25	35.2	35.2	CD
cord-005453-4057qib7	7765	26	%	%	NN
cord-005453-4057qib7	7765	27	(	(	-LRB-
cord-005453-4057qib7	7765	28	95	95	CD
cord-005453-4057qib7	7765	29	%	%	NN
cord-005453-4057qib7	7765	30	CI	CI	NNP
cord-005453-4057qib7	7765	31	22.7	22.7	CD
cord-005453-4057qib7	7765	32	-	-	HYPH
cord-005453-4057qib7	7765	33	47.9	47.9	CD
cord-005453-4057qib7	7765	34	%	%	NN
cord-005453-4057qib7	7765	35	)	)	-RRB-
cord-005453-4057qib7	7765	36	,	,	,
cord-005453-4057qib7	7765	37	only	only	RB
cord-005453-4057qib7	7765	38	5	5	CD
cord-005453-4057qib7	7765	39	(	(	-LRB-
cord-005453-4057qib7	7765	40	8.7	8.7	CD
cord-005453-4057qib7	7765	41	%	%	NN
cord-005453-4057qib7	7765	42	)	)	-RRB-
cord-005453-4057qib7	7765	43	patients	patient	NNS
cord-005453-4057qib7	7765	44	developed	develop	VBD
cord-005453-4057qib7	7765	45	severe	severe	JJ
cord-005453-4057qib7	7765	46	cGvHD	cgvhd	NN
cord-005453-4057qib7	7765	47	.	.	.
cord-005453-4057qib7	7766	1	Twenty	twenty	CD
cord-005453-4057qib7	7766	2	-	-	HYPH
cord-005453-4057qib7	7766	3	nine	nine	CD
cord-005453-4057qib7	7766	4	patients	patient	NNS
cord-005453-4057qib7	7766	5	(	(	-LRB-
cord-005453-4057qib7	7766	6	56.8	56.8	CD
cord-005453-4057qib7	7766	7	%	%	NN
cord-005453-4057qib7	7766	8	)	)	-RRB-
cord-005453-4057qib7	7766	9	discontinued	discontinue	VBN
cord-005453-4057qib7	7766	10	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7766	11	before	before	IN
cord-005453-4057qib7	7766	12	the	the	DT
cord-005453-4057qib7	7766	13	first	first	JJ
cord-005453-4057qib7	7766	14	year	year	NN
cord-005453-4057qib7	7766	15	of	of	IN
cord-005453-4057qib7	7766	16	transplant	transplant	NN
cord-005453-4057qib7	7766	17	.	.	.
cord-005453-4057qib7	7767	1	The	the	DT
cord-005453-4057qib7	7767	2	median	median	JJ
cord-005453-4057qib7	7767	3	duration	duration	NN
cord-005453-4057qib7	7767	4	of	of	IN
cord-005453-4057qib7	7767	5	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7767	6	for	for	IN
cord-005453-4057qib7	7767	7	patients	patient	NNS
cord-005453-4057qib7	7767	8	with	with	IN
cord-005453-4057qib7	7767	9	moderate	moderate	JJ
cord-005453-4057qib7	7767	10	-	-	HYPH
cord-005453-4057qib7	7767	11	severe	severe	JJ
cord-005453-4057qib7	7767	12	cGvHD	cgvhd	NN
cord-005453-4057qib7	7767	13	was	be	VBD
cord-005453-4057qib7	7767	14	488	488	CD
cord-005453-4057qib7	7767	15	days	day	NNS
cord-005453-4057qib7	7767	16	(	(	-LRB-
cord-005453-4057qib7	7767	17	207	207	CD
cord-005453-4057qib7	7767	18	-	-	HYPH
cord-005453-4057qib7	7767	19	2046	2046	CD
cord-005453-4057qib7	7767	20	)	)	-RRB-
cord-005453-4057qib7	7767	21	.	.	.
cord-005453-4057qib7	7768	1	At	at	IN
cord-005453-4057qib7	7768	2	2	2	CD
cord-005453-4057qib7	7768	3	years	year	NNS
cord-005453-4057qib7	7768	4	non	non	JJ
cord-005453-4057qib7	7768	5	-	-	JJ
cord-005453-4057qib7	7768	6	relapse	relapse	JJ
cord-005453-4057qib7	7768	7	mortality	mortality	NN
cord-005453-4057qib7	7768	8	(	(	-LRB-
cord-005453-4057qib7	7768	9	NRM	NRM	NNP
cord-005453-4057qib7	7768	10	)	)	-RRB-
cord-005453-4057qib7	7768	11	was	be	VBD
cord-005453-4057qib7	7768	12	21.9	21.9	CD
cord-005453-4057qib7	7768	13	%	%	NN
cord-005453-4057qib7	7768	14	(	(	-LRB-
cord-005453-4057qib7	7768	15	95	95	CD
cord-005453-4057qib7	7768	16	%	%	NN
cord-005453-4057qib7	7768	17	CI	CI	NNP
cord-005453-4057qib7	7768	18	,	,	,
cord-005453-4057qib7	7768	19	12.0	12.0	CD
cord-005453-4057qib7	7768	20	-	-	HYPH
cord-005453-4057qib7	7768	21	33.7	33.7	CD
cord-005453-4057qib7	7768	22	%	%	NN
cord-005453-4057qib7	7768	23	)	)	-RRB-
cord-005453-4057qib7	7768	24	.	.	.
cord-005453-4057qib7	7769	1	Thirty	thirty	CD
cord-005453-4057qib7	7769	2	-	-	HYPH
cord-005453-4057qib7	7769	3	nine	nine	CD
cord-005453-4057qib7	7769	4	(	(	-LRB-
cord-005453-4057qib7	7769	5	68	68	CD
cord-005453-4057qib7	7769	6	%	%	NN
cord-005453-4057qib7	7769	7	)	)	-RRB-
cord-005453-4057qib7	7769	8	patients	patient	NNS
cord-005453-4057qib7	7769	9	developed	develop	VBD
cord-005453-4057qib7	7769	10	relevant	relevant	JJ
cord-005453-4057qib7	7769	11	infectious	infectious	JJ
cord-005453-4057qib7	7769	12	complications	complication	NNS
cord-005453-4057qib7	7769	13	.	.	.
cord-005453-4057qib7	7770	1	Two	two	CD
cord-005453-4057qib7	7770	2	(	(	-LRB-
cord-005453-4057qib7	7770	3	3	3	CD
cord-005453-4057qib7	7770	4	%	%	NN
cord-005453-4057qib7	7770	5	)	)	-RRB-
cord-005453-4057qib7	7770	6	patients	patient	NNS
cord-005453-4057qib7	7770	7	died	die	VBD
cord-005453-4057qib7	7770	8	within	within	IN
cord-005453-4057qib7	7770	9	the	the	DT
cord-005453-4057qib7	7770	10	first	first	JJ
cord-005453-4057qib7	7770	11	30	30	CD
cord-005453-4057qib7	7770	12	days	day	NNS
cord-005453-4057qib7	7770	13	due	due	JJ
cord-005453-4057qib7	7770	14	to	to	TO
cord-005453-4057qib7	7770	15	gram	gram	VB
cord-005453-4057qib7	7770	16	negative	negative	JJ
cord-005453-4057qib7	7770	17	blood	blood	NN
cord-005453-4057qib7	7770	18	stream	stream	NN
cord-005453-4057qib7	7770	19	infection	infection	NN
cord-005453-4057qib7	7770	20	.	.	.
cord-005453-4057qib7	7771	1	Eleven	eleven	CD
cord-005453-4057qib7	7771	2	(	(	-LRB-
cord-005453-4057qib7	7771	3	19.2	19.2	CD
cord-005453-4057qib7	7771	4	%	%	NN
cord-005453-4057qib7	7771	5	)	)	-RRB-
cord-005453-4057qib7	7771	6	had	have	VBD
cord-005453-4057qib7	7771	7	at	at	RB
cord-005453-4057qib7	7771	8	least	least	RBS
cord-005453-4057qib7	7771	9	two	two	CD
cord-005453-4057qib7	7771	10	episodes	episode	NNS
cord-005453-4057qib7	7771	11	of	of	IN
cord-005453-4057qib7	7771	12	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	7771	13	(	(	-LRB-
cord-005453-4057qib7	7771	14	CMV	CMV	NNP
cord-005453-4057qib7	7771	15	)	)	-RRB-
cord-005453-4057qib7	7771	16	reactivation	reactivation	NN
cord-005453-4057qib7	7771	17	between	between	IN
cord-005453-4057qib7	7771	18	day	day	NN
cord-005453-4057qib7	7771	19	30	30	CD
cord-005453-4057qib7	7771	20	and	and	CC
cord-005453-4057qib7	7771	21	100	100	CD
cord-005453-4057qib7	7771	22	.	.	.
cord-005453-4057qib7	7772	1	Three	three	CD
cord-005453-4057qib7	7772	2	(	(	-LRB-
cord-005453-4057qib7	7772	3	5	5	CD
cord-005453-4057qib7	7772	4	%	%	NN
cord-005453-4057qib7	7772	5	)	)	-RRB-
cord-005453-4057qib7	7773	1	patients	patient	NNS
cord-005453-4057qib7	7773	2	developed	develop	VBD
cord-005453-4057qib7	7773	3	CMV	CMV	NNP
cord-005453-4057qib7	7773	4	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	7773	5	disease	disease	NN
cord-005453-4057qib7	7773	6	,	,	,
cord-005453-4057qib7	7773	7	2	2	CD
cord-005453-4057qib7	7773	8	(	(	-LRB-
cord-005453-4057qib7	7773	9	3	3	CD
cord-005453-4057qib7	7773	10	%	%	NN
cord-005453-4057qib7	7773	11	)	)	-RRB-
cord-005453-4057qib7	7773	12	had	have	VBD
cord-005453-4057qib7	7773	13	probable	probable	JJ
cord-005453-4057qib7	7773	14	invasive	invasive	JJ
cord-005453-4057qib7	7773	15	fungal	fungal	JJ
cord-005453-4057qib7	7773	16	infection	infection	NN
cord-005453-4057qib7	7773	17	and	and	CC
cord-005453-4057qib7	7773	18	1	1	CD
cord-005453-4057qib7	7773	19	(	(	-LRB-
cord-005453-4057qib7	7773	20	1.7	1.7	CD
cord-005453-4057qib7	7773	21	%	%	NN
cord-005453-4057qib7	7773	22	)	)	-RRB-
cord-005453-4057qib7	7773	23	,	,	,
cord-005453-4057qib7	7773	24	post	post	JJ
cord-005453-4057qib7	7773	25	-	-	JJ
cord-005453-4057qib7	7773	26	transplant	transplant	JJ
cord-005453-4057qib7	7773	27	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	7773	28	disorder	disorder	NN
cord-005453-4057qib7	7773	29	associated	associate	VBN
cord-005453-4057qib7	7773	30	to	to	IN
cord-005453-4057qib7	7773	31	Epstein	Epstein	NNP
cord-005453-4057qib7	7773	32	Barr	Barr	NNP
cord-005453-4057qib7	7773	33	Virus	Virus	NNP
cord-005453-4057qib7	7773	34	.	.	.
cord-005453-4057qib7	7774	1	With	with	IN
cord-005453-4057qib7	7774	2	a	a	DT
cord-005453-4057qib7	7774	3	median	median	NN
cord-005453-4057qib7	7774	4	follow	follow	NN
cord-005453-4057qib7	7774	5	up	up	IN
cord-005453-4057qib7	7774	6	of	of	IN
cord-005453-4057qib7	7774	7	28	28	CD
cord-005453-4057qib7	7774	8	months	month	NNS
cord-005453-4057qib7	7774	9	for	for	IN
cord-005453-4057qib7	7774	10	alive	alive	JJ
cord-005453-4057qib7	7774	11	patients	patient	NNS
cord-005453-4057qib7	7774	12	,	,	,
cord-005453-4057qib7	7774	13	the	the	DT
cord-005453-4057qib7	7774	14	GvHD	gvhd	NN
cord-005453-4057qib7	7774	15	and	and	CC
cord-005453-4057qib7	7774	16	relapse	relapse	VB
cord-005453-4057qib7	7774	17	free	free	JJ
cord-005453-4057qib7	7774	18	survival	survival	NN
cord-005453-4057qib7	7774	19	(	(	-LRB-
cord-005453-4057qib7	7774	20	GRFS	GRFS	NNP
cord-005453-4057qib7	7774	21	)	)	-RRB-
cord-005453-4057qib7	7774	22	at	at	IN
cord-005453-4057qib7	7774	23	one	one	CD
cord-005453-4057qib7	7774	24	year	year	NN
cord-005453-4057qib7	7774	25	,	,	,
cord-005453-4057qib7	7774	26	overall	overall	JJ
cord-005453-4057qib7	7774	27	survival	survival	NN
cord-005453-4057qib7	7774	28	(	(	-LRB-
cord-005453-4057qib7	7774	29	OS	OS	NNP
cord-005453-4057qib7	7774	30	)	)	-RRB-
cord-005453-4057qib7	7774	31	and	and	CC
cord-005453-4057qib7	7774	32	progression	progression	NN
cord-005453-4057qib7	7774	33	free	free	JJ
cord-005453-4057qib7	7774	34	survival	survival	NN
cord-005453-4057qib7	7774	35	(	(	-LRB-
cord-005453-4057qib7	7774	36	PFS	PFS	NNP
cord-005453-4057qib7	7774	37	)	)	-RRB-
cord-005453-4057qib7	7774	38	at	at	IN
cord-005453-4057qib7	7774	39	two	two	CD
cord-005453-4057qib7	7774	40	years	year	NNS
cord-005453-4057qib7	7774	41	were	be	VBD
cord-005453-4057qib7	7774	42	47.6	47.6	CD
cord-005453-4057qib7	7774	43	%	%	NN
cord-005453-4057qib7	7774	44	(	(	-LRB-
cord-005453-4057qib7	7774	45	95	95	CD
cord-005453-4057qib7	7774	46	%	%	NN
cord-005453-4057qib7	7774	47	CI	CI	NNP
cord-005453-4057qib7	7774	48	,	,	,
cord-005453-4057qib7	7774	49	42.8	42.8	CD
cord-005453-4057qib7	7774	50	-	-	SYM
cord-005453-4057qib7	7774	51	52.2	52.2	CD
cord-005453-4057qib7	7774	52	%	%	NN
cord-005453-4057qib7	7774	53	)	)	-RRB-
cord-005453-4057qib7	7774	54	,	,	,
cord-005453-4057qib7	7774	55	59	59	CD
cord-005453-4057qib7	7774	56	%	%	NN
cord-005453-4057qib7	7774	57	(	(	-LRB-
cord-005453-4057qib7	7774	58	95	95	CD
cord-005453-4057qib7	7774	59	%	%	NN
cord-005453-4057qib7	7774	60	CI	CI	NNP
cord-005453-4057qib7	7774	61	,	,	,
cord-005453-4057qib7	7774	62	54.5	54.5	CD
cord-005453-4057qib7	7774	63	-	-	HYPH
cord-005453-4057qib7	7774	64	63.2	63.2	CD
cord-005453-4057qib7	7774	65	%	%	NN
cord-005453-4057qib7	7774	66	)	)	-RRB-
cord-005453-4057qib7	7774	67	and	and	CC
cord-005453-4057qib7	7774	68	52	52	CD
cord-005453-4057qib7	7774	69	%	%	NN
cord-005453-4057qib7	7774	70	(	(	-LRB-
cord-005453-4057qib7	7774	71	95	95	CD
cord-005453-4057qib7	7774	72	%	%	NN
cord-005453-4057qib7	7774	73	CI	CI	NNP
cord-005453-4057qib7	7774	74	,	,	,
cord-005453-4057qib7	7774	75	46.9	46.9	CD
cord-005453-4057qib7	7774	76	-	-	SYM
cord-005453-4057qib7	7774	77	56.5	56.5	CD
cord-005453-4057qib7	7774	78	%	%	NN
cord-005453-4057qib7	7774	79	)	)	-RRB-
cord-005453-4057qib7	7774	80	,	,	,
cord-005453-4057qib7	7774	81	respectively	respectively	RB
cord-005453-4057qib7	7774	82	.	.	.
cord-005453-4057qib7	7775	1	The	the	DT
cord-005453-4057qib7	7775	2	relapse	relapse	NN
cord-005453-4057qib7	7775	3	incidence	incidence	NN
cord-005453-4057qib7	7775	4	at	at	IN
cord-005453-4057qib7	7775	5	two	two	CD
cord-005453-4057qib7	7775	6	years	year	NNS
cord-005453-4057qib7	7775	7	was	be	VBD
cord-005453-4057qib7	7775	8	26.3	26.3	CD
cord-005453-4057qib7	7775	9	%	%	NN
cord-005453-4057qib7	7775	10	(	(	-LRB-
cord-005453-4057qib7	7775	11	95	95	CD
cord-005453-4057qib7	7775	12	%	%	NN
cord-005453-4057qib7	7775	13	CI	CI	NNP
cord-005453-4057qib7	7775	14	14.7	14.7	CD
cord-005453-4057qib7	7775	15	-	-	HYPH
cord-005453-4057qib7	7775	16	39.4	39.4	CD
cord-005453-4057qib7	7775	17	%	%	NN
cord-005453-4057qib7	7775	18	)	)	-RRB-
cord-005453-4057qib7	7775	19	.	.	.
cord-005453-4057qib7	7776	1	Complete	complete	JJ
cord-005453-4057qib7	7776	2	remission	remission	NN
cord-005453-4057qib7	7776	3	at	at	IN
cord-005453-4057qib7	7776	4	transplant	transplant	NN
cord-005453-4057qib7	7776	5	was	be	VBD
cord-005453-4057qib7	7776	6	associated	associate	VBN
cord-005453-4057qib7	7776	7	with	with	IN
cord-005453-4057qib7	7776	8	better	well	JJR
cord-005453-4057qib7	7776	9	long	long	JJ
cord-005453-4057qib7	7776	10	term	term	NN
cord-005453-4057qib7	7776	11	survival	survival	NN
cord-005453-4057qib7	7776	12	(	(	-LRB-
cord-005453-4057qib7	7776	13	80	80	CD
cord-005453-4057qib7	7776	14	%	%	NN
cord-005453-4057qib7	7776	15	at	at	IN
cord-005453-4057qib7	7776	16	2	2	CD
cord-005453-4057qib7	7776	17	years	year	NNS
cord-005453-4057qib7	7776	18	,	,	,
cord-005453-4057qib7	7776	19	p	p	NN
cord-005453-4057qib7	7776	20	<	<	XX
cord-005453-4057qib7	7776	21	0.01	0.01	CD
cord-005453-4057qib7	7776	22	)	)	-RRB-
cord-005453-4057qib7	7776	23	.	.	.
cord-005453-4057qib7	7777	1	HLA	HLA	NNP
cord-005453-4057qib7	7777	2	disparity	disparity	NN
cord-005453-4057qib7	7777	3	did	do	VBD
cord-005453-4057qib7	7777	4	not	not	RB
cord-005453-4057qib7	7777	5	affect	affect	VB
cord-005453-4057qib7	7777	6	OS	OS	NNP
cord-005453-4057qib7	7777	7	(	(	-LRB-
cord-005453-4057qib7	7777	8	see	see	VB
cord-005453-4057qib7	7777	9	image	image	NN
cord-005453-4057qib7	7777	10	1A	1a	CD
cord-005453-4057qib7	7777	11	)	)	-RRB-
cord-005453-4057qib7	7777	12	.	.	.
cord-005453-4057qib7	7778	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7778	2	:	:	:
cord-005453-4057qib7	7779	1	The	the	DT
cord-005453-4057qib7	7779	2	use	use	NN
cord-005453-4057qib7	7779	3	of	of	IN
cord-005453-4057qib7	7779	4	low	low	JJ
cord-005453-4057qib7	7779	5	doses	dose	NNS
cord-005453-4057qib7	7779	6	of	of	IN
cord-005453-4057qib7	7779	7	ATG	ATG	NNP
cord-005453-4057qib7	7779	8	-	-	HYPH
cord-005453-4057qib7	7779	9	F	F	NNP
cord-005453-4057qib7	7779	10	is	be	VBZ
cord-005453-4057qib7	7779	11	protective	protective	JJ
cord-005453-4057qib7	7779	12	against	against	IN
cord-005453-4057qib7	7779	13	severe	severe	JJ
cord-005453-4057qib7	7779	14	forms	form	NNS
cord-005453-4057qib7	7779	15	of	of	IN
cord-005453-4057qib7	7779	16	acute	acute	JJ
cord-005453-4057qib7	7779	17	and	and	CC
cord-005453-4057qib7	7779	18	chronic	chronic	JJ
cord-005453-4057qib7	7779	19	GvHD	gvhd	NN
cord-005453-4057qib7	7779	20	in	in	IN
cord-005453-4057qib7	7779	21	a	a	DT
cord-005453-4057qib7	7779	22	cohort	cohort	NN
cord-005453-4057qib7	7779	23	with	with	IN
cord-005453-4057qib7	7779	24	high	high	JJ
cord-005453-4057qib7	7779	25	prevalence	prevalence	NN
cord-005453-4057qib7	7779	26	of	of	IN
cord-005453-4057qib7	7779	27	unrelated	unrelated	JJ
cord-005453-4057qib7	7779	28	donors	donor	NNS
cord-005453-4057qib7	7779	29	and	and	CC
cord-005453-4057qib7	7779	30	a	a	DT
cord-005453-4057qib7	7779	31	high	high	JJ
cord-005453-4057qib7	7779	32	median	median	NN
cord-005453-4057qib7	7779	33	age	age	NN
cord-005453-4057qib7	7779	34	.	.	.
cord-005453-4057qib7	7780	1	This	this	DT
cord-005453-4057qib7	7780	2	strategy	strategy	NN
cord-005453-4057qib7	7780	3	showed	show	VBD
cord-005453-4057qib7	7780	4	good	good	JJ
cord-005453-4057qib7	7780	5	results	result	NNS
cord-005453-4057qib7	7780	6	in	in	IN
cord-005453-4057qib7	7780	7	GRFS	GRFS	NNP
cord-005453-4057qib7	7780	8	,	,	,
cord-005453-4057qib7	7780	9	OS	OS	NNP
cord-005453-4057qib7	7780	10	and	and	CC
cord-005453-4057qib7	7780	11	PFS	PFS	NNP
cord-005453-4057qib7	7780	12	in	in	IN
cord-005453-4057qib7	7780	13	a	a	DT
cord-005453-4057qib7	7780	14	population	population	NN
cord-005453-4057qib7	7780	15	at	at	IN
cord-005453-4057qib7	7780	16	high	high	JJ
cord-005453-4057qib7	7780	17	risk	risk	NN
cord-005453-4057qib7	7780	18	for	for	IN
cord-005453-4057qib7	7780	19	developing	develop	VBG
cord-005453-4057qib7	7780	20	GvHD	gvhd	NN
cord-005453-4057qib7	7780	21	or	or	CC
cord-005453-4057qib7	7780	22	relapse	relapse	NN
cord-005453-4057qib7	7780	23	.	.	.
cord-005453-4057qib7	7781	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7781	2	:	:	:
cord-005453-4057qib7	7781	3	Nothing	nothing	NN
cord-005453-4057qib7	7781	4	to	to	TO
cord-005453-4057qib7	7781	5	declare	declare	VB
cord-005453-4057qib7	7781	6	Performance	performance	NN
cord-005453-4057qib7	7781	7	parameters	parameter	NNS
cord-005453-4057qib7	7781	8	of	of	IN
cord-005453-4057qib7	7781	9	a	a	DT
cord-005453-4057qib7	7781	10	ngs	ngs	NN
cord-005453-4057qib7	7781	11	-	-	HYPH
cord-005453-4057qib7	7781	12	product	product	NN
cord-005453-4057qib7	7781	13	for	for	IN
cord-005453-4057qib7	7781	14	chimerism	chimerism	NN
cord-005453-4057qib7	7781	15	monitoring	monitoring	NN
cord-005453-4057qib7	7781	16	-applicable	-applicable	NN
cord-005453-4057qib7	7782	1	in	in	IN
cord-005453-4057qib7	7782	2	patients	patient	NNS
cord-005453-4057qib7	7782	3	after	after	IN
cord-005453-4057qib7	7782	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7782	5	stem	stem	NN
cord-005453-4057qib7	7782	6	cell	cell	NN
cord-005453-4057qib7	7782	7	transplantation	transplantation	NN
cord-005453-4057qib7	7782	8	Methods	method	NNS
cord-005453-4057qib7	7782	9	:	:	:
cord-005453-4057qib7	7782	10	For	for	IN
cord-005453-4057qib7	7782	11	this	this	DT
cord-005453-4057qib7	7782	12	purpose	purpose	NN
cord-005453-4057qib7	7782	13	,	,	,
cord-005453-4057qib7	7782	14	samples	sample	NNS
cord-005453-4057qib7	7782	15	from	from	IN
cord-005453-4057qib7	7782	16	patients	patient	NNS
cord-005453-4057qib7	7782	17	with	with	IN
cord-005453-4057qib7	7782	18	mixed	mixed	JJ
cord-005453-4057qib7	7782	19	chimerism	chimerism	NN
cord-005453-4057qib7	7782	20	(	(	-LRB-
cord-005453-4057qib7	7782	21	MC	MC	NNP
cord-005453-4057qib7	7782	22	)	)	-RRB-
cord-005453-4057qib7	7782	23	with	with	IN
cord-005453-4057qib7	7782	24	increasing	increase	VBG
cord-005453-4057qib7	7782	25	amounts	amount	NNS
cord-005453-4057qib7	7782	26	of	of	IN
cord-005453-4057qib7	7782	27	recipient	recipient	NN
cord-005453-4057qib7	7782	28	DNA	DNA	NNP
cord-005453-4057qib7	7782	29	were	be	VBD
cord-005453-4057qib7	7782	30	analyzed	analyze	VBN
cord-005453-4057qib7	7782	31	and	and	CC
cord-005453-4057qib7	7782	32	compared	compare	VBN
cord-005453-4057qib7	7782	33	using	use	VBG
cord-005453-4057qib7	7782	34	realtime	realtime	JJ
cord-005453-4057qib7	7782	35	PCR	PCR	NNP
cord-005453-4057qib7	7782	36	of	of	IN
cord-005453-4057qib7	7782	37	insertions	insertion	NNS
cord-005453-4057qib7	7782	38	/	/	SYM
cord-005453-4057qib7	7782	39	deletions	deletion	NNS
cord-005453-4057qib7	7782	40	(	(	-LRB-
cord-005453-4057qib7	7782	41	indels	indel	NNS
cord-005453-4057qib7	7782	42	)	)	-RRB-
cord-005453-4057qib7	7782	43	,	,	,
cord-005453-4057qib7	7782	44	fragment	fragment	NN
cord-005453-4057qib7	7782	45	analysis	analysis	NN
cord-005453-4057qib7	7782	46	of	of	IN
cord-005453-4057qib7	7782	47	short	short	JJ
cord-005453-4057qib7	7782	48	-	-	HYPH
cord-005453-4057qib7	7782	49	tandem	tandem	NN
cord-005453-4057qib7	7782	50	repeats	repeat	NNS
cord-005453-4057qib7	7782	51	(	(	-LRB-
cord-005453-4057qib7	7782	52	STR	STR	NNP
cord-005453-4057qib7	7782	53	)	)	-RRB-
cord-005453-4057qib7	7782	54	and	and	CC
cord-005453-4057qib7	7782	55	NGS	ngs	NN
cord-005453-4057qib7	7782	56	of	of	IN
cord-005453-4057qib7	7782	57	indels	indel	NNS
cord-005453-4057qib7	7782	58	.	.	.
cord-005453-4057qib7	7783	1	Results	result	NNS
cord-005453-4057qib7	7783	2	:	:	:
cord-005453-4057qib7	7784	1	Whereas	whereas	IN
cord-005453-4057qib7	7784	2	real	real	JJ
cord-005453-4057qib7	7784	3	-	-	HYPH
cord-005453-4057qib7	7784	4	time	time	NN
cord-005453-4057qib7	7784	5	PCR	PCR	NNP
cord-005453-4057qib7	7784	6	displayed	display	VBD
cord-005453-4057qib7	7784	7	excellent	excellent	JJ
cord-005453-4057qib7	7784	8	sensitivity	sensitivity	NN
cord-005453-4057qib7	7784	9	down	down	RB
cord-005453-4057qib7	7784	10	to	to	IN
cord-005453-4057qib7	7784	11	0,01	0,01	NN
cord-005453-4057qib7	7784	12	%	%	NN
cord-005453-4057qib7	7784	13	MC	MC	NNP
cord-005453-4057qib7	7784	14	,	,	,
cord-005453-4057qib7	7784	15	but	but	CC
cord-005453-4057qib7	7784	16	poor	poor	JJ
cord-005453-4057qib7	7784	17	precision	precision	NN
cord-005453-4057qib7	7784	18	above	above	IN
cord-005453-4057qib7	7784	19	20	20	CD
cord-005453-4057qib7	7784	20	%	%	NN
cord-005453-4057qib7	7784	21	,	,	,
cord-005453-4057qib7	7784	22	fragment	fragment	NN
cord-005453-4057qib7	7784	23	analysis	analysis	NN
cord-005453-4057qib7	7784	24	exhibited	exhibit	VBD
cord-005453-4057qib7	7784	25	good	good	JJ
cord-005453-4057qib7	7784	26	precision	precision	NN
cord-005453-4057qib7	7784	27	with	with	IN
cord-005453-4057qib7	7784	28	limited	limited	JJ
cord-005453-4057qib7	7784	29	sensitivity	sensitivity	NN
cord-005453-4057qib7	7784	30	(	(	-LRB-
cord-005453-4057qib7	7784	31	>	>	NFP
cord-005453-4057qib7	7784	32	2,5	2,5	CD
cord-005453-4057qib7	7784	33	%	%	NN
cord-005453-4057qib7	7784	34	)	)	-RRB-
cord-005453-4057qib7	7784	35	.	.	.
cord-005453-4057qib7	7785	1	In	in	IN
cord-005453-4057qib7	7785	2	contrast	contrast	NN
cord-005453-4057qib7	7785	3	,	,	,
cord-005453-4057qib7	7785	4	NGS	NGS	NNP
cord-005453-4057qib7	7785	5	chimerism	chimerism	NN
cord-005453-4057qib7	7785	6	demonstrated	demonstrate	VBD
cord-005453-4057qib7	7785	7	good	good	JJ
cord-005453-4057qib7	7785	8	sensitivity	sensitivity	NN
cord-005453-4057qib7	7785	9	,	,	,
cord-005453-4057qib7	7785	10	with	with	IN
cord-005453-4057qib7	7785	11	a	a	DT
cord-005453-4057qib7	7785	12	limit	limit	NN
cord-005453-4057qib7	7785	13	of	of	IN
cord-005453-4057qib7	7785	14	detection	detection	NN
cord-005453-4057qib7	7785	15	(	(	-LRB-
cord-005453-4057qib7	7785	16	LOD	lod	NN
cord-005453-4057qib7	7785	17	)	)	-RRB-
cord-005453-4057qib7	7785	18	of	of	IN
cord-005453-4057qib7	7785	19	0,1	0,1	CD
cord-005453-4057qib7	7785	20	%	%	NN
cord-005453-4057qib7	7785	21	MC	MC	NNP
cord-005453-4057qib7	7785	22	,	,	,
cord-005453-4057qib7	7785	23	and	and	CC
cord-005453-4057qib7	7785	24	precision	precision	NN
cord-005453-4057qib7	7785	25	throughout	throughout	IN
cord-005453-4057qib7	7785	26	the	the	DT
cord-005453-4057qib7	7785	27	whole	whole	JJ
cord-005453-4057qib7	7785	28	spectrum	spectrum	NN
cord-005453-4057qib7	7785	29	of	of	IN
cord-005453-4057qib7	7785	30	patient	patient	NN
cord-005453-4057qib7	7785	31	/	/	SYM
cord-005453-4057qib7	7785	32	donor	donor	NN
cord-005453-4057qib7	7785	33	mixed	mixed	JJ
cord-005453-4057qib7	7785	34	chimerism	chimerism	NN
cord-005453-4057qib7	7785	35	.	.	.
cord-005453-4057qib7	7786	1	The	the	DT
cord-005453-4057qib7	7786	2	NGS	NGS	NNP
cord-005453-4057qib7	7786	3	chimerism	chimerism	NN
cord-005453-4057qib7	7786	4	product	product	NN
cord-005453-4057qib7	7786	5	(	(	-LRB-
cord-005453-4057qib7	7786	6	Devyser	Devyser	NNP
cord-005453-4057qib7	7786	7	Chimerism	Chimerism	NNP
cord-005453-4057qib7	7786	8	)	)	-RRB-
cord-005453-4057qib7	7786	9	exhibited	exhibit	VBD
cord-005453-4057qib7	7786	10	at	at	IN
cord-005453-4057qib7	7786	11	least	least	JJS
cord-005453-4057qib7	7786	12	three	three	CD
cord-005453-4057qib7	7786	13	(	(	-LRB-
cord-005453-4057qib7	7786	14	average	average	JJ
cord-005453-4057qib7	7786	15	eight	eight	CD
cord-005453-4057qib7	7786	16	)	)	-RRB-
cord-005453-4057qib7	7786	17	and	and	CC
cord-005453-4057qib7	7786	18	at	at	IN
cord-005453-4057qib7	7786	19	least	least	JJS
cord-005453-4057qib7	7786	20	two	two	CD
cord-005453-4057qib7	7786	21	(	(	-LRB-
cord-005453-4057qib7	7786	22	average	average	JJ
cord-005453-4057qib7	7786	23	5	5	CD
cord-005453-4057qib7	7786	24	)	)	-RRB-
cord-005453-4057qib7	7786	25	informative	informative	JJ
cord-005453-4057qib7	7786	26	genetic	genetic	JJ
cord-005453-4057qib7	7786	27	markers	marker	NNS
cord-005453-4057qib7	7786	28	(	(	-LRB-
cord-005453-4057qib7	7786	29	indels	indel	NNS
cord-005453-4057qib7	7786	30	)	)	-RRB-
cord-005453-4057qib7	7786	31	,	,	,
cord-005453-4057qib7	7786	32	suitable	suitable	JJ
cord-005453-4057qib7	7786	33	for	for	IN
cord-005453-4057qib7	7786	34	monitoring	monitor	VBG
cord-005453-4057qib7	7786	35	mixed	mixed	JJ
cord-005453-4057qib7	7786	36	chimerism	chimerism	NN
cord-005453-4057qib7	7786	37	of	of	IN
cord-005453-4057qib7	7786	38	patients	patient	NNS
cord-005453-4057qib7	7786	39	with	with	IN
cord-005453-4057qib7	7786	40	their	-PRON-	PRP$
cord-005453-4057qib7	7786	41	corresponding	corresponding	JJ
cord-005453-4057qib7	7786	42	matched	match	VBN
cord-005453-4057qib7	7786	43	unrelated	unrelated	JJ
cord-005453-4057qib7	7786	44	(	(	-LRB-
cord-005453-4057qib7	7786	45	60	60	CD
cord-005453-4057qib7	7786	46	)	)	-RRB-
cord-005453-4057qib7	7786	47	or	or	CC
cord-005453-4057qib7	7786	48	related	relate	VBN
cord-005453-4057qib7	7786	49	(	(	-LRB-
cord-005453-4057qib7	7786	50	56	56	CD
cord-005453-4057qib7	7786	51	)	)	-RRB-
cord-005453-4057qib7	7786	52	donor	donor	NN
cord-005453-4057qib7	7786	53	samples	sample	NNS
cord-005453-4057qib7	7786	54	.	.	.
cord-005453-4057qib7	7787	1	In	in	IN
cord-005453-4057qib7	7787	2	order	order	NN
cord-005453-4057qib7	7787	3	to	to	TO
cord-005453-4057qib7	7787	4	establish	establish	VB
cord-005453-4057qib7	7787	5	the	the	DT
cord-005453-4057qib7	7787	6	performance	performance	NN
cord-005453-4057qib7	7787	7	of	of	IN
cord-005453-4057qib7	7787	8	the	the	DT
cord-005453-4057qib7	7787	9	separate	separate	JJ
cord-005453-4057qib7	7787	10	techniques	technique	NNS
cord-005453-4057qib7	7787	11	for	for	IN
cord-005453-4057qib7	7787	12	determination	determination	NN
cord-005453-4057qib7	7787	13	of	of	IN
cord-005453-4057qib7	7787	14	mixed	mixed	JJ
cord-005453-4057qib7	7787	15	chimerism	chimerism	NN
cord-005453-4057qib7	7787	16	on	on	IN
cord-005453-4057qib7	7787	17	retrospective	retrospective	JJ
cord-005453-4057qib7	7787	18	patient	patient	NN
cord-005453-4057qib7	7787	19	samples	sample	NNS
cord-005453-4057qib7	7787	20	,	,	,
cord-005453-4057qib7	7787	21	a	a	DT
cord-005453-4057qib7	7787	22	cohort	cohort	NN
cord-005453-4057qib7	7787	23	of	of	IN
cord-005453-4057qib7	7787	24	27	27	CD
cord-005453-4057qib7	7787	25	patient	patient	NN
cord-005453-4057qib7	7787	26	monitoring	monitoring	NN
cord-005453-4057qib7	7787	27	samples	sample	NNS
cord-005453-4057qib7	7787	28	(	(	-LRB-
cord-005453-4057qib7	7787	29	3	3	CD
cord-005453-4057qib7	7787	30	-	-	SYM
cord-005453-4057qib7	7787	31	7	7	CD
cord-005453-4057qib7	7787	32	weeks	week	NNS
cord-005453-4057qib7	7787	33	post	post	JJ
cord-005453-4057qib7	7787	34	-	-	JJ
cord-005453-4057qib7	7787	35	HSCT	HSCT	NNP
cord-005453-4057qib7	7787	36	)	)	-RRB-
cord-005453-4057qib7	7787	37	with	with	IN
cord-005453-4057qib7	7787	38	low	low	JJ
cord-005453-4057qib7	7787	39	(	(	-LRB-
cord-005453-4057qib7	7787	40	<	<	NNP
cord-005453-4057qib7	7787	41	5	5	CD
cord-005453-4057qib7	7787	42	%	%	NN
cord-005453-4057qib7	7787	43	)	)	-RRB-
cord-005453-4057qib7	7787	44	,	,	,
cord-005453-4057qib7	7787	45	intermediate	intermediate	JJ
cord-005453-4057qib7	7787	46	or	or	CC
cord-005453-4057qib7	7787	47	high	high	JJ
cord-005453-4057qib7	7787	48	mixed	mixed	JJ
cord-005453-4057qib7	7787	49	chimerism	chimerism	NN
cord-005453-4057qib7	7787	50	(	(	-LRB-
cord-005453-4057qib7	7787	51	>	>	NFP
cord-005453-4057qib7	7787	52	20	20	CD
cord-005453-4057qib7	7787	53	%	%	NN
cord-005453-4057qib7	7787	54	)	)	-RRB-
cord-005453-4057qib7	7787	55	were	be	VBD
cord-005453-4057qib7	7787	56	included	include	VBN
cord-005453-4057qib7	7787	57	and	and	CC
cord-005453-4057qib7	7787	58	analyzed	analyze	VBN
cord-005453-4057qib7	7787	59	.	.	.
cord-005453-4057qib7	7788	1	DNA	DNA	NNP
cord-005453-4057qib7	7788	2	from	from	IN
cord-005453-4057qib7	7788	3	all	all	DT
cord-005453-4057qib7	7788	4	monitoring	monitoring	NN
cord-005453-4057qib7	7788	5	samples	sample	NNS
cord-005453-4057qib7	7788	6	was	be	VBD
cord-005453-4057qib7	7788	7	extracted	extract	VBN
cord-005453-4057qib7	7788	8	from	from	IN
cord-005453-4057qib7	7788	9	sorted	sorted	JJ
cord-005453-4057qib7	7788	10	cell	cell	NN
cord-005453-4057qib7	7788	11	fractions	fraction	NNS
cord-005453-4057qib7	7788	12	.	.	.
cord-005453-4057qib7	7789	1	The	the	DT
cord-005453-4057qib7	7789	2	results	result	NNS
cord-005453-4057qib7	7789	3	show	show	VBP
cord-005453-4057qib7	7789	4	that	that	IN
cord-005453-4057qib7	7789	5	although	although	IN
cord-005453-4057qib7	7789	6	all	all	DT
cord-005453-4057qib7	7789	7	evaluated	evaluate	VBN
cord-005453-4057qib7	7789	8	techniques	technique	NNS
cord-005453-4057qib7	7789	9	are	be	VBP
cord-005453-4057qib7	7789	10	suitable	suitable	JJ
cord-005453-4057qib7	7789	11	for	for	IN
cord-005453-4057qib7	7789	12	monitoring	monitor	VBG
cord-005453-4057qib7	7789	13	patient	patient	NN
cord-005453-4057qib7	7789	14	/	/	SYM
cord-005453-4057qib7	7789	15	donor	donor	NN
cord-005453-4057qib7	7789	16	chimerism	chimerism	NN
cord-005453-4057qib7	7789	17	after	after	IN
cord-005453-4057qib7	7789	18	allogeneic	allogeneic	JJ
cord-005453-4057qib7	7789	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7789	20	stem	stem	NN
cord-005453-4057qib7	7789	21	cell	cell	NN
cord-005453-4057qib7	7789	22	transplantation	transplantation	NN
cord-005453-4057qib7	7789	23	(	(	-LRB-
cord-005453-4057qib7	7789	24	HSCT	HSCT	NNP
cord-005453-4057qib7	7789	25	)	)	-RRB-
cord-005453-4057qib7	7789	26	,	,	,
cord-005453-4057qib7	7789	27	only	only	RB
cord-005453-4057qib7	7789	28	the	the	DT
cord-005453-4057qib7	7789	29	NGS	NGS	NNP
cord-005453-4057qib7	7789	30	chimerism	chimerism	NN
cord-005453-4057qib7	7789	31	product	product	NN
cord-005453-4057qib7	7789	32	exhibits	exhibit	VBZ
cord-005453-4057qib7	7789	33	high	high	JJ
cord-005453-4057qib7	7789	34	sensitivity	sensitivity	NN
cord-005453-4057qib7	7789	35	(	(	-LRB-
cord-005453-4057qib7	7789	36	LOD	lod	NN
cord-005453-4057qib7	7789	37	0,1	0,1	CD
cord-005453-4057qib7	7789	38	%	%	NN
cord-005453-4057qib7	7789	39	)	)	-RRB-
cord-005453-4057qib7	7789	40	and	and	CC
cord-005453-4057qib7	7789	41	a	a	DT
cord-005453-4057qib7	7789	42	broad	broad	JJ
cord-005453-4057qib7	7789	43	dynamic	dynamic	JJ
cord-005453-4057qib7	7789	44	range	range	NN
cord-005453-4057qib7	7789	45	(	(	-LRB-
cord-005453-4057qib7	7789	46	detection	detection	NN
cord-005453-4057qib7	7789	47	range	range	NN
cord-005453-4057qib7	7789	48	0,1	0,1	CD
cord-005453-4057qib7	7789	49	-	-	SYM
cord-005453-4057qib7	7789	50	100	100	CD
cord-005453-4057qib7	7789	51	%	%	NN
cord-005453-4057qib7	7789	52	)	)	-RRB-
cord-005453-4057qib7	7789	53	with	with	IN
cord-005453-4057qib7	7789	54	good	good	JJ
cord-005453-4057qib7	7789	55	precision	precision	NN
cord-005453-4057qib7	7789	56	and	and	CC
cord-005453-4057qib7	7789	57	accuracy	accuracy	NN
cord-005453-4057qib7	7789	58	throughout	throughout	IN
cord-005453-4057qib7	7789	59	the	the	DT
cord-005453-4057qib7	7789	60	whole	whole	JJ
cord-005453-4057qib7	7789	61	spectrum	spectrum	NN
cord-005453-4057qib7	7789	62	of	of	IN
cord-005453-4057qib7	7789	63	mixed	mixed	JJ
cord-005453-4057qib7	7789	64	chimerism	chimerism	NN
cord-005453-4057qib7	7789	65	(	(	-LRB-
cord-005453-4057qib7	7789	66	%	%	NN
cord-005453-4057qib7	7789	67	patient	patient	NN
cord-005453-4057qib7	7789	68	/	/	SYM
cord-005453-4057qib7	7789	69	donor	donor	NN
cord-005453-4057qib7	7789	70	)	)	-RRB-
cord-005453-4057qib7	7789	71	.	.	.
cord-005453-4057qib7	7790	1	In	in	IN
cord-005453-4057qib7	7790	2	addition	addition	NN
cord-005453-4057qib7	7790	3	,	,	,
cord-005453-4057qib7	7790	4	the	the	DT
cord-005453-4057qib7	7790	5	NGS	NGS	NNP
cord-005453-4057qib7	7790	6	chimerism	chimerism	NN
cord-005453-4057qib7	7790	7	product	product	NN
cord-005453-4057qib7	7790	8	employ	employ	VB
cord-005453-4057qib7	7790	9	24	24	CD
cord-005453-4057qib7	7790	10	non	non	JJ
cord-005453-4057qib7	7790	11	-	-	JJ
cord-005453-4057qib7	7790	12	population	population	JJ
cord-005453-4057qib7	7790	13	dependent	dependent	JJ
cord-005453-4057qib7	7790	14	highly	highly	RB
cord-005453-4057qib7	7790	15	informative	informative	JJ
cord-005453-4057qib7	7790	16	genetic	genetic	JJ
cord-005453-4057qib7	7790	17	markers	marker	NNS
cord-005453-4057qib7	7790	18	providing	provide	VBG
cord-005453-4057qib7	7790	19	stable	stable	JJ
cord-005453-4057qib7	7790	20	resolution	resolution	NN
cord-005453-4057qib7	7790	21	power	power	NN
cord-005453-4057qib7	7790	22	and	and	CC
cord-005453-4057qib7	7790	23	thus	thus	RB
cord-005453-4057qib7	7790	24	suitable	suitable	JJ
cord-005453-4057qib7	7790	25	for	for	IN
cord-005453-4057qib7	7790	26	monitoring	monitor	VBG
cord-005453-4057qib7	7790	27	mixed	mixed	JJ
cord-005453-4057qib7	7790	28	chimerism	chimerism	NN
cord-005453-4057qib7	7790	29	.	.	.
cord-005453-4057qib7	7791	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7791	2	:	:	:
cord-005453-4057qib7	7791	3	Dan	Dan	NNP
cord-005453-4057qib7	7791	4	Hauzenberger	Hauzenberger	NNP
cord-005453-4057qib7	7791	5	is	be	VBZ
cord-005453-4057qib7	7791	6	medical	medical	JJ
cord-005453-4057qib7	7791	7	adviser	adviser	NN
cord-005453-4057qib7	7791	8	at	at	IN
cord-005453-4057qib7	7791	9	Devyser	Devyser	NNP
cord-005453-4057qib7	7791	10	AB	AB	NNP
cord-005453-4057qib7	7791	11	and	and	CC
cord-005453-4057qib7	7791	12	shareholder	shareholder	NN
cord-005453-4057qib7	7791	13	in	in	IN
cord-005453-4057qib7	7791	14	Devyser	Devyser	NNP
cord-005453-4057qib7	7791	15	Holding	Holding	NNP
cord-005453-4057qib7	7791	16	Gender	Gender	NNP
cord-005453-4057qib7	7791	17	distribution	distribution	NN
cord-005453-4057qib7	7791	18	:	:	:
cord-005453-4057qib7	7791	19	male	male	JJ
cord-005453-4057qib7	7791	20	-59	-59	NNP
cord-005453-4057qib7	7791	21	%	%	NN
cord-005453-4057qib7	7791	22	(	(	-LRB-
cord-005453-4057qib7	7791	23	n=58	n=58	NN
cord-005453-4057qib7	7791	24	)	)	-RRB-
cord-005453-4057qib7	7791	25	,	,	,
cord-005453-4057qib7	7791	26	female	female	JJ
cord-005453-4057qib7	7791	27	-41	-41	NNP
cord-005453-4057qib7	7791	28	%	%	NN
cord-005453-4057qib7	7791	29	(	(	-LRB-
cord-005453-4057qib7	7791	30	n=41	n=41	RB
cord-005453-4057qib7	7791	31	)	)	-RRB-
cord-005453-4057qib7	7791	32	.	.	.
cord-005453-4057qib7	7792	1	Age	age	NN
cord-005453-4057qib7	7792	2	median	median	NN
cord-005453-4057qib7	7793	1	-5,8	-5,8	JJS
cord-005453-4057qib7	7793	2	years	year	NNS
cord-005453-4057qib7	7793	3	old	old	JJ
cord-005453-4057qib7	7793	4	(	(	-LRB-
cord-005453-4057qib7	7793	5	8	8	CD
cord-005453-4057qib7	7793	6	months	month	NNS
cord-005453-4057qib7	7793	7	-17	-17	CD
cord-005453-4057qib7	7793	8	)	)	-RRB-
cord-005453-4057qib7	7793	9	.	.	.
cord-005453-4057qib7	7794	1	Stem	stem	JJ
cord-005453-4057qib7	7794	2	cell	cell	NN
cord-005453-4057qib7	7794	3	source	source	NN
cord-005453-4057qib7	7794	4	:	:	:
cord-005453-4057qib7	7794	5	bone	bone	NN
cord-005453-4057qib7	7794	6	marrow	marrow	NN
cord-005453-4057qib7	7794	7	-80	-80	NNP
cord-005453-4057qib7	7794	8	%	%	NN
cord-005453-4057qib7	7794	9	(	(	-LRB-
cord-005453-4057qib7	7794	10	n=81	n=81	JJ
cord-005453-4057qib7	7794	11	)	)	-RRB-
cord-005453-4057qib7	7794	12	,	,	,
cord-005453-4057qib7	7794	13	peripheral	peripheral	JJ
cord-005453-4057qib7	7794	14	blood	blood	NN
cord-005453-4057qib7	7794	15	stem	stem	NN
cord-005453-4057qib7	7794	16	cells	cell	NNS
cord-005453-4057qib7	7794	17	-19	-19	IN
cord-005453-4057qib7	7794	18	%	%	NN
cord-005453-4057qib7	7794	19	(	(	-LRB-
cord-005453-4057qib7	7794	20	n=19	n=19	NN
cord-005453-4057qib7	7794	21	)	)	-RRB-
cord-005453-4057qib7	7794	22	.	.	.
cord-005453-4057qib7	7795	1	82	82	CD
cord-005453-4057qib7	7795	2	patients	patient	NNS
cord-005453-4057qib7	7795	3	(	(	-LRB-
cord-005453-4057qib7	7795	4	83	83	CD
cord-005453-4057qib7	7795	5	%	%	NN
cord-005453-4057qib7	7795	6	)	)	-RRB-
cord-005453-4057qib7	7795	7	received	receive	VBD
cord-005453-4057qib7	7795	8	10/10	10/10	CD
cord-005453-4057qib7	7795	9	matched	match	VBN
cord-005453-4057qib7	7795	10	unrelated	unrelated	JJ
cord-005453-4057qib7	7795	11	donors	donor	NNS
cord-005453-4057qib7	7795	12	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	7795	13	stem	stem	NN
cord-005453-4057qib7	7795	14	cells	cell	NNS
cord-005453-4057qib7	7795	15	transplantation	transplantation	NN
cord-005453-4057qib7	7795	16	and	and	CC
cord-005453-4057qib7	7795	17	17	17	CD
cord-005453-4057qib7	7795	18	patients	patient	NNS
cord-005453-4057qib7	7795	19	(	(	-LRB-
cord-005453-4057qib7	7795	20	17	17	CD
cord-005453-4057qib7	7795	21	%	%	NN
cord-005453-4057qib7	7795	22	)	)	-RRB-
cord-005453-4057qib7	7795	23	-9/10	-9/10	VBD
cord-005453-4057qib7	7795	24	matched	match	VBN
cord-005453-4057qib7	7795	25	unrelated	unrelated	JJ
cord-005453-4057qib7	7795	26	donors	donor	NNS
cord-005453-4057qib7	7795	27	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	7795	28	stem	stem	NN
cord-005453-4057qib7	7795	29	cells	cell	NNS
cord-005453-4057qib7	7795	30	transplantation	transplantation	NN
cord-005453-4057qib7	7795	31	.	.	.
cord-005453-4057qib7	7796	1	Differences	difference	NNS
cord-005453-4057qib7	7796	2	in	in	IN
cord-005453-4057qib7	7796	3	the	the	DT
cord-005453-4057qib7	7796	4	antigen	antigen	NN
cord-005453-4057qib7	7796	5	blood	blood	NN
cord-005453-4057qib7	7796	6	system	system	NN
cord-005453-4057qib7	7796	7	:	:	:
cord-005453-4057qib7	7796	8	single	single	JJ
cord-005453-4057qib7	7796	9	group	group	NN
cord-005453-4057qib7	7796	10	41	41	CD
cord-005453-4057qib7	7796	11	%	%	NN
cord-005453-4057qib7	7796	12	(	(	-LRB-
cord-005453-4057qib7	7796	13	n=40	n=40	FW
cord-005453-4057qib7	7796	14	)	)	-RRB-
cord-005453-4057qib7	7796	15	,	,	,
cord-005453-4057qib7	7796	16	minor	minor	JJ
cord-005453-4057qib7	7796	17	32	32	CD
cord-005453-4057qib7	7796	18	%	%	NN
cord-005453-4057qib7	7796	19	(	(	-LRB-
cord-005453-4057qib7	7796	20	n=31	n=31	NNP
cord-005453-4057qib7	7796	21	)	)	-RRB-
cord-005453-4057qib7	7796	22	,	,	,
cord-005453-4057qib7	7796	23	major	major	JJ
cord-005453-4057qib7	7796	24	20	20	CD
cord-005453-4057qib7	7796	25	%	%	NN
cord-005453-4057qib7	7796	26	(	(	-LRB-
cord-005453-4057qib7	7796	27	n=18	n=18	RB
cord-005453-4057qib7	7796	28	)	)	-RRB-
cord-005453-4057qib7	7796	29	,	,	,
cord-005453-4057qib7	7796	30	mixed	mix	VBN
cord-005453-4057qib7	7796	31	11	11	CD
cord-005453-4057qib7	7796	32	%	%	NN
cord-005453-4057qib7	7796	33	(	(	-LRB-
cord-005453-4057qib7	7796	34	n=9	n=9	NN
cord-005453-4057qib7	7796	35	)	)	-RRB-
cord-005453-4057qib7	7796	36	.	.	.
cord-005453-4057qib7	7797	1	Age	age	NN
cord-005453-4057qib7	7797	2	of	of	IN
cord-005453-4057qib7	7797	3	donor	donor	NN
cord-005453-4057qib7	7797	4	:	:	:
cord-005453-4057qib7	7797	5	18	18	CD
cord-005453-4057qib7	7797	6	-	-	SYM
cord-005453-4057qib7	7797	7	25	25	CD
cord-005453-4057qib7	7797	8	years	year	NNS
cord-005453-4057qib7	7797	9	old	old	JJ
cord-005453-4057qib7	7797	10	-25	-25	CD
cord-005453-4057qib7	7797	11	%	%	NN
cord-005453-4057qib7	7797	12	(	(	-LRB-
cord-005453-4057qib7	7797	13	n=16	n=16	NNP
cord-005453-4057qib7	7797	14	)	)	-RRB-
cord-005453-4057qib7	7797	15	,	,	,
cord-005453-4057qib7	7797	16	26	26	CD
cord-005453-4057qib7	7797	17	-	-	SYM
cord-005453-4057qib7	7797	18	35	35	CD
cord-005453-4057qib7	7797	19	-42	-42	JJR
cord-005453-4057qib7	7797	20	%	%	NN
cord-005453-4057qib7	7797	21	(	(	-LRB-
cord-005453-4057qib7	7797	22	n=27	n=27	NNP
cord-005453-4057qib7	7797	23	)	)	-RRB-
cord-005453-4057qib7	7797	24	,	,	,
cord-005453-4057qib7	7797	25	36	36	CD
cord-005453-4057qib7	7797	26	-	-	SYM
cord-005453-4057qib7	7797	27	45	45	CD
cord-005453-4057qib7	7797	28	-23	-23	CD
cord-005453-4057qib7	7797	29	%	%	NN
cord-005453-4057qib7	7797	30	(	(	-LRB-
cord-005453-4057qib7	7797	31	n=15	n=15	NNP
cord-005453-4057qib7	7797	32	)	)	-RRB-
cord-005453-4057qib7	7797	33	,	,	,
cord-005453-4057qib7	7797	34	46	46	CD
cord-005453-4057qib7	7797	35	and	and	CC
cord-005453-4057qib7	7797	36	more11	more11	NN
cord-005453-4057qib7	7797	37	%	%	NN
cord-005453-4057qib7	7797	38	(	(	-LRB-
cord-005453-4057qib7	7797	39	n=7	n=7	NN
cord-005453-4057qib7	7797	40	)	)	-RRB-
cord-005453-4057qib7	7797	41	.	.	.
cord-005453-4057qib7	7798	1	Gender	gender	NN
cord-005453-4057qib7	7798	2	differences	difference	NNS
cord-005453-4057qib7	7798	3	in	in	IN
cord-005453-4057qib7	7798	4	donor	donor	NN
cord-005453-4057qib7	7798	5	/	/	SYM
cord-005453-4057qib7	7798	6	recipient	recipient	NN
cord-005453-4057qib7	7798	7	:	:	:
cord-005453-4057qib7	7798	8	male	male	JJ
cord-005453-4057qib7	7798	9	/	/	SYM
cord-005453-4057qib7	7798	10	female	female	JJ
cord-005453-4057qib7	7798	11	25	25	CD
cord-005453-4057qib7	7798	12	%	%	NN
cord-005453-4057qib7	7798	13	(	(	-LRB-
cord-005453-4057qib7	7798	14	n=24	n=24	NNP
cord-005453-4057qib7	7798	15	)	)	-RRB-
cord-005453-4057qib7	7798	16	,	,	,
cord-005453-4057qib7	7798	17	female	female	JJ
cord-005453-4057qib7	7798	18	/	/	SYM
cord-005453-4057qib7	7798	19	male	male	JJ
cord-005453-4057qib7	7798	20	18	18	CD
cord-005453-4057qib7	7798	21	%	%	NN
cord-005453-4057qib7	7798	22	(	(	-LRB-
cord-005453-4057qib7	7798	23	n=18	n=18	RB
cord-005453-4057qib7	7798	24	)	)	-RRB-
cord-005453-4057qib7	7798	25	,	,	,
cord-005453-4057qib7	7798	26	one	one	CD
cord-005453-4057qib7	7798	27	sex	sex	NN
cord-005453-4057qib7	7798	28	57	57	CD
cord-005453-4057qib7	7798	29	%	%	NN
cord-005453-4057qib7	7798	30	(	(	-LRB-
cord-005453-4057qib7	7798	31	n=56	n=56	NN
cord-005453-4057qib7	7798	32	)	)	-RRB-
cord-005453-4057qib7	7798	33	.	.	.
cord-005453-4057qib7	7799	1	We	-PRON-	PRP
cord-005453-4057qib7	7799	2	also	also	RB
cord-005453-4057qib7	7799	3	took	take	VBD
cord-005453-4057qib7	7799	4	into	into	IN
cord-005453-4057qib7	7799	5	account	account	NN
cord-005453-4057qib7	7799	6	the	the	DT
cord-005453-4057qib7	7799	7	impact	impact	NN
cord-005453-4057qib7	7799	8	of	of	IN
cord-005453-4057qib7	7799	9	gender	gender	NN
cord-005453-4057qib7	7799	10	difference	difference	NN
cord-005453-4057qib7	7799	11	and	and	CC
cord-005453-4057qib7	7799	12	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	7799	13	serostatus	serostatus	NN
cord-005453-4057qib7	7799	14	in	in	IN
cord-005453-4057qib7	7799	15	the	the	DT
cord-005453-4057qib7	7799	16	donor	donor	NN
cord-005453-4057qib7	7799	17	/	/	SYM
cord-005453-4057qib7	7799	18	recipient	recipient	NN
cord-005453-4057qib7	7799	19	pair	pair	NN
cord-005453-4057qib7	7799	20	.	.	.
cord-005453-4057qib7	7800	1	Results	result	NNS
cord-005453-4057qib7	7800	2	:	:	:
cord-005453-4057qib7	7801	1	In	in	IN
cord-005453-4057qib7	7801	2	10/10	10/10	CD
cord-005453-4057qib7	7801	3	group	group	NN
cord-005453-4057qib7	7801	4	the	the	DT
cord-005453-4057qib7	7801	5	estimated	estimate	VBN
cord-005453-4057qib7	7801	6	probability	probability	NN
cord-005453-4057qib7	7801	7	of	of	IN
cord-005453-4057qib7	7801	8	overall	overall	JJ
cord-005453-4057qib7	7801	9	2-years	2-years	CD
cord-005453-4057qib7	7801	10	survive	survive	NN
cord-005453-4057qib7	7801	11	was	be	VBD
cord-005453-4057qib7	7801	12	76	76	CD
cord-005453-4057qib7	7801	13	%	%	NN
cord-005453-4057qib7	7801	14	and	and	CC
cord-005453-4057qib7	7801	15	in	in	IN
cord-005453-4057qib7	7801	16	the	the	DT
cord-005453-4057qib7	7801	17	9/10	9/10	CD
cord-005453-4057qib7	7801	18	group	group	NN
cord-005453-4057qib7	7801	19	2-years	2-years	CD
cord-005453-4057qib7	7801	20	survive	survive	NN
cord-005453-4057qib7	7801	21	was	be	VBD
cord-005453-4057qib7	7801	22	63	63	CD
cord-005453-4057qib7	7801	23	%	%	NN
cord-005453-4057qib7	7801	24	.	.	.
cord-005453-4057qib7	7802	1	The	the	DT
cord-005453-4057qib7	7802	2	increase	increase	NN
cord-005453-4057qib7	7802	3	in	in	IN
cord-005453-4057qib7	7802	4	donor	donor	NN
cord-005453-4057qib7	7802	5	age	age	NN
cord-005453-4057qib7	7802	6	of	of	IN
cord-005453-4057qib7	7802	7	10	10	CD
cord-005453-4057qib7	7802	8	years	year	NNS
cord-005453-4057qib7	7802	9	reduces	reduce	VBZ
cord-005453-4057qib7	7802	10	the	the	DT
cord-005453-4057qib7	7802	11	2-years	2-years	CD
cord-005453-4057qib7	7802	12	survive	survive	VBP
cord-005453-4057qib7	7802	13	by	by	IN
cord-005453-4057qib7	7802	14	9	9	CD
cord-005453-4057qib7	7802	15	-	-	SYM
cord-005453-4057qib7	7802	16	11	11	CD
cord-005453-4057qib7	7802	17	%	%	NN
cord-005453-4057qib7	7802	18	(	(	-LRB-
cord-005453-4057qib7	7802	19	p=0,117	p=0,117	NNP
cord-005453-4057qib7	7802	20	)	)	-RRB-
cord-005453-4057qib7	7802	21	,	,	,
cord-005453-4057qib7	7802	22	however	however	RB
cord-005453-4057qib7	7802	23	,	,	,
cord-005453-4057qib7	7802	24	the	the	DT
cord-005453-4057qib7	7802	25	2-years	2-years	CD
cord-005453-4057qib7	7802	26	survive	survive	VBP
cord-005453-4057qib7	7802	27	from	from	IN
cord-005453-4057qib7	7802	28	donors	donor	NNS
cord-005453-4057qib7	7802	29	over	over	IN
cord-005453-4057qib7	7802	30	46	46	CD
cord-005453-4057qib7	7802	31	years	year	NNS
cord-005453-4057qib7	7802	32	old	old	JJ
cord-005453-4057qib7	7802	33	was	be	VBD
cord-005453-4057qib7	7802	34	100	100	CD
cord-005453-4057qib7	7802	35	%	%	NN
cord-005453-4057qib7	7802	36	.	.	.
cord-005453-4057qib7	7803	1	We	-PRON-	PRP
cord-005453-4057qib7	7803	2	have	have	VBP
cord-005453-4057qib7	7803	3	found	find	VBN
cord-005453-4057qib7	7803	4	no	no	DT
cord-005453-4057qib7	7803	5	difference	difference	NN
cord-005453-4057qib7	7803	6	between	between	IN
cord-005453-4057qib7	7803	7	2-years	2-years	CD
cord-005453-4057qib7	7803	8	survive	survive	VBP
cord-005453-4057qib7	7803	9	in	in	IN
cord-005453-4057qib7	7803	10	transplants	transplant	NNS
cord-005453-4057qib7	7803	11	from	from	IN
cord-005453-4057qib7	7803	12	donors	donor	NNS
cord-005453-4057qib7	7803	13	that	that	WDT
cord-005453-4057qib7	7803	14	are	be	VBP
cord-005453-4057qib7	7803	15	compatible/	compatible/	VBN
cord-005453-4057qib7	7803	16	incompatible	incompatible	JJ
cord-005453-4057qib7	7803	17	with	with	IN
cord-005453-4057qib7	7803	18	the	the	DT
cord-005453-4057qib7	7803	19	antigen	antigen	NN
cord-005453-4057qib7	7803	20	blood	blood	NN
cord-005453-4057qib7	7803	21	system	system	NN
cord-005453-4057qib7	7803	22	,	,	,
cord-005453-4057qib7	7803	23	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	7803	24	serostatus	serostatus	NN
cord-005453-4057qib7	7803	25	,	,	,
cord-005453-4057qib7	7803	26	or	or	CC
cord-005453-4057qib7	7803	27	the	the	DT
cord-005453-4057qib7	7803	28	gender	gender	NN
cord-005453-4057qib7	7803	29	differences	difference	NNS
cord-005453-4057qib7	7803	30	in	in	IN
cord-005453-4057qib7	7803	31	donor/	donor/	CD
cord-005453-4057qib7	7803	32	recipient	recipient	NN
cord-005453-4057qib7	7803	33	.	.	.
cord-005453-4057qib7	7804	1	In	in	IN
cord-005453-4057qib7	7804	2	the	the	DT
cord-005453-4057qib7	7804	3	study	study	NN
cord-005453-4057qib7	7804	4	of	of	IN
cord-005453-4057qib7	7804	5	donor	donor	NN
cord-005453-4057qib7	7804	6	-	-	HYPH
cord-005453-4057qib7	7804	7	related	relate	VBN
cord-005453-4057qib7	7804	8	factors	factor	NNS
cord-005453-4057qib7	7804	9	,	,	,
cord-005453-4057qib7	7804	10	we	-PRON-	PRP
cord-005453-4057qib7	7804	11	found	find	VBD
cord-005453-4057qib7	7804	12	the	the	DT
cord-005453-4057qib7	7804	13	negative	negative	JJ
cord-005453-4057qib7	7804	14	impact	impact	NN
cord-005453-4057qib7	7804	15	of	of	IN
cord-005453-4057qib7	7804	16	an	an	DT
cord-005453-4057qib7	7804	17	human	human	JJ
cord-005453-4057qib7	7804	18	leucincompatibility	leucincompatibility	NN
cord-005453-4057qib7	7804	19	(	(	-LRB-
cord-005453-4057qib7	7804	20	9/10	9/10	CD
cord-005453-4057qib7	7804	21	)	)	-RRB-
cord-005453-4057qib7	7804	22	on	on	IN
cord-005453-4057qib7	7804	23	the	the	DT
cord-005453-4057qib7	7804	24	incidence	incidence	NN
cord-005453-4057qib7	7804	25	of	of	IN
cord-005453-4057qib7	7804	26	chronic	chronic	JJ
cord-005453-4057qib7	7804	27	GVHD	GVHD	NNP
cord-005453-4057qib7	7804	28	-29	-29	CD
cord-005453-4057qib7	7804	29	%	%	NN
cord-005453-4057qib7	7805	1	(	(	-LRB-
cord-005453-4057qib7	7805	2	p	p	NN
cord-005453-4057qib7	7805	3	=	=	SYM
cord-005453-4057qib7	7805	4	0.019	0.019	CD
cord-005453-4057qib7	7805	5	)	)	-RRB-
cord-005453-4057qib7	7805	6	.	.	.
cord-005453-4057qib7	7806	1	The	the	DT
cord-005453-4057qib7	7806	2	combination	combination	NN
cord-005453-4057qib7	7806	3	of	of	IN
cord-005453-4057qib7	7806	4	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	7806	5	positive	positive	JJ
cord-005453-4057qib7	7806	6	serostatus	serostatus	NN
cord-005453-4057qib7	7806	7	of	of	IN
cord-005453-4057qib7	7806	8	the	the	DT
cord-005453-4057qib7	7806	9	donor	donor	NN
cord-005453-4057qib7	7806	10	and	and	CC
cord-005453-4057qib7	7806	11	the	the	DT
cord-005453-4057qib7	7806	12	negative	negative	JJ
cord-005453-4057qib7	7806	13	status	status	NN
cord-005453-4057qib7	7806	14	of	of	IN
cord-005453-4057qib7	7806	15	the	the	DT
cord-005453-4057qib7	7806	16	recipient	recipient	NN
cord-005453-4057qib7	7806	17	increases	increase	VBZ
cord-005453-4057qib7	7806	18	the	the	DT
cord-005453-4057qib7	7806	19	risk	risk	NN
cord-005453-4057qib7	7806	20	of	of	IN
cord-005453-4057qib7	7806	21	primary	primary	JJ
cord-005453-4057qib7	7806	22	graft	graft	NN
cord-005453-4057qib7	7806	23	rejection	rejection	NN
cord-005453-4057qib7	7806	24	up	up	IN
cord-005453-4057qib7	7806	25	to	to	TO
cord-005453-4057qib7	7806	26	50	50	CD
cord-005453-4057qib7	7806	27	%	%	NN
cord-005453-4057qib7	7806	28	,	,	,
cord-005453-4057qib7	7806	29	in	in	IN
cord-005453-4057qib7	7806	30	comparison	comparison	NN
cord-005453-4057qib7	7806	31	with	with	IN
cord-005453-4057qib7	7806	32	others	other	NNS
cord-005453-4057qib7	7806	33	(	(	-LRB-
cord-005453-4057qib7	7806	34	p	p	NN
cord-005453-4057qib7	7806	35	=	=	SYM
cord-005453-4057qib7	7806	36	0.001	0.001	CD
cord-005453-4057qib7	7806	37	)	)	-RRB-
cord-005453-4057qib7	7806	38	.	.	.
cord-005453-4057qib7	7807	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7807	2	:	:	:
cord-005453-4057qib7	7808	1	Our	-PRON-	PRP$
cord-005453-4057qib7	7808	2	study	study	NN
cord-005453-4057qib7	7808	3	showed	show	VBD
cord-005453-4057qib7	7808	4	the	the	DT
cord-005453-4057qib7	7808	5	role	role	NN
cord-005453-4057qib7	7808	6	of	of	IN
cord-005453-4057qib7	7808	7	genetic	genetic	JJ
cord-005453-4057qib7	7808	8	matching	matching	NN
cord-005453-4057qib7	7808	9	on	on	IN
cord-005453-4057qib7	7808	10	the	the	DT
cord-005453-4057qib7	7808	11	HLA	HLA	NNP
cord-005453-4057qib7	7808	12	system	system	NN
cord-005453-4057qib7	7808	13	between	between	IN
cord-005453-4057qib7	7808	14	the	the	DT
cord-005453-4057qib7	7808	15	patient	patient	NN
cord-005453-4057qib7	7808	16	and	and	CC
cord-005453-4057qib7	7808	17	the	the	DT
cord-005453-4057qib7	7808	18	unrelated	unrelated	JJ
cord-005453-4057qib7	7808	19	donor	donor	NN
cord-005453-4057qib7	7808	20	,	,	,
cord-005453-4057qib7	7808	21	and	and	CC
cord-005453-4057qib7	7808	22	the	the	DT
cord-005453-4057qib7	7808	23	donors	donor	NNS
cord-005453-4057qib7	7808	24	age	age	NN
cord-005453-4057qib7	7808	25	value	value	NN
cord-005453-4057qib7	7808	26	.	.	.
cord-005453-4057qib7	7809	1	10/10	10/10	CD
cord-005453-4057qib7	7809	2	transplants	transplant	NNS
cord-005453-4057qib7	7809	3	have	have	VBP
cord-005453-4057qib7	7809	4	better	well	JJR
cord-005453-4057qib7	7809	5	outcome	outcome	NN
cord-005453-4057qib7	7809	6	and	and	CC
cord-005453-4057qib7	7809	7	lower	low	JJR
cord-005453-4057qib7	7809	8	incidence	incidence	NN
cord-005453-4057qib7	7809	9	of	of	IN
cord-005453-4057qib7	7809	10	severe	severe	JJ
cord-005453-4057qib7	7809	11	a.	a.	NN
cord-005453-4057qib7	7809	12	GvHD	GvHD	NNP
cord-005453-4057qib7	7809	13	and	and	CC
cord-005453-4057qib7	7809	14	ch	ch	NNP
cord-005453-4057qib7	7809	15	.	.	.
cord-005453-4057qib7	7810	1	GVHD	GVHD	NNP
cord-005453-4057qib7	7810	2	.	.	.
cord-005453-4057qib7	7811	1	Younger	young	JJR
cord-005453-4057qib7	7811	2	donor	donor	NN
cord-005453-4057qib7	7811	3	increases	increase	NNS
cord-005453-4057qib7	7811	4	2-years	2-years	CD
cord-005453-4057qib7	7811	5	survive	survive	VBP
cord-005453-4057qib7	7811	6	,	,	,
cord-005453-4057qib7	7811	7	but	but	CC
cord-005453-4057qib7	7811	8	there	there	EX
cord-005453-4057qib7	7811	9	is	be	VBZ
cord-005453-4057qib7	7811	10	a	a	DT
cord-005453-4057qib7	7811	11	significant	significant	JJ
cord-005453-4057qib7	7811	12	increase	increase	NN
cord-005453-4057qib7	7811	13	in	in	IN
cord-005453-4057qib7	7811	14	2-years	2-years	CD
cord-005453-4057qib7	7811	15	survive	survive	VBP
cord-005453-4057qib7	7811	16	if	if	IN
cord-005453-4057qib7	7811	17	the	the	DT
cord-005453-4057qib7	7811	18	donor	donor	NN
cord-005453-4057qib7	7811	19	is	be	VBZ
cord-005453-4057qib7	7811	20	over	over	IN
cord-005453-4057qib7	7811	21	46	46	CD
cord-005453-4057qib7	7811	22	years	year	NNS
cord-005453-4057qib7	7811	23	old	old	JJ
cord-005453-4057qib7	7811	24	.	.	.
cord-005453-4057qib7	7812	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7812	2	:	:	:
cord-005453-4057qib7	7812	3	Nothing	nothing	NN
cord-005453-4057qib7	7812	4	to	to	TO
cord-005453-4057qib7	7812	5	declare	declare	VB
cord-005453-4057qib7	7812	6	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	7812	7	stem	stem	NN
cord-005453-4057qib7	7812	8	cell	cell	NN
cord-005453-4057qib7	7812	9	transplantation	transplantation	NN
cord-005453-4057qib7	7812	10	in	in	IN
cord-005453-4057qib7	7812	11	chronic	chronic	JJ
cord-005453-4057qib7	7812	12	myelomonocytic	myelomonocytic	JJ
cord-005453-4057qib7	7812	13	leukemia	leukemia	NN
cord-005453-4057qib7	7812	14	.	.	.
cord-005453-4057qib7	7813	1	A	a	DT
cord-005453-4057qib7	7813	2	single	single	JJ
cord-005453-4057qib7	7813	3	center	center	NN
cord-005453-4057qib7	7813	4	experience	experience	NN
cord-005453-4057qib7	7814	1	Nine	nine	CD
cord-005453-4057qib7	7814	2	patients	patient	NNS
cord-005453-4057qib7	7814	3	(	(	-LRB-
cord-005453-4057qib7	7814	4	45	45	CD
cord-005453-4057qib7	7814	5	%	%	NN
cord-005453-4057qib7	7814	6	)	)	-RRB-
cord-005453-4057qib7	7814	7	relapsed	relapse	VBD
cord-005453-4057qib7	7814	8	with	with	IN
cord-005453-4057qib7	7814	9	a	a	DT
cord-005453-4057qib7	7814	10	median	median	NN
cord-005453-4057qib7	7814	11	of	of	IN
cord-005453-4057qib7	7814	12	6,3	6,3	CD
cord-005453-4057qib7	7814	13	months	month	NNS
cord-005453-4057qib7	7814	14	(	(	-LRB-
cord-005453-4057qib7	7814	15	1	1	CD
cord-005453-4057qib7	7814	16	-	-	SYM
cord-005453-4057qib7	7814	17	87	87	CD
cord-005453-4057qib7	7814	18	)	)	-RRB-
cord-005453-4057qib7	7814	19	with	with	IN
cord-005453-4057qib7	7814	20	different	different	JJ
cord-005453-4057qib7	7814	21	strategies	strategy	NNS
cord-005453-4057qib7	7814	22	at	at	IN
cord-005453-4057qib7	7814	23	this	this	DT
cord-005453-4057qib7	7814	24	point	point	NN
cord-005453-4057qib7	7814	25	:	:	:
cord-005453-4057qib7	7814	26	in	in	IN
cord-005453-4057qib7	7814	27	all	all	DT
cord-005453-4057qib7	7814	28	cases	case	NNS
cord-005453-4057qib7	7814	29	we	-PRON-	PRP
cord-005453-4057qib7	7814	30	modulated	modulate	VBD
cord-005453-4057qib7	7814	31	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	7814	32	,	,	,
cord-005453-4057qib7	7814	33	in	in	IN
cord-005453-4057qib7	7814	34	2	2	CD
cord-005453-4057qib7	7814	35	cases	case	NNS
cord-005453-4057qib7	7814	36	as	as	IN
cord-005453-4057qib7	7814	37	the	the	DT
cord-005453-4057qib7	7814	38	unique	unique	JJ
cord-005453-4057qib7	7814	39	strategy	strategy	NN
cord-005453-4057qib7	7814	40	,	,	,
cord-005453-4057qib7	7814	41	in	in	IN
cord-005453-4057qib7	7814	42	2	2	CD
cord-005453-4057qib7	7814	43	cases	case	NNS
cord-005453-4057qib7	7814	44	with	with	IN
cord-005453-4057qib7	7814	45	donor	donor	NN
cord-005453-4057qib7	7814	46	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	7814	47	infusion	infusion	NN
cord-005453-4057qib7	7814	48	(	(	-LRB-
cord-005453-4057qib7	7814	49	DLI	DLI	NNP
cord-005453-4057qib7	7814	50	)	)	-RRB-
cord-005453-4057qib7	7814	51	,	,	,
cord-005453-4057qib7	7814	52	in	in	IN
cord-005453-4057qib7	7814	53	3	3	CD
cord-005453-4057qib7	7814	54	cases	case	NNS
cord-005453-4057qib7	7814	55	we	-PRON-	PRP
cord-005453-4057qib7	7814	56	employed	employ	VBD
cord-005453-4057qib7	7814	57	hypometilating	hypometilate	VBG
cord-005453-4057qib7	7814	58	agents	agent	NNS
cord-005453-4057qib7	7814	59	(	(	-LRB-
cord-005453-4057qib7	7814	60	HMA	HMA	NNP
cord-005453-4057qib7	7814	61	)	)	-RRB-
cord-005453-4057qib7	7814	62	and	and	CC
cord-005453-4057qib7	7814	63	in	in	IN
cord-005453-4057qib7	7814	64	2	2	CD
cord-005453-4057qib7	7814	65	cases	case	NNS
cord-005453-4057qib7	7814	66	with	with	IN
cord-005453-4057qib7	7814	67	intensive	intensive	JJ
cord-005453-4057qib7	7814	68	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7814	69	,	,	,
cord-005453-4057qib7	7814	70	reaching	reach	VBG
cord-005453-4057qib7	7814	71	CR	CR	NNP
cord-005453-4057qib7	7814	72	only	only	RB
cord-005453-4057qib7	7814	73	in	in	IN
cord-005453-4057qib7	7814	74	two	two	CD
cord-005453-4057qib7	7814	75	patients	patient	NNS
cord-005453-4057qib7	7814	76	,	,	,
cord-005453-4057qib7	7814	77	one	one	CD
cord-005453-4057qib7	7814	78	of	of	IN
cord-005453-4057qib7	7814	79	them	-PRON-	PRP
cord-005453-4057qib7	7814	80	after	after	IN
cord-005453-4057qib7	7814	81	DLI	DLI	NNP
cord-005453-4057qib7	7814	82	and	and	CC
cord-005453-4057qib7	7814	83	the	the	DT
cord-005453-4057qib7	7814	84	other	other	JJ
cord-005453-4057qib7	7814	85	one	one	NN
cord-005453-4057qib7	7814	86	after	after	IN
cord-005453-4057qib7	7814	87	HMA	HMA	NNP
cord-005453-4057qib7	7814	88	and	and	CC
cord-005453-4057qib7	7814	89	consolidation	consolidation	NN
cord-005453-4057qib7	7814	90	with	with	IN
cord-005453-4057qib7	7814	91	a	a	DT
cord-005453-4057qib7	7814	92	second	second	JJ
cord-005453-4057qib7	7814	93	ASCT	ASCT	NNP
cord-005453-4057qib7	7814	94	.	.	.
cord-005453-4057qib7	7815	1	Eleven	eleven	CD
cord-005453-4057qib7	7815	2	patients	patient	NNS
cord-005453-4057qib7	7815	3	(	(	-LRB-
cord-005453-4057qib7	7815	4	55	55	CD
cord-005453-4057qib7	7815	5	%	%	NN
cord-005453-4057qib7	7815	6	)	)	-RRB-
cord-005453-4057qib7	7815	7	died	die	VBD
cord-005453-4057qib7	7815	8	being	be	VBG
cord-005453-4057qib7	7815	9	the	the	DT
cord-005453-4057qib7	7815	10	relapse	relapse	NN
cord-005453-4057qib7	7815	11	the	the	DT
cord-005453-4057qib7	7815	12	main	main	JJ
cord-005453-4057qib7	7815	13	cause	cause	NN
cord-005453-4057qib7	7815	14	(	(	-LRB-
cord-005453-4057qib7	7815	15	64	64	CD
cord-005453-4057qib7	7815	16	%	%	NN
cord-005453-4057qib7	7815	17	)	)	-RRB-
cord-005453-4057qib7	7815	18	.	.	.
cord-005453-4057qib7	7816	1	Transplant	transplant	NN
cord-005453-4057qib7	7816	2	related	relate	VBN
cord-005453-4057qib7	7816	3	mortality	mortality	NN
cord-005453-4057qib7	7816	4	(	(	-LRB-
cord-005453-4057qib7	7816	5	TRM	TRM	NNP
cord-005453-4057qib7	7816	6	)	)	-RRB-
cord-005453-4057qib7	7816	7	at	at	IN
cord-005453-4057qib7	7816	8	+100	+100	NNS
cord-005453-4057qib7	7816	9	were	be	VBD
cord-005453-4057qib7	7816	10	5	5	CD
cord-005453-4057qib7	7816	11	%	%	NN
cord-005453-4057qib7	7816	12	and	and	CC
cord-005453-4057qib7	7816	13	global	global	JJ
cord-005453-4057qib7	7816	14	TRM	TRM	NNP
cord-005453-4057qib7	7816	15	were	be	VBD
cord-005453-4057qib7	7816	16	15	15	CD
cord-005453-4057qib7	7816	17	%	%	NN
cord-005453-4057qib7	7816	18	.	.	.
cord-005453-4057qib7	7817	1	In	in	IN
cord-005453-4057qib7	7817	2	the	the	DT
cord-005453-4057qib7	7817	3	last	last	JJ
cord-005453-4057qib7	7817	4	follow	follow	NN
cord-005453-4057qib7	7817	5	-	-	HYPH
cord-005453-4057qib7	7817	6	up	up	NN
cord-005453-4057qib7	7817	7	,	,	,
cord-005453-4057qib7	7817	8	9	9	CD
cord-005453-4057qib7	7817	9	patients	patient	NNS
cord-005453-4057qib7	7817	10	(	(	-LRB-
cord-005453-4057qib7	7817	11	45	45	CD
cord-005453-4057qib7	7817	12	%	%	NN
cord-005453-4057qib7	7817	13	)	)	-RRB-
cord-005453-4057qib7	7817	14	are	be	VBP
cord-005453-4057qib7	7817	15	still	still	RB
cord-005453-4057qib7	7817	16	alive	alive	JJ
cord-005453-4057qib7	7817	17	,	,	,
cord-005453-4057qib7	7817	18	8	8	CD
cord-005453-4057qib7	7817	19	(	(	-LRB-
cord-005453-4057qib7	7817	20	89	89	CD
cord-005453-4057qib7	7817	21	%	%	NN
cord-005453-4057qib7	7817	22	)	)	-RRB-
cord-005453-4057qib7	7817	23	in	in	IN
cord-005453-4057qib7	7817	24	CR	CR	NNP
cord-005453-4057qib7	7817	25	and	and	CC
cord-005453-4057qib7	7817	26	1	1	CD
cord-005453-4057qib7	7817	27	(	(	-LRB-
cord-005453-4057qib7	7817	28	11	11	CD
cord-005453-4057qib7	7817	29	%	%	NN
cord-005453-4057qib7	7817	30	)	)	-RRB-
cord-005453-4057qib7	7817	31	in	in	IN
cord-005453-4057qib7	7817	32	relapse	relapse	NN
cord-005453-4057qib7	7817	33	situation	situation	NN
cord-005453-4057qib7	7817	34	.	.	.
cord-005453-4057qib7	7818	1	With	with	IN
cord-005453-4057qib7	7818	2	a	a	DT
cord-005453-4057qib7	7818	3	median	median	JJ
cord-005453-4057qib7	7818	4	follow	follow	NN
cord-005453-4057qib7	7818	5	-	-	HYPH
cord-005453-4057qib7	7818	6	up	up	NN
cord-005453-4057qib7	7818	7	of	of	IN
cord-005453-4057qib7	7818	8	58	58	CD
cord-005453-4057qib7	7818	9	months	month	NNS
cord-005453-4057qib7	7818	10	(	(	-LRB-
cord-005453-4057qib7	7818	11	5	5	CD
cord-005453-4057qib7	7818	12	-	-	SYM
cord-005453-4057qib7	7818	13	138	138	CD
cord-005453-4057qib7	7818	14	)	)	-RRB-
cord-005453-4057qib7	7818	15	,	,	,
cord-005453-4057qib7	7818	16	the	the	DT
cord-005453-4057qib7	7818	17	event	event	NN
cord-005453-4057qib7	7818	18	free	free	JJ
cord-005453-4057qib7	7818	19	survival	survival	NN
cord-005453-4057qib7	7818	20	(	(	-LRB-
cord-005453-4057qib7	7818	21	EFS	EFS	NNP
cord-005453-4057qib7	7818	22	)	)	-RRB-
cord-005453-4057qib7	7818	23	were	be	VBD
cord-005453-4057qib7	7818	24	19	19	CD
cord-005453-4057qib7	7818	25	months	month	NNS
cord-005453-4057qib7	7818	26	(	(	-LRB-
cord-005453-4057qib7	7818	27	5	5	CD
cord-005453-4057qib7	7818	28	-	-	SYM
cord-005453-4057qib7	7818	29	32	32	CD
cord-005453-4057qib7	7818	30	)	)	-RRB-
cord-005453-4057qib7	7818	31	and	and	CC
cord-005453-4057qib7	7818	32	the	the	DT
cord-005453-4057qib7	7818	33	overall	overall	JJ
cord-005453-4057qib7	7818	34	survival	survival	NN
cord-005453-4057qib7	7818	35	(	(	-LRB-
cord-005453-4057qib7	7818	36	OS	OS	NNP
cord-005453-4057qib7	7818	37	)	)	-RRB-
cord-005453-4057qib7	7818	38	were	be	VBD
cord-005453-4057qib7	7818	39	56	56	CD
cord-005453-4057qib7	7818	40	months	month	NNS
cord-005453-4057qib7	7818	41	(	(	-LRB-
cord-005453-4057qib7	7818	42	0	0	CD
cord-005453-4057qib7	7818	43	-	-	SYM
cord-005453-4057qib7	7818	44	116	116	CD
cord-005453-4057qib7	7818	45	)	)	-RRB-
cord-005453-4057qib7	7818	46	.	.	.
cord-005453-4057qib7	7819	1	We	-PRON-	PRP
cord-005453-4057qib7	7819	2	observed	observe	VBD
cord-005453-4057qib7	7819	3	advantage	advantage	NN
cord-005453-4057qib7	7819	4	in	in	IN
cord-005453-4057qib7	7819	5	terms	term	NNS
cord-005453-4057qib7	7819	6	of	of	IN
cord-005453-4057qib7	7819	7	OS	os	NN
cord-005453-4057qib7	7819	8	in	in	IN
cord-005453-4057qib7	7819	9	those	those	DT
cord-005453-4057qib7	7819	10	patients	patient	NNS
cord-005453-4057qib7	7819	11	that	that	WDT
cord-005453-4057qib7	7819	12	reach	reach	VBP
cord-005453-4057qib7	7819	13	CR	CR	NNP
cord-005453-4057qib7	7819	14	at	at	IN
cord-005453-4057qib7	7819	15	+100	+100	NNP
cord-005453-4057qib7	7819	16	post	post	NN
cord-005453-4057qib7	7819	17	ASCT	ASCT	NNP
cord-005453-4057qib7	7819	18	and	and	CC
cord-005453-4057qib7	7819	19	in	in	IN
cord-005453-4057qib7	7819	20	those	those	DT
cord-005453-4057qib7	7819	21	who	who	WP
cord-005453-4057qib7	7819	22	develop	develop	VBP
cord-005453-4057qib7	7819	23	chronic	chronic	JJ
cord-005453-4057qib7	7819	24	GVCHD	GVCHD	NNP
cord-005453-4057qib7	7819	25	(	(	-LRB-
cord-005453-4057qib7	7819	26	p=0.065	p=0.065	NNP
cord-005453-4057qib7	7820	1	and	and	CC
cord-005453-4057qib7	7820	2	p=0.012	p=0.012	NNP
cord-005453-4057qib7	7820	3	respectively	respectively	RB
cord-005453-4057qib7	7820	4	)	)	-RRB-
cord-005453-4057qib7	7821	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7821	2	:	:	:
cord-005453-4057qib7	7822	1	ASCT	ASCT	NNP
cord-005453-4057qib7	7822	2	is	be	VBZ
cord-005453-4057qib7	7822	3	still	still	RB
cord-005453-4057qib7	7822	4	the	the	DT
cord-005453-4057qib7	7822	5	only	only	JJ
cord-005453-4057qib7	7822	6	curative	curative	JJ
cord-005453-4057qib7	7822	7	option	option	NN
cord-005453-4057qib7	7822	8	despite	despite	IN
cord-005453-4057qib7	7822	9	the	the	DT
cord-005453-4057qib7	7822	10	high	high	JJ
cord-005453-4057qib7	7822	11	relapse	relapse	NN
cord-005453-4057qib7	7822	12	rates	rate	NNS
cord-005453-4057qib7	7822	13	.	.	.
cord-005453-4057qib7	7823	1	To	to	TO
cord-005453-4057qib7	7823	2	reach	reach	VB
cord-005453-4057qib7	7823	3	CR	CR	NNP
cord-005453-4057qib7	7823	4	at	at	IN
cord-005453-4057qib7	7823	5	+100	+100	NNP
cord-005453-4057qib7	7823	6	post	post	NN
cord-005453-4057qib7	7823	7	ASCT	ASCT	NNP
cord-005453-4057qib7	7823	8	and	and	CC
cord-005453-4057qib7	7823	9	the	the	DT
cord-005453-4057qib7	7823	10	development	development	NN
cord-005453-4057qib7	7823	11	of	of	IN
cord-005453-4057qib7	7823	12	chronic	chronic	JJ
cord-005453-4057qib7	7823	13	GVHD	GVHD	NNP
cord-005453-4057qib7	7823	14	seems	seem	VBZ
cord-005453-4057qib7	7823	15	that	that	IN
cord-005453-4057qib7	7823	16	they	-PRON-	PRP
cord-005453-4057qib7	7823	17	confer	confer	VBP
cord-005453-4057qib7	7823	18	advantage	advantage	NN
cord-005453-4057qib7	7823	19	in	in	IN
cord-005453-4057qib7	7823	20	terms	term	NNS
cord-005453-4057qib7	7823	21	of	of	IN
cord-005453-4057qib7	7823	22	OS	OS	NNP
cord-005453-4057qib7	7823	23	.	.	.
cord-005453-4057qib7	7824	1	The	the	DT
cord-005453-4057qib7	7824	2	importance	importance	NN
cord-005453-4057qib7	7824	3	of	of	IN
cord-005453-4057qib7	7824	4	knowing	know	VBG
cord-005453-4057qib7	7824	5	the	the	DT
cord-005453-4057qib7	7824	6	molecular	molecular	JJ
cord-005453-4057qib7	7824	7	profile	profile	NN
cord-005453-4057qib7	7824	8	of	of	IN
cord-005453-4057qib7	7824	9	the	the	DT
cord-005453-4057qib7	7824	10	entities	entity	NNS
cord-005453-4057qib7	7824	11	that	that	WDT
cord-005453-4057qib7	7824	12	we	-PRON-	PRP
cord-005453-4057qib7	7824	13	consider	consider	VBP
cord-005453-4057qib7	7824	14	for	for	IN
cord-005453-4057qib7	7824	15	ASCT	ASCT	NNP
cord-005453-4057qib7	7824	16	.	.	.
cord-005453-4057qib7	7825	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7825	2	This	this	DT
cord-005453-4057qib7	7825	3	study	study	NN
cord-005453-4057qib7	7825	4	documents	document	VBZ
cord-005453-4057qib7	7825	5	a	a	DT
cord-005453-4057qib7	7825	6	first	first	JJ
cord-005453-4057qib7	7825	7	experience	experience	NN
cord-005453-4057qib7	7825	8	of	of	IN
cord-005453-4057qib7	7825	9	a	a	DT
cord-005453-4057qib7	7825	10	cell	cell	NN
cord-005453-4057qib7	7825	11	processing	processing	NN
cord-005453-4057qib7	7825	12	lab	lab	NN
cord-005453-4057qib7	7825	13	seeking	seek	VBG
cord-005453-4057qib7	7825	14	to	to	TO
cord-005453-4057qib7	7825	15	integrate	integrate	VB
cord-005453-4057qib7	7825	16	process	process	NN
cord-005453-4057qib7	7825	17	automation	automation	NN
cord-005453-4057qib7	7825	18	technology	technology	NN
cord-005453-4057qib7	7825	19	to	to	TO
cord-005453-4057qib7	7825	20	wash	wash	VB
cord-005453-4057qib7	7825	21	and	and	CC
cord-005453-4057qib7	7825	22	volume	volume	NN
cord-005453-4057qib7	7825	23	reduce	reduce	NN
cord-005453-4057qib7	7825	24	products	product	NNS
cord-005453-4057qib7	7825	25	which	which	WDT
cord-005453-4057qib7	7825	26	can	can	MD
cord-005453-4057qib7	7825	27	account	account	VB
cord-005453-4057qib7	7825	28	for	for	IN
cord-005453-4057qib7	7825	29	the	the	DT
cord-005453-4057qib7	7825	30	initial	initial	JJ
cord-005453-4057qib7	7825	31	material	material	NN
cord-005453-4057qib7	7825	32	source	source	NN
cord-005453-4057qib7	7825	33	volume	volume	NN
cord-005453-4057qib7	7825	34	variability	variability	NN
cord-005453-4057qib7	7825	35	,	,	,
cord-005453-4057qib7	7825	36	product	product	NN
cord-005453-4057qib7	7825	37	characteristics	characteristic	NNS
cord-005453-4057qib7	7825	38	,	,	,
cord-005453-4057qib7	7825	39	and	and	CC
cord-005453-4057qib7	7825	40	number	number	NN
cord-005453-4057qib7	7825	41	of	of	IN
cord-005453-4057qib7	7825	42	bags	bag	NNS
cord-005453-4057qib7	7825	43	.	.	.
cord-005453-4057qib7	7826	1	Methods	method	NNS
cord-005453-4057qib7	7826	2	:	:	:
cord-005453-4057qib7	7826	3	Here	here	RB
cord-005453-4057qib7	7826	4	we	-PRON-	PRP
cord-005453-4057qib7	7826	5	report	report	VBP
cord-005453-4057qib7	7826	6	the	the	DT
cord-005453-4057qib7	7826	7	pre	pre	JJ
cord-005453-4057qib7	7826	8	-	-	JJ
cord-005453-4057qib7	7826	9	clinical	clinical	JJ
cord-005453-4057qib7	7826	10	assessment	assessment	NN
cord-005453-4057qib7	7826	11	of	of	IN
cord-005453-4057qib7	7826	12	the	the	DT
cord-005453-4057qib7	7826	13	lab	lab	NN
cord-005453-4057qib7	7826	14	's	's	POS
cord-005453-4057qib7	7826	15	initial	initial	JJ
cord-005453-4057qib7	7826	16	work	work	NN
cord-005453-4057qib7	7826	17	with	with	IN
cord-005453-4057qib7	7826	18	the	the	DT
cord-005453-4057qib7	7826	19	LOVO	LOVO	NNP
cord-005453-4057qib7	7826	20	Cell	Cell	NNP
cord-005453-4057qib7	7826	21	Processing	Processing	NNP
cord-005453-4057qib7	7826	22	System	System	NNP
cord-005453-4057qib7	7826	23	for	for	IN
cord-005453-4057qib7	7826	24	a	a	DT
cord-005453-4057qib7	7826	25	5	5	CD
cord-005453-4057qib7	7826	26	product	product	NN
cord-005453-4057qib7	7826	27	experience	experience	NN
cord-005453-4057qib7	7826	28	over	over	IN
cord-005453-4057qib7	7826	29	2	2	CD
cord-005453-4057qib7	7826	30	days	day	NNS
cord-005453-4057qib7	7826	31	with	with	IN
cord-005453-4057qib7	7826	32	1	1	CD
cord-005453-4057qib7	7826	33	machine	machine	NN
cord-005453-4057qib7	7826	34	.	.	.
cord-005453-4057qib7	7827	1	This	this	DT
cord-005453-4057qib7	7827	2	study	study	NN
cord-005453-4057qib7	7827	3	used	use	VBD
cord-005453-4057qib7	7827	4	products	product	NNS
cord-005453-4057qib7	7827	5	intended	intend	VBN
cord-005453-4057qib7	7827	6	for	for	IN
cord-005453-4057qib7	7827	7	destruction	destruction	NN
cord-005453-4057qib7	7827	8	.	.	.
cord-005453-4057qib7	7828	1	The	the	DT
cord-005453-4057qib7	7828	2	workflow	workflow	NN
cord-005453-4057qib7	7828	3	used	use	VBN
cord-005453-4057qib7	7828	4	parallel	parallel	JJ
cord-005453-4057qib7	7828	5	and	and	CC
cord-005453-4057qib7	7828	6	sequential	sequential	JJ
cord-005453-4057qib7	7828	7	processing	processing	NN
cord-005453-4057qib7	7828	8	schedule	schedule	NN
cord-005453-4057qib7	7828	9	.	.	.
cord-005453-4057qib7	7829	1	After	after	IN
cord-005453-4057qib7	7829	2	water	water	NN
cord-005453-4057qib7	7829	3	-	-	HYPH
cord-005453-4057qib7	7829	4	bath	bath	NN
cord-005453-4057qib7	7829	5	thawing	thawing	NN
cord-005453-4057qib7	7829	6	,	,	,
cord-005453-4057qib7	7829	7	bags	bag	NNS
cord-005453-4057qib7	7829	8	were	be	VBD
cord-005453-4057qib7	7829	9	sampled	sample	VBN
cord-005453-4057qib7	7829	10	,	,	,
cord-005453-4057qib7	7829	11	weighed	weigh	VBD
cord-005453-4057qib7	7829	12	to	to	TO
cord-005453-4057qib7	7829	13	determine	determine	VB
cord-005453-4057qib7	7829	14	volume	volume	NN
cord-005453-4057qib7	7829	15	,	,	,
cord-005453-4057qib7	7829	16	and	and	CC
cord-005453-4057qib7	7829	17	subsequently	subsequently	RB
cord-005453-4057qib7	7829	18	connected	connect	VBN
cord-005453-4057qib7	7829	19	to	to	IN
cord-005453-4057qib7	7829	20	LOVO	LOVO	NNP
cord-005453-4057qib7	7829	21	or	or	CC
cord-005453-4057qib7	7829	22	pooled	pool	VBD
cord-005453-4057qib7	7829	23	into	into	IN
cord-005453-4057qib7	7829	24	a	a	DT
cord-005453-4057qib7	7829	25	transfer	transfer	NN
cord-005453-4057qib7	7829	26	pack	pack	NN
cord-005453-4057qib7	7829	27	and	and	CC
cord-005453-4057qib7	7829	28	then	then	RB
cord-005453-4057qib7	7829	29	connected	connect	VBN
cord-005453-4057qib7	7829	30	to	to	IN
cord-005453-4057qib7	7829	31	LOVO	LOVO	NNP
cord-005453-4057qib7	7829	32	.	.	.
cord-005453-4057qib7	7830	1	The	the	DT
cord-005453-4057qib7	7830	2	bags	bag	NNS
cord-005453-4057qib7	7830	3	were	be	VBD
cord-005453-4057qib7	7830	4	then	then	RB
cord-005453-4057qib7	7830	5	diluted	dilute	VBN
cord-005453-4057qib7	7830	6	1:1	1:1	CD
cord-005453-4057qib7	7830	7	at	at	IN
cord-005453-4057qib7	7830	8	50	50	CD
cord-005453-4057qib7	7830	9	ml	ml	NNS
cord-005453-4057qib7	7830	10	/	/	SYM
cord-005453-4057qib7	7830	11	min	min	NN
cord-005453-4057qib7	7830	12	with	with	IN
cord-005453-4057qib7	7830	13	LOVO	LOVO	NNP
cord-005453-4057qib7	7830	14	at	at	IN
cord-005453-4057qib7	7830	15	+4	+4	NN
cord-005453-4057qib7	7830	16	-	-	HYPH
cord-005453-4057qib7	7830	17	8C	8c	CD
cord-005453-4057qib7	7830	18	using	use	VBG
cord-005453-4057qib7	7830	19	6	6	CD
cord-005453-4057qib7	7830	20	%	%	NN
cord-005453-4057qib7	7830	21	Hydroxyethylstarch	hydroxyethylstarch	RB
cord-005453-4057qib7	7830	22	130/0.4	130/0.4	CD
cord-005453-4057qib7	7831	1	(	(	-LRB-
cord-005453-4057qib7	7831	2	Voluven	Voluven	NNP
cord-005453-4057qib7	7831	3	,	,	,
cord-005453-4057qib7	7831	4	Fresenius	Fresenius	NNP
cord-005453-4057qib7	7831	5	Kabi	Kabi	NNP
cord-005453-4057qib7	7831	6	)	)	-RRB-
cord-005453-4057qib7	7831	7	and	and	CC
cord-005453-4057qib7	7831	8	processed	process	VBN
cord-005453-4057qib7	7831	9	using	use	VBG
cord-005453-4057qib7	7831	10	a	a	DT
cord-005453-4057qib7	7831	11	3	3	CD
cord-005453-4057qib7	7831	12	cycle	cycle	NN
cord-005453-4057qib7	7831	13	procedure	procedure	NN
cord-005453-4057qib7	7831	14	.	.	.
cord-005453-4057qib7	7832	1	After	after	IN
cord-005453-4057qib7	7832	2	processing	process	VBG
cord-005453-4057qib7	7832	3	the	the	DT
cord-005453-4057qib7	7832	4	bags	bag	NNS
cord-005453-4057qib7	7832	5	were	be	VBD
cord-005453-4057qib7	7832	6	weighed	weigh	VBN
cord-005453-4057qib7	7832	7	for	for	IN
cord-005453-4057qib7	7832	8	volume	volume	NN
cord-005453-4057qib7	7832	9	,	,	,
cord-005453-4057qib7	7832	10	sampled	sample	VBN
cord-005453-4057qib7	7832	11	,	,	,
cord-005453-4057qib7	7832	12	and	and	CC
cord-005453-4057qib7	7832	13	stored	store	VBN
cord-005453-4057qib7	7832	14	in	in	IN
cord-005453-4057qib7	7832	15	a	a	DT
cord-005453-4057qib7	7832	16	4	4	CD
cord-005453-4057qib7	7832	17	-	-	HYPH
cord-005453-4057qib7	7832	18	8C	8c	CD
cord-005453-4057qib7	7832	19	refrigerator	refrigerator	NN
cord-005453-4057qib7	7832	20	in	in	IN
cord-005453-4057qib7	7832	21	their	-PRON-	PRP$
cord-005453-4057qib7	7832	22	LOVO	LOVO	NNP
cord-005453-4057qib7	7832	23	final	final	JJ
cord-005453-4057qib7	7832	24	product	product	NN
cord-005453-4057qib7	7832	25	bags	bag	NNS
cord-005453-4057qib7	7832	26	.	.	.
cord-005453-4057qib7	7833	1	Samples	sample	NNS
cord-005453-4057qib7	7833	2	were	be	VBD
cord-005453-4057qib7	7833	3	assessed	assess	VBN
cord-005453-4057qib7	7833	4	from	from	IN
cord-005453-4057qib7	7833	5	T=0	T=0	NNP
cord-005453-4057qib7	7833	6	to	to	IN
cord-005453-4057qib7	7833	7	T=24	T=24	NNP
cord-005453-4057qib7	7833	8	hours	hour	NNS
cord-005453-4057qib7	7833	9	.	.	.
cord-005453-4057qib7	7834	1	Results	result	NNS
cord-005453-4057qib7	7834	2	:	:	:
cord-005453-4057qib7	7835	1	CD34	CD34	NNP
cord-005453-4057qib7	7835	2	+	+	CC
cord-005453-4057qib7	7835	3	viability	viability	NN
cord-005453-4057qib7	7835	4	and	and	CC
cord-005453-4057qib7	7835	5	absolute	absolute	JJ
cord-005453-4057qib7	7835	6	counts	count	NNS
cord-005453-4057qib7	7835	7	were	be	VBD
cord-005453-4057qib7	7835	8	determined	determine	VBN
cord-005453-4057qib7	7835	9	using	use	VBG
cord-005453-4057qib7	7835	10	flow	flow	NN
cord-005453-4057qib7	7835	11	cytometry	cytometry	NN
cord-005453-4057qib7	7835	12	.	.	.
cord-005453-4057qib7	7836	1	Processing	processing	NN
cord-005453-4057qib7	7836	2	duration	duration	NN
cord-005453-4057qib7	7836	3	and	and	CC
cord-005453-4057qib7	7836	4	solution	solution	NN
cord-005453-4057qib7	7836	5	volume	volume	NN
cord-005453-4057qib7	7836	6	consumed	consume	VBN
cord-005453-4057qib7	7836	7	was	be	VBD
cord-005453-4057qib7	7836	8	determined	determine	VBN
cord-005453-4057qib7	7836	9	by	by	IN
cord-005453-4057qib7	7836	10	the	the	DT
cord-005453-4057qib7	7836	11	LOVO	LOVO	NNP
cord-005453-4057qib7	7836	12	's	's	POS
cord-005453-4057qib7	7836	13	sensors	sensor	NNS
cord-005453-4057qib7	7836	14	and	and	CC
cord-005453-4057qib7	7836	15	confirmed	confirm	VBN
cord-005453-4057qib7	7836	16	by	by	IN
cord-005453-4057qib7	7836	17	the	the	DT
cord-005453-4057qib7	7836	18	operator	operator	NN
cord-005453-4057qib7	7836	19	.	.	.
cord-005453-4057qib7	7837	1	Data	Data	NNP
cord-005453-4057qib7	7837	2	is	be	VBZ
cord-005453-4057qib7	7837	3	presented	present	VBN
cord-005453-4057qib7	7837	4	as	as	IN
cord-005453-4057qib7	7837	5	a	a	DT
cord-005453-4057qib7	7837	6	percentage	percentage	NN
cord-005453-4057qib7	7837	7	relative	relative	JJ
cord-005453-4057qib7	7837	8	to	to	IN
cord-005453-4057qib7	7837	9	the	the	DT
cord-005453-4057qib7	7837	10	post	post	NN
cord-005453-4057qib7	7837	11	-	-	JJ
cord-005453-4057qib7	7837	12	thaw	thaw	JJ
cord-005453-4057qib7	7837	13	values	value	NNS
cord-005453-4057qib7	7837	14	.	.	.
cord-005453-4057qib7	7838	1	Note	note	VB
cord-005453-4057qib7	7838	2	,	,	,
cord-005453-4057qib7	7838	3	the	the	DT
cord-005453-4057qib7	7838	4	values	value	NNS
cord-005453-4057qib7	7838	5	presented	present	VBN
cord-005453-4057qib7	7838	6	are	be	VBP
cord-005453-4057qib7	7838	7	not	not	RB
cord-005453-4057qib7	7838	8	total	total	JJ
cord-005453-4057qib7	7838	9	process	process	NN
cord-005453-4057qib7	7838	10	yields	yield	NNS
cord-005453-4057qib7	7838	11	.	.	.
cord-005453-4057qib7	7839	1	The	the	DT
cord-005453-4057qib7	7839	2	results	result	NNS
cord-005453-4057qib7	7839	3	focus	focus	VBP
cord-005453-4057qib7	7839	4	on	on	IN
cord-005453-4057qib7	7839	5	the	the	DT
cord-005453-4057qib7	7839	6	LOVO	LOVO	NNP
cord-005453-4057qib7	7839	7	processing	processing	NN
cord-005453-4057qib7	7839	8	step	step	NN
cord-005453-4057qib7	7839	9	.	.	.
cord-005453-4057qib7	7840	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7840	2	:	:	:
cord-005453-4057qib7	7841	1	The	the	DT
cord-005453-4057qib7	7841	2	operators	operator	NNS
cord-005453-4057qib7	7841	3	easily	easily	RB
cord-005453-4057qib7	7841	4	integrated	integrate	VBD
cord-005453-4057qib7	7841	5	into	into	IN
cord-005453-4057qib7	7841	6	the	the	DT
cord-005453-4057qib7	7841	7	software	software	NN
cord-005453-4057qib7	7841	8	to	to	TO
cord-005453-4057qib7	7841	9	drive	drive	VB
cord-005453-4057qib7	7841	10	the	the	DT
cord-005453-4057qib7	7841	11	machine	machine	NN
cord-005453-4057qib7	7841	12	.	.	.
cord-005453-4057qib7	7842	1	The	the	DT
cord-005453-4057qib7	7842	2	machine	machine	NN
cord-005453-4057qib7	7842	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	7842	4	it	-PRON-	PRP
cord-005453-4057qib7	7842	5	's	be	VBZ
cord-005453-4057qib7	7842	6	flexibility	flexibility	NN
cord-005453-4057qib7	7842	7	with	with	IN
cord-005453-4057qib7	7842	8	a	a	DT
cord-005453-4057qib7	7842	9	wide	wide	JJ
cord-005453-4057qib7	7842	10	-	-	HYPH
cord-005453-4057qib7	7842	11	range	range	NN
cord-005453-4057qib7	7842	12	of	of	IN
cord-005453-4057qib7	7842	13	volumes	volume	NNS
cord-005453-4057qib7	7842	14	,	,	,
cord-005453-4057qib7	7842	15	cell	cell	NN
cord-005453-4057qib7	7842	16	-	-	HYPH
cord-005453-4057qib7	7842	17	inputs	input	NNS
cord-005453-4057qib7	7842	18	,	,	,
cord-005453-4057qib7	7842	19	and	and	CC
cord-005453-4057qib7	7842	20	number	number	NN
cord-005453-4057qib7	7842	21	of	of	IN
cord-005453-4057qib7	7842	22	bags	bag	NNS
cord-005453-4057qib7	7842	23	.	.	.
cord-005453-4057qib7	7843	1	The	the	DT
cord-005453-4057qib7	7843	2	LOVO	LOVO	NNP
cord-005453-4057qib7	7843	3	produced	produce	VBD
cord-005453-4057qib7	7843	4	products	product	NNS
cord-005453-4057qib7	7843	5	which	which	WDT
cord-005453-4057qib7	7843	6	meet	meet	VBP
cord-005453-4057qib7	7843	7	our	-PRON-	PRP$
cord-005453-4057qib7	7843	8	specifications	specification	NNS
cord-005453-4057qib7	7843	9	in	in	IN
cord-005453-4057qib7	7843	10	a	a	DT
cord-005453-4057qib7	7843	11	quick	quick	JJ
cord-005453-4057qib7	7843	12	and	and	CC
cord-005453-4057qib7	7843	13	reliable	reliable	JJ
cord-005453-4057qib7	7843	14	manner	manner	NN
cord-005453-4057qib7	7843	15	.	.	.
cord-005453-4057qib7	7844	1	Further	further	JJ
cord-005453-4057qib7	7844	2	work	work	NN
cord-005453-4057qib7	7844	3	on	on	IN
cord-005453-4057qib7	7844	4	this	this	DT
cord-005453-4057qib7	7844	5	platform	platform	NN
cord-005453-4057qib7	7844	6	will	will	MD
cord-005453-4057qib7	7844	7	be	be	VB
cord-005453-4057qib7	7844	8	performed	perform	VBN
cord-005453-4057qib7	7844	9	to	to	TO
cord-005453-4057qib7	7844	10	validate	validate	VB
cord-005453-4057qib7	7844	11	and	and	CC
cord-005453-4057qib7	7844	12	qualify	qualify	VB
cord-005453-4057qib7	7844	13	this	this	DT
cord-005453-4057qib7	7844	14	system	system	NN
cord-005453-4057qib7	7844	15	for	for	IN
cord-005453-4057qib7	7844	16	production	production	NN
cord-005453-4057qib7	7844	17	use	use	NN
cord-005453-4057qib7	7844	18	.	.	.
cord-005453-4057qib7	7845	1	properties	property	NNS
cord-005453-4057qib7	7845	2	.	.	.
cord-005453-4057qib7	7846	1	The	the	DT
cord-005453-4057qib7	7846	2	aim	aim	NN
cord-005453-4057qib7	7846	3	of	of	IN
cord-005453-4057qib7	7846	4	this	this	DT
cord-005453-4057qib7	7846	5	study	study	NN
cord-005453-4057qib7	7846	6	was	be	VBD
cord-005453-4057qib7	7846	7	to	to	TO
cord-005453-4057qib7	7846	8	evaluate	evaluate	VB
cord-005453-4057qib7	7846	9	prospectively	prospectively	RB
cord-005453-4057qib7	7846	10	the	the	DT
cord-005453-4057qib7	7846	11	efficacy	efficacy	NN
cord-005453-4057qib7	7846	12	of	of	IN
cord-005453-4057qib7	7846	13	a	a	DT
cord-005453-4057qib7	7846	14	FBM	FBM	NNP
cord-005453-4057qib7	7846	15	protocol	protocol	NN
cord-005453-4057qib7	7846	16	for	for	IN
cord-005453-4057qib7	7846	17	the	the	DT
cord-005453-4057qib7	7846	18	prevention	prevention	NN
cord-005453-4057qib7	7846	19	of	of	IN
cord-005453-4057qib7	7846	20	OM	OM	NNP
cord-005453-4057qib7	7846	21	in	in	IN
cord-005453-4057qib7	7846	22	patients	patient	NNS
cord-005453-4057qib7	7846	23	undergoing	undergo	VBG
cord-005453-4057qib7	7846	24	a	a	DT
cord-005453-4057qib7	7846	25	HSCT	HSCT	NNP
cord-005453-4057qib7	7846	26	.	.	.
cord-005453-4057qib7	7847	1	Methods	method	NNS
cord-005453-4057qib7	7847	2	:	:	:
cord-005453-4057qib7	7848	1	All	all	DT
cord-005453-4057qib7	7848	2	patients	patient	NNS
cord-005453-4057qib7	7848	3	consecutively	consecutively	RB
cord-005453-4057qib7	7848	4	who	who	WP
cord-005453-4057qib7	7848	5	underwent	undergo	VBD
cord-005453-4057qib7	7848	6	a	a	DT
cord-005453-4057qib7	7848	7	HSCT	HSCT	NNP
cord-005453-4057qib7	7848	8	at	at	IN
cord-005453-4057qib7	7848	9	our	-PRON-	PRP$
cord-005453-4057qib7	7848	10	Center	Center	NNP
cord-005453-4057qib7	7848	11	from	from	IN
cord-005453-4057qib7	7848	12	201X	201X	NNP
cord-005453-4057qib7	7848	13	onwards	onwards	RB
cord-005453-4057qib7	7848	14	received	receive	VBD
cord-005453-4057qib7	7848	15	five	five	CD
cord-005453-4057qib7	7848	16	weekly	weekly	JJ
cord-005453-4057qib7	7848	17	FBM	FBM	NNP
cord-005453-4057qib7	7848	18	sessions	session	NNS
cord-005453-4057qib7	7848	19	with	with	IN
cord-005453-4057qib7	7848	20	a	a	DT
cord-005453-4057qib7	7848	21	bidiodic	bidiodic	JJ
cord-005453-4057qib7	7848	22	laser	laser	NN
cord-005453-4057qib7	7848	23	(	(	-LRB-
cord-005453-4057qib7	7849	1	Lumix	Lumix	NNP
cord-005453-4057qib7	7849	2	2	2	CD
cord-005453-4057qib7	7849	3	®	®	NNPS
cord-005453-4057qib7	7849	4	,	,	,
cord-005453-4057qib7	7849	5	Prodent	Prodent	NNP
cord-005453-4057qib7	7849	6	,	,	,
cord-005453-4057qib7	7849	7	Italy	Italy	NNP
cord-005453-4057qib7	7849	8	)	)	-RRB-
cord-005453-4057qib7	7849	9	,	,	,
cord-005453-4057qib7	7849	10	which	which	WDT
cord-005453-4057qib7	7849	11	simultaneously	simultaneously	RB
cord-005453-4057qib7	7849	12	emitted	emit	VBD
cord-005453-4057qib7	7849	13	at	at	IN
cord-005453-4057qib7	7849	14	650	650	CD
cord-005453-4057qib7	7849	15	nm	nm	NN
cord-005453-4057qib7	7849	16	and	and	CC
cord-005453-4057qib7	7849	17	910	910	CD
cord-005453-4057qib7	7849	18	nm	nm	NN
cord-005453-4057qib7	7849	19	with	with	IN
cord-005453-4057qib7	7849	20	a	a	DT
cord-005453-4057qib7	7849	21	power	power	NN
cord-005453-4057qib7	7849	22	of	of	IN
cord-005453-4057qib7	7849	23	89mW	89mw	CD
cord-005453-4057qib7	7849	24	and	and	CC
cord-005453-4057qib7	7849	25	energy	energy	NN
cord-005453-4057qib7	7849	26	of	of	IN
cord-005453-4057qib7	7849	27	4J	4j	CD
cord-005453-4057qib7	7849	28	per	per	IN
cord-005453-4057qib7	7849	29	point	point	NN
cord-005453-4057qib7	7849	30	.	.	.
cord-005453-4057qib7	7850	1	The	the	DT
cord-005453-4057qib7	7850	2	procedure	procedure	NN
cord-005453-4057qib7	7850	3	started	start	VBD
cord-005453-4057qib7	7850	4	the	the	DT
cord-005453-4057qib7	7850	5	day	day	NN
cord-005453-4057qib7	7850	6	before	before	IN
cord-005453-4057qib7	7850	7	the	the	DT
cord-005453-4057qib7	7850	8	beginning	beginning	NN
cord-005453-4057qib7	7850	9	of	of	IN
cord-005453-4057qib7	7850	10	the	the	DT
cord-005453-4057qib7	7850	11	conditioning	conditioning	NN
cord-005453-4057qib7	7850	12	regimen	regimen	NN
cord-005453-4057qib7	7850	13	up	up	IN
cord-005453-4057qib7	7850	14	to	to	IN
cord-005453-4057qib7	7850	15	the	the	DT
cord-005453-4057qib7	7850	16	tenth	tenth	JJ
cord-005453-4057qib7	7850	17	day	day	NN
cord-005453-4057qib7	7850	18	post	post	NN
cord-005453-4057qib7	7850	19	-	-	NN
cord-005453-4057qib7	7850	20	transplant	transplant	NN
cord-005453-4057qib7	7850	21	.	.	.
cord-005453-4057qib7	7851	1	The	the	DT
cord-005453-4057qib7	7851	2	laser	laser	NN
cord-005453-4057qib7	7851	3	was	be	VBD
cord-005453-4057qib7	7851	4	applied	apply	VBN
cord-005453-4057qib7	7851	5	in	in	IN
cord-005453-4057qib7	7851	6	a	a	DT
cord-005453-4057qib7	7851	7	defocused	defocused	JJ
cord-005453-4057qib7	7851	8	mode	mode	NN
cord-005453-4057qib7	7851	9	on	on	IN
cord-005453-4057qib7	7851	10	each	each	DT
cord-005453-4057qib7	7851	11	of	of	IN
cord-005453-4057qib7	7851	12	the	the	DT
cord-005453-4057qib7	7851	13	mucosal	mucosal	JJ
cord-005453-4057qib7	7851	14	surfaces	surface	NNS
cord-005453-4057qib7	7851	15	(	(	-LRB-
cord-005453-4057qib7	7851	16	12	12	CD
cord-005453-4057qib7	7851	17	areas	area	NNS
cord-005453-4057qib7	7851	18	)	)	-RRB-
cord-005453-4057qib7	7851	19	.	.	.
cord-005453-4057qib7	7852	1	At	at	IN
cord-005453-4057qib7	7852	2	each	each	DT
cord-005453-4057qib7	7852	3	session	session	NN
cord-005453-4057qib7	7852	4	,	,	,
cord-005453-4057qib7	7852	5	the	the	DT
cord-005453-4057qib7	7852	6	morphine	morphine	NN
cord-005453-4057qib7	7852	7	dose	dose	NN
cord-005453-4057qib7	7852	8	,	,	,
cord-005453-4057qib7	7852	9	the	the	DT
cord-005453-4057qib7	7852	10	OM	om	NN
cord-005453-4057qib7	7852	11	level	level	NN
cord-005453-4057qib7	7852	12	(	(	-LRB-
cord-005453-4057qib7	7852	13	according	accord	VBG
cord-005453-4057qib7	7852	14	to	to	IN
cord-005453-4057qib7	7852	15	the	the	DT
cord-005453-4057qib7	7852	16	WHO	WHO	NNP
cord-005453-4057qib7	7852	17	scale	scale	NN
cord-005453-4057qib7	7852	18	)	)	-RRB-
cord-005453-4057qib7	7852	19	and	and	CC
cord-005453-4057qib7	7852	20	pain	pain	NN
cord-005453-4057qib7	7852	21	through	through	IN
cord-005453-4057qib7	7852	22	a	a	DT
cord-005453-4057qib7	7852	23	Numerical	numerical	JJ
cord-005453-4057qib7	7852	24	Rating	rating	NN
cord-005453-4057qib7	7852	25	Scale	scale	NN
cord-005453-4057qib7	7852	26	(	(	-LRB-
cord-005453-4057qib7	7852	27	NRS	NRS	NNP
cord-005453-4057qib7	7852	28	)	)	-RRB-
cord-005453-4057qib7	7852	29	were	be	VBD
cord-005453-4057qib7	7852	30	recorded	record	VBN
cord-005453-4057qib7	7852	31	.	.	.
cord-005453-4057qib7	7853	1	Results	result	NNS
cord-005453-4057qib7	7853	2	:	:	:
cord-005453-4057qib7	7854	1	27	27	CD
cord-005453-4057qib7	7854	2	consecutive	consecutive	JJ
cord-005453-4057qib7	7854	3	patients	patient	NNS
cord-005453-4057qib7	7854	4	(	(	-LRB-
cord-005453-4057qib7	7854	5	19	19	CD
cord-005453-4057qib7	7854	6	male/8	male/8	NN
cord-005453-4057qib7	7854	7	female	female	NN
cord-005453-4057qib7	7854	8	)	)	-RRB-
cord-005453-4057qib7	7854	9	submitted	submit	VBD
cord-005453-4057qib7	7854	10	to	to	IN
cord-005453-4057qib7	7854	11	a	a	DT
cord-005453-4057qib7	7854	12	HSCT	HSCT	NNP
cord-005453-4057qib7	7854	13	were	be	VBD
cord-005453-4057qib7	7854	14	analyzed	analyze	VBN
cord-005453-4057qib7	7854	15	.	.	.
cord-005453-4057qib7	7855	1	The	the	DT
cord-005453-4057qib7	7855	2	median	median	JJ
cord-005453-4057qib7	7855	3	age	age	NN
cord-005453-4057qib7	7855	4	was	be	VBD
cord-005453-4057qib7	7855	5	44	44	CD
cord-005453-4057qib7	7855	6	years	year	NNS
cord-005453-4057qib7	7856	1	(	(	-LRB-
cord-005453-4057qib7	7856	2	range	range	NNP
cord-005453-4057qib7	7856	3	4	4	CD
cord-005453-4057qib7	7856	4	-	-	SYM
cord-005453-4057qib7	7856	5	66	66	CD
cord-005453-4057qib7	7856	6	)	)	-RRB-
cord-005453-4057qib7	7856	7	.	.	.
cord-005453-4057qib7	7857	1	Eighteen	eighteen	CD
cord-005453-4057qib7	7857	2	patients	patient	NNS
cord-005453-4057qib7	7857	3	had	have	VBD
cord-005453-4057qib7	7857	4	acute	acute	JJ
cord-005453-4057qib7	7857	5	leukemia	leukemia	NN
cord-005453-4057qib7	7857	6	,	,	,
cord-005453-4057qib7	7857	7	3	3	CD
cord-005453-4057qib7	7857	8	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	7857	9	syndromes	syndrome	NNS
cord-005453-4057qib7	7857	10	,	,	,
cord-005453-4057qib7	7857	11	6	6	CD
cord-005453-4057qib7	7857	12	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	7857	13	diseases	disease	NNS
cord-005453-4057qib7	7857	14	.	.	.
cord-005453-4057qib7	7858	1	The	the	DT
cord-005453-4057qib7	7858	2	median	median	JJ
cord-005453-4057qib7	7858	3	number	number	NN
cord-005453-4057qib7	7858	4	of	of	IN
cord-005453-4057qib7	7858	5	treatment	treatment	NN
cord-005453-4057qib7	7858	6	lines	line	NNS
cord-005453-4057qib7	7858	7	before	before	IN
cord-005453-4057qib7	7858	8	HSCT	HSCT	NNP
cord-005453-4057qib7	7858	9	was	be	VBD
cord-005453-4057qib7	7858	10	2	2	CD
cord-005453-4057qib7	7858	11	(	(	-LRB-
cord-005453-4057qib7	7858	12	range	range	NNP
cord-005453-4057qib7	7858	13	1	1	CD
cord-005453-4057qib7	7858	14	-	-	SYM
cord-005453-4057qib7	7858	15	5	5	CD
cord-005453-4057qib7	7858	16	)	)	-RRB-
cord-005453-4057qib7	7858	17	.	.	.
cord-005453-4057qib7	7859	1	At	at	IN
cord-005453-4057qib7	7859	2	transplant	transplant	NN
cord-005453-4057qib7	7859	3	,	,	,
cord-005453-4057qib7	7859	4	13	13	CD
cord-005453-4057qib7	7859	5	patients	patient	NNS
cord-005453-4057qib7	7859	6	had	have	VBD
cord-005453-4057qib7	7859	7	advanced	advanced	JJ
cord-005453-4057qib7	7859	8	disease	disease	NN
cord-005453-4057qib7	7859	9	.	.	.
cord-005453-4057qib7	7860	1	The	the	DT
cord-005453-4057qib7	7860	2	myeloablative	myeloablative	JJ
cord-005453-4057qib7	7860	3	conditioning	conditioning	NN
cord-005453-4057qib7	7860	4	regimen	regimen	NN
cord-005453-4057qib7	7860	5	MAC	MAC	NNP
cord-005453-4057qib7	7861	1	(	(	-LRB-
cord-005453-4057qib7	7861	2	Thyotepa	Thyotepa	NNP
cord-005453-4057qib7	7861	3	,	,	,
cord-005453-4057qib7	7861	4	Busulphan	Busulphan	NNP
cord-005453-4057qib7	7861	5	,	,	,
cord-005453-4057qib7	7861	6	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	7861	7	)	)	-RRB-
cord-005453-4057qib7	7861	8	was	be	VBD
cord-005453-4057qib7	7861	9	employed	employ	VBN
cord-005453-4057qib7	7861	10	in	in	IN
cord-005453-4057qib7	7861	11	17	17	CD
cord-005453-4057qib7	7861	12	patients	patient	NNS
cord-005453-4057qib7	7861	13	;	;	:
cord-005453-4057qib7	7861	14	the	the	DT
cord-005453-4057qib7	7861	15	same	same	JJ
cord-005453-4057qib7	7861	16	conditioning	conditioning	NN
cord-005453-4057qib7	7861	17	,	,	,
cord-005453-4057qib7	7861	18	with	with	IN
cord-005453-4057qib7	7861	19	a	a	DT
cord-005453-4057qib7	7861	20	reduced	reduced	JJ
cord-005453-4057qib7	7861	21	dose	dose	NN
cord-005453-4057qib7	7861	22	of	of	IN
cord-005453-4057qib7	7861	23	Busulphan	Busulphan	NNP
cord-005453-4057qib7	7861	24	(	(	-LRB-
cord-005453-4057qib7	7861	25	RIC	RIC	NNP
cord-005453-4057qib7	7861	26	)	)	-RRB-
cord-005453-4057qib7	7861	27	,	,	,
cord-005453-4057qib7	7861	28	was	be	VBD
cord-005453-4057qib7	7861	29	infused	infuse	VBN
cord-005453-4057qib7	7861	30	in	in	IN
cord-005453-4057qib7	7861	31	10	10	CD
cord-005453-4057qib7	7861	32	patients	patient	NNS
cord-005453-4057qib7	7861	33	.	.	.
cord-005453-4057qib7	7862	1	Seven	seven	CD
cord-005453-4057qib7	7862	2	patients	patient	NNS
cord-005453-4057qib7	7862	3	(	(	-LRB-
cord-005453-4057qib7	7862	4	26	26	CD
cord-005453-4057qib7	7862	5	%	%	NN
cord-005453-4057qib7	7862	6	)	)	-RRB-
cord-005453-4057qib7	7862	7	had	have	VBD
cord-005453-4057qib7	7862	8	no	no	DT
cord-005453-4057qib7	7862	9	evidence	evidence	NN
cord-005453-4057qib7	7862	10	of	of	IN
cord-005453-4057qib7	7862	11	OM	OM	NNP
cord-005453-4057qib7	7862	12	.	.	.
cord-005453-4057qib7	7863	1	The	the	DT
cord-005453-4057qib7	7863	2	incidence	incidence	NN
cord-005453-4057qib7	7863	3	of	of	IN
cord-005453-4057qib7	7863	4	grade	grade	NN
cord-005453-4057qib7	7863	5	II	II	NNP
cord-005453-4057qib7	7863	6	-	-	HYPH
cord-005453-4057qib7	7863	7	IV	IV	NNP
cord-005453-4057qib7	7863	8	OM	OM	NNP
cord-005453-4057qib7	7863	9	was	be	VBD
cord-005453-4057qib7	7863	10	65	65	CD
cord-005453-4057qib7	7863	11	%	%	NN
cord-005453-4057qib7	7863	12	in	in	IN
cord-005453-4057qib7	7863	13	the	the	DT
cord-005453-4057qib7	7863	14	group	group	NN
cord-005453-4057qib7	7863	15	of	of	IN
cord-005453-4057qib7	7863	16	patients	patient	NNS
cord-005453-4057qib7	7863	17	receiving	receive	VBG
cord-005453-4057qib7	7863	18	MAC	MAC	NNP
cord-005453-4057qib7	7863	19	and	and	CC
cord-005453-4057qib7	7863	20	the	the	DT
cord-005453-4057qib7	7863	21	median	median	JJ
cord-005453-4057qib7	7863	22	duration	duration	NN
cord-005453-4057qib7	7863	23	12	12	CD
cord-005453-4057qib7	7863	24	days	day	NNS
cord-005453-4057qib7	7863	25	(	(	-LRB-
cord-005453-4057qib7	7863	26	range	range	NNP
cord-005453-4057qib7	7863	27	3	3	CD
cord-005453-4057qib7	7863	28	-	-	SYM
cord-005453-4057qib7	7863	29	28	28	CD
cord-005453-4057qib7	7863	30	)	)	-RRB-
cord-005453-4057qib7	7863	31	;	;	:
cord-005453-4057qib7	7863	32	grade	grade	NN
cord-005453-4057qib7	7863	33	4	4	CD
cord-005453-4057qib7	7863	34	OM	om	NN
cord-005453-4057qib7	7863	35	was	be	VBD
cord-005453-4057qib7	7863	36	observed	observe	VBN
cord-005453-4057qib7	7863	37	,	,	,
cord-005453-4057qib7	7863	38	for	for	IN
cord-005453-4057qib7	7863	39	1	1	CD
cord-005453-4057qib7	7863	40	day	day	NN
cord-005453-4057qib7	7863	41	,	,	,
cord-005453-4057qib7	7863	42	in	in	IN
cord-005453-4057qib7	7863	43	1	1	CD
cord-005453-4057qib7	7863	44	patient	patient	NN
cord-005453-4057qib7	7863	45	.	.	.
cord-005453-4057qib7	7864	1	In	in	IN
cord-005453-4057qib7	7864	2	the	the	DT
cord-005453-4057qib7	7864	3	RIC	RIC	NNP
cord-005453-4057qib7	7864	4	group	group	NN
cord-005453-4057qib7	7864	5	the	the	DT
cord-005453-4057qib7	7864	6	incidence	incidence	NN
cord-005453-4057qib7	7864	7	of	of	IN
cord-005453-4057qib7	7864	8	OM	OM	NNP
cord-005453-4057qib7	7864	9	was	be	VBD
cord-005453-4057qib7	7864	10	50	50	CD
cord-005453-4057qib7	7864	11	%	%	NN
cord-005453-4057qib7	7864	12	,	,	,
cord-005453-4057qib7	7864	13	the	the	DT
cord-005453-4057qib7	7864	14	median	median	JJ
cord-005453-4057qib7	7864	15	duration	duration	NN
cord-005453-4057qib7	7864	16	11	11	CD
cord-005453-4057qib7	7864	17	days	day	NNS
cord-005453-4057qib7	7864	18	(	(	-LRB-
cord-005453-4057qib7	7864	19	range	range	NNP
cord-005453-4057qib7	7864	20	7	7	CD
cord-005453-4057qib7	7864	21	-	-	SYM
cord-005453-4057qib7	7864	22	16	16	CD
cord-005453-4057qib7	7864	23	)	)	-RRB-
cord-005453-4057qib7	7864	24	;	;	:
cord-005453-4057qib7	7864	25	no	no	DT
cord-005453-4057qib7	7864	26	patient	patient	NN
cord-005453-4057qib7	7864	27	had	have	VBD
cord-005453-4057qib7	7864	28	evidence	evidence	NN
cord-005453-4057qib7	7864	29	of	of	IN
cord-005453-4057qib7	7864	30	grade	grade	NN
cord-005453-4057qib7	7864	31	IV	IV	NNP
cord-005453-4057qib7	7864	32	OM	OM	NNP
cord-005453-4057qib7	7864	33	.	.	.
cord-005453-4057qib7	7865	1	In	in	IN
cord-005453-4057qib7	7865	2	the	the	DT
cord-005453-4057qib7	7865	3	whole	whole	JJ
cord-005453-4057qib7	7865	4	population	population	NN
cord-005453-4057qib7	7865	5	,	,	,
cord-005453-4057qib7	7865	6	the	the	DT
cord-005453-4057qib7	7865	7	maximum	maximum	JJ
cord-005453-4057qib7	7865	8	NRS	NRS	NNP
cord-005453-4057qib7	7865	9	value	value	NN
cord-005453-4057qib7	7865	10	was	be	VBD
cord-005453-4057qib7	7865	11	4	4	CD
cord-005453-4057qib7	7865	12	.	.	.
cord-005453-4057qib7	7866	1	Morphine	Morphine	NNP
cord-005453-4057qib7	7866	2	administration	administration	NN
cord-005453-4057qib7	7866	3	was	be	VBD
cord-005453-4057qib7	7866	4	required	require	VBN
cord-005453-4057qib7	7866	5	in	in	IN
cord-005453-4057qib7	7866	6	23	23	CD
cord-005453-4057qib7	7866	7	patients	patient	NNS
cord-005453-4057qib7	7866	8	,	,	,
cord-005453-4057qib7	7866	9	due	due	IN
cord-005453-4057qib7	7866	10	to	to	IN
cord-005453-4057qib7	7866	11	the	the	DT
cord-005453-4057qib7	7866	12	occurrence	occurrence	NN
cord-005453-4057qib7	7866	13	of	of	IN
cord-005453-4057qib7	7866	14	non	non	JJ
cord-005453-4057qib7	7866	15	-	-	JJ
cord-005453-4057qib7	7866	16	oral	oral	JJ
cord-005453-4057qib7	7866	17	complications	complication	NNS
cord-005453-4057qib7	7866	18	.	.	.
cord-005453-4057qib7	7867	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7867	2	:	:	:
cord-005453-4057qib7	7868	1	In	in	IN
cord-005453-4057qib7	7868	2	our	-PRON-	PRP$
cord-005453-4057qib7	7868	3	experience	experience	NN
cord-005453-4057qib7	7868	4	,	,	,
cord-005453-4057qib7	7868	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7868	6	with	with	IN
cord-005453-4057qib7	7868	7	FBM	FBM	NNP
cord-005453-4057qib7	7868	8	to	to	TO
cord-005453-4057qib7	7868	9	prevent	prevent	VB
cord-005453-4057qib7	7868	10	or	or	CC
cord-005453-4057qib7	7868	11	reduce	reduce	VB
cord-005453-4057qib7	7868	12	OM	OM	NNP
cord-005453-4057qib7	7868	13	was	be	VBD
cord-005453-4057qib7	7868	14	safe	safe	JJ
cord-005453-4057qib7	7868	15	and	and	CC
cord-005453-4057qib7	7868	16	effective	effective	JJ
cord-005453-4057qib7	7868	17	,	,	,
cord-005453-4057qib7	7868	18	compared	compare	VBN
cord-005453-4057qib7	7868	19	to	to	IN
cord-005453-4057qib7	7868	20	results	result	NNS
cord-005453-4057qib7	7868	21	of	of	IN
cord-005453-4057qib7	7868	22	previous	previous	JJ
cord-005453-4057qib7	7868	23	experiences	experience	NNS
cord-005453-4057qib7	7868	24	reported	report	VBN
cord-005453-4057qib7	7868	25	in	in	IN
cord-005453-4057qib7	7868	26	the	the	DT
cord-005453-4057qib7	7868	27	literature	literature	NN
cord-005453-4057qib7	7868	28	,	,	,
cord-005453-4057qib7	7868	29	which	which	WDT
cord-005453-4057qib7	7868	30	used	use	VBD
cord-005453-4057qib7	7868	31	no	no	DT
cord-005453-4057qib7	7868	32	prevention	prevention	NN
cord-005453-4057qib7	7868	33	against	against	IN
cord-005453-4057qib7	7868	34	this	this	DT
cord-005453-4057qib7	7868	35	complication	complication	NN
cord-005453-4057qib7	7868	36	that	that	WDT
cord-005453-4057qib7	7868	37	negatively	negatively	RB
cord-005453-4057qib7	7868	38	affects	affect	VBZ
cord-005453-4057qib7	7868	39	the	the	DT
cord-005453-4057qib7	7868	40	quality	quality	NN
cord-005453-4057qib7	7868	41	of	of	IN
cord-005453-4057qib7	7868	42	life	life	NN
cord-005453-4057qib7	7868	43	of	of	IN
cord-005453-4057qib7	7868	44	transplanted	transplanted	JJ
cord-005453-4057qib7	7868	45	patients	patient	NNS
cord-005453-4057qib7	7868	46	.	.	.
cord-005453-4057qib7	7869	1	Further	further	JJ
cord-005453-4057qib7	7869	2	studies	study	NNS
cord-005453-4057qib7	7869	3	on	on	IN
cord-005453-4057qib7	7869	4	a	a	DT
cord-005453-4057qib7	7869	5	large	large	JJ
cord-005453-4057qib7	7869	6	series	series	NN
cord-005453-4057qib7	7869	7	of	of	IN
cord-005453-4057qib7	7869	8	are	be	VBP
cord-005453-4057qib7	7869	9	necessary	necessary	JJ
cord-005453-4057qib7	7869	10	to	to	TO
cord-005453-4057qib7	7869	11	confirm	confirm	VB
cord-005453-4057qib7	7869	12	our	-PRON-	PRP$
cord-005453-4057qib7	7869	13	results	result	NNS
cord-005453-4057qib7	7869	14	.	.	.
cord-005453-4057qib7	7870	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7870	2	:	:	:
cord-005453-4057qib7	7870	3	Nothing	nothing	NN
cord-005453-4057qib7	7870	4	to	to	TO
cord-005453-4057qib7	7870	5	declare	declare	VB
cord-005453-4057qib7	7870	6	Background	background	NN
cord-005453-4057qib7	7870	7	:	:	:
cord-005453-4057qib7	7871	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7871	2	abnormalities	abnormality	NNS
cord-005453-4057qib7	7871	3	are	be	VBP
cord-005453-4057qib7	7871	4	an	an	DT
cord-005453-4057qib7	7871	5	essential	essential	JJ
cord-005453-4057qib7	7871	6	part	part	NN
cord-005453-4057qib7	7871	7	of	of	IN
cord-005453-4057qib7	7871	8	prognostic	prognostic	JJ
cord-005453-4057qib7	7871	9	systems	system	NNS
cord-005453-4057qib7	7871	10	in	in	IN
cord-005453-4057qib7	7871	11	myeloid	myeloid	JJ
cord-005453-4057qib7	7871	12	malignancies	malignancy	NNS
cord-005453-4057qib7	7871	13	before	before	IN
cord-005453-4057qib7	7871	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7871	15	stem	stem	NN
cord-005453-4057qib7	7871	16	cell	cell	NN
cord-005453-4057qib7	7871	17	transplantation	transplantation	NN
cord-005453-4057qib7	7871	18	(	(	-LRB-
cord-005453-4057qib7	7871	19	HSCT	HSCT	NNP
cord-005453-4057qib7	7871	20	)	)	-RRB-
cord-005453-4057qib7	7871	21	,	,	,
cord-005453-4057qib7	7871	22	however	however	RB
cord-005453-4057qib7	7871	23	,	,	,
cord-005453-4057qib7	7871	24	their	-PRON-	PRP$
cord-005453-4057qib7	7871	25	role	role	NN
cord-005453-4057qib7	7871	26	in	in	IN
cord-005453-4057qib7	7871	27	posttransplantation	posttransplantation	NN
cord-005453-4057qib7	7871	28	prognosis	prognosis	NN
cord-005453-4057qib7	7871	29	is	be	VBZ
cord-005453-4057qib7	7871	30	unknown	unknown	JJ
cord-005453-4057qib7	7871	31	.	.	.
cord-005453-4057qib7	7872	1	The	the	DT
cord-005453-4057qib7	7872	2	aim	aim	NN
cord-005453-4057qib7	7872	3	of	of	IN
cord-005453-4057qib7	7872	4	this	this	DT
cord-005453-4057qib7	7872	5	study	study	NN
cord-005453-4057qib7	7872	6	was	be	VBD
cord-005453-4057qib7	7872	7	to	to	TO
cord-005453-4057qib7	7872	8	assess	assess	VB
cord-005453-4057qib7	7872	9	the	the	DT
cord-005453-4057qib7	7872	10	prognostic	prognostic	JJ
cord-005453-4057qib7	7872	11	impact	impact	NN
cord-005453-4057qib7	7872	12	of	of	IN
cord-005453-4057qib7	7872	13	genetic	genetic	JJ
cord-005453-4057qib7	7872	14	risk	risk	NN
cord-005453-4057qib7	7872	15	stratification	stratification	NN
cord-005453-4057qib7	7872	16	of	of	IN
cord-005453-4057qib7	7872	17	AML	AML	NNP
cord-005453-4057qib7	7872	18	and	and	CC
cord-005453-4057qib7	7872	19	MDS	MDS	NNP
cord-005453-4057qib7	7872	20	patients	patient	NNS
cord-005453-4057qib7	7872	21	on	on	IN
cord-005453-4057qib7	7872	22	posttransplantation	posttransplantation	NN
cord-005453-4057qib7	7872	23	course	course	NN
cord-005453-4057qib7	7872	24	,	,	,
cord-005453-4057qib7	7872	25	which	which	WDT
cord-005453-4057qib7	7872	26	could	could	MD
cord-005453-4057qib7	7872	27	be	be	VB
cord-005453-4057qib7	7872	28	an	an	DT
cord-005453-4057qib7	7872	29	additional	additional	JJ
cord-005453-4057qib7	7872	30	tool	tool	NN
cord-005453-4057qib7	7872	31	in	in	IN
cord-005453-4057qib7	7872	32	making	make	VBG
cord-005453-4057qib7	7872	33	decisions	decision	NNS
cord-005453-4057qib7	7872	34	regarding	regard	VBG
cord-005453-4057qib7	7872	35	preemptive	preemptive	JJ
cord-005453-4057qib7	7872	36	therapy	therapy	NN
cord-005453-4057qib7	7872	37	.	.	.
cord-005453-4057qib7	7873	1	Methods	method	NNS
cord-005453-4057qib7	7873	2	:	:	:
cord-005453-4057qib7	7874	1	A	a	DT
cord-005453-4057qib7	7874	2	retrospective	retrospective	JJ
cord-005453-4057qib7	7874	3	analysis	analysis	NN
cord-005453-4057qib7	7874	4	covering	cover	VBG
cord-005453-4057qib7	7874	5	patients	patient	NNS
cord-005453-4057qib7	7874	6	treated	treat	VBN
cord-005453-4057qib7	7874	7	with	with	IN
cord-005453-4057qib7	7874	8	allo	allo	NN
cord-005453-4057qib7	7874	9	-	-	HYPH
cord-005453-4057qib7	7874	10	HSCT	HSCT	NNP
cord-005453-4057qib7	7874	11	between	between	IN
cord-005453-4057qib7	7874	12	2012	2012	CD
cord-005453-4057qib7	7874	13	and	and	CC
cord-005453-4057qib7	7874	14	2018	2018	CD
cord-005453-4057qib7	7874	15	.	.	.
cord-005453-4057qib7	7875	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7875	2	studies	study	NNS
cord-005453-4057qib7	7875	3	included	include	VBD
cord-005453-4057qib7	7875	4	karyotyping	karyotyping	NN
cord-005453-4057qib7	7875	5	(	(	-LRB-
cord-005453-4057qib7	7875	6	C	C	NNP
cord-005453-4057qib7	7875	7	-	-	,
cord-005453-4057qib7	7875	8	and	and	CC
cord-005453-4057qib7	7875	9	Gbanding	Gbanding	NNP
cord-005453-4057qib7	7875	10	)	)	-RRB-
cord-005453-4057qib7	7875	11	and	and	CC
cord-005453-4057qib7	7875	12	fluorescence	fluorescence	VB
cord-005453-4057qib7	7875	13	in	in	IN
cord-005453-4057qib7	7875	14	situ	situ	NN
cord-005453-4057qib7	7875	15	hybridization	hybridization	NN
cord-005453-4057qib7	7875	16	(	(	-LRB-
cord-005453-4057qib7	7875	17	FISH	fish	NN
cord-005453-4057qib7	7875	18	)	)	-RRB-
cord-005453-4057qib7	7875	19	.	.	.
cord-005453-4057qib7	7876	1	The	the	DT
cord-005453-4057qib7	7876	2	number	number	NN
cord-005453-4057qib7	7876	3	of	of	IN
cord-005453-4057qib7	7876	4	analyzed	analyze	VBN
cord-005453-4057qib7	7876	5	cells	cell	NNS
cord-005453-4057qib7	7876	6	exceeded	exceed	VBD
cord-005453-4057qib7	7876	7	European	European	NNP
cord-005453-4057qib7	7876	8	Cytogenetics	Cytogenetics	NNP
cord-005453-4057qib7	7876	9	Association	Association	NNP
cord-005453-4057qib7	7876	10	guidelines	guideline	NNS
cord-005453-4057qib7	7876	11	(	(	-LRB-
cord-005453-4057qib7	7876	12	for	for	IN
cord-005453-4057qib7	7876	13	each	each	DT
cord-005453-4057qib7	7876	14	FISH	fish	NN
cord-005453-4057qib7	7876	15	at	at	IN
cord-005453-4057qib7	7876	16	least	least	RBS
cord-005453-4057qib7	7876	17	600	600	CD
cord-005453-4057qib7	7876	18	interphase	interphase	NN
cord-005453-4057qib7	7876	19	nuclei	nucleus	NNS
cord-005453-4057qib7	7876	20	were	be	VBD
cord-005453-4057qib7	7876	21	analyzed	analyze	VBN
cord-005453-4057qib7	7876	22	)	)	-RRB-
cord-005453-4057qib7	7876	23	.	.	.
cord-005453-4057qib7	7877	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7877	2	risk	risk	NN
cord-005453-4057qib7	7877	3	group	group	NN
cord-005453-4057qib7	7877	4	in	in	IN
cord-005453-4057qib7	7877	5	AML	AML	NNP
cord-005453-4057qib7	7877	6	was	be	VBD
cord-005453-4057qib7	7877	7	assessed	assess	VBN
cord-005453-4057qib7	7877	8	based	base	VBN
cord-005453-4057qib7	7877	9	on	on	IN
cord-005453-4057qib7	7877	10	the	the	DT
cord-005453-4057qib7	7877	11	ELN	ELN	NNP
cord-005453-4057qib7	7877	12	2017	2017	CD
cord-005453-4057qib7	7877	13	criteria	criterion	NNS
cord-005453-4057qib7	7877	14	.	.	.
cord-005453-4057qib7	7878	1	Patients	patient	NNS
cord-005453-4057qib7	7878	2	with	with	IN
cord-005453-4057qib7	7878	3	MDS	MDS	NNP
cord-005453-4057qib7	7878	4	were	be	VBD
cord-005453-4057qib7	7878	5	stratified	stratify	VBN
cord-005453-4057qib7	7878	6	into	into	IN
cord-005453-4057qib7	7878	7	three	three	CD
cord-005453-4057qib7	7878	8	groups	group	NNS
cord-005453-4057qib7	7878	9	;	;	,
cord-005453-4057qib7	7878	10	favorable	favorable	JJ
cord-005453-4057qib7	7878	11	(	(	-LRB-
cord-005453-4057qib7	7878	12	good	good	JJ
cord-005453-4057qib7	7878	13	and	and	CC
cord-005453-4057qib7	7878	14	very	very	RB
cord-005453-4057qib7	7878	15	good	good	JJ
cord-005453-4057qib7	7878	16	prognostic	prognostic	JJ
cord-005453-4057qib7	7878	17	score	score	NN
cord-005453-4057qib7	7878	18	)	)	-RRB-
cord-005453-4057qib7	7878	19	,	,	,
cord-005453-4057qib7	7878	20	intermediate	intermediate	JJ
cord-005453-4057qib7	7878	21	,	,	,
cord-005453-4057qib7	7878	22	and	and	CC
cord-005453-4057qib7	7878	23	adverse	adverse	JJ
cord-005453-4057qib7	7878	24	(	(	-LRB-
cord-005453-4057qib7	7878	25	poor	poor	JJ
cord-005453-4057qib7	7878	26	and	and	CC
cord-005453-4057qib7	7878	27	very	very	RB
cord-005453-4057qib7	7878	28	poor	poor	JJ
cord-005453-4057qib7	7878	29	)	)	-RRB-
cord-005453-4057qib7	7878	30	prognostic	prognostic	JJ
cord-005453-4057qib7	7878	31	score	score	NN
cord-005453-4057qib7	7878	32	according	accord	VBG
cord-005453-4057qib7	7878	33	to	to	IN
cord-005453-4057qib7	7878	34	IPSS	IPSS	NNP
cord-005453-4057qib7	7878	35	-	-	HYPH
cord-005453-4057qib7	7878	36	R	R	NNP
cord-005453-4057qib7	7878	37	2012	2012	CD
cord-005453-4057qib7	7878	38	.	.	.
cord-005453-4057qib7	7879	1	Interestingly	interestingly	RB
cord-005453-4057qib7	7879	2	,	,	,
cord-005453-4057qib7	7879	3	the	the	DT
cord-005453-4057qib7	7879	4	poorest	poor	JJS
cord-005453-4057qib7	7879	5	survival	survival	NN
cord-005453-4057qib7	7879	6	was	be	VBD
cord-005453-4057qib7	7879	7	in	in	IN
cord-005453-4057qib7	7879	8	patients	patient	NNS
cord-005453-4057qib7	7879	9	with	with	IN
cord-005453-4057qib7	7879	10	monosomy	monosomy	NN
cord-005453-4057qib7	7879	11	of	of	IN
cord-005453-4057qib7	7879	12	chromosome	chromosome	NN
cord-005453-4057qib7	7879	13	7	7	CD
cord-005453-4057qib7	7879	14	,	,	,
cord-005453-4057qib7	7879	15	which	which	WDT
cord-005453-4057qib7	7879	16	was	be	VBD
cord-005453-4057qib7	7879	17	present	present	JJ
cord-005453-4057qib7	7879	18	in	in	IN
cord-005453-4057qib7	7879	19	6	6	CD
cord-005453-4057qib7	7879	20	patients	patient	NNS
cord-005453-4057qib7	7879	21	of	of	IN
cord-005453-4057qib7	7879	22	whom	whom	WP
cord-005453-4057qib7	7879	23	5	5	CD
cord-005453-4057qib7	7879	24	succumbed	succumb	VBD
cord-005453-4057qib7	7879	25	to	to	IN
cord-005453-4057qib7	7879	26	refractory	refractory	JJ
cord-005453-4057qib7	7879	27	disease	disease	NN
cord-005453-4057qib7	7879	28	,	,	,
cord-005453-4057qib7	7879	29	while	while	IN
cord-005453-4057qib7	7879	30	all	all	DT
cord-005453-4057qib7	7879	31	patients	patient	NNS
cord-005453-4057qib7	7879	32	who	who	WP
cord-005453-4057qib7	7879	33	had	have	VBD
cord-005453-4057qib7	7879	34	deletion	deletion	NN
cord-005453-4057qib7	7879	35	of	of	IN
cord-005453-4057qib7	7879	36	long	long	JJ
cord-005453-4057qib7	7879	37	arm	arm	NN
cord-005453-4057qib7	7879	38	of	of	IN
cord-005453-4057qib7	7879	39	chromosome	chromosome	NN
cord-005453-4057qib7	7879	40	7	7	CD
cord-005453-4057qib7	7880	1	(	(	-LRB-
cord-005453-4057qib7	7880	2	del	del	DT
cord-005453-4057qib7	7880	3	7q)-are	7q)-are	NNP
cord-005453-4057qib7	7880	4	alive	alive	JJ
cord-005453-4057qib7	7880	5	at	at	IN
cord-005453-4057qib7	7880	6	the	the	DT
cord-005453-4057qib7	7880	7	time	time	NN
cord-005453-4057qib7	7880	8	of	of	IN
cord-005453-4057qib7	7880	9	writing	writing	NN
cord-005453-4057qib7	7880	10	of	of	IN
cord-005453-4057qib7	7880	11	this	this	DT
cord-005453-4057qib7	7880	12	report	report	NN
cord-005453-4057qib7	7880	13	after	after	IN
cord-005453-4057qib7	7880	14	a	a	DT
cord-005453-4057qib7	7880	15	median	median	JJ
cord-005453-4057qib7	7880	16	follow	follow	NN
cord-005453-4057qib7	7880	17	-	-	HYPH
cord-005453-4057qib7	7880	18	up	up	NN
cord-005453-4057qib7	7880	19	of	of	IN
cord-005453-4057qib7	7880	20	34	34	CD
cord-005453-4057qib7	7880	21	months	month	NNS
cord-005453-4057qib7	7880	22	(	(	-LRB-
cord-005453-4057qib7	7880	23	21	21	CD
cord-005453-4057qib7	7880	24	-	-	SYM
cord-005453-4057qib7	7880	25	73	73	CD
cord-005453-4057qib7	7880	26	)	)	-RRB-
cord-005453-4057qib7	7880	27	.	.	.
cord-005453-4057qib7	7881	1	Relapse	relapse	NN
cord-005453-4057qib7	7881	2	was	be	VBD
cord-005453-4057qib7	7881	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	7881	4	in	in	IN
cord-005453-4057qib7	7881	5	31	31	CD
cord-005453-4057qib7	7881	6	patients	patient	NNS
cord-005453-4057qib7	7881	7	(	(	-LRB-
cord-005453-4057qib7	7881	8	31	31	CD
cord-005453-4057qib7	7881	9	%	%	NN
cord-005453-4057qib7	7881	10	)	)	-RRB-
cord-005453-4057qib7	7881	11	,	,	,
cord-005453-4057qib7	7881	12	including	include	VBG
cord-005453-4057qib7	7881	13	;	;	:
cord-005453-4057qib7	7881	14	13	13	CD
cord-005453-4057qib7	7881	15	(	(	-LRB-
cord-005453-4057qib7	7881	16	42	42	CD
cord-005453-4057qib7	7881	17	%	%	NN
cord-005453-4057qib7	7881	18	)	)	-RRB-
cord-005453-4057qib7	7881	19	with	with	IN
cord-005453-4057qib7	7881	20	adverse	adverse	JJ
cord-005453-4057qib7	7881	21	,	,	,
cord-005453-4057qib7	7881	22	15	15	CD
cord-005453-4057qib7	7881	23	(	(	-LRB-
cord-005453-4057qib7	7881	24	48	48	CD
cord-005453-4057qib7	7881	25	%	%	NN
cord-005453-4057qib7	7881	26	)	)	-RRB-
cord-005453-4057qib7	7881	27	with	with	IN
cord-005453-4057qib7	7881	28	intermediate	intermediate	JJ
cord-005453-4057qib7	7881	29	and	and	CC
cord-005453-4057qib7	7881	30	3	3	CD
cord-005453-4057qib7	7881	31	(	(	-LRB-
cord-005453-4057qib7	7881	32	10	10	CD
cord-005453-4057qib7	7881	33	%	%	NN
cord-005453-4057qib7	7881	34	)	)	-RRB-
cord-005453-4057qib7	7881	35	with	with	IN
cord-005453-4057qib7	7881	36	favorable	favorable	JJ
cord-005453-4057qib7	7881	37	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7881	38	risk	risk	NN
cord-005453-4057qib7	7881	39	.	.	.
cord-005453-4057qib7	7882	1	Among	among	IN
cord-005453-4057qib7	7882	2	12	12	CD
cord-005453-4057qib7	7882	3	patients	patient	NNS
cord-005453-4057qib7	7882	4	with	with	IN
cord-005453-4057qib7	7882	5	a	a	DT
cord-005453-4057qib7	7882	6	complex	complex	JJ
cord-005453-4057qib7	7882	7	karyotype	karyotype	NN
cord-005453-4057qib7	7882	8	and/or	and/or	CC
cord-005453-4057qib7	7882	9	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7882	10	evolution	evolution	NN
cord-005453-4057qib7	7882	11	prior	prior	JJ
cord-005453-4057qib7	7882	12	HCT	hct	NN
cord-005453-4057qib7	7882	13	:	:	:
cord-005453-4057qib7	7882	14	8	8	CD
cord-005453-4057qib7	7882	15	patients	patient	NNS
cord-005453-4057qib7	7882	16	(	(	-LRB-
cord-005453-4057qib7	7882	17	67%)relapsed	67%)relapsed	NNP
cord-005453-4057qib7	7882	18	,	,	,
cord-005453-4057qib7	7882	19	including	include	VBG
cord-005453-4057qib7	7882	20	6	6	CD
cord-005453-4057qib7	7882	21	(	(	-LRB-
cord-005453-4057qib7	7882	22	50%)-who	50%)-who	CD
cord-005453-4057qib7	7882	23	died	die	VBD
cord-005453-4057qib7	7882	24	.	.	.
cord-005453-4057qib7	7883	1	Follow	follow	VB
cord-005453-4057qib7	7883	2	-	-	HYPH
cord-005453-4057qib7	7883	3	up	up	RP
cord-005453-4057qib7	7883	4	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7883	5	studies	study	NNS
cord-005453-4057qib7	7883	6	in	in	IN
cord-005453-4057qib7	7883	7	relapse	relapse	NN
cord-005453-4057qib7	7883	8	after	after	IN
cord-005453-4057qib7	7883	9	transplantation	transplantation	NN
cord-005453-4057qib7	7883	10	were	be	VBD
cord-005453-4057qib7	7883	11	performed	perform	VBN
cord-005453-4057qib7	7883	12	for	for	IN
cord-005453-4057qib7	7883	13	24	24	CD
cord-005453-4057qib7	7883	14	patients	patient	NNS
cord-005453-4057qib7	7883	15	;	;	:
cord-005453-4057qib7	7883	16	4	4	CD
cord-005453-4057qib7	7883	17	of	of	IN
cord-005453-4057qib7	7883	18	them	-PRON-	PRP
cord-005453-4057qib7	7883	19	(	(	-LRB-
cord-005453-4057qib7	7883	20	17	17	CD
cord-005453-4057qib7	7883	21	%	%	NN
cord-005453-4057qib7	7883	22	)	)	-RRB-
cord-005453-4057qib7	7883	23	had	have	VBD
cord-005453-4057qib7	7883	24	clonal	clonal	JJ
cord-005453-4057qib7	7883	25	evolutions	evolution	NNS
cord-005453-4057qib7	7883	26	of	of	IN
cord-005453-4057qib7	7883	27	the	the	DT
cord-005453-4057qib7	7883	28	original	original	JJ
cord-005453-4057qib7	7883	29	karyotype	karyotype	NN
cord-005453-4057qib7	7883	30	with	with	IN
cord-005453-4057qib7	7883	31	additional	additional	JJ
cord-005453-4057qib7	7883	32	abnormalities-(50	abnormalities-(50	NNS
cord-005453-4057qib7	7883	33	%	%	NN
cord-005453-4057qib7	7883	34	died	die	VBD
cord-005453-4057qib7	7883	35	)	)	-RRB-
cord-005453-4057qib7	7883	36	and	and	CC
cord-005453-4057qib7	7883	37	7	7	CD
cord-005453-4057qib7	7883	38	(	(	-LRB-
cord-005453-4057qib7	7883	39	29	29	CD
cord-005453-4057qib7	7883	40	%	%	NN
cord-005453-4057qib7	7883	41	)	)	-RRB-
cord-005453-4057qib7	7883	42	had	have	VBD
cord-005453-4057qib7	7883	43	new	new	JJ
cord-005453-4057qib7	7883	44	aberrations	aberration	NNS
cord-005453-4057qib7	7883	45	in	in	IN
cord-005453-4057qib7	7883	46	cells	cell	NNS
cord-005453-4057qib7	7883	47	without	without	IN
cord-005453-4057qib7	7883	48	primary	primary	JJ
cord-005453-4057qib7	7883	49	changes	change	NNS
cord-005453-4057qib7	7883	50	(	(	-LRB-
cord-005453-4057qib7	7883	51	all	all	DT
cord-005453-4057qib7	7883	52	died	die	VBD
cord-005453-4057qib7	7883	53	)	)	-RRB-
cord-005453-4057qib7	7883	54	.	.	.
cord-005453-4057qib7	7884	1	In	in	IN
cord-005453-4057qib7	7884	2	18	18	CD
cord-005453-4057qib7	7884	3	patients	patient	NNS
cord-005453-4057qib7	7884	4	(	(	-LRB-
cord-005453-4057qib7	7884	5	18	18	CD
cord-005453-4057qib7	7884	6	%	%	NN
cord-005453-4057qib7	7884	7	)	)	-RRB-
cord-005453-4057qib7	7884	8	(	(	-LRB-
cord-005453-4057qib7	7884	9	8	8	CD
cord-005453-4057qib7	7884	10	unfavorable	unfavorable	JJ
cord-005453-4057qib7	7884	11	,	,	,
cord-005453-4057qib7	7884	12	8	8	CD
cord-005453-4057qib7	7884	13	intermediate	intermediate	JJ
cord-005453-4057qib7	7884	14	group	group	NN
cord-005453-4057qib7	7884	15	)	)	-RRB-
cord-005453-4057qib7	7884	16	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7884	17	relapse	relapse	NN
cord-005453-4057qib7	7884	18	was	be	VBD
cord-005453-4057qib7	7884	19	diagnosed	diagnose	VBN
cord-005453-4057qib7	7884	20	by	by	IN
cord-005453-4057qib7	7884	21	FISH	fish	NN
cord-005453-4057qib7	7884	22	analysis	analysis	NN
cord-005453-4057qib7	7884	23	and	and	CC
cord-005453-4057qib7	7884	24	they	-PRON-	PRP
cord-005453-4057qib7	7884	25	were	be	VBD
cord-005453-4057qib7	7884	26	treated	treat	VBN
cord-005453-4057qib7	7884	27	with	with	IN
cord-005453-4057qib7	7884	28	azacitidine	azacitidine	NNP
cord-005453-4057qib7	7884	29	(	(	-LRB-
cord-005453-4057qib7	7884	30	+	+	``
cord-005453-4057qib7	7884	31	/-DLI	/-DLI	NNS
cord-005453-4057qib7	7884	32	)	)	-RRB-
cord-005453-4057qib7	7884	33	achieving	achieve	VBG
cord-005453-4057qib7	7884	34	CR	CR	NNP
cord-005453-4057qib7	7884	35	(	(	-LRB-
cord-005453-4057qib7	7884	36	N=9	N=9	NNP
cord-005453-4057qib7	7884	37	,	,	,
cord-005453-4057qib7	7884	38	50	50	CD
cord-005453-4057qib7	7884	39	%	%	NN
cord-005453-4057qib7	7884	40	)	)	-RRB-
cord-005453-4057qib7	7884	41	,	,	,
cord-005453-4057qib7	7884	42	stabilization-(N-=3	stabilization-(n-=3	NN
cord-005453-4057qib7	7884	43	,	,	,
cord-005453-4057qib7	7884	44	16	16	CD
cord-005453-4057qib7	7884	45	%	%	NN
cord-005453-4057qib7	7884	46	)	)	-RRB-
cord-005453-4057qib7	7884	47	,	,	,
cord-005453-4057qib7	7884	48	transient	transient	JJ
cord-005453-4057qib7	7884	49	response	response	NN
cord-005453-4057qib7	7884	50	(	(	-LRB-
cord-005453-4057qib7	7884	51	N=1	N=1	NNP
cord-005453-4057qib7	7884	52	)	)	-RRB-
cord-005453-4057qib7	7884	53	,	,	,
cord-005453-4057qib7	7884	54	while	while	IN
cord-005453-4057qib7	7884	55	5	5	CD
cord-005453-4057qib7	7884	56	deceased	deceased	JJ
cord-005453-4057qib7	7884	57	)	)	-RRB-
cord-005453-4057qib7	7884	58	.	.	.
cord-005453-4057qib7	7885	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7885	2	:	:	:
cord-005453-4057qib7	7886	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7886	2	studies	study	NNS
cord-005453-4057qib7	7886	3	in	in	IN
cord-005453-4057qib7	7886	4	patients	patient	NNS
cord-005453-4057qib7	7886	5	after	after	IN
cord-005453-4057qib7	7886	6	transplantation	transplantation	NN
cord-005453-4057qib7	7886	7	may	may	MD
cord-005453-4057qib7	7886	8	facilitate	facilitate	VB
cord-005453-4057qib7	7886	9	assessment	assessment	NN
cord-005453-4057qib7	7886	10	of	of	IN
cord-005453-4057qib7	7886	11	mortality	mortality	NN
cord-005453-4057qib7	7886	12	.	.	.
cord-005453-4057qib7	7887	1	Karyotype	Karyotype	NNP
cord-005453-4057qib7	7887	2	may	may	MD
cord-005453-4057qib7	7887	3	undergo	undergo	VB
cord-005453-4057qib7	7887	4	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7887	5	evolution	evolution	NN
cord-005453-4057qib7	7887	6	after	after	IN
cord-005453-4057qib7	7887	7	allo	allo	NN
cord-005453-4057qib7	7887	8	-	-	HYPH
cord-005453-4057qib7	7887	9	HSCT	HSCT	NNP
cord-005453-4057qib7	7887	10	.	.	.
cord-005453-4057qib7	7888	1	Patients	patient	NNS
cord-005453-4057qib7	7888	2	with	with	IN
cord-005453-4057qib7	7888	3	monosomy	monosomy	NN
cord-005453-4057qib7	7888	4	of	of	IN
cord-005453-4057qib7	7888	5	chromosome	chromosome	NN
cord-005453-4057qib7	7888	6	7	7	CD
cord-005453-4057qib7	7888	7	seem	seem	VBP
cord-005453-4057qib7	7888	8	to	to	TO
cord-005453-4057qib7	7888	9	have	have	VB
cord-005453-4057qib7	7888	10	a	a	DT
cord-005453-4057qib7	7888	11	particularly	particularly	RB
cord-005453-4057qib7	7888	12	poor	poor	JJ
cord-005453-4057qib7	7888	13	prognosis	prognosis	NN
cord-005453-4057qib7	7888	14	.	.	.
cord-005453-4057qib7	7889	1	Transplanted	transplanted	JJ
cord-005453-4057qib7	7889	2	patients	patient	NNS
cord-005453-4057qib7	7889	3	are	be	VBP
cord-005453-4057qib7	7889	4	vulnerable	vulnerable	JJ
cord-005453-4057qib7	7889	5	to	to	IN
cord-005453-4057qib7	7889	6	new	new	JJ
cord-005453-4057qib7	7889	7	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	7889	8	alterations	alteration	NNS
cord-005453-4057qib7	7889	9	.	.	.
cord-005453-4057qib7	7890	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7890	2	:	:	:
cord-005453-4057qib7	7890	3	Nothing	nothing	NN
cord-005453-4057qib7	7890	4	to	to	TO
cord-005453-4057qib7	7890	5	declare	declare	VB
cord-005453-4057qib7	7890	6	Methods	method	NNS
cord-005453-4057qib7	7890	7	:	:	:
cord-005453-4057qib7	7890	8	The	the	DT
cord-005453-4057qib7	7890	9	primary	primary	JJ
cord-005453-4057qib7	7890	10	end	end	NN
cord-005453-4057qib7	7890	11	-	-	HYPH
cord-005453-4057qib7	7890	12	points	point	NNS
cord-005453-4057qib7	7890	13	were	be	VBD
cord-005453-4057qib7	7890	14	the	the	DT
cord-005453-4057qib7	7890	15	rate	rate	NN
cord-005453-4057qib7	7890	16	of	of	IN
cord-005453-4057qib7	7890	17	Complete	complete	JJ
cord-005453-4057qib7	7890	18	Response	response	NN
cord-005453-4057qib7	7890	19	(	(	-LRB-
cord-005453-4057qib7	7890	20	CR	CR	NNP
cord-005453-4057qib7	7890	21	)	)	-RRB-
cord-005453-4057qib7	7890	22	,	,	,
cord-005453-4057qib7	7890	23	defined	define	VBN
cord-005453-4057qib7	7890	24	as	as	IN
cord-005453-4057qib7	7890	25	no	no	DT
cord-005453-4057qib7	7890	26	emesis	emesis	NN
cord-005453-4057qib7	7890	27	and	and	CC
cord-005453-4057qib7	7890	28	no	no	DT
cord-005453-4057qib7	7890	29	nausea	nausea	NN
cord-005453-4057qib7	7890	30	without	without	IN
cord-005453-4057qib7	7890	31	rescue	rescue	NN
cord-005453-4057qib7	7890	32	medications	medication	NNS
cord-005453-4057qib7	7890	33	,	,	,
cord-005453-4057qib7	7890	34	for	for	IN
cord-005453-4057qib7	7890	35	both	both	DT
cord-005453-4057qib7	7890	36	acute	acute	JJ
cord-005453-4057qib7	7890	37	(	(	-LRB-
cord-005453-4057qib7	7890	38	CR-24	CR-24	NNP
cord-005453-4057qib7	7890	39	)	)	-RRB-
cord-005453-4057qib7	7890	40	and	and	CC
cord-005453-4057qib7	7890	41	delayed	delay	VBN
cord-005453-4057qib7	7890	42	(	(	-LRB-
cord-005453-4057qib7	7890	43	CR	CR	NNP
cord-005453-4057qib7	7890	44	25	25	CD
cord-005453-4057qib7	7890	45	-	-	SYM
cord-005453-4057qib7	7890	46	120	120	CD
cord-005453-4057qib7	7890	47	)	)	-RRB-
cord-005453-4057qib7	7890	48	CINV	cinv	NN
cord-005453-4057qib7	7890	49	and	and	CC
cord-005453-4057qib7	7890	50	rate	rate	NN
cord-005453-4057qib7	7890	51	of	of	IN
cord-005453-4057qib7	7890	52	post	post	JJ
cord-005453-4057qib7	7890	53	-	-	JJ
cord-005453-4057qib7	7890	54	transplant	transplant	JJ
cord-005453-4057qib7	7890	55	complications	complication	NNS
cord-005453-4057qib7	7890	56	until	until	IN
cord-005453-4057qib7	7890	57	discharge	discharge	NN
cord-005453-4057qib7	7890	58	.	.	.
cord-005453-4057qib7	7891	1	We	-PRON-	PRP
cord-005453-4057qib7	7891	2	prospectively	prospectively	RB
cord-005453-4057qib7	7891	3	analyzed	analyze	VBD
cord-005453-4057qib7	7891	4	61	61	CD
cord-005453-4057qib7	7891	5	patients	patient	NNS
cord-005453-4057qib7	7891	6	undergoing	undergo	VBG
cord-005453-4057qib7	7891	7	Autologous	autologous	JJ
cord-005453-4057qib7	7891	8	(	(	-LRB-
cord-005453-4057qib7	7891	9	85	85	CD
cord-005453-4057qib7	7891	10	%	%	NN
cord-005453-4057qib7	7891	11	)	)	-RRB-
cord-005453-4057qib7	7891	12	and	and	CC
cord-005453-4057qib7	7891	13	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	7891	14	(	(	-LRB-
cord-005453-4057qib7	7891	15	15	15	CD
cord-005453-4057qib7	7891	16	%	%	NN
cord-005453-4057qib7	7891	17	)	)	-RRB-
cord-005453-4057qib7	7891	18	Stem	Stem	NNP
cord-005453-4057qib7	7891	19	Cell	cell	NN
cord-005453-4057qib7	7891	20	Transplantation	transplantation	NN
cord-005453-4057qib7	7891	21	and	and	CC
cord-005453-4057qib7	7891	22	receiving	receive	VBG
cord-005453-4057qib7	7891	23	CINV	CINV	NNP
cord-005453-4057qib7	7891	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7891	25	with	with	IN
cord-005453-4057qib7	7891	26	NEPA	NEPA	NNP
cord-005453-4057qib7	7891	27	and	and	CC
cord-005453-4057qib7	7891	28	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	7891	29	(	(	-LRB-
cord-005453-4057qib7	7891	30	schedules	schedule	NNS
cord-005453-4057qib7	7891	31	shown	show	VBN
cord-005453-4057qib7	7891	32	in	in	IN
cord-005453-4057qib7	7891	33	fig.1	fig.1	NN
cord-005453-4057qib7	7891	34	)	)	-RRB-
cord-005453-4057qib7	7891	35	.	.	.
cord-005453-4057qib7	7892	1	In	in	IN
cord-005453-4057qib7	7892	2	our	-PRON-	PRP$
cord-005453-4057qib7	7892	3	series	series	NN
cord-005453-4057qib7	7892	4	,	,	,
cord-005453-4057qib7	7892	5	30	30	CD
cord-005453-4057qib7	7892	6	patients	patient	NNS
cord-005453-4057qib7	7892	7	(	(	-LRB-
cord-005453-4057qib7	7892	8	49	49	CD
cord-005453-4057qib7	7892	9	%	%	NN
cord-005453-4057qib7	7892	10	)	)	-RRB-
cord-005453-4057qib7	7892	11	were	be	VBD
cord-005453-4057qib7	7892	12	female	female	JJ
cord-005453-4057qib7	7892	13	.	.	.
cord-005453-4057qib7	7893	1	Patients	patient	NNS
cord-005453-4057qib7	7893	2	median	median	JJ
cord-005453-4057qib7	7893	3	age	age	NN
cord-005453-4057qib7	7893	4	was	be	VBD
cord-005453-4057qib7	7893	5	55	55	CD
cord-005453-4057qib7	7893	6	years	year	NNS
cord-005453-4057qib7	7893	7	(	(	-LRB-
cord-005453-4057qib7	7893	8	20	20	CD
cord-005453-4057qib7	7893	9	-	-	SYM
cord-005453-4057qib7	7893	10	74	74	CD
cord-005453-4057qib7	7893	11	)	)	-RRB-
cord-005453-4057qib7	7893	12	.	.	.
cord-005453-4057qib7	7894	1	The	the	DT
cord-005453-4057qib7	7894	2	most	most	RBS
cord-005453-4057qib7	7894	3	frequent	frequent	JJ
cord-005453-4057qib7	7894	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	7894	5	were	be	VBD
cord-005453-4057qib7	7894	6	Myeloma	myeloma	NN
cord-005453-4057qib7	7894	7	(	(	-LRB-
cord-005453-4057qib7	7894	8	46	46	CD
cord-005453-4057qib7	7894	9	%	%	NN
cord-005453-4057qib7	7894	10	)	)	-RRB-
cord-005453-4057qib7	7894	11	and	and	CC
cord-005453-4057qib7	7894	12	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	7894	13	(	(	-LRB-
cord-005453-4057qib7	7894	14	39	39	CD
cord-005453-4057qib7	7894	15	%	%	NN
cord-005453-4057qib7	7894	16	)	)	-RRB-
cord-005453-4057qib7	7894	17	,	,	,
cord-005453-4057qib7	7894	18	while	while	IN
cord-005453-4057qib7	7894	19	15	15	CD
cord-005453-4057qib7	7894	20	%	%	NN
cord-005453-4057qib7	7894	21	of	of	IN
cord-005453-4057qib7	7894	22	patients	patient	NNS
cord-005453-4057qib7	7894	23	were	be	VBD
cord-005453-4057qib7	7894	24	diagnosed	diagnose	VBN
cord-005453-4057qib7	7894	25	with	with	IN
cord-005453-4057qib7	7894	26	AML	AML	NNP
cord-005453-4057qib7	7894	27	or	or	CC
cord-005453-4057qib7	7894	28	MDS	MDS	NNP
cord-005453-4057qib7	7894	29	.	.	.
cord-005453-4057qib7	7895	1	Myeloma	myeloma	NN
cord-005453-4057qib7	7895	2	patients	patient	NNS
cord-005453-4057qib7	7895	3	received	receive	VBD
cord-005453-4057qib7	7895	4	one	one	CD
cord-005453-4057qib7	7895	5	day	day	NN
cord-005453-4057qib7	7895	6	HD	HD	NNP
cord-005453-4057qib7	7895	7	-	-	HYPH
cord-005453-4057qib7	7895	8	CT	CT	NNP
cord-005453-4057qib7	7895	9	with	with	IN
cord-005453-4057qib7	7895	10	Melphalan	Melphalan	NNP
cord-005453-4057qib7	7895	11	(	(	-LRB-
cord-005453-4057qib7	7895	12	75	75	CD
cord-005453-4057qib7	7895	13	%	%	NN
cord-005453-4057qib7	7895	14	Mel200/25	mel200/25	NN
cord-005453-4057qib7	7895	15	%	%	NN
cord-005453-4057qib7	7895	16	Mel140	Mel140	.
cord-005453-4057qib7	7895	17	)	)	-RRB-
cord-005453-4057qib7	7895	18	.	.	.
cord-005453-4057qib7	7896	1	Lymphoma	lymphoma	NN
cord-005453-4057qib7	7896	2	patients	patient	NNS
cord-005453-4057qib7	7896	3	were	be	VBD
cord-005453-4057qib7	7896	4	conditioned	condition	VBN
cord-005453-4057qib7	7896	5	with	with	IN
cord-005453-4057qib7	7896	6	FEAM	FEAM	NNP
cord-005453-4057qib7	7896	7	(	(	-LRB-
cord-005453-4057qib7	7896	8	87,5	87,5	CD
cord-005453-4057qib7	7896	9	%	%	NN
cord-005453-4057qib7	7896	10	)	)	-RRB-
cord-005453-4057qib7	7896	11	or	or	CC
cord-005453-4057qib7	7897	1	TT_FLU_EDX	TT_FLU_EDX	NNP
cord-005453-4057qib7	7898	1	(	(	-LRB-
cord-005453-4057qib7	7898	2	12,5	12,5	CD
cord-005453-4057qib7	7898	3	%	%	NN
cord-005453-4057qib7	7898	4	)	)	-RRB-
cord-005453-4057qib7	7898	5	HD	HD	NNP
cord-005453-4057qib7	7898	6	-	-	HYPH
cord-005453-4057qib7	7898	7	CT	CT	NNP
cord-005453-4057qib7	7898	8	.	.	.
cord-005453-4057qib7	7899	1	Busulfan	Busulfan	NNP
cord-005453-4057qib7	7899	2	-	-	HYPH
cord-005453-4057qib7	7899	3	based	base	VBN
cord-005453-4057qib7	7899	4	MDs	MDs	NNP
cord-005453-4057qib7	7899	5	-	-	HYPH
cord-005453-4057qib7	7899	6	CT	CT	NNP
cord-005453-4057qib7	7899	7	regimen	regimen	NN
cord-005453-4057qib7	7899	8	was	be	VBD
cord-005453-4057qib7	7899	9	offered	offer	VBN
cord-005453-4057qib7	7899	10	to	to	IN
cord-005453-4057qib7	7899	11	AML	AML	NNP
cord-005453-4057qib7	7899	12	/	/	SYM
cord-005453-4057qib7	7899	13	MDS	MDS	NNP
cord-005453-4057qib7	7899	14	patients	patient	NNS
cord-005453-4057qib7	7899	15	.	.	.
cord-005453-4057qib7	7900	1	Results	result	NNS
cord-005453-4057qib7	7900	2	:	:	:
cord-005453-4057qib7	7901	1	The	the	DT
cord-005453-4057qib7	7901	2	incidence	incidence	NN
cord-005453-4057qib7	7901	3	of	of	IN
cord-005453-4057qib7	7901	4	CR-24	CR-24	NNP
cord-005453-4057qib7	7901	5	and	and	CC
cord-005453-4057qib7	7901	6	CR	CR	NNP
cord-005453-4057qib7	7901	7	25	25	CD
cord-005453-4057qib7	7901	8	-	-	SYM
cord-005453-4057qib7	7901	9	120	120	CD
cord-005453-4057qib7	7901	10	observed	observe	VBD
cord-005453-4057qib7	7901	11	was	be	VBD
cord-005453-4057qib7	7901	12	82	82	CD
cord-005453-4057qib7	7901	13	%	%	NN
cord-005453-4057qib7	7901	14	(	(	-LRB-
cord-005453-4057qib7	7901	15	50/61	50/61	CD
cord-005453-4057qib7	7901	16	)	)	-RRB-
cord-005453-4057qib7	7901	17	and	and	CC
cord-005453-4057qib7	7901	18	47,5	47,5	CD
cord-005453-4057qib7	7901	19	%	%	NN
cord-005453-4057qib7	7901	20	(	(	-LRB-
cord-005453-4057qib7	7901	21	29/61	29/61	CD
cord-005453-4057qib7	7901	22	)	)	-RRB-
cord-005453-4057qib7	7901	23	,	,	,
cord-005453-4057qib7	7901	24	respectively	respectively	RB
cord-005453-4057qib7	7901	25	.	.	.
cord-005453-4057qib7	7902	1	More	More	JJR
cord-005453-4057qib7	7902	2	than	than	IN
cord-005453-4057qib7	7902	3	grade	grade	NN
cord-005453-4057qib7	7902	4	1	1	CD
cord-005453-4057qib7	7902	5	nausea	nausea	NN
cord-005453-4057qib7	7902	6	and	and	CC
cord-005453-4057qib7	7902	7	vomiting	vomit	VBG
cord-005453-4057qib7	7903	1	(	(	-LRB-
cord-005453-4057qib7	7903	2	according	accord	VBG
cord-005453-4057qib7	7903	3	to	to	IN
cord-005453-4057qib7	7903	4	CTAE-4	CTAE-4	NNP
cord-005453-4057qib7	7903	5	)	)	-RRB-
cord-005453-4057qib7	7903	6	,	,	,
cord-005453-4057qib7	7903	7	was	be	VBD
cord-005453-4057qib7	7903	8	reported	report	VBN
cord-005453-4057qib7	7903	9	in	in	IN
cord-005453-4057qib7	7903	10	36	36	CD
cord-005453-4057qib7	7903	11	%	%	NN
cord-005453-4057qib7	7903	12	(	(	-LRB-
cord-005453-4057qib7	7903	13	22/61	22/61	CD
cord-005453-4057qib7	7903	14	)	)	-RRB-
cord-005453-4057qib7	7903	15	and	and	CC
cord-005453-4057qib7	7903	16	5	5	CD
cord-005453-4057qib7	7903	17	%	%	NN
cord-005453-4057qib7	7903	18	(	(	-LRB-
cord-005453-4057qib7	7903	19	3/61	3/61	CD
cord-005453-4057qib7	7903	20	)	)	-RRB-
cord-005453-4057qib7	7903	21	of	of	IN
cord-005453-4057qib7	7903	22	patients	patient	NNS
cord-005453-4057qib7	7903	23	,	,	,
cord-005453-4057qib7	7903	24	respectively	respectively	RB
cord-005453-4057qib7	7903	25	.	.	.
cord-005453-4057qib7	7904	1	Female	female	JJ
cord-005453-4057qib7	7904	2	sex	sex	NN
cord-005453-4057qib7	7904	3	was	be	VBD
cord-005453-4057qib7	7904	4	associated	associate	VBN
cord-005453-4057qib7	7904	5	with	with	IN
cord-005453-4057qib7	7904	6	an	an	DT
cord-005453-4057qib7	7904	7	increased	increase	VBN
cord-005453-4057qib7	7904	8	risk	risk	NN
cord-005453-4057qib7	7904	9	of	of	IN
cord-005453-4057qib7	7904	10	acute	acute	JJ
cord-005453-4057qib7	7904	11	(	(	-LRB-
cord-005453-4057qib7	7904	12	HR	HR	NNP
cord-005453-4057qib7	7904	13	19,6	19,6	CD
cord-005453-4057qib7	7904	14	;	;	:
cord-005453-4057qib7	7904	15	p	p	NN
cord-005453-4057qib7	7904	16	0,037	0,037	CD
cord-005453-4057qib7	7904	17	95	95	CD
cord-005453-4057qib7	7904	18	%	%	NN
cord-005453-4057qib7	7904	19	CI	CI	NNP
cord-005453-4057qib7	7904	20	7.980	7.980	CD
cord-005453-4057qib7	7904	21	-	-	HYPH
cord-005453-4057qib7	7904	22	2.191	2.191	CD
cord-005453-4057qib7	7904	23	)	)	-RRB-
cord-005453-4057qib7	7904	24	but	but	CC
cord-005453-4057qib7	7904	25	not	not	RB
cord-005453-4057qib7	7904	26	delayed	delay	VBN
cord-005453-4057qib7	7904	27	(	(	-LRB-
cord-005453-4057qib7	7904	28	HR	HR	NNP
cord-005453-4057qib7	7904	29	1,58	1,58	CD
cord-005453-4057qib7	7904	30	;	;	:
cord-005453-4057qib7	7904	31	p	p	NN
cord-005453-4057qib7	7904	32	0,06	0,06	CD
cord-005453-4057qib7	7904	33	95	95	CD
cord-005453-4057qib7	7904	34	%	%	NN
cord-005453-4057qib7	7904	35	CI	CI	NNP
cord-005453-4057qib7	7904	36	200	200	CD
cord-005453-4057qib7	7904	37	-	-	HYPH
cord-005453-4057qib7	7904	38	2.042	2.042	CD
cord-005453-4057qib7	7904	39	)	)	-RRB-
cord-005453-4057qib7	7904	40	CINV	CINV	NNP
cord-005453-4057qib7	7904	41	.	.	.
cord-005453-4057qib7	7905	1	Similar	similar	JJ
cord-005453-4057qib7	7905	2	rate	rate	NN
cord-005453-4057qib7	7905	3	of	of	IN
cord-005453-4057qib7	7905	4	CR24	CR24	NNP
cord-005453-4057qib7	7905	5	and	and	CC
cord-005453-4057qib7	7905	6	CR25	CR25	NNP
cord-005453-4057qib7	7905	7	-	-	HYPH
cord-005453-4057qib7	7905	8	120	120	NNP
cord-005453-4057qib7	7905	9	was	be	VBD
cord-005453-4057qib7	7905	10	observed	observe	VBN
cord-005453-4057qib7	7905	11	in	in	IN
cord-005453-4057qib7	7905	12	One	one	CD
cord-005453-4057qib7	7905	13	-	-	HYPH
cord-005453-4057qib7	7905	14	day	day	NN
cord-005453-4057qib7	7905	15	HD	hd	NN
cord-005453-4057qib7	7905	16	-	-	HYPH
cord-005453-4057qib7	7905	17	CT	CT	NNP
cord-005453-4057qib7	7905	18	(	(	-LRB-
cord-005453-4057qib7	7905	19	82	82	CD
cord-005453-4057qib7	7905	20	%	%	NN
cord-005453-4057qib7	7905	21	and	and	CC
cord-005453-4057qib7	7905	22	50	50	CD
cord-005453-4057qib7	7905	23	%	%	NN
cord-005453-4057qib7	7905	24	)	)	-RRB-
cord-005453-4057qib7	7905	25	compared	compare	VBN
cord-005453-4057qib7	7905	26	to	to	IN
cord-005453-4057qib7	7905	27	MDs	MDs	NNP
cord-005453-4057qib7	7905	28	-	-	HYPH
cord-005453-4057qib7	7905	29	CT	CT	NNP
cord-005453-4057qib7	7905	30	(	(	-LRB-
cord-005453-4057qib7	7905	31	89	89	CD
cord-005453-4057qib7	7905	32	%	%	NN
cord-005453-4057qib7	7905	33	and	and	CC
cord-005453-4057qib7	7905	34	42,5	42,5	CD
cord-005453-4057qib7	7905	35	%	%	NN
cord-005453-4057qib7	7905	36	)	)	-RRB-
cord-005453-4057qib7	7905	37	group	group	NN
cord-005453-4057qib7	7905	38	(	(	-LRB-
cord-005453-4057qib7	7905	39	pNS	pNS	NNP
cord-005453-4057qib7	7905	40	)	)	-RRB-
cord-005453-4057qib7	7905	41	.	.	.
cord-005453-4057qib7	7906	1	Median	median	JJ
cord-005453-4057qib7	7906	2	lenght	lenght	NN
cord-005453-4057qib7	7906	3	of	of	IN
cord-005453-4057qib7	7906	4	stay	stay	NN
cord-005453-4057qib7	7906	5	was	be	VBD
cord-005453-4057qib7	7906	6	23	23	CD
cord-005453-4057qib7	7906	7	days	day	NNS
cord-005453-4057qib7	7906	8	(	(	-LRB-
cord-005453-4057qib7	7906	9	15	15	CD
cord-005453-4057qib7	7906	10	-	-	SYM
cord-005453-4057qib7	7906	11	51	51	CD
cord-005453-4057qib7	7906	12	)	)	-RRB-
cord-005453-4057qib7	7906	13	.	.	.
cord-005453-4057qib7	7907	1	No	no	DT
cord-005453-4057qib7	7907	2	case	case	NN
cord-005453-4057qib7	7907	3	of	of	IN
cord-005453-4057qib7	7907	4	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	7907	5	and	and	CC
cord-005453-4057qib7	7907	6	no	no	DT
cord-005453-4057qib7	7907	7	exitus	exitus	NN
cord-005453-4057qib7	7907	8	was	be	VBD
cord-005453-4057qib7	7907	9	observed	observe	VBN
cord-005453-4057qib7	7907	10	.	.	.
cord-005453-4057qib7	7908	1	The	the	DT
cord-005453-4057qib7	7908	2	incidence	incidence	NN
cord-005453-4057qib7	7908	3	of	of	IN
cord-005453-4057qib7	7908	4	febrile	febrile	JJ
cord-005453-4057qib7	7908	5	neutropenia	neutropenia	NN
cord-005453-4057qib7	7908	6	was	be	VBD
cord-005453-4057qib7	7908	7	61	61	CD
cord-005453-4057qib7	7908	8	%	%	NN
cord-005453-4057qib7	7908	9	(	(	-LRB-
cord-005453-4057qib7	7908	10	70	70	CD
cord-005453-4057qib7	7908	11	%	%	NN
cord-005453-4057qib7	7908	12	FUO	fuo	NN
cord-005453-4057qib7	7908	13	;	;	:
cord-005453-4057qib7	7908	14	22	22	CD
cord-005453-4057qib7	7908	15	%	%	NN
cord-005453-4057qib7	7908	16	sepsis	sepsis	NN
cord-005453-4057qib7	7908	17	;	;	:
cord-005453-4057qib7	7908	18	18	18	CD
cord-005453-4057qib7	7908	19	%	%	NN
cord-005453-4057qib7	7908	20	pneumonia	pneumonia	NN
cord-005453-4057qib7	7908	21	)	)	-RRB-
cord-005453-4057qib7	7908	22	.	.	.
cord-005453-4057qib7	7909	1	Only	only	RB
cord-005453-4057qib7	7909	2	one	one	CD
cord-005453-4057qib7	7909	3	patient	patient	NN
cord-005453-4057qib7	7909	4	experienced	experience	VBD
cord-005453-4057qib7	7909	5	an	an	DT
cord-005453-4057qib7	7909	6	aGvHD	agvhd	NN
cord-005453-4057qib7	7909	7	on	on	IN
cord-005453-4057qib7	7909	8	day	day	NN
cord-005453-4057qib7	7909	9	+9	+9	CD
cord-005453-4057qib7	7909	10	.	.	.
cord-005453-4057qib7	7910	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	7910	2	(	(	-LRB-
cord-005453-4057qib7	7910	3	>	>	NFP
cord-005453-4057qib7	7910	4	1000	1000	CD
cord-005453-4057qib7	7910	5	/	/	SYM
cord-005453-4057qib7	7910	6	mcL	mcl	NN
cord-005453-4057qib7	7910	7	)	)	-RRB-
cord-005453-4057qib7	7910	8	and	and	CC
cord-005453-4057qib7	7910	9	Platelet	platelet	NN
cord-005453-4057qib7	7910	10	(	(	-LRB-
cord-005453-4057qib7	7910	11	>	>	NFP
cord-005453-4057qib7	7910	12	50000	50000	CD
cord-005453-4057qib7	7910	13	/	/	SYM
cord-005453-4057qib7	7910	14	mcL	mcl	NN
cord-005453-4057qib7	7910	15	)	)	-RRB-
cord-005453-4057qib7	7910	16	recovery	recovery	NN
cord-005453-4057qib7	7910	17	occurred	occur	VBD
cord-005453-4057qib7	7910	18	in	in	IN
cord-005453-4057qib7	7910	19	median	median	NN
cord-005453-4057qib7	7910	20	on	on	IN
cord-005453-4057qib7	7910	21	day	day	NN
cord-005453-4057qib7	7910	22	11	11	CD
cord-005453-4057qib7	7910	23	(	(	-LRB-
cord-005453-4057qib7	7910	24	9	9	CD
cord-005453-4057qib7	7910	25	-	-	SYM
cord-005453-4057qib7	7910	26	26	26	CD
cord-005453-4057qib7	7910	27	)	)	-RRB-
cord-005453-4057qib7	7910	28	and	and	CC
cord-005453-4057qib7	7910	29	on	on	IN
cord-005453-4057qib7	7910	30	day	day	NN
cord-005453-4057qib7	7910	31	15	15	CD
cord-005453-4057qib7	7910	32	(	(	-LRB-
cord-005453-4057qib7	7910	33	4	4	CD
cord-005453-4057qib7	7910	34	-	-	SYM
cord-005453-4057qib7	7910	35	45	45	CD
cord-005453-4057qib7	7910	36	)	)	-RRB-
cord-005453-4057qib7	7910	37	respectively	respectively	RB
cord-005453-4057qib7	7910	38	.	.	.
cord-005453-4057qib7	7911	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7911	2	:	:	:
cord-005453-4057qib7	7912	1	NEPA	NEPA	NNP
cord-005453-4057qib7	7912	2	seems	seem	VBZ
cord-005453-4057qib7	7912	3	to	to	TO
cord-005453-4057qib7	7912	4	be	be	VB
cord-005453-4057qib7	7912	5	safe	safe	JJ
cord-005453-4057qib7	7912	6	and	and	CC
cord-005453-4057qib7	7912	7	effective	effective	JJ
cord-005453-4057qib7	7912	8	in	in	IN
cord-005453-4057qib7	7912	9	preventing	prevent	VBG
cord-005453-4057qib7	7912	10	acute	acute	JJ
cord-005453-4057qib7	7912	11	and	and	CC
cord-005453-4057qib7	7912	12	delayed	delay	VBN
cord-005453-4057qib7	7912	13	CINV	CINV	NNP
cord-005453-4057qib7	7912	14	in	in	IN
cord-005453-4057qib7	7912	15	patients	patient	NNS
cord-005453-4057qib7	7912	16	receiving	receive	VBG
cord-005453-4057qib7	7912	17	both	both	DT
cord-005453-4057qib7	7912	18	one	one	CD
cord-005453-4057qib7	7912	19	day	day	NN
cord-005453-4057qib7	7912	20	HD	HD	NNP
cord-005453-4057qib7	7912	21	-	-	HYPH
cord-005453-4057qib7	7912	22	CT	CT	NNP
cord-005453-4057qib7	7912	23	and	and	CC
cord-005453-4057qib7	7912	24	MDs	MDs	NNP
cord-005453-4057qib7	7912	25	-	-	HYPH
cord-005453-4057qib7	7912	26	CT	CT	NNP
cord-005453-4057qib7	7912	27	as	as	IN
cord-005453-4057qib7	7912	28	conditioning	conditioning	NN
cord-005453-4057qib7	7912	29	regimen	regimen	NN
cord-005453-4057qib7	7912	30	for	for	IN
cord-005453-4057qib7	7912	31	HSCT	HSCT	NNP
cord-005453-4057qib7	7912	32	.	.	.
cord-005453-4057qib7	7913	1	More	More	JJR
cord-005453-4057qib7	7913	2	studies	study	NNS
cord-005453-4057qib7	7913	3	are	be	VBP
cord-005453-4057qib7	7913	4	needed	need	VBN
cord-005453-4057qib7	7913	5	to	to	TO
cord-005453-4057qib7	7913	6	define	define	VB
cord-005453-4057qib7	7913	7	the	the	DT
cord-005453-4057qib7	7913	8	better	well	JJR
cord-005453-4057qib7	7913	9	5-HT3RA	5-ht3ra	CD
cord-005453-4057qib7	7913	10	and	and	CC
cord-005453-4057qib7	7913	11	NK-1RA	NK-1RA	NNP
cord-005453-4057qib7	7913	12	combination	combination	NN
cord-005453-4057qib7	7913	13	and	and	CC
cord-005453-4057qib7	7913	14	the	the	DT
cord-005453-4057qib7	7913	15	better	well	JJR
cord-005453-4057qib7	7913	16	schedule	schedule	NN
cord-005453-4057qib7	7913	17	in	in	IN
cord-005453-4057qib7	7913	18	transplant	transplant	NN
cord-005453-4057qib7	7913	19	setting	setting	NN
cord-005453-4057qib7	7913	20	.	.	.
cord-005453-4057qib7	7914	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7914	2	:	:	:
cord-005453-4057qib7	7914	3	"	"	``
cord-005453-4057qib7	7914	4	Nothing	nothing	NN
cord-005453-4057qib7	7914	5	to	to	TO
cord-005453-4057qib7	7914	6	declare	declare	VB
cord-005453-4057qib7	7914	7	Background	background	NN
cord-005453-4057qib7	7914	8	:	:	:
cord-005453-4057qib7	7915	1	VOD	VOD	NNP
cord-005453-4057qib7	7915	2	and	and	CC
cord-005453-4057qib7	7915	3	TA	TA	NNP
cord-005453-4057qib7	7915	4	-	-	HYPH
cord-005453-4057qib7	7915	5	TMA	TMA	NNP
cord-005453-4057qib7	7915	6	represent	represent	VBP
cord-005453-4057qib7	7915	7	two	two	CD
cord-005453-4057qib7	7915	8	early	early	JJ
cord-005453-4057qib7	7915	9	endothelial	endothelial	JJ
cord-005453-4057qib7	7915	10	complications	complication	NNS
cord-005453-4057qib7	7915	11	occurring	occur	VBG
cord-005453-4057qib7	7915	12	after	after	IN
cord-005453-4057qib7	7915	13	allogeneic	allogeneic	NN
cord-005453-4057qib7	7915	14	stem	stem	NN
cord-005453-4057qib7	7915	15	cell	cell	NN
cord-005453-4057qib7	7915	16	transplantation	transplantation	NN
cord-005453-4057qib7	7915	17	(	(	-LRB-
cord-005453-4057qib7	7915	18	SCT	SCT	NNP
cord-005453-4057qib7	7915	19	)	)	-RRB-
cord-005453-4057qib7	7915	20	sharing	share	VBG
cord-005453-4057qib7	7915	21	many	many	JJ
cord-005453-4057qib7	7915	22	pre	pre	JJ
cord-005453-4057qib7	7915	23	-	-	JJ
cord-005453-4057qib7	7915	24	transplant	transplant	JJ
cord-005453-4057qib7	7915	25	risk	risk	NN
cord-005453-4057qib7	7915	26	factors	factor	NNS
cord-005453-4057qib7	7915	27	.	.	.
cord-005453-4057qib7	7916	1	The	the	DT
cord-005453-4057qib7	7916	2	aim	aim	NN
cord-005453-4057qib7	7916	3	of	of	IN
cord-005453-4057qib7	7916	4	our	-PRON-	PRP$
cord-005453-4057qib7	7916	5	study	study	NN
cord-005453-4057qib7	7916	6	is	be	VBZ
cord-005453-4057qib7	7916	7	to	to	TO
cord-005453-4057qib7	7916	8	evaluate	evaluate	VB
cord-005453-4057qib7	7916	9	the	the	DT
cord-005453-4057qib7	7916	10	impact	impact	NN
cord-005453-4057qib7	7916	11	of	of	IN
cord-005453-4057qib7	7916	12	donor	donor	NN
cord-005453-4057qib7	7916	13	graft	graft	NN
cord-005453-4057qib7	7916	14	composition	composition	NN
cord-005453-4057qib7	7916	15	,	,	,
cord-005453-4057qib7	7916	16	engraftment	engraftment	NNP
cord-005453-4057qib7	7916	17	kinetics	kinetic	NNS
cord-005453-4057qib7	7916	18	and	and	CC
cord-005453-4057qib7	7916	19	infections	infection	NNS
cord-005453-4057qib7	7916	20	on	on	IN
cord-005453-4057qib7	7916	21	the	the	DT
cord-005453-4057qib7	7916	22	development	development	NN
cord-005453-4057qib7	7916	23	of	of	IN
cord-005453-4057qib7	7916	24	these	these	DT
cord-005453-4057qib7	7916	25	endothelial	endothelial	JJ
cord-005453-4057qib7	7916	26	complications	complication	NNS
cord-005453-4057qib7	7916	27	(	(	-LRB-
cord-005453-4057qib7	7916	28	EC	EC	NNP
cord-005453-4057qib7	7916	29	)	)	-RRB-
cord-005453-4057qib7	7916	30	.	.	.
cord-005453-4057qib7	7917	1	Methods	method	NNS
cord-005453-4057qib7	7917	2	:	:	:
cord-005453-4057qib7	7917	3	We	-PRON-	PRP
cord-005453-4057qib7	7917	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	7917	5	reviewed	review	VBD
cord-005453-4057qib7	7917	6	55	55	CD
cord-005453-4057qib7	7917	7	consecutive	consecutive	JJ
cord-005453-4057qib7	7917	8	SCT	SCT	NNP
cord-005453-4057qib7	7917	9	recipients	recipient	NNS
cord-005453-4057qib7	7917	10	at	at	IN
cord-005453-4057qib7	7917	11	our	-PRON-	PRP$
cord-005453-4057qib7	7917	12	institu	institu	NN
cord-005453-4057qib7	7917	13	-	-	HYPH
cord-005453-4057qib7	7917	14	tion	tion	NN
cord-005453-4057qib7	7917	15	between	between	IN
cord-005453-4057qib7	7917	16	January	January	NNP
cord-005453-4057qib7	7917	17	2015	2015	CD
cord-005453-4057qib7	7917	18	and	and	CC
cord-005453-4057qib7	7917	19	June	June	NNP
cord-005453-4057qib7	7917	20	2018	2018	CD
cord-005453-4057qib7	7917	21	.	.	.
cord-005453-4057qib7	7918	1	The	the	DT
cord-005453-4057qib7	7918	2	median	median	JJ
cord-005453-4057qib7	7918	3	age	age	NN
cord-005453-4057qib7	7918	4	was	be	VBD
cord-005453-4057qib7	7918	5	48	48	CD
cord-005453-4057qib7	7918	6	years	year	NNS
cord-005453-4057qib7	7919	1	(	(	-LRB-
cord-005453-4057qib7	7919	2	range	range	NNP
cord-005453-4057qib7	7919	3	17	17	CD
cord-005453-4057qib7	7919	4	-	-	SYM
cord-005453-4057qib7	7919	5	65	65	CD
cord-005453-4057qib7	7919	6	)	)	-RRB-
cord-005453-4057qib7	7919	7	.	.	.
cord-005453-4057qib7	7920	1	Acute	acute	JJ
cord-005453-4057qib7	7920	2	leukemia	leukemia	NN
cord-005453-4057qib7	7920	3	was	be	VBD
cord-005453-4057qib7	7920	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	7920	5	in	in	IN
cord-005453-4057qib7	7920	6	33	33	CD
cord-005453-4057qib7	7920	7	patients	patient	NNS
cord-005453-4057qib7	7920	8	(	(	-LRB-
cord-005453-4057qib7	7920	9	60	60	CD
cord-005453-4057qib7	7920	10	%	%	NN
cord-005453-4057qib7	7920	11	)	)	-RRB-
cord-005453-4057qib7	7920	12	.	.	.
cord-005453-4057qib7	7921	1	Complete	complete	JJ
cord-005453-4057qib7	7921	2	remission	remission	NN
cord-005453-4057qib7	7921	3	was	be	VBD
cord-005453-4057qib7	7921	4	documented	document	VBN
cord-005453-4057qib7	7921	5	in	in	IN
cord-005453-4057qib7	7921	6	63	63	CD
cord-005453-4057qib7	7921	7	%	%	NN
cord-005453-4057qib7	7921	8	of	of	IN
cord-005453-4057qib7	7921	9	patients	patient	NNS
cord-005453-4057qib7	7921	10	at	at	IN
cord-005453-4057qib7	7921	11	transplant	transplant	NN
cord-005453-4057qib7	7921	12	.	.	.
cord-005453-4057qib7	7922	1	Donor	donor	NN
cord-005453-4057qib7	7922	2	source	source	NN
cord-005453-4057qib7	7922	3	was	be	VBD
cord-005453-4057qib7	7922	4	from	from	IN
cord-005453-4057qib7	7922	5	HLA	HLA	NNP
cord-005453-4057qib7	7922	6	mismatched	mismatched	JJ
cord-005453-4057qib7	7922	7	donor	donor	NN
cord-005453-4057qib7	7922	8	in	in	IN
cord-005453-4057qib7	7922	9	53	53	CD
cord-005453-4057qib7	7922	10	%	%	NN
cord-005453-4057qib7	7922	11	and	and	CC
cord-005453-4057qib7	7922	12	from	from	IN
cord-005453-4057qib7	7922	13	unrelated	unrelated	JJ
cord-005453-4057qib7	7922	14	donor	donor	NN
cord-005453-4057qib7	7922	15	in	in	IN
cord-005453-4057qib7	7922	16	56	56	CD
cord-005453-4057qib7	7922	17	%	%	NN
cord-005453-4057qib7	7922	18	of	of	IN
cord-005453-4057qib7	7922	19	the	the	DT
cord-005453-4057qib7	7922	20	patients	patient	NNS
cord-005453-4057qib7	7922	21	.	.	.
cord-005453-4057qib7	7923	1	HBV	HBV	NNP
cord-005453-4057qib7	7923	2	positive	positive	JJ
cord-005453-4057qib7	7923	3	patients	patient	NNS
cord-005453-4057qib7	7923	4	were	be	VBD
cord-005453-4057qib7	7923	5	13	13	CD
cord-005453-4057qib7	7923	6	%	%	NN
cord-005453-4057qib7	7923	7	of	of	IN
cord-005453-4057qib7	7923	8	the	the	DT
cord-005453-4057qib7	7923	9	sample	sample	NN
cord-005453-4057qib7	7923	10	.	.	.
cord-005453-4057qib7	7924	1	Conditioning	conditioning	NN
cord-005453-4057qib7	7924	2	regimen	regimen	NN
cord-005453-4057qib7	7924	3	was	be	VBD
cord-005453-4057qib7	7924	4	busulfan	busulfan	NN
cord-005453-4057qib7	7924	5	based	base	VBN
cord-005453-4057qib7	7924	6	in	in	IN
cord-005453-4057qib7	7924	7	63	63	CD
cord-005453-4057qib7	7924	8	%	%	NN
cord-005453-4057qib7	7924	9	of	of	IN
cord-005453-4057qib7	7924	10	patients	patient	NNS
cord-005453-4057qib7	7924	11	.	.	.
cord-005453-4057qib7	7925	1	Ursodeoxycholic	ursodeoxycholic	JJ
cord-005453-4057qib7	7925	2	acid	acid	NN
cord-005453-4057qib7	7925	3	and	and	CC
cord-005453-4057qib7	7925	4	unfractionated	unfractionated	JJ
cord-005453-4057qib7	7925	5	heparin	heparin	NN
cord-005453-4057qib7	7925	6	were	be	VBD
cord-005453-4057qib7	7925	7	given	give	VBN
cord-005453-4057qib7	7925	8	to	to	IN
cord-005453-4057qib7	7925	9	all	all	DT
cord-005453-4057qib7	7925	10	patients	patient	NNS
cord-005453-4057qib7	7925	11	as	as	IN
cord-005453-4057qib7	7925	12	VOD	VOD	NNP
cord-005453-4057qib7	7925	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7925	14	.	.	.
cord-005453-4057qib7	7926	1	Cyclosporine	cyclosporine	NN
cord-005453-4057qib7	7926	2	was	be	VBD
cord-005453-4057qib7	7926	3	used	use	VBN
cord-005453-4057qib7	7926	4	as	as	IN
cord-005453-4057qib7	7926	5	GvHD	GvHD	NNP
cord-005453-4057qib7	7926	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7926	7	.	.	.
cord-005453-4057qib7	7927	1	lymphocytic	lymphocytic	NNP
cord-005453-4057qib7	7927	2	subpopulation	subpopulation	NNP
cord-005453-4057qib7	7927	3	analysis	analysis	NN
cord-005453-4057qib7	7927	4	(	(	-LRB-
cord-005453-4057qib7	7927	5	CD3	CD3	NNP
cord-005453-4057qib7	7927	6	+	+	CC
cord-005453-4057qib7	7927	7	,	,	,
cord-005453-4057qib7	7927	8	CD4	CD4	NNP
cord-005453-4057qib7	7927	9	+	+	CC
cord-005453-4057qib7	7927	10	,	,	,
cord-005453-4057qib7	7927	11	CD8	CD8	NNP
cord-005453-4057qib7	7927	12	+	+	CC
cord-005453-4057qib7	7928	1	and	and	CC
cord-005453-4057qib7	7928	2	CD16+/CD56	cd16+/cd56	NN
cord-005453-4057qib7	7929	1	+	+	LS
cord-005453-4057qib7	7929	2	)	)	-RRB-
cord-005453-4057qib7	7929	3	and	and	CC
cord-005453-4057qib7	7929	4	CD34	CD34	NNP
cord-005453-4057qib7	7929	5	+	+	CC
cord-005453-4057qib7	7929	6	cells	cell	NNS
cord-005453-4057qib7	7929	7	count	count	VBP
cord-005453-4057qib7	7929	8	on	on	IN
cord-005453-4057qib7	7929	9	the	the	DT
cord-005453-4057qib7	7929	10	donor	donor	NN
cord-005453-4057qib7	7929	11	graft	graft	NN
cord-005453-4057qib7	7929	12	were	be	VBD
cord-005453-4057qib7	7929	13	performed	perform	VBN
cord-005453-4057qib7	7929	14	using	use	VBG
cord-005453-4057qib7	7929	15	BD	BD	NNP
cord-005453-4057qib7	7929	16	Facs	Facs	NNP
cord-005453-4057qib7	7929	17	Cantoll	Cantoll	NNP
cord-005453-4057qib7	7929	18	.	.	.
cord-005453-4057qib7	7930	1	All	all	DT
cord-005453-4057qib7	7930	2	patients	patient	NNS
cord-005453-4057qib7	7930	3	had	have	VBD
cord-005453-4057qib7	7930	4	routine	routine	JJ
cord-005453-4057qib7	7930	5	monitoring	monitoring	NN
cord-005453-4057qib7	7930	6	for	for	IN
cord-005453-4057qib7	7930	7	EBV	EBV	NNP
cord-005453-4057qib7	7930	8	and	and	CC
cord-005453-4057qib7	7930	9	CMV	CMV	NNP
cord-005453-4057qib7	7930	10	PCR	PCR	NNP
cord-005453-4057qib7	7930	11	,	,	,
cord-005453-4057qib7	7930	12	hemolysis	hemolysis	NN
cord-005453-4057qib7	7930	13	tests	test	NNS
cord-005453-4057qib7	7930	14	,	,	,
cord-005453-4057qib7	7930	15	creatinine	creatinine	NN
cord-005453-4057qib7	7930	16	and	and	CC
cord-005453-4057qib7	7930	17	electrolyte	electrolyte	JJ
cord-005453-4057qib7	7930	18	panels	panel	NNS
cord-005453-4057qib7	7930	19	,	,	,
cord-005453-4057qib7	7930	20	proteinuria	proteinuria	NN
cord-005453-4057qib7	7930	21	,	,	,
cord-005453-4057qib7	7930	22	complete	complete	JJ
cord-005453-4057qib7	7930	23	blood	blood	NN
cord-005453-4057qib7	7930	24	count	count	NN
cord-005453-4057qib7	7930	25	,	,	,
cord-005453-4057qib7	7930	26	blood	blood	NN
cord-005453-4057qib7	7930	27	pressure	pressure	NN
cord-005453-4057qib7	7930	28	and	and	CC
cord-005453-4057qib7	7930	29	Schistocytes	Schistocytes	NNPS
cord-005453-4057qib7	7930	30	by	by	IN
cord-005453-4057qib7	7930	31	direct	direct	JJ
cord-005453-4057qib7	7930	32	examination	examination	NN
cord-005453-4057qib7	7930	33	until	until	IN
cord-005453-4057qib7	7930	34	day	day	NN
cord-005453-4057qib7	7930	35	+100	+100	NNS
cord-005453-4057qib7	7930	36	.	.	.
cord-005453-4057qib7	7931	1	The	the	DT
cord-005453-4057qib7	7931	2	Fisher	Fisher	NNP
cord-005453-4057qib7	7931	3	's	's	POS
cord-005453-4057qib7	7931	4	exact	exact	JJ
cord-005453-4057qib7	7931	5	test	test	NN
cord-005453-4057qib7	7931	6	was	be	VBD
cord-005453-4057qib7	7931	7	used	use	VBN
cord-005453-4057qib7	7931	8	to	to	TO
cord-005453-4057qib7	7931	9	compare	compare	VB
cord-005453-4057qib7	7931	10	categorical	categorical	JJ
cord-005453-4057qib7	7931	11	variables	variable	NNS
cord-005453-4057qib7	7931	12	,	,	,
cord-005453-4057qib7	7931	13	while	while	IN
cord-005453-4057qib7	7931	14	continuous	continuous	JJ
cord-005453-4057qib7	7931	15	variables	variable	NNS
cord-005453-4057qib7	7931	16	were	be	VBD
cord-005453-4057qib7	7931	17	analyzed	analyze	VBN
cord-005453-4057qib7	7931	18	with	with	IN
cord-005453-4057qib7	7931	19	Anova	Anova	NNP
cord-005453-4057qib7	7931	20	test	test	NN
cord-005453-4057qib7	7931	21	.	.	.
cord-005453-4057qib7	7932	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	7932	2	of	of	IN
cord-005453-4057qib7	7932	3	VOD	VOD	NNP
cord-005453-4057qib7	7932	4	and	and	CC
cord-005453-4057qib7	7932	5	TA	TA	NNP
cord-005453-4057qib7	7932	6	-	-	HYPH
cord-005453-4057qib7	7932	7	TMA	TMA	NNP
cord-005453-4057qib7	7932	8	were	be	VBD
cord-005453-4057qib7	7932	9	carried	carry	VBN
cord-005453-4057qib7	7932	10	out	out	RP
cord-005453-4057qib7	7932	11	by	by	IN
cord-005453-4057qib7	7932	12	using	use	VBG
cord-005453-4057qib7	7932	13	EBMT	EBMT	NNP
cord-005453-4057qib7	7932	14	and	and	CC
cord-005453-4057qib7	7932	15	Cho	Cho	NNP
cord-005453-4057qib7	7932	16	criteria	criterion	NNS
cord-005453-4057qib7	7932	17	respectively	respectively	RB
cord-005453-4057qib7	7932	18	.	.	.
cord-005453-4057qib7	7933	1	Results	result	NNS
cord-005453-4057qib7	7933	2	:	:	:
cord-005453-4057qib7	7934	1	The	the	DT
cord-005453-4057qib7	7934	2	incidence	incidence	NN
cord-005453-4057qib7	7934	3	of	of	IN
cord-005453-4057qib7	7934	4	very	very	RB
cord-005453-4057qib7	7934	5	severe	severe	JJ
cord-005453-4057qib7	7934	6	VOD	vod	NN
cord-005453-4057qib7	7934	7	and	and	CC
cord-005453-4057qib7	7934	8	TMA	TMA	NNP
cord-005453-4057qib7	7934	9	was	be	VBD
cord-005453-4057qib7	7934	10	13	13	CD
cord-005453-4057qib7	7934	11	%	%	NN
cord-005453-4057qib7	7934	12	(	(	-LRB-
cord-005453-4057qib7	7934	13	7/55	7/55	CD
cord-005453-4057qib7	7934	14	)	)	-RRB-
cord-005453-4057qib7	7934	15	and	and	CC
cord-005453-4057qib7	7934	16	14,5	14,5	CD
cord-005453-4057qib7	7934	17	%	%	NN
cord-005453-4057qib7	7934	18	(	(	-LRB-
cord-005453-4057qib7	7934	19	8/55	8/55	CD
cord-005453-4057qib7	7934	20	)	)	-RRB-
cord-005453-4057qib7	7934	21	respectively	respectively	RB
cord-005453-4057qib7	7934	22	.	.	.
cord-005453-4057qib7	7935	1	CMV	CMV	NNP
cord-005453-4057qib7	7935	2	reactivations	reactivation	NNS
cord-005453-4057qib7	7935	3	with	with	IN
cord-005453-4057qib7	7935	4	viral	viral	JJ
cord-005453-4057qib7	7935	5	load	load	NN
cord-005453-4057qib7	7935	6	over	over	IN
cord-005453-4057qib7	7935	7	30.000	30.000	CD
cord-005453-4057qib7	7935	8	cv/	cv/	NNP
cord-005453-4057qib7	7935	9	ml	ml	NN
cord-005453-4057qib7	7935	10	was	be	VBD
cord-005453-4057qib7	7935	11	27	27	CD
cord-005453-4057qib7	7935	12	%	%	NN
cord-005453-4057qib7	7935	13	and	and	CC
cord-005453-4057qib7	7935	14	5	5	CD
cord-005453-4057qib7	7935	15	%	%	NN
cord-005453-4057qib7	7935	16	in	in	IN
cord-005453-4057qib7	7935	17	patients	patient	NNS
cord-005453-4057qib7	7935	18	with	with	IN
cord-005453-4057qib7	7935	19	and	and	CC
cord-005453-4057qib7	7935	20	without	without	IN
cord-005453-4057qib7	7935	21	EC	EC	NNP
cord-005453-4057qib7	7935	22	,	,	,
cord-005453-4057qib7	7935	23	respectively	respectively	RB
cord-005453-4057qib7	7935	24	(	(	-LRB-
cord-005453-4057qib7	7935	25	p	p	NN
cord-005453-4057qib7	7935	26	0,041	0,041	CD
cord-005453-4057qib7	7935	27	;	;	.
cord-005453-4057qib7	7936	1	HR	HR	NNP
cord-005453-4057qib7	7936	2	2,97	2,97	CD
cord-005453-4057qib7	7936	3	p0,0055	p0,0055	NNP
cord-005453-4057qib7	7937	1	95%CI	95%ci	CD
cord-005453-4057qib7	7937	2	1,38	1,38	CD
cord-005453-4057qib7	7937	3	-	-	HYPH
cord-005453-4057qib7	7937	4	6,4	6,4	CD
cord-005453-4057qib7	7937	5	)	)	-RRB-
cord-005453-4057qib7	7937	6	.	.	.
cord-005453-4057qib7	7938	1	The	the	DT
cord-005453-4057qib7	7938	2	median	median	JJ
cord-005453-4057qib7	7938	3	day	day	NN
cord-005453-4057qib7	7938	4	to	to	IN
cord-005453-4057qib7	7938	5	neutrophils	neutrophil	NNS
cord-005453-4057qib7	7938	6	(	(	-LRB-
cord-005453-4057qib7	7938	7	Ns	Ns	NNP
cord-005453-4057qib7	7938	8	)	)	-RRB-
cord-005453-4057qib7	7938	9	engraftment	engraftment	NNP
cord-005453-4057qib7	7938	10	(	(	-LRB-
cord-005453-4057qib7	7938	11	500	500	CD
cord-005453-4057qib7	7938	12	/	/	SYM
cord-005453-4057qib7	7938	13	ml	ml	NN
cord-005453-4057qib7	7938	14	and	and	CC
cord-005453-4057qib7	7938	15	1000	1000	CD
cord-005453-4057qib7	7938	16	/	/	SYM
cord-005453-4057qib7	7938	17	ml	ml	NN
cord-005453-4057qib7	7938	18	)	)	-RRB-
cord-005453-4057qib7	7938	19	was	be	VBD
cord-005453-4057qib7	7938	20	14	14	CD
cord-005453-4057qib7	7938	21	vs	vs	IN
cord-005453-4057qib7	7938	22	17	17	CD
cord-005453-4057qib7	7938	23	and	and	CC
cord-005453-4057qib7	7938	24	14,5	14,5	CD
cord-005453-4057qib7	7938	25	vs	vs	IN
cord-005453-4057qib7	7938	26	18	18	CD
cord-005453-4057qib7	7938	27	in	in	IN
cord-005453-4057qib7	7938	28	VOD	VOD	NNP
cord-005453-4057qib7	7938	29	/	/	SYM
cord-005453-4057qib7	7938	30	TMA	TMA	NNP
cord-005453-4057qib7	7938	31	group	group	NN
cord-005453-4057qib7	7938	32	vs	vs	IN
cord-005453-4057qib7	7938	33	control	control	NNP
cord-005453-4057qib7	7938	34	group	group	NNP
cord-005453-4057qib7	7938	35	(	(	-LRB-
cord-005453-4057qib7	7938	36	p0,03	p0,03	NNP
cord-005453-4057qib7	7938	37	and	and	CC
cord-005453-4057qib7	7938	38	0,027	0,027	CD
cord-005453-4057qib7	7938	39	,	,	,
cord-005453-4057qib7	7938	40	respectively	respectively	RB
cord-005453-4057qib7	7938	41	)	)	-RRB-
cord-005453-4057qib7	7938	42	.	.	.
cord-005453-4057qib7	7939	1	More	more	RBR
cord-005453-4057qib7	7939	2	rapid	rapid	JJ
cord-005453-4057qib7	7939	3	neutrophils	neutrophil	NNS
cord-005453-4057qib7	7939	4	engraftment	engraftment	NN
cord-005453-4057qib7	7939	5	(	(	-LRB-
cord-005453-4057qib7	7940	1	Ns	Ns	NNP
cord-005453-4057qib7	7940	2	>	>	XX
cord-005453-4057qib7	7941	1	500	500	CD
cord-005453-4057qib7	7941	2	/	/	SYM
cord-005453-4057qib7	7941	3	ml	ml	NN
cord-005453-4057qib7	7941	4	and	and	CC
cord-005453-4057qib7	7941	5	Ns>1000	Ns>1000	NNP
cord-005453-4057qib7	7941	6	/	/	SYM
cord-005453-4057qib7	7941	7	ml	ml	NN
cord-005453-4057qib7	7942	1	within	within	IN
cord-005453-4057qib7	7942	2	13	13	CD
cord-005453-4057qib7	7942	3	days	day	NNS
cord-005453-4057qib7	7942	4	)	)	-RRB-
cord-005453-4057qib7	7942	5	was	be	VBD
cord-005453-4057qib7	7942	6	related	relate	VBN
cord-005453-4057qib7	7942	7	to	to	IN
cord-005453-4057qib7	7942	8	a	a	DT
cord-005453-4057qib7	7942	9	higher	high	JJR
cord-005453-4057qib7	7942	10	risk	risk	NN
cord-005453-4057qib7	7942	11	of	of	IN
cord-005453-4057qib7	7942	12	EC	EC	NNP
cord-005453-4057qib7	7942	13	with	with	IN
cord-005453-4057qib7	7942	14	a	a	DT
cord-005453-4057qib7	7942	15	HR	hr	NN
cord-005453-4057qib7	7942	16	of	of	IN
cord-005453-4057qib7	7942	17	2,67	2,67	CD
cord-005453-4057qib7	7943	1	(	(	-LRB-
cord-005453-4057qib7	7943	2	p	p	NN
cord-005453-4057qib7	7943	3	0,015	0,015	CD
cord-005453-4057qib7	7943	4	;	;	:
cord-005453-4057qib7	7943	5	95%CI	95%ci	CD
cord-005453-4057qib7	7943	6	1,2	1,2	CD
cord-005453-4057qib7	7943	7	-	-	SYM
cord-005453-4057qib7	7943	8	5,9	5,9	CD
cord-005453-4057qib7	7943	9	)	)	-RRB-
cord-005453-4057qib7	7943	10	and	and	CC
cord-005453-4057qib7	7943	11	2,94	2,94	CD
cord-005453-4057qib7	7944	1	(	(	-LRB-
cord-005453-4057qib7	7944	2	p	p	NN
cord-005453-4057qib7	7944	3	0,006	0,006	CD
cord-005453-4057qib7	7944	4	;	;	:
cord-005453-4057qib7	7944	5	95	95	CD
cord-005453-4057qib7	7944	6	%	%	NN
cord-005453-4057qib7	7944	7	CI	CI	NNP
cord-005453-4057qib7	7944	8	1,4	1,4	CD
cord-005453-4057qib7	7944	9	-	-	HYPH
cord-005453-4057qib7	7944	10	6,3	6,3	CD
cord-005453-4057qib7	7944	11	)	)	-RRB-
cord-005453-4057qib7	7944	12	.	.	.
cord-005453-4057qib7	7945	1	Patients	patient	NNS
cord-005453-4057qib7	7945	2	with	with	IN
cord-005453-4057qib7	7945	3	EC	EC	NNP
cord-005453-4057qib7	7945	4	received	receive	VBD
cord-005453-4057qib7	7945	5	a	a	DT
cord-005453-4057qib7	7945	6	donor	donor	NN
cord-005453-4057qib7	7945	7	graft	graft	NN
cord-005453-4057qib7	7945	8	with	with	IN
cord-005453-4057qib7	7945	9	a	a	DT
cord-005453-4057qib7	7945	10	higher	high	JJR
cord-005453-4057qib7	7945	11	median	median	JJ
cord-005453-4057qib7	7945	12	numbers	number	NNS
cord-005453-4057qib7	7945	13	(	(	-LRB-
cord-005453-4057qib7	7945	14	x10e6	x10e6	NNP
cord-005453-4057qib7	7945	15	/	/	SYM
cord-005453-4057qib7	7945	16	Kg	Kg	NNP
cord-005453-4057qib7	7945	17	)	)	-RRB-
cord-005453-4057qib7	7945	18	of	of	IN
cord-005453-4057qib7	7945	19	CD3	CD3	NNP
cord-005453-4057qib7	7945	20	+	+	CC
cord-005453-4057qib7	7946	1	and	and	CC
cord-005453-4057qib7	7946	2	CD8	CD8	NNP
cord-005453-4057qib7	7946	3	+	+	CC
cord-005453-4057qib7	7946	4	(	(	-LRB-
cord-005453-4057qib7	7946	5	p>0,05	p>0,05	NNP
cord-005453-4057qib7	7946	6	)	)	-RRB-
cord-005453-4057qib7	7946	7	and	and	CC
cord-005453-4057qib7	7946	8	a	a	DT
cord-005453-4057qib7	7946	9	lower	low	JJR
cord-005453-4057qib7	7946	10	numbers	number	NNS
cord-005453-4057qib7	7946	11	(	(	-LRB-
cord-005453-4057qib7	7946	12	x10e6	x10e6	NNP
cord-005453-4057qib7	7946	13	/	/	SYM
cord-005453-4057qib7	7946	14	Kg	Kg	NNP
cord-005453-4057qib7	7946	15	)	)	-RRB-
cord-005453-4057qib7	7946	16	of	of	IN
cord-005453-4057qib7	7946	17	NK	NK	NNP
cord-005453-4057qib7	7946	18	cells	cell	NNS
cord-005453-4057qib7	7946	19	(	(	-LRB-
cord-005453-4057qib7	7946	20	p>0,05	p>0,05	NNP
cord-005453-4057qib7	7946	21	)	)	-RRB-
cord-005453-4057qib7	7946	22	.	.	.
cord-005453-4057qib7	7947	1	Patients	patient	NNS
cord-005453-4057qib7	7947	2	who	who	WP
cord-005453-4057qib7	7947	3	received	receive	VBD
cord-005453-4057qib7	7947	4	a	a	DT
cord-005453-4057qib7	7947	5	CD8	CD8	NNP
cord-005453-4057qib7	7947	6	+	+	SYM
cord-005453-4057qib7	7947	7	cells	cell	NNS
cord-005453-4057qib7	7947	8	count	count	VBP
cord-005453-4057qib7	7948	1	>	>	XX
cord-005453-4057qib7	7948	2	12x10e6	12x10e6	CD
cord-005453-4057qib7	7948	3	/	/	SYM
cord-005453-4057qib7	7948	4	Kg	Kg	NNP
cord-005453-4057qib7	7948	5	and	and	CC
cord-005453-4057qib7	7948	6	NK	NK	NNP
cord-005453-4057qib7	7948	7	cells	cell	NNS
cord-005453-4057qib7	7948	8	count	count	VBP
cord-005453-4057qib7	7949	1	<	<	XX
cord-005453-4057qib7	7949	2	2,5x10e6	2,5x10e6	CD
cord-005453-4057qib7	7949	3	/	/	SYM
cord-005453-4057qib7	7949	4	Kg	Kg	NNP
cord-005453-4057qib7	7949	5	presented	present	VBD
cord-005453-4057qib7	7949	6	a	a	DT
cord-005453-4057qib7	7949	7	Relative	Relative	NNP
cord-005453-4057qib7	7949	8	Risk	risk	NN
cord-005453-4057qib7	7949	9	of	of	IN
cord-005453-4057qib7	7949	10	EC	EC	NNP
cord-005453-4057qib7	7949	11	of	of	IN
cord-005453-4057qib7	7949	12	2,37	2,37	CD
cord-005453-4057qib7	7950	1	(	(	-LRB-
cord-005453-4057qib7	7950	2	p	p	NN
cord-005453-4057qib7	7950	3	0,036	0,036	CD
cord-005453-4057qib7	7950	4	;	;	:
cord-005453-4057qib7	7950	5	95	95	CD
cord-005453-4057qib7	7950	6	%	%	NN
cord-005453-4057qib7	7950	7	CI	CI	NNP
cord-005453-4057qib7	7950	8	1,06	1,06	CD
cord-005453-4057qib7	7950	9	-	-	HYPH
cord-005453-4057qib7	7950	10	5,3	5,3	CD
cord-005453-4057qib7	7950	11	)	)	-RRB-
cord-005453-4057qib7	7950	12	and	and	CC
cord-005453-4057qib7	7950	13	2,35	2,35	CD
cord-005453-4057qib7	7950	14	(	(	-LRB-
cord-005453-4057qib7	7950	15	p	p	NN
cord-005453-4057qib7	7950	16	0,004	0,004	CD
cord-005453-4057qib7	7950	17	;	;	:
cord-005453-4057qib7	7950	18	95	95	CD
cord-005453-4057qib7	7950	19	%	%	NN
cord-005453-4057qib7	7950	20	CI	CI	NNP
cord-005453-4057qib7	7950	21	1,02	1,02	CD
cord-005453-4057qib7	7950	22	-	-	HYPH
cord-005453-4057qib7	7950	23	5,4	5,4	CD
cord-005453-4057qib7	7950	24	)	)	-RRB-
cord-005453-4057qib7	7950	25	,	,	,
cord-005453-4057qib7	7950	26	respectively	respectively	RB
cord-005453-4057qib7	7950	27	.	.	.
cord-005453-4057qib7	7951	1	There	there	EX
cord-005453-4057qib7	7951	2	were	be	VBD
cord-005453-4057qib7	7951	3	no	no	DT
cord-005453-4057qib7	7951	4	differences	difference	NNS
cord-005453-4057qib7	7951	5	with	with	IN
cord-005453-4057qib7	7951	6	respect	respect	NN
cord-005453-4057qib7	7951	7	to	to	IN
cord-005453-4057qib7	7951	8	the	the	DT
cord-005453-4057qib7	7951	9	other	other	JJ
cord-005453-4057qib7	7951	10	analyzed	analyze	VBN
cord-005453-4057qib7	7951	11	variables	variable	NNS
cord-005453-4057qib7	7951	12	between	between	IN
cord-005453-4057qib7	7951	13	patients	patient	NNS
cord-005453-4057qib7	7951	14	who	who	WP
cord-005453-4057qib7	7951	15	developed	develop	VBD
cord-005453-4057qib7	7951	16	VOD	VOD	NNP
cord-005453-4057qib7	7951	17	/	/	SYM
cord-005453-4057qib7	7951	18	TMA	TMA	NNP
cord-005453-4057qib7	7951	19	compared	compare	VBN
cord-005453-4057qib7	7951	20	with	with	IN
cord-005453-4057qib7	7951	21	those	those	DT
cord-005453-4057qib7	7951	22	who	who	WP
cord-005453-4057qib7	7951	23	did	do	VBD
cord-005453-4057qib7	7951	24	not	not	RB
cord-005453-4057qib7	7951	25	.	.	.
cord-005453-4057qib7	7952	1	(	(	-LRB-
cord-005453-4057qib7	7952	2	Pic_01	Pic_01	NNP
cord-005453-4057qib7	7952	3	)	)	-RRB-
cord-005453-4057qib7	7952	4	Conclusions	conclusion	NNS
cord-005453-4057qib7	7952	5	:	:	:
cord-005453-4057qib7	7952	6	CMV	CMV	NNP
cord-005453-4057qib7	7952	7	viremia	viremia	NN
cord-005453-4057qib7	7952	8	,	,	,
cord-005453-4057qib7	7952	9	early	early	JJ
cord-005453-4057qib7	7952	10	neutrophils	neutrophil	NNS
cord-005453-4057qib7	7952	11	engraftment	engraftment	NN
cord-005453-4057qib7	7952	12	and	and	CC
cord-005453-4057qib7	7952	13	donor	donor	NN
cord-005453-4057qib7	7952	14	NK	NK	NNP
cord-005453-4057qib7	7952	15	and	and	CC
cord-005453-4057qib7	7952	16	CD8	CD8	NNP
cord-005453-4057qib7	7953	1	+	+	CC
cord-005453-4057qib7	7953	2	cells	cell	NNS
cord-005453-4057qib7	7953	3	infused	infuse	VBN
cord-005453-4057qib7	7953	4	are	be	VBP
cord-005453-4057qib7	7953	5	associated	associate	VBN
cord-005453-4057qib7	7953	6	with	with	IN
cord-005453-4057qib7	7953	7	the	the	DT
cord-005453-4057qib7	7953	8	risk	risk	NN
cord-005453-4057qib7	7953	9	of	of	IN
cord-005453-4057qib7	7953	10	VOD	VOD	NNP
cord-005453-4057qib7	7953	11	and	and	CC
cord-005453-4057qib7	7953	12	TMA	TMA	NNP
cord-005453-4057qib7	7953	13	.	.	.
cord-005453-4057qib7	7954	1	Very	very	RB
cord-005453-4057qib7	7954	2	few	few	JJ
cord-005453-4057qib7	7954	3	studies	study	NNS
cord-005453-4057qib7	7954	4	evaluated	evaluate	VBD
cord-005453-4057qib7	7954	5	the	the	DT
cord-005453-4057qib7	7954	6	link	link	NN
cord-005453-4057qib7	7954	7	between	between	IN
cord-005453-4057qib7	7954	8	these	these	DT
cord-005453-4057qib7	7954	9	variables	variable	NNS
cord-005453-4057qib7	7954	10	and	and	CC
cord-005453-4057qib7	7954	11	the	the	DT
cord-005453-4057qib7	7954	12	risk	risk	NN
cord-005453-4057qib7	7954	13	of	of	IN
cord-005453-4057qib7	7954	14	developing	develop	VBG
cord-005453-4057qib7	7954	15	such	such	JJ
cord-005453-4057qib7	7954	16	two	two	CD
cord-005453-4057qib7	7954	17	complications	complication	NNS
cord-005453-4057qib7	7954	18	.	.	.
cord-005453-4057qib7	7955	1	It	-PRON-	PRP
cord-005453-4057qib7	7955	2	could	could	MD
cord-005453-4057qib7	7955	3	be	be	VB
cord-005453-4057qib7	7955	4	interesting	interesting	JJ
cord-005453-4057qib7	7955	5	to	to	TO
cord-005453-4057qib7	7955	6	investigate	investigate	VB
cord-005453-4057qib7	7955	7	these	these	DT
cord-005453-4057qib7	7955	8	relationships	relationship	NNS
cord-005453-4057qib7	7955	9	on	on	IN
cord-005453-4057qib7	7955	10	larger	large	JJR
cord-005453-4057qib7	7955	11	series	series	NN
cord-005453-4057qib7	7955	12	.	.	.
cord-005453-4057qib7	7956	1	Clinical	clinical	JJ
cord-005453-4057qib7	7956	2	Trial	Trial	NNP
cord-005453-4057qib7	7956	3	Registry	Registry	NNP
cord-005453-4057qib7	7956	4	:	:	:
cord-005453-4057qib7	7957	1	Not	not	RB
cord-005453-4057qib7	7957	2	applicable	applicable	JJ
cord-005453-4057qib7	7957	3	Disclosure	disclosure	NN
cord-005453-4057qib7	7957	4	:	:	:
cord-005453-4057qib7	7957	5	Nothing	nothing	NN
cord-005453-4057qib7	7957	6	to	to	TO
cord-005453-4057qib7	7957	7	declare	declare	VB
cord-005453-4057qib7	7957	8	P358	P358	NNS
cord-005453-4057qib7	7958	1	When	when	WRB
cord-005453-4057qib7	7958	2	the	the	DT
cord-005453-4057qib7	7958	3	last	last	JJ
cord-005453-4057qib7	7958	4	hope	hope	NN
cord-005453-4057qib7	7958	5	turns	turn	VBZ
cord-005453-4057qib7	7958	6	out	out	RP
cord-005453-4057qib7	7958	7	to	to	TO
cord-005453-4057qib7	7958	8	be	be	VB
cord-005453-4057qib7	7958	9	just	just	RB
cord-005453-4057qib7	7958	10	as	as	RB
cord-005453-4057qib7	7958	11	good	good	JJ
cord-005453-4057qib7	7958	12	as	as	IN
cord-005453-4057qib7	7958	13	best	best	RB
cord-005453-4057qib7	7958	14	:	:	:
cord-005453-4057qib7	7958	15	haploSCT	haploSCT	NNP
cord-005453-4057qib7	7958	16	following	follow	VBG
cord-005453-4057qib7	7958	17	TBF	tbf	NN
cord-005453-4057qib7	7958	18	conditioning	conditioning	NN
cord-005453-4057qib7	7958	19	,	,	,
cord-005453-4057qib7	7958	20	PT	PT	NNP
cord-005453-4057qib7	7958	21	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7958	22	and	and	CC
cord-005453-4057qib7	7958	23	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	7958	24	as	as	IN
cord-005453-4057qib7	7958	25	GVHD	GVHD	NNP
cord-005453-4057qib7	7958	26	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7958	27	Background	background	NN
cord-005453-4057qib7	7958	28	:	:	:
cord-005453-4057qib7	7959	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	7959	2	stem	stem	NN
cord-005453-4057qib7	7959	3	cell	cell	NN
cord-005453-4057qib7	7959	4	transplantation	transplantation	NN
cord-005453-4057qib7	7959	5	is	be	VBZ
cord-005453-4057qib7	7959	6	an	an	DT
cord-005453-4057qib7	7959	7	effective	effective	JJ
cord-005453-4057qib7	7959	8	therapy	therapy	NN
cord-005453-4057qib7	7959	9	for	for	IN
cord-005453-4057qib7	7959	10	a	a	DT
cord-005453-4057qib7	7959	11	variety	variety	NN
cord-005453-4057qib7	7959	12	of	of	IN
cord-005453-4057qib7	7959	13	severe	severe	JJ
cord-005453-4057qib7	7959	14	hematological	hematological	JJ
cord-005453-4057qib7	7959	15	diseases	disease	NNS
cord-005453-4057qib7	7959	16	.	.	.
cord-005453-4057qib7	7960	1	In	in	IN
cord-005453-4057qib7	7960	2	last	last	JJ
cord-005453-4057qib7	7960	3	decades	decade	NNS
cord-005453-4057qib7	7960	4	,	,	,
cord-005453-4057qib7	7960	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	7960	6	SCT	SCT	NNP
cord-005453-4057qib7	7960	7	(	(	-LRB-
cord-005453-4057qib7	7960	8	haploSCT	haploSCT	NNP
cord-005453-4057qib7	7960	9	)	)	-RRB-
cord-005453-4057qib7	7960	10	followed	follow	VBN
cord-005453-4057qib7	7960	11	by	by	IN
cord-005453-4057qib7	7960	12	PTCy	PTCy	NNS
cord-005453-4057qib7	7960	13	as	as	IN
cord-005453-4057qib7	7960	14	GvHD	GvHD	NNP
cord-005453-4057qib7	7960	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7960	16	has	have	VBZ
cord-005453-4057qib7	7960	17	been	be	VBN
cord-005453-4057qib7	7960	18	reported	report	VBN
cord-005453-4057qib7	7960	19	as	as	IN
cord-005453-4057qib7	7960	20	a	a	DT
cord-005453-4057qib7	7960	21	valid	valid	JJ
cord-005453-4057qib7	7960	22	alternative	alternative	NN
cord-005453-4057qib7	7960	23	for	for	IN
cord-005453-4057qib7	7960	24	patients	patient	NNS
cord-005453-4057qib7	7960	25	who	who	WP
cord-005453-4057qib7	7960	26	lack	lack	VBP
cord-005453-4057qib7	7960	27	an	an	DT
cord-005453-4057qib7	7960	28	HLA	HLA	NNP
cord-005453-4057qib7	7960	29	matched	match	VBN
cord-005453-4057qib7	7960	30	donor	donor	NN
cord-005453-4057qib7	7960	31	.	.	.
cord-005453-4057qib7	7961	1	We	-PRON-	PRP
cord-005453-4057qib7	7961	2	therefore	therefore	RB
cord-005453-4057qib7	7961	3	analysed	analyse	VBD
cord-005453-4057qib7	7961	4	outcomes	outcome	NNS
cord-005453-4057qib7	7961	5	with	with	IN
cord-005453-4057qib7	7961	6	this	this	DT
cord-005453-4057qib7	7961	7	.	.	.
cord-005453-4057qib7	7962	1	Methods	method	NNS
cord-005453-4057qib7	7962	2	:	:	:
cord-005453-4057qib7	7962	3	38	38	CD
cord-005453-4057qib7	7962	4	patients	patient	NNS
cord-005453-4057qib7	7962	5	without	without	IN
cord-005453-4057qib7	7962	6	HLA	HLA	NNP
cord-005453-4057qib7	7962	7	-	-	HYPH
cord-005453-4057qib7	7962	8	matched	match	VBN
cord-005453-4057qib7	7962	9	donor	donor	NN
cord-005453-4057qib7	7962	10	received	receive	VBD
cord-005453-4057qib7	7962	11	a	a	DT
cord-005453-4057qib7	7962	12	haploSCT	haplosct	NN
cord-005453-4057qib7	7962	13	between	between	IN
cord-005453-4057qib7	7962	14	04/13	04/13	CD
cord-005453-4057qib7	7962	15	and	and	CC
cord-005453-4057qib7	7962	16	08/18	08/18	CD
cord-005453-4057qib7	7962	17	.	.	.
cord-005453-4057qib7	7963	1	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	7963	2	5	5	CD
cord-005453-4057qib7	7963	3	mg	mg	NNP
cord-005453-4057qib7	7963	4	/	/	SYM
cord-005453-4057qib7	7963	5	kg	kg	NN
cord-005453-4057qib7	7963	6	(	(	-LRB-
cord-005453-4057qib7	7963	7	2	2	CD
cord-005453-4057qib7	7963	8	days	day	NNS
cord-005453-4057qib7	7963	9	)	)	-RRB-
cord-005453-4057qib7	7963	10	,	,	,
cord-005453-4057qib7	7963	11	fludarabine	fludarabine	VBP
cord-005453-4057qib7	7963	12	50	50	CD
cord-005453-4057qib7	7963	13	mg	mg	NNP
cord-005453-4057qib7	7963	14	/	/	SYM
cord-005453-4057qib7	7963	15	m2	m2	NNP
cord-005453-4057qib7	7963	16	(	(	-LRB-
cord-005453-4057qib7	7963	17	3	3	CD
cord-005453-4057qib7	7963	18	days	day	NNS
cord-005453-4057qib7	7963	19	)	)	-RRB-
cord-005453-4057qib7	7963	20	and	and	CC
cord-005453-4057qib7	7963	21	oral	oral	JJ
cord-005453-4057qib7	7963	22	busulfan	busulfan	NN
cord-005453-4057qib7	7964	1	1	1	CD
cord-005453-4057qib7	7964	2	mg	mg	NNP
cord-005453-4057qib7	7964	3	/	/	SYM
cord-005453-4057qib7	7964	4	kg/6	kg/6	NNP
cord-005453-4057qib7	7964	5	h	h	NNP
cord-005453-4057qib7	7964	6	(	(	-LRB-
cord-005453-4057qib7	7964	7	3	3	CD
cord-005453-4057qib7	7964	8	days	day	NNS
cord-005453-4057qib7	7964	9	,	,	,
cord-005453-4057qib7	7964	10	with	with	IN
cord-005453-4057qib7	7964	11	PKD	PKD	NNP
cord-005453-4057qib7	7964	12	dose	dose	NN
cord-005453-4057qib7	7964	13	adjustments	adjustment	NNS
cord-005453-4057qib7	7964	14	)	)	-RRB-
cord-005453-4057qib7	7964	15	was	be	VBD
cord-005453-4057qib7	7964	16	used	use	VBN
cord-005453-4057qib7	7964	17	as	as	IN
cord-005453-4057qib7	7964	18	conditioning	conditioning	NN
cord-005453-4057qib7	7964	19	regiment	regiment	NN
cord-005453-4057qib7	7964	20	;	;	:
cord-005453-4057qib7	7964	21	in	in	IN
cord-005453-4057qib7	7964	22	patients	patient	NNS
cord-005453-4057qib7	7964	23	>	>	XX
cord-005453-4057qib7	7964	24	55	55	CD
cord-005453-4057qib7	7964	25	years	year	NNS
cord-005453-4057qib7	7964	26	busulfan	busulfan	NNP
cord-005453-4057qib7	7964	27	administration	administration	NNP
cord-005453-4057qib7	7964	28	was	be	VBD
cord-005453-4057qib7	7964	29	limited	limit	VBN
cord-005453-4057qib7	7964	30	to	to	IN
cord-005453-4057qib7	7964	31	two	two	CD
cord-005453-4057qib7	7964	32	days	day	NNS
cord-005453-4057qib7	7964	33	.	.	.
cord-005453-4057qib7	7965	1	GvHD	GvHD	NNP
cord-005453-4057qib7	7965	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	7965	3	consisted	consist	VBD
cord-005453-4057qib7	7965	4	of	of	IN
cord-005453-4057qib7	7965	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	7965	6	50	50	CD
cord-005453-4057qib7	7965	7	mg	mg	NNP
cord-005453-4057qib7	7965	8	/	/	SYM
cord-005453-4057qib7	7965	9	kg	kg	NNS
cord-005453-4057qib7	7965	10	on	on	IN
cord-005453-4057qib7	7965	11	day	day	NN
cord-005453-4057qib7	7965	12	+3	+3	NN
cord-005453-4057qib7	7965	13	and	and	CC
cord-005453-4057qib7	7965	14	+4	+4	NN
cord-005453-4057qib7	7965	15	,	,	,
cord-005453-4057qib7	7965	16	and	and	CC
cord-005453-4057qib7	7965	17	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	7965	18	as	as	IN
cord-005453-4057qib7	7965	19	a	a	DT
cord-005453-4057qib7	7965	20	continuous	continuous	JJ
cord-005453-4057qib7	7965	21	iv	iv	CD
cord-005453-4057qib7	7965	22	infusion	infusion	NN
cord-005453-4057qib7	7965	23	from	from	IN
cord-005453-4057qib7	7965	24	day	day	NN
cord-005453-4057qib7	7965	25	+5	+5	NFP
cord-005453-4057qib7	7965	26	.	.	.
cord-005453-4057qib7	7966	1	All	all	DT
cord-005453-4057qib7	7966	2	patients	patient	NNS
cord-005453-4057qib7	7966	3	received	receive	VBD
cord-005453-4057qib7	7966	4	PBSC	PBSC	NNP
cord-005453-4057qib7	7966	5	as	as	IN
cord-005453-4057qib7	7966	6	the	the	DT
cord-005453-4057qib7	7966	7	stem	stem	NN
cord-005453-4057qib7	7966	8	cell	cell	NN
cord-005453-4057qib7	7966	9	source	source	NN
cord-005453-4057qib7	7966	10	.	.	.
cord-005453-4057qib7	7967	1	Outcomes	outcome	NNS
cord-005453-4057qib7	7967	2	analysed	analyse	VBN
cord-005453-4057qib7	7967	3	were	be	VBD
cord-005453-4057qib7	7967	4	overall	overall	JJ
cord-005453-4057qib7	7967	5	survival	survival	NN
cord-005453-4057qib7	7967	6	(	(	-LRB-
cord-005453-4057qib7	7967	7	OS	OS	NNP
cord-005453-4057qib7	7967	8	)	)	-RRB-
cord-005453-4057qib7	7967	9	,	,	,
cord-005453-4057qib7	7967	10	progression	progression	NN
cord-005453-4057qib7	7967	11	free	free	JJ
cord-005453-4057qib7	7967	12	survival	survival	NN
cord-005453-4057qib7	7967	13	(	(	-LRB-
cord-005453-4057qib7	7967	14	PFS	PFS	NNP
cord-005453-4057qib7	7967	15	)	)	-RRB-
cord-005453-4057qib7	7967	16	;	;	,
cord-005453-4057qib7	7967	17	cumulative	cumulative	JJ
cord-005453-4057qib7	7967	18	incidences	incidence	NNS
cord-005453-4057qib7	7967	19	(	(	-LRB-
cord-005453-4057qib7	7967	20	CI	CI	NNP
cord-005453-4057qib7	7967	21	)	)	-RRB-
cord-005453-4057qib7	7967	22	of	of	IN
cord-005453-4057qib7	7967	23	GvHD	GvHD	NNP
cord-005453-4057qib7	7967	24	,	,	,
cord-005453-4057qib7	7967	25	relapse	relapse	NN
cord-005453-4057qib7	7967	26	and	and	CC
cord-005453-4057qib7	7967	27	non	non	JJ
cord-005453-4057qib7	7967	28	-	-	JJ
cord-005453-4057qib7	7967	29	relapsed	relapsed	JJ
cord-005453-4057qib7	7967	30	mortality	mortality	NN
cord-005453-4057qib7	7967	31	(	(	-LRB-
cord-005453-4057qib7	7967	32	NRM	NRM	NNP
cord-005453-4057qib7	7967	33	)	)	-RRB-
cord-005453-4057qib7	7967	34	.	.	.
cord-005453-4057qib7	7968	1	Results	result	NNS
cord-005453-4057qib7	7968	2	:	:	:
cord-005453-4057qib7	7969	1	Median	median	JJ
cord-005453-4057qib7	7969	2	ages	age	NNS
cord-005453-4057qib7	7969	3	was	be	VBD
cord-005453-4057qib7	7969	4	54	54	CD
cord-005453-4057qib7	7970	1	(	(	-LRB-
cord-005453-4057qib7	7970	2	range	range	VBP
cord-005453-4057qib7	7970	3	25	25	CD
cord-005453-4057qib7	7970	4	-	-	SYM
cord-005453-4057qib7	7970	5	71	71	CD
cord-005453-4057qib7	7970	6	)	)	-RRB-
cord-005453-4057qib7	7970	7	.	.	.
cord-005453-4057qib7	7971	1	53	53	CD
cord-005453-4057qib7	7971	2	%	%	NN
cord-005453-4057qib7	7971	3	male	male	NN
cord-005453-4057qib7	7971	4	and	and	CC
cord-005453-4057qib7	7971	5	47	47	CD
cord-005453-4057qib7	7971	6	%	%	NN
cord-005453-4057qib7	7971	7	female	female	NN
cord-005453-4057qib7	7971	8	.	.	.
cord-005453-4057qib7	7972	1	Diagnoses	diagnosis	NNS
cord-005453-4057qib7	7972	2	were	be	VBD
cord-005453-4057qib7	7972	3	:	:	:
cord-005453-4057qib7	7972	4	AML	AML	NNP
cord-005453-4057qib7	7972	5	20	20	CD
cord-005453-4057qib7	7972	6	(	(	-LRB-
cord-005453-4057qib7	7972	7	53	53	CD
cord-005453-4057qib7	7972	8	%	%	NN
cord-005453-4057qib7	7972	9	)	)	-RRB-
cord-005453-4057qib7	7972	10	,	,	,
cord-005453-4057qib7	7972	11	MDS	MDS	NNP
cord-005453-4057qib7	7972	12	7	7	CD
cord-005453-4057qib7	7972	13	(	(	-LRB-
cord-005453-4057qib7	7972	14	18	18	CD
cord-005453-4057qib7	7972	15	%	%	NN
cord-005453-4057qib7	7972	16	)	)	-RRB-
cord-005453-4057qib7	7972	17	,	,	,
cord-005453-4057qib7	7972	18	ALL	all	DT
cord-005453-4057qib7	7972	19	5	5	CD
cord-005453-4057qib7	7972	20	(	(	-LRB-
cord-005453-4057qib7	7972	21	13	13	CD
cord-005453-4057qib7	7972	22	%	%	NN
cord-005453-4057qib7	7972	23	)	)	-RRB-
cord-005453-4057qib7	7972	24	,	,	,
cord-005453-4057qib7	7972	25	HL	HL	NNP
cord-005453-4057qib7	7972	26	and	and	CC
cord-005453-4057qib7	7972	27	NHL	NHL	NNP
cord-005453-4057qib7	7972	28	5	5	CD
cord-005453-4057qib7	7972	29	(	(	-LRB-
cord-005453-4057qib7	7972	30	13	13	CD
cord-005453-4057qib7	7972	31	%	%	NN
cord-005453-4057qib7	7972	32	)	)	-RRB-
cord-005453-4057qib7	7972	33	,	,	,
cord-005453-4057qib7	7972	34	and	and	CC
cord-005453-4057qib7	7972	35	1	1	CD
cord-005453-4057qib7	7972	36	MM	MM	NNP
cord-005453-4057qib7	7972	37	(	(	-LRB-
cord-005453-4057qib7	7972	38	3	3	CD
cord-005453-4057qib7	7972	39	%	%	NN
cord-005453-4057qib7	7972	40	)	)	-RRB-
cord-005453-4057qib7	7972	41	.	.	.
cord-005453-4057qib7	7973	1	37	37	CD
cord-005453-4057qib7	7973	2	%	%	NN
cord-005453-4057qib7	7973	3	(	(	-LRB-
cord-005453-4057qib7	7973	4	N	n	CD
cord-005453-4057qib7	7973	5	14	14	CD
cord-005453-4057qib7	7973	6	)	)	-RRB-
cord-005453-4057qib7	7973	7	were	be	VBD
cord-005453-4057qib7	7973	8	transplanted	transplant	VBN
cord-005453-4057qib7	7973	9	in	in	IN
cord-005453-4057qib7	7973	10	early	early	JJ
cord-005453-4057qib7	7973	11	disease	disease	NN
cord-005453-4057qib7	7973	12	status	status	NN
cord-005453-4057qib7	7973	13	,	,	,
cord-005453-4057qib7	7973	14	while	while	IN
cord-005453-4057qib7	7973	15	most	most	JJS
cord-005453-4057qib7	7973	16	cases	case	NNS
cord-005453-4057qib7	7973	17	(	(	-LRB-
cord-005453-4057qib7	7973	18	63	63	CD
cord-005453-4057qib7	7973	19	%	%	NN
cord-005453-4057qib7	7973	20	)	)	-RRB-
cord-005453-4057qib7	7973	21	were	be	VBD
cord-005453-4057qib7	7973	22	in	in	IN
cord-005453-4057qib7	7973	23	advanced	advanced	JJ
cord-005453-4057qib7	7973	24	status	status	NN
cord-005453-4057qib7	7973	25	,	,	,
cord-005453-4057qib7	7973	26	including	include	VBG
cord-005453-4057qib7	7973	27	,	,	,
cord-005453-4057qib7	7973	28	second	second	JJ
cord-005453-4057qib7	7973	29	/	/	SYM
cord-005453-4057qib7	7973	30	third	third	JJ
cord-005453-4057qib7	7973	31	CR	CR	NNP
cord-005453-4057qib7	7973	32	(	(	-LRB-
cord-005453-4057qib7	7973	33	29	29	CD
cord-005453-4057qib7	7973	34	%	%	NN
cord-005453-4057qib7	7973	35	,	,	,
cord-005453-4057qib7	7973	36	N	n	CD
cord-005453-4057qib7	7973	37	11	11	CD
cord-005453-4057qib7	7973	38	)	)	-RRB-
cord-005453-4057qib7	7973	39	,	,	,
cord-005453-4057qib7	7973	40	one	one	CD
cord-005453-4057qib7	7973	41	(	(	-LRB-
cord-005453-4057qib7	7973	42	3	3	CD
cord-005453-4057qib7	7973	43	%	%	NN
cord-005453-4057qib7	7973	44	)	)	-RRB-
cord-005453-4057qib7	7974	1	in	in	IN
cord-005453-4057qib7	7974	2	aplasia	aplasia	NNP
cord-005453-4057qib7	7974	3	without	without	IN
cord-005453-4057qib7	7974	4	progressive	progressive	JJ
cord-005453-4057qib7	7974	5	disease	disease	NN
cord-005453-4057qib7	7974	6	and	and	CC
cord-005453-4057qib7	7974	7	23	23	CD
cord-005453-4057qib7	7974	8	%	%	NN
cord-005453-4057qib7	7974	9	(	(	-LRB-
cord-005453-4057qib7	7974	10	N	N	NNP
cord-005453-4057qib7	7974	11	9	9	CD
cord-005453-4057qib7	7974	12	)	)	-RRB-
cord-005453-4057qib7	7974	13	had	have	VBD
cord-005453-4057qib7	7974	14	active	active	JJ
cord-005453-4057qib7	7974	15	/	/	SYM
cord-005453-4057qib7	7974	16	progression	progression	NN
cord-005453-4057qib7	7974	17	disease	disease	NN
cord-005453-4057qib7	7974	18	,	,	,
cord-005453-4057qib7	7974	19	8	8	CD
cord-005453-4057qib7	7974	20	%	%	NN
cord-005453-4057qib7	7974	21	(	(	-LRB-
cord-005453-4057qib7	7974	22	N	N	NNP
cord-005453-4057qib7	7974	23	3	3	CD
cord-005453-4057qib7	7974	24	)	)	-RRB-
cord-005453-4057qib7	7974	25	had	have	VBD
cord-005453-4057qib7	7974	26	stable	stable	JJ
cord-005453-4057qib7	7974	27	disease	disease	NN
cord-005453-4057qib7	7974	28	;	;	:
cord-005453-4057qib7	7974	29	four	four	CD
cord-005453-4057qib7	7974	30	cases	case	NNS
cord-005453-4057qib7	7974	31	were	be	VBD
cord-005453-4057qib7	7974	32	second	second	JJ
cord-005453-4057qib7	7974	33	aloSCT	aloSCT	NNP
cord-005453-4057qib7	7974	34	.	.	.
cord-005453-4057qib7	7975	1	Thus	thus	RB
cord-005453-4057qib7	7975	2	,	,	,
cord-005453-4057qib7	7975	3	50	50	CD
cord-005453-4057qib7	7975	4	%	%	NN
cord-005453-4057qib7	7975	5	of	of	IN
cord-005453-4057qib7	7975	6	patients	patient	NNS
cord-005453-4057qib7	7975	7	had	have	VBD
cord-005453-4057qib7	7975	8	a	a	DT
cord-005453-4057qib7	7975	9	high	high	JJ
cord-005453-4057qib7	7975	10	or	or	CC
cord-005453-4057qib7	7975	11	very	very	RB
cord-005453-4057qib7	7975	12	high	high	JJ
cord-005453-4057qib7	7975	13	rDRI	rDRI	NNS
cord-005453-4057qib7	7975	14	and	and	CC
cord-005453-4057qib7	7975	15	50	50	CD
cord-005453-4057qib7	7975	16	%	%	NN
cord-005453-4057qib7	7975	17	had	have	VBD
cord-005453-4057qib7	7975	18	intermediate	intermediate	JJ
cord-005453-4057qib7	7975	19	.	.	.
cord-005453-4057qib7	7976	1	EBMT	EBMT	NNP
cord-005453-4057qib7	7976	2	score	score	NN
cord-005453-4057qib7	7976	3	was	be	VBD
cord-005453-4057qib7	7976	4	≤	≤	NNP
cord-005453-4057qib7	7976	5	4	4	CD
cord-005453-4057qib7	7976	6	was	be	VBD
cord-005453-4057qib7	7976	7	in	in	IN
cord-005453-4057qib7	7976	8	58	58	CD
cord-005453-4057qib7	7976	9	%	%	NN
cord-005453-4057qib7	7976	10	of	of	IN
cord-005453-4057qib7	7976	11	patients	patient	NNS
cord-005453-4057qib7	7976	12	(	(	-LRB-
cord-005453-4057qib7	7976	13	N	n	CD
cord-005453-4057qib7	7976	14	22	22	CD
cord-005453-4057qib7	7976	15	)	)	-RRB-
cord-005453-4057qib7	7976	16	.	.	.
cord-005453-4057qib7	7977	1	The	the	DT
cord-005453-4057qib7	7977	2	donor	donor	NN
cord-005453-4057qib7	7977	3	was	be	VBD
cord-005453-4057qib7	7977	4	as	as	IN
cord-005453-4057qib7	7977	5	son/	son/	CD
cord-005453-4057qib7	7977	6	daughter	daughter	NN
cord-005453-4057qib7	7977	7	in	in	IN
cord-005453-4057qib7	7977	8	50	50	CD
cord-005453-4057qib7	7977	9	%	%	NN
cord-005453-4057qib7	7977	10	,	,	,
cord-005453-4057qib7	7977	11	29	29	CD
cord-005453-4057qib7	7977	12	%	%	NN
cord-005453-4057qib7	7977	13	a	a	DT
cord-005453-4057qib7	7977	14	sibling	sibling	NN
cord-005453-4057qib7	7977	15	and	and	CC
cord-005453-4057qib7	7977	16	21	21	CD
cord-005453-4057qib7	7977	17	%	%	NN
cord-005453-4057qib7	7977	18	a	a	DT
cord-005453-4057qib7	7977	19	patient	patient	NN
cord-005453-4057qib7	7977	20	's	's	POS
cord-005453-4057qib7	7977	21	mother	mother	NN
cord-005453-4057qib7	7977	22	.	.	.
cord-005453-4057qib7	7978	1	Median	median	JJ
cord-005453-4057qib7	7978	2	time	time	NN
cord-005453-4057qib7	7978	3	to	to	IN
cord-005453-4057qib7	7978	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	7978	5	(	(	-LRB-
cord-005453-4057qib7	7978	6	0.5x10e9	0.5x10e9	NNP
cord-005453-4057qib7	7978	7	/	/	SYM
cord-005453-4057qib7	7978	8	L	l	NN
cord-005453-4057qib7	7978	9	)	)	-RRB-
cord-005453-4057qib7	7978	10	and	and	CC
cord-005453-4057qib7	7978	11	platelet	platelet	NN
cord-005453-4057qib7	7978	12	(	(	-LRB-
cord-005453-4057qib7	7978	13	>	>	NFP
cord-005453-4057qib7	7978	14	20x10e9	20x10e9	CD
cord-005453-4057qib7	7978	15	/	/	SYM
cord-005453-4057qib7	7978	16	L	l	NN
cord-005453-4057qib7	7978	17	)	)	-RRB-
cord-005453-4057qib7	7978	18	recoveries	recovery	NNS
cord-005453-4057qib7	7978	19	were	be	VBD
cord-005453-4057qib7	7978	20	+20	+20	CD
cord-005453-4057qib7	7978	21	and	and	CC
cord-005453-4057qib7	7978	22	+27	+27	NNP
cord-005453-4057qib7	7978	23	days	day	NNS
cord-005453-4057qib7	7978	24	,	,	,
cord-005453-4057qib7	7978	25	respectively	respectively	RB
cord-005453-4057qib7	7978	26	(	(	-LRB-
cord-005453-4057qib7	7978	27	G	G	NNP
cord-005453-4057qib7	7978	28	-	-	HYPH
cord-005453-4057qib7	7978	29	CSF	CSF	NNP
cord-005453-4057qib7	7978	30	was	be	VBD
cord-005453-4057qib7	7978	31	not	not	RB
cord-005453-4057qib7	7978	32	used	use	VBN
cord-005453-4057qib7	7978	33	)	)	-RRB-
cord-005453-4057qib7	7978	34	.	.	.
cord-005453-4057qib7	7979	1	Only	only	RB
cord-005453-4057qib7	7979	2	one	one	CD
cord-005453-4057qib7	7979	3	patient	patient	NN
cord-005453-4057qib7	7979	4	had	have	VBD
cord-005453-4057qib7	7979	5	a	a	DT
cord-005453-4057qib7	7979	6	primary	primary	JJ
cord-005453-4057qib7	7979	7	graft	graft	NN
cord-005453-4057qib7	7979	8	failure	failure	NN
cord-005453-4057qib7	7979	9	attributed	attribute	VBN
cord-005453-4057qib7	7979	10	to	to	IN
cord-005453-4057qib7	7979	11	anti	anti	JJ
cord-005453-4057qib7	7979	12	-	-	JJ
cord-005453-4057qib7	7979	13	HLA	HLA	NNP
cord-005453-4057qib7	7979	14	donor	donor	NN
cord-005453-4057qib7	7979	15	specific	specific	JJ
cord-005453-4057qib7	7979	16	antibodies	antibody	NNS
cord-005453-4057qib7	7979	17	.	.	.
cord-005453-4057qib7	7980	1	Median	median	JJ
cord-005453-4057qib7	7980	2	follow	follow	VBP
cord-005453-4057qib7	7980	3	up	up	RP
cord-005453-4057qib7	7980	4	in	in	IN
cord-005453-4057qib7	7980	5	survivor	survivor	NN
cord-005453-4057qib7	7980	6	is	be	VBZ
cord-005453-4057qib7	7980	7	22	22	CD
cord-005453-4057qib7	7980	8	months	month	NNS
cord-005453-4057qib7	7980	9	(	(	-LRB-
cord-005453-4057qib7	7980	10	range	range	NNP
cord-005453-4057qib7	7980	11	2	2	CD
cord-005453-4057qib7	7980	12	-	-	SYM
cord-005453-4057qib7	7980	13	63	63	CD
cord-005453-4057qib7	7980	14	)	)	-RRB-
cord-005453-4057qib7	7980	15	.	.	.
cord-005453-4057qib7	7981	1	Overall	overall	JJ
cord-005453-4057qib7	7981	2	survival	survival	NN
cord-005453-4057qib7	7981	3	is	be	VBZ
cord-005453-4057qib7	7981	4	81±6.5	81±6.5	CD
cord-005453-4057qib7	7981	5	%	%	NN
cord-005453-4057qib7	7981	6	(	(	-LRB-
cord-005453-4057qib7	7981	7	at	at	IN
cord-005453-4057qib7	7981	8	12	12	CD
cord-005453-4057qib7	7981	9	months	month	NNS
cord-005453-4057qib7	7981	10	)	)	-RRB-
cord-005453-4057qib7	7981	11	and	and	CC
cord-005453-4057qib7	7981	12	61±9	61±9	CD
cord-005453-4057qib7	7981	13	%	%	NN
cord-005453-4057qib7	7981	14	(	(	-LRB-
cord-005453-4057qib7	7981	15	at	at	IN
cord-005453-4057qib7	7981	16	63	63	CD
cord-005453-4057qib7	7981	17	months	month	NNS
cord-005453-4057qib7	7981	18	)	)	-RRB-
cord-005453-4057qib7	7981	19	.	.	.
cord-005453-4057qib7	7982	1	PFS	PFS	NNP
cord-005453-4057qib7	7982	2	is	be	VBZ
cord-005453-4057qib7	7982	3	67±8	67±8	CD
cord-005453-4057qib7	7982	4	%	%	NN
cord-005453-4057qib7	7982	5	and	and	CC
cord-005453-4057qib7	7982	6	52±9	52±9	CD
cord-005453-4057qib7	7982	7	%	%	NN
cord-005453-4057qib7	7982	8	respectively	respectively	RB
cord-005453-4057qib7	7982	9	.	.	.
cord-005453-4057qib7	7983	1	The	the	DT
cord-005453-4057qib7	7983	2	cumulative	cumulative	JJ
cord-005453-4057qib7	7983	3	incidence	incidence	NN
cord-005453-4057qib7	7983	4	of	of	IN
cord-005453-4057qib7	7983	5	relapse	relapse	NN
cord-005453-4057qib7	7983	6	was	be	VBD
cord-005453-4057qib7	7983	7	20	20	CD
cord-005453-4057qib7	7983	8	%	%	NN
cord-005453-4057qib7	7983	9	and	and	CC
cord-005453-4057qib7	7983	10	35	35	CD
cord-005453-4057qib7	7983	11	%	%	NN
cord-005453-4057qib7	7983	12	,	,	,
cord-005453-4057qib7	7983	13	respectively	respectively	RB
cord-005453-4057qib7	7983	14	,	,	,
cord-005453-4057qib7	7983	15	while	while	IN
cord-005453-4057qib7	7983	16	NRM	NRM	NNP
cord-005453-4057qib7	7983	17	is	be	VBZ
cord-005453-4057qib7	7983	18	13	13	CD
cord-005453-4057qib7	7983	19	%	%	NN
cord-005453-4057qib7	7983	20	at	at	IN
cord-005453-4057qib7	7983	21	63	63	CD
cord-005453-4057qib7	7983	22	months	month	NNS
cord-005453-4057qib7	7983	23	.	.	.
cord-005453-4057qib7	7984	1	Day	day	NN
cord-005453-4057qib7	7984	2	+120	+120	RB
cord-005453-4057qib7	7984	3	,	,	,
cord-005453-4057qib7	7984	4	grade	grade	NN
cord-005453-4057qib7	7984	5	2	2	CD
cord-005453-4057qib7	7984	6	-	-	SYM
cord-005453-4057qib7	7984	7	4	4	CD
cord-005453-4057qib7	7984	8	acute	acute	JJ
cord-005453-4057qib7	7984	9	GvHD	GvHD	NNP
cord-005453-4057qib7	7984	10	were	be	VBD
cord-005453-4057qib7	7984	11	13	13	CD
cord-005453-4057qib7	7984	12	%	%	NN
cord-005453-4057qib7	7984	13	,	,	,
cord-005453-4057qib7	7984	14	while	while	IN
cord-005453-4057qib7	7984	15	mild/	mild/	VBG
cord-005453-4057qib7	7984	16	moderate	moderate	JJ
cord-005453-4057qib7	7984	17	and	and	CC
cord-005453-4057qib7	7984	18	severe	severe	JJ
cord-005453-4057qib7	7984	19	chronic	chronic	JJ
cord-005453-4057qib7	7984	20	GvHD	gvhd	NN
cord-005453-4057qib7	7984	21	were	be	VBD
cord-005453-4057qib7	7984	22	6	6	CD
cord-005453-4057qib7	7984	23	%	%	NN
cord-005453-4057qib7	7984	24	and	and	CC
cord-005453-4057qib7	7984	25	3	3	CD
cord-005453-4057qib7	7984	26	%	%	NN
cord-005453-4057qib7	7984	27	respectively	respectively	RB
cord-005453-4057qib7	7984	28	.	.	.
cord-005453-4057qib7	7985	1	EBMT	EBMT	NNP
cord-005453-4057qib7	7985	2	≤	≤	NNP
cord-005453-4057qib7	7985	3	4	4	CD
cord-005453-4057qib7	7985	4	and	and	CC
cord-005453-4057qib7	7985	5	first	first	JJ
cord-005453-4057qib7	7985	6	aloSCT	aloSCT	NNP
cord-005453-4057qib7	7985	7	were	be	VBD
cord-005453-4057qib7	7985	8	the	the	DT
cord-005453-4057qib7	7985	9	only	only	JJ
cord-005453-4057qib7	7985	10	variables	variable	NNS
cord-005453-4057qib7	7985	11	to	to	TO
cord-005453-4057qib7	7985	12	clearly	clearly	RB
cord-005453-4057qib7	7985	13	impact	impact	VB
cord-005453-4057qib7	7985	14	60-months	60-months	CD
cord-005453-4057qib7	7985	15	OS	os	NN
cord-005453-4057qib7	7985	16	in	in	IN
cord-005453-4057qib7	7985	17	univariate	univariate	JJ
cord-005453-4057qib7	7985	18	analysis	analysis	NN
cord-005453-4057qib7	7985	19	.	.	.
cord-005453-4057qib7	7986	1	A	a	DT
cord-005453-4057qib7	7986	2	combined	combined	JJ
cord-005453-4057qib7	7986	3	covariate	covariate	NN
cord-005453-4057qib7	7986	4	of	of	IN
cord-005453-4057qib7	7986	5	ebmt	ebmt	NNP
cord-005453-4057qib7	7986	6	≤	≤	NNP
cord-005453-4057qib7	7986	7	4-no	4-no	CD
cord-005453-4057qib7	7986	8	prior	prior	IN
cord-005453-4057qib7	7986	9	aloSCT	aloSCT	NNP
cord-005453-4057qib7	7986	10	vs	vs	IN
cord-005453-4057qib7	7986	11	other	other	JJ
cord-005453-4057qib7	7986	12	patients	patient	NNS
cord-005453-4057qib7	7986	13	showed	show	VBD
cord-005453-4057qib7	7986	14	a	a	DT
cord-005453-4057qib7	7986	15	60	60	CD
cord-005453-4057qib7	7986	16	month	month	NN
cord-005453-4057qib7	7986	17	OS	OS	NNP
cord-005453-4057qib7	7986	18	81±13	81±13	NNP
cord-005453-4057qib7	7986	19	%	%	NN
cord-005453-4057qib7	7986	20	vs	vs	IN
cord-005453-4057qib7	7986	21	38±12	38±12	NNP
cord-005453-4057qib7	7986	22	%	%	NN
cord-005453-4057qib7	7986	23	(	(	-LRB-
cord-005453-4057qib7	7986	24	p	p	NN
cord-005453-4057qib7	7986	25	0.001	0.001	CD
cord-005453-4057qib7	7986	26	)	)	-RRB-
cord-005453-4057qib7	7986	27	,	,	,
cord-005453-4057qib7	7986	28	PFS	PFS	NNP
cord-005453-4057qib7	7986	29	65±13	65±13	NNP
cord-005453-4057qib7	7986	30	%	%	NN
cord-005453-4057qib7	7986	31	vs	vs	IN
cord-005453-4057qib7	7986	32	35±11	35±11	NNP
cord-005453-4057qib7	7986	33	%	%	NN
cord-005453-4057qib7	7986	34	(	(	-LRB-
cord-005453-4057qib7	7986	35	p	p	NN
cord-005453-4057qib7	7986	36	0.014	0.014	CD
cord-005453-4057qib7	7986	37	)	)	-RRB-
cord-005453-4057qib7	7986	38	and	and	CC
cord-005453-4057qib7	7986	39	NRM	NRM	NNP
cord-005453-4057qib7	7986	40	0	0	CD
cord-005453-4057qib7	7986	41	%	%	NN
cord-005453-4057qib7	7986	42	vs	vs	IN
cord-005453-4057qib7	7986	43	29	29	CD
cord-005453-4057qib7	7986	44	%	%	NN
cord-005453-4057qib7	7986	45	(	(	-LRB-
cord-005453-4057qib7	7986	46	p	p	NN
cord-005453-4057qib7	7986	47	0.008	0.008	CD
cord-005453-4057qib7	7986	48	)	)	-RRB-
cord-005453-4057qib7	7987	1	but	but	CC
cord-005453-4057qib7	7987	2	without	without	IN
cord-005453-4057qib7	7987	3	impact	impact	NN
cord-005453-4057qib7	7987	4	on	on	IN
cord-005453-4057qib7	7987	5	relapse	relapse	NN
cord-005453-4057qib7	7987	6	34	34	CD
cord-005453-4057qib7	7987	7	%	%	NN
cord-005453-4057qib7	7987	8	vs	vs	IN
cord-005453-4057qib7	7987	9	35	35	CD
cord-005453-4057qib7	7987	10	%	%	NN
cord-005453-4057qib7	7987	11	(	(	-LRB-
cord-005453-4057qib7	7987	12	p	p	NN
cord-005453-4057qib7	7987	13	0.68	0.68	CD
cord-005453-4057qib7	7987	14	)	)	-RRB-
cord-005453-4057qib7	7987	15	.	.	.
cord-005453-4057qib7	7988	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	7988	2	:	:	:
cord-005453-4057qib7	7988	3	HaploSCT	haplosct	XX
cord-005453-4057qib7	7989	1	with	with	IN
cord-005453-4057qib7	7989	2	an	an	DT
cord-005453-4057qib7	7989	3	age	age	NN
cord-005453-4057qib7	7989	4	-	-	HYPH
cord-005453-4057qib7	7989	5	adapted	adapt	VBN
cord-005453-4057qib7	7989	6	TBF	tbf	NN
cord-005453-4057qib7	7989	7	conditioning	conditioning	NN
cord-005453-4057qib7	7989	8	regimen	regimen	NN
cord-005453-4057qib7	7989	9	,	,	,
cord-005453-4057qib7	7989	10	PBSC	PBSC	NNP
cord-005453-4057qib7	7989	11	and	and	CC
cord-005453-4057qib7	7989	12	PTCy	PTCy	NNS
cord-005453-4057qib7	7989	13	followed	follow	VBN
cord-005453-4057qib7	7989	14	by	by	IN
cord-005453-4057qib7	7989	15	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	7989	16	,	,	,
cord-005453-4057qib7	7989	17	led	lead	VBD
cord-005453-4057qib7	7989	18	to	to	IN
cord-005453-4057qib7	7989	19	very	very	RB
cord-005453-4057qib7	7989	20	encouraging	encouraging	JJ
cord-005453-4057qib7	7989	21	results	result	NNS
cord-005453-4057qib7	7989	22	,	,	,
cord-005453-4057qib7	7989	23	mainly	mainly	RB
cord-005453-4057qib7	7989	24	in	in	IN
cord-005453-4057qib7	7989	25	patients	patient	NNS
cord-005453-4057qib7	7989	26	with	with	IN
cord-005453-4057qib7	7989	27	a	a	DT
cord-005453-4057qib7	7989	28	low	low	JJ
cord-005453-4057qib7	7989	29	EBMT	EBMT	NNP
cord-005453-4057qib7	7989	30	score	score	NN
cord-005453-4057qib7	7989	31	and	and	CC
cord-005453-4057qib7	7989	32	as	as	IN
cord-005453-4057qib7	7989	33	a	a	DT
cord-005453-4057qib7	7989	34	first	first	JJ
cord-005453-4057qib7	7989	35	aloSCT	alosct	NN
cord-005453-4057qib7	7989	36	.	.	.
cord-005453-4057qib7	7990	1	Although	although	IN
cord-005453-4057qib7	7990	2	formerly	formerly	RB
cord-005453-4057qib7	7990	3	considered	consider	VBN
cord-005453-4057qib7	7990	4	as	as	IN
cord-005453-4057qib7	7990	5	a	a	DT
cord-005453-4057qib7	7990	6	last	last	JJ
cord-005453-4057qib7	7990	7	aloSCT	aloSCT	NNP
cord-005453-4057qib7	7990	8	strategy	strategy	NN
cord-005453-4057qib7	7990	9	,	,	,
cord-005453-4057qib7	7990	10	we	-PRON-	PRP
cord-005453-4057qib7	7990	11	now	now	RB
cord-005453-4057qib7	7990	12	agree	agree	VBP
cord-005453-4057qib7	7990	13	that	that	IN
cord-005453-4057qib7	7990	14	the	the	DT
cord-005453-4057qib7	7990	15	time	time	NN
cord-005453-4057qib7	7990	16	has	have	VBZ
cord-005453-4057qib7	7990	17	come	come	VBN
cord-005453-4057qib7	7990	18	to	to	TO
cord-005453-4057qib7	7990	19	compare	compare	VB
cord-005453-4057qib7	7990	20	this	this	DT
cord-005453-4057qib7	7990	21	strategy	strategy	NN
cord-005453-4057qib7	7990	22	with	with	IN
cord-005453-4057qib7	7990	23	HLA	HLA	NNP
cord-005453-4057qib7	7990	24	MUD	MUD	NNP
cord-005453-4057qib7	7990	25	(	(	-LRB-
cord-005453-4057qib7	7990	26	and	and	CC
cord-005453-4057qib7	7990	27	even	even	RB
cord-005453-4057qib7	7990	28	elderly	elderly	JJ
cord-005453-4057qib7	7990	29	sibling	sibling	NN
cord-005453-4057qib7	7990	30	donors	donor	NNS
cord-005453-4057qib7	7990	31	)	)	-RRB-
cord-005453-4057qib7	7990	32	in	in	IN
cord-005453-4057qib7	7990	33	ongoing	ongoing	JJ
cord-005453-4057qib7	7990	34	prospective	prospective	JJ
cord-005453-4057qib7	7990	35	randomized	randomized	JJ
cord-005453-4057qib7	7990	36	multinational	multinational	JJ
cord-005453-4057qib7	7990	37	trials	trial	NNS
cord-005453-4057qib7	7990	38	.	.	.
cord-005453-4057qib7	7991	1	Disclosure	disclosure	NN
cord-005453-4057qib7	7991	2	:	:	:
cord-005453-4057qib7	7991	3	Nothing	nothing	NN
cord-005453-4057qib7	7991	4	to	to	TO
cord-005453-4057qib7	7991	5	disclosure	disclosure	NN
cord-005453-4057qib7	7991	6	Background	background	NN
cord-005453-4057qib7	7991	7	:	:	:
cord-005453-4057qib7	7991	8	Autologous	autologous	JJ
cord-005453-4057qib7	7991	9	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	7991	10	Stem	Stem	NNP
cord-005453-4057qib7	7991	11	Cell	Cell	NNP
cord-005453-4057qib7	7991	12	Transplantation	transplantation	NN
cord-005453-4057qib7	7991	13	(	(	-LRB-
cord-005453-4057qib7	7991	14	AutoSCT	AutoSCT	NNP
cord-005453-4057qib7	7991	15	)	)	-RRB-
cord-005453-4057qib7	7991	16	for	for	IN
cord-005453-4057qib7	7991	17	Acute	Acute	NNP
cord-005453-4057qib7	7991	18	Myeloid	Myeloid	NNP
cord-005453-4057qib7	7991	19	Leukaemia	Leukaemia	NNP
cord-005453-4057qib7	7991	20	(	(	-LRB-
cord-005453-4057qib7	7991	21	AML	AML	NNP
cord-005453-4057qib7	7991	22	)	)	-RRB-
cord-005453-4057qib7	7992	1	is	be	VBZ
cord-005453-4057qib7	7992	2	increasing	increase	VBG
cord-005453-4057qib7	7992	3	becoming	become	VBG
cord-005453-4057qib7	7992	4	a	a	DT
cord-005453-4057qib7	7992	5	viable	viable	JJ
cord-005453-4057qib7	7992	6	option	option	NN
cord-005453-4057qib7	7992	7	for	for	IN
cord-005453-4057qib7	7992	8	an	an	DT
cord-005453-4057qib7	7992	9	increasing	increase	VBG
cord-005453-4057qib7	7992	10	number	number	NN
cord-005453-4057qib7	7992	11	of	of	IN
cord-005453-4057qib7	7992	12	patients	patient	NNS
cord-005453-4057qib7	7992	13	due	due	JJ
cord-005453-4057qib7	7992	14	to	to	IN
cord-005453-4057qib7	7992	15	limited	limited	JJ
cord-005453-4057qib7	7992	16	availability	availability	NN
cord-005453-4057qib7	7992	17	of	of	IN
cord-005453-4057qib7	7992	18	matched	match	VBN
cord-005453-4057qib7	7992	19	sibling	sibling	NN
cord-005453-4057qib7	7992	20	or	or	CC
cord-005453-4057qib7	7992	21	unrelated	unrelated	JJ
cord-005453-4057qib7	7992	22	donor	donor	NN
cord-005453-4057qib7	7992	23	for	for	IN
cord-005453-4057qib7	7992	24	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	7992	25	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	7992	26	Stem	Stem	NNP
cord-005453-4057qib7	7992	27	Cell	cell	NN
cord-005453-4057qib7	7992	28	Transplantation	transplantation	NN
cord-005453-4057qib7	7992	29	(	(	-LRB-
cord-005453-4057qib7	7992	30	AlloSCT	AlloSCT	NNP
cord-005453-4057qib7	7992	31	)	)	-RRB-
cord-005453-4057qib7	7992	32	.	.	.
cord-005453-4057qib7	7993	1	We	-PRON-	PRP
cord-005453-4057qib7	7993	2	examined	examine	VBD
cord-005453-4057qib7	7993	3	the	the	DT
cord-005453-4057qib7	7993	4	relevant	relevant	JJ
cord-005453-4057qib7	7993	5	long	long	JJ
cord-005453-4057qib7	7993	6	-	-	HYPH
cord-005453-4057qib7	7993	7	term	term	NN
cord-005453-4057qib7	7993	8	outcomes	outcome	NNS
cord-005453-4057qib7	7993	9	in	in	IN
cord-005453-4057qib7	7993	10	our	-PRON-	PRP$
cord-005453-4057qib7	7993	11	local	local	JJ
cord-005453-4057qib7	7993	12	patient	patient	JJ
cord-005453-4057qib7	7993	13	cohort	cohort	NN
cord-005453-4057qib7	7993	14	.	.	.
cord-005453-4057qib7	7994	1	Methods	method	NNS
cord-005453-4057qib7	7994	2	:	:	:
cord-005453-4057qib7	7994	3	We	-PRON-	PRP
cord-005453-4057qib7	7994	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	7994	5	reviewed	review	VBD
cord-005453-4057qib7	7994	6	the	the	DT
cord-005453-4057qib7	7994	7	data	datum	NNS
cord-005453-4057qib7	7994	8	for	for	IN
cord-005453-4057qib7	7994	9	all	all	DT
cord-005453-4057qib7	7994	10	AutoSCT	autosct	CD
cord-005453-4057qib7	7994	11	done	do	VBN
cord-005453-4057qib7	7994	12	for	for	IN
cord-005453-4057qib7	7994	13	AML	AML	NNP
cord-005453-4057qib7	7994	14	in	in	IN
cord-005453-4057qib7	7994	15	our	-PRON-	PRP$
cord-005453-4057qib7	7994	16	centre	centre	NN
cord-005453-4057qib7	7994	17	over	over	IN
cord-005453-4057qib7	7994	18	a	a	DT
cord-005453-4057qib7	7994	19	17-years	17-years	CD
cord-005453-4057qib7	7994	20	period	period	NN
cord-005453-4057qib7	7994	21	between	between	IN
cord-005453-4057qib7	7994	22	1	1	CD
cord-005453-4057qib7	7994	23	st	st	NNP
cord-005453-4057qib7	7994	24	January	January	NNP
cord-005453-4057qib7	7994	25	2001	2001	CD
cord-005453-4057qib7	7994	26	until	until	IN
cord-005453-4057qib7	7994	27	31	31	CD
cord-005453-4057qib7	7994	28	st	st	NNP
cord-005453-4057qib7	7994	29	Dec	Dec	NNP
cord-005453-4057qib7	7994	30	2017	2017	CD
cord-005453-4057qib7	7994	31	from	from	IN
cord-005453-4057qib7	7994	32	our	-PRON-	PRP$
cord-005453-4057qib7	7994	33	electronic	electronic	JJ
cord-005453-4057qib7	7994	34	record	record	NN
cord-005453-4057qib7	7994	35	.	.	.
cord-005453-4057qib7	7995	1	Patients	patient	NNS
cord-005453-4057qib7	7995	2	with	with	IN
cord-005453-4057qib7	7995	3	Acute	acute	JJ
cord-005453-4057qib7	7995	4	Promyelocytic	Promyelocytic	NNP
cord-005453-4057qib7	7995	5	Leukaemia	Leukaemia	NNP
cord-005453-4057qib7	7995	6	(	(	-LRB-
cord-005453-4057qib7	7995	7	APML	APML	NNP
cord-005453-4057qib7	7995	8	)	)	-RRB-
cord-005453-4057qib7	7995	9	were	be	VBD
cord-005453-4057qib7	7995	10	excluded	exclude	VBN
cord-005453-4057qib7	7995	11	from	from	IN
cord-005453-4057qib7	7995	12	this	this	DT
cord-005453-4057qib7	7995	13	analysis	analysis	NN
cord-005453-4057qib7	7995	14	.	.	.
cord-005453-4057qib7	7996	1	Patients	patient	NNS
cord-005453-4057qib7	7996	2	were	be	VBD
cord-005453-4057qib7	7996	3	further	further	RB
cord-005453-4057qib7	7996	4	stratified	stratify	VBN
cord-005453-4057qib7	7996	5	based	base	VBN
cord-005453-4057qib7	7996	6	on	on	IN
cord-005453-4057qib7	7996	7	the	the	DT
cord-005453-4057qib7	7996	8	number	number	NN
cord-005453-4057qib7	7996	9	of	of	IN
cord-005453-4057qib7	7996	10	high	high	JJ
cord-005453-4057qib7	7996	11	risk	risk	NN
cord-005453-4057qib7	7996	12	features	feature	VBZ
cord-005453-4057qib7	7996	13	present	present	JJ
cord-005453-4057qib7	7996	14	;	;	:
cord-005453-4057qib7	7996	15	not	not	RB
cord-005453-4057qib7	7996	16	achieving	achieve	VBG
cord-005453-4057qib7	7996	17	complete	complete	JJ
cord-005453-4057qib7	7996	18	remission	remission	NN
cord-005453-4057qib7	7996	19	(	(	-LRB-
cord-005453-4057qib7	7996	20	CR	cr	NN
cord-005453-4057qib7	7996	21	)	)	-RRB-
cord-005453-4057qib7	7996	22	following	follow	VBG
cord-005453-4057qib7	7996	23	induction	induction	NN
cord-005453-4057qib7	7997	1	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	7997	2	,	,	,
cord-005453-4057qib7	7997	3	high	high	RB
cord-005453-4057qib7	7997	4	presenting	present	VBG
cord-005453-4057qib7	7997	5	total	total	JJ
cord-005453-4057qib7	7997	6	white	white	JJ
cord-005453-4057qib7	7997	7	cell	cell	NN
cord-005453-4057qib7	7997	8	count	count	NN
cord-005453-4057qib7	7997	9	(	(	-LRB-
cord-005453-4057qib7	7997	10	WBC	WBC	NNP
cord-005453-4057qib7	7997	11	>	>	XX
cord-005453-4057qib7	7998	1	100	100	CD
cord-005453-4057qib7	7998	2	x	x	SYM
cord-005453-4057qib7	7998	3	10	10	CD
cord-005453-4057qib7	7998	4	6	6	CD
cord-005453-4057qib7	7998	5	/ml	/ml	CD
cord-005453-4057qib7	7998	6	,	,	,
cord-005453-4057qib7	7998	7	adverse	adverse	JJ
cord-005453-4057qib7	7998	8	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	7998	9	(	(	-LRB-
cord-005453-4057qib7	7998	10	example	example	NN
cord-005453-4057qib7	7998	11	:	:	:
cord-005453-4057qib7	7998	12	complex	complex	JJ
cord-005453-4057qib7	7998	13	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	7998	14	)	)	-RRB-
cord-005453-4057qib7	7998	15	and	and	CC
cord-005453-4057qib7	7998	16	adverse	adverse	JJ
cord-005453-4057qib7	7998	17	molecular	molecular	JJ
cord-005453-4057qib7	7998	18	mutations	mutation	NNS
cord-005453-4057qib7	7999	1	(	(	-LRB-
cord-005453-4057qib7	7999	2	example	example	NN
cord-005453-4057qib7	7999	3	:	:	:
cord-005453-4057qib7	7999	4	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	7999	5	&	&	CC
cord-005453-4057qib7	7999	6	MLL	MLL	NNP
cord-005453-4057qib7	7999	7	gene	gene	NN
cord-005453-4057qib7	7999	8	arrangement	arrangement	NN
cord-005453-4057qib7	7999	9	)	)	-RRB-
cord-005453-4057qib7	7999	10	.	.	.
cord-005453-4057qib7	8000	1	Outcome	outcome	NN
cord-005453-4057qib7	8000	2	data	datum	NNS
cord-005453-4057qib7	8000	3	including	include	VBG
cord-005453-4057qib7	8000	4	mortality	mortality	NN
cord-005453-4057qib7	8000	5	(	(	-LRB-
cord-005453-4057qib7	8000	6	Overall	overall	JJ
cord-005453-4057qib7	8000	7	survival	survival	NN
cord-005453-4057qib7	8000	8	(	(	-LRB-
cord-005453-4057qib7	8000	9	OS	OS	NNP
cord-005453-4057qib7	8000	10	)	)	-RRB-
cord-005453-4057qib7	8000	11	and	and	CC
cord-005453-4057qib7	8000	12	non	non	JJ
cord-005453-4057qib7	8000	13	-	-	JJ
cord-005453-4057qib7	8000	14	relapse	relapse	JJ
cord-005453-4057qib7	8000	15	mortality	mortality	NN
cord-005453-4057qib7	8000	16	(	(	-LRB-
cord-005453-4057qib7	8000	17	NRM	NRM	NNP
cord-005453-4057qib7	8000	18	)	)	-RRB-
cord-005453-4057qib7	8000	19	)	)	-RRB-
cord-005453-4057qib7	8000	20	and	and	CC
cord-005453-4057qib7	8000	21	morbidity	morbidity	NN
cord-005453-4057qib7	8000	22	(	(	-LRB-
cord-005453-4057qib7	8000	23	leukaemia	leukaemia	NN
cord-005453-4057qib7	8000	24	free	free	JJ
cord-005453-4057qib7	8000	25	survival	survival	NN
cord-005453-4057qib7	8000	26	(	(	-LRB-
cord-005453-4057qib7	8000	27	LFS	LFS	NNP
cord-005453-4057qib7	8000	28	)	)	-RRB-
cord-005453-4057qib7	8000	29	)	)	-RRB-
cord-005453-4057qib7	8000	30	were	be	VBD
cord-005453-4057qib7	8000	31	recorded	record	VBN
cord-005453-4057qib7	8000	32	and	and	CC
cord-005453-4057qib7	8000	33	analysed	analyse	VBN
cord-005453-4057qib7	8000	34	.	.	.
cord-005453-4057qib7	8001	1	Results	result	NNS
cord-005453-4057qib7	8001	2	:	:	:
cord-005453-4057qib7	8002	1	A	a	DT
cord-005453-4057qib7	8002	2	total	total	NN
cord-005453-4057qib7	8002	3	of	of	IN
cord-005453-4057qib7	8002	4	64	64	CD
cord-005453-4057qib7	8002	5	patients	patient	NNS
cord-005453-4057qib7	8002	6	were	be	VBD
cord-005453-4057qib7	8002	7	identified	identify	VBN
cord-005453-4057qib7	8002	8	.	.	.
cord-005453-4057qib7	8003	1	Median	median	JJ
cord-005453-4057qib7	8003	2	age	age	NN
cord-005453-4057qib7	8003	3	at	at	IN
cord-005453-4057qib7	8003	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	8003	5	is	be	VBZ
cord-005453-4057qib7	8003	6	34-years	34-years	CD
cord-005453-4057qib7	8003	7	old	old	JJ
cord-005453-4057qib7	8003	8	.	.	.
cord-005453-4057qib7	8004	1	The	the	DT
cord-005453-4057qib7	8004	2	cohort	cohort	NN
cord-005453-4057qib7	8004	3	comprised	comprise	VBN
cord-005453-4057qib7	8004	4	of	of	IN
cord-005453-4057qib7	8004	5	34	34	CD
cord-005453-4057qib7	8004	6	males	male	NNS
cord-005453-4057qib7	8004	7	and	and	CC
cord-005453-4057qib7	8004	8	30	30	CD
cord-005453-4057qib7	8004	9	females	female	NNS
cord-005453-4057qib7	8004	10	.	.	.
cord-005453-4057qib7	8005	1	The	the	DT
cord-005453-4057qib7	8005	2	overall	overall	JJ
cord-005453-4057qib7	8005	3	median	median	JJ
cord-005453-4057qib7	8005	4	OS	os	NN
cord-005453-4057qib7	8005	5	and	and	CC
cord-005453-4057qib7	8005	6	median	median	JJ
cord-005453-4057qib7	8005	7	LFS	lfs	NN
cord-005453-4057qib7	8005	8	is	be	VBZ
cord-005453-4057qib7	8005	9	3.9	3.9	CD
cord-005453-4057qib7	8005	10	years	year	NNS
cord-005453-4057qib7	8005	11	and	and	CC
cord-005453-4057qib7	8005	12	2.2	2.2	CD
cord-005453-4057qib7	8005	13	years	year	NNS
cord-005453-4057qib7	8005	14	respectively	respectively	RB
cord-005453-4057qib7	8005	15	.	.	.
cord-005453-4057qib7	8006	1	The	the	DT
cord-005453-4057qib7	8006	2	NRM	NRM	NNP
cord-005453-4057qib7	8006	3	is	be	VBZ
cord-005453-4057qib7	8006	4	1.6	1.6	CD
cord-005453-4057qib7	8006	5	%	%	NN
cord-005453-4057qib7	8006	6	(	(	-LRB-
cord-005453-4057qib7	8006	7	1/64	1/64	CD
cord-005453-4057qib7	8006	8	)	)	-RRB-
cord-005453-4057qib7	8006	9	.	.	.
cord-005453-4057qib7	8007	1	There	there	EX
cord-005453-4057qib7	8007	2	was	be	VBD
cord-005453-4057qib7	8007	3	no	no	DT
cord-005453-4057qib7	8007	4	difference	difference	NN
cord-005453-4057qib7	8007	5	in	in	IN
cord-005453-4057qib7	8007	6	the	the	DT
cord-005453-4057qib7	8007	7	median	median	JJ
cord-005453-4057qib7	8007	8	OS	os	NN
cord-005453-4057qib7	8007	9	and	and	CC
cord-005453-4057qib7	8007	10	median	median	JJ
cord-005453-4057qib7	8007	11	LFS	lfs	NN
cord-005453-4057qib7	8007	12	for	for	IN
cord-005453-4057qib7	8007	13	the	the	DT
cord-005453-4057qib7	8007	14	patients	patient	NNS
cord-005453-4057qib7	8007	15	achieving	achieve	VBG
cord-005453-4057qib7	8007	16	CR	cr	NN
cord-005453-4057qib7	8007	17	following	follow	VBG
cord-005453-4057qib7	8007	18	induction	induction	NN
cord-005453-4057qib7	8007	19	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8007	20	and	and	CC
cord-005453-4057qib7	8007	21	those	those	DT
cord-005453-4057qib7	8007	22	not	not	RB
cord-005453-4057qib7	8007	23	in	in	IN
cord-005453-4057qib7	8007	24	CR	CR	NNP
cord-005453-4057qib7	8007	25	following	follow	VBG
cord-005453-4057qib7	8007	26	induction	induction	NN
cord-005453-4057qib7	8007	27	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8007	28	;	;	:
cord-005453-4057qib7	8007	29	4.4	4.4	CD
cord-005453-4057qib7	8007	30	years	year	NNS
cord-005453-4057qib7	8007	31	versus	versus	IN
cord-005453-4057qib7	8007	32	3.9	3.9	CD
cord-005453-4057qib7	8007	33	years	year	NNS
cord-005453-4057qib7	8007	34	(	(	-LRB-
cord-005453-4057qib7	8007	35	Log	log	JJ
cord-005453-4057qib7	8007	36	-	-	HYPH
cord-005453-4057qib7	8007	37	rank	rank	NN
cord-005453-4057qib7	8007	38	,	,	,
cord-005453-4057qib7	8007	39	p=0.9	p=0.9	NNP
cord-005453-4057qib7	8007	40	)	)	-RRB-
cord-005453-4057qib7	8007	41	and	and	CC
cord-005453-4057qib7	8007	42	3.4	3.4	CD
cord-005453-4057qib7	8007	43	years	year	NNS
cord-005453-4057qib7	8007	44	versus	versus	IN
cord-005453-4057qib7	8007	45	2.1	2.1	CD
cord-005453-4057qib7	8007	46	years	year	NNS
cord-005453-4057qib7	8007	47	(	(	-LRB-
cord-005453-4057qib7	8007	48	Log	log	JJ
cord-005453-4057qib7	8007	49	-	-	HYPH
cord-005453-4057qib7	8007	50	rank	rank	NN
cord-005453-4057qib7	8007	51	,	,	,
cord-005453-4057qib7	8007	52	p=0.9	p=0.9	NNP
cord-005453-4057qib7	8007	53	)	)	-RRB-
cord-005453-4057qib7	8007	54	respectively	respectively	RB
cord-005453-4057qib7	8007	55	.	.	.
cord-005453-4057qib7	8008	1	The	the	DT
cord-005453-4057qib7	8008	2	median	median	JJ
cord-005453-4057qib7	8008	3	OS	OS	NNP
cord-005453-4057qib7	8008	4	were	be	VBD
cord-005453-4057qib7	8008	5	statistically	statistically	RB
cord-005453-4057qib7	8008	6	significant	significant	JJ
cord-005453-4057qib7	8008	7	for	for	IN
cord-005453-4057qib7	8008	8	patients	patient	NNS
cord-005453-4057qib7	8008	9	with	with	IN
cord-005453-4057qib7	8008	10	zero	zero	CD
cord-005453-4057qib7	8008	11	versus	versus	IN
cord-005453-4057qib7	8008	12	one	one	CD
cord-005453-4057qib7	8008	13	and	and	CC
cord-005453-4057qib7	8008	14	two	two	CD
cord-005453-4057qib7	8008	15	and	and	CC
cord-005453-4057qib7	8008	16	more	more	JJR
cord-005453-4057qib7	8008	17	high	high	JJ
cord-005453-4057qib7	8008	18	risk	risk	NN
cord-005453-4057qib7	8008	19	features	feature	VBZ
cord-005453-4057qib7	8008	20	present	present	JJ
cord-005453-4057qib7	8008	21	;	;	:
cord-005453-4057qib7	8008	22	10.2	10.2	CD
cord-005453-4057qib7	8008	23	years	year	NNS
cord-005453-4057qib7	8008	24	versus	versus	IN
cord-005453-4057qib7	8008	25	3.7	3.7	CD
cord-005453-4057qib7	8008	26	years	year	NNS
cord-005453-4057qib7	8008	27	versus	versus	IN
cord-005453-4057qib7	8008	28	2.2	2.2	CD
cord-005453-4057qib7	8008	29	years	year	NNS
cord-005453-4057qib7	8008	30	(	(	-LRB-
cord-005453-4057qib7	8008	31	Log	log	JJ
cord-005453-4057qib7	8008	32	-	-	HYPH
cord-005453-4057qib7	8008	33	rank	rank	NN
cord-005453-4057qib7	8008	34	,	,	,
cord-005453-4057qib7	8008	35	p=0.4	p=0.4	NNP
cord-005453-4057qib7	8008	36	)	)	-RRB-
cord-005453-4057qib7	8008	37	respectively	respectively	RB
cord-005453-4057qib7	8008	38	.	.	.
cord-005453-4057qib7	8009	1	However	however	RB
cord-005453-4057qib7	8009	2	,	,	,
cord-005453-4057qib7	8009	3	the	the	DT
cord-005453-4057qib7	8009	4	median	median	JJ
cord-005453-4057qib7	8009	5	LFS	lfs	NN
cord-005453-4057qib7	8009	6	were	be	VBD
cord-005453-4057qib7	8009	7	not	not	RB
cord-005453-4057qib7	8009	8	statistically	statistically	RB
cord-005453-4057qib7	8009	9	significant	significant	JJ
cord-005453-4057qib7	8009	10	for	for	IN
cord-005453-4057qib7	8009	11	these	these	DT
cord-005453-4057qib7	8009	12	three	three	CD
cord-005453-4057qib7	8009	13	patient	patient	JJ
cord-005453-4057qib7	8009	14	cohorts	cohort	NNS
cord-005453-4057qib7	8009	15	;	;	:
cord-005453-4057qib7	8009	16	3.6	3.6	CD
cord-005453-4057qib7	8009	17	years	year	NNS
cord-005453-4057qib7	8009	18	versus	versus	IN
cord-005453-4057qib7	8009	19	1.9	1.9	CD
cord-005453-4057qib7	8009	20	years	year	NNS
cord-005453-4057qib7	8009	21	versus	versus	IN
cord-005453-4057qib7	8009	22	1.4	1.4	CD
cord-005453-4057qib7	8009	23	years	year	NNS
cord-005453-4057qib7	8009	24	(	(	-LRB-
cord-005453-4057qib7	8009	25	Log	log	JJ
cord-005453-4057qib7	8009	26	-	-	HYPH
cord-005453-4057qib7	8009	27	rank	rank	NN
cord-005453-4057qib7	8009	28	,	,	,
cord-005453-4057qib7	8009	29	p=0.7	p=0.7	NNP
cord-005453-4057qib7	8009	30	)	)	-RRB-
cord-005453-4057qib7	8009	31	respectively	respectively	RB
cord-005453-4057qib7	8009	32	.	.	.
cord-005453-4057qib7	8010	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8010	2	:	:	:
cord-005453-4057qib7	8011	1	In	in	IN
cord-005453-4057qib7	8011	2	our	-PRON-	PRP$
cord-005453-4057qib7	8011	3	patient	patient	JJ
cord-005453-4057qib7	8011	4	cohort	cohort	NN
cord-005453-4057qib7	8011	5	,	,	,
cord-005453-4057qib7	8011	6	AutoSCT	AutoSCT	NNP
cord-005453-4057qib7	8011	7	appeared	appear	VBD
cord-005453-4057qib7	8011	8	to	to	TO
cord-005453-4057qib7	8011	9	be	be	VB
cord-005453-4057qib7	8011	10	a	a	DT
cord-005453-4057qib7	8011	11	feasible	feasible	JJ
cord-005453-4057qib7	8011	12	option	option	NN
cord-005453-4057qib7	8011	13	for	for	IN
cord-005453-4057qib7	8011	14	patents	patent	NNS
cord-005453-4057qib7	8011	15	with	with	IN
cord-005453-4057qib7	8011	16	AML	AML	NNP
cord-005453-4057qib7	8011	17	without	without	IN
cord-005453-4057qib7	8011	18	matched	match	VBN
cord-005453-4057qib7	8011	19	sibling	sibling	NN
cord-005453-4057qib7	8011	20	or	or	CC
cord-005453-4057qib7	8011	21	unrelated	unrelated	JJ
cord-005453-4057qib7	8011	22	donor	donor	NN
cord-005453-4057qib7	8011	23	available	available	JJ
cord-005453-4057qib7	8011	24	.	.	.
cord-005453-4057qib7	8012	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8012	2	:	:	:
cord-005453-4057qib7	8012	3	None	none	NN
cord-005453-4057qib7	8012	4	to	to	TO
cord-005453-4057qib7	8012	5	declare	declare	VB
cord-005453-4057qib7	8012	6	Methods	method	NNS
cord-005453-4057qib7	8012	7	:	:	:
cord-005453-4057qib7	8012	8	Between	between	IN
cord-005453-4057qib7	8012	9	2014	2014	CD
cord-005453-4057qib7	8012	10	-	-	SYM
cord-005453-4057qib7	8012	11	2018	2018	CD
cord-005453-4057qib7	8012	12	,	,	,
cord-005453-4057qib7	8012	13	16	16	CD
cord-005453-4057qib7	8012	14	thalassemic	thalassemic	NNP
cord-005453-4057qib7	8012	15	patientsunderwent	patientsunderwent	NN
cord-005453-4057qib7	8012	16	HISCT	HISCT	NNP
cord-005453-4057qib7	8012	17	.	.	.
cord-005453-4057qib7	8013	1	The	the	DT
cord-005453-4057qib7	8013	2	median	median	JJ
cord-005453-4057qib7	8013	3	age	age	NN
cord-005453-4057qib7	8013	4	of	of	IN
cord-005453-4057qib7	8013	5	patients	patient	NNS
cord-005453-4057qib7	8013	6	was5	was5	NNS
cord-005453-4057qib7	8013	7	(	(	-LRB-
cord-005453-4057qib7	8013	8	1	1	CD
cord-005453-4057qib7	8013	9	-	-	SYM
cord-005453-4057qib7	8013	10	8)years	8)years	CD
cord-005453-4057qib7	8013	11	with	with	IN
cord-005453-4057qib7	8013	12	male	male	JJ
cord-005453-4057qib7	8013	13	preponderance	preponderance	NN
cord-005453-4057qib7	8013	14	(	(	-LRB-
cord-005453-4057qib7	8013	15	n=10	n=10	NNP
cord-005453-4057qib7	8013	16	,	,	,
cord-005453-4057qib7	8013	17	62.5	62.5	CD
cord-005453-4057qib7	8013	18	%	%	NN
cord-005453-4057qib7	8013	19	)	)	-RRB-
cord-005453-4057qib7	8013	20	.	.	.
cord-005453-4057qib7	8014	1	Across	across	IN
cord-005453-4057qib7	8014	2	the	the	DT
cord-005453-4057qib7	8014	3	gender	gender	NN
cord-005453-4057qib7	8014	4	and	and	CC
cord-005453-4057qib7	8014	5	ABO	ABO	NNP
cord-005453-4057qib7	8014	6	mismatch	mismatch	NN
cord-005453-4057qib7	8014	7	transplants	transplant	NNS
cord-005453-4057qib7	8014	8	were	be	VBD
cord-005453-4057qib7	8014	9	done	do	VBN
cord-005453-4057qib7	8014	10	in	in	IN
cord-005453-4057qib7	8014	11	43.7	43.7	CD
cord-005453-4057qib7	8014	12	%	%	NN
cord-005453-4057qib7	8014	13	and	and	CC
cord-005453-4057qib7	8014	14	25	25	CD
cord-005453-4057qib7	8014	15	%	%	NN
cord-005453-4057qib7	8014	16	of	of	IN
cord-005453-4057qib7	8014	17	patients	patient	NNS
cord-005453-4057qib7	8014	18	.	.	.
cord-005453-4057qib7	8015	1	Stem	stem	JJ
cord-005453-4057qib7	8015	2	cell	cell	NN
cord-005453-4057qib7	8015	3	source	source	NN
cord-005453-4057qib7	8015	4	was	be	VBD
cord-005453-4057qib7	8015	5	bone	bone	NN
cord-005453-4057qib7	8015	6	marrow	marrow	NN
cord-005453-4057qib7	8015	7	in	in	IN
cord-005453-4057qib7	8015	8	5	5	CD
cord-005453-4057qib7	8015	9	(	(	-LRB-
cord-005453-4057qib7	8015	10	31	31	CD
cord-005453-4057qib7	8015	11	%	%	NN
cord-005453-4057qib7	8015	12	)	)	-RRB-
cord-005453-4057qib7	8015	13	while	while	IN
cord-005453-4057qib7	8015	14	peripheral	peripheral	JJ
cord-005453-4057qib7	8015	15	blood	blood	NN
cord-005453-4057qib7	8015	16	in	in	IN
cord-005453-4057qib7	8015	17	11	11	CD
cord-005453-4057qib7	8015	18	(	(	-LRB-
cord-005453-4057qib7	8015	19	69	69	CD
cord-005453-4057qib7	8015	20	%	%	NN
cord-005453-4057qib7	8015	21	)	)	-RRB-
cord-005453-4057qib7	8015	22	of	of	IN
cord-005453-4057qib7	8015	23	patients	patient	NNS
cord-005453-4057qib7	8015	24	.	.	.
cord-005453-4057qib7	8016	1	Mean	mean	JJ
cord-005453-4057qib7	8016	2	stem	stem	NN
cord-005453-4057qib7	8016	3	cell	cell	NN
cord-005453-4057qib7	8016	4	dose	dose	NN
cord-005453-4057qib7	8016	5	was	be	VBD
cord-005453-4057qib7	8017	1	5.6	5.6	CD
cord-005453-4057qib7	8017	2	±	±	CD
cord-005453-4057qib7	8017	3	2.9	2.9	CD
cord-005453-4057qib7	8017	4	x	x	SYM
cord-005453-4057qib7	8017	5	10	10	CD
cord-005453-4057qib7	8017	6	6	6	CD
cord-005453-4057qib7	8017	7	cells	cell	NNS
cord-005453-4057qib7	8017	8	/	/	SYM
cord-005453-4057qib7	8017	9	kg	kg	NNS
cord-005453-4057qib7	8017	10	and	and	CC
cord-005453-4057qib7	8017	11	mean	mean	VB
cord-005453-4057qib7	8017	12	volume	volume	NN
cord-005453-4057qib7	8017	13	of	of	IN
cord-005453-4057qib7	8017	14	product	product	NN
cord-005453-4057qib7	8017	15	was	be	VBD
cord-005453-4057qib7	8017	16	188	188	CD
cord-005453-4057qib7	8017	17	±	±	CD
cord-005453-4057qib7	8017	18	60.58	60.58	CD
cord-005453-4057qib7	8017	19	ml	ml	NN
cord-005453-4057qib7	8017	20	.	.	.
cord-005453-4057qib7	8018	1	Preparative	preparative	JJ
cord-005453-4057qib7	8018	2	regimen	regimen	NN
cord-005453-4057qib7	8018	3	included	include	VBD
cord-005453-4057qib7	8018	4	Anti	Anti	NNP
cord-005453-4057qib7	8018	5	-	-	JJ
cord-005453-4057qib7	8018	6	thymocyte	thymocyte	JJ
cord-005453-4057qib7	8018	7	globulin	globulin	NN
cord-005453-4057qib7	8018	8	,	,	,
cord-005453-4057qib7	8018	9	Busulfan	Busulfan	NNP
cord-005453-4057qib7	8018	10	,	,	,
cord-005453-4057qib7	8018	11	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	8018	12	and	and	CC
cord-005453-4057qib7	8018	13	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	8018	14	.	.	.
cord-005453-4057qib7	8019	1	Graft	graft	NN
cord-005453-4057qib7	8019	2	versus	versus	IN
cord-005453-4057qib7	8019	3	host	host	NN
cord-005453-4057qib7	8019	4	disease	disease	NN
cord-005453-4057qib7	8019	5	(	(	-LRB-
cord-005453-4057qib7	8019	6	GvHD	GvHD	NNP
cord-005453-4057qib7	8019	7	)	)	-RRB-
cord-005453-4057qib7	8019	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8019	9	comprised	comprise	VBN
cord-005453-4057qib7	8019	10	of	of	IN
cord-005453-4057qib7	8019	11	posttransplant	posttransplant	NNP
cord-005453-4057qib7	8019	12	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	8019	13	on	on	IN
cord-005453-4057qib7	8019	14	day	day	NN
cord-005453-4057qib7	8019	15	+3	+3	NNP
cord-005453-4057qib7	8019	16	&	&	CC
cord-005453-4057qib7	8019	17	+4	+4	NNP
cord-005453-4057qib7	8019	18	followed	follow	VBN
cord-005453-4057qib7	8019	19	by	by	IN
cord-005453-4057qib7	8019	20	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	8019	21	and	and	CC
cord-005453-4057qib7	8019	22	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	8019	23	mofetil	mofetil	NNP
cord-005453-4057qib7	8019	24	.	.	.
cord-005453-4057qib7	8020	1	Patients	patient	NNS
cord-005453-4057qib7	8020	2	were	be	VBD
cord-005453-4057qib7	8020	3	observed	observe	VBN
cord-005453-4057qib7	8020	4	for	for	IN
cord-005453-4057qib7	8020	5	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8020	6	recovery	recovery	NN
cord-005453-4057qib7	8020	7	(	(	-LRB-
cord-005453-4057qib7	8020	8	neutrophil	neutrophil	NN
cord-005453-4057qib7	8020	9	and	and	CC
cord-005453-4057qib7	8020	10	platelet	platelet	NN
cord-005453-4057qib7	8020	11	engraftment	engraftment	NN
cord-005453-4057qib7	8020	12	)	)	-RRB-
cord-005453-4057qib7	8020	13	and	and	CC
cord-005453-4057qib7	8020	14	transplant	transplant	NN
cord-005453-4057qib7	8020	15	related	relate	VBN
cord-005453-4057qib7	8020	16	mortality	mortality	NN
cord-005453-4057qib7	8020	17	including	include	VBG
cord-005453-4057qib7	8020	18	acute	acute	JJ
cord-005453-4057qib7	8020	19	and	and	CC
cord-005453-4057qib7	8020	20	chronic	chronic	JJ
cord-005453-4057qib7	8020	21	GVHD	GVHD	NNP
cord-005453-4057qib7	8020	22	for	for	IN
cord-005453-4057qib7	8020	23	skin	skin	NN
cord-005453-4057qib7	8020	24	,	,	,
cord-005453-4057qib7	8020	25	gut	gut	NN
cord-005453-4057qib7	8020	26	,	,	,
cord-005453-4057qib7	8020	27	liverand	liverand	JJ
cord-005453-4057qib7	8020	28	lungs	lung	NNS
cord-005453-4057qib7	8020	29	,	,	,
cord-005453-4057qib7	8020	30	primary	primary	JJ
cord-005453-4057qib7	8020	31	and	and	CC
cord-005453-4057qib7	8020	32	secondary	secondary	JJ
cord-005453-4057qib7	8020	33	graft	graft	NN
cord-005453-4057qib7	8020	34	failure	failure	NN
cord-005453-4057qib7	8020	35	and	and	CC
cord-005453-4057qib7	8020	36	infectious	infectious	JJ
cord-005453-4057qib7	8020	37	complications	complication	NNS
cord-005453-4057qib7	8020	38	.	.	.
cord-005453-4057qib7	8021	1	Results	result	NNS
cord-005453-4057qib7	8021	2	:	:	:
cord-005453-4057qib7	8021	3	Nine(56.25	nine(56.25	CD
cord-005453-4057qib7	8021	4	%	%	NN
cord-005453-4057qib7	8021	5	)	)	-RRB-
cord-005453-4057qib7	8021	6	of	of	IN
cord-005453-4057qib7	8021	7	sixteenpatients	sixteenpatient	NNS
cord-005453-4057qib7	8021	8	were	be	VBD
cord-005453-4057qib7	8021	9	engrafted	engraft	VBN
cord-005453-4057qib7	8021	10	with	with	IN
cord-005453-4057qib7	8021	11	full	full	JJ
cord-005453-4057qib7	8021	12	donor	donor	NN
cord-005453-4057qib7	8021	13	chimerism	chimerism	NN
cord-005453-4057qib7	8021	14	.	.	.
cord-005453-4057qib7	8022	1	Twelve	twelve	CD
cord-005453-4057qib7	8022	2	(	(	-LRB-
cord-005453-4057qib7	8022	3	75	75	CD
cord-005453-4057qib7	8022	4	%	%	NN
cord-005453-4057qib7	8022	5	)	)	-RRB-
cord-005453-4057qib7	8022	6	patients	patient	NNS
cord-005453-4057qib7	8022	7	belonged	belong	VBD
cord-005453-4057qib7	8022	8	to	to	IN
cord-005453-4057qib7	8022	9	Pesaro	Pesaro	NNP
cord-005453-4057qib7	8022	10	class	class	NN
cord-005453-4057qib7	8022	11	I	i	NN
cord-005453-4057qib7	8022	12	and	and	CC
cord-005453-4057qib7	8022	13	4	4	CD
cord-005453-4057qib7	8022	14	(	(	-LRB-
cord-005453-4057qib7	8022	15	25	25	CD
cord-005453-4057qib7	8022	16	%	%	NN
cord-005453-4057qib7	8022	17	)	)	-RRB-
cord-005453-4057qib7	8022	18	toClass	toClass	NNP
cord-005453-4057qib7	8022	19	II	ii	CD
cord-005453-4057qib7	8022	20	patients	patient	NNS
cord-005453-4057qib7	8022	21	.	.	.
cord-005453-4057qib7	8023	1	Median	median	JJ
cord-005453-4057qib7	8023	2	time	time	NN
cord-005453-4057qib7	8023	3	to	to	IN
cord-005453-4057qib7	8023	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	8023	5	and	and	CC
cord-005453-4057qib7	8023	6	plateletengraftment	plateletengraftment	NN
cord-005453-4057qib7	8024	1	were13(11	were13(11	CD
cord-005453-4057qib7	8024	2	-	-	SYM
cord-005453-4057qib7	8024	3	20	20	CD
cord-005453-4057qib7	8024	4	)	)	-RRB-
cord-005453-4057qib7	8024	5	and16(12	and16(12	NNP
cord-005453-4057qib7	8024	6	-	-	HYPH
cord-005453-4057qib7	8024	7	36)days	36)days	CD
cord-005453-4057qib7	8024	8	respectively	respectively	RB
cord-005453-4057qib7	8024	9	.	.	.
cord-005453-4057qib7	8025	1	Average	average	JJ
cord-005453-4057qib7	8025	2	number	number	NN
cord-005453-4057qib7	8025	3	of	of	IN
cord-005453-4057qib7	8025	4	packed	pack	VBN
cord-005453-4057qib7	8025	5	red	red	JJ
cord-005453-4057qib7	8025	6	cell	cell	NN
cord-005453-4057qib7	8025	7	and	and	CC
cord-005453-4057qib7	8025	8	platelet	platelet	NN
cord-005453-4057qib7	8025	9	transfusions	transfusion	NNS
cord-005453-4057qib7	8025	10	were	be	VBD
cord-005453-4057qib7	8025	11	4.35±7.54	4.35±7.54	CD
cord-005453-4057qib7	8025	12	and	and	CC
cord-005453-4057qib7	8025	13	20.8	20.8	CD
cord-005453-4057qib7	8025	14	±19.18	±19.18	XX
cord-005453-4057qib7	8025	15	respectively	respectively	RB
cord-005453-4057qib7	8025	16	.	.	.
cord-005453-4057qib7	8026	1	Primary	primary	JJ
cord-005453-4057qib7	8026	2	graft	graft	NN
cord-005453-4057qib7	8026	3	failure	failure	NN
cord-005453-4057qib7	8026	4	was	be	VBD
cord-005453-4057qib7	8026	5	observed	observe	VBN
cord-005453-4057qib7	8026	6	in	in	IN
cord-005453-4057qib7	8026	7	3	3	CD
cord-005453-4057qib7	8026	8	(	(	-LRB-
cord-005453-4057qib7	8026	9	19	19	CD
cord-005453-4057qib7	8026	10	%	%	NN
cord-005453-4057qib7	8026	11	)	)	-RRB-
cord-005453-4057qib7	8026	12	and	and	CC
cord-005453-4057qib7	8026	13	secondary	secondary	JJ
cord-005453-4057qib7	8026	14	graft	graft	NN
cord-005453-4057qib7	8026	15	failure	failure	NN
cord-005453-4057qib7	8026	16	was	be	VBD
cord-005453-4057qib7	8026	17	observed	observe	VBN
cord-005453-4057qib7	8026	18	in	in	IN
cord-005453-4057qib7	8026	19	4	4	CD
cord-005453-4057qib7	8026	20	(	(	-LRB-
cord-005453-4057qib7	8026	21	25	25	CD
cord-005453-4057qib7	8026	22	%	%	NN
cord-005453-4057qib7	8026	23	)	)	-RRB-
cord-005453-4057qib7	8026	24	patients	patient	NNS
cord-005453-4057qib7	8026	25	.	.	.
cord-005453-4057qib7	8027	1	Two	two	CD
cord-005453-4057qib7	8027	2	patients	patient	NNS
cord-005453-4057qib7	8027	3	received	receive	VBD
cord-005453-4057qib7	8027	4	a	a	DT
cord-005453-4057qib7	8027	5	second	second	JJ
cord-005453-4057qib7	8027	6	dose	dose	NN
cord-005453-4057qib7	8027	7	of	of	IN
cord-005453-4057qib7	8027	8	stem	stem	NN
cord-005453-4057qib7	8027	9	cells	cell	NNS
cord-005453-4057qib7	8027	10	and	and	CC
cord-005453-4057qib7	8027	11	they	-PRON-	PRP
cord-005453-4057qib7	8027	12	engrafted	engraft	VBD
cord-005453-4057qib7	8027	13	at	at	IN
cord-005453-4057qib7	8027	14	20and	20and	CD
cord-005453-4057qib7	8027	15	32	32	CD
cord-005453-4057qib7	8027	16	days	day	NNS
cord-005453-4057qib7	8027	17	of	of	IN
cord-005453-4057qib7	8027	18	infusion	infusion	NN
cord-005453-4057qib7	8027	19	respectively.2	respectively.2	NN
cord-005453-4057qib7	8027	20	of	of	IN
cord-005453-4057qib7	8027	21	3	3	CD
cord-005453-4057qib7	8027	22	patients	patient	NNS
cord-005453-4057qib7	8027	23	with	with	IN
cord-005453-4057qib7	8027	24	primary	primary	JJ
cord-005453-4057qib7	8027	25	graft	graft	NN
cord-005453-4057qib7	8027	26	failure	failure	NN
cord-005453-4057qib7	8027	27	died	die	VBD
cord-005453-4057qib7	8027	28	,	,	,
cord-005453-4057qib7	8027	29	one	one	CD
cord-005453-4057qib7	8027	30	with	with	IN
cord-005453-4057qib7	8027	31	sepsis	sepsis	NN
cord-005453-4057qib7	8027	32	(	(	-LRB-
cord-005453-4057qib7	8027	33	day	day	NN
cord-005453-4057qib7	8027	34	+23	+23	CD
cord-005453-4057qib7	8027	35	)	)	-RRB-
cord-005453-4057qib7	8027	36	and	and	CC
cord-005453-4057qib7	8027	37	the	the	DT
cord-005453-4057qib7	8027	38	other	other	JJ
cord-005453-4057qib7	8027	39	because	because	IN
cord-005453-4057qib7	8027	40	of	of	IN
cord-005453-4057qib7	8027	41	intracranial	intracranial	JJ
cord-005453-4057qib7	8027	42	bleeding	bleeding	NN
cord-005453-4057qib7	8027	43	(	(	-LRB-
cord-005453-4057qib7	8028	1	day	day	NNP
cord-005453-4057qib7	8028	2	+21).Acute	+21).acute	JJ
cord-005453-4057qib7	8029	1	GvHDof	GvHDof	NFP
cord-005453-4057qib7	8029	2	gut	gut	NN
cord-005453-4057qib7	8029	3	and	and	CC
cord-005453-4057qib7	8029	4	skin	skin	NN
cord-005453-4057qib7	8029	5	(	(	-LRB-
cord-005453-4057qib7	8029	6	grade	grade	NN
cord-005453-4057qib7	8029	7	II	II	NNP
cord-005453-4057qib7	8029	8	-	-	HYPH
cord-005453-4057qib7	8029	9	III	III	NNP
cord-005453-4057qib7	8029	10	)	)	-RRB-
cord-005453-4057qib7	8029	11	was	be	VBD
cord-005453-4057qib7	8029	12	observed	observe	VBN
cord-005453-4057qib7	8029	13	in	in	IN
cord-005453-4057qib7	8029	14	2	2	CD
cord-005453-4057qib7	8029	15	patients	patient	NNS
cord-005453-4057qib7	8029	16	each	each	DT
cord-005453-4057qib7	8029	17	,	,	,
cord-005453-4057qib7	8029	18	within	within	IN
cord-005453-4057qib7	8029	19	first	first	JJ
cord-005453-4057qib7	8029	20	100	100	CD
cord-005453-4057qib7	8029	21	days	day	NNS
cord-005453-4057qib7	8029	22	post	post	NN
cord-005453-4057qib7	8029	23	-	-	NN
cord-005453-4057qib7	8029	24	transplant	transplant	NN
cord-005453-4057qib7	8029	25	.	.	.
cord-005453-4057qib7	8030	1	None	none	NN
cord-005453-4057qib7	8030	2	of	of	IN
cord-005453-4057qib7	8030	3	the	the	DT
cord-005453-4057qib7	8030	4	patients	patient	NNS
cord-005453-4057qib7	8030	5	had	have	VBD
cord-005453-4057qib7	8030	6	grade	grade	NN
cord-005453-4057qib7	8030	7	IV	IV	NNP
cord-005453-4057qib7	8030	8	GvHD	GvHD	NNP
cord-005453-4057qib7	8030	9	.	.	.
cord-005453-4057qib7	8031	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	8031	2	reactivation	reactivation	NN
cord-005453-4057qib7	8031	3	occurred	occur	VBD
cord-005453-4057qib7	8031	4	in	in	IN
cord-005453-4057qib7	8031	5	50	50	CD
cord-005453-4057qib7	8031	6	%	%	NN
cord-005453-4057qib7	8031	7	of	of	IN
cord-005453-4057qib7	8031	8	patients	patient	NNS
cord-005453-4057qib7	8031	9	,	,	,
cord-005453-4057qib7	8031	10	all	all	DT
cord-005453-4057qib7	8031	11	of	of	IN
cord-005453-4057qib7	8031	12	them	-PRON-	PRP
cord-005453-4057qib7	8031	13	received	receive	VBD
cord-005453-4057qib7	8031	14	pre	pre	JJ
cord-005453-4057qib7	8031	15	-	-	JJ
cord-005453-4057qib7	8031	16	emptive	emptive	JJ
cord-005453-4057qib7	8031	17	therapy	therapy	NN
cord-005453-4057qib7	8031	18	with	with	IN
cord-005453-4057qib7	8031	19	intravenous	intravenous	JJ
cord-005453-4057qib7	8031	20	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	8031	21	.	.	.
cord-005453-4057qib7	8032	1	None	none	NN
cord-005453-4057qib7	8032	2	of	of	IN
cord-005453-4057qib7	8032	3	them	-PRON-	PRP
cord-005453-4057qib7	8032	4	developed	develop	VBD
cord-005453-4057qib7	8032	5	CMV	CMV	NNP
cord-005453-4057qib7	8032	6	disease	disease	NN
cord-005453-4057qib7	8032	7	.	.	.
cord-005453-4057qib7	8033	1	Invasive	invasive	JJ
cord-005453-4057qib7	8033	2	fungal	fungal	NN
cord-005453-4057qib7	8033	3	infection	infection	NN
cord-005453-4057qib7	8033	4	was	be	VBD
cord-005453-4057qib7	8033	5	not	not	RB
cord-005453-4057qib7	8033	6	observed	observe	VBN
cord-005453-4057qib7	8033	7	in	in	IN
cord-005453-4057qib7	8033	8	any	any	DT
cord-005453-4057qib7	8033	9	of	of	IN
cord-005453-4057qib7	8033	10	the	the	DT
cord-005453-4057qib7	8033	11	patient	patient	NN
cord-005453-4057qib7	8033	12	.	.	.
cord-005453-4057qib7	8034	1	Culture	culture	NN
cord-005453-4057qib7	8034	2	proven	prove	VBN
cord-005453-4057qib7	8034	3	bacterialinfection	bacterialinfection	NN
cord-005453-4057qib7	8034	4	was	be	VBD
cord-005453-4057qib7	8034	5	documented	document	VBN
cord-005453-4057qib7	8034	6	in	in	IN
cord-005453-4057qib7	8034	7	62	62	CD
cord-005453-4057qib7	8034	8	%	%	NN
cord-005453-4057qib7	8034	9	of	of	IN
cord-005453-4057qib7	8034	10	patients	patient	NNS
cord-005453-4057qib7	8034	11	requiring	require	VBG
cord-005453-4057qib7	8034	12	intravenous	intravenous	JJ
cord-005453-4057qib7	8034	13	antibiotics	antibiotic	NNS
cord-005453-4057qib7	8034	14	during	during	IN
cord-005453-4057qib7	8034	15	first	first	JJ
cord-005453-4057qib7	8034	16	100	100	CD
cord-005453-4057qib7	8034	17	days	day	NNS
cord-005453-4057qib7	8034	18	post	post	NN
cord-005453-4057qib7	8034	19	-	-	NN
cord-005453-4057qib7	8034	20	transplant	transplant	NN
cord-005453-4057qib7	8034	21	.	.	.
cord-005453-4057qib7	8035	1	Overall	overall	JJ
cord-005453-4057qib7	8035	2	survival	survival	NN
cord-005453-4057qib7	8035	3	and	and	CC
cord-005453-4057qib7	8035	4	relapse	relapse	VB
cord-005453-4057qib7	8035	5	free	free	JJ
cord-005453-4057qib7	8035	6	survival	survival	NN
cord-005453-4057qib7	8035	7	were	be	VBD
cord-005453-4057qib7	8035	8	81.25	81.25	CD
cord-005453-4057qib7	8035	9	%	%	NN
cord-005453-4057qib7	8035	10	and	and	CC
cord-005453-4057qib7	8035	11	56.25	56.25	CD
cord-005453-4057qib7	8035	12	%	%	NN
cord-005453-4057qib7	8035	13	over	over	IN
cord-005453-4057qib7	8035	14	a	a	DT
cord-005453-4057qib7	8035	15	median	median	JJ
cord-005453-4057qib7	8035	16	follow	follow	NN
cord-005453-4057qib7	8035	17	-	-	HYPH
cord-005453-4057qib7	8035	18	up	up	NN
cord-005453-4057qib7	8035	19	of	of	IN
cord-005453-4057qib7	8035	20	500	500	CD
cord-005453-4057qib7	8035	21	(	(	-LRB-
cord-005453-4057qib7	8035	22	21	21	CD
cord-005453-4057qib7	8035	23	-	-	SYM
cord-005453-4057qib7	8035	24	1757	1757	CD
cord-005453-4057qib7	8035	25	)	)	-RRB-
cord-005453-4057qib7	8035	26	days	day	NNS
cord-005453-4057qib7	8035	27	.	.	.
cord-005453-4057qib7	8036	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8036	2	:	:	:
cord-005453-4057qib7	8037	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	8037	2	transplant	transplant	NN
cord-005453-4057qib7	8037	3	is	be	VBZ
cord-005453-4057qib7	8037	4	a	a	DT
cord-005453-4057qib7	8037	5	suitable	suitable	JJ
cord-005453-4057qib7	8037	6	modality	modality	NN
cord-005453-4057qib7	8037	7	for	for	IN
cord-005453-4057qib7	8037	8	thalassemic	thalassemic	NN
cord-005453-4057qib7	8037	9	patients	patient	NNS
cord-005453-4057qib7	8037	10	lacking	lack	VBG
cord-005453-4057qib7	8037	11	a	a	DT
cord-005453-4057qib7	8037	12	full	full	JJ
cord-005453-4057qib7	8037	13	matched	match	VBN
cord-005453-4057qib7	8037	14	donor	donor	NN
cord-005453-4057qib7	8037	15	in	in	IN
cord-005453-4057qib7	8037	16	Pakistan	Pakistan	NNP
cord-005453-4057qib7	8037	17	.	.	.
cord-005453-4057qib7	8038	1	In	in	IN
cord-005453-4057qib7	8038	2	view	view	NN
cord-005453-4057qib7	8038	3	of	of	IN
cord-005453-4057qib7	8038	4	our	-PRON-	PRP$
cord-005453-4057qib7	8038	5	results	result	NNS
cord-005453-4057qib7	8038	6	,	,	,
cord-005453-4057qib7	8038	7	we	-PRON-	PRP
cord-005453-4057qib7	8038	8	suggest	suggest	VBP
cord-005453-4057qib7	8038	9	that	that	IN
cord-005453-4057qib7	8038	10	thalassemia	thalassemia	NN
cord-005453-4057qib7	8038	11	patients	patient	NNS
cord-005453-4057qib7	8038	12	should	should	MD
cord-005453-4057qib7	8038	13	be	be	VB
cord-005453-4057qib7	8038	14	offered	offer	VBN
cord-005453-4057qib7	8038	15	HISCTas	HISCTas	NNP
cord-005453-4057qib7	8038	16	an	an	DT
cord-005453-4057qib7	8038	17	option	option	NN
cord-005453-4057qib7	8038	18	for	for	IN
cord-005453-4057qib7	8038	19	cure	cure	NN
cord-005453-4057qib7	8038	20	.	.	.
cord-005453-4057qib7	8039	1	Clinical	clinical	JJ
cord-005453-4057qib7	8039	2	Background	background	NN
cord-005453-4057qib7	8039	3	:	:	:
cord-005453-4057qib7	8040	1	Gemtuzumab	gemtuzumab	JJ
cord-005453-4057qib7	8040	2	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	8040	3	(	(	-LRB-
cord-005453-4057qib7	8040	4	GO	GO	NNP
cord-005453-4057qib7	8040	5	)	)	-RRB-
cord-005453-4057qib7	8040	6	is	be	VBZ
cord-005453-4057qib7	8040	7	an	an	DT
cord-005453-4057qib7	8040	8	anti	anti	JJ
cord-005453-4057qib7	8040	9	-	-	JJ
cord-005453-4057qib7	8040	10	CD33	CD33	NNP
cord-005453-4057qib7	8040	11	monoclonal	monoclonal	JJ
cord-005453-4057qib7	8040	12	antibody	antibody	NN
cord-005453-4057qib7	8040	13	with	with	IN
cord-005453-4057qib7	8040	14	significant	significant	JJ
cord-005453-4057qib7	8040	15	activity	activity	NN
cord-005453-4057qib7	8040	16	in	in	IN
cord-005453-4057qib7	8040	17	de	de	NNP
cord-005453-4057qib7	8040	18	novo	novo	NNP
cord-005453-4057qib7	8040	19	and	and	CC
cord-005453-4057qib7	8040	20	relapsed	relapse	VBD
cord-005453-4057qib7	8040	21	/	/	SYM
cord-005453-4057qib7	8040	22	refractory	refractory	JJ
cord-005453-4057qib7	8040	23	(	(	-LRB-
cord-005453-4057qib7	8040	24	R	r	NN
cord-005453-4057qib7	8040	25	/	/	SYM
cord-005453-4057qib7	8040	26	R	r	NN
cord-005453-4057qib7	8040	27	)	)	-RRB-
cord-005453-4057qib7	8040	28	acute	acute	JJ
cord-005453-4057qib7	8040	29	myeloid	myeloid	NN
cord-005453-4057qib7	8040	30	leukemia	leukemia	NN
cord-005453-4057qib7	8040	31	(	(	-LRB-
cord-005453-4057qib7	8040	32	AML	AML	NNP
cord-005453-4057qib7	8040	33	)	)	-RRB-
cord-005453-4057qib7	8040	34	.	.	.
cord-005453-4057qib7	8041	1	A	a	DT
cord-005453-4057qib7	8041	2	relevant	relevant	JJ
cord-005453-4057qib7	8041	3	side	side	NN
cord-005453-4057qib7	8041	4	effect	effect	NN
cord-005453-4057qib7	8041	5	consists	consist	VBZ
cord-005453-4057qib7	8041	6	of	of	IN
cord-005453-4057qib7	8041	7	hepatotoxicity	hepatotoxicity	NN
cord-005453-4057qib7	8041	8	and	and	CC
cord-005453-4057qib7	8041	9	especially	especially	RB
cord-005453-4057qib7	8041	10	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	8041	11	obstruction	obstruction	NN
cord-005453-4057qib7	8041	12	syndrome	syndrome	NN
cord-005453-4057qib7	8041	13	(	(	-LRB-
cord-005453-4057qib7	8041	14	SOS	SOS	NNP
cord-005453-4057qib7	8041	15	)	)	-RRB-
cord-005453-4057qib7	8041	16	.	.	.
cord-005453-4057qib7	8042	1	The	the	DT
cord-005453-4057qib7	8042	2	objective	objective	NN
cord-005453-4057qib7	8042	3	of	of	IN
cord-005453-4057qib7	8042	4	this	this	DT
cord-005453-4057qib7	8042	5	study	study	NN
cord-005453-4057qib7	8042	6	was	be	VBD
cord-005453-4057qib7	8042	7	to	to	TO
cord-005453-4057qib7	8042	8	analyze	analyze	VB
cord-005453-4057qib7	8042	9	tolerability	tolerability	NN
cord-005453-4057qib7	8042	10	of	of	IN
cord-005453-4057qib7	8042	11	GO	GO	NNP
cord-005453-4057qib7	8042	12	during	during	IN
cord-005453-4057qib7	8042	13	the	the	DT
cord-005453-4057qib7	8042	14	induction	induction	NN
cord-005453-4057qib7	8042	15	and	and	CC
cord-005453-4057qib7	8042	16	reinduction	reinduction	NN
cord-005453-4057qib7	8042	17	therapy	therapy	NN
cord-005453-4057qib7	8042	18	in	in	IN
cord-005453-4057qib7	8042	19	patients	patient	NNS
cord-005453-4057qib7	8042	20	with	with	IN
cord-005453-4057qib7	8042	21	AML	AML	NNP
cord-005453-4057qib7	8042	22	,	,	,
cord-005453-4057qib7	8042	23	and	and	CC
cord-005453-4057qib7	8042	24	its	-PRON-	PRP$
cord-005453-4057qib7	8042	25	possible	possible	JJ
cord-005453-4057qib7	8042	26	impact	impact	NN
cord-005453-4057qib7	8042	27	on	on	IN
cord-005453-4057qib7	8042	28	subsequent	subsequent	JJ
cord-005453-4057qib7	8042	29	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8042	30	stem	stem	NN
cord-005453-4057qib7	8042	31	cell	cell	NN
cord-005453-4057qib7	8042	32	transplantation	transplantation	NN
cord-005453-4057qib7	8042	33	(	(	-LRB-
cord-005453-4057qib7	8042	34	HSCT	HSCT	NNP
cord-005453-4057qib7	8042	35	)	)	-RRB-
cord-005453-4057qib7	8042	36	.	.	.
cord-005453-4057qib7	8043	1	Methods	method	NNS
cord-005453-4057qib7	8043	2	:	:	:
cord-005453-4057qib7	8043	3	From	from	IN
cord-005453-4057qib7	8043	4	2004	2004	CD
cord-005453-4057qib7	8043	5	to	to	IN
cord-005453-4057qib7	8043	6	2017	2017	CD
cord-005453-4057qib7	8043	7	,	,	,
cord-005453-4057qib7	8043	8	24	24	CD
cord-005453-4057qib7	8043	9	patients	patient	NNS
cord-005453-4057qib7	8043	10	who	who	WP
cord-005453-4057qib7	8043	11	had	have	VBD
cord-005453-4057qib7	8043	12	received	receive	VBN
cord-005453-4057qib7	8043	13	GO	GO	NNP
cord-005453-4057qib7	8043	14	in	in	IN
cord-005453-4057qib7	8043	15	three	three	CD
cord-005453-4057qib7	8043	16	hospitals	hospital	NNS
cord-005453-4057qib7	8043	17	were	be	VBD
cord-005453-4057qib7	8043	18	collected	collect	VBN
cord-005453-4057qib7	8043	19	and	and	CC
cord-005453-4057qib7	8043	20	their	-PRON-	PRP$
cord-005453-4057qib7	8043	21	medical	medical	JJ
cord-005453-4057qib7	8043	22	records	record	NNS
cord-005453-4057qib7	8043	23	were	be	VBD
cord-005453-4057qib7	8043	24	retrospectively	retrospectively	RB
cord-005453-4057qib7	8043	25	reviewed	review	VBN
cord-005453-4057qib7	8043	26	.	.	.
cord-005453-4057qib7	8044	1	Results	result	NNS
cord-005453-4057qib7	8044	2	:	:	:
cord-005453-4057qib7	8045	1	Fourteen	fourteen	CD
cord-005453-4057qib7	8045	2	patients	patient	NNS
cord-005453-4057qib7	8045	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	8045	4	with	with	IN
cord-005453-4057qib7	8045	5	de	de	NNP
cord-005453-4057qib7	8045	6	novo	novo	NNP
cord-005453-4057qib7	8045	7	AML	AML	NNP
cord-005453-4057qib7	8045	8	received	receive	VBD
cord-005453-4057qib7	8045	9	GO	GO	NNP
cord-005453-4057qib7	8045	10	(	(	-LRB-
cord-005453-4057qib7	8045	11	3mg	3mg	NNP
cord-005453-4057qib7	8045	12	/	/	SYM
cord-005453-4057qib7	8045	13	m	m	NN
cord-005453-4057qib7	8045	14	2	2	CD
cord-005453-4057qib7	8045	15	)	)	-RRB-
cord-005453-4057qib7	8045	16	on	on	IN
cord-005453-4057qib7	8045	17	day	day	NN
cord-005453-4057qib7	8045	18	+1	+1	-RRB-
cord-005453-4057qib7	8045	19	in	in	IN
cord-005453-4057qib7	8045	20	combination	combination	NN
cord-005453-4057qib7	8045	21	with	with	IN
cord-005453-4057qib7	8045	22	standard	standard	JJ
cord-005453-4057qib7	8045	23	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8045	24	(	(	-LRB-
cord-005453-4057qib7	8045	25	idarubicin	idarubicin	NNS
cord-005453-4057qib7	8045	26	and	and	CC
cord-005453-4057qib7	8045	27	cytarabine	cytarabine	NN
cord-005453-4057qib7	8045	28	,	,	,
cord-005453-4057qib7	8045	29	3x7	3x7	CD
cord-005453-4057qib7	8045	30	schedule	schedule	NN
cord-005453-4057qib7	8045	31	)	)	-RRB-
cord-005453-4057qib7	8045	32	as	as	IN
cord-005453-4057qib7	8045	33	induction	induction	NN
cord-005453-4057qib7	8045	34	therapy	therapy	NN
cord-005453-4057qib7	8045	35	.	.	.
cord-005453-4057qib7	8046	1	Hyperbilirubinemia	Hyperbilirubinemia	NNP
cord-005453-4057qib7	8047	1	(	(	-LRB-
cord-005453-4057qib7	8047	2	bilirubin	bilirubin	NN
cord-005453-4057qib7	8047	3	>	>	XX
cord-005453-4057qib7	8047	4	1.5	1.5	CD
cord-005453-4057qib7	8047	5	UNL	UNL	NNP
cord-005453-4057qib7	8047	6	)	)	-RRB-
cord-005453-4057qib7	8047	7	was	be	VBD
cord-005453-4057qib7	8047	8	detected	detect	VBN
cord-005453-4057qib7	8047	9	in	in	IN
cord-005453-4057qib7	8047	10	4	4	CD
cord-005453-4057qib7	8047	11	patients	patient	NNS
cord-005453-4057qib7	8047	12	and	and	CC
cord-005453-4057qib7	8047	13	increase	increase	NN
cord-005453-4057qib7	8047	14	of	of	IN
cord-005453-4057qib7	8047	15	aspartate	aspartate	NN
cord-005453-4057qib7	8047	16	aminotransferase	aminotransferase	NN
cord-005453-4057qib7	8047	17	(	(	-LRB-
cord-005453-4057qib7	8047	18	AST	AST	NNP
cord-005453-4057qib7	8047	19	)	)	-RRB-
cord-005453-4057qib7	8047	20	(	(	-LRB-
cord-005453-4057qib7	8047	21	>	>	NFP
cord-005453-4057qib7	8047	22	2.5	2.5	CD
cord-005453-4057qib7	8047	23	UNL	UNL	NNP
cord-005453-4057qib7	8047	24	)	)	-RRB-
cord-005453-4057qib7	8047	25	in	in	IN
cord-005453-4057qib7	8047	26	1	1	CD
cord-005453-4057qib7	8047	27	.	.	.
cord-005453-4057qib7	8048	1	Twelve	twelve	CD
cord-005453-4057qib7	8048	2	patients	patient	NNS
cord-005453-4057qib7	8048	3	achieved	achieve	VBD
cord-005453-4057qib7	8048	4	complete	complete	JJ
cord-005453-4057qib7	8048	5	remission	remission	NN
cord-005453-4057qib7	8048	6	(	(	-LRB-
cord-005453-4057qib7	8048	7	CR	CR	NNP
cord-005453-4057qib7	8048	8	)	)	-RRB-
cord-005453-4057qib7	8048	9	and	and	CC
cord-005453-4057qib7	8048	10	one	one	CD
cord-005453-4057qib7	8048	11	was	be	VBD
cord-005453-4057qib7	8048	12	refractory	refractory	JJ
cord-005453-4057qib7	8048	13	(	(	-LRB-
cord-005453-4057qib7	8048	14	1	1	CD
cord-005453-4057qib7	8048	15	not	not	RB
cord-005453-4057qib7	8048	16	evaluated	evaluate	VBN
cord-005453-4057qib7	8048	17	)	)	-RRB-
cord-005453-4057qib7	8048	18	.	.	.
cord-005453-4057qib7	8049	1	In	in	IN
cord-005453-4057qib7	8049	2	the	the	DT
cord-005453-4057qib7	8049	3	R	r	NN
cord-005453-4057qib7	8049	4	/	/	SYM
cord-005453-4057qib7	8049	5	R	r	NN
cord-005453-4057qib7	8049	6	setting	setting	NN
cord-005453-4057qib7	8049	7	,	,	,
cord-005453-4057qib7	8049	8	10	10	CD
cord-005453-4057qib7	8049	9	patients	patient	NNS
cord-005453-4057qib7	8049	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	8049	11	with	with	IN
cord-005453-4057qib7	8049	12	AML	AML	NNP
cord-005453-4057qib7	8049	13	(	(	-LRB-
cord-005453-4057qib7	8049	14	n=8	n=8	NNP
cord-005453-4057qib7	8049	15	)	)	-RRB-
cord-005453-4057qib7	8049	16	,	,	,
cord-005453-4057qib7	8049	17	biphenotypic	biphenotypic	JJ
cord-005453-4057qib7	8049	18	acute	acute	JJ
cord-005453-4057qib7	8049	19	leukemia	leukemia	NN
cord-005453-4057qib7	8049	20	(	(	-LRB-
cord-005453-4057qib7	8049	21	n=1	n=1	NN
cord-005453-4057qib7	8049	22	)	)	-RRB-
cord-005453-4057qib7	8049	23	and	and	CC
cord-005453-4057qib7	8049	24	acute	acute	JJ
cord-005453-4057qib7	8049	25	promyelocytic	promyelocytic	JJ
cord-005453-4057qib7	8049	26	leukemia	leukemia	NN
cord-005453-4057qib7	8049	27	(	(	-LRB-
cord-005453-4057qib7	8049	28	n=1	n=1	NN
cord-005453-4057qib7	8049	29	)	)	-RRB-
cord-005453-4057qib7	8049	30	received	receive	VBD
cord-005453-4057qib7	8049	31	GO	GO	NNP
cord-005453-4057qib7	8049	32	as	as	IN
cord-005453-4057qib7	8049	33	3rd	3rd	JJ
cord-005453-4057qib7	8049	34	or	or	CC
cord-005453-4057qib7	8049	35	subsequent	subsequent	JJ
cord-005453-4057qib7	8049	36	rescue	rescue	NN
cord-005453-4057qib7	8049	37	therapy	therapy	NN
cord-005453-4057qib7	8049	38	either	either	CC
cord-005453-4057qib7	8049	39	as	as	IN
cord-005453-4057qib7	8049	40	monotherapy	monotherapy	NN
cord-005453-4057qib7	8049	41	(	(	-LRB-
cord-005453-4057qib7	8049	42	n=4	n=4	NNP
cord-005453-4057qib7	8049	43	)	)	-RRB-
cord-005453-4057qib7	8049	44	or	or	CC
cord-005453-4057qib7	8049	45	in	in	IN
cord-005453-4057qib7	8049	46	combination	combination	NN
cord-005453-4057qib7	8049	47	with	with	IN
cord-005453-4057qib7	8049	48	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	8049	49	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8049	50	(	(	-LRB-
cord-005453-4057qib7	8049	51	n=5	n=5	NNP
cord-005453-4057qib7	8049	52	)	)	-RRB-
cord-005453-4057qib7	8049	53	.	.	.
cord-005453-4057qib7	8050	1	Prior	Prior	NNP
cord-005453-4057qib7	8050	2	HSCT	HSCT	NNP
cord-005453-4057qib7	8050	3	was	be	VBD
cord-005453-4057qib7	8050	4	performed	perform	VBN
cord-005453-4057qib7	8050	5	in	in	IN
cord-005453-4057qib7	8050	6	5	5	CD
cord-005453-4057qib7	8050	7	patients	patient	NNS
cord-005453-4057qib7	8050	8	(	(	-LRB-
cord-005453-4057qib7	8050	9	autologous	autologous	JJ
cord-005453-4057qib7	8050	10	[	[	-LRB-
cord-005453-4057qib7	8050	11	n=2	n=2	NNS
cord-005453-4057qib7	8050	12	]	]	-RRB-
cord-005453-4057qib7	8050	13	,	,	,
cord-005453-4057qib7	8050	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	8050	15	[	[	-LRB-
cord-005453-4057qib7	8050	16	n=3	n=3	NN
cord-005453-4057qib7	8050	17	]	]	-RRB-
cord-005453-4057qib7	8050	18	)	)	-RRB-
cord-005453-4057qib7	8050	19	.	.	.
cord-005453-4057qib7	8051	1	Rescue	rescue	NN
cord-005453-4057qib7	8051	2	therapy	therapy	NN
cord-005453-4057qib7	8051	3	was	be	VBD
cord-005453-4057qib7	8051	4	indicated	indicate	VBN
cord-005453-4057qib7	8051	5	for	for	IN
cord-005453-4057qib7	8051	6	refractoriness	refractoriness	NNP
cord-005453-4057qib7	8051	7	(	(	-LRB-
cord-005453-4057qib7	8051	8	n=2	n=2	NNS
cord-005453-4057qib7	8051	9	)	)	-RRB-
cord-005453-4057qib7	8051	10	,	,	,
cord-005453-4057qib7	8051	11	relapse	relapse	NN
cord-005453-4057qib7	8051	12	(	(	-LRB-
cord-005453-4057qib7	8051	13	n=5	n=5	NNP
cord-005453-4057qib7	8051	14	)	)	-RRB-
cord-005453-4057qib7	8051	15	,	,	,
cord-005453-4057qib7	8051	16	partial	partial	JJ
cord-005453-4057qib7	8051	17	response	response	NN
cord-005453-4057qib7	8051	18	(	(	-LRB-
cord-005453-4057qib7	8051	19	n=1	n=1	NN
cord-005453-4057qib7	8051	20	)	)	-RRB-
cord-005453-4057qib7	8051	21	or	or	CC
cord-005453-4057qib7	8051	22	absence	absence	NN
cord-005453-4057qib7	8051	23	of	of	IN
cord-005453-4057qib7	8051	24	donor	donor	NN
cord-005453-4057qib7	8051	25	(	(	-LRB-
cord-005453-4057qib7	8051	26	n=2	n=2	NNS
cord-005453-4057qib7	8051	27	)	)	-RRB-
cord-005453-4057qib7	8051	28	.	.	.
cord-005453-4057qib7	8052	1	Four	four	CD
cord-005453-4057qib7	8052	2	patients	patient	NNS
cord-005453-4057qib7	8052	3	received	receive	VBD
cord-005453-4057qib7	8052	4	3	3	CD
cord-005453-4057qib7	8052	5	doses	dose	NNS
cord-005453-4057qib7	8052	6	of	of	IN
cord-005453-4057qib7	8052	7	GO	GO	NNP
cord-005453-4057qib7	8052	8	(	(	-LRB-
cord-005453-4057qib7	8052	9	3	3	CD
cord-005453-4057qib7	8052	10	mg	mg	NNP
cord-005453-4057qib7	8052	11	/	/	SYM
cord-005453-4057qib7	8052	12	m	m	NNP
cord-005453-4057qib7	8052	13	2	2	CD
cord-005453-4057qib7	8052	14	)	)	-RRB-
cord-005453-4057qib7	8052	15	and	and	CC
cord-005453-4057qib7	8052	16	3	3	CD
cord-005453-4057qib7	8052	17	patients	patient	NNS
cord-005453-4057qib7	8052	18	,	,	,
cord-005453-4057qib7	8052	19	one	one	CD
cord-005453-4057qib7	8052	20	dose	dose	NN
cord-005453-4057qib7	8052	21	.	.	.
cord-005453-4057qib7	8053	1	Hyperbilirubinemia	Hyperbilirubinemia	NNP
cord-005453-4057qib7	8053	2	(	(	-LRB-
cord-005453-4057qib7	8053	3	>	>	NFP
cord-005453-4057qib7	8053	4	1.5	1.5	CD
cord-005453-4057qib7	8053	5	UNL	UNL	NNP
cord-005453-4057qib7	8053	6	)	)	-RRB-
cord-005453-4057qib7	8053	7	was	be	VBD
cord-005453-4057qib7	8053	8	observed	observe	VBN
cord-005453-4057qib7	8053	9	in	in	IN
cord-005453-4057qib7	8053	10	1	1	CD
cord-005453-4057qib7	8053	11	patient	patient	NN
cord-005453-4057qib7	8053	12	and	and	CC
cord-005453-4057qib7	8053	13	increase	increase	NN
cord-005453-4057qib7	8053	14	in	in	IN
cord-005453-4057qib7	8053	15	AST	ast	NN
cord-005453-4057qib7	8053	16	(	(	-LRB-
cord-005453-4057qib7	8053	17	>	>	NFP
cord-005453-4057qib7	8053	18	2.5	2.5	CD
cord-005453-4057qib7	8053	19	UNL	UNL	NNP
cord-005453-4057qib7	8053	20	)	)	-RRB-
cord-005453-4057qib7	8053	21	in	in	IN
cord-005453-4057qib7	8053	22	2	2	CD
cord-005453-4057qib7	8053	23	patients	patient	NNS
cord-005453-4057qib7	8053	24	.	.	.
cord-005453-4057qib7	8054	1	Seven	seven	CD
cord-005453-4057qib7	8054	2	patients	patient	NNS
cord-005453-4057qib7	8054	3	achieved	achieve	VBD
cord-005453-4057qib7	8054	4	CR	CR	NNP
cord-005453-4057qib7	8054	5	,	,	,
cord-005453-4057qib7	8054	6	1	1	CD
cord-005453-4057qib7	8054	7	was	be	VBD
cord-005453-4057qib7	8054	8	refractory	refractory	JJ
cord-005453-4057qib7	8054	9	,	,	,
cord-005453-4057qib7	8054	10	1	1	CD
cord-005453-4057qib7	8054	11	obtained	obtain	VBD
cord-005453-4057qib7	8054	12	partial	partial	JJ
cord-005453-4057qib7	8054	13	response	response	NN
cord-005453-4057qib7	8054	14	and	and	CC
cord-005453-4057qib7	8054	15	1	1	CD
cord-005453-4057qib7	8054	16	died	die	VBD
cord-005453-4057qib7	8054	17	early	early	RB
cord-005453-4057qib7	8054	18	during	during	IN
cord-005453-4057qib7	8054	19	induction	induction	NN
cord-005453-4057qib7	8054	20	)	)	-RRB-
cord-005453-4057qib7	8054	21	.	.	.
cord-005453-4057qib7	8055	1	Thirteen	thirteen	CD
cord-005453-4057qib7	8055	2	patients	patient	NNS
cord-005453-4057qib7	8055	3	received	receive	VBD
cord-005453-4057qib7	8055	4	subsequent	subsequent	JJ
cord-005453-4057qib7	8055	5	HSCT	HSCT	NNP
cord-005453-4057qib7	8055	6	(	(	-LRB-
cord-005453-4057qib7	8055	7	autologous	autologous	JJ
cord-005453-4057qib7	8055	8	[	[	-LRB-
cord-005453-4057qib7	8055	9	n=4	n=4	NNS
cord-005453-4057qib7	8055	10	]	]	-RRB-
cord-005453-4057qib7	8055	11	,	,	,
cord-005453-4057qib7	8055	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	8055	13	[	[	-LRB-
cord-005453-4057qib7	8055	14	n=9	n=9	NN
cord-005453-4057qib7	8055	15	]	]	-RRB-
cord-005453-4057qib7	8055	16	)	)	-RRB-
cord-005453-4057qib7	8055	17	after	after	IN
cord-005453-4057qib7	8055	18	GO	GO	NNP
cord-005453-4057qib7	8055	19	therapy	therapy	NN
cord-005453-4057qib7	8055	20	(	(	-LRB-
cord-005453-4057qib7	8055	21	10	10	CD
cord-005453-4057qib7	8055	22	in	in	IN
cord-005453-4057qib7	8055	23	the	the	DT
cord-005453-4057qib7	8055	24	de	de	FW
cord-005453-4057qib7	8055	25	novo	novo	NNP
cord-005453-4057qib7	8055	26	AML	AML	NNP
cord-005453-4057qib7	8055	27	and	and	CC
cord-005453-4057qib7	8055	28	3	3	CD
cord-005453-4057qib7	8055	29	in	in	IN
cord-005453-4057qib7	8055	30	the	the	DT
cord-005453-4057qib7	8055	31	R	r	NN
cord-005453-4057qib7	8055	32	/	/	SYM
cord-005453-4057qib7	8055	33	R	r	NN
cord-005453-4057qib7	8055	34	group	group	NN
cord-005453-4057qib7	8055	35	)	)	-RRB-
cord-005453-4057qib7	8055	36	.	.	.
cord-005453-4057qib7	8056	1	The	the	DT
cord-005453-4057qib7	8056	2	reasons	reason	NNS
cord-005453-4057qib7	8056	3	for	for	IN
cord-005453-4057qib7	8056	4	not	not	RB
cord-005453-4057qib7	8056	5	performing	perform	VBG
cord-005453-4057qib7	8056	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8056	7	in	in	IN
cord-005453-4057qib7	8056	8	the	the	DT
cord-005453-4057qib7	8056	9	remaining	remain	VBG
cord-005453-4057qib7	8056	10	11	11	CD
cord-005453-4057qib7	8056	11	patients	patient	NNS
cord-005453-4057qib7	8056	12	were	be	VBD
cord-005453-4057qib7	8056	13	:	:	:
cord-005453-4057qib7	8056	14	low	low	JJ
cord-005453-4057qib7	8056	15	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	8056	16	risk	risk	NN
cord-005453-4057qib7	8056	17	(	(	-LRB-
cord-005453-4057qib7	8056	18	n=1	n=1	FW
cord-005453-4057qib7	8056	19	)	)	-RRB-
cord-005453-4057qib7	8056	20	,	,	,
cord-005453-4057qib7	8056	21	active	active	JJ
cord-005453-4057qib7	8056	22	chronic	chronic	JJ
cord-005453-4057qib7	8056	23	graft	graft	NN
cord-005453-4057qib7	8056	24	versus	versus	IN
cord-005453-4057qib7	8056	25	host	host	NN
cord-005453-4057qib7	8056	26	disease	disease	NN
cord-005453-4057qib7	8056	27	(	(	-LRB-
cord-005453-4057qib7	8056	28	GvHD	GvHD	NNP
cord-005453-4057qib7	8056	29	)	)	-RRB-
cord-005453-4057qib7	8056	30	in	in	IN
cord-005453-4057qib7	8056	31	previous	previous	JJ
cord-005453-4057qib7	8056	32	HSCT	HSCT	NNP
cord-005453-4057qib7	8056	33	(	(	-LRB-
cord-005453-4057qib7	8056	34	n=1	n=1	NNP
cord-005453-4057qib7	8056	35	)	)	-RRB-
cord-005453-4057qib7	8056	36	,	,	,
cord-005453-4057qib7	8056	37	early	early	JJ
cord-005453-4057qib7	8056	38	death	death	NN
cord-005453-4057qib7	8056	39	during	during	IN
cord-005453-4057qib7	8056	40	treatment	treatment	NN
cord-005453-4057qib7	8056	41	(	(	-LRB-
cord-005453-4057qib7	8056	42	n=3	n=3	NN
cord-005453-4057qib7	8056	43	)	)	-RRB-
cord-005453-4057qib7	8056	44	,	,	,
cord-005453-4057qib7	8056	45	relapse	relapse	NN
cord-005453-4057qib7	8056	46	(	(	-LRB-
cord-005453-4057qib7	8056	47	n=1	n=1	CD
cord-005453-4057qib7	8056	48	)	)	-RRB-
cord-005453-4057qib7	8056	49	,	,	,
cord-005453-4057qib7	8056	50	severe	severe	JJ
cord-005453-4057qib7	8056	51	complications	complication	NNS
cord-005453-4057qib7	8056	52	in	in	IN
cord-005453-4057qib7	8056	53	rescue	rescue	NN
cord-005453-4057qib7	8056	54	treatments	treatment	NNS
cord-005453-4057qib7	8056	55	(	(	-LRB-
cord-005453-4057qib7	8056	56	n=1	n=1	CD
cord-005453-4057qib7	8056	57	)	)	-RRB-
cord-005453-4057qib7	8056	58	,	,	,
cord-005453-4057qib7	8056	59	and	and	CC
cord-005453-4057qib7	8056	60	unknown	unknown	JJ
cord-005453-4057qib7	8056	61	(	(	-LRB-
cord-005453-4057qib7	8056	62	n=4	n=4	JJ
cord-005453-4057qib7	8056	63	)	)	-RRB-
cord-005453-4057qib7	8056	64	.	.	.
cord-005453-4057qib7	8057	1	The	the	DT
cord-005453-4057qib7	8057	2	conditioning	conditioning	NN
cord-005453-4057qib7	8057	3	regimen	regimen	NN
cord-005453-4057qib7	8057	4	was	be	VBD
cord-005453-4057qib7	8057	5	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8057	6	(	(	-LRB-
cord-005453-4057qib7	8057	7	n=8	n=8	NNP
cord-005453-4057qib7	8057	8	)	)	-RRB-
cord-005453-4057qib7	8057	9	,	,	,
cord-005453-4057qib7	8057	10	non	non	JJ
cord-005453-4057qib7	8057	11	-	-	JJ
cord-005453-4057qib7	8057	12	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8057	13	(	(	-LRB-
cord-005453-4057qib7	8057	14	n=4	n=4	JJ
cord-005453-4057qib7	8057	15	)	)	-RRB-
cord-005453-4057qib7	8057	16	and	and	CC
cord-005453-4057qib7	8057	17	sequential	sequential	JJ
cord-005453-4057qib7	8057	18	(	(	-LRB-
cord-005453-4057qib7	8057	19	n=1	n=1	FW
cord-005453-4057qib7	8057	20	)	)	-RRB-
cord-005453-4057qib7	8057	21	,	,	,
cord-005453-4057qib7	8057	22	and	and	CC
cord-005453-4057qib7	8057	23	the	the	DT
cord-005453-4057qib7	8057	24	donors	donor	NNS
cord-005453-4057qib7	8057	25	were	be	VBD
cord-005453-4057qib7	8057	26	matched	match	VBN
cord-005453-4057qib7	8057	27	sibling	sibling	NN
cord-005453-4057qib7	8057	28	(	(	-LRB-
cord-005453-4057qib7	8057	29	n=6	n=6	NNP
cord-005453-4057qib7	8057	30	)	)	-RRB-
cord-005453-4057qib7	8057	31	or	or	CC
cord-005453-4057qib7	8057	32	unrelated	unrelated	JJ
cord-005453-4057qib7	8057	33	(	(	-LRB-
cord-005453-4057qib7	8057	34	n=3	n=3	NN
cord-005453-4057qib7	8057	35	)	)	-RRB-
cord-005453-4057qib7	8057	36	.	.	.
cord-005453-4057qib7	8058	1	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	8058	2	,	,	,
cord-005453-4057qib7	8058	3	methotrexate	methotrexate	NNP
cord-005453-4057qib7	8058	4	and	and	CC
cord-005453-4057qib7	8058	5	thymoglobulin	thymoglobulin	NNP
cord-005453-4057qib7	8058	6	were	be	VBD
cord-005453-4057qib7	8058	7	administered	administer	VBN
cord-005453-4057qib7	8058	8	as	as	IN
cord-005453-4057qib7	8058	9	GvHD	GvHD	NNP
cord-005453-4057qib7	8058	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8058	11	in	in	IN
cord-005453-4057qib7	8058	12	7	7	CD
cord-005453-4057qib7	8058	13	patients	patient	NNS
cord-005453-4057qib7	8058	14	and	and	CC
cord-005453-4057qib7	8058	15	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	8058	16	,	,	,
cord-005453-4057qib7	8058	17	mycophenolate	mycophenolate	JJ
cord-005453-4057qib7	8058	18	and	and	CC
cord-005453-4057qib7	8058	19	thymoglobulin	thymoglobulin	NNP
cord-005453-4057qib7	8058	20	in	in	IN
cord-005453-4057qib7	8058	21	3	3	CD
cord-005453-4057qib7	8058	22	.	.	.
cord-005453-4057qib7	8059	1	Hyperbilirubinemia	Hyperbilirubinemia	NNP
cord-005453-4057qib7	8059	2	was	be	VBD
cord-005453-4057qib7	8059	3	observed	observe	VBN
cord-005453-4057qib7	8059	4	in	in	IN
cord-005453-4057qib7	8059	5	2	2	CD
cord-005453-4057qib7	8059	6	patients	patient	NNS
cord-005453-4057qib7	8059	7	belonging	belong	VBG
cord-005453-4057qib7	8059	8	to	to	IN
cord-005453-4057qib7	8059	9	the	the	DT
cord-005453-4057qib7	8059	10	de	de	FW
cord-005453-4057qib7	8059	11	novo	novo	NNP
cord-005453-4057qib7	8059	12	AML	AML	NNP
cord-005453-4057qib7	8059	13	group	group	NN
cord-005453-4057qib7	8059	14	.	.	.
cord-005453-4057qib7	8060	1	Death	death	NN
cord-005453-4057qib7	8060	2	after	after	IN
cord-005453-4057qib7	8060	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8060	4	occurred	occur	VBD
cord-005453-4057qib7	8060	5	in	in	IN
cord-005453-4057qib7	8060	6	10	10	CD
cord-005453-4057qib7	8060	7	patients	patient	NNS
cord-005453-4057qib7	8060	8	due	due	JJ
cord-005453-4057qib7	8060	9	to	to	IN
cord-005453-4057qib7	8060	10	infection	infection	NN
cord-005453-4057qib7	8060	11	(	(	-LRB-
cord-005453-4057qib7	8060	12	n=5	n=5	NNP
cord-005453-4057qib7	8060	13	)	)	-RRB-
cord-005453-4057qib7	8060	14	,	,	,
cord-005453-4057qib7	8060	15	relapse	relapse	NN
cord-005453-4057qib7	8060	16	(	(	-LRB-
cord-005453-4057qib7	8060	17	n=3	n=3	NN
cord-005453-4057qib7	8060	18	)	)	-RRB-
cord-005453-4057qib7	8060	19	,	,	,
cord-005453-4057qib7	8060	20	GvHD	GvHD	NNP
cord-005453-4057qib7	8060	21	(	(	-LRB-
cord-005453-4057qib7	8060	22	n=1	n=1	NNS
cord-005453-4057qib7	8060	23	)	)	-RRB-
cord-005453-4057qib7	8060	24	and	and	CC
cord-005453-4057qib7	8060	25	traffic	traffic	NN
cord-005453-4057qib7	8060	26	accident	accident	NN
cord-005453-4057qib7	8060	27	(	(	-LRB-
cord-005453-4057qib7	8060	28	n=1	n=1	FW
cord-005453-4057qib7	8060	29	)	)	-RRB-
cord-005453-4057qib7	8060	30	.	.	.
cord-005453-4057qib7	8061	1	Three	three	CD
cord-005453-4057qib7	8061	2	patients	patient	NNS
cord-005453-4057qib7	8061	3	are	be	VBP
cord-005453-4057qib7	8061	4	currently	currently	RB
cord-005453-4057qib7	8061	5	alive	alive	JJ
cord-005453-4057qib7	8061	6	in	in	IN
cord-005453-4057qib7	8061	7	remission	remission	NN
cord-005453-4057qib7	8061	8	.	.	.
cord-005453-4057qib7	8062	1	No	no	DT
cord-005453-4057qib7	8062	2	SOS	SOS	NNP
cord-005453-4057qib7	8062	3	was	be	VBD
cord-005453-4057qib7	8062	4	observed	observe	VBN
cord-005453-4057qib7	8062	5	in	in	IN
cord-005453-4057qib7	8062	6	any	any	DT
cord-005453-4057qib7	8062	7	patient	patient	NN
cord-005453-4057qib7	8062	8	.	.	.
cord-005453-4057qib7	8063	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8063	2	:	:	:
cord-005453-4057qib7	8064	1	In	in	IN
cord-005453-4057qib7	8064	2	both	both	DT
cord-005453-4057qib7	8064	3	de	de	FW
cord-005453-4057qib7	8064	4	novo	novo	NNP
cord-005453-4057qib7	8064	5	and	and	CC
cord-005453-4057qib7	8064	6	R	R	NNP
cord-005453-4057qib7	8064	7	/	/	SYM
cord-005453-4057qib7	8064	8	R	R	NNP
cord-005453-4057qib7	8064	9	AML	AML	NNP
cord-005453-4057qib7	8065	1	the	the	DT
cord-005453-4057qib7	8065	2	administration	administration	NN
cord-005453-4057qib7	8065	3	of	of	IN
cord-005453-4057qib7	8065	4	low	low	JJ
cord-005453-4057qib7	8065	5	dose	dose	NN
cord-005453-4057qib7	8065	6	GO	GO	NNP
cord-005453-4057qib7	8065	7	is	be	VBZ
cord-005453-4057qib7	8065	8	feasible	feasible	JJ
cord-005453-4057qib7	8065	9	and	and	CC
cord-005453-4057qib7	8065	10	does	do	VBZ
cord-005453-4057qib7	8065	11	not	not	RB
cord-005453-4057qib7	8065	12	have	have	VB
cord-005453-4057qib7	8065	13	impact	impact	NN
cord-005453-4057qib7	8065	14	on	on	IN
cord-005453-4057qib7	8065	15	subsequent	subsequent	JJ
cord-005453-4057qib7	8065	16	HSCT	HSCT	NNP
cord-005453-4057qib7	8065	17	outcome	outcome	NN
cord-005453-4057qib7	8065	18	.	.	.
cord-005453-4057qib7	8066	1	Although	although	IN
cord-005453-4057qib7	8066	2	some	some	DT
cord-005453-4057qib7	8066	3	degree	degree	NN
cord-005453-4057qib7	8066	4	of	of	IN
cord-005453-4057qib7	8066	5	hepatotoxicity	hepatotoxicity	NN
cord-005453-4057qib7	8066	6	was	be	VBD
cord-005453-4057qib7	8066	7	observed	observe	VBN
cord-005453-4057qib7	8066	8	,	,	,
cord-005453-4057qib7	8066	9	no	no	DT
cord-005453-4057qib7	8066	10	cases	case	NNS
cord-005453-4057qib7	8066	11	of	of	IN
cord-005453-4057qib7	8066	12	SOS	SOS	NNP
cord-005453-4057qib7	8066	13	were	be	VBD
cord-005453-4057qib7	8066	14	observed	observe	VBN
cord-005453-4057qib7	8066	15	,	,	,
cord-005453-4057qib7	8066	16	either	either	CC
cord-005453-4057qib7	8066	17	before	before	IN
cord-005453-4057qib7	8066	18	or	or	CC
cord-005453-4057qib7	8066	19	after	after	IN
cord-005453-4057qib7	8066	20	HSCT	HSCT	NNP
cord-005453-4057qib7	8066	21	.	.	.
cord-005453-4057qib7	8067	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8067	2	:	:	:
cord-005453-4057qib7	8067	3	Supported	support	VBN
cord-005453-4057qib7	8067	4	by	by	IN
cord-005453-4057qib7	8067	5	grants	grant	NNS
cord-005453-4057qib7	8067	6	from	from	IN
cord-005453-4057qib7	8067	7	:	:	:
cord-005453-4057qib7	8067	8	Asociación	Asociación	NNP
cord-005453-4057qib7	8067	9	Española	Española	NNP
cord-005453-4057qib7	8067	10	Contra	Contra	NNP
cord-005453-4057qib7	8067	11	el	el	NNP
cord-005453-4057qib7	8067	12	Cáncer	Cáncer	NNP
cord-005453-4057qib7	8067	13	,	,	,
cord-005453-4057qib7	8067	14	AECC	AECC	NNP
cord-005453-4057qib7	8067	15	(	(	-LRB-
cord-005453-4057qib7	8067	16	GC16173697BIGA	GC16173697BIGA	NNP
cord-005453-4057qib7	8067	17	)	)	-RRB-
cord-005453-4057qib7	8067	18	,	,	,
cord-005453-4057qib7	8067	19	Instituto	Instituto	NNP
cord-005453-4057qib7	8067	20	Carlos	Carlos	NNP
cord-005453-4057qib7	8067	21	III	III	NNP
cord-005453-4057qib7	8067	22	(	(	-LRB-
cord-005453-4057qib7	8067	23	PI14/01971	PI14/01971	NNP
cord-005453-4057qib7	8067	24	FI	FI	NNP
cord-005453-4057qib7	8067	25	)	)	-RRB-
cord-005453-4057qib7	8067	26	,	,	,
cord-005453-4057qib7	8067	27	2017-SGR288	2017-sgr288	CD
cord-005453-4057qib7	8067	28	(	(	-LRB-
cord-005453-4057qib7	8067	29	GRC	GRC	NNP
cord-005453-4057qib7	8067	30	)	)	-RRB-
cord-005453-4057qib7	8067	31	,	,	.
cord-005453-4057qib7	8068	1	CERCA	CERCA	NNP
cord-005453-4057qib7	8068	2	Program	Program	NNP
cord-005453-4057qib7	8068	3	from	from	IN
cord-005453-4057qib7	8068	4	Generalitat	Generalitat	NNP
cord-005453-4057qib7	8068	5	de	de	NNP
cord-005453-4057qib7	8068	6	Catalunya	Catalunya	NNP
cord-005453-4057qib7	8068	7	,	,	,
cord-005453-4057qib7	8068	8	and	and	CC
cord-005453-4057qib7	8068	9	"	"	``
cord-005453-4057qib7	8068	10	La	La	NNP
cord-005453-4057qib7	8068	11	Caixa	Caixa	NNP
cord-005453-4057qib7	8068	12	"	"	''
cord-005453-4057qib7	8068	13	Foundation	Foundation	NNP
cord-005453-4057qib7	8068	14	.	.	.
cord-005453-4057qib7	8069	1	Outcome	outcome	NN
cord-005453-4057qib7	8069	2	of	of	IN
cord-005453-4057qib7	8069	3	allogeneic	allogeneic	JJ
cord-005453-4057qib7	8069	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8069	5	stem	stem	NN
cord-005453-4057qib7	8069	6	cell	cell	NN
cord-005453-4057qib7	8069	7	transplantation	transplantation	NN
cord-005453-4057qib7	8069	8	in	in	IN
cord-005453-4057qib7	8069	9	patients	patient	NNS
cord-005453-4057qib7	8069	10	with	with	IN
cord-005453-4057qib7	8069	11	benign	benign	JJ
cord-005453-4057qib7	8069	12	hematological	hematological	JJ
cord-005453-4057qib7	8069	13	disorders	disorder	NNS
cord-005453-4057qib7	8069	14	Saqib	Saqib	NNP
cord-005453-4057qib7	8069	15	Ansari	Ansari	NNP
cord-005453-4057qib7	8069	16	1	1	CD
cord-005453-4057qib7	8069	17	,	,	,
cord-005453-4057qib7	8069	18	Tahir	Tahir	NNP
cord-005453-4057qib7	8069	19	Shamsi	Shamsi	NNP
cord-005453-4057qib7	8069	20	1	1	CD
cord-005453-4057qib7	8069	21	,	,	,
cord-005453-4057qib7	8069	22	Uzma	Uzma	NNP
cord-005453-4057qib7	8069	23	Zaidi	Zaidi	NNP
cord-005453-4057qib7	8069	24	1	1	CD
cord-005453-4057qib7	8069	25	,	,	,
cord-005453-4057qib7	8069	26	Saima	Saima	NNP
cord-005453-4057qib7	8069	27	Siddiqui	Siddiqui	NNP
cord-005453-4057qib7	8069	28	1	1	CD
cord-005453-4057qib7	8069	29	,	,	,
cord-005453-4057qib7	8069	30	Tasneem	Tasneem	NNP
cord-005453-4057qib7	8069	31	Farzana	Farzana	NNP
cord-005453-4057qib7	8069	32	1	1	CD
cord-005453-4057qib7	8069	33	Background	Background	NNP
cord-005453-4057qib7	8069	34	:	:	:
cord-005453-4057qib7	8070	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	8070	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8070	3	stem	stem	NN
cord-005453-4057qib7	8070	4	cell	cell	NN
cord-005453-4057qib7	8070	5	transplantation	transplantation	NN
cord-005453-4057qib7	8070	6	is	be	VBZ
cord-005453-4057qib7	8070	7	a	a	DT
cord-005453-4057qib7	8070	8	potentially	potentially	RB
cord-005453-4057qib7	8070	9	curative	curative	JJ
cord-005453-4057qib7	8070	10	treatment	treatment	NN
cord-005453-4057qib7	8070	11	modality	modality	NN
cord-005453-4057qib7	8070	12	for	for	IN
cord-005453-4057qib7	8070	13	hematological	hematological	JJ
cord-005453-4057qib7	8070	14	disorders	disorder	NNS
cord-005453-4057qib7	8070	15	.	.	.
cord-005453-4057qib7	8071	1	We	-PRON-	PRP
cord-005453-4057qib7	8071	2	evaluated	evaluate	VBD
cord-005453-4057qib7	8071	3	the	the	DT
cord-005453-4057qib7	8071	4	outcome	outcome	NN
cord-005453-4057qib7	8071	5	of	of	IN
cord-005453-4057qib7	8071	6	patients	patient	NNS
cord-005453-4057qib7	8071	7	suffering	suffer	VBG
cord-005453-4057qib7	8071	8	from	from	IN
cord-005453-4057qib7	8071	9	benign	benign	JJ
cord-005453-4057qib7	8071	10	hematological	hematological	JJ
cord-005453-4057qib7	8071	11	disorders	disorder	NNS
cord-005453-4057qib7	8071	12	,	,	,
cord-005453-4057qib7	8071	13	including	include	VBG
cord-005453-4057qib7	8071	14	aplastic	aplastic	JJ
cord-005453-4057qib7	8071	15	anemia	anemia	NN
cord-005453-4057qib7	8071	16	,	,	,
cord-005453-4057qib7	8071	17	fanconi	fanconi	NNP
cord-005453-4057qib7	8071	18	's	's	POS
cord-005453-4057qib7	8071	19	anemia	anemia	NN
cord-005453-4057qib7	8071	20	and	and	CC
cord-005453-4057qib7	8071	21	thalassemia	thalassemia	NN
cord-005453-4057qib7	8071	22	after	after	IN
cord-005453-4057qib7	8071	23	matched	match	VBN
cord-005453-4057qib7	8071	24	related	related	JJ
cord-005453-4057qib7	8071	25	allogeneic	allogeneic	NN
cord-005453-4057qib7	8071	26	transplantation	transplantation	NN
cord-005453-4057qib7	8071	27	.	.	.
cord-005453-4057qib7	8072	1	Methods	method	NNS
cord-005453-4057qib7	8072	2	:	:	:
cord-005453-4057qib7	8073	1	All	all	DT
cord-005453-4057qib7	8073	2	patients	patient	NNS
cord-005453-4057qib7	8073	3	having	have	VBG
cord-005453-4057qib7	8073	4	hematological	hematological	JJ
cord-005453-4057qib7	8073	5	disorders	disorder	NNS
cord-005453-4057qib7	8073	6	including	include	VBG
cord-005453-4057qib7	8073	7	aplastic	aplastic	JJ
cord-005453-4057qib7	8073	8	anemia	anemia	NN
cord-005453-4057qib7	8073	9	(	(	-LRB-
cord-005453-4057qib7	8073	10	AA	AA	NNP
cord-005453-4057qib7	8073	11	)	)	-RRB-
cord-005453-4057qib7	8073	12	,	,	,
cord-005453-4057qib7	8073	13	beta	beta	NN
cord-005453-4057qib7	8073	14	thalassemia	thalassemia	NN
cord-005453-4057qib7	8073	15	(	(	-LRB-
cord-005453-4057qib7	8073	16	BTM	BTM	NNP
cord-005453-4057qib7	8073	17	)	)	-RRB-
cord-005453-4057qib7	8073	18	,	,	,
cord-005453-4057qib7	8073	19	fanconi	fanconi	NNP
cord-005453-4057qib7	8073	20	's	's	POS
cord-005453-4057qib7	8073	21	anemia	anemia	NN
cord-005453-4057qib7	8073	22	(	(	-LRB-
cord-005453-4057qib7	8073	23	FA	FA	NNP
cord-005453-4057qib7	8073	24	)	)	-RRB-
cord-005453-4057qib7	8073	25	and	and	CC
cord-005453-4057qib7	8073	26	severe	severe	JJ
cord-005453-4057qib7	8073	27	combined	combine	VBN
cord-005453-4057qib7	8073	28	immune	immune	JJ
cord-005453-4057qib7	8073	29	deficiency	deficiency	NN
cord-005453-4057qib7	8073	30	disorder	disorder	NN
cord-005453-4057qib7	8073	31	(	(	-LRB-
cord-005453-4057qib7	8073	32	SCID	SCID	NNP
cord-005453-4057qib7	8073	33	)	)	-RRB-
cord-005453-4057qib7	8073	34	with	with	IN
cord-005453-4057qib7	8073	35	HLA	HLA	NNP
cord-005453-4057qib7	8073	36	identical	identical	JJ
cord-005453-4057qib7	8073	37	related	related	JJ
cord-005453-4057qib7	8073	38	donors	donor	NNS
cord-005453-4057qib7	8073	39	who	who	WP
cord-005453-4057qib7	8073	40	underwent	undergo	VBD
cord-005453-4057qib7	8073	41	allogeneic	allogeneic	JJ
cord-005453-4057qib7	8073	42	transplantation	transplantation	NN
cord-005453-4057qib7	8073	43	were	be	VBD
cord-005453-4057qib7	8073	44	included	include	VBN
cord-005453-4057qib7	8073	45	.	.	.
cord-005453-4057qib7	8074	1	Donors	donor	NNS
cord-005453-4057qib7	8074	2	were	be	VBD
cord-005453-4057qib7	8074	3	given	give	VBN
cord-005453-4057qib7	8074	4	G	G	NNP
cord-005453-4057qib7	8074	5	-	-	HYPH
cord-005453-4057qib7	8074	6	CSF	CSF	NNP
cord-005453-4057qib7	8074	7	at	at	IN
cord-005453-4057qib7	8074	8	a	a	DT
cord-005453-4057qib7	8074	9	dose	dose	NN
cord-005453-4057qib7	8074	10	of	of	IN
cord-005453-4057qib7	8074	11	10	10	CD
cord-005453-4057qib7	8074	12	μg/	μg/	NNP
cord-005453-4057qib7	8074	13	kg	kg	NNP
cord-005453-4057qib7	8074	14	/	/	SYM
cord-005453-4057qib7	8074	15	day	day	NN
cord-005453-4057qib7	8074	16	daily	daily	RB
cord-005453-4057qib7	8074	17	for	for	IN
cord-005453-4057qib7	8074	18	four	four	CD
cord-005453-4057qib7	8074	19	days	day	NNS
cord-005453-4057qib7	8074	20	prior	prior	RB
cord-005453-4057qib7	8074	21	to	to	IN
cord-005453-4057qib7	8074	22	harvest	harvest	VB
cord-005453-4057qib7	8074	23	.	.	.
cord-005453-4057qib7	8075	1	The	the	DT
cord-005453-4057qib7	8075	2	conditioning	conditioning	NN
cord-005453-4057qib7	8075	3	regimens	regimen	NNS
cord-005453-4057qib7	8075	4	for	for	IN
cord-005453-4057qib7	8075	5	thalassemia	thalassemia	NN
cord-005453-4057qib7	8075	6	included	include	VBN
cord-005453-4057qib7	8075	7	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	8075	8	(	(	-LRB-
cord-005453-4057qib7	8075	9	CY	CY	NNP
cord-005453-4057qib7	8075	10	)	)	-RRB-
cord-005453-4057qib7	8075	11	+	+	CC
cord-005453-4057qib7	8075	12	busulfan	busulfan	NN
cord-005453-4057qib7	8075	13	(	(	-LRB-
cord-005453-4057qib7	8075	14	BU	BU	NNP
cord-005453-4057qib7	8075	15	)	)	-RRB-
cord-005453-4057qib7	8076	1	in	in	IN
cord-005453-4057qib7	8076	2	21	21	CD
cord-005453-4057qib7	8076	3	(	(	-LRB-
cord-005453-4057qib7	8076	4	20	20	CD
cord-005453-4057qib7	8076	5	%	%	NN
cord-005453-4057qib7	8076	6	)	)	-RRB-
cord-005453-4057qib7	8076	7	,	,	.
cord-005453-4057qib7	8077	1	BU	BU	NNP
cord-005453-4057qib7	8077	2	+	+	CC
cord-005453-4057qib7	8077	3	CY	CY	NNP
cord-005453-4057qib7	8077	4	+	+	CC
cord-005453-4057qib7	8077	5	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	8077	6	in	in	IN
cord-005453-4057qib7	8077	7	4	4	CD
cord-005453-4057qib7	8077	8	(	(	-LRB-
cord-005453-4057qib7	8077	9	4	4	CD
cord-005453-4057qib7	8077	10	%	%	NN
cord-005453-4057qib7	8077	11	)	)	-RRB-
cord-005453-4057qib7	8077	12	and	and	CC
cord-005453-4057qib7	8077	13	BU	BU	NNP
cord-005453-4057qib7	8077	14	+	+	SYM
cord-005453-4057qib7	8077	15	CY	CY	NNP
cord-005453-4057qib7	8077	16	+	+	CC
cord-005453-4057qib7	8077	17	Antithymocyte	Antithymocyte	NNP
cord-005453-4057qib7	8077	18	Globulin	Globulin	NNP
cord-005453-4057qib7	8077	19	(	(	-LRB-
cord-005453-4057qib7	8077	20	ATG	ATG	NNP
cord-005453-4057qib7	8077	21	)	)	-RRB-
cord-005453-4057qib7	8077	22	in	in	IN
cord-005453-4057qib7	8077	23	81(76	81(76	CD
cord-005453-4057qib7	8077	24	%	%	NN
cord-005453-4057qib7	8077	25	)	)	-RRB-
cord-005453-4057qib7	8077	26	.	.	.
cord-005453-4057qib7	8078	1	Conditioning	conditioning	NN
cord-005453-4057qib7	8078	2	regimens	regimen	NNS
cord-005453-4057qib7	8078	3	for	for	IN
cord-005453-4057qib7	8078	4	aplastic	aplastic	JJ
cord-005453-4057qib7	8078	5	anemia	anemia	NN
cord-005453-4057qib7	8078	6	included	include	VBN
cord-005453-4057qib7	8078	7	,	,	,
cord-005453-4057qib7	8078	8	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	8078	9	(	(	-LRB-
cord-005453-4057qib7	8078	10	FLU	FLU	NNP
cord-005453-4057qib7	8078	11	)	)	-RRB-
cord-005453-4057qib7	8078	12	+	+	SYM
cord-005453-4057qib7	8078	13	CY	CY	NNP
cord-005453-4057qib7	8078	14	in	in	IN
cord-005453-4057qib7	8078	15	38	38	CD
cord-005453-4057qib7	8078	16	(	(	-LRB-
cord-005453-4057qib7	8078	17	33	33	CD
cord-005453-4057qib7	8078	18	%	%	NN
cord-005453-4057qib7	8078	19	)	)	-RRB-
cord-005453-4057qib7	8078	20	,	,	,
cord-005453-4057qib7	8078	21	FLU	FLU	NNP
cord-005453-4057qib7	8078	22	+	+	SYM
cord-005453-4057qib7	8078	23	ATG	ATG	NNP
cord-005453-4057qib7	8078	24	in	in	IN
cord-005453-4057qib7	8078	25	28	28	CD
cord-005453-4057qib7	8078	26	(	(	-LRB-
cord-005453-4057qib7	8078	27	25	25	CD
cord-005453-4057qib7	8078	28	%	%	NN
cord-005453-4057qib7	8078	29	)	)	-RRB-
cord-005453-4057qib7	8078	30	and	and	CC
cord-005453-4057qib7	8078	31	CY	CY	NNP
cord-005453-4057qib7	8078	32	in	in	IN
cord-005453-4057qib7	8078	33	38	38	CD
cord-005453-4057qib7	8078	34	(	(	-LRB-
cord-005453-4057qib7	8078	35	33	33	CD
cord-005453-4057qib7	8078	36	%	%	NN
cord-005453-4057qib7	8078	37	)	)	-RRB-
cord-005453-4057qib7	8078	38	,	,	,
cord-005453-4057qib7	8078	39	CY+	CY+	NNP
cord-005453-4057qib7	8078	40	ATG	ATG	NNP
cord-005453-4057qib7	8078	41	in	in	IN
cord-005453-4057qib7	8078	42	9	9	CD
cord-005453-4057qib7	8078	43	(	(	-LRB-
cord-005453-4057qib7	8078	44	8	8	CD
cord-005453-4057qib7	8078	45	%	%	NN
cord-005453-4057qib7	8078	46	)	)	-RRB-
cord-005453-4057qib7	8078	47	patients	patient	NNS
cord-005453-4057qib7	8078	48	.	.	.
cord-005453-4057qib7	8079	1	For	for	IN
cord-005453-4057qib7	8079	2	Fanconi	Fanconi	NNP
cord-005453-4057qib7	8079	3	's	's	POS
cord-005453-4057qib7	8079	4	Anemia	Anemia	NNP
cord-005453-4057qib7	8079	5	FLU	FLU	NNP
cord-005453-4057qib7	8079	6	+	+	CC
cord-005453-4057qib7	8079	7	ATG	ATG	NNP
cord-005453-4057qib7	8079	8	in	in	IN
cord-005453-4057qib7	8079	9	12	12	CD
cord-005453-4057qib7	8079	10	(	(	-LRB-
cord-005453-4057qib7	8079	11	52	52	CD
cord-005453-4057qib7	8079	12	%	%	NN
cord-005453-4057qib7	8079	13	)	)	-RRB-
cord-005453-4057qib7	8079	14	,	,	,
cord-005453-4057qib7	8079	15	FLU	flu	NN
cord-005453-4057qib7	8079	16	in	in	IN
cord-005453-4057qib7	8079	17	2	2	CD
cord-005453-4057qib7	8079	18	(	(	-LRB-
cord-005453-4057qib7	8079	19	9	9	CD
cord-005453-4057qib7	8079	20	%	%	NN
cord-005453-4057qib7	8079	21	)	)	-RRB-
cord-005453-4057qib7	8079	22	,	,	,
cord-005453-4057qib7	8079	23	CY	CY	NNP
cord-005453-4057qib7	8079	24	+	+	CC
cord-005453-4057qib7	8079	25	ATG	ATG	NNP
cord-005453-4057qib7	8079	26	in	in	IN
cord-005453-4057qib7	8079	27	4	4	CD
cord-005453-4057qib7	8079	28	(	(	-LRB-
cord-005453-4057qib7	8079	29	17	17	CD
cord-005453-4057qib7	8079	30	%	%	NN
cord-005453-4057qib7	8079	31	)	)	-RRB-
cord-005453-4057qib7	8079	32	and	and	CC
cord-005453-4057qib7	8079	33	FLU+	FLU+	NNP
cord-005453-4057qib7	8079	34	CY	CY	NNP
cord-005453-4057qib7	8079	35	+	+	CC
cord-005453-4057qib7	8079	36	ATG	ATG	NNP
cord-005453-4057qib7	8079	37	in	in	IN
cord-005453-4057qib7	8079	38	5	5	CD
cord-005453-4057qib7	8079	39	(	(	-LRB-
cord-005453-4057qib7	8079	40	22	22	CD
cord-005453-4057qib7	8079	41	%	%	NN
cord-005453-4057qib7	8079	42	)	)	-RRB-
cord-005453-4057qib7	8079	43	.	.	.
cord-005453-4057qib7	8080	1	FLU	FLU	NNP
cord-005453-4057qib7	8080	2	+	+	SYM
cord-005453-4057qib7	8080	3	ATG	ATG	NNP
cord-005453-4057qib7	8080	4	in	in	IN
cord-005453-4057qib7	8080	5	2(25	2(25	CD
cord-005453-4057qib7	8080	6	%	%	NN
cord-005453-4057qib7	8080	7	)	)	-RRB-
cord-005453-4057qib7	8080	8	and	and	CC
cord-005453-4057qib7	8080	9	Cy	Cy	NNP
cord-005453-4057qib7	8080	10	given	give	VBN
cord-005453-4057qib7	8080	11	in	in	IN
cord-005453-4057qib7	8080	12	4	4	CD
cord-005453-4057qib7	8080	13	(	(	-LRB-
cord-005453-4057qib7	8080	14	50	50	CD
cord-005453-4057qib7	8080	15	%	%	NN
cord-005453-4057qib7	8080	16	)	)	-RRB-
cord-005453-4057qib7	8080	17	and	and	CC
cord-005453-4057qib7	8080	18	no	no	DT
cord-005453-4057qib7	8080	19	conditioning	conditioning	NN
cord-005453-4057qib7	8080	20	regimen	regimen	NN
cord-005453-4057qib7	8080	21	was	be	VBD
cord-005453-4057qib7	8080	22	offered	offer	VBN
cord-005453-4057qib7	8080	23	to	to	IN
cord-005453-4057qib7	8080	24	2	2	CD
cord-005453-4057qib7	8080	25	(	(	-LRB-
cord-005453-4057qib7	8080	26	25	25	CD
cord-005453-4057qib7	8080	27	%	%	NN
cord-005453-4057qib7	8080	28	)	)	-RRB-
cord-005453-4057qib7	8080	29	patients	patient	NNS
cord-005453-4057qib7	8080	30	with	with	IN
cord-005453-4057qib7	8080	31	SCID	SCID	NNP
cord-005453-4057qib7	8080	32	.	.	.
cord-005453-4057qib7	8081	1	Results	result	NNS
cord-005453-4057qib7	8081	2	:	:	:
cord-005453-4057qib7	8082	1	A	a	DT
cord-005453-4057qib7	8082	2	total	total	NN
cord-005453-4057qib7	8082	3	of	of	IN
cord-005453-4057qib7	8082	4	250	250	CD
cord-005453-4057qib7	8082	5	allogeneic	allogeneic	NN
cord-005453-4057qib7	8082	6	transplants	transplant	NNS
cord-005453-4057qib7	8082	7	were	be	VBD
cord-005453-4057qib7	8082	8	performed	perform	VBN
cord-005453-4057qib7	8082	9	for	for	IN
cord-005453-4057qib7	8082	10	benign	benign	JJ
cord-005453-4057qib7	8082	11	hematological	hematological	JJ
cord-005453-4057qib7	8082	12	disorders	disorder	NNS
cord-005453-4057qib7	8082	13	including	include	VBG
cord-005453-4057qib7	8082	14	AA	AA	NNP
cord-005453-4057qib7	8082	15	(	(	-LRB-
cord-005453-4057qib7	8082	16	n=113	n=113	NNP
cord-005453-4057qib7	8082	17	)	)	-RRB-
cord-005453-4057qib7	8082	18	,	,	,
cord-005453-4057qib7	8082	19	BTM	BTM	NNP
cord-005453-4057qib7	8082	20	(	(	-LRB-
cord-005453-4057qib7	8082	21	n=106	n=106	NNP
cord-005453-4057qib7	8082	22	)	)	-RRB-
cord-005453-4057qib7	8082	23	,	,	,
cord-005453-4057qib7	8082	24	FA	FA	NNP
cord-005453-4057qib7	8082	25	(	(	-LRB-
cord-005453-4057qib7	8082	26	n=23	n=23	NNP
cord-005453-4057qib7	8082	27	)	)	-RRB-
cord-005453-4057qib7	8082	28	and	and	CC
cord-005453-4057qib7	8082	29	SCID	SCID	NNP
cord-005453-4057qib7	8082	30	(	(	-LRB-
cord-005453-4057qib7	8082	31	n=8	n=8	NN
cord-005453-4057qib7	8082	32	)	)	-RRB-
cord-005453-4057qib7	8082	33	from	from	IN
cord-005453-4057qib7	8082	34	2011	2011	CD
cord-005453-4057qib7	8082	35	to	to	IN
cord-005453-4057qib7	8082	36	July	July	NNP
cord-005453-4057qib7	8082	37	2018	2018	CD
cord-005453-4057qib7	8082	38	.	.	.
cord-005453-4057qib7	8083	1	Median	median	JJ
cord-005453-4057qib7	8083	2	age	age	NN
cord-005453-4057qib7	8083	3	was	be	VBD
cord-005453-4057qib7	8083	4	7.5	7.5	CD
cord-005453-4057qib7	8083	5	years	year	NNS
cord-005453-4057qib7	8083	6	(	(	-LRB-
cord-005453-4057qib7	8083	7	range	range	VBP
cord-005453-4057qib7	8083	8	0.5	0.5	CD
cord-005453-4057qib7	8083	9	-48	-48	CD
cord-005453-4057qib7	8083	10	)	)	-RRB-
cord-005453-4057qib7	8083	11	.	.	.
cord-005453-4057qib7	8084	1	Across	across	IN
cord-005453-4057qib7	8084	2	the	the	DT
cord-005453-4057qib7	8084	3	gender	gender	NN
cord-005453-4057qib7	8084	4	and	and	CC
cord-005453-4057qib7	8084	5	ABO	ABO	NNP
cord-005453-4057qib7	8084	6	blood	blood	NN
cord-005453-4057qib7	8084	7	group	group	NN
cord-005453-4057qib7	8084	8	transplants	transplant	NNS
cord-005453-4057qib7	8084	9	were	be	VBD
cord-005453-4057qib7	8084	10	109	109	CD
cord-005453-4057qib7	8084	11	(	(	-LRB-
cord-005453-4057qib7	8084	12	43.6	43.6	CD
cord-005453-4057qib7	8084	13	%	%	NN
cord-005453-4057qib7	8084	14	)	)	-RRB-
cord-005453-4057qib7	8084	15	and	and	CC
cord-005453-4057qib7	8084	16	80	80	CD
cord-005453-4057qib7	8084	17	(	(	-LRB-
cord-005453-4057qib7	8084	18	32	32	CD
cord-005453-4057qib7	8084	19	%	%	NN
cord-005453-4057qib7	8084	20	)	)	-RRB-
cord-005453-4057qib7	8084	21	.	.	.
cord-005453-4057qib7	8085	1	The	the	DT
cord-005453-4057qib7	8085	2	median	median	JJ
cord-005453-4057qib7	8085	3	time	time	NN
cord-005453-4057qib7	8085	4	to	to	IN
cord-005453-4057qib7	8085	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	8085	6	and	and	CC
cord-005453-4057qib7	8085	7	platelet	platelet	NN
cord-005453-4057qib7	8085	8	recovery	recovery	NN
cord-005453-4057qib7	8085	9	was	be	VBD
cord-005453-4057qib7	8085	10	13	13	CD
cord-005453-4057qib7	8085	11	days	day	NNS
cord-005453-4057qib7	8086	1	(	(	-LRB-
cord-005453-4057qib7	8086	2	range	range	NN
cord-005453-4057qib7	8086	3	:	:	:
cord-005453-4057qib7	8086	4	9	9	CD
cord-005453-4057qib7	8086	5	-	-	SYM
cord-005453-4057qib7	8086	6	46	46	CD
cord-005453-4057qib7	8086	7	)	)	-RRB-
cord-005453-4057qib7	8086	8	and	and	CC
cord-005453-4057qib7	8086	9	18	18	CD
cord-005453-4057qib7	8086	10	(	(	-LRB-
cord-005453-4057qib7	8086	11	range	range	NN
cord-005453-4057qib7	8086	12	:	:	:
cord-005453-4057qib7	8086	13	10	10	CD
cord-005453-4057qib7	8086	14	-	-	SYM
cord-005453-4057qib7	8086	15	35	35	CD
cord-005453-4057qib7	8086	16	)	)	-RRB-
cord-005453-4057qib7	8086	17	.	.	.
cord-005453-4057qib7	8087	1	Primary	primary	JJ
cord-005453-4057qib7	8087	2	and	and	CC
cord-005453-4057qib7	8087	3	secondary	secondary	JJ
cord-005453-4057qib7	8087	4	graft	graft	NN
cord-005453-4057qib7	8087	5	failure	failure	NN
cord-005453-4057qib7	8087	6	was	be	VBD
cord-005453-4057qib7	8087	7	observed	observe	VBN
cord-005453-4057qib7	8087	8	in	in	IN
cord-005453-4057qib7	8087	9	34	34	CD
cord-005453-4057qib7	8087	10	(	(	-LRB-
cord-005453-4057qib7	8087	11	13.6	13.6	CD
cord-005453-4057qib7	8087	12	%	%	NN
cord-005453-4057qib7	8087	13	)	)	-RRB-
cord-005453-4057qib7	8087	14	and	and	CC
cord-005453-4057qib7	8087	15	29	29	CD
cord-005453-4057qib7	8087	16	(	(	-LRB-
cord-005453-4057qib7	8087	17	11.6	11.6	CD
cord-005453-4057qib7	8087	18	%	%	NN
cord-005453-4057qib7	8087	19	)	)	-RRB-
cord-005453-4057qib7	8087	20	.	.	.
cord-005453-4057qib7	8088	1	Overall	overall	JJ
cord-005453-4057qib7	8088	2	survival	survival	NN
cord-005453-4057qib7	8088	3	in	in	IN
cord-005453-4057qib7	8088	4	aplastic	aplastic	JJ
cord-005453-4057qib7	8088	5	anemia	anemia	NN
cord-005453-4057qib7	8088	6	(	(	-LRB-
cord-005453-4057qib7	8088	7	63/113	63/113	CD
cord-005453-4057qib7	8088	8	,	,	,
cord-005453-4057qib7	8088	9	56	56	CD
cord-005453-4057qib7	8088	10	%	%	NN
cord-005453-4057qib7	8088	11	)	)	-RRB-
cord-005453-4057qib7	8088	12	,	,	,
cord-005453-4057qib7	8088	13	beta	beta	NN
cord-005453-4057qib7	8088	14	thalassemia	thalassemia	NN
cord-005453-4057qib7	8088	15	(	(	-LRB-
cord-005453-4057qib7	8088	16	82/106	82/106	CD
cord-005453-4057qib7	8088	17	,	,	,
cord-005453-4057qib7	8088	18	77%),fanconi	77%),fanconi	CD
cord-005453-4057qib7	8088	19	's	's	POS
cord-005453-4057qib7	8088	20	anemia	anemia	NN
cord-005453-4057qib7	8088	21	(	(	-LRB-
cord-005453-4057qib7	8088	22	15/23	15/23	CD
cord-005453-4057qib7	8088	23	,	,	,
cord-005453-4057qib7	8088	24	65	65	CD
cord-005453-4057qib7	8088	25	%	%	NN
cord-005453-4057qib7	8088	26	)	)	-RRB-
cord-005453-4057qib7	8088	27	and	and	CC
cord-005453-4057qib7	8088	28	severe	severe	JJ
cord-005453-4057qib7	8088	29	combined	combine	VBN
cord-005453-4057qib7	8088	30	immune	immune	JJ
cord-005453-4057qib7	8088	31	deficiency	deficiency	NN
cord-005453-4057qib7	8088	32	disorder	disorder	NN
cord-005453-4057qib7	8088	33	(	(	-LRB-
cord-005453-4057qib7	8088	34	6/8	6/8	CD
cord-005453-4057qib7	8088	35	,	,	,
cord-005453-4057qib7	8088	36	75	75	CD
cord-005453-4057qib7	8088	37	%	%	NN
cord-005453-4057qib7	8088	38	)	)	-RRB-
cord-005453-4057qib7	8088	39	.	.	.
cord-005453-4057qib7	8089	1	Eighty	eighty	CD
cord-005453-4057qib7	8089	2	four	four	CD
cord-005453-4057qib7	8089	3	patients	patient	NNS
cord-005453-4057qib7	8089	4	expired	expire	VBD
cord-005453-4057qib7	8089	5	(	(	-LRB-
cord-005453-4057qib7	8089	6	33.6	33.6	CD
cord-005453-4057qib7	8089	7	%	%	NN
cord-005453-4057qib7	8089	8	)	)	-RRB-
cord-005453-4057qib7	8089	9	among	among	IN
cord-005453-4057qib7	8089	10	them	-PRON-	PRP
cord-005453-4057qib7	8089	11	41	41	CD
cord-005453-4057qib7	8089	12	patients	patient	NNS
cord-005453-4057qib7	8089	13	expired	expire	VBD
cord-005453-4057qib7	8089	14	within	within	IN
cord-005453-4057qib7	8089	15	100	100	CD
cord-005453-4057qib7	8089	16	days	day	NNS
cord-005453-4057qib7	8089	17	post	post	NN
cord-005453-4057qib7	8089	18	transplant	transplant	NN
cord-005453-4057qib7	8089	19	Main	main	JJ
cord-005453-4057qib7	8089	20	cause	cause	NN
cord-005453-4057qib7	8089	21	of	of	IN
cord-005453-4057qib7	8089	22	deaths	death	NNS
cord-005453-4057qib7	8089	23	included	include	VBD
cord-005453-4057qib7	8089	24	sepsis	sepsis	NN
cord-005453-4057qib7	8089	25	(	(	-LRB-
cord-005453-4057qib7	8089	26	31	31	CD
cord-005453-4057qib7	8089	27	%	%	NN
cord-005453-4057qib7	8089	28	)	)	-RRB-
cord-005453-4057qib7	8089	29	,	,	,
cord-005453-4057qib7	8089	30	multi	multi	JJ
cord-005453-4057qib7	8089	31	organ	organ	NN
cord-005453-4057qib7	8089	32	failure	failure	NN
cord-005453-4057qib7	8089	33	(	(	-LRB-
cord-005453-4057qib7	8089	34	6	6	CD
cord-005453-4057qib7	8089	35	%	%	NN
cord-005453-4057qib7	8089	36	)	)	-RRB-
cord-005453-4057qib7	8089	37	and	and	CC
cord-005453-4057qib7	8089	38	Gut	Gut	NNP
cord-005453-4057qib7	8089	39	GvHD	GvHD	NNP
cord-005453-4057qib7	8089	40	(	(	-LRB-
cord-005453-4057qib7	8089	41	5	5	CD
cord-005453-4057qib7	8089	42	%	%	NN
cord-005453-4057qib7	8089	43	)	)	-RRB-
cord-005453-4057qib7	8090	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8090	2	:	:	:
cord-005453-4057qib7	8091	1	In	in	IN
cord-005453-4057qib7	8091	2	developing	develop	VBG
cord-005453-4057qib7	8091	3	world	world	NN
cord-005453-4057qib7	8091	4	scenario	scenario	NN
cord-005453-4057qib7	8091	5	where	where	WRB
cord-005453-4057qib7	8091	6	non	non	JJ
cord-005453-4057qib7	8091	7	malignant	malignant	JJ
cord-005453-4057qib7	8091	8	disorders	disorder	NNS
cord-005453-4057qib7	8091	9	are	be	VBP
cord-005453-4057qib7	8091	10	leading	lead	VBG
cord-005453-4057qib7	8091	11	cause	cause	NN
cord-005453-4057qib7	8091	12	of	of	IN
cord-005453-4057qib7	8091	13	morbidity	morbidity	NN
cord-005453-4057qib7	8091	14	and	and	CC
cord-005453-4057qib7	8091	15	mortality	mortality	NN
cord-005453-4057qib7	8091	16	.	.	.
cord-005453-4057qib7	8092	1	Bone	Bone	NNP
cord-005453-4057qib7	8092	2	Marrow	Marrow	NNP
cord-005453-4057qib7	8092	3	Transplantation	transplantation	NN
cord-005453-4057qib7	8092	4	has	have	VBZ
cord-005453-4057qib7	8092	5	been	be	VBN
cord-005453-4057qib7	8092	6	successfully	successfully	RB
cord-005453-4057qib7	8092	7	implemented	implement	VBN
cord-005453-4057qib7	8092	8	with	with	IN
cord-005453-4057qib7	8092	9	better	well	JJR
cord-005453-4057qib7	8092	10	long	long	JJ
cord-005453-4057qib7	8092	11	term	term	NN
cord-005453-4057qib7	8092	12	diseases	disease	NNS
cord-005453-4057qib7	8092	13	free	free	JJ
cord-005453-4057qib7	8092	14	survival	survival	NN
cord-005453-4057qib7	8092	15	and	and	CC
cord-005453-4057qib7	8092	16	quality	quality	NN
cord-005453-4057qib7	8092	17	of	of	IN
cord-005453-4057qib7	8092	18	life	life	NN
cord-005453-4057qib7	8092	19	.	.	.
cord-005453-4057qib7	8093	1	Clinical	clinical	JJ
cord-005453-4057qib7	8093	2	Background	background	NN
cord-005453-4057qib7	8093	3	:	:	:
cord-005453-4057qib7	8093	4	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8093	5	cell	cell	NN
cord-005453-4057qib7	8093	6	transplantation	transplantation	NN
cord-005453-4057qib7	8093	7	(	(	-LRB-
cord-005453-4057qib7	8093	8	HCT	HCT	NNP
cord-005453-4057qib7	8093	9	)	)	-RRB-
cord-005453-4057qib7	8093	10	remains	remain	VBZ
cord-005453-4057qib7	8093	11	the	the	DT
cord-005453-4057qib7	8093	12	only	only	JJ
cord-005453-4057qib7	8093	13	curative	curative	JJ
cord-005453-4057qib7	8093	14	therapy	therapy	NN
cord-005453-4057qib7	8093	15	for	for	IN
cord-005453-4057qib7	8093	16	many	many	JJ
cord-005453-4057qib7	8093	17	diseases	disease	NNS
cord-005453-4057qib7	8093	18	,	,	,
cord-005453-4057qib7	8093	19	yet	yet	CC
cord-005453-4057qib7	8093	20	transplant	transplant	NN
cord-005453-4057qib7	8093	21	survivors	survivor	NNS
cord-005453-4057qib7	8093	22	carry	carry	VBP
cord-005453-4057qib7	8093	23	an	an	DT
cord-005453-4057qib7	8093	24	unusually	unusually	RB
cord-005453-4057qib7	8093	25	high	high	JJ
cord-005453-4057qib7	8093	26	burden	burden	NN
cord-005453-4057qib7	8093	27	of	of	IN
cord-005453-4057qib7	8093	28	morbidities	morbidity	NNS
cord-005453-4057qib7	8093	29	,	,	,
cord-005453-4057qib7	8093	30	primarily	primarily	RB
cord-005453-4057qib7	8093	31	because	because	IN
cord-005453-4057qib7	8093	32	of	of	IN
cord-005453-4057qib7	8093	33	exposure	exposure	NN
cord-005453-4057qib7	8093	34	to	to	IN
cord-005453-4057qib7	8093	35	intense	intense	JJ
cord-005453-4057qib7	8093	36	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8093	37	,	,	,
cord-005453-4057qib7	8093	38	radiation	radiation	NN
cord-005453-4057qib7	8093	39	and	and	CC
cord-005453-4057qib7	8093	40	/or	/or	.
cord-005453-4057qib7	8093	41	GVHD	GVHD	NNP
cord-005453-4057qib7	8093	42	.	.	.
cord-005453-4057qib7	8094	1	This	this	DT
cord-005453-4057qib7	8094	2	study	study	NN
cord-005453-4057qib7	8094	3	aimed	aim	VBD
cord-005453-4057qib7	8094	4	to	to	TO
cord-005453-4057qib7	8094	5	evaluate	evaluate	VB
cord-005453-4057qib7	8094	6	the	the	DT
cord-005453-4057qib7	8094	7	burden	burden	NN
cord-005453-4057qib7	8094	8	of	of	IN
cord-005453-4057qib7	8094	9	chronic	chronic	JJ
cord-005453-4057qib7	8094	10	diseases	disease	NNS
cord-005453-4057qib7	8094	11	at	at	IN
cord-005453-4057qib7	8094	12	the	the	DT
cord-005453-4057qib7	8094	13	end	end	NN
cord-005453-4057qib7	8094	14	of	of	IN
cord-005453-4057qib7	8094	15	life	life	NN
cord-005453-4057qib7	8094	16	after	after	IN
cord-005453-4057qib7	8094	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	8094	18	-	-	HYPH
cord-005453-4057qib7	8094	19	HCT	hct	NN
cord-005453-4057qib7	8094	20	and	and	CC
cord-005453-4057qib7	8094	21	to	to	TO
cord-005453-4057qib7	8094	22	identify	identify	VB
cord-005453-4057qib7	8094	23	the	the	DT
cord-005453-4057qib7	8094	24	disability	disability	NN
cord-005453-4057qib7	8094	25	-	-	HYPH
cord-005453-4057qib7	8094	26	adjusted	adjust	VBN
cord-005453-4057qib7	8094	27	life	life	NN
cord-005453-4057qib7	8094	28	years	year	NNS
cord-005453-4057qib7	8094	29	(	(	-LRB-
cord-005453-4057qib7	8094	30	DALY	DALY	NNP
cord-005453-4057qib7	8094	31	)	)	-RRB-
cord-005453-4057qib7	8094	32	.	.	.
cord-005453-4057qib7	8095	1	Methods	method	NNS
cord-005453-4057qib7	8095	2	:	:	:
cord-005453-4057qib7	8095	3	The	the	DT
cord-005453-4057qib7	8095	4	PubMed	PubMed	NNP
cord-005453-4057qib7	8095	5	,	,	,
cord-005453-4057qib7	8095	6	MEDLINE	MEDLINE	NNP
cord-005453-4057qib7	8095	7	,	,	,
cord-005453-4057qib7	8095	8	and	and	CC
cord-005453-4057qib7	8095	9	OVID	OVID	NNP
cord-005453-4057qib7	8095	10	databases	database	NNS
cord-005453-4057qib7	8095	11	were	be	VBD
cord-005453-4057qib7	8095	12	queried	query	VBN
cord-005453-4057qib7	8095	13	utilizing	utilize	VBG
cord-005453-4057qib7	8095	14	specific	specific	JJ
cord-005453-4057qib7	8095	15	MeSH	mesh	JJ
cord-005453-4057qib7	8095	16	terminology	terminology	NN
cord-005453-4057qib7	8095	17	(	(	-LRB-
cord-005453-4057qib7	8095	18	post	post	AFX
cord-005453-4057qib7	8095	19	,	,	,
cord-005453-4057qib7	8095	20	allo	allo	VB
cord-005453-4057qib7	8095	21	stem	stem	NN
cord-005453-4057qib7	8095	22	cell	cell	NN
cord-005453-4057qib7	8095	23	,	,	,
cord-005453-4057qib7	8095	24	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8095	25	,	,	,
cord-005453-4057qib7	8095	26	bone	bone	NN
cord-005453-4057qib7	8095	27	marrow	marrow	NN
cord-005453-4057qib7	8095	28	,	,	,
cord-005453-4057qib7	8095	29	transplantation).We	transplantation).We	NNP
cord-005453-4057qib7	8095	30	collected	collect	VBD
cord-005453-4057qib7	8095	31	data	datum	NNS
cord-005453-4057qib7	8095	32	on	on	IN
cord-005453-4057qib7	8095	33	the	the	DT
cord-005453-4057qib7	8095	34	impact	impact	NN
cord-005453-4057qib7	8095	35	of	of	IN
cord-005453-4057qib7	8095	36	the	the	DT
cord-005453-4057qib7	8095	37	HCT	hct	NN
cord-005453-4057qib7	8095	38	on	on	IN
cord-005453-4057qib7	8095	39	the	the	DT
cord-005453-4057qib7	8095	40	variables	variable	NNS
cord-005453-4057qib7	8095	41	affecting	affect	VBG
cord-005453-4057qib7	8095	42	survivor	survivor	NN
cord-005453-4057qib7	8095	43	's	's	POS
cord-005453-4057qib7	8095	44	health	health	NN
cord-005453-4057qib7	8095	45	in	in	IN
cord-005453-4057qib7	8095	46	all	all	DT
cord-005453-4057qib7	8095	47	aspects	aspect	NNS
cord-005453-4057qib7	8095	48	.The	.The	.
cord-005453-4057qib7	8096	1	rates	rate	NNS
cord-005453-4057qib7	8096	2	of	of	IN
cord-005453-4057qib7	8096	3	late	late	JJ
cord-005453-4057qib7	8096	4	complications	complication	NNS
cord-005453-4057qib7	8096	5	were	be	VBD
cord-005453-4057qib7	8096	6	compared	compare	VBN
cord-005453-4057qib7	8096	7	to	to	IN
cord-005453-4057qib7	8096	8	the	the	DT
cord-005453-4057qib7	8096	9	risks	risk	NNS
cord-005453-4057qib7	8096	10	in	in	IN
cord-005453-4057qib7	8096	11	the	the	DT
cord-005453-4057qib7	8096	12	general	general	JJ
cord-005453-4057qib7	8096	13	population	population	NN
cord-005453-4057qib7	8096	14	(	(	-LRB-
cord-005453-4057qib7	8096	15	United	United	NNP
cord-005453-4057qib7	8096	16	States	States	NNP
cord-005453-4057qib7	8096	17	)	)	-RRB-
cord-005453-4057qib7	8096	18	.	.	.
cord-005453-4057qib7	8097	1	Results	result	NNS
cord-005453-4057qib7	8097	2	:	:	:
cord-005453-4057qib7	8098	1	A	a	DT
cord-005453-4057qib7	8098	2	total	total	NN
cord-005453-4057qib7	8098	3	of	of	IN
cord-005453-4057qib7	8098	4	7	7	CD
cord-005453-4057qib7	8098	5	studies	study	NNS
cord-005453-4057qib7	8098	6	fulfilled	fulfil	VBD
cord-005453-4057qib7	8098	7	the	the	DT
cord-005453-4057qib7	8098	8	selection	selection	NN
cord-005453-4057qib7	8098	9	criteria	criterion	NNS
cord-005453-4057qib7	8098	10	totaling	total	VBG
cord-005453-4057qib7	8098	11	to	to	IN
cord-005453-4057qib7	8098	12	6619	6619	CD
cord-005453-4057qib7	8098	13	patients	patient	NNS
cord-005453-4057qib7	8098	14	(	(	-LRB-
cord-005453-4057qib7	8098	15	Table	table	NN
cord-005453-4057qib7	8098	16	1	1	CD
cord-005453-4057qib7	8098	17	)	)	-RRB-
cord-005453-4057qib7	8098	18	.	.	.
cord-005453-4057qib7	8099	1	Median	median	JJ
cord-005453-4057qib7	8099	2	OS	OS	NNP
cord-005453-4057qib7	8099	3	at	at	IN
cord-005453-4057qib7	8099	4	5-year	5-year	CD
cord-005453-4057qib7	8099	5	mark	mark	NN
cord-005453-4057qib7	8099	6	varied	vary	VBN
cord-005453-4057qib7	8099	7	widely	widely	RB
cord-005453-4057qib7	8099	8	between	between	IN
cord-005453-4057qib7	8099	9	studies	study	NNS
cord-005453-4057qib7	8099	10	from	from	IN
cord-005453-4057qib7	8099	11	19	19	CD
cord-005453-4057qib7	8099	12	%	%	NN
cord-005453-4057qib7	8099	13	to	to	IN
cord-005453-4057qib7	8099	14	92	92	CD
cord-005453-4057qib7	8099	15	%	%	NN
cord-005453-4057qib7	8099	16	.	.	.
cord-005453-4057qib7	8100	1	Majority	majority	NN
cord-005453-4057qib7	8100	2	of	of	IN
cord-005453-4057qib7	8100	3	the	the	DT
cord-005453-4057qib7	8100	4	patients	patient	NNS
cord-005453-4057qib7	8100	5	at	at	IN
cord-005453-4057qib7	8100	6	10-year	10-year	CD
cord-005453-4057qib7	8100	7	mark	mark	NN
cord-005453-4057qib7	8100	8	were	be	VBD
cord-005453-4057qib7	8100	9	found	find	VBN
cord-005453-4057qib7	8100	10	to	to	TO
cord-005453-4057qib7	8100	11	have	have	VB
cord-005453-4057qib7	8100	12	new	new	JJ
cord-005453-4057qib7	8100	13	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	8100	14	thereby	thereby	RB
cord-005453-4057qib7	8100	15	indicating	indicate	VBG
cord-005453-4057qib7	8100	16	a	a	DT
cord-005453-4057qib7	8100	17	huge	huge	JJ
cord-005453-4057qib7	8100	18	burden	burden	NN
cord-005453-4057qib7	8100	19	of	of	IN
cord-005453-4057qib7	8100	20	late	late	JJ
cord-005453-4057qib7	8100	21	effects	effect	NNS
cord-005453-4057qib7	8100	22	at	at	IN
cord-005453-4057qib7	8100	23	the	the	DT
cord-005453-4057qib7	8100	24	end	end	NN
cord-005453-4057qib7	8100	25	of	of	IN
cord-005453-4057qib7	8100	26	life	life	NN
cord-005453-4057qib7	8100	27	,	,	,
cord-005453-4057qib7	8100	28	though	though	IN
cord-005453-4057qib7	8100	29	exact	exact	JJ
cord-005453-4057qib7	8100	30	DALYs	daly	NNS
cord-005453-4057qib7	8100	31	could	could	MD
cord-005453-4057qib7	8100	32	not	not	RB
cord-005453-4057qib7	8100	33	be	be	VB
cord-005453-4057qib7	8100	34	calculated	calculate	VBN
cord-005453-4057qib7	8100	35	due	due	IN
cord-005453-4057qib7	8100	36	to	to	IN
cord-005453-4057qib7	8100	37	incomplete	incomplete	JJ
cord-005453-4057qib7	8100	38	data	datum	NNS
cord-005453-4057qib7	8100	39	.	.	.
cord-005453-4057qib7	8101	1	HCT	HCT	NNP
cord-005453-4057qib7	8101	2	survivors	survivor	NNS
cord-005453-4057qib7	8101	3	were	be	VBD
cord-005453-4057qib7	8101	4	found	find	VBN
cord-005453-4057qib7	8101	5	to	to	TO
cord-005453-4057qib7	8101	6	have	have	VB
cord-005453-4057qib7	8101	7	higher	high	JJR
cord-005453-4057qib7	8101	8	risk	risk	NN
cord-005453-4057qib7	8101	9	of	of	IN
cord-005453-4057qib7	8101	10	premature	premature	JJ
cord-005453-4057qib7	8101	11	arterial	arterial	JJ
cord-005453-4057qib7	8101	12	disease	disease	NN
cord-005453-4057qib7	8101	13	(	(	-LRB-
cord-005453-4057qib7	8101	14	PAD	pad	NN
cord-005453-4057qib7	8101	15	)	)	-RRB-
cord-005453-4057qib7	8101	16	at	at	IN
cord-005453-4057qib7	8101	17	6.8	6.8	CD
cord-005453-4057qib7	8101	18	%	%	NN
cord-005453-4057qib7	8101	19	compared	compare	VBN
cord-005453-4057qib7	8101	20	to	to	IN
cord-005453-4057qib7	8101	21	the	the	DT
cord-005453-4057qib7	8101	22	general	general	JJ
cord-005453-4057qib7	8101	23	population	population	NN
cord-005453-4057qib7	8101	24	,	,	,
cord-005453-4057qib7	8101	25	however	however	RB
cord-005453-4057qib7	8101	26	GVHD	GVHD	NNP
cord-005453-4057qib7	8101	27	or	or	CC
cord-005453-4057qib7	8101	28	the	the	DT
cord-005453-4057qib7	8101	29	addition	addition	NN
cord-005453-4057qib7	8101	30	of	of	IN
cord-005453-4057qib7	8101	31	TBI	TBI	NNP
cord-005453-4057qib7	8101	32	to	to	IN
cord-005453-4057qib7	8101	33	the	the	DT
cord-005453-4057qib7	8101	34	conditioning	conditioning	NN
cord-005453-4057qib7	8101	35	regimen	regimen	NN
cord-005453-4057qib7	8101	36	were	be	VBD
cord-005453-4057qib7	8101	37	not	not	RB
cord-005453-4057qib7	8101	38	found	find	VBN
cord-005453-4057qib7	8101	39	to	to	TO
cord-005453-4057qib7	8101	40	be	be	VB
cord-005453-4057qib7	8101	41	significantly	significantly	RB
cord-005453-4057qib7	8101	42	associated	associate	VBN
cord-005453-4057qib7	8101	43	with	with	IN
cord-005453-4057qib7	8101	44	PAD	pad	NN
cord-005453-4057qib7	8101	45	.	.	.
cord-005453-4057qib7	8102	1	Regarding	regard	VBG
cord-005453-4057qib7	8102	2	the	the	DT
cord-005453-4057qib7	8102	3	risk	risk	NN
cord-005453-4057qib7	8102	4	of	of	IN
cord-005453-4057qib7	8102	5	new	new	JJ
cord-005453-4057qib7	8102	6	cancers	cancer	NNS
cord-005453-4057qib7	8102	7	,	,	,
cord-005453-4057qib7	8102	8	the	the	DT
cord-005453-4057qib7	8102	9	cumulative	cumulative	JJ
cord-005453-4057qib7	8102	10	incidence	incidence	NN
cord-005453-4057qib7	8102	11	of	of	IN
cord-005453-4057qib7	8102	12	their	-PRON-	PRP$
cord-005453-4057qib7	8102	13	development	development	NN
cord-005453-4057qib7	8102	14	at	at	IN
cord-005453-4057qib7	8102	15	5	5	CD
cord-005453-4057qib7	8102	16	and	and	CC
cord-005453-4057qib7	8102	17	10	10	CD
cord-005453-4057qib7	8102	18	years	year	NNS
cord-005453-4057qib7	8102	19	was	be	VBD
cord-005453-4057qib7	8102	20	1.71	1.71	CD
cord-005453-4057qib7	8102	21	,	,	,
cord-005453-4057qib7	8102	22	and	and	CC
cord-005453-4057qib7	8102	23	3.61	3.61	CD
cord-005453-4057qib7	8102	24	,	,	,
cord-005453-4057qib7	8102	25	respectively	respectively	RB
cord-005453-4057qib7	8102	26	.	.	.
cord-005453-4057qib7	8103	1	Increased	increase	VBN
cord-005453-4057qib7	8103	2	risks	risk	NNS
cord-005453-4057qib7	8103	3	compared	compare	VBN
cord-005453-4057qib7	8103	4	with	with	IN
cord-005453-4057qib7	8103	5	the	the	DT
cord-005453-4057qib7	8103	6	general	general	JJ
cord-005453-4057qib7	8103	7	population	population	NN
cord-005453-4057qib7	8103	8	were	be	VBD
cord-005453-4057qib7	8103	9	seen	see	VBN
cord-005453-4057qib7	8103	10	for	for	IN
cord-005453-4057qib7	8103	11	some	some	DT
cord-005453-4057qib7	8103	12	solid	solid	JJ
cord-005453-4057qib7	8103	13	cancer	cancer	NN
cord-005453-4057qib7	8103	14	including	include	VBG
cord-005453-4057qib7	8103	15	cancers	cancer	NNS
cord-005453-4057qib7	8103	16	of	of	IN
cord-005453-4057qib7	8103	17	the	the	DT
cord-005453-4057qib7	8103	18	lip	lip	NN
cord-005453-4057qib7	8103	19	:	:	:
cord-005453-4057qib7	8103	20	P=0.02	p=0.02	NN
cord-005453-4057qib7	8103	21	,	,	,
cord-005453-4057qib7	8103	22	tonsils	tonsil	NNS
cord-005453-4057qib7	8103	23	:	:	:
cord-005453-4057qib7	8104	1	P=0.05	P=0.05	NNP
cord-005453-4057qib7	8104	2	,	,	,
cord-005453-4057qib7	8104	3	oropharynx	oropharynx	NN
cord-005453-4057qib7	8104	4	:	:	:
cord-005453-4057qib7	8105	1	P	p	NN
cord-005453-4057qib7	8105	2	<	<	XX
cord-005453-4057qib7	8105	3	0.01	0.01	CD
cord-005453-4057qib7	8106	1	,	,	,
cord-005453-4057qib7	8106	2	bone	bone	NN
cord-005453-4057qib7	8106	3	:	:	:
cord-005453-4057qib7	8106	4	P	p	NN
cord-005453-4057qib7	8106	5	<	<	XX
cord-005453-4057qib7	8106	6	0.01	0.01	CD
cord-005453-4057qib7	8106	7	,	,	,
cord-005453-4057qib7	8106	8	soft	soft	JJ
cord-005453-4057qib7	8106	9	tissue	tissue	NN
cord-005453-4057qib7	8106	10	:	:	:
cord-005453-4057qib7	8107	1	P	p	NN
cord-005453-4057qib7	8107	2	<	<	XX
cord-005453-4057qib7	8107	3	0.01	0.01	CD
cord-005453-4057qib7	8107	4	,	,	,
cord-005453-4057qib7	8107	5	and	and	CC
cord-005453-4057qib7	8107	6	vulva	vulva	NN
cord-005453-4057qib7	8107	7	:	:	:
cord-005453-4057qib7	8107	8	P=0.01	p=0.01	ADD
cord-005453-4057qib7	8107	9	.	.	.
cord-005453-4057qib7	8108	1	With	with	IN
cord-005453-4057qib7	8108	2	respect	respect	NN
cord-005453-4057qib7	8108	3	to	to	IN
cord-005453-4057qib7	8108	4	mental	mental	JJ
cord-005453-4057qib7	8108	5	health	health	NN
cord-005453-4057qib7	8108	6	,	,	,
cord-005453-4057qib7	8108	7	depression	depression	NN
cord-005453-4057qib7	8108	8	was	be	VBD
cord-005453-4057qib7	8108	9	prevalent	prevalent	JJ
cord-005453-4057qib7	8108	10	in	in	IN
cord-005453-4057qib7	8108	11	(	(	-LRB-
cord-005453-4057qib7	8108	12	10.8	10.8	CD
cord-005453-4057qib7	8108	13	%	%	NN
cord-005453-4057qib7	8108	14	)	)	-RRB-
cord-005453-4057qib7	8108	15	survivors	survivor	NNS
cord-005453-4057qib7	8108	16	,	,	,
cord-005453-4057qib7	8108	17	in	in	IN
cord-005453-4057qib7	8108	18	whom	whom	WP
cord-005453-4057qib7	8108	19	(	(	-LRB-
cord-005453-4057qib7	8108	20	82.5	82.5	CD
cord-005453-4057qib7	8108	21	%	%	NN
cord-005453-4057qib7	8108	22	)	)	-RRB-
cord-005453-4057qib7	8108	23	were	be	VBD
cord-005453-4057qib7	8108	24	still	still	RB
cord-005453-4057qib7	8108	25	on	on	IN
cord-005453-4057qib7	8108	26	antidepressants	antidepressant	NNS
cord-005453-4057qib7	8108	27	at	at	IN
cord-005453-4057qib7	8108	28	the	the	DT
cord-005453-4057qib7	8108	29	last	last	JJ
cord-005453-4057qib7	8108	30	follow	follow	NN
cord-005453-4057qib7	8108	31	-	-	HYPH
cord-005453-4057qib7	8108	32	up	up	NN
cord-005453-4057qib7	8108	33	.	.	.
cord-005453-4057qib7	8109	1	Cognitive	cognitive	JJ
cord-005453-4057qib7	8109	2	impairment	impairment	NN
cord-005453-4057qib7	8109	3	and	and	CC
cord-005453-4057qib7	8109	4	other	other	JJ
cord-005453-4057qib7	8109	5	psychiatric	psychiatric	JJ
cord-005453-4057qib7	8109	6	disorders	disorder	NNS
cord-005453-4057qib7	8109	7	were	be	VBD
cord-005453-4057qib7	8109	8	found	find	VBN
cord-005453-4057qib7	8109	9	in	in	IN
cord-005453-4057qib7	8109	10	(	(	-LRB-
cord-005453-4057qib7	8109	11	2.4	2.4	CD
cord-005453-4057qib7	8109	12	%	%	NN
cord-005453-4057qib7	8109	13	)	)	-RRB-
cord-005453-4057qib7	8109	14	and	and	CC
cord-005453-4057qib7	8109	15	(	(	-LRB-
cord-005453-4057qib7	8109	16	2.7	2.7	CD
cord-005453-4057qib7	8109	17	%	%	NN
cord-005453-4057qib7	8109	18	)	)	-RRB-
cord-005453-4057qib7	8109	19	survivors	survivor	NNS
cord-005453-4057qib7	8109	20	,	,	,
cord-005453-4057qib7	8109	21	respectively	respectively	RB
cord-005453-4057qib7	8109	22	.	.	.
cord-005453-4057qib7	8110	1	The	the	DT
cord-005453-4057qib7	8110	2	most	most	RBS
cord-005453-4057qib7	8110	3	common	common	JJ
cord-005453-4057qib7	8110	4	cause	cause	NN
cord-005453-4057qib7	8110	5	of	of	IN
cord-005453-4057qib7	8110	6	NRM	NRM	NNP
cord-005453-4057qib7	8110	7	in	in	IN
cord-005453-4057qib7	8110	8	the	the	DT
cord-005453-4057qib7	8110	9	first	first	JJ
cord-005453-4057qib7	8110	10	5	5	CD
cord-005453-4057qib7	8110	11	years	year	NNS
cord-005453-4057qib7	8110	12	was	be	VBD
cord-005453-4057qib7	8110	13	GVHD	GVHD	NNP
cord-005453-4057qib7	8110	14	.	.	.
cord-005453-4057qib7	8111	1	However	however	RB
cord-005453-4057qib7	8111	2	,	,	,
cord-005453-4057qib7	8111	3	after	after	IN
cord-005453-4057qib7	8111	4	10	10	CD
cord-005453-4057qib7	8111	5	years	year	NNS
cord-005453-4057qib7	8111	6	,	,	,
cord-005453-4057qib7	8111	7	the	the	DT
cord-005453-4057qib7	8111	8	leading	lead	VBG
cord-005453-4057qib7	8111	9	cause	cause	NN
cord-005453-4057qib7	8111	10	of	of	IN
cord-005453-4057qib7	8111	11	death	death	NN
cord-005453-4057qib7	8111	12	in	in	IN
cord-005453-4057qib7	8111	13	those	those	DT
cord-005453-4057qib7	8111	14	conditioned	condition	VBN
cord-005453-4057qib7	8111	15	with	with	IN
cord-005453-4057qib7	8111	16	MAC	MAC	NNP
cord-005453-4057qib7	8111	17	regimen	regimen	NN
cord-005453-4057qib7	8111	18	was	be	VBD
cord-005453-4057qib7	8111	19	secondary	secondary	JJ
cord-005453-4057qib7	8111	20	cancer	cancer	NN
cord-005453-4057qib7	8111	21	,	,	,
cord-005453-4057qib7	8111	22	but	but	CC
cord-005453-4057qib7	8111	23	in	in	IN
cord-005453-4057qib7	8111	24	the	the	DT
cord-005453-4057qib7	8111	25	RIC	RIC	NNP
cord-005453-4057qib7	8111	26	group	group	NN
cord-005453-4057qib7	8111	27	,	,	,
cord-005453-4057qib7	8111	28	new	new	JJ
cord-005453-4057qib7	8111	29	cancers	cancer	NNS
cord-005453-4057qib7	8111	30	and	and	CC
cord-005453-4057qib7	8111	31	GVHD	GVHD	NNP
cord-005453-4057qib7	8111	32	contributed	contribute	VBD
cord-005453-4057qib7	8111	33	equally	equally	RB
cord-005453-4057qib7	8111	34	.	.	.
cord-005453-4057qib7	8112	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8112	2	:	:	:
cord-005453-4057qib7	8113	1	HCT	HCT	NNP
cord-005453-4057qib7	8113	2	survivors	survivor	NNS
cord-005453-4057qib7	8113	3	remain	remain	VBP
cord-005453-4057qib7	8113	4	at	at	IN
cord-005453-4057qib7	8113	5	risk	risk	NN
cord-005453-4057qib7	8113	6	of	of	IN
cord-005453-4057qib7	8113	7	significant	significant	JJ
cord-005453-4057qib7	8113	8	complications	complication	NNS
cord-005453-4057qib7	8113	9	which	which	WDT
cord-005453-4057qib7	8113	10	lead	lead	VBP
cord-005453-4057qib7	8113	11	to	to	IN
cord-005453-4057qib7	8113	12	premature	premature	JJ
cord-005453-4057qib7	8113	13	death	death	NN
cord-005453-4057qib7	8113	14	and	and	CC
cord-005453-4057qib7	8113	15	their	-PRON-	PRP$
cord-005453-4057qib7	8113	16	burden	burden	NN
cord-005453-4057qib7	8113	17	of	of	IN
cord-005453-4057qib7	8113	18	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	8113	19	at	at	IN
cord-005453-4057qib7	8113	20	the	the	DT
cord-005453-4057qib7	8113	21	end	end	NN
cord-005453-4057qib7	8113	22	of	of	IN
cord-005453-4057qib7	8113	23	life	life	NN
cord-005453-4057qib7	8113	24	is	be	VBZ
cord-005453-4057qib7	8113	25	significantly	significantly	RB
cord-005453-4057qib7	8113	26	more	more	JJR
cord-005453-4057qib7	8113	27	than	than	IN
cord-005453-4057qib7	8113	28	that	that	DT
cord-005453-4057qib7	8113	29	of	of	IN
cord-005453-4057qib7	8113	30	general	general	JJ
cord-005453-4057qib7	8113	31	population	population	NN
cord-005453-4057qib7	8113	32	.	.	.
cord-005453-4057qib7	8114	1	Background	background	NN
cord-005453-4057qib7	8114	2	:	:	:
cord-005453-4057qib7	8115	1	Late	late	JJ
cord-005453-4057qib7	8115	2	onset	onset	NN
cord-005453-4057qib7	8115	3	Hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	8115	4	cystitis	cystitis	NN
cord-005453-4057qib7	8115	5	(	(	-LRB-
cord-005453-4057qib7	8115	6	HC	HC	NNP
cord-005453-4057qib7	8115	7	)	)	-RRB-
cord-005453-4057qib7	8115	8	is	be	VBZ
cord-005453-4057qib7	8115	9	a	a	DT
cord-005453-4057qib7	8115	10	common	common	JJ
cord-005453-4057qib7	8115	11	complication	complication	NN
cord-005453-4057qib7	8115	12	of	of	IN
cord-005453-4057qib7	8115	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8115	14	stem	stem	NN
cord-005453-4057qib7	8115	15	cell	cell	NN
cord-005453-4057qib7	8115	16	transplantation	transplantation	NN
cord-005453-4057qib7	8115	17	(	(	-LRB-
cord-005453-4057qib7	8115	18	HSCT	HSCT	NNP
cord-005453-4057qib7	8115	19	)	)	-RRB-
cord-005453-4057qib7	8115	20	frequently	frequently	RB
cord-005453-4057qib7	8115	21	associated	associate	VBN
cord-005453-4057qib7	8115	22	with	with	IN
cord-005453-4057qib7	8115	23	reactivation	reactivation	NN
cord-005453-4057qib7	8115	24	of	of	IN
cord-005453-4057qib7	8115	25	BK	BK	NNP
cord-005453-4057qib7	8115	26	virus	virus	NN
cord-005453-4057qib7	8115	27	(	(	-LRB-
cord-005453-4057qib7	8115	28	BK	BK	NNP
cord-005453-4057qib7	8115	29	-	-	HYPH
cord-005453-4057qib7	8115	30	HC).There	HC).There	NNP
cord-005453-4057qib7	8115	31	is	be	VBZ
cord-005453-4057qib7	8115	32	no	no	DT
cord-005453-4057qib7	8115	33	consensus	consensus	NN
cord-005453-4057qib7	8115	34	as	as	IN
cord-005453-4057qib7	8115	35	to	to	IN
cord-005453-4057qib7	8115	36	the	the	DT
cord-005453-4057qib7	8115	37	best	good	JJS
cord-005453-4057qib7	8115	38	therapy	therapy	NN
cord-005453-4057qib7	8115	39	for	for	IN
cord-005453-4057qib7	8115	40	BK	BK	NNP
cord-005453-4057qib7	8115	41	-	-	HYPH
cord-005453-4057qib7	8115	42	HC	HC	NNP
cord-005453-4057qib7	8115	43	,	,	,
cord-005453-4057qib7	8115	44	and	and	CC
cord-005453-4057qib7	8115	45	many	many	JJ
cord-005453-4057qib7	8115	46	different	different	JJ
cord-005453-4057qib7	8115	47	treatments	treatment	NNS
cord-005453-4057qib7	8115	48	have	have	VBP
cord-005453-4057qib7	8115	49	been	be	VBN
cord-005453-4057qib7	8115	50	reported	report	VBN
cord-005453-4057qib7	8115	51	.	.	.
cord-005453-4057qib7	8116	1	Hyper	hyper	JJ
cord-005453-4057qib7	8116	2	baric	baric	NN
cord-005453-4057qib7	8116	3	oxygen	oxygen	NN
cord-005453-4057qib7	8116	4	therapy	therapy	NN
cord-005453-4057qib7	8116	5	(	(	-LRB-
cord-005453-4057qib7	8116	6	HBOT	HBOT	NNP
cord-005453-4057qib7	8116	7	)	)	-RRB-
cord-005453-4057qib7	8116	8	is	be	VBZ
cord-005453-4057qib7	8116	9	used	use	VBN
cord-005453-4057qib7	8116	10	as	as	IN
cord-005453-4057qib7	8116	11	primary	primary	JJ
cord-005453-4057qib7	8116	12	or	or	CC
cord-005453-4057qib7	8116	13	adjuvant	adjuvant	JJ
cord-005453-4057qib7	8116	14	therapy	therapy	NN
cord-005453-4057qib7	8116	15	in	in	IN
cord-005453-4057qib7	8116	16	diverse	diverse	JJ
cord-005453-4057qib7	8116	17	clinical	clinical	JJ
cord-005453-4057qib7	8116	18	situations	situation	NNS
cord-005453-4057qib7	8116	19	involving	involve	VBG
cord-005453-4057qib7	8116	20	hypoxic	hypoxic	JJ
cord-005453-4057qib7	8116	21	injury	injury	NN
cord-005453-4057qib7	8116	22	to	to	IN
cord-005453-4057qib7	8116	23	tissues	tissue	NNS
cord-005453-4057qib7	8116	24	and	and	CC
cord-005453-4057qib7	8116	25	has	have	VBZ
cord-005453-4057qib7	8116	26	been	be	VBN
cord-005453-4057qib7	8116	27	explored	explore	VBN
cord-005453-4057qib7	8116	28	as	as	IN
cord-005453-4057qib7	8116	29	a	a	DT
cord-005453-4057qib7	8116	30	useful	useful	JJ
cord-005453-4057qib7	8116	31	tool	tool	NN
cord-005453-4057qib7	8116	32	in	in	IN
cord-005453-4057qib7	8116	33	treating	treat	VBG
cord-005453-4057qib7	8116	34	BK	BK	NNP
cord-005453-4057qib7	8116	35	-HC	-HC	NNP
cord-005453-4057qib7	8116	36	.	.	.
cord-005453-4057qib7	8117	1	We	-PRON-	PRP
cord-005453-4057qib7	8117	2	report	report	VBP
cord-005453-4057qib7	8117	3	our	-PRON-	PRP$
cord-005453-4057qib7	8117	4	experience	experience	NN
cord-005453-4057qib7	8117	5	with	with	IN
cord-005453-4057qib7	8117	6	HBOT	HBOT	NNP
cord-005453-4057qib7	8117	7	in	in	IN
cord-005453-4057qib7	8117	8	combination	combination	NN
cord-005453-4057qib7	8117	9	with	with	IN
cord-005453-4057qib7	8117	10	non	non	JJ
cord-005453-4057qib7	8117	11	-	-	JJ
cord-005453-4057qib7	8117	12	invasive	invasive	JJ
cord-005453-4057qib7	8117	13	supportive	supportive	JJ
cord-005453-4057qib7	8117	14	care	care	NN
cord-005453-4057qib7	8117	15	in	in	IN
cord-005453-4057qib7	8117	16	children	child	NNS
cord-005453-4057qib7	8117	17	and	and	CC
cord-005453-4057qib7	8117	18	adolescents	adolescent	NNS
cord-005453-4057qib7	8117	19	suffering	suffer	VBG
cord-005453-4057qib7	8117	20	from	from	IN
cord-005453-4057qib7	8117	21	BK	BK	NNP
cord-005453-4057qib7	8117	22	-	-	HYPH
cord-005453-4057qib7	8117	23	HC	HC	NNP
cord-005453-4057qib7	8117	24	following	follow	VBG
cord-005453-4057qib7	8117	25	allogeneic	allogeneic	IN
cord-005453-4057qib7	8117	26	HSCT	HSCT	NNP
cord-005453-4057qib7	8117	27	.	.	.
cord-005453-4057qib7	8118	1	Methods	method	NNS
cord-005453-4057qib7	8118	2	:	:	:
cord-005453-4057qib7	8119	1	The	the	DT
cord-005453-4057qib7	8119	2	computerized	computerized	JJ
cord-005453-4057qib7	8119	3	database	database	NN
cord-005453-4057qib7	8119	4	of	of	IN
cord-005453-4057qib7	8119	5	Schneider	Schneider	NNP
cord-005453-4057qib7	8119	6	Children´s	Children´s	NNP
cord-005453-4057qib7	8119	7	Medical	Medical	NNP
cord-005453-4057qib7	8119	8	Center	Center	NNP
cord-005453-4057qib7	8119	9	of	of	IN
cord-005453-4057qib7	8119	10	Israel	Israel	NNP
cord-005453-4057qib7	8119	11	was	be	VBD
cord-005453-4057qib7	8119	12	reviewed	review	VBN
cord-005453-4057qib7	8119	13	for	for	IN
cord-005453-4057qib7	8119	14	all	all	DT
cord-005453-4057qib7	8119	15	patients	patient	NNS
cord-005453-4057qib7	8119	16	aged	aged	JJ
cord-005453-4057qib7	8119	17	0	0	CD
cord-005453-4057qib7	8119	18	to	to	IN
cord-005453-4057qib7	8119	19	21	21	CD
cord-005453-4057qib7	8119	20	years	year	NNS
cord-005453-4057qib7	8119	21	who	who	WP
cord-005453-4057qib7	8119	22	underwent	undergo	VBD
cord-005453-4057qib7	8119	23	HSCT	HSCT	NNP
cord-005453-4057qib7	8119	24	between	between	IN
cord-005453-4057qib7	8119	25	January	January	NNP
cord-005453-4057qib7	8119	26	2000	2000	CD
cord-005453-4057qib7	8119	27	and	and	CC
cord-005453-4057qib7	8119	28	June	June	NNP
cord-005453-4057qib7	8119	29	2018	2018	CD
cord-005453-4057qib7	8119	30	and	and	CC
cord-005453-4057qib7	8119	31	developed	develop	VBD
cord-005453-4057qib7	8119	32	BK	BK	NNP
cord-005453-4057qib7	8119	33	-	-	HYPH
cord-005453-4057qib7	8119	34	HC	HC	NNP
cord-005453-4057qib7	8119	35	.	.	.
cord-005453-4057qib7	8120	1	HBOT	HBOT	NNP
cord-005453-4057qib7	8120	2	therapy	therapy	NN
cord-005453-4057qib7	8120	3	consisted	consist	VBD
cord-005453-4057qib7	8120	4	of	of	IN
cord-005453-4057qib7	8120	5	2	2	CD
cord-005453-4057qib7	8120	6	hours	hour	NNS
cord-005453-4057qib7	8120	7	sessions	session	NNS
cord-005453-4057qib7	8120	8	at	at	IN
cord-005453-4057qib7	8120	9	2	2	CD
cord-005453-4057qib7	8120	10	atmospheres	atmosphere	NNS
cord-005453-4057qib7	8120	11	,	,	,
cord-005453-4057qib7	8120	12	with	with	IN
cord-005453-4057qib7	8120	13	patients	patient	NNS
cord-005453-4057qib7	8120	14	breathing	breathe	VBG
cord-005453-4057qib7	8120	15	oxygen	oxygen	NN
cord-005453-4057qib7	8120	16	by	by	IN
cord-005453-4057qib7	8120	17	mask	mask	NN
cord-005453-4057qib7	8120	18	.	.	.
cord-005453-4057qib7	8121	1	Parents	parent	NNS
cord-005453-4057qib7	8121	2	accompanied	accompany	VBD
cord-005453-4057qib7	8121	3	patients	patient	NNS
cord-005453-4057qib7	8121	4	during	during	IN
cord-005453-4057qib7	8121	5	the	the	DT
cord-005453-4057qib7	8121	6	treatment	treatment	NN
cord-005453-4057qib7	8121	7	.	.	.
cord-005453-4057qib7	8122	1	Results	result	NNS
cord-005453-4057qib7	8122	2	:	:	:
cord-005453-4057qib7	8123	1	Fourteen	fourteen	CD
cord-005453-4057qib7	8123	2	patients	patient	NNS
cord-005453-4057qib7	8123	3	with	with	IN
cord-005453-4057qib7	8123	4	a	a	DT
cord-005453-4057qib7	8123	5	variety	variety	NN
cord-005453-4057qib7	8123	6	of	of	IN
cord-005453-4057qib7	8123	7	underlying	underlie	VBG
cord-005453-4057qib7	8123	8	diseases	disease	NNS
cord-005453-4057qib7	8123	9	received	receive	VBN
cord-005453-4057qib7	8123	10	(	(	-LRB-
cord-005453-4057qib7	8123	11	HBOT	HBOT	NNP
cord-005453-4057qib7	8123	12	)	)	-RRB-
cord-005453-4057qib7	8123	13	for	for	IN
cord-005453-4057qib7	8123	14	treatment	treatment	NN
cord-005453-4057qib7	8123	15	of	of	IN
cord-005453-4057qib7	8123	16	BK	BK	NNP
cord-005453-4057qib7	8123	17	-	-	HYPH
cord-005453-4057qib7	8123	18	HC	HC	NNP
cord-005453-4057qib7	8123	19	following	follow	VBG
cord-005453-4057qib7	8123	20	HSCT	HSCT	NNP
cord-005453-4057qib7	8123	21	.	.	.
cord-005453-4057qib7	8124	1	The	the	DT
cord-005453-4057qib7	8124	2	initial	initial	JJ
cord-005453-4057qib7	8124	3	treatment	treatment	NN
cord-005453-4057qib7	8124	4	for	for	IN
cord-005453-4057qib7	8124	5	children	child	NNS
cord-005453-4057qib7	8124	6	with	with	IN
cord-005453-4057qib7	8124	7	BK	BK	NNP
cord-005453-4057qib7	8124	8	-	-	HYPH
cord-005453-4057qib7	8124	9	HC	HC	NNP
cord-005453-4057qib7	8124	10	at	at	IN
cord-005453-4057qib7	8124	11	our	-PRON-	PRP$
cord-005453-4057qib7	8124	12	center	center	NN
cord-005453-4057qib7	8124	13	prior	prior	RB
cord-005453-4057qib7	8124	14	to	to	IN
cord-005453-4057qib7	8124	15	2008	2008	CD
cord-005453-4057qib7	8124	16	included	include	VBD
cord-005453-4057qib7	8124	17	continuous	continuous	JJ
cord-005453-4057qib7	8124	18	bladder	bladder	NN
cord-005453-4057qib7	8124	19	irrigation	irrigation	NN
cord-005453-4057qib7	8124	20	and	and	CC
cord-005453-4057qib7	8124	21	intravesicular	intravesicular	JJ
cord-005453-4057qib7	8124	22	instillation	instillation	NN
cord-005453-4057qib7	8124	23	of	of	IN
cord-005453-4057qib7	8124	24	various	various	JJ
cord-005453-4057qib7	8124	25	medications	medication	NNS
cord-005453-4057qib7	8124	26	.	.	.
cord-005453-4057qib7	8125	1	Beginning	begin	VBG
cord-005453-4057qib7	8125	2	in	in	IN
cord-005453-4057qib7	8125	3	2008	2008	CD
cord-005453-4057qib7	8125	4	,	,	,
cord-005453-4057qib7	8125	5	we	-PRON-	PRP
cord-005453-4057qib7	8125	6	adopted	adopt	VBD
cord-005453-4057qib7	8125	7	a	a	DT
cord-005453-4057qib7	8125	8	non	non	JJ
cord-005453-4057qib7	8125	9	-	-	JJ
cord-005453-4057qib7	8125	10	invasive	invasive	JJ
cord-005453-4057qib7	8125	11	strategy	strategy	NN
cord-005453-4057qib7	8125	12	that	that	WDT
cord-005453-4057qib7	8125	13	included	include	VBD
cord-005453-4057qib7	8125	14	the	the	DT
cord-005453-4057qib7	8125	15	administration	administration	NN
cord-005453-4057qib7	8125	16	of	of	IN
cord-005453-4057qib7	8125	17	oral	oral	JJ
cord-005453-4057qib7	8125	18	anticholinergics	anticholinergics	NNPS
cord-005453-4057qib7	8125	19	(	(	-LRB-
cord-005453-4057qib7	8125	20	oxybutinin	oxybutinin	NNP
cord-005453-4057qib7	8125	21	)	)	-RRB-
cord-005453-4057qib7	8125	22	,	,	,
cord-005453-4057qib7	8125	23	systemic	systemic	JJ
cord-005453-4057qib7	8125	24	pain	pain	NN
cord-005453-4057qib7	8125	25	management	management	NN
cord-005453-4057qib7	8125	26	,	,	,
cord-005453-4057qib7	8125	27	hyperhydration	hyperhydration	NN
cord-005453-4057qib7	8125	28	and	and	CC
cord-005453-4057qib7	8125	29	the	the	DT
cord-005453-4057qib7	8125	30	administration	administration	NN
cord-005453-4057qib7	8125	31	of	of	IN
cord-005453-4057qib7	8125	32	weekly	weekly	JJ
cord-005453-4057qib7	8125	33	Cidofovir	Cidofovir	NNPS
cord-005453-4057qib7	8125	34	with	with	IN
cord-005453-4057qib7	8125	35	Probenecid	Probenecid	NNP
cord-005453-4057qib7	8125	36	.	.	.
cord-005453-4057qib7	8126	1	HBOT	HBOT	NNP
cord-005453-4057qib7	8126	2	was	be	VBD
cord-005453-4057qib7	8126	3	administered	administer	VBN
cord-005453-4057qib7	8126	4	to	to	IN
cord-005453-4057qib7	8126	5	patients	patient	NNS
cord-005453-4057qib7	8126	6	who	who	WP
cord-005453-4057qib7	8126	7	failed	fail	VBD
cord-005453-4057qib7	8126	8	the	the	DT
cord-005453-4057qib7	8126	9	above	above	JJ
cord-005453-4057qib7	8126	10	regimen	regimen	NN
cord-005453-4057qib7	8126	11	.	.	.
cord-005453-4057qib7	8127	1	With	with	IN
cord-005453-4057qib7	8127	2	this	this	DT
cord-005453-4057qib7	8127	3	protocol	protocol	NN
cord-005453-4057qib7	8127	4	,	,	,
cord-005453-4057qib7	8127	5	the	the	DT
cord-005453-4057qib7	8127	6	average	average	JJ
cord-005453-4057qib7	8127	7	time	time	NN
cord-005453-4057qib7	8127	8	of	of	IN
cord-005453-4057qib7	8127	9	starting	start	VBG
cord-005453-4057qib7	8127	10	HBOT	HBOT	NNP
cord-005453-4057qib7	8127	11	dropped	drop	VBD
cord-005453-4057qib7	8127	12	from	from	IN
cord-005453-4057qib7	8127	13	13	13	CD
cord-005453-4057qib7	8127	14	(	(	-LRB-
cord-005453-4057qib7	8127	15	prior	prior	RB
cord-005453-4057qib7	8127	16	to	to	IN
cord-005453-4057qib7	8127	17	2008	2008	CD
cord-005453-4057qib7	8127	18	)	)	-RRB-
cord-005453-4057qib7	8127	19	to	to	IN
cord-005453-4057qib7	8127	20	9.8	9.8	CD
cord-005453-4057qib7	8127	21	days	day	NNS
cord-005453-4057qib7	8127	22	.	.	.
cord-005453-4057qib7	8128	1	The	the	DT
cord-005453-4057qib7	8128	2	median	median	JJ
cord-005453-4057qib7	8128	3	onset	onset	NN
cord-005453-4057qib7	8128	4	of	of	IN
cord-005453-4057qib7	8128	5	HC	HC	NNP
cord-005453-4057qib7	8128	6	was	be	VBD
cord-005453-4057qib7	8129	1	33	33	CD
cord-005453-4057qib7	8129	2	days	day	NNS
cord-005453-4057qib7	8129	3	post	post	NN
cord-005453-4057qib7	8129	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8129	5	.	.	.
cord-005453-4057qib7	8130	1	All	all	DT
cord-005453-4057qib7	8130	2	patients	patient	NNS
cord-005453-4057qib7	8130	3	were	be	VBD
cord-005453-4057qib7	8130	4	receiving	receive	VBG
cord-005453-4057qib7	8130	5	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	8130	6	treatment	treatment	NN
cord-005453-4057qib7	8130	7	at	at	IN
cord-005453-4057qib7	8130	8	the	the	DT
cord-005453-4057qib7	8130	9	onset	onset	NN
cord-005453-4057qib7	8130	10	of	of	IN
cord-005453-4057qib7	8130	11	BK	BK	NNP
cord-005453-4057qib7	8130	12	-	-	HYPH
cord-005453-4057qib7	8130	13	HC	HC	NNP
cord-005453-4057qib7	8130	14	.	.	.
cord-005453-4057qib7	8131	1	All	all	DT
cord-005453-4057qib7	8131	2	patients	patient	NNS
cord-005453-4057qib7	8131	3	suffered	suffer	VBD
cord-005453-4057qib7	8131	4	from	from	IN
cord-005453-4057qib7	8131	5	macrohematuria	macrohematuria	NNP
cord-005453-4057qib7	8131	6	with	with	IN
cord-005453-4057qib7	8131	7	blood	blood	NN
cord-005453-4057qib7	8131	8	clots	clot	NNS
cord-005453-4057qib7	8131	9	(	(	-LRB-
cord-005453-4057qib7	8131	10	grade	grade	NN
cord-005453-4057qib7	8131	11	III	iii	CD
cord-005453-4057qib7	8131	12	cystitis	cystitis	NNP
cord-005453-4057qib7	8131	13	)	)	-RRB-
cord-005453-4057qib7	8131	14	,	,	,
cord-005453-4057qib7	8131	15	12	12	CD
cord-005453-4057qib7	8131	16	(	(	-LRB-
cord-005453-4057qib7	8131	17	92.3	92.3	CD
cord-005453-4057qib7	8131	18	%	%	NN
cord-005453-4057qib7	8131	19	)	)	-RRB-
cord-005453-4057qib7	8131	20	experienced	experience	VBD
cord-005453-4057qib7	8131	21	severe	severe	JJ
cord-005453-4057qib7	8131	22	dysuria	dysuria	NNS
cord-005453-4057qib7	8131	23	and	and	CC
cord-005453-4057qib7	8131	24	11	11	CD
cord-005453-4057qib7	8131	25	(	(	-LRB-
cord-005453-4057qib7	8131	26	84.6	84.6	CD
cord-005453-4057qib7	8131	27	%	%	NN
cord-005453-4057qib7	8131	28	)	)	-RRB-
cord-005453-4057qib7	8131	29	urgency	urgency	NN
cord-005453-4057qib7	8131	30	.	.	.
cord-005453-4057qib7	8132	1	BK	BK	NNP
cord-005453-4057qib7	8132	2	viruria	viruria	NNP
cord-005453-4057qib7	8132	3	was	be	VBD
cord-005453-4057qib7	8132	4	present	present	JJ
cord-005453-4057qib7	8132	5	in	in	IN
cord-005453-4057qib7	8132	6	all	all	DT
cord-005453-4057qib7	8132	7	patients	patient	NNS
cord-005453-4057qib7	8132	8	,	,	,
cord-005453-4057qib7	8132	9	and	and	CC
cord-005453-4057qib7	8132	10	concurrent	concurrent	JJ
cord-005453-4057qib7	8132	11	BK	BK	NNP
cord-005453-4057qib7	8132	12	viremia	viremia	NN
cord-005453-4057qib7	8132	13	was	be	VBD
cord-005453-4057qib7	8132	14	detected	detect	VBN
cord-005453-4057qib7	8132	15	in	in	IN
cord-005453-4057qib7	8132	16	80	80	CD
cord-005453-4057qib7	8132	17	%	%	NN
cord-005453-4057qib7	8132	18	of	of	IN
cord-005453-4057qib7	8132	19	those	those	DT
cord-005453-4057qib7	8132	20	who	who	WP
cord-005453-4057qib7	8132	21	were	be	VBD
cord-005453-4057qib7	8132	22	tested	test	VBN
cord-005453-4057qib7	8132	23	.	.	.
cord-005453-4057qib7	8133	1	Patients	patient	NNS
cord-005453-4057qib7	8133	2	reported	report	VBD
cord-005453-4057qib7	8133	3	symptomatic	symptomatic	JJ
cord-005453-4057qib7	8133	4	improvement	improvement	NN
cord-005453-4057qib7	8133	5	at	at	IN
cord-005453-4057qib7	8133	6	a	a	DT
cord-005453-4057qib7	8133	7	mean	mean	NN
cord-005453-4057qib7	8133	8	of	of	IN
cord-005453-4057qib7	8133	9	3.6	3.6	CD
cord-005453-4057qib7	8133	10	days	day	NNS
cord-005453-4057qib7	8133	11	following	follow	VBG
cord-005453-4057qib7	8133	12	the	the	DT
cord-005453-4057qib7	8133	13	initiation	initiation	NN
cord-005453-4057qib7	8133	14	of	of	IN
cord-005453-4057qib7	8133	15	HBOT	HBOT	NNP
cord-005453-4057qib7	8133	16	.	.	.
cord-005453-4057qib7	8134	1	No	no	DT
cord-005453-4057qib7	8134	2	patient	patient	NN
cord-005453-4057qib7	8134	3	experienced	experience	VBD
cord-005453-4057qib7	8134	4	serious	serious	JJ
cord-005453-4057qib7	8134	5	adverse	adverse	JJ
cord-005453-4057qib7	8134	6	effects	effect	NNS
cord-005453-4057qib7	8134	7	due	due	IN
cord-005453-4057qib7	8134	8	to	to	IN
cord-005453-4057qib7	8134	9	HBOT	HBOT	NNP
cord-005453-4057qib7	8134	10	,	,	,
cord-005453-4057qib7	8134	11	but	but	CC
cord-005453-4057qib7	8134	12	two	two	CD
cord-005453-4057qib7	8134	13	patients	patient	NNS
cord-005453-4057qib7	8134	14	required	require	VBD
cord-005453-4057qib7	8134	15	insertion	insertion	NN
cord-005453-4057qib7	8134	16	of	of	IN
cord-005453-4057qib7	8134	17	tympanic	tympanic	JJ
cord-005453-4057qib7	8134	18	ventilation	ventilation	NN
cord-005453-4057qib7	8134	19	tubes	tube	NNS
cord-005453-4057qib7	8134	20	.	.	.
cord-005453-4057qib7	8135	1	Eleven	eleven	CD
cord-005453-4057qib7	8135	2	of	of	IN
cord-005453-4057qib7	8135	3	our	-PRON-	PRP$
cord-005453-4057qib7	8135	4	13	13	CD
cord-005453-4057qib7	8135	5	patients	patient	NNS
cord-005453-4057qib7	8135	6	(	(	-LRB-
cord-005453-4057qib7	8135	7	84.6	84.6	CD
cord-005453-4057qib7	8135	8	%	%	NN
cord-005453-4057qib7	8135	9	)	)	-RRB-
cord-005453-4057qib7	8135	10	experienced	experience	VBD
cord-005453-4057qib7	8135	11	complete	complete	JJ
cord-005453-4057qib7	8135	12	remission	remission	NN
cord-005453-4057qib7	8135	13	of	of	IN
cord-005453-4057qib7	8135	14	BK	BK	NNP
cord-005453-4057qib7	8135	15	-	-	HYPH
cord-005453-4057qib7	8135	16	HC	HC	NNP
cord-005453-4057qib7	8135	17	following	follow	VBG
cord-005453-4057qib7	8135	18	HBOT	HBOT	NNP
cord-005453-4057qib7	8135	19	,	,	,
cord-005453-4057qib7	8135	20	with	with	IN
cord-005453-4057qib7	8135	21	an	an	DT
cord-005453-4057qib7	8135	22	overall	overall	JJ
cord-005453-4057qib7	8135	23	response	response	NN
cord-005453-4057qib7	8135	24	rate	rate	NN
cord-005453-4057qib7	8135	25	of	of	IN
cord-005453-4057qib7	8135	26	92.3	92.3	CD
cord-005453-4057qib7	8135	27	%	%	NN
cord-005453-4057qib7	8135	28	(	(	-LRB-
cord-005453-4057qib7	8135	29	12/13	12/13	CD
cord-005453-4057qib7	8135	30	patients).Eight	patients).eight	NN
cord-005453-4057qib7	8135	31	of	of	IN
cord-005453-4057qib7	8135	32	our	-PRON-	PRP$
cord-005453-4057qib7	8135	33	patients	patient	NNS
cord-005453-4057qib7	8135	34	(	(	-LRB-
cord-005453-4057qib7	8135	35	61.5	61.5	CD
cord-005453-4057qib7	8135	36	%	%	NN
cord-005453-4057qib7	8135	37	)	)	-RRB-
cord-005453-4057qib7	8135	38	eventually	eventually	RB
cord-005453-4057qib7	8135	39	succumbed	succumb	VBD
cord-005453-4057qib7	8135	40	due	due	JJ
cord-005453-4057qib7	8135	41	to	to	IN
cord-005453-4057qib7	8135	42	either	either	CC
cord-005453-4057qib7	8135	43	HSCT	HSCT	NNP
cord-005453-4057qib7	8135	44	complications	complication	NNS
cord-005453-4057qib7	8135	45	or	or	CC
cord-005453-4057qib7	8135	46	disease	disease	NN
cord-005453-4057qib7	8135	47	relapse	relapse	NN
cord-005453-4057qib7	8135	48	.	.	.
cord-005453-4057qib7	8136	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8136	2	:	:	:
cord-005453-4057qib7	8137	1	Hyperbaric	hyperbaric	NN
cord-005453-4057qib7	8137	2	oxygen	oxygen	NN
cord-005453-4057qib7	8137	3	therapy	therapy	NN
cord-005453-4057qib7	8137	4	is	be	VBZ
cord-005453-4057qib7	8137	5	a	a	DT
cord-005453-4057qib7	8137	6	safe	safe	JJ
cord-005453-4057qib7	8137	7	,	,	,
cord-005453-4057qib7	8137	8	effective	effective	JJ
cord-005453-4057qib7	8137	9	,	,	,
cord-005453-4057qib7	8137	10	non	non	JJ
cord-005453-4057qib7	8137	11	-	-	JJ
cord-005453-4057qib7	8137	12	invasive	invasive	JJ
cord-005453-4057qib7	8137	13	and	and	CC
cord-005453-4057qib7	8137	14	well	well	RB
cord-005453-4057qib7	8137	15	tolerated	tolerate	VBN
cord-005453-4057qib7	8137	16	treatment	treatment	NN
cord-005453-4057qib7	8137	17	modality	modality	NN
cord-005453-4057qib7	8137	18	for	for	IN
cord-005453-4057qib7	8137	19	BK	BK	NNP
cord-005453-4057qib7	8137	20	-HC	-HC	:
cord-005453-4057qib7	8137	21	and	and	CC
cord-005453-4057qib7	8137	22	should	should	MD
cord-005453-4057qib7	8137	23	be	be	VB
cord-005453-4057qib7	8137	24	considered	consider	VBN
cord-005453-4057qib7	8137	25	for	for	IN
cord-005453-4057qib7	8137	26	first	first	JJ
cord-005453-4057qib7	8137	27	line	line	NN
cord-005453-4057qib7	8137	28	therapy	therapy	NN
cord-005453-4057qib7	8137	29	for	for	IN
cord-005453-4057qib7	8137	30	this	this	DT
cord-005453-4057qib7	8137	31	complication	complication	NN
cord-005453-4057qib7	8137	32	of	of	IN
cord-005453-4057qib7	8137	33	HSCT	HSCT	NNP
cord-005453-4057qib7	8137	34	.	.	.
cord-005453-4057qib7	8138	1	Clinical	clinical	JJ
cord-005453-4057qib7	8138	2	Background	background	NN
cord-005453-4057qib7	8138	3	:	:	:
cord-005453-4057qib7	8139	1	Every	every	DT
cord-005453-4057qib7	8139	2	year	year	NN
cord-005453-4057qib7	8139	3	,	,	,
cord-005453-4057qib7	8139	4	almost	almost	RB
cord-005453-4057qib7	8139	5	one	one	CD
cord-005453-4057qib7	8139	6	thousand	thousand	CD
cord-005453-4057qib7	8139	7	cases	case	NNS
cord-005453-4057qib7	8139	8	of	of	IN
cord-005453-4057qib7	8139	9	hematological	hematological	JJ
cord-005453-4057qib7	8139	10	malignancies	malignancy	NNS
cord-005453-4057qib7	8139	11	in	in	IN
cord-005453-4057qib7	8139	12	pediatric	pediatric	JJ
cord-005453-4057qib7	8139	13	population	population	NN
cord-005453-4057qib7	8139	14	are	be	VBP
cord-005453-4057qib7	8139	15	reported	report	VBN
cord-005453-4057qib7	8139	16	in	in	IN
cord-005453-4057qib7	8139	17	Peru	Peru	NNP
cord-005453-4057qib7	8139	18	.	.	.
cord-005453-4057qib7	8140	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	8140	2	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	8140	3	Stem	Stem	NNP
cord-005453-4057qib7	8140	4	Cell	cell	NN
cord-005453-4057qib7	8140	5	Transplantation	transplantation	NN
cord-005453-4057qib7	8140	6	(	(	-LRB-
cord-005453-4057qib7	8140	7	allo	allo	NN
cord-005453-4057qib7	8140	8	-	-	HYPH
cord-005453-4057qib7	8140	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8140	10	)	)	-RRB-
cord-005453-4057qib7	8140	11	is	be	VBZ
cord-005453-4057qib7	8140	12	an	an	DT
cord-005453-4057qib7	8140	13	alternative	alternative	JJ
cord-005453-4057qib7	8140	14	strategy	strategy	NN
cord-005453-4057qib7	8140	15	in	in	IN
cord-005453-4057qib7	8140	16	many	many	JJ
cord-005453-4057qib7	8140	17	of	of	IN
cord-005453-4057qib7	8140	18	these	these	DT
cord-005453-4057qib7	8140	19	cases	case	NNS
cord-005453-4057qib7	8140	20	.	.	.
cord-005453-4057qib7	8141	1	Only	only	RB
cord-005453-4057qib7	8141	2	between	between	IN
cord-005453-4057qib7	8141	3	20	20	CD
cord-005453-4057qib7	8141	4	-	-	SYM
cord-005453-4057qib7	8141	5	30	30	CD
cord-005453-4057qib7	8141	6	%	%	NN
cord-005453-4057qib7	8141	7	of	of	IN
cord-005453-4057qib7	8141	8	the	the	DT
cord-005453-4057qib7	8141	9	pediatric	pediatric	JJ
cord-005453-4057qib7	8141	10	population	population	NN
cord-005453-4057qib7	8141	11	that	that	WDT
cord-005453-4057qib7	8141	12	requires	require	VBZ
cord-005453-4057qib7	8141	13	a	a	DT
cord-005453-4057qib7	8141	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8141	15	has	have	VBZ
cord-005453-4057qib7	8141	16	a	a	DT
cord-005453-4057qib7	8141	17	compatible	compatible	JJ
cord-005453-4057qib7	8141	18	Human	human	JJ
cord-005453-4057qib7	8141	19	Leukocyte	Leukocyte	NNP
cord-005453-4057qib7	8141	20	Antigen	Antigen	NNP
cord-005453-4057qib7	8141	21	(	(	-LRB-
cord-005453-4057qib7	8141	22	HLA	HLA	NNP
cord-005453-4057qib7	8141	23	)	)	-RRB-
cord-005453-4057qib7	8141	24	donor	donor	NN
cord-005453-4057qib7	8141	25	.	.	.
cord-005453-4057qib7	8142	1	The	the	DT
cord-005453-4057qib7	8142	2	remaining	remain	VBG
cord-005453-4057qib7	8142	3	70	70	CD
cord-005453-4057qib7	8142	4	%	%	NN
cord-005453-4057qib7	8142	5	have	have	VBP
cord-005453-4057qib7	8142	6	to	to	TO
cord-005453-4057qib7	8142	7	access	access	VB
cord-005453-4057qib7	8142	8	international	international	JJ
cord-005453-4057qib7	8142	9	donor	donor	NN
cord-005453-4057qib7	8142	10	registries	registry	NNS
cord-005453-4057qib7	8142	11	,	,	,
cord-005453-4057qib7	8142	12	extending	extend	VBG
cord-005453-4057qib7	8142	13	the	the	DT
cord-005453-4057qib7	8142	14	awaiting	await	VBG
cord-005453-4057qib7	8142	15	time	time	NN
cord-005453-4057qib7	8142	16	and	and	CC
cord-005453-4057qib7	8142	17	conditioning	condition	VBG
cord-005453-4057qib7	8142	18	the	the	DT
cord-005453-4057qib7	8142	19	progress	progress	NN
cord-005453-4057qib7	8142	20	of	of	IN
cord-005453-4057qib7	8142	21	the	the	DT
cord-005453-4057qib7	8142	22	disease	disease	NN
cord-005453-4057qib7	8142	23	.	.	.
cord-005453-4057qib7	8143	1	Allo	Allo	NNP
cord-005453-4057qib7	8143	2	-	-	HYPH
cord-005453-4057qib7	8143	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8143	4	has	have	VBZ
cord-005453-4057qib7	8143	5	the	the	DT
cord-005453-4057qib7	8143	6	potential	potential	NN
cord-005453-4057qib7	8143	7	to	to	TO
cord-005453-4057qib7	8143	8	help	help	VB
cord-005453-4057qib7	8143	9	children	child	NNS
cord-005453-4057qib7	8143	10	with	with	IN
cord-005453-4057qib7	8143	11	several	several	JJ
cord-005453-4057qib7	8143	12	hematological	hematological	JJ
cord-005453-4057qib7	8143	13	disorders	disorder	NNS
cord-005453-4057qib7	8143	14	with	with	IN
cord-005453-4057qib7	8143	15	non	non	JJ
cord-005453-4057qib7	8143	16	-	-	JJ
cord-005453-4057qib7	8143	17	compatible	compatible	JJ
cord-005453-4057qib7	8143	18	HLA	HLA	NNP
cord-005453-4057qib7	8143	19	donor	donor	NN
cord-005453-4057qib7	8143	20	.	.	.
cord-005453-4057qib7	8144	1	HLA	HLA	NNP
cord-005453-4057qib7	8145	1	genotypically	genotypically	RB
cord-005453-4057qib7	8145	2	identical	identical	JJ
cord-005453-4057qib7	8145	3	sibling	sibling	NN
cord-005453-4057qib7	8145	4	donors	donor	NNS
cord-005453-4057qib7	8145	5	are	be	VBP
cord-005453-4057qib7	8145	6	the	the	DT
cord-005453-4057qib7	8145	7	best	good	JJS
cord-005453-4057qib7	8145	8	option	option	NN
cord-005453-4057qib7	8145	9	when	when	WRB
cord-005453-4057qib7	8145	10	pursuing	pursue	VBG
cord-005453-4057qib7	8145	11	an	an	DT
cord-005453-4057qib7	8145	12	HSCT	HSCT	NNP
cord-005453-4057qib7	8145	13	.	.	.
cord-005453-4057qib7	8146	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	8146	2	,	,	,
cord-005453-4057qib7	8146	3	patients	patient	NNS
cord-005453-4057qib7	8146	4	'	'	POS
cord-005453-4057qib7	8146	5	alternative	alternative	JJ
cord-005453-4057qib7	8146	6	sources	source	NNS
cord-005453-4057qib7	8146	7	of	of	IN
cord-005453-4057qib7	8146	8	stem	stem	NN
cord-005453-4057qib7	8146	9	cells	cell	NNS
cord-005453-4057qib7	8146	10	could	could	MD
cord-005453-4057qib7	8146	11	be	be	VB
cord-005453-4057qib7	8146	12	obtained	obtain	VBN
cord-005453-4057qib7	8146	13	from	from	IN
cord-005453-4057qib7	8146	14	an	an	DT
cord-005453-4057qib7	8146	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8146	16	donor	donor	NN
cord-005453-4057qib7	8146	17	like	like	IN
cord-005453-4057qib7	8146	18	one	one	CD
cord-005453-4057qib7	8146	19	of	of	IN
cord-005453-4057qib7	8146	20	their	-PRON-	PRP$
cord-005453-4057qib7	8146	21	parents	parent	NNS
cord-005453-4057qib7	8146	22	.	.	.
cord-005453-4057qib7	8147	1	The	the	DT
cord-005453-4057qib7	8147	2	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	8147	3	Transplantation	Transplantation	NNP
cord-005453-4057qib7	8147	4	Program	Program	NNP
cord-005453-4057qib7	8147	5	with	with	IN
cord-005453-4057qib7	8147	6	MACS	MACS	NNPS
cord-005453-4057qib7	8147	7	was	be	VBD
cord-005453-4057qib7	8147	8	implemented	implement	VBN
cord-005453-4057qib7	8147	9	in	in	IN
cord-005453-4057qib7	8147	10	Peru	Peru	NNP
cord-005453-4057qib7	8147	11	in	in	IN
cord-005453-4057qib7	8147	12	2016	2016	CD
cord-005453-4057qib7	8147	13	to	to	TO
cord-005453-4057qib7	8147	14	reduce	reduce	VB
cord-005453-4057qib7	8147	15	the	the	DT
cord-005453-4057qib7	8147	16	risk	risk	NN
cord-005453-4057qib7	8147	17	of	of	IN
cord-005453-4057qib7	8147	18	Graft	graft	NN
cord-005453-4057qib7	8147	19	-	-	HYPH
cord-005453-4057qib7	8147	20	versus	versus	IN
cord-005453-4057qib7	8147	21	-	-	HYPH
cord-005453-4057qib7	8147	22	Host	host	NN
cord-005453-4057qib7	8147	23	Disease	Disease	NNP
cord-005453-4057qib7	8147	24	(	(	-LRB-
cord-005453-4057qib7	8147	25	GvHD	GvHD	NNP
cord-005453-4057qib7	8147	26	)	)	-RRB-
cord-005453-4057qib7	8147	27	,	,	,
cord-005453-4057qib7	8147	28	support	support	VB
cord-005453-4057qib7	8147	29	the	the	DT
cord-005453-4057qib7	8147	30	immune	immune	JJ
cord-005453-4057qib7	8147	31	system	system	NN
cord-005453-4057qib7	8147	32	reconstitution	reconstitution	NN
cord-005453-4057qib7	8147	33	and	and	CC
cord-005453-4057qib7	8147	34	to	to	TO
cord-005453-4057qib7	8147	35	expand	expand	VB
cord-005453-4057qib7	8147	36	pool	pool	NN
cord-005453-4057qib7	8147	37	of	of	IN
cord-005453-4057qib7	8147	38	donors	donor	NNS
cord-005453-4057qib7	8147	39	.	.	.
cord-005453-4057qib7	8148	1	It	-PRON-	PRP
cord-005453-4057qib7	8148	2	allows	allow	VBZ
cord-005453-4057qib7	8148	3	patients	patient	NNS
cord-005453-4057qib7	8148	4	to	to	TO
cord-005453-4057qib7	8148	5	access	access	VB
cord-005453-4057qib7	8148	6	a	a	DT
cord-005453-4057qib7	8148	7	treatment	treatment	NN
cord-005453-4057qib7	8148	8	that	that	WDT
cord-005453-4057qib7	8148	9	is	be	VBZ
cord-005453-4057qib7	8148	10	efficient	efficient	JJ
cord-005453-4057qib7	8148	11	and	and	CC
cord-005453-4057qib7	8148	12	safe	safe	JJ
cord-005453-4057qib7	8148	13	,	,	,
cord-005453-4057qib7	8148	14	as	as	IN
cord-005453-4057qib7	8148	15	shown	show	VBN
cord-005453-4057qib7	8148	16	in	in	IN
cord-005453-4057qib7	8148	17	the	the	DT
cord-005453-4057qib7	8148	18	depletion	depletion	NN
cord-005453-4057qib7	8148	19	of	of	IN
cord-005453-4057qib7	8148	20	positive	positive	JJ
cord-005453-4057qib7	8148	21	TCRα	TCRα	NNS
cord-005453-4057qib7	8148	22	/	/	SYM
cord-005453-4057qib7	8148	23	β+	β+	NNP
cord-005453-4057qib7	8148	24	and	and	CC
cord-005453-4057qib7	8148	25	B	b	NN
cord-005453-4057qib7	8148	26	cells	cell	NNS
cord-005453-4057qib7	8148	27	procedures	procedure	NNS
cord-005453-4057qib7	8148	28	for	for	IN
cord-005453-4057qib7	8148	29	allo	allo	NN
cord-005453-4057qib7	8148	30	-	-	HYPH
cord-005453-4057qib7	8148	31	HSCT	HSCT	NNP
cord-005453-4057qib7	8148	32	.	.	.
cord-005453-4057qib7	8149	1	Methods	method	NNS
cord-005453-4057qib7	8149	2	:	:	:
cord-005453-4057qib7	8150	1	The	the	DT
cord-005453-4057qib7	8150	2	mobilized	mobilize	VBN
cord-005453-4057qib7	8150	3	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	8150	4	products	product	NNS
cord-005453-4057qib7	8150	5	(	(	-LRB-
cord-005453-4057qib7	8150	6	n=19	n=19	NNP
cord-005453-4057qib7	8150	7	)	)	-RRB-
cord-005453-4057qib7	8150	8	of	of	IN
cord-005453-4057qib7	8150	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8150	10	healthy	healthy	JJ
cord-005453-4057qib7	8150	11	donor	donor	NN
cord-005453-4057qib7	8150	12	was	be	VBD
cord-005453-4057qib7	8150	13	washed	wash	VBN
cord-005453-4057qib7	8150	14	to	to	TO
cord-005453-4057qib7	8150	15	remove	remove	VB
cord-005453-4057qib7	8150	16	platelets	platelet	NNS
cord-005453-4057qib7	8150	17	and	and	CC
cord-005453-4057qib7	8150	18	preparations	preparation	NNS
cord-005453-4057qib7	8150	19	were	be	VBD
cord-005453-4057qib7	8150	20	performed	perform	VBN
cord-005453-4057qib7	8150	21	according	accord	VBG
cord-005453-4057qib7	8150	22	to	to	IN
cord-005453-4057qib7	8150	23	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	8150	24	's	's	POS
cord-005453-4057qib7	8150	25	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	8150	26	®	®	NNP
cord-005453-4057qib7	8150	27	manual	manual	NN
cord-005453-4057qib7	8150	28	for	for	IN
cord-005453-4057qib7	8150	29	TCRα	TCRα	NNS
cord-005453-4057qib7	8150	30	/	/	SYM
cord-005453-4057qib7	8150	31	β+	β+	NNP
cord-005453-4057qib7	8150	32	and	and	CC
cord-005453-4057qib7	8150	33	CD19	CD19	NNP
cord-005453-4057qib7	8150	34	+	+	CC
cord-005453-4057qib7	8150	35	cell	cell	NN
cord-005453-4057qib7	8150	36	depletion	depletion	NN
cord-005453-4057qib7	8150	37	.	.	.
cord-005453-4057qib7	8151	1	Analysis	analysis	NN
cord-005453-4057qib7	8151	2	of	of	IN
cord-005453-4057qib7	8151	3	the	the	DT
cord-005453-4057qib7	8151	4	initial	initial	JJ
cord-005453-4057qib7	8151	5	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	8151	6	product	product	NN
cord-005453-4057qib7	8151	7	and	and	CC
cord-005453-4057qib7	8151	8	TCRα	TCRα	NNPS
cord-005453-4057qib7	8151	9	/	/	SYM
cord-005453-4057qib7	8151	10	β	β	NN
cord-005453-4057qib7	8151	11	+	+	CC
cord-005453-4057qib7	8151	12	and	and	CC
cord-005453-4057qib7	8151	13	CD19	CD19	NNP
cord-005453-4057qib7	8151	14	+	+	CC
cord-005453-4057qib7	8151	15	depleted	deplete	VBN
cord-005453-4057qib7	8151	16	graft	graft	NN
cord-005453-4057qib7	8151	17	(	(	-LRB-
cord-005453-4057qib7	8151	18	target	target	NN
cord-005453-4057qib7	8151	19	and	and	CC
cord-005453-4057qib7	8151	20	non	non	JJ
cord-005453-4057qib7	8151	21	-	-	JJ
cord-005453-4057qib7	8151	22	target	target	JJ
cord-005453-4057qib7	8151	23	product	product	NN
cord-005453-4057qib7	8151	24	)	)	-RRB-
cord-005453-4057qib7	8151	25	was	be	VBD
cord-005453-4057qib7	8151	26	performed	perform	VBN
cord-005453-4057qib7	8151	27	using	use	VBG
cord-005453-4057qib7	8151	28	flow	flow	NN
cord-005453-4057qib7	8151	29	cytometer	cytometer	NN
cord-005453-4057qib7	8151	30	.	.	.
cord-005453-4057qib7	8152	1	Cells	cell	NNS
cord-005453-4057qib7	8152	2	were	be	VBD
cord-005453-4057qib7	8152	3	analyzed	analyze	VBN
cord-005453-4057qib7	8152	4	for	for	IN
cord-005453-4057qib7	8152	5	CD3	CD3	NNP
cord-005453-4057qib7	8152	6	+	+	CC
cord-005453-4057qib7	8152	7	,	,	,
cord-005453-4057qib7	8152	8	CD45	CD45	NNP
cord-005453-4057qib7	8152	9	+	+	CC
cord-005453-4057qib7	8152	10	,	,	.
cord-005453-4057qib7	8153	1	7-AAD	7-aad	CD
cord-005453-4057qib7	8153	2	,	,	,
cord-005453-4057qib7	8153	3	CD20	CD20	NNP
cord-005453-4057qib7	8153	4	+	+	CC
cord-005453-4057qib7	8153	5	,	,	,
cord-005453-4057qib7	8153	6	TCRα	tcrα	NN
cord-005453-4057qib7	8153	7	/	/	SYM
cord-005453-4057qib7	8153	8	β+	β+	XX
cord-005453-4057qib7	8154	1	,	,	,
cord-005453-4057qib7	8154	2	TCRγ	TCRγ	NNP
cord-005453-4057qib7	8154	3	/	/	SYM
cord-005453-4057qib7	8154	4	δ	δ	NN
cord-005453-4057qib7	8155	1	+	+	UH
cord-005453-4057qib7	8155	2	,	,	,
cord-005453-4057qib7	8155	3	CD34	CD34	NNP
cord-005453-4057qib7	8155	4	+	+	CC
cord-005453-4057qib7	8155	5	and	and	CC
cord-005453-4057qib7	8155	6	CD133	CD133	NNP
cord-005453-4057qib7	8156	1	+	+	CC
cord-005453-4057qib7	8156	2	with	with	IN
cord-005453-4057qib7	8156	3	fluorochrome	fluorochrome	RB
cord-005453-4057qib7	8156	4	-	-	HYPH
cord-005453-4057qib7	8156	5	labeled	label	VBN
cord-005453-4057qib7	8156	6	antibodies	antibody	NNS
cord-005453-4057qib7	8156	7	from	from	IN
cord-005453-4057qib7	8156	8	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	8156	9	Biotec	Biotec	NNP
cord-005453-4057qib7	8156	10	using	use	VBG
cord-005453-4057qib7	8156	11	a	a	DT
cord-005453-4057qib7	8156	12	NovoCyte	NovoCyte	NNP
cord-005453-4057qib7	8156	13	Cytometer	Cytometer	NNP
cord-005453-4057qib7	8156	14	.	.	.
cord-005453-4057qib7	8157	1	The	the	DT
cord-005453-4057qib7	8157	2	results	result	NNS
cord-005453-4057qib7	8157	3	obtained	obtain	VBN
cord-005453-4057qib7	8157	4	with	with	IN
cord-005453-4057qib7	8157	5	the	the	DT
cord-005453-4057qib7	8157	6	ex	ex	FW
cord-005453-4057qib7	8157	7	vivo	vivo	NN
cord-005453-4057qib7	8157	8	T	t	NN
cord-005453-4057qib7	8157	9	-	-	HYPH
cord-005453-4057qib7	8157	10	cell	cell	NN
cord-005453-4057qib7	8157	11	depleted	deplete	VBN
cord-005453-4057qib7	8157	12	allo	allo	NN
cord-005453-4057qib7	8157	13	-	-	HYPH
cord-005453-4057qib7	8157	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8157	15	procedures	procedure	NNS
cord-005453-4057qib7	8157	16	show	show	VBP
cord-005453-4057qib7	8157	17	an	an	DT
cord-005453-4057qib7	8157	18	overall	overall	JJ
cord-005453-4057qib7	8157	19	survival	survival	NN
cord-005453-4057qib7	8157	20	(	(	-LRB-
cord-005453-4057qib7	8157	21	OS	OS	NNP
cord-005453-4057qib7	8157	22	)	)	-RRB-
cord-005453-4057qib7	8157	23	over	over	IN
cord-005453-4057qib7	8157	24	70	70	CD
cord-005453-4057qib7	8157	25	%	%	NN
cord-005453-4057qib7	8157	26	with	with	IN
cord-005453-4057qib7	8157	27	an	an	DT
cord-005453-4057qib7	8157	28	IC95	IC95	NNP
cord-005453-4057qib7	8157	29	%	%	NN
cord-005453-4057qib7	8157	30	at	at	IN
cord-005453-4057qib7	8157	31	the	the	DT
cord-005453-4057qib7	8157	32	end	end	NN
cord-005453-4057qib7	8157	33	of	of	IN
cord-005453-4057qib7	8157	34	the	the	DT
cord-005453-4057qib7	8157	35	first	first	JJ
cord-005453-4057qib7	8157	36	year	year	NN
cord-005453-4057qib7	8157	37	with	with	IN
cord-005453-4057qib7	8157	38	low	low	JJ
cord-005453-4057qib7	8157	39	incidence	incidence	NN
cord-005453-4057qib7	8157	40	of	of	IN
cord-005453-4057qib7	8157	41	GvHD	GvHD	NNP
cord-005453-4057qib7	8157	42	.	.	.
cord-005453-4057qib7	8158	1	MACS	mac	NNS
cord-005453-4057qib7	8158	2	of	of	IN
cord-005453-4057qib7	8158	3	TcRα/	TcRα/	NNP
cord-005453-4057qib7	8159	1	β+	β+	NNP
cord-005453-4057qib7	8159	2	and	and	CC
cord-005453-4057qib7	8160	1	CD19	CD19	NNP
cord-005453-4057qib7	8160	2	+	+	CC
cord-005453-4057qib7	8160	3	cells	cell	NNS
cord-005453-4057qib7	8160	4	are	be	VBP
cord-005453-4057qib7	8160	5	effective	effective	JJ
cord-005453-4057qib7	8160	6	(	(	-LRB-
cord-005453-4057qib7	8160	7	LogP	LogP	NNP
cord-005453-4057qib7	8160	8	3.9	3.9	CD
cord-005453-4057qib7	8160	9	and	and	CC
cord-005453-4057qib7	8160	10	LogP	LogP	NNP
cord-005453-4057qib7	8160	11	3.3	3.3	CD
cord-005453-4057qib7	8160	12	,	,	,
cord-005453-4057qib7	8160	13	respectively	respectively	RB
cord-005453-4057qib7	8160	14	)	)	-RRB-
cord-005453-4057qib7	8160	15	obtaining	obtain	VBG
cord-005453-4057qib7	8160	16	minimum	minimum	JJ
cord-005453-4057qib7	8160	17	levels	level	NNS
cord-005453-4057qib7	8160	18	of	of	IN
cord-005453-4057qib7	8160	19	depleted	depleted	JJ
cord-005453-4057qib7	8160	20	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	8160	21	within	within	IN
cord-005453-4057qib7	8160	22	clinical	clinical	JJ
cord-005453-4057qib7	8160	23	established	establish	VBN
cord-005453-4057qib7	8160	24	parameters	parameter	NNS
cord-005453-4057qib7	8160	25	for	for	IN
cord-005453-4057qib7	8160	26	diverse	diverse	JJ
cord-005453-4057qib7	8160	27	pathologies	pathology	NNS
cord-005453-4057qib7	8160	28	.	.	.
cord-005453-4057qib7	8161	1	In	in	IN
cord-005453-4057qib7	8161	2	addition	addition	NN
cord-005453-4057qib7	8161	3	,	,	,
cord-005453-4057qib7	8161	4	TcRα	TcRα	NNP
cord-005453-4057qib7	8161	5	/	/	SYM
cord-005453-4057qib7	8161	6	β+	β+	NNP
cord-005453-4057qib7	8161	7	and	and	CC
cord-005453-4057qib7	8161	8	CD19	CD19	NNP
cord-005453-4057qib7	8161	9	+	+	CC
cord-005453-4057qib7	8161	10	cell	cell	NN
cord-005453-4057qib7	8161	11	depletion	depletion	NN
cord-005453-4057qib7	8161	12	does	do	VBZ
cord-005453-4057qib7	8161	13	not	not	RB
cord-005453-4057qib7	8161	14	significantly	significantly	RB
cord-005453-4057qib7	8161	15	affect	affect	VB
cord-005453-4057qib7	8161	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8161	17	stem	stem	NN
cord-005453-4057qib7	8161	18	cell	cell	NN
cord-005453-4057qib7	8161	19	populations	population	NNS
cord-005453-4057qib7	8161	20	such	such	JJ
cord-005453-4057qib7	8161	21	as	as	IN
cord-005453-4057qib7	8161	22	CD34	CD34	NNP
cord-005453-4057qib7	8161	23	+	+	CC
cord-005453-4057qib7	8162	1	and	and	CC
cord-005453-4057qib7	8162	2	CD133	CD133	NNP
cord-005453-4057qib7	8163	1	+	+	CC
cord-005453-4057qib7	8163	2	cells	cell	NNS
cord-005453-4057qib7	8163	3	or	or	CC
cord-005453-4057qib7	8163	4	TcRγ	TcRγ	NNP
cord-005453-4057qib7	8163	5	/	/	SYM
cord-005453-4057qib7	8163	6	δ+	δ+	JJ
cord-005453-4057qib7	8163	7	cell	cell	NN
cord-005453-4057qib7	8163	8	population	population	NN
cord-005453-4057qib7	8163	9	.	.	.
cord-005453-4057qib7	8164	1	CD34	CD34	NNP
cord-005453-4057qib7	8164	2	+	+	CC
cord-005453-4057qib7	8164	3	and	and	CC
cord-005453-4057qib7	8164	4	TCR	TCR	NNP
cord-005453-4057qib7	8164	5	γ/	γ/	NNP
cord-005453-4057qib7	8165	1	δ	δ	NN
cord-005453-4057qib7	8165	2	cells	cell	NNS
cord-005453-4057qib7	8165	3	are	be	VBP
cord-005453-4057qib7	8165	4	highly	highly	RB
cord-005453-4057qib7	8165	5	recovered	recover	VBN
cord-005453-4057qib7	8165	6	(	(	-LRB-
cord-005453-4057qib7	8165	7	93.15	93.15	CD
cord-005453-4057qib7	8165	8	%	%	NN
cord-005453-4057qib7	8165	9	and	and	CC
cord-005453-4057qib7	8165	10	88.76	88.76	CD
cord-005453-4057qib7	8165	11	,	,	,
cord-005453-4057qib7	8165	12	respectively	respectively	RB
cord-005453-4057qib7	8165	13	)	)	-RRB-
cord-005453-4057qib7	8165	14	,	,	,
cord-005453-4057qib7	8165	15	which	which	WDT
cord-005453-4057qib7	8165	16	contributes	contribute	VBZ
cord-005453-4057qib7	8165	17	with	with	IN
cord-005453-4057qib7	8165	18	a	a	DT
cord-005453-4057qib7	8165	19	better	well	JJR
cord-005453-4057qib7	8165	20	engraftment	engraftment	NN
cord-005453-4057qib7	8165	21	after	after	IN
cord-005453-4057qib7	8165	22	allo	allo	NN
cord-005453-4057qib7	8165	23	-	-	HYPH
cord-005453-4057qib7	8165	24	HSCT	HSCT	NNP
cord-005453-4057qib7	8165	25	.	.	.
cord-005453-4057qib7	8166	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8166	2	:	:	:
cord-005453-4057qib7	8167	1	Peruvian	peruvian	JJ
cord-005453-4057qib7	8167	2	results	result	NNS
cord-005453-4057qib7	8167	3	oscillated	oscillate	VBD
cord-005453-4057qib7	8167	4	within	within	IN
cord-005453-4057qib7	8167	5	European	european	JJ
cord-005453-4057qib7	8167	6	ranges	range	NNS
cord-005453-4057qib7	8167	7	with	with	IN
cord-005453-4057qib7	8167	8	an	an	DT
cord-005453-4057qib7	8167	9	OS	os	NN
cord-005453-4057qib7	8167	10	over	over	IN
cord-005453-4057qib7	8167	11	70	70	CD
cord-005453-4057qib7	8167	12	%	%	NN
cord-005453-4057qib7	8167	13	.	.	.
cord-005453-4057qib7	8168	1	Our	-PRON-	PRP$
cord-005453-4057qib7	8168	2	data	data	NN
cord-005453-4057qib7	8168	3	suggests	suggest	VBZ
cord-005453-4057qib7	8168	4	that	that	IN
cord-005453-4057qib7	8168	5	the	the	DT
cord-005453-4057qib7	8168	6	MACS	MACS	NNPS
cord-005453-4057qib7	8168	7	method	method	NN
cord-005453-4057qib7	8168	8	is	be	VBZ
cord-005453-4057qib7	8168	9	an	an	DT
cord-005453-4057qib7	8168	10	efficient	efficient	JJ
cord-005453-4057qib7	8168	11	,	,	,
cord-005453-4057qib7	8168	12	effective	effective	JJ
cord-005453-4057qib7	8168	13	and	and	CC
cord-005453-4057qib7	8168	14	safe	safe	JJ
cord-005453-4057qib7	8168	15	strategy	strategy	NN
cord-005453-4057qib7	8168	16	for	for	IN
cord-005453-4057qib7	8168	17	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8168	18	HSCT	HSCT	NNP
cord-005453-4057qib7	8168	19	which	which	WDT
cord-005453-4057qib7	8168	20	has	have	VBZ
cord-005453-4057qib7	8168	21	a	a	DT
cord-005453-4057qib7	8168	22	remarkable	remarkable	JJ
cord-005453-4057qib7	8168	23	cost	cost	NN
cord-005453-4057qib7	8168	24	-	-	HYPH
cord-005453-4057qib7	8168	25	benefit	benefit	NN
cord-005453-4057qib7	8168	26	ratio	ratio	NN
cord-005453-4057qib7	8168	27	and	and	CC
cord-005453-4057qib7	8168	28	makes	make	VBZ
cord-005453-4057qib7	8168	29	it	-PRON-	PRP
cord-005453-4057qib7	8168	30	viable	viable	JJ
cord-005453-4057qib7	8168	31	in	in	IN
cord-005453-4057qib7	8168	32	countries	country	NNS
cord-005453-4057qib7	8168	33	of	of	IN
cord-005453-4057qib7	8168	34	the	the	DT
cord-005453-4057qib7	8168	35	Latin	latin	JJ
cord-005453-4057qib7	8168	36	American	american	JJ
cord-005453-4057qib7	8168	37	region	region	NN
cord-005453-4057qib7	8168	38	with	with	IN
cord-005453-4057qib7	8168	39	Peruvian	peruvian	JJ
cord-005453-4057qib7	8168	40	socio	socio	JJ
cord-005453-4057qib7	8168	41	-	-	HYPH
cord-005453-4057qib7	8168	42	economic	economic	JJ
cord-005453-4057qib7	8168	43	characteristics	characteristic	NNS
cord-005453-4057qib7	8168	44	.	.	.
cord-005453-4057qib7	8169	1	Evaluation	evaluation	NN
cord-005453-4057qib7	8169	2	of	of	IN
cord-005453-4057qib7	8169	3	genoresistance	genoresistance	NNP
cord-005453-4057qib7	8169	4	for	for	IN
cord-005453-4057qib7	8169	5	viral	viral	JJ
cord-005453-4057qib7	8169	6	reactivation	reactivation	NN
cord-005453-4057qib7	8169	7	treatment	treatment	NN
cord-005453-4057qib7	8169	8	has	have	VBZ
cord-005453-4057qib7	8169	9	been	be	VBN
cord-005453-4057qib7	8169	10	implemented	implement	VBN
cord-005453-4057qib7	8169	11	as	as	IN
cord-005453-4057qib7	8169	12	a	a	DT
cord-005453-4057qib7	8169	13	strategy	strategy	NN
cord-005453-4057qib7	8169	14	to	to	TO
cord-005453-4057qib7	8169	15	improve	improve	VB
cord-005453-4057qib7	8169	16	OS	OS	NNP
cord-005453-4057qib7	8169	17	.	.	.
cord-005453-4057qib7	8170	1	Better	well	JJR
cord-005453-4057qib7	8170	2	results	result	NNS
cord-005453-4057qib7	8170	3	are	be	VBP
cord-005453-4057qib7	8170	4	achieved	achieve	VBN
cord-005453-4057qib7	8170	5	in	in	IN
cord-005453-4057qib7	8170	6	patients	patient	NNS
cord-005453-4057qib7	8170	7	after	after	IN
cord-005453-4057qib7	8170	8	allo	allo	NN
cord-005453-4057qib7	8170	9	-	-	HYPH
cord-005453-4057qib7	8170	10	HSCT	HSCT	NNP
cord-005453-4057qib7	8170	11	with	with	IN
cord-005453-4057qib7	8170	12	the	the	DT
cord-005453-4057qib7	8170	13	validation	validation	NN
cord-005453-4057qib7	8170	14	of	of	IN
cord-005453-4057qib7	8170	15	these	these	DT
cord-005453-4057qib7	8170	16	tests	test	NNS
cord-005453-4057qib7	8170	17	in	in	IN
cord-005453-4057qib7	8170	18	Peru	Peru	NNP
cord-005453-4057qib7	8170	19	.	.	.
cord-005453-4057qib7	8171	1	Preliminary	preliminary	JJ
cord-005453-4057qib7	8171	2	pharmacoeconomic	pharmacoeconomic	JJ
cord-005453-4057qib7	8171	3	evaluations	evaluation	NNS
cord-005453-4057qib7	8171	4	allow	allow	VBP
cord-005453-4057qib7	8171	5	us	-PRON-	PRP
cord-005453-4057qib7	8171	6	to	to	TO
cord-005453-4057qib7	8171	7	establish	establish	VB
cord-005453-4057qib7	8171	8	Magnetic	Magnetic	NNP
cord-005453-4057qib7	8171	9	Activated	activate	VBN
cord-005453-4057qib7	8171	10	Cell	cell	NN
cord-005453-4057qib7	8171	11	Sorting	sorting	NN
cord-005453-4057qib7	8171	12	(	(	-LRB-
cord-005453-4057qib7	8171	13	MACS	MACS	NNPS
cord-005453-4057qib7	8171	14	)	)	-RRB-
cord-005453-4057qib7	8171	15	as	as	IN
cord-005453-4057qib7	8171	16	a	a	DT
cord-005453-4057qib7	8171	17	promissory	promissory	JJ
cord-005453-4057qib7	8171	18	strategy	strategy	NN
cord-005453-4057qib7	8171	19	compared	compare	VBN
cord-005453-4057qib7	8171	20	to	to	IN
cord-005453-4057qib7	8171	21	other	other	JJ
cord-005453-4057qib7	8171	22	alternatives	alternative	NNS
cord-005453-4057qib7	8171	23	for	for	IN
cord-005453-4057qib7	8171	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8171	25	HSCT	HSCT	NNP
cord-005453-4057qib7	8171	26	.	.	.
cord-005453-4057qib7	8172	1	It	-PRON-	PRP
cord-005453-4057qib7	8172	2	is	be	VBZ
cord-005453-4057qib7	8172	3	necessary	necessary	JJ
cord-005453-4057qib7	8172	4	to	to	TO
cord-005453-4057qib7	8172	5	increase	increase	VB
cord-005453-4057qib7	8172	6	the	the	DT
cord-005453-4057qib7	8172	7	number	number	NN
cord-005453-4057qib7	8172	8	of	of	IN
cord-005453-4057qib7	8172	9	procedures	procedure	NNS
cord-005453-4057qib7	8172	10	in	in	IN
cord-005453-4057qib7	8172	11	order	order	NN
cord-005453-4057qib7	8172	12	to	to	TO
cord-005453-4057qib7	8172	13	confirm	confirm	VB
cord-005453-4057qib7	8172	14	efficacy	efficacy	NN
cord-005453-4057qib7	8172	15	and	and	CC
cord-005453-4057qib7	8172	16	safety	safety	NN
cord-005453-4057qib7	8172	17	of	of	IN
cord-005453-4057qib7	8172	18	MACS	MACS	NNPS
cord-005453-4057qib7	8172	19	in	in	IN
cord-005453-4057qib7	8172	20	a	a	DT
cord-005453-4057qib7	8172	21	larger	large	JJR
cord-005453-4057qib7	8172	22	population	population	NN
cord-005453-4057qib7	8172	23	.	.	.
cord-005453-4057qib7	8173	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8173	2	:	:	:
cord-005453-4057qib7	8174	1	All	all	DT
cord-005453-4057qib7	8174	2	authors	author	NNS
cord-005453-4057qib7	8174	3	have	have	VBP
cord-005453-4057qib7	8174	4	no	no	DT
cord-005453-4057qib7	8174	5	conflicts	conflict	NNS
cord-005453-4057qib7	8174	6	of	of	IN
cord-005453-4057qib7	8174	7	interest	interest	NN
cord-005453-4057qib7	8174	8	.	.	.
cord-005453-4057qib7	8175	1	Abstract	Abstract	NNP
cord-005453-4057qib7	8175	2	already	already	RB
cord-005453-4057qib7	8175	3	published	publish	VBN
cord-005453-4057qib7	8175	4	.	.	.
cord-005453-4057qib7	8176	1	Micro	micro	JJ
cord-005453-4057qib7	8176	2	-	-	HYPH
cord-005453-4057qib7	8176	3	costing	costing	NN
cord-005453-4057qib7	8176	4	study	study	NN
cord-005453-4057qib7	8176	5	of	of	IN
cord-005453-4057qib7	8176	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8176	7	stem	stem	NN
cord-005453-4057qib7	8176	8	cell	cell	NN
cord-005453-4057qib7	8176	9	transplantation	transplantation	NN
cord-005453-4057qib7	8176	10	in	in	IN
cord-005453-4057qib7	8176	11	two	two	CD
cord-005453-4057qib7	8176	12	hospital	hospital	NN
cord-005453-4057qib7	8176	13	institutions	institution	NNS
cord-005453-4057qib7	8176	14	from	from	IN
cord-005453-4057qib7	8176	15	southern	southern	JJ
cord-005453-4057qib7	8176	16	of	of	IN
cord-005453-4057qib7	8176	17	Brazil	Brazil	NNP
cord-005453-4057qib7	8176	18	Background	Background	NNP
cord-005453-4057qib7	8176	19	:	:	:
cord-005453-4057qib7	8176	20	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8176	21	stem	stem	NN
cord-005453-4057qib7	8176	22	cell	cell	NN
cord-005453-4057qib7	8176	23	transplantation	transplantation	NN
cord-005453-4057qib7	8176	24	(	(	-LRB-
cord-005453-4057qib7	8176	25	HSCT	HSCT	NNP
cord-005453-4057qib7	8176	26	)	)	-RRB-
cord-005453-4057qib7	8176	27	is	be	VBZ
cord-005453-4057qib7	8176	28	a	a	DT
cord-005453-4057qib7	8176	29	potentially	potentially	RB
cord-005453-4057qib7	8176	30	curative	curative	JJ
cord-005453-4057qib7	8176	31	treatment	treatment	NN
cord-005453-4057qib7	8176	32	indicated	indicate	VBN
cord-005453-4057qib7	8176	33	for	for	IN
cord-005453-4057qib7	8176	34	patients	patient	NNS
cord-005453-4057qib7	8176	35	with	with	IN
cord-005453-4057qib7	8176	36	onco	onco	JJ
cord-005453-4057qib7	8176	37	-	-	HYPH
cord-005453-4057qib7	8176	38	hematological	hematological	JJ
cord-005453-4057qib7	8176	39	,	,	,
cord-005453-4057qib7	8176	40	hereditary	hereditary	JJ
cord-005453-4057qib7	8176	41	and	and	CC
cord-005453-4057qib7	8176	42	immunological	immunological	JJ
cord-005453-4057qib7	8176	43	diseases	disease	NNS
cord-005453-4057qib7	8176	44	.	.	.
cord-005453-4057qib7	8177	1	Considering	consider	VBG
cord-005453-4057qib7	8177	2	the	the	DT
cord-005453-4057qib7	8177	3	increase	increase	NN
cord-005453-4057qib7	8177	4	of	of	IN
cord-005453-4057qib7	8177	5	patients	patient	NNS
cord-005453-4057qib7	8177	6	indicated	indicate	VBN
cord-005453-4057qib7	8177	7	to	to	IN
cord-005453-4057qib7	8177	8	the	the	DT
cord-005453-4057qib7	8177	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8177	10	and	and	CC
cord-005453-4057qib7	8177	11	the	the	DT
cord-005453-4057qib7	8177	12	lack	lack	NN
cord-005453-4057qib7	8177	13	of	of	IN
cord-005453-4057qib7	8177	14	knowledge	knowledge	NN
cord-005453-4057qib7	8177	15	about	about	IN
cord-005453-4057qib7	8177	16	the	the	DT
cord-005453-4057qib7	8177	17	costs	cost	NNS
cord-005453-4057qib7	8177	18	resulting	result	VBG
cord-005453-4057qib7	8177	19	from	from	IN
cord-005453-4057qib7	8177	20	this	this	DT
cord-005453-4057qib7	8177	21	treatment	treatment	NN
cord-005453-4057qib7	8177	22	,	,	,
cord-005453-4057qib7	8177	23	is	be	VBZ
cord-005453-4057qib7	8177	24	important	important	JJ
cord-005453-4057qib7	8177	25	to	to	TO
cord-005453-4057qib7	8177	26	identify	identify	VB
cord-005453-4057qib7	8177	27	and	and	CC
cord-005453-4057qib7	8177	28	detail	detail	VB
cord-005453-4057qib7	8177	29	the	the	DT
cord-005453-4057qib7	8177	30	resources	resource	NNS
cord-005453-4057qib7	8177	31	consumed	consume	VBN
cord-005453-4057qib7	8177	32	in	in	IN
cord-005453-4057qib7	8177	33	each	each	DT
cord-005453-4057qib7	8177	34	phase	phase	NN
cord-005453-4057qib7	8177	35	of	of	IN
cord-005453-4057qib7	8177	36	HSCT	HSCT	NNP
cord-005453-4057qib7	8177	37	and	and	CC
cord-005453-4057qib7	8177	38	provide	provide	VB
cord-005453-4057qib7	8177	39	knowledge	knowledge	NN
cord-005453-4057qib7	8177	40	to	to	IN
cord-005453-4057qib7	8177	41	the	the	DT
cord-005453-4057qib7	8177	42	public	public	JJ
cord-005453-4057qib7	8177	43	health	health	NN
cord-005453-4057qib7	8177	44	brazilian	brazilian	NN
cord-005453-4057qib7	8177	45	system	system	NN
cord-005453-4057qib7	8177	46	.	.	.
cord-005453-4057qib7	8178	1	We	-PRON-	PRP
cord-005453-4057qib7	8178	2	aimed	aim	VBD
cord-005453-4057qib7	8178	3	measure	measure	VB
cord-005453-4057qib7	8178	4	the	the	DT
cord-005453-4057qib7	8178	5	total	total	JJ
cord-005453-4057qib7	8178	6	cost	cost	NN
cord-005453-4057qib7	8178	7	of	of	IN
cord-005453-4057qib7	8178	8	related	related	JJ
cord-005453-4057qib7	8178	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8178	10	,	,	,
cord-005453-4057qib7	8178	11	based	base	VBN
cord-005453-4057qib7	8178	12	on	on	IN
cord-005453-4057qib7	8178	13	micro	micro	JJ
cord-005453-4057qib7	8178	14	-	-	JJ
cord-005453-4057qib7	8178	15	costing	costing	JJ
cord-005453-4057qib7	8178	16	study	study	NN
cord-005453-4057qib7	8178	17	of	of	IN
cord-005453-4057qib7	8178	18	patients	patient	NNS
cord-005453-4057qib7	8178	19	assisted	assist	VBN
cord-005453-4057qib7	8178	20	in	in	IN
cord-005453-4057qib7	8178	21	two	two	CD
cord-005453-4057qib7	8178	22	hospitals	hospital	NNS
cord-005453-4057qib7	8178	23	in	in	IN
cord-005453-4057qib7	8178	24	the	the	DT
cord-005453-4057qib7	8178	25	South	South	NNP
cord-005453-4057qib7	8178	26	region	region	NN
cord-005453-4057qib7	8178	27	of	of	IN
cord-005453-4057qib7	8178	28	Brazil	Brazil	NNP
cord-005453-4057qib7	8178	29	.	.	.
cord-005453-4057qib7	8179	1	Methods	method	NNS
cord-005453-4057qib7	8179	2	:	:	:
cord-005453-4057qib7	8179	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8179	4	costs	cost	NNS
cord-005453-4057qib7	8179	5	were	be	VBD
cord-005453-4057qib7	8179	6	estimated	estimate	VBN
cord-005453-4057qib7	8179	7	using	use	VBG
cord-005453-4057qib7	8179	8	the	the	DT
cord-005453-4057qib7	8179	9	timedriven	timedriven	NNP
cord-005453-4057qib7	8179	10	activity	activity	NN
cord-005453-4057qib7	8179	11	based	base	VBN
cord-005453-4057qib7	8179	12	costing	costing	NN
cord-005453-4057qib7	8179	13	method	method	NN
cord-005453-4057qib7	8179	14	(	(	-LRB-
cord-005453-4057qib7	8179	15	TDABC	TDABC	NNP
cord-005453-4057qib7	8179	16	)	)	-RRB-
cord-005453-4057qib7	8179	17	,	,	,
cord-005453-4057qib7	8179	18	which	which	WDT
cord-005453-4057qib7	8179	19	measured	measure	VBD
cord-005453-4057qib7	8179	20	cost	cost	NN
cord-005453-4057qib7	8179	21	of	of	IN
cord-005453-4057qib7	8179	22	services	service	NNS
cord-005453-4057qib7	8179	23	/	/	SYM
cord-005453-4057qib7	8179	24	products	product	NNS
cord-005453-4057qib7	8179	25	based	base	VBN
cord-005453-4057qib7	8179	26	on	on	IN
cord-005453-4057qib7	8179	27	actual	actual	JJ
cord-005453-4057qib7	8179	28	consumption	consumption	NN
cord-005453-4057qib7	8179	29	of	of	IN
cord-005453-4057qib7	8179	30	resources	resource	NNS
cord-005453-4057qib7	8179	31	.	.	.
cord-005453-4057qib7	8180	1	We	-PRON-	PRP
cord-005453-4057qib7	8180	2	collected	collect	VBD
cord-005453-4057qib7	8180	3	data	datum	NNS
cord-005453-4057qib7	8180	4	from	from	IN
cord-005453-4057qib7	8180	5	medical	medical	JJ
cord-005453-4057qib7	8180	6	records	record	NNS
cord-005453-4057qib7	8180	7	of	of	IN
cord-005453-4057qib7	8180	8	12	12	CD
cord-005453-4057qib7	8180	9	patients	patient	NNS
cord-005453-4057qib7	8180	10	submitted	submit	VBN
cord-005453-4057qib7	8180	11	to	to	IN
cord-005453-4057qib7	8180	12	allogeneic	allogeneic	VB
cord-005453-4057qib7	8180	13	HSCT	HSCT	NNP
cord-005453-4057qib7	8180	14	in	in	IN
cord-005453-4057qib7	8180	15	2017	2017	CD
cord-005453-4057qib7	8180	16	from	from	IN
cord-005453-4057qib7	8180	17	public	public	JJ
cord-005453-4057qib7	8180	18	and	and	CC
cord-005453-4057qib7	8180	19	private	private	JJ
cord-005453-4057qib7	8180	20	(	(	-LRB-
cord-005453-4057qib7	8180	21	philanthropic	philanthropic	JJ
cord-005453-4057qib7	8180	22	)	)	-RRB-
cord-005453-4057qib7	8180	23	hospitals	hospital	NNS
cord-005453-4057qib7	8180	24	.	.	.
cord-005453-4057qib7	8181	1	We	-PRON-	PRP
cord-005453-4057qib7	8181	2	interviewed	interview	VBD
cord-005453-4057qib7	8181	3	professionals	professional	NNS
cord-005453-4057qib7	8181	4	involved	involve	VBN
cord-005453-4057qib7	8181	5	in	in	IN
cord-005453-4057qib7	8181	6	the	the	DT
cord-005453-4057qib7	8181	7	TCTH	TCTH	NNP
cord-005453-4057qib7	8181	8	activities	activity	NNS
cord-005453-4057qib7	8181	9	,	,	,
cord-005453-4057qib7	8181	10	we	-PRON-	PRP
cord-005453-4057qib7	8181	11	performed	perform	VBD
cord-005453-4057qib7	8181	12	chrono	chrono	NN
cord-005453-4057qib7	8181	13	-	-	HYPH
cord-005453-4057qib7	8181	14	analysis	analysis	NN
cord-005453-4057qib7	8181	15	and	and	CC
cord-005453-4057qib7	8181	16	,	,	,
cord-005453-4057qib7	8181	17	we	-PRON-	PRP
cord-005453-4057qib7	8181	18	consulted	consult	VBD
cord-005453-4057qib7	8181	19	financial	financial	JJ
cord-005453-4057qib7	8181	20	and	and	CC
cord-005453-4057qib7	8181	21	administrative	administrative	JJ
cord-005453-4057qib7	8181	22	systems	system	NNS
cord-005453-4057qib7	8181	23	reports	report	NNS
cord-005453-4057qib7	8181	24	of	of	IN
cord-005453-4057qib7	8181	25	hospitals	hospital	NNS
cord-005453-4057qib7	8181	26	.	.	.
cord-005453-4057qib7	8182	1	In	in	IN
cord-005453-4057qib7	8182	2	order	order	NN
cord-005453-4057qib7	8182	3	to	to	TO
cord-005453-4057qib7	8182	4	compare	compare	VB
cord-005453-4057qib7	8182	5	costs	cost	NNS
cord-005453-4057qib7	8182	6	according	accord	VBG
cord-005453-4057qib7	8182	7	to	to	IN
cord-005453-4057qib7	8182	8	clinical	clinical	JJ
cord-005453-4057qib7	8182	9	complications	complication	NNS
cord-005453-4057qib7	8182	10	observed	observe	VBN
cord-005453-4057qib7	8182	11	in	in	IN
cord-005453-4057qib7	8182	12	patients	patient	NNS
cord-005453-4057qib7	8182	13	,	,	,
cord-005453-4057qib7	8182	14	we	-PRON-	PRP
cord-005453-4057qib7	8182	15	grouped	group	VBD
cord-005453-4057qib7	8182	16	into	into	IN
cord-005453-4057qib7	8182	17	two	two	CD
cord-005453-4057qib7	8182	18	ranges	range	NNS
cord-005453-4057qib7	8182	19	of	of	IN
cord-005453-4057qib7	8182	20	complexity	complexity	NN
cord-005453-4057qib7	8182	21	:	:	:
cord-005453-4057qib7	8182	22	low/	low/	CD
cord-005453-4057qib7	8182	23	medium	medium	NN
cord-005453-4057qib7	8182	24	and	and	CC
cord-005453-4057qib7	8182	25	high	high	JJ
cord-005453-4057qib7	8182	26	.	.	.
cord-005453-4057qib7	8183	1	The	the	DT
cord-005453-4057qib7	8183	2	study	study	NN
cord-005453-4057qib7	8183	3	was	be	VBD
cord-005453-4057qib7	8183	4	divided	divide	VBN
cord-005453-4057qib7	8183	5	into	into	IN
cord-005453-4057qib7	8183	6	stages	stage	NNS
cord-005453-4057qib7	8183	7	:	:	:
cord-005453-4057qib7	8183	8	HSCT	HSCT	NNP
cord-005453-4057qib7	8183	9	processes	process	VBZ
cord-005453-4057qib7	8183	10	mapping	mapping	NN
cord-005453-4057qib7	8183	11	;	;	:
cord-005453-4057qib7	8183	12	costs	cost	NNS
cord-005453-4057qib7	8183	13	measurement	measurement	NN
cord-005453-4057qib7	8183	14	;	;	:
cord-005453-4057qib7	8183	15	and	and	CC
cord-005453-4057qib7	8183	16	analysis	analysis	NN
cord-005453-4057qib7	8183	17	of	of	IN
cord-005453-4057qib7	8183	18	results	result	NNS
cord-005453-4057qib7	8183	19	.	.	.
cord-005453-4057qib7	8184	1	Finally	finally	RB
cord-005453-4057qib7	8184	2	,	,	,
cord-005453-4057qib7	8184	3	the	the	DT
cord-005453-4057qib7	8184	4	costs	cost	NNS
cord-005453-4057qib7	8184	5	were	be	VBD
cord-005453-4057qib7	8184	6	compared	compare	VBN
cord-005453-4057qib7	8184	7	:	:	:
cord-005453-4057qib7	8184	8	by	by	IN
cord-005453-4057qib7	8184	9	activity	activity	NN
cord-005453-4057qib7	8184	10	,	,	,
cord-005453-4057qib7	8184	11	by	by	IN
cord-005453-4057qib7	8184	12	resource	resource	NN
cord-005453-4057qib7	8184	13	and	and	CC
cord-005453-4057qib7	8184	14	by	by	IN
cord-005453-4057qib7	8184	15	hospital	hospital	NN
cord-005453-4057qib7	8184	16	.	.	.
cord-005453-4057qib7	8185	1	This	this	DT
cord-005453-4057qib7	8185	2	study	study	NN
cord-005453-4057qib7	8185	3	was	be	VBD
cord-005453-4057qib7	8185	4	financed	finance	VBN
cord-005453-4057qib7	8185	5	by	by	IN
cord-005453-4057qib7	8185	6	PSID	PSID	NNP
cord-005453-4057qib7	8185	7	-	-	HYPH
cord-005453-4057qib7	8185	8	UHS	UHS	NNP
cord-005453-4057qib7	8185	9	,	,	,
cord-005453-4057qib7	8185	10	by	by	IN
cord-005453-4057qib7	8185	11	an	an	DT
cord-005453-4057qib7	8185	12	agreement	agreement	NN
cord-005453-4057qib7	8185	13	signed	sign	VBN
cord-005453-4057qib7	8185	14	between	between	IN
cord-005453-4057qib7	8185	15	Ministry	Ministry	NNP
cord-005453-4057qib7	8185	16	of	of	IN
cord-005453-4057qib7	8185	17	Health	Health	NNP
cord-005453-4057qib7	8185	18	and	and	CC
cord-005453-4057qib7	8185	19	Moinhos	Moinhos	NNP
cord-005453-4057qib7	8185	20	de	de	NNP
cord-005453-4057qib7	8185	21	Vento	Vento	NNP
cord-005453-4057qib7	8185	22	Hospital	Hospital	NNP
cord-005453-4057qib7	8185	23	,	,	,
cord-005453-4057qib7	8185	24	through	through	IN
cord-005453-4057qib7	8185	25	adjustment	adjustment	NN
cord-005453-4057qib7	8185	26	term	term	NN
cord-005453-4057qib7	8185	27	number	number	NN
cord-005453-4057qib7	8185	28	:	:	:
cord-005453-4057qib7	8185	29	04	04	CD
cord-005453-4057qib7	8185	30	/	/	SYM
cord-005453-4057qib7	8185	31	2014	2014	CD
cord-005453-4057qib7	8185	32	,	,	,
cord-005453-4057qib7	8185	33	and	and	CC
cord-005453-4057qib7	8185	34	approved	approve	VBN
cord-005453-4057qib7	8185	35	by	by	IN
cord-005453-4057qib7	8185	36	Research	Research	NNP
cord-005453-4057qib7	8185	37	Ethics	Ethics	NNP
cord-005453-4057qib7	8185	38	Committees	Committees	NNPS
cord-005453-4057qib7	8185	39	.	.	.
cord-005453-4057qib7	8186	1	Results	result	NNS
cord-005453-4057qib7	8186	2	:	:	:
cord-005453-4057qib7	8187	1	From	from	IN
cord-005453-4057qib7	8187	2	the	the	DT
cord-005453-4057qib7	8187	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8187	4	processes	process	NNS
cord-005453-4057qib7	8187	5	mapping	mapping	NN
cord-005453-4057qib7	8187	6	,	,	,
cord-005453-4057qib7	8187	7	the	the	DT
cord-005453-4057qib7	8187	8	following	following	JJ
cord-005453-4057qib7	8187	9	steps	step	NNS
cord-005453-4057qib7	8187	10	were	be	VBD
cord-005453-4057qib7	8187	11	defined	define	VBN
cord-005453-4057qib7	8187	12	:	:	:
cord-005453-4057qib7	8187	13	(	(	-LRB-
cord-005453-4057qib7	8187	14	I	i	NN
cord-005453-4057qib7	8187	15	)	)	-RRB-
cord-005453-4057qib7	8187	16	hospitalization	hospitalization	NN
cord-005453-4057qib7	8187	17	;	;	,
cord-005453-4057qib7	8187	18	(	(	-LRB-
cord-005453-4057qib7	8187	19	II	ii	NN
cord-005453-4057qib7	8187	20	)	)	-RRB-
cord-005453-4057qib7	8187	21	conditioning	conditioning	NN
cord-005453-4057qib7	8187	22	;	;	:
cord-005453-4057qib7	8187	23	(	(	-LRB-
cord-005453-4057qib7	8187	24	III	III	NNP
cord-005453-4057qib7	8187	25	)	)	-RRB-
cord-005453-4057qib7	8187	26	transplantation	transplantation	NN
cord-005453-4057qib7	8187	27	;	;	,
cord-005453-4057qib7	8187	28	(	(	-LRB-
cord-005453-4057qib7	8187	29	IV	IV	NNP
cord-005453-4057qib7	8187	30	)	)	-RRB-
cord-005453-4057qib7	8187	31	period	period	NN
cord-005453-4057qib7	8187	32	of	of	IN
cord-005453-4057qib7	8187	33	aplasia	aplasia	NNP
cord-005453-4057qib7	8187	34	;	;	:
cord-005453-4057qib7	8187	35	(	(	-LRB-
cord-005453-4057qib7	8187	36	V	v	NN
cord-005453-4057qib7	8187	37	)	)	-RRB-
cord-005453-4057qib7	8187	38	engraftment	engraftment	NN
cord-005453-4057qib7	8188	1	;	;	:
cord-005453-4057qib7	8188	2	(	(	-LRB-
cord-005453-4057qib7	8188	3	VI	VI	NNP
cord-005453-4057qib7	8188	4	)	)	-RRB-
cord-005453-4057qib7	8188	5	observation	observation	NN
cord-005453-4057qib7	8188	6	;	;	:
cord-005453-4057qib7	8188	7	(	(	-LRB-
cord-005453-4057qib7	8188	8	VII	VII	NNP
cord-005453-4057qib7	8188	9	)	)	-RRB-
cord-005453-4057qib7	8188	10	pre	pre	JJ
cord-005453-4057qib7	8188	11	-	-	JJ
cord-005453-4057qib7	8188	12	and	and	CC
cord-005453-4057qib7	8188	13	medical	medical	JJ
cord-005453-4057qib7	8188	14	discharge	discharge	NN
cord-005453-4057qib7	8188	15	.	.	.
cord-005453-4057qib7	8189	1	Seven	seven	CD
cord-005453-4057qib7	8189	2	patients	patient	NNS
cord-005453-4057qib7	8189	3	were	be	VBD
cord-005453-4057qib7	8189	4	classified	classify	VBN
cord-005453-4057qib7	8189	5	in	in	IN
cord-005453-4057qib7	8189	6	low	low	JJ
cord-005453-4057qib7	8189	7	/	/	SYM
cord-005453-4057qib7	8189	8	medium	medium	NN
cord-005453-4057qib7	8189	9	complexity	complexity	NN
cord-005453-4057qib7	8189	10	level	level	NN
cord-005453-4057qib7	8189	11	,	,	,
cord-005453-4057qib7	8189	12	with	with	IN
cord-005453-4057qib7	8189	13	hospitalization	hospitalization	NN
cord-005453-4057qib7	8189	14	median	median	JJ
cord-005453-4057qib7	8189	15	time	time	NN
cord-005453-4057qib7	8189	16	of	of	IN
cord-005453-4057qib7	8189	17	41	41	CD
cord-005453-4057qib7	8189	18	days	day	NNS
cord-005453-4057qib7	8189	19	and	and	CC
cord-005453-4057qib7	8189	20	an	an	DT
cord-005453-4057qib7	8189	21	median	median	JJ
cord-005453-4057qib7	8189	22	cost	cost	NN
cord-005453-4057qib7	8189	23	of	of	IN
cord-005453-4057qib7	8189	24	USD	usd	NN
cord-005453-4057qib7	8189	25	66,278.29	66,278.29	CD
cord-005453-4057qib7	8189	26	,	,	,
cord-005453-4057qib7	8189	27	whereas	whereas	IN
cord-005453-4057qib7	8189	28	the	the	DT
cord-005453-4057qib7	8189	29	other	other	JJ
cord-005453-4057qib7	8189	30	five	five	CD
cord-005453-4057qib7	8189	31	patients	patient	NNS
cord-005453-4057qib7	8189	32	,	,	,
cord-005453-4057qib7	8189	33	classified	classify	VBN
cord-005453-4057qib7	8189	34	as	as	IN
cord-005453-4057qib7	8189	35	high	high	JJ
cord-005453-4057qib7	8189	36	complexity	complexity	NN
cord-005453-4057qib7	8189	37	,	,	,
cord-005453-4057qib7	8189	38	presented	present	VBN
cord-005453-4057qib7	8189	39	median	median	JJ
cord-005453-4057qib7	8189	40	time	time	NN
cord-005453-4057qib7	8189	41	of	of	IN
cord-005453-4057qib7	8189	42	101	101	CD
cord-005453-4057qib7	8189	43	days	day	NNS
cord-005453-4057qib7	8189	44	and	and	CC
cord-005453-4057qib7	8189	45	median	median	JJ
cord-005453-4057qib7	8189	46	cost	cost	NN
cord-005453-4057qib7	8189	47	of	of	IN
cord-005453-4057qib7	8189	48	USD	USD	NNP
cord-005453-4057qib7	8189	49	300,367.13	300,367.13	CD
cord-005453-4057qib7	8189	50	.	.	.
cord-005453-4057qib7	8190	1	The	the	DT
cord-005453-4057qib7	8190	2	HSCT	HSCT	NNP
cord-005453-4057qib7	8190	3	costs	cost	VBZ
cord-005453-4057qib7	8190	4	evaluation	evaluation	NN
cord-005453-4057qib7	8190	5	identified	identify	VBD
cord-005453-4057qib7	8190	6	that	that	IN
cord-005453-4057qib7	8190	7	steps	step	VBZ
cord-005453-4057qib7	8190	8	II	II	NNP
cord-005453-4057qib7	8190	9	and	and	CC
cord-005453-4057qib7	8190	10	IV	IV	NNP
cord-005453-4057qib7	8190	11	presented	present	VBD
cord-005453-4057qib7	8190	12	greatest	great	JJS
cord-005453-4057qib7	8190	13	cost	cost	NN
cord-005453-4057qib7	8190	14	in	in	IN
cord-005453-4057qib7	8190	15	high	high	JJ
cord-005453-4057qib7	8190	16	complexity	complexity	NN
cord-005453-4057qib7	8190	17	patients	patient	NNS
cord-005453-4057qib7	8190	18	.	.	.
cord-005453-4057qib7	8191	1	Lower	low	JJR
cord-005453-4057qib7	8191	2	complexity	complexity	NN
cord-005453-4057qib7	8191	3	patients	patient	NNS
cord-005453-4057qib7	8191	4	presented	present	VBN
cord-005453-4057qib7	8191	5	,	,	,
cord-005453-4057qib7	8191	6	in	in	IN
cord-005453-4057qib7	8191	7	steps	step	NNS
cord-005453-4057qib7	8191	8	II	II	NNP
cord-005453-4057qib7	8191	9	and	and	CC
cord-005453-4057qib7	8191	10	IV	IV	NNP
cord-005453-4057qib7	8191	11	,	,	,
cord-005453-4057qib7	8191	12	median	median	JJ
cord-005453-4057qib7	8191	13	costs	cost	NNS
cord-005453-4057qib7	8191	14	of	of	IN
cord-005453-4057qib7	8191	15	USD	usd	NN
cord-005453-4057qib7	8191	16	44,274.52	44,274.52	CD
cord-005453-4057qib7	8191	17	while	while	IN
cord-005453-4057qib7	8191	18	in	in	IN
cord-005453-4057qib7	8191	19	higher	high	JJR
cord-005453-4057qib7	8191	20	complexity	complexity	NN
cord-005453-4057qib7	8191	21	USD	USD	NNP
cord-005453-4057qib7	8191	22	100,226.26	100,226.26	CD
cord-005453-4057qib7	8191	23	.	.	.
cord-005453-4057qib7	8192	1	In	in	IN
cord-005453-4057qib7	8192	2	addition	addition	NN
cord-005453-4057qib7	8192	3	,	,	,
cord-005453-4057qib7	8192	4	median	median	JJ
cord-005453-4057qib7	8192	5	costs	cost	NNS
cord-005453-4057qib7	8192	6	of	of	IN
cord-005453-4057qib7	8192	7	materials	material	NNS
cord-005453-4057qib7	8192	8	and	and	CC
cord-005453-4057qib7	8192	9	drugs	drug	NNS
cord-005453-4057qib7	8192	10	were	be	VBD
cord-005453-4057qib7	8192	11	USD	USD	NNP
cord-005453-4057qib7	8192	12	13,926.02	13,926.02	CD
cord-005453-4057qib7	8192	13	and	and	CC
cord-005453-4057qib7	8192	14	USD	USD	NNP
cord-005453-4057qib7	8192	15	181,094.15	181,094.15	CD
cord-005453-4057qib7	8192	16	in	in	IN
cord-005453-4057qib7	8192	17	lower	low	JJR
cord-005453-4057qib7	8192	18	and	and	CC
cord-005453-4057qib7	8192	19	higher	high	JJR
cord-005453-4057qib7	8192	20	complexity	complexity	NN
cord-005453-4057qib7	8192	21	patients	patient	NNS
cord-005453-4057qib7	8192	22	.	.	.
cord-005453-4057qib7	8193	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8193	2	:	:	:
cord-005453-4057qib7	8194	1	TDABC	tdabc	NN
cord-005453-4057qib7	8194	2	method	method	NN
cord-005453-4057qib7	8194	3	allowed	allow	VBD
cord-005453-4057qib7	8194	4	the	the	DT
cord-005453-4057qib7	8194	5	identification	identification	NN
cord-005453-4057qib7	8194	6	of	of	IN
cord-005453-4057qib7	8194	7	the	the	DT
cord-005453-4057qib7	8194	8	moment	moment	NN
cord-005453-4057qib7	8194	9	when	when	WRB
cord-005453-4057qib7	8194	10	patients	patient	NNS
cord-005453-4057qib7	8194	11	consume	consume	VBP
cord-005453-4057qib7	8194	12	the	the	DT
cord-005453-4057qib7	8194	13	most	most	JJS
cord-005453-4057qib7	8194	14	resources	resource	NNS
cord-005453-4057qib7	8194	15	.	.	.
cord-005453-4057qib7	8195	1	Of	of	IN
cord-005453-4057qib7	8195	2	all	all	PDT
cord-005453-4057qib7	8195	3	the	the	DT
cord-005453-4057qib7	8195	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8195	5	stages	stage	NNS
cord-005453-4057qib7	8195	6	,	,	,
cord-005453-4057qib7	8195	7	periods	period	NNS
cord-005453-4057qib7	8195	8	of	of	IN
cord-005453-4057qib7	8195	9	conditioning	conditioning	NN
cord-005453-4057qib7	8195	10	and	and	CC
cord-005453-4057qib7	8195	11	aplasia	aplasia	NNP
cord-005453-4057qib7	8195	12	presented	present	VBD
cord-005453-4057qib7	8195	13	higher	high	JJR
cord-005453-4057qib7	8195	14	costs	cost	NNS
cord-005453-4057qib7	8195	15	,	,	,
cord-005453-4057qib7	8195	16	representing	represent	VBG
cord-005453-4057qib7	8195	17	76.90	76.90	CD
cord-005453-4057qib7	8195	18	%	%	NN
cord-005453-4057qib7	8195	19	of	of	IN
cord-005453-4057qib7	8195	20	the	the	DT
cord-005453-4057qib7	8195	21	total	total	JJ
cord-005453-4057qib7	8195	22	hospitalization	hospitalization	NN
cord-005453-4057qib7	8195	23	value	value	NN
cord-005453-4057qib7	8195	24	.	.	.
cord-005453-4057qib7	8196	1	In	in	IN
cord-005453-4057qib7	8196	2	these	these	DT
cord-005453-4057qib7	8196	3	stages	stage	NNS
cord-005453-4057qib7	8196	4	,	,	,
cord-005453-4057qib7	8196	5	higher	high	JJR
cord-005453-4057qib7	8196	6	complexity	complexity	NN
cord-005453-4057qib7	8196	7	patients	patient	NNS
cord-005453-4057qib7	8196	8	presented	present	VBD
cord-005453-4057qib7	8196	9	three	three	CD
cord-005453-4057qib7	8196	10	times	time	NNS
cord-005453-4057qib7	8196	11	higher	high	JJR
cord-005453-4057qib7	8196	12	the	the	DT
cord-005453-4057qib7	8196	13	median	median	JJ
cord-005453-4057qib7	8196	14	cost	cost	NN
cord-005453-4057qib7	8196	15	.	.	.
cord-005453-4057qib7	8197	1	The	the	DT
cord-005453-4057qib7	8197	2	resources	resource	NNS
cord-005453-4057qib7	8197	3	that	that	WDT
cord-005453-4057qib7	8197	4	had	have	VBD
cord-005453-4057qib7	8197	5	the	the	DT
cord-005453-4057qib7	8197	6	greatest	great	JJS
cord-005453-4057qib7	8197	7	impact	impact	NN
cord-005453-4057qib7	8197	8	were	be	VBD
cord-005453-4057qib7	8197	9	medicines	medicine	NNS
cord-005453-4057qib7	8197	10	and	and	CC
cord-005453-4057qib7	8197	11	medical	medical	JJ
cord-005453-4057qib7	8197	12	materials	material	NNS
cord-005453-4057qib7	8197	13	,	,	,
cord-005453-4057qib7	8197	14	costing	cost	VBG
cord-005453-4057qib7	8197	15	120	120	CD
cord-005453-4057qib7	8197	16	times	time	NNS
cord-005453-4057qib7	8197	17	more	more	JJR
cord-005453-4057qib7	8197	18	than	than	IN
cord-005453-4057qib7	8197	19	lower	low	JJR
cord-005453-4057qib7	8197	20	complexity	complexity	NN
cord-005453-4057qib7	8197	21	patients	patient	NNS
cord-005453-4057qib7	8197	22	.	.	.
cord-005453-4057qib7	8198	1	Conclusion	conclusion	NN
cord-005453-4057qib7	8198	2	:	:	:
cord-005453-4057qib7	8199	1	This	this	DT
cord-005453-4057qib7	8199	2	study	study	NN
cord-005453-4057qib7	8199	3	allowed	allow	VBD
cord-005453-4057qib7	8199	4	a	a	DT
cord-005453-4057qib7	8199	5	detailed	detailed	JJ
cord-005453-4057qib7	8199	6	identification	identification	NN
cord-005453-4057qib7	8199	7	of	of	IN
cord-005453-4057qib7	8199	8	the	the	DT
cord-005453-4057qib7	8199	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8199	10	costs	cost	NNS
cord-005453-4057qib7	8199	11	in	in	IN
cord-005453-4057qib7	8199	12	patients	patient	NNS
cord-005453-4057qib7	8199	13	with	with	IN
cord-005453-4057qib7	8199	14	different	different	JJ
cord-005453-4057qib7	8199	15	complexity	complexity	NN
cord-005453-4057qib7	8199	16	ranges	range	VBZ
cord-005453-4057qib7	8199	17	in	in	IN
cord-005453-4057qib7	8199	18	two	two	CD
cord-005453-4057qib7	8199	19	hospitals	hospital	NNS
cord-005453-4057qib7	8199	20	from	from	IN
cord-005453-4057qib7	8199	21	southern	southern	JJ
cord-005453-4057qib7	8199	22	Brazil	Brazil	NNP
cord-005453-4057qib7	8199	23	.	.	.
cord-005453-4057qib7	8200	1	Therefore	therefore	RB
cord-005453-4057qib7	8200	2	,	,	,
cord-005453-4057qib7	8200	3	the	the	DT
cord-005453-4057qib7	8200	4	identification	identification	NN
cord-005453-4057qib7	8200	5	of	of	IN
cord-005453-4057qib7	8200	6	service	service	NN
cord-005453-4057qib7	8200	7	demand	demand	NN
cord-005453-4057qib7	8200	8	regarding	regard	VBG
cord-005453-4057qib7	8200	9	the	the	DT
cord-005453-4057qib7	8200	10	clinical	clinical	JJ
cord-005453-4057qib7	8200	11	complexity	complexity	NN
cord-005453-4057qib7	8200	12	,	,	,
cord-005453-4057qib7	8200	13	allows	allow	VBZ
cord-005453-4057qib7	8200	14	the	the	DT
cord-005453-4057qib7	8200	15	generation	generation	NN
cord-005453-4057qib7	8200	16	of	of	IN
cord-005453-4057qib7	8200	17	important	important	JJ
cord-005453-4057qib7	8200	18	information	information	NN
cord-005453-4057qib7	8200	19	for	for	IN
cord-005453-4057qib7	8200	20	the	the	DT
cord-005453-4057qib7	8200	21	management	management	NN
cord-005453-4057qib7	8200	22	of	of	IN
cord-005453-4057qib7	8200	23	the	the	DT
cord-005453-4057qib7	8200	24	best	good	JJS
cord-005453-4057qib7	8200	25	care	care	NN
cord-005453-4057qib7	8200	26	in	in	IN
cord-005453-4057qib7	8200	27	the	the	DT
cord-005453-4057qib7	8200	28	health	health	NN
cord-005453-4057qib7	8200	29	service	service	NN
cord-005453-4057qib7	8200	30	.	.	.
cord-005453-4057qib7	8201	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8201	2	 	 	_SP
cord-005453-4057qib7	8201	3	Background	Background	NNP
cord-005453-4057qib7	8201	4	:	:	:
cord-005453-4057qib7	8201	5	Immunodeficiency	Immunodeficiency	NNP
cord-005453-4057qib7	8201	6	due	due	IN
cord-005453-4057qib7	8201	7	to	to	IN
cord-005453-4057qib7	8201	8	LRBA	LRBA	NNP
cord-005453-4057qib7	8201	9	deficiency	deficiency	NN
cord-005453-4057qib7	8201	10	is	be	VBZ
cord-005453-4057qib7	8201	11	characterized	characterize	VBN
cord-005453-4057qib7	8201	12	by	by	IN
cord-005453-4057qib7	8201	13	hypogammaglobulinemia	hypogammaglobulinemia	NN
cord-005453-4057qib7	8201	14	and	and	CC
cord-005453-4057qib7	8201	15	autoimmunity	autoimmunity	NN
cord-005453-4057qib7	8201	16	.	.	.
cord-005453-4057qib7	8202	1	Hemolytic	hemolytic	JJ
cord-005453-4057qib7	8202	2	anemia	anemia	NN
cord-005453-4057qib7	8202	3	,	,	,
cord-005453-4057qib7	8202	4	lymphadenopathy	lymphadenopathy	JJ
cord-005453-4057qib7	8202	5	,	,	,
cord-005453-4057qib7	8202	6	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8202	7	hepatitis	hepatitis	NN
cord-005453-4057qib7	8202	8	and	and	CC
cord-005453-4057qib7	8202	9	,	,	,
cord-005453-4057qib7	8202	10	above	above	IN
cord-005453-4057qib7	8202	11	all	all	DT
cord-005453-4057qib7	8202	12	,	,	,
cord-005453-4057qib7	8202	13	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8202	14	enteropathy	enteropathy	NNP
cord-005453-4057qib7	8202	15	are	be	VBP
cord-005453-4057qib7	8202	16	the	the	DT
cord-005453-4057qib7	8202	17	fundamental	fundamental	JJ
cord-005453-4057qib7	8202	18	characteristics	characteristic	NNS
cord-005453-4057qib7	8202	19	of	of	IN
cord-005453-4057qib7	8202	20	these	these	DT
cord-005453-4057qib7	8202	21	patients	patient	NNS
cord-005453-4057qib7	8202	22	together	together	RB
cord-005453-4057qib7	8202	23	with	with	IN
cord-005453-4057qib7	8202	24	the	the	DT
cord-005453-4057qib7	8202	25	history	history	NN
cord-005453-4057qib7	8202	26	of	of	IN
cord-005453-4057qib7	8202	27	recurrent	recurrent	JJ
cord-005453-4057qib7	8202	28	invasive	invasive	JJ
cord-005453-4057qib7	8202	29	infections	infection	NNS
cord-005453-4057qib7	8202	30	.	.	.
cord-005453-4057qib7	8203	1	The	the	DT
cord-005453-4057qib7	8203	2	therapy	therapy	NN
cord-005453-4057qib7	8203	3	includes	include	VBZ
cord-005453-4057qib7	8203	4	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	8203	5	,	,	,
cord-005453-4057qib7	8203	6	endovenous	endovenous	JJ
cord-005453-4057qib7	8203	7	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	8203	8	.	.	.
cord-005453-4057qib7	8204	1	Bone	bone	NN
cord-005453-4057qib7	8204	2	marrow	marrow	NN
cord-005453-4057qib7	8204	3	transplantation	transplantation	NN
cord-005453-4057qib7	8204	4	is	be	VBZ
cord-005453-4057qib7	8204	5	the	the	DT
cord-005453-4057qib7	8204	6	final	final	JJ
cord-005453-4057qib7	8204	7	therapy	therapy	NN
cord-005453-4057qib7	8204	8	of	of	IN
cord-005453-4057qib7	8204	9	these	these	DT
cord-005453-4057qib7	8204	10	patients	patient	NNS
cord-005453-4057qib7	8204	11	,	,	,
cord-005453-4057qib7	8204	12	especially	especially	RB
cord-005453-4057qib7	8204	13	in	in	IN
cord-005453-4057qib7	8204	14	the	the	DT
cord-005453-4057qib7	8204	15	most	most	RBS
cord-005453-4057qib7	8204	16	serious	serious	JJ
cord-005453-4057qib7	8204	17	cases	case	NNS
cord-005453-4057qib7	8204	18	and	and	CC
cord-005453-4057qib7	8204	19	in	in	IN
cord-005453-4057qib7	8204	20	recent	recent	JJ
cord-005453-4057qib7	8204	21	years	year	NNS
cord-005453-4057qib7	8204	22	,	,	,
cord-005453-4057qib7	8204	23	also	also	RB
cord-005453-4057qib7	8204	24	on	on	IN
cord-005453-4057qib7	8204	25	the	the	DT
cord-005453-4057qib7	8204	26	light	light	NN
cord-005453-4057qib7	8204	27	of	of	IN
cord-005453-4057qib7	8204	28	increasingly	increasingly	RB
cord-005453-4057qib7	8204	29	targeted	target	VBN
cord-005453-4057qib7	8204	30	conditioning	conditioning	NN
cord-005453-4057qib7	8204	31	regimes	regime	NNS
cord-005453-4057qib7	8204	32	,	,	,
cord-005453-4057qib7	8204	33	it	-PRON-	PRP
cord-005453-4057qib7	8204	34	is	be	VBZ
cord-005453-4057qib7	8204	35	associated	associate	VBN
cord-005453-4057qib7	8204	36	with	with	IN
cord-005453-4057qib7	8204	37	ever	ever	RB
cord-005453-4057qib7	8204	38	better	well	JJR
cord-005453-4057qib7	8204	39	prognosis	prognosis	NN
cord-005453-4057qib7	8204	40	.	.	.
cord-005453-4057qib7	8205	1	Methods	method	NNS
cord-005453-4057qib7	8205	2	:	:	:
cord-005453-4057qib7	8205	3	We	-PRON-	PRP
cord-005453-4057qib7	8205	4	present	present	VBP
cord-005453-4057qib7	8205	5	the	the	DT
cord-005453-4057qib7	8205	6	case	case	NN
cord-005453-4057qib7	8205	7	of	of	IN
cord-005453-4057qib7	8205	8	Caterina	Caterina	NNP
cord-005453-4057qib7	8205	9	,	,	,
cord-005453-4057qib7	8205	10	an	an	DT
cord-005453-4057qib7	8205	11	8-year	8-year	JJ
cord-005453-4057qib7	8205	12	-	-	HYPH
cord-005453-4057qib7	8205	13	old	old	JJ
cord-005453-4057qib7	8205	14	patient	patient	NN
cord-005453-4057qib7	8205	15	with	with	IN
cord-005453-4057qib7	8205	16	LRBA	LRBA	NNP
cord-005453-4057qib7	8205	17	deficiency	deficiency	NN
cord-005453-4057qib7	8205	18	,	,	,
cord-005453-4057qib7	8205	19	diagnosed	diagnose	VBN
cord-005453-4057qib7	8205	20	at	at	IN
cord-005453-4057qib7	8205	21	5	5	CD
cord-005453-4057qib7	8205	22	years	year	NNS
cord-005453-4057qib7	8205	23	of	of	IN
cord-005453-4057qib7	8205	24	age	age	NN
cord-005453-4057qib7	8205	25	for	for	IN
cord-005453-4057qib7	8205	26	a	a	DT
cord-005453-4057qib7	8205	27	history	history	NN
cord-005453-4057qib7	8205	28	of	of	IN
cord-005453-4057qib7	8205	29	hypogammaglobulinemia	hypogammaglobulinemia	NN
cord-005453-4057qib7	8205	30	,	,	,
cord-005453-4057qib7	8205	31	recurring	recur	VBG
cord-005453-4057qib7	8205	32	invasive	invasive	JJ
cord-005453-4057qib7	8205	33	,	,	,
cord-005453-4057qib7	8205	34	bacterial	bacterial	JJ
cord-005453-4057qib7	8205	35	and	and	CC
cord-005453-4057qib7	8205	36	fungal	fungal	JJ
cord-005453-4057qib7	8205	37	infections	infection	NNS
cord-005453-4057qib7	8205	38	and	and	CC
cord-005453-4057qib7	8205	39	a	a	DT
cord-005453-4057qib7	8205	40	picture	picture	NN
cord-005453-4057qib7	8205	41	of	of	IN
cord-005453-4057qib7	8205	42	autoimmunity	autoimmunity	NN
cord-005453-4057qib7	8205	43	represented	represent	VBN
cord-005453-4057qib7	8205	44	by	by	IN
cord-005453-4057qib7	8205	45	AHIA	AHIA	NNP
cord-005453-4057qib7	8205	46	,	,	,
cord-005453-4057qib7	8205	47	myelitis	myelitis	NNP
cord-005453-4057qib7	8205	48	(	(	-LRB-
cord-005453-4057qib7	8205	49	C3-C5	C3-C5	NNP
cord-005453-4057qib7	8205	50	)	)	-RRB-
cord-005453-4057qib7	8205	51	,	,	,
cord-005453-4057qib7	8205	52	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8205	53	hepatitis	hepatitis	NN
cord-005453-4057qib7	8205	54	and	and	CC
cord-005453-4057qib7	8205	55	enteropathy	enteropathy	NNP
cord-005453-4057qib7	8205	56	in	in	IN
cord-005453-4057qib7	8205	57	treatment	treatment	NN
cord-005453-4057qib7	8205	58	with	with	IN
cord-005453-4057qib7	8205	59	abatacept	abatacept	NNP
cord-005453-4057qib7	8205	60	and	and	CC
cord-005453-4057qib7	8205	61	sirolimus	sirolimus	NNP
cord-005453-4057qib7	8205	62	.	.	.
cord-005453-4057qib7	8206	1	It	-PRON-	PRP
cord-005453-4057qib7	8206	2	also	also	RB
cord-005453-4057qib7	8206	3	presents	present	VBZ
cord-005453-4057qib7	8206	4	leptin	leptin	NN
cord-005453-4057qib7	8206	5	deficiency	deficiency	NN
cord-005453-4057qib7	8206	6	lipodystrophy	lipodystrophy	NNP
cord-005453-4057qib7	8206	7	.	.	.
cord-005453-4057qib7	8207	1	She	-PRON-	PRP
cord-005453-4057qib7	8207	2	presented	present	VBD
cord-005453-4057qib7	8207	3	to	to	IN
cord-005453-4057qib7	8207	4	our	-PRON-	PRP$
cord-005453-4057qib7	8207	5	observation	observation	NN
cord-005453-4057qib7	8207	6	for	for	IN
cord-005453-4057qib7	8207	7	ostemielitis	ostemielitis	NN
cord-005453-4057qib7	8207	8	in	in	IN
cord-005453-4057qib7	8207	9	multiple	multiple	JJ
cord-005453-4057qib7	8207	10	outbreaks	outbreak	NNS
cord-005453-4057qib7	8207	11	(	(	-LRB-
cord-005453-4057qib7	8207	12	tibia	tibia	NN
cord-005453-4057qib7	8207	13	,	,	,
cord-005453-4057qib7	8207	14	femur	femur	NN
cord-005453-4057qib7	8207	15	and	and	CC
cord-005453-4057qib7	8207	16	left	leave	VBD
cord-005453-4057qib7	8207	17	knee	knee	NN
cord-005453-4057qib7	8207	18	)	)	-RRB-
cord-005453-4057qib7	8207	19	secondary	secondary	JJ
cord-005453-4057qib7	8207	20	to	to	IN
cord-005453-4057qib7	8207	21	sepsis	sepsis	NN
cord-005453-4057qib7	8207	22	from	from	IN
cord-005453-4057qib7	8207	23	MRSA	MRSA	NNP
cord-005453-4057qib7	8207	24	.	.	.
cord-005453-4057qib7	8208	1	Broad	broad	JJ
cord-005453-4057qib7	8208	2	spectrum	spectrum	NN
cord-005453-4057qib7	8208	3	antibiotic	antibiotic	NN
cord-005453-4057qib7	8208	4	therapy	therapy	NN
cord-005453-4057qib7	8208	5	and	and	CC
cord-005453-4057qib7	8208	6	curettage	curettage	NN
cord-005453-4057qib7	8208	7	surgery	surgery	NN
cord-005453-4057qib7	8208	8	were	be	VBD
cord-005453-4057qib7	8208	9	performed	perform	VBN
cord-005453-4057qib7	8208	10	during	during	IN
cord-005453-4057qib7	8208	11	hospitalization	hospitalization	NN
cord-005453-4057qib7	8208	12	.	.	.
cord-005453-4057qib7	8209	1	After	after	IN
cord-005453-4057qib7	8209	2	5	5	CD
cord-005453-4057qib7	8209	3	months	month	NNS
cord-005453-4057qib7	8209	4	of	of	IN
cord-005453-4057qib7	8209	5	broad	broad	JJ
cord-005453-4057qib7	8209	6	-	-	HYPH
cord-005453-4057qib7	8209	7	spectrum	spectrum	NN
cord-005453-4057qib7	8209	8	antibiotic	antibiotic	NN
cord-005453-4057qib7	8209	9	therapy	therapy	NN
cord-005453-4057qib7	8209	10	(	(	-LRB-
cord-005453-4057qib7	8209	11	daptomycin	daptomycin	NNS
cord-005453-4057qib7	8209	12	,	,	,
cord-005453-4057qib7	8209	13	rifampicin	rifampicin	NNS
cord-005453-4057qib7	8209	14	,	,	,
cord-005453-4057qib7	8209	15	ceftaroline	ceftaroline	NNP
cord-005453-4057qib7	8209	16	,	,	,
cord-005453-4057qib7	8209	17	cotrimoxazole	cotrimoxazole	NNP
cord-005453-4057qib7	8209	18	,	,	,
cord-005453-4057qib7	8209	19	levofloxacin	levofloxacin	NNP
cord-005453-4057qib7	8209	20	,	,	,
cord-005453-4057qib7	8209	21	dalbavancin	dalbavancin	NNS
cord-005453-4057qib7	8209	22	)	)	-RRB-
cord-005453-4057qib7	8209	23	there	there	EX
cord-005453-4057qib7	8209	24	was	be	VBD
cord-005453-4057qib7	8209	25	resolution	resolution	NN
cord-005453-4057qib7	8209	26	of	of	IN
cord-005453-4057qib7	8209	27	the	the	DT
cord-005453-4057qib7	8209	28	infections	infection	NNS
cord-005453-4057qib7	8209	29	.	.	.
cord-005453-4057qib7	8210	1	Because	because	IN
cord-005453-4057qib7	8210	2	of	of	IN
cord-005453-4057qib7	8210	3	the	the	DT
cord-005453-4057qib7	8210	4	seriousness	seriousness	NN
cord-005453-4057qib7	8210	5	of	of	IN
cord-005453-4057qib7	8210	6	the	the	DT
cord-005453-4057qib7	8210	7	disease	disease	NN
cord-005453-4057qib7	8210	8	it	-PRON-	PRP
cord-005453-4057qib7	8210	9	is	be	VBZ
cord-005453-4057qib7	8210	10	therefore	therefore	RB
cord-005453-4057qib7	8210	11	decided	decide	VBN
cord-005453-4057qib7	8210	12	to	to	TO
cord-005453-4057qib7	8210	13	subject	subject	VB
cord-005453-4057qib7	8210	14	Catherine	Catherine	NNP
cord-005453-4057qib7	8210	15	to	to	IN
cord-005453-4057qib7	8210	16	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	8210	17	Stem	Stem	NNP
cord-005453-4057qib7	8210	18	Cell	Cell	NNP
cord-005453-4057qib7	8210	19	Transplantation	transplantation	NN
cord-005453-4057qib7	8210	20	.	.	.
cord-005453-4057qib7	8211	1	Results	result	NNS
cord-005453-4057qib7	8211	2	:	:	:
cord-005453-4057qib7	8212	1	Therefore	therefore	RB
cord-005453-4057qib7	8212	2	were	be	VBD
cord-005453-4057qib7	8212	3	performed	perform	VBN
cord-005453-4057qib7	8212	4	bone	bone	NN
cord-005453-4057qib7	8212	5	marrow	marrow	NN
cord-005453-4057qib7	8212	6	transplant	transplant	NN
cord-005453-4057qib7	8212	7	from	from	IN
cord-005453-4057qib7	8212	8	MUD	mud	NN
cord-005453-4057qib7	8212	9	after	after	IN
cord-005453-4057qib7	8212	10	conditioning	conditioning	NN
cord-005453-4057qib7	8212	11	at	at	IN
cord-005453-4057qib7	8212	12	reduced	reduce	VBN
cord-005453-4057qib7	8212	13	intensity	intensity	NN
cord-005453-4057qib7	8212	14	,	,	,
cord-005453-4057qib7	8212	15	delayed	delay	VBN
cord-005453-4057qib7	8212	16	in	in	IN
cord-005453-4057qib7	8212	17	9	9	CD
cord-005453-4057qib7	8212	18	days	day	NNS
cord-005453-4057qib7	8212	19	,	,	,
cord-005453-4057qib7	8212	20	with	with	IN
cord-005453-4057qib7	8212	21	treosulfan	treosulfan	NNP
cord-005453-4057qib7	8212	22	,	,	,
cord-005453-4057qib7	8212	23	fludarabine	fludarabine	NNP
cord-005453-4057qib7	8212	24	and	and	CC
cord-005453-4057qib7	8212	25	thiotepa	thiotepa	NN
cord-005453-4057qib7	8212	26	.	.	.
cord-005453-4057qib7	8213	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8213	2	for	for	IN
cord-005453-4057qib7	8213	3	GVHD	GVHD	NNP
cord-005453-4057qib7	8213	4	was	be	VBD
cord-005453-4057qib7	8213	5	performed	perform	VBN
cord-005453-4057qib7	8213	6	with	with	IN
cord-005453-4057qib7	8213	7	ATG	ATG	NNP
cord-005453-4057qib7	8213	8	(	(	-LRB-
cord-005453-4057qib7	8213	9	5	5	CD
cord-005453-4057qib7	8213	10	mg	mg	NNP
cord-005453-4057qib7	8213	11	/	/	SYM
cord-005453-4057qib7	8213	12	kg	kg	NNP
cord-005453-4057qib7	8213	13	/	/	SYM
cord-005453-4057qib7	8213	14	day	day	NN
cord-005453-4057qib7	8213	15	)	)	-RRB-
cord-005453-4057qib7	8213	16	,	,	,
cord-005453-4057qib7	8213	17	sirolimus	sirolimus	NNP
cord-005453-4057qib7	8213	18	(	(	-LRB-
cord-005453-4057qib7	8213	19	already	already	RB
cord-005453-4057qib7	8213	20	practiced	practice	VBN
cord-005453-4057qib7	8213	21	for	for	IN
cord-005453-4057qib7	8213	22	enteropathy	enteropathy	NNP
cord-005453-4057qib7	8213	23	)	)	-RRB-
cord-005453-4057qib7	8213	24	and	and	CC
cord-005453-4057qib7	8213	25	MMF	mmf	NN
cord-005453-4057qib7	8213	26	.	.	.
cord-005453-4057qib7	8214	1	Because	because	IN
cord-005453-4057qib7	8214	2	of	of	IN
cord-005453-4057qib7	8214	3	the	the	DT
cord-005453-4057qib7	8214	4	hepatic	hepatic	JJ
cord-005453-4057qib7	8214	5	picture	picture	NN
cord-005453-4057qib7	8214	6	,	,	,
cord-005453-4057qib7	8214	7	we	-PRON-	PRP
cord-005453-4057qib7	8214	8	also	also	RB
cord-005453-4057qib7	8214	9	performed	perform	VBD
cord-005453-4057qib7	8214	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8214	11	for	for	IN
cord-005453-4057qib7	8214	12	VOD	VOD	NNP
cord-005453-4057qib7	8214	13	with	with	IN
cord-005453-4057qib7	8214	14	defibrotide	defibrotide	NN
cord-005453-4057qib7	8214	15	for	for	IN
cord-005453-4057qib7	8214	16	21	21	CD
cord-005453-4057qib7	8214	17	days	day	NNS
cord-005453-4057qib7	8214	18	.	.	.
cord-005453-4057qib7	8215	1	Transplantation	transplantation	NN
cord-005453-4057qib7	8215	2	was	be	VBD
cord-005453-4057qib7	8215	3	performed	perform	VBN
cord-005453-4057qib7	8215	4	by	by	IN
cord-005453-4057qib7	8215	5	peripheral	peripheral	JJ
cord-005453-4057qib7	8215	6	stem	stem	NN
cord-005453-4057qib7	8215	7	cells	cell	NNS
cord-005453-4057qib7	8215	8	with	with	IN
cord-005453-4057qib7	8215	9	18	18	CD
cord-005453-4057qib7	8215	10	x	x	SYM
cord-005453-4057qib7	8215	11	10	10	CD
cord-005453-4057qib7	8215	12	^	^	SYM
cord-005453-4057qib7	8215	13	6	6	CD
cord-005453-4057qib7	8215	14	CD34	CD34	NNP
cord-005453-4057qib7	8215	15	/	/	SYM
cord-005453-4057qib7	8215	16	kg	kg	NNS
cord-005453-4057qib7	8215	17	and	and	CC
cord-005453-4057qib7	8215	18	30	30	CD
cord-005453-4057qib7	8215	19	x	x	SYM
cord-005453-4057qib7	8215	20	10	10	CD
cord-005453-4057qib7	8215	21	^	^	SYM
cord-005453-4057qib7	8215	22	6	6	CD
cord-005453-4057qib7	8215	23	CD3	CD3	NNP
cord-005453-4057qib7	8215	24	/	/	SYM
cord-005453-4057qib7	8215	25	kg	kg	NNP
cord-005453-4057qib7	8215	26	.	.	.
cord-005453-4057qib7	8216	1	The	the	DT
cord-005453-4057qib7	8216	2	patient	patient	NN
cord-005453-4057qib7	8216	3	had	have	VBD
cord-005453-4057qib7	8216	4	always	always	RB
cord-005453-4057qib7	8216	5	presented	present	VBN
cord-005453-4057qib7	8216	6	good	good	JJ
cord-005453-4057qib7	8216	7	general	general	JJ
cord-005453-4057qib7	8216	8	conditions	condition	NNS
cord-005453-4057qib7	8216	9	with	with	IN
cord-005453-4057qib7	8216	10	engrafment	engrafment	NN
cord-005453-4057qib7	8216	11	of	of	IN
cord-005453-4057qib7	8216	12	the	the	DT
cord-005453-4057qib7	8216	13	PMN	PMN	NNP
cord-005453-4057qib7	8216	14	to	to	IN
cord-005453-4057qib7	8216	15	the	the	DT
cord-005453-4057qib7	8216	16	D	d	NN
cord-005453-4057qib7	8216	17	+	+	SYM
cord-005453-4057qib7	8216	18	13	13	CD
cord-005453-4057qib7	8216	19	and	and	CC
cord-005453-4057qib7	8216	20	the	the	DT
cord-005453-4057qib7	8216	21	PLT	PLT	NNP
cord-005453-4057qib7	8216	22	to	to	IN
cord-005453-4057qib7	8216	23	the	the	DT
cord-005453-4057qib7	8216	24	D	d	NN
cord-005453-4057qib7	8216	25	+	+	SYM
cord-005453-4057qib7	8216	26	11	11	CD
cord-005453-4057qib7	8216	27	.	.	.
cord-005453-4057qib7	8217	1	The	the	DT
cord-005453-4057qib7	8217	2	chimerism	chimerism	NN
cord-005453-4057qib7	8217	3	at	at	IN
cord-005453-4057qib7	8217	4	D	d	NN
cord-005453-4057qib7	8217	5	+	+	CC
cord-005453-4057qib7	8217	6	20	20	CD
cord-005453-4057qib7	8217	7	was	be	VBD
cord-005453-4057qib7	8217	8	100	100	CD
cord-005453-4057qib7	8217	9	%	%	NN
cord-005453-4057qib7	8217	10	donor	donor	NN
cord-005453-4057qib7	8217	11	both	both	DT
cord-005453-4057qib7	8217	12	on	on	IN
cord-005453-4057qib7	8217	13	PMN	PMN	NNP
cord-005453-4057qib7	8217	14	and	and	CC
cord-005453-4057qib7	8217	15	on	on	IN
cord-005453-4057qib7	8217	16	PBL	PBL	NNP
cord-005453-4057qib7	8217	17	.	.	.
cord-005453-4057qib7	8218	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8218	2	for	for	IN
cord-005453-4057qib7	8218	3	GVHD	GVHD	NNP
cord-005453-4057qib7	8218	4	was	be	VBD
cord-005453-4057qib7	8218	5	changed	change	VBN
cord-005453-4057qib7	8218	6	on	on	IN
cord-005453-4057qib7	8218	7	D	D	NNP
cord-005453-4057qib7	8218	8	+	+	CC
cord-005453-4057qib7	8218	9	7	7	CD
cord-005453-4057qib7	8218	10	by	by	IN
cord-005453-4057qib7	8218	11	replacing	replace	VBG
cord-005453-4057qib7	8218	12	the	the	DT
cord-005453-4057qib7	8218	13	sirolimus	sirolimus	NN
cord-005453-4057qib7	8218	14	with	with	IN
cord-005453-4057qib7	8218	15	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	8218	16	for	for	IN
cord-005453-4057qib7	8218	17	the	the	DT
cord-005453-4057qib7	8218	18	appearance	appearance	NN
cord-005453-4057qib7	8218	19	of	of	IN
cord-005453-4057qib7	8218	20	grade	grade	NN
cord-005453-4057qib7	8218	21	I	-PRON-	PRP
cord-005453-4057qib7	8218	22	cutaneous	cutaneous	JJ
cord-005453-4057qib7	8218	23	GVHD	GVHD	NNP
cord-005453-4057qib7	8218	24	.	.	.
cord-005453-4057qib7	8219	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8219	2	:	:	:
cord-005453-4057qib7	8220	1	We	-PRON-	PRP
cord-005453-4057qib7	8220	2	have	have	VBP
cord-005453-4057qib7	8220	3	successfully	successfully	RB
cord-005453-4057qib7	8220	4	performed	perform	VBN
cord-005453-4057qib7	8220	5	bone	bone	NN
cord-005453-4057qib7	8220	6	marrow	marrow	NN
cord-005453-4057qib7	8220	7	transplantation	transplantation	NN
cord-005453-4057qib7	8220	8	in	in	IN
cord-005453-4057qib7	8220	9	patients	patient	NNS
cord-005453-4057qib7	8220	10	with	with	IN
cord-005453-4057qib7	8220	11	LRBA	LRBA	NNP
cord-005453-4057qib7	8220	12	deficiency	deficiency	NN
cord-005453-4057qib7	8220	13	.	.	.
cord-005453-4057qib7	8221	1	The	the	DT
cord-005453-4057qib7	8221	2	new	new	JJ
cord-005453-4057qib7	8221	3	antibiotic	antibiotic	JJ
cord-005453-4057qib7	8221	4	molecules	molecule	NNS
cord-005453-4057qib7	8221	5	,	,	,
cord-005453-4057qib7	8221	6	used	use	VBN
cord-005453-4057qib7	8221	7	to	to	TO
cord-005453-4057qib7	8221	8	induce	induce	VB
cord-005453-4057qib7	8221	9	infectious	infectious	JJ
cord-005453-4057qib7	8221	10	remission	remission	NN
cord-005453-4057qib7	8221	11	,	,	,
cord-005453-4057qib7	8221	12	the	the	DT
cord-005453-4057qib7	8221	13	new	new	JJ
cord-005453-4057qib7	8221	14	low	low	JJ
cord-005453-4057qib7	8221	15	-	-	HYPH
cord-005453-4057qib7	8221	16	intensity	intensity	NN
cord-005453-4057qib7	8221	17	regimens	regimen	NNS
cord-005453-4057qib7	8221	18	,	,	,
cord-005453-4057qib7	8221	19	the	the	DT
cord-005453-4057qib7	8221	20	prevention	prevention	NN
cord-005453-4057qib7	8221	21	of	of	IN
cord-005453-4057qib7	8221	22	the	the	DT
cord-005453-4057qib7	8221	23	most	most	RBS
cord-005453-4057qib7	8221	24	fearful	fearful	JJ
cord-005453-4057qib7	8221	25	complications	complication	NNS
cord-005453-4057qib7	8221	26	(	(	-LRB-
cord-005453-4057qib7	8221	27	VOD	VOD	NNP
cord-005453-4057qib7	8221	28	)	)	-RRB-
cord-005453-4057qib7	8221	29	have	have	VBP
cord-005453-4057qib7	8221	30	been	be	VBN
cord-005453-4057qib7	8221	31	the	the	DT
cord-005453-4057qib7	8221	32	key	key	NN
cord-005453-4057qib7	8221	33	to	to	IN
cord-005453-4057qib7	8221	34	success	success	NN
cord-005453-4057qib7	8221	35	in	in	IN
cord-005453-4057qib7	8221	36	such	such	JJ
cord-005453-4057qib7	8221	37	complicated	complicated	JJ
cord-005453-4057qib7	8221	38	case	case	NN
cord-005453-4057qib7	8221	39	.	.	.
cord-005453-4057qib7	8222	1	The	the	DT
cord-005453-4057qib7	8222	2	high	high	JJ
cord-005453-4057qib7	8222	3	number	number	NN
cord-005453-4057qib7	8222	4	of	of	IN
cord-005453-4057qib7	8222	5	CD34	CD34	NNP
cord-005453-4057qib7	8222	6	cells	cell	NNS
cord-005453-4057qib7	8222	7	infused	infuse	VBN
cord-005453-4057qib7	8222	8	with	with	IN
cord-005453-4057qib7	8222	9	a	a	DT
cord-005453-4057qib7	8222	10	controlled	control	VBN
cord-005453-4057qib7	8222	11	number	number	NN
cord-005453-4057qib7	8222	12	of	of	IN
cord-005453-4057qib7	8222	13	CD3	CD3	NNP
cord-005453-4057qib7	8222	14	were	be	VBD
cord-005453-4057qib7	8222	15	the	the	DT
cord-005453-4057qib7	8222	16	key	key	NN
cord-005453-4057qib7	8222	17	then	then	RB
cord-005453-4057qib7	8222	18	of	of	IN
cord-005453-4057qib7	8222	19	rapid	rapid	JJ
cord-005453-4057qib7	8222	20	engraftment	engraftment	NN
cord-005453-4057qib7	8222	21	with	with	IN
cord-005453-4057qib7	8222	22	minimal	minimal	JJ
cord-005453-4057qib7	8222	23	GVHD	GVHD	NNP
cord-005453-4057qib7	8222	24	readily	readily	RB
cord-005453-4057qib7	8222	25	controlled	control	VBN
cord-005453-4057qib7	8222	26	by	by	IN
cord-005453-4057qib7	8222	27	the	the	DT
cord-005453-4057qib7	8222	28	immunosuppressant	immunosuppressant	NN
cord-005453-4057qib7	8222	29	.	.	.
cord-005453-4057qib7	8223	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8223	2	Background	background	NN
cord-005453-4057qib7	8223	3	:	:	:
cord-005453-4057qib7	8224	1	In	in	IN
cord-005453-4057qib7	8224	2	the	the	DT
cord-005453-4057qib7	8224	3	absence	absence	NN
cord-005453-4057qib7	8224	4	of	of	IN
cord-005453-4057qib7	8224	5	HLA	HLA	NNP
cord-005453-4057qib7	8224	6	-	-	HYPH
cord-005453-4057qib7	8224	7	matched	match	VBN
cord-005453-4057qib7	8224	8	related	related	JJ
cord-005453-4057qib7	8224	9	donor	donor	NN
cord-005453-4057qib7	8224	10	,	,	,
cord-005453-4057qib7	8224	11	allogeneic	allogeneic	IN
cord-005453-4057qib7	8224	12	stem	stem	NN
cord-005453-4057qib7	8224	13	cell	cell	NN
cord-005453-4057qib7	8224	14	transplantation	transplantation	NN
cord-005453-4057qib7	8224	15	from	from	IN
cord-005453-4057qib7	8224	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8224	17	donors	donor	NNS
cord-005453-4057qib7	8224	18	are	be	VBP
cord-005453-4057qib7	8224	19	potential	potential	JJ
cord-005453-4057qib7	8224	20	alternatives	alternative	NNS
cord-005453-4057qib7	8224	21	for	for	IN
cord-005453-4057qib7	8224	22	patients	patient	NNS
cord-005453-4057qib7	8224	23	with	with	IN
cord-005453-4057qib7	8224	24	hematological	hematological	JJ
cord-005453-4057qib7	8224	25	malignencies	malignencie	NNS
cord-005453-4057qib7	8224	26	with	with	IN
cord-005453-4057qib7	8224	27	an	an	DT
cord-005453-4057qib7	8224	28	indication	indication	NN
cord-005453-4057qib7	8224	29	to	to	IN
cord-005453-4057qib7	8224	30	allogeneic	allogeneic	VB
cord-005453-4057qib7	8224	31	stem	stem	NN
cord-005453-4057qib7	8224	32	cell	cell	NN
cord-005453-4057qib7	8224	33	transplantation	transplantation	NN
cord-005453-4057qib7	8224	34	.	.	.
cord-005453-4057qib7	8225	1	Herein	herein	RB
cord-005453-4057qib7	8225	2	,	,	,
cord-005453-4057qib7	8225	3	we	-PRON-	PRP
cord-005453-4057qib7	8225	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	8225	5	assessed	assess	VBD
cord-005453-4057qib7	8225	6	the	the	DT
cord-005453-4057qib7	8225	7	outcome	outcome	NN
cord-005453-4057qib7	8225	8	of	of	IN
cord-005453-4057qib7	8225	9	haplo	haplo	NNP
cord-005453-4057qib7	8225	10	-	-	HYPH
cord-005453-4057qib7	8225	11	SCT	SCT	NNP
cord-005453-4057qib7	8225	12	for	for	IN
cord-005453-4057qib7	8225	13	patients	patient	NNS
cord-005453-4057qib7	8225	14	with	with	IN
cord-005453-4057qib7	8225	15	refractory	refractory	JJ
cord-005453-4057qib7	8225	16	hematological	hematological	JJ
cord-005453-4057qib7	8225	17	malignancies	malignancy	NNS
cord-005453-4057qib7	8225	18	.	.	.
cord-005453-4057qib7	8226	1	Methods	method	NNS
cord-005453-4057qib7	8226	2	:	:	:
cord-005453-4057qib7	8227	1	This	this	DT
cord-005453-4057qib7	8227	2	analysis	analysis	NN
cord-005453-4057qib7	8227	3	included	include	VBD
cord-005453-4057qib7	8227	4	27	27	CD
cord-005453-4057qib7	8227	5	consecutive	consecutive	JJ
cord-005453-4057qib7	8227	6	patients	patient	NNS
cord-005453-4057qib7	8227	7	who	who	WP
cord-005453-4057qib7	8227	8	underwent	undergo	VBD
cord-005453-4057qib7	8227	9	haplo	haplo	NNP
cord-005453-4057qib7	8227	10	-	-	HYPH
cord-005453-4057qib7	8227	11	SCT	SCT	NNP
cord-005453-4057qib7	8227	12	for	for	IN
cord-005453-4057qib7	8227	13	various	various	JJ
cord-005453-4057qib7	8227	14	hematological	hematological	JJ
cord-005453-4057qib7	8227	15	malignancies	malignancy	NNS
cord-005453-4057qib7	8227	16	at	at	IN
cord-005453-4057qib7	8227	17	our	-PRON-	PRP$
cord-005453-4057qib7	8227	18	center	center	NN
cord-005453-4057qib7	8227	19	between	between	IN
cord-005453-4057qib7	8227	20	October	October	NNP
cord-005453-4057qib7	8227	21	2010	2010	CD
cord-005453-4057qib7	8227	22	and	and	CC
cord-005453-4057qib7	8227	23	May	May	NNP
cord-005453-4057qib7	8227	24	2018	2018	CD
cord-005453-4057qib7	8227	25	.	.	.
cord-005453-4057qib7	8228	1	We	-PRON-	PRP
cord-005453-4057qib7	8228	2	used	use	VBD
cord-005453-4057qib7	8228	3	our	-PRON-	PRP$
cord-005453-4057qib7	8228	4	institutional	institutional	JJ
cord-005453-4057qib7	8228	5	database	database	NN
cord-005453-4057qib7	8228	6	to	to	TO
cord-005453-4057qib7	8228	7	evaluate	evaluate	VB
cord-005453-4057qib7	8228	8	details	detail	NNS
cord-005453-4057qib7	8228	9	and	and	CC
cord-005453-4057qib7	8228	10	characteristics	characteristic	NNS
cord-005453-4057qib7	8228	11	of	of	IN
cord-005453-4057qib7	8228	12	patients	patient	NNS
cord-005453-4057qib7	8228	13	and	and	CC
cord-005453-4057qib7	8228	14	transplant	transplant	NN
cord-005453-4057qib7	8228	15	outcomes	outcome	NNS
cord-005453-4057qib7	8228	16	.	.	.
cord-005453-4057qib7	8229	1	Results	result	NNS
cord-005453-4057qib7	8229	2	:	:	:
cord-005453-4057qib7	8230	1	Demographic	demographic	JJ
cord-005453-4057qib7	8230	2	features	feature	NNS
cord-005453-4057qib7	8230	3	of	of	IN
cord-005453-4057qib7	8230	4	the	the	DT
cord-005453-4057qib7	8230	5	patients	patient	NNS
cord-005453-4057qib7	8230	6	and	and	CC
cord-005453-4057qib7	8230	7	donors	donor	NNS
cord-005453-4057qib7	8230	8	have	have	VBP
cord-005453-4057qib7	8230	9	been	be	VBN
cord-005453-4057qib7	8230	10	summarized	summarize	VBN
cord-005453-4057qib7	8230	11	in	in	IN
cord-005453-4057qib7	8230	12	Table	Table	NNP
cord-005453-4057qib7	8230	13	1	1	CD
cord-005453-4057qib7	8230	14	.	.	.
cord-005453-4057qib7	8231	1	All	all	DT
cord-005453-4057qib7	8231	2	of	of	IN
cord-005453-4057qib7	8231	3	the	the	DT
cord-005453-4057qib7	8231	4	patients	patient	NNS
cord-005453-4057qib7	8231	5	had	have	VBD
cord-005453-4057qib7	8231	6	advanced	advanced	JJ
cord-005453-4057qib7	8231	7	disease	disease	NN
cord-005453-4057qib7	8231	8	with	with	IN
cord-005453-4057qib7	8231	9	a	a	DT
cord-005453-4057qib7	8231	10	high	high	JJ
cord-005453-4057qib7	8231	11	risk	risk	NN
cord-005453-4057qib7	8231	12	of	of	IN
cord-005453-4057qib7	8231	13	relapse	relapse	NN
cord-005453-4057qib7	8231	14	.	.	.
cord-005453-4057qib7	8232	1	The	the	DT
cord-005453-4057qib7	8232	2	majority	majority	NN
cord-005453-4057qib7	8232	3	of	of	IN
cord-005453-4057qib7	8232	4	patients	patient	NNS
cord-005453-4057qib7	8232	5	underwent	undergo	VBD
cord-005453-4057qib7	8232	6	haplo	haplo	NNP
cord-005453-4057qib7	8232	7	-	-	HYPH
cord-005453-4057qib7	8232	8	SCT	SCT	NNP
cord-005453-4057qib7	8232	9	from	from	IN
cord-005453-4057qib7	8232	10	their	-PRON-	PRP$
cord-005453-4057qib7	8232	11	parents	parent	NNS
cord-005453-4057qib7	8232	12	.	.	.
cord-005453-4057qib7	8233	1	Out	out	IN
cord-005453-4057qib7	8233	2	of	of	IN
cord-005453-4057qib7	8233	3	24	24	CD
cord-005453-4057qib7	8233	4	patients	patient	NNS
cord-005453-4057qib7	8233	5	,	,	,
cord-005453-4057qib7	8233	6	early	early	JJ
cord-005453-4057qib7	8233	7	transplant	transplant	NN
cord-005453-4057qib7	8233	8	-	-	HYPH
cord-005453-4057qib7	8233	9	related	relate	VBN
cord-005453-4057qib7	8233	10	mortality	mortality	NN
cord-005453-4057qib7	8233	11	was	be	VBD
cord-005453-4057qib7	8233	12	seen	see	VBN
cord-005453-4057qib7	8233	13	in	in	IN
cord-005453-4057qib7	8233	14	this	this	DT
cord-005453-4057qib7	8233	15	cohort	cohort	NN
cord-005453-4057qib7	8233	16	of	of	IN
cord-005453-4057qib7	8233	17	5	5	CD
cord-005453-4057qib7	8233	18	patients	patient	NNS
cord-005453-4057qib7	8233	19	.	.	.
cord-005453-4057qib7	8234	1	Four	four	CD
cord-005453-4057qib7	8234	2	patients	patient	NNS
cord-005453-4057qib7	8234	3	treated	treat	VBN
cord-005453-4057qib7	8234	4	with	with	IN
cord-005453-4057qib7	8234	5	second	second	JJ
cord-005453-4057qib7	8234	6	haplo	haplo	NNP
cord-005453-4057qib7	8234	7	-	-	HYPH
cord-005453-4057qib7	8234	8	SCT	SCT	NNP
cord-005453-4057qib7	8234	9	and	and	CC
cord-005453-4057qib7	8234	10	recovered	recover	VBD
cord-005453-4057qib7	8234	11	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	8234	12	after	after	IN
cord-005453-4057qib7	8234	13	second	second	JJ
cord-005453-4057qib7	8234	14	transplant	transplant	NN
cord-005453-4057qib7	8234	15	.	.	.
cord-005453-4057qib7	8235	1	The	the	DT
cord-005453-4057qib7	8235	2	remaining	remain	VBG
cord-005453-4057qib7	8235	3	19	19	CD
cord-005453-4057qib7	8235	4	patients	patient	NNS
cord-005453-4057qib7	8235	5	were	be	VBD
cord-005453-4057qib7	8235	6	followed	follow	VBN
cord-005453-4057qib7	8235	7	in	in	IN
cord-005453-4057qib7	8235	8	a	a	DT
cord-005453-4057qib7	8235	9	median	median	NN
cord-005453-4057qib7	8235	10	of	of	IN
cord-005453-4057qib7	8235	11	4	4	CD
cord-005453-4057qib7	8235	12	months	month	NNS
cord-005453-4057qib7	8235	13	.	.	.
cord-005453-4057qib7	8236	1	Donor	donor	NN
cord-005453-4057qib7	8236	2	type	type	NN
cord-005453-4057qib7	8236	3	ABO	ABO	NNP
cord-005453-4057qib7	8236	4	group	group	NN
cord-005453-4057qib7	8236	5	switch	switch	NN
cord-005453-4057qib7	8236	6	was	be	VBD
cord-005453-4057qib7	8236	7	observed	observe	VBN
cord-005453-4057qib7	8236	8	in	in	IN
cord-005453-4057qib7	8236	9	a	a	DT
cord-005453-4057qib7	8236	10	median	median	NN
cord-005453-4057qib7	8236	11	of	of	IN
cord-005453-4057qib7	8236	12	45	45	CD
cord-005453-4057qib7	8236	13	days	day	NNS
cord-005453-4057qib7	8236	14	(	(	-LRB-
cord-005453-4057qib7	8236	15	30	30	CD
cord-005453-4057qib7	8236	16	-	-	SYM
cord-005453-4057qib7	8236	17	60	60	CD
cord-005453-4057qib7	8236	18	days	day	NNS
cord-005453-4057qib7	8236	19	)	)	-RRB-
cord-005453-4057qib7	8236	20	after	after	IN
cord-005453-4057qib7	8236	21	transplant	transplant	NN
cord-005453-4057qib7	8236	22	.	.	.
cord-005453-4057qib7	8237	1	The	the	DT
cord-005453-4057qib7	8237	2	median	median	JJ
cord-005453-4057qib7	8237	3	time	time	NN
cord-005453-4057qib7	8237	4	for	for	IN
cord-005453-4057qib7	8237	5	engraftment	engraftment	NN
cord-005453-4057qib7	8237	6	was	be	VBD
cord-005453-4057qib7	8237	7	19	19	CD
cord-005453-4057qib7	8237	8	days	day	NNS
cord-005453-4057qib7	8237	9	(	(	-LRB-
cord-005453-4057qib7	8237	10	range	range	NN
cord-005453-4057qib7	8237	11	,	,	,
cord-005453-4057qib7	8237	12	15	15	CD
cord-005453-4057qib7	8237	13	-	-	SYM
cord-005453-4057qib7	8237	14	60	60	CD
cord-005453-4057qib7	8237	15	)	)	-RRB-
cord-005453-4057qib7	8237	16	for	for	IN
cord-005453-4057qib7	8237	17	all	all	DT
cord-005453-4057qib7	8237	18	patients	patient	NNS
cord-005453-4057qib7	8237	19	.	.	.
cord-005453-4057qib7	8238	1	After	after	IN
cord-005453-4057qib7	8238	2	the	the	DT
cord-005453-4057qib7	8238	3	first	first	JJ
cord-005453-4057qib7	8238	4	transplant	transplant	NN
cord-005453-4057qib7	8238	5	,	,	,
cord-005453-4057qib7	8238	6	9	9	CD
cord-005453-4057qib7	8238	7	patients	patient	NNS
cord-005453-4057qib7	8238	8	developed	develop	VBD
cord-005453-4057qib7	8238	9	acute	acute	JJ
cord-005453-4057qib7	8238	10	GVHD	GVHD	NNP
cord-005453-4057qib7	8238	11	(	(	-LRB-
cord-005453-4057qib7	8238	12	37.5	37.5	CD
cord-005453-4057qib7	8238	13	%	%	NN
cord-005453-4057qib7	8238	14	)	)	-RRB-
cord-005453-4057qib7	8238	15	with	with	IN
cord-005453-4057qib7	8238	16	7	7	CD
cord-005453-4057qib7	8238	17	patients	patient	NNS
cord-005453-4057qib7	8238	18	having	have	VBG
cord-005453-4057qib7	8238	19	grade	grade	NN
cord-005453-4057qib7	8238	20	II	II	NNP
cord-005453-4057qib7	8238	21	-	-	HYPH
cord-005453-4057qib7	8238	22	III	iii	CD
cord-005453-4057qib7	8238	23	acute	acute	JJ
cord-005453-4057qib7	8238	24	GVHD	GVHD	NNP
cord-005453-4057qib7	8238	25	.	.	.
cord-005453-4057qib7	8239	1	Five	five	CD
cord-005453-4057qib7	8239	2	(	(	-LRB-
cord-005453-4057qib7	8239	3	18.5	18.5	CD
cord-005453-4057qib7	8239	4	%	%	NN
cord-005453-4057qib7	8239	5	)	)	-RRB-
cord-005453-4057qib7	8239	6	had	have	VBD
cord-005453-4057qib7	8239	7	chronic	chronic	JJ
cord-005453-4057qib7	8239	8	GVHD	GVHD	NNP
cord-005453-4057qib7	8239	9	,	,	,
cord-005453-4057qib7	8239	10	none	none	NN
cord-005453-4057qib7	8239	11	of	of	IN
cord-005453-4057qib7	8239	12	them	-PRON-	PRP
cord-005453-4057qib7	8239	13	with	with	IN
cord-005453-4057qib7	8239	14	extensive	extensive	JJ
cord-005453-4057qib7	8239	15	manifestation	manifestation	NN
cord-005453-4057qib7	8239	16	.	.	.
cord-005453-4057qib7	8240	1	The	the	DT
cord-005453-4057qib7	8240	2	prepative	prepative	JJ
cord-005453-4057qib7	8240	3	regimen	regimen	NN
cord-005453-4057qib7	8240	4	was	be	VBD
cord-005453-4057qib7	8240	5	relatively	relatively	RB
cord-005453-4057qib7	8240	6	well	well	RB
cord-005453-4057qib7	8240	7	tolerated	tolerate	VBN
cord-005453-4057qib7	8240	8	with	with	IN
cord-005453-4057qib7	8240	9	limited	limited	JJ
cord-005453-4057qib7	8240	10	regimen	regimen	NN
cord-005453-4057qib7	8240	11	-	-	HYPH
cord-005453-4057qib7	8240	12	related	relate	VBN
cord-005453-4057qib7	8240	13	toxicity	toxicity	NN
cord-005453-4057qib7	8240	14	.	.	.
cord-005453-4057qib7	8241	1	CMV	CMV	NNP
cord-005453-4057qib7	8241	2	reactivation	reactivation	NN
cord-005453-4057qib7	8241	3	occurred	occur	VBD
cord-005453-4057qib7	8241	4	in	in	IN
cord-005453-4057qib7	8241	5	11	11	CD
cord-005453-4057qib7	8241	6	patients	patient	NNS
cord-005453-4057qib7	8241	7	(	(	-LRB-
cord-005453-4057qib7	8241	8	40.7	40.7	CD
cord-005453-4057qib7	8241	9	%	%	NN
cord-005453-4057qib7	8241	10	)	)	-RRB-
cord-005453-4057qib7	8241	11	during	during	IN
cord-005453-4057qib7	8241	12	the	the	DT
cord-005453-4057qib7	8241	13	follow	follow	NN
cord-005453-4057qib7	8241	14	-	-	HYPH
cord-005453-4057qib7	8241	15	up	up	NN
cord-005453-4057qib7	8241	16	of	of	IN
cord-005453-4057qib7	8241	17	the	the	DT
cord-005453-4057qib7	8241	18	study	study	NN
cord-005453-4057qib7	8241	19	.	.	.
cord-005453-4057qib7	8242	1	Eight	eight	CD
cord-005453-4057qib7	8242	2	patients	patient	NNS
cord-005453-4057qib7	8242	3	(	(	-LRB-
cord-005453-4057qib7	8242	4	29.6	29.6	CD
cord-005453-4057qib7	8242	5	%	%	NN
cord-005453-4057qib7	8242	6	)	)	-RRB-
cord-005453-4057qib7	8242	7	relapsed	relapse	VBD
cord-005453-4057qib7	8242	8	after	after	IN
cord-005453-4057qib7	8242	9	a	a	DT
cord-005453-4057qib7	8242	10	median	median	NN
cord-005453-4057qib7	8242	11	of	of	IN
cord-005453-4057qib7	8242	12	132	132	CD
cord-005453-4057qib7	8242	13	days	day	NNS
cord-005453-4057qib7	8242	14	post	post	NN
cord-005453-4057qib7	8242	15	transplant	transplant	NN
cord-005453-4057qib7	8242	16	(	(	-LRB-
cord-005453-4057qib7	8242	17	range	range	NN
cord-005453-4057qib7	8242	18	,	,	,
cord-005453-4057qib7	8242	19	45	45	CD
cord-005453-4057qib7	8242	20	-	-	SYM
cord-005453-4057qib7	8242	21	588	588	CD
cord-005453-4057qib7	8242	22	days	day	NNS
cord-005453-4057qib7	8242	23	)	)	-RRB-
cord-005453-4057qib7	8242	24	.	.	.
cord-005453-4057qib7	8243	1	CR	CR	NNP
cord-005453-4057qib7	8243	2	was	be	VBD
cord-005453-4057qib7	8243	3	achieved	achieve	VBN
cord-005453-4057qib7	8243	4	in	in	IN
cord-005453-4057qib7	8243	5	17	17	CD
cord-005453-4057qib7	8243	6	(	(	-LRB-
cord-005453-4057qib7	8243	7	63	63	CD
cord-005453-4057qib7	8243	8	%	%	NN
cord-005453-4057qib7	8243	9	)	)	-RRB-
cord-005453-4057qib7	8243	10	patients	patient	NNS
cord-005453-4057qib7	8243	11	after	after	IN
cord-005453-4057qib7	8243	12	haplo	haplo	NNP
cord-005453-4057qib7	8243	13	-	-	HYPH
cord-005453-4057qib7	8243	14	SCT	SCT	NNP
cord-005453-4057qib7	8243	15	.	.	.
cord-005453-4057qib7	8244	1	Mean	mean	JJ
cord-005453-4057qib7	8244	2	estimated	estimate	VBD
cord-005453-4057qib7	8244	3	5-year	5-year	CD
cord-005453-4057qib7	8244	4	OS	OS	NNP
cord-005453-4057qib7	8244	5	and	and	CC
cord-005453-4057qib7	8244	6	PFS	PFS	NNP
cord-005453-4057qib7	8244	7	are	be	VBP
cord-005453-4057qib7	8244	8	66.7%±0.9	66.7%±0.9	CD
cord-005453-4057qib7	8244	9	%	%	NN
cord-005453-4057qib7	8244	10	and	and	CC
cord-005453-4057qib7	8244	11	92.3%±0.7	92.3%±0.7	CD
cord-005453-4057qib7	8244	12	%	%	NN
cord-005453-4057qib7	8244	13	,	,	,
cord-005453-4057qib7	8244	14	respectively	respectively	RB
cord-005453-4057qib7	8244	15	.	.	.
cord-005453-4057qib7	8245	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8245	2	:	:	:
cord-005453-4057qib7	8246	1	Given	give	VBN
cord-005453-4057qib7	8246	2	the	the	DT
cord-005453-4057qib7	8246	3	growing	grow	VBG
cord-005453-4057qib7	8246	4	data	datum	NNS
cord-005453-4057qib7	8246	5	on	on	IN
cord-005453-4057qib7	8246	6	the	the	DT
cord-005453-4057qib7	8246	7	similarity	similarity	NN
cord-005453-4057qib7	8246	8	of	of	IN
cord-005453-4057qib7	8246	9	outcomes	outcome	NNS
cord-005453-4057qib7	8246	10	after	after	IN
cord-005453-4057qib7	8246	11	HLA	HLA	NNP
cord-005453-4057qib7	8246	12	-	-	HYPH
cord-005453-4057qib7	8246	13	matched	match	VBN
cord-005453-4057qib7	8246	14	and	and	CC
cord-005453-4057qib7	8246	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8246	16	SCT	SCT	NNP
cord-005453-4057qib7	8246	17	,	,	,
cord-005453-4057qib7	8246	18	further	further	JJ
cord-005453-4057qib7	8246	19	studies	study	NNS
cord-005453-4057qib7	8246	20	are	be	VBP
cord-005453-4057qib7	8246	21	required	require	VBN
cord-005453-4057qib7	8246	22	to	to	TO
cord-005453-4057qib7	8246	23	determine	determine	VB
cord-005453-4057qib7	8246	24	whether	whether	IN
cord-005453-4057qib7	8246	25	factors	factor	NNS
cord-005453-4057qib7	8246	26	may	may	MD
cord-005453-4057qib7	8246	27	be	be	VB
cord-005453-4057qib7	8246	28	more	more	RBR
cord-005453-4057qib7	8246	29	important	important	JJ
cord-005453-4057qib7	8246	30	for	for	IN
cord-005453-4057qib7	8246	31	donor	donor	NN
cord-005453-4057qib7	8246	32	selection	selection	NN
cord-005453-4057qib7	8246	33	than	than	IN
cord-005453-4057qib7	8246	34	HLAmatching	hlamatche	VBG
cord-005453-4057qib7	8246	35	.	.	.
cord-005453-4057qib7	8247	1	Clinical	clinical	JJ
cord-005453-4057qib7	8247	2	Trial	Trial	NNP
cord-005453-4057qib7	8247	3	Registry	Registry	NNP
cord-005453-4057qib7	8247	4	:	:	:
cord-005453-4057qib7	8248	1	-Disclosure	-disclosure	UH
cord-005453-4057qib7	8248	2	:	:	:
cord-005453-4057qib7	8248	3	Nothing	nothing	NN
cord-005453-4057qib7	8248	4	to	to	TO
cord-005453-4057qib7	8248	5	declare	declare	VB
cord-005453-4057qib7	8248	6	Outcome	outcome	NN
cord-005453-4057qib7	8248	7	of	of	IN
cord-005453-4057qib7	8248	8	allogeneic	allogeneic	NN
cord-005453-4057qib7	8248	9	stem	stem	NN
cord-005453-4057qib7	8248	10	cell	cell	NN
cord-005453-4057qib7	8248	11	transplantation	transplantation	NN
cord-005453-4057qib7	8248	12	for	for	IN
cord-005453-4057qib7	8248	13	hodgkin	hodgkin	NNP
cord-005453-4057qib7	8248	14	and	and	CC
cord-005453-4057qib7	8248	15	non	non	NNP
cord-005453-4057qib7	8248	16	-	-	JJ
cord-005453-4057qib7	8248	17	hodgkin	hodgkin	JJ
cord-005453-4057qib7	8248	18	lymphoma	lymphoma	NN
cord-005453-4057qib7	8248	19	:	:	:
cord-005453-4057qib7	8248	20	Single	single	JJ
cord-005453-4057qib7	8248	21	center	center	NN
cord-005453-4057qib7	8248	22	experince	experince	NN
cord-005453-4057qib7	8248	23	from	from	IN
cord-005453-4057qib7	8248	24	Turkey	Turkey	NNP
cord-005453-4057qib7	8248	25	Ayşe	Ayşe	NNP
cord-005453-4057qib7	8248	26	Uysal	Uysal	NNP
cord-005453-4057qib7	8248	27	1	1	CD
cord-005453-4057qib7	8248	28	,	,	,
cord-005453-4057qib7	8248	29	Hale	Hale	NNP
cord-005453-4057qib7	8248	30	Bülbül	Bülbül	NNP
cord-005453-4057qib7	8248	31	2	2	CD
cord-005453-4057qib7	8248	32	,	,	,
cord-005453-4057qib7	8248	33	Nur	Nur	NNP
cord-005453-4057qib7	8248	34	Akad	Akad	NNP
cord-005453-4057qib7	8248	35	Soyer	Soyer	NNP
cord-005453-4057qib7	8248	36	2	2	CD
cord-005453-4057qib7	8248	37	,	,	,
cord-005453-4057qib7	8248	38	Mahmut	Mahmut	NNP
cord-005453-4057qib7	8248	39	Tobu	Tobu	NNP
cord-005453-4057qib7	8248	40	2	2	CD
cord-005453-4057qib7	8248	41	,	,	,
cord-005453-4057qib7	8248	42	Murat	Murat	NNP
cord-005453-4057qib7	8248	43	Tombuloglu	Tombuloglu	NNP
cord-005453-4057qib7	8248	44	2	2	CD
cord-005453-4057qib7	8248	45	,	,	,
cord-005453-4057qib7	8248	46	Guray	Guray	NNP
cord-005453-4057qib7	8248	47	Saydam	Saydam	NNP
cord-005453-4057qib7	8248	48	2	2	CD
cord-005453-4057qib7	8248	49	,	,	,
cord-005453-4057qib7	8248	50	Filiz	Filiz	NNP
cord-005453-4057qib7	8248	51	Vural	Vural	NNP
cord-005453-4057qib7	8248	52	2	2	CD
cord-005453-4057qib7	8248	53	Background	Background	NNP
cord-005453-4057qib7	8248	54	:	:	:
cord-005453-4057qib7	8249	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	8249	2	SCT	SCT	NNP
cord-005453-4057qib7	8249	3	(	(	-LRB-
cord-005453-4057qib7	8249	4	alloSCT	alloSCT	NNP
cord-005453-4057qib7	8249	5	)	)	-RRB-
cord-005453-4057qib7	8249	6	is	be	VBZ
cord-005453-4057qib7	8249	7	generally	generally	RB
cord-005453-4057qib7	8249	8	optionally	optionally	RB
cord-005453-4057qib7	8249	9	treatment	treatment	NN
cord-005453-4057qib7	8249	10	choice	choice	NN
cord-005453-4057qib7	8249	11	for	for	IN
cord-005453-4057qib7	8249	12	young	young	JJ
cord-005453-4057qib7	8249	13	and	and	CC
cord-005453-4057qib7	8249	14	fit	fit	JJ
cord-005453-4057qib7	8249	15	patients	patient	NNS
cord-005453-4057qib7	8249	16	with	with	IN
cord-005453-4057qib7	8249	17	relapsed	relapse	VBN
cord-005453-4057qib7	8249	18	/	/	SYM
cord-005453-4057qib7	8249	19	refractory	refractory	JJ
cord-005453-4057qib7	8249	20	lymphoma	lymphoma	NN
cord-005453-4057qib7	8249	21	who	who	WP
cord-005453-4057qib7	8249	22	were	be	VBD
cord-005453-4057qib7	8249	23	heavily	heavily	RB
cord-005453-4057qib7	8249	24	pre	pre	VBN
cord-005453-4057qib7	8249	25	-	-	VBN
cord-005453-4057qib7	8249	26	treated	treat	VBN
cord-005453-4057qib7	8249	27	and	and	CC
cord-005453-4057qib7	8249	28	after	after	IN
cord-005453-4057qib7	8249	29	the	the	DT
cord-005453-4057qib7	8249	30	failure	failure	NN
cord-005453-4057qib7	8249	31	of	of	IN
cord-005453-4057qib7	8249	32	autologous	autologous	JJ
cord-005453-4057qib7	8249	33	stem	stem	NN
cord-005453-4057qib7	8249	34	cell	cell	NN
cord-005453-4057qib7	8249	35	transplantation	transplantation	NN
cord-005453-4057qib7	8249	36	(	(	-LRB-
cord-005453-4057qib7	8249	37	ASCT	ASCT	NNP
cord-005453-4057qib7	8249	38	)	)	-RRB-
cord-005453-4057qib7	8249	39	.	.	.
cord-005453-4057qib7	8250	1	Relapse	relapse	VB
cord-005453-4057qib7	8250	2	after	after	IN
cord-005453-4057qib7	8250	3	ASCT	ASCT	NNP
cord-005453-4057qib7	8250	4	is	be	VBZ
cord-005453-4057qib7	8250	5	associated	associate	VBN
cord-005453-4057qib7	8250	6	with	with	IN
cord-005453-4057qib7	8250	7	a	a	DT
cord-005453-4057qib7	8250	8	poor	poor	JJ
cord-005453-4057qib7	8250	9	prognosis	prognosis	NN
cord-005453-4057qib7	8250	10	and	and	CC
cord-005453-4057qib7	8250	11	alloSCT	alloSCT	NNP
cord-005453-4057qib7	8250	12	is	be	VBZ
cord-005453-4057qib7	8250	13	a	a	DT
cord-005453-4057qib7	8250	14	potentially	potentially	RB
cord-005453-4057qib7	8250	15	curative	curative	JJ
cord-005453-4057qib7	8250	16	therapy	therapy	NN
cord-005453-4057qib7	8250	17	for	for	IN
cord-005453-4057qib7	8250	18	lymphomas	lymphoma	NNS
cord-005453-4057qib7	8250	19	which	which	WDT
cord-005453-4057qib7	8250	20	have	have	VBP
cord-005453-4057qib7	8250	21	relapsed	relapse	VBN
cord-005453-4057qib7	8250	22	after	after	IN
cord-005453-4057qib7	8250	23	ASCT	ASCT	NNP
cord-005453-4057qib7	8250	24	.	.	.
cord-005453-4057qib7	8251	1	Methods	method	NNS
cord-005453-4057qib7	8251	2	:	:	:
cord-005453-4057qib7	8251	3	In	in	IN
cord-005453-4057qib7	8251	4	this	this	DT
cord-005453-4057qib7	8251	5	study	study	NN
cord-005453-4057qib7	8251	6	,	,	,
cord-005453-4057qib7	8251	7	we	-PRON-	PRP
cord-005453-4057qib7	8251	8	evaluated	evaluate	VBD
cord-005453-4057qib7	8251	9	19	19	CD
cord-005453-4057qib7	8251	10	patients	patient	NNS
cord-005453-4057qib7	8251	11	with	with	IN
cord-005453-4057qib7	8251	12	HL	HL	NNP
cord-005453-4057qib7	8251	13	and	and	CC
cord-005453-4057qib7	8251	14	NHL	NHL	NNP
cord-005453-4057qib7	8251	15	who	who	WP
cord-005453-4057qib7	8251	16	had	have	VBD
cord-005453-4057qib7	8251	17	treated	treat	VBN
cord-005453-4057qib7	8251	18	with	with	IN
cord-005453-4057qib7	8251	19	allo	allo	NN
cord-005453-4057qib7	8251	20	-	-	HYPH
cord-005453-4057qib7	8251	21	HSCT	HSCT	NNP
cord-005453-4057qib7	8251	22	between	between	IN
cord-005453-4057qib7	8251	23	November	November	NNP
cord-005453-4057qib7	8251	24	2014	2014	CD
cord-005453-4057qib7	8251	25	and	and	CC
cord-005453-4057qib7	8251	26	December	December	NNP
cord-005453-4057qib7	8251	27	2018	2018	CD
cord-005453-4057qib7	8251	28	in	in	IN
cord-005453-4057qib7	8251	29	Ege	Ege	NNP
cord-005453-4057qib7	8251	30	University	University	NNP
cord-005453-4057qib7	8251	31	Adult	Adult	NNP
cord-005453-4057qib7	8251	32	Hematology	Hematology	NNP
cord-005453-4057qib7	8251	33	Transplantation	Transplantation	NNP
cord-005453-4057qib7	8251	34	Unit	Unit	NNP
cord-005453-4057qib7	8251	35	.	.	.
cord-005453-4057qib7	8252	1	Results	result	NNS
cord-005453-4057qib7	8252	2	:	:	:
cord-005453-4057qib7	8253	1	Patients	patient	NNS
cord-005453-4057qib7	8253	2	,	,	,
cord-005453-4057qib7	8253	3	disease	disease	NN
cord-005453-4057qib7	8253	4	and	and	CC
cord-005453-4057qib7	8253	5	transplant	transplant	NN
cord-005453-4057qib7	8253	6	characteristics	characteristic	NNS
cord-005453-4057qib7	8253	7	were	be	VBD
cord-005453-4057qib7	8253	8	illustrated	illustrate	VBN
cord-005453-4057qib7	8253	9	in	in	IN
cord-005453-4057qib7	8253	10	table	table	NN
cord-005453-4057qib7	8253	11	.	.	.
cord-005453-4057qib7	8254	1	Histologic	Histologic	NNP
cord-005453-4057qib7	8254	2	subtype	subtype	NN
cord-005453-4057qib7	8254	3	of	of	IN
cord-005453-4057qib7	8254	4	NHL	NHL	NNP
cord-005453-4057qib7	8254	5	was	be	VBD
cord-005453-4057qib7	8254	6	evaluated	evaluate	VBN
cord-005453-4057qib7	8254	7	as	as	IN
cord-005453-4057qib7	8254	8	T	T	NNP
cord-005453-4057qib7	8254	9	cell	cell	NN
cord-005453-4057qib7	8254	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	8254	11	(	(	-LRB-
cord-005453-4057qib7	8254	12	n=8;61,5	n=8;61,5	IN
cord-005453-4057qib7	8254	13	%	%	NN
cord-005453-4057qib7	8254	14	)	)	-RRB-
cord-005453-4057qib7	8254	15	,	,	,
cord-005453-4057qib7	8254	16	mantle	mantle	NN
cord-005453-4057qib7	8254	17	cell	cell	NN
cord-005453-4057qib7	8254	18	(	(	-LRB-
cord-005453-4057qib7	8254	19	n=2;15,4	n=2;15,4	CD
cord-005453-4057qib7	8254	20	%	%	NN
cord-005453-4057qib7	8254	21	)	)	-RRB-
cord-005453-4057qib7	8254	22	,	,	,
cord-005453-4057qib7	8254	23	diffuse	diffuse	VB
cord-005453-4057qib7	8254	24	large	large	JJ
cord-005453-4057qib7	8254	25	B	b	NN
cord-005453-4057qib7	8254	26	-	-	HYPH
cord-005453-4057qib7	8254	27	cell	cell	NN
cord-005453-4057qib7	8254	28	lymphoma	lymphoma	NN
cord-005453-4057qib7	8254	29	(	(	-LRB-
cord-005453-4057qib7	8254	30	n=2;15,4	n=2;15,4	CD
cord-005453-4057qib7	8254	31	%	%	NN
cord-005453-4057qib7	8254	32	)	)	-RRB-
cord-005453-4057qib7	8254	33	and	and	CC
cord-005453-4057qib7	8254	34	B	b	NN
cord-005453-4057qib7	8254	35	-	-	HYPH
cord-005453-4057qib7	8254	36	cell	cell	NN
cord-005453-4057qib7	8254	37	lymphoma	lymphoma	NN
cord-005453-4057qib7	8254	38	,	,	,
cord-005453-4057qib7	8254	39	unclassifiable	unclassifiable	JJ
cord-005453-4057qib7	8254	40	,	,	,
cord-005453-4057qib7	8254	41	with	with	IN
cord-005453-4057qib7	8254	42	features	feature	NNS
cord-005453-4057qib7	8254	43	intermediate	intermediate	JJ
cord-005453-4057qib7	8254	44	between	between	IN
cord-005453-4057qib7	8254	45	DLBCL	DLBCL	NNP
cord-005453-4057qib7	8254	46	and	and	CC
cord-005453-4057qib7	8254	47	classical	classical	JJ
cord-005453-4057qib7	8254	48	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	8254	49	lymphoma	lymphoma	NN
cord-005453-4057qib7	8254	50	(	(	-LRB-
cord-005453-4057qib7	8254	51	n=1;7,7	n=1;7,7	NNP
cord-005453-4057qib7	8254	52	%	%	NN
cord-005453-4057qib7	8254	53	)	)	-RRB-
cord-005453-4057qib7	8254	54	.	.	.
cord-005453-4057qib7	8255	1	All	all	DT
cord-005453-4057qib7	8255	2	histologic	histologic	JJ
cord-005453-4057qib7	8255	3	subtype	subtype	NN
cord-005453-4057qib7	8255	4	of	of	IN
cord-005453-4057qib7	8255	5	HL	HL	NNP
cord-005453-4057qib7	8255	6	was	be	VBD
cord-005453-4057qib7	8255	7	determined	determine	VBN
cord-005453-4057qib7	8255	8	as	as	IN
cord-005453-4057qib7	8255	9	nodular	nodular	JJ
cord-005453-4057qib7	8255	10	sclerosing	sclerosing	NN
cord-005453-4057qib7	8255	11	.	.	.
cord-005453-4057qib7	8256	1	The	the	DT
cord-005453-4057qib7	8256	2	median	median	JJ
cord-005453-4057qib7	8256	3	number	number	NN
cord-005453-4057qib7	8256	4	of	of	IN
cord-005453-4057qib7	8256	5	prior	prior	JJ
cord-005453-4057qib7	8256	6	treatments	treatment	NNS
cord-005453-4057qib7	8256	7	before	before	IN
cord-005453-4057qib7	8256	8	allo	allo	NN
cord-005453-4057qib7	8256	9	-	-	HYPH
cord-005453-4057qib7	8256	10	HSCT	HSCT	NNP
cord-005453-4057qib7	8256	11	was	be	VBD
cord-005453-4057qib7	8256	12	3	3	CD
cord-005453-4057qib7	8257	1	(	(	-LRB-
cord-005453-4057qib7	8257	2	range	range	NN
cord-005453-4057qib7	8257	3	,	,	,
cord-005453-4057qib7	8257	4	1	1	CD
cord-005453-4057qib7	8257	5	-	-	SYM
cord-005453-4057qib7	8257	6	4	4	CD
cord-005453-4057qib7	8257	7	)	)	-RRB-
cord-005453-4057qib7	8257	8	.	.	.
cord-005453-4057qib7	8258	1	Twelve	twelve	CD
cord-005453-4057qib7	8258	2	(	(	-LRB-
cord-005453-4057qib7	8258	3	63,2	63,2	CD
cord-005453-4057qib7	8258	4	%	%	NN
cord-005453-4057qib7	8258	5	)	)	-RRB-
cord-005453-4057qib7	8258	6	patients	patient	NNS
cord-005453-4057qib7	8258	7	had	have	VBD
cord-005453-4057qib7	8258	8	refractory	refractory	JJ
cord-005453-4057qib7	8258	9	disease	disease	NN
cord-005453-4057qib7	8258	10	,	,	.
cord-005453-4057qib7	8259	1	3	3	LS
cord-005453-4057qib7	8259	2	(	(	-LRB-
cord-005453-4057qib7	8259	3	15,4	15,4	CD
cord-005453-4057qib7	8259	4	%	%	NN
cord-005453-4057qib7	8259	5	)	)	-RRB-
cord-005453-4057qib7	8259	6	patients	patient	NNS
cord-005453-4057qib7	8259	7	were	be	VBD
cord-005453-4057qib7	8259	8	in	in	IN
cord-005453-4057qib7	8259	9	complete	complete	JJ
cord-005453-4057qib7	8259	10	remission	remission	NN
cord-005453-4057qib7	8259	11	and	and	CC
cord-005453-4057qib7	8259	12	4	4	CD
cord-005453-4057qib7	8259	13	(	(	-LRB-
cord-005453-4057qib7	8259	14	21,1	21,1	CD
cord-005453-4057qib7	8259	15	%	%	NN
cord-005453-4057qib7	8259	16	)	)	-RRB-
cord-005453-4057qib7	8259	17	patients	patient	NNS
cord-005453-4057qib7	8259	18	were	be	VBD
cord-005453-4057qib7	8259	19	in	in	IN
cord-005453-4057qib7	8259	20	partial	partial	JJ
cord-005453-4057qib7	8259	21	remission	remission	NN
cord-005453-4057qib7	8259	22	before	before	IN
cord-005453-4057qib7	8259	23	allo	allo	NN
cord-005453-4057qib7	8259	24	-	-	HYPH
cord-005453-4057qib7	8259	25	HSCT	HSCT	NNP
cord-005453-4057qib7	8259	26	.	.	.
cord-005453-4057qib7	8260	1	The	the	DT
cord-005453-4057qib7	8260	2	median	median	JJ
cord-005453-4057qib7	8260	3	time	time	NN
cord-005453-4057qib7	8260	4	from	from	IN
cord-005453-4057qib7	8260	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	8260	6	to	to	IN
cord-005453-4057qib7	8260	7	alloSCT	alloSCT	NNP
cord-005453-4057qib7	8260	8	was	be	VBD
cord-005453-4057qib7	8260	9	24	24	CD
cord-005453-4057qib7	8261	1	(	(	-LRB-
cord-005453-4057qib7	8261	2	range	range	NN
cord-005453-4057qib7	8261	3	,	,	,
cord-005453-4057qib7	8261	4	8	8	CD
cord-005453-4057qib7	8261	5	-	-	SYM
cord-005453-4057qib7	8261	6	144	144	CD
cord-005453-4057qib7	8261	7	)	)	-RRB-
cord-005453-4057qib7	8261	8	months	month	NNS
cord-005453-4057qib7	8261	9	.	.	.
cord-005453-4057qib7	8262	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	8262	2	stem	stem	NN
cord-005453-4057qib7	8262	3	cell	cell	NN
cord-005453-4057qib7	8262	4	was	be	VBD
cord-005453-4057qib7	8262	5	used	use	VBN
cord-005453-4057qib7	8262	6	for	for	IN
cord-005453-4057qib7	8262	7	stem	stem	NN
cord-005453-4057qib7	8262	8	cell	cell	NN
cord-005453-4057qib7	8262	9	source	source	NN
cord-005453-4057qib7	8262	10	in	in	IN
cord-005453-4057qib7	8262	11	all	all	DT
cord-005453-4057qib7	8262	12	of	of	IN
cord-005453-4057qib7	8262	13	them	-PRON-	PRP
cord-005453-4057qib7	8262	14	.	.	.
cord-005453-4057qib7	8263	1	Total	total	JJ
cord-005453-4057qib7	8263	2	body	body	NN
cord-005453-4057qib7	8263	3	irritation	irritation	NN
cord-005453-4057qib7	8263	4	plus	plus	CC
cord-005453-4057qib7	8263	5	fludarabine	fludarabine	NN
cord-005453-4057qib7	8263	6	plus	plus	CC
cord-005453-4057qib7	8263	7	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	8263	8	and	and	CC
cord-005453-4057qib7	8263	9	busulfan	busulfan	NN
cord-005453-4057qib7	8263	10	plus	plus	CC
cord-005453-4057qib7	8263	11	cyclophosphamide	cyclophosphamide	NNP
cord-005453-4057qib7	8263	12	were	be	VBD
cord-005453-4057qib7	8263	13	preferred	prefer	VBN
cord-005453-4057qib7	8263	14	most	most	RBS
cord-005453-4057qib7	8263	15	frequently	frequently	RB
cord-005453-4057qib7	8263	16	for	for	IN
cord-005453-4057qib7	8263	17	conditioning	conditioning	NN
cord-005453-4057qib7	8263	18	as	as	IN
cord-005453-4057qib7	8263	19	non	non	JJ
cord-005453-4057qib7	8263	20	-	-	JJ
cord-005453-4057qib7	8263	21	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8263	22	and	and	CC
cord-005453-4057qib7	8263	23	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8263	24	,	,	,
cord-005453-4057qib7	8263	25	respectively	respectively	RB
cord-005453-4057qib7	8263	26	.	.	.
cord-005453-4057qib7	8264	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	8264	2	engraftment	engraftment	NN
cord-005453-4057qib7	8264	3	was	be	VBD
cord-005453-4057qib7	8264	4	occurred	occur	VBN
cord-005453-4057qib7	8264	5	median	median	NN
cord-005453-4057qib7	8264	6	of	of	IN
cord-005453-4057qib7	8264	7	17	17	CD
cord-005453-4057qib7	8264	8	(	(	-LRB-
cord-005453-4057qib7	8264	9	range	range	NN
cord-005453-4057qib7	8264	10	,	,	,
cord-005453-4057qib7	8264	11	10	10	CD
cord-005453-4057qib7	8264	12	-	-	SYM
cord-005453-4057qib7	8264	13	21	21	CD
cord-005453-4057qib7	8264	14	)	)	-RRB-
cord-005453-4057qib7	8264	15	days	day	NNS
cord-005453-4057qib7	8264	16	.	.	.
cord-005453-4057qib7	8265	1	Graft	graft	NN
cord-005453-4057qib7	8265	2	versus	versus	IN
cord-005453-4057qib7	8265	3	host	host	NN
cord-005453-4057qib7	8265	4	disease	disease	NN
cord-005453-4057qib7	8265	5	(	(	-LRB-
cord-005453-4057qib7	8265	6	GVHD	GVHD	NNP
cord-005453-4057qib7	8265	7	)	)	-RRB-
cord-005453-4057qib7	8265	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8265	9	was	be	VBD
cord-005453-4057qib7	8265	10	applied	apply	VBN
cord-005453-4057qib7	8266	1	all	all	DT
cord-005453-4057qib7	8266	2	of	of	IN
cord-005453-4057qib7	8266	3	them	-PRON-	PRP
cord-005453-4057qib7	8266	4	and	and	CC
cord-005453-4057qib7	8266	5	cyclosporine	cyclosporine	NNP
cord-005453-4057qib7	8266	6	plus	plus	CC
cord-005453-4057qib7	8266	7	methotrexate	methotrexate	NNP
cord-005453-4057qib7	8266	8	was	be	VBD
cord-005453-4057qib7	8266	9	preferred	prefer	VBN
cord-005453-4057qib7	8266	10	most	most	RBS
cord-005453-4057qib7	8266	11	frequently	frequently	RB
cord-005453-4057qib7	8266	12	(	(	-LRB-
cord-005453-4057qib7	8266	13	n=16;84,2	n=16;84,2	CD
cord-005453-4057qib7	8266	14	%	%	NN
cord-005453-4057qib7	8266	15	)	)	-RRB-
cord-005453-4057qib7	8266	16	.	.	.
cord-005453-4057qib7	8267	1	GVHD	GVHD	NNP
cord-005453-4057qib7	8267	2	was	be	VBD
cord-005453-4057qib7	8267	3	occurred	occur	VBN
cord-005453-4057qib7	8267	4	in	in	IN
cord-005453-4057qib7	8267	5	68,4	68,4	CD
cord-005453-4057qib7	8267	6	%	%	NN
cord-005453-4057qib7	8267	7	of	of	IN
cord-005453-4057qib7	8267	8	them	-PRON-	PRP
cord-005453-4057qib7	8267	9	(	(	-LRB-
cord-005453-4057qib7	8267	10	42,1	42,1	CD
cord-005453-4057qib7	8267	11	%	%	NN
cord-005453-4057qib7	8267	12	acute	acute	JJ
cord-005453-4057qib7	8267	13	GVHD	GVHD	NNP
cord-005453-4057qib7	8267	14	,	,	,
cord-005453-4057qib7	8267	15	31,6	31,6	CD
cord-005453-4057qib7	8267	16	%	%	NN
cord-005453-4057qib7	8267	17	chronic	chronic	JJ
cord-005453-4057qib7	8267	18	GVHD	GVHD	NNP
cord-005453-4057qib7	8267	19	and	and	CC
cord-005453-4057qib7	8267	20	7,7	7,7	CD
cord-005453-4057qib7	8267	21	%	%	NN
cord-005453-4057qib7	8267	22	both	both	DT
cord-005453-4057qib7	8267	23	)	)	-RRB-
cord-005453-4057qib7	8267	24	.	.	.
cord-005453-4057qib7	8268	1	Veno	Veno	NNP
cord-005453-4057qib7	8268	2	-	-	HYPH
cord-005453-4057qib7	8268	3	occlusive	occlusive	JJ
cord-005453-4057qib7	8268	4	disease	disease	NN
cord-005453-4057qib7	8268	5	(	(	-LRB-
cord-005453-4057qib7	8268	6	VOD	VOD	NNP
cord-005453-4057qib7	8268	7	)	)	-RRB-
cord-005453-4057qib7	8268	8	was	be	VBD
cord-005453-4057qib7	8268	9	occurred	occur	VBN
cord-005453-4057qib7	8268	10	in	in	IN
cord-005453-4057qib7	8268	11	2	2	CD
cord-005453-4057qib7	8268	12	(	(	-LRB-
cord-005453-4057qib7	8268	13	10,5	10,5	CD
cord-005453-4057qib7	8268	14	%	%	NN
cord-005453-4057qib7	8268	15	)	)	-RRB-
cord-005453-4057qib7	8268	16	patients	patient	NNS
cord-005453-4057qib7	8268	17	.	.	.
cord-005453-4057qib7	8269	1	Transplant	transplant	NN
cord-005453-4057qib7	8269	2	related	relate	VBN
cord-005453-4057qib7	8269	3	death	death	NN
cord-005453-4057qib7	8269	4	was	be	VBD
cord-005453-4057qib7	8269	5	observed	observe	VBN
cord-005453-4057qib7	8269	6	in	in	IN
cord-005453-4057qib7	8269	7	5	5	CD
cord-005453-4057qib7	8269	8	(	(	-LRB-
cord-005453-4057qib7	8269	9	26,3	26,3	CD
cord-005453-4057qib7	8269	10	%	%	NN
cord-005453-4057qib7	8269	11	)	)	-RRB-
cord-005453-4057qib7	8269	12	patients	patient	NNS
cord-005453-4057qib7	8269	13	.	.	.
cord-005453-4057qib7	8270	1	Overall	overall	JJ
cord-005453-4057qib7	8270	2	survival	survival	NN
cord-005453-4057qib7	8270	3	(	(	-LRB-
cord-005453-4057qib7	8270	4	OS	OS	NNP
cord-005453-4057qib7	8270	5	)	)	-RRB-
cord-005453-4057qib7	8270	6	and	and	CC
cord-005453-4057qib7	8270	7	disease	disease	NN
cord-005453-4057qib7	8270	8	-	-	HYPH
cord-005453-4057qib7	8270	9	free	free	JJ
cord-005453-4057qib7	8270	10	-	-	HYPH
cord-005453-4057qib7	8270	11	survival	survival	NN
cord-005453-4057qib7	8270	12	(	(	-LRB-
cord-005453-4057qib7	8270	13	DFS	DFS	NNP
cord-005453-4057qib7	8270	14	)	)	-RRB-
cord-005453-4057qib7	8270	15	were	be	VBD
cord-005453-4057qib7	8270	16	evaluated	evaluate	VBN
cord-005453-4057qib7	8270	17	as	as	IN
cord-005453-4057qib7	8270	18	median	median	NN
cord-005453-4057qib7	8270	19	9	9	CD
cord-005453-4057qib7	8270	20	(	(	-LRB-
cord-005453-4057qib7	8270	21	range	range	NN
cord-005453-4057qib7	8270	22	,	,	,
cord-005453-4057qib7	8270	23	0	0	CD
cord-005453-4057qib7	8270	24	-	-	SYM
cord-005453-4057qib7	8270	25	45	45	CD
cord-005453-4057qib7	8270	26	)	)	-RRB-
cord-005453-4057qib7	8270	27	and	and	CC
cord-005453-4057qib7	8270	28	7	7	CD
cord-005453-4057qib7	8270	29	(	(	-LRB-
cord-005453-4057qib7	8270	30	range	range	NN
cord-005453-4057qib7	8270	31	,	,	,
cord-005453-4057qib7	8270	32	0	0	CD
cord-005453-4057qib7	8270	33	-	-	SYM
cord-005453-4057qib7	8270	34	45	45	CD
cord-005453-4057qib7	8270	35	)	)	-RRB-
cord-005453-4057qib7	8270	36	months	month	NNS
cord-005453-4057qib7	8270	37	,	,	,
cord-005453-4057qib7	8270	38	respectively	respectively	RB
cord-005453-4057qib7	8270	39	.	.	.
cord-005453-4057qib7	8271	1	Analyze	Analyze	NNP
cord-005453-4057qib7	8271	2	of	of	IN
cord-005453-4057qib7	8271	3	OS	OS	NNP
cord-005453-4057qib7	8271	4	and	and	CC
cord-005453-4057qib7	8271	5	DFS	DFS	NNP
cord-005453-4057qib7	8271	6	was	be	VBD
cord-005453-4057qib7	8271	7	illustrated	illustrate	VBN
cord-005453-4057qib7	8271	8	in	in	IN
cord-005453-4057qib7	8271	9	figure	figure	NN
cord-005453-4057qib7	8271	10	.	.	.
cord-005453-4057qib7	8272	1	Six	six	CD
cord-005453-4057qib7	8272	2	patients	patient	NNS
cord-005453-4057qib7	8272	3	are	be	VBP
cord-005453-4057qib7	8272	4	alive	alive	JJ
cord-005453-4057qib7	8272	5	without	without	IN
cord-005453-4057qib7	8272	6	disease	disease	NN
cord-005453-4057qib7	8272	7	.	.	.
cord-005453-4057qib7	8273	1	After	after	IN
cord-005453-4057qib7	8273	2	a	a	DT
cord-005453-4057qib7	8273	3	rapid	rapid	JJ
cord-005453-4057qib7	8273	4	tapering	tapering	NN
cord-005453-4057qib7	8273	5	of	of	IN
cord-005453-4057qib7	8273	6	immunosuopressive	immunosuopressive	JJ
cord-005453-4057qib7	8273	7	therapy	therapy	NN
cord-005453-4057qib7	8273	8	was	be	VBD
cord-005453-4057qib7	8273	9	underwent	undergo	VBN
cord-005453-4057qib7	8273	10	a	a	DT
cord-005453-4057qib7	8273	11	therapy	therapy	NN
cord-005453-4057qib7	8273	12	with	with	IN
cord-005453-4057qib7	8273	13	ponatinibat	ponatinibat	NN
cord-005453-4057qib7	8273	14	dose	dose	NN
cord-005453-4057qib7	8273	15	of	of	IN
cord-005453-4057qib7	8273	16	45mg	45mg	NN
cord-005453-4057qib7	8273	17	/	/	SYM
cord-005453-4057qib7	8273	18	die	die	VB
cord-005453-4057qib7	8273	19	Results	result	NNS
cord-005453-4057qib7	8273	20	:	:	:
cord-005453-4057qib7	8273	21	Afther	Afther	NNP
cord-005453-4057qib7	8273	22	a	a	DT
cord-005453-4057qib7	8273	23	month	month	NN
cord-005453-4057qib7	8273	24	of	of	IN
cord-005453-4057qib7	8273	25	therapy	therapy	NN
cord-005453-4057qib7	8274	1	we	-PRON-	PRP
cord-005453-4057qib7	8274	2	observed	observe	VBD
cord-005453-4057qib7	8274	3	a	a	DT
cord-005453-4057qib7	8274	4	rapid	rapid	JJ
cord-005453-4057qib7	8274	5	decrease	decrease	NN
cord-005453-4057qib7	8274	6	in	in	IN
cord-005453-4057qib7	8274	7	minimal	minimal	JJ
cord-005453-4057qib7	8274	8	residual	residual	JJ
cord-005453-4057qib7	8274	9	disease	disease	NN
cord-005453-4057qib7	8274	10	on	on	IN
cord-005453-4057qib7	8274	11	molecular	molecular	JJ
cord-005453-4057qib7	8274	12	assessment	assessment	NN
cord-005453-4057qib7	8274	13	with	with	IN
cord-005453-4057qib7	8274	14	an	an	DT
cord-005453-4057qib7	8274	15	MMR	MMR	NNP
cord-005453-4057qib7	8274	16	of	of	IN
cord-005453-4057qib7	8274	17	P190-BCR	P190-BCR	NNP
cord-005453-4057qib7	8274	18	-	-	HYPH
cord-005453-4057qib7	8274	19	ABL	ABL	NNP
cord-005453-4057qib7	8274	20	/	/	SYM
cord-005453-4057qib7	8274	21	ABL	ABL	NNP
cord-005453-4057qib7	8275	1	non	non	JJ
cord-005453-4057qib7	8275	2	detectable	detectable	JJ
cord-005453-4057qib7	8275	3	confirmed	confirm	VBN
cord-005453-4057qib7	8275	4	by	by	IN
cord-005453-4057qib7	8275	5	bone	bone	NN
cord-005453-4057qib7	8275	6	marrow	marrow	NN
cord-005453-4057qib7	8275	7	revaluations	revaluation	NNS
cord-005453-4057qib7	8275	8	at	at	IN
cord-005453-4057qib7	8275	9	days	day	NNS
cord-005453-4057qib7	8275	10	+	+	SYM
cord-005453-4057qib7	8275	11	190	190	CD
cord-005453-4057qib7	8275	12	,	,	,
cord-005453-4057qib7	8275	13	+222nd	+222nd	NNP
cord-005453-4057qib7	8275	14	+244	+244	NNP
cord-005453-4057qib7	8275	15	after	after	IN
cord-005453-4057qib7	8275	16	the	the	DT
cord-005453-4057qib7	8275	17	salvage	salvage	NN
cord-005453-4057qib7	8275	18	therapy	therapy	NN
cord-005453-4057qib7	8275	19	.	.	.
cord-005453-4057qib7	8276	1	The	the	DT
cord-005453-4057qib7	8276	2	patient	patient	NN
cord-005453-4057qib7	8276	3	has	have	VBZ
cord-005453-4057qib7	8276	4	not	not	RB
cord-005453-4057qib7	8276	5	had	have	VBN
cord-005453-4057qib7	8276	6	experienced	experience	VBN
cord-005453-4057qib7	8276	7	of	of	IN
cord-005453-4057qib7	8276	8	graft	graft	NN
cord-005453-4057qib7	8276	9	-	-	HYPH
cord-005453-4057qib7	8276	10	versus	versus	IN
cord-005453-4057qib7	8276	11	-	-	HYPH
cord-005453-4057qib7	8276	12	host	host	NN
cord-005453-4057qib7	8276	13	disease	disease	NN
cord-005453-4057qib7	8276	14	,	,	,
cord-005453-4057qib7	8276	15	Ponatinib	Ponatinib	NNP
cord-005453-4057qib7	8276	16	treatment	treatment	NN
cord-005453-4057qib7	8276	17	was	be	VBD
cord-005453-4057qib7	8276	18	well	well	RB
cord-005453-4057qib7	8276	19	tolerated	tolerate	VBN
cord-005453-4057qib7	8276	20	and	and	CC
cord-005453-4057qib7	8276	21	considered	consider	VBN
cord-005453-4057qib7	8276	22	safe	safe	JJ
cord-005453-4057qib7	8276	23	with	with	IN
cord-005453-4057qib7	8276	24	easily	easily	RB
cord-005453-4057qib7	8276	25	manageable	manageable	JJ
cord-005453-4057qib7	8276	26	side	side	NN
cord-005453-4057qib7	8276	27	.	.	.
cord-005453-4057qib7	8277	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8277	2	:	:	:
cord-005453-4057qib7	8278	1	Maybe	maybe	RB
cord-005453-4057qib7	8278	2	in	in	IN
cord-005453-4057qib7	8278	3	the	the	DT
cord-005453-4057qib7	8278	4	era	era	NN
cord-005453-4057qib7	8278	5	of	of	IN
cord-005453-4057qib7	8278	6	tyrosine	tyrosine	NN
cord-005453-4057qib7	8278	7	kinase	kinase	NN
cord-005453-4057qib7	8278	8	inhibitors	inhibitor	NNS
cord-005453-4057qib7	8278	9	(	(	-LRB-
cord-005453-4057qib7	8278	10	TKIs	TKIs	NNP
cord-005453-4057qib7	8278	11	)	)	-RRB-
cord-005453-4057qib7	8278	12	,	,	,
cord-005453-4057qib7	8278	13	philadelphia	philadelphia	NNP
cord-005453-4057qib7	8278	14	chromosome	chromosome	NN
cord-005453-4057qib7	8278	15	positive	positive	JJ
cord-005453-4057qib7	8278	16	acute	acute	JJ
cord-005453-4057qib7	8278	17	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	8278	18	leukemia	leukemia	NN
cord-005453-4057qib7	8278	19	(	(	-LRB-
cord-005453-4057qib7	8278	20	Ph+	Ph+	NNP
cord-005453-4057qib7	8278	21	ALL	all	DT
cord-005453-4057qib7	8278	22	)	)	-RRB-
cord-005453-4057qib7	8279	1	it	-PRON-	PRP
cord-005453-4057qib7	8279	2	could	could	MD
cord-005453-4057qib7	8279	3	benefit	benefit	VB
cord-005453-4057qib7	8279	4	from	from	IN
cord-005453-4057qib7	8279	5	a	a	DT
cord-005453-4057qib7	8279	6	combined	combine	VBN
cord-005453-4057qib7	8279	7	treatment	treatment	NN
cord-005453-4057qib7	8279	8	between	between	IN
cord-005453-4057qib7	8279	9	transpalnt	transpalnt	NN
cord-005453-4057qib7	8279	10	and	and	CC
cord-005453-4057qib7	8279	11	TKIs	tki	NNS
cord-005453-4057qib7	8279	12	however	however	RB
cord-005453-4057qib7	8279	13	more	more	JJR
cord-005453-4057qib7	8279	14	studies	study	NNS
cord-005453-4057qib7	8279	15	are	be	VBP
cord-005453-4057qib7	8279	16	needed	need	VBN
cord-005453-4057qib7	8279	17	to	to	TO
cord-005453-4057qib7	8279	18	confirm	confirm	VB
cord-005453-4057qib7	8279	19	these	these	DT
cord-005453-4057qib7	8279	20	hypotheses	hypothesis	NNS
cord-005453-4057qib7	8279	21	.	.	.
cord-005453-4057qib7	8280	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8280	2	:	:	:
cord-005453-4057qib7	8280	3	nothing	nothing	NN
cord-005453-4057qib7	8280	4	to	to	TO
cord-005453-4057qib7	8280	5	declare	declare	VB
cord-005453-4057qib7	8280	6	Immunodeficiency	Immunodeficiency	NNP
cord-005453-4057qib7	8280	7	diseases	disease	NNS
cord-005453-4057qib7	8280	8	and	and	CC
cord-005453-4057qib7	8280	9	macrophage	macrophage	NN
cord-005453-4057qib7	8280	10	Background	background	NN
cord-005453-4057qib7	8280	11	:	:	:
cord-005453-4057qib7	8281	1	Although	although	IN
cord-005453-4057qib7	8281	2	a	a	DT
cord-005453-4057qib7	8281	3	number	number	NN
cord-005453-4057qib7	8281	4	of	of	IN
cord-005453-4057qib7	8281	5	patients	patient	NNS
cord-005453-4057qib7	8281	6	with	with	IN
cord-005453-4057qib7	8281	7	HIV	HIV	NNP
cord-005453-4057qib7	8281	8	infection	infection	NN
cord-005453-4057qib7	8281	9	and	and	CC
cord-005453-4057qib7	8281	10	hematological	hematological	JJ
cord-005453-4057qib7	8281	11	disease	disease	NN
cord-005453-4057qib7	8281	12	have	have	VBP
cord-005453-4057qib7	8281	13	successfully	successfully	RB
cord-005453-4057qib7	8281	14	undergone	undergo	VBN
cord-005453-4057qib7	8281	15	allogeneic	allogeneic	IN
cord-005453-4057qib7	8281	16	HSCT	HSCT	NNP
cord-005453-4057qib7	8281	17	together	together	RB
cord-005453-4057qib7	8281	18	with	with	IN
cord-005453-4057qib7	8281	19	combination	combination	NN
cord-005453-4057qib7	8281	20	anti	anti	JJ
cord-005453-4057qib7	8281	21	-	-	JJ
cord-005453-4057qib7	8281	22	retroviral	retroviral	JJ
cord-005453-4057qib7	8281	23	therapy	therapy	NN
cord-005453-4057qib7	8281	24	(	(	-LRB-
cord-005453-4057qib7	8281	25	cART	cART	NNP
cord-005453-4057qib7	8281	26	)	)	-RRB-
cord-005453-4057qib7	8281	27	,	,	,
cord-005453-4057qib7	8281	28	short	short	JJ
cord-005453-4057qib7	8281	29	and	and	CC
cord-005453-4057qib7	8281	30	long	long	JJ
cord-005453-4057qib7	8281	31	-	-	HYPH
cord-005453-4057qib7	8281	32	term	term	NN
cord-005453-4057qib7	8281	33	outcomes	outcome	NNS
cord-005453-4057qib7	8281	34	remain	remain	VBP
cord-005453-4057qib7	8281	35	not	not	RB
cord-005453-4057qib7	8281	36	well	well	RB
cord-005453-4057qib7	8281	37	known	known	JJ
cord-005453-4057qib7	8281	38	.	.	.
cord-005453-4057qib7	8282	1	We	-PRON-	PRP
cord-005453-4057qib7	8282	2	report	report	VBP
cord-005453-4057qib7	8282	3	the	the	DT
cord-005453-4057qib7	8282	4	largest	large	JJS
cord-005453-4057qib7	8282	5	Spanish	spanish	JJ
cord-005453-4057qib7	8282	6	experience	experience	NN
cord-005453-4057qib7	8282	7	of	of	IN
cord-005453-4057qib7	8282	8	HIV	HIV	NNP
cord-005453-4057qib7	8282	9	-	-	HYPH
cord-005453-4057qib7	8282	10	infected	infect	VBN
cord-005453-4057qib7	8282	11	adult	adult	NN
cord-005453-4057qib7	8282	12	patients	patient	NNS
cord-005453-4057qib7	8282	13	with	with	IN
cord-005453-4057qib7	8282	14	high	high	JJ
cord-005453-4057qib7	8282	15	-	-	HYPH
cord-005453-4057qib7	8282	16	risk	risk	NN
cord-005453-4057qib7	8282	17	hematological	hematological	JJ
cord-005453-4057qib7	8282	18	malignancies	malignancy	NNS
cord-005453-4057qib7	8282	19	with	with	IN
cord-005453-4057qib7	8282	20	allogeneic	allogeneic	NN
cord-005453-4057qib7	8282	21	HSCT	HSCT	NNP
cord-005453-4057qib7	8282	22	.	.	.
cord-005453-4057qib7	8283	1	Methods	method	NNS
cord-005453-4057qib7	8284	1	:	:	:
cord-005453-4057qib7	8284	2	We	-PRON-	PRP
cord-005453-4057qib7	8284	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	8284	4	reviewed	review	VBD
cord-005453-4057qib7	8284	5	22	22	CD
cord-005453-4057qib7	8284	6	HIV	HIV	NNP
cord-005453-4057qib7	8284	7	-	-	HYPH
cord-005453-4057qib7	8284	8	positive	positive	JJ
cord-005453-4057qib7	8284	9	patients	patient	NNS
cord-005453-4057qib7	8284	10	who	who	WP
cord-005453-4057qib7	8284	11	received	receive	VBD
cord-005453-4057qib7	8284	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	8284	13	HSCT	HSCT	NNP
cord-005453-4057qib7	8284	14	between	between	IN
cord-005453-4057qib7	8284	15	1999	1999	CD
cord-005453-4057qib7	8284	16	and	and	CC
cord-005453-4057qib7	8284	17	2018	2018	CD
cord-005453-4057qib7	8284	18	in	in	IN
cord-005453-4057qib7	8284	19	5	5	CD
cord-005453-4057qib7	8284	20	Spanish	spanish	JJ
cord-005453-4057qib7	8284	21	centers	center	NNS
cord-005453-4057qib7	8284	22	within	within	IN
cord-005453-4057qib7	8284	23	GETH	GETH	NNP
cord-005453-4057qib7	8284	24	(	(	-LRB-
cord-005453-4057qib7	8284	25	Grupo	Grupo	NNP
cord-005453-4057qib7	8284	26	Español	Español	NNP
cord-005453-4057qib7	8284	27	de	de	NNP
cord-005453-4057qib7	8284	28	Trasplante	Trasplante	NNP
cord-005453-4057qib7	8284	29	Hematopoyético	Hematopoyético	NNP
cord-005453-4057qib7	8284	30	y	y	NNP
cord-005453-4057qib7	8284	31	Terapia	Terapia	NNP
cord-005453-4057qib7	8284	32	Celular	Celular	NNP
cord-005453-4057qib7	8284	33	)	)	-RRB-
cord-005453-4057qib7	8284	34	.	.	.
cord-005453-4057qib7	8285	1	Results	result	NNS
cord-005453-4057qib7	8285	2	:	:	:
cord-005453-4057qib7	8286	1	Baseline	baseline	JJ
cord-005453-4057qib7	8286	2	and	and	CC
cord-005453-4057qib7	8286	3	transplant	transplant	NN
cord-005453-4057qib7	8286	4	characteristics	characteristic	NNS
cord-005453-4057qib7	8286	5	of	of	IN
cord-005453-4057qib7	8286	6	patients	patient	NNS
cord-005453-4057qib7	8286	7	are	be	VBP
cord-005453-4057qib7	8286	8	shown	show	VBN
cord-005453-4057qib7	8286	9	in	in	IN
cord-005453-4057qib7	8286	10	Table	Table	NNP
cord-005453-4057qib7	8286	11	1	1	CD
cord-005453-4057qib7	8286	12	.	.	.
cord-005453-4057qib7	8287	1	Median	median	JJ
cord-005453-4057qib7	8287	2	age	age	NN
cord-005453-4057qib7	8287	3	was	be	VBD
cord-005453-4057qib7	8287	4	44	44	CD
cord-005453-4057qib7	8287	5	years	year	NNS
cord-005453-4057qib7	8287	6	and	and	CC
cord-005453-4057qib7	8287	7	77	77	CD
cord-005453-4057qib7	8287	8	%	%	NN
cord-005453-4057qib7	8287	9	of	of	IN
cord-005453-4057qib7	8287	10	the	the	DT
cord-005453-4057qib7	8287	11	patients	patient	NNS
cord-005453-4057qib7	8287	12	were	be	VBD
cord-005453-4057qib7	8287	13	men	man	NNS
cord-005453-4057qib7	8287	14	.	.	.
cord-005453-4057qib7	8288	1	The	the	DT
cord-005453-4057qib7	8288	2	most	most	RBS
cord-005453-4057qib7	8288	3	frequent	frequent	JJ
cord-005453-4057qib7	8288	4	underlying	underlying	JJ
cord-005453-4057qib7	8288	5	malignancies	malignancy	NNS
cord-005453-4057qib7	8288	6	were	be	VBD
cord-005453-4057qib7	8288	7	non	non	JJ
cord-005453-4057qib7	8288	8	-	-	JJ
cord-005453-4057qib7	8288	9	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	8288	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	8288	11	(	(	-LRB-
cord-005453-4057qib7	8288	12	9	9	CD
cord-005453-4057qib7	8288	13	,	,	,
cord-005453-4057qib7	8288	14	41	41	CD
cord-005453-4057qib7	8288	15	%	%	NN
cord-005453-4057qib7	8288	16	)	)	-RRB-
cord-005453-4057qib7	8288	17	and	and	CC
cord-005453-4057qib7	8288	18	AML	AML	NNP
cord-005453-4057qib7	8288	19	(	(	-LRB-
cord-005453-4057qib7	8288	20	7	7	CD
cord-005453-4057qib7	8288	21	,	,	,
cord-005453-4057qib7	8288	22	31	31	CD
cord-005453-4057qib7	8288	23	%	%	NN
cord-005453-4057qib7	8288	24	)	)	-RRB-
cord-005453-4057qib7	8288	25	.	.	.
cord-005453-4057qib7	8289	1	In	in	IN
cord-005453-4057qib7	8289	2	half	half	NN
cord-005453-4057qib7	8289	3	of	of	IN
cord-005453-4057qib7	8289	4	the	the	DT
cord-005453-4057qib7	8289	5	patients	patient	NNS
cord-005453-4057qib7	8289	6	an	an	DT
cord-005453-4057qib7	8289	7	HLAidentical	HLAidentical	NNP
cord-005453-4057qib7	8289	8	sibling	sibling	NN
cord-005453-4057qib7	8289	9	was	be	VBD
cord-005453-4057qib7	8289	10	the	the	DT
cord-005453-4057qib7	8289	11	donor	donor	NN
cord-005453-4057qib7	8289	12	;	;	:
cord-005453-4057qib7	8289	13	and	and	CC
cord-005453-4057qib7	8289	14	in	in	IN
cord-005453-4057qib7	8289	15	the	the	DT
cord-005453-4057qib7	8289	16	other	other	JJ
cord-005453-4057qib7	8289	17	half	half	NN
cord-005453-4057qib7	8289	18	,	,	,
cord-005453-4057qib7	8289	19	an	an	DT
cord-005453-4057qib7	8289	20	alternative	alternative	JJ
cord-005453-4057qib7	8289	21	donor	donor	NN
cord-005453-4057qib7	8289	22	was	be	VBD
cord-005453-4057qib7	8289	23	used	use	VBN
cord-005453-4057qib7	8289	24	.	.	.
cord-005453-4057qib7	8290	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	8290	2	blood	blood	NN
cord-005453-4057qib7	8290	3	was	be	VBD
cord-005453-4057qib7	8290	4	used	use	VBN
cord-005453-4057qib7	8290	5	as	as	IN
cord-005453-4057qib7	8290	6	graft	graft	NN
cord-005453-4057qib7	8290	7	source	source	NN
cord-005453-4057qib7	8290	8	in	in	IN
cord-005453-4057qib7	8290	9	86	86	CD
cord-005453-4057qib7	8290	10	%	%	NN
cord-005453-4057qib7	8290	11	of	of	IN
cord-005453-4057qib7	8290	12	the	the	DT
cord-005453-4057qib7	8290	13	transplants	transplant	NNS
cord-005453-4057qib7	8290	14	.	.	.
cord-005453-4057qib7	8291	1	At	at	IN
cord-005453-4057qib7	8291	2	the	the	DT
cord-005453-4057qib7	8291	3	time	time	NN
cord-005453-4057qib7	8291	4	of	of	IN
cord-005453-4057qib7	8291	5	HSCT	HSCT	NNP
cord-005453-4057qib7	8291	6	,	,	,
cord-005453-4057qib7	8291	7	all	all	DT
cord-005453-4057qib7	8291	8	patients	patient	NNS
cord-005453-4057qib7	8291	9	had	have	VBD
cord-005453-4057qib7	8291	10	been	be	VBN
cord-005453-4057qib7	8291	11	receiving	receive	VBG
cord-005453-4057qib7	8291	12	suppressive	suppressive	JJ
cord-005453-4057qib7	8291	13	cART	cart	NN
cord-005453-4057qib7	8291	14	for	for	IN
cord-005453-4057qib7	8291	15	a	a	DT
cord-005453-4057qib7	8291	16	median	median	NN
cord-005453-4057qib7	8291	17	of	of	IN
cord-005453-4057qib7	8291	18	6	6	CD
cord-005453-4057qib7	8291	19	years	year	NNS
cord-005453-4057qib7	8291	20	and	and	CC
cord-005453-4057qib7	8291	21	only	only	RB
cord-005453-4057qib7	8291	22	2	2	CD
cord-005453-4057qib7	8291	23	of	of	IN
cord-005453-4057qib7	8291	24	them	-PRON-	PRP
cord-005453-4057qib7	8291	25	showed	show	VBD
cord-005453-4057qib7	8291	26	detectable	detectable	JJ
cord-005453-4057qib7	8291	27	plasma	plasma	NN
cord-005453-4057qib7	8291	28	HIV	HIV	NNP
cord-005453-4057qib7	8291	29	RNA	RNA	NNP
cord-005453-4057qib7	8291	30	,	,	,
cord-005453-4057qib7	8291	31	one	one	CD
cord-005453-4057qib7	8291	32	of	of	IN
cord-005453-4057qib7	8291	33	them	-PRON-	PRP
cord-005453-4057qib7	8291	34	because	because	IN
cord-005453-4057qib7	8291	35	of	of	IN
cord-005453-4057qib7	8291	36	poor	poor	JJ
cord-005453-4057qib7	8291	37	adherence	adherence	NN
cord-005453-4057qib7	8291	38	to	to	IN
cord-005453-4057qib7	8291	39	cART	cART	NNP
cord-005453-4057qib7	8291	40	together	together	RB
cord-005453-4057qib7	8291	41	with	with	IN
cord-005453-4057qib7	8291	42	the	the	DT
cord-005453-4057qib7	8291	43	accumulation	accumulation	NN
cord-005453-4057qib7	8291	44	of	of	IN
cord-005453-4057qib7	8291	45	multiple	multiple	JJ
cord-005453-4057qib7	8291	46	resistance	resistance	NN
cord-005453-4057qib7	8291	47	mutations	mutation	NNS
cord-005453-4057qib7	8291	48	;	;	:
cord-005453-4057qib7	8291	49	and	and	CC
cord-005453-4057qib7	8291	50	the	the	DT
cord-005453-4057qib7	8291	51	other	other	JJ
cord-005453-4057qib7	8291	52	patient	patient	NN
cord-005453-4057qib7	8291	53	had	have	VBD
cord-005453-4057qib7	8291	54	detectable	detectable	JJ
cord-005453-4057qib7	8291	55	HIV	HIV	NNP
cord-005453-4057qib7	8291	56	RNA	RNA	NNP
cord-005453-4057qib7	8291	57	at	at	IN
cord-005453-4057qib7	8291	58	low	low	JJ
cord-005453-4057qib7	8291	59	levels	level	NNS
cord-005453-4057qib7	8291	60	(	(	-LRB-
cord-005453-4057qib7	8291	61	<	<	XX
cord-005453-4057qib7	8291	62	150	150	CD
cord-005453-4057qib7	8291	63	copies	copy	NNS
cord-005453-4057qib7	8291	64	/	/	SYM
cord-005453-4057qib7	8291	65	mL	ml	NN
cord-005453-4057qib7	8291	66	)	)	-RRB-
cord-005453-4057qib7	8291	67	.	.	.
cord-005453-4057qib7	8292	1	All	all	DT
cord-005453-4057qib7	8292	2	patients	patient	NNS
cord-005453-4057qib7	8292	3	received	receive	VBD
cord-005453-4057qib7	8292	4	cART	cart	XX
cord-005453-4057qib7	8292	5	throughout	throughout	IN
cord-005453-4057qib7	8292	6	the	the	DT
cord-005453-4057qib7	8292	7	transplant	transplant	NN
cord-005453-4057qib7	8292	8	procedure	procedure	NN
cord-005453-4057qib7	8292	9	,	,	,
cord-005453-4057qib7	8292	10	being	be	VBG
cord-005453-4057qib7	8292	11	temporally	temporally	RB
cord-005453-4057qib7	8292	12	stopped	stop	VBN
cord-005453-4057qib7	8292	13	in	in	IN
cord-005453-4057qib7	8292	14	two	two	CD
cord-005453-4057qib7	8292	15	patients	patient	NNS
cord-005453-4057qib7	8292	16	due	due	JJ
cord-005453-4057qib7	8292	17	to	to	IN
cord-005453-4057qib7	8292	18	significant	significant	JJ
cord-005453-4057qib7	8292	19	mucositis	mucositis	NN
cord-005453-4057qib7	8292	20	.	.	.
cord-005453-4057qib7	8293	1	After	after	IN
cord-005453-4057qib7	8293	2	a	a	DT
cord-005453-4057qib7	8293	3	median	median	JJ
cord-005453-4057qib7	8293	4	follow	follow	NN
cord-005453-4057qib7	8293	5	-	-	HYPH
cord-005453-4057qib7	8293	6	up	up	NN
cord-005453-4057qib7	8293	7	of	of	IN
cord-005453-4057qib7	8293	8	65	65	CD
cord-005453-4057qib7	8293	9	months	month	NNS
cord-005453-4057qib7	8293	10	(	(	-LRB-
cord-005453-4057qib7	8293	11	8	8	CD
cord-005453-4057qib7	8293	12	-	-	SYM
cord-005453-4057qib7	8293	13	112	112	CD
cord-005453-4057qib7	8293	14	)	)	-RRB-
cord-005453-4057qib7	8293	15	,	,	,
cord-005453-4057qib7	8293	16	5-year	5-year	CD
cord-005453-4057qib7	8293	17	overall	overall	JJ
cord-005453-4057qib7	8293	18	survival	survival	NN
cord-005453-4057qib7	8293	19	(	(	-LRB-
cord-005453-4057qib7	8293	20	OS	OS	NNP
cord-005453-4057qib7	8293	21	)	)	-RRB-
cord-005453-4057qib7	8293	22	and	and	CC
cord-005453-4057qib7	8293	23	event	event	NN
cord-005453-4057qib7	8293	24	-	-	HYPH
cord-005453-4057qib7	8293	25	free	free	JJ
cord-005453-4057qib7	8293	26	survival	survival	NN
cord-005453-4057qib7	8293	27	(	(	-LRB-
cord-005453-4057qib7	8293	28	EFS	EFS	NNP
cord-005453-4057qib7	8293	29	)	)	-RRB-
cord-005453-4057qib7	8293	30	were	be	VBD
cord-005453-4057qib7	8293	31	46	46	CD
cord-005453-4057qib7	8293	32	%	%	NN
cord-005453-4057qib7	8293	33	.	.	.
cord-005453-4057qib7	8294	1	NRM	NRM	NNP
cord-005453-4057qib7	8294	2	was	be	VBD
cord-005453-4057qib7	8294	3	14	14	CD
cord-005453-4057qib7	8294	4	%	%	NN
cord-005453-4057qib7	8294	5	at	at	IN
cord-005453-4057qib7	8294	6	12	12	CD
cord-005453-4057qib7	8294	7	months	month	NNS
cord-005453-4057qib7	8294	8	and	and	CC
cord-005453-4057qib7	8294	9	relapse	relapse	NN
cord-005453-4057qib7	8294	10	was	be	VBD
cord-005453-4057qib7	8294	11	24	24	CD
cord-005453-4057qib7	8294	12	%	%	NN
cord-005453-4057qib7	8294	13	at	at	IN
cord-005453-4057qib7	8294	14	24	24	CD
cord-005453-4057qib7	8294	15	months	month	NNS
cord-005453-4057qib7	8294	16	.	.	.
cord-005453-4057qib7	8295	1	Grade	Grade	NNP
cord-005453-4057qib7	8295	2	II	II	NNP
cord-005453-4057qib7	8295	3	-	-	HYPH
cord-005453-4057qib7	8295	4	IV	IV	NNP
cord-005453-4057qib7	8295	5	aGvHD	agvhd	NN
cord-005453-4057qib7	8295	6	rate	rate	NN
cord-005453-4057qib7	8295	7	was	be	VBD
cord-005453-4057qib7	8295	8	40	40	CD
cord-005453-4057qib7	8295	9	%	%	NN
cord-005453-4057qib7	8295	10	,	,	,
cord-005453-4057qib7	8295	11	and	and	CC
cord-005453-4057qib7	8295	12	moderate	moderate	JJ
cord-005453-4057qib7	8295	13	/	/	SYM
cord-005453-4057qib7	8295	14	severe	severe	JJ
cord-005453-4057qib7	8295	15	cGvHD	cgvhd	NN
cord-005453-4057qib7	8295	16	rate	rate	NN
cord-005453-4057qib7	8295	17	was	be	VBD
cord-005453-4057qib7	8295	18	41	41	CD
cord-005453-4057qib7	8295	19	%	%	NN
cord-005453-4057qib7	8295	20	at	at	IN
cord-005453-4057qib7	8295	21	24	24	CD
cord-005453-4057qib7	8295	22	months	month	NNS
cord-005453-4057qib7	8295	23	.	.	.
cord-005453-4057qib7	8296	1	A	a	DT
cord-005453-4057qib7	8296	2	significant	significant	JJ
cord-005453-4057qib7	8296	3	proportion	proportion	NN
cord-005453-4057qib7	8296	4	of	of	IN
cord-005453-4057qib7	8296	5	patients	patient	NNS
cord-005453-4057qib7	8296	6	(	(	-LRB-
cord-005453-4057qib7	8296	7	68	68	CD
cord-005453-4057qib7	8296	8	%	%	NN
cord-005453-4057qib7	8296	9	)	)	-RRB-
cord-005453-4057qib7	8296	10	showed	show	VBD
cord-005453-4057qib7	8296	11	infectious	infectious	JJ
cord-005453-4057qib7	8296	12	complications	complication	NNS
cord-005453-4057qib7	8296	13	with	with	IN
cord-005453-4057qib7	8296	14	viral	viral	JJ
cord-005453-4057qib7	8296	15	infections	infection	NNS
cord-005453-4057qib7	8296	16	as	as	IN
cord-005453-4057qib7	8296	17	the	the	DT
cord-005453-4057qib7	8296	18	most	most	RBS
cord-005453-4057qib7	8296	19	frequent	frequent	JJ
cord-005453-4057qib7	8296	20	cause	cause	NN
cord-005453-4057qib7	8296	21	.	.	.
cord-005453-4057qib7	8297	1	Two	two	CD
cord-005453-4057qib7	8297	2	patients	patient	NNS
cord-005453-4057qib7	8297	3	had	have	VBD
cord-005453-4057qib7	8297	4	invasive	invasive	JJ
cord-005453-4057qib7	8297	5	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	8297	6	and	and	CC
cord-005453-4057qib7	8297	7	one	one	CD
cord-005453-4057qib7	8297	8	patient	patient	NN
cord-005453-4057qib7	8297	9	presented	present	VBN
cord-005453-4057qib7	8297	10	disseminated	disseminate	VBN
cord-005453-4057qib7	8297	11	tuberculosis	tuberculosis	NN
cord-005453-4057qib7	8297	12	.	.	.
cord-005453-4057qib7	8298	1	Causes	cause	NNS
cord-005453-4057qib7	8298	2	of	of	IN
cord-005453-4057qib7	8298	3	death	death	NN
cord-005453-4057qib7	8298	4	included	include	VBD
cord-005453-4057qib7	8298	5	infections	infection	NNS
cord-005453-4057qib7	8298	6	(	(	-LRB-
cord-005453-4057qib7	8298	7	50	50	CD
cord-005453-4057qib7	8298	8	%	%	NN
cord-005453-4057qib7	8298	9	)	)	-RRB-
cord-005453-4057qib7	8298	10	,	,	,
cord-005453-4057qib7	8298	11	relapse	relapse	NN
cord-005453-4057qib7	8298	12	(	(	-LRB-
cord-005453-4057qib7	8298	13	43	43	CD
cord-005453-4057qib7	8298	14	%	%	NN
cord-005453-4057qib7	8298	15	)	)	-RRB-
cord-005453-4057qib7	8298	16	and	and	CC
cord-005453-4057qib7	8298	17	toxicity	toxicity	NN
cord-005453-4057qib7	8298	18	(	(	-LRB-
cord-005453-4057qib7	8298	19	7	7	CD
cord-005453-4057qib7	8298	20	%	%	NN
cord-005453-4057qib7	8298	21	)	)	-RRB-
cord-005453-4057qib7	8298	22	.	.	.
cord-005453-4057qib7	8299	1	Among	among	IN
cord-005453-4057qib7	8299	2	the	the	DT
cord-005453-4057qib7	8299	3	6	6	CD
cord-005453-4057qib7	8299	4	patients	patient	NNS
cord-005453-4057qib7	8299	5	who	who	WP
cord-005453-4057qib7	8299	6	died	die	VBD
cord-005453-4057qib7	8299	7	due	due	IN
cord-005453-4057qib7	8299	8	to	to	IN
cord-005453-4057qib7	8299	9	infections	infection	NNS
cord-005453-4057qib7	8299	10	,	,	,
cord-005453-4057qib7	8299	11	3	3	CD
cord-005453-4057qib7	8299	12	had	have	VBD
cord-005453-4057qib7	8299	13	severe	severe	JJ
cord-005453-4057qib7	8299	14	chronic	chronic	JJ
cord-005453-4057qib7	8299	15	GVHD	GVHD	NNP
cord-005453-4057qib7	8299	16	and	and	CC
cord-005453-4057qib7	8299	17	were	be	VBD
cord-005453-4057qib7	8299	18	under	under	IN
cord-005453-4057qib7	8299	19	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	8299	20	therapy	therapy	NN
cord-005453-4057qib7	8299	21	.	.	.
cord-005453-4057qib7	8300	1	Two	two	CD
cord-005453-4057qib7	8300	2	patients	patient	NNS
cord-005453-4057qib7	8300	3	showed	show	VBD
cord-005453-4057qib7	8300	4	severe	severe	JJ
cord-005453-4057qib7	8300	5	toxicity	toxicity	NN
cord-005453-4057qib7	8300	6	related	relate	VBN
cord-005453-4057qib7	8300	7	to	to	IN
cord-005453-4057qib7	8300	8	drug	drug	NN
cord-005453-4057qib7	8300	9	interaction	interaction	NN
cord-005453-4057qib7	8300	10	with	with	IN
cord-005453-4057qib7	8300	11	anti	anti	JJ
cord-005453-4057qib7	8300	12	-	-	JJ
cord-005453-4057qib7	8300	13	retroviral	retroviral	JJ
cord-005453-4057qib7	8300	14	therapy	therapy	NN
cord-005453-4057qib7	8300	15	.	.	.
cord-005453-4057qib7	8301	1	All	all	DT
cord-005453-4057qib7	8301	2	survivors	survivor	NNS
cord-005453-4057qib7	8301	3	except	except	IN
cord-005453-4057qib7	8301	4	one	one	CD
cord-005453-4057qib7	8301	5	showed	show	VBD
cord-005453-4057qib7	8301	6	undetectable	undetectable	JJ
cord-005453-4057qib7	8301	7	HIV	HIV	NNP
cord-005453-4057qib7	8301	8	load	load	NN
cord-005453-4057qib7	8301	9	at	at	IN
cord-005453-4057qib7	8301	10	last	last	JJ
cord-005453-4057qib7	8301	11	follow	follow	NN
cord-005453-4057qib7	8301	12	-	-	HYPH
cord-005453-4057qib7	8301	13	up	up	NN
cord-005453-4057qib7	8301	14	after	after	IN
cord-005453-4057qib7	8301	15	HSCT	HSCT	NNP
cord-005453-4057qib7	8301	16	.	.	.
cord-005453-4057qib7	8302	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8302	2	:	:	:
cord-005453-4057qib7	8303	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	8303	2	HSCT	HSCT	NNP
cord-005453-4057qib7	8303	3	is	be	VBZ
cord-005453-4057qib7	8303	4	an	an	DT
cord-005453-4057qib7	8303	5	effective	effective	JJ
cord-005453-4057qib7	8303	6	therapy	therapy	NN
cord-005453-4057qib7	8303	7	for	for	IN
cord-005453-4057qib7	8303	8	high	high	JJ
cord-005453-4057qib7	8303	9	-	-	HYPH
cord-005453-4057qib7	8303	10	risk	risk	NN
cord-005453-4057qib7	8303	11	hematological	hematological	JJ
cord-005453-4057qib7	8303	12	malignancies	malignancy	NNS
cord-005453-4057qib7	8303	13	in	in	IN
cord-005453-4057qib7	8303	14	patients	patient	NNS
cord-005453-4057qib7	8303	15	with	with	IN
cord-005453-4057qib7	8303	16	HIV	HIV	NNP
cord-005453-4057qib7	8303	17	infection	infection	NN
cord-005453-4057qib7	8303	18	,	,	,
cord-005453-4057qib7	8303	19	providing	provide	VBG
cord-005453-4057qib7	8303	20	long	long	JJ
cord-005453-4057qib7	8303	21	-	-	HYPH
cord-005453-4057qib7	8303	22	term	term	NN
cord-005453-4057qib7	8303	23	disease	disease	NN
cord-005453-4057qib7	8303	24	free	free	JJ
cord-005453-4057qib7	8303	25	survival	survival	NN
cord-005453-4057qib7	8303	26	together	together	RB
cord-005453-4057qib7	8303	27	to	to	IN
cord-005453-4057qib7	8303	28	long	long	JJ
cord-005453-4057qib7	8303	29	-	-	HYPH
cord-005453-4057qib7	8303	30	term	term	NN
cord-005453-4057qib7	8303	31	HIV	HIV	NNP
cord-005453-4057qib7	8303	32	suppression	suppression	NN
cord-005453-4057qib7	8303	33	with	with	IN
cord-005453-4057qib7	8303	34	cART	cART	NNP
cord-005453-4057qib7	8303	35	.	.	.
cord-005453-4057qib7	8304	1	However	however	RB
cord-005453-4057qib7	8304	2	,	,	,
cord-005453-4057qib7	8304	3	drug	drug	NN
cord-005453-4057qib7	8304	4	interactions	interaction	NNS
cord-005453-4057qib7	8304	5	with	with	IN
cord-005453-4057qib7	8304	6	anti	anti	JJ
cord-005453-4057qib7	8304	7	-	-	JJ
cord-005453-4057qib7	8304	8	retroviral	retroviral	JJ
cord-005453-4057qib7	8304	9	agents	agent	NNS
cord-005453-4057qib7	8304	10	,	,	,
cord-005453-4057qib7	8304	11	occurrence	occurrence	NN
cord-005453-4057qib7	8304	12	of	of	IN
cord-005453-4057qib7	8304	13	GVHD	GVHD	NNP
cord-005453-4057qib7	8304	14	,	,	,
cord-005453-4057qib7	8304	15	and	and	CC
cord-005453-4057qib7	8304	16	frequent	frequent	JJ
cord-005453-4057qib7	8304	17	infectious	infectious	JJ
cord-005453-4057qib7	8304	18	complications	complication	NNS
cord-005453-4057qib7	8304	19	account	account	VBP
cord-005453-4057qib7	8304	20	for	for	IN
cord-005453-4057qib7	8304	21	a	a	DT
cord-005453-4057qib7	8304	22	complex	complex	JJ
cord-005453-4057qib7	8304	23	procedure	procedure	NN
cord-005453-4057qib7	8304	24	in	in	IN
cord-005453-4057qib7	8304	25	this	this	DT
cord-005453-4057qib7	8304	26	population	population	NN
cord-005453-4057qib7	8304	27	.	.	.
cord-005453-4057qib7	8305	1	Selected	select	VBN
cord-005453-4057qib7	8305	2	HIV	HIV	NNP
cord-005453-4057qib7	8305	3	-	-	HYPH
cord-005453-4057qib7	8305	4	infected	infect	VBN
cord-005453-4057qib7	8305	5	patients	patient	NNS
cord-005453-4057qib7	8305	6	with	with	IN
cord-005453-4057qib7	8305	7	hematological	hematological	JJ
cord-005453-4057qib7	8305	8	malignancies	malignancy	NNS
cord-005453-4057qib7	8305	9	should	should	MD
cord-005453-4057qib7	8305	10	be	be	VB
cord-005453-4057qib7	8305	11	considered	consider	VBN
cord-005453-4057qib7	8305	12	for	for	IN
cord-005453-4057qib7	8305	13	allo	allo	NN
cord-005453-4057qib7	8305	14	-	-	HYPH
cord-005453-4057qib7	8305	15	HSCT	HSCT	NNP
cord-005453-4057qib7	8305	16	when	when	WRB
cord-005453-4057qib7	8305	17	indicated	indicate	VBD
cord-005453-4057qib7	8305	18	,	,	,
cord-005453-4057qib7	8305	19	in	in	IN
cord-005453-4057qib7	8305	20	experienced	experienced	JJ
cord-005453-4057qib7	8305	21	centers	center	NNS
cord-005453-4057qib7	8305	22	,	,	,
cord-005453-4057qib7	8305	23	with	with	IN
cord-005453-4057qib7	8305	24	a	a	DT
cord-005453-4057qib7	8305	25	multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	8305	26	care	care	NN
cord-005453-4057qib7	8305	27	.	.	.
cord-005453-4057qib7	8306	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8306	2	Background	background	NN
cord-005453-4057qib7	8306	3	:	:	:
cord-005453-4057qib7	8306	4	Primary	primary	JJ
cord-005453-4057qib7	8306	5	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	8306	6	(	(	-LRB-
cord-005453-4057qib7	8306	7	PID	PID	NNP
cord-005453-4057qib7	8306	8	)	)	-RRB-
cord-005453-4057qib7	8306	9	are	be	VBP
cord-005453-4057qib7	8306	10	rare	rare	JJ
cord-005453-4057qib7	8306	11	diseases	disease	NNS
cord-005453-4057qib7	8306	12	often	often	RB
cord-005453-4057qib7	8306	13	associated	associate	VBN
cord-005453-4057qib7	8306	14	with	with	IN
cord-005453-4057qib7	8306	15	genetic	genetic	JJ
cord-005453-4057qib7	8306	16	defects	defect	NNS
cord-005453-4057qib7	8306	17	in	in	IN
cord-005453-4057qib7	8306	18	the	the	DT
cord-005453-4057qib7	8306	19	immune	immune	JJ
cord-005453-4057qib7	8306	20	system	system	NN
cord-005453-4057qib7	8306	21	,	,	,
cord-005453-4057qib7	8306	22	predisposing	predispose	VBG
cord-005453-4057qib7	8306	23	individuals	individual	NNS
cord-005453-4057qib7	8306	24	to	to	IN
cord-005453-4057qib7	8306	25	recurrent	recurrent	JJ
cord-005453-4057qib7	8306	26	infections	infection	NNS
cord-005453-4057qib7	8306	27	and	and	CC
cord-005453-4057qib7	8306	28	increased	increase	VBN
cord-005453-4057qib7	8306	29	risk	risk	NN
cord-005453-4057qib7	8306	30	of	of	IN
cord-005453-4057qib7	8306	31	allergy	allergy	NN
cord-005453-4057qib7	8306	32	,	,	,
cord-005453-4057qib7	8306	33	autoimmunity	autoimmunity	NN
cord-005453-4057qib7	8306	34	and	and	CC
cord-005453-4057qib7	8306	35	malignancy	malignancy	NN
cord-005453-4057qib7	8306	36	.	.	.
cord-005453-4057qib7	8307	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	8307	2	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	8307	3	stem	stem	NN
cord-005453-4057qib7	8307	4	cell	cell	NN
cord-005453-4057qib7	8307	5	transplantation	transplantation	NN
cord-005453-4057qib7	8307	6	(	(	-LRB-
cord-005453-4057qib7	8307	7	HSCT	HSCT	NNP
cord-005453-4057qib7	8307	8	)	)	-RRB-
cord-005453-4057qib7	8307	9	has	have	VBZ
cord-005453-4057qib7	8307	10	been	be	VBN
cord-005453-4057qib7	8307	11	successfully	successfully	RB
cord-005453-4057qib7	8307	12	used	use	VBN
cord-005453-4057qib7	8307	13	as	as	IN
cord-005453-4057qib7	8307	14	a	a	DT
cord-005453-4057qib7	8307	15	curative	curative	JJ
cord-005453-4057qib7	8307	16	therapy	therapy	NN
cord-005453-4057qib7	8307	17	for	for	IN
cord-005453-4057qib7	8307	18	most	most	JJS
cord-005453-4057qib7	8307	19	severe	severe	JJ
cord-005453-4057qib7	8307	20	forms	form	NNS
cord-005453-4057qib7	8307	21	of	of	IN
cord-005453-4057qib7	8307	22	PID	PID	NNP
cord-005453-4057qib7	8307	23	.	.	.
cord-005453-4057qib7	8308	1	Because	because	IN
cord-005453-4057qib7	8308	2	PID	PID	NNP
cord-005453-4057qib7	8308	3	is	be	VBZ
cord-005453-4057qib7	8308	4	a	a	DT
cord-005453-4057qib7	8308	5	genetic	genetic	JJ
cord-005453-4057qib7	8308	6	disease	disease	NN
cord-005453-4057qib7	8308	7	,	,	,
cord-005453-4057qib7	8308	8	<	<	XX
cord-005453-4057qib7	8308	9	25	25	CD
cord-005453-4057qib7	8308	10	%	%	NN
cord-005453-4057qib7	8308	11	of	of	IN
cord-005453-4057qib7	8308	12	these	these	DT
cord-005453-4057qib7	8308	13	children	child	NNS
cord-005453-4057qib7	8308	14	will	will	MD
cord-005453-4057qib7	8308	15	have	have	VB
cord-005453-4057qib7	8308	16	a	a	DT
cord-005453-4057qib7	8308	17	healthy	healthy	JJ
cord-005453-4057qib7	8308	18	,	,	,
cord-005453-4057qib7	8308	19	human	human	JJ
cord-005453-4057qib7	8308	20	leukocyte	leukocyte	NN
cord-005453-4057qib7	8308	21	antigen	antigen	NN
cord-005453-4057qib7	8308	22	(	(	-LRB-
cord-005453-4057qib7	8308	23	HLA	HLA	NNP
cord-005453-4057qib7	8308	24	)	)	-RRB-
cord-005453-4057qib7	8308	25	matched	match	VBD
cord-005453-4057qib7	8308	26	sibling	sibling	NN
cord-005453-4057qib7	8308	27	donor	donor	NN
cord-005453-4057qib7	8308	28	available	available	JJ
cord-005453-4057qib7	8308	29	,	,	,
cord-005453-4057qib7	8308	30	and	and	CC
cord-005453-4057qib7	8308	31	umbilical	umbilical	JJ
cord-005453-4057qib7	8308	32	cord	cord	NN
cord-005453-4057qib7	8308	33	blood	blood	NN
cord-005453-4057qib7	8308	34	grafts	graft	NNS
cord-005453-4057qib7	8308	35	from	from	IN
cord-005453-4057qib7	8308	36	unrelated	unrelated	JJ
cord-005453-4057qib7	8308	37	donors	donor	NNS
cord-005453-4057qib7	8308	38	are	be	VBP
cord-005453-4057qib7	8308	39	a	a	DT
cord-005453-4057qib7	8308	40	suitable	suitable	JJ
cord-005453-4057qib7	8308	41	alternative	alternative	JJ
cord-005453-4057qib7	8308	42	cell	cell	NN
cord-005453-4057qib7	8308	43	source	source	NN
cord-005453-4057qib7	8308	44	.	.	.
cord-005453-4057qib7	8309	1	We	-PRON-	PRP
cord-005453-4057qib7	8309	2	report	report	VBP
cord-005453-4057qib7	8309	3	the	the	DT
cord-005453-4057qib7	8309	4	results	result	NNS
cord-005453-4057qib7	8309	5	of	of	IN
cord-005453-4057qib7	8309	6	umbilical	umbilical	JJ
cord-005453-4057qib7	8309	7	cord	cord	NN
cord-005453-4057qib7	8309	8	blood	blood	NN
cord-005453-4057qib7	8309	9	transplantation	transplantation	NN
cord-005453-4057qib7	8309	10	(	(	-LRB-
cord-005453-4057qib7	8309	11	UCBT	UCBT	NNP
cord-005453-4057qib7	8309	12	)	)	-RRB-
cord-005453-4057qib7	8309	13	performed	perform	VBD
cord-005453-4057qib7	8309	14	in	in	IN
cord-005453-4057qib7	8309	15	112	112	CD
cord-005453-4057qib7	8309	16	patients	patient	NNS
cord-005453-4057qib7	8309	17	with	with	IN
cord-005453-4057qib7	8309	18	PID	PID	NNP
cord-005453-4057qib7	8309	19	between	between	IN
cord-005453-4057qib7	8309	20	2014	2014	CD
cord-005453-4057qib7	8309	21	and	and	CC
cord-005453-4057qib7	8309	22	2018	2018	CD
cord-005453-4057qib7	8309	23	at	at	IN
cord-005453-4057qib7	8309	24	Children	Children	NNP
cord-005453-4057qib7	8309	25	's	's	POS
cord-005453-4057qib7	8309	26	Hospital	Hospital	NNP
cord-005453-4057qib7	8309	27	of	of	IN
cord-005453-4057qib7	8309	28	Fudan	Fudan	NNP
cord-005453-4057qib7	8309	29	University	University	NNP
cord-005453-4057qib7	8309	30	in	in	IN
cord-005453-4057qib7	8309	31	China	China	NNP
cord-005453-4057qib7	8309	32	.	.	.
cord-005453-4057qib7	8310	1	Methods	method	NNS
cord-005453-4057qib7	8310	2	:	:	:
cord-005453-4057qib7	8310	3	112	112	CD
cord-005453-4057qib7	8310	4	patients	patient	NNS
cord-005453-4057qib7	8310	5	included	include	VBD
cord-005453-4057qib7	8310	6	chronic	chronic	JJ
cord-005453-4057qib7	8310	7	granulomatous	granulomatous	JJ
cord-005453-4057qib7	8310	8	disease	disease	NN
cord-005453-4057qib7	8310	9	(	(	-LRB-
cord-005453-4057qib7	8310	10	CGD	CGD	NNP
cord-005453-4057qib7	8310	11	,	,	,
cord-005453-4057qib7	8310	12	n=39	n=39	NNP
cord-005453-4057qib7	8310	13	)	)	-RRB-
cord-005453-4057qib7	8310	14	,	,	,
cord-005453-4057qib7	8310	15	severe	severe	JJ
cord-005453-4057qib7	8310	16	combined	combine	VBN
cord-005453-4057qib7	8310	17	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8310	18	(	(	-LRB-
cord-005453-4057qib7	8310	19	SCID	SCID	NNP
cord-005453-4057qib7	8310	20	,	,	,
cord-005453-4057qib7	8310	21	n=23	n=23	NNP
cord-005453-4057qib7	8310	22	)	)	-RRB-
cord-005453-4057qib7	8310	23	,	,	.
cord-005453-4057qib7	8311	1	interleukin-10	interleukin-10	NNP
cord-005453-4057qib7	8311	2	receptor	receptor	NN
cord-005453-4057qib7	8311	3	-	-	:
cord-005453-4057qib7	8311	4	a	a	DT
cord-005453-4057qib7	8311	5	deficiency	deficiency	NN
cord-005453-4057qib7	8311	6	(	(	-LRB-
cord-005453-4057qib7	8311	7	IL-10RaD	IL-10RaD	NNP
cord-005453-4057qib7	8311	8	,	,	,
cord-005453-4057qib7	8311	9	n=27	n=27	NNP
cord-005453-4057qib7	8311	10	)	)	-RRB-
cord-005453-4057qib7	8312	1	,	,	,
cord-005453-4057qib7	8312	2	Wiskott	Wiskott	NNP
cord-005453-4057qib7	8312	3	-	-	HYPH
cord-005453-4057qib7	8312	4	Aldrich	Aldrich	NNP
cord-005453-4057qib7	8312	5	syndrome	syndrome	NN
cord-005453-4057qib7	8312	6	(	(	-LRB-
cord-005453-4057qib7	8312	7	WAS	be	VBD
cord-005453-4057qib7	8312	8	,	,	,
cord-005453-4057qib7	8312	9	n=7	n=7	NNS
cord-005453-4057qib7	8312	10	)	)	-RRB-
cord-005453-4057qib7	8312	11	,	,	,
cord-005453-4057qib7	8312	12	leukocyte	leukocyte	NN
cord-005453-4057qib7	8312	13	adhesion	adhesion	NN
cord-005453-4057qib7	8312	14	deficiency	deficiency	NN
cord-005453-4057qib7	8312	15	(	(	-LRB-
cord-005453-4057qib7	8312	16	LAD	lad	NN
cord-005453-4057qib7	8312	17	,	,	,
cord-005453-4057qib7	8312	18	n=5	n=5	JJ
cord-005453-4057qib7	8312	19	)	)	-RRB-
cord-005453-4057qib7	8312	20	,	,	,
cord-005453-4057qib7	8312	21	severe	severe	JJ
cord-005453-4057qib7	8312	22	congenital	congenital	JJ
cord-005453-4057qib7	8312	23	neutropaenia	neutropaenia	NNS
cord-005453-4057qib7	8312	24	(	(	-LRB-
cord-005453-4057qib7	8312	25	SCN	SCN	NNP
cord-005453-4057qib7	8312	26	,	,	,
cord-005453-4057qib7	8312	27	n=3	n=3	NN
cord-005453-4057qib7	8312	28	)	)	-RRB-
cord-005453-4057qib7	8312	29	and	and	CC
cord-005453-4057qib7	8312	30	other	other	JJ
cord-005453-4057qib7	8312	31	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	8312	32	(	(	-LRB-
cord-005453-4057qib7	8312	33	n=8	n=8	NN
cord-005453-4057qib7	8312	34	)	)	-RRB-
cord-005453-4057qib7	8312	35	.	.	.
cord-005453-4057qib7	8313	1	All	all	DT
cord-005453-4057qib7	8313	2	patients	patient	NNS
cord-005453-4057qib7	8313	3	were	be	VBD
cord-005453-4057qib7	8313	4	assessed	assess	VBN
cord-005453-4057qib7	8313	5	by	by	IN
cord-005453-4057qib7	8313	6	clinical	clinical	JJ
cord-005453-4057qib7	8313	7	immunologist	immunologist	NN
cord-005453-4057qib7	8313	8	to	to	TO
cord-005453-4057qib7	8313	9	confirm	confirm	VB
cord-005453-4057qib7	8313	10	clinical	clinical	JJ
cord-005453-4057qib7	8313	11	phenotype	phenotype	NN
cord-005453-4057qib7	8313	12	and	and	CC
cord-005453-4057qib7	8313	13	genetic	genetic	JJ
cord-005453-4057qib7	8313	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	8313	15	.	.	.
cord-005453-4057qib7	8314	1	Median	median	JJ
cord-005453-4057qib7	8314	2	age	age	NN
cord-005453-4057qib7	8314	3	of	of	IN
cord-005453-4057qib7	8314	4	112	112	CD
cord-005453-4057qib7	8314	5	patients	patient	NNS
cord-005453-4057qib7	8314	6	was	be	VBD
cord-005453-4057qib7	8314	7	13	13	CD
cord-005453-4057qib7	8314	8	months	month	NNS
cord-005453-4057qib7	8314	9	(	(	-LRB-
cord-005453-4057qib7	8314	10	range	range	NN
cord-005453-4057qib7	8314	11	,	,	,
cord-005453-4057qib7	8314	12	2	2	CD
cord-005453-4057qib7	8314	13	to	to	TO
cord-005453-4057qib7	8314	14	144	144	CD
cord-005453-4057qib7	8314	15	months	month	NNS
cord-005453-4057qib7	8314	16	)	)	-RRB-
cord-005453-4057qib7	8314	17	,	,	,
cord-005453-4057qib7	8314	18	and	and	CC
cord-005453-4057qib7	8314	19	median	median	JJ
cord-005453-4057qib7	8314	20	body	body	NN
cord-005453-4057qib7	8314	21	weight	weight	NN
cord-005453-4057qib7	8314	22	was	be	VBD
cord-005453-4057qib7	8314	23	8.75	8.75	CD
cord-005453-4057qib7	8314	24	kg	kg	NN
cord-005453-4057qib7	8314	25	(	(	-LRB-
cord-005453-4057qib7	8314	26	range	range	NN
cord-005453-4057qib7	8314	27	,	,	,
cord-005453-4057qib7	8314	28	3.2	3.2	CD
cord-005453-4057qib7	8314	29	to	to	IN
cord-005453-4057qib7	8314	30	36	36	CD
cord-005453-4057qib7	8314	31	kg	kg	NNS
cord-005453-4057qib7	8314	32	)	)	-RRB-
cord-005453-4057qib7	8314	33	.	.	.
cord-005453-4057qib7	8315	1	All	all	DT
cord-005453-4057qib7	8315	2	patients	patient	NNS
cord-005453-4057qib7	8315	3	received	receive	VBD
cord-005453-4057qib7	8315	4	a	a	DT
cord-005453-4057qib7	8315	5	≤3/10	≤3/10	NNP
cord-005453-4057qib7	8315	6	HLA	HLA	NNP
cord-005453-4057qib7	8315	7	alleles	allele	NNS
cord-005453-4057qib7	8315	8	-	-	HYPH
cord-005453-4057qib7	8315	9	mismatched	mismatch	VBN
cord-005453-4057qib7	8315	10	cord	cord	NN
cord-005453-4057qib7	8315	11	blood	blood	NN
cord-005453-4057qib7	8315	12	unit	unit	NN
cord-005453-4057qib7	8315	13	,	,	,
cord-005453-4057qib7	8315	14	16	16	CD
cord-005453-4057qib7	8315	15	were	be	VBD
cord-005453-4057qib7	8315	16	HLA	HLA	NNP
cord-005453-4057qib7	8315	17	fully	fully	RB
cord-005453-4057qib7	8315	18	matched	match	VBN
cord-005453-4057qib7	8315	19	,	,	,
cord-005453-4057qib7	8315	20	28	28	CD
cord-005453-4057qib7	8315	21	were	be	VBD
cord-005453-4057qib7	8315	22	9/10	9/10	CD
cord-005453-4057qib7	8315	23	matched	match	VBN
cord-005453-4057qib7	8315	24	,	,	,
cord-005453-4057qib7	8315	25	49	49	CD
cord-005453-4057qib7	8315	26	were	be	VBD
cord-005453-4057qib7	8315	27	8/10	8/10	CD
cord-005453-4057qib7	8315	28	matched	match	VBN
cord-005453-4057qib7	8315	29	and	and	CC
cord-005453-4057qib7	8315	30	19	19	CD
cord-005453-4057qib7	8315	31	were	be	VBD
cord-005453-4057qib7	8315	32	7/10	7/10	CD
cord-005453-4057qib7	8315	33	matched	match	VBN
cord-005453-4057qib7	8315	34	.	.	.
cord-005453-4057qib7	8316	1	Median	median	JJ
cord-005453-4057qib7	8316	2	nucleated	nucleated	JJ
cord-005453-4057qib7	8316	3	cells	cell	NNS
cord-005453-4057qib7	8316	4	of	of	IN
cord-005453-4057qib7	8316	5	the	the	DT
cord-005453-4057qib7	8316	6	cord	cord	NN
cord-005453-4057qib7	8316	7	blood	blood	NN
cord-005453-4057qib7	8316	8	were	be	VBD
cord-005453-4057qib7	8316	9	14.23x10	14.23x10	CD
cord-005453-4057qib7	8316	10	7	7	CD
cord-005453-4057qib7	8317	1	/kg	/kg	.
cord-005453-4057qib7	8318	1	(	(	-LRB-
cord-005453-4057qib7	8318	2	range	range	NN
cord-005453-4057qib7	8318	3	,	,	,
cord-005453-4057qib7	8318	4	3.55	3.55	CD
cord-005453-4057qib7	8318	5	to	to	IN
cord-005453-4057qib7	8318	6	51.5	51.5	CD
cord-005453-4057qib7	8318	7	x10	x10	CD
cord-005453-4057qib7	8318	8	7	7	CD
cord-005453-4057qib7	8318	9	/kg	/kg	.
cord-005453-4057qib7	8318	10	)	)	-RRB-
cord-005453-4057qib7	8318	11	,	,	,
cord-005453-4057qib7	8318	12	and	and	CC
cord-005453-4057qib7	8318	13	median	median	JJ
cord-005453-4057qib7	8318	14	CD34	CD34	NNP
cord-005453-4057qib7	8318	15	+	+	CC
cord-005453-4057qib7	8318	16	cells	cell	NNS
cord-005453-4057qib7	8318	17	were	be	VBD
cord-005453-4057qib7	8318	18	3.86	3.86	CD
cord-005453-4057qib7	8318	19	x10	x10	CD
cord-005453-4057qib7	8318	20	5	5	CD
cord-005453-4057qib7	8319	1	/kg	/kg	.
cord-005453-4057qib7	8320	1	(	(	-LRB-
cord-005453-4057qib7	8320	2	range	range	NN
cord-005453-4057qib7	8320	3	,	,	,
cord-005453-4057qib7	8320	4	0.73	0.73	CD
cord-005453-4057qib7	8320	5	to	to	IN
cord-005453-4057qib7	8320	6	30.27	30.27	CD
cord-005453-4057qib7	8320	7	x10	x10	CD
cord-005453-4057qib7	8320	8	5	5	CD
cord-005453-4057qib7	8320	9	/kg	/kg	NFP
cord-005453-4057qib7	8320	10	)	)	-RRB-
cord-005453-4057qib7	8320	11	.	.	.
cord-005453-4057qib7	8321	1	Results	result	NNS
cord-005453-4057qib7	8321	2	:	:	:
cord-005453-4057qib7	8322	1	Median	median	JJ
cord-005453-4057qib7	8322	2	follow	follow	NN
cord-005453-4057qib7	8322	3	-	-	HYPH
cord-005453-4057qib7	8322	4	up	up	RP
cord-005453-4057qib7	8322	5	time	time	NN
cord-005453-4057qib7	8322	6	was	be	VBD
cord-005453-4057qib7	8322	7	13	13	CD
cord-005453-4057qib7	8322	8	months	month	NNS
cord-005453-4057qib7	8322	9	(	(	-LRB-
cord-005453-4057qib7	8322	10	range	range	NN
cord-005453-4057qib7	8322	11	,	,	,
cord-005453-4057qib7	8322	12	1	1	CD
cord-005453-4057qib7	8322	13	to	to	TO
cord-005453-4057qib7	8322	14	57	57	CD
cord-005453-4057qib7	8322	15	months	month	NNS
cord-005453-4057qib7	8322	16	)	)	-RRB-
cord-005453-4057qib7	8322	17	,	,	,
cord-005453-4057qib7	8322	18	the	the	DT
cord-005453-4057qib7	8322	19	overall	overall	JJ
cord-005453-4057qib7	8322	20	survival	survival	NN
cord-005453-4057qib7	8322	21	rate	rate	NN
cord-005453-4057qib7	8322	22	at	at	IN
cord-005453-4057qib7	8322	23	1	1	CD
cord-005453-4057qib7	8322	24	year	year	NN
cord-005453-4057qib7	8322	25	for	for	IN
cord-005453-4057qib7	8322	26	all	all	DT
cord-005453-4057qib7	8322	27	patients	patient	NNS
cord-005453-4057qib7	8322	28	was	be	VBD
cord-005453-4057qib7	8322	29	74.6	74.6	CD
cord-005453-4057qib7	8322	30	%	%	NN
cord-005453-4057qib7	8322	31	,	,	,
cord-005453-4057qib7	8322	32	and	and	CC
cord-005453-4057qib7	8322	33	was	be	VBD
cord-005453-4057qib7	8322	34	83.7	83.7	CD
cord-005453-4057qib7	8322	35	%	%	NN
cord-005453-4057qib7	8322	36	,	,	,
cord-005453-4057qib7	8322	37	78.3	78.3	CD
cord-005453-4057qib7	8322	38	%	%	NN
cord-005453-4057qib7	8322	39	and	and	CC
cord-005453-4057qib7	8322	40	60	60	CD
cord-005453-4057qib7	8322	41	%	%	NN
cord-005453-4057qib7	8322	42	for	for	IN
cord-005453-4057qib7	8322	43	CGD	CGD	NNP
cord-005453-4057qib7	8322	44	,	,	,
cord-005453-4057qib7	8322	45	SCID	SCID	NNP
cord-005453-4057qib7	8322	46	and	and	CC
cord-005453-4057qib7	8322	47	IL-10RaD	IL-10RaD	NNP
cord-005453-4057qib7	8322	48	,	,	,
cord-005453-4057qib7	8322	49	respectively	respectively	RB
cord-005453-4057qib7	8322	50	.	.	.
cord-005453-4057qib7	8323	1	27	27	CD
cord-005453-4057qib7	8323	2	patients	patient	NNS
cord-005453-4057qib7	8323	3	died	die	VBD
cord-005453-4057qib7	8323	4	,	,	,
cord-005453-4057qib7	8323	5	Most	Most	JJS
cord-005453-4057qib7	8323	6	deaths	death	NNS
cord-005453-4057qib7	8323	7	(	(	-LRB-
cord-005453-4057qib7	8323	8	19/27	19/27	CD
cord-005453-4057qib7	8323	9	,	,	,
cord-005453-4057qib7	8323	10	70.4	70.4	CD
cord-005453-4057qib7	8323	11	%	%	NN
cord-005453-4057qib7	8323	12	)	)	-RRB-
cord-005453-4057qib7	8323	13	occurred	occur	VBD
cord-005453-4057qib7	8323	14	in	in	IN
cord-005453-4057qib7	8323	15	+100	+100	NNP
cord-005453-4057qib7	8323	16	days	day	NNS
cord-005453-4057qib7	8323	17	after	after	IN
cord-005453-4057qib7	8323	18	transplantation	transplantation	NN
cord-005453-4057qib7	8323	19	,	,	,
cord-005453-4057qib7	8323	20	the	the	DT
cord-005453-4057qib7	8323	21	main	main	JJ
cord-005453-4057qib7	8323	22	cause	cause	NN
cord-005453-4057qib7	8323	23	of	of	IN
cord-005453-4057qib7	8323	24	death	death	NN
cord-005453-4057qib7	8323	25	was	be	VBD
cord-005453-4057qib7	8323	26	infection	infection	NN
cord-005453-4057qib7	8323	27	(	(	-LRB-
cord-005453-4057qib7	8323	28	24/	24/	CD
cord-005453-4057qib7	8323	29	27	27	CD
cord-005453-4057qib7	8323	30	,	,	,
cord-005453-4057qib7	8323	31	88.9	88.9	CD
cord-005453-4057qib7	8323	32	%	%	NN
cord-005453-4057qib7	8323	33	)	)	-RRB-
cord-005453-4057qib7	8323	34	.	.	.
cord-005453-4057qib7	8324	1	87/112	87/112	CD
cord-005453-4057qib7	8324	2	(	(	-LRB-
cord-005453-4057qib7	8324	3	77.7	77.7	CD
cord-005453-4057qib7	8324	4	%	%	NN
cord-005453-4057qib7	8324	5	)	)	-RRB-
cord-005453-4057qib7	8325	1	patients	patient	NNS
cord-005453-4057qib7	8325	2	engrafted	engraft	VBN
cord-005453-4057qib7	8325	3	,	,	,
cord-005453-4057qib7	8325	4	median	median	JJ
cord-005453-4057qib7	8325	5	time	time	NN
cord-005453-4057qib7	8325	6	of	of	IN
cord-005453-4057qib7	8325	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	8325	8	engraftment	engraftment	NN
cord-005453-4057qib7	8325	9	was	be	VBD
cord-005453-4057qib7	8325	10	24	24	CD
cord-005453-4057qib7	8325	11	days	day	NNS
cord-005453-4057qib7	8325	12	(	(	-LRB-
cord-005453-4057qib7	8325	13	range	range	NN
cord-005453-4057qib7	8325	14	,	,	,
cord-005453-4057qib7	8325	15	11	11	CD
cord-005453-4057qib7	8325	16	to	to	TO
cord-005453-4057qib7	8325	17	60	60	CD
cord-005453-4057qib7	8325	18	d	d	NN
cord-005453-4057qib7	8325	19	)	)	-RRB-
cord-005453-4057qib7	8325	20	,	,	,
cord-005453-4057qib7	8325	21	and	and	CC
cord-005453-4057qib7	8325	22	median	median	JJ
cord-005453-4057qib7	8325	23	time	time	NN
cord-005453-4057qib7	8325	24	of	of	IN
cord-005453-4057qib7	8325	25	platelet	platelet	NN
cord-005453-4057qib7	8325	26	engraftment	engraftment	NN
cord-005453-4057qib7	8325	27	was	be	VBD
cord-005453-4057qib7	8325	28	36	36	CD
cord-005453-4057qib7	8325	29	days	day	NNS
cord-005453-4057qib7	8325	30	(	(	-LRB-
cord-005453-4057qib7	8325	31	range	range	NN
cord-005453-4057qib7	8325	32	,	,	,
cord-005453-4057qib7	8325	33	9	9	CD
cord-005453-4057qib7	8325	34	to	to	TO
cord-005453-4057qib7	8325	35	59	59	CD
cord-005453-4057qib7	8325	36	d	d	NN
cord-005453-4057qib7	8325	37	)	)	-RRB-
cord-005453-4057qib7	8325	38	.	.	.
cord-005453-4057qib7	8326	1	The	the	DT
cord-005453-4057qib7	8326	2	cumulative	cumulative	JJ
cord-005453-4057qib7	8326	3	incidence	incidence	NN
cord-005453-4057qib7	8326	4	of	of	IN
cord-005453-4057qib7	8326	5	grade	grade	NN
cord-005453-4057qib7	8326	6	3	3	CD
cord-005453-4057qib7	8326	7	-	-	SYM
cord-005453-4057qib7	8326	8	4	4	CD
cord-005453-4057qib7	8326	9	acute	acute	JJ
cord-005453-4057qib7	8326	10	GVHD	GVHD	NNP
cord-005453-4057qib7	8326	11	was	be	VBD
cord-005453-4057qib7	8326	12	8.9	8.9	CD
cord-005453-4057qib7	8326	13	%	%	NN
cord-005453-4057qib7	8326	14	,	,	,
cord-005453-4057qib7	8326	15	and	and	CC
cord-005453-4057qib7	8326	16	that	that	DT
cord-005453-4057qib7	8326	17	of	of	IN
cord-005453-4057qib7	8326	18	chronic	chronic	JJ
cord-005453-4057qib7	8326	19	GVHD	GVHD	NNP
cord-005453-4057qib7	8326	20	was	be	VBD
cord-005453-4057qib7	8326	21	10.7	10.7	CD
cord-005453-4057qib7	8326	22	%	%	NN
cord-005453-4057qib7	8326	23	.	.	.
cord-005453-4057qib7	8327	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8327	2	:	:	:
cord-005453-4057qib7	8328	1	Unrelated	unrelated	JJ
cord-005453-4057qib7	8328	2	UCBT	UCBT	NNS
cord-005453-4057qib7	8328	3	should	should	MD
cord-005453-4057qib7	8328	4	be	be	VB
cord-005453-4057qib7	8328	5	considered	consider	VBN
cord-005453-4057qib7	8328	6	for	for	IN
cord-005453-4057qib7	8328	7	PID	PID	NNP
cord-005453-4057qib7	8328	8	patients	patient	NNS
cord-005453-4057qib7	8328	9	without	without	IN
cord-005453-4057qib7	8328	10	an	an	DT
cord-005453-4057qib7	8328	11	HLA	HLA	NNP
cord-005453-4057qib7	8328	12	-matched	-matched	JJ
cord-005453-4057qib7	8328	13	sibling	sibling	NN
cord-005453-4057qib7	8328	14	donor	donor	NN
cord-005453-4057qib7	8328	15	.	.	.
cord-005453-4057qib7	8329	1	Effective	effective	JJ
cord-005453-4057qib7	8329	2	control	control	NN
cord-005453-4057qib7	8329	3	of	of	IN
cord-005453-4057qib7	8329	4	infection	infection	NN
cord-005453-4057qib7	8329	5	before	before	RB
cord-005453-4057qib7	8329	6	and	and	CC
cord-005453-4057qib7	8330	1	after	after	IN
cord-005453-4057qib7	8330	2	transplantation	transplantation	NN
cord-005453-4057qib7	8330	3	is	be	VBZ
cord-005453-4057qib7	8330	4	important	important	JJ
cord-005453-4057qib7	8330	5	for	for	IN
cord-005453-4057qib7	8330	6	improving	improve	VBG
cord-005453-4057qib7	8330	7	survival	survival	NN
cord-005453-4057qib7	8330	8	.	.	.
cord-005453-4057qib7	8331	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8331	2	Background	background	NN
cord-005453-4057qib7	8331	3	:	:	:
cord-005453-4057qib7	8331	4	Dedicator	Dedicator	NNP
cord-005453-4057qib7	8331	5	of	of	IN
cord-005453-4057qib7	8331	6	cytokinesis	cytokinesis	NN
cord-005453-4057qib7	8332	1	(	(	-LRB-
cord-005453-4057qib7	8332	2	Dock	Dock	NNP
cord-005453-4057qib7	8332	3	8)	8)	NN
cord-005453-4057qib7	8332	4	deficiency	deficiency	NN
cord-005453-4057qib7	8332	5	causes	cause	VBZ
cord-005453-4057qib7	8332	6	a	a	DT
cord-005453-4057qib7	8332	7	combined	combine	VBN
cord-005453-4057qib7	8332	8	immune	immune	JJ
cord-005453-4057qib7	8332	9	deficiency	deficiency	NN
cord-005453-4057qib7	8332	10	characterised	characterise	VBN
cord-005453-4057qib7	8332	11	by	by	IN
cord-005453-4057qib7	8332	12	recurrent	recurrent	JJ
cord-005453-4057qib7	8332	13	bacterial	bacterial	JJ
cord-005453-4057qib7	8332	14	infections	infection	NNS
cord-005453-4057qib7	8332	15	,	,	,
cord-005453-4057qib7	8332	16	susceptibility	susceptibility	NN
cord-005453-4057qib7	8332	17	to	to	IN
cord-005453-4057qib7	8332	18	viral	viral	JJ
cord-005453-4057qib7	8332	19	infection	infection	NN
cord-005453-4057qib7	8332	20	,	,	,
cord-005453-4057qib7	8332	21	eczema	eczema	NN
cord-005453-4057qib7	8332	22	,	,	,
cord-005453-4057qib7	8332	23	food	food	NN
cord-005453-4057qib7	8332	24	allergies	allergy	NNS
cord-005453-4057qib7	8332	25	,	,	,
cord-005453-4057qib7	8332	26	vasculitis	vasculitis	NN
cord-005453-4057qib7	8332	27	and	and	CC
cord-005453-4057qib7	8332	28	increased	increase	VBN
cord-005453-4057qib7	8332	29	risk	risk	NN
cord-005453-4057qib7	8332	30	of	of	IN
cord-005453-4057qib7	8332	31	malignancy	malignancy	NN
cord-005453-4057qib7	8332	32	.	.	.
cord-005453-4057qib7	8333	1	Due	due	IN
cord-005453-4057qib7	8333	2	to	to	IN
cord-005453-4057qib7	8333	3	the	the	DT
cord-005453-4057qib7	8333	4	high	high	JJ
cord-005453-4057qib7	8333	5	morbidity	morbidity	NN
cord-005453-4057qib7	8333	6	and	and	CC
cord-005453-4057qib7	8333	7	mortality	mortality	NN
cord-005453-4057qib7	8333	8	of	of	IN
cord-005453-4057qib7	8333	9	the	the	DT
cord-005453-4057qib7	8333	10	disease	disease	NN
cord-005453-4057qib7	8333	11	HSCT	HSCT	NNP
cord-005453-4057qib7	8333	12	has	have	VBZ
cord-005453-4057qib7	8333	13	been	be	VBN
cord-005453-4057qib7	8333	14	increasingly	increasingly	RB
cord-005453-4057qib7	8333	15	offered	offer	VBN
cord-005453-4057qib7	8333	16	to	to	IN
cord-005453-4057qib7	8333	17	patients	patient	NNS
cord-005453-4057qib7	8333	18	as	as	IN
cord-005453-4057qib7	8333	19	a	a	DT
cord-005453-4057qib7	8333	20	potentially	potentially	RB
cord-005453-4057qib7	8333	21	curative	curative	JJ
cord-005453-4057qib7	8333	22	therapy	therapy	NN
cord-005453-4057qib7	8333	23	1	1	CD
cord-005453-4057qib7	8333	24	.	.	.
cord-005453-4057qib7	8334	1	Methods	method	NNS
cord-005453-4057qib7	8334	2	:	:	:
cord-005453-4057qib7	8334	3	We	-PRON-	PRP
cord-005453-4057qib7	8334	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	8334	5	reviewed	review	VBD
cord-005453-4057qib7	8334	6	the	the	DT
cord-005453-4057qib7	8334	7	outcomes	outcome	NNS
cord-005453-4057qib7	8334	8	of	of	IN
cord-005453-4057qib7	8334	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8334	10	for	for	IN
cord-005453-4057qib7	8334	11	patients	patient	NNS
cord-005453-4057qib7	8334	12	with	with	IN
cord-005453-4057qib7	8334	13	Dock	Dock	NNP
cord-005453-4057qib7	8334	14	8	8	CD
cord-005453-4057qib7	8334	15	deficiency	deficiency	NN
cord-005453-4057qib7	8334	16	at	at	IN
cord-005453-4057qib7	8334	17	Great	Great	NNP
cord-005453-4057qib7	8334	18	North	North	NNP
cord-005453-4057qib7	8334	19	Children	Children	NNP
cord-005453-4057qib7	8334	20	's	's	POS
cord-005453-4057qib7	8334	21	hospital	hospital	NN
cord-005453-4057qib7	8334	22	Newcastle	Newcastle	NNP
cord-005453-4057qib7	8334	23	upon	upon	IN
cord-005453-4057qib7	8334	24	Tyne	Tyne	NNP
cord-005453-4057qib7	8334	25	between	between	IN
cord-005453-4057qib7	8334	26	2011	2011	CD
cord-005453-4057qib7	8334	27	and	and	CC
cord-005453-4057qib7	8334	28	2018	2018	CD
cord-005453-4057qib7	8334	29	(	(	-LRB-
cord-005453-4057qib7	8334	30	5	5	CD
cord-005453-4057qib7	8334	31	in	in	IN
cord-005453-4057qib7	8334	32	published	publish	VBN
cord-005453-4057qib7	8334	33	reference	reference	NN
cord-005453-4057qib7	8334	34	)	)	-RRB-
cord-005453-4057qib7	8334	35	.	.	.
cord-005453-4057qib7	8335	1	Results	result	NNS
cord-005453-4057qib7	8335	2	:	:	:
cord-005453-4057qib7	8336	1	Ten	ten	CD
cord-005453-4057qib7	8336	2	patients	patient	NNS
cord-005453-4057qib7	8336	3	with	with	IN
cord-005453-4057qib7	8336	4	Dock	Dock	NNP
cord-005453-4057qib7	8336	5	8	8	CD
cord-005453-4057qib7	8336	6	deficiency	deficiency	NN
cord-005453-4057qib7	8336	7	were	be	VBD
cord-005453-4057qib7	8336	8	treated	treat	VBN
cord-005453-4057qib7	8336	9	with	with	IN
cord-005453-4057qib7	8336	10	HSCT	HSCT	NNP
cord-005453-4057qib7	8336	11	(	(	-LRB-
cord-005453-4057qib7	8336	12	Median	median	JJ
cord-005453-4057qib7	8336	13	age	age	NN
cord-005453-4057qib7	8336	14	7.5y	7.5y	CD
cord-005453-4057qib7	8336	15	range	range	NN
cord-005453-4057qib7	8336	16	4.5	4.5	CD
cord-005453-4057qib7	8336	17	-	-	HYPH
cord-005453-4057qib7	8336	18	16.8y	16.8y	CD
cord-005453-4057qib7	8336	19	)	)	-RRB-
cord-005453-4057qib7	8336	20	.	.	.
cord-005453-4057qib7	8337	1	Median	median	JJ
cord-005453-4057qib7	8337	2	duration	duration	NN
cord-005453-4057qib7	8337	3	of	of	IN
cord-005453-4057qib7	8337	4	follow	follow	NN
cord-005453-4057qib7	8337	5	up	up	RP
cord-005453-4057qib7	8337	6	was	be	VBD
cord-005453-4057qib7	8337	7	4.5years	4.5years	CD
cord-005453-4057qib7	8337	8	(	(	-LRB-
cord-005453-4057qib7	8337	9	range	range	VB
cord-005453-4057qib7	8337	10	1.3	1.3	CD
cord-005453-4057qib7	8337	11	-	-	SYM
cord-005453-4057qib7	8337	12	6.5y	6.5y	CD
cord-005453-4057qib7	8337	13	)	)	-RRB-
cord-005453-4057qib7	8337	14	.	.	.
cord-005453-4057qib7	8338	1	There	there	EX
cord-005453-4057qib7	8338	2	were	be	VBD
cord-005453-4057qib7	8338	3	a	a	DT
cord-005453-4057qib7	8338	4	range	range	NN
cord-005453-4057qib7	8338	5	of	of	IN
cord-005453-4057qib7	8338	6	donor	donor	NN
cord-005453-4057qib7	8338	7	sources	source	NNS
cord-005453-4057qib7	8338	8	(	(	-LRB-
cord-005453-4057qib7	8338	9	3	3	CD
cord-005453-4057qib7	8338	10	MSD	MSD	NNP
cord-005453-4057qib7	8338	11	,	,	,
cord-005453-4057qib7	8338	12	3	3	CD
cord-005453-4057qib7	8338	13	MUD	mud	NN
cord-005453-4057qib7	8338	14	and	and	CC
cord-005453-4057qib7	8338	15	4	4	CD
cord-005453-4057qib7	8338	16	TCR	TCR	NNP
cord-005453-4057qib7	8338	17	ab	ab	NNP
cord-005453-4057qib7	8338	18	/	/	SYM
cord-005453-4057qib7	8338	19	CD19	CD19	NNP
cord-005453-4057qib7	8338	20	+	+	CC
cord-005453-4057qib7	8338	21	depleted	deplete	VBN
cord-005453-4057qib7	8338	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8338	23	)	)	-RRB-
cord-005453-4057qib7	8338	24	,	,	,
cord-005453-4057qib7	8338	25	conditioning	conditioning	NN
cord-005453-4057qib7	8338	26	regimens	regimen	NNS
cord-005453-4057qib7	8338	27	(	(	-LRB-
cord-005453-4057qib7	8338	28	6	6	CD
cord-005453-4057qib7	8338	29	Treo	Treo	NNP
cord-005453-4057qib7	8338	30	-	-	HYPH
cord-005453-4057qib7	8338	31	Flu	Flu	NNP
cord-005453-4057qib7	8338	32	,	,	,
cord-005453-4057qib7	8338	33	4	4	CD
cord-005453-4057qib7	8338	34	Treo	Treo	NNP
cord-005453-4057qib7	8338	35	-	-	HYPH
cord-005453-4057qib7	8338	36	Flu	Flu	NNP
cord-005453-4057qib7	8338	37	-	-	HYPH
cord-005453-4057qib7	8338	38	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	8338	39	)	)	-RRB-
cord-005453-4057qib7	8338	40	and	and	CC
cord-005453-4057qib7	8338	41	serotherapy	serotherapy	NNP
cord-005453-4057qib7	8338	42	(	(	-LRB-
cord-005453-4057qib7	8338	43	5	5	CD
cord-005453-4057qib7	8338	44	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	8338	45	,	,	,
cord-005453-4057qib7	8338	46	3	3	CD
cord-005453-4057qib7	8338	47	ATG+Rituximab	atg+rituximab	NN
cord-005453-4057qib7	8338	48	,	,	,
cord-005453-4057qib7	8338	49	2	2	CD
cord-005453-4057qib7	8338	50	none	none	NN
cord-005453-4057qib7	8338	51	)	)	-RRB-
cord-005453-4057qib7	8338	52	.	.	.
cord-005453-4057qib7	8339	1	One	one	CD
cord-005453-4057qib7	8339	2	patient	patient	NN
cord-005453-4057qib7	8339	3	who	who	WP
cord-005453-4057qib7	8339	4	received	receive	VBD
cord-005453-4057qib7	8339	5	a	a	DT
cord-005453-4057qib7	8339	6	CD3	cd3	NN
cord-005453-4057qib7	8339	7	+	+	CC
cord-005453-4057qib7	8340	1	TCR	TCR	NNP
cord-005453-4057qib7	8340	2	alpha	alpha	NN
cord-005453-4057qib7	8340	3	beta	beta	NN
cord-005453-4057qib7	8340	4	/	/	SYM
cord-005453-4057qib7	8340	5	CD19	CD19	NNP
cord-005453-4057qib7	8341	1	+	+	CC
cord-005453-4057qib7	8341	2	depleted	deplete	VBN
cord-005453-4057qib7	8341	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8341	4	transplant	transplant	NN
cord-005453-4057qib7	8341	5	received	receive	VBD
cord-005453-4057qib7	8341	6	add	add	NN
cord-005453-4057qib7	8341	7	back	back	RP
cord-005453-4057qib7	8341	8	T	t	NN
cord-005453-4057qib7	8341	9	-	-	HYPH
cord-005453-4057qib7	8341	10	cells	cell	NNS
cord-005453-4057qib7	8341	11	with	with	IN
cord-005453-4057qib7	8341	12	caspacide	caspacide	NN
cord-005453-4057qib7	8341	13	molecular	molecular	JJ
cord-005453-4057qib7	8341	14	safety	safety	NN
cord-005453-4057qib7	8341	15	switch	switch	NN
cord-005453-4057qib7	8341	16	(	(	-LRB-
cord-005453-4057qib7	8341	17	Bellicum	Bellicum	NNP
cord-005453-4057qib7	8341	18	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	8341	19	)	)	-RRB-
cord-005453-4057qib7	8341	20	.	.	.
cord-005453-4057qib7	8342	1	Skin	skin	NN
cord-005453-4057qib7	8342	2	only	only	RB
cord-005453-4057qib7	8342	3	aGVHD	aGVHD	NNP
cord-005453-4057qib7	8342	4	occurred	occur	VBD
cord-005453-4057qib7	8342	5	in	in	IN
cord-005453-4057qib7	8342	6	3/10	3/10	CD
cord-005453-4057qib7	8342	7	patients	patient	NNS
cord-005453-4057qib7	8342	8	(	(	-LRB-
cord-005453-4057qib7	8342	9	1x	1x	CD
cord-005453-4057qib7	8342	10	stage	stage	NN
cord-005453-4057qib7	8342	11	1	1	CD
cord-005453-4057qib7	8342	12	,	,	,
cord-005453-4057qib7	8342	13	2x	2x	CD
cord-005453-4057qib7	8342	14	stage	stage	NN
cord-005453-4057qib7	8342	15	3	3	CD
cord-005453-4057qib7	8342	16	)	)	-RRB-
cord-005453-4057qib7	8342	17	.	.	.
cord-005453-4057qib7	8343	1	No	no	DT
cord-005453-4057qib7	8343	2	patients	patient	NNS
cord-005453-4057qib7	8343	3	had	have	VBD
cord-005453-4057qib7	8343	4	cGVHD	cGVHD	NNP
cord-005453-4057qib7	8343	5	.	.	.
cord-005453-4057qib7	8344	1	Overall	overall	JJ
cord-005453-4057qib7	8344	2	survival	survival	NN
cord-005453-4057qib7	8344	3	was	be	VBD
cord-005453-4057qib7	8344	4	60	60	CD
cord-005453-4057qib7	8344	5	%	%	NN
cord-005453-4057qib7	8344	6	(	(	-LRB-
cord-005453-4057qib7	8344	7	6/10	6/10	CD
cord-005453-4057qib7	8344	8	)	)	-RRB-
cord-005453-4057qib7	8344	9	.	.	.
cord-005453-4057qib7	8345	1	Survival	survival	NN
cord-005453-4057qib7	8345	2	was	be	VBD
cord-005453-4057qib7	8345	3	comparable	comparable	JJ
cord-005453-4057qib7	8345	4	regardless	regardless	RB
cord-005453-4057qib7	8345	5	of	of	IN
cord-005453-4057qib7	8345	6	donor	donor	NN
cord-005453-4057qib7	8345	7	source	source	NN
cord-005453-4057qib7	8345	8	.	.	.
cord-005453-4057qib7	8346	1	All	all	DT
cord-005453-4057qib7	8346	2	deaths	death	NNS
cord-005453-4057qib7	8346	3	occurred	occur	VBD
cord-005453-4057qib7	8346	4	within	within	IN
cord-005453-4057qib7	8346	5	13	13	CD
cord-005453-4057qib7	8346	6	months	month	NNS
cord-005453-4057qib7	8346	7	of	of	IN
cord-005453-4057qib7	8346	8	transplant	transplant	NN
cord-005453-4057qib7	8346	9	.	.	.
cord-005453-4057qib7	8347	1	The	the	DT
cord-005453-4057qib7	8347	2	4	4	CD
cord-005453-4057qib7	8347	3	patients	patient	NNS
cord-005453-4057qib7	8347	4	who	who	WP
cord-005453-4057qib7	8347	5	died	die	VBD
cord-005453-4057qib7	8347	6	had	have	VBD
cord-005453-4057qib7	8347	7	significant	significant	JJ
cord-005453-4057qib7	8347	8	burden	burden	NN
cord-005453-4057qib7	8347	9	of	of	IN
cord-005453-4057qib7	8347	10	disease	disease	NN
cord-005453-4057qib7	8347	11	pre	pre	VBN
cord-005453-4057qib7	8347	12	-	-	NN
cord-005453-4057qib7	8347	13	transplant	transplant	NN
cord-005453-4057qib7	8347	14	:	:	:
cord-005453-4057qib7	8347	15	1	1	CD
cord-005453-4057qib7	8347	16	patient	patient	NN
cord-005453-4057qib7	8347	17	had	have	VBD
cord-005453-4057qib7	8347	18	chronic	chronic	JJ
cord-005453-4057qib7	8347	19	liver	liver	NN
cord-005453-4057qib7	8347	20	failure	failure	NN
cord-005453-4057qib7	8347	21	secondary	secondary	JJ
cord-005453-4057qib7	8347	22	to	to	IN
cord-005453-4057qib7	8347	23	cryptosporidial	cryptosporidial	JJ
cord-005453-4057qib7	8347	24	sclerosing	sclerosing	NN
cord-005453-4057qib7	8348	1	cholangitis,1	cholangitis,1	NNP
cord-005453-4057qib7	8348	2	had	have	VBD
cord-005453-4057qib7	8348	3	a	a	DT
cord-005453-4057qib7	8348	4	cirrhotic	cirrhotic	JJ
cord-005453-4057qib7	8348	5	liver	liver	NN
cord-005453-4057qib7	8348	6	secondary	secondary	JJ
cord-005453-4057qib7	8348	7	to	to	IN
cord-005453-4057qib7	8348	8	cryptosporidium	cryptosporidium	NN
cord-005453-4057qib7	8348	9	,	,	,
cord-005453-4057qib7	8348	10	cerebral	cerebral	JJ
cord-005453-4057qib7	8348	11	vasculitis	vasculitis	NN
cord-005453-4057qib7	8348	12	,	,	,
cord-005453-4057qib7	8348	13	an	an	DT
cord-005453-4057qib7	8348	14	axillary	axillary	JJ
cord-005453-4057qib7	8348	15	aneurysm	aneurysm	NN
cord-005453-4057qib7	8348	16	and	and	CC
cord-005453-4057qib7	8348	17	aortic	aortic	JJ
cord-005453-4057qib7	8348	18	vasculitis	vasculitis	NN
cord-005453-4057qib7	8348	19	requiring	require	VBG
cord-005453-4057qib7	8348	20	grafting	grafting	NN
cord-005453-4057qib7	8348	21	of	of	IN
cord-005453-4057qib7	8348	22	an	an	DT
cord-005453-4057qib7	8348	23	ascending	ascend	VBG
cord-005453-4057qib7	8348	24	aortic	aortic	NN
cord-005453-4057qib7	8349	1	aneurysm,1	aneurysm,1	NNP
cord-005453-4057qib7	8349	2	was	be	VBD
cord-005453-4057qib7	8349	3	PN	PN	NNP
cord-005453-4057qib7	8349	4	dependent	dependent	JJ
cord-005453-4057qib7	8349	5	for	for	IN
cord-005453-4057qib7	8349	6	failure	failure	NN
cord-005453-4057qib7	8349	7	to	to	TO
cord-005453-4057qib7	8349	8	thrive	thrive	VB
cord-005453-4057qib7	8349	9	with	with	IN
cord-005453-4057qib7	8349	10	a	a	DT
cord-005453-4057qib7	8349	11	history	history	NN
cord-005453-4057qib7	8349	12	of	of	IN
cord-005453-4057qib7	8349	13	cryptosporidium	cryptosporidium	NN
cord-005453-4057qib7	8349	14	infection	infection	NN
cord-005453-4057qib7	8349	15	and	and	CC
cord-005453-4057qib7	8349	16	1	1	CD
cord-005453-4057qib7	8349	17	had	have	VBD
cord-005453-4057qib7	8349	18	candida	candida	NN
cord-005453-4057qib7	8349	19	in	in	IN
cord-005453-4057qib7	8349	20	a	a	DT
cord-005453-4057qib7	8349	21	BAL	bal	NN
cord-005453-4057qib7	8349	22	pre	pre	NN
cord-005453-4057qib7	8349	23	-	-	NN
cord-005453-4057qib7	8349	24	transplant	transplant	NN
cord-005453-4057qib7	8349	25	.	.	.
cord-005453-4057qib7	8350	1	Causes	cause	NNS
cord-005453-4057qib7	8350	2	of	of	IN
cord-005453-4057qib7	8350	3	death	death	NN
cord-005453-4057qib7	8350	4	in	in	IN
cord-005453-4057qib7	8350	5	these	these	DT
cord-005453-4057qib7	8350	6	patients	patient	NNS
cord-005453-4057qib7	8350	7	were	be	VBD
cord-005453-4057qib7	8350	8	:	:	:
cord-005453-4057qib7	8350	9	respiratory	respiratory	JJ
cord-005453-4057qib7	8350	10	failure	failure	NN
cord-005453-4057qib7	8350	11	(	(	-LRB-
cord-005453-4057qib7	8350	12	n=1	n=1	CD
cord-005453-4057qib7	8350	13	)	)	-RRB-
cord-005453-4057qib7	8350	14	,	,	,
cord-005453-4057qib7	8350	15	progressive	progressive	JJ
cord-005453-4057qib7	8350	16	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	8350	17	(	(	-LRB-
cord-005453-4057qib7	8350	18	n=1	n=1	CD
cord-005453-4057qib7	8350	19	)	)	-RRB-
cord-005453-4057qib7	8350	20	,	,	,
cord-005453-4057qib7	8350	21	multi	multi	JJ
cord-005453-4057qib7	8350	22	-	-	JJ
cord-005453-4057qib7	8350	23	organ	organ	JJ
cord-005453-4057qib7	8350	24	failure	failure	NN
cord-005453-4057qib7	8350	25	with	with	IN
cord-005453-4057qib7	8350	26	septic	septic	JJ
cord-005453-4057qib7	8350	27	shock	shock	NN
cord-005453-4057qib7	8350	28	and	and	CC
cord-005453-4057qib7	8350	29	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	8350	30	(	(	-LRB-
cord-005453-4057qib7	8350	31	n=1	n=1	FW
cord-005453-4057qib7	8350	32	)	)	-RRB-
cord-005453-4057qib7	8350	33	and	and	CC
cord-005453-4057qib7	8350	34	multiorgan	multiorgan	NN
cord-005453-4057qib7	8350	35	failure	failure	NN
cord-005453-4057qib7	8350	36	and	and	CC
cord-005453-4057qib7	8350	37	septic	septic	JJ
cord-005453-4057qib7	8350	38	shock	shock	NN
cord-005453-4057qib7	8350	39	after	after	IN
cord-005453-4057qib7	8350	40	treatment	treatment	NN
cord-005453-4057qib7	8350	41	for	for	IN
cord-005453-4057qib7	8350	42	TMA	TMA	NNP
cord-005453-4057qib7	8350	43	(	(	-LRB-
cord-005453-4057qib7	8350	44	n=1	n=1	NN
cord-005453-4057qib7	8350	45	)	)	-RRB-
cord-005453-4057qib7	8350	46	.	.	.
cord-005453-4057qib7	8351	1	Two	two	CD
cord-005453-4057qib7	8351	2	of	of	IN
cord-005453-4057qib7	8351	3	these	these	DT
cord-005453-4057qib7	8351	4	patients	patient	NNS
cord-005453-4057qib7	8351	5	had	have	VBD
cord-005453-4057qib7	8351	6	reactivation	reactivation	NN
cord-005453-4057qib7	8351	7	of	of	IN
cord-005453-4057qib7	8351	8	cryptosporidium	cryptosporidium	NN
cord-005453-4057qib7	8351	9	prior	prior	RB
cord-005453-4057qib7	8351	10	to	to	IN
cord-005453-4057qib7	8351	11	their	-PRON-	PRP$
cord-005453-4057qib7	8351	12	death	death	NN
cord-005453-4057qib7	8351	13	.	.	.
cord-005453-4057qib7	8352	1	Pretransplant	pretransplant	JJ
cord-005453-4057qib7	8352	2	cryptosporidium	cryptosporidium	NN
cord-005453-4057qib7	8352	3	was	be	VBD
cord-005453-4057qib7	8352	4	associated	associate	VBN
cord-005453-4057qib7	8352	5	with	with	IN
cord-005453-4057qib7	8352	6	mortality	mortality	NN
cord-005453-4057qib7	8352	7	(	(	-LRB-
cord-005453-4057qib7	8352	8	Graph	graph	NN
cord-005453-4057qib7	8352	9	1	1	CD
cord-005453-4057qib7	8352	10	)	)	-RRB-
cord-005453-4057qib7	8352	11	.	.	.
cord-005453-4057qib7	8353	1	One	one	CD
cord-005453-4057qib7	8353	2	patient	patient	NN
cord-005453-4057qib7	8353	3	who	who	WP
cord-005453-4057qib7	8353	4	survived	survive	VBD
cord-005453-4057qib7	8353	5	had	have	VBD
cord-005453-4057qib7	8353	6	suffered	suffer	VBN
cord-005453-4057qib7	8353	7	from	from	IN
cord-005453-4057qib7	8353	8	stroke	stroke	NN
cord-005453-4057qib7	8353	9	pretransplant	pretransplant	NN
cord-005453-4057qib7	8353	10	.	.	.
cord-005453-4057qib7	8354	1	One	one	CD
cord-005453-4057qib7	8354	2	suffered	suffer	VBD
cord-005453-4057qib7	8354	3	from	from	IN
cord-005453-4057qib7	8354	4	a	a	DT
cord-005453-4057qib7	8354	5	basilar	basilar	JJ
cord-005453-4057qib7	8354	6	artery	artery	NN
cord-005453-4057qib7	8354	7	aneurysm	aneurysm	NN
cord-005453-4057qib7	8354	8	7	7	CD
cord-005453-4057qib7	8354	9	years	year	NNS
cord-005453-4057qib7	8354	10	post	post	JJ
cord-005453-4057qib7	8354	11	-	-	NN
cord-005453-4057qib7	8354	12	transplant	transplant	NN
cord-005453-4057qib7	8354	13	at	at	IN
cord-005453-4057qib7	8354	14	19yo	19yo	NNP
cord-005453-4057qib7	8354	15	.	.	.
cord-005453-4057qib7	8355	1	At	at	IN
cord-005453-4057qib7	8355	2	the	the	DT
cord-005453-4057qib7	8355	3	time	time	NN
cord-005453-4057qib7	8355	4	of	of	IN
cord-005453-4057qib7	8355	5	latest	late	JJS
cord-005453-4057qib7	8355	6	follow	follow	VB
cord-005453-4057qib7	8355	7	up	up	RP
cord-005453-4057qib7	8355	8	donor	donor	NN
cord-005453-4057qib7	8355	9	chimerism	chimerism	NN
cord-005453-4057qib7	8355	10	was	be	VBD
cord-005453-4057qib7	8355	11	100	100	CD
cord-005453-4057qib7	8355	12	%	%	NN
cord-005453-4057qib7	8355	13	in	in	IN
cord-005453-4057qib7	8355	14	5/6	5/6	CD
cord-005453-4057qib7	8355	15	survivors	survivor	NNS
cord-005453-4057qib7	8355	16	and	and	CC
cord-005453-4057qib7	8355	17	high	high	JJ
cord-005453-4057qib7	8355	18	level	level	NN
cord-005453-4057qib7	8355	19	mixed	mix	VBN
cord-005453-4057qib7	8355	20	in	in	IN
cord-005453-4057qib7	8355	21	the	the	DT
cord-005453-4057qib7	8355	22	other(100	other(100	NNP
cord-005453-4057qib7	8355	23	%	%	NN
cord-005453-4057qib7	8355	24	CD3	CD3	NNP
cord-005453-4057qib7	8355	25	,	,	,
cord-005453-4057qib7	8355	26	89	89	CD
cord-005453-4057qib7	8355	27	%	%	NN
cord-005453-4057qib7	8355	28	CD15	CD15	NNP
cord-005453-4057qib7	8355	29	and	and	CC
cord-005453-4057qib7	8355	30	92	92	CD
cord-005453-4057qib7	8355	31	%	%	NN
cord-005453-4057qib7	8355	32	CD19	CD19	NNP
cord-005453-4057qib7	8355	33	)	)	-RRB-
cord-005453-4057qib7	8355	34	.	.	.
cord-005453-4057qib7	8356	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8356	2	:	:	:
cord-005453-4057qib7	8357	1	This	this	DT
cord-005453-4057qib7	8357	2	single	single	JJ
cord-005453-4057qib7	8357	3	centre	centre	NN
cord-005453-4057qib7	8357	4	study	study	NN
cord-005453-4057qib7	8357	5	of	of	IN
cord-005453-4057qib7	8357	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8357	7	for	for	IN
cord-005453-4057qib7	8357	8	patients	patient	NNS
cord-005453-4057qib7	8357	9	is	be	VBZ
cord-005453-4057qib7	8357	10	consistent	consistent	JJ
cord-005453-4057qib7	8357	11	with	with	IN
cord-005453-4057qib7	8357	12	literature	literature	NN
cord-005453-4057qib7	8357	13	indicating	indicate	VBG
cord-005453-4057qib7	8357	14	that	that	IN
cord-005453-4057qib7	8357	15	HSCT	HSCT	NNP
cord-005453-4057qib7	8357	16	is	be	VBZ
cord-005453-4057qib7	8357	17	a	a	DT
cord-005453-4057qib7	8357	18	potentially	potentially	RB
cord-005453-4057qib7	8357	19	curative	curative	JJ
cord-005453-4057qib7	8357	20	therapy	therapy	NN
cord-005453-4057qib7	8357	21	for	for	IN
cord-005453-4057qib7	8357	22	patients	patient	NNS
cord-005453-4057qib7	8357	23	with	with	IN
cord-005453-4057qib7	8357	24	DOCK	dock	NN
cord-005453-4057qib7	8357	25	8	8	CD
cord-005453-4057qib7	8357	26	deficiency	deficiency	NN
cord-005453-4057qib7	8357	27	.	.	.
cord-005453-4057qib7	8358	1	The	the	DT
cord-005453-4057qib7	8358	2	increased	increased	JJ
cord-005453-4057qib7	8358	3	morbidity	morbidity	NN
cord-005453-4057qib7	8358	4	associated	associate	VBN
cord-005453-4057qib7	8358	5	with	with	IN
cord-005453-4057qib7	8358	6	Cryptosporidial	cryptosporidial	JJ
cord-005453-4057qib7	8358	7	infection	infection	NN
cord-005453-4057qib7	8358	8	is	be	VBZ
cord-005453-4057qib7	8358	9	likely	likely	JJ
cord-005453-4057qib7	8358	10	to	to	TO
cord-005453-4057qib7	8358	11	be	be	VB
cord-005453-4057qib7	8358	12	a	a	DT
cord-005453-4057qib7	8358	13	consequence	consequence	NN
cord-005453-4057qib7	8358	14	of	of	IN
cord-005453-4057qib7	8358	15	overall	overall	JJ
cord-005453-4057qib7	8358	16	disease	disease	NN
cord-005453-4057qib7	8358	17	burden	burden	NN
cord-005453-4057qib7	8358	18	rather	rather	RB
cord-005453-4057qib7	8358	19	than	than	IN
cord-005453-4057qib7	8358	20	an	an	DT
cord-005453-4057qib7	8358	21	infection	infection	NN
cord-005453-4057qib7	8358	22	specific	specific	JJ
cord-005453-4057qib7	8358	23	effect	effect	NN
cord-005453-4057qib7	8358	24	.	.	.
cord-005453-4057qib7	8359	1	This	this	DT
cord-005453-4057qib7	8359	2	does	do	VBZ
cord-005453-4057qib7	8359	3	however	however	RB
cord-005453-4057qib7	8359	4	highlight	highlight	VB
cord-005453-4057qib7	8359	5	the	the	DT
cord-005453-4057qib7	8359	6	improved	improved	JJ
cord-005453-4057qib7	8359	7	outcomes	outcome	NNS
cord-005453-4057qib7	8359	8	of	of	IN
cord-005453-4057qib7	8359	9	transplant	transplant	NN
cord-005453-4057qib7	8359	10	prior	prior	RB
cord-005453-4057qib7	8359	11	to	to	IN
cord-005453-4057qib7	8359	12	development	development	NN
cord-005453-4057qib7	8359	13	of	of	IN
cord-005453-4057qib7	8359	14	multiple	multiple	JJ
cord-005453-4057qib7	8359	15	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	8359	16	and	and	CC
cord-005453-4057qib7	8359	17	suggests	suggest	VBZ
cord-005453-4057qib7	8359	18	that	that	IN
cord-005453-4057qib7	8359	19	HSCT	HSCT	NNP
cord-005453-4057qib7	8359	20	should	should	MD
cord-005453-4057qib7	8359	21	be	be	VB
cord-005453-4057qib7	8359	22	considered	consider	VBN
cord-005453-4057qib7	8359	23	early	early	JJ
cord-005453-4057qib7	8359	24	.	.	.
cord-005453-4057qib7	8360	1	It	-PRON-	PRP
cord-005453-4057qib7	8360	2	is	be	VBZ
cord-005453-4057qib7	8360	3	unclear	unclear	JJ
cord-005453-4057qib7	8360	4	whether	whether	IN
cord-005453-4057qib7	8360	5	the	the	DT
cord-005453-4057qib7	8360	6	late	late	JJ
cord-005453-4057qib7	8360	7	occurrence	occurrence	NN
cord-005453-4057qib7	8360	8	of	of	IN
cord-005453-4057qib7	8360	9	vascular	vascular	JJ
cord-005453-4057qib7	8360	10	complications	complication	NNS
cord-005453-4057qib7	8360	11	after	after	IN
cord-005453-4057qib7	8360	12	transplant	transplant	NN
cord-005453-4057qib7	8360	13	were	be	VBD
cord-005453-4057qib7	8360	14	caused	cause	VBN
cord-005453-4057qib7	8360	15	by	by	IN
cord-005453-4057qib7	8360	16	a	a	DT
cord-005453-4057qib7	8360	17	manifestation	manifestation	NN
cord-005453-4057qib7	8360	18	of	of	IN
cord-005453-4057qib7	8360	19	disease	disease	NN
cord-005453-4057qib7	8360	20	which	which	WDT
cord-005453-4057qib7	8360	21	is	be	VBZ
cord-005453-4057qib7	8360	22	not	not	RB
cord-005453-4057qib7	8360	23	corrected	correct	VBN
cord-005453-4057qib7	8360	24	by	by	IN
cord-005453-4057qib7	8360	25	transplant	transplant	NN
cord-005453-4057qib7	8360	26	or	or	CC
cord-005453-4057qib7	8360	27	a	a	DT
cord-005453-4057qib7	8360	28	result	result	NN
cord-005453-4057qib7	8360	29	of	of	IN
cord-005453-4057qib7	8360	30	vascular	vascular	JJ
cord-005453-4057qib7	8360	31	injury	injury	NN
cord-005453-4057qib7	8360	32	sustained	sustain	VBD
cord-005453-4057qib7	8360	33	pre	pre	JJ
cord-005453-4057qib7	8360	34	-	-	NN
cord-005453-4057qib7	8360	35	transplant	transplant	NN
cord-005453-4057qib7	8360	36	.	.	.
cord-005453-4057qib7	8361	1	Reference	reference	NN
cord-005453-4057qib7	8361	2	Methods	method	NNS
cord-005453-4057qib7	8361	3	:	:	:
cord-005453-4057qib7	8362	1	Referred	refer	VBN
cord-005453-4057qib7	8362	2	infants	infant	NNS
cord-005453-4057qib7	8362	3	underwent	undergo	VBD
cord-005453-4057qib7	8362	4	testing	test	VBG
cord-005453-4057qib7	8362	5	for	for	IN
cord-005453-4057qib7	8362	6	:	:	:
cord-005453-4057qib7	8362	7	immune	immune	JJ
cord-005453-4057qib7	8362	8	phenotype	phenotype	NN
cord-005453-4057qib7	8362	9	(	(	-LRB-
cord-005453-4057qib7	8362	10	ab	ab	NNP
cord-005453-4057qib7	8362	11	,	,	,
cord-005453-4057qib7	8362	12	gd	gd	NNP
cord-005453-4057qib7	8362	13	,	,	,
cord-005453-4057qib7	8362	14	naïve	naïve	JJ
cord-005453-4057qib7	8362	15	and	and	CC
cord-005453-4057qib7	8362	16	memory	memory	NN
cord-005453-4057qib7	8362	17	T	t	NN
cord-005453-4057qib7	8362	18	cell	cell	NN
cord-005453-4057qib7	8362	19	,	,	,
cord-005453-4057qib7	8362	20	B	b	NN
cord-005453-4057qib7	8362	21	cell	cell	NN
cord-005453-4057qib7	8362	22	and	and	CC
cord-005453-4057qib7	8362	23	NK	NK	NNP
cord-005453-4057qib7	8362	24	cell	cell	NN
cord-005453-4057qib7	8362	25	numbers	number	NNS
cord-005453-4057qib7	8362	26	)	)	-RRB-
cord-005453-4057qib7	8362	27	;	;	,
cord-005453-4057qib7	8362	28	functional	functional	JJ
cord-005453-4057qib7	8362	29	activity	activity	NN
cord-005453-4057qib7	8362	30	of	of	IN
cord-005453-4057qib7	8362	31	T	T	NNP
cord-005453-4057qib7	8362	32	and	and	CC
cord-005453-4057qib7	8362	33	NK	NK	NNP
cord-005453-4057qib7	8362	34	cells	cell	NNS
cord-005453-4057qib7	8362	35	;	;	:
cord-005453-4057qib7	8362	36	maternal	maternal	JJ
cord-005453-4057qib7	8362	37	engraftment	engraftment	NN
cord-005453-4057qib7	8362	38	;	;	:
cord-005453-4057qib7	8362	39	adenosine	adenosine	NN
cord-005453-4057qib7	8362	40	deaminase	deaminase	NNP
cord-005453-4057qib7	8362	41	(	(	-LRB-
cord-005453-4057qib7	8362	42	ADA	ADA	NNP
cord-005453-4057qib7	8362	43	)	)	-RRB-
cord-005453-4057qib7	8362	44	and	and	CC
cord-005453-4057qib7	8362	45	purine	purine	NN
cord-005453-4057qib7	8362	46	nucleoside	nucleoside	NN
cord-005453-4057qib7	8362	47	phosphorylase	phosphorylase	NN
cord-005453-4057qib7	8362	48	(	(	-LRB-
cord-005453-4057qib7	8362	49	PNP	PNP	NNP
cord-005453-4057qib7	8362	50	)	)	-RRB-
cord-005453-4057qib7	8362	51	enzyme	enzyme	NN
cord-005453-4057qib7	8362	52	activity	activity	NN
cord-005453-4057qib7	8362	53	;	;	:
cord-005453-4057qib7	8362	54	and	and	CC
cord-005453-4057qib7	8362	55	genetic	genetic	JJ
cord-005453-4057qib7	8362	56	testing	testing	NN
cord-005453-4057qib7	8362	57	.	.	.
cord-005453-4057qib7	8363	1	Those	those	DT
cord-005453-4057qib7	8363	2	with	with	IN
cord-005453-4057qib7	8363	3	a	a	DT
cord-005453-4057qib7	8363	4	confirmed	confirm	VBN
cord-005453-4057qib7	8363	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	8363	6	of	of	IN
cord-005453-4057qib7	8363	7	SCID	SCID	NNP
cord-005453-4057qib7	8363	8	underwent	undergo	VBD
cord-005453-4057qib7	8363	9	either	either	CC
cord-005453-4057qib7	8363	10	allogeneic	allogeneic	IN
cord-005453-4057qib7	8363	11	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8363	12	stem	stem	NN
cord-005453-4057qib7	8363	13	cell	cell	NN
cord-005453-4057qib7	8363	14	transplant	transplant	NN
cord-005453-4057qib7	8363	15	(	(	-LRB-
cord-005453-4057qib7	8363	16	HCT	HCT	NNP
cord-005453-4057qib7	8363	17	)	)	-RRB-
cord-005453-4057qib7	8363	18	or	or	CC
cord-005453-4057qib7	8363	19	(	(	-LRB-
cord-005453-4057qib7	8363	20	if	if	IN
cord-005453-4057qib7	8363	21	eligible	eligible	JJ
cord-005453-4057qib7	8363	22	)	)	-RRB-
cord-005453-4057qib7	8363	23	gene	gene	NN
cord-005453-4057qib7	8363	24	therapy	therapy	NN
cord-005453-4057qib7	8363	25	(	(	-LRB-
cord-005453-4057qib7	8363	26	GT	GT	NNP
cord-005453-4057qib7	8363	27	)	)	-RRB-
cord-005453-4057qib7	8363	28	.	.	.
cord-005453-4057qib7	8364	1	Infants	infant	NNS
cord-005453-4057qib7	8364	2	identified	identify	VBN
cord-005453-4057qib7	8364	3	as	as	IN
cord-005453-4057qib7	8364	4	having	have	VBG
cord-005453-4057qib7	8364	5	ADA	ADA	NNP
cord-005453-4057qib7	8364	6	deficiency	deficiency	NN
cord-005453-4057qib7	8364	7	as	as	IN
cord-005453-4057qib7	8364	8	the	the	DT
cord-005453-4057qib7	8364	9	etiology	etiology	NN
cord-005453-4057qib7	8364	10	of	of	IN
cord-005453-4057qib7	8364	11	their	-PRON-	PRP$
cord-005453-4057qib7	8364	12	SCID	SCID	NNP
cord-005453-4057qib7	8364	13	received	receive	VBD
cord-005453-4057qib7	8364	14	enzyme	enzyme	NN
cord-005453-4057qib7	8364	15	replacement	replacement	NN
cord-005453-4057qib7	8364	16	therapy	therapy	NN
cord-005453-4057qib7	8364	17	prior	prior	RB
cord-005453-4057qib7	8364	18	to	to	IN
cord-005453-4057qib7	8364	19	proceeding	proceed	VBG
cord-005453-4057qib7	8364	20	to	to	IN
cord-005453-4057qib7	8364	21	definitive	definitive	JJ
cord-005453-4057qib7	8364	22	therapy	therapy	NN
cord-005453-4057qib7	8364	23	.	.	.
cord-005453-4057qib7	8365	1	Results	result	NNS
cord-005453-4057qib7	8365	2	:	:	:
cord-005453-4057qib7	8366	1	Twenty	twenty	CD
cord-005453-4057qib7	8366	2	-	-	HYPH
cord-005453-4057qib7	8366	3	three	three	CD
cord-005453-4057qib7	8366	4	(	(	-LRB-
cord-005453-4057qib7	8366	5	66	66	CD
cord-005453-4057qib7	8366	6	%	%	NN
cord-005453-4057qib7	8366	7	)	)	-RRB-
cord-005453-4057qib7	8366	8	infants	infant	NNS
cord-005453-4057qib7	8366	9	were	be	VBD
cord-005453-4057qib7	8366	10	confirmed	confirm	VBN
cord-005453-4057qib7	8366	11	to	to	TO
cord-005453-4057qib7	8366	12	have	have	VB
cord-005453-4057qib7	8366	13	SCID	SCID	NNP
cord-005453-4057qib7	8366	14	.	.	.
cord-005453-4057qib7	8367	1	Three	three	CD
cord-005453-4057qib7	8367	2	(	(	-LRB-
cord-005453-4057qib7	8367	3	13	13	CD
cord-005453-4057qib7	8367	4	%	%	NN
cord-005453-4057qib7	8367	5	)	)	-RRB-
cord-005453-4057qib7	8367	6	of	of	IN
cord-005453-4057qib7	8367	7	these	these	DT
cord-005453-4057qib7	8367	8	infants	infant	NNS
cord-005453-4057qib7	8367	9	had	have	VBD
cord-005453-4057qib7	8367	10	a	a	DT
cord-005453-4057qib7	8367	11	family	family	NN
cord-005453-4057qib7	8367	12	history	history	NN
cord-005453-4057qib7	8367	13	of	of	IN
cord-005453-4057qib7	8367	14	SCID	SCID	NNP
cord-005453-4057qib7	8367	15	but	but	CC
cord-005453-4057qib7	8367	16	would	would	MD
cord-005453-4057qib7	8367	17	not	not	RB
cord-005453-4057qib7	8367	18	have	have	VB
cord-005453-4057qib7	8367	19	been	be	VBN
cord-005453-4057qib7	8367	20	identified	identify	VBN
cord-005453-4057qib7	8367	21	without	without	IN
cord-005453-4057qib7	8367	22	NBS	NBS	NNP
cord-005453-4057qib7	8367	23	.	.	.
cord-005453-4057qib7	8368	1	In	in	IN
cord-005453-4057qib7	8368	2	addition	addition	NN
cord-005453-4057qib7	8368	3	,	,	,
cord-005453-4057qib7	8368	4	one	one	CD
cord-005453-4057qib7	8368	5	infant	infant	NN
cord-005453-4057qib7	8368	6	,	,	,
cord-005453-4057qib7	8368	7	born	bear	VBN
cord-005453-4057qib7	8368	8	prematurely	prematurely	RB
cord-005453-4057qib7	8368	9	at	at	IN
cord-005453-4057qib7	8368	10	28	28	CD
cord-005453-4057qib7	8368	11	weeks	week	NNS
cord-005453-4057qib7	8368	12	,	,	,
cord-005453-4057qib7	8368	13	was	be	VBD
cord-005453-4057qib7	8368	14	diagnosed	diagnose	VBN
cord-005453-4057qib7	8368	15	as	as	IN
cord-005453-4057qib7	8368	16	having	have	VBG
cord-005453-4057qib7	8368	17	PNP	PNP	NNP
cord-005453-4057qib7	8368	18	deficiency	deficiency	NN
cord-005453-4057qib7	8368	19	only	only	RB
cord-005453-4057qib7	8368	20	after	after	IN
cord-005453-4057qib7	8368	21	developing	develop	VBG
cord-005453-4057qib7	8368	22	infections	infection	NNS
cord-005453-4057qib7	8368	23	.	.	.
cord-005453-4057qib7	8369	1	This	this	DT
cord-005453-4057qib7	8369	2	infant	infant	NN
cord-005453-4057qib7	8369	3	was	be	VBD
cord-005453-4057qib7	8369	4	identified	identify	VBN
cord-005453-4057qib7	8369	5	by	by	IN
cord-005453-4057qib7	8369	6	NBS	NBS	NNP
cord-005453-4057qib7	8369	7	but	but	CC
cord-005453-4057qib7	8369	8	repeat	repeat	VB
cord-005453-4057qib7	8369	9	testing	testing	NN
cord-005453-4057qib7	8369	10	at	at	IN
cord-005453-4057qib7	8369	11	32	32	CD
cord-005453-4057qib7	8369	12	weeks	week	NNS
cord-005453-4057qib7	8369	13	gestation	gestation	NN
cord-005453-4057qib7	8369	14	was	be	VBD
cord-005453-4057qib7	8369	15	normal	normal	JJ
cord-005453-4057qib7	8369	16	likely	likely	RB
cord-005453-4057qib7	8369	17	due	due	IN
cord-005453-4057qib7	8369	18	to	to	IN
cord-005453-4057qib7	8369	19	support	support	NN
cord-005453-4057qib7	8369	20	of	of	IN
cord-005453-4057qib7	8369	21	transient	transient	JJ
cord-005453-4057qib7	8369	22	T	t	NN
cord-005453-4057qib7	8369	23	cell	cell	NN
cord-005453-4057qib7	8369	24	production	production	NN
cord-005453-4057qib7	8369	25	from	from	IN
cord-005453-4057qib7	8369	26	exogenous	exogenous	JJ
cord-005453-4057qib7	8369	27	enzyme	enzyme	NN
cord-005453-4057qib7	8369	28	provided	provide	VBN
cord-005453-4057qib7	8369	29	by	by	IN
cord-005453-4057qib7	8369	30	red	red	JJ
cord-005453-4057qib7	8369	31	cell	cell	NN
cord-005453-4057qib7	8369	32	transfusion	transfusion	NN
cord-005453-4057qib7	8369	33	.	.	.
cord-005453-4057qib7	8370	1	Twelve	twelve	CD
cord-005453-4057qib7	8370	2	infants	infant	NNS
cord-005453-4057qib7	8370	3	with	with	IN
cord-005453-4057qib7	8370	4	confirmed	confirm	VBN
cord-005453-4057qib7	8370	5	low	low	JJ
cord-005453-4057qib7	8370	6	TRECs	trec	NNS
cord-005453-4057qib7	8370	7	had	have	VBD
cord-005453-4057qib7	8370	8	a	a	DT
cord-005453-4057qib7	8370	9	non	non	JJ
cord-005453-4057qib7	8370	10	-	-	JJ
cord-005453-4057qib7	8370	11	SCID	scid	JJ
cord-005453-4057qib7	8370	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	8370	13	:	:	:
cord-005453-4057qib7	8370	14	5	5	CD
cord-005453-4057qib7	8370	15	with	with	IN
cord-005453-4057qib7	8370	16	transient	transient	JJ
cord-005453-4057qib7	8370	17	lymphopenia	lymphopenia	NN
cord-005453-4057qib7	8370	18	of	of	IN
cord-005453-4057qib7	8370	19	infancy	infancy	NN
cord-005453-4057qib7	8370	20	who	who	WP
cord-005453-4057qib7	8370	21	normalized	normalize	VBD
cord-005453-4057qib7	8370	22	TREC	TREC	NNP
cord-005453-4057qib7	8370	23	,	,	,
cord-005453-4057qib7	8370	24	immune	immune	JJ
cord-005453-4057qib7	8370	25	phenotype	phenotype	NN
cord-005453-4057qib7	8370	26	and	and	CC
cord-005453-4057qib7	8370	27	function	function	NN
cord-005453-4057qib7	8370	28	,	,	,
cord-005453-4057qib7	8370	29	1	1	CD
cord-005453-4057qib7	8370	30	with	with	IN
cord-005453-4057qib7	8370	31	prenatal	prenatal	JJ
cord-005453-4057qib7	8370	32	exposure	exposure	NN
cord-005453-4057qib7	8370	33	to	to	IN
cord-005453-4057qib7	8370	34	6-mecaptopurine	6-mecaptopurine	CD
cord-005453-4057qib7	8370	35	(	(	-LRB-
cord-005453-4057qib7	8370	36	6-MP	6-mp	CD
cord-005453-4057qib7	8370	37	)	)	-RRB-
cord-005453-4057qib7	8370	38	,	,	,
cord-005453-4057qib7	8370	39	3	3	CD
cord-005453-4057qib7	8370	40	genetically	genetically	RB
cord-005453-4057qib7	8370	41	confirmed	confirm	VBN
cord-005453-4057qib7	8370	42	with	with	IN
cord-005453-4057qib7	8370	43	DiGeorge	DiGeorge	NNP
cord-005453-4057qib7	8370	44	Syndrome	Syndrome	NNP
cord-005453-4057qib7	8370	45	,	,	,
cord-005453-4057qib7	8370	46	and	and	CC
cord-005453-4057qib7	8370	47	3	3	CD
cord-005453-4057qib7	8370	48	with	with	IN
cord-005453-4057qib7	8370	49	prolonged	prolonged	JJ
cord-005453-4057qib7	8370	50	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	8370	51	.	.	.
cord-005453-4057qib7	8371	1	Of	of	IN
cord-005453-4057qib7	8371	2	the	the	DT
cord-005453-4057qib7	8371	3	three	three	CD
cord-005453-4057qib7	8371	4	with	with	IN
cord-005453-4057qib7	8371	5	prolonged	prolonged	JJ
cord-005453-4057qib7	8371	6	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	8371	7	,	,	,
cord-005453-4057qib7	8371	8	two	two	CD
cord-005453-4057qib7	8371	9	had	have	VBD
cord-005453-4057qib7	8371	10	recurrent	recurrent	JJ
cord-005453-4057qib7	8371	11	infections	infection	NNS
cord-005453-4057qib7	8371	12	:	:	:
cord-005453-4057qib7	8371	13	one	one	CD
cord-005453-4057qib7	8371	14	ultimately	ultimately	RB
cord-005453-4057qib7	8371	15	diagnosed	diagnose	VBN
cord-005453-4057qib7	8371	16	with	with	IN
cord-005453-4057qib7	8371	17	Ataxia	Ataxia	NNP
cord-005453-4057qib7	8371	18	Telangiectasia	Telangiectasia	NNP
cord-005453-4057qib7	8371	19	and	and	CC
cord-005453-4057qib7	8371	20	one	one	CD
cord-005453-4057qib7	8371	21	with	with	IN
cord-005453-4057qib7	8371	22	absent	absent	JJ
cord-005453-4057qib7	8371	23	TREC	TREC	NNP
cord-005453-4057qib7	8371	24	but	but	CC
cord-005453-4057qib7	8371	25	near	near	IN
cord-005453-4057qib7	8371	26	normal	normal	JJ
cord-005453-4057qib7	8371	27	number	number	NN
cord-005453-4057qib7	8371	28	of	of	IN
cord-005453-4057qib7	8371	29	T	t	NN
cord-005453-4057qib7	8371	30	cells	cell	NNS
cord-005453-4057qib7	8371	31	,	,	,
cord-005453-4057qib7	8371	32	normal	normal	JJ
cord-005453-4057qib7	8371	33	PHA	pha	NN
cord-005453-4057qib7	8371	34	but	but	CC
cord-005453-4057qib7	8371	35	no	no	DT
cord-005453-4057qib7	8371	36	specific	specific	JJ
cord-005453-4057qib7	8371	37	antigen	antigen	NN
cord-005453-4057qib7	8371	38	responses	response	NNS
cord-005453-4057qib7	8371	39	,	,	,
cord-005453-4057qib7	8371	40	and	and	CC
cord-005453-4057qib7	8371	41	absent	absent	JJ
cord-005453-4057qib7	8371	42	B	b	NN
cord-005453-4057qib7	8371	43	cells	cell	NNS
cord-005453-4057qib7	8371	44	who	who	WP
cord-005453-4057qib7	8371	45	will	will	MD
cord-005453-4057qib7	8371	46	be	be	VB
cord-005453-4057qib7	8371	47	undergoing	undergo	VBG
cord-005453-4057qib7	8371	48	transplant	transplant	NN
cord-005453-4057qib7	8371	49	in	in	IN
cord-005453-4057qib7	8371	50	the	the	DT
cord-005453-4057qib7	8371	51	near	near	JJ
cord-005453-4057qib7	8371	52	future	future	NN
cord-005453-4057qib7	8371	53	.	.	.
cord-005453-4057qib7	8372	1	The	the	DT
cord-005453-4057qib7	8372	2	third	third	JJ
cord-005453-4057qib7	8372	3	continues	continue	VBZ
cord-005453-4057qib7	8372	4	with	with	IN
cord-005453-4057qib7	8372	5	absent	absent	JJ
cord-005453-4057qib7	8372	6	TREC	TREC	NNP
cord-005453-4057qib7	8372	7	,	,	,
cord-005453-4057qib7	8372	8	short	short	JJ
cord-005453-4057qib7	8372	9	telomeres	telomere	NNS
cord-005453-4057qib7	8372	10	,	,	,
cord-005453-4057qib7	8372	11	low	low	JJ
cord-005453-4057qib7	8372	12	numbers	number	NNS
cord-005453-4057qib7	8372	13	of	of	IN
cord-005453-4057qib7	8372	14	a	a	DT
cord-005453-4057qib7	8372	15	/	/	SYM
cord-005453-4057qib7	8372	16	b	b	NN
cord-005453-4057qib7	8372	17	T	t	NN
cord-005453-4057qib7	8372	18	cells	cell	NNS
cord-005453-4057qib7	8372	19	,	,	,
cord-005453-4057qib7	8372	20	presence	presence	NN
cord-005453-4057qib7	8372	21	of	of	IN
cord-005453-4057qib7	8372	22	g	g	NN
cord-005453-4057qib7	8372	23	/	/	SYM
cord-005453-4057qib7	8372	24	d	d	NNP
cord-005453-4057qib7	8372	25	T	t	NN
cord-005453-4057qib7	8372	26	cells	cell	NNS
cord-005453-4057qib7	8372	27	,	,	,
cord-005453-4057qib7	8372	28	vaccine	vaccine	NN
cord-005453-4057qib7	8372	29	responses	response	NNS
cord-005453-4057qib7	8372	30	and	and	CC
cord-005453-4057qib7	8372	31	freedom	freedom	NN
cord-005453-4057qib7	8372	32	from	from	IN
cord-005453-4057qib7	8372	33	infection	infection	NN
cord-005453-4057qib7	8372	34	with	with	IN
cord-005453-4057qib7	8372	35	no	no	DT
cord-005453-4057qib7	8372	36	identified	identify	VBN
cord-005453-4057qib7	8372	37	genetic	genetic	JJ
cord-005453-4057qib7	8372	38	etiology	etiology	NN
cord-005453-4057qib7	8372	39	.	.	.
cord-005453-4057qib7	8373	1	In	in	IN
cord-005453-4057qib7	8373	2	summary	summary	NN
cord-005453-4057qib7	8373	3	,	,	,
cord-005453-4057qib7	8373	4	30	30	CD
cord-005453-4057qib7	8373	5	%	%	NN
cord-005453-4057qib7	8373	6	of	of	IN
cord-005453-4057qib7	8373	7	the	the	DT
cord-005453-4057qib7	8373	8	patients	patient	NNS
cord-005453-4057qib7	8373	9	referred	refer	VBN
cord-005453-4057qib7	8373	10	to	to	IN
cord-005453-4057qib7	8373	11	MSK	MSK	NNP
cord-005453-4057qib7	8373	12	with	with	IN
cord-005453-4057qib7	8373	13	confirmed	confirm	VBN
cord-005453-4057qib7	8373	14	abnormal	abnormal	JJ
cord-005453-4057qib7	8373	15	NBS	NBS	NNP
cord-005453-4057qib7	8373	16	for	for	IN
cord-005453-4057qib7	8373	17	SCID	SCID	NNP
cord-005453-4057qib7	8373	18	have	have	VBP
cord-005453-4057qib7	8373	19	a	a	DT
cord-005453-4057qib7	8373	20	non	non	JJ
cord-005453-4057qib7	8373	21	-	-	JJ
cord-005453-4057qib7	8373	22	SCID	scid	JJ
cord-005453-4057qib7	8373	23	diagnosis	diagnosis	NN
cord-005453-4057qib7	8373	24	.	.	.
cord-005453-4057qib7	8374	1	There	there	EX
cord-005453-4057qib7	8374	2	is	be	VBZ
cord-005453-4057qib7	8374	3	no	no	DT
cord-005453-4057qib7	8374	4	uniform	uniform	JJ
cord-005453-4057qib7	8374	5	collection	collection	NN
cord-005453-4057qib7	8374	6	of	of	IN
cord-005453-4057qib7	8374	7	data	datum	NNS
cord-005453-4057qib7	8374	8	for	for	IN
cord-005453-4057qib7	8374	9	these	these	DT
cord-005453-4057qib7	8374	10	infants	infant	NNS
cord-005453-4057qib7	8374	11	and	and	CC
cord-005453-4057qib7	8374	12	the	the	DT
cord-005453-4057qib7	8374	13	threshold	threshold	NN
cord-005453-4057qib7	8374	14	trigger	trigger	NN
cord-005453-4057qib7	8374	15	for	for	IN
cord-005453-4057qib7	8374	16	repeat	repeat	NN
cord-005453-4057qib7	8374	17	testing	testing	NN
cord-005453-4057qib7	8374	18	varies	vary	VBZ
cord-005453-4057qib7	8374	19	from	from	IN
cord-005453-4057qib7	8374	20	state	state	NN
cord-005453-4057qib7	8374	21	to	to	IN
cord-005453-4057qib7	8374	22	state	state	NN
cord-005453-4057qib7	8374	23	,	,	,
cord-005453-4057qib7	8374	24	so	so	CC
cord-005453-4057qib7	8374	25	the	the	DT
cord-005453-4057qib7	8374	26	incidence	incidence	NN
cord-005453-4057qib7	8374	27	of	of	IN
cord-005453-4057qib7	8374	28	significant	significant	JJ
cord-005453-4057qib7	8374	29	non	non	JJ
cord-005453-4057qib7	8374	30	-	-	JJ
cord-005453-4057qib7	8374	31	SCID	scid	JJ
cord-005453-4057qib7	8374	32	disorders	disorder	NNS
cord-005453-4057qib7	8374	33	identified	identify	VBN
cord-005453-4057qib7	8374	34	will	will	MD
cord-005453-4057qib7	8374	35	also	also	RB
cord-005453-4057qib7	8374	36	likely	likely	RB
cord-005453-4057qib7	8374	37	vary	vary	VB
cord-005453-4057qib7	8374	38	from	from	IN
cord-005453-4057qib7	8374	39	state	state	NN
cord-005453-4057qib7	8374	40	to	to	IN
cord-005453-4057qib7	8374	41	state	state	NN
cord-005453-4057qib7	8374	42	.	.	.
cord-005453-4057qib7	8375	1	Although	although	IN
cord-005453-4057qib7	8375	2	our	-PRON-	PRP$
cord-005453-4057qib7	8375	3	institution	institution	NN
cord-005453-4057qib7	8375	4	specific	specific	JJ
cord-005453-4057qib7	8375	5	experience	experience	NN
cord-005453-4057qib7	8375	6	is	be	VBZ
cord-005453-4057qib7	8375	7	biased	biased	JJ
cord-005453-4057qib7	8375	8	,	,	,
cord-005453-4057qib7	8375	9	as	as	IN
cord-005453-4057qib7	8375	10	most	most	JJS
cord-005453-4057qib7	8375	11	infants	infant	NNS
cord-005453-4057qib7	8375	12	had	have	VBD
cord-005453-4057qib7	8375	13	confirmation	confirmation	NN
cord-005453-4057qib7	8375	14	of	of	IN
cord-005453-4057qib7	8375	15	a	a	DT
cord-005453-4057qib7	8375	16	low	low	JJ
cord-005453-4057qib7	8375	17	number	number	NN
cord-005453-4057qib7	8375	18	of	of	IN
cord-005453-4057qib7	8375	19	TREC	TREC	NNP
cord-005453-4057qib7	8375	20	prior	prior	RB
cord-005453-4057qib7	8375	21	to	to	IN
cord-005453-4057qib7	8375	22	referral	referral	NN
cord-005453-4057qib7	8375	23	,	,	,
cord-005453-4057qib7	8375	24	the	the	DT
cord-005453-4057qib7	8375	25	significant	significant	JJ
cord-005453-4057qib7	8375	26	number	number	NN
cord-005453-4057qib7	8375	27	of	of	IN
cord-005453-4057qib7	8375	28	disorders	disorder	NNS
cord-005453-4057qib7	8375	29	in	in	IN
cord-005453-4057qib7	8375	30	the	the	DT
cord-005453-4057qib7	8375	31	non	non	JJ
cord-005453-4057qib7	8375	32	-	-	JJ
cord-005453-4057qib7	8375	33	SCID	scid	JJ
cord-005453-4057qib7	8375	34	cohort	cohort	NN
cord-005453-4057qib7	8375	35	emphasizes	emphasize	VBZ
cord-005453-4057qib7	8375	36	the	the	DT
cord-005453-4057qib7	8375	37	importance	importance	NN
cord-005453-4057qib7	8375	38	of	of	IN
cord-005453-4057qib7	8375	39	full	full	JJ
cord-005453-4057qib7	8375	40	evaluations	evaluation	NNS
cord-005453-4057qib7	8375	41	and	and	CC
cord-005453-4057qib7	8375	42	follow	follow	NN
cord-005453-4057qib7	8375	43	-	-	HYPH
cord-005453-4057qib7	8375	44	up	up	NN
cord-005453-4057qib7	8375	45	for	for	IN
cord-005453-4057qib7	8375	46	these	these	DT
cord-005453-4057qib7	8375	47	infants	infant	NNS
cord-005453-4057qib7	8375	48	.	.	.
cord-005453-4057qib7	8376	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8376	2	:	:	:
cord-005453-4057qib7	8377	1	None	none	NN
cord-005453-4057qib7	8377	2	of	of	IN
cord-005453-4057qib7	8377	3	these	these	DT
cord-005453-4057qib7	8377	4	relate	relate	VBP
cord-005453-4057qib7	8377	5	to	to	IN
cord-005453-4057qib7	8377	6	the	the	DT
cord-005453-4057qib7	8377	7	work	work	NN
cord-005453-4057qib7	8377	8	being	be	VBG
cord-005453-4057qib7	8377	9	presented	present	VBN
cord-005453-4057qib7	8377	10	.	.	.
cord-005453-4057qib7	8378	1	Susan	Susan	NNP
cord-005453-4057qib7	8378	2	Prockop	Prockop	NNP
cord-005453-4057qib7	8378	3	-research	-research	:
cord-005453-4057qib7	8378	4	funding	fund	VBG
cord-005453-4057qib7	8378	5	Mesoblast	Mesoblast	NNP
cord-005453-4057qib7	8378	6	and	and	CC
cord-005453-4057qib7	8378	7	Atara	Atara	NNP
cord-005453-4057qib7	8378	8	Biotherapeutics	Biotherapeutics	NNPS
cord-005453-4057qib7	8378	9	.	.	.
cord-005453-4057qib7	8379	1	Nancy	Nancy	NNP
cord-005453-4057qib7	8379	2	Kernan	Kernan	NNP
cord-005453-4057qib7	8379	3	-research	-research	:
cord-005453-4057qib7	8379	4	funding	fund	VBG
cord-005453-4057qib7	8379	5	Jaz	Jaz	NNP
cord-005453-4057qib7	8379	6	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	8379	7	.	.	.
cord-005453-4057qib7	8380	1	Richard	Richard	NNP
cord-005453-4057qib7	8381	1	O´Reilly	o´reilly	RB
cord-005453-4057qib7	8381	2	research	research	NN
cord-005453-4057qib7	8381	3	funding	funding	NN
cord-005453-4057qib7	8381	4	and	and	CC
cord-005453-4057qib7	8381	5	royalties	royalty	NNS
cord-005453-4057qib7	8381	6	Atara	Atara	NNP
cord-005453-4057qib7	8381	7	Biotherapeutics	Biotherapeutics	NNPS
cord-005453-4057qib7	8381	8	.	.	.
cord-005453-4057qib7	8382	1	Kevin	Kevin	NNP
cord-005453-4057qib7	8382	2	Curran	Curran	NNP
cord-005453-4057qib7	8382	3	consulting	consult	VBG
cord-005453-4057qib7	8382	4	Juno	Juno	NNP
cord-005453-4057qib7	8382	5	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	8382	6	,	,	,
cord-005453-4057qib7	8382	7	Novartis	Novartis	NNP
cord-005453-4057qib7	8382	8	.	.	.
cord-005453-4057qib7	8383	1	J.J.	J.J.	NNP
cord-005453-4057qib7	8383	2	Boelens	Boelens	NNP
cord-005453-4057qib7	8383	3	Avrobio	Avrobio	NNP
cord-005453-4057qib7	8383	4	,	,	,
cord-005453-4057qib7	8383	5	Magenta	Magenta	NNP
cord-005453-4057qib7	8383	6	,	,	,
cord-005453-4057qib7	8383	7	Chimerix	Chimerix	NNP
cord-005453-4057qib7	8383	8	and	and	CC
cord-005453-4057qib7	8383	9	BlueBird	BlueBird	NNP
cord-005453-4057qib7	8383	10	Bio	Bio	NNP
cord-005453-4057qib7	8383	11	Background	Background	NNP
cord-005453-4057qib7	8383	12	:	:	:
cord-005453-4057qib7	8383	13	Post	post	JJ
cord-005453-4057qib7	8383	14	-	-	JJ
cord-005453-4057qib7	8383	15	transplant	transplant	JJ
cord-005453-4057qib7	8383	16	autoimmune	autoimmune	NN
cord-005453-4057qib7	8383	17	cytopenia	cytopenia	NNP
cord-005453-4057qib7	8383	18	(	(	-LRB-
cord-005453-4057qib7	8383	19	AIC	AIC	NNP
cord-005453-4057qib7	8383	20	)	)	-RRB-
cord-005453-4057qib7	8383	21	is	be	VBZ
cord-005453-4057qib7	8383	22	challenging	challenge	VBG
cord-005453-4057qib7	8383	23	and	and	CC
cord-005453-4057qib7	8383	24	associated	associate	VBN
cord-005453-4057qib7	8383	25	with	with	IN
cord-005453-4057qib7	8383	26	substantial	substantial	JJ
cord-005453-4057qib7	8383	27	morbidity	morbidity	NN
cord-005453-4057qib7	8383	28	and	and	CC
cord-005453-4057qib7	8383	29	mortality	mortality	NN
cord-005453-4057qib7	8383	30	.	.	.
cord-005453-4057qib7	8384	1	We	-PRON-	PRP
cord-005453-4057qib7	8384	2	aimed	aim	VBD
cord-005453-4057qib7	8384	3	to	to	TO
cord-005453-4057qib7	8384	4	study	study	VB
cord-005453-4057qib7	8384	5	the	the	DT
cord-005453-4057qib7	8384	6	cumulative	cumulative	JJ
cord-005453-4057qib7	8384	7	incidence	incidence	NN
cord-005453-4057qib7	8384	8	(	(	-LRB-
cord-005453-4057qib7	8384	9	CI	CI	NNP
cord-005453-4057qib7	8384	10	)	)	-RRB-
cord-005453-4057qib7	8384	11	of	of	IN
cord-005453-4057qib7	8384	12	post	post	JJ
cord-005453-4057qib7	8384	13	-	-	JJ
cord-005453-4057qib7	8384	14	HCT	hct	JJ
cord-005453-4057qib7	8384	15	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8384	16	cytopenia	cytopenia	NN
cord-005453-4057qib7	8384	17	(	(	-LRB-
cord-005453-4057qib7	8384	18	AIC	AIC	NNP
cord-005453-4057qib7	8384	19	)	)	-RRB-
cord-005453-4057qib7	8384	20	and	and	CC
cord-005453-4057qib7	8384	21	its	-PRON-	PRP$
cord-005453-4057qib7	8384	22	predictors	predictor	NNS
cord-005453-4057qib7	8384	23	in	in	IN
cord-005453-4057qib7	8384	24	a	a	DT
cord-005453-4057qib7	8384	25	cohort	cohort	NN
cord-005453-4057qib7	8384	26	of	of	IN
cord-005453-4057qib7	8384	27	children	child	NNS
cord-005453-4057qib7	8384	28	with	with	IN
cord-005453-4057qib7	8384	29	primary	primary	JJ
cord-005453-4057qib7	8384	30	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8384	31	(	(	-LRB-
cord-005453-4057qib7	8384	32	PID	PID	NNP
cord-005453-4057qib7	8384	33	)	)	-RRB-
cord-005453-4057qib7	8384	34	.	.	.
cord-005453-4057qib7	8385	1	Methods	method	NNS
cord-005453-4057qib7	8385	2	:	:	:
cord-005453-4057qib7	8385	3	In	in	IN
cord-005453-4057qib7	8385	4	this	this	DT
cord-005453-4057qib7	8385	5	retrospective	retrospective	JJ
cord-005453-4057qib7	8385	6	study	study	NN
cord-005453-4057qib7	8385	7	,	,	,
cord-005453-4057qib7	8385	8	we	-PRON-	PRP
cord-005453-4057qib7	8385	9	included	include	VBD
cord-005453-4057qib7	8385	10	199	199	CD
cord-005453-4057qib7	8385	11	children	child	NNS
cord-005453-4057qib7	8385	12	with	with	IN
cord-005453-4057qib7	8385	13	PID	PID	NNP
cord-005453-4057qib7	8385	14	who	who	WP
cord-005453-4057qib7	8385	15	underwent	undergo	VBD
cord-005453-4057qib7	8385	16	their	-PRON-	PRP$
cord-005453-4057qib7	8385	17	first	first	JJ
cord-005453-4057qib7	8385	18	HSCT	HSCT	NNP
cord-005453-4057qib7	8385	19	with	with	IN
cord-005453-4057qib7	8385	20	fludarabine(F)-Treosulfan(T)±Thiotepa(Thio	fludarabine(F)-Treosulfan(T)±Thiotepa(Thio	NNP
cord-005453-4057qib7	8385	21	)	)	-RRB-
cord-005453-4057qib7	8385	22	at	at	IN
cord-005453-4057qib7	8385	23	Great	Great	NNP
cord-005453-4057qib7	8385	24	North	North	NNP
cord-005453-4057qib7	8385	25	Children	Children	NNPS
cord-005453-4057qib7	8385	26	's	's	POS
cord-005453-4057qib7	8385	27	Hospital	Hospital	NNP
cord-005453-4057qib7	8385	28	from	from	IN
cord-005453-4057qib7	8385	29	2007	2007	CD
cord-005453-4057qib7	8385	30	-	-	SYM
cord-005453-4057qib7	8385	31	2017	2017	CD
cord-005453-4057qib7	8385	32	.	.	.
cord-005453-4057qib7	8386	1	Main	main	JJ
cord-005453-4057qib7	8386	2	outcomes	outcome	NNS
cord-005453-4057qib7	8386	3	of	of	IN
cord-005453-4057qib7	8386	4	interest	interest	NN
cord-005453-4057qib7	8386	5	were	be	VBD
cord-005453-4057qib7	8386	6	the	the	DT
cord-005453-4057qib7	8386	7	CI	CI	NNP
cord-005453-4057qib7	8386	8	of	of	IN
cord-005453-4057qib7	8386	9	AIC	AIC	NNP
cord-005453-4057qib7	8386	10	and	and	CC
cord-005453-4057qib7	8386	11	its	-PRON-	PRP$
cord-005453-4057qib7	8386	12	predictors	predictor	NNS
cord-005453-4057qib7	8386	13	.	.	.
cord-005453-4057qib7	8387	1	Fine	fine	JJ
cord-005453-4057qib7	8387	2	-	-	HYPH
cord-005453-4057qib7	8387	3	and	and	CC
cord-005453-4057qib7	8387	4	-	-	HYPH
cord-005453-4057qib7	8387	5	Grey	grey	JJ
cord-005453-4057qib7	8387	6	regression	regression	NN
cord-005453-4057qib7	8387	7	models	model	NNS
cord-005453-4057qib7	8387	8	were	be	VBD
cord-005453-4057qib7	8387	9	used	use	VBN
cord-005453-4057qib7	8387	10	to	to	TO
cord-005453-4057qib7	8387	11	analyse	analyse	VB
cord-005453-4057qib7	8387	12	predictors	predictor	NNS
cord-005453-4057qib7	8387	13	of	of	IN
cord-005453-4057qib7	8387	14	AIC	AIC	NNP
cord-005453-4057qib7	8387	15	,	,	,
cord-005453-4057qib7	8387	16	considering	consider	VBG
cord-005453-4057qib7	8387	17	death	death	NN
cord-005453-4057qib7	8387	18	as	as	IN
cord-005453-4057qib7	8387	19	a	a	DT
cord-005453-4057qib7	8387	20	competing	compete	VBG
cord-005453-4057qib7	8387	21	event	event	NN
cord-005453-4057qib7	8387	22	.	.	.
cord-005453-4057qib7	8388	1	Variables	variable	NNS
cord-005453-4057qib7	8388	2	included	include	VBN
cord-005453-4057qib7	8388	3	were	be	VBD
cord-005453-4057qib7	8388	4	age	age	NN
cord-005453-4057qib7	8388	5	at	at	IN
cord-005453-4057qib7	8388	6	transplant	transplant	NN
cord-005453-4057qib7	8388	7	(	(	-LRB-
cord-005453-4057qib7	8388	8	<	<	NNP
cord-005453-4057qib7	8388	9	2.5	2.5	CD
cord-005453-4057qib7	8388	10	years	year	NNS
cord-005453-4057qib7	8388	11	vs	vs	IN
cord-005453-4057qib7	8388	12	>	>	XX
cord-005453-4057qib7	8388	13	2.5	2.5	CD
cord-005453-4057qib7	8388	14	years	year	NNS
cord-005453-4057qib7	8388	15	)	)	-RRB-
cord-005453-4057qib7	8388	16	,	,	,
cord-005453-4057qib7	8388	17	gender	gender	NN
cord-005453-4057qib7	8388	18	,	,	,
cord-005453-4057qib7	8388	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	8388	20	(	(	-LRB-
cord-005453-4057qib7	8388	21	SCID	SCID	NNP
cord-005453-4057qib7	8388	22	vs	vs	IN
cord-005453-4057qib7	8388	23	immune	immune	NN
cord-005453-4057qib7	8388	24	-	-	HYPH
cord-005453-4057qib7	8388	25	dysregulatory	dysregulatory	JJ
cord-005453-4057qib7	8388	26	disorders	disorder	NNS
cord-005453-4057qib7	8388	27	vs	vs	IN
cord-005453-4057qib7	8388	28	other	other	JJ
cord-005453-4057qib7	8388	29	PIDs	pid	NNS
cord-005453-4057qib7	8388	30	)	)	-RRB-
cord-005453-4057qib7	8388	31	,	,	,
cord-005453-4057qib7	8388	32	pre	pre	JJ
cord-005453-4057qib7	8388	33	-	-	JJ
cord-005453-4057qib7	8388	34	transplant	transplant	NN
cord-005453-4057qib7	8388	35	AIC	AIC	NNP
cord-005453-4057qib7	8388	36	,	,	,
cord-005453-4057qib7	8388	37	pre	pre	JJ
cord-005453-4057qib7	8388	38	-	-	JJ
cord-005453-4057qib7	8388	39	and	and	CC
cord-005453-4057qib7	8388	40	posttransplant	posttransplant	JJ
cord-005453-4057qib7	8388	41	respiratory	respiratory	JJ
cord-005453-4057qib7	8388	42	virus	virus	NN
cord-005453-4057qib7	8388	43	,	,	,
cord-005453-4057qib7	8388	44	donor	donor	NN
cord-005453-4057qib7	8388	45	(	(	-LRB-
cord-005453-4057qib7	8388	46	MFD	MFD	NNP
cord-005453-4057qib7	8388	47	vs	vs	IN
cord-005453-4057qib7	8388	48	MUD	mud	NN
cord-005453-4057qib7	8388	49	vs	vs	IN
cord-005453-4057qib7	8388	50	MMFD	MMFD	NNP
cord-005453-4057qib7	8388	51	/	/	SYM
cord-005453-4057qib7	8388	52	MMUD	MMUD	NNP
cord-005453-4057qib7	8388	53	vs	vs	IN
cord-005453-4057qib7	8388	54	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8388	55	donor	donor	NN
cord-005453-4057qib7	8388	56	)	)	-RRB-
cord-005453-4057qib7	8388	57	,	,	,
cord-005453-4057qib7	8388	58	ABO	ABO	NNP
cord-005453-4057qib7	8388	59	incompatibility	incompatibility	NN
cord-005453-4057qib7	8388	60	,	,	,
cord-005453-4057qib7	8388	61	conditioning	conditioning	NN
cord-005453-4057qib7	8388	62	(	(	-LRB-
cord-005453-4057qib7	8388	63	FT	FT	NNP
cord-005453-4057qib7	8388	64	vs	vs	IN
cord-005453-4057qib7	8388	65	FTThio	FTThio	NNP
cord-005453-4057qib7	8388	66	)	)	-RRB-
cord-005453-4057qib7	8388	67	,	,	,
cord-005453-4057qib7	8388	68	serotherapy	serotherapy	NNP
cord-005453-4057qib7	8388	69	(	(	-LRB-
cord-005453-4057qib7	8388	70	none	none	NN
cord-005453-4057qib7	8388	71	vs	vs	IN
cord-005453-4057qib7	8388	72	alemtuzumab	alemtuzumab	NNP
cord-005453-4057qib7	8388	73	0.3	0.3	CD
cord-005453-4057qib7	8388	74	-	-	SYM
cord-005453-4057qib7	8388	75	0.6	0.6	CD
cord-005453-4057qib7	8388	76	mg	mg	NN
cord-005453-4057qib7	8389	1	/kg	/kg	NFP
cord-005453-4057qib7	8389	2	vs	vs	IN
cord-005453-4057qib7	8389	3	alemtuzumab	alemtuzumab	NNP
cord-005453-4057qib7	8389	4	0.9	0.9	CD
cord-005453-4057qib7	8389	5	-	-	HYPH
cord-005453-4057qib7	8389	6	1.0mg	1.0mg	CD
cord-005453-4057qib7	8389	7	/	/	SYM
cord-005453-4057qib7	8389	8	kg	kg	NN
cord-005453-4057qib7	8389	9	vs	vs	IN
cord-005453-4057qib7	8389	10	ATG	ATG	NNP
cord-005453-4057qib7	8389	11	)	)	-RRB-
cord-005453-4057qib7	8389	12	,	,	,
cord-005453-4057qib7	8389	13	stem	stem	VBP
cord-005453-4057qib7	8389	14	cell	cell	NN
cord-005453-4057qib7	8389	15	source	source	NN
cord-005453-4057qib7	8390	1	(	(	-LRB-
cord-005453-4057qib7	8390	2	marrow	marrow	NN
cord-005453-4057qib7	8390	3	vs	vs	IN
cord-005453-4057qib7	8390	4	PBSC	PBSC	NNP
cord-005453-4057qib7	8390	5	vs	vs	IN
cord-005453-4057qib7	8390	6	cord	cord	NN
cord-005453-4057qib7	8390	7	vs	vs	IN
cord-005453-4057qib7	8390	8	exvivo	exvivo	NNP
cord-005453-4057qib7	8390	9	T	T	NNP
cord-005453-4057qib7	8390	10	depleted	deplete	VBN
cord-005453-4057qib7	8390	11	PBSC	PBSC	NNP
cord-005453-4057qib7	8390	12	)	)	-RRB-
cord-005453-4057qib7	8390	13	,	,	,
cord-005453-4057qib7	8390	14	infused	infuse	VBN
cord-005453-4057qib7	8390	15	stem	stem	NN
cord-005453-4057qib7	8390	16	cell	cell	NN
cord-005453-4057qib7	8390	17	doses	dose	NNS
cord-005453-4057qib7	8390	18	(	(	-LRB-
cord-005453-4057qib7	8390	19	TNC	TNC	NNP
cord-005453-4057qib7	8390	20	,	,	,
cord-005453-4057qib7	8390	21	CD34	CD34	NNP
cord-005453-4057qib7	8390	22	and	and	CC
cord-005453-4057qib7	8390	23	CD3	CD3	NNP
cord-005453-4057qib7	8390	24	)	)	-RRB-
cord-005453-4057qib7	8390	25	,	,	,
cord-005453-4057qib7	8390	26	aGvHD	aGvHD	NNP
cord-005453-4057qib7	8390	27	(	(	-LRB-
cord-005453-4057qib7	8390	28	none	none	NN
cord-005453-4057qib7	8390	29	vs	vs	IN
cord-005453-4057qib7	8390	30	any	any	DT
cord-005453-4057qib7	8390	31	aGvHD	agvhd	NN
cord-005453-4057qib7	8390	32	)	)	-RRB-
cord-005453-4057qib7	8390	33	,	,	,
cord-005453-4057qib7	8390	34	cGvHD	cGvHD	NNP
cord-005453-4057qib7	8390	35	(	(	-LRB-
cord-005453-4057qib7	8390	36	none	none	NN
cord-005453-4057qib7	8390	37	vs	vs	IN
cord-005453-4057qib7	8390	38	any	any	DT
cord-005453-4057qib7	8390	39	cGvHD	cgvhd	NN
cord-005453-4057qib7	8390	40	)	)	-RRB-
cord-005453-4057qib7	8390	41	,	,	,
cord-005453-4057qib7	8390	42	viral	viral	JJ
cord-005453-4057qib7	8390	43	infections	infection	NNS
cord-005453-4057qib7	8390	44	(	(	-LRB-
cord-005453-4057qib7	8390	45	CMV	CMV	NNP
cord-005453-4057qib7	8390	46	/	/	SYM
cord-005453-4057qib7	8390	47	adenovirus/	adenovirus/	NN
cord-005453-4057qib7	8390	48	EBV	EBV	NNP
cord-005453-4057qib7	8390	49	/	/	SYM
cord-005453-4057qib7	8390	50	HHV6	HHV6	NNP
cord-005453-4057qib7	8390	51	viraemia	viraemia	NN
cord-005453-4057qib7	8390	52	)	)	-RRB-
cord-005453-4057qib7	8390	53	,	,	,
cord-005453-4057qib7	8390	54	chimerism	chimerism	NN
cord-005453-4057qib7	8390	55	(	(	-LRB-
cord-005453-4057qib7	8390	56	full	full	JJ
cord-005453-4057qib7	8390	57	vs	vs	IN
cord-005453-4057qib7	8390	58	mixed	mixed	JJ
cord-005453-4057qib7	8390	59	chimerism	chimerism	NN
cord-005453-4057qib7	8390	60	(	(	-LRB-
cord-005453-4057qib7	8390	61	WB	WB	NNP
cord-005453-4057qib7	8390	62	<	<	XX
cord-005453-4057qib7	8390	63	95	95	CD
cord-005453-4057qib7	8390	64	%	%	NN
cord-005453-4057qib7	8390	65	)	)	-RRB-
cord-005453-4057qib7	8390	66	within	within	IN
cord-005453-4057qib7	8390	67	first	first	JJ
cord-005453-4057qib7	8390	68	year	year	NN
cord-005453-4057qib7	8390	69	post	post	NN
cord-005453-4057qib7	8390	70	-	-	JJ
cord-005453-4057qib7	8390	71	HCT	HCT	NNP
cord-005453-4057qib7	8390	72	)	)	-RRB-
cord-005453-4057qib7	8390	73	.	.	.
cord-005453-4057qib7	8391	1	Impact	Impact	NNP
cord-005453-4057qib7	8391	2	of	of	IN
cord-005453-4057qib7	8391	3	thymopoiesis	thymopoiesis	NN
cord-005453-4057qib7	8391	4	using	use	VBG
cord-005453-4057qib7	8391	5	naïve	naïve	JJ
cord-005453-4057qib7	8391	6	T	T	NNP
cord-005453-4057qib7	8391	7	cell	cell	NN
cord-005453-4057qib7	8391	8	recovery	recovery	NN
cord-005453-4057qib7	8391	9	was	be	VBD
cord-005453-4057qib7	8391	10	studied	study	VBN
cord-005453-4057qib7	8391	11	.	.	.
cord-005453-4057qib7	8392	1	Results	result	NNS
cord-005453-4057qib7	8392	2	:	:	:
cord-005453-4057qib7	8393	1	Median	median	JJ
cord-005453-4057qib7	8393	2	age	age	NN
cord-005453-4057qib7	8393	3	at	at	IN
cord-005453-4057qib7	8393	4	transplant	transplant	NN
cord-005453-4057qib7	8393	5	was	be	VBD
cord-005453-4057qib7	8393	6	2.4	2.4	CD
cord-005453-4057qib7	8393	7	years	year	NNS
cord-005453-4057qib7	8393	8	(	(	-LRB-
cord-005453-4057qib7	8393	9	range	range	NN
cord-005453-4057qib7	8393	10	,	,	,
cord-005453-4057qib7	8393	11	0.11	0.11	CD
cord-005453-4057qib7	8393	12	-	-	SYM
cord-005453-4057qib7	8393	13	18.3	18.3	CD
cord-005453-4057qib7	8393	14	years	year	NNS
cord-005453-4057qib7	8393	15	)	)	-RRB-
cord-005453-4057qib7	8393	16	.	.	.
cord-005453-4057qib7	8394	1	Primary	primary	JJ
cord-005453-4057qib7	8394	2	diagnoses	diagnosis	NNS
cord-005453-4057qib7	8394	3	were	be	VBD
cord-005453-4057qib7	8394	4	SCID	SCID	NNP
cord-005453-4057qib7	8394	5	(	(	-LRB-
cord-005453-4057qib7	8394	6	22	22	CD
cord-005453-4057qib7	8394	7	%	%	NN
cord-005453-4057qib7	8394	8	)	)	-RRB-
cord-005453-4057qib7	8394	9	,	,	,
cord-005453-4057qib7	8394	10	immune	immune	NN
cord-005453-4057qib7	8394	11	-	-	HYPH
cord-005453-4057qib7	8394	12	dysregulatory	dysregulatory	JJ
cord-005453-4057qib7	8394	13	disorders	disorder	NNS
cord-005453-4057qib7	8394	14	(	(	-LRB-
cord-005453-4057qib7	8394	15	28	28	CD
cord-005453-4057qib7	8394	16	%	%	NN
cord-005453-4057qib7	8394	17	)	)	-RRB-
cord-005453-4057qib7	8394	18	and	and	CC
cord-005453-4057qib7	8394	19	other	other	JJ
cord-005453-4057qib7	8394	20	PIDs	pid	NNS
cord-005453-4057qib7	8394	21	(	(	-LRB-
cord-005453-4057qib7	8394	22	50	50	CD
cord-005453-4057qib7	8394	23	%	%	NN
cord-005453-4057qib7	8394	24	)	)	-RRB-
cord-005453-4057qib7	8394	25	.	.	.
cord-005453-4057qib7	8395	1	Donors	donor	NNS
cord-005453-4057qib7	8395	2	were	be	VBD
cord-005453-4057qib7	8395	3	MFD	MFD	NNP
cord-005453-4057qib7	8395	4	(	(	-LRB-
cord-005453-4057qib7	8395	5	21	21	CD
cord-005453-4057qib7	8395	6	%	%	NN
cord-005453-4057qib7	8395	7	)	)	-RRB-
cord-005453-4057qib7	8395	8	,	,	,
cord-005453-4057qib7	8395	9	MUD	MUD	NNP
cord-005453-4057qib7	8395	10	(	(	-LRB-
cord-005453-4057qib7	8395	11	48	48	CD
cord-005453-4057qib7	8395	12	%	%	NN
cord-005453-4057qib7	8395	13	)	)	-RRB-
cord-005453-4057qib7	8395	14	,	,	,
cord-005453-4057qib7	8395	15	MMFD/	MMFD/	NNP
cord-005453-4057qib7	8395	16	MMUD	MMUD	NNP
cord-005453-4057qib7	8395	17	(	(	-LRB-
cord-005453-4057qib7	8395	18	16	16	CD
cord-005453-4057qib7	8395	19	%	%	NN
cord-005453-4057qib7	8395	20	)	)	-RRB-
cord-005453-4057qib7	8395	21	and	and	CC
cord-005453-4057qib7	8395	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8395	23	parents	parent	NNS
cord-005453-4057qib7	8395	24	(	(	-LRB-
cord-005453-4057qib7	8395	25	15	15	CD
cord-005453-4057qib7	8395	26	%	%	NN
cord-005453-4057qib7	8395	27	)	)	-RRB-
cord-005453-4057qib7	8395	28	.	.	.
cord-005453-4057qib7	8396	1	Stem	stem	JJ
cord-005453-4057qib7	8396	2	cell	cell	NN
cord-005453-4057qib7	8396	3	sources	source	NNS
cord-005453-4057qib7	8396	4	were	be	VBD
cord-005453-4057qib7	8396	5	marrow	marrow	NN
cord-005453-4057qib7	8396	6	(	(	-LRB-
cord-005453-4057qib7	8396	7	30	30	CD
cord-005453-4057qib7	8396	8	%	%	NN
cord-005453-4057qib7	8396	9	)	)	-RRB-
cord-005453-4057qib7	8396	10	,	,	,
cord-005453-4057qib7	8396	11	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	8396	12	PBSC	PBSC	NNP
cord-005453-4057qib7	8396	13	(	(	-LRB-
cord-005453-4057qib7	8396	14	38	38	CD
cord-005453-4057qib7	8396	15	%	%	NN
cord-005453-4057qib7	8396	16	)	)	-RRB-
cord-005453-4057qib7	8396	17	,	,	,
cord-005453-4057qib7	8396	18	ex	ex	NN
cord-005453-4057qib7	8396	19	-	-	NN
cord-005453-4057qib7	8396	20	vivo	vivo	JJ
cord-005453-4057qib7	8396	21	T	t	NN
cord-005453-4057qib7	8396	22	-	-	HYPH
cord-005453-4057qib7	8396	23	depleted	deplete	VBN
cord-005453-4057qib7	8396	24	PBSC	PBSC	NNP
cord-005453-4057qib7	8396	25	(	(	-LRB-
cord-005453-4057qib7	8396	26	23	23	CD
cord-005453-4057qib7	8396	27	%	%	NN
cord-005453-4057qib7	8396	28	)	)	-RRB-
cord-005453-4057qib7	8396	29	and	and	CC
cord-005453-4057qib7	8396	30	CB	CB	NNP
cord-005453-4057qib7	8396	31	(	(	-LRB-
cord-005453-4057qib7	8396	32	9	9	CD
cord-005453-4057qib7	8396	33	%	%	NN
cord-005453-4057qib7	8396	34	)	)	-RRB-
cord-005453-4057qib7	8396	35	.	.	.
cord-005453-4057qib7	8397	1	16	16	CD
cord-005453-4057qib7	8397	2	%	%	NN
cord-005453-4057qib7	8397	3	received	receive	VBD
cord-005453-4057qib7	8397	4	additional	additional	JJ
cord-005453-4057qib7	8397	5	thiotepa	thiotepa	NNS
cord-005453-4057qib7	8397	6	and	and	CC
cord-005453-4057qib7	8397	7	87	87	CD
cord-005453-4057qib7	8397	8	%	%	NN
cord-005453-4057qib7	8397	9	had	have	VBD
cord-005453-4057qib7	8397	10	CSA	CSA	NNP
cord-005453-4057qib7	8397	11	/	/	SYM
cord-005453-4057qib7	8397	12	MMF	MMF	NNP
cord-005453-4057qib7	8397	13	as	as	IN
cord-005453-4057qib7	8397	14	GvHD	GvHD	NNP
cord-005453-4057qib7	8397	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8397	16	.	.	.
cord-005453-4057qib7	8398	1	Median	median	JJ
cord-005453-4057qib7	8398	2	duration	duration	NN
cord-005453-4057qib7	8398	3	of	of	IN
cord-005453-4057qib7	8398	4	follow	follow	NN
cord-005453-4057qib7	8398	5	-	-	HYPH
cord-005453-4057qib7	8398	6	up	up	NN
cord-005453-4057qib7	8398	7	of	of	IN
cord-005453-4057qib7	8398	8	survivors	survivor	NNS
cord-005453-4057qib7	8398	9	was	be	VBD
cord-005453-4057qib7	8398	10	2.9	2.9	CD
cord-005453-4057qib7	8398	11	years	year	NNS
cord-005453-4057qib7	8398	12	(	(	-LRB-
cord-005453-4057qib7	8398	13	range	range	VBP
cord-005453-4057qib7	8398	14	0.2	0.2	CD
cord-005453-4057qib7	8398	15	to	to	IN
cord-005453-4057qib7	8398	16	10.2	10.2	CD
cord-005453-4057qib7	8398	17	years	year	NNS
cord-005453-4057qib7	8398	18	)	)	-RRB-
cord-005453-4057qib7	8398	19	.	.	.
cord-005453-4057qib7	8399	1	5-year	5-year	CD
cord-005453-4057qib7	8399	2	OS	os	NN
cord-005453-4057qib7	8399	3	for	for	IN
cord-005453-4057qib7	8399	4	the	the	DT
cord-005453-4057qib7	8399	5	entire	entire	JJ
cord-005453-4057qib7	8399	6	cohort	cohort	NN
cord-005453-4057qib7	8399	7	was	be	VBD
cord-005453-4057qib7	8399	8	81	81	CD
cord-005453-4057qib7	8399	9	%	%	NN
cord-005453-4057qib7	8399	10	.	.	.
cord-005453-4057qib7	8400	1	6-month	6-month	CD
cord-005453-4057qib7	8400	2	and	and	CC
cord-005453-4057qib7	8400	3	1-year	1-year	CD
cord-005453-4057qib7	8400	4	CI	CI	NNP
cord-005453-4057qib7	8400	5	of	of	IN
cord-005453-4057qib7	8400	6	AIC	AIC	NNP
cord-005453-4057qib7	8400	7	were	be	VBD
cord-005453-4057qib7	8400	8	5	5	CD
cord-005453-4057qib7	8400	9	%	%	NN
cord-005453-4057qib7	8400	10	and	and	CC
cord-005453-4057qib7	8400	11	13	13	CD
cord-005453-4057qib7	8400	12	%	%	NN
cord-005453-4057qib7	8400	13	.	.	.
cord-005453-4057qib7	8401	1	Of	of	IN
cord-005453-4057qib7	8401	2	21	21	CD
cord-005453-4057qib7	8401	3	developed	develop	VBN
cord-005453-4057qib7	8401	4	AIC	AIC	NNP
cord-005453-4057qib7	8401	5	,	,	,
cord-005453-4057qib7	8401	6	17	17	CD
cord-005453-4057qib7	8401	7	(	(	-LRB-
cord-005453-4057qib7	8401	8	80	80	CD
cord-005453-4057qib7	8401	9	%	%	NN
cord-005453-4057qib7	8401	10	)	)	-RRB-
cord-005453-4057qib7	8401	11	had	have	VBD
cord-005453-4057qib7	8401	12	AIHA	AIHA	NNP
cord-005453-4057qib7	8401	13	,	,	,
cord-005453-4057qib7	8401	14	3	3	CD
cord-005453-4057qib7	8401	15	(	(	-LRB-
cord-005453-4057qib7	8401	16	15	15	CD
cord-005453-4057qib7	8401	17	%	%	NN
cord-005453-4057qib7	8401	18	)	)	-RRB-
cord-005453-4057qib7	8402	1	had	have	VBD
cord-005453-4057qib7	8402	2	AIHA±ITP	AIHA±ITP	NNP
cord-005453-4057qib7	8402	3	and	and	CC
cord-005453-4057qib7	8402	4	1	1	CD
cord-005453-4057qib7	8402	5	(	(	-LRB-
cord-005453-4057qib7	8402	6	5	5	CD
cord-005453-4057qib7	8402	7	%	%	NN
cord-005453-4057qib7	8402	8	)	)	-RRB-
cord-005453-4057qib7	8402	9	had	have	VBD
cord-005453-4057qib7	8402	10	AIHA	AIHA	NNP
cord-005453-4057qib7	8402	11	±ITP±AIN	±ITP±AIN	NNP
cord-005453-4057qib7	8402	12	.	.	.
cord-005453-4057qib7	8403	1	Median	median	JJ
cord-005453-4057qib7	8403	2	onset	onset	NN
cord-005453-4057qib7	8403	3	of	of	IN
cord-005453-4057qib7	8403	4	AIC	AIC	NNP
cord-005453-4057qib7	8403	5	was	be	VBD
cord-005453-4057qib7	8403	6	6.2	6.2	CD
cord-005453-4057qib7	8403	7	months	month	NNS
cord-005453-4057qib7	8403	8	post	post	NN
cord-005453-4057qib7	8403	9	-	-	JJ
cord-005453-4057qib7	8403	10	HCT	hct	JJ
cord-005453-4057qib7	8403	11	(	(	-LRB-
cord-005453-4057qib7	8403	12	range	range	VBP
cord-005453-4057qib7	8403	13	0.2	0.2	CD
cord-005453-4057qib7	8403	14	-	-	HYPH
cord-005453-4057qib7	8403	15	12.8	12.8	CD
cord-005453-4057qib7	8403	16	months	month	NNS
cord-005453-4057qib7	8403	17	)	)	-RRB-
cord-005453-4057qib7	8403	18	.	.	.
cord-005453-4057qib7	8404	1	Patients	patient	NNS
cord-005453-4057qib7	8404	2	were	be	VBD
cord-005453-4057qib7	8404	3	treated	treat	VBN
cord-005453-4057qib7	8404	4	with	with	IN
cord-005453-4057qib7	8404	5	a	a	DT
cord-005453-4057qib7	8404	6	median	median	NN
cord-005453-4057qib7	8404	7	of	of	IN
cord-005453-4057qib7	8404	8	3	3	CD
cord-005453-4057qib7	8404	9	treatment	treatment	NN
cord-005453-4057qib7	8404	10	modalities	modality	NNS
cord-005453-4057qib7	8404	11	(	(	-LRB-
cord-005453-4057qib7	8404	12	range	range	NN
cord-005453-4057qib7	8404	13	,	,	,
cord-005453-4057qib7	8404	14	1	1	CD
cord-005453-4057qib7	8404	15	-	-	SYM
cord-005453-4057qib7	8404	16	4	4	CD
cord-005453-4057qib7	8404	17	)	)	-RRB-
cord-005453-4057qib7	8404	18	.	.	.
cord-005453-4057qib7	8405	1	One	one	CD
cord-005453-4057qib7	8405	2	(	(	-LRB-
cord-005453-4057qib7	8405	3	5	5	CD
cord-005453-4057qib7	8405	4	%	%	NN
cord-005453-4057qib7	8405	5	)	)	-RRB-
cord-005453-4057qib7	8405	6	had	have	VBD
cord-005453-4057qib7	8405	7	steroid	steroid	NN
cord-005453-4057qib7	8405	8	,	,	,
cord-005453-4057qib7	8405	9	8	8	CD
cord-005453-4057qib7	8405	10	(	(	-LRB-
cord-005453-4057qib7	8405	11	38	38	CD
cord-005453-4057qib7	8405	12	%	%	NN
cord-005453-4057qib7	8405	13	)	)	-RRB-
cord-005453-4057qib7	8405	14	had	have	VBD
cord-005453-4057qib7	8405	15	steroid+high	steroid+high	NN
cord-005453-4057qib7	8405	16	-	-	HYPH
cord-005453-4057qib7	8405	17	dose	dose	NN
cord-005453-4057qib7	8405	18	-	-	HYPH
cord-005453-4057qib7	8405	19	IVIg	ivig	NN
cord-005453-4057qib7	8405	20	,	,	,
cord-005453-4057qib7	8405	21	8	8	CD
cord-005453-4057qib7	8405	22	(	(	-LRB-
cord-005453-4057qib7	8405	23	38	38	CD
cord-005453-4057qib7	8405	24	%	%	NN
cord-005453-4057qib7	8405	25	)	)	-RRB-
cord-005453-4057qib7	8405	26	had	have	VBD
cord-005453-4057qib7	8405	27	steroid+high	steroid+high	NN
cord-005453-4057qib7	8405	28	-	-	HYPH
cord-005453-4057qib7	8405	29	dose	dose	NN
cord-005453-4057qib7	8405	30	-	-	HYPH
cord-005453-4057qib7	8405	31	IVIG+rituximab	ivig+rituximab	NN
cord-005453-4057qib7	8405	32	,	,	,
cord-005453-4057qib7	8405	33	1	1	CD
cord-005453-4057qib7	8405	34	(	(	-LRB-
cord-005453-4057qib7	8405	35	5	5	CD
cord-005453-4057qib7	8405	36	%	%	NN
cord-005453-4057qib7	8405	37	)	)	-RRB-
cord-005453-4057qib7	8405	38	had	have	VBD
cord-005453-4057qib7	8405	39	steroid	steroid	JJ
cord-005453-4057qib7	8405	40	+	+	CC
cord-005453-4057qib7	8405	41	high	high	JJ
cord-005453-4057qib7	8405	42	-	-	HYPH
cord-005453-4057qib7	8405	43	dose	dose	NN
cord-005453-4057qib7	8405	44	-	-	HYPH
cord-005453-4057qib7	8405	45	IVIG+sirolimus	ivig+sirolimus	NN
cord-005453-4057qib7	8405	46	and	and	CC
cord-005453-4057qib7	8405	47	3	3	CD
cord-005453-4057qib7	8405	48	(	(	-LRB-
cord-005453-4057qib7	8405	49	14	14	CD
cord-005453-4057qib7	8405	50	%	%	NN
cord-005453-4057qib7	8405	51	)	)	-RRB-
cord-005453-4057qib7	8405	52	had	have	VBD
cord-005453-4057qib7	8405	53	steroid	steroid	JJ
cord-005453-4057qib7	8405	54	+	+	CC
cord-005453-4057qib7	8405	55	high	high	JJ
cord-005453-4057qib7	8405	56	-	-	HYPH
cord-005453-4057qib7	8405	57	dose	dose	NN
cord-005453-4057qib7	8405	58	-	-	HYPH
cord-005453-4057qib7	8405	59	IVIg+rituximab+sirolimus	ivig+rituximab+sirolimus	NN
cord-005453-4057qib7	8405	60	.	.	.
cord-005453-4057qib7	8406	1	The	the	DT
cord-005453-4057qib7	8406	2	median	median	JJ
cord-005453-4057qib7	8406	3	time	time	NN
cord-005453-4057qib7	8406	4	to	to	IN
cord-005453-4057qib7	8406	5	resolution	resolution	NN
cord-005453-4057qib7	8406	6	in	in	IN
cord-005453-4057qib7	8406	7	18	18	CD
cord-005453-4057qib7	8406	8	(	(	-LRB-
cord-005453-4057qib7	8406	9	85	85	CD
cord-005453-4057qib7	8406	10	%	%	NN
cord-005453-4057qib7	8406	11	)	)	-RRB-
cord-005453-4057qib7	8406	12	who	who	WP
cord-005453-4057qib7	8406	13	achieved	achieve	VBD
cord-005453-4057qib7	8406	14	remission	remission	NN
cord-005453-4057qib7	8406	15	after	after	IN
cord-005453-4057qib7	8406	16	first	first	JJ
cord-005453-4057qib7	8406	17	AIC	AIC	NNP
cord-005453-4057qib7	8406	18	was	be	VBD
cord-005453-4057qib7	8406	19	6.5	6.5	CD
cord-005453-4057qib7	8406	20	months	month	NNS
cord-005453-4057qib7	8406	21	(	(	-LRB-
cord-005453-4057qib7	8406	22	range	range	VBP
cord-005453-4057qib7	8406	23	1.4	1.4	CD
cord-005453-4057qib7	8406	24	-	-	SYM
cord-005453-4057qib7	8406	25	28.6	28.6	CD
cord-005453-4057qib7	8406	26	months	month	NNS
cord-005453-4057qib7	8406	27	)	)	-RRB-
cord-005453-4057qib7	8406	28	.	.	.
cord-005453-4057qib7	8407	1	1	1	CD
cord-005453-4057qib7	8407	2	had	have	VBD
cord-005453-4057qib7	8407	3	one	one	CD
cord-005453-4057qib7	8407	4	relapse	relapse	NN
cord-005453-4057qib7	8407	5	and	and	CC
cord-005453-4057qib7	8407	6	2	2	CD
cord-005453-4057qib7	8407	7	had	have	VBD
cord-005453-4057qib7	8407	8	two	two	CD
cord-005453-4057qib7	8407	9	relapses	relapse	NNS
cord-005453-4057qib7	8407	10	.	.	.
cord-005453-4057qib7	8408	1	2	2	CD
cord-005453-4057qib7	8408	2	died	die	VBD
cord-005453-4057qib7	8408	3	after	after	IN
cord-005453-4057qib7	8408	4	development	development	NN
cord-005453-4057qib7	8408	5	of	of	IN
cord-005453-4057qib7	8408	6	AIC	AIC	NNP
cord-005453-4057qib7	8408	7	(	(	-LRB-
cord-005453-4057qib7	8408	8	1	1	CD
cord-005453-4057qib7	8408	9	aspergillus	aspergillus	NN
cord-005453-4057qib7	8408	10	pneumonia	pneumonia	NN
cord-005453-4057qib7	8408	11	;	;	:
cord-005453-4057qib7	8408	12	1	1	CD
cord-005453-4057qib7	8408	13	multi	multi	JJ
cord-005453-4057qib7	8408	14	-	-	JJ
cord-005453-4057qib7	8408	15	organ	organ	JJ
cord-005453-4057qib7	8408	16	failure	failure	NN
cord-005453-4057qib7	8408	17	)	)	-RRB-
cord-005453-4057qib7	8408	18	.	.	.
cord-005453-4057qib7	8409	1	Of	of	IN
cord-005453-4057qib7	8409	2	19	19	CD
cord-005453-4057qib7	8409	3	(	(	-LRB-
cord-005453-4057qib7	8409	4	91	91	CD
cord-005453-4057qib7	8409	5	%	%	NN
cord-005453-4057qib7	8409	6	)	)	-RRB-
cord-005453-4057qib7	8409	7	surviving	survive	VBG
cord-005453-4057qib7	8409	8	patients	patient	NNS
cord-005453-4057qib7	8409	9	after	after	IN
cord-005453-4057qib7	8409	10	AIC	AIC	NNP
cord-005453-4057qib7	8409	11	,	,	,
cord-005453-4057qib7	8409	12	4	4	CD
cord-005453-4057qib7	8409	13	had	have	VBD
cord-005453-4057qib7	8409	14	on	on	IN
cord-005453-4057qib7	8409	15	-	-	HYPH
cord-005453-4057qib7	8409	16	going	go	VBG
cord-005453-4057qib7	8409	17	AIHA	AIHA	NNP
cord-005453-4057qib7	8409	18	at	at	IN
cord-005453-4057qib7	8409	19	median	median	NN
cord-005453-4057qib7	8409	20	of	of	IN
cord-005453-4057qib7	8409	21	follow	follow	NN
cord-005453-4057qib7	8409	22	-	-	HYPH
cord-005453-4057qib7	8409	23	up	up	NN
cord-005453-4057qib7	8409	24	2.5	2.5	CD
cord-005453-4057qib7	8409	25	years	year	NNS
cord-005453-4057qib7	8409	26	post	post	NN
cord-005453-4057qib7	8409	27	-	-	JJ
cord-005453-4057qib7	8409	28	HCT	hct	JJ
cord-005453-4057qib7	8409	29	(	(	-LRB-
cord-005453-4057qib7	8409	30	range	range	VBP
cord-005453-4057qib7	8409	31	0.9	0.9	CD
cord-005453-4057qib7	8409	32	-	-	SYM
cord-005453-4057qib7	8409	33	4.8	4.8	CD
cord-005453-4057qib7	8409	34	years	year	NNS
cord-005453-4057qib7	8409	35	)	)	-RRB-
cord-005453-4057qib7	8409	36	.	.	.
cord-005453-4057qib7	8410	1	On	on	IN
cord-005453-4057qib7	8410	2	univariate	univariate	JJ
cord-005453-4057qib7	8410	3	completing	complete	VBG
cord-005453-4057qib7	8410	4	-	-	HYPH
cord-005453-4057qib7	8410	5	risk	risk	NN
cord-005453-4057qib7	8410	6	analysis	analysis	NN
cord-005453-4057qib7	8410	7	,	,	,
cord-005453-4057qib7	8410	8	age	age	NN
cord-005453-4057qib7	8410	9	at	at	IN
cord-005453-4057qib7	8410	10	transplant	transplant	NN
cord-005453-4057qib7	8410	11	>	>	XX
cord-005453-4057qib7	8410	12	2.5years	2.5years	XX
cord-005453-4057qib7	8411	1	(	(	-LRB-
cord-005453-4057qib7	8411	2	p=0.02	p=0.02	NN
cord-005453-4057qib7	8411	3	)	)	-RRB-
cord-005453-4057qib7	8411	4	and	and	CC
cord-005453-4057qib7	8411	5	pre	pre	JJ
cord-005453-4057qib7	8411	6	-	-	JJ
cord-005453-4057qib7	8411	7	transplant	transplant	NN
cord-005453-4057qib7	8411	8	AIC	AIC	NNP
cord-005453-4057qib7	8411	9	(	(	-LRB-
cord-005453-4057qib7	8411	10	p=0.02	p=0.02	NNP
cord-005453-4057qib7	8411	11	)	)	-RRB-
cord-005453-4057qib7	8411	12	were	be	VBD
cord-005453-4057qib7	8411	13	associated	associate	VBN
cord-005453-4057qib7	8411	14	with	with	IN
cord-005453-4057qib7	8411	15	higher	high	JJR
cord-005453-4057qib7	8411	16	incidence	incidence	NN
cord-005453-4057qib7	8411	17	of	of	IN
cord-005453-4057qib7	8411	18	AIC	AIC	NNP
cord-005453-4057qib7	8411	19	(	(	-LRB-
cord-005453-4057qib7	8411	20	Figure	Figure	NNP
cord-005453-4057qib7	8411	21	1a	1a	CD
cord-005453-4057qib7	8411	22	-Ic	-ic	CD
cord-005453-4057qib7	8411	23	)	)	-RRB-
cord-005453-4057qib7	8411	24	.	.	.
cord-005453-4057qib7	8412	1	On	on	IN
cord-005453-4057qib7	8412	2	Fine	fine	JJ
cord-005453-4057qib7	8412	3	-	-	HYPH
cord-005453-4057qib7	8412	4	and	and	CC
cord-005453-4057qib7	8412	5	-	-	HYPH
cord-005453-4057qib7	8412	6	grey	grey	NN
cord-005453-4057qib7	8412	7	models	model	NNS
cord-005453-4057qib7	8412	8	,	,	,
cord-005453-4057qib7	8412	9	only	only	RB
cord-005453-4057qib7	8412	10	age	age	NN
cord-005453-4057qib7	8412	11	at	at	IN
cord-005453-4057qib7	8412	12	transplant	transplant	NN
cord-005453-4057qib7	8412	13	(	(	-LRB-
cord-005453-4057qib7	8412	14	HR	HR	NNP
cord-005453-4057qib7	8412	15	3.08	3.08	CD
cord-005453-4057qib7	8412	16	,	,	,
cord-005453-4057qib7	8412	17	95%CI	95%ci	CD
cord-005453-4057qib7	8412	18	1.12	1.12	CD
cord-005453-4057qib7	8412	19	-	-	SYM
cord-005453-4057qib7	8412	20	8.49	8.49	CD
cord-005453-4057qib7	8412	21	,	,	,
cord-005453-4057qib7	8412	22	p=0.03	p=0.03	NNP
cord-005453-4057qib7	8412	23	)	)	-RRB-
cord-005453-4057qib7	8412	24	was	be	VBD
cord-005453-4057qib7	8412	25	independently	independently	RB
cord-005453-4057qib7	8412	26	associated	associate	VBN
cord-005453-4057qib7	8412	27	with	with	IN
cord-005453-4057qib7	8412	28	AIC	AIC	NNP
cord-005453-4057qib7	8412	29	.	.	.
cord-005453-4057qib7	8413	1	Of	of	IN
cord-005453-4057qib7	8413	2	157	157	CD
cord-005453-4057qib7	8413	3	with	with	IN
cord-005453-4057qib7	8413	4	complete	complete	JJ
cord-005453-4057qib7	8413	5	immune	immune	JJ
cord-005453-4057qib7	8413	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	8413	7	data	datum	NNS
cord-005453-4057qib7	8413	8	,	,	,
cord-005453-4057qib7	8413	9	naïve	naïve	JJ
cord-005453-4057qib7	8413	10	T	t	NN
cord-005453-4057qib7	8413	11	cells	cell	NNS
cord-005453-4057qib7	8413	12	>	>	XX
cord-005453-4057qib7	8414	1	100cells	100cells	NNP
cord-005453-4057qib7	8414	2	/	/	SYM
cord-005453-4057qib7	8414	3	mL	ml	NN
cord-005453-4057qib7	8414	4	at	at	IN
cord-005453-4057qib7	8414	5	6	6	CD
cord-005453-4057qib7	8414	6	months	month	NNS
cord-005453-4057qib7	8414	7	post	post	NN
cord-005453-4057qib7	8414	8	-	-	NN
cord-005453-4057qib7	8414	9	HCT	HCT	NNP
cord-005453-4057qib7	8414	10	was	be	VBD
cord-005453-4057qib7	8414	11	associated	associate	VBN
cord-005453-4057qib7	8414	12	lower	low	JJR
cord-005453-4057qib7	8414	13	incidence	incidence	NN
cord-005453-4057qib7	8414	14	of	of	IN
cord-005453-4057qib7	8414	15	AIC	AIC	NNP
cord-005453-4057qib7	8414	16	(	(	-LRB-
cord-005453-4057qib7	8414	17	HR	HR	NNP
cord-005453-4057qib7	8414	18	0.36	0.36	CD
cord-005453-4057qib7	8414	19	,	,	,
cord-005453-4057qib7	8414	20	95%CI	95%ci	CD
cord-005453-4057qib7	8414	21	0.15	0.15	CD
cord-005453-4057qib7	8414	22	-	-	HYPH
cord-005453-4057qib7	8414	23	0.91	0.91	CD
cord-005453-4057qib7	8414	24	,	,	,
cord-005453-4057qib7	8414	25	p=0.03	p=0.03	NN
cord-005453-4057qib7	8414	26	)	)	-RRB-
cord-005453-4057qib7	8414	27	(	(	-LRB-
cord-005453-4057qib7	8414	28	Figure	figure	NN
cord-005453-4057qib7	8414	29	1d	1d	CD
cord-005453-4057qib7	8414	30	)	)	-RRB-
cord-005453-4057qib7	8415	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8415	2	:	:	:
cord-005453-4057qib7	8416	1	Younger	young	JJR
cord-005453-4057qib7	8416	2	age	age	NN
cord-005453-4057qib7	8416	3	and	and	CC
cord-005453-4057qib7	8416	4	thymopoiesis	thymopoiesis	NN
cord-005453-4057qib7	8416	5	were	be	VBD
cord-005453-4057qib7	8416	6	associated	associate	VBN
cord-005453-4057qib7	8416	7	lower	low	JJR
cord-005453-4057qib7	8416	8	incidence	incidence	NN
cord-005453-4057qib7	8416	9	of	of	IN
cord-005453-4057qib7	8416	10	AIC	AIC	NNP
cord-005453-4057qib7	8416	11	in	in	IN
cord-005453-4057qib7	8416	12	children	child	NNS
cord-005453-4057qib7	8416	13	with	with	IN
cord-005453-4057qib7	8416	14	PID	PID	NNP
cord-005453-4057qib7	8416	15	after	after	IN
cord-005453-4057qib7	8416	16	HCT	HCT	NNP
cord-005453-4057qib7	8416	17	Clinical	Clinical	NNP
cord-005453-4057qib7	8416	18	Background	Background	NNP
cord-005453-4057qib7	8416	19	:	:	:
cord-005453-4057qib7	8417	1	Human	human	JJ
cord-005453-4057qib7	8417	2	heme	heme	NN
cord-005453-4057qib7	8418	1	-oxygenase-1	-oxygenase-1	NFP
cord-005453-4057qib7	8418	2	(	(	-LRB-
cord-005453-4057qib7	8418	3	HO-1	HO-1	NNP
cord-005453-4057qib7	8418	4	)	)	-RRB-
cord-005453-4057qib7	8418	5	deficiency	deficiency	NN
cord-005453-4057qib7	8418	6	has	have	VBZ
cord-005453-4057qib7	8418	7	been	be	VBN
cord-005453-4057qib7	8418	8	reported	report	VBN
cord-005453-4057qib7	8418	9	to	to	TO
cord-005453-4057qib7	8418	10	present	present	VB
cord-005453-4057qib7	8418	11	with	with	IN
cord-005453-4057qib7	8418	12	tetrad	tetrad	NN
cord-005453-4057qib7	8418	13	of	of	IN
cord-005453-4057qib7	8418	14	anemia	anemia	NN
cord-005453-4057qib7	8418	15	,	,	,
cord-005453-4057qib7	8418	16	nephritis	nephritis	NN
cord-005453-4057qib7	8418	17	,	,	,
cord-005453-4057qib7	8418	18	inflammation	inflammation	NN
cord-005453-4057qib7	8418	19	and	and	CC
cord-005453-4057qib7	8418	20	asplenia	asplenia	NN
cord-005453-4057qib7	8418	21	and	and	CC
cord-005453-4057qib7	8418	22	is	be	VBZ
cord-005453-4057qib7	8418	23	fatal	fatal	JJ
cord-005453-4057qib7	8418	24	if	if	IN
cord-005453-4057qib7	8418	25	not	not	RB
cord-005453-4057qib7	8418	26	treated	treat	VBN
cord-005453-4057qib7	8418	27	.	.	.
cord-005453-4057qib7	8419	1	Its	-PRON-	PRP$
cord-005453-4057qib7	8419	2	an	an	DT
cord-005453-4057qib7	8419	3	auto	auto	NN
cord-005453-4057qib7	8419	4	-	-	HYPH
cord-005453-4057qib7	8419	5	inflammatory	inflammatory	JJ
cord-005453-4057qib7	8419	6	disorder	disorder	NN
cord-005453-4057qib7	8419	7	.	.	.
cord-005453-4057qib7	8420	1	Macrophages/	Macrophages/	NNP
cord-005453-4057qib7	8420	2	Monocytes	Monocytes	NNP
cord-005453-4057qib7	8420	3	express	express	VBP
cord-005453-4057qib7	8420	4	HO-1	HO-1	NNP
cord-005453-4057qib7	8420	5	and	and	CC
cord-005453-4057qib7	8420	6	are	be	VBP
cord-005453-4057qib7	8420	7	engaged	engage	VBN
cord-005453-4057qib7	8420	8	in	in	IN
cord-005453-4057qib7	8420	9	recycling	recycling	NN
cord-005453-4057qib7	8420	10	of	of	IN
cord-005453-4057qib7	8420	11	red	red	JJ
cord-005453-4057qib7	8420	12	cells	cell	NNS
cord-005453-4057qib7	8420	13	.	.	.
cord-005453-4057qib7	8421	1	Human	human	JJ
cord-005453-4057qib7	8421	2	HO-1	HO-1	NNP
cord-005453-4057qib7	8421	3	deficiency	deficiency	NN
cord-005453-4057qib7	8421	4	results	result	NNS
cord-005453-4057qib7	8421	5	in	in	IN
cord-005453-4057qib7	8421	6	intravascular	intravascular	JJ
cord-005453-4057qib7	8421	7	hemolysis	hemolysis	NN
cord-005453-4057qib7	8421	8	and	and	CC
cord-005453-4057qib7	8421	9	severe	severe	JJ
cord-005453-4057qib7	8421	10	damage	damage	NN
cord-005453-4057qib7	8421	11	to	to	IN
cord-005453-4057qib7	8421	12	the	the	DT
cord-005453-4057qib7	8421	13	endothelial	endothelial	JJ
cord-005453-4057qib7	8421	14	system	system	NN
cord-005453-4057qib7	8421	15	,	,	,
cord-005453-4057qib7	8421	16	kidneys	kidney	NNS
cord-005453-4057qib7	8421	17	,	,	,
cord-005453-4057qib7	8421	18	and	and	CC
cord-005453-4057qib7	8421	19	other	other	JJ
cord-005453-4057qib7	8421	20	organs	organ	NNS
cord-005453-4057qib7	8421	21	.	.	.
cord-005453-4057qib7	8422	1	Transplantation	transplantation	NN
cord-005453-4057qib7	8422	2	of	of	IN
cord-005453-4057qib7	8422	3	either	either	DT
cord-005453-4057qib7	8422	4	healthy	healthy	JJ
cord-005453-4057qib7	8422	5	wild	wild	JJ
cord-005453-4057qib7	8422	6	type	type	NN
cord-005453-4057qib7	8422	7	macrophages	macrophage	NNS
cord-005453-4057qib7	8422	8	or	or	CC
cord-005453-4057qib7	8422	9	new	new	JJ
cord-005453-4057qib7	8422	10	macrophages	macrophage	NNS
cord-005453-4057qib7	8422	11	produced	produce	VBN
cord-005453-4057qib7	8422	12	by	by	IN
cord-005453-4057qib7	8422	13	SCT	SCT	NNP
cord-005453-4057qib7	8422	14	from	from	IN
cord-005453-4057qib7	8422	15	healthy	healthy	JJ
cord-005453-4057qib7	8422	16	donor	donor	NN
cord-005453-4057qib7	8422	17	has	have	VBZ
cord-005453-4057qib7	8422	18	been	be	VBN
cord-005453-4057qib7	8422	19	proven	prove	VBN
cord-005453-4057qib7	8422	20	to	to	TO
cord-005453-4057qib7	8422	21	be	be	VB
cord-005453-4057qib7	8422	22	curative	curative	JJ
cord-005453-4057qib7	8422	23	for	for	IN
cord-005453-4057qib7	8422	24	HO-1	HO-1	NNP
cord-005453-4057qib7	8422	25	deficiency	deficiency	NN
cord-005453-4057qib7	8422	26	in	in	IN
cord-005453-4057qib7	8422	27	mice	mouse	NNS
cord-005453-4057qib7	8422	28	.	.	.
cord-005453-4057qib7	8423	1	In	in	IN
cord-005453-4057qib7	8423	2	2018	2018	CD
cord-005453-4057qib7	8423	3	,	,	,
cord-005453-4057qib7	8423	4	we	-PRON-	PRP
cord-005453-4057qib7	8423	5	had	have	VBD
cord-005453-4057qib7	8423	6	reported	report	VBN
cord-005453-4057qib7	8423	7	first	first	JJ
cord-005453-4057qib7	8423	8	successful	successful	JJ
cord-005453-4057qib7	8423	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	8423	10	SCT	SCT	NNP
cord-005453-4057qib7	8423	11	for	for	IN
cord-005453-4057qib7	8423	12	human	human	JJ
cord-005453-4057qib7	8423	13	HO-1	HO-1	NNP
cord-005453-4057qib7	8423	14	deficiency	deficiency	NN
cord-005453-4057qib7	8423	15	.	.	.
cord-005453-4057qib7	8424	1	Here	here	RB
cord-005453-4057qib7	8424	2	we	-PRON-	PRP
cord-005453-4057qib7	8424	3	report	report	VBP
cord-005453-4057qib7	8424	4	second	second	JJ
cord-005453-4057qib7	8424	5	successful	successful	JJ
cord-005453-4057qib7	8424	6	non	non	JJ
cord-005453-4057qib7	8424	7	-	-	JJ
cord-005453-4057qib7	8424	8	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8424	9	MSD	MSD	NNP
cord-005453-4057qib7	8424	10	HSCT	HSCT	NNP
cord-005453-4057qib7	8424	11	for	for	IN
cord-005453-4057qib7	8424	12	a	a	DT
cord-005453-4057qib7	8424	13	child	child	NN
cord-005453-4057qib7	8424	14	with	with	IN
cord-005453-4057qib7	8424	15	HO-1	HO-1	NNP
cord-005453-4057qib7	8424	16	deficiency	deficiency	NN
cord-005453-4057qib7	8424	17	.	.	.
cord-005453-4057qib7	8425	1	Methods	method	NNS
cord-005453-4057qib7	8425	2	:	:	:
cord-005453-4057qib7	8426	1	A	a	DT
cord-005453-4057qib7	8426	2	9-yr	9-yr	JJ
cord-005453-4057qib7	8426	3	-	-	HYPH
cord-005453-4057qib7	8426	4	old	old	JJ
cord-005453-4057qib7	8426	5	-	-	HYPH
cord-005453-4057qib7	8426	6	girl	girl	NN
cord-005453-4057qib7	8426	7	presented	present	VBN
cord-005453-4057qib7	8426	8	with	with	IN
cord-005453-4057qib7	8426	9	complaints	complaint	NNS
cord-005453-4057qib7	8426	10	of	of	IN
cord-005453-4057qib7	8426	11	fever	fever	NN
cord-005453-4057qib7	8426	12	,	,	,
cord-005453-4057qib7	8426	13	anemia	anemia	NN
cord-005453-4057qib7	8426	14	and	and	CC
cord-005453-4057qib7	8426	15	severe	severe	JJ
cord-005453-4057qib7	8426	16	hypertension	hypertension	NN
cord-005453-4057qib7	8426	17	.	.	.
cord-005453-4057qib7	8427	1	In	in	IN
cord-005453-4057qib7	8427	2	the	the	DT
cord-005453-4057qib7	8427	3	past	past	NN
cord-005453-4057qib7	8427	4	,	,	,
cord-005453-4057qib7	8427	5	at	at	IN
cord-005453-4057qib7	8427	6	the	the	DT
cord-005453-4057qib7	8427	7	age	age	NN
cord-005453-4057qib7	8427	8	of	of	IN
cord-005453-4057qib7	8427	9	7	7	CD
cord-005453-4057qib7	8427	10	years	year	NNS
cord-005453-4057qib7	8427	11	she	-PRON-	PRP
cord-005453-4057qib7	8427	12	was	be	VBD
cord-005453-4057qib7	8427	13	admitted	admit	VBN
cord-005453-4057qib7	8427	14	for	for	IN
cord-005453-4057qib7	8427	15	high	high	JJ
cord-005453-4057qib7	8427	16	fever	fever	NN
cord-005453-4057qib7	8427	17	for	for	IN
cord-005453-4057qib7	8427	18	1	1	CD
cord-005453-4057qib7	8427	19	month	month	NN
cord-005453-4057qib7	8427	20	and	and	CC
cord-005453-4057qib7	8427	21	needed	need	VBD
cord-005453-4057qib7	8427	22	blood	blood	NN
cord-005453-4057qib7	8427	23	transfusion	transfusion	NN
cord-005453-4057qib7	8427	24	for	for	IN
cord-005453-4057qib7	8427	25	the	the	DT
cord-005453-4057qib7	8427	26	first	first	JJ
cord-005453-4057qib7	8427	27	time	time	NN
cord-005453-4057qib7	8427	28	for	for	IN
cord-005453-4057qib7	8427	29	severe	severe	JJ
cord-005453-4057qib7	8427	30	anemia	anemia	NN
cord-005453-4057qib7	8427	31	and	and	CC
cord-005453-4057qib7	8427	32	had	have	VBD
cord-005453-4057qib7	8427	33	high	high	JJ
cord-005453-4057qib7	8427	34	platelets	platelet	NNS
cord-005453-4057qib7	8427	35	and	and	CC
cord-005453-4057qib7	8427	36	high	high	JJ
cord-005453-4057qib7	8427	37	ferritin	ferritin	NN
cord-005453-4057qib7	8427	38	.	.	.
cord-005453-4057qib7	8428	1	She	-PRON-	PRP
cord-005453-4057qib7	8428	2	was	be	VBD
cord-005453-4057qib7	8428	3	treated	treat	VBN
cord-005453-4057qib7	8428	4	as	as	IN
cord-005453-4057qib7	8428	5	macrophage	macrophage	NN
cord-005453-4057qib7	8428	6	activation	activation	NN
cord-005453-4057qib7	8428	7	syndrome	syndrome	NN
cord-005453-4057qib7	8428	8	with	with	IN
cord-005453-4057qib7	8428	9	prednisolone	prednisolone	NNP
cord-005453-4057qib7	8428	10	alone	alone	RB
cord-005453-4057qib7	8428	11	and	and	CC
cord-005453-4057qib7	8428	12	later	later	RB
cord-005453-4057qib7	8428	13	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	8428	14	was	be	VBD
cord-005453-4057qib7	8428	15	added	add	VBN
cord-005453-4057qib7	8428	16	.	.	.
cord-005453-4057qib7	8429	1	She	-PRON-	PRP
cord-005453-4057qib7	8429	2	had	have	VBD
cord-005453-4057qib7	8429	3	short	short	JJ
cord-005453-4057qib7	8429	4	stature	stature	NN
cord-005453-4057qib7	8429	5	,	,	,
cord-005453-4057qib7	8429	6	abnormal	abnormal	JJ
cord-005453-4057qib7	8429	7	facies	facie	NNS
cord-005453-4057qib7	8429	8	but	but	CC
cord-005453-4057qib7	8429	9	normal	normal	JJ
cord-005453-4057qib7	8429	10	development	development	NN
cord-005453-4057qib7	8429	11	.	.	.
cord-005453-4057qib7	8430	1	Hemoglobin	hemoglobin	NN
cord-005453-4057qib7	8430	2	9	9	CD
cord-005453-4057qib7	8431	1	g	g	NNP
cord-005453-4057qib7	8431	2	/	/	SYM
cord-005453-4057qib7	8431	3	dl	dl	NN
cord-005453-4057qib7	8431	4	,	,	,
cord-005453-4057qib7	8431	5	urine	urine	NN
cord-005453-4057qib7	8431	6	for	for	IN
cord-005453-4057qib7	8431	7	haemoglobin	haemoglobin	NN
cord-005453-4057qib7	8431	8	was	be	VBD
cord-005453-4057qib7	8431	9	positive	positive	JJ
cord-005453-4057qib7	8431	10	,	,	,
cord-005453-4057qib7	8431	11	platelets	platelet	NNS
cord-005453-4057qib7	8432	1	1055	1055	CD
cord-005453-4057qib7	8432	2	,	,	,
cord-005453-4057qib7	8432	3	000	000	CD
cord-005453-4057qib7	8432	4	/	/	SYM
cord-005453-4057qib7	8432	5	ul	ul	NN
cord-005453-4057qib7	8432	6	,	,	,
cord-005453-4057qib7	8432	7	ferritin	ferritin	NN
cord-005453-4057qib7	8432	8	2568	2568	CD
cord-005453-4057qib7	8432	9	mcg	mcg	NNP
cord-005453-4057qib7	8432	10	/	/	SYM
cord-005453-4057qib7	8432	11	L	l	NN
cord-005453-4057qib7	8432	12	and	and	CC
cord-005453-4057qib7	8432	13	urine	urine	NN
cord-005453-4057qib7	8432	14	albumin	albumin	NN
cord-005453-4057qib7	8432	15	4	4	CD
cord-005453-4057qib7	8433	1	+	+	CC
cord-005453-4057qib7	8434	1	and	and	CC
cord-005453-4057qib7	8434	2	Urine	Urine	NNP
cord-005453-4057qib7	8434	3	RBC	RBC	NNP
cord-005453-4057qib7	8434	4	20	20	CD
cord-005453-4057qib7	8434	5	-	-	SYM
cord-005453-4057qib7	8434	6	30	30	CD
cord-005453-4057qib7	8434	7	/	/	SYM
cord-005453-4057qib7	8434	8	hpf	hpf	NN
cord-005453-4057qib7	8434	9	.	.	.
cord-005453-4057qib7	8435	1	Ultrasound	ultrasound	NN
cord-005453-4057qib7	8435	2	and	and	CC
cord-005453-4057qib7	8435	3	CT	CT	NNP
cord-005453-4057qib7	8435	4	scan	scan	JJ
cord-005453-4057qib7	8435	5	abdomen	abdoman	NNS
cord-005453-4057qib7	8435	6	showed	show	VBD
cord-005453-4057qib7	8435	7	asplenia	asplenia	NN
cord-005453-4057qib7	8435	8	.	.	.
cord-005453-4057qib7	8436	1	A	a	DT
cord-005453-4057qib7	8436	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	8436	3	of	of	IN
cord-005453-4057qib7	8436	4	HO-1	HO-1	NNP
cord-005453-4057qib7	8436	5	deficiency	deficiency	NN
cord-005453-4057qib7	8436	6	was	be	VBD
cord-005453-4057qib7	8436	7	suspected	suspect	VBN
cord-005453-4057qib7	8436	8	.	.	.
cord-005453-4057qib7	8437	1	Mutation	mutation	NN
cord-005453-4057qib7	8437	2	analysis	analysis	NN
cord-005453-4057qib7	8437	3	showed	show	VBD
cord-005453-4057qib7	8437	4	homozygous	homozygous	JJ
cord-005453-4057qib7	8437	5	missense	missense	NN
cord-005453-4057qib7	8437	6	mutations	mutation	NNS
cord-005453-4057qib7	8437	7	in	in	IN
cord-005453-4057qib7	8437	8	exon2	exon2	NN
cord-005453-4057qib7	8437	9	(	(	-LRB-
cord-005453-4057qib7	8437	10	R44X	R44X	NNP
cord-005453-4057qib7	8437	11	)	)	-RRB-
cord-005453-4057qib7	8437	12	on	on	IN
cord-005453-4057qib7	8437	13	chromosome	chromosome	NN
cord-005453-4057qib7	8437	14	22q12	22q12	CD
cord-005453-4057qib7	8437	15	,	,	,
cord-005453-4057qib7	8437	16	which	which	WDT
cord-005453-4057qib7	8437	17	would	would	MD
cord-005453-4057qib7	8437	18	result	result	VB
cord-005453-4057qib7	8437	19	in	in	IN
cord-005453-4057qib7	8437	20	the	the	DT
cord-005453-4057qib7	8437	21	absence	absence	NN
cord-005453-4057qib7	8437	22	of	of	IN
cord-005453-4057qib7	8437	23	the	the	DT
cord-005453-4057qib7	8437	24	functional	functional	JJ
cord-005453-4057qib7	8437	25	HO-1	HO-1	NNP
cord-005453-4057qib7	8437	26	protein	protein	NN
cord-005453-4057qib7	8437	27	.	.	.
cord-005453-4057qib7	8438	1	Both	both	DT
cord-005453-4057qib7	8438	2	parents	parent	NNS
cord-005453-4057qib7	8438	3	were	be	VBD
cord-005453-4057qib7	8438	4	carriers	carrier	NNS
cord-005453-4057qib7	8438	5	of	of	IN
cord-005453-4057qib7	8438	6	this	this	DT
cord-005453-4057qib7	8438	7	mutation	mutation	NN
cord-005453-4057qib7	8438	8	.	.	.
cord-005453-4057qib7	8439	1	We	-PRON-	PRP
cord-005453-4057qib7	8439	2	managed	manage	VBD
cord-005453-4057qib7	8439	3	her	-PRON-	PRP
cord-005453-4057qib7	8439	4	over	over	IN
cord-005453-4057qib7	8439	5	next	next	JJ
cord-005453-4057qib7	8439	6	6-years	6-years	CD
cord-005453-4057qib7	8439	7	with	with	IN
cord-005453-4057qib7	8439	8	prednisolone	prednisolone	NNP
cord-005453-4057qib7	8439	9	,	,	,
cord-005453-4057qib7	8439	10	hydroxyurea	hydroxyurea	NNP
cord-005453-4057qib7	8439	11	and	and	CC
cord-005453-4057qib7	8439	12	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	8439	13	mofetil	mofetil	NNP
cord-005453-4057qib7	8439	14	(	(	-LRB-
cord-005453-4057qib7	8439	15	MMF	MMF	NNP
cord-005453-4057qib7	8439	16	)	)	-RRB-
cord-005453-4057qib7	8439	17	.	.	.
cord-005453-4057qib7	8440	1	However	however	RB
cord-005453-4057qib7	8440	2	she	-PRON-	PRP
cord-005453-4057qib7	8440	3	remained	remain	VBD
cord-005453-4057qib7	8440	4	steroid	steroid	JJ
cord-005453-4057qib7	8440	5	dependent	dependent	JJ
cord-005453-4057qib7	8440	6	.	.	.
cord-005453-4057qib7	8441	1	HLA	HLA	NNP
cord-005453-4057qib7	8441	2	-	-	HYPH
cord-005453-4057qib7	8441	3	typing	typing	NN
cord-005453-4057qib7	8441	4	confirmed	confirm	VBD
cord-005453-4057qib7	8441	5	her	-PRON-	PRP
cord-005453-4057qib7	8441	6	healthy	healthy	JJ
cord-005453-4057qib7	8441	7	unaffected	unaffected	JJ
cord-005453-4057qib7	8441	8	13-year	13-year	JJ
cord-005453-4057qib7	8441	9	-	-	HYPH
cord-005453-4057qib7	8441	10	old	old	JJ
cord-005453-4057qib7	8441	11	brother	brother	NN
cord-005453-4057qib7	8441	12	to	to	TO
cord-005453-4057qib7	8441	13	be	be	VB
cord-005453-4057qib7	8441	14	a	a	DT
cord-005453-4057qib7	8441	15	fully	fully	RB
cord-005453-4057qib7	8441	16	matched	match	VBN
cord-005453-4057qib7	8441	17	donor	donor	NN
cord-005453-4057qib7	8441	18	.	.	.
cord-005453-4057qib7	8442	1	At	at	IN
cord-005453-4057qib7	8442	2	the	the	DT
cord-005453-4057qib7	8442	3	age	age	NN
cord-005453-4057qib7	8442	4	of	of	IN
cord-005453-4057qib7	8442	5	16	16	CD
cord-005453-4057qib7	8442	6	years	year	NNS
cord-005453-4057qib7	8442	7	she	-PRON-	PRP
cord-005453-4057qib7	8442	8	was	be	VBD
cord-005453-4057qib7	8442	9	taken	take	VBN
cord-005453-4057qib7	8442	10	up	up	RP
cord-005453-4057qib7	8442	11	for	for	IN
cord-005453-4057qib7	8442	12	MSD	MSD	NNP
cord-005453-4057qib7	8442	13	SCT	SCT	NNP
cord-005453-4057qib7	8442	14	after	after	IN
cord-005453-4057qib7	8442	15	taking	take	VBG
cord-005453-4057qib7	8442	16	informed	informed	JJ
cord-005453-4057qib7	8442	17	consent	consent	NN
cord-005453-4057qib7	8442	18	.	.	.
cord-005453-4057qib7	8443	1	She	-PRON-	PRP
cord-005453-4057qib7	8443	2	weighed	weigh	VBD
cord-005453-4057qib7	8443	3	just	just	RB
cord-005453-4057qib7	8443	4	16	16	CD
cord-005453-4057qib7	8443	5	kg	kg	NNS
cord-005453-4057qib7	8443	6	.	.	.
cord-005453-4057qib7	8444	1	We	-PRON-	PRP
cord-005453-4057qib7	8444	2	conditioned	condition	VBD
cord-005453-4057qib7	8444	3	her	-PRON-	PRP
cord-005453-4057qib7	8444	4	with	with	IN
cord-005453-4057qib7	8444	5	Alemtuzumab-0.8mg	Alemtuzumab-0.8mg	NNP
cord-005453-4057qib7	8444	6	/	/	SYM
cord-005453-4057qib7	8444	7	kg	kg	NN
cord-005453-4057qib7	8444	8	,	,	,
cord-005453-4057qib7	8444	9	Fludarabine-160mg	Fludarabine-160mg	NNP
cord-005453-4057qib7	8444	10	/	/	SYM
cord-005453-4057qib7	8444	11	m2	m2	NNP
cord-005453-4057qib7	8444	12	,	,	,
cord-005453-4057qib7	8444	13	Cyclophospamide-29mg	Cyclophospamide-29mg	NNP
cord-005453-4057qib7	8444	14	/	/	SYM
cord-005453-4057qib7	8444	15	kg	kg	NNP
cord-005453-4057qib7	8444	16	and	and	CC
cord-005453-4057qib7	8444	17	Total	total	JJ
cord-005453-4057qib7	8444	18	body	body	NN
cord-005453-4057qib7	8444	19	irradiation	irradiation	NN
cord-005453-4057qib7	8444	20	2	2	CD
cord-005453-4057qib7	8444	21	Gray	Gray	NNP
cord-005453-4057qib7	8444	22	.	.	.
cord-005453-4057qib7	8445	1	We	-PRON-	PRP
cord-005453-4057qib7	8445	2	infused	infuse	VBD
cord-005453-4057qib7	8445	3	9	9	CD
cord-005453-4057qib7	8445	4	million	million	CD
cord-005453-4057qib7	8445	5	/	/	SYM
cord-005453-4057qib7	8445	6	kg	kg	CD
cord-005453-4057qib7	8445	7	peripheral	peripheral	JJ
cord-005453-4057qib7	8445	8	blood	blood	NN
cord-005453-4057qib7	8445	9	stem	stem	NN
cord-005453-4057qib7	8445	10	cells	cell	NNS
cord-005453-4057qib7	8445	11	from	from	IN
cord-005453-4057qib7	8445	12	her	-PRON-	PRP$
cord-005453-4057qib7	8445	13	brother	brother	NN
cord-005453-4057qib7	8445	14	.	.	.
cord-005453-4057qib7	8446	1	Graft	graft	NN
cord-005453-4057qib7	8446	2	-	-	HYPH
cord-005453-4057qib7	8446	3	vs.-Host	vs.-host	NN
cord-005453-4057qib7	8446	4	disease	disease	NN
cord-005453-4057qib7	8446	5	(	(	-LRB-
cord-005453-4057qib7	8446	6	GVHD	GVHD	NNP
cord-005453-4057qib7	8446	7	)	)	-RRB-
cord-005453-4057qib7	8446	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8446	9	consisted	consist	VBD
cord-005453-4057qib7	8446	10	of	of	IN
cord-005453-4057qib7	8446	11	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	8446	12	&	&	CC
cord-005453-4057qib7	8446	13	MMF	MMF	NNP
cord-005453-4057qib7	8446	14	.	.	.
cord-005453-4057qib7	8447	1	Results	result	NNS
cord-005453-4057qib7	8447	2	:	:	:
cord-005453-4057qib7	8448	1	She	-PRON-	PRP
cord-005453-4057qib7	8448	2	tolerated	tolerate	VBD
cord-005453-4057qib7	8448	3	procedure	procedure	NN
cord-005453-4057qib7	8448	4	very	very	RB
cord-005453-4057qib7	8448	5	well	well	RB
cord-005453-4057qib7	8448	6	.	.	.
cord-005453-4057qib7	8449	1	Her	-PRON-	PRP$
cord-005453-4057qib7	8449	2	entire	entire	JJ
cord-005453-4057qib7	8449	3	hospital	hospital	NN
cord-005453-4057qib7	8449	4	stay	stay	NN
cord-005453-4057qib7	8449	5	was	be	VBD
cord-005453-4057qib7	8449	6	uneventful	uneventful	JJ
cord-005453-4057qib7	8449	7	and	and	CC
cord-005453-4057qib7	8450	1	lowest	low	JJS
cord-005453-4057qib7	8450	2	platelet	platelet	NN
cord-005453-4057qib7	8450	3	count	count	NN
cord-005453-4057qib7	8450	4	recorded	record	VBN
cord-005453-4057qib7	8450	5	was	be	VBD
cord-005453-4057qib7	8450	6	30,000	30,000	CD
cord-005453-4057qib7	8450	7	/	/	SYM
cord-005453-4057qib7	8450	8	ul	ul	NN
cord-005453-4057qib7	8450	9	.	.	.
cord-005453-4057qib7	8451	1	Her	-PRON-	PRP$
cord-005453-4057qib7	8451	2	neutrophils	neutrophil	NNS
cord-005453-4057qib7	8451	3	engrafted	engraft	VBN
cord-005453-4057qib7	8451	4	on	on	IN
cord-005453-4057qib7	8451	5	day	day	NN
cord-005453-4057qib7	8451	6	+13	+13	NN
cord-005453-4057qib7	8451	7	and	and	CC
cord-005453-4057qib7	8451	8	she	-PRON-	PRP
cord-005453-4057qib7	8451	9	was	be	VBD
cord-005453-4057qib7	8451	10	discharged	discharge	VBN
cord-005453-4057qib7	8451	11	on	on	IN
cord-005453-4057qib7	8451	12	day+19	day+19	NNP
cord-005453-4057qib7	8451	13	.	.	.
cord-005453-4057qib7	8452	1	His	-PRON-	PRP$
cord-005453-4057qib7	8452	2	urine	urine	NN
cord-005453-4057qib7	8452	3	albumin	albumin	NN
cord-005453-4057qib7	8452	4	was	be	VBD
cord-005453-4057qib7	8452	5	nil	nil	NN
cord-005453-4057qib7	8452	6	by	by	IN
cord-005453-4057qib7	8452	7	day+7	day+7	NNS
cord-005453-4057qib7	8452	8	.	.	.
cord-005453-4057qib7	8453	1	She	-PRON-	PRP
cord-005453-4057qib7	8453	2	had	have	VBD
cord-005453-4057qib7	8453	3	no	no	DT
cord-005453-4057qib7	8453	4	GVHD	GVHD	NNP
cord-005453-4057qib7	8453	5	.	.	.
cord-005453-4057qib7	8454	1	Her	-PRON-	PRP$
cord-005453-4057qib7	8454	2	chimerism	chimerism	NN
cord-005453-4057qib7	8454	3	on	on	IN
cord-005453-4057qib7	8454	4	day+22	day+22	NNP
cord-005453-4057qib7	8454	5	showed	show	VBD
cord-005453-4057qib7	8454	6	97	97	CD
cord-005453-4057qib7	8454	7	%	%	NN
cord-005453-4057qib7	8454	8	donor	donor	NN
cord-005453-4057qib7	8454	9	cells	cell	NNS
cord-005453-4057qib7	8454	10	,	,	,
cord-005453-4057qib7	8454	11	on	on	IN
cord-005453-4057qib7	8454	12	day+60	day+60	NNP
cord-005453-4057qib7	8454	13	was	be	VBD
cord-005453-4057qib7	8454	14	98	98	CD
cord-005453-4057qib7	8454	15	%	%	NN
cord-005453-4057qib7	8454	16	and	and	CC
cord-005453-4057qib7	8454	17	on	on	IN
cord-005453-4057qib7	8454	18	day+180	day+180	NNP
cord-005453-4057qib7	8454	19	was	be	VBD
cord-005453-4057qib7	8454	20	98	98	CD
cord-005453-4057qib7	8454	21	%	%	NN
cord-005453-4057qib7	8454	22	donor	donor	NN
cord-005453-4057qib7	8454	23	.	.	.
cord-005453-4057qib7	8455	1	Now	now	RB
cord-005453-4057qib7	8455	2	he	-PRON-	PRP
cord-005453-4057qib7	8455	3	is	be	VBZ
cord-005453-4057qib7	8455	4	day+210	day+210	NNP
cord-005453-4057qib7	8455	5	post	post	JJ
cord-005453-4057qib7	8455	6	-	-	JJ
cord-005453-4057qib7	8455	7	SCT	SCT	NNP
cord-005453-4057qib7	8455	8	and	and	CC
cord-005453-4057qib7	8455	9	doing	do	VBG
cord-005453-4057qib7	8455	10	well	well	RB
cord-005453-4057qib7	8455	11	.	.	.
cord-005453-4057qib7	8456	1	She	-PRON-	PRP
cord-005453-4057qib7	8456	2	has	have	VBZ
cord-005453-4057qib7	8456	3	no	no	DT
cord-005453-4057qib7	8456	4	evidence	evidence	NN
cord-005453-4057qib7	8456	5	of	of	IN
cord-005453-4057qib7	8456	6	hemolysis	hemolysis	NN
cord-005453-4057qib7	8456	7	,	,	,
cord-005453-4057qib7	8456	8	proteinuria	proteinuria	NN
cord-005453-4057qib7	8456	9	,	,	,
cord-005453-4057qib7	8456	10	hypertension	hypertension	NN
cord-005453-4057qib7	8456	11	,	,	,
cord-005453-4057qib7	8456	12	fever	fever	NN
cord-005453-4057qib7	8456	13	.	.	.
cord-005453-4057qib7	8457	1	She	-PRON-	PRP
cord-005453-4057qib7	8457	2	has	have	VBZ
cord-005453-4057qib7	8457	3	normal	normal	JJ
cord-005453-4057qib7	8457	4	ferritin	ferritin	NN
cord-005453-4057qib7	8457	5	and	and	CC
cord-005453-4057qib7	8457	6	platelets	platelet	NNS
cord-005453-4057qib7	8457	7	.	.	.
cord-005453-4057qib7	8458	1	She	-PRON-	PRP
cord-005453-4057qib7	8458	2	has	have	VBZ
cord-005453-4057qib7	8458	3	gained	gain	VBN
cord-005453-4057qib7	8458	4	3	3	CD
cord-005453-4057qib7	8458	5	cm	cm	NN
cord-005453-4057qib7	8458	6	height	height	NN
cord-005453-4057qib7	8458	7	and	and	CC
cord-005453-4057qib7	8458	8	5	5	CD
cord-005453-4057qib7	8458	9	kg	kg	NN
cord-005453-4057qib7	8458	10	weight	weight	NN
cord-005453-4057qib7	8458	11	in	in	IN
cord-005453-4057qib7	8458	12	last	last	JJ
cord-005453-4057qib7	8458	13	7	7	CD
cord-005453-4057qib7	8458	14	months	month	NNS
cord-005453-4057qib7	8458	15	.	.	.
cord-005453-4057qib7	8459	1	She	-PRON-	PRP
cord-005453-4057qib7	8459	2	had	have	VBD
cord-005453-4057qib7	8459	3	no	no	DT
cord-005453-4057qib7	8459	4	viral	viral	JJ
cord-005453-4057qib7	8459	5	reactivation	reactivation	NN
cord-005453-4057qib7	8459	6	and	and	CC
cord-005453-4057qib7	8459	7	her	-PRON-	PRP$
cord-005453-4057qib7	8459	8	immune	immune	JJ
cord-005453-4057qib7	8459	9	recovery	recovery	NN
cord-005453-4057qib7	8459	10	at	at	IN
cord-005453-4057qib7	8459	11	6	6	CD
cord-005453-4057qib7	8459	12	months	month	NNS
cord-005453-4057qib7	8459	13	post	post	NN
cord-005453-4057qib7	8460	1	SCT	SCT	NNP
cord-005453-4057qib7	8460	2	is	be	VBZ
cord-005453-4057qib7	8460	3	good	good	JJ
cord-005453-4057qib7	8460	4	.	.	.
cord-005453-4057qib7	8461	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8461	2	:	:	:
cord-005453-4057qib7	8462	1	Non	non	JJ
cord-005453-4057qib7	8462	2	-	-	JJ
cord-005453-4057qib7	8462	3	myeoablative	myeoablative	JJ
cord-005453-4057qib7	8462	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	8462	5	MSD	MSD	NNP
cord-005453-4057qib7	8462	6	SCT	SCT	NNP
cord-005453-4057qib7	8462	7	is	be	VBZ
cord-005453-4057qib7	8462	8	a	a	DT
cord-005453-4057qib7	8462	9	curative	curative	JJ
cord-005453-4057qib7	8462	10	treatment	treatment	NN
cord-005453-4057qib7	8462	11	option	option	NN
cord-005453-4057qib7	8462	12	for	for	IN
cord-005453-4057qib7	8462	13	human	human	JJ
cord-005453-4057qib7	8462	14	HO-1	HO-1	NNP
cord-005453-4057qib7	8462	15	deficiency	deficiency	NN
cord-005453-4057qib7	8462	16	.	.	.
cord-005453-4057qib7	8463	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8463	2	:	:	:
cord-005453-4057qib7	8464	1	Nil	Nil	NNP
cord-005453-4057qib7	8464	2	Two	two	CD
cord-005453-4057qib7	8464	3	decades	decade	NNS
cord-005453-4057qib7	8464	4	of	of	IN
cord-005453-4057qib7	8464	5	excellent	excellent	JJ
cord-005453-4057qib7	8464	6	transplant	transplant	NN
cord-005453-4057qib7	8464	7	survival	survival	NN
cord-005453-4057qib7	8464	8	in	in	IN
cord-005453-4057qib7	8464	9	children	child	NNS
cord-005453-4057qib7	8464	10	with	with	IN
cord-005453-4057qib7	8464	11	chronic	chronic	JJ
cord-005453-4057qib7	8464	12	granulomatous	granulomatous	JJ
cord-005453-4057qib7	8464	13	disease	disease	NN
cord-005453-4057qib7	8464	14	:	:	:
cord-005453-4057qib7	8464	15	A	a	DT
cord-005453-4057qib7	8464	16	report	report	NN
cord-005453-4057qib7	8464	17	from	from	IN
cord-005453-4057qib7	8464	18	a	a	DT
cord-005453-4057qib7	8464	19	supraregional	supraregional	JJ
cord-005453-4057qib7	8464	20	immunology	immunology	NN
cord-005453-4057qib7	8464	21	transplant	transplant	NN
cord-005453-4057qib7	8464	22	centre	centre	NN
cord-005453-4057qib7	8464	23	in	in	IN
cord-005453-4057qib7	8464	24	Europe	Europe	NNP
cord-005453-4057qib7	8464	25	Background	Background	NNP
cord-005453-4057qib7	8464	26	:	:	:
cord-005453-4057qib7	8464	27	Haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	8464	28	stem	stem	NN
cord-005453-4057qib7	8464	29	cell	cell	NN
cord-005453-4057qib7	8464	30	transplantation	transplantation	NN
cord-005453-4057qib7	8464	31	(	(	-LRB-
cord-005453-4057qib7	8464	32	HSCT	HSCT	NNP
cord-005453-4057qib7	8464	33	)	)	-RRB-
cord-005453-4057qib7	8464	34	confers	confer	VBZ
cord-005453-4057qib7	8464	35	life	life	NN
cord-005453-4057qib7	8464	36	-	-	HYPH
cord-005453-4057qib7	8464	37	long	long	JJ
cord-005453-4057qib7	8464	38	curative	curative	JJ
cord-005453-4057qib7	8464	39	therapy	therapy	NN
cord-005453-4057qib7	8464	40	for	for	IN
cord-005453-4057qib7	8464	41	chronic	chronic	JJ
cord-005453-4057qib7	8464	42	granulomatous	granulomatous	JJ
cord-005453-4057qib7	8464	43	disease	disease	NN
cord-005453-4057qib7	8464	44	(	(	-LRB-
cord-005453-4057qib7	8464	45	CGD	CGD	NNP
cord-005453-4057qib7	8464	46	)	)	-RRB-
cord-005453-4057qib7	8464	47	.	.	.
cord-005453-4057qib7	8465	1	The	the	DT
cord-005453-4057qib7	8465	2	ability	ability	NN
cord-005453-4057qib7	8465	3	of	of	IN
cord-005453-4057qib7	8465	4	donor	donor	NN
cord-005453-4057qib7	8465	5	-	-	HYPH
cord-005453-4057qib7	8465	6	derived	derive	VBN
cord-005453-4057qib7	8465	7	neutrophils	neutrophil	NNS
cord-005453-4057qib7	8465	8	to	to	TO
cord-005453-4057qib7	8465	9	replace	replace	VB
cord-005453-4057qib7	8465	10	recipient	recipient	NN
cord-005453-4057qib7	8465	11	's	's	POS
cord-005453-4057qib7	8465	12	defective	defective	JJ
cord-005453-4057qib7	8465	13	neutrophils	neutrophil	NNS
cord-005453-4057qib7	8465	14	makes	make	VBZ
cord-005453-4057qib7	8465	15	HSCT	HSCT	NNP
cord-005453-4057qib7	8465	16	a	a	DT
cord-005453-4057qib7	8465	17	superior	superior	JJ
cord-005453-4057qib7	8465	18	therapy	therapy	NN
cord-005453-4057qib7	8465	19	compared	compare	VBN
cord-005453-4057qib7	8465	20	to	to	IN
cord-005453-4057qib7	8465	21	conventional	conventional	JJ
cord-005453-4057qib7	8465	22	standard	standard	NN
cord-005453-4057qib7	8465	23	of	of	IN
cord-005453-4057qib7	8465	24	care	care	NN
cord-005453-4057qib7	8465	25	using	use	VBG
cord-005453-4057qib7	8465	26	antimicrobial	antimicrobial	JJ
cord-005453-4057qib7	8465	27	therapy	therapy	NN
cord-005453-4057qib7	8465	28	.	.	.
cord-005453-4057qib7	8466	1	Methods	method	NNS
cord-005453-4057qib7	8467	1	:	:	:
cord-005453-4057qib7	8467	2	We	-PRON-	PRP
cord-005453-4057qib7	8467	3	examined	examine	VBD
cord-005453-4057qib7	8467	4	the	the	DT
cord-005453-4057qib7	8467	5	outcome	outcome	NN
cord-005453-4057qib7	8467	6	of	of	IN
cord-005453-4057qib7	8467	7	children	child	NNS
cord-005453-4057qib7	8467	8	with	with	IN
cord-005453-4057qib7	8467	9	CGD	CGD	NNP
cord-005453-4057qib7	8467	10	who	who	WP
cord-005453-4057qib7	8467	11	received	receive	VBD
cord-005453-4057qib7	8467	12	a	a	DT
cord-005453-4057qib7	8467	13	first	first	JJ
cord-005453-4057qib7	8467	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8467	15	at	at	IN
cord-005453-4057qib7	8467	16	Great	Great	NNP
cord-005453-4057qib7	8467	17	North	North	NNP
cord-005453-4057qib7	8467	18	Children	Children	NNPS
cord-005453-4057qib7	8467	19	's	's	POS
cord-005453-4057qib7	8467	20	Hospital	Hospital	NNP
cord-005453-4057qib7	8467	21	from	from	IN
cord-005453-4057qib7	8467	22	1998	1998	CD
cord-005453-4057qib7	8467	23	to	to	IN
cord-005453-4057qib7	8467	24	2017	2017	CD
cord-005453-4057qib7	8467	25	.	.	.
cord-005453-4057qib7	8468	1	Outcomes	outcome	NNS
cord-005453-4057qib7	8468	2	included	include	VBD
cord-005453-4057qib7	8468	3	overall	overall	JJ
cord-005453-4057qib7	8468	4	survival	survival	NN
cord-005453-4057qib7	8468	5	(	(	-LRB-
cord-005453-4057qib7	8468	6	OS	OS	NNP
cord-005453-4057qib7	8468	7	)	)	-RRB-
cord-005453-4057qib7	8468	8	,	,	,
cord-005453-4057qib7	8468	9	event	event	NN
cord-005453-4057qib7	8468	10	-	-	HYPH
cord-005453-4057qib7	8468	11	free	free	JJ
cord-005453-4057qib7	8468	12	survival	survival	NN
cord-005453-4057qib7	8468	13	(	(	-LRB-
cord-005453-4057qib7	8468	14	ES	ES	NNP
cord-005453-4057qib7	8468	15	)	)	-RRB-
cord-005453-4057qib7	8468	16	,	,	,
cord-005453-4057qib7	8468	17	toxicity	toxicity	NN
cord-005453-4057qib7	8468	18	endpoints	endpoint	NNS
cord-005453-4057qib7	8468	19	,	,	,
cord-005453-4057qib7	8468	20	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8468	21	disease	disease	NN
cord-005453-4057qib7	8468	22	,	,	,
cord-005453-4057qib7	8468	23	long	long	JJ
cord-005453-4057qib7	8468	24	-	-	HYPH
cord-005453-4057qib7	8468	25	term	term	NN
cord-005453-4057qib7	8468	26	survival	survival	NN
cord-005453-4057qib7	8468	27	and	and	CC
cord-005453-4057qib7	8468	28	graft	graft	NN
cord-005453-4057qib7	8468	29	function	function	NN
cord-005453-4057qib7	8468	30	.	.	.
cord-005453-4057qib7	8469	1	Cox	Cox	NNP
cord-005453-4057qib7	8469	2	proportional	proportional	JJ
cord-005453-4057qib7	8469	3	-	-	HYPH
cord-005453-4057qib7	8469	4	hazard	hazard	NN
cord-005453-4057qib7	8469	5	models	model	NNS
cord-005453-4057qib7	8469	6	were	be	VBD
cord-005453-4057qib7	8469	7	used	use	VBN
cord-005453-4057qib7	8469	8	to	to	TO
cord-005453-4057qib7	8469	9	analyse	analyse	VB
cord-005453-4057qib7	8469	10	predictors	predictor	NNS
cord-005453-4057qib7	8469	11	of	of	IN
cord-005453-4057qib7	8469	12	OS	OS	NNP
cord-005453-4057qib7	8469	13	and	and	CC
cord-005453-4057qib7	8469	14	ES	ES	NNP
cord-005453-4057qib7	8469	15	.	.	.
cord-005453-4057qib7	8470	1	Variables	variable	NNS
cord-005453-4057qib7	8470	2	included	include	VBN
cord-005453-4057qib7	8470	3	for	for	IN
cord-005453-4057qib7	8470	4	predictor	predictor	NN
cord-005453-4057qib7	8470	5	analysis	analysis	NN
cord-005453-4057qib7	8470	6	were	be	VBD
cord-005453-4057qib7	8470	7	age	age	NN
cord-005453-4057qib7	8470	8	at	at	IN
cord-005453-4057qib7	8470	9	transplant	transplant	NN
cord-005453-4057qib7	8470	10	,	,	,
cord-005453-4057qib7	8470	11	donor	donor	NN
cord-005453-4057qib7	8470	12	,	,	,
cord-005453-4057qib7	8470	13	stem	stem	NN
cord-005453-4057qib7	8470	14	cell	cell	NN
cord-005453-4057qib7	8470	15	source	source	NN
cord-005453-4057qib7	8470	16	,	,	,
cord-005453-4057qib7	8470	17	stem	stem	NN
cord-005453-4057qib7	8470	18	cell	cell	NN
cord-005453-4057qib7	8470	19	doses	dose	NNS
cord-005453-4057qib7	8470	20	and	and	CC
cord-005453-4057qib7	8470	21	conditioning	conditioning	NN
cord-005453-4057qib7	8470	22	.	.	.
cord-005453-4057qib7	8471	1	Results	result	NNS
cord-005453-4057qib7	8471	2	:	:	:
cord-005453-4057qib7	8471	3	=	=	NFP
cord-005453-4057qib7	8472	1	55	55	CD
cord-005453-4057qib7	8472	2	children	child	NNS
cord-005453-4057qib7	8472	3	were	be	VBD
cord-005453-4057qib7	8472	4	included	include	VBN
cord-005453-4057qib7	8472	5	in	in	IN
cord-005453-4057qib7	8472	6	this	this	DT
cord-005453-4057qib7	8472	7	analysis	analysis	NN
cord-005453-4057qib7	8472	8	.	.	.
cord-005453-4057qib7	8473	1	Median	median	JJ
cord-005453-4057qib7	8473	2	age	age	NN
cord-005453-4057qib7	8473	3	of	of	IN
cord-005453-4057qib7	8473	4	transplant	transplant	NN
cord-005453-4057qib7	8473	5	was	be	VBD
cord-005453-4057qib7	8473	6	5.3	5.3	CD
cord-005453-4057qib7	8473	7	years	year	NNS
cord-005453-4057qib7	8473	8	(	(	-LRB-
cord-005453-4057qib7	8473	9	range	range	NN
cord-005453-4057qib7	8473	10	,	,	,
cord-005453-4057qib7	8473	11	0.6	0.6	CD
cord-005453-4057qib7	8473	12	-	-	SYM
cord-005453-4057qib7	8473	13	18.0	18.0	CD
cord-005453-4057qib7	8473	14	years	year	NNS
cord-005453-4057qib7	8473	15	)	)	-RRB-
cord-005453-4057qib7	8473	16	.	.	.
cord-005453-4057qib7	8474	1	45	45	CD
cord-005453-4057qib7	8474	2	(	(	-LRB-
cord-005453-4057qib7	8474	3	82	82	CD
cord-005453-4057qib7	8474	4	%	%	NN
cord-005453-4057qib7	8474	5	)	)	-RRB-
cord-005453-4057qib7	8474	6	had	have	VBD
cord-005453-4057qib7	8474	7	X	x	NN
cord-005453-4057qib7	8474	8	-	-	HYPH
cord-005453-4057qib7	8474	9	linked	link	VBN
cord-005453-4057qib7	8474	10	and	and	CC
cord-005453-4057qib7	8474	11	10	10	CD
cord-005453-4057qib7	8474	12	(	(	-LRB-
cord-005453-4057qib7	8474	13	18	18	CD
cord-005453-4057qib7	8474	14	%	%	NN
cord-005453-4057qib7	8474	15	)	)	-RRB-
cord-005453-4057qib7	8474	16	autosomal	autosomal	JJ
cord-005453-4057qib7	8474	17	recessive	recessive	JJ
cord-005453-4057qib7	8474	18	CGD	CGD	NNP
cord-005453-4057qib7	8474	19	.	.	.
cord-005453-4057qib7	8475	1	Twenty	twenty	CD
cord-005453-4057qib7	8475	2	(	(	-LRB-
cord-005453-4057qib7	8475	3	36	36	CD
cord-005453-4057qib7	8475	4	%	%	NN
cord-005453-4057qib7	8475	5	)	)	-RRB-
cord-005453-4057qib7	8475	6	had	have	VBD
cord-005453-4057qib7	8475	7	matched	match	VBN
cord-005453-4057qib7	8475	8	family	family	NN
cord-005453-4057qib7	8475	9	donor	donor	NN
cord-005453-4057qib7	8475	10	,	,	,
cord-005453-4057qib7	8475	11	31	31	CD
cord-005453-4057qib7	8475	12	(	(	-LRB-
cord-005453-4057qib7	8475	13	56	56	CD
cord-005453-4057qib7	8475	14	%	%	NN
cord-005453-4057qib7	8475	15	)	)	-RRB-
cord-005453-4057qib7	8475	16	had	have	VBD
cord-005453-4057qib7	8475	17	unrelated	unrelated	JJ
cord-005453-4057qib7	8475	18	donor	donor	NN
cord-005453-4057qib7	8475	19	and	and	CC
cord-005453-4057qib7	8475	20	4	4	CD
cord-005453-4057qib7	8475	21	(	(	-LRB-
cord-005453-4057qib7	8475	22	8	8	CD
cord-005453-4057qib7	8475	23	%	%	NN
cord-005453-4057qib7	8475	24	)	)	-RRB-
cord-005453-4057qib7	8475	25	had	have	VBD
cord-005453-4057qib7	8475	26	parental	parental	JJ
cord-005453-4057qib7	8475	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8475	28	donor	donor	NN
cord-005453-4057qib7	8475	29	.	.	.
cord-005453-4057qib7	8476	1	Prior	prior	RB
cord-005453-4057qib7	8476	2	to	to	IN
cord-005453-4057qib7	8476	3	2007	2007	CD
cord-005453-4057qib7	8476	4	,	,	,
cord-005453-4057qib7	8476	5	various	various	JJ
cord-005453-4057qib7	8476	6	conditioning	conditioning	NN
cord-005453-4057qib7	8476	7	regimens	regimen	NNS
cord-005453-4057qib7	8476	8	were	be	VBD
cord-005453-4057qib7	8476	9	used	use	VBN
cord-005453-4057qib7	8476	10	,	,	,
cord-005453-4057qib7	8476	11	with	with	IN
cord-005453-4057qib7	8476	12	21	21	CD
cord-005453-4057qib7	8476	13	(	(	-LRB-
cord-005453-4057qib7	8476	14	38	38	CD
cord-005453-4057qib7	8476	15	%	%	NN
cord-005453-4057qib7	8476	16	)	)	-RRB-
cord-005453-4057qib7	8476	17	patients	patient	NNS
cord-005453-4057qib7	8476	18	undergoing	undergo	VBG
cord-005453-4057qib7	8476	19	conditioning	conditioning	NN
cord-005453-4057qib7	8476	20	with	with	IN
cord-005453-4057qib7	8476	21	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	8476	22	guided	guide	VBN
cord-005453-4057qib7	8476	23	intravenous	intravenous	JJ
cord-005453-4057qib7	8476	24	(	(	-LRB-
cord-005453-4057qib7	8476	25	IV	IV	NNP
cord-005453-4057qib7	8476	26	)	)	-RRB-
cord-005453-4057qib7	8476	27	busulfan	busulfan	NNP
cord-005453-4057qib7	8476	28	(	(	-LRB-
cord-005453-4057qib7	8476	29	Bu	Bu	NNP
cord-005453-4057qib7	8476	30	)	)	-RRB-
cord-005453-4057qib7	8476	31	and	and	CC
cord-005453-4057qib7	8476	32	IV	IV	NNP
cord-005453-4057qib7	8476	33	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	8476	34	with	with	IN
cord-005453-4057qib7	8476	35	or	or	CC
cord-005453-4057qib7	8476	36	without	without	IN
cord-005453-4057qib7	8476	37	serotherapy	serotherapy	NNP
cord-005453-4057qib7	8476	38	.	.	.
cord-005453-4057qib7	8477	1	From	from	IN
cord-005453-4057qib7	8477	2	2007	2007	CD
cord-005453-4057qib7	8477	3	,	,	,
cord-005453-4057qib7	8477	4	the	the	DT
cord-005453-4057qib7	8477	5	conditioning	conditioning	NN
cord-005453-4057qib7	8477	6	regimen	regimen	NN
cord-005453-4057qib7	8477	7	was	be	VBD
cord-005453-4057qib7	8477	8	switched	switch	VBN
cord-005453-4057qib7	8477	9	to	to	IN
cord-005453-4057qib7	8477	10	Flu	Flu	NNP
cord-005453-4057qib7	8477	11	-	-	HYPH
cord-005453-4057qib7	8477	12	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	8477	13	-	-	HYPH
cord-005453-4057qib7	8477	14	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	8477	15	with	with	IN
cord-005453-4057qib7	8477	16	GvHD	GvHD	NNP
cord-005453-4057qib7	8477	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8477	18	using	use	VBG
cord-005453-4057qib7	8477	19	ciclosporin	ciclosporin	NNP
cord-005453-4057qib7	8477	20	(	(	-LRB-
cord-005453-4057qib7	8477	21	CSA	CSA	NNP
cord-005453-4057qib7	8477	22	)	)	-RRB-
cord-005453-4057qib7	8477	23	and	and	CC
cord-005453-4057qib7	8477	24	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	8477	25	mofetil	mofetil	NNP
cord-005453-4057qib7	8477	26	(	(	-LRB-
cord-005453-4057qib7	8477	27	MMF	MMF	NNP
cord-005453-4057qib7	8477	28	)	)	-RRB-
cord-005453-4057qib7	8477	29	for	for	IN
cord-005453-4057qib7	8477	30	family	family	NN
cord-005453-4057qib7	8477	31	and	and	CC
cord-005453-4057qib7	8477	32	unrelated	unrelated	JJ
cord-005453-4057qib7	8477	33	donors	donor	NNS
cord-005453-4057qib7	8477	34	(	(	-LRB-
cord-005453-4057qib7	8477	35	n=24	n=24	NNP
cord-005453-4057qib7	8477	36	,	,	,
cord-005453-4057qib7	8477	37	44	44	CD
cord-005453-4057qib7	8477	38	%	%	NN
cord-005453-4057qib7	8477	39	)	)	-RRB-
cord-005453-4057qib7	8477	40	.	.	.
cord-005453-4057qib7	8478	1	Flu	Flu	NNP
cord-005453-4057qib7	8478	2	-	-	HYPH
cord-005453-4057qib7	8478	3	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	8478	4	-	-	HYPH
cord-005453-4057qib7	8478	5	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	8478	6	-	-	HYPH
cord-005453-4057qib7	8478	7	ATG	ATG	NNP
cord-005453-4057qib7	8478	8	-	-	HYPH
cord-005453-4057qib7	8478	9	Rituximab	Rituximab	NNP
cord-005453-4057qib7	8478	10	was	be	VBD
cord-005453-4057qib7	8478	11	used	use	VBN
cord-005453-4057qib7	8478	12	for	for	IN
cord-005453-4057qib7	8478	13	CD3	CD3	NNP
cord-005453-4057qib7	8479	1	TCR	TCR	NNP
cord-005453-4057qib7	8479	2	alpha	alpha	NN
cord-005453-4057qib7	8479	3	-	-	HYPH
cord-005453-4057qib7	8479	4	beta	beta	NN
cord-005453-4057qib7	8480	1	CD19	CD19	NNP
cord-005453-4057qib7	8480	2	depleted	deplete	VBD
cord-005453-4057qib7	8480	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8480	4	grafts	graft	NNS
cord-005453-4057qib7	8480	5	(	(	-LRB-
cord-005453-4057qib7	8480	6	n=4	n=4	JJ
cord-005453-4057qib7	8480	7	,	,	,
cord-005453-4057qib7	8480	8	7	7	CD
cord-005453-4057qib7	8480	9	%	%	NN
cord-005453-4057qib7	8480	10	)	)	-RRB-
cord-005453-4057qib7	8480	11	.	.	.
cord-005453-4057qib7	8481	1	Ten	ten	CD
cord-005453-4057qib7	8481	2	(	(	-LRB-
cord-005453-4057qib7	8481	3	20	20	CD
cord-005453-4057qib7	8481	4	%	%	NN
cord-005453-4057qib7	8481	5	)	)	-RRB-
cord-005453-4057qib7	8481	6	patients	patient	NNS
cord-005453-4057qib7	8481	7	had	have	VBD
cord-005453-4057qib7	8481	8	grade	grade	NN
cord-005453-4057qib7	8481	9	II	II	NNP
cord-005453-4057qib7	8481	10	-	-	HYPH
cord-005453-4057qib7	8481	11	IV	IV	NNP
cord-005453-4057qib7	8481	12	acute	acute	JJ
cord-005453-4057qib7	8481	13	GvHD	GvHD	NNP
cord-005453-4057qib7	8481	14	while	while	IN
cord-005453-4057qib7	8481	15	5	5	CD
cord-005453-4057qib7	8481	16	had	have	VBD
cord-005453-4057qib7	8481	17	(	(	-LRB-
cord-005453-4057qib7	8481	18	9	9	CD
cord-005453-4057qib7	8481	19	%	%	NN
cord-005453-4057qib7	8481	20	)	)	-RRB-
cord-005453-4057qib7	8481	21	had	have	VBD
cord-005453-4057qib7	8481	22	grade	grade	NN
cord-005453-4057qib7	8481	23	III	III	NNP
cord-005453-4057qib7	8481	24	-	-	HYPH
cord-005453-4057qib7	8481	25	IV	IV	NNP
cord-005453-4057qib7	8481	26	acute	acute	JJ
cord-005453-4057qib7	8481	27	GvHD	GvHD	NNP
cord-005453-4057qib7	8481	28	.	.	.
cord-005453-4057qib7	8482	1	None	none	NN
cord-005453-4057qib7	8482	2	had	have	VBD
cord-005453-4057qib7	8482	3	chronic	chronic	JJ
cord-005453-4057qib7	8482	4	GvHD	GvHD	NNP
cord-005453-4057qib7	8482	5	.	.	.
cord-005453-4057qib7	8483	1	The	the	DT
cord-005453-4057qib7	8483	2	5-year	5-year	CD
cord-005453-4057qib7	8483	3	OS	os	NN
cord-005453-4057qib7	8483	4	for	for	IN
cord-005453-4057qib7	8483	5	the	the	DT
cord-005453-4057qib7	8483	6	entire	entire	JJ
cord-005453-4057qib7	8483	7	cohort	cohort	NN
cord-005453-4057qib7	8483	8	was	be	VBD
cord-005453-4057qib7	8483	9	89	89	CD
cord-005453-4057qib7	8483	10	%	%	NN
cord-005453-4057qib7	8483	11	(	(	-LRB-
cord-005453-4057qib7	8483	12	95	95	CD
cord-005453-4057qib7	8483	13	%	%	NN
cord-005453-4057qib7	8483	14	CI	CI	NNP
cord-005453-4057qib7	8483	15	,	,	,
cord-005453-4057qib7	8483	16	67	67	CD
cord-005453-4057qib7	8483	17	-	-	SYM
cord-005453-4057qib7	8483	18	95	95	CD
cord-005453-4057qib7	8483	19	%	%	NN
cord-005453-4057qib7	8483	20	)	)	-RRB-
cord-005453-4057qib7	8483	21	(	(	-LRB-
cord-005453-4057qib7	8483	22	Figure	figure	NN
cord-005453-4057qib7	8483	23	1	1	CD
cord-005453-4057qib7	8483	24	)	)	-RRB-
cord-005453-4057qib7	8483	25	.	.	.
cord-005453-4057qib7	8484	1	Analysis	analysis	NN
cord-005453-4057qib7	8484	2	by	by	IN
cord-005453-4057qib7	8484	3	age	age	NN
cord-005453-4057qib7	8484	4	at	at	IN
cord-005453-4057qib7	8484	5	transplant	transplant	NN
cord-005453-4057qib7	8484	6	revealed	reveal	VBD
cord-005453-4057qib7	8484	7	a	a	DT
cord-005453-4057qib7	8484	8	5-year	5-year	CD
cord-005453-4057qib7	8484	9	OS	os	NN
cord-005453-4057qib7	8484	10	of	of	IN
cord-005453-4057qib7	8484	11	100	100	CD
cord-005453-4057qib7	8484	12	%	%	NN
cord-005453-4057qib7	8484	13	for	for	IN
cord-005453-4057qib7	8484	14	children	child	NNS
cord-005453-4057qib7	8484	15	transplanted	transplant	VBN
cord-005453-4057qib7	8484	16	at	at	IN
cord-005453-4057qib7	8484	17	<	<	XX
cord-005453-4057qib7	8484	18	=	=	SYM
cord-005453-4057qib7	8484	19	5	5	CD
cord-005453-4057qib7	8484	20	years	year	NNS
cord-005453-4057qib7	8484	21	of	of	IN
cord-005453-4057qib7	8484	22	age	age	NN
cord-005453-4057qib7	8484	23	and	and	CC
cord-005453-4057qib7	8484	24	81	81	CD
cord-005453-4057qib7	8484	25	%	%	NN
cord-005453-4057qib7	8484	26	(	(	-LRB-
cord-005453-4057qib7	8484	27	95%CI	95%ci	CD
cord-005453-4057qib7	8484	28	,	,	,
cord-005453-4057qib7	8484	29	60	60	CD
cord-005453-4057qib7	8484	30	-	-	SYM
cord-005453-4057qib7	8484	31	92	92	CD
cord-005453-4057qib7	8484	32	%	%	NN
cord-005453-4057qib7	8484	33	)	)	-RRB-
cord-005453-4057qib7	8484	34	for	for	IN
cord-005453-4057qib7	8484	35	the	the	DT
cord-005453-4057qib7	8484	36	children	child	NNS
cord-005453-4057qib7	8484	37	>	>	XX
cord-005453-4057qib7	8484	38	5	5	CD
cord-005453-4057qib7	8484	39	years	year	NNS
cord-005453-4057qib7	8484	40	of	of	IN
cord-005453-4057qib7	8484	41	age	age	NN
cord-005453-4057qib7	8484	42	(	(	-LRB-
cord-005453-4057qib7	8484	43	p	p	NN
cord-005453-4057qib7	8484	44	<	<	XX
cord-005453-4057qib7	8484	45	0.04	0.04	CD
cord-005453-4057qib7	8484	46	)	)	-RRB-
cord-005453-4057qib7	8485	1	(	(	-LRB-
cord-005453-4057qib7	8485	2	Figure	figure	NN
cord-005453-4057qib7	8485	3	2	2	CD
cord-005453-4057qib7	8485	4	)	)	-RRB-
cord-005453-4057qib7	8485	5	.	.	.
cord-005453-4057qib7	8486	1	The	the	DT
cord-005453-4057qib7	8486	2	OS	OS	NNP
cord-005453-4057qib7	8486	3	was	be	VBD
cord-005453-4057qib7	8486	4	comparable	comparable	JJ
cord-005453-4057qib7	8486	5	between	between	IN
cord-005453-4057qib7	8486	6	match	match	NN
cord-005453-4057qib7	8486	7	family	family	NN
cord-005453-4057qib7	8486	8	donor	donor	NN
cord-005453-4057qib7	8486	9	(	(	-LRB-
cord-005453-4057qib7	8486	10	88	88	CD
cord-005453-4057qib7	8486	11	%	%	NN
cord-005453-4057qib7	8486	12	,	,	,
cord-005453-4057qib7	8486	13	95	95	CD
cord-005453-4057qib7	8486	14	%	%	NN
cord-005453-4057qib7	8486	15	CI	ci	NN
cord-005453-4057qib7	8486	16	,	,	,
cord-005453-4057qib7	8486	17	61	61	CD
cord-005453-4057qib7	8486	18	-	-	SYM
cord-005453-4057qib7	8486	19	97	97	CD
cord-005453-4057qib7	8486	20	%	%	NN
cord-005453-4057qib7	8486	21	)	)	-RRB-
cord-005453-4057qib7	8486	22	and	and	CC
cord-005453-4057qib7	8486	23	unrelated	unrelated	JJ
cord-005453-4057qib7	8486	24	donor	donor	NN
cord-005453-4057qib7	8486	25	transplant	transplant	NN
cord-005453-4057qib7	8486	26	(	(	-LRB-
cord-005453-4057qib7	8486	27	89	89	CD
cord-005453-4057qib7	8486	28	%	%	NN
cord-005453-4057qib7	8486	29	,	,	,
cord-005453-4057qib7	8486	30	71	71	CD
cord-005453-4057qib7	8486	31	-	-	SYM
cord-005453-4057qib7	8486	32	95	95	CD
cord-005453-4057qib7	8486	33	%	%	NN
cord-005453-4057qib7	8486	34	)	)	-RRB-
cord-005453-4057qib7	8487	1	(	(	-LRB-
cord-005453-4057qib7	8487	2	Figure	figure	NN
cord-005453-4057qib7	8487	3	3	3	CD
cord-005453-4057qib7	8487	4	)	)	-RRB-
cord-005453-4057qib7	8487	5	.	.	.
cord-005453-4057qib7	8488	1	All	all	DT
cord-005453-4057qib7	8488	2	four	four	CD
cord-005453-4057qib7	8488	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8488	4	transplants	transplant	NNS
cord-005453-4057qib7	8488	5	were	be	VBD
cord-005453-4057qib7	8488	6	successful	successful	JJ
cord-005453-4057qib7	8488	7	.	.	.
cord-005453-4057qib7	8489	1	The	the	DT
cord-005453-4057qib7	8489	2	5-year	5-year	CD
cord-005453-4057qib7	8489	3	ES	es	NN
cord-005453-4057qib7	8489	4	for	for	IN
cord-005453-4057qib7	8489	5	the	the	DT
cord-005453-4057qib7	8489	6	entire	entire	JJ
cord-005453-4057qib7	8489	7	cohort	cohort	NN
cord-005453-4057qib7	8489	8	was	be	VBD
cord-005453-4057qib7	8489	9	77	77	CD
cord-005453-4057qib7	8489	10	%	%	NN
cord-005453-4057qib7	8489	11	(	(	-LRB-
cord-005453-4057qib7	8489	12	95	95	CD
cord-005453-4057qib7	8489	13	%	%	NN
cord-005453-4057qib7	8489	14	CI	CI	NNP
cord-005453-4057qib7	8489	15	62	62	CD
cord-005453-4057qib7	8489	16	-	-	SYM
cord-005453-4057qib7	8489	17	87	87	CD
cord-005453-4057qib7	8489	18	%	%	NN
cord-005453-4057qib7	8489	19	)	)	-RRB-
cord-005453-4057qib7	8489	20	.	.	.
cord-005453-4057qib7	8490	1	None	none	NN
cord-005453-4057qib7	8490	2	of	of	IN
cord-005453-4057qib7	8490	3	the	the	DT
cord-005453-4057qib7	8490	4	variables	variable	NNS
cord-005453-4057qib7	8490	5	was	be	VBD
cord-005453-4057qib7	8490	6	associated	associate	VBN
cord-005453-4057qib7	8490	7	with	with	IN
cord-005453-4057qib7	8490	8	ES	ES	NNP
cord-005453-4057qib7	8490	9	.	.	.
cord-005453-4057qib7	8491	1	All	all	DT
cord-005453-4057qib7	8491	2	seven	seven	CD
cord-005453-4057qib7	8491	3	patients	patient	NNS
cord-005453-4057qib7	8491	4	with	with	IN
cord-005453-4057qib7	8491	5	slipping	slip	VBG
cord-005453-4057qib7	8491	6	chimerism	chimerism	NN
cord-005453-4057qib7	8491	7	received	receive	VBD
cord-005453-4057qib7	8491	8	a	a	DT
cord-005453-4057qib7	8491	9	successful	successful	JJ
cord-005453-4057qib7	8491	10	second	second	JJ
cord-005453-4057qib7	8491	11	transplant	transplant	NN
cord-005453-4057qib7	8491	12	.	.	.
cord-005453-4057qib7	8492	1	The	the	DT
cord-005453-4057qib7	8492	2	five	five	CD
cord-005453-4057qib7	8492	3	deaths	death	NNS
cord-005453-4057qib7	8492	4	were	be	VBD
cord-005453-4057qib7	8492	5	all	all	RB
cord-005453-4057qib7	8492	6	due	due	JJ
cord-005453-4057qib7	8492	7	to	to	IN
cord-005453-4057qib7	8492	8	transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	8492	9	complications	complication	NNS
cord-005453-4057qib7	8492	10	(	(	-LRB-
cord-005453-4057qib7	8492	11	2	2	CD
cord-005453-4057qib7	8492	12	multi	multi	JJ
cord-005453-4057qib7	8492	13	-	-	JJ
cord-005453-4057qib7	8492	14	organ	organ	JJ
cord-005453-4057qib7	8492	15	failures	failure	NNS
cord-005453-4057qib7	8492	16	;	;	:
cord-005453-4057qib7	8492	17	1	1	CD
cord-005453-4057qib7	8492	18	pulmonary	pulmonary	JJ
cord-005453-4057qib7	8492	19	haemorrhage	haemorrhage	NN
cord-005453-4057qib7	8492	20	;	;	:
cord-005453-4057qib7	8492	21	1	1	CD
cord-005453-4057qib7	8492	22	graft	graft	NN
cord-005453-4057qib7	8492	23	IV	IV	NNP
cord-005453-4057qib7	8492	24	acute	acute	JJ
cord-005453-4057qib7	8492	25	GvHD	GvHD	NNP
cord-005453-4057qib7	8492	26	;	;	:
cord-005453-4057qib7	8492	27	1	1	CD
cord-005453-4057qib7	8492	28	post	post	JJ
cord-005453-4057qib7	8492	29	-	-	JJ
cord-005453-4057qib7	8492	30	transplant	transplant	JJ
cord-005453-4057qib7	8492	31	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	8492	32	disease	disease	NN
cord-005453-4057qib7	8492	33	)	)	-RRB-
cord-005453-4057qib7	8492	34	.	.	.
cord-005453-4057qib7	8493	1	The	the	DT
cord-005453-4057qib7	8493	2	median	median	JJ
cord-005453-4057qib7	8493	3	age	age	NN
cord-005453-4057qib7	8493	4	at	at	IN
cord-005453-4057qib7	8493	5	transplant	transplant	NN
cord-005453-4057qib7	8493	6	of	of	IN
cord-005453-4057qib7	8493	7	deceased	deceased	JJ
cord-005453-4057qib7	8493	8	patients	patient	NNS
cord-005453-4057qib7	8493	9	was	be	VBD
cord-005453-4057qib7	8493	10	10.0	10.0	CD
cord-005453-4057qib7	8493	11	years	year	NNS
cord-005453-4057qib7	8494	1	(	(	-LRB-
cord-005453-4057qib7	8494	2	range	range	VBP
cord-005453-4057qib7	8494	3	8.4	8.4	CD
cord-005453-4057qib7	8494	4	to	to	TO
cord-005453-4057qib7	8494	5	18	18	CD
cord-005453-4057qib7	8494	6	years	year	NNS
cord-005453-4057qib7	8494	7	)	)	-RRB-
cord-005453-4057qib7	8494	8	.	.	.
cord-005453-4057qib7	8495	1	The	the	DT
cord-005453-4057qib7	8495	2	1-year	1-year	CD
cord-005453-4057qib7	8495	3	and	and	CC
cord-005453-4057qib7	8495	4	5-year	5-year	CD
cord-005453-4057qib7	8495	5	cumulative	cumulative	JJ
cord-005453-4057qib7	8495	6	incidence	incidence	NN
cord-005453-4057qib7	8495	7	of	of	IN
cord-005453-4057qib7	8495	8	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8495	9	diseases	disease	NNS
cord-005453-4057qib7	8495	10	were	be	VBD
cord-005453-4057qib7	8495	11	9	9	CD
cord-005453-4057qib7	8495	12	%	%	NN
cord-005453-4057qib7	8495	13	and	and	CC
cord-005453-4057qib7	8495	14	12	12	CD
cord-005453-4057qib7	8495	15	%	%	NN
cord-005453-4057qib7	8495	16	respectively	respectively	RB
cord-005453-4057qib7	8495	17	.	.	.
cord-005453-4057qib7	8496	1	Three	three	CD
cord-005453-4057qib7	8496	2	(	(	-LRB-
cord-005453-4057qib7	8496	3	5	5	CD
cord-005453-4057qib7	8496	4	%	%	NN
cord-005453-4057qib7	8496	5	)	)	-RRB-
cord-005453-4057qib7	8496	6	had	have	VBD
cord-005453-4057qib7	8496	7	immune	immune	JJ
cord-005453-4057qib7	8496	8	cytopenia	cytopenia	NNS
cord-005453-4057qib7	8496	9	while	while	IN
cord-005453-4057qib7	8496	10	3	3	CD
cord-005453-4057qib7	8496	11	(	(	-LRB-
cord-005453-4057qib7	8496	12	5	5	CD
cord-005453-4057qib7	8496	13	%	%	NN
cord-005453-4057qib7	8496	14	)	)	-RRB-
cord-005453-4057qib7	8496	15	had	have	VBD
cord-005453-4057qib7	8496	16	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8496	17	endocrinopathy	endocrinopathy	NNP
cord-005453-4057qib7	8496	18	(	(	-LRB-
cord-005453-4057qib7	8496	19	2	2	CD
cord-005453-4057qib7	8496	20	thyroid	thyroid	NN
cord-005453-4057qib7	8496	21	dysfunction	dysfunction	NN
cord-005453-4057qib7	8496	22	;	;	:
cord-005453-4057qib7	8496	23	1	1	CD
cord-005453-4057qib7	8496	24	type	type	NN
cord-005453-4057qib7	8496	25	1	1	CD
cord-005453-4057qib7	8496	26	diabetes	diabetes	NN
cord-005453-4057qib7	8496	27	mellitus	mellitus	NN
cord-005453-4057qib7	8496	28	)	)	-RRB-
cord-005453-4057qib7	8496	29	.	.	.
cord-005453-4057qib7	8497	1	The	the	DT
cord-005453-4057qib7	8497	2	median	median	JJ
cord-005453-4057qib7	8497	3	age	age	NN
cord-005453-4057qib7	8497	4	of	of	IN
cord-005453-4057qib7	8497	5	long	long	JJ
cord-005453-4057qib7	8497	6	-	-	HYPH
cord-005453-4057qib7	8497	7	term	term	NN
cord-005453-4057qib7	8497	8	survivors	survivor	NNS
cord-005453-4057qib7	8497	9	was	be	VBD
cord-005453-4057qib7	8497	10	14	14	CD
cord-005453-4057qib7	8497	11	years	year	NNS
cord-005453-4057qib7	8497	12	(	(	-LRB-
cord-005453-4057qib7	8497	13	range	range	NN
cord-005453-4057qib7	8497	14	,	,	,
cord-005453-4057qib7	8497	15	2	2	CD
cord-005453-4057qib7	8497	16	to	to	TO
cord-005453-4057qib7	8497	17	36	36	CD
cord-005453-4057qib7	8497	18	years	year	NNS
cord-005453-4057qib7	8497	19	)	)	-RRB-
cord-005453-4057qib7	8497	20	with	with	IN
cord-005453-4057qib7	8497	21	the	the	DT
cord-005453-4057qib7	8497	22	median	median	JJ
cord-005453-4057qib7	8497	23	duration	duration	NN
cord-005453-4057qib7	8497	24	of	of	IN
cord-005453-4057qib7	8497	25	follow	follow	NN
cord-005453-4057qib7	8497	26	-	-	HYPH
cord-005453-4057qib7	8497	27	up	up	NN
cord-005453-4057qib7	8497	28	of	of	IN
cord-005453-4057qib7	8497	29	6.5	6.5	CD
cord-005453-4057qib7	8497	30	years	year	NNS
cord-005453-4057qib7	8497	31	(	(	-LRB-
cord-005453-4057qib7	8497	32	range	range	NN
cord-005453-4057qib7	8497	33	,	,	,
cord-005453-4057qib7	8497	34	0.32	0.32	CD
cord-005453-4057qib7	8497	35	to	to	IN
cord-005453-4057qib7	8497	36	19.5	19.5	CD
cord-005453-4057qib7	8497	37	years	year	NNS
cord-005453-4057qib7	8497	38	)	)	-RRB-
cord-005453-4057qib7	8497	39	.	.	.
cord-005453-4057qib7	8498	1	There	there	EX
cord-005453-4057qib7	8498	2	was	be	VBD
cord-005453-4057qib7	8498	3	no	no	DT
cord-005453-4057qib7	8498	4	late	late	JJ
cord-005453-4057qib7	8498	5	death	death	NN
cord-005453-4057qib7	8498	6	in	in	IN
cord-005453-4057qib7	8498	7	the	the	DT
cord-005453-4057qib7	8498	8	entire	entire	JJ
cord-005453-4057qib7	8498	9	cohort	cohort	NN
cord-005453-4057qib7	8498	10	.	.	.
cord-005453-4057qib7	8499	1	The	the	DT
cord-005453-4057qib7	8499	2	median	median	JJ
cord-005453-4057qib7	8499	3	donor	donor	NN
cord-005453-4057qib7	8499	4	myeloid	myeloid	NN
cord-005453-4057qib7	8499	5	chimerism	chimerism	NN
cord-005453-4057qib7	8499	6	was	be	VBD
cord-005453-4057qib7	8499	7	100	100	CD
cord-005453-4057qib7	8499	8	%	%	NN
cord-005453-4057qib7	8499	9	(	(	-LRB-
cord-005453-4057qib7	8499	10	range	range	NN
cord-005453-4057qib7	8499	11	23	23	CD
cord-005453-4057qib7	8499	12	to	to	IN
cord-005453-4057qib7	8499	13	100	100	CD
cord-005453-4057qib7	8499	14	%	%	NN
cord-005453-4057qib7	8499	15	)	)	-RRB-
cord-005453-4057qib7	8500	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8500	2	:	:	:
cord-005453-4057qib7	8501	1	Despite	despite	IN
cord-005453-4057qib7	8501	2	the	the	DT
cord-005453-4057qib7	8501	3	limitations	limitation	NNS
cord-005453-4057qib7	8501	4	of	of	IN
cord-005453-4057qib7	8501	5	a	a	DT
cord-005453-4057qib7	8501	6	single	single	JJ
cord-005453-4057qib7	8501	7	centre	centre	NN
cord-005453-4057qib7	8501	8	study	study	NN
cord-005453-4057qib7	8501	9	,	,	,
cord-005453-4057qib7	8501	10	our	-PRON-	PRP$
cord-005453-4057qib7	8501	11	findings	finding	NNS
cord-005453-4057qib7	8501	12	confirm	confirm	VBP
cord-005453-4057qib7	8501	13	that	that	IN
cord-005453-4057qib7	8501	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8501	15	is	be	VBZ
cord-005453-4057qib7	8501	16	a	a	DT
cord-005453-4057qib7	8501	17	safe	safe	JJ
cord-005453-4057qib7	8501	18	and	and	CC
cord-005453-4057qib7	8501	19	longlasting	longlasting	JJ
cord-005453-4057qib7	8501	20	curative	curative	JJ
cord-005453-4057qib7	8501	21	therapy	therapy	NN
cord-005453-4057qib7	8501	22	for	for	IN
cord-005453-4057qib7	8501	23	children	child	NNS
cord-005453-4057qib7	8501	24	with	with	IN
cord-005453-4057qib7	8501	25	CGD	CGD	NNP
cord-005453-4057qib7	8501	26	Disclosure	Disclosure	NNP
cord-005453-4057qib7	8501	27	:	:	:
cord-005453-4057qib7	8502	1	None	none	NN
cord-005453-4057qib7	8503	1	Non	non	JJ
cord-005453-4057qib7	8503	2	-medical	-medical	JJ
cord-005453-4057qib7	8503	3	challenges	challenge	NNS
cord-005453-4057qib7	8503	4	in	in	IN
cord-005453-4057qib7	8503	5	the	the	DT
cord-005453-4057qib7	8503	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	8503	7	and	and	CC
cord-005453-4057qib7	8503	8	transplantation	transplantation	NN
cord-005453-4057qib7	8503	9	of	of	IN
cord-005453-4057qib7	8503	10	patients	patient	NNS
cord-005453-4057qib7	8503	11	with	with	IN
cord-005453-4057qib7	8503	12	primary	primary	JJ
cord-005453-4057qib7	8503	13	immune	immune	JJ
cord-005453-4057qib7	8503	14	deficiency	deficiency	NN
cord-005453-4057qib7	8503	15	:	:	:
cord-005453-4057qib7	8503	16	An	an	DT
cord-005453-4057qib7	8503	17	experience	experience	NN
cord-005453-4057qib7	8503	18	from	from	IN
cord-005453-4057qib7	8503	19	a	a	DT
cord-005453-4057qib7	8503	20	tertiary	tertiary	JJ
cord-005453-4057qib7	8503	21	care	care	NN
cord-005453-4057qib7	8503	22	center	center	NN
cord-005453-4057qib7	8503	23	in	in	IN
cord-005453-4057qib7	8503	24	India	India	NNP
cord-005453-4057qib7	8503	25	Sagar	Sagar	NNP
cord-005453-4057qib7	8503	26	Bhattad	Bhattad	NNP
cord-005453-4057qib7	8503	27	1	1	CD
cord-005453-4057qib7	8503	28	,	,	,
cord-005453-4057qib7	8503	29	Stalin	Stalin	NNP
cord-005453-4057qib7	8503	30	Ramprakash	Ramprakash	NNP
cord-005453-4057qib7	8503	31	1	1	CD
cord-005453-4057qib7	8503	32	,	,	,
cord-005453-4057qib7	8503	33	Raghuram	Raghuram	NNP
cord-005453-4057qib7	8503	34	CP	CP	NNP
cord-005453-4057qib7	8503	35	1	1	CD
cord-005453-4057qib7	8503	36	,	,	,
cord-005453-4057qib7	8503	37	Chetan	Chetan	NNP
cord-005453-4057qib7	8503	38	Ginigeri	Ginigeri	NNP
cord-005453-4057qib7	8503	39	1	1	CD
cord-005453-4057qib7	8503	40	,	,	,
cord-005453-4057qib7	8503	41	Fulvio	Fulvio	NNP
cord-005453-4057qib7	8503	42	Porta	Porta	NNP
cord-005453-4057qib7	8503	43	1,2	1,2	CD
cord-005453-4057qib7	8503	44	Background	background	NN
cord-005453-4057qib7	8503	45	:	:	:
cord-005453-4057qib7	8503	46	Primary	primary	JJ
cord-005453-4057qib7	8503	47	Immune	Immune	NNP
cord-005453-4057qib7	8503	48	Deficiencies	Deficiencies	NNPS
cord-005453-4057qib7	8503	49	(	(	-LRB-
cord-005453-4057qib7	8503	50	PID	PID	NNP
cord-005453-4057qib7	8503	51	)	)	-RRB-
cord-005453-4057qib7	8503	52	are	be	VBP
cord-005453-4057qib7	8503	53	increasingly	increasingly	RB
cord-005453-4057qib7	8503	54	being	be	VBG
cord-005453-4057qib7	8503	55	recognized	recognize	VBN
cord-005453-4057qib7	8503	56	in	in	IN
cord-005453-4057qib7	8503	57	several	several	JJ
cord-005453-4057qib7	8503	58	parts	part	NNS
cord-005453-4057qib7	8503	59	of	of	IN
cord-005453-4057qib7	8503	60	India	India	NNP
cord-005453-4057qib7	8503	61	.	.	.
cord-005453-4057qib7	8504	1	Despite	despite	IN
cord-005453-4057qib7	8504	2	being	be	VBG
cord-005453-4057qib7	8504	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	8504	4	,	,	,
cord-005453-4057qib7	8504	5	many	many	JJ
cord-005453-4057qib7	8504	6	patients	patient	NNS
cord-005453-4057qib7	8504	7	fail	fail	VBP
cord-005453-4057qib7	8504	8	to	to	TO
cord-005453-4057qib7	8504	9	receive	receive	VB
cord-005453-4057qib7	8504	10	optimal	optimal	JJ
cord-005453-4057qib7	8504	11	care	care	NN
cord-005453-4057qib7	8504	12	due	due	IN
cord-005453-4057qib7	8504	13	to	to	IN
cord-005453-4057qib7	8504	14	financial	financial	JJ
cord-005453-4057qib7	8504	15	and	and	CC
cord-005453-4057qib7	8504	16	social	social	JJ
cord-005453-4057qib7	8504	17	constraints	constraint	NNS
cord-005453-4057qib7	8504	18	.	.	.
cord-005453-4057qib7	8505	1	Methods	method	NNS
cord-005453-4057qib7	8505	2	:	:	:
cord-005453-4057qib7	8506	1	Case	case	NN
cord-005453-4057qib7	8506	2	records	record	NNS
cord-005453-4057qib7	8506	3	of	of	IN
cord-005453-4057qib7	8506	4	patients	patient	NNS
cord-005453-4057qib7	8506	5	diagnosed	diagnose	VBN
cord-005453-4057qib7	8506	6	and	and	CC
cord-005453-4057qib7	8506	7	treated	treat	VBN
cord-005453-4057qib7	8506	8	(	(	-LRB-
cord-005453-4057qib7	8506	9	including	include	VBG
cord-005453-4057qib7	8506	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8506	11	stem	stem	NN
cord-005453-4057qib7	8506	12	cell	cell	NN
cord-005453-4057qib7	8506	13	transplants	transplant	NNS
cord-005453-4057qib7	8506	14	)	)	-RRB-
cord-005453-4057qib7	8506	15	for	for	IN
cord-005453-4057qib7	8506	16	PID	pid	NN
cord-005453-4057qib7	8506	17	diseases	disease	NNS
cord-005453-4057qib7	8506	18	during	during	IN
cord-005453-4057qib7	8506	19	Feb	Feb	NNP
cord-005453-4057qib7	8506	20	2018	2018	CD
cord-005453-4057qib7	8506	21	-Nov	-nov	CD
cord-005453-4057qib7	8506	22	2019	2019	CD
cord-005453-4057qib7	8506	23	at	at	IN
cord-005453-4057qib7	8506	24	Aster	Aster	NNP
cord-005453-4057qib7	8506	25	CMI	CMI	NNP
cord-005453-4057qib7	8506	26	Hospital	Hospital	NNP
cord-005453-4057qib7	8506	27	,	,	,
cord-005453-4057qib7	8506	28	Bangalore	Bangalore	NNP
cord-005453-4057qib7	8506	29	,	,	,
cord-005453-4057qib7	8506	30	India	India	NNP
cord-005453-4057qib7	8506	31	were	be	VBD
cord-005453-4057qib7	8506	32	analysed	analyse	VBN
cord-005453-4057qib7	8506	33	.	.	.
cord-005453-4057qib7	8507	1	Factors	factor	NNS
cord-005453-4057qib7	8507	2	leading	lead	VBG
cord-005453-4057qib7	8507	3	to	to	IN
cord-005453-4057qib7	8507	4	deferred	deferred	JJ
cord-005453-4057qib7	8507	5	or	or	CC
cord-005453-4057qib7	8507	6	suboptimal	suboptimal	JJ
cord-005453-4057qib7	8507	7	care	care	NN
cord-005453-4057qib7	8507	8	were	be	VBD
cord-005453-4057qib7	8507	9	assessed	assess	VBN
cord-005453-4057qib7	8507	10	in	in	IN
cord-005453-4057qib7	8507	11	detail	detail	NN
cord-005453-4057qib7	8507	12	.	.	.
cord-005453-4057qib7	8508	1	Results	result	NNS
cord-005453-4057qib7	8508	2	:	:	:
cord-005453-4057qib7	8509	1	65	65	CD
cord-005453-4057qib7	8509	2	patients	patient	NNS
cord-005453-4057qib7	8509	3	with	with	IN
cord-005453-4057qib7	8509	4	various	various	JJ
cord-005453-4057qib7	8509	5	PIDs	pid	NNS
cord-005453-4057qib7	8509	6	were	be	VBD
cord-005453-4057qib7	8509	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	8509	8	during	during	IN
cord-005453-4057qib7	8509	9	the	the	DT
cord-005453-4057qib7	8509	10	study	study	NN
cord-005453-4057qib7	8509	11	period	period	NN
cord-005453-4057qib7	8509	12	(	(	-LRB-
cord-005453-4057qib7	8509	13	details	detail	NNS
cord-005453-4057qib7	8509	14	in	in	IN
cord-005453-4057qib7	8509	15	table	table	NN
cord-005453-4057qib7	8509	16	)	)	-RRB-
cord-005453-4057qib7	8509	17	.	.	.
cord-005453-4057qib7	8510	1	35	35	CD
cord-005453-4057qib7	8510	2	of	of	IN
cord-005453-4057qib7	8510	3	them	-PRON-	PRP
cord-005453-4057qib7	8510	4	warranted	warrant	VBD
cord-005453-4057qib7	8510	5	a	a	DT
cord-005453-4057qib7	8510	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8510	7	stem	stem	NN
cord-005453-4057qib7	8510	8	cell	cell	NN
cord-005453-4057qib7	8510	9	transplant	transplant	NN
cord-005453-4057qib7	8510	10	(	(	-LRB-
cord-005453-4057qib7	8510	11	HSCT	HSCT	NNP
cord-005453-4057qib7	8510	12	)	)	-RRB-
cord-005453-4057qib7	8510	13	as	as	IN
cord-005453-4057qib7	8510	14	definitive	definitive	JJ
cord-005453-4057qib7	8510	15	curative	curative	JJ
cord-005453-4057qib7	8510	16	treatment	treatment	NN
cord-005453-4057qib7	8510	17	.	.	.
cord-005453-4057qib7	8511	1	A	a	DT
cord-005453-4057qib7	8511	2	total	total	NN
cord-005453-4057qib7	8511	3	of	of	IN
cord-005453-4057qib7	8511	4	7	7	CD
cord-005453-4057qib7	8511	5	children	child	NNS
cord-005453-4057qib7	8511	6	received	receive	VBD
cord-005453-4057qib7	8511	7	9	9	CD
cord-005453-4057qib7	8511	8	HSCT	HSCT	NNP
cord-005453-4057qib7	8511	9	.	.	.
cord-005453-4057qib7	8512	1	2	2	CD
cord-005453-4057qib7	8512	2	of	of	IN
cord-005453-4057qib7	8512	3	them	-PRON-	PRP
cord-005453-4057qib7	8512	4	died	die	VBD
cord-005453-4057qib7	8512	5	while	while	IN
cord-005453-4057qib7	8512	6	5	5	CD
cord-005453-4057qib7	8512	7	of	of	IN
cord-005453-4057qib7	8512	8	them	-PRON-	PRP
cord-005453-4057qib7	8512	9	are	be	VBP
cord-005453-4057qib7	8512	10	alive	alive	JJ
cord-005453-4057qib7	8512	11	and	and	CC
cord-005453-4057qib7	8512	12	well	well	RB
cord-005453-4057qib7	8512	13	.	.	.
cord-005453-4057qib7	8513	1	17	17	CD
cord-005453-4057qib7	8513	2	children	child	NNS
cord-005453-4057qib7	8513	3	(	(	-LRB-
cord-005453-4057qib7	8513	4	13	13	CD
cord-005453-4057qib7	8513	5	with	with	IN
cord-005453-4057qib7	8513	6	Severe	severe	JJ
cord-005453-4057qib7	8513	7	Combined	Combined	NNP
cord-005453-4057qib7	8513	8	Immune	Immune	NNP
cord-005453-4057qib7	8513	9	Deficiency	deficiency	NN
cord-005453-4057qib7	8513	10	)	)	-RRB-
cord-005453-4057qib7	8513	11	died	die	VBD
cord-005453-4057qib7	8513	12	before	before	IN
cord-005453-4057qib7	8513	13	a	a	DT
cord-005453-4057qib7	8513	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8513	15	could	could	MD
cord-005453-4057qib7	8513	16	be	be	VB
cord-005453-4057qib7	8513	17	carried	carry	VBN
cord-005453-4057qib7	8513	18	out	out	RP
cord-005453-4057qib7	8513	19	.	.	.
cord-005453-4057qib7	8514	1	12	12	CD
cord-005453-4057qib7	8514	2	of	of	IN
cord-005453-4057qib7	8514	3	them	-PRON-	PRP
cord-005453-4057qib7	8514	4	were	be	VBD
cord-005453-4057qib7	8514	5	critically	critically	RB
cord-005453-4057qib7	8514	6	ill	ill	JJ
cord-005453-4057qib7	8514	7	at	at	IN
cord-005453-4057qib7	8514	8	presentation	presentation	NN
cord-005453-4057qib7	8514	9	,	,	,
cord-005453-4057qib7	8514	10	while	while	IN
cord-005453-4057qib7	8514	11	5	5	CD
cord-005453-4057qib7	8514	12	were	be	VBD
cord-005453-4057qib7	8514	13	stable	stable	JJ
cord-005453-4057qib7	8514	14	but	but	CC
cord-005453-4057qib7	8514	15	deferred	deferred	JJ
cord-005453-4057qib7	8514	16	further	further	JJ
cord-005453-4057qib7	8514	17	treatment	treatment	NN
cord-005453-4057qib7	8514	18	citing	cite	VBG
cord-005453-4057qib7	8514	19	financial	financial	JJ
cord-005453-4057qib7	8514	20	and	and	CC
cord-005453-4057qib7	8514	21	social	social	JJ
cord-005453-4057qib7	8514	22	constraints	constraint	NNS
cord-005453-4057qib7	8514	23	.	.	.
cord-005453-4057qib7	8515	1	11	11	CD
cord-005453-4057qib7	8515	2	children	child	NNS
cord-005453-4057qib7	8515	3	needing	need	VBG
cord-005453-4057qib7	8515	4	transplant	transplant	NN
cord-005453-4057qib7	8515	5	continue	continue	VBP
cord-005453-4057qib7	8515	6	to	to	TO
cord-005453-4057qib7	8515	7	remain	remain	VB
cord-005453-4057qib7	8515	8	on	on	IN
cord-005453-4057qib7	8515	9	follow	follow	NN
cord-005453-4057qib7	8515	10	-	-	HYPH
cord-005453-4057qib7	8515	11	up	up	NN
cord-005453-4057qib7	8515	12	and	and	CC
cord-005453-4057qib7	8515	13	have	have	VBP
cord-005453-4057qib7	8515	14	not	not	RB
cord-005453-4057qib7	8515	15	been	be	VBN
cord-005453-4057qib7	8515	16	transplanted	transplant	VBN
cord-005453-4057qib7	8515	17	to	to	IN
cord-005453-4057qib7	8515	18	date	date	NN
cord-005453-4057qib7	8515	19	(	(	-LRB-
cord-005453-4057qib7	8515	20	4	4	CD
cord-005453-4057qib7	8515	21	of	of	IN
cord-005453-4057qib7	8515	22	them	-PRON-	PRP
cord-005453-4057qib7	8515	23	have	have	VBP
cord-005453-4057qib7	8515	24	significant	significant	JJ
cord-005453-4057qib7	8515	25	financial	financial	JJ
cord-005453-4057qib7	8515	26	constraints	constraint	NNS
cord-005453-4057qib7	8515	27	,	,	,
cord-005453-4057qib7	8515	28	3	3	CD
cord-005453-4057qib7	8515	29	families	family	NNS
cord-005453-4057qib7	8515	30	are	be	VBP
cord-005453-4057qib7	8515	31	not	not	RB
cord-005453-4057qib7	8515	32	convinced	convince	VBN
cord-005453-4057qib7	8515	33	about	about	IN
cord-005453-4057qib7	8515	34	the	the	DT
cord-005453-4057qib7	8515	35	need	need	NN
cord-005453-4057qib7	8515	36	for	for	IN
cord-005453-4057qib7	8515	37	transplant	transplant	NN
cord-005453-4057qib7	8515	38	and	and	CC
cord-005453-4057qib7	8515	39	4	4	CD
cord-005453-4057qib7	8515	40	of	of	IN
cord-005453-4057qib7	8515	41	them	-PRON-	PRP
cord-005453-4057qib7	8515	42	are	be	VBP
cord-005453-4057qib7	8515	43	being	be	VBG
cord-005453-4057qib7	8515	44	prepared	prepare	VBN
cord-005453-4057qib7	8515	45	for	for	IN
cord-005453-4057qib7	8515	46	transplant	transplant	NN
cord-005453-4057qib7	8515	47	)	)	-RRB-
cord-005453-4057qib7	8515	48	.	.	.
cord-005453-4057qib7	8516	1	Table	table	NN
cord-005453-4057qib7	8516	2	:	:	:
cord-005453-4057qib7	8517	1	(	(	-LRB-
cord-005453-4057qib7	8517	2	SCID	SCID	NNP
cord-005453-4057qib7	8517	3	-Severe	-severe	RB
cord-005453-4057qib7	8517	4	Combined	Combined	NNP
cord-005453-4057qib7	8517	5	Immune	Immune	NNP
cord-005453-4057qib7	8517	6	Deficiency	deficiency	NN
cord-005453-4057qib7	8517	7	,	,	,
cord-005453-4057qib7	8517	8	VODI	VODI	NNP
cord-005453-4057qib7	8517	9	-	-	HYPH
cord-005453-4057qib7	8517	10	Veno	Veno	NNP
cord-005453-4057qib7	8517	11	-	-	HYPH
cord-005453-4057qib7	8517	12	Occlusive	Occlusive	NNP
cord-005453-4057qib7	8517	13	Disease	Disease	NNP
cord-005453-4057qib7	8517	14	with	with	IN
cord-005453-4057qib7	8517	15	Immunodeficiency	Immunodeficiency	NNP
cord-005453-4057qib7	8517	16	,	,	,
cord-005453-4057qib7	8517	17	CGD	CGD	NNP
cord-005453-4057qib7	8517	18	-Chronic	-chronic	CC
cord-005453-4057qib7	8517	19	granulomatous	granulomatous	JJ
cord-005453-4057qib7	8517	20	disease	disease	NN
cord-005453-4057qib7	8517	21	,	,	,
cord-005453-4057qib7	8517	22	HLH	HLH	NNP
cord-005453-4057qib7	8517	23	-Hemophagolymphohistiocytosis	-Hemophagolymphohistiocytosis	NNP
cord-005453-4057qib7	8518	1	,	,	,
cord-005453-4057qib7	8518	2	WAS	be	VBD
cord-005453-4057qib7	8518	3	-Wiskott	-Wiskott	NNP
cord-005453-4057qib7	8518	4	Aldrich	Aldrich	NNP
cord-005453-4057qib7	8518	5	Syndrome	Syndrome	NNP
cord-005453-4057qib7	8518	6	,	,	,
cord-005453-4057qib7	8518	7	XLT	XLT	NNP
cord-005453-4057qib7	8518	8	-X	-X	VBZ
cord-005453-4057qib7	8518	9	linked	link	VBN
cord-005453-4057qib7	8518	10	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	8518	11	,	,	,
cord-005453-4057qib7	8518	12	LAD	lad	NN
cord-005453-4057qib7	8518	13	-	-	HYPH
cord-005453-4057qib7	8518	14	Leukocyte	Leukocyte	NNP
cord-005453-4057qib7	8518	15	adhesion	adhesion	NN
cord-005453-4057qib7	8518	16	deficiency	deficiency	NN
cord-005453-4057qib7	8518	17	,	,	,
cord-005453-4057qib7	8518	18	MSMD	MSMD	NNP
cord-005453-4057qib7	8518	19	-Mendelian	-Mendelian	HYPH
cord-005453-4057qib7	8518	20	Susceptibility	Susceptibility	NNP
cord-005453-4057qib7	8518	21	to	to	IN
cord-005453-4057qib7	8518	22	Mycobacterial	Mycobacterial	NNP
cord-005453-4057qib7	8518	23	Disease	Disease	NNP
cord-005453-4057qib7	8518	24	,	,	,
cord-005453-4057qib7	8518	25	XLA	XLA	NNP
cord-005453-4057qib7	8518	26	-X	-X	VBZ
cord-005453-4057qib7	8518	27	linked	link	VBD
cord-005453-4057qib7	8518	28	Agammaglobulinemia	Agammaglobulinemia	NNP
cord-005453-4057qib7	8518	29	,	,	,
cord-005453-4057qib7	8518	30	CVID	CVID	NNP
cord-005453-4057qib7	8519	1	-Common	-Common	.
cord-005453-4057qib7	8520	1	Variable	variable	JJ
cord-005453-4057qib7	8520	2	Immune	Immune	NNP
cord-005453-4057qib7	8520	3	Deficiency	deficiency	NN
cord-005453-4057qib7	8520	4	,	,	,
cord-005453-4057qib7	8520	5	APECED	APECED	NNP
cord-005453-4057qib7	8520	6	-Autoimmune	-Autoimmune	NNP
cord-005453-4057qib7	8521	1	Polyendocrinopathy	Polyendocrinopathy	NNP
cord-005453-4057qib7	8522	1	Candidiasis	Candidiasis	NNP
cord-005453-4057qib7	8522	2	Ectodermal	Ectodermal	NNP
cord-005453-4057qib7	8522	3	Dystrophy	Dystrophy	NNP
cord-005453-4057qib7	8522	4	,	,	,
cord-005453-4057qib7	8522	5	CMCC	CMCC	NNP
cord-005453-4057qib7	8522	6	-Chronic	-Chronic	.
cord-005453-4057qib7	8523	1	MucoCutaneous	MucoCutaneous	NNP
cord-005453-4057qib7	8523	2	Candidiasis	Candidiasis	NNP
cord-005453-4057qib7	8523	3	,	,	,
cord-005453-4057qib7	8524	1	AT	at	IN
cord-005453-4057qib7	8524	2	-Ataxia	-Ataxia	:
cord-005453-4057qib7	8524	3	telangiectasia	telangiectasia	NNP
cord-005453-4057qib7	8524	4	)	)	-RRB-
cord-005453-4057qib7	8524	5	.	.	.
cord-005453-4057qib7	8525	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8525	2	:	:	:
cord-005453-4057qib7	8526	1	We	-PRON-	PRP
cord-005453-4057qib7	8526	2	present	present	VBP
cord-005453-4057qib7	8526	3	our	-PRON-	PRP$
cord-005453-4057qib7	8526	4	experience	experience	NN
cord-005453-4057qib7	8526	5	from	from	IN
cord-005453-4057qib7	8526	6	a	a	DT
cord-005453-4057qib7	8526	7	developing	develop	VBG
cord-005453-4057qib7	8526	8	country	country	NN
cord-005453-4057qib7	8526	9	and	and	CC
cord-005453-4057qib7	8526	10	discuss	discuss	VB
cord-005453-4057qib7	8526	11	non	non	JJ
cord-005453-4057qib7	8526	12	-	-	JJ
cord-005453-4057qib7	8526	13	medical	medical	JJ
cord-005453-4057qib7	8526	14	factors	factor	NNS
cord-005453-4057qib7	8526	15	leading	lead	VBG
cord-005453-4057qib7	8526	16	to	to	IN
cord-005453-4057qib7	8526	17	suboptimal	suboptimal	JJ
cord-005453-4057qib7	8526	18	care	care	NN
cord-005453-4057qib7	8526	19	in	in	IN
cord-005453-4057qib7	8526	20	children	child	NNS
cord-005453-4057qib7	8526	21	with	with	IN
cord-005453-4057qib7	8526	22	PID	PID	NNP
cord-005453-4057qib7	8526	23	.	.	.
cord-005453-4057qib7	8527	1	Only	only	RB
cord-005453-4057qib7	8527	2	20	20	CD
cord-005453-4057qib7	8527	3	%	%	NN
cord-005453-4057qib7	8527	4	children	child	NNS
cord-005453-4057qib7	8527	5	warranting	warrant	VBG
cord-005453-4057qib7	8527	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8527	7	could	could	MD
cord-005453-4057qib7	8527	8	be	be	VB
cord-005453-4057qib7	8527	9	transplanted	transplant	VBN
cord-005453-4057qib7	8527	10	in	in	IN
cord-005453-4057qib7	8527	11	our	-PRON-	PRP$
cord-005453-4057qib7	8527	12	cohort	cohort	NN
cord-005453-4057qib7	8527	13	.	.	.
cord-005453-4057qib7	8528	1	Among	among	IN
cord-005453-4057qib7	8528	2	those	those	DT
cord-005453-4057qib7	8528	3	where	where	WRB
cord-005453-4057qib7	8528	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8528	5	is	be	VBZ
cord-005453-4057qib7	8528	6	potentially	potentially	RB
cord-005453-4057qib7	8528	7	curative	curative	JJ
cord-005453-4057qib7	8528	8	48	48	CD
cord-005453-4057qib7	8528	9	%	%	NN
cord-005453-4057qib7	8528	10	of	of	IN
cord-005453-4057qib7	8528	11	children	child	NNS
cord-005453-4057qib7	8528	12	died	die	VBD
cord-005453-4057qib7	8528	13	before	before	IN
cord-005453-4057qib7	8528	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8528	15	could	could	MD
cord-005453-4057qib7	8528	16	be	be	VB
cord-005453-4057qib7	8528	17	offered	offer	VBN
cord-005453-4057qib7	8528	18	.	.	.
cord-005453-4057qib7	8529	1	Transplants	transplant	NNS
cord-005453-4057qib7	8529	2	in	in	IN
cord-005453-4057qib7	8529	3	developing	develop	VBG
cord-005453-4057qib7	8529	4	countries	country	NNS
cord-005453-4057qib7	8529	5	pose	pose	VBP
cord-005453-4057qib7	8529	6	unique	unique	JJ
cord-005453-4057qib7	8529	7	challenges	challenge	NNS
cord-005453-4057qib7	8529	8	due	due	JJ
cord-005453-4057qib7	8529	9	to	to	IN
cord-005453-4057qib7	8529	10	the	the	DT
cord-005453-4057qib7	8529	11	absence	absence	NN
cord-005453-4057qib7	8529	12	of	of	IN
cord-005453-4057qib7	8529	13	government	government	NN
cord-005453-4057qib7	8529	14	funding	funding	NN
cord-005453-4057qib7	8529	15	and/or	and/or	CC
cord-005453-4057qib7	8529	16	universal	universal	JJ
cord-005453-4057qib7	8529	17	insurance	insurance	NN
cord-005453-4057qib7	8529	18	coverage	coverage	NN
cord-005453-4057qib7	8529	19	.	.	.
cord-005453-4057qib7	8530	1	In	in	IN
cord-005453-4057qib7	8530	2	addition	addition	NN
cord-005453-4057qib7	8530	3	to	to	TO
cord-005453-4057qib7	8530	4	delay	delay	VB
cord-005453-4057qib7	8530	5	in	in	IN
cord-005453-4057qib7	8530	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	8530	7	and	and	CC
cord-005453-4057qib7	8530	8	critical	critical	JJ
cord-005453-4057qib7	8530	9	state	state	NN
cord-005453-4057qib7	8530	10	of	of	IN
cord-005453-4057qib7	8530	11	patients	patient	NNS
cord-005453-4057qib7	8530	12	at	at	IN
cord-005453-4057qib7	8530	13	admission	admission	NN
cord-005453-4057qib7	8530	14	,	,	,
cord-005453-4057qib7	8530	15	financial	financial	JJ
cord-005453-4057qib7	8530	16	and	and	CC
cord-005453-4057qib7	8530	17	social	social	JJ
cord-005453-4057qib7	8530	18	factors	factor	NNS
cord-005453-4057qib7	8530	19	significantly	significantly	RB
cord-005453-4057qib7	8530	20	contributed	contribute	VBD
cord-005453-4057qib7	8530	21	to	to	IN
cord-005453-4057qib7	8530	22	poor	poor	JJ
cord-005453-4057qib7	8530	23	outcome	outcome	NN
cord-005453-4057qib7	8530	24	.	.	.
cord-005453-4057qib7	8531	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8531	2	:	:	:
cord-005453-4057qib7	8532	1	None	none	NN
cord-005453-4057qib7	8533	1	The	the	DT
cord-005453-4057qib7	8533	2	outcome	outcome	NN
cord-005453-4057qib7	8533	3	of	of	IN
cord-005453-4057qib7	8533	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8533	5	stem	stem	NN
cord-005453-4057qib7	8533	6	cell	cell	NN
cord-005453-4057qib7	8533	7	transplantation	transplantation	NN
cord-005453-4057qib7	8533	8	(	(	-LRB-
cord-005453-4057qib7	8533	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8533	10	)	)	-RRB-
cord-005453-4057qib7	8533	11	in	in	IN
cord-005453-4057qib7	8533	12	pediatric	pediatric	JJ
cord-005453-4057qib7	8533	13	patients	patient	NNS
cord-005453-4057qib7	8533	14	with	with	IN
cord-005453-4057qib7	8533	15	hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	8533	16	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	8533	17	(	(	-LRB-
cord-005453-4057qib7	8533	18	HLH	HLH	NNP
cord-005453-4057qib7	8533	19	)	)	-RRB-
cord-005453-4057qib7	8533	20	in	in	IN
cord-005453-4057qib7	8533	21	Korea	Korea	NNP
cord-005453-4057qib7	8533	22	Methods	Methods	NNPS
cord-005453-4057qib7	8533	23	:	:	:
cord-005453-4057qib7	8534	1	The	the	DT
cord-005453-4057qib7	8534	2	Korea	Korea	NNP
cord-005453-4057qib7	8534	3	Histiocytosis	Histiocytosis	NNP
cord-005453-4057qib7	8534	4	Working	Working	NNP
cord-005453-4057qib7	8534	5	Party	Party	NNP
cord-005453-4057qib7	8534	6	retrospectively	retrospectively	RB
cord-005453-4057qib7	8534	7	collected	collect	VBD
cord-005453-4057qib7	8534	8	nation	nation	NN
cord-005453-4057qib7	8534	9	-	-	HYPH
cord-005453-4057qib7	8534	10	wide	wide	JJ
cord-005453-4057qib7	8534	11	data	datum	NNS
cord-005453-4057qib7	8534	12	from	from	IN
cord-005453-4057qib7	8534	13	the	the	DT
cord-005453-4057qib7	8534	14	patients	patient	NNS
cord-005453-4057qib7	8534	15	diagnosed	diagnose	VBN
cord-005453-4057qib7	8534	16	with	with	IN
cord-005453-4057qib7	8534	17	HLH	HLH	NNP
cord-005453-4057qib7	8534	18	and	and	CC
cord-005453-4057qib7	8534	19	underwent	undergo	VBD
cord-005453-4057qib7	8534	20	allogeneic	allogeneic	JJ
cord-005453-4057qib7	8534	21	HSCT	HSCT	NNP
cord-005453-4057qib7	8534	22	between	between	IN
cord-005453-4057qib7	8534	23	2009	2009	CD
cord-005453-4057qib7	8534	24	and	and	CC
cord-005453-4057qib7	8534	25	2017	2017	CD
cord-005453-4057qib7	8534	26	.	.	.
cord-005453-4057qib7	8535	1	The	the	DT
cord-005453-4057qib7	8535	2	clinical	clinical	JJ
cord-005453-4057qib7	8535	3	characteristics	characteristic	NNS
cord-005453-4057qib7	8535	4	and	and	CC
cord-005453-4057qib7	8535	5	treatment	treatment	NN
cord-005453-4057qib7	8535	6	outcomes	outcome	NNS
cord-005453-4057qib7	8535	7	of	of	IN
cord-005453-4057qib7	8535	8	the	the	DT
cord-005453-4057qib7	8535	9	patients	patient	NNS
cord-005453-4057qib7	8535	10	were	be	VBD
cord-005453-4057qib7	8535	11	analyzed	analyze	VBN
cord-005453-4057qib7	8535	12	.	.	.
cord-005453-4057qib7	8536	1	Results	result	NNS
cord-005453-4057qib7	8536	2	:	:	:
cord-005453-4057qib7	8537	1	A	a	DT
cord-005453-4057qib7	8537	2	total	total	NN
cord-005453-4057qib7	8537	3	of	of	IN
cord-005453-4057qib7	8537	4	44	44	CD
cord-005453-4057qib7	8537	5	patients	patient	NNS
cord-005453-4057qib7	8537	6	were	be	VBD
cord-005453-4057qib7	8537	7	enrolled	enrol	VBN
cord-005453-4057qib7	8537	8	.	.	.
cord-005453-4057qib7	8538	1	There	there	EX
cord-005453-4057qib7	8538	2	were	be	VBD
cord-005453-4057qib7	8538	3	31	31	CD
cord-005453-4057qib7	8538	4	patients	patient	NNS
cord-005453-4057qib7	8538	5	with	with	IN
cord-005453-4057qib7	8538	6	FHL	FHL	NNP
cord-005453-4057qib7	8538	7	(	(	-LRB-
cord-005453-4057qib7	8538	8	4	4	CD
cord-005453-4057qib7	8538	9	FHL2	FHL2	NNP
cord-005453-4057qib7	8538	10	,	,	,
cord-005453-4057qib7	8538	11	26	26	CD
cord-005453-4057qib7	8538	12	FHL3	FHL3	NNP
cord-005453-4057qib7	8538	13	,	,	,
cord-005453-4057qib7	8538	14	and	and	CC
cord-005453-4057qib7	8538	15	1	1	CD
cord-005453-4057qib7	8538	16	FHL4	FHL4	NNP
cord-005453-4057qib7	8538	17	)	)	-RRB-
cord-005453-4057qib7	8538	18	,	,	,
cord-005453-4057qib7	8538	19	7	7	CD
cord-005453-4057qib7	8538	20	infection	infection	NN
cord-005453-4057qib7	8538	21	associated	associate	VBD
cord-005453-4057qib7	8538	22	HLH	HLH	NNP
cord-005453-4057qib7	8538	23	,	,	,
cord-005453-4057qib7	8538	24	and	and	CC
cord-005453-4057qib7	8538	25	6	6	CD
cord-005453-4057qib7	8538	26	secondary	secondary	JJ
cord-005453-4057qib7	8538	27	HLH	hlh	NN
cord-005453-4057qib7	8538	28	of	of	IN
cord-005453-4057qib7	8538	29	unknown	unknown	JJ
cord-005453-4057qib7	8538	30	cause	cause	NN
cord-005453-4057qib7	8538	31	.	.	.
cord-005453-4057qib7	8539	1	All	all	PDT
cord-005453-4057qib7	8539	2	the	the	DT
cord-005453-4057qib7	8539	3	patients	patient	NNS
cord-005453-4057qib7	8539	4	were	be	VBD
cord-005453-4057qib7	8539	5	treated	treat	VBN
cord-005453-4057qib7	8539	6	with	with	IN
cord-005453-4057qib7	8539	7	HLH-2004	HLH-2004	NNP
cord-005453-4057qib7	8539	8	protocol	protocol	NN
cord-005453-4057qib7	8539	9	,	,	,
cord-005453-4057qib7	8539	10	and	and	CC
cord-005453-4057qib7	8539	11	30	30	CD
cord-005453-4057qib7	8539	12	patients	patient	NNS
cord-005453-4057qib7	8539	13	achieved	achieve	VBD
cord-005453-4057qib7	8539	14	complete	complete	JJ
cord-005453-4057qib7	8539	15	response	response	NN
cord-005453-4057qib7	8539	16	(	(	-LRB-
cord-005453-4057qib7	8539	17	CR	cr	NN
cord-005453-4057qib7	8539	18	)	)	-RRB-
cord-005453-4057qib7	8539	19	after	after	IN
cord-005453-4057qib7	8539	20	treatment	treatment	NN
cord-005453-4057qib7	8539	21	for	for	IN
cord-005453-4057qib7	8539	22	8	8	CD
cord-005453-4057qib7	8539	23	weeks	week	NNS
cord-005453-4057qib7	8539	24	,	,	,
cord-005453-4057qib7	8539	25	while	while	IN
cord-005453-4057qib7	8539	26	14	14	CD
cord-005453-4057qib7	8539	27	did	do	VBD
cord-005453-4057qib7	8539	28	not	not	RB
cord-005453-4057qib7	8539	29	.	.	.
cord-005453-4057qib7	8540	1	The	the	DT
cord-005453-4057qib7	8540	2	main	main	JJ
cord-005453-4057qib7	8540	3	reasons	reason	NNS
cord-005453-4057qib7	8540	4	for	for	IN
cord-005453-4057qib7	8540	5	receiving	receive	VBG
cord-005453-4057qib7	8540	6	transplantation	transplantation	NN
cord-005453-4057qib7	8540	7	were	be	VBD
cord-005453-4057qib7	8540	8	FHL	FHL	NNP
cord-005453-4057qib7	8540	9	in	in	IN
cord-005453-4057qib7	8540	10	26	26	CD
cord-005453-4057qib7	8540	11	,	,	,
cord-005453-4057qib7	8540	12	reactivation	reactivation	NN
cord-005453-4057qib7	8540	13	in	in	IN
cord-005453-4057qib7	8540	14	17	17	CD
cord-005453-4057qib7	8540	15	,	,	,
cord-005453-4057qib7	8540	16	and	and	CC
cord-005453-4057qib7	8540	17	refractory	refractory	JJ
cord-005453-4057qib7	8540	18	disease	disease	NN
cord-005453-4057qib7	8540	19	in	in	IN
cord-005453-4057qib7	8540	20	1	1	CD
cord-005453-4057qib7	8540	21	.	.	.
cord-005453-4057qib7	8541	1	The	the	DT
cord-005453-4057qib7	8541	2	conditioning	conditioning	NN
cord-005453-4057qib7	8541	3	regimens	regimen	NNS
cord-005453-4057qib7	8541	4	were	be	VBD
cord-005453-4057qib7	8541	5	busulfan	busulfan	NN
cord-005453-4057qib7	8541	6	-	-	HYPH
cord-005453-4057qib7	8541	7	based	base	VBN
cord-005453-4057qib7	8541	8	in	in	IN
cord-005453-4057qib7	8541	9	16	16	CD
cord-005453-4057qib7	8541	10	patients	patient	NNS
cord-005453-4057qib7	8541	11	,	,	,
cord-005453-4057qib7	8541	12	fludarabine	fludarabine	NN
cord-005453-4057qib7	8541	13	-	-	HYPH
cord-005453-4057qib7	8541	14	based	base	VBN
cord-005453-4057qib7	8541	15	in	in	IN
cord-005453-4057qib7	8541	16	4	4	CD
cord-005453-4057qib7	8541	17	,	,	,
cord-005453-4057qib7	8541	18	treosulfan	treosulfan	NNP
cord-005453-4057qib7	8541	19	-	-	HYPH
cord-005453-4057qib7	8541	20	based	base	VBN
cord-005453-4057qib7	8541	21	in	in	IN
cord-005453-4057qib7	8541	22	7	7	CD
cord-005453-4057qib7	8541	23	,	,	,
cord-005453-4057qib7	8541	24	and	and	CC
cord-005453-4057qib7	8541	25	busulfan	busulfan	NN
cord-005453-4057qib7	8541	26	/	/	SYM
cord-005453-4057qib7	8541	27	fludarabine	fludarabine	NN
cord-005453-4057qib7	8541	28	-	-	HYPH
cord-005453-4057qib7	8541	29	based	base	VBN
cord-005453-4057qib7	8541	30	in	in	IN
cord-005453-4057qib7	8541	31	17	17	CD
cord-005453-4057qib7	8541	32	.	.	.
cord-005453-4057qib7	8542	1	Stem	stem	JJ
cord-005453-4057qib7	8542	2	cell	cell	NN
cord-005453-4057qib7	8542	3	sources	source	NNS
cord-005453-4057qib7	8542	4	used	use	VBN
cord-005453-4057qib7	8542	5	for	for	IN
cord-005453-4057qib7	8542	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8542	7	were	be	VBD
cord-005453-4057qib7	8542	8	from	from	IN
cord-005453-4057qib7	8542	9	peripheral	peripheral	JJ
cord-005453-4057qib7	8542	10	blood	blood	NN
cord-005453-4057qib7	8542	11	in	in	IN
cord-005453-4057qib7	8542	12	36	36	CD
cord-005453-4057qib7	8542	13	patient	patient	NN
cord-005453-4057qib7	8542	14	,	,	,
cord-005453-4057qib7	8542	15	cord	cord	NN
cord-005453-4057qib7	8542	16	blood	blood	NN
cord-005453-4057qib7	8542	17	in	in	IN
cord-005453-4057qib7	8542	18	7	7	CD
cord-005453-4057qib7	8542	19	,	,	,
cord-005453-4057qib7	8542	20	and	and	CC
cord-005453-4057qib7	8542	21	bone	bone	NN
cord-005453-4057qib7	8542	22	marrow	marrow	NN
cord-005453-4057qib7	8542	23	in	in	IN
cord-005453-4057qib7	8542	24	1	1	CD
cord-005453-4057qib7	8542	25	.	.	.
cord-005453-4057qib7	8543	1	The	the	DT
cord-005453-4057qib7	8543	2	donor	donor	NN
cord-005453-4057qib7	8543	3	types	type	NNS
cord-005453-4057qib7	8543	4	of	of	IN
cord-005453-4057qib7	8543	5	HSCT	HSCT	NNP
cord-005453-4057qib7	8543	6	were	be	VBD
cord-005453-4057qib7	8543	7	unrelated	unrelated	JJ
cord-005453-4057qib7	8543	8	donor	donor	NN
cord-005453-4057qib7	8543	9	in	in	IN
cord-005453-4057qib7	8543	10	33	33	CD
cord-005453-4057qib7	8543	11	patients	patient	NNS
cord-005453-4057qib7	8543	12	and	and	CC
cord-005453-4057qib7	8543	13	related	relate	VBN
cord-005453-4057qib7	8543	14	in	in	IN
cord-005453-4057qib7	8543	15	11	11	CD
cord-005453-4057qib7	8543	16	(	(	-LRB-
cord-005453-4057qib7	8543	17	7	7	CD
cord-005453-4057qib7	8543	18	matched	match	VBN
cord-005453-4057qib7	8543	19	sibling	sibling	NN
cord-005453-4057qib7	8543	20	donor	donor	NN
cord-005453-4057qib7	8543	21	,	,	,
cord-005453-4057qib7	8543	22	4	4	CD
cord-005453-4057qib7	8543	23	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8543	24	donor	donor	NN
cord-005453-4057qib7	8543	25	,	,	,
cord-005453-4057qib7	8543	26	1	1	CD
cord-005453-4057qib7	8543	27	partially	partially	RB
cord-005453-4057qib7	8543	28	matched	match	VBN
cord-005453-4057qib7	8543	29	donor	donor	NN
cord-005453-4057qib7	8543	30	)	)	-RRB-
cord-005453-4057qib7	8543	31	.	.	.
cord-005453-4057qib7	8544	1	The	the	DT
cord-005453-4057qib7	8544	2	causes	cause	NNS
cord-005453-4057qib7	8544	3	of	of	IN
cord-005453-4057qib7	8544	4	death	death	NN
cord-005453-4057qib7	8544	5	of	of	IN
cord-005453-4057qib7	8544	6	7	7	CD
cord-005453-4057qib7	8544	7	patients	patient	NNS
cord-005453-4057qib7	8544	8	were	be	VBD
cord-005453-4057qib7	8544	9	disease	disease	NN
cord-005453-4057qib7	8544	10	reactivation/	reactivation/	ADD
cord-005453-4057qib7	8544	11	progression	progression	NN
cord-005453-4057qib7	8544	12	in	in	IN
cord-005453-4057qib7	8544	13	3	3	CD
cord-005453-4057qib7	8544	14	,	,	,
cord-005453-4057qib7	8544	15	acute	acute	JJ
cord-005453-4057qib7	8544	16	GVHD	GVHD	NNP
cord-005453-4057qib7	8544	17	with	with	IN
cord-005453-4057qib7	8544	18	/	/	SYM
cord-005453-4057qib7	8544	19	without	without	IN
cord-005453-4057qib7	8544	20	VOD	VOD	NNP
cord-005453-4057qib7	8544	21	in	in	IN
cord-005453-4057qib7	8544	22	3	3	CD
cord-005453-4057qib7	8544	23	,	,	,
cord-005453-4057qib7	8544	24	and	and	CC
cord-005453-4057qib7	8544	25	graft	graft	NN
cord-005453-4057qib7	8544	26	failure	failure	NN
cord-005453-4057qib7	8544	27	in	in	IN
cord-005453-4057qib7	8544	28	1	1	CD
cord-005453-4057qib7	8544	29	.	.	.
cord-005453-4057qib7	8545	1	Five	five	CD
cord-005453-4057qib7	8545	2	year	year	NN
cord-005453-4057qib7	8545	3	overall	overall	JJ
cord-005453-4057qib7	8545	4	survival	survival	NN
cord-005453-4057qib7	8545	5	rates	rate	NNS
cord-005453-4057qib7	8545	6	were	be	VBD
cord-005453-4057qib7	8545	7	82.4	82.4	CD
cord-005453-4057qib7	8545	8	%	%	NN
cord-005453-4057qib7	8545	9	,	,	,
cord-005453-4057qib7	8545	10	respectively	respectively	RB
cord-005453-4057qib7	8545	11	.	.	.
cord-005453-4057qib7	8546	1	The	the	DT
cord-005453-4057qib7	8546	2	disease	disease	NN
cord-005453-4057qib7	8546	3	status	status	NN
cord-005453-4057qib7	8546	4	at	at	IN
cord-005453-4057qib7	8546	5	the	the	DT
cord-005453-4057qib7	8546	6	time	time	NN
cord-005453-4057qib7	8546	7	of	of	IN
cord-005453-4057qib7	8546	8	HSCT	HSCT	NNP
cord-005453-4057qib7	8546	9	was	be	VBD
cord-005453-4057qib7	8546	10	CR	CR	NNP
cord-005453-4057qib7	8546	11	in	in	IN
cord-005453-4057qib7	8546	12	37	37	CD
cord-005453-4057qib7	8546	13	patients	patient	NNS
cord-005453-4057qib7	8546	14	,	,	,
cord-005453-4057qib7	8546	15	and	and	CC
cord-005453-4057qib7	8546	16	non	non	JJ
cord-005453-4057qib7	8546	17	-	-	JJ
cord-005453-4057qib7	8546	18	CR	CR	NNP
cord-005453-4057qib7	8546	19	in	in	IN
cord-005453-4057qib7	8546	20	7	7	CD
cord-005453-4057qib7	8546	21	.	.	.
cord-005453-4057qib7	8547	1	The	the	DT
cord-005453-4057qib7	8547	2	5-year	5-year	CD
cord-005453-4057qib7	8547	3	survival	survival	NN
cord-005453-4057qib7	8547	4	rate	rate	NN
cord-005453-4057qib7	8547	5	of	of	IN
cord-005453-4057qib7	8547	6	patients	patient	NNS
cord-005453-4057qib7	8547	7	who	who	WP
cord-005453-4057qib7	8547	8	received	receive	VBD
cord-005453-4057qib7	8547	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8547	10	in	in	IN
cord-005453-4057qib7	8547	11	CR	CR	NNP
cord-005453-4057qib7	8547	12	was	be	VBD
cord-005453-4057qib7	8547	13	87	87	CD
cord-005453-4057qib7	8547	14	%	%	NN
cord-005453-4057qib7	8547	15	and	and	CC
cord-005453-4057qib7	8547	16	63	63	CD
cord-005453-4057qib7	8547	17	%	%	NN
cord-005453-4057qib7	8547	18	for	for	IN
cord-005453-4057qib7	8547	19	patients	patient	NNS
cord-005453-4057qib7	8547	20	transplanted	transplant	VBN
cord-005453-4057qib7	8547	21	while	while	IN
cord-005453-4057qib7	8547	22	in	in	IN
cord-005453-4057qib7	8547	23	non	non	JJ
cord-005453-4057qib7	8547	24	-	-	JJ
cord-005453-4057qib7	8547	25	CR	cr	JJ
cord-005453-4057qib7	8547	26	status	status	NN
cord-005453-4057qib7	8547	27	(	(	-LRB-
cord-005453-4057qib7	8547	28	p=0.046	p=0.046	NNP
cord-005453-4057qib7	8547	29	)	)	-RRB-
cord-005453-4057qib7	8547	30	.	.	.
cord-005453-4057qib7	8548	1	Patients	patient	NNS
cord-005453-4057qib7	8548	2	who	who	WP
cord-005453-4057qib7	8548	3	received	receive	VBD
cord-005453-4057qib7	8548	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8548	5	using	use	VBG
cord-005453-4057qib7	8548	6	peripheral	peripheral	JJ
cord-005453-4057qib7	8548	7	blood	blood	NN
cord-005453-4057qib7	8548	8	stem	stem	NN
cord-005453-4057qib7	8548	9	cells	cell	NNS
cord-005453-4057qib7	8548	10	had	have	VBD
cord-005453-4057qib7	8548	11	a	a	DT
cord-005453-4057qib7	8548	12	better	well	JJR
cord-005453-4057qib7	8548	13	5-year	5-year	CD
cord-005453-4057qib7	8548	14	survival	survival	NN
cord-005453-4057qib7	8548	15	rate	rate	NN
cord-005453-4057qib7	8548	16	of	of	IN
cord-005453-4057qib7	8548	17	86	86	CD
cord-005453-4057qib7	8548	18	%	%	NN
cord-005453-4057qib7	8548	19	compared	compare	VBN
cord-005453-4057qib7	8548	20	to	to	IN
cord-005453-4057qib7	8548	21	75	75	CD
cord-005453-4057qib7	8548	22	%	%	NN
cord-005453-4057qib7	8548	23	of	of	IN
cord-005453-4057qib7	8548	24	patients	patient	NNS
cord-005453-4057qib7	8548	25	who	who	WP
cord-005453-4057qib7	8548	26	received	receive	VBD
cord-005453-4057qib7	8548	27	cord	cord	NN
cord-005453-4057qib7	8548	28	blood	blood	NN
cord-005453-4057qib7	8548	29	stem	stem	NN
cord-005453-4057qib7	8548	30	cells	cell	NNS
cord-005453-4057qib7	8548	31	,	,	,
cord-005453-4057qib7	8548	32	significantly	significantly	RB
cord-005453-4057qib7	8548	33	.	.	.
cord-005453-4057qib7	8549	1	The	the	DT
cord-005453-4057qib7	8549	2	presence	presence	NN
cord-005453-4057qib7	8549	3	of	of	IN
cord-005453-4057qib7	8549	4	neurologic	neurologic	JJ
cord-005453-4057qib7	8549	5	symptoms	symptom	NNS
cord-005453-4057qib7	8549	6	,	,	,
cord-005453-4057qib7	8549	7	disease	disease	NN
cord-005453-4057qib7	8549	8	status	status	NN
cord-005453-4057qib7	8549	9	after	after	IN
cord-005453-4057qib7	8549	10	intial	intial	JJ
cord-005453-4057qib7	8549	11	8	8	CD
cord-005453-4057qib7	8549	12	week	week	NN
cord-005453-4057qib7	8549	13	therapy	therapy	NN
cord-005453-4057qib7	8549	14	,	,	,
cord-005453-4057qib7	8549	15	conditioning	conditioning	NN
cord-005453-4057qib7	8549	16	regimen	regimen	NN
cord-005453-4057qib7	8549	17	,	,	,
cord-005453-4057qib7	8549	18	and	and	CC
cord-005453-4057qib7	8549	19	CD	CD	NNP
cord-005453-4057qib7	8549	20	34	34	CD
cord-005453-4057qib7	8549	21	positive	positive	JJ
cord-005453-4057qib7	8549	22	cell	cell	NN
cord-005453-4057qib7	8549	23	count	count	NN
cord-005453-4057qib7	8549	24	did	do	VBD
cord-005453-4057qib7	8549	25	not	not	RB
cord-005453-4057qib7	8549	26	have	have	VB
cord-005453-4057qib7	8549	27	statistically	statistically	RB
cord-005453-4057qib7	8549	28	significant	significant	JJ
cord-005453-4057qib7	8549	29	impact	impact	NN
cord-005453-4057qib7	8549	30	on	on	IN
cord-005453-4057qib7	8549	31	survival	survival	NN
cord-005453-4057qib7	8549	32	.	.	.
cord-005453-4057qib7	8550	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8550	2	:	:	:
cord-005453-4057qib7	8550	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8550	4	improved	improve	VBD
cord-005453-4057qib7	8550	5	the	the	DT
cord-005453-4057qib7	8550	6	survival	survival	NN
cord-005453-4057qib7	8550	7	of	of	IN
cord-005453-4057qib7	8550	8	patients	patient	NNS
cord-005453-4057qib7	8550	9	who	who	WP
cord-005453-4057qib7	8550	10	had	have	VBD
cord-005453-4057qib7	8550	11	familial	familial	JJ
cord-005453-4057qib7	8550	12	,	,	,
cord-005453-4057qib7	8550	13	or	or	CC
cord-005453-4057qib7	8550	14	relapsed	relapse	VBN
cord-005453-4057qib7	8550	15	,	,	,
cord-005453-4057qib7	8550	16	or	or	CC
cord-005453-4057qib7	8550	17	refractory	refractory	JJ
cord-005453-4057qib7	8550	18	HLH	HLH	NNP
cord-005453-4057qib7	8550	19	in	in	IN
cord-005453-4057qib7	8550	20	the	the	DT
cord-005453-4057qib7	8550	21	Korean	korean	JJ
cord-005453-4057qib7	8550	22	nation	nation	NN
cord-005453-4057qib7	8550	23	-	-	HYPH
cord-005453-4057qib7	8550	24	wide	wide	JJ
cord-005453-4057qib7	8550	25	HLH	HLH	NNP
cord-005453-4057qib7	8550	26	registry	registry	NN
cord-005453-4057qib7	8550	27	.	.	.
cord-005453-4057qib7	8551	1	These	these	DT
cord-005453-4057qib7	8551	2	results	result	NNS
cord-005453-4057qib7	8551	3	are	be	VBP
cord-005453-4057qib7	8551	4	similar	similar	JJ
cord-005453-4057qib7	8551	5	to	to	IN
cord-005453-4057qib7	8551	6	other	other	JJ
cord-005453-4057qib7	8551	7	reports	report	NNS
cord-005453-4057qib7	8551	8	in	in	IN
cord-005453-4057qib7	8551	9	the	the	DT
cord-005453-4057qib7	8551	10	literature	literature	NN
cord-005453-4057qib7	8551	11	.	.	.
cord-005453-4057qib7	8552	1	The	the	DT
cord-005453-4057qib7	8552	2	disease	disease	NN
cord-005453-4057qib7	8552	3	status	status	NN
cord-005453-4057qib7	8552	4	at	at	IN
cord-005453-4057qib7	8552	5	the	the	DT
cord-005453-4057qib7	8552	6	time	time	NN
cord-005453-4057qib7	8552	7	of	of	IN
cord-005453-4057qib7	8552	8	HSCT	HSCT	NNP
cord-005453-4057qib7	8552	9	and	and	CC
cord-005453-4057qib7	8552	10	the	the	DT
cord-005453-4057qib7	8552	11	stem	stem	NN
cord-005453-4057qib7	8552	12	cell	cell	NN
cord-005453-4057qib7	8552	13	source	source	NN
cord-005453-4057qib7	8552	14	of	of	IN
cord-005453-4057qib7	8552	15	the	the	DT
cord-005453-4057qib7	8552	16	transplant	transplant	NN
cord-005453-4057qib7	8552	17	were	be	VBD
cord-005453-4057qib7	8552	18	the	the	DT
cord-005453-4057qib7	8552	19	important	important	JJ
cord-005453-4057qib7	8552	20	prognostic	prognostic	JJ
cord-005453-4057qib7	8552	21	factors	factor	NNS
cord-005453-4057qib7	8552	22	that	that	WDT
cord-005453-4057qib7	8552	23	affected	affect	VBD
cord-005453-4057qib7	8552	24	the	the	DT
cord-005453-4057qib7	8552	25	survivals	survival	NNS
cord-005453-4057qib7	8552	26	of	of	IN
cord-005453-4057qib7	8552	27	the	the	DT
cord-005453-4057qib7	8552	28	HLH	HLH	NNP
cord-005453-4057qib7	8552	29	patients	patient	NNS
cord-005453-4057qib7	8552	30	who	who	WP
cord-005453-4057qib7	8552	31	underwent	undergo	VBD
cord-005453-4057qib7	8552	32	HSCT	HSCT	NNP
cord-005453-4057qib7	8552	33	.	.	.
cord-005453-4057qib7	8553	1	Clinical	clinical	JJ
cord-005453-4057qib7	8553	2	Trial	Trial	NNP
cord-005453-4057qib7	8553	3	Registry	Registry	NNP
cord-005453-4057qib7	8553	4	:	:	:
cord-005453-4057qib7	8553	5	No	no	DT
cord-005453-4057qib7	8553	6	registry	registry	NN
cord-005453-4057qib7	8553	7	number	number	NN
cord-005453-4057qib7	8553	8	.	.	.
cord-005453-4057qib7	8554	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8554	2	:	:	:
cord-005453-4057qib7	8555	1	To	to	IN
cord-005453-4057qib7	8555	2	the	the	DT
cord-005453-4057qib7	8555	3	best	good	JJS
cord-005453-4057qib7	8555	4	of	of	IN
cord-005453-4057qib7	8555	5	our	-PRON-	PRP$
cord-005453-4057qib7	8555	6	knowledge	knowledge	NN
cord-005453-4057qib7	8555	7	,	,	,
cord-005453-4057qib7	8555	8	the	the	DT
cord-005453-4057qib7	8555	9	named	name	VBN
cord-005453-4057qib7	8555	10	authors	author	NNS
cord-005453-4057qib7	8555	11	have	have	VBP
cord-005453-4057qib7	8555	12	no	no	DT
cord-005453-4057qib7	8555	13	conflict	conflict	NN
cord-005453-4057qib7	8555	14	of	of	IN
cord-005453-4057qib7	8555	15	interest	interest	NN
cord-005453-4057qib7	8555	16	,	,	,
cord-005453-4057qib7	8555	17	financial	financial	JJ
cord-005453-4057qib7	8555	18	or	or	CC
cord-005453-4057qib7	8555	19	otherwise	otherwise	RB
cord-005453-4057qib7	8555	20	P382	p382	CD
cord-005453-4057qib7	8555	21	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8555	22	cell	cell	NN
cord-005453-4057qib7	8555	23	transplantation	transplantation	NN
cord-005453-4057qib7	8555	24	with	with	IN
cord-005453-4057qib7	8555	25	reduced	reduce	VBN
cord-005453-4057qib7	8555	26	intensity	intensity	NN
cord-005453-4057qib7	8555	27	conditioning	conditioning	NN
cord-005453-4057qib7	8555	28	regimen	regimen	NN
cord-005453-4057qib7	8555	29	using	use	VBG
cord-005453-4057qib7	8555	30	fludarabine/	fludarabine/	CD
cord-005453-4057qib7	8555	31	busulfan	busulfan	NN
cord-005453-4057qib7	8555	32	and	and	CC
cord-005453-4057qib7	8555	33	fludarabine	fludarabine	NN
cord-005453-4057qib7	8555	34	/	/	SYM
cord-005453-4057qib7	8555	35	melphalan	melphalan	NN
cord-005453-4057qib7	8555	36	for	for	IN
cord-005453-4057qib7	8555	37	primary	primary	JJ
cord-005453-4057qib7	8555	38	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8555	39	diseases	disease	NNS
cord-005453-4057qib7	8555	40	Background	Background	NNP
cord-005453-4057qib7	8555	41	:	:	:
cord-005453-4057qib7	8555	42	Primary	primary	JJ
cord-005453-4057qib7	8555	43	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8555	44	disease	disease	NN
cord-005453-4057qib7	8555	45	(	(	-LRB-
cord-005453-4057qib7	8555	46	PID	PID	NNP
cord-005453-4057qib7	8555	47	)	)	-RRB-
cord-005453-4057qib7	8555	48	is	be	VBZ
cord-005453-4057qib7	8555	49	congenital	congenital	JJ
cord-005453-4057qib7	8555	50	disorders	disorder	NNS
cord-005453-4057qib7	8555	51	of	of	IN
cord-005453-4057qib7	8555	52	innate	innate	JJ
cord-005453-4057qib7	8555	53	or	or	CC
cord-005453-4057qib7	8555	54	acquired	acquire	VBN
cord-005453-4057qib7	8555	55	immune	immune	JJ
cord-005453-4057qib7	8555	56	system	system	NN
cord-005453-4057qib7	8555	57	.	.	.
cord-005453-4057qib7	8556	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8556	2	cell	cell	NN
cord-005453-4057qib7	8556	3	transplantation	transplantation	NN
cord-005453-4057qib7	8556	4	(	(	-LRB-
cord-005453-4057qib7	8556	5	HCT	HCT	NNP
cord-005453-4057qib7	8556	6	)	)	-RRB-
cord-005453-4057qib7	8556	7	was	be	VBD
cord-005453-4057qib7	8556	8	a	a	DT
cord-005453-4057qib7	8556	9	treatment	treatment	NN
cord-005453-4057qib7	8556	10	option	option	NN
cord-005453-4057qib7	8556	11	for	for	IN
cord-005453-4057qib7	8556	12	PIDs	pid	NNS
cord-005453-4057qib7	8556	13	with	with	IN
cord-005453-4057qib7	8556	14	life	life	NN
cord-005453-4057qib7	8556	15	-	-	HYPH
cord-005453-4057qib7	8556	16	threatening	threaten	VBG
cord-005453-4057qib7	8556	17	infections	infection	NNS
cord-005453-4057qib7	8556	18	or	or	CC
cord-005453-4057qib7	8556	19	immune	immune	JJ
cord-005453-4057qib7	8556	20	dysregulations	dysregulation	NNS
cord-005453-4057qib7	8556	21	.	.	.
cord-005453-4057qib7	8557	1	Reduced	reduced	JJ
cord-005453-4057qib7	8557	2	intensity	intensity	NN
cord-005453-4057qib7	8557	3	conditioning	conditioning	NN
cord-005453-4057qib7	8557	4	(	(	-LRB-
cord-005453-4057qib7	8557	5	RIC	RIC	NNP
cord-005453-4057qib7	8557	6	)	)	-RRB-
cord-005453-4057qib7	8557	7	was	be	VBD
cord-005453-4057qib7	8557	8	increasingly	increasingly	RB
cord-005453-4057qib7	8557	9	used	use	VBN
cord-005453-4057qib7	8557	10	to	to	TO
cord-005453-4057qib7	8557	11	prevent	prevent	VB
cord-005453-4057qib7	8557	12	complications	complication	NNS
cord-005453-4057qib7	8557	13	in	in	IN
cord-005453-4057qib7	8557	14	HCT	hct	NN
cord-005453-4057qib7	8557	15	,	,	,
cord-005453-4057qib7	8557	16	but	but	CC
cord-005453-4057qib7	8557	17	optimized	optimize	VBN
cord-005453-4057qib7	8557	18	regimens	regimen	NNS
cord-005453-4057qib7	8557	19	have	have	VBP
cord-005453-4057qib7	8557	20	not	not	RB
cord-005453-4057qib7	8557	21	been	be	VBN
cord-005453-4057qib7	8557	22	established	establish	VBN
cord-005453-4057qib7	8557	23	.	.	.
cord-005453-4057qib7	8558	1	We	-PRON-	PRP
cord-005453-4057qib7	8558	2	performed	perform	VBD
cord-005453-4057qib7	8558	3	HCT	hct	NN
cord-005453-4057qib7	8558	4	for	for	IN
cord-005453-4057qib7	8558	5	PIDs	pid	NNS
cord-005453-4057qib7	8558	6	with	with	IN
cord-005453-4057qib7	8558	7	RIC	RIC	NNP
cord-005453-4057qib7	8558	8	using	use	VBG
cord-005453-4057qib7	8558	9	fludarabine	fludarabine	NN
cord-005453-4057qib7	8558	10	and	and	CC
cord-005453-4057qib7	8558	11	busulfan	busulfan	NN
cord-005453-4057qib7	8558	12	(	(	-LRB-
cord-005453-4057qib7	8558	13	FluBU	FluBU	NNP
cord-005453-4057qib7	8558	14	)	)	-RRB-
cord-005453-4057qib7	8558	15	or	or	CC
cord-005453-4057qib7	8558	16	melphalan	melphalan	NNP
cord-005453-4057qib7	8558	17	(	(	-LRB-
cord-005453-4057qib7	8558	18	FluMel	FluMel	NNP
cord-005453-4057qib7	8558	19	)	)	-RRB-
cord-005453-4057qib7	8558	20	according	accord	VBG
cord-005453-4057qib7	8558	21	to	to	IN
cord-005453-4057qib7	8558	22	the	the	DT
cord-005453-4057qib7	8558	23	guidelines	guideline	NNS
cord-005453-4057qib7	8558	24	of	of	IN
cord-005453-4057qib7	8558	25	European	European	NNP
cord-005453-4057qib7	8558	26	Society	Society	NNP
cord-005453-4057qib7	8558	27	for	for	IN
cord-005453-4057qib7	8558	28	Immunodeficiencies	Immunodeficiencies	NNP
cord-005453-4057qib7	8558	29	(	(	-LRB-
cord-005453-4057qib7	8558	30	ESID	ESID	NNP
cord-005453-4057qib7	8558	31	)	)	-RRB-
cord-005453-4057qib7	8559	1	/	/	SYM
cord-005453-4057qib7	8559	2	European	European	NNP
cord-005453-4057qib7	8559	3	Society	Society	NNP
cord-005453-4057qib7	8559	4	for	for	IN
cord-005453-4057qib7	8559	5	Blood	blood	NN
cord-005453-4057qib7	8559	6	and	and	CC
cord-005453-4057qib7	8559	7	Marrow	marrow	NN
cord-005453-4057qib7	8559	8	Transplantation	transplantation	NN
cord-005453-4057qib7	8559	9	(	(	-LRB-
cord-005453-4057qib7	8559	10	EBMT	EBMT	NNP
cord-005453-4057qib7	8559	11	)	)	-RRB-
cord-005453-4057qib7	8559	12	,	,	,
cord-005453-4057qib7	8559	13	and	and	CC
cord-005453-4057qib7	8559	14	assessed	assess	VBD
cord-005453-4057qib7	8559	15	the	the	DT
cord-005453-4057qib7	8559	16	efficacy	efficacy	NN
cord-005453-4057qib7	8559	17	and	and	CC
cord-005453-4057qib7	8559	18	safety	safety	NN
cord-005453-4057qib7	8559	19	of	of	IN
cord-005453-4057qib7	8559	20	these	these	DT
cord-005453-4057qib7	8559	21	RIC	RIC	NNP
cord-005453-4057qib7	8559	22	.	.	.
cord-005453-4057qib7	8560	1	Methods	method	NNS
cord-005453-4057qib7	8560	2	:	:	:
cord-005453-4057qib7	8561	1	From	from	IN
cord-005453-4057qib7	8561	2	April	April	NNP
cord-005453-4057qib7	8561	3	2004	2004	CD
cord-005453-4057qib7	8561	4	to	to	IN
cord-005453-4057qib7	8561	5	December	December	NNP
cord-005453-4057qib7	8561	6	2017	2017	CD
cord-005453-4057qib7	8561	7	,	,	,
cord-005453-4057qib7	8561	8	42	42	CD
cord-005453-4057qib7	8561	9	PID	PID	NNP
cord-005453-4057qib7	8561	10	patients	patient	NNS
cord-005453-4057qib7	8561	11	underwent	undergo	VBD
cord-005453-4057qib7	8561	12	RIC	RIC	NNP
cord-005453-4057qib7	8561	13	-	-	HYPH
cord-005453-4057qib7	8561	14	HCT	HCT	NNP
cord-005453-4057qib7	8561	15	using	use	VBG
cord-005453-4057qib7	8561	16	FluBU	FluBU	NNP
cord-005453-4057qib7	8561	17	or	or	CC
cord-005453-4057qib7	8561	18	FluMel	FluMel	NNP
cord-005453-4057qib7	8561	19	in	in	IN
cord-005453-4057qib7	8561	20	TMDU	TMDU	NNP
cord-005453-4057qib7	8561	21	were	be	VBD
cord-005453-4057qib7	8561	22	analyzed	analyze	VBN
cord-005453-4057qib7	8561	23	retrospectively	retrospectively	RB
cord-005453-4057qib7	8561	24	.	.	.
cord-005453-4057qib7	8562	1	The	the	DT
cord-005453-4057qib7	8562	2	AUC	AUC	NNP
cord-005453-4057qib7	8562	3	of	of	IN
cord-005453-4057qib7	8562	4	BU	BU	NNP
cord-005453-4057qib7	8562	5	was	be	VBD
cord-005453-4057qib7	8562	6	set	set	VBN
cord-005453-4057qib7	8562	7	to	to	IN
cord-005453-4057qib7	8562	8	30	30	CD
cord-005453-4057qib7	8562	9	mg*hour	mg*hour	NNP
cord-005453-4057qib7	8562	10	/	/	SYM
cord-005453-4057qib7	8562	11	L	l	NN
cord-005453-4057qib7	8562	12	for	for	IN
cord-005453-4057qib7	8562	13	severe	severe	JJ
cord-005453-4057qib7	8562	14	combined	combine	VBN
cord-005453-4057qib7	8562	15	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8562	16	disease	disease	NN
cord-005453-4057qib7	8562	17	(	(	-LRB-
cord-005453-4057qib7	8562	18	SCID	SCID	NNP
cord-005453-4057qib7	8562	19	)	)	-RRB-
cord-005453-4057qib7	8562	20	and	and	CC
cord-005453-4057qib7	8562	21	60	60	CD
cord-005453-4057qib7	8562	22	mg*hour	mg*hour	NNP
cord-005453-4057qib7	8562	23	/	/	SYM
cord-005453-4057qib7	8562	24	L	l	NN
cord-005453-4057qib7	8562	25	for	for	IN
cord-005453-4057qib7	8562	26	non	non	JJ
cord-005453-4057qib7	8562	27	-	-	JJ
cord-005453-4057qib7	8562	28	SCID	scid	JJ
cord-005453-4057qib7	8562	29	.	.	.
cord-005453-4057qib7	8563	1	Overall	overall	JJ
cord-005453-4057qib7	8563	2	survival	survival	NN
cord-005453-4057qib7	8563	3	(	(	-LRB-
cord-005453-4057qib7	8563	4	OS	OS	NNP
cord-005453-4057qib7	8563	5	)	)	-RRB-
cord-005453-4057qib7	8563	6	was	be	VBD
cord-005453-4057qib7	8563	7	analyzed	analyze	VBN
cord-005453-4057qib7	8563	8	.	.	.
cord-005453-4057qib7	8564	1	Results	result	NNS
cord-005453-4057qib7	8564	2	:	:	:
cord-005453-4057qib7	8565	1	The	the	DT
cord-005453-4057qib7	8565	2	median	median	JJ
cord-005453-4057qib7	8565	3	age	age	NN
cord-005453-4057qib7	8565	4	at	at	IN
cord-005453-4057qib7	8565	5	HCT	HCT	NNP
cord-005453-4057qib7	8565	6	was	be	VBD
cord-005453-4057qib7	8565	7	2.0	2.0	CD
cord-005453-4057qib7	8565	8	(	(	-LRB-
cord-005453-4057qib7	8565	9	0.3	0.3	CD
cord-005453-4057qib7	8565	10	-	-	SYM
cord-005453-4057qib7	8565	11	21	21	CD
cord-005453-4057qib7	8565	12	)	)	-RRB-
cord-005453-4057qib7	8565	13	years	year	NNS
cord-005453-4057qib7	8565	14	old	old	JJ
cord-005453-4057qib7	8565	15	(	(	-LRB-
cord-005453-4057qib7	8565	16	35	35	CD
cord-005453-4057qib7	8565	17	male	male	NN
cord-005453-4057qib7	8565	18	and	and	CC
cord-005453-4057qib7	8565	19	7	7	CD
cord-005453-4057qib7	8565	20	female	female	JJ
cord-005453-4057qib7	8565	21	patients	patient	NNS
cord-005453-4057qib7	8565	22	)	)	-RRB-
cord-005453-4057qib7	8565	23	.	.	.
cord-005453-4057qib7	8566	1	FluBU	FluBU	NNP
cord-005453-4057qib7	8566	2	was	be	VBD
cord-005453-4057qib7	8566	3	used	use	VBN
cord-005453-4057qib7	8566	4	for	for	IN
cord-005453-4057qib7	8566	5	23	23	CD
cord-005453-4057qib7	8566	6	patients	patient	NNS
cord-005453-4057qib7	8566	7	(	(	-LRB-
cord-005453-4057qib7	8566	8	7	7	CD
cord-005453-4057qib7	8566	9	SCID	SCID	NNP
cord-005453-4057qib7	8566	10	,	,	,
cord-005453-4057qib7	8566	11	9	9	CD
cord-005453-4057qib7	8566	12	combined	combine	VBN
cord-005453-4057qib7	8566	13	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8566	14	disease	disease	NN
cord-005453-4057qib7	8566	15	(	(	-LRB-
cord-005453-4057qib7	8566	16	CID	CID	NNP
cord-005453-4057qib7	8566	17	)	)	-RRB-
cord-005453-4057qib7	8566	18	,	,	,
cord-005453-4057qib7	8566	19	3	3	CD
cord-005453-4057qib7	8566	20	ectodermal	ectodermal	JJ
cord-005453-4057qib7	8566	21	dysplasia	dysplasia	NN
cord-005453-4057qib7	8566	22	(	(	-LRB-
cord-005453-4057qib7	8566	23	EDA	EDA	NNP
cord-005453-4057qib7	8566	24	)	)	-RRB-
cord-005453-4057qib7	8566	25	,	,	,
cord-005453-4057qib7	8566	26	and	and	CC
cord-005453-4057qib7	8566	27	4	4	CD
cord-005453-4057qib7	8566	28	severe	severe	JJ
cord-005453-4057qib7	8566	29	congenital	congenital	JJ
cord-005453-4057qib7	8566	30	neutropenia	neutropenia	NN
cord-005453-4057qib7	8566	31	(	(	-LRB-
cord-005453-4057qib7	8566	32	SCN	SCN	NNP
cord-005453-4057qib7	8566	33	)	)	-RRB-
cord-005453-4057qib7	8566	34	)	)	-RRB-
cord-005453-4057qib7	8567	1	and	and	CC
cord-005453-4057qib7	8567	2	FluMel	FluMel	NNP
cord-005453-4057qib7	8567	3	was	be	VBD
cord-005453-4057qib7	8567	4	used	use	VBN
cord-005453-4057qib7	8567	5	for	for	IN
cord-005453-4057qib7	8567	6	19	19	CD
cord-005453-4057qib7	8567	7	patients	patient	NNS
cord-005453-4057qib7	8567	8	(	(	-LRB-
cord-005453-4057qib7	8567	9	8	8	CD
cord-005453-4057qib7	8567	10	SCID	SCID	NNP
cord-005453-4057qib7	8567	11	,	,	,
cord-005453-4057qib7	8567	12	6	6	CD
cord-005453-4057qib7	8567	13	CID	CID	NNP
cord-005453-4057qib7	8567	14	,	,	,
cord-005453-4057qib7	8567	15	4	4	CD
cord-005453-4057qib7	8567	16	XIAP	xiap	NN
cord-005453-4057qib7	8567	17	deficiency	deficiency	NN
cord-005453-4057qib7	8567	18	,	,	,
cord-005453-4057qib7	8567	19	and	and	CC
cord-005453-4057qib7	8567	20	1	1	CD
cord-005453-4057qib7	8567	21	EDA	EDA	NNP
cord-005453-4057qib7	8567	22	)	)	-RRB-
cord-005453-4057qib7	8567	23	.	.	.
cord-005453-4057qib7	8568	1	Anti	anti	JJ
cord-005453-4057qib7	8568	2	-	-	JJ
cord-005453-4057qib7	8568	3	thymocyte	thymocyte	JJ
cord-005453-4057qib7	8568	4	globulin	globulin	NN
cord-005453-4057qib7	8568	5	was	be	VBD
cord-005453-4057qib7	8568	6	used	use	VBN
cord-005453-4057qib7	8568	7	in	in	IN
cord-005453-4057qib7	8568	8	8	8	CD
cord-005453-4057qib7	8568	9	patients	patient	NNS
cord-005453-4057qib7	8568	10	of	of	IN
cord-005453-4057qib7	8568	11	FluBU	FluBU	NNP
cord-005453-4057qib7	8568	12	group	group	NN
cord-005453-4057qib7	8568	13	and	and	CC
cord-005453-4057qib7	8568	14	7	7	CD
cord-005453-4057qib7	8568	15	patients	patient	NNS
cord-005453-4057qib7	8568	16	of	of	IN
cord-005453-4057qib7	8568	17	FluMel	FluMel	NNP
cord-005453-4057qib7	8568	18	group	group	NN
cord-005453-4057qib7	8568	19	.	.	.
cord-005453-4057qib7	8569	1	Cord	cord	NN
cord-005453-4057qib7	8569	2	blood	blood	NN
cord-005453-4057qib7	8569	3	in	in	IN
cord-005453-4057qib7	8569	4	21	21	CD
cord-005453-4057qib7	8569	5	and	and	CC
cord-005453-4057qib7	8569	6	bone	bone	NN
cord-005453-4057qib7	8569	7	marrow	marrow	NN
cord-005453-4057qib7	8569	8	in	in	IN
cord-005453-4057qib7	8569	9	21	21	CD
cord-005453-4057qib7	8569	10	was	be	VBD
cord-005453-4057qib7	8569	11	used	use	VBN
cord-005453-4057qib7	8569	12	for	for	IN
cord-005453-4057qib7	8569	13	donor	donor	NN
cord-005453-4057qib7	8569	14	sources	source	NNS
cord-005453-4057qib7	8569	15	.	.	.
cord-005453-4057qib7	8570	1	Matched	matched	JJ
cord-005453-4057qib7	8570	2	donor	donor	NN
cord-005453-4057qib7	8570	3	was	be	VBD
cord-005453-4057qib7	8570	4	used	use	VBN
cord-005453-4057qib7	8570	5	for	for	IN
cord-005453-4057qib7	8570	6	7	7	CD
cord-005453-4057qib7	8570	7	and	and	CC
cord-005453-4057qib7	8570	8	8	8	CD
cord-005453-4057qib7	8570	9	patients	patient	NNS
cord-005453-4057qib7	8570	10	in	in	IN
cord-005453-4057qib7	8570	11	FluBU	FluBU	NNP
cord-005453-4057qib7	8570	12	and	and	CC
cord-005453-4057qib7	8570	13	FluMel	FluMel	NNP
cord-005453-4057qib7	8570	14	groups	group	NNS
cord-005453-4057qib7	8570	15	(	(	-LRB-
cord-005453-4057qib7	8570	16	30.4	30.4	CD
cord-005453-4057qib7	8570	17	%	%	NN
cord-005453-4057qib7	8570	18	and	and	CC
cord-005453-4057qib7	8570	19	42.1	42.1	CD
cord-005453-4057qib7	8570	20	%	%	NN
cord-005453-4057qib7	8570	21	)	)	-RRB-
cord-005453-4057qib7	8570	22	,	,	,
cord-005453-4057qib7	8570	23	respectively	respectively	RB
cord-005453-4057qib7	8570	24	.	.	.
cord-005453-4057qib7	8571	1	Median	median	JJ
cord-005453-4057qib7	8571	2	follow	follow	VBP
cord-005453-4057qib7	8571	3	up	up	RP
cord-005453-4057qib7	8571	4	period	period	NN
cord-005453-4057qib7	8571	5	was	be	VBD
cord-005453-4057qib7	8571	6	2.2	2.2	CD
cord-005453-4057qib7	8571	7	years	year	NNS
cord-005453-4057qib7	8571	8	.	.	.
cord-005453-4057qib7	8572	1	Two	two	CD
cord-005453-4057qib7	8572	2	years	year	NNS
cord-005453-4057qib7	8572	3	-	-	HYPH
cord-005453-4057qib7	8572	4	OS	os	NN
cord-005453-4057qib7	8572	5	of	of	IN
cord-005453-4057qib7	8572	6	all	all	DT
cord-005453-4057qib7	8572	7	patients	patient	NNS
cord-005453-4057qib7	8572	8	,	,	,
cord-005453-4057qib7	8572	9	FluBU	flubu	JJ
cord-005453-4057qib7	8572	10	group	group	NN
cord-005453-4057qib7	8572	11	patients	patient	NNS
cord-005453-4057qib7	8572	12	and	and	CC
cord-005453-4057qib7	8572	13	FluMel	FluMel	NNP
cord-005453-4057qib7	8572	14	group	group	NN
cord-005453-4057qib7	8572	15	patients	patient	NNS
cord-005453-4057qib7	8572	16	was	be	VBD
cord-005453-4057qib7	8572	17	79.6	79.6	CD
cord-005453-4057qib7	8572	18	%	%	NN
cord-005453-4057qib7	8572	19	,	,	,
cord-005453-4057qib7	8572	20	89.8	89.8	CD
cord-005453-4057qib7	8572	21	%	%	NN
cord-005453-4057qib7	8572	22	and	and	CC
cord-005453-4057qib7	8572	23	64.1	64.1	CD
cord-005453-4057qib7	8572	24	%	%	NN
cord-005453-4057qib7	8572	25	,	,	,
cord-005453-4057qib7	8572	26	respectively	respectively	RB
cord-005453-4057qib7	8572	27	.	.	.
cord-005453-4057qib7	8573	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	8573	2	engraftment	engraftment	NN
cord-005453-4057qib7	8573	3	was	be	VBD
cord-005453-4057qib7	8573	4	92.9	92.9	CD
cord-005453-4057qib7	8573	5	%	%	NN
cord-005453-4057qib7	8573	6	,	,	,
cord-005453-4057qib7	8573	7	91.3	91.3	CD
cord-005453-4057qib7	8573	8	%	%	NN
cord-005453-4057qib7	8573	9	and	and	CC
cord-005453-4057qib7	8573	10	94.7	94.7	CD
cord-005453-4057qib7	8573	11	%	%	NN
cord-005453-4057qib7	8573	12	(	(	-LRB-
cord-005453-4057qib7	8573	13	all	all	DT
cord-005453-4057qib7	8573	14	patients	patient	NNS
cord-005453-4057qib7	8573	15	,	,	,
cord-005453-4057qib7	8573	16	FluBU	FluBU	NNP
cord-005453-4057qib7	8573	17	group	group	NN
cord-005453-4057qib7	8573	18	and	and	CC
cord-005453-4057qib7	8573	19	FluMel	FluMel	NNP
cord-005453-4057qib7	8573	20	group	group	NN
cord-005453-4057qib7	8573	21	)	)	-RRB-
cord-005453-4057qib7	8573	22	.	.	.
cord-005453-4057qib7	8574	1	In	in	IN
cord-005453-4057qib7	8574	2	SCID	SCID	NNP
cord-005453-4057qib7	8574	3	,	,	,
cord-005453-4057qib7	8574	4	all	all	DT
cord-005453-4057qib7	8574	5	7	7	CD
cord-005453-4057qib7	8574	6	patients	patient	NNS
cord-005453-4057qib7	8574	7	in	in	IN
cord-005453-4057qib7	8574	8	FluBU	FluBU	NNP
cord-005453-4057qib7	8574	9	group	group	NN
cord-005453-4057qib7	8574	10	achieved	achieve	VBD
cord-005453-4057qib7	8574	11	engraftment	engraftment	NN
cord-005453-4057qib7	8574	12	and	and	CC
cord-005453-4057qib7	8574	13	survived	survive	VBD
cord-005453-4057qib7	8574	14	.	.	.
cord-005453-4057qib7	8575	1	Seven	seven	CD
cord-005453-4057qib7	8575	2	out	out	IN
cord-005453-4057qib7	8575	3	of	of	IN
cord-005453-4057qib7	8575	4	8	8	CD
cord-005453-4057qib7	8575	5	in	in	IN
cord-005453-4057qib7	8575	6	FluMel	FluMel	NNP
cord-005453-4057qib7	8575	7	group	group	NN
cord-005453-4057qib7	8575	8	achieved	achieve	VBD
cord-005453-4057qib7	8575	9	engraftment	engraftment	NN
cord-005453-4057qib7	8575	10	,	,	,
cord-005453-4057qib7	8575	11	but	but	CC
cord-005453-4057qib7	8575	12	1	1	CD
cord-005453-4057qib7	8575	13	patient	patient	NN
cord-005453-4057qib7	8575	14	had	have	VBD
cord-005453-4057qib7	8575	15	secondary	secondary	JJ
cord-005453-4057qib7	8575	16	graft	graft	NN
cord-005453-4057qib7	8575	17	failure	failure	NN
cord-005453-4057qib7	8575	18	and	and	CC
cord-005453-4057qib7	8575	19	3	3	CD
cord-005453-4057qib7	8575	20	patients	patient	NNS
cord-005453-4057qib7	8575	21	died	die	VBD
cord-005453-4057qib7	8575	22	.	.	.
cord-005453-4057qib7	8576	1	In	in	IN
cord-005453-4057qib7	8576	2	non	non	JJ
cord-005453-4057qib7	8576	3	-	-	JJ
cord-005453-4057qib7	8576	4	SCID	scid	JJ
cord-005453-4057qib7	8576	5	,	,	,
cord-005453-4057qib7	8576	6	14	14	CD
cord-005453-4057qib7	8576	7	out	out	IN
cord-005453-4057qib7	8576	8	of	of	IN
cord-005453-4057qib7	8576	9	16	16	CD
cord-005453-4057qib7	8576	10	in	in	IN
cord-005453-4057qib7	8576	11	FluBU	FluBU	NNP
cord-005453-4057qib7	8576	12	group	group	NN
cord-005453-4057qib7	8576	13	achieved	achieve	VBD
cord-005453-4057qib7	8576	14	engraftment	engraftment	NN
cord-005453-4057qib7	8576	15	,	,	,
cord-005453-4057qib7	8576	16	but	but	CC
cord-005453-4057qib7	8576	17	6	6	CD
cord-005453-4057qib7	8576	18	patients	patient	NNS
cord-005453-4057qib7	8576	19	had	have	VBD
cord-005453-4057qib7	8576	20	secondary	secondary	JJ
cord-005453-4057qib7	8576	21	graft	graft	NN
cord-005453-4057qib7	8576	22	failure	failure	NN
cord-005453-4057qib7	8576	23	.	.	.
cord-005453-4057qib7	8577	1	All	all	DT
cord-005453-4057qib7	8577	2	11	11	CD
cord-005453-4057qib7	8577	3	non	non	JJ
cord-005453-4057qib7	8577	4	-	-	JJ
cord-005453-4057qib7	8577	5	SCID	scid	JJ
cord-005453-4057qib7	8577	6	patients	patient	NNS
cord-005453-4057qib7	8577	7	in	in	IN
cord-005453-4057qib7	8577	8	FluMel	FluMel	NNP
cord-005453-4057qib7	8577	9	group	group	NN
cord-005453-4057qib7	8577	10	were	be	VBD
cord-005453-4057qib7	8577	11	engrafted	engraft	VBN
cord-005453-4057qib7	8577	12	and	and	CC
cord-005453-4057qib7	8577	13	survived	survive	VBD
cord-005453-4057qib7	8577	14	.	.	.
cord-005453-4057qib7	8578	1	Two	two	CD
cord-005453-4057qib7	8578	2	and	and	CC
cord-005453-4057qib7	8578	3	7	7	CD
cord-005453-4057qib7	8578	4	patients	patient	NNS
cord-005453-4057qib7	8578	5	in	in	IN
cord-005453-4057qib7	8578	6	FluBU	FluBU	NNP
cord-005453-4057qib7	8578	7	group	group	NN
cord-005453-4057qib7	8578	8	and	and	CC
cord-005453-4057qib7	8578	9	FluMel	FluMel	NNP
cord-005453-4057qib7	8578	10	group	group	NN
cord-005453-4057qib7	8578	11	suffered	suffer	VBD
cord-005453-4057qib7	8578	12	from	from	IN
cord-005453-4057qib7	8578	13	severe	severe	JJ
cord-005453-4057qib7	8578	14	acute	acute	JJ
cord-005453-4057qib7	8578	15	graft	graft	NN
cord-005453-4057qib7	8578	16	-	-	HYPH
cord-005453-4057qib7	8578	17	versus	versus	IN
cord-005453-4057qib7	8578	18	-	-	HYPH
cord-005453-4057qib7	8578	19	host	host	NN
cord-005453-4057qib7	8578	20	disease	disease	NN
cord-005453-4057qib7	8578	21	(	(	-LRB-
cord-005453-4057qib7	8578	22	grade	grade	NN
cord-005453-4057qib7	8578	23	III	III	NNP
cord-005453-4057qib7	8578	24	-	-	HYPH
cord-005453-4057qib7	8578	25	IV	IV	NNP
cord-005453-4057qib7	8578	26	)	)	-RRB-
cord-005453-4057qib7	8578	27	.	.	.
cord-005453-4057qib7	8579	1	Ten	ten	CD
cord-005453-4057qib7	8579	2	patients	patient	NNS
cord-005453-4057qib7	8579	3	had	have	VBD
cord-005453-4057qib7	8579	4	hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	8579	5	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	8579	6	(	(	-LRB-
cord-005453-4057qib7	8579	7	HLH	HLH	NNP
cord-005453-4057qib7	8579	8	)	)	-RRB-
cord-005453-4057qib7	8579	9	.	.	.
cord-005453-4057qib7	8580	1	Viral	viral	JJ
cord-005453-4057qib7	8580	2	reactivation	reactivation	NN
cord-005453-4057qib7	8580	3	or	or	CC
cord-005453-4057qib7	8580	4	infection	infection	NN
cord-005453-4057qib7	8580	5	was	be	VBD
cord-005453-4057qib7	8580	6	observed	observe	VBN
cord-005453-4057qib7	8580	7	in	in	IN
cord-005453-4057qib7	8580	8	20	20	CD
cord-005453-4057qib7	8580	9	patients	patient	NNS
cord-005453-4057qib7	8580	10	,	,	,
cord-005453-4057qib7	8580	11	and	and	CC
cord-005453-4057qib7	8580	12	resolved	resolve	VBN
cord-005453-4057qib7	8580	13	in	in	IN
cord-005453-4057qib7	8580	14	all	all	DT
cord-005453-4057qib7	8580	15	but	but	IN
cord-005453-4057qib7	8580	16	one	one	CD
cord-005453-4057qib7	8580	17	patient	patient	NN
cord-005453-4057qib7	8580	18	.	.	.
cord-005453-4057qib7	8581	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8581	2	:	:	:
cord-005453-4057qib7	8582	1	The	the	DT
cord-005453-4057qib7	8582	2	RIC	RIC	NNP
cord-005453-4057qib7	8582	3	-	-	HYPH
cord-005453-4057qib7	8582	4	HCT	HCT	NNP
cord-005453-4057qib7	8582	5	using	use	VBG
cord-005453-4057qib7	8582	6	FluBU	FluBU	NNP
cord-005453-4057qib7	8582	7	or	or	CC
cord-005453-4057qib7	8582	8	FluMel	FluMel	NNP
cord-005453-4057qib7	8582	9	was	be	VBD
cord-005453-4057qib7	8582	10	advantagous	advantagous	JJ
cord-005453-4057qib7	8582	11	for	for	IN
cord-005453-4057qib7	8582	12	neutrophil	neutrophil	NN
cord-005453-4057qib7	8582	13	engraftment	engraftment	NN
cord-005453-4057qib7	8582	14	,	,	,
cord-005453-4057qib7	8582	15	and	and	CC
cord-005453-4057qib7	8582	16	FluBU	FluBU	NNP
cord-005453-4057qib7	8582	17	for	for	IN
cord-005453-4057qib7	8582	18	SCID	SCID	NNP
cord-005453-4057qib7	8582	19	and	and	CC
cord-005453-4057qib7	8582	20	FluMel	FluMel	NNP
cord-005453-4057qib7	8582	21	for	for	IN
cord-005453-4057qib7	8582	22	CID	CID	NNP
cord-005453-4057qib7	8582	23	with	with	IN
cord-005453-4057qib7	8582	24	immune	immune	JJ
cord-005453-4057qib7	8582	25	dysregulation	dysregulation	NN
cord-005453-4057qib7	8582	26	may	may	MD
cord-005453-4057qib7	8582	27	be	be	VB
cord-005453-4057qib7	8582	28	an	an	DT
cord-005453-4057qib7	8582	29	effective	effective	JJ
cord-005453-4057qib7	8582	30	opinion	opinion	NN
cord-005453-4057qib7	8582	31	.	.	.
cord-005453-4057qib7	8583	1	FluBU	flubu	JJ
cord-005453-4057qib7	8583	2	regimen	regimen	NN
cord-005453-4057qib7	8583	3	needs	need	VBZ
cord-005453-4057qib7	8583	4	to	to	TO
cord-005453-4057qib7	8583	5	be	be	VB
cord-005453-4057qib7	8583	6	improved	improve	VBN
cord-005453-4057qib7	8583	7	for	for	IN
cord-005453-4057qib7	8583	8	secondary	secondary	JJ
cord-005453-4057qib7	8583	9	graft	graft	NN
cord-005453-4057qib7	8583	10	failure	failure	NN
cord-005453-4057qib7	8583	11	in	in	IN
cord-005453-4057qib7	8583	12	non	non	JJ
cord-005453-4057qib7	8583	13	-	-	JJ
cord-005453-4057qib7	8583	14	SCID	scid	JJ
cord-005453-4057qib7	8583	15	.	.	.
cord-005453-4057qib7	8584	1	Prevention	prevention	NN
cord-005453-4057qib7	8584	2	of	of	IN
cord-005453-4057qib7	8584	3	HLH	HLH	NNP
cord-005453-4057qib7	8584	4	after	after	IN
cord-005453-4057qib7	8584	5	transplantation	transplantation	NN
cord-005453-4057qib7	8584	6	using	use	VBG
cord-005453-4057qib7	8584	7	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	8584	8	palmitate	palmitate	NN
cord-005453-4057qib7	8584	9	will	will	MD
cord-005453-4057qib7	8584	10	be	be	VB
cord-005453-4057qib7	8584	11	considered	consider	VBN
cord-005453-4057qib7	8584	12	.	.	.
cord-005453-4057qib7	8585	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8585	2	:	:	:
cord-005453-4057qib7	8585	3	Nothing	nothing	NN
cord-005453-4057qib7	8585	4	to	to	TO
cord-005453-4057qib7	8585	5	declare	declare	VB
cord-005453-4057qib7	8585	6	.	.	.
cord-005453-4057qib7	8586	1	Survival	survival	NN
cord-005453-4057qib7	8586	2	after	after	IN
cord-005453-4057qib7	8586	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8586	4	stem	stem	NN
cord-005453-4057qib7	8586	5	cell	cell	NN
cord-005453-4057qib7	8586	6	transplantation	transplantation	NN
cord-005453-4057qib7	8586	7	with	with	IN
cord-005453-4057qib7	8587	1	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	8587	2	/	/	SYM
cord-005453-4057qib7	8587	3	CD19	CD19	NNP
cord-005453-4057qib7	8587	4	graft	graft	NN
cord-005453-4057qib7	8587	5	depletion	depletion	NN
cord-005453-4057qib7	8587	6	in	in	IN
cord-005453-4057qib7	8587	7	older	old	JJR
cord-005453-4057qib7	8587	8	children	child	NNS
cord-005453-4057qib7	8587	9	with	with	IN
cord-005453-4057qib7	8587	10	primary	primary	JJ
cord-005453-4057qib7	8587	11	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	8588	1	Background	background	NN
cord-005453-4057qib7	8588	2	:	:	:
cord-005453-4057qib7	8589	1	TCRαβ/	tcrαβ/	ADD
cord-005453-4057qib7	8590	1	CD19	CD19	NNP
cord-005453-4057qib7	8590	2	depletion	depletion	NN
cord-005453-4057qib7	8590	3	is	be	VBZ
cord-005453-4057qib7	8590	4	a	a	DT
cord-005453-4057qib7	8590	5	graft	graft	NN
cord-005453-4057qib7	8590	6	engineering	engineering	NN
cord-005453-4057qib7	8590	7	method	method	NN
cord-005453-4057qib7	8590	8	that	that	WDT
cord-005453-4057qib7	8590	9	proved	prove	VBD
cord-005453-4057qib7	8590	10	valuable	valuable	JJ
cord-005453-4057qib7	8590	11	in	in	IN
cord-005453-4057qib7	8590	12	increasing	increase	VBG
cord-005453-4057qib7	8590	13	the	the	DT
cord-005453-4057qib7	8590	14	survival	survival	NN
cord-005453-4057qib7	8590	15	rate	rate	NN
cord-005453-4057qib7	8590	16	after	after	IN
cord-005453-4057qib7	8590	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8590	18	stem	stem	NN
cord-005453-4057qib7	8590	19	cell	cell	NN
cord-005453-4057qib7	8590	20	transplantation	transplantation	NN
cord-005453-4057qib7	8590	21	(	(	-LRB-
cord-005453-4057qib7	8590	22	HSCT	HSCT	NNP
cord-005453-4057qib7	8590	23	)	)	-RRB-
cord-005453-4057qib7	8590	24	in	in	IN
cord-005453-4057qib7	8590	25	patients	patient	NNS
cord-005453-4057qib7	8590	26	with	with	IN
cord-005453-4057qib7	8590	27	primary	primary	JJ
cord-005453-4057qib7	8590	28	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	8590	29	(	(	-LRB-
cord-005453-4057qib7	8590	30	PID	PID	NNP
cord-005453-4057qib7	8590	31	)	)	-RRB-
cord-005453-4057qib7	8590	32	.	.	.
cord-005453-4057qib7	8591	1	Decreased	decrease	VBN
cord-005453-4057qib7	8591	2	survival	survival	NN
cord-005453-4057qib7	8591	3	rate	rate	NN
cord-005453-4057qib7	8591	4	in	in	IN
cord-005453-4057qib7	8591	5	older	old	JJR
cord-005453-4057qib7	8591	6	patients	patient	NNS
cord-005453-4057qib7	8591	7	with	with	IN
cord-005453-4057qib7	8591	8	PID	PID	NNP
cord-005453-4057qib7	8591	9	was	be	VBD
cord-005453-4057qib7	8591	10	previously	previously	RB
cord-005453-4057qib7	8591	11	reported	report	VBN
cord-005453-4057qib7	8591	12	after	after	IN
cord-005453-4057qib7	8591	13	transplantations	transplantation	NNS
cord-005453-4057qib7	8591	14	with	with	IN
cord-005453-4057qib7	8591	15	nonmanipulated	nonmanipulate	VBN
cord-005453-4057qib7	8591	16	grafts	graft	NNS
cord-005453-4057qib7	8591	17	.	.	.
cord-005453-4057qib7	8592	1	Methods	method	NNS
cord-005453-4057qib7	8592	2	:	:	:
cord-005453-4057qib7	8592	3	148	148	CD
cord-005453-4057qib7	8592	4	patients	patient	NNS
cord-005453-4057qib7	8592	5	with	with	IN
cord-005453-4057qib7	8592	6	various	various	JJ
cord-005453-4057qib7	8592	7	PID	pid	NN
cord-005453-4057qib7	8592	8	(	(	-LRB-
cord-005453-4057qib7	8592	9	excluding	exclude	VBG
cord-005453-4057qib7	8592	10	classic	classic	JJ
cord-005453-4057qib7	8592	11	SCID	SCID	NNP
cord-005453-4057qib7	8592	12	)	)	-RRB-
cord-005453-4057qib7	8592	13	who	who	WP
cord-005453-4057qib7	8592	14	received	receive	VBD
cord-005453-4057qib7	8592	15	allogenic	allogenic	JJ
cord-005453-4057qib7	8592	16	HSCT	HSCT	NNP
cord-005453-4057qib7	8592	17	with	with	IN
cord-005453-4057qib7	8592	18	TCRαβ/	TCRαβ/	NNP
cord-005453-4057qib7	8592	19	CD19	CD19	NNP
cord-005453-4057qib7	8592	20	graft	graft	NN
cord-005453-4057qib7	8592	21	depletion	depletion	NN
cord-005453-4057qib7	8592	22	from	from	IN
cord-005453-4057qib7	8592	23	2012	2012	CD
cord-005453-4057qib7	8592	24	to	to	IN
cord-005453-4057qib7	8592	25	September	September	NNP
cord-005453-4057qib7	8592	26	2018	2018	CD
cord-005453-4057qib7	8592	27	in	in	IN
cord-005453-4057qib7	8592	28	our	-PRON-	PRP$
cord-005453-4057qib7	8592	29	center	center	NN
cord-005453-4057qib7	8592	30	were	be	VBD
cord-005453-4057qib7	8592	31	analyzed	analyze	VBN
cord-005453-4057qib7	8592	32	.	.	.
cord-005453-4057qib7	8593	1	The	the	DT
cord-005453-4057qib7	8593	2	median	median	JJ
cord-005453-4057qib7	8593	3	age	age	NN
cord-005453-4057qib7	8593	4	at	at	IN
cord-005453-4057qib7	8593	5	HSCT	HSCT	NNP
cord-005453-4057qib7	8593	6	was	be	VBD
cord-005453-4057qib7	8593	7	3,5	3,5	CD
cord-005453-4057qib7	8593	8	years	year	NNS
cord-005453-4057qib7	8594	1	(	(	-LRB-
cord-005453-4057qib7	8594	2	range	range	VB
cord-005453-4057qib7	8594	3	0,43	0,43	CD
cord-005453-4057qib7	8594	4	-	-	HYPH
cord-005453-4057qib7	8594	5	17,63	17,63	CD
cord-005453-4057qib7	8594	6	)	)	-RRB-
cord-005453-4057qib7	8594	7	.	.	.
cord-005453-4057qib7	8595	1	Patients	patient	NNS
cord-005453-4057qib7	8595	2	were	be	VBD
cord-005453-4057qib7	8595	3	divided	divide	VBN
cord-005453-4057qib7	8595	4	into	into	IN
cord-005453-4057qib7	8595	5	3	3	CD
cord-005453-4057qib7	8595	6	age	age	NN
cord-005453-4057qib7	8595	7	groups	group	NNS
cord-005453-4057qib7	8595	8	:	:	:
cord-005453-4057qib7	8595	9	0	0	CD
cord-005453-4057qib7	8595	10	-	-	SYM
cord-005453-4057qib7	8595	11	6	6	CD
cord-005453-4057qib7	8595	12	years	year	NNS
cord-005453-4057qib7	8595	13	-95	-95	NN
cord-005453-4057qib7	8595	14	patients	patient	NNS
cord-005453-4057qib7	8595	15	,	,	,
cord-005453-4057qib7	8595	16	6	6	CD
cord-005453-4057qib7	8595	17	-	-	SYM
cord-005453-4057qib7	8595	18	12	12	CD
cord-005453-4057qib7	8595	19	years	year	NNS
cord-005453-4057qib7	8595	20	-30	-30	NN
cord-005453-4057qib7	8595	21	,	,	,
cord-005453-4057qib7	8595	22	12	12	CD
cord-005453-4057qib7	8595	23	-	-	SYM
cord-005453-4057qib7	8595	24	18	18	CD
cord-005453-4057qib7	8595	25	years	year	NNS
cord-005453-4057qib7	8595	26	-23	-23	NN
cord-005453-4057qib7	8595	27	.	.	.
cord-005453-4057qib7	8596	1	112	112	CD
cord-005453-4057qib7	8596	2	patients	patient	NNS
cord-005453-4057qib7	8596	3	received	receive	VBD
cord-005453-4057qib7	8596	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8596	5	from	from	IN
cord-005453-4057qib7	8596	6	matched	match	VBN
cord-005453-4057qib7	8596	7	unrelated	unrelated	JJ
cord-005453-4057qib7	8596	8	,	,	,
cord-005453-4057qib7	8596	9	31	31	CD
cord-005453-4057qib7	8596	10	-haploidentical	-haploidentical	JJ
cord-005453-4057qib7	8596	11	donors	donor	NNS
cord-005453-4057qib7	8596	12	,	,	,
cord-005453-4057qib7	8596	13	5	5	CD
cord-005453-4057qib7	8596	14	-siblings	-sibling	NNS
cord-005453-4057qib7	8596	15	.	.	.
cord-005453-4057qib7	8597	1	Conditioning	conditioning	NN
cord-005453-4057qib7	8597	2	regimens	regimen	NNS
cord-005453-4057qib7	8597	3	with	with	IN
cord-005453-4057qib7	8597	4	1	1	CD
cord-005453-4057qib7	8597	5	-	-	SYM
cord-005453-4057qib7	8597	6	2	2	CD
cord-005453-4057qib7	8597	7	alkylating	alkylating	JJ
cord-005453-4057qib7	8597	8	agents	agent	NNS
cord-005453-4057qib7	8597	9	and	and	CC
cord-005453-4057qib7	8597	10	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	8597	11	globulin	globulin	NNP
cord-005453-4057qib7	8597	12	were	be	VBD
cord-005453-4057qib7	8597	13	used	use	VBN
cord-005453-4057qib7	8597	14	in	in	IN
cord-005453-4057qib7	8597	15	all	all	DT
cord-005453-4057qib7	8597	16	patients	patient	NNS
cord-005453-4057qib7	8597	17	.	.	.
cord-005453-4057qib7	8598	1	113	113	CD
cord-005453-4057qib7	8598	2	patient	patient	NN
cord-005453-4057qib7	8598	3	received	receive	VBD
cord-005453-4057qib7	8598	4	short	short	JJ
cord-005453-4057qib7	8598	5	courses	course	NNS
cord-005453-4057qib7	8598	6	of	of	IN
cord-005453-4057qib7	8598	7	various	various	JJ
cord-005453-4057qib7	8598	8	posttransplant	posttransplant	NN
cord-005453-4057qib7	8598	9	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	8598	10	.	.	.
cord-005453-4057qib7	8599	1	Median	median	JJ
cord-005453-4057qib7	8599	2	follow	follow	VBP
cord-005453-4057qib7	8599	3	up	up	RP
cord-005453-4057qib7	8599	4	after	after	IN
cord-005453-4057qib7	8599	5	HSCT	HSCT	NNP
cord-005453-4057qib7	8599	6	is	be	VBZ
cord-005453-4057qib7	8599	7	1,95	1,95	CD
cord-005453-4057qib7	8599	8	years	year	NNS
cord-005453-4057qib7	8600	1	(	(	-LRB-
cord-005453-4057qib7	8600	2	range	range	NNP
cord-005453-4057qib7	8600	3	0,04	0,04	CD
cord-005453-4057qib7	8600	4	-	-	HYPH
cord-005453-4057qib7	8600	5	6,3	6,3	CD
cord-005453-4057qib7	8600	6	years	year	NNS
cord-005453-4057qib7	8600	7	)	)	-RRB-
cord-005453-4057qib7	8600	8	.	.	.
cord-005453-4057qib7	8601	1	Results	result	NNS
cord-005453-4057qib7	8601	2	:	:	:
cord-005453-4057qib7	8602	1	Overall	overall	JJ
cord-005453-4057qib7	8602	2	survival	survival	NN
cord-005453-4057qib7	8602	3	(	(	-LRB-
cord-005453-4057qib7	8602	4	OS	OS	NNP
cord-005453-4057qib7	8602	5	)	)	-RRB-
cord-005453-4057qib7	8602	6	in	in	IN
cord-005453-4057qib7	8602	7	148	148	CD
cord-005453-4057qib7	8602	8	patients	patient	NNS
cord-005453-4057qib7	8602	9	was	be	VBD
cord-005453-4057qib7	8602	10	0,85	0,85	CD
cord-005453-4057qib7	8602	11	(	(	-LRB-
cord-005453-4057qib7	8602	12	95	95	CD
cord-005453-4057qib7	8602	13	%	%	NN
cord-005453-4057qib7	8602	14	CI	CI	NNP
cord-005453-4057qib7	8602	15	0,79	0,79	CD
cord-005453-4057qib7	8602	16	-	-	HYPH
cord-005453-4057qib7	8602	17	0,91	0,91	CD
cord-005453-4057qib7	8602	18	)	)	-RRB-
cord-005453-4057qib7	8602	19	.	.	.
cord-005453-4057qib7	8603	1	We	-PRON-	PRP
cord-005453-4057qib7	8603	2	observed	observe	VBD
cord-005453-4057qib7	8603	3	similar	similar	JJ
cord-005453-4057qib7	8603	4	OS	os	NN
cord-005453-4057qib7	8603	5	in	in	IN
cord-005453-4057qib7	8603	6	the	the	DT
cord-005453-4057qib7	8603	7	younger	young	JJR
cord-005453-4057qib7	8603	8	age	age	NN
cord-005453-4057qib7	8603	9	groups	group	NNS
cord-005453-4057qib7	8603	10	:	:	:
cord-005453-4057qib7	8603	11	0,89	0,89	CD
cord-005453-4057qib7	8603	12	(	(	-LRB-
cord-005453-4057qib7	8603	13	95	95	CD
cord-005453-4057qib7	8603	14	%	%	NN
cord-005453-4057qib7	8603	15	CI	CI	NNP
cord-005453-4057qib7	8603	16	0,83	0,83	CD
cord-005453-4057qib7	8603	17	-	-	HYPH
cord-005453-4057qib7	8603	18	0,96	0,96	CD
cord-005453-4057qib7	8603	19	)	)	-RRB-
cord-005453-4057qib7	8603	20	in	in	IN
cord-005453-4057qib7	8603	21	0	0	CD
cord-005453-4057qib7	8603	22	-	-	SYM
cord-005453-4057qib7	8603	23	6	6	CD
cord-005453-4057qib7	8603	24	years	year	NNS
cord-005453-4057qib7	8603	25	and	and	CC
cord-005453-4057qib7	8603	26	0,89	0,89	CD
cord-005453-4057qib7	8603	27	(	(	-LRB-
cord-005453-4057qib7	8603	28	95	95	CD
cord-005453-4057qib7	8603	29	%	%	NN
cord-005453-4057qib7	8603	30	CI	CI	NNP
cord-005453-4057qib7	8603	31	0,78	0,78	NNP
cord-005453-4057qib7	8603	32	-	-	HYPH
cord-005453-4057qib7	8603	33	1,0	1,0	CD
cord-005453-4057qib7	8603	34	)	)	-RRB-
cord-005453-4057qib7	8603	35	in	in	IN
cord-005453-4057qib7	8603	36	6	6	CD
cord-005453-4057qib7	8603	37	-	-	SYM
cord-005453-4057qib7	8603	38	12	12	CD
cord-005453-4057qib7	8603	39	years	year	NNS
cord-005453-4057qib7	8603	40	of	of	IN
cord-005453-4057qib7	8603	41	age	age	NN
cord-005453-4057qib7	8603	42	.	.	.
cord-005453-4057qib7	8604	1	Seven	seven	CD
cord-005453-4057qib7	8604	2	of	of	IN
cord-005453-4057qib7	8604	3	23	23	CD
cord-005453-4057qib7	8604	4	patients	patient	NNS
cord-005453-4057qib7	8604	5	in	in	IN
cord-005453-4057qib7	8604	6	older	old	JJR
cord-005453-4057qib7	8604	7	group	group	NN
cord-005453-4057qib7	8604	8	(	(	-LRB-
cord-005453-4057qib7	8604	9	12	12	CD
cord-005453-4057qib7	8604	10	-	-	SYM
cord-005453-4057qib7	8604	11	18	18	CD
cord-005453-4057qib7	8604	12	years	year	NNS
cord-005453-4057qib7	8604	13	of	of	IN
cord-005453-4057qib7	8604	14	age	age	NN
cord-005453-4057qib7	8604	15	)	)	-RRB-
cord-005453-4057qib7	8604	16	died	die	VBD
cord-005453-4057qib7	8604	17	,	,	,
cord-005453-4057qib7	8604	18	the	the	DT
cord-005453-4057qib7	8604	19	OS	OS	NNP
cord-005453-4057qib7	8604	20	was	be	VBD
cord-005453-4057qib7	8604	21	only	only	RB
cord-005453-4057qib7	8604	22	0,65	0,65	CD
cord-005453-4057qib7	8605	1	(	(	-LRB-
cord-005453-4057qib7	8605	2	95	95	CD
cord-005453-4057qib7	8605	3	%	%	NN
cord-005453-4057qib7	8605	4	CI	CI	NNP
cord-005453-4057qib7	8605	5	0,43	0,43	CD
cord-005453-4057qib7	8605	6	-	-	HYPH
cord-005453-4057qib7	8605	7	0,86	0,86	CD
cord-005453-4057qib7	8605	8	)	)	-RRB-
cord-005453-4057qib7	8605	9	,	,	,
cord-005453-4057qib7	8605	10	p=0,065	p=0,065	NNP
cord-005453-4057qib7	8605	11	.	.	.
cord-005453-4057qib7	8606	1	All	all	DT
cord-005453-4057qib7	8606	2	patients	patient	NNS
cord-005453-4057qib7	8606	3	from	from	IN
cord-005453-4057qib7	8606	4	older	old	JJR
cord-005453-4057qib7	8606	5	age	age	NN
cord-005453-4057qib7	8606	6	group	group	NN
cord-005453-4057qib7	8606	7	who	who	WP
cord-005453-4057qib7	8606	8	died	die	VBD
cord-005453-4057qib7	8606	9	had	have	VBD
cord-005453-4057qib7	8606	10	combined	combine	VBN
cord-005453-4057qib7	8606	11	PID	pid	NN
cord-005453-4057qib7	8606	12	:	:	:
cord-005453-4057qib7	8606	13	1	1	CD
cord-005453-4057qib7	8606	14	-Wiscott	-Wiscott	NNP
cord-005453-4057qib7	8606	15	-	-	HYPH
cord-005453-4057qib7	8606	16	Aldrich	Aldrich	NNP
cord-005453-4057qib7	8606	17	syndrome	syndrome	NN
cord-005453-4057qib7	8606	18	,	,	,
cord-005453-4057qib7	8606	19	1	1	CD
cord-005453-4057qib7	8606	20	-undefined	-undefine	VBN
cord-005453-4057qib7	8606	21	PID	PID	NNP
cord-005453-4057qib7	8606	22	,	,	,
cord-005453-4057qib7	8606	23	1	1	CD
cord-005453-4057qib7	8606	24	-IL2RG	-IL2RG	NNP
cord-005453-4057qib7	8606	25	deficiency	deficiency	NN
cord-005453-4057qib7	8606	26	,	,	,
cord-005453-4057qib7	8606	27	1	1	CD
cord-005453-4057qib7	8606	28	-DCLRE1C	-dclre1c	NN
cord-005453-4057qib7	8606	29	deficiency	deficiency	NN
cord-005453-4057qib7	8606	30	,	,	,
cord-005453-4057qib7	8606	31	1	1	CD
cord-005453-4057qib7	8606	32	-Nijmegen	-nijmegen	IN
cord-005453-4057qib7	8606	33	breakage	breakage	NN
cord-005453-4057qib7	8606	34	syndrome	syndrome	NN
cord-005453-4057qib7	8606	35	(	(	-LRB-
cord-005453-4057qib7	8606	36	NBS	NBS	NNP
cord-005453-4057qib7	8606	37	)	)	-RRB-
cord-005453-4057qib7	8606	38	,	,	,
cord-005453-4057qib7	8606	39	1	1	CD
cord-005453-4057qib7	8606	40	-Kabuki	-Kabuki	NNP
cord-005453-4057qib7	8606	41	syndrome	syndrome	NN
cord-005453-4057qib7	8606	42	,	,	,
cord-005453-4057qib7	8606	43	1	1	CD
cord-005453-4057qib7	8606	44	-ICF	-icf	DT
cord-005453-4057qib7	8606	45	syndrome	syndrome	NN
cord-005453-4057qib7	8606	46	.	.	.
cord-005453-4057qib7	8607	1	The	the	DT
cord-005453-4057qib7	8607	2	median	median	JJ
cord-005453-4057qib7	8607	3	time	time	NN
cord-005453-4057qib7	8607	4	of	of	IN
cord-005453-4057qib7	8607	5	death	death	NN
cord-005453-4057qib7	8607	6	after	after	IN
cord-005453-4057qib7	8607	7	HSCT	HSCT	NNP
cord-005453-4057qib7	8607	8	was	be	VBD
cord-005453-4057qib7	8607	9	0,64	0,64	CD
cord-005453-4057qib7	8607	10	years	year	NNS
cord-005453-4057qib7	8607	11	(	(	-LRB-
cord-005453-4057qib7	8607	12	range	range	VBP
cord-005453-4057qib7	8607	13	0,26	0,26	CD
cord-005453-4057qib7	8607	14	-1,58	-1,58	NFP
cord-005453-4057qib7	8607	15	)	)	-RRB-
cord-005453-4057qib7	8607	16	.	.	.
cord-005453-4057qib7	8608	1	Six	six	CD
cord-005453-4057qib7	8608	2	of	of	IN
cord-005453-4057qib7	8608	3	those	those	DT
cord-005453-4057qib7	8608	4	had	have	VBD
cord-005453-4057qib7	8608	5	transplant	transplant	NN
cord-005453-4057qib7	8608	6	-	-	HYPH
cord-005453-4057qib7	8608	7	related	relate	VBN
cord-005453-4057qib7	8608	8	mortality	mortality	NN
cord-005453-4057qib7	8608	9	(	(	-LRB-
cord-005453-4057qib7	8608	10	TRM	TRM	NNP
cord-005453-4057qib7	8608	11	)	)	-RRB-
cord-005453-4057qib7	8608	12	.	.	.
cord-005453-4057qib7	8609	1	Five	five	CD
cord-005453-4057qib7	8609	2	patients	patient	NNS
cord-005453-4057qib7	8609	3	had	have	VBD
cord-005453-4057qib7	8609	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8609	5	-	-	HYPH
cord-005453-4057qib7	8609	6	associated	associate	VBN
cord-005453-4057qib7	8609	7	viral	viral	JJ
cord-005453-4057qib7	8609	8	infections	infection	NNS
cord-005453-4057qib7	8609	9	:	:	:
cord-005453-4057qib7	8609	10	2	2	CD
cord-005453-4057qib7	8609	11	-CMV	-CMV	:
cord-005453-4057qib7	8609	12	pneumonias	pneumonia	NNS
cord-005453-4057qib7	8609	13	,	,	,
cord-005453-4057qib7	8609	14	3	3	CD
cord-005453-4057qib7	8609	15	-ADV	-ADV	:
cord-005453-4057qib7	8609	16	infections	infection	NNS
cord-005453-4057qib7	8609	17	(	(	-LRB-
cord-005453-4057qib7	8609	18	1	1	CD
cord-005453-4057qib7	8609	19	-fulminant	-fulminant	JJ
cord-005453-4057qib7	8609	20	hepatitis	hepatitis	NN
cord-005453-4057qib7	8609	21	,	,	,
cord-005453-4057qib7	8609	22	2	2	CD
cord-005453-4057qib7	8609	23	-multiorgan	-multiorgan	CD
cord-005453-4057qib7	8609	24	)	)	-RRB-
cord-005453-4057qib7	8609	25	.	.	.
cord-005453-4057qib7	8610	1	Interestingly	interestingly	RB
cord-005453-4057qib7	8610	2	,	,	,
cord-005453-4057qib7	8610	3	2	2	CD
cord-005453-4057qib7	8610	4	of	of	IN
cord-005453-4057qib7	8610	5	them	-PRON-	PRP
cord-005453-4057qib7	8610	6	had	have	VBD
cord-005453-4057qib7	8610	7	prolonged	prolong	VBN
cord-005453-4057qib7	8610	8	history	history	NN
cord-005453-4057qib7	8610	9	of	of	IN
cord-005453-4057qib7	8610	10	disseminated	disseminate	VBN
cord-005453-4057qib7	8610	11	viral	viral	JJ
cord-005453-4057qib7	8610	12	infections	infection	NNS
cord-005453-4057qib7	8610	13	(	(	-LRB-
cord-005453-4057qib7	8610	14	ADV	ADV	NNP
cord-005453-4057qib7	8610	15	)	)	-RRB-
cord-005453-4057qib7	8610	16	,	,	,
cord-005453-4057qib7	8610	17	with	with	IN
cord-005453-4057qib7	8610	18	the	the	DT
cord-005453-4057qib7	8610	19	reduction	reduction	NN
cord-005453-4057qib7	8610	20	of	of	IN
cord-005453-4057qib7	8610	21	viral	viral	JJ
cord-005453-4057qib7	8610	22	load	load	NN
cord-005453-4057qib7	8610	23	in	in	IN
cord-005453-4057qib7	8610	24	blood	blood	NN
cord-005453-4057qib7	8610	25	and	and	CC
cord-005453-4057qib7	8610	26	other	other	JJ
cord-005453-4057qib7	8610	27	fluids	fluid	NNS
cord-005453-4057qib7	8610	28	and	and	CC
cord-005453-4057qib7	8610	29	tissues	tissue	NNS
cord-005453-4057qib7	8610	30	upon	upon	IN
cord-005453-4057qib7	8610	31	treatment	treatment	NN
cord-005453-4057qib7	8610	32	.	.	.
cord-005453-4057qib7	8611	1	One	one	CD
cord-005453-4057qib7	8611	2	patient	patient	NN
cord-005453-4057qib7	8611	3	with	with	IN
cord-005453-4057qib7	8611	4	Kabuki	Kabuki	NNP
cord-005453-4057qib7	8611	5	syndrome	syndrome	NN
cord-005453-4057qib7	8611	6	after	after	IN
cord-005453-4057qib7	8611	7	HSCT	HSCT	NNP
cord-005453-4057qib7	8611	8	developed	develop	VBD
cord-005453-4057qib7	8611	9	HHV8	HHV8	NNP
cord-005453-4057qib7	8611	10	associated	associate	VBD
cord-005453-4057qib7	8611	11	Kaposi	Kaposi	NNP
cord-005453-4057qib7	8611	12	sarcoma	sarcoma	NN
cord-005453-4057qib7	8611	13	,	,	,
cord-005453-4057qib7	8611	14	was	be	VBD
cord-005453-4057qib7	8611	15	successfully	successfully	RB
cord-005453-4057qib7	8611	16	treated	treat	VBN
cord-005453-4057qib7	8611	17	.	.	.
cord-005453-4057qib7	8612	1	Eventually	eventually	RB
cord-005453-4057qib7	8612	2	all	all	DT
cord-005453-4057qib7	8612	3	3	3	CD
cord-005453-4057qib7	8612	4	patients	patient	NNS
cord-005453-4057qib7	8612	5	with	with	IN
cord-005453-4057qib7	8612	6	reduction	reduction	NN
cord-005453-4057qib7	8612	7	of	of	IN
cord-005453-4057qib7	8612	8	viral	viral	JJ
cord-005453-4057qib7	8612	9	infection	infection	NN
cord-005453-4057qib7	8612	10	and	and	CC
cord-005453-4057qib7	8612	11	sarcoma	sarcoma	NN
cord-005453-4057qib7	8612	12	symptoms	symptom	NNS
cord-005453-4057qib7	8612	13	developed	develop	VBD
cord-005453-4057qib7	8612	14	multiorgan	multiorgan	NNP
cord-005453-4057qib7	8612	15	failure	failure	NN
cord-005453-4057qib7	8612	16	with	with	IN
cord-005453-4057qib7	8612	17	some	some	DT
cord-005453-4057qib7	8612	18	clinical	clinical	JJ
cord-005453-4057qib7	8612	19	and	and	CC
cord-005453-4057qib7	8612	20	laboratory	laboratory	NN
cord-005453-4057qib7	8612	21	evidences	evidence	NNS
cord-005453-4057qib7	8612	22	of	of	IN
cord-005453-4057qib7	8612	23	endothelium	endothelium	NN
cord-005453-4057qib7	8612	24	cell	cell	NN
cord-005453-4057qib7	8612	25	damage	damage	NN
cord-005453-4057qib7	8612	26	syndrome	syndrome	NN
cord-005453-4057qib7	8612	27	.	.	.
cord-005453-4057qib7	8613	1	One	one	CD
cord-005453-4057qib7	8613	2	patient	patient	NN
cord-005453-4057qib7	8613	3	with	with	IN
cord-005453-4057qib7	8613	4	NBS	NBS	NNP
cord-005453-4057qib7	8613	5	died	die	VBD
cord-005453-4057qib7	8613	6	of	of	IN
cord-005453-4057qib7	8613	7	high	high	JJ
cord-005453-4057qib7	8613	8	grade	grade	NN
cord-005453-4057qib7	8613	9	lymphoma	lymphoma	NN
cord-005453-4057qib7	8613	10	progression	progression	NN
cord-005453-4057qib7	8613	11	.	.	.
cord-005453-4057qib7	8614	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8614	2	:	:	:
cord-005453-4057qib7	8615	1	HSCT	HSCT	NNP
cord-005453-4057qib7	8615	2	with	with	IN
cord-005453-4057qib7	8615	3	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	8616	1	/CD19	/CD19	NNP
cord-005453-4057qib7	8616	2	depletion	depletion	NN
cord-005453-4057qib7	8616	3	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	8616	4	high	high	JJ
cord-005453-4057qib7	8616	5	survival	survival	NN
cord-005453-4057qib7	8616	6	rate	rate	NN
cord-005453-4057qib7	8616	7	in	in	IN
cord-005453-4057qib7	8616	8	148	148	CD
cord-005453-4057qib7	8616	9	patients	patient	NNS
cord-005453-4057qib7	8616	10	with	with	IN
cord-005453-4057qib7	8616	11	various	various	JJ
cord-005453-4057qib7	8616	12	PID	pid	NN
cord-005453-4057qib7	8616	13	.	.	.
cord-005453-4057qib7	8617	1	In	in	IN
cord-005453-4057qib7	8617	2	our	-PRON-	PRP$
cord-005453-4057qib7	8617	3	group	group	NN
cord-005453-4057qib7	8617	4	patients	patient	NNS
cord-005453-4057qib7	8617	5	'	'	POS
cord-005453-4057qib7	8617	6	age	age	NN
cord-005453-4057qib7	8617	7	older	old	JJR
cord-005453-4057qib7	8617	8	than	than	IN
cord-005453-4057qib7	8617	9	12	12	CD
cord-005453-4057qib7	8617	10	years	year	NNS
cord-005453-4057qib7	8617	11	predisposes	predispose	VBZ
cord-005453-4057qib7	8617	12	to	to	IN
cord-005453-4057qib7	8617	13	decreased	decrease	VBN
cord-005453-4057qib7	8617	14	posttransplant	posttransplant	JJ
cord-005453-4057qib7	8617	15	survival	survival	NN
cord-005453-4057qib7	8617	16	.	.	.
cord-005453-4057qib7	8618	1	Patients	patient	NNS
cord-005453-4057qib7	8618	2	with	with	IN
cord-005453-4057qib7	8618	3	combined	combined	JJ
cord-005453-4057qib7	8618	4	PID	pid	NN
cord-005453-4057qib7	8618	5	are	be	VBP
cord-005453-4057qib7	8618	6	at	at	IN
cord-005453-4057qib7	8618	7	higher	high	JJR
cord-005453-4057qib7	8618	8	risks	risk	NNS
cord-005453-4057qib7	8618	9	of	of	IN
cord-005453-4057qib7	8618	10	posttransplant	posttransplant	NN
cord-005453-4057qib7	8618	11	mortality	mortality	NN
cord-005453-4057qib7	8618	12	.	.	.
cord-005453-4057qib7	8619	1	We	-PRON-	PRP
cord-005453-4057qib7	8619	2	conclude	conclude	VBP
cord-005453-4057qib7	8619	3	that	that	IN
cord-005453-4057qib7	8619	4	at	at	IN
cord-005453-4057qib7	8619	5	least	least	JJS
cord-005453-4057qib7	8619	6	in	in	IN
cord-005453-4057qib7	8619	7	some	some	DT
cord-005453-4057qib7	8619	8	of	of	IN
cord-005453-4057qib7	8619	9	our	-PRON-	PRP$
cord-005453-4057qib7	8619	10	patients	patient	NNS
cord-005453-4057qib7	8619	11	with	with	IN
cord-005453-4057qib7	8619	12	prolonged	prolonged	JJ
cord-005453-4057qib7	8619	13	history	history	NN
cord-005453-4057qib7	8619	14	of	of	IN
cord-005453-4057qib7	8619	15	viral	viral	JJ
cord-005453-4057qib7	8619	16	infections	infection	NNS
cord-005453-4057qib7	8619	17	after	after	IN
cord-005453-4057qib7	8619	18	HSCT	HSCT	NNP
cord-005453-4057qib7	8619	19	the	the	DT
cord-005453-4057qib7	8619	20	cause	cause	NN
cord-005453-4057qib7	8619	21	of	of	IN
cord-005453-4057qib7	8619	22	death	death	NN
cord-005453-4057qib7	8619	23	could	could	MD
cord-005453-4057qib7	8619	24	be	be	VB
cord-005453-4057qib7	8619	25	multiorgan	multiorgan	NN
cord-005453-4057qib7	8619	26	failure	failure	NN
cord-005453-4057qib7	8619	27	due	due	JJ
cord-005453-4057qib7	8619	28	to	to	IN
cord-005453-4057qib7	8619	29	endothelium	endothelium	NN
cord-005453-4057qib7	8619	30	cell	cell	NN
cord-005453-4057qib7	8619	31	damage	damage	NN
cord-005453-4057qib7	8619	32	syndrome	syndrome	NN
cord-005453-4057qib7	8619	33	resulting	result	VBG
cord-005453-4057qib7	8619	34	from	from	IN
cord-005453-4057qib7	8619	35	persistent	persistent	JJ
cord-005453-4057qib7	8619	36	inflammation	inflammation	NN
cord-005453-4057qib7	8619	37	and	and	CC
cord-005453-4057qib7	8619	38	drug	drug	NN
cord-005453-4057qib7	8619	39	toxicity	toxicity	NN
cord-005453-4057qib7	8619	40	effects	effect	NNS
cord-005453-4057qib7	8619	41	.	.	.
cord-005453-4057qib7	8620	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8620	2	Background	background	NN
cord-005453-4057qib7	8620	3	:	:	:
cord-005453-4057qib7	8620	4	Chronic	chronic	JJ
cord-005453-4057qib7	8620	5	granulomatous	granulomatous	JJ
cord-005453-4057qib7	8620	6	disease	disease	NN
cord-005453-4057qib7	8620	7	(	(	-LRB-
cord-005453-4057qib7	8620	8	CGD	CGD	NNP
cord-005453-4057qib7	8620	9	)	)	-RRB-
cord-005453-4057qib7	8620	10	is	be	VBZ
cord-005453-4057qib7	8620	11	a	a	DT
cord-005453-4057qib7	8620	12	primary	primary	JJ
cord-005453-4057qib7	8620	13	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8620	14	(	(	-LRB-
cord-005453-4057qib7	8620	15	PID	PID	NNP
cord-005453-4057qib7	8620	16	)	)	-RRB-
cord-005453-4057qib7	8620	17	caused	cause	VBN
cord-005453-4057qib7	8620	18	by	by	IN
cord-005453-4057qib7	8620	19	a	a	DT
cord-005453-4057qib7	8620	20	mutation	mutation	NN
cord-005453-4057qib7	8620	21	in	in	IN
cord-005453-4057qib7	8620	22	1	1	CD
cord-005453-4057qib7	8620	23	of	of	IN
cord-005453-4057qib7	8620	24	the	the	DT
cord-005453-4057qib7	8620	25	5	5	CD
cord-005453-4057qib7	8620	26	subunits	subunit	NNS
cord-005453-4057qib7	8620	27	of	of	IN
cord-005453-4057qib7	8620	28	the	the	DT
cord-005453-4057qib7	8620	29	nicotinamide	nicotinamide	NN
cord-005453-4057qib7	8620	30	dinucleotide	dinucleotide	NN
cord-005453-4057qib7	8620	31	phosphate	phosphate	NN
cord-005453-4057qib7	8620	32	(	(	-LRB-
cord-005453-4057qib7	8620	33	NADPH	NADPH	NNP
cord-005453-4057qib7	8620	34	)	)	-RRB-
cord-005453-4057qib7	8620	35	oxidase	oxidase	NN
cord-005453-4057qib7	8620	36	,	,	,
cord-005453-4057qib7	8620	37	which	which	WDT
cord-005453-4057qib7	8620	38	leads	lead	VBZ
cord-005453-4057qib7	8620	39	to	to	IN
cord-005453-4057qib7	8620	40	a	a	DT
cord-005453-4057qib7	8620	41	reduction	reduction	NN
cord-005453-4057qib7	8620	42	in	in	IN
cord-005453-4057qib7	8620	43	the	the	DT
cord-005453-4057qib7	8620	44	microbicidal	microbicidal	JJ
cord-005453-4057qib7	8620	45	activity	activity	NN
cord-005453-4057qib7	8620	46	of	of	IN
cord-005453-4057qib7	8620	47	phagocytic	phagocytic	JJ
cord-005453-4057qib7	8620	48	cell	cell	NN
cord-005453-4057qib7	8620	49	.	.	.
cord-005453-4057qib7	8621	1	Starting	start	VBG
cord-005453-4057qib7	8621	2	at	at	IN
cord-005453-4057qib7	8621	3	an	an	DT
cord-005453-4057qib7	8621	4	early	early	JJ
cord-005453-4057qib7	8621	5	age	age	NN
cord-005453-4057qib7	8621	6	,	,	,
cord-005453-4057qib7	8621	7	CGD	CGD	NNP
cord-005453-4057qib7	8621	8	patients	patient	NNS
cord-005453-4057qib7	8621	9	suffer	suffer	VBP
cord-005453-4057qib7	8621	10	from	from	IN
cord-005453-4057qib7	8621	11	severe	severe	JJ
cord-005453-4057qib7	8621	12	recurrent	recurrent	JJ
cord-005453-4057qib7	8621	13	infections	infection	NNS
cord-005453-4057qib7	8621	14	,	,	,
cord-005453-4057qib7	8621	15	as	as	RB
cord-005453-4057qib7	8621	16	well	well	RB
cord-005453-4057qib7	8621	17	as	as	IN
cord-005453-4057qib7	8621	18	inflammatory	inflammatory	JJ
cord-005453-4057qib7	8621	19	events	event	NNS
cord-005453-4057qib7	8621	20	.	.	.
cord-005453-4057qib7	8622	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	8622	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8622	3	stem	stem	NN
cord-005453-4057qib7	8622	4	cell	cell	NN
cord-005453-4057qib7	8622	5	transplantation	transplantation	NN
cord-005453-4057qib7	8622	6	(	(	-LRB-
cord-005453-4057qib7	8622	7	HSCT	HSCT	NNP
cord-005453-4057qib7	8622	8	)	)	-RRB-
cord-005453-4057qib7	8622	9	is	be	VBZ
cord-005453-4057qib7	8622	10	a	a	DT
cord-005453-4057qib7	8622	11	curative	curative	JJ
cord-005453-4057qib7	8622	12	option	option	NN
cord-005453-4057qib7	8622	13	for	for	IN
cord-005453-4057qib7	8622	14	CGD	CGD	NNP
cord-005453-4057qib7	8622	15	in	in	IN
cord-005453-4057qib7	8622	16	patients	patient	NNS
cord-005453-4057qib7	8622	17	with	with	IN
cord-005453-4057qib7	8622	18	insufficient	insufficient	JJ
cord-005453-4057qib7	8622	19	benefit	benefit	NN
cord-005453-4057qib7	8622	20	from	from	IN
cord-005453-4057qib7	8622	21	supportive	supportive	JJ
cord-005453-4057qib7	8622	22	care	care	NN
cord-005453-4057qib7	8622	23	and	and	CC
cord-005453-4057qib7	8622	24	prophylactic	prophylactic	JJ
cord-005453-4057qib7	8622	25	antibiotics	antibiotic	NNS
cord-005453-4057qib7	8622	26	.	.	.
cord-005453-4057qib7	8623	1	We	-PRON-	PRP
cord-005453-4057qib7	8623	2	reported	report	VBD
cord-005453-4057qib7	8623	3	a	a	DT
cord-005453-4057qib7	8623	4	series	series	NN
cord-005453-4057qib7	8623	5	of	of	IN
cord-005453-4057qib7	8623	6	39	39	CD
cord-005453-4057qib7	8623	7	patients	patient	NNS
cord-005453-4057qib7	8623	8	with	with	IN
cord-005453-4057qib7	8623	9	CGD	CGD	NNP
cord-005453-4057qib7	8623	10	who	who	WP
cord-005453-4057qib7	8623	11	underwent	undergo	VBD
cord-005453-4057qib7	8623	12	Unrelated	unrelated	JJ
cord-005453-4057qib7	8623	13	umbilical	umbilical	JJ
cord-005453-4057qib7	8623	14	cord	cord	NN
cord-005453-4057qib7	8623	15	blood	blood	NN
cord-005453-4057qib7	8623	16	transplantation	transplantation	NN
cord-005453-4057qib7	8623	17	(	(	-LRB-
cord-005453-4057qib7	8623	18	UCBT	UCBT	NNP
cord-005453-4057qib7	8623	19	)	)	-RRB-
cord-005453-4057qib7	8623	20	at	at	IN
cord-005453-4057qib7	8623	21	our	-PRON-	PRP$
cord-005453-4057qib7	8623	22	center	center	NN
cord-005453-4057qib7	8623	23	.	.	.
cord-005453-4057qib7	8624	1	Methods	method	NNS
cord-005453-4057qib7	8625	1	:	:	:
cord-005453-4057qib7	8625	2	In	in	IN
cord-005453-4057qib7	8625	3	this	this	DT
cord-005453-4057qib7	8625	4	retrospective	retrospective	JJ
cord-005453-4057qib7	8625	5	study	study	NN
cord-005453-4057qib7	8625	6	,	,	,
cord-005453-4057qib7	8625	7	we	-PRON-	PRP
cord-005453-4057qib7	8625	8	observed	observe	VBD
cord-005453-4057qib7	8625	9	a	a	DT
cord-005453-4057qib7	8625	10	series	series	NN
cord-005453-4057qib7	8625	11	of	of	IN
cord-005453-4057qib7	8625	12	39	39	CD
cord-005453-4057qib7	8625	13	consecutive	consecutive	JJ
cord-005453-4057qib7	8625	14	UCBT	UCBT	NNS
cord-005453-4057qib7	8625	15	performed	perform	VBN
cord-005453-4057qib7	8625	16	at	at	IN
cord-005453-4057qib7	8625	17	our	-PRON-	PRP$
cord-005453-4057qib7	8625	18	center	center	NN
cord-005453-4057qib7	8625	19	in	in	IN
cord-005453-4057qib7	8625	20	children	child	NNS
cord-005453-4057qib7	8625	21	with	with	IN
cord-005453-4057qib7	8625	22	CGD	CGD	NNP
cord-005453-4057qib7	8625	23	between	between	IN
cord-005453-4057qib7	8625	24	2015	2015	CD
cord-005453-4057qib7	8625	25	and	and	CC
cord-005453-4057qib7	8625	26	2018.Median	2018.median	CD
cord-005453-4057qib7	8625	27	age	age	NN
cord-005453-4057qib7	8625	28	at	at	IN
cord-005453-4057qib7	8625	29	transplantation	transplantation	NN
cord-005453-4057qib7	8625	30	was	be	VBD
cord-005453-4057qib7	8625	31	17	17	CD
cord-005453-4057qib7	8625	32	months	month	NNS
cord-005453-4057qib7	8625	33	(	(	-LRB-
cord-005453-4057qib7	8625	34	range	range	NN
cord-005453-4057qib7	8625	35	,	,	,
cord-005453-4057qib7	8625	36	4	4	CD
cord-005453-4057qib7	8625	37	to	to	TO
cord-005453-4057qib7	8625	38	144	144	CD
cord-005453-4057qib7	8625	39	months	month	NNS
cord-005453-4057qib7	8625	40	)	)	-RRB-
cord-005453-4057qib7	8625	41	,	,	,
cord-005453-4057qib7	8625	42	Median	median	JJ
cord-005453-4057qib7	8625	43	body	body	NN
cord-005453-4057qib7	8625	44	weight	weight	NN
cord-005453-4057qib7	8625	45	was	be	VBD
cord-005453-4057qib7	8625	46	10	10	CD
cord-005453-4057qib7	8625	47	kg	kg	NN
cord-005453-4057qib7	8625	48	(	(	-LRB-
cord-005453-4057qib7	8625	49	range	range	NN
cord-005453-4057qib7	8625	50	,	,	,
cord-005453-4057qib7	8625	51	6	6	CD
cord-005453-4057qib7	8625	52	to	to	TO
cord-005453-4057qib7	8625	53	34	34	CD
cord-005453-4057qib7	8625	54	kg	kg	NNS
cord-005453-4057qib7	8625	55	)	)	-RRB-
cord-005453-4057qib7	8625	56	.	.	.
cord-005453-4057qib7	8626	1	32/39	32/39	CD
cord-005453-4057qib7	8626	2	patients	patient	NNS
cord-005453-4057qib7	8626	3	received	receive	VBD
cord-005453-4057qib7	8626	4	a	a	DT
cord-005453-4057qib7	8626	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8626	6	conditioning	conditioning	NN
cord-005453-4057qib7	8626	7	regimen	regimen	NN
cord-005453-4057qib7	8626	8	consisting	consist	VBG
cord-005453-4057qib7	8626	9	of	of	IN
cord-005453-4057qib7	8626	10	busulfan	busulfan	NN
cord-005453-4057qib7	8626	11	,	,	,
cord-005453-4057qib7	8626	12	fludarabine	fludarabine	NN
cord-005453-4057qib7	8626	13	,	,	,
cord-005453-4057qib7	8626	14	cytarabine	cytarabine	NN
cord-005453-4057qib7	8626	15	,	,	,
cord-005453-4057qib7	8626	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	8626	17	and	and	CC
cord-005453-4057qib7	8626	18	G	G	NNP
cord-005453-4057qib7	8626	19	-	-	HYPH
cord-005453-4057qib7	8626	20	CSF	CSF	NNP
cord-005453-4057qib7	8626	21	,	,	,
cord-005453-4057qib7	8626	22	7/39	7/39	CD
cord-005453-4057qib7	8626	23	patients	patient	NNS
cord-005453-4057qib7	8626	24	received	receive	VBD
cord-005453-4057qib7	8626	25	another	another	DT
cord-005453-4057qib7	8626	26	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8626	27	conditioning	conditioning	NN
cord-005453-4057qib7	8626	28	regimen	regimen	NN
cord-005453-4057qib7	8626	29	consisting	consist	VBG
cord-005453-4057qib7	8626	30	of	of	IN
cord-005453-4057qib7	8626	31	busulfan	busulfan	NN
cord-005453-4057qib7	8626	32	,	,	,
cord-005453-4057qib7	8626	33	fludarabine	fludarabine	NN
cord-005453-4057qib7	8626	34	,	,	,
cord-005453-4057qib7	8626	35	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	8626	36	and	and	CC
cord-005453-4057qib7	8626	37	ATG	ATG	NNP
cord-005453-4057qib7	8626	38	.	.	.
cord-005453-4057qib7	8627	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8627	2	for	for	IN
cord-005453-4057qib7	8627	3	graft	graft	NN
cord-005453-4057qib7	8627	4	-	-	HYPH
cord-005453-4057qib7	8627	5	versus	versus	IN
cord-005453-4057qib7	8627	6	-	-	HYPH
cord-005453-4057qib7	8627	7	host	host	NN
cord-005453-4057qib7	8627	8	disease	disease	NN
cord-005453-4057qib7	8627	9	(	(	-LRB-
cord-005453-4057qib7	8627	10	GVHD	GVHD	NNP
cord-005453-4057qib7	8627	11	)	)	-RRB-
cord-005453-4057qib7	8627	12	was	be	VBD
cord-005453-4057qib7	8627	13	tacrolimus	tacrolimus	JJ
cord-005453-4057qib7	8627	14	.	.	.
cord-005453-4057qib7	8628	1	Results	result	NNS
cord-005453-4057qib7	8628	2	:	:	:
cord-005453-4057qib7	8629	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	8629	2	occurred	occur	VBD
cord-005453-4057qib7	8629	3	in	in	IN
cord-005453-4057qib7	8629	4	29/39	29/39	CD
cord-005453-4057qib7	8629	5	(	(	-LRB-
cord-005453-4057qib7	8629	6	74.4	74.4	CD
cord-005453-4057qib7	8629	7	%	%	NN
cord-005453-4057qib7	8629	8	)	)	-RRB-
cord-005453-4057qib7	8629	9	patients	patient	NNS
cord-005453-4057qib7	8629	10	.	.	.
cord-005453-4057qib7	8630	1	10/39	10/39	CD
cord-005453-4057qib7	8630	2	(	(	-LRB-
cord-005453-4057qib7	8630	3	25.6	25.6	CD
cord-005453-4057qib7	8630	4	%	%	NN
cord-005453-4057qib7	8630	5	)	)	-RRB-
cord-005453-4057qib7	8630	6	patients	patient	NNS
cord-005453-4057qib7	8630	7	occurred	occur	VBD
cord-005453-4057qib7	8630	8	graft	graft	NN
cord-005453-4057qib7	8630	9	failure	failure	NN
cord-005453-4057qib7	8630	10	,	,	,
cord-005453-4057qib7	8630	11	all	all	DT
cord-005453-4057qib7	8630	12	of	of	IN
cord-005453-4057qib7	8630	13	them	-PRON-	PRP
cord-005453-4057qib7	8630	14	received	receive	VBD
cord-005453-4057qib7	8630	15	a	a	DT
cord-005453-4057qib7	8630	16	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8630	17	conditioning	conditioning	NN
cord-005453-4057qib7	8630	18	regimen	regimen	NN
cord-005453-4057qib7	8630	19	without	without	IN
cord-005453-4057qib7	8630	20	ATG	ATG	NNP
cord-005453-4057qib7	8630	21	.	.	.
cord-005453-4057qib7	8631	1	Median	median	JJ
cord-005453-4057qib7	8631	2	time	time	NN
cord-005453-4057qib7	8631	3	to	to	IN
cord-005453-4057qib7	8631	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	8631	5	and	and	CC
cord-005453-4057qib7	8631	6	platelet	platelet	NN
cord-005453-4057qib7	8631	7	engraftment	engraftment	NN
cord-005453-4057qib7	8631	8	were	be	VBD
cord-005453-4057qib7	8631	9	24	24	CD
cord-005453-4057qib7	8632	1	(	(	-LRB-
cord-005453-4057qib7	8632	2	rang	rang	NNP
cord-005453-4057qib7	8632	3	,	,	,
cord-005453-4057qib7	8632	4	14	14	CD
cord-005453-4057qib7	8632	5	-	-	SYM
cord-005453-4057qib7	8632	6	46	46	CD
cord-005453-4057qib7	8632	7	)	)	-RRB-
cord-005453-4057qib7	8632	8	and	and	CC
cord-005453-4057qib7	8632	9	36.5	36.5	CD
cord-005453-4057qib7	8632	10	(	(	-LRB-
cord-005453-4057qib7	8632	11	rang	rang	NNP
cord-005453-4057qib7	8632	12	,	,	,
cord-005453-4057qib7	8632	13	15	15	CD
cord-005453-4057qib7	8632	14	-	-	SYM
cord-005453-4057qib7	8632	15	51	51	CD
cord-005453-4057qib7	8632	16	)	)	-RRB-
cord-005453-4057qib7	8632	17	days	day	NNS
cord-005453-4057qib7	8632	18	.	.	.
cord-005453-4057qib7	8633	1	22/39	22/39	CD
cord-005453-4057qib7	8633	2	(	(	-LRB-
cord-005453-4057qib7	8633	3	56.4	56.4	CD
cord-005453-4057qib7	8633	4	%	%	NN
cord-005453-4057qib7	8633	5	)	)	-RRB-
cord-005453-4057qib7	8633	6	patients	patient	NNS
cord-005453-4057qib7	8633	7	developed	develop	VBD
cord-005453-4057qib7	8633	8	acute	acute	JJ
cord-005453-4057qib7	8633	9	GVHD	GVHD	NNP
cord-005453-4057qib7	8633	10	,	,	,
cord-005453-4057qib7	8633	11	with	with	IN
cord-005453-4057qib7	8633	12	4/39	4/39	CD
cord-005453-4057qib7	8633	13	(	(	-LRB-
cord-005453-4057qib7	8633	14	10.3	10.3	CD
cord-005453-4057qib7	8633	15	%	%	NN
cord-005453-4057qib7	8633	16	)	)	-RRB-
cord-005453-4057qib7	8633	17	episodes	episode	NNS
cord-005453-4057qib7	8633	18	of	of	IN
cord-005453-4057qib7	8633	19	grade	grade	NN
cord-005453-4057qib7	8633	20	III	III	NNP
cord-005453-4057qib7	8633	21	-	-	HYPH
cord-005453-4057qib7	8633	22	IV	IV	NNP
cord-005453-4057qib7	8633	23	aGVHD	aGVHD	NNP
cord-005453-4057qib7	8633	24	.	.	.
cord-005453-4057qib7	8634	1	Chronic	chronic	JJ
cord-005453-4057qib7	8634	2	GVHD	GVHD	NNP
cord-005453-4057qib7	8634	3	occurred	occur	VBD
cord-005453-4057qib7	8634	4	in	in	IN
cord-005453-4057qib7	8634	5	3/29	3/29	CD
cord-005453-4057qib7	8634	6	patients	patient	NNS
cord-005453-4057qib7	8634	7	(	(	-LRB-
cord-005453-4057qib7	8634	8	10.3	10.3	CD
cord-005453-4057qib7	8634	9	%	%	NN
cord-005453-4057qib7	8634	10	)	)	-RRB-
cord-005453-4057qib7	8634	11	.	.	.
cord-005453-4057qib7	8635	1	At	at	IN
cord-005453-4057qib7	8635	2	a	a	DT
cord-005453-4057qib7	8635	3	median	median	JJ
cord-005453-4057qib7	8635	4	follow	follow	NN
cord-005453-4057qib7	8635	5	-	-	HYPH
cord-005453-4057qib7	8635	6	up	up	NN
cord-005453-4057qib7	8635	7	of	of	IN
cord-005453-4057qib7	8635	8	17	17	CD
cord-005453-4057qib7	8635	9	months	month	NNS
cord-005453-4057qib7	8635	10	(	(	-LRB-
cord-005453-4057qib7	8635	11	rang	rang	NN
cord-005453-4057qib7	8635	12	,	,	,
cord-005453-4057qib7	8635	13	1	1	CD
cord-005453-4057qib7	8635	14	to	to	TO
cord-005453-4057qib7	8635	15	44	44	CD
cord-005453-4057qib7	8635	16	months	month	NNS
cord-005453-4057qib7	8635	17	)	)	-RRB-
cord-005453-4057qib7	8635	18	,	,	,
cord-005453-4057qib7	8635	19	the	the	DT
cord-005453-4057qib7	8635	20	overall	overall	JJ
cord-005453-4057qib7	8635	21	survival	survival	NN
cord-005453-4057qib7	8635	22	rate	rate	NN
cord-005453-4057qib7	8635	23	was	be	VBD
cord-005453-4057qib7	8635	24	83.7	83.7	CD
cord-005453-4057qib7	8635	25	%	%	NN
cord-005453-4057qib7	8635	26	,	,	,
cord-005453-4057qib7	8635	27	and	and	CC
cord-005453-4057qib7	8635	28	event	event	NN
cord-005453-4057qib7	8635	29	-	-	HYPH
cord-005453-4057qib7	8635	30	free	free	JJ
cord-005453-4057qib7	8635	31	survival	survival	NN
cord-005453-4057qib7	8635	32	rate	rate	NN
cord-005453-4057qib7	8635	33	was	be	VBD
cord-005453-4057qib7	8635	34	66.7	66.7	CD
cord-005453-4057qib7	8635	35	%	%	NN
cord-005453-4057qib7	8635	36	.	.	.
cord-005453-4057qib7	8636	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8636	2	:	:	:
cord-005453-4057qib7	8637	1	Unrelated	unrelated	JJ
cord-005453-4057qib7	8637	2	UCBT	UCBT	NNS
cord-005453-4057qib7	8637	3	should	should	MD
cord-005453-4057qib7	8637	4	be	be	VB
cord-005453-4057qib7	8637	5	considered	consider	VBN
cord-005453-4057qib7	8637	6	as	as	IN
cord-005453-4057qib7	8637	7	potential	potential	JJ
cord-005453-4057qib7	8637	8	curative	curative	JJ
cord-005453-4057qib7	8637	9	methods	method	NNS
cord-005453-4057qib7	8637	10	in	in	IN
cord-005453-4057qib7	8637	11	children	child	NNS
cord-005453-4057qib7	8637	12	with	with	IN
cord-005453-4057qib7	8637	13	CGD	CGD	NNP
cord-005453-4057qib7	8637	14	.	.	.
cord-005453-4057qib7	8638	1	CGD	CGD	NNP
cord-005453-4057qib7	8638	2	patients	patient	NNS
cord-005453-4057qib7	8638	3	who	who	WP
cord-005453-4057qib7	8638	4	used	use	VBD
cord-005453-4057qib7	8638	5	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8638	6	conditioning	conditioning	NN
cord-005453-4057qib7	8638	7	regimen	regimen	NN
cord-005453-4057qib7	8638	8	with	with	IN
cord-005453-4057qib7	8638	9	ATG	ATG	NNP
cord-005453-4057qib7	8638	10	shows	show	VBZ
cord-005453-4057qib7	8638	11	better	well	JJR
cord-005453-4057qib7	8638	12	graft	graft	NN
cord-005453-4057qib7	8638	13	and	and	CC
cord-005453-4057qib7	8638	14	survival	survival	NN
cord-005453-4057qib7	8638	15	.	.	.
cord-005453-4057qib7	8639	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8639	2	:	:	:
cord-005453-4057qib7	8639	3	Nothing	nothing	NN
cord-005453-4057qib7	8639	4	to	to	TO
cord-005453-4057qib7	8639	5	declare	declare	VB
cord-005453-4057qib7	8639	6	Background	background	NN
cord-005453-4057qib7	8639	7	:	:	:
cord-005453-4057qib7	8639	8	Invasive	invasive	JJ
cord-005453-4057qib7	8639	9	fungal	fungal	JJ
cord-005453-4057qib7	8639	10	infections	infection	NNS
cord-005453-4057qib7	8639	11	(	(	-LRB-
cord-005453-4057qib7	8639	12	IFI	IFI	NNP
cord-005453-4057qib7	8639	13	)	)	-RRB-
cord-005453-4057qib7	8639	14	remain	remain	VBP
cord-005453-4057qib7	8639	15	a	a	DT
cord-005453-4057qib7	8639	16	major	major	JJ
cord-005453-4057qib7	8639	17	cause	cause	NN
cord-005453-4057qib7	8639	18	of	of	IN
cord-005453-4057qib7	8639	19	treatment	treatment	NN
cord-005453-4057qib7	8639	20	-	-	HYPH
cord-005453-4057qib7	8639	21	related	relate	VBN
cord-005453-4057qib7	8639	22	morbidity	morbidity	NN
cord-005453-4057qib7	8639	23	and	and	CC
cord-005453-4057qib7	8639	24	mortality	mortality	NN
cord-005453-4057qib7	8639	25	in	in	IN
cord-005453-4057qib7	8639	26	AML	AML	NNP
cord-005453-4057qib7	8639	27	patients	patient	NNS
cord-005453-4057qib7	8639	28	.	.	.
cord-005453-4057qib7	8640	1	Although	although	IN
cord-005453-4057qib7	8640	2	not	not	RB
cord-005453-4057qib7	8640	3	uncommon	uncommon	JJ
cord-005453-4057qib7	8640	4	,	,	,
cord-005453-4057qib7	8640	5	the	the	DT
cord-005453-4057qib7	8640	6	presentation	presentation	NN
cord-005453-4057qib7	8640	7	of	of	IN
cord-005453-4057qib7	8640	8	unusually	unusually	RB
cord-005453-4057qib7	8640	9	severe	severe	JJ
cord-005453-4057qib7	8640	10	clinical	clinical	JJ
cord-005453-4057qib7	8640	11	features	feature	NNS
cord-005453-4057qib7	8640	12	might	may	MD
cord-005453-4057qib7	8640	13	be	be	VB
cord-005453-4057qib7	8640	14	indicative	indicative	JJ
cord-005453-4057qib7	8640	15	for	for	IN
cord-005453-4057qib7	8640	16	an	an	DT
cord-005453-4057qib7	8640	17	underlying	underlie	VBG
cord-005453-4057qib7	8640	18	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8640	19	.	.	.
cord-005453-4057qib7	8641	1	Caspase	Caspase	NNP
cord-005453-4057qib7	8641	2	-	-	HYPH
cord-005453-4057qib7	8641	3	associated	associate	VBN
cord-005453-4057qib7	8641	4	recruitment	recruitment	NN
cord-005453-4057qib7	8641	5	domain	domain	NN
cord-005453-4057qib7	8641	6	9	9	CD
cord-005453-4057qib7	8641	7	(	(	-LRB-
cord-005453-4057qib7	8641	8	CARD9	CARD9	NNP
cord-005453-4057qib7	8641	9	)	)	-RRB-
cord-005453-4057qib7	8641	10	is	be	VBZ
cord-005453-4057qib7	8641	11	recognized	recognize	VBN
cord-005453-4057qib7	8641	12	to	to	TO
cord-005453-4057qib7	8641	13	have	have	VB
cord-005453-4057qib7	8641	14	a	a	DT
cord-005453-4057qib7	8641	15	crucial	crucial	JJ
cord-005453-4057qib7	8641	16	role	role	NN
cord-005453-4057qib7	8641	17	in	in	IN
cord-005453-4057qib7	8641	18	effective	effective	JJ
cord-005453-4057qib7	8641	19	antifungal	antifungal	JJ
cord-005453-4057qib7	8641	20	response	response	NN
cord-005453-4057qib7	8641	21	,	,	,
cord-005453-4057qib7	8641	22	leading	lead	VBG
cord-005453-4057qib7	8641	23	to	to	IN
cord-005453-4057qib7	8641	24	Th1	th1	CD
cord-005453-4057qib7	8641	25	and	and	CC
cord-005453-4057qib7	8641	26	Th17	th17	CD
cord-005453-4057qib7	8641	27	differentiation	differentiation	NN
cord-005453-4057qib7	8641	28	and	and	CC
cord-005453-4057qib7	8641	29	to	to	IN
cord-005453-4057qib7	8641	30	the	the	DT
cord-005453-4057qib7	8641	31	initiation	initiation	NN
cord-005453-4057qib7	8641	32	of	of	IN
cord-005453-4057qib7	8641	33	the	the	DT
cord-005453-4057qib7	8641	34	inflammatory	inflammatory	JJ
cord-005453-4057qib7	8641	35	cytokine	cytokine	NN
cord-005453-4057qib7	8641	36	cascade	cascade	NN
cord-005453-4057qib7	8641	37	.	.	.
cord-005453-4057qib7	8642	1	Particularly	particularly	RB
cord-005453-4057qib7	8642	2	interferon	interferon	NN
cord-005453-4057qib7	8642	3	-	-	HYPH
cord-005453-4057qib7	8642	4	gamma	gamma	NN
cord-005453-4057qib7	8642	5	(	(	-LRB-
cord-005453-4057qib7	8642	6	IFNg	IFNg	NNP
cord-005453-4057qib7	8642	7	)	)	-RRB-
cord-005453-4057qib7	8642	8	increases	increase	VBZ
cord-005453-4057qib7	8642	9	macrophage	macrophage	NN
cord-005453-4057qib7	8642	10	activity	activity	NN
cord-005453-4057qib7	8642	11	.	.	.
cord-005453-4057qib7	8643	1	Patients	patient	NNS
cord-005453-4057qib7	8643	2	with	with	IN
cord-005453-4057qib7	8643	3	homozygous	homozygous	JJ
cord-005453-4057qib7	8643	4	CARD9	CARD9	NNS
cord-005453-4057qib7	8643	5	mutations	mutation	NNS
cord-005453-4057qib7	8643	6	are	be	VBP
cord-005453-4057qib7	8643	7	known	know	VBN
cord-005453-4057qib7	8643	8	to	to	TO
cord-005453-4057qib7	8643	9	have	have	VB
cord-005453-4057qib7	8643	10	a	a	DT
cord-005453-4057qib7	8643	11	significantly	significantly	RB
cord-005453-4057qib7	8643	12	increased	increase	VBN
cord-005453-4057qib7	8643	13	susceptibility	susceptibility	NN
cord-005453-4057qib7	8643	14	to	to	IN
cord-005453-4057qib7	8643	15	life	life	NN
cord-005453-4057qib7	8643	16	-	-	HYPH
cord-005453-4057qib7	8643	17	threatening	threaten	VBG
cord-005453-4057qib7	8643	18	systemic	systemic	JJ
cord-005453-4057qib7	8643	19	candidiasis	candidiasi	NNS
cord-005453-4057qib7	8643	20	.	.	.
cord-005453-4057qib7	8644	1	However	however	RB
cord-005453-4057qib7	8644	2	,	,	,
cord-005453-4057qib7	8644	3	some	some	DT
cord-005453-4057qib7	8644	4	sequence	sequence	NN
cord-005453-4057qib7	8644	5	variants	variant	NNS
cord-005453-4057qib7	8644	6	may	may	MD
cord-005453-4057qib7	8644	7	lead	lead	VB
cord-005453-4057qib7	8644	8	to	to	IN
cord-005453-4057qib7	8644	9	increased	increase	VBN
cord-005453-4057qib7	8644	10	IFI	IFI	NNP
cord-005453-4057qib7	8644	11	-	-	HYPH
cord-005453-4057qib7	8644	12	susceptibility	susceptibility	NN
cord-005453-4057qib7	8644	13	even	even	RB
cord-005453-4057qib7	8644	14	in	in	IN
cord-005453-4057qib7	8644	15	heterozygosity	heterozygosity	NN
cord-005453-4057qib7	8644	16	,	,	,
cord-005453-4057qib7	8644	17	e.g.	e.g.	RB
cord-005453-4057qib7	8644	18	under	under	IN
cord-005453-4057qib7	8644	19	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	8644	20	.	.	.
cord-005453-4057qib7	8645	1	IFN	IFN	NNP
cord-005453-4057qib7	8645	2	-	-	HYPH
cord-005453-4057qib7	8645	3	γ	γ	NNP
cord-005453-4057qib7	8645	4	has	have	VBZ
cord-005453-4057qib7	8645	5	been	be	VBN
cord-005453-4057qib7	8645	6	described	describe	VBN
cord-005453-4057qib7	8645	7	as	as	IN
cord-005453-4057qib7	8645	8	an	an	DT
cord-005453-4057qib7	8645	9	additive	additive	NN
cord-005453-4057qib7	8645	10	treatment	treatment	NN
cord-005453-4057qib7	8645	11	option	option	NN
cord-005453-4057qib7	8645	12	because	because	IN
cord-005453-4057qib7	8645	13	of	of	IN
cord-005453-4057qib7	8645	14	its	-PRON-	PRP$
cord-005453-4057qib7	8645	15	immune	immune	JJ
cord-005453-4057qib7	8645	16	stimulating	stimulating	JJ
cord-005453-4057qib7	8645	17	effect	effect	NN
cord-005453-4057qib7	8645	18	on	on	IN
cord-005453-4057qib7	8645	19	the	the	DT
cord-005453-4057qib7	8645	20	leukocyte	leukocyte	NN
cord-005453-4057qib7	8645	21	immune	immune	JJ
cord-005453-4057qib7	8645	22	response	response	NN
cord-005453-4057qib7	8645	23	in	in	IN
cord-005453-4057qib7	8645	24	a	a	DT
cord-005453-4057qib7	8645	25	situation	situation	NN
cord-005453-4057qib7	8645	26	of	of	IN
cord-005453-4057qib7	8645	27	immunological	immunological	JJ
cord-005453-4057qib7	8645	28	"	"	``
cord-005453-4057qib7	8645	29	blindness	blindness	NN
cord-005453-4057qib7	8645	30	"	"	''
cord-005453-4057qib7	8645	31	.	.	.
cord-005453-4057qib7	8646	1	Methods	method	NNS
cord-005453-4057qib7	8646	2	:	:	:
cord-005453-4057qib7	8646	3	Here	here	RB
cord-005453-4057qib7	8646	4	,	,	,
cord-005453-4057qib7	8646	5	we	-PRON-	PRP
cord-005453-4057qib7	8646	6	report	report	VBP
cord-005453-4057qib7	8646	7	the	the	DT
cord-005453-4057qib7	8646	8	case	case	NN
cord-005453-4057qib7	8646	9	of	of	IN
cord-005453-4057qib7	8646	10	an	an	DT
cord-005453-4057qib7	8646	11	11-year	11-year	JJ
cord-005453-4057qib7	8646	12	old	old	JJ
cord-005453-4057qib7	8646	13	male	male	NN
cord-005453-4057qib7	8646	14	with	with	IN
cord-005453-4057qib7	8646	15	AML	AML	NNP
cord-005453-4057qib7	8646	16	M6	M6	NNP
cord-005453-4057qib7	8646	17	with	with	IN
cord-005453-4057qib7	8646	18	a	a	DT
cord-005453-4057qib7	8646	19	severe	severe	JJ
cord-005453-4057qib7	8646	20	systemic	systemic	JJ
cord-005453-4057qib7	8646	21	candida	candida	NN
cord-005453-4057qib7	8646	22	tropicalis	tropicalis	NNP
cord-005453-4057qib7	8646	23	infection	infection	NN
cord-005453-4057qib7	8646	24	,	,	,
cord-005453-4057qib7	8646	25	unresponsive	unresponsive	JJ
cord-005453-4057qib7	8646	26	to	to	IN
cord-005453-4057qib7	8646	27	triple	triple	JJ
cord-005453-4057qib7	8646	28	-	-	HYPH
cord-005453-4057qib7	8646	29	antimycotic	antimycotic	JJ
cord-005453-4057qib7	8646	30	regimen	regimen	NN
cord-005453-4057qib7	8646	31	,	,	,
cord-005453-4057qib7	8646	32	leading	lead	VBG
cord-005453-4057qib7	8646	33	to	to	IN
cord-005453-4057qib7	8646	34	multi	multi	JJ
cord-005453-4057qib7	8646	35	-	-	JJ
cord-005453-4057qib7	8646	36	organ	organ	JJ
cord-005453-4057qib7	8646	37	failure	failure	NN
cord-005453-4057qib7	8646	38	.	.	.
cord-005453-4057qib7	8647	1	He	-PRON-	PRP
cord-005453-4057qib7	8647	2	was	be	VBD
cord-005453-4057qib7	8647	3	discovered	discover	VBN
cord-005453-4057qib7	8647	4	to	to	TO
cord-005453-4057qib7	8647	5	bear	bear	VB
cord-005453-4057qib7	8647	6	a	a	DT
cord-005453-4057qib7	8647	7	heterozygous	heterozygous	JJ
cord-005453-4057qib7	8647	8	CARD9	CARD9	NNP
cord-005453-4057qib7	8647	9	mutation	mutation	NN
cord-005453-4057qib7	8647	10	,	,	,
cord-005453-4057qib7	8647	11	and	and	CC
cord-005453-4057qib7	8647	12	IFN	IFN	NNP
cord-005453-4057qib7	8647	13	-	-	HYPH
cord-005453-4057qib7	8647	14	γ	γ	NNP
cord-005453-4057qib7	8647	15	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	8647	16	leaded	lead	VBN
cord-005453-4057qib7	8647	17	to	to	TO
cord-005453-4057qib7	8647	18	complete	complete	VB
cord-005453-4057qib7	8647	19	response	response	NN
cord-005453-4057qib7	8647	20	of	of	IN
cord-005453-4057qib7	8647	21	all	all	DT
cord-005453-4057qib7	8647	22	disseminated	disseminate	VBN
cord-005453-4057qib7	8647	23	infections	infection	NNS
cord-005453-4057qib7	8647	24	.	.	.
cord-005453-4057qib7	8648	1	Results	result	NNS
cord-005453-4057qib7	8648	2	:	:	:
cord-005453-4057qib7	8649	1	The	the	DT
cord-005453-4057qib7	8649	2	patient	patient	NN
cord-005453-4057qib7	8649	3	developed	develop	VBD
cord-005453-4057qib7	8649	4	septic	septic	JJ
cord-005453-4057qib7	8649	5	fever	fever	NN
cord-005453-4057qib7	8649	6	immediately	immediately	RB
cord-005453-4057qib7	8649	7	after	after	IN
cord-005453-4057qib7	8649	8	the	the	DT
cord-005453-4057qib7	8649	9	first	first	JJ
cord-005453-4057qib7	8649	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8649	11	cycle	cycle	NN
cord-005453-4057qib7	8649	12	.	.	.
cord-005453-4057qib7	8650	1	Unexpectedly	unexpectedly	RB
cord-005453-4057qib7	8650	2	,	,	,
cord-005453-4057qib7	8650	3	candida	candida	NNP
cord-005453-4057qib7	8650	4	tropicalis	tropicalis	NNP
cord-005453-4057qib7	8650	5	was	be	VBD
cord-005453-4057qib7	8650	6	confirmed	confirm	VBN
cord-005453-4057qib7	8650	7	in	in	IN
cord-005453-4057qib7	8650	8	the	the	DT
cord-005453-4057qib7	8650	9	blood	blood	NN
cord-005453-4057qib7	8650	10	culture	culture	NN
cord-005453-4057qib7	8650	11	within	within	IN
cord-005453-4057qib7	8650	12	24	24	CD
cord-005453-4057qib7	8650	13	hours	hour	NNS
cord-005453-4057qib7	8650	14	.	.	.
cord-005453-4057qib7	8651	1	Liposomal	Liposomal	NNP
cord-005453-4057qib7	8651	2	amphotericin	amphotericin	NNS
cord-005453-4057qib7	8651	3	B	b	NN
cord-005453-4057qib7	8651	4	(	(	-LRB-
cord-005453-4057qib7	8651	5	Ambisome	Ambisome	NNP
cord-005453-4057qib7	8651	6	®	®	NNP
cord-005453-4057qib7	8651	7	)	)	-RRB-
cord-005453-4057qib7	8651	8	was	be	VBD
cord-005453-4057qib7	8651	9	started	start	VBN
cord-005453-4057qib7	8651	10	immediately	immediately	RB
cord-005453-4057qib7	8651	11	,	,	,
cord-005453-4057qib7	8651	12	however	however	RB
cord-005453-4057qib7	8651	13	candida	candida	NNP
cord-005453-4057qib7	8651	14	rapidly	rapidly	RB
cord-005453-4057qib7	8651	15	disseminated	disseminate	VBN
cord-005453-4057qib7	8651	16	to	to	IN
cord-005453-4057qib7	8651	17	lungs	lung	NNS
cord-005453-4057qib7	8651	18	,	,	,
cord-005453-4057qib7	8651	19	liver	liver	NN
cord-005453-4057qib7	8651	20	,	,	,
cord-005453-4057qib7	8651	21	spleen	spleen	NNS
cord-005453-4057qib7	8651	22	,	,	,
cord-005453-4057qib7	8651	23	kidneys	kidney	NNS
cord-005453-4057qib7	8651	24	and	and	CC
cord-005453-4057qib7	8651	25	CNS	CNS	NNP
cord-005453-4057qib7	8651	26	despite	despite	IN
cord-005453-4057qib7	8651	27	extended	extend	VBN
cord-005453-4057qib7	8651	28	antimycotic	antimycotic	JJ
cord-005453-4057qib7	8651	29	therapy	therapy	NN
cord-005453-4057qib7	8651	30	with	with	IN
cord-005453-4057qib7	8651	31	caspofungin	caspofungin	NNP
cord-005453-4057qib7	8651	32	,	,	,
cord-005453-4057qib7	8651	33	voriconazole	voriconazole	NNP
cord-005453-4057qib7	8651	34	and	and	CC
cord-005453-4057qib7	8651	35	fluconazole	fluconazole	NN
cord-005453-4057qib7	8651	36	.	.	.
cord-005453-4057qib7	8652	1	The	the	DT
cord-005453-4057qib7	8652	2	patient	patient	NN
cord-005453-4057qib7	8652	3	was	be	VBD
cord-005453-4057qib7	8652	4	splenectomized	splenectomize	VBN
cord-005453-4057qib7	8652	5	due	due	IN
cord-005453-4057qib7	8652	6	to	to	IN
cord-005453-4057qib7	8652	7	massive	massive	JJ
cord-005453-4057qib7	8652	8	infiltration	infiltration	NN
cord-005453-4057qib7	8652	9	(	(	-LRB-
cord-005453-4057qib7	8652	10	Figure	figure	NN
cord-005453-4057qib7	8652	11	1	1	CD
cord-005453-4057qib7	8652	12	)	)	-RRB-
cord-005453-4057qib7	8652	13	.	.	.
cord-005453-4057qib7	8653	1	Genetic	genetic	JJ
cord-005453-4057qib7	8653	2	testing	testing	NN
cord-005453-4057qib7	8653	3	for	for	IN
cord-005453-4057qib7	8653	4	mycosis	mycosis	NNP
cord-005453-4057qib7	8653	5	predisposition	predisposition	NN
cord-005453-4057qib7	8653	6	revealed	reveal	VBD
cord-005453-4057qib7	8653	7	a	a	DT
cord-005453-4057qib7	8653	8	heterozygous	heterozygous	JJ
cord-005453-4057qib7	8653	9	mutation	mutation	NN
cord-005453-4057qib7	8653	10	in	in	IN
cord-005453-4057qib7	8653	11	the	the	DT
cord-005453-4057qib7	8653	12	CARD9	CARD9	NNP
cord-005453-4057qib7	8653	13	gene	gene	NN
cord-005453-4057qib7	8653	14	,	,	,
cord-005453-4057qib7	8653	15	inherited	inherit	VBN
cord-005453-4057qib7	8653	16	from	from	IN
cord-005453-4057qib7	8653	17	the	the	DT
cord-005453-4057qib7	8653	18	father	father	NN
cord-005453-4057qib7	8653	19	(	(	-LRB-
cord-005453-4057qib7	8653	20	c.809a	c.809a	XX
cord-005453-4057qib7	8654	1	>	>	XX
cord-005453-4057qib7	8655	1	T(p	t(p	UH
cord-005453-4057qib7	8655	2	.	.	.
cord-005453-4057qib7	8655	3	Glu270Val	Glu270Val	NNP
cord-005453-4057qib7	8655	4	)	)	-RRB-
cord-005453-4057qib7	8655	5	)	)	-RRB-
cord-005453-4057qib7	8655	6	.	.	.
cord-005453-4057qib7	8656	1	IFN	IFN	NNP
cord-005453-4057qib7	8656	2	-	-	HYPH
cord-005453-4057qib7	8656	3	γ	γ	NN
cord-005453-4057qib7	8656	4	treatment	treatment	NN
cord-005453-4057qib7	8656	5	was	be	VBD
cord-005453-4057qib7	8656	6	started	start	VBN
cord-005453-4057qib7	8656	7	(	(	-LRB-
cord-005453-4057qib7	8656	8	100	100	CD
cord-005453-4057qib7	8656	9	μg	μg	NNP
cord-005453-4057qib7	8656	10	subcutaneously	subcutaneously	RB
cord-005453-4057qib7	8656	11	,	,	,
cord-005453-4057qib7	8656	12	3	3	CD
cord-005453-4057qib7	8656	13	times	time	NNS
cord-005453-4057qib7	8656	14	per	per	IN
cord-005453-4057qib7	8656	15	week	week	NN
cord-005453-4057qib7	8656	16	)	)	-RRB-
cord-005453-4057qib7	8656	17	,	,	,
cord-005453-4057qib7	8656	18	leading	lead	VBG
cord-005453-4057qib7	8656	19	to	to	IN
cord-005453-4057qib7	8656	20	an	an	DT
cord-005453-4057qib7	8656	21	almost	almost	RB
cord-005453-4057qib7	8656	22	complete	complete	JJ
cord-005453-4057qib7	8656	23	response	response	NN
cord-005453-4057qib7	8656	24	of	of	IN
cord-005453-4057qib7	8656	25	disseminated	disseminate	VBN
cord-005453-4057qib7	8656	26	infections	infection	NNS
cord-005453-4057qib7	8656	27	.	.	.
cord-005453-4057qib7	8657	1	Due	due	IN
cord-005453-4057qib7	8657	2	to	to	IN
cord-005453-4057qib7	8657	3	the	the	DT
cord-005453-4057qib7	8657	4	severe	severe	JJ
cord-005453-4057qib7	8657	5	infection	infection	NN
cord-005453-4057qib7	8657	6	,	,	,
cord-005453-4057qib7	8657	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8657	8	had	have	VBD
cord-005453-4057qib7	8657	9	to	to	TO
cord-005453-4057qib7	8657	10	be	be	VB
cord-005453-4057qib7	8657	11	interrupted	interrupt	VBN
cord-005453-4057qib7	8657	12	after	after	IN
cord-005453-4057qib7	8657	13	one	one	CD
cord-005453-4057qib7	8657	14	course	course	NN
cord-005453-4057qib7	8657	15	.	.	.
cord-005453-4057qib7	8658	1	However	however	RB
cord-005453-4057qib7	8658	2	,	,	,
cord-005453-4057qib7	8658	3	bone	bone	NN
cord-005453-4057qib7	8658	4	marrow	marrow	NN
cord-005453-4057qib7	8658	5	remained	remain	VBD
cord-005453-4057qib7	8658	6	in	in	IN
cord-005453-4057qib7	8658	7	complete	complete	JJ
cord-005453-4057qib7	8658	8	remission	remission	NN
cord-005453-4057qib7	8658	9	for	for	IN
cord-005453-4057qib7	8658	10	almost	almost	RB
cord-005453-4057qib7	8658	11	one	one	CD
cord-005453-4057qib7	8658	12	year	year	NN
cord-005453-4057qib7	8658	13	.	.	.
cord-005453-4057qib7	8659	1	The	the	DT
cord-005453-4057qib7	8659	2	patient	patient	NN
cord-005453-4057qib7	8659	3	experienced	experience	VBD
cord-005453-4057qib7	8659	4	altogether	altogether	RB
cord-005453-4057qib7	8659	5	two	two	CD
cord-005453-4057qib7	8659	6	relapses	relapse	NNS
cord-005453-4057qib7	8659	7	requiring	require	VBG
cord-005453-4057qib7	8659	8	an	an	DT
cord-005453-4057qib7	8659	9	unrelated	unrelated	JJ
cord-005453-4057qib7	8659	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	8659	11	and	and	CC
cord-005453-4057qib7	8659	12	a	a	DT
cord-005453-4057qib7	8659	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8659	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8659	15	.	.	.
cord-005453-4057qib7	8660	1	Under	under	IN
cord-005453-4057qib7	8660	2	combined	combine	VBN
cord-005453-4057qib7	8660	3	IFN	IFN	NNP
cord-005453-4057qib7	8660	4	-	-	HYPH
cord-005453-4057qib7	8660	5	γ	γ	NNP
cord-005453-4057qib7	8660	6	and	and	CC
cord-005453-4057qib7	8660	7	ambisome/	ambisome/	NNP
cord-005453-4057qib7	8660	8	fluconazole	fluconazole	NN
cord-005453-4057qib7	8660	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8661	1	no	no	DT
cord-005453-4057qib7	8661	2	further	further	JJ
cord-005453-4057qib7	8661	3	mycosis	mycosis	NNP
cord-005453-4057qib7	8661	4	was	be	VBD
cord-005453-4057qib7	8661	5	observed	observe	VBN
cord-005453-4057qib7	8661	6	despite	despite	IN
cord-005453-4057qib7	8661	7	extensive	extensive	JJ
cord-005453-4057qib7	8661	8	and	and	CC
cord-005453-4057qib7	8661	9	prolonged	prolonged	JJ
cord-005453-4057qib7	8661	10	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	8661	11	.	.	.
cord-005453-4057qib7	8662	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8662	2	:	:	:
cord-005453-4057qib7	8663	1	IFI	IFI	NNP
cord-005453-4057qib7	8663	2	in	in	IN
cord-005453-4057qib7	8663	3	AML	AML	NNP
cord-005453-4057qib7	8663	4	patients	patient	NNS
cord-005453-4057qib7	8663	5	are	be	VBP
cord-005453-4057qib7	8663	6	common	common	JJ
cord-005453-4057qib7	8663	7	,	,	,
cord-005453-4057qib7	8663	8	however	however	RB
cord-005453-4057qib7	8663	9	an	an	DT
cord-005453-4057qib7	8663	10	unusual	unusual	JJ
cord-005453-4057qib7	8663	11	presentation	presentation	NN
cord-005453-4057qib7	8663	12	in	in	IN
cord-005453-4057qib7	8663	13	presumably	presumably	RB
cord-005453-4057qib7	8663	14	immune	immune	JJ
cord-005453-4057qib7	8663	15	competent	competent	JJ
cord-005453-4057qib7	8663	16	individuals	individual	NNS
cord-005453-4057qib7	8663	17	should	should	MD
cord-005453-4057qib7	8663	18	raise	raise	VB
cord-005453-4057qib7	8663	19	the	the	DT
cord-005453-4057qib7	8663	20	suspicion	suspicion	NN
cord-005453-4057qib7	8663	21	for	for	IN
cord-005453-4057qib7	8663	22	immunodeficiencies	immunodeficiency	NNS
cord-005453-4057qib7	8663	23	.	.	.
cord-005453-4057qib7	8664	1	In	in	IN
cord-005453-4057qib7	8664	2	our	-PRON-	PRP$
cord-005453-4057qib7	8664	3	case	case	NN
cord-005453-4057qib7	8664	4	,	,	,
cord-005453-4057qib7	8664	5	an	an	DT
cord-005453-4057qib7	8664	6	unexpected	unexpected	JJ
cord-005453-4057qib7	8664	7	early	early	JJ
cord-005453-4057qib7	8664	8	candida	candida	NN
cord-005453-4057qib7	8664	9	-	-	HYPH
cord-005453-4057qib7	8664	10	sepsis	sepsis	NN
cord-005453-4057qib7	8664	11	was	be	VBD
cord-005453-4057qib7	8664	12	completely	completely	RB
cord-005453-4057qib7	8664	13	unresponsive	unresponsive	JJ
cord-005453-4057qib7	8664	14	to	to	IN
cord-005453-4057qib7	8664	15	an	an	DT
cord-005453-4057qib7	8664	16	adequate	adequate	JJ
cord-005453-4057qib7	8664	17	multi	multi	JJ
cord-005453-4057qib7	8664	18	-	-	JJ
cord-005453-4057qib7	8664	19	agent	agent	JJ
cord-005453-4057qib7	8664	20	treatment	treatment	NN
cord-005453-4057qib7	8664	21	.	.	.
cord-005453-4057qib7	8665	1	While	while	IN
cord-005453-4057qib7	8665	2	IFN	IFN	NNP
cord-005453-4057qib7	8665	3	-	-	HYPH
cord-005453-4057qib7	8665	4	γ	γ	NNP
cord-005453-4057qib7	8665	5	is	be	VBZ
cord-005453-4057qib7	8665	6	used	use	VBN
cord-005453-4057qib7	8665	7	in	in	IN
cord-005453-4057qib7	8665	8	adults	adult	NNS
cord-005453-4057qib7	8665	9	as	as	IN
cord-005453-4057qib7	8665	10	an	an	DT
cord-005453-4057qib7	8665	11	immune	immune	JJ
cord-005453-4057qib7	8665	12	stimulatory	stimulatory	JJ
cord-005453-4057qib7	8665	13	cytokine	cytokine	NN
cord-005453-4057qib7	8665	14	,	,	,
cord-005453-4057qib7	8665	15	little	little	JJ
cord-005453-4057qib7	8665	16	data	datum	NNS
cord-005453-4057qib7	8665	17	are	be	VBP
cord-005453-4057qib7	8665	18	available	available	JJ
cord-005453-4057qib7	8665	19	for	for	IN
cord-005453-4057qib7	8665	20	children	child	NNS
cord-005453-4057qib7	8665	21	.	.	.
cord-005453-4057qib7	8666	1	To	to	IN
cord-005453-4057qib7	8666	2	our	-PRON-	PRP$
cord-005453-4057qib7	8666	3	knowledge	knowledge	NN
cord-005453-4057qib7	8666	4	,	,	,
cord-005453-4057qib7	8666	5	this	this	DT
cord-005453-4057qib7	8666	6	is	be	VBZ
cord-005453-4057qib7	8666	7	the	the	DT
cord-005453-4057qib7	8666	8	first	first	JJ
cord-005453-4057qib7	8666	9	case	case	NN
cord-005453-4057qib7	8666	10	of	of	IN
cord-005453-4057qib7	8666	11	successful	successful	JJ
cord-005453-4057qib7	8666	12	IFN	IFN	NNP
cord-005453-4057qib7	8666	13	-	-	HYPH
cord-005453-4057qib7	8666	14	γ	γ	NN
cord-005453-4057qib7	8666	15	treatment	treatment	NN
cord-005453-4057qib7	8666	16	of	of	IN
cord-005453-4057qib7	8666	17	a	a	DT
cord-005453-4057qib7	8666	18	pediatric	pediatric	JJ
cord-005453-4057qib7	8666	19	AML	AML	NNP
cord-005453-4057qib7	8666	20	patient	patient	NN
cord-005453-4057qib7	8666	21	with	with	IN
cord-005453-4057qib7	8666	22	disseminated	disseminate	VBN
cord-005453-4057qib7	8666	23	candida	candida	NN
cord-005453-4057qib7	8666	24	sepsis	sepsis	NN
cord-005453-4057qib7	8666	25	,	,	,
cord-005453-4057qib7	8666	26	bearing	bear	VBG
cord-005453-4057qib7	8666	27	a	a	DT
cord-005453-4057qib7	8666	28	CARD9	CARD9	NNP
cord-005453-4057qib7	8666	29	mutation	mutation	NN
cord-005453-4057qib7	8666	30	.	.	.
cord-005453-4057qib7	8667	1	Given	give	VBN
cord-005453-4057qib7	8667	2	the	the	DT
cord-005453-4057qib7	8667	3	elevated	elevated	JJ
cord-005453-4057qib7	8667	4	mortality	mortality	NN
cord-005453-4057qib7	8667	5	risk	risk	NN
cord-005453-4057qib7	8667	6	for	for	IN
cord-005453-4057qib7	8667	7	IFI	IFI	NNP
cord-005453-4057qib7	8667	8	,	,	,
cord-005453-4057qib7	8667	9	and	and	CC
cord-005453-4057qib7	8667	10	the	the	DT
cord-005453-4057qib7	8667	11	apparently	apparently	RB
cord-005453-4057qib7	8667	12	safe	safe	JJ
cord-005453-4057qib7	8667	13	and	and	CC
cord-005453-4057qib7	8667	14	well	well	RB
cord-005453-4057qib7	8667	15	-	-	HYPH
cord-005453-4057qib7	8667	16	tolerated	tolerate	VBN
cord-005453-4057qib7	8667	17	application	application	NN
cord-005453-4057qib7	8667	18	of	of	IN
cord-005453-4057qib7	8667	19	IFN	IFN	NNP
cord-005453-4057qib7	8667	20	-	-	HYPH
cord-005453-4057qib7	8667	21	γ	γ	NNP
cord-005453-4057qib7	8667	22	,	,	,
cord-005453-4057qib7	8667	23	an	an	DT
cord-005453-4057qib7	8667	24	adjuvant	adjuvant	NN
cord-005453-4057qib7	8667	25	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	8667	26	might	may	MD
cord-005453-4057qib7	8667	27	be	be	VB
cord-005453-4057qib7	8667	28	considered	consider	VBN
cord-005453-4057qib7	8667	29	.	.	.
cord-005453-4057qib7	8668	1	Further	further	JJ
cord-005453-4057qib7	8668	2	studies	study	NNS
cord-005453-4057qib7	8668	3	are	be	VBP
cord-005453-4057qib7	8668	4	needed	need	VBN
cord-005453-4057qib7	8668	5	to	to	TO
cord-005453-4057qib7	8668	6	define	define	VB
cord-005453-4057qib7	8668	7	the	the	DT
cord-005453-4057qib7	8668	8	indication	indication	NN
cord-005453-4057qib7	8668	9	and	and	CC
cord-005453-4057qib7	8668	10	duration	duration	NN
cord-005453-4057qib7	8668	11	of	of	IN
cord-005453-4057qib7	8668	12	this	this	DT
cord-005453-4057qib7	8668	13	kind	kind	NN
cord-005453-4057qib7	8668	14	of	of	IN
cord-005453-4057qib7	8668	15	adjunctive	adjunctive	JJ
cord-005453-4057qib7	8668	16	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	8668	17	.	.	.
cord-005453-4057qib7	8669	1	Moreover	moreover	RB
cord-005453-4057qib7	8669	2	,	,	,
cord-005453-4057qib7	8669	3	considering	consider	VBG
cord-005453-4057qib7	8669	4	the	the	DT
cord-005453-4057qib7	8669	5	wide	wide	JJ
cord-005453-4057qib7	8669	6	heterogeneity	heterogeneity	NN
cord-005453-4057qib7	8669	7	of	of	IN
cord-005453-4057qib7	8669	8	genetic	genetic	JJ
cord-005453-4057qib7	8669	9	mutations	mutation	NNS
cord-005453-4057qib7	8669	10	involved	involve	VBN
cord-005453-4057qib7	8669	11	in	in	IN
cord-005453-4057qib7	8669	12	IFI	IFI	NNP
cord-005453-4057qib7	8669	13	-	-	HYPH
cord-005453-4057qib7	8669	14	susceptibility	susceptibility	NN
cord-005453-4057qib7	8669	15	,	,	,
cord-005453-4057qib7	8669	16	genome	genome	NN
cord-005453-4057qib7	8669	17	-	-	HYPH
cord-005453-4057qib7	8669	18	wide	wide	JJ
cord-005453-4057qib7	8669	19	expression	expression	NN
cord-005453-4057qib7	8669	20	profiling	profiling	NN
cord-005453-4057qib7	8669	21	might	may	MD
cord-005453-4057qib7	8669	22	be	be	VB
cord-005453-4057qib7	8669	23	useful	useful	JJ
cord-005453-4057qib7	8669	24	for	for	IN
cord-005453-4057qib7	8669	25	pediatric	pediatric	JJ
cord-005453-4057qib7	8669	26	cancer	cancer	NN
cord-005453-4057qib7	8669	27	patients	patient	NNS
cord-005453-4057qib7	8669	28	,	,	,
cord-005453-4057qib7	8669	29	as	as	IN
cord-005453-4057qib7	8669	30	the	the	DT
cord-005453-4057qib7	8669	31	identification	identification	NN
cord-005453-4057qib7	8669	32	of	of	IN
cord-005453-4057qib7	8669	33	specific	specific	JJ
cord-005453-4057qib7	8669	34	immune	immune	JJ
cord-005453-4057qib7	8669	35	pathways	pathway	NNS
cord-005453-4057qib7	8669	36	might	may	MD
cord-005453-4057qib7	8669	37	help	help	VB
cord-005453-4057qib7	8669	38	to	to	TO
cord-005453-4057qib7	8669	39	identify	identify	VB
cord-005453-4057qib7	8669	40	individual	individual	JJ
cord-005453-4057qib7	8669	41	IFIsusceptibility	ifisusceptibility	NN
cord-005453-4057qib7	8669	42	in	in	IN
cord-005453-4057qib7	8669	43	order	order	NN
cord-005453-4057qib7	8669	44	to	to	TO
cord-005453-4057qib7	8669	45	improve	improve	VB
cord-005453-4057qib7	8669	46	the	the	DT
cord-005453-4057qib7	8669	47	outcome	outcome	NN
cord-005453-4057qib7	8669	48	of	of	IN
cord-005453-4057qib7	8669	49	those	those	DT
cord-005453-4057qib7	8669	50	high	high	JJ
cord-005453-4057qib7	8669	51	-	-	HYPH
cord-005453-4057qib7	8669	52	risk	risk	NN
cord-005453-4057qib7	8669	53	patients	patient	NNS
cord-005453-4057qib7	8669	54	.	.	.
cord-005453-4057qib7	8670	1	[	[	-LRB-
cord-005453-4057qib7	8670	2	[	[	-LRB-
cord-005453-4057qib7	8670	3	P385	p385	CD
cord-005453-4057qib7	8670	4	Image	image	NN
cord-005453-4057qib7	8670	5	]	]	-RRB-
cord-005453-4057qib7	8670	6	1	1	CD
cord-005453-4057qib7	8670	7	.	.	.
cord-005453-4057qib7	8671	1	Background	background	NN
cord-005453-4057qib7	8671	2	:	:	:
cord-005453-4057qib7	8672	1	Chronic	chronic	JJ
cord-005453-4057qib7	8672	2	granulomatous	granulomatous	JJ
cord-005453-4057qib7	8672	3	disease	disease	NN
cord-005453-4057qib7	8672	4	(	(	-LRB-
cord-005453-4057qib7	8672	5	CGD	CGD	NNP
cord-005453-4057qib7	8672	6	)	)	-RRB-
cord-005453-4057qib7	8672	7	is	be	VBZ
cord-005453-4057qib7	8672	8	curable	curable	JJ
cord-005453-4057qib7	8672	9	by	by	IN
cord-005453-4057qib7	8672	10	allogeneic	allogeneic	VBG
cord-005453-4057qib7	8672	11	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	8672	12	stem	stem	NN
cord-005453-4057qib7	8672	13	cell	cell	NN
cord-005453-4057qib7	8672	14	transplant	transplant	NN
cord-005453-4057qib7	8672	15	(	(	-LRB-
cord-005453-4057qib7	8672	16	HSCT	HSCT	NNP
cord-005453-4057qib7	8672	17	)	)	-RRB-
cord-005453-4057qib7	8672	18	.	.	.
cord-005453-4057qib7	8673	1	Recent	recent	JJ
cord-005453-4057qib7	8673	2	reports	report	NNS
cord-005453-4057qib7	8673	3	of	of	IN
cord-005453-4057qib7	8673	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8673	5	donor	donor	NN
cord-005453-4057qib7	8673	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8673	7	with	with	IN
cord-005453-4057qib7	8673	8	with	with	IN
cord-005453-4057qib7	8673	9	post	post	NN
cord-005453-4057qib7	8673	10	transplant	transplant	NN
cord-005453-4057qib7	8673	11	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	8673	12	(	(	-LRB-
cord-005453-4057qib7	8673	13	PTCy	PTCy	NNP
cord-005453-4057qib7	8673	14	)	)	-RRB-
cord-005453-4057qib7	8673	15	from	from	IN
cord-005453-4057qib7	8673	16	family	family	NN
cord-005453-4057qib7	8673	17	donors	donor	NNS
cord-005453-4057qib7	8673	18	in	in	IN
cord-005453-4057qib7	8673	19	pediatric	pediatric	JJ
cord-005453-4057qib7	8673	20	primary	primary	JJ
cord-005453-4057qib7	8673	21	immune	immune	JJ
cord-005453-4057qib7	8673	22	deficiencies	deficiency	NNS
cord-005453-4057qib7	8673	23	have	have	VBP
cord-005453-4057qib7	8673	24	shown	show	VBN
cord-005453-4057qib7	8673	25	encouraging	encouraging	JJ
cord-005453-4057qib7	8673	26	results	result	NNS
cord-005453-4057qib7	8673	27	.	.	.
cord-005453-4057qib7	8674	1	However	however	RB
cord-005453-4057qib7	8674	2	,	,	,
cord-005453-4057qib7	8674	3	it	-PRON-	PRP
cord-005453-4057qib7	8674	4	has	have	VBZ
cord-005453-4057qib7	8674	5	not	not	RB
cord-005453-4057qib7	8674	6	been	be	VBN
cord-005453-4057qib7	8674	7	reported	report	VBN
cord-005453-4057qib7	8674	8	in	in	IN
cord-005453-4057qib7	8674	9	CGD	CGD	NNP
cord-005453-4057qib7	8674	10	.	.	.
cord-005453-4057qib7	8675	1	Here	here	RB
cord-005453-4057qib7	8675	2	we	-PRON-	PRP
cord-005453-4057qib7	8675	3	describe	describe	VBP
cord-005453-4057qib7	8675	4	successful	successful	JJ
cord-005453-4057qib7	8675	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8675	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8675	7	in	in	IN
cord-005453-4057qib7	8675	8	a	a	DT
cord-005453-4057qib7	8675	9	child	child	NN
cord-005453-4057qib7	8675	10	with	with	IN
cord-005453-4057qib7	8675	11	CGD	CGD	NNP
cord-005453-4057qib7	8675	12	with	with	IN
cord-005453-4057qib7	8675	13	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8675	14	conditioning	conditioning	NN
cord-005453-4057qib7	8675	15	and	and	CC
cord-005453-4057qib7	8675	16	PTCy	PTCy	NNS
cord-005453-4057qib7	8675	17	.	.	.
cord-005453-4057qib7	8676	1	A	a	DT
cord-005453-4057qib7	8676	2	3	3	CD
cord-005453-4057qib7	8676	3	year	year	NN
cord-005453-4057qib7	8676	4	-	-	HYPH
cord-005453-4057qib7	8676	5	old	old	JJ
cord-005453-4057qib7	8676	6	,	,	,
cord-005453-4057qib7	8676	7	male	male	JJ
cord-005453-4057qib7	8676	8	child	child	NN
cord-005453-4057qib7	8676	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	8676	10	with	with	IN
cord-005453-4057qib7	8676	11	CGD	CGD	NNP
cord-005453-4057qib7	8676	12	showed	show	VBD
cord-005453-4057qib7	8676	13	oxidative	oxidative	JJ
cord-005453-4057qib7	8676	14	activity	activity	NN
cord-005453-4057qib7	8676	15	0.3	0.3	CD
cord-005453-4057qib7	8676	16	%	%	NN
cord-005453-4057qib7	8676	17	by	by	IN
cord-005453-4057qib7	8676	18	dihydrorhodamine	dihydrorhodamine	NNP
cord-005453-4057qib7	8676	19	(	(	-LRB-
cord-005453-4057qib7	8676	20	DHR	DHR	NNP
cord-005453-4057qib7	8676	21	)	)	-RRB-
cord-005453-4057qib7	8676	22	test	test	NN
cord-005453-4057qib7	8676	23	.	.	.
cord-005453-4057qib7	8677	1	He	-PRON-	PRP
cord-005453-4057qib7	8677	2	had	have	VBD
cord-005453-4057qib7	8677	3	no	no	DT
cord-005453-4057qib7	8677	4	matched	match	VBN
cord-005453-4057qib7	8677	5	related	related	JJ
cord-005453-4057qib7	8677	6	or	or	CC
cord-005453-4057qib7	8677	7	unrelated	unrelated	JJ
cord-005453-4057qib7	8677	8	donor	donor	NN
cord-005453-4057qib7	8677	9	available	available	JJ
cord-005453-4057qib7	8677	10	so	so	RB
cord-005453-4057qib7	8677	11	underwent	undergo	VBD
cord-005453-4057qib7	8677	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	8677	13	HSCT	HSCT	NNP
cord-005453-4057qib7	8677	14	after	after	IN
cord-005453-4057qib7	8677	15	taking	take	VBG
cord-005453-4057qib7	8677	16	informed	informed	JJ
cord-005453-4057qib7	8677	17	consent	consent	NN
cord-005453-4057qib7	8677	18	of	of	IN
cord-005453-4057qib7	8677	19	the	the	DT
cord-005453-4057qib7	8677	20	parents	parent	NNS
cord-005453-4057qib7	8677	21	in	in	IN
cord-005453-4057qib7	8677	22	May	May	NNP
cord-005453-4057qib7	8677	23	2018	2018	CD
cord-005453-4057qib7	8677	24	.	.	.
cord-005453-4057qib7	8678	1	Donor	donor	NN
cord-005453-4057qib7	8678	2	was	be	VBD
cord-005453-4057qib7	8678	3	his	-PRON-	PRP$
cord-005453-4057qib7	8678	4	5/10	5/10	CD
cord-005453-4057qib7	8678	5	HLA	HLA	NNP
cord-005453-4057qib7	8678	6	matched	match	VBN
cord-005453-4057qib7	8678	7	healthy	healthy	JJ
cord-005453-4057qib7	8678	8	elder	eld	JJR
cord-005453-4057qib7	8678	9	sister	sister	NN
cord-005453-4057qib7	8678	10	(	(	-LRB-
cord-005453-4057qib7	8678	11	oxidative	oxidative	JJ
cord-005453-4057qib7	8678	12	activity	activity	NN
cord-005453-4057qib7	8678	13	55	55	CD
cord-005453-4057qib7	8678	14	%	%	NN
cord-005453-4057qib7	8678	15	by	by	IN
cord-005453-4057qib7	8678	16	DHR	DHR	NNP
cord-005453-4057qib7	8678	17	)	)	-RRB-
cord-005453-4057qib7	8678	18	.	.	.
cord-005453-4057qib7	8679	1	He	-PRON-	PRP
cord-005453-4057qib7	8679	2	has	have	VBZ
cord-005453-4057qib7	8679	3	had	have	VBN
cord-005453-4057qib7	8679	4	multiple	multiple	JJ
cord-005453-4057qib7	8679	5	admissions	admission	NNS
cord-005453-4057qib7	8679	6	for	for	IN
cord-005453-4057qib7	8679	7	recurrent	recurrent	JJ
cord-005453-4057qib7	8679	8	pneumonia	pneumonia	NN
cord-005453-4057qib7	8679	9	prior	prior	RB
cord-005453-4057qib7	8679	10	to	to	IN
cord-005453-4057qib7	8679	11	HSCT	HSCT	NNP
cord-005453-4057qib7	8679	12	.	.	.
cord-005453-4057qib7	8680	1	The	the	DT
cord-005453-4057qib7	8680	2	conditioning	conditioning	NN
cord-005453-4057qib7	8680	3	was	be	VBD
cord-005453-4057qib7	8680	4	with	with	IN
cord-005453-4057qib7	8680	5	Rituximab	Rituximab	NNP
cord-005453-4057qib7	8680	6	100	100	CD
cord-005453-4057qib7	8680	7	mg	mg	NNP
cord-005453-4057qib7	8680	8	/	/	SYM
cord-005453-4057qib7	8680	9	m2	m2	NNP
cord-005453-4057qib7	8680	10	IV	IV	NNP
cord-005453-4057qib7	8680	11	on	on	IN
cord-005453-4057qib7	8680	12	day	day	NN
cord-005453-4057qib7	8680	13	-8	-8	NNPS
cord-005453-4057qib7	8680	14	,	,	,
cord-005453-4057qib7	8681	1	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	8681	2	10	10	CD
cord-005453-4057qib7	8681	3	mg/	mg/	NN
cord-005453-4057qib7	8681	4	kg	kg	NNP
cord-005453-4057qib7	8681	5	/	/	SYM
cord-005453-4057qib7	8681	6	dose	dose	NN
cord-005453-4057qib7	8681	7	intravenous	intravenous	JJ
cord-005453-4057qib7	8681	8	(	(	-LRB-
cord-005453-4057qib7	8681	9	IV	IV	NNP
cord-005453-4057qib7	8681	10	)	)	-RRB-
cord-005453-4057qib7	8681	11	for	for	IN
cord-005453-4057qib7	8681	12	1	1	CD
cord-005453-4057qib7	8681	13	day	day	NN
cord-005453-4057qib7	8681	14	(	(	-LRB-
cord-005453-4057qib7	8681	15	Day-7	Day-7	NNP
cord-005453-4057qib7	8681	16	)	)	-RRB-
cord-005453-4057qib7	8681	17	,	,	,
cord-005453-4057qib7	8681	18	Busulfan	Busulfan	NNP
cord-005453-4057qib7	8681	19	3.2	3.2	CD
cord-005453-4057qib7	8681	20	mg	mg	NNP
cord-005453-4057qib7	8681	21	/	/	SYM
cord-005453-4057qib7	8681	22	kg	kg	NNP
cord-005453-4057qib7	8681	23	/	/	SYM
cord-005453-4057qib7	8681	24	dose	dose	VBD
cord-005453-4057qib7	8681	25	daily	daily	JJ
cord-005453-4057qib7	8681	26	IV	IV	NNP
cord-005453-4057qib7	8681	27	for	for	IN
cord-005453-4057qib7	8681	28	4	4	CD
cord-005453-4057qib7	8681	29	days	day	NNS
cord-005453-4057qib7	8681	30	(	(	-LRB-
cord-005453-4057qib7	8681	31	Day	day	NN
cord-005453-4057qib7	8681	32	-6	-6	JJ
cord-005453-4057qib7	8681	33	to	to	IN
cord-005453-4057qib7	8681	34	-3	-3	NNP
cord-005453-4057qib7	8681	35	)	)	-RRB-
cord-005453-4057qib7	8681	36	and	and	CC
cord-005453-4057qib7	8681	37	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	8681	38	40	40	CD
cord-005453-4057qib7	8682	1	mg	mg	NNP
cord-005453-4057qib7	8682	2	/	/	SYM
cord-005453-4057qib7	8682	3	m2	m2	NNP
cord-005453-4057qib7	8682	4	/	/	SYM
cord-005453-4057qib7	8682	5	dose	dose	VBD
cord-005453-4057qib7	8682	6	daily	daily	JJ
cord-005453-4057qib7	8682	7	IV	IV	NNP
cord-005453-4057qib7	8682	8	for	for	IN
cord-005453-4057qib7	8682	9	4	4	CD
cord-005453-4057qib7	8682	10	days	day	NNS
cord-005453-4057qib7	8682	11	(	(	-LRB-
cord-005453-4057qib7	8682	12	Day	day	NN
cord-005453-4057qib7	8682	13	-6	-6	JJ
cord-005453-4057qib7	8682	14	to	to	IN
cord-005453-4057qib7	8682	15	-3	-3	NNP
cord-005453-4057qib7	8682	16	)	)	-RRB-
cord-005453-4057qib7	8682	17	and	and	CC
cord-005453-4057qib7	8682	18	rabbit	rabbit	NN
cord-005453-4057qib7	8682	19	anti	anti	JJ
cord-005453-4057qib7	8682	20	-	-	JJ
cord-005453-4057qib7	8682	21	thymoglubulin	thymoglubulin	JJ
cord-005453-4057qib7	8682	22	(	(	-LRB-
cord-005453-4057qib7	8682	23	thymoglobulin	thymoglobulin	NNP
cord-005453-4057qib7	8682	24	)	)	-RRB-
cord-005453-4057qib7	8683	1	1.5	1.5	CD
cord-005453-4057qib7	8683	2	mg/	mg/	NN
cord-005453-4057qib7	8683	3	kg	kg	NNP
cord-005453-4057qib7	8683	4	/	/	SYM
cord-005453-4057qib7	8683	5	dose	dose	VBD
cord-005453-4057qib7	8683	6	daily	daily	RB
cord-005453-4057qib7	8683	7	for	for	IN
cord-005453-4057qib7	8683	8	3	3	CD
cord-005453-4057qib7	8683	9	days	day	NNS
cord-005453-4057qib7	8683	10	(	(	-LRB-
cord-005453-4057qib7	8683	11	Day-4	Day-4	NNP
cord-005453-4057qib7	8683	12	to	to	IN
cord-005453-4057qib7	8683	13	-2	-2	NNP
cord-005453-4057qib7	8683	14	)	)	-RRB-
cord-005453-4057qib7	8683	15	.	.	.
cord-005453-4057qib7	8684	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	8684	2	blood	blood	NN
cord-005453-4057qib7	8684	3	stem	stem	NN
cord-005453-4057qib7	8684	4	cells	cell	NNS
cord-005453-4057qib7	8684	5	(	(	-LRB-
cord-005453-4057qib7	8684	6	8	8	CD
cord-005453-4057qib7	8684	7	million	million	CD
cord-005453-4057qib7	8684	8	/	/	SYM
cord-005453-4057qib7	8684	9	kg	kg	NN
cord-005453-4057qib7	8684	10	CD34	CD34	NNP
cord-005453-4057qib7	8684	11	+	+	CC
cord-005453-4057qib7	8684	12	cells	cell	NNS
cord-005453-4057qib7	8684	13	)	)	-RRB-
cord-005453-4057qib7	8684	14	were	be	VBD
cord-005453-4057qib7	8684	15	harvested	harvest	VBN
cord-005453-4057qib7	8684	16	from	from	IN
cord-005453-4057qib7	8684	17	his	-PRON-	PRP$
cord-005453-4057qib7	8684	18	sister	sister	NN
cord-005453-4057qib7	8684	19	and	and	CC
cord-005453-4057qib7	8684	20	transfused	transfuse	VBD
cord-005453-4057qib7	8684	21	to	to	IN
cord-005453-4057qib7	8684	22	the	the	DT
cord-005453-4057qib7	8684	23	patient	patient	NN
cord-005453-4057qib7	8684	24	on	on	IN
cord-005453-4057qib7	8684	25	Day	day	NN
cord-005453-4057qib7	8684	26	0	0	CD
cord-005453-4057qib7	8684	27	.	.	.
cord-005453-4057qib7	8685	1	Graft	graft	NN
cord-005453-4057qib7	8685	2	vs.	vs.	IN
cord-005453-4057qib7	8685	3	Host	host	NN
cord-005453-4057qib7	8685	4	disease	disease	NN
cord-005453-4057qib7	8685	5	(	(	-LRB-
cord-005453-4057qib7	8685	6	GVHD	GVHD	NNP
cord-005453-4057qib7	8685	7	)	)	-RRB-
cord-005453-4057qib7	8685	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8685	9	was	be	VBD
cord-005453-4057qib7	8685	10	with	with	IN
cord-005453-4057qib7	8685	11	PTCy	PTCy	NNPS
cord-005453-4057qib7	8685	12	50	50	CD
cord-005453-4057qib7	8685	13	mg/	mg/	NN
cord-005453-4057qib7	8685	14	kg	kg	NNS
cord-005453-4057qib7	8685	15	on	on	IN
cord-005453-4057qib7	8685	16	Day+3	Day+3	NNP
cord-005453-4057qib7	8685	17	&	&	CC
cord-005453-4057qib7	8685	18	4	4	CD
cord-005453-4057qib7	8685	19	,	,	,
cord-005453-4057qib7	8685	20	intravenous	intravenous	JJ
cord-005453-4057qib7	8685	21	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	8685	22	from	from	IN
cord-005453-4057qib7	8686	1	day-3	day-3	NNP
cord-005453-4057qib7	8686	2	(	(	-LRB-
cord-005453-4057qib7	8686	3	targeting	target	VBG
cord-005453-4057qib7	8686	4	levels	level	NNS
cord-005453-4057qib7	8686	5	150	150	CD
cord-005453-4057qib7	8686	6	-	-	SYM
cord-005453-4057qib7	8686	7	250	250	CD
cord-005453-4057qib7	8686	8	ng	ng	NN
cord-005453-4057qib7	8686	9	/	/	SYM
cord-005453-4057qib7	8686	10	ml	ml	NN
cord-005453-4057qib7	8686	11	)	)	-RRB-
cord-005453-4057qib7	8686	12	and	and	CC
cord-005453-4057qib7	8686	13	MMF	mmf	NN
cord-005453-4057qib7	8686	14	from	from	IN
cord-005453-4057qib7	8686	15	day+5	day+5	NNP
cord-005453-4057qib7	8686	16	.	.	.
cord-005453-4057qib7	8687	1	Results	result	NNS
cord-005453-4057qib7	8687	2	:	:	:
cord-005453-4057qib7	8688	1	His	-PRON-	PRP$
cord-005453-4057qib7	8688	2	neutrophils	neutrophil	NNS
cord-005453-4057qib7	8688	3	engrafted	engraft	VBD
cord-005453-4057qib7	8688	4	on	on	IN
cord-005453-4057qib7	8688	5	day+15	day+15	NNP
cord-005453-4057qib7	8688	6	and	and	CC
cord-005453-4057qib7	8688	7	platelets	platelet	NNS
cord-005453-4057qib7	8688	8	on	on	IN
cord-005453-4057qib7	8688	9	day+17	day+17	CD
cord-005453-4057qib7	8688	10	.	.	.
cord-005453-4057qib7	8689	1	Chimerism	chimerism	NN
cord-005453-4057qib7	8689	2	on	on	IN
cord-005453-4057qib7	8689	3	day+30	day+30	CD
cord-005453-4057qib7	8689	4	,	,	,
cord-005453-4057qib7	8689	5	100	100	CD
cord-005453-4057qib7	8689	6	and	and	CC
cord-005453-4057qib7	8689	7	6	6	CD
cord-005453-4057qib7	8689	8	months	month	NNS
cord-005453-4057qib7	8689	9	was	be	VBD
cord-005453-4057qib7	8689	10	fully	fully	RB
cord-005453-4057qib7	8689	11	donor	donor	NN
cord-005453-4057qib7	8689	12	.	.	.
cord-005453-4057qib7	8690	1	He	-PRON-	PRP
cord-005453-4057qib7	8690	2	developed	develop	VBD
cord-005453-4057qib7	8690	3	no	no	DT
cord-005453-4057qib7	8690	4	acute	acute	JJ
cord-005453-4057qib7	8690	5	or	or	CC
cord-005453-4057qib7	8690	6	chronic	chronic	JJ
cord-005453-4057qib7	8690	7	GVHD	GVHD	NNP
cord-005453-4057qib7	8690	8	.	.	.
cord-005453-4057qib7	8691	1	At	at	IN
cord-005453-4057qib7	8691	2	6	6	CD
cord-005453-4057qib7	8691	3	months	month	NNS
cord-005453-4057qib7	8691	4	his	-PRON-	PRP$
cord-005453-4057qib7	8691	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	8691	6	counts	count	NNS
cord-005453-4057qib7	8691	7	showed	show	VBD
cord-005453-4057qib7	8691	8	CD4	CD4	NNP
cord-005453-4057qib7	8691	9	-	-	HYPH
cord-005453-4057qib7	8691	10	280	280	CD
cord-005453-4057qib7	8691	11	/	/	SYM
cord-005453-4057qib7	8691	12	ul	ul	NN
cord-005453-4057qib7	8691	13	,	,	,
cord-005453-4057qib7	8691	14	CD8	CD8	NNP
cord-005453-4057qib7	8691	15	-	-	HYPH
cord-005453-4057qib7	8691	16	670	670	NNP
cord-005453-4057qib7	8691	17	/	/	SYM
cord-005453-4057qib7	8691	18	ul	ul	NN
cord-005453-4057qib7	8691	19	,	,	,
cord-005453-4057qib7	8691	20	CD19	CD19	NNP
cord-005453-4057qib7	8691	21	-	-	HYPH
cord-005453-4057qib7	8691	22	15	15	CD
cord-005453-4057qib7	8691	23	/	/	SYM
cord-005453-4057qib7	8691	24	ul	ul	NN
cord-005453-4057qib7	8692	1	and	and	CC
cord-005453-4057qib7	8692	2	CD16/56	cd16/56	CD
cord-005453-4057qib7	8692	3	-	-	HYPH
cord-005453-4057qib7	8692	4	120	120	CD
cord-005453-4057qib7	8692	5	/	/	SYM
cord-005453-4057qib7	8692	6	ul	ul	NN
cord-005453-4057qib7	8692	7	.	.	.
cord-005453-4057qib7	8693	1	His	-PRON-	PRP$
cord-005453-4057qib7	8693	2	had	have	VBD
cord-005453-4057qib7	8693	3	no	no	DT
cord-005453-4057qib7	8693	4	viral	viral	JJ
cord-005453-4057qib7	8693	5	reactivation	reactivation	NN
cord-005453-4057qib7	8693	6	.	.	.
cord-005453-4057qib7	8694	1	He	-PRON-	PRP
cord-005453-4057qib7	8694	2	is	be	VBZ
cord-005453-4057qib7	8694	3	disease	disease	NN
cord-005453-4057qib7	8694	4	free	free	JJ
cord-005453-4057qib7	8694	5	and	and	CC
cord-005453-4057qib7	8694	6	GVHD	GVHD	NNP
cord-005453-4057qib7	8694	7	free	free	JJ
cord-005453-4057qib7	8694	8	on	on	IN
cord-005453-4057qib7	8694	9	day+190	day+190	.
cord-005453-4057qib7	8695	1	post	post	NNP
cord-005453-4057qib7	8695	2	HSCT	HSCT	NNP
cord-005453-4057qib7	8695	3	and	and	CC
cord-005453-4057qib7	8695	4	is	be	VBZ
cord-005453-4057qib7	8695	5	on	on	IN
cord-005453-4057qib7	8695	6	tapering	taper	VBG
cord-005453-4057qib7	8695	7	doses	dose	NNS
cord-005453-4057qib7	8695	8	of	of	IN
cord-005453-4057qib7	8695	9	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	8695	10	.	.	.
cord-005453-4057qib7	8696	1	His	-PRON-	PRP$
cord-005453-4057qib7	8696	2	DHR	DHR	NNP
cord-005453-4057qib7	8696	3	test	test	NN
cord-005453-4057qib7	8696	4	showed	show	VBD
cord-005453-4057qib7	8696	5	oxidative	oxidative	JJ
cord-005453-4057qib7	8696	6	activity	activity	NN
cord-005453-4057qib7	8696	7	of	of	IN
cord-005453-4057qib7	8696	8	42	42	CD
cord-005453-4057qib7	8696	9	%	%	NN
cord-005453-4057qib7	8696	10	on	on	IN
cord-005453-4057qib7	8696	11	day	day	NN
cord-005453-4057qib7	8696	12	+100	+100	NNS
cord-005453-4057qib7	8696	13	.	.	.
cord-005453-4057qib7	8697	1	Background	background	NN
cord-005453-4057qib7	8697	2	:	:	:
cord-005453-4057qib7	8698	1	Primary	primary	JJ
cord-005453-4057qib7	8698	2	immune	immune	JJ
cord-005453-4057qib7	8698	3	deficiencies	deficiency	NNS
cord-005453-4057qib7	8698	4	(	(	-LRB-
cord-005453-4057qib7	8698	5	PID	PID	NNP
cord-005453-4057qib7	8698	6	)	)	-RRB-
cord-005453-4057qib7	8698	7	are	be	VBP
cord-005453-4057qib7	8698	8	a	a	DT
cord-005453-4057qib7	8698	9	functional	functional	JJ
cord-005453-4057qib7	8698	10	disorder	disorder	NN
cord-005453-4057qib7	8698	11	of	of	IN
cord-005453-4057qib7	8698	12	inheritance	inheritance	NN
cord-005453-4057qib7	8698	13	immune	immune	NN
cord-005453-4057qib7	8698	14	system	system	NN
cord-005453-4057qib7	8698	15	that	that	WDT
cord-005453-4057qib7	8698	16	increase	increase	VBP
cord-005453-4057qib7	8698	17	predisposition	predisposition	NN
cord-005453-4057qib7	8698	18	to	to	IN
cord-005453-4057qib7	8698	19	infectious	infectious	JJ
cord-005453-4057qib7	8698	20	disease	disease	NN
cord-005453-4057qib7	8698	21	in	in	IN
cord-005453-4057qib7	8698	22	number	number	NN
cord-005453-4057qib7	8698	23	and	and	CC
cord-005453-4057qib7	8698	24	severity	severity	NN
cord-005453-4057qib7	8698	25	.	.	.
cord-005453-4057qib7	8699	1	The	the	DT
cord-005453-4057qib7	8699	2	incidence	incidence	NN
cord-005453-4057qib7	8699	3	is	be	VBZ
cord-005453-4057qib7	8699	4	1	1	CD
cord-005453-4057qib7	8699	5	:	:	:
cord-005453-4057qib7	8699	6	10,000	10,000	CD
cord-005453-4057qib7	8699	7	birth	birth	NN
cord-005453-4057qib7	8699	8	live	live	RB
cord-005453-4057qib7	8699	9	;	;	:
cord-005453-4057qib7	8699	10	its	-PRON-	PRP$
cord-005453-4057qib7	8699	11	immunological	immunological	JJ
cord-005453-4057qib7	8699	12	dysregulation	dysregulation	NN
cord-005453-4057qib7	8699	13	may	may	MD
cord-005453-4057qib7	8699	14	increase	increase	VB
cord-005453-4057qib7	8699	15	the	the	DT
cord-005453-4057qib7	8699	16	predisposition	predisposition	NN
cord-005453-4057qib7	8699	17	of	of	IN
cord-005453-4057qib7	8699	18	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8699	19	diseases	disease	NNS
cord-005453-4057qib7	8699	20	and	and	CC
cord-005453-4057qib7	8699	21	malignancy	malignancy	NN
cord-005453-4057qib7	8699	22	,	,	,
cord-005453-4057qib7	8699	23	the	the	DT
cord-005453-4057qib7	8699	24	latter	latter	JJ
cord-005453-4057qib7	8699	25	being	be	VBG
cord-005453-4057qib7	8699	26	more	more	RBR
cord-005453-4057qib7	8699	27	frequent	frequent	JJ
cord-005453-4057qib7	8699	28	(	(	-LRB-
cord-005453-4057qib7	8699	29	4	4	CD
cord-005453-4057qib7	8699	30	-	-	SYM
cord-005453-4057qib7	8699	31	25	25	CD
cord-005453-4057qib7	8699	32	%	%	NN
cord-005453-4057qib7	8699	33	)	)	-RRB-
cord-005453-4057qib7	8699	34	.	.	.
cord-005453-4057qib7	8700	1	At	at	IN
cord-005453-4057qib7	8700	2	present	present	NN
cord-005453-4057qib7	8700	3	,	,	,
cord-005453-4057qib7	8700	4	the	the	DT
cord-005453-4057qib7	8700	5	only	only	JJ
cord-005453-4057qib7	8700	6	curative	curative	JJ
cord-005453-4057qib7	8700	7	treatment	treatment	NN
cord-005453-4057qib7	8700	8	is	be	VBZ
cord-005453-4057qib7	8700	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8700	10	stem	stem	NN
cord-005453-4057qib7	8700	11	cells	cell	NNS
cord-005453-4057qib7	8700	12	transplant	transplant	NN
cord-005453-4057qib7	8700	13	(	(	-LRB-
cord-005453-4057qib7	8700	14	HSCT	HSCT	NNP
cord-005453-4057qib7	8700	15	)	)	-RRB-
cord-005453-4057qib7	8700	16	.	.	.
cord-005453-4057qib7	8701	1	Methods	method	NNS
cord-005453-4057qib7	8701	2	:	:	:
cord-005453-4057qib7	8702	1	We	-PRON-	PRP
cord-005453-4057qib7	8702	2	describe	describe	VBP
cord-005453-4057qib7	8702	3	all	all	DT
cord-005453-4057qib7	8702	4	patients	patient	NNS
cord-005453-4057qib7	8702	5	transplanted	transplant	VBN
cord-005453-4057qib7	8702	6	with	with	IN
cord-005453-4057qib7	8702	7	Primary	Primary	NNP
cord-005453-4057qib7	8702	8	Immune	Immune	NNP
cord-005453-4057qib7	8702	9	Deficiencies	Deficiencies	NNPS
cord-005453-4057qib7	8702	10	at	at	IN
cord-005453-4057qib7	8702	11	Instituto	Instituto	NNP
cord-005453-4057qib7	8702	12	Nacional	Nacional	NNP
cord-005453-4057qib7	8702	13	de	de	NNP
cord-005453-4057qib7	8702	14	Pediatria	Pediatria	NNP
cord-005453-4057qib7	8702	15	.	.	.
cord-005453-4057qib7	8703	1	The	the	DT
cord-005453-4057qib7	8703	2	conditioning	conditioning	NN
cord-005453-4057qib7	8703	3	regimen	regimen	NN
cord-005453-4057qib7	8703	4	depended	depend	VBD
cord-005453-4057qib7	8703	5	on	on	IN
cord-005453-4057qib7	8703	6	the	the	DT
cord-005453-4057qib7	8703	7	type	type	NN
cord-005453-4057qib7	8703	8	donor	donor	NN
cord-005453-4057qib7	8703	9	and	and	CC
cord-005453-4057qib7	8703	10	pathology	pathology	NN
cord-005453-4057qib7	8703	11	:	:	:
cord-005453-4057qib7	8703	12	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8703	13	(	(	-LRB-
cord-005453-4057qib7	8703	14	41.07	41.07	CD
cord-005453-4057qib7	8703	15	%	%	NN
cord-005453-4057qib7	8703	16	)	)	-RRB-
cord-005453-4057qib7	8703	17	,	,	,
cord-005453-4057qib7	8703	18	reduced	reduce	VBN
cord-005453-4057qib7	8703	19	intensity	intensity	NN
cord-005453-4057qib7	8703	20	(	(	-LRB-
cord-005453-4057qib7	8703	21	37.5	37.5	CD
cord-005453-4057qib7	8703	22	%	%	NN
cord-005453-4057qib7	8703	23	)	)	-RRB-
cord-005453-4057qib7	8703	24	and	and	CC
cord-005453-4057qib7	8703	25	non	non	NNP
cord-005453-4057qib7	8703	26	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8703	27	(	(	-LRB-
cord-005453-4057qib7	8703	28	21.43	21.43	CD
cord-005453-4057qib7	8703	29	%	%	NN
cord-005453-4057qib7	8703	30	)	)	-RRB-
cord-005453-4057qib7	8703	31	without	without	IN
cord-005453-4057qib7	8703	32	modification	modification	NN
cord-005453-4057qib7	8703	33	statistically	statistically	RB
cord-005453-4057qib7	8703	34	significantly	significantly	RB
cord-005453-4057qib7	8703	35	in	in	IN
cord-005453-4057qib7	8703	36	overall	overall	JJ
cord-005453-4057qib7	8703	37	survival	survival	NN
cord-005453-4057qib7	8703	38	.	.	.
cord-005453-4057qib7	8704	1	Results	result	NNS
cord-005453-4057qib7	8704	2	:	:	:
cord-005453-4057qib7	8705	1	A	a	DT
cord-005453-4057qib7	8705	2	total	total	NN
cord-005453-4057qib7	8705	3	of	of	IN
cord-005453-4057qib7	8705	4	71	71	CD
cord-005453-4057qib7	8705	5	patients	patient	NNS
cord-005453-4057qib7	8705	6	were	be	VBD
cord-005453-4057qib7	8705	7	included	include	VBN
cord-005453-4057qib7	8705	8	from	from	IN
cord-005453-4057qib7	8705	9	1998	1998	CD
cord-005453-4057qib7	8705	10	to	to	IN
cord-005453-4057qib7	8705	11	January/2017	january/2017	XX
cord-005453-4057qib7	8705	12	.	.	.
cord-005453-4057qib7	8706	1	Severe	severe	JJ
cord-005453-4057qib7	8706	2	combined	combine	VBN
cord-005453-4057qib7	8706	3	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8706	4	(	(	-LRB-
cord-005453-4057qib7	8706	5	SCID	SCID	NNP
cord-005453-4057qib7	8706	6	)	)	-RRB-
cord-005453-4057qib7	8706	7	is	be	VBZ
cord-005453-4057qib7	8706	8	the	the	DT
cord-005453-4057qib7	8706	9	pathology	pathology	NN
cord-005453-4057qib7	8706	10	most	most	RBS
cord-005453-4057qib7	8706	11	frequently	frequently	RB
cord-005453-4057qib7	8706	12	transplanted	transplant	VBN
cord-005453-4057qib7	8706	13	(	(	-LRB-
cord-005453-4057qib7	8706	14	Figure	figure	NN
cord-005453-4057qib7	8706	15	1	1	CD
cord-005453-4057qib7	8706	16	)	)	-RRB-
cord-005453-4057qib7	8706	17	.	.	.
cord-005453-4057qib7	8707	1	Seventy	seventy	CD
cord-005453-4057qib7	8707	2	three	three	CD
cord-005453-4057qib7	8707	3	percent	percent	NN
cord-005453-4057qib7	8707	4	have	have	VBP
cord-005453-4057qib7	8707	5	molecular	molecular	JJ
cord-005453-4057qib7	8707	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	8707	7	,	,	,
cord-005453-4057qib7	8707	8	and	and	CC
cord-005453-4057qib7	8707	9	44.83	44.83	CD
cord-005453-4057qib7	8707	10	%	%	NN
cord-005453-4057qib7	8707	11	have	have	VBP
cord-005453-4057qib7	8707	12	cases	case	NNS
cord-005453-4057qib7	8707	13	of	of	IN
cord-005453-4057qib7	8707	14	family	family	NN
cord-005453-4057qib7	8707	15	PID	PID	NNP
cord-005453-4057qib7	8707	16	.	.	.
cord-005453-4057qib7	8708	1	The	the	DT
cord-005453-4057qib7	8708	2	most	most	RBS
cord-005453-4057qib7	8708	3	used	use	VBN
cord-005453-4057qib7	8708	4	sources	source	NNS
cord-005453-4057qib7	8708	5	were	be	VBD
cord-005453-4057qib7	8708	6	umbilical	umbilical	JJ
cord-005453-4057qib7	8708	7	cord	cord	NN
cord-005453-4057qib7	8708	8	blood	blood	NN
cord-005453-4057qib7	8708	9	(	(	-LRB-
cord-005453-4057qib7	8708	10	UCB	UCB	NNP
cord-005453-4057qib7	8708	11	)	)	-RRB-
cord-005453-4057qib7	8708	12	with	with	IN
cord-005453-4057qib7	8708	13	42.6	42.6	CD
cord-005453-4057qib7	8708	14	%	%	NN
cord-005453-4057qib7	8708	15	and	and	CC
cord-005453-4057qib7	8708	16	peripheral	peripheral	JJ
cord-005453-4057qib7	8708	17	blood	blood	NN
cord-005453-4057qib7	8708	18	(	(	-LRB-
cord-005453-4057qib7	8708	19	39.3	39.3	CD
cord-005453-4057qib7	8708	20	%	%	NN
cord-005453-4057qib7	8708	21	)	)	-RRB-
cord-005453-4057qib7	8708	22	,	,	.
cord-005453-4057qib7	8709	1	however	however	RB
cord-005453-4057qib7	8709	2	the	the	DT
cord-005453-4057qib7	8709	3	trend	trend	NN
cord-005453-4057qib7	8709	4	of	of	IN
cord-005453-4057qib7	8709	5	the	the	DT
cord-005453-4057qib7	8709	6	source	source	NN
cord-005453-4057qib7	8709	7	of	of	IN
cord-005453-4057qib7	8709	8	obtaining	obtain	VBG
cord-005453-4057qib7	8709	9	it	-PRON-	PRP
cord-005453-4057qib7	8709	10	has	have	VBZ
cord-005453-4057qib7	8709	11	been	be	VBN
cord-005453-4057qib7	8709	12	modified	modify	VBN
cord-005453-4057qib7	8709	13	a	a	DT
cord-005453-4057qib7	8709	14	few	few	JJ
cord-005453-4057qib7	8709	15	years	year	NNS
cord-005453-4057qib7	8709	16	ago	ago	RB
cord-005453-4057qib7	8710	1	(	(	-LRB-
cord-005453-4057qib7	8710	2	Figure	figure	NN
cord-005453-4057qib7	8710	3	2	2	CD
cord-005453-4057qib7	8710	4	)	)	-RRB-
cord-005453-4057qib7	8710	5	.	.	.
cord-005453-4057qib7	8711	1	The	the	DT
cord-005453-4057qib7	8711	2	median	median	JJ
cord-005453-4057qib7	8711	3	graft	graft	NN
cord-005453-4057qib7	8711	4	was	be	VBD
cord-005453-4057qib7	8711	5	14	14	CD
cord-005453-4057qib7	8711	6	days	day	NNS
cord-005453-4057qib7	8711	7	for	for	IN
cord-005453-4057qib7	8711	8	UCB	UCB	NNP
cord-005453-4057qib7	8711	9	,	,	,
cord-005453-4057qib7	8711	10	16	16	CD
cord-005453-4057qib7	8711	11	days	day	NNS
cord-005453-4057qib7	8711	12	for	for	IN
cord-005453-4057qib7	8711	13	bone	bone	NN
cord-005453-4057qib7	8711	14	marrow	marrow	NN
cord-005453-4057qib7	8711	15	(	(	-LRB-
cord-005453-4057qib7	8711	16	BM	BM	NNP
cord-005453-4057qib7	8711	17	)	)	-RRB-
cord-005453-4057qib7	8711	18	and	and	CC
cord-005453-4057qib7	8711	19	12	12	CD
cord-005453-4057qib7	8711	20	days	day	NNS
cord-005453-4057qib7	8711	21	for	for	IN
cord-005453-4057qib7	8711	22	peripheral	peripheral	JJ
cord-005453-4057qib7	8711	23	blood	blood	NN
cord-005453-4057qib7	8711	24	(	(	-LRB-
cord-005453-4057qib7	8711	25	PB	PB	NNP
cord-005453-4057qib7	8711	26	)	)	-RRB-
cord-005453-4057qib7	8712	1	(	(	-LRB-
cord-005453-4057qib7	8712	2	Figure	figure	NN
cord-005453-4057qib7	8712	3	3	3	CD
cord-005453-4057qib7	8712	4	)	)	-RRB-
cord-005453-4057qib7	8713	1	The	the	DT
cord-005453-4057qib7	8713	2	main	main	JJ
cord-005453-4057qib7	8713	3	complications	complication	NNS
cord-005453-4057qib7	8713	4	are	be	VBP
cord-005453-4057qib7	8713	5	infectious	infectious	JJ
cord-005453-4057qib7	8713	6	(	(	-LRB-
cord-005453-4057qib7	8713	7	bacterial	bacterial	JJ
cord-005453-4057qib7	8713	8	48.3	48.3	CD
cord-005453-4057qib7	8713	9	%	%	NN
cord-005453-4057qib7	8713	10	and	and	CC
cord-005453-4057qib7	8713	11	viral	viral	JJ
cord-005453-4057qib7	8713	12	39.7	39.7	CD
cord-005453-4057qib7	8713	13	%	%	NN
cord-005453-4057qib7	8713	14	)	)	-RRB-
cord-005453-4057qib7	8713	15	and	and	CC
cord-005453-4057qib7	8713	16	non	non	JJ
cord-005453-4057qib7	8713	17	-	-	JJ
cord-005453-4057qib7	8713	18	infectious	infectious	JJ
cord-005453-4057qib7	8713	19	as	as	IN
cord-005453-4057qib7	8713	20	pre	pre	JJ
cord-005453-4057qib7	8713	21	-	-	JJ
cord-005453-4057qib7	8713	22	graft	graft	JJ
cord-005453-4057qib7	8713	23	syndrome	syndrome	NN
cord-005453-4057qib7	8713	24	(	(	-LRB-
cord-005453-4057qib7	8713	25	23.1	23.1	CD
cord-005453-4057qib7	8713	26	%	%	NN
cord-005453-4057qib7	8713	27	)	)	-RRB-
cord-005453-4057qib7	8713	28	.	.	.
cord-005453-4057qib7	8714	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8714	2	:	:	:
cord-005453-4057qib7	8715	1	The	the	DT
cord-005453-4057qib7	8715	2	overall	overall	JJ
cord-005453-4057qib7	8715	3	survival	survival	NN
cord-005453-4057qib7	8715	4	was	be	VBD
cord-005453-4057qib7	8715	5	54.1	54.1	CD
cord-005453-4057qib7	8715	6	%	%	NN
cord-005453-4057qib7	8715	7	Survival	Survival	NNP
cord-005453-4057qib7	8715	8	according	accord	VBG
cord-005453-4057qib7	8715	9	to	to	IN
cord-005453-4057qib7	8715	10	pathology	pathology	NN
cord-005453-4057qib7	8715	11	was	be	VBD
cord-005453-4057qib7	8715	12	:	:	:
cord-005453-4057qib7	8715	13	100	100	CD
cord-005453-4057qib7	8715	14	%	%	NN
cord-005453-4057qib7	8715	15	Chediak	Chediak	NNP
cord-005453-4057qib7	8715	16	Higashi	Higashi	NNP
cord-005453-4057qib7	8715	17	syndrome	syndrome	NN
cord-005453-4057qib7	8715	18	,	,	,
cord-005453-4057qib7	8715	19	68	68	CD
cord-005453-4057qib7	8715	20	%	%	NN
cord-005453-4057qib7	8715	21	SCID	SCID	NNP
cord-005453-4057qib7	8715	22	,	,	,
cord-005453-4057qib7	8715	23	66.7	66.7	CD
cord-005453-4057qib7	8715	24	%	%	NN
cord-005453-4057qib7	8715	25	Griselli	Griselli	NNP
cord-005453-4057qib7	8715	26	syndrome	syndrome	NN
cord-005453-4057qib7	8715	27	,	,	,
cord-005453-4057qib7	8715	28	66.7	66.7	CD
cord-005453-4057qib7	8715	29	%	%	NN
cord-005453-4057qib7	8715	30	hyper	hyper	JJ
cord-005453-4057qib7	8715	31	IgM	IgM	NNP
cord-005453-4057qib7	8715	32	syndrome	syndrome	NN
cord-005453-4057qib7	8715	33	,	,	,
cord-005453-4057qib7	8715	34	60	60	CD
cord-005453-4057qib7	8715	35	%	%	NN
cord-005453-4057qib7	8715	36	WAS	be	VBD
cord-005453-4057qib7	8715	37	,	,	,
cord-005453-4057qib7	8715	38	57	57	CD
cord-005453-4057qib7	8715	39	%	%	NN
cord-005453-4057qib7	8715	40	CGD	CGD	NNP
cord-005453-4057qib7	8715	41	,	,	,
cord-005453-4057qib7	8715	42	50	50	CD
cord-005453-4057qib7	8715	43	%	%	NN
cord-005453-4057qib7	8715	44	Hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	8715	45	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	8715	46	.	.	.
cord-005453-4057qib7	8716	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8716	2	:	:	:
cord-005453-4057qib7	8717	1	Ramírez	Ramírez	NNP
cord-005453-4057qib7	8717	2	-	-	HYPH
cord-005453-4057qib7	8717	3	Uribe	Uribe	NNP
cord-005453-4057qib7	8717	4	Rosa	Rosa	NNP
cord-005453-4057qib7	8717	5	Maria	Maria	NNP
cord-005453-4057qib7	8717	6	Nideshda	Nideshda	NNP
cord-005453-4057qib7	8717	7	,	,	,
cord-005453-4057qib7	8717	8	Salazar	Salazar	NNP
cord-005453-4057qib7	8717	9	-	-	HYPH
cord-005453-4057qib7	8717	10	Rosales	Rosales	NNP
cord-005453-4057qib7	8717	11	Haydeé	Haydeé	NNP
cord-005453-4057qib7	8717	12	,	,	,
cord-005453-4057qib7	8717	13	Olaya	Olaya	NNP
cord-005453-4057qib7	8717	14	-	-	HYPH
cord-005453-4057qib7	8717	15	Vargas	Vargas	NNP
cord-005453-4057qib7	8717	16	Alberto	Alberto	NNP
cord-005453-4057qib7	8717	17	,	,	,
cord-005453-4057qib7	8717	18	López	López	NNP
cord-005453-4057qib7	8717	19	-	-	HYPH
cord-005453-4057qib7	8717	20	Hernández	Hernández	NNP
cord-005453-4057qib7	8717	21	Gerardo	Gerardo	NNP
cord-005453-4057qib7	8717	22	,	,	,
cord-005453-4057qib7	8717	23	del	del	NNP
cord-005453-4057qib7	8717	24	Campo	Campo	NNP
cord-005453-4057qib7	8717	25	-	-	HYPH
cord-005453-4057qib7	8717	26	Martínez	Martínez	NNP
cord-005453-4057qib7	8717	27	Maria	Maria	NNP
cord-005453-4057qib7	8717	28	de	de	IN
cord-005453-4057qib7	8717	29	los	los	NNP
cord-005453-4057qib7	8717	30	Àngeles	Àngeles	NNP
cord-005453-4057qib7	8718	1	We	-PRON-	PRP
cord-005453-4057qib7	8718	2	wish	wish	VBP
cord-005453-4057qib7	8718	3	to	to	TO
cord-005453-4057qib7	8718	4	confirm	confirm	VB
cord-005453-4057qib7	8718	5	that	that	IN
cord-005453-4057qib7	8718	6	there	there	EX
cord-005453-4057qib7	8718	7	are	be	VBP
cord-005453-4057qib7	8718	8	no	no	DT
cord-005453-4057qib7	8718	9	known	know	VBN
cord-005453-4057qib7	8718	10	conflicts	conflict	NNS
cord-005453-4057qib7	8718	11	of	of	IN
cord-005453-4057qib7	8718	12	interest	interest	NN
cord-005453-4057qib7	8718	13	associated	associate	VBN
cord-005453-4057qib7	8718	14	with	with	IN
cord-005453-4057qib7	8718	15	this	this	DT
cord-005453-4057qib7	8718	16	abstact	abstact	JJ
cord-005453-4057qib7	8718	17	,	,	,
cord-005453-4057qib7	8718	18	the	the	DT
cord-005453-4057qib7	8718	19	only	only	JJ
cord-005453-4057qib7	8718	20	financial	financial	JJ
cord-005453-4057qib7	8718	21	support	support	NN
cord-005453-4057qib7	8718	22	was	be	VBD
cord-005453-4057qib7	8718	23	provided	provide	VBN
cord-005453-4057qib7	8718	24	by	by	IN
cord-005453-4057qib7	8718	25	Mexican	Mexican	NNP
cord-005453-4057qib7	8718	26	Associations	Associations	NNPS
cord-005453-4057qib7	8718	27	that	that	IN
cord-005453-4057qib7	8718	28	helping	help	VBG
cord-005453-4057qib7	8718	29	children	child	NNS
cord-005453-4057qib7	8718	30	wiht	wiht	VB
cord-005453-4057qib7	8718	31	cancer	cancer	NN
cord-005453-4057qib7	8718	32	in	in	IN
cord-005453-4057qib7	8718	33	a	a	DT
cord-005453-4057qib7	8718	34	few	few	JJ
cord-005453-4057qib7	8718	35	patients	patient	NNS
cord-005453-4057qib7	8718	36	.	.	.
cord-005453-4057qib7	8719	1	Long	long	JJ
cord-005453-4057qib7	8719	2	-	-	HYPH
cord-005453-4057qib7	8719	3	term	term	NN
cord-005453-4057qib7	8719	4	outcome	outcome	NN
cord-005453-4057qib7	8719	5	following	follow	VBG
cord-005453-4057qib7	8719	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8719	7	stem	stem	NN
cord-005453-4057qib7	8719	8	cell	cell	NN
cord-005453-4057qib7	8719	9	transplantation	transplantation	NN
cord-005453-4057qib7	8719	10	of	of	IN
cord-005453-4057qib7	8719	11	Wiskott	Wiskott	NNP
cord-005453-4057qib7	8719	12	-	-	HYPH
cord-005453-4057qib7	8719	13	Aldrich	Aldrich	NNP
cord-005453-4057qib7	8719	14	syndrome	syndrome	NN
cord-005453-4057qib7	8719	15	in	in	IN
cord-005453-4057qib7	8719	16	a	a	DT
cord-005453-4057qib7	8719	17	single	single	JJ
cord-005453-4057qib7	8719	18	institute	institute	NN
cord-005453-4057qib7	8719	19	Mamoru	Mamoru	NNP
cord-005453-4057qib7	8719	20	Honda	Honda	NNP
cord-005453-4057qib7	8719	21	1,2	1,2	CD
cord-005453-4057qib7	8719	22	,	,	,
cord-005453-4057qib7	8719	23	Yukayo	Yukayo	NNP
cord-005453-4057qib7	8719	24	Terashita	Terashita	NNP
cord-005453-4057qib7	8719	25	1	1	CD
cord-005453-4057qib7	8719	26	,	,	,
cord-005453-4057qib7	8719	27	Minako	Minako	NNP
cord-005453-4057qib7	8719	28	Sugiyama	Sugiyama	NNP
cord-005453-4057qib7	8719	29	1	1	CD
cord-005453-4057qib7	8719	30	,	,	,
cord-005453-4057qib7	8719	31	Yuko	Yuko	NNP
cord-005453-4057qib7	8719	32	Cho	Cho	NNP
cord-005453-4057qib7	8719	33	1	1	CD
cord-005453-4057qib7	8719	34	,	,	,
cord-005453-4057qib7	8719	35	Akihiro	Akihiro	NNP
cord-005453-4057qib7	8719	36	Iguchi	Iguchi	NNP
cord-005453-4057qib7	8720	1	1	1	CD
cord-005453-4057qib7	8720	2	Background	background	NN
cord-005453-4057qib7	8720	3	:	:	:
cord-005453-4057qib7	8721	1	Wiskott	Wiskott	NNP
cord-005453-4057qib7	8721	2	-	-	HYPH
cord-005453-4057qib7	8721	3	Aldrich	Aldrich	NNP
cord-005453-4057qib7	8721	4	syndrome	syndrome	NN
cord-005453-4057qib7	8721	5	(	(	-LRB-
cord-005453-4057qib7	8721	6	WAS	be	VBD
cord-005453-4057qib7	8721	7	)	)	-RRB-
cord-005453-4057qib7	8721	8	is	be	VBZ
cord-005453-4057qib7	8721	9	an	an	DT
cord-005453-4057qib7	8721	10	Xlinked	xlinked	JJ
cord-005453-4057qib7	8721	11	disorder	disorder	NN
cord-005453-4057qib7	8721	12	of	of	IN
cord-005453-4057qib7	8721	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8721	14	cells	cell	NNS
cord-005453-4057qib7	8721	15	,	,	,
cord-005453-4057qib7	8721	16	characterized	characterize	VBN
cord-005453-4057qib7	8721	17	by	by	IN
cord-005453-4057qib7	8721	18	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	8721	19	with	with	IN
cord-005453-4057qib7	8721	20	small	small	JJ
cord-005453-4057qib7	8721	21	platelets	platelet	NNS
cord-005453-4057qib7	8721	22	,	,	,
cord-005453-4057qib7	8721	23	eczema	eczema	NN
cord-005453-4057qib7	8721	24	,	,	,
cord-005453-4057qib7	8721	25	and	and	CC
cord-005453-4057qib7	8721	26	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	8721	27	.	.	.
cord-005453-4057qib7	8722	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8722	2	stem	stem	NN
cord-005453-4057qib7	8722	3	cell	cell	NN
cord-005453-4057qib7	8722	4	transplantation	transplantation	NN
cord-005453-4057qib7	8722	5	(	(	-LRB-
cord-005453-4057qib7	8722	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8722	7	)	)	-RRB-
cord-005453-4057qib7	8722	8	is	be	VBZ
cord-005453-4057qib7	8722	9	the	the	DT
cord-005453-4057qib7	8722	10	only	only	JJ
cord-005453-4057qib7	8722	11	curative	curative	JJ
cord-005453-4057qib7	8722	12	treatment	treatment	NN
cord-005453-4057qib7	8722	13	,	,	,
cord-005453-4057qib7	8722	14	and	and	CC
cord-005453-4057qib7	8722	15	it	-PRON-	PRP
cord-005453-4057qib7	8722	16	is	be	VBZ
cord-005453-4057qib7	8722	17	recommended	recommend	VBN
cord-005453-4057qib7	8722	18	to	to	TO
cord-005453-4057qib7	8722	19	be	be	VB
cord-005453-4057qib7	8722	20	performed	perform	VBN
cord-005453-4057qib7	8722	21	as	as	RB
cord-005453-4057qib7	8722	22	soon	soon	RB
cord-005453-4057qib7	8722	23	as	as	IN
cord-005453-4057qib7	8722	24	WAS	be	VBD
cord-005453-4057qib7	8722	25	is	be	VBZ
cord-005453-4057qib7	8722	26	diagnosed	diagnose	VBN
cord-005453-4057qib7	8722	27	.	.	.
cord-005453-4057qib7	8723	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	8723	2	conditioning	conditioning	NN
cord-005453-4057qib7	8723	3	before	before	IN
cord-005453-4057qib7	8723	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8723	5	is	be	VBZ
cord-005453-4057qib7	8723	6	recommended	recommend	VBN
cord-005453-4057qib7	8723	7	because	because	IN
cord-005453-4057qib7	8723	8	there	there	EX
cord-005453-4057qib7	8723	9	is	be	VBZ
cord-005453-4057qib7	8723	10	a	a	DT
cord-005453-4057qib7	8723	11	high	high	JJ
cord-005453-4057qib7	8723	12	risk	risk	NN
cord-005453-4057qib7	8723	13	of	of	IN
cord-005453-4057qib7	8723	14	development	development	NN
cord-005453-4057qib7	8723	15	of	of	IN
cord-005453-4057qib7	8723	16	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8723	17	disease	disease	NN
cord-005453-4057qib7	8723	18	in	in	IN
cord-005453-4057qib7	8723	19	patients	patient	NNS
cord-005453-4057qib7	8723	20	with	with	IN
cord-005453-4057qib7	8723	21	mixed	mixed	JJ
cord-005453-4057qib7	8723	22	chimera	chimera	NN
cord-005453-4057qib7	8723	23	after	after	IN
cord-005453-4057qib7	8723	24	HSCT	HSCT	NNP
cord-005453-4057qib7	8723	25	.	.	.
cord-005453-4057qib7	8724	1	However	however	RB
cord-005453-4057qib7	8724	2	,	,	,
cord-005453-4057qib7	8724	3	there	there	EX
cord-005453-4057qib7	8724	4	are	be	VBP
cord-005453-4057qib7	8724	5	few	few	JJ
cord-005453-4057qib7	8724	6	reports	report	NNS
cord-005453-4057qib7	8724	7	about	about	IN
cord-005453-4057qib7	8724	8	late	late	JJ
cord-005453-4057qib7	8724	9	complications	complication	NNS
cord-005453-4057qib7	8724	10	such	such	JJ
cord-005453-4057qib7	8724	11	as	as	IN
cord-005453-4057qib7	8724	12	pubertal	pubertal	JJ
cord-005453-4057qib7	8724	13	development	development	NN
cord-005453-4057qib7	8724	14	and	and	CC
cord-005453-4057qib7	8724	15	eruption	eruption	NN
cord-005453-4057qib7	8724	16	of	of	IN
cord-005453-4057qib7	8724	17	teeth	tooth	NNS
cord-005453-4057qib7	8724	18	in	in	IN
cord-005453-4057qib7	8724	19	patients	patient	NNS
cord-005453-4057qib7	8724	20	with	with	IN
cord-005453-4057qib7	8724	21	WAS	be	VBD
cord-005453-4057qib7	8724	22	receiving	receive	VBG
cord-005453-4057qib7	8724	23	HSCT	HSCT	NNP
cord-005453-4057qib7	8724	24	.	.	.
cord-005453-4057qib7	8725	1	Thus	thus	RB
cord-005453-4057qib7	8725	2	,	,	,
cord-005453-4057qib7	8725	3	we	-PRON-	PRP
cord-005453-4057qib7	8725	4	evaluated	evaluate	VBD
cord-005453-4057qib7	8725	5	late	late	JJ
cord-005453-4057qib7	8725	6	complications	complication	NNS
cord-005453-4057qib7	8725	7	in	in	IN
cord-005453-4057qib7	8725	8	patients	patient	NNS
cord-005453-4057qib7	8725	9	with	with	IN
cord-005453-4057qib7	8725	10	WAS	be	VBD
cord-005453-4057qib7	8725	11	receiving	receive	VBG
cord-005453-4057qib7	8725	12	HSCT	HSCT	NNP
cord-005453-4057qib7	8725	13	at	at	IN
cord-005453-4057qib7	8725	14	Hokkaido	Hokkaido	NNP
cord-005453-4057qib7	8725	15	University	University	NNP
cord-005453-4057qib7	8725	16	Hospital	Hospital	NNP
cord-005453-4057qib7	8725	17	.	.	.
cord-005453-4057qib7	8726	1	Methods	method	NNS
cord-005453-4057qib7	8726	2	:	:	:
cord-005453-4057qib7	8727	1	We	-PRON-	PRP
cord-005453-4057qib7	8727	2	reviewed	review	VBD
cord-005453-4057qib7	8727	3	medical	medical	JJ
cord-005453-4057qib7	8727	4	records	record	NNS
cord-005453-4057qib7	8727	5	of	of	IN
cord-005453-4057qib7	8727	6	8	8	CD
cord-005453-4057qib7	8727	7	male	male	JJ
cord-005453-4057qib7	8727	8	patients	patient	NNS
cord-005453-4057qib7	8727	9	with	with	IN
cord-005453-4057qib7	8727	10	WAS	be	VBD
cord-005453-4057qib7	8727	11	who	who	WP
cord-005453-4057qib7	8727	12	received	receive	VBD
cord-005453-4057qib7	8727	13	HSCT	HSCT	NNP
cord-005453-4057qib7	8727	14	between	between	IN
cord-005453-4057qib7	8727	15	1995	1995	CD
cord-005453-4057qib7	8727	16	and	and	CC
cord-005453-4057qib7	8727	17	2017	2017	CD
cord-005453-4057qib7	8727	18	.	.	.
cord-005453-4057qib7	8728	1	Results	result	NNS
cord-005453-4057qib7	8728	2	:	:	:
cord-005453-4057qib7	8729	1	Mean	mean	JJ
cord-005453-4057qib7	8729	2	age	age	NN
cord-005453-4057qib7	8729	3	at	at	IN
cord-005453-4057qib7	8729	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8729	5	was	be	VBD
cord-005453-4057qib7	8729	6	1.4	1.4	CD
cord-005453-4057qib7	8729	7	(	(	-LRB-
cord-005453-4057qib7	8729	8	range	range	NN
cord-005453-4057qib7	8729	9	,	,	,
cord-005453-4057qib7	8729	10	0.6	0.6	CD
cord-005453-4057qib7	8729	11	-	-	SYM
cord-005453-4057qib7	8729	12	6.8	6.8	CD
cord-005453-4057qib7	8729	13	)	)	-RRB-
cord-005453-4057qib7	8729	14	years	year	NNS
cord-005453-4057qib7	8729	15	,	,	,
cord-005453-4057qib7	8729	16	and	and	CC
cord-005453-4057qib7	8729	17	median	median	JJ
cord-005453-4057qib7	8729	18	follow	follow	NN
cord-005453-4057qib7	8729	19	-	-	HYPH
cord-005453-4057qib7	8729	20	up	up	NN
cord-005453-4057qib7	8729	21	time	time	NN
cord-005453-4057qib7	8729	22	after	after	IN
cord-005453-4057qib7	8729	23	HSCT	HSCT	NNP
cord-005453-4057qib7	8729	24	was	be	VBD
cord-005453-4057qib7	8729	25	13.8	13.8	CD
cord-005453-4057qib7	8730	1	(	(	-LRB-
cord-005453-4057qib7	8730	2	range	range	VBP
cord-005453-4057qib7	8730	3	2.9	2.9	CD
cord-005453-4057qib7	8730	4	-	-	HYPH
cord-005453-4057qib7	8730	5	23.4	23.4	CD
cord-005453-4057qib7	8730	6	)	)	-RRB-
cord-005453-4057qib7	8730	7	years	year	NNS
cord-005453-4057qib7	8730	8	.	.	.
cord-005453-4057qib7	8731	1	Conditioning	conditioning	NN
cord-005453-4057qib7	8731	2	regimen	regimen	NN
cord-005453-4057qib7	8731	3	in	in	IN
cord-005453-4057qib7	8731	4	all	all	DT
cord-005453-4057qib7	8731	5	patients	patient	NNS
cord-005453-4057qib7	8731	6	comprised	comprise	VBN
cord-005453-4057qib7	8731	7	busulfan	busulfan	NN
cord-005453-4057qib7	8731	8	at	at	IN
cord-005453-4057qib7	8731	9	4	4	CD
cord-005453-4057qib7	8731	10	mg	mg	NNP
cord-005453-4057qib7	8731	11	/	/	SYM
cord-005453-4057qib7	8731	12	kg	kg	NN
cord-005453-4057qib7	8731	13	for	for	IN
cord-005453-4057qib7	8731	14	4	4	CD
cord-005453-4057qib7	8731	15	days	day	NNS
cord-005453-4057qib7	8731	16	and	and	CC
cord-005453-4057qib7	8731	17	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	8731	18	at	at	IN
cord-005453-4057qib7	8731	19	60	60	CD
cord-005453-4057qib7	8731	20	mg	mg	NN
cord-005453-4057qib7	8731	21	/	/	SYM
cord-005453-4057qib7	8731	22	kg	kg	NNS
cord-005453-4057qib7	8731	23	for	for	IN
cord-005453-4057qib7	8731	24	2	2	CD
cord-005453-4057qib7	8731	25	days	day	NNS
cord-005453-4057qib7	8731	26	or	or	CC
cord-005453-4057qib7	8732	1	50	50	CD
cord-005453-4057qib7	8732	2	mg	mg	NNP
cord-005453-4057qib7	8732	3	/	/	SYM
cord-005453-4057qib7	8732	4	kg	kg	NN
cord-005453-4057qib7	8732	5	for	for	IN
cord-005453-4057qib7	8732	6	4	4	CD
cord-005453-4057qib7	8732	7	days	day	NNS
cord-005453-4057qib7	8732	8	.	.	.
cord-005453-4057qib7	8733	1	Additionally	additionally	RB
cord-005453-4057qib7	8733	2	,	,	,
cord-005453-4057qib7	8733	3	anti	anti	JJ
cord-005453-4057qib7	8733	4	-	-	JJ
cord-005453-4057qib7	8733	5	thymocyte	thymocyte	JJ
cord-005453-4057qib7	8733	6	globulin	globulin	NN
cord-005453-4057qib7	8733	7	at	at	IN
cord-005453-4057qib7	8733	8	2.5	2.5	CD
cord-005453-4057qib7	8733	9	mg	mg	NNP
cord-005453-4057qib7	8733	10	/	/	SYM
cord-005453-4057qib7	8733	11	kg	kg	NNP
cord-005453-4057qib7	8733	12	/	/	SYM
cord-005453-4057qib7	8733	13	day	day	NN
cord-005453-4057qib7	8733	14	for	for	IN
cord-005453-4057qib7	8733	15	1	1	CD
cord-005453-4057qib7	8733	16	-	-	SYM
cord-005453-4057qib7	8733	17	2	2	CD
cord-005453-4057qib7	8733	18	days	day	NNS
cord-005453-4057qib7	8733	19	was	be	VBD
cord-005453-4057qib7	8733	20	administered	administer	VBN
cord-005453-4057qib7	8733	21	in	in	IN
cord-005453-4057qib7	8733	22	6	6	CD
cord-005453-4057qib7	8733	23	patients	patient	NNS
cord-005453-4057qib7	8733	24	.	.	.
cord-005453-4057qib7	8734	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	8734	2	,	,	,
cord-005453-4057qib7	8734	3	normal	normal	JJ
cord-005453-4057qib7	8734	4	platelet	platelet	NN
cord-005453-4057qib7	8734	5	count	count	NN
cord-005453-4057qib7	8734	6	,	,	,
cord-005453-4057qib7	8734	7	and	and	CC
cord-005453-4057qib7	8734	8	complete	complete	JJ
cord-005453-4057qib7	8734	9	chimera	chimera	NN
cord-005453-4057qib7	8734	10	were	be	VBD
cord-005453-4057qib7	8734	11	confirmed	confirm	VBN
cord-005453-4057qib7	8734	12	in	in	IN
cord-005453-4057qib7	8734	13	all	all	DT
cord-005453-4057qib7	8734	14	patients	patient	NNS
cord-005453-4057qib7	8734	15	.	.	.
cord-005453-4057qib7	8735	1	No	no	DT
cord-005453-4057qib7	8735	2	patients	patient	NNS
cord-005453-4057qib7	8735	3	showed	show	VBD
cord-005453-4057qib7	8735	4	complications	complication	NNS
cord-005453-4057qib7	8735	5	such	such	JJ
cord-005453-4057qib7	8735	6	as	as	IN
cord-005453-4057qib7	8735	7	severe	severe	JJ
cord-005453-4057qib7	8735	8	chronic	chronic	JJ
cord-005453-4057qib7	8735	9	graft	graft	NN
cord-005453-4057qib7	8735	10	-	-	HYPH
cord-005453-4057qib7	8735	11	versus	versus	IN
cord-005453-4057qib7	8735	12	-	-	HYPH
cord-005453-4057qib7	8735	13	host	host	NN
cord-005453-4057qib7	8735	14	disease	disease	NN
cord-005453-4057qib7	8735	15	,	,	,
cord-005453-4057qib7	8735	16	autoimmune	autoimmune	JJ
cord-005453-4057qib7	8735	17	disease	disease	NN
cord-005453-4057qib7	8735	18	,	,	,
cord-005453-4057qib7	8735	19	short	short	JJ
cord-005453-4057qib7	8735	20	stature	stature	NN
cord-005453-4057qib7	8735	21	(	(	-LRB-
cord-005453-4057qib7	8735	22	≤	≤	NN
cord-005453-4057qib7	8735	23	-2.0	-2.0	HYPH
cord-005453-4057qib7	8735	24	SD	sd	NN
cord-005453-4057qib7	8735	25	)	)	-RRB-
cord-005453-4057qib7	8735	26	and	and	CC
cord-005453-4057qib7	8735	27	second	second	JJ
cord-005453-4057qib7	8735	28	malignancy	malignancy	NN
cord-005453-4057qib7	8735	29	.	.	.
cord-005453-4057qib7	8736	1	However	however	RB
cord-005453-4057qib7	8736	2	,	,	,
cord-005453-4057qib7	8736	3	high	high	JJ
cord-005453-4057qib7	8736	4	IgE	IgE	NNP
cord-005453-4057qib7	8736	5	level	level	NN
cord-005453-4057qib7	8736	6	was	be	VBD
cord-005453-4057qib7	8736	7	observed	observe	VBN
cord-005453-4057qib7	8736	8	in	in	IN
cord-005453-4057qib7	8736	9	4	4	CD
cord-005453-4057qib7	8736	10	patients	patient	NNS
cord-005453-4057qib7	8736	11	.	.	.
cord-005453-4057qib7	8737	1	Pubertal	pubertal	JJ
cord-005453-4057qib7	8737	2	development	development	NN
cord-005453-4057qib7	8737	3	has	have	VBZ
cord-005453-4057qib7	8737	4	been	be	VBN
cord-005453-4057qib7	8737	5	confirmed	confirm	VBN
cord-005453-4057qib7	8737	6	in	in	IN
cord-005453-4057qib7	8737	7	6	6	CD
cord-005453-4057qib7	8737	8	patients	patient	NNS
cord-005453-4057qib7	8737	9	.	.	.
cord-005453-4057qib7	8738	1	Lack	lack	NN
cord-005453-4057qib7	8738	2	of	of	IN
cord-005453-4057qib7	8738	3	complete	complete	JJ
cord-005453-4057qib7	8738	4	eruption	eruption	NN
cord-005453-4057qib7	8738	5	of	of	IN
cord-005453-4057qib7	8738	6	permanent	permanent	JJ
cord-005453-4057qib7	8738	7	teeth	tooth	NNS
cord-005453-4057qib7	8738	8	has	have	VBZ
cord-005453-4057qib7	8738	9	been	be	VBN
cord-005453-4057qib7	8738	10	observed	observe	VBN
cord-005453-4057qib7	8738	11	in	in	IN
cord-005453-4057qib7	8738	12	3	3	CD
cord-005453-4057qib7	8738	13	patients	patient	NNS
cord-005453-4057qib7	8738	14	who	who	WP
cord-005453-4057qib7	8738	15	received	receive	VBD
cord-005453-4057qib7	8738	16	HSCT	HSCT	NNP
cord-005453-4057qib7	8738	17	at	at	IN
cord-005453-4057qib7	8738	18	age	age	NN
cord-005453-4057qib7	8738	19	of	of	IN
cord-005453-4057qib7	8738	20	<	<	$
cord-005453-4057qib7	8738	21	2	2	CD
cord-005453-4057qib7	8738	22	years	year	NNS
cord-005453-4057qib7	8738	23	.	.	.
cord-005453-4057qib7	8739	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8739	2	:	:	:
cord-005453-4057qib7	8740	1	Although	although	IN
cord-005453-4057qib7	8740	2	this	this	DT
cord-005453-4057qib7	8740	3	was	be	VBD
cord-005453-4057qib7	8740	4	a	a	DT
cord-005453-4057qib7	8740	5	small	small	JJ
cord-005453-4057qib7	8740	6	-	-	HYPH
cord-005453-4057qib7	8740	7	cohort	cohort	NN
cord-005453-4057qib7	8740	8	study	study	NN
cord-005453-4057qib7	8740	9	in	in	IN
cord-005453-4057qib7	8740	10	a	a	DT
cord-005453-4057qib7	8740	11	single	single	JJ
cord-005453-4057qib7	8740	12	institute	institute	NN
cord-005453-4057qib7	8740	13	,	,	,
cord-005453-4057qib7	8740	14	complete	complete	JJ
cord-005453-4057qib7	8740	15	chimera	chimera	NN
cord-005453-4057qib7	8740	16	has	have	VBZ
cord-005453-4057qib7	8740	17	been	be	VBN
cord-005453-4057qib7	8740	18	achieved	achieve	VBN
cord-005453-4057qib7	8740	19	in	in	IN
cord-005453-4057qib7	8740	20	all	all	DT
cord-005453-4057qib7	8740	21	patients	patient	NNS
cord-005453-4057qib7	8740	22	who	who	WP
cord-005453-4057qib7	8740	23	received	receive	VBD
cord-005453-4057qib7	8740	24	HSCT	HSCT	NNP
cord-005453-4057qib7	8740	25	with	with	IN
cord-005453-4057qib7	8740	26	busulfan	busulfan	NN
cord-005453-4057qib7	8740	27	-	-	HYPH
cord-005453-4057qib7	8740	28	based	base	VBN
cord-005453-4057qib7	8740	29	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8740	30	conditioning	conditioning	NN
cord-005453-4057qib7	8740	31	.	.	.
cord-005453-4057qib7	8741	1	However	however	RB
cord-005453-4057qib7	8741	2	,	,	,
cord-005453-4057qib7	8741	3	late	late	JJ
cord-005453-4057qib7	8741	4	complications	complication	NNS
cord-005453-4057qib7	8741	5	such	such	JJ
cord-005453-4057qib7	8741	6	as	as	IN
cord-005453-4057qib7	8741	7	male	male	JJ
cord-005453-4057qib7	8741	8	infertility	infertility	NN
cord-005453-4057qib7	8741	9	and	and	CC
cord-005453-4057qib7	8741	10	incomplete	incomplete	JJ
cord-005453-4057qib7	8741	11	eruption	eruption	NN
cord-005453-4057qib7	8741	12	of	of	IN
cord-005453-4057qib7	8741	13	permanent	permanent	JJ
cord-005453-4057qib7	8741	14	teeth	tooth	NNS
cord-005453-4057qib7	8741	15	remain	remain	VBP
cord-005453-4057qib7	8741	16	major	major	JJ
cord-005453-4057qib7	8741	17	problems	problem	NNS
cord-005453-4057qib7	8741	18	.	.	.
cord-005453-4057qib7	8742	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8742	2	:	:	:
cord-005453-4057qib7	8742	3	Nothing	nothing	NN
cord-005453-4057qib7	8742	4	to	to	TO
cord-005453-4057qib7	8742	5	declare	declare	VB
cord-005453-4057qib7	8742	6	Methods	method	NNS
cord-005453-4057qib7	8742	7	:	:	:
cord-005453-4057qib7	8742	8	We	-PRON-	PRP
cord-005453-4057qib7	8742	9	performed	perform	VBD
cord-005453-4057qib7	8742	10	unrelated	unrelated	JJ
cord-005453-4057qib7	8742	11	umbilical	umbilical	JJ
cord-005453-4057qib7	8742	12	cord	cord	NN
cord-005453-4057qib7	8742	13	blood	blood	NN
cord-005453-4057qib7	8742	14	transplantation	transplantation	NN
cord-005453-4057qib7	8742	15	(	(	-LRB-
cord-005453-4057qib7	8742	16	UCBT	UCBT	NNP
cord-005453-4057qib7	8742	17	)	)	-RRB-
cord-005453-4057qib7	8742	18	in	in	IN
cord-005453-4057qib7	8742	19	5	5	CD
cord-005453-4057qib7	8742	20	consecutive	consecutive	JJ
cord-005453-4057qib7	8742	21	children	child	NNS
cord-005453-4057qib7	8742	22	with	with	IN
cord-005453-4057qib7	8742	23	LAD	LAD	NNP
cord-005453-4057qib7	8742	24	-	-	HYPH
cord-005453-4057qib7	8742	25	I.	I.	NNP
cord-005453-4057qib7	8742	26	Median	Median	NNP
cord-005453-4057qib7	8742	27	age	age	NN
cord-005453-4057qib7	8742	28	of	of	IN
cord-005453-4057qib7	8742	29	5	5	CD
cord-005453-4057qib7	8742	30	children	child	NNS
cord-005453-4057qib7	8742	31	was	be	VBD
cord-005453-4057qib7	8742	32	13	13	CD
cord-005453-4057qib7	8742	33	months	month	NNS
cord-005453-4057qib7	8742	34	(	(	-LRB-
cord-005453-4057qib7	8742	35	range	range	NN
cord-005453-4057qib7	8742	36	,	,	,
cord-005453-4057qib7	8742	37	8	8	CD
cord-005453-4057qib7	8742	38	to	to	TO
cord-005453-4057qib7	8742	39	131	131	CD
cord-005453-4057qib7	8742	40	months	month	NNS
cord-005453-4057qib7	8742	41	)	)	-RRB-
cord-005453-4057qib7	8742	42	,	,	,
cord-005453-4057qib7	8742	43	and	and	CC
cord-005453-4057qib7	8742	44	median	median	JJ
cord-005453-4057qib7	8742	45	body	body	NN
cord-005453-4057qib7	8742	46	weight	weight	NN
cord-005453-4057qib7	8742	47	was	be	VBD
cord-005453-4057qib7	8742	48	13	13	CD
cord-005453-4057qib7	8742	49	kg	kg	NN
cord-005453-4057qib7	8742	50	(	(	-LRB-
cord-005453-4057qib7	8742	51	range	range	NN
cord-005453-4057qib7	8742	52	,	,	,
cord-005453-4057qib7	8742	53	8	8	CD
cord-005453-4057qib7	8742	54	to	to	IN
cord-005453-4057qib7	8742	55	24.3	24.3	CD
cord-005453-4057qib7	8742	56	kg	kg	NNS
cord-005453-4057qib7	8742	57	)	)	-RRB-
cord-005453-4057qib7	8742	58	.	.	.
cord-005453-4057qib7	8743	1	All	all	DT
cord-005453-4057qib7	8743	2	patients	patient	NNS
cord-005453-4057qib7	8743	3	received	receive	VBD
cord-005453-4057qib7	8743	4	myeloablative	myeloablative	NNP
cord-005453-4057qib7	8743	5	conditioning	conditioning	NN
cord-005453-4057qib7	8743	6	regimen	regimen	NN
cord-005453-4057qib7	8743	7	consisting	consist	VBG
cord-005453-4057qib7	8743	8	of	of	IN
cord-005453-4057qib7	8743	9	busulfan	busulfan	NN
cord-005453-4057qib7	8743	10	,	,	,
cord-005453-4057qib7	8743	11	fludarabine	fludarabine	NN
cord-005453-4057qib7	8743	12	and	and	CC
cord-005453-4057qib7	8743	13	cytarabine	cytarabine	NN
cord-005453-4057qib7	8743	14	.	.	.
cord-005453-4057qib7	8744	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8744	2	for	for	IN
cord-005453-4057qib7	8744	3	graft	graft	NN
cord-005453-4057qib7	8744	4	-	-	HYPH
cord-005453-4057qib7	8744	5	versus	versus	IN
cord-005453-4057qib7	8744	6	-	-	HYPH
cord-005453-4057qib7	8744	7	host	host	NN
cord-005453-4057qib7	8744	8	disease	disease	NN
cord-005453-4057qib7	8744	9	(	(	-LRB-
cord-005453-4057qib7	8744	10	GVHD	GVHD	NNP
cord-005453-4057qib7	8744	11	)	)	-RRB-
cord-005453-4057qib7	8744	12	was	be	VBD
cord-005453-4057qib7	8744	13	tacrolimus	tacrolimus	JJ
cord-005453-4057qib7	8744	14	.	.	.
cord-005453-4057qib7	8745	1	All	all	DT
cord-005453-4057qib7	8745	2	patients	patient	NNS
cord-005453-4057qib7	8745	3	received	receive	VBD
cord-005453-4057qib7	8745	4	a	a	DT
cord-005453-4057qib7	8745	5	≤2	≤2	NNP
cord-005453-4057qib7	8745	6	HLA	HLA	NNP
cord-005453-4057qib7	8745	7	alleles	allele	NNS
cord-005453-4057qib7	8745	8	-	-	HYPH
cord-005453-4057qib7	8745	9	mismatched	mismatch	VBN
cord-005453-4057qib7	8745	10	cord	cord	NN
cord-005453-4057qib7	8745	11	unit	unit	NN
cord-005453-4057qib7	8745	12	,	,	,
cord-005453-4057qib7	8745	13	1	1	CD
cord-005453-4057qib7	8745	14	was	be	VBD
cord-005453-4057qib7	8745	15	HLA	HLA	NNP
cord-005453-4057qib7	8745	16	fully	fully	RB
cord-005453-4057qib7	8745	17	matched	match	VBN
cord-005453-4057qib7	8745	18	,	,	,
cord-005453-4057qib7	8745	19	3	3	CD
cord-005453-4057qib7	8745	20	were	be	VBD
cord-005453-4057qib7	8745	21	9/10	9/10	CD
cord-005453-4057qib7	8745	22	matched	match	VBN
cord-005453-4057qib7	8745	23	,	,	,
cord-005453-4057qib7	8745	24	1	1	CD
cord-005453-4057qib7	8745	25	was	be	VBD
cord-005453-4057qib7	8745	26	8/10	8/10	CD
cord-005453-4057qib7	8745	27	matched	match	VBN
cord-005453-4057qib7	8745	28	.	.	.
cord-005453-4057qib7	8746	1	Median	median	JJ
cord-005453-4057qib7	8746	2	nucleated	nucleated	JJ
cord-005453-4057qib7	8746	3	cells	cell	NNS
cord-005453-4057qib7	8746	4	of	of	IN
cord-005453-4057qib7	8746	5	the	the	DT
cord-005453-4057qib7	8746	6	cord	cord	NN
cord-005453-4057qib7	8746	7	blood	blood	NN
cord-005453-4057qib7	8746	8	were	be	VBD
cord-005453-4057qib7	8746	9	14.23x10	14.23x10	CD
cord-005453-4057qib7	8746	10	7	7	CD
cord-005453-4057qib7	8747	1	/kg	/kg	.
cord-005453-4057qib7	8748	1	(	(	-LRB-
cord-005453-4057qib7	8748	2	range	range	NN
cord-005453-4057qib7	8748	3	,	,	,
cord-005453-4057qib7	8748	4	4.6	4.6	CD
cord-005453-4057qib7	8748	5	to	to	TO
cord-005453-4057qib7	8748	6	20.62	20.62	CD
cord-005453-4057qib7	8748	7	x10	x10	CD
cord-005453-4057qib7	8748	8	7	7	CD
cord-005453-4057qib7	8748	9	/kg	/kg	.
cord-005453-4057qib7	8748	10	)	)	-RRB-
cord-005453-4057qib7	8748	11	,	,	,
cord-005453-4057qib7	8748	12	and	and	CC
cord-005453-4057qib7	8748	13	median	median	JJ
cord-005453-4057qib7	8748	14	CD34	CD34	NNP
cord-005453-4057qib7	8748	15	+	+	CC
cord-005453-4057qib7	8748	16	cells	cell	NNS
cord-005453-4057qib7	8748	17	were	be	VBD
cord-005453-4057qib7	8748	18	3.87	3.87	CD
cord-005453-4057qib7	8748	19	x10	x10	CD
cord-005453-4057qib7	8748	20	5	5	CD
cord-005453-4057qib7	8748	21	/	/	SYM
cord-005453-4057qib7	8748	22	kg	kg	NN
cord-005453-4057qib7	8748	23	(	(	-LRB-
cord-005453-4057qib7	8748	24	range	range	NN
cord-005453-4057qib7	8748	25	,	,	,
cord-005453-4057qib7	8748	26	1.95	1.95	CD
cord-005453-4057qib7	8748	27	to	to	TO
cord-005453-4057qib7	8748	28	5.77	5.77	CD
cord-005453-4057qib7	8748	29	x10	x10	CD
cord-005453-4057qib7	8748	30	5	5	CD
cord-005453-4057qib7	8749	1	/kg	/kg	LS
cord-005453-4057qib7	8749	2	)	)	-RRB-
cord-005453-4057qib7	8749	3	.	.	.
cord-005453-4057qib7	8750	1	Results	result	NNS
cord-005453-4057qib7	8750	2	:	:	:
cord-005453-4057qib7	8751	1	All	all	DT
cord-005453-4057qib7	8751	2	patients	patient	NNS
cord-005453-4057qib7	8751	3	engrafted	engraft	VBD
cord-005453-4057qib7	8751	4	,	,	,
cord-005453-4057qib7	8751	5	median	median	JJ
cord-005453-4057qib7	8751	6	time	time	NN
cord-005453-4057qib7	8751	7	of	of	IN
cord-005453-4057qib7	8751	8	neutrophil	neutrophil	NN
cord-005453-4057qib7	8751	9	engraftment	engraftment	NN
cord-005453-4057qib7	8751	10	was	be	VBD
cord-005453-4057qib7	8751	11	24	24	CD
cord-005453-4057qib7	8751	12	days	day	NNS
cord-005453-4057qib7	8751	13	(	(	-LRB-
cord-005453-4057qib7	8751	14	range	range	NN
cord-005453-4057qib7	8751	15	,	,	,
cord-005453-4057qib7	8751	16	13	13	CD
cord-005453-4057qib7	8751	17	to	to	IN
cord-005453-4057qib7	8751	18	28d	28d	CD
cord-005453-4057qib7	8751	19	)	)	-RRB-
cord-005453-4057qib7	8751	20	,	,	,
cord-005453-4057qib7	8751	21	and	and	CC
cord-005453-4057qib7	8751	22	median	median	JJ
cord-005453-4057qib7	8751	23	time	time	NN
cord-005453-4057qib7	8751	24	of	of	IN
cord-005453-4057qib7	8751	25	platelet	platelet	NN
cord-005453-4057qib7	8751	26	engraftment	engraftment	NN
cord-005453-4057qib7	8751	27	was	be	VBD
cord-005453-4057qib7	8751	28	33	33	CD
cord-005453-4057qib7	8751	29	days	day	NNS
cord-005453-4057qib7	8751	30	(	(	-LRB-
cord-005453-4057qib7	8751	31	range	range	NN
cord-005453-4057qib7	8751	32	,	,	,
cord-005453-4057qib7	8751	33	32	32	CD
cord-005453-4057qib7	8751	34	to	to	IN
cord-005453-4057qib7	8751	35	56d	56d	CD
cord-005453-4057qib7	8751	36	)	)	-RRB-
cord-005453-4057qib7	8751	37	.	.	.
cord-005453-4057qib7	8752	1	Median	median	JJ
cord-005453-4057qib7	8752	2	follow	follow	NN
cord-005453-4057qib7	8752	3	-	-	HYPH
cord-005453-4057qib7	8752	4	up	up	RP
cord-005453-4057qib7	8752	5	time	time	NN
cord-005453-4057qib7	8752	6	was	be	VBD
cord-005453-4057qib7	8752	7	13	13	CD
cord-005453-4057qib7	8752	8	months	month	NNS
cord-005453-4057qib7	8752	9	(	(	-LRB-
cord-005453-4057qib7	8752	10	range	range	NN
cord-005453-4057qib7	8752	11	,	,	,
cord-005453-4057qib7	8752	12	2	2	CD
cord-005453-4057qib7	8752	13	to	to	TO
cord-005453-4057qib7	8752	14	25	25	CD
cord-005453-4057qib7	8752	15	months	month	NNS
cord-005453-4057qib7	8752	16	)	)	-RRB-
cord-005453-4057qib7	8752	17	,	,	,
cord-005453-4057qib7	8752	18	all	all	DT
cord-005453-4057qib7	8752	19	5	5	CD
cord-005453-4057qib7	8752	20	patients	patient	NNS
cord-005453-4057qib7	8752	21	were	be	VBD
cord-005453-4057qib7	8752	22	alive	alive	JJ
cord-005453-4057qib7	8752	23	with	with	IN
cord-005453-4057qib7	8752	24	continuous	continuous	JJ
cord-005453-4057qib7	8752	25	completely	completely	RB
cord-005453-4057qib7	8752	26	donor	donor	NN
cord-005453-4057qib7	8752	27	engraftment	engraftment	NN
cord-005453-4057qib7	8752	28	,	,	,
cord-005453-4057qib7	8752	29	and	and	CC
cord-005453-4057qib7	8752	30	achieved	achieve	VBN
cord-005453-4057qib7	8752	31	complete	complete	JJ
cord-005453-4057qib7	8752	32	clinical	clinical	JJ
cord-005453-4057qib7	8752	33	remissions	remission	NNS
cord-005453-4057qib7	8752	34	.	.	.
cord-005453-4057qib7	8753	1	4/5	4/5	CD
cord-005453-4057qib7	8753	2	patients	patient	NNS
cord-005453-4057qib7	8753	3	developed	develop	VBD
cord-005453-4057qib7	8753	4	grade	grade	NN
cord-005453-4057qib7	8753	5	II	II	NNP
cord-005453-4057qib7	8753	6	/	/	SYM
cord-005453-4057qib7	8753	7	III	iii	CD
cord-005453-4057qib7	8753	8	acute	acute	JJ
cord-005453-4057qib7	8753	9	graft	graft	NN
cord-005453-4057qib7	8753	10	-	-	HYPH
cord-005453-4057qib7	8753	11	versus	versus	IN
cord-005453-4057qib7	8753	12	-	-	HYPH
cord-005453-4057qib7	8753	13	host	host	NN
cord-005453-4057qib7	8753	14	disease	disease	NN
cord-005453-4057qib7	8753	15	(	(	-LRB-
cord-005453-4057qib7	8753	16	GVHD	GVHD	NNP
cord-005453-4057qib7	8753	17	)	)	-RRB-
cord-005453-4057qib7	8753	18	,	,	,
cord-005453-4057qib7	8753	19	and	and	CC
cord-005453-4057qib7	8753	20	1/5	1/5	CD
cord-005453-4057qib7	8753	21	patients	patient	NNS
cord-005453-4057qib7	8753	22	developed	develop	VBD
cord-005453-4057qib7	8753	23	chronic	chronic	JJ
cord-005453-4057qib7	8753	24	GVHD	GVHD	NNP
cord-005453-4057qib7	8753	25	with	with	IN
cord-005453-4057qib7	8753	26	skin	skin	NN
cord-005453-4057qib7	8753	27	.	.	.
cord-005453-4057qib7	8754	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8754	2	:	:	:
cord-005453-4057qib7	8755	1	It	-PRON-	PRP
cord-005453-4057qib7	8755	2	is	be	VBZ
cord-005453-4057qib7	8755	3	the	the	DT
cord-005453-4057qib7	8755	4	first	first	JJ
cord-005453-4057qib7	8755	5	successful	successful	JJ
cord-005453-4057qib7	8755	6	unrelated	unrelated	JJ
cord-005453-4057qib7	8755	7	UBCT	UBCT	NNP
cord-005453-4057qib7	8755	8	for	for	IN
cord-005453-4057qib7	8755	9	LAD	lad	NN
cord-005453-4057qib7	8756	1	-I	-i	WDT
cord-005453-4057qib7	8756	2	children	child	NNS
cord-005453-4057qib7	8756	3	in	in	IN
cord-005453-4057qib7	8756	4	China	China	NNP
cord-005453-4057qib7	8756	5	.	.	.
cord-005453-4057qib7	8757	1	Our	-PRON-	PRP$
cord-005453-4057qib7	8757	2	data	datum	NNS
cord-005453-4057qib7	8757	3	shows	show	VBZ
cord-005453-4057qib7	8757	4	UCBT	UCBT	NNP
cord-005453-4057qib7	8757	5	provided	provide	VBD
cord-005453-4057qib7	8757	6	excellent	excellent	JJ
cord-005453-4057qib7	8757	7	outcome	outcome	NN
cord-005453-4057qib7	8757	8	for	for	IN
cord-005453-4057qib7	8757	9	patients	patient	NNS
cord-005453-4057qib7	8757	10	with	with	IN
cord-005453-4057qib7	8757	11	LAD	LAD	NNP
cord-005453-4057qib7	8757	12	-	-	HYPH
cord-005453-4057qib7	8757	13	I.	I.	NNP
cord-005453-4057qib7	8757	14	Disclosure	disclosure	NN
cord-005453-4057qib7	8757	15	:	:	:
cord-005453-4057qib7	8757	16	Nothing	nothing	NN
cord-005453-4057qib7	8757	17	to	to	TO
cord-005453-4057qib7	8757	18	declare	declare	VB
cord-005453-4057qib7	8757	19	P390	P390	NNP
cord-005453-4057qib7	8757	20	Excellent	excellent	JJ
cord-005453-4057qib7	8757	21	outcome	outcome	NN
cord-005453-4057qib7	8757	22	using	use	VBG
cord-005453-4057qib7	8757	23	'	'	``
cord-005453-4057qib7	8757	24	NKTM	NKTM	NNP
cord-005453-4057qib7	8757	25	'	'	POS
cord-005453-4057qib7	8757	26	enriched	enrich	VBN
cord-005453-4057qib7	8757	27	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8757	28	stem	stem	NN
cord-005453-4057qib7	8757	29	cell	cell	NN
cord-005453-4057qib7	8757	30	transplants	transplant	NNS
cord-005453-4057qib7	8757	31	for	for	IN
cord-005453-4057qib7	8757	32	patients	patient	NNS
cord-005453-4057qib7	8757	33	with	with	IN
cord-005453-4057qib7	8757	34	inborn	inborn	JJ
cord-005453-4057qib7	8757	35	errors	error	NNS
cord-005453-4057qib7	8757	36	of	of	IN
cord-005453-4057qib7	8757	37	immunity	immunity	NN
cord-005453-4057qib7	8757	38	Results	result	NNS
cord-005453-4057qib7	8757	39	:	:	:
cord-005453-4057qib7	8757	40	Majority	majority	NN
cord-005453-4057qib7	8757	41	of	of	IN
cord-005453-4057qib7	8757	42	patients	patient	NNS
cord-005453-4057qib7	8757	43	in	in	IN
cord-005453-4057qib7	8757	44	the	the	DT
cord-005453-4057qib7	8757	45	2	2	CD
cord-005453-4057qib7	8757	46	cohorts	cohort	NNS
cord-005453-4057qib7	8757	47	had	have	VBD
cord-005453-4057qib7	8757	48	significant	significant	JJ
cord-005453-4057qib7	8757	49	infective	infective	JJ
cord-005453-4057qib7	8757	50	co	co	NNS
cord-005453-4057qib7	8757	51	-	-	NNS
cord-005453-4057qib7	8757	52	morbidities	morbidity	NNS
cord-005453-4057qib7	8757	53	at	at	IN
cord-005453-4057qib7	8757	54	the	the	DT
cord-005453-4057qib7	8757	55	time	time	NN
cord-005453-4057qib7	8757	56	of	of	IN
cord-005453-4057qib7	8757	57	HSCT	HSCT	NNP
cord-005453-4057qib7	8757	58	with	with	IN
cord-005453-4057qib7	8757	59	patients	patient	NNS
cord-005453-4057qib7	8757	60	in	in	IN
cord-005453-4057qib7	8757	61	the	the	DT
cord-005453-4057qib7	8757	62	later	later	JJ
cord-005453-4057qib7	8757	63	cohort	cohort	NN
cord-005453-4057qib7	8757	64	entering	enter	VBG
cord-005453-4057qib7	8757	65	HSCT	HSCT	NNP
cord-005453-4057qib7	8757	66	earlier	early	RBR
cord-005453-4057qib7	8757	67	.	.	.
cord-005453-4057qib7	8758	1	Patients	patient	NNS
cord-005453-4057qib7	8758	2	in	in	IN
cord-005453-4057qib7	8758	3	the	the	DT
cord-005453-4057qib7	8758	4	later	later	JJ
cord-005453-4057qib7	8758	5	cohort	cohort	NN
cord-005453-4057qib7	8758	6	were	be	VBD
cord-005453-4057qib7	8758	7	sicker	sick	JJR
cord-005453-4057qib7	8758	8	at	at	IN
cord-005453-4057qib7	8758	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8758	10	.	.	.
cord-005453-4057qib7	8759	1	Final	final	JJ
cord-005453-4057qib7	8759	2	engraftment	engraftment	NN
cord-005453-4057qib7	8759	3	occurred	occur	VBD
cord-005453-4057qib7	8759	4	in	in	IN
cord-005453-4057qib7	8759	5	all	all	DT
cord-005453-4057qib7	8759	6	except	except	IN
cord-005453-4057qib7	8759	7	1	1	CD
cord-005453-4057qib7	8759	8	patient	patient	NN
cord-005453-4057qib7	8759	9	who	who	WP
cord-005453-4057qib7	8759	10	received	receive	VBD
cord-005453-4057qib7	8759	11	a	a	DT
cord-005453-4057qib7	8759	12	HLA	HLA	NNP
cord-005453-4057qib7	8759	13	mis	mis	NN
cord-005453-4057qib7	8759	14	-	-	HYPH
cord-005453-4057qib7	8759	15	matched	match	VBN
cord-005453-4057qib7	8759	16	cord	cord	NN
cord-005453-4057qib7	8759	17	blood	blood	NN
cord-005453-4057qib7	8759	18	HSCT	HSCT	NNP
cord-005453-4057qib7	8759	19	.	.	.
cord-005453-4057qib7	8760	1	Graft	graft	NN
cord-005453-4057qib7	8760	2	failures	failure	NNS
cord-005453-4057qib7	8760	3	occurred	occur	VBD
cord-005453-4057qib7	8760	4	in	in	IN
cord-005453-4057qib7	8760	5	6	6	CD
cord-005453-4057qib7	8760	6	patients	patient	NNS
cord-005453-4057qib7	8760	7	(	(	-LRB-
cord-005453-4057qib7	8760	8	2	2	CD
cord-005453-4057qib7	8760	9	in	in	IN
cord-005453-4057qib7	8760	10	earlier	early	JJR
cord-005453-4057qib7	8760	11	and	and	CC
cord-005453-4057qib7	8760	12	4	4	CD
cord-005453-4057qib7	8760	13	in	in	IN
cord-005453-4057qib7	8760	14	later	later	JJ
cord-005453-4057qib7	8760	15	cohort	cohort	NN
cord-005453-4057qib7	8760	16	)	)	-RRB-
cord-005453-4057qib7	8760	17	;	;	:
cord-005453-4057qib7	8760	18	3	3	CD
cord-005453-4057qib7	8760	19	of	of	IN
cord-005453-4057qib7	8760	20	these	these	DT
cord-005453-4057qib7	8760	21	patients	patient	NNS
cord-005453-4057qib7	8760	22	received	receive	VBD
cord-005453-4057qib7	8760	23	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	8760	24	HSCTs	HSCTs	NNPS
cord-005453-4057qib7	8760	25	from	from	IN
cord-005453-4057qib7	8760	26	HLA	HLA	NNP
cord-005453-4057qib7	8760	27	mis	mis	NNP
cord-005453-4057qib7	8760	28	-	-	HYPH
cord-005453-4057qib7	8760	29	matched	match	VBN
cord-005453-4057qib7	8760	30	unrelated	unrelated	JJ
cord-005453-4057qib7	8760	31	donors	donor	NNS
cord-005453-4057qib7	8760	32	(	(	-LRB-
cord-005453-4057qib7	8760	33	1	1	CD
cord-005453-4057qib7	8760	34	CB	CB	NNP
cord-005453-4057qib7	8760	35	,	,	,
cord-005453-4057qib7	8760	36	2	2	CD
cord-005453-4057qib7	8760	37	BM	BM	NNP
cord-005453-4057qib7	8760	38	)	)	-RRB-
cord-005453-4057qib7	8760	39	.	.	.
cord-005453-4057qib7	8761	1	Second	second	JJ
cord-005453-4057qib7	8761	2	HSCT	HSCT	NNP
cord-005453-4057qib7	8761	3	were	be	VBD
cord-005453-4057qib7	8761	4	with	with	IN
cord-005453-4057qib7	8761	5	same	same	JJ
cord-005453-4057qib7	8761	6	donors	donor	NNS
cord-005453-4057qib7	8761	7	in	in	IN
cord-005453-4057qib7	8761	8	3	3	CD
cord-005453-4057qib7	8761	9	and	and	CC
cord-005453-4057qib7	8761	10	different	different	JJ
cord-005453-4057qib7	8761	11	donors	donor	NNS
cord-005453-4057qib7	8761	12	in	in	IN
cord-005453-4057qib7	8761	13	2	2	CD
cord-005453-4057qib7	8761	14	patients	patient	NNS
cord-005453-4057qib7	8761	15	.	.	.
cord-005453-4057qib7	8762	1	No	no	DT
cord-005453-4057qib7	8762	2	grade	grade	NN
cord-005453-4057qib7	8762	3	II	II	NNP
cord-005453-4057qib7	8762	4	to	to	IN
cord-005453-4057qib7	8762	5	IV	IV	NNP
cord-005453-4057qib7	8762	6	acute	acute	JJ
cord-005453-4057qib7	8762	7	GVHD	GVHD	NNP
cord-005453-4057qib7	8762	8	or	or	CC
cord-005453-4057qib7	8762	9	extensive	extensive	JJ
cord-005453-4057qib7	8762	10	GVHD	GVHD	NNP
cord-005453-4057qib7	8762	11	occurred	occur	VBD
cord-005453-4057qib7	8762	12	.	.	.
cord-005453-4057qib7	8763	1	One	one	CD
cord-005453-4057qib7	8763	2	patient	patient	NN
cord-005453-4057qib7	8763	3	(	(	-LRB-
cord-005453-4057qib7	8763	4	CBT	CBT	NNP
cord-005453-4057qib7	8763	5	)	)	-RRB-
cord-005453-4057qib7	8763	6	died	die	VBD
cord-005453-4057qib7	8763	7	of	of	IN
cord-005453-4057qib7	8763	8	infections/	infections/	CD
cord-005453-4057qib7	8763	9	non	non	JJ
cord-005453-4057qib7	8763	10	-	-	JJ
cord-005453-4057qib7	8763	11	engraftment	engraftment	JJ
cord-005453-4057qib7	8763	12	.	.	.
cord-005453-4057qib7	8764	1	All	all	DT
cord-005453-4057qib7	8764	2	9	9	CD
cord-005453-4057qib7	8764	3	patients	patient	NNS
cord-005453-4057qib7	8764	4	in	in	IN
cord-005453-4057qib7	8764	5	the	the	DT
cord-005453-4057qib7	8764	6	later	later	JJ
cord-005453-4057qib7	8764	7	cohort	cohort	NN
cord-005453-4057qib7	8764	8	compared	compare	VBN
cord-005453-4057qib7	8764	9	to	to	IN
cord-005453-4057qib7	8764	10	7	7	CD
cord-005453-4057qib7	8764	11	of	of	IN
cord-005453-4057qib7	8764	12	9	9	CD
cord-005453-4057qib7	8764	13	patients	patient	NNS
cord-005453-4057qib7	8764	14	in	in	IN
cord-005453-4057qib7	8764	15	earlier	early	JJR
cord-005453-4057qib7	8764	16	cohort	cohort	NN
cord-005453-4057qib7	8764	17	are	be	VBP
cord-005453-4057qib7	8764	18	alive	alive	JJ
cord-005453-4057qib7	8764	19	,	,	,
cord-005453-4057qib7	8764	20	engrafted	engraft	VBN
cord-005453-4057qib7	8764	21	and	and	CC
cord-005453-4057qib7	8764	22	cured	cure	VBN
cord-005453-4057qib7	8764	23	.	.	.
cord-005453-4057qib7	8765	1	Performance	performance	NN
cord-005453-4057qib7	8765	2	status	status	NN
cord-005453-4057qib7	8765	3	were	be	VBD
cord-005453-4057qib7	8765	4	100	100	CD
cord-005453-4057qib7	8765	5	%	%	NN
cord-005453-4057qib7	8765	6	in	in	IN
cord-005453-4057qib7	8765	7	all	all	DT
cord-005453-4057qib7	8765	8	alive	alive	JJ
cord-005453-4057qib7	8765	9	patients	patient	NNS
cord-005453-4057qib7	8765	10	.	.	.
cord-005453-4057qib7	8766	1	Of	of	IN
cord-005453-4057qib7	8766	2	the	the	DT
cord-005453-4057qib7	8766	3	9	9	CD
cord-005453-4057qib7	8766	4	patients	patient	NNS
cord-005453-4057qib7	8766	5	in	in	IN
cord-005453-4057qib7	8766	6	the	the	DT
cord-005453-4057qib7	8766	7	later	later	JJ
cord-005453-4057qib7	8766	8	cohort	cohort	NN
cord-005453-4057qib7	8766	9	,	,	,
cord-005453-4057qib7	8766	10	7	7	CD
cord-005453-4057qib7	8766	11	(	(	-LRB-
cord-005453-4057qib7	8766	12	6	6	CD
cord-005453-4057qib7	8766	13	HLA	HLA	NNP
cord-005453-4057qib7	8766	14	mis	mis	NN
cord-005453-4057qib7	8766	15	-	-	HYPH
cord-005453-4057qib7	8766	16	matched	match	VBN
cord-005453-4057qib7	8766	17	related	relate	VBN
cord-005453-4057qib7	8766	18	and	and	CC
cord-005453-4057qib7	8766	19	1	1	CD
cord-005453-4057qib7	8766	20	HLA	HLA	NNP
cord-005453-4057qib7	8766	21	matched	match	VBN
cord-005453-4057qib7	8766	22	related	related	JJ
cord-005453-4057qib7	8766	23	donors	donor	NNS
cord-005453-4057qib7	8766	24	)	)	-RRB-
cord-005453-4057qib7	8766	25	received	receive	VBD
cord-005453-4057qib7	8766	26	'	'	``
cord-005453-4057qib7	8766	27	NKTm	nktm	NN
cord-005453-4057qib7	8766	28	'	'	POS
cord-005453-4057qib7	8766	29	enriched	enrich	VBN
cord-005453-4057qib7	8766	30	HSCT	HSCT	NNP
cord-005453-4057qib7	8766	31	.	.	.
cord-005453-4057qib7	8767	1	In	in	IN
cord-005453-4057qib7	8767	2	the	the	DT
cord-005453-4057qib7	8767	3	6	6	CD
cord-005453-4057qib7	8767	4	HLA	HLA	NNP
cord-005453-4057qib7	8767	5	mis	mis	NN
cord-005453-4057qib7	8767	6	-	-	HYPH
cord-005453-4057qib7	8767	7	matched	match	VBN
cord-005453-4057qib7	8767	8	'	'	''
cord-005453-4057qib7	8767	9	NKTm	nktm	NN
cord-005453-4057qib7	8767	10	'	'	POS
cord-005453-4057qib7	8767	11	enriched	enrich	VBN
cord-005453-4057qib7	8767	12	HSCTs	hsct	NNS
cord-005453-4057qib7	8767	13	,	,	,
cord-005453-4057qib7	8767	14	patients	patient	NNS
cord-005453-4057qib7	8767	15	received	receive	VBD
cord-005453-4057qib7	8767	16	high	high	JJ
cord-005453-4057qib7	8767	17	CD34	CD34	NNP
cord-005453-4057qib7	8767	18	+	+	CC
cord-005453-4057qib7	8767	19	,	,	,
cord-005453-4057qib7	8767	20	CD3+CD45RO+	cd3+cd45ro+	NN
cord-005453-4057qib7	8767	21	and	and	CC
cord-005453-4057qib7	8767	22	NK	NK	NNP
cord-005453-4057qib7	8767	23	cell	cell	NN
cord-005453-4057qib7	8767	24	doses	dose	NNS
cord-005453-4057qib7	8767	25	,	,	,
cord-005453-4057qib7	8767	26	with	with	IN
cord-005453-4057qib7	8767	27	median	median	NN
cord-005453-4057qib7	8767	28	of	of	IN
cord-005453-4057qib7	8767	29	16.88	16.88	CD
cord-005453-4057qib7	8767	30	(	(	-LRB-
cord-005453-4057qib7	8767	31	range	range	NN
cord-005453-4057qib7	8767	32	,	,	,
cord-005453-4057qib7	8767	33	5.1	5.1	CD
cord-005453-4057qib7	8767	34	-36.5	-36.5	NFP
cord-005453-4057qib7	8767	35	)	)	-RRB-
cord-005453-4057qib7	8767	36	,	,	,
cord-005453-4057qib7	8767	37	113.9	113.9	CD
cord-005453-4057qib7	8767	38	(	(	-LRB-
cord-005453-4057qib7	8767	39	range	range	NN
cord-005453-4057qib7	8767	40	,	,	,
cord-005453-4057qib7	8767	41	3.3	3.3	CD
cord-005453-4057qib7	8767	42	-232.6	-232.6	CD
cord-005453-4057qib7	8767	43	)	)	-RRB-
cord-005453-4057qib7	8767	44	and	and	CC
cord-005453-4057qib7	8767	45	89.0	89.0	CD
cord-005453-4057qib7	8767	46	(	(	-LRB-
cord-005453-4057qib7	8767	47	range	range	NN
cord-005453-4057qib7	8767	48	,	,	,
cord-005453-4057qib7	8767	49	22	22	CD
cord-005453-4057qib7	8767	50	-654	-654	NN
cord-005453-4057qib7	8767	51	)	)	-RRB-
cord-005453-4057qib7	8767	52	x10	x10	CD
cord-005453-4057qib7	8767	53	6	6	CD
cord-005453-4057qib7	8767	54	/kg	/kg	NN
cord-005453-4057qib7	8767	55	,	,	,
cord-005453-4057qib7	8767	56	respectively	respectively	RB
cord-005453-4057qib7	8767	57	.	.	.
cord-005453-4057qib7	8768	1	No	no	DT
cord-005453-4057qib7	8768	2	invasive	invasive	JJ
cord-005453-4057qib7	8768	3	infections	infection	NNS
cord-005453-4057qib7	8768	4	occurred	occur	VBD
cord-005453-4057qib7	8768	5	in	in	IN
cord-005453-4057qib7	8768	6	these	these	DT
cord-005453-4057qib7	8768	7	patients	patient	NNS
cord-005453-4057qib7	8768	8	and	and	CC
cord-005453-4057qib7	8768	9	immune	immune	JJ
cord-005453-4057qib7	8768	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	8768	11	in	in	IN
cord-005453-4057qib7	8768	12	T	T	NNP
cord-005453-4057qib7	8768	13	,	,	,
cord-005453-4057qib7	8768	14	B	B	NNP
cord-005453-4057qib7	8768	15	,	,	,
cord-005453-4057qib7	8768	16	NK	NK	NNP
cord-005453-4057qib7	8768	17	compartments	compartment	NNS
cord-005453-4057qib7	8768	18	were	be	VBD
cord-005453-4057qib7	8768	19	complete	complete	JJ
cord-005453-4057qib7	8768	20	at	at	IN
cord-005453-4057qib7	8768	21	1	1	CD
cord-005453-4057qib7	8768	22	year	year	NN
cord-005453-4057qib7	8768	23	after	after	IN
cord-005453-4057qib7	8768	24	HSCT	HSCT	NNP
cord-005453-4057qib7	8768	25	with	with	IN
cord-005453-4057qib7	8768	26	CD4	CD4	NNP
cord-005453-4057qib7	8768	27	>	>	XX
cord-005453-4057qib7	8768	28	200	200	CD
cord-005453-4057qib7	8768	29	by	by	IN
cord-005453-4057qib7	8768	30	6	6	CD
cord-005453-4057qib7	8768	31	months	month	NNS
cord-005453-4057qib7	8768	32	and	and	CC
cord-005453-4057qib7	8769	1	TCRαb	TCRαb	NNP
cord-005453-4057qib7	8769	2	>	>	XX
cord-005453-4057qib7	8769	3	1500	1500	CD
cord-005453-4057qib7	8769	4	by	by	IN
cord-005453-4057qib7	8769	5	1	1	CD
cord-005453-4057qib7	8769	6	year	year	NN
cord-005453-4057qib7	8769	7	after	after	IN
cord-005453-4057qib7	8769	8	HSCT	HSCT	NNP
cord-005453-4057qib7	8769	9	.	.	.
cord-005453-4057qib7	8770	1	Background	background	NN
cord-005453-4057qib7	8770	2	:	:	:
cord-005453-4057qib7	8771	1	Viral	viral	JJ
cord-005453-4057qib7	8771	2	infections	infection	NNS
cord-005453-4057qib7	8771	3	contribute	contribute	VBP
cord-005453-4057qib7	8771	4	to	to	IN
cord-005453-4057qib7	8771	5	significant	significant	JJ
cord-005453-4057qib7	8771	6	morbidity	morbidity	NN
cord-005453-4057qib7	8771	7	and	and	CC
cord-005453-4057qib7	8771	8	mortality	mortality	NN
cord-005453-4057qib7	8771	9	after	after	IN
cord-005453-4057qib7	8771	10	allogeneic	allogeneic	JJ
cord-005453-4057qib7	8771	11	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8771	12	cell	cell	NN
cord-005453-4057qib7	8771	13	transplantation	transplantation	NN
cord-005453-4057qib7	8771	14	(	(	-LRB-
cord-005453-4057qib7	8771	15	allo	allo	NN
cord-005453-4057qib7	8771	16	-	-	HYPH
cord-005453-4057qib7	8771	17	HSCT	HSCT	NNP
cord-005453-4057qib7	8771	18	)	)	-RRB-
cord-005453-4057qib7	8771	19	,	,	,
cord-005453-4057qib7	8771	20	increasing	increase	VBG
cord-005453-4057qib7	8771	21	both	both	CC
cord-005453-4057qib7	8771	22	the	the	DT
cord-005453-4057qib7	8771	23	human	human	NN
cord-005453-4057qib7	8771	24	and	and	CC
cord-005453-4057qib7	8771	25	the	the	DT
cord-005453-4057qib7	8771	26	financial	financial	JJ
cord-005453-4057qib7	8771	27	cost	cost	NN
cord-005453-4057qib7	8771	28	.	.	.
cord-005453-4057qib7	8772	1	Antiviral	antiviral	JJ
cord-005453-4057qib7	8772	2	agents	agent	NNS
cord-005453-4057qib7	8772	3	are	be	VBP
cord-005453-4057qib7	8772	4	often	often	RB
cord-005453-4057qib7	8772	5	ineffective	ineffective	JJ
cord-005453-4057qib7	8772	6	or/	or/	NN
cord-005453-4057qib7	8772	7	and	and	CC
cord-005453-4057qib7	8772	8	associated	associate	VBN
cord-005453-4057qib7	8772	9	with	with	IN
cord-005453-4057qib7	8772	10	toxicity	toxicity	NN
cord-005453-4057qib7	8772	11	.	.	.
cord-005453-4057qib7	8773	1	Methods	method	NNS
cord-005453-4057qib7	8773	2	:	:	:
cord-005453-4057qib7	8774	1	In	in	IN
cord-005453-4057qib7	8774	2	view	view	NN
cord-005453-4057qib7	8774	3	of	of	IN
cord-005453-4057qib7	8774	4	T	t	NN
cord-005453-4057qib7	8774	5	-	-	HYPH
cord-005453-4057qib7	8774	6	cell	cell	NN
cord-005453-4057qib7	8774	7	anti	anti	JJ
cord-005453-4057qib7	8774	8	-	-	JJ
cord-005453-4057qib7	8774	9	viral	viral	JJ
cord-005453-4057qib7	8774	10	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	8774	11	in	in	IN
cord-005453-4057qib7	8774	12	Greece	Greece	NNP
cord-005453-4057qib7	8774	13	,	,	,
cord-005453-4057qib7	8774	14	we	-PRON-	PRP
cord-005453-4057qib7	8774	15	evaluated	evaluate	VBD
cord-005453-4057qib7	8774	16	the	the	DT
cord-005453-4057qib7	8774	17	actual	actual	JJ
cord-005453-4057qib7	8774	18	cost	cost	NN
cord-005453-4057qib7	8774	19	of	of	IN
cord-005453-4057qib7	8774	20	conventional	conventional	JJ
cord-005453-4057qib7	8774	21	pharmacotherapy	pharmacotherapy	NN
cord-005453-4057qib7	8774	22	for	for	IN
cord-005453-4057qib7	8774	23	CMV	CMV	NNP
cord-005453-4057qib7	8774	24	,	,	,
cord-005453-4057qib7	8774	25	EBV	EBV	NNP
cord-005453-4057qib7	8774	26	and	and	CC
cord-005453-4057qib7	8774	27	BKV	BKV	NNP
cord-005453-4057qib7	8774	28	reactivations	reactivation	NNS
cord-005453-4057qib7	8774	29	after	after	IN
cord-005453-4057qib7	8774	30	allo	allo	NN
cord-005453-4057qib7	8774	31	-	-	HYPH
cord-005453-4057qib7	8774	32	HSCT	HSCT	NNP
cord-005453-4057qib7	8774	33	,	,	,
cord-005453-4057qib7	8774	34	by	by	IN
cord-005453-4057qib7	8774	35	calculating	calculate	VBG
cord-005453-4057qib7	8774	36	the	the	DT
cord-005453-4057qib7	8774	37	costs	cost	NNS
cord-005453-4057qib7	8774	38	of	of	IN
cord-005453-4057qib7	8774	39	(	(	-LRB-
cord-005453-4057qib7	8774	40	i	i	NN
cord-005453-4057qib7	8774	41	)	)	-RRB-
cord-005453-4057qib7	8774	42	the	the	DT
cord-005453-4057qib7	8774	43	antiviral	antiviral	JJ
cord-005453-4057qib7	8774	44	agents	agent	NNS
cord-005453-4057qib7	8774	45	,	,	,
cord-005453-4057qib7	8774	46	(	(	-LRB-
cord-005453-4057qib7	8774	47	ii	ii	NN
cord-005453-4057qib7	8774	48	)	)	-RRB-
cord-005453-4057qib7	8775	1	the	the	DT
cord-005453-4057qib7	8775	2	treatment	treatment	NN
cord-005453-4057qib7	8775	3	(	(	-LRB-
cord-005453-4057qib7	8775	4	excluding	exclude	VBG
cord-005453-4057qib7	8775	5	transfusions	transfusion	NNS
cord-005453-4057qib7	8775	6	)	)	-RRB-
cord-005453-4057qib7	8775	7	of	of	IN
cord-005453-4057qib7	8775	8	antiviral	antiviral	JJ
cord-005453-4057qib7	8775	9	drug	drug	NN
cord-005453-4057qib7	8775	10	primary	primary	JJ
cord-005453-4057qib7	8775	11	toxicity	toxicity	NN
cord-005453-4057qib7	8775	12	(	(	-LRB-
cord-005453-4057qib7	8775	13	e.g.	e.g.	IN
cord-005453-4057qib7	8775	14	graft	graft	NN
cord-005453-4057qib7	8775	15	failure	failure	NN
cord-005453-4057qib7	8775	16	,	,	,
cord-005453-4057qib7	8775	17	cytopenias	cytopenia	NNS
cord-005453-4057qib7	8775	18	,	,	,
cord-005453-4057qib7	8775	19	renal	renal	JJ
cord-005453-4057qib7	8775	20	or	or	CC
cord-005453-4057qib7	8775	21	hepatic	hepatic	JJ
cord-005453-4057qib7	8775	22	dysfunction	dysfunction	NN
cord-005453-4057qib7	8775	23	)	)	-RRB-
cord-005453-4057qib7	8775	24	and	and	CC
cord-005453-4057qib7	8775	25	secondary	secondary	JJ
cord-005453-4057qib7	8775	26	toxicity	toxicity	NN
cord-005453-4057qib7	8775	27	(	(	-LRB-
cord-005453-4057qib7	8775	28	e.g.	e.g.	IN
cord-005453-4057qib7	8775	29	leukopenia	leukopenia	NN
cord-005453-4057qib7	8775	30	-	-	HYPH
cord-005453-4057qib7	8775	31	associated	associate	VBN
cord-005453-4057qib7	8775	32	bacterial	bacterial	JJ
cord-005453-4057qib7	8775	33	infections	infection	NNS
cord-005453-4057qib7	8775	34	)	)	-RRB-
cord-005453-4057qib7	8775	35	,	,	,
cord-005453-4057qib7	8775	36	iii	iii	NN
cord-005453-4057qib7	8775	37	)	)	-RRB-
cord-005453-4057qib7	8776	1	the	the	DT
cord-005453-4057qib7	8776	2	treatment	treatment	NN
cord-005453-4057qib7	8776	3	(	(	-LRB-
cord-005453-4057qib7	8776	4	excluding	exclude	VBG
cord-005453-4057qib7	8776	5	transfusions	transfusion	NNS
cord-005453-4057qib7	8776	6	,	,	,
cord-005453-4057qib7	8776	7	ie	ie	FW
cord-005453-4057qib7	8776	8	for	for	IN
cord-005453-4057qib7	8776	9	BK	BK	NNP
cord-005453-4057qib7	8776	10	cystitis	cystitis	NNP
cord-005453-4057qib7	8776	11	)	)	-RRB-
cord-005453-4057qib7	8776	12	of	of	IN
cord-005453-4057qib7	8776	13	infectionrelated	infectionrelate	VBN
cord-005453-4057qib7	8776	14	complications	complication	NNS
cord-005453-4057qib7	8776	15	,	,	,
cord-005453-4057qib7	8776	16	iv	iv	LS
cord-005453-4057qib7	8776	17	)	)	-RRB-
cord-005453-4057qib7	8777	1	the	the	DT
cord-005453-4057qib7	8777	2	transfusions	transfusion	NNS
cord-005453-4057qib7	8777	3	due	due	JJ
cord-005453-4057qib7	8777	4	to	to	IN
cord-005453-4057qib7	8777	5	treatmentrelated	treatmentrelate	VBN
cord-005453-4057qib7	8777	6	toxicity	toxicity	NN
cord-005453-4057qib7	8777	7	(	(	-LRB-
cord-005453-4057qib7	8777	8	ie	ie	NNP
cord-005453-4057qib7	8777	9	cytopenias	cytopenias	NNP
cord-005453-4057qib7	8777	10	)	)	-RRB-
cord-005453-4057qib7	8777	11	or	or	CC
cord-005453-4057qib7	8777	12	infection	infection	NN
cord-005453-4057qib7	8777	13	-	-	HYPH
cord-005453-4057qib7	8777	14	related	relate	VBN
cord-005453-4057qib7	8777	15	complications	complication	NNS
cord-005453-4057qib7	8777	16	(	(	-LRB-
cord-005453-4057qib7	8777	17	ie	ie	FW
cord-005453-4057qib7	8777	18	,	,	,
cord-005453-4057qib7	8777	19	BK	BK	NNP
cord-005453-4057qib7	8777	20	cystitis	cystitis	NNP
cord-005453-4057qib7	8777	21	)	)	-RRB-
cord-005453-4057qib7	8777	22	,	,	,
cord-005453-4057qib7	8777	23	v	v	LS
cord-005453-4057qib7	8777	24	)	)	-RRB-
cord-005453-4057qib7	8777	25	the	the	DT
cord-005453-4057qib7	8777	26	inpatient	inpatient	JJ
cord-005453-4057qib7	8777	27	or	or	CC
cord-005453-4057qib7	8777	28	outpatient	outpatient	JJ
cord-005453-4057qib7	8777	29	daily	daily	JJ
cord-005453-4057qib7	8777	30	care	care	NN
cord-005453-4057qib7	8777	31	.	.	.
cord-005453-4057qib7	8778	1	Notwithstanding	notwithstanding	IN
cord-005453-4057qib7	8778	2	that	that	DT
cord-005453-4057qib7	8778	3	blood	blood	NN
cord-005453-4057qib7	8778	4	and	and	CC
cord-005453-4057qib7	8778	5	its	-PRON-	PRP$
cord-005453-4057qib7	8778	6	products	product	NNS
cord-005453-4057qib7	8778	7	,	,	,
cord-005453-4057qib7	8778	8	as	as	IN
cord-005453-4057qib7	8778	9	a	a	DT
cord-005453-4057qib7	8778	10	common	common	JJ
cord-005453-4057qib7	8778	11	natural	natural	JJ
cord-005453-4057qib7	8778	12	good	good	NN
cord-005453-4057qib7	8778	13	,	,	,
cord-005453-4057qib7	8778	14	are	be	VBP
cord-005453-4057qib7	8778	15	provided	provide	VBN
cord-005453-4057qib7	8778	16	free	free	JJ
cord-005453-4057qib7	8778	17	in	in	IN
cord-005453-4057qib7	8778	18	our	-PRON-	PRP$
cord-005453-4057qib7	8778	19	country	country	NN
cord-005453-4057qib7	8778	20	,	,	,
cord-005453-4057qib7	8778	21	the	the	DT
cord-005453-4057qib7	8778	22	costs	cost	NNS
cord-005453-4057qib7	8778	23	related	relate	VBN
cord-005453-4057qib7	8778	24	to	to	IN
cord-005453-4057qib7	8778	25	blood	blood	NN
cord-005453-4057qib7	8778	26	and	and	CC
cord-005453-4057qib7	8778	27	platelet	platelet	NN
cord-005453-4057qib7	8778	28	collection	collection	NN
cord-005453-4057qib7	8778	29	,	,	,
cord-005453-4057qib7	8778	30	processing	processing	NN
cord-005453-4057qib7	8778	31	,	,	,
cord-005453-4057qib7	8778	32	storage	storage	NN
cord-005453-4057qib7	8778	33	,	,	,
cord-005453-4057qib7	8778	34	laboratory	laboratory	NN
cord-005453-4057qib7	8778	35	testing	testing	NN
cord-005453-4057qib7	8778	36	and	and	CC
cord-005453-4057qib7	8778	37	infusions	infusion	NNS
cord-005453-4057qib7	8778	38	were	be	VBD
cord-005453-4057qib7	8778	39	included	include	VBN
cord-005453-4057qib7	8778	40	in	in	IN
cord-005453-4057qib7	8778	41	our	-PRON-	PRP$
cord-005453-4057qib7	8778	42	model	model	NN
cord-005453-4057qib7	8778	43	.	.	.
cord-005453-4057qib7	8779	1	Results	result	NNS
cord-005453-4057qib7	8779	2	:	:	:
cord-005453-4057qib7	8780	1	The	the	DT
cord-005453-4057qib7	8780	2	treatment	treatment	NN
cord-005453-4057qib7	8780	3	cost	cost	NN
cord-005453-4057qib7	8780	4	of	of	IN
cord-005453-4057qib7	8780	5	CMV	CMV	NNP
cord-005453-4057qib7	8780	6	,	,	,
cord-005453-4057qib7	8780	7	EBV	EBV	NNP
cord-005453-4057qib7	8780	8	and	and	CC
cord-005453-4057qib7	8780	9	BKV	BKV	NNP
cord-005453-4057qib7	8780	10	reactivations	reactivation	NNS
cord-005453-4057qib7	8780	11	/	/	SYM
cord-005453-4057qib7	8780	12	infections	infection	NNS
cord-005453-4057qib7	8780	13	for	for	IN
cord-005453-4057qib7	8780	14	the	the	DT
cord-005453-4057qib7	8780	15	first	first	JJ
cord-005453-4057qib7	8780	16	six	six	CD
cord-005453-4057qib7	8780	17	months	month	NNS
cord-005453-4057qib7	8780	18	post	post	VBP
cord-005453-4057qib7	8780	19	allo	allo	NN
cord-005453-4057qib7	8780	20	-	-	HYPH
cord-005453-4057qib7	8780	21	HSCT	HSCT	NNP
cord-005453-4057qib7	8780	22	was	be	VBD
cord-005453-4057qib7	8780	23	evaluated	evaluate	VBN
cord-005453-4057qib7	8780	24	in	in	IN
cord-005453-4057qib7	8780	25	38/51	38/51	CD
cord-005453-4057qib7	8780	26	patients	patient	NNS
cord-005453-4057qib7	8780	27	who	who	WP
cord-005453-4057qib7	8780	28	reactivated	reactivate	VBD
cord-005453-4057qib7	8780	29	viruses	virus	NNS
cord-005453-4057qib7	8780	30	and	and	CC
cord-005453-4057qib7	8780	31	were	be	VBD
cord-005453-4057qib7	8780	32	transplanted	transplant	VBN
cord-005453-4057qib7	8780	33	between	between	IN
cord-005453-4057qib7	8780	34	10/2015	10/2015	CD
cord-005453-4057qib7	8780	35	-	-	SYM
cord-005453-4057qib7	8780	36	11/2016	11/2016	CD
cord-005453-4057qib7	8780	37	from	from	IN
cord-005453-4057qib7	8780	38	matched	match	VBN
cord-005453-4057qib7	8780	39	related	relate	VBN
cord-005453-4057qib7	8780	40	(	(	-LRB-
cord-005453-4057qib7	8780	41	17/51	17/51	CD
cord-005453-4057qib7	8780	42	)	)	-RRB-
cord-005453-4057qib7	8780	43	,	,	,
cord-005453-4057qib7	8780	44	matched	match	VBN
cord-005453-4057qib7	8780	45	unrelated	unrelated	JJ
cord-005453-4057qib7	8780	46	(	(	-LRB-
cord-005453-4057qib7	8780	47	20/51	20/51	CD
cord-005453-4057qib7	8780	48	)	)	-RRB-
cord-005453-4057qib7	8780	49	,	,	,
cord-005453-4057qib7	8780	50	mismatched	mismatch	VBN
cord-005453-4057qib7	8780	51	unrelated	unrelated	JJ
cord-005453-4057qib7	8780	52	(	(	-LRB-
cord-005453-4057qib7	8780	53	8/51	8/51	CD
cord-005453-4057qib7	8780	54	)	)	-RRB-
cord-005453-4057qib7	8780	55	,	,	,
cord-005453-4057qib7	8780	56	haploidentical	haploidentical	NNP
cord-005453-4057qib7	8780	57	(	(	-LRB-
cord-005453-4057qib7	8780	58	5/51	5/51	CD
cord-005453-4057qib7	8780	59	)	)	-RRB-
cord-005453-4057qib7	8780	60	and	and	CC
cord-005453-4057qib7	8780	61	mismatched	mismatch	VBD
cord-005453-4057qib7	8780	62	related	related	JJ
cord-005453-4057qib7	8780	63	donors	donor	NNS
cord-005453-4057qib7	8780	64	(	(	-LRB-
cord-005453-4057qib7	8780	65	1/51	1/51	CD
cord-005453-4057qib7	8780	66	)	)	-RRB-
cord-005453-4057qib7	8780	67	.	.	.
cord-005453-4057qib7	8781	1	We	-PRON-	PRP
cord-005453-4057qib7	8781	2	detected	detect	VBD
cord-005453-4057qib7	8781	3	29	29	CD
cord-005453-4057qib7	8781	4	CMV	CMV	NNP
cord-005453-4057qib7	8781	5	,	,	,
cord-005453-4057qib7	8781	6	35	35	CD
cord-005453-4057qib7	8781	7	EBV	EBV	NNP
cord-005453-4057qib7	8781	8	and	and	CC
cord-005453-4057qib7	8781	9	18	18	CD
cord-005453-4057qib7	8781	10	BKV	BKV	NNP
cord-005453-4057qib7	8781	11	infections	infection	NNS
cord-005453-4057qib7	8781	12	/	/	SYM
cord-005453-4057qib7	8781	13	reactivations	reactivation	NNS
cord-005453-4057qib7	8781	14	in	in	IN
cord-005453-4057qib7	8781	15	20	20	CD
cord-005453-4057qib7	8781	16	,	,	,
cord-005453-4057qib7	8781	17	32	32	CD
cord-005453-4057qib7	8781	18	and	and	CC
cord-005453-4057qib7	8781	19	17	17	CD
cord-005453-4057qib7	8781	20	patients	patient	NNS
cord-005453-4057qib7	8781	21	respectively	respectively	RB
cord-005453-4057qib7	8781	22	,	,	,
cord-005453-4057qib7	8781	23	with	with	IN
cord-005453-4057qib7	8781	24	a	a	DT
cord-005453-4057qib7	8781	25	mean	mean	NN
cord-005453-4057qib7	8781	26	of	of	IN
cord-005453-4057qib7	8781	27	2±0.4	2±0.4	CD
cord-005453-4057qib7	8781	28	infection	infection	NN
cord-005453-4057qib7	8781	29	per	per	IN
cord-005453-4057qib7	8781	30	patient	patient	NN
cord-005453-4057qib7	8781	31	from	from	IN
cord-005453-4057qib7	8781	32	all	all	DT
cord-005453-4057qib7	8781	33	three	three	CD
cord-005453-4057qib7	8781	34	viruses	virus	NNS
cord-005453-4057qib7	8781	35	(	(	-LRB-
cord-005453-4057qib7	8781	36	1	1	CD
cord-005453-4057qib7	8781	37	-	-	SYM
cord-005453-4057qib7	8781	38	7	7	CD
cord-005453-4057qib7	8781	39	/	/	SYM
cord-005453-4057qib7	8781	40	patient	patient	NN
cord-005453-4057qib7	8781	41	)	)	-RRB-
cord-005453-4057qib7	8781	42	.	.	.
cord-005453-4057qib7	8782	1	Of	of	IN
cord-005453-4057qib7	8782	2	note	note	NN
cord-005453-4057qib7	8782	3	,	,	,
cord-005453-4057qib7	8782	4	22/38	22/38	CD
cord-005453-4057qib7	8782	5	patients	patient	NNS
cord-005453-4057qib7	8782	6	experienced	experience	VBD
cord-005453-4057qib7	8782	7	reactivations	reactivation	NNS
cord-005453-4057qib7	8782	8	from	from	IN
cord-005453-4057qib7	8782	9	more	more	JJR
cord-005453-4057qib7	8782	10	than	than	IN
cord-005453-4057qib7	8782	11	one	one	CD
cord-005453-4057qib7	8782	12	virus	virus	NN
cord-005453-4057qib7	8782	13	,	,	,
cord-005453-4057qib7	8782	14	requiring	require	VBG
cord-005453-4057qib7	8782	15	repeated	repeat	VBN
cord-005453-4057qib7	8782	16	treatments	treatment	NNS
cord-005453-4057qib7	8782	17	with	with	IN
cord-005453-4057qib7	8782	18	antiviral	antiviral	JJ
cord-005453-4057qib7	8782	19	agents	agent	NNS
cord-005453-4057qib7	8782	20	and/or	and/or	CC
cord-005453-4057qib7	8782	21	rituximab	rituximab	NN
cord-005453-4057qib7	8782	22	.	.	.
cord-005453-4057qib7	8783	1	The	the	DT
cord-005453-4057qib7	8783	2	cost	cost	NN
cord-005453-4057qib7	8783	3	of	of	IN
cord-005453-4057qib7	8783	4	antiviral	antiviral	JJ
cord-005453-4057qib7	8783	5	agents	agent	NNS
cord-005453-4057qib7	8783	6	for	for	IN
cord-005453-4057qib7	8783	7	all	all	DT
cord-005453-4057qib7	8783	8	CMV	CMV	NNP
cord-005453-4057qib7	8783	9	,	,	,
cord-005453-4057qib7	8783	10	EBV	EBV	NNP
cord-005453-4057qib7	8783	11	and	and	CC
cord-005453-4057qib7	8783	12	BKV	BKV	NNP
cord-005453-4057qib7	8783	13	reactivations	reactivation	NNS
cord-005453-4057qib7	8783	14	/	/	SYM
cord-005453-4057qib7	8783	15	infections	infection	NNS
cord-005453-4057qib7	8783	16	was	be	VBD
cord-005453-4057qib7	8783	17	78,656	78,656	CD
cord-005453-4057qib7	8783	18	€	€	$
cord-005453-4057qib7	8783	19	,	,	,
cord-005453-4057qib7	8783	20	58,504	58,504	CD
cord-005453-4057qib7	8783	21	€	€	SYM
cord-005453-4057qib7	8783	22	and	and	CC
cord-005453-4057qib7	8783	23	11,331	11,331	CD
cord-005453-4057qib7	8784	1	€	€	$
cord-005453-4057qib7	8784	2	respectively	respectively	RB
cord-005453-4057qib7	8784	3	(	(	-LRB-
cord-005453-4057qib7	8784	4	3,146	3,146	CD
cord-005453-4057qib7	8784	5	€	€	$
cord-005453-4057qib7	8784	6	,	,	,
cord-005453-4057qib7	8784	7	2,089	2,089	CD
cord-005453-4057qib7	8784	8	€	€	SYM
cord-005453-4057qib7	8784	9	and	and	CC
cord-005453-4057qib7	8784	10	1,416	1,416	CD
cord-005453-4057qib7	8784	11	€	€	CD
cord-005453-4057qib7	8784	12	/patient	/patient	NN
cord-005453-4057qib7	8784	13	,	,	,
cord-005453-4057qib7	8784	14	respectively	respectively	RB
cord-005453-4057qib7	8784	15	)	)	-RRB-
cord-005453-4057qib7	8784	16	.	.	.
cord-005453-4057qib7	8785	1	The	the	DT
cord-005453-4057qib7	8785	2	treatment	treatment	NN
cord-005453-4057qib7	8785	3	cost	cost	NN
cord-005453-4057qib7	8785	4	of	of	IN
cord-005453-4057qib7	8785	5	toxicity	toxicity	NN
cord-005453-4057qib7	8785	6	related	relate	VBN
cord-005453-4057qib7	8785	7	to	to	IN
cord-005453-4057qib7	8785	8	antiviral	antiviral	JJ
cord-005453-4057qib7	8785	9	drugs	drug	NNS
cord-005453-4057qib7	8785	10	and	and	CC
cord-005453-4057qib7	8785	11	infection	infection	NN
cord-005453-4057qib7	8785	12	-	-	HYPH
cord-005453-4057qib7	8785	13	related	relate	VBN
cord-005453-4057qib7	8785	14	complications	complication	NNS
cord-005453-4057qib7	8785	15	was	be	VBD
cord-005453-4057qib7	8785	16	70,358	70,358	CD
cord-005453-4057qib7	8785	17	€	€	$
cord-005453-4057qib7	8785	18	(	(	-LRB-
cord-005453-4057qib7	8785	19	4,309€/patient	4,309€/patient	CD
cord-005453-4057qib7	8785	20	)	)	-RRB-
cord-005453-4057qib7	8785	21	excluding	exclude	VBG
cord-005453-4057qib7	8785	22	transfusions	transfusion	NNS
cord-005453-4057qib7	8785	23	and	and	CC
cord-005453-4057qib7	8785	24	676,107	676,107	CD
cord-005453-4057qib7	8785	25	€	€	XX
cord-005453-4057qib7	8785	26	(	(	-LRB-
cord-005453-4057qib7	8785	27	28,171€/patient	28,171€/patient	CD
cord-005453-4057qib7	8785	28	)	)	-RRB-
cord-005453-4057qib7	8785	29	including	include	VBG
cord-005453-4057qib7	8785	30	transfusions	transfusion	NNS
cord-005453-4057qib7	8785	31	.	.	.
cord-005453-4057qib7	8786	1	In	in	IN
cord-005453-4057qib7	8786	2	particular	particular	JJ
cord-005453-4057qib7	8786	3	,	,	,
cord-005453-4057qib7	8786	4	the	the	DT
cord-005453-4057qib7	8786	5	cost	cost	NN
cord-005453-4057qib7	8786	6	of	of	IN
cord-005453-4057qib7	8786	7	transfusions	transfusion	NNS
cord-005453-4057qib7	8786	8	for	for	IN
cord-005453-4057qib7	8786	9	BKV	bkv	JJ
cord-005453-4057qib7	8786	10	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	8786	11	cystitis	cystitis	NN
cord-005453-4057qib7	8786	12	reached	reach	VBD
cord-005453-4057qib7	8786	13	22,751€/patient	22,751€/patient	CD
cord-005453-4057qib7	8786	14	.	.	.
cord-005453-4057qib7	8787	1	Repeated	repeat	VBN
cord-005453-4057qib7	8787	2	(	(	-LRB-
cord-005453-4057qib7	8787	3	1	1	CD
cord-005453-4057qib7	8787	4	-	-	SYM
cord-005453-4057qib7	8787	5	5	5	CD
cord-005453-4057qib7	8787	6	)	)	-RRB-
cord-005453-4057qib7	8788	1	and/or	and/or	CC
cord-005453-4057qib7	8788	2	prolonged	prolonged	JJ
cord-005453-4057qib7	8788	3	(	(	-LRB-
cord-005453-4057qib7	8788	4	Δm	Δm	NNP
cord-005453-4057qib7	8788	5	38d	38d	NNS
cord-005453-4057qib7	8788	6	,	,	,
cord-005453-4057qib7	8788	7	range	range	NNP
cord-005453-4057qib7	8788	8	6	6	CD
cord-005453-4057qib7	8788	9	-	-	HYPH
cord-005453-4057qib7	8788	10	150d	150d	NNP
cord-005453-4057qib7	8788	11	)	)	-RRB-
cord-005453-4057qib7	8788	12	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	8788	13	were	be	VBD
cord-005453-4057qib7	8788	14	needed	need	VBN
cord-005453-4057qib7	8788	15	,	,	,
cord-005453-4057qib7	8788	16	up	up	IN
cord-005453-4057qib7	8788	17	to	to	IN
cord-005453-4057qib7	8788	18	a	a	DT
cord-005453-4057qib7	8788	19	total	total	NN
cord-005453-4057qib7	8788	20	of	of	IN
cord-005453-4057qib7	8788	21	745	745	CD
cord-005453-4057qib7	8788	22	and	and	CC
cord-005453-4057qib7	8788	23	159	159	CD
cord-005453-4057qib7	8788	24	days	day	NNS
cord-005453-4057qib7	8788	25	of	of	IN
cord-005453-4057qib7	8788	26	inpatient	inpatient	JJ
cord-005453-4057qib7	8788	27	hospitalization	hospitalization	NN
cord-005453-4057qib7	8788	28	and	and	CC
cord-005453-4057qib7	8788	29	short	short	JJ
cord-005453-4057qib7	8788	30	-	-	HYPH
cord-005453-4057qib7	8788	31	term	term	NN
cord-005453-4057qib7	8788	32	outpatient	outpatient	NN
cord-005453-4057qib7	8788	33	treatment	treatment	NN
cord-005453-4057qib7	8788	34	,	,	,
cord-005453-4057qib7	8788	35	respectively	respectively	RB
cord-005453-4057qib7	8788	36	.	.	.
cord-005453-4057qib7	8789	1	Hospitalizations	hospitalization	NNS
cord-005453-4057qib7	8789	2	further	further	RB
cord-005453-4057qib7	8789	3	increased	increase	VBD
cord-005453-4057qib7	8789	4	the	the	DT
cord-005453-4057qib7	8789	5	cost	cost	NN
cord-005453-4057qib7	8789	6	of	of	IN
cord-005453-4057qib7	8789	7	inpatient	inpatient	JJ
cord-005453-4057qib7	8789	8	and	and	CC
cord-005453-4057qib7	8789	9	outpatient	outpatient	JJ
cord-005453-4057qib7	8789	10	post	post	JJ
cord-005453-4057qib7	8789	11	-	-	JJ
cord-005453-4057qib7	8789	12	transplant	transplant	JJ
cord-005453-4057qib7	8789	13	care	care	NN
cord-005453-4057qib7	8789	14	by	by	IN
cord-005453-4057qib7	8789	15	81,640	81,640	CD
cord-005453-4057qib7	8789	16	€	€	SYM
cord-005453-4057qib7	8789	17	and	and	CC
cord-005453-4057qib7	8789	18	8,000	8,000	CD
cord-005453-4057qib7	8789	19	€	€	$
cord-005453-4057qib7	8789	20	respectively	respectively	RB
cord-005453-4057qib7	8789	21	(	(	-LRB-
cord-005453-4057qib7	8789	22	2,634	2,634	CD
cord-005453-4057qib7	8789	23	€	€	SYM
cord-005453-4057qib7	8789	24	and	and	CC
cord-005453-4057qib7	8789	25	500€/patient	500€/patient	CD
cord-005453-4057qib7	8789	26	,	,	,
cord-005453-4057qib7	8789	27	respectively	respectively	RB
cord-005453-4057qib7	8789	28	)	)	-RRB-
cord-005453-4057qib7	8789	29	,	,	,
cord-005453-4057qib7	8789	30	onthe	onthe	JJ
cord-005453-4057qib7	8789	31	basis	basis	NN
cord-005453-4057qib7	8789	32	of	of	IN
cord-005453-4057qib7	8789	33	a	a	DT
cord-005453-4057qib7	8789	34	,	,	,
cord-005453-4057qib7	8789	35	rather	rather	RB
cord-005453-4057qib7	8789	36	underestimating	underestimate	VBG
cord-005453-4057qib7	8789	37	the	the	DT
cord-005453-4057qib7	8789	38	true	true	JJ
cord-005453-4057qib7	8789	39	cost	cost	NN
cord-005453-4057qib7	8789	40	,	,	,
cord-005453-4057qib7	8789	41	fixed	fix	VBN
cord-005453-4057qib7	8789	42	,	,	,
cord-005453-4057qib7	8789	43	unified	unified	JJ
cord-005453-4057qib7	8789	44	hospitalization	hospitalization	NN
cord-005453-4057qib7	8789	45	fee	fee	NN
cord-005453-4057qib7	8789	46	(	(	-LRB-
cord-005453-4057qib7	8790	1	60€/day	60€/day	CD
cord-005453-4057qib7	8790	2	and	and	CC
cord-005453-4057qib7	8790	3	200	200	CD
cord-005453-4057qib7	8790	4	€	€	CD
cord-005453-4057qib7	8790	5	/day	/day	CD
cord-005453-4057qib7	8790	6	)	)	-RRB-
cord-005453-4057qib7	8790	7	.	.	.
cord-005453-4057qib7	8791	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8791	2	:	:	:
cord-005453-4057qib7	8792	1	Overall	overall	RB
cord-005453-4057qib7	8792	2	,	,	,
cord-005453-4057qib7	8792	3	in	in	IN
cord-005453-4057qib7	8792	4	a	a	DT
cord-005453-4057qib7	8792	5	six	six	CD
cord-005453-4057qib7	8792	6	-	-	HYPH
cord-005453-4057qib7	8792	7	month	month	NN
cord-005453-4057qib7	8792	8	study	study	NN
cord-005453-4057qib7	8792	9	period	period	NN
cord-005453-4057qib7	8792	10	,	,	,
cord-005453-4057qib7	8792	11	the	the	DT
cord-005453-4057qib7	8792	12	treatment	treatment	NN
cord-005453-4057qib7	8792	13	of	of	IN
cord-005453-4057qib7	8792	14	CMV	CMV	NNP
cord-005453-4057qib7	8792	15	,	,	,
cord-005453-4057qib7	8792	16	EBV	EBV	NNP
cord-005453-4057qib7	8792	17	and	and	CC
cord-005453-4057qib7	8792	18	BKV	BKV	NNP
cord-005453-4057qib7	8792	19	infections	infection	NNS
cord-005453-4057qib7	8792	20	substantially	substantially	RB
cord-005453-4057qib7	8792	21	increased	increase	VBD
cord-005453-4057qib7	8792	22	the	the	DT
cord-005453-4057qib7	8792	23	cost	cost	NN
cord-005453-4057qib7	8792	24	of	of	IN
cord-005453-4057qib7	8792	25	post	post	JJ
cord-005453-4057qib7	8792	26	-	-	JJ
cord-005453-4057qib7	8792	27	transplant	transplant	JJ
cord-005453-4057qib7	8792	28	care	care	NN
cord-005453-4057qib7	8792	29	by	by	IN
cord-005453-4057qib7	8792	30	956,283	956,283	CD
cord-005453-4057qib7	8792	31	€	€	NNPS
cord-005453-4057qib7	8792	32	(	(	-LRB-
cord-005453-4057qib7	8792	33	27,322€/patient	27,322€/patient	NNP
cord-005453-4057qib7	8792	34	)	)	-RRB-
cord-005453-4057qib7	8792	35	.	.	.
cord-005453-4057qib7	8793	1	The	the	DT
cord-005453-4057qib7	8793	2	actual	actual	JJ
cord-005453-4057qib7	8793	3	cost	cost	NN
cord-005453-4057qib7	8793	4	is	be	VBZ
cord-005453-4057qib7	8793	5	undoubtedly	undoubtedly	RB
cord-005453-4057qib7	8793	6	higher	high	JJR
cord-005453-4057qib7	8793	7	as	as	IN
cord-005453-4057qib7	8793	8	the	the	DT
cord-005453-4057qib7	8793	9	hospitalization	hospitalization	NN
cord-005453-4057qib7	8793	10	fee	fee	NN
cord-005453-4057qib7	8793	11	for	for	IN
cord-005453-4057qib7	8793	12	transplant	transplant	NN
cord-005453-4057qib7	8793	13	recipients	recipient	NNS
cord-005453-4057qib7	8793	14	is	be	VBZ
cord-005453-4057qib7	8793	15	largely	largely	RB
cord-005453-4057qib7	8793	16	underestimated	underestimate	VBN
cord-005453-4057qib7	8793	17	in	in	IN
cord-005453-4057qib7	8793	18	Greece	Greece	NNP
cord-005453-4057qib7	8793	19	.	.	.
cord-005453-4057qib7	8794	1	Considering	consider	VBG
cord-005453-4057qib7	8794	2	not	not	RB
cord-005453-4057qib7	8794	3	only	only	RB
cord-005453-4057qib7	8794	4	the	the	DT
cord-005453-4057qib7	8794	5	hematopoietic	hematopoietic	NN
cord-005453-4057qib7	8794	6	but	but	CC
cord-005453-4057qib7	8794	7	also	also	RB
cord-005453-4057qib7	8794	8	the	the	DT
cord-005453-4057qib7	8794	9	solid	solid	JJ
cord-005453-4057qib7	8794	10	organ	organ	NN
cord-005453-4057qib7	8794	11	transplant	transplant	NN
cord-005453-4057qib7	8794	12	recipients	recipient	NNS
cord-005453-4057qib7	8794	13	,	,	,
cord-005453-4057qib7	8794	14	the	the	DT
cord-005453-4057qib7	8794	15	financial	financial	JJ
cord-005453-4057qib7	8794	16	burden	burden	NN
cord-005453-4057qib7	8794	17	of	of	IN
cord-005453-4057qib7	8794	18	antiviral	antiviral	JJ
cord-005453-4057qib7	8794	19	treatment	treatment	NN
cord-005453-4057qib7	8794	20	for	for	IN
cord-005453-4057qib7	8794	21	national	national	JJ
cord-005453-4057qib7	8794	22	economies	economy	NNS
cord-005453-4057qib7	8794	23	is	be	VBZ
cord-005453-4057qib7	8794	24	enormous	enormous	JJ
cord-005453-4057qib7	8794	25	.	.	.
cord-005453-4057qib7	8795	1	Given	give	VBN
cord-005453-4057qib7	8795	2	that	that	DT
cord-005453-4057qib7	8795	3	antiviral	antiviral	JJ
cord-005453-4057qib7	8795	4	pharmacotherapy	pharmacotherapy	NN
cord-005453-4057qib7	8795	5	is	be	VBZ
cord-005453-4057qib7	8795	6	often	often	RB
cord-005453-4057qib7	8795	7	associated	associate	VBN
cord-005453-4057qib7	8795	8	with	with	IN
cord-005453-4057qib7	8795	9	suboptimal	suboptimal	JJ
cord-005453-4057qib7	8795	10	efficacy	efficacy	NN
cord-005453-4057qib7	8795	11	,	,	,
cord-005453-4057qib7	8795	12	toxicity	toxicity	NN
cord-005453-4057qib7	8795	13	,	,	,
cord-005453-4057qib7	8795	14	development	development	NN
cord-005453-4057qib7	8795	15	of	of	IN
cord-005453-4057qib7	8795	16	drug	drug	NN
cord-005453-4057qib7	8795	17	resistance	resistance	NN
cord-005453-4057qib7	8795	18	,	,	,
cord-005453-4057qib7	8795	19	reactivation	reactivation	NN
cord-005453-4057qib7	8795	20	recurrences	recurrence	NNS
cord-005453-4057qib7	8795	21	and	and	CC
cord-005453-4057qib7	8795	22	repeated	repeat	VBN
cord-005453-4057qib7	8795	23	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	8795	24	,	,	,
cord-005453-4057qib7	8795	25	it	-PRON-	PRP
cord-005453-4057qib7	8795	26	is	be	VBZ
cord-005453-4057qib7	8795	27	expected	expect	VBN
cord-005453-4057qib7	8795	28	that	that	IN
cord-005453-4057qib7	8795	29	a	a	DT
cord-005453-4057qib7	8795	30	one	one	CD
cord-005453-4057qib7	8795	31	-	-	HYPH
cord-005453-4057qib7	8795	32	time	time	NN
cord-005453-4057qib7	8795	33	treatment	treatment	NN
cord-005453-4057qib7	8795	34	with	with	IN
cord-005453-4057qib7	8795	35	multi	multi	JJ
cord-005453-4057qib7	8795	36	-	-	JJ
cord-005453-4057qib7	8795	37	virus	virus	JJ
cord-005453-4057qib7	8795	38	-	-	HYPH
cord-005453-4057qib7	8795	39	specific	specific	JJ
cord-005453-4057qib7	8795	40	T	t	NN
cord-005453-4057qib7	8795	41	cells	cell	NNS
cord-005453-4057qib7	8795	42	,	,	,
cord-005453-4057qib7	8795	43	able	able	JJ
cord-005453-4057qib7	8795	44	to	to	TO
cord-005453-4057qib7	8795	45	expand	expand	VB
cord-005453-4057qib7	8795	46	in	in	IN
cord-005453-4057qib7	8795	47	vivo	vivo	NN
cord-005453-4057qib7	8795	48	and	and	CC
cord-005453-4057qib7	8795	49	provide	provide	VB
cord-005453-4057qib7	8795	50	a	a	DT
cord-005453-4057qib7	8795	51	long	long	RB
cord-005453-4057qib7	8795	52	-	-	HYPH
cord-005453-4057qib7	8795	53	lasting	last	VBG
cord-005453-4057qib7	8795	54	protection	protection	NN
cord-005453-4057qib7	8795	55	without	without	IN
cord-005453-4057qib7	8795	56	significant	significant	JJ
cord-005453-4057qib7	8795	57	toxicity	toxicity	NN
cord-005453-4057qib7	8795	58	,	,	,
cord-005453-4057qib7	8795	59	will	will	MD
cord-005453-4057qib7	8795	60	serve	serve	VB
cord-005453-4057qib7	8795	61	as	as	IN
cord-005453-4057qib7	8795	62	a	a	DT
cord-005453-4057qib7	8795	63	powerful	powerful	JJ
cord-005453-4057qib7	8795	64	and	and	CC
cord-005453-4057qib7	8795	65	costeffective	costeffective	JJ
cord-005453-4057qib7	8795	66	treatment	treatment	NN
cord-005453-4057qib7	8795	67	over	over	IN
cord-005453-4057qib7	8795	68	conventional	conventional	JJ
cord-005453-4057qib7	8795	69	pharmacotherapy	pharmacotherapy	NN
cord-005453-4057qib7	8795	70	.	.	.
cord-005453-4057qib7	8796	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8796	2	:	:	:
cord-005453-4057qib7	8796	3	Nothing	nothing	NN
cord-005453-4057qib7	8796	4	to	to	TO
cord-005453-4057qib7	8796	5	declare	declare	VB
cord-005453-4057qib7	8796	6	Methods	method	NNS
cord-005453-4057qib7	8797	1	:	:	:
cord-005453-4057qib7	8797	2	This	this	DT
cord-005453-4057qib7	8797	3	is	be	VBZ
cord-005453-4057qib7	8797	4	a	a	DT
cord-005453-4057qib7	8797	5	single	single	JJ
cord-005453-4057qib7	8797	6	-	-	HYPH
cord-005453-4057qib7	8797	7	centre	centre	NN
cord-005453-4057qib7	8797	8	retrospective	retrospective	JJ
cord-005453-4057qib7	8797	9	analysis	analysis	NN
cord-005453-4057qib7	8797	10	of	of	IN
cord-005453-4057qib7	8797	11	293	293	CD
cord-005453-4057qib7	8797	12	consecutive	consecutive	JJ
cord-005453-4057qib7	8797	13	patients	patient	NNS
cord-005453-4057qib7	8797	14	who	who	WP
cord-005453-4057qib7	8797	15	underwent	undergo	VBD
cord-005453-4057qib7	8797	16	TCD	TCD	NNP
cord-005453-4057qib7	8797	17	allo	allo	NNP
cord-005453-4057qib7	8797	18	-	-	HYPH
cord-005453-4057qib7	8797	19	HSCTs	hsct	NNS
cord-005453-4057qib7	8797	20	for	for	IN
cord-005453-4057qib7	8797	21	myeloid	myeloid	JJ
cord-005453-4057qib7	8797	22	malignancies	malignancy	NNS
cord-005453-4057qib7	8797	23	between	between	IN
cord-005453-4057qib7	8797	24	January	January	NNP
cord-005453-4057qib7	8797	25	2012-June	2012-june	CD
cord-005453-4057qib7	8797	26	2016	2016	CD
cord-005453-4057qib7	8797	27	.	.	.
cord-005453-4057qib7	8798	1	EBV	EBV	NNP
cord-005453-4057qib7	8798	2	-	-	HYPH
cord-005453-4057qib7	8798	3	DNA	DNA	NNP
cord-005453-4057qib7	8798	4	was	be	VBD
cord-005453-4057qib7	8798	5	monitored	monitor	VBN
cord-005453-4057qib7	8798	6	frequently	frequently	RB
cord-005453-4057qib7	8798	7	on	on	IN
cord-005453-4057qib7	8798	8	whole	whole	JJ
cord-005453-4057qib7	8798	9	blood	blood	NN
cord-005453-4057qib7	8798	10	samples	sample	NNS
cord-005453-4057qib7	8798	11	with	with	IN
cord-005453-4057qib7	8798	12	standardised	standardised	JJ
cord-005453-4057qib7	8798	13	quantitative	quantitative	JJ
cord-005453-4057qib7	8798	14	real	real	JJ
cord-005453-4057qib7	8798	15	-	-	HYPH
cord-005453-4057qib7	8798	16	time	time	NN
cord-005453-4057qib7	8798	17	PCR	PCR	NNP
cord-005453-4057qib7	8798	18	.	.	.
cord-005453-4057qib7	8799	1	Serum	serum	NN
cord-005453-4057qib7	8799	2	protein	protein	NN
cord-005453-4057qib7	8799	3	electrophoresis	electrophoresis	NN
cord-005453-4057qib7	8799	4	was	be	VBD
cord-005453-4057qib7	8799	5	routinely	routinely	RB
cord-005453-4057qib7	8799	6	tested	test	VBN
cord-005453-4057qib7	8799	7	with	with	IN
cord-005453-4057qib7	8799	8	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	8799	9	subclasses	subclass	NNS
cord-005453-4057qib7	8799	10	identified	identify	VBN
cord-005453-4057qib7	8799	11	by	by	IN
cord-005453-4057qib7	8799	12	immunofixation	immunofixation	NN
cord-005453-4057qib7	8799	13	electrophoresis	electrophoresis	NNP
cord-005453-4057qib7	8799	14	.	.	.
cord-005453-4057qib7	8800	1	Histological	histological	JJ
cord-005453-4057qib7	8800	2	confirmation	confirmation	NN
cord-005453-4057qib7	8800	3	of	of	IN
cord-005453-4057qib7	8800	4	PTLD	PTLD	NNP
cord-005453-4057qib7	8800	5	was	be	VBD
cord-005453-4057qib7	8800	6	based	base	VBN
cord-005453-4057qib7	8800	7	on	on	IN
cord-005453-4057qib7	8800	8	standard	standard	NN
cord-005453-4057qib7	8800	9	WHO	WHO	NNP
cord-005453-4057qib7	8800	10	diagnostic	diagnostic	JJ
cord-005453-4057qib7	8800	11	criteria	criterion	NNS
cord-005453-4057qib7	8800	12	(	(	-LRB-
cord-005453-4057qib7	8800	13	'	'	``
cord-005453-4057qib7	8800	14	proven	prove	VBN
cord-005453-4057qib7	8800	15	'	'	''
cord-005453-4057qib7	8800	16	)	)	-RRB-
cord-005453-4057qib7	8800	17	,	,	,
cord-005453-4057qib7	8800	18	while	while	IN
cord-005453-4057qib7	8800	19	those	those	DT
cord-005453-4057qib7	8800	20	without	without	IN
cord-005453-4057qib7	8800	21	biopsy	biopsy	NN
cord-005453-4057qib7	8800	22	were	be	VBD
cord-005453-4057qib7	8800	23	classed	class	VBN
cord-005453-4057qib7	8800	24	as	as	IN
cord-005453-4057qib7	8800	25	'	'	``
cord-005453-4057qib7	8800	26	probable	probable	JJ
cord-005453-4057qib7	8800	27	'	'	''
cord-005453-4057qib7	8800	28	based	base	VBN
cord-005453-4057qib7	8800	29	on	on	IN
cord-005453-4057qib7	8800	30	clinical	clinical	JJ
cord-005453-4057qib7	8800	31	&	&	CC
cord-005453-4057qib7	8800	32	radiological	radiological	JJ
cord-005453-4057qib7	8800	33	criteria	criterion	NNS
cord-005453-4057qib7	8800	34	as	as	IN
cord-005453-4057qib7	8800	35	defined	define	VBN
cord-005453-4057qib7	8800	36	by	by	IN
cord-005453-4057qib7	8800	37	ECIL-6	ECIL-6	NNP
cord-005453-4057qib7	8800	38	guidelines	guideline	NNS
cord-005453-4057qib7	8800	39	.	.	.
cord-005453-4057qib7	8801	1	Results	result	NNS
cord-005453-4057qib7	8801	2	:	:	:
cord-005453-4057qib7	8802	1	Majority	majority	NN
cord-005453-4057qib7	8802	2	of	of	IN
cord-005453-4057qib7	8802	3	patients	patient	NNS
cord-005453-4057qib7	8802	4	had	have	VBD
cord-005453-4057qib7	8802	5	AML(n-152/293	aml(n-152/293	CD
cord-005453-4057qib7	8802	6	)	)	-RRB-
cord-005453-4057qib7	8802	7	and	and	CC
cord-005453-4057qib7	8802	8	MDS(n-107/293	MDS(n-107/293	NNP
cord-005453-4057qib7	8802	9	)	)	-RRB-
cord-005453-4057qib7	8802	10	with	with	IN
cord-005453-4057qib7	8802	11	a	a	DT
cord-005453-4057qib7	8802	12	median	median	JJ
cord-005453-4057qib7	8802	13	age	age	NN
cord-005453-4057qib7	8802	14	of	of	IN
cord-005453-4057qib7	8802	15	58	58	CD
cord-005453-4057qib7	8802	16	years(range	years(range	NNS
cord-005453-4057qib7	8802	17	.	.	.
cord-005453-4057qib7	8803	1	Median	median	JJ
cord-005453-4057qib7	8803	2	follow	follow	VBP
cord-005453-4057qib7	8803	3	up	up	IN
cord-005453-4057qib7	8803	4	of	of	IN
cord-005453-4057qib7	8803	5	survivors	survivor	NNS
cord-005453-4057qib7	8803	6	was	be	VBD
cord-005453-4057qib7	8803	7	32	32	CD
cord-005453-4057qib7	8803	8	months(range	months(range	CD
cord-005453-4057qib7	8803	9	4	4	CD
cord-005453-4057qib7	8803	10	-	-	SYM
cord-005453-4057qib7	8803	11	65	65	CD
cord-005453-4057qib7	8803	12	)	)	-RRB-
cord-005453-4057qib7	8803	13	.	.	.
cord-005453-4057qib7	8804	1	Majority	majority	NN
cord-005453-4057qib7	8804	2	of	of	IN
cord-005453-4057qib7	8804	3	patients(n-220/293;75	patients(n-220/293;75	NNP
cord-005453-4057qib7	8804	4	%	%	NN
cord-005453-4057qib7	8804	5	)	)	-RRB-
cord-005453-4057qib7	8804	6	developed	develop	VBD
cord-005453-4057qib7	8804	7	EBV	EBV	NNP
cord-005453-4057qib7	8804	8	-	-	HYPH
cord-005453-4057qib7	8804	9	R	R	NNP
cord-005453-4057qib7	8804	10	with	with	IN
cord-005453-4057qib7	8804	11	a	a	DT
cord-005453-4057qib7	8804	12	median	median	JJ
cord-005453-4057qib7	8804	13	time	time	NN
cord-005453-4057qib7	8804	14	of	of	IN
cord-005453-4057qib7	8804	15	79	79	CD
cord-005453-4057qib7	8804	16	days[Inter	days[inter	NN
cord-005453-4057qib7	8804	17	quartile	quartile	NNP
cord-005453-4057qib7	8804	18	range(IQR	range(IQR	NNP
cord-005453-4057qib7	8804	19	)	)	-RRB-
cord-005453-4057qib7	8804	20	27	27	CD
cord-005453-4057qib7	8804	21	-	-	SYM
cord-005453-4057qib7	8804	22	160	160	CD
cord-005453-4057qib7	8804	23	days	day	NNS
cord-005453-4057qib7	8804	24	]	]	-RRB-
cord-005453-4057qib7	8804	25	&	&	CC
cord-005453-4057qib7	8804	26	higher	high	JJR
cord-005453-4057qib7	8804	27	cumulative	cumulative	JJ
cord-005453-4057qib7	8804	28	incidence	incidence	NN
cord-005453-4057qib7	8804	29	with	with	IN
cord-005453-4057qib7	8804	30	ATG(n-132	ATG(n-132	NNP
cord-005453-4057qib7	8804	31	)	)	-RRB-
cord-005453-4057qib7	8804	32	versus	versus	IN
cord-005453-4057qib7	8804	33	Alemtuzumab(n-161)(p	alemtuzumab(n-161)(p	IN
cord-005453-4057qib7	8804	34	<	<	XX
cord-005453-4057qib7	8804	35	0.001	0.001	CD
cord-005453-4057qib7	8804	36	)	)	-RRB-
cord-005453-4057qib7	8804	37	.	.	.
cord-005453-4057qib7	8805	1	Figure-1a	Figure-1a	NNP
cord-005453-4057qib7	8805	2	shows	show	VBZ
cord-005453-4057qib7	8805	3	schematic	schematic	JJ
cord-005453-4057qib7	8805	4	representation	representation	NN
cord-005453-4057qib7	8805	5	of	of	IN
cord-005453-4057qib7	8805	6	EBV	EBV	NNP
cord-005453-4057qib7	8805	7	and	and	CC
cord-005453-4057qib7	8805	8	PTLD	PTLD	NNP
cord-005453-4057qib7	8805	9	events	event	NNS
cord-005453-4057qib7	8805	10	(	(	-LRB-
cord-005453-4057qib7	8805	11	cumulative	cumulative	JJ
cord-005453-4057qib7	8805	12	incidence	incidence	NN
cord-005453-4057qib7	8805	13	of	of	IN
cord-005453-4057qib7	8805	14	6.8%(95%CI-4.0%-10.6	6.8%(95%ci-4.0%-10.6	CD
cord-005453-4057qib7	8805	15	%	%	NN
cord-005453-4057qib7	8805	16	)	)	-RRB-
cord-005453-4057qib7	8805	17	at	at	IN
cord-005453-4057qib7	8805	18	12	12	CD
cord-005453-4057qib7	8805	19	months	month	NNS
cord-005453-4057qib7	8805	20	)	)	-RRB-
cord-005453-4057qib7	8805	21	.	.	.
cord-005453-4057qib7	8806	1	Significantly	significantly	RB
cord-005453-4057qib7	8806	2	higher	high	JJR
cord-005453-4057qib7	8806	3	peak	peak	NN
cord-005453-4057qib7	8806	4	EBV	EBV	NNP
cord-005453-4057qib7	8806	5	DNA	dna	NN
cord-005453-4057qib7	8806	6	viral	viral	JJ
cord-005453-4057qib7	8806	7	load(EVL	load(evl	NN
cord-005453-4057qib7	8806	8	)	)	-RRB-
cord-005453-4057qib7	8806	9	were	be	VBD
cord-005453-4057qib7	8806	10	noted	note	VBN
cord-005453-4057qib7	8806	11	in	in	IN
cord-005453-4057qib7	8806	12	patients	patient	NNS
cord-005453-4057qib7	8806	13	with	with	IN
cord-005453-4057qib7	8806	14	PTLD(p-	ptld(p-	CD
cord-005453-4057qib7	8806	15	<	<	XX
cord-005453-4057qib7	8806	16	0.001	0.001	CD
cord-005453-4057qib7	8806	17	)	)	-RRB-
cord-005453-4057qib7	8806	18	.	.	.
cord-005453-4057qib7	8807	1	Development	development	NN
cord-005453-4057qib7	8807	2	of	of	IN
cord-005453-4057qib7	8807	3	post	post	JJ
cord-005453-4057qib7	8807	4	-	-	JJ
cord-005453-4057qib7	8807	5	HSCT	HSCT	NNP
cord-005453-4057qib7	8807	6	MG	MG	NNP
cord-005453-4057qib7	8807	7	was	be	VBD
cord-005453-4057qib7	8807	8	observed	observe	VBN
cord-005453-4057qib7	8807	9	in	in	IN
cord-005453-4057qib7	8807	10	29%(n-85/292	29%(n-85/292	CD
cord-005453-4057qib7	8807	11	)	)	-RRB-
cord-005453-4057qib7	8807	12	.	.	.
cord-005453-4057qib7	8808	1	ROC	ROC	NNP
cord-005453-4057qib7	8808	2	curve	curve	NN
cord-005453-4057qib7	8808	3	identified	identify	VBD
cord-005453-4057qib7	8808	4	peak	peak	NN
cord-005453-4057qib7	8808	5	blood	blood	NN
cord-005453-4057qib7	8808	6	EVL>150,000	EVL>150,000	.
cord-005453-4057qib7	8809	1	copies	copy	NNS
cord-005453-4057qib7	8809	2	/	/	SYM
cord-005453-4057qib7	8809	3	ml	ml	XX
cord-005453-4057qib7	8809	4	significantly	significantly	RB
cord-005453-4057qib7	8809	5	correlated	correlate	VBD
cord-005453-4057qib7	8809	6	with	with	IN
cord-005453-4057qib7	8809	7	risk	risk	NN
cord-005453-4057qib7	8809	8	of	of	IN
cord-005453-4057qib7	8809	9	developing	develop	VBG
cord-005453-4057qib7	8809	10	PTLD	PTLD	NNP
cord-005453-4057qib7	8809	11	(	(	-LRB-
cord-005453-4057qib7	8809	12	sensitivity-70.6%,specificity-79.4%;AUC-0.82,p	sensitivity-70.6%,specificity-79.4%;auc-0.82,p	NN
cord-005453-4057qib7	8809	13	<	<	XX
cord-005453-4057qib7	8809	14	0.001	0.001	CD
cord-005453-4057qib7	8809	15	)	)	-RRB-
cord-005453-4057qib7	8809	16	.	.	.
cord-005453-4057qib7	8810	1	Based	base	VBN
cord-005453-4057qib7	8810	2	on	on	IN
cord-005453-4057qib7	8810	3	these	these	DT
cord-005453-4057qib7	8810	4	estimates	estimate	NNS
cord-005453-4057qib7	8810	5	,	,	,
cord-005453-4057qib7	8810	6	subgroup	subgroup	NN
cord-005453-4057qib7	8810	7	of	of	IN
cord-005453-4057qib7	8810	8	patients	patient	NNS
cord-005453-4057qib7	8810	9	with	with	IN
cord-005453-4057qib7	8810	10	no	no	DT
cord-005453-4057qib7	8810	11	EBV	EBV	NNP
cord-005453-4057qib7	8810	12	-	-	HYPH
cord-005453-4057qib7	8810	13	R(n-72/292	R(n-72/292	NNP
cord-005453-4057qib7	8810	14	)	)	-RRB-
cord-005453-4057qib7	8810	15	,	,	,
cord-005453-4057qib7	8810	16	peak	peak	NN
cord-005453-4057qib7	8810	17	EVL	EVL	NNP
cord-005453-4057qib7	8810	18	<	<	XX
cord-005453-4057qib7	8810	19	150,000	150,000	CD
cord-005453-4057qib7	8810	20	(	(	-LRB-
cord-005453-4057qib7	8810	21	<	<	NNP
cord-005453-4057qib7	8810	22	150k)copies/	150k)copies/	CD
cord-005453-4057qib7	8810	23	ml(n-165/292	ml(n-165/292	NNP
cord-005453-4057qib7	8810	24	)	)	-RRB-
cord-005453-4057qib7	8810	25	&	&	CC
cord-005453-4057qib7	8810	26	>	>	NNP
cord-005453-4057qib7	8810	27	150,000(>150k)copies	150,000(>150k)copies	CD
cord-005453-4057qib7	8810	28	/	/	SYM
cord-005453-4057qib7	8810	29	ml(n-55/292	ml(n-55/292	CD
cord-005453-4057qib7	8810	30	)	)	-RRB-
cord-005453-4057qib7	8810	31	were	be	VBD
cord-005453-4057qib7	8810	32	categorised	categorise	VBN
cord-005453-4057qib7	8810	33	in	in	IN
cord-005453-4057qib7	8810	34	6	6	CD
cord-005453-4057qib7	8810	35	groups	group	NNS
cord-005453-4057qib7	8810	36	along	along	IN
cord-005453-4057qib7	8810	37	patients	patient	NNS
cord-005453-4057qib7	8810	38	with	with	IN
cord-005453-4057qib7	8810	39	/	/	SYM
cord-005453-4057qib7	8810	40	without	without	IN
cord-005453-4057qib7	8810	41	MG	MG	NNP
cord-005453-4057qib7	8810	42	accordingly	accordingly	RB
cord-005453-4057qib7	8810	43	(	(	-LRB-
cord-005453-4057qib7	8810	44	Groups	group	NNS
cord-005453-4057qib7	8810	45	1	1	CD
cord-005453-4057qib7	8810	46	-	-	HYPH
cord-005453-4057qib7	8810	47	6;Figure-1b	6;figure-1b	CD
cord-005453-4057qib7	8810	48	)	)	-RRB-
cord-005453-4057qib7	8810	49	.	.	.
cord-005453-4057qib7	8811	1	Patients	patient	NNS
cord-005453-4057qib7	8811	2	with	with	IN
cord-005453-4057qib7	8811	3	EBV	EBV	NNP
cord-005453-4057qib7	8811	4	-	-	HYPH
cord-005453-4057qib7	8811	5	R	R	NNP
cord-005453-4057qib7	8811	6	had	have	VBD
cord-005453-4057qib7	8811	7	significantly	significantly	RB
cord-005453-4057qib7	8811	8	better	well	JJR
cord-005453-4057qib7	8811	9	OS	OS	NNP
cord-005453-4057qib7	8811	10	[	[	-LRB-
cord-005453-4057qib7	8811	11	5-year	5-year	CD
cord-005453-4057qib7	8811	12	OS	os	NN
cord-005453-4057qib7	8811	13	of	of	IN
cord-005453-4057qib7	8811	14	52	52	CD
cord-005453-4057qib7	8811	15	%	%	NN
cord-005453-4057qib7	8811	16	vs	vs	IN
cord-005453-4057qib7	8811	17	35%(no	35%(no	CD
cord-005453-4057qib7	8811	18	EBV	EBV	NNP
cord-005453-4057qib7	8811	19	-	-	HYPH
cord-005453-4057qib7	8811	20	R);Log	r);log	JJ
cord-005453-4057qib7	8811	21	-	-	HYPH
cord-005453-4057qib7	8811	22	rank	rank	NN
cord-005453-4057qib7	8811	23	p	p	NN
cord-005453-4057qib7	8811	24	<	<	XX
cord-005453-4057qib7	8812	1	0.001],with	0.001],with	NNP
cord-005453-4057qib7	8812	2	this	this	DT
cord-005453-4057qib7	8812	3	survival	survival	NN
cord-005453-4057qib7	8812	4	benefit	benefit	NN
cord-005453-4057qib7	8812	5	mainly	mainly	RB
cord-005453-4057qib7	8812	6	driven	drive	VBN
cord-005453-4057qib7	8812	7	by	by	IN
cord-005453-4057qib7	8812	8	subgroup	subgroup	NN
cord-005453-4057qib7	8812	9	of	of	IN
cord-005453-4057qib7	8812	10	patients	patient	NNS
cord-005453-4057qib7	8812	11	with	with	IN
cord-005453-4057qib7	8812	12	lower	low	JJR
cord-005453-4057qib7	8812	13	EVL	EVL	NNP
cord-005453-4057qib7	8812	14	(	(	-LRB-
cord-005453-4057qib7	8812	15	<	<	XX
cord-005453-4057qib7	8812	16	150k)(p	150k)(p	CD
cord-005453-4057qib7	8812	17	<	<	XX
cord-005453-4057qib7	8812	18	0.001	0.001	CD
cord-005453-4057qib7	8812	19	)	)	-RRB-
cord-005453-4057qib7	8812	20	.	.	.
cord-005453-4057qib7	8813	1	PTLD	PTLD	NNP
cord-005453-4057qib7	8813	2	patients	patient	NNS
cord-005453-4057qib7	8813	3	had	have	VBD
cord-005453-4057qib7	8813	4	trend	trend	NN
cord-005453-4057qib7	8813	5	towards	towards	IN
cord-005453-4057qib7	8813	6	inferior	inferior	JJ
cord-005453-4057qib7	8813	7	3-year	3-year	NNP
cord-005453-4057qib7	8813	8	OS(15	OS(15	NNS
cord-005453-4057qib7	8813	9	%	%	NN
cord-005453-4057qib7	8813	10	vs	vs	IN
cord-005453-4057qib7	8813	11	54%;p-0.051	54%;p-0.051	CD
cord-005453-4057qib7	8813	12	)	)	-RRB-
cord-005453-4057qib7	8813	13	.	.	.
cord-005453-4057qib7	8814	1	Patients	patient	NNS
cord-005453-4057qib7	8814	2	with	with	IN
cord-005453-4057qib7	8814	3	MG	MG	NNP
cord-005453-4057qib7	8814	4	had	have	VBD
cord-005453-4057qib7	8814	5	a	a	DT
cord-005453-4057qib7	8814	6	significantly	significantly	RB
cord-005453-4057qib7	8814	7	better	well	JJR
cord-005453-4057qib7	8814	8	OS	os	NN
cord-005453-4057qib7	8814	9	irrespective	irrespective	RB
cord-005453-4057qib7	8814	10	of	of	IN
cord-005453-4057qib7	8814	11	degree	degree	NN
cord-005453-4057qib7	8814	12	of	of	IN
cord-005453-4057qib7	8814	13	EVL	EVL	NNP
cord-005453-4057qib7	8814	14	(	(	-LRB-
cord-005453-4057qib7	8814	15	Group	Group	NNP
cord-005453-4057qib7	8814	16	1-	1-	CD
cord-005453-4057qib7	8815	1	3,p	3,p	LS
cord-005453-4057qib7	8815	2	<	<	XX
cord-005453-4057qib7	8815	3	0.001).We	0.001).we	CD
cord-005453-4057qib7	8815	4	report	report	VBP
cord-005453-4057qib7	8815	5	a	a	DT
cord-005453-4057qib7	8815	6	'	'	``
cord-005453-4057qib7	8815	7	sweet	sweet	JJ
cord-005453-4057qib7	8815	8	spot	spot	NN
cord-005453-4057qib7	8815	9	'	'	''
cord-005453-4057qib7	8815	10	of	of	IN
cord-005453-4057qib7	8815	11	low	low	JJ
cord-005453-4057qib7	8815	12	EVL	EVL	NNP
cord-005453-4057qib7	8815	13	&	&	CC
cord-005453-4057qib7	8815	14	presence	presence	NN
cord-005453-4057qib7	8815	15	of	of	IN
cord-005453-4057qib7	8815	16	MG	MG	NNP
cord-005453-4057qib7	8815	17	in	in	IN
cord-005453-4057qib7	8815	18	these	these	DT
cord-005453-4057qib7	8815	19	patients	patient	NNS
cord-005453-4057qib7	8815	20	,	,	,
cord-005453-4057qib7	8815	21	with	with	IN
cord-005453-4057qib7	8815	22	a	a	DT
cord-005453-4057qib7	8815	23	clear	clear	JJ
cord-005453-4057qib7	8815	24	survival	survival	NN
cord-005453-4057qib7	8815	25	advantage	advantage	NN
cord-005453-4057qib7	8815	26	compared	compare	VBN
cord-005453-4057qib7	8815	27	to	to	IN
cord-005453-4057qib7	8815	28	those	those	DT
cord-005453-4057qib7	8815	29	with	with	IN
cord-005453-4057qib7	8815	30	no	no	DT
cord-005453-4057qib7	8815	31	EBV	EBV	NNP
cord-005453-4057qib7	8815	32	-	-	HYPH
cord-005453-4057qib7	8815	33	R	R	NNP
cord-005453-4057qib7	8815	34	and/or	and/or	CC
cord-005453-4057qib7	8815	35	no	no	DT
cord-005453-4057qib7	8815	36	Mprotein	Mprotein	NNP
cord-005453-4057qib7	8816	1	(	(	-LRB-
cord-005453-4057qib7	8816	2	Group-2	Group-2	NNP
cord-005453-4057qib7	8816	3	5-year	5-year	CD
cord-005453-4057qib7	8816	4	OS	OS	NNP
cord-005453-4057qib7	8816	5	62	62	CD
cord-005453-4057qib7	8816	6	%	%	NN
cord-005453-4057qib7	8816	7	vs	vs	IN
cord-005453-4057qib7	8816	8	27	27	CD
cord-005453-4057qib7	8816	9	%	%	NN
cord-005453-4057qib7	8816	10	in	in	IN
cord-005453-4057qib7	8816	11	Group-6	Group-6	NNP
cord-005453-4057qib7	8816	12	;	;	:
cord-005453-4057qib7	8816	13	HR-0.15;95%CI:0.06	hr-0.15;95%ci:0.06	CD
cord-005453-4057qib7	8816	14	-	-	HYPH
cord-005453-4057qib7	8816	15	0.34;p	0.34;p	CD
cord-005453-4057qib7	8816	16	<	<	XX
cord-005453-4057qib7	8816	17	0.001;Figure1b	0.001;figure1b	CD
cord-005453-4057qib7	8816	18	)	)	-RRB-
cord-005453-4057qib7	8816	19	.	.	.
cord-005453-4057qib7	8817	1	Overall	overall	JJ
cord-005453-4057qib7	8817	2	cumulative	cumulative	JJ
cord-005453-4057qib7	8817	3	incidence	incidence	NN
cord-005453-4057qib7	8817	4	of	of	IN
cord-005453-4057qib7	8817	5	relapse	relapse	NN
cord-005453-4057qib7	8817	6	(	(	-LRB-
cord-005453-4057qib7	8817	7	CIR	CIR	NNP
cord-005453-4057qib7	8817	8	)	)	-RRB-
cord-005453-4057qib7	8817	9	was	be	VBD
cord-005453-4057qib7	8817	10	28%(95%CI:23	28%(95%ci:23	CD
cord-005453-4057qib7	8817	11	-	-	SYM
cord-005453-4057qib7	8817	12	37	37	CD
cord-005453-4057qib7	8817	13	)	)	-RRB-
cord-005453-4057qib7	8817	14	and	and	CC
cord-005453-4057qib7	8817	15	non	non	JJ
cord-005453-4057qib7	8817	16	-	-	JJ
cord-005453-4057qib7	8817	17	relapse	relapse	JJ
cord-005453-4057qib7	8817	18	-	-	HYPH
cord-005453-4057qib7	8817	19	mortality(NRM	mortality(NRM	NNP
cord-005453-4057qib7	8817	20	)	)	-RRB-
cord-005453-4057qib7	8817	21	of	of	IN
cord-005453-4057qib7	8817	22	24%(95%CI:18.6	24%(95%ci:18.6	CD
cord-005453-4057qib7	8817	23	-	-	SYM
cord-005453-4057qib7	8817	24	30	30	CD
cord-005453-4057qib7	8817	25	)	)	-RRB-
cord-005453-4057qib7	8817	26	at	at	IN
cord-005453-4057qib7	8817	27	5	5	CD
cord-005453-4057qib7	8817	28	years	year	NNS
cord-005453-4057qib7	8817	29	.	.	.
cord-005453-4057qib7	8818	1	Multivariate	Multivariate	NNP
cord-005453-4057qib7	8818	2	analysis(MVA	analysis(MVA	NNP
cord-005453-4057qib7	8818	3	)	)	-RRB-
cord-005453-4057qib7	8818	4	revealed	reveal	VBD
cord-005453-4057qib7	8818	5	absence	absence	NN
cord-005453-4057qib7	8818	6	of	of	IN
cord-005453-4057qib7	8818	7	M	M	NNP
cord-005453-4057qib7	8818	8	-	-	HYPH
cord-005453-4057qib7	8818	9	protein	protein	NN
cord-005453-4057qib7	8818	10	,	,	,
cord-005453-4057qib7	8818	11	high	high	JJ
cord-005453-4057qib7	8818	12	EVL	EVL	NNP
cord-005453-4057qib7	8818	13	(	(	-LRB-
cord-005453-4057qib7	8818	14	>	>	NFP
cord-005453-4057qib7	8818	15	150k	150k	CD
cord-005453-4057qib7	8818	16	copies	copy	NNS
cord-005453-4057qib7	8818	17	/	/	SYM
cord-005453-4057qib7	8818	18	ml	ml	NN
cord-005453-4057qib7	8818	19	)	)	-RRB-
cord-005453-4057qib7	8818	20	or	or	CC
cord-005453-4057qib7	8818	21	no	no	DT
cord-005453-4057qib7	8818	22	EBV	EBV	NNP
cord-005453-4057qib7	8818	23	-	-	HYPH
cord-005453-4057qib7	8818	24	R	r	NN
cord-005453-4057qib7	8818	25	and	and	CC
cord-005453-4057qib7	8818	26	absence	absence	NN
cord-005453-4057qib7	8818	27	of	of	IN
cord-005453-4057qib7	8818	28	any	any	DT
cord-005453-4057qib7	8818	29	GVHD	GVHD	NNP
cord-005453-4057qib7	8818	30	as	as	IN
cord-005453-4057qib7	8818	31	significant	significant	JJ
cord-005453-4057qib7	8818	32	factors	factor	NNS
cord-005453-4057qib7	8818	33	for	for	IN
cord-005453-4057qib7	8818	34	high	high	JJ
cord-005453-4057qib7	8818	35	CIR	CIR	NNP
cord-005453-4057qib7	8818	36	.	.	.
cord-005453-4057qib7	8819	1	Similarly	similarly	RB
cord-005453-4057qib7	8819	2	,	,	,
cord-005453-4057qib7	8819	3	high	high	JJ
cord-005453-4057qib7	8819	4	EVL	EVL	NNP
cord-005453-4057qib7	8819	5	or	or	CC
cord-005453-4057qib7	8819	6	no	no	DT
cord-005453-4057qib7	8819	7	EBV	EBV	NNP
cord-005453-4057qib7	8819	8	-	-	HYPH
cord-005453-4057qib7	8819	9	R	r	NN
cord-005453-4057qib7	8819	10	,	,	,
cord-005453-4057qib7	8819	11	absence	absence	NN
cord-005453-4057qib7	8819	12	of	of	IN
cord-005453-4057qib7	8819	13	M	M	NNP
cord-005453-4057qib7	8819	14	-	-	HYPH
cord-005453-4057qib7	8819	15	protein	protein	NNP
cord-005453-4057qib7	8819	16	and	and	CC
cord-005453-4057qib7	8819	17	ITU	ITU	NNP
cord-005453-4057qib7	8819	18	admission	admission	NN
cord-005453-4057qib7	8819	19	were	be	VBD
cord-005453-4057qib7	8819	20	significant	significant	JJ
cord-005453-4057qib7	8819	21	predictors	predictor	NNS
cord-005453-4057qib7	8819	22	of	of	IN
cord-005453-4057qib7	8819	23	high	high	JJ
cord-005453-4057qib7	8819	24	NRM	NRM	NNP
cord-005453-4057qib7	8819	25	.	.	.
cord-005453-4057qib7	8820	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8820	2	:	:	:
cord-005453-4057qib7	8821	1	This	this	DT
cord-005453-4057qib7	8821	2	study	study	NN
cord-005453-4057qib7	8821	3	adds	add	VBZ
cord-005453-4057qib7	8821	4	to	to	IN
cord-005453-4057qib7	8821	5	our	-PRON-	PRP$
cord-005453-4057qib7	8821	6	understanding	understanding	NN
cord-005453-4057qib7	8821	7	of	of	IN
cord-005453-4057qib7	8821	8	role	role	NN
cord-005453-4057qib7	8821	9	of	of	IN
cord-005453-4057qib7	8821	10	EBV	EBV	NNP
cord-005453-4057qib7	8821	11	viraemia	viraemia	NNP
cord-005453-4057qib7	8821	12	&	&	CC
cord-005453-4057qib7	8821	13	associated	associate	VBD
cord-005453-4057qib7	8821	14	MG	MG	NNP
cord-005453-4057qib7	8821	15	in	in	IN
cord-005453-4057qib7	8821	16	TCD	TCD	NNP
cord-005453-4057qib7	8821	17	-	-	HYPH
cord-005453-4057qib7	8821	18	HSCTs	HSCTs	NNP
cord-005453-4057qib7	8821	19	while	while	IN
cord-005453-4057qib7	8821	20	highlighting	highlight	VBG
cord-005453-4057qib7	8821	21	its	-PRON-	PRP$
cord-005453-4057qib7	8821	22	significant	significant	JJ
cord-005453-4057qib7	8821	23	impact	impact	NN
cord-005453-4057qib7	8821	24	on	on	IN
cord-005453-4057qib7	8821	25	risk	risk	NN
cord-005453-4057qib7	8821	26	of	of	IN
cord-005453-4057qib7	8821	27	PTLD	PTLD	NNP
cord-005453-4057qib7	8821	28	,	,	,
cord-005453-4057qib7	8821	29	OS	OS	NNP
cord-005453-4057qib7	8821	30	,	,	,
cord-005453-4057qib7	8821	31	NRM	NRM	NNP
cord-005453-4057qib7	8821	32	&	&	CC
cord-005453-4057qib7	8821	33	CIR	CIR	NNP
cord-005453-4057qib7	8821	34	.	.	.
cord-005453-4057qib7	8822	1	Low	low	JJ
cord-005453-4057qib7	8822	2	EBV	EBV	NNP
cord-005453-4057qib7	8822	3	burden	burden	NN
cord-005453-4057qib7	8822	4	and	and	CC
cord-005453-4057qib7	8822	5	development	development	NN
cord-005453-4057qib7	8822	6	of	of	IN
cord-005453-4057qib7	8822	7	MG	MG	NNP
cord-005453-4057qib7	8822	8	is	be	VBZ
cord-005453-4057qib7	8822	9	protective	protective	JJ
cord-005453-4057qib7	8822	10	with	with	IN
cord-005453-4057qib7	8822	11	significantly	significantly	RB
cord-005453-4057qib7	8822	12	better	well	JJR
cord-005453-4057qib7	8822	13	survival	survival	NN
cord-005453-4057qib7	8822	14	outcomes	outcome	NNS
cord-005453-4057qib7	8822	15	and	and	CC
cord-005453-4057qib7	8822	16	we	-PRON-	PRP
cord-005453-4057qib7	8822	17	recommend	recommend	VBP
cord-005453-4057qib7	8822	18	pre	pre	JJ
cord-005453-4057qib7	8822	19	-	-	JJ
cord-005453-4057qib7	8822	20	emptive	emptive	JJ
cord-005453-4057qib7	8822	21	approach	approach	NN
cord-005453-4057qib7	8822	22	of	of	IN
cord-005453-4057qib7	8822	23	using	use	VBG
cord-005453-4057qib7	8822	24	Rituximab	Rituximab	NNP
cord-005453-4057qib7	8822	25	for	for	IN
cord-005453-4057qib7	8822	26	EBV	EBV	NNP
cord-005453-4057qib7	8822	27	-	-	HYPH
cord-005453-4057qib7	8822	28	R	R	NNP
cord-005453-4057qib7	8822	29	/PTLD	/ptld	NN
cord-005453-4057qib7	8822	30	is	be	VBZ
cord-005453-4057qib7	8822	31	best	well	RBS
cord-005453-4057qib7	8822	32	employed	employ	VBN
cord-005453-4057qib7	8822	33	at	at	IN
cord-005453-4057qib7	8822	34	higher	high	JJR
cord-005453-4057qib7	8822	35	EBV	EBV	NNP
cord-005453-4057qib7	8822	36	burden	burden	NN
cord-005453-4057qib7	8822	37	(	(	-LRB-
cord-005453-4057qib7	8822	38	e.g.	e.g.	RB
cord-005453-4057qib7	8822	39	>	>	XX
cord-005453-4057qib7	8822	40	150k	150k	CD
cord-005453-4057qib7	8822	41	copies	copy	NNS
cord-005453-4057qib7	8822	42	/	/	SYM
cord-005453-4057qib7	8822	43	ml	ml	NN
cord-005453-4057qib7	8822	44	DNA	DNA	NNP
cord-005453-4057qib7	8822	45	)	)	-RRB-
cord-005453-4057qib7	8822	46	in	in	IN
cord-005453-4057qib7	8822	47	high	high	JJ
cord-005453-4057qib7	8822	48	risk	risk	NN
cord-005453-4057qib7	8822	49	patients	patient	NNS
cord-005453-4057qib7	8822	50	and	and	CC
cord-005453-4057qib7	8822	51	be	be	VB
cord-005453-4057qib7	8822	52	prospectively	prospectively	RB
cord-005453-4057qib7	8822	53	evaluated	evaluate	VBN
cord-005453-4057qib7	8822	54	in	in	IN
cord-005453-4057qib7	8822	55	future	future	JJ
cord-005453-4057qib7	8822	56	studies	study	NNS
cord-005453-4057qib7	8822	57	.	.	.
cord-005453-4057qib7	8823	1	Clinical	clinical	JJ
cord-005453-4057qib7	8823	2	Trial	Trial	NNP
cord-005453-4057qib7	8823	3	Registry	Registry	NNP
cord-005453-4057qib7	8823	4	:	:	:
cord-005453-4057qib7	8824	1	n	n	LS
cord-005453-4057qib7	8824	2	/	/	SYM
cord-005453-4057qib7	8824	3	a	a	DT
cord-005453-4057qib7	8824	4	Disclosure	disclosure	NN
cord-005453-4057qib7	8824	5	:	:	:
cord-005453-4057qib7	8824	6	Nothing	nothing	NN
cord-005453-4057qib7	8824	7	to	to	TO
cord-005453-4057qib7	8824	8	declare	declare	VB
cord-005453-4057qib7	8824	9	P394	P394	NNP
cord-005453-4057qib7	8824	10	Impact	Impact	NNP
cord-005453-4057qib7	8824	11	of	of	IN
cord-005453-4057qib7	8824	12	early	early	JJ
cord-005453-4057qib7	8824	13	candidemia	candidemia	NN
cord-005453-4057qib7	8824	14	on	on	IN
cord-005453-4057qib7	8824	15	the	the	DT
cord-005453-4057qib7	8824	16	long	long	JJ
cord-005453-4057qib7	8824	17	-	-	HYPH
cord-005453-4057qib7	8824	18	term	term	NN
cord-005453-4057qib7	8824	19	outcome	outcome	NN
cord-005453-4057qib7	8824	20	of	of	IN
cord-005453-4057qib7	8824	21	allogeneic	allogeneic	JJ
cord-005453-4057qib7	8824	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8824	23	stem	stem	NN
cord-005453-4057qib7	8824	24	cell	cell	NN
cord-005453-4057qib7	8824	25	transplant	transplant	NN
cord-005453-4057qib7	8824	26	in	in	IN
cord-005453-4057qib7	8824	27	non	non	JJ
cord-005453-4057qib7	8824	28	leukemic	leukemic	JJ
cord-005453-4057qib7	8824	29	patients	patient	NNS
cord-005453-4057qib7	8824	30	:	:	:
cord-005453-4057qib7	8824	31	An	an	DT
cord-005453-4057qib7	8824	32	outcome	outcome	NN
cord-005453-4057qib7	8824	33	analysis	analysis	NN
cord-005453-4057qib7	8824	34	on	on	IN
cord-005453-4057qib7	8824	35	behalf	behalf	NN
cord-005453-4057qib7	8824	36	of	of	IN
cord-005453-4057qib7	8824	37	IDWP	IDWP	NNP
cord-005453-4057qib7	8824	38	Background	Background	NNP
cord-005453-4057qib7	8824	39	:	:	:
cord-005453-4057qib7	8824	40	To	to	TO
cord-005453-4057qib7	8824	41	assess	assess	VB
cord-005453-4057qib7	8824	42	the	the	DT
cord-005453-4057qib7	8824	43	incidence	incidence	NN
cord-005453-4057qib7	8824	44	of	of	IN
cord-005453-4057qib7	8824	45	,	,	,
cord-005453-4057qib7	8824	46	and	and	CC
cord-005453-4057qib7	8824	47	risk	risk	NN
cord-005453-4057qib7	8824	48	factors	factor	NNS
cord-005453-4057qib7	8824	49	for	for	IN
cord-005453-4057qib7	8824	50	,	,	,
cord-005453-4057qib7	8824	51	Candida	Candida	NNP
cord-005453-4057qib7	8824	52	infection	infection	NN
cord-005453-4057qib7	8824	53	in	in	IN
cord-005453-4057qib7	8824	54	the	the	DT
cord-005453-4057qib7	8824	55	first	first	JJ
cord-005453-4057qib7	8824	56	100	100	CD
cord-005453-4057qib7	8824	57	days	day	NNS
cord-005453-4057qib7	8824	58	post	post	NN
cord-005453-4057qib7	8824	59	-	-	JJ
cord-005453-4057qib7	8824	60	allogeneic	allogeneic	JJ
cord-005453-4057qib7	8824	61	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8824	62	stem	stem	NN
cord-005453-4057qib7	8824	63	cell	cell	NN
cord-005453-4057qib7	8824	64	transplantation	transplantation	NN
cord-005453-4057qib7	8824	65	(	(	-LRB-
cord-005453-4057qib7	8824	66	HSCT	HSCT	NNP
cord-005453-4057qib7	8824	67	)	)	-RRB-
cord-005453-4057qib7	8824	68	and	and	CC
cord-005453-4057qib7	8824	69	the	the	DT
cord-005453-4057qib7	8824	70	impact	impact	NN
cord-005453-4057qib7	8824	71	on	on	IN
cord-005453-4057qib7	8824	72	long	long	JJ
cord-005453-4057qib7	8824	73	-	-	HYPH
cord-005453-4057qib7	8824	74	term	term	NN
cord-005453-4057qib7	8824	75	survival	survival	NN
cord-005453-4057qib7	8824	76	.	.	.
cord-005453-4057qib7	8825	1	Methods	method	NNS
cord-005453-4057qib7	8825	2	:	:	:
cord-005453-4057qib7	8826	1	Outcome	outcome	NN
cord-005453-4057qib7	8826	2	analysis	analysis	NN
cord-005453-4057qib7	8826	3	of	of	IN
cord-005453-4057qib7	8826	4	50,188	50,188	CD
cord-005453-4057qib7	8826	5	patients	patient	NNS
cord-005453-4057qib7	8826	6	,	,	,
cord-005453-4057qib7	8826	7	61	61	CD
cord-005453-4057qib7	8826	8	%	%	NN
cord-005453-4057qib7	8826	9	male	male	JJ
cord-005453-4057qib7	8826	10	,	,	,
cord-005453-4057qib7	8826	11	median	median	JJ
cord-005453-4057qib7	8826	12	age	age	NN
cord-005453-4057qib7	8826	13	46	46	CD
cord-005453-4057qib7	8826	14	years	year	NNS
cord-005453-4057qib7	8826	15	(	(	-LRB-
cord-005453-4057qib7	8826	16	range	range	VBP
cord-005453-4057qib7	8826	17	0	0	CD
cord-005453-4057qib7	8826	18	-	-	SYM
cord-005453-4057qib7	8826	19	80	80	CD
cord-005453-4057qib7	8826	20	)	)	-RRB-
cord-005453-4057qib7	8826	21	,	,	,
cord-005453-4057qib7	8826	22	with	with	IN
cord-005453-4057qib7	8826	23	diagnosis	diagnosis	NN
cord-005453-4057qib7	8826	24	of	of	IN
cord-005453-4057qib7	8826	25	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	8826	26	in	in	IN
cord-005453-4057qib7	8826	27	3176	3176	CD
cord-005453-4057qib7	8826	28	(	(	-LRB-
cord-005453-4057qib7	8826	29	6.3	6.3	CD
cord-005453-4057qib7	8826	30	%	%	NN
cord-005453-4057qib7	8826	31	)	)	-RRB-
cord-005453-4057qib7	8826	32	,	,	,
cord-005453-4057qib7	8826	33	bone	bone	NN
cord-005453-4057qib7	8826	34	marrow	marrow	NN
cord-005453-4057qib7	8826	35	failure	failure	NN
cord-005453-4057qib7	8826	36	in	in	IN
cord-005453-4057qib7	8826	37	7626	7626	CD
cord-005453-4057qib7	8826	38	(	(	-LRB-
cord-005453-4057qib7	8826	39	15.2	15.2	CD
cord-005453-4057qib7	8826	40	%	%	NN
cord-005453-4057qib7	8826	41	)	)	-RRB-
cord-005453-4057qib7	8826	42	,	,	,
cord-005453-4057qib7	8826	43	lymphoma	lymphoma	NN
cord-005453-4057qib7	8826	44	in	in	IN
cord-005453-4057qib7	8826	45	17743	17743	CD
cord-005453-4057qib7	8826	46	(	(	-LRB-
cord-005453-4057qib7	8826	47	35.4	35.4	CD
cord-005453-4057qib7	8826	48	%	%	NN
cord-005453-4057qib7	8826	49	)	)	-RRB-
cord-005453-4057qib7	8826	50	and	and	CC
cord-005453-4057qib7	8826	51	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	8826	52	/	/	SYM
cord-005453-4057qib7	8826	53	myeloproliferative	myeloproliferative	JJ
cord-005453-4057qib7	8826	54	disesases	disesase	NNS
cord-005453-4057qib7	8826	55	in	in	IN
cord-005453-4057qib7	8826	56	21643	21643	CD
cord-005453-4057qib7	8826	57	(	(	-LRB-
cord-005453-4057qib7	8826	58	43.1	43.1	CD
cord-005453-4057qib7	8826	59	%	%	NN
cord-005453-4057qib7	8826	60	)	)	-RRB-
cord-005453-4057qib7	8826	61	patients	patient	NNS
cord-005453-4057qib7	8826	62	who	who	WP
cord-005453-4057qib7	8826	63	underwent	undergo	VBD
cord-005453-4057qib7	8826	64	HSCT	HSCT	NNP
cord-005453-4057qib7	8826	65	from	from	IN
cord-005453-4057qib7	8826	66	2000	2000	CD
cord-005453-4057qib7	8826	67	to	to	IN
cord-005453-4057qib7	8826	68	2015	2015	CD
cord-005453-4057qib7	8826	69	:	:	:
cord-005453-4057qib7	8826	70	420	420	CD
cord-005453-4057qib7	8826	71	with	with	IN
cord-005453-4057qib7	8826	72	candidemia	candidemia	NN
cord-005453-4057qib7	8826	73	by	by	IN
cord-005453-4057qib7	8826	74	day	day	NN
cord-005453-4057qib7	8826	75	+	+	SYM
cord-005453-4057qib7	8826	76	100	100	CD
cord-005453-4057qib7	8826	77	,	,	,
cord-005453-4057qib7	8826	78	and	and	CC
cord-005453-4057qib7	8826	79	49,768	49,768	CD
cord-005453-4057qib7	8826	80	without	without	IN
cord-005453-4057qib7	8826	81	candidemia	candidemia	NN
cord-005453-4057qib7	8826	82	.	.	.
cord-005453-4057qib7	8827	1	The	the	DT
cord-005453-4057qib7	8827	2	incidence	incidence	NN
cord-005453-4057qib7	8827	3	of	of	IN
cord-005453-4057qib7	8827	4	100-day	100-day	CD
cord-005453-4057qib7	8827	5	candidemia	candidemia	NN
cord-005453-4057qib7	8827	6	was	be	VBD
cord-005453-4057qib7	8827	7	estimated	estimate	VBN
cord-005453-4057qib7	8827	8	by	by	IN
cord-005453-4057qib7	8827	9	using	use	VBG
cord-005453-4057qib7	8827	10	the	the	DT
cord-005453-4057qib7	8827	11	cumulative	cumulative	JJ
cord-005453-4057qib7	8827	12	incidence	incidence	NN
cord-005453-4057qib7	8827	13	method	method	NN
cord-005453-4057qib7	8827	14	.	.	.
cord-005453-4057qib7	8828	1	The	the	DT
cord-005453-4057qib7	8828	2	univariate	univariate	JJ
cord-005453-4057qib7	8828	3	and	and	CC
cord-005453-4057qib7	8828	4	multivariate	multivariate	JJ
cord-005453-4057qib7	8828	5	risk	risk	NN
cord-005453-4057qib7	8828	6	factor	factor	NN
cord-005453-4057qib7	8828	7	analysis	analysis	NN
cord-005453-4057qib7	8828	8	for	for	IN
cord-005453-4057qib7	8828	9	100-day	100-day	JJ
cord-005453-4057qib7	8828	10	candidemia	candidemia	NN
cord-005453-4057qib7	8828	11	was	be	VBD
cord-005453-4057qib7	8828	12	performed	perform	VBN
cord-005453-4057qib7	8828	13	with	with	IN
cord-005453-4057qib7	8828	14	the	the	DT
cord-005453-4057qib7	8828	15	cause	cause	NN
cord-005453-4057qib7	8828	16	-	-	HYPH
cord-005453-4057qib7	8828	17	specific	specific	JJ
cord-005453-4057qib7	8828	18	Cox	Cox	NNP
cord-005453-4057qib7	8828	19	regression	regression	NN
cord-005453-4057qib7	8828	20	model	model	NN
cord-005453-4057qib7	8828	21	.	.	.
cord-005453-4057qib7	8829	1	The	the	DT
cord-005453-4057qib7	8829	2	occurrence	occurrence	NN
cord-005453-4057qib7	8829	3	of	of	IN
cord-005453-4057qib7	8829	4	candidemia	candidemia	NN
cord-005453-4057qib7	8829	5	was	be	VBD
cord-005453-4057qib7	8829	6	analyzed	analyze	VBN
cord-005453-4057qib7	8829	7	as	as	IN
cord-005453-4057qib7	8829	8	a	a	DT
cord-005453-4057qib7	8829	9	timedependent	timedependent	NN
cord-005453-4057qib7	8829	10	covariate	covariate	NN
cord-005453-4057qib7	8829	11	.	.	.
cord-005453-4057qib7	8830	1	The	the	DT
cord-005453-4057qib7	8830	2	overall	overall	JJ
cord-005453-4057qib7	8830	3	survival	survival	NN
cord-005453-4057qib7	8830	4	and	and	CC
cord-005453-4057qib7	8830	5	non	non	JJ
cord-005453-4057qib7	8830	6	-	-	JJ
cord-005453-4057qib7	8830	7	relapse	relapse	JJ
cord-005453-4057qib7	8830	8	mortality	mortality	NN
cord-005453-4057qib7	8830	9	after	after	IN
cord-005453-4057qib7	8830	10	day	day	NN
cord-005453-4057qib7	8830	11	+100	+100	NNS
cord-005453-4057qib7	8830	12	were	be	VBD
cord-005453-4057qib7	8830	13	assessed	assess	VBN
cord-005453-4057qib7	8830	14	in	in	IN
cord-005453-4057qib7	8830	15	a	a	DT
cord-005453-4057qib7	8830	16	land	land	NN
cord-005453-4057qib7	8830	17	-	-	HYPH
cord-005453-4057qib7	8830	18	mark	mark	NN
cord-005453-4057qib7	8830	19	setting	setting	NN
cord-005453-4057qib7	8830	20	,	,	,
cord-005453-4057qib7	8830	21	this	this	DT
cord-005453-4057qib7	8830	22	analysis	analysis	NN
cord-005453-4057qib7	8830	23	was	be	VBD
cord-005453-4057qib7	8830	24	restricted	restrict	VBN
cord-005453-4057qib7	8830	25	to	to	IN
cord-005453-4057qib7	8830	26	patients	patient	NNS
cord-005453-4057qib7	8830	27	surviving	survive	VBG
cord-005453-4057qib7	8830	28	to	to	IN
cord-005453-4057qib7	8830	29	day	day	NN
cord-005453-4057qib7	8830	30	+100	+100	NNP
cord-005453-4057qib7	8830	31	post	post	NN
cord-005453-4057qib7	8830	32	transplant	transplant	NN
cord-005453-4057qib7	8830	33	.	.	.
cord-005453-4057qib7	8831	1	[	[	-LRB-
cord-005453-4057qib7	8831	2	[	[	-LRB-
cord-005453-4057qib7	8831	3	P393	P393	NNP
cord-005453-4057qib7	8831	4	Image	image	NN
cord-005453-4057qib7	8831	5	]	]	-RRB-
cord-005453-4057qib7	8831	6	1	1	CD
cord-005453-4057qib7	8831	7	.	.	.
cord-005453-4057qib7	8832	1	Figure	figure	NN
cord-005453-4057qib7	8832	2	1a	1a	CD
cord-005453-4057qib7	8832	3	-1b	-1b	.
cord-005453-4057qib7	8833	1	]	]	-RRB-
cord-005453-4057qib7	8833	2	Results	result	NNS
cord-005453-4057qib7	8833	3	:	:	:
cord-005453-4057qib7	8834	1	The	the	DT
cord-005453-4057qib7	8834	2	incidence	incidence	NN
cord-005453-4057qib7	8834	3	of	of	IN
cord-005453-4057qib7	8834	4	candidemia	candidemia	NN
cord-005453-4057qib7	8834	5	by	by	IN
cord-005453-4057qib7	8834	6	day	day	NN
cord-005453-4057qib7	8834	7	+100	+100	NNP
cord-005453-4057qib7	8834	8	was	be	VBD
cord-005453-4057qib7	8834	9	0.85	0.85	CD
cord-005453-4057qib7	8834	10	%	%	NN
cord-005453-4057qib7	8834	11	(	(	-LRB-
cord-005453-4057qib7	8834	12	95	95	CD
cord-005453-4057qib7	8834	13	%	%	NN
cord-005453-4057qib7	8834	14	C.I.	C.I.	NNP
cord-005453-4057qib7	8834	15	0.77	0.77	CD
cord-005453-4057qib7	8834	16	-	-	HYPH
cord-005453-4057qib7	8834	17	0.93	0.93	CD
cord-005453-4057qib7	8834	18	)	)	-RRB-
cord-005453-4057qib7	8834	19	(	(	-LRB-
cord-005453-4057qib7	8834	20	420/50,188	420/50,188	CD
cord-005453-4057qib7	8834	21	)	)	-RRB-
cord-005453-4057qib7	8834	22	and	and	CC
cord-005453-4057qib7	8834	23	occurred	occur	VBD
cord-005453-4057qib7	8834	24	at	at	IN
cord-005453-4057qib7	8834	25	a	a	DT
cord-005453-4057qib7	8834	26	median	median	NN
cord-005453-4057qib7	8834	27	of	of	IN
cord-005453-4057qib7	8834	28	17	17	CD
cord-005453-4057qib7	8834	29	days	day	NNS
cord-005453-4057qib7	8834	30	post	post	NN
cord-005453-4057qib7	8834	31	-	-	JJ
cord-005453-4057qib7	8834	32	HSCT	hsct	JJ
cord-005453-4057qib7	8834	33	(	(	-LRB-
cord-005453-4057qib7	8834	34	range	range	NN
cord-005453-4057qib7	8834	35	-7	-7	NNP
cord-005453-4057qib7	8834	36	-	-	HYPH
cord-005453-4057qib7	8834	37	100	100	CD
cord-005453-4057qib7	8834	38	)	)	-RRB-
cord-005453-4057qib7	8834	39	.	.	.
cord-005453-4057qib7	8835	1	Considering	consider	VBG
cord-005453-4057qib7	8835	2	the	the	DT
cord-005453-4057qib7	8835	3	candidemia	candidemia	NN
cord-005453-4057qib7	8835	4	within	within	IN
cord-005453-4057qib7	8835	5	100-day	100-day	CD
cord-005453-4057qib7	8835	6	from	from	IN
cord-005453-4057qib7	8835	7	HSCT	HSCT	NNP
cord-005453-4057qib7	8835	8	as	as	IN
cord-005453-4057qib7	8835	9	a	a	DT
cord-005453-4057qib7	8835	10	time	time	NN
cord-005453-4057qib7	8835	11	dependent	dependent	JJ
cord-005453-4057qib7	8835	12	covariate	covariate	NN
cord-005453-4057qib7	8835	13	,	,	,
cord-005453-4057qib7	8835	14	a	a	DT
cord-005453-4057qib7	8835	15	higher	high	JJR
cord-005453-4057qib7	8835	16	100-day	100-day	JJ
cord-005453-4057qib7	8835	17	non	non	JJ
cord-005453-4057qib7	8835	18	-	-	JJ
cord-005453-4057qib7	8835	19	relapsemortality	relapsemortality	JJ
cord-005453-4057qib7	8835	20	(	(	-LRB-
cord-005453-4057qib7	8835	21	NRM	NRM	NNP
cord-005453-4057qib7	8835	22	)	)	-RRB-
cord-005453-4057qib7	8835	23	(	(	-LRB-
cord-005453-4057qib7	8835	24	HR	HR	NNP
cord-005453-4057qib7	8835	25	3.47	3.47	CD
cord-005453-4057qib7	8835	26	(	(	-LRB-
cord-005453-4057qib7	8835	27	2.75	2.75	CD
cord-005453-4057qib7	8835	28	-	-	SYM
cord-005453-4057qib7	8835	29	4.38	4.38	CD
cord-005453-4057qib7	8835	30	)	)	-RRB-
cord-005453-4057qib7	8835	31	,	,	,
cord-005453-4057qib7	8835	32	p	p	NN
cord-005453-4057qib7	8835	33	<	<	XX
cord-005453-4057qib7	8835	34	0.0001	0.0001	CD
cord-005453-4057qib7	8835	35	)	)	-RRB-
cord-005453-4057qib7	8835	36	,	,	,
cord-005453-4057qib7	8835	37	and	and	CC
cord-005453-4057qib7	8835	38	a	a	DT
cord-005453-4057qib7	8835	39	lower	low	JJR
cord-005453-4057qib7	8835	40	100-day	100-day	JJ
cord-005453-4057qib7	8835	41	overall	overall	JJ
cord-005453-4057qib7	8835	42	-	-	HYPH
cord-005453-4057qib7	8835	43	survival	survival	NN
cord-005453-4057qib7	8835	44	(	(	-LRB-
cord-005453-4057qib7	8835	45	OS	OS	NNP
cord-005453-4057qib7	8835	46	)	)	-RRB-
cord-005453-4057qib7	8836	1	(	(	-LRB-
cord-005453-4057qib7	8836	2	HR	HR	NNP
cord-005453-4057qib7	8836	3	3.21	3.21	CD
cord-005453-4057qib7	8836	4	,	,	,
cord-005453-4057qib7	8836	5	95	95	CD
cord-005453-4057qib7	8836	6	%	%	NN
cord-005453-4057qib7	8836	7	CI	CI	NNP
cord-005453-4057qib7	8836	8	2.67	2.67	CD
cord-005453-4057qib7	8836	9	-	-	HYPH
cord-005453-4057qib7	8836	10	3.85	3.85	CD
cord-005453-4057qib7	8836	11	)	)	-RRB-
cord-005453-4057qib7	8836	12	,	,	,
cord-005453-4057qib7	8836	13	p	p	NN
cord-005453-4057qib7	8836	14	<	<	XX
cord-005453-4057qib7	8836	15	0.0001	0.0001	CD
cord-005453-4057qib7	8836	16	)	)	-RRB-
cord-005453-4057qib7	8836	17	were	be	VBD
cord-005453-4057qib7	8836	18	obtained	obtain	VBN
cord-005453-4057qib7	8836	19	from	from	IN
cord-005453-4057qib7	8836	20	the	the	DT
cord-005453-4057qib7	8836	21	Cox	Cox	NNP
cord-005453-4057qib7	8836	22	model	model	NN
cord-005453-4057qib7	8836	23	for	for	IN
cord-005453-4057qib7	8836	24	patients	patient	NNS
cord-005453-4057qib7	8836	25	with	with	IN
cord-005453-4057qib7	8836	26	candidemia	candidemia	NN
cord-005453-4057qib7	8836	27	.	.	.
cord-005453-4057qib7	8837	1	Factors	factor	NNS
cord-005453-4057qib7	8837	2	significantly	significantly	RB
cord-005453-4057qib7	8837	3	associated	associate	VBD
cord-005453-4057qib7	8837	4	with	with	IN
cord-005453-4057qib7	8837	5	candidemia	candidemia	NN
cord-005453-4057qib7	8837	6	occurrence	occurrence	NN
cord-005453-4057qib7	8837	7	in	in	IN
cord-005453-4057qib7	8837	8	the	the	DT
cord-005453-4057qib7	8837	9	multivariate	multivariate	JJ
cord-005453-4057qib7	8837	10	analysis	analysis	NN
cord-005453-4057qib7	8837	11	were	be	VBD
cord-005453-4057qib7	8837	12	:	:	:
cord-005453-4057qib7	8837	13	gender	gender	NN
cord-005453-4057qib7	8837	14	female	female	NN
cord-005453-4057qib7	8837	15	,	,	,
cord-005453-4057qib7	8837	16	increased	increase	VBN
cord-005453-4057qib7	8837	17	age	age	NN
cord-005453-4057qib7	8837	18	at	at	IN
cord-005453-4057qib7	8837	19	HSCT	HSCT	NNP
cord-005453-4057qib7	8837	20	,	,	,
cord-005453-4057qib7	8837	21	bone	bone	NN
cord-005453-4057qib7	8837	22	marrow	marrow	NN
cord-005453-4057qib7	8837	23	failure	failure	NN
cord-005453-4057qib7	8837	24	,	,	,
cord-005453-4057qib7	8837	25	lymphoma	lymphoma	NN
cord-005453-4057qib7	8837	26	or	or	CC
cord-005453-4057qib7	8837	27	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	8837	28	/	/	SYM
cord-005453-4057qib7	8837	29	myeloproliferative	myeloproliferative	JJ
cord-005453-4057qib7	8837	30	diagnosis	diagnosis	NN
cord-005453-4057qib7	8837	31	,	,	,
cord-005453-4057qib7	8837	32	bone	bone	NN
cord-005453-4057qib7	8837	33	marrow	marrow	NN
cord-005453-4057qib7	8837	34	or	or	CC
cord-005453-4057qib7	8837	35	cord	cord	NN
cord-005453-4057qib7	8837	36	blood	blood	NN
cord-005453-4057qib7	8837	37	stem	stem	NN
cord-005453-4057qib7	8837	38	cell	cell	NN
cord-005453-4057qib7	8837	39	source	source	NN
cord-005453-4057qib7	8837	40	,	,	,
cord-005453-4057qib7	8837	41	T	t	NN
cord-005453-4057qib7	8837	42	-	-	HYPH
cord-005453-4057qib7	8837	43	cell	cell	NN
cord-005453-4057qib7	8837	44	depletion	depletion	NN
cord-005453-4057qib7	8837	45	,	,	,
cord-005453-4057qib7	8837	46	less	less	CC
cord-005453-4057qib7	8837	47	recent	recent	JJ
cord-005453-4057qib7	8837	48	year	year	NN
cord-005453-4057qib7	8837	49	of	of	IN
cord-005453-4057qib7	8837	50	HSCT	HSCT	NNP
cord-005453-4057qib7	8837	51	.	.	.
cord-005453-4057qib7	8838	1	Among	among	IN
cord-005453-4057qib7	8838	2	patients	patient	NNS
cord-005453-4057qib7	8838	3	alive	alive	JJ
cord-005453-4057qib7	8838	4	at	at	IN
cord-005453-4057qib7	8838	5	day	day	NN
cord-005453-4057qib7	8838	6	+	+	CC
cord-005453-4057qib7	8838	7	100	100	CD
cord-005453-4057qib7	8838	8	,	,	,
cord-005453-4057qib7	8838	9	the	the	DT
cord-005453-4057qib7	8838	10	5-year	5-year	CD
cord-005453-4057qib7	8838	11	NRM	NRM	NNP
cord-005453-4057qib7	8838	12	and	and	CC
cord-005453-4057qib7	8838	13	OS	OS	NNP
cord-005453-4057qib7	8838	14	with	with	IN
cord-005453-4057qib7	8838	15	and	and	CC
cord-005453-4057qib7	8838	16	without	without	IN
cord-005453-4057qib7	8838	17	candidemia	candidemia	NN
cord-005453-4057qib7	8838	18	were	be	VBD
cord-005453-4057qib7	8838	19	28.2	28.2	CD
cord-005453-4057qib7	8838	20	%	%	NN
cord-005453-4057qib7	8838	21	vs.	vs.	IN
cord-005453-4057qib7	8838	22	18.8	18.8	CD
cord-005453-4057qib7	8838	23	%	%	NN
cord-005453-4057qib7	8838	24	,	,	,
cord-005453-4057qib7	8838	25	p	p	NN
cord-005453-4057qib7	8838	26	<	<	XX
cord-005453-4057qib7	8838	27	0.0001	0.0001	CD
cord-005453-4057qib7	8838	28	,	,	,
cord-005453-4057qib7	8838	29	and	and	CC
cord-005453-4057qib7	8838	30	50.5	50.5	CD
cord-005453-4057qib7	8838	31	%	%	NN
cord-005453-4057qib7	8838	32	vs.	vs.	IN
cord-005453-4057qib7	8838	33	60.7	60.7	CD
cord-005453-4057qib7	8838	34	%	%	NN
cord-005453-4057qib7	8838	35	,	,	,
cord-005453-4057qib7	8838	36	p	p	NN
cord-005453-4057qib7	8838	37	<	<	XX
cord-005453-4057qib7	8838	38	0.0001	0.0001	CD
cord-005453-4057qib7	8838	39	,	,	,
cord-005453-4057qib7	8838	40	respectively	respectively	RB
cord-005453-4057qib7	8838	41	,	,	,
cord-005453-4057qib7	8838	42	after	after	IN
cord-005453-4057qib7	8838	43	a	a	DT
cord-005453-4057qib7	8838	44	median	median	JJ
cord-005453-4057qib7	8838	45	follow	follow	NN
cord-005453-4057qib7	8838	46	-	-	HYPH
cord-005453-4057qib7	8838	47	up	up	NN
cord-005453-4057qib7	8838	48	of	of	IN
cord-005453-4057qib7	8838	49	4.3	4.3	CD
cord-005453-4057qib7	8838	50	years	year	NNS
cord-005453-4057qib7	8838	51	(	(	-LRB-
cord-005453-4057qib7	8838	52	95	95	CD
cord-005453-4057qib7	8838	53	%	%	NN
cord-005453-4057qib7	8838	54	CI	CI	NNP
cord-005453-4057qib7	8838	55	4.3	4.3	CD
cord-005453-4057qib7	8838	56	-	-	SYM
cord-005453-4057qib7	8838	57	4.4	4.4	CD
cord-005453-4057qib7	8838	58	)	)	-RRB-
cord-005453-4057qib7	8839	1	(	(	-LRB-
cord-005453-4057qib7	8839	2	Figure	figure	NN
cord-005453-4057qib7	8839	3	1	1	CD
cord-005453-4057qib7	8839	4	)	)	-RRB-
cord-005453-4057qib7	8839	5	.	.	.
cord-005453-4057qib7	8840	1	In	in	IN
cord-005453-4057qib7	8840	2	multivariate	multivariate	JJ
cord-005453-4057qib7	8840	3	analysis	analysis	NN
cord-005453-4057qib7	8840	4	,	,	,
cord-005453-4057qib7	8840	5	the	the	DT
cord-005453-4057qib7	8840	6	occurrence	occurrence	NN
cord-005453-4057qib7	8840	7	of	of	IN
cord-005453-4057qib7	8840	8	a	a	DT
cord-005453-4057qib7	8840	9	candidemia	candidemia	NN
cord-005453-4057qib7	8840	10	episode	episode	NN
cord-005453-4057qib7	8840	11	within	within	IN
cord-005453-4057qib7	8840	12	day	day	NN
cord-005453-4057qib7	8840	13	+	+	CC
cord-005453-4057qib7	8840	14	100	100	CD
cord-005453-4057qib7	8840	15	was	be	VBD
cord-005453-4057qib7	8840	16	an	an	DT
cord-005453-4057qib7	8840	17	independent	independent	JJ
cord-005453-4057qib7	8840	18	risk	risk	NN
cord-005453-4057qib7	8840	19	factor	factor	NN
cord-005453-4057qib7	8840	20	for	for	IN
cord-005453-4057qib7	8840	21	higher	high	JJR
cord-005453-4057qib7	8840	22	NRM	NRM	NNP
cord-005453-4057qib7	8840	23	,	,	,
cord-005453-4057qib7	8840	24	HR	HR	NNP
cord-005453-4057qib7	8840	25	1.52	1.52	CD
cord-005453-4057qib7	8840	26	(	(	-LRB-
cord-005453-4057qib7	8840	27	1.18	1.18	CD
cord-005453-4057qib7	8840	28	-	-	SYM
cord-005453-4057qib7	8840	29	1.97	1.97	CD
cord-005453-4057qib7	8840	30	)	)	-RRB-
cord-005453-4057qib7	8840	31	,	,	,
cord-005453-4057qib7	8840	32	p=0.0013	p=0.0013	NNP
cord-005453-4057qib7	8840	33	,	,	,
cord-005453-4057qib7	8840	34	and	and	CC
cord-005453-4057qib7	8840	35	lower	low	JJR
cord-005453-4057qib7	8840	36	OS	OS	NNP
cord-005453-4057qib7	8840	37	,	,	,
cord-005453-4057qib7	8840	38	HR	hr	NN
cord-005453-4057qib7	8840	39	1.30	1.30	CD
cord-005453-4057qib7	8840	40	(	(	-LRB-
cord-005453-4057qib7	8840	41	1.08	1.08	CD
cord-005453-4057qib7	8840	42	-	-	SYM
cord-005453-4057qib7	8840	43	1.57	1.57	CD
cord-005453-4057qib7	8840	44	)	)	-RRB-
cord-005453-4057qib7	8840	45	,	,	,
cord-005453-4057qib7	8840	46	p=0.0061	p=0.0061	NNS
cord-005453-4057qib7	8840	47	.	.	.
cord-005453-4057qib7	8841	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8841	2	:	:	:
cord-005453-4057qib7	8841	3	despite	despite	IN
cord-005453-4057qib7	8841	4	the	the	DT
cord-005453-4057qib7	8841	5	general	general	JJ
cord-005453-4057qib7	8841	6	improvements	improvement	NNS
cord-005453-4057qib7	8841	7	in	in	IN
cord-005453-4057qib7	8841	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8841	9	and	and	CC
cord-005453-4057qib7	8841	10	treatment	treatment	NN
cord-005453-4057qib7	8841	11	,	,	,
cord-005453-4057qib7	8841	12	the	the	DT
cord-005453-4057qib7	8841	13	occurrence	occurrence	NN
cord-005453-4057qib7	8841	14	of	of	IN
cord-005453-4057qib7	8841	15	early	early	JJ
cord-005453-4057qib7	8841	16	post	post	JJ
cord-005453-4057qib7	8841	17	-	-	JJ
cord-005453-4057qib7	8841	18	HSCT	hsct	JJ
cord-005453-4057qib7	8841	19	candidemia	candidemia	NN
cord-005453-4057qib7	8841	20	had	have	VBD
cord-005453-4057qib7	8841	21	a	a	DT
cord-005453-4057qib7	8841	22	negative	negative	JJ
cord-005453-4057qib7	8841	23	impact	impact	NN
cord-005453-4057qib7	8841	24	on	on	IN
cord-005453-4057qib7	8841	25	transplant	transplant	NN
cord-005453-4057qib7	8841	26	outcome	outcome	NN
cord-005453-4057qib7	8841	27	as	as	IN
cord-005453-4057qib7	8841	28	showed	show	VBD
cord-005453-4057qib7	8841	29	previously	previously	RB
cord-005453-4057qib7	8841	30	in	in	IN
cord-005453-4057qib7	8841	31	leukemic	leukemic	JJ
cord-005453-4057qib7	8841	32	patients	patient	NNS
cord-005453-4057qib7	8841	33	.	.	.
cord-005453-4057qib7	8842	1	Abstract	Abstract	NNP
cord-005453-4057qib7	8842	2	already	already	RB
cord-005453-4057qib7	8842	3	published	publish	VBN
cord-005453-4057qib7	8842	4	.	.	.
cord-005453-4057qib7	8843	1	Carbapenem	carbapenem	NN
cord-005453-4057qib7	8843	2	-	-	HYPH
cord-005453-4057qib7	8843	3	resistant	resistant	JJ
cord-005453-4057qib7	8843	4	enterobacteriaceae	enterobacteriaceae	NNS
cord-005453-4057qib7	8843	5	colonizationimportance	colonizationimportance	NN
cord-005453-4057qib7	8843	6	in	in	IN
cord-005453-4057qib7	8843	7	the	the	DT
cord-005453-4057qib7	8843	8	risk	risk	NN
cord-005453-4057qib7	8843	9	of	of	IN
cord-005453-4057qib7	8843	10	CRE	cre	NN
cord-005453-4057qib7	8843	11	bacteremia	bacteremia	NN
cord-005453-4057qib7	8843	12	and	and	CC
cord-005453-4057qib7	8843	13	mortality	mortality	NN
cord-005453-4057qib7	8843	14	in	in	IN
cord-005453-4057qib7	8843	15	stem	stem	NN
cord-005453-4057qib7	8843	16	cell	cell	NN
cord-005453-4057qib7	8843	17	transplant	transplant	NN
cord-005453-4057qib7	8843	18	(	(	-LRB-
cord-005453-4057qib7	8843	19	HSCT	HSCT	NNP
cord-005453-4057qib7	8843	20	)	)	-RRB-
cord-005453-4057qib7	8843	21	and	and	CC
cord-005453-4057qib7	8843	22	acute	acute	JJ
cord-005453-4057qib7	8843	23	leukemia	leukemia	NN
cord-005453-4057qib7	8843	24	patients	patient	NNS
cord-005453-4057qib7	8843	25	Marcia	Marcia	NNP
cord-005453-4057qib7	8843	26	Garnica	Garnica	NNP
cord-005453-4057qib7	8843	27	1,2	1,2	CD
cord-005453-4057qib7	8843	28	,	,	,
cord-005453-4057qib7	8843	29	Marco	Marco	NNP
cord-005453-4057qib7	8843	30	A	A	NNP
cord-005453-4057qib7	8843	31	F	F	NNP
cord-005453-4057qib7	8843	32	Bellizze	Bellizze	NNP
cord-005453-4057qib7	8843	33	1	1	CD
cord-005453-4057qib7	8843	34	,	,	,
cord-005453-4057qib7	8843	35	Priscila	Priscila	NNP
cord-005453-4057qib7	8843	36	G	G	NNP
cord-005453-4057qib7	8843	37	A	a	NN
cord-005453-4057qib7	8843	38	de	de	FW
cord-005453-4057qib7	8843	39	Jesus	Jesus	NNP
cord-005453-4057qib7	8843	40	1	1	CD
cord-005453-4057qib7	8843	41	,	,	,
cord-005453-4057qib7	8843	42	Rafaela	Rafaela	NNP
cord-005453-4057qib7	8843	43	R	r	NN
cord-005453-4057qib7	8843	44	C	c	NN
cord-005453-4057qib7	8843	45	Gomes	Gomes	NNP
cord-005453-4057qib7	8843	46	1	1	CD
cord-005453-4057qib7	8843	47	,	,	,
cord-005453-4057qib7	8843	48	Filipe	Filipe	NNP
cord-005453-4057qib7	8843	49	M	M	NNP
cord-005453-4057qib7	8843	50	Akamine	Akamine	NNP
cord-005453-4057qib7	8843	51	1	1	CD
cord-005453-4057qib7	8843	52	,	,	,
cord-005453-4057qib7	8843	53	Alan	Alan	NNP
cord-005453-4057qib7	8843	54	J	J	NNP
cord-005453-4057qib7	8843	55	Marçal	Marçal	NNP
cord-005453-4057qib7	8843	56	1	1	CD
cord-005453-4057qib7	8843	57	,	,	,
cord-005453-4057qib7	8843	58	Luzinete	Luzinete	NNP
cord-005453-4057qib7	8843	59	CO	CO	NNP
cord-005453-4057qib7	8843	60	Rangel	Rangel	NNP
cord-005453-4057qib7	8843	61	2	2	CD
cord-005453-4057qib7	8844	1	,	,	,
cord-005453-4057qib7	8844	2	Andreia	Andreia	NNP
cord-005453-4057qib7	8844	3	Assis	Assis	NNP
cord-005453-4057qib7	8844	4	2	2	CD
cord-005453-4057qib7	8844	5	,	,	,
cord-005453-4057qib7	8844	6	Marcia	Marcia	NNP
cord-005453-4057qib7	8844	7	Rejane	Rejane	NNP
cord-005453-4057qib7	8844	8	Valentim	Valentim	NNP
cord-005453-4057qib7	8844	9	2	2	CD
cord-005453-4057qib7	8844	10	,	,	,
cord-005453-4057qib7	8844	11	Angelo	Angelo	NNP
cord-005453-4057qib7	8844	12	Maiolino	Maiolino	NNP
cord-005453-4057qib7	8844	13	1	1	CD
cord-005453-4057qib7	8844	14	Background	Background	NNP
cord-005453-4057qib7	8844	15	:	:	:
cord-005453-4057qib7	8845	1	Spread	Spread	VBN
cord-005453-4057qib7	8845	2	of	of	IN
cord-005453-4057qib7	8845	3	infections	infection	NNS
cord-005453-4057qib7	8845	4	due	due	JJ
cord-005453-4057qib7	8845	5	to	to	IN
cord-005453-4057qib7	8845	6	Carbapenemresistant	Carbapenemresistant	NNP
cord-005453-4057qib7	8845	7	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-005453-4057qib7	8845	8	(	(	-LRB-
cord-005453-4057qib7	8845	9	CRE	CRE	NNP
cord-005453-4057qib7	8845	10	)	)	-RRB-
cord-005453-4057qib7	8845	11	is	be	VBZ
cord-005453-4057qib7	8845	12	a	a	DT
cord-005453-4057qib7	8845	13	worldwide	worldwide	JJ
cord-005453-4057qib7	8845	14	phenomenon	phenomenon	NN
cord-005453-4057qib7	8845	15	and	and	CC
cord-005453-4057qib7	8845	16	has	have	VBZ
cord-005453-4057qib7	8845	17	been	be	VBN
cord-005453-4057qib7	8845	18	associated	associate	VBN
cord-005453-4057qib7	8845	19	with	with	IN
cord-005453-4057qib7	8845	20	high	high	JJ
cord-005453-4057qib7	8845	21	mortality	mortality	NN
cord-005453-4057qib7	8845	22	and	and	CC
cord-005453-4057qib7	8845	23	clinical	clinical	JJ
cord-005453-4057qib7	8845	24	complications	complication	NNS
cord-005453-4057qib7	8845	25	.	.	.
cord-005453-4057qib7	8846	1	Gut	gut	NN
cord-005453-4057qib7	8846	2	translocation	translocation	NN
cord-005453-4057qib7	8846	3	is	be	VBZ
cord-005453-4057qib7	8846	4	the	the	DT
cord-005453-4057qib7	8846	5	most	most	RBS
cord-005453-4057qib7	8846	6	important	important	JJ
cord-005453-4057qib7	8846	7	portal	portal	NN
cord-005453-4057qib7	8846	8	of	of	IN
cord-005453-4057qib7	8846	9	entry	entry	NN
cord-005453-4057qib7	8846	10	of	of	IN
cord-005453-4057qib7	8846	11	bacteria	bacteria	NNS
cord-005453-4057qib7	8846	12	during	during	IN
cord-005453-4057qib7	8846	13	neutropenia	neutropenia	NN
cord-005453-4057qib7	8846	14	,	,	,
cord-005453-4057qib7	8846	15	and	and	CC
cord-005453-4057qib7	8846	16	CRE	CRE	NNP
cord-005453-4057qib7	8846	17	gut	gut	NN
cord-005453-4057qib7	8846	18	colonization	colonization	NN
cord-005453-4057qib7	8846	19	is	be	VBZ
cord-005453-4057qib7	8846	20	a	a	DT
cord-005453-4057qib7	8846	21	possible	possible	JJ
cord-005453-4057qib7	8846	22	risk	risk	NN
cord-005453-4057qib7	8846	23	factor	factor	NN
cord-005453-4057qib7	8846	24	for	for	IN
cord-005453-4057qib7	8846	25	bacteremia	bacteremia	NN
cord-005453-4057qib7	8846	26	during	during	IN
cord-005453-4057qib7	8846	27	neutropenia	neutropenia	NN
cord-005453-4057qib7	8846	28	.	.	.
cord-005453-4057qib7	8847	1	Goals	goal	NNS
cord-005453-4057qib7	8847	2	:	:	:
cord-005453-4057qib7	8848	1	In	in	IN
cord-005453-4057qib7	8848	2	the	the	DT
cord-005453-4057qib7	8848	3	present	present	JJ
cord-005453-4057qib7	8848	4	study	study	NN
cord-005453-4057qib7	8848	5	,	,	,
cord-005453-4057qib7	8848	6	we	-PRON-	PRP
cord-005453-4057qib7	8848	7	describe	describe	VBP
cord-005453-4057qib7	8848	8	the	the	DT
cord-005453-4057qib7	8848	9	frequencies	frequency	NNS
cord-005453-4057qib7	8848	10	of	of	IN
cord-005453-4057qib7	8848	11	CRE	CRE	NNP
cord-005453-4057qib7	8848	12	colonization	colonization	NN
cord-005453-4057qib7	8848	13	and	and	CC
cord-005453-4057qib7	8848	14	analyzed	analyze	VBD
cord-005453-4057qib7	8848	15	its	-PRON-	PRP$
cord-005453-4057qib7	8848	16	relationship	relationship	NN
cord-005453-4057qib7	8848	17	with	with	IN
cord-005453-4057qib7	8848	18	development	development	NN
cord-005453-4057qib7	8848	19	of	of	IN
cord-005453-4057qib7	8848	20	CRE	cre	NN
cord-005453-4057qib7	8848	21	bacteremia	bacteremia	NN
cord-005453-4057qib7	8848	22	and	and	CC
cord-005453-4057qib7	8848	23	mortality	mortality	NN
cord-005453-4057qib7	8848	24	in	in	IN
cord-005453-4057qib7	8848	25	two	two	CD
cord-005453-4057qib7	8848	26	different	different	JJ
cord-005453-4057qib7	8848	27	scenarios	scenario	NNS
cord-005453-4057qib7	8848	28	:	:	:
cord-005453-4057qib7	8848	29	stem	stem	VB
cord-005453-4057qib7	8848	30	cell	cell	NN
cord-005453-4057qib7	8848	31	transplant	transplant	NN
cord-005453-4057qib7	8848	32	patients	patient	NNS
cord-005453-4057qib7	8848	33	(	(	-LRB-
cord-005453-4057qib7	8848	34	HSCT	HSCT	NNP
cord-005453-4057qib7	8848	35	)	)	-RRB-
cord-005453-4057qib7	8848	36	and	and	CC
cord-005453-4057qib7	8848	37	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8848	38	patients	patient	NNS
cord-005453-4057qib7	8848	39	.	.	.
cord-005453-4057qib7	8849	1	Methods	method	NNS
cord-005453-4057qib7	8849	2	:	:	:
cord-005453-4057qib7	8849	3	Prospective	prospective	JJ
cord-005453-4057qib7	8849	4	cohorts	cohort	NNS
cord-005453-4057qib7	8849	5	of	of	IN
cord-005453-4057qib7	8849	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8849	7	(	(	-LRB-
cord-005453-4057qib7	8849	8	from	from	IN
cord-005453-4057qib7	8849	9	2012	2012	CD
cord-005453-4057qib7	8849	10	to	to	IN
cord-005453-4057qib7	8849	11	2017	2017	CD
cord-005453-4057qib7	8849	12	)	)	-RRB-
cord-005453-4057qib7	8849	13	and	and	CC
cord-005453-4057qib7	8849	14	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8849	15	patients	patient	NNS
cord-005453-4057qib7	8849	16	(	(	-LRB-
cord-005453-4057qib7	8849	17	from	from	IN
cord-005453-4057qib7	8849	18	2016	2016	CD
cord-005453-4057qib7	8849	19	to	to	IN
cord-005453-4057qib7	8849	20	2018	2018	CD
cord-005453-4057qib7	8849	21	)	)	-RRB-
cord-005453-4057qib7	8849	22	.	.	.
cord-005453-4057qib7	8850	1	HSCT	HSCT	NNP
cord-005453-4057qib7	8850	2	patients	patient	NNS
cord-005453-4057qib7	8850	3	were	be	VBD
cord-005453-4057qib7	8850	4	analyzed	analyze	VBN
cord-005453-4057qib7	8850	5	from	from	IN
cord-005453-4057qib7	8850	6	conditioning	conditioning	NN
cord-005453-4057qib7	8850	7	until	until	IN
cord-005453-4057qib7	8850	8	discharge	discharge	NN
cord-005453-4057qib7	8850	9	(	(	-LRB-
cord-005453-4057qib7	8850	10	pre	pre	JJ
cord-005453-4057qib7	8850	11	-	-	JJ
cord-005453-4057qib7	8850	12	engraphment	engraphment	JJ
cord-005453-4057qib7	8850	13	phase	phase	NN
cord-005453-4057qib7	8850	14	)	)	-RRB-
cord-005453-4057qib7	8850	15	and	and	CC
cord-005453-4057qib7	8850	16	leukemia	leukemia	NN
cord-005453-4057qib7	8850	17	patients	patient	NNS
cord-005453-4057qib7	8850	18	from	from	IN
cord-005453-4057qib7	8850	19	first	first	JJ
cord-005453-4057qib7	8850	20	induction	induction	NN
cord-005453-4057qib7	8850	21	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8850	22	until	until	IN
cord-005453-4057qib7	8850	23	last	last	JJ
cord-005453-4057qib7	8850	24	intensification	intensification	NN
cord-005453-4057qib7	8850	25	.	.	.
cord-005453-4057qib7	8851	1	If	if	IN
cord-005453-4057qib7	8851	2	an	an	DT
cord-005453-4057qib7	8851	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8851	4	was	be	VBD
cord-005453-4057qib7	8851	5	performed	perform	VBN
cord-005453-4057qib7	8851	6	in	in	IN
cord-005453-4057qib7	8851	7	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8851	8	patient	patient	NN
cord-005453-4057qib7	8851	9	the	the	DT
cord-005453-4057qib7	8851	10	patient	patient	NN
cord-005453-4057qib7	8851	11	was	be	VBD
cord-005453-4057qib7	8851	12	censored	censor	VBN
cord-005453-4057qib7	8851	13	in	in	IN
cord-005453-4057qib7	8851	14	leukemia	leukemia	NN
cord-005453-4057qib7	8851	15	cohort	cohort	NN
cord-005453-4057qib7	8851	16	and	and	CC
cord-005453-4057qib7	8851	17	included	include	VBD
cord-005453-4057qib7	8851	18	in	in	IN
cord-005453-4057qib7	8851	19	HSCT	HSCT	NNP
cord-005453-4057qib7	8851	20	cohort	cohort	NN
cord-005453-4057qib7	8851	21	.	.	.
cord-005453-4057qib7	8852	1	All	all	DT
cord-005453-4057qib7	8852	2	patients	patient	NNS
cord-005453-4057qib7	8852	3	had	have	VBD
cord-005453-4057qib7	8852	4	rectal	rectal	JJ
cord-005453-4057qib7	8852	5	swabs	swab	NNS
cord-005453-4057qib7	8852	6	performed	perform	VBN
cord-005453-4057qib7	8852	7	weekly	weekly	RB
cord-005453-4057qib7	8852	8	during	during	IN
cord-005453-4057qib7	8852	9	hospitalization	hospitalization	NN
cord-005453-4057qib7	8852	10	for	for	IN
cord-005453-4057qib7	8852	11	the	the	DT
cord-005453-4057qib7	8852	12	identification	identification	NN
cord-005453-4057qib7	8852	13	of	of	IN
cord-005453-4057qib7	8852	14	CRE	CRE	NNP
cord-005453-4057qib7	8852	15	colonization	colonization	NN
cord-005453-4057qib7	8852	16	.	.	.
cord-005453-4057qib7	8853	1	Patients	patient	NNS
cord-005453-4057qib7	8853	2	with	with	IN
cord-005453-4057qib7	8853	3	at	at	RB
cord-005453-4057qib7	8853	4	least	least	RBS
cord-005453-4057qib7	8853	5	one	one	CD
cord-005453-4057qib7	8853	6	positive	positive	JJ
cord-005453-4057qib7	8853	7	swab	swab	NN
cord-005453-4057qib7	8853	8	(	(	-LRB-
cord-005453-4057qib7	8853	9	CRE	CRE	NNP
cord-005453-4057qib7	8853	10	colonization	colonization	NN
cord-005453-4057qib7	8853	11	group	group	NN
cord-005453-4057qib7	8853	12	)	)	-RRB-
cord-005453-4057qib7	8853	13	were	be	VBD
cord-005453-4057qib7	8853	14	compared	compare	VBN
cord-005453-4057qib7	8853	15	to	to	IN
cord-005453-4057qib7	8853	16	patients	patient	NNS
cord-005453-4057qib7	8853	17	with	with	IN
cord-005453-4057qib7	8853	18	no	no	DT
cord-005453-4057qib7	8853	19	documentation	documentation	NN
cord-005453-4057qib7	8853	20	of	of	IN
cord-005453-4057qib7	8853	21	colonization	colonization	NN
cord-005453-4057qib7	8853	22	(	(	-LRB-
cord-005453-4057qib7	8853	23	controls	control	NNS
cord-005453-4057qib7	8853	24	)	)	-RRB-
cord-005453-4057qib7	8853	25	.	.	.
cord-005453-4057qib7	8854	1	The	the	DT
cord-005453-4057qib7	8854	2	outcomes	outcome	NNS
cord-005453-4057qib7	8854	3	analyzed	analyze	VBD
cord-005453-4057qib7	8854	4	were	be	VBD
cord-005453-4057qib7	8854	5	bacteremia	bacteremia	NN
cord-005453-4057qib7	8854	6	due	due	IN
cord-005453-4057qib7	8854	7	to	to	IN
cord-005453-4057qib7	8854	8	CRE	CRE	NNP
cord-005453-4057qib7	8854	9	,	,	,
cord-005453-4057qib7	8854	10	and	and	CC
cord-005453-4057qib7	8854	11	overall	overall	JJ
cord-005453-4057qib7	8854	12	mortality	mortality	NN
cord-005453-4057qib7	8854	13	.	.	.
cord-005453-4057qib7	8855	1	Results	result	NNS
cord-005453-4057qib7	8855	2	:	:	:
cord-005453-4057qib7	8856	1	There	there	EX
cord-005453-4057qib7	8856	2	were	be	VBD
cord-005453-4057qib7	8856	3	493	493	CD
cord-005453-4057qib7	8856	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8856	5	performed	perform	VBN
cord-005453-4057qib7	8856	6	during	during	IN
cord-005453-4057qib7	8856	7	the	the	DT
cord-005453-4057qib7	8856	8	study	study	NN
cord-005453-4057qib7	8856	9	(	(	-LRB-
cord-005453-4057qib7	8856	10	408	408	CD
cord-005453-4057qib7	8856	11	[	[	-LRB-
cord-005453-4057qib7	8856	12	83	83	CD
cord-005453-4057qib7	8856	13	%	%	NN
cord-005453-4057qib7	8856	14	]	]	-RRB-
cord-005453-4057qib7	8856	15	autologous	autologous	JJ
cord-005453-4057qib7	8856	16	and	and	CC
cord-005453-4057qib7	8856	17	85	85	CD
cord-005453-4057qib7	8856	18	[	[	-LRB-
cord-005453-4057qib7	8856	19	17	17	CD
cord-005453-4057qib7	8856	20	%	%	NN
cord-005453-4057qib7	8856	21	]	]	-RRB-
cord-005453-4057qib7	8856	22	allogeneic	allogeneic	NN
cord-005453-4057qib7	8856	23	)	)	-RRB-
cord-005453-4057qib7	8856	24	.	.	.
cord-005453-4057qib7	8857	1	Multiple	multiple	JJ
cord-005453-4057qib7	8857	2	myeloma	myeloma	NN
cord-005453-4057qib7	8857	3	and	and	CC
cord-005453-4057qib7	8857	4	Non	Non	NNP
cord-005453-4057qib7	8857	5	-	-	NNP
cord-005453-4057qib7	8857	6	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	8857	7	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	8857	8	were	be	VBD
cord-005453-4057qib7	8857	9	the	the	DT
cord-005453-4057qib7	8857	10	most	most	RBS
cord-005453-4057qib7	8857	11	frequent	frequent	JJ
cord-005453-4057qib7	8857	12	baseline	baseline	JJ
cord-005453-4057qib7	8857	13	diseases	disease	NNS
cord-005453-4057qib7	8857	14	(	(	-LRB-
cord-005453-4057qib7	8857	15	N=251	N=251	NNP
cord-005453-4057qib7	8857	16	;	;	:
cord-005453-4057qib7	8857	17	51	51	CD
cord-005453-4057qib7	8857	18	%	%	NN
cord-005453-4057qib7	8857	19	,	,	,
cord-005453-4057qib7	8857	20	and	and	CC
cord-005453-4057qib7	8857	21	N	n	NN
cord-005453-4057qib7	8857	22	=	=	SYM
cord-005453-4057qib7	8857	23	88	88	CD
cord-005453-4057qib7	8857	24	;	;	:
cord-005453-4057qib7	8857	25	18	18	CD
cord-005453-4057qib7	8857	26	%	%	NN
cord-005453-4057qib7	8857	27	)	)	-RRB-
cord-005453-4057qib7	8857	28	,	,	,
cord-005453-4057qib7	8857	29	respectively	respectively	RB
cord-005453-4057qib7	8857	30	.	.	.
cord-005453-4057qib7	8858	1	CRE	CRE	NNP
cord-005453-4057qib7	8858	2	colonization	colonization	NN
cord-005453-4057qib7	8858	3	was	be	VBD
cord-005453-4057qib7	8858	4	documented	document	VBN
cord-005453-4057qib7	8858	5	in	in	IN
cord-005453-4057qib7	8858	6	10	10	CD
cord-005453-4057qib7	8858	7	%	%	NN
cord-005453-4057qib7	8858	8	(	(	-LRB-
cord-005453-4057qib7	8858	9	N=50	N=50	NNP
cord-005453-4057qib7	8858	10	)	)	-RRB-
cord-005453-4057qib7	8858	11	,	,	,
cord-005453-4057qib7	8858	12	and	and	CC
cord-005453-4057qib7	8858	13	it	-PRON-	PRP
cord-005453-4057qib7	8858	14	was	be	VBD
cord-005453-4057qib7	8858	15	more	more	RBR
cord-005453-4057qib7	8858	16	frequent	frequent	JJ
cord-005453-4057qib7	8858	17	among	among	IN
cord-005453-4057qib7	8858	18	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	8858	19	HSCT	HSCT	NNP
cord-005453-4057qib7	8858	20	and	and	CC
cord-005453-4057qib7	8858	21	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8858	22	patients	patient	NNS
cord-005453-4057qib7	8858	23	(	(	-LRB-
cord-005453-4057qib7	8858	24	p	p	NN
cord-005453-4057qib7	8858	25	<	<	XX
cord-005453-4057qib7	8858	26	0.001	0.001	CD
cord-005453-4057qib7	8858	27	for	for	IN
cord-005453-4057qib7	8858	28	both	both	DT
cord-005453-4057qib7	8858	29	)	)	-RRB-
cord-005453-4057qib7	8858	30	.	.	.
cord-005453-4057qib7	8859	1	CRE	CRE	NNP
cord-005453-4057qib7	8859	2	colonized	colonize	VBN
cord-005453-4057qib7	8859	3	patients	patient	NNS
cord-005453-4057qib7	8859	4	had	have	VBD
cord-005453-4057qib7	8859	5	longer	long	JJR
cord-005453-4057qib7	8859	6	hospitalization	hospitalization	NN
cord-005453-4057qib7	8859	7	(	(	-LRB-
cord-005453-4057qib7	8859	8	25	25	CD
cord-005453-4057qib7	8859	9	vs.	vs.	NN
cord-005453-4057qib7	8859	10	20	20	CD
cord-005453-4057qib7	8859	11	days	day	NNS
cord-005453-4057qib7	8859	12	,	,	,
cord-005453-4057qib7	8859	13	p	p	NN
cord-005453-4057qib7	8859	14	<	<	XX
cord-005453-4057qib7	8859	15	0,001	0,001	CD
cord-005453-4057qib7	8859	16	)	)	-RRB-
cord-005453-4057qib7	8859	17	,	,	,
cord-005453-4057qib7	8859	18	higher	high	JJR
cord-005453-4057qib7	8859	19	frequency	frequency	NN
cord-005453-4057qib7	8859	20	of	of	IN
cord-005453-4057qib7	8859	21	CRE	cre	NN
cord-005453-4057qib7	8859	22	bacteremia	bacteremia	NN
cord-005453-4057qib7	8859	23	(	(	-LRB-
cord-005453-4057qib7	8859	24	6	6	CD
cord-005453-4057qib7	8859	25	%	%	NN
cord-005453-4057qib7	8859	26	vs.	vs.	CC
cord-005453-4057qib7	8859	27	0.2	0.2	CD
cord-005453-4057qib7	8859	28	%	%	NN
cord-005453-4057qib7	8859	29	;	;	:
cord-005453-4057qib7	8859	30	p=0.004	p=0.004	NNP
cord-005453-4057qib7	8859	31	)	)	-RRB-
cord-005453-4057qib7	8859	32	,	,	,
cord-005453-4057qib7	8859	33	and	and	CC
cord-005453-4057qib7	8859	34	mortality	mortality	NN
cord-005453-4057qib7	8859	35	(	(	-LRB-
cord-005453-4057qib7	8859	36	16	16	CD
cord-005453-4057qib7	8859	37	%	%	NN
cord-005453-4057qib7	8859	38	vs.	vs.	CC
cord-005453-4057qib7	8859	39	2.4	2.4	CD
cord-005453-4057qib7	8859	40	%	%	NN
cord-005453-4057qib7	8859	41	,	,	,
cord-005453-4057qib7	8859	42	p	p	NN
cord-005453-4057qib7	8859	43	<	<	XX
cord-005453-4057qib7	8859	44	0,001	0,001	CD
cord-005453-4057qib7	8859	45	)	)	-RRB-
cord-005453-4057qib7	8859	46	compared	compare	VBN
cord-005453-4057qib7	8859	47	to	to	IN
cord-005453-4057qib7	8859	48	non	non	JJ
cord-005453-4057qib7	8859	49	-	-	JJ
cord-005453-4057qib7	8859	50	colonized	colonize	VBN
cord-005453-4057qib7	8859	51	HSCT	HSCT	NNP
cord-005453-4057qib7	8859	52	.	.	.
cord-005453-4057qib7	8860	1	Negative	negative	JJ
cord-005453-4057qib7	8860	2	and	and	CC
cord-005453-4057qib7	8860	3	positive	positive	JJ
cord-005453-4057qib7	8860	4	predicted	predict	VBN
cord-005453-4057qib7	8860	5	values	value	NNS
cord-005453-4057qib7	8860	6	for	for	IN
cord-005453-4057qib7	8860	7	CRE	cre	NN
cord-005453-4057qib7	8860	8	bacteremia	bacteremia	NN
cord-005453-4057qib7	8860	9	were	be	VBD
cord-005453-4057qib7	8860	10	6	6	CD
cord-005453-4057qib7	8860	11	%	%	NN
cord-005453-4057qib7	8860	12	and	and	CC
cord-005453-4057qib7	8860	13	99	99	CD
cord-005453-4057qib7	8860	14	%	%	NN
cord-005453-4057qib7	8860	15	,	,	,
cord-005453-4057qib7	8860	16	respectively	respectively	RB
cord-005453-4057qib7	8860	17	.	.	.
cord-005453-4057qib7	8861	1	Thirty	thirty	CD
cord-005453-4057qib7	8861	2	-	-	HYPH
cord-005453-4057qib7	8861	3	one	one	CD
cord-005453-4057qib7	8861	4	patients	patient	NNS
cord-005453-4057qib7	8861	5	were	be	VBD
cord-005453-4057qib7	8861	6	analyzed	analyze	VBN
cord-005453-4057qib7	8861	7	in	in	IN
cord-005453-4057qib7	8861	8	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8861	9	cohort	cohort	NN
cord-005453-4057qib7	8861	10	,	,	,
cord-005453-4057qib7	8861	11	accounting	account	VBG
cord-005453-4057qib7	8861	12	to	to	IN
cord-005453-4057qib7	8861	13	92	92	CD
cord-005453-4057qib7	8861	14	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	8861	15	(	(	-LRB-
cord-005453-4057qib7	8861	16	median	median	JJ
cord-005453-4057qib7	8861	17	3	3	CD
cord-005453-4057qib7	8861	18	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	8861	19	per	per	IN
cord-005453-4057qib7	8861	20	patient	patient	NN
cord-005453-4057qib7	8861	21	,	,	,
cord-005453-4057qib7	8861	22	ranging	range	VBG
cord-005453-4057qib7	8861	23	from	from	IN
cord-005453-4057qib7	8861	24	1	1	CD
cord-005453-4057qib7	8861	25	to	to	IN
cord-005453-4057qib7	8861	26	6	6	CD
cord-005453-4057qib7	8861	27	)	)	-RRB-
cord-005453-4057qib7	8861	28	.	.	.
cord-005453-4057qib7	8862	1	The	the	DT
cord-005453-4057qib7	8862	2	median	median	JJ
cord-005453-4057qib7	8862	3	age	age	NN
cord-005453-4057qib7	8862	4	was	be	VBD
cord-005453-4057qib7	8862	5	58	58	CD
cord-005453-4057qib7	8862	6	years	year	NNS
cord-005453-4057qib7	8862	7	,	,	,
cord-005453-4057qib7	8862	8	and	and	CC
cord-005453-4057qib7	8862	9	90	90	CD
cord-005453-4057qib7	8862	10	%	%	NN
cord-005453-4057qib7	8862	11	AML	aml	NN
cord-005453-4057qib7	8862	12	vs.	vs.	CC
cord-005453-4057qib7	8862	13	10	10	CD
cord-005453-4057qib7	8862	14	%	%	NN
cord-005453-4057qib7	8862	15	ALL	all	DT
cord-005453-4057qib7	8862	16	.	.	.
cord-005453-4057qib7	8863	1	CRE	CRE	NNP
cord-005453-4057qib7	8863	2	colonization	colonization	NN
cord-005453-4057qib7	8863	3	was	be	VBD
cord-005453-4057qib7	8863	4	documented	document	VBN
cord-005453-4057qib7	8863	5	in	in	IN
cord-005453-4057qib7	8863	6	eight	eight	CD
cord-005453-4057qib7	8863	7	(	(	-LRB-
cord-005453-4057qib7	8863	8	26	26	CD
cord-005453-4057qib7	8863	9	%	%	NN
cord-005453-4057qib7	8863	10	)	)	-RRB-
cord-005453-4057qib7	8863	11	,	,	,
cord-005453-4057qib7	8863	12	with	with	IN
cord-005453-4057qib7	8863	13	a	a	DT
cord-005453-4057qib7	8863	14	median	median	JJ
cord-005453-4057qib7	8863	15	time	time	NN
cord-005453-4057qib7	8863	16	from	from	IN
cord-005453-4057qib7	8863	17	leukemia	leukemia	NN
cord-005453-4057qib7	8863	18	diagnosis	diagnosis	NN
cord-005453-4057qib7	8863	19	and	and	CC
cord-005453-4057qib7	8863	20	colonization	colonization	NN
cord-005453-4057qib7	8863	21	of	of	IN
cord-005453-4057qib7	8863	22	93	93	CD
cord-005453-4057qib7	8863	23	days	day	NNS
cord-005453-4057qib7	8863	24	(	(	-LRB-
cord-005453-4057qib7	8863	25	9	9	CD
cord-005453-4057qib7	8863	26	-503	-503	NN
cord-005453-4057qib7	8863	27	days	day	NNS
cord-005453-4057qib7	8863	28	)	)	-RRB-
cord-005453-4057qib7	8863	29	.	.	.
cord-005453-4057qib7	8864	1	CRE	CRE	NNP
cord-005453-4057qib7	8864	2	bacteremia	bacteremia	NN
cord-005453-4057qib7	8864	3	was	be	VBD
cord-005453-4057qib7	8864	4	documented	document	VBN
cord-005453-4057qib7	8864	5	only	only	RB
cord-005453-4057qib7	8864	6	in	in	IN
cord-005453-4057qib7	8864	7	colonized	colonize	VBN
cord-005453-4057qib7	8864	8	patients	patient	NNS
cord-005453-4057qib7	8864	9	(	(	-LRB-
cord-005453-4057qib7	8864	10	25	25	CD
cord-005453-4057qib7	8864	11	%	%	NN
cord-005453-4057qib7	8864	12	vs.	vs.	IN
cord-005453-4057qib7	8864	13	zero	zero	CD
cord-005453-4057qib7	8864	14	;	;	:
cord-005453-4057qib7	8864	15	p=0,046	p=0,046	NNP
cord-005453-4057qib7	8864	16	)	)	-RRB-
cord-005453-4057qib7	8864	17	.	.	.
cord-005453-4057qib7	8865	1	All	all	DT
cord-005453-4057qib7	8865	2	eight	eight	CD
cord-005453-4057qib7	8865	3	colonized	colonize	VBN
cord-005453-4057qib7	8865	4	patients	patient	NNS
cord-005453-4057qib7	8865	5	were	be	VBD
cord-005453-4057qib7	8865	6	submitted	submit	VBN
cord-005453-4057qib7	8865	7	to	to	IN
cord-005453-4057qib7	8865	8	other	other	JJ
cord-005453-4057qib7	8865	9	cycles	cycle	NNS
cord-005453-4057qib7	8865	10	of	of	IN
cord-005453-4057qib7	8865	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8865	12	after	after	IN
cord-005453-4057qib7	8865	13	colonization	colonization	NN
cord-005453-4057qib7	8865	14	,	,	,
cord-005453-4057qib7	8865	15	in	in	IN
cord-005453-4057qib7	8865	16	one	one	CD
cord-005453-4057qib7	8865	17	of	of	IN
cord-005453-4057qib7	8865	18	them	-PRON-	PRP
cord-005453-4057qib7	8865	19	CRE	CRE	NNP
cord-005453-4057qib7	8865	20	bacteremia	bacteremia	NN
cord-005453-4057qib7	8865	21	relapsed	relapse	VBD
cord-005453-4057qib7	8865	22	.	.	.
cord-005453-4057qib7	8866	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8866	2	:	:	:
cord-005453-4057qib7	8867	1	A	a	DT
cord-005453-4057qib7	8867	2	routine	routine	JJ
cord-005453-4057qib7	8867	3	surveillance	surveillance	NN
cord-005453-4057qib7	8867	4	of	of	IN
cord-005453-4057qib7	8867	5	CRE	CRE	NNP
cord-005453-4057qib7	8867	6	colonization	colonization	NN
cord-005453-4057qib7	8867	7	showed	show	VBD
cord-005453-4057qib7	8867	8	colonization	colonization	NN
cord-005453-4057qib7	8867	9	frequencies	frequency	NNS
cord-005453-4057qib7	8867	10	from	from	IN
cord-005453-4057qib7	8867	11	10	10	CD
cord-005453-4057qib7	8867	12	%	%	NN
cord-005453-4057qib7	8867	13	to	to	IN
cord-005453-4057qib7	8867	14	25	25	CD
cord-005453-4057qib7	8867	15	%	%	NN
cord-005453-4057qib7	8867	16	in	in	IN
cord-005453-4057qib7	8867	17	HSCT	HSCT	NNP
cord-005453-4057qib7	8867	18	and	and	CC
cord-005453-4057qib7	8867	19	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8867	20	patients	patient	NNS
cord-005453-4057qib7	8867	21	respectively	respectively	RB
cord-005453-4057qib7	8867	22	and	and	CC
cord-005453-4057qib7	8867	23	was	be	VBD
cord-005453-4057qib7	8867	24	effective	effective	JJ
cord-005453-4057qib7	8867	25	to	to	TO
cord-005453-4057qib7	8867	26	stratify	stratify	VB
cord-005453-4057qib7	8867	27	CRE	cre	NN
cord-005453-4057qib7	8867	28	bacteremia	bacteremia	NN
cord-005453-4057qib7	8867	29	risk	risk	NN
cord-005453-4057qib7	8867	30	as	as	IN
cord-005453-4057qib7	8867	31	the	the	DT
cord-005453-4057qib7	8867	32	predictive	predictive	JJ
cord-005453-4057qib7	8867	33	negative	negative	JJ
cord-005453-4057qib7	8867	34	value	value	NN
cord-005453-4057qib7	8867	35	was	be	VBD
cord-005453-4057qib7	8867	36	over	over	IN
cord-005453-4057qib7	8867	37	95	95	CD
cord-005453-4057qib7	8867	38	%	%	NN
cord-005453-4057qib7	8867	39	.	.	.
cord-005453-4057qib7	8868	1	Colonization	colonization	NN
cord-005453-4057qib7	8868	2	had	have	VBD
cord-005453-4057qib7	8868	3	association	association	NN
cord-005453-4057qib7	8868	4	with	with	IN
cord-005453-4057qib7	8868	5	CRE	CRE	NNP
cord-005453-4057qib7	8868	6	bacteremia	bacteremia	NN
cord-005453-4057qib7	8868	7	and	and	CC
cord-005453-4057qib7	8868	8	overall	overall	JJ
cord-005453-4057qib7	8868	9	mortality	mortality	NN
cord-005453-4057qib7	8868	10	.	.	.
cord-005453-4057qib7	8869	1	Efforts	effort	NNS
cord-005453-4057qib7	8869	2	to	to	TO
cord-005453-4057qib7	8869	3	minimize	minimize	VB
cord-005453-4057qib7	8869	4	risks	risk	NNS
cord-005453-4057qib7	8869	5	for	for	IN
cord-005453-4057qib7	8869	6	colonization	colonization	NN
cord-005453-4057qib7	8869	7	and	and	CC
cord-005453-4057qib7	8869	8	mortality	mortality	NN
cord-005453-4057qib7	8869	9	are	be	VBP
cord-005453-4057qib7	8869	10	necessary	necessary	JJ
cord-005453-4057qib7	8869	11	.	.	.
cord-005453-4057qib7	8870	1	The	the	DT
cord-005453-4057qib7	8870	2	information	information	NN
cord-005453-4057qib7	8870	3	of	of	IN
cord-005453-4057qib7	8870	4	surveillance	surveillance	NN
cord-005453-4057qib7	8870	5	can	can	MD
cord-005453-4057qib7	8870	6	be	be	VB
cord-005453-4057qib7	8870	7	a	a	DT
cord-005453-4057qib7	8870	8	tool	tool	NN
cord-005453-4057qib7	8870	9	to	to	TO
cord-005453-4057qib7	8870	10	improve	improve	VB
cord-005453-4057qib7	8870	11	adequacy	adequacy	NN
cord-005453-4057qib7	8870	12	in	in	IN
cord-005453-4057qib7	8870	13	empirical	empirical	JJ
cord-005453-4057qib7	8870	14	febrile	febrile	JJ
cord-005453-4057qib7	8870	15	neutropenia	neutropenia	NN
cord-005453-4057qib7	8870	16	therapy	therapy	NN
cord-005453-4057qib7	8870	17	in	in	IN
cord-005453-4057qib7	8870	18	HSCT	HSCT	NNP
cord-005453-4057qib7	8870	19	and	and	CC
cord-005453-4057qib7	8870	20	Leukemia	Leukemia	NNP
cord-005453-4057qib7	8870	21	patients	patient	NNS
cord-005453-4057qib7	8870	22	.	.	.
cord-005453-4057qib7	8871	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8871	2	:	:	:
cord-005453-4057qib7	8871	3	Nothing	nothing	NN
cord-005453-4057qib7	8871	4	to	to	TO
cord-005453-4057qib7	8871	5	declare	declare	VB
cord-005453-4057qib7	8871	6	Background	background	NN
cord-005453-4057qib7	8871	7	:	:	:
cord-005453-4057qib7	8872	1	The	the	DT
cord-005453-4057qib7	8872	2	incidence	incidence	NN
cord-005453-4057qib7	8872	3	of	of	IN
cord-005453-4057qib7	8872	4	hepatitis	hepatitis	NN
cord-005453-4057qib7	8872	5	B	B	NNP
cord-005453-4057qib7	8872	6	virus	virus	NN
cord-005453-4057qib7	8872	7	infection	infection	NN
cord-005453-4057qib7	8872	8	is	be	VBZ
cord-005453-4057qib7	8872	9	high	high	JJ
cord-005453-4057qib7	8872	10	to	to	IN
cord-005453-4057qib7	8872	11	6.2	6.2	CD
cord-005453-4057qib7	8872	12	%	%	NN
cord-005453-4057qib7	8872	13	in	in	IN
cord-005453-4057qib7	8872	14	Asian	asian	JJ
cord-005453-4057qib7	8872	15	population	population	NN
cord-005453-4057qib7	8872	16	,	,	,
cord-005453-4057qib7	8873	1	So	so	CC
cord-005453-4057qib7	8873	2	there	there	EX
cord-005453-4057qib7	8873	3	is	be	VBZ
cord-005453-4057qib7	8873	4	more	more	JJR
cord-005453-4057qib7	8873	5	and	and	CC
cord-005453-4057qib7	8873	6	more	more	JJR
cord-005453-4057qib7	8873	7	attention	attention	NN
cord-005453-4057qib7	8873	8	to	to	IN
cord-005453-4057qib7	8873	9	the	the	DT
cord-005453-4057qib7	8873	10	risk	risk	NN
cord-005453-4057qib7	8873	11	of	of	IN
cord-005453-4057qib7	8873	12	hepatitis	hepatitis	NN
cord-005453-4057qib7	8873	13	B	B	NNP
cord-005453-4057qib7	8873	14	virus(HBV	virus(HBV	NNP
cord-005453-4057qib7	8873	15	)	)	-RRB-
cord-005453-4057qib7	8873	16	reactivation	reactivation	NN
cord-005453-4057qib7	8873	17	in	in	IN
cord-005453-4057qib7	8873	18	the	the	DT
cord-005453-4057qib7	8873	19	hepatitis	hepatitis	NN
cord-005453-4057qib7	8873	20	B	B	NNP
cord-005453-4057qib7	8873	21	core	core	NN
cord-005453-4057qib7	8873	22	antibody	antibody	NN
cord-005453-4057qib7	8873	23	positive	positive	JJ
cord-005453-4057qib7	8873	24	patients	patient	NNS
cord-005453-4057qib7	8873	25	during	during	IN
cord-005453-4057qib7	8873	26	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	8873	27	,	,	,
cord-005453-4057qib7	8873	28	anti	anti	JJ
cord-005453-4057qib7	8873	29	-	-	JJ
cord-005453-4057qib7	8873	30	CD20	cd20	JJ
cord-005453-4057qib7	8873	31	monoclonal	monoclonal	JJ
cord-005453-4057qib7	8873	32	antibody	antibody	NN
cord-005453-4057qib7	8873	33	,	,	,
cord-005453-4057qib7	8873	34	HSCT	HSCT	NNP
cord-005453-4057qib7	8873	35	,	,	,
cord-005453-4057qib7	8873	36	or	or	CC
cord-005453-4057qib7	8873	37	other	other	JJ
cord-005453-4057qib7	8873	38	intense	intense	JJ
cord-005453-4057qib7	8873	39	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	8873	40	drug	drug	NN
cord-005453-4057qib7	8873	41	therapy	therapy	NN
cord-005453-4057qib7	8873	42	(	(	-LRB-
cord-005453-4057qib7	8873	43	ISDT	ISDT	NNP
cord-005453-4057qib7	8873	44	)	)	-RRB-
cord-005453-4057qib7	8873	45	.	.	.
cord-005453-4057qib7	8874	1	Hepatitis	Hepatitis	NNP
cord-005453-4057qib7	8874	2	B	B	NNP
cord-005453-4057qib7	8874	3	Core	Core	NNP
cord-005453-4057qib7	8874	4	Antibody	Antibody	NNP
cord-005453-4057qib7	8874	5	is	be	VBZ
cord-005453-4057qib7	8874	6	associated	associate	VBN
cord-005453-4057qib7	8874	7	with	with	IN
cord-005453-4057qib7	8874	8	a	a	DT
cord-005453-4057qib7	8874	9	significant	significant	JJ
cord-005453-4057qib7	8874	10	risk	risk	NN
cord-005453-4057qib7	8874	11	of	of	IN
cord-005453-4057qib7	8874	12	HBV	HBV	NNP
cord-005453-4057qib7	8874	13	reactivation	reactivation	NN
cord-005453-4057qib7	8874	14	in	in	IN
cord-005453-4057qib7	8874	15	patients	patient	NNS
cord-005453-4057qib7	8874	16	undergoing	undergo	VBG
cord-005453-4057qib7	8874	17	HSCT	HSCT	NNP
cord-005453-4057qib7	8874	18	.	.	.
cord-005453-4057qib7	8875	1	However	however	RB
cord-005453-4057qib7	8875	2	,	,	,
cord-005453-4057qib7	8875	3	There	there	EX
cord-005453-4057qib7	8875	4	are	be	VBP
cord-005453-4057qib7	8875	5	remain	remain	RB
cord-005453-4057qib7	8875	6	uncertain	uncertain	JJ
cord-005453-4057qib7	8875	7	that	that	IN
cord-005453-4057qib7	8875	8	the	the	DT
cord-005453-4057qib7	8875	9	effect	effect	NN
cord-005453-4057qib7	8875	10	of	of	IN
cord-005453-4057qib7	8875	11	anti	anti	JJ
cord-005453-4057qib7	8875	12	-	-	JJ
cord-005453-4057qib7	8875	13	HbsAg	hbsag	JJ
cord-005453-4057qib7	8875	14	antibodies	antibody	NNS
cord-005453-4057qib7	8875	15	in	in	IN
cord-005453-4057qib7	8875	16	hepatitis	hepatitis	NNP
cord-005453-4057qib7	8875	17	B	B	NNP
cord-005453-4057qib7	8875	18	virus	virus	NN
cord-005453-4057qib7	8875	19	reactivation	reactivation	NN
cord-005453-4057qib7	8875	20	among	among	IN
cord-005453-4057qib7	8875	21	the	the	DT
cord-005453-4057qib7	8875	22	hepatitis	hepatitis	NN
cord-005453-4057qib7	8875	23	B	B	NNP
cord-005453-4057qib7	8875	24	core	core	NN
cord-005453-4057qib7	8875	25	antibody	antibody	NN
cord-005453-4057qib7	8875	26	positive	positive	JJ
cord-005453-4057qib7	8875	27	patients	patient	NNS
cord-005453-4057qib7	8875	28	undergo	undergo	VBP
cord-005453-4057qib7	8875	29	HSCT	HSCT	NNP
cord-005453-4057qib7	8875	30	.	.	.
cord-005453-4057qib7	8876	1	We	-PRON-	PRP
cord-005453-4057qib7	8876	2	aim	aim	VBP
cord-005453-4057qib7	8876	3	to	to	TO
cord-005453-4057qib7	8876	4	investigate	investigate	VB
cord-005453-4057qib7	8876	5	the	the	DT
cord-005453-4057qib7	8876	6	role	role	NN
cord-005453-4057qib7	8876	7	of	of	IN
cord-005453-4057qib7	8876	8	the	the	DT
cord-005453-4057qib7	8876	9	anti	anti	JJ
cord-005453-4057qib7	8876	10	-	-	JJ
cord-005453-4057qib7	8876	11	HBs	hb	NNS
cord-005453-4057qib7	8876	12	and	and	CC
cord-005453-4057qib7	8876	13	the	the	DT
cord-005453-4057qib7	8876	14	necessity	necessity	NN
cord-005453-4057qib7	8876	15	of	of	IN
cord-005453-4057qib7	8876	16	anti	anti	JJ
cord-005453-4057qib7	8876	17	virus	virus	NN
cord-005453-4057qib7	8876	18	in	in	IN
cord-005453-4057qib7	8876	19	hepatitis	hepatitis	NNP
cord-005453-4057qib7	8876	20	B	B	NNP
cord-005453-4057qib7	8876	21	surface	surface	NN
cord-005453-4057qib7	8876	22	antigen(HBsAg	antigen(hbsag	ADD
cord-005453-4057qib7	8876	23	)	)	-RRB-
cord-005453-4057qib7	8876	24	negative	negative	JJ
cord-005453-4057qib7	8876	25	,	,	,
cord-005453-4057qib7	8876	26	hepatitis	hepatitis	NNP
cord-005453-4057qib7	8876	27	B	B	NNP
cord-005453-4057qib7	8876	28	core	core	NN
cord-005453-4057qib7	8876	29	antibody	antibody	NN
cord-005453-4057qib7	8876	30	positive	positive	JJ
cord-005453-4057qib7	8876	31	patients	patient	NNS
cord-005453-4057qib7	8876	32	during	during	IN
cord-005453-4057qib7	8876	33	HSCT	HSCT	NNP
cord-005453-4057qib7	8876	34	.	.	.
cord-005453-4057qib7	8877	1	Methods	method	NNS
cord-005453-4057qib7	8877	2	:	:	:
cord-005453-4057qib7	8877	3	we	-PRON-	PRP
cord-005453-4057qib7	8877	4	enrolled	enrol	VBD
cord-005453-4057qib7	8878	1	791	791	CD
cord-005453-4057qib7	8878	2	hematological	hematological	JJ
cord-005453-4057qib7	8878	3	malignant	malignant	JJ
cord-005453-4057qib7	8878	4	patients	patient	NNS
cord-005453-4057qib7	8878	5	received	receive	VBD
cord-005453-4057qib7	8878	6	HSCT	HSCT	NNP
cord-005453-4057qib7	8878	7	in	in	IN
cord-005453-4057qib7	8878	8	our	-PRON-	PRP$
cord-005453-4057qib7	8878	9	center	center	NN
cord-005453-4057qib7	8878	10	from	from	IN
cord-005453-4057qib7	8878	11	2008	2008	CD
cord-005453-4057qib7	8878	12	to	to	IN
cord-005453-4057qib7	8878	13	2016	2016	CD
cord-005453-4057qib7	8878	14	.	.	.
cord-005453-4057qib7	8879	1	we	-PRON-	PRP
cord-005453-4057qib7	8879	2	classified	classify	VBD
cord-005453-4057qib7	8879	3	665	665	CD
cord-005453-4057qib7	8879	4	HBsAg	hbsag	CD
cord-005453-4057qib7	8879	5	negative	negative	JJ
cord-005453-4057qib7	8879	6	and	and	CC
cord-005453-4057qib7	8879	7	undetectable	undetectable	JJ
cord-005453-4057qib7	8879	8	HBV	HBV	NNP
cord-005453-4057qib7	8879	9	DNA	DNA	NNP
cord-005453-4057qib7	8879	10	patients	patient	NNS
cord-005453-4057qib7	8879	11	into	into	IN
cord-005453-4057qib7	8879	12	4	4	CD
cord-005453-4057qib7	8879	13	groups	group	NNS
cord-005453-4057qib7	8879	14	as	as	IN
cord-005453-4057qib7	8879	15	anti	anti	NNP
cord-005453-4057qib7	8879	16	-	-	JJ
cord-005453-4057qib7	8879	17	HBc(-)anti	hbc(-)anti	NN
cord-005453-4057qib7	8879	18	-	-	HYPH
cord-005453-4057qib7	8879	19	HBs(-	hbs(-	NN
cord-005453-4057qib7	8879	20	)	)	-RRB-
cord-005453-4057qib7	8880	1	(	(	-LRB-
cord-005453-4057qib7	8880	2	n=189	n=189	CD
cord-005453-4057qib7	8880	3	)	)	-RRB-
cord-005453-4057qib7	8880	4	,	,	,
cord-005453-4057qib7	8880	5	anti	anti	JJ
cord-005453-4057qib7	8880	6	-	-	JJ
cord-005453-4057qib7	8880	7	HBc(-)anti	hbc(-)anti	JJ
cord-005453-4057qib7	8880	8	-	-	HYPH
cord-005453-4057qib7	8880	9	HBs(+	HBs(+	NNP
cord-005453-4057qib7	8880	10	)	)	-RRB-
cord-005453-4057qib7	8881	1	(	(	-LRB-
cord-005453-4057qib7	8881	2	n=176	n=176	NNP
cord-005453-4057qib7	8881	3	)	)	-RRB-
cord-005453-4057qib7	8881	4	,	,	,
cord-005453-4057qib7	8881	5	anti	anti	JJ
cord-005453-4057qib7	8881	6	-	-	JJ
cord-005453-4057qib7	8881	7	HBc(+	hbc(+	JJ
cord-005453-4057qib7	8881	8	)	)	-RRB-
cord-005453-4057qib7	8881	9	anti	anti	NNS
cord-005453-4057qib7	8881	10	-	-	NN
cord-005453-4057qib7	8881	11	HBs(-	hbs(-	JJ
cord-005453-4057qib7	8881	12	)	)	-RRB-
cord-005453-4057qib7	8881	13	(	(	-LRB-
cord-005453-4057qib7	8881	14	n=49	n=49	NNP
cord-005453-4057qib7	8881	15	)	)	-RRB-
cord-005453-4057qib7	8881	16	,	,	,
cord-005453-4057qib7	8881	17	and	and	CC
cord-005453-4057qib7	8881	18	anti	anti	JJ
cord-005453-4057qib7	8881	19	-	-	JJ
cord-005453-4057qib7	8881	20	HBc(+)anti	hbc(+)anti	JJ
cord-005453-4057qib7	8881	21	-	-	HYPH
cord-005453-4057qib7	8881	22	HBs(+	hbs(+	NN
cord-005453-4057qib7	8881	23	)	)	-RRB-
cord-005453-4057qib7	8882	1	(	(	-LRB-
cord-005453-4057qib7	8882	2	n=251	n=251	NNP
cord-005453-4057qib7	8882	3	)	)	-RRB-
cord-005453-4057qib7	8882	4	.	.	.
cord-005453-4057qib7	8883	1	Results	result	NNS
cord-005453-4057qib7	8883	2	:	:	:
cord-005453-4057qib7	8884	1	HBV	HBV	NNP
cord-005453-4057qib7	8884	2	reactivation	reactivation	NN
cord-005453-4057qib7	8884	3	was	be	VBD
cord-005453-4057qib7	8884	4	identified	identify	VBN
cord-005453-4057qib7	8884	5	in	in	IN
cord-005453-4057qib7	8884	6	16	16	CD
cord-005453-4057qib7	8884	7	patients	patient	NNS
cord-005453-4057qib7	8884	8	(	(	-LRB-
cord-005453-4057qib7	8884	9	2.4	2.4	CD
cord-005453-4057qib7	8884	10	%	%	NN
cord-005453-4057qib7	8884	11	)	)	-RRB-
cord-005453-4057qib7	8884	12	after	after	IN
cord-005453-4057qib7	8884	13	HSCT	HSCT	NNP
cord-005453-4057qib7	8884	14	.	.	.
cord-005453-4057qib7	8885	1	There	there	EX
cord-005453-4057qib7	8885	2	was	be	VBD
cord-005453-4057qib7	8885	3	a	a	DT
cord-005453-4057qib7	8885	4	significant	significant	JJ
cord-005453-4057qib7	8885	5	difference	difference	NN
cord-005453-4057qib7	8885	6	in	in	IN
cord-005453-4057qib7	8885	7	HBV	HBV	NNP
cord-005453-4057qib7	8885	8	reactivation	reactivation	NN
cord-005453-4057qib7	8885	9	rate	rate	NN
cord-005453-4057qib7	8885	10	in	in	IN
cord-005453-4057qib7	8885	11	anti	anti	JJ
cord-005453-4057qib7	8885	12	-	-	JJ
cord-005453-4057qib7	8885	13	HBc(+)anti	hbc(+)anti	NN
cord-005453-4057qib7	8885	14	-	-	HYPH
cord-005453-4057qib7	8885	15	HBs(-	hbs(-	NN
cord-005453-4057qib7	8885	16	)	)	-RRB-
cord-005453-4057qib7	8885	17	(	(	-LRB-
cord-005453-4057qib7	8885	18	12.2	12.2	CD
cord-005453-4057qib7	8885	19	%	%	NN
cord-005453-4057qib7	8885	20	)	)	-RRB-
cord-005453-4057qib7	8885	21	vs	vs	IN
cord-005453-4057qib7	8885	22	anti	anti	JJ
cord-005453-4057qib7	8885	23	-	-	JJ
cord-005453-4057qib7	8885	24	HBc(+)anti	hbc(+)anti	JJ
cord-005453-4057qib7	8885	25	-	-	HYPH
cord-005453-4057qib7	8885	26	HBs(+	hbs(+	NN
cord-005453-4057qib7	8885	27	)	)	-RRB-
cord-005453-4057qib7	8885	28	(	(	-LRB-
cord-005453-4057qib7	8885	29	2.8	2.8	CD
cord-005453-4057qib7	8885	30	%	%	NN
cord-005453-4057qib7	8885	31	)	)	-RRB-
cord-005453-4057qib7	8885	32	(	(	-LRB-
cord-005453-4057qib7	8885	33	p=0.01	p=0.01	NNP
cord-005453-4057qib7	8885	34	)	)	-RRB-
cord-005453-4057qib7	8885	35	and	and	CC
cord-005453-4057qib7	8885	36	anti	anti	JJ
cord-005453-4057qib7	8885	37	-	-	JJ
cord-005453-4057qib7	8885	38	HBc	hbc	JJ
cord-005453-4057qib7	8885	39	(	(	-LRB-
cord-005453-4057qib7	8885	40	+	+	SYM
cord-005453-4057qib7	8885	41	)	)	-RRB-
cord-005453-4057qib7	8885	42	anti	anti	NNS
cord-005453-4057qib7	8885	43	-	-	NN
cord-005453-4057qib7	8885	44	HBs(-	hbs(-	JJ
cord-005453-4057qib7	8885	45	)	)	-RRB-
cord-005453-4057qib7	8885	46	(	(	-LRB-
cord-005453-4057qib7	8885	47	12.2	12.2	CD
cord-005453-4057qib7	8885	48	%	%	NN
cord-005453-4057qib7	8885	49	)	)	-RRB-
cord-005453-4057qib7	8885	50	vs	vs	IN
cord-005453-4057qib7	8885	51	anti	anti	NNP
cord-005453-4057qib7	8885	52	-	-	JJ
cord-005453-4057qib7	8885	53	HBc(-)anti	hbc(-)anti	NN
cord-005453-4057qib7	8885	54	-	-	HYPH
cord-005453-4057qib7	8885	55	HBs(-	hbs(-	LS
cord-005453-4057qib7	8885	56	)	)	-RRB-
cord-005453-4057qib7	8885	57	(	(	-LRB-
cord-005453-4057qib7	8885	58	0.0	0.0	CD
cord-005453-4057qib7	8885	59	%	%	NN
cord-005453-4057qib7	8885	60	)	)	-RRB-
cord-005453-4057qib7	8885	61	(	(	-LRB-
cord-005453-4057qib7	8885	62	p=0.000	p=0.000	NNP
cord-005453-4057qib7	8885	63	)	)	-RRB-
cord-005453-4057qib7	8885	64	,	,	,
cord-005453-4057qib7	8885	65	anti	anti	JJ
cord-005453-4057qib7	8885	66	-	-	JJ
cord-005453-4057qib7	8885	67	HBc(+)anti	hbc(+)anti	NN
cord-005453-4057qib7	8885	68	-	-	HYPH
cord-005453-4057qib7	8885	69	HBs(-	hbs(-	NN
cord-005453-4057qib7	8885	70	)	)	-RRB-
cord-005453-4057qib7	8885	71	(	(	-LRB-
cord-005453-4057qib7	8885	72	12.2	12.2	CD
cord-005453-4057qib7	8885	73	%	%	NN
cord-005453-4057qib7	8885	74	)	)	-RRB-
cord-005453-4057qib7	8885	75	vs	vs	IN
cord-005453-4057qib7	8885	76	anti	anti	NNP
cord-005453-4057qib7	8885	77	-	-	NNS
cord-005453-4057qib7	8885	78	HBc(-	hbc(-	JJ
cord-005453-4057qib7	8885	79	)	)	-RRB-
cord-005453-4057qib7	8885	80	anti	anti	JJ
cord-005453-4057qib7	8885	81	-	-	JJ
cord-005453-4057qib7	8885	82	HBs(+	hbs(+	JJ
cord-005453-4057qib7	8885	83	)	)	-RRB-
cord-005453-4057qib7	8886	1	(	(	-LRB-
cord-005453-4057qib7	8886	2	1.7	1.7	CD
cord-005453-4057qib7	8886	3	%	%	NN
cord-005453-4057qib7	8886	4	)	)	-RRB-
cord-005453-4057qib7	8886	5	(	(	-LRB-
cord-005453-4057qib7	8886	6	p=0.004	p=0.004	NNP
cord-005453-4057qib7	8886	7	)	)	-RRB-
cord-005453-4057qib7	8886	8	,	,	,
cord-005453-4057qib7	8886	9	but	but	CC
cord-005453-4057qib7	8886	10	not	not	RB
cord-005453-4057qib7	8886	11	among	among	IN
cord-005453-4057qib7	8886	12	anti	anti	JJ
cord-005453-4057qib7	8886	13	-	-	JJ
cord-005453-4057qib7	8886	14	HBc(+	hbc(+	JJ
cord-005453-4057qib7	8886	15	)	)	-RRB-
cord-005453-4057qib7	8886	16	anti	anti	JJ
cord-005453-4057qib7	8886	17	-	-	JJ
cord-005453-4057qib7	8886	18	HBs(+	hbs(+	JJ
cord-005453-4057qib7	8886	19	)	)	-RRB-
cord-005453-4057qib7	8886	20	(	(	-LRB-
cord-005453-4057qib7	8886	21	2.8	2.8	CD
cord-005453-4057qib7	8886	22	%	%	NN
cord-005453-4057qib7	8886	23	)	)	-RRB-
cord-005453-4057qib7	8886	24	and	and	CC
cord-005453-4057qib7	8886	25	anti	anti	JJ
cord-005453-4057qib7	8886	26	-	-	JJ
cord-005453-4057qib7	8886	27	HBc(-)anti	hbc(-)anti	NN
cord-005453-4057qib7	8886	28	-	-	HYPH
cord-005453-4057qib7	8886	29	HBs(-	hbs(-	LS
cord-005453-4057qib7	8886	30	)	)	-RRB-
cord-005453-4057qib7	8886	31	(	(	-LRB-
cord-005453-4057qib7	8886	32	0	0	CD
cord-005453-4057qib7	8886	33	%	%	NN
cord-005453-4057qib7	8886	34	)	)	-RRB-
cord-005453-4057qib7	8886	35	and	and	CC
cord-005453-4057qib7	8886	36	anti	anti	JJ
cord-005453-4057qib7	8886	37	-	-	JJ
cord-005453-4057qib7	8886	38	HBc(-)anti	hbc(-)anti	JJ
cord-005453-4057qib7	8886	39	-	-	HYPH
cord-005453-4057qib7	8886	40	HBs(+	HBs(+	NNP
cord-005453-4057qib7	8886	41	)	)	-RRB-
cord-005453-4057qib7	8886	42	(	(	-LRB-
cord-005453-4057qib7	8886	43	1.7	1.7	CD
cord-005453-4057qib7	8886	44	%	%	NN
cord-005453-4057qib7	8886	45	)	)	-RRB-
cord-005453-4057qib7	8886	46	.	.	.
cord-005453-4057qib7	8887	1	Whereas	whereas	IN
cord-005453-4057qib7	8887	2	there	there	EX
cord-005453-4057qib7	8887	3	were	be	VBD
cord-005453-4057qib7	8887	4	no	no	DT
cord-005453-4057qib7	8887	5	difference	difference	NN
cord-005453-4057qib7	8887	6	according	accord	VBG
cord-005453-4057qib7	8887	7	to	to	IN
cord-005453-4057qib7	8887	8	the	the	DT
cord-005453-4057qib7	8887	9	donor	donor	NN
cord-005453-4057qib7	8887	10	viral	viral	NN
cord-005453-4057qib7	8887	11	profile(p=0.774	profile(p=0.774	FW
cord-005453-4057qib7	8887	12	)	)	-RRB-
cord-005453-4057qib7	8887	13	.	.	.
cord-005453-4057qib7	8888	1	The	the	DT
cord-005453-4057qib7	8888	2	median	median	JJ
cord-005453-4057qib7	8888	3	time	time	NN
cord-005453-4057qib7	8888	4	of	of	IN
cord-005453-4057qib7	8888	5	HBV	HBV	NNP
cord-005453-4057qib7	8888	6	reactivation	reactivation	NN
cord-005453-4057qib7	8888	7	in	in	IN
cord-005453-4057qib7	8888	8	HBsAg	hbsag	ADD
cord-005453-4057qib7	8889	1	negative	negative	JJ
cord-005453-4057qib7	8889	2	patients	patient	NNS
cord-005453-4057qib7	8889	3	accepted	accept	VBD
cord-005453-4057qib7	8889	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8889	5	was	be	VBD
cord-005453-4057qib7	8890	1	645	645	CD
cord-005453-4057qib7	8890	2	(	(	-LRB-
cord-005453-4057qib7	8890	3	455	455	CD
cord-005453-4057qib7	8890	4	-	-	SYM
cord-005453-4057qib7	8890	5	1957	1957	CD
cord-005453-4057qib7	8890	6	)	)	-RRB-
cord-005453-4057qib7	8890	7	days	day	NNS
cord-005453-4057qib7	8890	8	after	after	IN
cord-005453-4057qib7	8890	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8890	10	.	.	.
cord-005453-4057qib7	8891	1	All	all	DT
cord-005453-4057qib7	8891	2	of	of	IN
cord-005453-4057qib7	8891	3	the	the	DT
cord-005453-4057qib7	8891	4	patients	patient	NNS
cord-005453-4057qib7	8891	5	with	with	IN
cord-005453-4057qib7	8891	6	HBV	HBV	NNP
cord-005453-4057qib7	8891	7	reactivation	reactivation	NN
cord-005453-4057qib7	8891	8	have	have	VBP
cord-005453-4057qib7	8891	9	been	be	VBN
cord-005453-4057qib7	8891	10	controlled	control	VBN
cord-005453-4057qib7	8891	11	with	with	IN
cord-005453-4057qib7	8891	12	Nucleos(t)ide	nucleos(t)ide	JJ
cord-005453-4057qib7	8891	13	Analogues	Analogues	NNP
cord-005453-4057qib7	8891	14	drugs	drug	NNS
cord-005453-4057qib7	8891	15	,	,	,
cord-005453-4057qib7	8891	16	and	and	CC
cord-005453-4057qib7	8891	17	5	5	CD
cord-005453-4057qib7	8891	18	of	of	IN
cord-005453-4057qib7	8891	19	them	-PRON-	PRP
cord-005453-4057qib7	8891	20	achieved	achieve	VBD
cord-005453-4057qib7	8891	21	reverse	reverse	JJ
cord-005453-4057qib7	8891	22	seroconversion	seroconversion	NN
cord-005453-4057qib7	8891	23	which	which	WDT
cord-005453-4057qib7	8891	24	detect	detect	VBP
cord-005453-4057qib7	8891	25	persistent	persistent	JJ
cord-005453-4057qib7	8891	26	anti	anti	JJ
cord-005453-4057qib7	8891	27	-	-	JJ
cord-005453-4057qib7	8891	28	HbsAg	hbsag	JJ
cord-005453-4057qib7	8891	29	antibodies	antibody	NNS
cord-005453-4057qib7	8891	30	in	in	IN
cord-005453-4057qib7	8891	31	their	-PRON-	PRP$
cord-005453-4057qib7	8891	32	bodies	body	NNS
cord-005453-4057qib7	8891	33	.	.	.
cord-005453-4057qib7	8892	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8892	2	:	:	:
cord-005453-4057qib7	8893	1	The	the	DT
cord-005453-4057qib7	8893	2	anti	anti	JJ
cord-005453-4057qib7	8893	3	-	-	JJ
cord-005453-4057qib7	8893	4	HbsAg	hbsag	JJ
cord-005453-4057qib7	8893	5	antibodies	antibody	NNS
cord-005453-4057qib7	8893	6	negative	negative	JJ
cord-005453-4057qib7	8893	7	and	and	CC
cord-005453-4057qib7	8893	8	anti	anti	JJ
cord-005453-4057qib7	8893	9	-	-	JJ
cord-005453-4057qib7	8893	10	HBc	hbc	JJ
cord-005453-4057qib7	8893	11	positive	positive	JJ
cord-005453-4057qib7	8893	12	patients	patient	NNS
cord-005453-4057qib7	8893	13	have	have	VBP
cord-005453-4057qib7	8893	14	the	the	DT
cord-005453-4057qib7	8893	15	highest	high	JJS
cord-005453-4057qib7	8893	16	risk	risk	NN
cord-005453-4057qib7	8893	17	of	of	IN
cord-005453-4057qib7	8893	18	HBV	HBV	NNP
cord-005453-4057qib7	8893	19	reactivation	reactivation	NN
cord-005453-4057qib7	8893	20	after	after	IN
cord-005453-4057qib7	8893	21	HSCT	HSCT	NNP
cord-005453-4057qib7	8893	22	in	in	IN
cord-005453-4057qib7	8893	23	resolved	resolve	VBD
cord-005453-4057qib7	8893	24	HBV	HBV	NNP
cord-005453-4057qib7	8893	25	patients	patient	NNS
cord-005453-4057qib7	8893	26	.	.	.
cord-005453-4057qib7	8894	1	The	the	DT
cord-005453-4057qib7	8894	2	anti	anti	JJ
cord-005453-4057qib7	8894	3	-	-	JJ
cord-005453-4057qib7	8894	4	HbsAg	hbsag	JJ
cord-005453-4057qib7	8894	5	antibodies	antibody	NNS
cord-005453-4057qib7	8894	6	play	play	VBP
cord-005453-4057qib7	8894	7	a	a	DT
cord-005453-4057qib7	8894	8	protective	protective	JJ
cord-005453-4057qib7	8894	9	role	role	NN
cord-005453-4057qib7	8894	10	in	in	IN
cord-005453-4057qib7	8894	11	resolved	resolve	VBD
cord-005453-4057qib7	8894	12	HBV	HBV	NNP
cord-005453-4057qib7	8894	13	patients	patient	NNS
cord-005453-4057qib7	8894	14	receiving	receive	VBG
cord-005453-4057qib7	8894	15	HSCT	HSCT	NNP
cord-005453-4057qib7	8894	16	.	.	.
cord-005453-4057qib7	8895	1	We	-PRON-	PRP
cord-005453-4057qib7	8895	2	recommend	recommend	VBP
cord-005453-4057qib7	8895	3	not	not	RB
cord-005453-4057qib7	8895	4	prophylactic	prophylactic	JJ
cord-005453-4057qib7	8895	5	anti	anti	JJ
cord-005453-4057qib7	8895	6	hepatitis	hepatitis	NNP
cord-005453-4057qib7	8895	7	B	B	NNP
cord-005453-4057qib7	8895	8	virus	virus	NN
cord-005453-4057qib7	8895	9	in	in	IN
cord-005453-4057qib7	8895	10	HBsAg	hbsag	ADD
cord-005453-4057qib7	8895	11	negativity	negativity	NN
cord-005453-4057qib7	8895	12	and	and	CC
cord-005453-4057qib7	8895	13	anti	anti	JJ
cord-005453-4057qib7	8895	14	-	-	JJ
cord-005453-4057qib7	8895	15	HbsAg	HbsAg	NNP
cord-005453-4057qib7	8895	16	antibodies	antibody	NNS
cord-005453-4057qib7	8895	17	positive	positive	JJ
cord-005453-4057qib7	8895	18	patients	patient	NNS
cord-005453-4057qib7	8895	19	following	follow	VBG
cord-005453-4057qib7	8895	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8895	21	stem	stem	NN
cord-005453-4057qib7	8895	22	cell	cell	NN
cord-005453-4057qib7	8895	23	transplantation	transplantation	NN
cord-005453-4057qib7	8895	24	.	.	.
cord-005453-4057qib7	8896	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8896	2	:	:	:
cord-005453-4057qib7	8896	3	Nothing	nothing	NN
cord-005453-4057qib7	8896	4	to	to	TO
cord-005453-4057qib7	8896	5	declare	declare	VB
cord-005453-4057qib7	8896	6	Methods	method	NNS
cord-005453-4057qib7	8896	7	:	:	:
cord-005453-4057qib7	8896	8	2230	2230	CD
cord-005453-4057qib7	8896	9	allo	allo	NN
cord-005453-4057qib7	8896	10	-	-	HYPH
cord-005453-4057qib7	8896	11	HSCTs	hsct	NNS
cord-005453-4057qib7	8896	12	performed	perform	VBN
cord-005453-4057qib7	8896	13	between	between	IN
cord-005453-4057qib7	8896	14	1997	1997	CD
cord-005453-4057qib7	8896	15	and	and	CC
cord-005453-4057qib7	8896	16	2016	2016	CD
cord-005453-4057qib7	8896	17	for	for	IN
cord-005453-4057qib7	8896	18	acquired	acquire	VBN
cord-005453-4057qib7	8896	19	bone	bone	NN
cord-005453-4057qib7	8896	20	marrow	marrow	NN
cord-005453-4057qib7	8896	21	failure	failure	NN
cord-005453-4057qib7	8896	22	(	(	-LRB-
cord-005453-4057qib7	8896	23	70.6	70.6	CD
cord-005453-4057qib7	8896	24	%	%	NN
cord-005453-4057qib7	8896	25	)	)	-RRB-
cord-005453-4057qib7	8896	26	or	or	CC
cord-005453-4057qib7	8896	27	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	8896	28	(	(	-LRB-
cord-005453-4057qib7	8896	29	29.4	29.4	CD
cord-005453-4057qib7	8896	30	%	%	NN
cord-005453-4057qib7	8896	31	)	)	-RRB-
cord-005453-4057qib7	8896	32	,	,	,
cord-005453-4057qib7	8896	33	with	with	IN
cord-005453-4057qib7	8896	34	BM±CB	BM±CB	NNP
cord-005453-4057qib7	8896	35	(	(	-LRB-
cord-005453-4057qib7	8896	36	75.8	75.8	CD
cord-005453-4057qib7	8896	37	%	%	NN
cord-005453-4057qib7	8896	38	)	)	-RRB-
cord-005453-4057qib7	8896	39	or	or	CC
cord-005453-4057qib7	8896	40	PB±CB+BM	PB±CB+BM	NNP
cord-005453-4057qib7	8896	41	(	(	-LRB-
cord-005453-4057qib7	8896	42	24.2	24.2	CD
cord-005453-4057qib7	8896	43	%	%	NN
cord-005453-4057qib7	8896	44	)	)	-RRB-
cord-005453-4057qib7	8896	45	as	as	IN
cord-005453-4057qib7	8896	46	a	a	DT
cord-005453-4057qib7	8896	47	stem	stem	NN
cord-005453-4057qib7	8896	48	cell	cell	NN
cord-005453-4057qib7	8896	49	source	source	NN
cord-005453-4057qib7	8896	50	were	be	VBD
cord-005453-4057qib7	8896	51	included	include	VBN
cord-005453-4057qib7	8896	52	in	in	IN
cord-005453-4057qib7	8896	53	this	this	DT
cord-005453-4057qib7	8896	54	retrospective	retrospective	JJ
cord-005453-4057qib7	8896	55	Registry	registry	NN
cord-005453-4057qib7	8896	56	megafile	megafile	NN
cord-005453-4057qib7	8896	57	IDWP	IDWP	NNP
cord-005453-4057qib7	8896	58	EBMT	EBMT	NNP
cord-005453-4057qib7	8896	59	study	study	NN
cord-005453-4057qib7	8896	60	.	.	.
cord-005453-4057qib7	8897	1	Results	result	NNS
cord-005453-4057qib7	8897	2	:	:	:
cord-005453-4057qib7	8897	3	DEMOGRAPHICS	demographic	NNS
cord-005453-4057qib7	8897	4	:	:	:
cord-005453-4057qib7	8898	1	The	the	DT
cord-005453-4057qib7	8898	2	median	median	JJ
cord-005453-4057qib7	8898	3	age	age	NN
cord-005453-4057qib7	8898	4	of	of	IN
cord-005453-4057qib7	8898	5	recipient	recipient	NN
cord-005453-4057qib7	8898	6	was	be	VBD
cord-005453-4057qib7	8898	7	17.7	17.7	CD
cord-005453-4057qib7	8898	8	years	year	NNS
cord-005453-4057qib7	8899	1	(	(	-LRB-
cord-005453-4057qib7	8899	2	range	range	NN
cord-005453-4057qib7	8899	3	:	:	:
cord-005453-4057qib7	8899	4	0.1	0.1	CD
cord-005453-4057qib7	8899	5	-	-	SYM
cord-005453-4057qib7	8899	6	78	78	CD
cord-005453-4057qib7	8899	7	)	)	-RRB-
cord-005453-4057qib7	8899	8	,	,	,
cord-005453-4057qib7	8899	9	and	and	CC
cord-005453-4057qib7	8899	10	50.8	50.8	CD
cord-005453-4057qib7	8899	11	%	%	NN
cord-005453-4057qib7	8899	12	were	be	VBD
cord-005453-4057qib7	8899	13	children	child	NNS
cord-005453-4057qib7	8899	14	.	.	.
cord-005453-4057qib7	8900	1	79.0	79.0	CD
cord-005453-4057qib7	8900	2	%	%	NN
cord-005453-4057qib7	8900	3	recipients	recipient	NNS
cord-005453-4057qib7	8900	4	and	and	CC
cord-005453-4057qib7	8900	5	75.4	75.4	CD
cord-005453-4057qib7	8900	6	%	%	NN
cord-005453-4057qib7	8900	7	donors	donor	NNS
cord-005453-4057qib7	8900	8	were	be	VBD
cord-005453-4057qib7	8900	9	EBV	EBV	NNP
cord-005453-4057qib7	8900	10	-	-	HYPH
cord-005453-4057qib7	8900	11	seropositive	seropositive	JJ
cord-005453-4057qib7	8900	12	.	.	.
cord-005453-4057qib7	8901	1	67.8	67.8	CD
cord-005453-4057qib7	8901	2	%	%	NN
cord-005453-4057qib7	8901	3	had	have	VBD
cord-005453-4057qib7	8901	4	HSCT	HSCT	NNP
cord-005453-4057qib7	8901	5	from	from	IN
cord-005453-4057qib7	8901	6	a	a	DT
cord-005453-4057qib7	8901	7	matched	match	VBN
cord-005453-4057qib7	8901	8	family	family	NN
cord-005453-4057qib7	8901	9	donor	donor	NN
cord-005453-4057qib7	8901	10	,	,	,
cord-005453-4057qib7	8901	11	4.6	4.6	CD
cord-005453-4057qib7	8901	12	%	%	NN
cord-005453-4057qib7	8901	13	from	from	IN
cord-005453-4057qib7	8901	14	a	a	DT
cord-005453-4057qib7	8901	15	mismatched	mismatched	JJ
cord-005453-4057qib7	8901	16	family	family	NN
cord-005453-4057qib7	8901	17	donor	donor	NN
cord-005453-4057qib7	8901	18	,	,	,
cord-005453-4057qib7	8901	19	and	and	CC
cord-005453-4057qib7	8901	20	27.6	27.6	CD
cord-005453-4057qib7	8901	21	%	%	NN
cord-005453-4057qib7	8901	22	from	from	IN
cord-005453-4057qib7	8901	23	an	an	DT
cord-005453-4057qib7	8901	24	unrelated	unrelated	JJ
cord-005453-4057qib7	8901	25	donor	donor	NN
cord-005453-4057qib7	8901	26	.	.	.
cord-005453-4057qib7	8902	1	T	t	NN
cord-005453-4057qib7	8902	2	-	-	HYPH
cord-005453-4057qib7	8902	3	cell	cell	NN
cord-005453-4057qib7	8902	4	depletion	depletion	NN
cord-005453-4057qib7	8902	5	was	be	VBD
cord-005453-4057qib7	8902	6	performed	perform	VBN
cord-005453-4057qib7	8902	7	in	in	IN
cord-005453-4057qib7	8902	8	vivo	vivo	NN
cord-005453-4057qib7	8902	9	in	in	IN
cord-005453-4057qib7	8902	10	82.2	82.2	CD
cord-005453-4057qib7	8902	11	%	%	NN
cord-005453-4057qib7	8902	12	,	,	,
cord-005453-4057qib7	8902	13	and	and	CC
cord-005453-4057qib7	8902	14	ex	ex	FW
cord-005453-4057qib7	8902	15	vivo	vivo	NN
cord-005453-4057qib7	8902	16	in	in	IN
cord-005453-4057qib7	8902	17	6.6	6.6	CD
cord-005453-4057qib7	8902	18	%	%	NN
cord-005453-4057qib7	8902	19	patients	patient	NNS
cord-005453-4057qib7	8902	20	.	.	.
cord-005453-4057qib7	8903	1	Conditioning	conditioning	NN
cord-005453-4057qib7	8903	2	regimen	regimen	NN
cord-005453-4057qib7	8903	3	was	be	VBD
cord-005453-4057qib7	8903	4	myeloablative	myeloablative	JJ
cord-005453-4057qib7	8903	5	in	in	IN
cord-005453-4057qib7	8903	6	63.7	63.7	CD
cord-005453-4057qib7	8903	7	%	%	NN
cord-005453-4057qib7	8903	8	,	,	,
cord-005453-4057qib7	8903	9	RIC	RIC	NNP
cord-005453-4057qib7	8903	10	in	in	IN
cord-005453-4057qib7	8903	11	36.3	36.3	CD
cord-005453-4057qib7	8903	12	%	%	NN
cord-005453-4057qib7	8903	13	.	.	.
cord-005453-4057qib7	8904	1	Median	median	JJ
cord-005453-4057qib7	8904	2	follow	follow	NN
cord-005453-4057qib7	8904	3	-	-	HYPH
cord-005453-4057qib7	8904	4	up	up	NN
cord-005453-4057qib7	8904	5	was	be	VBD
cord-005453-4057qib7	8904	6	4.7	4.7	CD
cord-005453-4057qib7	8904	7	years	year	NNS
cord-005453-4057qib7	8904	8	(	(	-LRB-
cord-005453-4057qib7	8904	9	95	95	CD
cord-005453-4057qib7	8904	10	%	%	NN
cord-005453-4057qib7	8904	11	C.I.	C.I.	NNP
cord-005453-4057qib7	8904	12	4.3	4.3	CD
cord-005453-4057qib7	8904	13	-	-	HYPH
cord-005453-4057qib7	8904	14	5.0	5.0	CD
cord-005453-4057qib7	8904	15	)	)	-RRB-
cord-005453-4057qib7	8904	16	.	.	.
cord-005453-4057qib7	8905	1	TRANSPLANT	transplant	NN
cord-005453-4057qib7	8906	1	OUT	out	RB
cord-005453-4057qib7	8906	2	-	-	HYPH
cord-005453-4057qib7	8906	3	COMES	comes	NN
cord-005453-4057qib7	8906	4	:	:	:
cord-005453-4057qib7	8907	1	EBV	EBV	NNP
cord-005453-4057qib7	8907	2	-	-	HYPH
cord-005453-4057qib7	8907	3	seropositive	seropositive	JJ
cord-005453-4057qib7	8907	4	recipients	recipient	NNS
cord-005453-4057qib7	8907	5	in	in	IN
cord-005453-4057qib7	8907	6	comparison	comparison	NN
cord-005453-4057qib7	8907	7	to	to	IN
cord-005453-4057qib7	8907	8	EBV	EBV	NNP
cord-005453-4057qib7	8907	9	-	-	HYPH
cord-005453-4057qib7	8907	10	seronegative	seronegative	JJ
cord-005453-4057qib7	8907	11	recipients	recipient	NNS
cord-005453-4057qib7	8907	12	had	have	VBD
cord-005453-4057qib7	8907	13	lower	low	JJR
cord-005453-4057qib7	8907	14	OS	os	NN
cord-005453-4057qib7	8907	15	(	(	-LRB-
cord-005453-4057qib7	8907	16	85.4	85.4	CD
cord-005453-4057qib7	8907	17	%	%	NN
cord-005453-4057qib7	8907	18	vs	vs	IN
cord-005453-4057qib7	8907	19	88.4	88.4	CD
cord-005453-4057qib7	8907	20	%	%	NN
cord-005453-4057qib7	8907	21	,	,	,
cord-005453-4057qib7	8907	22	p=0.035	p=0.035	NNP
cord-005453-4057qib7	8907	23	)	)	-RRB-
cord-005453-4057qib7	8907	24	,	,	,
cord-005453-4057qib7	8907	25	and	and	CC
cord-005453-4057qib7	8907	26	higher	high	JJR
cord-005453-4057qib7	8907	27	NRM	NRM	NNP
cord-005453-4057qib7	8907	28	(	(	-LRB-
cord-005453-4057qib7	8907	29	10.0	10.0	CD
cord-005453-4057qib7	8907	30	%	%	NN
cord-005453-4057qib7	8907	31	vs	vs	IN
cord-005453-4057qib7	8907	32	6.4	6.4	CD
cord-005453-4057qib7	8907	33	%	%	NN
cord-005453-4057qib7	8907	34	,	,	,
cord-005453-4057qib7	8907	35	p=0.018	p=0.018	NNP
cord-005453-4057qib7	8907	36	)	)	-RRB-
cord-005453-4057qib7	8907	37	.	.	.
cord-005453-4057qib7	8908	1	No	no	DT
cord-005453-4057qib7	8908	2	other	other	JJ
cord-005453-4057qib7	8908	3	significant	significant	JJ
cord-005453-4057qib7	8908	4	differences	difference	NNS
cord-005453-4057qib7	8908	5	were	be	VBD
cord-005453-4057qib7	8908	6	found	find	VBN
cord-005453-4057qib7	8908	7	for	for	IN
cord-005453-4057qib7	8908	8	:	:	:
cord-005453-4057qib7	8908	9	RI	RI	NNP
cord-005453-4057qib7	8908	10	,	,	,
cord-005453-4057qib7	8908	11	RFS	RFS	NNP
cord-005453-4057qib7	8908	12	,	,	,
cord-005453-4057qib7	8908	13	and	and	CC
cord-005453-4057qib7	8908	14	acute	acute	JJ
cord-005453-4057qib7	8908	15	or	or	CC
cord-005453-4057qib7	8908	16	chronic	chronic	JJ
cord-005453-4057qib7	8908	17	GVHD	GVHD	NNP
cord-005453-4057qib7	8908	18	with	with	IN
cord-005453-4057qib7	8908	19	respect	respect	NN
cord-005453-4057qib7	8908	20	to	to	IN
cord-005453-4057qib7	8908	21	EBV	EBV	NNP
cord-005453-4057qib7	8908	22	pretransplant	pretransplant	NN
cord-005453-4057qib7	8908	23	serostatus	serostatus	NN
cord-005453-4057qib7	8908	24	donor	donor	NN
cord-005453-4057qib7	8908	25	and/or	and/or	CC
cord-005453-4057qib7	8908	26	recipient	recipient	NN
cord-005453-4057qib7	8908	27	.	.	.
cord-005453-4057qib7	8909	1	MULTI	multi	JJ
cord-005453-4057qib7	8909	2	-	-	JJ
cord-005453-4057qib7	8909	3	VARIATE	VARIATE	NNP
cord-005453-4057qib7	8909	4	ANALYSIS	analysis	NN
cord-005453-4057qib7	8909	5	:	:	:
cord-005453-4057qib7	8910	1	EBV	EBV	NNP
cord-005453-4057qib7	8910	2	serostatus	serostatus	NNP
cord-005453-4057qib7	8910	3	as	as	IN
cord-005453-4057qib7	8910	4	a	a	DT
cord-005453-4057qib7	8910	5	risk	risk	NN
cord-005453-4057qib7	8910	6	factor	factor	NN
cord-005453-4057qib7	8910	7	did	do	VBD
cord-005453-4057qib7	8910	8	not	not	RB
cord-005453-4057qib7	8910	9	reach	reach	VB
cord-005453-4057qib7	8910	10	significance	significance	NN
cord-005453-4057qib7	8910	11	,	,	,
cord-005453-4057qib7	8910	12	while	while	IN
cord-005453-4057qib7	8910	13	a	a	DT
cord-005453-4057qib7	8910	14	trend	trend	NN
cord-005453-4057qib7	8910	15	towards	towards	IN
cord-005453-4057qib7	8910	16	higher	high	JJR
cord-005453-4057qib7	8910	17	risk	risk	NN
cord-005453-4057qib7	8910	18	of	of	IN
cord-005453-4057qib7	8910	19	development	development	NN
cord-005453-4057qib7	8910	20	of	of	IN
cord-005453-4057qib7	8910	21	cGVHD	cGVHD	NNP
cord-005453-4057qib7	8910	22	(	(	-LRB-
cord-005453-4057qib7	8910	23	HR=1.31	HR=1.31	NNPS
cord-005453-4057qib7	8910	24	;	;	:
cord-005453-4057qib7	8910	25	95%CI	95%ci	CD
cord-005453-4057qib7	8910	26	0.97	0.97	CD
cord-005453-4057qib7	8910	27	-	-	HYPH
cord-005453-4057qib7	8910	28	1.78	1.78	CD
cord-005453-4057qib7	8910	29	;	;	:
cord-005453-4057qib7	8910	30	p=0.081	p=0.081	NNP
cord-005453-4057qib7	8910	31	)	)	-RRB-
cord-005453-4057qib7	8910	32	and	and	CC
cord-005453-4057qib7	8910	33	better	well	JJR
cord-005453-4057qib7	8910	34	survival	survival	NN
cord-005453-4057qib7	8910	35	(	(	-LRB-
cord-005453-4057qib7	8910	36	HR=0.78	HR=0.78	NNP
cord-005453-4057qib7	8910	37	;	;	:
cord-005453-4057qib7	8910	38	95%CI	95%ci	CD
cord-005453-4057qib7	8910	39	0.59	0.59	CD
cord-005453-4057qib7	8910	40	-	-	HYPH
cord-005453-4057qib7	8910	41	1.04	1.04	CD
cord-005453-4057qib7	8910	42	;	;	:
cord-005453-4057qib7	8910	43	p=0.087	p=0.087	NNP
cord-005453-4057qib7	8910	44	)	)	-RRB-
cord-005453-4057qib7	8910	45	in	in	IN
cord-005453-4057qib7	8910	46	allo	allo	NN
cord-005453-4057qib7	8910	47	-	-	HYPH
cord-005453-4057qib7	8910	48	HSCT	HSCT	NNP
cord-005453-4057qib7	8910	49	from	from	IN
cord-005453-4057qib7	8910	50	EBV	EBV	NNP
cord-005453-4057qib7	8910	51	-	-	HYPH
cord-005453-4057qib7	8910	52	seropositive	seropositive	JJ
cord-005453-4057qib7	8910	53	donors	donor	NNS
cord-005453-4057qib7	8910	54	.	.	.
cord-005453-4057qib7	8911	1	Allo	Allo	NNP
cord-005453-4057qib7	8911	2	-	-	HYPH
cord-005453-4057qib7	8911	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8911	4	in	in	IN
cord-005453-4057qib7	8911	5	EBV	EBV	NNP
cord-005453-4057qib7	8911	6	-	-	HYPH
cord-005453-4057qib7	8911	7	seropositive	seropositive	JJ
cord-005453-4057qib7	8911	8	recipients	recipient	NNS
cord-005453-4057qib7	8911	9	had	have	VBD
cord-005453-4057qib7	8911	10	a	a	DT
cord-005453-4057qib7	8911	11	trend	trend	NN
cord-005453-4057qib7	8911	12	towards	towards	IN
cord-005453-4057qib7	8911	13	lower	low	JJR
cord-005453-4057qib7	8911	14	risk	risk	NN
cord-005453-4057qib7	8911	15	of	of	IN
cord-005453-4057qib7	8911	16	development	development	NN
cord-005453-4057qib7	8911	17	of	of	IN
cord-005453-4057qib7	8911	18	cGVHD	cGVHD	NNP
cord-005453-4057qib7	8911	19	(	(	-LRB-
cord-005453-4057qib7	8911	20	HR=0.75	HR=0.75	NNP
cord-005453-4057qib7	8911	21	;	;	:
cord-005453-4057qib7	8911	22	95%CI	95%ci	CD
cord-005453-4057qib7	8911	23	0.56	0.56	CD
cord-005453-4057qib7	8911	24	-	-	HYPH
cord-005453-4057qib7	8911	25	1.02	1.02	CD
cord-005453-4057qib7	8911	26	;	;	:
cord-005453-4057qib7	8911	27	p=0.066	p=0.066	NNP
cord-005453-4057qib7	8911	28	)	)	-RRB-
cord-005453-4057qib7	8911	29	.	.	.
cord-005453-4057qib7	8912	1	When	when	WRB
cord-005453-4057qib7	8912	2	4	4	CD
cord-005453-4057qib7	8912	3	subgroups	subgroup	NNS
cord-005453-4057qib7	8912	4	(	(	-LRB-
cord-005453-4057qib7	8912	5	R-/D-	R-/D-	NNPS
cord-005453-4057qib7	8912	6	,	,	,
cord-005453-4057qib7	8912	7	R-/	r-/	NN
cord-005453-4057qib7	8912	8	D+	d+	NN
cord-005453-4057qib7	8912	9	,	,	,
cord-005453-4057qib7	8912	10	R+/D-	R+/D-	NNP
cord-005453-4057qib7	8912	11	,	,	,
cord-005453-4057qib7	8912	12	R+/D+	r+/d+	JJ
cord-005453-4057qib7	8912	13	EBV	EBV	NNP
cord-005453-4057qib7	8912	14	serology	serology	NN
cord-005453-4057qib7	8912	15	)	)	-RRB-
cord-005453-4057qib7	8912	16	were	be	VBD
cord-005453-4057qib7	8912	17	analyzed	analyze	VBN
cord-005453-4057qib7	8912	18	,	,	,
cord-005453-4057qib7	8912	19	the	the	DT
cord-005453-4057qib7	8912	20	EBV	EBV	NNP
cord-005453-4057qib7	8912	21	serostatus	serostatus	NN
cord-005453-4057qib7	8912	22	had	have	VBD
cord-005453-4057qib7	8912	23	no	no	DT
cord-005453-4057qib7	8912	24	significant	significant	JJ
cord-005453-4057qib7	8912	25	impact	impact	NN
cord-005453-4057qib7	8912	26	on	on	IN
cord-005453-4057qib7	8912	27	OS	OS	NNP
cord-005453-4057qib7	8912	28	,	,	,
cord-005453-4057qib7	8912	29	RFS	RFS	NNP
cord-005453-4057qib7	8912	30	,	,	,
cord-005453-4057qib7	8912	31	RI	RI	NNP
cord-005453-4057qib7	8912	32	,	,	,
cord-005453-4057qib7	8912	33	TRM	TRM	NNP
cord-005453-4057qib7	8912	34	and	and	CC
cord-005453-4057qib7	8912	35	development	development	NN
cord-005453-4057qib7	8912	36	of	of	IN
cord-005453-4057qib7	8912	37	acute	acute	JJ
cord-005453-4057qib7	8912	38	or	or	CC
cord-005453-4057qib7	8912	39	chronic	chronic	JJ
cord-005453-4057qib7	8912	40	GVHD	GVHD	NNP
cord-005453-4057qib7	8912	41	.	.	.
cord-005453-4057qib7	8913	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8913	2	:	:	:
cord-005453-4057qib7	8914	1	Allo	Allo	NNP
cord-005453-4057qib7	8914	2	-	-	HYPH
cord-005453-4057qib7	8914	3	HSCT	HSCT	NNP
cord-005453-4057qib7	8914	4	from	from	IN
cord-005453-4057qib7	8914	5	EBV	EBV	NNP
cord-005453-4057qib7	8914	6	-	-	HYPH
cord-005453-4057qib7	8914	7	seropositive	seropositive	JJ
cord-005453-4057qib7	8914	8	vs	vs	IN
cord-005453-4057qib7	8914	9	EBV	EBV	NNP
cord-005453-4057qib7	8914	10	-	-	HYPH
cord-005453-4057qib7	8914	11	seronegative	seronegative	JJ
cord-005453-4057qib7	8914	12	donors	donor	NNS
cord-005453-4057qib7	8914	13	are	be	VBP
cord-005453-4057qib7	8914	14	at	at	IN
cord-005453-4057qib7	8914	15	31	31	CD
cord-005453-4057qib7	8914	16	%	%	NN
cord-005453-4057qib7	8914	17	higher	high	JJR
cord-005453-4057qib7	8914	18	risk	risk	NN
cord-005453-4057qib7	8914	19	of	of	IN
cord-005453-4057qib7	8914	20	chronic	chronic	JJ
cord-005453-4057qib7	8914	21	GVHD	GVHD	NNP
cord-005453-4057qib7	8914	22	in	in	IN
cord-005453-4057qib7	8914	23	patients	patient	NNS
cord-005453-4057qib7	8914	24	with	with	IN
cord-005453-4057qib7	8914	25	non	non	JJ
cord-005453-4057qib7	8914	26	-	-	JJ
cord-005453-4057qib7	8914	27	malignant	malignant	JJ
cord-005453-4057qib7	8914	28	hematological	hematological	JJ
cord-005453-4057qib7	8914	29	disorders	disorder	NNS
cord-005453-4057qib7	8914	30	undergoing	undergo	VBG
cord-005453-4057qib7	8914	31	allo	allo	NN
cord-005453-4057qib7	8914	32	-	-	HYPH
cord-005453-4057qib7	8914	33	HSCT	HSCT	NNP
cord-005453-4057qib7	8914	34	,	,	,
cord-005453-4057qib7	8914	35	however	however	RB
cord-005453-4057qib7	8914	36	this	this	DT
cord-005453-4057qib7	8914	37	difference	difference	NN
cord-005453-4057qib7	8914	38	is	be	VBZ
cord-005453-4057qib7	8914	39	non	non	JJ
cord-005453-4057qib7	8914	40	-	-	JJ
cord-005453-4057qib7	8914	41	significant	significant	JJ
cord-005453-4057qib7	8914	42	in	in	IN
cord-005453-4057qib7	8914	43	multivariate	multivariate	JJ
cord-005453-4057qib7	8914	44	analysis	analysis	NN
cord-005453-4057qib7	8914	45	.	.	.
cord-005453-4057qib7	8915	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8915	2	:	:	:
cord-005453-4057qib7	8915	3	Nothing	nothing	NN
cord-005453-4057qib7	8915	4	to	to	TO
cord-005453-4057qib7	8915	5	declare	declare	VB
cord-005453-4057qib7	8915	6	.	.	.
cord-005453-4057qib7	8916	1	Results	result	NNS
cord-005453-4057qib7	8916	2	:	:	:
cord-005453-4057qib7	8917	1	Twenty	twenty	CD
cord-005453-4057qib7	8917	2	-	-	HYPH
cord-005453-4057qib7	8917	3	eight	eight	CD
cord-005453-4057qib7	8917	4	(	(	-LRB-
cord-005453-4057qib7	8917	5	30	30	CD
cord-005453-4057qib7	8917	6	%	%	NN
cord-005453-4057qib7	8917	7	)	)	-RRB-
cord-005453-4057qib7	8917	8	pts	pt	NNS
cord-005453-4057qib7	8917	9	(	(	-LRB-
cord-005453-4057qib7	8917	10	19	19	CD
cord-005453-4057qib7	8917	11	male	male	NN
cord-005453-4057qib7	8917	12	,	,	,
cord-005453-4057qib7	8917	13	9	9	CD
cord-005453-4057qib7	8917	14	female	female	NN
cord-005453-4057qib7	8917	15	)	)	-RRB-
cord-005453-4057qib7	8917	16	were	be	VBD
cord-005453-4057qib7	8917	17	tested	test	VBN
cord-005453-4057qib7	8917	18	positive	positive	JJ
cord-005453-4057qib7	8917	19	(	(	-LRB-
cord-005453-4057qib7	8917	20	group	group	NN
cord-005453-4057qib7	8917	21	1	1	CD
cord-005453-4057qib7	8917	22	)	)	-RRB-
cord-005453-4057qib7	8917	23	for	for	IN
cord-005453-4057qib7	8917	24	subtype	subtype	NN
cord-005453-4057qib7	8917	25	A	a	NN
cord-005453-4057qib7	8917	26	(	(	-LRB-
cord-005453-4057qib7	8917	27	n=4	n=4	JJ
cord-005453-4057qib7	8917	28	,	,	,
cord-005453-4057qib7	8917	29	14	14	CD
cord-005453-4057qib7	8917	30	%	%	NN
cord-005453-4057qib7	8917	31	)	)	-RRB-
cord-005453-4057qib7	8917	32	,	,	,
cord-005453-4057qib7	8917	33	B	B	NNP
cord-005453-4057qib7	8917	34	(	(	-LRB-
cord-005453-4057qib7	8917	35	n=18	n=18	CC
cord-005453-4057qib7	8917	36	,	,	,
cord-005453-4057qib7	8917	37	64	64	CD
cord-005453-4057qib7	8917	38	%	%	NN
cord-005453-4057qib7	8917	39	)	)	-RRB-
cord-005453-4057qib7	8917	40	or	or	CC
cord-005453-4057qib7	8917	41	A	a	DT
cord-005453-4057qib7	8917	42	(	(	-LRB-
cord-005453-4057qib7	8917	43	H1N1	H1N1	NNP
cord-005453-4057qib7	8917	44	)	)	-RRB-
cord-005453-4057qib7	8917	45	(	(	-LRB-
cord-005453-4057qib7	8917	46	n=6	n=6	NNP
cord-005453-4057qib7	8917	47	,	,	,
cord-005453-4057qib7	8917	48	21	21	CD
cord-005453-4057qib7	8917	49	%	%	NN
cord-005453-4057qib7	8917	50	)	)	-RRB-
cord-005453-4057qib7	8917	51	while	while	IN
cord-005453-4057qib7	8917	52	67	67	CD
cord-005453-4057qib7	8917	53	(	(	-LRB-
cord-005453-4057qib7	8917	54	70	70	CD
cord-005453-4057qib7	8917	55	%	%	NN
cord-005453-4057qib7	8917	56	)	)	-RRB-
cord-005453-4057qib7	8917	57	pts	pts	NN
cord-005453-4057qib7	8917	58	(	(	-LRB-
cord-005453-4057qib7	8917	59	32	32	CD
cord-005453-4057qib7	8917	60	male	male	NN
cord-005453-4057qib7	8917	61	,	,	,
cord-005453-4057qib7	8917	62	35	35	CD
cord-005453-4057qib7	8917	63	female	female	NN
cord-005453-4057qib7	8917	64	)	)	-RRB-
cord-005453-4057qib7	8917	65	were	be	VBD
cord-005453-4057qib7	8917	66	negative	negative	JJ
cord-005453-4057qib7	8917	67	(	(	-LRB-
cord-005453-4057qib7	8917	68	group	group	NN
cord-005453-4057qib7	8917	69	2	2	CD
cord-005453-4057qib7	8917	70	)	)	-RRB-
cord-005453-4057qib7	8917	71	.	.	.
cord-005453-4057qib7	8918	1	Vaccination	vaccination	NN
cord-005453-4057qib7	8918	2	rate	rate	NN
cord-005453-4057qib7	8918	3	in	in	IN
cord-005453-4057qib7	8918	4	group	group	NN
cord-005453-4057qib7	8918	5	1	1	CD
cord-005453-4057qib7	8918	6	(	(	-LRB-
cord-005453-4057qib7	8918	7	32	32	CD
cord-005453-4057qib7	8918	8	%	%	NN
cord-005453-4057qib7	8918	9	)	)	-RRB-
cord-005453-4057qib7	8918	10	was	be	VBD
cord-005453-4057qib7	8918	11	significantly	significantly	RB
cord-005453-4057qib7	8918	12	lower	low	JJR
cord-005453-4057qib7	8918	13	compared	compare	VBN
cord-005453-4057qib7	8918	14	to	to	IN
cord-005453-4057qib7	8918	15	group	group	NN
cord-005453-4057qib7	8918	16	2	2	CD
cord-005453-4057qib7	8918	17	(	(	-LRB-
cord-005453-4057qib7	8918	18	51	51	CD
cord-005453-4057qib7	8918	19	%	%	NN
cord-005453-4057qib7	8918	20	,	,	,
cord-005453-4057qib7	8918	21	p=0.002	p=0.002	NNP
cord-005453-4057qib7	8918	22	)	)	-RRB-
cord-005453-4057qib7	8918	23	.	.	.
cord-005453-4057qib7	8919	1	The	the	DT
cord-005453-4057qib7	8919	2	median	median	JJ
cord-005453-4057qib7	8919	3	time	time	NN
cord-005453-4057qib7	8919	4	after	after	IN
cord-005453-4057qib7	8919	5	transplantation	transplantation	NN
cord-005453-4057qib7	8919	6	(	(	-LRB-
cord-005453-4057qib7	8919	7	790	790	CD
cord-005453-4057qib7	8919	8	vs	vs	IN
cord-005453-4057qib7	8919	9	565	565	CD
cord-005453-4057qib7	8919	10	days	day	NNS
cord-005453-4057qib7	8919	11	)	)	-RRB-
cord-005453-4057qib7	8919	12	,	,	,
cord-005453-4057qib7	8919	13	T	t	NN
cord-005453-4057qib7	8919	14	-	-	HYPH
cord-005453-4057qib7	8919	15	cell	cell	NN
cord-005453-4057qib7	8919	16	counts	count	NNS
cord-005453-4057qib7	8919	17	(	(	-LRB-
cord-005453-4057qib7	8919	18	349	349	CD
cord-005453-4057qib7	8919	19	vs	vs	IN
cord-005453-4057qib7	8919	20	296/	296/	CD
cord-005453-4057qib7	8919	21	μl	μl	NNP
cord-005453-4057qib7	8919	22	)	)	-RRB-
cord-005453-4057qib7	8919	23	,	,	,
cord-005453-4057qib7	8919	24	Bcell	Bcell	NNP
cord-005453-4057qib7	8919	25	counts	count	VBZ
cord-005453-4057qib7	8919	26	(	(	-LRB-
cord-005453-4057qib7	8919	27	162	162	CD
cord-005453-4057qib7	8919	28	vs	vs	IN
cord-005453-4057qib7	8919	29	135/	135/	CD
cord-005453-4057qib7	8919	30	μl	μl	NN
cord-005453-4057qib7	8919	31	)	)	-RRB-
cord-005453-4057qib7	8919	32	,	,	,
cord-005453-4057qib7	8919	33	IgG	igg	NN
cord-005453-4057qib7	8919	34	-	-	HYPH
cord-005453-4057qib7	8919	35	level	level	NN
cord-005453-4057qib7	8919	36	(	(	-LRB-
cord-005453-4057qib7	8919	37	8,3	8,3	CD
cord-005453-4057qib7	8919	38	vs	vs	IN
cord-005453-4057qib7	8919	39	7,6	7,6	CD
cord-005453-4057qib7	8919	40	g/	g/	NNP
cord-005453-4057qib7	8919	41	l	l	NNP
cord-005453-4057qib7	8919	42	)	)	-RRB-
cord-005453-4057qib7	8919	43	,	,	,
cord-005453-4057qib7	8919	44	proportion	proportion	NN
cord-005453-4057qib7	8919	45	of	of	IN
cord-005453-4057qib7	8919	46	immunosuppressed	immunosuppressed	JJ
cord-005453-4057qib7	8919	47	pts	pt	NNS
cord-005453-4057qib7	8919	48	(	(	-LRB-
cord-005453-4057qib7	8919	49	75	75	CD
cord-005453-4057qib7	8919	50	%	%	NN
cord-005453-4057qib7	8919	51	vs	vs	IN
cord-005453-4057qib7	8919	52	63	63	CD
cord-005453-4057qib7	8919	53	%	%	NN
cord-005453-4057qib7	8919	54	)	)	-RRB-
cord-005453-4057qib7	8919	55	,	,	,
cord-005453-4057qib7	8919	56	male/	male/	CD
cord-005453-4057qib7	8919	57	female	female	JJ
cord-005453-4057qib7	8919	58	ratio	ratio	NN
cord-005453-4057qib7	8919	59	was	be	VBD
cord-005453-4057qib7	8919	60	not	not	RB
cord-005453-4057qib7	8919	61	significantly	significantly	RB
cord-005453-4057qib7	8919	62	different	different	JJ
cord-005453-4057qib7	8919	63	between	between	IN
cord-005453-4057qib7	8919	64	groups	group	NNS
cord-005453-4057qib7	8919	65	1	1	CD
cord-005453-4057qib7	8919	66	and	and	CC
cord-005453-4057qib7	8919	67	2	2	CD
cord-005453-4057qib7	8919	68	.	.	.
cord-005453-4057qib7	8920	1	Within	within	IN
cord-005453-4057qib7	8920	2	group	group	NN
cord-005453-4057qib7	8920	3	1	1	CD
cord-005453-4057qib7	8920	4	influenza	influenza	NN
cord-005453-4057qib7	8920	5	subtypes	subtype	NNS
cord-005453-4057qib7	8920	6	were	be	VBD
cord-005453-4057qib7	8920	7	similarly	similarly	RB
cord-005453-4057qib7	8920	8	distributed	distribute	VBN
cord-005453-4057qib7	8920	9	in	in	IN
cord-005453-4057qib7	8920	10	vaccinated	vaccinated	JJ
cord-005453-4057qib7	8920	11	and	and	CC
cord-005453-4057qib7	8920	12	not	not	RB
cord-005453-4057qib7	8920	13	vaccinated	vaccinate	VBN
cord-005453-4057qib7	8920	14	pts	pt	NNS
cord-005453-4057qib7	8920	15	(	(	-LRB-
cord-005453-4057qib7	8920	16	A	a	DT
cord-005453-4057qib7	8920	17	11	11	CD
cord-005453-4057qib7	8920	18	%	%	NN
cord-005453-4057qib7	8920	19	vs	vs	IN
cord-005453-4057qib7	8920	20	16	16	CD
cord-005453-4057qib7	8920	21	%	%	NN
cord-005453-4057qib7	8920	22	,	,	,
cord-005453-4057qib7	8920	23	B	b	NN
cord-005453-4057qib7	8920	24	67	67	CD
cord-005453-4057qib7	8920	25	%	%	NN
cord-005453-4057qib7	8920	26	vs	vs	IN
cord-005453-4057qib7	8920	27	63	63	CD
cord-005453-4057qib7	8920	28	%	%	NN
cord-005453-4057qib7	8920	29	,	,	,
cord-005453-4057qib7	8920	30	A	A	NNP
cord-005453-4057qib7	8920	31	(	(	-LRB-
cord-005453-4057qib7	8920	32	H1N1	H1N1	NNP
cord-005453-4057qib7	8920	33	)	)	-RRB-
cord-005453-4057qib7	8921	1	22	22	CD
cord-005453-4057qib7	8921	2	%	%	NN
cord-005453-4057qib7	8921	3	vs	vs	IN
cord-005453-4057qib7	8921	4	21	21	CD
cord-005453-4057qib7	8921	5	%	%	NN
cord-005453-4057qib7	8921	6	)	)	-RRB-
cord-005453-4057qib7	8921	7	.	.	.
cord-005453-4057qib7	8922	1	Pts	Pts	NNP
cord-005453-4057qib7	8922	2	.	.	.
cord-005453-4057qib7	8923	1	with	with	IN
cord-005453-4057qib7	8923	2	subtype	subtype	NN
cord-005453-4057qib7	8923	3	B	b	NN
cord-005453-4057qib7	8923	4	infection	infection	NN
cord-005453-4057qib7	8923	5	had	have	VBD
cord-005453-4057qib7	8923	6	higher	high	JJR
cord-005453-4057qib7	8923	7	levels	level	NNS
cord-005453-4057qib7	8923	8	of	of	IN
cord-005453-4057qib7	8923	9	T-(482	T-(482	NNP
cord-005453-4057qib7	8923	10	vs	vs	IN
cord-005453-4057qib7	8923	11	274/	274/	CD
cord-005453-4057qib7	8923	12	μl	μl	NNP
cord-005453-4057qib7	8923	13	)	)	-RRB-
cord-005453-4057qib7	8924	1	and	and	CC
cord-005453-4057qib7	8924	2	B	b	NN
cord-005453-4057qib7	8924	3	-	-	HYPH
cord-005453-4057qib7	8924	4	cells	cell	NNS
cord-005453-4057qib7	8924	5	(	(	-LRB-
cord-005453-4057qib7	8924	6	232	232	CD
cord-005453-4057qib7	8924	7	vs	vs	IN
cord-005453-4057qib7	8924	8	108/	108/	CD
cord-005453-4057qib7	8924	9	μl	μl	NN
cord-005453-4057qib7	8924	10	)	)	-RRB-
cord-005453-4057qib7	8924	11	and	and	CC
cord-005453-4057qib7	8924	12	a	a	DT
cord-005453-4057qib7	8924	13	longer	longer	RB
cord-005453-4057qib7	8924	14	follow	follow	VB
cord-005453-4057qib7	8924	15	up	up	RP
cord-005453-4057qib7	8924	16	from	from	IN
cord-005453-4057qib7	8924	17	SCT	SCT	NNP
cord-005453-4057qib7	8924	18	(	(	-LRB-
cord-005453-4057qib7	8924	19	1610	1610	CD
cord-005453-4057qib7	8924	20	vs	vs	IN
cord-005453-4057qib7	8924	21	470	470	CD
cord-005453-4057qib7	8924	22	days	day	NNS
cord-005453-4057qib7	8924	23	)	)	-RRB-
cord-005453-4057qib7	8924	24	compared	compare	VBN
cord-005453-4057qib7	8924	25	to	to	IN
cord-005453-4057qib7	8924	26	subtype	subtype	NN
cord-005453-4057qib7	8924	27	A	A	NNP
cord-005453-4057qib7	8924	28	/	/	SYM
cord-005453-4057qib7	8924	29	A	a	NN
cord-005453-4057qib7	8924	30	(	(	-LRB-
cord-005453-4057qib7	8924	31	H1N1	H1N1	NNP
cord-005453-4057qib7	8924	32	)	)	-RRB-
cord-005453-4057qib7	8924	33	infection	infection	NN
cord-005453-4057qib7	8924	34	but	but	CC
cord-005453-4057qib7	8924	35	differences	difference	NNS
cord-005453-4057qib7	8924	36	were	be	VBD
cord-005453-4057qib7	8924	37	not	not	RB
cord-005453-4057qib7	8924	38	significant	significant	JJ
cord-005453-4057qib7	8924	39	.	.	.
cord-005453-4057qib7	8925	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8925	2	:	:	:
cord-005453-4057qib7	8926	1	Influenza	influenza	NN
cord-005453-4057qib7	8926	2	could	could	MD
cord-005453-4057qib7	8926	3	be	be	VB
cord-005453-4057qib7	8926	4	proven	prove	VBN
cord-005453-4057qib7	8926	5	in	in	IN
cord-005453-4057qib7	8926	6	one	one	CD
cord-005453-4057qib7	8926	7	third	third	NN
cord-005453-4057qib7	8926	8	of	of	IN
cord-005453-4057qib7	8926	9	all	all	DT
cord-005453-4057qib7	8926	10	tested	test	VBN
cord-005453-4057qib7	8926	11	pts	pt	NNS
cord-005453-4057qib7	8926	12	.	.	.
cord-005453-4057qib7	8927	1	Dominance	dominance	NN
cord-005453-4057qib7	8927	2	of	of	IN
cord-005453-4057qib7	8927	3	B	b	NN
cord-005453-4057qib7	8927	4	and	and	CC
cord-005453-4057qib7	8927	5	A	A	NNP
cord-005453-4057qib7	8927	6	(	(	-LRB-
cord-005453-4057qib7	8927	7	H1N1	H1N1	NNP
cord-005453-4057qib7	8927	8	)	)	-RRB-
cord-005453-4057qib7	8927	9	pdm0e9	pdm0e9	NNP
cord-005453-4057qib7	8927	10	subtype	subtype	NN
cord-005453-4057qib7	8927	11	occurrence	occurrence	NN
cord-005453-4057qib7	8927	12	corresponded	correspond	VBD
cord-005453-4057qib7	8927	13	to	to	IN
cord-005453-4057qib7	8927	14	the	the	DT
cord-005453-4057qib7	8927	15	flu	flu	NN
cord-005453-4057qib7	8927	16	epidemic	epidemic	NN
cord-005453-4057qib7	8927	17	dissemination	dissemination	NN
cord-005453-4057qib7	8927	18	in	in	IN
cord-005453-4057qib7	8927	19	the	the	DT
cord-005453-4057qib7	8927	20	German	german	JJ
cord-005453-4057qib7	8927	21	population	population	NN
cord-005453-4057qib7	8927	22	.	.	.
cord-005453-4057qib7	8928	1	The	the	DT
cord-005453-4057qib7	8928	2	most	most	RBS
cord-005453-4057qib7	8928	3	important	important	JJ
cord-005453-4057qib7	8928	4	protective	protective	JJ
cord-005453-4057qib7	8928	5	factor	factor	NN
cord-005453-4057qib7	8928	6	for	for	IN
cord-005453-4057qib7	8928	7	outpatient	outpatient	NN
cord-005453-4057qib7	8928	8	SCT	SCT	NNP
cord-005453-4057qib7	8928	9	recipients	recipient	NNS
cord-005453-4057qib7	8928	10	was	be	VBD
cord-005453-4057qib7	8928	11	influenza	influenza	NN
cord-005453-4057qib7	8928	12	vaccination	vaccination	NN
cord-005453-4057qib7	8928	13	.	.	.
cord-005453-4057qib7	8929	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8929	2	:	:	:
cord-005453-4057qib7	8929	3	Nothing	nothing	NN
cord-005453-4057qib7	8929	4	to	to	TO
cord-005453-4057qib7	8929	5	declare	declare	VB
cord-005453-4057qib7	8929	6	Background	background	NN
cord-005453-4057qib7	8929	7	:	:	:
cord-005453-4057qib7	8929	8	CMV	CMV	NNP
cord-005453-4057qib7	8929	9	infection	infection	NN
cord-005453-4057qib7	8929	10	is	be	VBZ
cord-005453-4057qib7	8929	11	one	one	CD
cord-005453-4057qib7	8929	12	of	of	IN
cord-005453-4057qib7	8929	13	the	the	DT
cord-005453-4057qib7	8929	14	most	most	RBS
cord-005453-4057qib7	8929	15	frequent	frequent	JJ
cord-005453-4057qib7	8929	16	complications	complication	NNS
cord-005453-4057qib7	8929	17	after	after	IN
cord-005453-4057qib7	8929	18	HAPLO	HAPLO	NNP
cord-005453-4057qib7	8929	19	.	.	.
cord-005453-4057qib7	8930	1	Some	some	DT
cord-005453-4057qib7	8930	2	risk	risk	NN
cord-005453-4057qib7	8930	3	factors	factor	NNS
cord-005453-4057qib7	8930	4	are	be	VBP
cord-005453-4057qib7	8930	5	well	well	RB
cord-005453-4057qib7	8930	6	known	know	VBN
cord-005453-4057qib7	8930	7	but	but	CC
cord-005453-4057qib7	8930	8	the	the	DT
cord-005453-4057qib7	8930	9	best	good	JJS
cord-005453-4057qib7	8930	10	strategy	strategy	NN
cord-005453-4057qib7	8930	11	(	(	-LRB-
cord-005453-4057qib7	8930	12	prophylactic	prophylactic	JJ
cord-005453-4057qib7	8930	13	or	or	CC
cord-005453-4057qib7	8930	14	preemptive	preemptive	JJ
cord-005453-4057qib7	8930	15	treatment	treatment	NN
cord-005453-4057qib7	8930	16	)	)	-RRB-
cord-005453-4057qib7	8930	17	to	to	TO
cord-005453-4057qib7	8930	18	mitigate	mitigate	VB
cord-005453-4057qib7	8930	19	this	this	DT
cord-005453-4057qib7	8930	20	complication	complication	NN
cord-005453-4057qib7	8930	21	is	be	VBZ
cord-005453-4057qib7	8930	22	not	not	RB
cord-005453-4057qib7	8930	23	still	still	RB
cord-005453-4057qib7	8930	24	well	well	RB
cord-005453-4057qib7	8930	25	defined	define	VBN
cord-005453-4057qib7	8930	26	.	.	.
cord-005453-4057qib7	8931	1	The	the	DT
cord-005453-4057qib7	8931	2	primary	primary	JJ
cord-005453-4057qib7	8931	3	endpoint	endpoint	NN
cord-005453-4057qib7	8931	4	in	in	IN
cord-005453-4057qib7	8931	5	our	-PRON-	PRP$
cord-005453-4057qib7	8931	6	study	study	NN
cord-005453-4057qib7	8931	7	is	be	VBZ
cord-005453-4057qib7	8931	8	to	to	TO
cord-005453-4057qib7	8931	9	describe	describe	VB
cord-005453-4057qib7	8931	10	incidence	incidence	NN
cord-005453-4057qib7	8931	11	and	and	CC
cord-005453-4057qib7	8931	12	risk	risk	NN
cord-005453-4057qib7	8931	13	factors	factor	NNS
cord-005453-4057qib7	8931	14	to	to	TO
cord-005453-4057qib7	8931	15	develop	develop	VB
cord-005453-4057qib7	8931	16	CMV	CMV	NNP
cord-005453-4057qib7	8931	17	infection	infection	NN
cord-005453-4057qib7	8931	18	or	or	CC
cord-005453-4057qib7	8931	19	disease	disease	NN
cord-005453-4057qib7	8931	20	in	in	IN
cord-005453-4057qib7	8931	21	HAPLO	HAPLO	NNP
cord-005453-4057qib7	8931	22	.	.	.
cord-005453-4057qib7	8932	1	As	as	IN
cord-005453-4057qib7	8932	2	secondary	secondary	JJ
cord-005453-4057qib7	8932	3	objective	objective	NN
cord-005453-4057qib7	8932	4	we	-PRON-	PRP
cord-005453-4057qib7	8932	5	analyzed	analyze	VBD
cord-005453-4057qib7	8932	6	efficacytoxicity	efficacytoxicity	NN
cord-005453-4057qib7	8932	7	of	of	IN
cord-005453-4057qib7	8932	8	treatment	treatment	NN
cord-005453-4057qib7	8932	9	and	and	CC
cord-005453-4057qib7	8932	10	CMV	CMV	NNP
cord-005453-4057qib7	8932	11	related	relate	VBN
cord-005453-4057qib7	8932	12	mortality	mortality	NN
cord-005453-4057qib7	8932	13	.	.	.
cord-005453-4057qib7	8933	1	Methods	method	NNS
cord-005453-4057qib7	8933	2	:	:	:
cord-005453-4057qib7	8933	3	We	-PRON-	PRP
cord-005453-4057qib7	8933	4	analyzed	analyze	VBD
cord-005453-4057qib7	8933	5	60	60	CD
cord-005453-4057qib7	8933	6	patients	patient	NNS
cord-005453-4057qib7	8933	7	who	who	WP
cord-005453-4057qib7	8933	8	underwent	undergo	VBD
cord-005453-4057qib7	8933	9	HAPLO	HAPLO	NNP
cord-005453-4057qib7	8933	10	in	in	IN
cord-005453-4057qib7	8933	11	our	-PRON-	PRP$
cord-005453-4057qib7	8933	12	center	center	NN
cord-005453-4057qib7	8933	13	between	between	IN
cord-005453-4057qib7	8933	14	May	May	NNP
cord-005453-4057qib7	8933	15	2012	2012	CD
cord-005453-4057qib7	8933	16	and	and	CC
cord-005453-4057qib7	8933	17	May	May	NNP
cord-005453-4057qib7	8933	18	2018	2018	CD
cord-005453-4057qib7	8933	19	.	.	.
cord-005453-4057qib7	8934	1	All	all	DT
cord-005453-4057qib7	8934	2	of	of	IN
cord-005453-4057qib7	8934	3	them	-PRON-	PRP
cord-005453-4057qib7	8934	4	received	receive	VBD
cord-005453-4057qib7	8934	5	PTCy	PTCy	NNS
cord-005453-4057qib7	8934	6	(	(	-LRB-
cord-005453-4057qib7	8934	7	D+3	d+3	VB
cord-005453-4057qib7	8934	8	and	and	CC
cord-005453-4057qib7	8934	9	D+4	D+4	NNP
cord-005453-4057qib7	8934	10	)	)	-RRB-
cord-005453-4057qib7	8934	11	,	,	,
cord-005453-4057qib7	8934	12	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	8934	13	and	and	CC
cord-005453-4057qib7	8934	14	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	8934	15	as	as	IN
cord-005453-4057qib7	8934	16	graft	graft	NN
cord-005453-4057qib7	8934	17	versus	versus	IN
cord-005453-4057qib7	8934	18	host	host	NN
cord-005453-4057qib7	8934	19	disease	disease	NN
cord-005453-4057qib7	8934	20	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	8934	21	.	.	.
cord-005453-4057qib7	8935	1	A	a	DT
cord-005453-4057qib7	8935	2	preemptive	preemptive	JJ
cord-005453-4057qib7	8935	3	therapy	therapy	NN
cord-005453-4057qib7	8935	4	based	base	VBN
cord-005453-4057qib7	8935	5	on	on	IN
cord-005453-4057qib7	8935	6	viral	viral	JJ
cord-005453-4057qib7	8935	7	load	load	NN
cord-005453-4057qib7	8935	8	was	be	VBD
cord-005453-4057qib7	8935	9	applied	apply	VBN
cord-005453-4057qib7	8935	10	.	.	.
cord-005453-4057qib7	8936	1	Treatment	treatment	NN
cord-005453-4057qib7	8936	2	was	be	VBD
cord-005453-4057qib7	8936	3	started	start	VBN
cord-005453-4057qib7	8936	4	when	when	WRB
cord-005453-4057qib7	8936	5	>	>	XX
cord-005453-4057qib7	8936	6	1000	1000	CD
cord-005453-4057qib7	8936	7	UI	UI	NNP
cord-005453-4057qib7	8936	8	/	/	SYM
cord-005453-4057qib7	8936	9	mL	ml	NN
cord-005453-4057qib7	8936	10	of	of	IN
cord-005453-4057qib7	8936	11	CMV	CMV	NNP
cord-005453-4057qib7	8936	12	were	be	VBD
cord-005453-4057qib7	8936	13	detected	detect	VBN
cord-005453-4057qib7	8936	14	in	in	IN
cord-005453-4057qib7	8936	15	one	one	CD
cord-005453-4057qib7	8936	16	determination	determination	NN
cord-005453-4057qib7	8936	17	or	or	CC
cord-005453-4057qib7	8936	18	>	>	XX
cord-005453-4057qib7	8936	19	500	500	CD
cord-005453-4057qib7	8936	20	UI	UI	NNP
cord-005453-4057qib7	8936	21	/	/	SYM
cord-005453-4057qib7	8936	22	mL	ml	NN
cord-005453-4057qib7	8936	23	in	in	IN
cord-005453-4057qib7	8936	24	two	two	CD
cord-005453-4057qib7	8936	25	consecutive	consecutive	JJ
cord-005453-4057qib7	8936	26	determinations	determination	NNS
cord-005453-4057qib7	8936	27	.	.	.
cord-005453-4057qib7	8937	1	CMV	CMV	NNP
cord-005453-4057qib7	8937	2	analyses	analysis	NNS
cord-005453-4057qib7	8937	3	were	be	VBD
cord-005453-4057qib7	8937	4	made	make	VBN
cord-005453-4057qib7	8937	5	in	in	IN
cord-005453-4057qib7	8937	6	plasma	plasma	NN
cord-005453-4057qib7	8937	7	using	use	VBG
cord-005453-4057qib7	8937	8	Cobas	Cobas	NNP
cord-005453-4057qib7	8937	9	PCR	PCR	NNP
cord-005453-4057qib7	8937	10	technique	technique	NN
cord-005453-4057qib7	8937	11	®	®	NN
cord-005453-4057qib7	8937	12	and	and	CC
cord-005453-4057qib7	8938	1	positive	positive	JJ
cord-005453-4057qib7	8938	2	viral	viral	JJ
cord-005453-4057qib7	8938	3	load	load	NN
cord-005453-4057qib7	8938	4	cut	cut	VBN
cord-005453-4057qib7	8938	5	-	-	HYPH
cord-005453-4057qib7	8938	6	off	off	RP
cord-005453-4057qib7	8938	7	point	point	NN
cord-005453-4057qib7	8938	8	was	be	VBD
cord-005453-4057qib7	8938	9	137	137	CD
cord-005453-4057qib7	8938	10	UI	UI	NNP
cord-005453-4057qib7	8938	11	/	/	SYM
cord-005453-4057qib7	8938	12	mL.	ml.	NN
cord-005453-4057qib7	8939	1	The	the	DT
cord-005453-4057qib7	8939	2	CMV	CMV	NNP
cord-005453-4057qib7	8939	3	viremia	viremia	NN
cord-005453-4057qib7	8939	4	was	be	VBD
cord-005453-4057qib7	8939	5	determined	determine	VBN
cord-005453-4057qib7	8939	6	weekly	weekly	NN
cord-005453-4057qib7	8939	7	until	until	IN
cord-005453-4057qib7	8939	8	D+100	D+100	NNS
cord-005453-4057qib7	8939	9	and	and	CC
cord-005453-4057qib7	8939	10	then	then	RB
cord-005453-4057qib7	8939	11	every	every	DT
cord-005453-4057qib7	8939	12	two	two	CD
cord-005453-4057qib7	8939	13	weeks	week	NNS
cord-005453-4057qib7	8939	14	until	until	IN
cord-005453-4057qib7	8939	15	immune	immune	JJ
cord-005453-4057qib7	8939	16	reconstitution	reconstitution	NN
cord-005453-4057qib7	8939	17	.	.	.
cord-005453-4057qib7	8940	1	Results	result	NNS
cord-005453-4057qib7	8940	2	:	:	:
cord-005453-4057qib7	8941	1	The	the	DT
cord-005453-4057qib7	8941	2	CMV	CMV	NNP
cord-005453-4057qib7	8941	3	infection	infection	NN
cord-005453-4057qib7	8941	4	and	and	CC
cord-005453-4057qib7	8941	5	disease	disease	NN
cord-005453-4057qib7	8941	6	incidence	incidence	NN
cord-005453-4057qib7	8941	7	at	at	IN
cord-005453-4057qib7	8941	8	D	D	NNP
cord-005453-4057qib7	8941	9	+100	+100	NNP
cord-005453-4057qib7	8941	10	was	be	VBD
cord-005453-4057qib7	8941	11	61.3	61.3	CD
cord-005453-4057qib7	8941	12	%	%	NN
cord-005453-4057qib7	8941	13	(	(	-LRB-
cord-005453-4057qib7	8941	14	38	38	CD
cord-005453-4057qib7	8941	15	episodes	episode	NNS
cord-005453-4057qib7	8941	16	)	)	-RRB-
cord-005453-4057qib7	8941	17	and	and	CC
cord-005453-4057qib7	8941	18	19.4	19.4	CD
cord-005453-4057qib7	8941	19	%	%	NN
cord-005453-4057qib7	8941	20	(	(	-LRB-
cord-005453-4057qib7	8941	21	12	12	CD
cord-005453-4057qib7	8941	22	episodes	episode	NNS
cord-005453-4057qib7	8941	23	)	)	-RRB-
cord-005453-4057qib7	8941	24	,	,	,
cord-005453-4057qib7	8941	25	respectively	respectively	RB
cord-005453-4057qib7	8941	26	.	.	.
cord-005453-4057qib7	8942	1	CMV	CMV	NNP
cord-005453-4057qib7	8942	2	disease	disease	NN
cord-005453-4057qib7	8942	3	was	be	VBD
cord-005453-4057qib7	8942	4	digestive	digestive	JJ
cord-005453-4057qib7	8942	5	(	(	-LRB-
cord-005453-4057qib7	8942	6	n=8	n=8	NN
cord-005453-4057qib7	8942	7	)	)	-RRB-
cord-005453-4057qib7	8942	8	,	,	,
cord-005453-4057qib7	8942	9	pulmonar	pulmonar	NNP
cord-005453-4057qib7	8942	10	(	(	-LRB-
cord-005453-4057qib7	8942	11	n=2	n=2	NNP
cord-005453-4057qib7	8942	12	)	)	-RRB-
cord-005453-4057qib7	8942	13	,	,	,
cord-005453-4057qib7	8942	14	neurologic	neurologic	JJ
cord-005453-4057qib7	8942	15	(	(	-LRB-
cord-005453-4057qib7	8942	16	n=1	n=1	FW
cord-005453-4057qib7	8942	17	)	)	-RRB-
cord-005453-4057qib7	8942	18	and	and	CC
cord-005453-4057qib7	8942	19	disseminated	disseminate	VBN
cord-005453-4057qib7	8942	20	(	(	-LRB-
cord-005453-4057qib7	8942	21	n=1	n=1	CD
cord-005453-4057qib7	8942	22	)	)	-RRB-
cord-005453-4057qib7	8942	23	.	.	.
cord-005453-4057qib7	8943	1	The	the	DT
cord-005453-4057qib7	8943	2	median	median	JJ
cord-005453-4057qib7	8943	3	time	time	NN
cord-005453-4057qib7	8943	4	to	to	IN
cord-005453-4057qib7	8943	5	first	first	JJ
cord-005453-4057qib7	8943	6	CMV	CMV	NNP
cord-005453-4057qib7	8943	7	infection	infection	NN
cord-005453-4057qib7	8943	8	was	be	VBD
cord-005453-4057qib7	8943	9	39.5	39.5	CD
cord-005453-4057qib7	8943	10	days	day	NNS
cord-005453-4057qib7	8943	11	(	(	-LRB-
cord-005453-4057qib7	8943	12	20	20	CD
cord-005453-4057qib7	8943	13	-	-	SYM
cord-005453-4057qib7	8943	14	151	151	CD
cord-005453-4057qib7	8943	15	)	)	-RRB-
cord-005453-4057qib7	8943	16	.	.	.
cord-005453-4057qib7	8944	1	Thirty	thirty	CD
cord-005453-4057qib7	8944	2	-	-	HYPH
cord-005453-4057qib7	8944	3	six	six	CD
cord-005453-4057qib7	8944	4	patients	patient	NNS
cord-005453-4057qib7	8944	5	had	have	VBD
cord-005453-4057qib7	8944	6	at	at	RB
cord-005453-4057qib7	8944	7	least	least	RBS
cord-005453-4057qib7	8944	8	one	one	CD
cord-005453-4057qib7	8944	9	episode	episode	NN
cord-005453-4057qib7	8944	10	of	of	IN
cord-005453-4057qib7	8944	11	CMV	CMV	NNP
cord-005453-4057qib7	8944	12	infection	infection	NN
cord-005453-4057qib7	8944	13	:	:	:
cord-005453-4057qib7	8944	14	24	24	CD
cord-005453-4057qib7	8944	15	of	of	IN
cord-005453-4057qib7	8944	16	them	-PRON-	PRP
cord-005453-4057qib7	8944	17	(	(	-LRB-
cord-005453-4057qib7	8944	18	66.7	66.7	CD
cord-005453-4057qib7	8944	19	%	%	NN
cord-005453-4057qib7	8944	20	)	)	-RRB-
cord-005453-4057qib7	8944	21	had	have	VBD
cord-005453-4057qib7	8944	22	one	one	CD
cord-005453-4057qib7	8944	23	episode	episode	NN
cord-005453-4057qib7	8944	24	,	,	,
cord-005453-4057qib7	8944	25	7	7	CD
cord-005453-4057qib7	8944	26	(	(	-LRB-
cord-005453-4057qib7	8944	27	19.4	19.4	CD
cord-005453-4057qib7	8944	28	%	%	NN
cord-005453-4057qib7	8944	29	)	)	-RRB-
cord-005453-4057qib7	8944	30	had	have	VBD
cord-005453-4057qib7	8944	31	two	two	CD
cord-005453-4057qib7	8944	32	episodes	episode	NNS
cord-005453-4057qib7	8944	33	and	and	CC
cord-005453-4057qib7	8944	34	5	5	CD
cord-005453-4057qib7	8944	35	(	(	-LRB-
cord-005453-4057qib7	8944	36	13.9	13.9	CD
cord-005453-4057qib7	8944	37	%	%	NN
cord-005453-4057qib7	8944	38	)	)	-RRB-
cord-005453-4057qib7	8944	39	had	have	VBD
cord-005453-4057qib7	8944	40	3	3	CD
cord-005453-4057qib7	8944	41	or	or	CC
cord-005453-4057qib7	8944	42	more	more	JJR
cord-005453-4057qib7	8944	43	episodes	episode	NNS
cord-005453-4057qib7	8944	44	,	,	,
cord-005453-4057qib7	8944	45	respectively	respectively	RB
cord-005453-4057qib7	8944	46	.	.	.
cord-005453-4057qib7	8945	1	Only	only	RB
cord-005453-4057qib7	8945	2	pre	pre	JJ
cord-005453-4057qib7	8945	3	-	-	JJ
cord-005453-4057qib7	8945	4	transplantation	transplantation	JJ
cord-005453-4057qib7	8945	5	CMV	CMV	NNP
cord-005453-4057qib7	8945	6	status	status	NN
cord-005453-4057qib7	8945	7	was	be	VBD
cord-005453-4057qib7	8945	8	significantly	significantly	RB
cord-005453-4057qib7	8945	9	associated	associate	VBN
cord-005453-4057qib7	8945	10	with	with	IN
cord-005453-4057qib7	8945	11	CMV	CMV	NNP
cord-005453-4057qib7	8945	12	infection	infection	NN
cord-005453-4057qib7	8945	13	(	(	-LRB-
cord-005453-4057qib7	8945	14	p	p	NN
cord-005453-4057qib7	8945	15	<	<	XX
cord-005453-4057qib7	8945	16	0.001	0.001	CD
cord-005453-4057qib7	8945	17	)	)	-RRB-
cord-005453-4057qib7	8945	18	.	.	.
cord-005453-4057qib7	8946	1	Risk	risk	NN
cord-005453-4057qib7	8946	2	factors	factor	NNS
cord-005453-4057qib7	8946	3	are	be	VBP
cord-005453-4057qib7	8946	4	shown	show	VBN
cord-005453-4057qib7	8946	5	in	in	IN
cord-005453-4057qib7	8946	6	image	image	NN
cord-005453-4057qib7	8946	7	1	1	CD
cord-005453-4057qib7	8946	8	.	.	.
cord-005453-4057qib7	8947	1	The	the	DT
cord-005453-4057qib7	8947	2	median	median	JJ
cord-005453-4057qib7	8947	3	viral	viral	JJ
cord-005453-4057qib7	8947	4	load	load	NN
cord-005453-4057qib7	8947	5	in	in	IN
cord-005453-4057qib7	8947	6	first	first	JJ
cord-005453-4057qib7	8947	7	CMV	CMV	NNP
cord-005453-4057qib7	8947	8	infection	infection	NN
cord-005453-4057qib7	8947	9	and	and	CC
cord-005453-4057qib7	8947	10	disease	disease	NN
cord-005453-4057qib7	8947	11	was	be	VBD
cord-005453-4057qib7	8947	12	8314	8314	CD
cord-005453-4057qib7	8947	13	UI	UI	NNP
cord-005453-4057qib7	8947	14	/	/	SYM
cord-005453-4057qib7	8947	15	mL	ml	NN
cord-005453-4057qib7	8947	16	(	(	-LRB-
cord-005453-4057qib7	8947	17	542	542	CD
cord-005453-4057qib7	8947	18	-	-	SYM
cord-005453-4057qib7	8947	19	51158	51158	CD
cord-005453-4057qib7	8947	20	)	)	-RRB-
cord-005453-4057qib7	8947	21	and	and	CC
cord-005453-4057qib7	8947	22	24842	24842	CD
cord-005453-4057qib7	8947	23	UI	UI	NNP
cord-005453-4057qib7	8947	24	/	/	SYM
cord-005453-4057qib7	8947	25	ml	ml	NN
cord-005453-4057qib7	8947	26	(	(	-LRB-
cord-005453-4057qib7	8947	27	271	271	CD
cord-005453-4057qib7	8947	28	-	-	HYPH
cord-005453-4057qib7	8947	29	126279	126279	CD
cord-005453-4057qib7	8947	30	)	)	-RRB-
cord-005453-4057qib7	8947	31	,	,	,
cord-005453-4057qib7	8947	32	respectively	respectively	RB
cord-005453-4057qib7	8947	33	(	(	-LRB-
cord-005453-4057qib7	8947	34	p=0.02).The	p=0.02).The	NNP
cord-005453-4057qib7	8947	35	median	median	JJ
cord-005453-4057qib7	8947	36	counts	count	NNS
cord-005453-4057qib7	8947	37	of	of	IN
cord-005453-4057qib7	8947	38	CD4	CD4	NNP
cord-005453-4057qib7	8947	39	lymphocytes	lymphocyte	VBZ
cord-005453-4057qib7	8947	40	at	at	IN
cord-005453-4057qib7	8947	41	D+100	D+100	NNS
cord-005453-4057qib7	8947	42	in	in	IN
cord-005453-4057qib7	8947	43	CMV	CMV	NNP
cord-005453-4057qib7	8947	44	infection	infection	NN
cord-005453-4057qib7	8947	45	and	and	CC
cord-005453-4057qib7	8947	46	disease	disease	NN
cord-005453-4057qib7	8947	47	were	be	VBD
cord-005453-4057qib7	8947	48	262	262	CD
cord-005453-4057qib7	8947	49	/	/	SYM
cord-005453-4057qib7	8947	50	mm3	mm3	NNS
cord-005453-4057qib7	8947	51	and	and	CC
cord-005453-4057qib7	8947	52	120	120	CD
cord-005453-4057qib7	8947	53	/	/	SYM
cord-005453-4057qib7	8947	54	mm3	mm3	NNS
cord-005453-4057qib7	8947	55	,	,	,
cord-005453-4057qib7	8947	56	respectively	respectively	RB
cord-005453-4057qib7	8947	57	(	(	-LRB-
cord-005453-4057qib7	8947	58	p=0.09	p=0.09	NN
cord-005453-4057qib7	8947	59	)	)	-RRB-
cord-005453-4057qib7	8947	60	.	.	.
cord-005453-4057qib7	8948	1	Preemptive	preemptive	JJ
cord-005453-4057qib7	8948	2	therapy	therapy	NN
cord-005453-4057qib7	8948	3	for	for	IN
cord-005453-4057qib7	8948	4	the	the	DT
cord-005453-4057qib7	8948	5	first	first	JJ
cord-005453-4057qib7	8948	6	2	2	CD
cord-005453-4057qib7	8948	7	episodes	episode	NNS
cord-005453-4057qib7	8948	8	of	of	IN
cord-005453-4057qib7	8948	9	CMV	CMV	NNP
cord-005453-4057qib7	8948	10	infections	infection	NNS
cord-005453-4057qib7	8948	11	(	(	-LRB-
cord-005453-4057qib7	8948	12	n=48	n=48	NN
cord-005453-4057qib7	8948	13	)	)	-RRB-
cord-005453-4057qib7	8948	14	was	be	VBD
cord-005453-4057qib7	8948	15	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	8948	16	(	(	-LRB-
cord-005453-4057qib7	8948	17	58,3	58,3	CD
cord-005453-4057qib7	8948	18	%	%	NN
cord-005453-4057qib7	8948	19	)	)	-RRB-
cord-005453-4057qib7	8948	20	,	,	,
cord-005453-4057qib7	8948	21	ganciclovir	ganciclovir	FW
cord-005453-4057qib7	8948	22	(	(	-LRB-
cord-005453-4057qib7	8948	23	35.4	35.4	CD
cord-005453-4057qib7	8948	24	%	%	NN
cord-005453-4057qib7	8948	25	)	)	-RRB-
cord-005453-4057qib7	8948	26	or	or	CC
cord-005453-4057qib7	8948	27	foscarnet	foscarnet	NN
cord-005453-4057qib7	8948	28	(	(	-LRB-
cord-005453-4057qib7	8948	29	6.3	6.3	CD
cord-005453-4057qib7	8948	30	%	%	NN
cord-005453-4057qib7	8948	31	)	)	-RRB-
cord-005453-4057qib7	8948	32	,	,	,
cord-005453-4057qib7	8948	33	reaching	reach	VBG
cord-005453-4057qib7	8948	34	a	a	DT
cord-005453-4057qib7	8948	35	complete	complete	JJ
cord-005453-4057qib7	8948	36	viral	viral	JJ
cord-005453-4057qib7	8948	37	load	load	NN
cord-005453-4057qib7	8948	38	clearance	clearance	NN
cord-005453-4057qib7	8948	39	in	in	IN
cord-005453-4057qib7	8948	40	77	77	CD
cord-005453-4057qib7	8948	41	%	%	NN
cord-005453-4057qib7	8948	42	,	,	,
cord-005453-4057qib7	8948	43	with	with	IN
cord-005453-4057qib7	8948	44	a	a	DT
cord-005453-4057qib7	8948	45	median	median	JJ
cord-005453-4057qib7	8948	46	time	time	NN
cord-005453-4057qib7	8948	47	to	to	IN
cord-005453-4057qib7	8948	48	response	response	NN
cord-005453-4057qib7	8948	49	of	of	IN
cord-005453-4057qib7	8948	50	19.2	19.2	CD
cord-005453-4057qib7	8948	51	days	day	NNS
cord-005453-4057qib7	8948	52	(	(	-LRB-
cord-005453-4057qib7	8948	53	6	6	CD
cord-005453-4057qib7	8948	54	-	-	SYM
cord-005453-4057qib7	8948	55	34	34	CD
cord-005453-4057qib7	8948	56	)	)	-RRB-
cord-005453-4057qib7	8948	57	and	and	CC
cord-005453-4057qib7	8948	58	a	a	DT
cord-005453-4057qib7	8948	59	median	median	JJ
cord-005453-4057qib7	8948	60	treatment	treatment	NN
cord-005453-4057qib7	8948	61	duration	duration	NN
cord-005453-4057qib7	8948	62	of	of	IN
cord-005453-4057qib7	8948	63	21	21	CD
cord-005453-4057qib7	8948	64	days	day	NNS
cord-005453-4057qib7	8948	65	(	(	-LRB-
cord-005453-4057qib7	8948	66	2	2	CD
cord-005453-4057qib7	8948	67	-	-	SYM
cord-005453-4057qib7	8948	68	39	39	CD
cord-005453-4057qib7	8948	69	)	)	-RRB-
cord-005453-4057qib7	8948	70	.	.	.
cord-005453-4057qib7	8949	1	Grade	grade	NN
cord-005453-4057qib7	8949	2	III	III	NNP
cord-005453-4057qib7	8949	3	-	-	HYPH
cord-005453-4057qib7	8949	4	IV	IV	NNP
cord-005453-4057qib7	8949	5	toxicity	toxicity	NN
cord-005453-4057qib7	8949	6	(	(	-LRB-
cord-005453-4057qib7	8949	7	mainly	mainly	RB
cord-005453-4057qib7	8949	8	hematologic	hematologic	JJ
cord-005453-4057qib7	8949	9	)	)	-RRB-
cord-005453-4057qib7	8949	10	was	be	VBD
cord-005453-4057qib7	8949	11	observed	observe	VBN
cord-005453-4057qib7	8949	12	in	in	IN
cord-005453-4057qib7	8949	13	55.6	55.6	CD
cord-005453-4057qib7	8949	14	%	%	NN
cord-005453-4057qib7	8949	15	(	(	-LRB-
cord-005453-4057qib7	8949	16	n=28	n=28	RB
cord-005453-4057qib7	8949	17	)	)	-RRB-
cord-005453-4057qib7	8949	18	,	,	,
cord-005453-4057qib7	8949	19	30	30	CD
cord-005453-4057qib7	8949	20	%	%	NN
cord-005453-4057qib7	8949	21	(	(	-LRB-
cord-005453-4057qib7	8949	22	n=17	n=17	NNP
cord-005453-4057qib7	8949	23	)	)	-RRB-
cord-005453-4057qib7	8949	24	and	and	CC
cord-005453-4057qib7	8949	25	16.7	16.7	CD
cord-005453-4057qib7	8949	26	%	%	NN
cord-005453-4057qib7	8949	27	(	(	-LRB-
cord-005453-4057qib7	8949	28	n=3	n=3	NN
cord-005453-4057qib7	8949	29	)	)	-RRB-
cord-005453-4057qib7	8949	30	,	,	,
cord-005453-4057qib7	8949	31	respectively	respectively	RB
cord-005453-4057qib7	8949	32	.	.	.
cord-005453-4057qib7	8950	1	Three	three	CD
cord-005453-4057qib7	8950	2	patients	patient	NNS
cord-005453-4057qib7	8950	3	had	have	VBD
cord-005453-4057qib7	8950	4	an	an	DT
cord-005453-4057qib7	8950	5	UL54	UL54	NNP
cord-005453-4057qib7	8950	6	mutation	mutation	NN
cord-005453-4057qib7	8950	7	,	,	,
cord-005453-4057qib7	8950	8	one	one	CD
cord-005453-4057qib7	8950	9	of	of	IN
cord-005453-4057qib7	8950	10	them	-PRON-	PRP
cord-005453-4057qib7	8950	11	with	with	IN
cord-005453-4057qib7	8950	12	clinical	clinical	JJ
cord-005453-4057qib7	8950	13	and	and	CC
cord-005453-4057qib7	8950	14	microbiological	microbiological	JJ
cord-005453-4057qib7	8950	15	resistance	resistance	NN
cord-005453-4057qib7	8950	16	to	to	IN
cord-005453-4057qib7	8950	17	the	the	DT
cord-005453-4057qib7	8950	18	3	3	CD
cord-005453-4057qib7	8950	19	mentioned	mention	VBD
cord-005453-4057qib7	8950	20	drugs	drug	NNS
cord-005453-4057qib7	8950	21	.	.	.
cord-005453-4057qib7	8951	1	Three	three	CD
cord-005453-4057qib7	8951	2	patients	patient	NNS
cord-005453-4057qib7	8951	3	(	(	-LRB-
cord-005453-4057qib7	8951	4	5	5	CD
cord-005453-4057qib7	8951	5	%	%	NN
cord-005453-4057qib7	8951	6	)	)	-RRB-
cord-005453-4057qib7	8951	7	had	have	VBD
cord-005453-4057qib7	8951	8	a	a	DT
cord-005453-4057qib7	8951	9	graft	graft	NN
cord-005453-4057qib7	8951	10	failure	failure	NN
cord-005453-4057qib7	8951	11	secondary	secondary	JJ
cord-005453-4057qib7	8951	12	to	to	IN
cord-005453-4057qib7	8951	13	CMV	CMV	NNP
cord-005453-4057qib7	8951	14	infections	infection	NNS
cord-005453-4057qib7	8951	15	.	.	.
cord-005453-4057qib7	8952	1	Five	five	CD
cord-005453-4057qib7	8952	2	patients	patient	NNS
cord-005453-4057qib7	8952	3	(	(	-LRB-
cord-005453-4057qib7	8952	4	8.3	8.3	CD
cord-005453-4057qib7	8952	5	%	%	NN
cord-005453-4057qib7	8952	6	)	)	-RRB-
cord-005453-4057qib7	8952	7	died	die	VBD
cord-005453-4057qib7	8952	8	as	as	IN
cord-005453-4057qib7	8952	9	consequence	consequence	NN
cord-005453-4057qib7	8952	10	of	of	IN
cord-005453-4057qib7	8952	11	CMV	CMV	NNP
cord-005453-4057qib7	8952	12	infection	infection	NN
cord-005453-4057qib7	8952	13	:	:	:
cord-005453-4057qib7	8952	14	3	3	CD
cord-005453-4057qib7	8952	15	before	before	IN
cord-005453-4057qib7	8952	16	D+100	D+100	NNS
cord-005453-4057qib7	8952	17	secondary	secondary	JJ
cord-005453-4057qib7	8952	18	to	to	IN
cord-005453-4057qib7	8952	19	CMV	CMV	NNP
cord-005453-4057qib7	8952	20	disease	disease	NN
cord-005453-4057qib7	8952	21	(	(	-LRB-
cord-005453-4057qib7	8952	22	2	2	CD
cord-005453-4057qib7	8952	23	pulmonar	pulmonar	NNP
cord-005453-4057qib7	8952	24	,	,	,
cord-005453-4057qib7	8952	25	1	1	CD
cord-005453-4057qib7	8952	26	disseminated	disseminate	VBD
cord-005453-4057qib7	8952	27	)	)	-RRB-
cord-005453-4057qib7	8952	28	and	and	CC
cord-005453-4057qib7	8952	29	2	2	CD
cord-005453-4057qib7	8952	30	after	after	IN
cord-005453-4057qib7	8952	31	D+365	D+365	NNS
cord-005453-4057qib7	8952	32	due	due	IN
cord-005453-4057qib7	8952	33	to	to	IN
cord-005453-4057qib7	8952	34	graft	graft	NN
cord-005453-4057qib7	8952	35	failure	failure	NN
cord-005453-4057qib7	8952	36	and	and	CC
cord-005453-4057qib7	8952	37	infectious	infectious	JJ
cord-005453-4057qib7	8952	38	complications	complication	NNS
cord-005453-4057qib7	8952	39	.	.	.
cord-005453-4057qib7	8953	1	With	with	IN
cord-005453-4057qib7	8953	2	a	a	DT
cord-005453-4057qib7	8953	3	median	median	NN
cord-005453-4057qib7	8953	4	follow	follow	NN
cord-005453-4057qib7	8953	5	up	up	IN
cord-005453-4057qib7	8953	6	of	of	IN
cord-005453-4057qib7	8953	7	12.5	12.5	CD
cord-005453-4057qib7	8953	8	months	month	NNS
cord-005453-4057qib7	8953	9	,	,	,
cord-005453-4057qib7	8953	10	overall	overall	JJ
cord-005453-4057qib7	8953	11	survival	survival	NN
cord-005453-4057qib7	8953	12	at	at	IN
cord-005453-4057qib7	8953	13	18	18	CD
cord-005453-4057qib7	8953	14	months	month	NNS
cord-005453-4057qib7	8953	15	for	for	IN
cord-005453-4057qib7	8953	16	patients	patient	NNS
cord-005453-4057qib7	8953	17	who	who	WP
cord-005453-4057qib7	8953	18	had	have	VBD
cord-005453-4057qib7	8953	19	CMV	CMV	NNP
cord-005453-4057qib7	8953	20	infection	infection	NN
cord-005453-4057qib7	8953	21	was	be	VBD
cord-005453-4057qib7	8953	22	58.9	58.9	CD
cord-005453-4057qib7	8953	23	%	%	NN
cord-005453-4057qib7	8953	24	compared	compare	VBN
cord-005453-4057qib7	8953	25	to	to	IN
cord-005453-4057qib7	8953	26	66.5	66.5	CD
cord-005453-4057qib7	8953	27	%	%	NN
cord-005453-4057qib7	8953	28	for	for	IN
cord-005453-4057qib7	8953	29	those	those	DT
cord-005453-4057qib7	8953	30	who	who	WP
cord-005453-4057qib7	8953	31	had	have	VBD
cord-005453-4057qib7	8953	32	no	no	DT
cord-005453-4057qib7	8953	33	infection	infection	NN
cord-005453-4057qib7	8953	34	(	(	-LRB-
cord-005453-4057qib7	8953	35	p=0.08	p=0.08	NNP
cord-005453-4057qib7	8953	36	)	)	-RRB-
cord-005453-4057qib7	8953	37	.	.	.
cord-005453-4057qib7	8954	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	8954	2	:	:	:
cord-005453-4057qib7	8955	1	A	a	DT
cord-005453-4057qib7	8955	2	high	high	JJ
cord-005453-4057qib7	8955	3	incidence	incidence	NN
cord-005453-4057qib7	8955	4	of	of	IN
cord-005453-4057qib7	8955	5	CMV	CMV	NNP
cord-005453-4057qib7	8955	6	infection	infection	NN
cord-005453-4057qib7	8955	7	in	in	IN
cord-005453-4057qib7	8955	8	HAPLO	HAPLO	NNP
cord-005453-4057qib7	8955	9	with	with	IN
cord-005453-4057qib7	8955	10	PTCy	PTCy	NNS
cord-005453-4057qib7	8955	11	was	be	VBD
cord-005453-4057qib7	8955	12	shown	show	VBN
cord-005453-4057qib7	8955	13	in	in	IN
cord-005453-4057qib7	8955	14	our	-PRON-	PRP$
cord-005453-4057qib7	8955	15	series	series	NN
cord-005453-4057qib7	8955	16	and	and	CC
cord-005453-4057qib7	8955	17	it	-PRON-	PRP
cord-005453-4057qib7	8955	18	contributed	contribute	VBD
cord-005453-4057qib7	8955	19	to	to	IN
cord-005453-4057qib7	8955	20	mortality	mortality	NN
cord-005453-4057qib7	8955	21	in	in	IN
cord-005453-4057qib7	8955	22	8.3	8.3	CD
cord-005453-4057qib7	8955	23	%	%	NN
cord-005453-4057qib7	8955	24	of	of	IN
cord-005453-4057qib7	8955	25	patients	patient	NNS
cord-005453-4057qib7	8955	26	.	.	.
cord-005453-4057qib7	8956	1	Only	only	RB
cord-005453-4057qib7	8956	2	CMV	CMV	NNP
cord-005453-4057qib7	8956	3	status	status	NN
cord-005453-4057qib7	8956	4	(	(	-LRB-
cord-005453-4057qib7	8956	5	D-/R+	D-/R+	NNP
cord-005453-4057qib7	8956	6	and	and	CC
cord-005453-4057qib7	8956	7	D+/R+	D+/R+	NNP
cord-005453-4057qib7	8956	8	)	)	-RRB-
cord-005453-4057qib7	8956	9	was	be	VBD
cord-005453-4057qib7	8956	10	significantly	significantly	RB
cord-005453-4057qib7	8956	11	associated	associate	VBN
cord-005453-4057qib7	8956	12	with	with	IN
cord-005453-4057qib7	8956	13	higher	high	JJR
cord-005453-4057qib7	8956	14	risk	risk	NN
cord-005453-4057qib7	8956	15	of	of	IN
cord-005453-4057qib7	8956	16	infection	infection	NN
cord-005453-4057qib7	8956	17	.	.	.
cord-005453-4057qib7	8957	1	Identification	identification	NN
cord-005453-4057qib7	8957	2	of	of	IN
cord-005453-4057qib7	8957	3	high	high	JJ
cord-005453-4057qib7	8957	4	risk	risk	NN
cord-005453-4057qib7	8957	5	patients	patient	NNS
cord-005453-4057qib7	8957	6	and	and	CC
cord-005453-4057qib7	8957	7	new	new	JJ
cord-005453-4057qib7	8957	8	prophylactic	prophylactic	JJ
cord-005453-4057qib7	8957	9	and	and	CC
cord-005453-4057qib7	8957	10	treatment	treatment	NN
cord-005453-4057qib7	8957	11	strategies	strategy	NNS
cord-005453-4057qib7	8957	12	may	may	MD
cord-005453-4057qib7	8957	13	improve	improve	VB
cord-005453-4057qib7	8957	14	these	these	DT
cord-005453-4057qib7	8957	15	results	result	NNS
cord-005453-4057qib7	8957	16	.	.	.
cord-005453-4057qib7	8958	1	Disclosure	disclosure	NN
cord-005453-4057qib7	8958	2	:	:	:
cord-005453-4057qib7	8958	3	Nothing	nothing	NN
cord-005453-4057qib7	8958	4	to	to	TO
cord-005453-4057qib7	8958	5	declare	declare	VB
cord-005453-4057qib7	8958	6	.	.	.
cord-005453-4057qib7	8959	1	Methods	method	NNS
cord-005453-4057qib7	8959	2	:	:	:
cord-005453-4057qib7	8959	3	Consecutive	consecutive	JJ
cord-005453-4057qib7	8959	4	patients	patient	NNS
cord-005453-4057qib7	8959	5	admitted	admit	VBN
cord-005453-4057qib7	8959	6	at	at	IN
cord-005453-4057qib7	8959	7	the	the	DT
cord-005453-4057qib7	8959	8	SCT	SCT	NNP
cord-005453-4057qib7	8959	9	unit	unit	NN
cord-005453-4057qib7	8959	10	between	between	IN
cord-005453-4057qib7	8959	11	January-18	January-18	NNP
cord-005453-4057qib7	8959	12	to	to	IN
cord-005453-4057qib7	8959	13	November-18	November-18	NNP
cord-005453-4057qib7	8959	14	were	be	VBD
cord-005453-4057qib7	8959	15	reviewed	review	VBN
cord-005453-4057qib7	8959	16	.	.	.
cord-005453-4057qib7	8960	1	Only	only	RB
cord-005453-4057qib7	8960	2	first	first	JJ
cord-005453-4057qib7	8960	3	admission	admission	NN
cord-005453-4057qib7	8960	4	was	be	VBD
cord-005453-4057qib7	8960	5	analysed	analyse	VBN
cord-005453-4057qib7	8960	6	.	.	.
cord-005453-4057qib7	8961	1	Screening	screening	NN
cord-005453-4057qib7	8961	2	consisted	consist	VBD
cord-005453-4057qib7	8961	3	of	of	IN
cord-005453-4057qib7	8961	4	rectal	rectal	JJ
cord-005453-4057qib7	8961	5	and	and	CC
cord-005453-4057qib7	8961	6	perineal	perineal	NN
cord-005453-4057qib7	8961	7	swap	swap	NN
cord-005453-4057qib7	8961	8	on	on	IN
cord-005453-4057qib7	8961	9	admission	admission	NN
cord-005453-4057qib7	8961	10	and	and	CC
cord-005453-4057qib7	8961	11	weekly	weekly	NN
cord-005453-4057qib7	8961	12	until	until	IN
cord-005453-4057qib7	8961	13	discharge	discharge	NN
cord-005453-4057qib7	8961	14	.	.	.
cord-005453-4057qib7	8962	1	In	in	IN
cord-005453-4057qib7	8962	2	case	case	NN
cord-005453-4057qib7	8962	3	of	of	IN
cord-005453-4057qib7	8962	4	detection	detection	NN
cord-005453-4057qib7	8962	5	of	of	IN
cord-005453-4057qib7	8962	6	MDRO	MDRO	NNP
cord-005453-4057qib7	8962	7	,	,	,
cord-005453-4057qib7	8962	8	patients	patient	NNS
cord-005453-4057qib7	8962	9	were	be	VBD
cord-005453-4057qib7	8962	10	isolated	isolate	VBN
cord-005453-4057qib7	8962	11	and	and	CC
cord-005453-4057qib7	8962	12	infection	infection	NN
cord-005453-4057qib7	8962	13	control	control	NN
cord-005453-4057qib7	8962	14	strategies	strategy	NNS
cord-005453-4057qib7	8962	15	were	be	VBD
cord-005453-4057qib7	8962	16	applied	apply	VBN
cord-005453-4057qib7	8962	17	.	.	.
cord-005453-4057qib7	8963	1	Results	result	NNS
cord-005453-4057qib7	8963	2	:	:	:
cord-005453-4057qib7	8964	1	67	67	CD
cord-005453-4057qib7	8964	2	patients	patient	NNS
cord-005453-4057qib7	8964	3	were	be	VBD
cord-005453-4057qib7	8964	4	analysed	analyse	VBN
cord-005453-4057qib7	8964	5	,	,	,
cord-005453-4057qib7	8964	6	median	median	JJ
cord-005453-4057qib7	8964	7	age	age	NN
cord-005453-4057qib7	8964	8	53	53	CD
cord-005453-4057qib7	8964	9	years	year	NNS
cord-005453-4057qib7	8964	10	(	(	-LRB-
cord-005453-4057qib7	8964	11	18	18	CD
cord-005453-4057qib7	8964	12	-	-	SYM
cord-005453-4057qib7	8964	13	70	70	CD
cord-005453-4057qib7	8964	14	)	)	-RRB-
cord-005453-4057qib7	8964	15	.	.	.
cord-005453-4057qib7	8965	1	65	65	CD
cord-005453-4057qib7	8965	2	%	%	NN
cord-005453-4057qib7	8965	3	were	be	VBD
cord-005453-4057qib7	8965	4	male	male	JJ
cord-005453-4057qib7	8965	5	(	(	-LRB-
cord-005453-4057qib7	8965	6	n=44	n=44	NNP
cord-005453-4057qib7	8965	7	)	)	-RRB-
cord-005453-4057qib7	8965	8	.	.	.
cord-005453-4057qib7	8966	1	Median	median	JJ
cord-005453-4057qib7	8966	2	duration	duration	NN
cord-005453-4057qib7	8966	3	of	of	IN
cord-005453-4057qib7	8966	4	hospitalization	hospitalization	NN
cord-005453-4057qib7	8966	5	was	be	VBD
cord-005453-4057qib7	8966	6	30	30	CD
cord-005453-4057qib7	8966	7	days(16	days(16	NNP
cord-005453-4057qib7	8966	8	-	-	HYPH
cord-005453-4057qib7	8966	9	133	133	CD
cord-005453-4057qib7	8966	10	)	)	-RRB-
cord-005453-4057qib7	8966	11	.	.	.
cord-005453-4057qib7	8967	1	293	293	CD
cord-005453-4057qib7	8967	2	swabs	swab	NNS
cord-005453-4057qib7	8967	3	were	be	VBD
cord-005453-4057qib7	8967	4	performed	perform	VBN
cord-005453-4057qib7	8967	5	,	,	,
cord-005453-4057qib7	8967	6	with	with	IN
cord-005453-4057qib7	8967	7	a	a	DT
cord-005453-4057qib7	8967	8	median	median	NN
cord-005453-4057qib7	8967	9	of	of	IN
cord-005453-4057qib7	8967	10	4	4	CD
cord-005453-4057qib7	8967	11	swaps	swap	NNS
cord-005453-4057qib7	8967	12	/	/	SYM
cord-005453-4057qib7	8967	13	patient	patient	NN
cord-005453-4057qib7	8967	14	(	(	-LRB-
cord-005453-4057qib7	8967	15	1	1	CD
cord-005453-4057qib7	8967	16	)	)	-RRB-
cord-005453-4057qib7	8967	17	(	(	-LRB-
cord-005453-4057qib7	8967	18	2	2	LS
cord-005453-4057qib7	8967	19	)	)	-RRB-
cord-005453-4057qib7	8967	20	(	(	-LRB-
cord-005453-4057qib7	8967	21	3	3	LS
cord-005453-4057qib7	8967	22	)	)	-RRB-
cord-005453-4057qib7	8967	23	(	(	-LRB-
cord-005453-4057qib7	8967	24	4	4	LS
cord-005453-4057qib7	8967	25	)	)	-RRB-
cord-005453-4057qib7	8967	26	(	(	-LRB-
cord-005453-4057qib7	8967	27	5	5	LS
cord-005453-4057qib7	8967	28	)	)	-RRB-
cord-005453-4057qib7	8967	29	(	(	-LRB-
cord-005453-4057qib7	8967	30	6	6	LS
cord-005453-4057qib7	8967	31	)	)	-RRB-
cord-005453-4057qib7	8967	32	(	(	-LRB-
cord-005453-4057qib7	8967	33	7	7	CD
cord-005453-4057qib7	8967	34	)	)	-RRB-
cord-005453-4057qib7	8968	1	(	(	-LRB-
cord-005453-4057qib7	8968	2	8)	8)	NNP
cord-005453-4057qib7	8968	3	(	(	-LRB-
cord-005453-4057qib7	8968	4	9	9	CD
cord-005453-4057qib7	8968	5	)	)	-RRB-
cord-005453-4057qib7	8968	6	(	(	-LRB-
cord-005453-4057qib7	8968	7	10	10	CD
cord-005453-4057qib7	8968	8	)	)	-RRB-
cord-005453-4057qib7	8968	9	(	(	-LRB-
cord-005453-4057qib7	8968	10	11	11	CD
cord-005453-4057qib7	8968	11	)	)	-RRB-
cord-005453-4057qib7	8968	12	(	(	-LRB-
cord-005453-4057qib7	8968	13	12	12	CD
cord-005453-4057qib7	8968	14	)	)	-RRB-
cord-005453-4057qib7	8968	15	(	(	-LRB-
cord-005453-4057qib7	8968	16	13	13	CD
cord-005453-4057qib7	8968	17	)	)	-RRB-
cord-005453-4057qib7	8968	18	(	(	-LRB-
cord-005453-4057qib7	8968	19	14	14	CD
cord-005453-4057qib7	8968	20	)	)	-RRB-
cord-005453-4057qib7	8968	21	(	(	-LRB-
cord-005453-4057qib7	8968	22	15	15	CD
cord-005453-4057qib7	8968	23	)	)	-RRB-
cord-005453-4057qib7	8968	24	(	(	-LRB-
cord-005453-4057qib7	8968	25	16	16	CD
cord-005453-4057qib7	8968	26	)	)	-RRB-
cord-005453-4057qib7	8968	27	(	(	-LRB-
cord-005453-4057qib7	8968	28	17	17	CD
cord-005453-4057qib7	8968	29	)	)	-RRB-
cord-005453-4057qib7	8968	30	.	.	.
cord-005453-4057qib7	8969	1	Patient	patient	JJ
cord-005453-4057qib7	8969	2	characteristics	characteristic	NNS
cord-005453-4057qib7	8969	3	are	be	VBP
cord-005453-4057qib7	8969	4	shown	show	VBN
cord-005453-4057qib7	8969	5	in	in	IN
cord-005453-4057qib7	8969	6	Table	Table	NNP
cord-005453-4057qib7	8969	7	1	1	CD
cord-005453-4057qib7	8969	8	.	.	.
cord-005453-4057qib7	8970	1	60	60	CD
cord-005453-4057qib7	8970	2	patients	patient	NNS
cord-005453-4057qib7	8970	3	(	(	-LRB-
cord-005453-4057qib7	8970	4	90	90	CD
cord-005453-4057qib7	8970	5	%	%	NN
cord-005453-4057qib7	8970	6	)	)	-RRB-
cord-005453-4057qib7	8970	7	spiked	spiked	JJ
cord-005453-4057qib7	8970	8	fever	fever	NN
cord-005453-4057qib7	8970	9	in	in	IN
cord-005453-4057qib7	8970	10	a	a	DT
cord-005453-4057qib7	8970	11	median	median	NN
cord-005453-4057qib7	8970	12	of	of	IN
cord-005453-4057qib7	8970	13	9	9	CD
cord-005453-4057qib7	8970	14	days	day	NNS
cord-005453-4057qib7	8970	15	after	after	IN
cord-005453-4057qib7	8970	16	admission	admission	NN
cord-005453-4057qib7	8970	17	.	.	.
cord-005453-4057qib7	8971	1	13	13	CD
cord-005453-4057qib7	8971	2	%	%	NN
cord-005453-4057qib7	8971	3	(	(	-LRB-
cord-005453-4057qib7	8971	4	n=9	n=9	NN
cord-005453-4057qib7	8971	5	)	)	-RRB-
cord-005453-4057qib7	8971	6	had	have	VBD
cord-005453-4057qib7	8971	7	previous	previous	JJ
cord-005453-4057qib7	8971	8	documented	document	VBN
cord-005453-4057qib7	8971	9	MDRO	MDRO	NNP
cord-005453-4057qib7	8971	10	colonization	colonization	NN
cord-005453-4057qib7	8971	11	.	.	.
cord-005453-4057qib7	8972	1	Median	median	JJ
cord-005453-4057qib7	8972	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	8972	3	engraftment	engraftment	NN
cord-005453-4057qib7	8972	4	was	be	VBD
cord-005453-4057qib7	8972	5	15	15	CD
cord-005453-4057qib7	8972	6	days	day	NNS
cord-005453-4057qib7	8972	7	(	(	-LRB-
cord-005453-4057qib7	8972	8	95%CI	95%ci	CD
cord-005453-4057qib7	8972	9	14	14	CD
cord-005453-4057qib7	8972	10	-	-	SYM
cord-005453-4057qib7	8972	11	15	15	CD
cord-005453-4057qib7	8972	12	)	)	-RRB-
cord-005453-4057qib7	8972	13	,	,	.
cord-005453-4057qib7	8973	1	In	in	IN
cord-005453-4057qib7	8973	2	24	24	CD
cord-005453-4057qib7	8973	3	%	%	NN
cord-005453-4057qib7	8973	4	patients	patient	NNS
cord-005453-4057qib7	8973	5	(	(	-LRB-
cord-005453-4057qib7	8973	6	n=16	n=16	NNP
cord-005453-4057qib7	8973	7	)	)	-RRB-
cord-005453-4057qib7	8973	8	of	of	IN
cord-005453-4057qib7	8973	9	patients	patient	NNS
cord-005453-4057qib7	8973	10	had	have	VBD
cord-005453-4057qib7	8973	11	a	a	DT
cord-005453-4057qib7	8973	12	positive	positive	JJ
cord-005453-4057qib7	8973	13	screen	screen	NN
cord-005453-4057qib7	8973	14	:	:	:
cord-005453-4057qib7	8973	15	in	in	IN
cord-005453-4057qib7	8973	16	8	8	CD
cord-005453-4057qib7	8973	17	(	(	-LRB-
cord-005453-4057qib7	8973	18	50	50	CD
cord-005453-4057qib7	8973	19	%	%	NN
cord-005453-4057qib7	8973	20	)	)	-RRB-
cord-005453-4057qib7	8973	21	patients	patient	NNS
cord-005453-4057qib7	8973	22	at	at	IN
cord-005453-4057qib7	8973	23	baseline	baseline	NN
cord-005453-4057qib7	8973	24	and	and	CC
cord-005453-4057qib7	8973	25	in	in	IN
cord-005453-4057qib7	8973	26	8	8	CD
cord-005453-4057qib7	8973	27	(	(	-LRB-
cord-005453-4057qib7	8973	28	50	50	CD
cord-005453-4057qib7	8973	29	%	%	NN
cord-005453-4057qib7	8973	30	)	)	-RRB-
cord-005453-4057qib7	8973	31	patients	patient	NNS
cord-005453-4057qib7	8973	32	were	be	VBD
cord-005453-4057qib7	8973	33	detected	detect	VBN
cord-005453-4057qib7	8973	34	for	for	IN
cord-005453-4057qib7	8973	35	the	the	DT
cord-005453-4057qib7	8973	36	first	first	JJ
cord-005453-4057qib7	8973	37	time	time	NN
cord-005453-4057qib7	8973	38	beyond	beyond	IN
cord-005453-4057qib7	8973	39	baseline	baseline	JJ
cord-005453-4057qib7	8973	40	screen	screen	NN
cord-005453-4057qib7	8973	41	.	.	.
cord-005453-4057qib7	8974	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	8974	2	incidence	incidence	NN
cord-005453-4057qib7	8974	3	of	of	IN
cord-005453-4057qib7	8974	4	colonization	colonization	NN
cord-005453-4057qib7	8974	5	at	at	IN
cord-005453-4057qib7	8974	6	7	7	CD
cord-005453-4057qib7	8974	7	days	day	NNS
cord-005453-4057qib7	8974	8	was	be	VBD
cord-005453-4057qib7	8974	9	10.4	10.4	CD
cord-005453-4057qib7	8974	10	%	%	NN
cord-005453-4057qib7	8974	11	(	(	-LRB-
cord-005453-4057qib7	8974	12	95%CI	95%ci	CD
cord-005453-4057qib7	8974	13	3.2	3.2	CD
cord-005453-4057qib7	8974	14	-	-	HYPH
cord-005453-4057qib7	8974	15	17.6	17.6	CD
cord-005453-4057qib7	8974	16	)	)	-RRB-
cord-005453-4057qib7	8974	17	,	,	,
cord-005453-4057qib7	8974	18	at	at	IN
cord-005453-4057qib7	8974	19	15	15	CD
cord-005453-4057qib7	8974	20	days	day	NNS
cord-005453-4057qib7	8974	21	18	18	CD
cord-005453-4057qib7	8974	22	%	%	NN
cord-005453-4057qib7	8974	23	(	(	-LRB-
cord-005453-4057qib7	8974	24	95%CI	95%ci	CD
cord-005453-4057qib7	8974	25	8.2	8.2	CD
cord-005453-4057qib7	8974	26	-	-	HYPH
cord-005453-4057qib7	8974	27	27.8	27.8	CD
cord-005453-4057qib7	8974	28	)	)	-RRB-
cord-005453-4057qib7	8974	29	,	,	,
cord-005453-4057qib7	8974	30	and	and	CC
cord-005453-4057qib7	8974	31	at	at	IN
cord-005453-4057qib7	8974	32	30	30	CD
cord-005453-4057qib7	8974	33	days	day	NNS
cord-005453-4057qib7	8974	34	19.5	19.5	CD
cord-005453-4057qib7	8974	35	%	%	NN
cord-005453-4057qib7	8974	36	(	(	-LRB-
cord-005453-4057qib7	8974	37	9.9	9.9	CD
cord-005453-4057qib7	8974	38	-	-	SYM
cord-005453-4057qib7	8974	39	29.1	29.1	CD
cord-005453-4057qib7	8974	40	%	%	NN
cord-005453-4057qib7	8974	41	)	)	-RRB-
cord-005453-4057qib7	8974	42	(	(	-LRB-
cord-005453-4057qib7	8974	43	Figure	figure	NN
cord-005453-4057qib7	8974	44	1	1	CD
cord-005453-4057qib7	8974	45	)	)	-RRB-
cord-005453-4057qib7	8974	46	.	.	.
cord-005453-4057qib7	8975	1	MDRO	MDRO	NNP
cord-005453-4057qib7	8975	2	identified	identify	VBD
cord-005453-4057qib7	8975	3	were	be	VBD
cord-005453-4057qib7	8975	4	:	:	:
cord-005453-4057qib7	8975	5	8	8	CD
cord-005453-4057qib7	8975	6	with	with	IN
cord-005453-4057qib7	8975	7	extended	extend	VBN
cord-005453-4057qib7	8975	8	-	-	HYPH
cord-005453-4057qib7	8975	9	spectrum	spectrum	NN
cord-005453-4057qib7	8975	10	beta	beta	NN
cord-005453-4057qib7	8975	11	-	-	HYPH
cord-005453-4057qib7	8975	12	lactamases	lactamase	NNS
cord-005453-4057qib7	8975	13	producing	produce	VBG
cord-005453-4057qib7	8975	14	E.	E.	NNP
cord-005453-4057qib7	8975	15	Coli	Coli	NNP
cord-005453-4057qib7	8975	16	(	(	-LRB-
cord-005453-4057qib7	8975	17	ESBL	ESBL	NNP
cord-005453-4057qib7	8975	18	-	-	HYPH
cord-005453-4057qib7	8975	19	EC	EC	NNP
cord-005453-4057qib7	8975	20	)	)	-RRB-
cord-005453-4057qib7	8975	21	,	,	,
cord-005453-4057qib7	8975	22	4	4	CD
cord-005453-4057qib7	8975	23	multidrug	multidrug	NN
cord-005453-4057qib7	8975	24	-	-	HYPH
cord-005453-4057qib7	8975	25	resistant	resistant	JJ
cord-005453-4057qib7	8975	26	Pseudomonas	Pseudomonas	NNP
cord-005453-4057qib7	8975	27	aeruginosa	aeruginosa	NN
cord-005453-4057qib7	8975	28	(	(	-LRB-
cord-005453-4057qib7	8975	29	MR	MR	NNP
cord-005453-4057qib7	8975	30	-	-	HYPH
cord-005453-4057qib7	8975	31	PS	PS	NNP
cord-005453-4057qib7	8975	32	)	)	-RRB-
cord-005453-4057qib7	8975	33	,	,	,
cord-005453-4057qib7	8975	34	3	3	CD
cord-005453-4057qib7	8975	35	vancomycin	vancomycin	NN
cord-005453-4057qib7	8975	36	resistant	resistant	JJ
cord-005453-4057qib7	8975	37	Enterococci	Enterococci	NNP
cord-005453-4057qib7	8975	38	(	(	-LRB-
cord-005453-4057qib7	8975	39	VRE	VRE	NNP
cord-005453-4057qib7	8975	40	)	)	-RRB-
cord-005453-4057qib7	8975	41	and	and	CC
cord-005453-4057qib7	8975	42	1	1	CD
cord-005453-4057qib7	8975	43	patient	patient	NN
cord-005453-4057qib7	8975	44	with	with	IN
cord-005453-4057qib7	8976	1	carbapenemaseproducing	carbapenemaseproduce	VBG
cord-005453-4057qib7	8976	2	(	(	-LRB-
cord-005453-4057qib7	8976	3	CP	CP	NNP
cord-005453-4057qib7	8976	4	)	)	-RRB-
cord-005453-4057qib7	8976	5	Citrobacter	Citrobacter	NNP
cord-005453-4057qib7	8976	6	freundii	freundii	NNP
cord-005453-4057qib7	8976	7	.	.	.
cord-005453-4057qib7	8977	1	7/16	7/16	CD
cord-005453-4057qib7	8977	2	colonized	colonize	VBN
cord-005453-4057qib7	8977	3	patients	patient	NNS
cord-005453-4057qib7	8977	4	developed	develop	VBD
cord-005453-4057qib7	8977	5	MDRO	MDRO	NNP
cord-005453-4057qib7	8977	6	infection	infection	NN
cord-005453-4057qib7	8977	7	(	(	-LRB-
cord-005453-4057qib7	8977	8	44	44	CD
cord-005453-4057qib7	8977	9	%	%	NN
cord-005453-4057qib7	8977	10	)	)	-RRB-
cord-005453-4057qib7	8978	1	:	:	:
cord-005453-4057qib7	8978	2	4	4	CD
cord-005453-4057qib7	8978	3	patients	patient	NNS
cord-005453-4057qib7	8978	4	MR	MR	NNP
cord-005453-4057qib7	8978	5	-	-	HYPH
cord-005453-4057qib7	8978	6	PS	PS	NNP
cord-005453-4057qib7	8978	7	,	,	,
cord-005453-4057qib7	8978	8	site	site	NN
cord-005453-4057qib7	8978	9	of	of	IN
cord-005453-4057qib7	8978	10	infection	infection	NN
cord-005453-4057qib7	8978	11	was	be	VBD
cord-005453-4057qib7	8978	12	2	2	CD
cord-005453-4057qib7	8978	13	urinary	urinary	JJ
cord-005453-4057qib7	8978	14	tract	tract	NN
cord-005453-4057qib7	8978	15	infection	infection	NN
cord-005453-4057qib7	8978	16	(	(	-LRB-
cord-005453-4057qib7	8978	17	UTI	UTI	NNP
cord-005453-4057qib7	8978	18	)	)	-RRB-
cord-005453-4057qib7	8978	19	,	,	,
cord-005453-4057qib7	8978	20	1	1	CD
cord-005453-4057qib7	8978	21	urethritis	urethritis	NN
cord-005453-4057qib7	8978	22	,	,	,
cord-005453-4057qib7	8978	23	1	1	CD
cord-005453-4057qib7	8978	24	genital	genital	JJ
cord-005453-4057qib7	8978	25	ulcer	ulcer	NN
cord-005453-4057qib7	8978	26	.	.	.
cord-005453-4057qib7	8979	1	Two	two	CD
cord-005453-4057qib7	8979	2	patients	patient	NNS
cord-005453-4057qib7	8979	3	were	be	VBD
cord-005453-4057qib7	8979	4	treated	treat	VBN
cord-005453-4057qib7	8979	5	with	with	IN
cord-005453-4057qib7	8979	6	ceftolozane/	ceftolozane/	CD
cord-005453-4057qib7	8979	7	tazobactam	tazobactam	NNS
cord-005453-4057qib7	8979	8	,	,	,
cord-005453-4057qib7	8979	9	1	1	CD
cord-005453-4057qib7	8979	10	with	with	IN
cord-005453-4057qib7	8979	11	meropenem+amikacin;2	meropenem+amikacin;2	NNP
cord-005453-4057qib7	8979	12	patients	patient	NNS
cord-005453-4057qib7	8979	13	ESBL	ESBL	NNP
cord-005453-4057qib7	8979	14	-	-	HYPH
cord-005453-4057qib7	8979	15	EC	EC	NNP
cord-005453-4057qib7	8979	16	both	both	CC
cord-005453-4057qib7	8979	17	UTI	UTI	NNP
cord-005453-4057qib7	8979	18	treated	treat	VBD
cord-005453-4057qib7	8979	19	with	with	IN
cord-005453-4057qib7	8979	20	meropenem	meropenem	NNP
cord-005453-4057qib7	8979	21	;	;	:
cord-005453-4057qib7	8979	22	1	1	CD
cord-005453-4057qib7	8979	23	patient	patient	NN
cord-005453-4057qib7	8979	24	CPcitrobacter	CPcitrobacter	NNP
cord-005453-4057qib7	8979	25	freundii	freundii	JJ
cord-005453-4057qib7	8979	26	UTI	UTI	NNP
cord-005453-4057qib7	8979	27	treated	treat	VBN
cord-005453-4057qib7	8979	28	with	with	IN
cord-005453-4057qib7	8979	29	ceftazidime	ceftazidime	NNP
cord-005453-4057qib7	8979	30	/	/	SYM
cord-005453-4057qib7	8979	31	avibactam	avibactam	NNS
cord-005453-4057qib7	8979	32	.	.	.
cord-005453-4057qib7	8980	1	In	in	IN
cord-005453-4057qib7	8980	2	75	75	CD
cord-005453-4057qib7	8980	3	%	%	NN
cord-005453-4057qib7	8980	4	patients	patient	NNS
cord-005453-4057qib7	8980	5	(	(	-LRB-
cord-005453-4057qib7	8980	6	12/16	12/16	CD
cord-005453-4057qib7	8980	7	)	)	-RRB-
cord-005453-4057qib7	8980	8	antibiotic	antibiotic	JJ
cord-005453-4057qib7	8980	9	treatment	treatment	NN
cord-005453-4057qib7	8980	10	at	at	IN
cord-005453-4057qib7	8980	11	febrile	febrile	JJ
cord-005453-4057qib7	8980	12	episode	episode	NN
cord-005453-4057qib7	8980	13	was	be	VBD
cord-005453-4057qib7	8980	14	guided	guide	VBN
cord-005453-4057qib7	8980	15	by	by	IN
cord-005453-4057qib7	8980	16	positive	positive	JJ
cord-005453-4057qib7	8980	17	screening	screening	NN
cord-005453-4057qib7	8980	18	.	.	.
cord-005453-4057qib7	8981	1	No	no	DT
cord-005453-4057qib7	8981	2	MDRO	MDRO	NNP
cord-005453-4057qib7	8981	3	related	relate	VBD
cord-005453-4057qib7	8981	4	ICU	ICU	NNP
cord-005453-4057qib7	8981	5	admission	admission	NN
cord-005453-4057qib7	8981	6	or	or	CC
cord-005453-4057qib7	8981	7	mortality	mortality	NN
cord-005453-4057qib7	8981	8	was	be	VBD
cord-005453-4057qib7	8981	9	observed	observe	VBN
cord-005453-4057qib7	8981	10	.	.	.
cord-005453-4057qib7	8982	1	In	in	IN
cord-005453-4057qib7	8982	2	76	76	CD
cord-005453-4057qib7	8982	3	%	%	NN
cord-005453-4057qib7	8982	4	patients	patient	NNS
cord-005453-4057qib7	8982	5	(	(	-LRB-
cord-005453-4057qib7	8982	6	n=51	n=51	NNP
cord-005453-4057qib7	8982	7	)	)	-RRB-
cord-005453-4057qib7	8982	8	Background	background	NN
cord-005453-4057qib7	8982	9	:	:	:
cord-005453-4057qib7	8982	10	Hepatitis	hepatitis	NN
cord-005453-4057qib7	8982	11	E	e	NN
cord-005453-4057qib7	8982	12	virus	virus	NN
cord-005453-4057qib7	8982	13	(	(	-LRB-
cord-005453-4057qib7	8982	14	HEV	hev	NN
cord-005453-4057qib7	8982	15	)	)	-RRB-
cord-005453-4057qib7	8982	16	can	can	MD
cord-005453-4057qib7	8982	17	cause	cause	VB
cord-005453-4057qib7	8982	18	chronic	chronic	JJ
cord-005453-4057qib7	8982	19	infection	infection	NN
cord-005453-4057qib7	8982	20	and	and	CC
cord-005453-4057qib7	8982	21	liver	liver	NN
cord-005453-4057qib7	8982	22	cirrhosis	cirrhosis	NN
cord-005453-4057qib7	8982	23	in	in	IN
cord-005453-4057qib7	8982	24	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	8982	25	individuals	individual	NNS
cord-005453-4057qib7	8982	26	.	.	.
cord-005453-4057qib7	8983	1	There	there	EX
cord-005453-4057qib7	8983	2	is	be	VBZ
cord-005453-4057qib7	8983	3	limited	limited	JJ
cord-005453-4057qib7	8983	4	data	datum	NNS
cord-005453-4057qib7	8983	5	on	on	IN
cord-005453-4057qib7	8983	6	HEV	HEV	NNP
cord-005453-4057qib7	8983	7	infections	infection	NNS
cord-005453-4057qib7	8983	8	in	in	IN
cord-005453-4057qib7	8983	9	patients	patient	NNS
cord-005453-4057qib7	8983	10	undergoing	undergo	VBG
cord-005453-4057qib7	8983	11	allogeneic	allogeneic	IN
cord-005453-4057qib7	8983	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	8983	13	stem	stem	NN
cord-005453-4057qib7	8983	14	cell	cell	NN
cord-005453-4057qib7	8983	15	transplantation	transplantation	NN
cord-005453-4057qib7	8983	16	(	(	-LRB-
cord-005453-4057qib7	8983	17	HSCT	HSCT	NNP
cord-005453-4057qib7	8983	18	)	)	-RRB-
cord-005453-4057qib7	8983	19	.	.	.
cord-005453-4057qib7	8984	1	The	the	DT
cord-005453-4057qib7	8984	2	aim	aim	NN
cord-005453-4057qib7	8984	3	of	of	IN
cord-005453-4057qib7	8984	4	this	this	DT
cord-005453-4057qib7	8984	5	study	study	NN
cord-005453-4057qib7	8984	6	was	be	VBD
cord-005453-4057qib7	8984	7	to	to	TO
cord-005453-4057qib7	8984	8	investigate	investigate	VB
cord-005453-4057qib7	8984	9	the	the	DT
cord-005453-4057qib7	8984	10	frequency	frequency	NN
cord-005453-4057qib7	8984	11	and	and	CC
cord-005453-4057qib7	8984	12	clinical	clinical	JJ
cord-005453-4057qib7	8984	13	importance	importance	NN
cord-005453-4057qib7	8984	14	of	of	IN
cord-005453-4057qib7	8984	15	HEV	HEV	NNP
cord-005453-4057qib7	8984	16	in	in	IN
cord-005453-4057qib7	8984	17	a	a	DT
cord-005453-4057qib7	8984	18	Swedish	swedish	JJ
cord-005453-4057qib7	8984	19	cohort	cohort	NN
cord-005453-4057qib7	8984	20	of	of	IN
cord-005453-4057qib7	8984	21	HSCT	HSCT	NNP
cord-005453-4057qib7	8984	22	recipients	recipient	NNS
cord-005453-4057qib7	8984	23	.	.	.
cord-005453-4057qib7	8985	1	Methods	method	NNS
cord-005453-4057qib7	8985	2	:	:	:
cord-005453-4057qib7	8985	3	We	-PRON-	PRP
cord-005453-4057qib7	8985	4	analyzed	analyze	VBD
cord-005453-4057qib7	8985	5	serum	serum	NN
cord-005453-4057qib7	8985	6	samples	sample	NNS
cord-005453-4057qib7	8985	7	from	from	IN
cord-005453-4057qib7	8985	8	262	262	CD
cord-005453-4057qib7	8985	9	HSCT	HSCT	NNP
cord-005453-4057qib7	8985	10	patients	patient	NNS
cord-005453-4057qib7	8985	11	(	(	-LRB-
cord-005453-4057qib7	8985	12	241	241	CD
cord-005453-4057qib7	8985	13	adults	adult	NNS
cord-005453-4057qib7	8985	14	and	and	CC
cord-005453-4057qib7	8985	15	21	21	CD
cord-005453-4057qib7	8985	16	children	child	NNS
cord-005453-4057qib7	8985	17	)	)	-RRB-
cord-005453-4057qib7	8985	18	,	,	,
cord-005453-4057qib7	8985	19	collected	collect	VBN
cord-005453-4057qib7	8985	20	6	6	CD
cord-005453-4057qib7	8985	21	months	month	NNS
cord-005453-4057qib7	8985	22	after	after	IN
cord-005453-4057qib7	8985	23	HSCT	HSCT	NNP
cord-005453-4057qib7	8985	24	.	.	.
cord-005453-4057qib7	8986	1	HEV	HEV	NNP
cord-005453-4057qib7	8986	2	IgG	IgG	NNP
cord-005453-4057qib7	8986	3	and	and	CC
cord-005453-4057qib7	8986	4	IgM	IgM	NNP
cord-005453-4057qib7	8986	5	were	be	VBD
cord-005453-4057qib7	8986	6	detected	detect	VBN
cord-005453-4057qib7	8986	7	by	by	IN
cord-005453-4057qib7	8986	8	ELISA	ELISA	NNP
cord-005453-4057qib7	8986	9	(	(	-LRB-
cord-005453-4057qib7	8986	10	Dia	Dia	NNP
cord-005453-4057qib7	8986	11	.	.	.
cord-005453-4057qib7	8987	1	Pro	Pro	NNP
cord-005453-4057qib7	8987	2	®	®	NNP
cord-005453-4057qib7	8987	3	)	)	-RRB-
cord-005453-4057qib7	8987	4	,	,	,
cord-005453-4057qib7	8987	5	HEV	HEV	NNP
cord-005453-4057qib7	8987	6	RNA	RNA	NNP
cord-005453-4057qib7	8987	7	by	by	IN
cord-005453-4057qib7	8987	8	reverse	reverse	JJ
cord-005453-4057qib7	8987	9	transcriptase	transcriptase	NN
cord-005453-4057qib7	8987	10	PCR	pcr	NN
cord-005453-4057qib7	8987	11	,	,	,
cord-005453-4057qib7	8987	12	and	and	CC
cord-005453-4057qib7	8987	13	quantification	quantification	NN
cord-005453-4057qib7	8987	14	of	of	IN
cord-005453-4057qib7	8987	15	HEV	HEV	NNP
cord-005453-4057qib7	8987	16	RNA	RNA	NNP
cord-005453-4057qib7	8987	17	was	be	VBD
cord-005453-4057qib7	8987	18	performed	perform	VBN
cord-005453-4057qib7	8987	19	by	by	IN
cord-005453-4057qib7	8987	20	digital	digital	JJ
cord-005453-4057qib7	8987	21	PCR	PCR	NNP
cord-005453-4057qib7	8987	22	.	.	.
cord-005453-4057qib7	8988	1	In	in	IN
cord-005453-4057qib7	8988	2	all	all	DT
cord-005453-4057qib7	8988	3	patients	patient	NNS
cord-005453-4057qib7	8988	4	,	,	,
cord-005453-4057qib7	8988	5	who	who	WP
cord-005453-4057qib7	8988	6	were	be	VBD
cord-005453-4057qib7	8988	7	positive	positive	JJ
cord-005453-4057qib7	8988	8	for	for	IN
cord-005453-4057qib7	8988	9	HEV	HEV	NNP
cord-005453-4057qib7	8988	10	-	-	HYPH
cord-005453-4057qib7	8988	11	RNA	RNA	NNP
cord-005453-4057qib7	8988	12	and/or	and/or	CC
cord-005453-4057qib7	8988	13	serology	serology	NN
cord-005453-4057qib7	8988	14	at	at	IN
cord-005453-4057qib7	8988	15	6	6	CD
cord-005453-4057qib7	8988	16	months	month	NNS
cord-005453-4057qib7	8988	17	,	,	,
cord-005453-4057qib7	8988	18	also	also	RB
cord-005453-4057qib7	8988	19	samples	sample	NNS
cord-005453-4057qib7	8988	20	collected	collect	VBN
cord-005453-4057qib7	8988	21	at	at	IN
cord-005453-4057qib7	8988	22	the	the	DT
cord-005453-4057qib7	8988	23	time	time	NN
cord-005453-4057qib7	8988	24	of	of	IN
cord-005453-4057qib7	8988	25	HSCT	HSCT	NNP
cord-005453-4057qib7	8988	26	from	from	IN
cord-005453-4057qib7	8988	27	both	both	CC
cord-005453-4057qib7	8988	28	the	the	DT
cord-005453-4057qib7	8988	29	patients	patient	NNS
cord-005453-4057qib7	8988	30	and	and	CC
cord-005453-4057qib7	8988	31	their	-PRON-	PRP$
cord-005453-4057qib7	8988	32	donors	donor	NNS
cord-005453-4057qib7	8988	33	were	be	VBD
cord-005453-4057qib7	8988	34	analyzed	analyze	VBN
cord-005453-4057qib7	8988	35	.	.	.
cord-005453-4057qib7	8989	1	In	in	IN
cord-005453-4057qib7	8989	2	the	the	DT
cord-005453-4057qib7	8989	3	HEV	HEV	NNP
cord-005453-4057qib7	8989	4	RNA	RNA	NNP
cord-005453-4057qib7	8989	5	positive	positive	JJ
cord-005453-4057qib7	8989	6	patients	patient	NNS
cord-005453-4057qib7	8989	7	,	,	,
cord-005453-4057qib7	8989	8	additional	additional	JJ
cord-005453-4057qib7	8989	9	samples	sample	NNS
cord-005453-4057qib7	8989	10	were	be	VBD
cord-005453-4057qib7	8989	11	analyzed	analyze	VBN
cord-005453-4057qib7	8989	12	to	to	TO
cord-005453-4057qib7	8989	13	determine	determine	VB
cord-005453-4057qib7	8989	14	the	the	DT
cord-005453-4057qib7	8989	15	duration	duration	NN
cord-005453-4057qib7	8989	16	of	of	IN
cord-005453-4057qib7	8989	17	viremia	viremia	NN
cord-005453-4057qib7	8989	18	.	.	.
cord-005453-4057qib7	8990	1	Three	three	CD
cord-005453-4057qib7	8990	2	HEV	HEV	NNP
cord-005453-4057qib7	8990	3	RNA	RNA	NNP
cord-005453-4057qib7	8990	4	negative	negative	JJ
cord-005453-4057qib7	8990	5	controls	control	NNS
cord-005453-4057qib7	8990	6	were	be	VBD
cord-005453-4057qib7	8990	7	selected	select	VBN
cord-005453-4057qib7	8990	8	for	for	IN
cord-005453-4057qib7	8990	9	each	each	DT
cord-005453-4057qib7	8990	10	case	case	NN
cord-005453-4057qib7	8990	11	of	of	IN
cord-005453-4057qib7	8990	12	HEV	HEV	NNP
cord-005453-4057qib7	8990	13	infection	infection	NN
cord-005453-4057qib7	8990	14	,	,	,
cord-005453-4057qib7	8990	15	matched	match	VBN
cord-005453-4057qib7	8990	16	for	for	IN
cord-005453-4057qib7	8990	17	age	age	NN
cord-005453-4057qib7	8990	18	,	,	,
cord-005453-4057qib7	8990	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	8990	20	,	,	,
cord-005453-4057qib7	8990	21	conditioning	conditioning	NN
cord-005453-4057qib7	8990	22	regimen	regimen	NN
cord-005453-4057qib7	8990	23	and	and	CC
cord-005453-4057qib7	8990	24	donor	donor	NN
cord-005453-4057qib7	8990	25	type	type	NN
cord-005453-4057qib7	8990	26	.	.	.
cord-005453-4057qib7	8991	1	Results	result	NNS
cord-005453-4057qib7	8991	2	:	:	:
cord-005453-4057qib7	8992	1	HEV	HEV	NNP
cord-005453-4057qib7	8992	2	RNA	RNA	NNP
cord-005453-4057qib7	8992	3	was	be	VBD
cord-005453-4057qib7	8992	4	detected	detect	VBN
cord-005453-4057qib7	8992	5	in	in	IN
cord-005453-4057qib7	8992	6	8/262	8/262	CD
cord-005453-4057qib7	8992	7	(	(	-LRB-
cord-005453-4057qib7	8992	8	3.1	3.1	CD
cord-005453-4057qib7	8992	9	%	%	NN
cord-005453-4057qib7	8992	10	)	)	-RRB-
cord-005453-4057qib7	8992	11	patients	patient	NNS
cord-005453-4057qib7	8992	12	.	.	.
cord-005453-4057qib7	8993	1	In	in	IN
cord-005453-4057qib7	8993	2	three	three	CD
cord-005453-4057qib7	8993	3	of	of	IN
cord-005453-4057qib7	8993	4	the	the	DT
cord-005453-4057qib7	8993	5	patients	patient	NNS
cord-005453-4057qib7	8993	6	HEV	HEV	NNP
cord-005453-4057qib7	8993	7	RNA	RNA	NNP
cord-005453-4057qib7	8993	8	was	be	VBD
cord-005453-4057qib7	8993	9	positive	positive	JJ
cord-005453-4057qib7	8993	10	during	during	IN
cord-005453-4057qib7	8993	11	a	a	DT
cord-005453-4057qib7	8993	12	period	period	NN
cord-005453-4057qib7	8993	13	of	of	IN
cord-005453-4057qib7	8993	14	3	3	CD
cord-005453-4057qib7	8993	15	-	-	SYM
cord-005453-4057qib7	8993	16	8	8	CD
cord-005453-4057qib7	8993	17	months	month	NNS
cord-005453-4057qib7	8993	18	,	,	,
cord-005453-4057qib7	8993	19	and	and	CC
cord-005453-4057qib7	8993	20	two	two	CD
cord-005453-4057qib7	8993	21	of	of	IN
cord-005453-4057qib7	8993	22	these	these	DT
cord-005453-4057qib7	8993	23	patients	patient	NNS
cord-005453-4057qib7	8993	24	were	be	VBD
cord-005453-4057qib7	8993	25	infected	infect	VBN
cord-005453-4057qib7	8993	26	already	already	RB
cord-005453-4057qib7	8993	27	at	at	IN
cord-005453-4057qib7	8993	28	the	the	DT
cord-005453-4057qib7	8993	29	time	time	NN
cord-005453-4057qib7	8993	30	of	of	IN
cord-005453-4057qib7	8993	31	HSCT	HSCT	NNP
cord-005453-4057qib7	8993	32	.	.	.
cord-005453-4057qib7	8994	1	In	in	IN
cord-005453-4057qib7	8994	2	five	five	CD
cord-005453-4057qib7	8994	3	patients	patient	NNS
cord-005453-4057qib7	8994	4	HEV	HEV	NNP
cord-005453-4057qib7	8994	5	-	-	HYPH
cord-005453-4057qib7	8994	6	RNA	RNA	NNP
cord-005453-4057qib7	8994	7	was	be	VBD
cord-005453-4057qib7	8994	8	positive	positive	JJ
cord-005453-4057qib7	8994	9	,	,	,
cord-005453-4057qib7	8994	10	at	at	IN
cord-005453-4057qib7	8994	11	a	a	DT
cord-005453-4057qib7	8994	12	low	low	JJ
cord-005453-4057qib7	8994	13	level	level	NN
cord-005453-4057qib7	8994	14	,	,	,
cord-005453-4057qib7	8994	15	only	only	RB
cord-005453-4057qib7	8994	16	at	at	IN
cord-005453-4057qib7	8994	17	6	6	CD
cord-005453-4057qib7	8994	18	months	month	NNS
cord-005453-4057qib7	8994	19	.	.	.
cord-005453-4057qib7	8995	1	11/262	11/262	CD
cord-005453-4057qib7	8995	2	(	(	-LRB-
cord-005453-4057qib7	8995	3	4.2	4.2	CD
cord-005453-4057qib7	8995	4	%	%	NN
cord-005453-4057qib7	8995	5	)	)	-RRB-
cord-005453-4057qib7	8996	1	patients	patient	NNS
cord-005453-4057qib7	8996	2	had	have	VBD
cord-005453-4057qib7	8996	3	detectable	detectable	JJ
cord-005453-4057qib7	8996	4	HEV	HEV	NNP
cord-005453-4057qib7	8996	5	IgG	igg	NN
cord-005453-4057qib7	8996	6	and/or	and/or	CC
cord-005453-4057qib7	8996	7	IgM	IgM	NNP
cord-005453-4057qib7	8996	8	,	,	,
cord-005453-4057qib7	8996	9	whereof	whereof	WP
cord-005453-4057qib7	8996	10	eight	eight	CD
cord-005453-4057qib7	8996	11	patients	patient	NNS
cord-005453-4057qib7	8996	12	were	be	VBD
cord-005453-4057qib7	8996	13	HEV	HEV	NNP
cord-005453-4057qib7	8996	14	RNA	RNA	NNP
cord-005453-4057qib7	8996	15	negative	negative	JJ
cord-005453-4057qib7	8996	16	.	.	.
cord-005453-4057qib7	8997	1	In	in	IN
cord-005453-4057qib7	8997	2	4/8	4/8	CD
cord-005453-4057qib7	8997	3	(	(	-LRB-
cord-005453-4057qib7	8997	4	50	50	CD
cord-005453-4057qib7	8997	5	%	%	NN
cord-005453-4057qib7	8997	6	)	)	-RRB-
cord-005453-4057qib7	8997	7	patients	patient	NNS
cord-005453-4057qib7	8997	8	with	with	IN
cord-005453-4057qib7	8997	9	HEV	HEV	NNP
cord-005453-4057qib7	8997	10	infection	infection	NN
cord-005453-4057qib7	8998	1	(	(	-LRB-
cord-005453-4057qib7	8998	2	HEV	HEV	NNP
cord-005453-4057qib7	8998	3	RNA	RNA	NNP
cord-005453-4057qib7	8998	4	positive	positive	JJ
cord-005453-4057qib7	8998	5	)	)	-RRB-
cord-005453-4057qib7	8998	6	alanine	alanine	JJ
cord-005453-4057qib7	8998	7	aminotransferase	aminotransferase	NN
cord-005453-4057qib7	8998	8	(	(	-LRB-
cord-005453-4057qib7	8998	9	ALT	ALT	NNP
cord-005453-4057qib7	8998	10	)	)	-RRB-
cord-005453-4057qib7	8998	11	was	be	VBD
cord-005453-4057qib7	8998	12	>	>	NFP
cord-005453-4057qib7	8998	13	3	3	CD
cord-005453-4057qib7	8998	14	upper	upper	JJ
cord-005453-4057qib7	8998	15	limit	limit	NN
cord-005453-4057qib7	8998	16	of	of	IN
cord-005453-4057qib7	8998	17	normal	normal	JJ
cord-005453-4057qib7	8998	18	(	(	-LRB-
cord-005453-4057qib7	8998	19	ULN	ULN	NNP
cord-005453-4057qib7	8998	20	)	)	-RRB-
cord-005453-4057qib7	8998	21	,	,	,
cord-005453-4057qib7	8998	22	in	in	IN
cord-005453-4057qib7	8998	23	1/8	1/8	CD
cord-005453-4057qib7	8998	24	(	(	-LRB-
cord-005453-4057qib7	8998	25	12.5	12.5	CD
cord-005453-4057qib7	8998	26	%	%	NN
cord-005453-4057qib7	8998	27	)	)	-RRB-
cord-005453-4057qib7	8998	28	patients	patient	NNS
cord-005453-4057qib7	8998	29	>	>	XX
cord-005453-4057qib7	8998	30	1.5	1.5	CD
cord-005453-4057qib7	8998	31	ULN	ULN	NNP
cord-005453-4057qib7	8998	32	,	,	,
cord-005453-4057qib7	8998	33	and	and	CC
cord-005453-4057qib7	8998	34	in	in	IN
cord-005453-4057qib7	8998	35	3/8	3/8	CD
cord-005453-4057qib7	8998	36	(	(	-LRB-
cord-005453-4057qib7	8998	37	37.5	37.5	CD
cord-005453-4057qib7	8998	38	%	%	NN
cord-005453-4057qib7	8998	39	)	)	-RRB-
cord-005453-4057qib7	8999	1	patients	patient	NNS
cord-005453-4057qib7	8999	2	ALT	ALT	NNP
cord-005453-4057qib7	8999	3	was	be	VBD
cord-005453-4057qib7	8999	4	normal	normal	JJ
cord-005453-4057qib7	8999	5	,	,	,
cord-005453-4057qib7	8999	6	at	at	IN
cord-005453-4057qib7	8999	7	6	6	CD
cord-005453-4057qib7	8999	8	months	month	NNS
cord-005453-4057qib7	8999	9	after	after	IN
cord-005453-4057qib7	8999	10	HSCT	HSCT	NNP
cord-005453-4057qib7	8999	11	.	.	.
cord-005453-4057qib7	9000	1	Bilirubin	bilirubin	NN
cord-005453-4057qib7	9000	2	was	be	VBD
cord-005453-4057qib7	9000	3	elevated	elevate	VBN
cord-005453-4057qib7	9000	4	>	>	XX
cord-005453-4057qib7	9000	5	1.5	1.5	CD
cord-005453-4057qib7	9000	6	ULN	ULN	NNP
cord-005453-4057qib7	9000	7	in	in	IN
cord-005453-4057qib7	9000	8	1/8	1/8	CD
cord-005453-4057qib7	9000	9	(	(	-LRB-
cord-005453-4057qib7	9000	10	12.5	12.5	CD
cord-005453-4057qib7	9000	11	%	%	NN
cord-005453-4057qib7	9000	12	)	)	-RRB-
cord-005453-4057qib7	9000	13	patients	patient	NNS
cord-005453-4057qib7	9000	14	,	,	,
cord-005453-4057qib7	9000	15	and	and	CC
cord-005453-4057qib7	9000	16	>	>	XX
cord-005453-4057qib7	9000	17	3	3	CD
cord-005453-4057qib7	9000	18	ULN	ULN	NNP
cord-005453-4057qib7	9000	19	in	in	IN
cord-005453-4057qib7	9000	20	no	no	DT
cord-005453-4057qib7	9000	21	patient	patient	NN
cord-005453-4057qib7	9000	22	at	at	IN
cord-005453-4057qib7	9000	23	6	6	CD
cord-005453-4057qib7	9000	24	months	month	NNS
cord-005453-4057qib7	9000	25	after	after	IN
cord-005453-4057qib7	9000	26	HSCT	HSCT	NNP
cord-005453-4057qib7	9000	27	.	.	.
cord-005453-4057qib7	9001	1	Two	two	CD
cord-005453-4057qib7	9001	2	patients	patient	NNS
cord-005453-4057qib7	9001	3	died	die	VBD
cord-005453-4057qib7	9001	4	with	with	IN
cord-005453-4057qib7	9001	5	ongoing	ongoing	JJ
cord-005453-4057qib7	9001	6	signs	sign	NNS
cord-005453-4057qib7	9001	7	of	of	IN
cord-005453-4057qib7	9001	8	hepatitis	hepatitis	NN
cord-005453-4057qib7	9001	9	and	and	CC
cord-005453-4057qib7	9001	10	HEV	HEV	NNP
cord-005453-4057qib7	9001	11	RNA	RNA	NNP
cord-005453-4057qib7	9001	12	detected	detect	VBD
cord-005453-4057qib7	9001	13	in	in	IN
cord-005453-4057qib7	9001	14	blood	blood	NN
cord-005453-4057qib7	9001	15	.	.	.
cord-005453-4057qib7	9002	1	One	one	CD
cord-005453-4057qib7	9002	2	of	of	IN
cord-005453-4057qib7	9002	3	them	-PRON-	PRP
cord-005453-4057qib7	9002	4	developed	develop	VBD
cord-005453-4057qib7	9002	5	acute	acute	JJ
cord-005453-4057qib7	9002	6	liver	liver	NN
cord-005453-4057qib7	9002	7	failure	failure	NN
cord-005453-4057qib7	9002	8	,	,	,
cord-005453-4057qib7	9002	9	at	at	IN
cord-005453-4057qib7	9002	10	the	the	DT
cord-005453-4057qib7	9002	11	time	time	NN
cord-005453-4057qib7	9002	12	interpreted	interpret	VBN
cord-005453-4057qib7	9002	13	as	as	IN
cord-005453-4057qib7	9002	14	drug	drug	NN
cord-005453-4057qib7	9002	15	toxicity	toxicity	NN
cord-005453-4057qib7	9002	16	,	,	,
cord-005453-4057qib7	9002	17	and	and	CC
cord-005453-4057qib7	9002	18	died	die	VBD
cord-005453-4057qib7	9002	19	of	of	IN
cord-005453-4057qib7	9002	20	multi	multi	JJ
cord-005453-4057qib7	9002	21	-	-	JJ
cord-005453-4057qib7	9002	22	organ	organ	JJ
cord-005453-4057qib7	9002	23	failure	failure	NN
cord-005453-4057qib7	9002	24	.	.	.
cord-005453-4057qib7	9003	1	The	the	DT
cord-005453-4057qib7	9003	2	other	other	JJ
cord-005453-4057qib7	9003	3	patient	patient	NN
cord-005453-4057qib7	9003	4	died	die	VBD
cord-005453-4057qib7	9003	5	of	of	IN
cord-005453-4057qib7	9003	6	unrelated	unrelated	JJ
cord-005453-4057qib7	9003	7	causes	cause	NNS
cord-005453-4057qib7	9003	8	.	.	.
cord-005453-4057qib7	9004	1	The	the	DT
cord-005453-4057qib7	9004	2	remaining	remain	VBG
cord-005453-4057qib7	9004	3	six	six	CD
cord-005453-4057qib7	9004	4	patients	patient	NNS
cord-005453-4057qib7	9004	5	had	have	VBD
cord-005453-4057qib7	9004	6	cleared	clear	VBN
cord-005453-4057qib7	9004	7	the	the	DT
cord-005453-4057qib7	9004	8	infection	infection	NN
cord-005453-4057qib7	9004	9	at	at	IN
cord-005453-4057qib7	9004	10	7	7	CD
cord-005453-4057qib7	9004	11	-	-	SYM
cord-005453-4057qib7	9004	12	24	24	CD
cord-005453-4057qib7	9004	13	(	(	-LRB-
cord-005453-4057qib7	9004	14	median	median	JJ
cord-005453-4057qib7	9004	15	8.5	8.5	CD
cord-005453-4057qib7	9004	16	)	)	-RRB-
cord-005453-4057qib7	9004	17	months	month	NNS
cord-005453-4057qib7	9004	18	after	after	IN
cord-005453-4057qib7	9004	19	HSCT	HSCT	NNP
cord-005453-4057qib7	9004	20	.	.	.
cord-005453-4057qib7	9005	1	Active	active	JJ
cord-005453-4057qib7	9005	2	GVHD	GVHD	NNP
cord-005453-4057qib7	9005	3	was	be	VBD
cord-005453-4057qib7	9005	4	present	present	JJ
cord-005453-4057qib7	9005	5	at	at	IN
cord-005453-4057qib7	9005	6	6	6	CD
cord-005453-4057qib7	9005	7	months	month	NNS
cord-005453-4057qib7	9005	8	after	after	IN
cord-005453-4057qib7	9005	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9005	10	in	in	IN
cord-005453-4057qib7	9005	11	5/8	5/8	CD
cord-005453-4057qib7	9005	12	(	(	-LRB-
cord-005453-4057qib7	9005	13	62.5	62.5	CD
cord-005453-4057qib7	9005	14	%	%	NN
cord-005453-4057qib7	9005	15	)	)	-RRB-
cord-005453-4057qib7	9005	16	patients	patient	NNS
cord-005453-4057qib7	9005	17	with	with	IN
cord-005453-4057qib7	9005	18	HEV	HEV	NNP
cord-005453-4057qib7	9005	19	infection	infection	NN
cord-005453-4057qib7	9005	20	,	,	,
cord-005453-4057qib7	9005	21	involving	involve	VBG
cord-005453-4057qib7	9005	22	the	the	DT
cord-005453-4057qib7	9005	23	liver	liver	NN
cord-005453-4057qib7	9005	24	in	in	IN
cord-005453-4057qib7	9005	25	3	3	CD
cord-005453-4057qib7	9005	26	of	of	IN
cord-005453-4057qib7	9005	27	these	these	DT
cord-005453-4057qib7	9005	28	patients	patient	NNS
cord-005453-4057qib7	9005	29	.	.	.
cord-005453-4057qib7	9006	1	Corticosteroid	corticosteroid	JJ
cord-005453-4057qib7	9006	2	treatment	treatment	NN
cord-005453-4057qib7	9006	3	was	be	VBD
cord-005453-4057qib7	9006	4	ongoing	ongoing	JJ
cord-005453-4057qib7	9006	5	in	in	IN
cord-005453-4057qib7	9006	6	6/8	6/8	CD
cord-005453-4057qib7	9006	7	(	(	-LRB-
cord-005453-4057qib7	9006	8	75	75	CD
cord-005453-4057qib7	9006	9	%	%	NN
cord-005453-4057qib7	9006	10	)	)	-RRB-
cord-005453-4057qib7	9006	11	patients	patient	NNS
cord-005453-4057qib7	9006	12	;	;	:
cord-005453-4057qib7	9006	13	the	the	DT
cord-005453-4057qib7	9006	14	mean	mean	JJ
cord-005453-4057qib7	9006	15	dose	dose	NN
cord-005453-4057qib7	9006	16	during	during	IN
cord-005453-4057qib7	9006	17	the	the	DT
cord-005453-4057qib7	9006	18	14	14	CD
cord-005453-4057qib7	9006	19	preceding	precede	VBG
cord-005453-4057qib7	9006	20	days	day	NNS
cord-005453-4057qib7	9006	21	was	be	VBD
cord-005453-4057qib7	9006	22	>	>	NFP
cord-005453-4057qib7	9006	23	0.5	0.5	CD
cord-005453-4057qib7	9006	24	mg	mg	NNP
cord-005453-4057qib7	9006	25	/	/	SYM
cord-005453-4057qib7	9006	26	kg	kg	NNP
cord-005453-4057qib7	9006	27	in	in	IN
cord-005453-4057qib7	9006	28	1/8	1/8	CD
cord-005453-4057qib7	9006	29	(	(	-LRB-
cord-005453-4057qib7	9006	30	12.5	12.5	CD
cord-005453-4057qib7	9006	31	%	%	NN
cord-005453-4057qib7	9006	32	)	)	-RRB-
cord-005453-4057qib7	9006	33	patient	patient	NN
cord-005453-4057qib7	9006	34	,	,	,
cord-005453-4057qib7	9006	35	0.25	0.25	CD
cord-005453-4057qib7	9006	36	-	-	SYM
cord-005453-4057qib7	9006	37	0.5	0.5	CD
cord-005453-4057qib7	9006	38	mg/	mg/	NN
cord-005453-4057qib7	9006	39	kg	kg	NNP
cord-005453-4057qib7	9006	40	in	in	IN
cord-005453-4057qib7	9006	41	3/8	3/8	CD
cord-005453-4057qib7	9006	42	(	(	-LRB-
cord-005453-4057qib7	9006	43	37.5	37.5	CD
cord-005453-4057qib7	9006	44	%	%	NN
cord-005453-4057qib7	9006	45	)	)	-RRB-
cord-005453-4057qib7	9006	46	patients	patient	NNS
cord-005453-4057qib7	9006	47	,	,	,
cord-005453-4057qib7	9006	48	and	and	CC
cord-005453-4057qib7	9006	49	<	<	XX
cord-005453-4057qib7	9006	50	0.25	0.25	CD
cord-005453-4057qib7	9006	51	mg	mg	NNP
cord-005453-4057qib7	9006	52	/	/	SYM
cord-005453-4057qib7	9006	53	kg	kg	NNS
cord-005453-4057qib7	9006	54	in	in	IN
cord-005453-4057qib7	9006	55	4/8	4/8	CD
cord-005453-4057qib7	9006	56	(	(	-LRB-
cord-005453-4057qib7	9006	57	50	50	CD
cord-005453-4057qib7	9006	58	%	%	NN
cord-005453-4057qib7	9006	59	)	)	-RRB-
cord-005453-4057qib7	9006	60	patients	patient	NNS
cord-005453-4057qib7	9006	61	.	.	.
cord-005453-4057qib7	9007	1	HEV	HEV	NNP
cord-005453-4057qib7	9007	2	infection	infection	NN
cord-005453-4057qib7	9007	3	correlated	correlate	VBD
cord-005453-4057qib7	9007	4	to	to	IN
cord-005453-4057qib7	9007	5	elevated	elevate	VBN
cord-005453-4057qib7	9007	6	ALT	alt	NN
cord-005453-4057qib7	9007	7	>	>	XX
cord-005453-4057qib7	9007	8	1.5	1.5	CD
cord-005453-4057qib7	9007	9	ULN	ULN	NNP
cord-005453-4057qib7	9007	10	,	,	,
cord-005453-4057qib7	9007	11	OR	or	CC
cord-005453-4057qib7	9007	12	8.3	8.3	CD
cord-005453-4057qib7	9007	13	p=0	p=0	NNS
cord-005453-4057qib7	9007	14	.02	.02	NFP
cord-005453-4057qib7	9007	15	)	)	-RRB-
cord-005453-4057qib7	9007	16	and	and	CC
cord-005453-4057qib7	9007	17	>	>	XX
cord-005453-4057qib7	9007	18	3	3	CD
cord-005453-4057qib7	9007	19	ULN	ULN	NNP
cord-005453-4057qib7	9007	20	,	,	,
cord-005453-4057qib7	9007	21	p=0	p=0	NNP
cord-005453-4057qib7	9007	22	.02	.02	NFP
cord-005453-4057qib7	9007	23	)	)	-RRB-
cord-005453-4057qib7	9007	24	at	at	IN
cord-005453-4057qib7	9007	25	6	6	CD
cord-005453-4057qib7	9007	26	months	month	NNS
cord-005453-4057qib7	9007	27	,	,	,
cord-005453-4057qib7	9007	28	but	but	CC
cord-005453-4057qib7	9007	29	not	not	RB
cord-005453-4057qib7	9007	30	at	at	IN
cord-005453-4057qib7	9007	31	3	3	CD
cord-005453-4057qib7	9007	32	months	month	NNS
cord-005453-4057qib7	9007	33	,	,	,
cord-005453-4057qib7	9007	34	after	after	IN
cord-005453-4057qib7	9007	35	HSCT	HSCT	NNP
cord-005453-4057qib7	9007	36	,	,	,
cord-005453-4057qib7	9007	37	compared	compare	VBN
cord-005453-4057qib7	9007	38	to	to	IN
cord-005453-4057qib7	9007	39	HEV	HEV	NNP
cord-005453-4057qib7	9007	40	RNA	RNA	NNP
cord-005453-4057qib7	9007	41	negative	negative	JJ
cord-005453-4057qib7	9007	42	controls	control	NNS
cord-005453-4057qib7	9007	43	.	.	.
cord-005453-4057qib7	9008	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9008	2	:	:	:
cord-005453-4057qib7	9009	1	HEV	HEV	NNP
cord-005453-4057qib7	9009	2	infection	infection	NN
cord-005453-4057qib7	9009	3	was	be	VBD
cord-005453-4057qib7	9009	4	detected	detect	VBN
cord-005453-4057qib7	9009	5	in	in	IN
cord-005453-4057qib7	9009	6	3.1	3.1	CD
cord-005453-4057qib7	9009	7	%	%	NN
cord-005453-4057qib7	9009	8	of	of	IN
cord-005453-4057qib7	9009	9	patients	patient	NNS
cord-005453-4057qib7	9009	10	tested	test	VBN
cord-005453-4057qib7	9009	11	at	at	IN
cord-005453-4057qib7	9009	12	6	6	CD
cord-005453-4057qib7	9009	13	months	month	NNS
cord-005453-4057qib7	9009	14	after	after	IN
cord-005453-4057qib7	9009	15	HSCT	HSCT	NNP
cord-005453-4057qib7	9009	16	and	and	CC
cord-005453-4057qib7	9009	17	was	be	VBD
cord-005453-4057qib7	9009	18	correlated	correlate	VBN
cord-005453-4057qib7	9009	19	to	to	IN
cord-005453-4057qib7	9009	20	abnormal	abnormal	JJ
cord-005453-4057qib7	9009	21	ALT	alt	NN
cord-005453-4057qib7	9009	22	.	.	.
cord-005453-4057qib7	9010	1	Spontaneous	spontaneous	JJ
cord-005453-4057qib7	9010	2	clearance	clearance	NN
cord-005453-4057qib7	9010	3	was	be	VBD
cord-005453-4057qib7	9010	4	common	common	JJ
cord-005453-4057qib7	9010	5	but	but	CC
cord-005453-4057qib7	9010	6	one	one	CD
cord-005453-4057qib7	9010	7	patient	patient	NN
cord-005453-4057qib7	9010	8	died	die	VBD
cord-005453-4057qib7	9010	9	in	in	IN
cord-005453-4057qib7	9010	10	acute	acute	JJ
cord-005453-4057qib7	9010	11	liver	liver	NN
cord-005453-4057qib7	9010	12	failure	failure	NN
cord-005453-4057qib7	9010	13	,	,	,
cord-005453-4057qib7	9010	14	where	where	WRB
cord-005453-4057qib7	9010	15	HEV	HEV	NNP
cord-005453-4057qib7	9010	16	may	may	MD
cord-005453-4057qib7	9010	17	have	have	VB
cord-005453-4057qib7	9010	18	contributed	contribute	VBN
cord-005453-4057qib7	9010	19	.	.	.
cord-005453-4057qib7	9011	1	HEV	HEV	NNP
cord-005453-4057qib7	9011	2	infection	infection	NN
cord-005453-4057qib7	9011	3	is	be	VBZ
cord-005453-4057qib7	9011	4	a	a	DT
cord-005453-4057qib7	9011	5	differential	differential	JJ
cord-005453-4057qib7	9011	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	9011	7	in	in	IN
cord-005453-4057qib7	9011	8	patients	patient	NNS
cord-005453-4057qib7	9011	9	with	with	IN
cord-005453-4057qib7	9011	10	elevated	elevated	JJ
cord-005453-4057qib7	9011	11	ALT	alt	NN
cord-005453-4057qib7	9011	12	6	6	CD
cord-005453-4057qib7	9011	13	months	month	NNS
cord-005453-4057qib7	9011	14	after	after	IN
cord-005453-4057qib7	9011	15	HSCT	HSCT	NNP
cord-005453-4057qib7	9011	16	.	.	.
cord-005453-4057qib7	9012	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9012	2	:	:	:
cord-005453-4057qib7	9012	3	Nothing	nothing	NN
cord-005453-4057qib7	9012	4	to	to	TO
cord-005453-4057qib7	9012	5	declare	declare	VB
cord-005453-4057qib7	9012	6	Monitoring	monitoring	NN
cord-005453-4057qib7	9012	7	of	of	IN
cord-005453-4057qib7	9012	8	T	t	NN
cord-005453-4057qib7	9012	9	-	-	HYPH
cord-005453-4057qib7	9012	10	cell	cell	NN
cord-005453-4057qib7	9012	11	responses	response	NNS
cord-005453-4057qib7	9012	12	to	to	IN
cord-005453-4057qib7	9012	13	viral	viral	RB
cord-005453-4057qib7	9012	14	-	-	HYPH
cord-005453-4057qib7	9012	15	coded	code	VBN
cord-005453-4057qib7	9012	16	antigens	antigen	NNS
cord-005453-4057qib7	9012	17	in	in	IN
cord-005453-4057qib7	9012	18	pediatric	pediatric	JJ
cord-005453-4057qib7	9012	19	patients	patient	NNS
cord-005453-4057qib7	9012	20	receiving	receive	VBG
cord-005453-4057qib7	9012	21	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	9012	22	-	-	HYPH
cord-005453-4057qib7	9012	23	depleted	deplete	VBN
cord-005453-4057qib7	9012	24	haplo	haplo	NN
cord-005453-4057qib7	9012	25	-	-	HYPH
cord-005453-4057qib7	9012	26	HSCT	HSCT	NNP
cord-005453-4057qib7	9012	27	followed	follow	VBD
cord-005453-4057qib7	9012	28	by	by	IN
cord-005453-4057qib7	9012	29	BPX-501	BPX-501	NNP
cord-005453-4057qib7	9013	1	cell	cell	NN
cord-005453-4057qib7	9013	2	administration	administration	NN
cord-005453-4057qib7	9013	3	Background	Background	NNP
cord-005453-4057qib7	9013	4	:	:	:
cord-005453-4057qib7	9013	5	αβ	αβ	NNP
cord-005453-4057qib7	9013	6	T	t	NN
cord-005453-4057qib7	9013	7	-	-	HYPH
cord-005453-4057qib7	9013	8	cell	cell	NN
cord-005453-4057qib7	9013	9	-	-	HYPH
cord-005453-4057qib7	9013	10	depleted	deplete	VBN
cord-005453-4057qib7	9013	11	haplo	haplo	NN
cord-005453-4057qib7	9013	12	-	-	HYPH
cord-005453-4057qib7	9013	13	HSCT	HSCT	NNP
cord-005453-4057qib7	9013	14	is	be	VBZ
cord-005453-4057qib7	9013	15	an	an	DT
cord-005453-4057qib7	9013	16	effective	effective	JJ
cord-005453-4057qib7	9013	17	option	option	NN
cord-005453-4057qib7	9013	18	for	for	IN
cord-005453-4057qib7	9013	19	children	child	NNS
cord-005453-4057qib7	9013	20	with	with	IN
cord-005453-4057qib7	9013	21	hematological	hematological	JJ
cord-005453-4057qib7	9013	22	disorders	disorder	NNS
cord-005453-4057qib7	9013	23	in	in	IN
cord-005453-4057qib7	9013	24	need	need	NN
cord-005453-4057qib7	9013	25	of	of	IN
cord-005453-4057qib7	9013	26	an	an	DT
cord-005453-4057qib7	9013	27	allograft	allograft	NN
cord-005453-4057qib7	9013	28	.	.	.
cord-005453-4057qib7	9014	1	However	however	RB
cord-005453-4057qib7	9014	2	,	,	,
cord-005453-4057qib7	9014	3	recovery	recovery	NN
cord-005453-4057qib7	9014	4	of	of	IN
cord-005453-4057qib7	9014	5	adaptive	adaptive	JJ
cord-005453-4057qib7	9014	6	immunity	immunity	NN
cord-005453-4057qib7	9014	7	is	be	VBZ
cord-005453-4057qib7	9014	8	impaired	impair	VBN
cord-005453-4057qib7	9014	9	in	in	IN
cord-005453-4057qib7	9014	10	these	these	DT
cord-005453-4057qib7	9014	11	patients	patient	NNS
cord-005453-4057qib7	9014	12	.	.	.
cord-005453-4057qib7	9015	1	Thus	thus	RB
cord-005453-4057qib7	9015	2	,	,	,
cord-005453-4057qib7	9015	3	in	in	IN
cord-005453-4057qib7	9015	4	order	order	NN
cord-005453-4057qib7	9015	5	to	to	TO
cord-005453-4057qib7	9015	6	accelerate	accelerate	VB
cord-005453-4057qib7	9015	7	immune	immune	JJ
cord-005453-4057qib7	9015	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	9015	9	,	,	,
cord-005453-4057qib7	9015	10	we	-PRON-	PRP
cord-005453-4057qib7	9015	11	developed	develop	VBD
cord-005453-4057qib7	9015	12	a	a	DT
cord-005453-4057qib7	9015	13	novel	novel	JJ
cord-005453-4057qib7	9015	14	approach	approach	NN
cord-005453-4057qib7	9015	15	based	base	VBN
cord-005453-4057qib7	9015	16	on	on	IN
cord-005453-4057qib7	9015	17	post	post	JJ
cord-005453-4057qib7	9015	18	-	-	JJ
cord-005453-4057qib7	9015	19	transplant	transplant	JJ
cord-005453-4057qib7	9015	20	infusion	infusion	NN
cord-005453-4057qib7	9015	21	of	of	IN
cord-005453-4057qib7	9015	22	a	a	DT
cord-005453-4057qib7	9015	23	titrated	titrate	VBN
cord-005453-4057qib7	9015	24	number	number	NN
cord-005453-4057qib7	9015	25	of	of	IN
cord-005453-4057qib7	9015	26	donor	donor	NN
cord-005453-4057qib7	9015	27	T	t	NN
cord-005453-4057qib7	9015	28	cells	cell	NNS
cord-005453-4057qib7	9015	29	,	,	,
cord-005453-4057qib7	9015	30	transduced	transduce	VBN
cord-005453-4057qib7	9015	31	with	with	IN
cord-005453-4057qib7	9015	32	the	the	DT
cord-005453-4057qib7	9015	33	suicide	suicide	NN
cord-005453-4057qib7	9015	34	gene	gene	NN
cord-005453-4057qib7	9015	35	inducible	inducible	JJ
cord-005453-4057qib7	9015	36	-	-	:
cord-005453-4057qib7	9015	37	Caspase-9	Caspase-9	NNPS
cord-005453-4057qib7	9015	38	,	,	,
cord-005453-4057qib7	9015	39	iC9	ic9	FW
cord-005453-4057qib7	9015	40	(	(	-LRB-
cord-005453-4057qib7	9015	41	BPX-501	bpx-501	RB
cord-005453-4057qib7	9015	42	cells	cell	NNS
cord-005453-4057qib7	9015	43	,	,	,
cord-005453-4057qib7	9015	44	Sponsor	Sponsor	NNP
cord-005453-4057qib7	9015	45	Bellicum	Bellicum	NNP
cord-005453-4057qib7	9015	46	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	9015	47	®	®	VBP
cord-005453-4057qib7	9015	48	;	;	:
cord-005453-4057qib7	9015	49	NCT02065869	NCT02065869	NNP
cord-005453-4057qib7	9015	50	)	)	-RRB-
cord-005453-4057qib7	9015	51	.	.	.
cord-005453-4057qib7	9016	1	We	-PRON-	PRP
cord-005453-4057qib7	9016	2	previously	previously	RB
cord-005453-4057qib7	9016	3	reported	report	VBD
cord-005453-4057qib7	9016	4	on	on	IN
cord-005453-4057qib7	9016	5	immune	immune	JJ
cord-005453-4057qib7	9016	6	recovery	recovery	NN
cord-005453-4057qib7	9016	7	of	of	IN
cord-005453-4057qib7	9016	8	108	108	CD
cord-005453-4057qib7	9016	9	children	child	NNS
cord-005453-4057qib7	9016	10	transplanted	transplant	VBN
cord-005453-4057qib7	9016	11	at	at	IN
cord-005453-4057qib7	9016	12	our	-PRON-	PRP$
cord-005453-4057qib7	9016	13	institution	institution	NN
cord-005453-4057qib7	9016	14	,	,	,
cord-005453-4057qib7	9016	15	showing	show	VBG
cord-005453-4057qib7	9016	16	that	that	IN
cord-005453-4057qib7	9016	17	BPX-501	BPX-501	NNP
cord-005453-4057qib7	9016	18	cells	cell	NNS
cord-005453-4057qib7	9016	19	infused	infuse	VBN
cord-005453-4057qib7	9016	20	after	after	IN
cord-005453-4057qib7	9016	21	αβ	αβ	FW
cord-005453-4057qib7	9016	22	T	t	NN
cord-005453-4057qib7	9016	23	-	-	HYPH
cord-005453-4057qib7	9016	24	cell	cell	NN
cord-005453-4057qib7	9016	25	-	-	HYPH
cord-005453-4057qib7	9016	26	depleted	deplete	VBN
cord-005453-4057qib7	9016	27	haplo	haplo	NN
cord-005453-4057qib7	9016	28	-	-	HYPH
cord-005453-4057qib7	9016	29	HSCT	HSCT	NNP
cord-005453-4057qib7	9016	30	expand	expand	VBP
cord-005453-4057qib7	9016	31	in	in	IN
cord-005453-4057qib7	9016	32	-	-	HYPH
cord-005453-4057qib7	9016	33	vivo	vivo	NN
cord-005453-4057qib7	9016	34	and	and	CC
cord-005453-4057qib7	9016	35	persist	persist	VB
cord-005453-4057qib7	9016	36	over	over	IN
cord-005453-4057qib7	9016	37	time	time	NN
cord-005453-4057qib7	9016	38	,	,	,
cord-005453-4057qib7	9016	39	contributing	contribute	VBG
cord-005453-4057qib7	9016	40	to	to	TO
cord-005453-4057qib7	9016	41	fasten	fasten	VB
cord-005453-4057qib7	9016	42	adaptive	adaptive	JJ
cord-005453-4057qib7	9016	43	immunity	immunity	NN
cord-005453-4057qib7	9016	44	recovery	recovery	NN
cord-005453-4057qib7	9016	45	(	(	-LRB-
cord-005453-4057qib7	9016	46	Merli	Merli	NNP
cord-005453-4057qib7	9016	47	,	,	,
cord-005453-4057qib7	9016	48	ASH2017	ASH2017	NNP
cord-005453-4057qib7	9016	49	)	)	-RRB-
cord-005453-4057qib7	9016	50	.	.	.
cord-005453-4057qib7	9017	1	Here	here	RB
cord-005453-4057qib7	9017	2	,	,	,
cord-005453-4057qib7	9017	3	we	-PRON-	PRP
cord-005453-4057qib7	9017	4	report	report	VBP
cord-005453-4057qib7	9017	5	the	the	DT
cord-005453-4057qib7	9017	6	results	result	NNS
cord-005453-4057qib7	9017	7	of	of	IN
cord-005453-4057qib7	9017	8	lymphoproliferation	lymphoproliferation	NN
cord-005453-4057qib7	9017	9	assay	assay	NN
cord-005453-4057qib7	9017	10	to	to	IN
cord-005453-4057qib7	9017	11	viral	viral	RB
cord-005453-4057qib7	9017	12	-	-	HYPH
cord-005453-4057qib7	9017	13	encoded	encode	VBN
cord-005453-4057qib7	9017	14	antigens	antigen	NNS
cord-005453-4057qib7	9017	15	to	to	TO
cord-005453-4057qib7	9017	16	assess	assess	VB
cord-005453-4057qib7	9017	17	Tcell	Tcell	NNP
cord-005453-4057qib7	9017	18	function	function	NN
cord-005453-4057qib7	9017	19	in	in	IN
cord-005453-4057qib7	9017	20	patients	patient	NNS
cord-005453-4057qib7	9017	21	transplanted	transplant	VBN
cord-005453-4057qib7	9017	22	with	with	IN
cord-005453-4057qib7	9017	23	this	this	DT
cord-005453-4057qib7	9017	24	approach	approach	NN
cord-005453-4057qib7	9017	25	.	.	.
cord-005453-4057qib7	9018	1	Methods	method	NNS
cord-005453-4057qib7	9018	2	:	:	:
cord-005453-4057qib7	9018	3	We	-PRON-	PRP
cord-005453-4057qib7	9018	4	evaluated	evaluate	VBD
cord-005453-4057qib7	9018	5	142	142	CD
cord-005453-4057qib7	9018	6	children	child	NNS
cord-005453-4057qib7	9018	7	,	,	,
cord-005453-4057qib7	9018	8	78	78	CD
cord-005453-4057qib7	9018	9	male	male	NN
cord-005453-4057qib7	9018	10	and	and	CC
cord-005453-4057qib7	9018	11	64	64	CD
cord-005453-4057qib7	9018	12	female	female	NN
cord-005453-4057qib7	9018	13	.	.	.
cord-005453-4057qib7	9019	1	Median	median	JJ
cord-005453-4057qib7	9019	2	age	age	NN
cord-005453-4057qib7	9019	3	at	at	IN
cord-005453-4057qib7	9019	4	transplant	transplant	NN
cord-005453-4057qib7	9019	5	was	be	VBD
cord-005453-4057qib7	9019	6	5.7	5.7	CD
cord-005453-4057qib7	9019	7	years	year	NNS
cord-005453-4057qib7	9020	1	(	(	-LRB-
cord-005453-4057qib7	9020	2	range	range	NN
cord-005453-4057qib7	9020	3	0	0	NFP
cord-005453-4057qib7	9020	4	.	.	.
cord-005453-4057qib7	9021	1	[	[	-LRB-
cord-005453-4057qib7	9021	2	3	3	CD
cord-005453-4057qib7	9021	3	]	]	-RRB-
cord-005453-4057qib7	9021	4	[	[	-LRB-
cord-005453-4057qib7	9021	5	4	4	CD
cord-005453-4057qib7	9021	6	]	]	-RRB-
cord-005453-4057qib7	9021	7	[	[	-LRB-
cord-005453-4057qib7	9021	8	5	5	CD
cord-005453-4057qib7	9021	9	]	]	-RRB-
cord-005453-4057qib7	9021	10	[	[	-LRB-
cord-005453-4057qib7	9021	11	6	6	CD
cord-005453-4057qib7	9021	12	]	]	-RRB-
cord-005453-4057qib7	9021	13	[	[	-LRB-
cord-005453-4057qib7	9021	14	7	7	CD
cord-005453-4057qib7	9021	15	]	]	-RRB-
cord-005453-4057qib7	9022	1	[	[	-LRB-
cord-005453-4057qib7	9022	2	8	8	CD
cord-005453-4057qib7	9022	3	]	]	-RRB-
cord-005453-4057qib7	9022	4	[	[	-LRB-
cord-005453-4057qib7	9022	5	9	9	CD
cord-005453-4057qib7	9022	6	]	]	-RRB-
cord-005453-4057qib7	9022	7	[	[	-LRB-
cord-005453-4057qib7	9022	8	10	10	CD
cord-005453-4057qib7	9022	9	]	]	-RRB-
cord-005453-4057qib7	9022	10	[	[	-LRB-
cord-005453-4057qib7	9022	11	11	11	CD
cord-005453-4057qib7	9022	12	]	]	-RRB-
cord-005453-4057qib7	9023	1	[	[	-LRB-
cord-005453-4057qib7	9023	2	12	12	CD
cord-005453-4057qib7	9023	3	]	]	-RRB-
cord-005453-4057qib7	9023	4	[	[	-LRB-
cord-005453-4057qib7	9023	5	13	13	CD
cord-005453-4057qib7	9023	6	]	]	-RRB-
cord-005453-4057qib7	9024	1	[	[	-LRB-
cord-005453-4057qib7	9024	2	14	14	CD
cord-005453-4057qib7	9024	3	]	]	-RRB-
cord-005453-4057qib7	9025	1	[	[	-LRB-
cord-005453-4057qib7	9025	2	15	15	CD
cord-005453-4057qib7	9025	3	]	]	-RRB-
cord-005453-4057qib7	9025	4	[	[	-LRB-
cord-005453-4057qib7	9025	5	16	16	CD
cord-005453-4057qib7	9025	6	]	]	-RRB-
cord-005453-4057qib7	9025	7	[	[	-LRB-
cord-005453-4057qib7	9025	8	17	17	CD
cord-005453-4057qib7	9025	9	]	]	-RRB-
cord-005453-4057qib7	9025	10	[	[	-LRB-
cord-005453-4057qib7	9025	11	18	18	CD
cord-005453-4057qib7	9025	12	]	]	-RRB-
cord-005453-4057qib7	9025	13	.	.	.
cord-005453-4057qib7	9026	1	Patients	patient	NNS
cord-005453-4057qib7	9026	2	had	have	VBD
cord-005453-4057qib7	9026	3	either	either	CC
cord-005453-4057qib7	9026	4	malignant	malignant	JJ
cord-005453-4057qib7	9026	5	(	(	-LRB-
cord-005453-4057qib7	9026	6	69	69	CD
cord-005453-4057qib7	9026	7	children	child	NNS
cord-005453-4057qib7	9026	8	)	)	-RRB-
cord-005453-4057qib7	9026	9	and	and	CC
cord-005453-4057qib7	9026	10	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	9026	11	(	(	-LRB-
cord-005453-4057qib7	9026	12	73	73	CD
cord-005453-4057qib7	9026	13	)	)	-RRB-
cord-005453-4057qib7	9026	14	disorders	disorder	NNS
cord-005453-4057qib7	9026	15	.	.	.
cord-005453-4057qib7	9027	1	No	no	DT
cord-005453-4057qib7	9027	2	patient	patient	NN
cord-005453-4057qib7	9027	3	was	be	VBD
cord-005453-4057qib7	9027	4	given	give	VBN
cord-005453-4057qib7	9027	5	any	any	DT
cord-005453-4057qib7	9027	6	posttransplant	posttransplant	NN
cord-005453-4057qib7	9027	7	graft	graft	NN
cord-005453-4057qib7	9027	8	-	-	HYPH
cord-005453-4057qib7	9027	9	versus	versus	IN
cord-005453-4057qib7	9027	10	-	-	HYPH
cord-005453-4057qib7	9027	11	host	host	NN
cord-005453-4057qib7	9027	12	disease	disease	NN
cord-005453-4057qib7	9027	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9027	14	.	.	.
cord-005453-4057qib7	9028	1	Nine	nine	CD
cord-005453-4057qib7	9028	2	children	child	NNS
cord-005453-4057qib7	9028	3	were	be	VBD
cord-005453-4057qib7	9028	4	enrolled	enrol	VBN
cord-005453-4057qib7	9028	5	in	in	IN
cord-005453-4057qib7	9028	6	the	the	DT
cord-005453-4057qib7	9028	7	phase	phase	NN
cord-005453-4057qib7	9028	8	I	-PRON-	PRP
cord-005453-4057qib7	9028	9	portion	portion	NN
cord-005453-4057qib7	9028	10	of	of	IN
cord-005453-4057qib7	9028	11	the	the	DT
cord-005453-4057qib7	9028	12	trial	trial	NN
cord-005453-4057qib7	9028	13	consisting	consist	VBG
cord-005453-4057qib7	9028	14	of	of	IN
cord-005453-4057qib7	9028	15	3	3	CD
cord-005453-4057qib7	9028	16	cohorts	cohort	NNS
cord-005453-4057qib7	9028	17	receiving	receive	VBG
cord-005453-4057qib7	9028	18	escalating	escalate	VBG
cord-005453-4057qib7	9028	19	doses	dose	NNS
cord-005453-4057qib7	9028	20	of	of	IN
cord-005453-4057qib7	9028	21	BPX-501	BPX-501	NNP
cord-005453-4057qib7	9028	22	cells	cell	NNS
cord-005453-4057qib7	9028	23	.	.	.
cord-005453-4057qib7	9029	1	The	the	DT
cord-005453-4057qib7	9029	2	remaining	remain	VBG
cord-005453-4057qib7	9029	3	133	133	CD
cord-005453-4057qib7	9029	4	patients	patient	NNS
cord-005453-4057qib7	9029	5	(	(	-LRB-
cord-005453-4057qib7	9029	6	phase	phase	NN
cord-005453-4057qib7	9029	7	II	II	NNP
cord-005453-4057qib7	9029	8	portion	portion	NN
cord-005453-4057qib7	9029	9	)	)	-RRB-
cord-005453-4057qib7	9029	10	received	receive	VBD
cord-005453-4057qib7	9029	11	the	the	DT
cord-005453-4057qib7	9029	12	recommended	recommend	VBN
cord-005453-4057qib7	9029	13	dose	dose	NN
cord-005453-4057qib7	9029	14	of	of	IN
cord-005453-4057qib7	9029	15	1x10	1x10	CD
cord-005453-4057qib7	9029	16	6	6	CD
cord-005453-4057qib7	9029	17	BPX-501	BPX-501	NNP
cord-005453-4057qib7	9029	18	cells	cell	NNS
cord-005453-4057qib7	9029	19	/	/	SYM
cord-005453-4057qib7	9029	20	kg	kg	NNS
cord-005453-4057qib7	9029	21	identified	identify	VBN
cord-005453-4057qib7	9029	22	in	in	IN
cord-005453-4057qib7	9029	23	phase	phase	NN
cord-005453-4057qib7	9030	1	I.	I.	NNP
cord-005453-4057qib7	9030	2	BPX-501	BPX-501	NNP
cord-005453-4057qib7	9030	3	cells	cell	NNS
cord-005453-4057qib7	9030	4	were	be	VBD
cord-005453-4057qib7	9030	5	infused	infuse	VBN
cord-005453-4057qib7	9030	6	at	at	IN
cord-005453-4057qib7	9030	7	a	a	DT
cord-005453-4057qib7	9030	8	median	median	NN
cord-005453-4057qib7	9030	9	of	of	IN
cord-005453-4057qib7	9030	10	17	17	CD
cord-005453-4057qib7	9030	11	days	day	NNS
cord-005453-4057qib7	9030	12	post	post	NN
cord-005453-4057qib7	9030	13	-	-	JJ
cord-005453-4057qib7	9030	14	HSCT	HSCT	NNP
cord-005453-4057qib7	9030	15	(	(	-LRB-
cord-005453-4057qib7	9030	16	range	range	NNP
cord-005453-4057qib7	9030	17	10	10	CD
cord-005453-4057qib7	9030	18	-	-	SYM
cord-005453-4057qib7	9030	19	82	82	CD
cord-005453-4057qib7	9030	20	)	)	-RRB-
cord-005453-4057qib7	9030	21	.	.	.
cord-005453-4057qib7	9031	1	Antigendriven	Antigendriven	NNP
cord-005453-4057qib7	9031	2	activation	activation	NN
cord-005453-4057qib7	9031	3	of	of	IN
cord-005453-4057qib7	9031	4	peripheral	peripheral	JJ
cord-005453-4057qib7	9031	5	mononuclear	mononuclear	JJ
cord-005453-4057qib7	9031	6	cells	cell	NNS
cord-005453-4057qib7	9031	7	was	be	VBD
cord-005453-4057qib7	9031	8	evaluated	evaluate	VBN
cord-005453-4057qib7	9031	9	by	by	IN
cord-005453-4057qib7	9031	10	lymphoproliferation	lymphoproliferation	NN
cord-005453-4057qib7	9031	11	assay	assay	NN
cord-005453-4057qib7	9031	12	with	with	IN
cord-005453-4057qib7	9031	13	3	3	CD
cord-005453-4057qib7	9031	14	H	h	NN
cord-005453-4057qib7	9031	15	-	-	HYPH
cord-005453-4057qib7	9031	16	thymidine	thymidine	NN
cord-005453-4057qib7	9031	17	pulsing	pulse	VBG
cord-005453-4057qib7	9031	18	at	at	IN
cord-005453-4057qib7	9031	19	d+4	d+4	NNS
cord-005453-4057qib7	9031	20	and	and	CC
cord-005453-4057qib7	9031	21	harvesting	harvest	VBG
cord-005453-4057qib7	9031	22	at	at	IN
cord-005453-4057qib7	9031	23	d+5	d+5	CD
cord-005453-4057qib7	9031	24	.	.	.
cord-005453-4057qib7	9032	1	Stimuli	stimulus	NNS
cord-005453-4057qib7	9032	2	included	include	VBD
cord-005453-4057qib7	9032	3	PHA	PHA	NNP
cord-005453-4057qib7	9032	4	or	or	CC
cord-005453-4057qib7	9032	5	CMV	CMV	NNP
cord-005453-4057qib7	9032	6	,	,	,
cord-005453-4057qib7	9032	7	EBV	EBV	NNP
cord-005453-4057qib7	9032	8	and	and	CC
cord-005453-4057qib7	9032	9	AdV	adv	NN
cord-005453-4057qib7	9032	10	whole	whole	JJ
cord-005453-4057qib7	9032	11	viral	viral	JJ
cord-005453-4057qib7	9032	12	lysate	lysate	NN
cord-005453-4057qib7	9032	13	.	.	.
cord-005453-4057qib7	9033	1	Results	result	NNS
cord-005453-4057qib7	9033	2	are	be	VBP
cord-005453-4057qib7	9033	3	given	give	VBN
cord-005453-4057qib7	9033	4	as	as	IN
cord-005453-4057qib7	9033	5	stimulation	stimulation	NN
cord-005453-4057qib7	9033	6	indexes	index	NNS
cord-005453-4057qib7	9033	7	(	(	-LRB-
cord-005453-4057qib7	9033	8	SI	SI	NNP
cord-005453-4057qib7	9033	9	,	,	,
cord-005453-4057qib7	9033	10	cpm	cpm	NNP
cord-005453-4057qib7	9033	11	stimulated	stimulate	VBD
cord-005453-4057qib7	9033	12	sample	sample	NN
cord-005453-4057qib7	9033	13	/	/	SYM
cord-005453-4057qib7	9033	14	cpm	cpm	NNP
cord-005453-4057qib7	9033	15	unstimulated	unstimulated	JJ
cord-005453-4057qib7	9033	16	control	control	NN
cord-005453-4057qib7	9033	17	)	)	-RRB-
cord-005453-4057qib7	9033	18	.	.	.
cord-005453-4057qib7	9034	1	Thresholds	threshold	NNS
cord-005453-4057qib7	9034	2	for	for	IN
cord-005453-4057qib7	9034	3	positive	positive	JJ
cord-005453-4057qib7	9034	4	response	response	NN
cord-005453-4057qib7	9034	5	were	be	VBD
cord-005453-4057qib7	9034	6	arbitrarily	arbitrarily	RB
cord-005453-4057qib7	9034	7	set	set	VBN
cord-005453-4057qib7	9034	8	at	at	IN
cord-005453-4057qib7	9034	9	SI>3	SI>3	NNP
cord-005453-4057qib7	9034	10	for	for	IN
cord-005453-4057qib7	9034	11	viral	viral	RB
cord-005453-4057qib7	9034	12	-	-	HYPH
cord-005453-4057qib7	9034	13	encoded	encode	VBN
cord-005453-4057qib7	9034	14	antigens	antigen	NNS
cord-005453-4057qib7	9034	15	and	and	CC
cord-005453-4057qib7	9034	16	at	at	IN
cord-005453-4057qib7	9034	17	SI>5	SI>5	NNP
cord-005453-4057qib7	9034	18	for	for	IN
cord-005453-4057qib7	9034	19	mitogenic	mitogenic	JJ
cord-005453-4057qib7	9034	20	stimulation	stimulation	NN
cord-005453-4057qib7	9034	21	with	with	IN
cord-005453-4057qib7	9034	22	PHA	PHA	NNP
cord-005453-4057qib7	9034	23	.	.	.
cord-005453-4057qib7	9035	1	Fractions	fraction	NNS
cord-005453-4057qib7	9035	2	of	of	IN
cord-005453-4057qib7	9035	3	responders	responder	NNS
cord-005453-4057qib7	9035	4	are	be	VBP
cord-005453-4057qib7	9035	5	indicated	indicate	VBN
cord-005453-4057qib7	9035	6	in	in	IN
cord-005453-4057qib7	9035	7	the	the	DT
cord-005453-4057qib7	9035	8	figure	figure	NN
cord-005453-4057qib7	9035	9	.	.	.
cord-005453-4057qib7	9036	1	Results	result	NNS
cord-005453-4057qib7	9036	2	:	:	:
cord-005453-4057qib7	9037	1	Patients	patient	NNS
cord-005453-4057qib7	9037	2	were	be	VBD
cord-005453-4057qib7	9037	3	analyzed	analyze	VBN
cord-005453-4057qib7	9037	4	from	from	IN
cord-005453-4057qib7	9037	5	d+30	d+30	NN
cord-005453-4057qib7	9037	6	to	to	IN
cord-005453-4057qib7	9037	7	d+720	d+720	NNP
cord-005453-4057qib7	9037	8	post	post	VB
cord-005453-4057qib7	9037	9	-	-	JJ
cord-005453-4057qib7	9037	10	HSCT	HSCT	NNP
cord-005453-4057qib7	9037	11	.	.	.
cord-005453-4057qib7	9038	1	PHA	PHA	NNP
cord-005453-4057qib7	9038	2	responders	responder	NNS
cord-005453-4057qib7	9038	3	(	(	-LRB-
cord-005453-4057qib7	9038	4	A	a	NN
cord-005453-4057qib7	9038	5	)	)	-RRB-
cord-005453-4057qib7	9038	6	increased	increase	VBD
cord-005453-4057qib7	9038	7	to	to	IN
cord-005453-4057qib7	9038	8	80	80	CD
cord-005453-4057qib7	9038	9	%	%	NN
cord-005453-4057qib7	9038	10	,	,	,
cord-005453-4057qib7	9038	11	while	while	IN
cord-005453-4057qib7	9038	12	CMV	CMV	NNP
cord-005453-4057qib7	9038	13	(	(	-LRB-
cord-005453-4057qib7	9038	14	B	b	NN
cord-005453-4057qib7	9038	15	)	)	-RRB-
cord-005453-4057qib7	9038	16	,	,	,
cord-005453-4057qib7	9038	17	EBV	EBV	NNP
cord-005453-4057qib7	9038	18	(	(	-LRB-
cord-005453-4057qib7	9038	19	C	C	NNP
cord-005453-4057qib7	9038	20	)	)	-RRB-
cord-005453-4057qib7	9038	21	and	and	CC
cord-005453-4057qib7	9038	22	AdV	AdV	NNP
cord-005453-4057qib7	9038	23	(	(	-LRB-
cord-005453-4057qib7	9038	24	D	D	NNP
cord-005453-4057qib7	9038	25	)	)	-RRB-
cord-005453-4057qib7	9038	26	responders	responder	NNS
cord-005453-4057qib7	9038	27	were	be	VBD
cord-005453-4057qib7	9038	28	61	61	CD
cord-005453-4057qib7	9038	29	%	%	NN
cord-005453-4057qib7	9038	30	,	,	,
cord-005453-4057qib7	9038	31	52	52	CD
cord-005453-4057qib7	9038	32	%	%	NN
cord-005453-4057qib7	9038	33	and	and	CC
cord-005453-4057qib7	9038	34	61	61	CD
cord-005453-4057qib7	9038	35	%	%	NN
cord-005453-4057qib7	9038	36	at	at	IN
cord-005453-4057qib7	9038	37	2	2	CD
cord-005453-4057qib7	9038	38	years	year	NNS
cord-005453-4057qib7	9038	39	after	after	IN
cord-005453-4057qib7	9038	40	haplo	haplo	NN
cord-005453-4057qib7	9038	41	-	-	HYPH
cord-005453-4057qib7	9038	42	HSCT	HSCT	NNP
cord-005453-4057qib7	9038	43	.	.	.
cord-005453-4057qib7	9039	1	Responses	response	NNS
cord-005453-4057qib7	9039	2	to	to	IN
cord-005453-4057qib7	9039	3	EBV	EBV	NNP
cord-005453-4057qib7	9039	4	and	and	CC
cord-005453-4057qib7	9039	5	AdV	adv	NN
cord-005453-4057qib7	9039	6	antigens	antigen	NNS
cord-005453-4057qib7	9039	7	were	be	VBD
cord-005453-4057qib7	9039	8	slightly	slightly	RB
cord-005453-4057qib7	9039	9	delayed	delay	VBN
cord-005453-4057qib7	9039	10	but	but	CC
cord-005453-4057qib7	9039	11	improved	improve	VBN
cord-005453-4057qib7	9039	12	over	over	IN
cord-005453-4057qib7	9039	13	time	time	NN
cord-005453-4057qib7	9039	14	.	.	.
cord-005453-4057qib7	9040	1	Responses	response	NNS
cord-005453-4057qib7	9040	2	to	to	IN
cord-005453-4057qib7	9040	3	PHA	PHA	NNP
cord-005453-4057qib7	9040	4	and	and	CC
cord-005453-4057qib7	9040	5	to	to	IN
cord-005453-4057qib7	9040	6	CMV	CMV	NNP
cord-005453-4057qib7	9040	7	(	(	-LRB-
cord-005453-4057qib7	9040	8	E	E	NNP
cord-005453-4057qib7	9040	9	,	,	,
cord-005453-4057qib7	9040	10	F	F	NNP
cord-005453-4057qib7	9040	11	)	)	-RRB-
cord-005453-4057qib7	9040	12	were	be	VBD
cord-005453-4057qib7	9040	13	analyzed	analyze	VBN
cord-005453-4057qib7	9040	14	in	in	IN
cord-005453-4057qib7	9040	15	the	the	DT
cord-005453-4057qib7	9040	16	CMV	CMV	NNP
cord-005453-4057qib7	9040	17	-	-	HYPH
cord-005453-4057qib7	9040	18	reactivating	reactivate	VBG
cord-005453-4057qib7	9040	19	and	and	CC
cord-005453-4057qib7	9040	20	CMV	CMV	NNP
cord-005453-4057qib7	9040	21	-	-	HYPH
cord-005453-4057qib7	9040	22	non	non	JJ
cord-005453-4057qib7	9040	23	reactivating	reactivate	VBG
cord-005453-4057qib7	9040	24	groups	group	NNS
cord-005453-4057qib7	9041	1	(	(	-LRB-
cord-005453-4057qib7	9041	2	CMV	CMV	NNP
cord-005453-4057qib7	9041	3	-	-	HYPH
cord-005453-4057qib7	9041	4	yes	yes	NNP
cord-005453-4057qib7	9041	5	/	/	SYM
cord-005453-4057qib7	9041	6	CMV	CMV	NNP
cord-005453-4057qib7	9041	7	-	-	HYPH
cord-005453-4057qib7	9041	8	no	no	NN
cord-005453-4057qib7	9041	9	)	)	-RRB-
cord-005453-4057qib7	9041	10	.	.	.
cord-005453-4057qib7	9042	1	Significant	significant	JJ
cord-005453-4057qib7	9042	2	differences	difference	NNS
cord-005453-4057qib7	9042	3	in	in	IN
cord-005453-4057qib7	9042	4	PHA	PHA	NNP
cord-005453-4057qib7	9042	5	response	response	NN
cord-005453-4057qib7	9042	6	were	be	VBD
cord-005453-4057qib7	9042	7	observed	observe	VBN
cord-005453-4057qib7	9042	8	at	at	IN
cord-005453-4057qib7	9042	9	d+60	d+60	NNS
cord-005453-4057qib7	9042	10	and	and	CC
cord-005453-4057qib7	9042	11	d+270	d+270	NN
cord-005453-4057qib7	9042	12	.	.	.
cord-005453-4057qib7	9043	1	Moreover	moreover	RB
cord-005453-4057qib7	9043	2	,	,	,
cord-005453-4057qib7	9043	3	increased	increase	VBD
cord-005453-4057qib7	9043	4	CMV	CMV	NNP
cord-005453-4057qib7	9043	5	responses	response	NNS
cord-005453-4057qib7	9043	6	were	be	VBD
cord-005453-4057qib7	9043	7	observed	observe	VBN
cord-005453-4057qib7	9043	8	in	in	IN
cord-005453-4057qib7	9043	9	CMVreactivators	cmvreactivator	NNS
cord-005453-4057qib7	9043	10	at	at	IN
cord-005453-4057qib7	9043	11	d+270	d+270	CD
cord-005453-4057qib7	9043	12	,	,	,
cord-005453-4057qib7	9043	13	d+360	d+360	NNP
cord-005453-4057qib7	9043	14	and	and	CC
cord-005453-4057qib7	9043	15	d+720	d+720	NNS
cord-005453-4057qib7	9043	16	,	,	,
cord-005453-4057qib7	9043	17	with	with	IN
cord-005453-4057qib7	9043	18	approximately	approximately	RB
cord-005453-4057qib7	9043	19	100	100	CD
cord-005453-4057qib7	9043	20	%	%	NN
cord-005453-4057qib7	9043	21	of	of	IN
cord-005453-4057qib7	9043	22	responders	responder	NNS
cord-005453-4057qib7	9043	23	at	at	IN
cord-005453-4057qib7	9043	24	d+720	d+720	NNP
cord-005453-4057qib7	9043	25	,	,	,
cord-005453-4057qib7	9043	26	as	as	IN
cord-005453-4057qib7	9043	27	opposed	oppose	VBN
cord-005453-4057qib7	9043	28	to	to	IN
cord-005453-4057qib7	9043	29	CMVnon	CMVnon	NNP
cord-005453-4057qib7	9043	30	reactivators	reactivator	NNS
cord-005453-4057qib7	9043	31	which	which	WDT
cord-005453-4057qib7	9043	32	comprised	comprise	VBD
cord-005453-4057qib7	9043	33	50	50	CD
cord-005453-4057qib7	9043	34	%	%	NN
cord-005453-4057qib7	9043	35	responders	responder	NNS
cord-005453-4057qib7	9043	36	.	.	.
cord-005453-4057qib7	9044	1	Neither	neither	DT
cord-005453-4057qib7	9044	2	primary	primary	JJ
cord-005453-4057qib7	9044	3	disease	disease	NN
cord-005453-4057qib7	9044	4	,	,	,
cord-005453-4057qib7	9044	5	age	age	NN
cord-005453-4057qib7	9044	6	nor	nor	CC
cord-005453-4057qib7	9044	7	TBI	TBI	NNP
cord-005453-4057qib7	9044	8	during	during	IN
cord-005453-4057qib7	9044	9	the	the	DT
cord-005453-4057qib7	9044	10	conditioning	conditioning	NN
cord-005453-4057qib7	9044	11	regimen	regimen	NN
cord-005453-4057qib7	9044	12	influenced	influence	VBD
cord-005453-4057qib7	9044	13	proliferative	proliferative	JJ
cord-005453-4057qib7	9044	14	capacity	capacity	NN
cord-005453-4057qib7	9044	15	of	of	IN
cord-005453-4057qib7	9044	16	the	the	DT
cord-005453-4057qib7	9044	17	two	two	CD
cord-005453-4057qib7	9044	18	subgroups	subgroup	NNS
cord-005453-4057qib7	9044	19	(	(	-LRB-
cord-005453-4057qib7	9044	20	not	not	RB
cord-005453-4057qib7	9044	21	shown	show	VBN
cord-005453-4057qib7	9044	22	)	)	-RRB-
cord-005453-4057qib7	9044	23	.	.	.
cord-005453-4057qib7	9045	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9045	2	:	:	:
cord-005453-4057qib7	9046	1	We	-PRON-	PRP
cord-005453-4057qib7	9046	2	showed	show	VBD
cord-005453-4057qib7	9046	3	a	a	DT
cord-005453-4057qib7	9046	4	rapid	rapid	JJ
cord-005453-4057qib7	9046	5	recovery	recovery	NN
cord-005453-4057qib7	9046	6	over	over	IN
cord-005453-4057qib7	9046	7	time	time	NN
cord-005453-4057qib7	9046	8	of	of	IN
cord-005453-4057qib7	9046	9	T	t	NN
cord-005453-4057qib7	9046	10	-	-	HYPH
cord-005453-4057qib7	9046	11	cell	cell	NN
cord-005453-4057qib7	9046	12	function	function	NN
cord-005453-4057qib7	9046	13	after	after	IN
cord-005453-4057qib7	9046	14	αβ	αβ	XX
cord-005453-4057qib7	9046	15	T	t	NN
cord-005453-4057qib7	9046	16	-	-	HYPH
cord-005453-4057qib7	9046	17	cell	cell	NN
cord-005453-4057qib7	9046	18	-	-	HYPH
cord-005453-4057qib7	9046	19	depleted	deplete	VBN
cord-005453-4057qib7	9046	20	haplo	haplo	NN
cord-005453-4057qib7	9046	21	-	-	HYPH
cord-005453-4057qib7	9046	22	HSCT	HSCT	NNP
cord-005453-4057qib7	9046	23	followed	follow	VBD
cord-005453-4057qib7	9046	24	by	by	IN
cord-005453-4057qib7	9046	25	BPX-501	BPX-501	NNP
cord-005453-4057qib7	9046	26	cells	cell	NNS
cord-005453-4057qib7	9046	27	administration	administration	NN
cord-005453-4057qib7	9046	28	.	.	.
cord-005453-4057qib7	9047	1	When	when	WRB
cord-005453-4057qib7	9047	2	patients	patient	NNS
cord-005453-4057qib7	9047	3	were	be	VBD
cord-005453-4057qib7	9047	4	grouped	group	VBN
cord-005453-4057qib7	9047	5	according	accord	VBG
cord-005453-4057qib7	9047	6	to	to	IN
cord-005453-4057qib7	9047	7	CMV	CMV	NNP
cord-005453-4057qib7	9047	8	reactivation	reactivation	NN
cord-005453-4057qib7	9047	9	(	(	-LRB-
cord-005453-4057qib7	9047	10	previously	previously	RB
cord-005453-4057qib7	9047	11	demonstrated	demonstrate	VBN
cord-005453-4057qib7	9047	12	as	as	IN
cord-005453-4057qib7	9047	13	a	a	DT
cord-005453-4057qib7	9047	14	strong	strong	JJ
cord-005453-4057qib7	9047	15	driver	driver	NN
cord-005453-4057qib7	9047	16	of	of	IN
cord-005453-4057qib7	9047	17	immune	immune	JJ
cord-005453-4057qib7	9047	18	reconstitution	reconstitution	NN
cord-005453-4057qib7	9047	19	)	)	-RRB-
cord-005453-4057qib7	9047	20	,	,	,
cord-005453-4057qib7	9047	21	a	a	DT
cord-005453-4057qib7	9047	22	significant	significant	JJ
cord-005453-4057qib7	9047	23	difference	difference	NN
cord-005453-4057qib7	9047	24	in	in	IN
cord-005453-4057qib7	9047	25	the	the	DT
cord-005453-4057qib7	9047	26	number	number	NN
cord-005453-4057qib7	9047	27	of	of	IN
cord-005453-4057qib7	9047	28	responders	responder	NNS
cord-005453-4057qib7	9047	29	among	among	IN
cord-005453-4057qib7	9047	30	the	the	DT
cord-005453-4057qib7	9047	31	patients	patient	NNS
cord-005453-4057qib7	9047	32	experiencing	experience	VBG
cord-005453-4057qib7	9047	33	viral	viral	JJ
cord-005453-4057qib7	9047	34	reactivation	reactivation	NN
cord-005453-4057qib7	9047	35	was	be	VBD
cord-005453-4057qib7	9047	36	observed	observe	VBN
cord-005453-4057qib7	9047	37	using	use	VBG
cord-005453-4057qib7	9047	38	the	the	DT
cord-005453-4057qib7	9047	39	CMV	CMV	NNP
cord-005453-4057qib7	9047	40	lysate	lysate	NN
cord-005453-4057qib7	9047	41	only	only	RB
cord-005453-4057qib7	9047	42	but	but	CC
cord-005453-4057qib7	9047	43	not	not	RB
cord-005453-4057qib7	9047	44	the	the	DT
cord-005453-4057qib7	9047	45	immunodominant	immunodominant	NNP
cord-005453-4057qib7	9047	46	pp65	pp65	NNP
cord-005453-4057qib7	9047	47	protein	protein	NNP
cord-005453-4057qib7	9047	48	(	(	-LRB-
cord-005453-4057qib7	9047	49	not	not	RB
cord-005453-4057qib7	9047	50	shown	show	VBN
cord-005453-4057qib7	9047	51	)	)	-RRB-
cord-005453-4057qib7	9047	52	,	,	,
cord-005453-4057qib7	9047	53	suggesting	suggest	VBG
cord-005453-4057qib7	9047	54	that	that	IN
cord-005453-4057qib7	9047	55	other	other	JJ
cord-005453-4057qib7	9047	56	viral	viral	JJ
cord-005453-4057qib7	9047	57	antigens	antigen	NNS
cord-005453-4057qib7	9047	58	account	account	NN
cord-005453-4057qib7	9047	59	for	for	IN
cord-005453-4057qib7	9047	60	increased	increase	VBN
cord-005453-4057qib7	9047	61	T	t	NN
cord-005453-4057qib7	9047	62	-	-	HYPH
cord-005453-4057qib7	9047	63	cell	cell	NN
cord-005453-4057qib7	9047	64	responses	response	NNS
cord-005453-4057qib7	9047	65	.	.	.
cord-005453-4057qib7	9048	1	Results	result	NNS
cord-005453-4057qib7	9048	2	of	of	IN
cord-005453-4057qib7	9048	3	T	t	NN
cord-005453-4057qib7	9048	4	-	-	HYPH
cord-005453-4057qib7	9048	5	cell	cell	NN
cord-005453-4057qib7	9048	6	function	function	NN
cord-005453-4057qib7	9048	7	after	after	IN
cord-005453-4057qib7	9048	8	BPX	BPX	NNP
cord-005453-4057qib7	9048	9	administration	administration	NN
cord-005453-4057qib7	9048	10	complements	complement	VBZ
cord-005453-4057qib7	9048	11	the	the	DT
cord-005453-4057qib7	9048	12	phenotypic	phenotypic	JJ
cord-005453-4057qib7	9048	13	data	datum	NNS
cord-005453-4057qib7	9048	14	we	-PRON-	PRP
cord-005453-4057qib7	9048	15	already	already	RB
cord-005453-4057qib7	9048	16	reported	report	VBD
cord-005453-4057qib7	9048	17	.	.	.
cord-005453-4057qib7	9049	1	Clinical	clinical	JJ
cord-005453-4057qib7	9049	2	Trial	Trial	NNP
cord-005453-4057qib7	9049	3	Registry	Registry	NNP
cord-005453-4057qib7	9049	4	:	:	:
cord-005453-4057qib7	9050	1	NCT02065869	NCT02065869	NNP
cord-005453-4057qib7	9050	2	Disclosure	Disclosure	NNP
cord-005453-4057qib7	9050	3	:	:	:
cord-005453-4057qib7	9050	4	Nothing	nothing	NN
cord-005453-4057qib7	9050	5	to	to	TO
cord-005453-4057qib7	9050	6	declare	declare	VB
cord-005453-4057qib7	9050	7	.	.	.
cord-005453-4057qib7	9051	1	Background	background	NN
cord-005453-4057qib7	9051	2	:	:	:
cord-005453-4057qib7	9052	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	9052	2	(	(	-LRB-
cord-005453-4057qib7	9052	3	CMV	CMV	NNP
cord-005453-4057qib7	9052	4	)	)	-RRB-
cord-005453-4057qib7	9052	5	is	be	VBZ
cord-005453-4057qib7	9052	6	associated	associate	VBN
cord-005453-4057qib7	9052	7	with	with	IN
cord-005453-4057qib7	9052	8	significant	significant	JJ
cord-005453-4057qib7	9052	9	morbidity	morbidity	NN
cord-005453-4057qib7	9052	10	and	and	CC
cord-005453-4057qib7	9052	11	mortality	mortality	NN
cord-005453-4057qib7	9052	12	in	in	IN
cord-005453-4057qib7	9052	13	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9052	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9052	15	cell	cell	NN
cord-005453-4057qib7	9052	16	transplantation	transplantation	NN
cord-005453-4057qib7	9052	17	(	(	-LRB-
cord-005453-4057qib7	9052	18	allo	allo	NN
cord-005453-4057qib7	9052	19	-	-	HYPH
cord-005453-4057qib7	9052	20	HCT	HCT	NNP
cord-005453-4057qib7	9052	21	)	)	-RRB-
cord-005453-4057qib7	9052	22	patients	patient	NNS
cord-005453-4057qib7	9052	23	(	(	-LRB-
cord-005453-4057qib7	9052	24	pts	pts	NNP
cord-005453-4057qib7	9052	25	)	)	-RRB-
cord-005453-4057qib7	9052	26	.	.	.
cord-005453-4057qib7	9053	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	9053	2	incidence	incidence	NN
cord-005453-4057qib7	9053	3	of	of	IN
cord-005453-4057qib7	9053	4	CMV	CMV	NNP
cord-005453-4057qib7	9053	5	infection	infection	NN
cord-005453-4057qib7	9053	6	in	in	IN
cord-005453-4057qib7	9053	7	high	high	JJ
cord-005453-4057qib7	9053	8	-	-	HYPH
cord-005453-4057qib7	9053	9	risk	risk	NN
cord-005453-4057qib7	9053	10	patients	patient	NNS
cord-005453-4057qib7	9053	11	such	such	JJ
cord-005453-4057qib7	9053	12	as	as	IN
cord-005453-4057qib7	9053	13	CD34-selected	cd34-selected	CD
cord-005453-4057qib7	9053	14	or	or	CC
cord-005453-4057qib7	9053	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9053	16	HCT	HCT	NNP
cord-005453-4057qib7	9053	17	have	have	VBP
cord-005453-4057qib7	9053	18	been	be	VBN
cord-005453-4057qib7	9053	19	reported	report	VBN
cord-005453-4057qib7	9053	20	as	as	RB
cord-005453-4057qib7	9053	21	high	high	JJ
cord-005453-4057qib7	9053	22	as	as	IN
cord-005453-4057qib7	9053	23	61.8	61.8	CD
cord-005453-4057qib7	9053	24	-	-	HYPH
cord-005453-4057qib7	9053	25	84.5	84.5	CD
cord-005453-4057qib7	9053	26	%	%	NN
cord-005453-4057qib7	9053	27	and	and	CC
cord-005453-4057qib7	9053	28	53	53	CD
cord-005453-4057qib7	9053	29	-	-	SYM
cord-005453-4057qib7	9053	30	81	81	CD
cord-005453-4057qib7	9053	31	%	%	NN
cord-005453-4057qib7	9053	32	,	,	,
cord-005453-4057qib7	9053	33	respectively	respectively	RB
cord-005453-4057qib7	9053	34	.	.	.
cord-005453-4057qib7	9054	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9054	2	(	(	-LRB-
cord-005453-4057qib7	9054	3	LTV	LTV	NNP
cord-005453-4057qib7	9054	4	)	)	-RRB-
cord-005453-4057qib7	9054	5	was	be	VBD
cord-005453-4057qib7	9054	6	approved	approve	VBN
cord-005453-4057qib7	9054	7	in	in	IN
cord-005453-4057qib7	9054	8	11/2017	11/2017	CD
cord-005453-4057qib7	9054	9	for	for	IN
cord-005453-4057qib7	9054	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9054	11	(	(	-LRB-
cord-005453-4057qib7	9054	12	ppx	ppx	NNP
cord-005453-4057qib7	9054	13	)	)	-RRB-
cord-005453-4057qib7	9054	14	in	in	IN
cord-005453-4057qib7	9054	15	CMV	CMV	NNP
cord-005453-4057qib7	9054	16	-	-	HYPH
cord-005453-4057qib7	9054	17	seropositive	seropositive	JJ
cord-005453-4057qib7	9054	18	recipients	recipient	NNS
cord-005453-4057qib7	9054	19	(	(	-LRB-
cord-005453-4057qib7	9054	20	R+	R+	NNP
cord-005453-4057qib7	9054	21	)	)	-RRB-
cord-005453-4057qib7	9054	22	of	of	IN
cord-005453-4057qib7	9054	23	allo	allo	NN
cord-005453-4057qib7	9054	24	-	-	HYPH
cord-005453-4057qib7	9054	25	HCT	HCT	NNP
cord-005453-4057qib7	9054	26	.	.	.
cord-005453-4057qib7	9055	1	Since	since	IN
cord-005453-4057qib7	9055	2	12/2017	12/2017	CD
cord-005453-4057qib7	9055	3	,	,	,
cord-005453-4057qib7	9055	4	LTV	LTV	NNP
cord-005453-4057qib7	9055	5	ppx	ppx	NNP
cord-005453-4057qib7	9055	6	was	be	VBD
cord-005453-4057qib7	9055	7	implemented	implement	VBN
cord-005453-4057qib7	9055	8	at	at	IN
cord-005453-4057qib7	9055	9	our	-PRON-	PRP$
cord-005453-4057qib7	9055	10	center	center	NN
cord-005453-4057qib7	9055	11	for	for	IN
cord-005453-4057qib7	9055	12	both	both	CC
cord-005453-4057qib7	9055	13	primary	primary	JJ
cord-005453-4057qib7	9055	14	and	and	CC
cord-005453-4057qib7	9055	15	secondary	secondary	JJ
cord-005453-4057qib7	9055	16	ppx	ppx	NN
cord-005453-4057qib7	9055	17	.	.	.
cord-005453-4057qib7	9056	1	We	-PRON-	PRP
cord-005453-4057qib7	9056	2	report	report	VBP
cord-005453-4057qib7	9056	3	our	-PRON-	PRP$
cord-005453-4057qib7	9056	4	real	real	JJ
cord-005453-4057qib7	9056	5	-	-	HYPH
cord-005453-4057qib7	9056	6	world	world	NN
cord-005453-4057qib7	9056	7	experience	experience	NN
cord-005453-4057qib7	9056	8	.	.	.
cord-005453-4057qib7	9057	1	Methods	method	NNS
cord-005453-4057qib7	9057	2	:	:	:
cord-005453-4057qib7	9057	3	Adult	adult	NN
cord-005453-4057qib7	9057	4	CMV	CMV	NNP
cord-005453-4057qib7	9057	5	R+	r+	NN
cord-005453-4057qib7	9057	6	allo	allo	NN
cord-005453-4057qib7	9057	7	-	-	HYPH
cord-005453-4057qib7	9057	8	HCT	hct	NN
cord-005453-4057qib7	9057	9	pts	pts	NN
cord-005453-4057qib7	9057	10	who	who	WP
cord-005453-4057qib7	9057	11	initiated	initiate	VBD
cord-005453-4057qib7	9057	12	LTV	LTV	NNP
cord-005453-4057qib7	9057	13	as	as	IN
cord-005453-4057qib7	9057	14	primary	primary	JJ
cord-005453-4057qib7	9057	15	and/or	and/or	CC
cord-005453-4057qib7	9057	16	secondary	secondary	JJ
cord-005453-4057qib7	9057	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9057	18	were	be	VBD
cord-005453-4057qib7	9057	19	identified	identify	VBN
cord-005453-4057qib7	9057	20	between	between	IN
cord-005453-4057qib7	9057	21	1/1/2018	1/1/2018	CD
cord-005453-4057qib7	9057	22	and	and	CC
cord-005453-4057qib7	9057	23	6/30/18	6/30/18	CD
cord-005453-4057qib7	9057	24	.	.	.
cord-005453-4057qib7	9058	1	Cord	cord	NN
cord-005453-4057qib7	9058	2	blood	blood	NN
cord-005453-4057qib7	9058	3	transplants	transplant	NNS
cord-005453-4057qib7	9058	4	were	be	VBD
cord-005453-4057qib7	9058	5	excluded	exclude	VBN
cord-005453-4057qib7	9058	6	.	.	.
cord-005453-4057qib7	9059	1	The	the	DT
cord-005453-4057qib7	9059	2	primary	primary	JJ
cord-005453-4057qib7	9059	3	outcome	outcome	NN
cord-005453-4057qib7	9059	4	was	be	VBD
cord-005453-4057qib7	9059	5	the	the	DT
cord-005453-4057qib7	9059	6	incidence	incidence	NN
cord-005453-4057qib7	9059	7	of	of	IN
cord-005453-4057qib7	9059	8	clinically	clinically	RB
cord-005453-4057qib7	9059	9	significant	significant	JJ
cord-005453-4057qib7	9059	10	CMV	CMV	NNP
cord-005453-4057qib7	9059	11	infection	infection	NN
cord-005453-4057qib7	9059	12	(	(	-LRB-
cord-005453-4057qib7	9059	13	CMV	CMV	NNP
cord-005453-4057qib7	9059	14	viremia	viremia	NN
cord-005453-4057qib7	9059	15	requiring	require	VBG
cord-005453-4057qib7	9059	16	preemptive	preemptive	JJ
cord-005453-4057qib7	9059	17	treatment	treatment	NN
cord-005453-4057qib7	9059	18	or	or	CC
cord-005453-4057qib7	9059	19	CMV	CMV	NNP
cord-005453-4057qib7	9059	20	disease	disease	NN
cord-005453-4057qib7	9059	21	)	)	-RRB-
cord-005453-4057qib7	9059	22	.	.	.
cord-005453-4057qib7	9060	1	Pts	Pts	NNP
cord-005453-4057qib7	9060	2	were	be	VBD
cord-005453-4057qib7	9060	3	followed	follow	VBN
cord-005453-4057qib7	9060	4	through	through	IN
cord-005453-4057qib7	9060	5	9/2018	9/2018	CD
cord-005453-4057qib7	9060	6	.	.	.
cord-005453-4057qib7	9061	1	Results	result	NNS
cord-005453-4057qib7	9061	2	:	:	:
cord-005453-4057qib7	9062	1	53	53	CD
cord-005453-4057qib7	9062	2	pts	pt	NNS
cord-005453-4057qib7	9062	3	initiated	initiate	VBN
cord-005453-4057qib7	9062	4	LTV	LTV	NNP
cord-005453-4057qib7	9062	5	.	.	.
cord-005453-4057qib7	9063	1	69.8	69.8	CD
cord-005453-4057qib7	9063	2	%	%	NN
cord-005453-4057qib7	9063	3	pts	pt	NNS
cord-005453-4057qib7	9063	4	were	be	VBD
cord-005453-4057qib7	9063	5	at	at	IN
cord-005453-4057qib7	9063	6	high	high	JJ
cord-005453-4057qib7	9063	7	risk	risk	NN
cord-005453-4057qib7	9063	8	for	for	IN
cord-005453-4057qib7	9063	9	CMV	CMV	NNP
cord-005453-4057qib7	9063	10	reactivation	reactivation	NN
cord-005453-4057qib7	9063	11	and	and	CC
cord-005453-4057qib7	9063	12	disease	disease	NN
cord-005453-4057qib7	9063	13	(	(	-LRB-
cord-005453-4057qib7	9063	14	primarily	primarily	RB
cord-005453-4057qib7	9063	15	ex	ex	AFX
cord-005453-4057qib7	9063	16	vivo	vivo	NN
cord-005453-4057qib7	9063	17	T	t	NN
cord-005453-4057qib7	9063	18	-	-	HYPH
cord-005453-4057qib7	9063	19	cell	cell	NN
cord-005453-4057qib7	9063	20	depleted	deplete	VBN
cord-005453-4057qib7	9063	21	HCT	HCT	NNP
cord-005453-4057qib7	9063	22	[	[	-LRB-
cord-005453-4057qib7	9063	23	n	n	NN
cord-005453-4057qib7	9063	24	=	=	SYM
cord-005453-4057qib7	9063	25	18	18	CD
cord-005453-4057qib7	9063	26	;	;	:
cord-005453-4057qib7	9063	27	34	34	CD
cord-005453-4057qib7	9063	28	%	%	NN
cord-005453-4057qib7	9063	29	]	]	-RRB-
cord-005453-4057qib7	9063	30	or	or	CC
cord-005453-4057qib7	9063	31	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9063	32	T	t	NN
cord-005453-4057qib7	9063	33	-	-	HYPH
cord-005453-4057qib7	9063	34	replete	replete	JJ
cord-005453-4057qib7	9063	35	HCT	hct	NN
cord-005453-4057qib7	9063	36	[	[	-LRB-
cord-005453-4057qib7	9063	37	n	n	NN
cord-005453-4057qib7	9063	38	=	=	SYM
cord-005453-4057qib7	9063	39	12	12	CD
cord-005453-4057qib7	9063	40	;	;	:
cord-005453-4057qib7	9063	41	22.6	22.6	CD
cord-005453-4057qib7	9063	42	%	%	NN
cord-005453-4057qib7	9063	43	]	]	-RRB-
cord-005453-4057qib7	9063	44	)	)	-RRB-
cord-005453-4057qib7	9063	45	.	.	.
cord-005453-4057qib7	9064	1	The	the	DT
cord-005453-4057qib7	9064	2	most	most	RBS
cord-005453-4057qib7	9064	3	common	common	JJ
cord-005453-4057qib7	9064	4	indication	indication	NN
cord-005453-4057qib7	9064	5	for	for	IN
cord-005453-4057qib7	9064	6	HCT	HCT	NNP
cord-005453-4057qib7	9064	7	was	be	VBD
cord-005453-4057qib7	9064	8	acute	acute	JJ
cord-005453-4057qib7	9064	9	myeloid	myeloid	JJ
cord-005453-4057qib7	9064	10	leukemia	leukemia	NN
cord-005453-4057qib7	9065	1	(	(	-LRB-
cord-005453-4057qib7	9065	2	n	n	NN
cord-005453-4057qib7	9065	3	=	=	SYM
cord-005453-4057qib7	9065	4	16	16	CD
cord-005453-4057qib7	9065	5	;	;	:
cord-005453-4057qib7	9065	6	30.1	30.1	CD
cord-005453-4057qib7	9065	7	%	%	NN
cord-005453-4057qib7	9065	8	)	)	-RRB-
cord-005453-4057qib7	9065	9	and	and	CC
cord-005453-4057qib7	9065	10	the	the	DT
cord-005453-4057qib7	9065	11	majority	majority	NN
cord-005453-4057qib7	9065	12	of	of	IN
cord-005453-4057qib7	9065	13	patients	patient	NNS
cord-005453-4057qib7	9065	14	received	receive	VBD
cord-005453-4057qib7	9065	15	myeloablative	myeloablative	NNP
cord-005453-4057qib7	9065	16	conditioning	conditioning	NNP
cord-005453-4057qib7	9065	17	(	(	-LRB-
cord-005453-4057qib7	9065	18	n	n	NN
cord-005453-4057qib7	9065	19	=	=	SYM
cord-005453-4057qib7	9065	20	34	34	CD
cord-005453-4057qib7	9065	21	;	;	:
cord-005453-4057qib7	9065	22	64.2	64.2	CD
cord-005453-4057qib7	9065	23	%	%	NN
cord-005453-4057qib7	9065	24	)	)	-RRB-
cord-005453-4057qib7	9065	25	.	.	.
cord-005453-4057qib7	9066	1	39	39	CD
cord-005453-4057qib7	9066	2	pts	pts	NN
cord-005453-4057qib7	9066	3	(	(	-LRB-
cord-005453-4057qib7	9066	4	73.5	73.5	CD
cord-005453-4057qib7	9066	5	%	%	NN
cord-005453-4057qib7	9066	6	)	)	-RRB-
cord-005453-4057qib7	9066	7	received	receive	VBD
cord-005453-4057qib7	9066	8	LTV	LTV	NNP
cord-005453-4057qib7	9066	9	as	as	IN
cord-005453-4057qib7	9066	10	primary	primary	JJ
cord-005453-4057qib7	9066	11	ppx	ppx	NN
cord-005453-4057qib7	9066	12	after	after	IN
cord-005453-4057qib7	9066	13	HCT	HCT	NNP
cord-005453-4057qib7	9066	14	,	,	,
cord-005453-4057qib7	9066	15	with	with	IN
cord-005453-4057qib7	9066	16	a	a	DT
cord-005453-4057qib7	9066	17	median	median	JJ
cord-005453-4057qib7	9066	18	day	day	NN
cord-005453-4057qib7	9066	19	of	of	IN
cord-005453-4057qib7	9066	20	LTV	LTV	NNP
cord-005453-4057qib7	9066	21	initiation	initiation	NN
cord-005453-4057qib7	9066	22	of	of	IN
cord-005453-4057qib7	9066	23	D+7	D+7	NNP
cord-005453-4057qib7	9066	24	(	(	-LRB-
cord-005453-4057qib7	9066	25	range	range	VBP
cord-005453-4057qib7	9066	26	D+7	D+7	NNP
cord-005453-4057qib7	9066	27	─	─	NNPS
cord-005453-4057qib7	9066	28	D+40	D+40	NNP
cord-005453-4057qib7	9066	29	)	)	-RRB-
cord-005453-4057qib7	9066	30	.	.	.
cord-005453-4057qib7	9067	1	At	at	IN
cord-005453-4057qib7	9067	2	LTV	LTV	NNP
cord-005453-4057qib7	9067	3	initiation	initiation	NN
cord-005453-4057qib7	9067	4	,	,	,
cord-005453-4057qib7	9067	5	34	34	CD
cord-005453-4057qib7	9067	6	pts	pt	NNS
cord-005453-4057qib7	9067	7	had	have	VBD
cord-005453-4057qib7	9067	8	an	an	DT
cord-005453-4057qib7	9067	9	undetectable	undetectable	JJ
cord-005453-4057qib7	9067	10	CMV	CMV	NNP
cord-005453-4057qib7	9067	11	DNA	dna	NN
cord-005453-4057qib7	9067	12	,	,	,
cord-005453-4057qib7	9067	13	and	and	CC
cord-005453-4057qib7	9067	14	4	4	CD
cord-005453-4057qib7	9067	15	had	have	VBD
cord-005453-4057qib7	9067	16	CMV	CMV	NNP
cord-005453-4057qib7	9067	17	<	<	XX
cord-005453-4057qib7	9068	1	137	137	CD
cord-005453-4057qib7	9068	2	IU	IU	NNP
cord-005453-4057qib7	9068	3	/	/	SYM
cord-005453-4057qib7	9068	4	mL.	mL.	NNS
cord-005453-4057qib7	9068	5	Clinically	clinically	RB
cord-005453-4057qib7	9068	6	significant	significant	JJ
cord-005453-4057qib7	9068	7	CMV	CMV	NNP
cord-005453-4057qib7	9068	8	infection	infection	NN
cord-005453-4057qib7	9068	9	requiring	require	VBG
cord-005453-4057qib7	9068	10	preemptive	preemptive	JJ
cord-005453-4057qib7	9068	11	treatment	treatment	NN
cord-005453-4057qib7	9068	12	occurred	occur	VBD
cord-005453-4057qib7	9068	13	in	in	IN
cord-005453-4057qib7	9068	14	2	2	CD
cord-005453-4057qib7	9068	15	of	of	IN
cord-005453-4057qib7	9068	16	39	39	CD
cord-005453-4057qib7	9068	17	pts	pt	NNS
cord-005453-4057qib7	9068	18	(	(	-LRB-
cord-005453-4057qib7	9068	19	5.1	5.1	CD
cord-005453-4057qib7	9068	20	%	%	NN
cord-005453-4057qib7	9068	21	)	)	-RRB-
cord-005453-4057qib7	9068	22	.	.	.
cord-005453-4057qib7	9069	1	One	one	CD
cord-005453-4057qib7	9069	2	patient	patient	NN
cord-005453-4057qib7	9069	3	was	be	VBD
cord-005453-4057qib7	9069	4	treated	treat	VBN
cord-005453-4057qib7	9069	5	with	with	IN
cord-005453-4057qib7	9069	6	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	9069	7	(	(	-LRB-
cord-005453-4057qib7	9069	8	VGV	VGV	NNP
cord-005453-4057qib7	9069	9	)	)	-RRB-
cord-005453-4057qib7	9069	10	for	for	IN
cord-005453-4057qib7	9069	11	persistent	persistent	JJ
cord-005453-4057qib7	9069	12	CMV	CMV	NNP
cord-005453-4057qib7	9069	13	<	<	XX
cord-005453-4057qib7	9069	14	137	137	CD
cord-005453-4057qib7	9069	15	IU	IU	NNP
cord-005453-4057qib7	9069	16	/	/	SYM
cord-005453-4057qib7	9069	17	mL	ml	NN
cord-005453-4057qib7	9069	18	and	and	CC
cord-005453-4057qib7	9069	19	received	receive	VBD
cord-005453-4057qib7	9069	20	LTV	LTV	NNP
cord-005453-4057qib7	9069	21	as	as	IN
cord-005453-4057qib7	9069	22	secondary	secondary	JJ
cord-005453-4057qib7	9069	23	ppx	ppx	NN
cord-005453-4057qib7	9069	24	.	.	.
cord-005453-4057qib7	9070	1	A	a	DT
cord-005453-4057qib7	9070	2	2nd	2nd	JJ
cord-005453-4057qib7	9070	3	patient	patient	NN
cord-005453-4057qib7	9070	4	developed	develop	VBD
cord-005453-4057qib7	9070	5	persistently	persistently	RB
cord-005453-4057qib7	9070	6	detectable	detectable	JJ
cord-005453-4057qib7	9070	7	CMV	CMV	NNP
cord-005453-4057qib7	9070	8	(	(	-LRB-
cord-005453-4057qib7	9070	9	<	<	XX
cord-005453-4057qib7	9070	10	137	137	CD
cord-005453-4057qib7	9070	11	IU/	iu/	CD
cord-005453-4057qib7	9070	12	mL	ml	NN
cord-005453-4057qib7	9070	13	)	)	-RRB-
cord-005453-4057qib7	9070	14	and	and	CC
cord-005453-4057qib7	9070	15	breakthrough	breakthrough	VB
cord-005453-4057qib7	9070	16	CMV	CMV	NNP
cord-005453-4057qib7	9070	17	viremia	viremia	NN
cord-005453-4057qib7	9070	18	with	with	IN
cord-005453-4057qib7	9070	19	a	a	DT
cord-005453-4057qib7	9070	20	mutation	mutation	NN
cord-005453-4057qib7	9070	21	in	in	IN
cord-005453-4057qib7	9070	22	UL56	UL56	NNP
cord-005453-4057qib7	9070	23	at	at	IN
cord-005453-4057qib7	9070	24	site	site	NN
cord-005453-4057qib7	9070	25	C325YLTV	C325YLTV	NNP
cord-005453-4057qib7	9070	26	successfully	successfully	RB
cord-005453-4057qib7	9070	27	treated	treat	VBN
cord-005453-4057qib7	9070	28	with	with	IN
cord-005453-4057qib7	9070	29	VGV	VGV	NNP
cord-005453-4057qib7	9070	30	.	.	.
cord-005453-4057qib7	9071	1	The	the	DT
cord-005453-4057qib7	9071	2	median	median	JJ
cord-005453-4057qib7	9071	3	duration	duration	NN
cord-005453-4057qib7	9071	4	of	of	IN
cord-005453-4057qib7	9071	5	primary	primary	JJ
cord-005453-4057qib7	9071	6	LTV	LTV	NNP
cord-005453-4057qib7	9071	7	ppx	ppx	NNP
cord-005453-4057qib7	9071	8	was	be	VBD
cord-005453-4057qib7	9071	9	116	116	CD
cord-005453-4057qib7	9071	10	days	day	NNS
cord-005453-4057qib7	9071	11	(	(	-LRB-
cord-005453-4057qib7	9071	12	54	54	CD
cord-005453-4057qib7	9071	13	-	-	SYM
cord-005453-4057qib7	9071	14	221	221	CD
cord-005453-4057qib7	9071	15	)	)	-RRB-
cord-005453-4057qib7	9071	16	,	,	,
cord-005453-4057qib7	9071	17	with	with	IN
cord-005453-4057qib7	9071	18	primary	primary	JJ
cord-005453-4057qib7	9071	19	ppx	ppx	NN
cord-005453-4057qib7	9071	20	continuing	continue	VBG
cord-005453-4057qib7	9071	21	beyond	beyond	IN
cord-005453-4057qib7	9071	22	14	14	CD
cord-005453-4057qib7	9071	23	weeks	week	NNS
cord-005453-4057qib7	9071	24	post	post	NN
cord-005453-4057qib7	9071	25	HCT	hct	NN
cord-005453-4057qib7	9071	26	in	in	IN
cord-005453-4057qib7	9071	27	29	29	CD
cord-005453-4057qib7	9071	28	pts	pt	NNS
cord-005453-4057qib7	9071	29	.	.	.
cord-005453-4057qib7	9072	1	The	the	DT
cord-005453-4057qib7	9072	2	median	median	JJ
cord-005453-4057qib7	9072	3	additional	additional	JJ
cord-005453-4057qib7	9072	4	follow	follow	NN
cord-005453-4057qib7	9072	5	-	-	HYPH
cord-005453-4057qib7	9072	6	up	up	NN
cord-005453-4057qib7	9072	7	in	in	IN
cord-005453-4057qib7	9072	8	patients	patient	NNS
cord-005453-4057qib7	9072	9	who	who	WP
cord-005453-4057qib7	9072	10	discontinued	discontinue	VBD
cord-005453-4057qib7	9072	11	LTV	LTV	NNP
cord-005453-4057qib7	9072	12	was	be	VBD
cord-005453-4057qib7	9072	13	40	40	CD
cord-005453-4057qib7	9072	14	days	day	NNS
cord-005453-4057qib7	9072	15	(	(	-LRB-
cord-005453-4057qib7	9072	16	0	0	CD
cord-005453-4057qib7	9072	17	-	-	SYM
cord-005453-4057qib7	9072	18	154	154	CD
cord-005453-4057qib7	9072	19	)	)	-RRB-
cord-005453-4057qib7	9072	20	,	,	,
cord-005453-4057qib7	9072	21	without	without	IN
cord-005453-4057qib7	9072	22	clinically	clinically	RB
cord-005453-4057qib7	9072	23	significant	significant	JJ
cord-005453-4057qib7	9072	24	CMV	CMV	NNP
cord-005453-4057qib7	9072	25	infection	infection	NN
cord-005453-4057qib7	9072	26	to	to	IN
cord-005453-4057qib7	9072	27	date	date	NN
cord-005453-4057qib7	9072	28	.	.	.
cord-005453-4057qib7	9073	1	An	an	DT
cord-005453-4057qib7	9073	2	additional	additional	JJ
cord-005453-4057qib7	9073	3	14pts	14pts	NN
cord-005453-4057qib7	9073	4	(	(	-LRB-
cord-005453-4057qib7	9073	5	15	15	CD
cord-005453-4057qib7	9073	6	pts	pts	NN
cord-005453-4057qib7	9073	7	overall	overall	JJ
cord-005453-4057qib7	9073	8	;	;	:
cord-005453-4057qib7	9073	9	28.3	28.3	CD
cord-005453-4057qib7	9073	10	%	%	NN
cord-005453-4057qib7	9073	11	)	)	-RRB-
cord-005453-4057qib7	9073	12	received	receive	VBD
cord-005453-4057qib7	9073	13	LTV	LTV	NNP
cord-005453-4057qib7	9073	14	as	as	IN
cord-005453-4057qib7	9073	15	secondary	secondary	JJ
cord-005453-4057qib7	9073	16	ppx	ppx	NN
cord-005453-4057qib7	9073	17	after	after	IN
cord-005453-4057qib7	9073	18	CMV	CMV	NNP
cord-005453-4057qib7	9073	19	pre	pre	VBD
cord-005453-4057qib7	9073	20	-	-	JJ
cord-005453-4057qib7	9073	21	emptive	emptive	JJ
cord-005453-4057qib7	9073	22	therapy	therapy	NN
cord-005453-4057qib7	9073	23	.	.	.
cord-005453-4057qib7	9074	1	The	the	DT
cord-005453-4057qib7	9074	2	median	median	JJ
cord-005453-4057qib7	9074	3	duration	duration	NN
cord-005453-4057qib7	9074	4	of	of	IN
cord-005453-4057qib7	9074	5	secondary	secondary	JJ
cord-005453-4057qib7	9074	6	LTV	LTV	NNP
cord-005453-4057qib7	9074	7	ppx	ppx	NNP
cord-005453-4057qib7	9074	8	was	be	VBD
cord-005453-4057qib7	9074	9	127	127	CD
cord-005453-4057qib7	9074	10	days	day	NNS
cord-005453-4057qib7	9074	11	(	(	-LRB-
cord-005453-4057qib7	9074	12	18	18	CD
cord-005453-4057qib7	9074	13	-	-	SYM
cord-005453-4057qib7	9074	14	270	270	CD
cord-005453-4057qib7	9074	15	)	)	-RRB-
cord-005453-4057qib7	9074	16	,	,	,
cord-005453-4057qib7	9074	17	with	with	IN
cord-005453-4057qib7	9074	18	no	no	DT
cord-005453-4057qib7	9074	19	reactivation	reactivation	NN
cord-005453-4057qib7	9074	20	.	.	.
cord-005453-4057qib7	9075	1	LTV	LTV	NNP
cord-005453-4057qib7	9075	2	was	be	VBD
cord-005453-4057qib7	9075	3	not	not	RB
cord-005453-4057qib7	9075	4	discontinued	discontinue	VBN
cord-005453-4057qib7	9075	5	due	due	IN
cord-005453-4057qib7	9075	6	to	to	IN
cord-005453-4057qib7	9075	7	toxicity	toxicity	NN
cord-005453-4057qib7	9075	8	or	or	CC
cord-005453-4057qib7	9075	9	intolerance	intolerance	NN
cord-005453-4057qib7	9075	10	in	in	IN
cord-005453-4057qib7	9075	11	any	any	DT
cord-005453-4057qib7	9075	12	patient	patient	NN
cord-005453-4057qib7	9075	13	.	.	.
cord-005453-4057qib7	9076	1	CMV	CMV	NNP
cord-005453-4057qib7	9076	2	outcomes	outcome	NNS
cord-005453-4057qib7	9076	3	are	be	VBP
cord-005453-4057qib7	9076	4	summarized	summarize	VBN
cord-005453-4057qib7	9076	5	in	in	IN
cord-005453-4057qib7	9076	6	figure	figure	NN
cord-005453-4057qib7	9076	7	1	1	CD
cord-005453-4057qib7	9076	8	.	.	.
cord-005453-4057qib7	9077	1	All	all	DT
cord-005453-4057qib7	9077	2	-	-	HYPH
cord-005453-4057qib7	9077	3	cause	cause	NN
cord-005453-4057qib7	9077	4	mortality	mortality	NN
cord-005453-4057qib7	9077	5	for	for	IN
cord-005453-4057qib7	9077	6	the	the	DT
cord-005453-4057qib7	9077	7	53	53	CD
cord-005453-4057qib7	9077	8	pts	pt	NNS
cord-005453-4057qib7	9077	9	over	over	IN
cord-005453-4057qib7	9077	10	the	the	DT
cord-005453-4057qib7	9077	11	observational	observational	JJ
cord-005453-4057qib7	9077	12	period	period	NN
cord-005453-4057qib7	9077	13	was	be	VBD
cord-005453-4057qib7	9077	14	11.3	11.3	CD
cord-005453-4057qib7	9077	15	%	%	NN
cord-005453-4057qib7	9077	16	.	.	.
cord-005453-4057qib7	9078	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9078	2	:	:	:
cord-005453-4057qib7	9079	1	Primary	primary	JJ
cord-005453-4057qib7	9079	2	LTV	LTV	NNP
cord-005453-4057qib7	9079	3	ppx	ppx	NN
cord-005453-4057qib7	9079	4	significantly	significantly	RB
cord-005453-4057qib7	9079	5	reduced	reduce	VBD
cord-005453-4057qib7	9079	6	CMV	CMV	NNP
cord-005453-4057qib7	9079	7	reactivation	reactivation	NN
cord-005453-4057qib7	9079	8	,	,	,
cord-005453-4057qib7	9079	9	and	and	CC
cord-005453-4057qib7	9079	10	high	high	JJ
cord-005453-4057qib7	9079	11	-	-	HYPH
cord-005453-4057qib7	9079	12	risk	risk	NN
cord-005453-4057qib7	9079	13	patients	patient	NNS
cord-005453-4057qib7	9079	14	may	may	MD
cord-005453-4057qib7	9079	15	benefit	benefit	VB
cord-005453-4057qib7	9079	16	from	from	IN
cord-005453-4057qib7	9079	17	extended	extended	JJ
cord-005453-4057qib7	9079	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9079	19	.	.	.
cord-005453-4057qib7	9080	1	In	in	IN
cord-005453-4057qib7	9080	2	patients	patient	NNS
cord-005453-4057qib7	9080	3	who	who	WP
cord-005453-4057qib7	9080	4	received	receive	VBD
cord-005453-4057qib7	9080	5	preemptive	preemptive	JJ
cord-005453-4057qib7	9080	6	therapy	therapy	NN
cord-005453-4057qib7	9080	7	for	for	IN
cord-005453-4057qib7	9080	8	CMV	CMV	NNP
cord-005453-4057qib7	9080	9	,	,	,
cord-005453-4057qib7	9080	10	use	use	NN
cord-005453-4057qib7	9080	11	of	of	IN
cord-005453-4057qib7	9080	12	secondary	secondary	JJ
cord-005453-4057qib7	9080	13	ppx	ppx	NN
cord-005453-4057qib7	9080	14	showed	show	VBD
cord-005453-4057qib7	9080	15	no	no	DT
cord-005453-4057qib7	9080	16	recurrent	recurrent	JJ
cord-005453-4057qib7	9080	17	CMV	CMV	NNP
cord-005453-4057qib7	9080	18	reactivation	reactivation	NN
cord-005453-4057qib7	9080	19	.	.	.
cord-005453-4057qib7	9081	1	LTV	LTV	NNP
cord-005453-4057qib7	9081	2	is	be	VBZ
cord-005453-4057qib7	9081	3	well	well	RB
cord-005453-4057qib7	9081	4	tolerated	tolerate	VBN
cord-005453-4057qib7	9081	5	.	.	.
cord-005453-4057qib7	9082	1	Additional	additional	JJ
cord-005453-4057qib7	9082	2	studies	study	NNS
cord-005453-4057qib7	9082	3	are	be	VBP
cord-005453-4057qib7	9082	4	needed	need	VBN
cord-005453-4057qib7	9082	5	to	to	TO
cord-005453-4057qib7	9082	6	determine	determine	VB
cord-005453-4057qib7	9082	7	optimal	optimal	JJ
cord-005453-4057qib7	9082	8	ppx	ppx	NN
cord-005453-4057qib7	9082	9	duration	duration	NN
cord-005453-4057qib7	9082	10	and	and	CC
cord-005453-4057qib7	9082	11	to	to	TO
cord-005453-4057qib7	9082	12	clarify	clarify	VB
cord-005453-4057qib7	9082	13	role	role	NN
cord-005453-4057qib7	9082	14	of	of	IN
cord-005453-4057qib7	9082	15	secondary	secondary	JJ
cord-005453-4057qib7	9082	16	CMV	CMV	NNP
cord-005453-4057qib7	9082	17	ppx	ppx	NN
cord-005453-4057qib7	9082	18	in	in	IN
cord-005453-4057qib7	9082	19	high	high	JJ
cord-005453-4057qib7	9082	20	-	-	HYPH
cord-005453-4057qib7	9082	21	risk	risk	NN
cord-005453-4057qib7	9082	22	allo	allo	NN
cord-005453-4057qib7	9082	23	-	-	HYPH
cord-005453-4057qib7	9082	24	HCT	hct	NN
cord-005453-4057qib7	9082	25	.	.	.
cord-005453-4057qib7	9083	1	The	the	DT
cord-005453-4057qib7	9083	2	future	future	JJ
cord-005453-4057qib7	9083	3	standard	standard	NN
cord-005453-4057qib7	9083	4	of	of	IN
cord-005453-4057qib7	9083	5	care	care	NN
cord-005453-4057qib7	9083	6	will	will	MD
cord-005453-4057qib7	9083	7	likely	likely	RB
cord-005453-4057qib7	9083	8	include	include	VB
cord-005453-4057qib7	9083	9	extended	extend	VBN
cord-005453-4057qib7	9083	10	primary	primary	JJ
cord-005453-4057qib7	9083	11	ppx	ppx	NN
cord-005453-4057qib7	9083	12	and	and	CC
cord-005453-4057qib7	9083	13	secondary	secondary	JJ
cord-005453-4057qib7	9083	14	ppx	ppx	NN
cord-005453-4057qib7	9083	15	and	and	CC
cord-005453-4057qib7	9083	16	result	result	VB
cord-005453-4057qib7	9083	17	in	in	IN
cord-005453-4057qib7	9083	18	decreased	decreased	JJ
cord-005453-4057qib7	9083	19	morbidity	morbidity	NN
cord-005453-4057qib7	9083	20	and	and	CC
cord-005453-4057qib7	9083	21	mortality	mortality	NN
cord-005453-4057qib7	9083	22	associated	associate	VBN
cord-005453-4057qib7	9083	23	with	with	IN
cord-005453-4057qib7	9083	24	CMV	CMV	NNP
cord-005453-4057qib7	9083	25	.	.	.
cord-005453-4057qib7	9084	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9084	2	:	:	:
cord-005453-4057qib7	9085	1	Andrew	Andrew	NNP
cord-005453-4057qib7	9085	2	Lin	Lin	NNP
cord-005453-4057qib7	9085	3	-Nothing	-Nothing	.
cord-005453-4057qib7	9086	1	to	to	TO
cord-005453-4057qib7	9086	2	declare	declare	VB
cord-005453-4057qib7	9086	3	,	,	,
cord-005453-4057qib7	9086	4	Molly	Molly	NNP
cord-005453-4057qib7	9086	5	A.	A.	NNP
cord-005453-4057qib7	9086	6	Maloy	Maloy	NNP
cord-005453-4057qib7	9086	7	-Nothing	-nothing	NN
cord-005453-4057qib7	9086	8	to	to	TO
cord-005453-4057qib7	9086	9	declare	declare	VB
cord-005453-4057qib7	9086	10	,	,	,
cord-005453-4057qib7	9086	11	Valkal	Valkal	NNP
cord-005453-4057qib7	9086	12	Bhatt	Bhatt	NNP
cord-005453-4057qib7	9086	13	-Nothing	-nothe	VBG
cord-005453-4057qib7	9086	14	to	to	TO
cord-005453-4057qib7	9086	15	declare	declare	VB
cord-005453-4057qib7	9086	16	,	,	,
cord-005453-4057qib7	9086	17	Lauren	Lauren	NNP
cord-005453-4057qib7	9086	18	DeRespiris	DeRespiris	NNP
cord-005453-4057qib7	9086	19	-Nothing	-nothe	VBG
cord-005453-4057qib7	9086	20	to	to	TO
cord-005453-4057qib7	9086	21	declare	declare	VB
cord-005453-4057qib7	9086	22	,	,	,
cord-005453-4057qib7	9086	23	Meagan	Meagan	NNP
cord-005453-4057qib7	9086	24	Griffin	Griffin	NNP
cord-005453-4057qib7	9086	25	-Nothing	-nothe	VBG
cord-005453-4057qib7	9086	26	to	to	TO
cord-005453-4057qib7	9086	27	declare	declare	VB
cord-005453-4057qib7	9086	28	Carmen	Carmen	NNP
cord-005453-4057qib7	9086	29	Lau	Lau	NNP
cord-005453-4057qib7	9086	30	-Nothing	-nothe	VBG
cord-005453-4057qib7	9086	31	to	to	TO
cord-005453-4057qib7	9086	32	declare	declare	VB
cord-005453-4057qib7	9086	33	,	,	,
cord-005453-4057qib7	9086	34	Anthony	Anthony	NNP
cord-005453-4057qib7	9086	35	J.	J.	NNP
cord-005453-4057qib7	9086	36	Proli	Proli	NNP
cord-005453-4057qib7	9086	37	-Nothing	-nothe	VBG
cord-005453-4057qib7	9087	1	to	to	TO
cord-005453-4057qib7	9087	2	declare	declare	VB
cord-005453-4057qib7	9087	3	,	,	,
cord-005453-4057qib7	9087	4	Juliet	Juliet	NNP
cord-005453-4057qib7	9087	5	Barker	Barker	NNP
cord-005453-4057qib7	9087	6	-Angiocrine	-Angiocrine	NNP
cord-005453-4057qib7	9087	7	Bioscience	Bioscience	NNP
cord-005453-4057qib7	9087	8	,	,	,
cord-005453-4057qib7	9087	9	letermovir	letermovir	JJ
cord-005453-4057qib7	9087	10	primary	primary	JJ
cord-005453-4057qib7	9087	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9087	12	(	(	-LRB-
cord-005453-4057qib7	9087	13	PP	PP	NNP
cord-005453-4057qib7	9087	14	)	)	-RRB-
cord-005453-4057qib7	9087	15	has	have	VBZ
cord-005453-4057qib7	9087	16	been	be	VBN
cord-005453-4057qib7	9087	17	shown	show	VBN
cord-005453-4057qib7	9087	18	to	to	TO
cord-005453-4057qib7	9087	19	reduce	reduce	VB
cord-005453-4057qib7	9087	20	clinically	clinically	RB
cord-005453-4057qib7	9087	21	significant	significant	JJ
cord-005453-4057qib7	9087	22	CMV	CMV	NNP
cord-005453-4057qib7	9087	23	infection	infection	NN
cord-005453-4057qib7	9087	24	with	with	IN
cord-005453-4057qib7	9087	25	a	a	DT
cord-005453-4057qib7	9087	26	favorable	favorable	JJ
cord-005453-4057qib7	9087	27	safety	safety	NN
cord-005453-4057qib7	9087	28	profile	profile	NN
cord-005453-4057qib7	9087	29	.	.	.
cord-005453-4057qib7	9088	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9088	2	PP	PP	NNP
cord-005453-4057qib7	9088	3	will	will	MD
cord-005453-4057qib7	9088	4	improve	improve	VB
cord-005453-4057qib7	9088	5	the	the	DT
cord-005453-4057qib7	9088	6	outcome	outcome	NN
cord-005453-4057qib7	9088	7	of	of	IN
cord-005453-4057qib7	9088	8	seropositive	seropositive	JJ
cord-005453-4057qib7	9088	9	patients	patient	NNS
cord-005453-4057qib7	9088	10	.	.	.
cord-005453-4057qib7	9089	1	However	however	RB
cord-005453-4057qib7	9089	2	,	,	,
cord-005453-4057qib7	9089	3	patients	patient	NNS
cord-005453-4057qib7	9089	4	who	who	WP
cord-005453-4057qib7	9089	5	did	do	VBD
cord-005453-4057qib7	9089	6	not	not	RB
cord-005453-4057qib7	9089	7	benefit	benefit	VB
cord-005453-4057qib7	9089	8	from	from	IN
cord-005453-4057qib7	9089	9	PP	PP	NNP
cord-005453-4057qib7	9089	10	and	and	CC
cord-005453-4057qib7	9089	11	experienced	experience	VBD
cord-005453-4057qib7	9089	12	>	>	XX
cord-005453-4057qib7	9089	13	1	1	CD
cord-005453-4057qib7	9089	14	CMV	CMV	NNP
cord-005453-4057qib7	9089	15	episode	episode	NN
cord-005453-4057qib7	9089	16	(	(	-LRB-
cord-005453-4057qib7	9089	17	infection	infection	NN
cord-005453-4057qib7	9089	18	or	or	CC
cord-005453-4057qib7	9089	19	disease	disease	NN
cord-005453-4057qib7	9089	20	)	)	-RRB-
cord-005453-4057qib7	9089	21	after	after	IN
cord-005453-4057qib7	9089	22	HCT	HCT	NNP
cord-005453-4057qib7	9089	23	may	may	MD
cord-005453-4057qib7	9089	24	be	be	VB
cord-005453-4057qib7	9089	25	candidate	candidate	NN
cord-005453-4057qib7	9089	26	to	to	IN
cord-005453-4057qib7	9089	27	secondary	secondary	JJ
cord-005453-4057qib7	9089	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9089	29	(	(	-LRB-
cord-005453-4057qib7	9089	30	SP	SP	NNP
cord-005453-4057qib7	9089	31	)	)	-RRB-
cord-005453-4057qib7	9089	32	.	.	.
cord-005453-4057qib7	9090	1	Indeed	indeed	RB
cord-005453-4057qib7	9090	2	half	half	NN
cord-005453-4057qib7	9090	3	of	of	IN
cord-005453-4057qib7	9090	4	them	-PRON-	PRP
cord-005453-4057qib7	9090	5	will	will	MD
cord-005453-4057qib7	9090	6	have	have	VB
cord-005453-4057qib7	9090	7	>	>	$
cord-005453-4057qib7	9090	8	1	1	CD
cord-005453-4057qib7	9090	9	recurrent	recurrent	JJ
cord-005453-4057qib7	9090	10	episode	episode	NN
cord-005453-4057qib7	9090	11	after	after	IN
cord-005453-4057qib7	9090	12	pre	pre	JJ
cord-005453-4057qib7	9090	13	-	-	JJ
cord-005453-4057qib7	9090	14	emptive	emptive	JJ
cord-005453-4057qib7	9090	15	treatment	treatment	NN
cord-005453-4057qib7	9090	16	(	(	-LRB-
cord-005453-4057qib7	9090	17	PET	PET	NNP
cord-005453-4057qib7	9090	18	)	)	-RRB-
cord-005453-4057qib7	9090	19	.	.	.
cord-005453-4057qib7	9091	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9091	2	is	be	VBZ
cord-005453-4057qib7	9091	3	available	available	JJ
cord-005453-4057qib7	9091	4	since	since	IN
cord-005453-4057qib7	9091	5	November	November	NNP
cord-005453-4057qib7	9091	6	2017	2017	CD
cord-005453-4057qib7	9091	7	as	as	IN
cord-005453-4057qib7	9091	8	part	part	NN
cord-005453-4057qib7	9091	9	of	of	IN
cord-005453-4057qib7	9091	10	the	the	DT
cord-005453-4057qib7	9091	11	French	french	JJ
cord-005453-4057qib7	9091	12	early	early	JJ
cord-005453-4057qib7	9091	13	access	access	NN
cord-005453-4057qib7	9091	14	program	program	NN
cord-005453-4057qib7	9091	15	for	for	IN
cord-005453-4057qib7	9091	16	PP	PP	NNP
cord-005453-4057qib7	9091	17	and	and	CC
cord-005453-4057qib7	9091	18	SP	SP	NNP
cord-005453-4057qib7	9091	19	.	.	.
cord-005453-4057qib7	9092	1	We	-PRON-	PRP
cord-005453-4057qib7	9092	2	report	report	VBP
cord-005453-4057qib7	9092	3	the	the	DT
cord-005453-4057qib7	9092	4	outcome	outcome	NN
cord-005453-4057qib7	9092	5	of	of	IN
cord-005453-4057qib7	9092	6	patients	patient	NNS
cord-005453-4057qib7	9092	7	who	who	WP
cord-005453-4057qib7	9092	8	benefited	benefit	VBD
cord-005453-4057qib7	9092	9	from	from	IN
cord-005453-4057qib7	9092	10	letermovir	letermovir	NNS
cord-005453-4057qib7	9092	11	SP	SP	NNP
cord-005453-4057qib7	9092	12	in	in	IN
cord-005453-4057qib7	9092	13	the	the	DT
cord-005453-4057qib7	9092	14	context	context	NN
cord-005453-4057qib7	9092	15	of	of	IN
cord-005453-4057qib7	9092	16	this	this	DT
cord-005453-4057qib7	9092	17	program	program	NN
cord-005453-4057qib7	9092	18	.	.	.
cord-005453-4057qib7	9093	1	Methods	method	NNS
cord-005453-4057qib7	9093	2	:	:	:
cord-005453-4057qib7	9093	3	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9093	4	is	be	VBZ
cord-005453-4057qib7	9093	5	granted	grant	VBN
cord-005453-4057qib7	9093	6	,	,	,
cord-005453-4057qib7	9093	7	in	in	IN
cord-005453-4057qib7	9093	8	a	a	DT
cord-005453-4057qib7	9093	9	restrictive	restrictive	JJ
cord-005453-4057qib7	9093	10	manner	manner	NN
cord-005453-4057qib7	9093	11	,	,	,
cord-005453-4057qib7	9093	12	by	by	IN
cord-005453-4057qib7	9093	13	the	the	DT
cord-005453-4057qib7	9093	14	French	french	JJ
cord-005453-4057qib7	9093	15	drug	drug	NN
cord-005453-4057qib7	9093	16	agency	agency	NN
cord-005453-4057qib7	9093	17	(	(	-LRB-
cord-005453-4057qib7	9093	18	ANSM	ANSM	NNP
cord-005453-4057qib7	9093	19	)	)	-RRB-
cord-005453-4057qib7	9093	20	on	on	IN
cord-005453-4057qib7	9093	21	a	a	DT
cord-005453-4057qib7	9093	22	case	case	NN
cord-005453-4057qib7	9093	23	-	-	HYPH
cord-005453-4057qib7	9093	24	by	by	IN
cord-005453-4057qib7	9093	25	-	-	HYPH
cord-005453-4057qib7	9093	26	case	case	NN
cord-005453-4057qib7	9093	27	basis	basis	NN
cord-005453-4057qib7	9093	28	for	for	IN
cord-005453-4057qib7	9093	29	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9093	30	of	of	IN
cord-005453-4057qib7	9093	31	CMV	CMV	NNP
cord-005453-4057qib7	9093	32	episode	episode	NN
cord-005453-4057qib7	9093	33	,	,	,
cord-005453-4057qib7	9093	34	in	in	IN
cord-005453-4057qib7	9093	35	CMV	CMV	NNP
cord-005453-4057qib7	9093	36	-	-	HYPH
cord-005453-4057qib7	9093	37	seropositive	seropositive	JJ
cord-005453-4057qib7	9093	38	adult	adult	NN
cord-005453-4057qib7	9093	39	allogeneic	allogeneic	NN
cord-005453-4057qib7	9093	40	HCT	HCT	NNP
cord-005453-4057qib7	9093	41	recipients	recipient	NNS
cord-005453-4057qib7	9093	42	.	.	.
cord-005453-4057qib7	9094	1	SP	SP	NNP
cord-005453-4057qib7	9094	2	patients	patient	NNS
cord-005453-4057qib7	9094	3	should	should	MD
cord-005453-4057qib7	9094	4	have	have	VB
cord-005453-4057qib7	9094	5	a	a	DT
cord-005453-4057qib7	9094	6	negative	negative	JJ
cord-005453-4057qib7	9094	7	baseline	baseline	JJ
cord-005453-4057qib7	9094	8	CMV	CMV	NNP
cord-005453-4057qib7	9094	9	PCR	PCR	NNP
cord-005453-4057qib7	9094	10	,	,	,
cord-005453-4057qib7	9094	11	have	have	VBP
cord-005453-4057qib7	9094	12	already	already	RB
cord-005453-4057qib7	9094	13	experienced	experience	VBN
cord-005453-4057qib7	9094	14	>	>	XX
cord-005453-4057qib7	9094	15	1	1	CD
cord-005453-4057qib7	9094	16	CMV	CMV	NNP
cord-005453-4057qib7	9094	17	episode	episode	NN
cord-005453-4057qib7	9094	18	,	,	,
cord-005453-4057qib7	9094	19	in	in	IN
cord-005453-4057qib7	9094	20	the	the	DT
cord-005453-4057qib7	9094	21	context	context	NN
cord-005453-4057qib7	9094	22	of	of	IN
cord-005453-4057qib7	9094	23	a	a	DT
cord-005453-4057qib7	9094	24	potentially	potentially	RB
cord-005453-4057qib7	9094	25	harmful	harmful	JJ
cord-005453-4057qib7	9094	26	PET	pet	NN
cord-005453-4057qib7	9094	27	according	accord	VBG
cord-005453-4057qib7	9094	28	to	to	IN
cord-005453-4057qib7	9094	29	physicians	physician	NNS
cord-005453-4057qib7	9094	30	.	.	.
cord-005453-4057qib7	9095	1	Planned	plan	VBN
cord-005453-4057qib7	9095	2	letermovir	letermovir	NNP
cord-005453-4057qib7	9095	3	daily	daily	RB
cord-005453-4057qib7	9095	4	dose	dose	NN
cord-005453-4057qib7	9095	5	was	be	VBD
cord-005453-4057qib7	9095	6	240	240	CD
cord-005453-4057qib7	9095	7	mg	mg	NN
cord-005453-4057qib7	9095	8	in	in	IN
cord-005453-4057qib7	9095	9	case	case	NN
cord-005453-4057qib7	9095	10	of	of	IN
cord-005453-4057qib7	9095	11	concomitant	concomitant	JJ
cord-005453-4057qib7	9095	12	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	9095	13	and	and	CC
cord-005453-4057qib7	9095	14	480	480	CD
cord-005453-4057qib7	9095	15	mg	mg	NNS
cord-005453-4057qib7	9095	16	otherwise	otherwise	RB
cord-005453-4057qib7	9095	17	.	.	.
cord-005453-4057qib7	9096	1	All	all	DT
cord-005453-4057qib7	9096	2	patients	patient	NNS
cord-005453-4057qib7	9096	3	were	be	VBD
cord-005453-4057qib7	9096	4	routinely	routinely	RB
cord-005453-4057qib7	9096	5	screened	screen	VBN
cord-005453-4057qib7	9096	6	by	by	IN
cord-005453-4057qib7	9096	7	blood	blood	NN
cord-005453-4057qib7	9096	8	or	or	CC
cord-005453-4057qib7	9096	9	plasma	plasma	NN
cord-005453-4057qib7	9096	10	CMV	CMV	NNP
cord-005453-4057qib7	9096	11	PCR	PCR	NNP
cord-005453-4057qib7	9096	12	.	.	.
cord-005453-4057qib7	9097	1	Results	result	NNS
cord-005453-4057qib7	9097	2	:	:	:
cord-005453-4057qib7	9098	1	Between	between	IN
cord-005453-4057qib7	9098	2	November	November	NNP
cord-005453-4057qib7	9098	3	2017-July	2017-july	CD
cord-005453-4057qib7	9098	4	2018	2018	CD
cord-005453-4057qib7	9098	5	,	,	,
cord-005453-4057qib7	9098	6	57	57	CD
cord-005453-4057qib7	9098	7	patients	patient	NNS
cord-005453-4057qib7	9098	8	received	receive	VBD
cord-005453-4057qib7	9098	9	letermovir	letermovir	NNS
cord-005453-4057qib7	9098	10	in	in	IN
cord-005453-4057qib7	9098	11	the	the	DT
cord-005453-4057qib7	9098	12	early	early	JJ
cord-005453-4057qib7	9098	13	access	access	NN
cord-005453-4057qib7	9098	14	program	program	NN
cord-005453-4057qib7	9098	15	,	,	,
cord-005453-4057qib7	9098	16	22	22	CD
cord-005453-4057qib7	9098	17	for	for	IN
cord-005453-4057qib7	9098	18	PP	PP	NNP
cord-005453-4057qib7	9098	19	,	,	,
cord-005453-4057qib7	9098	20	and	and	CC
cord-005453-4057qib7	9098	21	35	35	CD
cord-005453-4057qib7	9098	22	for	for	IN
cord-005453-4057qib7	9098	23	SP	SP	NNP
cord-005453-4057qib7	9098	24	.	.	.
cord-005453-4057qib7	9099	1	Among	among	IN
cord-005453-4057qib7	9099	2	the	the	DT
cord-005453-4057qib7	9099	3	35	35	CD
cord-005453-4057qib7	9099	4	SP	SP	NNP
cord-005453-4057qib7	9099	5	patients	patient	NNS
cord-005453-4057qib7	9099	6	,	,	,
cord-005453-4057qib7	9099	7	6	6	CD
cord-005453-4057qib7	9099	8	had	have	VBD
cord-005453-4057qib7	9099	9	previous	previous	JJ
cord-005453-4057qib7	9099	10	CMV	CMV	NNP
cord-005453-4057qib7	9099	11	disease	disease	NN
cord-005453-4057qib7	9099	12	(	(	-LRB-
cord-005453-4057qib7	9099	13	gut	gut	NN
cord-005453-4057qib7	9099	14	:	:	:
cord-005453-4057qib7	9099	15	5	5	CD
cord-005453-4057qib7	9099	16	;	;	:
cord-005453-4057qib7	9099	17	CNS	CNS	NNP
cord-005453-4057qib7	9099	18	:	:	:
cord-005453-4057qib7	9099	19	1	1	CD
cord-005453-4057qib7	9099	20	)	)	-RRB-
cord-005453-4057qib7	9099	21	.	.	.
cord-005453-4057qib7	9100	1	Mean	mean	JJ
cord-005453-4057qib7	9100	2	age	age	NN
cord-005453-4057qib7	9100	3	was	be	VBD
cord-005453-4057qib7	9100	4	55±13	55±13	CD
cord-005453-4057qib7	9100	5	years	year	NNS
cord-005453-4057qib7	9100	6	,	,	,
cord-005453-4057qib7	9100	7	M	M	NNP
cord-005453-4057qib7	9100	8	/	/	SYM
cord-005453-4057qib7	9100	9	F	F	NNP
cord-005453-4057qib7	9100	10	ratio	ratio	NN
cord-005453-4057qib7	9100	11	was	be	VBD
cord-005453-4057qib7	9100	12	22/13	22/13	CD
cord-005453-4057qib7	9100	13	.	.	.
cord-005453-4057qib7	9101	1	The	the	DT
cord-005453-4057qib7	9101	2	SP	SP	NNP
cord-005453-4057qib7	9101	3	cohort	cohort	NN
cord-005453-4057qib7	9101	4	included	include	VBD
cord-005453-4057qib7	9101	5	one	one	CD
cord-005453-4057qib7	9101	6	cord	cord	NN
cord-005453-4057qib7	9101	7	blood	blood	NN
cord-005453-4057qib7	9101	8	and	and	CC
cord-005453-4057qib7	9101	9	10	10	CD
cord-005453-4057qib7	9101	10	haplo	haplo	NN
cord-005453-4057qib7	9101	11	-	-	HYPH
cord-005453-4057qib7	9101	12	identical	identical	JJ
cord-005453-4057qib7	9101	13	HCT	hct	NN
cord-005453-4057qib7	9101	14	.	.	.
cord-005453-4057qib7	9102	1	Main	main	JJ
cord-005453-4057qib7	9102	2	diagnoses	diagnosis	NNS
cord-005453-4057qib7	9102	3	were	be	VBD
cord-005453-4057qib7	9102	4	acute	acute	JJ
cord-005453-4057qib7	9102	5	leukemia	leukemia	NN
cord-005453-4057qib7	9102	6	(	(	-LRB-
cord-005453-4057qib7	9102	7	46	46	CD
cord-005453-4057qib7	9102	8	%	%	NN
cord-005453-4057qib7	9102	9	)	)	-RRB-
cord-005453-4057qib7	9102	10	and	and	CC
cord-005453-4057qib7	9102	11	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	9102	12	syndrome	syndrome	NN
cord-005453-4057qib7	9102	13	(	(	-LRB-
cord-005453-4057qib7	9102	14	26	26	CD
cord-005453-4057qib7	9102	15	%	%	NN
cord-005453-4057qib7	9102	16	)	)	-RRB-
cord-005453-4057qib7	9102	17	.	.	.
cord-005453-4057qib7	9103	1	The	the	DT
cord-005453-4057qib7	9103	2	conditioning	conditioning	NN
cord-005453-4057qib7	9103	3	regimen	regimen	NN
cord-005453-4057qib7	9103	4	was	be	VBD
cord-005453-4057qib7	9103	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9103	6	in	in	IN
cord-005453-4057qib7	9103	7	47	47	CD
cord-005453-4057qib7	9103	8	%	%	NN
cord-005453-4057qib7	9103	9	and	and	CC
cord-005453-4057qib7	9103	10	included	include	VBD
cord-005453-4057qib7	9103	11	ATG	ATG	NNP
cord-005453-4057qib7	9103	12	in	in	IN
cord-005453-4057qib7	9103	13	61	61	CD
cord-005453-4057qib7	9103	14	%	%	NN
cord-005453-4057qib7	9103	15	.	.	.
cord-005453-4057qib7	9104	1	Based	base	VBN
cord-005453-4057qib7	9104	2	on	on	IN
cord-005453-4057qib7	9104	3	available	available	JJ
cord-005453-4057qib7	9104	4	data	datum	NNS
cord-005453-4057qib7	9104	5	(	(	-LRB-
cord-005453-4057qib7	9104	6	6	6	CD
cord-005453-4057qib7	9104	7	missing	miss	VBG
cord-005453-4057qib7	9104	8	data	datum	NNS
cord-005453-4057qib7	9104	9	,	,	,
cord-005453-4057qib7	9104	10	md	md	NNP
cord-005453-4057qib7	9104	11	)	)	-RRB-
cord-005453-4057qib7	9104	12	,	,	,
cord-005453-4057qib7	9104	13	previous	previous	JJ
cord-005453-4057qib7	9104	14	GvHD	GvHD	NNP
cord-005453-4057qib7	9104	15	was	be	VBD
cord-005453-4057qib7	9104	16	present	present	JJ
cord-005453-4057qib7	9104	17	in	in	IN
cord-005453-4057qib7	9104	18	22	22	CD
cord-005453-4057qib7	9104	19	(	(	-LRB-
cord-005453-4057qib7	9104	20	76	76	CD
cord-005453-4057qib7	9104	21	%	%	NN
cord-005453-4057qib7	9104	22	)	)	-RRB-
cord-005453-4057qib7	9104	23	patients	patient	NNS
cord-005453-4057qib7	9104	24	,	,	,
cord-005453-4057qib7	9104	25	and	and	CC
cord-005453-4057qib7	9104	26	active	active	JJ
cord-005453-4057qib7	9104	27	at	at	IN
cord-005453-4057qib7	9104	28	letermovir	letermovir	NNP
cord-005453-4057qib7	9104	29	initiation	initiation	NN
cord-005453-4057qib7	9104	30	in	in	IN
cord-005453-4057qib7	9104	31	17	17	CD
cord-005453-4057qib7	9104	32	(	(	-LRB-
cord-005453-4057qib7	9104	33	59	59	CD
cord-005453-4057qib7	9104	34	%	%	NN
cord-005453-4057qib7	9104	35	)	)	-RRB-
cord-005453-4057qib7	9104	36	.	.	.
cord-005453-4057qib7	9105	1	Thirty	thirty	CD
cord-005453-4057qib7	9105	2	two	two	CD
cord-005453-4057qib7	9105	3	(	(	-LRB-
cord-005453-4057qib7	9105	4	91	91	CD
cord-005453-4057qib7	9105	5	%	%	NN
cord-005453-4057qib7	9105	6	)	)	-RRB-
cord-005453-4057qib7	9105	7	patients	patient	NNS
cord-005453-4057qib7	9105	8	were	be	VBD
cord-005453-4057qib7	9105	9	planned	plan	VBN
cord-005453-4057qib7	9105	10	to	to	TO
cord-005453-4057qib7	9105	11	receive	receive	VB
cord-005453-4057qib7	9105	12	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	9105	13	.	.	.
cord-005453-4057qib7	9106	1	Donor	donor	NN
cord-005453-4057qib7	9106	2	's	's	POS
cord-005453-4057qib7	9106	3	CMV	CMV	NNP
cord-005453-4057qib7	9106	4	serology	serology	NN
cord-005453-4057qib7	9106	5	was	be	VBD
cord-005453-4057qib7	9106	6	negative	negative	JJ
cord-005453-4057qib7	9106	7	in	in	IN
cord-005453-4057qib7	9106	8	12/15	12/15	CD
cord-005453-4057qib7	9106	9	(	(	-LRB-
cord-005453-4057qib7	9106	10	80	80	CD
cord-005453-4057qib7	9106	11	%	%	NN
cord-005453-4057qib7	9106	12	)	)	-RRB-
cord-005453-4057qib7	9106	13	(	(	-LRB-
cord-005453-4057qib7	9106	14	20	20	CD
cord-005453-4057qib7	9106	15	md	md	NNP
cord-005453-4057qib7	9106	16	)	)	-RRB-
cord-005453-4057qib7	9106	17	.	.	.
cord-005453-4057qib7	9107	1	At	at	IN
cord-005453-4057qib7	9107	2	baseline	baseline	NN
cord-005453-4057qib7	9107	3	,	,	,
cord-005453-4057qib7	9107	4	CMV	CMV	NNP
cord-005453-4057qib7	9107	5	PCR	PCR	NNP
cord-005453-4057qib7	9107	6	was	be	VBD
cord-005453-4057qib7	9107	7	detectable	detectable	JJ
cord-005453-4057qib7	9107	8	in	in	IN
cord-005453-4057qib7	9107	9	1/35	1/35	CD
cord-005453-4057qib7	9107	10	patients	patient	NNS
cord-005453-4057qib7	9107	11	.	.	.
cord-005453-4057qib7	9108	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9108	2	was	be	VBD
cord-005453-4057qib7	9108	3	initiated	initiate	VBN
cord-005453-4057qib7	9108	4	a	a	DT
cord-005453-4057qib7	9108	5	median	median	NN
cord-005453-4057qib7	9108	6	of	of	IN
cord-005453-4057qib7	9108	7	195	195	CD
cord-005453-4057qib7	9108	8	days	day	NNS
cord-005453-4057qib7	9108	9	(	(	-LRB-
cord-005453-4057qib7	9108	10	IQR	iqr	NN
cord-005453-4057qib7	9108	11	:	:	:
cord-005453-4057qib7	9108	12	154	154	CD
cord-005453-4057qib7	9108	13	-	-	SYM
cord-005453-4057qib7	9108	14	308	308	CD
cord-005453-4057qib7	9108	15	)	)	-RRB-
cord-005453-4057qib7	9108	16	after	after	IN
cord-005453-4057qib7	9108	17	transplant	transplant	NN
cord-005453-4057qib7	9108	18	for	for	IN
cord-005453-4057qib7	9108	19	a	a	DT
cord-005453-4057qib7	9108	20	mean	mean	JJ
cord-005453-4057qib7	9108	21	duration	duration	NN
cord-005453-4057qib7	9108	22	of	of	IN
cord-005453-4057qib7	9108	23	112	112	CD
cord-005453-4057qib7	9108	24	±	±	CD
cord-005453-4057qib7	9108	25	47	47	CD
cord-005453-4057qib7	9108	26	days	day	NNS
cord-005453-4057qib7	9108	27	.	.	.
cord-005453-4057qib7	9109	1	Only	only	RB
cord-005453-4057qib7	9109	2	one	one	CD
cord-005453-4057qib7	9109	3	(	(	-LRB-
cord-005453-4057qib7	9109	4	3	3	CD
cord-005453-4057qib7	9109	5	%	%	NN
cord-005453-4057qib7	9109	6	)	)	-RRB-
cord-005453-4057qib7	9109	7	patient	patient	NN
cord-005453-4057qib7	9109	8	developed	develop	VBD
cord-005453-4057qib7	9109	9	CMV	CMV	NNP
cord-005453-4057qib7	9109	10	breakthrough	breakthrough	NN
cord-005453-4057qib7	9109	11	.	.	.
cord-005453-4057qib7	9110	1	The	the	DT
cord-005453-4057qib7	9110	2	median	median	JJ
cord-005453-4057qib7	9110	3	follow	follow	NN
cord-005453-4057qib7	9110	4	-	-	HYPH
cord-005453-4057qib7	9110	5	up	up	NN
cord-005453-4057qib7	9110	6	from	from	IN
cord-005453-4057qib7	9110	7	letermovir	letermovir	NNP
cord-005453-4057qib7	9110	8	initiation	initiation	NN
cord-005453-4057qib7	9110	9	was	be	VBD
cord-005453-4057qib7	9110	10	103	103	CD
cord-005453-4057qib7	9110	11	days	day	NNS
cord-005453-4057qib7	9110	12	.	.	.
cord-005453-4057qib7	9111	1	Among	among	IN
cord-005453-4057qib7	9111	2	the	the	DT
cord-005453-4057qib7	9111	3	57	57	CD
cord-005453-4057qib7	9111	4	patients	patient	NNS
cord-005453-4057qib7	9111	5	exposed	expose	VBN
cord-005453-4057qib7	9111	6	to	to	IN
cord-005453-4057qib7	9111	7	letermovir	letermovir	NNP
cord-005453-4057qib7	9111	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9111	9	,	,	,
cord-005453-4057qib7	9111	10	two	two	CD
cord-005453-4057qib7	9111	11	patients	patient	NNS
cord-005453-4057qib7	9111	12	permanently	permanently	RB
cord-005453-4057qib7	9111	13	discontinued	discontinue	VBN
cord-005453-4057qib7	9111	14	because	because	IN
cord-005453-4057qib7	9111	15	of	of	IN
cord-005453-4057qib7	9111	16	letermovir	letermovir	NNS
cord-005453-4057qib7	9111	17	-	-	HYPH
cord-005453-4057qib7	9111	18	related	relate	VBN
cord-005453-4057qib7	9111	19	adverse	adverse	JJ
cord-005453-4057qib7	9111	20	events	event	NNS
cord-005453-4057qib7	9111	21	(	(	-LRB-
cord-005453-4057qib7	9111	22	acute	acute	JJ
cord-005453-4057qib7	9111	23	GvHD	gvhd	NN
cord-005453-4057qib7	9111	24	and	and	CC
cord-005453-4057qib7	9111	25	nephropathy	nephropathy	NN
cord-005453-4057qib7	9111	26	for	for	IN
cord-005453-4057qib7	9111	27	one	one	CD
cord-005453-4057qib7	9111	28	,	,	,
cord-005453-4057qib7	9111	29	loss	loss	NN
cord-005453-4057qib7	9111	30	of	of	IN
cord-005453-4057qib7	9111	31	appetite	appetite	NN
cord-005453-4057qib7	9111	32	,	,	,
cord-005453-4057qib7	9111	33	pruritus	pruritus	NN
cord-005453-4057qib7	9111	34	,	,	,
cord-005453-4057qib7	9111	35	diarrhoea	diarrhoea	NN
cord-005453-4057qib7	9111	36	and	and	CC
cord-005453-4057qib7	9111	37	weight	weight	NN
cord-005453-4057qib7	9111	38	loss	loss	NN
cord-005453-4057qib7	9111	39	for	for	IN
cord-005453-4057qib7	9111	40	the	the	DT
cord-005453-4057qib7	9111	41	other	other	JJ
cord-005453-4057qib7	9111	42	)	)	-RRB-
cord-005453-4057qib7	9111	43	;	;	:
cord-005453-4057qib7	9111	44	two	two	CD
cord-005453-4057qib7	9111	45	deaths	death	NNS
cord-005453-4057qib7	9111	46	occurred	occur	VBD
cord-005453-4057qib7	9111	47	with	with	IN
cord-005453-4057qib7	9111	48	no	no	DT
cord-005453-4057qib7	9111	49	causal	causal	JJ
cord-005453-4057qib7	9111	50	relationship	relationship	NN
cord-005453-4057qib7	9111	51	to	to	IN
cord-005453-4057qib7	9111	52	letermovir	letermovir	NNP
cord-005453-4057qib7	9111	53	.	.	.
cord-005453-4057qib7	9112	1	Data	datum	NNS
cord-005453-4057qib7	9112	2	were	be	VBD
cord-005453-4057qib7	9112	3	consistent	consistent	JJ
cord-005453-4057qib7	9112	4	with	with	IN
cord-005453-4057qib7	9112	5	the	the	DT
cord-005453-4057qib7	9112	6	known	know	VBN
cord-005453-4057qib7	9112	7	safety	safety	NN
cord-005453-4057qib7	9112	8	profile	profile	NN
cord-005453-4057qib7	9112	9	of	of	IN
cord-005453-4057qib7	9112	10	letermovir	letermovir	NNP
cord-005453-4057qib7	9112	11	.	.	.
cord-005453-4057qib7	9113	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9113	2	:	:	:
cord-005453-4057qib7	9114	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9114	2	is	be	VBZ
cord-005453-4057qib7	9114	3	or	or	CC
cord-005453-4057qib7	9114	4	will	will	MD
cord-005453-4057qib7	9114	5	be	be	VB
cord-005453-4057qib7	9114	6	soonly	soonly	RB
cord-005453-4057qib7	9114	7	available	available	JJ
cord-005453-4057qib7	9114	8	in	in	IN
cord-005453-4057qib7	9114	9	most	most	JJS
cord-005453-4057qib7	9114	10	European	european	JJ
cord-005453-4057qib7	9114	11	countries	country	NNS
cord-005453-4057qib7	9114	12	for	for	IN
cord-005453-4057qib7	9114	13	CMV	CMV	NNP
cord-005453-4057qib7	9114	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9114	15	in	in	IN
cord-005453-4057qib7	9114	16	HCT	HCT	NNP
cord-005453-4057qib7	9114	17	recipients	recipient	NNS
cord-005453-4057qib7	9114	18	.	.	.
cord-005453-4057qib7	9115	1	Pending	pende	VBG
cord-005453-4057qib7	9115	2	its	-PRON-	PRP$
cord-005453-4057qib7	9115	3	routine	routine	JJ
cord-005453-4057qib7	9115	4	use	use	NN
cord-005453-4057qib7	9115	5	,	,	,
cord-005453-4057qib7	9115	6	letermovir	letermovir	NNS
cord-005453-4057qib7	9115	7	used	use	VBN
cord-005453-4057qib7	9115	8	as	as	IN
cord-005453-4057qib7	9115	9	SP	SP	NNP
cord-005453-4057qib7	9115	10	was	be	VBD
cord-005453-4057qib7	9115	11	well	well	RB
cord-005453-4057qib7	9115	12	tolerated	tolerate	VBN
cord-005453-4057qib7	9115	13	and	and	CC
cord-005453-4057qib7	9115	14	effective	effective	JJ
cord-005453-4057qib7	9115	15	,	,	,
cord-005453-4057qib7	9115	16	with	with	IN
cord-005453-4057qib7	9115	17	only	only	RB
cord-005453-4057qib7	9115	18	1/35	1/35	CD
cord-005453-4057qib7	9115	19	patients	patient	NNS
cord-005453-4057qib7	9115	20	developing	develop	VBG
cord-005453-4057qib7	9115	21	a	a	DT
cord-005453-4057qib7	9115	22	breakthrough	breakthrough	NN
cord-005453-4057qib7	9115	23	infection	infection	NN
cord-005453-4057qib7	9115	24	.	.	.
cord-005453-4057qib7	9116	1	In	in	IN
cord-005453-4057qib7	9116	2	this	this	DT
cord-005453-4057qib7	9116	3	high	high	JJ
cord-005453-4057qib7	9116	4	-	-	HYPH
cord-005453-4057qib7	9116	5	risk	risk	NN
cord-005453-4057qib7	9116	6	population	population	NN
cord-005453-4057qib7	9116	7	for	for	IN
cord-005453-4057qib7	9116	8	CMV	CMV	NNP
cord-005453-4057qib7	9116	9	recurrence	recurrence	NN
cord-005453-4057qib7	9116	10	,	,	,
cord-005453-4057qib7	9116	11	letermovir	letermovir	NNS
cord-005453-4057qib7	9116	12	may	may	MD
cord-005453-4057qib7	9116	13	provide	provide	VB
cord-005453-4057qib7	9116	14	a	a	DT
cord-005453-4057qib7	9116	15	safe	safe	JJ
cord-005453-4057qib7	9116	16	bridge	bridge	NN
cord-005453-4057qib7	9116	17	between	between	IN
cord-005453-4057qib7	9116	18	PET	pet	NN
cord-005453-4057qib7	9116	19	and	and	CC
cord-005453-4057qib7	9116	20	specific	specific	JJ
cord-005453-4057qib7	9116	21	immune	immune	JJ
cord-005453-4057qib7	9116	22	reconstitution	reconstitution	NN
cord-005453-4057qib7	9116	23	,	,	,
cord-005453-4057qib7	9116	24	pending	pende	VBG
cord-005453-4057qib7	9116	25	tapering	taper	VBG
cord-005453-4057qib7	9116	26	or	or	CC
cord-005453-4057qib7	9116	27	discontinuation	discontinuation	NN
cord-005453-4057qib7	9116	28	of	of	IN
cord-005453-4057qib7	9116	29	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	9116	30	.	.	.
cord-005453-4057qib7	9117	1	Whether	whether	IN
cord-005453-4057qib7	9117	2	SP	SP	NNP
cord-005453-4057qib7	9117	3	may	may	MD
cord-005453-4057qib7	9117	4	improve	improve	VB
cord-005453-4057qib7	9117	5	survival	survival	NN
cord-005453-4057qib7	9117	6	deserves	deserve	VBZ
cord-005453-4057qib7	9117	7	further	further	JJ
cord-005453-4057qib7	9117	8	studies	study	NNS
cord-005453-4057qib7	9117	9	.	.	.
cord-005453-4057qib7	9118	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9118	2	:	:	:
cord-005453-4057qib7	9119	1	Thierry	Thierry	NNP
cord-005453-4057qib7	9119	2	Allavoine	Allavoine	NNP
cord-005453-4057qib7	9119	3	is	be	VBZ
cord-005453-4057qib7	9119	4	a	a	DT
cord-005453-4057qib7	9119	5	former	former	JJ
cord-005453-4057qib7	9119	6	employee	employee	NN
cord-005453-4057qib7	9119	7	of	of	IN
cord-005453-4057qib7	9119	8	MSD	MSD	NNP
cord-005453-4057qib7	9119	9	France	France	NNP
cord-005453-4057qib7	9119	10	,	,	,
cord-005453-4057qib7	9119	11	Nathalie	Nathalie	NNP
cord-005453-4057qib7	9119	12	Benard	Benard	NNP
cord-005453-4057qib7	9119	13	and	and	CC
cord-005453-4057qib7	9119	14	Amir	Amir	NNP
cord-005453-4057qib7	9119	15	Guidoum	Guidoum	NNP
cord-005453-4057qib7	9119	16	are	be	VBP
cord-005453-4057qib7	9119	17	employees	employee	NNS
cord-005453-4057qib7	9119	18	of	of	IN
cord-005453-4057qib7	9119	19	MSD	MSD	NNP
cord-005453-4057qib7	9119	20	France	France	NNP
cord-005453-4057qib7	9119	21	,	,	,
cord-005453-4057qib7	9119	22	Marion	Marion	NNP
cord-005453-4057qib7	9119	23	Masure	Masure	NNP
cord-005453-4057qib7	9119	24	is	be	VBZ
cord-005453-4057qib7	9119	25	an	an	DT
cord-005453-4057qib7	9119	26	employee	employee	NN
cord-005453-4057qib7	9119	27	of	of	IN
cord-005453-4057qib7	9119	28	ICTA	ICTA	NNP
cord-005453-4057qib7	9119	29	PM	PM	NNP
cord-005453-4057qib7	9119	30	,	,	,
cord-005453-4057qib7	9119	31	Sophie	Sophie	NNP
cord-005453-4057qib7	9119	32	Alain	Alain	NNP
cord-005453-4057qib7	9119	33	and	and	CC
cord-005453-4057qib7	9119	34	Catherine	Catherine	NNP
cord-005453-4057qib7	9119	35	Cordonnier	Cordonnier	NNP
cord-005453-4057qib7	9119	36	have	have	VBP
cord-005453-4057qib7	9119	37	participated	participate	VBN
cord-005453-4057qib7	9119	38	in	in	IN
cord-005453-4057qib7	9119	39	advisory	advisory	JJ
cord-005453-4057qib7	9119	40	boards	board	NNS
cord-005453-4057qib7	9119	41	and	and	CC
cord-005453-4057qib7	9119	42	have	have	VBP
cord-005453-4057qib7	9119	43	been	be	VBN
cord-005453-4057qib7	9119	44	members	member	NNS
cord-005453-4057qib7	9119	45	of	of	IN
cord-005453-4057qib7	9119	46	the	the	DT
cord-005453-4057qib7	9119	47	speaker	speaker	NNP
cord-005453-4057qib7	9119	48	bureau	bureau	NNP
cord-005453-4057qib7	9119	49	of	of	IN
cord-005453-4057qib7	9119	50	MSD	MSD	NNP
cord-005453-4057qib7	9119	51	.	.	.
cord-005453-4057qib7	9120	1	Ibrahim	Ibrahim	NNP
cord-005453-4057qib7	9120	2	Yacoub	Yacoub	NNP
cord-005453-4057qib7	9120	3	-	-	HYPH
cord-005453-4057qib7	9120	4	Agha	Agha	NNP
cord-005453-4057qib7	9120	5	has	have	VBZ
cord-005453-4057qib7	9120	6	received	receive	VBN
cord-005453-4057qib7	9120	7	honoraria	honorarium	NNS
cord-005453-4057qib7	9120	8	from	from	IN
cord-005453-4057qib7	9120	9	MSD	MSD	NNP
cord-005453-4057qib7	9120	10	,	,	,
cord-005453-4057qib7	9120	11	Other	other	JJ
cord-005453-4057qib7	9120	12	authors	author	NNS
cord-005453-4057qib7	9120	13	:	:	:
cord-005453-4057qib7	9120	14	nothing	nothing	NN
cord-005453-4057qib7	9120	15	to	to	TO
cord-005453-4057qib7	9120	16	declare	declare	VB
cord-005453-4057qib7	9120	17	P407	P407	NNP
cord-005453-4057qib7	9120	18	Real	real	JJ
cord-005453-4057qib7	9120	19	-	-	HYPH
cord-005453-4057qib7	9120	20	world	world	NN
cord-005453-4057qib7	9120	21	data	datum	NNS
cord-005453-4057qib7	9120	22	on	on	IN
cord-005453-4057qib7	9120	23	letermovir	letermovir	NNP
cord-005453-4057qib7	9120	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9120	25	for	for	IN
cord-005453-4057qib7	9120	26	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	9120	27	reactivation	reactivation	NN
cord-005453-4057qib7	9120	28	after	after	IN
cord-005453-4057qib7	9120	29	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9120	30	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9120	31	cell	cell	NN
cord-005453-4057qib7	9120	32	transplantation	transplantation	NN
cord-005453-4057qib7	9120	33	:	:	:
cord-005453-4057qib7	9120	34	A	a	DT
cord-005453-4057qib7	9120	35	single	single	JJ
cord-005453-4057qib7	9120	36	center	center	NN
cord-005453-4057qib7	9120	37	experience	experience	NN
cord-005453-4057qib7	9120	38	Patrick	Patrick	NNP
cord-005453-4057qib7	9120	39	Derigs	Derigs	NNP
cord-005453-4057qib7	9120	40	1	1	CD
cord-005453-4057qib7	9120	41	,	,	,
cord-005453-4057qib7	9120	42	Maria	Maria	NNP
cord-005453-4057qib7	9120	43	-	-	HYPH
cord-005453-4057qib7	9120	44	Luisa	Luisa	NNP
cord-005453-4057qib7	9120	45	Schubert	Schubert	NNP
cord-005453-4057qib7	9120	46	1	1	CD
cord-005453-4057qib7	9120	47	,	,	,
cord-005453-4057qib7	9120	48	Paul	Paul	NNP
cord-005453-4057qib7	9120	49	Schnitzler	Schnitzler	NNP
cord-005453-4057qib7	9120	50	1	1	CD
cord-005453-4057qib7	9120	51	,	,	,
cord-005453-4057qib7	9120	52	Carsten	Carsten	NNP
cord-005453-4057qib7	9120	53	Müller	Müller	NNP
cord-005453-4057qib7	9120	54	-	-	HYPH
cord-005453-4057qib7	9120	55	Tidow	Tidow	NNP
cord-005453-4057qib7	9120	56	1	1	CD
cord-005453-4057qib7	9120	57	,	,	,
cord-005453-4057qib7	9120	58	Peter	Peter	NNP
cord-005453-4057qib7	9120	59	Dreger	Dreger	NNP
cord-005453-4057qib7	9120	60	1	1	CD
cord-005453-4057qib7	9120	61	,	,	,
cord-005453-4057qib7	9120	62	Michael	Michael	NNP
cord-005453-4057qib7	9120	63	Schmitt	Schmitt	NNP
cord-005453-4057qib7	9120	64	1	1	CD
cord-005453-4057qib7	9120	65	1	1	CD
cord-005453-4057qib7	9120	66	Heidelberg	Heidelberg	NNP
cord-005453-4057qib7	9120	67	University	University	NNP
cord-005453-4057qib7	9120	68	Hospital	Hospital	NNP
cord-005453-4057qib7	9120	69	,	,	,
cord-005453-4057qib7	9120	70	Heidelberg	Heidelberg	NNP
cord-005453-4057qib7	9120	71	,	,	,
cord-005453-4057qib7	9120	72	Germany	Germany	NNP
cord-005453-4057qib7	9120	73	,	,	,
cord-005453-4057qib7	9120	74	Background	background	NN
cord-005453-4057qib7	9120	75	:	:	:
cord-005453-4057qib7	9120	76	Reactivation	reactivation	NN
cord-005453-4057qib7	9120	77	of	of	IN
cord-005453-4057qib7	9120	78	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	9120	79	(	(	-LRB-
cord-005453-4057qib7	9120	80	CMV	CMV	NNP
cord-005453-4057qib7	9120	81	)	)	-RRB-
cord-005453-4057qib7	9120	82	still	still	RB
cord-005453-4057qib7	9120	83	contributes	contribute	VBZ
cord-005453-4057qib7	9120	84	substantially	substantially	RB
cord-005453-4057qib7	9120	85	to	to	IN
cord-005453-4057qib7	9120	86	morbidity	morbidity	NN
cord-005453-4057qib7	9120	87	and	and	CC
cord-005453-4057qib7	9120	88	mortality	mortality	NN
cord-005453-4057qib7	9120	89	after	after	IN
cord-005453-4057qib7	9120	90	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9120	91	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9120	92	cell	cell	NN
cord-005453-4057qib7	9120	93	transplantation	transplantation	NN
cord-005453-4057qib7	9120	94	(	(	-LRB-
cord-005453-4057qib7	9120	95	alloHCT	alloHCT	NNP
cord-005453-4057qib7	9120	96	)	)	-RRB-
cord-005453-4057qib7	9120	97	.	.	.
cord-005453-4057qib7	9121	1	Recently	recently	RB
cord-005453-4057qib7	9121	2	,	,	,
cord-005453-4057qib7	9121	3	letermovir	letermovir	NNP
cord-005453-4057qib7	9121	4	became	become	VBD
cord-005453-4057qib7	9121	5	available	available	JJ
cord-005453-4057qib7	9121	6	as	as	IN
cord-005453-4057qib7	9121	7	the	the	DT
cord-005453-4057qib7	9121	8	first	first	JJ
cord-005453-4057qib7	9121	9	drug	drug	NN
cord-005453-4057qib7	9121	10	approved	approve	VBN
cord-005453-4057qib7	9121	11	in	in	IN
cord-005453-4057qib7	9121	12	Europe	Europe	NNP
cord-005453-4057qib7	9121	13	for	for	IN
cord-005453-4057qib7	9121	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9121	15	of	of	IN
cord-005453-4057qib7	9121	16	CMV	CMV	NNP
cord-005453-4057qib7	9121	17	reactivation	reactivation	NN
cord-005453-4057qib7	9121	18	in	in	IN
cord-005453-4057qib7	9121	19	seropositive	seropositive	JJ
cord-005453-4057qib7	9121	20	patients	patient	NNS
cord-005453-4057qib7	9121	21	who	who	WP
cord-005453-4057qib7	9121	22	have	have	VBP
cord-005453-4057qib7	9121	23	undergone	undergo	VBN
cord-005453-4057qib7	9121	24	alloHCT	allohct	XX
cord-005453-4057qib7	9121	25	.	.	.
cord-005453-4057qib7	9122	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9122	2	is	be	VBZ
cord-005453-4057qib7	9122	3	neither	neither	CC
cord-005453-4057qib7	9122	4	myelo	myelo	NN
cord-005453-4057qib7	9122	5	-	-	,
cord-005453-4057qib7	9122	6	nor	nor	CC
cord-005453-4057qib7	9122	7	nephrotoxic	nephrotoxic	NNP
cord-005453-4057qib7	9122	8	,	,	,
cord-005453-4057qib7	9122	9	and	and	CC
cord-005453-4057qib7	9122	10	significantly	significantly	RB
cord-005453-4057qib7	9122	11	reduced	reduce	VBD
cord-005453-4057qib7	9122	12	the	the	DT
cord-005453-4057qib7	9122	13	incidence	incidence	NN
cord-005453-4057qib7	9122	14	of	of	IN
cord-005453-4057qib7	9122	15	CMV	CMV	NNP
cord-005453-4057qib7	9122	16	reactivation	reactivation	NN
cord-005453-4057qib7	9122	17	in	in	IN
cord-005453-4057qib7	9122	18	a	a	DT
cord-005453-4057qib7	9122	19	pivotal	pivotal	JJ
cord-005453-4057qib7	9122	20	phase	phase	NN
cord-005453-4057qib7	9122	21	III	iii	CD
cord-005453-4057qib7	9122	22	trial	trial	NN
cord-005453-4057qib7	9122	23	(	(	-LRB-
cord-005453-4057qib7	9122	24	NEJM	NEJM	NNP
cord-005453-4057qib7	9122	25	2017	2017	CD
cord-005453-4057qib7	9122	26	;	;	:
cord-005453-4057qib7	9122	27	377:2433	377:2433	NNP
cord-005453-4057qib7	9122	28	)	)	-RRB-
cord-005453-4057qib7	9122	29	.	.	.
cord-005453-4057qib7	9123	1	Therefore	therefore	RB
cord-005453-4057qib7	9123	2	we	-PRON-	PRP
cord-005453-4057qib7	9123	3	adopted	adopt	VBD
cord-005453-4057qib7	9123	4	letermovir	letermovir	NNP
cord-005453-4057qib7	9123	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9123	6	according	accord	VBG
cord-005453-4057qib7	9123	7	to	to	IN
cord-005453-4057qib7	9123	8	the	the	DT
cord-005453-4057qib7	9123	9	label	label	NN
cord-005453-4057qib7	9123	10	as	as	IN
cord-005453-4057qib7	9123	11	standard	standard	JJ
cord-005453-4057qib7	9123	12	policy	policy	NN
cord-005453-4057qib7	9123	13	in	in	IN
cord-005453-4057qib7	9123	14	our	-PRON-	PRP$
cord-005453-4057qib7	9123	15	institution	institution	NN
cord-005453-4057qib7	9123	16	:	:	:
cord-005453-4057qib7	9124	1	In	in	IN
cord-005453-4057qib7	9124	2	seropositive	seropositive	JJ
cord-005453-4057qib7	9124	3	recipients	recipient	NNS
cord-005453-4057qib7	9124	4	letermovir	letermovir	NNS
cord-005453-4057qib7	9124	5	was	be	VBD
cord-005453-4057qib7	9124	6	initiated	initiate	VBN
cord-005453-4057qib7	9124	7	after	after	IN
cord-005453-4057qib7	9124	8	engraftment	engraftment	NN
cord-005453-4057qib7	9124	9	and	and	CC
cord-005453-4057qib7	9124	10	continued	continue	VBD
cord-005453-4057qib7	9124	11	until	until	IN
cord-005453-4057qib7	9124	12	day	day	NN
cord-005453-4057qib7	9124	13	+100	+100	NNS
cord-005453-4057qib7	9124	14	or	or	CC
cord-005453-4057qib7	9124	15	CMV	CMV	NNP
cord-005453-4057qib7	9124	16	reactivation	reactivation	NN
cord-005453-4057qib7	9124	17	.	.	.
cord-005453-4057qib7	9125	1	The	the	DT
cord-005453-4057qib7	9125	2	aim	aim	NN
cord-005453-4057qib7	9125	3	of	of	IN
cord-005453-4057qib7	9125	4	the	the	DT
cord-005453-4057qib7	9125	5	present	present	JJ
cord-005453-4057qib7	9125	6	study	study	NN
cord-005453-4057qib7	9125	7	was	be	VBD
cord-005453-4057qib7	9125	8	to	to	TO
cord-005453-4057qib7	9125	9	investigate	investigate	VB
cord-005453-4057qib7	9125	10	if	if	IN
cord-005453-4057qib7	9125	11	the	the	DT
cord-005453-4057qib7	9125	12	favorable	favorable	JJ
cord-005453-4057qib7	9125	13	trial	trial	NN
cord-005453-4057qib7	9125	14	results	result	NNS
cord-005453-4057qib7	9125	15	could	could	MD
cord-005453-4057qib7	9125	16	be	be	VB
cord-005453-4057qib7	9125	17	reproduced	reproduce	VBN
cord-005453-4057qib7	9125	18	under	under	IN
cord-005453-4057qib7	9125	19	real	real	JJ
cord-005453-4057qib7	9125	20	-	-	HYPH
cord-005453-4057qib7	9125	21	world	world	NN
cord-005453-4057qib7	9125	22	conditions	condition	NNS
cord-005453-4057qib7	9125	23	.	.	.
cord-005453-4057qib7	9126	1	Methods	method	NNS
cord-005453-4057qib7	9126	2	:	:	:
cord-005453-4057qib7	9126	3	The	the	DT
cord-005453-4057qib7	9126	4	study	study	NN
cord-005453-4057qib7	9126	5	cohort	cohort	NN
cord-005453-4057qib7	9126	6	consisted	consist	VBD
cord-005453-4057qib7	9126	7	of	of	IN
cord-005453-4057qib7	9126	8	the	the	DT
cord-005453-4057qib7	9126	9	first	first	JJ
cord-005453-4057qib7	9126	10	seropositive	seropositive	JJ
cord-005453-4057qib7	9126	11	35	35	CD
cord-005453-4057qib7	9126	12	patients	patient	NNS
cord-005453-4057qib7	9126	13	who	who	WP
cord-005453-4057qib7	9126	14	received	receive	VBD
cord-005453-4057qib7	9126	15	letermovir	letermovir	NNS
cord-005453-4057qib7	9126	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9126	17	at	at	IN
cord-005453-4057qib7	9126	18	our	-PRON-	PRP$
cord-005453-4057qib7	9126	19	institution	institution	NN
cord-005453-4057qib7	9126	20	(	(	-LRB-
cord-005453-4057qib7	9126	21	between	between	IN
cord-005453-4057qib7	9126	22	March	March	NNP
cord-005453-4057qib7	9126	23	and	and	CC
cord-005453-4057qib7	9126	24	August	August	NNP
cord-005453-4057qib7	9126	25	2018	2018	CD
cord-005453-4057qib7	9126	26	)	)	-RRB-
cord-005453-4057qib7	9126	27	.	.	.
cord-005453-4057qib7	9127	1	These	these	DT
cord-005453-4057qib7	9127	2	were	be	VBD
cord-005453-4057qib7	9127	3	compared	compare	VBN
cord-005453-4057qib7	9127	4	with	with	IN
cord-005453-4057qib7	9127	5	a	a	DT
cord-005453-4057qib7	9127	6	control	control	NN
cord-005453-4057qib7	9127	7	cohort	cohort	NN
cord-005453-4057qib7	9127	8	transplanted	transplant	VBN
cord-005453-4057qib7	9127	9	between	between	IN
cord-005453-4057qib7	9127	10	August	August	NNP
cord-005453-4057qib7	9127	11	2017	2017	CD
cord-005453-4057qib7	9127	12	and	and	CC
cord-005453-4057qib7	9127	13	March	March	NNP
cord-005453-4057qib7	9127	14	2018	2018	CD
cord-005453-4057qib7	9127	15	before	before	IN
cord-005453-4057qib7	9127	16	the	the	DT
cord-005453-4057qib7	9127	17	advent	advent	NN
cord-005453-4057qib7	9127	18	of	of	IN
cord-005453-4057qib7	9127	19	letermovir	letermovir	NNP
cord-005453-4057qib7	9127	20	.	.	.
cord-005453-4057qib7	9128	1	Study	study	VB
cord-005453-4057qib7	9128	2	and	and	CC
cord-005453-4057qib7	9128	3	control	control	NN
cord-005453-4057qib7	9128	4	cohorts	cohort	NNS
cord-005453-4057qib7	9128	5	were	be	VBD
cord-005453-4057qib7	9128	6	matched	match	VBN
cord-005453-4057qib7	9128	7	for	for	IN
cord-005453-4057qib7	9128	8	CMV	CMV	NNP
cord-005453-4057qib7	9128	9	donor	donor	NN
cord-005453-4057qib7	9128	10	/	/	SYM
cord-005453-4057qib7	9128	11	recipient	recipient	NN
cord-005453-4057qib7	9128	12	sero	sero	NN
cord-005453-4057qib7	9128	13	-	-	HYPH
cord-005453-4057qib7	9128	14	status	status	NN
cord-005453-4057qib7	9128	15	,	,	,
cord-005453-4057qib7	9128	16	underlying	underlie	VBG
cord-005453-4057qib7	9128	17	disease	disease	NN
cord-005453-4057qib7	9128	18	and	and	CC
cord-005453-4057qib7	9128	19	donor	donor	NN
cord-005453-4057qib7	9128	20	type	type	NN
cord-005453-4057qib7	9128	21	source	source	NN
cord-005453-4057qib7	9128	22	of	of	IN
cord-005453-4057qib7	9128	23	stem	stem	NN
cord-005453-4057qib7	9128	24	cells	cell	NNS
cord-005453-4057qib7	9128	25	and	and	CC
cord-005453-4057qib7	9128	26	application	application	NN
cord-005453-4057qib7	9128	27	of	of	IN
cord-005453-4057qib7	9128	28	ATG	ATG	NNP
cord-005453-4057qib7	9128	29	.	.	.
cord-005453-4057qib7	9129	1	CMV	CMV	NNP
cord-005453-4057qib7	9129	2	viremia	viremia	NN
cord-005453-4057qib7	9129	3	was	be	VBD
cord-005453-4057qib7	9129	4	monitored	monitor	VBN
cord-005453-4057qib7	9129	5	by	by	IN
cord-005453-4057qib7	9129	6	a	a	DT
cord-005453-4057qib7	9129	7	quantitative	quantitative	JJ
cord-005453-4057qib7	9129	8	PCR	PCR	NNP
cord-005453-4057qib7	9129	9	twice	twice	PDT
cord-005453-4057qib7	9129	10	a	a	DT
cord-005453-4057qib7	9129	11	week	week	NN
cord-005453-4057qib7	9129	12	during	during	IN
cord-005453-4057qib7	9129	13	the	the	DT
cord-005453-4057qib7	9129	14	inpatient	inpatient	JJ
cord-005453-4057qib7	9129	15	period	period	NN
cord-005453-4057qib7	9129	16	and	and	CC
cord-005453-4057qib7	9129	17	weekly	weekly	NN
cord-005453-4057qib7	9129	18	thereafter	thereafter	RB
cord-005453-4057qib7	9129	19	.	.	.
cord-005453-4057qib7	9130	1	Patients	patient	NNS
cord-005453-4057qib7	9130	2	reactivating	reactivate	VBG
cord-005453-4057qib7	9130	3	CMV	CMV	NNP
cord-005453-4057qib7	9130	4	prior	prior	RB
cord-005453-4057qib7	9130	5	to	to	IN
cord-005453-4057qib7	9130	6	engraftment	engraftment	NN
cord-005453-4057qib7	9130	7	were	be	VBD
cord-005453-4057qib7	9130	8	not	not	RB
cord-005453-4057qib7	9130	9	considered	consider	VBN
cord-005453-4057qib7	9130	10	as	as	IN
cord-005453-4057qib7	9130	11	event	event	NN
cord-005453-4057qib7	9130	12	in	in	IN
cord-005453-4057qib7	9130	13	both	both	DT
cord-005453-4057qib7	9130	14	groups	group	NNS
cord-005453-4057qib7	9130	15	.	.	.
cord-005453-4057qib7	9131	1	Results	result	NNS
cord-005453-4057qib7	9131	2	:	:	:
cord-005453-4057qib7	9132	1	No	no	DT
cord-005453-4057qib7	9132	2	major	major	JJ
cord-005453-4057qib7	9132	3	side	side	NN
cord-005453-4057qib7	9132	4	effects	effect	NNS
cord-005453-4057qib7	9132	5	of	of	IN
cord-005453-4057qib7	9132	6	letermovir	letermovir	NNS
cord-005453-4057qib7	9132	7	intake	intake	NN
cord-005453-4057qib7	9132	8	were	be	VBD
cord-005453-4057qib7	9132	9	observed	observe	VBN
cord-005453-4057qib7	9132	10	.	.	.
cord-005453-4057qib7	9133	1	With	with	IN
cord-005453-4057qib7	9133	2	altogether	altogether	RB
cord-005453-4057qib7	9133	3	5	5	CD
cord-005453-4057qib7	9133	4	reactivation	reactivation	NN
cord-005453-4057qib7	9133	5	events	event	NNS
cord-005453-4057qib7	9133	6	,	,	,
cord-005453-4057qib7	9133	7	the	the	DT
cord-005453-4057qib7	9133	8	cumulative	cumulative	JJ
cord-005453-4057qib7	9133	9	rate	rate	NN
cord-005453-4057qib7	9133	10	of	of	IN
cord-005453-4057qib7	9133	11	CMV	CMV	NNP
cord-005453-4057qib7	9133	12	reactivation	reactivation	NN
cord-005453-4057qib7	9133	13	on	on	IN
cord-005453-4057qib7	9133	14	day	day	NN
cord-005453-4057qib7	9133	15	+100	+100	NNP
cord-005453-4057qib7	9133	16	was	be	VBD
cord-005453-4057qib7	9133	17	14	14	CD
cord-005453-4057qib7	9133	18	%	%	NN
cord-005453-4057qib7	9133	19	(	(	-LRB-
cord-005453-4057qib7	9133	20	95%CI	95%ci	CD
cord-005453-4057qib7	9133	21	1	1	CD
cord-005453-4057qib7	9133	22	-	-	SYM
cord-005453-4057qib7	9133	23	45	45	CD
cord-005453-4057qib7	9133	24	%	%	NN
cord-005453-4057qib7	9133	25	)	)	-RRB-
cord-005453-4057qib7	9133	26	in	in	IN
cord-005453-4057qib7	9133	27	the	the	DT
cord-005453-4057qib7	9133	28	letermovir	letermovir	NNP
cord-005453-4057qib7	9133	29	cohort	cohort	NN
cord-005453-4057qib7	9133	30	and	and	CC
cord-005453-4057qib7	9133	31	thus	thus	RB
cord-005453-4057qib7	9133	32	significantly	significantly	RB
cord-005453-4057qib7	9133	33	lower	low	JJR
cord-005453-4057qib7	9133	34	than	than	IN
cord-005453-4057qib7	9133	35	in	in	IN
cord-005453-4057qib7	9133	36	the	the	DT
cord-005453-4057qib7	9133	37	control	control	NN
cord-005453-4057qib7	9133	38	group	group	NN
cord-005453-4057qib7	9133	39	(	(	-LRB-
cord-005453-4057qib7	9133	40	20	20	CD
cord-005453-4057qib7	9133	41	events	event	NNS
cord-005453-4057qib7	9133	42	,	,	,
cord-005453-4057qib7	9133	43	58	58	CD
cord-005453-4057qib7	9133	44	%	%	NN
cord-005453-4057qib7	9133	45	(	(	-LRB-
cord-005453-4057qib7	9133	46	95%CI	95%ci	CD
cord-005453-4057qib7	9133	47	42	42	CD
cord-005453-4057qib7	9133	48	-	-	SYM
cord-005453-4057qib7	9133	49	71	71	CD
cord-005453-4057qib7	9133	50	%	%	NN
cord-005453-4057qib7	9133	51	)	)	-RRB-
cord-005453-4057qib7	9133	52	;	;	:
cord-005453-4057qib7	9133	53	HR	HR	NNP
cord-005453-4057qib7	9133	54	0.23	0.23	CD
cord-005453-4057qib7	9133	55	(	(	-LRB-
cord-005453-4057qib7	9133	56	0.10	0.10	CD
cord-005453-4057qib7	9133	57	-	-	SYM
cord-005453-4057qib7	9133	58	0.51	0.51	CD
cord-005453-4057qib7	9133	59	)	)	-RRB-
cord-005453-4057qib7	9133	60	;	;	:
cord-005453-4057qib7	9133	61	p=0.0003	p=0.0003	NNP
cord-005453-4057qib7	9133	62	)	)	-RRB-
cord-005453-4057qib7	9133	63	.	.	.
cord-005453-4057qib7	9134	1	The	the	DT
cord-005453-4057qib7	9134	2	median	median	JJ
cord-005453-4057qib7	9134	3	time	time	NN
cord-005453-4057qib7	9134	4	to	to	IN
cord-005453-4057qib7	9134	5	reactivation	reactivation	NN
cord-005453-4057qib7	9134	6	was	be	VBD
cord-005453-4057qib7	9134	7	53	53	CD
cord-005453-4057qib7	9134	8	days	day	NNS
cord-005453-4057qib7	9134	9	for	for	IN
cord-005453-4057qib7	9134	10	the	the	DT
cord-005453-4057qib7	9134	11	control	control	NN
cord-005453-4057qib7	9134	12	group	group	NN
cord-005453-4057qib7	9134	13	and	and	CC
cord-005453-4057qib7	9134	14	not	not	RB
cord-005453-4057qib7	9134	15	reached	reach	VBN
cord-005453-4057qib7	9134	16	for	for	IN
cord-005453-4057qib7	9134	17	the	the	DT
cord-005453-4057qib7	9134	18	letermovir	letermovir	NNP
cord-005453-4057qib7	9134	19	group	group	NN
cord-005453-4057qib7	9134	20	.	.	.
cord-005453-4057qib7	9135	1	The	the	DT
cord-005453-4057qib7	9135	2	cumulative	cumulative	JJ
cord-005453-4057qib7	9135	3	number	number	NN
cord-005453-4057qib7	9135	4	of	of	IN
cord-005453-4057qib7	9135	5	days	day	NNS
cord-005453-4057qib7	9135	6	on	on	IN
cord-005453-4057qib7	9135	7	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	9135	8	before	before	IN
cord-005453-4057qib7	9135	9	d	d	NNP
cord-005453-4057qib7	9135	10	+100	+100	NNP
cord-005453-4057qib7	9135	11	was	be	VBD
cord-005453-4057qib7	9135	12	151d	151d	CD
cord-005453-4057qib7	9135	13	for	for	IN
cord-005453-4057qib7	9135	14	the	the	DT
cord-005453-4057qib7	9135	15	35	35	CD
cord-005453-4057qib7	9135	16	letermovir	letermovir	NNS
cord-005453-4057qib7	9135	17	patients	patient	NNS
cord-005453-4057qib7	9135	18	vs	vs	IN
cord-005453-4057qib7	9135	19	689d	689d	NNP
cord-005453-4057qib7	9135	20	for	for	IN
cord-005453-4057qib7	9135	21	the	the	DT
cord-005453-4057qib7	9135	22	35	35	CD
cord-005453-4057qib7	9135	23	control	control	NN
cord-005453-4057qib7	9135	24	patients	patient	NNS
cord-005453-4057qib7	9135	25	.	.	.
cord-005453-4057qib7	9136	1	There	there	EX
cord-005453-4057qib7	9136	2	were	be	VBD
cord-005453-4057qib7	9136	3	no	no	DT
cord-005453-4057qib7	9136	4	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	9136	5	for	for	IN
cord-005453-4057qib7	9136	6	foscavir	foscavir	NNP
cord-005453-4057qib7	9136	7	administration	administration	NN
cord-005453-4057qib7	9136	8	in	in	IN
cord-005453-4057qib7	9136	9	the	the	DT
cord-005453-4057qib7	9136	10	letermovir	letermovir	NNP
cord-005453-4057qib7	9136	11	group	group	NN
cord-005453-4057qib7	9136	12	compared	compare	VBN
cord-005453-4057qib7	9136	13	to	to	IN
cord-005453-4057qib7	9136	14	5	5	CD
cord-005453-4057qib7	9136	15	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	9136	16	in	in	IN
cord-005453-4057qib7	9136	17	the	the	DT
cord-005453-4057qib7	9136	18	control	control	NN
cord-005453-4057qib7	9136	19	group	group	NN
cord-005453-4057qib7	9136	20	.	.	.
cord-005453-4057qib7	9137	1	There	there	EX
cord-005453-4057qib7	9137	2	were	be	VBD
cord-005453-4057qib7	9137	3	2	2	CD
cord-005453-4057qib7	9137	4	deaths	death	NNS
cord-005453-4057qib7	9137	5	before	before	IN
cord-005453-4057qib7	9137	6	d	d	NNP
cord-005453-4057qib7	9137	7	+100	+100	NNS
cord-005453-4057qib7	9137	8	in	in	IN
cord-005453-4057qib7	9137	9	the	the	DT
cord-005453-4057qib7	9137	10	letermovir	letermovir	NNP
cord-005453-4057qib7	9137	11	group	group	NNP
cord-005453-4057qib7	9137	12	(	(	-LRB-
cord-005453-4057qib7	9137	13	one	one	CD
cord-005453-4057qib7	9137	14	PD	PD	NNP
cord-005453-4057qib7	9137	15	,	,	,
cord-005453-4057qib7	9137	16	one	one	CD
cord-005453-4057qib7	9137	17	NRM	NRM	NNP
cord-005453-4057qib7	9137	18	)	)	-RRB-
cord-005453-4057qib7	9137	19	and	and	CC
cord-005453-4057qib7	9137	20	3	3	CD
cord-005453-4057qib7	9137	21	deaths	death	NNS
cord-005453-4057qib7	9137	22	in	in	IN
cord-005453-4057qib7	9137	23	the	the	DT
cord-005453-4057qib7	9137	24	control	control	NN
cord-005453-4057qib7	9137	25	group	group	NN
cord-005453-4057qib7	9137	26	(	(	-LRB-
cord-005453-4057qib7	9137	27	all	all	DT
cord-005453-4057qib7	9137	28	PD	PD	NNP
cord-005453-4057qib7	9137	29	)	)	-RRB-
cord-005453-4057qib7	9137	30	.	.	.
cord-005453-4057qib7	9138	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9138	2	:	:	:
cord-005453-4057qib7	9139	1	This	this	DT
cord-005453-4057qib7	9139	2	observational	observational	JJ
cord-005453-4057qib7	9139	3	study	study	NN
cord-005453-4057qib7	9139	4	confirms	confirm	VBZ
cord-005453-4057qib7	9139	5	the	the	DT
cord-005453-4057qib7	9139	6	safety	safety	NN
cord-005453-4057qib7	9139	7	and	and	CC
cord-005453-4057qib7	9139	8	efficacy	efficacy	NN
cord-005453-4057qib7	9139	9	of	of	IN
cord-005453-4057qib7	9139	10	letermovir	letermovir	NNS
cord-005453-4057qib7	9139	11	for	for	IN
cord-005453-4057qib7	9139	12	the	the	DT
cord-005453-4057qib7	9139	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9139	14	of	of	IN
cord-005453-4057qib7	9139	15	CMV	CMV	NNP
cord-005453-4057qib7	9139	16	reactivation	reactivation	NN
cord-005453-4057qib7	9139	17	in	in	IN
cord-005453-4057qib7	9139	18	seropositive	seropositive	JJ
cord-005453-4057qib7	9139	19	patients	patient	NNS
cord-005453-4057qib7	9139	20	after	after	IN
cord-005453-4057qib7	9139	21	alloHCT	alloHCT	NNP
cord-005453-4057qib7	9139	22	in	in	IN
cord-005453-4057qib7	9139	23	a	a	DT
cord-005453-4057qib7	9139	24	real	real	JJ
cord-005453-4057qib7	9139	25	-	-	HYPH
cord-005453-4057qib7	9139	26	world	world	NN
cord-005453-4057qib7	9139	27	setting	setting	NN
cord-005453-4057qib7	9139	28	.	.	.
cord-005453-4057qib7	9140	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9140	2	results	result	NNS
cord-005453-4057qib7	9140	3	are	be	VBP
cord-005453-4057qib7	9140	4	in	in	IN
cord-005453-4057qib7	9140	5	good	good	JJ
cord-005453-4057qib7	9140	6	concordance	concordance	NN
cord-005453-4057qib7	9140	7	with	with	IN
cord-005453-4057qib7	9140	8	the	the	DT
cord-005453-4057qib7	9140	9	phase	phase	NN
cord-005453-4057qib7	9140	10	III	iii	CD
cord-005453-4057qib7	9140	11	trial	trial	NN
cord-005453-4057qib7	9140	12	.	.	.
cord-005453-4057qib7	9141	1	Although	although	IN
cord-005453-4057qib7	9141	2	letermovir	letermovir	NNS
cord-005453-4057qib7	9141	3	appeared	appear	VBD
cord-005453-4057qib7	9141	4	to	to	TO
cord-005453-4057qib7	9141	5	reduce	reduce	VB
cord-005453-4057qib7	9141	6	the	the	DT
cord-005453-4057qib7	9141	7	need	need	NN
cord-005453-4057qib7	9141	8	for	for	IN
cord-005453-4057qib7	9141	9	therapeutic	therapeutic	JJ
cord-005453-4057qib7	9141	10	valganciclovir	valganciclovir	NNS
cord-005453-4057qib7	9141	11	and	and	CC
cord-005453-4057qib7	9141	12	foscavir	foscavir	NNP
cord-005453-4057qib7	9141	13	tremendously	tremendously	RB
cord-005453-4057qib7	9141	14	,	,	,
cord-005453-4057qib7	9141	15	larger	large	JJR
cord-005453-4057qib7	9141	16	samples	sample	NNS
cord-005453-4057qib7	9141	17	with	with	IN
cord-005453-4057qib7	9141	18	longer	long	JJR
cord-005453-4057qib7	9141	19	follow	follow	NN
cord-005453-4057qib7	9141	20	-	-	HYPH
cord-005453-4057qib7	9141	21	up	up	NN
cord-005453-4057qib7	9141	22	are	be	VBP
cord-005453-4057qib7	9141	23	needed	need	VBN
cord-005453-4057qib7	9141	24	to	to	TO
cord-005453-4057qib7	9141	25	assess	assess	VB
cord-005453-4057qib7	9141	26	the	the	DT
cord-005453-4057qib7	9141	27	impact	impact	NN
cord-005453-4057qib7	9141	28	of	of	IN
cord-005453-4057qib7	9141	29	letermovir	letermovir	NNP
cord-005453-4057qib7	9141	30	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9141	31	on	on	IN
cord-005453-4057qib7	9141	32	non	non	JJ
cord-005453-4057qib7	9141	33	-	-	JJ
cord-005453-4057qib7	9141	34	relapse	relapse	JJ
cord-005453-4057qib7	9141	35	and	and	CC
cord-005453-4057qib7	9141	36	overall	overall	JJ
cord-005453-4057qib7	9141	37	mortality	mortality	NN
cord-005453-4057qib7	9141	38	as	as	RB
cord-005453-4057qib7	9141	39	well	well	RB
cord-005453-4057qib7	9141	40	as	as	IN
cord-005453-4057qib7	9141	41	on	on	IN
cord-005453-4057qib7	9141	42	resource	resource	NN
cord-005453-4057qib7	9141	43	consumption	consumption	NN
cord-005453-4057qib7	9141	44	.	.	.
cord-005453-4057qib7	9142	1	Background	background	NN
cord-005453-4057qib7	9142	2	:	:	:
cord-005453-4057qib7	9143	1	CMV	CMV	NNP
cord-005453-4057qib7	9143	2	viremia	viremia	NN
cord-005453-4057qib7	9143	3	occurs	occur	VBZ
cord-005453-4057qib7	9143	4	in	in	IN
cord-005453-4057qib7	9143	5	40%-80	40%-80	CD
cord-005453-4057qib7	9143	6	%	%	NN
cord-005453-4057qib7	9143	7	of	of	IN
cord-005453-4057qib7	9143	8	CMV	CMV	NNP
cord-005453-4057qib7	9143	9	R	R	NNP
cord-005453-4057qib7	9143	10	+	+	SYM
cord-005453-4057qib7	9143	11	HCT	hct	NN
cord-005453-4057qib7	9143	12	recipients	recipient	NNS
cord-005453-4057qib7	9143	13	.	.	.
cord-005453-4057qib7	9144	1	PET	pet	JJ
cord-005453-4057qib7	9144	2	use	use	NN
cord-005453-4057qib7	9144	3	has	have	VBZ
cord-005453-4057qib7	9144	4	reduced	reduce	VBN
cord-005453-4057qib7	9144	5	the	the	DT
cord-005453-4057qib7	9144	6	risk	risk	NN
cord-005453-4057qib7	9144	7	of	of	IN
cord-005453-4057qib7	9144	8	CMV	CMV	NNP
cord-005453-4057qib7	9144	9	end	end	NN
cord-005453-4057qib7	9144	10	-	-	HYPH
cord-005453-4057qib7	9144	11	organ	organ	NN
cord-005453-4057qib7	9144	12	disease	disease	NN
cord-005453-4057qib7	9144	13	(	(	-LRB-
cord-005453-4057qib7	9144	14	EOD	EOD	NNP
cord-005453-4057qib7	9144	15	)	)	-RRB-
cord-005453-4057qib7	9144	16	and	and	CC
cord-005453-4057qib7	9144	17	associated	associate	VBN
cord-005453-4057qib7	9144	18	mortality	mortality	NN
cord-005453-4057qib7	9144	19	;	;	:
cord-005453-4057qib7	9144	20	However	however	RB
cord-005453-4057qib7	9144	21	,	,	,
cord-005453-4057qib7	9144	22	PET	pet	JJ
cord-005453-4057qib7	9144	23	use	use	NN
cord-005453-4057qib7	9144	24	may	may	MD
cord-005453-4057qib7	9144	25	lead	lead	VB
cord-005453-4057qib7	9144	26	to	to	IN
cord-005453-4057qib7	9144	27	substantial	substantial	JJ
cord-005453-4057qib7	9144	28	antiviral	antiviral	JJ
cord-005453-4057qib7	9144	29	use	use	NN
cord-005453-4057qib7	9144	30	and	and	CC
cord-005453-4057qib7	9144	31	healthcare	healthcare	NN
cord-005453-4057qib7	9144	32	resource	resource	NN
cord-005453-4057qib7	9144	33	utilization	utilization	NN
cord-005453-4057qib7	9144	34	.	.	.
cord-005453-4057qib7	9145	1	Limited	limited	JJ
cord-005453-4057qib7	9145	2	real	real	JJ
cord-005453-4057qib7	9145	3	-	-	HYPH
cord-005453-4057qib7	9145	4	world	world	NN
cord-005453-4057qib7	9145	5	data	datum	NNS
cord-005453-4057qib7	9145	6	are	be	VBP
cord-005453-4057qib7	9145	7	available	available	JJ
cord-005453-4057qib7	9145	8	on	on	IN
cord-005453-4057qib7	9145	9	the	the	DT
cord-005453-4057qib7	9145	10	outcomes	outcome	NNS
cord-005453-4057qib7	9145	11	of	of	IN
cord-005453-4057qib7	9145	12	PET	pet	NN
cord-005453-4057qib7	9145	13	.	.	.
cord-005453-4057qib7	9146	1	Therefore	therefore	RB
cord-005453-4057qib7	9146	2	,	,	,
cord-005453-4057qib7	9146	3	we	-PRON-	PRP
cord-005453-4057qib7	9146	4	aimed	aim	VBD
cord-005453-4057qib7	9146	5	to	to	TO
cord-005453-4057qib7	9146	6	examine	examine	VB
cord-005453-4057qib7	9146	7	CMV	CMV	NNP
cord-005453-4057qib7	9146	8	outcomes	outcome	NNS
cord-005453-4057qib7	9146	9	(	(	-LRB-
cord-005453-4057qib7	9146	10	EOD	EOD	NNP
cord-005453-4057qib7	9146	11	,	,	,
cord-005453-4057qib7	9146	12	resistance	resistance	NN
cord-005453-4057qib7	9146	13	)	)	-RRB-
cord-005453-4057qib7	9146	14	,	,	,
cord-005453-4057qib7	9146	15	CMV	CMV	NNP
cord-005453-4057qib7	9146	16	-	-	HYPH
cord-005453-4057qib7	9146	17	related	relate	VBN
cord-005453-4057qib7	9146	18	mortality	mortality	NN
cord-005453-4057qib7	9146	19	by	by	IN
cord-005453-4057qib7	9146	20	Day	day	NN
cord-005453-4057qib7	9146	21	(	(	-LRB-
cord-005453-4057qib7	9146	22	D)180	D)180	NNP
cord-005453-4057qib7	9146	23	and	and	CC
cord-005453-4057qib7	9146	24	healthcare	healthcare	NN
cord-005453-4057qib7	9146	25	resource	resource	NN
cord-005453-4057qib7	9146	26	utilization	utilization	NN
cord-005453-4057qib7	9146	27	between	between	IN
cord-005453-4057qib7	9146	28	PET	pet	NN
cord-005453-4057qib7	9146	29	and	and	CC
cord-005453-4057qib7	9146	30	No	no	DT
cord-005453-4057qib7	9146	31	-	-	HYPH
cord-005453-4057qib7	9146	32	PET	pet	JJ
cord-005453-4057qib7	9146	33	groups	group	NNS
cord-005453-4057qib7	9146	34	among	among	IN
cord-005453-4057qib7	9146	35	CMV	CMV	NNP
cord-005453-4057qib7	9146	36	R+	r+	NN
cord-005453-4057qib7	9146	37	recipients	recipient	NNS
cord-005453-4057qib7	9146	38	undergoing	undergo	VBG
cord-005453-4057qib7	9146	39	first	first	JJ
cord-005453-4057qib7	9146	40	HCT	HCT	NNP
cord-005453-4057qib7	9146	41	.	.	.
cord-005453-4057qib7	9147	1	Methods	method	NNS
cord-005453-4057qib7	9147	2	:	:	:
cord-005453-4057qib7	9147	3	We	-PRON-	PRP
cord-005453-4057qib7	9147	4	conducted	conduct	VBD
cord-005453-4057qib7	9147	5	a	a	DT
cord-005453-4057qib7	9147	6	retrospective	retrospective	JJ
cord-005453-4057qib7	9147	7	cohort	cohort	NN
cord-005453-4057qib7	9147	8	study	study	NN
cord-005453-4057qib7	9147	9	of	of	IN
cord-005453-4057qib7	9147	10	adults	adult	NNS
cord-005453-4057qib7	9147	11	,	,	,
cord-005453-4057qib7	9148	1	CMV	CMV	NNP
cord-005453-4057qib7	9148	2	R+	r+	NN
cord-005453-4057qib7	9148	3	recipients	recipient	NNS
cord-005453-4057qib7	9148	4	of	of	IN
cord-005453-4057qib7	9148	5	first	first	JJ
cord-005453-4057qib7	9148	6	peripheral	peripheral	JJ
cord-005453-4057qib7	9148	7	blood	blood	NN
cord-005453-4057qib7	9148	8	or	or	CC
cord-005453-4057qib7	9148	9	marrow	marrow	NN
cord-005453-4057qib7	9148	10	allograft	allograft	NN
cord-005453-4057qib7	9148	11	at	at	IN
cord-005453-4057qib7	9148	12	MSKCC	MSKCC	NNS
cord-005453-4057qib7	9148	13	identified	identify	VBN
cord-005453-4057qib7	9148	14	from	from	IN
cord-005453-4057qib7	9148	15	March	March	NNP
cord-005453-4057qib7	9148	16	2013	2013	CD
cord-005453-4057qib7	9148	17	through	through	IN
cord-005453-4057qib7	9148	18	December	December	NNP
cord-005453-4057qib7	9148	19	2017	2017	CD
cord-005453-4057qib7	9148	20	.	.	.
cord-005453-4057qib7	9149	1	Data	datum	NNS
cord-005453-4057qib7	9149	2	was	be	VBD
cord-005453-4057qib7	9149	3	extracted	extract	VBN
cord-005453-4057qib7	9149	4	from	from	IN
cord-005453-4057qib7	9149	5	electronic	electronic	JJ
cord-005453-4057qib7	9149	6	medical	medical	JJ
cord-005453-4057qib7	9149	7	records	record	NNS
cord-005453-4057qib7	9149	8	and	and	CC
cord-005453-4057qib7	9149	9	HCT	hct	NN
cord-005453-4057qib7	9149	10	databases	database	NNS
cord-005453-4057qib7	9149	11	.	.	.
cord-005453-4057qib7	9150	1	CMV+	CMV+	NNP
cord-005453-4057qib7	9150	2	recipients	recipient	NNS
cord-005453-4057qib7	9150	3	were	be	VBD
cord-005453-4057qib7	9150	4	monitored	monitor	VBN
cord-005453-4057qib7	9150	5	weekly	weekly	RB
cord-005453-4057qib7	9150	6	by	by	IN
cord-005453-4057qib7	9150	7	quantitative	quantitative	JJ
cord-005453-4057qib7	9150	8	PCR	PCR	NNP
cord-005453-4057qib7	9150	9	assay	assay	NN
cord-005453-4057qib7	9150	10	starting	start	VBG
cord-005453-4057qib7	9150	11	on	on	IN
cord-005453-4057qib7	9150	12	D14	D14	NNP
cord-005453-4057qib7	9150	13	through	through	IN
cord-005453-4057qib7	9150	14	D180	d180	ADD
cord-005453-4057qib7	9150	15	post	post	NN
cord-005453-4057qib7	9150	16	HCT	hct	NN
cord-005453-4057qib7	9150	17	.	.	.
cord-005453-4057qib7	9151	1	Use	use	NN
cord-005453-4057qib7	9151	2	of	of	IN
cord-005453-4057qib7	9151	3	antiviral	antiviral	JJ
cord-005453-4057qib7	9151	4	therapy	therapy	NN
cord-005453-4057qib7	9151	5	for	for	IN
cord-005453-4057qib7	9151	6	CMV	CMV	NNP
cord-005453-4057qib7	9151	7	viremia	viremia	NN
cord-005453-4057qib7	9151	8	defined	define	VBD
cord-005453-4057qib7	9151	9	PET	PET	NNP
cord-005453-4057qib7	9151	10	.	.	.
cord-005453-4057qib7	9152	1	High	high	JJ
cord-005453-4057qib7	9152	2	CMV	CMV	NNP
cord-005453-4057qib7	9152	3	risk	risk	NN
cord-005453-4057qib7	9152	4	(	(	-LRB-
cord-005453-4057qib7	9152	5	HR	HR	NNP
cord-005453-4057qib7	9152	6	)	)	-RRB-
cord-005453-4057qib7	9152	7	comprised	comprise	VBD
cord-005453-4057qib7	9152	8	T	t	NN
cord-005453-4057qib7	9152	9	-	-	HYPH
cord-005453-4057qib7	9152	10	cell	cell	NN
cord-005453-4057qib7	9152	11	depleted	deplete	VBN
cord-005453-4057qib7	9153	1	(	(	-LRB-
cord-005453-4057qib7	9153	2	TCD	TCD	NNP
cord-005453-4057qib7	9153	3	)	)	-RRB-
cord-005453-4057qib7	9153	4	HCT	hct	NN
cord-005453-4057qib7	9153	5	by	by	IN
cord-005453-4057qib7	9153	6	CD34	CD34	NNP
cord-005453-4057qib7	9154	1	+	+	CC
cord-005453-4057qib7	9155	1	-selection	-selection	NN
cord-005453-4057qib7	9156	1	regardless	regardless	RB
cord-005453-4057qib7	9156	2	of	of	IN
cord-005453-4057qib7	9156	3	donor	donor	NN
cord-005453-4057qib7	9156	4	HLA	HLA	NNP
cord-005453-4057qib7	9156	5	match	match	NN
cord-005453-4057qib7	9156	6	or	or	CC
cord-005453-4057qib7	9156	7	conventional	conventional	JJ
cord-005453-4057qib7	9156	8	HCT	hct	NN
cord-005453-4057qib7	9156	9	from	from	IN
cord-005453-4057qib7	9156	10	mismatched	mismatched	JJ
cord-005453-4057qib7	9156	11	or	or	CC
cord-005453-4057qib7	9156	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9156	13	donors	donor	NNS
cord-005453-4057qib7	9156	14	;	;	:
cord-005453-4057qib7	9156	15	Low	low	JJ
cord-005453-4057qib7	9156	16	risk	risk	NN
cord-005453-4057qib7	9156	17	(	(	-LRB-
cord-005453-4057qib7	9156	18	LR	LR	NNP
cord-005453-4057qib7	9156	19	)	)	-RRB-
cord-005453-4057qib7	9156	20	included	include	VBD
cord-005453-4057qib7	9156	21	conventional	conventional	JJ
cord-005453-4057qib7	9156	22	HCT	hct	NN
cord-005453-4057qib7	9156	23	from	from	IN
cord-005453-4057qib7	9156	24	matched	match	VBN
cord-005453-4057qib7	9156	25	related	related	JJ
cord-005453-4057qib7	9156	26	donors	donor	NNS
cord-005453-4057qib7	9156	27	.	.	.
cord-005453-4057qib7	9157	1	CMV	CMV	NNP
cord-005453-4057qib7	9157	2	EOD	EOD	NNP
cord-005453-4057qib7	9157	3	was	be	VBD
cord-005453-4057qib7	9157	4	scored	score	VBN
cord-005453-4057qib7	9157	5	by	by	IN
cord-005453-4057qib7	9157	6	standard	standard	JJ
cord-005453-4057qib7	9157	7	criteria	criterion	NNS
cord-005453-4057qib7	9157	8	.	.	.
cord-005453-4057qib7	9158	1	CMV	CMV	NNP
cord-005453-4057qib7	9158	2	resistance	resistance	NN
cord-005453-4057qib7	9158	3	mutations	mutation	NNS
cord-005453-4057qib7	9158	4	were	be	VBD
cord-005453-4057qib7	9158	5	confirmed	confirm	VBN
cord-005453-4057qib7	9158	6	by	by	IN
cord-005453-4057qib7	9158	7	sequencing	sequence	VBG
cord-005453-4057qib7	9158	8	(	(	-LRB-
cord-005453-4057qib7	9158	9	Viracor	Viracor	NNP
cord-005453-4057qib7	9158	10	-	-	HYPH
cord-005453-4057qib7	9158	11	Eurofins	Eurofins	NNP
cord-005453-4057qib7	9158	12	)	)	-RRB-
cord-005453-4057qib7	9158	13	.	.	.
cord-005453-4057qib7	9159	1	Length	length	NN
cord-005453-4057qib7	9159	2	of	of	IN
cord-005453-4057qib7	9159	3	stay	stay	NN
cord-005453-4057qib7	9159	4	(	(	-LRB-
cord-005453-4057qib7	9159	5	LOS	LOS	NNP
cord-005453-4057qib7	9159	6	)	)	-RRB-
cord-005453-4057qib7	9159	7	for	for	IN
cord-005453-4057qib7	9159	8	HCT	hct	NN
cord-005453-4057qib7	9159	9	admissions	admission	NNS
cord-005453-4057qib7	9159	10	and	and	CC
cord-005453-4057qib7	9159	11	readmissions	readmission	NNS
cord-005453-4057qib7	9159	12	were	be	VBD
cord-005453-4057qib7	9159	13	identified	identify	VBN
cord-005453-4057qib7	9159	14	through	through	IN
cord-005453-4057qib7	9159	15	D180	D180	NNPS
cord-005453-4057qib7	9159	16	.	.	.
cord-005453-4057qib7	9160	1	Stratified	stratified	JJ
cord-005453-4057qib7	9160	2	analyses	analysis	NNS
cord-005453-4057qib7	9160	3	were	be	VBD
cord-005453-4057qib7	9160	4	performed	perform	VBN
cord-005453-4057qib7	9160	5	to	to	TO
cord-005453-4057qib7	9160	6	examine	examine	VB
cord-005453-4057qib7	9160	7	outcomes	outcome	NNS
cord-005453-4057qib7	9160	8	by	by	IN
cord-005453-4057qib7	9160	9	PET	pet	JJ
cord-005453-4057qib7	9160	10	use	use	NN
cord-005453-4057qib7	9160	11	and	and	CC
cord-005453-4057qib7	9160	12	CMV	CMV	NNP
cord-005453-4057qib7	9160	13	risk	risk	NN
cord-005453-4057qib7	9160	14	.	.	.
cord-005453-4057qib7	9161	1	Background	background	NN
cord-005453-4057qib7	9161	2	:	:	:
cord-005453-4057qib7	9162	1	In	in	IN
cord-005453-4057qib7	9162	2	a	a	DT
cord-005453-4057qib7	9162	3	Phase	Phase	NNP
cord-005453-4057qib7	9162	4	III	iii	CD
cord-005453-4057qib7	9162	5	randomized	randomized	JJ
cord-005453-4057qib7	9162	6	,	,	,
cord-005453-4057qib7	9162	7	double	double	JJ
cord-005453-4057qib7	9162	8	-	-	HYPH
cord-005453-4057qib7	9162	9	blind	blind	JJ
cord-005453-4057qib7	9162	10	,	,	,
cord-005453-4057qib7	9162	11	placebo	placebo	NN
cord-005453-4057qib7	9162	12	-	-	HYPH
cord-005453-4057qib7	9162	13	controlled	control	VBN
cord-005453-4057qib7	9162	14	study	study	NN
cord-005453-4057qib7	9162	15	of	of	IN
cord-005453-4057qib7	9162	16	CMV	CMV	NNP
cord-005453-4057qib7	9162	17	-	-	HYPH
cord-005453-4057qib7	9162	18	seropositive	seropositive	JJ
cord-005453-4057qib7	9162	19	post	post	JJ
cord-005453-4057qib7	9162	20	-	-	JJ
cord-005453-4057qib7	9162	21	HSCT	hsct	JJ
cord-005453-4057qib7	9162	22	recipients	recipient	NNS
cord-005453-4057qib7	9162	23	,	,	,
cord-005453-4057qib7	9162	24	letermovir	letermovir	NNP
cord-005453-4057qib7	9162	25	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9162	26	significantly	significantly	RB
cord-005453-4057qib7	9162	27	reduced	reduce	VBD
cord-005453-4057qib7	9162	28	the	the	DT
cord-005453-4057qib7	9162	29	incidence	incidence	NN
cord-005453-4057qib7	9162	30	of	of	IN
cord-005453-4057qib7	9162	31	clinically	clinically	RB
cord-005453-4057qib7	9162	32	significant	significant	JJ
cord-005453-4057qib7	9162	33	CMV	CMV	NNP
cord-005453-4057qib7	9162	34	infection	infection	NN
cord-005453-4057qib7	9162	35	through	through	IN
cord-005453-4057qib7	9162	36	week	week	NN
cord-005453-4057qib7	9162	37	24	24	CD
cord-005453-4057qib7	9162	38	.	.	.
cord-005453-4057qib7	9163	1	The	the	DT
cord-005453-4057qib7	9163	2	objective	objective	NN
cord-005453-4057qib7	9163	3	of	of	IN
cord-005453-4057qib7	9163	4	this	this	DT
cord-005453-4057qib7	9163	5	research	research	NN
cord-005453-4057qib7	9163	6	was	be	VBD
cord-005453-4057qib7	9163	7	to	to	TO
cord-005453-4057qib7	9163	8	assess	assess	VB
cord-005453-4057qib7	9163	9	the	the	DT
cord-005453-4057qib7	9163	10	impact	impact	NN
cord-005453-4057qib7	9163	11	of	of	IN
cord-005453-4057qib7	9163	12	CMV	CMV	NNP
cord-005453-4057qib7	9163	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9163	14	on	on	IN
cord-005453-4057qib7	9163	15	rates	rate	NNS
cord-005453-4057qib7	9163	16	of	of	IN
cord-005453-4057qib7	9163	17	rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9163	18	in	in	IN
cord-005453-4057qib7	9163	19	adult	adult	NN
cord-005453-4057qib7	9163	20	CMV	CMV	NNP
cord-005453-4057qib7	9163	21	seropositive	seropositive	JJ
cord-005453-4057qib7	9163	22	allogeneic	allogeneic	VBD
cord-005453-4057qib7	9163	23	HSCT	HSCT	NNP
cord-005453-4057qib7	9163	24	recipients	recipient	NNS
cord-005453-4057qib7	9163	25	from	from	IN
cord-005453-4057qib7	9163	26	the	the	DT
cord-005453-4057qib7	9163	27	letermovir	letermovir	NNS
cord-005453-4057qib7	9163	28	phase	phase	NN
cord-005453-4057qib7	9163	29	3	3	CD
cord-005453-4057qib7	9163	30	clinical	clinical	JJ
cord-005453-4057qib7	9163	31	trial	trial	NN
cord-005453-4057qib7	9163	32	.	.	.
cord-005453-4057qib7	9164	1	Methods	method	NNS
cord-005453-4057qib7	9164	2	:	:	:
cord-005453-4057qib7	9165	1	Rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9165	2	was	be	VBD
cord-005453-4057qib7	9165	3	recorded	record	VBN
cord-005453-4057qib7	9165	4	as	as	IN
cord-005453-4057qib7	9165	5	an	an	DT
cord-005453-4057qib7	9165	6	exploratory	exploratory	JJ
cord-005453-4057qib7	9165	7	endpoint	endpoint	NN
cord-005453-4057qib7	9165	8	in	in	IN
cord-005453-4057qib7	9165	9	the	the	DT
cord-005453-4057qib7	9165	10	clinical	clinical	JJ
cord-005453-4057qib7	9165	11	trial	trial	NN
cord-005453-4057qib7	9165	12	at	at	IN
cord-005453-4057qib7	9165	13	end	end	NN
cord-005453-4057qib7	9165	14	of	of	IN
cord-005453-4057qib7	9165	15	treatment	treatment	NN
cord-005453-4057qib7	9165	16	(	(	-LRB-
cord-005453-4057qib7	9165	17	Week14	Week14	NNP
cord-005453-4057qib7	9165	18	)	)	-RRB-
cord-005453-4057qib7	9165	19	,	,	,
cord-005453-4057qib7	9165	20	time	time	NN
cord-005453-4057qib7	9165	21	of	of	IN
cord-005453-4057qib7	9165	22	primary	primary	JJ
cord-005453-4057qib7	9165	23	endpoint	endpoint	NN
cord-005453-4057qib7	9165	24	(	(	-LRB-
cord-005453-4057qib7	9165	25	Week24	week24	NN
cord-005453-4057qib7	9165	26	)	)	-RRB-
cord-005453-4057qib7	9165	27	and	and	CC
cord-005453-4057qib7	9165	28	through	through	IN
cord-005453-4057qib7	9165	29	an	an	DT
cord-005453-4057qib7	9165	30	extended	extended	JJ
cord-005453-4057qib7	9165	31	follow	follow	NN
cord-005453-4057qib7	9165	32	-	-	HYPH
cord-005453-4057qib7	9165	33	up	up	NN
cord-005453-4057qib7	9165	34	period	period	NN
cord-005453-4057qib7	9165	35	(	(	-LRB-
cord-005453-4057qib7	9165	36	Week48	week48	NN
cord-005453-4057qib7	9165	37	)	)	-RRB-
cord-005453-4057qib7	9165	38	.	.	.
cord-005453-4057qib7	9166	1	CMV	CMV	NNP
cord-005453-4057qib7	9166	2	-	-	HYPH
cord-005453-4057qib7	9166	3	related	relate	VBN
cord-005453-4057qib7	9166	4	rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9166	5	was	be	VBD
cord-005453-4057qib7	9166	6	assessed	assess	VBN
cord-005453-4057qib7	9166	7	in	in	IN
cord-005453-4057qib7	9166	8	the	the	DT
cord-005453-4057qib7	9166	9	trial	trial	NN
cord-005453-4057qib7	9166	10	.	.	.
cord-005453-4057qib7	9167	1	Prespecified	prespecified	JJ
cord-005453-4057qib7	9167	2	analyses	analysis	NNS
cord-005453-4057qib7	9167	3	describe	describe	VBP
cord-005453-4057qib7	9167	4	the	the	DT
cord-005453-4057qib7	9167	5	observed	observed	JJ
cord-005453-4057qib7	9167	6	rates	rate	NNS
cord-005453-4057qib7	9167	7	of	of	IN
cord-005453-4057qib7	9167	8	rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9167	9	for	for	IN
cord-005453-4057qib7	9167	10	the	the	DT
cord-005453-4057qib7	9167	11	letermovir	letermovir	NNS
cord-005453-4057qib7	9167	12	and	and	CC
cord-005453-4057qib7	9167	13	placebo	placebo	NN
cord-005453-4057qib7	9167	14	groups	group	NNS
cord-005453-4057qib7	9167	15	at	at	IN
cord-005453-4057qib7	9167	16	the	the	DT
cord-005453-4057qib7	9167	17	specified	specified	JJ
cord-005453-4057qib7	9167	18	times	time	NNS
cord-005453-4057qib7	9167	19	.	.	.
cord-005453-4057qib7	9168	1	Fine	fine	JJ
cord-005453-4057qib7	9168	2	-	-	HYPH
cord-005453-4057qib7	9168	3	Gray	gray	JJ
cord-005453-4057qib7	9168	4	cumulative	cumulative	JJ
cord-005453-4057qib7	9168	5	incidence	incidence	NN
cord-005453-4057qib7	9168	6	function(CIF	function(cif	CD
cord-005453-4057qib7	9168	7	)	)	-RRB-
cord-005453-4057qib7	9169	1	regression	regression	NN
cord-005453-4057qib7	9169	2	models	model	NNS
cord-005453-4057qib7	9169	3	were	be	VBD
cord-005453-4057qib7	9169	4	used	use	VBN
cord-005453-4057qib7	9169	5	to	to	TO
cord-005453-4057qib7	9169	6	explore	explore	VB
cord-005453-4057qib7	9169	7	the	the	DT
cord-005453-4057qib7	9169	8	rate	rate	NN
cord-005453-4057qib7	9169	9	of	of	IN
cord-005453-4057qib7	9169	10	all	all	DT
cord-005453-4057qib7	9169	11	-	-	HYPH
cord-005453-4057qib7	9169	12	cause	cause	NN
cord-005453-4057qib7	9169	13	,	,	,
cord-005453-4057qib7	9169	14	and	and	CC
cord-005453-4057qib7	9169	15	CMV	CMV	NNP
cord-005453-4057qib7	9169	16	-	-	HYPH
cord-005453-4057qib7	9169	17	related	relate	VBN
cord-005453-4057qib7	9169	18	rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9169	19	accounting	accounting	NN
cord-005453-4057qib7	9169	20	for	for	IN
cord-005453-4057qib7	9169	21	the	the	DT
cord-005453-4057qib7	9169	22	competing	compete	VBG
cord-005453-4057qib7	9169	23	risk	risk	NN
cord-005453-4057qib7	9169	24	of	of	IN
cord-005453-4057qib7	9169	25	mortality	mortality	NN
cord-005453-4057qib7	9169	26	.	.	.
cord-005453-4057qib7	9170	1	A	a	DT
cord-005453-4057qib7	9170	2	multiple	multiple	JJ
cord-005453-4057qib7	9170	3	linear	linear	JJ
cord-005453-4057qib7	9170	4	regression	regression	NN
cord-005453-4057qib7	9170	5	model	model	NN
cord-005453-4057qib7	9170	6	was	be	VBD
cord-005453-4057qib7	9170	7	used	use	VBN
cord-005453-4057qib7	9170	8	to	to	TO
cord-005453-4057qib7	9170	9	describe	describe	VB
cord-005453-4057qib7	9170	10	the	the	DT
cord-005453-4057qib7	9170	11	cumulative	cumulative	JJ
cord-005453-4057qib7	9170	12	length	length	NN
cord-005453-4057qib7	9170	13	of	of	IN
cord-005453-4057qib7	9170	14	stay	stay	NN
cord-005453-4057qib7	9170	15	(	(	-LRB-
cord-005453-4057qib7	9170	16	LOS	LOS	NNP
cord-005453-4057qib7	9170	17	)	)	-RRB-
cord-005453-4057qib7	9170	18	for	for	IN
cord-005453-4057qib7	9170	19	all	all	DT
cord-005453-4057qib7	9170	20	-	-	HYPH
cord-005453-4057qib7	9170	21	cause	cause	NN
cord-005453-4057qib7	9170	22	rehospitalizations	rehospitalization	NNS
cord-005453-4057qib7	9170	23	that	that	WDT
cord-005453-4057qib7	9170	24	occurred	occur	VBD
cord-005453-4057qib7	9170	25	through	through	IN
cord-005453-4057qib7	9170	26	Week48	week48	CD
cord-005453-4057qib7	9171	1	(	(	-LRB-
cord-005453-4057qib7	9171	2	excluding	exclude	VBG
cord-005453-4057qib7	9171	3	time	time	NN
cord-005453-4057qib7	9171	4	of	of	IN
cord-005453-4057qib7	9171	5	initial	initial	JJ
cord-005453-4057qib7	9171	6	transplant	transplant	NN
cord-005453-4057qib7	9171	7	stay	stay	NN
cord-005453-4057qib7	9171	8	)	)	-RRB-
cord-005453-4057qib7	9171	9	.	.	.
cord-005453-4057qib7	9172	1	Results	result	NNS
cord-005453-4057qib7	9172	2	:	:	:
cord-005453-4057qib7	9173	1	Observed	observed	JJ
cord-005453-4057qib7	9173	2	rates	rate	NNS
cord-005453-4057qib7	9173	3	of	of	IN
cord-005453-4057qib7	9173	4	all	all	DT
cord-005453-4057qib7	9173	5	-	-	HYPH
cord-005453-4057qib7	9173	6	cause	cause	NN
cord-005453-4057qib7	9173	7	rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9173	8	were	be	VBD
cord-005453-4057qib7	9173	9	lower	low	JJR
cord-005453-4057qib7	9173	10	for	for	IN
cord-005453-4057qib7	9173	11	the	the	DT
cord-005453-4057qib7	9173	12	letermovir	letermovir	NNP
cord-005453-4057qib7	9173	13	group	group	NN
cord-005453-4057qib7	9173	14	compared	compare	VBN
cord-005453-4057qib7	9173	15	to	to	IN
cord-005453-4057qib7	9173	16	placebo	placebo	NN
cord-005453-4057qib7	9173	17	at	at	IN
cord-005453-4057qib7	9173	18	end	end	NN
cord-005453-4057qib7	9173	19	of	of	IN
cord-005453-4057qib7	9173	20	treatment	treatment	NN
cord-005453-4057qib7	9174	1	(	(	-LRB-
cord-005453-4057qib7	9174	2	36.6%vs.47	36.6%vs.47	CD
cord-005453-4057qib7	9174	3	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	9174	4	:	:	:
cord-005453-4057qib7	9175	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9175	2	was	be	VBD
cord-005453-4057qib7	9175	3	shown	show	VBN
cord-005453-4057qib7	9175	4	to	to	TO
cord-005453-4057qib7	9175	5	significantly	significantly	RB
cord-005453-4057qib7	9175	6	reduce	reduce	VB
cord-005453-4057qib7	9175	7	the	the	DT
cord-005453-4057qib7	9175	8	rate	rate	NN
cord-005453-4057qib7	9175	9	of	of	IN
cord-005453-4057qib7	9175	10	clinically	clinically	RB
cord-005453-4057qib7	9175	11	significant	significant	JJ
cord-005453-4057qib7	9175	12	CMV	CMV	NNP
cord-005453-4057qib7	9175	13	infection	infection	NN
cord-005453-4057qib7	9175	14	in	in	IN
cord-005453-4057qib7	9175	15	a	a	DT
cord-005453-4057qib7	9175	16	placebo	placebo	NN
cord-005453-4057qib7	9175	17	-	-	HYPH
cord-005453-4057qib7	9175	18	controlled	control	VBN
cord-005453-4057qib7	9175	19	randomized	randomized	JJ
cord-005453-4057qib7	9175	20	clinical	clinical	JJ
cord-005453-4057qib7	9175	21	trial	trial	NN
cord-005453-4057qib7	9175	22	.	.	.
cord-005453-4057qib7	9176	1	These	these	DT
cord-005453-4057qib7	9176	2	analyses	analysis	NNS
cord-005453-4057qib7	9176	3	suggest	suggest	VBP
cord-005453-4057qib7	9176	4	that	that	IN
cord-005453-4057qib7	9176	5	there	there	EX
cord-005453-4057qib7	9176	6	is	be	VBZ
cord-005453-4057qib7	9176	7	also	also	RB
cord-005453-4057qib7	9176	8	a	a	DT
cord-005453-4057qib7	9176	9	reduction	reduction	NN
cord-005453-4057qib7	9176	10	in	in	IN
cord-005453-4057qib7	9176	11	the	the	DT
cord-005453-4057qib7	9176	12	rate	rate	NN
cord-005453-4057qib7	9176	13	and	and	CC
cord-005453-4057qib7	9176	14	cumulative	cumulative	JJ
cord-005453-4057qib7	9176	15	days	day	NNS
cord-005453-4057qib7	9176	16	of	of	IN
cord-005453-4057qib7	9176	17	rehospitalization	rehospitalization	NN
cord-005453-4057qib7	9176	18	.	.	.
cord-005453-4057qib7	9177	1	This	this	DT
cord-005453-4057qib7	9177	2	trial	trial	NN
cord-005453-4057qib7	9177	3	was	be	VBD
cord-005453-4057qib7	9177	4	not	not	RB
cord-005453-4057qib7	9177	5	sufficiently	sufficiently	RB
cord-005453-4057qib7	9177	6	powered	powered	JJ
cord-005453-4057qib7	9177	7	to	to	TO
cord-005453-4057qib7	9177	8	detect	detect	VB
cord-005453-4057qib7	9177	9	differences	difference	NNS
cord-005453-4057qib7	9177	10	in	in	IN
cord-005453-4057qib7	9177	11	this	this	DT
cord-005453-4057qib7	9177	12	exploratory	exploratory	JJ
cord-005453-4057qib7	9177	13	endpoint	endpoint	NN
cord-005453-4057qib7	9177	14	.	.	.
cord-005453-4057qib7	9178	1	Nonetheless	nonetheless	RB
cord-005453-4057qib7	9178	2	,	,	,
cord-005453-4057qib7	9178	3	these	these	DT
cord-005453-4057qib7	9178	4	data	datum	NNS
cord-005453-4057qib7	9178	5	provide	provide	VBP
cord-005453-4057qib7	9178	6	valuable	valuable	JJ
cord-005453-4057qib7	9178	7	insights	insight	NNS
cord-005453-4057qib7	9178	8	into	into	IN
cord-005453-4057qib7	9178	9	the	the	DT
cord-005453-4057qib7	9178	10	economic	economic	JJ
cord-005453-4057qib7	9178	11	burden	burden	NN
cord-005453-4057qib7	9178	12	of	of	IN
cord-005453-4057qib7	9178	13	CMV	CMV	NNP
cord-005453-4057qib7	9178	14	.	.	.
cord-005453-4057qib7	9179	1	Real	real	JJ
cord-005453-4057qib7	9179	2	world	world	NN
cord-005453-4057qib7	9179	3	data	datum	NNS
cord-005453-4057qib7	9179	4	and	and	CC
cord-005453-4057qib7	9179	5	findings	finding	NNS
cord-005453-4057qib7	9179	6	from	from	IN
cord-005453-4057qib7	9179	7	future	future	JJ
cord-005453-4057qib7	9179	8	clinical	clinical	JJ
cord-005453-4057qib7	9179	9	trials	trial	NNS
cord-005453-4057qib7	9179	10	are	be	VBP
cord-005453-4057qib7	9179	11	needed	need	VBN
cord-005453-4057qib7	9179	12	to	to	TO
cord-005453-4057qib7	9179	13	better	better	RB
cord-005453-4057qib7	9179	14	understand	understand	VB
cord-005453-4057qib7	9179	15	the	the	DT
cord-005453-4057qib7	9179	16	nature	nature	NN
cord-005453-4057qib7	9179	17	of	of	IN
cord-005453-4057qib7	9179	18	the	the	DT
cord-005453-4057qib7	9179	19	association	association	NN
cord-005453-4057qib7	9179	20	between	between	IN
cord-005453-4057qib7	9179	21	CMV	CMV	NNP
cord-005453-4057qib7	9179	22	and	and	CC
cord-005453-4057qib7	9179	23	rehospitalizations	rehospitalization	NNS
cord-005453-4057qib7	9179	24	.	.	.
cord-005453-4057qib7	9180	1	Clinical	clinical	JJ
cord-005453-4057qib7	9180	2	Methods	method	NNS
cord-005453-4057qib7	9180	3	:	:	:
cord-005453-4057qib7	9181	1	All	all	DT
cord-005453-4057qib7	9181	2	consecutive	consecutive	JJ
cord-005453-4057qib7	9181	3	patients	patient	NNS
cord-005453-4057qib7	9181	4	with	with	IN
cord-005453-4057qib7	9181	5	hematologic	hematologic	JJ
cord-005453-4057qib7	9181	6	disorders	disorder	NNS
cord-005453-4057qib7	9181	7	who	who	WP
cord-005453-4057qib7	9181	8	received	receive	VBD
cord-005453-4057qib7	9181	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9181	10	at	at	IN
cord-005453-4057qib7	9181	11	our	-PRON-	PRP$
cord-005453-4057qib7	9181	12	Center	Center	NNP
cord-005453-4057qib7	9181	13	between	between	IN
cord-005453-4057qib7	9181	14	January	January	NNP
cord-005453-4057qib7	9181	15	2013	2013	CD
cord-005453-4057qib7	9181	16	and	and	CC
cord-005453-4057qib7	9181	17	August	August	NNP
cord-005453-4057qib7	9181	18	2018	2018	CD
cord-005453-4057qib7	9181	19	were	be	VBD
cord-005453-4057qib7	9181	20	included	include	VBN
cord-005453-4057qib7	9181	21	.	.	.
cord-005453-4057qib7	9182	1	Among	among	IN
cord-005453-4057qib7	9182	2	the	the	DT
cord-005453-4057qib7	9182	3	278	278	CD
cord-005453-4057qib7	9182	4	evaluable	evaluable	JJ
cord-005453-4057qib7	9182	5	patients	patient	NNS
cord-005453-4057qib7	9182	6	,	,	,
cord-005453-4057qib7	9182	7	172	172	CD
cord-005453-4057qib7	9182	8	received	receive	VBD
cord-005453-4057qib7	9182	9	levofloxacin	levofloxacin	NNS
cord-005453-4057qib7	9182	10	as	as	IN
cord-005453-4057qib7	9182	11	antibacterial	antibacterial	JJ
cord-005453-4057qib7	9182	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9182	13	(	(	-LRB-
cord-005453-4057qib7	9182	14	group	group	NN
cord-005453-4057qib7	9182	15	A	A	NNP
cord-005453-4057qib7	9182	16	)	)	-RRB-
cord-005453-4057qib7	9182	17	while	while	IN
cord-005453-4057qib7	9182	18	106	106	CD
cord-005453-4057qib7	9182	19	did	do	VBD
cord-005453-4057qib7	9182	20	not	not	RB
cord-005453-4057qib7	9182	21	receive	receive	VB
cord-005453-4057qib7	9182	22	any	any	DT
cord-005453-4057qib7	9182	23	FQ	FQ	NNP
cord-005453-4057qib7	9182	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9182	25	(	(	-LRB-
cord-005453-4057qib7	9182	26	group	group	NN
cord-005453-4057qib7	9182	27	B	B	NNP
cord-005453-4057qib7	9182	28	)	)	-RRB-
cord-005453-4057qib7	9182	29	.	.	.
cord-005453-4057qib7	9183	1	Baseline	baseline	JJ
cord-005453-4057qib7	9183	2	characteristics	characteristic	NNS
cord-005453-4057qib7	9183	3	were	be	VBD
cord-005453-4057qib7	9183	4	similar	similar	JJ
cord-005453-4057qib7	9183	5	in	in	IN
cord-005453-4057qib7	9183	6	the	the	DT
cord-005453-4057qib7	9183	7	two	two	CD
cord-005453-4057qib7	9183	8	groups	group	NNS
cord-005453-4057qib7	9183	9	,	,	,
cord-005453-4057qib7	9183	10	except	except	IN
cord-005453-4057qib7	9183	11	for	for	IN
cord-005453-4057qib7	9183	12	the	the	DT
cord-005453-4057qib7	9183	13	number	number	NN
cord-005453-4057qib7	9183	14	of	of	IN
cord-005453-4057qib7	9183	15	patients	patient	NNS
cord-005453-4057qib7	9183	16	with	with	IN
cord-005453-4057qib7	9183	17	advanced	advanced	JJ
cord-005453-4057qib7	9183	18	disease	disease	NN
cord-005453-4057qib7	9183	19	(	(	-LRB-
cord-005453-4057qib7	9183	20	34	34	CD
cord-005453-4057qib7	9183	21	%	%	NN
cord-005453-4057qib7	9183	22	in	in	IN
cord-005453-4057qib7	9183	23	group	group	NN
cord-005453-4057qib7	9183	24	A	a	NN
cord-005453-4057qib7	9183	25	and	and	CC
cord-005453-4057qib7	9183	26	47	47	CD
cord-005453-4057qib7	9183	27	%	%	NN
cord-005453-4057qib7	9183	28	in	in	IN
cord-005453-4057qib7	9183	29	group	group	NN
cord-005453-4057qib7	9183	30	B	B	NNP
cord-005453-4057qib7	9183	31	,	,	,
cord-005453-4057qib7	9183	32	p	p	NN
cord-005453-4057qib7	9183	33	0,042	0,042	CD
cord-005453-4057qib7	9183	34	)	)	-RRB-
cord-005453-4057qib7	9183	35	.	.	.
cord-005453-4057qib7	9184	1	Median	median	JJ
cord-005453-4057qib7	9184	2	duration	duration	NN
cord-005453-4057qib7	9184	3	of	of	IN
cord-005453-4057qib7	9184	4	neutropenia	neutropenia	NN
cord-005453-4057qib7	9184	5	was	be	VBD
cord-005453-4057qib7	9184	6	16	16	CD
cord-005453-4057qib7	9184	7	days	day	NNS
cord-005453-4057qib7	9185	1	(	(	-LRB-
cord-005453-4057qib7	9185	2	range	range	NNP
cord-005453-4057qib7	9185	3	9	9	CD
cord-005453-4057qib7	9185	4	-	-	SYM
cord-005453-4057qib7	9185	5	44	44	CD
cord-005453-4057qib7	9185	6	)	)	-RRB-
cord-005453-4057qib7	9185	7	in	in	IN
cord-005453-4057qib7	9185	8	group	group	NN
cord-005453-4057qib7	9185	9	A	a	NN
cord-005453-4057qib7	9185	10	and	and	CC
cord-005453-4057qib7	9185	11	14	14	CD
cord-005453-4057qib7	9185	12	days	day	NNS
cord-005453-4057qib7	9185	13	(	(	-LRB-
cord-005453-4057qib7	9185	14	range	range	NNP
cord-005453-4057qib7	9185	15	4	4	CD
cord-005453-4057qib7	9185	16	-	-	SYM
cord-005453-4057qib7	9185	17	31	31	CD
cord-005453-4057qib7	9185	18	)	)	-RRB-
cord-005453-4057qib7	9185	19	in	in	IN
cord-005453-4057qib7	9185	20	group	group	NN
cord-005453-4057qib7	9185	21	B.	B.	NNP
cord-005453-4057qib7	9185	22	A	a	DT
cord-005453-4057qib7	9185	23	positive	positive	JJ
cord-005453-4057qib7	9185	24	rectal	rectal	JJ
cord-005453-4057qib7	9185	25	swab	swab	NN
cord-005453-4057qib7	9185	26	for	for	IN
cord-005453-4057qib7	9185	27	Carbapenem	Carbapenem	NNP
cord-005453-4057qib7	9185	28	-	-	HYPH
cord-005453-4057qib7	9185	29	resistant	resistant	JJ
cord-005453-4057qib7	9185	30	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-005453-4057qib7	9185	31	(	(	-LRB-
cord-005453-4057qib7	9185	32	CRE	CRE	NNP
cord-005453-4057qib7	9185	33	)	)	-RRB-
cord-005453-4057qib7	9185	34	was	be	VBD
cord-005453-4057qib7	9185	35	detected	detect	VBN
cord-005453-4057qib7	9185	36	in	in	IN
cord-005453-4057qib7	9185	37	3	3	CD
cord-005453-4057qib7	9185	38	patients	patient	NNS
cord-005453-4057qib7	9185	39	in	in	IN
cord-005453-4057qib7	9185	40	group	group	NN
cord-005453-4057qib7	9185	41	A	a	NN
cord-005453-4057qib7	9185	42	and	and	CC
cord-005453-4057qib7	9185	43	8	8	CD
cord-005453-4057qib7	9185	44	patients	patient	NNS
cord-005453-4057qib7	9185	45	in	in	IN
cord-005453-4057qib7	9185	46	group	group	NN
cord-005453-4057qib7	9185	47	B.	B.	NNP
cord-005453-4057qib7	9185	48	Results	Results	NNP
cord-005453-4057qib7	9185	49	:	:	:
cord-005453-4057qib7	9186	1	Overall	overall	RB
cord-005453-4057qib7	9186	2	,	,	,
cord-005453-4057qib7	9186	3	BSI	BSI	NNP
cord-005453-4057qib7	9186	4	was	be	VBD
cord-005453-4057qib7	9186	5	detected	detect	VBN
cord-005453-4057qib7	9186	6	in	in	IN
cord-005453-4057qib7	9186	7	58	58	CD
cord-005453-4057qib7	9186	8	patients	patient	NNS
cord-005453-4057qib7	9186	9	(	(	-LRB-
cord-005453-4057qib7	9186	10	20,9	20,9	CD
cord-005453-4057qib7	9186	11	%	%	NN
cord-005453-4057qib7	9186	12	)	)	-RRB-
cord-005453-4057qib7	9186	13	,	,	,
cord-005453-4057qib7	9186	14	29	29	CD
cord-005453-4057qib7	9186	15	(	(	-LRB-
cord-005453-4057qib7	9186	16	16,9	16,9	CD
cord-005453-4057qib7	9186	17	%	%	NN
cord-005453-4057qib7	9186	18	)	)	-RRB-
cord-005453-4057qib7	9186	19	in	in	IN
cord-005453-4057qib7	9186	20	group	group	NN
cord-005453-4057qib7	9186	21	A	A	NNP
cord-005453-4057qib7	9186	22	and	and	CC
cord-005453-4057qib7	9186	23	29	29	CD
cord-005453-4057qib7	9186	24	(	(	-LRB-
cord-005453-4057qib7	9186	25	27,4	27,4	CD
cord-005453-4057qib7	9186	26	%	%	NN
cord-005453-4057qib7	9186	27	)	)	-RRB-
cord-005453-4057qib7	9186	28	in	in	IN
cord-005453-4057qib7	9186	29	group	group	NN
cord-005453-4057qib7	9186	30	B	B	NNP
cord-005453-4057qib7	9186	31	(	(	-LRB-
cord-005453-4057qib7	9186	32	p=0,048	p=0,048	NNP
cord-005453-4057qib7	9186	33	)	)	-RRB-
cord-005453-4057qib7	9186	34	.	.	.
cord-005453-4057qib7	9187	1	The	the	DT
cord-005453-4057qib7	9187	2	median	median	JJ
cord-005453-4057qib7	9187	3	onset	onset	NN
cord-005453-4057qib7	9187	4	of	of	IN
cord-005453-4057qib7	9187	5	BSI	BSI	NNP
cord-005453-4057qib7	9187	6	was	be	VBD
cord-005453-4057qib7	9187	7	8	8	CD
cord-005453-4057qib7	9187	8	days	day	NNS
cord-005453-4057qib7	9187	9	post	post	NN
cord-005453-4057qib7	9187	10	transplant	transplant	NN
cord-005453-4057qib7	9187	11	(	(	-LRB-
cord-005453-4057qib7	9187	12	range	range	NN
cord-005453-4057qib7	9187	13	0	0	CD
cord-005453-4057qib7	9187	14	-	-	HYPH
cord-005453-4057qib7	9187	15	28	28	CD
cord-005453-4057qib7	9187	16	)	)	-RRB-
cord-005453-4057qib7	9187	17	,	,	,
cord-005453-4057qib7	9187	18	without	without	IN
cord-005453-4057qib7	9187	19	significant	significant	JJ
cord-005453-4057qib7	9187	20	differences	difference	NNS
cord-005453-4057qib7	9187	21	between	between	IN
cord-005453-4057qib7	9187	22	the	the	DT
cord-005453-4057qib7	9187	23	two	two	CD
cord-005453-4057qib7	9187	24	groups	group	NNS
cord-005453-4057qib7	9187	25	.	.	.
cord-005453-4057qib7	9188	1	In	in	IN
cord-005453-4057qib7	9188	2	univariate	univariate	JJ
cord-005453-4057qib7	9188	3	analysis	analysis	NN
cord-005453-4057qib7	9188	4	,	,	,
cord-005453-4057qib7	9188	5	FQ	FQ	NNP
cord-005453-4057qib7	9188	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9188	7	(	(	-LRB-
cord-005453-4057qib7	9188	8	OR	or	CC
cord-005453-4057qib7	9188	9	0,54	0,54	CD
cord-005453-4057qib7	9188	10	;	;	:
cord-005453-4057qib7	9188	11	95	95	CD
cord-005453-4057qib7	9188	12	%	%	NN
cord-005453-4057qib7	9188	13	IC	IC	NNP
cord-005453-4057qib7	9188	14	0,30	0,30	NNP
cord-005453-4057qib7	9188	15	-	-	HYPH
cord-005453-4057qib7	9188	16	0,97	0,97	CD
cord-005453-4057qib7	9188	17	)	)	-RRB-
cord-005453-4057qib7	9188	18	and	and	CC
cord-005453-4057qib7	9188	19	bone	bone	NN
cord-005453-4057qib7	9188	20	marrow	marrow	NN
cord-005453-4057qib7	9188	21	stem	stem	NN
cord-005453-4057qib7	9188	22	cell	cell	NN
cord-005453-4057qib7	9188	23	source	source	NN
cord-005453-4057qib7	9188	24	(	(	-LRB-
cord-005453-4057qib7	9188	25	OR	or	CC
cord-005453-4057qib7	9188	26	2,08	2,08	CD
cord-005453-4057qib7	9188	27	;	;	:
cord-005453-4057qib7	9188	28	95	95	CD
cord-005453-4057qib7	9188	29	%	%	NN
cord-005453-4057qib7	9188	30	IC	IC	NNP
cord-005453-4057qib7	9188	31	1,05	1,05	NNP
cord-005453-4057qib7	9188	32	-	-	HYPH
cord-005453-4057qib7	9188	33	4,12	4,12	CD
cord-005453-4057qib7	9188	34	)	)	-RRB-
cord-005453-4057qib7	9188	35	were	be	VBD
cord-005453-4057qib7	9188	36	significant	significant	JJ
cord-005453-4057qib7	9188	37	factors	factor	NNS
cord-005453-4057qib7	9188	38	associated	associate	VBN
cord-005453-4057qib7	9188	39	with	with	IN
cord-005453-4057qib7	9188	40	the	the	DT
cord-005453-4057qib7	9188	41	risk	risk	NN
cord-005453-4057qib7	9188	42	of	of	IN
cord-005453-4057qib7	9188	43	BSI	BSI	NNP
cord-005453-4057qib7	9188	44	.	.	.
cord-005453-4057qib7	9189	1	Gramnegative	gramnegative	JJ
cord-005453-4057qib7	9189	2	bacteria	bacteria	NNS
cord-005453-4057qib7	9189	3	accounted	account	VBD
cord-005453-4057qib7	9189	4	for	for	IN
cord-005453-4057qib7	9189	5	44,8	44,8	CD
cord-005453-4057qib7	9189	6	%	%	NN
cord-005453-4057qib7	9189	7	(	(	-LRB-
cord-005453-4057qib7	9189	8	n=13	n=13	NNP
cord-005453-4057qib7	9189	9	)	)	-RRB-
cord-005453-4057qib7	9189	10	of	of	IN
cord-005453-4057qib7	9189	11	BSI	BSI	NNP
cord-005453-4057qib7	9189	12	in	in	IN
cord-005453-4057qib7	9189	13	group	group	NN
cord-005453-4057qib7	9189	14	A	A	NNP
cord-005453-4057qib7	9189	15	and	and	CC
cord-005453-4057qib7	9189	16	65,5	65,5	CD
cord-005453-4057qib7	9189	17	%	%	NN
cord-005453-4057qib7	9190	1	(	(	-LRB-
cord-005453-4057qib7	9190	2	n=	n=	NNP
cord-005453-4057qib7	9190	3	19	19	CD
cord-005453-4057qib7	9190	4	)	)	-RRB-
cord-005453-4057qib7	9190	5	in	in	IN
cord-005453-4057qib7	9190	6	group	group	NN
cord-005453-4057qib7	9190	7	B	B	NNP
cord-005453-4057qib7	9190	8	,	,	,
cord-005453-4057qib7	9190	9	and	and	CC
cord-005453-4057qib7	9190	10	gram	gram	NN
cord-005453-4057qib7	9190	11	-	-	HYPH
cord-005453-4057qib7	9190	12	positive	positive	JJ
cord-005453-4057qib7	9190	13	bacteria	bacteria	NNS
cord-005453-4057qib7	9190	14	for	for	IN
cord-005453-4057qib7	9190	15	48,3	48,3	CD
cord-005453-4057qib7	9190	16	%	%	NN
cord-005453-4057qib7	9191	1	(	(	-LRB-
cord-005453-4057qib7	9191	2	n=	n=	NNP
cord-005453-4057qib7	9191	3	14	14	CD
cord-005453-4057qib7	9191	4	)	)	-RRB-
cord-005453-4057qib7	9191	5	of	of	IN
cord-005453-4057qib7	9191	6	BSI	BSI	NNP
cord-005453-4057qib7	9191	7	in	in	IN
cord-005453-4057qib7	9191	8	group	group	NN
cord-005453-4057qib7	9191	9	A	A	NNP
cord-005453-4057qib7	9191	10	versus	versus	IN
cord-005453-4057qib7	9191	11	27,5	27,5	CD
cord-005453-4057qib7	9191	12	%	%	NN
cord-005453-4057qib7	9192	1	(	(	-LRB-
cord-005453-4057qib7	9192	2	n=	n=	NNP
cord-005453-4057qib7	9192	3	8)	8)	NNP
cord-005453-4057qib7	9193	1	in	in	IN
cord-005453-4057qib7	9193	2	group	group	NN
cord-005453-4057qib7	9193	3	B	B	NNP
cord-005453-4057qib7	9193	4	,	,	,
cord-005453-4057qib7	9193	5	without	without	IN
cord-005453-4057qib7	9193	6	statistically	statistically	RB
cord-005453-4057qib7	9193	7	significant	significant	JJ
cord-005453-4057qib7	9193	8	differences	difference	NNS
cord-005453-4057qib7	9193	9	(	(	-LRB-
cord-005453-4057qib7	9193	10	p	p	NN
cord-005453-4057qib7	9193	11	=	=	SYM
cord-005453-4057qib7	9193	12	0,16	0,16	NNP
cord-005453-4057qib7	9193	13	)	)	-RRB-
cord-005453-4057qib7	9193	14	.	.	.
cord-005453-4057qib7	9194	1	Polymicrobic	Polymicrobic	NNP
cord-005453-4057qib7	9194	2	BSI	BSI	NNP
cord-005453-4057qib7	9194	3	were	be	VBD
cord-005453-4057qib7	9194	4	6,9	6,9	CD
cord-005453-4057qib7	9194	5	%	%	NN
cord-005453-4057qib7	9194	6	(	(	-LRB-
cord-005453-4057qib7	9194	7	n=2	n=2	NNS
cord-005453-4057qib7	9194	8	)	)	-RRB-
cord-005453-4057qib7	9194	9	in	in	IN
cord-005453-4057qib7	9194	10	group	group	NN
cord-005453-4057qib7	9194	11	A	A	NNP
cord-005453-4057qib7	9194	12	and	and	CC
cord-005453-4057qib7	9194	13	6,9	6,9	CD
cord-005453-4057qib7	9194	14	%	%	NN
cord-005453-4057qib7	9194	15	(	(	-LRB-
cord-005453-4057qib7	9194	16	n=2	n=2	NNS
cord-005453-4057qib7	9194	17	)	)	-RRB-
cord-005453-4057qib7	9194	18	in	in	IN
cord-005453-4057qib7	9194	19	group	group	NN
cord-005453-4057qib7	9194	20	B.	B.	NNP
cord-005453-4057qib7	9194	21	MDRgram	MDRgram	NNP
cord-005453-4057qib7	9195	1	negative	negative	JJ
cord-005453-4057qib7	9195	2	BSI	BSI	NNP
cord-005453-4057qib7	9195	3	were	be	VBD
cord-005453-4057qib7	9195	4	detected	detect	VBN
cord-005453-4057qib7	9195	5	in	in	IN
cord-005453-4057qib7	9195	6	4	4	CD
cord-005453-4057qib7	9195	7	patients	patient	NNS
cord-005453-4057qib7	9195	8	(	(	-LRB-
cord-005453-4057qib7	9195	9	14	14	CD
cord-005453-4057qib7	9195	10	%	%	NN
cord-005453-4057qib7	9195	11	)	)	-RRB-
cord-005453-4057qib7	9195	12	in	in	IN
cord-005453-4057qib7	9195	13	group	group	NN
cord-005453-4057qib7	9195	14	A	A	NNP
cord-005453-4057qib7	9195	15	and	and	CC
cord-005453-4057qib7	9195	16	in	in	IN
cord-005453-4057qib7	9195	17	6	6	CD
cord-005453-4057qib7	9195	18	patients	patient	NNS
cord-005453-4057qib7	9195	19	(	(	-LRB-
cord-005453-4057qib7	9195	20	20,7	20,7	CD
cord-005453-4057qib7	9195	21	%	%	NN
cord-005453-4057qib7	9195	22	)	)	-RRB-
cord-005453-4057qib7	9195	23	in	in	IN
cord-005453-4057qib7	9195	24	group	group	NN
cord-005453-4057qib7	9195	25	B	b	NN
cord-005453-4057qib7	9195	26	(	(	-LRB-
cord-005453-4057qib7	9195	27	overall	overall	RB
cord-005453-4057qib7	9195	28	,	,	,
cord-005453-4057qib7	9195	29	2	2	CD
cord-005453-4057qib7	9195	30	CRE	cre	NN
cord-005453-4057qib7	9195	31	,	,	,
cord-005453-4057qib7	9195	32	7	7	CD
cord-005453-4057qib7	9195	33	ESBL	ESBL	NNP
cord-005453-4057qib7	9195	34	producing	produce	VBG
cord-005453-4057qib7	9195	35	enterobacteriaceae	enterobacteriaceae	NNS
cord-005453-4057qib7	9195	36	and	and	CC
cord-005453-4057qib7	9195	37	1	1	CD
cord-005453-4057qib7	9195	38	MDR	MDR	NNP
cord-005453-4057qib7	9195	39	-	-	HYPH
cord-005453-4057qib7	9195	40	Pseudomonas	Pseudomonas	NNP
cord-005453-4057qib7	9195	41	)	)	-RRB-
cord-005453-4057qib7	9195	42	.	.	.
cord-005453-4057qib7	9196	1	Death	death	NN
cord-005453-4057qib7	9196	2	attributable	attributable	JJ
cord-005453-4057qib7	9196	3	to	to	IN
cord-005453-4057qib7	9196	4	BSI	BSI	NNP
cord-005453-4057qib7	9196	5	occurred	occur	VBD
cord-005453-4057qib7	9196	6	in	in	IN
cord-005453-4057qib7	9196	7	6	6	CD
cord-005453-4057qib7	9196	8	of	of	IN
cord-005453-4057qib7	9196	9	58	58	CD
cord-005453-4057qib7	9196	10	patients	patient	NNS
cord-005453-4057qib7	9196	11	(	(	-LRB-
cord-005453-4057qib7	9196	12	10,3	10,3	CD
cord-005453-4057qib7	9196	13	%	%	NN
cord-005453-4057qib7	9196	14	)	)	-RRB-
cord-005453-4057qib7	9196	15	;	;	:
cord-005453-4057qib7	9196	16	5	5	CD
cord-005453-4057qib7	9196	17	of	of	IN
cord-005453-4057qib7	9196	18	these	these	DT
cord-005453-4057qib7	9196	19	patients	patient	NNS
cord-005453-4057qib7	9196	20	did	do	VBD
cord-005453-4057qib7	9196	21	not	not	RB
cord-005453-4057qib7	9196	22	receive	receive	VB
cord-005453-4057qib7	9196	23	FQ	FQ	NNP
cord-005453-4057qib7	9196	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9196	25	,	,	,
cord-005453-4057qib7	9196	26	but	but	CC
cord-005453-4057qib7	9196	27	2	2	CD
cord-005453-4057qib7	9196	28	of	of	IN
cord-005453-4057qib7	9196	29	them	-PRON-	PRP
cord-005453-4057qib7	9196	30	had	have	VBD
cord-005453-4057qib7	9196	31	both	both	CC
cord-005453-4057qib7	9196	32	a	a	DT
cord-005453-4057qib7	9196	33	pre	pre	JJ
cord-005453-4057qib7	9196	34	transplant	transplant	NN
cord-005453-4057qib7	9196	35	KPC	KPC	NNP
cord-005453-4057qib7	9196	36	colonization	colonization	NN
cord-005453-4057qib7	9196	37	and	and	CC
cord-005453-4057qib7	9196	38	active	active	JJ
cord-005453-4057qib7	9196	39	disease	disease	NN
cord-005453-4057qib7	9196	40	at	at	IN
cord-005453-4057qib7	9196	41	transplant	transplant	NN
cord-005453-4057qib7	9196	42	.	.	.
cord-005453-4057qib7	9197	1	Neither	neither	DT
cord-005453-4057qib7	9197	2	antibacterial	antibacterial	JJ
cord-005453-4057qib7	9197	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9197	4	(	(	-LRB-
cord-005453-4057qib7	9197	5	p	p	NN
cord-005453-4057qib7	9197	6	=	=	SYM
cord-005453-4057qib7	9197	7	0,98	0,98	CD
cord-005453-4057qib7	9197	8	)	)	-RRB-
cord-005453-4057qib7	9197	9	nor	nor	CC
cord-005453-4057qib7	9197	10	BSI	BSI	NNP
cord-005453-4057qib7	9197	11	(	(	-LRB-
cord-005453-4057qib7	9197	12	p	p	NN
cord-005453-4057qib7	9197	13	=	=	SYM
cord-005453-4057qib7	9197	14	0,4	0,4	CD
cord-005453-4057qib7	9197	15	)	)	-RRB-
cord-005453-4057qib7	9197	16	had	have	VBD
cord-005453-4057qib7	9197	17	a	a	DT
cord-005453-4057qib7	9197	18	significant	significant	JJ
cord-005453-4057qib7	9197	19	impact	impact	NN
cord-005453-4057qib7	9197	20	on	on	IN
cord-005453-4057qib7	9197	21	overall	overall	JJ
cord-005453-4057qib7	9197	22	survival	survival	NN
cord-005453-4057qib7	9197	23	(	(	-LRB-
cord-005453-4057qib7	9197	24	OS	OS	NNP
cord-005453-4057qib7	9197	25	)	)	-RRB-
cord-005453-4057qib7	9197	26	.	.	.
cord-005453-4057qib7	9198	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9198	2	:	:	:
cord-005453-4057qib7	9199	1	The	the	DT
cord-005453-4057qib7	9199	2	preliminary	preliminary	JJ
cord-005453-4057qib7	9199	3	data	datum	NNS
cord-005453-4057qib7	9199	4	of	of	IN
cord-005453-4057qib7	9199	5	our	-PRON-	PRP$
cord-005453-4057qib7	9199	6	study	study	NN
cord-005453-4057qib7	9199	7	show	show	NN
cord-005453-4057qib7	9199	8	that	that	IN
cord-005453-4057qib7	9199	9	FQ	FQ	NNP
cord-005453-4057qib7	9199	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9199	11	is	be	VBZ
cord-005453-4057qib7	9199	12	associated	associate	VBN
cord-005453-4057qib7	9199	13	with	with	IN
cord-005453-4057qib7	9199	14	a	a	DT
cord-005453-4057qib7	9199	15	reduced	reduce	VBN
cord-005453-4057qib7	9199	16	incidence	incidence	NN
cord-005453-4057qib7	9199	17	of	of	IN
cord-005453-4057qib7	9199	18	BSI	BSI	NNP
cord-005453-4057qib7	9199	19	,	,	,
cord-005453-4057qib7	9199	20	in	in	IN
cord-005453-4057qib7	9199	21	particular	particular	JJ
cord-005453-4057qib7	9199	22	Gram	gram	NN
cord-005453-4057qib7	9199	23	-	-	HYPH
cord-005453-4057qib7	9199	24	negative	negative	JJ
cord-005453-4057qib7	9199	25	infections	infection	NNS
cord-005453-4057qib7	9199	26	,	,	,
cord-005453-4057qib7	9199	27	with	with	IN
cord-005453-4057qib7	9199	28	no	no	DT
cord-005453-4057qib7	9199	29	impact	impact	NN
cord-005453-4057qib7	9199	30	on	on	IN
cord-005453-4057qib7	9199	31	OS	OS	NNP
cord-005453-4057qib7	9199	32	.	.	.
cord-005453-4057qib7	9200	1	The	the	DT
cord-005453-4057qib7	9200	2	limitations	limitation	NNS
cord-005453-4057qib7	9200	3	of	of	IN
cord-005453-4057qib7	9200	4	our	-PRON-	PRP$
cord-005453-4057qib7	9200	5	study	study	NN
cord-005453-4057qib7	9200	6	may	may	MD
cord-005453-4057qib7	9200	7	be	be	VB
cord-005453-4057qib7	9200	8	the	the	DT
cord-005453-4057qib7	9200	9	different	different	JJ
cord-005453-4057qib7	9200	10	group	group	NN
cord-005453-4057qib7	9200	11	sizes	size	NNS
cord-005453-4057qib7	9200	12	and	and	CC
cord-005453-4057qib7	9200	13	the	the	DT
cord-005453-4057qib7	9200	14	retrospective	retrospective	JJ
cord-005453-4057qib7	9200	15	nauture	nauture	NN
cord-005453-4057qib7	9200	16	of	of	IN
cord-005453-4057qib7	9200	17	the	the	DT
cord-005453-4057qib7	9200	18	study	study	NN
cord-005453-4057qib7	9200	19	.	.	.
cord-005453-4057qib7	9201	1	Whether	whether	IN
cord-005453-4057qib7	9201	2	antibacterial	antibacterial	JJ
cord-005453-4057qib7	9201	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9201	4	should	should	MD
cord-005453-4057qib7	9201	5	be	be	VB
cord-005453-4057qib7	9201	6	avoided	avoid	VBN
cord-005453-4057qib7	9201	7	in	in	IN
cord-005453-4057qib7	9201	8	the	the	DT
cord-005453-4057qib7	9201	9	pre	pre	JJ
cord-005453-4057qib7	9201	10	-	-	JJ
cord-005453-4057qib7	9201	11	engraftment	engraftment	JJ
cord-005453-4057qib7	9201	12	period	period	NN
cord-005453-4057qib7	9201	13	in	in	IN
cord-005453-4057qib7	9201	14	still	still	RB
cord-005453-4057qib7	9201	15	a	a	DT
cord-005453-4057qib7	9201	16	matter	matter	NN
cord-005453-4057qib7	9201	17	of	of	IN
cord-005453-4057qib7	9201	18	debate	debate	NN
cord-005453-4057qib7	9201	19	and	and	CC
cord-005453-4057qib7	9201	20	needs	need	VBZ
cord-005453-4057qib7	9201	21	to	to	TO
cord-005453-4057qib7	9201	22	be	be	VB
cord-005453-4057qib7	9201	23	evaluated	evaluate	VBN
cord-005453-4057qib7	9201	24	in	in	IN
cord-005453-4057qib7	9201	25	larger	large	JJR
cord-005453-4057qib7	9201	26	prospective	prospective	JJ
cord-005453-4057qib7	9201	27	studies	study	NNS
cord-005453-4057qib7	9201	28	.	.	.
cord-005453-4057qib7	9202	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9202	2	:	:	:
cord-005453-4057qib7	9202	3	Nothing	nothing	NN
cord-005453-4057qib7	9202	4	to	to	TO
cord-005453-4057qib7	9202	5	disclose	disclose	VB
cord-005453-4057qib7	9202	6	.	.	.
cord-005453-4057qib7	9203	1	Gillen	Gillen	NNP
cord-005453-4057qib7	9203	2	Oarbeascoa	Oarbeascoa	NNP
cord-005453-4057qib7	9203	3	1	1	CD
cord-005453-4057qib7	9203	4	,	,	,
cord-005453-4057qib7	9203	5	Nieves	Nieves	NNP
cord-005453-4057qib7	9203	6	Dorado	Dorado	NNP
cord-005453-4057qib7	9203	7	1,2	1,2	CD
cord-005453-4057qib7	9203	8	,	,	,
cord-005453-4057qib7	9203	9	Laura	Laura	NNP
cord-005453-4057qib7	9203	10	Solan	Solan	NNP
cord-005453-4057qib7	9203	11	1,2	1,2	CD
cord-005453-4057qib7	9203	12	,	,	,
cord-005453-4057qib7	9203	13	Rebeca	Rebeca	NNP
cord-005453-4057qib7	9203	14	Bailen	Bailen	NNP
cord-005453-4057qib7	9203	15	1,2	1,2	CD
cord-005453-4057qib7	9203	16	,	,	,
cord-005453-4057qib7	9203	17	Pascual	Pascual	NNP
cord-005453-4057qib7	9203	18	Balsalobre	Balsalobre	NNP
cord-005453-4057qib7	9203	19	1,2	1,2	CD
cord-005453-4057qib7	9203	20	,	,	,
cord-005453-4057qib7	9203	21	Carolina	Carolina	NNP
cord-005453-4057qib7	9203	22	Martinez	Martinez	NNP
cord-005453-4057qib7	9203	23	-	-	HYPH
cord-005453-4057qib7	9203	24	Laperche	Laperche	NNP
cord-005453-4057qib7	9203	25	1,2	1,2	CD
cord-005453-4057qib7	9203	26	,	,	,
cord-005453-4057qib7	9203	27	Ismael	Ismael	NNP
cord-005453-4057qib7	9203	28	Buño	Buño	NNP
cord-005453-4057qib7	9203	29	1,2	1,2	CD
cord-005453-4057qib7	9203	30	,	,	,
cord-005453-4057qib7	9203	31	Javier	Javier	NNP
cord-005453-4057qib7	9203	32	Anguita	Anguita	NNP
cord-005453-4057qib7	9203	33	1,2	1,2	CD
cord-005453-4057qib7	9203	34	,	,	,
cord-005453-4057qib7	9203	35	Jose	Jose	NNP
cord-005453-4057qib7	9203	36	Luis	Luis	NNP
cord-005453-4057qib7	9203	37	Diez	Diez	NNP
cord-005453-4057qib7	9203	38	-	-	HYPH
cord-005453-4057qib7	9203	39	Martin	Martin	NNP
cord-005453-4057qib7	9203	40	1,2,3	1,2,3	CD
cord-005453-4057qib7	9203	41	,	,	,
cord-005453-4057qib7	9203	42	Mi	Mi	NNP
cord-005453-4057qib7	9203	43	Kwon	Kwon	NNP
cord-005453-4057qib7	9203	44	1,2	1,2	CD
cord-005453-4057qib7	9203	45	1	1	CD
cord-005453-4057qib7	9203	46	Hospital	Hospital	NNP
cord-005453-4057qib7	9203	47	General	General	NNP
cord-005453-4057qib7	9203	48	Universitario	Universitario	NNP
cord-005453-4057qib7	9203	49	Gregorio	Gregorio	NNP
cord-005453-4057qib7	9203	50	Marañón	Marañón	NNP
cord-005453-4057qib7	9203	51	,	,	,
cord-005453-4057qib7	9203	52	Hematology	Hematology	NNP
cord-005453-4057qib7	9203	53	,	,	,
cord-005453-4057qib7	9203	54	Madrid	Madrid	NNP
cord-005453-4057qib7	9203	55	,	,	,
cord-005453-4057qib7	9203	56	Spain	Spain	NNP
cord-005453-4057qib7	9203	57	,	,	,
cord-005453-4057qib7	9203	58	2	2	CD
cord-005453-4057qib7	9203	59	Instituto	Instituto	NNP
cord-005453-4057qib7	9203	60	de	de	NNP
cord-005453-4057qib7	9203	61	Investigación	Investigación	NNP
cord-005453-4057qib7	9203	62	Sanitaria	Sanitaria	NNP
cord-005453-4057qib7	9203	63	Gregorio	Gregorio	NNP
cord-005453-4057qib7	9203	64	Marañón	Marañón	NNP
cord-005453-4057qib7	9203	65	,	,	,
cord-005453-4057qib7	9203	66	Madrid	Madrid	NNP
cord-005453-4057qib7	9203	67	,	,	,
cord-005453-4057qib7	9203	68	Spain	Spain	NNP
cord-005453-4057qib7	9203	69	,	,	,
cord-005453-4057qib7	9203	70	3	3	CD
cord-005453-4057qib7	9203	71	Universidad	Universidad	NNP
cord-005453-4057qib7	9203	72	Complutense	Complutense	NNP
cord-005453-4057qib7	9203	73	de	de	NNP
cord-005453-4057qib7	9203	74	Madrid	Madrid	NNP
cord-005453-4057qib7	9203	75	,	,	,
cord-005453-4057qib7	9203	76	Madrid	Madrid	NNP
cord-005453-4057qib7	9203	77	,	,	,
cord-005453-4057qib7	9204	1	Spain	Spain	NNP
cord-005453-4057qib7	9204	2	Background	Background	NNP
cord-005453-4057qib7	9204	3	:	:	:
cord-005453-4057qib7	9205	1	Incidence	incidence	NN
cord-005453-4057qib7	9205	2	and	and	CC
cord-005453-4057qib7	9205	3	outcome	outcome	NN
cord-005453-4057qib7	9205	4	of	of	IN
cord-005453-4057qib7	9205	5	Invasive	invasive	JJ
cord-005453-4057qib7	9205	6	Fungal	Fungal	NNP
cord-005453-4057qib7	9205	7	Infection	infection	NN
cord-005453-4057qib7	9205	8	(	(	-LRB-
cord-005453-4057qib7	9205	9	IFI	IFI	NNP
cord-005453-4057qib7	9205	10	)	)	-RRB-
cord-005453-4057qib7	9205	11	are	be	VBP
cord-005453-4057qib7	9205	12	not	not	RB
cord-005453-4057qib7	9205	13	well	well	RB
cord-005453-4057qib7	9205	14	characterized	characterize	VBN
cord-005453-4057qib7	9205	15	in	in	IN
cord-005453-4057qib7	9205	16	the	the	DT
cord-005453-4057qib7	9205	17	setting	setting	NN
cord-005453-4057qib7	9205	18	of	of	IN
cord-005453-4057qib7	9205	19	peripheral	peripheral	JJ
cord-005453-4057qib7	9205	20	blood	blood	NN
cord-005453-4057qib7	9205	21	,	,	,
cord-005453-4057qib7	9205	22	non	non	JJ
cord-005453-4057qib7	9205	23	-	-	JJ
cord-005453-4057qib7	9205	24	manipulated	manipulate	VBN
cord-005453-4057qib7	9205	25	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9205	26	stem	stem	NN
cord-005453-4057qib7	9205	27	cell	cell	NN
cord-005453-4057qib7	9205	28	transplantation	transplantation	NN
cord-005453-4057qib7	9205	29	with	with	IN
cord-005453-4057qib7	9205	30	postransplant	postransplant	NN
cord-005453-4057qib7	9205	31	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	9205	32	(	(	-LRB-
cord-005453-4057qib7	9205	33	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	9205	34	)	)	-RRB-
cord-005453-4057qib7	9205	35	.	.	.
cord-005453-4057qib7	9206	1	The	the	DT
cord-005453-4057qib7	9206	2	aim	aim	NN
cord-005453-4057qib7	9206	3	of	of	IN
cord-005453-4057qib7	9206	4	the	the	DT
cord-005453-4057qib7	9206	5	study	study	NN
cord-005453-4057qib7	9206	6	was	be	VBD
cord-005453-4057qib7	9206	7	to	to	TO
cord-005453-4057qib7	9206	8	analyze	analyze	VB
cord-005453-4057qib7	9206	9	incidence	incidence	NN
cord-005453-4057qib7	9206	10	and	and	CC
cord-005453-4057qib7	9206	11	risk	risk	NN
cord-005453-4057qib7	9206	12	factors	factor	NNS
cord-005453-4057qib7	9206	13	of	of	IN
cord-005453-4057qib7	9206	14	IFI	IFI	NNP
cord-005453-4057qib7	9206	15	in	in	IN
cord-005453-4057qib7	9206	16	patients	patient	NNS
cord-005453-4057qib7	9206	17	who	who	WP
cord-005453-4057qib7	9206	18	underwent	undergo	VBD
cord-005453-4057qib7	9206	19	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	9206	20	at	at	IN
cord-005453-4057qib7	9206	21	our	-PRON-	PRP$
cord-005453-4057qib7	9206	22	institution	institution	NN
cord-005453-4057qib7	9206	23	.	.	.
cord-005453-4057qib7	9207	1	Methods	method	NNS
cord-005453-4057qib7	9207	2	:	:	:
cord-005453-4057qib7	9207	3	132	132	CD
cord-005453-4057qib7	9207	4	consecutive	consecutive	JJ
cord-005453-4057qib7	9207	5	patients	patient	NNS
cord-005453-4057qib7	9207	6	who	who	WP
cord-005453-4057qib7	9207	7	underwent	undergo	VBD
cord-005453-4057qib7	9207	8	peripheral	peripheral	JJ
cord-005453-4057qib7	9207	9	blood	blood	NN
cord-005453-4057qib7	9207	10	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	9207	11	with	with	IN
cord-005453-4057qib7	9207	12	postransplant	postransplant	NN
cord-005453-4057qib7	9207	13	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	9207	14	between	between	IN
cord-005453-4057qib7	9207	15	2011	2011	CD
cord-005453-4057qib7	9207	16	and	and	CC
cord-005453-4057qib7	9207	17	2017	2017	CD
cord-005453-4057qib7	9207	18	at	at	IN
cord-005453-4057qib7	9207	19	our	-PRON-	PRP$
cord-005453-4057qib7	9207	20	centre	centre	NN
cord-005453-4057qib7	9207	21	were	be	VBD
cord-005453-4057qib7	9207	22	reviewed	review	VBN
cord-005453-4057qib7	9207	23	.	.	.
cord-005453-4057qib7	9208	1	IFI	IFI	NNP
cord-005453-4057qib7	9208	2	was	be	VBD
cord-005453-4057qib7	9208	3	classified	classify	VBN
cord-005453-4057qib7	9208	4	according	accord	VBG
cord-005453-4057qib7	9208	5	to	to	IN
cord-005453-4057qib7	9208	6	EORTC	EORTC	NNP
cord-005453-4057qib7	9208	7	definitions	definition	NNS
cord-005453-4057qib7	9208	8	.	.	.
cord-005453-4057qib7	9209	1	Proven	proven	JJ
cord-005453-4057qib7	9209	2	and	and	CC
cord-005453-4057qib7	9209	3	probable	probable	JJ
cord-005453-4057qib7	9209	4	IFI	IFI	NNP
cord-005453-4057qib7	9209	5	were	be	VBD
cord-005453-4057qib7	9209	6	included	include	VBN
cord-005453-4057qib7	9209	7	.	.	.
cord-005453-4057qib7	9210	1	Results	result	NNS
cord-005453-4057qib7	9210	2	:	:	:
cord-005453-4057qib7	9211	1	Patients´characteristics	patients´characteristic	NNS
cord-005453-4057qib7	9211	2	are	be	VBP
cord-005453-4057qib7	9211	3	shown	show	VBN
cord-005453-4057qib7	9211	4	in	in	IN
cord-005453-4057qib7	9211	5	Table	Table	NNP
cord-005453-4057qib7	9211	6	1	1	CD
cord-005453-4057qib7	9211	7	.	.	.
cord-005453-4057qib7	9212	1	Primary	primary	JJ
cord-005453-4057qib7	9212	2	antifungal	antifungal	JJ
cord-005453-4057qib7	9212	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9212	4	was	be	VBD
cord-005453-4057qib7	9212	5	performed	perform	VBN
cord-005453-4057qib7	9212	6	with	with	IN
cord-005453-4057qib7	9212	7	micafungin	micafungin	NNP
cord-005453-4057qib7	9212	8	from	from	IN
cord-005453-4057qib7	9212	9	day	day	NN
cord-005453-4057qib7	9212	10	-1	-1	CD
cord-005453-4057qib7	9212	11	until	until	IN
cord-005453-4057qib7	9212	12	oral	oral	JJ
cord-005453-4057qib7	9212	13	intake	intake	NN
cord-005453-4057qib7	9212	14	,	,	,
cord-005453-4057qib7	9212	15	followed	follow	VBN
cord-005453-4057qib7	9212	16	by	by	IN
cord-005453-4057qib7	9212	17	posaconazole	posaconazole	NNP
cord-005453-4057qib7	9212	18	until	until	IN
cord-005453-4057qib7	9212	19	day	day	NN
cord-005453-4057qib7	9212	20	+35	+35	CD
cord-005453-4057qib7	9212	21	.	.	.
cord-005453-4057qib7	9213	1	Patients	patient	NNS
cord-005453-4057qib7	9213	2	on	on	IN
cord-005453-4057qib7	9213	3	steroid	steroid	NN
cord-005453-4057qib7	9213	4	treatment	treatment	NN
cord-005453-4057qib7	9213	5	for	for	IN
cord-005453-4057qib7	9213	6	GVHD	GVHD	NNP
cord-005453-4057qib7	9213	7	received	receive	VBD
cord-005453-4057qib7	9213	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9213	9	with	with	IN
cord-005453-4057qib7	9213	10	micafungin	micafungin	NNP
cord-005453-4057qib7	9213	11	or	or	CC
cord-005453-4057qib7	9213	12	posaconazole	posaconazole	NNP
cord-005453-4057qib7	9213	13	.	.	.
cord-005453-4057qib7	9214	1	92	92	CD
cord-005453-4057qib7	9214	2	%	%	NN
cord-005453-4057qib7	9214	3	of	of	IN
cord-005453-4057qib7	9214	4	patients	patient	NNS
cord-005453-4057qib7	9214	5	obtained	obtain	VBN
cord-005453-4057qib7	9214	6	neutrophil	neutrophil	NN
cord-005453-4057qib7	9214	7	engraftment	engraftment	NN
cord-005453-4057qib7	9214	8	.	.	.
cord-005453-4057qib7	9215	1	Twenty	twenty	CD
cord-005453-4057qib7	9215	2	-	-	HYPH
cord-005453-4057qib7	9215	3	two	two	CD
cord-005453-4057qib7	9215	4	episodes	episode	NNS
cord-005453-4057qib7	9215	5	of	of	IN
cord-005453-4057qib7	9215	6	IFI	IFI	NNP
cord-005453-4057qib7	9215	7	were	be	VBD
cord-005453-4057qib7	9215	8	observed	observe	VBN
cord-005453-4057qib7	9215	9	in	in	IN
cord-005453-4057qib7	9215	10	20	20	CD
cord-005453-4057qib7	9215	11	patients	patient	NNS
cord-005453-4057qib7	9215	12	:	:	:
cord-005453-4057qib7	9215	13	10	10	CD
cord-005453-4057qib7	9215	14	proven	prove	VBN
cord-005453-4057qib7	9215	15	and	and	CC
cord-005453-4057qib7	9215	16	12	12	CD
cord-005453-4057qib7	9215	17	probable	probable	JJ
cord-005453-4057qib7	9215	18	,	,	,
cord-005453-4057qib7	9215	19	with	with	IN
cord-005453-4057qib7	9215	20	a	a	DT
cord-005453-4057qib7	9215	21	cumulative	cumulative	JJ
cord-005453-4057qib7	9215	22	incidence	incidence	NN
cord-005453-4057qib7	9215	23	of	of	IN
cord-005453-4057qib7	9215	24	IFI	IFI	NNP
cord-005453-4057qib7	9215	25	of	of	IN
cord-005453-4057qib7	9215	26	17	17	CD
cord-005453-4057qib7	9215	27	%	%	NN
cord-005453-4057qib7	9215	28	at	at	IN
cord-005453-4057qib7	9215	29	500	500	CD
cord-005453-4057qib7	9215	30	days	day	NNS
cord-005453-4057qib7	9215	31	.	.	.
cord-005453-4057qib7	9216	1	Most	most	RBS
cord-005453-4057qib7	9216	2	commonly	commonly	RB
cord-005453-4057qib7	9216	3	isolated	isolate	VBN
cord-005453-4057qib7	9216	4	organism	organism	NN
cord-005453-4057qib7	9216	5	was	be	VBD
cord-005453-4057qib7	9216	6	Aspergillus	aspergillus	NN
cord-005453-4057qib7	9216	7	spp	spp	NNS
cord-005453-4057qib7	9216	8	(	(	-LRB-
cord-005453-4057qib7	9216	9	n=5	n=5	NNP
cord-005453-4057qib7	9216	10	)	)	-RRB-
cord-005453-4057qib7	9216	11	,	,	,
cord-005453-4057qib7	9216	12	followed	follow	VBN
cord-005453-4057qib7	9216	13	by	by	IN
cord-005453-4057qib7	9216	14	Candida	Candida	NNP
cord-005453-4057qib7	9216	15	spp	spp	NNS
cord-005453-4057qib7	9216	16	(	(	-LRB-
cord-005453-4057qib7	9216	17	n=4	n=4	NNS
cord-005453-4057qib7	9216	18	:	:	:
cord-005453-4057qib7	9216	19	1	1	CD
cord-005453-4057qib7	9216	20	C.	C.	NNP
cord-005453-4057qib7	9216	21	kruseii	kruseii	NNP
cord-005453-4057qib7	9216	22	and	and	CC
cord-005453-4057qib7	9216	23	3	3	CD
cord-005453-4057qib7	9216	24	C.	C.	NNP
cord-005453-4057qib7	9216	25	parapsilosis	parapsilosis	NNP
cord-005453-4057qib7	9216	26	)	)	-RRB-
cord-005453-4057qib7	9216	27	,	,	,
cord-005453-4057qib7	9216	28	and	and	CC
cord-005453-4057qib7	9216	29	Fusarium	Fusarium	NNP
cord-005453-4057qib7	9216	30	spp	spp	NNS
cord-005453-4057qib7	9216	31	(	(	-LRB-
cord-005453-4057qib7	9216	32	n=2	n=2	NNS
cord-005453-4057qib7	9216	33	)	)	-RRB-
cord-005453-4057qib7	9216	34	.	.	.
cord-005453-4057qib7	9217	1	Isolated	isolated	JJ
cord-005453-4057qib7	9217	2	cases	case	NNS
cord-005453-4057qib7	9217	3	of	of	IN
cord-005453-4057qib7	9217	4	Inonotus	Inonotus	NNP
cord-005453-4057qib7	9217	5	spp	spp	NNS
cord-005453-4057qib7	9217	6	,	,	,
cord-005453-4057qib7	9217	7	Mucor	Mucor	NNP
cord-005453-4057qib7	9217	8	spp	spp	NNS
cord-005453-4057qib7	9217	9	and	and	CC
cord-005453-4057qib7	9217	10	Trichosporon	Trichosporon	NNP
cord-005453-4057qib7	9217	11	Ashii	Ashii	NNP
cord-005453-4057qib7	9217	12	were	be	VBD
cord-005453-4057qib7	9217	13	observed	observe	VBN
cord-005453-4057qib7	9217	14	.	.	.
cord-005453-4057qib7	9218	1	Pulmonary	pulmonary	JJ
cord-005453-4057qib7	9218	2	involvement	involvement	NN
cord-005453-4057qib7	9218	3	was	be	VBD
cord-005453-4057qib7	9218	4	the	the	DT
cord-005453-4057qib7	9218	5	most	most	RBS
cord-005453-4057qib7	9218	6	frequent	frequent	JJ
cord-005453-4057qib7	9218	7	clinical	clinical	JJ
cord-005453-4057qib7	9218	8	presentation	presentation	NN
cord-005453-4057qib7	9218	9	(	(	-LRB-
cord-005453-4057qib7	9218	10	n=10	n=10	NNP
cord-005453-4057qib7	9218	11	)	)	-RRB-
cord-005453-4057qib7	9218	12	,	,	,
cord-005453-4057qib7	9218	13	followed	follow	VBN
cord-005453-4057qib7	9218	14	by	by	IN
cord-005453-4057qib7	9218	15	fungemia	fungemia	NNP
cord-005453-4057qib7	9218	16	(	(	-LRB-
cord-005453-4057qib7	9218	17	n=5	n=5	NNP
cord-005453-4057qib7	9218	18	:	:	:
cord-005453-4057qib7	9218	19	4	4	CD
cord-005453-4057qib7	9218	20	Candidemia	Candidemia	NNP
cord-005453-4057qib7	9218	21	,	,	,
cord-005453-4057qib7	9218	22	1	1	CD
cord-005453-4057qib7	9218	23	Trichosporon	Trichosporon	NNP
cord-005453-4057qib7	9218	24	Ashii	Ashii	NNP
cord-005453-4057qib7	9218	25	)	)	-RRB-
cord-005453-4057qib7	9218	26	and	and	CC
cord-005453-4057qib7	9218	27	skin	skin	NN
cord-005453-4057qib7	9218	28	-	-	HYPH
cord-005453-4057qib7	9218	29	pulmonary	pulmonary	JJ
cord-005453-4057qib7	9218	30	involvement	involvement	NN
cord-005453-4057qib7	9218	31	(	(	-LRB-
cord-005453-4057qib7	9218	32	n=2	n=2	NNS
cord-005453-4057qib7	9218	33	)	)	-RRB-
cord-005453-4057qib7	9218	34	.	.	.
cord-005453-4057qib7	9219	1	Among	among	IN
cord-005453-4057qib7	9219	2	patients	patient	NNS
cord-005453-4057qib7	9219	3	with	with	IN
cord-005453-4057qib7	9219	4	lung	lung	NN
cord-005453-4057qib7	9219	5	involvement	involvement	NN
cord-005453-4057qib7	9219	6	,	,	,
cord-005453-4057qib7	9219	7	10	10	CD
cord-005453-4057qib7	9219	8	showed	show	VBD
cord-005453-4057qib7	9219	9	probable	probable	JJ
cord-005453-4057qib7	9219	10	IFI	IFI	NNP
cord-005453-4057qib7	9219	11	:	:	:
cord-005453-4057qib7	9219	12	5	5	CD
cord-005453-4057qib7	9219	13	with	with	IN
cord-005453-4057qib7	9219	14	elevated	elevated	JJ
cord-005453-4057qib7	9219	15	serum	serum	NN
cord-005453-4057qib7	9219	16	galactomannan	galactomannan	NN
cord-005453-4057qib7	9219	17	and	and	CC
cord-005453-4057qib7	9219	18	3	3	CD
cord-005453-4057qib7	9219	19	positive	positive	JJ
cord-005453-4057qib7	9219	20	galactomannan	galactomannan	NNP
cord-005453-4057qib7	9219	21	in	in	IN
cord-005453-4057qib7	9219	22	bronchoalveolar	bronchoalveolar	NNP
cord-005453-4057qib7	9219	23	lavage	lavage	NNP
cord-005453-4057qib7	9219	24	(	(	-LRB-
cord-005453-4057qib7	9219	25	BAL	BAL	NNP
cord-005453-4057qib7	9219	26	)	)	-RRB-
cord-005453-4057qib7	9219	27	.	.	.
cord-005453-4057qib7	9220	1	There	there	EX
cord-005453-4057qib7	9220	2	were	be	VBD
cord-005453-4057qib7	9220	3	2	2	CD
cord-005453-4057qib7	9220	4	patients	patient	NNS
cord-005453-4057qib7	9220	5	without	without	IN
cord-005453-4057qib7	9220	6	galactomannan	galactomannan	NNP
cord-005453-4057qib7	9220	7	,	,	,
cord-005453-4057qib7	9220	8	one	one	CD
cord-005453-4057qib7	9220	9	with	with	IN
cord-005453-4057qib7	9220	10	a	a	DT
cord-005453-4057qib7	9220	11	positive	positive	JJ
cord-005453-4057qib7	9220	12	BAL	bal	NN
cord-005453-4057qib7	9220	13	culture	culture	NN
cord-005453-4057qib7	9220	14	for	for	IN
cord-005453-4057qib7	9220	15	Penicillum	Penicillum	NNP
cord-005453-4057qib7	9220	16	spp	spp	NNS
cord-005453-4057qib7	9220	17	and	and	CC
cord-005453-4057qib7	9220	18	the	the	DT
cord-005453-4057qib7	9220	19	other	other	JJ
cord-005453-4057qib7	9220	20	with	with	IN
cord-005453-4057qib7	9220	21	an	an	DT
cord-005453-4057qib7	9220	22	Aspergillus	aspergillus	NN
cord-005453-4057qib7	9220	23	spp	spp	NN
cord-005453-4057qib7	9220	24	.	.	.
cord-005453-4057qib7	9221	1	Median	median	JJ
cord-005453-4057qib7	9221	2	time	time	NN
cord-005453-4057qib7	9221	3	to	to	IN
cord-005453-4057qib7	9221	4	IFI	IFI	NNP
cord-005453-4057qib7	9221	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	9221	6	was	be	VBD
cord-005453-4057qib7	9221	7	21	21	CD
cord-005453-4057qib7	9221	8	days	day	NNS
cord-005453-4057qib7	9221	9	.	.	.
cord-005453-4057qib7	9222	1	Thirteen	thirteen	CD
cord-005453-4057qib7	9222	2	cases	case	NNS
cord-005453-4057qib7	9222	3	were	be	VBD
cord-005453-4057qib7	9222	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	9222	5	in	in	IN
cord-005453-4057qib7	9222	6	the	the	DT
cord-005453-4057qib7	9222	7	pre	pre	JJ
cord-005453-4057qib7	9222	8	-	-	JJ
cord-005453-4057qib7	9222	9	engraftment	engraftment	JJ
cord-005453-4057qib7	9222	10	period	period	NN
cord-005453-4057qib7	9222	11	,	,	,
cord-005453-4057qib7	9222	12	4	4	CD
cord-005453-4057qib7	9222	13	after	after	IN
cord-005453-4057qib7	9222	14	engraftment	engraftment	NN
cord-005453-4057qib7	9222	15	and	and	CC
cord-005453-4057qib7	9222	16	5	5	CD
cord-005453-4057qib7	9222	17	cases	case	NNS
cord-005453-4057qib7	9222	18	after	after	IN
cord-005453-4057qib7	9222	19	day	day	NN
cord-005453-4057qib7	9222	20	+30	+30	CD
cord-005453-4057qib7	9222	21	.	.	.
cord-005453-4057qib7	9223	1	Among	among	IN
cord-005453-4057qib7	9223	2	patients	patient	NNS
cord-005453-4057qib7	9223	3	with	with	IN
cord-005453-4057qib7	9223	4	late	late	JJ
cord-005453-4057qib7	9223	5	IFI	IFI	NNP
cord-005453-4057qib7	9223	6	,	,	,
cord-005453-4057qib7	9223	7	median	median	JJ
cord-005453-4057qib7	9223	8	time	time	NN
cord-005453-4057qib7	9223	9	to	to	IN
cord-005453-4057qib7	9223	10	development	development	NN
cord-005453-4057qib7	9223	11	was	be	VBD
cord-005453-4057qib7	9223	12	220	220	CD
cord-005453-4057qib7	9223	13	days	day	NNS
cord-005453-4057qib7	9223	14	.	.	.
cord-005453-4057qib7	9224	1	All	all	DT
cord-005453-4057qib7	9224	2	of	of	IN
cord-005453-4057qib7	9224	3	them	-PRON-	PRP
cord-005453-4057qib7	9224	4	were	be	VBD
cord-005453-4057qib7	9224	5	associated	associate	VBN
cord-005453-4057qib7	9224	6	with	with	IN
cord-005453-4057qib7	9224	7	GVHD	GVHD	NNP
cord-005453-4057qib7	9224	8	(	(	-LRB-
cord-005453-4057qib7	9224	9	3	3	CD
cord-005453-4057qib7	9224	10	grade	grade	NN
cord-005453-4057qib7	9224	11	III	III	NNP
cord-005453-4057qib7	9224	12	-	-	HYPH
cord-005453-4057qib7	9224	13	IV	IV	NNP
cord-005453-4057qib7	9224	14	acute	acute	JJ
cord-005453-4057qib7	9224	15	GVHD	GVHD	NNP
cord-005453-4057qib7	9224	16	and	and	CC
cord-005453-4057qib7	9224	17	2	2	CD
cord-005453-4057qib7	9224	18	moderate	moderate	JJ
cord-005453-4057qib7	9224	19	/	/	SYM
cord-005453-4057qib7	9224	20	severe	severe	JJ
cord-005453-4057qib7	9224	21	chronic	chronic	JJ
cord-005453-4057qib7	9224	22	GVHD	GVHD	NNP
cord-005453-4057qib7	9224	23	)	)	-RRB-
cord-005453-4057qib7	9224	24	.	.	.
cord-005453-4057qib7	9225	1	IFI	IFI	NNP
cord-005453-4057qib7	9225	2	outcome	outcome	NN
cord-005453-4057qib7	9225	3	was	be	VBD
cord-005453-4057qib7	9225	4	favorable	favorable	JJ
cord-005453-4057qib7	9225	5	in	in	IN
cord-005453-4057qib7	9225	6	13	13	CD
cord-005453-4057qib7	9225	7	out	out	IN
cord-005453-4057qib7	9225	8	of	of	IN
cord-005453-4057qib7	9225	9	the	the	DT
cord-005453-4057qib7	9225	10	22	22	CD
cord-005453-4057qib7	9225	11	IFI	IFI	NNP
cord-005453-4057qib7	9225	12	.	.	.
cord-005453-4057qib7	9226	1	Treatment	treatment	NN
cord-005453-4057qib7	9226	2	was	be	VBD
cord-005453-4057qib7	9226	3	liposomal	liposomal	JJ
cord-005453-4057qib7	9226	4	amphotericin	amphotericin	NNS
cord-005453-4057qib7	9226	5	B	B	NNP
cord-005453-4057qib7	9226	6	in	in	IN
cord-005453-4057qib7	9226	7	7	7	CD
cord-005453-4057qib7	9226	8	cases	case	NNS
cord-005453-4057qib7	9226	9	,	,	,
cord-005453-4057qib7	9226	10	voriconazole	voriconazole	NN
cord-005453-4057qib7	9226	11	in	in	IN
cord-005453-4057qib7	9226	12	4	4	CD
cord-005453-4057qib7	9226	13	and	and	CC
cord-005453-4057qib7	9226	14	combined	combine	VBN
cord-005453-4057qib7	9226	15	treatment	treatment	NN
cord-005453-4057qib7	9226	16	(	(	-LRB-
cord-005453-4057qib7	9226	17	amphotericin	amphotericin	NNS
cord-005453-4057qib7	9226	18	B	B	NNP
cord-005453-4057qib7	9226	19	and	and	CC
cord-005453-4057qib7	9226	20	azole	azole	NNP
cord-005453-4057qib7	9226	21	)	)	-RRB-
cord-005453-4057qib7	9226	22	in	in	IN
cord-005453-4057qib7	9226	23	6	6	CD
cord-005453-4057qib7	9226	24	.	.	.
cord-005453-4057qib7	9227	1	There	there	EX
cord-005453-4057qib7	9227	2	were	be	VBD
cord-005453-4057qib7	9227	3	7	7	CD
cord-005453-4057qib7	9227	4	IFI	IFI	NNP
cord-005453-4057qib7	9227	5	related	relate	VBN
cord-005453-4057qib7	9227	6	deaths	death	NNS
cord-005453-4057qib7	9227	7	,	,	,
cord-005453-4057qib7	9227	8	with	with	IN
cord-005453-4057qib7	9227	9	a	a	DT
cord-005453-4057qib7	9227	10	cumulative	cumulative	JJ
cord-005453-4057qib7	9227	11	incidence	incidence	NN
cord-005453-4057qib7	9227	12	of	of	IN
cord-005453-4057qib7	9227	13	IFI	IFI	NNP
cord-005453-4057qib7	9227	14	related	relate	VBN
cord-005453-4057qib7	9227	15	death	death	NN
cord-005453-4057qib7	9227	16	of	of	IN
cord-005453-4057qib7	9227	17	6.4	6.4	CD
cord-005453-4057qib7	9227	18	%	%	NN
cord-005453-4057qib7	9227	19	.	.	.
cord-005453-4057qib7	9228	1	Prior	prior	JJ
cord-005453-4057qib7	9228	2	transplant	transplant	NN
cord-005453-4057qib7	9228	3	(	(	-LRB-
cord-005453-4057qib7	9228	4	OR	or	CC
cord-005453-4057qib7	9228	5	4.5	4.5	CD
cord-005453-4057qib7	9228	6	,	,	,
cord-005453-4057qib7	9228	7	p	p	NN
cord-005453-4057qib7	9228	8	<	<	XX
cord-005453-4057qib7	9228	9	0.01	0.01	CD
cord-005453-4057qib7	9228	10	)	)	-RRB-
cord-005453-4057qib7	9228	11	,	,	,
cord-005453-4057qib7	9228	12	particularly	particularly	RB
cord-005453-4057qib7	9228	13	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	9228	14	was	be	VBD
cord-005453-4057qib7	9228	15	associated	associate	VBN
cord-005453-4057qib7	9228	16	to	to	IN
cord-005453-4057qib7	9228	17	IFI	IFI	NNP
cord-005453-4057qib7	9228	18	development	development	NN
cord-005453-4057qib7	9228	19	(	(	-LRB-
cord-005453-4057qib7	9228	20	OR	OR	NNP
cord-005453-4057qib7	9228	21	8.2	8.2	CD
cord-005453-4057qib7	9228	22	,	,	,
cord-005453-4057qib7	9228	23	p	p	NN
cord-005453-4057qib7	9228	24	<	<	XX
cord-005453-4057qib7	9228	25	0.01	0.01	CD
cord-005453-4057qib7	9228	26	)	)	-RRB-
cord-005453-4057qib7	9228	27	.	.	.
cord-005453-4057qib7	9229	1	Patients	patient	NNS
cord-005453-4057qib7	9229	2	with	with	IN
cord-005453-4057qib7	9229	3	previous	previous	JJ
cord-005453-4057qib7	9229	4	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	9229	5	presented	present	VBN
cord-005453-4057qib7	9229	6	IFI	IFI	NNP
cord-005453-4057qib7	9229	7	mainly	mainly	RB
cord-005453-4057qib7	9229	8	from	from	IN
cord-005453-4057qib7	9229	9	molds	mold	NNS
cord-005453-4057qib7	9229	10	:	:	:
cord-005453-4057qib7	9230	1	3	3	CD
cord-005453-4057qib7	9230	2	Aspergillus	aspergillus	NN
cord-005453-4057qib7	9230	3	,	,	,
cord-005453-4057qib7	9230	4	2	2	CD
cord-005453-4057qib7	9230	5	Fusarium	fusarium	NN
cord-005453-4057qib7	9230	6	,	,	,
cord-005453-4057qib7	9230	7	Inonotus	Inonotus	NNP
cord-005453-4057qib7	9230	8	,	,	,
cord-005453-4057qib7	9230	9	Trichosporon	Trichosporon	NNP
cord-005453-4057qib7	9230	10	and	and	CC
cord-005453-4057qib7	9230	11	Mucor	Mucor	NNP
cord-005453-4057qib7	9230	12	.	.	.
cord-005453-4057qib7	9231	1	There	there	EX
cord-005453-4057qib7	9231	2	were	be	VBD
cord-005453-4057qib7	9231	3	also	also	RB
cord-005453-4057qib7	9231	4	2	2	CD
cord-005453-4057qib7	9231	5	candidemia	candidemia	NN
cord-005453-4057qib7	9231	6	episodes	episode	NNS
cord-005453-4057qib7	9231	7	.	.	.
cord-005453-4057qib7	9232	1	No	no	DT
cord-005453-4057qib7	9232	2	other	other	JJ
cord-005453-4057qib7	9232	3	factors	factor	NNS
cord-005453-4057qib7	9232	4	were	be	VBD
cord-005453-4057qib7	9232	5	significantly	significantly	RB
cord-005453-4057qib7	9232	6	associated	associate	VBN
cord-005453-4057qib7	9232	7	to	to	IN
cord-005453-4057qib7	9232	8	IFI	IFI	NNP
cord-005453-4057qib7	9232	9	occurrence	occurrence	NN
cord-005453-4057qib7	9232	10	.	.	.
cord-005453-4057qib7	9233	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9233	2	:	:	:
cord-005453-4057qib7	9234	1	In	in	IN
cord-005453-4057qib7	9234	2	our	-PRON-	PRP$
cord-005453-4057qib7	9234	3	experience	experience	NN
cord-005453-4057qib7	9234	4	,	,	,
cord-005453-4057qib7	9234	5	cumulative	cumulative	JJ
cord-005453-4057qib7	9234	6	incidence	incidence	NN
cord-005453-4057qib7	9234	7	of	of	IN
cord-005453-4057qib7	9234	8	IFI	IFI	NNP
cord-005453-4057qib7	9234	9	in	in	IN
cord-005453-4057qib7	9234	10	the	the	DT
cord-005453-4057qib7	9234	11	setting	setting	NN
cord-005453-4057qib7	9234	12	of	of	IN
cord-005453-4057qib7	9234	13	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	9234	14	with	with	IN
cord-005453-4057qib7	9234	15	posttransplant	posttransplant	NN
cord-005453-4057qib7	9234	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	9234	17	was	be	VBD
cord-005453-4057qib7	9234	18	similar	similar	JJ
cord-005453-4057qib7	9234	19	than	than	IN
cord-005453-4057qib7	9234	20	observed	observed	JJ
cord-005453-4057qib7	9234	21	in	in	IN
cord-005453-4057qib7	9234	22	previous	previous	JJ
cord-005453-4057qib7	9234	23	studies	study	NNS
cord-005453-4057qib7	9234	24	in	in	IN
cord-005453-4057qib7	9234	25	alloSCT	alloSCT	NNP
cord-005453-4057qib7	9234	26	.	.	.
cord-005453-4057qib7	9235	1	Having	have	VBG
cord-005453-4057qib7	9235	2	received	receive	VBN
cord-005453-4057qib7	9235	3	a	a	DT
cord-005453-4057qib7	9235	4	previous	previous	JJ
cord-005453-4057qib7	9235	5	SCT	SCT	NNP
cord-005453-4057qib7	9235	6	,	,	,
cord-005453-4057qib7	9235	7	especially	especially	RB
cord-005453-4057qib7	9235	8	alloSCT	alloSCT	NNP
cord-005453-4057qib7	9235	9	,	,	,
cord-005453-4057qib7	9235	10	was	be	VBD
cord-005453-4057qib7	9235	11	the	the	DT
cord-005453-4057qib7	9235	12	most	most	RBS
cord-005453-4057qib7	9235	13	significant	significant	JJ
cord-005453-4057qib7	9235	14	factor	factor	NN
cord-005453-4057qib7	9235	15	related	relate	VBN
cord-005453-4057qib7	9235	16	to	to	IN
cord-005453-4057qib7	9235	17	IFI	IFI	NNP
cord-005453-4057qib7	9235	18	development	development	NN
cord-005453-4057qib7	9235	19	.	.	.
cord-005453-4057qib7	9236	1	This	this	DT
cord-005453-4057qib7	9236	2	high	high	JJ
cord-005453-4057qib7	9236	3	risk	risk	NN
cord-005453-4057qib7	9236	4	population	population	NN
cord-005453-4057qib7	9236	5	should	should	MD
cord-005453-4057qib7	9236	6	be	be	VB
cord-005453-4057qib7	9236	7	closely	closely	RB
cord-005453-4057qib7	9236	8	monitored	monitor	VBN
cord-005453-4057qib7	9236	9	and	and	CC
cord-005453-4057qib7	9236	10	could	could	MD
cord-005453-4057qib7	9236	11	benefit	benefit	VB
cord-005453-4057qib7	9236	12	from	from	IN
cord-005453-4057qib7	9236	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9236	14	with	with	IN
cord-005453-4057qib7	9236	15	azoles	azole	NNS
cord-005453-4057qib7	9236	16	.	.	.
cord-005453-4057qib7	9237	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9237	2	:	:	:
cord-005453-4057qib7	9237	3	Nothing	nothing	NN
cord-005453-4057qib7	9237	4	to	to	TO
cord-005453-4057qib7	9237	5	declare	declare	VB
cord-005453-4057qib7	9237	6	.	.	.
cord-005453-4057qib7	9238	1	Methods	method	NNS
cord-005453-4057qib7	9238	2	:	:	:
cord-005453-4057qib7	9239	1	RSV	RSV	NNP
cord-005453-4057qib7	9239	2	infection	infection	NN
cord-005453-4057qib7	9239	3	was	be	VBD
cord-005453-4057qib7	9239	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	9239	5	in	in	IN
cord-005453-4057qib7	9239	6	nasal	nasal	NN
cord-005453-4057qib7	9239	7	wash	wash	NNP
cord-005453-4057qib7	9239	8	(	(	-LRB-
cord-005453-4057qib7	9239	9	NW	NW	NNP
cord-005453-4057qib7	9239	10	)	)	-RRB-
cord-005453-4057qib7	9239	11	or	or	CC
cord-005453-4057qib7	9239	12	bronchoalveolar	bronchoalveolar	NNP
cord-005453-4057qib7	9239	13	fluid	fluid	NN
cord-005453-4057qib7	9239	14	(	(	-LRB-
cord-005453-4057qib7	9239	15	BAL	BAL	NNP
cord-005453-4057qib7	9239	16	)	)	-RRB-
cord-005453-4057qib7	9239	17	by	by	IN
cord-005453-4057qib7	9239	18	DFA	DFA	NNP
cord-005453-4057qib7	9239	19	(	(	-LRB-
cord-005453-4057qib7	9239	20	Millipore	Millipore	NNP
cord-005453-4057qib7	9239	21	,	,	,
cord-005453-4057qib7	9239	22	USA	USA	NNP
cord-005453-4057qib7	9239	23	)	)	-RRB-
cord-005453-4057qib7	9239	24	or	or	CC
cord-005453-4057qib7	9239	25	PCR	PCR	NNP
cord-005453-4057qib7	9239	26	(	(	-LRB-
cord-005453-4057qib7	9239	27	Seeplex	Seeplex	NNP
cord-005453-4057qib7	9239	28	,	,	,
cord-005453-4057qib7	9239	29	Seegene	Seegene	NNP
cord-005453-4057qib7	9239	30	,	,	,
cord-005453-4057qib7	9239	31	KOR	KOR	NNP
cord-005453-4057qib7	9239	32	)	)	-RRB-
cord-005453-4057qib7	9239	33	.	.	.
cord-005453-4057qib7	9240	1	URTI	URTI	NNP
cord-005453-4057qib7	9240	2	and	and	CC
cord-005453-4057qib7	9240	3	LRTI	LRTI	NNP
cord-005453-4057qib7	9240	4	were	be	VBD
cord-005453-4057qib7	9240	5	defined	define	VBN
cord-005453-4057qib7	9240	6	according	accord	VBG
cord-005453-4057qib7	9240	7	to	to	IN
cord-005453-4057qib7	9240	8	ECIL-4	ECIL-4	NNP
cord-005453-4057qib7	9240	9	guidelines	guideline	NNS
cord-005453-4057qib7	9240	10	.	.	.
cord-005453-4057qib7	9241	1	Death	death	NN
cord-005453-4057qib7	9241	2	from	from	IN
cord-005453-4057qib7	9241	3	all	all	DT
cord-005453-4057qib7	9241	4	causes	cause	NNS
cord-005453-4057qib7	9241	5	was	be	VBD
cord-005453-4057qib7	9241	6	assessed	assess	VBN
cord-005453-4057qib7	9241	7	within	within	IN
cord-005453-4057qib7	9241	8	90	90	CD
cord-005453-4057qib7	9241	9	days	day	NNS
cord-005453-4057qib7	9241	10	after	after	IN
cord-005453-4057qib7	9241	11	RSV	RSV	NNP
cord-005453-4057qib7	9241	12	infection	infection	NN
cord-005453-4057qib7	9241	13	and	and	CC
cord-005453-4057qib7	9241	14	was	be	VBD
cord-005453-4057qib7	9241	15	attributed	attribute	VBN
cord-005453-4057qib7	9241	16	to	to	IN
cord-005453-4057qib7	9241	17	RSV	RSV	NNP
cord-005453-4057qib7	9241	18	if	if	IN
cord-005453-4057qib7	9241	19	the	the	DT
cord-005453-4057qib7	9241	20	patient	patient	NN
cord-005453-4057qib7	9241	21	had	have	VBD
cord-005453-4057qib7	9241	22	persistent	persistent	JJ
cord-005453-4057qib7	9241	23	or	or	CC
cord-005453-4057qib7	9241	24	progressive	progressive	JJ
cord-005453-4057qib7	9241	25	RSV	rsv	NN
cord-005453-4057qib7	9241	26	infection	infection	NN
cord-005453-4057qib7	9241	27	with	with	IN
cord-005453-4057qib7	9241	28	respiratory	respiratory	JJ
cord-005453-4057qib7	9241	29	failure	failure	NN
cord-005453-4057qib7	9241	30	at	at	IN
cord-005453-4057qib7	9241	31	the	the	DT
cord-005453-4057qib7	9241	32	time	time	NN
cord-005453-4057qib7	9241	33	of	of	IN
cord-005453-4057qib7	9241	34	death	death	NN
cord-005453-4057qib7	9241	35	.	.	.
cord-005453-4057qib7	9242	1	Neutropenia	neutropenia	NN
cord-005453-4057qib7	9242	2	and	and	CC
cord-005453-4057qib7	9242	3	lymphocytopenia	lymphocytopenia	NNP
cord-005453-4057qib7	9242	4	were	be	VBD
cord-005453-4057qib7	9242	5	defined	define	VBN
cord-005453-4057qib7	9242	6	as	as	IN
cord-005453-4057qib7	9242	7	an	an	DT
cord-005453-4057qib7	9242	8	absolute	absolute	JJ
cord-005453-4057qib7	9242	9	neutrophil	neutrophil	NN
cord-005453-4057qib7	9242	10	count	count	NN
cord-005453-4057qib7	9242	11	(	(	-LRB-
cord-005453-4057qib7	9242	12	ANC	ANC	NNP
cord-005453-4057qib7	9242	13	)	)	-RRB-
cord-005453-4057qib7	9242	14	<	<	XX
cord-005453-4057qib7	9243	1	500	500	CD
cord-005453-4057qib7	9243	2	/	/	SYM
cord-005453-4057qib7	9243	3	uL	ul	NN
cord-005453-4057qib7	9243	4	and	and	CC
cord-005453-4057qib7	9243	5	absolute	absolute	JJ
cord-005453-4057qib7	9243	6	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9243	7	count	count	NN
cord-005453-4057qib7	9243	8	(	(	-LRB-
cord-005453-4057qib7	9243	9	ALC	ALC	NNP
cord-005453-4057qib7	9243	10	)	)	-RRB-
cord-005453-4057qib7	9244	1	<	<	NNP
cord-005453-4057qib7	9244	2	200	200	CD
cord-005453-4057qib7	9244	3	/	/	SYM
cord-005453-4057qib7	9244	4	uL	ul	NN
cord-005453-4057qib7	9244	5	,	,	,
cord-005453-4057qib7	9244	6	respectively	respectively	RB
cord-005453-4057qib7	9244	7	.	.	.
cord-005453-4057qib7	9245	1	Results	result	NNS
cord-005453-4057qib7	9245	2	:	:	:
cord-005453-4057qib7	9246	1	Median	median	JJ
cord-005453-4057qib7	9246	2	number	number	NN
cord-005453-4057qib7	9246	3	of	of	IN
cord-005453-4057qib7	9246	4	confirmed	confirm	VBN
cord-005453-4057qib7	9246	5	RSV	RSV	NNP
cord-005453-4057qib7	9246	6	infections	infection	NNS
cord-005453-4057qib7	9246	7	per	per	IN
cord-005453-4057qib7	9246	8	year	year	NN
cord-005453-4057qib7	9246	9	was	be	VBD
cord-005453-4057qib7	9246	10	12	12	CD
cord-005453-4057qib7	9246	11	,	,	,
cord-005453-4057qib7	9246	12	ranging	range	VBG
cord-005453-4057qib7	9246	13	from	from	IN
cord-005453-4057qib7	9246	14	5	5	CD
cord-005453-4057qib7	9246	15	to	to	IN
cord-005453-4057qib7	9246	16	34	34	CD
cord-005453-4057qib7	9246	17	.	.	.
cord-005453-4057qib7	9247	1	An	an	DT
cord-005453-4057qib7	9247	2	outbreak	outbreak	NN
cord-005453-4057qib7	9247	3	of	of	IN
cord-005453-4057qib7	9247	4	RSV	RSV	NNP
cord-005453-4057qib7	9247	5	was	be	VBD
cord-005453-4057qib7	9247	6	detected	detect	VBN
cord-005453-4057qib7	9247	7	in	in	IN
cord-005453-4057qib7	9247	8	2017	2017	CD
cord-005453-4057qib7	9247	9	,	,	,
cord-005453-4057qib7	9247	10	possibly	possibly	RB
cord-005453-4057qib7	9247	11	due	due	IN
cord-005453-4057qib7	9247	12	to	to	IN
cord-005453-4057qib7	9247	13	a	a	DT
cord-005453-4057qib7	9247	14	lack	lack	NN
cord-005453-4057qib7	9247	15	of	of	IN
cord-005453-4057qib7	9247	16	compliance	compliance	NN
cord-005453-4057qib7	9247	17	with	with	IN
cord-005453-4057qib7	9247	18	contact	contact	NN
cord-005453-4057qib7	9247	19	precautions	precaution	NNS
cord-005453-4057qib7	9247	20	in	in	IN
cord-005453-4057qib7	9247	21	the	the	DT
cord-005453-4057qib7	9247	22	unit	unit	NN
cord-005453-4057qib7	9247	23	.	.	.
cord-005453-4057qib7	9248	1	Median	median	JJ
cord-005453-4057qib7	9248	2	patients	patient	NNS
cord-005453-4057qib7	9248	3	'	'	POS
cord-005453-4057qib7	9248	4	age	age	NN
cord-005453-4057qib7	9248	5	was	be	VBD
cord-005453-4057qib7	9248	6	26	26	CD
cord-005453-4057qib7	9248	7	years	year	NNS
cord-005453-4057qib7	9248	8	and	and	CC
cord-005453-4057qib7	9248	9	time	time	NN
cord-005453-4057qib7	9248	10	to	to	IN
cord-005453-4057qib7	9248	11	RSV	RSV	NNP
cord-005453-4057qib7	9248	12	infection	infection	NN
cord-005453-4057qib7	9249	1	was	be	VBD
cord-005453-4057qib7	9249	2	day	day	NN
cord-005453-4057qib7	9249	3	80	80	CD
cord-005453-4057qib7	9249	4	(	(	-LRB-
cord-005453-4057qib7	9249	5	-11	-11	''
cord-005453-4057qib7	9249	6	to	to	IN
cord-005453-4057qib7	9249	7	1837	1837	CD
cord-005453-4057qib7	9249	8	)	)	-RRB-
cord-005453-4057qib7	9249	9	.	.	.
cord-005453-4057qib7	9250	1	Twenty	twenty	CD
cord-005453-4057qib7	9250	2	-	-	HYPH
cord-005453-4057qib7	9250	3	three	three	CD
cord-005453-4057qib7	9250	4	patients	patient	NNS
cord-005453-4057qib7	9250	5	(	(	-LRB-
cord-005453-4057qib7	9250	6	pts	pt	NNS
cord-005453-4057qib7	9250	7	)	)	-RRB-
cord-005453-4057qib7	9250	8	had	have	VBD
cord-005453-4057qib7	9250	9	received	receive	VBN
cord-005453-4057qib7	9250	10	an	an	DT
cord-005453-4057qib7	9250	11	autologous	autologous	JJ
cord-005453-4057qib7	9250	12	transplantation	transplantation	NN
cord-005453-4057qib7	9250	13	(	(	-LRB-
cord-005453-4057qib7	9250	14	17.2	17.2	CD
cord-005453-4057qib7	9250	15	%	%	NN
cord-005453-4057qib7	9250	16	)	)	-RRB-
cord-005453-4057qib7	9250	17	and	and	CC
cord-005453-4057qib7	9250	18	111	111	CD
cord-005453-4057qib7	9250	19	were	be	VBD
cord-005453-4057qib7	9250	20	allogeneic	allogeneic	VBN
cord-005453-4057qib7	9250	21	HSCT	HSCT	NNP
cord-005453-4057qib7	9250	22	recipients	recipient	NNS
cord-005453-4057qib7	9250	23	(	(	-LRB-
cord-005453-4057qib7	9250	24	82,8	82,8	CD
cord-005453-4057qib7	9250	25	%	%	NN
cord-005453-4057qib7	9250	26	)	)	-RRB-
cord-005453-4057qib7	9250	27	.	.	.
cord-005453-4057qib7	9251	1	Median	median	JJ
cord-005453-4057qib7	9251	2	time	time	NN
cord-005453-4057qib7	9251	3	to	to	IN
cord-005453-4057qib7	9251	4	engraftment	engraftment	NN
cord-005453-4057qib7	9251	5	was	be	VBD
cord-005453-4057qib7	9251	6	15	15	CD
cord-005453-4057qib7	9251	7	days	day	NNS
cord-005453-4057qib7	9251	8	,	,	,
cord-005453-4057qib7	9251	9	ranging	range	VBG
cord-005453-4057qib7	9251	10	from	from	IN
cord-005453-4057qib7	9251	11	10	10	CD
cord-005453-4057qib7	9251	12	to	to	TO
cord-005453-4057qib7	9251	13	27	27	CD
cord-005453-4057qib7	9251	14	days	day	NNS
cord-005453-4057qib7	9251	15	.	.	.
cord-005453-4057qib7	9252	1	At	at	IN
cord-005453-4057qib7	9252	2	RSV	RSV	NNP
cord-005453-4057qib7	9252	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	9252	4	,	,	,
cord-005453-4057qib7	9252	5	108	108	CD
cord-005453-4057qib7	9252	6	pts	pt	NNS
cord-005453-4057qib7	9252	7	presented	present	VBN
cord-005453-4057qib7	9252	8	with	with	IN
cord-005453-4057qib7	9252	9	URTI	URTI	NNP
cord-005453-4057qib7	9252	10	(	(	-LRB-
cord-005453-4057qib7	9252	11	80.6	80.6	CD
cord-005453-4057qib7	9252	12	%	%	NN
cord-005453-4057qib7	9252	13	)	)	-RRB-
cord-005453-4057qib7	9252	14	and	and	CC
cord-005453-4057qib7	9252	15	26	26	CD
cord-005453-4057qib7	9252	16	with	with	IN
cord-005453-4057qib7	9252	17	LRTI	LRTI	NNP
cord-005453-4057qib7	9252	18	(	(	-LRB-
cord-005453-4057qib7	9252	19	19.4	19.4	CD
cord-005453-4057qib7	9252	20	)	)	-RRB-
cord-005453-4057qib7	9252	21	.	.	.
cord-005453-4057qib7	9253	1	Surprisingly	surprisingly	RB
cord-005453-4057qib7	9253	2	,	,	,
cord-005453-4057qib7	9253	3	around	around	IN
cord-005453-4057qib7	9253	4	18	18	CD
cord-005453-4057qib7	9253	5	%	%	NN
cord-005453-4057qib7	9253	6	of	of	IN
cord-005453-4057qib7	9253	7	the	the	DT
cord-005453-4057qib7	9253	8	auto	auto	NN
cord-005453-4057qib7	9253	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9253	10	recipients	recipient	NNS
cord-005453-4057qib7	9253	11	had	have	VBD
cord-005453-4057qib7	9253	12	RSV	RSV	NNP
cord-005453-4057qib7	9253	13	pneumonia	pneumonia	NN
cord-005453-4057qib7	9253	14	at	at	IN
cord-005453-4057qib7	9253	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	9253	16	.	.	.
cord-005453-4057qib7	9254	1	Variables	variable	NNS
cord-005453-4057qib7	9254	2	significantly	significantly	RB
cord-005453-4057qib7	9254	3	associated	associate	VBD
cord-005453-4057qib7	9254	4	with	with	IN
cord-005453-4057qib7	9254	5	LRTI	LRTI	NNS
cord-005453-4057qib7	9254	6	at	at	IN
cord-005453-4057qib7	9254	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	9254	8	were	be	VBD
cord-005453-4057qib7	9254	9	MUD	mud	NN
cord-005453-4057qib7	9254	10	HSCT	HSCT	NNP
cord-005453-4057qib7	9254	11	(	(	-LRB-
cord-005453-4057qib7	9255	1	No/	No/	NNP
cord-005453-4057qib7	9255	2	Yes	yes	UH
cord-005453-4057qib7	9255	3	,	,	,
cord-005453-4057qib7	9255	4	OR	or	CC
cord-005453-4057qib7	9255	5	0.42	0.42	CD
cord-005453-4057qib7	9255	6	;	;	:
cord-005453-4057qib7	9255	7	CI95	CI95	NNP
cord-005453-4057qib7	9255	8	0.20	0.20	CD
cord-005453-4057qib7	9255	9	-	-	HYPH
cord-005453-4057qib7	9255	10	0.89	0.89	CD
cord-005453-4057qib7	9255	11	)	)	-RRB-
cord-005453-4057qib7	9255	12	;	;	:
cord-005453-4057qib7	9255	13	ANC	ANC	NNP
cord-005453-4057qib7	9255	14	<	<	XX
cord-005453-4057qib7	9255	15	500	500	CD
cord-005453-4057qib7	9256	1	/uL	/uL	NFP
cord-005453-4057qib7	9256	2	(	(	-LRB-
cord-005453-4057qib7	9256	3	OR	or	CC
cord-005453-4057qib7	9256	4	2.75	2.75	CD
cord-005453-4057qib7	9256	5	;	;	:
cord-005453-4057qib7	9256	6	CI95	CI95	NNP
cord-005453-4057qib7	9256	7	1.01	1.01	CD
cord-005453-4057qib7	9256	8	-	-	SYM
cord-005453-4057qib7	9256	9	7.45	7.45	CD
cord-005453-4057qib7	9256	10	)	)	-RRB-
cord-005453-4057qib7	9257	1	;	;	:
cord-005453-4057qib7	9257	2	ALC	ALC	NNP
cord-005453-4057qib7	9257	3	<	<	XX
cord-005453-4057qib7	9257	4	200	200	CD
cord-005453-4057qib7	9257	5	/	/	SYM
cord-005453-4057qib7	9257	6	uL	ul	NN
cord-005453-4057qib7	9257	7	(	(	-LRB-
cord-005453-4057qib7	9257	8	OR	or	CC
cord-005453-4057qib7	9257	9	3.25	3.25	CD
cord-005453-4057qib7	9257	10	;	;	:
cord-005453-4057qib7	9257	11	CI95	CI95	NNP
cord-005453-4057qib7	9257	12	1.12	1.12	CD
cord-005453-4057qib7	9257	13	-	-	HYPH
cord-005453-4057qib7	9257	14	9.45	9.45	CD
cord-005453-4057qib7	9257	15	)	)	-RRB-
cord-005453-4057qib7	9257	16	;	;	:
cord-005453-4057qib7	9257	17	and	and	CC
cord-005453-4057qib7	9257	18	recent	recent	JJ
cord-005453-4057qib7	9257	19	or	or	CC
cord-005453-4057qib7	9257	20	pre	pre	JJ
cord-005453-4057qib7	9257	21	-	-	JJ
cord-005453-4057qib7	9257	22	engraftment	engraftment	JJ
cord-005453-4057qib7	9257	23	HSCT	HSCT	NNP
cord-005453-4057qib7	9257	24	(	(	-LRB-
cord-005453-4057qib7	9257	25	No/	No/	NNP
cord-005453-4057qib7	9258	1	Yes	yes	UH
cord-005453-4057qib7	9258	2	,	,	,
cord-005453-4057qib7	9258	3	OR	or	CC
cord-005453-4057qib7	9258	4	0.38	0.38	CD
cord-005453-4057qib7	9258	5	CI9	CI9	NNP
cord-005453-4057qib7	9258	6	0.14	0.14	CD
cord-005453-4057qib7	9258	7	-	-	SYM
cord-005453-4057qib7	9258	8	0.98	0.98	CD
cord-005453-4057qib7	9258	9	)	)	-RRB-
cord-005453-4057qib7	9258	10	.	.	.
cord-005453-4057qib7	9259	1	Among	among	IN
cord-005453-4057qib7	9259	2	the	the	DT
cord-005453-4057qib7	9259	3	108	108	CD
cord-005453-4057qib7	9259	4	pts	pt	NNS
cord-005453-4057qib7	9259	5	with	with	IN
cord-005453-4057qib7	9259	6	URTI	URTI	NNP
cord-005453-4057qib7	9259	7	at	at	IN
cord-005453-4057qib7	9259	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	9259	9	,	,	,
cord-005453-4057qib7	9259	10	19	19	CD
cord-005453-4057qib7	9259	11	progressed	progress	VBD
cord-005453-4057qib7	9259	12	to	to	IN
cord-005453-4057qib7	9259	13	LRTI	LRTI	NNP
cord-005453-4057qib7	9259	14	(	(	-LRB-
cord-005453-4057qib7	9259	15	17.6	17.6	CD
cord-005453-4057qib7	9259	16	%	%	NN
cord-005453-4057qib7	9259	17	)	)	-RRB-
cord-005453-4057qib7	9259	18	.	.	.
cord-005453-4057qib7	9260	1	Forty	forty	CD
cord-005453-4057qib7	9260	2	-	-	HYPH
cord-005453-4057qib7	9260	3	four	four	CD
cord-005453-4057qib7	9260	4	of	of	IN
cord-005453-4057qib7	9260	5	the	the	DT
cord-005453-4057qib7	9260	6	134	134	CD
cord-005453-4057qib7	9260	7	pts	pt	NNS
cord-005453-4057qib7	9260	8	died	die	VBD
cord-005453-4057qib7	9260	9	(	(	-LRB-
cord-005453-4057qib7	9260	10	32.8	32.8	CD
cord-005453-4057qib7	9260	11	%	%	NN
cord-005453-4057qib7	9260	12	)	)	-RRB-
cord-005453-4057qib7	9260	13	and	and	CC
cord-005453-4057qib7	9260	14	mortality	mortality	NN
cord-005453-4057qib7	9260	15	rate	rate	NN
cord-005453-4057qib7	9260	16	was	be	VBD
cord-005453-4057qib7	9260	17	significantly	significantly	RB
cord-005453-4057qib7	9260	18	higher	high	JJR
cord-005453-4057qib7	9260	19	in	in	IN
cord-005453-4057qib7	9260	20	pts	pts	NN
cord-005453-4057qib7	9260	21	with	with	IN
cord-005453-4057qib7	9260	22	LRTI	LRTI	NNS
cord-005453-4057qib7	9260	23	in	in	IN
cord-005453-4057qib7	9260	24	comparison	comparison	NN
cord-005453-4057qib7	9260	25	with	with	IN
cord-005453-4057qib7	9260	26	pts	pt	NNS
cord-005453-4057qib7	9260	27	with	with	IN
cord-005453-4057qib7	9260	28	URTI	URTI	NNP
cord-005453-4057qib7	9260	29	(	(	-LRB-
cord-005453-4057qib7	9260	30	53.8	53.8	CD
cord-005453-4057qib7	9260	31	%	%	NN
cord-005453-4057qib7	9260	32	versus	versus	IN
cord-005453-4057qib7	9260	33	27.8	27.8	CD
cord-005453-4057qib7	9260	34	%	%	NN
cord-005453-4057qib7	9260	35	,	,	,
cord-005453-4057qib7	9260	36	p=0.011	p=0.011	NNP
cord-005453-4057qib7	9260	37	)	)	-RRB-
cord-005453-4057qib7	9260	38	.	.	.
cord-005453-4057qib7	9261	1	Death	death	NN
cord-005453-4057qib7	9261	2	was	be	VBD
cord-005453-4057qib7	9261	3	attributed	attribute	VBN
cord-005453-4057qib7	9261	4	to	to	IN
cord-005453-4057qib7	9261	5	RSV	RSV	NNP
cord-005453-4057qib7	9261	6	in	in	IN
cord-005453-4057qib7	9261	7	11	11	CD
cord-005453-4057qib7	9261	8	of	of	IN
cord-005453-4057qib7	9261	9	the	the	DT
cord-005453-4057qib7	9261	10	44	44	CD
cord-005453-4057qib7	9261	11	pts	pt	NNS
cord-005453-4057qib7	9261	12	who	who	WP
cord-005453-4057qib7	9261	13	died	die	VBD
cord-005453-4057qib7	9261	14	(	(	-LRB-
cord-005453-4057qib7	9261	15	25	25	CD
cord-005453-4057qib7	9261	16	%	%	NN
cord-005453-4057qib7	9261	17	)	)	-RRB-
cord-005453-4057qib7	9261	18	.	.	.
cord-005453-4057qib7	9262	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9262	2	:	:	:
cord-005453-4057qib7	9263	1	Autologous	autologous	JJ
cord-005453-4057qib7	9263	2	HSCT	HSCT	NNP
cord-005453-4057qib7	9263	3	recipients	recipient	NNS
cord-005453-4057qib7	9263	4	are	be	VBP
cord-005453-4057qib7	9263	5	also	also	RB
cord-005453-4057qib7	9263	6	at	at	IN
cord-005453-4057qib7	9263	7	risk	risk	NN
cord-005453-4057qib7	9263	8	of	of	IN
cord-005453-4057qib7	9263	9	LRTI	LRTI	NNS
cord-005453-4057qib7	9263	10	caused	cause	VBN
cord-005453-4057qib7	9263	11	by	by	IN
cord-005453-4057qib7	9263	12	RSV	RSV	NNP
cord-005453-4057qib7	9263	13	.	.	.
cord-005453-4057qib7	9264	1	Risk	risk	NN
cord-005453-4057qib7	9264	2	of	of	IN
cord-005453-4057qib7	9264	3	RSV	RSV	NNP
cord-005453-4057qib7	9264	4	LRTI	LRTI	NNP
cord-005453-4057qib7	9264	5	is	be	VBZ
cord-005453-4057qib7	9264	6	higher	high	JJR
cord-005453-4057qib7	9264	7	in	in	IN
cord-005453-4057qib7	9264	8	MUD	mud	NN
cord-005453-4057qib7	9264	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9264	10	,	,	,
cord-005453-4057qib7	9264	11	infection	infection	NN
cord-005453-4057qib7	9264	12	acquired	acquire	VBD
cord-005453-4057qib7	9264	13	pre	pre	NN
cord-005453-4057qib7	9264	14	-	-	NN
cord-005453-4057qib7	9264	15	engraftment	engraftment	JJ
cord-005453-4057qib7	9264	16	or	or	CC
cord-005453-4057qib7	9264	17	early	early	RB
cord-005453-4057qib7	9264	18	after	after	IN
cord-005453-4057qib7	9264	19	HSCT	HSCT	NNP
cord-005453-4057qib7	9264	20	,	,	,
cord-005453-4057qib7	9264	21	and	and	CC
cord-005453-4057qib7	9264	22	low	low	JJ
cord-005453-4057qib7	9264	23	neutrophil	neutrophil	NN
cord-005453-4057qib7	9264	24	and	and	CC
cord-005453-4057qib7	9264	25	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9264	26	counts	count	NNS
cord-005453-4057qib7	9264	27	.	.	.
cord-005453-4057qib7	9265	1	Continued	continued	JJ
cord-005453-4057qib7	9265	2	education	education	NN
cord-005453-4057qib7	9265	3	is	be	VBZ
cord-005453-4057qib7	9265	4	necessary	necessary	JJ
cord-005453-4057qib7	9265	5	to	to	TO
cord-005453-4057qib7	9265	6	sustain	sustain	VB
cord-005453-4057qib7	9265	7	compliance	compliance	NN
cord-005453-4057qib7	9265	8	to	to	IN
cord-005453-4057qib7	9265	9	contact	contact	VB
cord-005453-4057qib7	9265	10	precautions	precaution	NNS
cord-005453-4057qib7	9265	11	in	in	IN
cord-005453-4057qib7	9265	12	HSCT	HSCT	NNP
cord-005453-4057qib7	9265	13	units	unit	NNS
cord-005453-4057qib7	9265	14	.	.	.
cord-005453-4057qib7	9266	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9266	2	Background	background	NN
cord-005453-4057qib7	9266	3	:	:	:
cord-005453-4057qib7	9267	1	Measles	measles	NN
cord-005453-4057qib7	9267	2	is	be	VBZ
cord-005453-4057qib7	9267	3	a	a	DT
cord-005453-4057qib7	9267	4	life	life	NN
cord-005453-4057qib7	9267	5	-	-	HYPH
cord-005453-4057qib7	9267	6	threatening	threaten	VBG
cord-005453-4057qib7	9267	7	infection	infection	NN
cord-005453-4057qib7	9267	8	after	after	IN
cord-005453-4057qib7	9267	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	9267	10	HCT	hct	NN
cord-005453-4057qib7	9267	11	.	.	.
cord-005453-4057qib7	9268	1	Due	due	IN
cord-005453-4057qib7	9268	2	to	to	IN
cord-005453-4057qib7	9268	3	the	the	DT
cord-005453-4057qib7	9268	4	decreased	decrease	VBN
cord-005453-4057qib7	9268	5	coverage	coverage	NN
cord-005453-4057qib7	9268	6	of	of	IN
cord-005453-4057qib7	9268	7	vaccination	vaccination	NN
cord-005453-4057qib7	9268	8	in	in	IN
cord-005453-4057qib7	9268	9	many	many	JJ
cord-005453-4057qib7	9268	10	countries	country	NNS
cord-005453-4057qib7	9268	11	,	,	,
cord-005453-4057qib7	9268	12	the	the	DT
cord-005453-4057qib7	9268	13	disease	disease	NN
cord-005453-4057qib7	9268	14	reappears	reappear	VBZ
cord-005453-4057qib7	9268	15	,	,	,
cord-005453-4057qib7	9268	16	increasing	increase	VBG
cord-005453-4057qib7	9268	17	the	the	DT
cord-005453-4057qib7	9268	18	risk	risk	NN
cord-005453-4057qib7	9268	19	of	of	IN
cord-005453-4057qib7	9268	20	outbreaks	outbreak	NNS
cord-005453-4057qib7	9268	21	worldwide	worldwide	RB
cord-005453-4057qib7	9268	22	.	.	.
cord-005453-4057qib7	9269	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	9269	2	HCT	hct	NN
cord-005453-4057qib7	9269	3	recipients	recipient	NNS
cord-005453-4057qib7	9269	4	have	have	VBP
cord-005453-4057qib7	9269	5	been	be	VBN
cord-005453-4057qib7	9269	6	shown	show	VBN
cord-005453-4057qib7	9269	7	to	to	TO
cord-005453-4057qib7	9269	8	be	be	VB
cord-005453-4057qib7	9269	9	seropositive	seropositive	JJ
cord-005453-4057qib7	9269	10	for	for	IN
cord-005453-4057qib7	9269	11	measles	measle	NNS
cord-005453-4057qib7	9269	12	in	in	IN
cord-005453-4057qib7	9269	13	roughly	roughly	RB
cord-005453-4057qib7	9269	14	40	40	CD
cord-005453-4057qib7	9269	15	-	-	SYM
cord-005453-4057qib7	9269	16	50	50	CD
cord-005453-4057qib7	9269	17	%	%	NN
cord-005453-4057qib7	9269	18	of	of	IN
cord-005453-4057qib7	9269	19	the	the	DT
cord-005453-4057qib7	9269	20	cases	case	NNS
cord-005453-4057qib7	9269	21	3	3	CD
cord-005453-4057qib7	9269	22	years	year	NNS
cord-005453-4057qib7	9269	23	after	after	IN
cord-005453-4057qib7	9269	24	transplant	transplant	NN
cord-005453-4057qib7	9269	25	.	.	.
cord-005453-4057qib7	9270	1	However	however	RB
cord-005453-4057qib7	9270	2	,	,	,
cord-005453-4057qib7	9270	3	these	these	DT
cord-005453-4057qib7	9270	4	data	datum	NNS
cord-005453-4057qib7	9270	5	were	be	VBD
cord-005453-4057qib7	9270	6	obtained	obtain	VBN
cord-005453-4057qib7	9270	7	before	before	IN
cord-005453-4057qib7	9270	8	the	the	DT
cord-005453-4057qib7	9270	9	2000	2000	CD
cord-005453-4057qib7	9270	10	's	's	POS
cord-005453-4057qib7	9270	11	from	from	IN
cord-005453-4057qib7	9270	12	HCT	HCT	NNP
cord-005453-4057qib7	9270	13	populations	population	NNS
cord-005453-4057qib7	9270	14	mainly	mainly	RB
cord-005453-4057qib7	9270	15	conditioned	condition	VBN
cord-005453-4057qib7	9270	16	with	with	IN
cord-005453-4057qib7	9270	17	myeloablative	myeloablative	NNP
cord-005453-4057qib7	9270	18	(	(	-LRB-
cord-005453-4057qib7	9270	19	MA	MA	NNP
cord-005453-4057qib7	9270	20	)	)	-RRB-
cord-005453-4057qib7	9270	21	regimens	regimen	NNS
cord-005453-4057qib7	9270	22	.	.	.
cord-005453-4057qib7	9271	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9271	2	aim	aim	NN
cord-005453-4057qib7	9271	3	was	be	VBD
cord-005453-4057qib7	9271	4	to	to	TO
cord-005453-4057qib7	9271	5	assess	assess	VB
cord-005453-4057qib7	9271	6	measles	measles	NN
cord-005453-4057qib7	9271	7	immunity	immunity	NN
cord-005453-4057qib7	9271	8	before	before	IN
cord-005453-4057qib7	9271	9	considering	consider	VBG
cord-005453-4057qib7	9271	10	vaccination	vaccination	NN
cord-005453-4057qib7	9271	11	in	in	IN
cord-005453-4057qib7	9271	12	a	a	DT
cord-005453-4057qib7	9271	13	cohort	cohort	NN
cord-005453-4057qib7	9271	14	of	of	IN
cord-005453-4057qib7	9271	15	HCT	HCT	NNP
cord-005453-4057qib7	9271	16	survivors	survivor	NNS
cord-005453-4057qib7	9271	17	including	include	VBG
cord-005453-4057qib7	9271	18	patients	patient	NNS
cord-005453-4057qib7	9271	19	conditioned	condition	VBN
cord-005453-4057qib7	9271	20	with	with	IN
cord-005453-4057qib7	9271	21	reduced	reduce	VBN
cord-005453-4057qib7	9271	22	intensity	intensity	NN
cord-005453-4057qib7	9271	23	(	(	-LRB-
cord-005453-4057qib7	9271	24	RIC	RIC	NNP
cord-005453-4057qib7	9271	25	)	)	-RRB-
cord-005453-4057qib7	9271	26	or	or	CC
cord-005453-4057qib7	9271	27	non	non	JJ
cord-005453-4057qib7	9271	28	-	-	JJ
cord-005453-4057qib7	9271	29	MA	ma	JJ
cord-005453-4057qib7	9271	30	regimens	regimen	NNS
cord-005453-4057qib7	9271	31	.	.	.
cord-005453-4057qib7	9272	1	Methods	method	NNS
cord-005453-4057qib7	9272	2	:	:	:
cord-005453-4057qib7	9272	3	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	9272	4	HCT	hct	NN
cord-005453-4057qib7	9272	5	adult	adult	NN
cord-005453-4057qib7	9272	6	recipients	recipient	NNS
cord-005453-4057qib7	9272	7	who	who	WP
cord-005453-4057qib7	9272	8	had	have	VBD
cord-005453-4057qib7	9272	9	not	not	RB
cord-005453-4057qib7	9272	10	been	be	VBN
cord-005453-4057qib7	9272	11	vaccinated	vaccinate	VBN
cord-005453-4057qib7	9272	12	for	for	IN
cord-005453-4057qib7	9272	13	measles	measle	NNS
cord-005453-4057qib7	9272	14	since	since	IN
cord-005453-4057qib7	9272	15	HCT	HCT	NNP
cord-005453-4057qib7	9272	16	were	be	VBD
cord-005453-4057qib7	9272	17	routinely	routinely	RB
cord-005453-4057qib7	9272	18	screened	screen	VBN
cord-005453-4057qib7	9272	19	for	for	IN
cord-005453-4057qib7	9272	20	measles	measles	NN
cord-005453-4057qib7	9272	21	immunity	immunity	NN
cord-005453-4057qib7	9272	22	.	.	.
cord-005453-4057qib7	9273	1	Measles	measles	JJ
cord-005453-4057qib7	9273	2	IgG	igg	NN
cord-005453-4057qib7	9273	3	titers	titer	NNS
cord-005453-4057qib7	9273	4	were	be	VBD
cord-005453-4057qib7	9273	5	determined	determine	VBN
cord-005453-4057qib7	9273	6	with	with	IN
cord-005453-4057qib7	9273	7	a	a	DT
cord-005453-4057qib7	9273	8	chemiluminescence	chemiluminescence	NN
cord-005453-4057qib7	9273	9	immunoassay	immunoassay	NN
cord-005453-4057qib7	9273	10	(	(	-LRB-
cord-005453-4057qib7	9273	11	Liaison	Liaison	NNP
cord-005453-4057qib7	9273	12	Measles	Measles	NNP
cord-005453-4057qib7	9273	13	IgG	igg	NN
cord-005453-4057qib7	9273	14	Kit	kit	NN
cord-005453-4057qib7	9273	15	,	,	,
cord-005453-4057qib7	9273	16	Liaison	Liaison	NNP
cord-005453-4057qib7	9273	17	XL	XL	NNP
cord-005453-4057qib7	9273	18	analyser	analyser	NN
cord-005453-4057qib7	9273	19	,	,	,
cord-005453-4057qib7	9273	20	Diasorin	Diasorin	NNP
cord-005453-4057qib7	9273	21	,	,	,
cord-005453-4057qib7	9273	22	Italy	Italy	NNP
cord-005453-4057qib7	9273	23	)	)	-RRB-
cord-005453-4057qib7	9273	24	.	.	.
cord-005453-4057qib7	9274	1	Patients	patient	NNS
cord-005453-4057qib7	9274	2	were	be	VBD
cord-005453-4057qib7	9274	3	considered	consider	VBN
cord-005453-4057qib7	9274	4	to	to	TO
cord-005453-4057qib7	9274	5	be	be	VB
cord-005453-4057qib7	9274	6	seropositive	seropositive	JJ
cord-005453-4057qib7	9274	7	if	if	IN
cord-005453-4057qib7	9274	8	the	the	DT
cord-005453-4057qib7	9274	9	IgG	IgG	NNP
cord-005453-4057qib7	9274	10	titer	titer	NN
cord-005453-4057qib7	9274	11	was	be	VBD
cord-005453-4057qib7	9274	12	>	>	NFP
cord-005453-4057qib7	9274	13	16.5	16.5	CD
cord-005453-4057qib7	9274	14	UA	UA	NNP
cord-005453-4057qib7	9274	15	/	/	SYM
cord-005453-4057qib7	9274	16	mL.	mL.	NNP
cord-005453-4057qib7	9274	17	Risk	risk	NN
cord-005453-4057qib7	9274	18	factors	factor	NNS
cord-005453-4057qib7	9274	19	for	for	IN
cord-005453-4057qib7	9274	20	seropositivity	seropositivity	NN
cord-005453-4057qib7	9274	21	were	be	VBD
cord-005453-4057qib7	9274	22	analyzed	analyze	VBN
cord-005453-4057qib7	9274	23	.	.	.
cord-005453-4057qib7	9275	1	Qualitative	qualitative	JJ
cord-005453-4057qib7	9275	2	variables	variable	NNS
cord-005453-4057qib7	9275	3	were	be	VBD
cord-005453-4057qib7	9275	4	described	describe	VBN
cord-005453-4057qib7	9275	5	as	as	IN
cord-005453-4057qib7	9275	6	numbers	number	NNS
cord-005453-4057qib7	9275	7	(	(	-LRB-
cord-005453-4057qib7	9275	8	%	%	NN
cord-005453-4057qib7	9275	9	)	)	-RRB-
cord-005453-4057qib7	9275	10	and	and	CC
cord-005453-4057qib7	9275	11	compared	compare	VBN
cord-005453-4057qib7	9275	12	using	use	VBG
cord-005453-4057qib7	9275	13	the	the	DT
cord-005453-4057qib7	9275	14	chi-2	chi-2	NNP
cord-005453-4057qib7	9275	15	test	test	NN
cord-005453-4057qib7	9275	16	or	or	CC
cord-005453-4057qib7	9275	17	Fisher	Fisher	NNP
cord-005453-4057qib7	9275	18	exact	exact	JJ
cord-005453-4057qib7	9275	19	test	test	NN
cord-005453-4057qib7	9275	20	as	as	IN
cord-005453-4057qib7	9275	21	appropriate	appropriate	JJ
cord-005453-4057qib7	9275	22	.	.	.
cord-005453-4057qib7	9276	1	Quantitative	quantitative	JJ
cord-005453-4057qib7	9276	2	variables	variable	NNS
cord-005453-4057qib7	9276	3	were	be	VBD
cord-005453-4057qib7	9276	4	described	describe	VBN
cord-005453-4057qib7	9276	5	as	as	IN
cord-005453-4057qib7	9276	6	median	median	NN
cord-005453-4057qib7	9276	7	or	or	CC
cord-005453-4057qib7	9276	8	mean	mean	JJ
cord-005453-4057qib7	9276	9	(	(	-LRB-
cord-005453-4057qib7	9276	10	range	range	NN
cord-005453-4057qib7	9276	11	)	)	-RRB-
cord-005453-4057qib7	9276	12	and	and	CC
cord-005453-4057qib7	9276	13	compared	compare	VBN
cord-005453-4057qib7	9276	14	using	use	VBG
cord-005453-4057qib7	9276	15	the	the	DT
cord-005453-4057qib7	9276	16	Kruskall	Kruskall	NNP
cord-005453-4057qib7	9276	17	-	-	HYPH
cord-005453-4057qib7	9276	18	Wallis	Wallis	NNP
cord-005453-4057qib7	9276	19	test	test	NN
cord-005453-4057qib7	9276	20	.	.	.
cord-005453-4057qib7	9277	1	ORs	or	NNS
cord-005453-4057qib7	9277	2	were	be	VBD
cord-005453-4057qib7	9277	3	estimated	estimate	VBN
cord-005453-4057qib7	9277	4	separately	separately	RB
cord-005453-4057qib7	9277	5	for	for	IN
cord-005453-4057qib7	9277	6	factor	factor	NN
cord-005453-4057qib7	9277	7	yielding	yield	VBG
cord-005453-4057qib7	9277	8	a	a	DT
cord-005453-4057qib7	9277	9	P	p	NN
cord-005453-4057qib7	9277	10	-	-	HYPH
cord-005453-4057qib7	9277	11	value	value	NN
cord-005453-4057qib7	9277	12	<	<	XX
cord-005453-4057qib7	9277	13	0.20	0.20	CD
cord-005453-4057qib7	9277	14	in	in	IN
cord-005453-4057qib7	9277	15	the	the	DT
cord-005453-4057qib7	9277	16	univariate	univariate	JJ
cord-005453-4057qib7	9277	17	analysis	analysis	NN
cord-005453-4057qib7	9277	18	using	use	VBG
cord-005453-4057qib7	9277	19	logistic	logistic	JJ
cord-005453-4057qib7	9277	20	regression	regression	NN
cord-005453-4057qib7	9277	21	models	model	NNS
cord-005453-4057qib7	9277	22	.	.	.
cord-005453-4057qib7	9278	1	Results	result	NNS
cord-005453-4057qib7	9278	2	:	:	:
cord-005453-4057qib7	9279	1	Eighty	eighty	CD
cord-005453-4057qib7	9279	2	-	-	HYPH
cord-005453-4057qib7	9279	3	six	six	CD
cord-005453-4057qib7	9279	4	patients	patient	NNS
cord-005453-4057qib7	9279	5	,	,	,
cord-005453-4057qib7	9279	6	transplanted	transplant	VBD
cord-005453-4057qib7	9279	7	1.5	1.5	CD
cord-005453-4057qib7	9279	8	to	to	TO
cord-005453-4057qib7	9279	9	38	38	CD
cord-005453-4057qib7	9279	10	years	year	NNS
cord-005453-4057qib7	9279	11	(	(	-LRB-
cord-005453-4057qib7	9279	12	mean	mean	VB
cord-005453-4057qib7	9279	13	:	:	:
cord-005453-4057qib7	9279	14	13,5	13,5	CD
cord-005453-4057qib7	9279	15	years	year	NNS
cord-005453-4057qib7	9279	16	)	)	-RRB-
cord-005453-4057qib7	9279	17	ago	ago	RB
cord-005453-4057qib7	9279	18	,	,	,
cord-005453-4057qib7	9279	19	were	be	VBD
cord-005453-4057qib7	9279	20	included	include	VBN
cord-005453-4057qib7	9279	21	.	.	.
cord-005453-4057qib7	9280	1	The	the	DT
cord-005453-4057qib7	9280	2	mean	mean	JJ
cord-005453-4057qib7	9280	3	age	age	NN
cord-005453-4057qib7	9280	4	was	be	VBD
cord-005453-4057qib7	9280	5	53	53	CD
cord-005453-4057qib7	9280	6	years	year	NNS
cord-005453-4057qib7	9281	1	(	(	-LRB-
cord-005453-4057qib7	9281	2	range	range	NN
cord-005453-4057qib7	9281	3	:	:	:
cord-005453-4057qib7	9281	4	21	21	CD
cord-005453-4057qib7	9281	5	-	-	SYM
cord-005453-4057qib7	9281	6	79	79	CD
cord-005453-4057qib7	9281	7	)	)	-RRB-
cord-005453-4057qib7	9281	8	,	,	.
cord-005453-4057qib7	9282	1	the	the	DT
cord-005453-4057qib7	9282	2	sex	sex	NN
cord-005453-4057qib7	9282	3	ratio	ratio	NN
cord-005453-4057qib7	9282	4	M	M	NNP
cord-005453-4057qib7	9282	5	/	/	SYM
cord-005453-4057qib7	9282	6	F	f	NN
cord-005453-4057qib7	9282	7	:	:	:
cord-005453-4057qib7	9282	8	0,5	0,5	NFP
cord-005453-4057qib7	9282	9	.	.	.
cord-005453-4057qib7	9283	1	The	the	DT
cord-005453-4057qib7	9283	2	underlying	underlie	VBG
cord-005453-4057qib7	9283	3	diseases	disease	NNS
cord-005453-4057qib7	9283	4	were	be	VBD
cord-005453-4057qib7	9283	5	acute	acute	JJ
cord-005453-4057qib7	9283	6	leukemia	leukemia	NN
cord-005453-4057qib7	9283	7	:	:	:
cord-005453-4057qib7	9283	8	49	49	CD
cord-005453-4057qib7	9283	9	(	(	-LRB-
cord-005453-4057qib7	9283	10	57	57	CD
cord-005453-4057qib7	9283	11	%	%	NN
cord-005453-4057qib7	9283	12	)	)	-RRB-
cord-005453-4057qib7	9283	13	,	,	,
cord-005453-4057qib7	9283	14	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	9283	15	syndrome	syndrome	NN
cord-005453-4057qib7	9283	16	:	:	:
cord-005453-4057qib7	9283	17	5	5	CD
cord-005453-4057qib7	9283	18	(	(	-LRB-
cord-005453-4057qib7	9283	19	6	6	CD
cord-005453-4057qib7	9283	20	%	%	NN
cord-005453-4057qib7	9283	21	)	)	-RRB-
cord-005453-4057qib7	9283	22	,	,	,
cord-005453-4057qib7	9283	23	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	9283	24	diseases	disease	NNS
cord-005453-4057qib7	9283	25	:	:	:
cord-005453-4057qib7	9283	26	17	17	CD
cord-005453-4057qib7	9283	27	(	(	-LRB-
cord-005453-4057qib7	9283	28	19.5	19.5	CD
cord-005453-4057qib7	9283	29	%	%	NN
cord-005453-4057qib7	9283	30	)	)	-RRB-
cord-005453-4057qib7	9283	31	,	,	,
cord-005453-4057qib7	9283	32	myeloproliferative	myeloproliferative	JJ
cord-005453-4057qib7	9283	33	neoplasms	neoplasm	NNS
cord-005453-4057qib7	9283	34	:	:	:
cord-005453-4057qib7	9283	35	11	11	CD
cord-005453-4057qib7	9283	36	(	(	-LRB-
cord-005453-4057qib7	9283	37	13	13	CD
cord-005453-4057qib7	9283	38	%	%	NN
cord-005453-4057qib7	9283	39	)	)	-RRB-
cord-005453-4057qib7	9283	40	and	and	CC
cord-005453-4057qib7	9283	41	non	non	JJ
cord-005453-4057qib7	9283	42	-	-	JJ
cord-005453-4057qib7	9283	43	malignant	malignant	JJ
cord-005453-4057qib7	9283	44	diseases	disease	NNS
cord-005453-4057qib7	9283	45	:	:	:
cord-005453-4057qib7	9283	46	4	4	CD
cord-005453-4057qib7	9283	47	(	(	-LRB-
cord-005453-4057qib7	9283	48	4.5	4.5	CD
cord-005453-4057qib7	9283	49	%	%	NN
cord-005453-4057qib7	9283	50	)	)	-RRB-
cord-005453-4057qib7	9283	51	.	.	.
cord-005453-4057qib7	9284	1	The	the	DT
cord-005453-4057qib7	9284	2	HCT	HCT	NNP
cord-005453-4057qib7	9284	3	was	be	VBD
cord-005453-4057qib7	9284	4	performed	perform	VBN
cord-005453-4057qib7	9284	5	from	from	IN
cord-005453-4057qib7	9284	6	an	an	DT
cord-005453-4057qib7	9284	7	HLA	HLA	NNP
cord-005453-4057qib7	9284	8	-	-	HYPH
cord-005453-4057qib7	9284	9	identical	identical	JJ
cord-005453-4057qib7	9284	10	donor	donor	NN
cord-005453-4057qib7	9284	11	in	in	IN
cord-005453-4057qib7	9284	12	52	52	CD
cord-005453-4057qib7	9284	13	,	,	,
cord-005453-4057qib7	9284	14	an	an	DT
cord-005453-4057qib7	9284	15	unrelated	unrelated	JJ
cord-005453-4057qib7	9284	16	donor	donor	NN
cord-005453-4057qib7	9284	17	in	in	IN
cord-005453-4057qib7	9284	18	30	30	CD
cord-005453-4057qib7	9284	19	,	,	,
cord-005453-4057qib7	9284	20	and	and	CC
cord-005453-4057qib7	9284	21	a	a	DT
cord-005453-4057qib7	9284	22	cord	cord	NN
cord-005453-4057qib7	9284	23	-	-	HYPH
cord-005453-4057qib7	9284	24	blood	blood	NN
cord-005453-4057qib7	9284	25	in	in	IN
cord-005453-4057qib7	9284	26	4	4	CD
cord-005453-4057qib7	9284	27	.	.	.
cord-005453-4057qib7	9285	1	Conditioning	conditioning	NN
cord-005453-4057qib7	9285	2	regimen	regimen	NN
cord-005453-4057qib7	9285	3	were	be	VBD
cord-005453-4057qib7	9285	4	MA	MA	NNP
cord-005453-4057qib7	9285	5	in	in	IN
cord-005453-4057qib7	9285	6	48	48	CD
cord-005453-4057qib7	9285	7	(	(	-LRB-
cord-005453-4057qib7	9285	8	56	56	CD
cord-005453-4057qib7	9285	9	%	%	NN
cord-005453-4057qib7	9285	10	)	)	-RRB-
cord-005453-4057qib7	9285	11	,	,	,
cord-005453-4057qib7	9285	12	RIC	RIC	NNP
cord-005453-4057qib7	9285	13	in	in	IN
cord-005453-4057qib7	9285	14	20	20	CD
cord-005453-4057qib7	9285	15	(	(	-LRB-
cord-005453-4057qib7	9285	16	23	23	CD
cord-005453-4057qib7	9285	17	%	%	NN
cord-005453-4057qib7	9285	18	)	)	-RRB-
cord-005453-4057qib7	9285	19	and	and	CC
cord-005453-4057qib7	9285	20	non	non	JJ
cord-005453-4057qib7	9285	21	-	-	JJ
cord-005453-4057qib7	9285	22	MA	MA	NNP
cord-005453-4057qib7	9285	23	in	in	IN
cord-005453-4057qib7	9285	24	18	18	CD
cord-005453-4057qib7	9285	25	(	(	-LRB-
cord-005453-4057qib7	9285	26	21	21	CD
cord-005453-4057qib7	9285	27	%	%	NN
cord-005453-4057qib7	9285	28	)	)	-RRB-
cord-005453-4057qib7	9285	29	patients	patient	NNS
cord-005453-4057qib7	9286	1	No	no	DT
cord-005453-4057qib7	9286	2	patient	patient	NN
cord-005453-4057qib7	9286	3	had	have	VBD
cord-005453-4057qib7	9286	4	experienced	experience	VBN
cord-005453-4057qib7	9286	5	measles	measle	NNS
cord-005453-4057qib7	9286	6	or	or	CC
cord-005453-4057qib7	9286	7	had	have	VBD
cord-005453-4057qib7	9286	8	received	receive	VBN
cord-005453-4057qib7	9286	9	measles	measle	NNS
cord-005453-4057qib7	9286	10	vaccination	vaccination	NN
cord-005453-4057qib7	9286	11	since	since	IN
cord-005453-4057qib7	9286	12	transplant	transplant	NN
cord-005453-4057qib7	9286	13	.	.	.
cord-005453-4057qib7	9287	1	Fifty	fifty	CD
cord-005453-4057qib7	9287	2	-	-	HYPH
cord-005453-4057qib7	9287	3	seven	seven	CD
cord-005453-4057qib7	9287	4	of	of	IN
cord-005453-4057qib7	9287	5	the	the	DT
cord-005453-4057qib7	9287	6	86	86	CD
cord-005453-4057qib7	9287	7	(	(	-LRB-
cord-005453-4057qib7	9287	8	66	66	CD
cord-005453-4057qib7	9287	9	%	%	NN
cord-005453-4057qib7	9287	10	)	)	-RRB-
cord-005453-4057qib7	9287	11	patients	patient	NNS
cord-005453-4057qib7	9287	12	were	be	VBD
cord-005453-4057qib7	9287	13	seropositive	seropositive	JJ
cord-005453-4057qib7	9287	14	for	for	IN
cord-005453-4057qib7	9287	15	measles	measle	NNS
cord-005453-4057qib7	9287	16	.	.	.
cord-005453-4057qib7	9288	1	Measles	Measles	NNP
cord-005453-4057qib7	9288	2	seropositivity	seropositivity	NN
cord-005453-4057qib7	9288	3	was	be	VBD
cord-005453-4057qib7	9288	4	not	not	RB
cord-005453-4057qib7	9288	5	associated	associate	VBN
cord-005453-4057qib7	9288	6	with	with	IN
cord-005453-4057qib7	9288	7	conditioning	conditioning	NN
cord-005453-4057qib7	9288	8	regimen	regimen	NN
cord-005453-4057qib7	9288	9	,	,	,
cord-005453-4057qib7	9288	10	patient	patient	JJ
cord-005453-4057qib7	9288	11	age	age	NN
cord-005453-4057qib7	9288	12	at	at	IN
cord-005453-4057qib7	9288	13	transplant	transplant	NN
cord-005453-4057qib7	9288	14	,	,	,
cord-005453-4057qib7	9288	15	patient	patient	JJ
cord-005453-4057qib7	9288	16	age	age	NN
cord-005453-4057qib7	9288	17	at	at	IN
cord-005453-4057qib7	9288	18	time	time	NN
cord-005453-4057qib7	9288	19	of	of	IN
cord-005453-4057qib7	9288	20	assessment	assessment	NN
cord-005453-4057qib7	9288	21	,	,	,
cord-005453-4057qib7	9289	1	donor	donor	NN
cord-005453-4057qib7	9289	2	age	age	NN
cord-005453-4057qib7	9289	3	at	at	IN
cord-005453-4057qib7	9289	4	transplant	transplant	NN
cord-005453-4057qib7	9289	5	,	,	,
cord-005453-4057qib7	9289	6	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9289	7	count	count	NN
cord-005453-4057qib7	9289	8	or	or	CC
cord-005453-4057qib7	9289	9	gammaglobulin	gammaglobulin	NN
cord-005453-4057qib7	9289	10	levels	level	NNS
cord-005453-4057qib7	9289	11	,	,	,
cord-005453-4057qib7	9289	12	or	or	CC
cord-005453-4057qib7	9289	13	type	type	NN
cord-005453-4057qib7	9289	14	of	of	IN
cord-005453-4057qib7	9289	15	transplant	transplant	NN
cord-005453-4057qib7	9289	16	(	(	-LRB-
cord-005453-4057qib7	9289	17	HLAid	HLAid	NNP
cord-005453-4057qib7	9289	18	.	.	.
cord-005453-4057qib7	9290	1	vs	vs	IN
cord-005453-4057qib7	9290	2	others	other	NNS
cord-005453-4057qib7	9290	3	)	)	-RRB-
cord-005453-4057qib7	9290	4	measles	measle	NNS
cord-005453-4057qib7	9290	5	vaccination	vaccination	NN
cord-005453-4057qib7	9290	6	before	before	IN
cord-005453-4057qib7	9290	7	transplant	transplant	NN
cord-005453-4057qib7	9290	8	or	or	CC
cord-005453-4057qib7	9290	9	previous	previous	JJ
cord-005453-4057qib7	9290	10	measles	measle	NNS
cord-005453-4057qib7	9290	11	before	before	IN
cord-005453-4057qib7	9290	12	transplant	transplant	NN
cord-005453-4057qib7	9290	13	.	.	.
cord-005453-4057qib7	9291	1	The	the	DT
cord-005453-4057qib7	9291	2	only	only	JJ
cord-005453-4057qib7	9291	3	parameters	parameter	NNS
cord-005453-4057qib7	9291	4	significantly	significantly	RB
cord-005453-4057qib7	9291	5	associated	associate	VBN
cord-005453-4057qib7	9291	6	to	to	IN
cord-005453-4057qib7	9291	7	seropositivity	seropositivity	NN
cord-005453-4057qib7	9291	8	were	be	VBD
cord-005453-4057qib7	9291	9	absence	absence	NN
cord-005453-4057qib7	9291	10	of	of	IN
cord-005453-4057qib7	9291	11	previous	previous	JJ
cord-005453-4057qib7	9291	12	GvHD	gvhd	NN
cord-005453-4057qib7	9291	13	(	(	-LRB-
cord-005453-4057qib7	9291	14	any	any	DT
cord-005453-4057qib7	9291	15	type	type	NN
cord-005453-4057qib7	9291	16	or	or	CC
cord-005453-4057qib7	9291	17	severity	severity	NN
cord-005453-4057qib7	9291	18	,	,	,
cord-005453-4057qib7	9291	19	p=0,033	p=0,033	NNP
cord-005453-4057qib7	9292	1	OR	or	CC
cord-005453-4057qib7	9292	2	0,31	0,31	CD
cord-005453-4057qib7	9293	1	[	[	-LRB-
cord-005453-4057qib7	9293	2	0,10	0,10	NN
cord-005453-4057qib7	9293	3	-	-	HYPH
cord-005453-4057qib7	9293	4	0,94	0,94	CD
cord-005453-4057qib7	9293	5	]	]	-RRB-
cord-005453-4057qib7	9293	6	)	)	-RRB-
cord-005453-4057qib7	9293	7	,	,	,
cord-005453-4057qib7	9293	8	and	and	CC
cord-005453-4057qib7	9293	9	absence	absence	NN
cord-005453-4057qib7	9293	10	of	of	IN
cord-005453-4057qib7	9293	11	previous	previous	JJ
cord-005453-4057qib7	9293	12	extensive	extensive	JJ
cord-005453-4057qib7	9293	13	chronic	chronic	JJ
cord-005453-4057qib7	9293	14	GvHD	gvhd	NN
cord-005453-4057qib7	9293	15	(	(	-LRB-
cord-005453-4057qib7	9293	16	OR	or	CC
cord-005453-4057qib7	9293	17	0	0	CD
cord-005453-4057qib7	9293	18	,	,	,
cord-005453-4057qib7	9293	19	28	28	CD
cord-005453-4057qib7	9293	20	[	[	-LRB-
cord-005453-4057qib7	9293	21	0	0	CD
cord-005453-4057qib7	9293	22	,	,	,
cord-005453-4057qib7	9293	23	87	87	CD
cord-005453-4057qib7	9293	24	]	]	-RRB-
cord-005453-4057qib7	9293	25	p0,027	p0,027	CD
cord-005453-4057qib7	9293	26	)	)	-RRB-
cord-005453-4057qib7	9293	27	.	.	.
cord-005453-4057qib7	9294	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9294	2	:	:	:
cord-005453-4057qib7	9295	1	Sixty	sixty	CD
cord-005453-4057qib7	9295	2	-	-	HYPH
cord-005453-4057qib7	9295	3	seven	seven	CD
cord-005453-4057qib7	9295	4	percent	percent	NN
cord-005453-4057qib7	9295	5	of	of	IN
cord-005453-4057qib7	9295	6	allogeneic	allogeneic	NN
cord-005453-4057qib7	9295	7	HCT	hct	NN
cord-005453-4057qib7	9295	8	are	be	VBP
cord-005453-4057qib7	9295	9	seropositive	seropositive	JJ
cord-005453-4057qib7	9295	10	for	for	IN
cord-005453-4057qib7	9295	11	measles	measle	NNS
cord-005453-4057qib7	9295	12	at	at	IN
cord-005453-4057qib7	9295	13	a	a	DT
cord-005453-4057qib7	9295	14	median	median	NN
cord-005453-4057qib7	9295	15	of	of	IN
cord-005453-4057qib7	9295	16	7	7	CD
cord-005453-4057qib7	9295	17	years	year	NNS
cord-005453-4057qib7	9295	18	after	after	IN
cord-005453-4057qib7	9295	19	HCT	hct	NN
cord-005453-4057qib7	9295	20	before	before	IN
cord-005453-4057qib7	9295	21	vaccination	vaccination	NN
cord-005453-4057qib7	9295	22	.	.	.
cord-005453-4057qib7	9296	1	The	the	DT
cord-005453-4057qib7	9296	2	only	only	JJ
cord-005453-4057qib7	9296	3	risk	risk	NN
cord-005453-4057qib7	9296	4	factor	factor	NN
cord-005453-4057qib7	9296	5	strongly	strongly	RB
cord-005453-4057qib7	9296	6	associated	associate	VBD
cord-005453-4057qib7	9296	7	with	with	IN
cord-005453-4057qib7	9296	8	seronegativity	seronegativity	NN
cord-005453-4057qib7	9296	9	is	be	VBZ
cord-005453-4057qib7	9296	10	extensive	extensive	JJ
cord-005453-4057qib7	9296	11	chronic	chronic	JJ
cord-005453-4057qib7	9296	12	GvHD	gvhd	NN
cord-005453-4057qib7	9296	13	.	.	.
cord-005453-4057qib7	9297	1	In	in	IN
cord-005453-4057qib7	9297	2	patients	patient	NNS
cord-005453-4057qib7	9297	3	Background	background	NN
cord-005453-4057qib7	9297	4	:	:	:
cord-005453-4057qib7	9297	5	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	9297	6	(	(	-LRB-
cord-005453-4057qib7	9297	7	CMV	CMV	NNP
cord-005453-4057qib7	9297	8	)	)	-RRB-
cord-005453-4057qib7	9297	9	reactivation	reactivation	NN
cord-005453-4057qib7	9297	10	is	be	VBZ
cord-005453-4057qib7	9297	11	a	a	DT
cord-005453-4057qib7	9297	12	frequent	frequent	JJ
cord-005453-4057qib7	9297	13	complication	complication	NN
cord-005453-4057qib7	9297	14	after	after	IN
cord-005453-4057qib7	9297	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9297	16	stem	stem	NN
cord-005453-4057qib7	9297	17	cell	cell	NN
cord-005453-4057qib7	9297	18	transplantation	transplantation	NN
cord-005453-4057qib7	9297	19	(	(	-LRB-
cord-005453-4057qib7	9297	20	HSCT	HSCT	NNP
cord-005453-4057qib7	9297	21	)	)	-RRB-
cord-005453-4057qib7	9297	22	.	.	.
cord-005453-4057qib7	9298	1	Extracellular	Extracellular	NNP
cord-005453-4057qib7	9298	2	Vesicles	Vesicles	NNP
cord-005453-4057qib7	9298	3	(	(	-LRB-
cord-005453-4057qib7	9298	4	EVs	ev	NNS
cord-005453-4057qib7	9298	5	)	)	-RRB-
cord-005453-4057qib7	9298	6	have	have	VBP
cord-005453-4057qib7	9298	7	emerged	emerge	VBN
cord-005453-4057qib7	9298	8	as	as	IN
cord-005453-4057qib7	9298	9	a	a	DT
cord-005453-4057qib7	9298	10	promising	promising	JJ
cord-005453-4057qib7	9298	11	new	new	JJ
cord-005453-4057qib7	9298	12	category	category	NN
cord-005453-4057qib7	9298	13	of	of	IN
cord-005453-4057qib7	9298	14	biological	biological	JJ
cord-005453-4057qib7	9298	15	biomarkers	biomarker	NNS
cord-005453-4057qib7	9298	16	in	in	IN
cord-005453-4057qib7	9298	17	different	different	JJ
cord-005453-4057qib7	9298	18	scenarios	scenario	NNS
cord-005453-4057qib7	9298	19	,	,	,
cord-005453-4057qib7	9298	20	including	include	VBG
cord-005453-4057qib7	9298	21	inflammation	inflammation	NN
cord-005453-4057qib7	9298	22	,	,	,
cord-005453-4057qib7	9298	23	tissue	tissue	NN
cord-005453-4057qib7	9298	24	damage	damage	NN
cord-005453-4057qib7	9298	25	,	,	,
cord-005453-4057qib7	9298	26	cancer	cancer	NN
cord-005453-4057qib7	9298	27	and	and	CC
cord-005453-4057qib7	9298	28	viral	viral	JJ
cord-005453-4057qib7	9298	29	infections	infection	NNS
cord-005453-4057qib7	9298	30	.	.	.
cord-005453-4057qib7	9299	1	We	-PRON-	PRP
cord-005453-4057qib7	9299	2	recently	recently	RB
cord-005453-4057qib7	9299	3	reported	report	VBD
cord-005453-4057qib7	9299	4	on	on	IN
cord-005453-4057qib7	9299	5	the	the	DT
cord-005453-4057qib7	9299	6	potential	potential	JJ
cord-005453-4057qib7	9299	7	use	use	NN
cord-005453-4057qib7	9299	8	of	of	IN
cord-005453-4057qib7	9299	9	serum	serum	NN
cord-005453-4057qib7	9299	10	EVs	ev	NNS
cord-005453-4057qib7	9299	11	as	as	IN
cord-005453-4057qib7	9299	12	biomarkers	biomarker	NNS
cord-005453-4057qib7	9299	13	of	of	IN
cord-005453-4057qib7	9299	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	9300	1	(	(	-LRB-
cord-005453-4057qib7	9300	2	Lia	Lia	NNP
cord-005453-4057qib7	9300	3	G.	G.	NNP
cord-005453-4057qib7	9300	4	et	et	NNP
cord-005453-4057qib7	9300	5	al	al	NNP
cord-005453-4057qib7	9300	6	.	.	.
cord-005453-4057qib7	9301	1	Leukemia	leukemia	NN
cord-005453-4057qib7	9301	2	(	(	-LRB-
cord-005453-4057qib7	9301	3	2018	2018	CD
cord-005453-4057qib7	9301	4	)	)	-RRB-
cord-005453-4057qib7	9301	5	32	32	CD
cord-005453-4057qib7	9301	6	,	,	,
cord-005453-4057qib7	9301	7	765	765	CD
cord-005453-4057qib7	9301	8	)	)	-RRB-
cord-005453-4057qib7	9301	9	.	.	.
cord-005453-4057qib7	9302	1	Here	here	RB
cord-005453-4057qib7	9302	2	,	,	,
cord-005453-4057qib7	9302	3	we	-PRON-	PRP
cord-005453-4057qib7	9302	4	investigated	investigate	VBD
cord-005453-4057qib7	9302	5	the	the	DT
cord-005453-4057qib7	9302	6	potential	potential	JJ
cord-005453-4057qib7	9302	7	correlation	correlation	NN
cord-005453-4057qib7	9302	8	of	of	IN
cord-005453-4057qib7	9302	9	CMV	CMV	NNP
cord-005453-4057qib7	9302	10	reactivation	reactivation	NN
cord-005453-4057qib7	9302	11	with	with	IN
cord-005453-4057qib7	9302	12	plasma	plasma	NN
cord-005453-4057qib7	9302	13	EVs	ev	NNS
cord-005453-4057qib7	9302	14	in	in	IN
cord-005453-4057qib7	9302	15	post	post	JJ
cord-005453-4057qib7	9302	16	-	-	JJ
cord-005453-4057qib7	9302	17	transplant	transplant	NN
cord-005453-4057qib7	9302	18	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	9302	19	(	(	-LRB-
cord-005453-4057qib7	9302	20	PTCY	PTCY	NNP
cord-005453-4057qib7	9302	21	)	)	-RRB-
cord-005453-4057qib7	9302	22	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9302	23	-	-	HYPH
cord-005453-4057qib7	9302	24	HSCT	HSCT	NNP
cord-005453-4057qib7	9302	25	(	(	-LRB-
cord-005453-4057qib7	9302	26	Haplo	Haplo	NNP
cord-005453-4057qib7	9302	27	-	-	HYPH
cord-005453-4057qib7	9302	28	HSCT	HSCT	NNP
cord-005453-4057qib7	9302	29	)	)	-RRB-
cord-005453-4057qib7	9302	30	.	.	.
cord-005453-4057qib7	9303	1	Methods	method	NNS
cord-005453-4057qib7	9303	2	:	:	:
cord-005453-4057qib7	9303	3	Plasma	plasma	NN
cord-005453-4057qib7	9303	4	samples	sample	NNS
cord-005453-4057qib7	9303	5	were	be	VBD
cord-005453-4057qib7	9303	6	collected	collect	VBN
cord-005453-4057qib7	9303	7	after	after	IN
cord-005453-4057qib7	9303	8	mononuclear	mononuclear	JJ
cord-005453-4057qib7	9303	9	cell	cell	NN
cord-005453-4057qib7	9303	10	separation	separation	NN
cord-005453-4057qib7	9303	11	at	at	IN
cord-005453-4057qib7	9303	12	given	give	VBN
cord-005453-4057qib7	9303	13	time	time	NN
cord-005453-4057qib7	9303	14	-	-	HYPH
cord-005453-4057qib7	9303	15	points	point	NNS
cord-005453-4057qib7	9303	16	(	(	-LRB-
cord-005453-4057qib7	9303	17	pre	pre	JJ
cord-005453-4057qib7	9303	18	-	-	NN
cord-005453-4057qib7	9303	19	transplant	transplant	NN
cord-005453-4057qib7	9303	20	,	,	,
cord-005453-4057qib7	9303	21	on	on	IN
cord-005453-4057qib7	9303	22	day	day	NN
cord-005453-4057qib7	9303	23	0	0	CD
cord-005453-4057qib7	9303	24	,	,	,
cord-005453-4057qib7	9303	25	3	3	CD
cord-005453-4057qib7	9303	26	,	,	,
cord-005453-4057qib7	9303	27	7	7	CD
cord-005453-4057qib7	9303	28	,	,	,
cord-005453-4057qib7	9303	29	14	14	CD
cord-005453-4057qib7	9303	30	,	,	,
cord-005453-4057qib7	9303	31	21	21	CD
cord-005453-4057qib7	9303	32	,	,	,
cord-005453-4057qib7	9303	33	28	28	CD
cord-005453-4057qib7	9303	34	,	,	,
cord-005453-4057qib7	9303	35	35	35	CD
cord-005453-4057qib7	9303	36	,	,	,
cord-005453-4057qib7	9303	37	45	45	CD
cord-005453-4057qib7	9303	38	,	,	,
cord-005453-4057qib7	9303	39	60	60	CD
cord-005453-4057qib7	9303	40	,	,	,
cord-005453-4057qib7	9303	41	75	75	CD
cord-005453-4057qib7	9303	42	and	and	CC
cord-005453-4057qib7	9303	43	90	90	CD
cord-005453-4057qib7	9303	44	after	after	IN
cord-005453-4057qib7	9303	45	Haplo	Haplo	NNP
cord-005453-4057qib7	9303	46	-	-	HYPH
cord-005453-4057qib7	9303	47	HSCT	HSCT	NNP
cord-005453-4057qib7	9303	48	)	)	-RRB-
cord-005453-4057qib7	9303	49	and	and	CC
cord-005453-4057qib7	9303	50	EVs	ev	NNS
cord-005453-4057qib7	9303	51	were	be	VBD
cord-005453-4057qib7	9303	52	extracted	extract	VBN
cord-005453-4057qib7	9303	53	by	by	IN
cord-005453-4057qib7	9303	54	a	a	DT
cord-005453-4057qib7	9303	55	protamine	protamine	NN
cord-005453-4057qib7	9303	56	-	-	HYPH
cord-005453-4057qib7	9303	57	based	base	VBN
cord-005453-4057qib7	9303	58	precipitation	precipitation	NN
cord-005453-4057qib7	9303	59	method	method	NN
cord-005453-4057qib7	9303	60	and	and	CC
cord-005453-4057qib7	9303	61	their	-PRON-	PRP$
cord-005453-4057qib7	9303	62	concentration	concentration	NN
cord-005453-4057qib7	9303	63	and	and	CC
cord-005453-4057qib7	9303	64	dimension	dimension	NN
cord-005453-4057qib7	9303	65	were	be	VBD
cord-005453-4057qib7	9303	66	characterized	characterize	VBN
cord-005453-4057qib7	9303	67	by	by	IN
cord-005453-4057qib7	9303	68	Nano	Nano	NNP
cord-005453-4057qib7	9303	69	-	-	HYPH
cord-005453-4057qib7	9303	70	tracking	track	VBG
cord-005453-4057qib7	9303	71	Particle	Particle	NNP
cord-005453-4057qib7	9303	72	Analysis	Analysis	NNP
cord-005453-4057qib7	9303	73	(	(	-LRB-
cord-005453-4057qib7	9303	74	Nanosight	Nanosight	NNP
cord-005453-4057qib7	9303	75	)	)	-RRB-
cord-005453-4057qib7	9303	76	.	.	.
cord-005453-4057qib7	9304	1	After	after	IN
cord-005453-4057qib7	9304	2	extraction	extraction	NN
cord-005453-4057qib7	9304	3	,	,	,
cord-005453-4057qib7	9304	4	EVs	ev	NNS
cord-005453-4057qib7	9304	5	were	be	VBD
cord-005453-4057qib7	9304	6	analyzed	analyze	VBN
cord-005453-4057qib7	9304	7	by	by	IN
cord-005453-4057qib7	9304	8	flowcytometry	flowcytometry	NN
cord-005453-4057qib7	9304	9	(	(	-LRB-
cord-005453-4057qib7	9304	10	Guava	Guava	NNP
cord-005453-4057qib7	9304	11	EasyCyte	EasyCyte	NNP
cord-005453-4057qib7	9304	12	Flow	Flow	NNP
cord-005453-4057qib7	9304	13	Cytometer	Cytometer	NNP
cord-005453-4057qib7	9304	14	)	)	-RRB-
cord-005453-4057qib7	9304	15	with	with	IN
cord-005453-4057qib7	9304	16	a	a	DT
cord-005453-4057qib7	9304	17	panel	panel	NN
cord-005453-4057qib7	9304	18	of	of	IN
cord-005453-4057qib7	9304	19	14	14	CD
cord-005453-4057qib7	9304	20	antibodies	antibody	NNS
cord-005453-4057qib7	9304	21	(	(	-LRB-
cord-005453-4057qib7	9304	22	CD44	CD44	NNP
cord-005453-4057qib7	9304	23	,	,	,
cord-005453-4057qib7	9304	24	CD138	CD138	NNP
cord-005453-4057qib7	9304	25	,	,	,
cord-005453-4057qib7	9304	26	CD146	CD146	NNP
cord-005453-4057qib7	9304	27	,	,	,
cord-005453-4057qib7	9304	28	KRT18	KRT18	NNP
cord-005453-4057qib7	9304	29	,	,	,
cord-005453-4057qib7	9304	30	CD120a	CD120a	NNP
cord-005453-4057qib7	9304	31	,	,	,
cord-005453-4057qib7	9304	32	CD8	CD8	NNP
cord-005453-4057qib7	9304	33	,	,	,
cord-005453-4057qib7	9304	34	CD30	CD30	NNP
cord-005453-4057qib7	9304	35	,	,	,
cord-005453-4057qib7	9304	36	CD106	cd106	CD
cord-005453-4057qib7	9304	37	,	,	,
cord-005453-4057qib7	9304	38	CD25	CD25	NNP
cord-005453-4057qib7	9304	39	,	,	,
cord-005453-4057qib7	9304	40	CD26	CD26	NNP
cord-005453-4057qib7	9304	41	,	,	,
cord-005453-4057qib7	9304	42	CD31	CD31	NNP
cord-005453-4057qib7	9304	43	,	,	,
cord-005453-4057qib7	9304	44	CD144	CD144	NNP
cord-005453-4057qib7	9304	45	,	,	,
cord-005453-4057qib7	9304	46	CD86	CD86	NNP
cord-005453-4057qib7	9304	47	,	,	,
cord-005453-4057qib7	9304	48	and	and	CC
cord-005453-4057qib7	9304	49	CD140a	CD140a	NNP
cord-005453-4057qib7	9304	50	)	)	-RRB-
cord-005453-4057qib7	9304	51	.	.	.
cord-005453-4057qib7	9305	1	Results	result	NNS
cord-005453-4057qib7	9305	2	:	:	:
cord-005453-4057qib7	9306	1	Thirty	thirty	CD
cord-005453-4057qib7	9306	2	-	-	HYPH
cord-005453-4057qib7	9306	3	two	two	CD
cord-005453-4057qib7	9306	4	patients	patient	NNS
cord-005453-4057qib7	9306	5	with	with	IN
cord-005453-4057qib7	9306	6	hematological	hematological	JJ
cord-005453-4057qib7	9306	7	malignancies	malignancy	NNS
cord-005453-4057qib7	9306	8	underwent	undergo	VBD
cord-005453-4057qib7	9306	9	haplo	haplo	NN
cord-005453-4057qib7	9306	10	-	-	HYPH
cord-005453-4057qib7	9306	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9306	12	between	between	IN
cord-005453-4057qib7	9306	13	2011	2011	CD
cord-005453-4057qib7	9306	14	and	and	CC
cord-005453-4057qib7	9306	15	2015	2015	CD
cord-005453-4057qib7	9306	16	.	.	.
cord-005453-4057qib7	9307	1	CMV	CMV	NNP
cord-005453-4057qib7	9307	2	reactivation	reactivation	NN
cord-005453-4057qib7	9307	3	was	be	VBD
cord-005453-4057qib7	9307	4	observed	observe	VBN
cord-005453-4057qib7	9307	5	in	in	IN
cord-005453-4057qib7	9307	6	20/32	20/32	CD
cord-005453-4057qib7	9307	7	(	(	-LRB-
cord-005453-4057qib7	9307	8	62,5	62,5	CD
cord-005453-4057qib7	9307	9	%	%	NN
cord-005453-4057qib7	9307	10	)	)	-RRB-
cord-005453-4057qib7	9307	11	and	and	CC
cord-005453-4057qib7	9307	12	occurred	occur	VBD
cord-005453-4057qib7	9307	13	at	at	IN
cord-005453-4057qib7	9307	14	a	a	DT
cord-005453-4057qib7	9307	15	median	median	NN
cord-005453-4057qib7	9307	16	of	of	IN
cord-005453-4057qib7	9307	17	50	50	CD
cord-005453-4057qib7	9307	18	(	(	-LRB-
cord-005453-4057qib7	9307	19	range	range	NN
cord-005453-4057qib7	9307	20	:	:	:
cord-005453-4057qib7	9307	21	10	10	CD
cord-005453-4057qib7	9307	22	-	-	SYM
cord-005453-4057qib7	9307	23	275	275	CD
cord-005453-4057qib7	9307	24	)	)	-RRB-
cord-005453-4057qib7	9307	25	days	day	NNS
cord-005453-4057qib7	9307	26	after	after	IN
cord-005453-4057qib7	9307	27	transplant	transplant	NN
cord-005453-4057qib7	9307	28	.	.	.
cord-005453-4057qib7	9308	1	Preliminary	preliminary	JJ
cord-005453-4057qib7	9308	2	analysis	analysis	NN
cord-005453-4057qib7	9308	3	(	(	-LRB-
cord-005453-4057qib7	9308	4	17/32	17/32	CD
cord-005453-4057qib7	9308	5	patients	patient	NNS
cord-005453-4057qib7	9308	6	)	)	-RRB-
cord-005453-4057qib7	9308	7	showed	show	VBD
cord-005453-4057qib7	9308	8	that	that	IN
cord-005453-4057qib7	9308	9	CD140a	CD140a	NNP
cord-005453-4057qib7	9308	10	fluorescence	fluorescence	NN
cord-005453-4057qib7	9308	11	(	(	-LRB-
cord-005453-4057qib7	9308	12	platelet	platelet	NN
cord-005453-4057qib7	9308	13	-	-	HYPH
cord-005453-4057qib7	9308	14	derived	derive	VBN
cord-005453-4057qib7	9308	15	growth	growth	NN
cord-005453-4057qib7	9308	16	factor	factor	NN
cord-005453-4057qib7	9308	17	receptor	receptor	NN
cord-005453-4057qib7	9308	18	-	-	HYPH
cord-005453-4057qib7	9308	19	α	α	NN
cord-005453-4057qib7	9308	20	or	or	CC
cord-005453-4057qib7	9308	21	PDGFR	PDGFR	NNP
cord-005453-4057qib7	9308	22	-	-	HYPH
cord-005453-4057qib7	9308	23	α	α	NNP
cord-005453-4057qib7	9308	24	)	)	-RRB-
cord-005453-4057qib7	9308	25	,	,	,
cord-005453-4057qib7	9308	26	CD30	CD30	NNP
cord-005453-4057qib7	9308	27	fluorescence	fluorescence	NN
cord-005453-4057qib7	9308	28	(	(	-LRB-
cord-005453-4057qib7	9308	29	Ki-1	Ki-1	NNP
cord-005453-4057qib7	9308	30	antigen	antigen	NNP
cord-005453-4057qib7	9308	31	)	)	-RRB-
cord-005453-4057qib7	9308	32	and	and	CC
cord-005453-4057qib7	9308	33	CD144	cd144	NN
cord-005453-4057qib7	9308	34	fluorescence	fluorescence	NN
cord-005453-4057qib7	9308	35	(	(	-LRB-
cord-005453-4057qib7	9308	36	VE	VE	NNP
cord-005453-4057qib7	9308	37	-	-	HYPH
cord-005453-4057qib7	9308	38	Cadherin	Cadherin	NNP
cord-005453-4057qib7	9308	39	)	)	-RRB-
cord-005453-4057qib7	9308	40	were	be	VBD
cord-005453-4057qib7	9308	41	associated	associate	VBN
cord-005453-4057qib7	9308	42	with	with	IN
cord-005453-4057qib7	9308	43	an	an	DT
cord-005453-4057qib7	9308	44	increased	increase	VBN
cord-005453-4057qib7	9308	45	risk	risk	NN
cord-005453-4057qib7	9308	46	of	of	IN
cord-005453-4057qib7	9308	47	CMV	CMV	NNP
cord-005453-4057qib7	9308	48	reactivation	reactivation	NN
cord-005453-4057qib7	9308	49	(	(	-LRB-
cord-005453-4057qib7	9308	50	OR	or	CC
cord-005453-4057qib7	9308	51	2.67	2.67	CD
cord-005453-4057qib7	9308	52	p=0.045	p=0.045	NNS
cord-005453-4057qib7	9308	53	;	;	:
cord-005453-4057qib7	9308	54	OR	or	CC
cord-005453-4057qib7	9308	55	3.11	3.11	CD
cord-005453-4057qib7	9308	56	p=0.011	p=0.011	XX
cord-005453-4057qib7	9308	57	;	;	:
cord-005453-4057qib7	9308	58	OR	or	CC
cord-005453-4057qib7	9308	59	2.37	2.37	CD
cord-005453-4057qib7	9308	60	p=0.08	p=0.08	NNP
cord-005453-4057qib7	9308	61	)	)	-RRB-
cord-005453-4057qib7	9308	62	,	,	,
cord-005453-4057qib7	9308	63	whereas	whereas	IN
cord-005453-4057qib7	9308	64	CD31	CD31	NNP
cord-005453-4057qib7	9308	65	(	(	-LRB-
cord-005453-4057qib7	9308	66	platelet	platelet	JJ
cord-005453-4057qib7	9308	67	endothelial	endothelial	JJ
cord-005453-4057qib7	9308	68	cell	cell	NN
cord-005453-4057qib7	9308	69	adhesion	adhesion	NN
cord-005453-4057qib7	9308	70	molecule	molecule	NN
cord-005453-4057qib7	9308	71	,	,	,
cord-005453-4057qib7	9308	72	PECAM-1	PECAM-1	NNP
cord-005453-4057qib7	9308	73	)	)	-RRB-
cord-005453-4057qib7	9309	1	concentration	concentration	NN
cord-005453-4057qib7	9309	2	level	level	NN
cord-005453-4057qib7	9309	3	was	be	VBD
cord-005453-4057qib7	9309	4	associated	associate	VBN
cord-005453-4057qib7	9309	5	with	with	IN
cord-005453-4057qib7	9309	6	a	a	DT
cord-005453-4057qib7	9309	7	decreased	decreased	JJ
cord-005453-4057qib7	9309	8	risk	risk	NN
cord-005453-4057qib7	9309	9	of	of	IN
cord-005453-4057qib7	9309	10	CMV	CMV	NNP
cord-005453-4057qib7	9309	11	reactivation	reactivation	NN
cord-005453-4057qib7	9309	12	(	(	-LRB-
cord-005453-4057qib7	9309	13	OR	or	CC
cord-005453-4057qib7	9309	14	0.26	0.26	CD
cord-005453-4057qib7	9309	15	,	,	,
cord-005453-4057qib7	9309	16	p=0.032	p=0.032	NNPS
cord-005453-4057qib7	9309	17	)	)	-RRB-
cord-005453-4057qib7	9309	18	.	.	.
cord-005453-4057qib7	9310	1	All	all	PDT
cord-005453-4057qib7	9310	2	these	these	DT
cord-005453-4057qib7	9310	3	biomarkers	biomarker	NNS
cord-005453-4057qib7	9310	4	showed	show	VBD
cord-005453-4057qib7	9310	5	a	a	DT
cord-005453-4057qib7	9310	6	signal	signal	NN
cord-005453-4057qib7	9310	7	change	change	NN
cord-005453-4057qib7	9310	8	before	before	IN
cord-005453-4057qib7	9310	9	CMV	CMV	NNP
cord-005453-4057qib7	9310	10	reactivation	reactivation	NN
cord-005453-4057qib7	9310	11	(	(	-LRB-
cord-005453-4057qib7	9310	12	an	an	DT
cord-005453-4057qib7	9310	13	increase	increase	NN
cord-005453-4057qib7	9310	14	with	with	IN
cord-005453-4057qib7	9310	15	CD140a	CD140a	NNP
cord-005453-4057qib7	9310	16	,	,	,
cord-005453-4057qib7	9310	17	CD30	CD30	NNP
cord-005453-4057qib7	9310	18	and	and	CC
cord-005453-4057qib7	9310	19	CD144	CD144	NNP
cord-005453-4057qib7	9310	20	,	,	,
cord-005453-4057qib7	9310	21	a	a	DT
cord-005453-4057qib7	9310	22	reduction	reduction	NN
cord-005453-4057qib7	9310	23	with	with	IN
cord-005453-4057qib7	9310	24	CD31	CD31	NNP
cord-005453-4057qib7	9310	25	)	)	-RRB-
cord-005453-4057qib7	9310	26	.	.	.
cord-005453-4057qib7	9311	1	(	(	-LRB-
cord-005453-4057qib7	9311	2	Figure	figure	NN
cord-005453-4057qib7	9311	3	1	1	CD
cord-005453-4057qib7	9311	4	)	)	-RRB-
cord-005453-4057qib7	9311	5	.	.	.
cord-005453-4057qib7	9312	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9312	2	:	:	:
cord-005453-4057qib7	9313	1	We	-PRON-	PRP
cord-005453-4057qib7	9313	2	observed	observe	VBD
cord-005453-4057qib7	9313	3	a	a	DT
cord-005453-4057qib7	9313	4	potential	potential	JJ
cord-005453-4057qib7	9313	5	association	association	NN
cord-005453-4057qib7	9313	6	of	of	IN
cord-005453-4057qib7	9313	7	4	4	CD
cord-005453-4057qib7	9313	8	EVs	evs	NN
cord-005453-4057qib7	9313	9	membrane	membrane	NN
cord-005453-4057qib7	9313	10	proteins	protein	NNS
cord-005453-4057qib7	9313	11	with	with	IN
cord-005453-4057qib7	9313	12	CMV	CMV	NNP
cord-005453-4057qib7	9313	13	reactivation	reactivation	NN
cord-005453-4057qib7	9313	14	:	:	:
cord-005453-4057qib7	9313	15	CD140a	CD140a	NNP
cord-005453-4057qib7	9313	16	,	,	,
cord-005453-4057qib7	9313	17	CD30	CD30	NNP
cord-005453-4057qib7	9313	18	,	,	,
cord-005453-4057qib7	9313	19	CD144	CD144	NNP
cord-005453-4057qib7	9313	20	and	and	CC
cord-005453-4057qib7	9313	21	CD31	CD31	NNP
cord-005453-4057qib7	9313	22	.	.	.
cord-005453-4057qib7	9314	1	These	these	DT
cord-005453-4057qib7	9314	2	proteins	protein	NNS
cord-005453-4057qib7	9314	3	are	be	VBP
cord-005453-4057qib7	9314	4	crucial	crucial	JJ
cord-005453-4057qib7	9314	5	for	for	IN
cord-005453-4057qib7	9314	6	endothelium	endothelium	NN
cord-005453-4057qib7	9314	7	and	and	CC
cord-005453-4057qib7	9314	8	immune	immune	JJ
cord-005453-4057qib7	9314	9	cells	cell	NNS
cord-005453-4057qib7	9314	10	interaction	interaction	NN
cord-005453-4057qib7	9314	11	.	.	.
cord-005453-4057qib7	9315	1	CMV	CMV	NNP
cord-005453-4057qib7	9315	2	can	can	MD
cord-005453-4057qib7	9315	3	infect	infect	VB
cord-005453-4057qib7	9315	4	different	different	JJ
cord-005453-4057qib7	9315	5	cell	cell	NN
cord-005453-4057qib7	9315	6	types	type	NNS
cord-005453-4057qib7	9315	7	including	include	VBG
cord-005453-4057qib7	9315	8	endothelial	endothelial	JJ
cord-005453-4057qib7	9315	9	cells	cell	NNS
cord-005453-4057qib7	9315	10	(	(	-LRB-
cord-005453-4057qib7	9315	11	Bentz	Bentz	NNP
cord-005453-4057qib7	9315	12	GL	GL	NNP
cord-005453-4057qib7	9315	13	.	.	.
cord-005453-4057qib7	9316	1	PNAS	PNAS	NNP
cord-005453-4057qib7	9316	2	105	105	CD
cord-005453-4057qib7	9316	3	(	(	-LRB-
cord-005453-4057qib7	9316	4	14	14	CD
cord-005453-4057qib7	9316	5	)	)	-RRB-
cord-005453-4057qib7	9316	6	2008	2008	CD
cord-005453-4057qib7	9316	7	)	)	-RRB-
cord-005453-4057qib7	9316	8	.	.	.
cord-005453-4057qib7	9317	1	Moreover	moreover	RB
cord-005453-4057qib7	9317	2	,	,	,
cord-005453-4057qib7	9317	3	CD140a	CD140a	NNP
cord-005453-4057qib7	9317	4	(	(	-LRB-
cord-005453-4057qib7	9317	5	PDGFR	PDGFR	NNP
cord-005453-4057qib7	9317	6	-	-	HYPH
cord-005453-4057qib7	9317	7	α	α	NNP
cord-005453-4057qib7	9317	8	)	)	-RRB-
cord-005453-4057qib7	9317	9	has	have	VBZ
cord-005453-4057qib7	9317	10	been	be	VBN
cord-005453-4057qib7	9317	11	shown	show	VBN
cord-005453-4057qib7	9317	12	to	to	TO
cord-005453-4057qib7	9317	13	function	function	VB
cord-005453-4057qib7	9317	14	as	as	IN
cord-005453-4057qib7	9317	15	an	an	DT
cord-005453-4057qib7	9317	16	entry	entry	NN
cord-005453-4057qib7	9317	17	receptor	receptor	NN
cord-005453-4057qib7	9317	18	for	for	IN
cord-005453-4057qib7	9317	19	CMV	CMV	NNP
cord-005453-4057qib7	9317	20	expressing	express	VBG
cord-005453-4057qib7	9318	1	gH	gH	NNP
cord-005453-4057qib7	9318	2	/	/	SYM
cord-005453-4057qib7	9318	3	gL	gL	NNP
cord-005453-4057qib7	9318	4	/	/	SYM
cord-005453-4057qib7	9318	5	gO	go	VB
cord-005453-4057qib7	9318	6	complex	complex	JJ
cord-005453-4057qib7	9319	1	(	(	-LRB-
cord-005453-4057qib7	9319	2	Wu	Wu	NNP
cord-005453-4057qib7	9319	3	Y.	Y.	NNP
cord-005453-4057qib7	9319	4	et	et	NNP
cord-005453-4057qib7	9319	5	al	al	NNP
cord-005453-4057qib7	9319	6	.	.	.
cord-005453-4057qib7	9320	1	PLoS	PLoS	NNP
cord-005453-4057qib7	9320	2	Pathog	Pathog	NNP
cord-005453-4057qib7	9320	3	13	13	CD
cord-005453-4057qib7	9320	4	(	(	-LRB-
cord-005453-4057qib7	9320	5	4	4	CD
cord-005453-4057qib7	9320	6	)	)	-RRB-
cord-005453-4057qib7	9320	7	2017	2017	CD
cord-005453-4057qib7	9320	8	)	)	-RRB-
cord-005453-4057qib7	9320	9	.	.	.
cord-005453-4057qib7	9321	1	We	-PRON-	PRP
cord-005453-4057qib7	9321	2	plan	plan	VBP
cord-005453-4057qib7	9321	3	to	to	TO
cord-005453-4057qib7	9321	4	implement	implement	VB
cord-005453-4057qib7	9321	5	our	-PRON-	PRP$
cord-005453-4057qib7	9321	6	analysis	analysis	NN
cord-005453-4057qib7	9321	7	characterizing	characterize	VBG
cord-005453-4057qib7	9321	8	EVs	EVs	NNP
cord-005453-4057qib7	9321	9	contents	content	NNS
cord-005453-4057qib7	9321	10	(	(	-LRB-
cord-005453-4057qib7	9321	11	miRNAs	miRNAs	NNP
cord-005453-4057qib7	9321	12	)	)	-RRB-
cord-005453-4057qib7	9321	13	and	and	CC
cord-005453-4057qib7	9321	14	will	will	MD
cord-005453-4057qib7	9321	15	be	be	VB
cord-005453-4057qib7	9321	16	applied	apply	VBN
cord-005453-4057qib7	9321	17	to	to	TO
cord-005453-4057qib7	9321	18	investigate	investigate	VB
cord-005453-4057qib7	9321	19	other	other	JJ
cord-005453-4057qib7	9321	20	viral	viral	JJ
cord-005453-4057qib7	9321	21	reactivations	reactivation	NNS
cord-005453-4057qib7	9321	22	(	(	-LRB-
cord-005453-4057qib7	9321	23	e.g.	e.g.	RB
cord-005453-4057qib7	9321	24	Epstein	Epstein	NNP
cord-005453-4057qib7	9321	25	Barr	Barr	NNP
cord-005453-4057qib7	9321	26	Virus	Virus	NNP
cord-005453-4057qib7	9321	27	and	and	CC
cord-005453-4057qib7	9321	28	Human	Human	NNP
cord-005453-4057qib7	9321	29	Herpes	Herpes	NNP
cord-005453-4057qib7	9321	30	Virus	Virus	NNP
cord-005453-4057qib7	9321	31	6	6	CD
cord-005453-4057qib7	9321	32	)	)	-RRB-
cord-005453-4057qib7	9321	33	.	.	.
cord-005453-4057qib7	9322	1	[	[	-LRB-
cord-005453-4057qib7	9322	2	[	[	-LRB-
cord-005453-4057qib7	9322	3	P414	P414	NNP
cord-005453-4057qib7	9322	4	Image	image	NN
cord-005453-4057qib7	9322	5	]	]	-RRB-
cord-005453-4057qib7	9322	6	1	1	CD
cord-005453-4057qib7	9322	7	.	.	.
cord-005453-4057qib7	9323	1	Methods	method	NNS
cord-005453-4057qib7	9323	2	:	:	:
cord-005453-4057qib7	9323	3	To	to	TO
cord-005453-4057qib7	9323	4	explore	explore	VB
cord-005453-4057qib7	9323	5	the	the	DT
cord-005453-4057qib7	9323	6	value	value	NN
cord-005453-4057qib7	9323	7	of	of	IN
cord-005453-4057qib7	9323	8	CMV	CMV	NNP
cord-005453-4057qib7	9323	9	DNA	DNA	NNP
cord-005453-4057qib7	9323	10	extracted	extract	VBN
cord-005453-4057qib7	9323	11	from	from	IN
cord-005453-4057qib7	9323	12	GI	GI	NNP
cord-005453-4057qib7	9323	13	tissue	tissue	NN
cord-005453-4057qib7	9323	14	for	for	IN
cord-005453-4057qib7	9323	15	the	the	DT
cord-005453-4057qib7	9323	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	9323	17	of	of	IN
cord-005453-4057qib7	9323	18	CMV	CMV	NNP
cord-005453-4057qib7	9323	19	gastroenteritis	gastroenteritis	NN
cord-005453-4057qib7	9323	20	,	,	,
cord-005453-4057qib7	9323	21	we	-PRON-	PRP
cord-005453-4057qib7	9323	22	retrospectively	retrospectively	RB
cord-005453-4057qib7	9323	23	evaluated	evaluate	VBD
cord-005453-4057qib7	9323	24	71	71	CD
cord-005453-4057qib7	9323	25	patients	patient	NNS
cord-005453-4057qib7	9323	26	,	,	,
cord-005453-4057qib7	9323	27	aged	aged	JJ
cord-005453-4057qib7	9323	28	17	17	CD
cord-005453-4057qib7	9323	29	-	-	SYM
cord-005453-4057qib7	9323	30	67	67	CD
cord-005453-4057qib7	9323	31	(	(	-LRB-
cord-005453-4057qib7	9323	32	median	median	JJ
cord-005453-4057qib7	9323	33	44.8	44.8	CD
cord-005453-4057qib7	9323	34	years	year	NNS
cord-005453-4057qib7	9323	35	)	)	-RRB-
cord-005453-4057qib7	9323	36	who	who	WP
cord-005453-4057qib7	9323	37	received	receive	VBD
cord-005453-4057qib7	9323	38	allo	allo	NN
cord-005453-4057qib7	9323	39	-	-	HYPH
cord-005453-4057qib7	9323	40	HCT	hct	NN
cord-005453-4057qib7	9323	41	from	from	IN
cord-005453-4057qib7	9323	42	sibling(26	sibling(26	NNP
cord-005453-4057qib7	9323	43	)	)	-RRB-
cord-005453-4057qib7	9323	44	,	,	,
cord-005453-4057qib7	9323	45	matched	match	VBN
cord-005453-4057qib7	9323	46	unrelated(40	unrelated(40	NNP
cord-005453-4057qib7	9323	47	)	)	-RRB-
cord-005453-4057qib7	9323	48	or	or	CC
cord-005453-4057qib7	9323	49	haploidentical	haploidentical	NNP
cord-005453-4057qib7	9323	50	donors(5	donors(5	NNP
cord-005453-4057qib7	9323	51	)	)	-RRB-
cord-005453-4057qib7	9323	52	,	,	,
cord-005453-4057qib7	9323	53	after	after	IN
cord-005453-4057qib7	9323	54	receiving	receive	VBG
cord-005453-4057qib7	9323	55	myeloablative	myeloablative	NNP
cord-005453-4057qib7	9323	56	(	(	-LRB-
cord-005453-4057qib7	9323	57	56	56	CD
cord-005453-4057qib7	9323	58	)	)	-RRB-
cord-005453-4057qib7	9323	59	or	or	CC
cord-005453-4057qib7	9323	60	reduced	reduce	VBN
cord-005453-4057qib7	9323	61	intensity	intensity	NN
cord-005453-4057qib7	9323	62	conditioning(15	conditioning(15	NNP
cord-005453-4057qib7	9323	63	)	)	-RRB-
cord-005453-4057qib7	9323	64	.	.	.
cord-005453-4057qib7	9324	1	They	-PRON-	PRP
cord-005453-4057qib7	9324	2	all	all	DT
cord-005453-4057qib7	9324	3	underwent	undergo	VBD
cord-005453-4057qib7	9324	4	endoscopy	endoscopy	NN
cord-005453-4057qib7	9324	5	for	for	IN
cord-005453-4057qib7	9324	6	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	9324	7	symptoms	symptom	NNS
cord-005453-4057qib7	9324	8	between	between	IN
cord-005453-4057qib7	9324	9	2012	2012	CD
cord-005453-4057qib7	9324	10	-	-	SYM
cord-005453-4057qib7	9324	11	2018	2018	CD
cord-005453-4057qib7	9324	12	.	.	.
cord-005453-4057qib7	9325	1	CMV	CMV	NNP
cord-005453-4057qib7	9325	2	DNA	DNA	NNP
cord-005453-4057qib7	9325	3	from	from	IN
cord-005453-4057qib7	9325	4	tissue	tissue	NN
cord-005453-4057qib7	9325	5	samples	sample	NNS
cord-005453-4057qib7	9325	6	and	and	CC
cord-005453-4057qib7	9325	7	parallel	parallel	JJ
cord-005453-4057qib7	9325	8	blood	blood	NN
cord-005453-4057qib7	9325	9	samples	sample	NNS
cord-005453-4057qib7	9325	10	were	be	VBD
cord-005453-4057qib7	9325	11	measured	measure	VBN
cord-005453-4057qib7	9325	12	by	by	IN
cord-005453-4057qib7	9325	13	Q	Q	NNP
cord-005453-4057qib7	9325	14	-	-	HYPH
cord-005453-4057qib7	9325	15	PCR	PCR	NNP
cord-005453-4057qib7	9325	16	.	.	.
cord-005453-4057qib7	9326	1	Positive	positive	JJ
cord-005453-4057qib7	9326	2	CMV	CMV	NNP
cord-005453-4057qib7	9326	3	DNA	dna	NN
cord-005453-4057qib7	9326	4	on	on	IN
cord-005453-4057qib7	9326	5	the	the	DT
cord-005453-4057qib7	9326	6	tissue	tissue	NN
cord-005453-4057qib7	9326	7	was	be	VBD
cord-005453-4057qib7	9326	8	considered	consider	VBN
cord-005453-4057qib7	9326	9	CMV	CMV	NNP
cord-005453-4057qib7	9326	10	GI	GI	NNP
cord-005453-4057qib7	9326	11	infection	infection	NN
cord-005453-4057qib7	9326	12	.	.	.
cord-005453-4057qib7	9327	1	CMV	CMV	NNP
cord-005453-4057qib7	9327	2	GI	GI	NNP
cord-005453-4057qib7	9327	3	disease	disease	NN
cord-005453-4057qib7	9327	4	was	be	VBD
cord-005453-4057qib7	9327	5	proven	prove	VBN
cord-005453-4057qib7	9327	6	with	with	IN
cord-005453-4057qib7	9327	7	the	the	DT
cord-005453-4057qib7	9327	8	identification	identification	NN
cord-005453-4057qib7	9327	9	of	of	IN
cord-005453-4057qib7	9327	10	CMV	CMV	NNP
cord-005453-4057qib7	9327	11	inclusion	inclusion	NN
cord-005453-4057qib7	9327	12	bodies	body	NNS
cord-005453-4057qib7	9327	13	or	or	CC
cord-005453-4057qib7	9327	14	positive	positive	JJ
cord-005453-4057qib7	9327	15	immunehistochemical	immunehistochemical	JJ
cord-005453-4057qib7	9327	16	staining	staining	NN
cord-005453-4057qib7	9327	17	using	use	VBG
cord-005453-4057qib7	9327	18	anti	anti	JJ
cord-005453-4057qib7	9327	19	-	-	JJ
cord-005453-4057qib7	9327	20	CMV	CMV	NNP
cord-005453-4057qib7	9327	21	antibodies	antibody	NNS
cord-005453-4057qib7	9327	22	.	.	.
cord-005453-4057qib7	9328	1	Results	result	NNS
cord-005453-4057qib7	9328	2	:	:	:
cord-005453-4057qib7	9329	1	Overall	overall	RB
cord-005453-4057qib7	9329	2	,	,	,
cord-005453-4057qib7	9329	3	91	91	CD
cord-005453-4057qib7	9329	4	endoscopic	endoscopic	JJ
cord-005453-4057qib7	9329	5	tests	test	NNS
cord-005453-4057qib7	9329	6	were	be	VBD
cord-005453-4057qib7	9329	7	performed	perform	VBN
cord-005453-4057qib7	9329	8	(	(	-LRB-
cord-005453-4057qib7	9329	9	55	55	CD
cord-005453-4057qib7	9329	10	gastro-,36	gastro-,36	CD
cord-005453-4057qib7	9329	11	colonoscopies	colonoscopy	NNS
cord-005453-4057qib7	9329	12	)	)	-RRB-
cord-005453-4057qib7	9329	13	at	at	IN
cord-005453-4057qib7	9329	14	a	a	DT
cord-005453-4057qib7	9329	15	median	median	NN
cord-005453-4057qib7	9329	16	of	of	IN
cord-005453-4057qib7	9329	17	73	73	CD
cord-005453-4057qib7	9329	18	days	day	NNS
cord-005453-4057qib7	9329	19	(	(	-LRB-
cord-005453-4057qib7	9329	20	IQR:145	IQR:145	NNP
cord-005453-4057qib7	9329	21	)	)	-RRB-
cord-005453-4057qib7	9329	22	post	post	NN
cord-005453-4057qib7	9329	23	transplantation	transplantation	NN
cord-005453-4057qib7	9329	24	.	.	.
cord-005453-4057qib7	9330	1	Symptoms	symptom	NNS
cord-005453-4057qib7	9330	2	included	include	VBD
cord-005453-4057qib7	9330	3	nausea	nausea	NN
cord-005453-4057qib7	9330	4	,	,	,
cord-005453-4057qib7	9330	5	vomiting	vomiting	NN
cord-005453-4057qib7	9330	6	,	,	,
cord-005453-4057qib7	9330	7	diarrhea	diarrhea	NN
cord-005453-4057qib7	9330	8	,	,	,
cord-005453-4057qib7	9330	9	abdominal	abdominal	JJ
cord-005453-4057qib7	9330	10	pain	pain	NN
cord-005453-4057qib7	9330	11	and	and	CC
cord-005453-4057qib7	9330	12	weight	weight	NN
cord-005453-4057qib7	9330	13	loss	loss	NN
cord-005453-4057qib7	9330	14	.	.	.
cord-005453-4057qib7	9331	1	CMV	CMV	NNP
cord-005453-4057qib7	9331	2	DNA	DNA	NNP
cord-005453-4057qib7	9331	3	was	be	VBD
cord-005453-4057qib7	9331	4	positive	positive	JJ
cord-005453-4057qib7	9331	5	in	in	IN
cord-005453-4057qib7	9331	6	41/91	41/91	CD
cord-005453-4057qib7	9331	7	tissue	tissue	NN
cord-005453-4057qib7	9331	8	samples	sample	NNS
cord-005453-4057qib7	9331	9	:	:	:
cord-005453-4057qib7	9332	1	median	median	JJ
cord-005453-4057qib7	9332	2	536	536	CD
cord-005453-4057qib7	9332	3	copies	copy	NNS
cord-005453-4057qib7	9332	4	/	/	SYM
cord-005453-4057qib7	9332	5	ml	ml	NN
cord-005453-4057qib7	9332	6	,	,	,
cord-005453-4057qib7	9332	7	range	range	NN
cord-005453-4057qib7	9332	8	:	:	:
cord-005453-4057qib7	9332	9	11	11	CD
cord-005453-4057qib7	9332	10	-	-	HYPH
cord-005453-4057qib7	9332	11	131x10	131x10	CD
cord-005453-4057qib7	9332	12	^	^	SYM
cord-005453-4057qib7	9332	13	6	6	CD
cord-005453-4057qib7	9332	14	.	.	.
cord-005453-4057qib7	9333	1	Only	only	RB
cord-005453-4057qib7	9333	2	half	half	JJ
cord-005453-4057qib7	9333	3	patients	patient	NNS
cord-005453-4057qib7	9333	4	(	(	-LRB-
cord-005453-4057qib7	9333	5	22/41	22/41	CD
cord-005453-4057qib7	9333	6	)	)	-RRB-
cord-005453-4057qib7	9333	7	had	have	VBD
cord-005453-4057qib7	9333	8	concurrent	concurrent	JJ
cord-005453-4057qib7	9333	9	CMV	CMV	NNP
cord-005453-4057qib7	9333	10	viremia	viremia	NN
cord-005453-4057qib7	9333	11	(	(	-LRB-
cord-005453-4057qib7	9333	12	plasma	plasma	NN
cord-005453-4057qib7	9333	13	viral	viral	JJ
cord-005453-4057qib7	9333	14	load>100c	load>100c	NNP
cord-005453-4057qib7	9333	15	/	/	SYM
cord-005453-4057qib7	9333	16	ml	ml	NN
cord-005453-4057qib7	9333	17	)	)	-RRB-
cord-005453-4057qib7	9333	18	.	.	.
cord-005453-4057qib7	9334	1	CMV	CMV	NNP
cord-005453-4057qib7	9334	2	GI	GI	NNP
cord-005453-4057qib7	9334	3	infection	infection	NN
cord-005453-4057qib7	9334	4	was	be	VBD
cord-005453-4057qib7	9334	5	not	not	RB
cord-005453-4057qib7	9334	6	correlated	correlate	VBN
cord-005453-4057qib7	9334	7	to	to	IN
cord-005453-4057qib7	9334	8	the	the	DT
cord-005453-4057qib7	9334	9	type	type	NN
cord-005453-4057qib7	9334	10	of	of	IN
cord-005453-4057qib7	9334	11	transplant	transplant	NN
cord-005453-4057qib7	9334	12	,	,	,
cord-005453-4057qib7	9334	13	acute	acute	JJ
cord-005453-4057qib7	9334	14	or	or	CC
cord-005453-4057qib7	9334	15	chronic	chronic	JJ
cord-005453-4057qib7	9334	16	GvHD	gvhd	NN
cord-005453-4057qib7	9334	17	.	.	.
cord-005453-4057qib7	9335	1	GI	GI	NNP
cord-005453-4057qib7	9335	2	CMV	CMV	NNP
cord-005453-4057qib7	9335	3	disease	disease	NN
cord-005453-4057qib7	9335	4	was	be	VBD
cord-005453-4057qib7	9335	5	documented	document	VBN
cord-005453-4057qib7	9335	6	by	by	IN
cord-005453-4057qib7	9335	7	biopsy	biopsy	NN
cord-005453-4057qib7	9335	8	in	in	IN
cord-005453-4057qib7	9335	9	13	13	CD
cord-005453-4057qib7	9335	10	patients	patient	NNS
cord-005453-4057qib7	9335	11	.	.	.
cord-005453-4057qib7	9336	1	CMV	CMV	NNP
cord-005453-4057qib7	9336	2	DNA	DNA	NNP
cord-005453-4057qib7	9336	3	of	of	IN
cord-005453-4057qib7	9336	4	the	the	DT
cord-005453-4057qib7	9336	5	tissue	tissue	NN
cord-005453-4057qib7	9336	6	,	,	,
cord-005453-4057qib7	9336	7	but	but	CC
cord-005453-4057qib7	9336	8	not	not	RB
cord-005453-4057qib7	9336	9	the	the	DT
cord-005453-4057qib7	9336	10	plasma	plasma	NN
cord-005453-4057qib7	9336	11	viral	viral	JJ
cord-005453-4057qib7	9336	12	load	load	NN
cord-005453-4057qib7	9336	13	,	,	,
cord-005453-4057qib7	9336	14	was	be	VBD
cord-005453-4057qib7	9336	15	a	a	DT
cord-005453-4057qib7	9336	16	predictor	predictor	NN
cord-005453-4057qib7	9336	17	of	of	IN
cord-005453-4057qib7	9336	18	biopsy	biopsy	NN
cord-005453-4057qib7	9336	19	positivity	positivity	NN
cord-005453-4057qib7	9336	20	(	(	-LRB-
cord-005453-4057qib7	9336	21	OR	or	NN
cord-005453-4057qib7	9336	22	:	:	:
cord-005453-4057qib7	9336	23	1.6	1.6	CD
cord-005453-4057qib7	9336	24	,	,	,
cord-005453-4057qib7	9336	25	95%CI	95%ci	CD
cord-005453-4057qib7	9336	26	:	:	SYM
cord-005453-4057qib7	9336	27	1.1	1.1	CD
cord-005453-4057qib7	9336	28	-	-	SYM
cord-005453-4057qib7	9336	29	1.8	1.8	CD
cord-005453-4057qib7	9336	30	,	,	,
cord-005453-4057qib7	9336	31	p=0.006	p=0.006	NNS
cord-005453-4057qib7	9336	32	)	)	-RRB-
cord-005453-4057qib7	9336	33	.	.	.
cord-005453-4057qib7	9337	1	Thirty	thirty	CD
cord-005453-4057qib7	9337	2	-	-	HYPH
cord-005453-4057qib7	9337	3	six	six	CD
cord-005453-4057qib7	9337	4	out	out	IN
cord-005453-4057qib7	9337	5	of	of	IN
cord-005453-4057qib7	9337	6	41	41	CD
cord-005453-4057qib7	9337	7	CMV	CMV	NNP
cord-005453-4057qib7	9337	8	DNA	DNA	NNP
cord-005453-4057qib7	9337	9	positive	positive	JJ
cord-005453-4057qib7	9337	10	patients	patient	NNS
cord-005453-4057qib7	9337	11	received	receive	VBD
cord-005453-4057qib7	9337	12	specific	specific	JJ
cord-005453-4057qib7	9337	13	treatment	treatment	NN
cord-005453-4057qib7	9337	14	for	for	IN
cord-005453-4057qib7	9337	15	at	at	RB
cord-005453-4057qib7	9337	16	least	least	RBS
cord-005453-4057qib7	9337	17	10	10	CD
cord-005453-4057qib7	9337	18	days	day	NNS
cord-005453-4057qib7	9337	19	.	.	.
cord-005453-4057qib7	9338	1	Symptoms	symptom	NNS
cord-005453-4057qib7	9338	2	resolved	resolve	VBD
cord-005453-4057qib7	9338	3	in	in	IN
cord-005453-4057qib7	9338	4	21/36	21/36	CD
cord-005453-4057qib7	9338	5	patients	patient	NNS
cord-005453-4057qib7	9338	6	(	(	-LRB-
cord-005453-4057qib7	9338	7	60	60	CD
cord-005453-4057qib7	9338	8	%	%	NN
cord-005453-4057qib7	9338	9	)	)	-RRB-
cord-005453-4057qib7	9338	10	and	and	CC
cord-005453-4057qib7	9338	11	the	the	DT
cord-005453-4057qib7	9338	12	GI	GI	NNP
cord-005453-4057qib7	9338	13	viral	viral	JJ
cord-005453-4057qib7	9338	14	load	load	NN
cord-005453-4057qib7	9338	15	was	be	VBD
cord-005453-4057qib7	9338	16	not	not	RB
cord-005453-4057qib7	9338	17	a	a	DT
cord-005453-4057qib7	9338	18	significant	significant	JJ
cord-005453-4057qib7	9338	19	factor	factor	NN
cord-005453-4057qib7	9338	20	to	to	TO
cord-005453-4057qib7	9338	21	predict	predict	VB
cord-005453-4057qib7	9338	22	cure	cure	NN
cord-005453-4057qib7	9338	23	.	.	.
cord-005453-4057qib7	9339	1	GI	GI	NNP
cord-005453-4057qib7	9339	2	GvHD	GvHD	NNP
cord-005453-4057qib7	9339	3	was	be	VBD
cord-005453-4057qib7	9339	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	9339	5	in	in	IN
cord-005453-4057qib7	9339	6	42/91	42/91	CD
cord-005453-4057qib7	9339	7	patients	patient	NNS
cord-005453-4057qib7	9339	8	,	,	,
cord-005453-4057qib7	9339	9	among	among	IN
cord-005453-4057qib7	9339	10	which	which	WDT
cord-005453-4057qib7	9339	11	45%(19/42	45%(19/42	CD
cord-005453-4057qib7	9339	12	)	)	-RRB-
cord-005453-4057qib7	9339	13	with	with	IN
cord-005453-4057qib7	9339	14	CMV	CMV	NNP
cord-005453-4057qib7	9339	15	DNA	dna	NN
cord-005453-4057qib7	9339	16	positivity	positivity	NN
cord-005453-4057qib7	9339	17	.	.	.
cord-005453-4057qib7	9340	1	Median	median	JJ
cord-005453-4057qib7	9340	2	OS	OS	NNP
cord-005453-4057qib7	9340	3	was	be	VBD
cord-005453-4057qib7	9340	4	453	453	CD
cord-005453-4057qib7	9340	5	days	day	NNS
cord-005453-4057qib7	9340	6	(	(	-LRB-
cord-005453-4057qib7	9340	7	95%CI	95%ci	CD
cord-005453-4057qib7	9340	8	:	:	:
cord-005453-4057qib7	9340	9	297	297	CD
cord-005453-4057qib7	9340	10	-	-	SYM
cord-005453-4057qib7	9340	11	608	608	CD
cord-005453-4057qib7	9340	12	)	)	-RRB-
cord-005453-4057qib7	9340	13	for	for	IN
cord-005453-4057qib7	9340	14	patients	patient	NNS
cord-005453-4057qib7	9340	15	with	with	IN
cord-005453-4057qib7	9340	16	CMV	CMV	NNP
cord-005453-4057qib7	9340	17	infection	infection	NN
cord-005453-4057qib7	9340	18	,	,	,
cord-005453-4057qib7	9340	19	similar	similar	JJ
cord-005453-4057qib7	9340	20	to	to	IN
cord-005453-4057qib7	9340	21	those	those	DT
cord-005453-4057qib7	9340	22	without	without	IN
cord-005453-4057qib7	9340	23	(	(	-LRB-
cord-005453-4057qib7	9340	24	median	median	JJ
cord-005453-4057qib7	9340	25	OS	os	NN
cord-005453-4057qib7	9340	26	:	:	:
cord-005453-4057qib7	9340	27	890	890	CD
cord-005453-4057qib7	9340	28	,	,	,
cord-005453-4057qib7	9340	29	95%CI	95%ci	CD
cord-005453-4057qib7	9340	30	:	:	:
cord-005453-4057qib7	9340	31	80	80	CD
cord-005453-4057qib7	9340	32	-	-	SYM
cord-005453-4057qib7	9340	33	1699	1699	CD
cord-005453-4057qib7	9340	34	days	day	NNS
cord-005453-4057qib7	9340	35	,	,	,
cord-005453-4057qib7	9340	36	p	p	NN
cord-005453-4057qib7	9340	37	=	=	SYM
cord-005453-4057qib7	9340	38	ns	ns	NNP
cord-005453-4057qib7	9340	39	)	)	-RRB-
cord-005453-4057qib7	9340	40	.	.	.
cord-005453-4057qib7	9341	1	We	-PRON-	PRP
cord-005453-4057qib7	9341	2	studied	study	VBD
cord-005453-4057qib7	9341	3	separately	separately	RB
cord-005453-4057qib7	9341	4	endoscopies	endoscopy	NNS
cord-005453-4057qib7	9341	5	of	of	IN
cord-005453-4057qib7	9341	6	the	the	DT
cord-005453-4057qib7	9341	7	upper	upper	JJ
cord-005453-4057qib7	9341	8	(	(	-LRB-
cord-005453-4057qib7	9341	9	55/91	55/91	CD
cord-005453-4057qib7	9341	10	)	)	-RRB-
cord-005453-4057qib7	9341	11	or	or	CC
cord-005453-4057qib7	9341	12	lower	low	JJR
cord-005453-4057qib7	9341	13	GI	GI	NNP
cord-005453-4057qib7	9341	14	tract	tract	NN
cord-005453-4057qib7	9341	15	(	(	-LRB-
cord-005453-4057qib7	9341	16	36/91	36/91	CD
cord-005453-4057qib7	9341	17	)	)	-RRB-
cord-005453-4057qib7	9341	18	.	.	.
cord-005453-4057qib7	9342	1	There	there	EX
cord-005453-4057qib7	9342	2	was	be	VBD
cord-005453-4057qib7	9342	3	no	no	DT
cord-005453-4057qib7	9342	4	significant	significant	JJ
cord-005453-4057qib7	9342	5	relationship	relationship	NN
cord-005453-4057qib7	9342	6	between	between	IN
cord-005453-4057qib7	9342	7	CMV	CMV	NNP
cord-005453-4057qib7	9342	8	gastritis	gastritis	NN
cord-005453-4057qib7	9342	9	proven	prove	VBN
cord-005453-4057qib7	9342	10	by	by	IN
cord-005453-4057qib7	9342	11	biopsy	biopsy	NN
cord-005453-4057qib7	9342	12	and	and	CC
cord-005453-4057qib7	9342	13	CMV	CMV	NNP
cord-005453-4057qib7	9342	14	DNA	DNA	NNP
cord-005453-4057qib7	9342	15	levels	level	NNS
cord-005453-4057qib7	9342	16	in	in	IN
cord-005453-4057qib7	9342	17	gastric	gastric	JJ
cord-005453-4057qib7	9342	18	tissue	tissue	NN
cord-005453-4057qib7	9342	19	.	.	.
cord-005453-4057qib7	9343	1	However	however	RB
cord-005453-4057qib7	9343	2	,	,	,
cord-005453-4057qib7	9343	3	the	the	DT
cord-005453-4057qib7	9343	4	viral	viral	JJ
cord-005453-4057qib7	9343	5	load	load	NN
cord-005453-4057qib7	9343	6	of	of	IN
cord-005453-4057qib7	9343	7	the	the	DT
cord-005453-4057qib7	9343	8	colon	colon	NN
cord-005453-4057qib7	9343	9	was	be	VBD
cord-005453-4057qib7	9343	10	a	a	DT
cord-005453-4057qib7	9343	11	predictor	predictor	NN
cord-005453-4057qib7	9343	12	of	of	IN
cord-005453-4057qib7	9343	13	CMV	CMV	NNP
cord-005453-4057qib7	9343	14	enteritis	enteritis	NN
cord-005453-4057qib7	9343	15	(	(	-LRB-
cord-005453-4057qib7	9343	16	OR	or	NN
cord-005453-4057qib7	9343	17	:	:	:
cord-005453-4057qib7	9343	18	1.9	1.9	CD
cord-005453-4057qib7	9343	19	,	,	,
cord-005453-4057qib7	9343	20	95%CI	95%ci	CD
cord-005453-4057qib7	9343	21	:	:	:
cord-005453-4057qib7	9343	22	1.9	1.9	CD
cord-005453-4057qib7	9343	23	-	-	SYM
cord-005453-4057qib7	9343	24	3	3	CD
cord-005453-4057qib7	9343	25	,	,	,
cord-005453-4057qib7	9343	26	p=0.007	p=0.007	NNP
cord-005453-4057qib7	9343	27	)	)	-RRB-
cord-005453-4057qib7	9343	28	.	.	.
cord-005453-4057qib7	9344	1	The	the	DT
cord-005453-4057qib7	9344	2	AUROC	AUROC	NNP
cord-005453-4057qib7	9344	3	of	of	IN
cord-005453-4057qib7	9344	4	the	the	DT
cord-005453-4057qib7	9344	5	Q	Q	NNP
cord-005453-4057qib7	9344	6	-	-	HYPH
cord-005453-4057qib7	9344	7	PCR	PCR	NNP
cord-005453-4057qib7	9344	8	was	be	VBD
cord-005453-4057qib7	9344	9	0.849	0.849	CD
cord-005453-4057qib7	9345	1	(	(	-LRB-
cord-005453-4057qib7	9345	2	95%CI	95%ci	CD
cord-005453-4057qib7	9345	3	:	:	:
cord-005453-4057qib7	9345	4	0.659	0.659	CD
cord-005453-4057qib7	9345	5	to	to	IN
cord-005453-4057qib7	9345	6	1	1	CD
cord-005453-4057qib7	9345	7	)	)	-RRB-
cord-005453-4057qib7	9345	8	,	,	,
cord-005453-4057qib7	9345	9	the	the	DT
cord-005453-4057qib7	9345	10	sensitivity	sensitivity	NN
cord-005453-4057qib7	9345	11	was	be	VBD
cord-005453-4057qib7	9345	12	85.7	85.7	CD
cord-005453-4057qib7	9345	13	%	%	NN
cord-005453-4057qib7	9345	14	and	and	CC
cord-005453-4057qib7	9345	15	the	the	DT
cord-005453-4057qib7	9345	16	specificity	specificity	NN
cord-005453-4057qib7	9345	17	was	be	VBD
cord-005453-4057qib7	9345	18	78.6	78.6	CD
cord-005453-4057qib7	9345	19	%	%	NN
cord-005453-4057qib7	9345	20	with	with	IN
cord-005453-4057qib7	9345	21	a	a	DT
cord-005453-4057qib7	9345	22	cutoff	cutoff	NN
cord-005453-4057qib7	9345	23	value	value	NN
cord-005453-4057qib7	9345	24	of	of	IN
cord-005453-4057qib7	9345	25	370	370	CD
cord-005453-4057qib7	9345	26	copies	copy	NNS
cord-005453-4057qib7	9345	27	/	/	SYM
cord-005453-4057qib7	9345	28	ml	ml	NN
cord-005453-4057qib7	9345	29	DNA	dna	NN
cord-005453-4057qib7	9345	30	.	.	.
cord-005453-4057qib7	9346	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9346	2	:	:	:
cord-005453-4057qib7	9347	1	Pathognomonic	Pathognomonic	NNP
cord-005453-4057qib7	9347	2	findings	finding	NNS
cord-005453-4057qib7	9347	3	in	in	IN
cord-005453-4057qib7	9347	4	the	the	DT
cord-005453-4057qib7	9347	5	biopsy	biopsy	NN
cord-005453-4057qib7	9347	6	remain	remain	VBP
cord-005453-4057qib7	9347	7	the	the	DT
cord-005453-4057qib7	9347	8	gold	gold	NN
cord-005453-4057qib7	9347	9	standard	standard	NN
cord-005453-4057qib7	9347	10	for	for	IN
cord-005453-4057qib7	9347	11	the	the	DT
cord-005453-4057qib7	9347	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	9347	13	,	,	,
cord-005453-4057qib7	9347	14	especially	especially	RB
cord-005453-4057qib7	9347	15	for	for	IN
cord-005453-4057qib7	9347	16	the	the	DT
cord-005453-4057qib7	9347	17	upper	upper	JJ
cord-005453-4057qib7	9347	18	GI	GI	NNP
cord-005453-4057qib7	9347	19	tract	tract	NN
cord-005453-4057qib7	9347	20	.	.	.
cord-005453-4057qib7	9348	1	However	however	RB
cord-005453-4057qib7	9348	2	,	,	,
cord-005453-4057qib7	9348	3	when	when	WRB
cord-005453-4057qib7	9348	4	the	the	DT
cord-005453-4057qib7	9348	5	lower	low	JJR
cord-005453-4057qib7	9348	6	GI	GI	NNP
cord-005453-4057qib7	9348	7	tract	tract	NN
cord-005453-4057qib7	9348	8	is	be	VBZ
cord-005453-4057qib7	9348	9	involved	involve	VBN
cord-005453-4057qib7	9348	10	,	,	,
cord-005453-4057qib7	9348	11	quantification	quantification	NN
cord-005453-4057qib7	9348	12	of	of	IN
cord-005453-4057qib7	9348	13	CMV	CMV	NNP
cord-005453-4057qib7	9348	14	viral	viral	JJ
cord-005453-4057qib7	9348	15	load	load	NN
cord-005453-4057qib7	9348	16	in	in	IN
cord-005453-4057qib7	9348	17	the	the	DT
cord-005453-4057qib7	9348	18	tissue	tissue	NN
cord-005453-4057qib7	9348	19	may	may	MD
cord-005453-4057qib7	9348	20	be	be	VB
cord-005453-4057qib7	9348	21	a	a	DT
cord-005453-4057qib7	9348	22	valuable	valuable	JJ
cord-005453-4057qib7	9348	23	tool	tool	NN
cord-005453-4057qib7	9348	24	to	to	TO
cord-005453-4057qib7	9348	25	support	support	VB
cord-005453-4057qib7	9348	26	the	the	DT
cord-005453-4057qib7	9348	27	diagnosis	diagnosis	NN
cord-005453-4057qib7	9348	28	.	.	.
cord-005453-4057qib7	9349	1	Positivity	positivity	NN
cord-005453-4057qib7	9349	2	of	of	IN
cord-005453-4057qib7	9349	3	CMV	CMV	NNP
cord-005453-4057qib7	9349	4	DNA	DNA	NNP
cord-005453-4057qib7	9349	5	of	of	IN
cord-005453-4057qib7	9349	6	the	the	DT
cord-005453-4057qib7	9349	7	GI	GI	NNP
cord-005453-4057qib7	9349	8	tissue	tissue	NN
cord-005453-4057qib7	9349	9	,	,	,
cord-005453-4057qib7	9349	10	in	in	IN
cord-005453-4057qib7	9349	11	linearity	linearity	NN
cord-005453-4057qib7	9349	12	to	to	IN
cord-005453-4057qib7	9349	13	the	the	DT
cord-005453-4057qib7	9349	14	CMV	CMV	NNP
cord-005453-4057qib7	9349	15	viremia	viremia	NN
cord-005453-4057qib7	9349	16	,	,	,
cord-005453-4057qib7	9349	17	may	may	MD
cord-005453-4057qib7	9349	18	guide	guide	VB
cord-005453-4057qib7	9349	19	to	to	IN
cord-005453-4057qib7	9349	20	preemptive	preemptive	JJ
cord-005453-4057qib7	9349	21	treatment	treatment	NN
cord-005453-4057qib7	9349	22	for	for	IN
cord-005453-4057qib7	9349	23	prevention	prevention	NN
cord-005453-4057qib7	9349	24	of	of	IN
cord-005453-4057qib7	9349	25	CMV	CMV	NNP
cord-005453-4057qib7	9349	26	disease	disease	NN
cord-005453-4057qib7	9349	27	.	.	.
cord-005453-4057qib7	9350	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9350	2	:	:	:
cord-005453-4057qib7	9350	3	Nothing	nothing	NN
cord-005453-4057qib7	9350	4	to	to	TO
cord-005453-4057qib7	9350	5	declare	declare	VB
cord-005453-4057qib7	9350	6	Background	background	NN
cord-005453-4057qib7	9350	7	:	:	:
cord-005453-4057qib7	9350	8	Clostridium	clostridium	NN
cord-005453-4057qib7	9350	9	difficile	difficile	NN
cord-005453-4057qib7	9350	10	infection	infection	NN
cord-005453-4057qib7	9350	11	(	(	-LRB-
cord-005453-4057qib7	9350	12	CDI	CDI	NNP
cord-005453-4057qib7	9350	13	)	)	-RRB-
cord-005453-4057qib7	9350	14	is	be	VBZ
cord-005453-4057qib7	9350	15	caused	cause	VBN
cord-005453-4057qib7	9350	16	by	by	IN
cord-005453-4057qib7	9350	17	CD	cd	NN
cord-005453-4057qib7	9350	18	overgrowth	overgrowth	NN
cord-005453-4057qib7	9350	19	in	in	IN
cord-005453-4057qib7	9350	20	antibiotic	antibiotic	JJ
cord-005453-4057qib7	9350	21	-	-	HYPH
cord-005453-4057qib7	9350	22	disturbed	disturbed	JJ
cord-005453-4057qib7	9350	23	intestinal	intestinal	JJ
cord-005453-4057qib7	9350	24	microbiota	microbiota	NN
cord-005453-4057qib7	9350	25	.	.	.
cord-005453-4057qib7	9351	1	Antibiotics	antibiotic	NNS
cord-005453-4057qib7	9351	2	targeting	target	VBG
cord-005453-4057qib7	9351	3	unselectively	unselectively	RB
cord-005453-4057qib7	9351	4	beneficial	beneficial	JJ
cord-005453-4057qib7	9351	5	for	for	IN
cord-005453-4057qib7	9351	6	T	t	NN
cord-005453-4057qib7	9351	7	-	-	HYPH
cord-005453-4057qib7	9351	8	regulatory	regulatory	JJ
cord-005453-4057qib7	9351	9	cell	cell	NN
cord-005453-4057qib7	9351	10	formation	formation	NN
cord-005453-4057qib7	9351	11	strains	strain	NNS
cord-005453-4057qib7	9351	12	of	of	IN
cord-005453-4057qib7	9351	13	Clostridiales	Clostridiales	NNP
cord-005453-4057qib7	9351	14	may	may	MD
cord-005453-4057qib7	9351	15	increase	increase	VB
cord-005453-4057qib7	9351	16	pro	pro	JJ
cord-005453-4057qib7	9351	17	-	-	JJ
cord-005453-4057qib7	9351	18	inflammatory	inflammatory	JJ
cord-005453-4057qib7	9351	19	processes	process	NNS
cord-005453-4057qib7	9351	20	in	in	IN
cord-005453-4057qib7	9351	21	the	the	DT
cord-005453-4057qib7	9351	22	guts	gut	NNS
cord-005453-4057qib7	9351	23	promoting	promote	VBG
cord-005453-4057qib7	9351	24	or	or	CC
cord-005453-4057qib7	9351	25	augmenting	augment	VBG
cord-005453-4057qib7	9351	26	the	the	DT
cord-005453-4057qib7	9351	27	development	development	NN
cord-005453-4057qib7	9351	28	of	of	IN
cord-005453-4057qib7	9351	29	graft	graft	NN
cord-005453-4057qib7	9351	30	vs.	vs.	FW
cord-005453-4057qib7	9351	31	host	host	NN
cord-005453-4057qib7	9351	32	disease	disease	NN
cord-005453-4057qib7	9351	33	(	(	-LRB-
cord-005453-4057qib7	9351	34	GVHD	GVHD	NNP
cord-005453-4057qib7	9351	35	)	)	-RRB-
cord-005453-4057qib7	9351	36	.	.	.
cord-005453-4057qib7	9352	1	The	the	DT
cord-005453-4057qib7	9352	2	efficacy	efficacy	NN
cord-005453-4057qib7	9352	3	of	of	IN
cord-005453-4057qib7	9352	4	CDI	CDI	NNP
cord-005453-4057qib7	9352	5	treatment	treatment	NN
cord-005453-4057qib7	9352	6	has	have	VBZ
cord-005453-4057qib7	9352	7	impact	impact	NN
cord-005453-4057qib7	9352	8	on	on	IN
cord-005453-4057qib7	9352	9	the	the	DT
cord-005453-4057qib7	9352	10	persistence	persistence	NN
cord-005453-4057qib7	9352	11	of	of	IN
cord-005453-4057qib7	9352	12	inflammation	inflammation	NN
cord-005453-4057qib7	9352	13	which	which	WDT
cord-005453-4057qib7	9352	14	might	may	MD
cord-005453-4057qib7	9352	15	influence	influence	VB
cord-005453-4057qib7	9352	16	the	the	DT
cord-005453-4057qib7	9352	17	alloreactive	alloreactive	JJ
cord-005453-4057qib7	9352	18	reactions	reaction	NNS
cord-005453-4057qib7	9352	19	.	.	.
cord-005453-4057qib7	9353	1	Methods	method	NNS
cord-005453-4057qib7	9353	2	:	:	:
cord-005453-4057qib7	9353	3	We	-PRON-	PRP
cord-005453-4057qib7	9353	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	9353	5	and	and	CC
cord-005453-4057qib7	9353	6	,	,	,
cord-005453-4057qib7	9353	7	from	from	IN
cord-005453-4057qib7	9353	8	2016	2016	CD
cord-005453-4057qib7	9353	9	,	,	,
cord-005453-4057qib7	9353	10	prospectively	prospectively	RB
cord-005453-4057qib7	9353	11	analyzed	analyze	VBD
cord-005453-4057qib7	9353	12	the	the	DT
cord-005453-4057qib7	9353	13	data	datum	NNS
cord-005453-4057qib7	9353	14	from	from	IN
cord-005453-4057qib7	9353	15	5	5	CD
cord-005453-4057qib7	9353	16	transplant	transplant	NN
cord-005453-4057qib7	9353	17	centers	center	NNS
cord-005453-4057qib7	9353	18	concerning	concern	VBG
cord-005453-4057qib7	9353	19	CDI	CDI	NNP
cord-005453-4057qib7	9353	20	occurrence	occurrence	NN
cord-005453-4057qib7	9353	21	,	,	,
cord-005453-4057qib7	9353	22	treatment	treatment	NN
cord-005453-4057qib7	9353	23	efficacy	efficacy	NN
cord-005453-4057qib7	9353	24	,	,	,
cord-005453-4057qib7	9353	25	and	and	CC
cord-005453-4057qib7	9353	26	GVHD	GVHD	NNP
cord-005453-4057qib7	9353	27	development	development	NN
cord-005453-4057qib7	9353	28	.	.	.
cord-005453-4057qib7	9354	1	The	the	DT
cord-005453-4057qib7	9354	2	study	study	NN
cord-005453-4057qib7	9354	3	included	include	VBD
cord-005453-4057qib7	9354	4	77	77	CD
cord-005453-4057qib7	9354	5	patients	patient	NNS
cord-005453-4057qib7	9354	6	with	with	IN
cord-005453-4057qib7	9354	7	hematological	hematological	JJ
cord-005453-4057qib7	9354	8	malignancies	malignancy	NNS
cord-005453-4057qib7	9354	9	who	who	WP
cord-005453-4057qib7	9354	10	underwent	undergo	VBD
cord-005453-4057qib7	9354	11	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9354	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9354	13	cell	cell	NN
cord-005453-4057qib7	9354	14	transplantation	transplantation	NN
cord-005453-4057qib7	9354	15	(	(	-LRB-
cord-005453-4057qib7	9354	16	alloHCT	alloHCT	NNP
cord-005453-4057qib7	9354	17	)	)	-RRB-
cord-005453-4057qib7	9354	18	between	between	IN
cord-005453-4057qib7	9354	19	2012	2012	CD
cord-005453-4057qib7	9354	20	-	-	SYM
cord-005453-4057qib7	9354	21	2018	2018	CD
cord-005453-4057qib7	9354	22	.	.	.
cord-005453-4057qib7	9355	1	Results	result	NNS
cord-005453-4057qib7	9355	2	:	:	:
cord-005453-4057qib7	9356	1	Median	median	JJ
cord-005453-4057qib7	9356	2	time	time	NN
cord-005453-4057qib7	9356	3	to	to	IN
cord-005453-4057qib7	9356	4	CDI	CDI	NNP
cord-005453-4057qib7	9356	5	was	be	VBD
cord-005453-4057qib7	9356	6	14	14	CD
cord-005453-4057qib7	9356	7	days	day	NNS
cord-005453-4057qib7	9356	8	post	post	NN
cord-005453-4057qib7	9356	9	-	-	JJ
cord-005453-4057qib7	9356	10	alloHCT	allohct	JJ
cord-005453-4057qib7	9356	11	with	with	IN
cord-005453-4057qib7	9356	12	detection	detection	NN
cord-005453-4057qib7	9356	13	of	of	IN
cord-005453-4057qib7	9356	14	both	both	DT
cord-005453-4057qib7	9356	15	toxins	toxin	NNS
cord-005453-4057qib7	9356	16	A	A	NNP
cord-005453-4057qib7	9356	17	and	and	CC
cord-005453-4057qib7	9356	18	B	b	NN
cord-005453-4057qib7	9356	19	in	in	IN
cord-005453-4057qib7	9356	20	57	57	CD
cord-005453-4057qib7	9356	21	%	%	NN
cord-005453-4057qib7	9356	22	of	of	IN
cord-005453-4057qib7	9356	23	cases	case	NNS
cord-005453-4057qib7	9356	24	.	.	.
cord-005453-4057qib7	9357	1	Disturbance	disturbance	NN
cord-005453-4057qib7	9357	2	of	of	IN
cord-005453-4057qib7	9357	3	intestinal	intestinal	JJ
cord-005453-4057qib7	9357	4	microbiome	microbiome	NN
cord-005453-4057qib7	9357	5	was	be	VBD
cord-005453-4057qib7	9357	6	confirmed	confirm	VBN
cord-005453-4057qib7	9357	7	by	by	IN
cord-005453-4057qib7	9357	8	a	a	DT
cord-005453-4057qib7	9357	9	59	59	CD
cord-005453-4057qib7	9357	10	%	%	NN
cord-005453-4057qib7	9357	11	rate	rate	NN
cord-005453-4057qib7	9357	12	of	of	IN
cord-005453-4057qib7	9357	13	colonization	colonization	NN
cord-005453-4057qib7	9357	14	with	with	IN
cord-005453-4057qib7	9357	15	multidrug	multidrug	NN
cord-005453-4057qib7	9357	16	-	-	HYPH
cord-005453-4057qib7	9357	17	resistant	resistant	JJ
cord-005453-4057qib7	9357	18	bacteria	bacteria	NNS
cord-005453-4057qib7	9357	19	(	(	-LRB-
cord-005453-4057qib7	9357	20	MDRB	MDRB	NNP
cord-005453-4057qib7	9357	21	)	)	-RRB-
cord-005453-4057qib7	9357	22	.	.	.
cord-005453-4057qib7	9358	1	The	the	DT
cord-005453-4057qib7	9358	2	CDI	CDI	NNP
cord-005453-4057qib7	9358	3	symptoms	symptom	NNS
cord-005453-4057qib7	9358	4	resolved	resolve	VBN
cord-005453-4057qib7	9358	5	with	with	IN
cord-005453-4057qib7	9358	6	the	the	DT
cord-005453-4057qib7	9358	7	negative	negative	JJ
cord-005453-4057qib7	9358	8	toxins	toxin	NNS
cord-005453-4057qib7	9358	9	after	after	IN
cord-005453-4057qib7	9358	10	the	the	DT
cord-005453-4057qib7	9358	11	first	first	JJ
cord-005453-4057qib7	9358	12	line	line	NN
cord-005453-4057qib7	9358	13	treatment	treatment	NN
cord-005453-4057qib7	9358	14	in	in	IN
cord-005453-4057qib7	9358	15	76.6	76.6	CD
cord-005453-4057qib7	9358	16	%	%	NN
cord-005453-4057qib7	9358	17	of	of	IN
cord-005453-4057qib7	9358	18	patients	patient	NNS
cord-005453-4057qib7	9358	19	.	.	.
cord-005453-4057qib7	9359	1	The	the	DT
cord-005453-4057qib7	9359	2	median	median	JJ
cord-005453-4057qib7	9359	3	time	time	NN
cord-005453-4057qib7	9359	4	to	to	IN
cord-005453-4057qib7	9359	5	remission	remission	NN
cord-005453-4057qib7	9359	6	and	and	CC
cord-005453-4057qib7	9359	7	therapy	therapy	NN
cord-005453-4057qib7	9359	8	duration	duration	NN
cord-005453-4057qib7	9359	9	was	be	VBD
cord-005453-4057qib7	9359	10	8	8	CD
cord-005453-4057qib7	9359	11	and	and	CC
cord-005453-4057qib7	9359	12	10	10	CD
cord-005453-4057qib7	9359	13	days	day	NNS
cord-005453-4057qib7	9359	14	,	,	,
cord-005453-4057qib7	9359	15	respectively	respectively	RB
cord-005453-4057qib7	9359	16	.	.	.
cord-005453-4057qib7	9360	1	Fifteen	fifteen	CD
cord-005453-4057qib7	9360	2	therapeutic	therapeutic	JJ
cord-005453-4057qib7	9360	3	failures	failure	NNS
cord-005453-4057qib7	9360	4	were	be	VBD
cord-005453-4057qib7	9360	5	observed	observe	VBN
cord-005453-4057qib7	9360	6	after	after	IN
cord-005453-4057qib7	9360	7	treatment	treatment	NN
cord-005453-4057qib7	9360	8	with	with	IN
cord-005453-4057qib7	9360	9	metronidazole	metronidazole	NNP
cord-005453-4057qib7	9360	10	(	(	-LRB-
cord-005453-4057qib7	9360	11	10	10	CD
cord-005453-4057qib7	9360	12	)	)	-RRB-
cord-005453-4057qib7	9360	13	,	,	,
cord-005453-4057qib7	9360	14	vancomycin	vancomycin	FW
cord-005453-4057qib7	9360	15	(	(	-LRB-
cord-005453-4057qib7	9360	16	2	2	CD
cord-005453-4057qib7	9360	17	)	)	-RRB-
cord-005453-4057qib7	9360	18	and	and	CC
cord-005453-4057qib7	9360	19	a	a	DT
cord-005453-4057qib7	9360	20	combination	combination	NN
cord-005453-4057qib7	9360	21	therapy	therapy	NN
cord-005453-4057qib7	9360	22	(	(	-LRB-
cord-005453-4057qib7	9360	23	3	3	CD
cord-005453-4057qib7	9360	24	)	)	-RRB-
cord-005453-4057qib7	9360	25	.	.	.
cord-005453-4057qib7	9361	1	Eleven	eleven	CD
cord-005453-4057qib7	9361	2	patients	patient	NNS
cord-005453-4057qib7	9361	3	responded	respond	VBD
cord-005453-4057qib7	9361	4	to	to	IN
cord-005453-4057qib7	9361	5	second	second	JJ
cord-005453-4057qib7	9361	6	line	line	NN
cord-005453-4057qib7	9361	7	treatment	treatment	NN
cord-005453-4057qib7	9361	8	.	.	.
cord-005453-4057qib7	9362	1	Thirty	thirty	CD
cord-005453-4057qib7	9362	2	-	-	HYPH
cord-005453-4057qib7	9362	3	seven	seven	CD
cord-005453-4057qib7	9362	4	(	(	-LRB-
cord-005453-4057qib7	9362	5	48	48	CD
cord-005453-4057qib7	9362	6	%	%	NN
cord-005453-4057qib7	9362	7	)	)	-RRB-
cord-005453-4057qib7	9362	8	patients	patient	NNS
cord-005453-4057qib7	9362	9	died	die	VBD
cord-005453-4057qib7	9362	10	due	due	IN
cord-005453-4057qib7	9362	11	to	to	IN
cord-005453-4057qib7	9362	12	infections	infection	NNS
cord-005453-4057qib7	9362	13	(	(	-LRB-
cord-005453-4057qib7	9362	14	17	17	CD
cord-005453-4057qib7	9362	15	)	)	-RRB-
cord-005453-4057qib7	9362	16	,	,	,
cord-005453-4057qib7	9362	17	relapses	relapse	NNS
cord-005453-4057qib7	9362	18	(	(	-LRB-
cord-005453-4057qib7	9362	19	10	10	CD
cord-005453-4057qib7	9362	20	)	)	-RRB-
cord-005453-4057qib7	9362	21	and	and	CC
cord-005453-4057qib7	9362	22	GVHD	GVHD	NNP
cord-005453-4057qib7	9362	23	/	/	SYM
cord-005453-4057qib7	9362	24	infections	infection	NNS
cord-005453-4057qib7	9362	25	(	(	-LRB-
cord-005453-4057qib7	9362	26	10	10	CD
cord-005453-4057qib7	9362	27	)	)	-RRB-
cord-005453-4057qib7	9362	28	.	.	.
cord-005453-4057qib7	9363	1	We	-PRON-	PRP
cord-005453-4057qib7	9363	2	noted	note	VBD
cord-005453-4057qib7	9363	3	recurrent	recurrent	JJ
cord-005453-4057qib7	9363	4	CDI	CDI	NNP
cord-005453-4057qib7	9363	5	in	in	IN
cord-005453-4057qib7	9363	6	6	6	CD
cord-005453-4057qib7	9363	7	cases	case	NNS
cord-005453-4057qib7	9363	8	.	.	.
cord-005453-4057qib7	9364	1	Eight	eight	CD
cord-005453-4057qib7	9364	2	patients	patient	NNS
cord-005453-4057qib7	9364	3	died	die	VBD
cord-005453-4057qib7	9364	4	with	with	IN
cord-005453-4057qib7	9364	5	active	active	JJ
cord-005453-4057qib7	9364	6	CDI	CDI	NNP
cord-005453-4057qib7	9364	7	.	.	.
cord-005453-4057qib7	9365	1	We	-PRON-	PRP
cord-005453-4057qib7	9365	2	observed	observe	VBD
cord-005453-4057qib7	9365	3	occurrence	occurrence	NN
cord-005453-4057qib7	9365	4	or	or	CC
cord-005453-4057qib7	9365	5	exacerbation	exacerbation	NN
cord-005453-4057qib7	9365	6	of	of	IN
cord-005453-4057qib7	9365	7	GVHD	GVHD	NNP
cord-005453-4057qib7	9365	8	in	in	IN
cord-005453-4057qib7	9365	9	35	35	CD
cord-005453-4057qib7	9365	10	(	(	-LRB-
cord-005453-4057qib7	9365	11	44	44	CD
cord-005453-4057qib7	9365	12	%	%	NN
cord-005453-4057qib7	9365	13	)	)	-RRB-
cord-005453-4057qib7	9365	14	patients	patient	NNS
cord-005453-4057qib7	9365	15	following	follow	VBG
cord-005453-4057qib7	9365	16	CDI	CDI	NNP
cord-005453-4057qib7	9365	17	,	,	,
cord-005453-4057qib7	9365	18	including	include	VBG
cord-005453-4057qib7	9365	19	25	25	CD
cord-005453-4057qib7	9365	20	cases	case	NNS
cord-005453-4057qib7	9365	21	with	with	IN
cord-005453-4057qib7	9365	22	gut	gut	NN
cord-005453-4057qib7	9365	23	involvement	involvement	NN
cord-005453-4057qib7	9365	24	(	(	-LRB-
cord-005453-4057qib7	9365	25	GI	GI	NNP
cord-005453-4057qib7	9365	26	-	-	HYPH
cord-005453-4057qib7	9365	27	GVHD	GVHD	NNP
cord-005453-4057qib7	9365	28	)	)	-RRB-
cord-005453-4057qib7	9365	29	.	.	.
cord-005453-4057qib7	9366	1	Treatment	treatment	NN
cord-005453-4057qib7	9366	2	with	with	IN
cord-005453-4057qib7	9366	3	metronidazole	metronidazole	NN
cord-005453-4057qib7	9366	4	and	and	CC
cord-005453-4057qib7	9366	5	failure	failure	NN
cord-005453-4057qib7	9366	6	of	of	IN
cord-005453-4057qib7	9366	7	the	the	DT
cord-005453-4057qib7	9366	8	first	first	JJ
cord-005453-4057qib7	9366	9	line	line	NN
cord-005453-4057qib7	9366	10	therapy	therapy	NN
cord-005453-4057qib7	9366	11	increased	increase	VBD
cord-005453-4057qib7	9366	12	the	the	DT
cord-005453-4057qib7	9366	13	development	development	NN
cord-005453-4057qib7	9366	14	or	or	CC
cord-005453-4057qib7	9366	15	escalation	escalation	NN
cord-005453-4057qib7	9366	16	of	of	IN
cord-005453-4057qib7	9366	17	GI	GI	NNP
cord-005453-4057qib7	9366	18	-	-	HYPH
cord-005453-4057qib7	9366	19	GVHD	GVHD	NNP
cord-005453-4057qib7	9366	20	(	(	-LRB-
cord-005453-4057qib7	9366	21	p=	p=	NNP
cord-005453-4057qib7	9366	22	0.03	0.03	CD
cord-005453-4057qib7	9366	23	and	and	CC
cord-005453-4057qib7	9366	24	p	p	NN
cord-005453-4057qib7	9366	25	<	<	XX
cord-005453-4057qib7	9366	26	0.001	0.001	CD
cord-005453-4057qib7	9366	27	,	,	,
cord-005453-4057qib7	9366	28	respectively	respectively	RB
cord-005453-4057qib7	9366	29	)	)	-RRB-
cord-005453-4057qib7	9366	30	.	.	.
cord-005453-4057qib7	9367	1	The	the	DT
cord-005453-4057qib7	9367	2	duration	duration	NN
cord-005453-4057qib7	9367	3	of	of	IN
cord-005453-4057qib7	9367	4	CDI	CDI	NNP
cord-005453-4057qib7	9367	5	exceeding	exceed	VBG
cord-005453-4057qib7	9367	6	10	10	CD
cord-005453-4057qib7	9367	7	days	day	NNS
cord-005453-4057qib7	9367	8	also	also	RB
cord-005453-4057qib7	9367	9	had	have	VBD
cord-005453-4057qib7	9367	10	impact	impact	NN
cord-005453-4057qib7	9367	11	on	on	IN
cord-005453-4057qib7	9367	12	the	the	DT
cord-005453-4057qib7	9367	13	GI	GI	NNP
cord-005453-4057qib7	9367	14	-	-	HYPH
cord-005453-4057qib7	9367	15	GVHD	GVHD	NNP
cord-005453-4057qib7	9367	16	incidence	incidence	NN
cord-005453-4057qib7	9367	17	(	(	-LRB-
cord-005453-4057qib7	9367	18	p=	p=	NNP
cord-005453-4057qib7	9367	19	0.002	0.002	CD
cord-005453-4057qib7	9367	20	)	)	-RRB-
cord-005453-4057qib7	9367	21	.	.	.
cord-005453-4057qib7	9368	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9368	2	:	:	:
cord-005453-4057qib7	9368	3	1	1	CD
cord-005453-4057qib7	9368	4	.	.	.
cord-005453-4057qib7	9369	1	Patients	patient	NNS
cord-005453-4057qib7	9369	2	colonized	colonize	VBN
cord-005453-4057qib7	9369	3	with	with	IN
cord-005453-4057qib7	9369	4	MDRB	MDRB	NNP
cord-005453-4057qib7	9369	5	are	be	VBP
cord-005453-4057qib7	9369	6	at	at	IN
cord-005453-4057qib7	9369	7	high	high	JJ
cord-005453-4057qib7	9369	8	risk	risk	NN
cord-005453-4057qib7	9369	9	of	of	IN
cord-005453-4057qib7	9369	10	CDI	CDI	NNP
cord-005453-4057qib7	9369	11	.	.	.
cord-005453-4057qib7	9370	1	2	2	LS
cord-005453-4057qib7	9370	2	.	.	.
cord-005453-4057qib7	9371	1	High	high	JJ
cord-005453-4057qib7	9371	2	mortality	mortality	NN
cord-005453-4057qib7	9371	3	due	due	IN
cord-005453-4057qib7	9371	4	to	to	IN
cord-005453-4057qib7	9371	5	infections	infection	NNS
cord-005453-4057qib7	9371	6	and/or	and/or	CC
cord-005453-4057qib7	9371	7	GVHD	GVHD	NNP
cord-005453-4057qib7	9371	8	in	in	IN
cord-005453-4057qib7	9371	9	patients	patient	NNS
cord-005453-4057qib7	9371	10	with	with	IN
cord-005453-4057qib7	9371	11	CDI	CDI	NNP
cord-005453-4057qib7	9371	12	.	.	.
cord-005453-4057qib7	9372	1	3	3	LS
cord-005453-4057qib7	9372	2	.	.	.
cord-005453-4057qib7	9373	1	Due	due	IN
cord-005453-4057qib7	9373	2	to	to	TO
cord-005453-4057qib7	9373	3	lower	lower	VB
cord-005453-4057qib7	9373	4	efficacy	efficacy	NN
cord-005453-4057qib7	9373	5	and	and	CC
cord-005453-4057qib7	9373	6	harmful	harmful	JJ
cord-005453-4057qib7	9373	7	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	9373	8	impact	impact	NN
cord-005453-4057qib7	9373	9	,	,	,
cord-005453-4057qib7	9373	10	metronidazole	metronidazole	NNP
cord-005453-4057qib7	9373	11	should	should	MD
cord-005453-4057qib7	9373	12	not	not	RB
cord-005453-4057qib7	9373	13	be	be	VB
cord-005453-4057qib7	9373	14	the	the	DT
cord-005453-4057qib7	9373	15	first	first	JJ
cord-005453-4057qib7	9373	16	line	line	NN
cord-005453-4057qib7	9373	17	treatment	treatment	NN
cord-005453-4057qib7	9373	18	in	in	IN
cord-005453-4057qib7	9373	19	CDI	CDI	NNP
cord-005453-4057qib7	9373	20	post	post	NN
cord-005453-4057qib7	9373	21	-	-	NN
cord-005453-4057qib7	9373	22	HCT	hct	NN
cord-005453-4057qib7	9373	23	.	.	.
cord-005453-4057qib7	9374	1	4	4	LS
cord-005453-4057qib7	9374	2	.	.	.
cord-005453-4057qib7	9375	1	Emphasis	emphasis	NN
cord-005453-4057qib7	9375	2	must	must	MD
cord-005453-4057qib7	9375	3	be	be	VB
cord-005453-4057qib7	9375	4	put	put	VBN
cord-005453-4057qib7	9375	5	on	on	IN
cord-005453-4057qib7	9375	6	fast	fast	JJ
cord-005453-4057qib7	9375	7	CDI	CDI	NNP
cord-005453-4057qib7	9375	8	resolution	resolution	NN
cord-005453-4057qib7	9375	9	to	to	TO
cord-005453-4057qib7	9375	10	interrupt	interrupt	VB
cord-005453-4057qib7	9375	11	a	a	DT
cord-005453-4057qib7	9375	12	vicious	vicious	JJ
cord-005453-4057qib7	9375	13	circle	circle	NN
cord-005453-4057qib7	9375	14	of	of	IN
cord-005453-4057qib7	9375	15	the	the	DT
cord-005453-4057qib7	9375	16	intestinal	intestinal	JJ
cord-005453-4057qib7	9375	17	inflammatory	inflammatory	JJ
cord-005453-4057qib7	9375	18	processes	process	NNS
cord-005453-4057qib7	9375	19	.	.	.
cord-005453-4057qib7	9376	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9376	2	:	:	:
cord-005453-4057qib7	9376	3	Nothing	nothing	NN
cord-005453-4057qib7	9376	4	to	to	TO
cord-005453-4057qib7	9376	5	declare	declare	VB
cord-005453-4057qib7	9376	6	Establishing	establish	VBG
cord-005453-4057qib7	9376	7	optimal	optimal	JJ
cord-005453-4057qib7	9376	8	preemptive	preemptive	JJ
cord-005453-4057qib7	9376	9	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	9376	10	therapy	therapy	NN
cord-005453-4057qib7	9376	11	threshold	threshold	NN
cord-005453-4057qib7	9376	12	post	post	NN
cord-005453-4057qib7	9376	13	allogeneic	allogeneic	NN
cord-005453-4057qib7	9376	14	HCT	hct	NN
cord-005453-4057qib7	9376	15	in	in	IN
cord-005453-4057qib7	9376	16	a	a	DT
cord-005453-4057qib7	9376	17	patient	patient	JJ
cord-005453-4057qib7	9376	18	population	population	NN
cord-005453-4057qib7	9376	19	with	with	IN
cord-005453-4057qib7	9376	20	high	high	JJ
cord-005453-4057qib7	9376	21	prevalence	prevalence	NN
cord-005453-4057qib7	9376	22	of	of	IN
cord-005453-4057qib7	9376	23	seropositive	seropositive	JJ
cord-005453-4057qib7	9376	24	status	status	NN
cord-005453-4057qib7	9376	25	Background	background	NN
cord-005453-4057qib7	9376	26	:	:	:
cord-005453-4057qib7	9376	27	Preemptive	preemptive	JJ
cord-005453-4057qib7	9376	28	therapy	therapy	NN
cord-005453-4057qib7	9376	29	(	(	-LRB-
cord-005453-4057qib7	9376	30	PET	PET	NNP
cord-005453-4057qib7	9376	31	)	)	-RRB-
cord-005453-4057qib7	9376	32	for	for	IN
cord-005453-4057qib7	9377	1	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	9377	2	(	(	-LRB-
cord-005453-4057qib7	9377	3	CMV	CMV	NNP
cord-005453-4057qib7	9377	4	)	)	-RRB-
cord-005453-4057qib7	9377	5	reactivation	reactivation	NN
cord-005453-4057qib7	9377	6	post	post	NN
cord-005453-4057qib7	9378	1	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9378	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9378	3	stem	stem	NN
cord-005453-4057qib7	9378	4	cell	cell	NN
cord-005453-4057qib7	9378	5	transplantation	transplantation	NN
cord-005453-4057qib7	9378	6	(	(	-LRB-
cord-005453-4057qib7	9378	7	HCT	HCT	NNP
cord-005453-4057qib7	9378	8	)	)	-RRB-
cord-005453-4057qib7	9378	9	was	be	VBD
cord-005453-4057qib7	9378	10	shown	show	VBN
cord-005453-4057qib7	9378	11	to	to	TO
cord-005453-4057qib7	9378	12	decrease	decrease	VB
cord-005453-4057qib7	9378	13	the	the	DT
cord-005453-4057qib7	9378	14	incidence	incidence	NN
cord-005453-4057qib7	9378	15	of	of	IN
cord-005453-4057qib7	9378	16	CMV	CMV	NNP
cord-005453-4057qib7	9378	17	disease	disease	NN
cord-005453-4057qib7	9378	18	.	.	.
cord-005453-4057qib7	9379	1	However	however	RB
cord-005453-4057qib7	9379	2	,	,	,
cord-005453-4057qib7	9379	3	the	the	DT
cord-005453-4057qib7	9379	4	optimal	optimal	JJ
cord-005453-4057qib7	9379	5	PET	pet	NN
cord-005453-4057qib7	9379	6	threshold	threshold	NN
cord-005453-4057qib7	9379	7	is	be	VBZ
cord-005453-4057qib7	9379	8	unknown	unknown	JJ
cord-005453-4057qib7	9379	9	and	and	CC
cord-005453-4057qib7	9379	10	there	there	EX
cord-005453-4057qib7	9379	11	are	be	VBP
cord-005453-4057qib7	9379	12	significant	significant	JJ
cord-005453-4057qib7	9379	13	toxicities	toxicity	NNS
cord-005453-4057qib7	9379	14	associated	associate	VBN
cord-005453-4057qib7	9379	15	with	with	IN
cord-005453-4057qib7	9379	16	anti	anti	JJ
cord-005453-4057qib7	9379	17	-	-	JJ
cord-005453-4057qib7	9379	18	CMV	CMV	NNP
cord-005453-4057qib7	9379	19	therapy	therapy	NN
cord-005453-4057qib7	9379	20	.	.	.
cord-005453-4057qib7	9380	1	At	at	IN
cord-005453-4057qib7	9380	2	our	-PRON-	PRP$
cord-005453-4057qib7	9380	3	institution	institution	NN
cord-005453-4057qib7	9380	4	,	,	,
cord-005453-4057qib7	9380	5	we	-PRON-	PRP
cord-005453-4057qib7	9380	6	initiate	initiate	VBP
cord-005453-4057qib7	9380	7	PET	pet	NN
cord-005453-4057qib7	9380	8	at	at	IN
cord-005453-4057qib7	9380	9	CMV	CMV	NNP
cord-005453-4057qib7	9380	10	DNA	DNA	NNP
cord-005453-4057qib7	9380	11	titer	titer	NN
cord-005453-4057qib7	9380	12	above	above	IN
cord-005453-4057qib7	9380	13	1000	1000	CD
cord-005453-4057qib7	9380	14	copies	copy	NNS
cord-005453-4057qib7	9380	15	/	/	SYM
cord-005453-4057qib7	9380	16	mL	ml	NN
cord-005453-4057qib7	9380	17	(	(	-LRB-
cord-005453-4057qib7	9380	18	1560	1560	CD
cord-005453-4057qib7	9380	19	IU	IU	NNP
cord-005453-4057qib7	9380	20	/	/	SYM
cord-005453-4057qib7	9380	21	mL	mL	NNP
cord-005453-4057qib7	9380	22	)	)	-RRB-
cord-005453-4057qib7	9380	23	.	.	.
cord-005453-4057qib7	9381	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9381	2	aim	aim	NN
cord-005453-4057qib7	9381	3	was	be	VBD
cord-005453-4057qib7	9381	4	to	to	TO
cord-005453-4057qib7	9381	5	examine	examine	VB
cord-005453-4057qib7	9381	6	the	the	DT
cord-005453-4057qib7	9381	7	efficacy	efficacy	NN
cord-005453-4057qib7	9381	8	of	of	IN
cord-005453-4057qib7	9381	9	this	this	DT
cord-005453-4057qib7	9381	10	approach	approach	NN
cord-005453-4057qib7	9381	11	including	include	VBG
cord-005453-4057qib7	9381	12	the	the	DT
cord-005453-4057qib7	9381	13	incidence	incidence	NN
cord-005453-4057qib7	9381	14	of	of	IN
cord-005453-4057qib7	9381	15	spontaneous	spontaneous	JJ
cord-005453-4057qib7	9381	16	clearance	clearance	NN
cord-005453-4057qib7	9381	17	in	in	IN
cord-005453-4057qib7	9381	18	a	a	DT
cord-005453-4057qib7	9381	19	population	population	NN
cord-005453-4057qib7	9381	20	with	with	IN
cord-005453-4057qib7	9381	21	high	high	JJ
cord-005453-4057qib7	9381	22	prevalence	prevalence	NN
cord-005453-4057qib7	9381	23	of	of	IN
cord-005453-4057qib7	9381	24	CMV	CMV	NNP
cord-005453-4057qib7	9381	25	seropositive	seropositive	JJ
cord-005453-4057qib7	9381	26	status	status	NN
cord-005453-4057qib7	9381	27	.	.	.
cord-005453-4057qib7	9382	1	Methods	method	NNS
cord-005453-4057qib7	9382	2	:	:	:
cord-005453-4057qib7	9383	1	After	after	IN
cord-005453-4057qib7	9383	2	due	due	JJ
cord-005453-4057qib7	9383	3	IRB	IRB	NNP
cord-005453-4057qib7	9383	4	approval	approval	NN
cord-005453-4057qib7	9383	5	,	,	,
cord-005453-4057qib7	9383	6	patients	patient	NNS
cord-005453-4057qib7	9383	7	that	that	IN
cord-005453-4057qib7	9383	8	underwent	undergo	VBD
cord-005453-4057qib7	9383	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	9383	10	HCT	HCT	NNP
cord-005453-4057qib7	9383	11	were	be	VBD
cord-005453-4057qib7	9383	12	identified	identify	VBN
cord-005453-4057qib7	9383	13	and	and	CC
cord-005453-4057qib7	9383	14	records	record	NNS
cord-005453-4057qib7	9383	15	retrospectively	retrospectively	RB
cord-005453-4057qib7	9383	16	extracted	extract	VBN
cord-005453-4057qib7	9383	17	.	.	.
cord-005453-4057qib7	9384	1	CMV	CMV	NNP
cord-005453-4057qib7	9384	2	reactivation	reactivation	NN
cord-005453-4057qib7	9384	3	was	be	VBD
cord-005453-4057qib7	9384	4	defined	define	VBN
cord-005453-4057qib7	9384	5	as	as	IN
cord-005453-4057qib7	9385	1	the	the	DT
cord-005453-4057qib7	9385	2	first	first	JJ
cord-005453-4057qib7	9385	3	detectable	detectable	JJ
cord-005453-4057qib7	9385	4	viral	viral	JJ
cord-005453-4057qib7	9385	5	titer	titer	NN
cord-005453-4057qib7	9385	6	post	post	NN
cord-005453-4057qib7	9385	7	HCT	hct	NN
cord-005453-4057qib7	9385	8	from	from	IN
cord-005453-4057qib7	9385	9	plasma	plasma	NN
cord-005453-4057qib7	9385	10	samples	sample	NNS
cord-005453-4057qib7	9385	11	whereas	whereas	IN
cord-005453-4057qib7	9385	12	clearance	clearance	NN
cord-005453-4057qib7	9385	13	of	of	IN
cord-005453-4057qib7	9385	14	viremia	viremia	NN
cord-005453-4057qib7	9385	15	as	as	IN
cord-005453-4057qib7	9385	16	the	the	DT
cord-005453-4057qib7	9385	17	first	first	JJ
cord-005453-4057qib7	9385	18	date	date	NN
cord-005453-4057qib7	9385	19	of	of	IN
cord-005453-4057qib7	9385	20	two	two	CD
cord-005453-4057qib7	9385	21	negative	negative	JJ
cord-005453-4057qib7	9385	22	PCR	PCR	NNP
cord-005453-4057qib7	9385	23	values	value	NNS
cord-005453-4057qib7	9385	24	obtained	obtain	VBN
cord-005453-4057qib7	9385	25	at	at	IN
cord-005453-4057qib7	9385	26	least	least	RBS
cord-005453-4057qib7	9385	27	1	1	CD
cord-005453-4057qib7	9385	28	week	week	NN
cord-005453-4057qib7	9385	29	apart	apart	RB
cord-005453-4057qib7	9385	30	.	.	.
cord-005453-4057qib7	9386	1	CMV	CMV	NNP
cord-005453-4057qib7	9386	2	monitoring	monitoring	NN
cord-005453-4057qib7	9386	3	was	be	VBD
cord-005453-4057qib7	9386	4	initiated	initiate	VBN
cord-005453-4057qib7	9386	5	post	post	NN
cord-005453-4057qib7	9387	1	HCT	HCT	NNP
cord-005453-4057qib7	9387	2	performed	perform	VBD
cord-005453-4057qib7	9387	3	at	at	IN
cord-005453-4057qib7	9387	4	least	least	JJS
cord-005453-4057qib7	9387	5	weekly	weekly	RB
cord-005453-4057qib7	9387	6	during	during	IN
cord-005453-4057qib7	9387	7	the	the	DT
cord-005453-4057qib7	9387	8	first	first	JJ
cord-005453-4057qib7	9387	9	100	100	CD
cord-005453-4057qib7	9387	10	days	day	NNS
cord-005453-4057qib7	9387	11	and	and	CC
cord-005453-4057qib7	9387	12	every	every	DT
cord-005453-4057qib7	9387	13	2	2	CD
cord-005453-4057qib7	9387	14	-	-	SYM
cord-005453-4057qib7	9387	15	4	4	CD
cord-005453-4057qib7	9387	16	weeks	week	NNS
cord-005453-4057qib7	9387	17	thereafter	thereafter	RB
cord-005453-4057qib7	9387	18	.	.	.
cord-005453-4057qib7	9388	1	A	a	DT
cord-005453-4057qib7	9388	2	high	high	JJ
cord-005453-4057qib7	9388	3	sensitivity	sensitivity	NN
cord-005453-4057qib7	9388	4	assay	assay	NN
cord-005453-4057qib7	9388	5	Abbott	Abbott	NNP
cord-005453-4057qib7	9388	6	RealTime	RealTime	NNP
cord-005453-4057qib7	9388	7	CMV	CMV	NNP
cord-005453-4057qib7	9388	8	was	be	VBD
cord-005453-4057qib7	9388	9	used	use	VBN
cord-005453-4057qib7	9388	10	with	with	IN
cord-005453-4057qib7	9388	11	detection	detection	NN
cord-005453-4057qib7	9388	12	threshold	threshold	NN
cord-005453-4057qib7	9388	13	of	of	IN
cord-005453-4057qib7	9388	14	20	20	CD
cord-005453-4057qib7	9388	15	copies	copy	NNS
cord-005453-4057qib7	9388	16	/	/	SYM
cord-005453-4057qib7	9388	17	mL	ml	NN
cord-005453-4057qib7	9388	18	(	(	-LRB-
cord-005453-4057qib7	9388	19	31.2	31.2	CD
cord-005453-4057qib7	9388	20	IU	IU	NNP
cord-005453-4057qib7	9388	21	/	/	SYM
cord-005453-4057qib7	9388	22	mL	mL	NNP
cord-005453-4057qib7	9388	23	)	)	-RRB-
cord-005453-4057qib7	9388	24	.	.	.
cord-005453-4057qib7	9389	1	Analysis	analysis	NN
cord-005453-4057qib7	9389	2	was	be	VBD
cord-005453-4057qib7	9389	3	computed	compute	VBN
cord-005453-4057qib7	9389	4	using	use	VBG
cord-005453-4057qib7	9389	5	JMP	JMP	NNP
cord-005453-4057qib7	9389	6	v.	v.	CC
cord-005453-4057qib7	9389	7	14.0.1	14.0.1	CD
cord-005453-4057qib7	9389	8	Results	result	NNS
cord-005453-4057qib7	9389	9	:	:	:
cord-005453-4057qib7	9389	10	A.	A.	NNP
cord-005453-4057qib7	9389	11	Baseline	baseline	JJ
cord-005453-4057qib7	9389	12	characteristics	characteristic	NNS
cord-005453-4057qib7	9389	13	:	:	:
cord-005453-4057qib7	9389	14	A	a	DT
cord-005453-4057qib7	9389	15	total	total	NN
cord-005453-4057qib7	9389	16	of	of	IN
cord-005453-4057qib7	9389	17	195	195	CD
cord-005453-4057qib7	9389	18	patients	patient	NNS
cord-005453-4057qib7	9389	19	were	be	VBD
cord-005453-4057qib7	9389	20	identified	identify	VBN
cord-005453-4057qib7	9389	21	and	and	CC
cord-005453-4057qib7	9389	22	included	include	VBN
cord-005453-4057qib7	9389	23	with	with	IN
cord-005453-4057qib7	9389	24	a	a	DT
cord-005453-4057qib7	9389	25	median	median	NN
cord-005453-4057qib7	9389	26	follow	follow	NN
cord-005453-4057qib7	9389	27	up	up	IN
cord-005453-4057qib7	9389	28	of	of	IN
cord-005453-4057qib7	9389	29	18.1	18.1	CD
cord-005453-4057qib7	9389	30	(	(	-LRB-
cord-005453-4057qib7	9389	31	0.7	0.7	CD
cord-005453-4057qib7	9389	32	-	-	HYPH
cord-005453-4057qib7	9389	33	95.6	95.6	CD
cord-005453-4057qib7	9389	34	)	)	-RRB-
cord-005453-4057qib7	9389	35	months	month	NNS
cord-005453-4057qib7	9389	36	.	.	.
cord-005453-4057qib7	9390	1	Median	median	JJ
cord-005453-4057qib7	9390	2	age	age	NN
cord-005453-4057qib7	9390	3	was	be	VBD
cord-005453-4057qib7	9390	4	26	26	CD
cord-005453-4057qib7	9390	5	(	(	-LRB-
cord-005453-4057qib7	9390	6	14	14	CD
cord-005453-4057qib7	9390	7	-	-	SYM
cord-005453-4057qib7	9390	8	63	63	CD
cord-005453-4057qib7	9390	9	)	)	-RRB-
cord-005453-4057qib7	9390	10	years	year	NNS
cord-005453-4057qib7	9390	11	and	and	CC
cord-005453-4057qib7	9390	12	58	58	CD
cord-005453-4057qib7	9390	13	%	%	NN
cord-005453-4057qib7	9390	14	were	be	VBD
cord-005453-4057qib7	9390	15	male	male	JJ
cord-005453-4057qib7	9390	16	.	.	.
cord-005453-4057qib7	9391	1	Indication	indication	NN
cord-005453-4057qib7	9391	2	for	for	IN
cord-005453-4057qib7	9391	3	HCT	HCT	NNP
cord-005453-4057qib7	9391	4	was	be	VBD
cord-005453-4057qib7	9391	5	for	for	IN
cord-005453-4057qib7	9391	6	a	a	DT
cord-005453-4057qib7	9391	7	malignant	malignant	JJ
cord-005453-4057qib7	9391	8	disorder	disorder	NN
cord-005453-4057qib7	9391	9	in	in	IN
cord-005453-4057qib7	9391	10	77	77	CD
cord-005453-4057qib7	9391	11	%	%	NN
cord-005453-4057qib7	9391	12	of	of	IN
cord-005453-4057qib7	9391	13	cases	case	NNS
cord-005453-4057qib7	9391	14	.	.	.
cord-005453-4057qib7	9392	1	The	the	DT
cord-005453-4057qib7	9392	2	majority	majority	NN
cord-005453-4057qib7	9392	3	had	have	VBD
cord-005453-4057qib7	9392	4	a	a	DT
cord-005453-4057qib7	9392	5	matched	match	VBN
cord-005453-4057qib7	9392	6	related	related	JJ
cord-005453-4057qib7	9392	7	donor	donor	NN
cord-005453-4057qib7	9392	8	(	(	-LRB-
cord-005453-4057qib7	9392	9	87	87	CD
cord-005453-4057qib7	9392	10	%	%	NN
cord-005453-4057qib7	9392	11	)	)	-RRB-
cord-005453-4057qib7	9392	12	and	and	CC
cord-005453-4057qib7	9392	13	CMV	CMV	NNP
cord-005453-4057qib7	9392	14	IgG	igg	NN
cord-005453-4057qib7	9392	15	was	be	VBD
cord-005453-4057qib7	9392	16	positive	positive	JJ
cord-005453-4057qib7	9392	17	in	in	IN
cord-005453-4057qib7	9392	18	both	both	DT
cord-005453-4057qib7	9392	19	donor	donor	NN
cord-005453-4057qib7	9392	20	and	and	CC
cord-005453-4057qib7	9392	21	recipient	recipient	NN
cord-005453-4057qib7	9392	22	in	in	IN
cord-005453-4057qib7	9392	23	98	98	CD
cord-005453-4057qib7	9392	24	%	%	NN
cord-005453-4057qib7	9392	25	of	of	IN
cord-005453-4057qib7	9392	26	cases	case	NNS
cord-005453-4057qib7	9392	27	.	.	.
cord-005453-4057qib7	9393	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	9393	2	conditioning	conditioning	NN
cord-005453-4057qib7	9393	3	was	be	VBD
cord-005453-4057qib7	9393	4	given	give	VBN
cord-005453-4057qib7	9393	5	to	to	IN
cord-005453-4057qib7	9393	6	117	117	CD
cord-005453-4057qib7	9393	7	(	(	-LRB-
cord-005453-4057qib7	9393	8	60	60	CD
cord-005453-4057qib7	9393	9	%	%	NN
cord-005453-4057qib7	9393	10	)	)	-RRB-
cord-005453-4057qib7	9393	11	and	and	CC
cord-005453-4057qib7	9393	12	109	109	CD
cord-005453-4057qib7	9393	13	(	(	-LRB-
cord-005453-4057qib7	9393	14	56	56	CD
cord-005453-4057qib7	9393	15	%	%	NN
cord-005453-4057qib7	9393	16	)	)	-RRB-
cord-005453-4057qib7	9393	17	received	receive	VBD
cord-005453-4057qib7	9393	18	TBI	TBI	NNP
cord-005453-4057qib7	9393	19	.	.	.
cord-005453-4057qib7	9394	1	In	in	IN
cord-005453-4057qib7	9394	2	vivo	vivo	NNP
cord-005453-4057qib7	9394	3	T	t	NN
cord-005453-4057qib7	9394	4	-	-	HYPH
cord-005453-4057qib7	9394	5	cell	cell	NN
cord-005453-4057qib7	9394	6	depletion	depletion	NN
cord-005453-4057qib7	9394	7	was	be	VBD
cord-005453-4057qib7	9394	8	given	give	VBN
cord-005453-4057qib7	9394	9	to	to	IN
cord-005453-4057qib7	9394	10	76	76	CD
cord-005453-4057qib7	9394	11	(	(	-LRB-
cord-005453-4057qib7	9394	12	39	39	CD
cord-005453-4057qib7	9394	13	%	%	NN
cord-005453-4057qib7	9394	14	)	)	-RRB-
cord-005453-4057qib7	9394	15	;	;	:
cord-005453-4057qib7	9394	16	ATG	ATG	NNP
cord-005453-4057qib7	9394	17	in	in	IN
cord-005453-4057qib7	9394	18	39	39	CD
cord-005453-4057qib7	9394	19	(	(	-LRB-
cord-005453-4057qib7	9394	20	20	20	CD
cord-005453-4057qib7	9394	21	%	%	NN
cord-005453-4057qib7	9394	22	)	)	-RRB-
cord-005453-4057qib7	9394	23	and	and	CC
cord-005453-4057qib7	9394	24	alemtuzumab	alemtuzumab	VBN
cord-005453-4057qib7	9394	25	in	in	IN
cord-005453-4057qib7	9394	26	37	37	CD
cord-005453-4057qib7	9394	27	(	(	-LRB-
cord-005453-4057qib7	9394	28	19	19	CD
cord-005453-4057qib7	9394	29	%	%	NN
cord-005453-4057qib7	9394	30	)	)	-RRB-
cord-005453-4057qib7	9394	31	.	.	.
cord-005453-4057qib7	9395	1	B.	B.	NNP
cord-005453-4057qib7	9395	2	CMV	CMV	NNP
cord-005453-4057qib7	9395	3	Reactivation	Reactivation	NNP
cord-005453-4057qib7	9395	4	and	and	CC
cord-005453-4057qib7	9395	5	PET	pet	NN
cord-005453-4057qib7	9395	6	:	:	:
cord-005453-4057qib7	9395	7	A	a	DT
cord-005453-4057qib7	9395	8	total	total	NN
cord-005453-4057qib7	9395	9	of	of	IN
cord-005453-4057qib7	9395	10	178	178	CD
cord-005453-4057qib7	9395	11	(	(	-LRB-
cord-005453-4057qib7	9395	12	91	91	CD
cord-005453-4057qib7	9395	13	%	%	NN
cord-005453-4057qib7	9395	14	)	)	-RRB-
cord-005453-4057qib7	9395	15	patients	patient	NNS
cord-005453-4057qib7	9395	16	had	have	VBD
cord-005453-4057qib7	9395	17	a	a	DT
cord-005453-4057qib7	9395	18	positive	positive	JJ
cord-005453-4057qib7	9395	19	CMV	CMV	NNP
cord-005453-4057qib7	9395	20	PCR	PCR	NNP
cord-005453-4057qib7	9395	21	with	with	IN
cord-005453-4057qib7	9395	22	median	median	JJ
cord-005453-4057qib7	9395	23	days	day	NNS
cord-005453-4057qib7	9395	24	to	to	IN
cord-005453-4057qib7	9395	25	reactivation	reactivation	NN
cord-005453-4057qib7	9395	26	post	post	NN
cord-005453-4057qib7	9395	27	HCT	hct	NN
cord-005453-4057qib7	9395	28	of	of	IN
cord-005453-4057qib7	9395	29	17	17	CD
cord-005453-4057qib7	9395	30	;	;	:
cord-005453-4057qib7	9395	31	129	129	CD
cord-005453-4057qib7	9395	32	(	(	-LRB-
cord-005453-4057qib7	9395	33	66	66	CD
cord-005453-4057qib7	9395	34	%	%	NN
cord-005453-4057qib7	9395	35	)	)	-RRB-
cord-005453-4057qib7	9395	36	patients	patient	NNS
cord-005453-4057qib7	9395	37	had	have	VBD
cord-005453-4057qib7	9395	38	peak	peak	NN
cord-005453-4057qib7	9395	39	CMV	CMV	NNP
cord-005453-4057qib7	9396	1	titer	titer	NN
cord-005453-4057qib7	9396	2	<	<	XX
cord-005453-4057qib7	9396	3	1000	1000	CD
cord-005453-4057qib7	9396	4	copies	copy	NNS
cord-005453-4057qib7	9396	5	/	/	SYM
cord-005453-4057qib7	9396	6	mL	ml	NN
cord-005453-4057qib7	9396	7	(	(	-LRB-
cord-005453-4057qib7	9396	8	low	low	JJ
cord-005453-4057qib7	9396	9	titer	titer	NN
cord-005453-4057qib7	9396	10	)	)	-RRB-
cord-005453-4057qib7	9397	1	whereas	whereas	IN
cord-005453-4057qib7	9397	2	the	the	DT
cord-005453-4057qib7	9397	3	remaining	remain	VBG
cord-005453-4057qib7	9397	4	49	49	CD
cord-005453-4057qib7	9397	5	(	(	-LRB-
cord-005453-4057qib7	9397	6	25	25	CD
cord-005453-4057qib7	9397	7	%	%	NN
cord-005453-4057qib7	9397	8	)	)	-RRB-
cord-005453-4057qib7	9397	9	had	have	VBD
cord-005453-4057qib7	9397	10	a	a	DT
cord-005453-4057qib7	9397	11	peak	peak	NN
cord-005453-4057qib7	9397	12	titer	titer	NN
cord-005453-4057qib7	9397	13	≥	≥	CD
cord-005453-4057qib7	9397	14	1000	1000	CD
cord-005453-4057qib7	9397	15	copies	copy	NNS
cord-005453-4057qib7	9397	16	/	/	SYM
cord-005453-4057qib7	9397	17	mL	ml	NN
cord-005453-4057qib7	9397	18	(	(	-LRB-
cord-005453-4057qib7	9397	19	high	high	JJ
cord-005453-4057qib7	9397	20	titer	titer	NN
cord-005453-4057qib7	9397	21	)	)	-RRB-
cord-005453-4057qib7	9397	22	.	.	.
cord-005453-4057qib7	9398	1	Patients	patient	NNS
cord-005453-4057qib7	9398	2	with	with	IN
cord-005453-4057qib7	9398	3	high	high	JJ
cord-005453-4057qib7	9398	4	titer	titer	NN
cord-005453-4057qib7	9398	5	were	be	VBD
cord-005453-4057qib7	9398	6	more	more	RBR
cord-005453-4057qib7	9398	7	likely	likely	JJ
cord-005453-4057qib7	9398	8	to	to	TO
cord-005453-4057qib7	9398	9	be	be	VB
cord-005453-4057qib7	9398	10	older	old	JJR
cord-005453-4057qib7	9398	11	(	(	-LRB-
cord-005453-4057qib7	9398	12	p	p	NN
cord-005453-4057qib7	9398	13	=	=	SYM
cord-005453-4057qib7	9398	14	0.019	0.019	CD
cord-005453-4057qib7	9398	15	)	)	-RRB-
cord-005453-4057qib7	9398	16	,	,	,
cord-005453-4057qib7	9398	17	have	have	VBP
cord-005453-4057qib7	9398	18	malignant	malignant	JJ
cord-005453-4057qib7	9398	19	disease	disease	NN
cord-005453-4057qib7	9398	20	(	(	-LRB-
cord-005453-4057qib7	9398	21	p	p	NN
cord-005453-4057qib7	9398	22	=	=	SYM
cord-005453-4057qib7	9398	23	0.019	0.019	CD
cord-005453-4057qib7	9398	24	)	)	-RRB-
cord-005453-4057qib7	9398	25	,	,	,
cord-005453-4057qib7	9398	26	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9398	27	or	or	CC
cord-005453-4057qib7	9398	28	unrelated	unrelated	JJ
cord-005453-4057qib7	9398	29	donor	donor	NN
cord-005453-4057qib7	9398	30	(	(	-LRB-
cord-005453-4057qib7	9398	31	p	p	NN
cord-005453-4057qib7	9398	32	<	<	XX
cord-005453-4057qib7	9398	33	0.0001	0.0001	CD
cord-005453-4057qib7	9398	34	)	)	-RRB-
cord-005453-4057qib7	9398	35	and	and	CC
cord-005453-4057qib7	9398	36	higher	high	JJR
cord-005453-4057qib7	9398	37	incidence	incidence	NN
cord-005453-4057qib7	9398	38	of	of	IN
cord-005453-4057qib7	9398	39	aGvHD	agvhd	NN
cord-005453-4057qib7	9398	40	grade	grade	NN
cord-005453-4057qib7	9398	41	II	II	NNP
cord-005453-4057qib7	9398	42	-	-	HYPH
cord-005453-4057qib7	9398	43	IV	IV	NNP
cord-005453-4057qib7	9398	44	(	(	-LRB-
cord-005453-4057qib7	9398	45	P	p	NN
cord-005453-4057qib7	9398	46	=	=	SYM
cord-005453-4057qib7	9398	47	0.003	0.003	CD
cord-005453-4057qib7	9398	48	)	)	-RRB-
cord-005453-4057qib7	9398	49	as	as	IN
cord-005453-4057qib7	9398	50	shown	show	VBN
cord-005453-4057qib7	9398	51	in	in	IN
cord-005453-4057qib7	9398	52	the	the	DT
cord-005453-4057qib7	9398	53	table	table	NN
cord-005453-4057qib7	9398	54	.	.	.
cord-005453-4057qib7	9399	1	Median	median	JJ
cord-005453-4057qib7	9399	2	peak	peak	NN
cord-005453-4057qib7	9399	3	titers	titer	NNS
cord-005453-4057qib7	9399	4	for	for	IN
cord-005453-4057qib7	9399	5	the	the	DT
cord-005453-4057qib7	9399	6	low	low	JJ
cord-005453-4057qib7	9399	7	and	and	CC
cord-005453-4057qib7	9399	8	high	high	JJ
cord-005453-4057qib7	9399	9	groups	group	NNS
cord-005453-4057qib7	9399	10	were	be	VBD
cord-005453-4057qib7	9399	11	111	111	CD
cord-005453-4057qib7	9399	12	vs.	vs.	IN
cord-005453-4057qib7	9399	13	4638	4638	CD
cord-005453-4057qib7	9399	14	,	,	,
cord-005453-4057qib7	9399	15	respectively	respectively	RB
cord-005453-4057qib7	9399	16	(	(	-LRB-
cord-005453-4057qib7	9399	17	p	p	NN
cord-005453-4057qib7	9399	18	<	<	XX
cord-005453-4057qib7	9399	19	0.0001).120	0.0001).120	NNP
cord-005453-4057qib7	9399	20	(	(	-LRB-
cord-005453-4057qib7	9399	21	93	93	CD
cord-005453-4057qib7	9399	22	%	%	NN
cord-005453-4057qib7	9399	23	)	)	-RRB-
cord-005453-4057qib7	9399	24	patients	patient	NNS
cord-005453-4057qib7	9399	25	with	with	IN
cord-005453-4057qib7	9399	26	low	low	JJ
cord-005453-4057qib7	9399	27	titers	titer	NNS
cord-005453-4057qib7	9399	28	cleared	clear	VBD
cord-005453-4057qib7	9399	29	spontaneously	spontaneously	RB
cord-005453-4057qib7	9399	30	with	with	IN
cord-005453-4057qib7	9399	31	median	median	JJ
cord-005453-4057qib7	9399	32	time	time	NN
cord-005453-4057qib7	9399	33	to	to	IN
cord-005453-4057qib7	9399	34	clearance	clearance	NN
cord-005453-4057qib7	9399	35	of	of	IN
cord-005453-4057qib7	9399	36	40	40	CD
cord-005453-4057qib7	9399	37	days	day	NNS
cord-005453-4057qib7	9399	38	(	(	-LRB-
cord-005453-4057qib7	9399	39	4	4	CD
cord-005453-4057qib7	9399	40	-	-	SYM
cord-005453-4057qib7	9399	41	188	188	CD
cord-005453-4057qib7	9399	42	)	)	-RRB-
cord-005453-4057qib7	9399	43	,	,	,
cord-005453-4057qib7	9399	44	1	1	CD
cord-005453-4057qib7	9399	45	(	(	-LRB-
cord-005453-4057qib7	9399	46	1	1	CD
cord-005453-4057qib7	9399	47	%	%	NN
cord-005453-4057qib7	9399	48	)	)	-RRB-
cord-005453-4057qib7	9399	49	received	receive	VBD
cord-005453-4057qib7	9399	50	anti	anti	JJ
cord-005453-4057qib7	9399	51	CMV	CMV	NNP
cord-005453-4057qib7	9399	52	therapy	therapy	NN
cord-005453-4057qib7	9399	53	and	and	CC
cord-005453-4057qib7	9399	54	the	the	DT
cord-005453-4057qib7	9399	55	remaining	remain	VBG
cord-005453-4057qib7	9399	56	died	die	VBD
cord-005453-4057qib7	9399	57	with	with	IN
cord-005453-4057qib7	9399	58	active	active	JJ
cord-005453-4057qib7	9399	59	viremia	viremia	NN
cord-005453-4057qib7	9399	60	(	(	-LRB-
cord-005453-4057qib7	9400	1	range	range	VBP
cord-005453-4057qib7	9400	2	49	49	CD
cord-005453-4057qib7	9400	3	-	-	SYM
cord-005453-4057qib7	9400	4	561	561	CD
cord-005453-4057qib7	9400	5	copies	copy	NNS
cord-005453-4057qib7	9400	6	/mL	/mL	.
cord-005453-4057qib7	9400	7	)	)	-RRB-
cord-005453-4057qib7	9400	8	with	with	IN
cord-005453-4057qib7	9400	9	active	active	JJ
cord-005453-4057qib7	9400	10	disease	disease	NN
cord-005453-4057qib7	9400	11	.	.	.
cord-005453-4057qib7	9401	1	One	one	CD
cord-005453-4057qib7	9401	2	patient	patient	NN
cord-005453-4057qib7	9401	3	in	in	IN
cord-005453-4057qib7	9401	4	the	the	DT
cord-005453-4057qib7	9401	5	high	high	JJ
cord-005453-4057qib7	9401	6	titer	titer	NN
cord-005453-4057qib7	9401	7	group	group	NN
cord-005453-4057qib7	9401	8	developed	develop	VBD
cord-005453-4057qib7	9401	9	CMV	CMV	NNP
cord-005453-4057qib7	9401	10	disease	disease	NN
cord-005453-4057qib7	9401	11	.	.	.
cord-005453-4057qib7	9402	1	2-year	2-year	CD
cord-005453-4057qib7	9402	2	OS	OS	NNP
cord-005453-4057qib7	9402	3	and	and	CC
cord-005453-4057qib7	9402	4	CI	CI	NNP
cord-005453-4057qib7	9402	5	-	-	HYPH
cord-005453-4057qib7	9402	6	NRM	NRM	NNP
cord-005453-4057qib7	9402	7	was	be	VBD
cord-005453-4057qib7	9402	8	67.9	67.9	CD
cord-005453-4057qib7	9402	9	%	%	NN
cord-005453-4057qib7	9402	10	vs.	vs.	CC
cord-005453-4057qib7	9402	11	55.4	55.4	CD
cord-005453-4057qib7	9402	12	%	%	NN
cord-005453-4057qib7	9402	13	(	(	-LRB-
cord-005453-4057qib7	9402	14	p	p	NN
cord-005453-4057qib7	9402	15	=	=	SYM
cord-005453-4057qib7	9402	16	0.1	0.1	CD
cord-005453-4057qib7	9402	17	)	)	-RRB-
cord-005453-4057qib7	9402	18	and	and	CC
cord-005453-4057qib7	9402	19	8	8	CD
cord-005453-4057qib7	9402	20	%	%	NN
cord-005453-4057qib7	9402	21	vs.	vs.	IN
cord-005453-4057qib7	9402	22	19.1	19.1	CD
cord-005453-4057qib7	9402	23	%	%	NN
cord-005453-4057qib7	9402	24	(	(	-LRB-
cord-005453-4057qib7	9402	25	p	p	NN
cord-005453-4057qib7	9402	26	=	=	SYM
cord-005453-4057qib7	9402	27	0.034	0.034	CD
cord-005453-4057qib7	9402	28	)	)	-RRB-
cord-005453-4057qib7	9402	29	in	in	IN
cord-005453-4057qib7	9402	30	the	the	DT
cord-005453-4057qib7	9402	31	low	low	JJ
cord-005453-4057qib7	9402	32	and	and	CC
cord-005453-4057qib7	9402	33	high	high	JJ
cord-005453-4057qib7	9402	34	titer	titer	NN
cord-005453-4057qib7	9402	35	groups	group	NNS
cord-005453-4057qib7	9402	36	,	,	,
cord-005453-4057qib7	9402	37	respectively	respectively	RB
cord-005453-4057qib7	9402	38	.	.	.
cord-005453-4057qib7	9403	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9403	2	:	:	:
cord-005453-4057qib7	9404	1	CMV	CMV	NNP
cord-005453-4057qib7	9404	2	reactivation	reactivation	NN
cord-005453-4057qib7	9404	3	was	be	VBD
cord-005453-4057qib7	9404	4	high	high	JJ
cord-005453-4057qib7	9404	5	in	in	IN
cord-005453-4057qib7	9404	6	this	this	DT
cord-005453-4057qib7	9404	7	cohort	cohort	NN
cord-005453-4057qib7	9404	8	however	however	RB
cord-005453-4057qib7	9404	9	of	of	IN
cord-005453-4057qib7	9404	10	low	low	JJ
cord-005453-4057qib7	9404	11	titer	titer	NN
cord-005453-4057qib7	9404	12	viremia	viremia	NN
cord-005453-4057qib7	9404	13	in	in	IN
cord-005453-4057qib7	9404	14	over	over	IN
cord-005453-4057qib7	9404	15	70	70	CD
cord-005453-4057qib7	9404	16	%	%	NN
cord-005453-4057qib7	9404	17	.	.	.
cord-005453-4057qib7	9405	1	A	a	DT
cord-005453-4057qib7	9405	2	PET	pet	NN
cord-005453-4057qib7	9405	3	threshold	threshold	NN
cord-005453-4057qib7	9405	4	of	of	IN
cord-005453-4057qib7	9405	5	1000	1000	CD
cord-005453-4057qib7	9405	6	copies	copy	NNS
cord-005453-4057qib7	9405	7	/	/	SYM
cord-005453-4057qib7	9405	8	mL	ml	NN
cord-005453-4057qib7	9405	9	(	(	-LRB-
cord-005453-4057qib7	9405	10	1560	1560	CD
cord-005453-4057qib7	9405	11	IU	IU	NNP
cord-005453-4057qib7	9405	12	/	/	SYM
cord-005453-4057qib7	9405	13	mL	mL	NNP
cord-005453-4057qib7	9405	14	)	)	-RRB-
cord-005453-4057qib7	9405	15	appears	appear	VBZ
cord-005453-4057qib7	9405	16	desirable	desirable	JJ
cord-005453-4057qib7	9405	17	as	as	IN
cord-005453-4057qib7	9405	18	it	-PRON-	PRP
cord-005453-4057qib7	9405	19	was	be	VBD
cord-005453-4057qib7	9405	20	associated	associate	VBN
cord-005453-4057qib7	9405	21	with	with	IN
cord-005453-4057qib7	9405	22	spontaneous	spontaneous	JJ
cord-005453-4057qib7	9405	23	clearance	clearance	NN
cord-005453-4057qib7	9405	24	in	in	IN
cord-005453-4057qib7	9405	25	almost	almost	RB
cord-005453-4057qib7	9405	26	all	all	DT
cord-005453-4057qib7	9405	27	patients	patient	NNS
cord-005453-4057qib7	9405	28	while	while	IN
cord-005453-4057qib7	9405	29	minimizing	minimize	VBG
cord-005453-4057qib7	9405	30	treatment	treatment	NN
cord-005453-4057qib7	9405	31	related	relate	VBN
cord-005453-4057qib7	9405	32	toxicity	toxicity	NN
cord-005453-4057qib7	9405	33	.	.	.
cord-005453-4057qib7	9406	1	Validation	validation	NN
cord-005453-4057qib7	9406	2	of	of	IN
cord-005453-4057qib7	9406	3	these	these	DT
cord-005453-4057qib7	9406	4	observations	observation	NNS
cord-005453-4057qib7	9406	5	is	be	VBZ
cord-005453-4057qib7	9406	6	warranted	warrant	VBN
cord-005453-4057qib7	9406	7	.	.	.
cord-005453-4057qib7	9407	1	Background	background	NN
cord-005453-4057qib7	9407	2	:	:	:
cord-005453-4057qib7	9408	1	The	the	DT
cord-005453-4057qib7	9408	2	risk	risk	NN
cord-005453-4057qib7	9408	3	of	of	IN
cord-005453-4057qib7	9408	4	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9408	5	pneumonia	pneumonia	NN
cord-005453-4057qib7	9408	6	often	often	RB
cord-005453-4057qib7	9408	7	warrants	warrant	VBZ
cord-005453-4057qib7	9408	8	antifungal	antifungal	JJ
cord-005453-4057qib7	9408	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9408	10	for	for	IN
cord-005453-4057qib7	9408	11	recipients	recipient	NNS
cord-005453-4057qib7	9408	12	of	of	IN
cord-005453-4057qib7	9408	13	blood	blood	NN
cord-005453-4057qib7	9408	14	and	and	CC
cord-005453-4057qib7	9408	15	marrow	marrow	NN
cord-005453-4057qib7	9408	16	or	or	CC
cord-005453-4057qib7	9408	17	solid	solid	JJ
cord-005453-4057qib7	9408	18	organ	organ	NN
cord-005453-4057qib7	9408	19	transplantation	transplantation	NN
cord-005453-4057qib7	9408	20	.	.	.
cord-005453-4057qib7	9409	1	However	however	RB
cord-005453-4057qib7	9409	2	,	,	,
cord-005453-4057qib7	9409	3	complications	complication	NNS
cord-005453-4057qib7	9409	4	such	such	JJ
cord-005453-4057qib7	9409	5	as	as	IN
cord-005453-4057qib7	9409	6	myelosuppression	myelosuppression	NNP
cord-005453-4057qib7	9409	7	,	,	,
cord-005453-4057qib7	9409	8	nephrotoxicity	nephrotoxicity	NNP
cord-005453-4057qib7	9409	9	,	,	,
cord-005453-4057qib7	9409	10	and	and	CC
cord-005453-4057qib7	9409	11	intolerance	intolerance	NN
cord-005453-4057qib7	9409	12	with	with	IN
cord-005453-4057qib7	9409	13	the	the	DT
cord-005453-4057qib7	9409	14	existing	exist	VBG
cord-005453-4057qib7	9409	15	standard	standard	NN
cord-005453-4057qib7	9409	16	,	,	,
cord-005453-4057qib7	9409	17	trimethoprim	trimethoprim	NNP
cord-005453-4057qib7	9409	18	/	/	SYM
cord-005453-4057qib7	9409	19	sulfamethoxazole	sulfamethoxazole	NNP
cord-005453-4057qib7	9409	20	(	(	-LRB-
cord-005453-4057qib7	9409	21	TMP	TMP	NNP
cord-005453-4057qib7	9409	22	/	/	SYM
cord-005453-4057qib7	9409	23	SMX	SMX	NNP
cord-005453-4057qib7	9409	24	)	)	-RRB-
cord-005453-4057qib7	9409	25	,	,	,
cord-005453-4057qib7	9409	26	may	may	MD
cord-005453-4057qib7	9409	27	hinder	hinder	VB
cord-005453-4057qib7	9409	28	or	or	CC
cord-005453-4057qib7	9409	29	interrupt	interrupt	VB
cord-005453-4057qib7	9409	30	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9409	31	.	.	.
cord-005453-4057qib7	9410	1	Rezafungin	Rezafungin	NNP
cord-005453-4057qib7	9410	2	(	(	-LRB-
cord-005453-4057qib7	9410	3	RZF	RZF	NNP
cord-005453-4057qib7	9410	4	)	)	-RRB-
cord-005453-4057qib7	9410	5	is	be	VBZ
cord-005453-4057qib7	9410	6	a	a	DT
cord-005453-4057qib7	9410	7	novel	novel	JJ
cord-005453-4057qib7	9410	8	echinocandin	echinocandin	NNS
cord-005453-4057qib7	9410	9	in	in	IN
cord-005453-4057qib7	9410	10	development	development	NN
cord-005453-4057qib7	9410	11	for	for	IN
cord-005453-4057qib7	9410	12	prevention	prevention	NN
cord-005453-4057qib7	9410	13	of	of	IN
cord-005453-4057qib7	9410	14	invasive	invasive	JJ
cord-005453-4057qib7	9410	15	fungal	fungal	NN
cord-005453-4057qib7	9410	16	disease	disease	NN
cord-005453-4057qib7	9410	17	caused	cause	VBN
cord-005453-4057qib7	9410	18	by	by	IN
cord-005453-4057qib7	9410	19	Candida	Candida	NNP
cord-005453-4057qib7	9410	20	,	,	,
cord-005453-4057qib7	9410	21	Aspergillus	Aspergillus	NNP
cord-005453-4057qib7	9410	22	,	,	,
cord-005453-4057qib7	9410	23	and	and	CC
cord-005453-4057qib7	9410	24	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9410	25	species	specie	NNS
cord-005453-4057qib7	9410	26	in	in	IN
cord-005453-4057qib7	9410	27	blood	blood	NN
cord-005453-4057qib7	9410	28	and	and	CC
cord-005453-4057qib7	9410	29	marrow	marrow	NN
cord-005453-4057qib7	9410	30	transplant	transplant	NN
cord-005453-4057qib7	9410	31	patients	patient	NNS
cord-005453-4057qib7	9410	32	.	.	.
cord-005453-4057qib7	9411	1	RZF	RZF	NNP
cord-005453-4057qib7	9411	2	has	have	VBZ
cord-005453-4057qib7	9411	3	a	a	DT
cord-005453-4057qib7	9411	4	favorable	favorable	JJ
cord-005453-4057qib7	9411	5	safety	safety	NN
cord-005453-4057qib7	9411	6	and	and	CC
cord-005453-4057qib7	9411	7	tolerability	tolerability	NN
cord-005453-4057qib7	9411	8	profile	profile	NN
cord-005453-4057qib7	9411	9	and	and	CC
cord-005453-4057qib7	9411	10	a	a	DT
cord-005453-4057qib7	9411	11	low	low	JJ
cord-005453-4057qib7	9411	12	risk	risk	NN
cord-005453-4057qib7	9411	13	of	of	IN
cord-005453-4057qib7	9411	14	drug	drug	NN
cord-005453-4057qib7	9411	15	-	-	HYPH
cord-005453-4057qib7	9411	16	drug	drug	NN
cord-005453-4057qib7	9411	17	interactions	interaction	NNS
cord-005453-4057qib7	9411	18	.	.	.
cord-005453-4057qib7	9412	1	Furthermore	furthermore	RB
cord-005453-4057qib7	9412	2	,	,	,
cord-005453-4057qib7	9412	3	the	the	DT
cord-005453-4057qib7	9412	4	stability	stability	NN
cord-005453-4057qib7	9412	5	and	and	CC
cord-005453-4057qib7	9412	6	pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	9412	7	of	of	IN
cord-005453-4057qib7	9412	8	RZF	RZF	NNP
cord-005453-4057qib7	9412	9	allow	allow	VBP
cord-005453-4057qib7	9412	10	for	for	IN
cord-005453-4057qib7	9412	11	once	once	RB
cord-005453-4057qib7	9412	12	-	-	HYPH
cord-005453-4057qib7	9412	13	weekly	weekly	NN
cord-005453-4057qib7	9412	14	dosing	dosing	NN
cord-005453-4057qib7	9412	15	and	and	CC
cord-005453-4057qib7	9412	16	broad	broad	JJ
cord-005453-4057qib7	9412	17	distribution	distribution	NN
cord-005453-4057qib7	9412	18	to	to	IN
cord-005453-4057qib7	9412	19	the	the	DT
cord-005453-4057qib7	9412	20	lung	lung	NN
cord-005453-4057qib7	9412	21	and	and	CC
cord-005453-4057qib7	9412	22	other	other	JJ
cord-005453-4057qib7	9412	23	target	target	NN
cord-005453-4057qib7	9412	24	organs	organ	NNS
cord-005453-4057qib7	9412	25	.	.	.
cord-005453-4057qib7	9413	1	RZF	RZF	NNP
cord-005453-4057qib7	9413	2	was	be	VBD
cord-005453-4057qib7	9413	3	shown	show	VBN
cord-005453-4057qib7	9413	4	to	to	TO
cord-005453-4057qib7	9413	5	prevent	prevent	VB
cord-005453-4057qib7	9413	6	in	in	IN
cord-005453-4057qib7	9413	7	vitro	vitro	FW
cord-005453-4057qib7	9413	8	Pneumocystis	pneumocystis	NN
cord-005453-4057qib7	9413	9	biofilm	biofilm	NN
cord-005453-4057qib7	9413	10	formation	formation	NN
cord-005453-4057qib7	9413	11	and	and	CC
cord-005453-4057qib7	9413	12	to	to	TO
cord-005453-4057qib7	9413	13	reduce	reduce	VB
cord-005453-4057qib7	9413	14	the	the	DT
cord-005453-4057qib7	9413	15	viability	viability	NN
cord-005453-4057qib7	9413	16	of	of	IN
cord-005453-4057qib7	9413	17	mature	mature	JJ
cord-005453-4057qib7	9413	18	biofilms	biofilm	NNS
cord-005453-4057qib7	9413	19	.	.	.
cord-005453-4057qib7	9414	1	A	a	DT
cord-005453-4057qib7	9414	2	previous	previous	JJ
cord-005453-4057qib7	9414	3	prophylactic	prophylactic	JJ
cord-005453-4057qib7	9414	4	study	study	NN
cord-005453-4057qib7	9414	5	was	be	VBD
cord-005453-4057qib7	9414	6	conducted	conduct	VBN
cord-005453-4057qib7	9414	7	using	use	VBG
cord-005453-4057qib7	9414	8	a	a	DT
cord-005453-4057qib7	9414	9	broader	broad	JJR
cord-005453-4057qib7	9414	10	range	range	NN
cord-005453-4057qib7	9414	11	of	of	IN
cord-005453-4057qib7	9414	12	RZF	RZF	NNP
cord-005453-4057qib7	9414	13	doses	dose	NNS
cord-005453-4057qib7	9414	14	.	.	.
cord-005453-4057qib7	9415	1	In	in	IN
cord-005453-4057qib7	9415	2	the	the	DT
cord-005453-4057qib7	9415	3	current	current	JJ
cord-005453-4057qib7	9415	4	study	study	NN
cord-005453-4057qib7	9415	5	,	,	,
cord-005453-4057qib7	9415	6	the	the	DT
cord-005453-4057qib7	9415	7	efficacy	efficacy	NN
cord-005453-4057qib7	9415	8	of	of	IN
cord-005453-4057qib7	9415	9	RZF	RZF	NNP
cord-005453-4057qib7	9415	10	was	be	VBD
cord-005453-4057qib7	9415	11	evaluated	evaluate	VBN
cord-005453-4057qib7	9415	12	to	to	TO
cord-005453-4057qib7	9415	13	better	well	RBR
cord-005453-4057qib7	9415	14	understand	understand	VB
cord-005453-4057qib7	9415	15	the	the	DT
cord-005453-4057qib7	9415	16	minimum	minimum	JJ
cord-005453-4057qib7	9415	17	doses	dose	NNS
cord-005453-4057qib7	9415	18	necessary	necessary	JJ
cord-005453-4057qib7	9415	19	to	to	TO
cord-005453-4057qib7	9415	20	prevent	prevent	VB
cord-005453-4057qib7	9415	21	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9415	22	growth	growth	NN
cord-005453-4057qib7	9415	23	in	in	IN
cord-005453-4057qib7	9415	24	a	a	DT
cord-005453-4057qib7	9415	25	mouse	mouse	NN
cord-005453-4057qib7	9415	26	model	model	NN
cord-005453-4057qib7	9415	27	.	.	.
cord-005453-4057qib7	9416	1	Methods	method	NNS
cord-005453-4057qib7	9416	2	:	:	:
cord-005453-4057qib7	9417	1	C3H	C3H	NNP
cord-005453-4057qib7	9417	2	/	/	SYM
cord-005453-4057qib7	9417	3	HeN	hen	JJ
cord-005453-4057qib7	9417	4	mice	mouse	NNS
cord-005453-4057qib7	9417	5	were	be	VBD
cord-005453-4057qib7	9417	6	immunosuppressed	immunosuppressed	JJ
cord-005453-4057qib7	9418	1	(	(	-LRB-
cord-005453-4057qib7	9418	2	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	9418	3	4	4	CD
cord-005453-4057qib7	9418	4	mg	mg	NNP
cord-005453-4057qib7	9418	5	/	/	SYM
cord-005453-4057qib7	9418	6	L	L	NNP
cord-005453-4057qib7	9418	7	in	in	IN
cord-005453-4057qib7	9418	8	acidified	acidified	JJ
cord-005453-4057qib7	9418	9	drinking	drinking	NN
cord-005453-4057qib7	9418	10	water	water	NN
cord-005453-4057qib7	9418	11	)	)	-RRB-
cord-005453-4057qib7	9418	12	and	and	CC
cord-005453-4057qib7	9418	13	then	then	RB
cord-005453-4057qib7	9418	14	infected	infect	VBN
cord-005453-4057qib7	9418	15	intranasally	intranasally	RB
cord-005453-4057qib7	9418	16	with	with	IN
cord-005453-4057qib7	9418	17	P.	P.	NNP
cord-005453-4057qib7	9418	18	murina	murina	NNP
cord-005453-4057qib7	9418	19	(	(	-LRB-
cord-005453-4057qib7	9418	20	2	2	CD
cord-005453-4057qib7	9418	21	x	x	SYM
cord-005453-4057qib7	9418	22	10	10	CD
cord-005453-4057qib7	9418	23	6	6	CD
cord-005453-4057qib7	9419	1	/50	/50	NNP
cord-005453-4057qib7	9419	2	μL	μL	NNP
cord-005453-4057qib7	9419	3	)	)	-RRB-
cord-005453-4057qib7	9419	4	.	.	.
cord-005453-4057qib7	9420	1	Given	give	VBN
cord-005453-4057qib7	9420	2	the	the	DT
cord-005453-4057qib7	9420	3	slow	slow	JJ
cord-005453-4057qib7	9420	4	growth	growth	NN
cord-005453-4057qib7	9420	5	of	of	IN
cord-005453-4057qib7	9420	6	P.	P.	NNP
cord-005453-4057qib7	9420	7	murina	murina	NN
cord-005453-4057qib7	9420	8	,	,	,
cord-005453-4057qib7	9420	9	test	test	NN
cord-005453-4057qib7	9420	10	agents	agent	NNS
cord-005453-4057qib7	9420	11	were	be	VBD
cord-005453-4057qib7	9420	12	administered	administer	VBN
cord-005453-4057qib7	9420	13	at	at	IN
cord-005453-4057qib7	9420	14	the	the	DT
cord-005453-4057qib7	9420	15	same	same	JJ
cord-005453-4057qib7	9420	16	time	time	NN
cord-005453-4057qib7	9420	17	mice	mouse	NNS
cord-005453-4057qib7	9420	18	were	be	VBD
cord-005453-4057qib7	9420	19	inoculated	inoculate	VBN
cord-005453-4057qib7	9420	20	to	to	TO
cord-005453-4057qib7	9420	21	test	test	VB
cord-005453-4057qib7	9420	22	for	for	IN
cord-005453-4057qib7	9420	23	prophylactic	prophylactic	JJ
cord-005453-4057qib7	9420	24	efficacy	efficacy	NN
cord-005453-4057qib7	9420	25	.	.	.
cord-005453-4057qib7	9421	1	Mice	mouse	NNS
cord-005453-4057qib7	9421	2	received	receive	VBD
cord-005453-4057qib7	9421	3	intraperitoneal	intraperitoneal	JJ
cord-005453-4057qib7	9421	4	injections	injection	NNS
cord-005453-4057qib7	9421	5	of	of	IN
cord-005453-4057qib7	9421	6	either	either	DT
cord-005453-4057qib7	9421	7	vehicle	vehicle	NN
cord-005453-4057qib7	9421	8	(	(	-LRB-
cord-005453-4057qib7	9421	9	control	control	NN
cord-005453-4057qib7	9421	10	/	/	SYM
cord-005453-4057qib7	9421	11	steroid	steroid	NN
cord-005453-4057qib7	9421	12	[	[	-LRB-
cord-005453-4057qib7	9421	13	C	C	NNP
cord-005453-4057qib7	9421	14	/	/	SYM
cord-005453-4057qib7	9421	15	S	S	NNP
cord-005453-4057qib7	9421	16	]	]	-RRB-
cord-005453-4057qib7	9421	17	)	)	-RRB-
cord-005453-4057qib7	9422	1	,	,	,
cord-005453-4057qib7	9422	2	TMP/	TMP/	NNP
cord-005453-4057qib7	9422	3	SMX	SMX	NNP
cord-005453-4057qib7	9422	4	50/250	50/250	CD
cord-005453-4057qib7	9422	5	mg	mg	NNP
cord-005453-4057qib7	9422	6	/	/	SYM
cord-005453-4057qib7	9422	7	kg/3x	kg/3x	NNP
cord-005453-4057qib7	9422	8	/	/	SYM
cord-005453-4057qib7	9422	9	week	week	NN
cord-005453-4057qib7	9422	10	(	(	-LRB-
cord-005453-4057qib7	9422	11	wk	wk	NNP
cord-005453-4057qib7	9422	12	)	)	-RRB-
cord-005453-4057qib7	9422	13	,	,	,
cord-005453-4057qib7	9422	14	caspofungin	caspofungin	NNP
cord-005453-4057qib7	9422	15	5	5	CD
cord-005453-4057qib7	9422	16	mg	mg	NNP
cord-005453-4057qib7	9422	17	/	/	SYM
cord-005453-4057qib7	9422	18	kg	kg	NNP
cord-005453-4057qib7	9422	19	once	once	RB
cord-005453-4057qib7	9422	20	daily	daily	RB
cord-005453-4057qib7	9422	21	,	,	,
cord-005453-4057qib7	9422	22	or	or	CC
cord-005453-4057qib7	9422	23	RZF	RZF	NNP
cord-005453-4057qib7	9422	24	5	5	CD
cord-005453-4057qib7	9423	1	mg	mg	NNP
cord-005453-4057qib7	9423	2	/	/	SYM
cord-005453-4057qib7	9423	3	kg	kg	NNP
cord-005453-4057qib7	9423	4	or	or	CC
cord-005453-4057qib7	9423	5	0.5	0.5	CD
cord-005453-4057qib7	9423	6	mg	mg	NNP
cord-005453-4057qib7	9423	7	/	/	SYM
cord-005453-4057qib7	9423	8	kg	kg	NNP
cord-005453-4057qib7	9423	9	once	once	RB
cord-005453-4057qib7	9423	10	daily	daily	RB
cord-005453-4057qib7	9423	11	,	,	,
cord-005453-4057qib7	9423	12	1x	1x	CD
cord-005453-4057qib7	9423	13	,	,	,
cord-005453-4057qib7	9423	14	or	or	CC
cord-005453-4057qib7	9423	15	2x	2x	CD
cord-005453-4057qib7	9423	16	/	/	SYM
cord-005453-4057qib7	9423	17	wk	wk	NN
cord-005453-4057qib7	9423	18	.	.	.
cord-005453-4057qib7	9424	1	After	after	IN
cord-005453-4057qib7	9424	2	a	a	DT
cord-005453-4057qib7	9424	3	6-week	6-week	NNP
cord-005453-4057qib7	9424	4	dosing	dosing	NN
cord-005453-4057qib7	9424	5	period	period	NN
cord-005453-4057qib7	9424	6	,	,	,
cord-005453-4057qib7	9424	7	mice	mouse	NNS
cord-005453-4057qib7	9424	8	were	be	VBD
cord-005453-4057qib7	9424	9	sacrificed	sacrifice	VBN
cord-005453-4057qib7	9424	10	and	and	CC
cord-005453-4057qib7	9424	11	lung	lung	NN
cord-005453-4057qib7	9424	12	homogenates	homogenate	NNS
cord-005453-4057qib7	9424	13	were	be	VBD
cord-005453-4057qib7	9424	14	processed	process	VBN
cord-005453-4057qib7	9424	15	for	for	IN
cord-005453-4057qib7	9424	16	analysis	analysis	NN
cord-005453-4057qib7	9424	17	to	to	TO
cord-005453-4057qib7	9424	18	quantify	quantify	VB
cord-005453-4057qib7	9424	19	the	the	DT
cord-005453-4057qib7	9424	20	nuclei	nucleus	NNS
cord-005453-4057qib7	9424	21	(	(	-LRB-
cord-005453-4057qib7	9424	22	trophic	trophic	NN
cord-005453-4057qib7	9424	23	)	)	-RRB-
cord-005453-4057qib7	9424	24	and	and	CC
cord-005453-4057qib7	9424	25	asci	asci	NNP
cord-005453-4057qib7	9424	26	(	(	-LRB-
cord-005453-4057qib7	9424	27	cyst	cyst	NNP
cord-005453-4057qib7	9424	28	)	)	-RRB-
cord-005453-4057qib7	9424	29	forms	form	NNS
cord-005453-4057qib7	9424	30	of	of	IN
cord-005453-4057qib7	9424	31	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9424	32	.	.	.
cord-005453-4057qib7	9425	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9425	2	efficacy	efficacy	NN
cord-005453-4057qib7	9425	3	was	be	VBD
cord-005453-4057qib7	9425	4	based	base	VBN
cord-005453-4057qib7	9425	5	on	on	IN
cord-005453-4057qib7	9425	6	reduction	reduction	NN
cord-005453-4057qib7	9425	7	of	of	IN
cord-005453-4057qib7	9425	8	organism	organism	NN
cord-005453-4057qib7	9425	9	burden	burden	NN
cord-005453-4057qib7	9425	10	compared	compare	VBN
cord-005453-4057qib7	9425	11	with	with	IN
cord-005453-4057qib7	9425	12	C	C	NNP
cord-005453-4057qib7	9425	13	/	/	SYM
cord-005453-4057qib7	9425	14	S.	S.	NNP
cord-005453-4057qib7	9425	15	Nuclei	Nuclei	NNP
cord-005453-4057qib7	9425	16	and	and	CC
cord-005453-4057qib7	9425	17	asci	asci	NNP
cord-005453-4057qib7	9425	18	counts	count	NNS
cord-005453-4057qib7	9425	19	were	be	VBD
cord-005453-4057qib7	9425	20	log	log	NN
cord-005453-4057qib7	9425	21	transformed	transform	VBN
cord-005453-4057qib7	9425	22	and	and	CC
cord-005453-4057qib7	9425	23	analyzed	analyze	VBN
cord-005453-4057qib7	9425	24	by	by	IN
cord-005453-4057qib7	9425	25	ANOVA	ANOVA	NNP
cord-005453-4057qib7	9425	26	;	;	,
cord-005453-4057qib7	9425	27	individual	individual	JJ
cord-005453-4057qib7	9425	28	groups	group	NNS
cord-005453-4057qib7	9425	29	were	be	VBD
cord-005453-4057qib7	9425	30	compared	compare	VBN
cord-005453-4057qib7	9425	31	by	by	IN
cord-005453-4057qib7	9425	32	the	the	DT
cord-005453-4057qib7	9425	33	Student	Student	NNP
cord-005453-4057qib7	9425	34	-	-	HYPH
cord-005453-4057qib7	9425	35	Newman	Newman	NNP
cord-005453-4057qib7	9425	36	-	-	HYPH
cord-005453-4057qib7	9425	37	Keuls	Keuls	NNP
cord-005453-4057qib7	9425	38	t	t	NN
cord-005453-4057qib7	9425	39	test	test	NN
cord-005453-4057qib7	9425	40	.	.	.
cord-005453-4057qib7	9426	1	Survival	survival	NN
cord-005453-4057qib7	9426	2	rates	rate	NNS
cord-005453-4057qib7	9426	3	were	be	VBD
cord-005453-4057qib7	9426	4	compared	compare	VBN
cord-005453-4057qib7	9426	5	using	use	VBG
cord-005453-4057qib7	9426	6	GraphPad	GraphPad	NNP
cord-005453-4057qib7	9426	7	Prism	Prism	NNP
cord-005453-4057qib7	9426	8	v5	v5	NN
cord-005453-4057qib7	9426	9	.	.	.
cord-005453-4057qib7	9427	1	Results	result	NNS
cord-005453-4057qib7	9427	2	:	:	:
cord-005453-4057qib7	9428	1	All	all	DT
cord-005453-4057qib7	9428	2	mice	mouse	NNS
cord-005453-4057qib7	9428	3	in	in	IN
cord-005453-4057qib7	9428	4	the	the	DT
cord-005453-4057qib7	9428	5	RZF	RZF	NNP
cord-005453-4057qib7	9428	6	groups	group	NNS
cord-005453-4057qib7	9428	7	had	have	VBD
cord-005453-4057qib7	9428	8	significantly	significantly	RB
cord-005453-4057qib7	9428	9	reduced	reduce	VBN
cord-005453-4057qib7	9428	10	nuclei	nucleus	NNS
cord-005453-4057qib7	9428	11	and	and	CC
cord-005453-4057qib7	9428	12	asci	asci	JJ
cord-005453-4057qib7	9428	13	burdens	burden	NNS
cord-005453-4057qib7	9428	14	compared	compare	VBN
cord-005453-4057qib7	9428	15	with	with	IN
cord-005453-4057qib7	9428	16	the	the	DT
cord-005453-4057qib7	9428	17	C	C	NNP
cord-005453-4057qib7	9428	18	/	/	SYM
cord-005453-4057qib7	9428	19	S	S	NNP
cord-005453-4057qib7	9428	20	group	group	NN
cord-005453-4057qib7	9428	21	,	,	,
cord-005453-4057qib7	9428	22	and	and	CC
cord-005453-4057qib7	9428	23	all	all	DT
cord-005453-4057qib7	9428	24	but	but	IN
cord-005453-4057qib7	9428	25	the	the	DT
cord-005453-4057qib7	9428	26	lowest	low	JJS
cord-005453-4057qib7	9428	27	doses	dose	NNS
cord-005453-4057qib7	9428	28	of	of	IN
cord-005453-4057qib7	9428	29	RZF	RZF	NNP
cord-005453-4057qib7	9428	30	(	(	-LRB-
cord-005453-4057qib7	9428	31	0.5	0.5	CD
cord-005453-4057qib7	9428	32	mg	mg	NNP
cord-005453-4057qib7	9428	33	/	/	SYM
cord-005453-4057qib7	9428	34	kg	kg	NNP
cord-005453-4057qib7	9429	1	1x	1x	JJ
cord-005453-4057qib7	9429	2	or	or	CC
cord-005453-4057qib7	9429	3	2x	2x	CD
cord-005453-4057qib7	9429	4	/	/	SYM
cord-005453-4057qib7	9429	5	wk	wk	NN
cord-005453-4057qib7	9429	6	)	)	-RRB-
cord-005453-4057qib7	9429	7	worked	work	VBD
cord-005453-4057qib7	9429	8	as	as	RB
cord-005453-4057qib7	9429	9	well	well	RB
cord-005453-4057qib7	9429	10	as	as	IN
cord-005453-4057qib7	9429	11	TMP	TMP	NNP
cord-005453-4057qib7	9429	12	/	/	SYM
cord-005453-4057qib7	9429	13	SMX	SMX	NNP
cord-005453-4057qib7	9429	14	at	at	IN
cord-005453-4057qib7	9429	15	reducing	reduce	VBG
cord-005453-4057qib7	9429	16	nuclei	nucleus	NNS
cord-005453-4057qib7	9429	17	levels	level	NNS
cord-005453-4057qib7	9429	18	.	.	.
cord-005453-4057qib7	9430	1	Similarly	similarly	RB
cord-005453-4057qib7	9430	2	,	,	,
cord-005453-4057qib7	9430	3	all	all	DT
cord-005453-4057qib7	9430	4	RZF	RZF	NNP
cord-005453-4057qib7	9430	5	groups	group	NNS
cord-005453-4057qib7	9430	6	except	except	IN
cord-005453-4057qib7	9430	7	for	for	IN
cord-005453-4057qib7	9430	8	the	the	DT
cord-005453-4057qib7	9430	9	0.5	0.5	CD
cord-005453-4057qib7	9430	10	mg	mg	NNP
cord-005453-4057qib7	9430	11	/	/	SYM
cord-005453-4057qib7	9430	12	kg	kg	NNP
cord-005453-4057qib7	9430	13	1x	1x	CD
cord-005453-4057qib7	9430	14	/	/	SYM
cord-005453-4057qib7	9430	15	wk	wk	NN
cord-005453-4057qib7	9430	16	group	group	NN
cord-005453-4057qib7	9430	17	showed	show	VBD
cord-005453-4057qib7	9430	18	reductions	reduction	NNS
cord-005453-4057qib7	9430	19	in	in	IN
cord-005453-4057qib7	9430	20	asci	asci	NNP
cord-005453-4057qib7	9430	21	levels	level	NNS
cord-005453-4057qib7	9430	22	comparable	comparable	JJ
cord-005453-4057qib7	9430	23	to	to	IN
cord-005453-4057qib7	9430	24	that	that	DT
cord-005453-4057qib7	9430	25	of	of	IN
cord-005453-4057qib7	9430	26	TMP	TMP	NNP
cord-005453-4057qib7	9430	27	/	/	SYM
cord-005453-4057qib7	9430	28	SMX	SMX	NNP
cord-005453-4057qib7	9430	29	.	.	.
cord-005453-4057qib7	9431	1	The	the	DT
cord-005453-4057qib7	9431	2	survival	survival	NN
cord-005453-4057qib7	9431	3	rates	rate	NNS
cord-005453-4057qib7	9431	4	were	be	VBD
cord-005453-4057qib7	9431	5	not	not	RB
cord-005453-4057qib7	9431	6	statistically	statistically	RB
cord-005453-4057qib7	9431	7	different	different	JJ
cord-005453-4057qib7	9431	8	between	between	IN
cord-005453-4057qib7	9431	9	treatment	treatment	NN
cord-005453-4057qib7	9431	10	groups	group	NNS
cord-005453-4057qib7	9431	11	.	.	.
cord-005453-4057qib7	9432	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9432	2	:	:	:
cord-005453-4057qib7	9433	1	RZF	RZF	NNP
cord-005453-4057qib7	9433	2	demonstrated	demonstrate	VBD
cord-005453-4057qib7	9433	3	potent	potent	JJ
cord-005453-4057qib7	9433	4	in	in	IN
cord-005453-4057qib7	9433	5	vivo	vivo	NN
cord-005453-4057qib7	9433	6	efficacy	efficacy	NN
cord-005453-4057qib7	9433	7	for	for	IN
cord-005453-4057qib7	9433	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9433	9	against	against	IN
cord-005453-4057qib7	9433	10	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9433	11	in	in	IN
cord-005453-4057qib7	9433	12	an	an	DT
cord-005453-4057qib7	9433	13	in	in	IN
cord-005453-4057qib7	9433	14	vivo	vivo	NN
cord-005453-4057qib7	9433	15	mouse	mouse	NN
cord-005453-4057qib7	9433	16	infection	infection	NN
cord-005453-4057qib7	9433	17	model	model	NN
cord-005453-4057qib7	9433	18	at	at	IN
cord-005453-4057qib7	9433	19	dose	dose	NN
cord-005453-4057qib7	9433	20	regimens	regimen	NNS
cord-005453-4057qib7	9433	21	much	much	RB
cord-005453-4057qib7	9433	22	lower	low	JJR
cord-005453-4057qib7	9433	23	than	than	IN
cord-005453-4057qib7	9433	24	the	the	DT
cord-005453-4057qib7	9433	25	human	human	JJ
cord-005453-4057qib7	9433	26	equivalent	equivalent	NN
cord-005453-4057qib7	9433	27	Phase	Phase	NNP
cord-005453-4057qib7	9433	28	3	3	CD
cord-005453-4057qib7	9433	29	regimen	regimen	NN
cord-005453-4057qib7	9433	30	.	.	.
cord-005453-4057qib7	9434	1	These	these	DT
cord-005453-4057qib7	9434	2	data	datum	NNS
cord-005453-4057qib7	9434	3	support	support	VBP
cord-005453-4057qib7	9434	4	the	the	DT
cord-005453-4057qib7	9434	5	development	development	NN
cord-005453-4057qib7	9434	6	of	of	IN
cord-005453-4057qib7	9434	7	RZF	RZF	NNP
cord-005453-4057qib7	9434	8	for	for	IN
cord-005453-4057qib7	9434	9	the	the	DT
cord-005453-4057qib7	9434	10	prevention	prevention	NN
cord-005453-4057qib7	9434	11	of	of	IN
cord-005453-4057qib7	9434	12	invasive	invasive	JJ
cord-005453-4057qib7	9434	13	fungal	fungal	JJ
cord-005453-4057qib7	9434	14	infections	infection	NNS
cord-005453-4057qib7	9434	15	including	include	VBG
cord-005453-4057qib7	9434	16	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9434	17	pneumonia	pneumonia	NN
cord-005453-4057qib7	9434	18	.	.	.
cord-005453-4057qib7	9435	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9435	2	:	:	:
cord-005453-4057qib7	9435	3	Melanie	Melanie	NNP
cord-005453-4057qib7	9435	4	T.	T.	NNP
cord-005453-4057qib7	9435	5	Cushion	Cushion	NNP
cord-005453-4057qib7	9435	6	:	:	:
cord-005453-4057qib7	9435	7	research	research	NN
cord-005453-4057qib7	9435	8	funding	funding	NN
cord-005453-4057qib7	9435	9	(	(	-LRB-
cord-005453-4057qib7	9435	10	Cidara	Cidara	NNP
cord-005453-4057qib7	9435	11	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9435	12	)	)	-RRB-
cord-005453-4057qib7	9436	1	Taylor	Taylor	NNP
cord-005453-4057qib7	9436	2	Sandison	Sandison	NNP
cord-005453-4057qib7	9436	3	:	:	:
cord-005453-4057qib7	9436	4	employee	employee	NN
cord-005453-4057qib7	9436	5	,	,	,
cord-005453-4057qib7	9436	6	stockholder	stockholder	NN
cord-005453-4057qib7	9436	7	(	(	-LRB-
cord-005453-4057qib7	9436	8	Cidara	Cidara	NNP
cord-005453-4057qib7	9436	9	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9436	10	)	)	-RRB-
cord-005453-4057qib7	9437	1	Alan	Alan	NNP
cord-005453-4057qib7	9437	2	Ashbaugh	Ashbaugh	NNP
cord-005453-4057qib7	9437	3	:	:	:
cord-005453-4057qib7	9437	4	Nothing	nothing	NN
cord-005453-4057qib7	9437	5	to	to	TO
cord-005453-4057qib7	9437	6	declare	declare	VB
cord-005453-4057qib7	9437	7	.	.	.
cord-005453-4057qib7	9438	1	Yuhua	Yuhua	NNP
cord-005453-4057qib7	9438	2	Ru	Ru	NNP
cord-005453-4057qib7	9438	3	1,2	1,2	CD
cord-005453-4057qib7	9438	4	,	,	,
cord-005453-4057qib7	9438	5	Ziling	Ziling	NNP
cord-005453-4057qib7	9438	6	Zhu	Zhu	NNP
cord-005453-4057qib7	9438	7	1,2	1,2	CD
cord-005453-4057qib7	9438	8	,	,	,
cord-005453-4057qib7	9438	9	Yang	Yang	NNP
cord-005453-4057qib7	9438	10	Xu	Xu	NNP
cord-005453-4057qib7	9438	11	1,2	1,2	CD
cord-005453-4057qib7	9438	12	,	,	,
cord-005453-4057qib7	9438	13	Suning	Suning	NNP
cord-005453-4057qib7	9438	14	Chen	Chen	NNP
cord-005453-4057qib7	9438	15	1,2	1,2	CD
cord-005453-4057qib7	9439	1	,	,	,
cord-005453-4057qib7	9439	2	Xiaowen	Xiaowen	NNP
cord-005453-4057qib7	9439	3	Tang	Tang	NNP
cord-005453-4057qib7	9439	4	Background	Background	NNP
cord-005453-4057qib7	9439	5	:	:	:
cord-005453-4057qib7	9440	1	Immunocompromising	immunocompromising	NN
cord-005453-4057qib7	9440	2	period	period	NN
cord-005453-4057qib7	9440	3	following	follow	VBG
cord-005453-4057qib7	9440	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	9440	5	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9440	6	stem	stem	NN
cord-005453-4057qib7	9440	7	cell	cell	NN
cord-005453-4057qib7	9440	8	transplantation	transplantation	NN
cord-005453-4057qib7	9440	9	(	(	-LRB-
cord-005453-4057qib7	9440	10	allo	allo	NN
cord-005453-4057qib7	9440	11	-	-	HYPH
cord-005453-4057qib7	9440	12	HSCT	HSCT	NNP
cord-005453-4057qib7	9440	13	)	)	-RRB-
cord-005453-4057qib7	9440	14	may	may	MD
cord-005453-4057qib7	9440	15	allow	allow	VB
cord-005453-4057qib7	9440	16	opportunistic	opportunistic	JJ
cord-005453-4057qib7	9440	17	pathogens	pathogen	NNS
cord-005453-4057qib7	9440	18	to	to	TO
cord-005453-4057qib7	9440	19	thrive	thrive	VB
cord-005453-4057qib7	9440	20	and	and	CC
cord-005453-4057qib7	9440	21	result	result	VB
cord-005453-4057qib7	9440	22	in	in	IN
cord-005453-4057qib7	9440	23	fatal	fatal	JJ
cord-005453-4057qib7	9440	24	complications	complication	NNS
cord-005453-4057qib7	9440	25	.	.	.
cord-005453-4057qib7	9441	1	Epstein	Epstein	NNP
cord-005453-4057qib7	9441	2	-	-	HYPH
cord-005453-4057qib7	9441	3	Barr	Barr	NNP
cord-005453-4057qib7	9441	4	virus	virus	NN
cord-005453-4057qib7	9441	5	(	(	-LRB-
cord-005453-4057qib7	9441	6	EBV	EBV	NNP
cord-005453-4057qib7	9441	7	)	)	-RRB-
cord-005453-4057qib7	9441	8	infects	infect	VBZ
cord-005453-4057qib7	9441	9	more	more	JJR
cord-005453-4057qib7	9441	10	than	than	IN
cord-005453-4057qib7	9441	11	90	90	CD
cord-005453-4057qib7	9441	12	%	%	NN
cord-005453-4057qib7	9441	13	of	of	IN
cord-005453-4057qib7	9441	14	Chinese	chinese	JJ
cord-005453-4057qib7	9441	15	population	population	NN
cord-005453-4057qib7	9441	16	,	,	,
cord-005453-4057qib7	9441	17	and	and	CC
cord-005453-4057qib7	9441	18	its	-PRON-	PRP$
cord-005453-4057qib7	9441	19	reactivation	reactivation	NN
cord-005453-4057qib7	9441	20	after	after	IN
cord-005453-4057qib7	9441	21	HSCT	HSCT	NNP
cord-005453-4057qib7	9441	22	is	be	VBZ
cord-005453-4057qib7	9441	23	one	one	CD
cord-005453-4057qib7	9441	24	of	of	IN
cord-005453-4057qib7	9441	25	the	the	DT
cord-005453-4057qib7	9441	26	major	major	JJ
cord-005453-4057qib7	9441	27	concerns	concern	NNS
cord-005453-4057qib7	9441	28	due	due	IN
cord-005453-4057qib7	9441	29	to	to	IN
cord-005453-4057qib7	9441	30	the	the	DT
cord-005453-4057qib7	9441	31	increased	increase	VBN
cord-005453-4057qib7	9441	32	risk	risk	NN
cord-005453-4057qib7	9441	33	of	of	IN
cord-005453-4057qib7	9441	34	EBV	EBV	NNP
cord-005453-4057qib7	9441	35	diseases	disease	NNS
cord-005453-4057qib7	9441	36	and	and	CC
cord-005453-4057qib7	9441	37	post	post	JJ
cord-005453-4057qib7	9441	38	-	-	JJ
cord-005453-4057qib7	9441	39	transplant	transplant	JJ
cord-005453-4057qib7	9441	40	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	9441	41	disease	disease	NN
cord-005453-4057qib7	9441	42	.	.	.
cord-005453-4057qib7	9442	1	With	with	IN
cord-005453-4057qib7	9442	2	the	the	DT
cord-005453-4057qib7	9442	3	development	development	NN
cord-005453-4057qib7	9442	4	of	of	IN
cord-005453-4057qib7	9442	5	infection	infection	NN
cord-005453-4057qib7	9442	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9442	7	and	and	CC
cord-005453-4057qib7	9442	8	supportive	supportive	JJ
cord-005453-4057qib7	9442	9	care	care	NN
cord-005453-4057qib7	9442	10	after	after	IN
cord-005453-4057qib7	9442	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9442	12	,	,	,
cord-005453-4057qib7	9442	13	demographic	demographic	JJ
cord-005453-4057qib7	9442	14	data	datum	NNS
cord-005453-4057qib7	9442	15	on	on	IN
cord-005453-4057qib7	9442	16	EBV	EBV	NNP
cord-005453-4057qib7	9442	17	reactivation	reactivation	NN
cord-005453-4057qib7	9442	18	post	post	JJ
cord-005453-4057qib7	9442	19	-	-	JJ
cord-005453-4057qib7	9442	20	HSCT	HSCT	NNP
cord-005453-4057qib7	9442	21	needs	need	VBZ
cord-005453-4057qib7	9442	22	to	to	TO
cord-005453-4057qib7	9442	23	be	be	VB
cord-005453-4057qib7	9442	24	updated	update	VBN
cord-005453-4057qib7	9442	25	.	.	.
cord-005453-4057qib7	9443	1	Methods	method	NNS
cord-005453-4057qib7	9443	2	:	:	:
cord-005453-4057qib7	9443	3	We	-PRON-	PRP
cord-005453-4057qib7	9443	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	9443	5	analyzed	analyze	VBD
cord-005453-4057qib7	9443	6	the	the	DT
cord-005453-4057qib7	9443	7	data	datum	NNS
cord-005453-4057qib7	9443	8	of	of	IN
cord-005453-4057qib7	9443	9	patients	patient	NNS
cord-005453-4057qib7	9443	10	who	who	WP
cord-005453-4057qib7	9443	11	received	receive	VBD
cord-005453-4057qib7	9443	12	allo	allo	NN
cord-005453-4057qib7	9443	13	-	-	HYPH
cord-005453-4057qib7	9443	14	HSCT	HSCT	NNP
cord-005453-4057qib7	9443	15	between	between	IN
cord-005453-4057qib7	9443	16	July	July	NNP
cord-005453-4057qib7	9443	17	2011	2011	CD
cord-005453-4057qib7	9443	18	and	and	CC
cord-005453-4057qib7	9443	19	July	July	NNP
cord-005453-4057qib7	9443	20	2014	2014	CD
cord-005453-4057qib7	9443	21	in	in	IN
cord-005453-4057qib7	9443	22	the	the	DT
cord-005453-4057qib7	9443	23	First	First	NNP
cord-005453-4057qib7	9443	24	Affiliated	Affiliated	NNP
cord-005453-4057qib7	9443	25	Hospital	Hospital	NNP
cord-005453-4057qib7	9443	26	of	of	IN
cord-005453-4057qib7	9443	27	Soochow	Soochow	NNP
cord-005453-4057qib7	9443	28	University	University	NNP
cord-005453-4057qib7	9443	29	.	.	.
cord-005453-4057qib7	9444	1	Quantitative	quantitative	JJ
cord-005453-4057qib7	9444	2	PCR	PCR	NNP
cord-005453-4057qib7	9444	3	(	(	-LRB-
cord-005453-4057qib7	9444	4	Q	Q	NNP
cord-005453-4057qib7	9444	5	-	-	HYPH
cord-005453-4057qib7	9444	6	PCR	PCR	NNP
cord-005453-4057qib7	9444	7	)	)	-RRB-
cord-005453-4057qib7	9444	8	was	be	VBD
cord-005453-4057qib7	9444	9	used	use	VBN
cord-005453-4057qib7	9444	10	to	to	TO
cord-005453-4057qib7	9444	11	monitor	monitor	VB
cord-005453-4057qib7	9444	12	EBV	EBV	NNP
cord-005453-4057qib7	9444	13	-	-	HYPH
cord-005453-4057qib7	9444	14	DNA	dna	NN
cord-005453-4057qib7	9444	15	load	load	NN
cord-005453-4057qib7	9444	16	in	in	IN
cord-005453-4057qib7	9444	17	peripheral	peripheral	JJ
cord-005453-4057qib7	9444	18	blood	blood	NN
cord-005453-4057qib7	9444	19	dynamically	dynamically	RB
cord-005453-4057qib7	9444	20	.	.	.
cord-005453-4057qib7	9445	1	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	9445	2	(	(	-LRB-
cord-005453-4057qib7	9445	3	pre	pre	JJ
cord-005453-4057qib7	9445	4	-	-	JJ
cord-005453-4057qib7	9445	5	HSCT	HSCT	NNP
cord-005453-4057qib7	9445	6	)	)	-RRB-
cord-005453-4057qib7	9445	7	followed	follow	VBN
cord-005453-4057qib7	9445	8	by	by	IN
cord-005453-4057qib7	9445	9	acyclovir	acyclovir	NNP
cord-005453-4057qib7	9445	10	was	be	VBD
cord-005453-4057qib7	9445	11	given	give	VBN
cord-005453-4057qib7	9445	12	as	as	IN
cord-005453-4057qib7	9445	13	viral	viral	JJ
cord-005453-4057qib7	9445	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9445	15	.	.	.
cord-005453-4057qib7	9446	1	The	the	DT
cord-005453-4057qib7	9446	2	treatment	treatment	NN
cord-005453-4057qib7	9446	3	protocol	protocol	NN
cord-005453-4057qib7	9446	4	for	for	IN
cord-005453-4057qib7	9446	5	EBV	EBV	NNP
cord-005453-4057qib7	9446	6	reactivation	reactivation	NN
cord-005453-4057qib7	9446	7	consisted	consist	VBD
cord-005453-4057qib7	9446	8	of	of	IN
cord-005453-4057qib7	9446	9	tapering	taper	VBG
cord-005453-4057qib7	9446	10	of	of	IN
cord-005453-4057qib7	9446	11	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	9446	12	agents	agent	NNS
cord-005453-4057qib7	9446	13	,	,	,
cord-005453-4057qib7	9446	14	antiviral	antiviral	JJ
cord-005453-4057qib7	9446	15	agents	agent	NNS
cord-005453-4057qib7	9446	16	(	(	-LRB-
cord-005453-4057qib7	9446	17	including	include	VBG
cord-005453-4057qib7	9446	18	ganciclovir	ganciclovir	NN
cord-005453-4057qib7	9446	19	and	and	CC
cord-005453-4057qib7	9446	20	sodium	sodium	NN
cord-005453-4057qib7	9446	21	phosphonatel	phosphonatel	NN
cord-005453-4057qib7	9446	22	)	)	-RRB-
cord-005453-4057qib7	9446	23	,	,	,
cord-005453-4057qib7	9446	24	and	and	CC
cord-005453-4057qib7	9446	25	rituximab	rituximab	VBN
cord-005453-4057qib7	9446	26	for	for	IN
cord-005453-4057qib7	9446	27	persistent	persistent	JJ
cord-005453-4057qib7	9446	28	positive	positive	JJ
cord-005453-4057qib7	9446	29	patients	patient	NNS
cord-005453-4057qib7	9446	30	.	.	.
cord-005453-4057qib7	9447	1	Results	result	NNS
cord-005453-4057qib7	9447	2	:	:	:
cord-005453-4057qib7	9448	1	Totally	totally	RB
cord-005453-4057qib7	9448	2	890	890	CD
cord-005453-4057qib7	9448	3	cases	case	NNS
cord-005453-4057qib7	9448	4	from	from	IN
cord-005453-4057qib7	9448	5	most	most	JJS
cord-005453-4057qib7	9448	6	of	of	IN
cord-005453-4057qib7	9448	7	the	the	DT
cord-005453-4057qib7	9448	8	provinces	province	NNS
cord-005453-4057qib7	9448	9	in	in	IN
cord-005453-4057qib7	9448	10	China	China	NNP
cord-005453-4057qib7	9448	11	were	be	VBD
cord-005453-4057qib7	9448	12	enrolled	enrol	VBN
cord-005453-4057qib7	9448	13	(	(	-LRB-
cord-005453-4057qib7	9448	14	characterized	characterize	VBN
cord-005453-4057qib7	9448	15	in	in	IN
cord-005453-4057qib7	9448	16	Table	Table	NNP
cord-005453-4057qib7	9448	17	1	1	CD
cord-005453-4057qib7	9448	18	)	)	-RRB-
cord-005453-4057qib7	9448	19	,	,	,
cord-005453-4057qib7	9448	20	among	among	IN
cord-005453-4057qib7	9448	21	whom	whom	WP
cord-005453-4057qib7	9448	22	EBV	EBV	NNP
cord-005453-4057qib7	9448	23	reactivation	reactivation	NN
cord-005453-4057qib7	9448	24	developed	develop	VBN
cord-005453-4057qib7	9448	25	in	in	IN
cord-005453-4057qib7	9448	26	175	175	CD
cord-005453-4057qib7	9448	27	recipients	recipient	NNS
cord-005453-4057qib7	9448	28	.	.	.
cord-005453-4057qib7	9449	1	Most	Most	JJS
cord-005453-4057qib7	9449	2	reactivation	reactivation	NN
cord-005453-4057qib7	9449	3	events	event	NNS
cord-005453-4057qib7	9449	4	(	(	-LRB-
cord-005453-4057qib7	9449	5	95.4	95.4	CD
cord-005453-4057qib7	9449	6	%	%	NN
cord-005453-4057qib7	9449	7	)	)	-RRB-
cord-005453-4057qib7	9449	8	occurred	occur	VBD
cord-005453-4057qib7	9449	9	in	in	IN
cord-005453-4057qib7	9449	10	the	the	DT
cord-005453-4057qib7	9449	11	first	first	JJ
cord-005453-4057qib7	9449	12	year	year	NN
cord-005453-4057qib7	9449	13	post	post	NN
cord-005453-4057qib7	9449	14	-	-	JJ
cord-005453-4057qib7	9449	15	HSCT	HSCT	NNP
cord-005453-4057qib7	9449	16	,	,	,
cord-005453-4057qib7	9449	17	with	with	IN
cord-005453-4057qib7	9449	18	a	a	DT
cord-005453-4057qib7	9449	19	peak	peak	NN
cord-005453-4057qib7	9449	20	of	of	IN
cord-005453-4057qib7	9449	21	113.8	113.8	CD
cord-005453-4057qib7	9449	22	incidence	incidence	NN
cord-005453-4057qib7	9449	23	rates	rate	NNS
cord-005453-4057qib7	9449	24	per	per	IN
cord-005453-4057qib7	9449	25	100	100	CD
cord-005453-4057qib7	9449	26	personyears	personyear	NNS
cord-005453-4057qib7	9449	27	at	at	IN
cord-005453-4057qib7	9449	28	the	the	DT
cord-005453-4057qib7	9449	29	second	second	JJ
cord-005453-4057qib7	9449	30	month	month	NN
cord-005453-4057qib7	9449	31	.	.	.
cord-005453-4057qib7	9450	1	Besides	besides	RB
cord-005453-4057qib7	9450	2	,	,	,
cord-005453-4057qib7	9450	3	more	more	JJR
cord-005453-4057qib7	9450	4	episodes	episode	NNS
cord-005453-4057qib7	9450	5	of	of	IN
cord-005453-4057qib7	9450	6	lateonset	lateonset	NN
cord-005453-4057qib7	9450	7	reactivation	reactivation	NN
cord-005453-4057qib7	9450	8	occurred	occur	VBD
cord-005453-4057qib7	9450	9	in	in	IN
cord-005453-4057qib7	9450	10	patients	patient	NNS
cord-005453-4057qib7	9450	11	receiving	receive	VBG
cord-005453-4057qib7	9450	12	grafts	graft	NNS
cord-005453-4057qib7	9450	13	from	from	IN
cord-005453-4057qib7	9450	14	haploidientical	haploidientical	JJ
cord-005453-4057qib7	9450	15	donors	donor	NNS
cord-005453-4057qib7	9450	16	(	(	-LRB-
cord-005453-4057qib7	9450	17	Figure	figure	NN
cord-005453-4057qib7	9450	18	1A	1a	NN
cord-005453-4057qib7	9450	19	)	)	-RRB-
cord-005453-4057qib7	9450	20	.	.	.
cord-005453-4057qib7	9451	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	9451	2	analyses	analysis	NNS
cord-005453-4057qib7	9451	3	revealed	reveal	VBD
cord-005453-4057qib7	9451	4	that	that	IN
cord-005453-4057qib7	9451	5	the	the	DT
cord-005453-4057qib7	9451	6	major	major	JJ
cord-005453-4057qib7	9451	7	impactors	impactor	NNS
cord-005453-4057qib7	9451	8	of	of	IN
cord-005453-4057qib7	9451	9	EBV	EBV	NNP
cord-005453-4057qib7	9451	10	reactivation	reactivation	NN
cord-005453-4057qib7	9451	11	included	include	VBD
cord-005453-4057qib7	9451	12	ATG	ATG	NNP
cord-005453-4057qib7	9451	13	as	as	IN
cord-005453-4057qib7	9451	14	GVHD	GVHD	NNP
cord-005453-4057qib7	9451	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9451	16	(	(	-LRB-
cord-005453-4057qib7	9451	17	p	p	NN
cord-005453-4057qib7	9451	18	<	<	XX
cord-005453-4057qib7	9451	19	0.001	0.001	CD
cord-005453-4057qib7	9451	20	)	)	-RRB-
cord-005453-4057qib7	9451	21	,	,	,
cord-005453-4057qib7	9451	22	HLAmismatched	hlamismatched	JJ
cord-005453-4057qib7	9451	23	donor	donor	NN
cord-005453-4057qib7	9451	24	(	(	-LRB-
cord-005453-4057qib7	9451	25	p=0.001	p=0.001	NNP
cord-005453-4057qib7	9451	26	)	)	-RRB-
cord-005453-4057qib7	9451	27	and	and	CC
cord-005453-4057qib7	9451	28	the	the	DT
cord-005453-4057qib7	9451	29	appearance	appearance	NN
cord-005453-4057qib7	9451	30	of	of	IN
cord-005453-4057qib7	9451	31	chornic	chornic	NNP
cord-005453-4057qib7	9451	32	GVHD	GVHD	NNP
cord-005453-4057qib7	9451	33	(	(	-LRB-
cord-005453-4057qib7	9451	34	p=0.042	p=0.042	NNP
cord-005453-4057qib7	9451	35	)	)	-RRB-
cord-005453-4057qib7	9451	36	.	.	.
cord-005453-4057qib7	9452	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	9452	2	incidence	incidence	NN
cord-005453-4057qib7	9452	3	of	of	IN
cord-005453-4057qib7	9452	4	EBV	EBV	NNP
cord-005453-4057qib7	9452	5	reactivation	reactivation	NN
cord-005453-4057qib7	9452	6	was	be	VBD
cord-005453-4057qib7	9452	7	low	low	JJ
cord-005453-4057qib7	9452	8	(	(	-LRB-
cord-005453-4057qib7	9452	9	2.9	2.9	CD
cord-005453-4057qib7	9452	10	%	%	NN
cord-005453-4057qib7	9452	11	)	)	-RRB-
cord-005453-4057qib7	9452	12	among	among	IN
cord-005453-4057qib7	9452	13	890	890	CD
cord-005453-4057qib7	9452	14	patients	patient	NNS
cord-005453-4057qib7	9452	15	with	with	IN
cord-005453-4057qib7	9452	16	no	no	DT
cord-005453-4057qib7	9452	17	major	major	JJ
cord-005453-4057qib7	9452	18	risk	risk	NN
cord-005453-4057qib7	9452	19	factors	factor	NNS
cord-005453-4057qib7	9452	20	,	,	,
cord-005453-4057qib7	9452	21	but	but	CC
cord-005453-4057qib7	9452	22	increased	increase	VBD
cord-005453-4057qib7	9452	23	to	to	IN
cord-005453-4057qib7	9452	24	11.7	11.7	CD
cord-005453-4057qib7	9452	25	%	%	NN
cord-005453-4057qib7	9452	26	,	,	,
cord-005453-4057qib7	9452	27	27.3	27.3	CD
cord-005453-4057qib7	9452	28	%	%	NN
cord-005453-4057qib7	9452	29	or	or	CC
cord-005453-4057qib7	9452	30	41.9	41.9	CD
cord-005453-4057qib7	9452	31	%	%	NN
cord-005453-4057qib7	9452	32	with	with	IN
cord-005453-4057qib7	9452	33	1	1	CD
cord-005453-4057qib7	9452	34	,	,	,
cord-005453-4057qib7	9452	35	2	2	CD
cord-005453-4057qib7	9452	36	,	,	,
cord-005453-4057qib7	9452	37	and	and	CC
cord-005453-4057qib7	9452	38	3	3	CD
cord-005453-4057qib7	9452	39	major	major	JJ
cord-005453-4057qib7	9452	40	risk	risk	NN
cord-005453-4057qib7	9452	41	factors	factor	NNS
cord-005453-4057qib7	9452	42	,	,	,
cord-005453-4057qib7	9452	43	respectively	respectively	RB
cord-005453-4057qib7	9452	44	(	(	-LRB-
cord-005453-4057qib7	9452	45	Figure	figure	NN
cord-005453-4057qib7	9452	46	1B	1b	CD
cord-005453-4057qib7	9452	47	)	)	-RRB-
cord-005453-4057qib7	9452	48	.	.	.
cord-005453-4057qib7	9453	1	There	there	EX
cord-005453-4057qib7	9453	2	was	be	VBD
cord-005453-4057qib7	9453	3	no	no	DT
cord-005453-4057qib7	9453	4	statistical	statistical	JJ
cord-005453-4057qib7	9453	5	difference	difference	NN
cord-005453-4057qib7	9453	6	of	of	IN
cord-005453-4057qib7	9453	7	overall	overall	JJ
cord-005453-4057qib7	9453	8	survival	survival	NN
cord-005453-4057qib7	9453	9	between	between	IN
cord-005453-4057qib7	9453	10	people	people	NNS
cord-005453-4057qib7	9453	11	with	with	IN
cord-005453-4057qib7	9453	12	or	or	CC
cord-005453-4057qib7	9453	13	without	without	IN
cord-005453-4057qib7	9453	14	EBV	EBV	NNP
cord-005453-4057qib7	9453	15	reactivation	reactivation	NN
cord-005453-4057qib7	9453	16	(	(	-LRB-
cord-005453-4057qib7	9453	17	p=0.871	p=0.871	NN
cord-005453-4057qib7	9453	18	)	)	-RRB-
cord-005453-4057qib7	9453	19	.	.	.
cord-005453-4057qib7	9454	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9454	2	:	:	:
cord-005453-4057qib7	9455	1	We	-PRON-	PRP
cord-005453-4057qib7	9455	2	concluded	conclude	VBD
cord-005453-4057qib7	9455	3	that	that	IN
cord-005453-4057qib7	9455	4	there	there	EX
cord-005453-4057qib7	9455	5	are	be	VBP
cord-005453-4057qib7	9455	6	similar	similar	JJ
cord-005453-4057qib7	9455	7	EBV	EBV	NNP
cord-005453-4057qib7	9455	8	reactivation	reactivation	NN
cord-005453-4057qib7	9455	9	impactors	impactor	NNS
cord-005453-4057qib7	9455	10	in	in	IN
cord-005453-4057qib7	9455	11	Chinese	chinese	JJ
cord-005453-4057qib7	9455	12	population	population	NN
cord-005453-4057qib7	9455	13	compared	compare	VBN
cord-005453-4057qib7	9455	14	to	to	IN
cord-005453-4057qib7	9455	15	literatures	literature	NNS
cord-005453-4057qib7	9455	16	,	,	,
cord-005453-4057qib7	9455	17	including	include	VBG
cord-005453-4057qib7	9455	18	ATG	ATG	NNP
cord-005453-4057qib7	9455	19	use	use	NN
cord-005453-4057qib7	9455	20	,	,	,
cord-005453-4057qib7	9455	21	HLA	HLA	NNP
cord-005453-4057qib7	9455	22	-	-	HYPH
cord-005453-4057qib7	9455	23	mismatched	mismatch	VBN
cord-005453-4057qib7	9455	24	donor	donor	NN
cord-005453-4057qib7	9455	25	and	and	CC
cord-005453-4057qib7	9455	26	the	the	DT
cord-005453-4057qib7	9455	27	appearance	appearance	NN
cord-005453-4057qib7	9455	28	of	of	IN
cord-005453-4057qib7	9455	29	chronic	chronic	JJ
cord-005453-4057qib7	9455	30	GVHD	GVHD	NNP
cord-005453-4057qib7	9455	31	.	.	.
cord-005453-4057qib7	9456	1	Additionally	additionally	RB
cord-005453-4057qib7	9456	2	,	,	,
cord-005453-4057qib7	9456	3	incidences	incidence	NNS
cord-005453-4057qib7	9456	4	of	of	IN
cord-005453-4057qib7	9456	5	EBV	EBV	NNP
cord-005453-4057qib7	9456	6	reactivation	reactivation	NN
cord-005453-4057qib7	9456	7	increased	increase	VBD
cord-005453-4057qib7	9456	8	significantly	significantly	RB
cord-005453-4057qib7	9456	9	with	with	IN
cord-005453-4057qib7	9456	10	the	the	DT
cord-005453-4057qib7	9456	11	accumulation	accumulation	NN
cord-005453-4057qib7	9456	12	of	of	IN
cord-005453-4057qib7	9456	13	risk	risk	NN
cord-005453-4057qib7	9456	14	factors	factor	NNS
cord-005453-4057qib7	9456	15	.	.	.
cord-005453-4057qib7	9457	1	However	however	RB
cord-005453-4057qib7	9457	2	,	,	,
cord-005453-4057qib7	9457	3	EBV	EBV	NNP
cord-005453-4057qib7	9457	4	reactivation	reactivation	NN
cord-005453-4057qib7	9457	5	had	have	VBD
cord-005453-4057qib7	9457	6	no	no	DT
cord-005453-4057qib7	9457	7	impact	impact	NN
cord-005453-4057qib7	9457	8	on	on	IN
cord-005453-4057qib7	9457	9	overall	overall	JJ
cord-005453-4057qib7	9457	10	survival	survival	NN
cord-005453-4057qib7	9457	11	in	in	IN
cord-005453-4057qib7	9457	12	current	current	JJ
cord-005453-4057qib7	9457	13	virus	virus	NN
cord-005453-4057qib7	9457	14	management	management	NN
cord-005453-4057qib7	9457	15	protocol	protocol	NN
cord-005453-4057qib7	9457	16	.	.	.
cord-005453-4057qib7	9458	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9458	2	:	:	:
cord-005453-4057qib7	9458	3	Nothing	nothing	NN
cord-005453-4057qib7	9458	4	to	to	TO
cord-005453-4057qib7	9458	5	declare	declare	VB
cord-005453-4057qib7	9458	6	Background	background	NN
cord-005453-4057qib7	9458	7	:	:	:
cord-005453-4057qib7	9459	1	Several	several	JJ
cord-005453-4057qib7	9459	2	studies	study	NNS
cord-005453-4057qib7	9459	3	have	have	VBP
cord-005453-4057qib7	9459	4	shown	show	VBN
cord-005453-4057qib7	9459	5	loss	loss	NN
cord-005453-4057qib7	9459	6	of	of	IN
cord-005453-4057qib7	9459	7	diversity	diversity	NN
cord-005453-4057qib7	9459	8	of	of	IN
cord-005453-4057qib7	9459	9	the	the	DT
cord-005453-4057qib7	9459	10	gut	gut	NN
cord-005453-4057qib7	9459	11	microbiome	microbiome	NN
cord-005453-4057qib7	9459	12	in	in	IN
cord-005453-4057qib7	9459	13	association	association	NN
cord-005453-4057qib7	9459	14	with	with	IN
cord-005453-4057qib7	9459	15	significant	significant	JJ
cord-005453-4057qib7	9459	16	gut	gut	NN
cord-005453-4057qib7	9459	17	injury	injury	NN
cord-005453-4057qib7	9459	18	following	follow	VBG
cord-005453-4057qib7	9459	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9459	20	stem	stem	NN
cord-005453-4057qib7	9459	21	cell	cell	NN
cord-005453-4057qib7	9459	22	transplantation	transplantation	NN
cord-005453-4057qib7	9459	23	(	(	-LRB-
cord-005453-4057qib7	9459	24	HSCT	HSCT	NNP
cord-005453-4057qib7	9459	25	)	)	-RRB-
cord-005453-4057qib7	9459	26	.	.	.
cord-005453-4057qib7	9460	1	Prolonged	prolonged	JJ
cord-005453-4057qib7	9460	2	broad	broad	JJ
cord-005453-4057qib7	9460	3	spectrum	spectrum	NN
cord-005453-4057qib7	9460	4	antibiotic	antibiotic	NN
cord-005453-4057qib7	9460	5	use	use	NN
cord-005453-4057qib7	9460	6	further	further	RB
cord-005453-4057qib7	9460	7	promotes	promote	VBZ
cord-005453-4057qib7	9460	8	loss	loss	NN
cord-005453-4057qib7	9460	9	of	of	IN
cord-005453-4057qib7	9460	10	microbiome	microbiome	NN
cord-005453-4057qib7	9460	11	diversity	diversity	NN
cord-005453-4057qib7	9460	12	and	and	CC
cord-005453-4057qib7	9460	13	increases	increase	VBZ
cord-005453-4057qib7	9460	14	the	the	DT
cord-005453-4057qib7	9460	15	risk	risk	NN
cord-005453-4057qib7	9460	16	of	of	IN
cord-005453-4057qib7	9460	17	intestinal	intestinal	JJ
cord-005453-4057qib7	9460	18	colonization	colonization	NN
cord-005453-4057qib7	9460	19	by	by	IN
cord-005453-4057qib7	9460	20	multi	multi	JJ
cord-005453-4057qib7	9460	21	-	-	JJ
cord-005453-4057qib7	9460	22	drug	drug	JJ
cord-005453-4057qib7	9460	23	-	-	HYPH
cord-005453-4057qib7	9460	24	resistant	resistant	JJ
cord-005453-4057qib7	9460	25	(	(	-LRB-
cord-005453-4057qib7	9460	26	MDR	MDR	NNP
cord-005453-4057qib7	9460	27	)	)	-RRB-
cord-005453-4057qib7	9460	28	bacteria	bacteria	NNS
cord-005453-4057qib7	9460	29	.	.	.
cord-005453-4057qib7	9461	1	Aims	aim	NNS
cord-005453-4057qib7	9461	2	of	of	IN
cord-005453-4057qib7	9461	3	this	this	DT
cord-005453-4057qib7	9461	4	study	study	NN
cord-005453-4057qib7	9461	5	were	be	VBD
cord-005453-4057qib7	9461	6	to	to	TO
cord-005453-4057qib7	9461	7	prospectively	prospectively	RB
cord-005453-4057qib7	9461	8	evaluate	evaluate	VB
cord-005453-4057qib7	9461	9	the	the	DT
cord-005453-4057qib7	9461	10	overall	overall	JJ
cord-005453-4057qib7	9461	11	changes	change	NNS
cord-005453-4057qib7	9461	12	in	in	IN
cord-005453-4057qib7	9461	13	gut	gut	NN
cord-005453-4057qib7	9461	14	microbiome	microbiome	NN
cord-005453-4057qib7	9461	15	composition	composition	NN
cord-005453-4057qib7	9461	16	after	after	IN
cord-005453-4057qib7	9461	17	HSCT	HSCT	NNP
cord-005453-4057qib7	9461	18	and	and	CC
cord-005453-4057qib7	9461	19	differences	difference	NNS
cord-005453-4057qib7	9461	20	in	in	IN
cord-005453-4057qib7	9461	21	patients	patient	NNS
cord-005453-4057qib7	9461	22	colonized	colonize	VBN
cord-005453-4057qib7	9461	23	by	by	IN
cord-005453-4057qib7	9461	24	MDR	MDR	NNP
cord-005453-4057qib7	9461	25	bacteria	bacteria	NNS
cord-005453-4057qib7	9461	26	and	and	CC
cord-005453-4057qib7	9461	27	treated	treat	VBN
cord-005453-4057qib7	9461	28	with	with	IN
cord-005453-4057qib7	9461	29	carbapenems	carbapenem	NNS
cord-005453-4057qib7	9461	30	.	.	.
cord-005453-4057qib7	9462	1	Methods	method	NNS
cord-005453-4057qib7	9463	1	:	:	:
cord-005453-4057qib7	9463	2	We	-PRON-	PRP
cord-005453-4057qib7	9463	3	performed	perform	VBD
cord-005453-4057qib7	9463	4	a	a	DT
cord-005453-4057qib7	9463	5	prospective	prospective	JJ
cord-005453-4057qib7	9463	6	observational	observational	JJ
cord-005453-4057qib7	9463	7	study	study	NN
cord-005453-4057qib7	9463	8	evaluating	evaluate	VBG
cord-005453-4057qib7	9463	9	the	the	DT
cord-005453-4057qib7	9463	10	gut	gut	NN
cord-005453-4057qib7	9463	11	microbiota	microbiota	NN
cord-005453-4057qib7	9463	12	of	of	IN
cord-005453-4057qib7	9463	13	20	20	CD
cord-005453-4057qib7	9463	14	hematological	hematological	JJ
cord-005453-4057qib7	9463	15	patients	patient	NNS
cord-005453-4057qib7	9463	16	undergoing	undergo	VBG
cord-005453-4057qib7	9463	17	HSCT	HSCT	NNP
cord-005453-4057qib7	9463	18	,	,	,
cord-005453-4057qib7	9463	19	from	from	IN
cord-005453-4057qib7	9463	20	admission	admission	NN
cord-005453-4057qib7	9463	21	(	(	-LRB-
cord-005453-4057qib7	9463	22	T0	T0	NNP
cord-005453-4057qib7	9463	23	)	)	-RRB-
cord-005453-4057qib7	9463	24	through	through	IN
cord-005453-4057qib7	9463	25	day	day	NN
cord-005453-4057qib7	9463	26	+28	+28	NNP
cord-005453-4057qib7	9463	27	(	(	-LRB-
cord-005453-4057qib7	9463	28	T5	T5	NNP
cord-005453-4057qib7	9463	29	)	)	-RRB-
cord-005453-4057qib7	9463	30	.	.	.
cord-005453-4057qib7	9464	1	Fecal	fecal	JJ
cord-005453-4057qib7	9464	2	microbiota	microbiota	NN
cord-005453-4057qib7	9464	3	was	be	VBD
cord-005453-4057qib7	9464	4	assessed	assess	VBN
cord-005453-4057qib7	9464	5	by	by	IN
cord-005453-4057qib7	9464	6	16S	16s	JJ
cord-005453-4057qib7	9464	7	amplicon	amplicon	NN
cord-005453-4057qib7	9464	8	-	-	HYPH
cord-005453-4057qib7	9464	9	based	base	VBN
cord-005453-4057qib7	9464	10	sequencing	sequencing	NN
cord-005453-4057qib7	9464	11	.	.	.
cord-005453-4057qib7	9465	1	Clinical	clinical	JJ
cord-005453-4057qib7	9465	2	,	,	,
cord-005453-4057qib7	9465	3	and	and	CC
cord-005453-4057qib7	9465	4	microbiological	microbiological	JJ
cord-005453-4057qib7	9465	5	data	datum	NNS
cord-005453-4057qib7	9465	6	as	as	RB
cord-005453-4057qib7	9465	7	well	well	RB
cord-005453-4057qib7	9465	8	as	as	IN
cord-005453-4057qib7	9465	9	fecal	fecal	JJ
cord-005453-4057qib7	9465	10	samples	sample	NNS
cord-005453-4057qib7	9465	11	were	be	VBD
cord-005453-4057qib7	9465	12	collected	collect	VBN
cord-005453-4057qib7	9465	13	every	every	DT
cord-005453-4057qib7	9465	14	7	7	CD
cord-005453-4057qib7	9465	15	th	th	DT
cord-005453-4057qib7	9465	16	day	day	NN
cord-005453-4057qib7	9465	17	from	from	IN
cord-005453-4057qib7	9465	18	admission	admission	NN
cord-005453-4057qib7	9465	19	.	.	.
cord-005453-4057qib7	9466	1	Results	result	NNS
cord-005453-4057qib7	9466	2	:	:	:
cord-005453-4057qib7	9467	1	One	one	CD
cord-005453-4057qib7	9467	2	-	-	HYPH
cord-005453-4057qib7	9467	3	hundred	hundred	CD
cord-005453-4057qib7	9467	4	fecal	fecal	JJ
cord-005453-4057qib7	9467	5	samples	sample	NNS
cord-005453-4057qib7	9467	6	were	be	VBD
cord-005453-4057qib7	9467	7	analyzed	analyze	VBN
cord-005453-4057qib7	9467	8	.	.	.
cord-005453-4057qib7	9468	1	Overall	overall	RB
cord-005453-4057qib7	9468	2	,	,	,
cord-005453-4057qib7	9468	3	we	-PRON-	PRP
cord-005453-4057qib7	9468	4	found	find	VBD
cord-005453-4057qib7	9468	5	a	a	DT
cord-005453-4057qib7	9468	6	progressive	progressive	JJ
cord-005453-4057qib7	9468	7	decrease	decrease	NN
cord-005453-4057qib7	9468	8	of	of	IN
cord-005453-4057qib7	9468	9	bacterial	bacterial	JJ
cord-005453-4057qib7	9468	10	richness	richness	NN
cord-005453-4057qib7	9468	11	from	from	IN
cord-005453-4057qib7	9468	12	T0	T0	NNP
cord-005453-4057qib7	9468	13	to	to	IN
cord-005453-4057qib7	9468	14	T5	T5	NNP
cord-005453-4057qib7	9468	15	,	,	,
cord-005453-4057qib7	9468	16	with	with	IN
cord-005453-4057qib7	9468	17	a	a	DT
cord-005453-4057qib7	9468	18	significant	significant	JJ
cord-005453-4057qib7	9468	19	reduction	reduction	NN
cord-005453-4057qib7	9468	20	of	of	IN
cord-005453-4057qib7	9468	21	Blautia	Blautia	NNP
cord-005453-4057qib7	9468	22	,	,	,
cord-005453-4057qib7	9468	23	Ruminococcus	Ruminococcus	NNP
cord-005453-4057qib7	9468	24	and	and	CC
cord-005453-4057qib7	9468	25	Dorea	Dorea	NNP
cord-005453-4057qib7	9468	26	species	specie	NNS
cord-005453-4057qib7	9468	27	,	,	,
cord-005453-4057qib7	9468	28	which	which	WDT
cord-005453-4057qib7	9468	29	are	be	VBP
cord-005453-4057qib7	9468	30	strictly	strictly	RB
cord-005453-4057qib7	9468	31	associated	associate	VBN
cord-005453-4057qib7	9468	32	with	with	IN
cord-005453-4057qib7	9468	33	the	the	DT
cord-005453-4057qib7	9468	34	production	production	NN
cord-005453-4057qib7	9468	35	of	of	IN
cord-005453-4057qib7	9468	36	short	short	JJ
cord-005453-4057qib7	9468	37	chain	chain	NN
cord-005453-4057qib7	9468	38	fatty	fatty	JJ
cord-005453-4057qib7	9468	39	acids	acid	NNS
cord-005453-4057qib7	9468	40	(	(	-LRB-
cord-005453-4057qib7	9468	41	SCA	SCA	NNP
cord-005453-4057qib7	9468	42	)	)	-RRB-
cord-005453-4057qib7	9468	43	(	(	-LRB-
cord-005453-4057qib7	9468	44	Fig.1	Fig.1	NNP
cord-005453-4057qib7	9468	45	)	)	-RRB-
cord-005453-4057qib7	9468	46	.	.	.
cord-005453-4057qib7	9469	1	Moreover	moreover	RB
cord-005453-4057qib7	9469	2	,	,	,
cord-005453-4057qib7	9469	3	in	in	IN
cord-005453-4057qib7	9469	4	the	the	DT
cord-005453-4057qib7	9469	5	30	30	CD
cord-005453-4057qib7	9469	6	%	%	NN
cord-005453-4057qib7	9469	7	(	(	-LRB-
cord-005453-4057qib7	9469	8	no.6	no.6	NNP
cord-005453-4057qib7	9469	9	)	)	-RRB-
cord-005453-4057qib7	9469	10	of	of	IN
cord-005453-4057qib7	9469	11	patients	patient	NNS
cord-005453-4057qib7	9469	12	who	who	WP
cord-005453-4057qib7	9469	13	were	be	VBD
cord-005453-4057qib7	9469	14	colonized	colonize	VBN
cord-005453-4057qib7	9469	15	by	by	IN
cord-005453-4057qib7	9469	16	ESBL	ESBL	NNP
cord-005453-4057qib7	9469	17	bacteria	bacteria	NNS
cord-005453-4057qib7	9469	18	,	,	,
cord-005453-4057qib7	9469	19	we	-PRON-	PRP
cord-005453-4057qib7	9469	20	observed	observe	VBD
cord-005453-4057qib7	9469	21	a	a	DT
cord-005453-4057qib7	9469	22	significant	significant	JJ
cord-005453-4057qib7	9469	23	reduction	reduction	NN
cord-005453-4057qib7	9469	24	of	of	IN
cord-005453-4057qib7	9469	25	Clostridium	clostridium	NN
cord-005453-4057qib7	9469	26	spp	spp	NNS
cord-005453-4057qib7	9469	27	and	and	CC
cord-005453-4057qib7	9469	28	Bifidobacterium	bifidobacterium	NN
cord-005453-4057qib7	9469	29	species	specie	NNS
cord-005453-4057qib7	9469	30	.	.	.
cord-005453-4057qib7	9470	1	As	as	IN
cord-005453-4057qib7	9470	2	for	for	IN
cord-005453-4057qib7	9470	3	antibiotic	antibiotic	JJ
cord-005453-4057qib7	9470	4	therapies	therapy	NNS
cord-005453-4057qib7	9470	5	,	,	,
cord-005453-4057qib7	9470	6	carbapenems	carbapenem	NNS
cord-005453-4057qib7	9470	7	were	be	VBD
cord-005453-4057qib7	9470	8	used	use	VBN
cord-005453-4057qib7	9470	9	as	as	IN
cord-005453-4057qib7	9470	10	second	second	JJ
cord-005453-4057qib7	9470	11	line	line	NN
cord-005453-4057qib7	9470	12	treatment	treatment	NN
cord-005453-4057qib7	9470	13	of	of	IN
cord-005453-4057qib7	9470	14	febrile	febrile	JJ
cord-005453-4057qib7	9470	15	neutropenia	neutropenia	NN
cord-005453-4057qib7	9470	16	in	in	IN
cord-005453-4057qib7	9470	17	50	50	CD
cord-005453-4057qib7	9470	18	%	%	NN
cord-005453-4057qib7	9470	19	(	(	-LRB-
cord-005453-4057qib7	9470	20	no	no	DT
cord-005453-4057qib7	9470	21	9	9	CD
cord-005453-4057qib7	9470	22	)	)	-RRB-
cord-005453-4057qib7	9470	23	of	of	IN
cord-005453-4057qib7	9470	24	cases	case	NNS
cord-005453-4057qib7	9470	25	,	,	,
cord-005453-4057qib7	9470	26	usually	usually	RB
cord-005453-4057qib7	9470	27	associated	associate	VBN
cord-005453-4057qib7	9470	28	with	with	IN
cord-005453-4057qib7	9470	29	aminoglycosides	aminoglycoside	NNS
cord-005453-4057qib7	9470	30	.	.	.
cord-005453-4057qib7	9471	1	In	in	IN
cord-005453-4057qib7	9471	2	patients	patient	NNS
cord-005453-4057qib7	9471	3	treated	treat	VBN
cord-005453-4057qib7	9471	4	with	with	IN
cord-005453-4057qib7	9471	5	meropenem	meropenem	NNP
cord-005453-4057qib7	9471	6	,	,	,
cord-005453-4057qib7	9471	7	a	a	DT
cord-005453-4057qib7	9471	8	strong	strong	JJ
cord-005453-4057qib7	9471	9	decline	decline	NN
cord-005453-4057qib7	9471	10	of	of	IN
cord-005453-4057qib7	9471	11	Blautia	Blautia	NNP
cord-005453-4057qib7	9471	12	and	and	CC
cord-005453-4057qib7	9471	13	Ruminococcus	Ruminococcus	NNP
cord-005453-4057qib7	9471	14	species	specie	NNS
cord-005453-4057qib7	9471	15	was	be	VBD
cord-005453-4057qib7	9471	16	observed	observe	VBN
cord-005453-4057qib7	9471	17	.	.	.
cord-005453-4057qib7	9472	1	This	this	DT
cord-005453-4057qib7	9472	2	finding	finding	NN
cord-005453-4057qib7	9472	3	suggests	suggest	VBZ
cord-005453-4057qib7	9472	4	a	a	DT
cord-005453-4057qib7	9472	5	correlation	correlation	NN
cord-005453-4057qib7	9472	6	between	between	IN
cord-005453-4057qib7	9472	7	carbapenem	carbapenem	NNP
cord-005453-4057qib7	9472	8	regimens	regimen	NNS
cord-005453-4057qib7	9472	9	and	and	CC
cord-005453-4057qib7	9472	10	increase	increase	NN
cord-005453-4057qib7	9472	11	of	of	IN
cord-005453-4057qib7	9472	12	pro	pro	JJ
cord-005453-4057qib7	9472	13	-	-	JJ
cord-005453-4057qib7	9472	14	inflammatory	inflammatory	JJ
cord-005453-4057qib7	9472	15	bacterial	bacterial	JJ
cord-005453-4057qib7	9472	16	strains	strain	NNS
cord-005453-4057qib7	9472	17	in	in	IN
cord-005453-4057qib7	9472	18	the	the	DT
cord-005453-4057qib7	9472	19	gut	gut	NN
cord-005453-4057qib7	9472	20	.	.	.
cord-005453-4057qib7	9473	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9473	2	:	:	:
cord-005453-4057qib7	9474	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9474	2	data	data	NN
cord-005453-4057qib7	9474	3	support	support	VBP
cord-005453-4057qib7	9474	4	the	the	DT
cord-005453-4057qib7	9474	5	hypothesis	hypothesis	NN
cord-005453-4057qib7	9474	6	that	that	DT
cord-005453-4057qib7	9474	7	loss	loss	NN
cord-005453-4057qib7	9474	8	of	of	IN
cord-005453-4057qib7	9474	9	intestinal	intestinal	JJ
cord-005453-4057qib7	9474	10	commensals	commensal	NNS
cord-005453-4057qib7	9474	11	that	that	WDT
cord-005453-4057qib7	9474	12	produce	produce	VBP
cord-005453-4057qib7	9474	13	short	short	JJ
cord-005453-4057qib7	9474	14	-	-	HYPH
cord-005453-4057qib7	9474	15	chain	chain	NN
cord-005453-4057qib7	9474	16	fatty	fatty	JJ
cord-005453-4057qib7	9474	17	acids	acid	NNS
cord-005453-4057qib7	9474	18	may	may	MD
cord-005453-4057qib7	9474	19	increase	increase	VB
cord-005453-4057qib7	9474	20	dysbiosis	dysbiosis	NN
cord-005453-4057qib7	9474	21	.	.	.
cord-005453-4057qib7	9475	1	Moreover	moreover	RB
cord-005453-4057qib7	9475	2	,	,	,
cord-005453-4057qib7	9475	3	for	for	IN
cord-005453-4057qib7	9475	4	the	the	DT
cord-005453-4057qib7	9475	5	first	first	JJ
cord-005453-4057qib7	9475	6	time	time	NN
cord-005453-4057qib7	9475	7	we	-PRON-	PRP
cord-005453-4057qib7	9475	8	report	report	VBP
cord-005453-4057qib7	9475	9	significant	significant	JJ
cord-005453-4057qib7	9475	10	and	and	CC
cord-005453-4057qib7	9475	11	progressive	progressive	JJ
cord-005453-4057qib7	9475	12	alterations	alteration	NNS
cord-005453-4057qib7	9475	13	in	in	IN
cord-005453-4057qib7	9475	14	the	the	DT
cord-005453-4057qib7	9475	15	composition	composition	NN
cord-005453-4057qib7	9475	16	of	of	IN
cord-005453-4057qib7	9475	17	Blautia	Blautia	NNP
cord-005453-4057qib7	9475	18	,	,	,
cord-005453-4057qib7	9475	19	Ruminococcus	Ruminococcus	NNP
cord-005453-4057qib7	9475	20	and	and	CC
cord-005453-4057qib7	9475	21	Bifidobacterium	Bifidobacterium	NNP
cord-005453-4057qib7	9475	22	species	specie	NNS
cord-005453-4057qib7	9475	23	in	in	IN
cord-005453-4057qib7	9475	24	patients	patient	NNS
cord-005453-4057qib7	9475	25	treated	treat	VBN
cord-005453-4057qib7	9475	26	with	with	IN
cord-005453-4057qib7	9475	27	meropenem	meropenem	NNP
cord-005453-4057qib7	9475	28	and	and	CC
cord-005453-4057qib7	9475	29	colonized	colonize	VBN
cord-005453-4057qib7	9475	30	by	by	IN
cord-005453-4057qib7	9475	31	ESBL	ESBL	NNP
cord-005453-4057qib7	9475	32	bacteria	bacteria	NNS
cord-005453-4057qib7	9475	33	,	,	,
cord-005453-4057qib7	9475	34	respectively	respectively	RB
cord-005453-4057qib7	9475	35	.	.	.
cord-005453-4057qib7	9476	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9476	2	findings	finding	NNS
cord-005453-4057qib7	9476	3	offer	offer	VBP
cord-005453-4057qib7	9476	4	potential	potential	JJ
cord-005453-4057qib7	9476	5	modifiable	modifiable	JJ
cord-005453-4057qib7	9476	6	targets	target	NNS
cord-005453-4057qib7	9476	7	to	to	TO
cord-005453-4057qib7	9476	8	reduce	reduce	VB
cord-005453-4057qib7	9476	9	risk	risk	NN
cord-005453-4057qib7	9476	10	of	of	IN
cord-005453-4057qib7	9476	11	colonization	colonization	NN
cord-005453-4057qib7	9476	12	by	by	IN
cord-005453-4057qib7	9476	13	MDR	MDR	NNP
cord-005453-4057qib7	9476	14	bacteria	bacteria	NNS
cord-005453-4057qib7	9476	15	and	and	CC
cord-005453-4057qib7	9476	16	to	to	TO
cord-005453-4057qib7	9476	17	promote	promote	VB
cord-005453-4057qib7	9476	18	a	a	DT
cord-005453-4057qib7	9476	19	carbapenem	carbapenem	NN
cord-005453-4057qib7	9476	20	-	-	HYPH
cord-005453-4057qib7	9476	21	sparing	spare	VBG
cord-005453-4057qib7	9476	22	approach	approach	NN
cord-005453-4057qib7	9476	23	in	in	IN
cord-005453-4057qib7	9476	24	the	the	DT
cord-005453-4057qib7	9476	25	HSCT	HSCT	NNP
cord-005453-4057qib7	9476	26	setting	setting	NN
cord-005453-4057qib7	9476	27	.	.	.
cord-005453-4057qib7	9477	1	Clinical	clinical	JJ
cord-005453-4057qib7	9477	2	Background	background	NN
cord-005453-4057qib7	9477	3	:	:	:
cord-005453-4057qib7	9477	4	CMV	CMV	NNP
cord-005453-4057qib7	9477	5	is	be	VBZ
cord-005453-4057qib7	9477	6	associated	associate	VBN
cord-005453-4057qib7	9477	7	with	with	IN
cord-005453-4057qib7	9477	8	significant	significant	JJ
cord-005453-4057qib7	9477	9	morbidity	morbidity	NN
cord-005453-4057qib7	9477	10	after	after	IN
cord-005453-4057qib7	9477	11	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9477	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9477	13	stem	stem	NN
cord-005453-4057qib7	9477	14	cell	cell	NN
cord-005453-4057qib7	9477	15	transplantation	transplantation	NN
cord-005453-4057qib7	9477	16	.	.	.
cord-005453-4057qib7	9478	1	Strategies	strategy	NNS
cord-005453-4057qib7	9478	2	to	to	TO
cord-005453-4057qib7	9478	3	prevent	prevent	VB
cord-005453-4057qib7	9478	4	CMV	CMV	NNP
cord-005453-4057qib7	9478	5	-	-	HYPH
cord-005453-4057qib7	9478	6	related	relate	VBN
cord-005453-4057qib7	9478	7	complications	complication	NNS
cord-005453-4057qib7	9478	8	include	include	VBP
cord-005453-4057qib7	9478	9	universal	universal	JJ
cord-005453-4057qib7	9478	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9478	11	and	and	CC
cord-005453-4057qib7	9478	12	preemptive	preemptive	JJ
cord-005453-4057qib7	9478	13	therapy	therapy	NN
cord-005453-4057qib7	9478	14	,	,	,
cord-005453-4057qib7	9478	15	more	more	RBR
cord-005453-4057qib7	9478	16	widely	widely	RB
cord-005453-4057qib7	9478	17	spread	spread	VBN
cord-005453-4057qib7	9478	18	.	.	.
cord-005453-4057qib7	9479	1	Antivirals	antiviral	NNS
cord-005453-4057qib7	9479	2	used	use	VBD
cord-005453-4057qib7	9479	3	for	for	IN
cord-005453-4057qib7	9479	4	CMV	CMV	NNP
cord-005453-4057qib7	9479	5	reactivation	reactivation	NN
cord-005453-4057qib7	9479	6	(	(	-LRB-
cord-005453-4057qib7	9479	7	CMV	CMV	NNP
cord-005453-4057qib7	9479	8	-	-	HYPH
cord-005453-4057qib7	9479	9	R	R	NNP
cord-005453-4057qib7	9479	10	)	)	-RRB-
cord-005453-4057qib7	9479	11	produces	produce	VBZ
cord-005453-4057qib7	9479	12	major	major	JJ
cord-005453-4057qib7	9479	13	toxicities	toxicity	NNS
cord-005453-4057qib7	9479	14	and	and	CC
cord-005453-4057qib7	9479	15	costs	cost	NNS
cord-005453-4057qib7	9479	16	.	.	.
cord-005453-4057qib7	9480	1	Rate	rate	NN
cord-005453-4057qib7	9480	2	and	and	CC
cord-005453-4057qib7	9480	3	characterization	characterization	NN
cord-005453-4057qib7	9480	4	of	of	IN
cord-005453-4057qib7	9480	5	CMV	CMV	NNP
cord-005453-4057qib7	9480	6	-	-	HYPH
cord-005453-4057qib7	9480	7	R	R	NNP
cord-005453-4057qib7	9480	8	after	after	IN
cord-005453-4057qib7	9480	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9480	10	transplantation	transplantation	NN
cord-005453-4057qib7	9480	11	with	with	IN
cord-005453-4057qib7	9480	12	post	post	JJ
cord-005453-4057qib7	9480	13	-	-	JJ
cord-005453-4057qib7	9480	14	transplant	transplant	NN
cord-005453-4057qib7	9480	15	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	9480	16	(	(	-LRB-
cord-005453-4057qib7	9480	17	Haplo	Haplo	NNP
cord-005453-4057qib7	9480	18	PT	PT	NNP
cord-005453-4057qib7	9480	19	-	-	HYPH
cord-005453-4057qib7	9480	20	Cy	Cy	NNP
cord-005453-4057qib7	9480	21	)	)	-RRB-
cord-005453-4057qib7	9480	22	is	be	VBZ
cord-005453-4057qib7	9480	23	scarce	scarce	JJ
cord-005453-4057qib7	9480	24	.	.	.
cord-005453-4057qib7	9481	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9481	2	goal	goal	NN
cord-005453-4057qib7	9481	3	was	be	VBD
cord-005453-4057qib7	9481	4	to	to	TO
cord-005453-4057qib7	9481	5	analyze	analyze	VB
cord-005453-4057qib7	9481	6	CMV	CMV	NNP
cord-005453-4057qib7	9481	7	-	-	HYPH
cord-005453-4057qib7	9481	8	R	r	NN
cord-005453-4057qib7	9481	9	rate	rate	NN
cord-005453-4057qib7	9481	10	after	after	IN
cord-005453-4057qib7	9481	11	Haplo	Haplo	NNP
cord-005453-4057qib7	9481	12	PT	PT	NNP
cord-005453-4057qib7	9481	13	-	-	HYPH
cord-005453-4057qib7	9481	14	Cy	Cy	NNP
cord-005453-4057qib7	9481	15	,	,	,
cord-005453-4057qib7	9481	16	outcome	outcome	NN
cord-005453-4057qib7	9481	17	,	,	,
cord-005453-4057qib7	9481	18	complications	complication	NNS
cord-005453-4057qib7	9481	19	associated	associate	VBN
cord-005453-4057qib7	9481	20	to	to	IN
cord-005453-4057qib7	9481	21	therapy	therapy	NN
cord-005453-4057qib7	9481	22	,	,	,
cord-005453-4057qib7	9481	23	and	and	CC
cord-005453-4057qib7	9481	24	to	to	TO
cord-005453-4057qib7	9481	25	identify	identify	VB
cord-005453-4057qib7	9481	26	risk	risk	NN
cord-005453-4057qib7	9481	27	factors	factor	NNS
cord-005453-4057qib7	9481	28	.	.	.
cord-005453-4057qib7	9482	1	Methods	method	NNS
cord-005453-4057qib7	9482	2	:	:	:
cord-005453-4057qib7	9483	1	One	one	CD
cord-005453-4057qib7	9483	2	hundred	hundred	CD
cord-005453-4057qib7	9483	3	Haplo	Haplo	NNP
cord-005453-4057qib7	9483	4	PT	PT	NNP
cord-005453-4057qib7	9483	5	-	-	HYPH
cord-005453-4057qib7	9483	6	Cy	Cy	NNP
cord-005453-4057qib7	9483	7	transplants	transplant	NNS
cord-005453-4057qib7	9483	8	using	use	VBG
cord-005453-4057qib7	9483	9	peripheral	peripheral	JJ
cord-005453-4057qib7	9483	10	blood	blood	NN
cord-005453-4057qib7	9483	11	as	as	IN
cord-005453-4057qib7	9483	12	stem	stem	NN
cord-005453-4057qib7	9483	13	cell	cell	NN
cord-005453-4057qib7	9483	14	source	source	NN
cord-005453-4057qib7	9483	15	performed	perform	VBN
cord-005453-4057qib7	9483	16	between	between	IN
cord-005453-4057qib7	9483	17	2011	2011	CD
cord-005453-4057qib7	9483	18	and	and	CC
cord-005453-4057qib7	9483	19	2016	2016	CD
cord-005453-4057qib7	9483	20	in	in	IN
cord-005453-4057qib7	9483	21	our	-PRON-	PRP$
cord-005453-4057qib7	9483	22	center	center	NN
cord-005453-4057qib7	9483	23	have	have	VBP
cord-005453-4057qib7	9483	24	been	be	VBN
cord-005453-4057qib7	9483	25	retrospectively	retrospectively	RB
cord-005453-4057qib7	9483	26	reviewed	review	VBN
cord-005453-4057qib7	9483	27	.	.	.
cord-005453-4057qib7	9484	1	GVHD	GVHD	NNP
cord-005453-4057qib7	9484	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9484	3	consisted	consist	VBD
cord-005453-4057qib7	9484	4	of	of	IN
cord-005453-4057qib7	9484	5	PT	PT	NNP
cord-005453-4057qib7	9484	6	-	-	HYPH
cord-005453-4057qib7	9484	7	Cy	Cy	NNP
cord-005453-4057qib7	9484	8	50	50	CD
cord-005453-4057qib7	9484	9	mg/	mg/	NN
cord-005453-4057qib7	9484	10	kg	kg	NNP
cord-005453-4057qib7	9484	11	/	/	SYM
cord-005453-4057qib7	9484	12	day	day	NN
cord-005453-4057qib7	9484	13	on	on	IN
cord-005453-4057qib7	9484	14	days	day	NNS
cord-005453-4057qib7	9484	15	+3	+3	NNP
cord-005453-4057qib7	9484	16	and	and	CC
cord-005453-4057qib7	9484	17	+4	+4	NN
cord-005453-4057qib7	9484	18	,	,	,
cord-005453-4057qib7	9484	19	MMF	mmf	NN
cord-005453-4057qib7	9484	20	and	and	CC
cord-005453-4057qib7	9484	21	CsA	csa	NN
cord-005453-4057qib7	9484	22	from	from	IN
cord-005453-4057qib7	9484	23	day	day	NN
cord-005453-4057qib7	9484	24	+5	+5	NFP
cord-005453-4057qib7	9484	25	for	for	IN
cord-005453-4057qib7	9484	26	all	all	DT
cord-005453-4057qib7	9484	27	cases	case	NNS
cord-005453-4057qib7	9484	28	.	.	.
cord-005453-4057qib7	9485	1	CMV	CMV	NNP
cord-005453-4057qib7	9485	2	PCR	PCR	NNP
cord-005453-4057qib7	9485	3	was	be	VBD
cord-005453-4057qib7	9485	4	performed	perform	VBN
cord-005453-4057qib7	9485	5	in	in	IN
cord-005453-4057qib7	9485	6	a	a	DT
cord-005453-4057qib7	9485	7	biweekly	biweekly	JJ
cord-005453-4057qib7	9485	8	basis	basis	NN
cord-005453-4057qib7	9485	9	during	during	IN
cord-005453-4057qib7	9485	10	admission	admission	NN
cord-005453-4057qib7	9485	11	for	for	IN
cord-005453-4057qib7	9485	12	transplant	transplant	NN
cord-005453-4057qib7	9485	13	and	and	CC
cord-005453-4057qib7	9485	14	treatment	treatment	NN
cord-005453-4057qib7	9485	15	,	,	,
cord-005453-4057qib7	9485	16	and	and	CC
cord-005453-4057qib7	9485	17	weekly	weekly	RB
cord-005453-4057qib7	9485	18	thereafter	thereafter	RB
cord-005453-4057qib7	9485	19	.	.	.
cord-005453-4057qib7	9486	1	CMV	CMV	NNP
cord-005453-4057qib7	9486	2	-	-	HYPH
cord-005453-4057qib7	9486	3	R	R	NNP
cord-005453-4057qib7	9486	4	was	be	VBD
cord-005453-4057qib7	9486	5	considered	consider	VBN
cord-005453-4057qib7	9486	6	with	with	IN
cord-005453-4057qib7	9486	7	any	any	DT
cord-005453-4057qib7	9486	8	CMV	CMV	NNP
cord-005453-4057qib7	9486	9	DNA	dna	NN
cord-005453-4057qib7	9486	10	level	level	NN
cord-005453-4057qib7	9486	11	by	by	IN
cord-005453-4057qib7	9486	12	PCR	PCR	NNP
cord-005453-4057qib7	9486	13	assay	assay	NN
cord-005453-4057qib7	9486	14	above	above	IN
cord-005453-4057qib7	9486	15	100	100	CD
cord-005453-4057qib7	9486	16	copies	copy	NNS
cord-005453-4057qib7	9486	17	/	/	SYM
cord-005453-4057qib7	9486	18	ml	ml	NN
cord-005453-4057qib7	9486	19	.	.	.
cord-005453-4057qib7	9487	1	Prior	prior	RB
cord-005453-4057qib7	9487	2	four	four	CD
cord-005453-4057qib7	9487	3	consecutive	consecutive	JJ
cord-005453-4057qib7	9487	4	negative	negative	JJ
cord-005453-4057qib7	9487	5	weekly	weekly	JJ
cord-005453-4057qib7	9487	6	PCRs	pcr	NNS
cord-005453-4057qib7	9487	7	were	be	VBD
cord-005453-4057qib7	9487	8	needed	need	VBN
cord-005453-4057qib7	9487	9	to	to	TO
cord-005453-4057qib7	9487	10	consider	consider	VB
cord-005453-4057qib7	9487	11	a	a	DT
cord-005453-4057qib7	9487	12	new	new	JJ
cord-005453-4057qib7	9487	13	reactivation	reactivation	NN
cord-005453-4057qib7	9487	14	episode	episode	NN
cord-005453-4057qib7	9487	15	.	.	.
cord-005453-4057qib7	9488	1	Preemptive	preemptive	JJ
cord-005453-4057qib7	9488	2	strategy	strategy	NN
cord-005453-4057qib7	9488	3	was	be	VBD
cord-005453-4057qib7	9488	4	applied	apply	VBN
cord-005453-4057qib7	9488	5	in	in	IN
cord-005453-4057qib7	9488	6	all	all	DT
cord-005453-4057qib7	9488	7	cases	case	NNS
cord-005453-4057qib7	9488	8	.	.	.
cord-005453-4057qib7	9489	1	Data	datum	NNS
cord-005453-4057qib7	9489	2	collected	collect	VBN
cord-005453-4057qib7	9489	3	in	in	IN
cord-005453-4057qib7	9489	4	relation	relation	NN
cord-005453-4057qib7	9489	5	to	to	IN
cord-005453-4057qib7	9489	6	CMV	CMV	NNP
cord-005453-4057qib7	9489	7	-	-	HYPH
cord-005453-4057qib7	9489	8	R	R	NNP
cord-005453-4057qib7	9489	9	included	include	VBD
cord-005453-4057qib7	9489	10	:	:	:
cord-005453-4057qib7	9489	11	CMV	CMV	NNP
cord-005453-4057qib7	9489	12	serostatus	serostatus	NN
cord-005453-4057qib7	9489	13	of	of	IN
cord-005453-4057qib7	9489	14	donor	donor	NN
cord-005453-4057qib7	9489	15	/	/	SYM
cord-005453-4057qib7	9489	16	recipient	recipient	NN
cord-005453-4057qib7	9489	17	(	(	-LRB-
cord-005453-4057qib7	9489	18	D	D	NNP
cord-005453-4057qib7	9489	19	/	/	SYM
cord-005453-4057qib7	9489	20	R	r	NN
cord-005453-4057qib7	9489	21	)	)	-RRB-
cord-005453-4057qib7	9489	22	,	,	,
cord-005453-4057qib7	9489	23	number	number	NN
cord-005453-4057qib7	9489	24	of	of	IN
cord-005453-4057qib7	9489	25	CMV	CMV	NNP
cord-005453-4057qib7	9489	26	reactivations	reactivation	NNS
cord-005453-4057qib7	9489	27	,	,	,
cord-005453-4057qib7	9489	28	length	length	NN
cord-005453-4057qib7	9489	29	of	of	IN
cord-005453-4057qib7	9489	30	each	each	DT
cord-005453-4057qib7	9489	31	reactivation	reactivation	NN
cord-005453-4057qib7	9489	32	,	,	,
cord-005453-4057qib7	9489	33	antiviral	antiviral	JJ
cord-005453-4057qib7	9489	34	treatment	treatment	NN
cord-005453-4057qib7	9489	35	used	use	VBN
cord-005453-4057qib7	9489	36	,	,	,
cord-005453-4057qib7	9489	37	need	need	VBP
cord-005453-4057qib7	9489	38	for	for	IN
cord-005453-4057qib7	9489	39	admission	admission	NN
cord-005453-4057qib7	9489	40	to	to	TO
cord-005453-4057qib7	9489	41	receive	receive	VB
cord-005453-4057qib7	9489	42	treatment	treatment	NN
cord-005453-4057qib7	9489	43	and	and	CC
cord-005453-4057qib7	9489	44	adverse	adverse	JJ
cord-005453-4057qib7	9489	45	events	event	NNS
cord-005453-4057qib7	9489	46	related	relate	VBN
cord-005453-4057qib7	9489	47	to	to	IN
cord-005453-4057qib7	9489	48	CMV	CMV	NNP
cord-005453-4057qib7	9489	49	reactivation	reactivation	NN
cord-005453-4057qib7	9489	50	and/or	and/or	CC
cord-005453-4057qib7	9489	51	antiviral	antiviral	JJ
cord-005453-4057qib7	9489	52	treatment	treatment	NN
cord-005453-4057qib7	9489	53	.	.	.
cord-005453-4057qib7	9490	1	Results	result	NNS
cord-005453-4057qib7	9490	2	:	:	:
cord-005453-4057qib7	9491	1	Patients	patient	NNS
cord-005453-4057qib7	9491	2	characteristics	characteristic	NNS
cord-005453-4057qib7	9491	3	are	be	VBP
cord-005453-4057qib7	9491	4	summarized	summarize	VBN
cord-005453-4057qib7	9491	5	in	in	IN
cord-005453-4057qib7	9491	6	Table	Table	NNP
cord-005453-4057qib7	9491	7	 	 	_SP
cord-005453-4057qib7	9491	8	1	1	CD
cord-005453-4057qib7	9491	9	.	.	.
cord-005453-4057qib7	9492	1	Among	among	IN
cord-005453-4057qib7	9492	2	100	100	CD
cord-005453-4057qib7	9492	3	patients	patient	NNS
cord-005453-4057qib7	9492	4	,	,	,
cord-005453-4057qib7	9492	5	78	78	CD
cord-005453-4057qib7	9492	6	of	of	IN
cord-005453-4057qib7	9492	7	them	-PRON-	PRP
cord-005453-4057qib7	9492	8	with	with	IN
cord-005453-4057qib7	9492	9	positive	positive	JJ
cord-005453-4057qib7	9492	10	CMV	CMV	NNP
cord-005453-4057qib7	9492	11	serology	serology	NN
cord-005453-4057qib7	9492	12	,	,	,
cord-005453-4057qib7	9492	13	128	128	CD
cord-005453-4057qib7	9492	14	episodes	episode	NNS
cord-005453-4057qib7	9492	15	of	of	IN
cord-005453-4057qib7	9492	16	CMV	CMV	NNP
cord-005453-4057qib7	9492	17	-	-	HYPH
cord-005453-4057qib7	9492	18	R	R	NNP
cord-005453-4057qib7	9492	19	were	be	VBD
cord-005453-4057qib7	9492	20	detected	detect	VBN
cord-005453-4057qib7	9492	21	.	.	.
cord-005453-4057qib7	9493	1	Seventysix	Seventysix	NNP
cord-005453-4057qib7	9493	2	patients	patient	NNS
cord-005453-4057qib7	9493	3	(	(	-LRB-
cord-005453-4057qib7	9493	4	76	76	CD
cord-005453-4057qib7	9493	5	%	%	NN
cord-005453-4057qib7	9493	6	)	)	-RRB-
cord-005453-4057qib7	9493	7	had	have	VBD
cord-005453-4057qib7	9493	8	at	at	RB
cord-005453-4057qib7	9493	9	least	least	RBS
cord-005453-4057qib7	9493	10	one	one	CD
cord-005453-4057qib7	9493	11	CMV	CMV	NNP
cord-005453-4057qib7	9493	12	-	-	HYPH
cord-005453-4057qib7	9493	13	R	R	NNP
cord-005453-4057qib7	9493	14	in	in	IN
cord-005453-4057qib7	9493	15	a	a	DT
cord-005453-4057qib7	9493	16	median	median	NN
cord-005453-4057qib7	9493	17	of	of	IN
cord-005453-4057qib7	9493	18	30	30	CD
cord-005453-4057qib7	9493	19	days	day	NNS
cord-005453-4057qib7	9493	20	after	after	IN
cord-005453-4057qib7	9493	21	transplant	transplant	NN
cord-005453-4057qib7	9493	22	.	.	.
cord-005453-4057qib7	9494	1	None	none	NN
cord-005453-4057qib7	9494	2	of	of	IN
cord-005453-4057qib7	9494	3	them	-PRON-	PRP
cord-005453-4057qib7	9494	4	had	have	VBD
cord-005453-4057qib7	9494	5	CMV	CMV	NNP
cord-005453-4057qib7	9494	6	disease	disease	NN
cord-005453-4057qib7	9494	7	or	or	CC
cord-005453-4057qib7	9494	8	die	die	VB
cord-005453-4057qib7	9494	9	as	as	IN
cord-005453-4057qib7	9494	10	a	a	DT
cord-005453-4057qib7	9494	11	consequence	consequence	NN
cord-005453-4057qib7	9494	12	of	of	IN
cord-005453-4057qib7	9494	13	CMV	CMV	NNP
cord-005453-4057qib7	9494	14	-	-	HYPH
cord-005453-4057qib7	9494	15	R.	R.	NNP
cord-005453-4057qib7	9494	16	Median	median	JJ
cord-005453-4057qib7	9494	17	duration	duration	NN
cord-005453-4057qib7	9494	18	was	be	VBD
cord-005453-4057qib7	9494	19	22	22	CD
cord-005453-4057qib7	9494	20	days	day	NNS
cord-005453-4057qib7	9494	21	(	(	-LRB-
cord-005453-4057qib7	9494	22	15	15	CD
cord-005453-4057qib7	9494	23	-	-	SYM
cord-005453-4057qib7	9494	24	37	37	CD
cord-005453-4057qib7	9494	25	)	)	-RRB-
cord-005453-4057qib7	9494	26	.	.	.
cord-005453-4057qib7	9495	1	Valganciclovir	Valganciclovir	NNP
cord-005453-4057qib7	9495	2	or	or	CC
cord-005453-4057qib7	9495	3	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	9495	4	was	be	VBD
cord-005453-4057qib7	9495	5	used	use	VBN
cord-005453-4057qib7	9495	6	in	in	IN
cord-005453-4057qib7	9495	7	101	101	CD
cord-005453-4057qib7	9495	8	episodes	episode	NNS
cord-005453-4057qib7	9495	9	(	(	-LRB-
cord-005453-4057qib7	9495	10	79	79	CD
cord-005453-4057qib7	9495	11	%	%	NN
cord-005453-4057qib7	9495	12	)	)	-RRB-
cord-005453-4057qib7	9495	13	.	.	.
cord-005453-4057qib7	9496	1	Foscarnet	Foscarnet	NNP
cord-005453-4057qib7	9496	2	was	be	VBD
cord-005453-4057qib7	9496	3	used	use	VBN
cord-005453-4057qib7	9496	4	in	in	IN
cord-005453-4057qib7	9496	5	43	43	CD
cord-005453-4057qib7	9496	6	episodes	episode	NNS
cord-005453-4057qib7	9496	7	(	(	-LRB-
cord-005453-4057qib7	9496	8	34	34	CD
cord-005453-4057qib7	9496	9	%	%	NN
cord-005453-4057qib7	9496	10	)	)	-RRB-
cord-005453-4057qib7	9496	11	.	.	.
cord-005453-4057qib7	9497	1	Six	six	CD
cord-005453-4057qib7	9497	2	of	of	IN
cord-005453-4057qib7	9497	3	the	the	DT
cord-005453-4057qib7	9497	4	episodes	episode	NNS
cord-005453-4057qib7	9497	5	occurred	occur	VBD
cord-005453-4057qib7	9497	6	after	after	IN
cord-005453-4057qib7	9497	7	initial	initial	JJ
cord-005453-4057qib7	9497	8	discharge	discharge	NN
cord-005453-4057qib7	9497	9	,	,	,
cord-005453-4057qib7	9497	10	and	and	CC
cord-005453-4057qib7	9497	11	required	require	VBN
cord-005453-4057qib7	9497	12	re	re	NN
cord-005453-4057qib7	9497	13	-	-	NN
cord-005453-4057qib7	9497	14	admission	admission	NN
cord-005453-4057qib7	9497	15	for	for	IN
cord-005453-4057qib7	9497	16	treatment	treatment	NN
cord-005453-4057qib7	9497	17	,	,	,
cord-005453-4057qib7	9497	18	with	with	IN
cord-005453-4057qib7	9497	19	a	a	DT
cord-005453-4057qib7	9497	20	median	median	JJ
cord-005453-4057qib7	9497	21	length	length	NN
cord-005453-4057qib7	9497	22	of	of	IN
cord-005453-4057qib7	9497	23	hospitalization	hospitalization	NN
cord-005453-4057qib7	9497	24	of	of	IN
cord-005453-4057qib7	9497	25	16	16	CD
cord-005453-4057qib7	9497	26	days	day	NNS
cord-005453-4057qib7	9497	27	(	(	-LRB-
cord-005453-4057qib7	9497	28	6	6	CD
cord-005453-4057qib7	9497	29	-	-	SYM
cord-005453-4057qib7	9497	30	27	27	CD
cord-005453-4057qib7	9497	31	)	)	-RRB-
cord-005453-4057qib7	9497	32	.	.	.
cord-005453-4057qib7	9498	1	Cytopenias	Cytopenias	NNP
cord-005453-4057qib7	9498	2	requiring	require	VBG
cord-005453-4057qib7	9498	3	transfusion	transfusion	NN
cord-005453-4057qib7	9498	4	or	or	CC
cord-005453-4057qib7	9498	5	G	G	NNP
cord-005453-4057qib7	9498	6	-	-	HYPH
cord-005453-4057qib7	9498	7	CSF	csf	NN
cord-005453-4057qib7	9498	8	support	support	NN
cord-005453-4057qib7	9498	9	occurred	occur	VBD
cord-005453-4057qib7	9498	10	in	in	IN
cord-005453-4057qib7	9498	11	36	36	CD
cord-005453-4057qib7	9498	12	episodes	episode	NNS
cord-005453-4057qib7	9498	13	(	(	-LRB-
cord-005453-4057qib7	9498	14	36	36	CD
cord-005453-4057qib7	9498	15	%	%	NN
cord-005453-4057qib7	9498	16	)	)	-RRB-
cord-005453-4057qib7	9498	17	treated	treat	VBN
cord-005453-4057qib7	9498	18	with	with	IN
cord-005453-4057qib7	9498	19	ganciclovir	ganciclovir	NNS
cord-005453-4057qib7	9498	20	or	or	CC
cord-005453-4057qib7	9498	21	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	9498	22	.	.	.
cord-005453-4057qib7	9499	1	Three	three	CD
cord-005453-4057qib7	9499	2	of	of	IN
cord-005453-4057qib7	9499	3	them	-PRON-	PRP
cord-005453-4057qib7	9499	4	needed	need	VBD
cord-005453-4057qib7	9499	5	further	further	RB
cord-005453-4057qib7	9499	6	CD34	CD34	NNP
cord-005453-4057qib7	9499	7	+	+	CC
cord-005453-4057qib7	9499	8	cells	cell	NNS
cord-005453-4057qib7	9499	9	booster	booster	NN
cord-005453-4057qib7	9499	10	for	for	IN
cord-005453-4057qib7	9499	11	graft	graft	NN
cord-005453-4057qib7	9499	12	rescue	rescue	NN
cord-005453-4057qib7	9499	13	.	.	.
cord-005453-4057qib7	9500	1	Mild	mild	JJ
cord-005453-4057qib7	9500	2	acute	acute	JJ
cord-005453-4057qib7	9500	3	renal	renal	JJ
cord-005453-4057qib7	9500	4	failure	failure	NN
cord-005453-4057qib7	9500	5	and	and	CC
cord-005453-4057qib7	9500	6	genital	genital	JJ
cord-005453-4057qib7	9500	7	ulcers	ulcer	NNS
cord-005453-4057qib7	9500	8	were	be	VBD
cord-005453-4057qib7	9500	9	found	find	VBN
cord-005453-4057qib7	9500	10	in	in	IN
cord-005453-4057qib7	9500	11	21	21	CD
cord-005453-4057qib7	9500	12	(	(	-LRB-
cord-005453-4057qib7	9500	13	49	49	CD
cord-005453-4057qib7	9500	14	%	%	NN
cord-005453-4057qib7	9500	15	)	)	-RRB-
cord-005453-4057qib7	9500	16	and	and	CC
cord-005453-4057qib7	9500	17	5	5	CD
cord-005453-4057qib7	9500	18	(	(	-LRB-
cord-005453-4057qib7	9500	19	11,6	11,6	CD
cord-005453-4057qib7	9500	20	%	%	NN
cord-005453-4057qib7	9500	21	)	)	-RRB-
cord-005453-4057qib7	9500	22	events	event	NNS
cord-005453-4057qib7	9500	23	treated	treat	VBN
cord-005453-4057qib7	9500	24	with	with	IN
cord-005453-4057qib7	9500	25	foscarnet	foscarnet	NN
cord-005453-4057qib7	9500	26	,	,	,
cord-005453-4057qib7	9500	27	respectively	respectively	RB
cord-005453-4057qib7	9500	28	.	.	.
cord-005453-4057qib7	9501	1	No	no	DT
cord-005453-4057qib7	9501	2	cases	case	NNS
cord-005453-4057qib7	9501	3	of	of	IN
cord-005453-4057qib7	9501	4	severe	severe	JJ
cord-005453-4057qib7	9501	5	renal	renal	JJ
cord-005453-4057qib7	9501	6	failure	failure	NN
cord-005453-4057qib7	9501	7	were	be	VBD
cord-005453-4057qib7	9501	8	observed	observe	VBN
cord-005453-4057qib7	9501	9	.	.	.
cord-005453-4057qib7	9502	1	Serological	serological	JJ
cord-005453-4057qib7	9502	2	status	status	NN
cord-005453-4057qib7	9502	3	different	different	JJ
cord-005453-4057qib7	9502	4	than	than	IN
cord-005453-4057qib7	9502	5	negative	negative	JJ
cord-005453-4057qib7	9502	6	/	/	SYM
cord-005453-4057qib7	9502	7	negative	negative	JJ
cord-005453-4057qib7	9502	8	(	(	-LRB-
cord-005453-4057qib7	9502	9	N	N	NNP
cord-005453-4057qib7	9502	10	/	/	SYM
cord-005453-4057qib7	9502	11	N	N	NNP
cord-005453-4057qib7	9502	12	)	)	-RRB-
cord-005453-4057qib7	9502	13	(	(	-LRB-
cord-005453-4057qib7	9502	14	p	p	NN
cord-005453-4057qib7	9502	15	0.001	0.001	CD
cord-005453-4057qib7	9502	16	)	)	-RRB-
cord-005453-4057qib7	9502	17	and	and	CC
cord-005453-4057qib7	9502	18	older	old	JJR
cord-005453-4057qib7	9502	19	age	age	NN
cord-005453-4057qib7	9502	20	(	(	-LRB-
cord-005453-4057qib7	9502	21	46	46	CD
cord-005453-4057qib7	9502	22	vs	vs	IN
cord-005453-4057qib7	9502	23	38	38	CD
cord-005453-4057qib7	9502	24	years	year	NNS
cord-005453-4057qib7	9502	25	,	,	,
cord-005453-4057qib7	9502	26	p	p	NN
cord-005453-4057qib7	9502	27	0.02	0.02	CD
cord-005453-4057qib7	9502	28	)	)	-RRB-
cord-005453-4057qib7	9502	29	were	be	VBD
cord-005453-4057qib7	9502	30	significantly	significantly	RB
cord-005453-4057qib7	9502	31	associated	associate	VBN
cord-005453-4057qib7	9502	32	with	with	IN
cord-005453-4057qib7	9502	33	CMV	CMV	NNP
cord-005453-4057qib7	9502	34	-	-	HYPH
cord-005453-4057qib7	9502	35	R.	R.	NNP
cord-005453-4057qib7	9503	1	No	no	DT
cord-005453-4057qib7	9503	2	relationship	relationship	NN
cord-005453-4057qib7	9503	3	was	be	VBD
cord-005453-4057qib7	9503	4	observed	observe	VBN
cord-005453-4057qib7	9503	5	with	with	IN
cord-005453-4057qib7	9503	6	gender	gender	NN
cord-005453-4057qib7	9503	7	,	,	,
cord-005453-4057qib7	9503	8	disease	disease	NN
cord-005453-4057qib7	9503	9	,	,	,
cord-005453-4057qib7	9503	10	donor	donor	NN
cord-005453-4057qib7	9503	11	relationship	relationship	NN
cord-005453-4057qib7	9503	12	,	,	,
cord-005453-4057qib7	9503	13	conditioning	conditioning	NN
cord-005453-4057qib7	9503	14	,	,	,
cord-005453-4057qib7	9503	15	GvHD	GvHD	NNP
cord-005453-4057qib7	9503	16	or	or	CC
cord-005453-4057qib7	9503	17	cells	cell	NNS
cord-005453-4057qib7	9503	18	infused	infuse	VBN
cord-005453-4057qib7	9503	19	.	.	.
cord-005453-4057qib7	9504	1	More	More	JJR
cord-005453-4057qib7	9504	2	than	than	IN
cord-005453-4057qib7	9504	3	2	2	CD
cord-005453-4057qib7	9504	4	reactivations	reactivation	NNS
cord-005453-4057qib7	9504	5	were	be	VBD
cord-005453-4057qib7	9504	6	more	more	RBR
cord-005453-4057qib7	9504	7	frequent	frequent	JJ
cord-005453-4057qib7	9504	8	among	among	IN
cord-005453-4057qib7	9504	9	patients	patient	NNS
cord-005453-4057qib7	9504	10	with	with	IN
cord-005453-4057qib7	9504	11	grade	grade	NN
cord-005453-4057qib7	9504	12	II	II	NNP
cord-005453-4057qib7	9504	13	-	-	HYPH
cord-005453-4057qib7	9504	14	IV	IV	NNP
cord-005453-4057qib7	9504	15	acute	acute	JJ
cord-005453-4057qib7	9504	16	GvHD	GvHD	NNP
cord-005453-4057qib7	9504	17	(	(	-LRB-
cord-005453-4057qib7	9504	18	aGvHD	agvhd	NN
cord-005453-4057qib7	9504	19	)	)	-RRB-
cord-005453-4057qib7	9504	20	and	and	CC
cord-005453-4057qib7	9504	21	moderate	moderate	JJ
cord-005453-4057qib7	9504	22	-	-	HYPH
cord-005453-4057qib7	9504	23	severe	severe	JJ
cord-005453-4057qib7	9504	24	chronic	chronic	NN
cord-005453-4057qib7	9504	25	GvHD	gvhd	NN
cord-005453-4057qib7	9504	26	(	(	-LRB-
cord-005453-4057qib7	9504	27	cGvHD	cgvhd	NN
cord-005453-4057qib7	9504	28	)	)	-RRB-
cord-005453-4057qib7	9504	29	.	.	.
cord-005453-4057qib7	9505	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9505	2	:	:	:
cord-005453-4057qib7	9506	1	In	in	IN
cord-005453-4057qib7	9506	2	our	-PRON-	PRP$
cord-005453-4057qib7	9506	3	experience	experience	NN
cord-005453-4057qib7	9506	4	,	,	,
cord-005453-4057qib7	9506	5	rate	rate	NN
cord-005453-4057qib7	9506	6	of	of	IN
cord-005453-4057qib7	9506	7	CMV	CMV	NNP
cord-005453-4057qib7	9506	8	-	-	HYPH
cord-005453-4057qib7	9506	9	R	R	NNP
cord-005453-4057qib7	9506	10	after	after	IN
cord-005453-4057qib7	9506	11	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	9506	12	Haplo	Haplo	NNP
cord-005453-4057qib7	9506	13	PT	PT	NNP
cord-005453-4057qib7	9506	14	-	-	HYPH
cord-005453-4057qib7	9506	15	Cy	Cy	NNP
cord-005453-4057qib7	9506	16	,	,	,
cord-005453-4057qib7	9506	17	using	use	VBG
cord-005453-4057qib7	9506	18	PBSC	PBSC	NNP
cord-005453-4057qib7	9506	19	as	as	IN
cord-005453-4057qib7	9506	20	stem	stem	NN
cord-005453-4057qib7	9506	21	cell	cell	NN
cord-005453-4057qib7	9506	22	source	source	NN
cord-005453-4057qib7	9506	23	,	,	,
cord-005453-4057qib7	9506	24	is	be	VBZ
cord-005453-4057qib7	9506	25	considerably	considerably	RB
cord-005453-4057qib7	9506	26	high	high	JJ
cord-005453-4057qib7	9506	27	.	.	.
cord-005453-4057qib7	9507	1	A	a	DT
cord-005453-4057qib7	9507	2	significant	significant	JJ
cord-005453-4057qib7	9507	3	proportion	proportion	NN
cord-005453-4057qib7	9507	4	of	of	IN
cord-005453-4057qib7	9507	5	patients	patient	NNS
cord-005453-4057qib7	9507	6	presented	present	VBD
cord-005453-4057qib7	9507	7	complications	complication	NNS
cord-005453-4057qib7	9507	8	associated	associate	VBN
cord-005453-4057qib7	9507	9	with	with	IN
cord-005453-4057qib7	9507	10	CMV	CMV	NNP
cord-005453-4057qib7	9507	11	-	-	HYPH
cord-005453-4057qib7	9507	12	R	R	NNP
cord-005453-4057qib7	9507	13	and	and	CC
cord-005453-4057qib7	9507	14	its	-PRON-	PRP$
cord-005453-4057qib7	9507	15	treatment	treatment	NN
cord-005453-4057qib7	9507	16	.	.	.
cord-005453-4057qib7	9508	1	CMV	CMV	NNP
cord-005453-4057qib7	9508	2	serological	serological	JJ
cord-005453-4057qib7	9508	3	status	status	NN
cord-005453-4057qib7	9508	4	other	other	JJ
cord-005453-4057qib7	9508	5	than	than	IN
cord-005453-4057qib7	9508	6	N	N	NNP
cord-005453-4057qib7	9508	7	/	/	SYM
cord-005453-4057qib7	9508	8	N	N	NNP
cord-005453-4057qib7	9508	9	and	and	CC
cord-005453-4057qib7	9508	10	older	old	JJR
cord-005453-4057qib7	9508	11	age	age	NN
cord-005453-4057qib7	9508	12	are	be	VBP
cord-005453-4057qib7	9508	13	associated	associate	VBN
cord-005453-4057qib7	9508	14	with	with	IN
cord-005453-4057qib7	9508	15	high	high	JJ
cord-005453-4057qib7	9508	16	risk	risk	NN
cord-005453-4057qib7	9508	17	of	of	IN
cord-005453-4057qib7	9508	18	CMV	CMV	NNP
cord-005453-4057qib7	9508	19	-	-	HYPH
cord-005453-4057qib7	9508	20	R.	R.	NNP
cord-005453-4057qib7	9508	21	Patients	Patients	NNP
cord-005453-4057qib7	9508	22	with	with	IN
cord-005453-4057qib7	9508	23	grade	grade	NN
cord-005453-4057qib7	9508	24	II	II	NNP
cord-005453-4057qib7	9508	25	-	-	HYPH
cord-005453-4057qib7	9508	26	IV	IV	NNP
cord-005453-4057qib7	9508	27	aGvHD	aGvHD	NNP
cord-005453-4057qib7	9508	28	are	be	VBP
cord-005453-4057qib7	9508	29	at	at	IN
cord-005453-4057qib7	9508	30	higher	high	JJR
cord-005453-4057qib7	9508	31	risk	risk	NN
cord-005453-4057qib7	9508	32	of	of	IN
cord-005453-4057qib7	9508	33	multiple	multiple	JJ
cord-005453-4057qib7	9508	34	reactivations	reactivation	NNS
cord-005453-4057qib7	9508	35	.	.	.
cord-005453-4057qib7	9509	1	This	this	DT
cord-005453-4057qib7	9509	2	population	population	NN
cord-005453-4057qib7	9509	3	could	could	MD
cord-005453-4057qib7	9509	4	be	be	VB
cord-005453-4057qib7	9509	5	benefited	benefit	VBN
cord-005453-4057qib7	9509	6	from	from	IN
cord-005453-4057qib7	9509	7	primary	primary	JJ
cord-005453-4057qib7	9509	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9509	9	,	,	,
cord-005453-4057qib7	9509	10	in	in	IN
cord-005453-4057qib7	9509	11	order	order	NN
cord-005453-4057qib7	9509	12	to	to	TO
cord-005453-4057qib7	9509	13	decrease	decrease	VB
cord-005453-4057qib7	9509	14	treatment´s	treatment´s	NNP
cord-005453-4057qib7	9509	15	complications	complication	NNS
cord-005453-4057qib7	9509	16	,	,	,
cord-005453-4057qib7	9509	17	re	re	NNS
cord-005453-4057qib7	9509	18	-	-	NNS
cord-005453-4057qib7	9509	19	admissions	admission	NNS
cord-005453-4057qib7	9509	20	and	and	CC
cord-005453-4057qib7	9509	21	costs	cost	NNS
cord-005453-4057qib7	9509	22	.	.	.
cord-005453-4057qib7	9510	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9510	2	:	:	:
cord-005453-4057qib7	9510	3	Nothing	nothing	NN
cord-005453-4057qib7	9510	4	to	to	TO
cord-005453-4057qib7	9510	5	declare	declare	VB
cord-005453-4057qib7	9510	6	.	.	.
cord-005453-4057qib7	9511	1	Impact	impact	NN
cord-005453-4057qib7	9511	2	of	of	IN
cord-005453-4057qib7	9511	3	infectious	infectious	JJ
cord-005453-4057qib7	9511	4	events	event	NNS
cord-005453-4057qib7	9511	5	occurring	occur	VBG
cord-005453-4057qib7	9511	6	during	during	IN
cord-005453-4057qib7	9511	7	the	the	DT
cord-005453-4057qib7	9511	8	first	first	JJ
cord-005453-4057qib7	9511	9	hundred	hundred	CD
cord-005453-4057qib7	9511	10	days	day	NNS
cord-005453-4057qib7	9511	11	after	after	IN
cord-005453-4057qib7	9511	12	hsct	hsct	NNP
cord-005453-4057qib7	9511	13	for	for	IN
cord-005453-4057qib7	9511	14	hematological	hematological	JJ
cord-005453-4057qib7	9511	15	malignancy	malignancy	NN
cord-005453-4057qib7	9511	16	:	:	:
cord-005453-4057qib7	9512	1	A	a	DT
cord-005453-4057qib7	9512	2	monocentric	monocentric	JJ
cord-005453-4057qib7	9512	3	retrospective	retrospective	JJ
cord-005453-4057qib7	9512	4	study	study	NN
cord-005453-4057qib7	9512	5	over	over	IN
cord-005453-4057qib7	9512	6	a	a	DT
cord-005453-4057qib7	9512	7	five	five	CD
cord-005453-4057qib7	9512	8	-	-	HYPH
cord-005453-4057qib7	9512	9	year	year	NN
cord-005453-4057qib7	9512	10	period	period	NN
cord-005453-4057qib7	9512	11	Marie	Marie	NNP
cord-005453-4057qib7	9512	12	-	-	HYPH
cord-005453-4057qib7	9512	13	Pierre	Pierre	NNP
cord-005453-4057qib7	9512	14	Ledoux	Ledoux	NNP
cord-005453-4057qib7	9512	15	1	1	CD
cord-005453-4057qib7	9512	16	,	,	,
cord-005453-4057qib7	9512	17	Célestine	Célestine	NNP
cord-005453-4057qib7	9512	18	Simand	Simand	NNP
cord-005453-4057qib7	9512	19	1,2	1,2	CD
cord-005453-4057qib7	9512	20	,	,	,
cord-005453-4057qib7	9512	21	Karin	Karin	NNP
cord-005453-4057qib7	9512	22	Bilger	Bilger	NNP
cord-005453-4057qib7	9512	23	1	1	CD
cord-005453-4057qib7	9512	24	,	,	,
cord-005453-4057qib7	9512	25	Annegret	Annegret	NNP
cord-005453-4057qib7	9512	26	Laplace	Laplace	NNP
cord-005453-4057qib7	9512	27	1	1	CD
cord-005453-4057qib7	9513	1	,	,	,
cord-005453-4057qib7	9513	2	Bruno	Bruno	NNP
cord-005453-4057qib7	9513	3	Lioure	Lioure	NNP
cord-005453-4057qib7	9513	4	1	1	CD
cord-005453-4057qib7	9513	5	Background	Background	NNP
cord-005453-4057qib7	9513	6	:	:	:
cord-005453-4057qib7	9514	1	Patients	patient	NNS
cord-005453-4057qib7	9514	2	undergoing	undergo	VBG
cord-005453-4057qib7	9514	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9514	4	stem	stem	NN
cord-005453-4057qib7	9514	5	cells	cell	NNS
cord-005453-4057qib7	9514	6	transplantation	transplantation	NN
cord-005453-4057qib7	9514	7	(	(	-LRB-
cord-005453-4057qib7	9514	8	HSCT	HSCT	NNP
cord-005453-4057qib7	9514	9	)	)	-RRB-
cord-005453-4057qib7	9514	10	for	for	IN
cord-005453-4057qib7	9514	11	hematological	hematological	JJ
cord-005453-4057qib7	9514	12	malignancy	malignancy	NN
cord-005453-4057qib7	9514	13	often	often	RB
cord-005453-4057qib7	9514	14	present	present	JJ
cord-005453-4057qib7	9514	15	with	with	IN
cord-005453-4057qib7	9514	16	infectious	infectious	JJ
cord-005453-4057qib7	9514	17	events	event	NNS
cord-005453-4057qib7	9514	18	in	in	IN
cord-005453-4057qib7	9514	19	the	the	DT
cord-005453-4057qib7	9514	20	early	early	JJ
cord-005453-4057qib7	9514	21	stages	stage	NNS
cord-005453-4057qib7	9514	22	of	of	IN
cord-005453-4057qib7	9514	23	the	the	DT
cord-005453-4057qib7	9514	24	procedure	procedure	NN
cord-005453-4057qib7	9514	25	,	,	,
cord-005453-4057qib7	9514	26	some	some	DT
cord-005453-4057qib7	9514	27	of	of	IN
cord-005453-4057qib7	9514	28	which	which	WDT
cord-005453-4057qib7	9514	29	having	have	VBG
cord-005453-4057qib7	9514	30	a	a	DT
cord-005453-4057qib7	9514	31	documented	document	VBN
cord-005453-4057qib7	9514	32	impact	impact	NN
cord-005453-4057qib7	9514	33	on	on	IN
cord-005453-4057qib7	9514	34	the	the	DT
cord-005453-4057qib7	9514	35	outcome	outcome	NN
cord-005453-4057qib7	9514	36	of	of	IN
cord-005453-4057qib7	9514	37	the	the	DT
cord-005453-4057qib7	9514	38	graft	graft	NN
cord-005453-4057qib7	9514	39	.	.	.
cord-005453-4057qib7	9515	1	For	for	IN
cord-005453-4057qib7	9515	2	instance	instance	NN
cord-005453-4057qib7	9515	3	,	,	,
cord-005453-4057qib7	9515	4	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	9515	5	(	(	-LRB-
cord-005453-4057qib7	9515	6	CMV	CMV	NNP
cord-005453-4057qib7	9515	7	)	)	-RRB-
cord-005453-4057qib7	9515	8	has	have	VBZ
cord-005453-4057qib7	9515	9	been	be	VBN
cord-005453-4057qib7	9515	10	shown	show	VBN
cord-005453-4057qib7	9515	11	by	by	IN
cord-005453-4057qib7	9515	12	some	some	DT
cord-005453-4057qib7	9515	13	authors	author	NNS
cord-005453-4057qib7	9515	14	to	to	TO
cord-005453-4057qib7	9515	15	have	have	VB
cord-005453-4057qib7	9515	16	a	a	DT
cord-005453-4057qib7	9515	17	protecting	protect	VBG
cord-005453-4057qib7	9515	18	effect	effect	NN
cord-005453-4057qib7	9515	19	against	against	IN
cord-005453-4057qib7	9515	20	relapse	relapse	NN
cord-005453-4057qib7	9515	21	,	,	,
cord-005453-4057qib7	9515	22	whose	whose	WP$
cord-005453-4057qib7	9515	23	features	feature	NNS
cord-005453-4057qib7	9515	24	remain	remain	VBP
cord-005453-4057qib7	9515	25	to	to	TO
cord-005453-4057qib7	9515	26	be	be	VB
cord-005453-4057qib7	9515	27	elucidated	elucidate	VBN
cord-005453-4057qib7	9515	28	.	.	.
cord-005453-4057qib7	9516	1	We	-PRON-	PRP
cord-005453-4057qib7	9516	2	conducted	conduct	VBD
cord-005453-4057qib7	9516	3	a	a	DT
cord-005453-4057qib7	9516	4	retrospective	retrospective	JJ
cord-005453-4057qib7	9516	5	monocentric	monocentric	JJ
cord-005453-4057qib7	9516	6	study	study	NN
cord-005453-4057qib7	9516	7	regarding	regard	VBG
cord-005453-4057qib7	9516	8	the	the	DT
cord-005453-4057qib7	9516	9	outcome	outcome	NN
cord-005453-4057qib7	9516	10	in	in	IN
cord-005453-4057qib7	9516	11	terms	term	NNS
cord-005453-4057qib7	9516	12	of	of	IN
cord-005453-4057qib7	9516	13	graft	graft	NN
cord-005453-4057qib7	9516	14	versus	versus	IN
cord-005453-4057qib7	9516	15	host	host	NN
cord-005453-4057qib7	9516	16	(	(	-LRB-
cord-005453-4057qib7	9516	17	GvHD	GvHD	NNP
cord-005453-4057qib7	9516	18	)	)	-RRB-
cord-005453-4057qib7	9516	19	,	,	,
cord-005453-4057qib7	9516	20	relapse	relapse	NN
cord-005453-4057qib7	9516	21	and	and	CC
cord-005453-4057qib7	9516	22	survival	survival	NN
cord-005453-4057qib7	9516	23	of	of	IN
cord-005453-4057qib7	9516	24	224	224	CD
cord-005453-4057qib7	9516	25	consecutive	consecutive	JJ
cord-005453-4057qib7	9516	26	patients	patient	NNS
cord-005453-4057qib7	9516	27	over	over	IN
cord-005453-4057qib7	9516	28	a	a	DT
cord-005453-4057qib7	9516	29	period	period	NN
cord-005453-4057qib7	9516	30	of	of	IN
cord-005453-4057qib7	9516	31	5	5	CD
cord-005453-4057qib7	9516	32	years	year	NNS
cord-005453-4057qib7	9516	33	,	,	,
cord-005453-4057qib7	9516	34	whether	whether	IN
cord-005453-4057qib7	9516	35	they	-PRON-	PRP
cord-005453-4057qib7	9516	36	presented	present	VBD
cord-005453-4057qib7	9516	37	or	or	CC
cord-005453-4057qib7	9516	38	not	not	RB
cord-005453-4057qib7	9516	39	with	with	IN
cord-005453-4057qib7	9516	40	an	an	DT
cord-005453-4057qib7	9516	41	infectious	infectious	JJ
cord-005453-4057qib7	9516	42	event	event	NN
cord-005453-4057qib7	9516	43	by	by	IN
cord-005453-4057qib7	9516	44	day	day	NN
cord-005453-4057qib7	9516	45	100	100	CD
cord-005453-4057qib7	9516	46	among	among	IN
cord-005453-4057qib7	9516	47	the	the	DT
cord-005453-4057qib7	9516	48	following	follow	VBG
cord-005453-4057qib7	9516	49	:	:	:
cord-005453-4057qib7	9516	50	CMV	CMV	NNP
cord-005453-4057qib7	9516	51	viremia	viremia	NN
cord-005453-4057qib7	9516	52	,	,	,
cord-005453-4057qib7	9516	53	Epstein	Epstein	NNP
cord-005453-4057qib7	9516	54	-	-	HYPH
cord-005453-4057qib7	9516	55	Barr	Barr	NNP
cord-005453-4057qib7	9516	56	virus	virus	NN
cord-005453-4057qib7	9516	57	(	(	-LRB-
cord-005453-4057qib7	9516	58	EBV	EBV	NNP
cord-005453-4057qib7	9516	59	)	)	-RRB-
cord-005453-4057qib7	9516	60	viremia	viremia	NNP
cord-005453-4057qib7	9516	61	,	,	,
cord-005453-4057qib7	9516	62	Human	human	JJ
cord-005453-4057qib7	9516	63	herpes	herpe	NNS
cord-005453-4057qib7	9516	64	virus	virus	NN
cord-005453-4057qib7	9516	65	6	6	CD
cord-005453-4057qib7	9516	66	(	(	-LRB-
cord-005453-4057qib7	9516	67	HHV6	HHV6	NNP
cord-005453-4057qib7	9516	68	)	)	-RRB-
cord-005453-4057qib7	9516	69	viremia	viremia	NN
cord-005453-4057qib7	9516	70	,	,	,
cord-005453-4057qib7	9516	71	BK	BK	NNP
cord-005453-4057qib7	9516	72	virus	virus	NN
cord-005453-4057qib7	9516	73	(	(	-LRB-
cord-005453-4057qib7	9516	74	BKV	BKV	NNP
cord-005453-4057qib7	9516	75	)	)	-RRB-
cord-005453-4057qib7	9516	76	viruria	viruria	NNS
cord-005453-4057qib7	9516	77	,	,	,
cord-005453-4057qib7	9516	78	bacterial	bacterial	JJ
cord-005453-4057qib7	9516	79	bloodstream	bloodstream	NN
cord-005453-4057qib7	9516	80	infection	infection	NN
cord-005453-4057qib7	9516	81	(	(	-LRB-
cord-005453-4057qib7	9516	82	BSI	BSI	NNP
cord-005453-4057qib7	9516	83	)	)	-RRB-
cord-005453-4057qib7	9516	84	or	or	CC
cord-005453-4057qib7	9516	85	invasive	invasive	JJ
cord-005453-4057qib7	9516	86	fungal	fungal	JJ
cord-005453-4057qib7	9516	87	infection	infection	NN
cord-005453-4057qib7	9516	88	.	.	.
cord-005453-4057qib7	9517	1	Results	result	NNS
cord-005453-4057qib7	9517	2	:	:	:
cord-005453-4057qib7	9518	1	A	a	DT
cord-005453-4057qib7	9518	2	high	high	JJ
cord-005453-4057qib7	9518	3	proportion	proportion	NN
cord-005453-4057qib7	9518	4	of	of	IN
cord-005453-4057qib7	9518	5	CMV	CMV	NNP
cord-005453-4057qib7	9518	6	seropositive	seropositive	JJ
cord-005453-4057qib7	9518	7	recipients	recipient	NNS
cord-005453-4057qib7	9518	8	underwent	undergo	VBD
cord-005453-4057qib7	9518	9	a	a	DT
cord-005453-4057qib7	9518	10	viral	viral	JJ
cord-005453-4057qib7	9518	11	reactivation	reactivation	NN
cord-005453-4057qib7	9518	12	of	of	IN
cord-005453-4057qib7	9518	13	CMV	CMV	NNP
cord-005453-4057qib7	9518	14	by	by	IN
cord-005453-4057qib7	9518	15	day	day	NN
cord-005453-4057qib7	9518	16	100	100	CD
cord-005453-4057qib7	9518	17	of	of	IN
cord-005453-4057qib7	9518	18	the	the	DT
cord-005453-4057qib7	9518	19	HSCT	HSCT	NNP
cord-005453-4057qib7	9518	20	:	:	:
cord-005453-4057qib7	9519	1	81	81	CD
cord-005453-4057qib7	9519	2	%	%	NN
cord-005453-4057qib7	9519	3	if	if	IN
cord-005453-4057qib7	9519	4	the	the	DT
cord-005453-4057qib7	9519	5	donor	donor	NN
cord-005453-4057qib7	9519	6	is	be	VBZ
cord-005453-4057qib7	9519	7	seronegative	seronegative	JJ
cord-005453-4057qib7	9519	8	and	and	CC
cord-005453-4057qib7	9519	9	74	74	CD
cord-005453-4057qib7	9519	10	%	%	NN
cord-005453-4057qib7	9519	11	if	if	IN
cord-005453-4057qib7	9519	12	the	the	DT
cord-005453-4057qib7	9519	13	donor	donor	NN
cord-005453-4057qib7	9519	14	is	be	VBZ
cord-005453-4057qib7	9519	15	seropositive	seropositive	JJ
cord-005453-4057qib7	9519	16	.	.	.
cord-005453-4057qib7	9520	1	We	-PRON-	PRP
cord-005453-4057qib7	9520	2	observed	observe	VBD
cord-005453-4057qib7	9520	3	that	that	IN
cord-005453-4057qib7	9520	4	CMV	CMV	NNP
cord-005453-4057qib7	9520	5	was	be	VBD
cord-005453-4057qib7	9520	6	n't	not	RB
cord-005453-4057qib7	9520	7	associated	associate	VBN
cord-005453-4057qib7	9520	8	with	with	IN
cord-005453-4057qib7	9520	9	a	a	DT
cord-005453-4057qib7	9520	10	lower	low	JJR
cord-005453-4057qib7	9520	11	relapse	relapse	NN
cord-005453-4057qib7	9520	12	rate	rate	NN
cord-005453-4057qib7	9520	13	in	in	IN
cord-005453-4057qib7	9520	14	our	-PRON-	PRP$
cord-005453-4057qib7	9520	15	cohort	cohort	NN
cord-005453-4057qib7	9520	16	,	,	,
cord-005453-4057qib7	9520	17	and	and	CC
cord-005453-4057qib7	9520	18	data	datum	NNS
cord-005453-4057qib7	9520	19	were	be	VBD
cord-005453-4057qib7	9520	20	n't	not	RB
cord-005453-4057qib7	9520	21	sufficient	sufficient	JJ
cord-005453-4057qib7	9520	22	to	to	TO
cord-005453-4057qib7	9520	23	conclude	conclude	VB
cord-005453-4057qib7	9520	24	firmly	firmly	RB
cord-005453-4057qib7	9520	25	,	,	,
cord-005453-4057qib7	9520	26	but	but	CC
cord-005453-4057qib7	9520	27	showed	show	VBD
cord-005453-4057qib7	9520	28	a	a	DT
cord-005453-4057qib7	9520	29	trend	trend	NN
cord-005453-4057qib7	9520	30	towards	towards	IN
cord-005453-4057qib7	9520	31	a	a	DT
cord-005453-4057qib7	9520	32	worse	bad	JJR
cord-005453-4057qib7	9520	33	acute	acute	JJ
cord-005453-4057qib7	9520	34	GvHD	GvHD	NNP
cord-005453-4057qib7	9520	35	(	(	-LRB-
cord-005453-4057qib7	9520	36	hazard	hazard	NN
cord-005453-4057qib7	9520	37	ratio	ratio	NN
cord-005453-4057qib7	9520	38	HR	HR	NNP
cord-005453-4057qib7	9520	39	2.08	2.08	CD
cord-005453-4057qib7	9520	40	,	,	,
cord-005453-4057qib7	9521	1	pvalue	pvalue	NNP
cord-005453-4057qib7	9521	2	0.06	0.06	CD
cord-005453-4057qib7	9521	3	)	)	-RRB-
cord-005453-4057qib7	9521	4	.	.	.
cord-005453-4057qib7	9522	1	No	no	DT
cord-005453-4057qib7	9522	2	significant	significant	JJ
cord-005453-4057qib7	9522	3	correlation	correlation	NN
cord-005453-4057qib7	9522	4	was	be	VBD
cord-005453-4057qib7	9522	5	found	find	VBN
cord-005453-4057qib7	9522	6	for	for	IN
cord-005453-4057qib7	9522	7	EBV	EBV	NNP
cord-005453-4057qib7	9522	8	viremia	viremia	NN
cord-005453-4057qib7	9522	9	.	.	.
cord-005453-4057qib7	9523	1	Occurring	occur	VBG
cord-005453-4057qib7	9523	2	in	in	IN
cord-005453-4057qib7	9523	3	26	26	CD
cord-005453-4057qib7	9523	4	%	%	NN
cord-005453-4057qib7	9523	5	of	of	IN
cord-005453-4057qib7	9523	6	our	-PRON-	PRP$
cord-005453-4057qib7	9523	7	patients	patient	NNS
cord-005453-4057qib7	9523	8	and	and	CC
cord-005453-4057qib7	9523	9	mostly	mostly	RB
cord-005453-4057qib7	9523	10	with	with	IN
cord-005453-4057qib7	9523	11	an	an	DT
cord-005453-4057qib7	9523	12	early	early	JJ
cord-005453-4057qib7	9523	13	timing	timing	NN
cord-005453-4057qib7	9523	14	,	,	,
cord-005453-4057qib7	9523	15	HHV6	HHV6	NNP
cord-005453-4057qib7	9523	16	strongly	strongly	RB
cord-005453-4057qib7	9523	17	correlated	correlate	VBD
cord-005453-4057qib7	9523	18	with	with	IN
cord-005453-4057qib7	9523	19	worse	bad	JJR
cord-005453-4057qib7	9523	20	acute	acute	JJ
cord-005453-4057qib7	9523	21	GvHD	gvhd	NN
cord-005453-4057qib7	9523	22	(	(	-LRB-
cord-005453-4057qib7	9523	23	HR	HR	NNP
cord-005453-4057qib7	9523	24	3.25	3.25	CD
cord-005453-4057qib7	9523	25	,	,	,
cord-005453-4057qib7	9523	26	p	p	NN
cord-005453-4057qib7	9523	27	-	-	HYPH
cord-005453-4057qib7	9523	28	value	value	NN
cord-005453-4057qib7	9523	29	<	<	XX
cord-005453-4057qib7	9523	30	0.001	0.001	CD
cord-005453-4057qib7	9523	31	)	)	-RRB-
cord-005453-4057qib7	9523	32	but	but	CC
cord-005453-4057qib7	9523	33	its	-PRON-	PRP$
cord-005453-4057qib7	9523	34	impact	impact	NN
cord-005453-4057qib7	9523	35	on	on	IN
cord-005453-4057qib7	9523	36	survival	survival	NN
cord-005453-4057qib7	9523	37	was	be	VBD
cord-005453-4057qib7	9523	38	not	not	RB
cord-005453-4057qib7	9523	39	significant	significant	JJ
cord-005453-4057qib7	9523	40	.	.	.
cord-005453-4057qib7	9524	1	BKV	BKV	NNP
cord-005453-4057qib7	9524	2	(	(	-LRB-
cord-005453-4057qib7	9524	3	27	27	CD
cord-005453-4057qib7	9524	4	%	%	NN
cord-005453-4057qib7	9524	5	of	of	IN
cord-005453-4057qib7	9524	6	our	-PRON-	PRP$
cord-005453-4057qib7	9524	7	patients	patient	NNS
cord-005453-4057qib7	9524	8	)	)	-RRB-
cord-005453-4057qib7	9524	9	and	and	CC
cord-005453-4057qib7	9524	10	BSI	BSI	NNP
cord-005453-4057qib7	9524	11	(	(	-LRB-
cord-005453-4057qib7	9524	12	46	46	CD
cord-005453-4057qib7	9524	13	%	%	NN
cord-005453-4057qib7	9524	14	of	of	IN
cord-005453-4057qib7	9524	15	our	-PRON-	PRP$
cord-005453-4057qib7	9524	16	patients	patient	NNS
cord-005453-4057qib7	9524	17	)	)	-RRB-
cord-005453-4057qib7	9524	18	both	both	DT
cord-005453-4057qib7	9524	19	correlated	correlate	VBD
cord-005453-4057qib7	9524	20	with	with	IN
cord-005453-4057qib7	9524	21	poorer	poor	JJR
cord-005453-4057qib7	9524	22	outcome	outcome	NN
cord-005453-4057qib7	9524	23	in	in	IN
cord-005453-4057qib7	9524	24	terms	term	NNS
cord-005453-4057qib7	9524	25	of	of	IN
cord-005453-4057qib7	9524	26	overall	overall	JJ
cord-005453-4057qib7	9524	27	survival	survival	NN
cord-005453-4057qib7	9524	28	(	(	-LRB-
cord-005453-4057qib7	9524	29	logrank	logrank	NNP
cord-005453-4057qib7	9524	30	<	<	XX
cord-005453-4057qib7	9524	31	0.001	0.001	CD
cord-005453-4057qib7	9524	32	and	and	CC
cord-005453-4057qib7	9524	33	0.014	0.014	CD
cord-005453-4057qib7	9524	34	respectively	respectively	RB
cord-005453-4057qib7	9524	35	)	)	-RRB-
cord-005453-4057qib7	9524	36	although	although	IN
cord-005453-4057qib7	9524	37	not	not	RB
cord-005453-4057qib7	9524	38	significantly	significantly	RB
cord-005453-4057qib7	9524	39	associated	associate	VBN
cord-005453-4057qib7	9524	40	with	with	IN
cord-005453-4057qib7	9524	41	relapse	relapse	NN
cord-005453-4057qib7	9524	42	or	or	CC
cord-005453-4057qib7	9524	43	acute	acute	JJ
cord-005453-4057qib7	9524	44	GvHD	gvhd	NN
cord-005453-4057qib7	9524	45	.	.	.
cord-005453-4057qib7	9525	1	Fungal	fungal	JJ
cord-005453-4057qib7	9525	2	infections	infection	NNS
cord-005453-4057qib7	9525	3	were	be	VBD
cord-005453-4057qib7	9525	4	too	too	RB
cord-005453-4057qib7	9525	5	rare	rare	JJ
cord-005453-4057qib7	9525	6	events	event	NNS
cord-005453-4057qib7	9525	7	to	to	TO
cord-005453-4057qib7	9525	8	draw	draw	VB
cord-005453-4057qib7	9525	9	any	any	DT
cord-005453-4057qib7	9525	10	conclusion	conclusion	NN
cord-005453-4057qib7	9525	11	.	.	.
cord-005453-4057qib7	9526	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9526	2	:	:	:
cord-005453-4057qib7	9527	1	Thus	thus	RB
cord-005453-4057qib7	9527	2	,	,	,
cord-005453-4057qib7	9527	3	contrary	contrary	JJ
cord-005453-4057qib7	9527	4	to	to	IN
cord-005453-4057qib7	9527	5	many	many	JJ
cord-005453-4057qib7	9527	6	studies	study	NNS
cord-005453-4057qib7	9527	7	,	,	,
cord-005453-4057qib7	9527	8	we	-PRON-	PRP
cord-005453-4057qib7	9527	9	found	find	VBD
cord-005453-4057qib7	9527	10	no	no	DT
cord-005453-4057qib7	9527	11	protection	protection	NN
cord-005453-4057qib7	9527	12	against	against	IN
cord-005453-4057qib7	9527	13	relapse	relapse	NN
cord-005453-4057qib7	9527	14	induced	induce	VBN
cord-005453-4057qib7	9527	15	by	by	IN
cord-005453-4057qib7	9527	16	CMV	CMV	NNP
cord-005453-4057qib7	9527	17	,	,	,
cord-005453-4057qib7	9527	18	although	although	IN
cord-005453-4057qib7	9527	19	the	the	DT
cord-005453-4057qib7	9527	20	trend	trend	NN
cord-005453-4057qib7	9527	21	for	for	IN
cord-005453-4057qib7	9527	22	worse	bad	JJR
cord-005453-4057qib7	9527	23	acute	acute	JJ
cord-005453-4057qib7	9527	24	GvHD	GvHD	NNP
cord-005453-4057qib7	9527	25	was	be	VBD
cord-005453-4057qib7	9527	26	obvious	obvious	JJ
cord-005453-4057qib7	9527	27	.	.	.
cord-005453-4057qib7	9528	1	The	the	DT
cord-005453-4057qib7	9528	2	mechanisms	mechanism	NNS
cord-005453-4057qib7	9528	3	behind	behind	IN
cord-005453-4057qib7	9528	4	this	this	DT
cord-005453-4057qib7	9528	5	discordance	discordance	NN
cord-005453-4057qib7	9528	6	could	could	MD
cord-005453-4057qib7	9528	7	include	include	VB
cord-005453-4057qib7	9528	8	early	early	JJ
cord-005453-4057qib7	9528	9	treatment	treatment	NN
cord-005453-4057qib7	9528	10	,	,	,
cord-005453-4057qib7	9528	11	but	but	CC
cord-005453-4057qib7	9528	12	remain	remain	VBP
cord-005453-4057qib7	9528	13	to	to	TO
cord-005453-4057qib7	9528	14	be	be	VB
cord-005453-4057qib7	9528	15	studied	study	VBN
cord-005453-4057qib7	9528	16	.	.	.
cord-005453-4057qib7	9529	1	Whether	whether	IN
cord-005453-4057qib7	9529	2	HHV6	HHV6	NNP
cord-005453-4057qib7	9529	3	is	be	VBZ
cord-005453-4057qib7	9529	4	a	a	DT
cord-005453-4057qib7	9529	5	cause	cause	NN
cord-005453-4057qib7	9529	6	rather	rather	RB
cord-005453-4057qib7	9529	7	than	than	IN
cord-005453-4057qib7	9529	8	a	a	DT
cord-005453-4057qib7	9529	9	consequence	consequence	NN
cord-005453-4057qib7	9529	10	of	of	IN
cord-005453-4057qib7	9529	11	acute	acute	JJ
cord-005453-4057qib7	9529	12	GvHD	gvhd	NN
cord-005453-4057qib7	9529	13	or	or	CC
cord-005453-4057qib7	9529	14	its	-PRON-	PRP$
cord-005453-4057qib7	9529	15	treatment	treatment	NN
cord-005453-4057qib7	9529	16	is	be	VBZ
cord-005453-4057qib7	9529	17	debated	debate	VBN
cord-005453-4057qib7	9529	18	,	,	,
cord-005453-4057qib7	9529	19	but	but	CC
cord-005453-4057qib7	9529	20	the	the	DT
cord-005453-4057qib7	9529	21	correlation	correlation	NN
cord-005453-4057qib7	9529	22	is	be	VBZ
cord-005453-4057qib7	9529	23	strong	strong	JJ
cord-005453-4057qib7	9529	24	and	and	CC
cord-005453-4057qib7	9529	25	the	the	DT
cord-005453-4057qib7	9529	26	sequence	sequence	NN
cord-005453-4057qib7	9529	27	of	of	IN
cord-005453-4057qib7	9529	28	events	event	NNS
cord-005453-4057qib7	9529	29	suggests	suggest	VBZ
cord-005453-4057qib7	9529	30	HHV6	HHV6	NNP
cord-005453-4057qib7	9529	31	might	may	MD
cord-005453-4057qib7	9529	32	act	act	VB
cord-005453-4057qib7	9529	33	as	as	IN
cord-005453-4057qib7	9529	34	a	a	DT
cord-005453-4057qib7	9529	35	trigger	trigger	NN
cord-005453-4057qib7	9529	36	for	for	IN
cord-005453-4057qib7	9529	37	GvHD	GvHD	NNP
cord-005453-4057qib7	9529	38	.	.	.
cord-005453-4057qib7	9530	1	The	the	DT
cord-005453-4057qib7	9530	2	association	association	NN
cord-005453-4057qib7	9530	3	between	between	IN
cord-005453-4057qib7	9530	4	BKV	BKV	NNP
cord-005453-4057qib7	9530	5	viruria	viruria	NNS
cord-005453-4057qib7	9530	6	and	and	CC
cord-005453-4057qib7	9530	7	a	a	DT
cord-005453-4057qib7	9530	8	higher	high	JJR
cord-005453-4057qib7	9530	9	mortality	mortality	NN
cord-005453-4057qib7	9530	10	is	be	VBZ
cord-005453-4057qib7	9530	11	in	in	IN
cord-005453-4057qib7	9530	12	contrast	contrast	NN
cord-005453-4057qib7	9530	13	with	with	IN
cord-005453-4057qib7	9530	14	previous	previous	JJ
cord-005453-4057qib7	9530	15	observations	observation	NNS
cord-005453-4057qib7	9530	16	,	,	,
cord-005453-4057qib7	9530	17	and	and	CC
cord-005453-4057qib7	9530	18	the	the	DT
cord-005453-4057qib7	9530	19	lack	lack	NN
cord-005453-4057qib7	9530	20	for	for	IN
cord-005453-4057qib7	9530	21	association	association	NN
cord-005453-4057qib7	9530	22	with	with	IN
cord-005453-4057qib7	9530	23	GvHD	GvHD	NNP
cord-005453-4057qib7	9530	24	and	and	CC
cord-005453-4057qib7	9530	25	relapse	relapse	NN
cord-005453-4057qib7	9530	26	could	could	MD
cord-005453-4057qib7	9530	27	suggest	suggest	VB
cord-005453-4057qib7	9530	28	BKV	BKV	NNP
cord-005453-4057qib7	9530	29	is	be	VBZ
cord-005453-4057qib7	9530	30	a	a	DT
cord-005453-4057qib7	9530	31	surrogate	surrogate	NN
cord-005453-4057qib7	9530	32	for	for	IN
cord-005453-4057qib7	9530	33	poor	poor	JJ
cord-005453-4057qib7	9530	34	immune	immune	JJ
cord-005453-4057qib7	9530	35	recovery	recovery	NN
cord-005453-4057qib7	9530	36	and	and	CC
cord-005453-4057qib7	9530	37	therefore	therefore	RB
cord-005453-4057qib7	9530	38	other	other	JJ
cord-005453-4057qib7	9530	39	causes	cause	NNS
cord-005453-4057qib7	9530	40	of	of	IN
cord-005453-4057qib7	9530	41	non	non	JJ
cord-005453-4057qib7	9530	42	-	-	JJ
cord-005453-4057qib7	9530	43	relapse	relapse	JJ
cord-005453-4057qib7	9530	44	mortality	mortality	NN
cord-005453-4057qib7	9530	45	.	.	.
cord-005453-4057qib7	9531	1	In	in	IN
cord-005453-4057qib7	9531	2	addition	addition	NN
cord-005453-4057qib7	9531	3	to	to	IN
cord-005453-4057qib7	9531	4	the	the	DT
cord-005453-4057qib7	9531	5	direct	direct	JJ
cord-005453-4057qib7	9531	6	lethal	lethal	JJ
cord-005453-4057qib7	9531	7	risk	risk	NN
cord-005453-4057qib7	9531	8	of	of	IN
cord-005453-4057qib7	9531	9	bacteriemia	bacteriemia	NN
cord-005453-4057qib7	9531	10	,	,	,
cord-005453-4057qib7	9531	11	BSI	BSI	NNP
cord-005453-4057qib7	9531	12	also	also	RB
cord-005453-4057qib7	9531	13	are	be	VBP
cord-005453-4057qib7	9531	14	a	a	DT
cord-005453-4057qib7	9531	15	promoter	promoter	NN
cord-005453-4057qib7	9531	16	of	of	IN
cord-005453-4057qib7	9531	17	late	late	JJ
cord-005453-4057qib7	9531	18	non	non	JJ
cord-005453-4057qib7	9531	19	-	-	JJ
cord-005453-4057qib7	9531	20	relapse	relapse	JJ
cord-005453-4057qib7	9531	21	mortality	mortality	NN
cord-005453-4057qib7	9531	22	through	through	IN
cord-005453-4057qib7	9531	23	indirect	indirect	JJ
cord-005453-4057qib7	9531	24	toxicity	toxicity	NN
cord-005453-4057qib7	9531	25	.	.	.
cord-005453-4057qib7	9532	1	Through	through	IN
cord-005453-4057qib7	9532	2	the	the	DT
cord-005453-4057qib7	9532	3	expansion	expansion	NN
cord-005453-4057qib7	9532	4	of	of	IN
cord-005453-4057qib7	9532	5	immune	immune	JJ
cord-005453-4057qib7	9532	6	effectors	effector	NNS
cord-005453-4057qib7	9532	7	they	-PRON-	PRP
cord-005453-4057qib7	9532	8	promote	promote	VBP
cord-005453-4057qib7	9532	9	,	,	,
cord-005453-4057qib7	9532	10	one	one	PRP
cord-005453-4057qib7	9532	11	could	could	MD
cord-005453-4057qib7	9532	12	assume	assume	VB
cord-005453-4057qib7	9532	13	that	that	IN
cord-005453-4057qib7	9532	14	infectious	infectious	JJ
cord-005453-4057qib7	9532	15	events	event	NNS
cord-005453-4057qib7	9532	16	play	play	VBP
cord-005453-4057qib7	9532	17	a	a	DT
cord-005453-4057qib7	9532	18	role	role	NN
cord-005453-4057qib7	9532	19	in	in	IN
cord-005453-4057qib7	9532	20	GvHD	gvhd	NN
cord-005453-4057qib7	9532	21	and	and	CC
cord-005453-4057qib7	9532	22	GvL	gvl	NN
cord-005453-4057qib7	9532	23	,	,	,
cord-005453-4057qib7	9532	24	and	and	CC
cord-005453-4057qib7	9532	25	therefore	therefore	RB
cord-005453-4057qib7	9532	26	have	have	VBP
cord-005453-4057qib7	9532	27	an	an	DT
cord-005453-4057qib7	9532	28	interference	interference	NN
cord-005453-4057qib7	9532	29	with	with	IN
cord-005453-4057qib7	9532	30	relapse	relapse	NN
cord-005453-4057qib7	9532	31	.	.	.
cord-005453-4057qib7	9533	1	However	however	RB
cord-005453-4057qib7	9533	2	,	,	,
cord-005453-4057qib7	9533	3	the	the	DT
cord-005453-4057qib7	9533	4	association	association	NN
cord-005453-4057qib7	9533	5	between	between	IN
cord-005453-4057qib7	9533	6	each	each	DT
cord-005453-4057qib7	9533	7	infectious	infectious	JJ
cord-005453-4057qib7	9533	8	event	event	NN
cord-005453-4057qib7	9533	9	and	and	CC
cord-005453-4057qib7	9533	10	outcome	outcome	NN
cord-005453-4057qib7	9533	11	remains	remain	VBZ
cord-005453-4057qib7	9533	12	to	to	TO
cord-005453-4057qib7	9533	13	be	be	VB
cord-005453-4057qib7	9533	14	clarified	clarify	VBN
cord-005453-4057qib7	9533	15	to	to	TO
cord-005453-4057qib7	9533	16	guide	guide	VB
cord-005453-4057qib7	9533	17	our	-PRON-	PRP$
cord-005453-4057qib7	9533	18	prophylactic	prophylactic	JJ
cord-005453-4057qib7	9533	19	and	and	CC
cord-005453-4057qib7	9533	20	therapeutic	therapeutic	JJ
cord-005453-4057qib7	9533	21	choices	choice	NNS
cord-005453-4057qib7	9533	22	by	by	IN
cord-005453-4057qib7	9533	23	a	a	DT
cord-005453-4057qib7	9533	24	better	well	JJR
cord-005453-4057qib7	9533	25	understanding	understanding	NN
cord-005453-4057qib7	9533	26	of	of	IN
cord-005453-4057qib7	9533	27	the	the	DT
cord-005453-4057qib7	9533	28	bright	bright	JJ
cord-005453-4057qib7	9533	29	and	and	CC
cord-005453-4057qib7	9533	30	dark	dark	JJ
cord-005453-4057qib7	9533	31	sides	side	NNS
cord-005453-4057qib7	9533	32	of	of	IN
cord-005453-4057qib7	9533	33	infectious	infectious	JJ
cord-005453-4057qib7	9533	34	events	event	NNS
cord-005453-4057qib7	9533	35	.	.	.
cord-005453-4057qib7	9534	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9534	2	Background	background	NN
cord-005453-4057qib7	9534	3	:	:	:
cord-005453-4057qib7	9534	4	Rezafungin	Rezafungin	NNP
cord-005453-4057qib7	9534	5	(	(	-LRB-
cord-005453-4057qib7	9534	6	RZF	RZF	NNP
cord-005453-4057qib7	9534	7	)	)	-RRB-
cord-005453-4057qib7	9534	8	is	be	VBZ
cord-005453-4057qib7	9534	9	a	a	DT
cord-005453-4057qib7	9534	10	novel	novel	JJ
cord-005453-4057qib7	9534	11	echinocandin	echinocandin	NNS
cord-005453-4057qib7	9534	12	in	in	IN
cord-005453-4057qib7	9534	13	Phase	phase	NN
cord-005453-4057qib7	9534	14	3	3	CD
cord-005453-4057qib7	9534	15	development	development	NN
cord-005453-4057qib7	9534	16	for	for	IN
cord-005453-4057qib7	9534	17	treatment	treatment	NN
cord-005453-4057qib7	9534	18	of	of	IN
cord-005453-4057qib7	9534	19	candidaemia	candidaemia	NN
cord-005453-4057qib7	9534	20	and	and	CC
cord-005453-4057qib7	9534	21	invasive	invasive	JJ
cord-005453-4057qib7	9534	22	candidiasis	candidiasi	NNS
cord-005453-4057qib7	9534	23	and	and	CC
cord-005453-4057qib7	9534	24	for	for	IN
cord-005453-4057qib7	9534	25	antifungal	antifungal	JJ
cord-005453-4057qib7	9534	26	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9534	27	against	against	IN
cord-005453-4057qib7	9534	28	invasive	invasive	JJ
cord-005453-4057qib7	9534	29	fungal	fungal	JJ
cord-005453-4057qib7	9534	30	diseases	disease	NNS
cord-005453-4057qib7	9534	31	caused	cause	VBN
cord-005453-4057qib7	9534	32	by	by	IN
cord-005453-4057qib7	9534	33	Candida	Candida	NNP
cord-005453-4057qib7	9534	34	,	,	,
cord-005453-4057qib7	9534	35	Aspergillus	Aspergillus	NNP
cord-005453-4057qib7	9534	36	,	,	,
cord-005453-4057qib7	9534	37	and	and	CC
cord-005453-4057qib7	9534	38	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9534	39	in	in	IN
cord-005453-4057qib7	9534	40	blood	blood	NN
cord-005453-4057qib7	9534	41	and	and	CC
cord-005453-4057qib7	9534	42	marrow	marrow	NN
cord-005453-4057qib7	9534	43	transplant	transplant	NN
cord-005453-4057qib7	9534	44	patients	patient	NNS
cord-005453-4057qib7	9534	45	.	.	.
cord-005453-4057qib7	9535	1	RZF	RZF	NNP
cord-005453-4057qib7	9535	2	is	be	VBZ
cord-005453-4057qib7	9535	3	differentiated	differentiate	VBN
cord-005453-4057qib7	9535	4	by	by	IN
cord-005453-4057qib7	9535	5	stable	stable	JJ
cord-005453-4057qib7	9535	6	,	,	,
cord-005453-4057qib7	9535	7	prolonged	prolonged	JJ
cord-005453-4057qib7	9535	8	pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	9535	9	(	(	-LRB-
cord-005453-4057qib7	9535	10	PK	PK	NNP
cord-005453-4057qib7	9535	11	)	)	-RRB-
cord-005453-4057qib7	9535	12	that	that	WDT
cord-005453-4057qib7	9535	13	allow	allow	VBP
cord-005453-4057qib7	9535	14	for	for	IN
cord-005453-4057qib7	9535	15	once	once	RB
cord-005453-4057qib7	9535	16	-	-	HYPH
cord-005453-4057qib7	9535	17	weekly	weekly	NN
cord-005453-4057qib7	9535	18	dosing	dosing	NN
cord-005453-4057qib7	9535	19	and	and	CC
cord-005453-4057qib7	9535	20	a	a	DT
cord-005453-4057qib7	9535	21	PK	PK	NNP
cord-005453-4057qib7	9535	22	-	-	HYPH
cord-005453-4057qib7	9535	23	pharmacodynamic	pharmacodynamic	JJ
cord-005453-4057qib7	9535	24	(	(	-LRB-
cord-005453-4057qib7	9535	25	PD	PD	NNP
cord-005453-4057qib7	9535	26	)	)	-RRB-
cord-005453-4057qib7	9535	27	profile	profile	NN
cord-005453-4057qib7	9535	28	correlating	correlate	VBG
cord-005453-4057qib7	9535	29	with	with	IN
cord-005453-4057qib7	9535	30	efficacy	efficacy	NN
cord-005453-4057qib7	9535	31	.	.	.
cord-005453-4057qib7	9536	1	Clinical	clinical	JJ
cord-005453-4057qib7	9536	2	in	in	IN
cord-005453-4057qib7	9536	3	vivo	vivo	NN
cord-005453-4057qib7	9536	4	evaluations	evaluation	NNS
cord-005453-4057qib7	9536	5	of	of	IN
cord-005453-4057qib7	9536	6	drug	drug	NN
cord-005453-4057qib7	9536	7	interaction	interaction	NN
cord-005453-4057qib7	9536	8	potential	potential	NN
cord-005453-4057qib7	9536	9	were	be	VBD
cord-005453-4057qib7	9536	10	performed	perform	VBN
cord-005453-4057qib7	9536	11	proactively	proactively	RB
cord-005453-4057qib7	9536	12	to	to	TO
cord-005453-4057qib7	9536	13	assess	assess	VB
cord-005453-4057qib7	9536	14	the	the	DT
cord-005453-4057qib7	9536	15	risk	risk	NN
cord-005453-4057qib7	9536	16	of	of	IN
cord-005453-4057qib7	9536	17	drug	drug	NN
cord-005453-4057qib7	9536	18	-	-	HYPH
cord-005453-4057qib7	9536	19	drug	drug	NN
cord-005453-4057qib7	9536	20	interactions	interaction	NNS
cord-005453-4057qib7	9536	21	(	(	-LRB-
cord-005453-4057qib7	9536	22	DDIs	ddi	NNS
cord-005453-4057qib7	9536	23	)	)	-RRB-
cord-005453-4057qib7	9536	24	with	with	IN
cord-005453-4057qib7	9536	25	respect	respect	NN
cord-005453-4057qib7	9536	26	to	to	IN
cord-005453-4057qib7	9536	27	the	the	DT
cord-005453-4057qib7	9536	28	Phase	phase	NN
cord-005453-4057qib7	9536	29	3	3	CD
cord-005453-4057qib7	9536	30	dose	dose	NN
cord-005453-4057qib7	9536	31	of	of	IN
cord-005453-4057qib7	9536	32	400	400	CD
cord-005453-4057qib7	9536	33	mg	mg	NNS
cord-005453-4057qib7	9536	34	once	once	RB
cord-005453-4057qib7	9536	35	weekly	weekly	RB
cord-005453-4057qib7	9536	36	and	and	CC
cord-005453-4057qib7	9536	37	known	know	VBN
cord-005453-4057qib7	9536	38	PK	PK	NNP
cord-005453-4057qib7	9536	39	exposure	exposure	NN
cord-005453-4057qib7	9536	40	in	in	IN
cord-005453-4057qib7	9536	41	healthy	healthy	JJ
cord-005453-4057qib7	9536	42	individuals	individual	NNS
cord-005453-4057qib7	9536	43	.	.	.
cord-005453-4057qib7	9537	1	Methods	method	NNS
cord-005453-4057qib7	9537	2	:	:	:
cord-005453-4057qib7	9538	1	This	this	DT
cord-005453-4057qib7	9538	2	open	open	JJ
cord-005453-4057qib7	9538	3	-	-	HYPH
cord-005453-4057qib7	9538	4	label	label	NN
cord-005453-4057qib7	9538	5	study	study	NN
cord-005453-4057qib7	9538	6	of	of	IN
cord-005453-4057qib7	9538	7	26	26	CD
cord-005453-4057qib7	9538	8	healthy	healthy	JJ
cord-005453-4057qib7	9538	9	inpatients	inpatient	NNS
cord-005453-4057qib7	9538	10	assessed	assess	VBD
cord-005453-4057qib7	9538	11	DDIs	ddi	NNS
cord-005453-4057qib7	9538	12	between	between	IN
cord-005453-4057qib7	9538	13	RZF	RZF	NNP
cord-005453-4057qib7	9538	14	(	(	-LRB-
cord-005453-4057qib7	9538	15	as	as	IN
cord-005453-4057qib7	9538	16	perpetrator	perpetrator	NN
cord-005453-4057qib7	9538	17	)	)	-RRB-
cord-005453-4057qib7	9538	18	and	and	CC
cord-005453-4057qib7	9538	19	drugs	drug	NNS
cord-005453-4057qib7	9538	20	known	know	VBN
cord-005453-4057qib7	9538	21	to	to	TO
cord-005453-4057qib7	9538	22	have	have	VB
cord-005453-4057qib7	9538	23	interactions	interaction	NNS
cord-005453-4057qib7	9538	24	with	with	IN
cord-005453-4057qib7	9538	25	CYP	CYP	NNP
cord-005453-4057qib7	9538	26	enzymes	enzyme	NNS
cord-005453-4057qib7	9538	27	and	and	CC
cord-005453-4057qib7	9538	28	transporters	transporter	NNS
cord-005453-4057qib7	9538	29	(	(	-LRB-
cord-005453-4057qib7	9538	30	probe	probe	VBP
cord-005453-4057qib7	9538	31	drugs	drug	NNS
cord-005453-4057qib7	9538	32	)	)	-RRB-
cord-005453-4057qib7	9539	1	:	:	:
cord-005453-4057qib7	9539	2	repaglinide	repaglinide	NNP
cord-005453-4057qib7	9539	3	(	(	-LRB-
cord-005453-4057qib7	9539	4	CYP2C8	CYP2C8	NNP
cord-005453-4057qib7	9539	5	)	)	-RRB-
cord-005453-4057qib7	9539	6	,	,	,
cord-005453-4057qib7	9539	7	metformin	metformin	NNP
cord-005453-4057qib7	9539	8	(	(	-LRB-
cord-005453-4057qib7	9539	9	OCT	OCT	NNP
cord-005453-4057qib7	9539	10	/	/	SYM
cord-005453-4057qib7	9539	11	MATE	mate	NN
cord-005453-4057qib7	9539	12	)	)	-RRB-
cord-005453-4057qib7	9539	13	,	,	,
cord-005453-4057qib7	9539	14	rosuvastatin	rosuvastatin	NNP
cord-005453-4057qib7	9539	15	(	(	-LRB-
cord-005453-4057qib7	9539	16	BCRP	BCRP	NNP
cord-005453-4057qib7	9539	17	/	/	SYM
cord-005453-4057qib7	9539	18	OATP	OATP	NNP
cord-005453-4057qib7	9539	19	)	)	-RRB-
cord-005453-4057qib7	9539	20	,	,	,
cord-005453-4057qib7	9539	21	pitavastatin	pitavastatin	NNP
cord-005453-4057qib7	9539	22	(	(	-LRB-
cord-005453-4057qib7	9539	23	OATP	OATP	NNP
cord-005453-4057qib7	9539	24	)	)	-RRB-
cord-005453-4057qib7	9539	25	,	,	,
cord-005453-4057qib7	9539	26	caffeine	caffeine	NN
cord-005453-4057qib7	9539	27	(	(	-LRB-
cord-005453-4057qib7	9539	28	CYP1A2	CYP1A2	NNP
cord-005453-4057qib7	9539	29	)	)	-RRB-
cord-005453-4057qib7	9539	30	,	,	,
cord-005453-4057qib7	9539	31	efavirenz	efavirenz	NNP
cord-005453-4057qib7	9539	32	(	(	-LRB-
cord-005453-4057qib7	9539	33	CYP2B6	CYP2B6	NNP
cord-005453-4057qib7	9539	34	)	)	-RRB-
cord-005453-4057qib7	9539	35	,	,	,
cord-005453-4057qib7	9539	36	midazolam	midazolam	NNP
cord-005453-4057qib7	9539	37	(	(	-LRB-
cord-005453-4057qib7	9539	38	CYP3A4	CYP3A4	NNP
cord-005453-4057qib7	9539	39	)	)	-RRB-
cord-005453-4057qib7	9539	40	,	,	,
cord-005453-4057qib7	9539	41	and	and	CC
cord-005453-4057qib7	9539	42	digoxin	digoxin	NN
cord-005453-4057qib7	9539	43	(	(	-LRB-
cord-005453-4057qib7	9539	44	P	p	NN
cord-005453-4057qib7	9539	45	-	-	HYPH
cord-005453-4057qib7	9539	46	gp	gp	NN
cord-005453-4057qib7	9539	47	)	)	-RRB-
cord-005453-4057qib7	9539	48	,	,	,
cord-005453-4057qib7	9539	49	as	as	RB
cord-005453-4057qib7	9539	50	well	well	RB
cord-005453-4057qib7	9539	51	as	as	IN
cord-005453-4057qib7	9539	52	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	9539	53	,	,	,
cord-005453-4057qib7	9539	54	a	a	DT
cord-005453-4057qib7	9539	55	drug	drug	NN
cord-005453-4057qib7	9539	56	likely	likely	JJ
cord-005453-4057qib7	9539	57	to	to	TO
cord-005453-4057qib7	9539	58	be	be	VB
cord-005453-4057qib7	9539	59	coadministered	coadministere	VBN
cord-005453-4057qib7	9539	60	with	with	IN
cord-005453-4057qib7	9539	61	RZF	RZF	NNP
cord-005453-4057qib7	9539	62	.	.	.
cord-005453-4057qib7	9540	1	An	an	DT
cord-005453-4057qib7	9540	2	initial	initial	JJ
cord-005453-4057qib7	9540	3	dose	dose	NN
cord-005453-4057qib7	9540	4	of	of	IN
cord-005453-4057qib7	9540	5	RZF	RZF	NNP
cord-005453-4057qib7	9540	6	600	600	CD
cord-005453-4057qib7	9540	7	mg	mg	NN
cord-005453-4057qib7	9540	8	was	be	VBD
cord-005453-4057qib7	9540	9	administered	administer	VBN
cord-005453-4057qib7	9540	10	on	on	IN
cord-005453-4057qib7	9540	11	the	the	DT
cord-005453-4057qib7	9540	12	first	first	JJ
cord-005453-4057qib7	9540	13	dosing	dosing	JJ
cord-005453-4057qib7	9540	14	day	day	NN
cord-005453-4057qib7	9540	15	,	,	,
cord-005453-4057qib7	9540	16	to	to	TO
cord-005453-4057qib7	9540	17	approximate	approximate	VB
cord-005453-4057qib7	9540	18	a	a	DT
cord-005453-4057qib7	9540	19	steady	steady	JJ
cord-005453-4057qib7	9540	20	state	state	NN
cord-005453-4057qib7	9540	21	plasma	plasma	NN
cord-005453-4057qib7	9540	22	concentration	concentration	NN
cord-005453-4057qib7	9540	23	of	of	IN
cord-005453-4057qib7	9540	24	multiple	multiple	JJ
cord-005453-4057qib7	9540	25	once	once	RB
cord-005453-4057qib7	9540	26	-	-	HYPH
cord-005453-4057qib7	9540	27	weekly	weekly	JJ
cord-005453-4057qib7	9540	28	400-mg	400-mg	CD
cord-005453-4057qib7	9540	29	doses	dose	NNS
cord-005453-4057qib7	9540	30	,	,	,
cord-005453-4057qib7	9540	31	followed	follow	VBN
cord-005453-4057qib7	9540	32	by	by	IN
cord-005453-4057qib7	9540	33	2	2	CD
cord-005453-4057qib7	9540	34	once	once	RB
cord-005453-4057qib7	9540	35	-	-	HYPH
cord-005453-4057qib7	9540	36	weekly	weekly	JJ
cord-005453-4057qib7	9540	37	400-mg	400-mg	CD
cord-005453-4057qib7	9540	38	doses	dose	NNS
cord-005453-4057qib7	9540	39	on	on	IN
cord-005453-4057qib7	9540	40	days	day	NNS
cord-005453-4057qib7	9540	41	10	10	CD
cord-005453-4057qib7	9540	42	and	and	CC
cord-005453-4057qib7	9540	43	15	15	CD
cord-005453-4057qib7	9540	44	.	.	.
cord-005453-4057qib7	9541	1	Probe	probe	NN
cord-005453-4057qib7	9541	2	drug	drug	NN
cord-005453-4057qib7	9541	3	cocktails	cocktail	NNS
cord-005453-4057qib7	9541	4	containing	contain	VBG
cord-005453-4057qib7	9541	5	≥2	≥2	NNP
cord-005453-4057qib7	9541	6	drugs	drug	NNS
cord-005453-4057qib7	9541	7	were	be	VBD
cord-005453-4057qib7	9541	8	administered	administer	VBN
cord-005453-4057qib7	9541	9	,	,	,
cord-005453-4057qib7	9541	10	once	once	RB
cord-005453-4057qib7	9541	11	before	before	IN
cord-005453-4057qib7	9541	12	and	and	CC
cord-005453-4057qib7	9541	13	once	once	RB
cord-005453-4057qib7	9541	14	after	after	IN
cord-005453-4057qib7	9541	15	RZF	RZF	NNP
cord-005453-4057qib7	9541	16	administration	administration	NN
cord-005453-4057qib7	9541	17	,	,	,
cord-005453-4057qib7	9541	18	on	on	IN
cord-005453-4057qib7	9541	19	a	a	DT
cord-005453-4057qib7	9541	20	schedule	schedule	NN
cord-005453-4057qib7	9541	21	designed	design	VBN
cord-005453-4057qib7	9541	22	to	to	TO
cord-005453-4057qib7	9541	23	allow	allow	VB
cord-005453-4057qib7	9541	24	for	for	IN
cord-005453-4057qib7	9541	25	washout	washout	NN
cord-005453-4057qib7	9541	26	between	between	IN
cord-005453-4057qib7	9541	27	doses	dose	NNS
cord-005453-4057qib7	9541	28	and	and	CC
cord-005453-4057qib7	9541	29	to	to	TO
cord-005453-4057qib7	9541	30	limit	limit	VB
cord-005453-4057qib7	9541	31	interactions	interaction	NNS
cord-005453-4057qib7	9541	32	with	with	IN
cord-005453-4057qib7	9541	33	other	other	JJ
cord-005453-4057qib7	9541	34	probe	probe	NN
cord-005453-4057qib7	9541	35	and	and	CC
cord-005453-4057qib7	9541	36	test	test	NN
cord-005453-4057qib7	9541	37	drugs	drug	NNS
cord-005453-4057qib7	9541	38	.	.	.
cord-005453-4057qib7	9542	1	Samples	sample	NNS
cord-005453-4057qib7	9542	2	were	be	VBD
cord-005453-4057qib7	9542	3	analysed	analyse	VBN
cord-005453-4057qib7	9542	4	to	to	TO
cord-005453-4057qib7	9542	5	determine	determine	VB
cord-005453-4057qib7	9542	6	respective	respective	JJ
cord-005453-4057qib7	9542	7	drug	drug	NN
cord-005453-4057qib7	9542	8	concentrations	concentration	NNS
cord-005453-4057qib7	9542	9	in	in	IN
cord-005453-4057qib7	9542	10	plasma	plasma	NN
cord-005453-4057qib7	9542	11	(	(	-LRB-
cord-005453-4057qib7	9542	12	except	except	IN
cord-005453-4057qib7	9542	13	for	for	IN
cord-005453-4057qib7	9542	14	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	9542	15	which	which	WDT
cord-005453-4057qib7	9542	16	was	be	VBD
cord-005453-4057qib7	9542	17	in	in	IN
cord-005453-4057qib7	9542	18	whole	whole	JJ
cord-005453-4057qib7	9542	19	blood	blood	NN
cord-005453-4057qib7	9542	20	)	)	-RRB-
cord-005453-4057qib7	9542	21	to	to	TO
cord-005453-4057qib7	9542	22	characterize	characterize	VB
cord-005453-4057qib7	9542	23	the	the	DT
cord-005453-4057qib7	9542	24	PK	PK	NNP
cord-005453-4057qib7	9542	25	profile	profile	NN
cord-005453-4057qib7	9542	26	of	of	IN
cord-005453-4057qib7	9542	27	each	each	DT
cord-005453-4057qib7	9542	28	analyte	analyte	NN
cord-005453-4057qib7	9542	29	.	.	.
cord-005453-4057qib7	9543	1	Area	area	NN
cord-005453-4057qib7	9543	2	under	under	IN
cord-005453-4057qib7	9543	3	curve	curve	NN
cord-005453-4057qib7	9543	4	(	(	-LRB-
cord-005453-4057qib7	9543	5	AUC	AUC	NNP
cord-005453-4057qib7	9543	6	)	)	-RRB-
cord-005453-4057qib7	9543	7	and	and	CC
cord-005453-4057qib7	9543	8	maximum	maximum	JJ
cord-005453-4057qib7	9543	9	concentration	concentration	NN
cord-005453-4057qib7	9543	10	(	(	-LRB-
cord-005453-4057qib7	9543	11	C	C	NNP
cord-005453-4057qib7	9543	12	max	max	NNP
cord-005453-4057qib7	9543	13	)	)	-RRB-
cord-005453-4057qib7	9543	14	were	be	VBD
cord-005453-4057qib7	9543	15	calculated	calculate	VBN
cord-005453-4057qib7	9543	16	from	from	IN
cord-005453-4057qib7	9543	17	the	the	DT
cord-005453-4057qib7	9543	18	plasma	plasma	NN
cord-005453-4057qib7	9543	19	/	/	SYM
cord-005453-4057qib7	9543	20	blood	blood	NN
cord-005453-4057qib7	9543	21	concentration	concentration	NN
cord-005453-4057qib7	9543	22	-	-	HYPH
cord-005453-4057qib7	9543	23	time	time	NN
cord-005453-4057qib7	9543	24	profiles	profile	NNS
cord-005453-4057qib7	9543	25	by	by	IN
cord-005453-4057qib7	9543	26	noncompartmental	noncompartmental	JJ
cord-005453-4057qib7	9543	27	analysis	analysis	NN
cord-005453-4057qib7	9543	28	.	.	.
cord-005453-4057qib7	9544	1	Ln	ln	NN
cord-005453-4057qib7	9544	2	-	-	HYPH
cord-005453-4057qib7	9544	3	transformed	transform	VBN
cord-005453-4057qib7	9544	4	PK	PK	NNP
cord-005453-4057qib7	9544	5	parameters	parameter	NNS
cord-005453-4057qib7	9544	6	were	be	VBD
cord-005453-4057qib7	9544	7	statistically	statistically	RB
cord-005453-4057qib7	9544	8	analysed	analyse	VBN
cord-005453-4057qib7	9544	9	using	use	VBG
cord-005453-4057qib7	9544	10	an	an	DT
cord-005453-4057qib7	9544	11	Analysis	Analysis	NNP
cord-005453-4057qib7	9544	12	of	of	IN
cord-005453-4057qib7	9544	13	Variance	variance	NN
cord-005453-4057qib7	9544	14	model	model	NN
cord-005453-4057qib7	9544	15	.	.	.
cord-005453-4057qib7	9545	1	The	the	DT
cord-005453-4057qib7	9545	2	ratio	ratio	NN
cord-005453-4057qib7	9545	3	of	of	IN
cord-005453-4057qib7	9545	4	geometric	geometric	JJ
cord-005453-4057qib7	9545	5	least	least	JJS
cord-005453-4057qib7	9545	6	squared	squared	JJ
cord-005453-4057qib7	9545	7	means	mean	NNS
cord-005453-4057qib7	9545	8	between	between	IN
cord-005453-4057qib7	9545	9	each	each	DT
cord-005453-4057qib7	9545	10	substrate	substrate	JJ
cord-005453-4057qib7	9545	11	drug	drug	NN
cord-005453-4057qib7	9545	12	when	when	WRB
cord-005453-4057qib7	9545	13	administered	administer	VBN
cord-005453-4057qib7	9545	14	with	with	IN
cord-005453-4057qib7	9545	15	and	and	CC
cord-005453-4057qib7	9545	16	without	without	IN
cord-005453-4057qib7	9545	17	RZF	RZF	NNP
cord-005453-4057qib7	9545	18	and	and	CC
cord-005453-4057qib7	9545	19	corresponding	correspond	VBG
cord-005453-4057qib7	9545	20	90	90	CD
cord-005453-4057qib7	9545	21	%	%	NN
cord-005453-4057qib7	9545	22	confidence	confidence	NN
cord-005453-4057qib7	9545	23	intervals	interval	NNS
cord-005453-4057qib7	9545	24	(	(	-LRB-
cord-005453-4057qib7	9545	25	CIs	CIs	NNP
cord-005453-4057qib7	9545	26	)	)	-RRB-
cord-005453-4057qib7	9545	27	were	be	VBD
cord-005453-4057qib7	9545	28	calculated	calculate	VBN
cord-005453-4057qib7	9545	29	for	for	IN
cord-005453-4057qib7	9545	30	lntransformed	lntransformed	NNP
cord-005453-4057qib7	9545	31	C	C	NNP
cord-005453-4057qib7	9545	32	max	max	NNP
cord-005453-4057qib7	9545	33	and	and	CC
cord-005453-4057qib7	9545	34	AUC	AUC	NNP
cord-005453-4057qib7	9545	35	.	.	.
cord-005453-4057qib7	9546	1	Results	result	NNS
cord-005453-4057qib7	9546	2	:	:	:
cord-005453-4057qib7	9547	1	When	when	WRB
cord-005453-4057qib7	9547	2	RZF	RZF	NNP
cord-005453-4057qib7	9547	3	was	be	VBD
cord-005453-4057qib7	9547	4	given	give	VBN
cord-005453-4057qib7	9547	5	concomitantly	concomitantly	RB
cord-005453-4057qib7	9547	6	with	with	IN
cord-005453-4057qib7	9547	7	the	the	DT
cord-005453-4057qib7	9547	8	probe	probe	NN
cord-005453-4057qib7	9547	9	drugs	drug	NNS
cord-005453-4057qib7	9547	10	,	,	,
cord-005453-4057qib7	9547	11	six	six	CD
cord-005453-4057qib7	9547	12	of	of	IN
cord-005453-4057qib7	9547	13	nine	nine	CD
cord-005453-4057qib7	9547	14	substrates	substrate	NNS
cord-005453-4057qib7	9547	15	(	(	-LRB-
cord-005453-4057qib7	9547	16	metformin	metformin	NNP
cord-005453-4057qib7	9547	17	,	,	,
cord-005453-4057qib7	9547	18	pitavastatin	pitavastatin	NNP
cord-005453-4057qib7	9547	19	,	,	,
cord-005453-4057qib7	9547	20	caffeine	caffeine	NN
cord-005453-4057qib7	9547	21	,	,	,
cord-005453-4057qib7	9547	22	efavirenz	efavirenz	NNP
cord-005453-4057qib7	9547	23	,	,	,
cord-005453-4057qib7	9547	24	midazolam	midazolam	NN
cord-005453-4057qib7	9547	25	,	,	,
cord-005453-4057qib7	9547	26	and	and	CC
cord-005453-4057qib7	9547	27	digoxin	digoxin	NN
cord-005453-4057qib7	9547	28	)	)	-RRB-
cord-005453-4057qib7	9547	29	statistically	statistically	RB
cord-005453-4057qib7	9547	30	demonstrated	demonstrate	VBD
cord-005453-4057qib7	9547	31	the	the	DT
cord-005453-4057qib7	9547	32	absence	absence	NN
cord-005453-4057qib7	9547	33	of	of	IN
cord-005453-4057qib7	9547	34	drug	drug	NN
cord-005453-4057qib7	9547	35	-	-	HYPH
cord-005453-4057qib7	9547	36	drug	drug	NN
cord-005453-4057qib7	9547	37	interaction	interaction	NN
cord-005453-4057qib7	9547	38	,	,	,
cord-005453-4057qib7	9547	39	as	as	IN
cord-005453-4057qib7	9547	40	their	-PRON-	PRP$
cord-005453-4057qib7	9547	41	90	90	CD
cord-005453-4057qib7	9547	42	%	%	NN
cord-005453-4057qib7	9547	43	CI	CI	NNP
cord-005453-4057qib7	9547	44	were	be	VBD
cord-005453-4057qib7	9547	45	all	all	DT
cord-005453-4057qib7	9547	46	included	include	VBN
cord-005453-4057qib7	9547	47	within	within	IN
cord-005453-4057qib7	9547	48	the	the	DT
cord-005453-4057qib7	9547	49	default	default	NN
cord-005453-4057qib7	9547	50	80	80	CD
cord-005453-4057qib7	9547	51	-	-	SYM
cord-005453-4057qib7	9547	52	125	125	CD
cord-005453-4057qib7	9547	53	%	%	NN
cord-005453-4057qib7	9547	54	noeffect	noeffect	NNP
cord-005453-4057qib7	9547	55	boundary	boundary	NN
cord-005453-4057qib7	9547	56	.	.	.
cord-005453-4057qib7	9548	1	Three	three	CD
cord-005453-4057qib7	9548	2	substrates	substrate	NNS
cord-005453-4057qib7	9548	3	had	have	VBD
cord-005453-4057qib7	9548	4	the	the	DT
cord-005453-4057qib7	9548	5	upper	upper	JJ
cord-005453-4057qib7	9548	6	(	(	-LRB-
cord-005453-4057qib7	9548	7	repaglinide	repaglinide	NNP
cord-005453-4057qib7	9548	8	and	and	CC
cord-005453-4057qib7	9548	9	rosuvastatin	rosuvastatin	NNP
cord-005453-4057qib7	9548	10	)	)	-RRB-
cord-005453-4057qib7	9548	11	or	or	CC
cord-005453-4057qib7	9548	12	lower	low	JJR
cord-005453-4057qib7	9548	13	(	(	-LRB-
cord-005453-4057qib7	9548	14	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	9548	15	)	)	-RRB-
cord-005453-4057qib7	9548	16	bounds	bound	NNS
cord-005453-4057qib7	9548	17	of	of	IN
cord-005453-4057qib7	9548	18	their	-PRON-	PRP$
cord-005453-4057qib7	9548	19	CI	ci	NN
cord-005453-4057qib7	9548	20	falling	fall	VBG
cord-005453-4057qib7	9548	21	just	just	RB
cord-005453-4057qib7	9548	22	outside	outside	RB
cord-005453-4057qib7	9548	23	of	of	IN
cord-005453-4057qib7	9548	24	this	this	DT
cord-005453-4057qib7	9548	25	range	range	NN
cord-005453-4057qib7	9549	1	(	(	-LRB-
cord-005453-4057qib7	9549	2	Figure	figure	NN
cord-005453-4057qib7	9549	3	1	1	CD
cord-005453-4057qib7	9549	4	)	)	-RRB-
cord-005453-4057qib7	9549	5	,	,	,
cord-005453-4057qib7	9549	6	and	and	CC
cord-005453-4057qib7	9549	7	these	these	DT
cord-005453-4057qib7	9549	8	changes	change	NNS
cord-005453-4057qib7	9549	9	are	be	VBP
cord-005453-4057qib7	9549	10	considered	consider	VBN
cord-005453-4057qib7	9549	11	unlikely	unlikely	JJ
cord-005453-4057qib7	9549	12	to	to	TO
cord-005453-4057qib7	9549	13	be	be	VB
cord-005453-4057qib7	9549	14	clinically	clinically	RB
cord-005453-4057qib7	9549	15	significant	significant	JJ
cord-005453-4057qib7	9549	16	.	.	.
cord-005453-4057qib7	9550	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9550	2	:	:	:
cord-005453-4057qib7	9551	1	No	no	DT
cord-005453-4057qib7	9551	2	meaningful	meaningful	JJ
cord-005453-4057qib7	9551	3	PK	PK	NNP
cord-005453-4057qib7	9551	4	interactions	interaction	NNS
cord-005453-4057qib7	9551	5	were	be	VBD
cord-005453-4057qib7	9551	6	observed	observe	VBN
cord-005453-4057qib7	9551	7	between	between	IN
cord-005453-4057qib7	9551	8	RZF	RZF	NNP
cord-005453-4057qib7	9551	9	and	and	CC
cord-005453-4057qib7	9551	10	9	9	CD
cord-005453-4057qib7	9551	11	drugs	drug	NNS
cord-005453-4057qib7	9551	12	known	know	VBN
cord-005453-4057qib7	9551	13	to	to	TO
cord-005453-4057qib7	9551	14	have	have	VB
cord-005453-4057qib7	9551	15	DDIs	ddi	NNS
cord-005453-4057qib7	9551	16	and/or	and/or	CC
cord-005453-4057qib7	9551	17	likely	likely	JJ
cord-005453-4057qib7	9551	18	to	to	TO
cord-005453-4057qib7	9551	19	be	be	VB
cord-005453-4057qib7	9551	20	coadministered	coadministere	VBN
cord-005453-4057qib7	9551	21	with	with	IN
cord-005453-4057qib7	9551	22	RZF	RZF	NNP
cord-005453-4057qib7	9551	23	.	.	.
cord-005453-4057qib7	9552	1	These	these	DT
cord-005453-4057qib7	9552	2	findings	finding	NNS
cord-005453-4057qib7	9552	3	provide	provide	VBP
cord-005453-4057qib7	9552	4	evidence	evidence	NN
cord-005453-4057qib7	9552	5	that	that	IN
cord-005453-4057qib7	9552	6	no	no	DT
cord-005453-4057qib7	9552	7	dose	dose	NN
cord-005453-4057qib7	9552	8	adjustment	adjustment	NN
cord-005453-4057qib7	9552	9	is	be	VBZ
cord-005453-4057qib7	9552	10	expected	expect	VBN
cord-005453-4057qib7	9552	11	when	when	WRB
cord-005453-4057qib7	9552	12	RZF	RZF	NNP
cord-005453-4057qib7	9552	13	is	be	VBZ
cord-005453-4057qib7	9552	14	co	co	VBN
cord-005453-4057qib7	9552	15	-	-	VBN
cord-005453-4057qib7	9552	16	administered	administer	VBN
cord-005453-4057qib7	9552	17	with	with	IN
cord-005453-4057qib7	9552	18	these	these	DT
cord-005453-4057qib7	9552	19	commonly	commonly	RB
cord-005453-4057qib7	9552	20	used	use	VBN
cord-005453-4057qib7	9552	21	drugs	drug	NNS
cord-005453-4057qib7	9552	22	,	,	,
cord-005453-4057qib7	9552	23	which	which	WDT
cord-005453-4057qib7	9552	24	stand	stand	VBP
cord-005453-4057qib7	9552	25	in	in	IN
cord-005453-4057qib7	9552	26	contrast	contrast	NN
cord-005453-4057qib7	9552	27	with	with	IN
cord-005453-4057qib7	9552	28	the	the	DT
cord-005453-4057qib7	9552	29	DDI	DDI	NNP
cord-005453-4057qib7	9552	30	complications	complication	NNS
cord-005453-4057qib7	9552	31	widely	widely	RB
cord-005453-4057qib7	9552	32	associated	associate	VBN
cord-005453-4057qib7	9552	33	with	with	IN
cord-005453-4057qib7	9552	34	azole	azole	NNP
cord-005453-4057qib7	9552	35	antifungals	antifungal	NNS
cord-005453-4057qib7	9552	36	.	.	.
cord-005453-4057qib7	9553	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9553	2	:	:	:
cord-005453-4057qib7	9554	1	Voon	Voon	NNP
cord-005453-4057qib7	9554	2	Ong	Ong	NNP
cord-005453-4057qib7	9554	3	:	:	:
cord-005453-4057qib7	9554	4	employee	employee	NN
cord-005453-4057qib7	9554	5	,	,	,
cord-005453-4057qib7	9554	6	stockholder	stockholder	NN
cord-005453-4057qib7	9554	7	(	(	-LRB-
cord-005453-4057qib7	9554	8	Cidara	Cidara	NNP
cord-005453-4057qib7	9554	9	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9554	10	)	)	-RRB-
cord-005453-4057qib7	9554	11	,	,	,
cord-005453-4057qib7	9554	12	Michael	Michael	NNP
cord-005453-4057qib7	9554	13	Boily	Boily	NNP
cord-005453-4057qib7	9554	14	:	:	:
cord-005453-4057qib7	9554	15	employee	employee	NN
cord-005453-4057qib7	9554	16	(	(	-LRB-
cord-005453-4057qib7	9554	17	Altasciences	Altasciences	NNP
cord-005453-4057qib7	9554	18	)	)	-RRB-
cord-005453-4057qib7	9554	19	,	,	,
cord-005453-4057qib7	9554	20	Hong	Hong	NNP
cord-005453-4057qib7	9554	21	Wong	Wong	NNP
cord-005453-4057qib7	9554	22	:	:	:
cord-005453-4057qib7	9554	23	employee	employee	NN
cord-005453-4057qib7	9554	24	(	(	-LRB-
cord-005453-4057qib7	9554	25	Altasciences	Altasciences	NNP
cord-005453-4057qib7	9554	26	)	)	-RRB-
cord-005453-4057qib7	9554	27	,	,	,
cord-005453-4057qib7	9554	28	Taylor	Taylor	NNP
cord-005453-4057qib7	9554	29	Sandison	Sandison	NNP
cord-005453-4057qib7	9554	30	:	:	:
cord-005453-4057qib7	9554	31	employee	employee	NN
cord-005453-4057qib7	9554	32	,	,	,
cord-005453-4057qib7	9554	33	stockholder	stockholder	NN
cord-005453-4057qib7	9554	34	(	(	-LRB-
cord-005453-4057qib7	9554	35	Cidara	Cidara	NNP
cord-005453-4057qib7	9554	36	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9554	37	)	)	-RRB-
cord-005453-4057qib7	9554	38	,	,	,
cord-005453-4057qib7	9554	39	Shawn	Shawn	NNP
cord-005453-4057qib7	9554	40	Flanagan	Flanagan	NNP
cord-005453-4057qib7	9554	41	:	:	:
cord-005453-4057qib7	9554	42	employee	employee	NN
cord-005453-4057qib7	9554	43	,	,	,
cord-005453-4057qib7	9554	44	stockholder	stockholder	NN
cord-005453-4057qib7	9554	45	(	(	-LRB-
cord-005453-4057qib7	9554	46	Cidara	Cidara	NNP
cord-005453-4057qib7	9554	47	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9554	48	)	)	-RRB-
cord-005453-4057qib7	9554	49	Abstract	Abstract	NNP
cord-005453-4057qib7	9554	50	withdrawn	withdraw	VBN
cord-005453-4057qib7	9554	51	.	.	.
cord-005453-4057qib7	9555	1	Background	background	NN
cord-005453-4057qib7	9555	2	:	:	:
cord-005453-4057qib7	9555	3	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	9555	4	(	(	-LRB-
cord-005453-4057qib7	9555	5	CMV	CMV	NNP
cord-005453-4057qib7	9555	6	)	)	-RRB-
cord-005453-4057qib7	9555	7	continues	continue	VBZ
cord-005453-4057qib7	9555	8	to	to	TO
cord-005453-4057qib7	9555	9	cause	cause	VB
cord-005453-4057qib7	9555	10	morbidity	morbidity	NN
cord-005453-4057qib7	9555	11	following	following	NN
cord-005453-4057qib7	9555	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	9555	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9555	14	stem	stem	NN
cord-005453-4057qib7	9555	15	cell	cell	NN
cord-005453-4057qib7	9555	16	transplantation	transplantation	NN
cord-005453-4057qib7	9555	17	(	(	-LRB-
cord-005453-4057qib7	9555	18	HSCT	HSCT	NNP
cord-005453-4057qib7	9555	19	)	)	-RRB-
cord-005453-4057qib7	9555	20	.	.	.
cord-005453-4057qib7	9556	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9556	2	is	be	VBZ
cord-005453-4057qib7	9556	3	a	a	DT
cord-005453-4057qib7	9556	4	newly	newly	RB
cord-005453-4057qib7	9556	5	approved	approve	VBN
cord-005453-4057qib7	9556	6	drug	drug	NN
cord-005453-4057qib7	9556	7	for	for	IN
cord-005453-4057qib7	9556	8	CMV	CMV	NNP
cord-005453-4057qib7	9556	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9556	10	in	in	IN
cord-005453-4057qib7	9556	11	CMV	CMV	NNP
cord-005453-4057qib7	9556	12	-	-	HYPH
cord-005453-4057qib7	9556	13	seropositive	seropositive	JJ
cord-005453-4057qib7	9556	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	9556	15	HSCT	HSCT	NNP
cord-005453-4057qib7	9556	16	recipients	recipient	NNS
cord-005453-4057qib7	9556	17	.	.	.
cord-005453-4057qib7	9557	1	However	however	RB
cord-005453-4057qib7	9557	2	,	,	,
cord-005453-4057qib7	9557	3	there	there	EX
cord-005453-4057qib7	9557	4	is	be	VBZ
cord-005453-4057qib7	9557	5	a	a	DT
cord-005453-4057qib7	9557	6	paucity	paucity	NN
cord-005453-4057qib7	9557	7	of	of	IN
cord-005453-4057qib7	9557	8	data	datum	NNS
cord-005453-4057qib7	9557	9	for	for	IN
cord-005453-4057qib7	9557	10	its	-PRON-	PRP$
cord-005453-4057qib7	9557	11	efficacy	efficacy	NN
cord-005453-4057qib7	9557	12	in	in	IN
cord-005453-4057qib7	9557	13	patients	patient	NNS
cord-005453-4057qib7	9557	14	receiving	receive	VBG
cord-005453-4057qib7	9557	15	in	in	IN
cord-005453-4057qib7	9557	16	-	-	HYPH
cord-005453-4057qib7	9557	17	vivo	vivo	NN
cord-005453-4057qib7	9557	18	T	t	NN
cord-005453-4057qib7	9557	19	-	-	HYPH
cord-005453-4057qib7	9557	20	cell	cell	NN
cord-005453-4057qib7	9557	21	depletion	depletion	NN
cord-005453-4057qib7	9557	22	(	(	-LRB-
cord-005453-4057qib7	9557	23	TCD	TCD	NNP
cord-005453-4057qib7	9557	24	)	)	-RRB-
cord-005453-4057qib7	9557	25	.	.	.
cord-005453-4057qib7	9558	1	At	at	IN
cord-005453-4057qib7	9558	2	Weill	Weill	NNP
cord-005453-4057qib7	9558	3	Cornell	Cornell	NNP
cord-005453-4057qib7	9558	4	Medical	Medical	NNP
cord-005453-4057qib7	9558	5	Center	Center	NNP
cord-005453-4057qib7	9558	6	,	,	,
cord-005453-4057qib7	9558	7	we	-PRON-	PRP
cord-005453-4057qib7	9558	8	perform	perform	VBP
cord-005453-4057qib7	9558	9	in	in	IN
cord-005453-4057qib7	9558	10	-	-	HYPH
cord-005453-4057qib7	9558	11	vivo	vivo	NN
cord-005453-4057qib7	9558	12	TCD	tcd	NN
cord-005453-4057qib7	9558	13	with	with	IN
cord-005453-4057qib7	9558	14	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	9558	15	for	for	IN
cord-005453-4057qib7	9558	16	related	related	JJ
cord-005453-4057qib7	9558	17	and	and	CC
cord-005453-4057qib7	9558	18	HLA	HLA	NNP
cord-005453-4057qib7	9558	19	-	-	HYPH
cord-005453-4057qib7	9558	20	identical	identical	JJ
cord-005453-4057qib7	9558	21	unrelated	unrelated	JJ
cord-005453-4057qib7	9558	22	transplants	transplant	NNS
cord-005453-4057qib7	9558	23	,	,	,
cord-005453-4057qib7	9558	24	and	and	CC
cord-005453-4057qib7	9558	25	anti	anti	JJ
cord-005453-4057qib7	9558	26	-	-	JJ
cord-005453-4057qib7	9558	27	thymocyte	thymocyte	JJ
cord-005453-4057qib7	9558	28	globulin	globulin	NN
cord-005453-4057qib7	9558	29	for	for	IN
cord-005453-4057qib7	9558	30	umbilical	umbilical	JJ
cord-005453-4057qib7	9558	31	cord	cord	NN
cord-005453-4057qib7	9558	32	blood	blood	NN
cord-005453-4057qib7	9558	33	transplant	transplant	NN
cord-005453-4057qib7	9558	34	supported	support	VBN
cord-005453-4057qib7	9558	35	by	by	IN
cord-005453-4057qib7	9558	36	third	third	JJ
cord-005453-4057qib7	9558	37	party	party	NN
cord-005453-4057qib7	9558	38	accessory	accessory	NN
cord-005453-4057qib7	9558	39	cells	cell	NNS
cord-005453-4057qib7	9558	40	(	(	-LRB-
cord-005453-4057qib7	9559	1	haplo	haplo	NN
cord-005453-4057qib7	9559	2	-	-	HYPH
cord-005453-4057qib7	9559	3	cord	cord	NN
cord-005453-4057qib7	9559	4	transplant).Although	transplant).although	NN
cord-005453-4057qib7	9560	1	these	these	DT
cord-005453-4057qib7	9560	2	drugs	drug	NNS
cord-005453-4057qib7	9560	3	reduce	reduce	VBP
cord-005453-4057qib7	9560	4	the	the	DT
cord-005453-4057qib7	9560	5	frequency	frequency	NN
cord-005453-4057qib7	9560	6	of	of	IN
cord-005453-4057qib7	9560	7	Graft	graft	NN
cord-005453-4057qib7	9560	8	-	-	HYPH
cord-005453-4057qib7	9560	9	Versus	Versus	NNP
cord-005453-4057qib7	9560	10	-	-	HYPH
cord-005453-4057qib7	9560	11	Host	Host	NNP
cord-005453-4057qib7	9560	12	-	-	HYPH
cord-005453-4057qib7	9560	13	Disease	Disease	NNP
cord-005453-4057qib7	9560	14	(	(	-LRB-
cord-005453-4057qib7	9560	15	GVHD	GVHD	NNP
cord-005453-4057qib7	9560	16	)	)	-RRB-
cord-005453-4057qib7	9560	17	,	,	,
cord-005453-4057qib7	9560	18	they	-PRON-	PRP
cord-005453-4057qib7	9560	19	significantly	significantly	RB
cord-005453-4057qib7	9560	20	delay	delay	VBP
cord-005453-4057qib7	9560	21	T	t	NN
cord-005453-4057qib7	9560	22	-	-	HYPH
cord-005453-4057qib7	9560	23	cell	cell	NN
cord-005453-4057qib7	9560	24	immune	immune	JJ
cord-005453-4057qib7	9560	25	reconstitution	reconstitution	NN
cord-005453-4057qib7	9560	26	post	post	NN
cord-005453-4057qib7	9560	27	HSCT	HSCT	NNP
cord-005453-4057qib7	9560	28	,	,	,
cord-005453-4057qib7	9560	29	and	and	CC
cord-005453-4057qib7	9560	30	may	may	MD
cord-005453-4057qib7	9560	31	cause	cause	VB
cord-005453-4057qib7	9560	32	higher	high	JJR
cord-005453-4057qib7	9560	33	rates	rate	NNS
cord-005453-4057qib7	9560	34	of	of	IN
cord-005453-4057qib7	9560	35	CMV	CMV	NNP
cord-005453-4057qib7	9560	36	reactivation	reactivation	NN
cord-005453-4057qib7	9560	37	.	.	.
cord-005453-4057qib7	9561	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9561	2	historical	historical	JJ
cord-005453-4057qib7	9561	3	rate	rate	NN
cord-005453-4057qib7	9561	4	of	of	IN
cord-005453-4057qib7	9561	5	CMV	CMV	NNP
cord-005453-4057qib7	9561	6	reactivation	reactivation	NN
cord-005453-4057qib7	9561	7	in	in	IN
cord-005453-4057qib7	9561	8	CMV	CMV	NNP
cord-005453-4057qib7	9561	9	seropositive	seropositive	JJ
cord-005453-4057qib7	9561	10	recipients	recipient	NNS
cord-005453-4057qib7	9561	11	receiving	receive	VBG
cord-005453-4057qib7	9561	12	high	high	JJ
cord-005453-4057qib7	9561	13	dose	dose	NN
cord-005453-4057qib7	9561	14	valacyclovir	valacyclovir	NNP
cord-005453-4057qib7	9561	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9561	16	is	be	VBZ
cord-005453-4057qib7	9561	17	approximately	approximately	RB
cord-005453-4057qib7	9561	18	35	35	CD
cord-005453-4057qib7	9561	19	%	%	NN
cord-005453-4057qib7	9561	20	.	.	.
cord-005453-4057qib7	9562	1	Therefore	therefore	RB
cord-005453-4057qib7	9562	2	,	,	,
cord-005453-4057qib7	9562	3	we	-PRON-	PRP
cord-005453-4057qib7	9562	4	implemented	implement	VBD
cord-005453-4057qib7	9562	5	letermovir	letermovir	NNS
cord-005453-4057qib7	9562	6	for	for	IN
cord-005453-4057qib7	9562	7	CMV	CMV	NNP
cord-005453-4057qib7	9562	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9562	9	in	in	IN
cord-005453-4057qib7	9562	10	February	February	NNP
cord-005453-4057qib7	9562	11	2018	2018	CD
cord-005453-4057qib7	9562	12	.	.	.
cord-005453-4057qib7	9563	1	The	the	DT
cord-005453-4057qib7	9563	2	primary	primary	JJ
cord-005453-4057qib7	9563	3	aim	aim	NN
cord-005453-4057qib7	9563	4	of	of	IN
cord-005453-4057qib7	9563	5	this	this	DT
cord-005453-4057qib7	9563	6	study	study	NN
cord-005453-4057qib7	9563	7	is	be	VBZ
cord-005453-4057qib7	9563	8	to	to	TO
cord-005453-4057qib7	9563	9	determine	determine	VB
cord-005453-4057qib7	9563	10	the	the	DT
cord-005453-4057qib7	9563	11	incidence	incidence	NN
cord-005453-4057qib7	9563	12	of	of	IN
cord-005453-4057qib7	9563	13	CMV	CMV	NNP
cord-005453-4057qib7	9563	14	infection	infection	NN
cord-005453-4057qib7	9563	15	(	(	-LRB-
cord-005453-4057qib7	9563	16	defined	define	VBN
cord-005453-4057qib7	9563	17	as	as	IN
cord-005453-4057qib7	9563	18	CMV	CMV	NNP
cord-005453-4057qib7	9563	19	viremia	viremia	NN
cord-005453-4057qib7	9563	20	warranting	warrant	VBG
cord-005453-4057qib7	9563	21	treatment	treatment	NN
cord-005453-4057qib7	9563	22	or	or	CC
cord-005453-4057qib7	9563	23	development	development	NN
cord-005453-4057qib7	9563	24	of	of	IN
cord-005453-4057qib7	9563	25	end	end	NN
cord-005453-4057qib7	9563	26	-	-	HYPH
cord-005453-4057qib7	9563	27	organ	organ	NN
cord-005453-4057qib7	9563	28	disease	disease	NN
cord-005453-4057qib7	9563	29	)	)	-RRB-
cord-005453-4057qib7	9563	30	in	in	IN
cord-005453-4057qib7	9563	31	TCD	TCD	NNP
cord-005453-4057qib7	9563	32	CMV	CMV	NNP
cord-005453-4057qib7	9563	33	seropositive	seropositive	JJ
cord-005453-4057qib7	9563	34	allogeneic	allogeneic	VBD
cord-005453-4057qib7	9563	35	HSCT	HSCT	NNP
cord-005453-4057qib7	9563	36	patients	patient	NNS
cord-005453-4057qib7	9563	37	who	who	WP
cord-005453-4057qib7	9563	38	received	receive	VBD
cord-005453-4057qib7	9563	39	letermovir	letermovir	NNS
cord-005453-4057qib7	9563	40	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9563	41	.	.	.
cord-005453-4057qib7	9564	1	Methods	method	NNS
cord-005453-4057qib7	9564	2	:	:	:
cord-005453-4057qib7	9564	3	This	this	DT
cord-005453-4057qib7	9564	4	is	be	VBZ
cord-005453-4057qib7	9564	5	a	a	DT
cord-005453-4057qib7	9564	6	single	single	JJ
cord-005453-4057qib7	9564	7	center	center	NN
cord-005453-4057qib7	9564	8	,	,	,
cord-005453-4057qib7	9564	9	retrospective	retrospective	JJ
cord-005453-4057qib7	9564	10	cohort	cohort	NN
cord-005453-4057qib7	9564	11	study	study	NN
cord-005453-4057qib7	9564	12	to	to	TO
cord-005453-4057qib7	9564	13	determine	determine	VB
cord-005453-4057qib7	9564	14	the	the	DT
cord-005453-4057qib7	9564	15	incidence	incidence	NN
cord-005453-4057qib7	9564	16	of	of	IN
cord-005453-4057qib7	9564	17	CMV	CMV	NNP
cord-005453-4057qib7	9564	18	infection	infection	NN
cord-005453-4057qib7	9564	19	in	in	IN
cord-005453-4057qib7	9564	20	adult	adult	NN
cord-005453-4057qib7	9564	21	,	,	,
cord-005453-4057qib7	9564	22	CMV	CMV	NNP
cord-005453-4057qib7	9564	23	-	-	HYPH
cord-005453-4057qib7	9564	24	seropositive	seropositive	JJ
cord-005453-4057qib7	9564	25	recipients	recipient	NNS
cord-005453-4057qib7	9564	26	receiving	receive	VBG
cord-005453-4057qib7	9564	27	letermovir	letermovir	NNS
cord-005453-4057qib7	9564	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9564	29	after	after	IN
cord-005453-4057qib7	9564	30	in	in	IN
cord-005453-4057qib7	9564	31	vivo	vivo	NNP
cord-005453-4057qib7	9564	32	TCD	TCD	NNP
cord-005453-4057qib7	9564	33	HSCT	HSCT	NNP
cord-005453-4057qib7	9564	34	with	with	IN
cord-005453-4057qib7	9564	35	ATG	ATG	NNP
cord-005453-4057qib7	9564	36	or	or	CC
cord-005453-4057qib7	9564	37	alemtuzumab	alemtuzumab	VBN
cord-005453-4057qib7	9564	38	for	for	IN
cord-005453-4057qib7	9564	39	GVHD	GVHD	NNP
cord-005453-4057qib7	9564	40	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9564	41	.	.	.
cord-005453-4057qib7	9565	1	All	all	DT
cord-005453-4057qib7	9565	2	included	include	VBN
cord-005453-4057qib7	9565	3	subjects	subject	NNS
cord-005453-4057qib7	9565	4	were	be	VBD
cord-005453-4057qib7	9565	5	at	at	RB
cord-005453-4057qib7	9565	6	least	least	RBS
cord-005453-4057qib7	9565	7	100	100	CD
cord-005453-4057qib7	9565	8	days	day	NNS
cord-005453-4057qib7	9565	9	post	post	NN
cord-005453-4057qib7	9565	10	-	-	NN
cord-005453-4057qib7	9565	11	transplant	transplant	NN
cord-005453-4057qib7	9565	12	.	.	.
cord-005453-4057qib7	9566	1	Results	result	NNS
cord-005453-4057qib7	9566	2	:	:	:
cord-005453-4057qib7	9567	1	31	31	CD
cord-005453-4057qib7	9567	2	allogeneic	allogeneic	NN
cord-005453-4057qib7	9567	3	HSCT	HSCT	NNP
cord-005453-4057qib7	9567	4	transplant	transplant	NN
cord-005453-4057qib7	9567	5	recipients	recipient	NNS
cord-005453-4057qib7	9567	6	met	meet	VBD
cord-005453-4057qib7	9567	7	inclusion	inclusion	NN
cord-005453-4057qib7	9567	8	criteria	criterion	NNS
cord-005453-4057qib7	9567	9	.	.	.
cord-005453-4057qib7	9568	1	Median	median	JJ
cord-005453-4057qib7	9568	2	age	age	NN
cord-005453-4057qib7	9568	3	was	be	VBD
cord-005453-4057qib7	9568	4	60	60	CD
cord-005453-4057qib7	9568	5	years	year	NNS
cord-005453-4057qib7	9568	6	,	,	,
cord-005453-4057qib7	9568	7	IQR	IQR	NNP
cord-005453-4057qib7	9568	8	[	[	-LRB-
cord-005453-4057qib7	9568	9	47	47	CD
cord-005453-4057qib7	9568	10	,	,	,
cord-005453-4057qib7	9568	11	67	67	CD
cord-005453-4057qib7	9568	12	]	]	-RRB-
cord-005453-4057qib7	9568	13	and	and	CC
cord-005453-4057qib7	9568	14	48	48	CD
cord-005453-4057qib7	9568	15	%	%	NN
cord-005453-4057qib7	9568	16	were	be	VBD
cord-005453-4057qib7	9568	17	male	male	JJ
cord-005453-4057qib7	9568	18	.	.	.
cord-005453-4057qib7	9569	1	Eight	eight	CD
cord-005453-4057qib7	9569	2	(	(	-LRB-
cord-005453-4057qib7	9569	3	26	26	CD
cord-005453-4057qib7	9569	4	%	%	NN
cord-005453-4057qib7	9569	5	)	)	-RRB-
cord-005453-4057qib7	9569	6	had	have	VBD
cord-005453-4057qib7	9569	7	a	a	DT
cord-005453-4057qib7	9569	8	matched	match	VBN
cord-005453-4057qib7	9569	9	related	related	JJ
cord-005453-4057qib7	9569	10	donor	donor	NN
cord-005453-4057qib7	9569	11	,	,	,
cord-005453-4057qib7	9569	12	six	six	CD
cord-005453-4057qib7	9569	13	(	(	-LRB-
cord-005453-4057qib7	9569	14	19	19	CD
cord-005453-4057qib7	9569	15	%	%	NN
cord-005453-4057qib7	9569	16	)	)	-RRB-
cord-005453-4057qib7	9569	17	had	have	VBD
cord-005453-4057qib7	9569	18	a	a	DT
cord-005453-4057qib7	9569	19	matched	match	VBN
cord-005453-4057qib7	9569	20	unrelated	unrelated	JJ
cord-005453-4057qib7	9569	21	donor	donor	NN
cord-005453-4057qib7	9569	22	,	,	,
cord-005453-4057qib7	9569	23	and	and	CC
cord-005453-4057qib7	9569	24	17	17	CD
cord-005453-4057qib7	9569	25	(	(	-LRB-
cord-005453-4057qib7	9569	26	55	55	CD
cord-005453-4057qib7	9569	27	%	%	NN
cord-005453-4057qib7	9569	28	)	)	-RRB-
cord-005453-4057qib7	9569	29	were	be	VBD
cord-005453-4057qib7	9569	30	haplo	haplo	NN
cord-005453-4057qib7	9569	31	-	-	HYPH
cord-005453-4057qib7	9569	32	cord	cord	NN
cord-005453-4057qib7	9569	33	transplants	transplant	NNS
cord-005453-4057qib7	9569	34	.	.	.
cord-005453-4057qib7	9570	1	Their	-PRON-	PRP$
cord-005453-4057qib7	9570	2	underlying	underlying	JJ
cord-005453-4057qib7	9570	3	malignancy	malignancy	NN
cord-005453-4057qib7	9570	4	and	and	CC
cord-005453-4057qib7	9570	5	conditioning	conditioning	NN
cord-005453-4057qib7	9570	6	regimens	regimen	NNS
cord-005453-4057qib7	9570	7	are	be	VBP
cord-005453-4057qib7	9570	8	summarized	summarize	VBN
cord-005453-4057qib7	9570	9	in	in	IN
cord-005453-4057qib7	9570	10	Table	Table	NNP
cord-005453-4057qib7	9570	11	1	1	CD
cord-005453-4057qib7	9570	12	.	.	.
cord-005453-4057qib7	9571	1	17	17	CD
cord-005453-4057qib7	9571	2	(	(	-LRB-
cord-005453-4057qib7	9571	3	55	55	CD
cord-005453-4057qib7	9571	4	%	%	NN
cord-005453-4057qib7	9571	5	)	)	-RRB-
cord-005453-4057qib7	9571	6	received	receive	VBD
cord-005453-4057qib7	9571	7	ATG	ATG	NNP
cord-005453-4057qib7	9571	8	and	and	CC
cord-005453-4057qib7	9571	9	14	14	CD
cord-005453-4057qib7	9571	10	(	(	-LRB-
cord-005453-4057qib7	9571	11	45	45	CD
cord-005453-4057qib7	9571	12	%	%	NN
cord-005453-4057qib7	9571	13	)	)	-RRB-
cord-005453-4057qib7	9571	14	received	receive	VBD
cord-005453-4057qib7	9571	15	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	9571	16	for	for	IN
cord-005453-4057qib7	9571	17	GVHD	GVHD	NNP
cord-005453-4057qib7	9571	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9571	19	.	.	.
cord-005453-4057qib7	9572	1	Median	median	JJ
cord-005453-4057qib7	9572	2	follow	follow	VBP
cord-005453-4057qib7	9572	3	up	up	RP
cord-005453-4057qib7	9572	4	time	time	NN
cord-005453-4057qib7	9572	5	for	for	IN
cord-005453-4057qib7	9572	6	survivors	survivor	NNS
cord-005453-4057qib7	9572	7	is	be	VBZ
cord-005453-4057qib7	9572	8	141	141	CD
cord-005453-4057qib7	9572	9	days	day	NNS
cord-005453-4057qib7	9572	10	,	,	,
cord-005453-4057qib7	9572	11	IQR	IQR	NNP
cord-005453-4057qib7	9572	12	[	[	-LRB-
cord-005453-4057qib7	9572	13	107	107	CD
cord-005453-4057qib7	9572	14	,	,	,
cord-005453-4057qib7	9572	15	187	187	CD
cord-005453-4057qib7	9572	16	]	]	-RRB-
cord-005453-4057qib7	9572	17	.	.	.
cord-005453-4057qib7	9573	1	The	the	DT
cord-005453-4057qib7	9573	2	incidence	incidence	NN
cord-005453-4057qib7	9573	3	of	of	IN
cord-005453-4057qib7	9573	4	CMV	CMV	NNP
cord-005453-4057qib7	9573	5	infection	infection	NN
cord-005453-4057qib7	9573	6	in	in	IN
cord-005453-4057qib7	9573	7	the	the	DT
cord-005453-4057qib7	9573	8	first	first	JJ
cord-005453-4057qib7	9573	9	100	100	CD
cord-005453-4057qib7	9573	10	days	day	NNS
cord-005453-4057qib7	9573	11	post	post	NN
cord-005453-4057qib7	9573	12	-	-	NN
cord-005453-4057qib7	9573	13	transplant	transplant	NN
cord-005453-4057qib7	9573	14	was	be	VBD
cord-005453-4057qib7	9573	15	3	3	CD
cord-005453-4057qib7	9573	16	%	%	NN
cord-005453-4057qib7	9573	17	as	as	IN
cord-005453-4057qib7	9573	18	only	only	RB
cord-005453-4057qib7	9573	19	one	one	CD
cord-005453-4057qib7	9573	20	patient	patient	NN
cord-005453-4057qib7	9573	21	reactivated	reactivate	VBN
cord-005453-4057qib7	9573	22	with	with	IN
cord-005453-4057qib7	9573	23	detectable	detectable	JJ
cord-005453-4057qib7	9573	24	CMV	CMV	NNP
cord-005453-4057qib7	9573	25	viremia	viremia	NN
cord-005453-4057qib7	9573	26	.	.	.
cord-005453-4057qib7	9574	1	This	this	DT
cord-005453-4057qib7	9574	2	same	same	JJ
cord-005453-4057qib7	9574	3	patient	patient	NN
cord-005453-4057qib7	9574	4	developed	develop	VBD
cord-005453-4057qib7	9574	5	CMV	CMV	NNP
cord-005453-4057qib7	9574	6	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	9574	7	with	with	IN
cord-005453-4057qib7	9574	8	documented	document	VBN
cord-005453-4057qib7	9574	9	UL	ul	NN
cord-005453-4057qib7	9574	10	56	56	CD
cord-005453-4057qib7	9574	11	resistance	resistance	NN
cord-005453-4057qib7	9574	12	,	,	,
cord-005453-4057qib7	9574	13	and	and	CC
cord-005453-4057qib7	9574	14	was	be	VBD
cord-005453-4057qib7	9574	15	successfully	successfully	RB
cord-005453-4057qib7	9574	16	treated	treat	VBN
cord-005453-4057qib7	9574	17	with	with	IN
cord-005453-4057qib7	9574	18	ganciclovir	ganciclovir	NNS
cord-005453-4057qib7	9574	19	.	.	.
cord-005453-4057qib7	9575	1	The	the	DT
cord-005453-4057qib7	9575	2	incidence	incidence	NN
cord-005453-4057qib7	9575	3	of	of	IN
cord-005453-4057qib7	9575	4	CMV	CMV	NNP
cord-005453-4057qib7	9575	5	infection	infection	NN
cord-005453-4057qib7	9575	6	within	within	IN
cord-005453-4057qib7	9575	7	the	the	DT
cord-005453-4057qib7	9575	8	first	first	JJ
cord-005453-4057qib7	9575	9	150	150	CD
cord-005453-4057qib7	9575	10	days	day	NNS
cord-005453-4057qib7	9575	11	post	post	NN
cord-005453-4057qib7	9575	12	-	-	NN
cord-005453-4057qib7	9575	13	transplant	transplant	NN
cord-005453-4057qib7	9575	14	was	be	VBD
cord-005453-4057qib7	9575	15	5	5	CD
cord-005453-4057qib7	9575	16	%	%	NN
cord-005453-4057qib7	9575	17	(	(	-LRB-
cord-005453-4057qib7	9575	18	1/19	1/19	CD
cord-005453-4057qib7	9575	19	patients	patient	NNS
cord-005453-4057qib7	9575	20	)	)	-RRB-
cord-005453-4057qib7	9575	21	.	.	.
cord-005453-4057qib7	9576	1	Six	six	CD
cord-005453-4057qib7	9576	2	patients	patient	NNS
cord-005453-4057qib7	9576	3	(	(	-LRB-
cord-005453-4057qib7	9576	4	19	19	CD
cord-005453-4057qib7	9576	5	%	%	NN
cord-005453-4057qib7	9576	6	)	)	-RRB-
cord-005453-4057qib7	9576	7	developed	develop	VBN
cord-005453-4057qib7	9576	8	acute	acute	JJ
cord-005453-4057qib7	9576	9	GVHD	GVHD	NNP
cord-005453-4057qib7	9576	10	in	in	IN
cord-005453-4057qib7	9576	11	the	the	DT
cord-005453-4057qib7	9576	12	first	first	JJ
cord-005453-4057qib7	9576	13	100	100	CD
cord-005453-4057qib7	9576	14	days	day	NNS
cord-005453-4057qib7	9576	15	,	,	,
cord-005453-4057qib7	9576	16	and	and	CC
cord-005453-4057qib7	9576	17	one	one	NN
cord-005453-4057qib7	9576	18	(	(	-LRB-
cord-005453-4057qib7	9576	19	3	3	CD
cord-005453-4057qib7	9576	20	%	%	NN
cord-005453-4057qib7	9576	21	)	)	-RRB-
cord-005453-4057qib7	9576	22	had	have	VBD
cord-005453-4057qib7	9576	23	relapse	relapse	NN
cord-005453-4057qib7	9576	24	of	of	IN
cord-005453-4057qib7	9576	25	their	-PRON-	PRP$
cord-005453-4057qib7	9576	26	malignancy	malignancy	NN
cord-005453-4057qib7	9576	27	.	.	.
cord-005453-4057qib7	9577	1	Five	five	CD
cord-005453-4057qib7	9577	2	patients	patient	NNS
cord-005453-4057qib7	9577	3	(	(	-LRB-
cord-005453-4057qib7	9577	4	16	16	CD
cord-005453-4057qib7	9577	5	%	%	NN
cord-005453-4057qib7	9577	6	)	)	-RRB-
cord-005453-4057qib7	9577	7	died	die	VBD
cord-005453-4057qib7	9577	8	within	within	IN
cord-005453-4057qib7	9577	9	100	100	CD
cord-005453-4057qib7	9577	10	days	day	NNS
cord-005453-4057qib7	9577	11	post	post	NN
cord-005453-4057qib7	9577	12	-	-	NN
cord-005453-4057qib7	9577	13	transplant	transplant	NN
cord-005453-4057qib7	9577	14	,	,	,
cord-005453-4057qib7	9577	15	but	but	CC
cord-005453-4057qib7	9577	16	none	none	NN
cord-005453-4057qib7	9577	17	of	of	IN
cord-005453-4057qib7	9577	18	these	these	DT
cord-005453-4057qib7	9577	19	deaths	death	NNS
cord-005453-4057qib7	9577	20	were	be	VBD
cord-005453-4057qib7	9577	21	CMV	CMV	NNP
cord-005453-4057qib7	9577	22	related	relate	VBN
cord-005453-4057qib7	9577	23	.	.	.
cord-005453-4057qib7	9578	1	Background	background	NN
cord-005453-4057qib7	9578	2	:	:	:
cord-005453-4057qib7	9579	1	Infectious	infectious	JJ
cord-005453-4057qib7	9579	2	complications	complication	NNS
cord-005453-4057qib7	9579	3	caused	cause	VBN
cord-005453-4057qib7	9579	4	by	by	IN
cord-005453-4057qib7	9579	5	endogenous	endogenous	JJ
cord-005453-4057qib7	9579	6	adenovirus	adenovirus	NN
cord-005453-4057qib7	9579	7	(	(	-LRB-
cord-005453-4057qib7	9579	8	AdV	adv	NN
cord-005453-4057qib7	9579	9	)	)	-RRB-
cord-005453-4057qib7	9579	10	are	be	VBP
cord-005453-4057qib7	9579	11	common	common	JJ
cord-005453-4057qib7	9579	12	and	and	CC
cord-005453-4057qib7	9579	13	associated	associate	VBN
cord-005453-4057qib7	9579	14	with	with	IN
cord-005453-4057qib7	9579	15	morbidity	morbidity	NN
cord-005453-4057qib7	9579	16	and	and	CC
cord-005453-4057qib7	9579	17	mortality	mortality	NN
cord-005453-4057qib7	9579	18	rates	rate	NNS
cord-005453-4057qib7	9579	19	in	in	IN
cord-005453-4057qib7	9579	20	patients	patient	NNS
cord-005453-4057qib7	9579	21	after	after	IN
cord-005453-4057qib7	9579	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9579	23	stem	stem	NN
cord-005453-4057qib7	9579	24	cell	cell	NN
cord-005453-4057qib7	9579	25	transplantation	transplantation	NN
cord-005453-4057qib7	9579	26	(	(	-LRB-
cord-005453-4057qib7	9579	27	HSCT	HSCT	NNP
cord-005453-4057qib7	9579	28	)	)	-RRB-
cord-005453-4057qib7	9579	29	.	.	.
cord-005453-4057qib7	9580	1	AdV	adv	NN
cord-005453-4057qib7	9580	2	infections	infection	NNS
cord-005453-4057qib7	9580	3	occur	occur	VBP
cord-005453-4057qib7	9580	4	in	in	IN
cord-005453-4057qib7	9580	5	about	about	RB
cord-005453-4057qib7	9580	6	3	3	CD
cord-005453-4057qib7	9580	7	%	%	NN
cord-005453-4057qib7	9580	8	to	to	TO
cord-005453-4057qib7	9580	9	20	20	CD
cord-005453-4057qib7	9580	10	%	%	NN
cord-005453-4057qib7	9580	11	of	of	IN
cord-005453-4057qib7	9580	12	HSCT	HSCT	NNP
cord-005453-4057qib7	9580	13	recipients	recipient	NNS
cord-005453-4057qib7	9580	14	,	,	,
cord-005453-4057qib7	9580	15	with	with	IN
cord-005453-4057qib7	9580	16	significantly	significantly	RB
cord-005453-4057qib7	9580	17	higher	high	JJR
cord-005453-4057qib7	9580	18	rates	rate	NNS
cord-005453-4057qib7	9580	19	in	in	IN
cord-005453-4057qib7	9580	20	pediatric	pediatric	JJ
cord-005453-4057qib7	9580	21	patients	patient	NNS
cord-005453-4057qib7	9580	22	.	.	.
cord-005453-4057qib7	9581	1	A	a	DT
cord-005453-4057qib7	9581	2	better	well	JJR
cord-005453-4057qib7	9581	3	understanding	understanding	NN
cord-005453-4057qib7	9581	4	of	of	IN
cord-005453-4057qib7	9581	5	adenoviral	adenoviral	JJ
cord-005453-4057qib7	9581	6	-	-	HYPH
cord-005453-4057qib7	9581	7	specific	specific	JJ
cord-005453-4057qib7	9581	8	T	t	NN
cord-005453-4057qib7	9581	9	-	-	HYPH
cord-005453-4057qib7	9581	10	cells	cell	NNS
cord-005453-4057qib7	9581	11	(	(	-LRB-
cord-005453-4057qib7	9581	12	AdvT	AdvT	NNP
cord-005453-4057qib7	9581	13	)	)	-RRB-
cord-005453-4057qib7	9581	14	response	response	NN
cord-005453-4057qib7	9581	15	in	in	IN
cord-005453-4057qib7	9581	16	donors	donor	NNS
cord-005453-4057qib7	9581	17	can	can	MD
cord-005453-4057qib7	9581	18	serve	serve	VB
cord-005453-4057qib7	9581	19	as	as	IN
cord-005453-4057qib7	9581	20	a	a	DT
cord-005453-4057qib7	9581	21	basis	basis	NN
cord-005453-4057qib7	9581	22	to	to	TO
cord-005453-4057qib7	9581	23	develop	develop	VB
cord-005453-4057qib7	9581	24	more	more	JJR
cord-005453-4057qib7	9581	25	effective	effective	JJ
cord-005453-4057qib7	9581	26	strategies	strategy	NNS
cord-005453-4057qib7	9581	27	for	for	IN
cord-005453-4057qib7	9581	28	antiviral	antiviral	JJ
cord-005453-4057qib7	9581	29	therapy	therapy	NN
cord-005453-4057qib7	9581	30	.	.	.
cord-005453-4057qib7	9582	1	Methods	method	NNS
cord-005453-4057qib7	9582	2	:	:	:
cord-005453-4057qib7	9582	3	Frequencies	frequency	NNS
cord-005453-4057qib7	9582	4	of	of	IN
cord-005453-4057qib7	9582	5	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	9582	6	(	(	-LRB-
cord-005453-4057qib7	9582	7	CMV)-and	cmv)-and	JJ
cord-005453-4057qib7	9582	8	AdV	adv	NN
cord-005453-4057qib7	9582	9	-	-	HYPH
cord-005453-4057qib7	9582	10	specific	specific	JJ
cord-005453-4057qib7	9582	11	T	t	NN
cord-005453-4057qib7	9582	12	cells	cell	NNS
cord-005453-4057qib7	9582	13	were	be	VBD
cord-005453-4057qib7	9582	14	determined	determine	VBN
cord-005453-4057qib7	9582	15	by	by	IN
cord-005453-4057qib7	9582	16	enzyme	enzyme	NN
cord-005453-4057qib7	9582	17	-	-	HYPH
cord-005453-4057qib7	9582	18	linked	link	VBN
cord-005453-4057qib7	9582	19	immunospot	immunospot	NNS
cord-005453-4057qib7	9582	20	(	(	-LRB-
cord-005453-4057qib7	9582	21	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	9582	22	)	)	-RRB-
cord-005453-4057qib7	9582	23	assays	assays	RB
cord-005453-4057qib7	9582	24	with	with	IN
cord-005453-4057qib7	9582	25	AdV5	AdV5	JJR
cord-005453-4057qib7	9582	26	Hexon	Hexon	NNP
cord-005453-4057qib7	9582	27	and	and	CC
cord-005453-4057qib7	9582	28	CMVpp65	CMVpp65	NNP
cord-005453-4057qib7	9582	29	respectively	respectively	RB
cord-005453-4057qib7	9582	30	in	in	IN
cord-005453-4057qib7	9582	31	80	80	CD
cord-005453-4057qib7	9582	32	health	health	NN
cord-005453-4057qib7	9582	33	donors	donor	NNS
cord-005453-4057qib7	9582	34	.	.	.
cord-005453-4057qib7	9583	1	We	-PRON-	PRP
cord-005453-4057qib7	9583	2	used	use	VBD
cord-005453-4057qib7	9583	3	3x10	3x10	CD
cord-005453-4057qib7	9583	4	5	5	CD
cord-005453-4057qib7	9583	5	of	of	IN
cord-005453-4057qib7	9583	6	mononuclear	mononuclear	JJ
cord-005453-4057qib7	9583	7	cells	cell	NNS
cord-005453-4057qib7	9583	8	(	(	-LRB-
cord-005453-4057qib7	9583	9	MNC	MNC	NNP
cord-005453-4057qib7	9583	10	)	)	-RRB-
cord-005453-4057qib7	9583	11	per	per	RB
cord-005453-4057qib7	9583	12	well	well	RB
cord-005453-4057qib7	9583	13	in	in	IN
cord-005453-4057qib7	9583	14	ELISPOT	ELISPOT	NNP
cord-005453-4057qib7	9583	15	assays	assay	NNS
cord-005453-4057qib7	9583	16	.	.	.
cord-005453-4057qib7	9584	1	All	all	DT
cord-005453-4057qib7	9584	2	donors	donor	NNS
cord-005453-4057qib7	9584	3	were	be	VBD
cord-005453-4057qib7	9584	4	divided	divide	VBN
cord-005453-4057qib7	9584	5	into	into	IN
cord-005453-4057qib7	9584	6	3	3	CD
cord-005453-4057qib7	9584	7	groups	group	NNS
cord-005453-4057qib7	9584	8	according	accord	VBG
cord-005453-4057qib7	9584	9	to	to	IN
cord-005453-4057qib7	9584	10	the	the	DT
cord-005453-4057qib7	9584	11	number	number	NN
cord-005453-4057qib7	9584	12	of	of	IN
cord-005453-4057qib7	9584	13	spots	spot	NNS
cord-005453-4057qib7	9584	14	per	per	IN
cord-005453-4057qib7	9584	15	well	well	RB
cord-005453-4057qib7	9584	16	(	(	-LRB-
cord-005453-4057qib7	9584	17	SPW	SPW	NNP
cord-005453-4057qib7	9584	18	)	)	-RRB-
cord-005453-4057qib7	9584	19	as	as	IN
cord-005453-4057qib7	9584	20	follows	follow	VBZ
cord-005453-4057qib7	9584	21	:	:	:
cord-005453-4057qib7	9584	22	high	high	JJ
cord-005453-4057qib7	9584	23	responders	responder	NNS
cord-005453-4057qib7	9584	24	(	(	-LRB-
cord-005453-4057qib7	9584	25	HR	HR	NNP
cord-005453-4057qib7	9584	26	)	)	-RRB-
cord-005453-4057qib7	9584	27	(	(	-LRB-
cord-005453-4057qib7	9584	28	≥50	≥50	DT
cord-005453-4057qib7	9584	29	spots	spot	NNS
cord-005453-4057qib7	9584	30	;	;	,
cord-005453-4057qib7	9584	31	n=32	n=32	NNP
cord-005453-4057qib7	9584	32	)	)	-RRB-
cord-005453-4057qib7	9584	33	,	,	,
cord-005453-4057qib7	9584	34	low	low	JJ
cord-005453-4057qib7	9584	35	responders	responder	NNS
cord-005453-4057qib7	9584	36	(	(	-LRB-
cord-005453-4057qib7	9584	37	LR	LR	NNP
cord-005453-4057qib7	9584	38	)	)	-RRB-
cord-005453-4057qib7	9584	39	(	(	-LRB-
cord-005453-4057qib7	9584	40	>	>	NFP
cord-005453-4057qib7	9584	41	10	10	CD
cord-005453-4057qib7	9584	42	and	and	CC
cord-005453-4057qib7	9584	43	<	<	XX
cord-005453-4057qib7	9584	44	50	50	CD
cord-005453-4057qib7	9584	45	spots	spot	NNS
cord-005453-4057qib7	9584	46	;	;	:
cord-005453-4057qib7	9584	47	n=39	n=39	NNP
cord-005453-4057qib7	9584	48	)	)	-RRB-
cord-005453-4057qib7	9584	49	,	,	,
cord-005453-4057qib7	9584	50	nonresponders	nonresponders	NNP
cord-005453-4057qib7	9584	51	(	(	-LRB-
cord-005453-4057qib7	9584	52	NR	NR	NNP
cord-005453-4057qib7	9584	53	)	)	-RRB-
cord-005453-4057qib7	9584	54	(	(	-LRB-
cord-005453-4057qib7	9584	55	≤10	≤10	``
cord-005453-4057qib7	9584	56	spots	spot	NNS
cord-005453-4057qib7	9584	57	;	;	:
cord-005453-4057qib7	9584	58	n=9	n=9	NN
cord-005453-4057qib7	9584	59	)	)	-RRB-
cord-005453-4057qib7	9584	60	.	.	.
cord-005453-4057qib7	9585	1	The	the	DT
cord-005453-4057qib7	9585	2	average	average	JJ
cord-005453-4057qib7	9585	3	spot	spot	NN
cord-005453-4057qib7	9585	4	area	area	NN
cord-005453-4057qib7	9585	5	of	of	IN
cord-005453-4057qib7	9585	6	AdV	adv	NN
cord-005453-4057qib7	9585	7	-	-	:
cord-005453-4057qib7	9585	8	and	and	CC
cord-005453-4057qib7	9585	9	CMV	CMV	NNP
cord-005453-4057qib7	9585	10	-	-	HYPH
cord-005453-4057qib7	9585	11	specific	specific	JJ
cord-005453-4057qib7	9585	12	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	9585	13	was	be	VBD
cord-005453-4057qib7	9585	14	calculated	calculate	VBN
cord-005453-4057qib7	9585	15	by	by	IN
cord-005453-4057qib7	9585	16	ImmunoSpot	ImmunoSpot	NNP
cord-005453-4057qib7	9585	17	®	®	POS
cord-005453-4057qib7	9585	18	MultiPlate	MultiPlate	NNP
cord-005453-4057qib7	9585	19	AutoCount	AutoCount	NNP
cord-005453-4057qib7	9585	20	™	™	NN
cord-005453-4057qib7	9585	21	.	.	.
cord-005453-4057qib7	9586	1	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	9586	2	and	and	CC
cord-005453-4057qib7	9586	3	CD45RO+	CD45RO+	NNP
cord-005453-4057qib7	9586	4	T	T	NNP
cord-005453-4057qib7	9586	5	-	-	HYPH
cord-005453-4057qib7	9586	6	cells	cell	NNS
cord-005453-4057qib7	9586	7	were	be	VBD
cord-005453-4057qib7	9586	8	generated	generate	VBN
cord-005453-4057qib7	9586	9	by	by	IN
cord-005453-4057qib7	9586	10	immunomagnetic	immunomagnetic	JJ
cord-005453-4057qib7	9586	11	negative	negative	JJ
cord-005453-4057qib7	9586	12	selection	selection	NN
cord-005453-4057qib7	9586	13	.	.	.
cord-005453-4057qib7	9587	1	HLA	HLA	NNP
cord-005453-4057qib7	9587	2	typing	type	VBG
cord-005453-4057qib7	9587	3	for	for	IN
cord-005453-4057qib7	9587	4	class	class	NN
cord-005453-4057qib7	9588	1	I	-PRON-	PRP
cord-005453-4057qib7	9588	2	and	and	CC
cord-005453-4057qib7	9588	3	II	II	NNP
cord-005453-4057qib7	9588	4	was	be	VBD
cord-005453-4057qib7	9588	5	performed	perform	VBN
cord-005453-4057qib7	9588	6	by	by	IN
cord-005453-4057qib7	9588	7	Sequence	Sequence	NNP
cord-005453-4057qib7	9588	8	Specific	Specific	NNP
cord-005453-4057qib7	9588	9	Oligonucleotides	Oligonucleotides	NNP
cord-005453-4057qib7	9588	10	technology	technology	NN
cord-005453-4057qib7	9588	11	.	.	.
cord-005453-4057qib7	9589	1	Statistical	statistical	JJ
cord-005453-4057qib7	9589	2	analysis	analysis	NN
cord-005453-4057qib7	9589	3	was	be	VBD
cord-005453-4057qib7	9589	4	performed	perform	VBN
cord-005453-4057qib7	9589	5	using	use	VBG
cord-005453-4057qib7	9589	6	GraphPad	GraphPad	NNP
cord-005453-4057qib7	9589	7	Prism	Prism	NNP
cord-005453-4057qib7	9589	8	v7.00	v7.00	NN
cord-005453-4057qib7	9589	9	software	software	NN
cord-005453-4057qib7	9589	10	.	.	.
cord-005453-4057qib7	9590	1	Levels	level	NNS
cord-005453-4057qib7	9590	2	of	of	IN
cord-005453-4057qib7	9590	3	significance	significance	NN
cord-005453-4057qib7	9590	4	were	be	VBD
cord-005453-4057qib7	9590	5	calculated	calculate	VBN
cord-005453-4057qib7	9590	6	by	by	IN
cord-005453-4057qib7	9590	7	Mann	Mann	NNP
cord-005453-4057qib7	9590	8	-	-	HYPH
cord-005453-4057qib7	9590	9	Whitney	Whitney	NNP
cord-005453-4057qib7	9590	10	rank	rank	NN
cord-005453-4057qib7	9590	11	-	-	HYPH
cord-005453-4057qib7	9590	12	sum	sum	NN
cord-005453-4057qib7	9590	13	test	test	NN
cord-005453-4057qib7	9590	14	,	,	,
cord-005453-4057qib7	9590	15	expressed	express	VBD
cord-005453-4057qib7	9590	16	as	as	IN
cord-005453-4057qib7	9590	17	p	p	NN
cord-005453-4057qib7	9590	18	-	-	HYPH
cord-005453-4057qib7	9590	19	values	value	NNS
cord-005453-4057qib7	9590	20	(	(	-LRB-
cord-005453-4057qib7	9590	21	p	p	NN
cord-005453-4057qib7	9590	22	<	<	XX
cord-005453-4057qib7	9590	23	0.05	0.05	CD
cord-005453-4057qib7	9590	24	)	)	-RRB-
cord-005453-4057qib7	9590	25	.	.	.
cord-005453-4057qib7	9591	1	Results	result	NNS
cord-005453-4057qib7	9591	2	:	:	:
cord-005453-4057qib7	9592	1	The	the	DT
cord-005453-4057qib7	9592	2	median	median	JJ
cord-005453-4057qib7	9592	3	frequency	frequency	NN
cord-005453-4057qib7	9592	4	per	per	IN
cord-005453-4057qib7	9592	5	well	well	NN
cord-005453-4057qib7	9592	6	of	of	IN
cord-005453-4057qib7	9592	7	AdvTs	AdvTs	NNP
cord-005453-4057qib7	9592	8	were	be	VBD
cord-005453-4057qib7	9592	9	72	72	CD
cord-005453-4057qib7	9592	10	in	in	IN
cord-005453-4057qib7	9592	11	HR	HR	NNP
cord-005453-4057qib7	9592	12	group	group	NN
cord-005453-4057qib7	9592	13	,	,	,
cord-005453-4057qib7	9592	14	24	24	CD
cord-005453-4057qib7	9592	15	in	in	IN
cord-005453-4057qib7	9592	16	LR	LR	NNP
cord-005453-4057qib7	9592	17	group	group	NN
cord-005453-4057qib7	9592	18	,	,	,
cord-005453-4057qib7	9592	19	4	4	CD
cord-005453-4057qib7	9592	20	in	in	IN
cord-005453-4057qib7	9592	21	NR	NR	NNP
cord-005453-4057qib7	9592	22	group	group	NN
cord-005453-4057qib7	9592	23	.	.	.
cord-005453-4057qib7	9593	1	The	the	DT
cord-005453-4057qib7	9593	2	median	median	JJ
cord-005453-4057qib7	9593	3	SPW	SPW	NNP
cord-005453-4057qib7	9593	4	of	of	IN
cord-005453-4057qib7	9593	5	CMV	CMV	NNP
cord-005453-4057qib7	9593	6	-	-	HYPH
cord-005453-4057qib7	9593	7	specific	specific	JJ
cord-005453-4057qib7	9593	8	T	T	NNP
cord-005453-4057qib7	9593	9	cells	cell	NNS
cord-005453-4057qib7	9593	10	in	in	IN
cord-005453-4057qib7	9593	11	donors	donor	NNS
cord-005453-4057qib7	9594	1	MNC	MNC	NNP
cord-005453-4057qib7	9594	2	were	be	VBD
cord-005453-4057qib7	9594	3	147	147	CD
cord-005453-4057qib7	9594	4	and	and	CC
cord-005453-4057qib7	9594	5	didn´t	didn´t	TO
cord-005453-4057qib7	9594	6	differ	differ	VB
cord-005453-4057qib7	9594	7	between	between	IN
cord-005453-4057qib7	9594	8	3	3	CD
cord-005453-4057qib7	9594	9	groups	group	NNS
cord-005453-4057qib7	9594	10	.	.	.
cord-005453-4057qib7	9595	1	Antiviral	antiviral	JJ
cord-005453-4057qib7	9595	2	activity	activity	NN
cord-005453-4057qib7	9595	3	may	may	MD
cord-005453-4057qib7	9595	4	depend	depend	VB
cord-005453-4057qib7	9595	5	not	not	RB
cord-005453-4057qib7	9595	6	only	only	RB
cord-005453-4057qib7	9595	7	on	on	IN
cord-005453-4057qib7	9595	8	the	the	DT
cord-005453-4057qib7	9595	9	amount	amount	NN
cord-005453-4057qib7	9595	10	of	of	IN
cord-005453-4057qib7	9595	11	AdvT	AdvT	NNP
cord-005453-4057qib7	9595	12	but	but	CC
cord-005453-4057qib7	9595	13	also	also	RB
cord-005453-4057qib7	9595	14	on	on	IN
cord-005453-4057qib7	9595	15	their	-PRON-	PRP$
cord-005453-4057qib7	9595	16	ability	ability	NN
cord-005453-4057qib7	9595	17	to	to	TO
cord-005453-4057qib7	9595	18	produce	produce	VB
cord-005453-4057qib7	9595	19	IFNγ	IFNγ	NNS
cord-005453-4057qib7	9595	20	.	.	.
cord-005453-4057qib7	9596	1	The	the	DT
cord-005453-4057qib7	9596	2	average	average	JJ
cord-005453-4057qib7	9596	3	spot	spot	NN
cord-005453-4057qib7	9596	4	area	area	NN
cord-005453-4057qib7	9596	5	for	for	IN
cord-005453-4057qib7	9596	6	AdvT	AdvT	NNP
cord-005453-4057qib7	9596	7	did	do	VBD
cord-005453-4057qib7	9596	8	not	not	RB
cord-005453-4057qib7	9596	9	differ	differ	VB
cord-005453-4057qib7	9596	10	between	between	IN
cord-005453-4057qib7	9596	11	HR	hr	NN
cord-005453-4057qib7	9596	12	,	,	,
cord-005453-4057qib7	9596	13	LR	LR	NNP
cord-005453-4057qib7	9596	14	and	and	CC
cord-005453-4057qib7	9596	15	NR	NR	NNP
cord-005453-4057qib7	9596	16	groups	group	NNS
cord-005453-4057qib7	9596	17	and	and	CC
cord-005453-4057qib7	9596	18	were	be	VBD
cord-005453-4057qib7	9596	19	22,4	22,4	CD
cord-005453-4057qib7	9596	20	,	,	,
cord-005453-4057qib7	9596	21	23,1	23,1	CD
cord-005453-4057qib7	9596	22	and	and	CC
cord-005453-4057qib7	9596	23	19,1	19,1	CD
cord-005453-4057qib7	9596	24	mm	mm	CD
cord-005453-4057qib7	9596	25	2	2	CD
cord-005453-4057qib7	9596	26	respectively	respectively	RB
cord-005453-4057qib7	9596	27	.	.	.
cord-005453-4057qib7	9597	1	The	the	DT
cord-005453-4057qib7	9597	2	median	median	NN
cord-005453-4057qib7	9597	3	of	of	IN
cord-005453-4057qib7	9597	4	the	the	DT
cord-005453-4057qib7	9597	5	average	average	JJ
cord-005453-4057qib7	9597	6	spot	spot	NN
cord-005453-4057qib7	9597	7	area	area	NN
cord-005453-4057qib7	9597	8	for	for	IN
cord-005453-4057qib7	9597	9	anti	anti	JJ
cord-005453-4057qib7	9597	10	-	-	JJ
cord-005453-4057qib7	9597	11	CMV	CMV	NNP
cord-005453-4057qib7	9597	12	T	t	NN
cord-005453-4057qib7	9597	13	-	-	HYPH
cord-005453-4057qib7	9597	14	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	9597	15	was	be	VBD
cord-005453-4057qib7	9597	16	equal	equal	JJ
cord-005453-4057qib7	9597	17	to	to	IN
cord-005453-4057qib7	9597	18	13,5	13,5	CD
cord-005453-4057qib7	9597	19	mm	mm	CD
cord-005453-4057qib7	9597	20	2	2	CD
cord-005453-4057qib7	9597	21	.	.	.
cord-005453-4057qib7	9598	1	Thus	thus	RB
cord-005453-4057qib7	9598	2	,	,	,
cord-005453-4057qib7	9598	3	the	the	DT
cord-005453-4057qib7	9598	4	frequency	frequency	NN
cord-005453-4057qib7	9598	5	of	of	IN
cord-005453-4057qib7	9598	6	AdvT	AdvT	NNP
cord-005453-4057qib7	9598	7	was	be	VBD
cord-005453-4057qib7	9598	8	lower	low	JJR
cord-005453-4057qib7	9598	9	than	than	IN
cord-005453-4057qib7	9598	10	CMV	CMV	NNP
cord-005453-4057qib7	9598	11	-	-	HYPH
cord-005453-4057qib7	9598	12	specific	specific	JJ
cord-005453-4057qib7	9598	13	T	t	NN
cord-005453-4057qib7	9598	14	-	-	HYPH
cord-005453-4057qib7	9598	15	cells	cell	NNS
cord-005453-4057qib7	9598	16	,	,	,
cord-005453-4057qib7	9598	17	but	but	CC
cord-005453-4057qib7	9598	18	AdvT	AdvT	NNP
cord-005453-4057qib7	9598	19	have	have	VB
cord-005453-4057qib7	9598	20	the	the	DT
cord-005453-4057qib7	9598	21	ability	ability	NN
cord-005453-4057qib7	9598	22	to	to	TO
cord-005453-4057qib7	9598	23	produce	produce	VB
cord-005453-4057qib7	9598	24	more	more	JJR
cord-005453-4057qib7	9598	25	IFNγ	IFNγ	NNS
cord-005453-4057qib7	9598	26	per	per	IN
cord-005453-4057qib7	9598	27	cell	cell	NN
cord-005453-4057qib7	9598	28	(	(	-LRB-
cord-005453-4057qib7	9598	29	p	p	NN
cord-005453-4057qib7	9598	30	<	<	XX
cord-005453-4057qib7	9598	31	0.0001	0.0001	CD
cord-005453-4057qib7	9598	32	)	)	-RRB-
cord-005453-4057qib7	9598	33	.	.	.
cord-005453-4057qib7	9599	1	In	in	IN
cord-005453-4057qib7	9599	2	order	order	NN
cord-005453-4057qib7	9599	3	to	to	TO
cord-005453-4057qib7	9599	4	evaluate	evaluate	VB
cord-005453-4057qib7	9599	5	the	the	DT
cord-005453-4057qib7	9599	6	distribution	distribution	NN
cord-005453-4057qib7	9599	7	of	of	IN
cord-005453-4057qib7	9599	8	the	the	DT
cord-005453-4057qib7	9599	9	AdvT	AdvT	NNP
cord-005453-4057qib7	9599	10	between	between	IN
cord-005453-4057qib7	9599	11	naive	naive	JJ
cord-005453-4057qib7	9599	12	and	and	CC
cord-005453-4057qib7	9599	13	memory	memory	NN
cord-005453-4057qib7	9599	14	T	t	NN
cord-005453-4057qib7	9599	15	cell	cell	NN
cord-005453-4057qib7	9599	16	compartments	compartment	NNS
cord-005453-4057qib7	9599	17	,	,	,
cord-005453-4057qib7	9599	18	we	-PRON-	PRP
cord-005453-4057qib7	9599	19	evaluated	evaluate	VBD
cord-005453-4057qib7	9599	20	response	response	NN
cord-005453-4057qib7	9599	21	to	to	IN
cord-005453-4057qib7	9599	22	AdV	adv	NN
cord-005453-4057qib7	9599	23	in	in	IN
cord-005453-4057qib7	9599	24	preselected	preselected	JJ
cord-005453-4057qib7	9599	25	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	9599	26	and	and	CC
cord-005453-4057qib7	9599	27	CD45RO+	CD45RO+	NNP
cord-005453-4057qib7	9599	28	fractions	fraction	NNS
cord-005453-4057qib7	9599	29	of	of	IN
cord-005453-4057qib7	9599	30	T	t	NN
cord-005453-4057qib7	9599	31	-	-	HYPH
cord-005453-4057qib7	9599	32	cells	cell	NNS
cord-005453-4057qib7	9599	33	in	in	IN
cord-005453-4057qib7	9599	34	a	a	DT
cord-005453-4057qib7	9599	35	group	group	NN
cord-005453-4057qib7	9599	36	of	of	IN
cord-005453-4057qib7	9599	37	17	17	CD
cord-005453-4057qib7	9599	38	donors	donor	NNS
cord-005453-4057qib7	9599	39	.	.	.
cord-005453-4057qib7	9600	1	The	the	DT
cord-005453-4057qib7	9600	2	median	median	JJ
cord-005453-4057qib7	9600	3	frequency	frequency	NN
cord-005453-4057qib7	9600	4	of	of	IN
cord-005453-4057qib7	9600	5	AdvT	AdvT	NNP
cord-005453-4057qib7	9600	6	in	in	IN
cord-005453-4057qib7	9600	7	unfractionated	unfractionated	JJ
cord-005453-4057qib7	9600	8	MNC	MNC	NNP
cord-005453-4057qib7	9600	9	was	be	VBD
cord-005453-4057qib7	9600	10	87	87	CD
cord-005453-4057qib7	9600	11	;	;	:
cord-005453-4057qib7	9600	12	the	the	DT
cord-005453-4057qib7	9600	13	median	median	JJ
cord-005453-4057qib7	9600	14	frequency	frequency	NN
cord-005453-4057qib7	9600	15	of	of	IN
cord-005453-4057qib7	9600	16	AdvT	AdvT	NNP
cord-005453-4057qib7	9600	17	in	in	IN
cord-005453-4057qib7	9600	18	CD45RA	cd45ra	NN
cord-005453-4057qib7	9600	19	and	and	CC
cord-005453-4057qib7	9600	20	CD45RO	cd45ro	JJ
cord-005453-4057qib7	9600	21	fractions	fraction	NNS
cord-005453-4057qib7	9600	22	were	be	VBD
cord-005453-4057qib7	9600	23	2	2	CD
cord-005453-4057qib7	9600	24	and	and	CC
cord-005453-4057qib7	9600	25	73	73	CD
cord-005453-4057qib7	9600	26	,	,	,
cord-005453-4057qib7	9600	27	respectively	respectively	RB
cord-005453-4057qib7	9600	28	.	.	.
cord-005453-4057qib7	9601	1	The	the	DT
cord-005453-4057qib7	9601	2	amounts	amount	NNS
cord-005453-4057qib7	9601	3	of	of	IN
cord-005453-4057qib7	9601	4	CD45RA	cd45ra	NN
cord-005453-4057qib7	9601	5	and	and	CC
cord-005453-4057qib7	9601	6	CD45RO	CD45RO	NNP
cord-005453-4057qib7	9601	7	Tcells	Tcells	NNP
cord-005453-4057qib7	9601	8	were	be	VBD
cord-005453-4057qib7	9601	9	normalized	normalize	VBN
cord-005453-4057qib7	9601	10	to	to	IN
cord-005453-4057qib7	9601	11	their	-PRON-	PRP$
cord-005453-4057qib7	9601	12	amounts	amount	NNS
cord-005453-4057qib7	9601	13	in	in	IN
cord-005453-4057qib7	9601	14	MNC	MNC	NNP
cord-005453-4057qib7	9601	15	.	.	.
cord-005453-4057qib7	9602	1	We	-PRON-	PRP
cord-005453-4057qib7	9602	2	evaluated	evaluate	VBD
cord-005453-4057qib7	9602	3	the	the	DT
cord-005453-4057qib7	9602	4	impact	impact	NN
cord-005453-4057qib7	9602	5	of	of	IN
cord-005453-4057qib7	9602	6	HLA	HLA	NNP
cord-005453-4057qib7	9602	7	-	-	HYPH
cord-005453-4057qib7	9602	8	alleles	allele	NNS
cord-005453-4057qib7	9602	9	on	on	IN
cord-005453-4057qib7	9602	10	the	the	DT
cord-005453-4057qib7	9602	11	anti	anti	JJ
cord-005453-4057qib7	9602	12	-	-	JJ
cord-005453-4057qib7	9602	13	AdV	adv	JJ
cord-005453-4057qib7	9602	14	response	response	NN
cord-005453-4057qib7	9602	15	of	of	IN
cord-005453-4057qib7	9602	16	T	T	NNP
cord-005453-4057qib7	9602	17	-	-	HYPH
cord-005453-4057qib7	9602	18	cells	cell	NNS
cord-005453-4057qib7	9602	19	in	in	IN
cord-005453-4057qib7	9602	20	different	different	JJ
cord-005453-4057qib7	9602	21	groups	group	NNS
cord-005453-4057qib7	9602	22	and	and	CC
cord-005453-4057qib7	9602	23	found	find	VBD
cord-005453-4057qib7	9602	24	2	2	CD
cord-005453-4057qib7	9602	25	association	association	NN
cord-005453-4057qib7	9602	26	:	:	:
cord-005453-4057qib7	9602	27	HLA	HLA	NNP
cord-005453-4057qib7	9602	28	-	-	HYPH
cord-005453-4057qib7	9602	29	A*1	A*1	NNP
cord-005453-4057qib7	9602	30	with	with	IN
cord-005453-4057qib7	9602	31	HR	hr	NN
cord-005453-4057qib7	9602	32	group	group	NN
cord-005453-4057qib7	9602	33	(	(	-LRB-
cord-005453-4057qib7	9602	34	P	p	NN
cord-005453-4057qib7	9602	35	-	-	HYPH
cord-005453-4057qib7	9602	36	value=0,0043	value=0,0043	NN
cord-005453-4057qib7	9602	37	;	;	:
cord-005453-4057qib7	9602	38	RR=1,954	rr=1,954	NN
cord-005453-4057qib7	9602	39	;	;	:
cord-005453-4057qib7	9602	40	95	95	CD
cord-005453-4057qib7	9602	41	%	%	NN
cord-005453-4057qib7	9602	42	CI	ci	NN
cord-005453-4057qib7	9602	43	:	:	:
cord-005453-4057qib7	9603	1	1,285	1,285	CD
cord-005453-4057qib7	9603	2	to	to	IN
cord-005453-4057qib7	9603	3	2,604	2,604	CD
cord-005453-4057qib7	9603	4	)	)	-RRB-
cord-005453-4057qib7	9603	5	and	and	CC
cord-005453-4057qib7	9603	6	HLA	HLA	NNP
cord-005453-4057qib7	9603	7	-	-	HYPH
cord-005453-4057qib7	9603	8	A*31	A*31	NNP
cord-005453-4057qib7	9603	9	with	with	IN
cord-005453-4057qib7	9603	10	LR	LR	NNP
cord-005453-4057qib7	9603	11	group	group	NN
cord-005453-4057qib7	9603	12	0251	0251	CD
cord-005453-4057qib7	9603	13	;	;	:
cord-005453-4057qib7	9603	14	RR=1	RR=1	NNP
cord-005453-4057qib7	9603	15	,	,	,
cord-005453-4057qib7	9603	16	889	889	CD
cord-005453-4057qib7	9603	17	;	;	:
cord-005453-4057qib7	9603	18	95	95	CD
cord-005453-4057qib7	9603	19	%	%	NN
cord-005453-4057qib7	9603	20	CI	ci	NN
cord-005453-4057qib7	9603	21	:	:	:
cord-005453-4057qib7	9603	22	1	1	CD
cord-005453-4057qib7	9603	23	,	,	,
cord-005453-4057qib7	9603	24	135	135	CD
cord-005453-4057qib7	9603	25	to	to	TO
cord-005453-4057qib7	9603	26	4	4	CD
cord-005453-4057qib7	9603	27	,	,	,
cord-005453-4057qib7	9603	28	426	426	CD
cord-005453-4057qib7	9603	29	)	)	-RRB-
cord-005453-4057qib7	9603	30	.	.	.
cord-005453-4057qib7	9604	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9604	2	:	:	:
cord-005453-4057qib7	9605	1	In	in	IN
cord-005453-4057qib7	9605	2	this	this	DT
cord-005453-4057qib7	9605	3	study	study	NN
cord-005453-4057qib7	9605	4	the	the	DT
cord-005453-4057qib7	9605	5	frequency	frequency	NN
cord-005453-4057qib7	9605	6	of	of	IN
cord-005453-4057qib7	9605	7	donors	donor	NNS
cord-005453-4057qib7	9605	8	with	with	IN
cord-005453-4057qib7	9605	9	AdvT	AdvT	NNP
cord-005453-4057qib7	9605	10	is	be	VBZ
cord-005453-4057qib7	9605	11	88,75	88,75	CD
cord-005453-4057qib7	9605	12	%	%	NN
cord-005453-4057qib7	9605	13	which	which	WDT
cord-005453-4057qib7	9605	14	corresponds	correspond	VBZ
cord-005453-4057qib7	9605	15	to	to	IN
cord-005453-4057qib7	9605	16	the	the	DT
cord-005453-4057qib7	9605	17	reported	report	VBN
cord-005453-4057qib7	9605	18	frequency	frequency	NN
cord-005453-4057qib7	9605	19	of	of	IN
cord-005453-4057qib7	9605	20	AdV	adv	NN
cord-005453-4057qib7	9605	21	-	-	HYPH
cord-005453-4057qib7	9605	22	seropositive	seropositive	JJ
cord-005453-4057qib7	9605	23	people	people	NNS
cord-005453-4057qib7	9605	24	(	(	-LRB-
cord-005453-4057qib7	9605	25	95	95	CD
cord-005453-4057qib7	9605	26	%	%	NN
cord-005453-4057qib7	9605	27	)	)	-RRB-
cord-005453-4057qib7	9605	28	in	in	IN
cord-005453-4057qib7	9605	29	population	population	NN
cord-005453-4057qib7	9605	30	of	of	IN
cord-005453-4057qib7	9605	31	Russia	Russia	NNP
cord-005453-4057qib7	9605	32	.	.	.
cord-005453-4057qib7	9606	1	AdvT	AdvT	NNP
cord-005453-4057qib7	9606	2	are	be	VBP
cord-005453-4057qib7	9606	3	exclusively	exclusively	RB
cord-005453-4057qib7	9606	4	CD45RO	cd45ro	JJ
cord-005453-4057qib7	9606	5	-	-	HYPH
cord-005453-4057qib7	9606	6	positive	positive	JJ
cord-005453-4057qib7	9606	7	cells	cell	NNS
cord-005453-4057qib7	9606	8	.	.	.
cord-005453-4057qib7	9607	1	The	the	DT
cord-005453-4057qib7	9607	2	analysis	analysis	NN
cord-005453-4057qib7	9607	3	of	of	IN
cord-005453-4057qib7	9607	4	AdvT	AdvT	NNP
cord-005453-4057qib7	9607	5	in	in	IN
cord-005453-4057qib7	9607	6	potential	potential	JJ
cord-005453-4057qib7	9607	7	HSCT	HSCT	NNP
cord-005453-4057qib7	9607	8	donors	donor	NNS
cord-005453-4057qib7	9607	9	will	will	MD
cord-005453-4057qib7	9607	10	allow	allow	VB
cord-005453-4057qib7	9607	11	to	to	TO
cord-005453-4057qib7	9607	12	determine	determine	VB
cord-005453-4057qib7	9607	13	more	more	RBR
cord-005453-4057qib7	9607	14	accurately	accurately	RB
cord-005453-4057qib7	9607	15	the	the	DT
cord-005453-4057qib7	9607	16	amounts	amount	NNS
cord-005453-4057qib7	9607	17	and	and	CC
cord-005453-4057qib7	9607	18	functional	functional	JJ
cord-005453-4057qib7	9607	19	activity	activity	NN
cord-005453-4057qib7	9607	20	of	of	IN
cord-005453-4057qib7	9607	21	specific	specific	JJ
cord-005453-4057qib7	9607	22	antiviral	antiviral	JJ
cord-005453-4057qib7	9607	23	T	t	NN
cord-005453-4057qib7	9607	24	-	-	HYPH
cord-005453-4057qib7	9607	25	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	9607	26	administered	administer	VBN
cord-005453-4057qib7	9607	27	to	to	TO
cord-005453-4057qib7	9607	28	patient	patient	VB
cord-005453-4057qib7	9607	29	and	and	CC
cord-005453-4057qib7	9607	30	optimize	optimize	VB
cord-005453-4057qib7	9607	31	antiviral	antiviral	JJ
cord-005453-4057qib7	9607	32	therapy	therapy	NN
cord-005453-4057qib7	9607	33	.	.	.
cord-005453-4057qib7	9608	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9608	2	:	:	:
cord-005453-4057qib7	9608	3	Nothing	nothing	NN
cord-005453-4057qib7	9608	4	to	to	TO
cord-005453-4057qib7	9608	5	declare	declare	VB
cord-005453-4057qib7	9608	6	P429	P429	NNP
cord-005453-4057qib7	9608	7	abstract	abstract	JJ
cord-005453-4057qib7	9608	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	9608	9	.	.	.
cord-005453-4057qib7	9609	1	Chemotaxis	chemotaxis	NN
cord-005453-4057qib7	9609	2	and	and	CC
cord-005453-4057qib7	9609	3	exhaustion	exhaustion	NN
cord-005453-4057qib7	9609	4	of	of	IN
cord-005453-4057qib7	9609	5	γδ	γδ	NN
cord-005453-4057qib7	9609	6	T	t	NN
cord-005453-4057qib7	9609	7	cells	cell	NNS
cord-005453-4057qib7	9609	8	in	in	IN
cord-005453-4057qib7	9609	9	the	the	DT
cord-005453-4057qib7	9609	10	allografts	allograft	NNS
cord-005453-4057qib7	9609	11	are	be	VBP
cord-005453-4057qib7	9609	12	associated	associate	VBN
cord-005453-4057qib7	9609	13	with	with	IN
cord-005453-4057qib7	9609	14	CMV	CMV	NNP
cord-005453-4057qib7	9609	15	reactivation	reactivation	NN
cord-005453-4057qib7	9609	16	after	after	IN
cord-005453-4057qib7	9609	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9609	18	transplantation	transplantation	NN
cord-005453-4057qib7	9609	19	Background	background	NN
cord-005453-4057qib7	9609	20	:	:	:
cord-005453-4057qib7	9610	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	9610	2	(	(	-LRB-
cord-005453-4057qib7	9610	3	CMV	CMV	NNP
cord-005453-4057qib7	9610	4	)	)	-RRB-
cord-005453-4057qib7	9610	5	reactivation	reactivation	NN
cord-005453-4057qib7	9610	6	and	and	CC
cord-005453-4057qib7	9610	7	its	-PRON-	PRP$
cord-005453-4057qib7	9610	8	related	related	JJ
cord-005453-4057qib7	9610	9	diseases	disease	NNS
cord-005453-4057qib7	9610	10	remain	remain	VBP
cord-005453-4057qib7	9610	11	the	the	DT
cord-005453-4057qib7	9610	12	most	most	RBS
cord-005453-4057qib7	9610	13	common	common	JJ
cord-005453-4057qib7	9610	14	and	and	CC
cord-005453-4057qib7	9610	15	serious	serious	JJ
cord-005453-4057qib7	9610	16	complications	complication	NNS
cord-005453-4057qib7	9610	17	in	in	IN
cord-005453-4057qib7	9610	18	patients	patient	NNS
cord-005453-4057qib7	9610	19	who	who	WP
cord-005453-4057qib7	9610	20	underwentallogeneic	underwentallogeneic	VBZ
cord-005453-4057qib7	9610	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9610	22	stem	stem	NN
cord-005453-4057qib7	9610	23	cell	cell	NN
cord-005453-4057qib7	9610	24	transplantation	transplantation	NN
cord-005453-4057qib7	9610	25	(	(	-LRB-
cord-005453-4057qib7	9610	26	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	9610	27	)	)	-RRB-
cord-005453-4057qib7	9610	28	.	.	.
cord-005453-4057qib7	9611	1	We	-PRON-	PRP
cord-005453-4057qib7	9611	2	previously	previously	RB
cord-005453-4057qib7	9611	3	reported	report	VBD
cord-005453-4057qib7	9611	4	that	that	IN
cord-005453-4057qib7	9611	5	the	the	DT
cord-005453-4057qib7	9611	6	incidences	incidence	NNS
cord-005453-4057qib7	9611	7	of	of	IN
cord-005453-4057qib7	9611	8	total	total	JJ
cord-005453-4057qib7	9611	9	and	and	CC
cord-005453-4057qib7	9611	10	refractory	refractory	JJ
cord-005453-4057qib7	9611	11	CMV	CMV	NNP
cord-005453-4057qib7	9611	12	reactivation	reactivation	NN
cord-005453-4057qib7	9611	13	reached	reach	VBD
cord-005453-4057qib7	9611	14	approximately	approximately	RB
cord-005453-4057qib7	9611	15	90	90	CD
cord-005453-4057qib7	9611	16	%	%	NN
cord-005453-4057qib7	9611	17	and	and	CC
cord-005453-4057qib7	9611	18	50	50	CD
cord-005453-4057qib7	9611	19	%	%	NN
cord-005453-4057qib7	9611	20	after	after	IN
cord-005453-4057qib7	9611	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9611	22	HSCT	HSCT	NNP
cord-005453-4057qib7	9611	23	.	.	.
cord-005453-4057qib7	9612	1	While	while	IN
cord-005453-4057qib7	9612	2	majority	majority	NN
cord-005453-4057qib7	9612	3	of	of	IN
cord-005453-4057qib7	9612	4	studies	study	NNS
cord-005453-4057qib7	9612	5	in	in	IN
cord-005453-4057qib7	9612	6	the	the	DT
cord-005453-4057qib7	9612	7	literatures	literature	NNS
cord-005453-4057qib7	9612	8	focused	focus	VBN
cord-005453-4057qib7	9612	9	on	on	IN
cord-005453-4057qib7	9612	10	the	the	DT
cord-005453-4057qib7	9612	11	adaptive	adaptive	JJ
cord-005453-4057qib7	9612	12	CD8	CD8	NNP
cord-005453-4057qib7	9612	13	+	+	CC
cord-005453-4057qib7	9612	14	αβ	αβ	NNP
cord-005453-4057qib7	9612	15	T	T	NNP
cord-005453-4057qib7	9612	16	cellsand	cellsand	NN
cord-005453-4057qib7	9612	17	NK	NK	NNP
cord-005453-4057qib7	9612	18	cells	cell	NNS
cord-005453-4057qib7	9612	19	in	in	IN
cord-005453-4057qib7	9612	20	anti	anti	JJ
cord-005453-4057qib7	9612	21	-	-	JJ
cord-005453-4057qib7	9612	22	CMV	CMV	NNP
cord-005453-4057qib7	9612	23	immunity	immunity	NN
cord-005453-4057qib7	9612	24	,	,	,
cord-005453-4057qib7	9612	25	increasing	increase	VBG
cord-005453-4057qib7	9612	26	evidences	evidence	NNS
cord-005453-4057qib7	9612	27	highlighted	highlight	VBD
cord-005453-4057qib7	9612	28	the	the	DT
cord-005453-4057qib7	9612	29	important	important	JJ
cord-005453-4057qib7	9612	30	role	role	NN
cord-005453-4057qib7	9612	31	of	of	IN
cord-005453-4057qib7	9612	32	γδT	γδt	NN
cord-005453-4057qib7	9612	33	cells	cell	NNS
cord-005453-4057qib7	9612	34	in	in	IN
cord-005453-4057qib7	9612	35	this	this	DT
cord-005453-4057qib7	9612	36	context	context	NN
cord-005453-4057qib7	9612	37	.	.	.
cord-005453-4057qib7	9613	1	A	a	DT
cord-005453-4057qib7	9613	2	progressive	progressive	JJ
cord-005453-4057qib7	9613	3	and	and	CC
cord-005453-4057qib7	9613	4	prolonged	prolonged	JJ
cord-005453-4057qib7	9613	5	expansion	expansion	NN
cord-005453-4057qib7	9613	6	of	of	IN
cord-005453-4057qib7	9613	7	Vδ1	Vδ1	NNP
cord-005453-4057qib7	9613	8	+	+	SYM
cord-005453-4057qib7	9613	9	T	t	NN
cord-005453-4057qib7	9613	10	cells	cell	NNS
cord-005453-4057qib7	9613	11	in	in	IN
cord-005453-4057qib7	9613	12	response	response	NN
cord-005453-4057qib7	9613	13	to	to	IN
cord-005453-4057qib7	9613	14	CMV	CMV	NNP
cord-005453-4057qib7	9613	15	reactivation	reactivation	NN
cord-005453-4057qib7	9613	16	was	be	VBD
cord-005453-4057qib7	9613	17	observed	observe	VBN
cord-005453-4057qib7	9613	18	after	after	IN
cord-005453-4057qib7	9613	19	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	9613	20	.	.	.
cord-005453-4057qib7	9614	1	The	the	DT
cord-005453-4057qib7	9614	2	effect	effect	NN
cord-005453-4057qib7	9614	3	of	of	IN
cord-005453-4057qib7	9614	4	Vδ1	vδ1	NN
cord-005453-4057qib7	9614	5	+	+	SYM
cord-005453-4057qib7	9614	6	T	t	NN
cord-005453-4057qib7	9614	7	cells	cell	NNS
cord-005453-4057qib7	9614	8	associated	associate	VBN
cord-005453-4057qib7	9614	9	with	with	IN
cord-005453-4057qib7	9614	10	CMV	CMV	NNP
cord-005453-4057qib7	9614	11	clearance	clearance	NN
cord-005453-4057qib7	9614	12	has	have	VBZ
cord-005453-4057qib7	9614	13	been	be	VBN
cord-005453-4057qib7	9614	14	reported	report	VBN
cord-005453-4057qib7	9614	15	in	in	IN
cord-005453-4057qib7	9614	16	vitro	vitro	FW
cord-005453-4057qib7	9614	17	and	and	CC
cord-005453-4057qib7	9614	18	in	in	IN
cord-005453-4057qib7	9614	19	vivo	vivo	NNP
cord-005453-4057qib7	9614	20	.	.	.
cord-005453-4057qib7	9615	1	In	in	IN
cord-005453-4057qib7	9615	2	contrast	contrast	NN
cord-005453-4057qib7	9615	3	to	to	IN
cord-005453-4057qib7	9615	4	the	the	DT
cord-005453-4057qib7	9615	5	reconstituted	reconstitute	VBN
cord-005453-4057qib7	9615	6	γδT	γδT	NNP
cord-005453-4057qib7	9615	7	cells	cell	NNS
cord-005453-4057qib7	9615	8	post	post	VBP
cord-005453-4057qib7	9615	9	transplantation	transplantation	NN
cord-005453-4057qib7	9615	10	,	,	,
cord-005453-4057qib7	9615	11	whether	whether	IN
cord-005453-4057qib7	9615	12	the	the	DT
cord-005453-4057qib7	9615	13	phenotypes	phenotype	NNS
cord-005453-4057qib7	9615	14	of	of	IN
cord-005453-4057qib7	9615	15	γδT	γδt	NN
cord-005453-4057qib7	9615	16	subsets	subset	NNS
cord-005453-4057qib7	9615	17	in	in	IN
cord-005453-4057qib7	9615	18	allografts	allograft	NNS
cord-005453-4057qib7	9615	19	correlate	correlate	VBP
cord-005453-4057qib7	9615	20	to	to	IN
cord-005453-4057qib7	9615	21	CMV	CMV	NNP
cord-005453-4057qib7	9615	22	reactivation	reactivation	NN
cord-005453-4057qib7	9615	23	in	in	IN
cord-005453-4057qib7	9615	24	HSCT	HSCT	NNP
cord-005453-4057qib7	9615	25	recipients	recipient	NNS
cord-005453-4057qib7	9615	26	have	have	VBP
cord-005453-4057qib7	9615	27	not	not	RB
cord-005453-4057qib7	9615	28	been	be	VBN
cord-005453-4057qib7	9615	29	documented	document	VBN
cord-005453-4057qib7	9615	30	.	.	.
cord-005453-4057qib7	9616	1	Methods	method	NNS
cord-005453-4057qib7	9616	2	:	:	:
cord-005453-4057qib7	9616	3	The	the	DT
cord-005453-4057qib7	9616	4	proportions	proportion	NNS
cord-005453-4057qib7	9616	5	and	and	CC
cord-005453-4057qib7	9616	6	phenotypes	phenotype	NNS
cord-005453-4057qib7	9616	7	of	of	IN
cord-005453-4057qib7	9616	8	γδ	γδ	NN
cord-005453-4057qib7	9616	9	T	t	NN
cord-005453-4057qib7	9616	10	cells	cell	NNS
cord-005453-4057qib7	9616	11	were	be	VBD
cord-005453-4057qib7	9616	12	detected	detect	VBN
cord-005453-4057qib7	9616	13	inallografts	inallografts	NNP
cord-005453-4057qib7	9617	1	those	those	DT
cord-005453-4057qib7	9617	2	were	be	VBD
cord-005453-4057qib7	9617	3	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	9617	4	G	G	NNP
cord-005453-4057qib7	9617	5	-	-	HYPH
cord-005453-4057qib7	9617	6	CSF	csf	NN
cord-005453-4057qib7	9617	7	-	-	HYPH
cord-005453-4057qib7	9617	8	mobilized	mobilize	VBN
cord-005453-4057qib7	9617	9	bone	bone	NN
cord-005453-4057qib7	9617	10	marrow	marrow	NN
cord-005453-4057qib7	9617	11	(	(	-LRB-
cord-005453-4057qib7	9617	12	BM	BM	NNP
cord-005453-4057qib7	9617	13	)	)	-RRB-
cord-005453-4057qib7	9617	14	and	and	CC
cord-005453-4057qib7	9617	15	peripheral	peripheral	JJ
cord-005453-4057qib7	9617	16	blood	blood	NN
cord-005453-4057qib7	9617	17	(	(	-LRB-
cord-005453-4057qib7	9617	18	PB	PB	NNP
cord-005453-4057qib7	9617	19	)	)	-RRB-
cord-005453-4057qib7	9617	20	harvests	harvest	VBZ
cord-005453-4057qib7	9617	21	from	from	IN
cord-005453-4057qib7	9617	22	20	20	CD
cord-005453-4057qib7	9617	23	donors	donor	NNS
cord-005453-4057qib7	9617	24	for	for	IN
cord-005453-4057qib7	9617	25	haploHSCT	haploHSCT	NNP
cord-005453-4057qib7	9617	26	.	.	.
cord-005453-4057qib7	9618	1	BM	BM	NNP
cord-005453-4057qib7	9618	2	grafts	graft	NNS
cord-005453-4057qib7	9618	3	were	be	VBD
cord-005453-4057qib7	9618	4	collected	collect	VBN
cord-005453-4057qib7	9618	5	by	by	IN
cord-005453-4057qib7	9618	6	aspiration	aspiration	NN
cord-005453-4057qib7	9618	7	on	on	IN
cord-005453-4057qib7	9618	8	the	the	DT
cord-005453-4057qib7	9618	9	fourth	fourth	JJ
cord-005453-4057qib7	9618	10	day	day	NN
cord-005453-4057qib7	9618	11	of	of	IN
cord-005453-4057qib7	9618	12	G	G	NNP
cord-005453-4057qib7	9618	13	-	-	HYPH
cord-005453-4057qib7	9618	14	CSF	csf	NN
cord-005453-4057qib7	9618	15	treatment	treatment	NN
cord-005453-4057qib7	9618	16	(	(	-LRB-
cord-005453-4057qib7	9618	17	filgrastim	filgrastim	NNP
cord-005453-4057qib7	9618	18	,	,	,
cord-005453-4057qib7	9618	19	5	5	CD
cord-005453-4057qib7	9618	20	μg	μg	NNP
cord-005453-4057qib7	9618	21	/	/	SYM
cord-005453-4057qib7	9618	22	kg	kg	NNP
cord-005453-4057qib7	9618	23	/	/	SYM
cord-005453-4057qib7	9618	24	day	day	NN
cord-005453-4057qib7	9618	25	)	)	-RRB-
cord-005453-4057qib7	9618	26	,	,	,
cord-005453-4057qib7	9618	27	and	and	CC
cord-005453-4057qib7	9618	28	PB	PB	NNP
cord-005453-4057qib7	9618	29	grafts	graft	NNS
cord-005453-4057qib7	9618	30	were	be	VBD
cord-005453-4057qib7	9618	31	obtained	obtain	VBN
cord-005453-4057qib7	9618	32	on	on	IN
cord-005453-4057qib7	9618	33	the	the	DT
cord-005453-4057qib7	9618	34	fifth	fifth	JJ
cord-005453-4057qib7	9618	35	day	day	NN
cord-005453-4057qib7	9618	36	by	by	IN
cord-005453-4057qib7	9618	37	leukapheresis	leukapheresis	NNP
cord-005453-4057qib7	9618	38	.	.	.
cord-005453-4057qib7	9619	1	Immunophenotyping	immunophenotype	VBG
cord-005453-4057qib7	9619	2	for	for	IN
cord-005453-4057qib7	9619	3	γδ	γδ	NNP
cord-005453-4057qib7	9619	4	T	t	NN
cord-005453-4057qib7	9619	5	-	-	HYPH
cord-005453-4057qib7	9619	6	cell	cell	NN
cord-005453-4057qib7	9619	7	subpopulations	subpopulation	NNS
cord-005453-4057qib7	9619	8	,	,	,
cord-005453-4057qib7	9619	9	including	include	VBG
cord-005453-4057qib7	9619	10	the	the	DT
cord-005453-4057qib7	9619	11	expression	expression	NN
cord-005453-4057qib7	9619	12	of	of	IN
cord-005453-4057qib7	9619	13	CD3	CD3	NNP
cord-005453-4057qib7	9619	14	,	,	,
cord-005453-4057qib7	9619	15	CD4	CD4	NNP
cord-005453-4057qib7	9619	16	,	,	,
cord-005453-4057qib7	9619	17	CD8	CD8	NNP
cord-005453-4057qib7	9619	18	,	,	,
cord-005453-4057qib7	9619	19	TCRγδ	TCRγδ	NNP
cord-005453-4057qib7	9619	20	,	,	,
cord-005453-4057qib7	9619	21	TCRVδ1	TCRVδ1	NNP
cord-005453-4057qib7	9619	22	,	,	,
cord-005453-4057qib7	9619	23	TCRVδ2	TCRVδ2	NNP
cord-005453-4057qib7	9619	24	,	,	,
cord-005453-4057qib7	9619	25	HLA	HLA	NNP
cord-005453-4057qib7	9619	26	-	-	HYPH
cord-005453-4057qib7	9619	27	DR	DR	NNP
cord-005453-4057qib7	9619	28	,	,	,
cord-005453-4057qib7	9619	29	NKG2D	NKG2D	NNP
cord-005453-4057qib7	9619	30	,	,	,
cord-005453-4057qib7	9619	31	CXCR4	CXCR4	NNP
cord-005453-4057qib7	9619	32	,	,	,
cord-005453-4057qib7	9619	33	CCR5	CCR5	NNP
cord-005453-4057qib7	9619	34	,	,	,
cord-005453-4057qib7	9619	35	PD1	PD1	NNP
cord-005453-4057qib7	9619	36	,	,	,
cord-005453-4057qib7	9619	37	ki67	ki67	NNP
cord-005453-4057qib7	9619	38	,	,	,
cord-005453-4057qib7	9619	39	IFNγ	IFNγ	NNS
cord-005453-4057qib7	9619	40	,	,	,
cord-005453-4057qib7	9619	41	TNFα	TNFα	NNS
cord-005453-4057qib7	9619	42	,	,	,
cord-005453-4057qib7	9619	43	and	and	CC
cord-005453-4057qib7	9619	44	IL-17	IL-17	NNP
cord-005453-4057qib7	9619	45	,	,	,
cord-005453-4057qib7	9619	46	was	be	VBD
cord-005453-4057qib7	9619	47	performed	perform	VBN
cord-005453-4057qib7	9619	48	using	use	VBG
cord-005453-4057qib7	9619	49	flow	flow	NN
cord-005453-4057qib7	9619	50	cytometry	cytometry	NN
cord-005453-4057qib7	9619	51	.	.	.
cord-005453-4057qib7	9620	1	For	for	IN
cord-005453-4057qib7	9620	2	detection	detection	NN
cord-005453-4057qib7	9620	3	of	of	IN
cord-005453-4057qib7	9620	4	the	the	DT
cord-005453-4057qib7	9620	5	intracellular	intracellular	JJ
cord-005453-4057qib7	9620	6	cytokines	cytokine	NNS
cord-005453-4057qib7	9620	7	,	,	,
cord-005453-4057qib7	9620	8	BM	BM	NNP
cord-005453-4057qib7	9620	9	and	and	CC
cord-005453-4057qib7	9620	10	PB	PB	NNP
cord-005453-4057qib7	9620	11	grafts	graft	NNS
cord-005453-4057qib7	9620	12	were	be	VBD
cord-005453-4057qib7	9620	13	pre	pre	JJ
cord-005453-4057qib7	9620	14	-	-	JJ
cord-005453-4057qib7	9620	15	stimulated	stimulate	VBN
cord-005453-4057qib7	9621	1	with	with	IN
cord-005453-4057qib7	9621	2	1x	1x	CD
cord-005453-4057qib7	9621	3	Cell	Cell	NNP
cord-005453-4057qib7	9621	4	Stimulation	stimulation	NN
cord-005453-4057qib7	9621	5	Cocktail	cocktail	NN
cord-005453-4057qib7	9621	6	(	(	-LRB-
cord-005453-4057qib7	9621	7	500x	500x	NNPS
cord-005453-4057qib7	9621	8	,	,	,
cord-005453-4057qib7	9621	9	eBioscience	eBioscience	NNP
cord-005453-4057qib7	9621	10	)	)	-RRB-
cord-005453-4057qib7	9621	11	.	.	.
cord-005453-4057qib7	9622	1	CMV	CMV	NNP
cord-005453-4057qib7	9622	2	DNA	DNA	NNP
cord-005453-4057qib7	9622	3	in	in	IN
cord-005453-4057qib7	9622	4	the	the	DT
cord-005453-4057qib7	9622	5	peripheral	peripheral	JJ
cord-005453-4057qib7	9622	6	blood	blood	NN
cord-005453-4057qib7	9622	7	of	of	IN
cord-005453-4057qib7	9622	8	recipients	recipient	NNS
cord-005453-4057qib7	9622	9	was	be	VBD
cord-005453-4057qib7	9622	10	routinely	routinely	RB
cord-005453-4057qib7	9622	11	monitored	monitor	VBN
cord-005453-4057qib7	9622	12	by	by	IN
cord-005453-4057qib7	9622	13	quantitative	quantitative	JJ
cord-005453-4057qib7	9622	14	PCR	PCR	NNP
cord-005453-4057qib7	9622	15	.	.	.
cord-005453-4057qib7	9623	1	The	the	DT
cord-005453-4057qib7	9623	2	association	association	NN
cord-005453-4057qib7	9623	3	of	of	IN
cord-005453-4057qib7	9623	4	γδ	γδ	NNP
cord-005453-4057qib7	9623	5	T	T	NNP
cord-005453-4057qib7	9623	6	-	-	HYPH
cord-005453-4057qib7	9623	7	cell	cell	NN
cord-005453-4057qib7	9623	8	contents	content	NNS
cord-005453-4057qib7	9623	9	in	in	IN
cord-005453-4057qib7	9623	10	allografts	allograft	NNS
cord-005453-4057qib7	9623	11	with	with	IN
cord-005453-4057qib7	9623	12	CMV	CMV	NNP
cord-005453-4057qib7	9623	13	reactivation	reactivation	NN
cord-005453-4057qib7	9623	14	in	in	IN
cord-005453-4057qib7	9623	15	haploHSCT	haploHSCT	NNP
cord-005453-4057qib7	9623	16	recipients	recipient	NNS
cord-005453-4057qib7	9623	17	was	be	VBD
cord-005453-4057qib7	9623	18	analyzed	analyze	VBN
cord-005453-4057qib7	9623	19	using	use	VBG
cord-005453-4057qib7	9623	20	the	the	DT
cord-005453-4057qib7	9623	21	Mann	Mann	NNP
cord-005453-4057qib7	9623	22	-	-	HYPH
cord-005453-4057qib7	9623	23	Whitney	Whitney	NNP
cord-005453-4057qib7	9623	24	U	U	NNP
cord-005453-4057qib7	9623	25	test	test	NN
cord-005453-4057qib7	9623	26	and	and	CC
cord-005453-4057qib7	9623	27	Spearman	Spearman	NNP
cord-005453-4057qib7	9623	28	test	test	NN
cord-005453-4057qib7	9623	29	.	.	.
cord-005453-4057qib7	9624	1	All	all	DT
cord-005453-4057qib7	9624	2	calculations	calculation	NNS
cord-005453-4057qib7	9624	3	were	be	VBD
cord-005453-4057qib7	9624	4	performed	perform	VBN
cord-005453-4057qib7	9624	5	using	use	VBG
cord-005453-4057qib7	9624	6	SPSS	SPSS	NNP
cord-005453-4057qib7	9624	7	22.0	22.0	CD
cord-005453-4057qib7	9624	8	statistical	statistical	JJ
cord-005453-4057qib7	9624	9	software	software	NN
cord-005453-4057qib7	9624	10	.	.	.
cord-005453-4057qib7	9625	1	Results	result	NNS
cord-005453-4057qib7	9625	2	:	:	:
cord-005453-4057qib7	9626	1	We	-PRON-	PRP
cord-005453-4057qib7	9626	2	found	find	VBD
cord-005453-4057qib7	9626	3	that	that	IN
cord-005453-4057qib7	9626	4	the	the	DT
cord-005453-4057qib7	9626	5	proportions	proportion	NNS
cord-005453-4057qib7	9626	6	of	of	IN
cord-005453-4057qib7	9626	7	total	total	NN
cord-005453-4057qib7	9626	8	γδ	γδ	NN
cord-005453-4057qib7	9626	9	T	t	NN
cord-005453-4057qib7	9626	10	cells	cell	NNS
cord-005453-4057qib7	9626	11	,	,	,
cord-005453-4057qib7	9626	12	and	and	CC
cord-005453-4057qib7	9626	13	Vδ1	vδ1	NN
cord-005453-4057qib7	9626	14	and	and	CC
cord-005453-4057qib7	9626	15	Vδ2	vδ2	JJ
cord-005453-4057qib7	9626	16	subsets	subset	NNS
cord-005453-4057qib7	9626	17	in	in	IN
cord-005453-4057qib7	9626	18	both	both	DT
cord-005453-4057qib7	9626	19	BM	BM	NNP
cord-005453-4057qib7	9626	20	and	and	CC
cord-005453-4057qib7	9626	21	PB	PB	NNP
cord-005453-4057qib7	9626	22	grafts	graft	NNS
cord-005453-4057qib7	9626	23	for	for	IN
cord-005453-4057qib7	9626	24	CMV+	CMV+	NNP
cord-005453-4057qib7	9626	25	and	and	CC
cord-005453-4057qib7	9626	26	CMV	CMV	NNP
cord-005453-4057qib7	9626	27	-	-	HYPH
cord-005453-4057qib7	9626	28	recipients	recipient	NNS
cord-005453-4057qib7	9626	29	were	be	VBD
cord-005453-4057qib7	9626	30	comparable	comparable	JJ
cord-005453-4057qib7	9626	31	.	.	.
cord-005453-4057qib7	9627	1	Neither	neither	CC
cord-005453-4057qib7	9627	2	the	the	DT
cord-005453-4057qib7	9627	3	expression	expression	NN
cord-005453-4057qib7	9627	4	of	of	IN
cord-005453-4057qib7	9627	5	HLA	HLA	NNP
cord-005453-4057qib7	9627	6	-	-	HYPH
cord-005453-4057qib7	9627	7	DR	DR	NNP
cord-005453-4057qib7	9627	8	nor	nor	CC
cord-005453-4057qib7	9627	9	NKG2D	nkg2d	NN
cord-005453-4057qib7	9627	10	in	in	IN
cord-005453-4057qib7	9627	11	the	the	DT
cord-005453-4057qib7	9627	12	allografts	allograft	NNS
cord-005453-4057qib7	9627	13	were	be	VBD
cord-005453-4057qib7	9627	14	significantly	significantly	RB
cord-005453-4057qib7	9627	15	different	different	JJ
cord-005453-4057qib7	9627	16	in	in	IN
cord-005453-4057qib7	9627	17	correlation	correlation	NN
cord-005453-4057qib7	9627	18	to	to	IN
cord-005453-4057qib7	9627	19	CMV	CMV	NNP
cord-005453-4057qib7	9627	20	reactivation	reactivation	NN
cord-005453-4057qib7	9627	21	after	after	IN
cord-005453-4057qib7	9627	22	HSCT	HSCT	NNP
cord-005453-4057qib7	9627	23	.	.	.
cord-005453-4057qib7	9628	1	The	the	DT
cord-005453-4057qib7	9628	2	productions	production	NNS
cord-005453-4057qib7	9628	3	of	of	IN
cord-005453-4057qib7	9628	4	intracellular	intracellular	JJ
cord-005453-4057qib7	9628	5	cytokines	cytokine	NNS
cord-005453-4057qib7	9628	6	of	of	IN
cord-005453-4057qib7	9628	7	γδ	γδ	NN
cord-005453-4057qib7	9628	8	T	T	NNP
cord-005453-4057qib7	9628	9	subsets	subset	NNS
cord-005453-4057qib7	9628	10	did	do	VBD
cord-005453-4057qib7	9628	11	not	not	RB
cord-005453-4057qib7	9628	12	varied	varied	JJ
cord-005453-4057qib7	9628	13	in	in	IN
cord-005453-4057qib7	9628	14	BM	BM	NNP
cord-005453-4057qib7	9628	15	and	and	CC
cord-005453-4057qib7	9628	16	PB	PB	NNP
cord-005453-4057qib7	9628	17	grafts	graft	NNS
cord-005453-4057qib7	9628	18	for	for	IN
cord-005453-4057qib7	9628	19	CMV+	CMV+	NNP
cord-005453-4057qib7	9628	20	and	and	CC
cord-005453-4057qib7	9628	21	CMV	CMV	NNP
cord-005453-4057qib7	9628	22	-	-	HYPH
cord-005453-4057qib7	9628	23	recipients	recipient	NNS
cord-005453-4057qib7	9628	24	.	.	.
cord-005453-4057qib7	9629	1	Interestingly	interestingly	RB
cord-005453-4057qib7	9629	2	,	,	,
cord-005453-4057qib7	9629	3	the	the	DT
cord-005453-4057qib7	9629	4	proportions	proportion	NNS
cord-005453-4057qib7	9629	5	of	of	IN
cord-005453-4057qib7	9629	6	CXCR4+Vδ1	CXCR4+Vδ1	NNP
cord-005453-4057qib7	9629	7	and	and	CC
cord-005453-4057qib7	9629	8	CCR5+Vδ1	ccr5+vδ1	JJ
cord-005453-4057qib7	9629	9	cells	cell	NNS
cord-005453-4057qib7	9629	10	in	in	IN
cord-005453-4057qib7	9629	11	BM	BM	NNP
cord-005453-4057qib7	9629	12	grafts	graft	NNS
cord-005453-4057qib7	9629	13	for	for	IN
cord-005453-4057qib7	9629	14	CMV	CMV	NNP
cord-005453-4057qib7	9629	15	+	+	CC
cord-005453-4057qib7	9629	16	recipients	recipient	NNS
cord-005453-4057qib7	9629	17	were	be	VBD
cord-005453-4057qib7	9629	18	significantly	significantly	RB
cord-005453-4057qib7	9629	19	higher	high	JJR
cord-005453-4057qib7	9629	20	than	than	IN
cord-005453-4057qib7	9629	21	those	those	DT
cord-005453-4057qib7	9629	22	for	for	IN
cord-005453-4057qib7	9629	23	CMVrecipients	cmvrecipient	NNS
cord-005453-4057qib7	9629	24	(	(	-LRB-
cord-005453-4057qib7	9629	25	P	p	NN
cord-005453-4057qib7	9629	26	=	=	SYM
cord-005453-4057qib7	9629	27	0.012	0.012	CD
cord-005453-4057qib7	9629	28	and	and	CC
cord-005453-4057qib7	9629	29	0.045	0.045	CD
cord-005453-4057qib7	9629	30	,	,	,
cord-005453-4057qib7	9629	31	respectively	respectively	RB
cord-005453-4057qib7	9629	32	)	)	-RRB-
cord-005453-4057qib7	9629	33	.	.	.
cord-005453-4057qib7	9630	1	Meanwhile	meanwhile	RB
cord-005453-4057qib7	9630	2	,	,	,
cord-005453-4057qib7	9630	3	PMA	PMA	NNP
cord-005453-4057qib7	9630	4	-	-	HYPH
cord-005453-4057qib7	9630	5	stimulated	stimulate	VBN
cord-005453-4057qib7	9630	6	ki67+Vδ1	ki67+vδ1	JJ
cord-005453-4057qib7	9630	7	cells	cell	NNS
cord-005453-4057qib7	9630	8	in	in	IN
cord-005453-4057qib7	9630	9	BM	BM	NNP
cord-005453-4057qib7	9630	10	grafts	graft	NNS
cord-005453-4057qib7	9630	11	for	for	IN
cord-005453-4057qib7	9630	12	CMV+	CMV+	NNP
cord-005453-4057qib7	9630	13	recipients	recipient	NNS
cord-005453-4057qib7	9630	14	were	be	VBD
cord-005453-4057qib7	9630	15	less	less	JJR
cord-005453-4057qib7	9630	16	than	than	IN
cord-005453-4057qib7	9630	17	those	those	DT
cord-005453-4057qib7	9630	18	for	for	IN
cord-005453-4057qib7	9630	19	CMV	CMV	NNP
cord-005453-4057qib7	9630	20	-	-	HYPH
cord-005453-4057qib7	9630	21	recipients	recipient	NNS
cord-005453-4057qib7	9630	22	(	(	-LRB-
cord-005453-4057qib7	9630	23	P	p	NN
cord-005453-4057qib7	9630	24	=	=	SYM
cord-005453-4057qib7	9630	25	0.039	0.039	CD
cord-005453-4057qib7	9630	26	)	)	-RRB-
cord-005453-4057qib7	9630	27	.	.	.
cord-005453-4057qib7	9631	1	In	in	IN
cord-005453-4057qib7	9631	2	parallel	parallel	NN
cord-005453-4057qib7	9631	3	,	,	,
cord-005453-4057qib7	9631	4	the	the	DT
cord-005453-4057qib7	9631	5	concentration	concentration	NN
cord-005453-4057qib7	9631	6	of	of	IN
cord-005453-4057qib7	9631	7	PD1+Vδ1	pd1+vδ1	JJ
cord-005453-4057qib7	9631	8	cells	cell	NNS
cord-005453-4057qib7	9631	9	in	in	IN
cord-005453-4057qib7	9631	10	PB	PB	NNP
cord-005453-4057qib7	9631	11	grafts	graft	NNS
cord-005453-4057qib7	9631	12	for	for	IN
cord-005453-4057qib7	9631	13	CMV+	CMV+	NNP
cord-005453-4057qib7	9631	14	recipients	recipient	NNS
cord-005453-4057qib7	9631	15	were	be	VBD
cord-005453-4057qib7	9631	16	significantly	significantly	RB
cord-005453-4057qib7	9631	17	higher	high	JJR
cord-005453-4057qib7	9631	18	than	than	IN
cord-005453-4057qib7	9631	19	those	those	DT
cord-005453-4057qib7	9631	20	for	for	IN
cord-005453-4057qib7	9631	21	CMV	CMV	NNP
cord-005453-4057qib7	9631	22	-	-	HYPH
cord-005453-4057qib7	9631	23	recipients	recipient	NNS
cord-005453-4057qib7	9631	24	(	(	-LRB-
cord-005453-4057qib7	9631	25	P	p	NN
cord-005453-4057qib7	9631	26	=	=	SYM
cord-005453-4057qib7	9631	27	0.023	0.023	CD
cord-005453-4057qib7	9631	28	)	)	-RRB-
cord-005453-4057qib7	9631	29	.	.	.
cord-005453-4057qib7	9632	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9632	2	:	:	:
cord-005453-4057qib7	9633	1	This	this	DT
cord-005453-4057qib7	9633	2	study	study	NN
cord-005453-4057qib7	9633	3	is	be	VBZ
cord-005453-4057qib7	9633	4	the	the	DT
cord-005453-4057qib7	9633	5	first	first	JJ
cord-005453-4057qib7	9633	6	to	to	TO
cord-005453-4057qib7	9633	7	connect	connect	VB
cord-005453-4057qib7	9633	8	the	the	DT
cord-005453-4057qib7	9633	9	chemotaxis	chemotaxis	NN
cord-005453-4057qib7	9633	10	and	and	CC
cord-005453-4057qib7	9633	11	exhaustion	exhaustion	NN
cord-005453-4057qib7	9633	12	of	of	IN
cord-005453-4057qib7	9633	13	γδ	γδ	NN
cord-005453-4057qib7	9633	14	T	t	NN
cord-005453-4057qib7	9633	15	cells	cell	NNS
cord-005453-4057qib7	9633	16	in	in	IN
cord-005453-4057qib7	9633	17	grafts	graft	NNS
cord-005453-4057qib7	9633	18	to	to	IN
cord-005453-4057qib7	9633	19	the	the	DT
cord-005453-4057qib7	9633	20	risk	risk	NN
cord-005453-4057qib7	9633	21	of	of	IN
cord-005453-4057qib7	9633	22	CMV	CMV	NNP
cord-005453-4057qib7	9633	23	infection	infection	NN
cord-005453-4057qib7	9633	24	after	after	IN
cord-005453-4057qib7	9633	25	allogeneic	allogeneic	NN
cord-005453-4057qib7	9633	26	HSCT	HSCT	NNP
cord-005453-4057qib7	9633	27	.	.	.
cord-005453-4057qib7	9634	1	Future	future	JJ
cord-005453-4057qib7	9634	2	studies	study	NNS
cord-005453-4057qib7	9634	3	should	should	MD
cord-005453-4057qib7	9634	4	explore	explore	VB
cord-005453-4057qib7	9634	5	how	how	WRB
cord-005453-4057qib7	9634	6	the	the	DT
cord-005453-4057qib7	9634	7	expressions	expression	NNS
cord-005453-4057qib7	9634	8	of	of	IN
cord-005453-4057qib7	9634	9	chemokines	chemokine	NNS
cord-005453-4057qib7	9634	10	and	and	CC
cord-005453-4057qib7	9634	11	exhaustion	exhaustion	NN
cord-005453-4057qib7	9634	12	marker	marker	NN
cord-005453-4057qib7	9634	13	on	on	IN
cord-005453-4057qib7	9634	14	the	the	DT
cord-005453-4057qib7	9634	15	effector	effector	NN
cord-005453-4057qib7	9634	16	γδ	γδ	IN
cord-005453-4057qib7	9634	17	T	T	NNP
cord-005453-4057qib7	9634	18	cells	cell	NNS
cord-005453-4057qib7	9634	19	in	in	IN
cord-005453-4057qib7	9634	20	allografts	allograft	NNS
cord-005453-4057qib7	9634	21	facilitate	facilitate	VBP
cord-005453-4057qib7	9634	22	CMV	CMV	NNP
cord-005453-4057qib7	9634	23	replication	replication	NN
cord-005453-4057qib7	9634	24	and/or	and/or	CC
cord-005453-4057qib7	9634	25	dissemination	dissemination	NN
cord-005453-4057qib7	9634	26	in	in	IN
cord-005453-4057qib7	9634	27	the	the	DT
cord-005453-4057qib7	9634	28	setting	setting	NN
cord-005453-4057qib7	9634	29	of	of	IN
cord-005453-4057qib7	9634	30	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9634	31	transplantation	transplantation	NN
cord-005453-4057qib7	9634	32	.	.	.
cord-005453-4057qib7	9635	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9635	2	:	:	:
cord-005453-4057qib7	9636	1	All	all	DT
cord-005453-4057qib7	9636	2	authors	author	NNS
cord-005453-4057qib7	9636	3	do	do	VBP
cord-005453-4057qib7	9636	4	not	not	RB
cord-005453-4057qib7	9636	5	have	have	VB
cord-005453-4057qib7	9636	6	conflicts	conflict	NNS
cord-005453-4057qib7	9636	7	of	of	IN
cord-005453-4057qib7	9636	8	interest	interest	NN
cord-005453-4057qib7	9636	9	.	.	.
cord-005453-4057qib7	9637	1	This	this	DT
cord-005453-4057qib7	9637	2	study	study	NN
cord-005453-4057qib7	9637	3	is	be	VBZ
cord-005453-4057qib7	9637	4	supported	support	VBN
cord-005453-4057qib7	9637	5	by	by	IN
cord-005453-4057qib7	9637	6	the	the	DT
cord-005453-4057qib7	9637	7	National	National	NNP
cord-005453-4057qib7	9637	8	Natural	Natural	NNP
cord-005453-4057qib7	9637	9	Science	Science	NNP
cord-005453-4057qib7	9637	10	Foundation	Foundation	NNP
cord-005453-4057qib7	9637	11	of	of	IN
cord-005453-4057qib7	9637	12	China	China	NNP
cord-005453-4057qib7	9637	13	(	(	-LRB-
cord-005453-4057qib7	9637	14	Grants	grant	NNS
cord-005453-4057qib7	9637	15	No.81770191	No.81770191	NNP
cord-005453-4057qib7	9637	16	and	and	CC
cord-005453-4057qib7	9637	17	No.81670167	No.81670167	NNP
cord-005453-4057qib7	9637	18	)	)	-RRB-
cord-005453-4057qib7	9638	1	Results	result	NNS
cord-005453-4057qib7	9638	2	:	:	:
cord-005453-4057qib7	9639	1	Incidence	incidence	NN
cord-005453-4057qib7	9639	2	of	of	IN
cord-005453-4057qib7	9639	3	IC	IC	NNP
cord-005453-4057qib7	9639	4	was	be	VBD
cord-005453-4057qib7	9639	5	2,9	2,9	CD
cord-005453-4057qib7	9639	6	%	%	NN
cord-005453-4057qib7	9639	7	:	:	:
cord-005453-4057qib7	9639	8	allo	allo	NN
cord-005453-4057qib7	9639	9	-	-	HYPH
cord-005453-4057qib7	9639	10	HSCT	HSCT	NNP
cord-005453-4057qib7	9639	11	-3	-3	NNP
cord-005453-4057qib7	9639	12	%	%	NN
cord-005453-4057qib7	9639	13	(	(	-LRB-
cord-005453-4057qib7	9639	14	n=15	n=15	NNP
cord-005453-4057qib7	9639	15	)	)	-RRB-
cord-005453-4057qib7	9639	16	,	,	,
cord-005453-4057qib7	9639	17	auto	auto	NN
cord-005453-4057qib7	9639	18	-	-	HYPH
cord-005453-4057qib7	9639	19	HSCT	HSCT	NNP
cord-005453-4057qib7	9639	20	-2,7	-2,7	NN
cord-005453-4057qib7	9639	21	%	%	NN
cord-005453-4057qib7	9639	22	(	(	-LRB-
cord-005453-4057qib7	9639	23	n=7	n=7	NN
cord-005453-4057qib7	9639	24	)	)	-RRB-
cord-005453-4057qib7	9639	25	.	.	.
cord-005453-4057qib7	9640	1	The	the	DT
cord-005453-4057qib7	9640	2	etiology	etiology	NN
cord-005453-4057qib7	9640	3	:	:	:
cord-005453-4057qib7	9640	4	C.	C.	NNP
cord-005453-4057qib7	9640	5	parapsilosis	parapsilosis	NNP
cord-005453-4057qib7	9640	6	50	50	CD
cord-005453-4057qib7	9640	7	%	%	NN
cord-005453-4057qib7	9640	8	,	,	,
cord-005453-4057qib7	9640	9	C.	C.	NNP
cord-005453-4057qib7	9640	10	albicans	albican	NNS
cord-005453-4057qib7	9640	11	27	27	CD
cord-005453-4057qib7	9640	12	%	%	NN
cord-005453-4057qib7	9640	13	,	,	,
cord-005453-4057qib7	9640	14	C.	C.	NNP
cord-005453-4057qib7	9640	15	krusei	krusei	NNP
cord-005453-4057qib7	9640	16	14	14	CD
cord-005453-4057qib7	9640	17	%	%	NN
cord-005453-4057qib7	9640	18	,	,	,
cord-005453-4057qib7	9640	19	Candida	Candida	NNP
cord-005453-4057qib7	9640	20	tropicalis	tropicalis	NNP
cord-005453-4057qib7	9640	21	5	5	CD
cord-005453-4057qib7	9640	22	%	%	NN
cord-005453-4057qib7	9640	23	,	,	,
cord-005453-4057qib7	9640	24	Candida	Candida	NNP
cord-005453-4057qib7	9640	25	dubliniensis	dubliniensis	NN
cord-005453-4057qib7	9640	26	4	4	CD
cord-005453-4057qib7	9640	27	%	%	NN
cord-005453-4057qib7	9640	28	.	.	.
cord-005453-4057qib7	9641	1	The	the	DT
cord-005453-4057qib7	9641	2	most	most	RBS
cord-005453-4057qib7	9641	3	frequent	frequent	JJ
cord-005453-4057qib7	9641	4	underlying	underlie	VBG
cord-005453-4057qib7	9641	5	diseases	disease	NNS
cord-005453-4057qib7	9641	6	was	be	VBD
cord-005453-4057qib7	9641	7	acute	acute	JJ
cord-005453-4057qib7	9641	8	leukemia	leukemia	NN
cord-005453-4057qib7	9641	9	-45	-45	NNP
cord-005453-4057qib7	9641	10	%	%	NN
cord-005453-4057qib7	9641	11	(	(	-LRB-
cord-005453-4057qib7	9641	12	n=10	n=10	NNP
cord-005453-4057qib7	9641	13	)	)	-RRB-
cord-005453-4057qib7	9641	14	.	.	.
cord-005453-4057qib7	9642	1	The	the	DT
cord-005453-4057qib7	9642	2	median	median	JJ
cord-005453-4057qib7	9642	3	age	age	NN
cord-005453-4057qib7	9642	4	was	be	VBD
cord-005453-4057qib7	9642	5	8	8	CD
cord-005453-4057qib7	9642	6	y.o	y.o	NNP
cord-005453-4057qib7	9642	7	.	.	.
cord-005453-4057qib7	9643	1	[	[	-LRB-
cord-005453-4057qib7	9643	2	3	3	CD
cord-005453-4057qib7	9643	3	month	month	NN
cord-005453-4057qib7	9643	4	-18	-18	SYM
cord-005453-4057qib7	9643	5	years	year	NNS
cord-005453-4057qib7	9643	6	]	]	-RRB-
cord-005453-4057qib7	9643	7	.	.	.
cord-005453-4057qib7	9644	1	The	the	DT
cord-005453-4057qib7	9644	2	median	median	JJ
cord-005453-4057qib7	9644	3	day	day	NN
cord-005453-4057qib7	9644	4	of	of	IN
cord-005453-4057qib7	9644	5	onset	onset	NN
cord-005453-4057qib7	9644	6	of	of	IN
cord-005453-4057qib7	9644	7	IC	IC	NNP
cord-005453-4057qib7	9644	8	after	after	IN
cord-005453-4057qib7	9644	9	allo	allo	NN
cord-005453-4057qib7	9644	10	-	-	HYPH
cord-005453-4057qib7	9644	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9644	12	was	be	VBD
cord-005453-4057qib7	9644	13	63	63	CD
cord-005453-4057qib7	9644	14	,	,	,
cord-005453-4057qib7	9644	15	auto	auto	NN
cord-005453-4057qib7	9644	16	-	-	HYPH
cord-005453-4057qib7	9644	17	HSCT	HSCT	NNP
cord-005453-4057qib7	9644	18	-12	-12	:
cord-005453-4057qib7	9644	19	[	[	-LRB-
cord-005453-4057qib7	9644	20	3	3	CD
cord-005453-4057qib7	9644	21	]	]	-RRB-
cord-005453-4057qib7	9644	22	[	[	-LRB-
cord-005453-4057qib7	9644	23	4	4	CD
cord-005453-4057qib7	9644	24	]	]	-RRB-
cord-005453-4057qib7	9644	25	[	[	-LRB-
cord-005453-4057qib7	9644	26	5	5	CD
cord-005453-4057qib7	9644	27	]	]	-RRB-
cord-005453-4057qib7	9644	28	[	[	-LRB-
cord-005453-4057qib7	9644	29	6	6	CD
cord-005453-4057qib7	9644	30	]	]	-RRB-
cord-005453-4057qib7	9644	31	[	[	-LRB-
cord-005453-4057qib7	9644	32	7	7	CD
cord-005453-4057qib7	9644	33	]	]	-RRB-
cord-005453-4057qib7	9645	1	[	[	-LRB-
cord-005453-4057qib7	9645	2	8	8	CD
cord-005453-4057qib7	9645	3	]	]	-RRB-
cord-005453-4057qib7	9645	4	[	[	-LRB-
cord-005453-4057qib7	9645	5	9	9	CD
cord-005453-4057qib7	9645	6	]	]	-RRB-
cord-005453-4057qib7	9645	7	[	[	-LRB-
cord-005453-4057qib7	9645	8	10	10	CD
cord-005453-4057qib7	9645	9	]	]	-RRB-
cord-005453-4057qib7	9645	10	[	[	-LRB-
cord-005453-4057qib7	9645	11	11	11	CD
cord-005453-4057qib7	9645	12	]	]	-RRB-
cord-005453-4057qib7	9646	1	[	[	-LRB-
cord-005453-4057qib7	9646	2	12	12	CD
cord-005453-4057qib7	9646	3	]	]	-RRB-
cord-005453-4057qib7	9646	4	[	[	-LRB-
cord-005453-4057qib7	9646	5	13	13	CD
cord-005453-4057qib7	9646	6	]	]	-RRB-
cord-005453-4057qib7	9647	1	[	[	-LRB-
cord-005453-4057qib7	9647	2	14	14	CD
cord-005453-4057qib7	9647	3	]	]	-RRB-
cord-005453-4057qib7	9648	1	[	[	-LRB-
cord-005453-4057qib7	9648	2	15	15	CD
cord-005453-4057qib7	9648	3	]	]	-RRB-
cord-005453-4057qib7	9648	4	[	[	-LRB-
cord-005453-4057qib7	9648	5	16	16	CD
cord-005453-4057qib7	9648	6	]	]	-RRB-
cord-005453-4057qib7	9648	7	[	[	-LRB-
cord-005453-4057qib7	9648	8	17	17	CD
cord-005453-4057qib7	9648	9	]	]	-RRB-
cord-005453-4057qib7	9648	10	[	[	-LRB-
cord-005453-4057qib7	9648	11	18	18	CD
cord-005453-4057qib7	9648	12	]	]	-RRB-
cord-005453-4057qib7	9648	13	[	[	-LRB-
cord-005453-4057qib7	9648	14	19	19	CD
cord-005453-4057qib7	9648	15	]	]	-RRB-
cord-005453-4057qib7	9648	16	[	[	-LRB-
cord-005453-4057qib7	9648	17	20	20	CD
cord-005453-4057qib7	9648	18	]	]	-RRB-
cord-005453-4057qib7	9648	19	.	.	.
cord-005453-4057qib7	9649	1	Febrile	febrile	JJ
cord-005453-4057qib7	9649	2	fever	fever	NN
cord-005453-4057qib7	9649	3	was	be	VBD
cord-005453-4057qib7	9649	4	the	the	DT
cord-005453-4057qib7	9649	5	main	main	JJ
cord-005453-4057qib7	9649	6	clinical	clinical	JJ
cord-005453-4057qib7	9649	7	symptom	symptom	NN
cord-005453-4057qib7	9649	8	;	;	:
cord-005453-4057qib7	9649	9	septic	septic	JJ
cord-005453-4057qib7	9649	10	syndrome	syndrome	NN
cord-005453-4057qib7	9649	11	develops	develop	VBZ
cord-005453-4057qib7	9649	12	in	in	IN
cord-005453-4057qib7	9649	13	32	32	CD
cord-005453-4057qib7	9649	14	%	%	NN
cord-005453-4057qib7	9649	15	cases	case	NNS
cord-005453-4057qib7	9649	16	.	.	.
cord-005453-4057qib7	9650	1	Antifungal	antifungal	JJ
cord-005453-4057qib7	9650	2	therapy	therapy	NN
cord-005453-4057qib7	9650	3	was	be	VBD
cord-005453-4057qib7	9650	4	with	with	IN
cord-005453-4057qib7	9650	5	echinocandins	echinocandin	NNS
cord-005453-4057qib7	9650	6	-23	-23	CD
cord-005453-4057qib7	9650	7	%	%	NN
cord-005453-4057qib7	9650	8	,	,	,
cord-005453-4057qib7	9650	9	lipid	lipid	NN
cord-005453-4057qib7	9650	10	ampho	ampho	NN
cord-005453-4057qib7	9650	11	B	b	NN
cord-005453-4057qib7	9651	1	-27	-27	CD
cord-005453-4057qib7	9651	2	%	%	NN
cord-005453-4057qib7	9651	3	,	,	,
cord-005453-4057qib7	9651	4	azoles	azoles	NNP
cord-005453-4057qib7	9651	5	(	(	-LRB-
cord-005453-4057qib7	9651	6	fluconazole	fluconazole	NNP
cord-005453-4057qib7	9651	7	,	,	,
cord-005453-4057qib7	9651	8	voriconazole	voriconazole	NN
cord-005453-4057qib7	9651	9	)	)	-RRB-
cord-005453-4057qib7	9652	1	-32	-32	NN
cord-005453-4057qib7	9652	2	%	%	NN
cord-005453-4057qib7	9652	3	,	,	,
cord-005453-4057qib7	9652	4	without	without	IN
cord-005453-4057qib7	9652	5	therapy	therapy	NN
cord-005453-4057qib7	9652	6	(	(	-LRB-
cord-005453-4057qib7	9652	7	the	the	DT
cord-005453-4057qib7	9652	8	early	early	JJ
cord-005453-4057qib7	9652	9	mortality	mortality	NN
cord-005453-4057qib7	9652	10	)	)	-RRB-
cord-005453-4057qib7	9652	11	-18	-18	CD
cord-005453-4057qib7	9652	12	%	%	NN
cord-005453-4057qib7	9652	13	.	.	.
cord-005453-4057qib7	9653	1	Overall	overall	JJ
cord-005453-4057qib7	9653	2	survival	survival	NN
cord-005453-4057qib7	9653	3	(	(	-LRB-
cord-005453-4057qib7	9653	4	OS	OS	NNP
cord-005453-4057qib7	9653	5	)	)	-RRB-
cord-005453-4057qib7	9653	6	at	at	IN
cord-005453-4057qib7	9653	7	30	30	CD
cord-005453-4057qib7	9653	8	days	day	NNS
cord-005453-4057qib7	9653	9	from	from	IN
cord-005453-4057qib7	9653	10	diagnosis	diagnosis	NN
cord-005453-4057qib7	9653	11	of	of	IN
cord-005453-4057qib7	9653	12	invasive	invasive	JJ
cord-005453-4057qib7	9653	13	candidiasis	candidiasis	NN
cord-005453-4057qib7	9653	14	was	be	VBD
cord-005453-4057qib7	9653	15	50	50	CD
cord-005453-4057qib7	9653	16	%	%	NN
cord-005453-4057qib7	9653	17	.	.	.
cord-005453-4057qib7	9654	1	The	the	DT
cord-005453-4057qib7	9654	2	central	central	JJ
cord-005453-4057qib7	9654	3	venous	venous	JJ
cord-005453-4057qib7	9654	4	catheter	catheter	NN
cord-005453-4057qib7	9654	5	(	(	-LRB-
cord-005453-4057qib7	9654	6	CVC	CVC	NNP
cord-005453-4057qib7	9654	7	)	)	-RRB-
cord-005453-4057qib7	9654	8	removal	removal	NN
cord-005453-4057qib7	9654	9	was	be	VBD
cord-005453-4057qib7	9654	10	the	the	DT
cord-005453-4057qib7	9654	11	only	only	JJ
cord-005453-4057qib7	9654	12	factor	factor	NN
cord-005453-4057qib7	9654	13	significantly	significantly	RB
cord-005453-4057qib7	9654	14	improved	improve	VBD
cord-005453-4057qib7	9654	15	OS	OS	NNP
cord-005453-4057qib7	9654	16	(	(	-LRB-
cord-005453-4057qib7	9654	17	70	70	CD
cord-005453-4057qib7	9654	18	%	%	NN
cord-005453-4057qib7	9654	19	vs	vs	IN
cord-005453-4057qib7	9654	20	33	33	CD
cord-005453-4057qib7	9654	21	%	%	NN
cord-005453-4057qib7	9654	22	,	,	,
cord-005453-4057qib7	9654	23	p=0,035	p=0,035	NNP
cord-005453-4057qib7	9654	24	)	)	-RRB-
cord-005453-4057qib7	9654	25	.	.	.
cord-005453-4057qib7	9655	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9655	2	:	:	:
cord-005453-4057qib7	9656	1	Incidence	incidence	NN
cord-005453-4057qib7	9656	2	of	of	IN
cord-005453-4057qib7	9656	3	invasive	invasive	JJ
cord-005453-4057qib7	9656	4	candidiasis	candidiasi	NNS
cord-005453-4057qib7	9656	5	in	in	IN
cord-005453-4057qib7	9656	6	children	child	NNS
cord-005453-4057qib7	9656	7	after	after	IN
cord-005453-4057qib7	9656	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9656	9	stem	stem	NN
cord-005453-4057qib7	9656	10	cell	cell	NN
cord-005453-4057qib7	9656	11	transplantation	transplantation	NN
cord-005453-4057qib7	9656	12	was	be	VBD
cord-005453-4057qib7	9656	13	2.9	2.9	CD
cord-005453-4057qib7	9656	14	%	%	NN
cord-005453-4057qib7	9656	15	.	.	.
cord-005453-4057qib7	9657	1	The	the	DT
cord-005453-4057qib7	9657	2	main	main	JJ
cord-005453-4057qib7	9657	3	etiology	etiology	NN
cord-005453-4057qib7	9657	4	agent	agent	NN
cord-005453-4057qib7	9657	5	was	be	VBD
cord-005453-4057qib7	9657	6	C.	C.	NNP
cord-005453-4057qib7	9657	7	parapsilosis	parapsilosis	NNP
cord-005453-4057qib7	9657	8	.	.	.
cord-005453-4057qib7	9658	1	Invasive	invasive	JJ
cord-005453-4057qib7	9658	2	candidiasis	candidiasis	NN
cord-005453-4057qib7	9658	3	infections	infection	NNS
cord-005453-4057qib7	9658	4	most	most	RBS
cord-005453-4057qib7	9658	5	often	often	RB
cord-005453-4057qib7	9658	6	affect	affect	VBP
cord-005453-4057qib7	9658	7	leukemia	leukemia	NN
cord-005453-4057qib7	9658	8	patients	patient	NNS
cord-005453-4057qib7	9658	9	,	,	,
cord-005453-4057qib7	9658	10	developed	develop	VBN
cord-005453-4057qib7	9658	11	later	later	RB
cord-005453-4057qib7	9658	12	after	after	IN
cord-005453-4057qib7	9658	13	allo	allo	NN
cord-005453-4057qib7	9658	14	-	-	HYPH
cord-005453-4057qib7	9658	15	HSCT	HSCT	NNP
cord-005453-4057qib7	9658	16	than	than	IN
cord-005453-4057qib7	9658	17	auto	auto	NN
cord-005453-4057qib7	9658	18	-	-	HYPH
cord-005453-4057qib7	9658	19	HSCT	HSCT	NNP
cord-005453-4057qib7	9658	20	.	.	.
cord-005453-4057qib7	9659	1	Overall	overall	JJ
cord-005453-4057qib7	9659	2	survival	survival	NN
cord-005453-4057qib7	9659	3	at	at	IN
cord-005453-4057qib7	9659	4	30	30	CD
cord-005453-4057qib7	9659	5	days	day	NNS
cord-005453-4057qib7	9659	6	from	from	IN
cord-005453-4057qib7	9659	7	the	the	DT
cord-005453-4057qib7	9659	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	9659	9	was	be	VBD
cord-005453-4057qib7	9659	10	50	50	CD
cord-005453-4057qib7	9659	11	%	%	NN
cord-005453-4057qib7	9659	12	.	.	.
cord-005453-4057qib7	9660	1	Removing	remove	VBG
cord-005453-4057qib7	9660	2	of	of	IN
cord-005453-4057qib7	9660	3	CVC	CVC	NNP
cord-005453-4057qib7	9660	4	improved	improve	VBD
cord-005453-4057qib7	9660	5	overall	overall	JJ
cord-005453-4057qib7	9660	6	survival	survival	NN
cord-005453-4057qib7	9660	7	in	in	IN
cord-005453-4057qib7	9660	8	children	child	NNS
cord-005453-4057qib7	9660	9	with	with	IN
cord-005453-4057qib7	9660	10	invasive	invasive	JJ
cord-005453-4057qib7	9660	11	candida	candida	NN
cord-005453-4057qib7	9660	12	infections	infection	NNS
cord-005453-4057qib7	9660	13	after	after	IN
cord-005453-4057qib7	9660	14	HSCT	HSCT	NNP
cord-005453-4057qib7	9660	15	.	.	.
cord-005453-4057qib7	9661	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9661	2	:	:	:
cord-005453-4057qib7	9661	3	Nothing	nothing	NN
cord-005453-4057qib7	9661	4	to	to	TO
cord-005453-4057qib7	9661	5	declare	declare	VB
cord-005453-4057qib7	9661	6	Background	background	NN
cord-005453-4057qib7	9661	7	:	:	:
cord-005453-4057qib7	9661	8	Graft	graft	NN
cord-005453-4057qib7	9661	9	versus	versus	IN
cord-005453-4057qib7	9661	10	host	host	NN
cord-005453-4057qib7	9661	11	disease	disease	NN
cord-005453-4057qib7	9661	12	(	(	-LRB-
cord-005453-4057qib7	9661	13	GvHD	GvHD	NNP
cord-005453-4057qib7	9661	14	)	)	-RRB-
cord-005453-4057qib7	9661	15	and	and	CC
cord-005453-4057qib7	9661	16	virusassociated	virusassociate	VBD
cord-005453-4057qib7	9661	17	enteropathy	enteropathy	NNP
cord-005453-4057qib7	9661	18	in	in	IN
cord-005453-4057qib7	9661	19	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9661	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9661	21	stem	stem	NN
cord-005453-4057qib7	9661	22	cell	cell	NN
cord-005453-4057qib7	9661	23	transplantation	transplantation	NN
cord-005453-4057qib7	9661	24	(	(	-LRB-
cord-005453-4057qib7	9661	25	allo	allo	NN
cord-005453-4057qib7	9661	26	-	-	HYPH
cord-005453-4057qib7	9661	27	HSCT	HSCT	NNP
cord-005453-4057qib7	9661	28	)	)	-RRB-
cord-005453-4057qib7	9661	29	may	may	MD
cord-005453-4057qib7	9661	30	cause	cause	VB
cord-005453-4057qib7	9661	31	severe	severe	JJ
cord-005453-4057qib7	9661	32	quantitative	quantitative	JJ
cord-005453-4057qib7	9661	33	and	and	CC
cord-005453-4057qib7	9661	34	qualitative	qualitative	JJ
cord-005453-4057qib7	9661	35	composition	composition	NN
cord-005453-4057qib7	9661	36	changes	change	NNS
cord-005453-4057qib7	9661	37	of	of	IN
cord-005453-4057qib7	9661	38	intestinal	intestinal	JJ
cord-005453-4057qib7	9661	39	microbiota	microbiota	NN
cord-005453-4057qib7	9661	40	,	,	,
cord-005453-4057qib7	9661	41	leading	lead	VBG
cord-005453-4057qib7	9661	42	to	to	IN
cord-005453-4057qib7	9661	43	the	the	DT
cord-005453-4057qib7	9661	44	development	development	NN
cord-005453-4057qib7	9661	45	of	of	IN
cord-005453-4057qib7	9661	46	small	small	JJ
cord-005453-4057qib7	9661	47	intestinal	intestinal	JJ
cord-005453-4057qib7	9661	48	bacterial	bacterial	JJ
cord-005453-4057qib7	9661	49	overgrowth	overgrowth	NN
cord-005453-4057qib7	9661	50	(	(	-LRB-
cord-005453-4057qib7	9661	51	SIBO	SIBO	NNP
cord-005453-4057qib7	9661	52	)	)	-RRB-
cord-005453-4057qib7	9661	53	on	on	IN
cord-005453-4057qib7	9661	54	the	the	DT
cord-005453-4057qib7	9661	55	background	background	NN
cord-005453-4057qib7	9661	56	of	of	IN
cord-005453-4057qib7	9661	57	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	9661	58	,	,	,
cord-005453-4057qib7	9661	59	which	which	WDT
cord-005453-4057qib7	9661	60	can	can	MD
cord-005453-4057qib7	9661	61	have	have	VB
cord-005453-4057qib7	9661	62	a	a	DT
cord-005453-4057qib7	9661	63	negative	negative	JJ
cord-005453-4057qib7	9661	64	impact	impact	NN
cord-005453-4057qib7	9661	65	on	on	IN
cord-005453-4057qib7	9661	66	treatment	treatment	NN
cord-005453-4057qib7	9661	67	effectiveness	effectiveness	NN
cord-005453-4057qib7	9661	68	.	.	.
cord-005453-4057qib7	9662	1	The	the	DT
cord-005453-4057qib7	9662	2	gold	gold	NN
cord-005453-4057qib7	9662	3	standard	standard	NN
cord-005453-4057qib7	9662	4	for	for	IN
cord-005453-4057qib7	9662	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	9662	6	and	and	CC
cord-005453-4057qib7	9662	7	the	the	DT
cord-005453-4057qib7	9662	8	main	main	JJ
cord-005453-4057qib7	9662	9	criterion	criterion	NN
cord-005453-4057qib7	9662	10	for	for	IN
cord-005453-4057qib7	9662	11	SIBO	SIBO	NNP
cord-005453-4057qib7	9662	12	is	be	VBZ
cord-005453-4057qib7	9662	13	the	the	DT
cord-005453-4057qib7	9662	14	detection	detection	NN
cord-005453-4057qib7	9662	15	in	in	IN
cord-005453-4057qib7	9662	16	the	the	DT
cord-005453-4057qib7	9662	17	jejunum	jejunum	NN
cord-005453-4057qib7	9662	18	aspirate	aspirate	VB
cord-005453-4057qib7	9662	19	>	>	XX
cord-005453-4057qib7	9662	20	10	10	CD
cord-005453-4057qib7	9662	21	5	5	CD
cord-005453-4057qib7	9663	1	/ml	/ml	.
cord-005453-4057qib7	9664	1	bacteria	bacteria	NNS
cord-005453-4057qib7	9664	2	and/or	and/or	CC
cord-005453-4057qib7	9664	3	the	the	DT
cord-005453-4057qib7	9664	4	appearance	appearance	NN
cord-005453-4057qib7	9664	5	of	of	IN
cord-005453-4057qib7	9664	6	colonlike	colonlike	NNP
cord-005453-4057qib7	9664	7	microbiota	microbiota	NN
cord-005453-4057qib7	9664	8	in	in	IN
cord-005453-4057qib7	9664	9	small	small	JJ
cord-005453-4057qib7	9664	10	intestine	intestine	NN
cord-005453-4057qib7	9664	11	.	.	.
cord-005453-4057qib7	9665	1	It	-PRON-	PRP
cord-005453-4057qib7	9665	2	is	be	VBZ
cord-005453-4057qib7	9665	3	also	also	RB
cord-005453-4057qib7	9665	4	acceptable	acceptable	JJ
cord-005453-4057qib7	9665	5	to	to	TO
cord-005453-4057qib7	9665	6	use	use	VB
cord-005453-4057qib7	9665	7	an	an	DT
cord-005453-4057qib7	9665	8	alternative	alternative	JJ
cord-005453-4057qib7	9665	9	non	non	JJ
cord-005453-4057qib7	9665	10	-	-	JJ
cord-005453-4057qib7	9665	11	invasive	invasive	JJ
cord-005453-4057qib7	9665	12	technique	technique	NN
cord-005453-4057qib7	9665	13	-hydrogen	-hydrogen	NN
cord-005453-4057qib7	9665	14	breath	breath	NN
cord-005453-4057qib7	9665	15	test	test	NN
cord-005453-4057qib7	9665	16	,	,	,
cord-005453-4057qib7	9665	17	which	which	WDT
cord-005453-4057qib7	9665	18	could	could	MD
cord-005453-4057qib7	9665	19	be	be	VB
cord-005453-4057qib7	9665	20	especially	especially	RB
cord-005453-4057qib7	9665	21	important	important	JJ
cord-005453-4057qib7	9665	22	in	in	IN
cord-005453-4057qib7	9665	23	patients	patient	NNS
cord-005453-4057qib7	9665	24	with	with	IN
cord-005453-4057qib7	9665	25	severe	severe	JJ
cord-005453-4057qib7	9665	26	mucositis	mucositis	NN
cord-005453-4057qib7	9665	27	,	,	,
cord-005453-4057qib7	9665	28	grade	grade	NN
cord-005453-4057qib7	9665	29	III	III	NNP
cord-005453-4057qib7	9665	30	-	-	HYPH
cord-005453-4057qib7	9665	31	IV	IV	NNP
cord-005453-4057qib7	9665	32	and	and	CC
cord-005453-4057qib7	9665	33	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	9665	34	grade	grade	NN
cord-005453-4057qib7	9665	35	IV	IV	NNP
cord-005453-4057qib7	9665	36	.	.	.
cord-005453-4057qib7	9666	1	SIBO	SIBO	NNP
cord-005453-4057qib7	9666	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	9666	3	in	in	IN
cord-005453-4057qib7	9666	4	the	the	DT
cord-005453-4057qib7	9666	5	setting	setting	NN
cord-005453-4057qib7	9666	6	of	of	IN
cord-005453-4057qib7	9666	7	the	the	DT
cord-005453-4057qib7	9666	8	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	9666	9	tract	tract	NN
cord-005453-4057qib7	9666	10	damage	damage	NN
cord-005453-4057qib7	9666	11	and	and	CC
cord-005453-4057qib7	9666	12	dysfunction	dysfunction	NN
cord-005453-4057qib7	9666	13	in	in	IN
cord-005453-4057qib7	9666	14	patients	patient	NNS
cord-005453-4057qib7	9666	15	treated	treat	VBN
cord-005453-4057qib7	9666	16	with	with	IN
cord-005453-4057qib7	9666	17	allo	allo	NN
cord-005453-4057qib7	9666	18	-	-	HYPH
cord-005453-4057qib7	9666	19	HSCT	HSCT	NNP
cord-005453-4057qib7	9666	20	is	be	VBZ
cord-005453-4057qib7	9666	21	insufficiently	insufficiently	RB
cord-005453-4057qib7	9666	22	studied	study	VBN
cord-005453-4057qib7	9666	23	.	.	.
cord-005453-4057qib7	9667	1	Methods	method	NNS
cord-005453-4057qib7	9667	2	:	:	:
cord-005453-4057qib7	9668	1	The	the	DT
cord-005453-4057qib7	9668	2	study	study	NN
cord-005453-4057qib7	9668	3	included	include	VBD
cord-005453-4057qib7	9668	4	7	7	CD
cord-005453-4057qib7	9668	5	patients	patient	NNS
cord-005453-4057qib7	9668	6	with	with	IN
cord-005453-4057qib7	9668	7	acute	acute	JJ
cord-005453-4057qib7	9668	8	myeloid	myeloid	NN
cord-005453-4057qib7	9668	9	leukemia	leukemia	NN
cord-005453-4057qib7	9668	10	(	(	-LRB-
cord-005453-4057qib7	9668	11	n=3	n=3	NN
cord-005453-4057qib7	9668	12	)	)	-RRB-
cord-005453-4057qib7	9668	13	,	,	,
cord-005453-4057qib7	9668	14	acute	acute	JJ
cord-005453-4057qib7	9668	15	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	9668	16	leukemia	leukemia	NN
cord-005453-4057qib7	9668	17	(	(	-LRB-
cord-005453-4057qib7	9668	18	n=1	n=1	CD
cord-005453-4057qib7	9668	19	)	)	-RRB-
cord-005453-4057qib7	9668	20	,	,	,
cord-005453-4057qib7	9668	21	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	9668	22	syndrome	syndrome	NN
cord-005453-4057qib7	9668	23	(	(	-LRB-
cord-005453-4057qib7	9668	24	n=1	n=1	CD
cord-005453-4057qib7	9668	25	)	)	-RRB-
cord-005453-4057qib7	9668	26	,	,	,
cord-005453-4057qib7	9668	27	non	non	JJ
cord-005453-4057qib7	9668	28	-	-	JJ
cord-005453-4057qib7	9668	29	Hodgkin´s	hodgkin´s	JJ
cord-005453-4057qib7	9668	30	lymphoma	lymphoma	NN
cord-005453-4057qib7	9668	31	(	(	-LRB-
cord-005453-4057qib7	9668	32	n=1	n=1	CD
cord-005453-4057qib7	9668	33	)	)	-RRB-
cord-005453-4057qib7	9668	34	,	,	,
cord-005453-4057qib7	9668	35	Hurler	Hurler	NNP
cord-005453-4057qib7	9668	36	syndrome	syndrome	NN
cord-005453-4057qib7	9668	37	(	(	-LRB-
cord-005453-4057qib7	9668	38	n=1	n=1	CD
cord-005453-4057qib7	9668	39	)	)	-RRB-
cord-005453-4057qib7	9668	40	,	,	,
cord-005453-4057qib7	9668	41	who	who	WP
cord-005453-4057qib7	9668	42	underwent	undergo	VBD
cord-005453-4057qib7	9668	43	allo	allo	NN
cord-005453-4057qib7	9668	44	-	-	HYPH
cord-005453-4057qib7	9668	45	HSCT	HSCT	NNP
cord-005453-4057qib7	9668	46	from	from	IN
cord-005453-4057qib7	9668	47	an	an	DT
cord-005453-4057qib7	9668	48	unrelated	unrelated	JJ
cord-005453-4057qib7	9668	49	(	(	-LRB-
cord-005453-4057qib7	9668	50	n=4	n=4	JJ
cord-005453-4057qib7	9668	51	)	)	-RRB-
cord-005453-4057qib7	9668	52	and	and	CC
cord-005453-4057qib7	9668	53	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9668	54	donor	donor	NN
cord-005453-4057qib7	9668	55	(	(	-LRB-
cord-005453-4057qib7	9668	56	n=3	n=3	NN
cord-005453-4057qib7	9668	57	)	)	-RRB-
cord-005453-4057qib7	9668	58	,	,	,
cord-005453-4057qib7	9668	59	and	and	CC
cord-005453-4057qib7	9668	60	which	which	WDT
cord-005453-4057qib7	9668	61	were	be	VBD
cord-005453-4057qib7	9668	62	complicated	complicate	VBN
cord-005453-4057qib7	9668	63	by	by	IN
cord-005453-4057qib7	9668	64	enteropathy	enteropathy	NNP
cord-005453-4057qib7	9668	65	development	development	NN
cord-005453-4057qib7	9668	66	.	.	.
cord-005453-4057qib7	9669	1	In	in	IN
cord-005453-4057qib7	9669	2	2	2	CD
cord-005453-4057qib7	9669	3	cases	case	NNS
cord-005453-4057qib7	9669	4	,	,	,
cord-005453-4057qib7	9669	5	the	the	DT
cord-005453-4057qib7	9669	6	enteropathy	enteropathy	NNP
cord-005453-4057qib7	9669	7	reason	reason	NN
cord-005453-4057qib7	9669	8	was	be	VBD
cord-005453-4057qib7	9669	9	a	a	DT
cord-005453-4057qib7	9669	10	combination	combination	NN
cord-005453-4057qib7	9669	11	of	of	IN
cord-005453-4057qib7	9669	12	intestinal	intestinal	JJ
cord-005453-4057qib7	9669	13	GvHD	gvhd	NN
cord-005453-4057qib7	9669	14	and	and	CC
cord-005453-4057qib7	9669	15	viral	viral	JJ
cord-005453-4057qib7	9669	16	colitis	colitis	NN
cord-005453-4057qib7	9669	17	(	(	-LRB-
cord-005453-4057qib7	9669	18	HHV-6	HHV-6	NNP
cord-005453-4057qib7	9669	19	)	)	-RRB-
cord-005453-4057qib7	9669	20	,	,	,
cord-005453-4057qib7	9669	21	in	in	IN
cord-005453-4057qib7	9669	22	5	5	CD
cord-005453-4057qib7	9669	23	cases	case	NNS
cord-005453-4057qib7	9669	24	-viral	-viral	JJ
cord-005453-4057qib7	9669	25	colitis	colitis	NN
cord-005453-4057qib7	9669	26	(	(	-LRB-
cord-005453-4057qib7	9669	27	HHV-6	HHV-6	NNP
cord-005453-4057qib7	9669	28	)	)	-RRB-
cord-005453-4057qib7	9669	29	.	.	.
cord-005453-4057qib7	9670	1	All	all	DT
cord-005453-4057qib7	9670	2	patients	patient	NNS
cord-005453-4057qib7	9670	3	had	have	VBD
cord-005453-4057qib7	9670	4	esophagogastroduodenoscopy	esophagogastroduodenoscopy	NNS
cord-005453-4057qib7	9670	5	with	with	IN
cord-005453-4057qib7	9670	6	species	specie	NNS
cord-005453-4057qib7	9670	7	aspiration	aspiration	NN
cord-005453-4057qib7	9670	8	from	from	IN
cord-005453-4057qib7	9670	9	descending	descend	VBG
cord-005453-4057qib7	9670	10	part	part	NN
cord-005453-4057qib7	9670	11	of	of	IN
cord-005453-4057qib7	9670	12	the	the	DT
cord-005453-4057qib7	9670	13	duodenum	duodenum	NN
cord-005453-4057qib7	9670	14	and	and	CC
cord-005453-4057qib7	9670	15	feces	fece	NNS
cord-005453-4057qib7	9670	16	collection	collection	NN
cord-005453-4057qib7	9670	17	,	,	,
cord-005453-4057qib7	9670	18	with	with	IN
cord-005453-4057qib7	9670	19	further	further	JJ
cord-005453-4057qib7	9670	20	bacteria	bacteria	NNS
cord-005453-4057qib7	9670	21	PCR	PCR	NNP
cord-005453-4057qib7	9670	22	identification	identification	NN
cord-005453-4057qib7	9670	23	.	.	.
cord-005453-4057qib7	9671	1	Hydrogen	hydrogen	NN
cord-005453-4057qib7	9671	2	breath	breath	NN
cord-005453-4057qib7	9671	3	test	test	NN
cord-005453-4057qib7	9671	4	was	be	VBD
cord-005453-4057qib7	9671	5	performed	perform	VBN
cord-005453-4057qib7	9671	6	also	also	RB
cord-005453-4057qib7	9671	7	in	in	IN
cord-005453-4057qib7	9671	8	which	which	WDT
cord-005453-4057qib7	9671	9	patients	patient	NNS
cord-005453-4057qib7	9671	10	were	be	VBD
cord-005453-4057qib7	9671	11	treated	treat	VBN
cord-005453-4057qib7	9671	12	with	with	IN
cord-005453-4057qib7	9671	13	oral	oral	JJ
cord-005453-4057qib7	9671	14	lactose	lactose	NN
cord-005453-4057qib7	9671	15	2	2	CD
cord-005453-4057qib7	9671	16	g	g	NN
cord-005453-4057qib7	9671	17	/	/	SYM
cord-005453-4057qib7	9671	18	kg	kg	NN
cord-005453-4057qib7	9671	19	with	with	IN
cord-005453-4057qib7	9671	20	subsequent	subsequent	JJ
cord-005453-4057qib7	9671	21	hydrogen	hydrogen	NN
cord-005453-4057qib7	9671	22	assessment	assessment	NN
cord-005453-4057qib7	9671	23	after	after	IN
cord-005453-4057qib7	9671	24	30	30	CD
cord-005453-4057qib7	9671	25	and	and	CC
cord-005453-4057qib7	9671	26	60	60	CD
cord-005453-4057qib7	9671	27	minutes	minute	NNS
cord-005453-4057qib7	9671	28	.	.	.
cord-005453-4057qib7	9672	1	The	the	DT
cord-005453-4057qib7	9672	2	study	study	NN
cord-005453-4057qib7	9672	3	was	be	VBD
cord-005453-4057qib7	9672	4	performed	perform	VBN
cord-005453-4057qib7	9672	5	in	in	IN
cord-005453-4057qib7	9672	6	the	the	DT
cord-005453-4057qib7	9672	7	period	period	NN
cord-005453-4057qib7	9672	8	from	from	IN
cord-005453-4057qib7	9672	9	20	20	CD
cord-005453-4057qib7	9672	10	to	to	TO
cord-005453-4057qib7	9672	11	741	741	CD
cord-005453-4057qib7	9672	12	days	day	NNS
cord-005453-4057qib7	9672	13	after	after	IN
cord-005453-4057qib7	9672	14	allo	allo	NN
cord-005453-4057qib7	9672	15	-	-	HYPH
cord-005453-4057qib7	9672	16	HSCT	HSCT	NNP
cord-005453-4057qib7	9672	17	.	.	.
cord-005453-4057qib7	9673	1	Results	result	NNS
cord-005453-4057qib7	9673	2	:	:	:
cord-005453-4057qib7	9674	1	According	accord	VBG
cord-005453-4057qib7	9674	2	to	to	IN
cord-005453-4057qib7	9674	3	feces	fece	NNS
cord-005453-4057qib7	9674	4	analysis	analysis	NN
cord-005453-4057qib7	9674	5	data	datum	NNS
cord-005453-4057qib7	9674	6	,	,	,
cord-005453-4057qib7	9674	7	colon	colon	NN
cord-005453-4057qib7	9674	8	microbiota	microbiota	NN
cord-005453-4057qib7	9674	9	composition	composition	NN
cord-005453-4057qib7	9674	10	significantly	significantly	RB
cord-005453-4057qib7	9674	11	differed	differ	VBD
cord-005453-4057qib7	9674	12	from	from	IN
cord-005453-4057qib7	9674	13	the	the	DT
cord-005453-4057qib7	9674	14	reference	reference	NN
cord-005453-4057qib7	9674	15	values	value	NNS
cord-005453-4057qib7	9674	16	.	.	.
cord-005453-4057qib7	9675	1	At	at	IN
cord-005453-4057qib7	9675	2	the	the	DT
cord-005453-4057qib7	9675	3	same	same	JJ
cord-005453-4057qib7	9675	4	time	time	NN
cord-005453-4057qib7	9675	5	total	total	JJ
cord-005453-4057qib7	9675	6	bacterial	bacterial	JJ
cord-005453-4057qib7	9675	7	mass	mass	NN
cord-005453-4057qib7	9675	8	of	of	IN
cord-005453-4057qib7	9675	9	the	the	DT
cord-005453-4057qib7	9675	10	duodenum	duodenum	NN
cord-005453-4057qib7	9675	11	was	be	VBD
cord-005453-4057qib7	9675	12	less	less	JJR
cord-005453-4057qib7	9675	13	in	in	IN
cord-005453-4057qib7	9675	14	comparison	comparison	NN
cord-005453-4057qib7	9675	15	with	with	IN
cord-005453-4057qib7	9675	16	colon	colon	NN
cord-005453-4057qib7	9675	17	microbiota	microbiota	NN
cord-005453-4057qib7	9675	18	:	:	:
cord-005453-4057qib7	9676	1	2E+08	2e+08	CD
cord-005453-4057qib7	9676	2	(	(	-LRB-
cord-005453-4057qib7	9676	3	2E+7/8E+9	2E+7/8E+9	NNP
cord-005453-4057qib7	9676	4	)	)	-RRB-
cord-005453-4057qib7	9676	5	and	and	CC
cord-005453-4057qib7	9676	6	9E+10	9e+10	CD
cord-005453-4057qib7	9676	7	(	(	-LRB-
cord-005453-4057qib7	9676	8	9E+7/3E+12	9e+7/3e+12	CD
cord-005453-4057qib7	9676	9	)	)	-RRB-
cord-005453-4057qib7	9676	10	,	,	,
cord-005453-4057qib7	9676	11	respectively	respectively	RB
cord-005453-4057qib7	9676	12	(	(	-LRB-
cord-005453-4057qib7	9676	13	p	p	NN
cord-005453-4057qib7	9676	14	<	<	XX
cord-005453-4057qib7	9676	15	0.004	0.004	CD
cord-005453-4057qib7	9676	16	)	)	-RRB-
cord-005453-4057qib7	9676	17	.	.	.
cord-005453-4057qib7	9677	1	Quantitative	quantitative	JJ
cord-005453-4057qib7	9677	2	composition	composition	NN
cord-005453-4057qib7	9677	3	of	of	IN
cord-005453-4057qib7	9677	4	the	the	DT
cord-005453-4057qib7	9677	5	duodenal	duodenal	JJ
cord-005453-4057qib7	9677	6	microbiota	microbiota	NN
cord-005453-4057qib7	9677	7	was	be	VBD
cord-005453-4057qib7	9677	8	comparable	comparable	JJ
cord-005453-4057qib7	9677	9	to	to	IN
cord-005453-4057qib7	9677	10	that	that	DT
cord-005453-4057qib7	9677	11	of	of	IN
cord-005453-4057qib7	9677	12	colon	colon	NN
cord-005453-4057qib7	9677	13	:	:	:
cord-005453-4057qib7	9678	1	Lactobacillus	lactobacillus	NN
cord-005453-4057qib7	9678	2	spp	spp	NNS
cord-005453-4057qib7	9678	3	.	.	.
cord-005453-4057qib7	9678	4	4E+5	4e+5	CD
cord-005453-4057qib7	9679	1	(	(	-LRB-
cord-005453-4057qib7	9679	2	1E+5/2E+7	1e+5/2e+7	CD
cord-005453-4057qib7	9679	3	)	)	-RRB-
cord-005453-4057qib7	9679	4	>	>	XX
cord-005453-4057qib7	9680	1	1.5	1.5	CD
cord-005453-4057qib7	9680	2	E+5	e+5	JJ
cord-005453-4057qib7	9680	3	(	(	-LRB-
cord-005453-4057qib7	9680	4	1E+5/4E+11	1e+5/4e+11	CD
cord-005453-4057qib7	9680	5	)	)	-RRB-
cord-005453-4057qib7	9680	6	,	,	,
cord-005453-4057qib7	9680	7	(	(	-LRB-
cord-005453-4057qib7	9680	8	p=0.48	p=0.48	NNP
cord-005453-4057qib7	9680	9	)	)	-RRB-
cord-005453-4057qib7	9680	10	;	;	:
cord-005453-4057qib7	9680	11	Bifidobacterium	bifidobacterium	NN
cord-005453-4057qib7	9680	12	spp	spp	NNS
cord-005453-4057qib7	9680	13	.	.	.
cord-005453-4057qib7	9680	14	6E+6	6e+6	CD
cord-005453-4057qib7	9681	1	(	(	-LRB-
cord-005453-4057qib7	9681	2	1E+05/3E+7	1e+05/3e+7	CD
cord-005453-4057qib7	9681	3	)	)	-RRB-
cord-005453-4057qib7	9682	1	<	<	XX
cord-005453-4057qib7	9683	1	7.5	7.5	CD
cord-005453-4057qib7	9683	2	E+6	e+6	NN
cord-005453-4057qib7	9683	3	(	(	-LRB-
cord-005453-4057qib7	9683	4	2E+5/1E+9	2E+5/1E+9	NNS
cord-005453-4057qib7	9683	5	)	)	-RRB-
cord-005453-4057qib7	9683	6	,	,	,
cord-005453-4057qib7	9683	7	(	(	-LRB-
cord-005453-4057qib7	9683	8	p=0.423	p=0.423	NNP
cord-005453-4057qib7	9683	9	)	)	-RRB-
cord-005453-4057qib7	9683	10	;	;	:
cord-005453-4057qib7	9683	11	Escherichia	Escherichia	NNP
cord-005453-4057qib7	9683	12	coli	coli	NNS
cord-005453-4057qib7	9683	13	7E+5	7e+5	CD
cord-005453-4057qib7	9684	1	(	(	-LRB-
cord-005453-4057qib7	9684	2	1E+5/2E+6	1e+5/2e+6	CD
cord-005453-4057qib7	9684	3	)	)	-RRB-
cord-005453-4057qib7	9685	1	>	>	XX
cord-005453-4057qib7	9686	1	5E+5	5e+5	LS
cord-005453-4057qib7	9687	1	(	(	-LRB-
cord-005453-4057qib7	9687	2	4E+5/9E+5	4e+5/9e+5	LS
cord-005453-4057qib7	9687	3	)	)	-RRB-
cord-005453-4057qib7	9687	4	,	,	,
cord-005453-4057qib7	9687	5	(	(	-LRB-
cord-005453-4057qib7	9687	6	p=0.2	p=0.2	NNP
cord-005453-4057qib7	9687	7	)	)	-RRB-
cord-005453-4057qib7	9687	8	;	;	:
cord-005453-4057qib7	9687	9	Bacteroides	Bacteroides	NNP
cord-005453-4057qib7	9687	10	fragilis	fragilis	NN
cord-005453-4057qib7	9687	11	group	group	NN
cord-005453-4057qib7	9687	12	6E+6	6e+6	CD
cord-005453-4057qib7	9687	13	(	(	-LRB-
cord-005453-4057qib7	9687	14	0E+0/8E+9	0e+0/8e+9	NN
cord-005453-4057qib7	9687	15	)	)	-RRB-
cord-005453-4057qib7	9688	1	>	>	XX
cord-005453-4057qib7	9688	2	5E+6	5e+6	CD
cord-005453-4057qib7	9688	3	(	(	-LRB-
cord-005453-4057qib7	9688	4	2E+5/3E	2E+5/3E	NNP
cord-005453-4057qib7	9688	5	+12	+12	NNP
cord-005453-4057qib7	9688	6	)	)	-RRB-
cord-005453-4057qib7	9688	7	,	,	,
cord-005453-4057qib7	9688	8	(	(	-LRB-
cord-005453-4057qib7	9688	9	p=1.0	p=1.0	NNP
cord-005453-4057qib7	9688	10	)	)	-RRB-
cord-005453-4057qib7	9688	11	;	;	:
cord-005453-4057qib7	9688	12	Faecalibacterium	Faecalibacterium	NNP
cord-005453-4057qib7	9688	13	prausnitzii	prausnitzii	NN
cord-005453-4057qib7	9688	14	1E+6	1e+6	CD
cord-005453-4057qib7	9688	15	(	(	-LRB-
cord-005453-4057qib7	9688	16	0E+0/	0e+0/	CD
cord-005453-4057qib7	9688	17	1E+7	1e+7	CD
cord-005453-4057qib7	9688	18	)	)	-RRB-
cord-005453-4057qib7	9689	1	<	<	XX
cord-005453-4057qib7	9690	1	1.5	1.5	CD
cord-005453-4057qib7	9690	2	E+6	e+6	NN
cord-005453-4057qib7	9690	3	(	(	-LRB-
cord-005453-4057qib7	9690	4	1E+5/3E+10	1e+5/3e+10	CD
cord-005453-4057qib7	9690	5	)	)	-RRB-
cord-005453-4057qib7	9690	6	,	,	,
cord-005453-4057qib7	9690	7	(	(	-LRB-
cord-005453-4057qib7	9690	8	p=0.54	p=0.54	NNP
cord-005453-4057qib7	9690	9	)	)	-RRB-
cord-005453-4057qib7	9690	10	,	,	,
cord-005453-4057qib7	9690	11	indicating	indicate	VBG
cord-005453-4057qib7	9690	12	the	the	DT
cord-005453-4057qib7	9690	13	presence	presence	NN
cord-005453-4057qib7	9690	14	of	of	IN
cord-005453-4057qib7	9690	15	SIBO	SIBO	NNP
cord-005453-4057qib7	9690	16	.	.	.
cord-005453-4057qib7	9691	1	In	in	IN
cord-005453-4057qib7	9691	2	this	this	DT
cord-005453-4057qib7	9691	3	case	case	NN
cord-005453-4057qib7	9691	4	,	,	,
cord-005453-4057qib7	9691	5	the	the	DT
cord-005453-4057qib7	9691	6	hydrogen	hydrogen	NN
cord-005453-4057qib7	9691	7	breath	breath	NN
cord-005453-4057qib7	9691	8	test	test	NN
cord-005453-4057qib7	9691	9	was	be	VBD
cord-005453-4057qib7	9691	10	completely	completely	RB
cord-005453-4057qib7	9691	11	uninformative	uninformative	JJ
cord-005453-4057qib7	9691	12	:	:	:
cord-005453-4057qib7	9691	13	basal	basal	JJ
cord-005453-4057qib7	9691	14	values	value	NNS
cord-005453-4057qib7	9691	15	-0.035	-0.035	NNP
cord-005453-4057qib7	9692	1	(	(	-LRB-
cord-005453-4057qib7	9692	2	0.01/0.06	0.01/0.06	NNP
cord-005453-4057qib7	9692	3	)	)	-RRB-
cord-005453-4057qib7	9693	1	ppm	ppm	NN
cord-005453-4057qib7	9693	2	,	,	,
cord-005453-4057qib7	9693	3	hydrogen	hydrogen	NN
cord-005453-4057qib7	9693	4	concentration	concentration	NN
cord-005453-4057qib7	9693	5	in	in	IN
cord-005453-4057qib7	9693	6	30	30	CD
cord-005453-4057qib7	9693	7	minutes	minute	NNS
cord-005453-4057qib7	9693	8	-0.04	-0.04	CD
cord-005453-4057qib7	9693	9	(	(	-LRB-
cord-005453-4057qib7	9693	10	0.01/	0.01/	CD
cord-005453-4057qib7	9693	11	0.06	0.06	CD
cord-005453-4057qib7	9693	12	)	)	-RRB-
cord-005453-4057qib7	9694	1	ppm	ppm	NN
cord-005453-4057qib7	9694	2	,	,	,
cord-005453-4057qib7	9694	3	in	in	IN
cord-005453-4057qib7	9694	4	60	60	CD
cord-005453-4057qib7	9694	5	minutes	minute	NNS
cord-005453-4057qib7	9694	6	-0.02	-0.02	CD
cord-005453-4057qib7	9694	7	(	(	-LRB-
cord-005453-4057qib7	9694	8	0.01/0.07	0.01/0.07	CD
cord-005453-4057qib7	9694	9	)	)	-RRB-
cord-005453-4057qib7	9694	10	ppm	ppm	NN
cord-005453-4057qib7	9694	11	,	,	,
cord-005453-4057qib7	9694	12	which	which	WDT
cord-005453-4057qib7	9694	13	is	be	VBZ
cord-005453-4057qib7	9694	14	less	less	JJR
cord-005453-4057qib7	9694	15	than	than	IN
cord-005453-4057qib7	9694	16	in	in	IN
cord-005453-4057qib7	9694	17	healthy	healthy	JJ
cord-005453-4057qib7	9694	18	volunteers	volunteer	NNS
cord-005453-4057qib7	9694	19	.	.	.
cord-005453-4057qib7	9695	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9695	2	:	:	:
cord-005453-4057qib7	9696	1	Quantitative	quantitative	JJ
cord-005453-4057qib7	9696	2	composition	composition	NN
cord-005453-4057qib7	9696	3	of	of	IN
cord-005453-4057qib7	9696	4	the	the	DT
cord-005453-4057qib7	9696	5	duodenal	duodenal	NN
cord-005453-4057qib7	9696	6	and	and	CC
cord-005453-4057qib7	9696	7	colon	colon	NN
cord-005453-4057qib7	9696	8	microbiota	microbiota	NN
cord-005453-4057qib7	9696	9	is	be	VBZ
cord-005453-4057qib7	9696	10	similar	similar	JJ
cord-005453-4057qib7	9696	11	in	in	IN
cord-005453-4057qib7	9696	12	the	the	DT
cord-005453-4057qib7	9696	13	case	case	NN
cord-005453-4057qib7	9696	14	of	of	IN
cord-005453-4057qib7	9696	15	intestinal	intestinal	JJ
cord-005453-4057qib7	9696	16	GvHD	gvhd	NN
cord-005453-4057qib7	9696	17	and/or	and/or	CC
cord-005453-4057qib7	9696	18	virus	virus	NN
cord-005453-4057qib7	9696	19	-	-	HYPH
cord-005453-4057qib7	9696	20	associated	associate	VBN
cord-005453-4057qib7	9696	21	enteropathy	enteropathy	NNP
cord-005453-4057qib7	9696	22	in	in	IN
cord-005453-4057qib7	9696	23	allo	allo	NN
cord-005453-4057qib7	9696	24	-	-	HYPH
cord-005453-4057qib7	9696	25	HSCT	HSCT	NNP
cord-005453-4057qib7	9696	26	patients	patient	NNS
cord-005453-4057qib7	9696	27	,	,	,
cord-005453-4057qib7	9696	28	which	which	WDT
cord-005453-4057qib7	9696	29	may	may	MD
cord-005453-4057qib7	9696	30	be	be	VB
cord-005453-4057qib7	9696	31	of	of	IN
cord-005453-4057qib7	9696	32	diagnostic	diagnostic	JJ
cord-005453-4057qib7	9696	33	value	value	NN
cord-005453-4057qib7	9696	34	for	for	IN
cord-005453-4057qib7	9696	35	SIBO	SIBO	NNP
cord-005453-4057qib7	9696	36	confirmation	confirmation	NN
cord-005453-4057qib7	9696	37	.	.	.
cord-005453-4057qib7	9697	1	The	the	DT
cord-005453-4057qib7	9697	2	hydrogen	hydrogen	NN
cord-005453-4057qib7	9697	3	breath	breath	NN
cord-005453-4057qib7	9697	4	test	test	NN
cord-005453-4057qib7	9697	5	is	be	VBZ
cord-005453-4057qib7	9697	6	an	an	DT
cord-005453-4057qib7	9697	7	uninformative	uninformative	JJ
cord-005453-4057qib7	9697	8	method	method	NN
cord-005453-4057qib7	9697	9	for	for	IN
cord-005453-4057qib7	9697	10	SIBO	SIBO	NNP
cord-005453-4057qib7	9697	11	identification	identification	NN
cord-005453-4057qib7	9697	12	in	in	IN
cord-005453-4057qib7	9697	13	patients	patient	NNS
cord-005453-4057qib7	9697	14	after	after	IN
cord-005453-4057qib7	9697	15	allo	allo	NN
cord-005453-4057qib7	9697	16	-	-	HYPH
cord-005453-4057qib7	9697	17	HSCT	HSCT	NNP
cord-005453-4057qib7	9697	18	.	.	.
cord-005453-4057qib7	9698	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9698	2	:	:	:
cord-005453-4057qib7	9698	3	Nothing	nothing	NN
cord-005453-4057qib7	9698	4	to	to	TO
cord-005453-4057qib7	9698	5	declare	declare	VB
cord-005453-4057qib7	9698	6	Johannes	Johannes	NNP
cord-005453-4057qib7	9698	7	Schulte	Schulte	NNP
cord-005453-4057qib7	9698	8	1	1	CD
cord-005453-4057qib7	9698	9	,	,	,
cord-005453-4057qib7	9698	10	Patrick	Patrick	NNP
cord-005453-4057qib7	9698	11	Hundsdörfer	Hundsdörfer	NNP
cord-005453-4057qib7	9698	12	1	1	CD
cord-005453-4057qib7	9698	13	,	,	,
cord-005453-4057qib7	9698	14	Sebastian	Sebastian	NNP
cord-005453-4057qib7	9698	15	Voigt	Voigt	NNP
cord-005453-4057qib7	9698	16	1	1	CD
cord-005453-4057qib7	9698	17	Background	Background	NNP
cord-005453-4057qib7	9698	18	:	:	:
cord-005453-4057qib7	9698	19	Adenovirus	Adenovirus	NNP
cord-005453-4057qib7	9698	20	(	(	-LRB-
cord-005453-4057qib7	9698	21	AdV	adv	NN
cord-005453-4057qib7	9698	22	)	)	-RRB-
cord-005453-4057qib7	9698	23	infections	infection	NNS
cord-005453-4057qib7	9698	24	or	or	CC
cord-005453-4057qib7	9698	25	reactivations	reactivation	NNS
cord-005453-4057qib7	9698	26	frequently	frequently	RB
cord-005453-4057qib7	9698	27	occur	occur	VBP
cord-005453-4057qib7	9698	28	in	in	IN
cord-005453-4057qib7	9698	29	the	the	DT
cord-005453-4057qib7	9698	30	pediatric	pediatric	JJ
cord-005453-4057qib7	9698	31	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9698	32	stem	stem	NN
cord-005453-4057qib7	9698	33	cell	cell	NN
cord-005453-4057qib7	9698	34	transplant	transplant	NN
cord-005453-4057qib7	9698	35	(	(	-LRB-
cord-005453-4057qib7	9698	36	SCT	SCT	NNP
cord-005453-4057qib7	9698	37	)	)	-RRB-
cord-005453-4057qib7	9698	38	setting	setting	NN
cord-005453-4057qib7	9698	39	and	and	CC
cord-005453-4057qib7	9698	40	these	these	DT
cord-005453-4057qib7	9698	41	infections	infection	NNS
cord-005453-4057qib7	9698	42	contribute	contribute	VBP
cord-005453-4057qib7	9698	43	to	to	IN
cord-005453-4057qib7	9698	44	increased	increase	VBN
cord-005453-4057qib7	9698	45	morbidity	morbidity	NN
cord-005453-4057qib7	9698	46	and	and	CC
cord-005453-4057qib7	9698	47	mortality	mortality	NN
cord-005453-4057qib7	9698	48	.	.	.
cord-005453-4057qib7	9699	1	The	the	DT
cord-005453-4057qib7	9699	2	nucleotide	nucleotide	JJ
cord-005453-4057qib7	9699	3	analog	analog	NN
cord-005453-4057qib7	9699	4	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9699	5	might	may	MD
cord-005453-4057qib7	9699	6	be	be	VB
cord-005453-4057qib7	9699	7	effective	effective	JJ
cord-005453-4057qib7	9699	8	in	in	IN
cord-005453-4057qib7	9699	9	reducing	reduce	VBG
cord-005453-4057qib7	9699	10	AdV	adv	NN
cord-005453-4057qib7	9699	11	load	load	NN
cord-005453-4057qib7	9699	12	,	,	,
cord-005453-4057qib7	9699	13	however	however	RB
cord-005453-4057qib7	9699	14	,	,	,
cord-005453-4057qib7	9699	15	nephrotoxicity	nephrotoxicity	NNP
cord-005453-4057qib7	9699	16	is	be	VBZ
cord-005453-4057qib7	9699	17	a	a	DT
cord-005453-4057qib7	9699	18	considerable	considerable	JJ
cord-005453-4057qib7	9699	19	side	side	NN
cord-005453-4057qib7	9699	20	effect	effect	NN
cord-005453-4057qib7	9699	21	.	.	.
cord-005453-4057qib7	9700	1	The	the	DT
cord-005453-4057qib7	9700	2	new	new	JJ
cord-005453-4057qib7	9700	3	antiviral	antiviral	JJ
cord-005453-4057qib7	9700	4	compound	compound	NN
cord-005453-4057qib7	9700	5	Brincidofovir	Brincidofovir	NNP
cord-005453-4057qib7	9700	6	(	(	-LRB-
cord-005453-4057qib7	9700	7	BCV	BCV	NNP
cord-005453-4057qib7	9700	8	,	,	,
cord-005453-4057qib7	9700	9	CMX-001	cmx-001	PRP
cord-005453-4057qib7	9700	10	)	)	-RRB-
cord-005453-4057qib7	9700	11	,	,	,
cord-005453-4057qib7	9700	12	a	a	DT
cord-005453-4057qib7	9700	13	lipid	lipid	NN
cord-005453-4057qib7	9700	14	-	-	HYPH
cord-005453-4057qib7	9700	15	conjugate	conjugate	NN
cord-005453-4057qib7	9700	16	nucleotide	nucleotide	JJ
cord-005453-4057qib7	9700	17	analog	analog	NN
cord-005453-4057qib7	9700	18	with	with	IN
cord-005453-4057qib7	9700	19	broad	broad	JJ
cord-005453-4057qib7	9700	20	-	-	HYPH
cord-005453-4057qib7	9700	21	spectrum	spectrum	NN
cord-005453-4057qib7	9700	22	antiviral	antiviral	JJ
cord-005453-4057qib7	9700	23	activity	activity	NN
cord-005453-4057qib7	9700	24	in	in	IN
cord-005453-4057qib7	9700	25	vitro	vitro	FW
cord-005453-4057qib7	9700	26	,	,	,
cord-005453-4057qib7	9700	27	has	have	VBZ
cord-005453-4057qib7	9700	28	been	be	VBN
cord-005453-4057qib7	9700	29	reported	report	VBN
cord-005453-4057qib7	9700	30	to	to	TO
cord-005453-4057qib7	9700	31	be	be	VB
cord-005453-4057qib7	9700	32	effective	effective	JJ
cord-005453-4057qib7	9700	33	in	in	IN
cord-005453-4057qib7	9700	34	cases	case	NNS
cord-005453-4057qib7	9700	35	where	where	WRB
cord-005453-4057qib7	9700	36	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9700	37	treatment	treatment	NN
cord-005453-4057qib7	9700	38	was	be	VBD
cord-005453-4057qib7	9700	39	unsuccessful	unsuccessful	JJ
cord-005453-4057qib7	9700	40	.	.	.
cord-005453-4057qib7	9701	1	Methods	method	NNS
cord-005453-4057qib7	9701	2	:	:	:
cord-005453-4057qib7	9701	3	Data	datum	NNS
cord-005453-4057qib7	9701	4	of	of	IN
cord-005453-4057qib7	9701	5	eight	eight	CD
cord-005453-4057qib7	9701	6	pediatric	pediatric	JJ
cord-005453-4057qib7	9701	7	patients	patient	NNS
cord-005453-4057qib7	9701	8	undergoing	undergo	VBG
cord-005453-4057qib7	9701	9	SCT	SCT	NNP
cord-005453-4057qib7	9701	10	for	for	IN
cord-005453-4057qib7	9701	11	malignant	malignant	JJ
cord-005453-4057qib7	9701	12	and	and	CC
cord-005453-4057qib7	9701	13	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	9701	14	indications	indication	NNS
cord-005453-4057qib7	9701	15	were	be	VBD
cord-005453-4057qib7	9701	16	analyzed	analyze	VBN
cord-005453-4057qib7	9701	17	.	.	.
cord-005453-4057qib7	9702	1	All	all	DT
cord-005453-4057qib7	9702	2	patients	patient	NNS
cord-005453-4057qib7	9702	3	were	be	VBD
cord-005453-4057qib7	9702	4	weekly	weekly	RB
cord-005453-4057qib7	9702	5	monitored	monitor	VBN
cord-005453-4057qib7	9702	6	for	for	IN
cord-005453-4057qib7	9702	7	AdV	adv	NN
cord-005453-4057qib7	9702	8	viremia	viremia	NN
cord-005453-4057qib7	9702	9	by	by	IN
cord-005453-4057qib7	9702	10	PCR	PCR	NNP
cord-005453-4057qib7	9702	11	.	.	.
cord-005453-4057qib7	9703	1	In	in	IN
cord-005453-4057qib7	9703	2	case	case	NN
cord-005453-4057qib7	9703	3	two	two	CD
cord-005453-4057qib7	9703	4	consecutive	consecutive	JJ
cord-005453-4057qib7	9703	5	positive	positive	JJ
cord-005453-4057qib7	9703	6	AdV	adv	NN
cord-005453-4057qib7	9703	7	PCR	PCR	NNP
cord-005453-4057qib7	9703	8	results	result	NNS
cord-005453-4057qib7	9703	9	indicating	indicate	VBG
cord-005453-4057qib7	9703	10	a	a	DT
cord-005453-4057qib7	9703	11	viral	viral	JJ
cord-005453-4057qib7	9703	12	copy	copy	NN
cord-005453-4057qib7	9703	13	number	number	NN
cord-005453-4057qib7	9703	14	>	>	XX
cord-005453-4057qib7	9704	1	1000	1000	CD
cord-005453-4057qib7	9704	2	/	/	SYM
cord-005453-4057qib7	9704	3	ml	ml	NNS
cord-005453-4057qib7	9704	4	were	be	VBD
cord-005453-4057qib7	9704	5	documented	document	VBN
cord-005453-4057qib7	9704	6	,	,	,
cord-005453-4057qib7	9704	7	patients	patient	NNS
cord-005453-4057qib7	9704	8	received	receive	VBD
cord-005453-4057qib7	9704	9	a	a	DT
cord-005453-4057qib7	9704	10	weekly	weekly	JJ
cord-005453-4057qib7	9704	11	dose	dose	NN
cord-005453-4057qib7	9704	12	of	of	IN
cord-005453-4057qib7	9704	13	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9704	14	.	.	.
cord-005453-4057qib7	9705	1	If	if	IN
cord-005453-4057qib7	9705	2	no	no	DT
cord-005453-4057qib7	9705	3	reduction	reduction	NN
cord-005453-4057qib7	9705	4	of	of	IN
cord-005453-4057qib7	9705	5	AdV	adv	NN
cord-005453-4057qib7	9705	6	load	load	NN
cord-005453-4057qib7	9705	7	was	be	VBD
cord-005453-4057qib7	9705	8	seen	see	VBN
cord-005453-4057qib7	9705	9	within	within	IN
cord-005453-4057qib7	9705	10	two	two	CD
cord-005453-4057qib7	9705	11	weeks	week	NNS
cord-005453-4057qib7	9705	12	after	after	IN
cord-005453-4057qib7	9705	13	the	the	DT
cord-005453-4057qib7	9705	14	commencement	commencement	NN
cord-005453-4057qib7	9705	15	of	of	IN
cord-005453-4057qib7	9705	16	treatment	treatment	NN
cord-005453-4057qib7	9705	17	or	or	CC
cord-005453-4057qib7	9705	18	side	side	NN
cord-005453-4057qib7	9705	19	effects	effect	NNS
cord-005453-4057qib7	9705	20	demanded	demand	VBD
cord-005453-4057qib7	9705	21	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9705	22	discontinuation	discontinuation	NN
cord-005453-4057qib7	9705	23	,	,	,
cord-005453-4057qib7	9705	24	BCV	BCV	NNP
cord-005453-4057qib7	9705	25	was	be	VBD
cord-005453-4057qib7	9705	26	obtained	obtain	VBN
cord-005453-4057qib7	9705	27	through	through	IN
cord-005453-4057qib7	9705	28	an	an	DT
cord-005453-4057qib7	9705	29	emergency	emergency	NN
cord-005453-4057qib7	9705	30	expanded	expand	VBN
cord-005453-4057qib7	9705	31	access	access	NN
cord-005453-4057qib7	9705	32	programme	programme	NN
cord-005453-4057qib7	9705	33	.	.	.
cord-005453-4057qib7	9706	1	Results	result	NNS
cord-005453-4057qib7	9706	2	:	:	:
cord-005453-4057qib7	9707	1	Eight	eight	CD
cord-005453-4057qib7	9707	2	pediatric	pediatric	JJ
cord-005453-4057qib7	9707	3	patients	patient	NNS
cord-005453-4057qib7	9707	4	developed	develop	VBD
cord-005453-4057qib7	9707	5	AdV	adv	NN
cord-005453-4057qib7	9707	6	viremia	viremia	NN
cord-005453-4057qib7	9707	7	with	with	IN
cord-005453-4057qib7	9707	8	maximum	maximum	JJ
cord-005453-4057qib7	9707	9	viral	viral	JJ
cord-005453-4057qib7	9707	10	loads	load	NNS
cord-005453-4057qib7	9707	11	ranging	range	VBG
cord-005453-4057qib7	9707	12	between	between	IN
cord-005453-4057qib7	9707	13	9350	9350	CD
cord-005453-4057qib7	9707	14	and	and	CC
cord-005453-4057qib7	9707	15	4430000	4430000	CD
cord-005453-4057qib7	9707	16	copies	copy	NNS
cord-005453-4057qib7	9707	17	/	/	SYM
cord-005453-4057qib7	9707	18	ml	ml	NN
cord-005453-4057qib7	9707	19	.	.	.
cord-005453-4057qib7	9708	1	Six	six	CD
cord-005453-4057qib7	9708	2	patients	patient	NNS
cord-005453-4057qib7	9708	3	had	have	VBD
cord-005453-4057qib7	9708	4	C	c	NN
cord-005453-4057qib7	9708	5	type	type	NN
cord-005453-4057qib7	9708	6	AdV	adv	NN
cord-005453-4057qib7	9708	7	and	and	CC
cord-005453-4057qib7	9708	8	two	two	CD
cord-005453-4057qib7	9708	9	patients	patient	NNS
cord-005453-4057qib7	9708	10	had	have	VBD
cord-005453-4057qib7	9708	11	non	non	AFX
cord-005453-4057qib7	9708	12	C	c	NN
cord-005453-4057qib7	9708	13	type	type	NN
cord-005453-4057qib7	9708	14	AdV	adv	NN
cord-005453-4057qib7	9708	15	infections	infection	NNS
cord-005453-4057qib7	9708	16	.	.	.
cord-005453-4057qib7	9709	1	Five	five	CD
cord-005453-4057qib7	9709	2	patients	patient	NNS
cord-005453-4057qib7	9709	3	had	have	VBD
cord-005453-4057qib7	9709	4	viral	viral	JJ
cord-005453-4057qib7	9709	5	co	co	NNS
cord-005453-4057qib7	9709	6	-	-	NNS
cord-005453-4057qib7	9709	7	infections	infection	NNS
cord-005453-4057qib7	9709	8	:	:	:
cord-005453-4057qib7	9709	9	two	two	CD
cord-005453-4057qib7	9709	10	had	have	VBD
cord-005453-4057qib7	9709	11	an	an	DT
cord-005453-4057qib7	9709	12	additional	additional	JJ
cord-005453-4057qib7	9709	13	CMV	CMV	NNP
cord-005453-4057qib7	9709	14	infection	infection	NN
cord-005453-4057qib7	9709	15	,	,	,
cord-005453-4057qib7	9709	16	one	one	PRP
cord-005453-4057qib7	9709	17	had	have	VBD
cord-005453-4057qib7	9709	18	an	an	DT
cord-005453-4057qib7	9709	19	Epstein	Epstein	NNP
cord-005453-4057qib7	9709	20	-	-	HYPH
cord-005453-4057qib7	9709	21	Barr	Barr	NNP
cord-005453-4057qib7	9709	22	virus	virus	NN
cord-005453-4057qib7	9709	23	(	(	-LRB-
cord-005453-4057qib7	9709	24	EBV	EBV	NNP
cord-005453-4057qib7	9709	25	)	)	-RRB-
cord-005453-4057qib7	9709	26	and	and	CC
cord-005453-4057qib7	9709	27	Herpes	Herpes	NNP
cord-005453-4057qib7	9709	28	simplex	simplex	NN
cord-005453-4057qib7	9709	29	virus	virus	NN
cord-005453-4057qib7	9709	30	co	co	NN
cord-005453-4057qib7	9709	31	-	-	NN
cord-005453-4057qib7	9709	32	infection	infection	NN
cord-005453-4057qib7	9709	33	,	,	,
cord-005453-4057qib7	9709	34	one	one	CD
cord-005453-4057qib7	9709	35	patient	patient	NN
cord-005453-4057qib7	9709	36	had	have	VBD
cord-005453-4057qib7	9709	37	an	an	DT
cord-005453-4057qib7	9709	38	EBV	EBV	NNP
cord-005453-4057qib7	9709	39	co	co	NN
cord-005453-4057qib7	9709	40	-	-	NN
cord-005453-4057qib7	9709	41	infection	infection	NN
cord-005453-4057qib7	9709	42	and	and	CC
cord-005453-4057qib7	9709	43	one	one	CD
cord-005453-4057qib7	9709	44	patient	patient	NN
cord-005453-4057qib7	9709	45	had	have	VBD
cord-005453-4057qib7	9709	46	a	a	DT
cord-005453-4057qib7	9709	47	BK	BK	NNP
cord-005453-4057qib7	9709	48	virus	virus	NN
cord-005453-4057qib7	9709	49	co	co	NN
cord-005453-4057qib7	9709	50	-	-	NN
cord-005453-4057qib7	9709	51	infection	infection	NN
cord-005453-4057qib7	9709	52	.	.	.
cord-005453-4057qib7	9710	1	All	all	DT
cord-005453-4057qib7	9710	2	eight	eight	CD
cord-005453-4057qib7	9710	3	patients	patient	NNS
cord-005453-4057qib7	9710	4	initially	initially	RB
cord-005453-4057qib7	9710	5	received	receive	VBD
cord-005453-4057qib7	9710	6	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9710	7	,	,	,
cord-005453-4057qib7	9710	8	however	however	RB
cord-005453-4057qib7	9710	9	,	,	,
cord-005453-4057qib7	9710	10	a	a	DT
cord-005453-4057qib7	9710	11	substantial	substantial	JJ
cord-005453-4057qib7	9710	12	decrease	decrease	NN
cord-005453-4057qib7	9710	13	in	in	IN
cord-005453-4057qib7	9710	14	AdV	adv	NN
cord-005453-4057qib7	9710	15	load	load	NN
cord-005453-4057qib7	9710	16	could	could	MD
cord-005453-4057qib7	9710	17	not	not	RB
cord-005453-4057qib7	9710	18	be	be	VB
cord-005453-4057qib7	9710	19	observed	observe	VBN
cord-005453-4057qib7	9710	20	in	in	IN
cord-005453-4057qib7	9710	21	any	any	DT
cord-005453-4057qib7	9710	22	patient	patient	NN
cord-005453-4057qib7	9710	23	after	after	IN
cord-005453-4057qib7	9710	24	a	a	DT
cord-005453-4057qib7	9710	25	two	two	CD
cord-005453-4057qib7	9710	26	-	-	HYPH
cord-005453-4057qib7	9710	27	week	week	NN
cord-005453-4057qib7	9710	28	administration	administration	NN
cord-005453-4057qib7	9710	29	course	course	NN
cord-005453-4057qib7	9710	30	.	.	.
cord-005453-4057qib7	9711	1	Except	except	IN
cord-005453-4057qib7	9711	2	in	in	IN
cord-005453-4057qib7	9711	3	one	one	CD
cord-005453-4057qib7	9711	4	patient	patient	NN
cord-005453-4057qib7	9711	5	who	who	WP
cord-005453-4057qib7	9711	6	had	have	VBD
cord-005453-4057qib7	9711	7	extensive	extensive	JJ
cord-005453-4057qib7	9711	8	intestinal	intestinal	JJ
cord-005453-4057qib7	9711	9	graft	graft	NN
cord-005453-4057qib7	9711	10	-	-	HYPH
cord-005453-4057qib7	9711	11	versus	versus	IN
cord-005453-4057qib7	9711	12	host	host	NN
cord-005453-4057qib7	9711	13	disease	disease	NN
cord-005453-4057qib7	9711	14	(	(	-LRB-
cord-005453-4057qib7	9711	15	GvHD	GvHD	NNP
cord-005453-4057qib7	9711	16	)	)	-RRB-
cord-005453-4057qib7	9711	17	,	,	,
cord-005453-4057qib7	9711	18	AdV	adv	NN
cord-005453-4057qib7	9711	19	infection	infection	NN
cord-005453-4057qib7	9711	20	was	be	VBD
cord-005453-4057qib7	9711	21	cleared	clear	VBN
cord-005453-4057qib7	9711	22	in	in	IN
cord-005453-4057qib7	9711	23	all	all	DT
cord-005453-4057qib7	9711	24	patients	patient	NNS
cord-005453-4057qib7	9711	25	within	within	IN
cord-005453-4057qib7	9711	26	three	three	CD
cord-005453-4057qib7	9711	27	weeks	week	NNS
cord-005453-4057qib7	9711	28	after	after	IN
cord-005453-4057qib7	9711	29	the	the	DT
cord-005453-4057qib7	9711	30	beginning	beginning	NN
cord-005453-4057qib7	9711	31	of	of	IN
cord-005453-4057qib7	9711	32	BCV	BCV	NNP
cord-005453-4057qib7	9711	33	treatment	treatment	NN
cord-005453-4057qib7	9711	34	.	.	.
cord-005453-4057qib7	9712	1	In	in	IN
cord-005453-4057qib7	9712	2	addition	addition	NN
cord-005453-4057qib7	9712	3	,	,	,
cord-005453-4057qib7	9712	4	all	all	DT
cord-005453-4057qib7	9712	5	coinfections	coinfection	NNS
cord-005453-4057qib7	9712	6	were	be	VBD
cord-005453-4057qib7	9712	7	cleared	clear	VBN
cord-005453-4057qib7	9712	8	.	.	.
cord-005453-4057qib7	9713	1	No	no	DT
cord-005453-4057qib7	9713	2	nephrotoxicity	nephrotoxicity	NN
cord-005453-4057qib7	9713	3	or	or	CC
cord-005453-4057qib7	9713	4	other	other	JJ
cord-005453-4057qib7	9713	5	side	side	NN
cord-005453-4057qib7	9713	6	effects	effect	NNS
cord-005453-4057qib7	9713	7	were	be	VBD
cord-005453-4057qib7	9713	8	observed	observe	VBN
cord-005453-4057qib7	9713	9	.	.	.
cord-005453-4057qib7	9714	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9714	2	:	:	:
cord-005453-4057qib7	9715	1	BCV	BCV	NNP
cord-005453-4057qib7	9715	2	was	be	VBD
cord-005453-4057qib7	9715	3	effective	effective	JJ
cord-005453-4057qib7	9715	4	in	in	IN
cord-005453-4057qib7	9715	5	all	all	DT
cord-005453-4057qib7	9715	6	but	but	IN
cord-005453-4057qib7	9715	7	one	one	CD
cord-005453-4057qib7	9715	8	patient	patient	NN
cord-005453-4057qib7	9715	9	.	.	.
cord-005453-4057qib7	9716	1	Oral	oral	JJ
cord-005453-4057qib7	9716	2	BCV	BCV	NNP
cord-005453-4057qib7	9716	3	might	may	MD
cord-005453-4057qib7	9716	4	not	not	RB
cord-005453-4057qib7	9716	5	be	be	VB
cord-005453-4057qib7	9716	6	effective	effective	JJ
cord-005453-4057qib7	9716	7	in	in	IN
cord-005453-4057qib7	9716	8	advanced	advanced	JJ
cord-005453-4057qib7	9716	9	upper	upper	JJ
cord-005453-4057qib7	9716	10	gut	gut	NN
cord-005453-4057qib7	9716	11	GvHD	GvHD	NNP
cord-005453-4057qib7	9716	12	,	,	,
cord-005453-4057qib7	9716	13	especially	especially	RB
cord-005453-4057qib7	9716	14	when	when	WRB
cord-005453-4057qib7	9716	15	applied	apply	VBN
cord-005453-4057qib7	9716	16	via	via	IN
cord-005453-4057qib7	9716	17	a	a	DT
cord-005453-4057qib7	9716	18	gastric	gastric	JJ
cord-005453-4057qib7	9716	19	tube	tube	NN
cord-005453-4057qib7	9716	20	,	,	,
cord-005453-4057qib7	9716	21	yet	yet	CC
cord-005453-4057qib7	9716	22	this	this	DT
cord-005453-4057qib7	9716	23	was	be	VBD
cord-005453-4057qib7	9716	24	observed	observe	VBN
cord-005453-4057qib7	9716	25	in	in	IN
cord-005453-4057qib7	9716	26	only	only	RB
cord-005453-4057qib7	9716	27	one	one	CD
cord-005453-4057qib7	9716	28	patient	patient	NN
cord-005453-4057qib7	9716	29	.	.	.
cord-005453-4057qib7	9717	1	Eventually	eventually	RB
cord-005453-4057qib7	9717	2	,	,	,
cord-005453-4057qib7	9717	3	without	without	IN
cord-005453-4057qib7	9717	4	nephrotoxic	nephrotoxic	NNP
cord-005453-4057qib7	9717	5	side	side	NN
cord-005453-4057qib7	9717	6	effects	effect	NNS
cord-005453-4057qib7	9717	7	,	,	,
cord-005453-4057qib7	9717	8	BCV	BCV	NNP
cord-005453-4057qib7	9717	9	could	could	MD
cord-005453-4057qib7	9717	10	be	be	VB
cord-005453-4057qib7	9717	11	an	an	DT
cord-005453-4057qib7	9717	12	useful	useful	JJ
cord-005453-4057qib7	9717	13	alternative	alternative	NN
cord-005453-4057qib7	9717	14	to	to	IN
cord-005453-4057qib7	9717	15	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9717	16	.	.	.
cord-005453-4057qib7	9718	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9718	2	:	:	:
cord-005453-4057qib7	9718	3	Nothing	nothing	NN
cord-005453-4057qib7	9718	4	to	to	TO
cord-005453-4057qib7	9718	5	declare	declare	VB
cord-005453-4057qib7	9718	6	.	.	.
cord-005453-4057qib7	9719	1	Background	background	NN
cord-005453-4057qib7	9719	2	:	:	:
cord-005453-4057qib7	9720	1	The	the	DT
cord-005453-4057qib7	9720	2	use	use	NN
cord-005453-4057qib7	9720	3	of	of	IN
cord-005453-4057qib7	9720	4	post	post	JJ
cord-005453-4057qib7	9720	5	-	-	JJ
cord-005453-4057qib7	9720	6	transplant	transplant	JJ
cord-005453-4057qib7	9720	7	high	high	JJ
cord-005453-4057qib7	9720	8	-	-	HYPH
cord-005453-4057qib7	9720	9	dose	dose	NN
cord-005453-4057qib7	9720	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	9720	11	(	(	-LRB-
cord-005453-4057qib7	9720	12	PTCY	PTCY	NNP
cord-005453-4057qib7	9720	13	)	)	-RRB-
cord-005453-4057qib7	9720	14	has	have	VBZ
cord-005453-4057qib7	9720	15	overcome	overcome	VBN
cord-005453-4057qib7	9720	16	the	the	DT
cord-005453-4057qib7	9720	17	need	need	NN
cord-005453-4057qib7	9720	18	for	for	IN
cord-005453-4057qib7	9720	19	extensive	extensive	JJ
cord-005453-4057qib7	9720	20	depletion	depletion	NN
cord-005453-4057qib7	9720	21	of	of	IN
cord-005453-4057qib7	9720	22	T	t	NN
cord-005453-4057qib7	9720	23	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	9720	24	from	from	IN
cord-005453-4057qib7	9720	25	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9720	26	donor	donor	NN
cord-005453-4057qib7	9720	27	grafts	graft	NNS
cord-005453-4057qib7	9720	28	,	,	,
cord-005453-4057qib7	9720	29	which	which	WDT
cord-005453-4057qib7	9720	30	traditionally	traditionally	RB
cord-005453-4057qib7	9720	31	resulted	result	VBD
cord-005453-4057qib7	9720	32	in	in	IN
cord-005453-4057qib7	9720	33	severe	severe	JJ
cord-005453-4057qib7	9720	34	and	and	CC
cord-005453-4057qib7	9720	35	prolonged	prolonged	JJ
cord-005453-4057qib7	9720	36	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	9720	37	.	.	.
cord-005453-4057qib7	9721	1	However	however	RB
cord-005453-4057qib7	9721	2	,	,	,
cord-005453-4057qib7	9721	3	reconstitution	reconstitution	NN
cord-005453-4057qib7	9721	4	of	of	IN
cord-005453-4057qib7	9721	5	cellular	cellular	JJ
cord-005453-4057qib7	9721	6	immunity	immunity	NN
cord-005453-4057qib7	9721	7	may	may	MD
cord-005453-4057qib7	9721	8	be	be	VB
cord-005453-4057qib7	9721	9	delayed	delay	VBN
cord-005453-4057qib7	9721	10	even	even	RB
cord-005453-4057qib7	9721	11	after	after	IN
cord-005453-4057qib7	9721	12	T	t	NN
cord-005453-4057qib7	9721	13	cell	cell	NN
cord-005453-4057qib7	9721	14	replete	replete	JJ
cord-005453-4057qib7	9721	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9721	16	stem	stem	NN
cord-005453-4057qib7	9721	17	cell	cell	NN
cord-005453-4057qib7	9721	18	transplantation	transplantation	NN
cord-005453-4057qib7	9721	19	(	(	-LRB-
cord-005453-4057qib7	9721	20	haplo	haplo	NNP
cord-005453-4057qib7	9721	21	-	-	HYPH
cord-005453-4057qib7	9721	22	SCT	SCT	NNP
cord-005453-4057qib7	9721	23	)	)	-RRB-
cord-005453-4057qib7	9721	24	with	with	IN
cord-005453-4057qib7	9721	25	PTCY	PTCY	NNP
cord-005453-4057qib7	9721	26	.	.	.
cord-005453-4057qib7	9722	1	The	the	DT
cord-005453-4057qib7	9722	2	study	study	NN
cord-005453-4057qib7	9722	3	of	of	IN
cord-005453-4057qib7	9722	4	the	the	DT
cord-005453-4057qib7	9722	5	incidence	incidence	NN
cord-005453-4057qib7	9722	6	and	and	CC
cord-005453-4057qib7	9722	7	severity	severity	NN
cord-005453-4057qib7	9722	8	of	of	IN
cord-005453-4057qib7	9722	9	viral	viral	JJ
cord-005453-4057qib7	9722	10	reactivation	reactivation	NN
cord-005453-4057qib7	9722	11	is	be	VBZ
cord-005453-4057qib7	9722	12	therefore	therefore	RB
cord-005453-4057qib7	9722	13	relevant	relevant	JJ
cord-005453-4057qib7	9722	14	to	to	IN
cord-005453-4057qib7	9722	15	the	the	DT
cord-005453-4057qib7	9722	16	outcomes	outcome	NNS
cord-005453-4057qib7	9722	17	of	of	IN
cord-005453-4057qib7	9722	18	haplo	haplo	NNP
cord-005453-4057qib7	9722	19	-	-	HYPH
cord-005453-4057qib7	9722	20	SCT	SCT	NNP
cord-005453-4057qib7	9722	21	with	with	IN
cord-005453-4057qib7	9722	22	PTCY	PTCY	NNP
cord-005453-4057qib7	9722	23	.	.	.
cord-005453-4057qib7	9723	1	Methods	method	NNS
cord-005453-4057qib7	9723	2	:	:	:
cord-005453-4057qib7	9724	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9724	2	study	study	NN
cord-005453-4057qib7	9724	3	enrolled	enrol	VBD
cord-005453-4057qib7	9724	4	42	42	CD
cord-005453-4057qib7	9724	5	patients	patient	NNS
cord-005453-4057qib7	9724	6	(	(	-LRB-
cord-005453-4057qib7	9724	7	women	woman	NNS
cord-005453-4057qib7	9724	8	/	/	SYM
cord-005453-4057qib7	9724	9	men	man	NNS
cord-005453-4057qib7	9724	10	,	,	,
cord-005453-4057qib7	9724	11	19/23	19/23	CD
cord-005453-4057qib7	9724	12	)	)	-RRB-
cord-005453-4057qib7	9724	13	,	,	,
cord-005453-4057qib7	9724	14	who	who	WP
cord-005453-4057qib7	9724	15	underwent	undergo	VBD
cord-005453-4057qib7	9724	16	T	T	NNP
cord-005453-4057qib7	9724	17	cell	cell	NN
cord-005453-4057qib7	9724	18	replete	replete	JJ
cord-005453-4057qib7	9724	19	haplo	haplo	NNP
cord-005453-4057qib7	9724	20	-	-	HYPH
cord-005453-4057qib7	9724	21	SCT	SCT	NNP
cord-005453-4057qib7	9724	22	from	from	IN
cord-005453-4057qib7	9724	23	12/	12/	CD
cord-005453-4057qib7	9724	24	2013	2013	CD
cord-005453-4057qib7	9724	25	to	to	IN
cord-005453-4057qib7	9724	26	10/2018	10/2018	CD
cord-005453-4057qib7	9724	27	and	and	CC
cord-005453-4057qib7	9724	28	achieved	achieve	VBN
cord-005453-4057qib7	9724	29	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9724	30	engraftment	engraftment	NN
cord-005453-4057qib7	9724	31	.	.	.
cord-005453-4057qib7	9725	1	Median	median	JJ
cord-005453-4057qib7	9725	2	age	age	NN
cord-005453-4057qib7	9725	3	at	at	IN
cord-005453-4057qib7	9725	4	transplant	transplant	NN
cord-005453-4057qib7	9725	5	was	be	VBD
cord-005453-4057qib7	9725	6	53.5	53.5	CD
cord-005453-4057qib7	9725	7	years	year	NNS
cord-005453-4057qib7	9726	1	(	(	-LRB-
cord-005453-4057qib7	9726	2	range	range	NN
cord-005453-4057qib7	9726	3	,	,	,
cord-005453-4057qib7	9726	4	19	19	CD
cord-005453-4057qib7	9726	5	-	-	SYM
cord-005453-4057qib7	9726	6	70	70	CD
cord-005453-4057qib7	9726	7	)	)	-RRB-
cord-005453-4057qib7	9726	8	.	.	.
cord-005453-4057qib7	9727	1	The	the	DT
cord-005453-4057qib7	9727	2	underlying	underlying	JJ
cord-005453-4057qib7	9727	3	disease	disease	NN
cord-005453-4057qib7	9727	4	was	be	VBD
cord-005453-4057qib7	9727	5	AML	AML	NNP
cord-005453-4057qib7	9727	6	(	(	-LRB-
cord-005453-4057qib7	9727	7	n=17	n=17	NNP
cord-005453-4057qib7	9727	8	)	)	-RRB-
cord-005453-4057qib7	9727	9	,	,	,
cord-005453-4057qib7	9727	10	ALL	all	DT
cord-005453-4057qib7	9727	11	(	(	-LRB-
cord-005453-4057qib7	9727	12	n=9	n=9	NN
cord-005453-4057qib7	9727	13	)	)	-RRB-
cord-005453-4057qib7	9727	14	,	,	,
cord-005453-4057qib7	9727	15	MDS	MDS	NNP
cord-005453-4057qib7	9727	16	(	(	-LRB-
cord-005453-4057qib7	9727	17	n=9	n=9	NN
cord-005453-4057qib7	9727	18	)	)	-RRB-
cord-005453-4057qib7	9727	19	,	,	,
cord-005453-4057qib7	9727	20	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	9727	21	(	(	-LRB-
cord-005453-4057qib7	9727	22	n=4	n=4	NNP
cord-005453-4057qib7	9727	23	)	)	-RRB-
cord-005453-4057qib7	9727	24	,	,	,
cord-005453-4057qib7	9727	25	CML	CML	NNP
cord-005453-4057qib7	9727	26	(	(	-LRB-
cord-005453-4057qib7	9727	27	n=2	n=2	NNP
cord-005453-4057qib7	9727	28	)	)	-RRB-
cord-005453-4057qib7	9727	29	,	,	,
cord-005453-4057qib7	9727	30	or	or	CC
cord-005453-4057qib7	9727	31	CLL	CLL	NNP
cord-005453-4057qib7	9727	32	(	(	-LRB-
cord-005453-4057qib7	9727	33	n=1	n=1	NN
cord-005453-4057qib7	9727	34	)	)	-RRB-
cord-005453-4057qib7	9727	35	.	.	.
cord-005453-4057qib7	9728	1	The	the	DT
cord-005453-4057qib7	9728	2	conditioning	conditioning	NN
cord-005453-4057qib7	9728	3	regimen	regimen	NN
cord-005453-4057qib7	9728	4	was	be	VBD
cord-005453-4057qib7	9728	5	myeloablative	myeloablative	NNP
cord-005453-4057qib7	9728	6	(	(	-LRB-
cord-005453-4057qib7	9728	7	n=31	n=31	NNP
cord-005453-4057qib7	9728	8	)	)	-RRB-
cord-005453-4057qib7	9728	9	,	,	,
cord-005453-4057qib7	9728	10	reduced	reduce	VBN
cord-005453-4057qib7	9728	11	-	-	HYPH
cord-005453-4057qib7	9728	12	intensity	intensity	NN
cord-005453-4057qib7	9728	13	(	(	-LRB-
cord-005453-4057qib7	9728	14	n=10	n=10	NNP
cord-005453-4057qib7	9728	15	)	)	-RRB-
cord-005453-4057qib7	9728	16	or	or	CC
cord-005453-4057qib7	9728	17	non	non	JJ
cord-005453-4057qib7	9728	18	-	-	JJ
cord-005453-4057qib7	9728	19	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9728	20	(	(	-LRB-
cord-005453-4057qib7	9728	21	n=1	n=1	JJ
cord-005453-4057qib7	9728	22	)	)	-RRB-
cord-005453-4057qib7	9728	23	.	.	.
cord-005453-4057qib7	9729	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	9729	2	blood	blood	NN
cord-005453-4057qib7	9729	3	was	be	VBD
cord-005453-4057qib7	9729	4	the	the	DT
cord-005453-4057qib7	9729	5	graft	graft	NN
cord-005453-4057qib7	9729	6	source	source	NN
cord-005453-4057qib7	9729	7	in	in	IN
cord-005453-4057qib7	9729	8	the	the	DT
cord-005453-4057qib7	9729	9	majority	majority	NN
cord-005453-4057qib7	9729	10	of	of	IN
cord-005453-4057qib7	9729	11	cases	case	NNS
cord-005453-4057qib7	9729	12	(	(	-LRB-
cord-005453-4057qib7	9729	13	n=29	n=29	NNP
cord-005453-4057qib7	9729	14	)	)	-RRB-
cord-005453-4057qib7	9729	15	and	and	CC
cord-005453-4057qib7	9729	16	bone	bone	NN
cord-005453-4057qib7	9729	17	marrow	marrow	NN
cord-005453-4057qib7	9729	18	in	in	IN
cord-005453-4057qib7	9729	19	the	the	DT
cord-005453-4057qib7	9729	20	remaining	remain	VBG
cord-005453-4057qib7	9729	21	(	(	-LRB-
cord-005453-4057qib7	9729	22	n=13	n=13	NNP
cord-005453-4057qib7	9729	23	)	)	-RRB-
cord-005453-4057qib7	9729	24	.	.	.
cord-005453-4057qib7	9730	1	Recipient	recipient	NN
cord-005453-4057qib7	9730	2	/	/	SYM
cord-005453-4057qib7	9730	3	donor	donor	NN
cord-005453-4057qib7	9730	4	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	9730	5	(	(	-LRB-
cord-005453-4057qib7	9730	6	CMV	CMV	NNP
cord-005453-4057qib7	9730	7	)	)	-RRB-
cord-005453-4057qib7	9730	8	serostatus	serostatus	NNP
cord-005453-4057qib7	9730	9	was	be	VBD
cord-005453-4057qib7	9730	10	-/-(n=2	-/-(n=2	CD
cord-005453-4057qib7	9730	11	)	)	-RRB-
cord-005453-4057qib7	9730	12	,	,	,
cord-005453-4057qib7	9730	13	-/+	-/+	NNP
cord-005453-4057qib7	9731	1	(	(	-LRB-
cord-005453-4057qib7	9731	2	n=	n=	NNP
cord-005453-4057qib7	9731	3	4	4	CD
cord-005453-4057qib7	9731	4	)	)	-RRB-
cord-005453-4057qib7	9731	5	,	,	,
cord-005453-4057qib7	9731	6	+	+	CC
cord-005453-4057qib7	9731	7	/-(n=8	/-(n=8	.
cord-005453-4057qib7	9731	8	)	)	-RRB-
cord-005453-4057qib7	9731	9	,	,	,
cord-005453-4057qib7	9731	10	or	or	CC
cord-005453-4057qib7	9732	1	+	+	CC
cord-005453-4057qib7	9732	2	/+	/+	.
cord-005453-4057qib7	9733	1	(	(	-LRB-
cord-005453-4057qib7	9733	2	n=28	n=28	RB
cord-005453-4057qib7	9733	3	)	)	-RRB-
cord-005453-4057qib7	9733	4	.	.	.
cord-005453-4057qib7	9734	1	The	the	DT
cord-005453-4057qib7	9734	2	combination	combination	NN
cord-005453-4057qib7	9734	3	of	of	IN
cord-005453-4057qib7	9734	4	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	9734	5	and	and	CC
cord-005453-4057qib7	9734	6	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	9734	7	mofetil	mofetil	NNP
cord-005453-4057qib7	9734	8	was	be	VBD
cord-005453-4057qib7	9734	9	administered	administer	VBN
cord-005453-4057qib7	9734	10	in	in	IN
cord-005453-4057qib7	9734	11	addition	addition	NN
cord-005453-4057qib7	9734	12	to	to	IN
cord-005453-4057qib7	9734	13	PTCY	PTCY	NNP
cord-005453-4057qib7	9734	14	for	for	IN
cord-005453-4057qib7	9734	15	prevention	prevention	NN
cord-005453-4057qib7	9734	16	of	of	IN
cord-005453-4057qib7	9734	17	graftversus	graftversus	NNP
cord-005453-4057qib7	9734	18	-	-	HYPH
cord-005453-4057qib7	9734	19	host	host	NN
cord-005453-4057qib7	9734	20	disease	disease	NN
cord-005453-4057qib7	9734	21	.	.	.
cord-005453-4057qib7	9735	1	CMV	CMV	NNP
cord-005453-4057qib7	9735	2	,	,	,
cord-005453-4057qib7	9735	3	Epstein	Epstein	NNP
cord-005453-4057qib7	9735	4	-	-	HYPH
cord-005453-4057qib7	9735	5	Barr	Barr	NNP
cord-005453-4057qib7	9735	6	virus	virus	NN
cord-005453-4057qib7	9735	7	(	(	-LRB-
cord-005453-4057qib7	9735	8	EBV	EBV	NNP
cord-005453-4057qib7	9735	9	)	)	-RRB-
cord-005453-4057qib7	9735	10	,	,	,
cord-005453-4057qib7	9735	11	and	and	CC
cord-005453-4057qib7	9735	12	human	human	JJ
cord-005453-4057qib7	9735	13	herpesvirus-6	herpesvirus-6	NNP
cord-005453-4057qib7	9735	14	(	(	-LRB-
cord-005453-4057qib7	9735	15	HHV-6	HHV-6	NNP
cord-005453-4057qib7	9735	16	)	)	-RRB-
cord-005453-4057qib7	9735	17	reactivation	reactivation	NN
cord-005453-4057qib7	9735	18	was	be	VBD
cord-005453-4057qib7	9735	19	monitored	monitor	VBN
cord-005453-4057qib7	9735	20	by	by	IN
cord-005453-4057qib7	9735	21	real	real	JJ
cord-005453-4057qib7	9735	22	-	-	HYPH
cord-005453-4057qib7	9735	23	time	time	NN
cord-005453-4057qib7	9735	24	quantitative	quantitative	JJ
cord-005453-4057qib7	9735	25	PCR	PCR	NNP
cord-005453-4057qib7	9735	26	(	(	-LRB-
cord-005453-4057qib7	9735	27	RQ	RQ	NNP
cord-005453-4057qib7	9735	28	-	-	HYPH
cord-005453-4057qib7	9735	29	PCR	PCR	NNP
cord-005453-4057qib7	9735	30	)	)	-RRB-
cord-005453-4057qib7	9735	31	in	in	IN
cord-005453-4057qib7	9735	32	blood	blood	NN
cord-005453-4057qib7	9736	1	twice	twice	NNP
cord-005453-4057qib7	9736	2	weekly	weekly	JJ
cord-005453-4057qib7	9736	3	post	post	JJ
cord-005453-4057qib7	9736	4	haplo	haplo	NNP
cord-005453-4057qib7	9736	5	-	-	HYPH
cord-005453-4057qib7	9736	6	SCT	SCT	NNP
cord-005453-4057qib7	9736	7	.	.	.
cord-005453-4057qib7	9737	1	BK	BK	NNP
cord-005453-4057qib7	9737	2	virus	virus	NN
cord-005453-4057qib7	9737	3	(	(	-LRB-
cord-005453-4057qib7	9737	4	BKV	BKV	NNP
cord-005453-4057qib7	9737	5	)	)	-RRB-
cord-005453-4057qib7	9737	6	reactivation	reactivation	NN
cord-005453-4057qib7	9737	7	was	be	VBD
cord-005453-4057qib7	9737	8	assessed	assess	VBN
cord-005453-4057qib7	9737	9	by	by	IN
cord-005453-4057qib7	9737	10	RQ	RQ	NNP
cord-005453-4057qib7	9737	11	-	-	HYPH
cord-005453-4057qib7	9737	12	PCR	PCR	NNP
cord-005453-4057qib7	9737	13	in	in	IN
cord-005453-4057qib7	9737	14	urine	urine	NN
cord-005453-4057qib7	9737	15	and/or	and/or	CC
cord-005453-4057qib7	9737	16	blood	blood	NN
cord-005453-4057qib7	9737	17	specimens	specimen	NNS
cord-005453-4057qib7	9737	18	in	in	IN
cord-005453-4057qib7	9737	19	cases	case	NNS
cord-005453-4057qib7	9737	20	with	with	IN
cord-005453-4057qib7	9737	21	symptoms	symptom	NNS
cord-005453-4057qib7	9737	22	suggestive	suggestive	JJ
cord-005453-4057qib7	9737	23	of	of	IN
cord-005453-4057qib7	9737	24	BKV	bkv	NN
cord-005453-4057qib7	9737	25	-	-	HYPH
cord-005453-4057qib7	9737	26	associated	associate	VBN
cord-005453-4057qib7	9737	27	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9737	28	cystitis	cystitis	NN
cord-005453-4057qib7	9737	29	(	(	-LRB-
cord-005453-4057qib7	9737	30	HC	HC	NNP
cord-005453-4057qib7	9737	31	)	)	-RRB-
cord-005453-4057qib7	9737	32	.	.	.
cord-005453-4057qib7	9738	1	Results	result	NNS
cord-005453-4057qib7	9738	2	:	:	:
cord-005453-4057qib7	9739	1	With	with	IN
cord-005453-4057qib7	9739	2	a	a	DT
cord-005453-4057qib7	9739	3	median	median	JJ
cord-005453-4057qib7	9739	4	follow	follow	NN
cord-005453-4057qib7	9739	5	-	-	HYPH
cord-005453-4057qib7	9739	6	up	up	NN
cord-005453-4057qib7	9739	7	time	time	NN
cord-005453-4057qib7	9739	8	of	of	IN
cord-005453-4057qib7	9739	9	25	25	CD
cord-005453-4057qib7	9739	10	months	month	NNS
cord-005453-4057qib7	9739	11	(	(	-LRB-
cord-005453-4057qib7	9739	12	range	range	NN
cord-005453-4057qib7	9739	13	,	,	,
cord-005453-4057qib7	9739	14	,	,	,
cord-005453-4057qib7	9739	15	the	the	DT
cord-005453-4057qib7	9739	16	cumulative	cumulative	JJ
cord-005453-4057qib7	9739	17	incidences	incidence	NNS
cord-005453-4057qib7	9739	18	(	(	-LRB-
cord-005453-4057qib7	9739	19	CIN	CIN	NNP
cord-005453-4057qib7	9739	20	)	)	-RRB-
cord-005453-4057qib7	9739	21	of	of	IN
cord-005453-4057qib7	9739	22	relapse	relapse	NN
cord-005453-4057qib7	9739	23	and	and	CC
cord-005453-4057qib7	9739	24	non	non	JJ
cord-005453-4057qib7	9739	25	-	-	JJ
cord-005453-4057qib7	9739	26	relapse	relapse	JJ
cord-005453-4057qib7	9739	27	mortality	mortality	NN
cord-005453-4057qib7	9739	28	(	(	-LRB-
cord-005453-4057qib7	9739	29	NRM	NRM	NNP
cord-005453-4057qib7	9739	30	)	)	-RRB-
cord-005453-4057qib7	9739	31	were	be	VBD
cord-005453-4057qib7	9739	32	15.5	15.5	CD
cord-005453-4057qib7	9739	33	%	%	NN
cord-005453-4057qib7	9739	34	(	(	-LRB-
cord-005453-4057qib7	9739	35	95	95	CD
cord-005453-4057qib7	9739	36	%	%	NN
cord-005453-4057qib7	9739	37	CI	CI	NNP
cord-005453-4057qib7	9739	38	,	,	,
cord-005453-4057qib7	9739	39	6.2	6.2	CD
cord-005453-4057qib7	9739	40	-	-	SYM
cord-005453-4057qib7	9739	41	28.6	28.6	CD
cord-005453-4057qib7	9739	42	%	%	NN
cord-005453-4057qib7	9739	43	)	)	-RRB-
cord-005453-4057qib7	9739	44	and	and	CC
cord-005453-4057qib7	9739	45	33.3	33.3	CD
cord-005453-4057qib7	9739	46	%	%	NN
cord-005453-4057qib7	9739	47	(	(	-LRB-
cord-005453-4057qib7	9739	48	95	95	CD
cord-005453-4057qib7	9739	49	%	%	NN
cord-005453-4057qib7	9739	50	CI	CI	NNP
cord-005453-4057qib7	9739	51	,	,	,
cord-005453-4057qib7	9739	52	18.9	18.9	CD
cord-005453-4057qib7	9739	53	-	-	SYM
cord-005453-4057qib7	9739	54	48.2	48.2	CD
cord-005453-4057qib7	9739	55	%	%	NN
cord-005453-4057qib7	9739	56	)	)	-RRB-
cord-005453-4057qib7	9739	57	at	at	IN
cord-005453-4057qib7	9739	58	2	2	CD
cord-005453-4057qib7	9739	59	years	year	NNS
cord-005453-4057qib7	9739	60	,	,	,
cord-005453-4057qib7	9739	61	respectively	respectively	RB
cord-005453-4057qib7	9739	62	.	.	.
cord-005453-4057qib7	9740	1	Median	median	JJ
cord-005453-4057qib7	9740	2	disease	disease	NN
cord-005453-4057qib7	9740	3	-	-	HYPH
cord-005453-4057qib7	9740	4	free	free	JJ
cord-005453-4057qib7	9740	5	(	(	-LRB-
cord-005453-4057qib7	9740	6	DFS	DFS	NNP
cord-005453-4057qib7	9740	7	)	)	-RRB-
cord-005453-4057qib7	9740	8	and	and	CC
cord-005453-4057qib7	9740	9	overall	overall	JJ
cord-005453-4057qib7	9740	10	survival	survival	NN
cord-005453-4057qib7	9740	11	(	(	-LRB-
cord-005453-4057qib7	9740	12	OS	OS	NNP
cord-005453-4057qib7	9740	13	)	)	-RRB-
cord-005453-4057qib7	9740	14	were	be	VBD
cord-005453-4057qib7	9740	15	53.3	53.3	CD
cord-005453-4057qib7	9740	16	%	%	NN
cord-005453-4057qib7	9740	17	(	(	-LRB-
cord-005453-4057qib7	9740	18	95	95	CD
cord-005453-4057qib7	9740	19	%	%	NN
cord-005453-4057qib7	9740	20	CI	CI	NNP
cord-005453-4057qib7	9740	21	,	,	,
cord-005453-4057qib7	9740	22	39.5	39.5	CD
cord-005453-4057qib7	9740	23	-	-	HYPH
cord-005453-4057qib7	9740	24	71.9	71.9	CD
cord-005453-4057qib7	9740	25	%	%	NN
cord-005453-4057qib7	9740	26	)	)	-RRB-
cord-005453-4057qib7	9740	27	and	and	CC
cord-005453-4057qib7	9740	28	58.4	58.4	CD
cord-005453-4057qib7	9740	29	%	%	NN
cord-005453-4057qib7	9740	30	(	(	-LRB-
cord-005453-4057qib7	9740	31	95	95	CD
cord-005453-4057qib7	9740	32	%	%	NN
cord-005453-4057qib7	9740	33	CI	CI	NNP
cord-005453-4057qib7	9740	34	,	,	,
cord-005453-4057qib7	9740	35	44.6	44.6	CD
cord-005453-4057qib7	9740	36	-	-	SYM
cord-005453-4057qib7	9740	37	76.5	76.5	CD
cord-005453-4057qib7	9740	38	%	%	NN
cord-005453-4057qib7	9740	39	)	)	-RRB-
cord-005453-4057qib7	9740	40	at	at	IN
cord-005453-4057qib7	9740	41	2	2	CD
cord-005453-4057qib7	9740	42	years	year	NNS
cord-005453-4057qib7	9740	43	,	,	,
cord-005453-4057qib7	9740	44	respectively	respectively	RB
cord-005453-4057qib7	9740	45	.	.	.
cord-005453-4057qib7	9741	1	The	the	DT
cord-005453-4057qib7	9741	2	CIN	CIN	NNP
cord-005453-4057qib7	9741	3	of	of	IN
cord-005453-4057qib7	9741	4	CMV	CMV	NNP
cord-005453-4057qib7	9741	5	reactivation	reactivation	NN
cord-005453-4057qib7	9741	6	/	/	SYM
cord-005453-4057qib7	9741	7	infection	infection	NN
cord-005453-4057qib7	9741	8	(	(	-LRB-
cord-005453-4057qib7	9741	9	>	>	NFP
cord-005453-4057qib7	9741	10	100	100	CD
cord-005453-4057qib7	9741	11	copies	copy	NNS
cord-005453-4057qib7	9741	12	/	/	SYM
cord-005453-4057qib7	9741	13	ml	ml	NN
cord-005453-4057qib7	9741	14	)	)	-RRB-
cord-005453-4057qib7	9741	15	reached	reach	VBD
cord-005453-4057qib7	9741	16	75.7	75.7	CD
cord-005453-4057qib7	9741	17	%	%	NN
cord-005453-4057qib7	9741	18	(	(	-LRB-
cord-005453-4057qib7	9741	19	95	95	CD
cord-005453-4057qib7	9741	20	%	%	NN
cord-005453-4057qib7	9741	21	CI	CI	NNP
cord-005453-4057qib7	9741	22	,	,	,
cord-005453-4057qib7	9741	23	58.8	58.8	CD
cord-005453-4057qib7	9741	24	-	-	HYPH
cord-005453-4057qib7	9741	25	86.4	86.4	CD
cord-005453-4057qib7	9741	26	%	%	NN
cord-005453-4057qib7	9741	27	)	)	-RRB-
cord-005453-4057qib7	9741	28	at	at	IN
cord-005453-4057qib7	9741	29	3	3	CD
cord-005453-4057qib7	9741	30	months	month	NNS
cord-005453-4057qib7	9741	31	.	.	.
cord-005453-4057qib7	9742	1	CMV	CMV	NNP
cord-005453-4057qib7	9742	2	infection	infection	NN
cord-005453-4057qib7	9742	3	developed	develop	VBD
cord-005453-4057qib7	9742	4	in	in	IN
cord-005453-4057qib7	9742	5	30	30	CD
cord-005453-4057qib7	9742	6	out	out	IN
cord-005453-4057qib7	9742	7	of	of	IN
cord-005453-4057qib7	9742	8	40	40	CD
cord-005453-4057qib7	9742	9	patients	patient	NNS
cord-005453-4057qib7	9742	10	who	who	WP
cord-005453-4057qib7	9742	11	were	be	VBD
cord-005453-4057qib7	9742	12	at	at	IN
cord-005453-4057qib7	9742	13	risk	risk	NN
cord-005453-4057qib7	9742	14	,	,	,
cord-005453-4057qib7	9742	15	whereas	whereas	IN
cord-005453-4057qib7	9742	16	recurrent	recurrent	JJ
cord-005453-4057qib7	9742	17	CMV	CMV	NNP
cord-005453-4057qib7	9742	18	reactivation	reactivation	NN
cord-005453-4057qib7	9742	19	was	be	VBD
cord-005453-4057qib7	9742	20	observed	observe	VBN
cord-005453-4057qib7	9742	21	in	in	IN
cord-005453-4057qib7	9742	22	15	15	CD
cord-005453-4057qib7	9742	23	patients	patient	NNS
cord-005453-4057qib7	9742	24	with	with	IN
cord-005453-4057qib7	9742	25	a	a	DT
cord-005453-4057qib7	9742	26	median	median	JJ
cord-005453-4057qib7	9742	27	number	number	NN
cord-005453-4057qib7	9742	28	of	of	IN
cord-005453-4057qib7	9742	29	2	2	CD
cord-005453-4057qib7	9742	30	episodes	episode	NNS
cord-005453-4057qib7	9742	31	(	(	-LRB-
cord-005453-4057qib7	9742	32	range	range	NN
cord-005453-4057qib7	9742	33	,	,	,
cord-005453-4057qib7	9742	34	2	2	CD
cord-005453-4057qib7	9742	35	-	-	SYM
cord-005453-4057qib7	9742	36	6	6	CD
cord-005453-4057qib7	9742	37	)	)	-RRB-
cord-005453-4057qib7	9742	38	per	per	IN
cord-005453-4057qib7	9742	39	patient	patient	NN
cord-005453-4057qib7	9742	40	.	.	.
cord-005453-4057qib7	9743	1	The	the	DT
cord-005453-4057qib7	9743	2	median	median	JJ
cord-005453-4057qib7	9743	3	total	total	JJ
cord-005453-4057qib7	9743	4	duration	duration	NN
cord-005453-4057qib7	9743	5	of	of	IN
cord-005453-4057qib7	9743	6	antiviral	antiviral	JJ
cord-005453-4057qib7	9743	7	therapy	therapy	NN
cord-005453-4057qib7	9743	8	for	for	IN
cord-005453-4057qib7	9743	9	CMV	CMV	NNP
cord-005453-4057qib7	9743	10	infection	infection	NN
cord-005453-4057qib7	9743	11	was	be	VBD
cord-005453-4057qib7	9743	12	27	27	CD
cord-005453-4057qib7	9743	13	days	day	NNS
cord-005453-4057qib7	9743	14	(	(	-LRB-
cord-005453-4057qib7	9743	15	range	range	NN
cord-005453-4057qib7	9743	16	,	,	,
cord-005453-4057qib7	9743	17	14	14	CD
cord-005453-4057qib7	9743	18	-	-	SYM
cord-005453-4057qib7	9743	19	199	199	CD
cord-005453-4057qib7	9743	20	)	)	-RRB-
cord-005453-4057qib7	9743	21	.	.	.
cord-005453-4057qib7	9744	1	CMV	CMV	NNP
cord-005453-4057qib7	9744	2	disease	disease	NN
cord-005453-4057qib7	9744	3	(	(	-LRB-
cord-005453-4057qib7	9744	4	pneumonia	pneumonia	NN
cord-005453-4057qib7	9744	5	)	)	-RRB-
cord-005453-4057qib7	9744	6	was	be	VBD
cord-005453-4057qib7	9744	7	documented	document	VBN
cord-005453-4057qib7	9744	8	in	in	IN
cord-005453-4057qib7	9744	9	2	2	CD
cord-005453-4057qib7	9744	10	patients	patient	NNS
cord-005453-4057qib7	9744	11	.	.	.
cord-005453-4057qib7	9745	1	The	the	DT
cord-005453-4057qib7	9745	2	CIN	CIN	NNP
cord-005453-4057qib7	9745	3	of	of	IN
cord-005453-4057qib7	9745	4	EBV	EBV	NNP
cord-005453-4057qib7	9745	5	reactivation	reactivation	NN
cord-005453-4057qib7	9745	6	(	(	-LRB-
cord-005453-4057qib7	9745	7	>	>	NFP
cord-005453-4057qib7	9745	8	1,000	1,000	CD
cord-005453-4057qib7	9745	9	copies	copy	NNS
cord-005453-4057qib7	9745	10	/	/	SYM
cord-005453-4057qib7	9745	11	ml	ml	NN
cord-005453-4057qib7	9745	12	)	)	-RRB-
cord-005453-4057qib7	9745	13	was	be	VBD
cord-005453-4057qib7	9745	14	50.9	50.9	CD
cord-005453-4057qib7	9745	15	%	%	NN
cord-005453-4057qib7	9745	16	(	(	-LRB-
cord-005453-4057qib7	9745	17	95	95	CD
cord-005453-4057qib7	9745	18	%	%	NN
cord-005453-4057qib7	9745	19	CI	CI	NNP
cord-005453-4057qib7	9745	20	,	,	,
cord-005453-4057qib7	9745	21	34.2	34.2	CD
cord-005453-4057qib7	9745	22	-	-	HYPH
cord-005453-4057qib7	9745	23	65.3	65.3	CD
cord-005453-4057qib7	9745	24	%	%	NN
cord-005453-4057qib7	9745	25	)	)	-RRB-
cord-005453-4057qib7	9745	26	at	at	IN
cord-005453-4057qib7	9745	27	12	12	CD
cord-005453-4057qib7	9745	28	months	month	NNS
cord-005453-4057qib7	9745	29	.	.	.
cord-005453-4057qib7	9746	1	No	no	DT
cord-005453-4057qib7	9746	2	case	case	NN
cord-005453-4057qib7	9746	3	of	of	IN
cord-005453-4057qib7	9746	4	EBV	EBV	NNP
cord-005453-4057qib7	9746	5	-	-	HYPH
cord-005453-4057qib7	9746	6	related	relate	VBN
cord-005453-4057qib7	9746	7	post	post	JJ
cord-005453-4057qib7	9746	8	-	-	JJ
cord-005453-4057qib7	9746	9	transplant	transplant	JJ
cord-005453-4057qib7	9746	10	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	9746	11	disorder	disorder	NN
cord-005453-4057qib7	9746	12	was	be	VBD
cord-005453-4057qib7	9746	13	observed	observe	VBN
cord-005453-4057qib7	9746	14	,	,	,
cord-005453-4057qib7	9746	15	however	however	RB
cord-005453-4057qib7	9746	16	preemptive	preemptive	JJ
cord-005453-4057qib7	9746	17	therapy	therapy	NN
cord-005453-4057qib7	9746	18	with	with	IN
cord-005453-4057qib7	9746	19	rituximab	rituximab	NNP
cord-005453-4057qib7	9746	20	was	be	VBD
cord-005453-4057qib7	9746	21	required	require	VBN
cord-005453-4057qib7	9746	22	in	in	IN
cord-005453-4057qib7	9746	23	2	2	CD
cord-005453-4057qib7	9746	24	patients	patient	NNS
cord-005453-4057qib7	9746	25	with	with	IN
cord-005453-4057qib7	9746	26	rapidly	rapidly	RB
cord-005453-4057qib7	9746	27	increasing	increase	VBG
cord-005453-4057qib7	9746	28	EBV	EBV	NNP
cord-005453-4057qib7	9746	29	viral	viral	JJ
cord-005453-4057qib7	9746	30	load	load	NN
cord-005453-4057qib7	9746	31	.	.	.
cord-005453-4057qib7	9747	1	HHV-6	HHV-6	NNP
cord-005453-4057qib7	9747	2	reactivation	reactivation	NN
cord-005453-4057qib7	9747	3	(	(	-LRB-
cord-005453-4057qib7	9747	4	>	>	NFP
cord-005453-4057qib7	9747	5	1,000	1,000	CD
cord-005453-4057qib7	9747	6	copies	copy	NNS
cord-005453-4057qib7	9747	7	/	/	SYM
cord-005453-4057qib7	9747	8	ml	ml	NN
cord-005453-4057qib7	9747	9	)	)	-RRB-
cord-005453-4057qib7	9747	10	was	be	VBD
cord-005453-4057qib7	9747	11	observed	observe	VBN
cord-005453-4057qib7	9747	12	in	in	IN
cord-005453-4057qib7	9747	13	5	5	CD
cord-005453-4057qib7	9747	14	patients	patient	NNS
cord-005453-4057qib7	9747	15	(	(	-LRB-
cord-005453-4057qib7	9747	16	CIN	CIN	NNP
cord-005453-4057qib7	9747	17	,	,	,
cord-005453-4057qib7	9747	18	12.3	12.3	CD
cord-005453-4057qib7	9747	19	%	%	NN
cord-005453-4057qib7	9747	20	at	at	IN
cord-005453-4057qib7	9747	21	6	6	CD
cord-005453-4057qib7	9747	22	months	month	NNS
cord-005453-4057qib7	9747	23	;	;	:
cord-005453-4057qib7	9747	24	95	95	CD
cord-005453-4057qib7	9747	25	%	%	NN
cord-005453-4057qib7	9747	26	CI	CI	NNP
cord-005453-4057qib7	9747	27	,	,	,
cord-005453-4057qib7	9747	28	4.4	4.4	CD
cord-005453-4057qib7	9747	29	-	-	SYM
cord-005453-4057qib7	9747	30	24.5	24.5	CD
cord-005453-4057qib7	9747	31	%	%	NN
cord-005453-4057qib7	9747	32	)	)	-RRB-
cord-005453-4057qib7	9747	33	,	,	,
cord-005453-4057qib7	9747	34	with	with	IN
cord-005453-4057qib7	9747	35	none	none	NN
cord-005453-4057qib7	9747	36	of	of	IN
cord-005453-4057qib7	9747	37	them	-PRON-	PRP
cord-005453-4057qib7	9747	38	requiring	require	VBG
cord-005453-4057qib7	9747	39	specific	specific	JJ
cord-005453-4057qib7	9747	40	therapy	therapy	NN
cord-005453-4057qib7	9747	41	.	.	.
cord-005453-4057qib7	9748	1	BKV	BKV	NNP
cord-005453-4057qib7	9748	2	-	-	HYPH
cord-005453-4057qib7	9748	3	related	relate	VBN
cord-005453-4057qib7	9748	4	HC	HC	NNP
cord-005453-4057qib7	9748	5	occurred	occur	VBD
cord-005453-4057qib7	9748	6	at	at	IN
cord-005453-4057qib7	9748	7	a	a	DT
cord-005453-4057qib7	9748	8	CIN	CIN	NNP
cord-005453-4057qib7	9748	9	of	of	IN
cord-005453-4057qib7	9748	10	23.9	23.9	CD
cord-005453-4057qib7	9748	11	%	%	NN
cord-005453-4057qib7	9748	12	(	(	-LRB-
cord-005453-4057qib7	9748	13	95	95	CD
cord-005453-4057qib7	9748	14	%	%	NN
cord-005453-4057qib7	9748	15	CI	CI	NNP
cord-005453-4057qib7	9748	16	,	,	,
cord-005453-4057qib7	9748	17	12.3	12.3	CD
cord-005453-4057qib7	9748	18	-	-	HYPH
cord-005453-4057qib7	9748	19	37.7	37.7	CD
cord-005453-4057qib7	9748	20	%	%	NN
cord-005453-4057qib7	9748	21	)	)	-RRB-
cord-005453-4057qib7	9748	22	at	at	IN
cord-005453-4057qib7	9748	23	6	6	CD
cord-005453-4057qib7	9748	24	months	month	NNS
cord-005453-4057qib7	9748	25	.	.	.
cord-005453-4057qib7	9749	1	Cystoscopy	Cystoscopy	NNP
cord-005453-4057qib7	9749	2	for	for	IN
cord-005453-4057qib7	9749	3	bladder	bladder	NN
cord-005453-4057qib7	9749	4	hemostasis	hemostasis	NN
cord-005453-4057qib7	9749	5	was	be	VBD
cord-005453-4057qib7	9749	6	required	require	VBN
cord-005453-4057qib7	9749	7	in	in	IN
cord-005453-4057qib7	9749	8	4/11	4/11	CD
cord-005453-4057qib7	9749	9	and	and	CC
cord-005453-4057qib7	9749	10	nephrostomy	nephrostomy	VB
cord-005453-4057qib7	9749	11	in	in	IN
cord-005453-4057qib7	9749	12	1/11	1/11	CD
cord-005453-4057qib7	9749	13	patients	patient	NNS
cord-005453-4057qib7	9749	14	with	with	IN
cord-005453-4057qib7	9749	15	HC	HC	NNP
cord-005453-4057qib7	9749	16	.	.	.
cord-005453-4057qib7	9750	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9750	2	:	:	:
cord-005453-4057qib7	9751	1	Despite	despite	IN
cord-005453-4057qib7	9751	2	preservation	preservation	NN
cord-005453-4057qib7	9751	3	of	of	IN
cord-005453-4057qib7	9751	4	non	non	JJ
cord-005453-4057qib7	9751	5	-	-	JJ
cord-005453-4057qib7	9751	6	alloreactive	alloreactive	JJ
cord-005453-4057qib7	9751	7	memory	memory	NN
cord-005453-4057qib7	9751	8	T	T	NNP
cord-005453-4057qib7	9751	9	cells	cell	NNS
cord-005453-4057qib7	9751	10	,	,	,
cord-005453-4057qib7	9751	11	haplo	haplo	NN
cord-005453-4057qib7	9751	12	-	-	HYPH
cord-005453-4057qib7	9751	13	SCT	SCT	NNP
cord-005453-4057qib7	9751	14	with	with	IN
cord-005453-4057qib7	9751	15	PTCY	PTCY	NNP
cord-005453-4057qib7	9751	16	is	be	VBZ
cord-005453-4057qib7	9751	17	associated	associate	VBN
cord-005453-4057qib7	9751	18	with	with	IN
cord-005453-4057qib7	9751	19	substantial	substantial	JJ
cord-005453-4057qib7	9751	20	rates	rate	NNS
cord-005453-4057qib7	9751	21	of	of	IN
cord-005453-4057qib7	9751	22	viral	viral	JJ
cord-005453-4057qib7	9751	23	reactivation	reactivation	NN
cord-005453-4057qib7	9751	24	(	(	-LRB-
cord-005453-4057qib7	9751	25	especially	especially	RB
cord-005453-4057qib7	9751	26	CMV	CMV	NNP
cord-005453-4057qib7	9751	27	and	and	CC
cord-005453-4057qib7	9751	28	BKV	BKV	NNP
cord-005453-4057qib7	9751	29	)	)	-RRB-
cord-005453-4057qib7	9751	30	resulting	result	VBG
cord-005453-4057qib7	9751	31	in	in	IN
cord-005453-4057qib7	9751	32	the	the	DT
cord-005453-4057qib7	9751	33	need	need	NN
cord-005453-4057qib7	9751	34	for	for	IN
cord-005453-4057qib7	9751	35	prolonged	prolong	VBN
cord-005453-4057qib7	9751	36	antiviral	antiviral	JJ
cord-005453-4057qib7	9751	37	therapy	therapy	NN
cord-005453-4057qib7	9751	38	and	and	CC
cord-005453-4057qib7	9751	39	considerable	considerable	JJ
cord-005453-4057qib7	9751	40	morbidity	morbidity	NN
cord-005453-4057qib7	9751	41	as	as	RB
cord-005453-4057qib7	9751	42	well	well	RB
cord-005453-4057qib7	9751	43	.	.	.
cord-005453-4057qib7	9752	1	Therefore	therefore	RB
cord-005453-4057qib7	9752	2	,	,	,
cord-005453-4057qib7	9752	3	strategies	strategy	NNS
cord-005453-4057qib7	9752	4	to	to	TO
cord-005453-4057qib7	9752	5	prevent	prevent	VB
cord-005453-4057qib7	9752	6	viral	viral	JJ
cord-005453-4057qib7	9752	7	reactivation	reactivation	NN
cord-005453-4057qib7	9752	8	and	and	CC
cord-005453-4057qib7	9752	9	disease	disease	NN
cord-005453-4057qib7	9752	10	are	be	VBP
cord-005453-4057qib7	9752	11	still	still	RB
cord-005453-4057qib7	9752	12	warranted	warrant	VBN
cord-005453-4057qib7	9752	13	in	in	IN
cord-005453-4057qib7	9752	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9752	15	stem	stem	NN
cord-005453-4057qib7	9752	16	cell	cell	NN
cord-005453-4057qib7	9752	17	transplantation	transplantation	NN
cord-005453-4057qib7	9752	18	.	.	.
cord-005453-4057qib7	9753	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9753	2	:	:	:
cord-005453-4057qib7	9753	3	Nothing	nothing	NN
cord-005453-4057qib7	9753	4	to	to	TO
cord-005453-4057qib7	9753	5	declare	declare	VB
cord-005453-4057qib7	9753	6	.	.	.
cord-005453-4057qib7	9754	1	Background	background	NN
cord-005453-4057qib7	9754	2	:	:	:
cord-005453-4057qib7	9755	1	Adenovirus(AdV	adenovirus(adv	LS
cord-005453-4057qib7	9755	2	)	)	-RRB-
cord-005453-4057qib7	9755	3	infections	infection	NNS
cord-005453-4057qib7	9755	4	are	be	VBP
cord-005453-4057qib7	9755	5	a	a	DT
cord-005453-4057qib7	9755	6	wellrecognised	wellrecognised	JJ
cord-005453-4057qib7	9755	7	cause	cause	NN
cord-005453-4057qib7	9755	8	of	of	IN
cord-005453-4057qib7	9755	9	morbidity	morbidity	NN
cord-005453-4057qib7	9755	10	and	and	CC
cord-005453-4057qib7	9755	11	mortality	mortality	NN
cord-005453-4057qib7	9755	12	in	in	IN
cord-005453-4057qib7	9755	13	children	child	NNS
cord-005453-4057qib7	9755	14	and	and	CC
cord-005453-4057qib7	9755	15	adults	adult	NNS
cord-005453-4057qib7	9755	16	receiving	receive	VBG
cord-005453-4057qib7	9755	17	an	an	DT
cord-005453-4057qib7	9755	18	allogenic	allogenic	JJ
cord-005453-4057qib7	9755	19	stem	stem	NN
cord-005453-4057qib7	9755	20	cell	cell	NN
cord-005453-4057qib7	9756	1	transplant(HSCT).The	transplant(hsct).the	CD
cord-005453-4057qib7	9756	2	reported	report	VBN
cord-005453-4057qib7	9756	3	incidence	incidence	NN
cord-005453-4057qib7	9756	4	of	of	IN
cord-005453-4057qib7	9756	5	AdV	adv	NN
cord-005453-4057qib7	9756	6	infection	infection	NN
cord-005453-4057qib7	9756	7	is	be	VBZ
cord-005453-4057qib7	9756	8	higher(6%-42	higher(6%-42	NNP
cord-005453-4057qib7	9756	9	%	%	NN
cord-005453-4057qib7	9756	10	)	)	-RRB-
cord-005453-4057qib7	9756	11	in	in	IN
cord-005453-4057qib7	9756	12	paediatric	paediatric	JJ
cord-005453-4057qib7	9756	13	HSCT	HSCT	NNP
cord-005453-4057qib7	9756	14	than	than	IN
cord-005453-4057qib7	9756	15	in	in	IN
cord-005453-4057qib7	9756	16	adults(3	adults(3	CD
cord-005453-4057qib7	9756	17	-	-	HYPH
cord-005453-4057qib7	9756	18	27%),but	27%),but	CD
cord-005453-4057qib7	9757	1	we	-PRON-	PRP
cord-005453-4057qib7	9757	2	currently	currently	RB
cord-005453-4057qib7	9757	3	lack	lack	VBP
cord-005453-4057qib7	9757	4	accurate	accurate	JJ
cord-005453-4057qib7	9757	5	data	datum	NNS
cord-005453-4057qib7	9757	6	of	of	IN
cord-005453-4057qib7	9757	7	AdV	adv	NN
cord-005453-4057qib7	9757	8	infection	infection	NN
cord-005453-4057qib7	9757	9	burden	burden	NN
cord-005453-4057qib7	9757	10	among	among	IN
cord-005453-4057qib7	9757	11	adults	adult	NNS
cord-005453-4057qib7	9757	12	.	.	.
cord-005453-4057qib7	9758	1	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9758	2	has	have	VBZ
cord-005453-4057qib7	9758	3	been	be	VBN
cord-005453-4057qib7	9758	4	extensively	extensively	RB
cord-005453-4057qib7	9758	5	used	use	VBN
cord-005453-4057qib7	9758	6	as	as	IN
cord-005453-4057qib7	9758	7	a	a	DT
cord-005453-4057qib7	9758	8	pre	pre	JJ
cord-005453-4057qib7	9758	9	-	-	JJ
cord-005453-4057qib7	9758	10	emptive	emptive	JJ
cord-005453-4057qib7	9758	11	anti	anti	JJ
cord-005453-4057qib7	9758	12	-	-	JJ
cord-005453-4057qib7	9758	13	adenoviral	adenoviral	JJ
cord-005453-4057qib7	9758	14	therapy	therapy	NN
cord-005453-4057qib7	9758	15	and	and	CC
cord-005453-4057qib7	9758	16	is	be	VBZ
cord-005453-4057qib7	9758	17	current	current	JJ
cord-005453-4057qib7	9758	18	standard	standard	NN
cord-005453-4057qib7	9758	19	of	of	IN
cord-005453-4057qib7	9758	20	care	care	NN
cord-005453-4057qib7	9758	21	.	.	.
cord-005453-4057qib7	9759	1	We	-PRON-	PRP
cord-005453-4057qib7	9759	2	present	present	VBP
cord-005453-4057qib7	9759	3	our	-PRON-	PRP$
cord-005453-4057qib7	9759	4	single	single	JJ
cord-005453-4057qib7	9759	5	centre	centre	NN
cord-005453-4057qib7	9759	6	experience	experience	NN
cord-005453-4057qib7	9759	7	of	of	IN
cord-005453-4057qib7	9759	8	AdV	adv	NN
cord-005453-4057qib7	9759	9	incidence	incidence	NN
cord-005453-4057qib7	9759	10	and	and	CC
cord-005453-4057qib7	9759	11	outcomes	outcome	NNS
cord-005453-4057qib7	9759	12	with	with	IN
cord-005453-4057qib7	9759	13	pre	pre	JJ
cord-005453-4057qib7	9759	14	-	-	JJ
cord-005453-4057qib7	9759	15	emptive	emptive	JJ
cord-005453-4057qib7	9759	16	approach	approach	NN
cord-005453-4057qib7	9759	17	in	in	IN
cord-005453-4057qib7	9759	18	adult	adult	NN
cord-005453-4057qib7	9759	19	patients	patient	NNS
cord-005453-4057qib7	9759	20	receiving	receive	VBG
cord-005453-4057qib7	9759	21	T	t	NN
cord-005453-4057qib7	9759	22	-	-	HYPH
cord-005453-4057qib7	9759	23	cell	cell	NN
cord-005453-4057qib7	9759	24	depleted(TCD	depleted(tcd	NN
cord-005453-4057qib7	9759	25	)	)	-RRB-
cord-005453-4057qib7	9759	26	HSCTs	hsct	NNS
cord-005453-4057qib7	9759	27	for	for	IN
cord-005453-4057qib7	9759	28	myeloid	myeloid	JJ
cord-005453-4057qib7	9759	29	disorders	disorder	NNS
cord-005453-4057qib7	9759	30	.	.	.
cord-005453-4057qib7	9760	1	Methods	method	NNS
cord-005453-4057qib7	9760	2	:	:	:
cord-005453-4057qib7	9760	3	This	this	DT
cord-005453-4057qib7	9760	4	is	be	VBZ
cord-005453-4057qib7	9760	5	a	a	DT
cord-005453-4057qib7	9760	6	single	single	JJ
cord-005453-4057qib7	9760	7	-	-	HYPH
cord-005453-4057qib7	9760	8	centre	centre	NN
cord-005453-4057qib7	9760	9	retrospective	retrospective	JJ
cord-005453-4057qib7	9760	10	analysis	analysis	NN
cord-005453-4057qib7	9760	11	of	of	IN
cord-005453-4057qib7	9760	12	332	332	CD
cord-005453-4057qib7	9760	13	consecutive	consecutive	JJ
cord-005453-4057qib7	9760	14	HSCT	HSCT	NNP
cord-005453-4057qib7	9760	15	patients	patient	NNS
cord-005453-4057qib7	9760	16	for	for	IN
cord-005453-4057qib7	9760	17	myeloid	myeloid	JJ
cord-005453-4057qib7	9760	18	disorders	disorder	NNS
cord-005453-4057qib7	9760	19	including	include	VBG
cord-005453-4057qib7	9760	20	AML	AML	NNP
cord-005453-4057qib7	9760	21	,	,	,
cord-005453-4057qib7	9760	22	MDS	MDS	NNP
cord-005453-4057qib7	9760	23	,	,	,
cord-005453-4057qib7	9760	24	MPN	MPN	NNP
cord-005453-4057qib7	9760	25	&	&	CC
cord-005453-4057qib7	9760	26	Aplastic	Aplastic	NNP
cord-005453-4057qib7	9760	27	Anaemia	Anaemia	NNP
cord-005453-4057qib7	9760	28	between	between	IN
cord-005453-4057qib7	9760	29	January	January	NNP
cord-005453-4057qib7	9760	30	2012-June	2012-june	CD
cord-005453-4057qib7	9760	31	2016	2016	CD
cord-005453-4057qib7	9760	32	using	use	VBG
cord-005453-4057qib7	9760	33	ATG	ATG	NNP
cord-005453-4057qib7	9760	34	or	or	CC
cord-005453-4057qib7	9760	35	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	9760	36	based	base	VBD
cord-005453-4057qib7	9760	37	TCD.AdV	tcd.adv	NN
cord-005453-4057qib7	9760	38	screening	screening	NN
cord-005453-4057qib7	9760	39	was	be	VBD
cord-005453-4057qib7	9760	40	performed	perform	VBN
cord-005453-4057qib7	9760	41	in	in	IN
cord-005453-4057qib7	9760	42	all	all	DT
cord-005453-4057qib7	9760	43	patients	patient	NNS
cord-005453-4057qib7	9760	44	with	with	IN
cord-005453-4057qib7	9760	45	standardised	standardised	JJ
cord-005453-4057qib7	9760	46	real	real	JJ
cord-005453-4057qib7	9760	47	time	time	NN
cord-005453-4057qib7	9760	48	quantitative	quantitative	JJ
cord-005453-4057qib7	9760	49	PCR	PCR	NNP
cord-005453-4057qib7	9760	50	on	on	IN
cord-005453-4057qib7	9760	51	weekly	weekly	JJ
cord-005453-4057qib7	9760	52	basis	basis	NN
cord-005453-4057qib7	9760	53	during	during	IN
cord-005453-4057qib7	9760	54	standard	standard	JJ
cord-005453-4057qib7	9760	55	risk	risk	NN
cord-005453-4057qib7	9760	56	period	period	NN
cord-005453-4057qib7	9760	57	.	.	.
cord-005453-4057qib7	9761	1	Figure	figure	NN
cord-005453-4057qib7	9761	2	1A	1a	NN
cord-005453-4057qib7	9761	3	-1B	-1b	NN
cord-005453-4057qib7	9761	4	]	]	-RRB-
cord-005453-4057qib7	9762	1	Results	result	NNS
cord-005453-4057qib7	9762	2	:	:	:
cord-005453-4057qib7	9762	3	Baseline	baseline	JJ
cord-005453-4057qib7	9762	4	characteristics	characteristic	NNS
cord-005453-4057qib7	9762	5	(	(	-LRB-
cord-005453-4057qib7	9762	6	Table1	Table1	NNP
cord-005453-4057qib7	9762	7	)	)	-RRB-
cord-005453-4057qib7	9762	8	of	of	IN
cord-005453-4057qib7	9762	9	patients	patient	NNS
cord-005453-4057qib7	9762	10	were	be	VBD
cord-005453-4057qib7	9762	11	similar	similar	JJ
cord-005453-4057qib7	9762	12	across	across	IN
cord-005453-4057qib7	9762	13	both	both	DT
cord-005453-4057qib7	9762	14	cohorts	cohort	NNS
cord-005453-4057qib7	9762	15	with	with	IN
cord-005453-4057qib7	9762	16	or	or	CC
cord-005453-4057qib7	9762	17	without	without	IN
cord-005453-4057qib7	9762	18	AdV	adv	NN
cord-005453-4057qib7	9762	19	infection	infection	NN
cord-005453-4057qib7	9762	20	.	.	.
cord-005453-4057qib7	9763	1	Overall	overall	JJ
cord-005453-4057qib7	9763	2	12.6%(n-42/332	12.6%(n-42/332	CD
cord-005453-4057qib7	9763	3	)	)	-RRB-
cord-005453-4057qib7	9763	4	patients	patient	NNS
cord-005453-4057qib7	9763	5	were	be	VBD
cord-005453-4057qib7	9763	6	positive	positive	JJ
cord-005453-4057qib7	9763	7	for	for	IN
cord-005453-4057qib7	9763	8	AdV	adv	NN
cord-005453-4057qib7	9763	9	DNA	DNA	NNP
cord-005453-4057qib7	9763	10	on	on	RP
cord-005453-4057qib7	9763	11	atleast	atleast	IN
cord-005453-4057qib7	9763	12	one	one	CD
cord-005453-4057qib7	9763	13	of	of	IN
cord-005453-4057qib7	9763	14	the	the	DT
cord-005453-4057qib7	9763	15	sanctuary	sanctuary	NN
cord-005453-4057qib7	9763	16	sites(upper	sites(upper	CC
cord-005453-4057qib7	9763	17	respiratory	respiratory	JJ
cord-005453-4057qib7	9763	18	airway	airway	NN
cord-005453-4057qib7	9763	19	,	,	,
cord-005453-4057qib7	9763	20	blood	blood	NN
cord-005453-4057qib7	9763	21	,	,	,
cord-005453-4057qib7	9763	22	faeces	faece	NNS
cord-005453-4057qib7	9763	23	,	,	,
cord-005453-4057qib7	9763	24	urine	urine	NN
cord-005453-4057qib7	9763	25	)	)	-RRB-
cord-005453-4057qib7	9763	26	and	and	CC
cord-005453-4057qib7	9763	27	45%(n-19/42	45%(n-19/42	CD
cord-005453-4057qib7	9763	28	)	)	-RRB-
cord-005453-4057qib7	9763	29	of	of	IN
cord-005453-4057qib7	9763	30	these	these	DT
cord-005453-4057qib7	9763	31	experienced	experience	VBN
cord-005453-4057qib7	9763	32	disseminated	disseminate	VBN
cord-005453-4057qib7	9763	33	infection(defined	infection(define	VBN
cord-005453-4057qib7	9763	34	by	by	IN
cord-005453-4057qib7	9763	35	AdV	adv	NN
cord-005453-4057qib7	9763	36	in	in	IN
cord-005453-4057qib7	9763	37	≥2	≥2	NNP
cord-005453-4057qib7	9763	38	sanctuary	sanctuary	NN
cord-005453-4057qib7	9763	39	sites	site	NNS
cord-005453-4057qib7	9763	40	or	or	CC
cord-005453-4057qib7	9763	41	rising	rise	VBG
cord-005453-4057qib7	9763	42	AdV	adv	NN
cord-005453-4057qib7	9763	43	DNA	dna	NN
cord-005453-4057qib7	9763	44	copies	copy	NNS
cord-005453-4057qib7	9763	45	in	in	IN
cord-005453-4057qib7	9763	46	blood	blood	NN
cord-005453-4057qib7	9763	47	)	)	-RRB-
cord-005453-4057qib7	9763	48	,	,	,
cord-005453-4057qib7	9763	49	while	while	IN
cord-005453-4057qib7	9763	50	2	2	CD
cord-005453-4057qib7	9763	51	developed	develop	VBD
cord-005453-4057qib7	9763	52	typical	typical	JJ
cord-005453-4057qib7	9763	53	adenoviral	adenoviral	JJ
cord-005453-4057qib7	9763	54	disease	disease	NN
cord-005453-4057qib7	9763	55	(	(	-LRB-
cord-005453-4057qib7	9763	56	pulmonary	pulmonary	NNP
cord-005453-4057qib7	9763	57	)	)	-RRB-
cord-005453-4057qib7	9763	58	.	.	.
cord-005453-4057qib7	9764	1	Among	among	IN
cord-005453-4057qib7	9764	2	patients	patient	NNS
cord-005453-4057qib7	9764	3	with	with	IN
cord-005453-4057qib7	9764	4	disseminated	disseminate	VBN
cord-005453-4057qib7	9764	5	infection	infection	NN
cord-005453-4057qib7	9764	6	,	,	,
cord-005453-4057qib7	9764	7	majority	majority	NN
cord-005453-4057qib7	9764	8	had	have	VBD
cord-005453-4057qib7	9764	9	AdV	adv	NN
cord-005453-4057qib7	9764	10	in	in	IN
cord-005453-4057qib7	9764	11	gastro	gastro	JJ
cord-005453-4057qib7	9764	12	-	-	HYPH
cord-005453-4057qib7	9764	13	intestinal(42%),10.5	intestinal(42%),10.5	JJ
cord-005453-4057qib7	9764	14	%	%	NN
cord-005453-4057qib7	9764	15	in	in	IN
cord-005453-4057qib7	9764	16	genitourinary	genitourinary	JJ
cord-005453-4057qib7	9764	17	and	and	CC
cord-005453-4057qib7	9764	18	21	21	CD
cord-005453-4057qib7	9764	19	%	%	NN
cord-005453-4057qib7	9764	20	as	as	IN
cord-005453-4057qib7	9764	21	both	both	DT
cord-005453-4057qib7	9764	22	sanctuary	sanctuary	NN
cord-005453-4057qib7	9764	23	site	site	NN
cord-005453-4057qib7	9764	24	of	of	IN
cord-005453-4057qib7	9764	25	infection	infection	NN
cord-005453-4057qib7	9764	26	,	,	,
cord-005453-4057qib7	9764	27	in	in	IN
cord-005453-4057qib7	9764	28	addition	addition	NN
cord-005453-4057qib7	9764	29	to	to	IN
cord-005453-4057qib7	9764	30	blood	blood	NN
cord-005453-4057qib7	9764	31	viraemia(85	viraemia(85	NN
cord-005453-4057qib7	9764	32	%	%	NN
cord-005453-4057qib7	9764	33	of	of	IN
cord-005453-4057qib7	9764	34	all	all	DT
cord-005453-4057qib7	9764	35	cases).Cumulative	cases).cumulative	JJ
cord-005453-4057qib7	9764	36	incidence	incidence	NN
cord-005453-4057qib7	9764	37	of	of	IN
cord-005453-4057qib7	9764	38	AdV	adv	NN
cord-005453-4057qib7	9764	39	infection	infection	NN
cord-005453-4057qib7	9764	40	was	be	VBD
cord-005453-4057qib7	9764	41	10.6%(95%CI:7.6	10.6%(95%ci:7.6	CD
cord-005453-4057qib7	9764	42	-	-	SYM
cord-005453-4057qib7	9764	43	14.2	14.2	CD
cord-005453-4057qib7	9764	44	%	%	NN
cord-005453-4057qib7	9764	45	)	)	-RRB-
cord-005453-4057qib7	9764	46	at	at	IN
cord-005453-4057qib7	9764	47	12	12	CD
cord-005453-4057qib7	9764	48	months	month	NNS
cord-005453-4057qib7	9764	49	with	with	IN
cord-005453-4057qib7	9764	50	median	median	JJ
cord-005453-4057qib7	9764	51	time	time	NN
cord-005453-4057qib7	9764	52	of	of	IN
cord-005453-4057qib7	9764	53	108	108	CD
cord-005453-4057qib7	9764	54	days(IQR:19	days(iqr:19	NN
cord-005453-4057qib7	9764	55	-	-	HYPH
cord-005453-4057qib7	9764	56	304	304	CD
cord-005453-4057qib7	9764	57	days	day	NNS
cord-005453-4057qib7	9764	58	)	)	-RRB-
cord-005453-4057qib7	9764	59	to	to	TO
cord-005453-4057qib7	9764	60	detect	detect	VB
cord-005453-4057qib7	9764	61	AdV	adv	NN
cord-005453-4057qib7	9764	62	-	-	HYPH
cord-005453-4057qib7	9764	63	DNA	dna	NN
cord-005453-4057qib7	9764	64	post	post	NN
cord-005453-4057qib7	9764	65	HSCT.Overall	hsct.overall	NN
cord-005453-4057qib7	9764	66	survival(OS	survival(os	JJ
cord-005453-4057qib7	9764	67	)	)	-RRB-
cord-005453-4057qib7	9764	68	at	at	IN
cord-005453-4057qib7	9764	69	5	5	CD
cord-005453-4057qib7	9764	70	years	year	NNS
cord-005453-4057qib7	9764	71	for	for	IN
cord-005453-4057qib7	9764	72	whole	whole	JJ
cord-005453-4057qib7	9764	73	cohort	cohort	NN
cord-005453-4057qib7	9764	74	was	be	VBD
cord-005453-4057qib7	9764	75	41%(95%CI:31	41%(95%ci:31	CD
cord-005453-4057qib7	9764	76	-	-	HYPH
cord-005453-4057qib7	9764	77	50;Median	50;median	CD
cord-005453-4057qib7	9764	78	OS-57months	OS-57months	NNP
cord-005453-4057qib7	9764	79	)	)	-RRB-
cord-005453-4057qib7	9764	80	with	with	IN
cord-005453-4057qib7	9764	81	no	no	DT
cord-005453-4057qib7	9764	82	statistical	statistical	JJ
cord-005453-4057qib7	9764	83	difference	difference	NN
cord-005453-4057qib7	9764	84	between	between	IN
cord-005453-4057qib7	9764	85	patients	patient	NNS
cord-005453-4057qib7	9764	86	with	with	IN
cord-005453-4057qib7	9764	87	disseminated	disseminate	VBN
cord-005453-4057qib7	9764	88	AdV	adv	NN
cord-005453-4057qib7	9764	89	infection	infection	NN
cord-005453-4057qib7	9764	90	vs	vs	IN
cord-005453-4057qib7	9764	91	those	those	DT
cord-005453-4057qib7	9764	92	with	with	IN
cord-005453-4057qib7	9764	93	none(log	none(log	NN
cord-005453-4057qib7	9764	94	rank	rank	NN
cord-005453-4057qib7	9764	95	;	;	:
cord-005453-4057qib7	9764	96	p-0.68	p-0.68	NNS
cord-005453-4057qib7	9764	97	;	;	:
cord-005453-4057qib7	9764	98	Fig-1a	fig-1a	ADD
cord-005453-4057qib7	9764	99	)	)	-RRB-
cord-005453-4057qib7	9764	100	.	.	.
cord-005453-4057qib7	9765	1	Overall	overall	JJ
cord-005453-4057qib7	9765	2	cumulative	cumulative	JJ
cord-005453-4057qib7	9765	3	incidence	incidence	NN
cord-005453-4057qib7	9765	4	of	of	IN
cord-005453-4057qib7	9765	5	non	non	JJ
cord-005453-4057qib7	9765	6	-	-	JJ
cord-005453-4057qib7	9765	7	relapse	relapse	JJ
cord-005453-4057qib7	9765	8	mortality	mortality	NN
cord-005453-4057qib7	9765	9	(	(	-LRB-
cord-005453-4057qib7	9765	10	NRM	NRM	NNP
cord-005453-4057qib7	9765	11	)	)	-RRB-
cord-005453-4057qib7	9765	12	was	be	VBD
cord-005453-4057qib7	9765	13	23%(95%CI:18	23%(95%ci:18	CD
cord-005453-4057qib7	9765	14	-	-	SYM
cord-005453-4057qib7	9765	15	28	28	CD
cord-005453-4057qib7	9765	16	%	%	NN
cord-005453-4057qib7	9765	17	)	)	-RRB-
cord-005453-4057qib7	9765	18	and	and	CC
cord-005453-4057qib7	9765	19	relapse(CIR	relapse(CIR	NNP
cord-005453-4057qib7	9765	20	)	)	-RRB-
cord-005453-4057qib7	9765	21	was	be	VBD
cord-005453-4057qib7	9765	22	25.5%(95%CI:19	25.5%(95%ci:19	CD
cord-005453-4057qib7	9765	23	-	-	SYM
cord-005453-4057qib7	9765	24	32	32	CD
cord-005453-4057qib7	9765	25	%	%	NN
cord-005453-4057qib7	9765	26	)	)	-RRB-
cord-005453-4057qib7	9765	27	at	at	IN
cord-005453-4057qib7	9765	28	5	5	CD
cord-005453-4057qib7	9765	29	years	year	NNS
cord-005453-4057qib7	9765	30	,	,	,
cord-005453-4057qib7	9765	31	but	but	CC
cord-005453-4057qib7	9765	32	no	no	DT
cord-005453-4057qib7	9765	33	statistical	statistical	JJ
cord-005453-4057qib7	9765	34	difference	difference	NN
cord-005453-4057qib7	9765	35	noted	note	VBN
cord-005453-4057qib7	9765	36	between	between	IN
cord-005453-4057qib7	9765	37	patients	patient	NNS
cord-005453-4057qib7	9765	38	with	with	IN
cord-005453-4057qib7	9765	39	disseminated	disseminate	VBN
cord-005453-4057qib7	9765	40	AdV	adv	NN
cord-005453-4057qib7	9765	41	infection	infection	NN
cord-005453-4057qib7	9765	42	&	&	CC
cord-005453-4057qib7	9765	43	those	those	DT
cord-005453-4057qib7	9765	44	with	with	IN
cord-005453-4057qib7	9765	45	none(NRM	none(NRM	NNS
cord-005453-4057qib7	9765	46	:	:	:
cord-005453-4057qib7	9766	1	p-0.31;CIR	p-0.31;CIR	NNP
cord-005453-4057qib7	9766	2	:	:	:
cord-005453-4057qib7	9767	1	p-0.50;Gray	p-0.50;Gray	NNP
cord-005453-4057qib7	9767	2	test).Pre	test).Pre	NNP
cord-005453-4057qib7	9767	3	-	-	HYPH
cord-005453-4057qib7	9767	4	emptive	emptive	JJ
cord-005453-4057qib7	9767	5	therapy	therapy	NN
cord-005453-4057qib7	9767	6	with	with	IN
cord-005453-4057qib7	9767	7	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	9767	8	(	(	-LRB-
cord-005453-4057qib7	9767	9	3mg	3mg	NNP
cord-005453-4057qib7	9767	10	/	/	SYM
cord-005453-4057qib7	9767	11	kg	kg	NNP
cord-005453-4057qib7	9767	12	weekly	weekly	JJ
cord-005453-4057qib7	9767	13	IV	IV	NNP
cord-005453-4057qib7	9767	14	infusion	infusion	NN
cord-005453-4057qib7	9767	15	for	for	IN
cord-005453-4057qib7	9767	16	2	2	CD
cord-005453-4057qib7	9767	17	weeks	week	NNS
cord-005453-4057qib7	9767	18	and	and	CC
cord-005453-4057qib7	9767	19	fortnightly	fortnightly	RB
cord-005453-4057qib7	9767	20	thereafter	thereafter	RB
cord-005453-4057qib7	9767	21	until	until	IN
cord-005453-4057qib7	9767	22	infection	infection	NN
cord-005453-4057qib7	9767	23	free	free	JJ
cord-005453-4057qib7	9767	24	)	)	-RRB-
cord-005453-4057qib7	9767	25	was	be	VBD
cord-005453-4057qib7	9767	26	required	require	VBN
cord-005453-4057qib7	9767	27	in	in	IN
cord-005453-4057qib7	9767	28	33%(14/42	33%(14/42	CD
cord-005453-4057qib7	9767	29	)	)	-RRB-
cord-005453-4057qib7	9767	30	of	of	IN
cord-005453-4057qib7	9767	31	symptomatic	symptomatic	JJ
cord-005453-4057qib7	9767	32	AdV	adv	NN
cord-005453-4057qib7	9767	33	infection	infection	NN
cord-005453-4057qib7	9767	34	patients	patient	NNS
cord-005453-4057qib7	9767	35	and	and	CC
cord-005453-4057qib7	9767	36	52%(10/19	52%(10/19	CD
cord-005453-4057qib7	9767	37	)	)	-RRB-
cord-005453-4057qib7	9767	38	with	with	IN
cord-005453-4057qib7	9767	39	disseminated	disseminate	VBN
cord-005453-4057qib7	9767	40	infections	infection	NNS
cord-005453-4057qib7	9767	41	.	.	.
cord-005453-4057qib7	9768	1	One	one	CD
cord-005453-4057qib7	9768	2	patient	patient	NN
cord-005453-4057qib7	9768	3	required	require	VBN
cord-005453-4057qib7	9768	4	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	9768	5	therapy	therapy	NN
cord-005453-4057qib7	9768	6	for	for	IN
cord-005453-4057qib7	9768	7	refractory	refractory	JJ
cord-005453-4057qib7	9768	8	disease	disease	NN
cord-005453-4057qib7	9768	9	,	,	,
cord-005453-4057qib7	9768	10	but	but	CC
cord-005453-4057qib7	9768	11	one	one	CD
cord-005453-4057qib7	9768	12	patient	patient	NN
cord-005453-4057qib7	9768	13	died	die	VBD
cord-005453-4057qib7	9768	14	due	due	IN
cord-005453-4057qib7	9768	15	to	to	IN
cord-005453-4057qib7	9768	16	severe	severe	JJ
cord-005453-4057qib7	9768	17	sepsis	sepsis	NN
cord-005453-4057qib7	9768	18	,	,	,
cord-005453-4057qib7	9768	19	before	before	IN
cord-005453-4057qib7	9768	20	AdV	adv	NN
cord-005453-4057qib7	9768	21	specific	specific	JJ
cord-005453-4057qib7	9768	22	therapy	therapy	NN
cord-005453-4057qib7	9768	23	could	could	MD
cord-005453-4057qib7	9768	24	be	be	VB
cord-005453-4057qib7	9768	25	given	give	VBN
cord-005453-4057qib7	9768	26	.	.	.
cord-005453-4057qib7	9769	1	Remaining	remain	VBG
cord-005453-4057qib7	9769	2	patients	patient	NNS
cord-005453-4057qib7	9769	3	were	be	VBD
cord-005453-4057qib7	9769	4	monitored	monitor	VBN
cord-005453-4057qib7	9769	5	and	and	CC
cord-005453-4057qib7	9769	6	all	all	DT
cord-005453-4057qib7	9769	7	self	self	NN
cord-005453-4057qib7	9769	8	-	-	HYPH
cord-005453-4057qib7	9769	9	recovered	recover	VBN
cord-005453-4057qib7	9769	10	on	on	IN
cord-005453-4057qib7	9769	11	cessation	cessation	NN
cord-005453-4057qib7	9769	12	of	of	IN
cord-005453-4057qib7	9769	13	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	9769	14	.	.	.
cord-005453-4057qib7	9770	1	All	all	DT
cord-005453-4057qib7	9770	2	patients	patient	NNS
cord-005453-4057qib7	9770	3	treated	treat	VBN
cord-005453-4057qib7	9770	4	with	with	IN
cord-005453-4057qib7	9770	5	cidofovir	cidofovir	NNS
cord-005453-4057qib7	9770	6	developed	develop	VBD
cord-005453-4057qib7	9770	7	renal	renal	JJ
cord-005453-4057qib7	9770	8	impairment(defined	impairment(define	VBN
cord-005453-4057qib7	9770	9	by	by	IN
cord-005453-4057qib7	9770	10	atleast	atleast	NN
cord-005453-4057qib7	9770	11	>	>	XX
cord-005453-4057qib7	9770	12	25	25	CD
cord-005453-4057qib7	9770	13	%	%	NN
cord-005453-4057qib7	9770	14	increase	increase	NN
cord-005453-4057qib7	9770	15	in	in	IN
cord-005453-4057qib7	9770	16	baseline	baseline	NN
cord-005453-4057qib7	9770	17	creatinine),however	creatinine),however	NNP
cord-005453-4057qib7	9770	18	majority(73	majority(73	NNP
cord-005453-4057qib7	9770	19	%	%	NN
cord-005453-4057qib7	9770	20	)	)	-RRB-
cord-005453-4057qib7	9770	21	recovered	recover	VBD
cord-005453-4057qib7	9770	22	their	-PRON-	PRP$
cord-005453-4057qib7	9770	23	renal	renal	JJ
cord-005453-4057qib7	9770	24	function	function	NN
cord-005453-4057qib7	9770	25	near	near	IN
cord-005453-4057qib7	9770	26	their	-PRON-	PRP$
cord-005453-4057qib7	9770	27	baseline	baseline	NN
cord-005453-4057qib7	9770	28	(	(	-LRB-
cord-005453-4057qib7	9770	29	Fig-1b	Fig-1b	NNP
cord-005453-4057qib7	9770	30	)	)	-RRB-
cord-005453-4057qib7	9770	31	.	.	.
cord-005453-4057qib7	9771	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9771	2	:	:	:
cord-005453-4057qib7	9772	1	AdV	AdV	NNP
cord-005453-4057qib7	9772	2	infection	infection	NN
cord-005453-4057qib7	9772	3	remains	remain	VBZ
cord-005453-4057qib7	9772	4	a	a	DT
cord-005453-4057qib7	9772	5	significant	significant	JJ
cord-005453-4057qib7	9772	6	cause	cause	NN
cord-005453-4057qib7	9772	7	of	of	IN
cord-005453-4057qib7	9772	8	morbidity	morbidity	NN
cord-005453-4057qib7	9772	9	in	in	IN
cord-005453-4057qib7	9772	10	adult	adult	NN
cord-005453-4057qib7	9772	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9772	12	patients	patient	NNS
cord-005453-4057qib7	9772	13	,	,	,
cord-005453-4057qib7	9772	14	however	however	RB
cord-005453-4057qib7	9772	15	pre	pre	JJ
cord-005453-4057qib7	9772	16	-	-	JJ
cord-005453-4057qib7	9772	17	emptive	emptive	JJ
cord-005453-4057qib7	9772	18	management	management	NN
cord-005453-4057qib7	9772	19	with	with	IN
cord-005453-4057qib7	9772	20	cidofovir	cidofovir	NNP
cord-005453-4057qib7	9772	21	has	have	VBZ
cord-005453-4057qib7	9772	22	improved	improve	VBN
cord-005453-4057qib7	9772	23	OS	OS	NNP
cord-005453-4057qib7	9772	24	and	and	CC
cord-005453-4057qib7	9772	25	NRM	NRM	NNP
cord-005453-4057qib7	9772	26	despite	despite	IN
cord-005453-4057qib7	9772	27	use	use	NN
cord-005453-4057qib7	9772	28	of	of	IN
cord-005453-4057qib7	9772	29	TCD	TCD	NNP
cord-005453-4057qib7	9772	30	conditioning	conditioning	NN
cord-005453-4057qib7	9772	31	.	.	.
cord-005453-4057qib7	9773	1	Renal	renal	JJ
cord-005453-4057qib7	9773	2	toxicity	toxicity	NN
cord-005453-4057qib7	9773	3	remains	remain	VBZ
cord-005453-4057qib7	9773	4	common	common	JJ
cord-005453-4057qib7	9773	5	with	with	IN
cord-005453-4057qib7	9773	6	cidofovir	cidofovir	NNS
cord-005453-4057qib7	9773	7	but	but	CC
cord-005453-4057qib7	9773	8	with	with	IN
cord-005453-4057qib7	9773	9	use	use	NN
cord-005453-4057qib7	9773	10	of	of	IN
cord-005453-4057qib7	9773	11	intermediate	intermediate	JJ
cord-005453-4057qib7	9773	12	doses	dose	NNS
cord-005453-4057qib7	9773	13	,	,	,
cord-005453-4057qib7	9773	14	majority	majority	NN
cord-005453-4057qib7	9773	15	do	do	VBP
cord-005453-4057qib7	9773	16	recover	recover	VB
cord-005453-4057qib7	9773	17	their	-PRON-	PRP$
cord-005453-4057qib7	9773	18	renal	renal	JJ
cord-005453-4057qib7	9773	19	functions	function	NNS
cord-005453-4057qib7	9773	20	.	.	.
cord-005453-4057qib7	9774	1	Clinical	clinical	JJ
cord-005453-4057qib7	9774	2	Trial	Trial	NNP
cord-005453-4057qib7	9774	3	Registry	Registry	NNP
cord-005453-4057qib7	9774	4	:	:	:
cord-005453-4057qib7	9775	1	n	n	LS
cord-005453-4057qib7	9775	2	/	/	SYM
cord-005453-4057qib7	9775	3	a	a	DT
cord-005453-4057qib7	9775	4	Disclosure	disclosure	NN
cord-005453-4057qib7	9775	5	:	:	:
cord-005453-4057qib7	9775	6	Nothing	nothing	NN
cord-005453-4057qib7	9775	7	to	to	TO
cord-005453-4057qib7	9775	8	declare	declare	VB
cord-005453-4057qib7	9775	9	Background	background	NN
cord-005453-4057qib7	9775	10	:	:	:
cord-005453-4057qib7	9775	11	Publications	publication	NNS
cord-005453-4057qib7	9775	12	on	on	IN
cord-005453-4057qib7	9775	13	invasive	invasive	JJ
cord-005453-4057qib7	9775	14	fungal	fungal	NN
cord-005453-4057qib7	9775	15	disease	disease	NN
cord-005453-4057qib7	9775	16	(	(	-LRB-
cord-005453-4057qib7	9775	17	IFD	IFD	NNP
cord-005453-4057qib7	9775	18	)	)	-RRB-
cord-005453-4057qib7	9775	19	in	in	IN
cord-005453-4057qib7	9775	20	lymphoma	lymphoma	NN
cord-005453-4057qib7	9775	21	patients	patient	NNS
cord-005453-4057qib7	9775	22	are	be	VBP
cord-005453-4057qib7	9775	23	limited	limit	VBN
cord-005453-4057qib7	9775	24	especially	especially	RB
cord-005453-4057qib7	9775	25	after	after	IN
cord-005453-4057qib7	9775	26	allo	allo	NN
cord-005453-4057qib7	9775	27	-	-	HYPH
cord-005453-4057qib7	9775	28	HSCT	HSCT	NNP
cord-005453-4057qib7	9775	29	.	.	.
cord-005453-4057qib7	9776	1	There	there	EX
cord-005453-4057qib7	9776	2	are	be	VBP
cord-005453-4057qib7	9776	3	no	no	DT
cord-005453-4057qib7	9776	4	data	data	NN
cord-005453-4057qib7	9776	5	on	on	IN
cord-005453-4057qib7	9776	6	outcome	outcome	NN
cord-005453-4057qib7	9776	7	of	of	IN
cord-005453-4057qib7	9776	8	allo	allo	NN
cord-005453-4057qib7	9776	9	-	-	HYPH
cord-005453-4057qib7	9776	10	HSCT	HSCT	NNP
cord-005453-4057qib7	9776	11	in	in	IN
cord-005453-4057qib7	9776	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	9776	13	patients	patient	NNS
cord-005453-4057qib7	9776	14	with	with	IN
cord-005453-4057qib7	9776	15	prior	prior	JJ
cord-005453-4057qib7	9776	16	IFD	IFD	NNP
cord-005453-4057qib7	9776	17	.	.	.
cord-005453-4057qib7	9777	1	This	this	DT
cord-005453-4057qib7	9777	2	study	study	NN
cord-005453-4057qib7	9777	3	focuses	focus	VBZ
cord-005453-4057qib7	9777	4	on	on	IN
cord-005453-4057qib7	9777	5	epidemiology	epidemiology	NN
cord-005453-4057qib7	9777	6	of	of	IN
cord-005453-4057qib7	9777	7	IFD	IFD	NNP
cord-005453-4057qib7	9777	8	before	before	IN
cord-005453-4057qib7	9777	9	and	and	CC
cord-005453-4057qib7	9777	10	after	after	IN
cord-005453-4057qib7	9777	11	allo	allo	NN
cord-005453-4057qib7	9777	12	-	-	HYPH
cord-005453-4057qib7	9777	13	HSCT	HSCT	NNP
cord-005453-4057qib7	9777	14	in	in	IN
cord-005453-4057qib7	9777	15	children	child	NNS
cord-005453-4057qib7	9777	16	and	and	CC
cord-005453-4057qib7	9777	17	adults	adult	NNS
cord-005453-4057qib7	9777	18	with	with	IN
cord-005453-4057qib7	9777	19	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	9777	20	's	's	POS
cord-005453-4057qib7	9777	21	lymphoma	lymphoma	NN
cord-005453-4057qib7	9777	22	(	(	-LRB-
cord-005453-4057qib7	9777	23	HL	HL	NNP
cord-005453-4057qib7	9777	24	)	)	-RRB-
cord-005453-4057qib7	9777	25	.	.	.
cord-005453-4057qib7	9778	1	Methods	method	NNS
cord-005453-4057qib7	9778	2	:	:	:
cord-005453-4057qib7	9778	3	Single	single	JJ
cord-005453-4057qib7	9778	4	center	center	NN
cord-005453-4057qib7	9778	5	prospective	prospective	JJ
cord-005453-4057qib7	9778	6	study	study	NN
cord-005453-4057qib7	9778	7	included	include	VBD
cord-005453-4057qib7	9778	8	86	86	CD
cord-005453-4057qib7	9778	9	patients	patient	NNS
cord-005453-4057qib7	9778	10	with	with	IN
cord-005453-4057qib7	9778	11	classical	classical	JJ
cord-005453-4057qib7	9778	12	r	r	NN
cord-005453-4057qib7	9778	13	/	/	SYM
cord-005453-4057qib7	9778	14	r	r	NN
cord-005453-4057qib7	9778	15	HL	HL	NNP
cord-005453-4057qib7	9778	16	who	who	WP
cord-005453-4057qib7	9778	17	received	receive	VBD
cord-005453-4057qib7	9778	18	allo	allo	NN
cord-005453-4057qib7	9778	19	-	-	HYPH
cord-005453-4057qib7	9778	20	HSCT	HSCT	NNP
cord-005453-4057qib7	9778	21	from	from	IN
cord-005453-4057qib7	9778	22	2002	2002	CD
cord-005453-4057qib7	9778	23	to	to	IN
cord-005453-4057qib7	9778	24	2018	2018	CD
cord-005453-4057qib7	9778	25	.	.	.
cord-005453-4057qib7	9779	1	The	the	DT
cord-005453-4057qib7	9779	2	median	median	JJ
cord-005453-4057qib7	9779	3	age	age	NN
cord-005453-4057qib7	9779	4	was	be	VBD
cord-005453-4057qib7	9779	5	27	27	CD
cord-005453-4057qib7	9779	6	(	(	-LRB-
cord-005453-4057qib7	9779	7	13	13	CD
cord-005453-4057qib7	9779	8	-	-	SYM
cord-005453-4057qib7	9779	9	49	49	CD
cord-005453-4057qib7	9779	10	)	)	-RRB-
cord-005453-4057qib7	9779	11	y.o	y.o	NNP
cord-005453-4057qib7	9779	12	.	.	NNP
cord-005453-4057qib7	9779	13	,	,	,
cord-005453-4057qib7	9779	14	children	child	NNS
cord-005453-4057qib7	9779	15	(	(	-LRB-
cord-005453-4057qib7	9779	16	<	<	NNP
cord-005453-4057qib7	9779	17	18	18	CD
cord-005453-4057qib7	9779	18	yo	yo	NNS
cord-005453-4057qib7	9779	19	)	)	-RRB-
cord-005453-4057qib7	9779	20	-13	-13	CD
cord-005453-4057qib7	9779	21	%	%	NN
cord-005453-4057qib7	9779	22	.	.	.
cord-005453-4057qib7	9780	1	Allo	Allo	NNP
cord-005453-4057qib7	9780	2	-	-	HYPH
cord-005453-4057qib7	9780	3	HSCT	HSCT	NNP
cord-005453-4057qib7	9780	4	from	from	IN
cord-005453-4057qib7	9780	5	MUD	MUD	NNP
cord-005453-4057qib7	9780	6	was	be	VBD
cord-005453-4057qib7	9780	7	performed	perform	VBN
cord-005453-4057qib7	9780	8	in	in	IN
cord-005453-4057qib7	9780	9	45,4	45,4	CD
cord-005453-4057qib7	9780	10	%	%	NN
cord-005453-4057qib7	9780	11	(	(	-LRB-
cord-005453-4057qib7	9780	12	n=39	n=39	NNP
cord-005453-4057qib7	9780	13	)	)	-RRB-
cord-005453-4057qib7	9780	14	,	,	,
cord-005453-4057qib7	9780	15	MRD	MRD	NNP
cord-005453-4057qib7	9780	16	-24,4	-24,4	NNP
cord-005453-4057qib7	9780	17	%	%	NN
cord-005453-4057qib7	9780	18	(	(	-LRB-
cord-005453-4057qib7	9780	19	n=21	n=21	NNP
cord-005453-4057qib7	9780	20	)	)	-RRB-
cord-005453-4057qib7	9780	21	,	,	,
cord-005453-4057qib7	9780	22	MMUD	MMUD	NNP
cord-005453-4057qib7	9780	23	-15,1	-15,1	IN
cord-005453-4057qib7	9780	24	%	%	NN
cord-005453-4057qib7	9780	25	(	(	-LRB-
cord-005453-4057qib7	9780	26	n=13	n=13	NNP
cord-005453-4057qib7	9780	27	)	)	-RRB-
cord-005453-4057qib7	9780	28	,	,	,
cord-005453-4057qib7	9780	29	haplo	haplo	NNP
cord-005453-4057qib7	9780	30	-15,1	-15,1	NNP
cord-005453-4057qib7	9780	31	%	%	NN
cord-005453-4057qib7	9780	32	(	(	-LRB-
cord-005453-4057qib7	9780	33	n=13	n=13	NNP
cord-005453-4057qib7	9780	34	)	)	-RRB-
cord-005453-4057qib7	9780	35	,	,	,
cord-005453-4057qib7	9780	36	with	with	IN
cord-005453-4057qib7	9780	37	RIC	RIC	NNP
cord-005453-4057qib7	9780	38	(	(	-LRB-
cord-005453-4057qib7	9780	39	100	100	CD
cord-005453-4057qib7	9780	40	%	%	NN
cord-005453-4057qib7	9780	41	)	)	-RRB-
cord-005453-4057qib7	9780	42	and	and	CC
cord-005453-4057qib7	9780	43	predominantly	predominantly	RB
cord-005453-4057qib7	9780	44	PTCY	PTCY	NNP
cord-005453-4057qib7	9780	45	-	-	HYPH
cord-005453-4057qib7	9780	46	based	base	VBN
cord-005453-4057qib7	9780	47	GvHD	GvHD	NNP
cord-005453-4057qib7	9780	48	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9780	49	(	(	-LRB-
cord-005453-4057qib7	9780	50	71	71	CD
cord-005453-4057qib7	9780	51	%	%	NN
cord-005453-4057qib7	9780	52	)	)	-RRB-
cord-005453-4057qib7	9780	53	.	.	.
cord-005453-4057qib7	9781	1	Primary	primary	JJ
cord-005453-4057qib7	9781	2	antifungal	antifungal	JJ
cord-005453-4057qib7	9781	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9781	4	was	be	VBD
cord-005453-4057qib7	9781	5	fluconazole	fluconazole	NN
cord-005453-4057qib7	9781	6	in	in	IN
cord-005453-4057qib7	9781	7	85	85	CD
cord-005453-4057qib7	9781	8	%	%	NN
cord-005453-4057qib7	9781	9	,	,	,
cord-005453-4057qib7	9781	10	secondary	secondary	JJ
cord-005453-4057qib7	9781	11	-voriconazole	-voriconazole	NN
cord-005453-4057qib7	9782	1	(	(	-LRB-
cord-005453-4057qib7	9782	2	100	100	CD
cord-005453-4057qib7	9782	3	%	%	NN
cord-005453-4057qib7	9782	4	)	)	-RRB-
cord-005453-4057qib7	9782	5	.	.	.
cord-005453-4057qib7	9783	1	EORTC	EORTC	NNP
cord-005453-4057qib7	9783	2	/	/	SYM
cord-005453-4057qib7	9783	3	MSG	MSG	NNP
cord-005453-4057qib7	9783	4	2008	2008	CD
cord-005453-4057qib7	9783	5	criteria	criterion	NNS
cord-005453-4057qib7	9783	6	for	for	IN
cord-005453-4057qib7	9783	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	9783	8	and	and	CC
cord-005453-4057qib7	9783	9	bronchoscopy	bronchoscopy	NN
cord-005453-4057qib7	9783	10	before	before	IN
cord-005453-4057qib7	9783	11	allo	allo	NN
cord-005453-4057qib7	9783	12	-	-	HYPH
cord-005453-4057qib7	9783	13	HSCT	HSCT	NNP
cord-005453-4057qib7	9783	14	in	in	IN
cord-005453-4057qib7	9783	15	pts	pts	NN
cord-005453-4057qib7	9783	16	with	with	IN
cord-005453-4057qib7	9783	17	CT	CT	NNP
cord-005453-4057qib7	9783	18	-	-	HYPH
cord-005453-4057qib7	9783	19	scan	scan	JJ
cord-005453-4057qib7	9783	20	lung	lung	NN
cord-005453-4057qib7	9783	21	lesions	lesion	NNS
cord-005453-4057qib7	9783	22	were	be	VBD
cord-005453-4057qib7	9783	23	used	use	VBN
cord-005453-4057qib7	9783	24	.	.	.
cord-005453-4057qib7	9784	1	"	"	''
cord-005453-4057qib7	9785	1	Active	active	JJ
cord-005453-4057qib7	9785	2	IFD	IFD	NNP
cord-005453-4057qib7	9785	3	"	"	''
cord-005453-4057qib7	9785	4	means	mean	VBZ
cord-005453-4057qib7	9785	5	IFD	IFD	NNP
cord-005453-4057qib7	9785	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	9785	7	just	just	RB
cord-005453-4057qib7	9785	8	before	before	IN
cord-005453-4057qib7	9785	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9785	10	.	.	.
cord-005453-4057qib7	9786	1	Median	median	JJ
cord-005453-4057qib7	9786	2	follow	follow	NN
cord-005453-4057qib7	9786	3	-	-	HYPH
cord-005453-4057qib7	9786	4	up	up	RP
cord-005453-4057qib7	9786	5	time	time	NN
cord-005453-4057qib7	9786	6	was	be	VBD
cord-005453-4057qib7	9786	7	12	12	CD
cord-005453-4057qib7	9786	8	months	month	NNS
cord-005453-4057qib7	9786	9	.	.	.
cord-005453-4057qib7	9787	1	Results	result	NNS
cord-005453-4057qib7	9787	2	:	:	:
cord-005453-4057qib7	9787	3	Incidence	incidence	NN
cord-005453-4057qib7	9787	4	of	of	IN
cord-005453-4057qib7	9787	5	IFD	IFD	NNP
cord-005453-4057qib7	9787	6	before	before	IN
cord-005453-4057qib7	9787	7	allo	allo	NN
cord-005453-4057qib7	9787	8	-	-	HYPH
cord-005453-4057qib7	9787	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9787	10	was	be	VBD
cord-005453-4057qib7	9787	11	12,8	12,8	CD
cord-005453-4057qib7	9787	12	%	%	NN
cord-005453-4057qib7	9787	13	(	(	-LRB-
cord-005453-4057qib7	9787	14	n=11	n=11	NNP
cord-005453-4057qib7	9787	15	)	)	-RRB-
cord-005453-4057qib7	9787	16	.	.	.
cord-005453-4057qib7	9788	1	IFD	IFD	NNP
cord-005453-4057qib7	9788	2	prior	prior	RB
cord-005453-4057qib7	9788	3	to	to	IN
cord-005453-4057qib7	9788	4	HSCT	HSCT	NNP
cord-005453-4057qib7	9788	5	were	be	VBD
cord-005453-4057qib7	9788	6	invasive	invasive	JJ
cord-005453-4057qib7	9788	7	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	9788	8	(	(	-LRB-
cord-005453-4057qib7	9788	9	IA	IA	NNP
cord-005453-4057qib7	9788	10	)	)	-RRB-
cord-005453-4057qib7	9788	11	with	with	IN
cord-005453-4057qib7	9788	12	lungs	lung	NNS
cord-005453-4057qib7	9788	13	involvement	involvement	NN
cord-005453-4057qib7	9788	14	.	.	.
cord-005453-4057qib7	9789	1	Antifungal	antifungal	JJ
cord-005453-4057qib7	9789	2	therapy	therapy	NN
cord-005453-4057qib7	9789	3	before	before	IN
cord-005453-4057qib7	9789	4	allo	allo	NN
cord-005453-4057qib7	9789	5	-	-	HYPH
cord-005453-4057qib7	9789	6	HSCT	HSCT	NNP
cord-005453-4057qib7	9789	7	was	be	VBD
cord-005453-4057qib7	9789	8	used	use	VBN
cord-005453-4057qib7	9789	9	in	in	IN
cord-005453-4057qib7	9789	10	81,8	81,8	CD
cord-005453-4057qib7	9789	11	%	%	NN
cord-005453-4057qib7	9789	12	pts	pts	NN
cord-005453-4057qib7	9789	13	with	with	IN
cord-005453-4057qib7	9789	14	median	median	JJ
cord-005453-4057qib7	9789	15	duration	duration	NN
cord-005453-4057qib7	9789	16	-2	-2	CD
cord-005453-4057qib7	9789	17	months	month	NNS
cord-005453-4057qib7	9789	18	.	.	.
cord-005453-4057qib7	9790	1	Complete	complete	JJ
cord-005453-4057qib7	9790	2	response	response	NN
cord-005453-4057qib7	9790	3	to	to	IN
cord-005453-4057qib7	9790	4	antifungal	antifungal	JJ
cord-005453-4057qib7	9790	5	therapy	therapy	NN
cord-005453-4057qib7	9790	6	was	be	VBD
cord-005453-4057qib7	9790	7	in	in	IN
cord-005453-4057qib7	9790	8	45,4	45,4	CD
cord-005453-4057qib7	9790	9	%	%	NN
cord-005453-4057qib7	9790	10	pts	pt	NNS
cord-005453-4057qib7	9790	11	,	,	,
cord-005453-4057qib7	9790	12	partial	partial	JJ
cord-005453-4057qib7	9790	13	response	response	NN
cord-005453-4057qib7	9790	14	or	or	CC
cord-005453-4057qib7	9790	15	stabilization	stabilization	NN
cord-005453-4057qib7	9790	16	-36,4	-36,4	NN
cord-005453-4057qib7	9790	17	%	%	NN
cord-005453-4057qib7	9790	18	,	,	,
cord-005453-4057qib7	9790	19	and	and	CC
cord-005453-4057qib7	9790	20	18,2	18,2	CD
cord-005453-4057qib7	9790	21	%	%	NN
cord-005453-4057qib7	9790	22	pts	pt	NNS
cord-005453-4057qib7	9790	23	had	have	VBD
cord-005453-4057qib7	9790	24	an	an	DT
cord-005453-4057qib7	9790	25	"	"	``
cord-005453-4057qib7	9790	26	active	active	JJ
cord-005453-4057qib7	9790	27	IFD	ifd	NN
cord-005453-4057qib7	9790	28	"	"	''
cord-005453-4057qib7	9790	29	.	.	.
cord-005453-4057qib7	9791	1	After	after	IN
cord-005453-4057qib7	9791	2	allo	allo	NN
cord-005453-4057qib7	9791	3	-	-	HYPH
cord-005453-4057qib7	9791	4	HSCT	HSCT	NNP
cord-005453-4057qib7	9791	5	all	all	DT
cord-005453-4057qib7	9791	6	pts	pts	NN
cord-005453-4057qib7	9791	7	received	receive	VBD
cord-005453-4057qib7	9791	8	voriconazole	voriconazole	NN
cord-005453-4057qib7	9791	9	as	as	IN
cord-005453-4057qib7	9791	10	an	an	DT
cord-005453-4057qib7	9791	11	antifungal	antifungal	JJ
cord-005453-4057qib7	9791	12	therapy	therapy	NN
cord-005453-4057qib7	9791	13	or	or	CC
cord-005453-4057qib7	9791	14	secondary	secondary	JJ
cord-005453-4057qib7	9791	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9791	16	.	.	.
cord-005453-4057qib7	9792	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	9792	2	incidence	incidence	NN
cord-005453-4057qib7	9792	3	of	of	IN
cord-005453-4057qib7	9792	4	relapse	relapse	NN
cord-005453-4057qib7	9792	5	or	or	CC
cord-005453-4057qib7	9792	6	progression	progression	NN
cord-005453-4057qib7	9792	7	of	of	IN
cord-005453-4057qib7	9792	8	IA	IA	NNP
cord-005453-4057qib7	9792	9	after	after	IN
cord-005453-4057qib7	9792	10	allo	allo	NNP
cord-005453-4057qib7	9792	11	-	-	HYPH
cord-005453-4057qib7	9792	12	HSCT	HSCT	NNP
cord-005453-4057qib7	9792	13	was	be	VBD
cord-005453-4057qib7	9792	14	18,2	18,2	CD
cord-005453-4057qib7	9792	15	%	%	NN
cord-005453-4057qib7	9792	16	with	with	IN
cord-005453-4057qib7	9792	17	the	the	DT
cord-005453-4057qib7	9792	18	median	median	JJ
cord-005453-4057qib7	9792	19	49	49	CD
cord-005453-4057qib7	9792	20	day	day	NN
cord-005453-4057qib7	9792	21	after	after	IN
cord-005453-4057qib7	9792	22	HSCT	HSCT	NNP
cord-005453-4057qib7	9792	23	,	,	,
cord-005453-4057qib7	9792	24	which	which	WDT
cord-005453-4057qib7	9792	25	were	be	VBD
cord-005453-4057qib7	9792	26	successfully	successfully	RB
cord-005453-4057qib7	9792	27	treated	treat	VBN
cord-005453-4057qib7	9792	28	with	with	IN
cord-005453-4057qib7	9792	29	voriconazole	voriconazole	NNP
cord-005453-4057qib7	9792	30	in	in	IN
cord-005453-4057qib7	9792	31	post	post	NN
cord-005453-4057qib7	9792	32	HSCT	HSCT	NNP
cord-005453-4057qib7	9792	33	period	period	NN
cord-005453-4057qib7	9792	34	.	.	.
cord-005453-4057qib7	9793	1	Incidence	incidence	NN
cord-005453-4057qib7	9793	2	of	of	IN
cord-005453-4057qib7	9793	3	IFD	IFD	NNP
cord-005453-4057qib7	9793	4	after	after	IN
cord-005453-4057qib7	9793	5	allo	allo	NN
cord-005453-4057qib7	9793	6	-	-	HYPH
cord-005453-4057qib7	9793	7	HSCT	HSCT	NNP
cord-005453-4057qib7	9793	8	for	for	IN
cord-005453-4057qib7	9793	9	naïve	naïve	JJ
cord-005453-4057qib7	9793	10	patients	patient	NNS
cord-005453-4057qib7	9793	11	was	be	VBD
cord-005453-4057qib7	9793	12	17,6	17,6	CD
cord-005453-4057qib7	9793	13	%	%	NN
cord-005453-4057qib7	9793	14	(	(	-LRB-
cord-005453-4057qib7	9793	15	n=13/74	n=13/74	CD
cord-005453-4057qib7	9793	16	)	)	-RRB-
cord-005453-4057qib7	9793	17	.	.	.
cord-005453-4057qib7	9794	1	Etiology	etiology	NN
cord-005453-4057qib7	9794	2	of	of	IN
cord-005453-4057qib7	9794	3	IFD	IFD	NNP
cord-005453-4057qib7	9794	4	after	after	IN
cord-005453-4057qib7	9794	5	allo	allo	NN
cord-005453-4057qib7	9794	6	-	-	HYPH
cord-005453-4057qib7	9794	7	HSCT	HSCT	NNP
cord-005453-4057qib7	9794	8	was	be	VBD
cord-005453-4057qib7	9794	9	IA	IA	NNP
cord-005453-4057qib7	9794	10	-69	-69	NNP
cord-005453-4057qib7	9794	11	%	%	NN
cord-005453-4057qib7	9794	12	,	,	,
cord-005453-4057qib7	9794	13	invasive	invasive	JJ
cord-005453-4057qib7	9794	14	candidiasis	candidiasis	NN
cord-005453-4057qib7	9794	15	(	(	-LRB-
cord-005453-4057qib7	9794	16	IC	IC	NNP
cord-005453-4057qib7	9794	17	)	)	-RRB-
cord-005453-4057qib7	9794	18	-15	-15	CD
cord-005453-4057qib7	9794	19	%	%	NN
cord-005453-4057qib7	9794	20	,	,	,
cord-005453-4057qib7	9794	21	mucormycosis	mucormycosis	NN
cord-005453-4057qib7	9794	22	-8	-8	NNP
cord-005453-4057qib7	9794	23	%	%	NN
cord-005453-4057qib7	9794	24	and	and	CC
cord-005453-4057qib7	9794	25	8	8	CD
cord-005453-4057qib7	9794	26	%	%	NN
cord-005453-4057qib7	9794	27	combined	combine	VBN
cord-005453-4057qib7	9794	28	IFD	IFD	NNP
cord-005453-4057qib7	9794	29	caused	cause	VBN
cord-005453-4057qib7	9794	30	by	by	IN
cord-005453-4057qib7	9794	31	Aspergillus	aspergillus	NN
cord-005453-4057qib7	9794	32	fumigatus	fumigatus	NN
cord-005453-4057qib7	9794	33	+	+	CC
cord-005453-4057qib7	9794	34	Rhizopus	Rhizopus	NNP
cord-005453-4057qib7	9794	35	stolonifer	stolonifer	NN
cord-005453-4057qib7	9794	36	.	.	.
cord-005453-4057qib7	9795	1	The	the	DT
cord-005453-4057qib7	9795	2	median	median	JJ
cord-005453-4057qib7	9795	3	day	day	NN
cord-005453-4057qib7	9795	4	of	of	IN
cord-005453-4057qib7	9795	5	onset	onset	NN
cord-005453-4057qib7	9795	6	of	of	IN
cord-005453-4057qib7	9795	7	IFD	IFD	NNP
cord-005453-4057qib7	9795	8	after	after	IN
cord-005453-4057qib7	9795	9	allo	allo	NN
cord-005453-4057qib7	9795	10	-	-	HYPH
cord-005453-4057qib7	9795	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9795	12	was	be	VBD
cord-005453-4057qib7	9795	13	day+	day+	NNP
cord-005453-4057qib7	9795	14	114	114	CD
cord-005453-4057qib7	9795	15	and	and	CC
cord-005453-4057qib7	9795	16	was	be	VBD
cord-005453-4057qib7	9795	17	associated	associate	VBN
cord-005453-4057qib7	9795	18	with	with	IN
cord-005453-4057qib7	9795	19	post	post	JJ
cord-005453-4057qib7	9795	20	-	-	JJ
cord-005453-4057qib7	9795	21	HSCT	hsct	JJ
cord-005453-4057qib7	9795	22	relapse	relapse	NN
cord-005453-4057qib7	9795	23	of	of	IN
cord-005453-4057qib7	9795	24	HL	HL	NNP
cord-005453-4057qib7	9795	25	(	(	-LRB-
cord-005453-4057qib7	9795	26	p=0,04	p=0,04	NNP
cord-005453-4057qib7	9795	27	)	)	-RRB-
cord-005453-4057qib7	9795	28	.	.	.
cord-005453-4057qib7	9796	1	The	the	DT
cord-005453-4057qib7	9796	2	main	main	JJ
cord-005453-4057qib7	9796	3	site	site	NN
cord-005453-4057qib7	9796	4	of	of	IN
cord-005453-4057qib7	9796	5	infection	infection	NN
cord-005453-4057qib7	9796	6	were	be	VBD
cord-005453-4057qib7	9796	7	lungs	lung	NNS
cord-005453-4057qib7	9796	8	(	(	-LRB-
cord-005453-4057qib7	9796	9	88	88	CD
cord-005453-4057qib7	9796	10	%	%	NN
cord-005453-4057qib7	9796	11	)	)	-RRB-
cord-005453-4057qib7	9796	12	,	,	,
cord-005453-4057qib7	9796	13	the	the	DT
cord-005453-4057qib7	9796	14	main	main	JJ
cord-005453-4057qib7	9796	15	clinical	clinical	JJ
cord-005453-4057qib7	9796	16	symptom	symptom	NN
cord-005453-4057qib7	9796	17	-febrile	-febrile	NN
cord-005453-4057qib7	9796	18	fever	fever	NN
cord-005453-4057qib7	9796	19	(	(	-LRB-
cord-005453-4057qib7	9796	20	100	100	CD
cord-005453-4057qib7	9796	21	%	%	NN
cord-005453-4057qib7	9796	22	)	)	-RRB-
cord-005453-4057qib7	9796	23	.	.	.
cord-005453-4057qib7	9797	1	Antifungal	antifungal	JJ
cord-005453-4057qib7	9797	2	therapy	therapy	NN
cord-005453-4057qib7	9797	3	was	be	VBD
cord-005453-4057qib7	9797	4	used	use	VBN
cord-005453-4057qib7	9797	5	in	in	IN
cord-005453-4057qib7	9797	6	all	all	DT
cord-005453-4057qib7	9797	7	patients	patient	NNS
cord-005453-4057qib7	9797	8	:	:	:
cord-005453-4057qib7	9797	9	voriconazole	voriconazole	NNP
cord-005453-4057qib7	9797	10	-59	-59	NNP
cord-005453-4057qib7	9797	11	%	%	NN
cord-005453-4057qib7	9797	12	,	,	,
cord-005453-4057qib7	9797	13	micafungin	micafungin	NNP
cord-005453-4057qib7	9797	14	-17	-17	CD
cord-005453-4057qib7	9797	15	%	%	NN
cord-005453-4057qib7	9797	16	,	,	,
cord-005453-4057qib7	9797	17	posaconazole	posaconazole	NNP
cord-005453-4057qib7	9797	18	-8	-8	NNP
cord-005453-4057qib7	9797	19	%	%	NN
cord-005453-4057qib7	9797	20	,	,	,
cord-005453-4057qib7	9797	21	lipid	lipid	NN
cord-005453-4057qib7	9797	22	amphotericin	amphotericin	NNS
cord-005453-4057qib7	9797	23	B	b	NN
cord-005453-4057qib7	9797	24	-8	-8	NNP
cord-005453-4057qib7	9797	25	%	%	NN
cord-005453-4057qib7	9797	26	and	and	CC
cord-005453-4057qib7	9797	27	combination	combination	NN
cord-005453-4057qib7	9797	28	lipid	lipid	NN
cord-005453-4057qib7	9797	29	amphotericin	amphotericin	NNS
cord-005453-4057qib7	9797	30	B	B	NNP
cord-005453-4057qib7	9797	31	with	with	IN
cord-005453-4057qib7	9797	32	caspofungin	caspofungin	NNP
cord-005453-4057qib7	9797	33	-8	-8	NNP
cord-005453-4057qib7	9797	34	%	%	NN
cord-005453-4057qib7	9797	35	.	.	.
cord-005453-4057qib7	9798	1	Overall	overall	JJ
cord-005453-4057qib7	9798	2	survival	survival	NN
cord-005453-4057qib7	9798	3	(	(	-LRB-
cord-005453-4057qib7	9798	4	OS	OS	NNP
cord-005453-4057qib7	9798	5	)	)	-RRB-
cord-005453-4057qib7	9798	6	at	at	IN
cord-005453-4057qib7	9798	7	12	12	CD
cord-005453-4057qib7	9798	8	weeks	week	NNS
cord-005453-4057qib7	9798	9	from	from	IN
cord-005453-4057qib7	9798	10	the	the	DT
cord-005453-4057qib7	9798	11	diagnosis	diagnosis	NN
cord-005453-4057qib7	9798	12	of	of	IN
cord-005453-4057qib7	9798	13	IFD	IFD	NNP
cord-005453-4057qib7	9798	14	after	after	IN
cord-005453-4057qib7	9798	15	allo	allo	NN
cord-005453-4057qib7	9798	16	-	-	HYPH
cord-005453-4057qib7	9798	17	HSCT	HSCT	NNP
cord-005453-4057qib7	9798	18	was	be	VBD
cord-005453-4057qib7	9798	19	80	80	CD
cord-005453-4057qib7	9798	20	%	%	NN
cord-005453-4057qib7	9798	21	.	.	.
cord-005453-4057qib7	9799	1	The	the	DT
cord-005453-4057qib7	9799	2	2-year	2-year	CD
cord-005453-4057qib7	9799	3	OS	os	NN
cord-005453-4057qib7	9799	4	in	in	IN
cord-005453-4057qib7	9799	5	children	child	NNS
cord-005453-4057qib7	9799	6	and	and	CC
cord-005453-4057qib7	9799	7	adult	adult	NN
cord-005453-4057qib7	9799	8	with	with	IN
cord-005453-4057qib7	9799	9	HL	HL	NNP
cord-005453-4057qib7	9799	10	after	after	IN
cord-005453-4057qib7	9799	11	allo	allo	NN
cord-005453-4057qib7	9799	12	-	-	HYPH
cord-005453-4057qib7	9799	13	HSCT	HSCT	NNP
cord-005453-4057qib7	9799	14	was	be	VBD
cord-005453-4057qib7	9799	15	73,3	73,3	CD
cord-005453-4057qib7	9799	16	%	%	NN
cord-005453-4057qib7	9799	17	.	.	.
cord-005453-4057qib7	9800	1	Development	development	NN
cord-005453-4057qib7	9800	2	of	of	IN
cord-005453-4057qib7	9800	3	IFD	IFD	NNP
cord-005453-4057qib7	9800	4	after	after	IN
cord-005453-4057qib7	9800	5	allo	allo	NN
cord-005453-4057qib7	9800	6	-	-	HYPH
cord-005453-4057qib7	9800	7	HSCT	HSCT	NNP
cord-005453-4057qib7	9800	8	do	do	VBP
cord-005453-4057qib7	9800	9	not	not	RB
cord-005453-4057qib7	9800	10	decrease	decrease	VB
cord-005453-4057qib7	9800	11	the	the	DT
cord-005453-4057qib7	9800	12	2-year	2-year	CD
cord-005453-4057qib7	9800	13	OS	os	NN
cord-005453-4057qib7	9800	14	rate	rate	NN
cord-005453-4057qib7	9800	15	(	(	-LRB-
cord-005453-4057qib7	9800	16	69,2	69,2	CD
cord-005453-4057qib7	9800	17	%	%	NN
cord-005453-4057qib7	9800	18	vs	vs	IN
cord-005453-4057qib7	9800	19	74	74	CD
cord-005453-4057qib7	9800	20	%	%	NN
cord-005453-4057qib7	9800	21	,	,	,
cord-005453-4057qib7	9800	22	p=0,77	p=0,77	ADD
cord-005453-4057qib7	9800	23	)	)	-RRB-
cord-005453-4057qib7	9800	24	.	.	.
cord-005453-4057qib7	9801	1	The	the	DT
cord-005453-4057qib7	9801	2	impact	impact	NN
cord-005453-4057qib7	9801	3	of	of	IN
cord-005453-4057qib7	9801	4	prior	prior	JJ
cord-005453-4057qib7	9801	5	IFD	IFD	NNP
cord-005453-4057qib7	9801	6	on	on	IN
cord-005453-4057qib7	9801	7	2-year	2-year	CD
cord-005453-4057qib7	9801	8	OS	os	NN
cord-005453-4057qib7	9801	9	in	in	IN
cord-005453-4057qib7	9801	10	allo	allo	NN
cord-005453-4057qib7	9801	11	-	-	HYPH
cord-005453-4057qib7	9801	12	HSCT	HSCT	NNP
cord-005453-4057qib7	9801	13	recipients	recipient	NNS
cord-005453-4057qib7	9801	14	was	be	VBD
cord-005453-4057qib7	9801	15	not	not	RB
cord-005453-4057qib7	9801	16	statistically	statistically	RB
cord-005453-4057qib7	9801	17	significant	significant	JJ
cord-005453-4057qib7	9801	18	in	in	IN
cord-005453-4057qib7	9801	19	all	all	DT
cord-005453-4057qib7	9801	20	group	group	NN
cord-005453-4057qib7	9801	21	(	(	-LRB-
cord-005453-4057qib7	9801	22	63,6	63,6	CD
cord-005453-4057qib7	9801	23	%	%	NN
cord-005453-4057qib7	9801	24	vs	vs	IN
cord-005453-4057qib7	9801	25	74,7	74,7	CD
cord-005453-4057qib7	9801	26	%	%	NN
cord-005453-4057qib7	9801	27	,	,	,
cord-005453-4057qib7	9801	28	p=0,47	p=0,47	NNP
cord-005453-4057qib7	9801	29	)	)	-RRB-
cord-005453-4057qib7	9801	30	,	,	,
cord-005453-4057qib7	9801	31	and	and	CC
cord-005453-4057qib7	9801	32	separately	separately	RB
cord-005453-4057qib7	9801	33	in	in	IN
cord-005453-4057qib7	9801	34	children	child	NNS
cord-005453-4057qib7	9801	35	and	and	CC
cord-005453-4057qib7	9801	36	adults	adult	NNS
cord-005453-4057qib7	9801	37	.	.	.
cord-005453-4057qib7	9802	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9802	2	:	:	:
cord-005453-4057qib7	9803	1	Incidence	incidence	NN
cord-005453-4057qib7	9803	2	of	of	IN
cord-005453-4057qib7	9803	3	IFD	IFD	NNP
cord-005453-4057qib7	9803	4	in	in	IN
cord-005453-4057qib7	9803	5	children	child	NNS
cord-005453-4057qib7	9803	6	and	and	CC
cord-005453-4057qib7	9803	7	adults	adult	NNS
cord-005453-4057qib7	9803	8	with	with	IN
cord-005453-4057qib7	9803	9	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	9803	10	's	's	POS
cord-005453-4057qib7	9803	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	9803	12	before	before	IN
cord-005453-4057qib7	9803	13	allo	allo	NN
cord-005453-4057qib7	9803	14	-	-	HYPH
cord-005453-4057qib7	9803	15	HSCT	HSCT	NNP
cord-005453-4057qib7	9803	16	was	be	VBD
cord-005453-4057qib7	9803	17	12,8	12,8	CD
cord-005453-4057qib7	9803	18	%	%	NN
cord-005453-4057qib7	9803	19	.	.	.
cord-005453-4057qib7	9804	1	Incidence	incidence	NN
cord-005453-4057qib7	9804	2	of	of	IN
cord-005453-4057qib7	9804	3	IFD	IFD	NNP
cord-005453-4057qib7	9804	4	after	after	IN
cord-005453-4057qib7	9804	5	allo	allo	NN
cord-005453-4057qib7	9804	6	-	-	HYPH
cord-005453-4057qib7	9804	7	HSCT	HSCT	NNP
cord-005453-4057qib7	9804	8	in	in	IN
cord-005453-4057qib7	9804	9	patients	patient	NNS
cord-005453-4057qib7	9804	10	with	with	IN
cord-005453-4057qib7	9804	11	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	9804	12	's	's	POS
cord-005453-4057qib7	9804	13	lymphoma	lymphoma	NN
cord-005453-4057qib7	9804	14	was	be	VBD
cord-005453-4057qib7	9804	15	17,6	17,6	CD
cord-005453-4057qib7	9804	16	%	%	NN
cord-005453-4057qib7	9804	17	.	.	.
cord-005453-4057qib7	9805	1	The	the	DT
cord-005453-4057qib7	9805	2	major	major	JJ
cord-005453-4057qib7	9805	3	etiology	etiology	NN
cord-005453-4057qib7	9805	4	agents	agent	NNS
cord-005453-4057qib7	9805	5	as	as	IN
cord-005453-4057qib7	9805	6	before	before	IN
cord-005453-4057qib7	9805	7	as	as	IN
cord-005453-4057qib7	9805	8	after	after	IN
cord-005453-4057qib7	9805	9	allo	allo	NN
cord-005453-4057qib7	9805	10	-	-	HYPH
cord-005453-4057qib7	9805	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9805	12	were	be	VBD
cord-005453-4057qib7	9805	13	Aspergillus	aspergillus	NN
cord-005453-4057qib7	9805	14	spp	spp	NNS
cord-005453-4057qib7	9805	15	.	.	.
cord-005453-4057qib7	9806	1	IFD	IFD	NNP
cord-005453-4057qib7	9806	2	was	be	VBD
cord-005453-4057qib7	9806	3	a	a	DT
cord-005453-4057qib7	9806	4	late	late	JJ
cord-005453-4057qib7	9806	5	complication	complication	NN
cord-005453-4057qib7	9806	6	after	after	IN
cord-005453-4057qib7	9806	7	allo	allo	NN
cord-005453-4057qib7	9806	8	-	-	HYPH
cord-005453-4057qib7	9806	9	HSCT	HSCT	NNP
cord-005453-4057qib7	9806	10	and	and	CC
cord-005453-4057qib7	9806	11	associated	associate	VBN
cord-005453-4057qib7	9806	12	with	with	IN
cord-005453-4057qib7	9806	13	post	post	JJ
cord-005453-4057qib7	9806	14	-	-	JJ
cord-005453-4057qib7	9806	15	HSCT	hsct	JJ
cord-005453-4057qib7	9806	16	relapse	relapse	NN
cord-005453-4057qib7	9806	17	.	.	.
cord-005453-4057qib7	9807	1	Despite	despite	IN
cord-005453-4057qib7	9807	2	the	the	DT
cord-005453-4057qib7	9807	3	high	high	JJ
cord-005453-4057qib7	9807	4	incidence	incidence	NN
cord-005453-4057qib7	9807	5	IFD	IFD	NNP
cord-005453-4057qib7	9807	6	before	before	IN
cord-005453-4057qib7	9807	7	or	or	CC
cord-005453-4057qib7	9807	8	after	after	IN
cord-005453-4057qib7	9807	9	allo	allo	NN
cord-005453-4057qib7	9807	10	-	-	HYPH
cord-005453-4057qib7	9807	11	HSCT	HSCT	NNP
cord-005453-4057qib7	9807	12	did	do	VBD
cord-005453-4057qib7	9807	13	n't	not	RB
cord-005453-4057qib7	9807	14	influence	influence	VB
cord-005453-4057qib7	9807	15	the	the	DT
cord-005453-4057qib7	9807	16	outcome	outcome	NN
cord-005453-4057qib7	9807	17	in	in	IN
cord-005453-4057qib7	9807	18	children	child	NNS
cord-005453-4057qib7	9807	19	and	and	CC
cord-005453-4057qib7	9807	20	adults	adult	NNS
cord-005453-4057qib7	9807	21	with	with	IN
cord-005453-4057qib7	9807	22	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	9807	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	9807	24	.	.	.
cord-005453-4057qib7	9808	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9808	2	:	:	:
cord-005453-4057qib7	9808	3	Nothing	nothing	NN
cord-005453-4057qib7	9808	4	to	to	TO
cord-005453-4057qib7	9808	5	declare	declare	VB
cord-005453-4057qib7	9808	6	Our	-PRON-	PRP$
cord-005453-4057qib7	9808	7	community	community	NN
cord-005453-4057qib7	9808	8	has	have	VBZ
cord-005453-4057qib7	9808	9	high	high	JJ
cord-005453-4057qib7	9808	10	CMV	CMV	NNP
cord-005453-4057qib7	9808	11	positive	positive	JJ
cord-005453-4057qib7	9808	12	serostatus	serostatus	NN
cord-005453-4057qib7	9808	13	,	,	,
cord-005453-4057qib7	9808	14	which	which	WDT
cord-005453-4057qib7	9808	15	is	be	VBZ
cord-005453-4057qib7	9808	16	a	a	DT
cord-005453-4057qib7	9808	17	known	known	JJ
cord-005453-4057qib7	9808	18	risk	risk	NN
cord-005453-4057qib7	9808	19	for	for	IN
cord-005453-4057qib7	9808	20	CMV	CMV	NNP
cord-005453-4057qib7	9808	21	infection	infection	NN
cord-005453-4057qib7	9808	22	or	or	CC
cord-005453-4057qib7	9808	23	reactivation	reactivation	NN
cord-005453-4057qib7	9808	24	.	.	.
cord-005453-4057qib7	9809	1	We	-PRON-	PRP
cord-005453-4057qib7	9809	2	conducted	conduct	VBD
cord-005453-4057qib7	9809	3	a	a	DT
cord-005453-4057qib7	9809	4	study	study	NN
cord-005453-4057qib7	9809	5	to	to	TO
cord-005453-4057qib7	9809	6	explore	explore	VB
cord-005453-4057qib7	9809	7	the	the	DT
cord-005453-4057qib7	9809	8	incidence	incidence	NN
cord-005453-4057qib7	9809	9	and	and	CC
cord-005453-4057qib7	9809	10	outcome	outcome	NN
cord-005453-4057qib7	9809	11	of	of	IN
cord-005453-4057qib7	9809	12	CMV	CMV	NNP
cord-005453-4057qib7	9809	13	infection	infection	NN
cord-005453-4057qib7	9809	14	among	among	IN
cord-005453-4057qib7	9809	15	post	post	JJ
cord-005453-4057qib7	9809	16	-	-	JJ
cord-005453-4057qib7	9809	17	HSCT	hsct	JJ
cord-005453-4057qib7	9809	18	children	child	NNS
cord-005453-4057qib7	9809	19	.	.	.
cord-005453-4057qib7	9810	1	Methods	method	NNS
cord-005453-4057qib7	9810	2	:	:	:
cord-005453-4057qib7	9810	3	Medical	Medical	NNP
cord-005453-4057qib7	9810	4	Records	Records	NNPS
cord-005453-4057qib7	9810	5	of	of	IN
cord-005453-4057qib7	9810	6	pediatric	pediatric	JJ
cord-005453-4057qib7	9810	7	patients	patient	NNS
cord-005453-4057qib7	9810	8	(	(	-LRB-
cord-005453-4057qib7	9810	9	Age	age	NN
cord-005453-4057qib7	9810	10	≤	≤	NN
cord-005453-4057qib7	9810	11	14	14	CD
cord-005453-4057qib7	9810	12	years	year	NNS
cord-005453-4057qib7	9810	13	)	)	-RRB-
cord-005453-4057qib7	9810	14	undergoing	undergo	VBG
cord-005453-4057qib7	9810	15	single	single	JJ
cord-005453-4057qib7	9810	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	9810	17	HSCT	HSCT	NNP
cord-005453-4057qib7	9810	18	from	from	IN
cord-005453-4057qib7	9810	19	January	January	NNP
cord-005453-4057qib7	9810	20	2014	2014	CD
cord-005453-4057qib7	9810	21	to	to	IN
cord-005453-4057qib7	9810	22	December	December	NNP
cord-005453-4057qib7	9810	23	2016	2016	CD
cord-005453-4057qib7	9810	24	,	,	,
cord-005453-4057qib7	9810	25	at	at	IN
cord-005453-4057qib7	9810	26	King	King	NNP
cord-005453-4057qib7	9810	27	Faisal	Faisal	NNP
cord-005453-4057qib7	9810	28	Specialist	Specialist	NNP
cord-005453-4057qib7	9810	29	Hospital	Hospital	NNP
cord-005453-4057qib7	9810	30	and	and	CC
cord-005453-4057qib7	9810	31	Research	Research	NNP
cord-005453-4057qib7	9810	32	Centre	Centre	NNP
cord-005453-4057qib7	9810	33	,	,	,
cord-005453-4057qib7	9810	34	Riyadh	Riyadh	NNP
cord-005453-4057qib7	9810	35	,	,	,
cord-005453-4057qib7	9810	36	Saudi	Saudi	NNP
cord-005453-4057qib7	9810	37	Arabia	Arabia	NNP
cord-005453-4057qib7	9810	38	,	,	,
cord-005453-4057qib7	9810	39	were	be	VBD
cord-005453-4057qib7	9810	40	reviewed	review	VBN
cord-005453-4057qib7	9810	41	.	.	.
cord-005453-4057qib7	9811	1	All	all	DT
cord-005453-4057qib7	9811	2	patients	patient	NNS
cord-005453-4057qib7	9811	3	with	with	IN
cord-005453-4057qib7	9811	4	active	active	JJ
cord-005453-4057qib7	9811	5	CMV	CMV	NNP
cord-005453-4057qib7	9811	6	infection	infection	NN
cord-005453-4057qib7	9811	7	or	or	CC
cord-005453-4057qib7	9811	8	disease	disease	NN
cord-005453-4057qib7	9811	9	before	before	RB
cord-005453-4057qib7	9811	10	and	and	CC
cord-005453-4057qib7	9811	11	during	during	IN
cord-005453-4057qib7	9811	12	transplant	transplant	NN
cord-005453-4057qib7	9811	13	were	be	VBD
cord-005453-4057qib7	9811	14	excluded	exclude	VBN
cord-005453-4057qib7	9811	15	.	.	.
cord-005453-4057qib7	9812	1	A	a	DT
cord-005453-4057qib7	9812	2	total	total	NN
cord-005453-4057qib7	9812	3	of	of	IN
cord-005453-4057qib7	9812	4	307	307	CD
cord-005453-4057qib7	9812	5	patients	patient	NNS
cord-005453-4057qib7	9812	6	were	be	VBD
cord-005453-4057qib7	9812	7	included	include	VBN
cord-005453-4057qib7	9812	8	in	in	IN
cord-005453-4057qib7	9812	9	the	the	DT
cord-005453-4057qib7	9812	10	study	study	NN
cord-005453-4057qib7	9812	11	;	;	:
cord-005453-4057qib7	9812	12	160	160	CD
cord-005453-4057qib7	9812	13	were	be	VBD
cord-005453-4057qib7	9812	14	female	female	JJ
cord-005453-4057qib7	9812	15	.	.	.
cord-005453-4057qib7	9813	1	Median	median	JJ
cord-005453-4057qib7	9813	2	age	age	NN
cord-005453-4057qib7	9813	3	at	at	IN
cord-005453-4057qib7	9813	4	HSCT	HSCT	NNP
cord-005453-4057qib7	9813	5	was	be	VBD
cord-005453-4057qib7	9813	6	5	5	CD
cord-005453-4057qib7	9813	7	years	year	NNS
cord-005453-4057qib7	9813	8	.	.	.
cord-005453-4057qib7	9814	1	Recipient	recipient	NN
cord-005453-4057qib7	9814	2	CMV	CMV	NNP
cord-005453-4057qib7	9814	3	serostatus	serostatus	NN
cord-005453-4057qib7	9814	4	was	be	VBD
cord-005453-4057qib7	9814	5	positive	positive	JJ
cord-005453-4057qib7	9814	6	in	in	IN
cord-005453-4057qib7	9814	7	213	213	CD
cord-005453-4057qib7	9814	8	patients	patient	NNS
cord-005453-4057qib7	9814	9	before	before	IN
cord-005453-4057qib7	9814	10	HSCT	HSCT	NNP
cord-005453-4057qib7	9814	11	,	,	,
cord-005453-4057qib7	9814	12	and	and	CC
cord-005453-4057qib7	9814	13	232	232	CD
cord-005453-4057qib7	9814	14	donors	donor	NNS
cord-005453-4057qib7	9814	15	were	be	VBD
cord-005453-4057qib7	9814	16	CMVpositive	CMVpositive	NNP
cord-005453-4057qib7	9814	17	.	.	.
cord-005453-4057qib7	9815	1	The	the	DT
cord-005453-4057qib7	9815	2	Recipient	Recipient	NNP
cord-005453-4057qib7	9815	3	-	-	HYPH
cord-005453-4057qib7	9815	4	donor	donor	NN
cord-005453-4057qib7	9815	5	(	(	-LRB-
cord-005453-4057qib7	9815	6	R	r	NN
cord-005453-4057qib7	9815	7	/	/	SYM
cord-005453-4057qib7	9815	8	D	d	NN
cord-005453-4057qib7	9815	9	)	)	-RRB-
cord-005453-4057qib7	9815	10	serology	serology	NN
cord-005453-4057qib7	9815	11	was	be	VBD
cord-005453-4057qib7	9815	12	63.7	63.7	CD
cord-005453-4057qib7	9815	13	%	%	NN
cord-005453-4057qib7	9815	14	R	r	NN
cord-005453-4057qib7	9815	15	+	+	CC
cord-005453-4057qib7	9815	16	/D+	/D+	NNP
cord-005453-4057qib7	9815	17	,	,	,
cord-005453-4057qib7	9815	18	15.3	15.3	CD
cord-005453-4057qib7	9815	19	%	%	NN
cord-005453-4057qib7	9815	20	R+/D-	R+/D-	NNP
cord-005453-4057qib7	9815	21	,	,	,
cord-005453-4057qib7	9815	22	13.7	13.7	CD
cord-005453-4057qib7	9815	23	%	%	NN
cord-005453-4057qib7	9815	24	R-/D+	r-/d+	NN
cord-005453-4057qib7	9815	25	,	,	,
cord-005453-4057qib7	9815	26	and	and	CC
cord-005453-4057qib7	9815	27	7.3	7.3	CD
cord-005453-4057qib7	9815	28	%	%	NN
cord-005453-4057qib7	9815	29	R-/D-	R-/D-	NNPS
cord-005453-4057qib7	9815	30	.	.	.
cord-005453-4057qib7	9816	1	Indication	indication	NN
cord-005453-4057qib7	9816	2	for	for	IN
cord-005453-4057qib7	9816	3	HSCT	HSCT	NNP
cord-005453-4057qib7	9816	4	was	be	VBD
cord-005453-4057qib7	9816	5	Immune	Immune	NNP
cord-005453-4057qib7	9816	6	Disorders	Disorders	NNPS
cord-005453-4057qib7	9816	7	24.1	24.1	CD
cord-005453-4057qib7	9816	8	%	%	NN
cord-005453-4057qib7	9816	9	,	,	,
cord-005453-4057qib7	9817	1	Hemoglobinopathies	Hemoglobinopathies	NNP
cord-005453-4057qib7	9817	2	20.8	20.8	CD
cord-005453-4057qib7	9817	3	%	%	NN
cord-005453-4057qib7	9817	4	,	,	,
cord-005453-4057qib7	9817	5	Bone	Bone	NNP
cord-005453-4057qib7	9817	6	Marrow	Marrow	NNP
cord-005453-4057qib7	9817	7	Failure	Failure	NNP
cord-005453-4057qib7	9817	8	20.5	20.5	CD
cord-005453-4057qib7	9817	9	%	%	NN
cord-005453-4057qib7	9817	10	,	,	,
cord-005453-4057qib7	9817	11	Malignant	malignant	JJ
cord-005453-4057qib7	9817	12	Disorders	Disorders	NNPS
cord-005453-4057qib7	9817	13	20.5	20.5	CD
cord-005453-4057qib7	9817	14	%	%	NN
cord-005453-4057qib7	9817	15	,	,	,
cord-005453-4057qib7	9817	16	Histiocytic	Histiocytic	NNP
cord-005453-4057qib7	9817	17	8.1	8.1	CD
cord-005453-4057qib7	9817	18	%	%	NN
cord-005453-4057qib7	9817	19	,	,	,
cord-005453-4057qib7	9817	20	and	and	CC
cord-005453-4057qib7	9817	21	Metabolic	metabolic	JJ
cord-005453-4057qib7	9817	22	Disorders	disorder	NNS
cord-005453-4057qib7	9817	23	5.9	5.9	CD
cord-005453-4057qib7	9817	24	%	%	NN
cord-005453-4057qib7	9817	25	.	.	.
cord-005453-4057qib7	9818	1	Source	source	NN
cord-005453-4057qib7	9818	2	of	of	IN
cord-005453-4057qib7	9818	3	stem	stem	NN
cord-005453-4057qib7	9818	4	cells	cell	NNS
cord-005453-4057qib7	9818	5	was	be	VBD
cord-005453-4057qib7	9818	6	Bone	Bone	NNP
cord-005453-4057qib7	9818	7	marrow	marrow	NN
cord-005453-4057qib7	9818	8	in	in	IN
cord-005453-4057qib7	9818	9	223	223	CD
cord-005453-4057qib7	9819	1	,	,	,
cord-005453-4057qib7	9819	2	Cord	cord	NN
cord-005453-4057qib7	9819	3	blood	blood	NN
cord-005453-4057qib7	9819	4	in	in	IN
cord-005453-4057qib7	9819	5	74	74	CD
cord-005453-4057qib7	9819	6	and	and	CC
cord-005453-4057qib7	9819	7	Peripheral	Peripheral	NNP
cord-005453-4057qib7	9819	8	Blood	Blood	NNP
cord-005453-4057qib7	9819	9	Stem	Stem	NNP
cord-005453-4057qib7	9819	10	Cell	cell	NN
cord-005453-4057qib7	9819	11	in	in	IN
cord-005453-4057qib7	9819	12	10	10	CD
cord-005453-4057qib7	9819	13	cases	case	NNS
cord-005453-4057qib7	9819	14	.	.	.
cord-005453-4057qib7	9820	1	Donor	donor	NN
cord-005453-4057qib7	9820	2	was	be	VBD
cord-005453-4057qib7	9820	3	matched	match	VBN
cord-005453-4057qib7	9820	4	related	relate	VBN
cord-005453-4057qib7	9820	5	among	among	IN
cord-005453-4057qib7	9820	6	198	198	CD
cord-005453-4057qib7	9820	7	,	,	,
cord-005453-4057qib7	9820	8	Unrelated	unrelated	JJ
cord-005453-4057qib7	9820	9	matched	match	VBD
cord-005453-4057qib7	9820	10	/	/	SYM
cord-005453-4057qib7	9820	11	mismatched	mismatch	VBN
cord-005453-4057qib7	9820	12	in	in	IN
cord-005453-4057qib7	9820	13	74	74	CD
cord-005453-4057qib7	9820	14	,	,	,
cord-005453-4057qib7	9820	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9820	16	24	24	CD
cord-005453-4057qib7	9820	17	,	,	,
cord-005453-4057qib7	9820	18	and	and	CC
cord-005453-4057qib7	9820	19	Related	relate	VBN
cord-005453-4057qib7	9820	20	with	with	IN
cord-005453-4057qib7	9820	21	1-Antigen	1-antigen	CD
cord-005453-4057qib7	9820	22	mismatch	mismatch	NN
cord-005453-4057qib7	9820	23	in	in	IN
cord-005453-4057qib7	9820	24	11	11	CD
cord-005453-4057qib7	9820	25	.	.	.
cord-005453-4057qib7	9821	1	Total	total	JJ
cord-005453-4057qib7	9821	2	body	body	NN
cord-005453-4057qib7	9821	3	irradiation	irradiation	NN
cord-005453-4057qib7	9821	4	(	(	-LRB-
cord-005453-4057qib7	9821	5	TBI	TBI	NNP
cord-005453-4057qib7	9821	6	)	)	-RRB-
cord-005453-4057qib7	9821	7	based	base	VBN
cord-005453-4057qib7	9821	8	conditioning	conditioning	NN
cord-005453-4057qib7	9821	9	was	be	VBD
cord-005453-4057qib7	9821	10	used	use	VBN
cord-005453-4057qib7	9821	11	for	for	IN
cord-005453-4057qib7	9821	12	47	47	CD
cord-005453-4057qib7	9821	13	patients	patient	NNS
cord-005453-4057qib7	9821	14	,	,	,
cord-005453-4057qib7	9821	15	while	while	IN
cord-005453-4057qib7	9821	16	ATG	ATG	NNP
cord-005453-4057qib7	9821	17	was	be	VBD
cord-005453-4057qib7	9821	18	used	use	VBN
cord-005453-4057qib7	9821	19	in	in	IN
cord-005453-4057qib7	9821	20	169	169	CD
cord-005453-4057qib7	9821	21	patients	patient	NNS
cord-005453-4057qib7	9821	22	.	.	.
cord-005453-4057qib7	9822	1	Results	result	NNS
cord-005453-4057qib7	9822	2	:	:	:
cord-005453-4057qib7	9823	1	Out	out	IN
cord-005453-4057qib7	9823	2	of	of	IN
cord-005453-4057qib7	9823	3	a	a	DT
cord-005453-4057qib7	9823	4	total	total	NN
cord-005453-4057qib7	9823	5	of	of	IN
cord-005453-4057qib7	9823	6	307	307	CD
cord-005453-4057qib7	9823	7	patients	patient	NNS
cord-005453-4057qib7	9823	8	,	,	,
cord-005453-4057qib7	9823	9	101	101	CD
cord-005453-4057qib7	9823	10	patients	patient	NNS
cord-005453-4057qib7	9823	11	developed	develop	VBD
cord-005453-4057qib7	9823	12	CMV	CMV	NNP
cord-005453-4057qib7	9823	13	infection	infection	NN
cord-005453-4057qib7	9823	14	post	post	JJ
cord-005453-4057qib7	9823	15	-	-	JJ
cord-005453-4057qib7	9823	16	HSCT	HSCT	NNP
cord-005453-4057qib7	9823	17	(	(	-LRB-
cord-005453-4057qib7	9823	18	32.9	32.9	CD
cord-005453-4057qib7	9823	19	%	%	NN
cord-005453-4057qib7	9823	20	)	)	-RRB-
cord-005453-4057qib7	9823	21	.	.	.
cord-005453-4057qib7	9824	1	Incidence	incidence	NN
cord-005453-4057qib7	9824	2	in	in	IN
cord-005453-4057qib7	9824	3	female	female	JJ
cord-005453-4057qib7	9824	4	recipients	recipient	NNS
cord-005453-4057qib7	9824	5	was	be	VBD
cord-005453-4057qib7	9824	6	high	high	JJ
cord-005453-4057qib7	9824	7	(	(	-LRB-
cord-005453-4057qib7	9824	8	38.1	38.1	CD
cord-005453-4057qib7	9824	9	%	%	NN
cord-005453-4057qib7	9824	10	versus	versus	IN
cord-005453-4057qib7	9824	11	27.2	27.2	CD
cord-005453-4057qib7	9824	12	%	%	NN
cord-005453-4057qib7	9824	13	,	,	,
cord-005453-4057qib7	9824	14	p	p	NN
cord-005453-4057qib7	9824	15	-	-	HYPH
cord-005453-4057qib7	9824	16	value	value	NN
cord-005453-4057qib7	9824	17	0.042	0.042	CD
cord-005453-4057qib7	9824	18	)	)	-RRB-
cord-005453-4057qib7	9824	19	.	.	.
cord-005453-4057qib7	9825	1	Both	both	DT
cord-005453-4057qib7	9825	2	recipient	recipient	NN
cord-005453-4057qib7	9825	3	and	and	CC
cord-005453-4057qib7	9825	4	donor	donor	NN
cord-005453-4057qib7	9825	5	CMV	CMV	NNP
cord-005453-4057qib7	9825	6	serology	serology	NN
cord-005453-4057qib7	9825	7	positive	positive	JJ
cord-005453-4057qib7	9825	8	(	(	-LRB-
cord-005453-4057qib7	9825	9	42.5	42.5	CD
cord-005453-4057qib7	9825	10	%	%	NN
cord-005453-4057qib7	9825	11	)	)	-RRB-
cord-005453-4057qib7	9825	12	developed	develop	VBD
cord-005453-4057qib7	9825	13	CMV	CMV	NNP
cord-005453-4057qib7	9825	14	infection	infection	NN
cord-005453-4057qib7	9826	1	(	(	-LRB-
cord-005453-4057qib7	9826	2	p	p	NN
cord-005453-4057qib7	9826	3	-	-	HYPH
cord-005453-4057qib7	9826	4	value	value	NN
cord-005453-4057qib7	9826	5	<	<	XX
cord-005453-4057qib7	9826	6	0.001	0.001	CD
cord-005453-4057qib7	9826	7	)	)	-RRB-
cord-005453-4057qib7	9826	8	.	.	.
cord-005453-4057qib7	9827	1	However	however	RB
cord-005453-4057qib7	9827	2	,	,	,
cord-005453-4057qib7	9827	3	no	no	DT
cord-005453-4057qib7	9827	4	CMV	CMV	NNP
cord-005453-4057qib7	9827	5	infection	infection	NN
cord-005453-4057qib7	9827	6	in	in	IN
cord-005453-4057qib7	9827	7	both	both	DT
cord-005453-4057qib7	9827	8	recipient	recipient	NN
cord-005453-4057qib7	9827	9	and	and	CC
cord-005453-4057qib7	9827	10	donor	donor	NN
cord-005453-4057qib7	9827	11	negative	negative	JJ
cord-005453-4057qib7	9827	12	group	group	NN
cord-005453-4057qib7	9827	13	(	(	-LRB-
cord-005453-4057qib7	9827	14	R-/D-	R-/D-	NNP
cord-005453-4057qib7	9827	15	)	)	-RRB-
cord-005453-4057qib7	9827	16	.	.	.
cord-005453-4057qib7	9828	1	The	the	DT
cord-005453-4057qib7	9828	2	incidence	incidence	NN
cord-005453-4057qib7	9828	3	of	of	IN
cord-005453-4057qib7	9828	4	CMV	CMV	NNP
cord-005453-4057qib7	9828	5	infection	infection	NN
cord-005453-4057qib7	9828	6	post	post	NN
cord-005453-4057qib7	9828	7	-	-	JJ
cord-005453-4057qib7	9828	8	HSCT	HSCT	NNP
cord-005453-4057qib7	9828	9	was	be	VBD
cord-005453-4057qib7	9828	10	high	high	JJ
cord-005453-4057qib7	9828	11	in	in	IN
cord-005453-4057qib7	9828	12	patients	patient	NNS
cord-005453-4057qib7	9828	13	received	receive	VBD
cord-005453-4057qib7	9828	14	TBI	TBI	NNP
cord-005453-4057qib7	9828	15	based	base	VBN
cord-005453-4057qib7	9828	16	conditioning	conditioning	NN
cord-005453-4057qib7	9828	17	(	(	-LRB-
cord-005453-4057qib7	9828	18	22	22	CD
cord-005453-4057qib7	9828	19	out	out	IN
cord-005453-4057qib7	9828	20	of	of	IN
cord-005453-4057qib7	9828	21	47	47	CD
cord-005453-4057qib7	9828	22	,	,	,
cord-005453-4057qib7	9828	23	46	46	CD
cord-005453-4057qib7	9828	24	.8	.8	CD
cord-005453-4057qib7	9828	25	%	%	NN
cord-005453-4057qib7	9828	26	,	,	,
cord-005453-4057qib7	9828	27	p	p	NN
cord-005453-4057qib7	9828	28	-	-	HYPH
cord-005453-4057qib7	9828	29	value	value	NN
cord-005453-4057qib7	9828	30	0.027	0.027	CD
cord-005453-4057qib7	9828	31	)	)	-RRB-
cord-005453-4057qib7	9828	32	,	,	,
cord-005453-4057qib7	9828	33	and	and	CC
cord-005453-4057qib7	9828	34	in	in	IN
cord-005453-4057qib7	9828	35	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9828	36	transplant	transplant	NN
cord-005453-4057qib7	9828	37	with	with	IN
cord-005453-4057qib7	9828	38	66.7	66.7	CD
cord-005453-4057qib7	9828	39	%	%	NN
cord-005453-4057qib7	9828	40	(	(	-LRB-
cord-005453-4057qib7	9828	41	p	p	NN
cord-005453-4057qib7	9828	42	-	-	HYPH
cord-005453-4057qib7	9828	43	value	value	NN
cord-005453-4057qib7	9828	44	0.008	0.008	CD
cord-005453-4057qib7	9828	45	)	)	-RRB-
cord-005453-4057qib7	9828	46	.	.	.
cord-005453-4057qib7	9829	1	Source	source	NN
cord-005453-4057qib7	9829	2	of	of	IN
cord-005453-4057qib7	9829	3	stem	stem	NN
cord-005453-4057qib7	9829	4	cells	cell	NNS
cord-005453-4057qib7	9829	5	,	,	,
cord-005453-4057qib7	9829	6	myeloablative	myeloablative	NNP
cord-005453-4057qib7	9829	7	versus	versus	IN
cord-005453-4057qib7	9829	8	nonmyeloablative	nonmyeloablative	JJ
cord-005453-4057qib7	9829	9	conditioning	conditioning	NN
cord-005453-4057qib7	9829	10	,	,	,
cord-005453-4057qib7	9829	11	ATG	ATG	NNP
cord-005453-4057qib7	9829	12	use	use	NN
cord-005453-4057qib7	9829	13	in	in	IN
cord-005453-4057qib7	9829	14	conditioning	conditioning	NN
cord-005453-4057qib7	9829	15	and	and	CC
cord-005453-4057qib7	9829	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	9829	17	,	,	,
cord-005453-4057qib7	9829	18	did	do	VBD
cord-005453-4057qib7	9829	19	not	not	RB
cord-005453-4057qib7	9829	20	exhibit	exhibit	VB
cord-005453-4057qib7	9829	21	significant	significant	JJ
cord-005453-4057qib7	9829	22	association	association	NN
cord-005453-4057qib7	9829	23	with	with	IN
cord-005453-4057qib7	9829	24	CMV	CMV	NNP
cord-005453-4057qib7	9829	25	infection	infection	NN
cord-005453-4057qib7	9829	26	.	.	.
cord-005453-4057qib7	9830	1	In	in	IN
cord-005453-4057qib7	9830	2	multivariable	multivariable	JJ
cord-005453-4057qib7	9830	3	setting	setting	NN
cord-005453-4057qib7	9830	4	,	,	,
cord-005453-4057qib7	9830	5	when	when	WRB
cord-005453-4057qib7	9830	6	adjusted	adjust	VBN
cord-005453-4057qib7	9830	7	for	for	IN
cord-005453-4057qib7	9830	8	primary	primary	JJ
cord-005453-4057qib7	9830	9	indication	indication	NN
cord-005453-4057qib7	9830	10	for	for	IN
cord-005453-4057qib7	9830	11	transplant	transplant	NN
cord-005453-4057qib7	9830	12	,	,	,
cord-005453-4057qib7	9830	13	Donor	Donor	NNP
cord-005453-4057qib7	9830	14	HLA	HLA	NNP
cord-005453-4057qib7	9830	15	Type	Type	NNP
cord-005453-4057qib7	9830	16	,	,	,
cord-005453-4057qib7	9830	17	TBI	TBI	NNP
cord-005453-4057qib7	9830	18	based	base	VBN
cord-005453-4057qib7	9830	19	conditioning	conditioning	NN
cord-005453-4057qib7	9830	20	and	and	CC
cord-005453-4057qib7	9830	21	Recipient	Recipient	NNP
cord-005453-4057qib7	9830	22	and	and	CC
cord-005453-4057qib7	9830	23	Donor	Donor	NNP
cord-005453-4057qib7	9830	24	CMV	CMV	NNP
cord-005453-4057qib7	9830	25	Serology	Serology	NNP
cord-005453-4057qib7	9830	26	at	at	IN
cord-005453-4057qib7	9830	27	transplant	transplant	NN
cord-005453-4057qib7	9830	28	,	,	,
cord-005453-4057qib7	9830	29	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9830	30	donor	donor	NN
cord-005453-4057qib7	9830	31	(	(	-LRB-
cord-005453-4057qib7	9830	32	Odds	Odds	NNPS
cord-005453-4057qib7	9830	33	ratio	ratio	NN
cord-005453-4057qib7	9830	34	:	:	:
cord-005453-4057qib7	9830	35	3.491	3.491	CD
cord-005453-4057qib7	9830	36	,	,	,
cord-005453-4057qib7	9830	37	P	P	NNP
cord-005453-4057qib7	9830	38	-	-	HYPH
cord-005453-4057qib7	9830	39	Value	value	NN
cord-005453-4057qib7	9830	40	:	:	:
cord-005453-4057qib7	9830	41	0.041	0.041	CD
cord-005453-4057qib7	9830	42	)	)	-RRB-
cord-005453-4057qib7	9830	43	and	and	CC
cord-005453-4057qib7	9830	44	Donor	Donor	NNP
cord-005453-4057qib7	9830	45	-	-	HYPH
cord-005453-4057qib7	9830	46	Recipient	Recipient	NNP
cord-005453-4057qib7	9830	47	CMV	CMV	NNP
cord-005453-4057qib7	9830	48	sero	sero	NN
cord-005453-4057qib7	9830	49	-	-	HYPH
cord-005453-4057qib7	9830	50	positivity	positivity	NN
cord-005453-4057qib7	9830	51	(	(	-LRB-
cord-005453-4057qib7	9830	52	Odds	odd	NNS
cord-005453-4057qib7	9830	53	ratio	ratio	NN
cord-005453-4057qib7	9830	54	:	:	:
cord-005453-4057qib7	9830	55	2.228	2.228	CD
cord-005453-4057qib7	9830	56	,	,	,
cord-005453-4057qib7	9830	57	P	p	NN
cord-005453-4057qib7	9830	58	-	-	HYPH
cord-005453-4057qib7	9830	59	Value	value	NN
cord-005453-4057qib7	9830	60	:	:	:
cord-005453-4057qib7	9830	61	0.007	0.007	CD
cord-005453-4057qib7	9830	62	)	)	-RRB-
cord-005453-4057qib7	9830	63	were	be	VBD
cord-005453-4057qib7	9830	64	found	find	VBN
cord-005453-4057qib7	9830	65	to	to	TO
cord-005453-4057qib7	9830	66	be	be	VB
cord-005453-4057qib7	9830	67	significant	significant	JJ
cord-005453-4057qib7	9830	68	risk	risk	NN
cord-005453-4057qib7	9830	69	factors	factor	NNS
cord-005453-4057qib7	9830	70	.	.	.
cord-005453-4057qib7	9831	1	CMV	CMV	NNP
cord-005453-4057qib7	9831	2	infection	infection	NN
cord-005453-4057qib7	9831	3	resolution	resolution	NN
cord-005453-4057qib7	9831	4	rate	rate	NN
cord-005453-4057qib7	9831	5	was	be	VBD
cord-005453-4057qib7	9831	6	83.2	83.2	CD
cord-005453-4057qib7	9831	7	%	%	NN
cord-005453-4057qib7	9831	8	(	(	-LRB-
cord-005453-4057qib7	9831	9	84	84	CD
cord-005453-4057qib7	9831	10	)	)	-RRB-
cord-005453-4057qib7	9831	11	.	.	.
cord-005453-4057qib7	9832	1	With	with	IN
cord-005453-4057qib7	9832	2	a	a	DT
cord-005453-4057qib7	9832	3	median	median	JJ
cord-005453-4057qib7	9832	4	follow	follow	NN
cord-005453-4057qib7	9832	5	-	-	HYPH
cord-005453-4057qib7	9832	6	up	up	NN
cord-005453-4057qib7	9832	7	time	time	NN
cord-005453-4057qib7	9832	8	of	of	IN
cord-005453-4057qib7	9832	9	32.9	32.9	CD
cord-005453-4057qib7	9832	10	±1.5	±1.5	VBG
cord-005453-4057qib7	9832	11	months	month	NNS
cord-005453-4057qib7	9832	12	from	from	IN
cord-005453-4057qib7	9832	13	infusion	infusion	NN
cord-005453-4057qib7	9832	14	,	,	,
cord-005453-4057qib7	9832	15	five	five	CD
cord-005453-4057qib7	9832	16	-	-	HYPH
cord-005453-4057qib7	9832	17	year	year	NN
cord-005453-4057qib7	9832	18	overall	overall	JJ
cord-005453-4057qib7	9832	19	survival	survival	NN
cord-005453-4057qib7	9832	20	of	of	IN
cord-005453-4057qib7	9832	21	CMV	CMV	NNP
cord-005453-4057qib7	9832	22	infected	infected	JJ
cord-005453-4057qib7	9832	23	group	group	NN
cord-005453-4057qib7	9832	24	was	be	VBD
cord-005453-4057qib7	9832	25	lower	low	JJR
cord-005453-4057qib7	9832	26	(	(	-LRB-
cord-005453-4057qib7	9832	27	0.658±0.087	0.658±0.087	CD
cord-005453-4057qib7	9832	28	)	)	-RRB-
cord-005453-4057qib7	9832	29	as	as	IN
cord-005453-4057qib7	9832	30	compared	compare	VBN
cord-005453-4057qib7	9832	31	to	to	IN
cord-005453-4057qib7	9832	32	non	non	JJ
cord-005453-4057qib7	9832	33	-	-	JJ
cord-005453-4057qib7	9832	34	CMV	CMV	NNP
cord-005453-4057qib7	9832	35	infected	infect	VBN
cord-005453-4057qib7	9832	36	(	(	-LRB-
cord-005453-4057qib7	9832	37	0.706±0.032	0.706±0.032	CD
cord-005453-4057qib7	9832	38	,	,	,
cord-005453-4057qib7	9832	39	P	p	NN
cord-005453-4057qib7	9832	40	-	-	HYPH
cord-005453-4057qib7	9832	41	Value	value	NN
cord-005453-4057qib7	9832	42	:	:	:
cord-005453-4057qib7	9832	43	0.285	0.285	CD
cord-005453-4057qib7	9832	44	)	)	-RRB-
cord-005453-4057qib7	9832	45	.	.	.
cord-005453-4057qib7	9833	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9833	2	:	:	:
cord-005453-4057qib7	9834	1	Incidence	incidence	NN
cord-005453-4057qib7	9834	2	of	of	IN
cord-005453-4057qib7	9834	3	CMV	CMV	NNP
cord-005453-4057qib7	9834	4	infection	infection	NN
cord-005453-4057qib7	9834	5	post	post	JJ
cord-005453-4057qib7	9834	6	-	-	JJ
cord-005453-4057qib7	9834	7	HSCT	HSCT	NNP
cord-005453-4057qib7	9834	8	in	in	IN
cord-005453-4057qib7	9834	9	our	-PRON-	PRP$
cord-005453-4057qib7	9834	10	center	center	NN
cord-005453-4057qib7	9834	11	is	be	VBZ
cord-005453-4057qib7	9834	12	comparable	comparable	JJ
cord-005453-4057qib7	9834	13	to	to	IN
cord-005453-4057qib7	9834	14	other	other	JJ
cord-005453-4057qib7	9834	15	centers	center	NNS
cord-005453-4057qib7	9834	16	.	.	.
cord-005453-4057qib7	9835	1	Our	-PRON-	PRP$
cord-005453-4057qib7	9835	2	data	datum	NNS
cord-005453-4057qib7	9835	3	suggest	suggest	VBP
cord-005453-4057qib7	9835	4	that	that	IN
cord-005453-4057qib7	9835	5	donor	donor	NN
cord-005453-4057qib7	9835	6	-	-	HYPH
cord-005453-4057qib7	9835	7	recipient	recipient	NN
cord-005453-4057qib7	9835	8	CMV	CMV	NNP
cord-005453-4057qib7	9835	9	positive	positive	JJ
cord-005453-4057qib7	9835	10	serostatus	serostatus	NN
cord-005453-4057qib7	9835	11	,	,	,
cord-005453-4057qib7	9835	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	9835	13	Donor	Donor	NNP
cord-005453-4057qib7	9835	14	,	,	,
cord-005453-4057qib7	9835	15	and	and	CC
cord-005453-4057qib7	9835	16	use	use	NN
cord-005453-4057qib7	9835	17	of	of	IN
cord-005453-4057qib7	9835	18	TBI	TBI	NNP
cord-005453-4057qib7	9835	19	based	base	VBN
cord-005453-4057qib7	9835	20	conditioning	conditioning	NN
cord-005453-4057qib7	9835	21	necessitate	necessitate	VBP
cord-005453-4057qib7	9835	22	close	close	JJ
cord-005453-4057qib7	9835	23	attention	attention	NN
cord-005453-4057qib7	9835	24	and	and	CC
cord-005453-4057qib7	9835	25	surveillance	surveillance	NN
cord-005453-4057qib7	9835	26	.	.	.
cord-005453-4057qib7	9836	1	Background	background	NN
cord-005453-4057qib7	9836	2	:	:	:
cord-005453-4057qib7	9837	1	Toxoplasmosis	toxoplasmosis	NN
cord-005453-4057qib7	9837	2	is	be	VBZ
cord-005453-4057qib7	9837	3	a	a	DT
cord-005453-4057qib7	9837	4	rare	rare	JJ
cord-005453-4057qib7	9837	5	and	and	CC
cord-005453-4057qib7	9837	6	underestimated	underestimated	JJ
cord-005453-4057qib7	9837	7	complication	complication	NN
cord-005453-4057qib7	9837	8	following	follow	VBG
cord-005453-4057qib7	9837	9	allogeneic	allogeneic	IN
cord-005453-4057qib7	9837	10	stem	stem	NN
cord-005453-4057qib7	9837	11	cell	cell	NN
cord-005453-4057qib7	9837	12	transplantation	transplantation	NN
cord-005453-4057qib7	9837	13	(	(	-LRB-
cord-005453-4057qib7	9837	14	allo	allo	FW
cord-005453-4057qib7	9837	15	-	-	HYPH
cord-005453-4057qib7	9837	16	SCT	SCT	NNP
cord-005453-4057qib7	9837	17	)	)	-RRB-
cord-005453-4057qib7	9837	18	with	with	IN
cord-005453-4057qib7	9837	19	an	an	DT
cord-005453-4057qib7	9837	20	often	often	RB
cord-005453-4057qib7	9837	21	fatal	fatal	JJ
cord-005453-4057qib7	9837	22	course	course	NN
cord-005453-4057qib7	9837	23	.	.	.
cord-005453-4057qib7	9838	1	This	this	DT
cord-005453-4057qib7	9838	2	is	be	VBZ
cord-005453-4057qib7	9838	3	in	in	IN
cord-005453-4057qib7	9838	4	part	part	NN
cord-005453-4057qib7	9838	5	due	due	IN
cord-005453-4057qib7	9838	6	to	to	IN
cord-005453-4057qib7	9838	7	limited	limited	JJ
cord-005453-4057qib7	9838	8	diagnostics	diagnostic	NNS
cord-005453-4057qib7	9838	9	relying	rely	VBG
cord-005453-4057qib7	9838	10	mainly	mainly	RB
cord-005453-4057qib7	9838	11	on	on	IN
cord-005453-4057qib7	9838	12	imaging	imaging	NN
cord-005453-4057qib7	9838	13	and	and	CC
cord-005453-4057qib7	9838	14	detection	detection	NN
cord-005453-4057qib7	9838	15	of	of	IN
cord-005453-4057qib7	9838	16	parasite	parasite	NN
cord-005453-4057qib7	9838	17	DNA	dna	NN
cord-005453-4057qib7	9838	18	by	by	IN
cord-005453-4057qib7	9838	19	PCR	PCR	NNP
cord-005453-4057qib7	9838	20	.	.	.
cord-005453-4057qib7	9839	1	We	-PRON-	PRP
cord-005453-4057qib7	9839	2	present	present	VBP
cord-005453-4057qib7	9839	3	here	here	RB
cord-005453-4057qib7	9839	4	eleven	eleven	CD
cord-005453-4057qib7	9839	5	cases	case	NNS
cord-005453-4057qib7	9839	6	of	of	IN
cord-005453-4057qib7	9839	7	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	9839	8	disease	disease	NN
cord-005453-4057qib7	9839	9	following	follow	VBG
cord-005453-4057qib7	9839	10	allo	allo	NNP
cord-005453-4057qib7	9839	11	-	-	HYPH
cord-005453-4057qib7	9839	12	SCT	SCT	NNP
cord-005453-4057qib7	9839	13	.	.	.
cord-005453-4057qib7	9840	1	Methods	method	NNS
cord-005453-4057qib7	9840	2	:	:	:
cord-005453-4057qib7	9840	3	We	-PRON-	PRP
cord-005453-4057qib7	9840	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	9840	5	analyzed	analyze	VBD
cord-005453-4057qib7	9840	6	534	534	CD
cord-005453-4057qib7	9840	7	consecutive	consecutive	JJ
cord-005453-4057qib7	9840	8	adult	adult	NN
cord-005453-4057qib7	9840	9	patients	patient	NNS
cord-005453-4057qib7	9840	10	who	who	WP
cord-005453-4057qib7	9840	11	received	receive	VBD
cord-005453-4057qib7	9840	12	an	an	DT
cord-005453-4057qib7	9840	13	allo	allo	NN
cord-005453-4057qib7	9840	14	-	-	HYPH
cord-005453-4057qib7	9840	15	SCT	sct	NN
cord-005453-4057qib7	9840	16	in	in	IN
cord-005453-4057qib7	9840	17	our	-PRON-	PRP$
cord-005453-4057qib7	9840	18	Bone	Bone	NNP
cord-005453-4057qib7	9840	19	Marrow	Marrow	NNP
cord-005453-4057qib7	9840	20	Transplant	Transplant	NNP
cord-005453-4057qib7	9840	21	Unit	unit	NN
cord-005453-4057qib7	9840	22	between	between	IN
cord-005453-4057qib7	9840	23	July	July	NNP
cord-005453-4057qib7	9840	24	2008	2008	CD
cord-005453-4057qib7	9840	25	and	and	CC
cord-005453-4057qib7	9840	26	July	July	NNP
cord-005453-4057qib7	9840	27	2018	2018	CD
cord-005453-4057qib7	9840	28	.	.	.
cord-005453-4057qib7	9841	1	Eleven	eleven	CD
cord-005453-4057qib7	9841	2	(	(	-LRB-
cord-005453-4057qib7	9841	3	2	2	CD
cord-005453-4057qib7	9841	4	%	%	NN
cord-005453-4057qib7	9841	5	)	)	-RRB-
cord-005453-4057qib7	9841	6	of	of	IN
cord-005453-4057qib7	9841	7	these	these	DT
cord-005453-4057qib7	9841	8	patients	patient	NNS
cord-005453-4057qib7	9841	9	were	be	VBD
cord-005453-4057qib7	9841	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	9841	11	of	of	IN
cord-005453-4057qib7	9841	12	Toxoplasma	Toxoplasma	NNP
cord-005453-4057qib7	9841	13	disease	disease	NN
cord-005453-4057qib7	9841	14	.	.	.
cord-005453-4057qib7	9842	1	The	the	DT
cord-005453-4057qib7	9842	2	main	main	JJ
cord-005453-4057qib7	9842	3	characteristics	characteristic	NNS
cord-005453-4057qib7	9842	4	of	of	IN
cord-005453-4057qib7	9842	5	the	the	DT
cord-005453-4057qib7	9842	6	patients	patient	NNS
cord-005453-4057qib7	9842	7	are	be	VBP
cord-005453-4057qib7	9842	8	shown	show	VBN
cord-005453-4057qib7	9842	9	in	in	IN
cord-005453-4057qib7	9842	10	table	table	NN
cord-005453-4057qib7	9842	11	1	1	CD
cord-005453-4057qib7	9842	12	.	.	.
cord-005453-4057qib7	9843	1	All	all	DT
cord-005453-4057qib7	9843	2	patients	patient	NNS
cord-005453-4057qib7	9843	3	,	,	,
cord-005453-4057qib7	9843	4	except	except	IN
cord-005453-4057qib7	9843	5	two	two	CD
cord-005453-4057qib7	9843	6	cord	cord	NN
cord-005453-4057qib7	9843	7	blood	blood	NN
cord-005453-4057qib7	9843	8	,	,	,
cord-005453-4057qib7	9843	9	have	have	VBP
cord-005453-4057qib7	9843	10	received	receive	VBN
cord-005453-4057qib7	9843	11	peripheral	peripheral	JJ
cord-005453-4057qib7	9843	12	blood	blood	NN
cord-005453-4057qib7	9843	13	stem	stem	NN
cord-005453-4057qib7	9843	14	cells	cell	NNS
cord-005453-4057qib7	9843	15	.	.	.
cord-005453-4057qib7	9844	1	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	9844	2	-	-	HYPH
cord-005453-4057qib7	9844	3	based	base	VBN
cord-005453-4057qib7	9844	4	conditioning	conditioning	NN
cord-005453-4057qib7	9844	5	regimes	regime	NNS
cord-005453-4057qib7	9844	6	were	be	VBD
cord-005453-4057qib7	9844	7	used	use	VBN
cord-005453-4057qib7	9844	8	in	in	IN
cord-005453-4057qib7	9844	9	all	all	DT
cord-005453-4057qib7	9844	10	patients	patient	NNS
cord-005453-4057qib7	9844	11	.	.	.
cord-005453-4057qib7	9845	1	Only	only	RB
cord-005453-4057qib7	9845	2	the	the	DT
cord-005453-4057qib7	9845	3	two	two	CD
cord-005453-4057qib7	9845	4	cord	cord	NN
cord-005453-4057qib7	9845	5	blood	blood	NN
cord-005453-4057qib7	9845	6	patients	patient	NNS
cord-005453-4057qib7	9845	7	received	receive	VBD
cord-005453-4057qib7	9845	8	Thymoglobulin	Thymoglobulin	NNP
cord-005453-4057qib7	9845	9	in	in	IN
cord-005453-4057qib7	9845	10	the	the	DT
cord-005453-4057qib7	9845	11	conditioning	conditioning	NN
cord-005453-4057qib7	9845	12	.	.	.
cord-005453-4057qib7	9846	1	Graft	graft	NN
cord-005453-4057qib7	9846	2	-	-	HYPH
cord-005453-4057qib7	9846	3	versus	versus	IN
cord-005453-4057qib7	9846	4	-	-	HYPH
cord-005453-4057qib7	9846	5	host	host	NN
cord-005453-4057qib7	9846	6	disease	disease	NN
cord-005453-4057qib7	9846	7	(	(	-LRB-
cord-005453-4057qib7	9846	8	GVHD	GVHD	NNP
cord-005453-4057qib7	9846	9	)	)	-RRB-
cord-005453-4057qib7	9846	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9846	11	consisted	consist	VBD
cord-005453-4057qib7	9846	12	on	on	IN
cord-005453-4057qib7	9846	13	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	9846	14	plus	plus	CC
cord-005453-4057qib7	9846	15	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	9846	16	mofetil	mofetil	NNP
cord-005453-4057qib7	9846	17	in	in	IN
cord-005453-4057qib7	9846	18	5	5	CD
cord-005453-4057qib7	9846	19	(	(	-LRB-
cord-005453-4057qib7	9846	20	46	46	CD
cord-005453-4057qib7	9846	21	%	%	NN
cord-005453-4057qib7	9846	22	)	)	-RRB-
cord-005453-4057qib7	9846	23	patients	patient	NNS
cord-005453-4057qib7	9846	24	and	and	CC
cord-005453-4057qib7	9846	25	post	post	JJ
cord-005453-4057qib7	9846	26	-	-	JJ
cord-005453-4057qib7	9846	27	transplant	transplant	NN
cord-005453-4057qib7	9846	28	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	9846	29	followed	follow	VBN
cord-005453-4057qib7	9846	30	by	by	IN
cord-005453-4057qib7	9846	31	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	9846	32	in	in	IN
cord-005453-4057qib7	9846	33	4	4	CD
cord-005453-4057qib7	9846	34	(	(	-LRB-
cord-005453-4057qib7	9846	35	36	36	CD
cord-005453-4057qib7	9846	36	%	%	NN
cord-005453-4057qib7	9846	37	)	)	-RRB-
cord-005453-4057qib7	9846	38	.	.	.
cord-005453-4057qib7	9847	1	Before	before	IN
cord-005453-4057qib7	9847	2	the	the	DT
cord-005453-4057qib7	9847	3	allo	allo	NNP
cord-005453-4057qib7	9847	4	-	-	HYPH
cord-005453-4057qib7	9847	5	SCT	SCT	NNP
cord-005453-4057qib7	9847	6	was	be	VBD
cord-005453-4057qib7	9847	7	performed	perform	VBN
cord-005453-4057qib7	9847	8	the	the	DT
cord-005453-4057qib7	9847	9	IgG	IgG	NNP
cord-005453-4057qib7	9847	10	/	/	SYM
cord-005453-4057qib7	9847	11	IgM	IgM	NNP
cord-005453-4057qib7	9847	12	Toxoplasma	Toxoplasma	NNP
cord-005453-4057qib7	9847	13	serology	serology	NN
cord-005453-4057qib7	9847	14	of	of	IN
cord-005453-4057qib7	9847	15	the	the	DT
cord-005453-4057qib7	9847	16	recipient	recipient	NN
cord-005453-4057qib7	9847	17	and	and	CC
cord-005453-4057qib7	9847	18	donor	donor	NN
cord-005453-4057qib7	9847	19	.	.	.
cord-005453-4057qib7	9848	1	We	-PRON-	PRP
cord-005453-4057qib7	9848	2	reviewed	review	VBD
cord-005453-4057qib7	9848	3	the	the	DT
cord-005453-4057qib7	9848	4	absolute	absolute	JJ
cord-005453-4057qib7	9848	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9848	6	count	count	NN
cord-005453-4057qib7	9848	7	(	(	-LRB-
cord-005453-4057qib7	9848	8	ALC	ALC	NNP
cord-005453-4057qib7	9848	9	)	)	-RRB-
cord-005453-4057qib7	9848	10	and	and	CC
cord-005453-4057qib7	9848	11	CD4	CD4	NNP
cord-005453-4057qib7	9848	12	+	+	CC
cord-005453-4057qib7	9848	13	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9848	14	count	count	NN
cord-005453-4057qib7	9848	15	within	within	IN
cord-005453-4057qib7	9848	16	four	four	CD
cord-005453-4057qib7	9848	17	weeks	week	NNS
cord-005453-4057qib7	9848	18	prior	prior	RB
cord-005453-4057qib7	9848	19	to	to	IN
cord-005453-4057qib7	9848	20	the	the	DT
cord-005453-4057qib7	9848	21	diagnosis	diagnosis	NN
cord-005453-4057qib7	9848	22	of	of	IN
cord-005453-4057qib7	9848	23	toxoplasmosis	toxoplasmosis	NN
cord-005453-4057qib7	9848	24	,	,	,
cord-005453-4057qib7	9848	25	and	and	CC
cord-005453-4057qib7	9848	26	if	if	IN
cord-005453-4057qib7	9848	27	the	the	DT
cord-005453-4057qib7	9848	28	patients	patient	NNS
cord-005453-4057qib7	9848	29	took	take	VBD
cord-005453-4057qib7	9848	30	effective	effective	JJ
cord-005453-4057qib7	9848	31	primary	primary	JJ
cord-005453-4057qib7	9848	32	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9848	33	for	for	IN
cord-005453-4057qib7	9848	34	this	this	DT
cord-005453-4057qib7	9848	35	parasite	parasite	NN
cord-005453-4057qib7	9848	36	.	.	.
cord-005453-4057qib7	9849	1	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	9849	2	disease	disease	NN
cord-005453-4057qib7	9849	3	was	be	VBD
cord-005453-4057qib7	9849	4	defined	define	VBN
cord-005453-4057qib7	9849	5	as	as	IN
cord-005453-4057qib7	9849	6	the	the	DT
cord-005453-4057qib7	9849	7	presence	presence	NN
cord-005453-4057qib7	9849	8	of	of	IN
cord-005453-4057qib7	9849	9	Toxoplasma	toxoplasma	JJ
cord-005453-4057qib7	9849	10	infection	infection	NN
cord-005453-4057qib7	9849	11	plus	plus	IN
cord-005453-4057qib7	9849	12	clinical	clinical	JJ
cord-005453-4057qib7	9849	13	,	,	,
cord-005453-4057qib7	9849	14	radiological	radiological	JJ
cord-005453-4057qib7	9849	15	or	or	CC
cord-005453-4057qib7	9849	16	pathological	pathological	JJ
cord-005453-4057qib7	9849	17	evidence	evidence	NN
cord-005453-4057qib7	9849	18	.	.	.
cord-005453-4057qib7	9850	1	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	9850	2	disease	disease	NN
cord-005453-4057qib7	9850	3	was	be	VBD
cord-005453-4057qib7	9850	4	considered	consider	VBN
cord-005453-4057qib7	9850	5	the	the	DT
cord-005453-4057qib7	9850	6	main	main	JJ
cord-005453-4057qib7	9850	7	cause	cause	NN
cord-005453-4057qib7	9850	8	of	of	IN
cord-005453-4057qib7	9850	9	death	death	NN
cord-005453-4057qib7	9850	10	when	when	WRB
cord-005453-4057qib7	9850	11	no	no	DT
cord-005453-4057qib7	9850	12	other	other	JJ
cord-005453-4057qib7	9850	13	major	major	JJ
cord-005453-4057qib7	9850	14	life	life	NN
cord-005453-4057qib7	9850	15	-	-	HYPH
cord-005453-4057qib7	9850	16	threatening	threaten	VBG
cord-005453-4057qib7	9850	17	infection	infection	NN
cord-005453-4057qib7	9850	18	or	or	CC
cord-005453-4057qib7	9850	19	other	other	JJ
cord-005453-4057qib7	9850	20	potential	potential	JJ
cord-005453-4057qib7	9850	21	fatal	fatal	JJ
cord-005453-4057qib7	9850	22	complication	complication	NN
cord-005453-4057qib7	9850	23	occurred	occur	VBD
cord-005453-4057qib7	9850	24	immediately	immediately	RB
cord-005453-4057qib7	9850	25	before	before	IN
cord-005453-4057qib7	9850	26	death	death	NN
cord-005453-4057qib7	9850	27	.	.	.
cord-005453-4057qib7	9851	1	Results	result	NNS
cord-005453-4057qib7	9851	2	:	:	:
cord-005453-4057qib7	9852	1	Median	median	JJ
cord-005453-4057qib7	9852	2	(	(	-LRB-
cord-005453-4057qib7	9852	3	range	range	NN
cord-005453-4057qib7	9852	4	)	)	-RRB-
cord-005453-4057qib7	9852	5	age	age	NN
cord-005453-4057qib7	9852	6	(	(	-LRB-
cord-005453-4057qib7	9852	7	years	year	NNS
cord-005453-4057qib7	9852	8	)	)	-RRB-
cord-005453-4057qib7	9852	9	of	of	IN
cord-005453-4057qib7	9852	10	the	the	DT
cord-005453-4057qib7	9852	11	eleven	eleven	CD
cord-005453-4057qib7	9852	12	patients	patient	NNS
cord-005453-4057qib7	9852	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	9852	14	with	with	IN
cord-005453-4057qib7	9852	15	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	9852	16	disease	disease	NN
cord-005453-4057qib7	9852	17	was	be	VBD
cord-005453-4057qib7	9852	18	54	54	CD
cord-005453-4057qib7	9852	19	(	(	-LRB-
cord-005453-4057qib7	9852	20	19	19	CD
cord-005453-4057qib7	9852	21	-	-	SYM
cord-005453-4057qib7	9852	22	69	69	CD
cord-005453-4057qib7	9852	23	)	)	-RRB-
cord-005453-4057qib7	9852	24	.	.	.
cord-005453-4057qib7	9853	1	For	for	IN
cord-005453-4057qib7	9853	2	pancytopenia	pancytopenia	NNP
cord-005453-4057qib7	9853	3	,	,	,
cord-005453-4057qib7	9853	4	no	no	DT
cord-005453-4057qib7	9853	5	patient	patient	NN
cord-005453-4057qib7	9853	6	received	receive	VBD
cord-005453-4057qib7	9853	7	trimethoprimsufmethoxazole	trimethoprimsufmethoxazole	NNP
cord-005453-4057qib7	9853	8	(	(	-LRB-
cord-005453-4057qib7	9853	9	TMP	TMP	NNP
cord-005453-4057qib7	9853	10	-	-	HYPH
cord-005453-4057qib7	9853	11	SMZ	SMZ	NNP
cord-005453-4057qib7	9853	12	)	)	-RRB-
cord-005453-4057qib7	9853	13	but	but	CC
cord-005453-4057qib7	9853	14	pentamidine	pentamidine	NN
cord-005453-4057qib7	9853	15	for	for	IN
cord-005453-4057qib7	9853	16	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9853	17	jirovecii	jirovecii	NNP
cord-005453-4057qib7	9853	18	-	-	HYPH
cord-005453-4057qib7	9853	19	pneumonia	pneumonia	NNP
cord-005453-4057qib7	9853	20	(	(	-LRB-
cord-005453-4057qib7	9853	21	PcP	PcP	NNP
cord-005453-4057qib7	9853	22	)	)	-RRB-
cord-005453-4057qib7	9853	23	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9853	24	in	in	IN
cord-005453-4057qib7	9853	25	10	10	CD
cord-005453-4057qib7	9853	26	cases	case	NNS
cord-005453-4057qib7	9853	27	and	and	CC
cord-005453-4057qib7	9853	28	atovaquone	atovaquone	NN
cord-005453-4057qib7	9853	29	in	in	IN
cord-005453-4057qib7	9853	30	one	one	CD
cord-005453-4057qib7	9853	31	.	.	.
cord-005453-4057qib7	9854	1	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	9854	2	serology	serology	NN
cord-005453-4057qib7	9854	3	pretransplant	pretransplant	NN
cord-005453-4057qib7	9854	4	was	be	VBD
cord-005453-4057qib7	9854	5	positive	positive	JJ
cord-005453-4057qib7	9854	6	(	(	-LRB-
cord-005453-4057qib7	9854	7	IgG+/IgM-	IgG+/IgM-	NNP
cord-005453-4057qib7	9854	8	)	)	-RRB-
cord-005453-4057qib7	9855	1	in	in	IN
cord-005453-4057qib7	9855	2	ten	ten	CD
cord-005453-4057qib7	9855	3	of	of	IN
cord-005453-4057qib7	9855	4	the	the	DT
cord-005453-4057qib7	9855	5	eleven	eleven	CD
cord-005453-4057qib7	9855	6	patients	patient	NNS
cord-005453-4057qib7	9855	7	.	.	.
cord-005453-4057qib7	9856	1	All	all	DT
cord-005453-4057qib7	9856	2	donors	donor	NNS
cord-005453-4057qib7	9856	3	were	be	VBD
cord-005453-4057qib7	9856	4	seronegative	seronegative	JJ
cord-005453-4057qib7	9856	5	(	(	-LRB-
cord-005453-4057qib7	9856	6	IgG-/IgM-	IgG-/IgM-	NNP
cord-005453-4057qib7	9856	7	)	)	-RRB-
cord-005453-4057qib7	9856	8	except	except	IN
cord-005453-4057qib7	9856	9	two	two	CD
cord-005453-4057qib7	9856	10	.	.	.
cord-005453-4057qib7	9857	1	Toxoplasmosis	toxoplasmosis	NN
cord-005453-4057qib7	9857	2	was	be	VBD
cord-005453-4057qib7	9857	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	9857	4	a	a	DT
cord-005453-4057qib7	9857	5	median	median	NN
cord-005453-4057qib7	9857	6	(	(	-LRB-
cord-005453-4057qib7	9857	7	range	range	NN
cord-005453-4057qib7	9857	8	)	)	-RRB-
cord-005453-4057qib7	9857	9	of	of	IN
cord-005453-4057qib7	9857	10	85	85	CD
cord-005453-4057qib7	9857	11	days	day	NNS
cord-005453-4057qib7	9857	12	(	(	-LRB-
cord-005453-4057qib7	9857	13	35	35	CD
cord-005453-4057qib7	9857	14	-	-	SYM
cord-005453-4057qib7	9857	15	330	330	CD
cord-005453-4057qib7	9857	16	)	)	-RRB-
cord-005453-4057qib7	9857	17	post	post	NN
cord-005453-4057qib7	9857	18	allo	allo	NNP
cord-005453-4057qib7	9857	19	-	-	HYPH
cord-005453-4057qib7	9857	20	STC	STC	NNP
cord-005453-4057qib7	9857	21	.	.	.
cord-005453-4057qib7	9858	1	The	the	DT
cord-005453-4057qib7	9858	2	clinical	clinical	JJ
cord-005453-4057qib7	9858	3	presentations	presentation	NNS
cord-005453-4057qib7	9858	4	were	be	VBD
cord-005453-4057qib7	9858	5	as	as	RB
cord-005453-4057qib7	9858	6	cerebral	cerebral	JJ
cord-005453-4057qib7	9858	7	-	-	:
cord-005453-4057qib7	9858	8	encephalitis	encephalitis	JJ
cord-005453-4057qib7	9858	9	(	(	-LRB-
cord-005453-4057qib7	9858	10	n=4	n=4	NNS
cord-005453-4057qib7	9858	11	)	)	-RRB-
cord-005453-4057qib7	9858	12	,	,	,
cord-005453-4057qib7	9858	13	chorioretinitis	chorioretinitis	NNP
cord-005453-4057qib7	9858	14	(	(	-LRB-
cord-005453-4057qib7	9858	15	n=3	n=3	NN
cord-005453-4057qib7	9858	16	)	)	-RRB-
cord-005453-4057qib7	9858	17	,	,	,
cord-005453-4057qib7	9858	18	pneumonitis	pneumonitis	NNP
cord-005453-4057qib7	9858	19	(	(	-LRB-
cord-005453-4057qib7	9858	20	n=2	n=2	NNS
cord-005453-4057qib7	9858	21	)	)	-RRB-
cord-005453-4057qib7	9858	22	and	and	CC
cord-005453-4057qib7	9858	23	disseminated	disseminate	VBN
cord-005453-4057qib7	9858	24	toxoplasmosis	toxoplasmosis	NN
cord-005453-4057qib7	9858	25	(	(	-LRB-
cord-005453-4057qib7	9858	26	n=2	n=2	NNS
cord-005453-4057qib7	9858	27	)	)	-RRB-
cord-005453-4057qib7	9858	28	.	.	.
cord-005453-4057qib7	9859	1	One	one	CD
cord-005453-4057qib7	9859	2	case	case	NN
cord-005453-4057qib7	9859	3	,	,	,
cord-005453-4057qib7	9859	4	patient	patient	JJ
cord-005453-4057qib7	9859	5	and	and	CC
cord-005453-4057qib7	9859	6	donor	donor	NN
cord-005453-4057qib7	9859	7	seronegative	seronegative	JJ
cord-005453-4057qib7	9859	8	pre	pre	JJ
cord-005453-4057qib7	9859	9	-	-	NN
cord-005453-4057qib7	9859	10	transplant	transplant	NN
cord-005453-4057qib7	9859	11	,	,	,
cord-005453-4057qib7	9859	12	was	be	VBD
cord-005453-4057qib7	9859	13	presented	present	VBN
cord-005453-4057qib7	9859	14	as	as	IN
cord-005453-4057qib7	9859	15	a	a	DT
cord-005453-4057qib7	9859	16	primary	primary	JJ
cord-005453-4057qib7	9859	17	infection	infection	NN
cord-005453-4057qib7	9859	18	in	in	IN
cord-005453-4057qib7	9859	19	form	form	NN
cord-005453-4057qib7	9859	20	of	of	IN
cord-005453-4057qib7	9859	21	chorioretinitis	chorioretinitis	NNP
cord-005453-4057qib7	9859	22	.	.	.
cord-005453-4057qib7	9860	1	All	all	DT
cord-005453-4057qib7	9860	2	three	three	CD
cord-005453-4057qib7	9860	3	patients	patient	NNS
cord-005453-4057qib7	9860	4	with	with	IN
cord-005453-4057qib7	9860	5	chorioretinitis	chorioretinitis	NNP
cord-005453-4057qib7	9860	6	were	be	VBD
cord-005453-4057qib7	9860	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	9860	8	after	after	IN
cord-005453-4057qib7	9860	9	day	day	NN
cord-005453-4057qib7	9860	10	+100	+100	NNS
cord-005453-4057qib7	9860	11	of	of	IN
cord-005453-4057qib7	9860	12	allo	allo	NN
cord-005453-4057qib7	9860	13	-	-	HYPH
cord-005453-4057qib7	9860	14	SCT	SCT	NNP
cord-005453-4057qib7	9860	15	.	.	.
cord-005453-4057qib7	9861	1	At	at	IN
cord-005453-4057qib7	9861	2	the	the	DT
cord-005453-4057qib7	9861	3	time	time	NN
cord-005453-4057qib7	9861	4	of	of	IN
cord-005453-4057qib7	9861	5	Toxoplasma	Toxoplasma	NNP
cord-005453-4057qib7	9861	6	disease	disease	NN
cord-005453-4057qib7	9861	7	,	,	,
cord-005453-4057qib7	9861	8	8	8	CD
cord-005453-4057qib7	9861	9	of	of	IN
cord-005453-4057qib7	9861	10	11	11	CD
cord-005453-4057qib7	9861	11	(	(	-LRB-
cord-005453-4057qib7	9861	12	73	73	CD
cord-005453-4057qib7	9861	13	%	%	NN
cord-005453-4057qib7	9861	14	)	)	-RRB-
cord-005453-4057qib7	9861	15	of	of	IN
cord-005453-4057qib7	9861	16	patients	patient	NNS
cord-005453-4057qib7	9861	17	had	have	VBD
cord-005453-4057qib7	9861	18	an	an	DT
cord-005453-4057qib7	9861	19	ALC	alc	NN
cord-005453-4057qib7	9861	20	<	<	XX
cord-005453-4057qib7	9861	21	500	500	CD
cord-005453-4057qib7	9861	22	cells	cell	NNS
cord-005453-4057qib7	9861	23	/	/	SYM
cord-005453-4057qib7	9861	24	μl	μl	VBP
cord-005453-4057qib7	9861	25	and	and	CC
cord-005453-4057qib7	9861	26	all	all	DT
cord-005453-4057qib7	9861	27	of	of	IN
cord-005453-4057qib7	9861	28	them	-PRON-	PRP
cord-005453-4057qib7	9861	29	with	with	IN
cord-005453-4057qib7	9861	30	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	9861	31	therapy	therapy	NN
cord-005453-4057qib7	9861	32	and	and	CC
cord-005453-4057qib7	9861	33	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	9861	34	for	for	IN
cord-005453-4057qib7	9861	35	acute	acute	JJ
cord-005453-4057qib7	9861	36	or	or	CC
cord-005453-4057qib7	9861	37	chronic	chronic	JJ
cord-005453-4057qib7	9861	38	GVHD	GVHD	NNP
cord-005453-4057qib7	9861	39	.	.	.
cord-005453-4057qib7	9862	1	We	-PRON-	PRP
cord-005453-4057qib7	9862	2	had	have	VBD
cord-005453-4057qib7	9862	3	CD4	CD4	NNP
cord-005453-4057qib7	9862	4	+	+	CC
cord-005453-4057qib7	9862	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9862	6	count	count	NN
cord-005453-4057qib7	9862	7	only	only	RB
cord-005453-4057qib7	9862	8	in	in	IN
cord-005453-4057qib7	9862	9	four	four	CD
cord-005453-4057qib7	9862	10	patients	patient	NNS
cord-005453-4057qib7	9862	11	and	and	CC
cord-005453-4057qib7	9862	12	in	in	IN
cord-005453-4057qib7	9862	13	three	three	CD
cord-005453-4057qib7	9862	14	of	of	IN
cord-005453-4057qib7	9862	15	them	-PRON-	PRP
cord-005453-4057qib7	9862	16	was	be	VBD
cord-005453-4057qib7	9862	17	<	<	XX
cord-005453-4057qib7	9862	18	200	200	CD
cord-005453-4057qib7	9862	19	cells/	cells/	CD
cord-005453-4057qib7	9863	1	μL.	μL.	NNP
cord-005453-4057qib7	9863	2	Eight	eight	CD
cord-005453-4057qib7	9863	3	of	of	IN
cord-005453-4057qib7	9863	4	the	the	DT
cord-005453-4057qib7	9863	5	eleven	eleven	CD
cord-005453-4057qib7	9863	6	(	(	-LRB-
cord-005453-4057qib7	9863	7	73	73	CD
cord-005453-4057qib7	9863	8	%	%	NN
cord-005453-4057qib7	9863	9	)	)	-RRB-
cord-005453-4057qib7	9864	1	patients	patient	NNS
cord-005453-4057qib7	9864	2	died	die	VBD
cord-005453-4057qib7	9864	3	,	,	,
cord-005453-4057qib7	9864	4	with	with	IN
cord-005453-4057qib7	9864	5	a	a	DT
cord-005453-4057qib7	9864	6	median	median	NN
cord-005453-4057qib7	9864	7	(	(	-LRB-
cord-005453-4057qib7	9864	8	range	range	NN
cord-005453-4057qib7	9864	9	)	)	-RRB-
cord-005453-4057qib7	9864	10	of	of	IN
cord-005453-4057qib7	9864	11	21	21	CD
cord-005453-4057qib7	9864	12	days	day	NNS
cord-005453-4057qib7	9864	13	(	(	-LRB-
cord-005453-4057qib7	9864	14	9	9	CD
cord-005453-4057qib7	9864	15	-	-	SYM
cord-005453-4057qib7	9864	16	65	65	CD
cord-005453-4057qib7	9864	17	)	)	-RRB-
cord-005453-4057qib7	9864	18	since	since	IN
cord-005453-4057qib7	9864	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	9864	20	of	of	IN
cord-005453-4057qib7	9864	21	toxoplasmosis	toxoplasmosis	NN
cord-005453-4057qib7	9864	22	,	,	,
cord-005453-4057qib7	9864	23	and	and	CC
cord-005453-4057qib7	9864	24	in	in	IN
cord-005453-4057qib7	9864	25	6	6	CD
cord-005453-4057qib7	9864	26	of	of	IN
cord-005453-4057qib7	9864	27	them	-PRON-	PRP
cord-005453-4057qib7	9864	28	the	the	DT
cord-005453-4057qib7	9864	29	Toxoplasma	Toxoplasma	NNP
cord-005453-4057qib7	9864	30	disease	disease	NN
cord-005453-4057qib7	9864	31	was	be	VBD
cord-005453-4057qib7	9864	32	the	the	DT
cord-005453-4057qib7	9864	33	main	main	JJ
cord-005453-4057qib7	9864	34	cause	cause	NN
cord-005453-4057qib7	9864	35	of	of	IN
cord-005453-4057qib7	9864	36	death	death	NN
cord-005453-4057qib7	9864	37	.	.	.
cord-005453-4057qib7	9865	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9865	2	:	:	:
cord-005453-4057qib7	9866	1	In	in	IN
cord-005453-4057qib7	9866	2	our	-PRON-	PRP$
cord-005453-4057qib7	9866	3	series	series	NN
cord-005453-4057qib7	9866	4	,	,	,
cord-005453-4057qib7	9866	5	the	the	DT
cord-005453-4057qib7	9866	6	incidence	incidence	NN
cord-005453-4057qib7	9866	7	of	of	IN
cord-005453-4057qib7	9866	8	Toxoplasma	toxoplasma	JJ
cord-005453-4057qib7	9866	9	disease	disease	NN
cord-005453-4057qib7	9866	10	after	after	IN
cord-005453-4057qib7	9866	11	allo	allo	NN
cord-005453-4057qib7	9866	12	-	-	HYPH
cord-005453-4057qib7	9866	13	SCT	SCT	NNP
cord-005453-4057qib7	9866	14	is	be	VBZ
cord-005453-4057qib7	9866	15	low	low	JJ
cord-005453-4057qib7	9866	16	and	and	CC
cord-005453-4057qib7	9866	17	is	be	VBZ
cord-005453-4057qib7	9866	18	related	relate	VBN
cord-005453-4057qib7	9866	19	to	to	IN
cord-005453-4057qib7	9866	20	high	high	JJ
cord-005453-4057qib7	9866	21	mortality	mortality	NN
cord-005453-4057qib7	9866	22	,	,	,
cord-005453-4057qib7	9866	23	in	in	IN
cord-005453-4057qib7	9866	24	accordance	accordance	NN
cord-005453-4057qib7	9866	25	with	with	IN
cord-005453-4057qib7	9866	26	what	what	WP
cord-005453-4057qib7	9866	27	has	have	VBZ
cord-005453-4057qib7	9866	28	been	be	VBN
cord-005453-4057qib7	9866	29	reported	report	VBN
cord-005453-4057qib7	9866	30	by	by	IN
cord-005453-4057qib7	9866	31	other	other	JJ
cord-005453-4057qib7	9866	32	groups	group	NNS
cord-005453-4057qib7	9866	33	.	.	.
cord-005453-4057qib7	9867	1	Positive	positive	JJ
cord-005453-4057qib7	9867	2	pre	pre	JJ
cord-005453-4057qib7	9867	3	-	-	JJ
cord-005453-4057qib7	9867	4	transplant	transplant	JJ
cord-005453-4057qib7	9867	5	serology	serology	NN
cord-005453-4057qib7	9867	6	and	and	CC
cord-005453-4057qib7	9867	7	GVHD	GVHD	NNP
cord-005453-4057qib7	9867	8	and	and	CC
cord-005453-4057qib7	9867	9	its	-PRON-	PRP$
cord-005453-4057qib7	9867	10	treatment	treatment	NN
cord-005453-4057qib7	9867	11	were	be	VBD
cord-005453-4057qib7	9867	12	factors	factor	NNS
cord-005453-4057qib7	9867	13	strongly	strongly	RB
cord-005453-4057qib7	9867	14	related	relate	VBN
cord-005453-4057qib7	9867	15	with	with	IN
cord-005453-4057qib7	9867	16	toxoplasmosis	toxoplasmosi	NNS
cord-005453-4057qib7	9867	17	.	.	.
cord-005453-4057qib7	9868	1	We	-PRON-	PRP
cord-005453-4057qib7	9868	2	encourage	encourage	VBP
cord-005453-4057qib7	9868	3	the	the	DT
cord-005453-4057qib7	9868	4	use	use	NN
cord-005453-4057qib7	9868	5	of	of	IN
cord-005453-4057qib7	9868	6	TMP	tmp	NN
cord-005453-4057qib7	9868	7	-	-	HYPH
cord-005453-4057qib7	9868	8	SMZ	SMZ	NNP
cord-005453-4057qib7	9868	9	instead	instead	RB
cord-005453-4057qib7	9868	10	of	of	IN
cord-005453-4057qib7	9868	11	pentamidine	pentamidine	NNP
cord-005453-4057qib7	9868	12	for	for	IN
cord-005453-4057qib7	9868	13	PcP	pcp	JJ
cord-005453-4057qib7	9868	14	-	-	HYPH
cord-005453-4057qib7	9868	15	pneumonia	pneumonia	NN
cord-005453-4057qib7	9868	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9868	17	in	in	IN
cord-005453-4057qib7	9868	18	patients	patient	NNS
cord-005453-4057qib7	9868	19	seropositive	seropositive	JJ
cord-005453-4057qib7	9868	20	for	for	IN
cord-005453-4057qib7	9868	21	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	9868	22	gondii	gondii	NNP
cord-005453-4057qib7	9868	23	pre	pre	NN
cord-005453-4057qib7	9868	24	-	-	NN
cord-005453-4057qib7	9868	25	transplant	transplant	NN
cord-005453-4057qib7	9868	26	.	.	.
cord-005453-4057qib7	9869	1	Clinical	clinical	JJ
cord-005453-4057qib7	9869	2	Trial	Trial	NNP
cord-005453-4057qib7	9869	3	Registry	Registry	NNP
cord-005453-4057qib7	9869	4	:	:	:
cord-005453-4057qib7	9870	1	Data	datum	NNS
cord-005453-4057qib7	9870	2	about	about	IN
cord-005453-4057qib7	9870	3	its	-PRON-	PRP$
cord-005453-4057qib7	9870	4	epidemiology	epidemiology	NN
cord-005453-4057qib7	9870	5	in	in	IN
cord-005453-4057qib7	9870	6	children	child	NNS
cord-005453-4057qib7	9870	7	are	be	VBP
cord-005453-4057qib7	9870	8	scarce	scarce	JJ
cord-005453-4057qib7	9870	9	.	.	.
cord-005453-4057qib7	9871	1	We	-PRON-	PRP
cord-005453-4057qib7	9871	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	9871	3	analyzed	analyze	VBD
cord-005453-4057qib7	9871	4	the	the	DT
cord-005453-4057qib7	9871	5	incidence	incidence	NN
cord-005453-4057qib7	9871	6	,	,	,
cord-005453-4057qib7	9871	7	the	the	DT
cord-005453-4057qib7	9871	8	severity	severity	NN
cord-005453-4057qib7	9871	9	and	and	CC
cord-005453-4057qib7	9871	10	the	the	DT
cord-005453-4057qib7	9871	11	risk	risk	NN
cord-005453-4057qib7	9871	12	factors	factor	NNS
cord-005453-4057qib7	9871	13	that	that	WDT
cord-005453-4057qib7	9871	14	contribute	contribute	VBP
cord-005453-4057qib7	9871	15	to	to	IN
cord-005453-4057qib7	9871	16	the	the	DT
cord-005453-4057qib7	9871	17	manifestation	manifestation	NN
cord-005453-4057qib7	9871	18	of	of	IN
cord-005453-4057qib7	9871	19	this	this	DT
cord-005453-4057qib7	9871	20	complication	complication	NN
cord-005453-4057qib7	9871	21	in	in	IN
cord-005453-4057qib7	9871	22	a	a	DT
cord-005453-4057qib7	9871	23	pediatric	pediatric	JJ
cord-005453-4057qib7	9871	24	population	population	NN
cord-005453-4057qib7	9871	25	.	.	.
cord-005453-4057qib7	9872	1	Methods	method	NNS
cord-005453-4057qib7	9872	2	:	:	:
cord-005453-4057qib7	9872	3	During	during	IN
cord-005453-4057qib7	9872	4	a	a	DT
cord-005453-4057qib7	9872	5	10-year	10-year	CD
cord-005453-4057qib7	9872	6	period	period	NN
cord-005453-4057qib7	9872	7	(	(	-LRB-
cord-005453-4057qib7	9872	8	January	January	NNP
cord-005453-4057qib7	9872	9	2008	2008	CD
cord-005453-4057qib7	9872	10	-June	-June	NNP
cord-005453-4057qib7	9872	11	2018	2018	CD
cord-005453-4057qib7	9872	12	)	)	-RRB-
cord-005453-4057qib7	9873	1	we	-PRON-	PRP
cord-005453-4057qib7	9873	2	performed	perform	VBD
cord-005453-4057qib7	9873	3	in	in	IN
cord-005453-4057qib7	9873	4	our	-PRON-	PRP$
cord-005453-4057qib7	9873	5	center	center	NN
cord-005453-4057qib7	9873	6	376	376	CD
cord-005453-4057qib7	9873	7	allogeneic	allogeneic	NN
cord-005453-4057qib7	9873	8	transplantations	transplantation	NNS
cord-005453-4057qib7	9873	9	,	,	,
cord-005453-4057qib7	9873	10	237	237	CD
cord-005453-4057qib7	9873	11	for	for	IN
cord-005453-4057qib7	9873	12	malignant	malignant	JJ
cord-005453-4057qib7	9873	13	hematological	hematological	JJ
cord-005453-4057qib7	9873	14	diseases	disease	NNS
cord-005453-4057qib7	9873	15	and	and	CC
cord-005453-4057qib7	9873	16	139	139	CD
cord-005453-4057qib7	9873	17	for	for	IN
cord-005453-4057qib7	9873	18	non	non	JJ
cord-005453-4057qib7	9873	19	-	-	JJ
cord-005453-4057qib7	9873	20	malignant	malignant	JJ
cord-005453-4057qib7	9873	21	.	.	.
cord-005453-4057qib7	9874	1	The	the	DT
cord-005453-4057qib7	9874	2	majority	majority	NN
cord-005453-4057qib7	9874	3	of	of	IN
cord-005453-4057qib7	9874	4	our	-PRON-	PRP$
cord-005453-4057qib7	9874	5	patients	patient	NNS
cord-005453-4057qib7	9874	6	received	receive	VBD
cord-005453-4057qib7	9874	7	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9874	8	conditioning	conditioning	NN
cord-005453-4057qib7	9874	9	regimens	regimen	NNS
cord-005453-4057qib7	9874	10	.	.	.
cord-005453-4057qib7	9875	1	Diagnostic	diagnostic	JJ
cord-005453-4057qib7	9875	2	criteria	criterion	NNS
cord-005453-4057qib7	9875	3	of	of	IN
cord-005453-4057qib7	9875	4	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9875	5	cystitis	cystiti	NNS
cord-005453-4057qib7	9875	6	were	be	VBD
cord-005453-4057qib7	9875	7	the	the	DT
cord-005453-4057qib7	9875	8	detection	detection	NN
cord-005453-4057qib7	9875	9	of	of	IN
cord-005453-4057qib7	9875	10	the	the	DT
cord-005453-4057qib7	9875	11	virus	virus	NN
cord-005453-4057qib7	9875	12	with	with	IN
cord-005453-4057qib7	9875	13	PCR	PCR	NNP
cord-005453-4057qib7	9875	14	in	in	IN
cord-005453-4057qib7	9875	15	urine	urine	NN
cord-005453-4057qib7	9875	16	samples	sample	NNS
cord-005453-4057qib7	9875	17	and/or	and/or	CC
cord-005453-4057qib7	9875	18	in	in	IN
cord-005453-4057qib7	9875	19	blood	blood	NN
cord-005453-4057qib7	9875	20	samples	sample	NNS
cord-005453-4057qib7	9875	21	,	,	,
cord-005453-4057qib7	9875	22	in	in	IN
cord-005453-4057qib7	9875	23	combination	combination	NN
cord-005453-4057qib7	9875	24	with	with	IN
cord-005453-4057qib7	9875	25	hematuria	hematuria	NN
cord-005453-4057qib7	9875	26	and	and	CC
cord-005453-4057qib7	9875	27	lower	low	JJR
cord-005453-4057qib7	9875	28	urinary	urinary	JJ
cord-005453-4057qib7	9875	29	tract	tract	NN
cord-005453-4057qib7	9875	30	symptoms	symptom	NNS
cord-005453-4057qib7	9875	31	(	(	-LRB-
cord-005453-4057qib7	9875	32	dysuria	dysuria	NNP
cord-005453-4057qib7	9875	33	,	,	,
cord-005453-4057qib7	9875	34	urinary	urinary	JJ
cord-005453-4057qib7	9875	35	frequency	frequency	NN
cord-005453-4057qib7	9875	36	,	,	,
cord-005453-4057qib7	9875	37	urgency	urgency	NN
cord-005453-4057qib7	9875	38	,	,	,
cord-005453-4057qib7	9875	39	suprapubic	suprapubic	NN
cord-005453-4057qib7	9875	40	pain	pain	NN
cord-005453-4057qib7	9875	41	)	)	-RRB-
cord-005453-4057qib7	9875	42	that	that	WDT
cord-005453-4057qib7	9875	43	could	could	MD
cord-005453-4057qib7	9875	44	n't	not	RB
cord-005453-4057qib7	9875	45	be	be	VB
cord-005453-4057qib7	9875	46	attributed	attribute	VBN
cord-005453-4057qib7	9875	47	to	to	IN
cord-005453-4057qib7	9875	48	any	any	DT
cord-005453-4057qib7	9875	49	other	other	JJ
cord-005453-4057qib7	9875	50	reason	reason	NN
cord-005453-4057qib7	9875	51	.	.	.
cord-005453-4057qib7	9876	1	We	-PRON-	PRP
cord-005453-4057qib7	9876	2	defined	define	VBD
cord-005453-4057qib7	9876	3	the	the	DT
cord-005453-4057qib7	9876	4	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9876	5	cystitis	cystitis	NN
cord-005453-4057qib7	9876	6	as	as	IN
cord-005453-4057qib7	9876	7	severe	severe	JJ
cord-005453-4057qib7	9876	8	when	when	WRB
cord-005453-4057qib7	9876	9	one	one	CD
cord-005453-4057qib7	9876	10	of	of	IN
cord-005453-4057qib7	9876	11	the	the	DT
cord-005453-4057qib7	9876	12	following	following	JJ
cord-005453-4057qib7	9876	13	factors	factor	NNS
cord-005453-4057qib7	9876	14	was	be	VBD
cord-005453-4057qib7	9876	15	present	present	JJ
cord-005453-4057qib7	9876	16	:	:	:
cord-005453-4057qib7	9876	17	formation	formation	NN
cord-005453-4057qib7	9876	18	of	of	IN
cord-005453-4057qib7	9876	19	clots	clot	NNS
cord-005453-4057qib7	9876	20	and	and	CC
cord-005453-4057qib7	9876	21	continuous	continuous	JJ
cord-005453-4057qib7	9876	22	bladder	bladder	NN
cord-005453-4057qib7	9876	23	irrigation	irrigation	NN
cord-005453-4057qib7	9876	24	,	,	,
cord-005453-4057qib7	9876	25	obstructive	obstructive	JJ
cord-005453-4057qib7	9876	26	uropathy	uropathy	NNP
cord-005453-4057qib7	9876	27	with	with	IN
cord-005453-4057qib7	9876	28	creatinine	creatinine	NN
cord-005453-4057qib7	9876	29	elevation	elevation	NN
cord-005453-4057qib7	9876	30	or	or	CC
cord-005453-4057qib7	9876	31	need	need	NN
cord-005453-4057qib7	9876	32	for	for	IN
cord-005453-4057qib7	9876	33	urological	urological	JJ
cord-005453-4057qib7	9876	34	intervention	intervention	NN
cord-005453-4057qib7	9876	35	.	.	.
cord-005453-4057qib7	9877	1	Results	result	NNS
cord-005453-4057qib7	9877	2	:	:	:
cord-005453-4057qib7	9878	1	A	a	DT
cord-005453-4057qib7	9878	2	total	total	NN
cord-005453-4057qib7	9878	3	of	of	IN
cord-005453-4057qib7	9878	4	376	376	CD
cord-005453-4057qib7	9878	5	patients	patient	NNS
cord-005453-4057qib7	9878	6	with	with	IN
cord-005453-4057qib7	9878	7	median	median	JJ
cord-005453-4057qib7	9878	8	age	age	NN
cord-005453-4057qib7	9878	9	7,2	7,2	CD
cord-005453-4057qib7	9878	10	years	year	NNS
cord-005453-4057qib7	9879	1	(	(	-LRB-
cord-005453-4057qib7	9879	2	0,5	0,5	CD
cord-005453-4057qib7	9879	3	-	-	SYM
cord-005453-4057qib7	9879	4	20	20	CD
cord-005453-4057qib7	9879	5	)	)	-RRB-
cord-005453-4057qib7	9879	6	were	be	VBD
cord-005453-4057qib7	9879	7	studied	study	VBN
cord-005453-4057qib7	9879	8	.	.	.
cord-005453-4057qib7	9880	1	37	37	CD
cord-005453-4057qib7	9880	2	children	child	NNS
cord-005453-4057qib7	9880	3	(	(	-LRB-
cord-005453-4057qib7	9880	4	10	10	CD
cord-005453-4057qib7	9880	5	%	%	NN
cord-005453-4057qib7	9880	6	,	,	,
cord-005453-4057qib7	9880	7	95	95	CD
cord-005453-4057qib7	9880	8	%	%	NN
cord-005453-4057qib7	9880	9	CI	ci	NN
cord-005453-4057qib7	9880	10	,	,	,
cord-005453-4057qib7	9880	11	7,2	7,2	CD
cord-005453-4057qib7	9880	12	-	-	HYPH
cord-005453-4057qib7	9880	13	13,3	13,3	CD
cord-005453-4057qib7	9880	14	)	)	-RRB-
cord-005453-4057qib7	9880	15	manifested	manifest	VBD
cord-005453-4057qib7	9880	16	BK	BK	NNP
cord-005453-4057qib7	9880	17	virus	virus	NN
cord-005453-4057qib7	9880	18	associated	associate	VBD
cord-005453-4057qib7	9880	19	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9880	20	cystitis	cystitis	NN
cord-005453-4057qib7	9880	21	with	with	IN
cord-005453-4057qib7	9880	22	median	median	JJ
cord-005453-4057qib7	9880	23	age	age	NN
cord-005453-4057qib7	9880	24	12,9	12,9	CD
cord-005453-4057qib7	9880	25	years	year	NNS
cord-005453-4057qib7	9880	26	(	(	-LRB-
cord-005453-4057qib7	9880	27	5	5	CD
cord-005453-4057qib7	9880	28	,	,	,
cord-005453-4057qib7	9880	29	[	[	-LRB-
cord-005453-4057qib7	9880	30	1	1	CD
cord-005453-4057qib7	9880	31	]	]	-RRB-
cord-005453-4057qib7	9880	32	[	[	-LRB-
cord-005453-4057qib7	9880	33	2	2	CD
cord-005453-4057qib7	9880	34	]	]	-RRB-
cord-005453-4057qib7	9880	35	[	[	-LRB-
cord-005453-4057qib7	9880	36	3	3	CD
cord-005453-4057qib7	9880	37	]	]	-RRB-
cord-005453-4057qib7	9880	38	[	[	-LRB-
cord-005453-4057qib7	9880	39	4	4	CD
cord-005453-4057qib7	9880	40	]	]	-RRB-
cord-005453-4057qib7	9880	41	[	[	-LRB-
cord-005453-4057qib7	9880	42	5	5	CD
cord-005453-4057qib7	9880	43	]	]	-RRB-
cord-005453-4057qib7	9880	44	[	[	-LRB-
cord-005453-4057qib7	9880	45	6	6	CD
cord-005453-4057qib7	9880	46	]	]	-RRB-
cord-005453-4057qib7	9880	47	[	[	-LRB-
cord-005453-4057qib7	9880	48	7	7	CD
cord-005453-4057qib7	9880	49	]	]	-RRB-
cord-005453-4057qib7	9880	50	[	[	-LRB-
cord-005453-4057qib7	9880	51	8	8	CD
cord-005453-4057qib7	9880	52	]	]	-RRB-
cord-005453-4057qib7	9880	53	[	[	-LRB-
cord-005453-4057qib7	9880	54	9	9	CD
cord-005453-4057qib7	9880	55	]	]	-RRB-
cord-005453-4057qib7	9880	56	[	[	-LRB-
cord-005453-4057qib7	9880	57	10	10	CD
cord-005453-4057qib7	9880	58	]	]	-RRB-
cord-005453-4057qib7	9880	59	[	[	-LRB-
cord-005453-4057qib7	9880	60	11	11	CD
cord-005453-4057qib7	9880	61	]	]	-RRB-
cord-005453-4057qib7	9880	62	[	[	-LRB-
cord-005453-4057qib7	9880	63	12	12	CD
cord-005453-4057qib7	9880	64	]	]	-RRB-
cord-005453-4057qib7	9880	65	[	[	-LRB-
cord-005453-4057qib7	9880	66	13	13	CD
cord-005453-4057qib7	9880	67	]	]	-RRB-
cord-005453-4057qib7	9880	68	[	[	-LRB-
cord-005453-4057qib7	9880	69	14	14	CD
cord-005453-4057qib7	9880	70	]	]	-RRB-
cord-005453-4057qib7	9880	71	[	[	-LRB-
cord-005453-4057qib7	9880	72	15	15	CD
cord-005453-4057qib7	9880	73	]	]	-RRB-
cord-005453-4057qib7	9880	74	[	[	-LRB-
cord-005453-4057qib7	9880	75	16	16	CD
cord-005453-4057qib7	9880	76	]	]	-RRB-
cord-005453-4057qib7	9880	77	[	[	-LRB-
cord-005453-4057qib7	9880	78	17	17	CD
cord-005453-4057qib7	9880	79	]	]	-RRB-
cord-005453-4057qib7	9880	80	[	[	-LRB-
cord-005453-4057qib7	9880	81	18	18	CD
cord-005453-4057qib7	9880	82	]	]	-RRB-
cord-005453-4057qib7	9880	83	5	5	CD
cord-005453-4057qib7	9880	84	)	)	-RRB-
cord-005453-4057qib7	9880	85	.	.	.
cord-005453-4057qib7	9881	1	Onset	onset	NN
cord-005453-4057qib7	9881	2	of	of	IN
cord-005453-4057qib7	9881	3	cystitis	cystitis	NN
cord-005453-4057qib7	9881	4	occurred	occur	VBD
cord-005453-4057qib7	9881	5	at	at	IN
cord-005453-4057qib7	9881	6	a	a	DT
cord-005453-4057qib7	9881	7	median	median	JJ
cord-005453-4057qib7	9881	8	time	time	NN
cord-005453-4057qib7	9881	9	of	of	IN
cord-005453-4057qib7	9881	10	27	27	CD
cord-005453-4057qib7	9881	11	days	day	NNS
cord-005453-4057qib7	9881	12	(	(	-LRB-
cord-005453-4057qib7	9881	13	day	day	NN
cord-005453-4057qib7	9881	14	+	+	CC
cord-005453-4057qib7	9881	15	-day	-day	:
cord-005453-4057qib7	9881	16	+52	+52	NN
cord-005453-4057qib7	9881	17	)	)	-RRB-
cord-005453-4057qib7	9881	18	after	after	IN
cord-005453-4057qib7	9881	19	transplantation	transplantation	NN
cord-005453-4057qib7	9881	20	.	.	.
cord-005453-4057qib7	9882	1	In	in	IN
cord-005453-4057qib7	9882	2	17	17	CD
cord-005453-4057qib7	9882	3	children	child	NNS
cord-005453-4057qib7	9882	4	cystitis	cystitis	NN
cord-005453-4057qib7	9882	5	was	be	VBD
cord-005453-4057qib7	9882	6	severe	severe	JJ
cord-005453-4057qib7	9882	7	.	.	.
cord-005453-4057qib7	9883	1	The	the	DT
cord-005453-4057qib7	9883	2	median	median	JJ
cord-005453-4057qib7	9883	3	duration	duration	NN
cord-005453-4057qib7	9883	4	of	of	IN
cord-005453-4057qib7	9883	5	symptoms	symptom	NNS
cord-005453-4057qib7	9883	6	was	be	VBD
cord-005453-4057qib7	9883	7	27	27	CD
cord-005453-4057qib7	9883	8	days	day	NNS
cord-005453-4057qib7	9883	9	(	(	-LRB-
cord-005453-4057qib7	9883	10	8	8	CD
cord-005453-4057qib7	9883	11	-	-	SYM
cord-005453-4057qib7	9883	12	200	200	CD
cord-005453-4057qib7	9883	13	)	)	-RRB-
cord-005453-4057qib7	9883	14	.	.	.
cord-005453-4057qib7	9884	1	The	the	DT
cord-005453-4057qib7	9884	2	median	median	JJ
cord-005453-4057qib7	9884	3	time	time	NN
cord-005453-4057qib7	9884	4	of	of	IN
cord-005453-4057qib7	9884	5	hospitalization	hospitalization	NN
cord-005453-4057qib7	9884	6	for	for	IN
cord-005453-4057qib7	9884	7	children	child	NNS
cord-005453-4057qib7	9884	8	with	with	IN
cord-005453-4057qib7	9884	9	severe	severe	JJ
cord-005453-4057qib7	9884	10	cystitis	cystitis	NN
cord-005453-4057qib7	9884	11	was	be	VBD
cord-005453-4057qib7	9884	12	70	70	CD
cord-005453-4057qib7	9884	13	days	day	NNS
cord-005453-4057qib7	9884	14	(	(	-LRB-
cord-005453-4057qib7	9884	15	29	29	CD
cord-005453-4057qib7	9884	16	-	-	SYM
cord-005453-4057qib7	9884	17	242	242	CD
cord-005453-4057qib7	9884	18	)	)	-RRB-
cord-005453-4057qib7	9885	1	whereas	whereas	IN
cord-005453-4057qib7	9885	2	for	for	IN
cord-005453-4057qib7	9885	3	those	those	DT
cord-005453-4057qib7	9885	4	who	who	WP
cord-005453-4057qib7	9885	5	did	do	VBD
cord-005453-4057qib7	9885	6	n't	not	RB
cord-005453-4057qib7	9885	7	manifest	manifest	VB
cord-005453-4057qib7	9885	8	cystitis	cystitis	NN
cord-005453-4057qib7	9885	9	was	be	VBD
cord-005453-4057qib7	9885	10	45	45	CD
cord-005453-4057qib7	9885	11	(	(	-LRB-
cord-005453-4057qib7	9885	12	25	25	CD
cord-005453-4057qib7	9885	13	-	-	SYM
cord-005453-4057qib7	9885	14	184	184	CD
cord-005453-4057qib7	9885	15	)	)	-RRB-
cord-005453-4057qib7	9885	16	.	.	.
cord-005453-4057qib7	9886	1	In	in	IN
cord-005453-4057qib7	9886	2	25	25	CD
cord-005453-4057qib7	9886	3	of	of	IN
cord-005453-4057qib7	9886	4	the	the	DT
cord-005453-4057qib7	9886	5	37	37	CD
cord-005453-4057qib7	9886	6	patients	patient	NNS
cord-005453-4057qib7	9886	7	we	-PRON-	PRP
cord-005453-4057qib7	9886	8	examined	examine	VBD
cord-005453-4057qib7	9886	9	the	the	DT
cord-005453-4057qib7	9886	10	presence	presence	NN
cord-005453-4057qib7	9886	11	of	of	IN
cord-005453-4057qib7	9886	12	the	the	DT
cord-005453-4057qib7	9886	13	virus	virus	NN
cord-005453-4057qib7	9886	14	not	not	RB
cord-005453-4057qib7	9886	15	only	only	RB
cord-005453-4057qib7	9886	16	in	in	IN
cord-005453-4057qib7	9886	17	urine	urine	NN
cord-005453-4057qib7	9886	18	but	but	CC
cord-005453-4057qib7	9886	19	also	also	RB
cord-005453-4057qib7	9886	20	in	in	IN
cord-005453-4057qib7	9886	21	blood	blood	NN
cord-005453-4057qib7	9886	22	samples	sample	NNS
cord-005453-4057qib7	9886	23	.	.	.
cord-005453-4057qib7	9887	1	In	in	IN
cord-005453-4057qib7	9887	2	11	11	CD
cord-005453-4057qib7	9887	3	of	of	IN
cord-005453-4057qib7	9887	4	them	-PRON-	PRP
cord-005453-4057qib7	9887	5	the	the	DT
cord-005453-4057qib7	9887	6	test	test	NN
cord-005453-4057qib7	9887	7	was	be	VBD
cord-005453-4057qib7	9887	8	positive	positive	JJ
cord-005453-4057qib7	9887	9	and	and	CC
cord-005453-4057qib7	9887	10	almost	almost	RB
cord-005453-4057qib7	9887	11	half	half	NN
cord-005453-4057qib7	9887	12	of	of	IN
cord-005453-4057qib7	9887	13	them	-PRON-	PRP
cord-005453-4057qib7	9887	14	(	(	-LRB-
cord-005453-4057qib7	9887	15	6	6	CD
cord-005453-4057qib7	9887	16	)	)	-RRB-
cord-005453-4057qib7	9887	17	manifested	manifest	VBD
cord-005453-4057qib7	9887	18	severe	severe	JJ
cord-005453-4057qib7	9887	19	cystitis	cystitis	NN
cord-005453-4057qib7	9887	20	.	.	.
cord-005453-4057qib7	9888	1	The	the	DT
cord-005453-4057qib7	9888	2	risk	risk	NN
cord-005453-4057qib7	9888	3	factors	factor	NNS
cord-005453-4057qib7	9888	4	that	that	WDT
cord-005453-4057qib7	9888	5	were	be	VBD
cord-005453-4057qib7	9888	6	examined	examine	VBN
cord-005453-4057qib7	9888	7	were	be	VBD
cord-005453-4057qib7	9888	8	age	age	NN
cord-005453-4057qib7	9888	9	,	,	,
cord-005453-4057qib7	9888	10	administration	administration	NN
cord-005453-4057qib7	9888	11	of	of	IN
cord-005453-4057qib7	9888	12	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	9888	13	globulin	globulin	NNP
cord-005453-4057qib7	9888	14	,	,	,
cord-005453-4057qib7	9888	15	type	type	NN
cord-005453-4057qib7	9888	16	of	of	IN
cord-005453-4057qib7	9888	17	disease	disease	NN
cord-005453-4057qib7	9888	18	,	,	,
cord-005453-4057qib7	9888	19	graft	graft	NN
cord-005453-4057qib7	9888	20	source	source	NN
cord-005453-4057qib7	9888	21	,	,	,
cord-005453-4057qib7	9888	22	type	type	NN
cord-005453-4057qib7	9888	23	of	of	IN
cord-005453-4057qib7	9888	24	donor	donor	NN
cord-005453-4057qib7	9888	25	and	and	CC
cord-005453-4057qib7	9888	26	the	the	DT
cord-005453-4057qib7	9888	27	presence	presence	NN
cord-005453-4057qib7	9888	28	of	of	IN
cord-005453-4057qib7	9888	29	acute	acute	JJ
cord-005453-4057qib7	9888	30	Graft	graft	NN
cord-005453-4057qib7	9888	31	versus	versus	IN
cord-005453-4057qib7	9888	32	Host	Host	NNP
cord-005453-4057qib7	9888	33	Disease	Disease	NNP
cord-005453-4057qib7	9888	34	(	(	-LRB-
cord-005453-4057qib7	9888	35	aGvHD	agvhd	NN
cord-005453-4057qib7	9888	36	)	)	-RRB-
cord-005453-4057qib7	9888	37	.	.	.
cord-005453-4057qib7	9889	1	In	in	IN
cord-005453-4057qib7	9889	2	multivariable	multivariable	JJ
cord-005453-4057qib7	9889	3	analysis	analysis	NN
cord-005453-4057qib7	9889	4	,	,	,
cord-005453-4057qib7	9889	5	independent	independent	JJ
cord-005453-4057qib7	9889	6	risk	risk	NN
cord-005453-4057qib7	9889	7	factors	factor	NNS
cord-005453-4057qib7	9889	8	for	for	IN
cord-005453-4057qib7	9889	9	the	the	DT
cord-005453-4057qib7	9889	10	manifestation	manifestation	NN
cord-005453-4057qib7	9889	11	of	of	IN
cord-005453-4057qib7	9889	12	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9889	13	cystitis	cystitis	NN
cord-005453-4057qib7	9889	14	were	be	VBD
cord-005453-4057qib7	9889	15	age	age	NN
cord-005453-4057qib7	9889	16	>	>	XX
cord-005453-4057qib7	9889	17	6	6	CD
cord-005453-4057qib7	9889	18	years	year	NNS
cord-005453-4057qib7	9889	19	old	old	JJ
cord-005453-4057qib7	9889	20	(	(	-LRB-
cord-005453-4057qib7	9889	21	HR	HR	NNP
cord-005453-4057qib7	9889	22	:	:	:
cord-005453-4057qib7	9889	23	8,46	8,46	CD
cord-005453-4057qib7	9889	24	,	,	,
cord-005453-4057qib7	9889	25	95	95	CD
cord-005453-4057qib7	9889	26	%	%	NN
cord-005453-4057qib7	9889	27	CI	CI	NNP
cord-005453-4057qib7	9889	28	,	,	,
cord-005453-4057qib7	9889	29	2,86	2,86	CD
cord-005453-4057qib7	9889	30	-	-	SYM
cord-005453-4057qib7	9889	31	25	25	CD
cord-005453-4057qib7	9889	32	,	,	,
cord-005453-4057qib7	9889	33	p	p	NN
cord-005453-4057qib7	9889	34	<	<	XX
cord-005453-4057qib7	9889	35	0,001	0,001	CD
cord-005453-4057qib7	9889	36	)	)	-RRB-
cord-005453-4057qib7	9889	37	,	,	,
cord-005453-4057qib7	9889	38	transplantation	transplantation	NN
cord-005453-4057qib7	9889	39	for	for	IN
cord-005453-4057qib7	9889	40	malignant	malignant	JJ
cord-005453-4057qib7	9889	41	disease	disease	NN
cord-005453-4057qib7	9889	42	(	(	-LRB-
cord-005453-4057qib7	9889	43	HR	hr	NN
cord-005453-4057qib7	9889	44	:	:	:
cord-005453-4057qib7	9889	45	2,26	2,26	CD
cord-005453-4057qib7	9889	46	,	,	,
cord-005453-4057qib7	9889	47	95	95	CD
cord-005453-4057qib7	9889	48	%	%	NN
cord-005453-4057qib7	9889	49	CI	ci	NN
cord-005453-4057qib7	9889	50	,	,	,
cord-005453-4057qib7	9889	51	0,97	0,97	CD
cord-005453-4057qib7	9889	52	-	-	HYPH
cord-005453-4057qib7	9889	53	5,27	5,27	CD
cord-005453-4057qib7	9889	54	,	,	,
cord-005453-4057qib7	9889	55	P=0,05	P=0,05	NNP
cord-005453-4057qib7	9889	56	)	)	-RRB-
cord-005453-4057qib7	9889	57	and	and	CC
cord-005453-4057qib7	9889	58	the	the	DT
cord-005453-4057qib7	9889	59	presence	presence	NN
cord-005453-4057qib7	9889	60	of	of	IN
cord-005453-4057qib7	9889	61	aGvHD	agvhd	NN
cord-005453-4057qib7	9889	62	(	(	-LRB-
cord-005453-4057qib7	9889	63	HR	HR	NNP
cord-005453-4057qib7	9889	64	:	:	:
cord-005453-4057qib7	9889	65	4,04	4,04	CD
cord-005453-4057qib7	9889	66	,	,	,
cord-005453-4057qib7	9889	67	95	95	CD
cord-005453-4057qib7	9889	68	%	%	NN
cord-005453-4057qib7	9889	69	CI	ci	NN
cord-005453-4057qib7	9889	70	,	,	,
cord-005453-4057qib7	9889	71	2,01	2,01	CD
cord-005453-4057qib7	9889	72	-	-	SYM
cord-005453-4057qib7	9889	73	8,1	8,1	NN
cord-005453-4057qib7	9889	74	,	,	,
cord-005453-4057qib7	9889	75	P	p	NN
cord-005453-4057qib7	9889	76	<	<	XX
cord-005453-4057qib7	9889	77	0,001	0,001	CD
cord-005453-4057qib7	9889	78	)	)	-RRB-
cord-005453-4057qib7	9889	79	.	.	.
cord-005453-4057qib7	9890	1	The	the	DT
cord-005453-4057qib7	9890	2	overall	overall	JJ
cord-005453-4057qib7	9890	3	survival	survival	NN
cord-005453-4057qib7	9890	4	of	of	IN
cord-005453-4057qib7	9890	5	children	child	NNS
cord-005453-4057qib7	9890	6	with	with	IN
cord-005453-4057qib7	9890	7	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9890	8	cystitis	cystitis	NN
cord-005453-4057qib7	9890	9	was	be	VBD
cord-005453-4057qib7	9890	10	46,3	46,3	CD
cord-005453-4057qib7	9890	11	%	%	NN
cord-005453-4057qib7	9890	12	vs	vs	IN
cord-005453-4057qib7	9890	13	69,3	69,3	CD
cord-005453-4057qib7	9890	14	%	%	NN
cord-005453-4057qib7	9890	15	of	of	IN
cord-005453-4057qib7	9890	16	those	those	DT
cord-005453-4057qib7	9890	17	who	who	WP
cord-005453-4057qib7	9890	18	did	do	VBD
cord-005453-4057qib7	9890	19	n't	not	RB
cord-005453-4057qib7	9890	20	manifest	manifest	VB
cord-005453-4057qib7	9890	21	this	this	DT
cord-005453-4057qib7	9890	22	complication	complication	NN
cord-005453-4057qib7	9890	23	,	,	,
cord-005453-4057qib7	9890	24	but	but	CC
cord-005453-4057qib7	9890	25	in	in	IN
cord-005453-4057qib7	9890	26	multivariable	multivariable	JJ
cord-005453-4057qib7	9890	27	analysis	analysis	NN
cord-005453-4057qib7	9890	28	for	for	IN
cord-005453-4057qib7	9890	29	survival	survival	NN
cord-005453-4057qib7	9890	30	cystitis	cystitis	NNP
cord-005453-4057qib7	9890	31	was	be	VBD
cord-005453-4057qib7	9890	32	n't	not	RB
cord-005453-4057qib7	9890	33	a	a	DT
cord-005453-4057qib7	9890	34	statistically	statistically	RB
cord-005453-4057qib7	9890	35	significant	significant	JJ
cord-005453-4057qib7	9890	36	risk	risk	NN
cord-005453-4057qib7	9890	37	factor	factor	NN
cord-005453-4057qib7	9890	38	.	.	.
cord-005453-4057qib7	9891	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9891	2	:	:	:
cord-005453-4057qib7	9892	1	According	accord	VBG
cord-005453-4057qib7	9892	2	to	to	IN
cord-005453-4057qib7	9892	3	our	-PRON-	PRP$
cord-005453-4057qib7	9892	4	results	result	NNS
cord-005453-4057qib7	9892	5	,	,	,
cord-005453-4057qib7	9892	6	stem	stem	NN
cord-005453-4057qib7	9892	7	cell	cell	NN
cord-005453-4057qib7	9892	8	transplantation	transplantation	NN
cord-005453-4057qib7	9892	9	in	in	IN
cord-005453-4057qib7	9892	10	children	child	NNS
cord-005453-4057qib7	9892	11	>	>	XX
cord-005453-4057qib7	9892	12	6	6	CD
cord-005453-4057qib7	9892	13	years	year	NNS
cord-005453-4057qib7	9892	14	old	old	JJ
cord-005453-4057qib7	9892	15	who	who	WP
cord-005453-4057qib7	9892	16	suffer	suffer	VBP
cord-005453-4057qib7	9892	17	from	from	IN
cord-005453-4057qib7	9892	18	a	a	DT
cord-005453-4057qib7	9892	19	malignant	malignant	JJ
cord-005453-4057qib7	9892	20	disease	disease	NN
cord-005453-4057qib7	9892	21	and	and	CC
cord-005453-4057qib7	9892	22	the	the	DT
cord-005453-4057qib7	9892	23	presence	presence	NN
cord-005453-4057qib7	9892	24	of	of	IN
cord-005453-4057qib7	9892	25	aGvHD	aGvHD	NNP
cord-005453-4057qib7	9892	26	consist	consist	VBP
cord-005453-4057qib7	9892	27	independent	independent	JJ
cord-005453-4057qib7	9892	28	risk	risk	NN
cord-005453-4057qib7	9892	29	factors	factor	NNS
cord-005453-4057qib7	9892	30	for	for	IN
cord-005453-4057qib7	9892	31	the	the	DT
cord-005453-4057qib7	9892	32	manifestation	manifestation	NN
cord-005453-4057qib7	9892	33	of	of	IN
cord-005453-4057qib7	9892	34	BK	BK	NNP
cord-005453-4057qib7	9892	35	virus	virus	NN
cord-005453-4057qib7	9892	36	associated	associate	VBD
cord-005453-4057qib7	9892	37	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9892	38	cystitis	cystitis	NN
cord-005453-4057qib7	9892	39	.	.	.
cord-005453-4057qib7	9893	1	The	the	DT
cord-005453-4057qib7	9893	2	identification	identification	NN
cord-005453-4057qib7	9893	3	of	of	IN
cord-005453-4057qib7	9893	4	the	the	DT
cord-005453-4057qib7	9893	5	risk	risk	NN
cord-005453-4057qib7	9893	6	factors	factor	NNS
cord-005453-4057qib7	9893	7	of	of	IN
cord-005453-4057qib7	9893	8	this	this	DT
cord-005453-4057qib7	9893	9	serious	serious	JJ
cord-005453-4057qib7	9893	10	complication	complication	NN
cord-005453-4057qib7	9893	11	will	will	MD
cord-005453-4057qib7	9893	12	contribute	contribute	VB
cord-005453-4057qib7	9893	13	to	to	IN
cord-005453-4057qib7	9893	14	better	well	JJR
cord-005453-4057qib7	9893	15	management	management	NN
cord-005453-4057qib7	9893	16	of	of	IN
cord-005453-4057qib7	9893	17	transplanted	transplanted	JJ
cord-005453-4057qib7	9893	18	patients	patient	NNS
cord-005453-4057qib7	9893	19	.	.	.
cord-005453-4057qib7	9894	1	Further	further	JJ
cord-005453-4057qib7	9894	2	research	research	NN
cord-005453-4057qib7	9894	3	through	through	IN
cord-005453-4057qib7	9894	4	prospective	prospective	JJ
cord-005453-4057qib7	9894	5	trials	trial	NNS
cord-005453-4057qib7	9894	6	can	can	MD
cord-005453-4057qib7	9894	7	contribute	contribute	VB
cord-005453-4057qib7	9894	8	to	to	IN
cord-005453-4057qib7	9894	9	the	the	DT
cord-005453-4057qib7	9894	10	better	well	JJR
cord-005453-4057qib7	9894	11	understanding	understanding	NN
cord-005453-4057qib7	9894	12	of	of	IN
cord-005453-4057qib7	9894	13	the	the	DT
cord-005453-4057qib7	9894	14	pathophysiology	pathophysiology	NN
cord-005453-4057qib7	9894	15	of	of	IN
cord-005453-4057qib7	9894	16	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	9894	17	cystitis	cystitis	NN
cord-005453-4057qib7	9894	18	and	and	CC
cord-005453-4057qib7	9894	19	to	to	IN
cord-005453-4057qib7	9894	20	the	the	DT
cord-005453-4057qib7	9894	21	establishment	establishment	NN
cord-005453-4057qib7	9894	22	of	of	IN
cord-005453-4057qib7	9894	23	appropriate	appropriate	JJ
cord-005453-4057qib7	9894	24	diagnostic	diagnostic	JJ
cord-005453-4057qib7	9894	25	and	and	CC
cord-005453-4057qib7	9894	26	therapeutic	therapeutic	JJ
cord-005453-4057qib7	9894	27	guidelines	guideline	NNS
cord-005453-4057qib7	9894	28	.	.	.
cord-005453-4057qib7	9895	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9895	2	:	:	:
cord-005453-4057qib7	9895	3	Nothing	nothing	NN
cord-005453-4057qib7	9895	4	to	to	TO
cord-005453-4057qib7	9895	5	declare	declare	VB
cord-005453-4057qib7	9895	6	P442	P442	NNP
cord-005453-4057qib7	9895	7	Impact	Impact	NNP
cord-005453-4057qib7	9895	8	of	of	IN
cord-005453-4057qib7	9895	9	natural	natural	JJ
cord-005453-4057qib7	9895	10	killer	killer	NN
cord-005453-4057qib7	9895	11	cell	cell	NN
cord-005453-4057qib7	9895	12	reconstitution	reconstitution	NN
cord-005453-4057qib7	9895	13	on	on	IN
cord-005453-4057qib7	9895	14	outcomes	outcome	NNS
cord-005453-4057qib7	9895	15	in	in	IN
cord-005453-4057qib7	9895	16	patients	patient	NNS
cord-005453-4057qib7	9895	17	with	with	IN
cord-005453-4057qib7	9895	18	early	early	JJ
cord-005453-4057qib7	9895	19	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	9895	20	reactivation	reactivation	NN
cord-005453-4057qib7	9895	21	after	after	IN
cord-005453-4057qib7	9895	22	allogeneic	allogeneic	NN
cord-005453-4057qib7	9895	23	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9895	24	stem	stem	NN
cord-005453-4057qib7	9895	25	cell	cell	NN
cord-005453-4057qib7	9895	26	transplantation	transplantation	NN
cord-005453-4057qib7	9895	27	Background	background	NN
cord-005453-4057qib7	9895	28	:	:	:
cord-005453-4057qib7	9896	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	9896	2	(	(	-LRB-
cord-005453-4057qib7	9896	3	CMV	CMV	NNP
cord-005453-4057qib7	9896	4	)	)	-RRB-
cord-005453-4057qib7	9896	5	reactivation	reactivation	NN
cord-005453-4057qib7	9896	6	influences	influence	VBZ
cord-005453-4057qib7	9896	7	survival	survival	NN
cord-005453-4057qib7	9896	8	after	after	IN
cord-005453-4057qib7	9896	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9896	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9896	11	stem	stem	NN
cord-005453-4057qib7	9896	12	cell	cell	NN
cord-005453-4057qib7	9896	13	transplantation	transplantation	NN
cord-005453-4057qib7	9896	14	(	(	-LRB-
cord-005453-4057qib7	9896	15	SCT	SCT	NNP
cord-005453-4057qib7	9896	16	)	)	-RRB-
cord-005453-4057qib7	9896	17	and	and	CC
cord-005453-4057qib7	9896	18	induces	induce	VBZ
cord-005453-4057qib7	9896	19	natural	natural	JJ
cord-005453-4057qib7	9896	20	killer	killer	NN
cord-005453-4057qib7	9896	21	(	(	-LRB-
cord-005453-4057qib7	9896	22	NK	NK	NNP
cord-005453-4057qib7	9896	23	)	)	-RRB-
cord-005453-4057qib7	9896	24	cell	cell	NN
cord-005453-4057qib7	9896	25	expansion	expansion	NN
cord-005453-4057qib7	9896	26	.	.	.
cord-005453-4057qib7	9897	1	We	-PRON-	PRP
cord-005453-4057qib7	9897	2	evaluated	evaluate	VBD
cord-005453-4057qib7	9897	3	NK	NK	NNP
cord-005453-4057qib7	9897	4	cell	cell	NN
cord-005453-4057qib7	9897	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	9897	6	and	and	CC
cord-005453-4057qib7	9897	7	clinical	clinical	JJ
cord-005453-4057qib7	9897	8	outcomes	outcome	NNS
cord-005453-4057qib7	9897	9	following	follow	VBG
cord-005453-4057qib7	9897	10	early	early	JJ
cord-005453-4057qib7	9897	11	CMV	CMV	NNP
cord-005453-4057qib7	9897	12	reactivation	reactivation	NN
cord-005453-4057qib7	9897	13	after	after	IN
cord-005453-4057qib7	9897	14	SCT	SCT	NNP
cord-005453-4057qib7	9897	15	.	.	.
cord-005453-4057qib7	9898	1	Methods	method	NNS
cord-005453-4057qib7	9898	2	:	:	:
cord-005453-4057qib7	9899	1	Lymphocyte	lymphocyte	NN
cord-005453-4057qib7	9899	2	subsets	subset	NNS
cord-005453-4057qib7	9899	3	were	be	VBD
cord-005453-4057qib7	9899	4	measured	measure	VBN
cord-005453-4057qib7	9899	5	by	by	IN
cord-005453-4057qib7	9899	6	flow	flow	NN
cord-005453-4057qib7	9899	7	cytometry	cytometry	NN
cord-005453-4057qib7	9899	8	on	on	IN
cord-005453-4057qib7	9899	9	day	day	NN
cord-005453-4057qib7	9899	10	100	100	CD
cord-005453-4057qib7	9899	11	in	in	IN
cord-005453-4057qib7	9899	12	patients	patient	NNS
cord-005453-4057qib7	9899	13	with	with	IN
cord-005453-4057qib7	9899	14	hematologic	hematologic	JJ
cord-005453-4057qib7	9899	15	malignancies	malignancy	NNS
cord-005453-4057qib7	9899	16	undergoing	undergo	VBG
cord-005453-4057qib7	9899	17	SCT	SCT	NNP
cord-005453-4057qib7	9899	18	between	between	IN
cord-005453-4057qib7	9899	19	January	January	NNP
cord-005453-4057qib7	9899	20	2009	2009	CD
cord-005453-4057qib7	9899	21	and	and	CC
cord-005453-4057qib7	9899	22	December	December	NNP
cord-005453-4057qib7	9899	23	2017	2017	CD
cord-005453-4057qib7	9899	24	at	at	IN
cord-005453-4057qib7	9899	25	Kanagawa	Kanagawa	NNP
cord-005453-4057qib7	9899	26	Cancer	Cancer	NNP
cord-005453-4057qib7	9899	27	Center	Center	NNP
cord-005453-4057qib7	9899	28	,	,	,
cord-005453-4057qib7	9899	29	excluding	exclude	VBG
cord-005453-4057qib7	9899	30	patients	patient	NNS
cord-005453-4057qib7	9899	31	with	with	IN
cord-005453-4057qib7	9899	32	graft	graft	NN
cord-005453-4057qib7	9899	33	failure	failure	NN
cord-005453-4057qib7	9899	34	or	or	CC
cord-005453-4057qib7	9899	35	death	death	NN
cord-005453-4057qib7	9899	36	within	within	IN
cord-005453-4057qib7	9899	37	100	100	CD
cord-005453-4057qib7	9899	38	days	day	NNS
cord-005453-4057qib7	9899	39	.	.	.
cord-005453-4057qib7	9900	1	CMV	CMV	NNP
cord-005453-4057qib7	9900	2	reactivation	reactivation	NN
cord-005453-4057qib7	9900	3	was	be	VBD
cord-005453-4057qib7	9900	4	defined	define	VBN
cord-005453-4057qib7	9900	5	as	as	IN
cord-005453-4057qib7	9900	6	initiation	initiation	NN
cord-005453-4057qib7	9900	7	of	of	IN
cord-005453-4057qib7	9900	8	preemptive	preemptive	JJ
cord-005453-4057qib7	9900	9	CMV	CMV	NNP
cord-005453-4057qib7	9900	10	therapy	therapy	NN
cord-005453-4057qib7	9900	11	following	follow	VBG
cord-005453-4057qib7	9900	12	pp65	pp65	NNP
cord-005453-4057qib7	9900	13	antigenemia	antigenemia	NNP
cord-005453-4057qib7	9900	14	surveillance	surveillance	NN
cord-005453-4057qib7	9900	15	.	.	.
cord-005453-4057qib7	9901	1	Results	result	NNS
cord-005453-4057qib7	9901	2	:	:	:
cord-005453-4057qib7	9902	1	The	the	DT
cord-005453-4057qib7	9902	2	subjects	subject	NNS
cord-005453-4057qib7	9902	3	were	be	VBD
cord-005453-4057qib7	9902	4	152	152	CD
cord-005453-4057qib7	9902	5	males	male	NNS
cord-005453-4057qib7	9902	6	and	and	CC
cord-005453-4057qib7	9902	7	94	94	CD
cord-005453-4057qib7	9902	8	females	female	NNS
cord-005453-4057qib7	9902	9	with	with	IN
cord-005453-4057qib7	9902	10	a	a	DT
cord-005453-4057qib7	9902	11	median	median	JJ
cord-005453-4057qib7	9902	12	age	age	NN
cord-005453-4057qib7	9902	13	of	of	IN
cord-005453-4057qib7	9902	14	51	51	CD
cord-005453-4057qib7	9902	15	years	year	NNS
cord-005453-4057qib7	9903	1	(	(	-LRB-
cord-005453-4057qib7	9903	2	range	range	NN
cord-005453-4057qib7	9903	3	:	:	:
cord-005453-4057qib7	9903	4	18	18	CD
cord-005453-4057qib7	9903	5	-	-	SYM
cord-005453-4057qib7	9903	6	69	69	CD
cord-005453-4057qib7	9903	7	years	year	NNS
cord-005453-4057qib7	9903	8	)	)	-RRB-
cord-005453-4057qib7	9903	9	.	.	.
cord-005453-4057qib7	9904	1	The	the	DT
cord-005453-4057qib7	9904	2	median	median	JJ
cord-005453-4057qib7	9904	3	follow	follow	NN
cord-005453-4057qib7	9904	4	-	-	HYPH
cord-005453-4057qib7	9904	5	up	up	NN
cord-005453-4057qib7	9904	6	period	period	NN
cord-005453-4057qib7	9904	7	for	for	IN
cord-005453-4057qib7	9904	8	survivors	survivor	NNS
cord-005453-4057qib7	9904	9	was	be	VBD
cord-005453-4057qib7	9904	10	3.2	3.2	CD
cord-005453-4057qib7	9904	11	years	year	NNS
cord-005453-4057qib7	9904	12	(	(	-LRB-
cord-005453-4057qib7	9904	13	range	range	NN
cord-005453-4057qib7	9904	14	:	:	:
cord-005453-4057qib7	9904	15	0.8	0.8	CD
cord-005453-4057qib7	9904	16	-	-	HYPH
cord-005453-4057qib7	9904	17	9.6	9.6	CD
cord-005453-4057qib7	9904	18	years	year	NNS
cord-005453-4057qib7	9904	19	)	)	-RRB-
cord-005453-4057qib7	9904	20	.	.	.
cord-005453-4057qib7	9905	1	There	there	EX
cord-005453-4057qib7	9905	2	were	be	VBD
cord-005453-4057qib7	9905	3	128	128	CD
cord-005453-4057qib7	9905	4	patients	patient	NNS
cord-005453-4057qib7	9905	5	with	with	IN
cord-005453-4057qib7	9905	6	acute	acute	JJ
cord-005453-4057qib7	9905	7	myeloid	myeloid	NN
cord-005453-4057qib7	9905	8	leukemia	leukemia	NN
cord-005453-4057qib7	9905	9	,	,	,
cord-005453-4057qib7	9905	10	64	64	CD
cord-005453-4057qib7	9905	11	with	with	IN
cord-005453-4057qib7	9905	12	acute	acute	JJ
cord-005453-4057qib7	9905	13	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	9905	14	leukemia	leukemia	NN
cord-005453-4057qib7	9905	15	,	,	,
cord-005453-4057qib7	9905	16	32	32	CD
cord-005453-4057qib7	9905	17	with	with	IN
cord-005453-4057qib7	9905	18	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	9905	19	syndromes	syndrome	NNS
cord-005453-4057qib7	9905	20	,	,	,
cord-005453-4057qib7	9905	21	and	and	CC
cord-005453-4057qib7	9905	22	22	22	CD
cord-005453-4057qib7	9905	23	with	with	IN
cord-005453-4057qib7	9905	24	other	other	JJ
cord-005453-4057qib7	9905	25	diseases	disease	NNS
cord-005453-4057qib7	9905	26	.	.	.
cord-005453-4057qib7	9906	1	At	at	IN
cord-005453-4057qib7	9906	2	transplantation	transplantation	NN
cord-005453-4057qib7	9906	3	,	,	,
cord-005453-4057qib7	9906	4	166	166	CD
cord-005453-4057qib7	9906	5	patients	patient	NNS
cord-005453-4057qib7	9906	6	were	be	VBD
cord-005453-4057qib7	9906	7	standard	standard	JJ
cord-005453-4057qib7	9906	8	risk	risk	NN
cord-005453-4057qib7	9906	9	and	and	CC
cord-005453-4057qib7	9906	10	80	80	CD
cord-005453-4057qib7	9906	11	were	be	VBD
cord-005453-4057qib7	9906	12	high	high	JJ
cord-005453-4057qib7	9906	13	risk	risk	NN
cord-005453-4057qib7	9906	14	.	.	.
cord-005453-4057qib7	9907	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	9907	2	conditioning	conditioning	NN
cord-005453-4057qib7	9907	3	and	and	CC
cord-005453-4057qib7	9907	4	reduced	reduce	VBN
cord-005453-4057qib7	9907	5	-	-	HYPH
cord-005453-4057qib7	9907	6	intensity	intensity	NN
cord-005453-4057qib7	9907	7	conditioning	conditioning	NN
cord-005453-4057qib7	9907	8	were	be	VBD
cord-005453-4057qib7	9907	9	employed	employ	VBN
cord-005453-4057qib7	9907	10	in	in	IN
cord-005453-4057qib7	9907	11	99	99	CD
cord-005453-4057qib7	9907	12	and	and	CC
cord-005453-4057qib7	9907	13	147	147	CD
cord-005453-4057qib7	9907	14	patients	patient	NNS
cord-005453-4057qib7	9907	15	,	,	,
cord-005453-4057qib7	9907	16	respectively	respectively	RB
cord-005453-4057qib7	9907	17	.	.	.
cord-005453-4057qib7	9908	1	Bone	bone	NN
cord-005453-4057qib7	9908	2	marrow	marrow	NN
cord-005453-4057qib7	9908	3	transplantation	transplantation	NN
cord-005453-4057qib7	9908	4	,	,	,
cord-005453-4057qib7	9908	5	peripheral	peripheral	JJ
cord-005453-4057qib7	9908	6	blood	blood	NN
cord-005453-4057qib7	9908	7	stem	stem	NN
cord-005453-4057qib7	9908	8	cell	cell	NN
cord-005453-4057qib7	9908	9	transplantation	transplantation	NN
cord-005453-4057qib7	9908	10	,	,	,
cord-005453-4057qib7	9908	11	and	and	CC
cord-005453-4057qib7	9908	12	cord	cord	NN
cord-005453-4057qib7	9908	13	blood	blood	NN
cord-005453-4057qib7	9908	14	transplantation	transplantation	NN
cord-005453-4057qib7	9908	15	was	be	VBD
cord-005453-4057qib7	9908	16	performed	perform	VBN
cord-005453-4057qib7	9908	17	in	in	IN
cord-005453-4057qib7	9908	18	98	98	CD
cord-005453-4057qib7	9908	19	,	,	,
cord-005453-4057qib7	9908	20	36	36	CD
cord-005453-4057qib7	9908	21	,	,	,
cord-005453-4057qib7	9908	22	and	and	CC
cord-005453-4057qib7	9908	23	112	112	CD
cord-005453-4057qib7	9908	24	patients	patient	NNS
cord-005453-4057qib7	9908	25	,	,	,
cord-005453-4057qib7	9908	26	respectively	respectively	RB
cord-005453-4057qib7	9908	27	.	.	.
cord-005453-4057qib7	9909	1	CMV	CMV	NNP
cord-005453-4057qib7	9909	2	reactivation	reactivation	NN
cord-005453-4057qib7	9909	3	occurred	occur	VBD
cord-005453-4057qib7	9909	4	in	in	IN
cord-005453-4057qib7	9909	5	141	141	CD
cord-005453-4057qib7	9909	6	patients	patient	NNS
cord-005453-4057qib7	9909	7	(	(	-LRB-
cord-005453-4057qib7	9909	8	57	57	CD
cord-005453-4057qib7	9909	9	%	%	NN
cord-005453-4057qib7	9909	10	)	)	-RRB-
cord-005453-4057qib7	9909	11	at	at	IN
cord-005453-4057qib7	9909	12	a	a	DT
cord-005453-4057qib7	9909	13	median	median	NN
cord-005453-4057qib7	9909	14	of	of	IN
cord-005453-4057qib7	9909	15	45	45	CD
cord-005453-4057qib7	9909	16	days	day	NNS
cord-005453-4057qib7	9909	17	(	(	-LRB-
cord-005453-4057qib7	9909	18	range	range	NN
cord-005453-4057qib7	9909	19	:	:	:
cord-005453-4057qib7	9909	20	15	15	CD
cord-005453-4057qib7	9909	21	-	-	SYM
cord-005453-4057qib7	9909	22	93	93	CD
cord-005453-4057qib7	9909	23	days	day	NNS
cord-005453-4057qib7	9909	24	)	)	-RRB-
cord-005453-4057qib7	9909	25	after	after	IN
cord-005453-4057qib7	9909	26	SCT	SCT	NNP
cord-005453-4057qib7	9909	27	.	.	.
cord-005453-4057qib7	9910	1	Grade	Grade	NNP
cord-005453-4057qib7	9910	2	II	II	NNP
cord-005453-4057qib7	9910	3	-	-	HYPH
cord-005453-4057qib7	9910	4	IV	IV	NNP
cord-005453-4057qib7	9910	5	acute	acute	JJ
cord-005453-4057qib7	9910	6	GVHD	GVHD	NNP
cord-005453-4057qib7	9910	7	and	and	CC
cord-005453-4057qib7	9910	8	chronic	chronic	JJ
cord-005453-4057qib7	9910	9	GVHD	GVHD	NNP
cord-005453-4057qib7	9910	10	affected	affect	VBD
cord-005453-4057qib7	9910	11	89	89	CD
cord-005453-4057qib7	9910	12	patients	patient	NNS
cord-005453-4057qib7	9910	13	(	(	-LRB-
cord-005453-4057qib7	9910	14	36	36	CD
cord-005453-4057qib7	9910	15	%	%	NN
cord-005453-4057qib7	9910	16	)	)	-RRB-
cord-005453-4057qib7	9910	17	and	and	CC
cord-005453-4057qib7	9910	18	80	80	CD
cord-005453-4057qib7	9910	19	patients	patient	NNS
cord-005453-4057qib7	9910	20	(	(	-LRB-
cord-005453-4057qib7	9910	21	33	33	CD
cord-005453-4057qib7	9910	22	%	%	NN
cord-005453-4057qib7	9910	23	)	)	-RRB-
cord-005453-4057qib7	9910	24	,	,	,
cord-005453-4057qib7	9910	25	respectively	respectively	RB
cord-005453-4057qib7	9910	26	.	.	.
cord-005453-4057qib7	9911	1	Among	among	IN
cord-005453-4057qib7	9911	2	all	all	DT
cord-005453-4057qib7	9911	3	patients	patient	NNS
cord-005453-4057qib7	9911	4	,	,	,
cord-005453-4057qib7	9911	5	5-year	5-year	CD
cord-005453-4057qib7	9911	6	overall	overall	JJ
cord-005453-4057qib7	9911	7	survival	survival	NN
cord-005453-4057qib7	9911	8	(	(	-LRB-
cord-005453-4057qib7	9911	9	OS	OS	NNP
cord-005453-4057qib7	9911	10	)	)	-RRB-
cord-005453-4057qib7	9911	11	,	,	,
cord-005453-4057qib7	9911	12	cumulative	cumulative	JJ
cord-005453-4057qib7	9911	13	nonrelapse	nonrelapse	JJ
cord-005453-4057qib7	9911	14	mortality	mortality	NN
cord-005453-4057qib7	9911	15	(	(	-LRB-
cord-005453-4057qib7	9911	16	NRM	NRM	NNP
cord-005453-4057qib7	9911	17	)	)	-RRB-
cord-005453-4057qib7	9911	18	,	,	,
cord-005453-4057qib7	9911	19	and	and	CC
cord-005453-4057qib7	9911	20	cumulative	cumulative	JJ
cord-005453-4057qib7	9911	21	relapse	relapse	NN
cord-005453-4057qib7	9911	22	(	(	-LRB-
cord-005453-4057qib7	9911	23	CIR	CIR	NNP
cord-005453-4057qib7	9911	24	)	)	-RRB-
cord-005453-4057qib7	9911	25	rates	rate	NNS
cord-005453-4057qib7	9911	26	were	be	VBD
cord-005453-4057qib7	9911	27	66	66	CD
cord-005453-4057qib7	9911	28	%	%	NN
cord-005453-4057qib7	9911	29	,	,	,
cord-005453-4057qib7	9911	30	10	10	CD
cord-005453-4057qib7	9911	31	%	%	NN
cord-005453-4057qib7	9911	32	,	,	,
cord-005453-4057qib7	9911	33	and	and	CC
cord-005453-4057qib7	9911	34	33	33	CD
cord-005453-4057qib7	9911	35	%	%	NN
cord-005453-4057qib7	9911	36	,	,	,
cord-005453-4057qib7	9911	37	respectively	respectively	RB
cord-005453-4057qib7	9911	38	.	.	.
cord-005453-4057qib7	9912	1	In	in	IN
cord-005453-4057qib7	9912	2	patients	patient	NNS
cord-005453-4057qib7	9912	3	without	without	IN
cord-005453-4057qib7	9912	4	CMV	CMV	NNP
cord-005453-4057qib7	9912	5	reactivation	reactivation	NN
cord-005453-4057qib7	9912	6	(	(	-LRB-
cord-005453-4057qib7	9912	7	CMVR-	CMVR-	NNP
cord-005453-4057qib7	9912	8	)	)	-RRB-
cord-005453-4057qib7	9912	9	versus	versus	IN
cord-005453-4057qib7	9912	10	patients	patient	NNS
cord-005453-4057qib7	9912	11	with	with	IN
cord-005453-4057qib7	9912	12	CMV	CMV	NNP
cord-005453-4057qib7	9912	13	reactivation	reactivation	NN
cord-005453-4057qib7	9912	14	(	(	-LRB-
cord-005453-4057qib7	9912	15	CMVR+	CMVR+	NNP
cord-005453-4057qib7	9912	16	)	)	-RRB-
cord-005453-4057qib7	9912	17	,	,	.
cord-005453-4057qib7	9913	1	5-year	5-year	CD
cord-005453-4057qib7	9913	2	OS	OS	NNP
cord-005453-4057qib7	9913	3	,	,	,
cord-005453-4057qib7	9913	4	NRM	NRM	NNP
cord-005453-4057qib7	9913	5	,	,	,
cord-005453-4057qib7	9913	6	and	and	CC
cord-005453-4057qib7	9913	7	CIR	CIR	NNP
cord-005453-4057qib7	9913	8	were	be	VBD
cord-005453-4057qib7	9913	9	79	79	CD
cord-005453-4057qib7	9913	10	%	%	NN
cord-005453-4057qib7	9913	11	vs.	vs.	IN
cord-005453-4057qib7	9913	12	55	55	CD
cord-005453-4057qib7	9913	13	%	%	NN
cord-005453-4057qib7	9914	1	(	(	-LRB-
cord-005453-4057qib7	9914	2	p	p	NN
cord-005453-4057qib7	9914	3	<	<	XX
cord-005453-4057qib7	9914	4	0.001	0.001	CD
cord-005453-4057qib7	9914	5	)	)	-RRB-
cord-005453-4057qib7	9914	6	,	,	,
cord-005453-4057qib7	9914	7	3	3	CD
cord-005453-4057qib7	9914	8	%	%	NN
cord-005453-4057qib7	9914	9	vs.	vs.	CC
cord-005453-4057qib7	9914	10	16	16	CD
cord-005453-4057qib7	9914	11	%	%	NN
cord-005453-4057qib7	9914	12	(	(	-LRB-
cord-005453-4057qib7	9914	13	p	p	NN
cord-005453-4057qib7	9914	14	=	=	SYM
cord-005453-4057qib7	9914	15	0.005	0.005	CD
cord-005453-4057qib7	9914	16	)	)	-RRB-
cord-005453-4057qib7	9914	17	,	,	,
cord-005453-4057qib7	9914	18	and	and	CC
cord-005453-4057qib7	9914	19	27	27	CD
cord-005453-4057qib7	9914	20	%	%	NN
cord-005453-4057qib7	9914	21	vs.	vs.	IN
cord-005453-4057qib7	9914	22	38	38	CD
cord-005453-4057qib7	9914	23	%	%	NN
cord-005453-4057qib7	9914	24	(	(	-LRB-
cord-005453-4057qib7	9914	25	p	p	NN
cord-005453-4057qib7	9914	26	=	=	SYM
cord-005453-4057qib7	9914	27	0.142	0.142	CD
cord-005453-4057qib7	9914	28	)	)	-RRB-
cord-005453-4057qib7	9914	29	,	,	,
cord-005453-4057qib7	9914	30	respectively	respectively	RB
cord-005453-4057qib7	9914	31	.	.	.
cord-005453-4057qib7	9915	1	Among	among	IN
cord-005453-4057qib7	9915	2	all	all	DT
cord-005453-4057qib7	9915	3	patients	patient	NNS
cord-005453-4057qib7	9915	4	,	,	,
cord-005453-4057qib7	9915	5	the	the	DT
cord-005453-4057qib7	9915	6	median	median	JJ
cord-005453-4057qib7	9915	7	level	level	NN
cord-005453-4057qib7	9915	8	of	of	IN
cord-005453-4057qib7	9915	9	CD3-CD56	cd3-cd56	NN
cord-005453-4057qib7	9915	10	+	+	CC
cord-005453-4057qib7	9915	11	cells	cell	NNS
cord-005453-4057qib7	9915	12	,	,	,
cord-005453-4057qib7	9916	1	CD16	CD16	NNP
cord-005453-4057qib7	9916	2	+	+	SYM
cord-005453-4057qib7	9916	3	CD57cells	CD57cells	NNP
cord-005453-4057qib7	9916	4	,	,	,
cord-005453-4057qib7	9916	5	and	and	CC
cord-005453-4057qib7	9916	6	CD16+CD57	CD16+CD57	NNP
cord-005453-4057qib7	9916	7	+	+	CC
cord-005453-4057qib7	9916	8	cells	cell	NNS
cord-005453-4057qib7	9916	9	on	on	IN
cord-005453-4057qib7	9916	10	day	day	NN
cord-005453-4057qib7	9916	11	100	100	CD
cord-005453-4057qib7	9916	12	was	be	VBD
cord-005453-4057qib7	9916	13	236/	236/	CD
cord-005453-4057qib7	9917	1	μl	μl	IN
cord-005453-4057qib7	9918	1	(	(	-LRB-
cord-005453-4057qib7	9918	2	range	range	NN
cord-005453-4057qib7	9918	3	:	:	:
cord-005453-4057qib7	9918	4	19	19	CD
cord-005453-4057qib7	9918	5	-	-	SYM
cord-005453-4057qib7	9918	6	2150	2150	CD
cord-005453-4057qib7	9918	7	/	/	SYM
cord-005453-4057qib7	9918	8	μl	μl	NN
cord-005453-4057qib7	9918	9	)	)	-RRB-
cord-005453-4057qib7	9918	10	,	,	.
cord-005453-4057qib7	9919	1	275	275	CD
cord-005453-4057qib7	9919	2	/	/	SYM
cord-005453-4057qib7	9919	3	μl	μl	NN
cord-005453-4057qib7	9919	4	(	(	-LRB-
cord-005453-4057qib7	9919	5	9	9	CD
cord-005453-4057qib7	9919	6	-	-	SYM
cord-005453-4057qib7	9919	7	2660	2660	CD
cord-005453-4057qib7	9919	8	/	/	SYM
cord-005453-4057qib7	9919	9	μl	μl	NN
cord-005453-4057qib7	9919	10	)	)	-RRB-
cord-005453-4057qib7	9919	11	,	,	,
cord-005453-4057qib7	9919	12	and	and	CC
cord-005453-4057qib7	9919	13	98	98	CD
cord-005453-4057qib7	9919	14	/	/	SYM
cord-005453-4057qib7	9919	15	μl	μl	NN
cord-005453-4057qib7	9919	16	(	(	-LRB-
cord-005453-4057qib7	9919	17	3	3	CD
cord-005453-4057qib7	9919	18	-	-	SYM
cord-005453-4057qib7	9919	19	1767	1767	CD
cord-005453-4057qib7	9919	20	/	/	SYM
cord-005453-4057qib7	9919	21	μl	μl	NN
cord-005453-4057qib7	9919	22	)	)	-RRB-
cord-005453-4057qib7	9919	23	,	,	,
cord-005453-4057qib7	9919	24	respectively	respectively	RB
cord-005453-4057qib7	9919	25	.	.	.
cord-005453-4057qib7	9920	1	NK	NK	NNP
cord-005453-4057qib7	9920	2	cell	cell	NN
cord-005453-4057qib7	9920	3	subsets	subset	NNS
cord-005453-4057qib7	9920	4	showed	show	VBD
cord-005453-4057qib7	9920	5	no	no	DT
cord-005453-4057qib7	9920	6	significant	significant	JJ
cord-005453-4057qib7	9920	7	differences	difference	NNS
cord-005453-4057qib7	9920	8	between	between	IN
cord-005453-4057qib7	9920	9	CMVR	CMVR	NNP
cord-005453-4057qib7	9920	10	-	-	:
cord-005453-4057qib7	9920	11	and	and	CC
cord-005453-4057qib7	9920	12	CMVR+	CMVR+	NNP
cord-005453-4057qib7	9920	13	patients	patient	NNS
cord-005453-4057qib7	9920	14	.	.	.
cord-005453-4057qib7	9921	1	When	when	WRB
cord-005453-4057qib7	9921	2	patients	patient	NNS
cord-005453-4057qib7	9921	3	were	be	VBD
cord-005453-4057qib7	9921	4	divided	divide	VBN
cord-005453-4057qib7	9921	5	into	into	IN
cord-005453-4057qib7	9921	6	low	low	JJ
cord-005453-4057qib7	9921	7	and	and	CC
cord-005453-4057qib7	9921	8	high	high	JJ
cord-005453-4057qib7	9921	9	groups	group	NNS
cord-005453-4057qib7	9921	10	at	at	IN
cord-005453-4057qib7	9921	11	the	the	DT
cord-005453-4057qib7	9921	12	median	median	JJ
cord-005453-4057qib7	9921	13	level	level	NN
cord-005453-4057qib7	9921	14	of	of	IN
cord-005453-4057qib7	9921	15	each	each	DT
cord-005453-4057qib7	9921	16	NK	NK	NNP
cord-005453-4057qib7	9921	17	cell	cell	NN
cord-005453-4057qib7	9921	18	subset	subset	VBN
cord-005453-4057qib7	9921	19	,	,	,
cord-005453-4057qib7	9921	20	CMVR+	CMVR+	NNP
cord-005453-4057qib7	9921	21	patients	patient	NNS
cord-005453-4057qib7	9921	22	with	with	IN
cord-005453-4057qib7	9921	23	high	high	JJ
cord-005453-4057qib7	9921	24	CD3-CD56	cd3-cd56	NN
cord-005453-4057qib7	9922	1	+	+	UH
cord-005453-4057qib7	9922	2	,	,	,
cord-005453-4057qib7	9922	3	CD16+CD57-	CD16+CD57-	NNP
cord-005453-4057qib7	9922	4	,	,	,
cord-005453-4057qib7	9922	5	or	or	CC
cord-005453-4057qib7	9922	6	CD16+CD57	CD16+CD57	NNP
cord-005453-4057qib7	9922	7	+	+	CC
cord-005453-4057qib7	9922	8	cells	cell	NNS
cord-005453-4057qib7	9922	9	showed	show	VBD
cord-005453-4057qib7	9922	10	significantly	significantly	RB
cord-005453-4057qib7	9922	11	better	well	JJR
cord-005453-4057qib7	9922	12	5-year	5-year	CD
cord-005453-4057qib7	9922	13	OS	os	NN
cord-005453-4057qib7	9922	14	than	than	IN
cord-005453-4057qib7	9922	15	those	those	DT
cord-005453-4057qib7	9922	16	with	with	IN
cord-005453-4057qib7	9922	17	low	low	JJ
cord-005453-4057qib7	9922	18	cells	cell	NNS
cord-005453-4057qib7	9922	19	(	(	-LRB-
cord-005453-4057qib7	9922	20	72	72	CD
cord-005453-4057qib7	9922	21	%	%	NN
cord-005453-4057qib7	9922	22	vs.	vs.	CC
cord-005453-4057qib7	9922	23	35	35	CD
cord-005453-4057qib7	9922	24	%	%	NN
cord-005453-4057qib7	9922	25	,	,	,
cord-005453-4057qib7	9922	26	p	p	NN
cord-005453-4057qib7	9922	27	<	<	XX
cord-005453-4057qib7	9922	28	0.001	0.001	CD
cord-005453-4057qib7	9922	29	;	;	:
cord-005453-4057qib7	9922	30	69	69	CD
cord-005453-4057qib7	9922	31	%	%	NN
cord-005453-4057qib7	9922	32	vs.	vs.	IN
cord-005453-4057qib7	9922	33	40	40	CD
cord-005453-4057qib7	9922	34	%	%	NN
cord-005453-4057qib7	9922	35	,	,	,
cord-005453-4057qib7	9922	36	p	p	NN
cord-005453-4057qib7	9922	37	<	<	XX
cord-005453-4057qib7	9922	38	0.001	0.001	CD
cord-005453-4057qib7	9922	39	;	;	:
cord-005453-4057qib7	9922	40	66	66	CD
cord-005453-4057qib7	9922	41	%	%	NN
cord-005453-4057qib7	9922	42	vs.	vs.	IN
cord-005453-4057qib7	9922	43	45	45	CD
cord-005453-4057qib7	9922	44	%	%	NN
cord-005453-4057qib7	9922	45	,	,	,
cord-005453-4057qib7	9922	46	p	p	NN
cord-005453-4057qib7	9922	47	=	=	SYM
cord-005453-4057qib7	9922	48	0.001	0.001	CD
cord-005453-4057qib7	9922	49	,	,	,
cord-005453-4057qib7	9922	50	respectively	respectively	RB
cord-005453-4057qib7	9922	51	)	)	-RRB-
cord-005453-4057qib7	9922	52	.	.	.
cord-005453-4057qib7	9923	1	High	high	JJ
cord-005453-4057qib7	9923	2	CD3-CD56	cd3-cd56	NN
cord-005453-4057qib7	9923	3	+	+	CC
cord-005453-4057qib7	9924	1	cells	cell	NNS
cord-005453-4057qib7	9924	2	were	be	VBD
cord-005453-4057qib7	9924	3	significantly	significantly	RB
cord-005453-4057qib7	9924	4	associated	associate	VBN
cord-005453-4057qib7	9924	5	with	with	IN
cord-005453-4057qib7	9924	6	lower	low	JJR
cord-005453-4057qib7	9924	7	NRM	NRM	NNP
cord-005453-4057qib7	9924	8	(	(	-LRB-
cord-005453-4057qib7	9924	9	7	7	CD
cord-005453-4057qib7	9924	10	%	%	NN
cord-005453-4057qib7	9924	11	vs.	vs.	IN
cord-005453-4057qib7	9924	12	26	26	CD
cord-005453-4057qib7	9924	13	%	%	NN
cord-005453-4057qib7	9924	14	,	,	,
cord-005453-4057qib7	9924	15	p	p	NN
cord-005453-4057qib7	9924	16	=	=	SYM
cord-005453-4057qib7	9924	17	0.002	0.002	CD
cord-005453-4057qib7	9924	18	)	)	-RRB-
cord-005453-4057qib7	9924	19	,	,	,
cord-005453-4057qib7	9924	20	while	while	IN
cord-005453-4057qib7	9924	21	high	high	JJ
cord-005453-4057qib7	9924	22	CD16+CD57-cells	cd16+cd57-cell	NNS
cord-005453-4057qib7	9924	23	were	be	VBD
cord-005453-4057qib7	9924	24	significantly	significantly	RB
cord-005453-4057qib7	9924	25	associated	associate	VBN
cord-005453-4057qib7	9924	26	with	with	IN
cord-005453-4057qib7	9924	27	lower	low	JJR
cord-005453-4057qib7	9924	28	CIR	CIR	NNP
cord-005453-4057qib7	9924	29	(	(	-LRB-
cord-005453-4057qib7	9924	30	26	26	CD
cord-005453-4057qib7	9924	31	%	%	NN
cord-005453-4057qib7	9924	32	vs.	vs.	CC
cord-005453-4057qib7	9924	33	50	50	CD
cord-005453-4057qib7	9924	34	%	%	NN
cord-005453-4057qib7	9924	35	,	,	,
cord-005453-4057qib7	9924	36	p	p	NN
cord-005453-4057qib7	9924	37	=	=	SYM
cord-005453-4057qib7	9924	38	0.007	0.007	CD
cord-005453-4057qib7	9924	39	)	)	-RRB-
cord-005453-4057qib7	9924	40	.	.	.
cord-005453-4057qib7	9925	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	9925	2	analysis	analysis	NN
cord-005453-4057qib7	9925	3	confirmed	confirm	VBD
cord-005453-4057qib7	9925	4	these	these	DT
cord-005453-4057qib7	9925	5	NK	NK	NNP
cord-005453-4057qib7	9925	6	cell	cell	NN
cord-005453-4057qib7	9925	7	subsets	subset	NNS
cord-005453-4057qib7	9925	8	as	as	IN
cord-005453-4057qib7	9925	9	prognostic	prognostic	JJ
cord-005453-4057qib7	9925	10	factors	factor	NNS
cord-005453-4057qib7	9925	11	in	in	IN
cord-005453-4057qib7	9925	12	CMVR+	CMVR+	NNP
cord-005453-4057qib7	9925	13	patients	patient	NNS
cord-005453-4057qib7	9925	14	.	.	.
cord-005453-4057qib7	9926	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9926	2	:	:	:
cord-005453-4057qib7	9926	3	NK	nk	NN
cord-005453-4057qib7	9926	4	cell	cell	NN
cord-005453-4057qib7	9926	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	9926	6	may	may	MD
cord-005453-4057qib7	9926	7	contribute	contribute	VB
cord-005453-4057qib7	9926	8	to	to	IN
cord-005453-4057qib7	9926	9	improved	improve	VBN
cord-005453-4057qib7	9926	10	transplantation	transplantation	NN
cord-005453-4057qib7	9926	11	outcomes	outcome	NNS
cord-005453-4057qib7	9926	12	in	in	IN
cord-005453-4057qib7	9926	13	subgroups	subgroup	NNS
cord-005453-4057qib7	9926	14	of	of	IN
cord-005453-4057qib7	9926	15	CMVR	CMVR	NNP
cord-005453-4057qib7	9926	16	+	+	SYM
cord-005453-4057qib7	9926	17	patients	patient	NNS
cord-005453-4057qib7	9926	18	.	.	.
cord-005453-4057qib7	9927	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9927	2	:	:	:
cord-005453-4057qib7	9927	3	Nothing	nothing	NN
cord-005453-4057qib7	9927	4	to	to	TO
cord-005453-4057qib7	9927	5	declare	declare	VB
cord-005453-4057qib7	9927	6	Background	background	NN
cord-005453-4057qib7	9927	7	:	:	:
cord-005453-4057qib7	9927	8	Rezafungin	Rezafungin	NNP
cord-005453-4057qib7	9927	9	(	(	-LRB-
cord-005453-4057qib7	9927	10	RZF	RZF	NNP
cord-005453-4057qib7	9927	11	)	)	-RRB-
cord-005453-4057qib7	9927	12	is	be	VBZ
cord-005453-4057qib7	9927	13	a	a	DT
cord-005453-4057qib7	9927	14	novel	novel	JJ
cord-005453-4057qib7	9927	15	echinocandin	echinocandin	NNS
cord-005453-4057qib7	9927	16	in	in	IN
cord-005453-4057qib7	9927	17	development	development	NN
cord-005453-4057qib7	9927	18	for	for	IN
cord-005453-4057qib7	9927	19	prevention	prevention	NN
cord-005453-4057qib7	9927	20	of	of	IN
cord-005453-4057qib7	9927	21	invasive	invasive	JJ
cord-005453-4057qib7	9927	22	fungal	fungal	JJ
cord-005453-4057qib7	9927	23	infections	infection	NNS
cord-005453-4057qib7	9927	24	caused	cause	VBN
cord-005453-4057qib7	9927	25	by	by	IN
cord-005453-4057qib7	9927	26	Candida	Candida	NNP
cord-005453-4057qib7	9927	27	,	,	,
cord-005453-4057qib7	9927	28	Aspergillus	Aspergillus	NNP
cord-005453-4057qib7	9927	29	,	,	,
cord-005453-4057qib7	9927	30	and	and	CC
cord-005453-4057qib7	9927	31	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9927	32	spp	spp	NNS
cord-005453-4057qib7	9927	33	.	.	.
cord-005453-4057qib7	9928	1	in	in	IN
cord-005453-4057qib7	9928	2	patients	patient	NNS
cord-005453-4057qib7	9928	3	at	at	IN
cord-005453-4057qib7	9928	4	high	high	JJ
cord-005453-4057qib7	9928	5	risk	risk	NN
cord-005453-4057qib7	9928	6	of	of	IN
cord-005453-4057qib7	9928	7	infection	infection	NN
cord-005453-4057qib7	9928	8	.	.	.
cord-005453-4057qib7	9929	1	RZF	RZF	NNP
cord-005453-4057qib7	9929	2	has	have	VBZ
cord-005453-4057qib7	9929	3	demonstrated	demonstrate	VBN
cord-005453-4057qib7	9929	4	in	in	IN
cord-005453-4057qib7	9929	5	vivo	vivo	NN
cord-005453-4057qib7	9929	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9929	7	efficacy	efficacy	NN
cord-005453-4057qib7	9929	8	and	and	CC
cord-005453-4057qib7	9929	9	low	low	JJ
cord-005453-4057qib7	9929	10	risk	risk	NN
cord-005453-4057qib7	9929	11	of	of	IN
cord-005453-4057qib7	9929	12	drug	drug	NN
cord-005453-4057qib7	9929	13	-	-	HYPH
cord-005453-4057qib7	9929	14	drug	drug	NN
cord-005453-4057qib7	9929	15	interactions	interaction	NNS
cord-005453-4057qib7	9929	16	.	.	.
cord-005453-4057qib7	9930	1	Furthermore	furthermore	RB
cord-005453-4057qib7	9930	2	,	,	,
cord-005453-4057qib7	9930	3	the	the	DT
cord-005453-4057qib7	9930	4	stability	stability	NN
cord-005453-4057qib7	9930	5	and	and	CC
cord-005453-4057qib7	9930	6	PK	PK	NNP
cord-005453-4057qib7	9930	7	profile	profile	NN
cord-005453-4057qib7	9930	8	of	of	IN
cord-005453-4057qib7	9930	9	RZF	RZF	NNP
cord-005453-4057qib7	9930	10	allow	allow	VB
cord-005453-4057qib7	9930	11	for	for	IN
cord-005453-4057qib7	9930	12	once	once	RB
cord-005453-4057qib7	9930	13	-	-	HYPH
cord-005453-4057qib7	9930	14	weekly	weekly	NN
cord-005453-4057qib7	9930	15	dosing	dosing	NN
cord-005453-4057qib7	9930	16	.	.	.
cord-005453-4057qib7	9931	1	RZF	RZF	NNP
cord-005453-4057qib7	9931	2	is	be	VBZ
cord-005453-4057qib7	9931	3	also	also	RB
cord-005453-4057qib7	9931	4	in	in	IN
cord-005453-4057qib7	9931	5	development	development	NN
cord-005453-4057qib7	9931	6	for	for	IN
cord-005453-4057qib7	9931	7	treatment	treatment	NN
cord-005453-4057qib7	9931	8	of	of	IN
cord-005453-4057qib7	9931	9	candidemia	candidemia	NN
cord-005453-4057qib7	9931	10	and	and	CC
cord-005453-4057qib7	9931	11	invasive	invasive	JJ
cord-005453-4057qib7	9931	12	candidiasis	candidiasi	NNS
cord-005453-4057qib7	9931	13	using	use	VBG
cord-005453-4057qib7	9931	14	a	a	DT
cord-005453-4057qib7	9931	15	dosing	dose	VBG
cord-005453-4057qib7	9931	16	regimen	regimen	NN
cord-005453-4057qib7	9931	17	of	of	IN
cord-005453-4057qib7	9931	18	RZF	RZF	NNP
cord-005453-4057qib7	9931	19	400	400	CD
cord-005453-4057qib7	9931	20	mg	mg	NNS
cord-005453-4057qib7	9931	21	followed	follow	VBD
cord-005453-4057qib7	9931	22	by	by	IN
cord-005453-4057qib7	9931	23	200	200	CD
cord-005453-4057qib7	9931	24	mg	mg	NNP
cord-005453-4057qib7	9931	25	once	once	RB
cord-005453-4057qib7	9931	26	-	-	HYPH
cord-005453-4057qib7	9931	27	weekly	weekly	NN
cord-005453-4057qib7	9931	28	,	,	,
cord-005453-4057qib7	9931	29	which	which	WDT
cord-005453-4057qib7	9931	30	achieved	achieve	VBD
cord-005453-4057qib7	9931	31	>	>	XX
cord-005453-4057qib7	9931	32	90	90	CD
cord-005453-4057qib7	9931	33	%	%	NN
cord-005453-4057qib7	9931	34	target	target	NN
cord-005453-4057qib7	9931	35	attainment	attainment	JJ
cord-005453-4057qib7	9931	36	against	against	IN
cord-005453-4057qib7	9931	37	Candida	Candida	NNP
cord-005453-4057qib7	9931	38	.	.	.
cord-005453-4057qib7	9932	1	While	while	IN
cord-005453-4057qib7	9932	2	lower	low	JJR
cord-005453-4057qib7	9932	3	doses	dose	NNS
cord-005453-4057qib7	9932	4	might	may	MD
cord-005453-4057qib7	9932	5	be	be	VB
cord-005453-4057qib7	9932	6	useful	useful	JJ
cord-005453-4057qib7	9932	7	to	to	TO
cord-005453-4057qib7	9932	8	prevent	prevent	VB
cord-005453-4057qib7	9932	9	Candida	Candida	NNP
cord-005453-4057qib7	9932	10	and	and	CC
cord-005453-4057qib7	9932	11	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	9932	12	,	,	,
cord-005453-4057qib7	9932	13	invasive	invasive	JJ
cord-005453-4057qib7	9932	14	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	9932	15	is	be	VBZ
cord-005453-4057qib7	9932	16	a	a	DT
cord-005453-4057qib7	9932	17	different	different	JJ
cord-005453-4057qib7	9932	18	challenge	challenge	NN
cord-005453-4057qib7	9932	19	.	.	.
cord-005453-4057qib7	9933	1	We	-PRON-	PRP
cord-005453-4057qib7	9933	2	evaluated	evaluate	VBD
cord-005453-4057qib7	9933	3	RZF	RZF	NNP
cord-005453-4057qib7	9933	4	dosing	dose	VBG
cord-005453-4057qib7	9933	5	for	for	IN
cord-005453-4057qib7	9933	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9933	7	against	against	IN
cord-005453-4057qib7	9933	8	Aspergillus	aspergillus	NN
cord-005453-4057qib7	9933	9	fumigatus	fumigatus	NN
cord-005453-4057qib7	9933	10	in	in	IN
cord-005453-4057qib7	9933	11	blood	blood	NN
cord-005453-4057qib7	9933	12	and	and	CC
cord-005453-4057qib7	9933	13	marrow	marrow	NN
cord-005453-4057qib7	9933	14	transplant	transplant	NN
cord-005453-4057qib7	9933	15	(	(	-LRB-
cord-005453-4057qib7	9933	16	BMT	BMT	NNP
cord-005453-4057qib7	9933	17	)	)	-RRB-
cord-005453-4057qib7	9933	18	patients	patient	NNS
cord-005453-4057qib7	9933	19	using	use	VBG
cord-005453-4057qib7	9933	20	PK	PK	NNP
cord-005453-4057qib7	9933	21	/	/	SYM
cord-005453-4057qib7	9933	22	PD	PD	NNP
cord-005453-4057qib7	9933	23	simulations	simulation	NNS
cord-005453-4057qib7	9933	24	of	of	IN
cord-005453-4057qib7	9933	25	the	the	DT
cord-005453-4057qib7	9933	26	treatment	treatment	NN
cord-005453-4057qib7	9933	27	dosing	dose	VBG
cord-005453-4057qib7	9933	28	regimen	regimen	NN
cord-005453-4057qib7	9933	29	.	.	.
cord-005453-4057qib7	9934	1	Methods	method	NNS
cord-005453-4057qib7	9934	2	:	:	:
cord-005453-4057qib7	9935	1	A	a	DT
cord-005453-4057qib7	9935	2	previous	previous	JJ
cord-005453-4057qib7	9935	3	population	population	NN
cord-005453-4057qib7	9935	4	PK	PK	NNP
cord-005453-4057qib7	9935	5	model	model	NN
cord-005453-4057qib7	9935	6	was	be	VBD
cord-005453-4057qib7	9935	7	refined	refine	VBN
cord-005453-4057qib7	9935	8	using	use	VBG
cord-005453-4057qib7	9935	9	data	datum	NNS
cord-005453-4057qib7	9935	10	from	from	IN
cord-005453-4057qib7	9935	11	Phase	phase	NN
cord-005453-4057qib7	9935	12	1	1	CD
cord-005453-4057qib7	9935	13	and	and	CC
cord-005453-4057qib7	9935	14	Phase	phase	NN
cord-005453-4057qib7	9935	15	2	2	CD
cord-005453-4057qib7	9935	16	trials	trial	NNS
cord-005453-4057qib7	9935	17	of	of	IN
cord-005453-4057qib7	9935	18	IV	IV	NNP
cord-005453-4057qib7	9935	19	RZF	RZF	NNP
cord-005453-4057qib7	9936	1	(	(	-LRB-
cord-005453-4057qib7	9936	2	NONMEM	NONMEM	NNP
cord-005453-4057qib7	9936	3	Vers	Vers	NNP
cord-005453-4057qib7	9936	4	7.2	7.2	CD
cord-005453-4057qib7	9936	5	)	)	-RRB-
cord-005453-4057qib7	9936	6	.	.	.
cord-005453-4057qib7	9937	1	Stepwise	Stepwise	NNP
cord-005453-4057qib7	9937	2	forward	forward	RB
cord-005453-4057qib7	9937	3	selection	selection	NN
cord-005453-4057qib7	9937	4	(	(	-LRB-
cord-005453-4057qib7	9937	5	α	α	NN
cord-005453-4057qib7	9937	6	=	=	SYM
cord-005453-4057qib7	9937	7	0.01	0.01	CD
cord-005453-4057qib7	9937	8	)	)	-RRB-
cord-005453-4057qib7	9937	9	and	and	CC
cord-005453-4057qib7	9937	10	backward	backward	JJ
cord-005453-4057qib7	9937	11	elimination	elimination	NN
cord-005453-4057qib7	9937	12	(	(	-LRB-
cord-005453-4057qib7	9937	13	α	α	NN
cord-005453-4057qib7	9937	14	=	=	SYM
cord-005453-4057qib7	9937	15	0.001	0.001	CD
cord-005453-4057qib7	9937	16	)	)	-RRB-
cord-005453-4057qib7	9937	17	were	be	VBD
cord-005453-4057qib7	9937	18	used	use	VBN
cord-005453-4057qib7	9937	19	to	to	TO
cord-005453-4057qib7	9937	20	assess	assess	VB
cord-005453-4057qib7	9937	21	for	for	IN
cord-005453-4057qib7	9937	22	relationships	relationship	NNS
cord-005453-4057qib7	9937	23	between	between	IN
cord-005453-4057qib7	9937	24	interindividual	interindividual	NNP
cord-005453-4057qib7	9937	25	PK	PK	NNP
cord-005453-4057qib7	9937	26	variability	variability	NN
cord-005453-4057qib7	9937	27	and	and	CC
cord-005453-4057qib7	9937	28	covariates	covariate	NNS
cord-005453-4057qib7	9937	29	,	,	,
cord-005453-4057qib7	9937	30	such	such	JJ
cord-005453-4057qib7	9937	31	as	as	IN
cord-005453-4057qib7	9937	32	age	age	NN
cord-005453-4057qib7	9937	33	,	,	,
cord-005453-4057qib7	9937	34	sex	sex	NN
cord-005453-4057qib7	9937	35	,	,	,
cord-005453-4057qib7	9937	36	BSA	BSA	NNP
cord-005453-4057qib7	9937	37	,	,	,
cord-005453-4057qib7	9937	38	albumin	albumin	NN
cord-005453-4057qib7	9937	39	,	,	,
cord-005453-4057qib7	9937	40	liver	liver	NN
cord-005453-4057qib7	9937	41	and	and	CC
cord-005453-4057qib7	9937	42	renal	renal	JJ
cord-005453-4057qib7	9937	43	function	function	NN
cord-005453-4057qib7	9937	44	markers	marker	NNS
cord-005453-4057qib7	9937	45	,	,	,
cord-005453-4057qib7	9937	46	and	and	CC
cord-005453-4057qib7	9937	47	infection	infection	NN
cord-005453-4057qib7	9937	48	status	status	NN
cord-005453-4057qib7	9937	49	.	.	.
cord-005453-4057qib7	9938	1	The	the	DT
cord-005453-4057qib7	9938	2	final	final	JJ
cord-005453-4057qib7	9938	3	model	model	NN
cord-005453-4057qib7	9938	4	was	be	VBD
cord-005453-4057qib7	9938	5	validated	validate	VBN
cord-005453-4057qib7	9938	6	by	by	IN
cord-005453-4057qib7	9938	7	comparing	compare	VBG
cord-005453-4057qib7	9938	8	model	model	NN
cord-005453-4057qib7	9938	9	-	-	HYPH
cord-005453-4057qib7	9938	10	based	base	VBN
cord-005453-4057qib7	9938	11	predictions	prediction	NNS
cord-005453-4057qib7	9938	12	to	to	IN
cord-005453-4057qib7	9938	13	observed	observed	JJ
cord-005453-4057qib7	9938	14	data	datum	NNS
cord-005453-4057qib7	9938	15	.	.	.
cord-005453-4057qib7	9939	1	The	the	DT
cord-005453-4057qib7	9939	2	model	model	NN
cord-005453-4057qib7	9939	3	and	and	CC
cord-005453-4057qib7	9939	4	demographic	demographic	JJ
cord-005453-4057qib7	9939	5	data	datum	NNS
cord-005453-4057qib7	9939	6	from	from	IN
cord-005453-4057qib7	9939	7	100	100	CD
cord-005453-4057qib7	9939	8	BMT	BMT	NNP
cord-005453-4057qib7	9939	9	recipients	recipient	NNS
cord-005453-4057qib7	9939	10	at	at	IN
cord-005453-4057qib7	9939	11	Stanford	Stanford	NNP
cord-005453-4057qib7	9939	12	Medical	Medical	NNP
cord-005453-4057qib7	9939	13	Center	Center	NNP
cord-005453-4057qib7	9939	14	were	be	VBD
cord-005453-4057qib7	9939	15	used	use	VBN
cord-005453-4057qib7	9939	16	for	for	IN
cord-005453-4057qib7	9939	17	Monte	Monte	NNP
cord-005453-4057qib7	9939	18	Carlo	Carlo	NNP
cord-005453-4057qib7	9939	19	simulation	simulation	NN
cord-005453-4057qib7	9939	20	(	(	-LRB-
cord-005453-4057qib7	9939	21	n=2,000	n=2,000	NNP
cord-005453-4057qib7	9939	22	)	)	-RRB-
cord-005453-4057qib7	9939	23	of	of	IN
cord-005453-4057qib7	9939	24	expected	expect	VBN
cord-005453-4057qib7	9939	25	RZF	RZF	NNP
cord-005453-4057qib7	9939	26	concentrationtime	concentrationtime	NN
cord-005453-4057qib7	9939	27	profiles	profile	NNS
cord-005453-4057qib7	9939	28	in	in	IN
cord-005453-4057qib7	9939	29	BMT	BMT	NNP
cord-005453-4057qib7	9939	30	patients	patient	NNS
cord-005453-4057qib7	9939	31	receiving	receive	VBG
cord-005453-4057qib7	9939	32	IV	IV	NNP
cord-005453-4057qib7	9939	33	RZF	RZF	NNP
cord-005453-4057qib7	9939	34	400	400	CD
cord-005453-4057qib7	9939	35	mg	mg	NN
cord-005453-4057qib7	9939	36	on	on	IN
cord-005453-4057qib7	9939	37	Week	week	NN
cord-005453-4057qib7	9939	38	1	1	CD
cord-005453-4057qib7	9939	39	followed	follow	VBD
cord-005453-4057qib7	9939	40	by	by	IN
cord-005453-4057qib7	9939	41	200	200	CD
cord-005453-4057qib7	9939	42	mg	mg	NNP
cord-005453-4057qib7	9939	43	weekly	weekly	NN
cord-005453-4057qib7	9939	44	x	x	SYM
cord-005453-4057qib7	9939	45	11	11	CD
cord-005453-4057qib7	9939	46	.	.	.
cord-005453-4057qib7	9940	1	Of	of	IN
cord-005453-4057qib7	9940	2	the	the	DT
cord-005453-4057qib7	9940	3	100	100	CD
cord-005453-4057qib7	9940	4	patients	patient	NNS
cord-005453-4057qib7	9940	5	included	include	VBN
cord-005453-4057qib7	9940	6	in	in	IN
cord-005453-4057qib7	9940	7	the	the	DT
cord-005453-4057qib7	9940	8	demographic	demographic	JJ
cord-005453-4057qib7	9940	9	dataset	dataset	NN
cord-005453-4057qib7	9940	10	,	,	,
cord-005453-4057qib7	9940	11	39	39	CD
cord-005453-4057qib7	9940	12	were	be	VBD
cord-005453-4057qib7	9940	13	female	female	JJ
cord-005453-4057qib7	9940	14	(	(	-LRB-
cord-005453-4057qib7	9940	15	mean	mean	JJ
cord-005453-4057qib7	9940	16	values	value	NNS
cord-005453-4057qib7	9940	17	at	at	IN
cord-005453-4057qib7	9940	18	baseline	baseline	NN
cord-005453-4057qib7	9940	19	:	:	:
cord-005453-4057qib7	9940	20	age	age	NN
cord-005453-4057qib7	9940	21	,	,	,
cord-005453-4057qib7	9940	22	58	58	CD
cord-005453-4057qib7	9940	23	years	year	NNS
cord-005453-4057qib7	9940	24	[	[	-LRB-
cord-005453-4057qib7	9940	25	19	19	CD
cord-005453-4057qib7	9940	26	-	-	SYM
cord-005453-4057qib7	9940	27	75	75	CD
cord-005453-4057qib7	9940	28	years	year	NNS
cord-005453-4057qib7	9940	29	]	]	-RRB-
cord-005453-4057qib7	9940	30	;	;	:
cord-005453-4057qib7	9940	31	weight	weight	NN
cord-005453-4057qib7	9940	32	,	,	,
cord-005453-4057qib7	9940	33	69.8	69.8	CD
cord-005453-4057qib7	9940	34	kg	kg	NN
cord-005453-4057qib7	9940	35	[	[	-LRB-
cord-005453-4057qib7	9940	36	42	42	CD
cord-005453-4057qib7	9940	37	-	-	SYM
cord-005453-4057qib7	9940	38	123	123	CD
cord-005453-4057qib7	9940	39	kg	kg	NNS
cord-005453-4057qib7	9940	40	]	]	-RRB-
cord-005453-4057qib7	9940	41	)	)	-RRB-
cord-005453-4057qib7	9940	42	.	.	.
cord-005453-4057qib7	9941	1	The	the	DT
cord-005453-4057qib7	9941	2	median	median	NN
cord-005453-4057qib7	9941	3	(	(	-LRB-
cord-005453-4057qib7	9941	4	range	range	NN
cord-005453-4057qib7	9941	5	)	)	-RRB-
cord-005453-4057qib7	9941	6	BSA	BSA	NNP
cord-005453-4057qib7	9941	7	in	in	IN
cord-005453-4057qib7	9941	8	the	the	DT
cord-005453-4057qib7	9941	9	demographic	demographic	JJ
cord-005453-4057qib7	9941	10	dataset	dataset	NN
cord-005453-4057qib7	9941	11	was	be	VBD
cord-005453-4057qib7	9941	12	1.84	1.84	CD
cord-005453-4057qib7	9941	13	m	m	NN
cord-005453-4057qib7	9941	14	2	2	CD
cord-005453-4057qib7	9941	15	(	(	-LRB-
cord-005453-4057qib7	9941	16	1.27	1.27	CD
cord-005453-4057qib7	9941	17	-	-	SYM
cord-005453-4057qib7	9941	18	2.61	2.61	CD
cord-005453-4057qib7	9941	19	)	)	-RRB-
cord-005453-4057qib7	9941	20	,	,	,
cord-005453-4057qib7	9941	21	and	and	CC
cord-005453-4057qib7	9941	22	albumin	albumin	NN
cord-005453-4057qib7	9941	23	was	be	VBD
cord-005453-4057qib7	9941	24	3.35	3.35	CD
cord-005453-4057qib7	9941	25	g	g	NN
cord-005453-4057qib7	9941	26	/	/	SYM
cord-005453-4057qib7	9941	27	dL	dl	NN
cord-005453-4057qib7	9941	28	(	(	-LRB-
cord-005453-4057qib7	9941	29	1.8	1.8	CD
cord-005453-4057qib7	9941	30	-	-	SYM
cord-005453-4057qib7	9941	31	4.43	4.43	CD
cord-005453-4057qib7	9941	32	g	g	NN
cord-005453-4057qib7	9941	33	/	/	SYM
cord-005453-4057qib7	9941	34	dL	dl	NN
cord-005453-4057qib7	9941	35	)	)	-RRB-
cord-005453-4057qib7	9941	36	.	.	.
cord-005453-4057qib7	9942	1	Free	free	JJ
cord-005453-4057qib7	9942	2	-	-	HYPH
cord-005453-4057qib7	9942	3	drug	drug	NN
cord-005453-4057qib7	9942	4	concentration	concentration	NN
cord-005453-4057qib7	9942	5	-	-	HYPH
cord-005453-4057qib7	9942	6	time	time	NN
cord-005453-4057qib7	9942	7	profiles	profile	NNS
cord-005453-4057qib7	9942	8	were	be	VBD
cord-005453-4057qib7	9942	9	evaluated	evaluate	VBN
cord-005453-4057qib7	9942	10	(	(	-LRB-
cord-005453-4057qib7	9942	11	97.4	97.4	CD
cord-005453-4057qib7	9942	12	%	%	NN
cord-005453-4057qib7	9942	13	human	human	JJ
cord-005453-4057qib7	9942	14	protein	protein	NN
cord-005453-4057qib7	9942	15	-	-	HYPH
cord-005453-4057qib7	9942	16	binding	bind	VBG
cord-005453-4057qib7	9942	17	)	)	-RRB-
cord-005453-4057qib7	9942	18	relative	relative	NN
cord-005453-4057qib7	9942	19	to	to	IN
cord-005453-4057qib7	9942	20	the	the	DT
cord-005453-4057qib7	9942	21	A.	a.	NN
cord-005453-4057qib7	9942	22	fumigatus	fumigatus	NN
cord-005453-4057qib7	9942	23	minimal	minimal	JJ
cord-005453-4057qib7	9942	24	effective	effective	JJ
cord-005453-4057qib7	9942	25	concentration	concentration	NN
cord-005453-4057qib7	9942	26	required	require	VBN
cord-005453-4057qib7	9942	27	to	to	TO
cord-005453-4057qib7	9942	28	inhibit	inhibit	VB
cord-005453-4057qib7	9942	29	100	100	CD
cord-005453-4057qib7	9942	30	%	%	NN
cord-005453-4057qib7	9942	31	of	of	IN
cord-005453-4057qib7	9942	32	isolates	isolate	NNS
cord-005453-4057qib7	9942	33	tested	test	VBN
cord-005453-4057qib7	9942	34	(	(	-LRB-
cord-005453-4057qib7	9942	35	MEC	MEC	NNP
cord-005453-4057qib7	9942	36	100	100	CD
cord-005453-4057qib7	9942	37	;	;	:
cord-005453-4057qib7	9942	38	JMI	JMI	NNP
cord-005453-4057qib7	9942	39	2014	2014	CD
cord-005453-4057qib7	9942	40	-	-	SYM
cord-005453-4057qib7	9942	41	2017	2017	CD
cord-005453-4057qib7	9942	42	SENTRY	SENTRY	NNP
cord-005453-4057qib7	9942	43	international	international	JJ
cord-005453-4057qib7	9942	44	surveillance	surveillance	NN
cord-005453-4057qib7	9942	45	data	datum	NNS
cord-005453-4057qib7	9942	46	)	)	-RRB-
cord-005453-4057qib7	9942	47	.	.	.
cord-005453-4057qib7	9943	1	Results	result	NNS
cord-005453-4057qib7	9943	2	:	:	:
cord-005453-4057qib7	9944	1	The	the	DT
cord-005453-4057qib7	9944	2	population	population	NN
cord-005453-4057qib7	9944	3	PK	PK	NNP
cord-005453-4057qib7	9944	4	model	model	NN
cord-005453-4057qib7	9944	5	was	be	VBD
cord-005453-4057qib7	9944	6	a	a	DT
cord-005453-4057qib7	9944	7	linear	linear	JJ
cord-005453-4057qib7	9944	8	,	,	,
cord-005453-4057qib7	9944	9	4compartment	4compartment	CD
cord-005453-4057qib7	9944	10	model	model	NN
cord-005453-4057qib7	9944	11	with	with	IN
cord-005453-4057qib7	9944	12	zero	zero	CD
cord-005453-4057qib7	9944	13	order	order	NN
cord-005453-4057qib7	9944	14	IV	IV	NNP
cord-005453-4057qib7	9944	15	input	input	NN
cord-005453-4057qib7	9944	16	.	.	.
cord-005453-4057qib7	9945	1	Albumin	albumin	NN
cord-005453-4057qib7	9945	2	,	,	,
cord-005453-4057qib7	9945	3	sex	sex	NN
cord-005453-4057qib7	9945	4	,	,	,
cord-005453-4057qib7	9945	5	infection	infection	NN
cord-005453-4057qib7	9945	6	status	status	NN
cord-005453-4057qib7	9945	7	,	,	,
cord-005453-4057qib7	9945	8	and	and	CC
cord-005453-4057qib7	9945	9	body	body	NN
cord-005453-4057qib7	9945	10	surface	surface	NN
cord-005453-4057qib7	9945	11	area	area	NN
cord-005453-4057qib7	9945	12	were	be	VBD
cord-005453-4057qib7	9945	13	statistically	statistically	RB
cord-005453-4057qib7	9945	14	significant	significant	JJ
cord-005453-4057qib7	9945	15	predictors	predictor	NNS
cord-005453-4057qib7	9945	16	of	of	IN
cord-005453-4057qib7	9945	17	interindividual	interindividual	JJ
cord-005453-4057qib7	9945	18	variability	variability	NN
cord-005453-4057qib7	9945	19	;	;	:
cord-005453-4057qib7	9945	20	clinical	clinical	JJ
cord-005453-4057qib7	9945	21	significance	significance	NN
cord-005453-4057qib7	9945	22	of	of	IN
cord-005453-4057qib7	9945	23	these	these	DT
cord-005453-4057qib7	9945	24	factors	factor	NNS
cord-005453-4057qib7	9945	25	was	be	VBD
cord-005453-4057qib7	9945	26	not	not	RB
cord-005453-4057qib7	9945	27	determined	determine	VBN
cord-005453-4057qib7	9945	28	.	.	.
cord-005453-4057qib7	9946	1	The	the	DT
cord-005453-4057qib7	9946	2	model	model	NN
cord-005453-4057qib7	9946	3	provided	provide	VBD
cord-005453-4057qib7	9946	4	precise	precise	JJ
cord-005453-4057qib7	9946	5	,	,	,
cord-005453-4057qib7	9946	6	unbiased	unbiased	JJ
cord-005453-4057qib7	9946	7	fits	fit	NNS
cord-005453-4057qib7	9946	8	to	to	IN
cord-005453-4057qib7	9946	9	the	the	DT
cord-005453-4057qib7	9946	10	observed	observed	JJ
cord-005453-4057qib7	9946	11	data	datum	NNS
cord-005453-4057qib7	9946	12	(	(	-LRB-
cord-005453-4057qib7	9946	13	r	r	NN
cord-005453-4057qib7	9946	14	2	2	CD
cord-005453-4057qib7	9946	15	=	=	SYM
cord-005453-4057qib7	9946	16	0.993	0.993	CD
cord-005453-4057qib7	9946	17	observed	observe	VBD
cord-005453-4057qib7	9946	18	vs	vs	IN
cord-005453-4057qib7	9946	19	individual	individual	NN
cord-005453-4057qib7	9946	20	-	-	HYPH
cord-005453-4057qib7	9946	21	predicted	predict	VBN
cord-005453-4057qib7	9946	22	concentrations	concentration	NNS
cord-005453-4057qib7	9946	23	)	)	-RRB-
cord-005453-4057qib7	9946	24	.	.	.
cord-005453-4057qib7	9947	1	RZF	RZF	NNP
cord-005453-4057qib7	9947	2	plasma	plasma	NN
cord-005453-4057qib7	9947	3	free	free	JJ
cord-005453-4057qib7	9947	4	-	-	HYPH
cord-005453-4057qib7	9947	5	drug	drug	NN
cord-005453-4057qib7	9947	6	concentrations	concentration	NNS
cord-005453-4057qib7	9947	7	at	at	IN
cord-005453-4057qib7	9947	8	weeks	week	NNS
cord-005453-4057qib7	9947	9	1	1	CD
cord-005453-4057qib7	9947	10	,	,	,
cord-005453-4057qib7	9947	11	2	2	CD
cord-005453-4057qib7	9947	12	,	,	,
cord-005453-4057qib7	9947	13	and	and	CC
cord-005453-4057qib7	9947	14	12	12	CD
cord-005453-4057qib7	9947	15	were	be	VBD
cord-005453-4057qib7	9947	16	above	above	IN
cord-005453-4057qib7	9947	17	the	the	DT
cord-005453-4057qib7	9947	18	A.	a.	NN
cord-005453-4057qib7	9947	19	fumigatus	fumigatus	NN
cord-005453-4057qib7	9947	20	MEC	MEC	NNP
cord-005453-4057qib7	9947	21	100	100	CD
cord-005453-4057qib7	9947	22	(	(	-LRB-
cord-005453-4057qib7	9947	23	0.03	0.03	CD
cord-005453-4057qib7	9947	24	mg	mg	NNP
cord-005453-4057qib7	9947	25	/	/	SYM
cord-005453-4057qib7	9947	26	L	L	NNP
cord-005453-4057qib7	9947	27	)	)	-RRB-
cord-005453-4057qib7	9947	28	for	for	IN
cord-005453-4057qib7	9947	29	the	the	DT
cord-005453-4057qib7	9947	30	entire	entire	JJ
cord-005453-4057qib7	9947	31	dosing	dosing	NN
cord-005453-4057qib7	9947	32	interval	interval	NN
cord-005453-4057qib7	9947	33	in	in	IN
cord-005453-4057qib7	9947	34	98.0	98.0	CD
cord-005453-4057qib7	9947	35	%	%	NN
cord-005453-4057qib7	9947	36	,	,	,
cord-005453-4057qib7	9947	37	92.0	92.0	CD
cord-005453-4057qib7	9947	38	%	%	NN
cord-005453-4057qib7	9947	39	,	,	,
cord-005453-4057qib7	9947	40	and	and	CC
cord-005453-4057qib7	9947	41	90.2	90.2	CD
cord-005453-4057qib7	9947	42	%	%	NN
cord-005453-4057qib7	9947	43	of	of	IN
cord-005453-4057qib7	9947	44	simulated	simulated	JJ
cord-005453-4057qib7	9947	45	patients	patient	NNS
cord-005453-4057qib7	9947	46	,	,	,
cord-005453-4057qib7	9947	47	respectively	respectively	RB
cord-005453-4057qib7	9947	48	,	,	,
cord-005453-4057qib7	9947	49	and	and	CC
cord-005453-4057qib7	9947	50	in	in	IN
cord-005453-4057qib7	9947	51	≥99.8	≥99.8	JJ
cord-005453-4057qib7	9947	52	%	%	NN
cord-005453-4057qib7	9947	53	for	for	IN
cord-005453-4057qib7	9947	54	all	all	DT
cord-005453-4057qib7	9947	55	12	12	CD
cord-005453-4057qib7	9947	56	weeks	week	NNS
cord-005453-4057qib7	9947	57	based	base	VBN
cord-005453-4057qib7	9947	58	on	on	IN
cord-005453-4057qib7	9947	59	the	the	DT
cord-005453-4057qib7	9947	60	MEC	MEC	NNP
cord-005453-4057qib7	9947	61	90	90	CD
cord-005453-4057qib7	9947	62	(	(	-LRB-
cord-005453-4057qib7	9947	63	0.015	0.015	CD
cord-005453-4057qib7	9947	64	mg	mg	NNP
cord-005453-4057qib7	9947	65	/	/	SYM
cord-005453-4057qib7	9947	66	L	L	NNP
cord-005453-4057qib7	9947	67	)	)	-RRB-
cord-005453-4057qib7	9947	68	.	.	.
cord-005453-4057qib7	9948	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9948	2	:	:	:
cord-005453-4057qib7	9949	1	These	these	DT
cord-005453-4057qib7	9949	2	data	datum	NNS
cord-005453-4057qib7	9949	3	modelled	model	VBN
cord-005453-4057qib7	9949	4	from	from	IN
cord-005453-4057qib7	9949	5	BMT	BMT	NNP
cord-005453-4057qib7	9949	6	patients	patient	NNS
cord-005453-4057qib7	9949	7	support	support	VBP
cord-005453-4057qib7	9949	8	the	the	DT
cord-005453-4057qib7	9949	9	RZF	RZF	NNP
cord-005453-4057qib7	9949	10	dosing	dose	VBG
cord-005453-4057qib7	9949	11	regimen	regimen	NN
cord-005453-4057qib7	9949	12	of	of	IN
cord-005453-4057qib7	9949	13	400	400	CD
cord-005453-4057qib7	9949	14	mg	mg	NNP
cord-005453-4057qib7	9949	15	IV	IV	NNP
cord-005453-4057qib7	9949	16	followed	follow	VBD
cord-005453-4057qib7	9949	17	by	by	IN
cord-005453-4057qib7	9949	18	200	200	CD
cord-005453-4057qib7	9949	19	mg	mg	NNP
cord-005453-4057qib7	9949	20	once	once	RB
cord-005453-4057qib7	9949	21	-	-	HYPH
cord-005453-4057qib7	9949	22	weekly	weekly	NN
cord-005453-4057qib7	9949	23	for	for	IN
cord-005453-4057qib7	9949	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9949	25	against	against	IN
cord-005453-4057qib7	9949	26	A.	a.	NN
cord-005453-4057qib7	9949	27	fumigatus	fumigatus	NN
cord-005453-4057qib7	9949	28	.	.	.
cord-005453-4057qib7	9950	1	Current	current	JJ
cord-005453-4057qib7	9950	2	antifungal	antifungal	JJ
cord-005453-4057qib7	9950	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9950	4	may	may	MD
cord-005453-4057qib7	9950	5	be	be	VB
cord-005453-4057qib7	9950	6	limited	limit	VBN
cord-005453-4057qib7	9950	7	by	by	IN
cord-005453-4057qib7	9950	8	toxicity	toxicity	NN
cord-005453-4057qib7	9950	9	,	,	,
cord-005453-4057qib7	9950	10	DDIs	ddi	NNS
cord-005453-4057qib7	9950	11	,	,	,
cord-005453-4057qib7	9950	12	or	or	CC
cord-005453-4057qib7	9950	13	patient	patient	NN
cord-005453-4057qib7	9950	14	factors	factor	NNS
cord-005453-4057qib7	9950	15	such	such	JJ
cord-005453-4057qib7	9950	16	as	as	IN
cord-005453-4057qib7	9950	17	mucositis	mucositis	NNP
cord-005453-4057qib7	9950	18	.	.	.
cord-005453-4057qib7	9951	1	The	the	DT
cord-005453-4057qib7	9951	2	PK	PK	NNP
cord-005453-4057qib7	9951	3	of	of	IN
cord-005453-4057qib7	9951	4	RZF	RZF	NNP
cord-005453-4057qib7	9951	5	and	and	CC
cord-005453-4057qib7	9951	6	its	-PRON-	PRP$
cord-005453-4057qib7	9951	7	spectrum	spectrum	NN
cord-005453-4057qib7	9951	8	,	,	,
cord-005453-4057qib7	9951	9	safety	safety	NN
cord-005453-4057qib7	9951	10	,	,	,
cord-005453-4057qib7	9951	11	tolerability	tolerability	NN
cord-005453-4057qib7	9951	12	,	,	,
cord-005453-4057qib7	9951	13	and	and	CC
cord-005453-4057qib7	9951	14	lack	lack	NN
cord-005453-4057qib7	9951	15	of	of	IN
cord-005453-4057qib7	9951	16	DDIs	ddi	NNS
cord-005453-4057qib7	9951	17	may	may	MD
cord-005453-4057qib7	9951	18	address	address	VB
cord-005453-4057qib7	9951	19	current	current	JJ
cord-005453-4057qib7	9951	20	unmet	unmet	JJ
cord-005453-4057qib7	9951	21	needs	need	NNS
cord-005453-4057qib7	9951	22	in	in	IN
cord-005453-4057qib7	9951	23	IFI	IFI	NNP
cord-005453-4057qib7	9951	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9951	25	for	for	IN
cord-005453-4057qib7	9951	26	BMT	BMT	NNP
cord-005453-4057qib7	9951	27	and	and	CC
cord-005453-4057qib7	9951	28	other	other	JJ
cord-005453-4057qib7	9951	29	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	9951	30	patients	patient	NNS
cord-005453-4057qib7	9951	31	.	.	.
cord-005453-4057qib7	9952	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9952	2	:	:	:
cord-005453-4057qib7	9952	3	Janice	Janice	NNP
cord-005453-4057qib7	9952	4	Brown	Brown	NNP
cord-005453-4057qib7	9952	5	:	:	:
cord-005453-4057qib7	9952	6	Research	research	NN
cord-005453-4057qib7	9952	7	funding	funding	NN
cord-005453-4057qib7	9952	8	,	,	,
cord-005453-4057qib7	9952	9	Cidara	Cidara	NNP
cord-005453-4057qib7	9952	10	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9952	11	,	,	,
cord-005453-4057qib7	9952	12	Elizabeth	Elizabeth	NNP
cord-005453-4057qib7	9952	13	Lakota	Lakota	NNP
cord-005453-4057qib7	9952	14	:	:	:
cord-005453-4057qib7	9952	15	Research	research	NN
cord-005453-4057qib7	9952	16	funding	funding	NN
cord-005453-4057qib7	9952	17	,	,	,
cord-005453-4057qib7	9952	18	Cidara	Cidara	NNP
cord-005453-4057qib7	9952	19	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9952	20	,	,	,
cord-005453-4057qib7	9952	21	Shawn	Shawn	NNP
cord-005453-4057qib7	9952	22	Flanagan	Flanagan	NNP
cord-005453-4057qib7	9953	1	:	:	:
cord-005453-4057qib7	9953	2	Employment	employment	NN
cord-005453-4057qib7	9953	3	,	,	,
cord-005453-4057qib7	9953	4	Cidara	Cidara	NNP
cord-005453-4057qib7	9953	5	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9953	6	,	,	,
cord-005453-4057qib7	9953	7	Taylor	Taylor	NNP
cord-005453-4057qib7	9953	8	Sandison	Sandison	NNP
cord-005453-4057qib7	9953	9	:	:	:
cord-005453-4057qib7	9953	10	Employment	Employment	NNP
cord-005453-4057qib7	9953	11	,	,	,
cord-005453-4057qib7	9953	12	Cidara	Cidara	NNP
cord-005453-4057qib7	9953	13	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9953	14	,	,	,
cord-005453-4057qib7	9953	15	Voon	Voon	NNP
cord-005453-4057qib7	9953	16	Ong	Ong	NNP
cord-005453-4057qib7	9953	17	:	:	:
cord-005453-4057qib7	9953	18	Employment	Employment	NNP
cord-005453-4057qib7	9953	19	,	,	,
cord-005453-4057qib7	9953	20	Cidara	Cidara	NNP
cord-005453-4057qib7	9953	21	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9953	22	,	,	,
cord-005453-4057qib7	9953	23	Christopher	Christopher	NNP
cord-005453-4057qib7	9953	24	Rubino	Rubino	NNP
cord-005453-4057qib7	9953	25	:	:	:
cord-005453-4057qib7	9953	26	Research	research	NN
cord-005453-4057qib7	9953	27	funding	funding	NN
cord-005453-4057qib7	9953	28	,	,	,
cord-005453-4057qib7	9953	29	Cidara	Cidara	NNP
cord-005453-4057qib7	9953	30	Therapeutics	Therapeutics	NNPS
cord-005453-4057qib7	9953	31	P444	P444	NNP
cord-005453-4057qib7	9954	1	Is	be	VBZ
cord-005453-4057qib7	9954	2	fungal	fungal	JJ
cord-005453-4057qib7	9954	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9954	4	necessary	necessary	JJ
cord-005453-4057qib7	9954	5	in	in	IN
cord-005453-4057qib7	9954	6	non	non	JJ
cord-005453-4057qib7	9954	7	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9954	8	peripheral	peripheral	JJ
cord-005453-4057qib7	9954	9	blood	blood	NN
cord-005453-4057qib7	9954	10	stem	stem	NN
cord-005453-4057qib7	9954	11	cell	cell	NN
cord-005453-4057qib7	9954	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	9954	13	transplantation	transplantation	NN
cord-005453-4057qib7	9954	14	in	in	IN
cord-005453-4057qib7	9954	15	the	the	DT
cord-005453-4057qib7	9954	16	pre	pre	JJ
cord-005453-4057qib7	9954	17	-	-	JJ
cord-005453-4057qib7	9954	18	engrafment	engrafment	JJ
cord-005453-4057qib7	9954	19	period	period	NN
cord-005453-4057qib7	9954	20	?	?	.
cord-005453-4057qib7	9955	1	Julien	Julien	NNP
cord-005453-4057qib7	9955	2	Vaidie	Vaidie	NNP
cord-005453-4057qib7	9955	3	1	1	CD
cord-005453-4057qib7	9955	4	,	,	,
cord-005453-4057qib7	9955	5	Jean	Jean	NNP
cord-005453-4057qib7	9955	6	-	-	HYPH
cord-005453-4057qib7	9955	7	Baptiste	Baptiste	NNP
cord-005453-4057qib7	9955	8	Woillard	Woillard	NNP
cord-005453-4057qib7	9955	9	1	1	CD
cord-005453-4057qib7	9955	10	,	,	,
cord-005453-4057qib7	9955	11	Stéphane	Stéphane	NNP
cord-005453-4057qib7	9955	12	Girault	Girault	NNP
cord-005453-4057qib7	9955	13	1	1	CD
cord-005453-4057qib7	9955	14	,	,	,
cord-005453-4057qib7	9955	15	Marie	Marie	NNP
cord-005453-4057qib7	9955	16	-	-	HYPH
cord-005453-4057qib7	9955	17	Laure	Laure	NNP
cord-005453-4057qib7	9955	18	Dardé	Dardé	NNP
cord-005453-4057qib7	9955	19	1	1	CD
cord-005453-4057qib7	9955	20	,	,	,
cord-005453-4057qib7	9955	21	Arnaud	Arnaud	NNP
cord-005453-4057qib7	9955	22	Jaccard	Jaccard	NNP
cord-005453-4057qib7	9955	23	1	1	CD
cord-005453-4057qib7	9955	24	,	,	,
cord-005453-4057qib7	9955	25	Daniel	Daniel	NNP
cord-005453-4057qib7	9955	26	Ajzenberg	Ajzenberg	NNP
cord-005453-4057qib7	9955	27	1	1	CD
cord-005453-4057qib7	9955	28	,	,	,
cord-005453-4057qib7	9955	29	Bernard	Bernard	NNP
cord-005453-4057qib7	9955	30	Bouteille	Bouteille	NNP
cord-005453-4057qib7	9955	31	1	1	CD
cord-005453-4057qib7	9956	1	,	,	,
cord-005453-4057qib7	9956	2	Pascal	Pascal	NNP
cord-005453-4057qib7	9956	3	Turlure	Turlure	NNP
cord-005453-4057qib7	9956	4	1	1	CD
cord-005453-4057qib7	9956	5	Background	Background	NNP
cord-005453-4057qib7	9956	6	:	:	:
cord-005453-4057qib7	9956	7	Non	non	JJ
cord-005453-4057qib7	9956	8	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9956	9	peripheral	peripheral	JJ
cord-005453-4057qib7	9956	10	blood	blood	NN
cord-005453-4057qib7	9956	11	stem	stem	NN
cord-005453-4057qib7	9956	12	cell	cell	NN
cord-005453-4057qib7	9956	13	transplantation	transplantation	NN
cord-005453-4057qib7	9956	14	(	(	-LRB-
cord-005453-4057qib7	9956	15	PBSC	PBSC	NNP
cord-005453-4057qib7	9956	16	)	)	-RRB-
cord-005453-4057qib7	9956	17	,	,	,
cord-005453-4057qib7	9956	18	by	by	IN
cord-005453-4057qib7	9956	19	limiting	limit	VBG
cord-005453-4057qib7	9956	20	toxicity	toxicity	NN
cord-005453-4057qib7	9956	21	,	,	,
cord-005453-4057qib7	9956	22	can	can	MD
cord-005453-4057qib7	9956	23	be	be	VB
cord-005453-4057qib7	9956	24	proposed	propose	VBN
cord-005453-4057qib7	9956	25	to	to	IN
cord-005453-4057qib7	9956	26	elderly	elderly	JJ
cord-005453-4057qib7	9956	27	patients	patient	NNS
cord-005453-4057qib7	9956	28	or	or	CC
cord-005453-4057qib7	9956	29	patients	patient	NNS
cord-005453-4057qib7	9956	30	with	with	IN
cord-005453-4057qib7	9956	31	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	9956	32	.	.	.
cord-005453-4057qib7	9957	1	However	however	RB
cord-005453-4057qib7	9957	2	,	,	,
cord-005453-4057qib7	9957	3	fungal	fungal	JJ
cord-005453-4057qib7	9957	4	infections	infection	NNS
cord-005453-4057qib7	9957	5	remain	remain	VBP
cord-005453-4057qib7	9957	6	a	a	DT
cord-005453-4057qib7	9957	7	key	key	JJ
cord-005453-4057qib7	9957	8	issue	issue	NN
cord-005453-4057qib7	9957	9	that	that	WDT
cord-005453-4057qib7	9957	10	can	can	MD
cord-005453-4057qib7	9957	11	negatively	negatively	RB
cord-005453-4057qib7	9957	12	impact	impact	VB
cord-005453-4057qib7	9957	13	outcome	outcome	NN
cord-005453-4057qib7	9957	14	,	,	,
cord-005453-4057qib7	9957	15	and	and	CC
cord-005453-4057qib7	9957	16	increase	increase	VB
cord-005453-4057qib7	9957	17	duration	duration	NN
cord-005453-4057qib7	9957	18	and	and	CC
cord-005453-4057qib7	9957	19	cost	cost	NN
cord-005453-4057qib7	9957	20	of	of	IN
cord-005453-4057qib7	9957	21	hospitalization	hospitalization	NN
cord-005453-4057qib7	9957	22	.	.	.
cord-005453-4057qib7	9958	1	Systematic	systematic	JJ
cord-005453-4057qib7	9958	2	fungal	fungal	JJ
cord-005453-4057qib7	9958	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9958	4	have	have	VBP
cord-005453-4057qib7	9958	5	demonstrated	demonstrate	VBN
cord-005453-4057qib7	9958	6	benefits	benefit	NNS
cord-005453-4057qib7	9958	7	in	in	IN
cord-005453-4057qib7	9958	8	outcome	outcome	NN
cord-005453-4057qib7	9958	9	in	in	IN
cord-005453-4057qib7	9958	10	the	the	DT
cord-005453-4057qib7	9958	11	context	context	NN
cord-005453-4057qib7	9958	12	of	of	IN
cord-005453-4057qib7	9958	13	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9958	14	conditioning	conditioning	NN
cord-005453-4057qib7	9958	15	but	but	CC
cord-005453-4057qib7	9958	16	are	be	VBP
cord-005453-4057qib7	9958	17	not	not	RB
cord-005453-4057qib7	9958	18	currently	currently	RB
cord-005453-4057qib7	9958	19	in	in	IN
cord-005453-4057qib7	9958	20	reduced	reduce	VBN
cord-005453-4057qib7	9958	21	intensity	intensity	NN
cord-005453-4057qib7	9958	22	conditioning	conditioning	NN
cord-005453-4057qib7	9958	23	allograft	allograft	NN
cord-005453-4057qib7	9958	24	with	with	IN
cord-005453-4057qib7	9958	25	PBSC	PBSC	NNP
cord-005453-4057qib7	9958	26	.	.	.
cord-005453-4057qib7	9959	1	Fluconazole	fluconazole	NN
cord-005453-4057qib7	9959	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9959	3	is	be	VBZ
cord-005453-4057qib7	9959	4	currently	currently	RB
cord-005453-4057qib7	9959	5	recommended	recommend	VBN
cord-005453-4057qib7	9959	6	in	in	IN
cord-005453-4057qib7	9959	7	this	this	DT
cord-005453-4057qib7	9959	8	situation	situation	NN
cord-005453-4057qib7	9959	9	(	(	-LRB-
cord-005453-4057qib7	9959	10	ECIL	ECIL	NNP
cord-005453-4057qib7	9959	11	)	)	-RRB-
cord-005453-4057qib7	9959	12	.	.	.
cord-005453-4057qib7	9960	1	Methods	method	NNS
cord-005453-4057qib7	9960	2	:	:	:
cord-005453-4057qib7	9960	3	Primary	primary	JJ
cord-005453-4057qib7	9960	4	objective	objective	NN
cord-005453-4057qib7	9960	5	of	of	IN
cord-005453-4057qib7	9960	6	this	this	DT
cord-005453-4057qib7	9960	7	retrospective	retrospective	JJ
cord-005453-4057qib7	9960	8	study	study	NN
cord-005453-4057qib7	9960	9	was	be	VBD
cord-005453-4057qib7	9960	10	to	to	TO
cord-005453-4057qib7	9960	11	evaluate	evaluate	VB
cord-005453-4057qib7	9960	12	fungal	fungal	JJ
cord-005453-4057qib7	9960	13	infection	infection	NN
cord-005453-4057qib7	9960	14	incidence	incidence	NN
cord-005453-4057qib7	9960	15	after	after	IN
cord-005453-4057qib7	9960	16	allograft	allograft	NN
cord-005453-4057qib7	9960	17	procedure	procedure	NN
cord-005453-4057qib7	9960	18	in	in	IN
cord-005453-4057qib7	9960	19	patients	patient	NNS
cord-005453-4057qib7	9960	20	who	who	WP
cord-005453-4057qib7	9960	21	received	receive	VBD
cord-005453-4057qib7	9960	22	a	a	DT
cord-005453-4057qib7	9960	23	non	non	JJ
cord-005453-4057qib7	9960	24	myeloablative	myeloablative	JJ
cord-005453-4057qib7	9960	25	allograft	allograft	NN
cord-005453-4057qib7	9960	26	with	with	IN
cord-005453-4057qib7	9960	27	PBSC	PBSC	NNP
cord-005453-4057qib7	9960	28	in	in	IN
cord-005453-4057qib7	9960	29	Limoges	Limoges	NNP
cord-005453-4057qib7	9960	30	University	University	NNP
cord-005453-4057qib7	9960	31	Hospital	Hospital	NNP
cord-005453-4057qib7	9960	32	between	between	IN
cord-005453-4057qib7	9960	33	june	june	NNP
cord-005453-4057qib7	9960	34	2009	2009	CD
cord-005453-4057qib7	9960	35	and	and	CC
cord-005453-4057qib7	9960	36	june	june	NNP
cord-005453-4057qib7	9960	37	2018	2018	CD
cord-005453-4057qib7	9960	38	.	.	.
cord-005453-4057qib7	9961	1	Patients	patient	NNS
cord-005453-4057qib7	9961	2	received	receive	VBD
cord-005453-4057qib7	9961	3	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	9961	4	30	30	CD
cord-005453-4057qib7	9961	5	mg	mg	NNP
cord-005453-4057qib7	9961	6	/	/	SYM
cord-005453-4057qib7	9961	7	m2	m2	NNP
cord-005453-4057qib7	9961	8	/	/	SYM
cord-005453-4057qib7	9961	9	day	day	NN
cord-005453-4057qib7	9961	10	between	between	IN
cord-005453-4057qib7	9961	11	D-6	D-6	NNP
cord-005453-4057qib7	9961	12	and	and	CC
cord-005453-4057qib7	9961	13	D-2	D-2	NNP
cord-005453-4057qib7	9961	14	before	before	IN
cord-005453-4057qib7	9961	15	allograft	allograft	NN
cord-005453-4057qib7	9961	16	and	and	CC
cord-005453-4057qib7	9961	17	Busulfan	Busulfan	NNP
cord-005453-4057qib7	9961	18	3.2	3.2	CD
cord-005453-4057qib7	9961	19	mg	mg	NNP
cord-005453-4057qib7	9961	20	/	/	SYM
cord-005453-4057qib7	9961	21	kg	kg	NNP
cord-005453-4057qib7	9961	22	/	/	SYM
cord-005453-4057qib7	9961	23	day	day	NN
cord-005453-4057qib7	9961	24	at	at	IN
cord-005453-4057qib7	9961	25	D-4	D-4	NNP
cord-005453-4057qib7	9961	26	and	and	CC
cord-005453-4057qib7	9961	27	D-3	D-3	NNP
cord-005453-4057qib7	9961	28	.	.	.
cord-005453-4057qib7	9962	1	GvH	GvH	NNP
cord-005453-4057qib7	9962	2	prophylaxis	prophylaxis	NNP
cord-005453-4057qib7	9962	3	consisted	consist	VBD
cord-005453-4057qib7	9962	4	in	in	IN
cord-005453-4057qib7	9962	5	rabbit	rabbit	NN
cord-005453-4057qib7	9962	6	anti	anti	JJ
cord-005453-4057qib7	9962	7	-	-	JJ
cord-005453-4057qib7	9962	8	lymphocyte	lymphocyte	JJ
cord-005453-4057qib7	9962	9	serum	serum	NN
cord-005453-4057qib7	9962	10	at	at	IN
cord-005453-4057qib7	9962	11	the	the	DT
cord-005453-4057qib7	9962	12	dose	dose	NN
cord-005453-4057qib7	9962	13	of	of	IN
cord-005453-4057qib7	9962	14	2.5	2.5	CD
cord-005453-4057qib7	9962	15	mg	mg	NNP
cord-005453-4057qib7	9962	16	/	/	SYM
cord-005453-4057qib7	9962	17	kg	kg	NNS
cord-005453-4057qib7	9962	18	at	at	IN
cord-005453-4057qib7	9962	19	D-2	D-2	NNP
cord-005453-4057qib7	9962	20	and	and	CC
cord-005453-4057qib7	9962	21	D-1	D-1	NNP
cord-005453-4057qib7	9962	22	,	,	,
cord-005453-4057qib7	9962	23	and	and	CC
cord-005453-4057qib7	9962	24	ciclosporin	ciclosporin	NN
cord-005453-4057qib7	9962	25	at	at	IN
cord-005453-4057qib7	9962	26	the	the	DT
cord-005453-4057qib7	9962	27	beginning	beginning	NN
cord-005453-4057qib7	9962	28	dose	dose	NN
cord-005453-4057qib7	9962	29	of	of	IN
cord-005453-4057qib7	9962	30	3mg	3mg	NN
cord-005453-4057qib7	9962	31	/	/	SYM
cord-005453-4057qib7	9962	32	kg	kg	NN
cord-005453-4057qib7	9962	33	per	per	IN
cord-005453-4057qib7	9962	34	os	os	NN
cord-005453-4057qib7	9962	35	twice	twice	PDT
cord-005453-4057qib7	9962	36	a	a	DT
cord-005453-4057qib7	9962	37	day	day	NN
cord-005453-4057qib7	9962	38	.	.	.
cord-005453-4057qib7	9963	1	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	9963	2	mofetil	mofetil	NNP
cord-005453-4057qib7	9963	3	was	be	VBD
cord-005453-4057qib7	9963	4	adding	add	VBG
cord-005453-4057qib7	9963	5	for	for	IN
cord-005453-4057qib7	9963	6	patients	patient	NNS
cord-005453-4057qib7	9963	7	with	with	IN
cord-005453-4057qib7	9963	8	HLA	HLA	NNP
cord-005453-4057qib7	9963	9	-	-	HYPH
cord-005453-4057qib7	9963	10	matched	match	VBN
cord-005453-4057qib7	9963	11	or	or	CC
cord-005453-4057qib7	9963	12	mismatched	mismatch	VBN
cord-005453-4057qib7	9963	13	unrelated	unrelated	JJ
cord-005453-4057qib7	9963	14	donors	donor	NNS
cord-005453-4057qib7	9963	15	.	.	.
cord-005453-4057qib7	9964	1	Patients	patient	NNS
cord-005453-4057qib7	9964	2	did	do	VBD
cord-005453-4057qib7	9964	3	not	not	RB
cord-005453-4057qib7	9964	4	systematically	systematically	RB
cord-005453-4057qib7	9964	5	receive	receive	VB
cord-005453-4057qib7	9964	6	antifungal	antifungal	JJ
cord-005453-4057qib7	9964	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9964	8	during	during	IN
cord-005453-4057qib7	9964	9	the	the	DT
cord-005453-4057qib7	9964	10	neutropenic	neutropenic	JJ
cord-005453-4057qib7	9964	11	pre	pre	JJ
cord-005453-4057qib7	9964	12	-	-	JJ
cord-005453-4057qib7	9964	13	engraftment	engraftment	JJ
cord-005453-4057qib7	9964	14	period	period	NN
cord-005453-4057qib7	9964	15	.	.	.
cord-005453-4057qib7	9965	1	When	when	WRB
cord-005453-4057qib7	9965	2	patients	patient	NNS
cord-005453-4057qib7	9965	3	had	have	VBD
cord-005453-4057qib7	9965	4	fever	fever	NN
cord-005453-4057qib7	9965	5	during	during	IN
cord-005453-4057qib7	9965	6	more	more	JJR
cord-005453-4057qib7	9965	7	than	than	IN
cord-005453-4057qib7	9965	8	72	72	CD
cord-005453-4057qib7	9965	9	hours	hour	NNS
cord-005453-4057qib7	9965	10	,	,	,
cord-005453-4057qib7	9965	11	an	an	DT
cord-005453-4057qib7	9965	12	empirical	empirical	JJ
cord-005453-4057qib7	9965	13	fungal	fungal	NN
cord-005453-4057qib7	9965	14	treatment	treatment	NN
cord-005453-4057qib7	9965	15	(	(	-LRB-
cord-005453-4057qib7	9965	16	caspofungine	caspofungine	NNP
cord-005453-4057qib7	9965	17	)	)	-RRB-
cord-005453-4057qib7	9965	18	was	be	VBD
cord-005453-4057qib7	9965	19	added	add	VBN
cord-005453-4057qib7	9965	20	to	to	IN
cord-005453-4057qib7	9965	21	empirical	empirical	JJ
cord-005453-4057qib7	9965	22	antibiotics	antibiotic	NNS
cord-005453-4057qib7	9965	23	.	.	.
cord-005453-4057qib7	9966	1	As	as	RB
cord-005453-4057qib7	9966	2	soon	soon	RB
cord-005453-4057qib7	9966	3	as	as	IN
cord-005453-4057qib7	9966	4	neutropenic	neutropenic	RB
cord-005453-4057qib7	9966	5	recovered	recover	VBN
cord-005453-4057qib7	9966	6	and	and	CC
cord-005453-4057qib7	9966	7	in	in	IN
cord-005453-4057qib7	9966	8	the	the	DT
cord-005453-4057qib7	9966	9	case	case	NN
cord-005453-4057qib7	9966	10	of	of	IN
cord-005453-4057qib7	9966	11	apyrexia	apyrexia	NNS
cord-005453-4057qib7	9966	12	without	without	IN
cord-005453-4057qib7	9966	13	microbiologic	microbiologic	NNP
cord-005453-4057qib7	9966	14	documentation	documentation	NN
cord-005453-4057qib7	9966	15	,	,	,
cord-005453-4057qib7	9966	16	antimicrobial	antimicrobial	JJ
cord-005453-4057qib7	9966	17	treatments	treatment	NNS
cord-005453-4057qib7	9966	18	were	be	VBD
cord-005453-4057qib7	9966	19	stopped	stop	VBN
cord-005453-4057qib7	9966	20	while	while	IN
cord-005453-4057qib7	9966	21	in	in	IN
cord-005453-4057qib7	9966	22	the	the	DT
cord-005453-4057qib7	9966	23	case	case	NN
cord-005453-4057qib7	9966	24	of	of	IN
cord-005453-4057qib7	9966	25	microbiologic	microbiologic	JJ
cord-005453-4057qib7	9966	26	documentation	documentation	NN
cord-005453-4057qib7	9966	27	,	,	,
cord-005453-4057qib7	9966	28	treatments	treatment	NNS
cord-005453-4057qib7	9966	29	were	be	VBD
cord-005453-4057qib7	9966	30	adjusted	adjust	VBN
cord-005453-4057qib7	9966	31	to	to	IN
cord-005453-4057qib7	9966	32	germ	germ	NN
cord-005453-4057qib7	9966	33	in	in	IN
cord-005453-4057qib7	9966	34	term	term	NN
cord-005453-4057qib7	9966	35	of	of	IN
cord-005453-4057qib7	9966	36	dosing	dosing	NN
cord-005453-4057qib7	9966	37	and	and	CC
cord-005453-4057qib7	9966	38	time	time	NN
cord-005453-4057qib7	9966	39	of	of	IN
cord-005453-4057qib7	9966	40	administration	administration	NN
cord-005453-4057qib7	9966	41	following	follow	VBG
cord-005453-4057qib7	9966	42	recommendations	recommendation	NNS
cord-005453-4057qib7	9966	43	.	.	.
cord-005453-4057qib7	9967	1	However	however	RB
cord-005453-4057qib7	9967	2	,	,	,
cord-005453-4057qib7	9967	3	some	some	DT
cord-005453-4057qib7	9967	4	patients	patient	NNS
cord-005453-4057qib7	9967	5	received	receive	VBD
cord-005453-4057qib7	9967	6	antifungal	antifungal	JJ
cord-005453-4057qib7	9967	7	azole	azole	NNP
cord-005453-4057qib7	9967	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9967	9	during	during	IN
cord-005453-4057qib7	9967	10	the	the	DT
cord-005453-4057qib7	9967	11	neutropenic	neutropenic	JJ
cord-005453-4057qib7	9967	12	pre	pre	JJ
cord-005453-4057qib7	9967	13	-	-	JJ
cord-005453-4057qib7	9967	14	engraftment	engraftment	JJ
cord-005453-4057qib7	9967	15	period	period	NN
cord-005453-4057qib7	9967	16	in	in	IN
cord-005453-4057qib7	9967	17	case	case	NN
cord-005453-4057qib7	9967	18	of	of	IN
cord-005453-4057qib7	9967	19	history	history	NN
cord-005453-4057qib7	9967	20	of	of	IN
cord-005453-4057qib7	9967	21	previous	previous	JJ
cord-005453-4057qib7	9967	22	invasive	invasive	JJ
cord-005453-4057qib7	9967	23	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	9967	24	(	(	-LRB-
cord-005453-4057qib7	9967	25	IA	IA	NNP
cord-005453-4057qib7	9967	26	)	)	-RRB-
cord-005453-4057qib7	9967	27	,	,	,
cord-005453-4057qib7	9967	28	or	or	CC
cord-005453-4057qib7	9967	29	a	a	DT
cord-005453-4057qib7	9967	30	nasal	nasal	JJ
cord-005453-4057qib7	9967	31	colonization	colonization	NN
cord-005453-4057qib7	9967	32	by	by	IN
cord-005453-4057qib7	9967	33	Aspergillus	Aspergillus	NNP
cord-005453-4057qib7	9967	34	.	.	.
cord-005453-4057qib7	9968	1	In	in	IN
cord-005453-4057qib7	9968	2	post	post	JJ
cord-005453-4057qib7	9968	3	-	-	JJ
cord-005453-4057qib7	9968	4	engraftment	engraftment	JJ
cord-005453-4057qib7	9968	5	period	period	NN
cord-005453-4057qib7	9968	6	,	,	,
cord-005453-4057qib7	9968	7	posaconasole	posaconasole	NN
cord-005453-4057qib7	9968	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9968	9	was	be	VBD
cord-005453-4057qib7	9968	10	administered	administer	VBN
cord-005453-4057qib7	9968	11	for	for	IN
cord-005453-4057qib7	9968	12	patients	patient	NNS
cord-005453-4057qib7	9968	13	with	with	IN
cord-005453-4057qib7	9968	14	systemic	systemic	JJ
cord-005453-4057qib7	9968	15	corticotherapy	corticotherapy	NN
cord-005453-4057qib7	9968	16	for	for	IN
cord-005453-4057qib7	9968	17	acute	acute	JJ
cord-005453-4057qib7	9968	18	graft	graft	NN
cord-005453-4057qib7	9968	19	-	-	HYPH
cord-005453-4057qib7	9968	20	versus	versus	IN
cord-005453-4057qib7	9968	21	-	-	HYPH
cord-005453-4057qib7	9968	22	host	host	NN
cord-005453-4057qib7	9968	23	disease	disease	NN
cord-005453-4057qib7	9968	24	.	.	.
cord-005453-4057qib7	9969	1	Results	result	NNS
cord-005453-4057qib7	9969	2	:	:	:
cord-005453-4057qib7	9970	1	91	91	CD
cord-005453-4057qib7	9970	2	patients	patient	NNS
cord-005453-4057qib7	9970	3	were	be	VBD
cord-005453-4057qib7	9970	4	evaluated	evaluate	VBN
cord-005453-4057qib7	9970	5	(	(	-LRB-
cord-005453-4057qib7	9970	6	median	median	JJ
cord-005453-4057qib7	9970	7	[	[	-LRB-
cord-005453-4057qib7	9970	8	min	min	NNP
cord-005453-4057qib7	9970	9	-	-	HYPH
cord-005453-4057qib7	9970	10	max	max	NNP
cord-005453-4057qib7	9970	11	]	]	-RRB-
cord-005453-4057qib7	9970	12	age	age	NN
cord-005453-4057qib7	9970	13	of	of	IN
cord-005453-4057qib7	9970	14	60	60	CD
cord-005453-4057qib7	9970	15	[	[	-LRB-
cord-005453-4057qib7	9970	16	33	33	CD
cord-005453-4057qib7	9970	17	-	-	SYM
cord-005453-4057qib7	9970	18	71	71	CD
cord-005453-4057qib7	9970	19	]	]	-RRB-
cord-005453-4057qib7	9970	20	years	year	NNS
cord-005453-4057qib7	9970	21	)	)	-RRB-
cord-005453-4057qib7	9970	22	.	.	.
cord-005453-4057qib7	9971	1	20	20	CD
cord-005453-4057qib7	9971	2	%	%	NN
cord-005453-4057qib7	9971	3	of	of	IN
cord-005453-4057qib7	9971	4	patients	patient	NNS
cord-005453-4057qib7	9971	5	received	receive	VBD
cord-005453-4057qib7	9971	6	an	an	DT
cord-005453-4057qib7	9971	7	HLAidentical	HLAidentical	NNP
cord-005453-4057qib7	9971	8	related	related	JJ
cord-005453-4057qib7	9971	9	donor	donor	NN
cord-005453-4057qib7	9971	10	,	,	,
cord-005453-4057qib7	9971	11	69	69	CD
cord-005453-4057qib7	9971	12	%	%	NN
cord-005453-4057qib7	9971	13	an	an	DT
cord-005453-4057qib7	9971	14	HLA	HLA	NNP
cord-005453-4057qib7	9971	15	-	-	HYPH
cord-005453-4057qib7	9971	16	matched	match	VBN
cord-005453-4057qib7	9971	17	related	related	JJ
cord-005453-4057qib7	9971	18	donor	donor	NN
cord-005453-4057qib7	9971	19	and	and	CC
cord-005453-4057qib7	9971	20	11	11	CD
cord-005453-4057qib7	9971	21	%	%	NN
cord-005453-4057qib7	9971	22	an	an	DT
cord-005453-4057qib7	9971	23	HLA	HLA	NNP
cord-005453-4057qib7	9971	24	-	-	HYPH
cord-005453-4057qib7	9971	25	mismatched	mismatch	VBN
cord-005453-4057qib7	9971	26	unrelated	unrelated	JJ
cord-005453-4057qib7	9971	27	donor	donor	NN
cord-005453-4057qib7	9971	28	.	.	.
cord-005453-4057qib7	9972	1	The	the	DT
cord-005453-4057qib7	9972	2	five	five	CD
cord-005453-4057qib7	9972	3	years	year	NNS
cord-005453-4057qib7	9972	4	overall	overall	JJ
cord-005453-4057qib7	9972	5	survival	survival	NN
cord-005453-4057qib7	9972	6	and	and	CC
cord-005453-4057qib7	9972	7	survival	survival	NN
cord-005453-4057qib7	9972	8	without	without	IN
cord-005453-4057qib7	9972	9	relapse	relapse	NN
cord-005453-4057qib7	9972	10	or	or	CC
cord-005453-4057qib7	9972	11	GvHD	GvHD	NNP
cord-005453-4057qib7	9972	12	were	be	VBD
cord-005453-4057qib7	9972	13	70	70	CD
cord-005453-4057qib7	9972	14	%	%	NN
cord-005453-4057qib7	9973	1	IC95	IC95	NNP
cord-005453-4057qib7	9973	2	[	[	-LRB-
cord-005453-4057qib7	9973	3	59%-81	59%-81	CD
cord-005453-4057qib7	9973	4	%	%	NN
cord-005453-4057qib7	9973	5	]	]	-RRB-
cord-005453-4057qib7	9973	6	and	and	CC
cord-005453-4057qib7	9973	7	62	62	CD
cord-005453-4057qib7	9973	8	%	%	NN
cord-005453-4057qib7	9973	9	respectively	respectively	RB
cord-005453-4057qib7	9973	10	IC	IC	NNP
cord-005453-4057qib7	9973	11	95	95	CD
cord-005453-4057qib7	9973	12	[	[	-LRB-
cord-005453-4057qib7	9973	13	52%-73	52%-73	CD
cord-005453-4057qib7	9973	14	%	%	NN
cord-005453-4057qib7	9973	15	]	]	-RRB-
cord-005453-4057qib7	9973	16	.	.	.
cord-005453-4057qib7	9974	1	The	the	DT
cord-005453-4057qib7	9974	2	median	median	JJ
cord-005453-4057qib7	9974	3	time	time	NN
cord-005453-4057qib7	9974	4	for	for	IN
cord-005453-4057qib7	9974	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	9974	6	recovery	recovery	NN
cord-005453-4057qib7	9974	7	was	be	VBD
cord-005453-4057qib7	9974	8	15	15	CD
cord-005453-4057qib7	9974	9	days	day	NNS
cord-005453-4057qib7	9974	10	.	.	.
cord-005453-4057qib7	9975	1	79	79	CD
cord-005453-4057qib7	9975	2	patients	patient	NNS
cord-005453-4057qib7	9975	3	did	do	VBD
cord-005453-4057qib7	9975	4	not	not	RB
cord-005453-4057qib7	9975	5	receive	receive	VB
cord-005453-4057qib7	9975	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9975	7	and	and	CC
cord-005453-4057qib7	9975	8	only	only	RB
cord-005453-4057qib7	9975	9	12	12	CD
cord-005453-4057qib7	9975	10	patients	patient	NNS
cord-005453-4057qib7	9975	11	received	receive	VBD
cord-005453-4057qib7	9975	12	systematic	systematic	JJ
cord-005453-4057qib7	9975	13	fungal	fungal	NN
cord-005453-4057qib7	9975	14	azole	azole	NNP
cord-005453-4057qib7	9975	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9975	16	in	in	IN
cord-005453-4057qib7	9975	17	the	the	DT
cord-005453-4057qib7	9975	18	pre	pre	JJ
cord-005453-4057qib7	9975	19	-	-	JJ
cord-005453-4057qib7	9975	20	engraftment	engraftment	JJ
cord-005453-4057qib7	9975	21	period	period	NN
cord-005453-4057qib7	9975	22	.	.	.
cord-005453-4057qib7	9976	1	Two	two	CD
cord-005453-4057qib7	9976	2	patients	patient	NNS
cord-005453-4057qib7	9976	3	received	receive	VBD
cord-005453-4057qib7	9976	4	an	an	DT
cord-005453-4057qib7	9976	5	empirical	empirical	JJ
cord-005453-4057qib7	9976	6	treatment	treatment	NN
cord-005453-4057qib7	9976	7	by	by	IN
cord-005453-4057qib7	9976	8	caspofungine	caspofungine	NNP
cord-005453-4057qib7	9976	9	.	.	.
cord-005453-4057qib7	9977	1	Only	only	RB
cord-005453-4057qib7	9977	2	1	1	CD
cord-005453-4057qib7	9977	3	IFI	IFI	NNP
cord-005453-4057qib7	9977	4	was	be	VBD
cord-005453-4057qib7	9977	5	documented	document	VBN
cord-005453-4057qib7	9977	6	during	during	IN
cord-005453-4057qib7	9977	7	the	the	DT
cord-005453-4057qib7	9977	8	neutropenic	neutropenic	JJ
cord-005453-4057qib7	9977	9	period	period	NN
cord-005453-4057qib7	9977	10	:	:	:
cord-005453-4057qib7	9977	11	candida	candida	NNP
cord-005453-4057qib7	9977	12	krusei	krusei	NNP
cord-005453-4057qib7	9977	13	in	in	IN
cord-005453-4057qib7	9977	14	blood	blood	NN
cord-005453-4057qib7	9977	15	culture	culture	NN
cord-005453-4057qib7	9977	16	.	.	.
cord-005453-4057qib7	9978	1	In	in	IN
cord-005453-4057qib7	9978	2	the	the	DT
cord-005453-4057qib7	9978	3	post	post	JJ
cord-005453-4057qib7	9978	4	engraftment	engraftment	NN
cord-005453-4057qib7	9978	5	period	period	NN
cord-005453-4057qib7	9978	6	,	,	,
cord-005453-4057qib7	9978	7	37	37	CD
cord-005453-4057qib7	9978	8	patients	patient	NNS
cord-005453-4057qib7	9978	9	with	with	IN
cord-005453-4057qib7	9978	10	acute	acute	JJ
cord-005453-4057qib7	9978	11	GVHD	GVHD	NNP
cord-005453-4057qib7	9978	12	treated	treat	VBN
cord-005453-4057qib7	9978	13	by	by	IN
cord-005453-4057qib7	9978	14	corticotherapy	corticotherapy	NNP
cord-005453-4057qib7	9978	15	received	receive	VBD
cord-005453-4057qib7	9978	16	an	an	DT
cord-005453-4057qib7	9978	17	antifungal	antifungal	JJ
cord-005453-4057qib7	9978	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9978	19	by	by	IN
cord-005453-4057qib7	9978	20	posaconazole	posaconazole	NN
cord-005453-4057qib7	9978	21	and	and	CC
cord-005453-4057qib7	9978	22	only	only	RB
cord-005453-4057qib7	9978	23	1	1	CD
cord-005453-4057qib7	9978	24	patient	patient	NN
cord-005453-4057qib7	9978	25	had	have	VBD
cord-005453-4057qib7	9978	26	a	a	DT
cord-005453-4057qib7	9978	27	probable	probable	JJ
cord-005453-4057qib7	9978	28	IA	IA	NNP
cord-005453-4057qib7	9978	29	at	at	IN
cord-005453-4057qib7	9978	30	day	day	NN
cord-005453-4057qib7	9978	31	100	100	CD
cord-005453-4057qib7	9978	32	despite	despite	IN
cord-005453-4057qib7	9978	33	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9978	34	by	by	IN
cord-005453-4057qib7	9978	35	posaconasole	posaconasole	NN
cord-005453-4057qib7	9978	36	.	.	.
cord-005453-4057qib7	9979	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9979	2	:	:	:
cord-005453-4057qib7	9980	1	Except	except	IN
cord-005453-4057qib7	9980	2	for	for	IN
cord-005453-4057qib7	9980	3	patients	patient	NNS
cord-005453-4057qib7	9980	4	with	with	IN
cord-005453-4057qib7	9980	5	previous	previous	JJ
cord-005453-4057qib7	9980	6	history	history	NN
cord-005453-4057qib7	9980	7	of	of	IN
cord-005453-4057qib7	9980	8	IFI	IFI	NNP
cord-005453-4057qib7	9980	9	,	,	,
cord-005453-4057qib7	9980	10	our	-PRON-	PRP$
cord-005453-4057qib7	9980	11	results	result	NNS
cord-005453-4057qib7	9980	12	provide	provide	VBP
cord-005453-4057qib7	9980	13	additional	additional	JJ
cord-005453-4057qib7	9980	14	arguments	argument	NNS
cord-005453-4057qib7	9980	15	against	against	IN
cord-005453-4057qib7	9980	16	systematic	systematic	JJ
cord-005453-4057qib7	9980	17	fungal	fungal	JJ
cord-005453-4057qib7	9980	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9980	19	after	after	IN
cord-005453-4057qib7	9980	20	reduced	reduce	VBN
cord-005453-4057qib7	9980	21	intensity	intensity	NN
cord-005453-4057qib7	9980	22	conditioning	conditioning	NN
cord-005453-4057qib7	9980	23	with	with	IN
cord-005453-4057qib7	9980	24	PBSC	PBSC	NNP
cord-005453-4057qib7	9980	25	allogenic	allogenic	JJ
cord-005453-4057qib7	9980	26	transplantation	transplantation	NN
cord-005453-4057qib7	9980	27	in	in	IN
cord-005453-4057qib7	9980	28	the	the	DT
cord-005453-4057qib7	9980	29	pre	pre	JJ
cord-005453-4057qib7	9980	30	-	-	JJ
cord-005453-4057qib7	9980	31	engraftment	engraftment	JJ
cord-005453-4057qib7	9980	32	period	period	NN
cord-005453-4057qib7	9980	33	with	with	IN
cord-005453-4057qib7	9980	34	a	a	DT
cord-005453-4057qib7	9980	35	very	very	RB
cord-005453-4057qib7	9980	36	low	low	JJ
cord-005453-4057qib7	9980	37	incidence	incidence	NN
cord-005453-4057qib7	9980	38	of	of	IN
cord-005453-4057qib7	9980	39	invasive	invasive	JJ
cord-005453-4057qib7	9980	40	fungal	fungal	JJ
cord-005453-4057qib7	9980	41	infections	infection	NNS
cord-005453-4057qib7	9980	42	.	.	.
cord-005453-4057qib7	9981	1	In	in	IN
cord-005453-4057qib7	9981	2	post	post	JJ
cord-005453-4057qib7	9981	3	-	-	JJ
cord-005453-4057qib7	9981	4	engrafment	engrafment	JJ
cord-005453-4057qib7	9981	5	period	period	NN
cord-005453-4057qib7	9981	6	,	,	,
cord-005453-4057qib7	9981	7	posaconazole	posaconazole	NNP
cord-005453-4057qib7	9981	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	9981	9	is	be	VBZ
cord-005453-4057qib7	9981	10	required	require	VBN
cord-005453-4057qib7	9981	11	for	for	IN
cord-005453-4057qib7	9981	12	patient	patient	NN
cord-005453-4057qib7	9981	13	with	with	IN
cord-005453-4057qib7	9981	14	GVHD	GVHD	NNP
cord-005453-4057qib7	9981	15	treated	treat	VBN
cord-005453-4057qib7	9981	16	by	by	IN
cord-005453-4057qib7	9981	17	corticotherapy	corticotherapy	NNP
cord-005453-4057qib7	9981	18	.	.	.
cord-005453-4057qib7	9982	1	Disclosure	disclosure	NN
cord-005453-4057qib7	9982	2	Methods	method	NNS
cord-005453-4057qib7	9982	3	:	:	:
cord-005453-4057qib7	9983	1	A	a	DT
cord-005453-4057qib7	9983	2	simple	simple	JJ
cord-005453-4057qib7	9983	3	,	,	,
cord-005453-4057qib7	9983	4	rapid	rapid	JJ
cord-005453-4057qib7	9983	5	and	and	CC
cord-005453-4057qib7	9983	6	sensitive	sensitive	JJ
cord-005453-4057qib7	9983	7	method	method	NN
cord-005453-4057qib7	9983	8	using	use	VBG
cord-005453-4057qib7	9983	9	HPLC	HPLC	NNP
cord-005453-4057qib7	9983	10	with	with	IN
cord-005453-4057qib7	9983	11	a	a	DT
cord-005453-4057qib7	9983	12	diode	diode	NN
cord-005453-4057qib7	9983	13	-	-	HYPH
cord-005453-4057qib7	9983	14	array	array	NN
cord-005453-4057qib7	9983	15	detector	detector	NN
cord-005453-4057qib7	9983	16	(	(	-LRB-
cord-005453-4057qib7	9983	17	DAD	DAD	NNP
cord-005453-4057qib7	9983	18	)	)	-RRB-
cord-005453-4057qib7	9983	19	was	be	VBD
cord-005453-4057qib7	9983	20	developed	develop	VBN
cord-005453-4057qib7	9983	21	and	and	CC
cord-005453-4057qib7	9983	22	validated	validate	VBN
cord-005453-4057qib7	9983	23	for	for	IN
cord-005453-4057qib7	9983	24	the	the	DT
cord-005453-4057qib7	9983	25	quantification	quantification	NN
cord-005453-4057qib7	9983	26	of	of	IN
cord-005453-4057qib7	9983	27	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9983	28	in	in	IN
cord-005453-4057qib7	9983	29	human	human	JJ
cord-005453-4057qib7	9983	30	serum	serum	NN
cord-005453-4057qib7	9983	31	using	use	VBG
cord-005453-4057qib7	9983	32	Sorafenib	Sorafenib	NNP
cord-005453-4057qib7	9983	33	as	as	IN
cord-005453-4057qib7	9983	34	internal	internal	JJ
cord-005453-4057qib7	9983	35	standard	standard	NN
cord-005453-4057qib7	9983	36	.	.	.
cord-005453-4057qib7	9984	1	After	after	IN
cord-005453-4057qib7	9984	2	pretreating	pretreate	VBG
cord-005453-4057qib7	9984	3	serum	serum	NN
cord-005453-4057qib7	9984	4	samples	sample	NNS
cord-005453-4057qib7	9984	5	by	by	IN
cord-005453-4057qib7	9984	6	liquid	liquid	NN
cord-005453-4057qib7	9984	7	-	-	HYPH
cord-005453-4057qib7	9984	8	liquid	liquid	NN
cord-005453-4057qib7	9984	9	extraction	extraction	NN
cord-005453-4057qib7	9984	10	with	with	IN
cord-005453-4057qib7	9984	11	tert	tert	NNP
cord-005453-4057qib7	9984	12	-	-	HYPH
cord-005453-4057qib7	9984	13	Butyl	butyl	NN
cord-005453-4057qib7	9984	14	methyl	methyl	NN
cord-005453-4057qib7	9984	15	ether	ether	NN
cord-005453-4057qib7	9984	16	,	,	,
cord-005453-4057qib7	9984	17	separation	separation	NN
cord-005453-4057qib7	9984	18	was	be	VBD
cord-005453-4057qib7	9984	19	achieved	achieve	VBN
cord-005453-4057qib7	9984	20	on	on	IN
cord-005453-4057qib7	9984	21	a	a	DT
cord-005453-4057qib7	9984	22	X	x	NN
cord-005453-4057qib7	9984	23	-	-	NNP
cord-005453-4057qib7	9984	24	Terra	Terra	NNP
cord-005453-4057qib7	9984	25	RP-18	RP-18	NNP
cord-005453-4057qib7	9984	26	column	column	NN
cord-005453-4057qib7	9984	27	(	(	-LRB-
cord-005453-4057qib7	9984	28	Dimension	dimension	NN
cord-005453-4057qib7	9984	29	150	150	CD
cord-005453-4057qib7	9984	30	x	x	SYM
cord-005453-4057qib7	9984	31	2.1	2.1	CD
cord-005453-4057qib7	9984	32	mm	mm	NN
cord-005453-4057qib7	9984	33	,	,	,
cord-005453-4057qib7	9984	34	5μm	5μm	NN
cord-005453-4057qib7	9984	35	)	)	-RRB-
cord-005453-4057qib7	9984	36	at	at	IN
cord-005453-4057qib7	9984	37	30	30	CD
cord-005453-4057qib7	9984	38	0	0	CD
cord-005453-4057qib7	9984	39	C	c	NN
cord-005453-4057qib7	9984	40	using	use	VBG
cord-005453-4057qib7	9984	41	gradient	gradient	NN
cord-005453-4057qib7	9984	42	elution	elution	NN
cord-005453-4057qib7	9984	43	with	with	IN
cord-005453-4057qib7	9984	44	a	a	DT
cord-005453-4057qib7	9984	45	mobile	mobile	JJ
cord-005453-4057qib7	9984	46	phase	phase	NN
cord-005453-4057qib7	9984	47	of	of	IN
cord-005453-4057qib7	9984	48	20	20	CD
cord-005453-4057qib7	9984	49	mM	mm	CD
cord-005453-4057qib7	9984	50	ammonium	ammonium	NN
cord-005453-4057qib7	9984	51	bicarbonate	bicarbonate	NN
cord-005453-4057qib7	9984	52	pH	pH	NNP
cord-005453-4057qib7	9984	53	7.8	7.8	CD
cord-005453-4057qib7	9984	54	(	(	-LRB-
cord-005453-4057qib7	9984	55	mobile	mobile	JJ
cord-005453-4057qib7	9984	56	phase	phase	NN
cord-005453-4057qib7	9984	57	solvent	solvent	NN
cord-005453-4057qib7	9984	58	-	-	:
cord-005453-4057qib7	9984	59	A	a	NN
cord-005453-4057qib7	9984	60	)	)	-RRB-
cord-005453-4057qib7	9984	61	and	and	CC
cord-005453-4057qib7	9984	62	acetonitrile:20mM	acetonitrile:20mm	CD
cord-005453-4057qib7	9984	63	ammonium	ammonium	NN
cord-005453-4057qib7	9984	64	bicarbonate	bicarbonate	NN
cord-005453-4057qib7	9984	65	pH	pH	NNP
cord-005453-4057qib7	9984	66	9.2	9.2	CD
cord-005453-4057qib7	9984	67	(	(	-LRB-
cord-005453-4057qib7	9984	68	mobile	mobile	JJ
cord-005453-4057qib7	9984	69	phase	phase	NN
cord-005453-4057qib7	9984	70	solvent	solvent	NN
cord-005453-4057qib7	9984	71	-	-	HYPH
cord-005453-4057qib7	9984	72	B	b	NN
cord-005453-4057qib7	9984	73	)	)	-RRB-
cord-005453-4057qib7	9984	74	.	.	.
cord-005453-4057qib7	9985	1	Samples	sample	NNS
cord-005453-4057qib7	9985	2	were	be	VBD
cord-005453-4057qib7	9985	3	eluted	elute	VBN
cord-005453-4057qib7	9985	4	at	at	IN
cord-005453-4057qib7	9985	5	a	a	DT
cord-005453-4057qib7	9985	6	flow	flow	NN
cord-005453-4057qib7	9985	7	rate	rate	NN
cord-005453-4057qib7	9985	8	of	of	IN
cord-005453-4057qib7	9985	9	0.3ml	0.3ml	CD
cord-005453-4057qib7	9985	10	/	/	SYM
cord-005453-4057qib7	9985	11	min	min	NN
cord-005453-4057qib7	9985	12	throughout	throughout	IN
cord-005453-4057qib7	9985	13	the	the	DT
cord-005453-4057qib7	9985	14	20-minute	20-minute	JJ
cord-005453-4057qib7	9985	15	run	run	NN
cord-005453-4057qib7	9985	16	.	.	.
cord-005453-4057qib7	9986	1	UV	uv	NN
cord-005453-4057qib7	9986	2	wavelength	wavelength	NN
cord-005453-4057qib7	9986	3	mode	mode	NN
cord-005453-4057qib7	9986	4	was	be	VBD
cord-005453-4057qib7	9986	5	used	use	VBN
cord-005453-4057qib7	9986	6	,	,	,
cord-005453-4057qib7	9986	7	detection	detection	NN
cord-005453-4057qib7	9986	8	was	be	VBD
cord-005453-4057qib7	9986	9	at	at	IN
cord-005453-4057qib7	9986	10	260	260	CD
cord-005453-4057qib7	9986	11	nm	nm	NN
cord-005453-4057qib7	9986	12	.	.	.
cord-005453-4057qib7	9987	1	Results	result	NNS
cord-005453-4057qib7	9987	2	:	:	:
cord-005453-4057qib7	9988	1	The	the	DT
cord-005453-4057qib7	9988	2	calibration	calibration	NN
cord-005453-4057qib7	9988	3	curve	curve	NN
cord-005453-4057qib7	9988	4	was	be	VBD
cord-005453-4057qib7	9988	5	linear	linear	JJ
cord-005453-4057qib7	9988	6	(	(	-LRB-
cord-005453-4057qib7	9988	7	r	r	NN
cord-005453-4057qib7	9988	8	>	>	XX
cord-005453-4057qib7	9988	9	0.99	0.99	CD
cord-005453-4057qib7	9988	10	)	)	-RRB-
cord-005453-4057qib7	9988	11	in	in	IN
cord-005453-4057qib7	9988	12	a	a	DT
cord-005453-4057qib7	9988	13	concentration	concentration	NN
cord-005453-4057qib7	9988	14	range	range	NN
cord-005453-4057qib7	9988	15	of	of	IN
cord-005453-4057qib7	9988	16	25	25	CD
cord-005453-4057qib7	9988	17	-5000	-5000	NNS
cord-005453-4057qib7	9988	18	ng	ng	NN
cord-005453-4057qib7	9988	19	/	/	SYM
cord-005453-4057qib7	9988	20	ml	ml	NN
cord-005453-4057qib7	9988	21	for	for	IN
cord-005453-4057qib7	9988	22	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9988	23	.	.	.
cord-005453-4057qib7	9989	1	The	the	DT
cord-005453-4057qib7	9989	2	HPLC	HPLC	NNP
cord-005453-4057qib7	9989	3	assay	assay	NN
cord-005453-4057qib7	9989	4	established	establish	VBN
cord-005453-4057qib7	9989	5	for	for	IN
cord-005453-4057qib7	9989	6	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9989	7	determination	determination	NN
cord-005453-4057qib7	9989	8	showed	show	VBD
cord-005453-4057qib7	9989	9	a	a	DT
cord-005453-4057qib7	9989	10	high	high	JJ
cord-005453-4057qib7	9989	11	rate	rate	NN
cord-005453-4057qib7	9989	12	of	of	IN
cord-005453-4057qib7	9989	13	accuracy	accuracy	NN
cord-005453-4057qib7	9989	14	and	and	CC
cord-005453-4057qib7	9989	15	precision	precision	NN
cord-005453-4057qib7	9989	16	with	with	IN
cord-005453-4057qib7	9989	17	an	an	DT
cord-005453-4057qib7	9989	18	intraday	intraday	NN
cord-005453-4057qib7	9989	19	variability	variability	NN
cord-005453-4057qib7	9989	20	of	of	IN
cord-005453-4057qib7	9989	21	-9.21	-9.21	CD
cord-005453-4057qib7	9989	22	to	to	IN
cord-005453-4057qib7	9989	23	12	12	CD
cord-005453-4057qib7	9989	24	%	%	NN
cord-005453-4057qib7	9989	25	(	(	-LRB-
cord-005453-4057qib7	9989	26	accuracy	accuracy	NN
cord-005453-4057qib7	9989	27	)	)	-RRB-
cord-005453-4057qib7	9989	28	and	and	CC
cord-005453-4057qib7	9989	29	0.31	0.31	CD
cord-005453-4057qib7	9989	30	to	to	TO
cord-005453-4057qib7	9989	31	3.75	3.75	CD
cord-005453-4057qib7	9989	32	%	%	NN
cord-005453-4057qib7	9989	33	(	(	-LRB-
cord-005453-4057qib7	9989	34	precision	precision	NN
cord-005453-4057qib7	9989	35	)	)	-RRB-
cord-005453-4057qib7	9989	36	and	and	CC
cord-005453-4057qib7	9989	37	an	an	DT
cord-005453-4057qib7	9989	38	interday	interday	NN
cord-005453-4057qib7	9989	39	variability	variability	NN
cord-005453-4057qib7	9989	40	of	of	IN
cord-005453-4057qib7	9989	41	-2.6	-2.6	NN
cord-005453-4057qib7	9989	42	to	to	IN
cord-005453-4057qib7	9989	43	6.9	6.9	CD
cord-005453-4057qib7	9989	44	%	%	NN
cord-005453-4057qib7	9989	45	(	(	-LRB-
cord-005453-4057qib7	9989	46	accuracy	accuracy	NN
cord-005453-4057qib7	9989	47	)	)	-RRB-
cord-005453-4057qib7	9989	48	and	and	CC
cord-005453-4057qib7	9989	49	3.74	3.74	CD
cord-005453-4057qib7	9989	50	to	to	TO
cord-005453-4057qib7	9989	51	7.41	7.41	CD
cord-005453-4057qib7	9989	52	%	%	NN
cord-005453-4057qib7	9989	53	(	(	-LRB-
cord-005453-4057qib7	9989	54	precision	precision	NN
cord-005453-4057qib7	9989	55	)	)	-RRB-
cord-005453-4057qib7	9989	56	,	,	,
cord-005453-4057qib7	9989	57	respectively	respectively	RB
cord-005453-4057qib7	9989	58	.	.	.
cord-005453-4057qib7	9990	1	16	16	CD
cord-005453-4057qib7	9991	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9991	2	serum	serum	NN
cord-005453-4057qib7	9991	3	concentrations	concentration	NNS
cord-005453-4057qib7	9991	4	of	of	IN
cord-005453-4057qib7	9991	5	9	9	CD
cord-005453-4057qib7	9991	6	patients	patient	NNS
cord-005453-4057qib7	9991	7	(	(	-LRB-
cord-005453-4057qib7	9991	8	8	8	CD
cord-005453-4057qib7	9991	9	male	male	JJ
cord-005453-4057qib7	9991	10	/	/	SYM
cord-005453-4057qib7	9991	11	1	1	CD
cord-005453-4057qib7	9991	12	female	female	NN
cord-005453-4057qib7	9991	13	,	,	,
cord-005453-4057qib7	9991	14	mean	mean	VB
cord-005453-4057qib7	9991	15	age	age	NN
cord-005453-4057qib7	9991	16	66.3	66.3	CD
cord-005453-4057qib7	9991	17	years	year	NNS
cord-005453-4057qib7	9991	18	)	)	-RRB-
cord-005453-4057qib7	9991	19	were	be	VBD
cord-005453-4057qib7	9991	20	determined	determine	VBN
cord-005453-4057qib7	9991	21	in	in	IN
cord-005453-4057qib7	9991	22	daily	daily	JJ
cord-005453-4057qib7	9991	23	clinical	clinical	JJ
cord-005453-4057qib7	9991	24	practice	practice	NN
cord-005453-4057qib7	9991	25	.	.	.
cord-005453-4057qib7	9992	1	The	the	DT
cord-005453-4057qib7	9992	2	mean	mean	JJ
cord-005453-4057qib7	9992	3	concentration	concentration	NN
cord-005453-4057qib7	9992	4	was	be	VBD
cord-005453-4057qib7	9992	5	4752	4752	CD
cord-005453-4057qib7	9992	6	ng	ng	NNP
cord-005453-4057qib7	9992	7	/	/	SYM
cord-005453-4057qib7	9992	8	ml	ml	NN
cord-005453-4057qib7	9992	9	(	(	-LRB-
cord-005453-4057qib7	9992	10	median	median	JJ
cord-005453-4057qib7	9992	11	4163	4163	CD
cord-005453-4057qib7	9992	12	ng	ng	NNP
cord-005453-4057qib7	9992	13	/	/	SYM
cord-005453-4057qib7	9992	14	ml	ml	NN
cord-005453-4057qib7	9992	15	,	,	,
cord-005453-4057qib7	9992	16	standard	standard	JJ
cord-005453-4057qib7	9992	17	deviation	deviation	NN
cord-005453-4057qib7	9992	18	3925	3925	CD
cord-005453-4057qib7	9992	19	ng	ng	NNP
cord-005453-4057qib7	9992	20	/	/	SYM
cord-005453-4057qib7	9992	21	ml	ml	XX
cord-005453-4057qib7	9992	22	,	,	,
cord-005453-4057qib7	9993	1	range	range	VBP
cord-005453-4057qib7	9993	2	89	89	CD
cord-005453-4057qib7	9994	1	-11452	-11452	:
cord-005453-4057qib7	9994	2	ng	ng	NNP
cord-005453-4057qib7	9994	3	/	/	SYM
cord-005453-4057qib7	9994	4	ml	ml	NN
cord-005453-4057qib7	9994	5	)	)	-RRB-
cord-005453-4057qib7	9994	6	.	.	.
cord-005453-4057qib7	9995	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	9995	2	:	:	:
cord-005453-4057qib7	9996	1	The	the	DT
cord-005453-4057qib7	9996	2	newly	newly	RB
cord-005453-4057qib7	9996	3	developed	develop	VBN
cord-005453-4057qib7	9996	4	HPLC	HPLC	NNP
cord-005453-4057qib7	9996	5	method	method	NN
cord-005453-4057qib7	9996	6	is	be	VBZ
cord-005453-4057qib7	9996	7	useful	useful	JJ
cord-005453-4057qib7	9996	8	for	for	IN
cord-005453-4057qib7	9996	9	the	the	DT
cord-005453-4057qib7	9996	10	determination	determination	NN
cord-005453-4057qib7	9996	11	of	of	IN
cord-005453-4057qib7	9996	12	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9996	13	concentrations	concentration	NNS
cord-005453-4057qib7	9996	14	.	.	.
cord-005453-4057qib7	9997	1	Patient	patient	NN
cord-005453-4057qib7	9997	2	samples	sample	NNS
cord-005453-4057qib7	9997	3	analyzed	analyze	VBN
cord-005453-4057qib7	9997	4	in	in	IN
cord-005453-4057qib7	9997	5	a	a	DT
cord-005453-4057qib7	9997	6	routine	routine	JJ
cord-005453-4057qib7	9997	7	clinical	clinical	JJ
cord-005453-4057qib7	9997	8	setting	setting	NN
cord-005453-4057qib7	9997	9	demonstrated	demonstrate	VBD
cord-005453-4057qib7	9997	10	considerable	considerable	JJ
cord-005453-4057qib7	9997	11	interindividual	interindividual	JJ
cord-005453-4057qib7	9997	12	variability	variability	NN
cord-005453-4057qib7	9997	13	.	.	.
cord-005453-4057qib7	9998	1	All	all	DT
cord-005453-4057qib7	9998	2	measured	measure	VBN
cord-005453-4057qib7	9998	3	concentrations	concentration	NNS
cord-005453-4057qib7	9998	4	were	be	VBD
cord-005453-4057qib7	9998	5	above	above	IN
cord-005453-4057qib7	9998	6	the	the	DT
cord-005453-4057qib7	9998	7	EC50	EC50	NNP
cord-005453-4057qib7	9998	8	of	of	IN
cord-005453-4057qib7	9998	9	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9998	10	.	.	.
cord-005453-4057qib7	9999	1	Monitoring	monitor	VBG
cord-005453-4057qib7	9999	2	the	the	DT
cord-005453-4057qib7	9999	3	concentration	concentration	NN
cord-005453-4057qib7	9999	4	of	of	IN
cord-005453-4057qib7	9999	5	Letermovir	Letermovir	NNP
cord-005453-4057qib7	9999	6	could	could	MD
cord-005453-4057qib7	9999	7	help	help	VB
cord-005453-4057qib7	9999	8	to	to	TO
cord-005453-4057qib7	9999	9	prevent	prevent	VB
cord-005453-4057qib7	9999	10	over	over	RP
cord-005453-4057qib7	9999	11	-	-	HYPH
cord-005453-4057qib7	9999	12	or	or	CC
cord-005453-4057qib7	9999	13	underexposure	underexposure	NN
cord-005453-4057qib7	9999	14	,	,	,
cord-005453-4057qib7	9999	15	especially	especially	RB
cord-005453-4057qib7	9999	16	in	in	IN
cord-005453-4057qib7	9999	17	patients	patient	NNS
cord-005453-4057qib7	9999	18	with	with	IN
cord-005453-4057qib7	9999	19	polypharmacy	polypharmacy	NNS
cord-005453-4057qib7	9999	20	which	which	WDT
cord-005453-4057qib7	9999	21	is	be	VBZ
cord-005453-4057qib7	9999	22	frequent	frequent	JJ
cord-005453-4057qib7	9999	23	in	in	IN
cord-005453-4057qib7	9999	24	allogeneic	allogeneic	JJ
cord-005453-4057qib7	9999	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	9999	26	stem	stem	NN
cord-005453-4057qib7	9999	27	cell	cell	NN
cord-005453-4057qib7	9999	28	transplant	transplant	NN
cord-005453-4057qib7	9999	29	recipients	recipient	NNS
cord-005453-4057qib7	9999	30	.	.	.
cord-005453-4057qib7	10000	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10000	2	Background	background	NN
cord-005453-4057qib7	10000	3	:	:	:
cord-005453-4057qib7	10001	1	The	the	DT
cord-005453-4057qib7	10001	2	use	use	NN
cord-005453-4057qib7	10001	3	of	of	IN
cord-005453-4057qib7	10001	4	preemptive	preemptive	JJ
cord-005453-4057qib7	10001	5	strategy	strategy	NN
cord-005453-4057qib7	10001	6	(	(	-LRB-
cord-005453-4057qib7	10001	7	PET	PET	NNP
cord-005453-4057qib7	10001	8	)	)	-RRB-
cord-005453-4057qib7	10001	9	has	have	VBZ
cord-005453-4057qib7	10001	10	lowered	lower	VBN
cord-005453-4057qib7	10001	11	the	the	DT
cord-005453-4057qib7	10001	12	incidence	incidence	NN
cord-005453-4057qib7	10001	13	of	of	IN
cord-005453-4057qib7	10001	14	CMV	CMV	NNP
cord-005453-4057qib7	10001	15	disease	disease	NN
cord-005453-4057qib7	10001	16	in	in	IN
cord-005453-4057qib7	10001	17	allo	allo	NN
cord-005453-4057qib7	10001	18	-	-	HYPH
cord-005453-4057qib7	10001	19	SCT	sct	NN
cord-005453-4057qib7	10001	20	to	to	IN
cord-005453-4057qib7	10001	21	5	5	CD
cord-005453-4057qib7	10001	22	-	-	SYM
cord-005453-4057qib7	10001	23	10	10	CD
cord-005453-4057qib7	10001	24	%	%	NN
cord-005453-4057qib7	10001	25	.	.	.
cord-005453-4057qib7	10002	1	Nonetheless	nonetheless	RB
cord-005453-4057qib7	10002	2	the	the	DT
cord-005453-4057qib7	10002	3	use	use	NN
cord-005453-4057qib7	10002	4	of	of	IN
cord-005453-4057qib7	10002	5	this	this	DT
cord-005453-4057qib7	10002	6	strategy	strategy	NN
cord-005453-4057qib7	10002	7	implies	imply	VBZ
cord-005453-4057qib7	10002	8	that	that	IN
cord-005453-4057qib7	10002	9	more	more	JJR
cord-005453-4057qib7	10002	10	than	than	IN
cord-005453-4057qib7	10002	11	50	50	CD
cord-005453-4057qib7	10002	12	%	%	NN
cord-005453-4057qib7	10002	13	of	of	IN
cord-005453-4057qib7	10002	14	seropositive	seropositive	JJ
cord-005453-4057qib7	10002	15	patients	patient	NNS
cord-005453-4057qib7	10002	16	will	will	MD
cord-005453-4057qib7	10002	17	replicate	replicate	VB
cord-005453-4057qib7	10002	18	CMV	CMV	NNP
cord-005453-4057qib7	10002	19	.	.	.
cord-005453-4057qib7	10003	1	Several	several	JJ
cord-005453-4057qib7	10003	2	studies	study	NNS
cord-005453-4057qib7	10003	3	have	have	VBP
cord-005453-4057qib7	10003	4	shown	show	VBN
cord-005453-4057qib7	10003	5	that	that	IN
cord-005453-4057qib7	10003	6	CMV	CMV	NNP
cord-005453-4057qib7	10003	7	replication	replication	NN
cord-005453-4057qib7	10003	8	is	be	VBZ
cord-005453-4057qib7	10003	9	detrimental	detrimental	JJ
cord-005453-4057qib7	10003	10	for	for	IN
cord-005453-4057qib7	10003	11	patient	patient	JJ
cord-005453-4057qib7	10003	12	survival	survival	NN
cord-005453-4057qib7	10003	13	although	although	IN
cord-005453-4057qib7	10003	14	the	the	DT
cord-005453-4057qib7	10003	15	viral	viral	JJ
cord-005453-4057qib7	10003	16	load	load	NN
cord-005453-4057qib7	10003	17	related	relate	VBN
cord-005453-4057qib7	10003	18	to	to	IN
cord-005453-4057qib7	10003	19	this	this	DT
cord-005453-4057qib7	10003	20	bad	bad	JJ
cord-005453-4057qib7	10003	21	outcome	outcome	NN
cord-005453-4057qib7	10003	22	variates	variate	NNS
cord-005453-4057qib7	10003	23	among	among	IN
cord-005453-4057qib7	10003	24	studies	study	NNS
cord-005453-4057qib7	10003	25	.	.	.
cord-005453-4057qib7	10004	1	Objective	objective	NN
cord-005453-4057qib7	10004	2	:	:	:
cord-005453-4057qib7	10005	1	To	to	TO
cord-005453-4057qib7	10005	2	analyse	analyse	VB
cord-005453-4057qib7	10005	3	thel	thel	NNP
cord-005453-4057qib7	10005	4	impact	impact	NN
cord-005453-4057qib7	10005	5	of	of	IN
cord-005453-4057qib7	10005	6	CMV	CMV	NNP
cord-005453-4057qib7	10005	7	replication	replication	NN
cord-005453-4057qib7	10005	8	in	in	IN
cord-005453-4057qib7	10005	9	overall	overall	JJ
cord-005453-4057qib7	10005	10	survival	survival	NN
cord-005453-4057qib7	10005	11	(	(	-LRB-
cord-005453-4057qib7	10005	12	OS	OS	NNP
cord-005453-4057qib7	10005	13	)	)	-RRB-
cord-005453-4057qib7	10005	14	in	in	IN
cord-005453-4057qib7	10005	15	allo	allo	NN
cord-005453-4057qib7	10005	16	-	-	HYPH
cord-005453-4057qib7	10005	17	HCT	hct	NN
cord-005453-4057qib7	10005	18	patients	patient	NNS
cord-005453-4057qib7	10005	19	.	.	.
cord-005453-4057qib7	10006	1	Methods	method	NNS
cord-005453-4057qib7	10006	2	:	:	:
cord-005453-4057qib7	10006	3	To	to	TO
cord-005453-4057qib7	10006	4	analyse	analyse	VB
cord-005453-4057qib7	10006	5	the	the	DT
cord-005453-4057qib7	10006	6	impact	impact	NN
cord-005453-4057qib7	10006	7	of	of	IN
cord-005453-4057qib7	10006	8	CMV	CMV	NNP
cord-005453-4057qib7	10006	9	replication	replication	NN
cord-005453-4057qib7	10006	10	in	in	IN
cord-005453-4057qib7	10006	11	OS	OS	NNP
cord-005453-4057qib7	10006	12	we	-PRON-	PRP
cord-005453-4057qib7	10006	13	perform	perform	VBP
cord-005453-4057qib7	10006	14	a	a	DT
cord-005453-4057qib7	10006	15	unicentric	unicentric	JJ
cord-005453-4057qib7	10006	16	,	,	,
cord-005453-4057qib7	10006	17	retrospective	retrospective	JJ
cord-005453-4057qib7	10006	18	study	study	NN
cord-005453-4057qib7	10006	19	on	on	IN
cord-005453-4057qib7	10006	20	117	117	CD
cord-005453-4057qib7	10006	21	consecutive	consecutive	JJ
cord-005453-4057qib7	10006	22	first	first	JJ
cord-005453-4057qib7	10006	23	allo	allo	NN
cord-005453-4057qib7	10006	24	-	-	HYPH
cord-005453-4057qib7	10006	25	HSCT	HSCT	NNP
cord-005453-4057qib7	10006	26	patients	patient	NNS
cord-005453-4057qib7	10006	27	transplanted	transplant	VBN
cord-005453-4057qib7	10006	28	between	between	IN
cord-005453-4057qib7	10006	29	Jan-2015	Jan-2015	NNP
cord-005453-4057qib7	10006	30	and	and	CC
cord-005453-4057qib7	10006	31	Oct-2018	Oct-2018	NNP
cord-005453-4057qib7	10006	32	with	with	IN
cord-005453-4057qib7	10006	33	a	a	DT
cord-005453-4057qib7	10006	34	median	median	JJ
cord-005453-4057qib7	10006	35	follow	follow	NN
cord-005453-4057qib7	10006	36	-	-	HYPH
cord-005453-4057qib7	10006	37	up	up	NN
cord-005453-4057qib7	10006	38	of	of	IN
cord-005453-4057qib7	10006	39	398	398	CD
cord-005453-4057qib7	10006	40	days	day	NNS
cord-005453-4057qib7	10006	41	(	(	-LRB-
cord-005453-4057qib7	10006	42	5	5	CD
cord-005453-4057qib7	10006	43	-	-	SYM
cord-005453-4057qib7	10006	44	1266	1266	CD
cord-005453-4057qib7	10006	45	)	)	-RRB-
cord-005453-4057qib7	10006	46	.	.	.
cord-005453-4057qib7	10007	1	All	all	DT
cord-005453-4057qib7	10007	2	patients	patient	NNS
cord-005453-4057qib7	10007	3	were	be	VBD
cord-005453-4057qib7	10007	4	monitored	monitor	VBN
cord-005453-4057qib7	10007	5	post	post	JJ
cord-005453-4057qib7	10007	6	-	-	JJ
cord-005453-4057qib7	10007	7	HCT	hct	NN
cord-005453-4057qib7	10007	8	with	with	IN
cord-005453-4057qib7	10007	9	real	real	JJ
cord-005453-4057qib7	10007	10	time	time	NN
cord-005453-4057qib7	10008	1	PCR	PCR	NNP
cord-005453-4057qib7	10008	2	Cobas	Cobas	NNP
cord-005453-4057qib7	10008	3	-	-	HYPH
cord-005453-4057qib7	10008	4	Taqman	Taqman	NNP
cord-005453-4057qib7	10008	5	®	®	.
cord-005453-4057qib7	10008	6	/Cobas6800	/cobas6800	XX
cord-005453-4057qib7	10008	7	®	®	:
cord-005453-4057qib7	10008	8	(	(	-LRB-
cord-005453-4057qib7	10008	9	rtPCR	rtpcr	XX
cord-005453-4057qib7	10008	10	)	)	-RRB-
cord-005453-4057qib7	10009	1	in	in	IN
cord-005453-4057qib7	10009	2	plasma	plasma	NN
cord-005453-4057qib7	10009	3	.	.	.
cord-005453-4057qib7	10010	1	The	the	DT
cord-005453-4057qib7	10010	2	cut	cut	NN
cord-005453-4057qib7	10010	3	-	-	HYPH
cord-005453-4057qib7	10010	4	off	off	NN
cord-005453-4057qib7	10010	5	for	for	IN
cord-005453-4057qib7	10010	6	inception	inception	NN
cord-005453-4057qib7	10010	7	of	of	IN
cord-005453-4057qib7	10010	8	PET	PET	NNP
cord-005453-4057qib7	10010	9	was	be	VBD
cord-005453-4057qib7	10010	10	150	150	CD
cord-005453-4057qib7	10010	11	IU	IU	NNP
cord-005453-4057qib7	10010	12	/	/	,
cord-005453-4057qib7	10010	13	ml	ml	NN
cord-005453-4057qib7	10010	14	.	.	.
cord-005453-4057qib7	10011	1	CMV	CMV	NNP
cord-005453-4057qib7	10011	2	mutations	mutation	NNS
cord-005453-4057qib7	10012	1	(	(	-LRB-
cord-005453-4057qib7	10012	2	UL54	UL54	NNP
cord-005453-4057qib7	10012	3	/	/	SYM
cord-005453-4057qib7	10012	4	UL97gene	UL97gene	NNP
cord-005453-4057qib7	10012	5	)	)	-RRB-
cord-005453-4057qib7	10012	6	,	,	,
cord-005453-4057qib7	10012	7	were	be	VBD
cord-005453-4057qib7	10012	8	studied	study	VBN
cord-005453-4057qib7	10012	9	in	in	IN
cord-005453-4057qib7	10012	10	plasma	plasma	NN
cord-005453-4057qib7	10012	11	samples	sample	NNS
cord-005453-4057qib7	10012	12	by	by	IN
cord-005453-4057qib7	10012	13	Sanger	Sanger	NNP
cord-005453-4057qib7	10012	14	sequencing	sequencing	NN
cord-005453-4057qib7	10012	15	,	,	,
cord-005453-4057qib7	10012	16	median	median	JJ
cord-005453-4057qib7	10012	17	CMV	CMV	NNP
cord-005453-4057qib7	10012	18	Viral	Viral	NNP
cord-005453-4057qib7	10012	19	load	load	NN
cord-005453-4057qib7	10012	20	3130	3130	CD
cord-005453-4057qib7	10012	21	IU	IU	NNP
cord-005453-4057qib7	10012	22	/	/	SYM
cord-005453-4057qib7	10012	23	ml	ml	NN
cord-005453-4057qib7	10012	24	(	(	-LRB-
cord-005453-4057qib7	10012	25	565	565	CD
cord-005453-4057qib7	10012	26	-	-	SYM
cord-005453-4057qib7	10012	27	23900	23900	CD
cord-005453-4057qib7	10012	28	)	)	-RRB-
cord-005453-4057qib7	10012	29	.	.	.
cord-005453-4057qib7	10013	1	Results	result	NNS
cord-005453-4057qib7	10013	2	:	:	:
cord-005453-4057qib7	10013	3	Patients	patient	NNS
cord-005453-4057qib7	10013	4	(	(	-LRB-
cord-005453-4057qib7	10013	5	117	117	CD
cord-005453-4057qib7	10013	6	)	)	-RRB-
cord-005453-4057qib7	10013	7	:	:	:
cord-005453-4057qib7	10013	8	women	woman	NNS
cord-005453-4057qib7	10013	9	/	/	SYM
cord-005453-4057qib7	10013	10	men	man	NNS
cord-005453-4057qib7	10013	11	(	(	-LRB-
cord-005453-4057qib7	10013	12	49%/51	49%/51	CD
cord-005453-4057qib7	10013	13	%	%	NN
cord-005453-4057qib7	10013	14	)	)	-RRB-
cord-005453-4057qib7	10014	1	,	,	,
cord-005453-4057qib7	10014	2	median	median	JJ
cord-005453-4057qib7	10014	3	age	age	NN
cord-005453-4057qib7	10014	4	was	be	VBD
cord-005453-4057qib7	10014	5	55	55	CD
cord-005453-4057qib7	10014	6	years	year	NNS
cord-005453-4057qib7	10015	1	(	(	-LRB-
cord-005453-4057qib7	10015	2	range	range	NNP
cord-005453-4057qib7	10015	3	18	18	CD
cord-005453-4057qib7	10015	4	-	-	SYM
cord-005453-4057qib7	10015	5	71	71	CD
cord-005453-4057qib7	10015	6	)	)	-RRB-
cord-005453-4057qib7	10015	7	.	.	.
cord-005453-4057qib7	10016	1	101	101	CD
cord-005453-4057qib7	10016	2	identical	identical	JJ
cord-005453-4057qib7	10016	3	allogeneic	allogeneic	IN
cord-005453-4057qib7	10016	4	SCTs	sct	NNS
cord-005453-4057qib7	10016	5	(	(	-LRB-
cord-005453-4057qib7	10016	6	86	86	CD
cord-005453-4057qib7	10016	7	%	%	NN
cord-005453-4057qib7	10016	8	)	)	-RRB-
cord-005453-4057qib7	10016	9	,	,	,
cord-005453-4057qib7	10016	10	16	16	CD
cord-005453-4057qib7	10016	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10016	12	SCTs	sct	NNS
cord-005453-4057qib7	10016	13	(	(	-LRB-
cord-005453-4057qib7	10016	14	14	14	CD
cord-005453-4057qib7	10016	15	%	%	NN
cord-005453-4057qib7	10016	16	)	)	-RRB-
cord-005453-4057qib7	10016	17	.	.	.
cord-005453-4057qib7	10017	1	Donors	donor	NNS
cord-005453-4057qib7	10017	2	were	be	VBD
cord-005453-4057qib7	10017	3	related	relate	VBN
cord-005453-4057qib7	10017	4	in	in	IN
cord-005453-4057qib7	10017	5	60	60	CD
cord-005453-4057qib7	10017	6	cases	case	NNS
cord-005453-4057qib7	10017	7	(	(	-LRB-
cord-005453-4057qib7	10017	8	51	51	CD
cord-005453-4057qib7	10017	9	%	%	NN
cord-005453-4057qib7	10017	10	)	)	-RRB-
cord-005453-4057qib7	10017	11	and	and	CC
cord-005453-4057qib7	10017	12	57	57	CD
cord-005453-4057qib7	10017	13	(	(	-LRB-
cord-005453-4057qib7	10017	14	49	49	CD
cord-005453-4057qib7	10017	15	%	%	NN
cord-005453-4057qib7	10017	16	)	)	-RRB-
cord-005453-4057qib7	10017	17	unrelated	unrelated	JJ
cord-005453-4057qib7	10017	18	.	.	.
cord-005453-4057qib7	10018	1	Progenitors	progenitor	NNS
cord-005453-4057qib7	10018	2	source	source	NN
cord-005453-4057qib7	10018	3	was	be	VBD
cord-005453-4057qib7	10018	4	98	98	CD
cord-005453-4057qib7	10018	5	%	%	NN
cord-005453-4057qib7	10018	6	peripheral	peripheral	JJ
cord-005453-4057qib7	10018	7	blood	blood	NN
cord-005453-4057qib7	10018	8	and	and	CC
cord-005453-4057qib7	10018	9	2	2	CD
cord-005453-4057qib7	10018	10	%	%	NN
cord-005453-4057qib7	10018	11	bone	bone	NN
cord-005453-4057qib7	10018	12	marrow	marrow	NN
cord-005453-4057qib7	10018	13	.	.	.
cord-005453-4057qib7	10019	1	CMV	CMV	NNP
cord-005453-4057qib7	10019	2	status	status	NN
cord-005453-4057qib7	10019	3	was	be	VBD
cord-005453-4057qib7	10019	4	(	(	-LRB-
cord-005453-4057qib7	10019	5	D+/R+	D+/R+	NNP
cord-005453-4057qib7	10019	6	)	)	-RRB-
cord-005453-4057qib7	10019	7	in	in	IN
cord-005453-4057qib7	10019	8	51%(n=60	51%(n=60	CD
cord-005453-4057qib7	10019	9	)	)	-RRB-
cord-005453-4057qib7	10019	10	,	,	,
cord-005453-4057qib7	10019	11	(	(	-LRB-
cord-005453-4057qib7	10019	12	D+/R-	D+/R-	NNP
cord-005453-4057qib7	10019	13	)	)	-RRB-
cord-005453-4057qib7	10019	14	in	in	IN
cord-005453-4057qib7	10019	15	9%(n=11	9%(n=11	CD
cord-005453-4057qib7	10019	16	)	)	-RRB-
cord-005453-4057qib7	10019	17	,	,	,
cord-005453-4057qib7	10019	18	(	(	-LRB-
cord-005453-4057qib7	10019	19	D-/R+	D-/R+	NNP
cord-005453-4057qib7	10019	20	)	)	-RRB-
cord-005453-4057qib7	10019	21	in	in	IN
cord-005453-4057qib7	10019	22	26	26	CD
cord-005453-4057qib7	10019	23	%	%	NN
cord-005453-4057qib7	10019	24	(	(	-LRB-
cord-005453-4057qib7	10019	25	n=31	n=31	NNP
cord-005453-4057qib7	10019	26	)	)	-RRB-
cord-005453-4057qib7	10019	27	and	and	CC
cord-005453-4057qib7	10019	28	(	(	-LRB-
cord-005453-4057qib7	10019	29	D-/R-	D-/R-	NNP
cord-005453-4057qib7	10019	30	)	)	-RRB-
cord-005453-4057qib7	10019	31	in	in	IN
cord-005453-4057qib7	10019	32	11	11	CD
cord-005453-4057qib7	10019	33	%	%	NN
cord-005453-4057qib7	10019	34	(	(	-LRB-
cord-005453-4057qib7	10019	35	n=13	n=13	NNP
cord-005453-4057qib7	10019	36	)	)	-RRB-
cord-005453-4057qib7	10019	37	,	,	,
cord-005453-4057qib7	10019	38	unknown	unknown	JJ
cord-005453-4057qib7	10019	39	2	2	CD
cord-005453-4057qib7	10019	40	cases	case	NNS
cord-005453-4057qib7	10019	41	.	.	.
cord-005453-4057qib7	10020	1	Positive	positive	JJ
cord-005453-4057qib7	10020	2	PCRs	pcr	NNS
cord-005453-4057qib7	10020	3	were	be	VBD
cord-005453-4057qib7	10020	4	detected	detect	VBN
cord-005453-4057qib7	10020	5	in	in	IN
cord-005453-4057qib7	10020	6	63	63	CD
cord-005453-4057qib7	10020	7	patients	patient	NNS
cord-005453-4057qib7	10020	8	:	:	:
cord-005453-4057qib7	10021	1	one	one	CD
cord-005453-4057qib7	10021	2	episode	episode	NN
cord-005453-4057qib7	10021	3	in	in	IN
cord-005453-4057qib7	10021	4	41	41	CD
cord-005453-4057qib7	10021	5	(	(	-LRB-
cord-005453-4057qib7	10021	6	65	65	CD
cord-005453-4057qib7	10021	7	%	%	NN
cord-005453-4057qib7	10021	8	)	)	-RRB-
cord-005453-4057qib7	10021	9	;	;	:
cord-005453-4057qib7	10021	10	2	2	CD
cord-005453-4057qib7	10021	11	episodes	episode	NNS
cord-005453-4057qib7	10021	12	in	in	IN
cord-005453-4057qib7	10021	13	15(24	15(24	CD
cord-005453-4057qib7	10021	14	%	%	NN
cord-005453-4057qib7	10021	15	)	)	-RRB-
cord-005453-4057qib7	10021	16	and	and	CC
cord-005453-4057qib7	10021	17	3	3	CD
cord-005453-4057qib7	10021	18	to	to	TO
cord-005453-4057qib7	10021	19	5	5	CD
cord-005453-4057qib7	10021	20	episodes	episode	NNS
cord-005453-4057qib7	10021	21	in	in	IN
cord-005453-4057qib7	10021	22	7	7	CD
cord-005453-4057qib7	10021	23	patients	patient	NNS
cord-005453-4057qib7	10021	24	(	(	-LRB-
cord-005453-4057qib7	10021	25	11	11	CD
cord-005453-4057qib7	10021	26	%	%	NN
cord-005453-4057qib7	10021	27	)	)	-RRB-
cord-005453-4057qib7	10021	28	.	.	.
cord-005453-4057qib7	10022	1	Fifty	fifty	CD
cord-005453-4057qib7	10022	2	-	-	HYPH
cord-005453-4057qib7	10022	3	five	five	CD
cord-005453-4057qib7	10022	4	patients	patient	NNS
cord-005453-4057qib7	10022	5	(	(	-LRB-
cord-005453-4057qib7	10022	6	87	87	CD
cord-005453-4057qib7	10022	7	%	%	NN
cord-005453-4057qib7	10022	8	)	)	-RRB-
cord-005453-4057qib7	10022	9	received	receive	VBD
cord-005453-4057qib7	10022	10	preemptive	preemptive	JJ
cord-005453-4057qib7	10022	11	therapy	therapy	NN
cord-005453-4057qib7	10022	12	.	.	.
cord-005453-4057qib7	10023	1	Fourteen	fourteen	CD
cord-005453-4057qib7	10023	2	episodes	episode	NNS
cord-005453-4057qib7	10023	3	(	(	-LRB-
cord-005453-4057qib7	10023	4	25	25	CD
cord-005453-4057qib7	10023	5	%	%	NN
cord-005453-4057qib7	10023	6	)	)	-RRB-
cord-005453-4057qib7	10023	7	were	be	VBD
cord-005453-4057qib7	10023	8	refractory/	refractory/	CD
cord-005453-4057qib7	10023	9	probable	probable	JJ
cord-005453-4057qib7	10023	10	refractory	refractory	JJ
cord-005453-4057qib7	10023	11	CMV	CMV	NNP
cord-005453-4057qib7	10023	12	infections	infection	NNS
cord-005453-4057qib7	10023	13	(	(	-LRB-
cord-005453-4057qib7	10023	14	according	accord	VBG
cord-005453-4057qib7	10023	15	to	to	IN
cord-005453-4057qib7	10023	16	the	the	DT
cord-005453-4057qib7	10023	17	criteria	criterion	NNS
cord-005453-4057qib7	10023	18	of	of	IN
cord-005453-4057qib7	10023	19	Chemaly	Chemaly	NNP
cord-005453-4057qib7	10023	20	R.	R.	NNP
cord-005453-4057qib7	10023	21	CID	CID	NNP
cord-005453-4057qib7	10023	22	2018	2018	CD
cord-005453-4057qib7	10023	23	)	)	-RRB-
cord-005453-4057qib7	10023	24	.	.	.
cord-005453-4057qib7	10024	1	A	a	DT
cord-005453-4057qib7	10024	2	resistant	resistant	JJ
cord-005453-4057qib7	10024	3	mutation	mutation	NN
cord-005453-4057qib7	10025	1	(	(	-LRB-
cord-005453-4057qib7	10025	2	UL54	UL54	NNP
cord-005453-4057qib7	10025	3	gene	gene	NN
cord-005453-4057qib7	10025	4	)	)	-RRB-
cord-005453-4057qib7	10025	5	was	be	VBD
cord-005453-4057qib7	10025	6	detected	detect	VBN
cord-005453-4057qib7	10025	7	in	in	IN
cord-005453-4057qib7	10025	8	one	one	CD
cord-005453-4057qib7	10025	9	patient	patient	NN
cord-005453-4057qib7	10025	10	with	with	IN
cord-005453-4057qib7	10025	11	refractory	refractory	JJ
cord-005453-4057qib7	10025	12	infection	infection	NN
cord-005453-4057qib7	10025	13	Patients	patient	NNS
cord-005453-4057qib7	10025	14	that	that	WDT
cord-005453-4057qib7	10025	15	developed	develop	VBD
cord-005453-4057qib7	10025	16	CMV	CMV	NNP
cord-005453-4057qib7	10025	17	infection	infection	NN
cord-005453-4057qib7	10025	18	had	have	VBD
cord-005453-4057qib7	10025	19	an	an	DT
cord-005453-4057qib7	10025	20	inferior	inferior	JJ
cord-005453-4057qib7	10025	21	non	non	JJ
cord-005453-4057qib7	10025	22	-	-	JJ
cord-005453-4057qib7	10025	23	significant	significant	JJ
cord-005453-4057qib7	10025	24	OS	os	NN
cord-005453-4057qib7	10025	25	at	at	IN
cord-005453-4057qib7	10025	26	3	3	CD
cord-005453-4057qib7	10025	27	years	year	NNS
cord-005453-4057qib7	10025	28	(	(	-LRB-
cord-005453-4057qib7	10025	29	61,3	61,3	CD
cord-005453-4057qib7	10025	30	%	%	NN
cord-005453-4057qib7	10025	31	VS	VS	NNP
cord-005453-4057qib7	10025	32	76,8	76,8	CD
cord-005453-4057qib7	10025	33	%	%	NN
cord-005453-4057qib7	10025	34	Log	log	JJ
cord-005453-4057qib7	10025	35	-	-	HYPH
cord-005453-4057qib7	10025	36	rank	rank	NN
cord-005453-4057qib7	10025	37	P	p	NN
cord-005453-4057qib7	10025	38	0,346	0,346	CD
cord-005453-4057qib7	10025	39	)	)	-RRB-
cord-005453-4057qib7	10025	40	.	.	.
cord-005453-4057qib7	10026	1	Those	those	DT
cord-005453-4057qib7	10026	2	patients	patient	NNS
cord-005453-4057qib7	10026	3	that	that	WDT
cord-005453-4057qib7	10026	4	received	receive	VBD
cord-005453-4057qib7	10026	5	PET	pet	NN
cord-005453-4057qib7	10026	6	for	for	IN
cord-005453-4057qib7	10026	7	CMV	CMV	NNP
cord-005453-4057qib7	10026	8	had	have	VBD
cord-005453-4057qib7	10026	9	a	a	DT
cord-005453-4057qib7	10026	10	significant	significant	JJ
cord-005453-4057qib7	10026	11	inferior	inferior	JJ
cord-005453-4057qib7	10026	12	OS	os	NN
cord-005453-4057qib7	10026	13	compared	compare	VBN
cord-005453-4057qib7	10026	14	with	with	IN
cord-005453-4057qib7	10026	15	those	those	DT
cord-005453-4057qib7	10026	16	that	that	WDT
cord-005453-4057qib7	10026	17	replicate	replicate	VBP
cord-005453-4057qib7	10026	18	CMV	CMV	NNP
cord-005453-4057qib7	10026	19	but	but	CC
cord-005453-4057qib7	10026	20	did	do	VBD
cord-005453-4057qib7	10026	21	n't	not	RB
cord-005453-4057qib7	10026	22	receive	receive	VB
cord-005453-4057qib7	10026	23	preemptive	preemptive	JJ
cord-005453-4057qib7	10026	24	therapy	therapy	NN
cord-005453-4057qib7	10026	25	(	(	-LRB-
cord-005453-4057qib7	10027	1	55,6	55,6	CD
cord-005453-4057qib7	10027	2	%	%	NN
cord-005453-4057qib7	10027	3	vs	vs	IN
cord-005453-4057qib7	10027	4	100	100	CD
cord-005453-4057qib7	10027	5	%	%	NN
cord-005453-4057qib7	10027	6	,	,	,
cord-005453-4057qib7	10027	7	Log	Log	NNP
cord-005453-4057qib7	10027	8	rank	rank	NN
cord-005453-4057qib7	10027	9	p=0.04	p=0.04	NN
cord-005453-4057qib7	10027	10	)	)	-RRB-
cord-005453-4057qib7	10027	11	.	.	.
cord-005453-4057qib7	10028	1	OS	os	NN
cord-005453-4057qib7	10028	2	of	of	IN
cord-005453-4057qib7	10028	3	patients	patient	NNS
cord-005453-4057qib7	10028	4	that	that	WDT
cord-005453-4057qib7	10028	5	received	receive	VBD
cord-005453-4057qib7	10028	6	PET	PET	NNP
cord-005453-4057qib7	10028	7	was	be	VBD
cord-005453-4057qib7	10028	8	inferior	inferior	JJ
cord-005453-4057qib7	10028	9	compared	compare	VBN
cord-005453-4057qib7	10028	10	with	with	IN
cord-005453-4057qib7	10028	11	those	those	DT
cord-005453-4057qib7	10028	12	without	without	IN
cord-005453-4057qib7	10028	13	PET	pet	NN
cord-005453-4057qib7	10028	14	(	(	-LRB-
cord-005453-4057qib7	10028	15	with	with	IN
cord-005453-4057qib7	10028	16	or	or	CC
cord-005453-4057qib7	10028	17	without	without	IN
cord-005453-4057qib7	10028	18	infection	infection	NN
cord-005453-4057qib7	10028	19	)	)	-RRB-
cord-005453-4057qib7	10028	20	(	(	-LRB-
cord-005453-4057qib7	10028	21	55,6	55,6	CD
cord-005453-4057qib7	10028	22	%	%	NN
cord-005453-4057qib7	10028	23	VS	VS	NNP
cord-005453-4057qib7	10028	24	79,9	79,9	CD
cord-005453-4057qib7	10028	25	%	%	NN
cord-005453-4057qib7	10028	26	,	,	,
cord-005453-4057qib7	10028	27	Logrank	Logrank	NNP
cord-005453-4057qib7	10028	28	P	P	NNP
cord-005453-4057qib7	10028	29	0,05	0,05	NN
cord-005453-4057qib7	10028	30	)	)	-RRB-
cord-005453-4057qib7	10028	31	.	.	.
cord-005453-4057qib7	10029	1	No	no	DT
cord-005453-4057qib7	10029	2	difference	difference	NN
cord-005453-4057qib7	10029	3	in	in	IN
cord-005453-4057qib7	10029	4	survival	survival	NN
cord-005453-4057qib7	10029	5	was	be	VBD
cord-005453-4057qib7	10029	6	found	find	VBN
cord-005453-4057qib7	10029	7	for	for	IN
cord-005453-4057qib7	10029	8	those	those	DT
cord-005453-4057qib7	10029	9	patients	patient	NNS
cord-005453-4057qib7	10029	10	treated	treat	VBN
cord-005453-4057qib7	10029	11	pre	pre	JJ
cord-005453-4057qib7	10029	12	-	-	JJ
cord-005453-4057qib7	10029	13	emptively	emptively	RB
cord-005453-4057qib7	10029	14	that	that	WDT
cord-005453-4057qib7	10029	15	were	be	VBD
cord-005453-4057qib7	10029	16	refractory	refractory	JJ
cord-005453-4057qib7	10029	17	vs	vs	IN
cord-005453-4057qib7	10029	18	no	no	DT
cord-005453-4057qib7	10029	19	refractory	refractory	NN
cord-005453-4057qib7	10029	20	(	(	-LRB-
cord-005453-4057qib7	10029	21	53	53	CD
cord-005453-4057qib7	10029	22	%	%	NN
cord-005453-4057qib7	10029	23	vs	vs	IN
cord-005453-4057qib7	10029	24	57,1	57,1	CD
cord-005453-4057qib7	10029	25	%	%	NN
cord-005453-4057qib7	10029	26	,	,	,
cord-005453-4057qib7	10029	27	Log	log	JJ
cord-005453-4057qib7	10029	28	-	-	HYPH
cord-005453-4057qib7	10029	29	rank	rank	NN
cord-005453-4057qib7	10029	30	P	p	NN
cord-005453-4057qib7	10029	31	0,51	0,51	CD
cord-005453-4057qib7	10029	32	)	)	-RRB-
cord-005453-4057qib7	10029	33	.	.	.
cord-005453-4057qib7	10030	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10030	2	:	:	:
cord-005453-4057qib7	10031	1	Patients	patient	NNS
cord-005453-4057qib7	10031	2	that	that	WDT
cord-005453-4057qib7	10031	3	received	receive	VBD
cord-005453-4057qib7	10031	4	preemptive	preemptive	JJ
cord-005453-4057qib7	10031	5	therapy	therapy	NN
cord-005453-4057qib7	10031	6	had	have	VBD
cord-005453-4057qib7	10031	7	a	a	DT
cord-005453-4057qib7	10031	8	significant	significant	JJ
cord-005453-4057qib7	10031	9	inferior	inferior	JJ
cord-005453-4057qib7	10031	10	overall	overall	JJ
cord-005453-4057qib7	10031	11	survival	survival	NN
cord-005453-4057qib7	10031	12	compared	compare	VBN
cord-005453-4057qib7	10031	13	with	with	IN
cord-005453-4057qib7	10031	14	those	those	DT
cord-005453-4057qib7	10031	15	that	that	WDT
cord-005453-4057qib7	10031	16	didn´t	didn´t	TO
cord-005453-4057qib7	10031	17	replicate	replicate	VB
cord-005453-4057qib7	10031	18	and	and	CC
cord-005453-4057qib7	10031	19	those	those	DT
cord-005453-4057qib7	10031	20	that	that	WDT
cord-005453-4057qib7	10031	21	replicate	replicate	VBP
cord-005453-4057qib7	10031	22	CMV	CMV	NNP
cord-005453-4057qib7	10031	23	but	but	CC
cord-005453-4057qib7	10031	24	did	do	VBD
cord-005453-4057qib7	10031	25	n't	not	RB
cord-005453-4057qib7	10031	26	receive	receive	VB
cord-005453-4057qib7	10031	27	preemptive	preemptive	JJ
cord-005453-4057qib7	10031	28	therapy	therapy	NN
cord-005453-4057qib7	10031	29	.	.	.
cord-005453-4057qib7	10032	1	This	this	DT
cord-005453-4057qib7	10032	2	reinforce	reinforce	VB
cord-005453-4057qib7	10032	3	the	the	DT
cord-005453-4057qib7	10032	4	relevance	relevance	NN
cord-005453-4057qib7	10032	5	of	of	IN
cord-005453-4057qib7	10032	6	prophylactic	prophylactic	JJ
cord-005453-4057qib7	10032	7	strategies	strategy	NNS
cord-005453-4057qib7	10032	8	for	for	IN
cord-005453-4057qib7	10032	9	CMV	CMV	NNP
cord-005453-4057qib7	10032	10	with	with	IN
cord-005453-4057qib7	10032	11	drugs	drug	NNS
cord-005453-4057qib7	10032	12	with	with	IN
cord-005453-4057qib7	10032	13	good	good	JJ
cord-005453-4057qib7	10032	14	safety	safety	NN
cord-005453-4057qib7	10032	15	profile	profile	NN
cord-005453-4057qib7	10032	16	like	like	IN
cord-005453-4057qib7	10032	17	letermovir	letermovir	NNS
cord-005453-4057qib7	10032	18	that	that	IN
cord-005453-4057qib7	10032	19	in	in	IN
cord-005453-4057qib7	10032	20	a	a	DT
cord-005453-4057qib7	10032	21	randomised	randomised	JJ
cord-005453-4057qib7	10032	22	trial	trial	NN
cord-005453-4057qib7	10032	23	proved	prove	VBD
cord-005453-4057qib7	10032	24	to	to	TO
cord-005453-4057qib7	10032	25	decrease	decrease	VB
cord-005453-4057qib7	10032	26	the	the	DT
cord-005453-4057qib7	10032	27	need	need	NN
cord-005453-4057qib7	10032	28	for	for	IN
cord-005453-4057qib7	10032	29	preemptive	preemptive	JJ
cord-005453-4057qib7	10032	30	therapy	therapy	NN
cord-005453-4057qib7	10032	31	.	.	.
cord-005453-4057qib7	10033	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10033	2	:	:	:
cord-005453-4057qib7	10033	3	Rafael	Rafael	NNP
cord-005453-4057qib7	10033	4	,	,	,
cord-005453-4057qib7	10033	5	de	de	FW
cord-005453-4057qib7	10033	6	la	la	NNP
cord-005453-4057qib7	10033	7	Camara	Camara	NNP
cord-005453-4057qib7	10033	8	:	:	:
cord-005453-4057qib7	10033	9	has	have	VBZ
cord-005453-4057qib7	10033	10	received	receive	VBN
cord-005453-4057qib7	10033	11	grants	grant	NNS
cord-005453-4057qib7	10033	12	from	from	IN
cord-005453-4057qib7	10033	13	Astellas	Astellas	NNP
cord-005453-4057qib7	10033	14	,	,	,
cord-005453-4057qib7	10033	15	Gilead	Gilead	NNP
cord-005453-4057qib7	10033	16	,	,	,
cord-005453-4057qib7	10033	17	Janssen	Janssen	NNP
cord-005453-4057qib7	10033	18	,	,	,
cord-005453-4057qib7	10033	19	Merck	Merck	NNP
cord-005453-4057qib7	10033	20	,	,	,
cord-005453-4057qib7	10033	21	Novartis	Novartis	NNP
cord-005453-4057qib7	10033	22	and	and	CC
cord-005453-4057qib7	10033	23	Pfizer	Pfizer	NNP
cord-005453-4057qib7	10033	24	Clinical	Clinical	NNP
cord-005453-4057qib7	10033	25	evaluation	evaluation	NN
cord-005453-4057qib7	10033	26	of	of	IN
cord-005453-4057qib7	10033	27	stenotrophomonas	stenotrophomonas	NNP
cord-005453-4057qib7	10033	28	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10033	29	infection	infection	NN
cord-005453-4057qib7	10033	30	in	in	IN
cord-005453-4057qib7	10033	31	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10033	32	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10033	33	stem	stem	NN
cord-005453-4057qib7	10033	34	cell	cell	NN
cord-005453-4057qib7	10033	35	transplant	transplant	NN
cord-005453-4057qib7	10033	36	recipients	recipient	NNS
cord-005453-4057qib7	10033	37	-retrospective	-retrospective	IN
cord-005453-4057qib7	10033	38	single	single	JJ
cord-005453-4057qib7	10033	39	-	-	HYPH
cord-005453-4057qib7	10033	40	center	center	NN
cord-005453-4057qib7	10033	41	data	data	NN
cord-005453-4057qib7	10033	42	analysis	analysis	NN
cord-005453-4057qib7	10033	43	negative	negative	JJ
cord-005453-4057qib7	10033	44	bacillus	bacillus	NN
cord-005453-4057qib7	10033	45	that	that	WDT
cord-005453-4057qib7	10033	46	causes	cause	VBZ
cord-005453-4057qib7	10033	47	severe	severe	JJ
cord-005453-4057qib7	10033	48	infections	infection	NNS
cord-005453-4057qib7	10033	49	associated	associate	VBN
cord-005453-4057qib7	10033	50	with	with	IN
cord-005453-4057qib7	10033	51	high	high	JJ
cord-005453-4057qib7	10033	52	morbidity	morbidity	NN
cord-005453-4057qib7	10033	53	and	and	CC
cord-005453-4057qib7	10033	54	mortality	mortality	NN
cord-005453-4057qib7	10033	55	in	in	IN
cord-005453-4057qib7	10033	56	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	10033	57	patients	patient	NNS
cord-005453-4057qib7	10033	58	.	.	.
cord-005453-4057qib7	10034	1	The	the	DT
cord-005453-4057qib7	10034	2	aim	aim	NN
cord-005453-4057qib7	10034	3	of	of	IN
cord-005453-4057qib7	10034	4	our	-PRON-	PRP$
cord-005453-4057qib7	10034	5	study	study	NN
cord-005453-4057qib7	10034	6	was	be	VBD
cord-005453-4057qib7	10034	7	to	to	TO
cord-005453-4057qib7	10034	8	determine	determine	VB
cord-005453-4057qib7	10034	9	incidence	incidence	NN
cord-005453-4057qib7	10034	10	,	,	,
cord-005453-4057qib7	10034	11	characteristics	characteristic	NNS
cord-005453-4057qib7	10034	12	and	and	CC
cord-005453-4057qib7	10034	13	outcome	outcome	NN
cord-005453-4057qib7	10034	14	of	of	IN
cord-005453-4057qib7	10034	15	S.	S.	NNP
cord-005453-4057qib7	10034	16	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10034	17	infection	infection	NN
cord-005453-4057qib7	10034	18	in	in	IN
cord-005453-4057qib7	10034	19	patients	patient	NNS
cord-005453-4057qib7	10034	20	(	(	-LRB-
cord-005453-4057qib7	10034	21	pts	pts	NN
cord-005453-4057qib7	10034	22	)	)	-RRB-
cord-005453-4057qib7	10034	23	who	who	WP
cord-005453-4057qib7	10034	24	underwent	undergo	VBD
cord-005453-4057qib7	10034	25	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10034	26	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10034	27	stem	stem	NN
cord-005453-4057qib7	10034	28	cell	cell	NN
cord-005453-4057qib7	10034	29	transplantations	transplantation	NNS
cord-005453-4057qib7	10034	30	(	(	-LRB-
cord-005453-4057qib7	10034	31	allo	allo	NN
cord-005453-4057qib7	10034	32	-	-	HYPH
cord-005453-4057qib7	10034	33	HSCT	HSCT	NNP
cord-005453-4057qib7	10034	34	)	)	-RRB-
cord-005453-4057qib7	10034	35	in	in	IN
cord-005453-4057qib7	10034	36	Institute	Institute	NNP
cord-005453-4057qib7	10034	37	of	of	IN
cord-005453-4057qib7	10034	38	Hematology	Hematology	NNP
cord-005453-4057qib7	10034	39	and	and	CC
cord-005453-4057qib7	10034	40	Transfusion	Transfusion	NNP
cord-005453-4057qib7	10034	41	Medicine	Medicine	NNP
cord-005453-4057qib7	10034	42	between	between	IN
cord-005453-4057qib7	10034	43	October	October	NNP
cord-005453-4057qib7	10034	44	2010	2010	CD
cord-005453-4057qib7	10034	45	and	and	CC
cord-005453-4057qib7	10034	46	November	November	NNP
cord-005453-4057qib7	10034	47	2018	2018	CD
cord-005453-4057qib7	10034	48	.	.	.
cord-005453-4057qib7	10035	1	Methods	method	NNS
cord-005453-4057qib7	10035	2	:	:	:
cord-005453-4057qib7	10035	3	We	-PRON-	PRP
cord-005453-4057qib7	10035	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	10035	5	evaluated	evaluate	VBD
cord-005453-4057qib7	10035	6	incidence	incidence	NN
cord-005453-4057qib7	10035	7	,	,	,
cord-005453-4057qib7	10035	8	clinical	clinical	JJ
cord-005453-4057qib7	10035	9	features	feature	NNS
cord-005453-4057qib7	10035	10	and	and	CC
cord-005453-4057qib7	10035	11	outcome	outcome	NN
cord-005453-4057qib7	10035	12	of	of	IN
cord-005453-4057qib7	10035	13	S.	S.	NNP
cord-005453-4057qib7	10035	14	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10035	15	infections	infection	NNS
cord-005453-4057qib7	10035	16	in	in	IN
cord-005453-4057qib7	10035	17	338	338	CD
cord-005453-4057qib7	10035	18	consecutive	consecutive	JJ
cord-005453-4057qib7	10035	19	patients	patient	NNS
cord-005453-4057qib7	10035	20	with	with	IN
cord-005453-4057qib7	10035	21	median	median	JJ
cord-005453-4057qib7	10035	22	age-42	age-42	NN
cord-005453-4057qib7	10035	23	years	year	NNS
cord-005453-4057qib7	10035	24	(	(	-LRB-
cord-005453-4057qib7	10035	25	range	range	VBP
cord-005453-4057qib7	10035	26	19	19	CD
cord-005453-4057qib7	10035	27	-	-	SYM
cord-005453-4057qib7	10035	28	71	71	CD
cord-005453-4057qib7	10035	29	)	)	-RRB-
cord-005453-4057qib7	10035	30	,	,	,
cord-005453-4057qib7	10035	31	who	who	WP
cord-005453-4057qib7	10035	32	underwent	undergo	VBD
cord-005453-4057qib7	10035	33	allo	allo	NN
cord-005453-4057qib7	10035	34	-	-	HYPH
cord-005453-4057qib7	10035	35	HSCT	HSCT	NNP
cord-005453-4057qib7	10035	36	from	from	IN
cord-005453-4057qib7	10035	37	unrelated	unrelated	JJ
cord-005453-4057qib7	10035	38	donors	donor	NNS
cord-005453-4057qib7	10035	39	-238	-238	JJ
cord-005453-4057qib7	10035	40	(	(	-LRB-
cord-005453-4057qib7	10035	41	70.4	70.4	CD
cord-005453-4057qib7	10035	42	%	%	NN
cord-005453-4057qib7	10035	43	)	)	-RRB-
cord-005453-4057qib7	10035	44	,	,	,
cord-005453-4057qib7	10035	45	matched	match	VBN
cord-005453-4057qib7	10035	46	sibling	sibling	NN
cord-005453-4057qib7	10035	47	donors	donor	NNS
cord-005453-4057qib7	10035	48	-87	-87	NNP
cord-005453-4057qib7	10035	49	(	(	-LRB-
cord-005453-4057qib7	10035	50	25.7	25.7	CD
cord-005453-4057qib7	10035	51	%	%	NN
cord-005453-4057qib7	10035	52	)	)	-RRB-
cord-005453-4057qib7	10035	53	and	and	CC
cord-005453-4057qib7	10035	54	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10035	55	donors	donor	NNS
cord-005453-4057qib7	10035	56	-13	-13	CD
cord-005453-4057qib7	10035	57	(	(	-LRB-
cord-005453-4057qib7	10035	58	3.9	3.9	CD
cord-005453-4057qib7	10035	59	%	%	NN
cord-005453-4057qib7	10035	60	)	)	-RRB-
cord-005453-4057qib7	10035	61	in	in	IN
cord-005453-4057qib7	10035	62	our	-PRON-	PRP$
cord-005453-4057qib7	10035	63	center	center	NN
cord-005453-4057qib7	10035	64	.	.	.
cord-005453-4057qib7	10036	1	S.	S.	NNP
cord-005453-4057qib7	10036	2	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10036	3	was	be	VBD
cord-005453-4057qib7	10036	4	detected	detect	VBN
cord-005453-4057qib7	10036	5	by	by	IN
cord-005453-4057qib7	10036	6	culture	culture	NN
cord-005453-4057qib7	10036	7	-	-	HYPH
cord-005453-4057qib7	10036	8	based	base	VBN
cord-005453-4057qib7	10036	9	microbiological	microbiological	JJ
cord-005453-4057qib7	10036	10	tests	test	NNS
cord-005453-4057qib7	10036	11	.	.	.
cord-005453-4057qib7	10037	1	Invasive	invasive	JJ
cord-005453-4057qib7	10037	2	infection	infection	NN
cord-005453-4057qib7	10037	3	was	be	VBD
cord-005453-4057qib7	10037	4	defined	define	VBN
cord-005453-4057qib7	10037	5	by	by	IN
cord-005453-4057qib7	10037	6	isolation	isolation	NN
cord-005453-4057qib7	10037	7	S.	S.	NNP
cord-005453-4057qib7	10037	8	maltophilia	maltophilia	NN
cord-005453-4057qib7	10037	9	from	from	IN
cord-005453-4057qib7	10037	10	cultures	culture	NNS
cord-005453-4057qib7	10037	11	in	in	IN
cord-005453-4057qib7	10037	12	the	the	DT
cord-005453-4057qib7	10037	13	presence	presence	NN
cord-005453-4057qib7	10037	14	of	of	IN
cord-005453-4057qib7	10037	15	both	both	DT
cord-005453-4057qib7	10037	16	clinical	clinical	JJ
cord-005453-4057qib7	10037	17	symptoms	symptom	NNS
cord-005453-4057qib7	10037	18	and	and	CC
cord-005453-4057qib7	10037	19	signs	sign	NNS
cord-005453-4057qib7	10037	20	of	of	IN
cord-005453-4057qib7	10037	21	infection	infection	NN
cord-005453-4057qib7	10037	22	-blood	-blood	:
cord-005453-4057qib7	10037	23	stream	stream	NN
cord-005453-4057qib7	10037	24	infection	infection	NN
cord-005453-4057qib7	10037	25	(	(	-LRB-
cord-005453-4057qib7	10037	26	BSI	BSI	NNP
cord-005453-4057qib7	10037	27	)	)	-RRB-
cord-005453-4057qib7	10037	28	,	,	,
cord-005453-4057qib7	10037	29	pneumonia	pneumonia	NN
cord-005453-4057qib7	10037	30	with	with	IN
cord-005453-4057qib7	10037	31	or	or	CC
cord-005453-4057qib7	10037	32	without	without	IN
cord-005453-4057qib7	10037	33	pulmonary	pulmonary	JJ
cord-005453-4057qib7	10037	34	haemorrhage	haemorrhage	NN
cord-005453-4057qib7	10037	35	.	.	.
cord-005453-4057qib7	10038	1	The	the	DT
cord-005453-4057qib7	10038	2	only	only	JJ
cord-005453-4057qib7	10038	3	colonization	colonization	NN
cord-005453-4057qib7	10038	4	status	status	NN
cord-005453-4057qib7	10038	5	was	be	VBD
cord-005453-4057qib7	10038	6	defined	define	VBN
cord-005453-4057qib7	10038	7	as	as	IN
cord-005453-4057qib7	10038	8	S.	S.	NNP
cord-005453-4057qib7	10038	9	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10038	10	culture	culture	NN
cord-005453-4057qib7	10038	11	-	-	HYPH
cord-005453-4057qib7	10038	12	positive	positive	JJ
cord-005453-4057qib7	10038	13	samples	sample	NNS
cord-005453-4057qib7	10038	14	in	in	IN
cord-005453-4057qib7	10038	15	the	the	DT
cord-005453-4057qib7	10038	16	absence	absence	NN
cord-005453-4057qib7	10038	17	of	of	IN
cord-005453-4057qib7	10038	18	infection	infection	NN
cord-005453-4057qib7	10038	19	symptoms	symptom	NNS
cord-005453-4057qib7	10038	20	.	.	.
cord-005453-4057qib7	10039	1	In	in	IN
cord-005453-4057qib7	10039	2	vitro	vitro	FW
cord-005453-4057qib7	10039	3	susceptibility	susceptibility	NN
cord-005453-4057qib7	10039	4	tests	test	NNS
cord-005453-4057qib7	10039	5	to	to	IN
cord-005453-4057qib7	10039	6	antibiotics	antibiotic	NNS
cord-005453-4057qib7	10039	7	were	be	VBD
cord-005453-4057qib7	10039	8	performed	perform	VBN
cord-005453-4057qib7	10039	9	.	.	.
cord-005453-4057qib7	10040	1	Results	result	NNS
cord-005453-4057qib7	10040	2	:	:	:
cord-005453-4057qib7	10040	3	21	21	CD
cord-005453-4057qib7	10040	4	pts	pt	NNS
cord-005453-4057qib7	10040	5	(	(	-LRB-
cord-005453-4057qib7	10040	6	6.2	6.2	CD
cord-005453-4057qib7	10040	7	%	%	NN
cord-005453-4057qib7	10040	8	)	)	-RRB-
cord-005453-4057qib7	10040	9	with	with	IN
cord-005453-4057qib7	10040	10	median	median	JJ
cord-005453-4057qib7	10040	11	age-46	age-46	NN
cord-005453-4057qib7	10040	12	years	year	NNS
cord-005453-4057qib7	10040	13	(	(	-LRB-
cord-005453-4057qib7	10040	14	range	range	VBP
cord-005453-4057qib7	10040	15	19	19	CD
cord-005453-4057qib7	10040	16	-	-	SYM
cord-005453-4057qib7	10040	17	66	66	CD
cord-005453-4057qib7	10040	18	)	)	-RRB-
cord-005453-4057qib7	10040	19	with	with	IN
cord-005453-4057qib7	10040	20	S.maltophilia	s.maltophilia	JJ
cord-005453-4057qib7	10040	21	culture	culture	NN
cord-005453-4057qib7	10040	22	positive	positive	JJ
cord-005453-4057qib7	10040	23	samples	sample	NNS
cord-005453-4057qib7	10040	24	were	be	VBD
cord-005453-4057qib7	10040	25	identified	identify	VBN
cord-005453-4057qib7	10040	26	.	.	.
cord-005453-4057qib7	10041	1	19	19	CD
cord-005453-4057qib7	10041	2	(	(	-LRB-
cord-005453-4057qib7	10041	3	90.5	90.5	CD
cord-005453-4057qib7	10041	4	%	%	NN
cord-005453-4057qib7	10041	5	)	)	-RRB-
cord-005453-4057qib7	10041	6	underwent	undergo	VBD
cord-005453-4057qib7	10041	7	allo	allo	NN
cord-005453-4057qib7	10041	8	-	-	HYPH
cord-005453-4057qib7	10041	9	HSCT	HSCT	NNP
cord-005453-4057qib7	10041	10	from	from	IN
cord-005453-4057qib7	10041	11	unrelated	unrelated	JJ
cord-005453-4057qib7	10041	12	donors	donor	NNS
cord-005453-4057qib7	10041	13	,	,	,
cord-005453-4057qib7	10041	14	1-from	1-from	CD
cord-005453-4057qib7	10041	15	matched	match	VBN
cord-005453-4057qib7	10041	16	sibling	sibling	NN
cord-005453-4057qib7	10041	17	donor	donor	NN
cord-005453-4057qib7	10041	18	and	and	CC
cord-005453-4057qib7	10041	19	1-from	1-from	CD
cord-005453-4057qib7	10041	20	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10041	21	donor	donor	NN
cord-005453-4057qib7	10041	22	.	.	.
cord-005453-4057qib7	10042	1	Among	among	IN
cord-005453-4057qib7	10042	2	them	-PRON-	PRP
cord-005453-4057qib7	10042	3	BSI	BSI	NNP
cord-005453-4057qib7	10042	4	developed	develop	VBD
cord-005453-4057qib7	10042	5	in	in	IN
cord-005453-4057qib7	10042	6	7	7	CD
cord-005453-4057qib7	10042	7	pts	pts	NN
cord-005453-4057qib7	10042	8	(	(	-LRB-
cord-005453-4057qib7	10042	9	33.3	33.3	CD
cord-005453-4057qib7	10042	10	%	%	NN
cord-005453-4057qib7	10042	11	)	)	-RRB-
cord-005453-4057qib7	10042	12	,	,	,
cord-005453-4057qib7	10042	13	pneumonia	pneumonia	NN
cord-005453-4057qib7	10042	14	in	in	IN
cord-005453-4057qib7	10042	15	4	4	CD
cord-005453-4057qib7	10042	16	pts	pt	NNS
cord-005453-4057qib7	10042	17	(	(	-LRB-
cord-005453-4057qib7	10042	18	19	19	CD
cord-005453-4057qib7	10042	19	%	%	NN
cord-005453-4057qib7	10042	20	)	)	-RRB-
cord-005453-4057qib7	10043	1	-with	-with	:
cord-005453-4057qib7	10043	2	fulminant	fulminant	JJ
cord-005453-4057qib7	10043	3	and	and	CC
cord-005453-4057qib7	10043	4	fatal	fatal	JJ
cord-005453-4057qib7	10043	5	pulmonary	pulmonary	JJ
cord-005453-4057qib7	10043	6	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	10043	7	in	in	IN
cord-005453-4057qib7	10043	8	3	3	CD
cord-005453-4057qib7	10043	9	pts	pts	NN
cord-005453-4057qib7	10043	10	(	(	-LRB-
cord-005453-4057qib7	10043	11	14.3	14.3	CD
cord-005453-4057qib7	10043	12	%	%	NN
cord-005453-4057qib7	10043	13	)	)	-RRB-
cord-005453-4057qib7	10043	14	.	.	.
cord-005453-4057qib7	10044	1	All	all	DT
cord-005453-4057qib7	10044	2	patients	patient	NNS
cord-005453-4057qib7	10044	3	with	with	IN
cord-005453-4057qib7	10044	4	pneumonia	pneumonia	NN
cord-005453-4057qib7	10044	5	demonstrated	demonstrate	VBD
cord-005453-4057qib7	10044	6	BSI	BSI	NNP
cord-005453-4057qib7	10044	7	.	.	.
cord-005453-4057qib7	10045	1	Positive	positive	JJ
cord-005453-4057qib7	10045	2	sputum	sputum	NN
cord-005453-4057qib7	10045	3	cultures	culture	NNS
cord-005453-4057qib7	10045	4	were	be	VBD
cord-005453-4057qib7	10045	5	detected	detect	VBN
cord-005453-4057qib7	10045	6	in	in	IN
cord-005453-4057qib7	10045	7	6	6	CD
cord-005453-4057qib7	10045	8	pts	pt	NNS
cord-005453-4057qib7	10045	9	,	,	,
cord-005453-4057qib7	10045	10	in	in	IN
cord-005453-4057qib7	10045	11	4	4	CD
cord-005453-4057qib7	10045	12	pts	pt	NNS
cord-005453-4057qib7	10045	13	hemoptysis	hemoptysis	NNP
cord-005453-4057qib7	10045	14	was	be	VBD
cord-005453-4057qib7	10045	15	observed	observe	VBN
cord-005453-4057qib7	10045	16	.	.	.
cord-005453-4057qib7	10046	1	The	the	DT
cord-005453-4057qib7	10046	2	rest	rest	NN
cord-005453-4057qib7	10046	3	of	of	IN
cord-005453-4057qib7	10046	4	isolated	isolate	VBN
cord-005453-4057qib7	10046	5	strains	strain	NNS
cord-005453-4057qib7	10046	6	were	be	VBD
cord-005453-4057qib7	10046	7	identified	identify	VBN
cord-005453-4057qib7	10046	8	as	as	IN
cord-005453-4057qib7	10046	9	colonization	colonization	NN
cord-005453-4057qib7	10046	10	(	(	-LRB-
cord-005453-4057qib7	10046	11	throat	throat	NN
cord-005453-4057qib7	10046	12	-in	-in	SYM
cord-005453-4057qib7	10046	13	3	3	CD
cord-005453-4057qib7	10046	14	pts	pts	NN
cord-005453-4057qib7	10046	15	,	,	,
cord-005453-4057qib7	10046	16	stool	stool	NN
cord-005453-4057qib7	10046	17	-in	-in	SYM
cord-005453-4057qib7	10046	18	9	9	CD
cord-005453-4057qib7	10046	19	pts	pt	NNS
cord-005453-4057qib7	10046	20	)	)	-RRB-
cord-005453-4057qib7	10046	21	.	.	.
cord-005453-4057qib7	10047	1	All	all	DT
cord-005453-4057qib7	10047	2	7	7	CD
cord-005453-4057qib7	10047	3	patients	patient	NNS
cord-005453-4057qib7	10047	4	with	with	IN
cord-005453-4057qib7	10047	5	invasive	invasive	JJ
cord-005453-4057qib7	10047	6	S.	S.	NNP
cord-005453-4057qib7	10047	7	maltophilia	maltophilia	NN
cord-005453-4057qib7	10047	8	infection	infection	NN
cord-005453-4057qib7	10047	9	before	before	IN
cord-005453-4057qib7	10047	10	pathogen	pathogen	NN
cord-005453-4057qib7	10047	11	identification	identification	NN
cord-005453-4057qib7	10047	12	demonstrated	demonstrate	VBD
cord-005453-4057qib7	10047	13	persistent	persistent	JJ
cord-005453-4057qib7	10047	14	fever	fever	NN
cord-005453-4057qib7	10047	15	despite	despite	IN
cord-005453-4057qib7	10047	16	of	of	IN
cord-005453-4057qib7	10047	17	the	the	DT
cord-005453-4057qib7	10047	18	use	use	NN
cord-005453-4057qib7	10047	19	of	of	IN
cord-005453-4057qib7	10047	20	broadspectrum	broadspectrum	NNP
cord-005453-4057qib7	10047	21	antibiotics	antibiotic	NNS
cord-005453-4057qib7	10047	22	(	(	-LRB-
cord-005453-4057qib7	10047	23	carbapenems	carbapenem	NNS
cord-005453-4057qib7	10047	24	,	,	,
cord-005453-4057qib7	10047	25	glycopeptides	glycopeptides	NNP
cord-005453-4057qib7	10047	26	,	,	,
cord-005453-4057qib7	10047	27	aminoglycosides	aminoglycoside	NNS
cord-005453-4057qib7	10047	28	,	,	,
cord-005453-4057qib7	10047	29	colistin	colistin	NNP
cord-005453-4057qib7	10047	30	)	)	-RRB-
cord-005453-4057qib7	10047	31	,	,	,
cord-005453-4057qib7	10047	32	prophylactic	prophylactic	JJ
cord-005453-4057qib7	10047	33	antifungals	antifungal	NNS
cord-005453-4057qib7	10047	34	and	and	CC
cord-005453-4057qib7	10047	35	antivirals	antiviral	NNS
cord-005453-4057qib7	10047	36	.	.	.
cord-005453-4057qib7	10048	1	All	all	DT
cord-005453-4057qib7	10048	2	of	of	IN
cord-005453-4057qib7	10048	3	them	-PRON-	PRP
cord-005453-4057qib7	10048	4	received	receive	VBD
cord-005453-4057qib7	10048	5	fluoroquinolone	fluoroquinolone	NN
cord-005453-4057qib7	10048	6	(	(	-LRB-
cord-005453-4057qib7	10048	7	ciprofloxacin	ciprofloxacin	NNP
cord-005453-4057qib7	10048	8	)	)	-RRB-
cord-005453-4057qib7	10048	9	as	as	IN
cord-005453-4057qib7	10048	10	a	a	DT
cord-005453-4057qib7	10048	11	standard	standard	JJ
cord-005453-4057qib7	10048	12	antibacterial	antibacterial	JJ
cord-005453-4057qib7	10048	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10048	14	before	before	IN
cord-005453-4057qib7	10048	15	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10048	16	fever	fever	NN
cord-005453-4057qib7	10048	17	occurred	occur	VBD
cord-005453-4057qib7	10048	18	.	.	.
cord-005453-4057qib7	10049	1	All	all	DT
cord-005453-4057qib7	10049	2	3	3	CD
cord-005453-4057qib7	10049	3	patients	patient	NNS
cord-005453-4057qib7	10049	4	(	(	-LRB-
cord-005453-4057qib7	10049	5	100	100	CD
cord-005453-4057qib7	10049	6	%	%	NN
cord-005453-4057qib7	10049	7	)	)	-RRB-
cord-005453-4057qib7	10049	8	with	with	IN
cord-005453-4057qib7	10049	9	BSI	BSI	NNP
cord-005453-4057qib7	10049	10	,	,	,
cord-005453-4057qib7	10049	11	pneumonia	pneumonia	NN
cord-005453-4057qib7	10049	12	and	and	CC
cord-005453-4057qib7	10049	13	pulmonary	pulmonary	JJ
cord-005453-4057qib7	10049	14	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	10049	15	died	die	VBD
cord-005453-4057qib7	10049	16	before	before	IN
cord-005453-4057qib7	10049	17	engraftment	engraftment	NNP
cord-005453-4057qib7	10049	18	(	(	-LRB-
cord-005453-4057qib7	10049	19	ANC	ANC	NNP
cord-005453-4057qib7	10049	20	-0.0	-0.0	HYPH
cord-005453-4057qib7	10049	21	G	G	NNP
cord-005453-4057qib7	10049	22	/	/	SYM
cord-005453-4057qib7	10049	23	L	l	NN
cord-005453-4057qib7	10049	24	)	)	-RRB-
cord-005453-4057qib7	10049	25	-2	-2	NN
cord-005453-4057qib7	10049	26	of	of	IN
cord-005453-4057qib7	10049	27	them	-PRON-	PRP
cord-005453-4057qib7	10049	28	during	during	IN
cord-005453-4057qib7	10049	29	48	48	CD
cord-005453-4057qib7	10049	30	-	-	SYM
cord-005453-4057qib7	10049	31	72	72	CD
cord-005453-4057qib7	10049	32	hours	hour	NNS
cord-005453-4057qib7	10049	33	from	from	IN
cord-005453-4057qib7	10049	34	the	the	DT
cord-005453-4057qib7	10049	35	onset	onset	NN
cord-005453-4057qib7	10049	36	of	of	IN
cord-005453-4057qib7	10049	37	a	a	DT
cord-005453-4057qib7	10049	38	positive	positive	JJ
cord-005453-4057qib7	10049	39	blood	blood	NN
cord-005453-4057qib7	10049	40	culture	culture	NN
cord-005453-4057qib7	10049	41	for	for	IN
cord-005453-4057qib7	10049	42	S.	S.	NNP
cord-005453-4057qib7	10049	43	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10049	44	.	.	.
cord-005453-4057qib7	10050	1	The	the	DT
cord-005453-4057qib7	10050	2	C	C	NNP
cord-005453-4057qib7	10050	3	-	-	HYPH
cord-005453-4057qib7	10050	4	reactive	reactive	JJ
cord-005453-4057qib7	10050	5	protein	protein	NN
cord-005453-4057qib7	10050	6	(	(	-LRB-
cord-005453-4057qib7	10050	7	CRP	CRP	NNP
cord-005453-4057qib7	10050	8	)	)	-RRB-
cord-005453-4057qib7	10050	9	concentration	concentration	NN
cord-005453-4057qib7	10050	10	before	before	IN
cord-005453-4057qib7	10050	11	identification	identification	NN
cord-005453-4057qib7	10050	12	of	of	IN
cord-005453-4057qib7	10050	13	S.	S.	NNP
cord-005453-4057qib7	10050	14	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10050	15	invasive	invasive	JJ
cord-005453-4057qib7	10050	16	infection	infection	NN
cord-005453-4057qib7	10050	17	was	be	VBD
cord-005453-4057qib7	10050	18	>	>	XX
cord-005453-4057qib7	10050	19	26x-69x	26x-69x	CD
cord-005453-4057qib7	10050	20	upper	upper	JJ
cord-005453-4057qib7	10050	21	normal	normal	JJ
cord-005453-4057qib7	10050	22	limits	limit	NNS
cord-005453-4057qib7	10050	23	(	(	-LRB-
cord-005453-4057qib7	10050	24	UNL	UNL	NNP
cord-005453-4057qib7	10050	25	)	)	-RRB-
cord-005453-4057qib7	10050	26	.	.	.
cord-005453-4057qib7	10051	1	Susceptibility	susceptibility	NN
cord-005453-4057qib7	10051	2	to	to	IN
cord-005453-4057qib7	10051	3	antibiotics	antibiotic	NNS
cord-005453-4057qib7	10051	4	of	of	IN
cord-005453-4057qib7	10051	5	isolated	isolate	VBN
cord-005453-4057qib7	10051	6	strains	strain	NNS
cord-005453-4057qib7	10051	7	from	from	IN
cord-005453-4057qib7	10051	8	blood	blood	NN
cord-005453-4057qib7	10051	9	and	and	CC
cord-005453-4057qib7	10051	10	sputum	sputum	NN
cord-005453-4057qib7	10051	11	was	be	VBD
cord-005453-4057qib7	10051	12	respectively	respectively	RB
cord-005453-4057qib7	10051	13	:	:	:
cord-005453-4057qib7	10051	14	86	86	CD
cord-005453-4057qib7	10051	15	%	%	NN
cord-005453-4057qib7	10051	16	and	and	CC
cord-005453-4057qib7	10051	17	100	100	CD
cord-005453-4057qib7	10051	18	%	%	NN
cord-005453-4057qib7	10051	19	for	for	IN
cord-005453-4057qib7	10051	20	ceftazidime	ceftazidime	NN
cord-005453-4057qib7	10051	21	,	,	,
cord-005453-4057qib7	10051	22	100	100	CD
cord-005453-4057qib7	10051	23	%	%	NN
cord-005453-4057qib7	10051	24	and	and	CC
cord-005453-4057qib7	10051	25	100	100	CD
cord-005453-4057qib7	10051	26	%	%	NN
cord-005453-4057qib7	10051	27	for	for	IN
cord-005453-4057qib7	10051	28	trimethoprim	trimethoprim	NNP
cord-005453-4057qib7	10051	29	-	-	HYPH
cord-005453-4057qib7	10051	30	sulfamethoxazole	sulfamethoxazole	NNP
cord-005453-4057qib7	10051	31	,	,	,
cord-005453-4057qib7	10051	32	64	64	CD
cord-005453-4057qib7	10051	33	%	%	NN
cord-005453-4057qib7	10051	34	and	and	CC
cord-005453-4057qib7	10051	35	50	50	CD
cord-005453-4057qib7	10051	36	%	%	NN
cord-005453-4057qib7	10051	37	for	for	IN
cord-005453-4057qib7	10051	38	levofloxacin	levofloxacin	NNS
cord-005453-4057qib7	10051	39	;	;	:
cord-005453-4057qib7	10051	40	while	while	IN
cord-005453-4057qib7	10051	41	56	56	CD
cord-005453-4057qib7	10051	42	%	%	NN
cord-005453-4057qib7	10051	43	and	and	CC
cord-005453-4057qib7	10051	44	50	50	CD
cord-005453-4057qib7	10051	45	%	%	NN
cord-005453-4057qib7	10051	46	strains	strain	NNS
cord-005453-4057qib7	10051	47	were	be	VBD
cord-005453-4057qib7	10051	48	resistant	resistant	JJ
cord-005453-4057qib7	10051	49	to	to	IN
cord-005453-4057qib7	10051	50	ciprofloxacin	ciprofloxacin	NN
cord-005453-4057qib7	10051	51	.	.	.
cord-005453-4057qib7	10052	1	1-year	1-year	CD
cord-005453-4057qib7	10052	2	overal	overal	JJ
cord-005453-4057qib7	10052	3	survival	survival	NN
cord-005453-4057qib7	10052	4	(	(	-LRB-
cord-005453-4057qib7	10052	5	OS	OS	NNP
cord-005453-4057qib7	10052	6	)	)	-RRB-
cord-005453-4057qib7	10052	7	and	and	CC
cord-005453-4057qib7	10052	8	2-y	2-y	CD
cord-005453-4057qib7	10052	9	OS	os	NN
cord-005453-4057qib7	10052	10	for	for	IN
cord-005453-4057qib7	10052	11	this	this	DT
cord-005453-4057qib7	10052	12	group	group	NN
cord-005453-4057qib7	10052	13	was	be	VBD
cord-005453-4057qib7	10052	14	52.4	52.4	CD
cord-005453-4057qib7	10052	15	%	%	NN
cord-005453-4057qib7	10052	16	and	and	CC
cord-005453-4057qib7	10052	17	47.6	47.6	CD
cord-005453-4057qib7	10052	18	%	%	NN
cord-005453-4057qib7	10052	19	respectively	respectively	RB
cord-005453-4057qib7	10052	20	compared	compare	VBN
cord-005453-4057qib7	10052	21	with	with	IN
cord-005453-4057qib7	10052	22	77.2	77.2	CD
cord-005453-4057qib7	10052	23	%	%	NN
cord-005453-4057qib7	10052	24	and	and	CC
cord-005453-4057qib7	10052	25	68.3	68.3	CD
cord-005453-4057qib7	10052	26	%	%	NN
cord-005453-4057qib7	10052	27	for	for	IN
cord-005453-4057qib7	10052	28	group	group	NN
cord-005453-4057qib7	10052	29	without	without	IN
cord-005453-4057qib7	10052	30	S.	S.	NNP
cord-005453-4057qib7	10052	31	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10052	32	infection	infection	NN
cord-005453-4057qib7	10052	33	.	.	.
cord-005453-4057qib7	10053	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10053	2	:	:	:
cord-005453-4057qib7	10054	1	S.	S.	NNP
cord-005453-4057qib7	10054	2	maltophilia	maltophilia	VBD
cord-005453-4057qib7	10054	3	invasive	invasive	JJ
cord-005453-4057qib7	10054	4	infections	infection	NNS
cord-005453-4057qib7	10054	5	are	be	VBP
cord-005453-4057qib7	10054	6	associated	associate	VBN
cord-005453-4057qib7	10054	7	with	with	IN
cord-005453-4057qib7	10054	8	high	high	JJ
cord-005453-4057qib7	10054	9	morbidity	morbidity	NN
cord-005453-4057qib7	10054	10	and	and	CC
cord-005453-4057qib7	10054	11	mortality	mortality	NN
cord-005453-4057qib7	10054	12	in	in	IN
cord-005453-4057qib7	10054	13	allo	allo	NN
cord-005453-4057qib7	10054	14	-	-	HYPH
cord-005453-4057qib7	10054	15	HSCT	HSCT	NNP
cord-005453-4057qib7	10054	16	recipients	recipient	NNS
cord-005453-4057qib7	10054	17	especially	especially	RB
cord-005453-4057qib7	10054	18	in	in	IN
cord-005453-4057qib7	10054	19	the	the	DT
cord-005453-4057qib7	10054	20	period	period	NN
cord-005453-4057qib7	10054	21	from	from	IN
cord-005453-4057qib7	10054	22	conditioning	conditioning	NN
cord-005453-4057qib7	10054	23	therapy	therapy	NN
cord-005453-4057qib7	10054	24	to	to	IN
cord-005453-4057qib7	10054	25	engraftment	engraftment	NNP
cord-005453-4057qib7	10054	26	.	.	.
cord-005453-4057qib7	10055	1	An	an	DT
cord-005453-4057qib7	10055	2	exposure	exposure	NN
cord-005453-4057qib7	10055	3	to	to	IN
cord-005453-4057qib7	10055	4	broad	broad	JJ
cord-005453-4057qib7	10055	5	-	-	HYPH
cord-005453-4057qib7	10055	6	spectrum	spectrum	NN
cord-005453-4057qib7	10055	7	antibiotics	antibiotic	NNS
cord-005453-4057qib7	10055	8	in	in	IN
cord-005453-4057qib7	10055	9	the	the	DT
cord-005453-4057qib7	10055	10	treatment	treatment	NN
cord-005453-4057qib7	10055	11	of	of	IN
cord-005453-4057qib7	10055	12	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10055	13	fever	fever	NN
cord-005453-4057qib7	10055	14	or	or	CC
cord-005453-4057qib7	10055	15	confirmed	confirm	VBD
cord-005453-4057qib7	10055	16	bacteremia	bacteremia	NN
cord-005453-4057qib7	10055	17	of	of	IN
cord-005453-4057qib7	10055	18	other	other	JJ
cord-005453-4057qib7	10055	19	etiology	etiology	NN
cord-005453-4057qib7	10055	20	is	be	VBZ
cord-005453-4057qib7	10055	21	one	one	CD
cord-005453-4057qib7	10055	22	of	of	IN
cord-005453-4057qib7	10055	23	risk	risk	NN
cord-005453-4057qib7	10055	24	factors	factor	NNS
cord-005453-4057qib7	10055	25	of	of	IN
cord-005453-4057qib7	10055	26	breakthrough	breakthrough	NN
cord-005453-4057qib7	10055	27	S.	S.	NNP
cord-005453-4057qib7	10055	28	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10055	29	infections	infection	NNS
cord-005453-4057qib7	10055	30	.	.	.
cord-005453-4057qib7	10056	1	Empiric	empiric	NN
cord-005453-4057qib7	10056	2	therapy	therapy	NN
cord-005453-4057qib7	10056	3	against	against	IN
cord-005453-4057qib7	10056	4	S.	S.	NNP
cord-005453-4057qib7	10056	5	maltophilia	maltophilia	NNP
cord-005453-4057qib7	10056	6	in	in	IN
cord-005453-4057qib7	10056	7	selected	select	VBN
cord-005453-4057qib7	10056	8	patients	patient	NNS
cord-005453-4057qib7	10056	9	in	in	IN
cord-005453-4057qib7	10056	10	risk	risk	NN
cord-005453-4057qib7	10056	11	of	of	IN
cord-005453-4057qib7	10056	12	such	such	JJ
cord-005453-4057qib7	10056	13	infection	infection	NN
cord-005453-4057qib7	10056	14	before	before	IN
cord-005453-4057qib7	10056	15	pathogen	pathogen	NN
cord-005453-4057qib7	10056	16	identification	identification	NN
cord-005453-4057qib7	10056	17	may	may	MD
cord-005453-4057qib7	10056	18	be	be	VB
cord-005453-4057qib7	10056	19	lifesaving	lifesave	VBG
cord-005453-4057qib7	10056	20	procedure	procedure	NN
cord-005453-4057qib7	10056	21	.	.	.
cord-005453-4057qib7	10057	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10057	2	:	:	:
cord-005453-4057qib7	10057	3	Nothing	nothing	NN
cord-005453-4057qib7	10057	4	to	to	TO
cord-005453-4057qib7	10057	5	declare	declare	VB
cord-005453-4057qib7	10057	6	.	.	.
cord-005453-4057qib7	10058	1	Role	role	NN
cord-005453-4057qib7	10058	2	of	of	IN
cord-005453-4057qib7	10058	3	CMV	CMV	NNP
cord-005453-4057qib7	10058	4	reactivation	reactivation	NN
cord-005453-4057qib7	10058	5	following	follow	VBG
cord-005453-4057qib7	10058	6	allogeneic	allogeneic	IN
cord-005453-4057qib7	10058	7	stem	stem	NN
cord-005453-4057qib7	10058	8	cell	cell	NN
cord-005453-4057qib7	10058	9	transplantation	transplantation	NN
cord-005453-4057qib7	10058	10	in	in	IN
cord-005453-4057qib7	10058	11	preventing	prevent	VBG
cord-005453-4057qib7	10058	12	relapses	relapse	NNS
cord-005453-4057qib7	10058	13	in	in	IN
cord-005453-4057qib7	10058	14	patients	patient	NNS
cord-005453-4057qib7	10058	15	with	with	IN
cord-005453-4057qib7	10058	16	acute	acute	JJ
cord-005453-4057qib7	10058	17	myeloid	myeloid	NN
cord-005453-4057qib7	10058	18	leukemia	leukemia	NN
cord-005453-4057qib7	10058	19	Background	background	NN
cord-005453-4057qib7	10058	20	:	:	:
cord-005453-4057qib7	10059	1	Cytomegalovirus(CMV	Cytomegalovirus(CMV	NNP
cord-005453-4057qib7	10059	2	)	)	-RRB-
cord-005453-4057qib7	10059	3	reactivation	reactivation	NN
cord-005453-4057qib7	10059	4	is	be	VBZ
cord-005453-4057qib7	10059	5	common	common	JJ
cord-005453-4057qib7	10059	6	in	in	IN
cord-005453-4057qib7	10059	7	patients	patient	NNS
cord-005453-4057qib7	10059	8	undergoing	undergo	VBG
cord-005453-4057qib7	10059	9	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	10059	10	Stem	Stem	NNP
cord-005453-4057qib7	10059	11	Cell	Cell	NNP
cord-005453-4057qib7	10059	12	transplantation	transplantation	NN
cord-005453-4057qib7	10059	13	.	.	.
cord-005453-4057qib7	10060	1	It	-PRON-	PRP
cord-005453-4057qib7	10060	2	has	have	VBZ
cord-005453-4057qib7	10060	3	been	be	VBN
cord-005453-4057qib7	10060	4	shown	show	VBN
cord-005453-4057qib7	10060	5	recently	recently	RB
cord-005453-4057qib7	10060	6	that	that	IN
cord-005453-4057qib7	10060	7	CMV	CMV	NNP
cord-005453-4057qib7	10060	8	reactivation	reactivation	NN
cord-005453-4057qib7	10060	9	is	be	VBZ
cord-005453-4057qib7	10060	10	associated	associate	VBN
cord-005453-4057qib7	10060	11	with	with	IN
cord-005453-4057qib7	10060	12	reduced	reduced	JJ
cord-005453-4057qib7	10060	13	risks	risk	NNS
cord-005453-4057qib7	10060	14	of	of	IN
cord-005453-4057qib7	10060	15	relapse	relapse	NN
cord-005453-4057qib7	10060	16	in	in	IN
cord-005453-4057qib7	10060	17	patients	patient	NNS
cord-005453-4057qib7	10060	18	undergoing	undergo	VBG
cord-005453-4057qib7	10060	19	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	10060	20	Stem	Stem	NNP
cord-005453-4057qib7	10060	21	Cell	Cell	NNP
cord-005453-4057qib7	10060	22	Transplantation	transplantation	NN
cord-005453-4057qib7	10060	23	for	for	IN
cord-005453-4057qib7	10060	24	AML	AML	NNP
cord-005453-4057qib7	10060	25	.	.	.
cord-005453-4057qib7	10061	1	However	however	RB
cord-005453-4057qib7	10061	2	the	the	DT
cord-005453-4057qib7	10061	3	analysis	analysis	NN
cord-005453-4057qib7	10061	4	of	of	IN
cord-005453-4057qib7	10061	5	CIBMTR	CIBMTR	NNP
cord-005453-4057qib7	10061	6	data	datum	NNS
cord-005453-4057qib7	10061	7	did	do	VBD
cord-005453-4057qib7	10061	8	not	not	RB
cord-005453-4057qib7	10061	9	show	show	VB
cord-005453-4057qib7	10061	10	any	any	DT
cord-005453-4057qib7	10061	11	effect	effect	NN
cord-005453-4057qib7	10061	12	of	of	IN
cord-005453-4057qib7	10061	13	CMV	CMV	NNP
cord-005453-4057qib7	10061	14	reactivation	reactivation	NN
cord-005453-4057qib7	10061	15	on	on	IN
cord-005453-4057qib7	10061	16	relapse	relapse	NN
cord-005453-4057qib7	10061	17	.	.	.
cord-005453-4057qib7	10062	1	With	with	IN
cord-005453-4057qib7	10062	2	this	this	DT
cord-005453-4057qib7	10062	3	background	background	NN
cord-005453-4057qib7	10062	4	we	-PRON-	PRP
cord-005453-4057qib7	10062	5	conducted	conduct	VBD
cord-005453-4057qib7	10062	6	an	an	DT
cord-005453-4057qib7	10062	7	analysis	analysis	NN
cord-005453-4057qib7	10062	8	of	of	IN
cord-005453-4057qib7	10062	9	patients	patient	NNS
cord-005453-4057qib7	10062	10	suffering	suffer	VBG
cord-005453-4057qib7	10062	11	from	from	IN
cord-005453-4057qib7	10062	12	AML	AML	NNP
cord-005453-4057qib7	10062	13	who	who	WP
cord-005453-4057qib7	10062	14	are	be	VBP
cord-005453-4057qib7	10062	15	undergoing	undergo	VBG
cord-005453-4057qib7	10062	16	Allo	Allo	NNP
cord-005453-4057qib7	10062	17	-	-	HYPH
cord-005453-4057qib7	10062	18	SCT	SCT	NNP
cord-005453-4057qib7	10062	19	for	for	IN
cord-005453-4057qib7	10062	20	their	-PRON-	PRP$
cord-005453-4057qib7	10062	21	long	long	JJ
cord-005453-4057qib7	10062	22	term	term	NN
cord-005453-4057qib7	10062	23	disease	disease	NN
cord-005453-4057qib7	10062	24	free	free	JJ
cord-005453-4057qib7	10062	25	survival	survival	NN
cord-005453-4057qib7	10062	26	with	with	IN
cord-005453-4057qib7	10062	27	respect	respect	NN
cord-005453-4057qib7	10062	28	to	to	IN
cord-005453-4057qib7	10062	29	CMV	CMV	NNP
cord-005453-4057qib7	10062	30	reactivation	reactivation	NN
cord-005453-4057qib7	10062	31	.	.	.
cord-005453-4057qib7	10063	1	Methods	method	NNS
cord-005453-4057qib7	10063	2	:	:	:
cord-005453-4057qib7	10063	3	After	after	IN
cord-005453-4057qib7	10063	4	obtaining	obtain	VBG
cord-005453-4057qib7	10063	5	permission	permission	NN
cord-005453-4057qib7	10063	6	from	from	IN
cord-005453-4057qib7	10063	7	hospital	hospital	NN
cord-005453-4057qib7	10063	8	medical	medical	JJ
cord-005453-4057qib7	10063	9	records	records	NNPS
cord-005453-4057qib7	10063	10	committee	committee	NN
cord-005453-4057qib7	10063	11	,	,	,
cord-005453-4057qib7	10063	12	we	-PRON-	PRP
cord-005453-4057qib7	10063	13	retrospectively	retrospectively	RB
cord-005453-4057qib7	10063	14	analysed	analyse	VBD
cord-005453-4057qib7	10063	15	data	datum	NNS
cord-005453-4057qib7	10063	16	from	from	IN
cord-005453-4057qib7	10063	17	electronic	electronic	JJ
cord-005453-4057qib7	10063	18	medical	medical	JJ
cord-005453-4057qib7	10063	19	records	record	NNS
cord-005453-4057qib7	10063	20	of	of	IN
cord-005453-4057qib7	10063	21	patients	patient	NNS
cord-005453-4057qib7	10063	22	undergoing	undergo	VBG
cord-005453-4057qib7	10063	23	Allo	Allo	NNP
cord-005453-4057qib7	10063	24	-	-	HYPH
cord-005453-4057qib7	10063	25	SCT	SCT	NNP
cord-005453-4057qib7	10063	26	for	for	IN
cord-005453-4057qib7	10063	27	AML	AML	NNP
cord-005453-4057qib7	10063	28	at	at	IN
cord-005453-4057qib7	10063	29	our	-PRON-	PRP$
cord-005453-4057qib7	10063	30	center	center	NN
cord-005453-4057qib7	10063	31	between	between	IN
cord-005453-4057qib7	10063	32	January	January	NNP
cord-005453-4057qib7	10063	33	2013	2013	CD
cord-005453-4057qib7	10063	34	to	to	IN
cord-005453-4057qib7	10063	35	August	August	NNP
cord-005453-4057qib7	10063	36	2018	2018	CD
cord-005453-4057qib7	10063	37	.	.	.
cord-005453-4057qib7	10064	1	Patients	patient	NNS
cord-005453-4057qib7	10064	2	who	who	WP
cord-005453-4057qib7	10064	3	underwent	undergo	VBD
cord-005453-4057qib7	10064	4	Matched	matched	JJ
cord-005453-4057qib7	10064	5	sibling	sibling	NN
cord-005453-4057qib7	10064	6	,	,	,
cord-005453-4057qib7	10064	7	Matched	match	VBN
cord-005453-4057qib7	10064	8	unrelated	unrelated	JJ
cord-005453-4057qib7	10064	9	and	and	CC
cord-005453-4057qib7	10064	10	partially	partially	RB
cord-005453-4057qib7	10064	11	matched	match	VBN
cord-005453-4057qib7	10064	12	Allo	Allo	NNP
cord-005453-4057qib7	10064	13	SCT	SCT	NNP
cord-005453-4057qib7	10064	14	were	be	VBD
cord-005453-4057qib7	10064	15	included	include	VBN
cord-005453-4057qib7	10064	16	.	.	.
cord-005453-4057qib7	10065	1	All	all	DT
cord-005453-4057qib7	10065	2	patients	patient	NNS
cord-005453-4057qib7	10065	3	underwent	undergo	VBD
cord-005453-4057qib7	10065	4	CMV	CMV	NNP
cord-005453-4057qib7	10065	5	monitoring	monitor	VBG
cord-005453-4057qib7	10065	6	with	with	IN
cord-005453-4057qib7	10065	7	weekly	weekly	JJ
cord-005453-4057qib7	10065	8	PCR	PCR	NNP
cord-005453-4057qib7	10065	9	starting	start	VBG
cord-005453-4057qib7	10065	10	from	from	IN
cord-005453-4057qib7	10065	11	the	the	DT
cord-005453-4057qib7	10065	12	time	time	NN
cord-005453-4057qib7	10065	13	of	of	IN
cord-005453-4057qib7	10065	14	engraftment	engraftment	NN
cord-005453-4057qib7	10065	15	till	till	IN
cord-005453-4057qib7	10065	16	D+100	D+100	NNS
cord-005453-4057qib7	10065	17	following	follow	VBG
cord-005453-4057qib7	10065	18	Allo	Allo	NNP
cord-005453-4057qib7	10065	19	SCT	SCT	NNP
cord-005453-4057qib7	10065	20	.	.	.
cord-005453-4057qib7	10066	1	Value	value	NN
cord-005453-4057qib7	10066	2	of	of	IN
cord-005453-4057qib7	10066	3	≥	≥	CD
cord-005453-4057qib7	10066	4	1000	1000	CD
cord-005453-4057qib7	10066	5	copies	copy	NNS
cord-005453-4057qib7	10066	6	/	/	SYM
cord-005453-4057qib7	10066	7	mcl	mcl	NNP
cord-005453-4057qib7	10066	8	was	be	VBD
cord-005453-4057qib7	10066	9	considered	consider	VBN
cord-005453-4057qib7	10066	10	as	as	IN
cord-005453-4057qib7	10066	11	cut	cut	VBN
cord-005453-4057qib7	10066	12	off	off	RP
cord-005453-4057qib7	10066	13	for	for	IN
cord-005453-4057qib7	10066	14	initiation	initiation	NN
cord-005453-4057qib7	10066	15	of	of	IN
cord-005453-4057qib7	10066	16	treatment	treatment	NN
cord-005453-4057qib7	10066	17	in	in	IN
cord-005453-4057qib7	10066	18	matched	match	VBN
cord-005453-4057qib7	10066	19	sibling	sibling	NN
cord-005453-4057qib7	10066	20	donor	donor	NN
cord-005453-4057qib7	10066	21	transplant	transplant	NN
cord-005453-4057qib7	10066	22	but	but	CC
cord-005453-4057qib7	10066	23	in	in	IN
cord-005453-4057qib7	10066	24	unrelated	unrelated	JJ
cord-005453-4057qib7	10066	25	donor	donor	NN
cord-005453-4057qib7	10066	26	or	or	CC
cord-005453-4057qib7	10066	27	partially	partially	RB
cord-005453-4057qib7	10066	28	matched	match	VBN
cord-005453-4057qib7	10066	29	donor	donor	NN
cord-005453-4057qib7	10066	30	transplants	transplant	NNS
cord-005453-4057qib7	10066	31	,	,	,
cord-005453-4057qib7	10066	32	≥	≥	CD
cord-005453-4057qib7	10066	33	500	500	CD
cord-005453-4057qib7	10066	34	copies	copy	NNS
cord-005453-4057qib7	10066	35	/	/	SYM
cord-005453-4057qib7	10066	36	mcl	mcl	NNP
cord-005453-4057qib7	10066	37	was	be	VBD
cord-005453-4057qib7	10066	38	used	use	VBN
cord-005453-4057qib7	10066	39	as	as	IN
cord-005453-4057qib7	10066	40	cut	cut	VBN
cord-005453-4057qib7	10066	41	off	off	RP
cord-005453-4057qib7	10066	42	for	for	IN
cord-005453-4057qib7	10066	43	initiation	initiation	NN
cord-005453-4057qib7	10066	44	of	of	IN
cord-005453-4057qib7	10066	45	pre	pre	JJ
cord-005453-4057qib7	10066	46	emptive	emptive	JJ
cord-005453-4057qib7	10066	47	therapy	therapy	NN
cord-005453-4057qib7	10066	48	.	.	.
cord-005453-4057qib7	10067	1	Results	result	NNS
cord-005453-4057qib7	10067	2	:	:	:
cord-005453-4057qib7	10067	3	Total	total	NN
cord-005453-4057qib7	10067	4	of	of	IN
cord-005453-4057qib7	10067	5	96	96	CD
cord-005453-4057qib7	10067	6	patients	patient	NNS
cord-005453-4057qib7	10067	7	were	be	VBD
cord-005453-4057qib7	10067	8	included	include	VBN
cord-005453-4057qib7	10067	9	in	in	IN
cord-005453-4057qib7	10067	10	study	study	NN
cord-005453-4057qib7	10067	11	.	.	.
cord-005453-4057qib7	10068	1	Median	median	JJ
cord-005453-4057qib7	10068	2	age	age	NN
cord-005453-4057qib7	10068	3	was	be	VBD
cord-005453-4057qib7	10068	4	28.01	28.01	CD
cord-005453-4057qib7	10068	5	±	±	NNP
cord-005453-4057qib7	10068	6	17.09years	17.09years	CD
cord-005453-4057qib7	10068	7	(	(	-LRB-
cord-005453-4057qib7	10068	8	2	2	CD
cord-005453-4057qib7	10068	9	-	-	HYPH
cord-005453-4057qib7	10068	10	69yrs	69yrs	NN
cord-005453-4057qib7	10068	11	)	)	-RRB-
cord-005453-4057qib7	10068	12	.	.	.
cord-005453-4057qib7	10069	1	60(62.5	60(62.5	CD
cord-005453-4057qib7	10069	2	%	%	NN
cord-005453-4057qib7	10069	3	)	)	-RRB-
cord-005453-4057qib7	10069	4	,	,	.
cord-005453-4057qib7	10070	1	30(31.3	30(31.3	CD
cord-005453-4057qib7	10070	2	%	%	NN
cord-005453-4057qib7	10070	3	)	)	-RRB-
cord-005453-4057qib7	10070	4	and	and	CC
cord-005453-4057qib7	10070	5	6(6.3	6(6.3	CD
cord-005453-4057qib7	10070	6	%	%	NN
cord-005453-4057qib7	10070	7	)	)	-RRB-
cord-005453-4057qib7	10070	8	patients	patient	NNS
cord-005453-4057qib7	10070	9	underwent	undergo	VBD
cord-005453-4057qib7	10070	10	Matched	Matched	NNP
cord-005453-4057qib7	10070	11	Sibling	Sibling	NNP
cord-005453-4057qib7	10070	12	,	,	,
cord-005453-4057qib7	10070	13	Haplo	Haplo	NNP
cord-005453-4057qib7	10070	14	(	(	-LRB-
cord-005453-4057qib7	10070	15	Partially	partially	RB
cord-005453-4057qib7	10070	16	matched	match	VBN
cord-005453-4057qib7	10070	17	)	)	-RRB-
cord-005453-4057qib7	10070	18	and	and	CC
cord-005453-4057qib7	10070	19	MUD	mud	NN
cord-005453-4057qib7	10070	20	transplantation	transplantation	NN
cord-005453-4057qib7	10070	21	respectively	respectively	RB
cord-005453-4057qib7	10070	22	.	.	.
cord-005453-4057qib7	10071	1	Median	median	JJ
cord-005453-4057qib7	10071	2	follow	follow	VBP
cord-005453-4057qib7	10071	3	up	up	RP
cord-005453-4057qib7	10071	4	was	be	VBD
cord-005453-4057qib7	10071	5	15	15	CD
cord-005453-4057qib7	10071	6	months(1	months(1	NN
cord-005453-4057qib7	10071	7	-	-	HYPH
cord-005453-4057qib7	10071	8	73months	73months	CD
cord-005453-4057qib7	10071	9	)	)	-RRB-
cord-005453-4057qib7	10071	10	.	.	.
cord-005453-4057qib7	10072	1	(	(	-LRB-
cord-005453-4057qib7	10072	2	Table	table	NN
cord-005453-4057qib7	10072	3	1	1	CD
cord-005453-4057qib7	10072	4	)	)	-RRB-
cord-005453-4057qib7	10073	1	Acute	acute	JJ
cord-005453-4057qib7	10073	2	GVHD	GVHD	NNP
cord-005453-4057qib7	10074	1	(	(	-LRB-
cord-005453-4057qib7	10074	2	Grade2	Grade2	NNP
cord-005453-4057qib7	10074	3	-	-	HYPH
cord-005453-4057qib7	10074	4	4	4	CD
cord-005453-4057qib7	10074	5	)	)	-RRB-
cord-005453-4057qib7	10074	6	was	be	VBD
cord-005453-4057qib7	10074	7	observed	observe	VBN
cord-005453-4057qib7	10074	8	in	in	IN
cord-005453-4057qib7	10074	9	50(52.1	50(52.1	CD
cord-005453-4057qib7	10074	10	%	%	NN
cord-005453-4057qib7	10074	11	)	)	-RRB-
cord-005453-4057qib7	10074	12	of	of	IN
cord-005453-4057qib7	10074	13	patients	patient	NNS
cord-005453-4057qib7	10074	14	.	.	.
cord-005453-4057qib7	10075	1	CMV	CMV	NNP
cord-005453-4057qib7	10075	2	reactivation	reactivation	NN
cord-005453-4057qib7	10075	3	occurred	occur	VBD
cord-005453-4057qib7	10075	4	in	in	IN
cord-005453-4057qib7	10075	5	70(72.9	70(72.9	CD
cord-005453-4057qib7	10075	6	%	%	NN
cord-005453-4057qib7	10075	7	)	)	-RRB-
cord-005453-4057qib7	10075	8	of	of	IN
cord-005453-4057qib7	10075	9	patients	patient	NNS
cord-005453-4057qib7	10075	10	.	.	.
cord-005453-4057qib7	10076	1	Overall	overall	JJ
cord-005453-4057qib7	10076	2	survival	survival	NN
cord-005453-4057qib7	10076	3	at	at	IN
cord-005453-4057qib7	10076	4	last	last	JJ
cord-005453-4057qib7	10076	5	follow	follow	NN
cord-005453-4057qib7	10076	6	up	up	RP
cord-005453-4057qib7	10076	7	was	be	VBD
cord-005453-4057qib7	10076	8	63.5	63.5	CD
cord-005453-4057qib7	10076	9	%	%	NN
cord-005453-4057qib7	10076	10	(	(	-LRB-
cord-005453-4057qib7	10076	11	61/	61/	CD
cord-005453-4057qib7	10076	12	96patients	96patients	CD
cord-005453-4057qib7	10076	13	)	)	-RRB-
cord-005453-4057qib7	10076	14	.	.	.
cord-005453-4057qib7	10077	1	17(17.7	17(17.7	CD
cord-005453-4057qib7	10077	2	%	%	NN
cord-005453-4057qib7	10077	3	)	)	-RRB-
cord-005453-4057qib7	10077	4	patients	patient	NNS
cord-005453-4057qib7	10077	5	relapsed	relapse	VBD
cord-005453-4057qib7	10077	6	during	during	IN
cord-005453-4057qib7	10077	7	follow	follow	NN
cord-005453-4057qib7	10077	8	up	up	RP
cord-005453-4057qib7	10077	9	.	.	.
cord-005453-4057qib7	10078	1	Relapse	relapse	VB
cord-005453-4057qib7	10078	2	free	free	JJ
cord-005453-4057qib7	10078	3	survival	survival	NN
cord-005453-4057qib7	10078	4	at	at	IN
cord-005453-4057qib7	10078	5	at	at	IN
cord-005453-4057qib7	10078	6	last	last	JJ
cord-005453-4057qib7	10078	7	follow	follow	NN
cord-005453-4057qib7	10078	8	up	up	RP
cord-005453-4057qib7	10078	9	was	be	VBD
cord-005453-4057qib7	10078	10	61.5	61.5	CD
cord-005453-4057qib7	10078	11	%	%	NN
cord-005453-4057qib7	10078	12	.	.	.
cord-005453-4057qib7	10079	1	64(90.1	64(90.1	CD
cord-005453-4057qib7	10079	2	%	%	NN
cord-005453-4057qib7	10079	3	)	)	-RRB-
cord-005453-4057qib7	10079	4	of	of	IN
cord-005453-4057qib7	10079	5	70	70	CD
cord-005453-4057qib7	10079	6	patients	patient	NNS
cord-005453-4057qib7	10079	7	who	who	WP
cord-005453-4057qib7	10079	8	had	have	VBD
cord-005453-4057qib7	10079	9	CMV	CMV	NNP
cord-005453-4057qib7	10079	10	reactivation	reactivation	NN
cord-005453-4057qib7	10079	11	didń	didń	NNP
cord-005453-4057qib7	10079	12	t	t	NN
cord-005453-4057qib7	10079	13	relapse	relapse	NN
cord-005453-4057qib7	10079	14	,	,	,
cord-005453-4057qib7	10079	15	whereas	whereas	IN
cord-005453-4057qib7	10079	16	10(40	10(40	CD
cord-005453-4057qib7	10079	17	%	%	NN
cord-005453-4057qib7	10079	18	)	)	-RRB-
cord-005453-4057qib7	10079	19	of	of	IN
cord-005453-4057qib7	10079	20	25	25	CD
cord-005453-4057qib7	10079	21	patients	patient	NNS
cord-005453-4057qib7	10079	22	who	who	WP
cord-005453-4057qib7	10079	23	didn´t	didn´t	TO
cord-005453-4057qib7	10079	24	have	have	VB
cord-005453-4057qib7	10079	25	CMV	CMV	NNP
cord-005453-4057qib7	10079	26	reactivation	reactivation	NN
cord-005453-4057qib7	10079	27	relapsed	relapse	VBN
cord-005453-4057qib7	10079	28	which	which	WDT
cord-005453-4057qib7	10079	29	was	be	VBD
cord-005453-4057qib7	10079	30	statistically	statistically	RB
cord-005453-4057qib7	10079	31	strongly	strongly	RB
cord-005453-4057qib7	10079	32	significant	significant	JJ
cord-005453-4057qib7	10079	33	P	p	NN
cord-005453-4057qib7	10079	34	<	<	XX
cord-005453-4057qib7	10079	35	0.001	0.001	CD
cord-005453-4057qib7	10079	36	.	.	.
cord-005453-4057qib7	10080	1	(	(	-LRB-
cord-005453-4057qib7	10080	2	Figure	figure	NN
cord-005453-4057qib7	10080	3	1	1	CD
cord-005453-4057qib7	10080	4	)	)	-RRB-
cord-005453-4057qib7	10081	1	Similar	similar	JJ
cord-005453-4057qib7	10081	2	results	result	NNS
cord-005453-4057qib7	10081	3	were	be	VBD
cord-005453-4057qib7	10081	4	seen	see	VBN
cord-005453-4057qib7	10081	5	in	in	IN
cord-005453-4057qib7	10081	6	recently	recently	RB
cord-005453-4057qib7	10081	7	published	publish	VBN
cord-005453-4057qib7	10081	8	paper	paper	NN
cord-005453-4057qib7	10081	9	from	from	IN
cord-005453-4057qib7	10081	10	Japanese	japanese	JJ
cord-005453-4057qib7	10081	11	Society	Society	NNP
cord-005453-4057qib7	10081	12	For	for	IN
cord-005453-4057qib7	10081	13	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	10081	14	Cell	Cell	NNP
cord-005453-4057qib7	10081	15	Transplantation	Transplantation	NNP
cord-005453-4057qib7	10081	16	(	(	-LRB-
cord-005453-4057qib7	10081	17	JSHCT	JSHCT	NNP
cord-005453-4057qib7	10081	18	)	)	-RRB-
cord-005453-4057qib7	10082	1	Transplantation	transplantation	NN
cord-005453-4057qib7	10082	2	-	-	HYPH
cord-005453-4057qib7	10082	3	Related	relate	VBN
cord-005453-4057qib7	10082	4	Complication	complication	NN
cord-005453-4057qib7	10082	5	Working	Working	NNP
cord-005453-4057qib7	10082	6	Group	Group	NNP
cord-005453-4057qib7	10082	7	.	.	.
cord-005453-4057qib7	10083	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10083	2	:	:	:
cord-005453-4057qib7	10083	3	1	1	CD
cord-005453-4057qib7	10083	4	.	.	.
cord-005453-4057qib7	10084	1	CMV	CMV	NNP
cord-005453-4057qib7	10084	2	reactivation	reactivation	NN
cord-005453-4057qib7	10084	3	following	follow	VBG
cord-005453-4057qib7	10084	4	Allo	Allo	NNP
cord-005453-4057qib7	10084	5	SCT	SCT	NNP
cord-005453-4057qib7	10084	6	had	have	VBD
cord-005453-4057qib7	10084	7	beneficial	beneficial	JJ
cord-005453-4057qib7	10084	8	effect	effect	NN
cord-005453-4057qib7	10084	9	on	on	IN
cord-005453-4057qib7	10084	10	preventing	prevent	VBG
cord-005453-4057qib7	10084	11	relapse	relapse	NN
cord-005453-4057qib7	10084	12	in	in	IN
cord-005453-4057qib7	10084	13	patients	patient	NNS
cord-005453-4057qib7	10084	14	with	with	IN
cord-005453-4057qib7	10084	15	AML	AML	NNP
cord-005453-4057qib7	10084	16	.	.	.
cord-005453-4057qib7	10085	1	2	2	LS
cord-005453-4057qib7	10085	2	.	.	.
cord-005453-4057qib7	10086	1	Probable	probable	JJ
cord-005453-4057qib7	10086	2	immune	immune	JJ
cord-005453-4057qib7	10086	3	activation	activation	NN
cord-005453-4057qib7	10086	4	resulting	result	VBG
cord-005453-4057qib7	10086	5	due	due	IN
cord-005453-4057qib7	10086	6	to	to	IN
cord-005453-4057qib7	10086	7	CMV	CMV	NNP
cord-005453-4057qib7	10086	8	reactivation	reactivation	NN
cord-005453-4057qib7	10086	9	may	may	MD
cord-005453-4057qib7	10086	10	result	result	VB
cord-005453-4057qib7	10086	11	in	in	IN
cord-005453-4057qib7	10086	12	better	well	JJR
cord-005453-4057qib7	10086	13	graft	graft	NN
cord-005453-4057qib7	10086	14	versus	versus	IN
cord-005453-4057qib7	10086	15	leukemia	leukemia	NN
cord-005453-4057qib7	10086	16	effect	effect	NN
cord-005453-4057qib7	10086	17	preventing	prevent	VBG
cord-005453-4057qib7	10086	18	subsequent	subsequent	JJ
cord-005453-4057qib7	10086	19	relapses	relapse	NNS
cord-005453-4057qib7	10086	20	.	.	.
cord-005453-4057qib7	10087	1	[	[	-LRB-
cord-005453-4057qib7	10087	2	Background	background	NN
cord-005453-4057qib7	10087	3	:	:	:
cord-005453-4057qib7	10087	4	Human	human	JJ
cord-005453-4057qib7	10087	5	herpesvirus	herpesvirus	NN
cord-005453-4057qib7	10087	6	6	6	CD
cord-005453-4057qib7	10087	7	(	(	-LRB-
cord-005453-4057qib7	10087	8	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10087	9	)	)	-RRB-
cord-005453-4057qib7	10087	10	causes	cause	VBZ
cord-005453-4057qib7	10087	11	lifethreating	lifethreate	VBG
cord-005453-4057qib7	10087	12	central	central	JJ
cord-005453-4057qib7	10087	13	nervous	nervous	JJ
cord-005453-4057qib7	10087	14	system	system	NN
cord-005453-4057qib7	10087	15	disorders	disorder	NNS
cord-005453-4057qib7	10087	16	such	such	JJ
cord-005453-4057qib7	10087	17	as	as	RB
cord-005453-4057qib7	10087	18	encephalitis	encephalitis	RB
cord-005453-4057qib7	10087	19	after	after	IN
cord-005453-4057qib7	10087	20	allogeneic	allogeneic	NN
cord-005453-4057qib7	10087	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10087	22	stem	stem	NN
cord-005453-4057qib7	10087	23	cell	cell	NN
cord-005453-4057qib7	10087	24	transplantation	transplantation	NN
cord-005453-4057qib7	10087	25	(	(	-LRB-
cord-005453-4057qib7	10087	26	HSCT	HSCT	NNP
cord-005453-4057qib7	10087	27	)	)	-RRB-
cord-005453-4057qib7	10087	28	.	.	.
cord-005453-4057qib7	10088	1	Recent	recent	JJ
cord-005453-4057qib7	10088	2	studies	study	NNS
cord-005453-4057qib7	10088	3	showed	show	VBD
cord-005453-4057qib7	10088	4	that	that	IN
cord-005453-4057qib7	10088	5	CD134	CD134	NNP
cord-005453-4057qib7	10088	6	,	,	,
cord-005453-4057qib7	10088	7	a	a	DT
cord-005453-4057qib7	10088	8	member	member	NN
cord-005453-4057qib7	10088	9	of	of	IN
cord-005453-4057qib7	10088	10	the	the	DT
cord-005453-4057qib7	10088	11	tumor	tumor	NN
cord-005453-4057qib7	10088	12	necrosis	necrosis	NN
cord-005453-4057qib7	10088	13	factor	factor	NN
cord-005453-4057qib7	10088	14	receptor	receptor	NN
cord-005453-4057qib7	10088	15	superfamily	superfamily	NN
cord-005453-4057qib7	10088	16	,	,	,
cord-005453-4057qib7	10088	17	has	have	VBZ
cord-005453-4057qib7	10088	18	been	be	VBN
cord-005453-4057qib7	10088	19	implicated	implicate	VBN
cord-005453-4057qib7	10088	20	as	as	IN
cord-005453-4057qib7	10088	21	a	a	DT
cord-005453-4057qib7	10088	22	specific	specific	JJ
cord-005453-4057qib7	10088	23	receptor	receptor	NN
cord-005453-4057qib7	10088	24	of	of	IN
cord-005453-4057qib7	10088	25	HHV-6B	HHV-6B	NNP
cord-005453-4057qib7	10088	26	,	,	,
cord-005453-4057qib7	10088	27	and	and	CC
cord-005453-4057qib7	10088	28	that	that	IN
cord-005453-4057qib7	10088	29	its	-PRON-	PRP$
cord-005453-4057qib7	10088	30	expression	expression	NN
cord-005453-4057qib7	10088	31	levels	level	NNS
cord-005453-4057qib7	10088	32	in	in	IN
cord-005453-4057qib7	10088	33	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	10088	34	T	t	NN
cord-005453-4057qib7	10088	35	cells	cell	NNS
cord-005453-4057qib7	10088	36	after	after	IN
cord-005453-4057qib7	10088	37	HSCT	HSCT	NNP
cord-005453-4057qib7	10088	38	could	could	MD
cord-005453-4057qib7	10088	39	be	be	VB
cord-005453-4057qib7	10088	40	related	relate	VBN
cord-005453-4057qib7	10088	41	to	to	IN
cord-005453-4057qib7	10088	42	the	the	DT
cord-005453-4057qib7	10088	43	reactivation	reactivation	NN
cord-005453-4057qib7	10088	44	of	of	IN
cord-005453-4057qib7	10088	45	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10088	46	.	.	.
cord-005453-4057qib7	10089	1	Real	real	JJ
cord-005453-4057qib7	10089	2	-	-	HYPH
cord-005453-4057qib7	10089	3	time	time	NN
cord-005453-4057qib7	10089	4	quantitative	quantitative	JJ
cord-005453-4057qib7	10089	5	polymerase	polymerase	NN
cord-005453-4057qib7	10089	6	chain	chain	NN
cord-005453-4057qib7	10089	7	reaction	reaction	NN
cord-005453-4057qib7	10089	8	analysis	analysis	NN
cord-005453-4057qib7	10089	9	(	(	-LRB-
cord-005453-4057qib7	10089	10	qPCR	qPCR	NNP
cord-005453-4057qib7	10089	11	)	)	-RRB-
cord-005453-4057qib7	10089	12	is	be	VBZ
cord-005453-4057qib7	10089	13	the	the	DT
cord-005453-4057qib7	10089	14	most	most	RBS
cord-005453-4057qib7	10089	15	commonly	commonly	RB
cord-005453-4057qib7	10089	16	used	use	VBN
cord-005453-4057qib7	10089	17	method	method	NN
cord-005453-4057qib7	10089	18	for	for	IN
cord-005453-4057qib7	10089	19	detecting	detect	VBG
cord-005453-4057qib7	10089	20	and	and	CC
cord-005453-4057qib7	10089	21	evaluating	evaluate	VBG
cord-005453-4057qib7	10089	22	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10089	23	reactivation	reactivation	NN
cord-005453-4057qib7	10089	24	after	after	IN
cord-005453-4057qib7	10089	25	HSCT	HSCT	NNP
cord-005453-4057qib7	10089	26	,	,	,
cord-005453-4057qib7	10089	27	but	but	CC
cord-005453-4057qib7	10089	28	more	more	RBR
cord-005453-4057qib7	10089	29	sensitive	sensitive	JJ
cord-005453-4057qib7	10089	30	detection	detection	NN
cord-005453-4057qib7	10089	31	method	method	NN
cord-005453-4057qib7	10089	32	is	be	VBZ
cord-005453-4057qib7	10089	33	required	require	VBN
cord-005453-4057qib7	10089	34	.	.	.
cord-005453-4057qib7	10090	1	We	-PRON-	PRP
cord-005453-4057qib7	10090	2	recently	recently	RB
cord-005453-4057qib7	10090	3	developed	develop	VBD
cord-005453-4057qib7	10090	4	a	a	DT
cord-005453-4057qib7	10090	5	new	new	JJ
cord-005453-4057qib7	10090	6	monitoring	monitoring	NN
cord-005453-4057qib7	10090	7	method	method	NN
cord-005453-4057qib7	10090	8	for	for	IN
cord-005453-4057qib7	10090	9	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10090	10	reactivation	reactivation	NN
cord-005453-4057qib7	10090	11	using	use	VBG
cord-005453-4057qib7	10090	12	digital	digital	JJ
cord-005453-4057qib7	10090	13	PCR	PCR	NNP
cord-005453-4057qib7	10090	14	(	(	-LRB-
cord-005453-4057qib7	10090	15	dPCR	dPCR	NNP
cord-005453-4057qib7	10090	16	)	)	-RRB-
cord-005453-4057qib7	10090	17	which	which	WDT
cord-005453-4057qib7	10090	18	provides	provide	VBZ
cord-005453-4057qib7	10090	19	high	high	JJ
cord-005453-4057qib7	10090	20	sensitivity	sensitivity	NN
cord-005453-4057qib7	10090	21	of	of	IN
cord-005453-4057qib7	10090	22	detecting	detect	VBG
cord-005453-4057qib7	10090	23	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10090	24	DNA	dna	NN
cord-005453-4057qib7	10090	25	in	in	IN
cord-005453-4057qib7	10090	26	clinical	clinical	JJ
cord-005453-4057qib7	10090	27	samples	sample	NNS
cord-005453-4057qib7	10090	28	.	.	.
cord-005453-4057qib7	10091	1	In	in	IN
cord-005453-4057qib7	10091	2	this	this	DT
cord-005453-4057qib7	10091	3	prospective	prospective	JJ
cord-005453-4057qib7	10091	4	study	study	NN
cord-005453-4057qib7	10091	5	,	,	,
cord-005453-4057qib7	10091	6	we	-PRON-	PRP
cord-005453-4057qib7	10091	7	evaluated	evaluate	VBD
cord-005453-4057qib7	10091	8	the	the	DT
cord-005453-4057qib7	10091	9	relationship	relationship	NN
cord-005453-4057qib7	10091	10	between	between	IN
cord-005453-4057qib7	10091	11	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10091	12	reactivation	reactivation	NN
cord-005453-4057qib7	10091	13	monitored	monitor	VBN
cord-005453-4057qib7	10091	14	by	by	IN
cord-005453-4057qib7	10091	15	dPCR	dpcr	NN
cord-005453-4057qib7	10091	16	and	and	CC
cord-005453-4057qib7	10091	17	expression	expression	NN
cord-005453-4057qib7	10091	18	of	of	IN
cord-005453-4057qib7	10091	19	CD134	cd134	CD
cord-005453-4057qib7	10091	20	on	on	IN
cord-005453-4057qib7	10091	21	CD4	CD4	NNP
cord-005453-4057qib7	10091	22	+	+	CC
cord-005453-4057qib7	10091	23	T	t	NN
cord-005453-4057qib7	10091	24	cells	cell	NNS
cord-005453-4057qib7	10091	25	before	before	IN
cord-005453-4057qib7	10091	26	and	and	CC
cord-005453-4057qib7	10091	27	after	after	IN
cord-005453-4057qib7	10091	28	allogeneic	allogeneic	NN
cord-005453-4057qib7	10091	29	HSCT	HSCT	NNP
cord-005453-4057qib7	10091	30	.	.	.
cord-005453-4057qib7	10092	1	Methods	method	NNS
cord-005453-4057qib7	10092	2	:	:	:
cord-005453-4057qib7	10092	3	Thirty	thirty	CD
cord-005453-4057qib7	10092	4	-	-	HYPH
cord-005453-4057qib7	10092	5	four	four	CD
cord-005453-4057qib7	10092	6	patients	patient	NNS
cord-005453-4057qib7	10092	7	who	who	WP
cord-005453-4057qib7	10092	8	underwent	undergo	VBD
cord-005453-4057qib7	10092	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10092	10	HSCT	HSCT	NNP
cord-005453-4057qib7	10092	11	for	for	IN
cord-005453-4057qib7	10092	12	hematological	hematological	JJ
cord-005453-4057qib7	10092	13	diseases	disease	NNS
cord-005453-4057qib7	10092	14	at	at	IN
cord-005453-4057qib7	10092	15	Keio	Keio	NNP
cord-005453-4057qib7	10092	16	University	University	NNP
cord-005453-4057qib7	10092	17	Hospital	Hospital	NNP
cord-005453-4057qib7	10092	18	(	(	-LRB-
cord-005453-4057qib7	10092	19	Tokyo	Tokyo	NNP
cord-005453-4057qib7	10092	20	,	,	,
cord-005453-4057qib7	10092	21	Japan	Japan	NNP
cord-005453-4057qib7	10092	22	)	)	-RRB-
cord-005453-4057qib7	10092	23	between	between	IN
cord-005453-4057qib7	10092	24	January	January	NNP
cord-005453-4057qib7	10092	25	2017	2017	CD
cord-005453-4057qib7	10092	26	and	and	CC
cord-005453-4057qib7	10092	27	March	March	NNP
cord-005453-4057qib7	10092	28	2018	2018	CD
cord-005453-4057qib7	10092	29	were	be	VBD
cord-005453-4057qib7	10092	30	consecutively	consecutively	RB
cord-005453-4057qib7	10092	31	enrolled	enrol	VBN
cord-005453-4057qib7	10092	32	into	into	IN
cord-005453-4057qib7	10092	33	this	this	DT
cord-005453-4057qib7	10092	34	study	study	NN
cord-005453-4057qib7	10092	35	.	.	.
cord-005453-4057qib7	10093	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	10093	2	blood	blood	NN
cord-005453-4057qib7	10093	3	samples	sample	NNS
cord-005453-4057qib7	10093	4	of	of	IN
cord-005453-4057qib7	10093	5	the	the	DT
cord-005453-4057qib7	10093	6	patients	patient	NNS
cord-005453-4057qib7	10093	7	were	be	VBD
cord-005453-4057qib7	10093	8	obtained	obtain	VBN
cord-005453-4057qib7	10093	9	before	before	IN
cord-005453-4057qib7	10093	10	the	the	DT
cord-005453-4057qib7	10093	11	conditioning	conditioning	NN
cord-005453-4057qib7	10093	12	(	(	-LRB-
cord-005453-4057qib7	10093	13	PRE	PRE	NNP
cord-005453-4057qib7	10093	14	)	)	-RRB-
cord-005453-4057qib7	10093	15	,	,	,
cord-005453-4057qib7	10093	16	the	the	DT
cord-005453-4057qib7	10093	17	day	day	NN
cord-005453-4057qib7	10093	18	of	of	IN
cord-005453-4057qib7	10093	19	transplant	transplant	NN
cord-005453-4057qib7	10093	20	(	(	-LRB-
cord-005453-4057qib7	10093	21	Day	day	NN
cord-005453-4057qib7	10093	22	0	0	CD
cord-005453-4057qib7	10093	23	)	)	-RRB-
cord-005453-4057qib7	10093	24	,	,	,
cord-005453-4057qib7	10093	25	and	and	CC
cord-005453-4057qib7	10093	26	weekly	weekly	RB
cord-005453-4057qib7	10093	27	during	during	IN
cord-005453-4057qib7	10093	28	the	the	DT
cord-005453-4057qib7	10093	29	first	first	JJ
cord-005453-4057qib7	10093	30	month	month	NN
cord-005453-4057qib7	10093	31	after	after	IN
cord-005453-4057qib7	10093	32	transplantation	transplantation	NN
cord-005453-4057qib7	10093	33	(	(	-LRB-
cord-005453-4057qib7	10093	34	Days	Days	NNP
cord-005453-4057qib7	10093	35	7	7	CD
cord-005453-4057qib7	10093	36	,	,	,
cord-005453-4057qib7	10093	37	14	14	CD
cord-005453-4057qib7	10093	38	,	,	,
cord-005453-4057qib7	10093	39	21	21	CD
cord-005453-4057qib7	10093	40	,	,	,
cord-005453-4057qib7	10093	41	and	and	CC
cord-005453-4057qib7	10093	42	28	28	CD
cord-005453-4057qib7	10093	43	)	)	-RRB-
cord-005453-4057qib7	10093	44	.	.	.
cord-005453-4057qib7	10094	1	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10094	2	viral	viral	JJ
cord-005453-4057qib7	10094	3	load	load	NN
cord-005453-4057qib7	10094	4	in	in	IN
cord-005453-4057qib7	10094	5	plasma	plasma	NN
cord-005453-4057qib7	10094	6	was	be	VBD
cord-005453-4057qib7	10094	7	quantitatively	quantitatively	RB
cord-005453-4057qib7	10094	8	measured	measure	VBN
cord-005453-4057qib7	10094	9	by	by	IN
cord-005453-4057qib7	10094	10	dPCR	dPCR	NNP
cord-005453-4057qib7	10094	11	.	.	.
cord-005453-4057qib7	10095	1	The	the	DT
cord-005453-4057qib7	10095	2	primers	primer	NNS
cord-005453-4057qib7	10095	3	and	and	CC
cord-005453-4057qib7	10095	4	a	a	DT
cord-005453-4057qib7	10095	5	probe	probe	NN
cord-005453-4057qib7	10095	6	of	of	IN
cord-005453-4057qib7	10095	7	dPCR	dPCR	NNP
cord-005453-4057qib7	10095	8	for	for	IN
cord-005453-4057qib7	10095	9	HHV-6B	HHV-6B	NNP
cord-005453-4057qib7	10095	10	were	be	VBD
cord-005453-4057qib7	10095	11	selected	select	VBN
cord-005453-4057qib7	10095	12	from	from	IN
cord-005453-4057qib7	10095	13	immediate	immediate	JJ
cord-005453-4057qib7	10095	14	-	-	HYPH
cord-005453-4057qib7	10095	15	early	early	JJ
cord-005453-4057qib7	10095	16	1	1	CD
cord-005453-4057qib7	10095	17	(	(	-LRB-
cord-005453-4057qib7	10095	18	IE-1	IE-1	NNP
cord-005453-4057qib7	10095	19	)	)	-RRB-
cord-005453-4057qib7	10095	20	protein	protein	NN
cord-005453-4057qib7	10095	21	transactivator	transactivator	NN
cord-005453-4057qib7	10095	22	region	region	NN
cord-005453-4057qib7	10095	23	(	(	-LRB-
cord-005453-4057qib7	10095	24	U90	U90	NNP
cord-005453-4057qib7	10095	25	)	)	-RRB-
cord-005453-4057qib7	10095	26	.	.	.
cord-005453-4057qib7	10096	1	We	-PRON-	PRP
cord-005453-4057qib7	10096	2	evaluated	evaluate	VBD
cord-005453-4057qib7	10096	3	the	the	DT
cord-005453-4057qib7	10096	4	relationship	relationship	NN
cord-005453-4057qib7	10096	5	between	between	IN
cord-005453-4057qib7	10096	6	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10096	7	reactivation	reactivation	NN
cord-005453-4057qib7	10096	8	and	and	CC
cord-005453-4057qib7	10096	9	the	the	DT
cord-005453-4057qib7	10096	10	serial	serial	JJ
cord-005453-4057qib7	10096	11	expression	expression	NN
cord-005453-4057qib7	10096	12	rates	rate	NNS
cord-005453-4057qib7	10096	13	of	of	IN
cord-005453-4057qib7	10096	14	CD134	cd134	CD
cord-005453-4057qib7	10096	15	in	in	IN
cord-005453-4057qib7	10096	16	CD4	CD4	NNP
cord-005453-4057qib7	10096	17	+	+	CC
cord-005453-4057qib7	10096	18	T	t	NN
cord-005453-4057qib7	10096	19	cells	cell	NNS
cord-005453-4057qib7	10096	20	(	(	-LRB-
cord-005453-4057qib7	10096	21	CD134	CD134	NNP
cord-005453-4057qib7	10096	22	/	/	SYM
cord-005453-4057qib7	10096	23	CD4	CD4	NNP
cord-005453-4057qib7	10096	24	ratio	ratio	NN
cord-005453-4057qib7	10096	25	)	)	-RRB-
cord-005453-4057qib7	10096	26	measured	measure	VBN
cord-005453-4057qib7	10096	27	by	by	IN
cord-005453-4057qib7	10096	28	flow	flow	NN
cord-005453-4057qib7	10096	29	cytometry	cytometry	NN
cord-005453-4057qib7	10096	30	before	before	IN
cord-005453-4057qib7	10096	31	and	and	CC
cord-005453-4057qib7	10096	32	after	after	IN
cord-005453-4057qib7	10096	33	HSCT	HSCT	NNP
cord-005453-4057qib7	10096	34	.	.	.
cord-005453-4057qib7	10097	1	Results	result	NNS
cord-005453-4057qib7	10097	2	:	:	:
cord-005453-4057qib7	10098	1	Median	median	JJ
cord-005453-4057qib7	10098	2	age	age	NN
cord-005453-4057qib7	10098	3	of	of	IN
cord-005453-4057qib7	10098	4	the	the	DT
cord-005453-4057qib7	10098	5	patients	patient	NNS
cord-005453-4057qib7	10098	6	was	be	VBD
cord-005453-4057qib7	10098	7	51.5	51.5	CD
cord-005453-4057qib7	10098	8	years	year	NNS
cord-005453-4057qib7	10098	9	.	.	.
cord-005453-4057qib7	10099	1	Onethird	onethird	NN
cord-005453-4057qib7	10099	2	of	of	IN
cord-005453-4057qib7	10099	3	patients	patient	NNS
cord-005453-4057qib7	10099	4	received	receive	VBD
cord-005453-4057qib7	10099	5	cord	cord	NN
cord-005453-4057qib7	10099	6	blood	blood	NN
cord-005453-4057qib7	10099	7	as	as	IN
cord-005453-4057qib7	10099	8	a	a	DT
cord-005453-4057qib7	10099	9	stem	stem	NN
cord-005453-4057qib7	10099	10	cell	cell	NN
cord-005453-4057qib7	10099	11	source	source	NN
cord-005453-4057qib7	10099	12	.	.	.
cord-005453-4057qib7	10100	1	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10100	2	reactivation	reactivation	NN
cord-005453-4057qib7	10100	3	was	be	VBD
cord-005453-4057qib7	10100	4	detected	detect	VBN
cord-005453-4057qib7	10100	5	in	in	IN
cord-005453-4057qib7	10100	6	23	23	CD
cord-005453-4057qib7	10100	7	patients	patient	NNS
cord-005453-4057qib7	10100	8	(	(	-LRB-
cord-005453-4057qib7	10100	9	68	68	CD
cord-005453-4057qib7	10100	10	%	%	NN
cord-005453-4057qib7	10100	11	)	)	-RRB-
cord-005453-4057qib7	10100	12	with	with	IN
cord-005453-4057qib7	10100	13	dPCR	dPCR	NNP
cord-005453-4057qib7	10100	14	.	.	.
cord-005453-4057qib7	10101	1	A	a	DT
cord-005453-4057qib7	10101	2	comparison	comparison	NN
cord-005453-4057qib7	10101	3	of	of	IN
cord-005453-4057qib7	10101	4	CD134	cd134	CD
cord-005453-4057qib7	10101	5	/	/	SYM
cord-005453-4057qib7	10101	6	CD4	CD4	NNP
cord-005453-4057qib7	10101	7	ratio	ratio	NN
cord-005453-4057qib7	10101	8	between	between	IN
cord-005453-4057qib7	10101	9	the	the	DT
cord-005453-4057qib7	10101	10	patients	patient	NNS
cord-005453-4057qib7	10101	11	with	with	IN
cord-005453-4057qib7	10101	12	and	and	CC
cord-005453-4057qib7	10101	13	without	without	IN
cord-005453-4057qib7	10101	14	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10101	15	reactivation	reactivation	NN
cord-005453-4057qib7	10101	16	after	after	IN
cord-005453-4057qib7	10101	17	HSCT	HSCT	NNP
cord-005453-4057qib7	10101	18	revealed	reveal	VBD
cord-005453-4057qib7	10101	19	that	that	IN
cord-005453-4057qib7	10101	20	CD134	CD134	NNP
cord-005453-4057qib7	10101	21	/	/	SYM
cord-005453-4057qib7	10101	22	CD4	CD4	NNP
cord-005453-4057qib7	10101	23	ratio	ratio	NN
cord-005453-4057qib7	10101	24	was	be	VBD
cord-005453-4057qib7	10101	25	significantly	significantly	RB
cord-005453-4057qib7	10101	26	higher	high	JJR
cord-005453-4057qib7	10101	27	in	in	IN
cord-005453-4057qib7	10101	28	patients	patient	NNS
cord-005453-4057qib7	10101	29	with	with	IN
cord-005453-4057qib7	10101	30	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10101	31	reactivation	reactivation	NN
cord-005453-4057qib7	10101	32	than	than	IN
cord-005453-4057qib7	10101	33	those	those	DT
cord-005453-4057qib7	10101	34	without	without	IN
cord-005453-4057qib7	10101	35	before	before	IN
cord-005453-4057qib7	10101	36	conditioning	conditioning	NN
cord-005453-4057qib7	10102	1	(	(	-LRB-
cord-005453-4057qib7	10102	2	In	in	IN
cord-005453-4057qib7	10102	3	contrast	contrast	NN
cord-005453-4057qib7	10102	4	,	,	,
cord-005453-4057qib7	10102	5	there	there	EX
cord-005453-4057qib7	10102	6	was	be	VBD
cord-005453-4057qib7	10102	7	no	no	DT
cord-005453-4057qib7	10102	8	such	such	JJ
cord-005453-4057qib7	10102	9	significant	significant	JJ
cord-005453-4057qib7	10102	10	difference	difference	NN
cord-005453-4057qib7	10102	11	after	after	IN
cord-005453-4057qib7	10102	12	transplant	transplant	NN
cord-005453-4057qib7	10102	13	(	(	-LRB-
cord-005453-4057qib7	10102	14	Days	Days	NNP
cord-005453-4057qib7	10102	15	7	7	CD
cord-005453-4057qib7	10102	16	to	to	IN
cord-005453-4057qib7	10102	17	28	28	CD
cord-005453-4057qib7	10102	18	)	)	-RRB-
cord-005453-4057qib7	10102	19	.	.	.
cord-005453-4057qib7	10103	1	In	in	IN
cord-005453-4057qib7	10103	2	multivariate	multivariate	JJ
cord-005453-4057qib7	10103	3	analysis	analysis	NN
cord-005453-4057qib7	10103	4	,	,	,
cord-005453-4057qib7	10103	5	higher	high	JJR
cord-005453-4057qib7	10103	6	CD134	CD134	NNP
cord-005453-4057qib7	10103	7	/	/	SYM
cord-005453-4057qib7	10103	8	CD4	CD4	NNP
cord-005453-4057qib7	10103	9	ratio	ratio	NN
cord-005453-4057qib7	10103	10	before	before	IN
cord-005453-4057qib7	10103	11	conditioning	conditioning	NN
cord-005453-4057qib7	10103	12	(	(	-LRB-
cord-005453-4057qib7	10103	13	odds	odd	NNS
cord-005453-4057qib7	10103	14	ratio	ratio	NN
cord-005453-4057qib7	10103	15	(	(	-LRB-
cord-005453-4057qib7	10103	16	OR	or	NN
cord-005453-4057qib7	10103	17	)	)	-RRB-
cord-005453-4057qib7	10103	18	=	=	NFP
cord-005453-4057qib7	10104	1	10.5	10.5	CD
cord-005453-4057qib7	10104	2	,	,	,
cord-005453-4057qib7	10104	3	95	95	CD
cord-005453-4057qib7	10104	4	%	%	NN
cord-005453-4057qib7	10104	5	confidence	confidence	NN
cord-005453-4057qib7	10104	6	interval	interval	NN
cord-005453-4057qib7	10104	7	(	(	-LRB-
cord-005453-4057qib7	10104	8	CI	CI	NNP
cord-005453-4057qib7	10104	9	)	)	-RRB-
cord-005453-4057qib7	10104	10	:	:	:
cord-005453-4057qib7	10105	1	1.3	1.3	CD
cord-005453-4057qib7	10105	2	-	-	HYPH
cord-005453-4057qib7	10105	3	85.1	85.1	CD
cord-005453-4057qib7	10105	4	,	,	,
cord-005453-4057qib7	10105	5	P	p	NN
cord-005453-4057qib7	10105	6	=	=	SYM
cord-005453-4057qib7	10105	7	0.03	0.03	CD
cord-005453-4057qib7	10105	8	)	)	-RRB-
cord-005453-4057qib7	10105	9	and	and	CC
cord-005453-4057qib7	10105	10	stem	stem	NN
cord-005453-4057qib7	10105	11	cell	cell	NN
cord-005453-4057qib7	10105	12	source	source	NN
cord-005453-4057qib7	10105	13	from	from	IN
cord-005453-4057qib7	10105	14	human	human	JJ
cord-005453-4057qib7	10105	15	leukocyte	leukocyte	NN
cord-005453-4057qib7	10105	16	antigen	antigen	NN
cord-005453-4057qib7	10105	17	mismatched	mismatched	JJ
cord-005453-4057qib7	10105	18	donor	donor	NN
cord-005453-4057qib7	10105	19	(	(	-LRB-
cord-005453-4057qib7	10105	20	including	include	VBG
cord-005453-4057qib7	10105	21	all	all	DT
cord-005453-4057qib7	10105	22	cord	cord	NN
cord-005453-4057qib7	10105	23	blood	blood	NN
cord-005453-4057qib7	10105	24	transplantation	transplantation	NN
cord-005453-4057qib7	10105	25	cases	case	NNS
cord-005453-4057qib7	10105	26	)	)	-RRB-
cord-005453-4057qib7	10105	27	(	(	-LRB-
cord-005453-4057qib7	10105	28	OR	or	CC
cord-005453-4057qib7	10105	29	=	=	SYM
cord-005453-4057qib7	10105	30	15.4	15.4	CD
cord-005453-4057qib7	10105	31	,	,	,
cord-005453-4057qib7	10105	32	95%CI	95%ci	CD
cord-005453-4057qib7	10105	33	:	:	:
cord-005453-4057qib7	10105	34	2.0	2.0	CD
cord-005453-4057qib7	10105	35	-	-	SYM
cord-005453-4057qib7	10105	36	121.0	121.0	CD
cord-005453-4057qib7	10105	37	,	,	,
cord-005453-4057qib7	10105	38	P	p	NN
cord-005453-4057qib7	10105	39	=	=	SYM
cord-005453-4057qib7	10105	40	0.04	0.04	CD
cord-005453-4057qib7	10105	41	)	)	-RRB-
cord-005453-4057qib7	10105	42	remained	remain	VBD
cord-005453-4057qib7	10105	43	to	to	TO
cord-005453-4057qib7	10105	44	be	be	VB
cord-005453-4057qib7	10105	45	significantly	significantly	RB
cord-005453-4057qib7	10105	46	associated	associate	VBN
cord-005453-4057qib7	10105	47	with	with	IN
cord-005453-4057qib7	10105	48	the	the	DT
cord-005453-4057qib7	10105	49	incidence	incidence	NN
cord-005453-4057qib7	10105	50	of	of	IN
cord-005453-4057qib7	10105	51	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10105	52	reactivation	reactivation	NN
cord-005453-4057qib7	10105	53	.	.	.
cord-005453-4057qib7	10106	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10106	2	:	:	:
cord-005453-4057qib7	10107	1	Higher	high	JJR
cord-005453-4057qib7	10107	2	CD134	cd134	CD
cord-005453-4057qib7	10107	3	expression	expression	NN
cord-005453-4057qib7	10107	4	rate	rate	NN
cord-005453-4057qib7	10107	5	in	in	IN
cord-005453-4057qib7	10107	6	CD4	CD4	NNP
cord-005453-4057qib7	10107	7	+	+	CC
cord-005453-4057qib7	10107	8	T	t	NN
cord-005453-4057qib7	10107	9	cells	cell	NNS
cord-005453-4057qib7	10107	10	before	before	IN
cord-005453-4057qib7	10107	11	HSCT	HSCT	NNP
cord-005453-4057qib7	10107	12	was	be	VBD
cord-005453-4057qib7	10107	13	associated	associate	VBN
cord-005453-4057qib7	10107	14	with	with	IN
cord-005453-4057qib7	10107	15	higher	high	JJR
cord-005453-4057qib7	10107	16	risk	risk	NN
cord-005453-4057qib7	10107	17	of	of	IN
cord-005453-4057qib7	10107	18	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10107	19	reactivation	reactivation	NN
cord-005453-4057qib7	10107	20	,	,	,
cord-005453-4057qib7	10107	21	which	which	WDT
cord-005453-4057qib7	10107	22	could	could	MD
cord-005453-4057qib7	10107	23	be	be	VB
cord-005453-4057qib7	10107	24	a	a	DT
cord-005453-4057qib7	10107	25	promising	promising	JJ
cord-005453-4057qib7	10107	26	marker	marker	NN
cord-005453-4057qib7	10107	27	for	for	IN
cord-005453-4057qib7	10107	28	predicting	predict	VBG
cord-005453-4057qib7	10107	29	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10107	30	reactivation	reactivation	NN
cord-005453-4057qib7	10107	31	after	after	IN
cord-005453-4057qib7	10107	32	allogeneic	allogeneic	NN
cord-005453-4057qib7	10107	33	HSCT	HSCT	NNP
cord-005453-4057qib7	10107	34	.	.	.
cord-005453-4057qib7	10108	1	Careful	careful	JJ
cord-005453-4057qib7	10108	2	observation	observation	NN
cord-005453-4057qib7	10108	3	and	and	CC
cord-005453-4057qib7	10108	4	monitoring	monitoring	NN
cord-005453-4057qib7	10108	5	may	may	MD
cord-005453-4057qib7	10108	6	be	be	VB
cord-005453-4057qib7	10108	7	needed	need	VBN
cord-005453-4057qib7	10108	8	in	in	IN
cord-005453-4057qib7	10108	9	CD134	cd134	CD
cord-005453-4057qib7	10108	10	highly	highly	RB
cord-005453-4057qib7	10108	11	expressed	express	VBD
cord-005453-4057qib7	10108	12	patients	patient	NNS
cord-005453-4057qib7	10108	13	.	.	.
cord-005453-4057qib7	10109	1	It	-PRON-	PRP
cord-005453-4057qib7	10109	2	is	be	VBZ
cord-005453-4057qib7	10109	3	a	a	DT
cord-005453-4057qib7	10109	4	subject	subject	NN
cord-005453-4057qib7	10109	5	of	of	IN
cord-005453-4057qib7	10109	6	further	further	JJ
cord-005453-4057qib7	10109	7	research	research	NN
cord-005453-4057qib7	10109	8	to	to	TO
cord-005453-4057qib7	10109	9	clarify	clarify	VB
cord-005453-4057qib7	10109	10	the	the	DT
cord-005453-4057qib7	10109	11	role	role	NN
cord-005453-4057qib7	10109	12	of	of	IN
cord-005453-4057qib7	10110	1	CD134	cd134	CD
cord-005453-4057qib7	10110	2	+	+	CC
cord-005453-4057qib7	10110	3	CD4	CD4	NNP
cord-005453-4057qib7	10110	4	+	+	CC
cord-005453-4057qib7	10110	5	T	t	NN
cord-005453-4057qib7	10110	6	cell	cell	NN
cord-005453-4057qib7	10110	7	in	in	IN
cord-005453-4057qib7	10110	8	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10110	9	reactivation	reactivation	NN
cord-005453-4057qib7	10110	10	.	.	.
cord-005453-4057qib7	10111	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10111	2	:	:	:
cord-005453-4057qib7	10111	3	Nothing	nothing	NN
cord-005453-4057qib7	10111	4	to	to	TO
cord-005453-4057qib7	10111	5	declare	declare	VB
cord-005453-4057qib7	10111	6	.	.	.
cord-005453-4057qib7	10112	1	Methods	method	NNS
cord-005453-4057qib7	10112	2	:	:	:
cord-005453-4057qib7	10113	1	Criteria	criterion	NNS
cord-005453-4057qib7	10113	2	for	for	IN
cord-005453-4057qib7	10113	3	the	the	DT
cord-005453-4057qib7	10113	4	administration	administration	NN
cord-005453-4057qib7	10113	5	of	of	IN
cord-005453-4057qib7	10113	6	ICI	ICI	NNP
cord-005453-4057qib7	10113	7	(	(	-LRB-
cord-005453-4057qib7	10113	8	Vistide	Vistide	NNP
cord-005453-4057qib7	10113	9	)	)	-RRB-
cord-005453-4057qib7	10113	10	were	be	VBD
cord-005453-4057qib7	10113	11	grade	grade	NN
cord-005453-4057qib7	10113	12	III	III	NNP
cord-005453-4057qib7	10113	13	-	-	HYPH
cord-005453-4057qib7	10113	14	IV	IV	NNP
cord-005453-4057qib7	10113	15	(	(	-LRB-
cord-005453-4057qib7	10113	16	clinically	clinically	RB
cord-005453-4057qib7	10113	17	significant	significant	JJ
cord-005453-4057qib7	10113	18	hematuria	hematuria	NN
cord-005453-4057qib7	10113	19	with	with	IN
cord-005453-4057qib7	10113	20	clots	clot	NNS
cord-005453-4057qib7	10113	21	)	)	-RRB-
cord-005453-4057qib7	10114	1	BK	BK	NNP
cord-005453-4057qib7	10114	2	-	-	HYPH
cord-005453-4057qib7	10114	3	related	relate	VBN
cord-005453-4057qib7	10114	4	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	10114	5	cystitis	cystitis	NN
cord-005453-4057qib7	10114	6	after	after	IN
cord-005453-4057qib7	10114	7	allo	allo	NN
cord-005453-4057qib7	10114	8	-	-	HYPH
cord-005453-4057qib7	10114	9	HCT	HCT	NNP
cord-005453-4057qib7	10114	10	which	which	WDT
cord-005453-4057qib7	10114	11	showed	show	VBD
cord-005453-4057qib7	10114	12	no	no	DT
cord-005453-4057qib7	10114	13	improvement	improvement	NN
cord-005453-4057qib7	10114	14	after	after	IN
cord-005453-4057qib7	10114	15	symptomatic	symptomatic	JJ
cord-005453-4057qib7	10114	16	therapy	therapy	NN
cord-005453-4057qib7	10114	17	with	with	IN
cord-005453-4057qib7	10114	18	hyperhydration	hyperhydration	NN
cord-005453-4057qib7	10114	19	and	and	CC
cord-005453-4057qib7	10114	20	bladder	bladder	NN
cord-005453-4057qib7	10114	21	irrigation	irrigation	NN
cord-005453-4057qib7	10114	22	.	.	.
cord-005453-4057qib7	10115	1	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	10115	2	was	be	VBD
cord-005453-4057qib7	10115	3	diluted	dilute	VBN
cord-005453-4057qib7	10115	4	in	in	IN
cord-005453-4057qib7	10115	5	100	100	CD
cord-005453-4057qib7	10115	6	mL	mL	NNS
cord-005453-4057qib7	10115	7	of	of	IN
cord-005453-4057qib7	10115	8	normal	normal	JJ
cord-005453-4057qib7	10115	9	saline	saline	NN
cord-005453-4057qib7	10115	10	and	and	CC
cord-005453-4057qib7	10115	11	installed	instal	VBN
cord-005453-4057qib7	10115	12	via	via	IN
cord-005453-4057qib7	10115	13	a	a	DT
cord-005453-4057qib7	10115	14	Foley	Foley	NNP
cord-005453-4057qib7	10115	15	catheter	catheter	NN
cord-005453-4057qib7	10115	16	which	which	WDT
cord-005453-4057qib7	10115	17	was	be	VBD
cord-005453-4057qib7	10115	18	blocked	block	VBN
cord-005453-4057qib7	10115	19	for	for	IN
cord-005453-4057qib7	10115	20	1	1	CD
cord-005453-4057qib7	10115	21	hour	hour	NN
cord-005453-4057qib7	10115	22	.	.	.
cord-005453-4057qib7	10116	1	Not	not	RB
cord-005453-4057qib7	10116	2	knowing	know	VBG
cord-005453-4057qib7	10116	3	the	the	DT
cord-005453-4057qib7	10116	4	level	level	NN
cord-005453-4057qib7	10116	5	of	of	IN
cord-005453-4057qib7	10116	6	absorption	absorption	NN
cord-005453-4057qib7	10116	7	of	of	IN
cord-005453-4057qib7	10116	8	the	the	DT
cord-005453-4057qib7	10116	9	drug	drug	NN
cord-005453-4057qib7	10116	10	we	-PRON-	PRP
cord-005453-4057qib7	10116	11	decided	decide	VBD
cord-005453-4057qib7	10116	12	to	to	TO
cord-005453-4057qib7	10116	13	give	give	VB
cord-005453-4057qib7	10116	14	probenecid	probenecid	JJ
cord-005453-4057qib7	10116	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10116	16	in	in	IN
cord-005453-4057qib7	10116	17	all	all	DT
cord-005453-4057qib7	10116	18	patients	patient	NNS
cord-005453-4057qib7	10116	19	.	.	.
cord-005453-4057qib7	10117	1	ICI	ICI	NNP
cord-005453-4057qib7	10117	2	was	be	VBD
cord-005453-4057qib7	10117	3	repeated	repeat	VBN
cord-005453-4057qib7	10117	4	weekly	weekly	RB
cord-005453-4057qib7	10117	5	according	accord	VBG
cord-005453-4057qib7	10117	6	to	to	IN
cord-005453-4057qib7	10117	7	severity	severity	NN
cord-005453-4057qib7	10117	8	of	of	IN
cord-005453-4057qib7	10117	9	symptoms	symptom	NNS
cord-005453-4057qib7	10117	10	.	.	.
cord-005453-4057qib7	10118	1	Urine	urine	NN
cord-005453-4057qib7	10118	2	and	and	CC
cord-005453-4057qib7	10118	3	plasma	plasma	NN
cord-005453-4057qib7	10118	4	BKV	bkv	NN
cord-005453-4057qib7	10118	5	viral	viral	JJ
cord-005453-4057qib7	10118	6	loads	load	NNS
cord-005453-4057qib7	10118	7	were	be	VBD
cord-005453-4057qib7	10118	8	quantified	quantify	VBN
cord-005453-4057qib7	10118	9	by	by	IN
cord-005453-4057qib7	10118	10	RQ	rq	NN
cord-005453-4057qib7	10118	11	-	-	HYPH
cord-005453-4057qib7	10118	12	PCR	PCR	NNP
cord-005453-4057qib7	10118	13	Results	result	NNS
cord-005453-4057qib7	10118	14	:	:	:
cord-005453-4057qib7	10118	15	Six	six	CD
cord-005453-4057qib7	10118	16	patients	patient	NNS
cord-005453-4057qib7	10118	17	(	(	-LRB-
cord-005453-4057qib7	10118	18	median	median	NN
cord-005453-4057qib7	10118	19	38	38	CD
cord-005453-4057qib7	10118	20	years	year	NNS
cord-005453-4057qib7	10118	21	,	,	,
cord-005453-4057qib7	10118	22	29	29	CD
cord-005453-4057qib7	10118	23	-	-	SYM
cord-005453-4057qib7	10118	24	51	51	CD
cord-005453-4057qib7	10118	25	)	)	-RRB-
cord-005453-4057qib7	10118	26	received	receive	VBD
cord-005453-4057qib7	10118	27	ICI	ICI	NNP
cord-005453-4057qib7	10118	28	after	after	IN
cord-005453-4057qib7	10118	29	allo	allo	NN
cord-005453-4057qib7	10118	30	-	-	HYPH
cord-005453-4057qib7	10118	31	HCT	hct	NN
cord-005453-4057qib7	10118	32	.	.	.
cord-005453-4057qib7	10119	1	Patients	patient	NNS
cord-005453-4057qib7	10119	2	had	have	VBD
cord-005453-4057qib7	10119	3	haematological	haematological	JJ
cord-005453-4057qib7	10119	4	malignancies	malignancy	NNS
cord-005453-4057qib7	10119	5	(	(	-LRB-
cord-005453-4057qib7	10119	6	AML	AML	NNP
cord-005453-4057qib7	10119	7	2	2	CD
cord-005453-4057qib7	10119	8	,	,	,
cord-005453-4057qib7	10119	9	ALL	all	DT
cord-005453-4057qib7	10119	10	3	3	CD
cord-005453-4057qib7	10119	11	,	,	,
cord-005453-4057qib7	10119	12	MDS	MDS	NNP
cord-005453-4057qib7	10119	13	1	1	CD
cord-005453-4057qib7	10119	14	)	)	-RRB-
cord-005453-4057qib7	10119	15	,	,	,
cord-005453-4057qib7	10119	16	received	receive	VBD
cord-005453-4057qib7	10119	17	busilfex	busilfex	NNP
cord-005453-4057qib7	10119	18	-	-	HYPH
cord-005453-4057qib7	10119	19	based	base	VBN
cord-005453-4057qib7	10119	20	myeloablative	myeloablative	NNP
cord-005453-4057qib7	10119	21	conditioning	conditioning	NN
cord-005453-4057qib7	10119	22	and	and	CC
cord-005453-4057qib7	10119	23	a	a	DT
cord-005453-4057qib7	10119	24	graft	graft	NN
cord-005453-4057qib7	10119	25	(	(	-LRB-
cord-005453-4057qib7	10119	26	PBSC	PBSC	NNP
cord-005453-4057qib7	10119	27	5	5	CD
cord-005453-4057qib7	10119	28	,	,	,
cord-005453-4057qib7	10119	29	BM	BM	NNP
cord-005453-4057qib7	10119	30	1	1	CD
cord-005453-4057qib7	10119	31	)	)	-RRB-
cord-005453-4057qib7	10119	32	from	from	IN
cord-005453-4057qib7	10119	33	a	a	DT
cord-005453-4057qib7	10119	34	7/8	7/8	CD
cord-005453-4057qib7	10119	35	HLA	HLA	NNP
cord-005453-4057qib7	10119	36	-	-	HYPH
cord-005453-4057qib7	10119	37	matched	match	VBN
cord-005453-4057qib7	10119	38	(	(	-LRB-
cord-005453-4057qib7	10119	39	4pts	4pts	CD
cord-005453-4057qib7	10119	40	)	)	-RRB-
cord-005453-4057qib7	10119	41	,	,	,
cord-005453-4057qib7	10119	42	8/8	8/8	CD
cord-005453-4057qib7	10119	43	(	(	-LRB-
cord-005453-4057qib7	10119	44	1pt	1pt	NNP
cord-005453-4057qib7	10119	45	)	)	-RRB-
cord-005453-4057qib7	10119	46	or	or	CC
cord-005453-4057qib7	10119	47	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10119	48	(	(	-LRB-
cord-005453-4057qib7	10119	49	1pt	1pt	NNP
cord-005453-4057qib7	10119	50	)	)	-RRB-
cord-005453-4057qib7	10119	51	donor	donor	NN
cord-005453-4057qib7	10119	52	.	.	.
cord-005453-4057qib7	10120	1	Median	median	JJ
cord-005453-4057qib7	10120	2	time	time	NN
cord-005453-4057qib7	10120	3	for	for	IN
cord-005453-4057qib7	10120	4	the	the	DT
cord-005453-4057qib7	10120	5	onset	onset	NN
cord-005453-4057qib7	10120	6	of	of	IN
cord-005453-4057qib7	10120	7	BKV	BKV	NNP
cord-005453-4057qib7	10120	8	-	-	HYPH
cord-005453-4057qib7	10120	9	HC	HC	NNP
cord-005453-4057qib7	10120	10	after	after	IN
cord-005453-4057qib7	10120	11	allo	allo	NN
cord-005453-4057qib7	10120	12	-	-	HYPH
cord-005453-4057qib7	10120	13	HCT	HCT	NNP
cord-005453-4057qib7	10120	14	were	be	VBD
cord-005453-4057qib7	10120	15	53.5	53.5	CD
cord-005453-4057qib7	10120	16	days	day	NNS
cord-005453-4057qib7	10121	1	(	(	-LRB-
cord-005453-4057qib7	10121	2	range	range	NNP
cord-005453-4057qib7	10121	3	32	32	CD
cord-005453-4057qib7	10121	4	-	-	SYM
cord-005453-4057qib7	10121	5	117	117	CD
cord-005453-4057qib7	10121	6	)	)	-RRB-
cord-005453-4057qib7	10121	7	.	.	.
cord-005453-4057qib7	10122	1	All	all	DT
cord-005453-4057qib7	10122	2	patients	patient	NNS
cord-005453-4057qib7	10122	3	were	be	VBD
cord-005453-4057qib7	10122	4	under	under	IN
cord-005453-4057qib7	10122	5	standard	standard	JJ
cord-005453-4057qib7	10122	6	cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	10122	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10122	8	and	and	CC
cord-005453-4057qib7	10122	9	none	none	NN
cord-005453-4057qib7	10122	10	of	of	IN
cord-005453-4057qib7	10122	11	the	the	DT
cord-005453-4057qib7	10122	12	patients	patient	NNS
cord-005453-4057qib7	10122	13	had	have	VBD
cord-005453-4057qib7	10122	14	any	any	DT
cord-005453-4057qib7	10122	15	signs	sign	NNS
cord-005453-4057qib7	10122	16	of	of	IN
cord-005453-4057qib7	10122	17	acute	acute	JJ
cord-005453-4057qib7	10122	18	GvHD	gvhd	NN
cord-005453-4057qib7	10122	19	at	at	IN
cord-005453-4057qib7	10122	20	the	the	DT
cord-005453-4057qib7	10122	21	time	time	NN
cord-005453-4057qib7	10122	22	of	of	IN
cord-005453-4057qib7	10122	23	onset	onset	NN
cord-005453-4057qib7	10122	24	of	of	IN
cord-005453-4057qib7	10122	25	HC	HC	NNP
cord-005453-4057qib7	10122	26	.	.	.
cord-005453-4057qib7	10123	1	The	the	DT
cord-005453-4057qib7	10123	2	median	median	JJ
cord-005453-4057qib7	10123	3	PCR	PCR	NNP
cord-005453-4057qib7	10123	4	-	-	HYPH
cord-005453-4057qib7	10123	5	BKV	BKV	NNP
cord-005453-4057qib7	10123	6	viral	viral	JJ
cord-005453-4057qib7	10123	7	load	load	NN
cord-005453-4057qib7	10123	8	at	at	IN
cord-005453-4057qib7	10123	9	the	the	DT
cord-005453-4057qib7	10123	10	onset	onset	NN
cord-005453-4057qib7	10123	11	of	of	IN
cord-005453-4057qib7	10123	12	BKV	BKV	NNP
cord-005453-4057qib7	10123	13	-	-	HYPH
cord-005453-4057qib7	10123	14	HC	HC	NNP
cord-005453-4057qib7	10123	15	in	in	IN
cord-005453-4057qib7	10123	16	urine	urine	NN
cord-005453-4057qib7	10123	17	and	and	CC
cord-005453-4057qib7	10123	18	plasma	plasma	NN
cord-005453-4057qib7	10123	19	were	be	VBD
cord-005453-4057qib7	10123	20	5.75x10	5.75x10	CD
cord-005453-4057qib7	10123	21	8	8	CD
cord-005453-4057qib7	10124	1	(	(	-LRB-
cord-005453-4057qib7	10124	2	range	range	VBP
cord-005453-4057qib7	10124	3	0.15x10	0.15x10	CD
cord-005453-4057qib7	10124	4	8	8	CD
cord-005453-4057qib7	10124	5	-59x10	-59x10	SYM
cord-005453-4057qib7	10124	6	8	8	CD
cord-005453-4057qib7	10124	7	)	)	-RRB-
cord-005453-4057qib7	10125	1	and	and	CC
cord-005453-4057qib7	10125	2	141.5	141.5	CD
cord-005453-4057qib7	10125	3	(	(	-LRB-
cord-005453-4057qib7	10125	4	range	range	NN
cord-005453-4057qib7	10125	5	0	0	CD
cord-005453-4057qib7	10125	6	-	-	HYPH
cord-005453-4057qib7	10125	7	255	255	CD
cord-005453-4057qib7	10125	8	)	)	-RRB-
cord-005453-4057qib7	10125	9	,	,	,
cord-005453-4057qib7	10125	10	respectively	respectively	RB
cord-005453-4057qib7	10125	11	.	.	.
cord-005453-4057qib7	10126	1	The	the	DT
cord-005453-4057qib7	10126	2	median	median	JJ
cord-005453-4057qib7	10126	3	maximum	maximum	JJ
cord-005453-4057qib7	10126	4	PCR	PCR	NNP
cord-005453-4057qib7	10126	5	-	-	HYPH
cord-005453-4057qib7	10126	6	BKV	BKV	NNP
cord-005453-4057qib7	10126	7	viral	viral	JJ
cord-005453-4057qib7	10126	8	load	load	NN
cord-005453-4057qib7	10126	9	in	in	IN
cord-005453-4057qib7	10126	10	urine	urine	NN
cord-005453-4057qib7	10126	11	and	and	CC
cord-005453-4057qib7	10126	12	plasma	plasma	NN
cord-005453-4057qib7	10126	13	were	be	VBD
cord-005453-4057qib7	10126	14	37.5x10	37.5x10	CD
cord-005453-4057qib7	10126	15	8	8	CD
cord-005453-4057qib7	10127	1	(	(	-LRB-
cord-005453-4057qib7	10127	2	range	range	NN
cord-005453-4057qib7	10127	3	4.7x10	4.7x10	CD
cord-005453-4057qib7	10127	4	8	8	CD
cord-005453-4057qib7	10127	5	-450x10	-450x10	SYM
cord-005453-4057qib7	10127	6	8	8	CD
cord-005453-4057qib7	10127	7	)	)	-RRB-
cord-005453-4057qib7	10127	8	and	and	CC
cord-005453-4057qib7	10127	9	1.100	1.100	CD
cord-005453-4057qib7	10128	1	(	(	-LRB-
cord-005453-4057qib7	10128	2	range	range	NN
cord-005453-4057qib7	10128	3	0	0	CD
cord-005453-4057qib7	10128	4	-	-	CD
cord-005453-4057qib7	10128	5	400.000	400.000	CD
cord-005453-4057qib7	10128	6	)	)	-RRB-
cord-005453-4057qib7	10128	7	,	,	,
cord-005453-4057qib7	10128	8	respectively	respectively	RB
cord-005453-4057qib7	10128	9	.	.	.
cord-005453-4057qib7	10129	1	Five	five	CD
cord-005453-4057qib7	10129	2	patients	patient	NNS
cord-005453-4057qib7	10129	3	had	have	VBD
cord-005453-4057qib7	10129	4	impaired	impair	VBN
cord-005453-4057qib7	10129	5	renal	renal	JJ
cord-005453-4057qib7	10129	6	function	function	NN
cord-005453-4057qib7	10129	7	(	(	-LRB-
cord-005453-4057qib7	10129	8	median	median	NN
cord-005453-4057qib7	10129	9	eGFR	egfr	NN
cord-005453-4057qib7	10129	10	49	49	CD
cord-005453-4057qib7	10129	11	ml	ml	NNS
cord-005453-4057qib7	10129	12	/	/	SYM
cord-005453-4057qib7	10129	13	min	min	NN
cord-005453-4057qib7	10129	14	,	,	,
cord-005453-4057qib7	10129	15	range	range	VBP
cord-005453-4057qib7	10129	16	33	33	CD
cord-005453-4057qib7	10129	17	-	-	SYM
cord-005453-4057qib7	10129	18	53	53	CD
cord-005453-4057qib7	10129	19	)	)	-RRB-
cord-005453-4057qib7	10129	20	at	at	IN
cord-005453-4057qib7	10129	21	first	first	JJ
cord-005453-4057qib7	10129	22	ICI	ICI	NNP
cord-005453-4057qib7	10129	23	which	which	WDT
cord-005453-4057qib7	10129	24	was	be	VBD
cord-005453-4057qib7	10129	25	probably	probably	RB
cord-005453-4057qib7	10129	26	multifactorial	multifactorial	JJ
cord-005453-4057qib7	10129	27	.	.	.
cord-005453-4057qib7	10130	1	The	the	DT
cord-005453-4057qib7	10130	2	median	median	JJ
cord-005453-4057qib7	10130	3	dose	dose	NN
cord-005453-4057qib7	10130	4	of	of	IN
cord-005453-4057qib7	10130	5	intravesical	intravesical	JJ
cord-005453-4057qib7	10130	6	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10130	7	was	be	VBD
cord-005453-4057qib7	10130	8	5	5	CD
cord-005453-4057qib7	10130	9	mg	mg	NNP
cord-005453-4057qib7	10130	10	/	/	SYM
cord-005453-4057qib7	10130	11	kg	kg	NNP
cord-005453-4057qib7	10130	12	(	(	-LRB-
cord-005453-4057qib7	10130	13	range	range	VBP
cord-005453-4057qib7	10130	14	2.5	2.5	CD
cord-005453-4057qib7	10130	15	-	-	SYM
cord-005453-4057qib7	10130	16	5	5	CD
cord-005453-4057qib7	10130	17	mg	mg	NNP
cord-005453-4057qib7	10130	18	/	/	SYM
cord-005453-4057qib7	10130	19	kg	kg	NNP
cord-005453-4057qib7	10130	20	)	)	-RRB-
cord-005453-4057qib7	10130	21	and	and	CC
cord-005453-4057qib7	10130	22	a	a	DT
cord-005453-4057qib7	10130	23	median	median	JJ
cord-005453-4057qib7	10130	24	number	number	NN
cord-005453-4057qib7	10130	25	of	of	IN
cord-005453-4057qib7	10130	26	3.5	3.5	CD
cord-005453-4057qib7	10130	27	instillations	instillation	NNS
cord-005453-4057qib7	10130	28	(	(	-LRB-
cord-005453-4057qib7	10130	29	range	range	NNP
cord-005453-4057qib7	10130	30	2	2	CD
cord-005453-4057qib7	10130	31	-	-	SYM
cord-005453-4057qib7	10130	32	7	7	CD
cord-005453-4057qib7	10130	33	)	)	-RRB-
cord-005453-4057qib7	10130	34	were	be	VBD
cord-005453-4057qib7	10130	35	given	give	VBN
cord-005453-4057qib7	10130	36	.	.	.
cord-005453-4057qib7	10131	1	In	in	IN
cord-005453-4057qib7	10131	2	5/6	5/6	CD
cord-005453-4057qib7	10131	3	cases	case	NNS
cord-005453-4057qib7	10131	4	symptoms	symptom	NNS
cord-005453-4057qib7	10131	5	of	of	IN
cord-005453-4057qib7	10131	6	cystitis	cystitis	NN
cord-005453-4057qib7	10131	7	improved	improve	VBD
cord-005453-4057qib7	10131	8	dramatically	dramatically	RB
cord-005453-4057qib7	10131	9	and	and	CC
cord-005453-4057qib7	10131	10	hematuria	hematuria	NN
cord-005453-4057qib7	10131	11	resolved	resolve	VBN
cord-005453-4057qib7	10131	12	.	.	.
cord-005453-4057qib7	10132	1	Virological	virological	JJ
cord-005453-4057qib7	10132	2	response	response	NN
cord-005453-4057qib7	10132	3	(	(	-LRB-
cord-005453-4057qib7	10132	4	at	at	IN
cord-005453-4057qib7	10132	5	least	least	JJS
cord-005453-4057qib7	10132	6	1	1	CD
cord-005453-4057qib7	10132	7	log	log	NN
cord-005453-4057qib7	10132	8	reduction	reduction	NN
cord-005453-4057qib7	10132	9	)	)	-RRB-
cord-005453-4057qib7	10132	10	was	be	VBD
cord-005453-4057qib7	10132	11	observed	observe	VBN
cord-005453-4057qib7	10132	12	in	in	IN
cord-005453-4057qib7	10132	13	all	all	DT
cord-005453-4057qib7	10132	14	5	5	CD
cord-005453-4057qib7	10132	15	cases	case	NNS
cord-005453-4057qib7	10132	16	.	.	.
cord-005453-4057qib7	10133	1	Two	two	CD
cord-005453-4057qib7	10133	2	patients	patient	NNS
cord-005453-4057qib7	10133	3	experienced	experience	VBD
cord-005453-4057qib7	10133	4	relapse	relapse	NN
cord-005453-4057qib7	10133	5	of	of	IN
cord-005453-4057qib7	10133	6	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	10133	7	cystitis	cystitis	NN
cord-005453-4057qib7	10133	8	and	and	CC
cord-005453-4057qib7	10133	9	were	be	VBD
cord-005453-4057qib7	10133	10	retreated	retreat	VBN
cord-005453-4057qib7	10133	11	with	with	IN
cord-005453-4057qib7	10133	12	ICI	ICI	NNP
cord-005453-4057qib7	10133	13	which	which	WDT
cord-005453-4057qib7	10133	14	resulted	result	VBD
cord-005453-4057qib7	10133	15	in	in	IN
cord-005453-4057qib7	10133	16	resolution	resolution	NN
cord-005453-4057qib7	10133	17	of	of	IN
cord-005453-4057qib7	10133	18	the	the	DT
cord-005453-4057qib7	10133	19	symptoms	symptom	NNS
cord-005453-4057qib7	10133	20	and	and	CC
cord-005453-4057qib7	10133	21	the	the	DT
cord-005453-4057qib7	10133	22	hematuria	hematuria	NN
cord-005453-4057qib7	10133	23	.	.	.
cord-005453-4057qib7	10134	1	No	no	DT
cord-005453-4057qib7	10134	2	deterioration	deterioration	NN
cord-005453-4057qib7	10134	3	of	of	IN
cord-005453-4057qib7	10134	4	renal	renal	JJ
cord-005453-4057qib7	10134	5	function	function	NN
cord-005453-4057qib7	10134	6	of	of	IN
cord-005453-4057qib7	10134	7	other	other	JJ
cord-005453-4057qib7	10134	8	systemic	systemic	JJ
cord-005453-4057qib7	10134	9	adverse	adverse	JJ
cord-005453-4057qib7	10134	10	effects	effect	NNS
cord-005453-4057qib7	10134	11	were	be	VBD
cord-005453-4057qib7	10134	12	observed	observe	VBN
cord-005453-4057qib7	10134	13	.	.	.
cord-005453-4057qib7	10135	1	After	after	IN
cord-005453-4057qib7	10135	2	a	a	DT
cord-005453-4057qib7	10135	3	median	median	NN
cord-005453-4057qib7	10135	4	follow	follow	NN
cord-005453-4057qib7	10135	5	up	up	IN
cord-005453-4057qib7	10135	6	of	of	IN
cord-005453-4057qib7	10135	7	190.5	190.5	CD
cord-005453-4057qib7	10135	8	days	day	NNS
cord-005453-4057qib7	10135	9	after	after	IN
cord-005453-4057qib7	10135	10	transplantation	transplantation	NN
cord-005453-4057qib7	10135	11	(	(	-LRB-
cord-005453-4057qib7	10135	12	range	range	NNP
cord-005453-4057qib7	10135	13	105	105	CD
cord-005453-4057qib7	10135	14	-	-	SYM
cord-005453-4057qib7	10135	15	360	360	CD
cord-005453-4057qib7	10135	16	)	)	-RRB-
cord-005453-4057qib7	10135	17	,	,	,
cord-005453-4057qib7	10135	18	3/6	3/6	CD
cord-005453-4057qib7	10135	19	patients	patient	NNS
cord-005453-4057qib7	10135	20	are	be	VBP
cord-005453-4057qib7	10135	21	alive	alive	JJ
cord-005453-4057qib7	10135	22	without	without	IN
cord-005453-4057qib7	10135	23	cystitis	cystitis	NN
cord-005453-4057qib7	10135	24	symptomatology	symptomatology	NN
cord-005453-4057qib7	10135	25	and	and	CC
cord-005453-4057qib7	10135	26	3	3	CD
cord-005453-4057qib7	10135	27	died	die	VBD
cord-005453-4057qib7	10135	28	(	(	-LRB-
cord-005453-4057qib7	10135	29	1	1	CD
cord-005453-4057qib7	10135	30	due	due	JJ
cord-005453-4057qib7	10135	31	to	to	IN
cord-005453-4057qib7	10135	32	relapse	relapse	NN
cord-005453-4057qib7	10135	33	and	and	CC
cord-005453-4057qib7	10135	34	2	2	CD
cord-005453-4057qib7	10135	35	due	due	IN
cord-005453-4057qib7	10135	36	to	to	IN
cord-005453-4057qib7	10135	37	TRM	TRM	NNP
cord-005453-4057qib7	10135	38	)	)	-RRB-
cord-005453-4057qib7	10135	39	.	.	.
cord-005453-4057qib7	10136	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10136	2	:	:	:
cord-005453-4057qib7	10137	1	In	in	IN
cord-005453-4057qib7	10137	2	this	this	DT
cord-005453-4057qib7	10137	3	retrospective	retrospective	JJ
cord-005453-4057qib7	10137	4	study	study	NN
cord-005453-4057qib7	10137	5	we	-PRON-	PRP
cord-005453-4057qib7	10137	6	propose	propose	VBP
cord-005453-4057qib7	10137	7	that	that	IN
cord-005453-4057qib7	10137	8	local	local	JJ
cord-005453-4057qib7	10137	9	therapy	therapy	NN
cord-005453-4057qib7	10137	10	of	of	IN
cord-005453-4057qib7	10137	11	BKV	BKV	NNP
cord-005453-4057qib7	10137	12	-	-	HYPH
cord-005453-4057qib7	10137	13	HC	HC	NNP
cord-005453-4057qib7	10137	14	with	with	IN
cord-005453-4057qib7	10137	15	ICI	ICI	NNP
cord-005453-4057qib7	10137	16	is	be	VBZ
cord-005453-4057qib7	10137	17	safe	safe	JJ
cord-005453-4057qib7	10137	18	and	and	CC
cord-005453-4057qib7	10137	19	has	have	VBZ
cord-005453-4057qib7	10137	20	high	high	JJ
cord-005453-4057qib7	10137	21	clinical	clinical	JJ
cord-005453-4057qib7	10137	22	and	and	CC
cord-005453-4057qib7	10137	23	virological	virological	JJ
cord-005453-4057qib7	10137	24	response	response	NN
cord-005453-4057qib7	10137	25	rates	rate	NNS
cord-005453-4057qib7	10137	26	.	.	.
cord-005453-4057qib7	10138	1	The	the	DT
cord-005453-4057qib7	10138	2	administration	administration	NN
cord-005453-4057qib7	10138	3	of	of	IN
cord-005453-4057qib7	10138	4	ICI	ICI	NNP
cord-005453-4057qib7	10138	5	after	after	IN
cord-005453-4057qib7	10138	6	allo	allo	NN
cord-005453-4057qib7	10138	7	-	-	HYPH
cord-005453-4057qib7	10138	8	HCT	hct	NN
cord-005453-4057qib7	10138	9	should	should	MD
cord-005453-4057qib7	10138	10	be	be	VB
cord-005453-4057qib7	10138	11	controlled	control	VBN
cord-005453-4057qib7	10138	12	in	in	IN
cord-005453-4057qib7	10138	13	prospective	prospective	JJ
cord-005453-4057qib7	10138	14	randomized	randomized	JJ
cord-005453-4057qib7	10138	15	trials	trial	NNS
cord-005453-4057qib7	10138	16	.	.	.
cord-005453-4057qib7	10139	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10139	2	:	:	:
cord-005453-4057qib7	10139	3	Nothing	nothing	NN
cord-005453-4057qib7	10139	4	to	to	TO
cord-005453-4057qib7	10139	5	declare	declare	VB
cord-005453-4057qib7	10139	6	Background	background	NN
cord-005453-4057qib7	10139	7	:	:	:
cord-005453-4057qib7	10140	1	Since	since	IN
cord-005453-4057qib7	10140	2	CMV	CMV	NNP
cord-005453-4057qib7	10140	3	-	-	HYPH
cord-005453-4057qib7	10140	4	preemptive	preemptive	JJ
cord-005453-4057qib7	10140	5	therapy	therapy	NN
cord-005453-4057qib7	10140	6	approach	approach	NN
cord-005453-4057qib7	10140	7	was	be	VBD
cord-005453-4057qib7	10140	8	implemented	implement	VBN
cord-005453-4057qib7	10140	9	,	,	,
cord-005453-4057qib7	10140	10	CMV	CMV	NNP
cord-005453-4057qib7	10140	11	disease	disease	NN
cord-005453-4057qib7	10140	12	frequency	frequency	NN
cord-005453-4057qib7	10140	13	is	be	VBZ
cord-005453-4057qib7	10140	14	very	very	RB
cord-005453-4057qib7	10140	15	low	low	JJ
cord-005453-4057qib7	10140	16	.	.	.
cord-005453-4057qib7	10141	1	However	however	RB
cord-005453-4057qib7	10141	2	,	,	,
cord-005453-4057qib7	10141	3	CMV	CMV	NNP
cord-005453-4057qib7	10141	4	reactivation	reactivation	NN
cord-005453-4057qib7	10141	5	and	and	CC
cord-005453-4057qib7	10141	6	the	the	DT
cord-005453-4057qib7	10141	7	need	need	NN
cord-005453-4057qib7	10141	8	of	of	IN
cord-005453-4057qib7	10141	9	using	use	VBG
cord-005453-4057qib7	10141	10	nephrotoxic	nephrotoxic	NNP
cord-005453-4057qib7	10141	11	plus	plus	CC
cord-005453-4057qib7	10141	12	/	/	SYM
cord-005453-4057qib7	10141	13	less	less	JJR
cord-005453-4057qib7	10141	14	myelotoxic	myelotoxic	JJ
cord-005453-4057qib7	10141	15	drugs	drug	NNS
cord-005453-4057qib7	10141	16	is	be	VBZ
cord-005453-4057qib7	10141	17	very	very	RB
cord-005453-4057qib7	10141	18	frequent	frequent	JJ
cord-005453-4057qib7	10141	19	.	.	.
cord-005453-4057qib7	10142	1	In	in	IN
cord-005453-4057qib7	10142	2	addition	addition	NN
cord-005453-4057qib7	10142	3	to	to	IN
cord-005453-4057qib7	10142	4	the	the	DT
cord-005453-4057qib7	10142	5	toxicity	toxicity	NN
cord-005453-4057qib7	10142	6	of	of	IN
cord-005453-4057qib7	10142	7	the	the	DT
cord-005453-4057qib7	10142	8	medications	medication	NNS
cord-005453-4057qib7	10142	9	to	to	TO
cord-005453-4057qib7	10142	10	avoid	avoid	VB
cord-005453-4057qib7	10142	11	CMV	CMV	NNP
cord-005453-4057qib7	10142	12	disease	disease	NN
cord-005453-4057qib7	10142	13	,	,	,
cord-005453-4057qib7	10142	14	other	other	JJ
cord-005453-4057qib7	10142	15	potential	potential	JJ
cord-005453-4057qib7	10142	16	adverse	adverse	JJ
cord-005453-4057qib7	10142	17	effects	effect	NNS
cord-005453-4057qib7	10142	18	of	of	IN
cord-005453-4057qib7	10142	19	CMV	CMV	NNP
cord-005453-4057qib7	10142	20	have	have	VBP
cord-005453-4057qib7	10142	21	been	be	VBN
cord-005453-4057qib7	10142	22	mentioned	mention	VBN
cord-005453-4057qib7	10142	23	in	in	IN
cord-005453-4057qib7	10142	24	medical	medical	JJ
cord-005453-4057qib7	10142	25	literature	literature	NN
cord-005453-4057qib7	10142	26	.	.	.
cord-005453-4057qib7	10143	1	In	in	IN
cord-005453-4057qib7	10143	2	this	this	DT
cord-005453-4057qib7	10143	3	study	study	NN
cord-005453-4057qib7	10143	4	,	,	,
cord-005453-4057qib7	10143	5	we	-PRON-	PRP
cord-005453-4057qib7	10143	6	wanted	want	VBD
cord-005453-4057qib7	10143	7	to	to	TO
cord-005453-4057qib7	10143	8	estimate	estimate	VB
cord-005453-4057qib7	10143	9	how	how	WRB
cord-005453-4057qib7	10143	10	recipient	recipient	NN
cord-005453-4057qib7	10143	11	/	/	SYM
cord-005453-4057qib7	10143	12	donor	donor	NN
cord-005453-4057qib7	10143	13	serologic	serologic	NN
cord-005453-4057qib7	10143	14	status	status	NN
cord-005453-4057qib7	10143	15	influences	influence	VBZ
cord-005453-4057qib7	10143	16	the	the	DT
cord-005453-4057qib7	10143	17	outcome	outcome	NN
cord-005453-4057qib7	10143	18	of	of	IN
cord-005453-4057qib7	10143	19	allo	allo	NN
cord-005453-4057qib7	10143	20	-	-	HYPH
cord-005453-4057qib7	10143	21	HSCT	HSCT	NNP
cord-005453-4057qib7	10143	22	in	in	IN
cord-005453-4057qib7	10143	23	our	-PRON-	PRP$
cord-005453-4057qib7	10143	24	most	most	RBS
cord-005453-4057qib7	10143	25	recent	recent	JJ
cord-005453-4057qib7	10143	26	series	series	NN
cord-005453-4057qib7	10143	27	of	of	IN
cord-005453-4057qib7	10143	28	patients	patient	NNS
cord-005453-4057qib7	10143	29	.	.	.
cord-005453-4057qib7	10144	1	Methods	method	NNS
cord-005453-4057qib7	10144	2	:	:	:
cord-005453-4057qib7	10145	1	the	the	DT
cord-005453-4057qib7	10145	2	population	population	NN
cord-005453-4057qib7	10145	3	analyzed	analyze	VBD
cord-005453-4057qib7	10145	4	for	for	IN
cord-005453-4057qib7	10145	5	this	this	DT
cord-005453-4057qib7	10145	6	report	report	NN
cord-005453-4057qib7	10145	7	is	be	VBZ
cord-005453-4057qib7	10145	8	the	the	DT
cord-005453-4057qib7	10145	9	all	all	DT
cord-005453-4057qib7	10145	10	224	224	CD
cord-005453-4057qib7	10145	11	patients	patient	NNS
cord-005453-4057qib7	10145	12	who	who	WP
cord-005453-4057qib7	10145	13	underwent	undergo	VBD
cord-005453-4057qib7	10145	14	allo	allo	NN
cord-005453-4057qib7	10145	15	-	-	HYPH
cord-005453-4057qib7	10145	16	HSCT	HSCT	NNP
cord-005453-4057qib7	10145	17	during	during	IN
cord-005453-4057qib7	10145	18	the	the	DT
cord-005453-4057qib7	10145	19	4-year	4-year	JJ
cord-005453-4057qib7	10145	20	period	period	NN
cord-005453-4057qib7	10145	21	from	from	IN
cord-005453-4057qib7	10145	22	October	October	NNP
cord-005453-4057qib7	10145	23	2014	2014	CD
cord-005453-4057qib7	10145	24	September	September	NNP
cord-005453-4057qib7	10145	25	2018	2018	CD
cord-005453-4057qib7	10145	26	in	in	IN
cord-005453-4057qib7	10145	27	our	-PRON-	PRP$
cord-005453-4057qib7	10145	28	Unit	unit	NN
cord-005453-4057qib7	10145	29	.	.	.
cord-005453-4057qib7	10146	1	Median	median	JJ
cord-005453-4057qib7	10146	2	age	age	NN
cord-005453-4057qib7	10146	3	at	at	IN
cord-005453-4057qib7	10146	4	transplant	transplant	NN
cord-005453-4057qib7	10146	5	was	be	VBD
cord-005453-4057qib7	10146	6	52	52	CD
cord-005453-4057qib7	10146	7	years	year	NNS
cord-005453-4057qib7	10147	1	(	(	-LRB-
cord-005453-4057qib7	10147	2	range	range	NN
cord-005453-4057qib7	10147	3	:	:	:
cord-005453-4057qib7	10147	4	7	7	CD
cord-005453-4057qib7	10147	5	-	-	SYM
cord-005453-4057qib7	10147	6	69	69	CD
cord-005453-4057qib7	10147	7	)	)	-RRB-
cord-005453-4057qib7	10147	8	.	.	.
cord-005453-4057qib7	10148	1	One	one	CD
cord-005453-4057qib7	10148	2	hundred	hundred	CD
cord-005453-4057qib7	10148	3	and	and	CC
cord-005453-4057qib7	10148	4	thirty	thirty	CD
cord-005453-4057qib7	10148	5	were	be	VBD
cord-005453-4057qib7	10148	6	male	male	JJ
cord-005453-4057qib7	10148	7	(	(	-LRB-
cord-005453-4057qib7	10148	8	58	58	CD
cord-005453-4057qib7	10148	9	%	%	NN
cord-005453-4057qib7	10148	10	)	)	-RRB-
cord-005453-4057qib7	10148	11	and	and	CC
cord-005453-4057qib7	10148	12	94	94	CD
cord-005453-4057qib7	10148	13	were	be	VBD
cord-005453-4057qib7	10148	14	female	female	JJ
cord-005453-4057qib7	10148	15	(	(	-LRB-
cord-005453-4057qib7	10148	16	42	42	CD
cord-005453-4057qib7	10148	17	%	%	NN
cord-005453-4057qib7	10148	18	)	)	-RRB-
cord-005453-4057qib7	10148	19	.	.	.
cord-005453-4057qib7	10149	1	Baseline	baseline	JJ
cord-005453-4057qib7	10149	2	diseases	disease	NNS
cord-005453-4057qib7	10149	3	were	be	VBD
cord-005453-4057qib7	10149	4	:	:	:
cord-005453-4057qib7	10149	5	83	83	CD
cord-005453-4057qib7	10149	6	AML	AML	NNP
cord-005453-4057qib7	10149	7	,	,	,
cord-005453-4057qib7	10149	8	51	51	CD
cord-005453-4057qib7	10149	9	LPD	LPD	NNP
cord-005453-4057qib7	10149	10	,	,	,
cord-005453-4057qib7	10149	11	29	29	CD
cord-005453-4057qib7	10149	12	ALL	all	DT
cord-005453-4057qib7	10149	13	,	,	,
cord-005453-4057qib7	10149	14	29	29	CD
cord-005453-4057qib7	10149	15	MDS	MDS	NNP
cord-005453-4057qib7	10149	16	,	,	,
cord-005453-4057qib7	10149	17	14	14	CD
cord-005453-4057qib7	10149	18	MPD	MPD	NNP
cord-005453-4057qib7	10149	19	,	,	,
cord-005453-4057qib7	10149	20	12	12	CD
cord-005453-4057qib7	10149	21	MM	MM	NNP
cord-005453-4057qib7	10149	22	,	,	,
cord-005453-4057qib7	10149	23	and	and	CC
cord-005453-4057qib7	10149	24	6	6	CD
cord-005453-4057qib7	10149	25	BMF	bmf	NN
cord-005453-4057qib7	10149	26	.	.	.
cord-005453-4057qib7	10150	1	Donor	donor	NN
cord-005453-4057qib7	10150	2	was	be	VBD
cord-005453-4057qib7	10150	3	unrelated	unrelated	JJ
cord-005453-4057qib7	10150	4	in	in	IN
cord-005453-4057qib7	10150	5	120	120	CD
cord-005453-4057qib7	10150	6	transplants	transplant	NNS
cord-005453-4057qib7	10150	7	(	(	-LRB-
cord-005453-4057qib7	10150	8	54,5	54,5	CD
cord-005453-4057qib7	10150	9	%	%	NN
cord-005453-4057qib7	10150	10	)	)	-RRB-
cord-005453-4057qib7	10150	11	and	and	CC
cord-005453-4057qib7	10150	12	was	be	VBD
cord-005453-4057qib7	10150	13	family	family	NN
cord-005453-4057qib7	10150	14	in	in	IN
cord-005453-4057qib7	10150	15	104	104	CD
cord-005453-4057qib7	10150	16	(	(	-LRB-
cord-005453-4057qib7	10150	17	45,5	45,5	CD
cord-005453-4057qib7	10150	18	%	%	NN
cord-005453-4057qib7	10150	19	)	)	-RRB-
cord-005453-4057qib7	10150	20	(	(	-LRB-
cord-005453-4057qib7	10150	21	including	include	VBG
cord-005453-4057qib7	10150	22	34	34	CD
cord-005453-4057qib7	10150	23	haplo	haplo	NN
cord-005453-4057qib7	10150	24	-	-	HYPH
cord-005453-4057qib7	10150	25	identical	identical	JJ
cord-005453-4057qib7	10150	26	)	)	-RRB-
cord-005453-4057qib7	10150	27	.	.	.
cord-005453-4057qib7	10151	1	Conditioning	conditioning	NN
cord-005453-4057qib7	10151	2	regimen	regimen	NN
cord-005453-4057qib7	10151	3	was	be	VBD
cord-005453-4057qib7	10151	4	RIC	RIC	NNP
cord-005453-4057qib7	10151	5	in	in	IN
cord-005453-4057qib7	10151	6	121	121	CD
cord-005453-4057qib7	10151	7	procedures	procedure	NNS
cord-005453-4057qib7	10151	8	(	(	-LRB-
cord-005453-4057qib7	10151	9	54	54	CD
cord-005453-4057qib7	10151	10	%	%	NN
cord-005453-4057qib7	10151	11	)	)	-RRB-
cord-005453-4057qib7	10151	12	and	and	CC
cord-005453-4057qib7	10151	13	intensive	intensive	JJ
cord-005453-4057qib7	10151	14	in	in	IN
cord-005453-4057qib7	10151	15	103	103	CD
cord-005453-4057qib7	10151	16	(	(	-LRB-
cord-005453-4057qib7	10151	17	46	46	CD
cord-005453-4057qib7	10151	18	%	%	NN
cord-005453-4057qib7	10151	19	)	)	-RRB-
cord-005453-4057qib7	10151	20	.	.	.
cord-005453-4057qib7	10152	1	Stem	stem	JJ
cord-005453-4057qib7	10152	2	cell	cell	NN
cord-005453-4057qib7	10152	3	source	source	NN
cord-005453-4057qib7	10152	4	was	be	VBD
cord-005453-4057qib7	10152	5	PB	PB	NNP
cord-005453-4057qib7	10152	6	in	in	IN
cord-005453-4057qib7	10152	7	210	210	CD
cord-005453-4057qib7	10152	8	(	(	-LRB-
cord-005453-4057qib7	10152	9	93,7	93,7	CD
cord-005453-4057qib7	10152	10	%	%	NN
cord-005453-4057qib7	10152	11	)	)	-RRB-
cord-005453-4057qib7	10152	12	and	and	CC
cord-005453-4057qib7	10152	13	BM	BM	NNP
cord-005453-4057qib7	10152	14	in	in	IN
cord-005453-4057qib7	10152	15	14	14	CD
cord-005453-4057qib7	10152	16	cases	case	NNS
cord-005453-4057qib7	10152	17	(	(	-LRB-
cord-005453-4057qib7	10152	18	6,3	6,3	CD
cord-005453-4057qib7	10152	19	%	%	NN
cord-005453-4057qib7	10152	20	)	)	-RRB-
cord-005453-4057qib7	10152	21	.	.	.
cord-005453-4057qib7	10153	1	Median	median	JJ
cord-005453-4057qib7	10153	2	follow	follow	NN
cord-005453-4057qib7	10153	3	-	-	HYPH
cord-005453-4057qib7	10153	4	up	up	NN
cord-005453-4057qib7	10153	5	was	be	VBD
cord-005453-4057qib7	10153	6	23	23	CD
cord-005453-4057qib7	10153	7	months	month	NNS
cord-005453-4057qib7	10154	1	(	(	-LRB-
cord-005453-4057qib7	10154	2	range	range	NN
cord-005453-4057qib7	10154	3	:	:	:
cord-005453-4057qib7	10154	4	3	3	CD
cord-005453-4057qib7	10154	5	-	-	SYM
cord-005453-4057qib7	10154	6	50	50	CD
cord-005453-4057qib7	10154	7	)	)	-RRB-
cord-005453-4057qib7	10154	8	.	.	.
cord-005453-4057qib7	10155	1	Patient	Patient	NNP
cord-005453-4057qib7	10155	2	's	's	POS
cord-005453-4057qib7	10155	3	and	and	CC
cord-005453-4057qib7	10155	4	donor	donor	NN
cord-005453-4057qib7	10155	5	's	's	POS
cord-005453-4057qib7	10155	6	CMV	CMV	NNP
cord-005453-4057qib7	10155	7	IgG	igg	NN
cord-005453-4057qib7	10155	8	were	be	VBD
cord-005453-4057qib7	10155	9	positive	positive	JJ
cord-005453-4057qib7	10155	10	in	in	IN
cord-005453-4057qib7	10155	11	188	188	CD
cord-005453-4057qib7	10155	12	(	(	-LRB-
cord-005453-4057qib7	10155	13	82,6	82,6	CD
cord-005453-4057qib7	10155	14	%	%	NN
cord-005453-4057qib7	10155	15	)	)	-RRB-
cord-005453-4057qib7	10155	16	and	and	CC
cord-005453-4057qib7	10155	17	92	92	CD
cord-005453-4057qib7	10155	18	(	(	-LRB-
cord-005453-4057qib7	10155	19	58,5	58,5	CD
cord-005453-4057qib7	10155	20	%	%	NN
cord-005453-4057qib7	10155	21	)	)	-RRB-
cord-005453-4057qib7	10155	22	,	,	,
cord-005453-4057qib7	10155	23	respectively	respectively	RB
cord-005453-4057qib7	10155	24	.	.	.
cord-005453-4057qib7	10156	1	Recipient	recipient	NN
cord-005453-4057qib7	10156	2	/	/	SYM
cord-005453-4057qib7	10156	3	donor	donor	NN
cord-005453-4057qib7	10156	4	serology	serology	NN
cord-005453-4057qib7	10156	5	was	be	VBD
cord-005453-4057qib7	10156	6	+	+	CD
cord-005453-4057qib7	10156	7	/-(risk	/-(risk	CD
cord-005453-4057qib7	10156	8	group	group	NN
cord-005453-4057qib7	10156	9	1	1	CD
cord-005453-4057qib7	10156	10	)	)	-RRB-
cord-005453-4057qib7	10156	11	in	in	IN
cord-005453-4057qib7	10156	12	62	62	CD
cord-005453-4057qib7	10156	13	(	(	-LRB-
cord-005453-4057qib7	10156	14	27,7	27,7	CD
cord-005453-4057qib7	10156	15	%	%	NN
cord-005453-4057qib7	10156	16	)	)	-RRB-
cord-005453-4057qib7	10156	17	,	,	,
cord-005453-4057qib7	10156	18	+	+	CC
cord-005453-4057qib7	10156	19	/+	/+	.
cord-005453-4057qib7	10157	1	(	(	-LRB-
cord-005453-4057qib7	10157	2	risk	risk	NN
cord-005453-4057qib7	10157	3	group	group	NN
cord-005453-4057qib7	10157	4	2	2	CD
cord-005453-4057qib7	10157	5	)	)	-RRB-
cord-005453-4057qib7	10157	6	in	in	IN
cord-005453-4057qib7	10157	7	126	126	CD
cord-005453-4057qib7	10157	8	(	(	-LRB-
cord-005453-4057qib7	10157	9	56,3	56,3	CD
cord-005453-4057qib7	10157	10	%	%	NN
cord-005453-4057qib7	10157	11	)	)	-RRB-
cord-005453-4057qib7	10157	12	,	,	.
cord-005453-4057qib7	10158	1	-/+	-/+	.
cord-005453-4057qib7	10159	1	(	(	-LRB-
cord-005453-4057qib7	10159	2	risk	risk	NN
cord-005453-4057qib7	10159	3	group	group	NN
cord-005453-4057qib7	10159	4	3	3	CD
cord-005453-4057qib7	10159	5	)	)	-RRB-
cord-005453-4057qib7	10159	6	in	in	IN
cord-005453-4057qib7	10159	7	6	6	CD
cord-005453-4057qib7	10159	8	(	(	-LRB-
cord-005453-4057qib7	10159	9	2,6	2,6	CD
cord-005453-4057qib7	10159	10	%	%	NN
cord-005453-4057qib7	10159	11	)	)	-RRB-
cord-005453-4057qib7	10160	1	y	y	NNP
cord-005453-4057qib7	10160	2	-/-(risk	-/-(risk	NNP
cord-005453-4057qib7	10160	3	group	group	NNP
cord-005453-4057qib7	10160	4	4	4	CD
cord-005453-4057qib7	10160	5	)	)	-RRB-
cord-005453-4057qib7	10160	6	in	in	IN
cord-005453-4057qib7	10160	7	30	30	CD
cord-005453-4057qib7	10160	8	(	(	-LRB-
cord-005453-4057qib7	10160	9	13,4	13,4	CD
cord-005453-4057qib7	10160	10	%	%	NN
cord-005453-4057qib7	10160	11	)	)	-RRB-
cord-005453-4057qib7	10160	12	.	.	.
cord-005453-4057qib7	10161	1	Results	result	NNS
cord-005453-4057qib7	10161	2	:	:	:
cord-005453-4057qib7	10161	3	two	two	CD
cord-005453-4057qib7	10161	4	pts	pt	NNS
cord-005453-4057qib7	10161	5	underwent	undergo	VBD
cord-005453-4057qib7	10161	6	a	a	DT
cord-005453-4057qib7	10161	7	second	second	JJ
cord-005453-4057qib7	10161	8	transplant	transplant	NN
cord-005453-4057qib7	10161	9	before	before	IN
cord-005453-4057qib7	10161	10	day	day	NN
cord-005453-4057qib7	10161	11	+100	+100	NNS
cord-005453-4057qib7	10161	12	due	due	IN
cord-005453-4057qib7	10161	13	to	to	IN
cord-005453-4057qib7	10161	14	graft	graft	NN
cord-005453-4057qib7	10161	15	failure	failure	NN
cord-005453-4057qib7	10161	16	.	.	.
cord-005453-4057qib7	10162	1	Overall	overall	JJ
cord-005453-4057qib7	10162	2	mortalities	mortality	NNS
cord-005453-4057qib7	10162	3	(	(	-LRB-
cord-005453-4057qib7	10162	4	OM	OM	NNP
cord-005453-4057qib7	10162	5	)	)	-RRB-
cord-005453-4057qib7	10162	6	at	at	IN
cord-005453-4057qib7	10162	7	days	day	NNS
cord-005453-4057qib7	10162	8	+100	+100	NNP
cord-005453-4057qib7	10162	9	and	and	CC
cord-005453-4057qib7	10162	10	+365	+365	NNP
cord-005453-4057qib7	10162	11	of	of	IN
cord-005453-4057qib7	10162	12	the	the	DT
cord-005453-4057qib7	10162	13	rest	rest	NN
cord-005453-4057qib7	10162	14	of	of	IN
cord-005453-4057qib7	10162	15	the	the	DT
cord-005453-4057qib7	10162	16	series	series	NN
cord-005453-4057qib7	10162	17	(	(	-LRB-
cord-005453-4057qib7	10162	18	222	222	CD
cord-005453-4057qib7	10162	19	pts	pt	NNS
cord-005453-4057qib7	10162	20	)	)	-RRB-
cord-005453-4057qib7	10162	21	are	be	VBP
cord-005453-4057qib7	10162	22	shown	show	VBN
cord-005453-4057qib7	10162	23	in	in	IN
cord-005453-4057qib7	10162	24	table	table	NN
cord-005453-4057qib7	10162	25	.	.	.
cord-005453-4057qib7	10163	1	The	the	DT
cord-005453-4057qib7	10163	2	highest	high	JJS
cord-005453-4057qib7	10163	3	risk	risk	NN
cord-005453-4057qib7	10163	4	group	group	NN
cord-005453-4057qib7	10163	5	(	(	-LRB-
cord-005453-4057qib7	10163	6	recipient	recipient	NN
cord-005453-4057qib7	10163	7	CMV	CMV	NNP
cord-005453-4057qib7	10163	8	+	+	CC
cord-005453-4057qib7	10164	1	/	/	SYM
cord-005453-4057qib7	10164	2	donor	donor	NN
cord-005453-4057qib7	10164	3	CMV	CMV	NNP
cord-005453-4057qib7	10164	4	-	-	,
cord-005453-4057qib7	10164	5	)	)	-RRB-
cord-005453-4057qib7	10164	6	exhibited	exhibit	VBD
cord-005453-4057qib7	10164	7	more	more	RBR
cord-005453-4057qib7	10164	8	than	than	IN
cord-005453-4057qib7	10164	9	double	double	JJ
cord-005453-4057qib7	10164	10	OM	om	NN
cord-005453-4057qib7	10164	11	at	at	IN
cord-005453-4057qib7	10164	12	day	day	NN
cord-005453-4057qib7	10164	13	+100	+100	NNS
cord-005453-4057qib7	10164	14	and	and	CC
cord-005453-4057qib7	10164	15	more	more	JJR
cord-005453-4057qib7	10164	16	than	than	IN
cord-005453-4057qib7	10164	17	four	four	CD
cord-005453-4057qib7	10164	18	times	time	NNS
cord-005453-4057qib7	10164	19	OM	OM	NNP
cord-005453-4057qib7	10164	20	at	at	IN
cord-005453-4057qib7	10164	21	day	day	NN
cord-005453-4057qib7	10164	22	+365	+365	NNP
cord-005453-4057qib7	10164	23	,	,	,
cord-005453-4057qib7	10164	24	when	when	WRB
cord-005453-4057qib7	10164	25	compared	compare	VBN
cord-005453-4057qib7	10164	26	with	with	IN
cord-005453-4057qib7	10164	27	pts	pt	NNS
cord-005453-4057qib7	10164	28	at	at	IN
cord-005453-4057qib7	10164	29	lowest	low	JJS
cord-005453-4057qib7	10164	30	risk	risk	NN
cord-005453-4057qib7	10164	31	(	(	-LRB-
cord-005453-4057qib7	10164	32	recipient	recipient	NN
cord-005453-4057qib7	10164	33	CMV	CMV	NNP
cord-005453-4057qib7	10164	34	-	-	,
cord-005453-4057qib7	10164	35	)	)	-RRB-
cord-005453-4057qib7	10164	36	.	.	.
cord-005453-4057qib7	10165	1	Those	those	DT
cord-005453-4057qib7	10165	2	striking	striking	JJ
cord-005453-4057qib7	10165	3	differences	difference	NNS
cord-005453-4057qib7	10165	4	were	be	VBD
cord-005453-4057qib7	10165	5	mainly	mainly	RB
cord-005453-4057qib7	10165	6	due	due	JJ
cord-005453-4057qib7	10165	7	to	to	IN
cord-005453-4057qib7	10165	8	NRM	NRM	NNP
cord-005453-4057qib7	10165	9	.	.	.
cord-005453-4057qib7	10166	1	OM	OM	NNP
cord-005453-4057qib7	10166	2	for	for	IN
cord-005453-4057qib7	10166	3	risk	risk	NN
cord-005453-4057qib7	10166	4	group	group	NN
cord-005453-4057qib7	10166	5	II	II	NNP
cord-005453-4057qib7	10167	1	(	(	-LRB-
cord-005453-4057qib7	10167	2	recipient	recipient	NN
cord-005453-4057qib7	10167	3	CMV	CMV	NNP
cord-005453-4057qib7	10167	4	+	+	CC
cord-005453-4057qib7	10167	5	/	/	SYM
cord-005453-4057qib7	10167	6	donor	donor	NN
cord-005453-4057qib7	10167	7	CMV	CMV	NNP
cord-005453-4057qib7	10167	8	+	+	CC
cord-005453-4057qib7	10167	9	)	)	-RRB-
cord-005453-4057qib7	10167	10	was	be	VBD
cord-005453-4057qib7	10167	11	intermediate	intermediate	JJ
cord-005453-4057qib7	10167	12	.	.	.
cord-005453-4057qib7	10168	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10168	2	:	:	:
cord-005453-4057qib7	10168	3	in	in	IN
cord-005453-4057qib7	10168	4	our	-PRON-	PRP$
cord-005453-4057qib7	10168	5	studied	study	VBN
cord-005453-4057qib7	10168	6	population	population	NN
cord-005453-4057qib7	10168	7	,	,	,
cord-005453-4057qib7	10168	8	mainly	mainly	RB
cord-005453-4057qib7	10168	9	adult	adult	NN
cord-005453-4057qib7	10168	10	patients	patient	NNS
cord-005453-4057qib7	10168	11	,	,	,
cord-005453-4057qib7	10168	12	the	the	DT
cord-005453-4057qib7	10168	13	combination	combination	NN
cord-005453-4057qib7	10168	14	of	of	IN
cord-005453-4057qib7	10168	15	CMV	CMV	NNP
cord-005453-4057qib7	10168	16	-	-	HYPH
cord-005453-4057qib7	10168	17	seropositive	seropositive	JJ
cord-005453-4057qib7	10168	18	patient	patient	NN
cord-005453-4057qib7	10168	19	with	with	IN
cord-005453-4057qib7	10168	20	a	a	DT
cord-005453-4057qib7	10168	21	CMV	CMV	NNP
cord-005453-4057qib7	10168	22	-	-	HYPH
cord-005453-4057qib7	10168	23	seronegative	seronegative	JJ
cord-005453-4057qib7	10168	24	donor	donor	NN
cord-005453-4057qib7	10168	25	had	have	VBD
cord-005453-4057qib7	10168	26	a	a	DT
cord-005453-4057qib7	10168	27	very	very	RB
cord-005453-4057qib7	10168	28	clear	clear	JJ
cord-005453-4057qib7	10168	29	adverse	adverse	JJ
cord-005453-4057qib7	10168	30	impact	impact	NN
cord-005453-4057qib7	10168	31	on	on	IN
cord-005453-4057qib7	10168	32	HSCT	HSCT	NNP
cord-005453-4057qib7	10168	33	outcome	outcome	NN
cord-005453-4057qib7	10168	34	.	.	.
cord-005453-4057qib7	10169	1	As	as	IN
cord-005453-4057qib7	10169	2	a	a	DT
cord-005453-4057qib7	10169	3	result	result	NN
cord-005453-4057qib7	10169	4	,	,	,
cord-005453-4057qib7	10169	5	we	-PRON-	PRP
cord-005453-4057qib7	10169	6	considered	consider	VBD
cord-005453-4057qib7	10169	7	that	that	IN
cord-005453-4057qib7	10169	8	the	the	DT
cord-005453-4057qib7	10169	9	election	election	NN
cord-005453-4057qib7	10169	10	of	of	IN
cord-005453-4057qib7	10169	11	a	a	DT
cord-005453-4057qib7	10169	12	CMV	CMV	NNP
cord-005453-4057qib7	10169	13	-	-	HYPH
cord-005453-4057qib7	10169	14	positive	positive	JJ
cord-005453-4057qib7	10169	15	donor	donor	NN
cord-005453-4057qib7	10169	16	for	for	IN
cord-005453-4057qib7	10169	17	a	a	DT
cord-005453-4057qib7	10169	18	CMV	CMV	NNP
cord-005453-4057qib7	10169	19	-	-	HYPH
cord-005453-4057qib7	10169	20	positive	positive	JJ
cord-005453-4057qib7	10169	21	patient	patient	NN
cord-005453-4057qib7	10169	22	continues	continue	VBZ
cord-005453-4057qib7	10169	23	to	to	TO
cord-005453-4057qib7	10169	24	be	be	VB
cord-005453-4057qib7	10169	25	strongly	strongly	RB
cord-005453-4057qib7	10169	26	advisable	advisable	JJ
cord-005453-4057qib7	10169	27	,	,	,
cord-005453-4057qib7	10169	28	whenever	whenever	WRB
cord-005453-4057qib7	10169	29	is	be	VBZ
cord-005453-4057qib7	10169	30	possible	possible	JJ
cord-005453-4057qib7	10169	31	.	.	.
cord-005453-4057qib7	10170	1	On	on	IN
cord-005453-4057qib7	10170	2	the	the	DT
cord-005453-4057qib7	10170	3	other	other	JJ
cord-005453-4057qib7	10170	4	hand	hand	NN
cord-005453-4057qib7	10170	5	,	,	,
cord-005453-4057qib7	10170	6	once	once	IN
cord-005453-4057qib7	10170	7	Letermovir	Letermovir	NNP
cord-005453-4057qib7	10170	8	has	have	VBZ
cord-005453-4057qib7	10170	9	proved	prove	VBN
cord-005453-4057qib7	10170	10	to	to	TO
cord-005453-4057qib7	10170	11	be	be	VB
cord-005453-4057qib7	10170	12	efficient	efficient	JJ
cord-005453-4057qib7	10170	13	and	and	CC
cord-005453-4057qib7	10170	14	well	well	RB
cord-005453-4057qib7	10170	15	-	-	HYPH
cord-005453-4057qib7	10170	16	tolerated	tolerate	VBN
cord-005453-4057qib7	10170	17	and	and	CC
cord-005453-4057qib7	10170	18	has	have	VBZ
cord-005453-4057qib7	10170	19	been	be	VBN
cord-005453-4057qib7	10170	20	licensed	license	VBN
cord-005453-4057qib7	10170	21	for	for	IN
cord-005453-4057qib7	10170	22	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10170	23	of	of	IN
cord-005453-4057qib7	10170	24	CMV	CMV	NNP
cord-005453-4057qib7	10170	25	in	in	IN
cord-005453-4057qib7	10170	26	high	high	JJ
cord-005453-4057qib7	10170	27	risk	risk	NN
cord-005453-4057qib7	10170	28	recipients	recipient	NNS
cord-005453-4057qib7	10170	29	,	,	,
cord-005453-4057qib7	10170	30	this	this	DT
cord-005453-4057qib7	10170	31	approach	approach	NN
cord-005453-4057qib7	10170	32	appears	appear	VBZ
cord-005453-4057qib7	10170	33	to	to	TO
cord-005453-4057qib7	10170	34	be	be	VB
cord-005453-4057qib7	10170	35	very	very	RB
cord-005453-4057qib7	10170	36	attractive	attractive	JJ
cord-005453-4057qib7	10170	37	to	to	TO
cord-005453-4057qib7	10170	38	try	try	VB
cord-005453-4057qib7	10170	39	to	to	TO
cord-005453-4057qib7	10170	40	avoid	avoid	VB
cord-005453-4057qib7	10170	41	the	the	DT
cord-005453-4057qib7	10170	42	adverse	adverse	JJ
cord-005453-4057qib7	10170	43	impact	impact	NN
cord-005453-4057qib7	10170	44	of	of	IN
cord-005453-4057qib7	10170	45	recipient	recipient	NN
cord-005453-4057qib7	10170	46	CMV	CMV	NNP
cord-005453-4057qib7	10170	47	-	-	HYPH
cord-005453-4057qib7	10170	48	seropositivity	seropositivity	NN
cord-005453-4057qib7	10170	49	,	,	,
cord-005453-4057qib7	10170	50	particularly	particularly	RB
cord-005453-4057qib7	10170	51	when	when	WRB
cord-005453-4057qib7	10170	52	finally	finally	RB
cord-005453-4057qib7	10170	53	chosen	choose	VBN
cord-005453-4057qib7	10170	54	donor	donor	NN
cord-005453-4057qib7	10170	55	is	be	VBZ
cord-005453-4057qib7	10170	56	CMV	CMV	NNP
cord-005453-4057qib7	10170	57	negative	negative	JJ
cord-005453-4057qib7	10170	58	.	.	.
cord-005453-4057qib7	10171	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10171	2	:	:	:
cord-005453-4057qib7	10171	3	Nothing	nothing	NN
cord-005453-4057qib7	10171	4	to	to	TO
cord-005453-4057qib7	10171	5	declare	declare	VB
cord-005453-4057qib7	10171	6	An	an	DT
cord-005453-4057qib7	10171	7	active	active	JJ
cord-005453-4057qib7	10171	8	surveillance	surveillance	NN
cord-005453-4057qib7	10171	9	and	and	CC
cord-005453-4057qib7	10171	10	an	an	DT
cord-005453-4057qib7	10171	11	early	early	JJ
cord-005453-4057qib7	10171	12	and	and	CC
cord-005453-4057qib7	10171	13	individualized	individualized	JJ
cord-005453-4057qib7	10171	14	management	management	NN
cord-005453-4057qib7	10171	15	is	be	VBZ
cord-005453-4057qib7	10171	16	critical	critical	JJ
cord-005453-4057qib7	10171	17	to	to	TO
cord-005453-4057qib7	10171	18	avoid	avoid	VB
cord-005453-4057qib7	10171	19	mortality	mortality	NN
cord-005453-4057qib7	10171	20	from	from	IN
cord-005453-4057qib7	10171	21	respiratory	respiratory	JJ
cord-005453-4057qib7	10171	22	viral	viral	JJ
cord-005453-4057qib7	10171	23	infections	infection	NNS
cord-005453-4057qib7	10171	24	in	in	IN
cord-005453-4057qib7	10171	25	allo	allo	NN
cord-005453-4057qib7	10171	26	-	-	HYPH
cord-005453-4057qib7	10171	27	HSCT	HSCT	NNP
cord-005453-4057qib7	10171	28	recipients	recipient	NNS
cord-005453-4057qib7	10171	29	Background	Background	NNP
cord-005453-4057qib7	10171	30	:	:	:
cord-005453-4057qib7	10171	31	Respiratory	respiratory	JJ
cord-005453-4057qib7	10171	32	viral	viral	JJ
cord-005453-4057qib7	10171	33	infections	infection	NNS
cord-005453-4057qib7	10171	34	(	(	-LRB-
cord-005453-4057qib7	10171	35	RVIs	rvi	NNS
cord-005453-4057qib7	10171	36	)	)	-RRB-
cord-005453-4057qib7	10171	37	are	be	VBP
cord-005453-4057qib7	10171	38	frequent	frequent	JJ
cord-005453-4057qib7	10171	39	among	among	IN
cord-005453-4057qib7	10171	40	the	the	DT
cord-005453-4057qib7	10171	41	general	general	JJ
cord-005453-4057qib7	10171	42	population	population	NN
cord-005453-4057qib7	10171	43	.	.	.
cord-005453-4057qib7	10172	1	In	in	IN
cord-005453-4057qib7	10172	2	transplant	transplant	NN
cord-005453-4057qib7	10172	3	recipients	recipient	NNS
cord-005453-4057qib7	10172	4	,	,	,
cord-005453-4057qib7	10172	5	RVIs	rvi	NNS
cord-005453-4057qib7	10172	6	are	be	VBP
cord-005453-4057qib7	10172	7	known	know	VBN
cord-005453-4057qib7	10172	8	to	to	TO
cord-005453-4057qib7	10172	9	cause	cause	VB
cord-005453-4057qib7	10172	10	an	an	DT
cord-005453-4057qib7	10172	11	important	important	JJ
cord-005453-4057qib7	10172	12	morbidity	morbidity	NN
cord-005453-4057qib7	10172	13	and	and	CC
cord-005453-4057qib7	10172	14	potential	potential	JJ
cord-005453-4057qib7	10172	15	mortality	mortality	NN
cord-005453-4057qib7	10172	16	.	.	.
cord-005453-4057qib7	10173	1	For	for	IN
cord-005453-4057qib7	10173	2	this	this	DT
cord-005453-4057qib7	10173	3	reason	reason	NN
cord-005453-4057qib7	10173	4	and	and	CC
cord-005453-4057qib7	10173	5	several	several	JJ
cord-005453-4057qib7	10173	6	others	other	NNS
cord-005453-4057qib7	10173	7	,	,	,
cord-005453-4057qib7	10173	8	as	as	IN
cord-005453-4057qib7	10173	9	the	the	DT
cord-005453-4057qib7	10173	10	need	need	NN
cord-005453-4057qib7	10173	11	of	of	IN
cord-005453-4057qib7	10173	12	preventing	prevent	VBG
cord-005453-4057qib7	10173	13	other	other	JJ
cord-005453-4057qib7	10173	14	pts	pt	NNS
cord-005453-4057qib7	10173	15	from	from	IN
cord-005453-4057qib7	10173	16	contagious	contagious	JJ
cord-005453-4057qib7	10173	17	or	or	CC
cord-005453-4057qib7	10173	18	avoiding	avoid	VBG
cord-005453-4057qib7	10173	19	misdiagnosis	misdiagnosis	NN
cord-005453-4057qib7	10173	20	with	with	IN
cord-005453-4057qib7	10173	21	other	other	JJ
cord-005453-4057qib7	10173	22	infections	infection	NNS
cord-005453-4057qib7	10173	23	processes	process	NNS
cord-005453-4057qib7	10173	24	,	,	,
cord-005453-4057qib7	10173	25	a	a	DT
cord-005453-4057qib7	10173	26	high	high	JJ
cord-005453-4057qib7	10173	27	index	index	NN
cord-005453-4057qib7	10173	28	of	of	IN
cord-005453-4057qib7	10173	29	suspicion	suspicion	NN
cord-005453-4057qib7	10173	30	of	of	IN
cord-005453-4057qib7	10173	31	VRIs	vris	NN
cord-005453-4057qib7	10173	32	is	be	VBZ
cord-005453-4057qib7	10173	33	necessary	necessary	JJ
cord-005453-4057qib7	10173	34	.	.	.
cord-005453-4057qib7	10174	1	During	during	IN
cord-005453-4057qib7	10174	2	the	the	DT
cord-005453-4057qib7	10174	3	last	last	JJ
cord-005453-4057qib7	10174	4	few	few	JJ
cord-005453-4057qib7	10174	5	years	year	NNS
cord-005453-4057qib7	10174	6	,	,	,
cord-005453-4057qib7	10174	7	we	-PRON-	PRP
cord-005453-4057qib7	10174	8	have	have	VBP
cord-005453-4057qib7	10174	9	implemented	implement	VBN
cord-005453-4057qib7	10174	10	an	an	DT
cord-005453-4057qib7	10174	11	active	active	JJ
cord-005453-4057qib7	10174	12	and	and	CC
cord-005453-4057qib7	10174	13	systematic	systematic	JJ
cord-005453-4057qib7	10174	14	surveillance	surveillance	NN
cord-005453-4057qib7	10174	15	policy	policy	NN
cord-005453-4057qib7	10174	16	orientedto	orientedto	NN
cord-005453-4057qib7	10174	17	early	early	JJ
cord-005453-4057qib7	10174	18	detection	detection	NN
cord-005453-4057qib7	10174	19	and	and	CC
cord-005453-4057qib7	10174	20	management	management	NN
cord-005453-4057qib7	10174	21	of	of	IN
cord-005453-4057qib7	10174	22	RVIs	rvi	NNS
cord-005453-4057qib7	10174	23	in	in	IN
cord-005453-4057qib7	10174	24	the	the	DT
cord-005453-4057qib7	10174	25	HSCT	HSCT	NNP
cord-005453-4057qib7	10174	26	recipients	recipient	NNS
cord-005453-4057qib7	10174	27	.	.	.
cord-005453-4057qib7	10175	1	Methods	method	NNS
cord-005453-4057qib7	10175	2	:	:	:
cord-005453-4057qib7	10176	1	The	the	DT
cord-005453-4057qib7	10176	2	population	population	NN
cord-005453-4057qib7	10176	3	analyzed	analyze	VBD
cord-005453-4057qib7	10176	4	for	for	IN
cord-005453-4057qib7	10176	5	this	this	DT
cord-005453-4057qib7	10176	6	report	report	NN
cord-005453-4057qib7	10176	7	is	be	VBZ
cord-005453-4057qib7	10176	8	the	the	DT
cord-005453-4057qib7	10176	9	175	175	CD
cord-005453-4057qib7	10176	10	patients	patient	NNS
cord-005453-4057qib7	10176	11	who	who	WP
cord-005453-4057qib7	10176	12	underwent	undergo	VBD
cord-005453-4057qib7	10176	13	allo	allo	NN
cord-005453-4057qib7	10176	14	-	-	HYPH
cord-005453-4057qib7	10176	15	HSCT	HSCT	NNP
cord-005453-4057qib7	10176	16	from	from	IN
cord-005453-4057qib7	10176	17	January	January	NNP
cord-005453-4057qib7	10176	18	2015	2015	CD
cord-005453-4057qib7	10176	19	through	through	IN
cord-005453-4057qib7	10176	20	March	March	NNP
cord-005453-4057qib7	10176	21	2018	2018	CD
cord-005453-4057qib7	10176	22	in	in	IN
cord-005453-4057qib7	10176	23	our	-PRON-	PRP$
cord-005453-4057qib7	10176	24	Unit	unit	NN
cord-005453-4057qib7	10176	25	.	.	.
cord-005453-4057qib7	10177	1	Median	median	JJ
cord-005453-4057qib7	10177	2	age	age	NN
cord-005453-4057qib7	10177	3	at	at	IN
cord-005453-4057qib7	10177	4	transplant	transplant	NN
cord-005453-4057qib7	10177	5	was	be	VBD
cord-005453-4057qib7	10177	6	51	51	CD
cord-005453-4057qib7	10177	7	years	year	NNS
cord-005453-4057qib7	10178	1	(	(	-LRB-
cord-005453-4057qib7	10178	2	range	range	NN
cord-005453-4057qib7	10178	3	:	:	:
cord-005453-4057qib7	10178	4	7	7	CD
cord-005453-4057qib7	10178	5	-	-	SYM
cord-005453-4057qib7	10178	6	69	69	CD
cord-005453-4057qib7	10178	7	)	)	-RRB-
cord-005453-4057qib7	10178	8	.	.	.
cord-005453-4057qib7	10179	1	One	one	CD
cord-005453-4057qib7	10179	2	hundred	hundred	CD
cord-005453-4057qib7	10179	3	and	and	CC
cord-005453-4057qib7	10179	4	four	four	CD
cord-005453-4057qib7	10179	5	were	be	VBD
cord-005453-4057qib7	10179	6	male	male	JJ
cord-005453-4057qib7	10179	7	(	(	-LRB-
cord-005453-4057qib7	10179	8	59.4	59.4	CD
cord-005453-4057qib7	10179	9	%	%	NN
cord-005453-4057qib7	10179	10	)	)	-RRB-
cord-005453-4057qib7	10179	11	and	and	CC
cord-005453-4057qib7	10179	12	71	71	CD
cord-005453-4057qib7	10179	13	were	be	VBD
cord-005453-4057qib7	10179	14	female	female	JJ
cord-005453-4057qib7	10179	15	(	(	-LRB-
cord-005453-4057qib7	10179	16	40,6	40,6	CD
cord-005453-4057qib7	10179	17	%	%	NN
cord-005453-4057qib7	10179	18	)	)	-RRB-
cord-005453-4057qib7	10179	19	.	.	.
cord-005453-4057qib7	10180	1	Baseline	baseline	JJ
cord-005453-4057qib7	10180	2	diseases	disease	NNS
cord-005453-4057qib7	10180	3	were	be	VBD
cord-005453-4057qib7	10180	4	:	:	:
cord-005453-4057qib7	10180	5	64	64	CD
cord-005453-4057qib7	10180	6	AML	AML	NNP
cord-005453-4057qib7	10180	7	,	,	,
cord-005453-4057qib7	10180	8	38	38	CD
cord-005453-4057qib7	10180	9	LPD	LPD	NNP
cord-005453-4057qib7	10180	10	,	,	,
cord-005453-4057qib7	10180	11	23	23	CD
cord-005453-4057qib7	10180	12	ALL	all	DT
cord-005453-4057qib7	10180	13	,	,	,
cord-005453-4057qib7	10180	14	19	19	CD
cord-005453-4057qib7	10180	15	MDS	MDS	NNP
cord-005453-4057qib7	10180	16	,	,	,
cord-005453-4057qib7	10180	17	15	15	CD
cord-005453-4057qib7	10180	18	MPD	MPD	NNP
cord-005453-4057qib7	10180	19	,	,	,
cord-005453-4057qib7	10180	20	10	10	CD
cord-005453-4057qib7	10180	21	MM	mm	NN
cord-005453-4057qib7	10180	22	,	,	,
cord-005453-4057qib7	10180	23	and	and	CC
cord-005453-4057qib7	10180	24	6	6	CD
cord-005453-4057qib7	10180	25	BMF	bmf	NN
cord-005453-4057qib7	10180	26	.	.	.
cord-005453-4057qib7	10181	1	Donor	donor	NN
cord-005453-4057qib7	10181	2	was	be	VBD
cord-005453-4057qib7	10181	3	unrelated	unrelated	JJ
cord-005453-4057qib7	10181	4	in	in	IN
cord-005453-4057qib7	10181	5	92	92	CD
cord-005453-4057qib7	10181	6	transplants	transplant	NNS
cord-005453-4057qib7	10181	7	(	(	-LRB-
cord-005453-4057qib7	10181	8	52.6	52.6	CD
cord-005453-4057qib7	10181	9	%	%	NN
cord-005453-4057qib7	10181	10	)	)	-RRB-
cord-005453-4057qib7	10181	11	and	and	CC
cord-005453-4057qib7	10181	12	was	be	VBD
cord-005453-4057qib7	10181	13	family	family	NN
cord-005453-4057qib7	10181	14	in	in	IN
cord-005453-4057qib7	10181	15	83	83	CD
cord-005453-4057qib7	10181	16	(	(	-LRB-
cord-005453-4057qib7	10181	17	47.4	47.4	CD
cord-005453-4057qib7	10181	18	%	%	NN
cord-005453-4057qib7	10181	19	)	)	-RRB-
cord-005453-4057qib7	10181	20	(	(	-LRB-
cord-005453-4057qib7	10181	21	including	include	VBG
cord-005453-4057qib7	10181	22	29	29	CD
cord-005453-4057qib7	10181	23	haplo	haplo	NN
cord-005453-4057qib7	10181	24	-	-	HYPH
cord-005453-4057qib7	10181	25	identical	identical	JJ
cord-005453-4057qib7	10181	26	)	)	-RRB-
cord-005453-4057qib7	10181	27	.	.	.
cord-005453-4057qib7	10182	1	Conditioning	conditioning	NN
cord-005453-4057qib7	10182	2	regimen	regimen	NN
cord-005453-4057qib7	10182	3	was	be	VBD
cord-005453-4057qib7	10182	4	reduced	reduce	VBN
cord-005453-4057qib7	10182	5	in	in	IN
cord-005453-4057qib7	10182	6	91	91	CD
cord-005453-4057qib7	10182	7	procedures	procedure	NNS
cord-005453-4057qib7	10182	8	(	(	-LRB-
cord-005453-4057qib7	10182	9	52	52	CD
cord-005453-4057qib7	10182	10	%	%	NN
cord-005453-4057qib7	10182	11	)	)	-RRB-
cord-005453-4057qib7	10182	12	and	and	CC
cord-005453-4057qib7	10182	13	intensive	intensive	JJ
cord-005453-4057qib7	10182	14	in	in	IN
cord-005453-4057qib7	10182	15	84	84	CD
cord-005453-4057qib7	10182	16	(	(	-LRB-
cord-005453-4057qib7	10182	17	48%).Stem	48%).stem	CD
cord-005453-4057qib7	10182	18	cell	cell	NN
cord-005453-4057qib7	10182	19	source	source	NN
cord-005453-4057qib7	10182	20	was	be	VBD
cord-005453-4057qib7	10182	21	PB	PB	NNP
cord-005453-4057qib7	10182	22	in	in	IN
cord-005453-4057qib7	10182	23	163	163	CD
cord-005453-4057qib7	10182	24	(	(	-LRB-
cord-005453-4057qib7	10182	25	93.1	93.1	CD
cord-005453-4057qib7	10182	26	%	%	NN
cord-005453-4057qib7	10182	27	)	)	-RRB-
cord-005453-4057qib7	10182	28	and	and	CC
cord-005453-4057qib7	10182	29	BM	BM	NNP
cord-005453-4057qib7	10182	30	in	in	IN
cord-005453-4057qib7	10182	31	12	12	CD
cord-005453-4057qib7	10182	32	pts	pt	NNS
cord-005453-4057qib7	10182	33	(	(	-LRB-
cord-005453-4057qib7	10182	34	6.9%).Median	6.9%).median	CD
cord-005453-4057qib7	10182	35	follow	follow	NN
cord-005453-4057qib7	10182	36	-	-	HYPH
cord-005453-4057qib7	10182	37	up	up	NN
cord-005453-4057qib7	10182	38	was	be	VBD
cord-005453-4057qib7	10182	39	27	27	CD
cord-005453-4057qib7	10182	40	months	month	NNS
cord-005453-4057qib7	10183	1	(	(	-LRB-
cord-005453-4057qib7	10183	2	range	range	NN
cord-005453-4057qib7	10183	3	:	:	:
cord-005453-4057qib7	10183	4	8	8	CD
cord-005453-4057qib7	10183	5	-	-	SYM
cord-005453-4057qib7	10183	6	46	46	CD
cord-005453-4057qib7	10183	7	)	)	-RRB-
cord-005453-4057qib7	10183	8	;	;	:
cord-005453-4057qib7	10183	9	at	at	IN
cord-005453-4057qib7	10183	10	the	the	DT
cord-005453-4057qib7	10183	11	close	close	NN
cord-005453-4057qib7	10183	12	of	of	IN
cord-005453-4057qib7	10183	13	the	the	DT
cord-005453-4057qib7	10183	14	analysis	analysis	NN
cord-005453-4057qib7	10183	15	,	,	,
cord-005453-4057qib7	10183	16	majority	majority	NN
cord-005453-4057qib7	10183	17	of	of	IN
cord-005453-4057qib7	10183	18	the	the	DT
cord-005453-4057qib7	10183	19	series	series	NN
cord-005453-4057qib7	10183	20	(	(	-LRB-
cord-005453-4057qib7	10183	21	89.1	89.1	CD
cord-005453-4057qib7	10183	22	%	%	NN
cord-005453-4057qib7	10183	23	)	)	-RRB-
cord-005453-4057qib7	10183	24	had	have	VBD
cord-005453-4057qib7	10183	25	a	a	DT
cord-005453-4057qib7	10183	26	follow	follow	NN
cord-005453-4057qib7	10183	27	-	-	HYPH
cord-005453-4057qib7	10183	28	up	up	NN
cord-005453-4057qib7	10183	29	superior	superior	JJ
cord-005453-4057qib7	10183	30	to	to	IN
cord-005453-4057qib7	10183	31	one	one	CD
cord-005453-4057qib7	10183	32	year	year	NN
cord-005453-4057qib7	10183	33	from	from	IN
cord-005453-4057qib7	10183	34	HSCT	HSCT	NNP
cord-005453-4057qib7	10183	35	.	.	.
cord-005453-4057qib7	10184	1	A	a	DT
cord-005453-4057qib7	10184	2	throat	throat	NN
cord-005453-4057qib7	10184	3	swab(TS	swab(ts	NN
cord-005453-4057qib7	10184	4	)	)	-RRB-
cord-005453-4057qib7	10184	5	was	be	VBD
cord-005453-4057qib7	10184	6	taken	take	VBN
cord-005453-4057qib7	10184	7	from	from	IN
cord-005453-4057qib7	10184	8	every	every	DT
cord-005453-4057qib7	10184	9	patient	patient	NN
cord-005453-4057qib7	10184	10	with	with	IN
cord-005453-4057qib7	10184	11	any	any	DT
cord-005453-4057qib7	10184	12	,	,	,
cord-005453-4057qib7	10184	13	even	even	RB
cord-005453-4057qib7	10184	14	minor	minor	JJ
cord-005453-4057qib7	10184	15	,	,	,
cord-005453-4057qib7	10184	16	respiratory	respiratory	JJ
cord-005453-4057qib7	10184	17	symptoms	symptom	NNS
cord-005453-4057qib7	10184	18	.	.	.
cord-005453-4057qib7	10185	1	The	the	DT
cord-005453-4057qib7	10185	2	respiratorysamples	respiratorysample	NNS
cord-005453-4057qib7	10185	3	were	be	VBD
cord-005453-4057qib7	10185	4	tested	test	VBN
cord-005453-4057qib7	10185	5	whith	whith	IN
cord-005453-4057qib7	10185	6	a	a	DT
cord-005453-4057qib7	10185	7	complete	complete	JJ
cord-005453-4057qib7	10185	8	PCR	PCR	NNP
cord-005453-4057qib7	10185	9	panel	panel	NN
cord-005453-4057qib7	10185	10	of	of	IN
cord-005453-4057qib7	10185	11	human	human	JJ
cord-005453-4057qib7	10185	12	respiratory	respiratory	JJ
cord-005453-4057qib7	10185	13	viruses	virus	NNS
cord-005453-4057qib7	10185	14	:	:	:
cord-005453-4057qib7	10185	15	rhinovirus	rhinovirus	NN
cord-005453-4057qib7	10185	16	(	(	-LRB-
cord-005453-4057qib7	10185	17	RV	RV	NNP
cord-005453-4057qib7	10185	18	)	)	-RRB-
cord-005453-4057qib7	10185	19	,	,	,
cord-005453-4057qib7	10185	20	influenza	influenza	NN
cord-005453-4057qib7	10185	21	A	a	NN
cord-005453-4057qib7	10185	22	and	and	CC
cord-005453-4057qib7	10185	23	B	B	NNP
cord-005453-4057qib7	10185	24	virus	virus	NN
cord-005453-4057qib7	10185	25	(	(	-LRB-
cord-005453-4057qib7	10185	26	IV	IV	NNP
cord-005453-4057qib7	10185	27	-	-	HYPH
cord-005453-4057qib7	10185	28	A	A	NNP
cord-005453-4057qib7	10185	29	,	,	,
cord-005453-4057qib7	10185	30	IV	IV	NNP
cord-005453-4057qib7	10185	31	-	-	HYPH
cord-005453-4057qib7	10185	32	B	B	NNP
cord-005453-4057qib7	10185	33	)	)	-RRB-
cord-005453-4057qib7	10185	34	,	,	,
cord-005453-4057qib7	10185	35	parainfluenza	parainfluenza	NNP
cord-005453-4057qib7	10185	36	virus	virus	NNP
cord-005453-4057qib7	10185	37	(	(	-LRB-
cord-005453-4057qib7	10185	38	PIVs	piv	NNS
cord-005453-4057qib7	10185	39	1	1	CD
cord-005453-4057qib7	10185	40	-	-	SYM
cord-005453-4057qib7	10185	41	4	4	CD
cord-005453-4057qib7	10185	42	)	)	-RRB-
cord-005453-4057qib7	10185	43	,	,	,
cord-005453-4057qib7	10185	44	respiratory	respiratory	JJ
cord-005453-4057qib7	10185	45	syncytial	syncytial	JJ
cord-005453-4057qib7	10185	46	virus	virus	NN
cord-005453-4057qib7	10185	47	(	(	-LRB-
cord-005453-4057qib7	10185	48	RSV	RSV	NNP
cord-005453-4057qib7	10185	49	)	)	-RRB-
cord-005453-4057qib7	10185	50	,	,	,
cord-005453-4057qib7	10185	51	metapneumovirus	metapneumovirus	NNP
cord-005453-4057qib7	10185	52	(	(	-LRB-
cord-005453-4057qib7	10185	53	MPV	MPV	NNP
cord-005453-4057qib7	10185	54	)	)	-RRB-
cord-005453-4057qib7	10185	55	,	,	,
cord-005453-4057qib7	10185	56	coronavirus	coronavirus	NN
cord-005453-4057qib7	10185	57	(	(	-LRB-
cord-005453-4057qib7	10185	58	CoV	CoV	NNP
cord-005453-4057qib7	10185	59	)	)	-RRB-
cord-005453-4057qib7	10185	60	,	,	,
cord-005453-4057qib7	10185	61	adenovirus	adenovirus	NN
cord-005453-4057qib7	10185	62	(	(	-LRB-
cord-005453-4057qib7	10185	63	AdV	AdV	NNP
cord-005453-4057qib7	10185	64	)	)	-RRB-
cord-005453-4057qib7	10185	65	,	,	,
cord-005453-4057qib7	10185	66	and	and	CC
cord-005453-4057qib7	10185	67	bocavirus	bocavirus	NNP
cord-005453-4057qib7	10185	68	(	(	-LRB-
cord-005453-4057qib7	10185	69	BoV	BoV	NNP
cord-005453-4057qib7	10185	70	)	)	-RRB-
cord-005453-4057qib7	10185	71	.	.	.
cord-005453-4057qib7	10186	1	Results	result	NNS
cord-005453-4057qib7	10186	2	:	:	:
cord-005453-4057qib7	10187	1	Day	day	NN
cord-005453-4057qib7	10187	2	+100	+100	.
cord-005453-4057qib7	10188	1	overall	overall	JJ
cord-005453-4057qib7	10188	2	mortality	mortality	NN
cord-005453-4057qib7	10188	3	of	of	IN
cord-005453-4057qib7	10188	4	the	the	DT
cord-005453-4057qib7	10188	5	series	series	NN
cord-005453-4057qib7	10188	6	was	be	VBD
cord-005453-4057qib7	10188	7	8,6	8,6	CD
cord-005453-4057qib7	10188	8	%	%	NN
cord-005453-4057qib7	10188	9	.	.	.
cord-005453-4057qib7	10189	1	Day	day	NN
cord-005453-4057qib7	10189	2	+365	+365	NNP
cord-005453-4057qib7	10189	3	overall	overall	JJ
cord-005453-4057qib7	10189	4	mortality	mortality	NN
cord-005453-4057qib7	10189	5	was	be	VBD
cord-005453-4057qib7	10189	6	25,1	25,1	CD
cord-005453-4057qib7	10189	7	%	%	NN
cord-005453-4057qib7	10189	8	(	(	-LRB-
cord-005453-4057qib7	10189	9	13,7	13,7	CD
cord-005453-4057qib7	10189	10	%	%	NN
cord-005453-4057qib7	10189	11	nonrelapse	nonrelapse	JJ
cord-005453-4057qib7	10189	12	mortality	mortality	NN
cord-005453-4057qib7	10189	13	-NRM-	-NRM-	,
cord-005453-4057qib7	10189	14	,	,	,
cord-005453-4057qib7	10189	15	and	and	CC
cord-005453-4057qib7	10189	16	11,4	11,4	CD
cord-005453-4057qib7	10189	17	%	%	NN
cord-005453-4057qib7	10189	18	progression	progression	NN
cord-005453-4057qib7	10189	19	/	/	SYM
cord-005453-4057qib7	10189	20	relapse	relapse	NN
cord-005453-4057qib7	10189	21	mortality	mortality	NN
cord-005453-4057qib7	10189	22	)	)	-RRB-
cord-005453-4057qib7	10189	23	.	.	.
cord-005453-4057qib7	10190	1	Causes	cause	NNS
cord-005453-4057qib7	10190	2	of	of	IN
cord-005453-4057qib7	10190	3	NRM	NRM	NNP
cord-005453-4057qib7	10190	4	reflected	reflect	VBN
cord-005453-4057qib7	10190	5	in	in	IN
cord-005453-4057qib7	10190	6	table	table	NN
cord-005453-4057qib7	10190	7	1	1	CD
cord-005453-4057qib7	10190	8	.	.	.
cord-005453-4057qib7	10191	1	No	no	DT
cord-005453-4057qib7	10191	2	patients	patient	NNS
cord-005453-4057qib7	10191	3	died	die	VBD
cord-005453-4057qib7	10191	4	due	due	IN
cord-005453-4057qib7	10191	5	to	to	IN
cord-005453-4057qib7	10191	6	RVIs	rvi	NNS
cord-005453-4057qib7	10191	7	.	.	.
cord-005453-4057qib7	10192	1	From	from	IN
cord-005453-4057qib7	10192	2	1	1	CD
cord-005453-4057qib7	10192	3	st	st	NNP
cord-005453-4057qib7	10192	4	July	July	NNP
cord-005453-4057qib7	10192	5	2016	2016	CD
cord-005453-4057qib7	10192	6	through	through	IN
cord-005453-4057qib7	10192	7	30	30	CD
cord-005453-4057qib7	10192	8	th	th	DT
cord-005453-4057qib7	10192	9	June	June	NNP
cord-005453-4057qib7	10192	10	2018	2018	CD
cord-005453-4057qib7	10192	11	(	(	-LRB-
cord-005453-4057qib7	10192	12	a	a	DT
cord-005453-4057qib7	10192	13	24-month	24-month	JJ
cord-005453-4057qib7	10192	14	period	period	NN
cord-005453-4057qib7	10192	15	)	)	-RRB-
cord-005453-4057qib7	10192	16	,	,	,
cord-005453-4057qib7	10192	17	581	581	CD
cord-005453-4057qib7	10192	18	TS	ts	NN
cord-005453-4057qib7	10192	19	samples	sample	NNS
cord-005453-4057qib7	10192	20	were	be	VBD
cord-005453-4057qib7	10192	21	obtained	obtain	VBN
cord-005453-4057qib7	10192	22	from	from	IN
cord-005453-4057qib7	10192	23	129	129	CD
cord-005453-4057qib7	10192	24	pts	pt	NNS
cord-005453-4057qib7	10192	25	(	(	-LRB-
cord-005453-4057qib7	10193	1	73,7%).The	73,7%).the	CD
cord-005453-4057qib7	10193	2	median	median	JJ
cord-005453-4057qib7	10193	3	number	number	NN
cord-005453-4057qib7	10193	4	of	of	IN
cord-005453-4057qib7	10193	5	samples	sample	NNS
cord-005453-4057qib7	10193	6	/	/	SYM
cord-005453-4057qib7	10193	7	patient	patient	NN
cord-005453-4057qib7	10193	8	was	be	VBD
cord-005453-4057qib7	10193	9	3	3	CD
cord-005453-4057qib7	10194	1	(	(	-LRB-
cord-005453-4057qib7	10194	2	range	range	NN
cord-005453-4057qib7	10194	3	:	:	:
cord-005453-4057qib7	10194	4	1	1	CD
cord-005453-4057qib7	10194	5	-	-	SYM
cord-005453-4057qib7	10194	6	17).A	17).a	CD
cord-005453-4057qib7	10194	7	total	total	NN
cord-005453-4057qib7	10194	8	of	of	IN
cord-005453-4057qib7	10194	9	162	162	CD
cord-005453-4057qib7	10195	1	(	(	-LRB-
cord-005453-4057qib7	10195	2	1	1	CD
cord-005453-4057qib7	10195	3	-	-	SYM
cord-005453-4057qib7	10195	4	8	8	CD
cord-005453-4057qib7	10195	5	)	)	-RRB-
cord-005453-4057qib7	10195	6	RVIs	rvi	NNS
cord-005453-4057qib7	10195	7	episodes	episode	NNS
cord-005453-4057qib7	10195	8	were	be	VBD
cord-005453-4057qib7	10195	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	10195	10	in	in	IN
cord-005453-4057qib7	10195	11	87	87	CD
cord-005453-4057qib7	10195	12	pts	pt	NNS
cord-005453-4057qib7	10195	13	(	(	-LRB-
cord-005453-4057qib7	10195	14	49,7%).The	49,7%).the	CD
cord-005453-4057qib7	10195	15	median	median	JJ
cord-005453-4057qib7	10195	16	presentation	presentation	NN
cord-005453-4057qib7	10195	17	of	of	IN
cord-005453-4057qib7	10195	18	the	the	DT
cord-005453-4057qib7	10195	19	first	first	JJ
cord-005453-4057qib7	10195	20	RVI	RVI	NNP
cord-005453-4057qib7	10195	21	was	be	VBD
cord-005453-4057qib7	10195	22	at	at	IN
cord-005453-4057qib7	10195	23	the	the	DT
cord-005453-4057qib7	10195	24	day	day	NN
cord-005453-4057qib7	10195	25	+	+	SYM
cord-005453-4057qib7	10195	26	226	226	CD
cord-005453-4057qib7	10195	27	(	(	-LRB-
cord-005453-4057qib7	10195	28	3	3	CD
cord-005453-4057qib7	10195	29	-	-	SYM
cord-005453-4057qib7	10195	30	924	924	CD
cord-005453-4057qib7	10195	31	)	)	-RRB-
cord-005453-4057qib7	10196	1	post	post	JJ
cord-005453-4057qib7	10196	2	-	-	JJ
cord-005453-4057qib7	10196	3	HSCT	HSCT	NNP
cord-005453-4057qib7	10196	4	.	.	.
cord-005453-4057qib7	10197	1	The	the	DT
cord-005453-4057qib7	10197	2	viral	viral	JJ
cord-005453-4057qib7	10197	3	distribution	distribution	NN
cord-005453-4057qib7	10197	4	was	be	VBD
cord-005453-4057qib7	10197	5	:	:	:
cord-005453-4057qib7	10197	6	47	47	CD
cord-005453-4057qib7	10197	7	RV	RV	NNP
cord-005453-4057qib7	10197	8	(	(	-LRB-
cord-005453-4057qib7	10197	9	26.6	26.6	CD
cord-005453-4057qib7	10197	10	%	%	NN
cord-005453-4057qib7	10197	11	)	)	-RRB-
cord-005453-4057qib7	10197	12	,	,	,
cord-005453-4057qib7	10197	13	36	36	CD
cord-005453-4057qib7	10197	14	IV	IV	NNP
cord-005453-4057qib7	10197	15	(	(	-LRB-
cord-005453-4057qib7	10197	16	20.3	20.3	CD
cord-005453-4057qib7	10197	17	%	%	NN
cord-005453-4057qib7	10197	18	)	)	-RRB-
cord-005453-4057qib7	10197	19	,	,	,
cord-005453-4057qib7	10197	20	33	33	CD
cord-005453-4057qib7	10197	21	PIV	PIV	NNP
cord-005453-4057qib7	10197	22	(	(	-LRB-
cord-005453-4057qib7	10197	23	18.6	18.6	CD
cord-005453-4057qib7	10197	24	%	%	NN
cord-005453-4057qib7	10197	25	)	)	-RRB-
cord-005453-4057qib7	10197	26	,	,	,
cord-005453-4057qib7	10197	27	28	28	CD
cord-005453-4057qib7	10197	28	RSV	RSV	NNP
cord-005453-4057qib7	10197	29	(	(	-LRB-
cord-005453-4057qib7	10197	30	15.8	15.8	CD
cord-005453-4057qib7	10197	31	%	%	NN
cord-005453-4057qib7	10197	32	)	)	-RRB-
cord-005453-4057qib7	10197	33	,	,	,
cord-005453-4057qib7	10197	34	12	12	CD
cord-005453-4057qib7	10197	35	MPV	MPV	NNP
cord-005453-4057qib7	10197	36	(	(	-LRB-
cord-005453-4057qib7	10197	37	6.8	6.8	CD
cord-005453-4057qib7	10197	38	%	%	NN
cord-005453-4057qib7	10197	39	)	)	-RRB-
cord-005453-4057qib7	10197	40	,	,	,
cord-005453-4057qib7	10197	41	11	11	CD
cord-005453-4057qib7	10197	42	CoV	cov	NN
cord-005453-4057qib7	10197	43	(	(	-LRB-
cord-005453-4057qib7	10197	44	6.2	6.2	CD
cord-005453-4057qib7	10197	45	%	%	NN
cord-005453-4057qib7	10197	46	)	)	-RRB-
cord-005453-4057qib7	10197	47	,	,	,
cord-005453-4057qib7	10197	48	9	9	CD
cord-005453-4057qib7	10197	49	AdV	adv	NN
cord-005453-4057qib7	10197	50	(	(	-LRB-
cord-005453-4057qib7	10197	51	5.1	5.1	CD
cord-005453-4057qib7	10197	52	%	%	NN
cord-005453-4057qib7	10197	53	)	)	-RRB-
cord-005453-4057qib7	10197	54	,	,	,
cord-005453-4057qib7	10197	55	and	and	CC
cord-005453-4057qib7	10197	56	1	1	CD
cord-005453-4057qib7	10197	57	BoV	bov	NN
cord-005453-4057qib7	10197	58	(	(	-LRB-
cord-005453-4057qib7	10197	59	0.6%).There	0.6%).there	CD
cord-005453-4057qib7	10197	60	were	be	VBD
cord-005453-4057qib7	10197	61	13	13	CD
cord-005453-4057qib7	10197	62	mixed	mixed	JJ
cord-005453-4057qib7	10197	63	(	(	-LRB-
cord-005453-4057qib7	10197	64	two	two	CD
cord-005453-4057qib7	10197	65	or	or	CC
cord-005453-4057qib7	10197	66	more	more	JJR
cord-005453-4057qib7	10197	67	viruses	virus	NNS
cord-005453-4057qib7	10197	68	)	)	-RRB-
cord-005453-4057qib7	10197	69	RVI	RVI	NNP
cord-005453-4057qib7	10197	70	episodes	episode	NNS
cord-005453-4057qib7	10197	71	.	.	.
cord-005453-4057qib7	10198	1	The	the	DT
cord-005453-4057qib7	10198	2	temporary	temporary	JJ
cord-005453-4057qib7	10198	3	distribution	distribution	NN
cord-005453-4057qib7	10198	4	of	of	IN
cord-005453-4057qib7	10198	5	VRI	VRI	NNP
cord-005453-4057qib7	10198	6	episodes	episode	NNS
cord-005453-4057qib7	10198	7	is	be	VBZ
cord-005453-4057qib7	10198	8	shown	show	VBN
cord-005453-4057qib7	10198	9	in	in	IN
cord-005453-4057qib7	10198	10	figure	figure	NN
cord-005453-4057qib7	10198	11	1	1	CD
cord-005453-4057qib7	10198	12	.	.	.
cord-005453-4057qib7	10199	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10199	2	:	:	:
cord-005453-4057qib7	10200	1	1	1	LS
cord-005453-4057qib7	10200	2	)	)	-RRB-
cord-005453-4057qib7	10200	3	Symptomatic	symptomatic	JJ
cord-005453-4057qib7	10200	4	infections	infection	NNS
cord-005453-4057qib7	10200	5	due	due	JJ
cord-005453-4057qib7	10200	6	to	to	IN
cord-005453-4057qib7	10200	7	respiratory	respiratory	JJ
cord-005453-4057qib7	10200	8	viruses	virus	NNS
cord-005453-4057qib7	10200	9	are	be	VBP
cord-005453-4057qib7	10200	10	very	very	RB
cord-005453-4057qib7	10200	11	frequent	frequent	JJ
cord-005453-4057qib7	10200	12	among	among	IN
cord-005453-4057qib7	10200	13	the	the	DT
cord-005453-4057qib7	10200	14	allo	allo	NN
cord-005453-4057qib7	10200	15	-	-	HYPH
cord-005453-4057qib7	10200	16	HSCT	HSCT	NNP
cord-005453-4057qib7	10200	17	recipients	recipient	NNS
cord-005453-4057qib7	10200	18	.	.	.
cord-005453-4057qib7	10201	1	2	2	LS
cord-005453-4057qib7	10201	2	)	)	-RRB-
cord-005453-4057qib7	10202	1	A	a	DT
cord-005453-4057qib7	10202	2	high	high	JJ
cord-005453-4057qib7	10202	3	level	level	NN
cord-005453-4057qib7	10202	4	of	of	IN
cord-005453-4057qib7	10202	5	suspicion	suspicion	NN
cord-005453-4057qib7	10202	6	,	,	,
cord-005453-4057qib7	10202	7	as	as	RB
cord-005453-4057qib7	10202	8	well	well	RB
cord-005453-4057qib7	10202	9	as	as	IN
cord-005453-4057qib7	10202	10	an	an	DT
cord-005453-4057qib7	10202	11	early	early	JJ
cord-005453-4057qib7	10202	12	and	and	CC
cord-005453-4057qib7	10202	13	systematic	systematic	JJ
cord-005453-4057qib7	10202	14	screening	screening	NN
cord-005453-4057qib7	10202	15	and	and	CC
cord-005453-4057qib7	10202	16	management	management	NN
cord-005453-4057qib7	10202	17	policy	policy	NN
cord-005453-4057qib7	10202	18	,	,	,
cord-005453-4057qib7	10202	19	are	be	VBP
cord-005453-4057qib7	10202	20	critical	critical	JJ
cord-005453-4057qib7	10202	21	to	to	TO
cord-005453-4057qib7	10202	22	avoid	avoid	VB
cord-005453-4057qib7	10202	23	potential	potential	JJ
cord-005453-4057qib7	10202	24	attributable	attributable	JJ
cord-005453-4057qib7	10202	25	mortality	mortality	NN
cord-005453-4057qib7	10202	26	and	and	CC
cord-005453-4057qib7	10202	27	the	the	DT
cord-005453-4057qib7	10202	28	nosocomial	nosocomial	JJ
cord-005453-4057qib7	10202	29	spread	spread	NN
cord-005453-4057qib7	10202	30	of	of	IN
cord-005453-4057qib7	10202	31	RVIs	rvi	NNS
cord-005453-4057qib7	10202	32	among	among	IN
cord-005453-4057qib7	10202	33	the	the	DT
cord-005453-4057qib7	10202	34	transplant	transplant	NN
cord-005453-4057qib7	10202	35	recipients	recipient	NNS
cord-005453-4057qib7	10202	36	.	.	.
cord-005453-4057qib7	10203	1	3	3	LS
cord-005453-4057qib7	10203	2	)	)	-RRB-
cord-005453-4057qib7	10204	1	In	in	IN
cord-005453-4057qib7	10204	2	our	-PRON-	PRP$
cord-005453-4057qib7	10204	3	series	series	NN
cord-005453-4057qib7	10204	4	,	,	,
cord-005453-4057qib7	10204	5	rhinovirus	rhinovirus	NN
cord-005453-4057qib7	10204	6	,	,	,
cord-005453-4057qib7	10204	7	parainfluenza	parainfluenza	NNP
cord-005453-4057qib7	10204	8	and	and	CC
cord-005453-4057qib7	10204	9	adenovirus	adenovirus	NN
cord-005453-4057qib7	10204	10	might	may	MD
cord-005453-4057qib7	10204	11	be	be	VB
cord-005453-4057qib7	10204	12	detected	detect	VBN
cord-005453-4057qib7	10204	13	at	at	IN
cord-005453-4057qib7	10204	14	any	any	DT
cord-005453-4057qib7	10204	15	moment	moment	NN
cord-005453-4057qib7	10204	16	of	of	IN
cord-005453-4057qib7	10204	17	the	the	DT
cord-005453-4057qib7	10204	18	year	year	NN
cord-005453-4057qib7	10204	19	;	;	:
cord-005453-4057qib7	10204	20	the	the	DT
cord-005453-4057qib7	10204	21	rest	rest	NN
cord-005453-4057qib7	10204	22	of	of	IN
cord-005453-4057qib7	10204	23	the	the	DT
cord-005453-4057qib7	10204	24	viruses	virus	NNS
cord-005453-4057qib7	10204	25	showed	show	VBD
cord-005453-4057qib7	10204	26	a	a	DT
cord-005453-4057qib7	10204	27	clear	clear	JJ
cord-005453-4057qib7	10204	28	seasonal	seasonal	JJ
cord-005453-4057qib7	10204	29	pattern	pattern	NN
cord-005453-4057qib7	10204	30	(	(	-LRB-
cord-005453-4057qib7	10204	31	November	November	NNP
cord-005453-4057qib7	10204	32	to	to	IN
cord-005453-4057qib7	10204	33	April	April	NNP
cord-005453-4057qib7	10204	34	)	)	-RRB-
cord-005453-4057qib7	10204	35	.	.	.
cord-005453-4057qib7	10205	1	[	[	-LRB-
cord-005453-4057qib7	10205	2	[	[	-LRB-
cord-005453-4057qib7	10205	3	P452	p452	JJ
cord-005453-4057qib7	10205	4	Image	image	NN
cord-005453-4057qib7	10205	5	]	]	-RRB-
cord-005453-4057qib7	10205	6	1	1	CD
cord-005453-4057qib7	10205	7	.	.	.
cord-005453-4057qib7	10206	1	Background	background	NN
cord-005453-4057qib7	10206	2	:	:	:
cord-005453-4057qib7	10207	1	Trimethoprim	Trimethoprim	NNP
cord-005453-4057qib7	10207	2	-	-	HYPH
cord-005453-4057qib7	10207	3	sulfamethoxazole	sulfamethoxazole	NNP
cord-005453-4057qib7	10207	4	(	(	-LRB-
cord-005453-4057qib7	10207	5	TMP	TMP	NNP
cord-005453-4057qib7	10207	6	-	-	HYPH
cord-005453-4057qib7	10207	7	SMX	SMX	NNP
cord-005453-4057qib7	10207	8	)	)	-RRB-
cord-005453-4057qib7	10207	9	is	be	VBZ
cord-005453-4057qib7	10207	10	the	the	DT
cord-005453-4057qib7	10207	11	most	most	RBS
cord-005453-4057qib7	10207	12	suitable	suitable	JJ
cord-005453-4057qib7	10207	13	drug	drug	NN
cord-005453-4057qib7	10207	14	for	for	IN
cord-005453-4057qib7	10207	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10207	16	against	against	IN
cord-005453-4057qib7	10207	17	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	10207	18	pneumonia	pneumonia	NN
cord-005453-4057qib7	10207	19	and	and	CC
cord-005453-4057qib7	10207	20	infections	infection	NNS
cord-005453-4057qib7	10207	21	with	with	IN
cord-005453-4057qib7	10207	22	Toxoplasma	toxoplasma	NN
cord-005453-4057qib7	10207	23	after	after	IN
cord-005453-4057qib7	10207	24	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10207	25	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	10207	26	stem	stem	NN
cord-005453-4057qib7	10207	27	cell	cell	NN
cord-005453-4057qib7	10207	28	transplantation	transplantation	NN
cord-005453-4057qib7	10207	29	(	(	-LRB-
cord-005453-4057qib7	10207	30	allo	allo	NN
cord-005453-4057qib7	10207	31	-	-	HYPH
cord-005453-4057qib7	10207	32	HSCT	HSCT	NNP
cord-005453-4057qib7	10207	33	)	)	-RRB-
cord-005453-4057qib7	10207	34	.	.	.
cord-005453-4057qib7	10208	1	Allergic	allergic	JJ
cord-005453-4057qib7	10208	2	reactions	reaction	NNS
cord-005453-4057qib7	10208	3	or	or	CC
cord-005453-4057qib7	10208	4	hypersensitivities	hypersensitivity	NNS
cord-005453-4057qib7	10208	5	,	,	,
cord-005453-4057qib7	10208	6	mainly	mainly	RB
cord-005453-4057qib7	10208	7	exanthemas	exanthemas	NNP
cord-005453-4057qib7	10208	8	,	,	,
cord-005453-4057qib7	10208	9	occur	occur	VBP
cord-005453-4057qib7	10208	10	in	in	IN
cord-005453-4057qib7	10208	11	about	about	RB
cord-005453-4057qib7	10208	12	3	3	CD
cord-005453-4057qib7	10208	13	-	-	SYM
cord-005453-4057qib7	10208	14	5	5	CD
cord-005453-4057qib7	10208	15	%	%	NN
cord-005453-4057qib7	10208	16	of	of	IN
cord-005453-4057qib7	10208	17	the	the	DT
cord-005453-4057qib7	10208	18	patients	patient	NNS
cord-005453-4057qib7	10208	19	,	,	,
cord-005453-4057qib7	10208	20	usually	usually	RB
cord-005453-4057qib7	10208	21	resulting	result	VBG
cord-005453-4057qib7	10208	22	in	in	IN
cord-005453-4057qib7	10208	23	the	the	DT
cord-005453-4057qib7	10208	24	use	use	NN
cord-005453-4057qib7	10208	25	of	of	IN
cord-005453-4057qib7	10208	26	alternative	alternative	JJ
cord-005453-4057qib7	10208	27	prophylactic	prophylactic	JJ
cord-005453-4057qib7	10208	28	drugs	drug	NNS
cord-005453-4057qib7	10208	29	(	(	-LRB-
cord-005453-4057qib7	10208	30	e.g.	e.g.	RB
cord-005453-4057qib7	10208	31	pentamidine	pentamidine	NNP
cord-005453-4057qib7	10208	32	or	or	CC
cord-005453-4057qib7	10208	33	atovaquone	atovaquone	NNP
cord-005453-4057qib7	10208	34	)	)	-RRB-
cord-005453-4057qib7	10208	35	.	.	.
cord-005453-4057qib7	10209	1	It	-PRON-	PRP
cord-005453-4057qib7	10209	2	has	have	VBZ
cord-005453-4057qib7	10209	3	been	be	VBN
cord-005453-4057qib7	10209	4	hypothesised	hypothesise	VBN
cord-005453-4057qib7	10209	5	that	that	IN
cord-005453-4057qib7	10209	6	allergies	allergy	NNS
cord-005453-4057qib7	10209	7	might	may	MD
cord-005453-4057qib7	10209	8	be	be	VB
cord-005453-4057qib7	10209	9	cured	cure	VBN
cord-005453-4057qib7	10209	10	with	with	IN
cord-005453-4057qib7	10209	11	allo	allo	NN
cord-005453-4057qib7	10209	12	-	-	HYPH
cord-005453-4057qib7	10209	13	HSCT	HSCT	NNP
cord-005453-4057qib7	10209	14	.	.	.
cord-005453-4057qib7	10210	1	Methods	method	NNS
cord-005453-4057qib7	10210	2	:	:	:
cord-005453-4057qib7	10210	3	We	-PRON-	PRP
cord-005453-4057qib7	10210	4	conducted	conduct	VBD
cord-005453-4057qib7	10210	5	a	a	DT
cord-005453-4057qib7	10210	6	retrospective	retrospective	JJ
cord-005453-4057qib7	10210	7	chart	chart	NN
cord-005453-4057qib7	10210	8	review	review	NN
cord-005453-4057qib7	10210	9	of	of	IN
cord-005453-4057qib7	10210	10	patients	patient	NNS
cord-005453-4057qib7	10210	11	with	with	IN
cord-005453-4057qib7	10210	12	TMP	TMP	NNP
cord-005453-4057qib7	10210	13	-	-	HYPH
cord-005453-4057qib7	10210	14	SMX	smx	NN
cord-005453-4057qib7	10210	15	re	re	NN
cord-005453-4057qib7	10210	16	-	-	NN
cord-005453-4057qib7	10210	17	exposition	exposition	NN
cord-005453-4057qib7	10210	18	after	after	IN
cord-005453-4057qib7	10210	19	allo	allo	NN
cord-005453-4057qib7	10210	20	-	-	HYPH
cord-005453-4057qib7	10210	21	HSCT	HSCT	NNP
cord-005453-4057qib7	10210	22	from	from	IN
cord-005453-4057qib7	10210	23	December	December	NNP
cord-005453-4057qib7	10210	24	2017	2017	CD
cord-005453-4057qib7	10210	25	to	to	IN
cord-005453-4057qib7	10210	26	September	September	NNP
cord-005453-4057qib7	10210	27	2018	2018	CD
cord-005453-4057qib7	10210	28	.	.	.
cord-005453-4057qib7	10211	1	Follow	follow	VB
cord-005453-4057qib7	10211	2	-	-	HYPH
cord-005453-4057qib7	10211	3	up	up	NN
cord-005453-4057qib7	10211	4	is	be	VBZ
cord-005453-4057qib7	10211	5	current	current	JJ
cord-005453-4057qib7	10211	6	as	as	IN
cord-005453-4057qib7	10211	7	of	of	IN
cord-005453-4057qib7	10211	8	December	December	NNP
cord-005453-4057qib7	10211	9	2018	2018	CD
cord-005453-4057qib7	10211	10	.	.	.
cord-005453-4057qib7	10212	1	Results	result	NNS
cord-005453-4057qib7	10212	2	:	:	:
cord-005453-4057qib7	10213	1	Six	six	CD
cord-005453-4057qib7	10213	2	patients	patient	NNS
cord-005453-4057qib7	10213	3	(	(	-LRB-
cord-005453-4057qib7	10213	4	f	f	NNP
cord-005453-4057qib7	10213	5	/	/	SYM
cord-005453-4057qib7	10213	6	m	m	NN
cord-005453-4057qib7	10213	7	:	:	:
cord-005453-4057qib7	10213	8	4/2	4/2	CD
cord-005453-4057qib7	10213	9	,	,	,
cord-005453-4057qib7	10213	10	median	median	JJ
cord-005453-4057qib7	10213	11	age	age	NN
cord-005453-4057qib7	10213	12	:	:	:
cord-005453-4057qib7	10213	13	45	45	CD
cord-005453-4057qib7	10213	14	years	year	NNS
cord-005453-4057qib7	10213	15	,	,	,
cord-005453-4057qib7	10213	16	range	range	NN
cord-005453-4057qib7	10213	17	:	:	:
cord-005453-4057qib7	10213	18	25	25	CD
cord-005453-4057qib7	10214	1	-66	-66	CD
cord-005453-4057qib7	10214	2	years	year	NNS
cord-005453-4057qib7	10214	3	)	)	-RRB-
cord-005453-4057qib7	10214	4	with	with	IN
cord-005453-4057qib7	10214	5	a	a	DT
cord-005453-4057qib7	10214	6	history	history	NN
cord-005453-4057qib7	10214	7	of	of	IN
cord-005453-4057qib7	10214	8	TMP	TMP	NNP
cord-005453-4057qib7	10214	9	-	-	HYPH
cord-005453-4057qib7	10214	10	SMX	smx	NN
cord-005453-4057qib7	10214	11	hypersensitivity	hypersensitivity	NN
cord-005453-4057qib7	10214	12	prior	prior	RB
cord-005453-4057qib7	10214	13	to	to	IN
cord-005453-4057qib7	10214	14	allo	allo	NN
cord-005453-4057qib7	10214	15	-	-	HYPH
cord-005453-4057qib7	10214	16	HSCT	HSCT	NNP
cord-005453-4057qib7	10215	1	were	be	VBD
cord-005453-4057qib7	10215	2	re	re	VBN
cord-005453-4057qib7	10215	3	-	-	VBN
cord-005453-4057qib7	10215	4	exposed	expose	VBN
cord-005453-4057qib7	10215	5	to	to	IN
cord-005453-4057qib7	10215	6	TMP	TMP	NNP
cord-005453-4057qib7	10215	7	-	-	HYPH
cord-005453-4057qib7	10215	8	SMX	SMX	NNP
cord-005453-4057qib7	10215	9	after	after	IN
cord-005453-4057qib7	10215	10	engraftment	engraftment	NN
cord-005453-4057qib7	10215	11	of	of	IN
cord-005453-4057qib7	10215	12	a	a	DT
cord-005453-4057qib7	10215	13	matched	match	VBN
cord-005453-4057qib7	10215	14	related	relate	VBN
cord-005453-4057qib7	10215	15	(	(	-LRB-
cord-005453-4057qib7	10215	16	MRD	MRD	NNP
cord-005453-4057qib7	10215	17	,	,	,
cord-005453-4057qib7	10215	18	n=1	n=1	CD
cord-005453-4057qib7	10215	19	)	)	-RRB-
cord-005453-4057qib7	10215	20	or	or	CC
cord-005453-4057qib7	10215	21	matched	match	VBN
cord-005453-4057qib7	10215	22	unrelated	unrelated	JJ
cord-005453-4057qib7	10215	23	(	(	-LRB-
cord-005453-4057qib7	10215	24	MUD	mud	NN
cord-005453-4057qib7	10215	25	,	,	,
cord-005453-4057qib7	10215	26	n=5	n=5	JJ
cord-005453-4057qib7	10215	27	)	)	-RRB-
cord-005453-4057qib7	10215	28	donor	donor	NN
cord-005453-4057qib7	10215	29	.	.	.
cord-005453-4057qib7	10216	1	Median	median	JJ
cord-005453-4057qib7	10216	2	time	time	NN
cord-005453-4057qib7	10216	3	to	to	TO
cord-005453-4057qib7	10216	4	re	re	VB
cord-005453-4057qib7	10216	5	-	-	NN
cord-005453-4057qib7	10216	6	exposition	exposition	NN
cord-005453-4057qib7	10216	7	was	be	VBD
cord-005453-4057qib7	10216	8	18.5	18.5	CD
cord-005453-4057qib7	10217	1	(	(	-LRB-
cord-005453-4057qib7	10217	2	range	range	NN
cord-005453-4057qib7	10217	3	:	:	:
cord-005453-4057qib7	10217	4	11	11	CD
cord-005453-4057qib7	10217	5	-	-	SYM
cord-005453-4057qib7	10217	6	341	341	CD
cord-005453-4057qib7	10217	7	)	)	-RRB-
cord-005453-4057qib7	10217	8	days	day	NNS
cord-005453-4057qib7	10217	9	after	after	IN
cord-005453-4057qib7	10217	10	allo	allo	NN
cord-005453-4057qib7	10217	11	-	-	HYPH
cord-005453-4057qib7	10217	12	HSCT	HSCT	NNP
cord-005453-4057qib7	10217	13	with	with	IN
cord-005453-4057qib7	10217	14	one	one	CD
cord-005453-4057qib7	10217	15	oral	oral	JJ
cord-005453-4057qib7	10217	16	dose	dose	NN
cord-005453-4057qib7	10217	17	of	of	IN
cord-005453-4057qib7	10217	18	TMP	TMP	NNP
cord-005453-4057qib7	10217	19	-	-	HYPH
cord-005453-4057qib7	10217	20	SMX	SMX	NNP
cord-005453-4057qib7	10217	21	.	.	.
cord-005453-4057qib7	10218	1	In	in	IN
cord-005453-4057qib7	10218	2	four	four	CD
cord-005453-4057qib7	10218	3	patients	patient	NNS
cord-005453-4057qib7	10218	4	,	,	,
cord-005453-4057qib7	10218	5	TMP	TMP	NNP
cord-005453-4057qib7	10218	6	-	-	HYPH
cord-005453-4057qib7	10218	7	SMX	SMX	NNP
cord-005453-4057qib7	10218	8	was	be	VBD
cord-005453-4057qib7	10218	9	tolerated	tolerate	VBN
cord-005453-4057qib7	10218	10	without	without	IN
cord-005453-4057qib7	10218	11	any	any	DT
cord-005453-4057qib7	10218	12	signs	sign	NNS
cord-005453-4057qib7	10218	13	of	of	IN
cord-005453-4057qib7	10218	14	hypersensitivity	hypersensitivity	NN
cord-005453-4057qib7	10218	15	reactions	reaction	NNS
cord-005453-4057qib7	10218	16	and	and	CC
cord-005453-4057qib7	10218	17	has	have	VBZ
cord-005453-4057qib7	10218	18	been	be	VBN
cord-005453-4057qib7	10218	19	continued	continue	VBN
cord-005453-4057qib7	10218	20	for	for	IN
cord-005453-4057qib7	10218	21	a	a	DT
cord-005453-4057qib7	10218	22	median	median	NN
cord-005453-4057qib7	10218	23	of	of	IN
cord-005453-4057qib7	10218	24	231	231	CD
cord-005453-4057qib7	10218	25	days	day	NNS
cord-005453-4057qib7	10218	26	(	(	-LRB-
cord-005453-4057qib7	10218	27	range	range	VBP
cord-005453-4057qib7	10218	28	87	87	CD
cord-005453-4057qib7	10218	29	-	-	SYM
cord-005453-4057qib7	10218	30	315	315	CD
cord-005453-4057qib7	10218	31	)	)	-RRB-
cord-005453-4057qib7	10218	32	until	until	IN
cord-005453-4057qib7	10218	33	last	last	JJ
cord-005453-4057qib7	10218	34	followup	followup	NN
cord-005453-4057qib7	10218	35	.	.	.
cord-005453-4057qib7	10219	1	One	one	CD
cord-005453-4057qib7	10219	2	patient	patient	NN
cord-005453-4057qib7	10219	3	(	(	-LRB-
cord-005453-4057qib7	10219	4	MUD	mud	NN
cord-005453-4057qib7	10219	5	,	,	,
cord-005453-4057qib7	10219	6	re	re	NN
cord-005453-4057qib7	10219	7	-	-	NN
cord-005453-4057qib7	10219	8	exposition	exposition	NN
cord-005453-4057qib7	10219	9	at	at	IN
cord-005453-4057qib7	10219	10	d+341	d+341	NNP
cord-005453-4057qib7	10219	11	)	)	-RRB-
cord-005453-4057qib7	10219	12	experienced	experience	VBD
cord-005453-4057qib7	10219	13	pruritus	pruritus	NN
cord-005453-4057qib7	10219	14	and	and	CC
cord-005453-4057qib7	10219	15	erythema	erythema	NN
cord-005453-4057qib7	10219	16	some	some	DT
cord-005453-4057qib7	10219	17	hours	hour	NNS
cord-005453-4057qib7	10219	18	after	after	IN
cord-005453-4057qib7	10219	19	tablet	tablet	NN
cord-005453-4057qib7	10219	20	intake	intake	NN
cord-005453-4057qib7	10219	21	.	.	.
cord-005453-4057qib7	10220	1	Another	another	DT
cord-005453-4057qib7	10220	2	patient	patient	NN
cord-005453-4057qib7	10220	3	(	(	-LRB-
cord-005453-4057qib7	10220	4	MUD	mud	NN
cord-005453-4057qib7	10220	5	,	,	,
cord-005453-4057qib7	10220	6	re	re	NN
cord-005453-4057qib7	10220	7	-	-	NN
cord-005453-4057qib7	10220	8	exposition	exposition	NN
cord-005453-4057qib7	10220	9	at	at	IN
cord-005453-4057qib7	10220	10	d+18	d+18	ADD
cord-005453-4057qib7	10220	11	)	)	-RRB-
cord-005453-4057qib7	10220	12	developed	develop	VBD
cord-005453-4057qib7	10220	13	an	an	DT
cord-005453-4057qib7	10220	14	exanthema	exanthema	JJ
cord-005453-4057qib7	10220	15	one	one	CD
cord-005453-4057qib7	10220	16	day	day	NN
cord-005453-4057qib7	10220	17	after	after	IN
cord-005453-4057qib7	10220	18	re	re	NN
cord-005453-4057qib7	10220	19	-	-	NN
cord-005453-4057qib7	10220	20	exposition	exposition	NN
cord-005453-4057qib7	10220	21	which	which	WDT
cord-005453-4057qib7	10220	22	was	be	VBD
cord-005453-4057qib7	10220	23	later	later	RB
cord-005453-4057qib7	10220	24	diagnosed	diagnose	VBN
cord-005453-4057qib7	10220	25	as	as	IN
cord-005453-4057qib7	10220	26	a	a	DT
cord-005453-4057qib7	10220	27	cutaneous	cutaneous	JJ
cord-005453-4057qib7	10220	28	GvHD	gvhd	NN
cord-005453-4057qib7	10220	29	.	.	.
cord-005453-4057qib7	10221	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10221	2	:	:	:
cord-005453-4057qib7	10222	1	Re	re	NN
cord-005453-4057qib7	10222	2	-	-	NN
cord-005453-4057qib7	10222	3	exposition	exposition	NN
cord-005453-4057qib7	10222	4	of	of	IN
cord-005453-4057qib7	10222	5	TMP	TMP	NNP
cord-005453-4057qib7	10222	6	-	-	HYPH
cord-005453-4057qib7	10222	7	SMX	SMX	NNP
cord-005453-4057qib7	10222	8	in	in	IN
cord-005453-4057qib7	10222	9	patients	patient	NNS
cord-005453-4057qib7	10222	10	with	with	IN
cord-005453-4057qib7	10222	11	prior	prior	JJ
cord-005453-4057qib7	10222	12	hypersensitivity	hypersensitivity	NN
cord-005453-4057qib7	10222	13	is	be	VBZ
cord-005453-4057qib7	10222	14	feasible	feasible	JJ
cord-005453-4057qib7	10222	15	after	after	IN
cord-005453-4057qib7	10222	16	allo	allo	NN
cord-005453-4057qib7	10222	17	-	-	HYPH
cord-005453-4057qib7	10222	18	HSCT	HSCT	NNP
cord-005453-4057qib7	10222	19	.	.	.
cord-005453-4057qib7	10223	1	After	after	IN
cord-005453-4057qib7	10223	2	successful	successful	JJ
cord-005453-4057qib7	10223	3	re	re	NN
cord-005453-4057qib7	10223	4	-	-	NN
cord-005453-4057qib7	10223	5	exposition	exposition	NN
cord-005453-4057qib7	10223	6	,	,	,
cord-005453-4057qib7	10223	7	patients	patient	NNS
cord-005453-4057qib7	10223	8	can	can	MD
cord-005453-4057qib7	10223	9	be	be	VB
cord-005453-4057qib7	10223	10	treated	treat	VBN
cord-005453-4057qib7	10223	11	with	with	IN
cord-005453-4057qib7	10223	12	the	the	DT
cord-005453-4057qib7	10223	13	best	well	RBS
cord-005453-4057qib7	10223	14	-	-	HYPH
cord-005453-4057qib7	10223	15	studied	study	VBN
cord-005453-4057qib7	10223	16	drug	drug	NN
cord-005453-4057qib7	10223	17	for	for	IN
cord-005453-4057qib7	10223	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10223	19	of	of	IN
cord-005453-4057qib7	10223	20	infections	infection	NNS
cord-005453-4057qib7	10223	21	with	with	IN
cord-005453-4057qib7	10223	22	Pneumocystis	Pneumocystis	NNP
cord-005453-4057qib7	10223	23	and	and	CC
cord-005453-4057qib7	10223	24	Toxoplasma	Toxoplasma	NNP
cord-005453-4057qib7	10223	25	.	.	.
cord-005453-4057qib7	10224	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10224	2	:	:	:
cord-005453-4057qib7	10224	3	Nothing	nothing	NN
cord-005453-4057qib7	10224	4	to	to	TO
cord-005453-4057qib7	10224	5	declare	declare	VB
cord-005453-4057qib7	10224	6	Brincidofovir	Brincidofovir	NNP
cord-005453-4057qib7	10224	7	for	for	IN
cord-005453-4057qib7	10224	8	adenoviremia	adenoviremia	NN
cord-005453-4057qib7	10224	9	in	in	IN
cord-005453-4057qib7	10224	10	paediatric	paediatric	JJ
cord-005453-4057qib7	10224	11	HSCT	HSCT	NNP
cord-005453-4057qib7	10224	12	for	for	IN
cord-005453-4057qib7	10224	13	primary	primary	JJ
cord-005453-4057qib7	10224	14	immune	immune	JJ
cord-005453-4057qib7	10224	15	deficiency	deficiency	NN
cord-005453-4057qib7	10225	1	Background	background	NN
cord-005453-4057qib7	10225	2	:	:	:
cord-005453-4057qib7	10225	3	Reactivation	reactivation	NN
cord-005453-4057qib7	10225	4	of	of	IN
cord-005453-4057qib7	10225	5	adenovirus	adenovirus	NN
cord-005453-4057qib7	10225	6	is	be	VBZ
cord-005453-4057qib7	10225	7	a	a	DT
cord-005453-4057qib7	10225	8	severe	severe	JJ
cord-005453-4057qib7	10225	9	complication	complication	NN
cord-005453-4057qib7	10225	10	of	of	IN
cord-005453-4057qib7	10225	11	HSCT	HSCT	NNP
cord-005453-4057qib7	10225	12	associated	associate	VBN
cord-005453-4057qib7	10225	13	with	with	IN
cord-005453-4057qib7	10225	14	significant	significant	JJ
cord-005453-4057qib7	10225	15	morbidity	morbidity	NN
cord-005453-4057qib7	10225	16	and	and	CC
cord-005453-4057qib7	10225	17	mortality	mortality	NN
cord-005453-4057qib7	10225	18	,	,	,
cord-005453-4057qib7	10225	19	particularly	particularly	RB
cord-005453-4057qib7	10225	20	for	for	IN
cord-005453-4057qib7	10225	21	children	child	NNS
cord-005453-4057qib7	10225	22	with	with	IN
cord-005453-4057qib7	10225	23	primary	primary	JJ
cord-005453-4057qib7	10225	24	immune	immune	JJ
cord-005453-4057qib7	10225	25	deficiency	deficiency	NN
cord-005453-4057qib7	10225	26	(	(	-LRB-
cord-005453-4057qib7	10225	27	PID	PID	NNP
cord-005453-4057qib7	10225	28	)	)	-RRB-
cord-005453-4057qib7	10225	29	.	.	.
cord-005453-4057qib7	10226	1	The	the	DT
cord-005453-4057qib7	10226	2	only	only	JJ
cord-005453-4057qib7	10226	3	drug	drug	NN
cord-005453-4057qib7	10226	4	currently	currently	RB
cord-005453-4057qib7	10226	5	licensed	license	VBN
cord-005453-4057qib7	10226	6	to	to	TO
cord-005453-4057qib7	10226	7	treat	treat	VB
cord-005453-4057qib7	10226	8	adenovirus	adenovirus	NN
cord-005453-4057qib7	10226	9	infection	infection	NN
cord-005453-4057qib7	10226	10	is	be	VBZ
cord-005453-4057qib7	10226	11	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10226	12	.	.	.
cord-005453-4057qib7	10227	1	Brincidofovir	Brincidofovir	NNP
cord-005453-4057qib7	10227	2	is	be	VBZ
cord-005453-4057qib7	10227	3	a	a	DT
cord-005453-4057qib7	10227	4	lipidlinked	lipidlinked	JJ
cord-005453-4057qib7	10227	5	derivative	derivative	NN
cord-005453-4057qib7	10227	6	of	of	IN
cord-005453-4057qib7	10227	7	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10227	8	which	which	WDT
cord-005453-4057qib7	10227	9	has	have	VBZ
cord-005453-4057qib7	10227	10	been	be	VBN
cord-005453-4057qib7	10227	11	shown	show	VBN
cord-005453-4057qib7	10227	12	to	to	TO
cord-005453-4057qib7	10227	13	be	be	VB
cord-005453-4057qib7	10227	14	a	a	DT
cord-005453-4057qib7	10227	15	safe	safe	JJ
cord-005453-4057qib7	10227	16	and	and	CC
cord-005453-4057qib7	10227	17	effective	effective	JJ
cord-005453-4057qib7	10227	18	alternative	alternative	JJ
cord-005453-4057qib7	10227	19	treatment	treatment	NN
cord-005453-4057qib7	10227	20	to	to	IN
cord-005453-4057qib7	10227	21	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10227	22	.	.	.
cord-005453-4057qib7	10228	1	There	there	EX
cord-005453-4057qib7	10228	2	is	be	VBZ
cord-005453-4057qib7	10228	3	limited	limited	JJ
cord-005453-4057qib7	10228	4	data	datum	NNS
cord-005453-4057qib7	10228	5	describing	describe	VBG
cord-005453-4057qib7	10228	6	the	the	DT
cord-005453-4057qib7	10228	7	use	use	NN
cord-005453-4057qib7	10228	8	of	of	IN
cord-005453-4057qib7	10228	9	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10228	10	in	in	IN
cord-005453-4057qib7	10228	11	patients	patient	NNS
cord-005453-4057qib7	10228	12	undergoing	undergo	VBG
cord-005453-4057qib7	10228	13	HSCT	HSCT	NNP
cord-005453-4057qib7	10228	14	for	for	IN
cord-005453-4057qib7	10228	15	primary	primary	JJ
cord-005453-4057qib7	10228	16	immune	immune	JJ
cord-005453-4057qib7	10228	17	deficiency	deficiency	NN
cord-005453-4057qib7	10228	18	.	.	.
cord-005453-4057qib7	10229	1	We	-PRON-	PRP
cord-005453-4057qib7	10229	2	reviewed	review	VBD
cord-005453-4057qib7	10229	3	all	all	DT
cord-005453-4057qib7	10229	4	patients	patient	NNS
cord-005453-4057qib7	10229	5	who	who	WP
cord-005453-4057qib7	10229	6	received	receive	VBD
cord-005453-4057qib7	10229	7	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10229	8	after	after	IN
cord-005453-4057qib7	10229	9	undergoing	undergo	VBG
cord-005453-4057qib7	10229	10	HSCT	HSCT	NNP
cord-005453-4057qib7	10229	11	for	for	IN
cord-005453-4057qib7	10229	12	primary	primary	JJ
cord-005453-4057qib7	10229	13	immune	immune	JJ
cord-005453-4057qib7	10229	14	deficiencies	deficiency	NNS
cord-005453-4057qib7	10229	15	between	between	IN
cord-005453-4057qib7	10229	16	2016	2016	CD
cord-005453-4057qib7	10229	17	and	and	CC
cord-005453-4057qib7	10229	18	2018	2018	CD
cord-005453-4057qib7	10229	19	at	at	IN
cord-005453-4057qib7	10229	20	the	the	DT
cord-005453-4057qib7	10229	21	Great	Great	NNP
cord-005453-4057qib7	10229	22	North	North	NNP
cord-005453-4057qib7	10229	23	Children	Children	NNPS
cord-005453-4057qib7	10229	24	's	's	POS
cord-005453-4057qib7	10229	25	Hospital	Hospital	NNP
cord-005453-4057qib7	10229	26	,	,	,
cord-005453-4057qib7	10229	27	Newcastle	Newcastle	NNP
cord-005453-4057qib7	10229	28	Upon	upon	IN
cord-005453-4057qib7	10229	29	Tyne	Tyne	NNP
cord-005453-4057qib7	10229	30	,	,	,
cord-005453-4057qib7	10229	31	UK	UK	NNP
cord-005453-4057qib7	10229	32	.	.	.
cord-005453-4057qib7	10230	1	Results	result	NNS
cord-005453-4057qib7	10230	2	:	:	:
cord-005453-4057qib7	10231	1	Of	of	IN
cord-005453-4057qib7	10231	2	78	78	CD
cord-005453-4057qib7	10231	3	patients	patient	NNS
cord-005453-4057qib7	10231	4	transplanted	transplant	VBN
cord-005453-4057qib7	10231	5	for	for	IN
cord-005453-4057qib7	10231	6	PID	PID	NNP
cord-005453-4057qib7	10231	7	,	,	,
cord-005453-4057qib7	10231	8	11	11	CD
cord-005453-4057qib7	10231	9	developed	develop	VBD
cord-005453-4057qib7	10231	10	significant	significant	JJ
cord-005453-4057qib7	10231	11	adenoviraemia	adenoviraemia	NN
cord-005453-4057qib7	10231	12	(	(	-LRB-
cord-005453-4057qib7	10231	13	14	14	CD
cord-005453-4057qib7	10231	14	%	%	NN
cord-005453-4057qib7	10231	15	)	)	-RRB-
cord-005453-4057qib7	10231	16	.	.	.
cord-005453-4057qib7	10232	1	All	all	DT
cord-005453-4057qib7	10232	2	were	be	VBD
cord-005453-4057qib7	10232	3	treated	treat	VBN
cord-005453-4057qib7	10232	4	with	with	IN
cord-005453-4057qib7	10232	5	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10232	6	initially	initially	RB
cord-005453-4057qib7	10232	7	but	but	CC
cord-005453-4057qib7	10232	8	6	6	CD
cord-005453-4057qib7	10232	9	were	be	VBD
cord-005453-4057qib7	10232	10	switched	switch	VBN
cord-005453-4057qib7	10232	11	to	to	IN
cord-005453-4057qib7	10232	12	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10232	13	because	because	IN
cord-005453-4057qib7	10232	14	of	of	IN
cord-005453-4057qib7	10232	15	a	a	DT
cord-005453-4057qib7	10232	16	failure	failure	NN
cord-005453-4057qib7	10232	17	to	to	TO
cord-005453-4057qib7	10232	18	respond	respond	VB
cord-005453-4057qib7	10232	19	or	or	CC
cord-005453-4057qib7	10232	20	because	because	IN
cord-005453-4057qib7	10232	21	of	of	IN
cord-005453-4057qib7	10232	22	renal	renal	JJ
cord-005453-4057qib7	10232	23	toxicity	toxicity	NN
cord-005453-4057qib7	10232	24	.	.	.
cord-005453-4057qib7	10233	1	Of	of	IN
cord-005453-4057qib7	10233	2	these	these	DT
cord-005453-4057qib7	10233	3	,	,	,
cord-005453-4057qib7	10233	4	4	4	CD
cord-005453-4057qib7	10233	5	resolved	resolve	VBD
cord-005453-4057qib7	10233	6	their	-PRON-	PRP$
cord-005453-4057qib7	10233	7	adenoviraemia	adenoviraemia	NN
cord-005453-4057qib7	10233	8	within	within	IN
cord-005453-4057qib7	10233	9	21	21	CD
cord-005453-4057qib7	10233	10	days	day	NNS
cord-005453-4057qib7	10233	11	of	of	IN
cord-005453-4057qib7	10233	12	commencing	commence	VBG
cord-005453-4057qib7	10233	13	treatment	treatment	NN
cord-005453-4057qib7	10233	14	(	(	-LRB-
cord-005453-4057qib7	10233	15	figure	figure	NN
cord-005453-4057qib7	10233	16	1	1	CD
cord-005453-4057qib7	10233	17	)	)	-RRB-
cord-005453-4057qib7	10233	18	.	.	.
cord-005453-4057qib7	10234	1	Donor	donor	NN
cord-005453-4057qib7	10234	2	sources	source	NNS
cord-005453-4057qib7	10234	3	were	be	VBD
cord-005453-4057qib7	10234	4	TCR	TCR	NNP
cord-005453-4057qib7	10235	1	alpha	alpha	NN
cord-005453-4057qib7	10235	2	/	/	SYM
cord-005453-4057qib7	10235	3	beta	beta	NN
cord-005453-4057qib7	10236	1	/CD19	/CD19	NNP
cord-005453-4057qib7	10236	2	depleted	deplete	VBN
cord-005453-4057qib7	10236	3	haplo	haplo	NN
cord-005453-4057qib7	10236	4	-	-	HYPH
cord-005453-4057qib7	10236	5	identical	identical	JJ
cord-005453-4057qib7	10236	6	(	(	-LRB-
cord-005453-4057qib7	10236	7	n=4	n=4	JJ
cord-005453-4057qib7	10236	8	)	)	-RRB-
cord-005453-4057qib7	10237	1	,	,	,
cord-005453-4057qib7	10237	2	TCR	TCR	NNP
cord-005453-4057qib7	10237	3	alpha	alpha	NN
cord-005453-4057qib7	10237	4	/	/	SYM
cord-005453-4057qib7	10237	5	beta	beta	NN
cord-005453-4057qib7	10237	6	/	/	SYM
cord-005453-4057qib7	10237	7	CD19	CD19	NNP
cord-005453-4057qib7	10237	8	depleted	deplete	VBD
cord-005453-4057qib7	10237	9	MMUD	MMUD	NNP
cord-005453-4057qib7	10237	10	(	(	-LRB-
cord-005453-4057qib7	10237	11	n=1	n=1	NN
cord-005453-4057qib7	10237	12	)	)	-RRB-
cord-005453-4057qib7	10237	13	and	and	CC
cord-005453-4057qib7	10237	14	12/12	12/12	CD
cord-005453-4057qib7	10237	15	MUD	mud	NN
cord-005453-4057qib7	10237	16	(	(	-LRB-
cord-005453-4057qib7	10237	17	n=1	n=1	FW
cord-005453-4057qib7	10237	18	)	)	-RRB-
cord-005453-4057qib7	10237	19	.	.	.
cord-005453-4057qib7	10238	1	Patients	patient	NNS
cord-005453-4057qib7	10238	2	were	be	VBD
cord-005453-4057qib7	10238	3	conditioned	condition	VBN
cord-005453-4057qib7	10238	4	with	with	IN
cord-005453-4057qib7	10238	5	Treosulphan	Treosulphan	NNP
cord-005453-4057qib7	10238	6	/	/	SYM
cord-005453-4057qib7	10238	7	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	10238	8	/	/	SYM
cord-005453-4057qib7	10238	9	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	10238	10	/	/	SYM
cord-005453-4057qib7	10238	11	ATG/	ATG/	NNP
cord-005453-4057qib7	10238	12	Rituximab	Rituximab	NNP
cord-005453-4057qib7	10238	13	(	(	-LRB-
cord-005453-4057qib7	10238	14	n=4	n=4	NNS
cord-005453-4057qib7	10238	15	)	)	-RRB-
cord-005453-4057qib7	10238	16	,	,	,
cord-005453-4057qib7	10238	17	Treosulphan	Treosulphan	NNP
cord-005453-4057qib7	10238	18	/	/	SYM
cord-005453-4057qib7	10238	19	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	10238	20	/	/	SYM
cord-005453-4057qib7	10238	21	ATG	ATG	NNP
cord-005453-4057qib7	10238	22	/	/	SYM
cord-005453-4057qib7	10238	23	Rituximab	Rituximab	NNP
cord-005453-4057qib7	10238	24	(	(	-LRB-
cord-005453-4057qib7	10238	25	n=1	n=1	NN
cord-005453-4057qib7	10238	26	)	)	-RRB-
cord-005453-4057qib7	10238	27	or	or	CC
cord-005453-4057qib7	10238	28	Treosulphan	Treosulphan	NNP
cord-005453-4057qib7	10238	29	/	/	SYM
cord-005453-4057qib7	10238	30	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	10238	31	/	/	SYM
cord-005453-4057qib7	10238	32	Alemtuzumab/	alemtuzumab/	CC
cord-005453-4057qib7	10238	33	GCSF	GCSF	NNP
cord-005453-4057qib7	10238	34	/	/	SYM
cord-005453-4057qib7	10238	35	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	10238	36	(	(	-LRB-
cord-005453-4057qib7	10238	37	n=1	n=1	NN
cord-005453-4057qib7	10238	38	)	)	-RRB-
cord-005453-4057qib7	10238	39	.	.	.
cord-005453-4057qib7	10239	1	Occurrence	occurrence	NN
cord-005453-4057qib7	10239	2	of	of	IN
cord-005453-4057qib7	10239	3	aGVHD	agvhd	NN
cord-005453-4057qib7	10239	4	and	and	CC
cord-005453-4057qib7	10239	5	treatment	treatment	NN
cord-005453-4057qib7	10239	6	of	of	IN
cord-005453-4057qib7	10239	7	aGVHD	aGVHD	NNP
cord-005453-4057qib7	10239	8	are	be	VBP
cord-005453-4057qib7	10239	9	outlined	outline	VBN
cord-005453-4057qib7	10239	10	in	in	IN
cord-005453-4057qib7	10239	11	table	table	NN
cord-005453-4057qib7	10239	12	1	1	CD
cord-005453-4057qib7	10239	13	.	.	.
cord-005453-4057qib7	10240	1	Patient	patient	NN
cord-005453-4057qib7	10240	2	5	5	CD
cord-005453-4057qib7	10240	3	died	die	VBD
cord-005453-4057qib7	10240	4	+111	+111	NNP
cord-005453-4057qib7	10240	5	days	day	NNS
cord-005453-4057qib7	10240	6	post	post	NN
cord-005453-4057qib7	10240	7	-	-	NN
cord-005453-4057qib7	10240	8	transplant	transplant	NN
cord-005453-4057qib7	10240	9	of	of	IN
cord-005453-4057qib7	10240	10	multi	multi	JJ
cord-005453-4057qib7	10240	11	-	-	JJ
cord-005453-4057qib7	10240	12	organ	organ	JJ
cord-005453-4057qib7	10240	13	failure	failure	NN
cord-005453-4057qib7	10240	14	,	,	,
cord-005453-4057qib7	10240	15	severe	severe	JJ
cord-005453-4057qib7	10240	16	thrombotic	thrombotic	JJ
cord-005453-4057qib7	10240	17	microangiopathy	microangiopathy	NN
cord-005453-4057qib7	10240	18	and	and	CC
cord-005453-4057qib7	10240	19	sepsis	sepsis	NN
cord-005453-4057qib7	10240	20	.	.	.
cord-005453-4057qib7	10241	1	Although	although	IN
cord-005453-4057qib7	10241	2	Patient	Patient	NNP
cord-005453-4057qib7	10241	3	2	2	CD
cord-005453-4057qib7	10241	4	initially	initially	RB
cord-005453-4057qib7	10241	5	responded	respond	VBD
cord-005453-4057qib7	10241	6	to	to	IN
cord-005453-4057qib7	10241	7	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10241	8	,	,	,
cord-005453-4057qib7	10241	9	reactivation	reactivation	NN
cord-005453-4057qib7	10241	10	occurred	occur	VBD
cord-005453-4057qib7	10241	11	after	after	IN
cord-005453-4057qib7	10241	12	cessation	cessation	NN
cord-005453-4057qib7	10241	13	of	of	IN
cord-005453-4057qib7	10241	14	treatment	treatment	NN
cord-005453-4057qib7	10241	15	;	;	:
cord-005453-4057qib7	10241	16	severe	severe	JJ
cord-005453-4057qib7	10241	17	diarrhoea	diarrhoea	NN
cord-005453-4057qib7	10241	18	precluded	preclude	VBD
cord-005453-4057qib7	10241	19	the	the	DT
cord-005453-4057qib7	10241	20	reintroduction	reintroduction	NN
cord-005453-4057qib7	10241	21	of	of	IN
cord-005453-4057qib7	10241	22	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10241	23	and	and	CC
cord-005453-4057qib7	10241	24	the	the	DT
cord-005453-4057qib7	10241	25	adenoviraemia	adenoviraemia	NN
cord-005453-4057qib7	10241	26	persisted	persist	VBD
cord-005453-4057qib7	10241	27	with	with	IN
cord-005453-4057qib7	10241	28	poor	poor	JJ
cord-005453-4057qib7	10241	29	immune	immune	JJ
cord-005453-4057qib7	10241	30	reconstitution	reconstitution	NN
cord-005453-4057qib7	10241	31	.	.	.
cord-005453-4057qib7	10242	1	Treatment	treatment	NN
cord-005453-4057qib7	10242	2	with	with	IN
cord-005453-4057qib7	10242	3	addback	addback	NNP
cord-005453-4057qib7	10242	4	T	T	NNP
cord-005453-4057qib7	10242	5	cells	cell	NNS
cord-005453-4057qib7	10242	6	was	be	VBD
cord-005453-4057qib7	10242	7	attempted	attempt	VBN
cord-005453-4057qib7	10242	8	however	however	RB
cord-005453-4057qib7	10242	9	the	the	DT
cord-005453-4057qib7	10242	10	patient	patient	NN
cord-005453-4057qib7	10242	11	died	die	VBD
cord-005453-4057qib7	10242	12	194	194	CD
cord-005453-4057qib7	10242	13	days	day	NNS
cord-005453-4057qib7	10242	14	post	post	JJ
cord-005453-4057qib7	10242	15	-	-	NN
cord-005453-4057qib7	10242	16	transplant	transplant	NN
cord-005453-4057qib7	10242	17	after	after	IN
cord-005453-4057qib7	10242	18	a	a	DT
cord-005453-4057qib7	10242	19	cerebral	cerebral	JJ
cord-005453-4057qib7	10242	20	haemorrhage	haemorrhage	NN
cord-005453-4057qib7	10242	21	.	.	.
cord-005453-4057qib7	10243	1	Patient	Patient	NNP
cord-005453-4057qib7	10243	2	3	3	CD
cord-005453-4057qib7	10243	3	had	have	VBD
cord-005453-4057qib7	10243	4	long	long	RB
cord-005453-4057qib7	10243	5	-	-	HYPH
cord-005453-4057qib7	10243	6	standing	stand	VBG
cord-005453-4057qib7	10243	7	chronic	chronic	JJ
cord-005453-4057qib7	10243	8	diarrhoea	diarrhoea	NN
cord-005453-4057qib7	10243	9	which	which	WDT
cord-005453-4057qib7	10243	10	was	be	VBD
cord-005453-4057qib7	10243	11	thought	think	VBN
cord-005453-4057qib7	10243	12	not	not	RB
cord-005453-4057qib7	10243	13	severe	severe	JJ
cord-005453-4057qib7	10243	14	enough	enough	RB
cord-005453-4057qib7	10243	15	to	to	TO
cord-005453-4057qib7	10243	16	warrant	warrant	VB
cord-005453-4057qib7	10243	17	cessation	cessation	NN
cord-005453-4057qib7	10243	18	of	of	IN
cord-005453-4057qib7	10243	19	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10243	20	treatment	treatment	NN
cord-005453-4057qib7	10243	21	.	.	.
cord-005453-4057qib7	10244	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10244	2	:	:	:
cord-005453-4057qib7	10245	1	The	the	DT
cord-005453-4057qib7	10245	2	complete	complete	JJ
cord-005453-4057qib7	10245	3	resolution	resolution	NN
cord-005453-4057qib7	10245	4	of	of	IN
cord-005453-4057qib7	10245	5	adenoviraemia	adenoviraemia	NN
cord-005453-4057qib7	10245	6	in	in	IN
cord-005453-4057qib7	10245	7	4/6	4/6	CD
cord-005453-4057qib7	10245	8	patients	patient	NNS
cord-005453-4057qib7	10245	9	who	who	WP
cord-005453-4057qib7	10245	10	had	have	VBD
cord-005453-4057qib7	10245	11	previously	previously	RB
cord-005453-4057qib7	10245	12	failed	fail	VBN
cord-005453-4057qib7	10245	13	to	to	TO
cord-005453-4057qib7	10245	14	respond	respond	VB
cord-005453-4057qib7	10245	15	to	to	IN
cord-005453-4057qib7	10245	16	prior	prior	JJ
cord-005453-4057qib7	10245	17	therapy	therapy	NN
cord-005453-4057qib7	10245	18	with	with	IN
cord-005453-4057qib7	10245	19	cidofovir	cidofovir	NNP
cord-005453-4057qib7	10245	20	suggests	suggest	VBZ
cord-005453-4057qib7	10245	21	that	that	IN
cord-005453-4057qib7	10245	22	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10245	23	may	may	MD
cord-005453-4057qib7	10245	24	be	be	VB
cord-005453-4057qib7	10245	25	an	an	DT
cord-005453-4057qib7	10245	26	effective	effective	JJ
cord-005453-4057qib7	10245	27	treatment	treatment	NN
cord-005453-4057qib7	10245	28	option	option	NN
cord-005453-4057qib7	10245	29	for	for	IN
cord-005453-4057qib7	10245	30	adenoviral	adenoviral	NNP
cord-005453-4057qib7	10245	31	reactivation	reactivation	NN
cord-005453-4057qib7	10245	32	post	post	NN
cord-005453-4057qib7	10245	33	-	-	JJ
cord-005453-4057qib7	10245	34	HSCT	HSCT	NNP
cord-005453-4057qib7	10245	35	for	for	IN
cord-005453-4057qib7	10245	36	PID	PID	NNP
cord-005453-4057qib7	10245	37	.	.	.
cord-005453-4057qib7	10246	1	However	however	RB
cord-005453-4057qib7	10246	2	,	,	,
cord-005453-4057qib7	10246	3	resolution	resolution	NN
cord-005453-4057qib7	10246	4	of	of	IN
cord-005453-4057qib7	10246	5	adenoviraemia	adenoviraemia	NNP
cord-005453-4057qib7	10246	6	is	be	VBZ
cord-005453-4057qib7	10246	7	influenced	influence	VBN
cord-005453-4057qib7	10246	8	by	by	IN
cord-005453-4057qib7	10246	9	many	many	JJ
cord-005453-4057qib7	10246	10	other	other	JJ
cord-005453-4057qib7	10246	11	factors	factor	NNS
cord-005453-4057qib7	10246	12	,	,	,
cord-005453-4057qib7	10246	13	including	include	VBG
cord-005453-4057qib7	10246	14	the	the	DT
cord-005453-4057qib7	10246	15	adequacy	adequacy	NN
cord-005453-4057qib7	10246	16	of	of	IN
cord-005453-4057qib7	10246	17	immune	immune	JJ
cord-005453-4057qib7	10246	18	reconstitution	reconstitution	NN
cord-005453-4057qib7	10246	19	,	,	,
cord-005453-4057qib7	10246	20	the	the	DT
cord-005453-4057qib7	10246	21	degree	degree	NN
cord-005453-4057qib7	10246	22	of	of	IN
cord-005453-4057qib7	10246	23	induced	induce	VBN
cord-005453-4057qib7	10246	24	immune	immune	JJ
cord-005453-4057qib7	10246	25	suppression	suppression	NN
cord-005453-4057qib7	10246	26	and	and	CC
cord-005453-4057qib7	10246	27	the	the	DT
cord-005453-4057qib7	10246	28	presence	presence	NN
cord-005453-4057qib7	10246	29	of	of	IN
cord-005453-4057qib7	10246	30	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	10246	31	such	such	JJ
cord-005453-4057qib7	10246	32	as	as	IN
cord-005453-4057qib7	10246	33	GVHD	GVHD	NNP
cord-005453-4057qib7	10246	34	.	.	.
cord-005453-4057qib7	10247	1	Due	due	IN
cord-005453-4057qib7	10247	2	to	to	IN
cord-005453-4057qib7	10247	3	the	the	DT
cord-005453-4057qib7	10247	4	small	small	JJ
cord-005453-4057qib7	10247	5	sample	sample	NN
cord-005453-4057qib7	10247	6	size	size	NN
cord-005453-4057qib7	10247	7	it	-PRON-	PRP
cord-005453-4057qib7	10247	8	was	be	VBD
cord-005453-4057qib7	10247	9	difficult	difficult	JJ
cord-005453-4057qib7	10247	10	to	to	TO
cord-005453-4057qib7	10247	11	assess	assess	VB
cord-005453-4057qib7	10247	12	the	the	DT
cord-005453-4057qib7	10247	13	relative	relative	JJ
cord-005453-4057qib7	10247	14	importance	importance	NN
cord-005453-4057qib7	10247	15	of	of	IN
cord-005453-4057qib7	10247	16	these	these	DT
cord-005453-4057qib7	10247	17	factors	factor	NNS
cord-005453-4057qib7	10247	18	in	in	IN
cord-005453-4057qib7	10247	19	this	this	DT
cord-005453-4057qib7	10247	20	cohort	cohort	NN
cord-005453-4057qib7	10247	21	.	.	.
cord-005453-4057qib7	10248	1	Brincidofovir	Brincidofovir	NNP
cord-005453-4057qib7	10248	2	was	be	VBD
cord-005453-4057qib7	10248	3	well	well	RB
cord-005453-4057qib7	10248	4	tolerated	tolerate	VBN
cord-005453-4057qib7	10248	5	however	however	RB
cord-005453-4057qib7	10248	6	its	-PRON-	PRP$
cord-005453-4057qib7	10248	7	effectiveness	effectiveness	NN
cord-005453-4057qib7	10248	8	may	may	MD
cord-005453-4057qib7	10248	9	have	have	VB
cord-005453-4057qib7	10248	10	been	be	VBN
cord-005453-4057qib7	10248	11	limited	limit	VBN
cord-005453-4057qib7	10248	12	by	by	IN
cord-005453-4057qib7	10248	13	poor	poor	JJ
cord-005453-4057qib7	10248	14	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	10248	15	function	function	NN
cord-005453-4057qib7	10248	16	in	in	IN
cord-005453-4057qib7	10248	17	one	one	CD
cord-005453-4057qib7	10248	18	patient	patient	NN
cord-005453-4057qib7	10248	19	(	(	-LRB-
cord-005453-4057qib7	10248	20	Patient	Patient	NNP
cord-005453-4057qib7	10248	21	3	3	CD
cord-005453-4057qib7	10248	22	)	)	-RRB-
cord-005453-4057qib7	10248	23	and	and	CC
cord-005453-4057qib7	10248	24	could	could	MD
cord-005453-4057qib7	10248	25	not	not	RB
cord-005453-4057qib7	10248	26	be	be	VB
cord-005453-4057qib7	10248	27	used	use	VBN
cord-005453-4057qib7	10248	28	after	after	IN
cord-005453-4057qib7	10248	29	a	a	DT
cord-005453-4057qib7	10248	30	viral	viral	JJ
cord-005453-4057qib7	10248	31	reactivation	reactivation	NN
cord-005453-4057qib7	10248	32	in	in	IN
cord-005453-4057qib7	10248	33	another	another	DT
cord-005453-4057qib7	10248	34	for	for	IN
cord-005453-4057qib7	10248	35	the	the	DT
cord-005453-4057qib7	10248	36	same	same	JJ
cord-005453-4057qib7	10248	37	reason	reason	NN
cord-005453-4057qib7	10248	38	.	.	.
cord-005453-4057qib7	10249	1	Further	further	JJ
cord-005453-4057qib7	10249	2	studies	study	NNS
cord-005453-4057qib7	10249	3	of	of	IN
cord-005453-4057qib7	10249	4	the	the	DT
cord-005453-4057qib7	10249	5	use	use	NN
cord-005453-4057qib7	10249	6	of	of	IN
cord-005453-4057qib7	10249	7	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	10249	8	in	in	IN
cord-005453-4057qib7	10249	9	this	this	DT
cord-005453-4057qib7	10249	10	specific	specific	JJ
cord-005453-4057qib7	10249	11	cohort	cohort	NN
cord-005453-4057qib7	10249	12	are	be	VBP
cord-005453-4057qib7	10249	13	needed	need	VBN
cord-005453-4057qib7	10249	14	to	to	TO
cord-005453-4057qib7	10249	15	clarify	clarify	VB
cord-005453-4057qib7	10249	16	the	the	DT
cord-005453-4057qib7	10249	17	role	role	NN
cord-005453-4057qib7	10249	18	and	and	CC
cord-005453-4057qib7	10249	19	effectiveness	effectiveness	NN
cord-005453-4057qib7	10249	20	of	of	IN
cord-005453-4057qib7	10249	21	this	this	DT
cord-005453-4057qib7	10249	22	treatment	treatment	NN
cord-005453-4057qib7	10249	23	.	.	.
cord-005453-4057qib7	10250	1	Background	background	NN
cord-005453-4057qib7	10250	2	:	:	:
cord-005453-4057qib7	10251	1	There	there	EX
cord-005453-4057qib7	10251	2	is	be	VBZ
cord-005453-4057qib7	10251	3	a	a	DT
cord-005453-4057qib7	10251	4	high	high	JJ
cord-005453-4057qib7	10251	5	prevalence	prevalence	NN
cord-005453-4057qib7	10251	6	of	of	IN
cord-005453-4057qib7	10251	7	CMV	CMV	NNP
cord-005453-4057qib7	10251	8	seropositivity	seropositivity	NN
cord-005453-4057qib7	10251	9	in	in	IN
cord-005453-4057qib7	10251	10	Algerian	algerian	JJ
cord-005453-4057qib7	10251	11	population	population	NN
cord-005453-4057qib7	10251	12	.	.	.
cord-005453-4057qib7	10252	1	Because	because	IN
cord-005453-4057qib7	10252	2	of	of	IN
cord-005453-4057qib7	10252	3	high	high	JJ
cord-005453-4057qib7	10252	4	morbidity	morbidity	NN
cord-005453-4057qib7	10252	5	and	and	CC
cord-005453-4057qib7	10252	6	mortality	mortality	NN
cord-005453-4057qib7	10252	7	in	in	IN
cord-005453-4057qib7	10252	8	pts	pt	NNS
cord-005453-4057qib7	10252	9	who	who	WP
cord-005453-4057qib7	10252	10	underwent	undergo	VBD
cord-005453-4057qib7	10252	11	allo	allo	NNP
cord-005453-4057qib7	10252	12	SCT	SCT	NNP
cord-005453-4057qib7	10252	13	with	with	IN
cord-005453-4057qib7	10252	14	CMV	CMV	NNP
cord-005453-4057qib7	10252	15	reactivation	reactivation	NN
cord-005453-4057qib7	10252	16	,	,	,
cord-005453-4057qib7	10252	17	effective	effective	JJ
cord-005453-4057qib7	10252	18	surveillance	surveillance	NN
cord-005453-4057qib7	10252	19	and	and	CC
cord-005453-4057qib7	10252	20	timely	timely	JJ
cord-005453-4057qib7	10252	21	treatment	treatment	NN
cord-005453-4057qib7	10252	22	using	use	VBG
cord-005453-4057qib7	10252	23	anti	anti	JJ
cord-005453-4057qib7	10252	24	-	-	JJ
cord-005453-4057qib7	10252	25	viral	viral	JJ
cord-005453-4057qib7	10252	26	therapy	therapy	NN
cord-005453-4057qib7	10252	27	s	s	NNS
cord-005453-4057qib7	10252	28	required	require	VBN
cord-005453-4057qib7	10252	29	.	.	.
cord-005453-4057qib7	10253	1	The	the	DT
cord-005453-4057qib7	10253	2	risk	risk	NN
cord-005453-4057qib7	10253	3	of	of	IN
cord-005453-4057qib7	10253	4	CMV	CMV	NNP
cord-005453-4057qib7	10253	5	reactivation	reactivation	NN
cord-005453-4057qib7	10253	6	depends	depend	VBZ
cord-005453-4057qib7	10253	7	on	on	IN
cord-005453-4057qib7	10253	8	the	the	DT
cord-005453-4057qib7	10253	9	type	type	NN
cord-005453-4057qib7	10253	10	of	of	IN
cord-005453-4057qib7	10253	11	stem	stem	NN
cord-005453-4057qib7	10253	12	cell	cell	NN
cord-005453-4057qib7	10253	13	source	source	NN
cord-005453-4057qib7	10253	14	,	,	,
cord-005453-4057qib7	10253	15	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	10253	16	(	(	-LRB-
cord-005453-4057qib7	10253	17	IS	be	VBZ
cord-005453-4057qib7	10253	18	)	)	-RRB-
cord-005453-4057qib7	10253	19	and	and	CC
cord-005453-4057qib7	10253	20	serological	serological	JJ
cord-005453-4057qib7	10253	21	status	status	NN
cord-005453-4057qib7	10253	22	of	of	IN
cord-005453-4057qib7	10253	23	the	the	DT
cord-005453-4057qib7	10253	24	donor/	donor/	CD
cord-005453-4057qib7	10253	25	recipient	recipient	NN
cord-005453-4057qib7	10253	26	pair	pair	NN
cord-005453-4057qib7	10253	27	.	.	.
cord-005453-4057qib7	10254	1	Methods	method	NNS
cord-005453-4057qib7	10254	2	:	:	:
cord-005453-4057qib7	10254	3	over	over	IN
cord-005453-4057qib7	10254	4	a	a	DT
cord-005453-4057qib7	10254	5	24	24	CD
cord-005453-4057qib7	10254	6	months	month	NNS
cord-005453-4057qib7	10254	7	period	period	NN
cord-005453-4057qib7	10254	8	(	(	-LRB-
cord-005453-4057qib7	10254	9	from	from	IN
cord-005453-4057qib7	10254	10	01/01/2016	01/01/2016	CD
cord-005453-4057qib7	10254	11	to	to	IN
cord-005453-4057qib7	10254	12	31/12/2017	31/12/2017	CD
cord-005453-4057qib7	10254	13	)	)	-RRB-
cord-005453-4057qib7	10254	14	,	,	,
cord-005453-4057qib7	10254	15	254	254	CD
cord-005453-4057qib7	10254	16	pts	pt	NNS
cord-005453-4057qib7	10254	17	underwent	undergo	VBD
cord-005453-4057qib7	10254	18	allo	allo	NN
cord-005453-4057qib7	10254	19	-	-	HYPH
cord-005453-4057qib7	10254	20	HSCT	HSCT	NNP
cord-005453-4057qib7	10254	21	for	for	IN
cord-005453-4057qib7	10254	22	malignant	malignant	JJ
cord-005453-4057qib7	10254	23	or	or	CC
cord-005453-4057qib7	10254	24	non	non	JJ
cord-005453-4057qib7	10254	25	-	-	JJ
cord-005453-4057qib7	10254	26	malignant	malignant	JJ
cord-005453-4057qib7	10254	27	hematology	hematology	NN
cord-005453-4057qib7	10254	28	diseases	disease	NNS
cord-005453-4057qib7	10254	29	of	of	IN
cord-005453-4057qib7	10254	30	which	which	WDT
cord-005453-4057qib7	10254	31	246	246	CD
cord-005453-4057qib7	10254	32	pts	pt	NNS
cord-005453-4057qib7	10254	33	are	be	VBP
cord-005453-4057qib7	10254	34	evaluated	evaluate	VBN
cord-005453-4057qib7	10254	35	for	for	IN
cord-005453-4057qib7	10254	36	this	this	DT
cord-005453-4057qib7	10254	37	study	study	NN
cord-005453-4057qib7	10254	38	.	.	.
cord-005453-4057qib7	10255	1	CMV	CMV	NNP
cord-005453-4057qib7	10255	2	reactivation	reactivation	NN
cord-005453-4057qib7	10255	3	was	be	VBD
cord-005453-4057qib7	10255	4	observed	observe	VBN
cord-005453-4057qib7	10255	5	in	in	IN
cord-005453-4057qib7	10255	6	66	66	CD
cord-005453-4057qib7	10255	7	pts	pt	NNS
cord-005453-4057qib7	10255	8	(	(	-LRB-
cord-005453-4057qib7	10255	9	26.82	26.82	CD
cord-005453-4057qib7	10255	10	%	%	NN
cord-005453-4057qib7	10255	11	)	)	-RRB-
cord-005453-4057qib7	10256	1	(	(	-LRB-
cord-005453-4057qib7	10256	2	AML	AML	NNP
cord-005453-4057qib7	10256	3	:	:	:
cord-005453-4057qib7	10256	4	33	33	CD
cord-005453-4057qib7	10256	5	pts	pt	NNS
cord-005453-4057qib7	10256	6	,	,	,
cord-005453-4057qib7	10256	7	ALL	all	DT
cord-005453-4057qib7	10256	8	:	:	:
cord-005453-4057qib7	10256	9	8	8	CD
cord-005453-4057qib7	10256	10	pts	pt	NNS
cord-005453-4057qib7	10256	11	,	,	,
cord-005453-4057qib7	10256	12	CML	CML	NNP
cord-005453-4057qib7	10256	13	:	:	:
cord-005453-4057qib7	10256	14	4	4	CD
cord-005453-4057qib7	10256	15	pts	pt	NNS
cord-005453-4057qib7	10256	16	,	,	,
cord-005453-4057qib7	10256	17	multiple	multiple	JJ
cord-005453-4057qib7	10256	18	Myeloma	myeloma	NN
cord-005453-4057qib7	10256	19	:	:	:
cord-005453-4057qib7	10256	20	2	2	CD
cord-005453-4057qib7	10256	21	pt	pt	NN
cord-005453-4057qib7	10256	22	,	,	,
cord-005453-4057qib7	10256	23	NHL	NHL	NNP
cord-005453-4057qib7	10256	24	skin	skin	NN
cord-005453-4057qib7	10256	25	:	:	:
cord-005453-4057qib7	10256	26	1	1	CD
cord-005453-4057qib7	10256	27	pt	pt	NN
cord-005453-4057qib7	10256	28	,	,	,
cord-005453-4057qib7	10256	29	primary	primary	JJ
cord-005453-4057qib7	10256	30	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	10256	31	:	:	:
cord-005453-4057qib7	10256	32	1	1	CD
cord-005453-4057qib7	10256	33	pt	pt	NN
cord-005453-4057qib7	10256	34	,	,	,
cord-005453-4057qib7	10256	35	Aplastic	aplastic	JJ
cord-005453-4057qib7	10256	36	anemia	anemia	NN
cord-005453-4057qib7	10256	37	:	:	:
cord-005453-4057qib7	10256	38	14	14	CD
cord-005453-4057qib7	10256	39	pts	pt	NNS
cord-005453-4057qib7	10256	40	,	,	,
cord-005453-4057qib7	10256	41	Fanconi	Fanconi	NNP
cord-005453-4057qib7	10256	42	anemia	anemia	NN
cord-005453-4057qib7	10256	43	:	:	:
cord-005453-4057qib7	10256	44	2	2	CD
cord-005453-4057qib7	10256	45	pts	pt	NNS
cord-005453-4057qib7	10256	46	,	,	,
cord-005453-4057qib7	10256	47	β	β	NN
cord-005453-4057qib7	10256	48	-	-	HYPH
cord-005453-4057qib7	10256	49	thalassemia	thalassemia	NN
cord-005453-4057qib7	10256	50	:	:	:
cord-005453-4057qib7	10256	51	1	1	CD
cord-005453-4057qib7	10256	52	pt	pt	NN
cord-005453-4057qib7	10256	53	)	)	-RRB-
cord-005453-4057qib7	10256	54	,	,	,
cord-005453-4057qib7	10256	55	with	with	IN
cord-005453-4057qib7	10256	56	a	a	DT
cord-005453-4057qib7	10256	57	median	median	JJ
cord-005453-4057qib7	10256	58	age	age	NN
cord-005453-4057qib7	10256	59	of	of	IN
cord-005453-4057qib7	10256	60	30	30	CD
cord-005453-4057qib7	10256	61	years	year	NNS
cord-005453-4057qib7	10256	62	(	(	-LRB-
cord-005453-4057qib7	10256	63	4	4	CD
cord-005453-4057qib7	10256	64	-	-	SYM
cord-005453-4057qib7	10256	65	54	54	CD
cord-005453-4057qib7	10256	66	)	)	-RRB-
cord-005453-4057qib7	10256	67	,	,	,
cord-005453-4057qib7	10256	68	sex	sex	NN
cord-005453-4057qib7	10256	69	ratio	ratio	NN
cord-005453-4057qib7	10256	70	(	(	-LRB-
cord-005453-4057qib7	10256	71	M	M	NNP
cord-005453-4057qib7	10256	72	/	/	SYM
cord-005453-4057qib7	10256	73	F	F	NNP
cord-005453-4057qib7	10256	74	)	)	-RRB-
cord-005453-4057qib7	10256	75	of	of	IN
cord-005453-4057qib7	10256	76	1.75	1.75	CD
cord-005453-4057qib7	10256	77	.	.	.
cord-005453-4057qib7	10257	1	Allo	Allo	NNP
cord-005453-4057qib7	10257	2	-	-	HYPH
cord-005453-4057qib7	10257	3	HSCT	HSCT	NNP
cord-005453-4057qib7	10257	4	done	do	VBN
cord-005453-4057qib7	10257	5	with	with	IN
cord-005453-4057qib7	10257	6	sibling	sibling	NN
cord-005453-4057qib7	10257	7	donors	donor	NNS
cord-005453-4057qib7	10257	8	:	:	:
cord-005453-4057qib7	10257	9	51	51	CD
cord-005453-4057qib7	10257	10	pts	pt	NNS
cord-005453-4057qib7	10257	11	,	,	,
cord-005453-4057qib7	10257	12	Haplo	Haplo	NNP
cord-005453-4057qib7	10257	13	-	-	HYPH
cord-005453-4057qib7	10257	14	identical	identical	JJ
cord-005453-4057qib7	10257	15	donors	donor	NNS
cord-005453-4057qib7	10257	16	:	:	:
cord-005453-4057qib7	10257	17	14	14	CD
cord-005453-4057qib7	10257	18	pts	pt	NNS
cord-005453-4057qib7	10257	19	and	and	CC
cord-005453-4057qib7	10257	20	Pheno	Pheno	NNP
cord-005453-4057qib7	10257	21	-	-	HYPH
cord-005453-4057qib7	10257	22	identical	identical	JJ
cord-005453-4057qib7	10257	23	donor	donor	NN
cord-005453-4057qib7	10257	24	:	:	:
cord-005453-4057qib7	10257	25	1	1	CD
cord-005453-4057qib7	10257	26	pt	pt	NN
cord-005453-4057qib7	10257	27	.	.	.
cord-005453-4057qib7	10258	1	All	all	DT
cord-005453-4057qib7	10258	2	pts	pt	NNS
cord-005453-4057qib7	10258	3	were	be	VBD
cord-005453-4057qib7	10258	4	treated	treat	VBN
cord-005453-4057qib7	10258	5	by	by	IN
cord-005453-4057qib7	10258	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10258	7	alone	alone	RB
cord-005453-4057qib7	10258	8	with	with	IN
cord-005453-4057qib7	10258	9	myéloablative	myéloablative	JJ
cord-005453-4057qib7	10258	10	conditioning	conditioning	NN
cord-005453-4057qib7	10258	11	(	(	-LRB-
cord-005453-4057qib7	10258	12	MAC	MAC	NNP
cord-005453-4057qib7	10258	13	)	)	-RRB-
cord-005453-4057qib7	10258	14	in	in	IN
cord-005453-4057qib7	10258	15	41	41	CD
cord-005453-4057qib7	10258	16	pts	pt	NNS
cord-005453-4057qib7	10258	17	and	and	CC
cord-005453-4057qib7	10258	18	reduced	reduce	VBN
cord-005453-4057qib7	10258	19	intensity	intensity	NN
cord-005453-4057qib7	10258	20	(	(	-LRB-
cord-005453-4057qib7	10258	21	RIC	RIC	NNP
cord-005453-4057qib7	10258	22	)	)	-RRB-
cord-005453-4057qib7	10258	23	in	in	IN
cord-005453-4057qib7	10258	24	25	25	CD
cord-005453-4057qib7	10258	25	pts	pt	NNS
cord-005453-4057qib7	10258	26	.	.	.
cord-005453-4057qib7	10259	1	All	all	DT
cord-005453-4057qib7	10259	2	pts	pt	NNS
cord-005453-4057qib7	10259	3	received	receive	VBD
cord-005453-4057qib7	10259	4	peripheral	peripheral	JJ
cord-005453-4057qib7	10259	5	blood	blood	NN
cord-005453-4057qib7	10259	6	stem	stem	NN
cord-005453-4057qib7	10259	7	cells	cell	NNS
cord-005453-4057qib7	10259	8	with	with	IN
cord-005453-4057qib7	10259	9	an	an	DT
cord-005453-4057qib7	10259	10	average	average	JJ
cord-005453-4057qib7	10259	11	rate	rate	NN
cord-005453-4057qib7	10259	12	of	of	IN
cord-005453-4057qib7	10259	13	CD34	CD34	NNP
cord-005453-4057qib7	10259	14	+	+	CC
cord-005453-4057qib7	10259	15	cells	cell	NNS
cord-005453-4057qib7	10259	16	:	:	:
cord-005453-4057qib7	10259	17	7	7	CD
cord-005453-4057qib7	10259	18	,	,	,
cord-005453-4057qib7	10259	19	8.10	8.10	CD
cord-005453-4057qib7	10259	20	6	6	CD
cord-005453-4057qib7	10260	1	/kg	/kg	NFP
cord-005453-4057qib7	10260	2	(	(	-LRB-
cord-005453-4057qib7	10260	3	3.4	3.4	CD
cord-005453-4057qib7	10260	4	-	-	SYM
cord-005453-4057qib7	10260	5	12.7	12.7	CD
cord-005453-4057qib7	10260	6	)	)	-RRB-
cord-005453-4057qib7	10260	7	.	.	.
cord-005453-4057qib7	10261	1	Additional	additional	JJ
cord-005453-4057qib7	10261	2	bone	bone	NN
cord-005453-4057qib7	10261	3	marrow	marrow	NN
cord-005453-4057qib7	10261	4	graft	graft	NN
cord-005453-4057qib7	10261	5	was	be	VBD
cord-005453-4057qib7	10261	6	used	use	VBN
cord-005453-4057qib7	10261	7	in	in	IN
cord-005453-4057qib7	10261	8	7	7	CD
cord-005453-4057qib7	10261	9	pts	pt	NNS
cord-005453-4057qib7	10261	10	that	that	WDT
cord-005453-4057qib7	10261	11	received	receive	VBD
cord-005453-4057qib7	10261	12	a	a	DT
cord-005453-4057qib7	10261	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10261	14	graft	graft	NN
cord-005453-4057qib7	10261	15	without	without	IN
cord-005453-4057qib7	10261	16	PT	PT	NNP
cord-005453-4057qib7	10261	17	-	-	HYPH
cord-005453-4057qib7	10261	18	cy	cy	NNP
cord-005453-4057qib7	10261	19	.	.	.
cord-005453-4057qib7	10262	1	GVH	GVH	NNP
cord-005453-4057qib7	10262	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10262	3	associated	associate	VBD
cord-005453-4057qib7	10262	4	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	10262	5	(	(	-LRB-
cord-005453-4057qib7	10262	6	cSA	cSA	NNP
cord-005453-4057qib7	10262	7	)	)	-RRB-
cord-005453-4057qib7	10262	8	and	and	CC
cord-005453-4057qib7	10262	9	methotrexate	methotrexate	NNP
cord-005453-4057qib7	10262	10	(	(	-LRB-
cord-005453-4057qib7	10262	11	sibling	sibling	NN
cord-005453-4057qib7	10262	12	and	and	CC
cord-005453-4057qib7	10262	13	phenoidentical	phenoidentical	JJ
cord-005453-4057qib7	10262	14	)	)	-RRB-
cord-005453-4057qib7	10262	15	;	;	:
cord-005453-4057qib7	10262	16	cSA	csa	XX
cord-005453-4057qib7	10262	17	-	-	HYPH
cord-005453-4057qib7	10262	18	MTX	MTX	NNP
cord-005453-4057qib7	10262	19	-	-	HYPH
cord-005453-4057qib7	10262	20	MMF	mmf	NN
cord-005453-4057qib7	10262	21	or	or	CC
cord-005453-4057qib7	10262	22	cSA	csa	NN
cord-005453-4057qib7	10262	23	-	-	HYPH
cord-005453-4057qib7	10262	24	MTX	MTX	NNP
cord-005453-4057qib7	10262	25	-	-	HYPH
cord-005453-4057qib7	10262	26	Cyclophosphamid	Cyclophosphamid	NNP
cord-005453-4057qib7	10262	27	(	(	-LRB-
cord-005453-4057qib7	10262	28	haplo	haplo	NN
cord-005453-4057qib7	10262	29	-	-	HYPH
cord-005453-4057qib7	10262	30	identical	identical	JJ
cord-005453-4057qib7	10262	31	)	)	-RRB-
cord-005453-4057qib7	10262	32	.	.	.
cord-005453-4057qib7	10263	1	Before	before	IN
cord-005453-4057qib7	10263	2	transplantation	transplantation	NN
cord-005453-4057qib7	10263	3	,	,	,
cord-005453-4057qib7	10263	4	donor	donor	NN
cord-005453-4057qib7	10263	5	/	/	SYM
cord-005453-4057qib7	10263	6	recipient	recipient	NN
cord-005453-4057qib7	10263	7	pair	pair	NN
cord-005453-4057qib7	10263	8	is	be	VBZ
cord-005453-4057qib7	10263	9	at	at	IN
cord-005453-4057qib7	10263	10	high	high	JJ
cord-005453-4057qib7	10263	11	risk	risk	NN
cord-005453-4057qib7	10263	12	reactivation	reactivation	NN
cord-005453-4057qib7	10263	13	in	in	IN
cord-005453-4057qib7	10263	14	65	65	CD
cord-005453-4057qib7	10263	15	pts	pts	NN
cord-005453-4057qib7	10263	16	(	(	-LRB-
cord-005453-4057qib7	10263	17	98.4	98.4	CD
cord-005453-4057qib7	10263	18	%	%	NN
cord-005453-4057qib7	10263	19	)	)	-RRB-
cord-005453-4057qib7	10263	20	.	.	.
cord-005453-4057qib7	10264	1	Detection	detection	NN
cord-005453-4057qib7	10264	2	of	of	IN
cord-005453-4057qib7	10264	3	CMV	CMV	NNP
cord-005453-4057qib7	10264	4	reactivation	reactivation	NN
cord-005453-4057qib7	10264	5	done	do	VBN
cord-005453-4057qib7	10264	6	by	by	IN
cord-005453-4057qib7	10264	7	Antigenaemia	Antigenaemia	NNP
cord-005453-4057qib7	10264	8	pp65	pp65	NNP
cord-005453-4057qib7	10264	9	or	or	CC
cord-005453-4057qib7	10264	10	by	by	IN
cord-005453-4057qib7	10264	11	quantitative	quantitative	JJ
cord-005453-4057qib7	10264	12	PCR	PCR	NNP
cord-005453-4057qib7	10264	13	weekly	weekly	NN
cord-005453-4057qib7	10264	14	for	for	IN
cord-005453-4057qib7	10264	15	the	the	DT
cord-005453-4057qib7	10264	16	first	first	JJ
cord-005453-4057qib7	10264	17	3	3	CD
cord-005453-4057qib7	10264	18	months	month	NNS
cord-005453-4057qib7	10264	19	and	and	CC
cord-005453-4057qib7	10264	20	during	during	IN
cord-005453-4057qib7	10264	21	an	an	DT
cord-005453-4057qib7	10264	22	IS	IS	NNP
cord-005453-4057qib7	10264	23	treatment	treatment	NN
cord-005453-4057qib7	10264	24	for	for	IN
cord-005453-4057qib7	10264	25	acute	acute	JJ
cord-005453-4057qib7	10264	26	or	or	CC
cord-005453-4057qib7	10264	27	chronic	chronic	JJ
cord-005453-4057qib7	10264	28	GVHD	GVHD	NNP
cord-005453-4057qib7	10264	29	.	.	.
cord-005453-4057qib7	10265	1	Pre	pre	JJ
cord-005453-4057qib7	10265	2	-	-	JJ
cord-005453-4057qib7	10265	3	emptive	emptive	JJ
cord-005453-4057qib7	10265	4	therapy	therapy	NN
cord-005453-4057qib7	10265	5	is	be	VBZ
cord-005453-4057qib7	10265	6	initiated	initiate	VBN
cord-005453-4057qib7	10265	7	by	by	IN
cord-005453-4057qib7	10265	8	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10265	9	as	as	RB
cord-005453-4057qib7	10265	10	soon	soon	RB
cord-005453-4057qib7	10265	11	as	as	IN
cord-005453-4057qib7	10265	12	positivity	positivity	NN
cord-005453-4057qib7	10265	13	of	of	IN
cord-005453-4057qib7	10265	14	antigenaemia	antigenaemia	NN
cord-005453-4057qib7	10265	15	or	or	CC
cord-005453-4057qib7	10265	16	increased	increase	VBN
cord-005453-4057qib7	10265	17	viral	viral	JJ
cord-005453-4057qib7	10265	18	load	load	NN
cord-005453-4057qib7	10265	19	in	in	IN
cord-005453-4057qib7	10265	20	PCR	PCR	NNP
cord-005453-4057qib7	10265	21	.	.	.
cord-005453-4057qib7	10266	1	Results	result	NNS
cord-005453-4057qib7	10266	2	:	:	:
cord-005453-4057qib7	10267	1	A	a	DT
cord-005453-4057qib7	10267	2	first	first	JJ
cord-005453-4057qib7	10267	3	reactivation	reactivation	NN
cord-005453-4057qib7	10267	4	occurred	occur	VBD
cord-005453-4057qib7	10267	5	on	on	IN
cord-005453-4057qib7	10267	6	average	average	JJ
cord-005453-4057qib7	10267	7	day	day	NN
cord-005453-4057qib7	10267	8	44	44	CD
cord-005453-4057qib7	10267	9	(	(	-LRB-
cord-005453-4057qib7	10267	10	16	16	CD
cord-005453-4057qib7	10267	11	-	-	SYM
cord-005453-4057qib7	10267	12	83	83	CD
cord-005453-4057qib7	10267	13	)	)	-RRB-
cord-005453-4057qib7	10267	14	in	in	IN
cord-005453-4057qib7	10267	15	66	66	CD
cord-005453-4057qib7	10267	16	pts	pt	NNS
cord-005453-4057qib7	10267	17	(	(	-LRB-
cord-005453-4057qib7	10267	18	26.82	26.82	CD
cord-005453-4057qib7	10267	19	%	%	NN
cord-005453-4057qib7	10267	20	)	)	-RRB-
cord-005453-4057qib7	10267	21	of	of	IN
cord-005453-4057qib7	10267	22	which	which	WDT
cord-005453-4057qib7	10267	23	32	32	CD
cord-005453-4057qib7	10267	24	pts	pt	NNS
cord-005453-4057qib7	10267	25	under	under	IN
cord-005453-4057qib7	10267	26	Corticotherapy	Corticotherapy	NNP
cord-005453-4057qib7	10267	27	for	for	IN
cord-005453-4057qib7	10267	28	acute	acute	JJ
cord-005453-4057qib7	10267	29	GVHD	GVHD	NNP
cord-005453-4057qib7	10267	30	(	(	-LRB-
cord-005453-4057qib7	10267	31	27	27	CD
cord-005453-4057qib7	10267	32	pts	pt	NNS
cord-005453-4057qib7	10267	33	)	)	-RRB-
cord-005453-4057qib7	10267	34	,	,	,
cord-005453-4057qib7	10267	35	Thrombotic	Thrombotic	NNP
cord-005453-4057qib7	10267	36	Micro	Micro	NNP
cord-005453-4057qib7	10267	37	-	-	HYPH
cord-005453-4057qib7	10267	38	Angiopathy	Angiopathy	NNP
cord-005453-4057qib7	10267	39	(	(	-LRB-
cord-005453-4057qib7	10267	40	1	1	CD
cord-005453-4057qib7	10267	41	pt	pt	NN
cord-005453-4057qib7	10267	42	)	)	-RRB-
cord-005453-4057qib7	10267	43	and	and	CC
cord-005453-4057qib7	10267	44	renal	renal	JJ
cord-005453-4057qib7	10267	45	failure	failure	NN
cord-005453-4057qib7	10267	46	(	(	-LRB-
cord-005453-4057qib7	10267	47	4	4	CD
cord-005453-4057qib7	10267	48	pts	pts	CD
cord-005453-4057qib7	10267	49	)	)	-RRB-
cord-005453-4057qib7	10267	50	or	or	CC
cord-005453-4057qib7	10267	51	due	due	IN
cord-005453-4057qib7	10267	52	to	to	IN
cord-005453-4057qib7	10267	53	a	a	DT
cord-005453-4057qib7	10267	54	reinforced	reinforce	VBN
cord-005453-4057qib7	10267	55	IS	be	VBZ
cord-005453-4057qib7	10267	56	for	for	IN
cord-005453-4057qib7	10267	57	Haplo	Haplo	NNP
cord-005453-4057qib7	10267	58	-	-	HYPH
cord-005453-4057qib7	10267	59	identical	identical	JJ
cord-005453-4057qib7	10267	60	transplantation	transplantation	NN
cord-005453-4057qib7	10267	61	(	(	-LRB-
cord-005453-4057qib7	10267	62	5	5	CD
cord-005453-4057qib7	10267	63	pts	pts	CD
cord-005453-4057qib7	10267	64	)	)	-RRB-
cord-005453-4057qib7	10267	65	.	.	.
cord-005453-4057qib7	10268	1	One	one	CD
cord-005453-4057qib7	10268	2	pt	pt	NN
cord-005453-4057qib7	10268	3	with	with	IN
cord-005453-4057qib7	10268	4	chronic	chronic	JJ
cord-005453-4057qib7	10268	5	GVHD	GVHD	NNP
cord-005453-4057qib7	10268	6	presented	present	VBD
cord-005453-4057qib7	10268	7	a	a	DT
cord-005453-4057qib7	10268	8	late	late	JJ
cord-005453-4057qib7	10268	9	reactivation	reactivation	NN
cord-005453-4057qib7	10268	10	18	18	CD
cord-005453-4057qib7	10268	11	months	month	NNS
cord-005453-4057qib7	10268	12	after	after	IN
cord-005453-4057qib7	10268	13	transplant	transplant	NN
cord-005453-4057qib7	10268	14	.	.	.
cord-005453-4057qib7	10269	1	Twenty	twenty	CD
cord-005453-4057qib7	10269	2	pts	pt	NNS
cord-005453-4057qib7	10269	3	presented	present	VBD
cord-005453-4057qib7	10269	4	a	a	DT
cord-005453-4057qib7	10269	5	2	2	CD
cord-005453-4057qib7	10269	6	nd	nd	NNP
cord-005453-4057qib7	10269	7	reactivation	reactivation	NN
cord-005453-4057qib7	10269	8	on	on	IN
cord-005453-4057qib7	10269	9	average	average	JJ
cord-005453-4057qib7	10269	10	day	day	NN
cord-005453-4057qib7	10269	11	135	135	CD
cord-005453-4057qib7	10269	12	(	(	-LRB-
cord-005453-4057qib7	10269	13	106	106	CD
cord-005453-4057qib7	10269	14	-	-	SYM
cord-005453-4057qib7	10269	15	180	180	CD
cord-005453-4057qib7	10269	16	)	)	-RRB-
cord-005453-4057qib7	10269	17	and	and	CC
cord-005453-4057qib7	10269	18	8	8	CD
cord-005453-4057qib7	10269	19	pts	pt	NNS
cord-005453-4057qib7	10269	20	a	a	DT
cord-005453-4057qib7	10269	21	3	3	CD
cord-005453-4057qib7	10269	22	rd	rd	NN
cord-005453-4057qib7	10269	23	reactivation	reactivation	NN
cord-005453-4057qib7	10269	24	on	on	IN
cord-005453-4057qib7	10269	25	average	average	JJ
cord-005453-4057qib7	10269	26	day	day	NN
cord-005453-4057qib7	10269	27	136	136	CD
cord-005453-4057qib7	10269	28	(	(	-LRB-
cord-005453-4057qib7	10269	29	130	130	CD
cord-005453-4057qib7	10269	30	-	-	SYM
cord-005453-4057qib7	10269	31	143	143	CD
cord-005453-4057qib7	10269	32	)	)	-RRB-
cord-005453-4057qib7	10269	33	.	.	.
cord-005453-4057qib7	10270	1	Pre	pre	JJ
cord-005453-4057qib7	10270	2	-	-	JJ
cord-005453-4057qib7	10270	3	emptive	emptive	JJ
cord-005453-4057qib7	10270	4	treatment	treatment	NN
cord-005453-4057qib7	10270	5	is	be	VBZ
cord-005453-4057qib7	10270	6	introduced	introduce	VBN
cord-005453-4057qib7	10270	7	in	in	IN
cord-005453-4057qib7	10270	8	the	the	DT
cord-005453-4057qib7	10270	9	first	first	JJ
cord-005453-4057qib7	10270	10	episode	episode	NN
cord-005453-4057qib7	10270	11	by	by	IN
cord-005453-4057qib7	10270	12	a	a	DT
cord-005453-4057qib7	10270	13	viral	viral	JJ
cord-005453-4057qib7	10270	14	DNA	dna	NN
cord-005453-4057qib7	10270	15	polymerase	polymerase	NN
cord-005453-4057qib7	10270	16	inhibitor	inhibitor	NN
cord-005453-4057qib7	10270	17	(	(	-LRB-
cord-005453-4057qib7	10270	18	Ganciclovir	ganciclovir	NN
cord-005453-4057qib7	10270	19	:	:	:
cord-005453-4057qib7	10270	20	22	22	CD
cord-005453-4057qib7	10270	21	pts	pt	NNS
cord-005453-4057qib7	10270	22	;	;	:
cord-005453-4057qib7	10270	23	Valganciclovir	Valganciclovir	NNP
cord-005453-4057qib7	10270	24	:	:	:
cord-005453-4057qib7	10270	25	43	43	CD
cord-005453-4057qib7	10270	26	pts	pt	NNS
cord-005453-4057qib7	10270	27	,	,	,
cord-005453-4057qib7	10270	28	Foscarnet	foscarnet	NN
cord-005453-4057qib7	10270	29	:	:	:
cord-005453-4057qib7	10270	30	1	1	CD
cord-005453-4057qib7	10270	31	pt	pt	NN
cord-005453-4057qib7	10270	32	)	)	-RRB-
cord-005453-4057qib7	10270	33	.	.	.
cord-005453-4057qib7	10271	1	The	the	DT
cord-005453-4057qib7	10271	2	negativity	negativity	NN
cord-005453-4057qib7	10271	3	of	of	IN
cord-005453-4057qib7	10271	4	antigenaemia	antigenaemia	NN
cord-005453-4057qib7	10271	5	is	be	VBZ
cord-005453-4057qib7	10271	6	observed	observe	VBN
cord-005453-4057qib7	10271	7	on	on	IN
cord-005453-4057qib7	10271	8	average	average	JJ
cord-005453-4057qib7	10271	9	at	at	IN
cord-005453-4057qib7	10271	10	5	5	CD
cord-005453-4057qib7	10271	11	days	day	NNS
cord-005453-4057qib7	10271	12	of	of	IN
cord-005453-4057qib7	10271	13	treatment	treatment	NN
cord-005453-4057qib7	10271	14	(	(	-LRB-
cord-005453-4057qib7	10271	15	3	3	CD
cord-005453-4057qib7	10271	16	)	)	-RRB-
cord-005453-4057qib7	10271	17	(	(	-LRB-
cord-005453-4057qib7	10271	18	4	4	LS
cord-005453-4057qib7	10271	19	)	)	-RRB-
cord-005453-4057qib7	10271	20	(	(	-LRB-
cord-005453-4057qib7	10271	21	5	5	LS
cord-005453-4057qib7	10271	22	)	)	-RRB-
cord-005453-4057qib7	10271	23	(	(	-LRB-
cord-005453-4057qib7	10271	24	6	6	LS
cord-005453-4057qib7	10271	25	)	)	-RRB-
cord-005453-4057qib7	10271	26	(	(	-LRB-
cord-005453-4057qib7	10271	27	7	7	CD
cord-005453-4057qib7	10271	28	)	)	-RRB-
cord-005453-4057qib7	10271	29	.	.	.
cord-005453-4057qib7	10272	1	Second	second	JJ
cord-005453-4057qib7	10272	2	line	line	NN
cord-005453-4057qib7	10272	3	treatment	treatment	NN
cord-005453-4057qib7	10272	4	was	be	VBD
cord-005453-4057qib7	10272	5	required	require	VBN
cord-005453-4057qib7	10272	6	in	in	IN
cord-005453-4057qib7	10272	7	14	14	CD
cord-005453-4057qib7	10272	8	pts	pt	NNS
cord-005453-4057qib7	10272	9	(	(	-LRB-
cord-005453-4057qib7	10272	10	22	22	CD
cord-005453-4057qib7	10272	11	%	%	NN
cord-005453-4057qib7	10272	12	)	)	-RRB-
cord-005453-4057qib7	10272	13	due	due	IN
cord-005453-4057qib7	10272	14	to	to	IN
cord-005453-4057qib7	10272	15	resistance	resistance	NN
cord-005453-4057qib7	10272	16	(	(	-LRB-
cord-005453-4057qib7	10272	17	12	12	CD
cord-005453-4057qib7	10272	18	pts	pt	NNS
cord-005453-4057qib7	10272	19	)	)	-RRB-
cord-005453-4057qib7	10272	20	,	,	,
cord-005453-4057qib7	10272	21	severe	severe	JJ
cord-005453-4057qib7	10272	22	cytopenia	cytopenia	NNP
cord-005453-4057qib7	10272	23	(	(	-LRB-
cord-005453-4057qib7	10272	24	1pt	1pt	NNP
cord-005453-4057qib7	10272	25	)	)	-RRB-
cord-005453-4057qib7	10272	26	or	or	CC
cord-005453-4057qib7	10272	27	renal	renal	JJ
cord-005453-4057qib7	10272	28	failure	failure	NN
cord-005453-4057qib7	10272	29	(	(	-LRB-
cord-005453-4057qib7	10272	30	1	1	CD
cord-005453-4057qib7	10272	31	pt	pt	NN
cord-005453-4057qib7	10272	32	)	)	-RRB-
cord-005453-4057qib7	10272	33	.	.	.
cord-005453-4057qib7	10273	1	The	the	DT
cord-005453-4057qib7	10273	2	onset	onset	NN
cord-005453-4057qib7	10273	3	of	of	IN
cord-005453-4057qib7	10273	4	severe	severe	JJ
cord-005453-4057qib7	10273	5	cytopenia	cytopenia	NNS
cord-005453-4057qib7	10273	6	imposed	impose	VBD
cord-005453-4057qib7	10273	7	a	a	DT
cord-005453-4057qib7	10273	8	dose	dose	JJ
cord-005453-4057qib7	10273	9	reduction	reduction	NN
cord-005453-4057qib7	10273	10	(	(	-LRB-
cord-005453-4057qib7	10273	11	4	4	CD
cord-005453-4057qib7	10273	12	pts	pts	CD
cord-005453-4057qib7	10273	13	)	)	-RRB-
cord-005453-4057qib7	10273	14	or	or	CC
cord-005453-4057qib7	10273	15	a	a	DT
cord-005453-4057qib7	10273	16	therapeutic	therapeutic	JJ
cord-005453-4057qib7	10273	17	stop	stop	NN
cord-005453-4057qib7	10273	18	(	(	-LRB-
cord-005453-4057qib7	10273	19	6	6	CD
cord-005453-4057qib7	10273	20	pts	pts	CD
cord-005453-4057qib7	10273	21	)	)	-RRB-
cord-005453-4057qib7	10273	22	before	before	IN
cord-005453-4057qib7	10273	23	15	15	CD
cord-005453-4057qib7	10273	24	days	day	NNS
cord-005453-4057qib7	10273	25	.	.	.
cord-005453-4057qib7	10274	1	Two	two	CD
cord-005453-4057qib7	10274	2	pts	pt	NNS
cord-005453-4057qib7	10274	3	received	receive	VBD
cord-005453-4057qib7	10274	4	additional	additional	JJ
cord-005453-4057qib7	10274	5	maintenance	maintenance	NN
cord-005453-4057qib7	10274	6	treatment	treatment	NN
cord-005453-4057qib7	10274	7	for	for	IN
cord-005453-4057qib7	10274	8	negativation	negativation	NN
cord-005453-4057qib7	10274	9	delay	delay	NN
cord-005453-4057qib7	10274	10	.	.	.
cord-005453-4057qib7	10275	1	Three	three	CD
cord-005453-4057qib7	10275	2	pts	pt	NNS
cord-005453-4057qib7	10275	3	(	(	-LRB-
cord-005453-4057qib7	10275	4	4.5	4.5	CD
cord-005453-4057qib7	10275	5	%	%	NN
cord-005453-4057qib7	10275	6	)	)	-RRB-
cord-005453-4057qib7	10275	7	died	die	VBD
cord-005453-4057qib7	10275	8	from	from	IN
cord-005453-4057qib7	10275	9	CMV	CMV	NNP
cord-005453-4057qib7	10275	10	infections	infection	NNS
cord-005453-4057qib7	10275	11	resistant	resistant	JJ
cord-005453-4057qib7	10275	12	to	to	IN
cord-005453-4057qib7	10275	13	antiviral	antiviral	JJ
cord-005453-4057qib7	10275	14	treatment	treatment	NN
cord-005453-4057qib7	10276	1	(	(	-LRB-
cord-005453-4057qib7	10276	2	pneumonia	pneumonia	NN
cord-005453-4057qib7	10276	3	:	:	:
cord-005453-4057qib7	10276	4	2	2	CD
cord-005453-4057qib7	10276	5	,	,	,
cord-005453-4057qib7	10276	6	Colitis	colitis	NN
cord-005453-4057qib7	10276	7	:	:	:
cord-005453-4057qib7	10276	8	1	1	CD
cord-005453-4057qib7	10276	9	)	)	-RRB-
cord-005453-4057qib7	10276	10	.	.	.
cord-005453-4057qib7	10277	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10277	2	:	:	:
cord-005453-4057qib7	10278	1	CMV	CMV	NNP
cord-005453-4057qib7	10278	2	infection	infection	NN
cord-005453-4057qib7	10278	3	is	be	VBZ
cord-005453-4057qib7	10278	4	a	a	DT
cord-005453-4057qib7	10278	5	serious	serious	JJ
cord-005453-4057qib7	10278	6	complication	complication	NN
cord-005453-4057qib7	10278	7	after	after	IN
cord-005453-4057qib7	10278	8	allo	allo	NN
cord-005453-4057qib7	10278	9	-	-	HYPH
cord-005453-4057qib7	10278	10	HSCT	HSCT	NNP
cord-005453-4057qib7	10278	11	.	.	.
cord-005453-4057qib7	10279	1	In	in	IN
cord-005453-4057qib7	10279	2	the	the	DT
cord-005453-4057qib7	10279	3	absence	absence	NN
cord-005453-4057qib7	10279	4	of	of	IN
cord-005453-4057qib7	10279	5	vaccination	vaccination	NN
cord-005453-4057qib7	10279	6	,	,	,
cord-005453-4057qib7	10279	7	the	the	DT
cord-005453-4057qib7	10279	8	systematic	systematic	JJ
cord-005453-4057qib7	10279	9	monitoring	monitoring	NN
cord-005453-4057qib7	10279	10	for	for	IN
cord-005453-4057qib7	10279	11	CMV	CMV	NNP
cord-005453-4057qib7	10279	12	reactivation	reactivation	NN
cord-005453-4057qib7	10279	13	is	be	VBZ
cord-005453-4057qib7	10279	14	strongly	strongly	RB
cord-005453-4057qib7	10279	15	recommended	recommend	VBN
cord-005453-4057qib7	10279	16	for	for	IN
cord-005453-4057qib7	10279	17	the	the	DT
cord-005453-4057qib7	10279	18	establishment	establishment	NN
cord-005453-4057qib7	10279	19	of	of	IN
cord-005453-4057qib7	10279	20	a	a	DT
cord-005453-4057qib7	10279	21	rapid	rapid	JJ
cord-005453-4057qib7	10279	22	and	and	CC
cord-005453-4057qib7	10279	23	effective	effective	JJ
cord-005453-4057qib7	10279	24	preemptive	preemptive	JJ
cord-005453-4057qib7	10279	25	treatment	treatment	NN
cord-005453-4057qib7	10279	26	.	.	.
cord-005453-4057qib7	10280	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10280	2	:	:	:
cord-005453-4057qib7	10280	3	Nothing	nothing	NN
cord-005453-4057qib7	10280	4	to	to	TO
cord-005453-4057qib7	10280	5	declare	declare	VB
cord-005453-4057qib7	10280	6	P456	P456	NNP
cord-005453-4057qib7	10280	7	Abstract	Abstract	NNP
cord-005453-4057qib7	10280	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	10280	9	.	.	.
cord-005453-4057qib7	10281	1	Results	result	NNS
cord-005453-4057qib7	10281	2	:	:	:
cord-005453-4057qib7	10282	1	In	in	IN
cord-005453-4057qib7	10282	2	transplanted	transplanted	JJ
cord-005453-4057qib7	10282	3	group	group	NN
cord-005453-4057qib7	10282	4	,	,	,
cord-005453-4057qib7	10282	5	episodes	episode	NNS
cord-005453-4057qib7	10282	6	of	of	IN
cord-005453-4057qib7	10282	7	BKV	BKV	NNP
cord-005453-4057qib7	10282	8	reactivation	reactivation	NN
cord-005453-4057qib7	10282	9	occurred	occur	VBD
cord-005453-4057qib7	10282	10	in	in	IN
cord-005453-4057qib7	10282	11	54	54	CD
cord-005453-4057qib7	10282	12	patients	patient	NNS
cord-005453-4057qib7	10282	13	(	(	-LRB-
cord-005453-4057qib7	10282	14	42	42	CD
cord-005453-4057qib7	10282	15	%	%	NN
cord-005453-4057qib7	10282	16	)	)	-RRB-
cord-005453-4057qib7	10282	17	.	.	.
cord-005453-4057qib7	10283	1	In	in	IN
cord-005453-4057qib7	10283	2	26	26	CD
cord-005453-4057qib7	10283	3	cases	case	NNS
cord-005453-4057qib7	10283	4	only	only	RB
cord-005453-4057qib7	10283	5	urine	urine	NN
cord-005453-4057qib7	10283	6	colonization	colonization	NN
cord-005453-4057qib7	10283	7	(	(	-LRB-
cord-005453-4057qib7	10283	8	C	C	NNP
cord-005453-4057qib7	10283	9	)	)	-RRB-
cord-005453-4057qib7	10283	10	found	find	VBN
cord-005453-4057qib7	10283	11	before	before	IN
cord-005453-4057qib7	10283	12	HSCT	HSCT	NNP
cord-005453-4057qib7	10283	13	.	.	.
cord-005453-4057qib7	10284	1	In	in	IN
cord-005453-4057qib7	10284	2	this	this	DT
cord-005453-4057qib7	10284	3	group	group	NN
cord-005453-4057qib7	10284	4	in	in	IN
cord-005453-4057qib7	10284	5	10	10	CD
cord-005453-4057qib7	10284	6	patients	patient	NNS
cord-005453-4057qib7	10284	7	(	(	-LRB-
cord-005453-4057qib7	10284	8	39	39	CD
cord-005453-4057qib7	10284	9	%	%	NN
cord-005453-4057qib7	10284	10	)	)	-RRB-
cord-005453-4057qib7	10285	1	virus	virus	NN
cord-005453-4057qib7	10285	2	was	be	VBD
cord-005453-4057qib7	10285	3	transmitted	transmit	VBN
cord-005453-4057qib7	10285	4	from	from	IN
cord-005453-4057qib7	10285	5	urine	urine	NN
cord-005453-4057qib7	10285	6	to	to	IN
cord-005453-4057qib7	10285	7	the	the	DT
cord-005453-4057qib7	10285	8	blood	blood	NN
cord-005453-4057qib7	10285	9	(	(	-LRB-
cord-005453-4057qib7	10285	10	B	b	NN
cord-005453-4057qib7	10285	11	)	)	-RRB-
cord-005453-4057qib7	10285	12	.	.	.
cord-005453-4057qib7	10286	1	Dysuria	Dysuria	NNP
cord-005453-4057qib7	10286	2	and/or	and/or	CC
cord-005453-4057qib7	10286	3	HC	HC	NNP
cord-005453-4057qib7	10286	4	were	be	VBD
cord-005453-4057qib7	10286	5	observed	observe	VBN
cord-005453-4057qib7	10286	6	in	in	IN
cord-005453-4057qib7	10286	7	4/26	4/26	CD
cord-005453-4057qib7	10286	8	(	(	-LRB-
cord-005453-4057qib7	10286	9	15	15	CD
cord-005453-4057qib7	10286	10	%	%	NN
cord-005453-4057qib7	10286	11	)	)	-RRB-
cord-005453-4057qib7	10286	12	patients	patient	NNS
cord-005453-4057qib7	10286	13	.	.	.
cord-005453-4057qib7	10287	1	All	all	DT
cord-005453-4057qib7	10287	2	of	of	IN
cord-005453-4057qib7	10287	3	them	-PRON-	PRP
cord-005453-4057qib7	10287	4	(	(	-LRB-
cord-005453-4057qib7	10287	5	100	100	CD
cord-005453-4057qib7	10287	6	%	%	NN
cord-005453-4057qib7	10287	7	)	)	-RRB-
cord-005453-4057qib7	10287	8	had	have	VBD
cord-005453-4057qib7	10287	9	urine	urine	NN
cord-005453-4057qib7	10287	10	and	and	CC
cord-005453-4057qib7	10287	11	serum	serum	NN
cord-005453-4057qib7	10287	12	involvement	involvement	NN
cord-005453-4057qib7	10287	13	.	.	.
cord-005453-4057qib7	10288	1	In	in	IN
cord-005453-4057qib7	10288	2	28	28	CD
cord-005453-4057qib7	10288	3	cases	case	NNS
cord-005453-4057qib7	10288	4	BKV	BKV	NNP
cord-005453-4057qib7	10288	5	replication	replication	NN
cord-005453-4057qib7	10288	6	was	be	VBD
cord-005453-4057qib7	10288	7	found	find	VBN
cord-005453-4057qib7	10288	8	after	after	IN
cord-005453-4057qib7	10288	9	HSCT	HSCT	NNP
cord-005453-4057qib7	10288	10	(	(	-LRB-
cord-005453-4057qib7	10289	1	3	3	LS
cord-005453-4057qib7	10289	2	-cases	-cases	:
cord-005453-4057qib7	10289	3	detected	detect	VBN
cord-005453-4057qib7	10289	4	in	in	IN
cord-005453-4057qib7	10289	5	urine	urine	NN
cord-005453-4057qib7	10289	6	,	,	,
cord-005453-4057qib7	10289	7	25	25	CD
cord-005453-4057qib7	10289	8	cases	case	NNS
cord-005453-4057qib7	10289	9	-	-	:
cord-005453-4057qib7	10289	10	bothserum	bothserum	NNS
cord-005453-4057qib7	10289	11	and	and	CC
cord-005453-4057qib7	10289	12	urine	urine	NN
cord-005453-4057qib7	10289	13	)	)	-RRB-
cord-005453-4057qib7	10289	14	.	.	.
cord-005453-4057qib7	10290	1	Dysuric	Dysuric	NNP
cord-005453-4057qib7	10290	2	syndromes	syndrome	NNS
cord-005453-4057qib7	10291	1	and/or	and/or	CC
cord-005453-4057qib7	10291	2	HC	HC	NNP
cord-005453-4057qib7	10291	3	were	be	VBD
cord-005453-4057qib7	10291	4	found	find	VBN
cord-005453-4057qib7	10291	5	in	in	IN
cord-005453-4057qib7	10291	6	5/28	5/28	CD
cord-005453-4057qib7	10291	7	of	of	IN
cord-005453-4057qib7	10291	8	cases	case	NNS
cord-005453-4057qib7	10291	9	(	(	-LRB-
cord-005453-4057qib7	10292	1	18%)-all	18%)-all	CD
cord-005453-4057qib7	10292	2	in	in	IN
cord-005453-4057qib7	10292	3	patients	patient	NNS
cord-005453-4057qib7	10292	4	with	with	IN
cord-005453-4057qib7	10292	5	serum	serum	NN
cord-005453-4057qib7	10292	6	and	and	CC
cord-005453-4057qib7	10292	7	urine	urine	NN
cord-005453-4057qib7	10292	8	involvement	involvement	NN
cord-005453-4057qib7	10292	9	.	.	.
cord-005453-4057qib7	10293	1	Urinary	urinary	JJ
cord-005453-4057qib7	10293	2	tract	tract	NN
cord-005453-4057qib7	10293	3	was	be	VBD
cord-005453-4057qib7	10293	4	always	always	RB
cord-005453-4057qib7	10293	5	first	first	JJ
cord-005453-4057qib7	10293	6	location	location	NN
cord-005453-4057qib7	10293	7	of	of	IN
cord-005453-4057qib7	10293	8	the	the	DT
cord-005453-4057qib7	10293	9	virus	virus	NN
cord-005453-4057qib7	10293	10	.	.	.
cord-005453-4057qib7	10294	1	There	there	EX
cord-005453-4057qib7	10294	2	was	be	VBD
cord-005453-4057qib7	10294	3	no	no	DT
cord-005453-4057qib7	10294	4	case	case	NN
cord-005453-4057qib7	10294	5	of	of	IN
cord-005453-4057qib7	10294	6	isolated	isolated	JJ
cord-005453-4057qib7	10294	7	serum	serum	NN
cord-005453-4057qib7	10294	8	reactivation	reactivation	NN
cord-005453-4057qib7	10294	9	.	.	.
cord-005453-4057qib7	10295	1	The	the	DT
cord-005453-4057qib7	10295	2	incidence	incidence	NN
cord-005453-4057qib7	10295	3	of	of	IN
cord-005453-4057qib7	10295	4	BK	BK	NNP
cord-005453-4057qib7	10295	5	infection	infection	NN
cord-005453-4057qib7	10295	6	was	be	VBD
cord-005453-4057qib7	10295	7	higher	high	JJR
cord-005453-4057qib7	10295	8	in	in	IN
cord-005453-4057qib7	10295	9	patients	patient	NNS
cord-005453-4057qib7	10295	10	older	old	JJR
cord-005453-4057qib7	10295	11	than	than	IN
cord-005453-4057qib7	10295	12	>	>	XX
cord-005453-4057qib7	10295	13	5	5	CD
cord-005453-4057qib7	10295	14	yrs	yrs	NN
cord-005453-4057qib7	10296	1	(	(	-LRB-
cord-005453-4057qib7	10296	2	p	p	NN
cord-005453-4057qib7	10296	3	<	<	XX
cord-005453-4057qib7	10296	4	0.05	0.05	CD
cord-005453-4057qib7	10296	5	)	)	-RRB-
cord-005453-4057qib7	10296	6	,	,	,
cord-005453-4057qib7	10296	7	transplanted	transplant	VBN
cord-005453-4057qib7	10296	8	from	from	IN
cord-005453-4057qib7	10296	9	family	family	NN
cord-005453-4057qib7	10296	10	donor	donor	NN
cord-005453-4057qib7	10296	11	(	(	-LRB-
cord-005453-4057qib7	10296	12	MSD	MSD	NNP
cord-005453-4057qib7	10296	13	)	)	-RRB-
cord-005453-4057qib7	10296	14	(	(	-LRB-
cord-005453-4057qib7	10296	15	p	p	NN
cord-005453-4057qib7	10296	16	<	<	XX
cord-005453-4057qib7	10296	17	0.05	0.05	CD
cord-005453-4057qib7	10296	18	)	)	-RRB-
cord-005453-4057qib7	10296	19	.	.	.
cord-005453-4057qib7	10297	1	MUD	mud	NN
cord-005453-4057qib7	10297	2	recipients	recipient	NNS
cord-005453-4057qib7	10297	3	had	have	VBD
cord-005453-4057qib7	10297	4	more	more	RBR
cord-005453-4057qib7	10297	5	often	often	RB
cord-005453-4057qib7	10297	6	both	both	DT
cord-005453-4057qib7	10297	7	serum	serum	NN
cord-005453-4057qib7	10297	8	and	and	CC
cord-005453-4057qib7	10297	9	urine	urine	NN
cord-005453-4057qib7	10297	10	reactivation	reactivation	NN
cord-005453-4057qib7	10297	11	(	(	-LRB-
cord-005453-4057qib7	10297	12	p	p	NN
cord-005453-4057qib7	10297	13	<	<	XX
cord-005453-4057qib7	10297	14	0.05	0.05	CD
cord-005453-4057qib7	10297	15	)	)	-RRB-
cord-005453-4057qib7	10297	16	than	than	IN
cord-005453-4057qib7	10297	17	isolated	isolate	VBN
cord-005453-4057qib7	10297	18	urine	urine	NN
cord-005453-4057qib7	10297	19	involvement	involvement	NN
cord-005453-4057qib7	10297	20	.	.	.
cord-005453-4057qib7	10298	1	Sex	sex	NN
cord-005453-4057qib7	10298	2	,	,	,
cord-005453-4057qib7	10298	3	day	day	NN
cord-005453-4057qib7	10298	4	of	of	IN
cord-005453-4057qib7	10298	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	10298	6	recovery	recovery	NN
cord-005453-4057qib7	10298	7	,	,	,
cord-005453-4057qib7	10298	8	conditioning	conditioning	NN
cord-005453-4057qib7	10298	9	regimen	regimen	NN
cord-005453-4057qib7	10298	10	,	,	,
cord-005453-4057qib7	10298	11	or	or	CC
cord-005453-4057qib7	10298	12	use	use	NN
cord-005453-4057qib7	10298	13	of	of	IN
cord-005453-4057qib7	10298	14	total	total	JJ
cord-005453-4057qib7	10298	15	body	body	NN
cord-005453-4057qib7	10298	16	irradiation	irradiation	NN
cord-005453-4057qib7	10298	17	were	be	VBD
cord-005453-4057qib7	10298	18	not	not	RB
cord-005453-4057qib7	10298	19	significant	significant	JJ
cord-005453-4057qib7	10298	20	risk	risk	NN
cord-005453-4057qib7	10298	21	factors	factor	NNS
cord-005453-4057qib7	10298	22	for	for	IN
cord-005453-4057qib7	10298	23	BKV	BKV	NNP
cord-005453-4057qib7	10298	24	infection	infection	NN
cord-005453-4057qib7	10298	25	,	,	,
cord-005453-4057qib7	10298	26	or	or	CC
cord-005453-4057qib7	10298	27	HC	HC	NNP
cord-005453-4057qib7	10298	28	.	.	.
cord-005453-4057qib7	10299	1	Six	six	CD
cord-005453-4057qib7	10299	2	patients	patient	NNS
cord-005453-4057qib7	10299	3	were	be	VBD
cord-005453-4057qib7	10299	4	treated	treat	VBN
cord-005453-4057qib7	10299	5	with	with	IN
cord-005453-4057qib7	10299	6	Cidofovir	Cidofovir	NNP
cord-005453-4057qib7	10299	7	(	(	-LRB-
cord-005453-4057qib7	10299	8	range	range	NNP
cord-005453-4057qib7	10299	9	1	1	CD
cord-005453-4057qib7	10299	10	-	-	SYM
cord-005453-4057qib7	10299	11	4	4	CD
cord-005453-4057qib7	10299	12	doses	dose	NNS
cord-005453-4057qib7	10299	13	)	)	-RRB-
cord-005453-4057qib7	10299	14	with	with	IN
cord-005453-4057qib7	10299	15	good	good	JJ
cord-005453-4057qib7	10299	16	response	response	NN
cord-005453-4057qib7	10299	17	.	.	.
cord-005453-4057qib7	10300	1	There	there	EX
cord-005453-4057qib7	10300	2	was	be	VBD
cord-005453-4057qib7	10300	3	no	no	DT
cord-005453-4057qib7	10300	4	death	death	NN
cord-005453-4057qib7	10300	5	due	due	IN
cord-005453-4057qib7	10300	6	to	to	IN
cord-005453-4057qib7	10300	7	evident	evident	JJ
cord-005453-4057qib7	10300	8	BKV	BKV	NNP
cord-005453-4057qib7	10300	9	infection	infection	NN
cord-005453-4057qib7	10300	10	.	.	.
cord-005453-4057qib7	10301	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10301	2	:	:	:
cord-005453-4057qib7	10302	1	BKV	BKV	NNP
cord-005453-4057qib7	10302	2	reactivation	reactivation	NN
cord-005453-4057qib7	10302	3	remains	remain	VBZ
cord-005453-4057qib7	10302	4	one	one	CD
cord-005453-4057qib7	10302	5	of	of	IN
cord-005453-4057qib7	10302	6	the	the	DT
cord-005453-4057qib7	10302	7	most	most	RBS
cord-005453-4057qib7	10302	8	frequent	frequent	JJ
cord-005453-4057qib7	10302	9	infectious	infectious	JJ
cord-005453-4057qib7	10302	10	complication	complication	NN
cord-005453-4057qib7	10302	11	in	in	IN
cord-005453-4057qib7	10302	12	children	child	NNS
cord-005453-4057qib7	10302	13	undergoing	undergo	VBG
cord-005453-4057qib7	10302	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	10302	15	HSCT	HSCT	NNP
cord-005453-4057qib7	10302	16	.	.	.
cord-005453-4057qib7	10303	1	Most	Most	JJS
cord-005453-4057qib7	10303	2	of	of	IN
cord-005453-4057qib7	10303	3	patients	patient	NNS
cord-005453-4057qib7	10303	4	experienced	experience	VBD
cord-005453-4057qib7	10303	5	mild	mild	JJ
cord-005453-4057qib7	10303	6	infection	infection	NN
cord-005453-4057qib7	10303	7	and	and	CC
cord-005453-4057qib7	10303	8	age	age	NN
cord-005453-4057qib7	10303	9	<	<	XX
cord-005453-4057qib7	10303	10	5	5	CD
cord-005453-4057qib7	10303	11	years	year	NNS
cord-005453-4057qib7	10303	12	was	be	VBD
cord-005453-4057qib7	10303	13	the	the	DT
cord-005453-4057qib7	10303	14	positive	positive	JJ
cord-005453-4057qib7	10303	15	prognostic	prognostic	JJ
cord-005453-4057qib7	10303	16	factor	factor	NN
cord-005453-4057qib7	10303	17	influencing	influence	VBG
cord-005453-4057qib7	10303	18	its	-PRON-	PRP$
cord-005453-4057qib7	10303	19	incidence	incidence	NN
cord-005453-4057qib7	10303	20	.	.	.
cord-005453-4057qib7	10304	1	BKV	bkv	NN
cord-005453-4057qib7	10304	2	monitoring	monitoring	NN
cord-005453-4057qib7	10304	3	and	and	CC
cord-005453-4057qib7	10304	4	prompt	prompt	JJ
cord-005453-4057qib7	10304	5	treatment	treatment	NN
cord-005453-4057qib7	10304	6	of	of	IN
cord-005453-4057qib7	10304	7	HC	HC	NNP
cord-005453-4057qib7	10304	8	resulted	result	VBD
cord-005453-4057qib7	10304	9	in	in	IN
cord-005453-4057qib7	10304	10	excellent	excellent	JJ
cord-005453-4057qib7	10304	11	outcome	outcome	NN
cord-005453-4057qib7	10304	12	.	.	.
cord-005453-4057qib7	10305	1	We	-PRON-	PRP
cord-005453-4057qib7	10305	2	observed	observe	VBD
cord-005453-4057qib7	10305	3	surprisingly	surprisingly	RB
cord-005453-4057qib7	10305	4	high	high	JJ
cord-005453-4057qib7	10305	5	rate	rate	NN
cord-005453-4057qib7	10305	6	of	of	IN
cord-005453-4057qib7	10305	7	new	new	JJ
cord-005453-4057qib7	10305	8	BKV	BKV	NNP
cord-005453-4057qib7	10305	9	replication	replication	NN
cord-005453-4057qib7	10305	10	after	after	IN
cord-005453-4057qib7	10305	11	HSCT	HSCT	NNP
cord-005453-4057qib7	10305	12	.	.	.
cord-005453-4057qib7	10306	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10306	2	:	:	:
cord-005453-4057qib7	10306	3	Nothing	nothing	NN
cord-005453-4057qib7	10306	4	to	to	TO
cord-005453-4057qib7	10306	5	declare	declare	VB
cord-005453-4057qib7	10306	6	Background	background	NN
cord-005453-4057qib7	10306	7	:	:	:
cord-005453-4057qib7	10306	8	High	high	JJ
cord-005453-4057qib7	10306	9	-	-	HYPH
cord-005453-4057qib7	10306	10	dose	dose	NN
cord-005453-4057qib7	10306	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10306	12	(	(	-LRB-
cord-005453-4057qib7	10306	13	HD	HD	NNP
cord-005453-4057qib7	10306	14	-	-	HYPH
cord-005453-4057qib7	10306	15	CT	CT	NNP
cord-005453-4057qib7	10306	16	)	)	-RRB-
cord-005453-4057qib7	10306	17	and	and	CC
cord-005453-4057qib7	10306	18	auto	auto	NN
cord-005453-4057qib7	10306	19	PBSCT	PBSCT	NNP
cord-005453-4057qib7	10306	20	have	have	VBP
cord-005453-4057qib7	10306	21	been	be	VBN
cord-005453-4057qib7	10306	22	the	the	DT
cord-005453-4057qib7	10306	23	standard	standard	JJ
cord-005453-4057qib7	10306	24	therapy	therapy	NN
cord-005453-4057qib7	10306	25	for	for	IN
cord-005453-4057qib7	10306	26	multiple	multiple	JJ
cord-005453-4057qib7	10306	27	myeloma	myeloma	NN
cord-005453-4057qib7	10306	28	(	(	-LRB-
cord-005453-4057qib7	10306	29	MM	MM	NNP
cord-005453-4057qib7	10306	30	)	)	-RRB-
cord-005453-4057qib7	10306	31	for	for	IN
cord-005453-4057qib7	10306	32	more	more	JJR
cord-005453-4057qib7	10306	33	than	than	IN
cord-005453-4057qib7	10306	34	two	two	CD
cord-005453-4057qib7	10306	35	decades	decade	NNS
cord-005453-4057qib7	10306	36	,	,	,
cord-005453-4057qib7	10306	37	despite	despite	IN
cord-005453-4057qib7	10306	38	a	a	DT
cord-005453-4057qib7	10306	39	wide	wide	JJ
cord-005453-4057qib7	10306	40	range	range	NN
cord-005453-4057qib7	10306	41	of	of	IN
cord-005453-4057qib7	10306	42	new	new	JJ
cord-005453-4057qib7	10306	43	therapeutic	therapeutic	JJ
cord-005453-4057qib7	10306	44	options	option	NNS
cord-005453-4057qib7	10306	45	.	.	.
cord-005453-4057qib7	10307	1	Recurrent	recurrent	JJ
cord-005453-4057qib7	10307	2	/	/	SYM
cord-005453-4057qib7	10307	3	refractory	refractory	JJ
cord-005453-4057qib7	10307	4	malignant	malignant	JJ
cord-005453-4057qib7	10307	5	lymphomas	lymphoma	NNS
cord-005453-4057qib7	10307	6	and	and	CC
cord-005453-4057qib7	10307	7	recurrent	recurrent	JJ
cord-005453-4057qib7	10307	8	/	/	SYM
cord-005453-4057qib7	10307	9	metastatic	metastatic	JJ
cord-005453-4057qib7	10307	10	germ	germ	NN
cord-005453-4057qib7	10307	11	cell	cell	NN
cord-005453-4057qib7	10307	12	tumors	tumor	NNS
cord-005453-4057qib7	10307	13	(	(	-LRB-
cord-005453-4057qib7	10307	14	GCT	GCT	NNP
cord-005453-4057qib7	10307	15	)	)	-RRB-
cord-005453-4057qib7	10307	16	also	also	RB
cord-005453-4057qib7	10307	17	benefit	benefit	VBP
cord-005453-4057qib7	10307	18	from	from	IN
cord-005453-4057qib7	10307	19	this	this	DT
cord-005453-4057qib7	10307	20	intensive	intensive	JJ
cord-005453-4057qib7	10307	21	therapy	therapy	NN
cord-005453-4057qib7	10307	22	.	.	.
cord-005453-4057qib7	10308	1	In	in	IN
cord-005453-4057qib7	10308	2	comparison	comparison	NN
cord-005453-4057qib7	10308	3	to	to	IN
cord-005453-4057qib7	10308	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	10308	5	transplantation	transplantation	NN
cord-005453-4057qib7	10308	6	,	,	,
cord-005453-4057qib7	10308	7	this	this	DT
cord-005453-4057qib7	10308	8	treatment	treatment	NN
cord-005453-4057qib7	10308	9	is	be	VBZ
cord-005453-4057qib7	10308	10	known	know	VBN
cord-005453-4057qib7	10308	11	for	for	IN
cord-005453-4057qib7	10308	12	lower	low	JJR
cord-005453-4057qib7	10308	13	complication	complication	NN
cord-005453-4057qib7	10308	14	rates	rate	NNS
cord-005453-4057qib7	10308	15	,	,	,
cord-005453-4057qib7	10308	16	e.g.	e.g.	IN
cord-005453-4057qib7	10308	17	infections	infection	NNS
cord-005453-4057qib7	10308	18	.	.	.
cord-005453-4057qib7	10309	1	However	however	RB
cord-005453-4057qib7	10309	2	previous	previous	JJ
cord-005453-4057qib7	10309	3	studies	study	NNS
cord-005453-4057qib7	10309	4	have	have	VBP
cord-005453-4057qib7	10309	5	schown	schown	NN
cord-005453-4057qib7	10309	6	that	that	IN
cord-005453-4057qib7	10309	7	treatment	treatment	NN
cord-005453-4057qib7	10309	8	related	relate	VBN
cord-005453-4057qib7	10309	9	toxicity	toxicity	NN
cord-005453-4057qib7	10309	10	may	may	MD
cord-005453-4057qib7	10309	11	not	not	RB
cord-005453-4057qib7	10309	12	be	be	VB
cord-005453-4057qib7	10309	13	underestimated	underestimate	VBN
cord-005453-4057qib7	10309	14	and	and	CC
cord-005453-4057qib7	10309	15	depending	depend	VBG
cord-005453-4057qib7	10309	16	on	on	IN
cord-005453-4057qib7	10309	17	the	the	DT
cord-005453-4057qib7	10309	18	conditioning	conditioning	NN
cord-005453-4057qib7	10309	19	regimen	regimen	NN
cord-005453-4057qib7	10309	20	used	use	VBN
cord-005453-4057qib7	10309	21	.	.	.
cord-005453-4057qib7	10310	1	Methods	method	NNS
cord-005453-4057qib7	10310	2	:	:	:
cord-005453-4057qib7	10310	3	We	-PRON-	PRP
cord-005453-4057qib7	10310	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	10310	5	analyzed	analyze	VBD
cord-005453-4057qib7	10310	6	193	193	CD
cord-005453-4057qib7	10310	7	patients	patient	NNS
cord-005453-4057qib7	10310	8	(	(	-LRB-
cord-005453-4057qib7	10310	9	225	225	CD
cord-005453-4057qib7	10310	10	cases	case	NNS
cord-005453-4057qib7	10310	11	)	)	-RRB-
cord-005453-4057qib7	10310	12	who	who	WP
cord-005453-4057qib7	10310	13	underwent	undergo	VBD
cord-005453-4057qib7	10310	14	HD	HD	NNP
cord-005453-4057qib7	10310	15	-	-	HYPH
cord-005453-4057qib7	10310	16	CT	CT	NNP
cord-005453-4057qib7	10310	17	plus	plus	CC
cord-005453-4057qib7	10310	18	auto	auto	NN
cord-005453-4057qib7	10310	19	PBSCT	PBSCT	NNP
cord-005453-4057qib7	10310	20	between	between	IN
cord-005453-4057qib7	10310	21	2011	2011	CD
cord-005453-4057qib7	10310	22	and	and	CC
cord-005453-4057qib7	10310	23	2017	2017	CD
cord-005453-4057qib7	10310	24	in	in	IN
cord-005453-4057qib7	10310	25	a	a	DT
cord-005453-4057qib7	10310	26	single	single	JJ
cord-005453-4057qib7	10310	27	-	-	HYPH
cord-005453-4057qib7	10310	28	center	center	NN
cord-005453-4057qib7	10310	29	study	study	NN
cord-005453-4057qib7	10310	30	.	.	.
cord-005453-4057qib7	10311	1	To	to	TO
cord-005453-4057qib7	10311	2	anlyze	anlyze	VB
cord-005453-4057qib7	10311	3	the	the	DT
cord-005453-4057qib7	10311	4	incidence	incidence	NN
cord-005453-4057qib7	10311	5	of	of	IN
cord-005453-4057qib7	10311	6	infections	infection	NNS
cord-005453-4057qib7	10311	7	depending	depend	VBG
cord-005453-4057qib7	10311	8	on	on	IN
cord-005453-4057qib7	10311	9	the	the	DT
cord-005453-4057qib7	10311	10	conditioning	conditioning	NN
cord-005453-4057qib7	10311	11	regimen	regimen	NN
cord-005453-4057qib7	10311	12	,	,	,
cord-005453-4057qib7	10311	13	we	-PRON-	PRP
cord-005453-4057qib7	10311	14	formed	form	VBD
cord-005453-4057qib7	10311	15	the	the	DT
cord-005453-4057qib7	10311	16	following	follow	VBG
cord-005453-4057qib7	10311	17	categories	category	NNS
cord-005453-4057qib7	10311	18	based	base	VBN
cord-005453-4057qib7	10311	19	on	on	IN
cord-005453-4057qib7	10311	20	the	the	DT
cord-005453-4057qib7	10311	21	AGIHO	AGIHO	NNP
cord-005453-4057qib7	10311	22	:	:	:
cord-005453-4057qib7	10311	23	no	no	DT
cord-005453-4057qib7	10311	24	infections	infection	NNS
cord-005453-4057qib7	10311	25	,	,	,
cord-005453-4057qib7	10311	26	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10311	27	fever	fever	NN
cord-005453-4057qib7	10311	28	,	,	,
cord-005453-4057qib7	10311	29	sepsis	sepsis	NN
cord-005453-4057qib7	10311	30	and	and	CC
cord-005453-4057qib7	10311	31	severe	severe	JJ
cord-005453-4057qib7	10311	32	sepsis	sepsis	NN
cord-005453-4057qib7	10311	33	.	.	.
cord-005453-4057qib7	10312	1	Results	result	NNS
cord-005453-4057qib7	10312	2	:	:	:
cord-005453-4057qib7	10313	1	The	the	DT
cord-005453-4057qib7	10313	2	median	median	JJ
cord-005453-4057qib7	10313	3	age	age	NN
cord-005453-4057qib7	10313	4	in	in	IN
cord-005453-4057qib7	10313	5	this	this	DT
cord-005453-4057qib7	10313	6	analysis	analysis	NN
cord-005453-4057qib7	10313	7	was	be	VBD
cord-005453-4057qib7	10313	8	59	59	CD
cord-005453-4057qib7	10313	9	years	year	NNS
cord-005453-4057qib7	10313	10	;	;	:
cord-005453-4057qib7	10313	11	74.2	74.2	CD
cord-005453-4057qib7	10313	12	%	%	NN
cord-005453-4057qib7	10313	13	were	be	VBD
cord-005453-4057qib7	10313	14	male	male	JJ
cord-005453-4057qib7	10313	15	.	.	.
cord-005453-4057qib7	10314	1	The	the	DT
cord-005453-4057qib7	10314	2	most	most	RBS
cord-005453-4057qib7	10314	3	frequent	frequent	JJ
cord-005453-4057qib7	10314	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	10314	5	was	be	VBD
cord-005453-4057qib7	10314	6	MM	MM	NNP
cord-005453-4057qib7	10314	7	(	(	-LRB-
cord-005453-4057qib7	10314	8	62.7	62.7	CD
cord-005453-4057qib7	10314	9	%	%	NN
cord-005453-4057qib7	10314	10	)	)	-RRB-
cord-005453-4057qib7	10314	11	receiving	receive	VBG
cord-005453-4057qib7	10314	12	high	high	JJ
cord-005453-4057qib7	10314	13	dose	dose	NN
cord-005453-4057qib7	10314	14	melphalan	melphalan	NN
cord-005453-4057qib7	10314	15	(	(	-LRB-
cord-005453-4057qib7	10314	16	MEL	MEL	NNP
cord-005453-4057qib7	10314	17	)	)	-RRB-
cord-005453-4057qib7	10314	18	,	,	,
cord-005453-4057qib7	10314	19	followed	follow	VBN
cord-005453-4057qib7	10314	20	by	by	IN
cord-005453-4057qib7	10314	21	malignant	malignant	JJ
cord-005453-4057qib7	10314	22	lymphoma	lymphoma	NN
cord-005453-4057qib7	10314	23	(	(	-LRB-
cord-005453-4057qib7	10314	24	26.7	26.7	CD
cord-005453-4057qib7	10314	25	%	%	NN
cord-005453-4057qib7	10314	26	)	)	-RRB-
cord-005453-4057qib7	10314	27	receiving	receive	VBG
cord-005453-4057qib7	10314	28	BEAM	BEAM	NNP
cord-005453-4057qib7	10314	29	(	(	-LRB-
cord-005453-4057qib7	10314	30	BCNU	BCNU	NNP
cord-005453-4057qib7	10314	31	,	,	,
cord-005453-4057qib7	10314	32	etoposide	etoposide	JJ
cord-005453-4057qib7	10314	33	cytarabine	cytarabine	NN
cord-005453-4057qib7	10314	34	,	,	,
cord-005453-4057qib7	10314	35	melphalan	melphalan	NNP
cord-005453-4057qib7	10314	36	)	)	-RRB-
cord-005453-4057qib7	10314	37	and	and	CC
cord-005453-4057qib7	10314	38	relapsed	relapse	VBD
cord-005453-4057qib7	10314	39	/	/	SYM
cord-005453-4057qib7	10314	40	metastatic	metastatic	JJ
cord-005453-4057qib7	10314	41	germ	germ	NN
cord-005453-4057qib7	10314	42	cell	cell	NN
cord-005453-4057qib7	10314	43	tumours	tumour	NNS
cord-005453-4057qib7	10314	44	(	(	-LRB-
cord-005453-4057qib7	10314	45	GCT	GCT	NNP
cord-005453-4057qib7	10314	46	)	)	-RRB-
cord-005453-4057qib7	10314	47	(	(	-LRB-
cord-005453-4057qib7	10314	48	9.8	9.8	CD
cord-005453-4057qib7	10314	49	%	%	NN
cord-005453-4057qib7	10314	50	)	)	-RRB-
cord-005453-4057qib7	10314	51	receiving	receive	VBG
cord-005453-4057qib7	10314	52	high	high	JJ
cord-005453-4057qib7	10314	53	dose	dose	NN
cord-005453-4057qib7	10314	54	carboplatin	carboplatin	NNS
cord-005453-4057qib7	10314	55	/	/	SYM
cord-005453-4057qib7	10314	56	etoposide	etoposide	JJ
cord-005453-4057qib7	10314	57	(	(	-LRB-
cord-005453-4057qib7	10314	58	CE	CE	NNP
cord-005453-4057qib7	10314	59	)	)	-RRB-
cord-005453-4057qib7	10314	60	.	.	.
cord-005453-4057qib7	10315	1	8	8	CD
cord-005453-4057qib7	10315	2	%	%	NN
cord-005453-4057qib7	10315	3	of	of	IN
cord-005453-4057qib7	10315	4	all	all	DT
cord-005453-4057qib7	10315	5	patients	patient	NNS
cord-005453-4057qib7	10315	6	developed	develop	VBD
cord-005453-4057qib7	10315	7	severe	severe	JJ
cord-005453-4057qib7	10315	8	sepsis	sepsis	NN
cord-005453-4057qib7	10315	9	,	,	,
cord-005453-4057qib7	10315	10	5	5	CD
cord-005453-4057qib7	10315	11	patients	patient	NNS
cord-005453-4057qib7	10315	12	had	have	VBD
cord-005453-4057qib7	10315	13	to	to	TO
cord-005453-4057qib7	10315	14	be	be	VB
cord-005453-4057qib7	10315	15	ventilated	ventilate	VBN
cord-005453-4057qib7	10315	16	and	and	CC
cord-005453-4057qib7	10315	17	2	2	CD
cord-005453-4057qib7	10315	18	patients	patient	NNS
cord-005453-4057qib7	10315	19	died	die	VBD
cord-005453-4057qib7	10315	20	.	.	.
cord-005453-4057qib7	10316	1	Sepsis	sepsis	NN
cord-005453-4057qib7	10316	2	was	be	VBD
cord-005453-4057qib7	10316	3	documented	document	VBN
cord-005453-4057qib7	10316	4	in	in	IN
cord-005453-4057qib7	10316	5	25.3	25.3	CD
cord-005453-4057qib7	10316	6	%	%	NN
cord-005453-4057qib7	10316	7	of	of	IN
cord-005453-4057qib7	10316	8	all	all	DT
cord-005453-4057qib7	10316	9	cases	case	NNS
cord-005453-4057qib7	10316	10	(	(	-LRB-
cord-005453-4057qib7	10316	11	57	57	CD
cord-005453-4057qib7	10316	12	cases	case	NNS
cord-005453-4057qib7	10316	13	)	)	-RRB-
cord-005453-4057qib7	10316	14	.	.	.
cord-005453-4057qib7	10317	1	The	the	DT
cord-005453-4057qib7	10317	2	majority	majority	NN
cord-005453-4057qib7	10317	3	of	of	IN
cord-005453-4057qib7	10317	4	patients	patient	NNS
cord-005453-4057qib7	10317	5	(	(	-LRB-
cord-005453-4057qib7	10317	6	58.2	58.2	CD
cord-005453-4057qib7	10317	7	%	%	NN
cord-005453-4057qib7	10317	8	,	,	,
cord-005453-4057qib7	10317	9	131	131	CD
cord-005453-4057qib7	10317	10	cases	case	NNS
cord-005453-4057qib7	10317	11	)	)	-RRB-
cord-005453-4057qib7	10317	12	developed	develop	VBD
cord-005453-4057qib7	10317	13	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10317	14	fever	fever	NN
cord-005453-4057qib7	10317	15	and	and	CC
cord-005453-4057qib7	10317	16	8.4	8.4	CD
cord-005453-4057qib7	10317	17	%	%	NN
cord-005453-4057qib7	10317	18	(	(	-LRB-
cord-005453-4057qib7	10317	19	19	19	CD
cord-005453-4057qib7	10317	20	cases	case	NNS
cord-005453-4057qib7	10317	21	)	)	-RRB-
cord-005453-4057qib7	10317	22	didn´t	didn´t	.
cord-005453-4057qib7	10318	1	have	have	VBP
cord-005453-4057qib7	10318	2	any	any	DT
cord-005453-4057qib7	10318	3	infection	infection	NN
cord-005453-4057qib7	10318	4	complications	complication	NNS
cord-005453-4057qib7	10318	5	.	.	.
cord-005453-4057qib7	10319	1	The	the	DT
cord-005453-4057qib7	10319	2	BEAM	BEAM	NNP
cord-005453-4057qib7	10319	3	conditioning	conditioning	NN
cord-005453-4057qib7	10319	4	regimen	regimen	NN
cord-005453-4057qib7	10319	5	showed	show	VBD
cord-005453-4057qib7	10319	6	the	the	DT
cord-005453-4057qib7	10319	7	highest	high	JJS
cord-005453-4057qib7	10319	8	tendency	tendency	NN
cord-005453-4057qib7	10319	9	to	to	TO
cord-005453-4057qib7	10319	10	result	result	VB
cord-005453-4057qib7	10319	11	in	in	IN
cord-005453-4057qib7	10319	12	a	a	DT
cord-005453-4057qib7	10319	13	septic	septic	JJ
cord-005453-4057qib7	10319	14	course	course	NN
cord-005453-4057qib7	10319	15	(	(	-LRB-
cord-005453-4057qib7	10319	16	43.3	43.3	CD
cord-005453-4057qib7	10319	17	%	%	NN
cord-005453-4057qib7	10319	18	)	)	-RRB-
cord-005453-4057qib7	10319	19	,	,	,
cord-005453-4057qib7	10319	20	followed	follow	VBN
cord-005453-4057qib7	10319	21	by	by	IN
cord-005453-4057qib7	10319	22	CE	CE	NNP
cord-005453-4057qib7	10319	23	(	(	-LRB-
cord-005453-4057qib7	10319	24	27.3	27.3	CD
cord-005453-4057qib7	10319	25	%	%	NN
cord-005453-4057qib7	10319	26	)	)	-RRB-
cord-005453-4057qib7	10319	27	and	and	CC
cord-005453-4057qib7	10319	28	MEL	MEL	NNP
cord-005453-4057qib7	10319	29	(	(	-LRB-
cord-005453-4057qib7	10319	30	24.1	24.1	CD
cord-005453-4057qib7	10319	31	%	%	NN
cord-005453-4057qib7	10319	32	)	)	-RRB-
cord-005453-4057qib7	10319	33	.	.	.
cord-005453-4057qib7	10320	1	The	the	DT
cord-005453-4057qib7	10320	2	most	most	RBS
cord-005453-4057qib7	10320	3	commonly	commonly	RB
cord-005453-4057qib7	10320	4	documented	document	VBN
cord-005453-4057qib7	10320	5	pathogen	pathogen	NN
cord-005453-4057qib7	10320	6	in	in	IN
cord-005453-4057qib7	10320	7	153	153	CD
cord-005453-4057qib7	10320	8	blood	blood	NN
cord-005453-4057qib7	10320	9	cultures	culture	NNS
cord-005453-4057qib7	10320	10	was	be	VBD
cord-005453-4057qib7	10320	11	S.	S.	NNP
cord-005453-4057qib7	10320	12	epidermidis	epidermidi	NNS
cord-005453-4057qib7	10320	13	(	(	-LRB-
cord-005453-4057qib7	10320	14	41.7	41.7	CD
cord-005453-4057qib7	10320	15	%	%	NN
cord-005453-4057qib7	10320	16	)	)	-RRB-
cord-005453-4057qib7	10320	17	,	,	,
cord-005453-4057qib7	10320	18	followed	follow	VBN
cord-005453-4057qib7	10320	19	by	by	IN
cord-005453-4057qib7	10320	20	E.	E.	NNP
cord-005453-4057qib7	10320	21	coli	coli	NNS
cord-005453-4057qib7	10320	22	(	(	-LRB-
cord-005453-4057qib7	10320	23	18.5	18.5	CD
cord-005453-4057qib7	10320	24	%	%	NN
cord-005453-4057qib7	10320	25	)	)	-RRB-
cord-005453-4057qib7	10320	26	and	and	CC
cord-005453-4057qib7	10320	27	S.	S.	NNP
cord-005453-4057qib7	10320	28	mitis	mitis	NNP
cord-005453-4057qib7	10320	29	(	(	-LRB-
cord-005453-4057qib7	10320	30	9.9	9.9	CD
cord-005453-4057qib7	10320	31	%	%	NN
cord-005453-4057qib7	10320	32	)	)	-RRB-
cord-005453-4057qib7	10320	33	.	.	.
cord-005453-4057qib7	10321	1	Only	only	RB
cord-005453-4057qib7	10321	2	in	in	IN
cord-005453-4057qib7	10321	3	one	one	CD
cord-005453-4057qib7	10321	4	blood	blood	NN
cord-005453-4057qib7	10321	5	culture	culture	NN
cord-005453-4057qib7	10321	6	we	-PRON-	PRP
cord-005453-4057qib7	10321	7	detected	detect	VBD
cord-005453-4057qib7	10321	8	a	a	DT
cord-005453-4057qib7	10321	9	multi	multi	JJ
cord-005453-4057qib7	10321	10	-	-	JJ
cord-005453-4057qib7	10321	11	resistant	resistant	JJ
cord-005453-4057qib7	10321	12	pathogen	pathogen	NN
cord-005453-4057qib7	10321	13	(	(	-LRB-
cord-005453-4057qib7	10321	14	3MRGN	3mrgn	CD
cord-005453-4057qib7	10321	15	E.	E.	NNP
cord-005453-4057qib7	10321	16	coli	coli	NNS
cord-005453-4057qib7	10321	17	)	)	-RRB-
cord-005453-4057qib7	10321	18	.	.	.
cord-005453-4057qib7	10322	1	P.	P.	NNP
cord-005453-4057qib7	10322	2	aeruginosa	aeruginosa	NN
cord-005453-4057qib7	10322	3	was	be	VBD
cord-005453-4057qib7	10322	4	detected	detect	VBN
cord-005453-4057qib7	10322	5	in	in	IN
cord-005453-4057qib7	10322	6	4	4	CD
cord-005453-4057qib7	10322	7	blood	blood	NN
cord-005453-4057qib7	10322	8	cultures	culture	NNS
cord-005453-4057qib7	10322	9	(	(	-LRB-
cord-005453-4057qib7	10322	10	2.6	2.6	CD
cord-005453-4057qib7	10322	11	%	%	NN
cord-005453-4057qib7	10322	12	)	)	-RRB-
cord-005453-4057qib7	10322	13	,	,	,
cord-005453-4057qib7	10322	14	L.	L.	NNP
cord-005453-4057qib7	10322	15	monocytogenes	monocytogenes	NN
cord-005453-4057qib7	10322	16	in	in	IN
cord-005453-4057qib7	10322	17	2	2	CD
cord-005453-4057qib7	10322	18	(	(	-LRB-
cord-005453-4057qib7	10322	19	1.3	1.3	CD
cord-005453-4057qib7	10322	20	%	%	NN
cord-005453-4057qib7	10322	21	)	)	-RRB-
cord-005453-4057qib7	10322	22	and	and	CC
cord-005453-4057qib7	10322	23	S.	S.	NNP
cord-005453-4057qib7	10322	24	aureus	aureus	NN
cord-005453-4057qib7	10322	25	in	in	IN
cord-005453-4057qib7	10322	26	6	6	CD
cord-005453-4057qib7	10322	27	(	(	-LRB-
cord-005453-4057qib7	10322	28	4	4	CD
cord-005453-4057qib7	10322	29	%	%	NN
cord-005453-4057qib7	10322	30	)	)	-RRB-
cord-005453-4057qib7	10322	31	.	.	.
cord-005453-4057qib7	10323	1	77.8	77.8	CD
cord-005453-4057qib7	10323	2	%	%	NN
cord-005453-4057qib7	10323	3	of	of	IN
cord-005453-4057qib7	10323	4	all	all	DT
cord-005453-4057qib7	10323	5	patients	patient	NNS
cord-005453-4057qib7	10323	6	developed	develop	VBD
cord-005453-4057qib7	10323	7	diarrhea	diarrhea	NN
cord-005453-4057qib7	10323	8	,	,	,
cord-005453-4057qib7	10323	9	only	only	RB
cord-005453-4057qib7	10323	10	in	in	IN
cord-005453-4057qib7	10323	11	10.9	10.9	CD
cord-005453-4057qib7	10323	12	%	%	NN
cord-005453-4057qib7	10323	13	of	of	IN
cord-005453-4057qib7	10323	14	these	these	DT
cord-005453-4057qib7	10323	15	cases	case	NNS
cord-005453-4057qib7	10323	16	we	-PRON-	PRP
cord-005453-4057qib7	10323	17	could	could	MD
cord-005453-4057qib7	10323	18	detect	detect	VB
cord-005453-4057qib7	10323	19	C.	C.	NNP
cord-005453-4057qib7	10323	20	difficile	difficile	NN
cord-005453-4057qib7	10323	21	.	.	.
cord-005453-4057qib7	10324	1	The	the	DT
cord-005453-4057qib7	10324	2	conditioning	conditioning	NN
cord-005453-4057qib7	10324	3	regimen	regimen	NN
cord-005453-4057qib7	10324	4	shows	show	VBZ
cord-005453-4057qib7	10324	5	no	no	DT
cord-005453-4057qib7	10324	6	significant	significant	JJ
cord-005453-4057qib7	10324	7	effect	effect	NN
cord-005453-4057qib7	10324	8	on	on	IN
cord-005453-4057qib7	10324	9	the	the	DT
cord-005453-4057qib7	10324	10	incidence	incidence	NN
cord-005453-4057qib7	10324	11	of	of	IN
cord-005453-4057qib7	10324	12	C.	C.	NNP
cord-005453-4057qib7	10324	13	difficile	difficile	NN
cord-005453-4057qib7	10324	14	.	.	.
cord-005453-4057qib7	10325	1	The	the	DT
cord-005453-4057qib7	10325	2	mean	mean	NN
cord-005453-4057qib7	10325	3	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10325	4	period	period	NN
cord-005453-4057qib7	10325	5	was	be	VBD
cord-005453-4057qib7	10325	6	13.5	13.5	CD
cord-005453-4057qib7	10325	7	days	day	NNS
cord-005453-4057qib7	10325	8	in	in	IN
cord-005453-4057qib7	10325	9	malignant	malignant	JJ
cord-005453-4057qib7	10325	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	10325	11	patients	patient	NNS
cord-005453-4057qib7	10325	12	,	,	,
cord-005453-4057qib7	10325	13	followed	follow	VBN
cord-005453-4057qib7	10325	14	by	by	IN
cord-005453-4057qib7	10325	15	10.8	10.8	CD
cord-005453-4057qib7	10325	16	in	in	IN
cord-005453-4057qib7	10325	17	MM	MM	NNP
cord-005453-4057qib7	10325	18	patients	patient	NNS
cord-005453-4057qib7	10325	19	and	and	CC
cord-005453-4057qib7	10325	20	8.7	8.7	CD
cord-005453-4057qib7	10325	21	days	day	NNS
cord-005453-4057qib7	10325	22	in	in	IN
cord-005453-4057qib7	10325	23	GCT	GCT	NNP
cord-005453-4057qib7	10325	24	patients	patient	NNS
cord-005453-4057qib7	10325	25	.	.	.
cord-005453-4057qib7	10326	1	The	the	DT
cord-005453-4057qib7	10326	2	hospital	hospital	NN
cord-005453-4057qib7	10326	3	discharge	discharge	NN
cord-005453-4057qib7	10326	4	,	,	,
cord-005453-4057qib7	10326	5	calculated	calculate	VBN
cord-005453-4057qib7	10326	6	from	from	IN
cord-005453-4057qib7	10326	7	the	the	DT
cord-005453-4057qib7	10326	8	day	day	NN
cord-005453-4057qib7	10326	9	of	of	IN
cord-005453-4057qib7	10326	10	transplantation	transplantation	NN
cord-005453-4057qib7	10326	11	,	,	,
cord-005453-4057qib7	10326	12	was	be	VBD
cord-005453-4057qib7	10326	13	significantly	significantly	RB
cord-005453-4057qib7	10326	14	different	different	JJ
cord-005453-4057qib7	10326	15	:	:	:
cord-005453-4057qib7	10326	16	for	for	IN
cord-005453-4057qib7	10326	17	malignant	malignant	JJ
cord-005453-4057qib7	10326	18	lymphoma	lymphoma	NN
cord-005453-4057qib7	10327	1	the	the	DT
cord-005453-4057qib7	10327	2	mean	mean	NN
cord-005453-4057qib7	10327	3	was	be	VBD
cord-005453-4057qib7	10327	4	20.8	20.8	CD
cord-005453-4057qib7	10327	5	days	day	NNS
cord-005453-4057qib7	10327	6	,	,	,
cord-005453-4057qib7	10327	7	for	for	IN
cord-005453-4057qib7	10327	8	MM	MM	NNP
cord-005453-4057qib7	10327	9	19.6	19.6	CD
cord-005453-4057qib7	10327	10	days	day	NNS
cord-005453-4057qib7	10327	11	and	and	CC
cord-005453-4057qib7	10327	12	for	for	IN
cord-005453-4057qib7	10327	13	GCT	GCT	NNP
cord-005453-4057qib7	10327	14	14.5	14.5	CD
cord-005453-4057qib7	10327	15	days	day	NNS
cord-005453-4057qib7	10327	16	.	.	.
cord-005453-4057qib7	10328	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10328	2	:	:	:
cord-005453-4057qib7	10329	1	Our	-PRON-	PRP$
cord-005453-4057qib7	10329	2	data	datum	NNS
cord-005453-4057qib7	10329	3	correspond	correspond	VBP
cord-005453-4057qib7	10329	4	to	to	IN
cord-005453-4057qib7	10329	5	former	former	JJ
cord-005453-4057qib7	10329	6	published	publish	VBN
cord-005453-4057qib7	10329	7	results	result	NNS
cord-005453-4057qib7	10329	8	by	by	IN
cord-005453-4057qib7	10329	9	many	many	JJ
cord-005453-4057qib7	10329	10	groups	group	NNS
cord-005453-4057qib7	10329	11	.	.	.
cord-005453-4057qib7	10330	1	The	the	DT
cord-005453-4057qib7	10330	2	BEAM	BEAM	NNP
cord-005453-4057qib7	10330	3	regimen	regimen	NN
cord-005453-4057qib7	10330	4	shows	show	VBZ
cord-005453-4057qib7	10330	5	the	the	DT
cord-005453-4057qib7	10330	6	highest	high	JJS
cord-005453-4057qib7	10330	7	infectious	infectious	JJ
cord-005453-4057qib7	10330	8	complication	complication	NN
cord-005453-4057qib7	10330	9	rate	rate	NN
cord-005453-4057qib7	10330	10	followed	follow	VBN
cord-005453-4057qib7	10330	11	by	by	IN
cord-005453-4057qib7	10330	12	CE	CE	NNP
cord-005453-4057qib7	10330	13	and	and	CC
cord-005453-4057qib7	10330	14	MEL	MEL	NNP
cord-005453-4057qib7	10330	15	.	.	.
cord-005453-4057qib7	10331	1	The	the	DT
cord-005453-4057qib7	10331	2	duration	duration	NN
cord-005453-4057qib7	10331	3	of	of	IN
cord-005453-4057qib7	10331	4	neutropenia	neutropenia	NN
cord-005453-4057qib7	10331	5	and	and	CC
cord-005453-4057qib7	10331	6	hospital	hospital	NN
cord-005453-4057qib7	10331	7	stay	stay	NN
cord-005453-4057qib7	10331	8	depends	depend	VBZ
cord-005453-4057qib7	10331	9	on	on	IN
cord-005453-4057qib7	10331	10	the	the	DT
cord-005453-4057qib7	10331	11	conditioning	conditioning	NN
cord-005453-4057qib7	10331	12	regimen	regimen	NN
cord-005453-4057qib7	10331	13	.	.	.
cord-005453-4057qib7	10332	1	The	the	DT
cord-005453-4057qib7	10332	2	type	type	NN
cord-005453-4057qib7	10332	3	of	of	IN
cord-005453-4057qib7	10332	4	infectious	infectious	JJ
cord-005453-4057qib7	10332	5	complication	complication	NN
cord-005453-4057qib7	10332	6	does	do	VBZ
cord-005453-4057qib7	10332	7	n't	not	RB
cord-005453-4057qib7	10332	8	effect	effect	VB
cord-005453-4057qib7	10332	9	the	the	DT
cord-005453-4057qib7	10332	10	progression	progression	NN
cord-005453-4057qib7	10332	11	free	free	JJ
cord-005453-4057qib7	10332	12	-	-	HYPH
cord-005453-4057qib7	10332	13	and	and	CC
cord-005453-4057qib7	10332	14	overall	overall	JJ
cord-005453-4057qib7	10332	15	survival	survival	NN
cord-005453-4057qib7	10332	16	in	in	IN
cord-005453-4057qib7	10332	17	our	-PRON-	PRP$
cord-005453-4057qib7	10332	18	analysis	analysis	NN
cord-005453-4057qib7	10332	19	.	.	.
cord-005453-4057qib7	10333	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10333	2	:	:	:
cord-005453-4057qib7	10333	3	Nothing	nothing	NN
cord-005453-4057qib7	10333	4	to	to	TO
cord-005453-4057qib7	10333	5	declare	declare	VB
cord-005453-4057qib7	10333	6	.	.	.
cord-005453-4057qib7	10334	1	Impact	impact	NN
cord-005453-4057qib7	10334	2	of	of	IN
cord-005453-4057qib7	10334	3	donor	donor	NN
cord-005453-4057qib7	10334	4	and	and	CC
cord-005453-4057qib7	10334	5	recipient	recipient	NN
cord-005453-4057qib7	10334	6	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	10334	7	serostatus	serostatus	NN
cord-005453-4057qib7	10334	8	on	on	IN
cord-005453-4057qib7	10334	9	outcomes	outcome	NNS
cord-005453-4057qib7	10334	10	of	of	IN
cord-005453-4057qib7	10334	11	unrelated	unrelated	JJ
cord-005453-4057qib7	10334	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	10334	13	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	10334	14	stem	stem	NN
cord-005453-4057qib7	10334	15	cell	cell	NN
cord-005453-4057qib7	10334	16	transplantation	transplantation	NN
cord-005453-4057qib7	10334	17	Background	background	NN
cord-005453-4057qib7	10334	18	:	:	:
cord-005453-4057qib7	10334	19	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	10334	20	(	(	-LRB-
cord-005453-4057qib7	10334	21	CMV	CMV	NNP
cord-005453-4057qib7	10334	22	)	)	-RRB-
cord-005453-4057qib7	10334	23	is	be	VBZ
cord-005453-4057qib7	10334	24	an	an	DT
cord-005453-4057qib7	10334	25	important	important	JJ
cord-005453-4057qib7	10334	26	cause	cause	NN
cord-005453-4057qib7	10334	27	of	of	IN
cord-005453-4057qib7	10334	28	morbidity	morbidity	NN
cord-005453-4057qib7	10334	29	and	and	CC
cord-005453-4057qib7	10334	30	mortality	mortality	NN
cord-005453-4057qib7	10334	31	in	in	IN
cord-005453-4057qib7	10334	32	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10334	33	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	10334	34	stem	stem	NN
cord-005453-4057qib7	10334	35	cell	cell	NN
cord-005453-4057qib7	10334	36	transplant	transplant	NN
cord-005453-4057qib7	10334	37	(	(	-LRB-
cord-005453-4057qib7	10334	38	HSCT	HSCT	NNP
cord-005453-4057qib7	10334	39	)	)	-RRB-
cord-005453-4057qib7	10334	40	patients	patient	NNS
cord-005453-4057qib7	10334	41	.	.	.
cord-005453-4057qib7	10335	1	The	the	DT
cord-005453-4057qib7	10335	2	aim	aim	NN
cord-005453-4057qib7	10335	3	of	of	IN
cord-005453-4057qib7	10335	4	our	-PRON-	PRP$
cord-005453-4057qib7	10335	5	study	study	NN
cord-005453-4057qib7	10335	6	is	be	VBZ
cord-005453-4057qib7	10335	7	to	to	TO
cord-005453-4057qib7	10335	8	evaluate	evaluate	VB
cord-005453-4057qib7	10335	9	the	the	DT
cord-005453-4057qib7	10335	10	outcomes	outcome	NNS
cord-005453-4057qib7	10335	11	of	of	IN
cord-005453-4057qib7	10335	12	our	-PRON-	PRP$
cord-005453-4057qib7	10335	13	CMV	CMV	NNP
cord-005453-4057qib7	10335	14	seropositive	seropositive	JJ
cord-005453-4057qib7	10335	15	recipients	recipient	NNS
cord-005453-4057qib7	10335	16	who	who	WP
cord-005453-4057qib7	10335	17	received	receive	VBD
cord-005453-4057qib7	10335	18	grafts	graft	NNS
cord-005453-4057qib7	10335	19	from	from	IN
cord-005453-4057qib7	10335	20	seropositive	seropositive	JJ
cord-005453-4057qib7	10335	21	unrelated	unrelated	JJ
cord-005453-4057qib7	10335	22	donors	donor	NNS
cord-005453-4057qib7	10335	23	(	(	-LRB-
cord-005453-4057qib7	10335	24	D+R+	D+R+	NNP
cord-005453-4057qib7	10335	25	)	)	-RRB-
cord-005453-4057qib7	10335	26	compared	compare	VBN
cord-005453-4057qib7	10335	27	with	with	IN
cord-005453-4057qib7	10335	28	grafts	graft	NNS
cord-005453-4057qib7	10335	29	from	from	IN
cord-005453-4057qib7	10335	30	seronegative	seronegative	JJ
cord-005453-4057qib7	10335	31	unrelated	unrelated	JJ
cord-005453-4057qib7	10335	32	donors	donor	NNS
cord-005453-4057qib7	10335	33	(	(	-LRB-
cord-005453-4057qib7	10335	34	D	d	NN
cord-005453-4057qib7	10335	35	-	-	HYPH
cord-005453-4057qib7	10335	36	R+	r+	NN
cord-005453-4057qib7	10335	37	)	)	-RRB-
cord-005453-4057qib7	10335	38	.	.	.
cord-005453-4057qib7	10336	1	Methods	method	NNS
cord-005453-4057qib7	10336	2	:	:	:
cord-005453-4057qib7	10336	3	This	this	DT
cord-005453-4057qib7	10336	4	is	be	VBZ
cord-005453-4057qib7	10336	5	a	a	DT
cord-005453-4057qib7	10336	6	retrospective	retrospective	JJ
cord-005453-4057qib7	10336	7	single	single	JJ
cord-005453-4057qib7	10336	8	center	center	NN
cord-005453-4057qib7	10336	9	study	study	NN
cord-005453-4057qib7	10336	10	on	on	IN
cord-005453-4057qib7	10336	11	a	a	DT
cord-005453-4057qib7	10336	12	series	series	NN
cord-005453-4057qib7	10336	13	of	of	IN
cord-005453-4057qib7	10336	14	CMV	CMV	NNP
cord-005453-4057qib7	10336	15	seropositive	seropositive	JJ
cord-005453-4057qib7	10336	16	recipients	recipient	NNS
cord-005453-4057qib7	10336	17	who	who	WP
cord-005453-4057qib7	10336	18	underwent	undergo	VBD
cord-005453-4057qib7	10336	19	HSCT	HSCT	NNP
cord-005453-4057qib7	10336	20	from	from	IN
cord-005453-4057qib7	10336	21	unrelated	unrelated	JJ
cord-005453-4057qib7	10336	22	donors	donor	NNS
cord-005453-4057qib7	10336	23	between	between	IN
cord-005453-4057qib7	10336	24	Febuary	Febuary	NNP
cord-005453-4057qib7	10336	25	2012	2012	CD
cord-005453-4057qib7	10336	26	to	to	IN
cord-005453-4057qib7	10336	27	July	July	NNP
cord-005453-4057qib7	10336	28	2018	2018	CD
cord-005453-4057qib7	10336	29	.	.	.
cord-005453-4057qib7	10337	1	A	a	DT
cord-005453-4057qib7	10337	2	total	total	NN
cord-005453-4057qib7	10337	3	of	of	IN
cord-005453-4057qib7	10337	4	96	96	CD
cord-005453-4057qib7	10337	5	patients	patient	NNS
cord-005453-4057qib7	10337	6	were	be	VBD
cord-005453-4057qib7	10337	7	analyzed	analyze	VBN
cord-005453-4057qib7	10337	8	.	.	.
cord-005453-4057qib7	10338	1	Their	-PRON-	PRP$
cord-005453-4057qib7	10338	2	clinical	clinical	JJ
cord-005453-4057qib7	10338	3	course	course	NN
cord-005453-4057qib7	10338	4	and	and	CC
cord-005453-4057qib7	10338	5	laboratory	laboratory	NN
cord-005453-4057qib7	10338	6	results	result	NNS
cord-005453-4057qib7	10338	7	were	be	VBD
cord-005453-4057qib7	10338	8	reviewed	review	VBN
cord-005453-4057qib7	10338	9	for	for	IN
cord-005453-4057qib7	10338	10	evidence	evidence	NN
cord-005453-4057qib7	10338	11	of	of	IN
cord-005453-4057qib7	10338	12	CMV	CMV	NNP
cord-005453-4057qib7	10338	13	reactivation	reactivation	NN
cord-005453-4057qib7	10338	14	and/or	and/or	CC
cord-005453-4057qib7	10338	15	CMV	CMV	NNP
cord-005453-4057qib7	10338	16	disease	disease	NN
cord-005453-4057qib7	10338	17	.	.	.
cord-005453-4057qib7	10339	1	We	-PRON-	PRP
cord-005453-4057qib7	10339	2	defined	define	VBD
cord-005453-4057qib7	10339	3	CMV	CMV	NNP
cord-005453-4057qib7	10339	4	infection	infection	NN
cord-005453-4057qib7	10339	5	as	as	IN
cord-005453-4057qib7	10339	6	detection	detection	NN
cord-005453-4057qib7	10339	7	of	of	IN
cord-005453-4057qib7	10339	8	CMV	CMV	NNP
cord-005453-4057qib7	10339	9	reactivation	reactivation	NN
cord-005453-4057qib7	10339	10	or	or	CC
cord-005453-4057qib7	10339	11	primary	primary	JJ
cord-005453-4057qib7	10339	12	infection	infection	NN
cord-005453-4057qib7	10339	13	by	by	IN
cord-005453-4057qib7	10339	14	antigenaemia	antigenaemia	NN
cord-005453-4057qib7	10339	15	or	or	CC
cord-005453-4057qib7	10339	16	polymerase	polymerase	NN
cord-005453-4057qib7	10339	17	chain	chain	NN
cord-005453-4057qib7	10339	18	reaction	reaction	NN
cord-005453-4057qib7	10339	19	(	(	-LRB-
cord-005453-4057qib7	10339	20	PCR	PCR	NNP
cord-005453-4057qib7	10339	21	)	)	-RRB-
cord-005453-4057qib7	10339	22	assays	assay	NNS
cord-005453-4057qib7	10339	23	,	,	,
cord-005453-4057qib7	10339	24	but	but	CC
cord-005453-4057qib7	10339	25	was	be	VBD
cord-005453-4057qib7	10339	26	not	not	RB
cord-005453-4057qib7	10339	27	accompanied	accompany	VBN
cord-005453-4057qib7	10339	28	by	by	IN
cord-005453-4057qib7	10339	29	signs	sign	NNS
cord-005453-4057qib7	10339	30	and/or	and/or	CC
cord-005453-4057qib7	10339	31	symptoms	symptom	NNS
cord-005453-4057qib7	10339	32	suggestive	suggestive	JJ
cord-005453-4057qib7	10339	33	of	of	IN
cord-005453-4057qib7	10339	34	a	a	DT
cord-005453-4057qib7	10339	35	systemic	systemic	JJ
cord-005453-4057qib7	10339	36	disease	disease	NN
cord-005453-4057qib7	10339	37	.	.	.
cord-005453-4057qib7	10340	1	CMV	CMV	NNP
cord-005453-4057qib7	10340	2	disease	disease	NN
cord-005453-4057qib7	10340	3	occurred	occur	VBD
cord-005453-4057qib7	10340	4	when	when	WRB
cord-005453-4057qib7	10340	5	CMV	CMV	NNP
cord-005453-4057qib7	10340	6	was	be	VBD
cord-005453-4057qib7	10340	7	isolated	isolate	VBN
cord-005453-4057qib7	10340	8	from	from	IN
cord-005453-4057qib7	10340	9	any	any	DT
cord-005453-4057qib7	10340	10	site	site	NN
cord-005453-4057qib7	10340	11	in	in	IN
cord-005453-4057qib7	10340	12	association	association	NN
cord-005453-4057qib7	10340	13	with	with	IN
cord-005453-4057qib7	10340	14	organspecific	organspecific	JJ
cord-005453-4057qib7	10340	15	signs	sign	NNS
cord-005453-4057qib7	10340	16	and/or	and/or	CC
cord-005453-4057qib7	10340	17	symptoms	symptom	NNS
cord-005453-4057qib7	10340	18	.	.	.
cord-005453-4057qib7	10341	1	Monitoring	monitor	VBG
cord-005453-4057qib7	10341	2	for	for	IN
cord-005453-4057qib7	10341	3	CMV	CMV	NNP
cord-005453-4057qib7	10341	4	infection	infection	NN
cord-005453-4057qib7	10341	5	commenced	commence	VBD
cord-005453-4057qib7	10341	6	upon	upon	IN
cord-005453-4057qib7	10341	7	engraftment	engraftment	NNP
cord-005453-4057qib7	10341	8	(	(	-LRB-
cord-005453-4057qib7	10341	9	approximately	approximately	RB
cord-005453-4057qib7	10341	10	Day	day	NN
cord-005453-4057qib7	10341	11	+14	+14	CD
cord-005453-4057qib7	10341	12	)	)	-RRB-
cord-005453-4057qib7	10341	13	.	.	.
cord-005453-4057qib7	10342	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	10342	2	blood	blood	NN
cord-005453-4057qib7	10342	3	samples	sample	NNS
cord-005453-4057qib7	10342	4	were	be	VBD
cord-005453-4057qib7	10342	5	sent	send	VBN
cord-005453-4057qib7	10342	6	twice	twice	RB
cord-005453-4057qib7	10342	7	a	a	DT
cord-005453-4057qib7	10342	8	week	week	NN
cord-005453-4057qib7	10342	9	for	for	IN
cord-005453-4057qib7	10342	10	CMV	CMV	NNP
cord-005453-4057qib7	10342	11	antigenaemia	antigenaemia	NN
cord-005453-4057qib7	10342	12	or	or	CC
cord-005453-4057qib7	10342	13	CMV	CMV	NNP
cord-005453-4057qib7	10342	14	quantitative	quantitative	JJ
cord-005453-4057qib7	10342	15	PCR	PCR	NNP
cord-005453-4057qib7	10342	16	.	.	.
cord-005453-4057qib7	10343	1	The	the	DT
cord-005453-4057qib7	10343	2	duration	duration	NN
cord-005453-4057qib7	10343	3	of	of	IN
cord-005453-4057qib7	10343	4	twice	twice	JJ
cord-005453-4057qib7	10343	5	weekly	weekly	JJ
cord-005453-4057qib7	10343	6	monitoring	monitoring	NN
cord-005453-4057qib7	10343	7	was	be	VBD
cord-005453-4057qib7	10343	8	at	at	IN
cord-005453-4057qib7	10343	9	least	least	JJS
cord-005453-4057qib7	10343	10	about	about	RB
cord-005453-4057qib7	10343	11	100	100	CD
cord-005453-4057qib7	10343	12	days	day	NNS
cord-005453-4057qib7	10343	13	.	.	.
cord-005453-4057qib7	10344	1	Longer	long	RBR
cord-005453-4057qib7	10344	2	monitoring	monitoring	NN
cord-005453-4057qib7	10344	3	was	be	VBD
cord-005453-4057qib7	10344	4	performed	perform	VBN
cord-005453-4057qib7	10344	5	in	in	IN
cord-005453-4057qib7	10344	6	patients	patient	NNS
cord-005453-4057qib7	10344	7	who	who	WP
cord-005453-4057qib7	10344	8	experienced	experience	VBD
cord-005453-4057qib7	10344	9	CMV	CMV	NNP
cord-005453-4057qib7	10344	10	infection	infection	NN
cord-005453-4057qib7	10344	11	after	after	IN
cord-005453-4057qib7	10344	12	HSCT	HSCT	NNP
cord-005453-4057qib7	10344	13	.	.	.
cord-005453-4057qib7	10345	1	Results	result	NNS
cord-005453-4057qib7	10345	2	:	:	:
cord-005453-4057qib7	10346	1	All	all	DT
cord-005453-4057qib7	10346	2	patients	patient	NNS
cord-005453-4057qib7	10346	3	received	receive	VBD
cord-005453-4057qib7	10346	4	graft	graft	NN
cord-005453-4057qib7	10346	5	-	-	HYPH
cord-005453-4057qib7	10346	6	versus	versus	IN
cord-005453-4057qib7	10346	7	-	-	HYPH
cord-005453-4057qib7	10346	8	host	host	NN
cord-005453-4057qib7	10346	9	-	-	HYPH
cord-005453-4057qib7	10346	10	disease	disease	NN
cord-005453-4057qib7	10346	11	(	(	-LRB-
cord-005453-4057qib7	10346	12	GVHD	GVHD	NNP
cord-005453-4057qib7	10346	13	)	)	-RRB-
cord-005453-4057qib7	10346	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10346	15	using	use	VBG
cord-005453-4057qib7	10346	16	Anti	Anti	NNP
cord-005453-4057qib7	10346	17	-	-	NNP
cord-005453-4057qib7	10346	18	Thymocyte	Thymocyte	NNP
cord-005453-4057qib7	10346	19	globulin	globulin	NN
cord-005453-4057qib7	10346	20	(	(	-LRB-
cord-005453-4057qib7	10346	21	ATG	ATG	NNP
cord-005453-4057qib7	10346	22	)	)	-RRB-
cord-005453-4057qib7	10346	23	at	at	IN
cord-005453-4057qib7	10346	24	4.5mg	4.5mg	CD
cord-005453-4057qib7	10346	25	/	/	SYM
cord-005453-4057qib7	10346	26	kg	kg	NNS
cord-005453-4057qib7	10346	27	in	in	IN
cord-005453-4057qib7	10346	28	addition	addition	NN
cord-005453-4057qib7	10346	29	to	to	IN
cord-005453-4057qib7	10346	30	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	10346	31	or	or	CC
cord-005453-4057qib7	10346	32	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	10346	33	.	.	.
cord-005453-4057qib7	10347	1	Among	among	IN
cord-005453-4057qib7	10347	2	the	the	DT
cord-005453-4057qib7	10347	3	entire	entire	JJ
cord-005453-4057qib7	10347	4	cohort	cohort	NN
cord-005453-4057qib7	10347	5	of	of	IN
cord-005453-4057qib7	10347	6	96	96	CD
cord-005453-4057qib7	10347	7	patients	patient	NNS
cord-005453-4057qib7	10347	8	,	,	,
cord-005453-4057qib7	10347	9	72	72	CD
cord-005453-4057qib7	10347	10	(	(	-LRB-
cord-005453-4057qib7	10347	11	75	75	CD
cord-005453-4057qib7	10347	12	%	%	NN
cord-005453-4057qib7	10347	13	)	)	-RRB-
cord-005453-4057qib7	10347	14	had	have	VBD
cord-005453-4057qib7	10347	15	CMV	CMV	NNP
cord-005453-4057qib7	10347	16	infection	infection	NN
cord-005453-4057qib7	10347	17	,	,	,
cord-005453-4057qib7	10347	18	including	include	VBG
cord-005453-4057qib7	10347	19	23	23	CD
cord-005453-4057qib7	10347	20	(	(	-LRB-
cord-005453-4057qib7	10347	21	82.1	82.1	CD
cord-005453-4057qib7	10347	22	%	%	NN
cord-005453-4057qib7	10347	23	)	)	-RRB-
cord-005453-4057qib7	10347	24	out	out	IN
cord-005453-4057qib7	10347	25	of	of	IN
cord-005453-4057qib7	10347	26	28	28	CD
cord-005453-4057qib7	10347	27	patients	patient	NNS
cord-005453-4057qib7	10347	28	from	from	IN
cord-005453-4057qib7	10347	29	the	the	DT
cord-005453-4057qib7	10347	30	D	d	NN
cord-005453-4057qib7	10347	31	-	-	HYPH
cord-005453-4057qib7	10347	32	R+	r+	NN
cord-005453-4057qib7	10347	33	group	group	NN
cord-005453-4057qib7	10347	34	and	and	CC
cord-005453-4057qib7	10347	35	49	49	CD
cord-005453-4057qib7	10347	36	(	(	-LRB-
cord-005453-4057qib7	10347	37	72	72	CD
cord-005453-4057qib7	10347	38	%	%	NN
cord-005453-4057qib7	10347	39	)	)	-RRB-
cord-005453-4057qib7	10347	40	out	out	IN
cord-005453-4057qib7	10347	41	of	of	IN
cord-005453-4057qib7	10347	42	68	68	CD
cord-005453-4057qib7	10347	43	patients	patient	NNS
cord-005453-4057qib7	10347	44	from	from	IN
cord-005453-4057qib7	10347	45	the	the	DT
cord-005453-4057qib7	10347	46	D+R	D+R	NNP
cord-005453-4057qib7	10347	47	+	+	CC
cord-005453-4057qib7	10347	48	group	group	NN
cord-005453-4057qib7	10347	49	.	.	.
cord-005453-4057qib7	10348	1	16	16	CD
cord-005453-4057qib7	10348	2	patients	patient	NNS
cord-005453-4057qib7	10348	3	(	(	-LRB-
cord-005453-4057qib7	10348	4	57.1	57.1	CD
cord-005453-4057qib7	10348	5	%	%	NN
cord-005453-4057qib7	10348	6	)	)	-RRB-
cord-005453-4057qib7	10348	7	from	from	IN
cord-005453-4057qib7	10348	8	the	the	DT
cord-005453-4057qib7	10348	9	D	d	NN
cord-005453-4057qib7	10348	10	-	-	HYPH
cord-005453-4057qib7	10348	11	R+	r+	NN
cord-005453-4057qib7	10348	12	group	group	NN
cord-005453-4057qib7	10348	13	and	and	CC
cord-005453-4057qib7	10348	14	19	19	CD
cord-005453-4057qib7	10348	15	patients	patient	NNS
cord-005453-4057qib7	10348	16	(	(	-LRB-
cord-005453-4057qib7	10348	17	27.5	27.5	CD
cord-005453-4057qib7	10348	18	%	%	NN
cord-005453-4057qib7	10348	19	)	)	-RRB-
cord-005453-4057qib7	10348	20	from	from	IN
cord-005453-4057qib7	10348	21	the	the	DT
cord-005453-4057qib7	10348	22	D+R+	D+R+	NNP
cord-005453-4057qib7	10348	23	group	group	NN
cord-005453-4057qib7	10348	24	had	have	VBD
cord-005453-4057qib7	10348	25	≧2	≧2	NNS
cord-005453-4057qib7	10349	1	CMV	CMV	NNP
cord-005453-4057qib7	10349	2	reactivation	reactivation	NN
cord-005453-4057qib7	10349	3	above	above	IN
cord-005453-4057qib7	10349	4	the	the	DT
cord-005453-4057qib7	10349	5	threshold	threshold	NN
cord-005453-4057qib7	10349	6	for	for	IN
cord-005453-4057qib7	10349	7	preemptive	preemptive	JJ
cord-005453-4057qib7	10349	8	therapy	therapy	NN
cord-005453-4057qib7	10349	9	respectively	respectively	RB
cord-005453-4057qib7	10349	10	;	;	:
cord-005453-4057qib7	10349	11	p=0.007	p=0.007	VB
cord-005453-4057qib7	10349	12	.	.	.
cord-005453-4057qib7	10350	1	11	11	CD
cord-005453-4057qib7	10350	2	patients	patient	NNS
cord-005453-4057qib7	10350	3	developed	develop	VBD
cord-005453-4057qib7	10350	4	CMV	CMV	NNP
cord-005453-4057qib7	10350	5	disease	disease	NN
cord-005453-4057qib7	10350	6	,	,	,
cord-005453-4057qib7	10350	7	6	6	CD
cord-005453-4057qib7	10350	8	(	(	-LRB-
cord-005453-4057qib7	10350	9	21.4	21.4	CD
cord-005453-4057qib7	10350	10	%	%	NN
cord-005453-4057qib7	10350	11	)	)	-RRB-
cord-005453-4057qib7	10350	12	from	from	IN
cord-005453-4057qib7	10350	13	the	the	DT
cord-005453-4057qib7	10350	14	D	d	NN
cord-005453-4057qib7	10350	15	-	-	HYPH
cord-005453-4057qib7	10350	16	R+	r+	NN
cord-005453-4057qib7	10350	17	group	group	NN
cord-005453-4057qib7	10350	18	and	and	CC
cord-005453-4057qib7	10350	19	5	5	CD
cord-005453-4057qib7	10350	20	(	(	-LRB-
cord-005453-4057qib7	10350	21	7.4	7.4	CD
cord-005453-4057qib7	10350	22	%	%	NN
cord-005453-4057qib7	10350	23	)	)	-RRB-
cord-005453-4057qib7	10350	24	from	from	IN
cord-005453-4057qib7	10350	25	the	the	DT
cord-005453-4057qib7	10350	26	D	d	NN
cord-005453-4057qib7	10350	27	+	+	CC
cord-005453-4057qib7	10350	28	R+	r+	NN
cord-005453-4057qib7	10350	29	group	group	NN
cord-005453-4057qib7	10350	30	.	.	.
cord-005453-4057qib7	10351	1	CMV	CMV	NNP
cord-005453-4057qib7	10351	2	resistance	resistance	NN
cord-005453-4057qib7	10351	3	to	to	IN
cord-005453-4057qib7	10351	4	both	both	DT
cord-005453-4057qib7	10351	5	foscarnet	foscarnet	VB
cord-005453-4057qib7	10351	6	and	and	CC
cord-005453-4057qib7	10351	7	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	10351	8	was	be	VBD
cord-005453-4057qib7	10351	9	detected	detect	VBN
cord-005453-4057qib7	10351	10	in	in	IN
cord-005453-4057qib7	10351	11	3	3	CD
cord-005453-4057qib7	10351	12	patients	patient	NNS
cord-005453-4057qib7	10351	13	(	(	-LRB-
cord-005453-4057qib7	10351	14	10.7	10.7	CD
cord-005453-4057qib7	10351	15	%	%	NN
cord-005453-4057qib7	10351	16	)	)	-RRB-
cord-005453-4057qib7	10351	17	from	from	IN
cord-005453-4057qib7	10351	18	the	the	DT
cord-005453-4057qib7	10351	19	D	d	NN
cord-005453-4057qib7	10351	20	-	-	HYPH
cord-005453-4057qib7	10351	21	R+	r+	NN
cord-005453-4057qib7	10351	22	group	group	NN
cord-005453-4057qib7	10351	23	but	but	CC
cord-005453-4057qib7	10351	24	none	none	NN
cord-005453-4057qib7	10351	25	from	from	IN
cord-005453-4057qib7	10351	26	the	the	DT
cord-005453-4057qib7	10351	27	D+R+	D+R+	NNP
cord-005453-4057qib7	10351	28	group	group	NN
cord-005453-4057qib7	10351	29	.	.	.
cord-005453-4057qib7	10352	1	2	2	CD
cord-005453-4057qib7	10352	2	patients	patient	NNS
cord-005453-4057qib7	10352	3	died	die	VBD
cord-005453-4057qib7	10352	4	due	due	IN
cord-005453-4057qib7	10352	5	to	to	IN
cord-005453-4057qib7	10352	6	CMV	CMV	NNP
cord-005453-4057qib7	10352	7	disease	disease	NN
cord-005453-4057qib7	10352	8	,	,	,
cord-005453-4057qib7	10352	9	both	both	DT
cord-005453-4057qib7	10352	10	were	be	VBD
cord-005453-4057qib7	10352	11	from	from	IN
cord-005453-4057qib7	10352	12	D	d	NN
cord-005453-4057qib7	10352	13	-	-	HYPH
cord-005453-4057qib7	10352	14	R+	r+	NN
cord-005453-4057qib7	10352	15	group	group	NN
cord-005453-4057qib7	10352	16	.	.	.
cord-005453-4057qib7	10353	1	2	2	CD
cord-005453-4057qib7	10353	2	year	year	NN
cord-005453-4057qib7	10353	3	overall	overall	JJ
cord-005453-4057qib7	10353	4	survival	survival	NN
cord-005453-4057qib7	10353	5	(	(	-LRB-
cord-005453-4057qib7	10353	6	OS	OS	NNP
cord-005453-4057qib7	10353	7	)	)	-RRB-
cord-005453-4057qib7	10353	8	were	be	VBD
cord-005453-4057qib7	10353	9	60	60	CD
cord-005453-4057qib7	10353	10	%	%	NN
cord-005453-4057qib7	10353	11	versus	versus	IN
cord-005453-4057qib7	10353	12	55	55	CD
cord-005453-4057qib7	10353	13	%	%	NN
cord-005453-4057qib7	10353	14	for	for	IN
cord-005453-4057qib7	10353	15	D	d	NN
cord-005453-4057qib7	10353	16	-	-	HYPH
cord-005453-4057qib7	10353	17	R+	r+	NN
cord-005453-4057qib7	10353	18	group	group	NN
cord-005453-4057qib7	10353	19	and	and	CC
cord-005453-4057qib7	10353	20	D+R+	D+R+	NNP
cord-005453-4057qib7	10353	21	group	group	NN
cord-005453-4057qib7	10353	22	respectively	respectively	RB
cord-005453-4057qib7	10353	23	;	;	.
cord-005453-4057qib7	10354	1	p=0.706	p=0.706	NNP
cord-005453-4057qib7	10354	2	.	.	.
cord-005453-4057qib7	10355	1	Median	median	JJ
cord-005453-4057qib7	10355	2	survival	survival	NN
cord-005453-4057qib7	10355	3	was	be	VBD
cord-005453-4057qib7	10355	4	not	not	RB
cord-005453-4057qib7	10355	5	reached	reach	VBN
cord-005453-4057qib7	10355	6	at	at	IN
cord-005453-4057qib7	10355	7	2	2	CD
cord-005453-4057qib7	10355	8	years	year	NNS
cord-005453-4057qib7	10355	9	.	.	.
cord-005453-4057qib7	10356	1	2	2	CD
cord-005453-4057qib7	10356	2	year	year	NN
cord-005453-4057qib7	10356	3	non	non	JJ
cord-005453-4057qib7	10356	4	-	-	JJ
cord-005453-4057qib7	10356	5	relapse	relapse	JJ
cord-005453-4057qib7	10356	6	mortality	mortality	NN
cord-005453-4057qib7	10356	7	(	(	-LRB-
cord-005453-4057qib7	10356	8	NRM	NRM	NNP
cord-005453-4057qib7	10356	9	)	)	-RRB-
cord-005453-4057qib7	10356	10	were	be	VBD
cord-005453-4057qib7	10356	11	35	35	CD
cord-005453-4057qib7	10356	12	%	%	NN
cord-005453-4057qib7	10356	13	for	for	IN
cord-005453-4057qib7	10356	14	D	d	NN
cord-005453-4057qib7	10356	15	-	-	HYPH
cord-005453-4057qib7	10356	16	R+	r+	NN
cord-005453-4057qib7	10356	17	group	group	NN
cord-005453-4057qib7	10356	18	and	and	CC
cord-005453-4057qib7	10356	19	24	24	CD
cord-005453-4057qib7	10356	20	%	%	NN
cord-005453-4057qib7	10356	21	for	for	IN
cord-005453-4057qib7	10356	22	D	d	NN
cord-005453-4057qib7	10356	23	+	+	CC
cord-005453-4057qib7	10356	24	R+	r+	NN
cord-005453-4057qib7	10356	25	group	group	NN
cord-005453-4057qib7	10356	26	respectively	respectively	RB
cord-005453-4057qib7	10356	27	;	;	:
cord-005453-4057qib7	10356	28	p=0.37	p=0.37	NNP
cord-005453-4057qib7	10356	29	.	.	.
cord-005453-4057qib7	10357	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10357	2	:	:	:
cord-005453-4057qib7	10358	1	The	the	DT
cord-005453-4057qib7	10358	2	incidence	incidence	NN
cord-005453-4057qib7	10358	3	of	of	IN
cord-005453-4057qib7	10358	4	recurrent	recurrent	JJ
cord-005453-4057qib7	10358	5	CMV	CMV	NNP
cord-005453-4057qib7	10358	6	infection	infection	NN
cord-005453-4057qib7	10358	7	was	be	VBD
cord-005453-4057qib7	10358	8	higher	high	JJR
cord-005453-4057qib7	10358	9	in	in	IN
cord-005453-4057qib7	10358	10	the	the	DT
cord-005453-4057qib7	10358	11	D	d	NN
cord-005453-4057qib7	10358	12	-	-	HYPH
cord-005453-4057qib7	10358	13	R+	r+	NN
cord-005453-4057qib7	10358	14	group	group	NN
cord-005453-4057qib7	10358	15	compared	compare	VBN
cord-005453-4057qib7	10358	16	to	to	IN
cord-005453-4057qib7	10358	17	the	the	DT
cord-005453-4057qib7	10358	18	D+R+	D+R+	NNP
cord-005453-4057qib7	10358	19	group	group	NN
cord-005453-4057qib7	10358	20	.	.	.
cord-005453-4057qib7	10359	1	There	there	EX
cord-005453-4057qib7	10359	2	were	be	VBD
cord-005453-4057qib7	10359	3	no	no	DT
cord-005453-4057qib7	10359	4	statistically	statistically	RB
cord-005453-4057qib7	10359	5	significant	significant	JJ
cord-005453-4057qib7	10359	6	differences	difference	NNS
cord-005453-4057qib7	10359	7	between	between	IN
cord-005453-4057qib7	10359	8	the	the	DT
cord-005453-4057qib7	10359	9	2	2	CD
cord-005453-4057qib7	10359	10	groups	group	NNS
cord-005453-4057qib7	10359	11	in	in	IN
cord-005453-4057qib7	10359	12	terms	term	NNS
cord-005453-4057qib7	10359	13	of	of	IN
cord-005453-4057qib7	10359	14	OS	OS	NNP
cord-005453-4057qib7	10359	15	and	and	CC
cord-005453-4057qib7	10359	16	NRM	NRM	NNP
cord-005453-4057qib7	10359	17	.	.	.
cord-005453-4057qib7	10360	1	However	however	RB
cord-005453-4057qib7	10360	2	,	,	,
cord-005453-4057qib7	10360	3	there	there	EX
cord-005453-4057qib7	10360	4	was	be	VBD
cord-005453-4057qib7	10360	5	a	a	DT
cord-005453-4057qib7	10360	6	trend	trend	NN
cord-005453-4057qib7	10360	7	towards	towards	IN
cord-005453-4057qib7	10360	8	higher	high	JJR
cord-005453-4057qib7	10360	9	NRM	NRM	NNP
cord-005453-4057qib7	10360	10	in	in	IN
cord-005453-4057qib7	10360	11	the	the	DT
cord-005453-4057qib7	10360	12	D	d	NN
cord-005453-4057qib7	10360	13	-	-	HYPH
cord-005453-4057qib7	10360	14	R+	r+	NN
cord-005453-4057qib7	10360	15	group	group	NN
cord-005453-4057qib7	10360	16	compared	compare	VBN
cord-005453-4057qib7	10360	17	to	to	IN
cord-005453-4057qib7	10360	18	D+R+	D+R+	NNP
cord-005453-4057qib7	10360	19	group	group	NN
cord-005453-4057qib7	10360	20	.	.	.
cord-005453-4057qib7	10361	1	Our	-PRON-	PRP$
cord-005453-4057qib7	10361	2	findings	finding	NNS
cord-005453-4057qib7	10361	3	suggest	suggest	VBP
cord-005453-4057qib7	10361	4	that	that	IN
cord-005453-4057qib7	10361	5	for	for	IN
cord-005453-4057qib7	10361	6	matched	match	VBN
cord-005453-4057qib7	10361	7	unrelated	unrelated	JJ
cord-005453-4057qib7	10361	8	HSCT	HSCT	NNP
cord-005453-4057qib7	10361	9	,	,	,
cord-005453-4057qib7	10361	10	it	-PRON-	PRP
cord-005453-4057qib7	10361	11	may	may	MD
cord-005453-4057qib7	10361	12	still	still	RB
cord-005453-4057qib7	10361	13	be	be	VB
cord-005453-4057qib7	10361	14	important	important	JJ
cord-005453-4057qib7	10361	15	to	to	TO
cord-005453-4057qib7	10361	16	select	select	VB
cord-005453-4057qib7	10361	17	a	a	DT
cord-005453-4057qib7	10361	18	seropositive	seropositive	JJ
cord-005453-4057qib7	10361	19	donor	donor	NN
cord-005453-4057qib7	10361	20	for	for	IN
cord-005453-4057qib7	10361	21	a	a	DT
cord-005453-4057qib7	10361	22	seropositive	seropositive	JJ
cord-005453-4057qib7	10361	23	recipient	recipient	NN
cord-005453-4057qib7	10361	24	.	.	.
cord-005453-4057qib7	10362	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10362	2	:	:	:
cord-005453-4057qib7	10363	1	None	none	NN
cord-005453-4057qib7	10363	2	Background	background	NN
cord-005453-4057qib7	10363	3	:	:	:
cord-005453-4057qib7	10364	1	It´s	It´s	NNP
cord-005453-4057qib7	10364	2	known	know	VBD
cord-005453-4057qib7	10364	3	that	that	IN
cord-005453-4057qib7	10364	4	some	some	DT
cord-005453-4057qib7	10364	5	patients	patient	NNS
cord-005453-4057qib7	10364	6	submitted	submit	VBN
cord-005453-4057qib7	10364	7	to	to	IN
cord-005453-4057qib7	10364	8	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10364	9	stem	stem	NN
cord-005453-4057qib7	10364	10	cell	cell	NN
cord-005453-4057qib7	10364	11	transplantation	transplantation	NN
cord-005453-4057qib7	10364	12	(	(	-LRB-
cord-005453-4057qib7	10364	13	ASCT	ASCT	NNP
cord-005453-4057qib7	10364	14	)	)	-RRB-
cord-005453-4057qib7	10364	15	could	could	MD
cord-005453-4057qib7	10364	16	present	present	VB
cord-005453-4057qib7	10364	17	a	a	DT
cord-005453-4057qib7	10364	18	greater	great	JJR
cord-005453-4057qib7	10364	19	susceptibility	susceptibility	NN
cord-005453-4057qib7	10364	20	to	to	IN
cord-005453-4057qib7	10364	21	infection	infection	NN
cord-005453-4057qib7	10364	22	even	even	RB
cord-005453-4057qib7	10364	23	when	when	WRB
cord-005453-4057qib7	10364	24	they	-PRON-	PRP
cord-005453-4057qib7	10364	25	are	be	VBP
cord-005453-4057qib7	10364	26	in	in	IN
cord-005453-4057qib7	10364	27	long	long	JJ
cord-005453-4057qib7	10364	28	term	term	NN
cord-005453-4057qib7	10364	29	complete	complete	JJ
cord-005453-4057qib7	10364	30	remission	remission	NN
cord-005453-4057qib7	10364	31	or	or	CC
cord-005453-4057qib7	10364	32	potentially	potentially	RB
cord-005453-4057qib7	10364	33	cured	cure	VBN
cord-005453-4057qib7	10364	34	.	.	.
cord-005453-4057qib7	10365	1	This	this	DT
cord-005453-4057qib7	10365	2	fact	fact	NN
cord-005453-4057qib7	10365	3	is	be	VBZ
cord-005453-4057qib7	10365	4	related	relate	VBN
cord-005453-4057qib7	10365	5	to	to	IN
cord-005453-4057qib7	10365	6	the	the	DT
cord-005453-4057qib7	10365	7	dynamic	dynamic	JJ
cord-005453-4057qib7	10365	8	of	of	IN
cord-005453-4057qib7	10365	9	immunological	immunological	JJ
cord-005453-4057qib7	10365	10	recovery	recovery	NN
cord-005453-4057qib7	10365	11	that	that	WDT
cord-005453-4057qib7	10365	12	is	be	VBZ
cord-005453-4057qib7	10365	13	variable	variable	JJ
cord-005453-4057qib7	10365	14	in	in	IN
cord-005453-4057qib7	10365	15	every	every	DT
cord-005453-4057qib7	10365	16	single	single	JJ
cord-005453-4057qib7	10365	17	patients	patient	NNS
cord-005453-4057qib7	10365	18	and	and	CC
cord-005453-4057qib7	10365	19	it	-PRON-	PRP
cord-005453-4057qib7	10365	20	is	be	VBZ
cord-005453-4057qib7	10365	21	dependent	dependent	JJ
cord-005453-4057qib7	10365	22	from	from	IN
cord-005453-4057qib7	10365	23	many	many	JJ
cord-005453-4057qib7	10365	24	factors	factor	NNS
cord-005453-4057qib7	10365	25	:	:	:
cord-005453-4057qib7	10365	26	the	the	DT
cord-005453-4057qib7	10365	27	haematological	haematological	JJ
cord-005453-4057qib7	10365	28	disease	disease	NN
cord-005453-4057qib7	10365	29	,	,	,
cord-005453-4057qib7	10365	30	the	the	DT
cord-005453-4057qib7	10365	31	conditioning	conditioning	NN
cord-005453-4057qib7	10365	32	regimen	regimen	NN
cord-005453-4057qib7	10365	33	,	,	,
cord-005453-4057qib7	10365	34	the	the	DT
cord-005453-4057qib7	10365	35	age	age	NN
cord-005453-4057qib7	10365	36	of	of	IN
cord-005453-4057qib7	10365	37	patient	patient	NN
cord-005453-4057qib7	10365	38	and	and	CC
cord-005453-4057qib7	10365	39	donor	donor	NN
cord-005453-4057qib7	10365	40	,	,	,
cord-005453-4057qib7	10365	41	the	the	DT
cord-005453-4057qib7	10365	42	number	number	NN
cord-005453-4057qib7	10365	43	of	of	IN
cord-005453-4057qib7	10365	44	stem	stem	NN
cord-005453-4057qib7	10365	45	cell	cell	NN
cord-005453-4057qib7	10365	46	and	and	CC
cord-005453-4057qib7	10365	47	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	10365	48	infused	infuse	VBN
cord-005453-4057qib7	10365	49	,	,	,
cord-005453-4057qib7	10365	50	the	the	DT
cord-005453-4057qib7	10365	51	anti	anti	JJ
cord-005453-4057qib7	10365	52	-	-	JJ
cord-005453-4057qib7	10365	53	GvHD	gvhd	JJ
cord-005453-4057qib7	10365	54	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10365	55	,	,	,
cord-005453-4057qib7	10365	56	the	the	DT
cord-005453-4057qib7	10365	57	use	use	NN
cord-005453-4057qib7	10365	58	of	of	IN
cord-005453-4057qib7	10365	59	anti	anti	NNS
cord-005453-4057qib7	10365	60	-	-	NNS
cord-005453-4057qib7	10365	61	Thimoglobulins	Thimoglobulins	NNPS
cord-005453-4057qib7	10365	62	and	and	CC
cord-005453-4057qib7	10365	63	others	other	NNS
cord-005453-4057qib7	10365	64	.	.	.
cord-005453-4057qib7	10366	1	In	in	IN
cord-005453-4057qib7	10366	2	clinical	clinical	JJ
cord-005453-4057qib7	10366	3	practise	practise	NN
cord-005453-4057qib7	10366	4	we	-PRON-	PRP
cord-005453-4057qib7	10366	5	can	can	MD
cord-005453-4057qib7	10366	6	observe	observe	VB
cord-005453-4057qib7	10366	7	patients	patient	NNS
cord-005453-4057qib7	10366	8	who	who	WP
cord-005453-4057qib7	10366	9	are	be	VBP
cord-005453-4057qib7	10366	10	potentially	potentially	RB
cord-005453-4057qib7	10366	11	cured	cure	VBN
cord-005453-4057qib7	10366	12	,	,	,
cord-005453-4057qib7	10366	13	who	who	WP
cord-005453-4057qib7	10366	14	tapered	taper	VBD
cord-005453-4057qib7	10366	15	and	and	CC
cord-005453-4057qib7	10366	16	stopped	stop	VBD
cord-005453-4057qib7	10366	17	the	the	DT
cord-005453-4057qib7	10366	18	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	10366	19	treatment	treatment	NN
cord-005453-4057qib7	10366	20	months	month	NNS
cord-005453-4057qib7	10366	21	or	or	CC
cord-005453-4057qib7	10366	22	years	year	NNS
cord-005453-4057qib7	10366	23	ago	ago	RB
cord-005453-4057qib7	10366	24	and	and	CC
cord-005453-4057qib7	10366	25	who	who	WP
cord-005453-4057qib7	10366	26	are	be	VBP
cord-005453-4057qib7	10366	27	suddenly	suddenly	RB
cord-005453-4057qib7	10366	28	graved	grave	VBN
cord-005453-4057qib7	10366	29	from	from	IN
cord-005453-4057qib7	10366	30	opportunistic	opportunistic	JJ
cord-005453-4057qib7	10366	31	infections	infection	NNS
cord-005453-4057qib7	10366	32	.	.	.
cord-005453-4057qib7	10367	1	The	the	DT
cord-005453-4057qib7	10367	2	largest	large	JJS
cord-005453-4057qib7	10367	3	part	part	NN
cord-005453-4057qib7	10367	4	of	of	IN
cord-005453-4057qib7	10367	5	these	these	DT
cord-005453-4057qib7	10367	6	infections	infection	NNS
cord-005453-4057qib7	10367	7	is	be	VBZ
cord-005453-4057qib7	10367	8	represented	represent	VBN
cord-005453-4057qib7	10367	9	from	from	IN
cord-005453-4057qib7	10367	10	Varicella	varicella	NN
cord-005453-4057qib7	10367	11	-	-	HYPH
cord-005453-4057qib7	10367	12	Zoster	Zoster	NNP
cord-005453-4057qib7	10367	13	Virus	virus	NN
cord-005453-4057qib7	10367	14	(	(	-LRB-
cord-005453-4057qib7	10367	15	VZV	VZV	NNP
cord-005453-4057qib7	10367	16	)	)	-RRB-
cord-005453-4057qib7	10367	17	cutaneous	cutaneous	JJ
cord-005453-4057qib7	10367	18	eruption	eruption	NN
cord-005453-4057qib7	10367	19	.	.	.
cord-005453-4057qib7	10368	1	Methods	method	NNS
cord-005453-4057qib7	10368	2	:	:	:
cord-005453-4057qib7	10368	3	In	in	IN
cord-005453-4057qib7	10368	4	this	this	DT
cord-005453-4057qib7	10368	5	report	report	NN
cord-005453-4057qib7	10368	6	we	-PRON-	PRP
cord-005453-4057qib7	10368	7	retrospectively	retrospectively	RB
cord-005453-4057qib7	10368	8	analysed	analyse	VBD
cord-005453-4057qib7	10368	9	a	a	DT
cord-005453-4057qib7	10368	10	monocentric	monocentric	JJ
cord-005453-4057qib7	10368	11	cohort	cohort	NN
cord-005453-4057qib7	10368	12	of	of	IN
cord-005453-4057qib7	10368	13	38	38	CD
cord-005453-4057qib7	10368	14	patients	patient	NNS
cord-005453-4057qib7	10368	15	submitted	submit	VBN
cord-005453-4057qib7	10368	16	to	to	IN
cord-005453-4057qib7	10368	17	ASCT	ASCT	NNP
cord-005453-4057qib7	10368	18	for	for	IN
cord-005453-4057qib7	10368	19	haematological	haematological	JJ
cord-005453-4057qib7	10368	20	malignancies	malignancy	NNS
cord-005453-4057qib7	10368	21	from	from	IN
cord-005453-4057qib7	10368	22	a	a	DT
cord-005453-4057qib7	10368	23	median	median	JJ
cord-005453-4057qib7	10368	24	time	time	NN
cord-005453-4057qib7	10368	25	of	of	IN
cord-005453-4057qib7	10368	26	30	30	CD
cord-005453-4057qib7	10368	27	months	month	NNS
cord-005453-4057qib7	10368	28	.	.	.
cord-005453-4057qib7	10369	1	All	all	DT
cord-005453-4057qib7	10369	2	of	of	IN
cord-005453-4057qib7	10369	3	them	-PRON-	PRP
cord-005453-4057qib7	10369	4	were	be	VBD
cord-005453-4057qib7	10369	5	free	free	JJ
cord-005453-4057qib7	10369	6	of	of	IN
cord-005453-4057qib7	10369	7	disease	disease	NN
cord-005453-4057qib7	10369	8	.	.	.
cord-005453-4057qib7	10370	1	They	-PRON-	PRP
cord-005453-4057qib7	10370	2	stopped	stop	VBD
cord-005453-4057qib7	10370	3	the	the	DT
cord-005453-4057qib7	10370	4	immuno	immuno	JJ
cord-005453-4057qib7	10370	5	-	-	HYPH
cord-005453-4057qib7	10370	6	suppressive	suppressive	JJ
cord-005453-4057qib7	10370	7	treatment	treatment	NN
cord-005453-4057qib7	10370	8	in	in	IN
cord-005453-4057qib7	10370	9	a	a	DT
cord-005453-4057qib7	10370	10	median	median	JJ
cord-005453-4057qib7	10370	11	time	time	NN
cord-005453-4057qib7	10370	12	of	of	IN
cord-005453-4057qib7	10370	13	270	270	CD
cord-005453-4057qib7	10370	14	days	day	NNS
cord-005453-4057qib7	10370	15	after	after	IN
cord-005453-4057qib7	10370	16	ASCT	ASCT	NNP
cord-005453-4057qib7	10370	17	(	(	-LRB-
cord-005453-4057qib7	10370	18	range	range	NN
cord-005453-4057qib7	10370	19	:	:	:
cord-005453-4057qib7	10370	20	160	160	CD
cord-005453-4057qib7	10370	21	-	-	HYPH
cord-005453-4057qib7	10370	22	1642	1642	CD
cord-005453-4057qib7	10370	23	)	)	-RRB-
cord-005453-4057qib7	10370	24	and	and	CC
cord-005453-4057qib7	10370	25	did	do	VBD
cord-005453-4057qib7	10370	26	not	not	RB
cord-005453-4057qib7	10370	27	present	present	VB
cord-005453-4057qib7	10370	28	later	later	RBR
cord-005453-4057qib7	10370	29	chronic	chronic	JJ
cord-005453-4057qib7	10370	30	GvHD	gvhd	NN
cord-005453-4057qib7	10370	31	needing	need	VBG
cord-005453-4057qib7	10370	32	treatment	treatment	NN
cord-005453-4057qib7	10370	33	neither	neither	CC
cord-005453-4057qib7	10370	34	other	other	JJ
cord-005453-4057qib7	10370	35	moderate	moderate	JJ
cord-005453-4057qib7	10370	36	or	or	CC
cord-005453-4057qib7	10370	37	severe	severe	JJ
cord-005453-4057qib7	10370	38	chronic	chronic	JJ
cord-005453-4057qib7	10370	39	post	post	NN
cord-005453-4057qib7	10370	40	transplant	transplant	NN
cord-005453-4057qib7	10370	41	complications	complication	NNS
cord-005453-4057qib7	10370	42	nor	nor	CC
cord-005453-4057qib7	10370	43	other	other	JJ
cord-005453-4057qib7	10370	44	diseases	disease	NNS
cord-005453-4057qib7	10370	45	.	.	.
cord-005453-4057qib7	10371	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	10371	2	treatment	treatment	NN
cord-005453-4057qib7	10371	3	with	with	IN
cord-005453-4057qib7	10371	4	anti	anti	JJ
cord-005453-4057qib7	10371	5	viral	viral	JJ
cord-005453-4057qib7	10371	6	agents	agent	NNS
cord-005453-4057qib7	10371	7	(	(	-LRB-
cord-005453-4057qib7	10371	8	Acyclovir	Acyclovir	NNP
cord-005453-4057qib7	10371	9	or	or	CC
cord-005453-4057qib7	10371	10	Valacyclovir	Valacyclovir	NNP
cord-005453-4057qib7	10371	11	)	)	-RRB-
cord-005453-4057qib7	10371	12	has	have	VBZ
cord-005453-4057qib7	10371	13	been	be	VBN
cord-005453-4057qib7	10371	14	conducted	conduct	VBN
cord-005453-4057qib7	10371	15	simultaneously	simultaneously	RB
cord-005453-4057qib7	10371	16	to	to	IN
cord-005453-4057qib7	10371	17	immuno	immuno	JJ
cord-005453-4057qib7	10371	18	-	-	HYPH
cord-005453-4057qib7	10371	19	suppressive	suppressive	JJ
cord-005453-4057qib7	10371	20	treatment	treatment	NN
cord-005453-4057qib7	10371	21	and	and	CC
cord-005453-4057qib7	10371	22	for	for	IN
cord-005453-4057qib7	10371	23	a	a	DT
cord-005453-4057qib7	10371	24	period	period	NN
cord-005453-4057qib7	10371	25	ranging	range	VBG
cord-005453-4057qib7	10371	26	between	between	IN
cord-005453-4057qib7	10371	27	1	1	CD
cord-005453-4057qib7	10371	28	to	to	TO
cord-005453-4057qib7	10371	29	6	6	CD
cord-005453-4057qib7	10371	30	months	month	NNS
cord-005453-4057qib7	10371	31	after	after	IN
cord-005453-4057qib7	10371	32	its	-PRON-	PRP$
cord-005453-4057qib7	10371	33	suspension	suspension	NN
cord-005453-4057qib7	10371	34	.	.	.
cord-005453-4057qib7	10372	1	In	in	IN
cord-005453-4057qib7	10372	2	this	this	DT
cord-005453-4057qib7	10372	3	cohort	cohort	NN
cord-005453-4057qib7	10372	4	of	of	IN
cord-005453-4057qib7	10372	5	patients	patient	NNS
cord-005453-4057qib7	10372	6	we	-PRON-	PRP
cord-005453-4057qib7	10372	7	considered	consider	VBD
cord-005453-4057qib7	10372	8	the	the	DT
cord-005453-4057qib7	10372	9	incidence	incidence	NN
cord-005453-4057qib7	10372	10	of	of	IN
cord-005453-4057qib7	10372	11	VZV	VZV	NNP
cord-005453-4057qib7	10372	12	eruption	eruption	NN
cord-005453-4057qib7	10372	13	occurred	occur	VBD
cord-005453-4057qib7	10372	14	after	after	IN
cord-005453-4057qib7	10372	15	the	the	DT
cord-005453-4057qib7	10372	16	suspension	suspension	NN
cord-005453-4057qib7	10372	17	of	of	IN
cord-005453-4057qib7	10372	18	the	the	DT
cord-005453-4057qib7	10372	19	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	10372	20	treatment	treatment	NN
cord-005453-4057qib7	10372	21	,	,	,
cord-005453-4057qib7	10372	22	and	and	CC
cord-005453-4057qib7	10372	23	we	-PRON-	PRP
cord-005453-4057qib7	10372	24	analysed	analyse	VBD
cord-005453-4057qib7	10372	25	the	the	DT
cord-005453-4057qib7	10372	26	immunological	immunological	JJ
cord-005453-4057qib7	10372	27	recovery	recovery	NN
cord-005453-4057qib7	10372	28	in	in	IN
cord-005453-4057qib7	10372	29	terms	term	NNS
cord-005453-4057qib7	10372	30	of	of	IN
cord-005453-4057qib7	10372	31	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	10372	32	sub	sub	NN
cord-005453-4057qib7	10372	33	-	-	JJ
cord-005453-4057qib7	10372	34	population	population	NN
cord-005453-4057qib7	10372	35	after	after	IN
cord-005453-4057qib7	10372	36	6	6	CD
cord-005453-4057qib7	10372	37	,	,	,
cord-005453-4057qib7	10372	38	12	12	CD
cord-005453-4057qib7	10372	39	,	,	,
cord-005453-4057qib7	10372	40	18	18	CD
cord-005453-4057qib7	10372	41	and	and	CC
cord-005453-4057qib7	10372	42	24	24	CD
cord-005453-4057qib7	10372	43	months	month	NNS
cord-005453-4057qib7	10372	44	from	from	IN
cord-005453-4057qib7	10372	45	ASCT	ASCT	NNP
cord-005453-4057qib7	10372	46	.	.	.
cord-005453-4057qib7	10373	1	Results	result	NNS
cord-005453-4057qib7	10373	2	:	:	:
cord-005453-4057qib7	10374	1	Of	of	IN
cord-005453-4057qib7	10374	2	these	these	DT
cord-005453-4057qib7	10374	3	38	38	CD
cord-005453-4057qib7	10374	4	patients	patient	NNS
cord-005453-4057qib7	10374	5	considered	consider	VBN
cord-005453-4057qib7	10374	6	,	,	,
cord-005453-4057qib7	10374	7	10	10	CD
cord-005453-4057qib7	10374	8	developed	develop	VBD
cord-005453-4057qib7	10374	9	at	at	IN
cord-005453-4057qib7	10374	10	least	least	RBS
cord-005453-4057qib7	10374	11	one	one	CD
cord-005453-4057qib7	10374	12	VZV	VZV	NNP
cord-005453-4057qib7	10374	13	manifestation	manifestation	NN
cord-005453-4057qib7	10374	14	.	.	.
cord-005453-4057qib7	10375	1	All	all	PDT
cord-005453-4057qib7	10375	2	the	the	DT
cord-005453-4057qib7	10375	3	VZV	VZV	NNP
cord-005453-4057qib7	10375	4	presentation	presentation	NN
cord-005453-4057qib7	10375	5	were	be	VBD
cord-005453-4057qib7	10375	6	cutaneous	cutaneous	JJ
cord-005453-4057qib7	10375	7	,	,	,
cord-005453-4057qib7	10375	8	we	-PRON-	PRP
cord-005453-4057qib7	10375	9	did	do	VBD
cord-005453-4057qib7	10375	10	not	not	RB
cord-005453-4057qib7	10375	11	observe	observe	VB
cord-005453-4057qib7	10375	12	neurological	neurological	JJ
cord-005453-4057qib7	10375	13	,	,	,
cord-005453-4057qib7	10375	14	ophthalmic	ophthalmic	JJ
cord-005453-4057qib7	10375	15	or	or	CC
cord-005453-4057qib7	10375	16	visceral	visceral	JJ
cord-005453-4057qib7	10375	17	presentation	presentation	NN
cord-005453-4057qib7	10375	18	.	.	.
cord-005453-4057qib7	10376	1	All	all	PDT
cord-005453-4057qib7	10376	2	the	the	DT
cord-005453-4057qib7	10376	3	VZV	VZV	NNP
cord-005453-4057qib7	10376	4	manifestation	manifestation	NN
cord-005453-4057qib7	10376	5	occurred	occur	VBD
cord-005453-4057qib7	10376	6	in	in	IN
cord-005453-4057qib7	10376	7	patients	patient	NNS
cord-005453-4057qib7	10376	8	who	who	WP
cord-005453-4057qib7	10376	9	ended	end	VBD
cord-005453-4057qib7	10376	10	the	the	DT
cord-005453-4057qib7	10376	11	anti	anti	JJ
cord-005453-4057qib7	10376	12	-	-	JJ
cord-005453-4057qib7	10376	13	viral	viral	JJ
cord-005453-4057qib7	10376	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10376	15	.	.	.
cord-005453-4057qib7	10377	1	Median	median	JJ
cord-005453-4057qib7	10377	2	time	time	NN
cord-005453-4057qib7	10377	3	of	of	IN
cord-005453-4057qib7	10377	4	presentation	presentation	NN
cord-005453-4057qib7	10377	5	was	be	VBD
cord-005453-4057qib7	10377	6	575	575	CD
cord-005453-4057qib7	10377	7	days	day	NNS
cord-005453-4057qib7	10377	8	after	after	IN
cord-005453-4057qib7	10377	9	ASCT	ASCT	NNP
cord-005453-4057qib7	10377	10	(	(	-LRB-
cord-005453-4057qib7	10377	11	range	range	NN
cord-005453-4057qib7	10377	12	:	:	:
cord-005453-4057qib7	10377	13	174	174	CD
cord-005453-4057qib7	10377	14	-	-	SYM
cord-005453-4057qib7	10377	15	1642	1642	CD
cord-005453-4057qib7	10377	16	)	)	-RRB-
cord-005453-4057qib7	10378	1	The	the	DT
cord-005453-4057qib7	10378	2	remaining	remain	VBG
cord-005453-4057qib7	10378	3	28	28	CD
cord-005453-4057qib7	10378	4	patients	patient	NNS
cord-005453-4057qib7	10378	5	did	do	VBD
cord-005453-4057qib7	10378	6	not	not	RB
cord-005453-4057qib7	10378	7	present	present	VB
cord-005453-4057qib7	10378	8	VZV	VZV	NNP
cord-005453-4057qib7	10378	9	manifestation	manifestation	NN
cord-005453-4057qib7	10378	10	nor	nor	CC
cord-005453-4057qib7	10378	11	other	other	JJ
cord-005453-4057qib7	10378	12	kind	kind	NN
cord-005453-4057qib7	10378	13	of	of	IN
cord-005453-4057qib7	10378	14	opportunistic	opportunistic	JJ
cord-005453-4057qib7	10378	15	infection	infection	NN
cord-005453-4057qib7	10378	16	despite	despite	IN
cord-005453-4057qib7	10378	17	the	the	DT
cord-005453-4057qib7	10378	18	absence	absence	NN
cord-005453-4057qib7	10378	19	of	of	IN
cord-005453-4057qib7	10378	20	anti	anti	JJ
cord-005453-4057qib7	10378	21	-	-	JJ
cord-005453-4057qib7	10378	22	viral	viral	JJ
cord-005453-4057qib7	10378	23	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10378	24	.	.	.
cord-005453-4057qib7	10379	1	The	the	DT
cord-005453-4057qib7	10379	2	analysis	analysis	NN
cord-005453-4057qib7	10379	3	of	of	IN
cord-005453-4057qib7	10379	4	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	10379	5	sub	sub	NN
cord-005453-4057qib7	10379	6	-	-	HYPH
cord-005453-4057qib7	10379	7	population	population	NN
cord-005453-4057qib7	10379	8	after	after	IN
cord-005453-4057qib7	10379	9	6	6	CD
cord-005453-4057qib7	10379	10	-	-	HYPH
cord-005453-4057qib7	10379	11	12	12	CD
cord-005453-4057qib7	10379	12	-	-	SYM
cord-005453-4057qib7	10379	13	18	18	CD
cord-005453-4057qib7	10379	14	and	and	CC
cord-005453-4057qib7	10379	15	24	24	CD
cord-005453-4057qib7	10379	16	months	month	NNS
cord-005453-4057qib7	10379	17	did	do	VBD
cord-005453-4057qib7	10379	18	not	not	RB
cord-005453-4057qib7	10379	19	show	show	VB
cord-005453-4057qib7	10379	20	a	a	DT
cord-005453-4057qib7	10379	21	significant	significant	JJ
cord-005453-4057qib7	10379	22	difference	difference	NN
cord-005453-4057qib7	10379	23	in	in	IN
cord-005453-4057qib7	10379	24	B	B	NNP
cord-005453-4057qib7	10379	25	,	,	,
cord-005453-4057qib7	10379	26	T	T	NNP
cord-005453-4057qib7	10379	27	,	,	,
cord-005453-4057qib7	10379	28	T4	T4	NNP
cord-005453-4057qib7	10379	29	,	,	,
cord-005453-4057qib7	10379	30	T8	T8	NNP
cord-005453-4057qib7	10379	31	and	and	CC
cord-005453-4057qib7	10379	32	NK	NK	NNP
cord-005453-4057qib7	10379	33	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	10379	34	in	in	IN
cord-005453-4057qib7	10379	35	the	the	DT
cord-005453-4057qib7	10379	36	different	different	JJ
cord-005453-4057qib7	10379	37	post	post	NN
cord-005453-4057qib7	10379	38	transplant	transplant	NN
cord-005453-4057qib7	10379	39	period	period	NN
cord-005453-4057qib7	10379	40	.	.	.
cord-005453-4057qib7	10380	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10380	2	:	:	:
cord-005453-4057qib7	10381	1	VZV	VZV	NNP
cord-005453-4057qib7	10381	2	reactivation	reactivation	NN
cord-005453-4057qib7	10381	3	seems	seem	VBZ
cord-005453-4057qib7	10381	4	not	not	RB
cord-005453-4057qib7	10381	5	to	to	TO
cord-005453-4057qib7	10381	6	be	be	VB
cord-005453-4057qib7	10381	7	correlated	correlate	VBN
cord-005453-4057qib7	10381	8	with	with	IN
cord-005453-4057qib7	10381	9	the	the	DT
cord-005453-4057qib7	10381	10	number	number	NN
cord-005453-4057qib7	10381	11	of	of	IN
cord-005453-4057qib7	10381	12	the	the	DT
cord-005453-4057qib7	10381	13	different	different	JJ
cord-005453-4057qib7	10381	14	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	10381	15	subpopulations	subpopulation	NNS
cord-005453-4057qib7	10381	16	in	in	IN
cord-005453-4057qib7	10381	17	the	the	DT
cord-005453-4057qib7	10381	18	post	post	JJ
cord-005453-4057qib7	10381	19	transplant	transplant	NN
cord-005453-4057qib7	10381	20	period	period	NN
cord-005453-4057qib7	10381	21	.	.	.
cord-005453-4057qib7	10382	1	Actually	actually	RB
cord-005453-4057qib7	10382	2	it	-PRON-	PRP
cord-005453-4057qib7	10382	3	is	be	VBZ
cord-005453-4057qib7	10382	4	not	not	RB
cord-005453-4057qib7	10382	5	possible	possible	JJ
cord-005453-4057qib7	10382	6	to	to	TO
cord-005453-4057qib7	10382	7	distinguish	distinguish	VB
cord-005453-4057qib7	10382	8	patients	patient	NNS
cord-005453-4057qib7	10382	9	more	more	RBR
cord-005453-4057qib7	10382	10	suitable	suitable	JJ
cord-005453-4057qib7	10382	11	of	of	IN
cord-005453-4057qib7	10382	12	VZV	VZV	NNP
cord-005453-4057qib7	10382	13	reactivation	reactivation	NN
cord-005453-4057qib7	10382	14	on	on	IN
cord-005453-4057qib7	10382	15	the	the	DT
cord-005453-4057qib7	10382	16	basis	basis	NN
cord-005453-4057qib7	10382	17	of	of	IN
cord-005453-4057qib7	10382	18	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	10382	19	sub	sub	NN
cord-005453-4057qib7	10382	20	-	-	HYPH
cord-005453-4057qib7	10382	21	populations	population	NNS
cord-005453-4057qib7	10382	22	analysis	analysis	NN
cord-005453-4057qib7	10382	23	,	,	,
cord-005453-4057qib7	10382	24	so	so	RB
cord-005453-4057qib7	10382	25	anti	anti	JJ
cord-005453-4057qib7	10382	26	-	-	JJ
cord-005453-4057qib7	10382	27	viral	viral	JJ
cord-005453-4057qib7	10382	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10382	29	should	should	MD
cord-005453-4057qib7	10382	30	be	be	VB
cord-005453-4057qib7	10382	31	prolonged	prolong	VBN
cord-005453-4057qib7	10382	32	for	for	IN
cord-005453-4057qib7	10382	33	a	a	DT
cord-005453-4057qib7	10382	34	medium	medium	JJ
cord-005453-4057qib7	10382	35	period	period	NN
cord-005453-4057qib7	10382	36	after	after	IN
cord-005453-4057qib7	10382	37	suspension	suspension	NN
cord-005453-4057qib7	10382	38	of	of	IN
cord-005453-4057qib7	10382	39	immuno	immuno	JJ
cord-005453-4057qib7	10382	40	-	-	JJ
cord-005453-4057qib7	10382	41	suppressive	suppressive	JJ
cord-005453-4057qib7	10382	42	drugs	drug	NNS
cord-005453-4057qib7	10382	43	.	.	.
cord-005453-4057qib7	10383	1	In	in	IN
cord-005453-4057qib7	10383	2	absence	absence	NN
cord-005453-4057qib7	10383	3	of	of	IN
cord-005453-4057qib7	10383	4	anti	anti	JJ
cord-005453-4057qib7	10383	5	viral	viral	JJ
cord-005453-4057qib7	10383	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10383	7	a	a	DT
cord-005453-4057qib7	10383	8	careful	careful	JJ
cord-005453-4057qib7	10383	9	clinical	clinical	JJ
cord-005453-4057qib7	10383	10	surveillance	surveillance	NN
cord-005453-4057qib7	10383	11	should	should	MD
cord-005453-4057qib7	10383	12	be	be	VB
cord-005453-4057qib7	10383	13	performed	perform	VBN
cord-005453-4057qib7	10383	14	in	in	IN
cord-005453-4057qib7	10383	15	order	order	NN
cord-005453-4057qib7	10383	16	to	to	TO
cord-005453-4057qib7	10383	17	treat	treat	VB
cord-005453-4057qib7	10383	18	early	early	JJ
cord-005453-4057qib7	10383	19	eventual	eventual	JJ
cord-005453-4057qib7	10383	20	VZV	VZV	NNP
cord-005453-4057qib7	10383	21	manifestations	manifestation	NNS
cord-005453-4057qib7	10383	22	.	.	.
cord-005453-4057qib7	10384	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10384	2	Background	background	NN
cord-005453-4057qib7	10384	3	:	:	:
cord-005453-4057qib7	10384	4	Infection	infection	NN
cord-005453-4057qib7	10384	5	and	and	CC
cord-005453-4057qib7	10384	6	disease	disease	NN
cord-005453-4057qib7	10384	7	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	10384	8	(	(	-LRB-
cord-005453-4057qib7	10384	9	CMV	CMV	NNP
cord-005453-4057qib7	10384	10	)	)	-RRB-
cord-005453-4057qib7	10384	11	are	be	VBP
cord-005453-4057qib7	10384	12	common	common	JJ
cord-005453-4057qib7	10384	13	problems	problem	NNS
cord-005453-4057qib7	10384	14	in	in	IN
cord-005453-4057qib7	10384	15	patients	patient	NNS
cord-005453-4057qib7	10384	16	undergoing	undergo	VBG
cord-005453-4057qib7	10384	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10384	18	stem	stem	NN
cord-005453-4057qib7	10384	19	cell	cell	NN
cord-005453-4057qib7	10384	20	transplantation	transplantation	NN
cord-005453-4057qib7	10384	21	(	(	-LRB-
cord-005453-4057qib7	10384	22	HSCT	HSCT	NNP
cord-005453-4057qib7	10384	23	)	)	-RRB-
cord-005453-4057qib7	10384	24	.	.	.
cord-005453-4057qib7	10385	1	CMV	CMV	NNP
cord-005453-4057qib7	10385	2	infection	infection	NN
cord-005453-4057qib7	10385	3	has	have	VBZ
cord-005453-4057qib7	10385	4	a	a	DT
cord-005453-4057qib7	10385	5	high	high	JJ
cord-005453-4057qib7	10385	6	overall	overall	JJ
cord-005453-4057qib7	10385	7	seroprevalence	seroprevalence	NN
cord-005453-4057qib7	10385	8	,	,	,
cord-005453-4057qib7	10385	9	therefore	therefore	RB
cord-005453-4057qib7	10385	10	,	,	,
cord-005453-4057qib7	10385	11	during	during	IN
cord-005453-4057qib7	10385	12	the	the	DT
cord-005453-4057qib7	10385	13	first	first	JJ
cord-005453-4057qib7	10385	14	100days	100days	CD
cord-005453-4057qib7	10385	15	post	post	NN
cord-005453-4057qib7	10385	16	-	-	JJ
cord-005453-4057qib7	10385	17	HSCT	HSCT	NNP
cord-005453-4057qib7	10385	18	,	,	,
cord-005453-4057qib7	10385	19	it	-PRON-	PRP
cord-005453-4057qib7	10385	20	is	be	VBZ
cord-005453-4057qib7	10385	21	important	important	JJ
cord-005453-4057qib7	10385	22	to	to	TO
cord-005453-4057qib7	10385	23	prevent	prevent	VB
cord-005453-4057qib7	10385	24	reactivation	reactivation	NN
cord-005453-4057qib7	10385	25	of	of	IN
cord-005453-4057qib7	10385	26	CMV	CMV	NNP
cord-005453-4057qib7	10385	27	.	.	.
cord-005453-4057qib7	10386	1	The	the	DT
cord-005453-4057qib7	10386	2	international	international	JJ
cord-005453-4057qib7	10386	3	clinical	clinical	JJ
cord-005453-4057qib7	10386	4	recommendation	recommendation	NN
cord-005453-4057qib7	10386	5	is	be	VBZ
cord-005453-4057qib7	10386	6	the	the	DT
cord-005453-4057qib7	10386	7	use	use	NN
cord-005453-4057qib7	10386	8	of	of	IN
cord-005453-4057qib7	10386	9	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	10386	10	as	as	IN
cord-005453-4057qib7	10386	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10386	12	in	in	IN
cord-005453-4057qib7	10386	13	HSCT	HSCT	NNP
cord-005453-4057qib7	10386	14	patients	patient	NNS
cord-005453-4057qib7	10386	15	;	;	:
cord-005453-4057qib7	10386	16	however	however	RB
cord-005453-4057qib7	10386	17	,	,	,
cord-005453-4057qib7	10386	18	the	the	DT
cord-005453-4057qib7	10386	19	cost	cost	NN
cord-005453-4057qib7	10386	20	of	of	IN
cord-005453-4057qib7	10386	21	this	this	DT
cord-005453-4057qib7	10386	22	treatment	treatment	NN
cord-005453-4057qib7	10386	23	is	be	VBZ
cord-005453-4057qib7	10386	24	not	not	RB
cord-005453-4057qib7	10386	25	accessible	accessible	JJ
cord-005453-4057qib7	10386	26	for	for	IN
cord-005453-4057qib7	10386	27	our	-PRON-	PRP$
cord-005453-4057qib7	10386	28	population	population	NN
cord-005453-4057qib7	10386	29	.	.	.
cord-005453-4057qib7	10387	1	In	in	IN
cord-005453-4057qib7	10387	2	this	this	DT
cord-005453-4057qib7	10387	3	respect	respect	NN
cord-005453-4057qib7	10387	4	it	-PRON-	PRP
cord-005453-4057qib7	10387	5	has	have	VBZ
cord-005453-4057qib7	10387	6	been	be	VBN
cord-005453-4057qib7	10387	7	used	use	VBN
cord-005453-4057qib7	10387	8	as	as	IN
cord-005453-4057qib7	10387	9	an	an	DT
cord-005453-4057qib7	10387	10	alternative	alternative	JJ
cord-005453-4057qib7	10387	11	Valganciclovir	Valganciclovir	NNPS
cord-005453-4057qib7	10387	12	because	because	IN
cord-005453-4057qib7	10387	13	of	of	IN
cord-005453-4057qib7	10387	14	its	-PRON-	PRP$
cord-005453-4057qib7	10387	15	lower	low	JJR
cord-005453-4057qib7	10387	16	cost	cost	NN
cord-005453-4057qib7	10387	17	and	and	CC
cord-005453-4057qib7	10387	18	oral	oral	JJ
cord-005453-4057qib7	10387	19	administration	administration	NN
cord-005453-4057qib7	10387	20	.	.	.
cord-005453-4057qib7	10388	1	Our	-PRON-	PRP$
cord-005453-4057qib7	10388	2	study´s	study´s	NNP
cord-005453-4057qib7	10388	3	aim	aim	NN
cord-005453-4057qib7	10388	4	was	be	VBD
cord-005453-4057qib7	10388	5	to	to	TO
cord-005453-4057qib7	10388	6	assess	assess	VB
cord-005453-4057qib7	10388	7	the	the	DT
cord-005453-4057qib7	10388	8	response	response	NN
cord-005453-4057qib7	10388	9	and	and	CC
cord-005453-4057qib7	10388	10	safety	safety	NN
cord-005453-4057qib7	10388	11	of	of	IN
cord-005453-4057qib7	10388	12	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	10388	13	in	in	IN
cord-005453-4057qib7	10388	14	comparison	comparison	NN
cord-005453-4057qib7	10388	15	with	with	IN
cord-005453-4057qib7	10388	16	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	10388	17	to	to	TO
cord-005453-4057qib7	10388	18	prevent	prevent	VB
cord-005453-4057qib7	10388	19	viremia	viremia	NN
cord-005453-4057qib7	10388	20	and	and	CC
cord-005453-4057qib7	10388	21	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	10388	22	disease	disease	NN
cord-005453-4057qib7	10388	23	in	in	IN
cord-005453-4057qib7	10388	24	patients	patient	NNS
cord-005453-4057qib7	10388	25	undergoing	undergo	VBG
cord-005453-4057qib7	10388	26	allogeneic	allogeneic	IN
cord-005453-4057qib7	10388	27	HSCT	HSCT	NNP
cord-005453-4057qib7	10388	28	Methods	Methods	NNPS
cord-005453-4057qib7	10388	29	:	:	:
cord-005453-4057qib7	10388	30	A	a	DT
cord-005453-4057qib7	10388	31	retrospective	retrospective	JJ
cord-005453-4057qib7	10388	32	study	study	NN
cord-005453-4057qib7	10388	33	was	be	VBD
cord-005453-4057qib7	10388	34	performed	perform	VBN
cord-005453-4057qib7	10388	35	on	on	IN
cord-005453-4057qib7	10388	36	patients	patient	NNS
cord-005453-4057qib7	10388	37	who	who	WP
cord-005453-4057qib7	10388	38	receive	receive	VBP
cord-005453-4057qib7	10388	39	an	an	DT
cord-005453-4057qib7	10388	40	HSCT	HSCT	NNP
cord-005453-4057qib7	10388	41	-	-	HYPH
cord-005453-4057qib7	10388	42	allo	allo	NN
cord-005453-4057qib7	10388	43	between	between	IN
cord-005453-4057qib7	10388	44	January	January	NNP
cord-005453-4057qib7	10388	45	2014	2014	CD
cord-005453-4057qib7	10388	46	and	and	CC
cord-005453-4057qib7	10388	47	August	August	NNP
cord-005453-4057qib7	10388	48	2018	2018	CD
cord-005453-4057qib7	10388	49	.	.	.
cord-005453-4057qib7	10389	1	Participants	participant	NNS
cord-005453-4057qib7	10389	2	were	be	VBD
cord-005453-4057qib7	10389	3	enrolled	enrol	VBN
cord-005453-4057qib7	10389	4	in	in	IN
cord-005453-4057qib7	10389	5	two	two	CD
cord-005453-4057qib7	10389	6	groups	group	NNS
cord-005453-4057qib7	10389	7	according	accord	VBG
cord-005453-4057qib7	10389	8	to	to	IN
cord-005453-4057qib7	10389	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10389	10	treatment	treatment	NN
cord-005453-4057qib7	10389	11	:	:	:
cord-005453-4057qib7	10390	1	(	(	-LRB-
cord-005453-4057qib7	10390	2	a	a	LS
cord-005453-4057qib7	10390	3	)	)	-RRB-
cord-005453-4057qib7	10390	4	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	10390	5	5mg/	5mg/	CD
cord-005453-4057qib7	10391	1	k	k	NNP
cord-005453-4057qib7	10392	1	once	once	RB
cord-005453-4057qib7	10392	2	daily	daily	RB
cord-005453-4057qib7	10392	3	and	and	CC
cord-005453-4057qib7	10392	4	(	(	-LRB-
cord-005453-4057qib7	10392	5	b	b	NN
cord-005453-4057qib7	10392	6	)	)	-RRB-
cord-005453-4057qib7	10392	7	valganciclovir	valganciclovir	VBZ
cord-005453-4057qib7	10392	8	450	450	CD
cord-005453-4057qib7	10392	9	mg	mg	NNS
cord-005453-4057qib7	10392	10	twice	twice	RB
cord-005453-4057qib7	10392	11	daily	daily	RB
cord-005453-4057qib7	10392	12	for	for	IN
cord-005453-4057qib7	10392	13	7	7	CD
cord-005453-4057qib7	10392	14	days	day	NNS
cord-005453-4057qib7	10392	15	pretransplant	pretransplant	NN
cord-005453-4057qib7	10392	16	,	,	,
cord-005453-4057qib7	10392	17	at	at	IN
cord-005453-4057qib7	10392	18	day	day	NN
cord-005453-4057qib7	10392	19	+100	+100	NNS
cord-005453-4057qib7	10392	20	;	;	:
cord-005453-4057qib7	10392	21	viremia	viremia	NNP
cord-005453-4057qib7	10392	22	was	be	VBD
cord-005453-4057qib7	10392	23	measured	measure	VBN
cord-005453-4057qib7	10392	24	by	by	IN
cord-005453-4057qib7	10392	25	PCR	PCR	NNP
cord-005453-4057qib7	10392	26	.	.	.
cord-005453-4057qib7	10393	1	Demographic	demographic	JJ
cord-005453-4057qib7	10393	2	and	and	CC
cord-005453-4057qib7	10393	3	clinical	clinical	JJ
cord-005453-4057qib7	10393	4	information	information	NN
cord-005453-4057qib7	10393	5	was	be	VBD
cord-005453-4057qib7	10393	6	collected	collect	VBN
cord-005453-4057qib7	10393	7	from	from	IN
cord-005453-4057qib7	10393	8	medical	medical	JJ
cord-005453-4057qib7	10393	9	records	record	NNS
cord-005453-4057qib7	10393	10	and	and	CC
cord-005453-4057qib7	10393	11	furthermore	furthermore	RB
cord-005453-4057qib7	10393	12	analyzed	analyze	VBN
cord-005453-4057qib7	10393	13	in	in	IN
cord-005453-4057qib7	10393	14	SPSS	SPSS	NNP
cord-005453-4057qib7	10393	15	v21	v21	NN
cord-005453-4057qib7	10393	16	.	.	.
cord-005453-4057qib7	10394	1	Results	result	NNS
cord-005453-4057qib7	10394	2	:	:	:
cord-005453-4057qib7	10394	3	Sixty	sixty	CD
cord-005453-4057qib7	10394	4	-	-	HYPH
cord-005453-4057qib7	10394	5	eight	eight	CD
cord-005453-4057qib7	10394	6	patients	patient	NNS
cord-005453-4057qib7	10394	7	were	be	VBD
cord-005453-4057qib7	10394	8	enrolled	enrol	VBN
cord-005453-4057qib7	10394	9	in	in	IN
cord-005453-4057qib7	10394	10	the	the	DT
cord-005453-4057qib7	10394	11	study	study	NN
cord-005453-4057qib7	10394	12	,	,	,
cord-005453-4057qib7	10394	13	54	54	CD
cord-005453-4057qib7	10394	14	%	%	NN
cord-005453-4057qib7	10394	15	male	male	NN
cord-005453-4057qib7	10394	16	,	,	,
cord-005453-4057qib7	10394	17	the	the	DT
cord-005453-4057qib7	10394	18	median	median	JJ
cord-005453-4057qib7	10394	19	age	age	NN
cord-005453-4057qib7	10394	20	was	be	VBD
cord-005453-4057qib7	10394	21	34	34	CD
cord-005453-4057qib7	10394	22	years	year	NNS
cord-005453-4057qib7	10394	23	(	(	-LRB-
cord-005453-4057qib7	10394	24	19	19	CD
cord-005453-4057qib7	10394	25	-	-	SYM
cord-005453-4057qib7	10394	26	61	61	CD
cord-005453-4057qib7	10394	27	)	)	-RRB-
cord-005453-4057qib7	10394	28	with	with	IN
cord-005453-4057qib7	10394	29	the	the	DT
cord-005453-4057qib7	10394	30	following	follow	VBG
cord-005453-4057qib7	10394	31	diagnoses	diagnosis	NNS
cord-005453-4057qib7	10395	1	:	:	:
cord-005453-4057qib7	10395	2	acute	acute	JJ
cord-005453-4057qib7	10395	3	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	10395	4	leukemia	leukemia	NN
cord-005453-4057qib7	10395	5	44	44	CD
cord-005453-4057qib7	10395	6	%	%	NN
cord-005453-4057qib7	10395	7	,	,	,
cord-005453-4057qib7	10395	8	acute	acute	JJ
cord-005453-4057qib7	10395	9	myeloblastic	myeloblastic	JJ
cord-005453-4057qib7	10395	10	leukemia	leukemia	NN
cord-005453-4057qib7	10395	11	26.5	26.5	CD
cord-005453-4057qib7	10395	12	%	%	NN
cord-005453-4057qib7	10395	13	,	,	,
cord-005453-4057qib7	10395	14	granulocytic	granulocytic	JJ
cord-005453-4057qib7	10395	15	chronic	chronic	JJ
cord-005453-4057qib7	10395	16	leukemia	leukemia	NN
cord-005453-4057qib7	10395	17	17.6	17.6	CD
cord-005453-4057qib7	10395	18	%	%	NN
cord-005453-4057qib7	10395	19	,	,	,
cord-005453-4057qib7	10395	20	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	10395	21	syndrome	syndrome	NN
cord-005453-4057qib7	10395	22	4.4	4.4	CD
cord-005453-4057qib7	10395	23	%	%	NN
cord-005453-4057qib7	10395	24	,	,	,
cord-005453-4057qib7	10395	25	dendritic	dendritic	JJ
cord-005453-4057qib7	10395	26	cell	cell	NN
cord-005453-4057qib7	10395	27	neoplasia	neoplasia	NN
cord-005453-4057qib7	10395	28	4.4	4.4	CD
cord-005453-4057qib7	10395	29	%	%	NN
cord-005453-4057qib7	10395	30	,	,	,
cord-005453-4057qib7	10395	31	and	and	CC
cord-005453-4057qib7	10395	32	aplastic	aplastic	JJ
cord-005453-4057qib7	10395	33	anemia	anemia	NN
cord-005453-4057qib7	10395	34	2.9	2.9	CD
cord-005453-4057qib7	10395	35	%	%	NN
cord-005453-4057qib7	10395	36	.	.	.
cord-005453-4057qib7	10396	1	Ninety	ninety	CD
cord-005453-4057qib7	10396	2	-	-	HYPH
cord-005453-4057qib7	10396	3	one	one	CD
cord-005453-4057qib7	10396	4	percet	percet	NNS
cord-005453-4057qib7	10396	5	of	of	IN
cord-005453-4057qib7	10396	6	the	the	DT
cord-005453-4057qib7	10396	7	patients	patient	NNS
cord-005453-4057qib7	10396	8	received	receive	VBD
cord-005453-4057qib7	10396	9	a	a	DT
cord-005453-4057qib7	10396	10	transplant	transplant	NN
cord-005453-4057qib7	10396	11	from	from	IN
cord-005453-4057qib7	10396	12	an	an	DT
cord-005453-4057qib7	10396	13	identical	identical	JJ
cord-005453-4057qib7	10396	14	HLA	HLA	NNP
cord-005453-4057qib7	10396	15	donor	donor	NN
cord-005453-4057qib7	10396	16	and	and	CC
cord-005453-4057qib7	10396	17	8.8	8.8	CD
cord-005453-4057qib7	10396	18	%	%	NN
cord-005453-4057qib7	10396	19	received	receive	VBD
cord-005453-4057qib7	10396	20	a	a	DT
cord-005453-4057qib7	10396	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10396	22	transplant	transplant	NN
cord-005453-4057qib7	10396	23	.	.	.
cord-005453-4057qib7	10397	1	Thirty	thirty	CD
cord-005453-4057qib7	10397	2	-	-	HYPH
cord-005453-4057qib7	10397	3	four	four	CD
cord-005453-4057qib7	10397	4	patients	patient	NNS
cord-005453-4057qib7	10397	5	received	receive	VBD
cord-005453-4057qib7	10397	6	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10397	7	(	(	-LRB-
cord-005453-4057qib7	10397	8	G1	G1	NNP
cord-005453-4057qib7	10397	9	)	)	-RRB-
cord-005453-4057qib7	10397	10	and	and	CC
cord-005453-4057qib7	10397	11	thirtyfour	thirtyfour	NNP
cord-005453-4057qib7	10397	12	Valganciclovir	Valganciclovir	NNP
cord-005453-4057qib7	10397	13	(	(	-LRB-
cord-005453-4057qib7	10397	14	G2	G2	NNP
cord-005453-4057qib7	10397	15	)	)	-RRB-
cord-005453-4057qib7	10397	16	.	.	.
cord-005453-4057qib7	10398	1	Median	median	JJ
cord-005453-4057qib7	10398	2	age	age	NN
cord-005453-4057qib7	10398	3	was	be	VBD
cord-005453-4057qib7	10398	4	39	39	CD
cord-005453-4057qib7	10398	5	vs28	vs28	NNP
cord-005453-4057qib7	10398	6	years	year	NNS
cord-005453-4057qib7	10398	7	(	(	-LRB-
cord-005453-4057qib7	10398	8	p=0.022	p=0.022	NNP
cord-005453-4057qib7	10398	9	)	)	-RRB-
cord-005453-4057qib7	10398	10	,	,	,
cord-005453-4057qib7	10398	11	intermediate	intermediate	JJ
cord-005453-4057qib7	10398	12	risk	risk	NN
cord-005453-4057qib7	10398	13	CMV	CMV	NNP
cord-005453-4057qib7	10398	14	85	85	CD
cord-005453-4057qib7	10398	15	%	%	NN
cord-005453-4057qib7	10398	16	vs	vs	IN
cord-005453-4057qib7	10398	17	76	76	CD
cord-005453-4057qib7	10398	18	(	(	-LRB-
cord-005453-4057qib7	10398	19	p=0.048	p=0.048	NNP
cord-005453-4057qib7	10398	20	)	)	-RRB-
cord-005453-4057qib7	10398	21	,	,	,
cord-005453-4057qib7	10398	22	associated	associate	VBN
cord-005453-4057qib7	10398	23	bacterial	bacterial	JJ
cord-005453-4057qib7	10398	24	infections	infection	NNS
cord-005453-4057qib7	10398	25	was	be	VBD
cord-005453-4057qib7	10398	26	15%vs	15%v	VBN
cord-005453-4057qib7	10398	27	32	32	CD
cord-005453-4057qib7	10398	28	%	%	NN
cord-005453-4057qib7	10398	29	(	(	-LRB-
cord-005453-4057qib7	10398	30	p=0.15	p=0.15	NNP
cord-005453-4057qib7	10398	31	)	)	-RRB-
cord-005453-4057qib7	10398	32	,	,	,
cord-005453-4057qib7	10398	33	and	and	CC
cord-005453-4057qib7	10398	34	fungal	fungal	JJ
cord-005453-4057qib7	10398	35	infections	infection	NNS
cord-005453-4057qib7	10398	36	6	6	CD
cord-005453-4057qib7	10398	37	%	%	NN
cord-005453-4057qib7	10398	38	vs9	vs9	NN
cord-005453-4057qib7	10398	39	%	%	NN
cord-005453-4057qib7	10398	40	respectively	respectively	RB
cord-005453-4057qib7	10398	41	(	(	-LRB-
cord-005453-4057qib7	10398	42	p=0.5	p=0.5	NNP
cord-005453-4057qib7	10398	43	)	)	-RRB-
cord-005453-4057qib7	10398	44	.	.	.
cord-005453-4057qib7	10399	1	The	the	DT
cord-005453-4057qib7	10399	2	reactivation	reactivation	NN
cord-005453-4057qib7	10399	3	by	by	IN
cord-005453-4057qib7	10399	4	CMV	CMV	NNP
cord-005453-4057qib7	10399	5	was	be	VBD
cord-005453-4057qib7	10399	6	presented	present	VBN
cord-005453-4057qib7	10399	7	in	in	IN
cord-005453-4057qib7	10399	8	21	21	CD
cord-005453-4057qib7	10399	9	%	%	NN
cord-005453-4057qib7	10399	10	vs	vs	IN
cord-005453-4057qib7	10399	11	15	15	CD
cord-005453-4057qib7	10399	12	%	%	NN
cord-005453-4057qib7	10399	13	respectively	respectively	RB
cord-005453-4057qib7	10399	14	(	(	-LRB-
cord-005453-4057qib7	10399	15	p=0.70	p=0.70	NN
cord-005453-4057qib7	10399	16	)	)	-RRB-
cord-005453-4057qib7	10399	17	.	.	.
cord-005453-4057qib7	10400	1	There	there	EX
cord-005453-4057qib7	10400	2	were	be	VBD
cord-005453-4057qib7	10400	3	no	no	DT
cord-005453-4057qib7	10400	4	significant	significant	JJ
cord-005453-4057qib7	10400	5	differences	difference	NNS
cord-005453-4057qib7	10400	6	in	in	IN
cord-005453-4057qib7	10400	7	fever	fever	NN
cord-005453-4057qib7	10400	8	,	,	,
cord-005453-4057qib7	10400	9	bacterial	bacterial	JJ
cord-005453-4057qib7	10400	10	isolation	isolation	NN
cord-005453-4057qib7	10400	11	,	,	,
cord-005453-4057qib7	10400	12	dysfunction	dysfunction	NN
cord-005453-4057qib7	10400	13	or	or	CC
cord-005453-4057qib7	10400	14	graft	graft	NN
cord-005453-4057qib7	10400	15	failure	failure	NN
cord-005453-4057qib7	10400	16	,	,	,
cord-005453-4057qib7	10400	17	presence	presence	NN
cord-005453-4057qib7	10400	18	and	and	CC
cord-005453-4057qib7	10400	19	degree	degree	NN
cord-005453-4057qib7	10400	20	of	of	IN
cord-005453-4057qib7	10400	21	acute	acute	JJ
cord-005453-4057qib7	10400	22	or	or	CC
cord-005453-4057qib7	10400	23	chronic	chronic	JJ
cord-005453-4057qib7	10400	24	GVHD	GVHD	NNP
cord-005453-4057qib7	10400	25	and	and	CC
cord-005453-4057qib7	10400	26	relapse	relapse	NN
cord-005453-4057qib7	10400	27	of	of	IN
cord-005453-4057qib7	10400	28	the	the	DT
cord-005453-4057qib7	10400	29	disease	disease	NN
cord-005453-4057qib7	10400	30	.	.	.
cord-005453-4057qib7	10401	1	The	the	DT
cord-005453-4057qib7	10401	2	most	most	RBS
cord-005453-4057qib7	10401	3	relevant	relevant	JJ
cord-005453-4057qib7	10401	4	characteristics	characteristic	NNS
cord-005453-4057qib7	10401	5	and	and	CC
cord-005453-4057qib7	10401	6	complications	complication	NNS
cord-005453-4057qib7	10401	7	are	be	VBP
cord-005453-4057qib7	10401	8	described	describe	VBN
cord-005453-4057qib7	10401	9	in	in	IN
cord-005453-4057qib7	10401	10	table	table	NN
cord-005453-4057qib7	10401	11	1	1	CD
cord-005453-4057qib7	10401	12	.	.	.
cord-005453-4057qib7	10402	1	Within	within	IN
cord-005453-4057qib7	10402	2	the	the	DT
cord-005453-4057qib7	10402	3	whole	whole	JJ
cord-005453-4057qib7	10402	4	group	group	NN
cord-005453-4057qib7	10402	5	there	there	EX
cord-005453-4057qib7	10402	6	were	be	VBD
cord-005453-4057qib7	10402	7	28	28	CD
cord-005453-4057qib7	10402	8	deaths	death	NNS
cord-005453-4057qib7	10402	9	,	,	,
cord-005453-4057qib7	10402	10	53	53	CD
cord-005453-4057qib7	10402	11	%	%	NN
cord-005453-4057qib7	10402	12	in	in	IN
cord-005453-4057qib7	10402	13	the	the	DT
cord-005453-4057qib7	10402	14	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10402	15	group	group	NN
cord-005453-4057qib7	10402	16	and	and	CC
cord-005453-4057qib7	10402	17	32	32	CD
cord-005453-4057qib7	10402	18	%	%	NN
cord-005453-4057qib7	10402	19	in	in	IN
cord-005453-4057qib7	10402	20	Valganciclovir	Valganciclovir	NNP
cord-005453-4057qib7	10402	21	group	group	NN
cord-005453-4057qib7	10402	22	(	(	-LRB-
cord-005453-4057qib7	10402	23	p=0.14	p=0.14	NNP
cord-005453-4057qib7	10402	24	)	)	-RRB-
cord-005453-4057qib7	10402	25	,	,	,
cord-005453-4057qib7	10402	26	overall	overall	JJ
cord-005453-4057qib7	10402	27	survival	survival	NN
cord-005453-4057qib7	10402	28	1-year	1-year	CD
cord-005453-4057qib7	10402	29	was	be	VBD
cord-005453-4057qib7	10402	30	66	66	CD
cord-005453-4057qib7	10402	31	%	%	NN
cord-005453-4057qib7	10402	32	vs	vs	IN
cord-005453-4057qib7	10402	33	80	80	CD
cord-005453-4057qib7	10402	34	%	%	NN
cord-005453-4057qib7	10403	1	(	(	-LRB-
cord-005453-4057qib7	10403	2	p=0.58	p=0.58	JJ
cord-005453-4057qib7	10403	3	)	)	-RRB-
cord-005453-4057qib7	10403	4	respectively	respectively	RB
cord-005453-4057qib7	10404	1	;	;	:
cord-005453-4057qib7	10404	2	in	in	IN
cord-005453-4057qib7	10404	3	both	both	DT
cord-005453-4057qib7	10404	4	groups	group	NNS
cord-005453-4057qib7	10404	5	72	72	CD
cord-005453-4057qib7	10404	6	%	%	NN
cord-005453-4057qib7	10404	7	was	be	VBD
cord-005453-4057qib7	10404	8	associated	associate	VBN
cord-005453-4057qib7	10404	9	with	with	IN
cord-005453-4057qib7	10404	10	relapse	relapse	NN
cord-005453-4057qib7	10404	11	and	and	CC
cord-005453-4057qib7	10404	12	28	28	CD
cord-005453-4057qib7	10404	13	%	%	NN
cord-005453-4057qib7	10404	14	associated	associate	VBN
cord-005453-4057qib7	10404	15	with	with	IN
cord-005453-4057qib7	10404	16	transplantation	transplantation	NN
cord-005453-4057qib7	10404	17	.	.	.
cord-005453-4057qib7	10405	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10405	2	:	:	:
cord-005453-4057qib7	10406	1	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10406	2	and	and	CC
cord-005453-4057qib7	10406	3	Valganciclovir	Valganciclovir	NNPS
cord-005453-4057qib7	10406	4	were	be	VBD
cord-005453-4057qib7	10406	5	effective	effective	JJ
cord-005453-4057qib7	10406	6	in	in	IN
cord-005453-4057qib7	10406	7	preventing	prevent	VBG
cord-005453-4057qib7	10406	8	the	the	DT
cord-005453-4057qib7	10406	9	reactivation	reactivation	NN
cord-005453-4057qib7	10406	10	of	of	IN
cord-005453-4057qib7	10406	11	CMV	CMV	NNP
cord-005453-4057qib7	10406	12	,	,	,
cord-005453-4057qib7	10406	13	the	the	DT
cord-005453-4057qib7	10406	14	only	only	JJ
cord-005453-4057qib7	10406	15	statistically	statistically	RB
cord-005453-4057qib7	10406	16	significant	significant	JJ
cord-005453-4057qib7	10406	17	difference	difference	NN
cord-005453-4057qib7	10407	1	was	be	VBD
cord-005453-4057qib7	10407	2	that	that	IN
cord-005453-4057qib7	10407	3	the	the	DT
cord-005453-4057qib7	10407	4	presentation	presentation	NN
cord-005453-4057qib7	10407	5	of	of	IN
cord-005453-4057qib7	10407	6	the	the	DT
cord-005453-4057qib7	10407	7	disease	disease	NN
cord-005453-4057qib7	10407	8	appeared	appear	VBD
cord-005453-4057qib7	10407	9	earlier	early	RBR
cord-005453-4057qib7	10407	10	in	in	IN
cord-005453-4057qib7	10407	11	the	the	DT
cord-005453-4057qib7	10407	12	Valganciclovir	Valganciclovir	NNP
cord-005453-4057qib7	10407	13	group	group	NN
cord-005453-4057qib7	10407	14	.	.	.
cord-005453-4057qib7	10408	1	No	no	DT
cord-005453-4057qib7	10408	2	difference	difference	NN
cord-005453-4057qib7	10408	3	in	in	IN
cord-005453-4057qib7	10408	4	toxicity	toxicity	NN
cord-005453-4057qib7	10408	5	between	between	IN
cord-005453-4057qib7	10408	6	the	the	DT
cord-005453-4057qib7	10408	7	groups	group	NNS
cord-005453-4057qib7	10408	8	was	be	VBD
cord-005453-4057qib7	10408	9	identified	identify	VBN
cord-005453-4057qib7	10408	10	.	.	.
cord-005453-4057qib7	10409	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10409	2	:	:	:
cord-005453-4057qib7	10410	1	None	none	NN
cord-005453-4057qib7	10410	2	declared	declare	VBD
cord-005453-4057qib7	10410	3	Background	background	NN
cord-005453-4057qib7	10410	4	:	:	:
cord-005453-4057qib7	10411	1	Invasive	invasive	JJ
cord-005453-4057qib7	10411	2	pulmonary	pulmonary	JJ
cord-005453-4057qib7	10411	3	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	10411	4	(	(	-LRB-
cord-005453-4057qib7	10411	5	IPA	IPA	NNP
cord-005453-4057qib7	10411	6	)	)	-RRB-
cord-005453-4057qib7	10411	7	is	be	VBZ
cord-005453-4057qib7	10411	8	a	a	DT
cord-005453-4057qib7	10411	9	severe	severe	JJ
cord-005453-4057qib7	10411	10	and	and	CC
cord-005453-4057qib7	10411	11	serious	serious	JJ
cord-005453-4057qib7	10411	12	complication	complication	NN
cord-005453-4057qib7	10411	13	that	that	WDT
cord-005453-4057qib7	10411	14	occurs	occur	VBZ
cord-005453-4057qib7	10411	15	in	in	IN
cord-005453-4057qib7	10411	16	the	the	DT
cord-005453-4057qib7	10411	17	immediate	immediate	JJ
cord-005453-4057qib7	10411	18	post	post	JJ
cord-005453-4057qib7	10411	19	-	-	JJ
cord-005453-4057qib7	10411	20	transplant	transplant	JJ
cord-005453-4057qib7	10411	21	period	period	NN
cord-005453-4057qib7	10411	22	due	due	IN
cord-005453-4057qib7	10411	23	to	to	IN
cord-005453-4057qib7	10411	24	severe	severe	JJ
cord-005453-4057qib7	10411	25	neutropenia	neutropenia	NN
cord-005453-4057qib7	10411	26	or	or	CC
cord-005453-4057qib7	10411	27	late	late	RB
cord-005453-4057qib7	10411	28	usually	usually	RB
cord-005453-4057qib7	10411	29	following	follow	VBG
cord-005453-4057qib7	10411	30	prolonged	prolong	VBN
cord-005453-4057qib7	10411	31	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	10411	32	therapy	therapy	NN
cord-005453-4057qib7	10411	33	during	during	IN
cord-005453-4057qib7	10411	34	treatment	treatment	NN
cord-005453-4057qib7	10411	35	of	of	IN
cord-005453-4057qib7	10411	36	graft	graft	NN
cord-005453-4057qib7	10411	37	-	-	HYPH
cord-005453-4057qib7	10411	38	versus	versus	IN
cord-005453-4057qib7	10411	39	-	-	HYPH
cord-005453-4057qib7	10411	40	host	host	NN
cord-005453-4057qib7	10411	41	disease	disease	NN
cord-005453-4057qib7	10411	42	(	(	-LRB-
cord-005453-4057qib7	10411	43	GVHD	GVHD	NNP
cord-005453-4057qib7	10411	44	)	)	-RRB-
cord-005453-4057qib7	10411	45	.	.	.
cord-005453-4057qib7	10412	1	The	the	DT
cord-005453-4057qib7	10412	2	objective	objective	NN
cord-005453-4057qib7	10412	3	of	of	IN
cord-005453-4057qib7	10412	4	this	this	DT
cord-005453-4057qib7	10412	5	study	study	NN
cord-005453-4057qib7	10412	6	is	be	VBZ
cord-005453-4057qib7	10412	7	to	to	TO
cord-005453-4057qib7	10412	8	analyze	analyze	VB
cord-005453-4057qib7	10412	9	the	the	DT
cord-005453-4057qib7	10412	10	epidemiological	epidemiological	JJ
cord-005453-4057qib7	10412	11	,	,	,
cord-005453-4057qib7	10412	12	diagnostic	diagnostic	JJ
cord-005453-4057qib7	10412	13	and	and	CC
cord-005453-4057qib7	10412	14	evolutionary	evolutionary	JJ
cord-005453-4057qib7	10412	15	characteristics	characteristic	NNS
cord-005453-4057qib7	10412	16	of	of	IN
cord-005453-4057qib7	10412	17	this	this	DT
cord-005453-4057qib7	10412	18	major	major	JJ
cord-005453-4057qib7	10412	19	complication	complication	NN
cord-005453-4057qib7	10412	20	over	over	IN
cord-005453-4057qib7	10412	21	a	a	DT
cord-005453-4057qib7	10412	22	period	period	NN
cord-005453-4057qib7	10412	23	of	of	IN
cord-005453-4057qib7	10412	24	3	3	CD
cord-005453-4057qib7	10412	25	years	year	NNS
cord-005453-4057qib7	10412	26	.	.	.
cord-005453-4057qib7	10413	1	Methods	method	NNS
cord-005453-4057qib7	10413	2	:	:	:
cord-005453-4057qib7	10413	3	From	from	IN
cord-005453-4057qib7	10413	4	January	January	NNP
cord-005453-4057qib7	10413	5	2015	2015	CD
cord-005453-4057qib7	10413	6	to	to	IN
cord-005453-4057qib7	10413	7	December	December	NNP
cord-005453-4057qib7	10413	8	2017	2017	CD
cord-005453-4057qib7	10413	9	,	,	,
cord-005453-4057qib7	10413	10	392	392	CD
cord-005453-4057qib7	10413	11	patients	patient	NNS
cord-005453-4057qib7	10413	12	(	(	-LRB-
cord-005453-4057qib7	10413	13	pts	pts	NNP
cord-005453-4057qib7	10413	14	)	)	-RRB-
cord-005453-4057qib7	10413	15	received	receive	VBD
cord-005453-4057qib7	10413	16	an	an	DT
cord-005453-4057qib7	10413	17	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10413	18	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10413	19	stem	stem	NN
cord-005453-4057qib7	10413	20	cell	cell	NN
cord-005453-4057qib7	10413	21	transplantation	transplantation	NN
cord-005453-4057qib7	10413	22	(	(	-LRB-
cord-005453-4057qib7	10413	23	allo	allo	NNP
cord-005453-4057qib7	10413	24	HSCT	HSCT	NNP
cord-005453-4057qib7	10413	25	)	)	-RRB-
cord-005453-4057qib7	10413	26	for	for	IN
cord-005453-4057qib7	10413	27	malignant	malignant	JJ
cord-005453-4057qib7	10413	28	and	and	CC
cord-005453-4057qib7	10413	29	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	10413	30	haematological	haematological	JJ
cord-005453-4057qib7	10413	31	diseases	disease	NNS
cord-005453-4057qib7	10413	32	.	.	.
cord-005453-4057qib7	10414	1	During	during	IN
cord-005453-4057qib7	10414	2	the	the	DT
cord-005453-4057qib7	10414	3	transplant	transplant	NN
cord-005453-4057qib7	10414	4	procedure	procedure	NN
cord-005453-4057qib7	10414	5	,	,	,
cord-005453-4057qib7	10414	6	anti	anti	JJ
cord-005453-4057qib7	10414	7	-	-	JJ
cord-005453-4057qib7	10414	8	infectious	infectious	JJ
cord-005453-4057qib7	10414	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10414	10	consisted	consist	VBD
cord-005453-4057qib7	10414	11	of	of	IN
cord-005453-4057qib7	10414	12	pts	pts	NN
cord-005453-4057qib7	10414	13	isolation	isolation	NN
cord-005453-4057qib7	10414	14	,	,	,
cord-005453-4057qib7	10414	15	digestive	digestive	JJ
cord-005453-4057qib7	10414	16	decontamination	decontamination	NN
cord-005453-4057qib7	10414	17	,	,	,
cord-005453-4057qib7	10414	18	Fluconazole	Fluconazole	NNP
cord-005453-4057qib7	10414	19	and	and	CC
cord-005453-4057qib7	10414	20	Aciclovir	Aciclovir	NNP
cord-005453-4057qib7	10414	21	.	.	.
cord-005453-4057qib7	10415	1	Secondary	secondary	JJ
cord-005453-4057qib7	10415	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10415	3	done	do	VBN
cord-005453-4057qib7	10415	4	for	for	IN
cord-005453-4057qib7	10415	5	pts	pt	NNS
cord-005453-4057qib7	10415	6	with	with	IN
cord-005453-4057qib7	10415	7	prior	prior	JJ
cord-005453-4057qib7	10415	8	history	history	NN
cord-005453-4057qib7	10415	9	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	10415	10	.	.	.
cord-005453-4057qib7	10416	1	During	during	IN
cord-005453-4057qib7	10416	2	the	the	DT
cord-005453-4057qib7	10416	3	follow	follow	NN
cord-005453-4057qib7	10416	4	-	-	HYPH
cord-005453-4057qib7	10416	5	up	up	NN
cord-005453-4057qib7	10416	6	,	,	,
cord-005453-4057qib7	10416	7	a	a	DT
cord-005453-4057qib7	10416	8	standard	standard	JJ
cord-005453-4057qib7	10416	9	chest	chest	NN
cord-005453-4057qib7	10416	10	X	x	NN
cord-005453-4057qib7	10416	11	-	-	NN
cord-005453-4057qib7	10416	12	ray	ray	NN
cord-005453-4057qib7	10416	13	is	be	VBZ
cord-005453-4057qib7	10416	14	performed	perform	VBN
cord-005453-4057qib7	10416	15	systematically	systematically	RB
cord-005453-4057qib7	10416	16	at	at	IN
cord-005453-4057qib7	10416	17	each	each	DT
cord-005453-4057qib7	10416	18	control	control	NN
cord-005453-4057qib7	10416	19	or	or	CC
cord-005453-4057qib7	10416	20	in	in	IN
cord-005453-4057qib7	10416	21	case	case	NN
cord-005453-4057qib7	10416	22	of	of	IN
cord-005453-4057qib7	10416	23	clinical	clinical	JJ
cord-005453-4057qib7	10416	24	signs	sign	NNS
cord-005453-4057qib7	10416	25	a	a	DT
cord-005453-4057qib7	10416	26	thoracic	thoracic	JJ
cord-005453-4057qib7	10416	27	CT	ct	NN
cord-005453-4057qib7	10416	28	scan	scan	NN
cord-005453-4057qib7	10416	29	is	be	VBZ
cord-005453-4057qib7	10416	30	requested	request	VBN
cord-005453-4057qib7	10416	31	from	from	IN
cord-005453-4057qib7	10416	32	suspicion	suspicion	NN
cord-005453-4057qib7	10416	33	.	.	.
cord-005453-4057qib7	10417	1	The	the	DT
cord-005453-4057qib7	10417	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	10417	3	of	of	IN
cord-005453-4057qib7	10417	4	IPA	IPA	NNP
cord-005453-4057qib7	10417	5	is	be	VBZ
cord-005453-4057qib7	10417	6	made	make	VBN
cord-005453-4057qib7	10417	7	according	accord	VBG
cord-005453-4057qib7	10417	8	to	to	IN
cord-005453-4057qib7	10417	9	the	the	DT
cord-005453-4057qib7	10417	10	criteria	criterion	NNS
cord-005453-4057qib7	10417	11	of	of	IN
cord-005453-4057qib7	10417	12	the	the	DT
cord-005453-4057qib7	10417	13	EORTC	EORTC	NNP
cord-005453-4057qib7	10417	14	-	-	HYPH
cord-005453-4057qib7	10417	15	MSG	MSG	NNP
cord-005453-4057qib7	10417	16	based	base	VBN
cord-005453-4057qib7	10417	17	on	on	IN
cord-005453-4057qib7	10417	18	the	the	DT
cord-005453-4057qib7	10417	19	predisposing	predispose	VBG
cord-005453-4057qib7	10417	20	criteria	criterion	NNS
cord-005453-4057qib7	10417	21	of	of	IN
cord-005453-4057qib7	10417	22	the	the	DT
cord-005453-4057qib7	10417	23	host	host	NN
cord-005453-4057qib7	10417	24	and	and	CC
cord-005453-4057qib7	10417	25	clinico	clinico	NN
cord-005453-4057qib7	10417	26	-	-	HYPH
cord-005453-4057qib7	10417	27	radiological	radiological	JJ
cord-005453-4057qib7	10417	28	criteria	criterion	NNS
cord-005453-4057qib7	10417	29	(	(	-LRB-
cord-005453-4057qib7	10417	30	possible	possible	JJ
cord-005453-4057qib7	10417	31	infection	infection	NN
cord-005453-4057qib7	10417	32	)	)	-RRB-
cord-005453-4057qib7	10417	33	.	.	.
cord-005453-4057qib7	10418	1	Galactomannan	Galactomannan	NNP
cord-005453-4057qib7	10418	2	antigen	antigen	NN
cord-005453-4057qib7	10418	3	and	and	CC
cord-005453-4057qib7	10418	4	histopathology	histopathology	NN
cord-005453-4057qib7	10418	5	criteria	criterion	NNS
cord-005453-4057qib7	10418	6	are	be	VBP
cord-005453-4057qib7	10418	7	not	not	RB
cord-005453-4057qib7	10418	8	common	common	JJ
cord-005453-4057qib7	10418	9	practice	practice	NN
cord-005453-4057qib7	10418	10	.	.	.
cord-005453-4057qib7	10419	1	Results	result	NNS
cord-005453-4057qib7	10419	2	:	:	:
cord-005453-4057qib7	10420	1	A	a	DT
cord-005453-4057qib7	10420	2	total	total	NN
cord-005453-4057qib7	10420	3	of	of	IN
cord-005453-4057qib7	10420	4	29	29	CD
cord-005453-4057qib7	10420	5	IPA	IPA	NNP
cord-005453-4057qib7	10420	6	episodes	episode	NNS
cord-005453-4057qib7	10420	7	(	(	-LRB-
cord-005453-4057qib7	10420	8	7	7	CD
cord-005453-4057qib7	10420	9	%	%	NN
cord-005453-4057qib7	10420	10	)	)	-RRB-
cord-005453-4057qib7	10420	11	were	be	VBD
cord-005453-4057qib7	10420	12	identified	identify	VBN
cord-005453-4057qib7	10420	13	in	in	IN
cord-005453-4057qib7	10420	14	26	26	CD
cord-005453-4057qib7	10420	15	pts	pt	NNS
cord-005453-4057qib7	10420	16	(	(	-LRB-
cord-005453-4057qib7	10420	17	AML	AML	NNP
cord-005453-4057qib7	10420	18	:	:	:
cord-005453-4057qib7	10420	19	15	15	CD
cord-005453-4057qib7	10420	20	,	,	,
cord-005453-4057qib7	10420	21	AA	AA	NNP
cord-005453-4057qib7	10420	22	:	:	:
cord-005453-4057qib7	10420	23	5	5	CD
cord-005453-4057qib7	10420	24	,	,	,
cord-005453-4057qib7	10420	25	ALL	all	DT
cord-005453-4057qib7	10420	26	3	3	CD
cord-005453-4057qib7	10420	27	,	,	,
cord-005453-4057qib7	10420	28	CML	CML	NNP
cord-005453-4057qib7	10420	29	2	2	CD
cord-005453-4057qib7	10420	30	,	,	,
cord-005453-4057qib7	10420	31	MM	MM	NNP
cord-005453-4057qib7	10420	32	1	1	CD
cord-005453-4057qib7	10420	33	)	)	-RRB-
cord-005453-4057qib7	10420	34	of	of	IN
cord-005453-4057qib7	10420	35	median	median	JJ
cord-005453-4057qib7	10420	36	age	age	NN
cord-005453-4057qib7	10420	37	36	36	CD
cord-005453-4057qib7	10420	38	(	(	-LRB-
cord-005453-4057qib7	10420	39	8	8	CD
cord-005453-4057qib7	10420	40	-	-	SYM
cord-005453-4057qib7	10420	41	56	56	CD
cord-005453-4057qib7	10420	42	)	)	-RRB-
cord-005453-4057qib7	10420	43	,	,	,
cord-005453-4057qib7	10420	44	sex	sex	NN
cord-005453-4057qib7	10420	45	ratio	ratio	NN
cord-005453-4057qib7	10420	46	:	:	:
cord-005453-4057qib7	10420	47	0.44	0.44	CD
cord-005453-4057qib7	10420	48	.	.	.
cord-005453-4057qib7	10421	1	All	all	DT
cord-005453-4057qib7	10421	2	of	of	IN
cord-005453-4057qib7	10421	3	them	-PRON-	PRP
cord-005453-4057qib7	10421	4	had	have	VBD
cord-005453-4057qib7	10421	5	transplantation	transplantation	NN
cord-005453-4057qib7	10421	6	from	from	IN
cord-005453-4057qib7	10421	7	a	a	DT
cord-005453-4057qib7	10421	8	family	family	NN
cord-005453-4057qib7	10421	9	donor	donor	NN
cord-005453-4057qib7	10421	10	(	(	-LRB-
cord-005453-4057qib7	10421	11	geno	geno	NNP
cord-005453-4057qib7	10421	12	-	-	HYPH
cord-005453-4057qib7	10421	13	identical	identical	JJ
cord-005453-4057qib7	10421	14	:	:	:
cord-005453-4057qib7	10421	15	22	22	CD
cord-005453-4057qib7	10421	16	,	,	,
cord-005453-4057qib7	10421	17	haplo	haplo	NN
cord-005453-4057qib7	10421	18	-	-	HYPH
cord-005453-4057qib7	10421	19	identical	identical	JJ
cord-005453-4057qib7	10421	20	:	:	:
cord-005453-4057qib7	10421	21	4	4	LS
cord-005453-4057qib7	10421	22	)	)	-RRB-
cord-005453-4057qib7	10421	23	with	with	IN
cord-005453-4057qib7	10421	24	conditioning	conditioning	NN
cord-005453-4057qib7	10421	25	by	by	IN
cord-005453-4057qib7	10421	26	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10421	27	alone	alone	RB
cord-005453-4057qib7	10421	28	and	and	CC
cord-005453-4057qib7	10421	29	a	a	DT
cord-005453-4057qib7	10421	30	graft	graft	NN
cord-005453-4057qib7	10421	31	of	of	IN
cord-005453-4057qib7	10421	32	CSP	CSP	NNP
cord-005453-4057qib7	10421	33	(	(	-LRB-
cord-005453-4057qib7	10421	34	24	24	CD
cord-005453-4057qib7	10421	35	pts	pt	NNS
cord-005453-4057qib7	10421	36	)	)	-RRB-
cord-005453-4057qib7	10421	37	and	and	CC
cord-005453-4057qib7	10421	38	peripheral	peripheral	JJ
cord-005453-4057qib7	10421	39	stem	stem	NN
cord-005453-4057qib7	10421	40	cells	cell	NNS
cord-005453-4057qib7	10421	41	-	-	HYPH
cord-005453-4057qib7	10421	42	bone	bone	NN
cord-005453-4057qib7	10421	43	marrow	marrow	NN
cord-005453-4057qib7	10421	44	(	(	-LRB-
cord-005453-4057qib7	10421	45	2	2	CD
cord-005453-4057qib7	10421	46	pts	pts	CD
cord-005453-4057qib7	10421	47	)	)	-RRB-
cord-005453-4057qib7	10421	48	.	.	.
cord-005453-4057qib7	10422	1	All	all	DT
cord-005453-4057qib7	10422	2	pts	pts	NN
cord-005453-4057qib7	10422	3	had	have	VBD
cord-005453-4057qib7	10422	4	at	at	RB
cord-005453-4057qib7	10422	5	least	least	RBS
cord-005453-4057qib7	10422	6	one	one	CD
cord-005453-4057qib7	10422	7	predisposing	predispose	VBG
cord-005453-4057qib7	10422	8	risk	risk	NN
cord-005453-4057qib7	10422	9	factor	factor	NN
cord-005453-4057qib7	10422	10	:	:	:
cord-005453-4057qib7	10422	11	antecedent	antecedent	NN
cord-005453-4057qib7	10422	12	of	of	IN
cord-005453-4057qib7	10422	13	aspergillosis	aspergillosis	NNP
cord-005453-4057qib7	10422	14	(	(	-LRB-
cord-005453-4057qib7	10422	15	3	3	CD
cord-005453-4057qib7	10422	16	pts	pts	CD
cord-005453-4057qib7	10422	17	)	)	-RRB-
cord-005453-4057qib7	10422	18	,	,	,
cord-005453-4057qib7	10422	19	prolonged	prolong	VBN
cord-005453-4057qib7	10422	20	neutropenia	neutropenia	NN
cord-005453-4057qib7	10423	1	>	>	XX
cord-005453-4057qib7	10423	2	10	10	CD
cord-005453-4057qib7	10423	3	d	d	NN
cord-005453-4057qib7	10423	4	(	(	-LRB-
cord-005453-4057qib7	10423	5	5	5	CD
cord-005453-4057qib7	10423	6	pts	pts	CD
cord-005453-4057qib7	10423	7	)	)	-RRB-
cord-005453-4057qib7	10423	8	,	,	,
cord-005453-4057qib7	10423	9	acute	acute	JJ
cord-005453-4057qib7	10423	10	GVHD	GVHD	NNP
cord-005453-4057qib7	10423	11	(	(	-LRB-
cord-005453-4057qib7	10423	12	8	8	CD
cord-005453-4057qib7	10423	13	pts	pt	NNS
cord-005453-4057qib7	10423	14	)	)	-RRB-
cord-005453-4057qib7	10423	15	,	,	,
cord-005453-4057qib7	10423	16	chronic	chronic	JJ
cord-005453-4057qib7	10423	17	GVHD	GVHD	NNP
cord-005453-4057qib7	10423	18	(	(	-LRB-
cord-005453-4057qib7	10423	19	4	4	CD
cord-005453-4057qib7	10423	20	pts	pts	CD
cord-005453-4057qib7	10423	21	)	)	-RRB-
cord-005453-4057qib7	10423	22	,	,	,
cord-005453-4057qib7	10423	23	prolonged	prolong	VBN
cord-005453-4057qib7	10423	24	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	10423	25	therapy	therapy	NN
cord-005453-4057qib7	10423	26	≥	≥	CD
cord-005453-4057qib7	10423	27	0,3	0,3	CD
cord-005453-4057qib7	10424	1	mg	mg	NNP
cord-005453-4057qib7	10425	1	/kg	/kg	NFP
cord-005453-4057qib7	10425	2	/	/	SYM
cord-005453-4057qib7	10425	3	day	day	NN
cord-005453-4057qib7	10425	4	exceeding	exceed	VBG
cord-005453-4057qib7	10425	5	21	21	CD
cord-005453-4057qib7	10425	6	days	day	NNS
cord-005453-4057qib7	10425	7	(	(	-LRB-
cord-005453-4057qib7	10425	8	12	12	CD
cord-005453-4057qib7	10425	9	pts	pt	NNS
cord-005453-4057qib7	10425	10	)	)	-RRB-
cord-005453-4057qib7	10425	11	.	.	.
cord-005453-4057qib7	10426	1	The	the	DT
cord-005453-4057qib7	10426	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	10426	3	of	of	IN
cord-005453-4057qib7	10426	4	API	API	NNP
cord-005453-4057qib7	10426	5	was	be	VBD
cord-005453-4057qib7	10426	6	possible	possible	JJ
cord-005453-4057qib7	10426	7	on	on	IN
cord-005453-4057qib7	10426	8	average	average	JJ
cord-005453-4057qib7	10426	9	at	at	IN
cord-005453-4057qib7	10426	10	J172	J172	NNP
cord-005453-4057qib7	10426	11	(	(	-LRB-
cord-005453-4057qib7	10426	12	20	20	CD
cord-005453-4057qib7	10426	13	-	-	SYM
cord-005453-4057qib7	10426	14	930	930	CD
cord-005453-4057qib7	10426	15	)	)	-RRB-
cord-005453-4057qib7	10426	16	after	after	IN
cord-005453-4057qib7	10426	17	appearance	appearance	NN
cord-005453-4057qib7	10426	18	of	of	IN
cord-005453-4057qib7	10426	19	clinical	clinical	JJ
cord-005453-4057qib7	10426	20	signs	sign	NNS
cord-005453-4057qib7	10426	21	(	(	-LRB-
cord-005453-4057qib7	10426	22	in	in	IN
cord-005453-4057qib7	10426	23	all	all	DT
cord-005453-4057qib7	10426	24	cases	case	NNS
cord-005453-4057qib7	10426	25	)	)	-RRB-
cord-005453-4057qib7	10426	26	and	and	CC
cord-005453-4057qib7	10426	27	evocative	evocative	JJ
cord-005453-4057qib7	10426	28	radiological	radiological	JJ
cord-005453-4057qib7	10426	29	in	in	IN
cord-005453-4057qib7	10426	30	25	25	CD
cord-005453-4057qib7	10426	31	cases	case	NNS
cord-005453-4057qib7	10426	32	(	(	-LRB-
cord-005453-4057qib7	10426	33	in	in	IN
cord-005453-4057qib7	10426	34	4	4	CD
cord-005453-4057qib7	10426	35	cases	case	NNS
cord-005453-4057qib7	10426	36	,	,	,
cord-005453-4057qib7	10426	37	the	the	DT
cord-005453-4057qib7	10426	38	standard	standard	JJ
cord-005453-4057qib7	10426	39	chest	chest	NN
cord-005453-4057qib7	10426	40	x	x	NN
cord-005453-4057qib7	10426	41	-	-	NN
cord-005453-4057qib7	10426	42	ray	ray	NN
cord-005453-4057qib7	10426	43	was	be	VBD
cord-005453-4057qib7	10426	44	normal	normal	JJ
cord-005453-4057qib7	10426	45	)	)	-RRB-
cord-005453-4057qib7	10426	46	.	.	.
cord-005453-4057qib7	10427	1	At	at	IN
cord-005453-4057qib7	10427	2	the	the	DT
cord-005453-4057qib7	10427	3	time	time	NN
cord-005453-4057qib7	10427	4	of	of	IN
cord-005453-4057qib7	10427	5	thoracic	thoracic	JJ
cord-005453-4057qib7	10427	6	CT	CT	NNP
cord-005453-4057qib7	10427	7	scan	scan	NN
cord-005453-4057qib7	10427	8	,	,	,
cord-005453-4057qib7	10427	9	11	11	CD
cord-005453-4057qib7	10427	10	pts	pt	NNS
cord-005453-4057qib7	10427	11	(	(	-LRB-
cord-005453-4057qib7	10427	12	37	37	CD
cord-005453-4057qib7	10427	13	%	%	NN
cord-005453-4057qib7	10427	14	)	)	-RRB-
cord-005453-4057qib7	10427	15	had	have	VBD
cord-005453-4057qib7	10427	16	characteristic	characteristic	JJ
cord-005453-4057qib7	10427	17	signs	sign	NNS
cord-005453-4057qib7	10427	18	:	:	:
cord-005453-4057qib7	10427	19	halo	halo	NNP
cord-005453-4057qib7	10427	20	sign	sign	NN
cord-005453-4057qib7	10427	21	(	(	-LRB-
cord-005453-4057qib7	10427	22	6	6	CD
cord-005453-4057qib7	10427	23	pts	pts	CD
cord-005453-4057qib7	10427	24	)	)	-RRB-
cord-005453-4057qib7	10427	25	,	,	,
cord-005453-4057qib7	10427	26	crescent	crescent	NN
cord-005453-4057qib7	10427	27	sign	sign	NN
cord-005453-4057qib7	10427	28	(	(	-LRB-
cord-005453-4057qib7	10427	29	1	1	CD
cord-005453-4057qib7	10427	30	pt	pt	NN
cord-005453-4057qib7	10427	31	)	)	-RRB-
cord-005453-4057qib7	10427	32	and	and	CC
cord-005453-4057qib7	10427	33	cavity	cavity	NN
cord-005453-4057qib7	10427	34	(	(	-LRB-
cord-005453-4057qib7	10427	35	4	4	CD
cord-005453-4057qib7	10427	36	pts	pts	CD
cord-005453-4057qib7	10427	37	)	)	-RRB-
cord-005453-4057qib7	10427	38	.	.	.
cord-005453-4057qib7	10428	1	Other	other	JJ
cord-005453-4057qib7	10428	2	minor	minor	JJ
cord-005453-4057qib7	10428	3	radiological	radiological	JJ
cord-005453-4057qib7	10428	4	signs	sign	NNS
cord-005453-4057qib7	10428	5	are	be	VBP
cord-005453-4057qib7	10428	6	found	find	VBN
cord-005453-4057qib7	10428	7	in	in	IN
cord-005453-4057qib7	10428	8	the	the	DT
cord-005453-4057qib7	10428	9	other	other	JJ
cord-005453-4057qib7	10428	10	pts	pt	NNS
cord-005453-4057qib7	10428	11	.	.	.
cord-005453-4057qib7	10429	1	Empirical	empirical	JJ
cord-005453-4057qib7	10429	2	first	first	JJ
cord-005453-4057qib7	10429	3	-	-	HYPH
cord-005453-4057qib7	10429	4	line	line	NN
cord-005453-4057qib7	10429	5	antifungal	antifungal	JJ
cord-005453-4057qib7	10429	6	therapy	therapy	NN
cord-005453-4057qib7	10429	7	was	be	VBD
cord-005453-4057qib7	10429	8	started	start	VBN
cord-005453-4057qib7	10429	9	as	as	IN
cord-005453-4057qib7	10429	10	monotherapy	monotherapy	NN
cord-005453-4057qib7	10429	11	in	in	IN
cord-005453-4057qib7	10429	12	14	14	CD
cord-005453-4057qib7	10429	13	pts	pt	NNS
cord-005453-4057qib7	10429	14	(	(	-LRB-
cord-005453-4057qib7	10429	15	Voriconazole	Voriconazole	NNP
cord-005453-4057qib7	10429	16	:	:	:
cord-005453-4057qib7	10429	17	8	8	CD
cord-005453-4057qib7	10429	18	,	,	,
cord-005453-4057qib7	10429	19	Caspofungin	Caspofungin	NNP
cord-005453-4057qib7	10429	20	:	:	:
cord-005453-4057qib7	10429	21	6	6	CD
cord-005453-4057qib7	10429	22	pts	pts	CD
cord-005453-4057qib7	10429	23	)	)	-RRB-
cord-005453-4057qib7	10429	24	or	or	CC
cord-005453-4057qib7	10429	25	in	in	IN
cord-005453-4057qib7	10429	26	combination	combination	NN
cord-005453-4057qib7	10429	27	in	in	IN
cord-005453-4057qib7	10429	28	12	12	CD
cord-005453-4057qib7	10429	29	pts	pt	NNS
cord-005453-4057qib7	10429	30	.	.	.
cord-005453-4057qib7	10430	1	A	a	DT
cord-005453-4057qib7	10430	2	secondline	secondline	NN
cord-005453-4057qib7	10430	3	treatment	treatment	NN
cord-005453-4057qib7	10430	4	was	be	VBD
cord-005453-4057qib7	10430	5	required	require	VBN
cord-005453-4057qib7	10430	6	in	in	IN
cord-005453-4057qib7	10430	7	10	10	CD
cord-005453-4057qib7	10430	8	pts	pt	NNS
cord-005453-4057qib7	10430	9	for	for	IN
cord-005453-4057qib7	10430	10	failure	failure	NN
cord-005453-4057qib7	10430	11	after	after	IN
cord-005453-4057qib7	10430	12	an	an	DT
cord-005453-4057qib7	10430	13	average	average	JJ
cord-005453-4057qib7	10430	14	duration	duration	NN
cord-005453-4057qib7	10430	15	of	of	IN
cord-005453-4057qib7	10430	16	7	7	CD
cord-005453-4057qib7	10430	17	days	day	NNS
cord-005453-4057qib7	10430	18	.	.	.
cord-005453-4057qib7	10431	1	Three	three	CD
cord-005453-4057qib7	10431	2	pts	pt	NNS
cord-005453-4057qib7	10431	3	presented	present	VBD
cord-005453-4057qib7	10431	4	a	a	DT
cord-005453-4057qib7	10431	5	second	second	JJ
cord-005453-4057qib7	10431	6	episode	episode	NN
cord-005453-4057qib7	10431	7	after	after	IN
cord-005453-4057qib7	10431	8	an	an	DT
cord-005453-4057qib7	10431	9	average	average	JJ
cord-005453-4057qib7	10431	10	delay	delay	NN
cord-005453-4057qib7	10431	11	of	of	IN
cord-005453-4057qib7	10431	12	5	5	CD
cord-005453-4057qib7	10431	13	months	month	NNS
cord-005453-4057qib7	10431	14	(	(	-LRB-
cord-005453-4057qib7	10431	15	3	3	CD
cord-005453-4057qib7	10431	16	)	)	-RRB-
cord-005453-4057qib7	10431	17	(	(	-LRB-
cord-005453-4057qib7	10431	18	4	4	LS
cord-005453-4057qib7	10431	19	)	)	-RRB-
cord-005453-4057qib7	10431	20	(	(	-LRB-
cord-005453-4057qib7	10431	21	5	5	LS
cord-005453-4057qib7	10431	22	)	)	-RRB-
cord-005453-4057qib7	10431	23	(	(	-LRB-
cord-005453-4057qib7	10431	24	6	6	LS
cord-005453-4057qib7	10431	25	)	)	-RRB-
cord-005453-4057qib7	10431	26	with	with	IN
cord-005453-4057qib7	10431	27	a	a	DT
cord-005453-4057qib7	10431	28	favorable	favorable	JJ
cord-005453-4057qib7	10431	29	evolution	evolution	NN
cord-005453-4057qib7	10431	30	of	of	IN
cord-005453-4057qib7	10431	31	resumption	resumption	NN
cord-005453-4057qib7	10431	32	of	of	IN
cord-005453-4057qib7	10431	33	thetreatment	thetreatment	NN
cord-005453-4057qib7	10431	34	.	.	.
cord-005453-4057qib7	10432	1	Fourteen	fourteen	CD
cord-005453-4057qib7	10432	2	pts	pts	NN
cord-005453-4057qib7	10432	3	(	(	-LRB-
cord-005453-4057qib7	10432	4	54	54	CD
cord-005453-4057qib7	10432	5	%	%	NN
cord-005453-4057qib7	10432	6	)	)	-RRB-
cord-005453-4057qib7	10432	7	are	be	VBP
cord-005453-4057qib7	10432	8	alive	alive	JJ
cord-005453-4057qib7	10432	9	with	with	IN
cord-005453-4057qib7	10432	10	complete	complete	JJ
cord-005453-4057qib7	10432	11	resolution	resolution	NN
cord-005453-4057qib7	10432	12	after	after	IN
cord-005453-4057qib7	10432	13	a	a	DT
cord-005453-4057qib7	10432	14	median	median	JJ
cord-005453-4057qib7	10432	15	treatment	treatment	NN
cord-005453-4057qib7	10432	16	time	time	NN
cord-005453-4057qib7	10432	17	of	of	IN
cord-005453-4057qib7	10432	18	10	10	CD
cord-005453-4057qib7	10432	19	months	month	NNS
cord-005453-4057qib7	10432	20	(	(	-LRB-
cord-005453-4057qib7	10432	21	2	2	CD
cord-005453-4057qib7	10432	22	-	-	SYM
cord-005453-4057qib7	10432	23	19	19	CD
cord-005453-4057qib7	10432	24	)	)	-RRB-
cord-005453-4057qib7	10432	25	.	.	.
cord-005453-4057qib7	10433	1	Twelve	twelve	CD
cord-005453-4057qib7	10433	2	pts	pt	NNS
cord-005453-4057qib7	10433	3	(	(	-LRB-
cord-005453-4057qib7	10433	4	46	46	CD
cord-005453-4057qib7	10433	5	%	%	NN
cord-005453-4057qib7	10433	6	)	)	-RRB-
cord-005453-4057qib7	10433	7	died	die	VBD
cord-005453-4057qib7	10433	8	rapidly	rapidly	RB
cord-005453-4057qib7	10433	9	on	on	IN
cord-005453-4057qib7	10433	10	average	average	JJ
cord-005453-4057qib7	10433	11	14	14	CD
cord-005453-4057qib7	10433	12	days	day	NNS
cord-005453-4057qib7	10433	13	after	after	IN
cord-005453-4057qib7	10433	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	10433	15	(	(	-LRB-
cord-005453-4057qib7	10433	16	IPA	IPA	NNP
cord-005453-4057qib7	10433	17	11	11	CD
cord-005453-4057qib7	10433	18	,	,	,
cord-005453-4057qib7	10433	19	relapse	relapse	NN
cord-005453-4057qib7	10433	20	of	of	IN
cord-005453-4057qib7	10433	21	his	-PRON-	PRP$
cord-005453-4057qib7	10433	22	disease	disease	NN
cord-005453-4057qib7	10433	23	:	:	:
cord-005453-4057qib7	10433	24	1	1	LS
cord-005453-4057qib7	10433	25	)	)	-RRB-
cord-005453-4057qib7	10433	26	Conclusions	conclusion	NNS
cord-005453-4057qib7	10433	27	:	:	:
cord-005453-4057qib7	10434	1	IPA	IPA	NNP
cord-005453-4057qib7	10434	2	occurring	occur	VBG
cord-005453-4057qib7	10434	3	after	after	IN
cord-005453-4057qib7	10434	4	an	an	DT
cord-005453-4057qib7	10434	5	allograft	allograft	NN
cord-005453-4057qib7	10434	6	of	of	IN
cord-005453-4057qib7	10434	7	allo	allo	NN
cord-005453-4057qib7	10434	8	-	-	HYPH
cord-005453-4057qib7	10434	9	HSCT	HSCT	NNP
cord-005453-4057qib7	10434	10	is	be	VBZ
cord-005453-4057qib7	10434	11	a	a	DT
cord-005453-4057qib7	10434	12	severe	severe	JJ
cord-005453-4057qib7	10434	13	complication	complication	NN
cord-005453-4057qib7	10434	14	with	with	IN
cord-005453-4057qib7	10434	15	high	high	JJ
cord-005453-4057qib7	10434	16	mortality	mortality	NN
cord-005453-4057qib7	10434	17	.	.	.
cord-005453-4057qib7	10435	1	It	-PRON-	PRP
cord-005453-4057qib7	10435	2	is	be	VBZ
cord-005453-4057qib7	10435	3	essential	essential	JJ
cord-005453-4057qib7	10435	4	,	,	,
cord-005453-4057qib7	10435	5	in	in	IN
cord-005453-4057qib7	10435	6	each	each	DT
cord-005453-4057qib7	10435	7	case	case	NN
cord-005453-4057qib7	10435	8	,	,	,
cord-005453-4057qib7	10435	9	to	to	TO
cord-005453-4057qib7	10435	10	identify	identify	VB
cord-005453-4057qib7	10435	11	the	the	DT
cord-005453-4057qib7	10435	12	pts	pts	NN
cord-005453-4057qib7	10435	13	with	with	IN
cord-005453-4057qib7	10435	14	risk	risk	NN
cord-005453-4057qib7	10435	15	factors	factor	NNS
cord-005453-4057qib7	10435	16	,	,	,
cord-005453-4057qib7	10435	17	perform	perform	VB
cord-005453-4057qib7	10435	18	a	a	DT
cord-005453-4057qib7	10435	19	thoracic	thoracic	JJ
cord-005453-4057qib7	10435	20	CT	ct	NN
cord-005453-4057qib7	10435	21	-	-	NN
cord-005453-4057qib7	10435	22	scan	scan	NN
cord-005453-4057qib7	10435	23	,	,	,
cord-005453-4057qib7	10435	24	send	send	VB
cord-005453-4057qib7	10435	25	serum	serum	NN
cord-005453-4057qib7	10435	26	serology	serology	NN
cord-005453-4057qib7	10435	27	for	for	IN
cord-005453-4057qib7	10435	28	apergillus	apergillus	NNP
cord-005453-4057qib7	10436	1	galactomannan	galactomannan	NNP
cord-005453-4057qib7	10436	2	antigenand	antigenand	NNP
cord-005453-4057qib7	10436	3	start	start	VB
cord-005453-4057qib7	10436	4	specific	specific	JJ
cord-005453-4057qib7	10436	5	treatment	treatment	NN
cord-005453-4057qib7	10436	6	as	as	RB
cord-005453-4057qib7	10436	7	soon	soon	RB
cord-005453-4057qib7	10436	8	as	as	IN
cord-005453-4057qib7	10436	9	possible	possible	JJ
cord-005453-4057qib7	10436	10	while	while	IN
cord-005453-4057qib7	10436	11	waiting	wait	VBG
cord-005453-4057qib7	10436	12	to	to	TO
cord-005453-4057qib7	10436	13	be	be	VB
cord-005453-4057qib7	10436	14	able	able	JJ
cord-005453-4057qib7	10436	15	to	to	TO
cord-005453-4057qib7	10436	16	reinforce	reinforce	VB
cord-005453-4057qib7	10436	17	the	the	DT
cord-005453-4057qib7	10436	18	diagnosis	diagnosis	NN
cord-005453-4057qib7	10436	19	by	by	IN
cord-005453-4057qib7	10436	20	direct	direct	JJ
cord-005453-4057qib7	10436	21	examination	examination	NN
cord-005453-4057qib7	10436	22	or	or	CC
cord-005453-4057qib7	10436	23	sputum	sputum	NN
cord-005453-4057qib7	10436	24	or	or	CC
cord-005453-4057qib7	10436	25	brochoalveolar	brochoalveolar	JJ
cord-005453-4057qib7	10436	26	lavage	lavage	NN
cord-005453-4057qib7	10436	27	with	with	IN
cord-005453-4057qib7	10436	28	aspiration	aspiration	NN
cord-005453-4057qib7	10436	29	.	.	.
cord-005453-4057qib7	10437	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10437	2	:	:	:
cord-005453-4057qib7	10437	3	Nothing	nothing	NN
cord-005453-4057qib7	10437	4	to	to	TO
cord-005453-4057qib7	10437	5	declare	declare	VB
cord-005453-4057qib7	10437	6	Background	background	NN
cord-005453-4057qib7	10437	7	:	:	:
cord-005453-4057qib7	10437	8	CMV	CMV	NNP
cord-005453-4057qib7	10437	9	(	(	-LRB-
cord-005453-4057qib7	10437	10	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	10437	11	)	)	-RRB-
cord-005453-4057qib7	10437	12	has	have	VBZ
cord-005453-4057qib7	10437	13	a	a	DT
cord-005453-4057qib7	10437	14	prevalence	prevalence	NN
cord-005453-4057qib7	10437	15	varying	vary	VBG
cord-005453-4057qib7	10437	16	between	between	IN
cord-005453-4057qib7	10437	17	45	45	CD
cord-005453-4057qib7	10437	18	-	-	SYM
cord-005453-4057qib7	10437	19	100	100	CD
cord-005453-4057qib7	10437	20	%	%	NN
cord-005453-4057qib7	10437	21	.	.	.
cord-005453-4057qib7	10438	1	Its	-PRON-	PRP$
cord-005453-4057qib7	10438	2	pathogenicity	pathogenicity	NN
cord-005453-4057qib7	10438	3	is	be	VBZ
cord-005453-4057qib7	10438	4	relatively	relatively	RB
cord-005453-4057qib7	10438	5	low	low	JJ
cord-005453-4057qib7	10438	6	in	in	IN
cord-005453-4057qib7	10438	7	the	the	DT
cord-005453-4057qib7	10438	8	general	general	JJ
cord-005453-4057qib7	10438	9	population	population	NN
cord-005453-4057qib7	10438	10	,	,	,
cord-005453-4057qib7	10438	11	usually	usually	RB
cord-005453-4057qib7	10438	12	resulting	result	VBG
cord-005453-4057qib7	10438	13	in	in	IN
cord-005453-4057qib7	10438	14	a	a	DT
cord-005453-4057qib7	10438	15	selflimiting	selflimite	VBG
cord-005453-4057qib7	10438	16	viral	viral	JJ
cord-005453-4057qib7	10438	17	illness	illness	NN
cord-005453-4057qib7	10438	18	.	.	.
cord-005453-4057qib7	10439	1	In	in	IN
cord-005453-4057qib7	10439	2	an	an	DT
cord-005453-4057qib7	10439	3	immunosuppressed	immunosuppressed	JJ
cord-005453-4057qib7	10439	4	host	host	NN
cord-005453-4057qib7	10439	5	,	,	,
cord-005453-4057qib7	10439	6	infection	infection	NN
cord-005453-4057qib7	10439	7	can	can	MD
cord-005453-4057qib7	10439	8	lead	lead	VB
cord-005453-4057qib7	10439	9	to	to	IN
cord-005453-4057qib7	10439	10	life	life	NN
cord-005453-4057qib7	10439	11	threatening	threaten	VBG
cord-005453-4057qib7	10439	12	illness	illness	NN
cord-005453-4057qib7	10439	13	.	.	.
cord-005453-4057qib7	10440	1	Disseminated	disseminate	VBN
cord-005453-4057qib7	10440	2	CMV	CMV	NNP
cord-005453-4057qib7	10440	3	infection	infection	NN
cord-005453-4057qib7	10440	4	can	can	MD
cord-005453-4057qib7	10440	5	manifest	manifest	VB
cord-005453-4057qib7	10440	6	in	in	IN
cord-005453-4057qib7	10440	7	a	a	DT
cord-005453-4057qib7	10440	8	number	number	NN
cord-005453-4057qib7	10440	9	of	of	IN
cord-005453-4057qib7	10440	10	organs	organ	NNS
cord-005453-4057qib7	10440	11	and	and	CC
cord-005453-4057qib7	10440	12	is	be	VBZ
cord-005453-4057qib7	10440	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	10440	14	using	use	VBG
cord-005453-4057qib7	10440	15	internationally	internationally	RB
cord-005453-4057qib7	10440	16	accepted	accept	VBN
cord-005453-4057qib7	10440	17	criteria	criterion	NNS
cord-005453-4057qib7	10440	18	.	.	.
cord-005453-4057qib7	10441	1	In	in	IN
cord-005453-4057qib7	10441	2	the	the	DT
cord-005453-4057qib7	10441	3	post	post	JJ
cord-005453-4057qib7	10441	4	solid	solid	JJ
cord-005453-4057qib7	10441	5	organ	organ	NN
cord-005453-4057qib7	10441	6	and	and	CC
cord-005453-4057qib7	10441	7	stem	stem	NN
cord-005453-4057qib7	10441	8	cell	cell	NN
cord-005453-4057qib7	10441	9	transplant	transplant	NN
cord-005453-4057qib7	10441	10	(	(	-LRB-
cord-005453-4057qib7	10441	11	SCT	SCT	NNP
cord-005453-4057qib7	10441	12	)	)	-RRB-
cord-005453-4057qib7	10441	13	setting	setting	NN
cord-005453-4057qib7	10441	14	,	,	,
cord-005453-4057qib7	10441	15	it	-PRON-	PRP
cord-005453-4057qib7	10441	16	is	be	VBZ
cord-005453-4057qib7	10441	17	postulated	postulate	VBN
cord-005453-4057qib7	10441	18	that	that	IN
cord-005453-4057qib7	10441	19	it	-PRON-	PRP
cord-005453-4057qib7	10441	20	is	be	VBZ
cord-005453-4057qib7	10441	21	viral	viral	JJ
cord-005453-4057qib7	10441	22	reactivation	reactivation	NN
cord-005453-4057qib7	10441	23	,	,	,
cord-005453-4057qib7	10441	24	rather	rather	RB
cord-005453-4057qib7	10441	25	than	than	IN
cord-005453-4057qib7	10441	26	primary	primary	JJ
cord-005453-4057qib7	10441	27	reinfection	reinfection	NN
cord-005453-4057qib7	10441	28	that	that	WDT
cord-005453-4057qib7	10441	29	leads	lead	VBZ
cord-005453-4057qib7	10441	30	to	to	IN
cord-005453-4057qib7	10441	31	CMV	CMV	NNP
cord-005453-4057qib7	10441	32	viraemia	viraemia	NN
cord-005453-4057qib7	10441	33	.	.	.
cord-005453-4057qib7	10442	1	Prevention	prevention	NN
cord-005453-4057qib7	10442	2	of	of	IN
cord-005453-4057qib7	10442	3	reactivation	reactivation	NN
cord-005453-4057qib7	10442	4	requires	require	VBZ
cord-005453-4057qib7	10442	5	the	the	DT
cord-005453-4057qib7	10442	6	presence	presence	NN
cord-005453-4057qib7	10442	7	of	of	IN
cord-005453-4057qib7	10442	8	a	a	DT
cord-005453-4057qib7	10442	9	competent	competent	JJ
cord-005453-4057qib7	10442	10	immune	immune	JJ
cord-005453-4057qib7	10442	11	system	system	NN
cord-005453-4057qib7	10442	12	,	,	,
cord-005453-4057qib7	10442	13	mediated	mediate	VBN
cord-005453-4057qib7	10442	14	by	by	IN
cord-005453-4057qib7	10442	15	T	T	NNP
cord-005453-4057qib7	10442	16	-	-	HYPH
cord-005453-4057qib7	10442	17	cells	cell	NNS
cord-005453-4057qib7	10442	18	.	.	.
cord-005453-4057qib7	10443	1	This	this	DT
cord-005453-4057qib7	10443	2	accounts	account	VBZ
cord-005453-4057qib7	10443	3	for	for	IN
cord-005453-4057qib7	10443	4	the	the	DT
cord-005453-4057qib7	10443	5	increased	increase	VBN
cord-005453-4057qib7	10443	6	incidence	incidence	NN
cord-005453-4057qib7	10443	7	in	in	IN
cord-005453-4057qib7	10443	8	intensive	intensive	JJ
cord-005453-4057qib7	10443	9	and	and	CC
cord-005453-4057qib7	10443	10	T	t	NN
cord-005453-4057qib7	10443	11	-	-	HYPH
cord-005453-4057qib7	10443	12	cell	cell	NN
cord-005453-4057qib7	10443	13	depleting	deplete	VBG
cord-005453-4057qib7	10443	14	SCT	SCT	NNP
cord-005453-4057qib7	10443	15	conditioning	conditioning	NN
cord-005453-4057qib7	10443	16	regimens	regimen	NNS
cord-005453-4057qib7	10443	17	.	.	.
cord-005453-4057qib7	10444	1	Despite	despite	IN
cord-005453-4057qib7	10444	2	improved	improved	JJ
cord-005453-4057qib7	10444	3	outcomes	outcome	NNS
cord-005453-4057qib7	10444	4	following	follow	VBG
cord-005453-4057qib7	10444	5	the	the	DT
cord-005453-4057qib7	10444	6	introduction	introduction	NN
cord-005453-4057qib7	10444	7	of	of	IN
cord-005453-4057qib7	10444	8	CMV	CMV	NNP
cord-005453-4057qib7	10444	9	monitoring	monitoring	NN
cord-005453-4057qib7	10444	10	by	by	IN
cord-005453-4057qib7	10444	11	PCR	PCR	NNP
cord-005453-4057qib7	10444	12	and	and	CC
cord-005453-4057qib7	10444	13	pre	pre	JJ
cord-005453-4057qib7	10444	14	-	-	JJ
cord-005453-4057qib7	10444	15	emptive	emptive	JJ
cord-005453-4057qib7	10444	16	treatments	treatment	NNS
cord-005453-4057qib7	10444	17	(	(	-LRB-
cord-005453-4057qib7	10444	18	current	current	JJ
cord-005453-4057qib7	10444	19	UK	UK	NNP
cord-005453-4057qib7	10444	20	guidance	guidance	NN
cord-005453-4057qib7	10444	21	)	)	-RRB-
cord-005453-4057qib7	10444	22	,	,	,
cord-005453-4057qib7	10444	23	CMV	CMV	NNP
cord-005453-4057qib7	10444	24	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	10444	25	still	still	RB
cord-005453-4057qib7	10444	26	carries	carry	VBZ
cord-005453-4057qib7	10444	27	a	a	DT
cord-005453-4057qib7	10444	28	high	high	JJ
cord-005453-4057qib7	10444	29	mortality	mortality	NN
cord-005453-4057qib7	10444	30	.	.	.
cord-005453-4057qib7	10445	1	The	the	DT
cord-005453-4057qib7	10445	2	use	use	NN
cord-005453-4057qib7	10445	3	of	of	IN
cord-005453-4057qib7	10445	4	CMV	CMV	NNP
cord-005453-4057qib7	10445	5	specific	specific	JJ
cord-005453-4057qib7	10445	6	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	10445	7	(	(	-LRB-
cord-005453-4057qib7	10445	8	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10445	9	)	)	-RRB-
cord-005453-4057qib7	10445	10	for	for	IN
cord-005453-4057qib7	10445	11	the	the	DT
cord-005453-4057qib7	10445	12	treatment	treatment	NN
cord-005453-4057qib7	10445	13	of	of	IN
cord-005453-4057qib7	10445	14	this	this	DT
cord-005453-4057qib7	10445	15	complication	complication	NN
cord-005453-4057qib7	10445	16	is	be	VBZ
cord-005453-4057qib7	10445	17	generally	generally	RB
cord-005453-4057qib7	10445	18	not	not	RB
cord-005453-4057qib7	10445	19	recommended	recommend	VBN
cord-005453-4057qib7	10445	20	post	post	NN
cord-005453-4057qib7	10445	21	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10445	22	or	or	CC
cord-005453-4057qib7	10445	23	SCT	SCT	NNP
cord-005453-4057qib7	10445	24	in	in	IN
cord-005453-4057qib7	10445	25	haematological	haematological	JJ
cord-005453-4057qib7	10445	26	cancers	cancer	NNS
cord-005453-4057qib7	10445	27	due	due	JJ
cord-005453-4057qib7	10445	28	to	to	IN
cord-005453-4057qib7	10445	29	lack	lack	NN
cord-005453-4057qib7	10445	30	of	of	IN
cord-005453-4057qib7	10445	31	evidence	evidence	NN
cord-005453-4057qib7	10445	32	.	.	.
cord-005453-4057qib7	10446	1	However	however	RB
cord-005453-4057qib7	10446	2	,	,	,
cord-005453-4057qib7	10446	3	CMVIGs	cmvig	NNS
cord-005453-4057qib7	10446	4	are	be	VBP
cord-005453-4057qib7	10446	5	widely	widely	RB
cord-005453-4057qib7	10446	6	used	use	VBN
cord-005453-4057qib7	10446	7	in	in	IN
cord-005453-4057qib7	10446	8	the	the	DT
cord-005453-4057qib7	10446	9	setting	setting	NN
cord-005453-4057qib7	10446	10	of	of	IN
cord-005453-4057qib7	10446	11	CMV	CMV	NNP
cord-005453-4057qib7	10446	12	reactivation	reactivation	NN
cord-005453-4057qib7	10446	13	post	post	VBP
cord-005453-4057qib7	10446	14	solid	solid	JJ
cord-005453-4057qib7	10446	15	organ	organ	NN
cord-005453-4057qib7	10446	16	transplants	transplant	NNS
cord-005453-4057qib7	10446	17	.	.	.
cord-005453-4057qib7	10447	1	We	-PRON-	PRP
cord-005453-4057qib7	10447	2	report	report	VBP
cord-005453-4057qib7	10447	3	the	the	DT
cord-005453-4057qib7	10447	4	use	use	NN
cord-005453-4057qib7	10447	5	of	of	IN
cord-005453-4057qib7	10447	6	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10447	7	in	in	IN
cord-005453-4057qib7	10447	8	patients	patient	NNS
cord-005453-4057qib7	10447	9	with	with	IN
cord-005453-4057qib7	10447	10	suspected	suspect	VBN
cord-005453-4057qib7	10447	11	CMV	CMV	NNP
cord-005453-4057qib7	10447	12	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	10447	13	at	at	IN
cord-005453-4057qib7	10447	14	a	a	DT
cord-005453-4057qib7	10447	15	single	single	JJ
cord-005453-4057qib7	10447	16	UK	UK	NNP
cord-005453-4057qib7	10447	17	centre	centre	NN
cord-005453-4057qib7	10447	18	.	.	.
cord-005453-4057qib7	10448	1	The	the	DT
cord-005453-4057qib7	10448	2	aims	aim	NNS
cord-005453-4057qib7	10448	3	of	of	IN
cord-005453-4057qib7	10448	4	this	this	DT
cord-005453-4057qib7	10448	5	retrospective	retrospective	JJ
cord-005453-4057qib7	10448	6	study	study	NN
cord-005453-4057qib7	10448	7	were	be	VBD
cord-005453-4057qib7	10448	8	to	to	TO
cord-005453-4057qib7	10448	9	establish	establish	VB
cord-005453-4057qib7	10448	10	safety	safety	NN
cord-005453-4057qib7	10448	11	and	and	CC
cord-005453-4057qib7	10448	12	review	review	VB
cord-005453-4057qib7	10448	13	efficacy	efficacy	NN
cord-005453-4057qib7	10448	14	in	in	IN
cord-005453-4057qib7	10448	15	this	this	DT
cord-005453-4057qib7	10448	16	highly	highly	RB
cord-005453-4057qib7	10448	17	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	10448	18	group	group	NN
cord-005453-4057qib7	10448	19	of	of	IN
cord-005453-4057qib7	10448	20	patients	patient	NNS
cord-005453-4057qib7	10448	21	.	.	.
cord-005453-4057qib7	10449	1	Methods	method	NNS
cord-005453-4057qib7	10449	2	:	:	:
cord-005453-4057qib7	10450	1	Data	datum	NNS
cord-005453-4057qib7	10450	2	was	be	VBD
cord-005453-4057qib7	10450	3	collected	collect	VBN
cord-005453-4057qib7	10450	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	10450	5	on	on	IN
cord-005453-4057qib7	10450	6	the	the	DT
cord-005453-4057qib7	10450	7	use	use	NN
cord-005453-4057qib7	10450	8	of	of	IN
cord-005453-4057qib7	10450	9	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10450	10	in	in	IN
cord-005453-4057qib7	10450	11	patients	patient	NNS
cord-005453-4057qib7	10450	12	with	with	IN
cord-005453-4057qib7	10450	13	haematological	haematological	JJ
cord-005453-4057qib7	10450	14	cancers	cancer	NNS
cord-005453-4057qib7	10450	15	post	post	NN
cord-005453-4057qib7	10450	16	SCT	SCT	NNP
cord-005453-4057qib7	10450	17	or	or	CC
cord-005453-4057qib7	10450	18	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10450	19	alone	alone	RB
cord-005453-4057qib7	10450	20	between	between	IN
cord-005453-4057qib7	10450	21	2007	2007	CD
cord-005453-4057qib7	10450	22	and	and	CC
cord-005453-4057qib7	10450	23	2017	2017	CD
cord-005453-4057qib7	10450	24	at	at	IN
cord-005453-4057qib7	10450	25	Manchester	Manchester	NNP
cord-005453-4057qib7	10450	26	Royal	Royal	NNP
cord-005453-4057qib7	10450	27	Infirmary	Infirmary	NNP
cord-005453-4057qib7	10450	28	,	,	,
cord-005453-4057qib7	10450	29	UK	UK	NNP
cord-005453-4057qib7	10450	30	.	.	.
cord-005453-4057qib7	10451	1	All	all	DT
cord-005453-4057qib7	10451	2	patients	patient	NNS
cord-005453-4057qib7	10451	3	included	include	VBD
cord-005453-4057qib7	10451	4	had	have	VBD
cord-005453-4057qib7	10451	5	CMV	CMV	NNP
cord-005453-4057qib7	10451	6	positive	positive	JJ
cord-005453-4057qib7	10451	7	PCR	pcr	NN
cord-005453-4057qib7	10451	8	in	in	IN
cord-005453-4057qib7	10451	9	blood	blood	NN
cord-005453-4057qib7	10451	10	(	(	-LRB-
cord-005453-4057qib7	10451	11	and	and	CC
cord-005453-4057qib7	10451	12	or	or	CC
cord-005453-4057qib7	10451	13	from	from	IN
cord-005453-4057qib7	10451	14	bronchoscopy	bronchoscopy	NN
cord-005453-4057qib7	10451	15	)	)	-RRB-
cord-005453-4057qib7	10451	16	,	,	,
cord-005453-4057qib7	10451	17	as	as	RB
cord-005453-4057qib7	10451	18	well	well	RB
cord-005453-4057qib7	10451	19	as	as	IN
cord-005453-4057qib7	10451	20	high	high	JJ
cord-005453-4057qib7	10451	21	resolution	resolution	NN
cord-005453-4057qib7	10451	22	CT	CT	NNP
cord-005453-4057qib7	10451	23	imaging	image	VBG
cord-005453-4057qib7	10451	24	evidence	evidence	NN
cord-005453-4057qib7	10451	25	of	of	IN
cord-005453-4057qib7	10451	26	CMV	CMV	NNP
cord-005453-4057qib7	10451	27	infection	infection	NN
cord-005453-4057qib7	10451	28	.	.	.
cord-005453-4057qib7	10452	1	The	the	DT
cord-005453-4057qib7	10452	2	data	datum	NNS
cord-005453-4057qib7	10452	3	was	be	VBD
cord-005453-4057qib7	10452	4	sourced	source	VBN
cord-005453-4057qib7	10452	5	from	from	IN
cord-005453-4057qib7	10452	6	pharmacy	pharmacy	NN
cord-005453-4057qib7	10452	7	database	database	NN
cord-005453-4057qib7	10452	8	and	and	CC
cord-005453-4057qib7	10452	9	crossreferenced	crossreference	VBN
cord-005453-4057qib7	10452	10	with	with	IN
cord-005453-4057qib7	10452	11	a	a	DT
cord-005453-4057qib7	10452	12	departmental	departmental	JJ
cord-005453-4057qib7	10452	13	list	list	NN
cord-005453-4057qib7	10452	14	.	.	.
cord-005453-4057qib7	10453	1	For	for	IN
cord-005453-4057qib7	10453	2	each	each	DT
cord-005453-4057qib7	10453	3	patient	patient	NN
cord-005453-4057qib7	10453	4	identified	identify	VBN
cord-005453-4057qib7	10453	5	,	,	,
cord-005453-4057qib7	10453	6	case	case	NN
cord-005453-4057qib7	10453	7	notes	note	NNS
cord-005453-4057qib7	10453	8	and	and	CC
cord-005453-4057qib7	10453	9	prescriptions	prescription	NNS
cord-005453-4057qib7	10453	10	were	be	VBD
cord-005453-4057qib7	10453	11	sourced	source	VBN
cord-005453-4057qib7	10453	12	.	.	.
cord-005453-4057qib7	10454	1	Data	datum	NNS
cord-005453-4057qib7	10454	2	collected	collect	VBD
cord-005453-4057qib7	10454	3	included	include	VBN
cord-005453-4057qib7	10454	4	patient	patient	JJ
cord-005453-4057qib7	10454	5	baseline	baseline	JJ
cord-005453-4057qib7	10454	6	characteristics	characteristic	NNS
cord-005453-4057qib7	10454	7	,	,	,
cord-005453-4057qib7	10454	8	timing	timing	NN
cord-005453-4057qib7	10454	9	of	of	IN
cord-005453-4057qib7	10454	10	treatment	treatment	NN
cord-005453-4057qib7	10454	11	,	,	,
cord-005453-4057qib7	10454	12	number	number	NN
cord-005453-4057qib7	10454	13	of	of	IN
cord-005453-4057qib7	10454	14	doses	dose	NNS
cord-005453-4057qib7	10454	15	of	of	IN
cord-005453-4057qib7	10454	16	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10454	17	and	and	CC
cord-005453-4057qib7	10454	18	outcome	outcome	NN
cord-005453-4057qib7	10454	19	.	.	.
cord-005453-4057qib7	10455	1	Results	result	NNS
cord-005453-4057qib7	10455	2	:	:	:
cord-005453-4057qib7	10456	1	Eight	eight	CD
cord-005453-4057qib7	10456	2	patients	patient	NNS
cord-005453-4057qib7	10456	3	received	receive	VBD
cord-005453-4057qib7	10456	4	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10456	5	for	for	IN
cord-005453-4057qib7	10456	6	suspected	suspect	VBN
cord-005453-4057qib7	10456	7	CMV	CMV	NNP
cord-005453-4057qib7	10456	8	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	10456	9	.	.	.
cord-005453-4057qib7	10457	1	Seven	seven	CD
cord-005453-4057qib7	10457	2	patients	patient	NNS
cord-005453-4057qib7	10457	3	were	be	VBD
cord-005453-4057qib7	10457	4	post	post	JJ
cord-005453-4057qib7	10457	5	SCT	SCT	NNP
cord-005453-4057qib7	10457	6	and	and	CC
cord-005453-4057qib7	10457	7	one	one	CD
cord-005453-4057qib7	10457	8	patient	patient	NN
cord-005453-4057qib7	10457	9	was	be	VBD
cord-005453-4057qib7	10457	10	severely	severely	RB
cord-005453-4057qib7	10457	11	immunosuppressed	immunosuppressed	JJ
cord-005453-4057qib7	10457	12	with	with	IN
cord-005453-4057qib7	10457	13	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10457	14	alone	alone	JJ
cord-005453-4057qib7	10457	15	.	.	.
cord-005453-4057qib7	10458	1	Median	median	JJ
cord-005453-4057qib7	10458	2	age	age	NN
cord-005453-4057qib7	10458	3	was	be	VBD
cord-005453-4057qib7	10458	4	40	40	CD
cord-005453-4057qib7	10458	5	years	year	NNS
cord-005453-4057qib7	10459	1	(	(	-LRB-
cord-005453-4057qib7	10459	2	range	range	NNP
cord-005453-4057qib7	10459	3	16	16	CD
cord-005453-4057qib7	10459	4	-	-	SYM
cord-005453-4057qib7	10459	5	68	68	CD
cord-005453-4057qib7	10459	6	)	)	-RRB-
cord-005453-4057qib7	10459	7	.	.	.
cord-005453-4057qib7	10460	1	The	the	DT
cord-005453-4057qib7	10460	2	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10460	3	regimen	regimen	NN
cord-005453-4057qib7	10460	4	used	use	VBD
cord-005453-4057qib7	10460	5	was	be	VBD
cord-005453-4057qib7	10460	6	4ml	4ml	JJ
cord-005453-4057qib7	10460	7	/	/	SYM
cord-005453-4057qib7	10460	8	kg	kg	NNS
cord-005453-4057qib7	10460	9	of	of	IN
cord-005453-4057qib7	10460	10	Cytotect	Cytotect	NNP
cord-005453-4057qib7	10461	1	®	®	VBN
cord-005453-4057qib7	10461	2	on	on	IN
cord-005453-4057qib7	10461	3	days	day	NNS
cord-005453-4057qib7	10461	4	0	0	CD
cord-005453-4057qib7	10461	5	,	,	,
cord-005453-4057qib7	10461	6	2	2	CD
cord-005453-4057qib7	10461	7	,	,	,
cord-005453-4057qib7	10461	8	4	4	CD
cord-005453-4057qib7	10461	9	and	and	CC
cord-005453-4057qib7	10461	10	6	6	CD
cord-005453-4057qib7	10461	11	,	,	,
cord-005453-4057qib7	10461	12	followed	follow	VBN
cord-005453-4057qib7	10461	13	by	by	IN
cord-005453-4057qib7	10461	14	2ml	2ml	NNP
cord-005453-4057qib7	10461	15	/	/	SYM
cord-005453-4057qib7	10461	16	kg	kg	NN
cord-005453-4057qib7	10461	17	every	every	DT
cord-005453-4057qib7	10461	18	four	four	CD
cord-005453-4057qib7	10461	19	days	day	NNS
cord-005453-4057qib7	10461	20	until	until	IN
cord-005453-4057qib7	10461	21	resolution	resolution	NN
cord-005453-4057qib7	10461	22	of	of	IN
cord-005453-4057qib7	10461	23	symptoms	symptom	NNS
cord-005453-4057qib7	10461	24	.	.	.
cord-005453-4057qib7	10462	1	There	there	EX
cord-005453-4057qib7	10462	2	were	be	VBD
cord-005453-4057qib7	10462	3	no	no	DT
cord-005453-4057qib7	10462	4	infusion	infusion	NN
cord-005453-4057qib7	10462	5	related	relate	VBN
cord-005453-4057qib7	10462	6	reactions	reaction	NNS
cord-005453-4057qib7	10462	7	observed	observe	VBD
cord-005453-4057qib7	10462	8	.	.	.
cord-005453-4057qib7	10463	1	Patients	patient	NNS
cord-005453-4057qib7	10463	2	received	receive	VBD
cord-005453-4057qib7	10463	3	a	a	DT
cord-005453-4057qib7	10463	4	median	median	NN
cord-005453-4057qib7	10463	5	of	of	IN
cord-005453-4057qib7	10463	6	4	4	CD
cord-005453-4057qib7	10463	7	doses	dose	NNS
cord-005453-4057qib7	10463	8	of	of	IN
cord-005453-4057qib7	10463	9	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10463	10	.	.	.
cord-005453-4057qib7	10464	1	Four	four	CD
cord-005453-4057qib7	10464	2	out	out	IN
cord-005453-4057qib7	10464	3	of	of	IN
cord-005453-4057qib7	10464	4	8	8	CD
cord-005453-4057qib7	10464	5	patients	patient	NNS
cord-005453-4057qib7	10464	6	responded	respond	VBD
cord-005453-4057qib7	10464	7	to	to	IN
cord-005453-4057qib7	10464	8	the	the	DT
cord-005453-4057qib7	10464	9	treatment	treatment	NN
cord-005453-4057qib7	10464	10	and	and	CC
cord-005453-4057qib7	10464	11	showed	show	VBD
cord-005453-4057qib7	10464	12	full	full	JJ
cord-005453-4057qib7	10464	13	recovery	recovery	NN
cord-005453-4057qib7	10464	14	but	but	CC
cord-005453-4057qib7	10464	15	only	only	RB
cord-005453-4057qib7	10464	16	3	3	CD
cord-005453-4057qib7	10464	17	are	be	VBP
cord-005453-4057qib7	10464	18	alive	alive	JJ
cord-005453-4057qib7	10464	19	and	and	CC
cord-005453-4057qib7	10464	20	well	well	RB
cord-005453-4057qib7	10464	21	to	to	IN
cord-005453-4057qib7	10464	22	date	date	NN
cord-005453-4057qib7	10464	23	.	.	.
cord-005453-4057qib7	10465	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10465	2	:	:	:
cord-005453-4057qib7	10466	1	This	this	DT
cord-005453-4057qib7	10466	2	study	study	NN
cord-005453-4057qib7	10466	3	shows	show	VBZ
cord-005453-4057qib7	10466	4	that	that	IN
cord-005453-4057qib7	10466	5	the	the	DT
cord-005453-4057qib7	10466	6	use	use	NN
cord-005453-4057qib7	10466	7	of	of	IN
cord-005453-4057qib7	10466	8	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10466	9	is	be	VBZ
cord-005453-4057qib7	10466	10	safe	safe	JJ
cord-005453-4057qib7	10466	11	in	in	IN
cord-005453-4057qib7	10466	12	the	the	DT
cord-005453-4057qib7	10466	13	post	post	JJ
cord-005453-4057qib7	10466	14	-	-	JJ
cord-005453-4057qib7	10466	15	SCT	sct	JJ
cord-005453-4057qib7	10466	16	setting	setting	NN
cord-005453-4057qib7	10466	17	of	of	IN
cord-005453-4057qib7	10466	18	acutely	acutely	RB
cord-005453-4057qib7	10466	19	unwell	unwell	JJ
cord-005453-4057qib7	10466	20	patients	patient	NNS
cord-005453-4057qib7	10466	21	with	with	IN
cord-005453-4057qib7	10466	22	multi	multi	JJ
cord-005453-4057qib7	10466	23	-	-	JJ
cord-005453-4057qib7	10466	24	organ	organ	JJ
cord-005453-4057qib7	10466	25	failure	failure	NN
cord-005453-4057qib7	10466	26	.	.	.
cord-005453-4057qib7	10467	1	Despite	despite	IN
cord-005453-4057qib7	10467	2	limitations	limitation	NNS
cord-005453-4057qib7	10467	3	of	of	IN
cord-005453-4057qib7	10467	4	retrospective	retrospective	JJ
cord-005453-4057qib7	10467	5	studies	study	NNS
cord-005453-4057qib7	10467	6	,	,	,
cord-005453-4057qib7	10467	7	there	there	EX
cord-005453-4057qib7	10467	8	appears	appear	VBZ
cord-005453-4057qib7	10467	9	to	to	TO
cord-005453-4057qib7	10467	10	be	be	VB
cord-005453-4057qib7	10467	11	benefit	benefit	NN
cord-005453-4057qib7	10467	12	for	for	IN
cord-005453-4057qib7	10467	13	the	the	DT
cord-005453-4057qib7	10467	14	use	use	NN
cord-005453-4057qib7	10467	15	of	of	IN
cord-005453-4057qib7	10467	16	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10467	17	in	in	IN
cord-005453-4057qib7	10467	18	our	-PRON-	PRP$
cord-005453-4057qib7	10467	19	patient	patient	JJ
cord-005453-4057qib7	10467	20	population	population	NN
cord-005453-4057qib7	10467	21	,	,	,
cord-005453-4057qib7	10467	22	with	with	IN
cord-005453-4057qib7	10467	23	50	50	CD
cord-005453-4057qib7	10467	24	%	%	NN
cord-005453-4057qib7	10467	25	of	of	IN
cord-005453-4057qib7	10467	26	patients	patient	NNS
cord-005453-4057qib7	10467	27	showing	show	VBG
cord-005453-4057qib7	10467	28	a	a	DT
cord-005453-4057qib7	10467	29	full	full	JJ
cord-005453-4057qib7	10467	30	recovery	recovery	NN
cord-005453-4057qib7	10467	31	from	from	IN
cord-005453-4057qib7	10467	32	that	that	DT
cord-005453-4057qib7	10467	33	episode	episode	NN
cord-005453-4057qib7	10467	34	.	.	.
cord-005453-4057qib7	10468	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	10468	2	SCT	SCT	NNP
cord-005453-4057qib7	10468	3	plays	play	VBZ
cord-005453-4057qib7	10468	4	a	a	DT
cord-005453-4057qib7	10468	5	confounding	confounding	JJ
cord-005453-4057qib7	10468	6	role	role	NN
cord-005453-4057qib7	10468	7	in	in	IN
cord-005453-4057qib7	10468	8	the	the	DT
cord-005453-4057qib7	10468	9	outcome	outcome	NN
cord-005453-4057qib7	10468	10	of	of	IN
cord-005453-4057qib7	10468	11	patients	patient	NNS
cord-005453-4057qib7	10468	12	although	although	IN
cord-005453-4057qib7	10468	13	the	the	DT
cord-005453-4057qib7	10468	14	numbers	number	NNS
cord-005453-4057qib7	10468	15	in	in	IN
cord-005453-4057qib7	10468	16	our	-PRON-	PRP$
cord-005453-4057qib7	10468	17	study	study	NN
cord-005453-4057qib7	10468	18	are	be	VBP
cord-005453-4057qib7	10468	19	small	small	JJ
cord-005453-4057qib7	10468	20	.	.	.
cord-005453-4057qib7	10469	1	There	there	EX
cord-005453-4057qib7	10469	2	is	be	VBZ
cord-005453-4057qib7	10469	3	clearly	clearly	RB
cord-005453-4057qib7	10469	4	a	a	DT
cord-005453-4057qib7	10469	5	need	need	NN
cord-005453-4057qib7	10469	6	for	for	IN
cord-005453-4057qib7	10469	7	better	well	JJR
cord-005453-4057qib7	10469	8	treatments	treatment	NNS
cord-005453-4057qib7	10469	9	of	of	IN
cord-005453-4057qib7	10469	10	CMV	CMV	NNP
cord-005453-4057qib7	10469	11	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	10469	12	.	.	.
cord-005453-4057qib7	10470	1	CMVIG	CMVIG	NNP
cord-005453-4057qib7	10470	2	is	be	VBZ
cord-005453-4057qib7	10470	3	a	a	DT
cord-005453-4057qib7	10470	4	promising	promising	JJ
cord-005453-4057qib7	10470	5	treatment	treatment	NN
cord-005453-4057qib7	10470	6	but	but	CC
cord-005453-4057qib7	10470	7	further	further	JJ
cord-005453-4057qib7	10470	8	studies	study	NNS
cord-005453-4057qib7	10470	9	are	be	VBP
cord-005453-4057qib7	10470	10	needed	need	VBN
cord-005453-4057qib7	10470	11	to	to	TO
cord-005453-4057qib7	10470	12	identify	identify	VB
cord-005453-4057qib7	10470	13	the	the	DT
cord-005453-4057qib7	10470	14	optimal	optimal	JJ
cord-005453-4057qib7	10470	15	dosing	dose	VBG
cord-005453-4057qib7	10470	16	regimen	regimen	NN
cord-005453-4057qib7	10470	17	and	and	CC
cord-005453-4057qib7	10470	18	provide	provide	VB
cord-005453-4057qib7	10470	19	evidence	evidence	NN
cord-005453-4057qib7	10470	20	of	of	IN
cord-005453-4057qib7	10470	21	efficacy	efficacy	NN
cord-005453-4057qib7	10470	22	.	.	.
cord-005453-4057qib7	10471	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10471	2	:	:	:
cord-005453-4057qib7	10472	1	Biotest	Biotest	NNP
cord-005453-4057qib7	10472	2	-	-	HYPH
cord-005453-4057qib7	10472	3	Honaria	Honaria	NNP
cord-005453-4057qib7	10472	4	P464	P464	NNP
cord-005453-4057qib7	10472	5	Abstract	Abstract	NNP
cord-005453-4057qib7	10472	6	withdrawn	withdraw	VBN
cord-005453-4057qib7	10472	7	.	.	.
cord-005453-4057qib7	10473	1	Background	background	NN
cord-005453-4057qib7	10473	2	:	:	:
cord-005453-4057qib7	10474	1	The	the	DT
cord-005453-4057qib7	10474	2	risk	risk	NN
cord-005453-4057qib7	10474	3	of	of	IN
cord-005453-4057qib7	10474	4	fungal	fungal	JJ
cord-005453-4057qib7	10474	5	infection	infection	NN
cord-005453-4057qib7	10474	6	related	relate	VBN
cord-005453-4057qib7	10474	7	to	to	IN
cord-005453-4057qib7	10474	8	allogeneic	allogeneic	NN
cord-005453-4057qib7	10474	9	transplantation	transplantation	NN
cord-005453-4057qib7	10474	10	is	be	VBZ
cord-005453-4057qib7	10474	11	a	a	DT
cord-005453-4057qib7	10474	12	well	well	RB
cord-005453-4057qib7	10474	13	-	-	HYPH
cord-005453-4057qib7	10474	14	known	know	VBN
cord-005453-4057qib7	10474	15	cause	cause	NN
cord-005453-4057qib7	10474	16	of	of	IN
cord-005453-4057qib7	10474	17	morbidity	morbidity	NN
cord-005453-4057qib7	10474	18	and	and	CC
cord-005453-4057qib7	10474	19	mortality	mortality	NN
cord-005453-4057qib7	10474	20	.	.	.
cord-005453-4057qib7	10475	1	The	the	DT
cord-005453-4057qib7	10475	2	main	main	JJ
cord-005453-4057qib7	10475	3	agents	agent	NNS
cord-005453-4057qib7	10475	4	implicated	implicate	VBN
cord-005453-4057qib7	10475	5	are	be	VBP
cord-005453-4057qib7	10475	6	yeast	yeast	NN
cord-005453-4057qib7	10475	7	during	during	IN
cord-005453-4057qib7	10475	8	the	the	DT
cord-005453-4057qib7	10475	9	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10475	10	period	period	NN
cord-005453-4057qib7	10475	11	and	and	CC
cord-005453-4057qib7	10475	12	filamentous	filamentous	JJ
cord-005453-4057qib7	10475	13	fungi	fungus	NNS
cord-005453-4057qib7	10475	14	after	after	IN
cord-005453-4057qib7	10475	15	this	this	DT
cord-005453-4057qib7	10475	16	period	period	NN
cord-005453-4057qib7	10475	17	.	.	.
cord-005453-4057qib7	10476	1	Methods	method	NNS
cord-005453-4057qib7	10476	2	:	:	:
cord-005453-4057qib7	10476	3	We	-PRON-	PRP
cord-005453-4057qib7	10476	4	decided	decide	VBD
cord-005453-4057qib7	10476	5	to	to	TO
cord-005453-4057qib7	10476	6	evaluate	evaluate	VB
cord-005453-4057qib7	10476	7	the	the	DT
cord-005453-4057qib7	10476	8	effectiveness	effectiveness	NN
cord-005453-4057qib7	10476	9	of	of	IN
cord-005453-4057qib7	10476	10	a	a	DT
cord-005453-4057qib7	10476	11	prophylactic	prophylactic	JJ
cord-005453-4057qib7	10476	12	regimen	regimen	NN
cord-005453-4057qib7	10476	13	containing	contain	VBG
cord-005453-4057qib7	10476	14	fluconazole	fluconazole	NN
cord-005453-4057qib7	10476	15	since	since	IN
cord-005453-4057qib7	10476	16	day	day	NN
cord-005453-4057qib7	10476	17	-3	-3	NNP
cord-005453-4057qib7	10476	18	.	.	.
cord-005453-4057qib7	10477	1	After	after	IN
cord-005453-4057qib7	10477	2	discharge	discharge	NN
cord-005453-4057qib7	10477	3	fluconazole	fluconazole	NNP
cord-005453-4057qib7	10477	4	was	be	VBD
cord-005453-4057qib7	10477	5	kept	keep	VBN
cord-005453-4057qib7	10477	6	until	until	IN
cord-005453-4057qib7	10477	7	day	day	NN
cord-005453-4057qib7	10477	8	or	or	CC
cord-005453-4057qib7	10477	9	75	75	CD
cord-005453-4057qib7	10477	10	or	or	CC
cord-005453-4057qib7	10477	11	switched	switch	VBN
cord-005453-4057qib7	10477	12	to	to	IN
cord-005453-4057qib7	10477	13	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10477	14	in	in	IN
cord-005453-4057qib7	10477	15	high	high	JJ
cord-005453-4057qib7	10477	16	-	-	HYPH
cord-005453-4057qib7	10477	17	risk	risk	NN
cord-005453-4057qib7	10477	18	patients	patient	NNS
cord-005453-4057qib7	10477	19	.	.	.
cord-005453-4057qib7	10478	1	Patients	patient	NNS
cord-005453-4057qib7	10478	2	with	with	IN
cord-005453-4057qib7	10478	3	GvHD	GvHD	NNP
cord-005453-4057qib7	10478	4	under	under	IN
cord-005453-4057qib7	10478	5	steroids	steroid	NNS
cord-005453-4057qib7	10478	6	were	be	VBD
cord-005453-4057qib7	10478	7	kept	keep	VBN
cord-005453-4057qib7	10478	8	under	under	IN
cord-005453-4057qib7	10478	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10478	10	.	.	.
cord-005453-4057qib7	10479	1	The	the	DT
cord-005453-4057qib7	10479	2	group	group	NN
cord-005453-4057qib7	10479	3	of	of	IN
cord-005453-4057qib7	10479	4	high	high	JJ
cord-005453-4057qib7	10479	5	risk	risk	NN
cord-005453-4057qib7	10479	6	patients	patient	NNS
cord-005453-4057qib7	10479	7	was	be	VBD
cord-005453-4057qib7	10479	8	defined	define	VBN
cord-005453-4057qib7	10479	9	by	by	IN
cord-005453-4057qib7	10479	10	one	one	CD
cord-005453-4057qib7	10479	11	of	of	IN
cord-005453-4057qib7	10479	12	the	the	DT
cord-005453-4057qib7	10479	13	following	follow	VBG
cord-005453-4057qib7	10479	14	variables	variable	NNS
cord-005453-4057qib7	10479	15	:	:	:
cord-005453-4057qib7	10479	16	1-Non	1-Non	NNP
cord-005453-4057qib7	10479	17	related	related	JJ
cord-005453-4057qib7	10479	18	donors	donor	NNS
cord-005453-4057qib7	10479	19	2-ATG	2-atg	CD
cord-005453-4057qib7	10479	20	,	,	,
cord-005453-4057qib7	10479	21	campath	campath	NN
cord-005453-4057qib7	10479	22	or	or	CC
cord-005453-4057qib7	10479	23	fludarabine	fludarabine	NN
cord-005453-4057qib7	10479	24	in	in	IN
cord-005453-4057qib7	10479	25	the	the	DT
cord-005453-4057qib7	10479	26	conditioning	conditioning	NN
cord-005453-4057qib7	10479	27	3-Presence	3-presence	CD
cord-005453-4057qib7	10479	28	of	of	IN
cord-005453-4057qib7	10479	29	GvHD	GvHD	NNP
cord-005453-4057qib7	10479	30	with	with	IN
cord-005453-4057qib7	10479	31	need	need	NN
cord-005453-4057qib7	10479	32	of	of	IN
cord-005453-4057qib7	10479	33	steroids	steroid	NNS
cord-005453-4057qib7	10479	34	above	above	IN
cord-005453-4057qib7	10479	35	0.5	0.5	CD
cord-005453-4057qib7	10479	36	mg	mg	NNP
cord-005453-4057qib7	10479	37	/	/	SYM
cord-005453-4057qib7	10479	38	kg	kg	NNP
cord-005453-4057qib7	10480	1	We	-PRON-	PRP
cord-005453-4057qib7	10480	2	have	have	VBP
cord-005453-4057qib7	10480	3	analyzed	analyze	VBN
cord-005453-4057qib7	10480	4	the	the	DT
cord-005453-4057qib7	10480	5	patients	patient	NNS
cord-005453-4057qib7	10480	6	submitted	submit	VBN
cord-005453-4057qib7	10480	7	to	to	IN
cord-005453-4057qib7	10480	8	alloBMT	allobmt	RB
cord-005453-4057qib7	10480	9	during	during	IN
cord-005453-4057qib7	10480	10	2016	2016	CD
cord-005453-4057qib7	10480	11	and	and	CC
cord-005453-4057qib7	10480	12	2017	2017	CD
cord-005453-4057qib7	10480	13	.	.	.
cord-005453-4057qib7	10481	1	All	all	DT
cord-005453-4057qib7	10481	2	patients	patient	NNS
cord-005453-4057qib7	10481	3	were	be	VBD
cord-005453-4057qib7	10481	4	first	first	RB
cord-005453-4057qib7	10481	5	admitted	admit	VBN
cord-005453-4057qib7	10481	6	to	to	IN
cord-005453-4057qib7	10481	7	an	an	DT
cord-005453-4057qib7	10481	8	isolation	isolation	NN
cord-005453-4057qib7	10481	9	room	room	NN
cord-005453-4057qib7	10481	10	with	with	IN
cord-005453-4057qib7	10481	11	HEPA	HEPA	NNP
cord-005453-4057qib7	10481	12	filters	filter	NNS
cord-005453-4057qib7	10481	13	.	.	.
cord-005453-4057qib7	10482	1	Patients	patient	NNS
cord-005453-4057qib7	10482	2	under	under	IN
cord-005453-4057qib7	10482	3	secondary	secondary	JJ
cord-005453-4057qib7	10482	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10482	5	were	be	VBD
cord-005453-4057qib7	10482	6	excluded	exclude	VBN
cord-005453-4057qib7	10482	7	.	.	.
cord-005453-4057qib7	10483	1	Breakthrough	breakthrough	JJ
cord-005453-4057qib7	10483	2	fungal	fungal	JJ
cord-005453-4057qib7	10483	3	infections	infection	NNS
cord-005453-4057qib7	10483	4	during	during	IN
cord-005453-4057qib7	10483	5	the	the	DT
cord-005453-4057qib7	10483	6	first	first	JJ
cord-005453-4057qib7	10483	7	year	year	NN
cord-005453-4057qib7	10483	8	and	and	CC
cord-005453-4057qib7	10483	9	toxicity	toxicity	NN
cord-005453-4057qib7	10483	10	leading	lead	VBG
cord-005453-4057qib7	10483	11	to	to	IN
cord-005453-4057qib7	10483	12	discontinuation	discontinuation	NN
cord-005453-4057qib7	10483	13	was	be	VBD
cord-005453-4057qib7	10483	14	evaluated	evaluate	VBN
cord-005453-4057qib7	10483	15	.	.	.
cord-005453-4057qib7	10484	1	Results	result	NNS
cord-005453-4057qib7	10484	2	:	:	:
cord-005453-4057qib7	10485	1	Sixty	sixty	CD
cord-005453-4057qib7	10485	2	six	six	CD
cord-005453-4057qib7	10485	3	patients	patient	NNS
cord-005453-4057qib7	10485	4	were	be	VBD
cord-005453-4057qib7	10485	5	included	include	VBN
cord-005453-4057qib7	10485	6	with	with	IN
cord-005453-4057qib7	10485	7	67	67	CD
cord-005453-4057qib7	10485	8	transplants	transplant	NNS
cord-005453-4057qib7	10485	9	.	.	.
cord-005453-4057qib7	10486	1	Male	male	JJ
cord-005453-4057qib7	10486	2	/	/	SYM
cord-005453-4057qib7	10486	3	female	female	JJ
cord-005453-4057qib7	10486	4	ratio	ratio	NN
cord-005453-4057qib7	10486	5	was	be	VBD
cord-005453-4057qib7	10486	6	36/30	36/30	CD
cord-005453-4057qib7	10486	7	.	.	.
cord-005453-4057qib7	10487	1	The	the	DT
cord-005453-4057qib7	10487	2	age	age	NN
cord-005453-4057qib7	10487	3	range	range	NN
cord-005453-4057qib7	10487	4	was	be	VBD
cord-005453-4057qib7	10487	5	0.6	0.6	CD
cord-005453-4057qib7	10487	6	-	-	SYM
cord-005453-4057qib7	10487	7	64	64	CD
cord-005453-4057qib7	10487	8	yo	yo	NN
cord-005453-4057qib7	10487	9	with	with	IN
cord-005453-4057qib7	10487	10	a	a	DT
cord-005453-4057qib7	10487	11	median	median	NN
cord-005453-4057qib7	10487	12	of	of	IN
cord-005453-4057qib7	10487	13	37	37	CD
cord-005453-4057qib7	10487	14	.	.	.
cord-005453-4057qib7	10488	1	Malignant	malignant	JJ
cord-005453-4057qib7	10488	2	(	(	-LRB-
cord-005453-4057qib7	10488	3	53	53	CD
cord-005453-4057qib7	10488	4	)	)	-RRB-
cord-005453-4057qib7	10488	5	and	and	CC
cord-005453-4057qib7	10488	6	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	10488	7	(	(	-LRB-
cord-005453-4057qib7	10488	8	13)diagnosis	13)diagnosis	CD
cord-005453-4057qib7	10488	9	were	be	VBD
cord-005453-4057qib7	10488	10	included	include	VBN
cord-005453-4057qib7	10488	11	.	.	.
cord-005453-4057qib7	10489	1	Donor	donor	NN
cord-005453-4057qib7	10489	2	type	type	NN
cord-005453-4057qib7	10489	3	was	be	VBD
cord-005453-4057qib7	10489	4	Related	relate	VBN
cord-005453-4057qib7	10489	5	(	(	-LRB-
cord-005453-4057qib7	10489	6	16	16	CD
cord-005453-4057qib7	10489	7	)	)	-RRB-
cord-005453-4057qib7	10489	8	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	10489	9	(	(	-LRB-
cord-005453-4057qib7	10489	10	9	9	CD
cord-005453-4057qib7	10489	11	)	)	-RRB-
cord-005453-4057qib7	10489	12	and	and	CC
cord-005453-4057qib7	10489	13	non	non	JJ
cord-005453-4057qib7	10489	14	-	-	JJ
cord-005453-4057qib7	10489	15	related	related	JJ
cord-005453-4057qib7	10489	16	(	(	-LRB-
cord-005453-4057qib7	10489	17	42	42	CD
cord-005453-4057qib7	10489	18	)	)	-RRB-
cord-005453-4057qib7	10489	19	.	.	.
cord-005453-4057qib7	10490	1	The	the	DT
cord-005453-4057qib7	10490	2	conditioning	conditioning	NN
cord-005453-4057qib7	10490	3	regimen	regimen	NN
cord-005453-4057qib7	10490	4	includes	include	VBZ
cord-005453-4057qib7	10490	5	ATG	ATG	NNP
cord-005453-4057qib7	10490	6	in	in	IN
cord-005453-4057qib7	10490	7	21	21	CD
cord-005453-4057qib7	10490	8	,	,	,
cord-005453-4057qib7	10490	9	campath	campath	NN
cord-005453-4057qib7	10490	10	in	in	IN
cord-005453-4057qib7	10490	11	5	5	CD
cord-005453-4057qib7	10490	12	and	and	CC
cord-005453-4057qib7	10490	13	fludarabine	fludarabine	NN
cord-005453-4057qib7	10490	14	in	in	IN
cord-005453-4057qib7	10490	15	41	41	CD
cord-005453-4057qib7	10490	16	.	.	.
cord-005453-4057qib7	10491	1	Fourteen	fourteen	CD
cord-005453-4057qib7	10491	2	patients	patient	NNS
cord-005453-4057qib7	10491	3	were	be	VBD
cord-005453-4057qib7	10491	4	treated	treat	VBN
cord-005453-4057qib7	10491	5	after	after	IN
cord-005453-4057qib7	10491	6	discharge	discharge	NN
cord-005453-4057qib7	10491	7	with	with	IN
cord-005453-4057qib7	10491	8	fluconazole	fluconazole	NN
cord-005453-4057qib7	10491	9	and	and	CC
cord-005453-4057qib7	10491	10	52	52	CD
cord-005453-4057qib7	10491	11	with	with	IN
cord-005453-4057qib7	10491	12	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10491	13	.	.	.
cord-005453-4057qib7	10492	1	Three	three	CD
cord-005453-4057qib7	10492	2	patients	patient	NNS
cord-005453-4057qib7	10492	3	fluconazole	fluconazole	NN
cord-005453-4057qib7	10492	4	were	be	VBD
cord-005453-4057qib7	10492	5	switched	switch	VBN
cord-005453-4057qib7	10492	6	to	to	IN
cord-005453-4057qib7	10492	7	micafungin	micafungin	NNP
cord-005453-4057qib7	10492	8	for	for	IN
cord-005453-4057qib7	10492	9	hepatic	hepatic	JJ
cord-005453-4057qib7	10492	10	toxicity	toxicity	NN
cord-005453-4057qib7	10492	11	,	,	,
cord-005453-4057qib7	10492	12	two	two	CD
cord-005453-4057qib7	10492	13	cases	case	NNS
cord-005453-4057qib7	10492	14	to	to	IN
cord-005453-4057qib7	10492	15	amphotericin	amphotericin	NNS
cord-005453-4057qib7	10492	16	due	due	IN
cord-005453-4057qib7	10492	17	to	to	IN
cord-005453-4057qib7	10492	18	persistent	persistent	JJ
cord-005453-4057qib7	10492	19	fever	fever	NN
cord-005453-4057qib7	10492	20	and	and	CC
cord-005453-4057qib7	10492	21	in	in	IN
cord-005453-4057qib7	10492	22	one	one	CD
cord-005453-4057qib7	10492	23	case	case	NN
cord-005453-4057qib7	10492	24	to	to	IN
cord-005453-4057qib7	10492	25	caspofungin	caspofungin	NNP
cord-005453-4057qib7	10492	26	for	for	IN
cord-005453-4057qib7	10492	27	a	a	DT
cord-005453-4057qib7	10492	28	proven	prove	VBN
cord-005453-4057qib7	10492	29	fungal	fungal	JJ
cord-005453-4057qib7	10492	30	infection	infection	NN
cord-005453-4057qib7	10492	31	(	(	-LRB-
cord-005453-4057qib7	10492	32	candida	candida	NNP
cord-005453-4057qib7	10492	33	parapsilosis	parapsilosis	NN
cord-005453-4057qib7	10492	34	in	in	IN
cord-005453-4057qib7	10492	35	blood	blood	NN
cord-005453-4057qib7	10492	36	stream	stream	NN
cord-005453-4057qib7	10492	37	in	in	IN
cord-005453-4057qib7	10492	38	day	day	NN
cord-005453-4057qib7	10492	39	+18	+18	CD
cord-005453-4057qib7	10492	40	)	)	-RRB-
cord-005453-4057qib7	10492	41	.	.	.
cord-005453-4057qib7	10493	1	After	after	IN
cord-005453-4057qib7	10493	2	discharge	discharge	NN
cord-005453-4057qib7	10493	3	and	and	CC
cord-005453-4057qib7	10493	4	during	during	IN
cord-005453-4057qib7	10493	5	the	the	DT
cord-005453-4057qib7	10493	6	first	first	JJ
cord-005453-4057qib7	10493	7	year	year	NN
cord-005453-4057qib7	10493	8	of	of	IN
cord-005453-4057qib7	10493	9	follow	follow	NN
cord-005453-4057qib7	10493	10	-	-	HYPH
cord-005453-4057qib7	10493	11	up	up	NN
cord-005453-4057qib7	10493	12	a	a	DT
cord-005453-4057qib7	10493	13	single	single	JJ
cord-005453-4057qib7	10493	14	case	case	NN
cord-005453-4057qib7	10493	15	of	of	IN
cord-005453-4057qib7	10493	16	possible	possible	JJ
cord-005453-4057qib7	10493	17	fungal	fungal	JJ
cord-005453-4057qib7	10493	18	infection	infection	NN
cord-005453-4057qib7	10493	19	was	be	VBD
cord-005453-4057qib7	10493	20	diagnosed	diagnose	VBN
cord-005453-4057qib7	10493	21	,	,	,
cord-005453-4057qib7	10493	22	in	in	IN
cord-005453-4057qib7	10493	23	a	a	DT
cord-005453-4057qib7	10493	24	patient	patient	NN
cord-005453-4057qib7	10493	25	with	with	IN
cord-005453-4057qib7	10493	26	GvHD	GvHD	NNP
cord-005453-4057qib7	10493	27	with	with	IN
cord-005453-4057qib7	10493	28	a	a	DT
cord-005453-4057qib7	10493	29	lung	lung	NN
cord-005453-4057qib7	10493	30	nodule	nodule	NN
cord-005453-4057qib7	10493	31	.	.	.
cord-005453-4057qib7	10494	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10494	2	:	:	:
cord-005453-4057qib7	10495	1	During	during	IN
cord-005453-4057qib7	10495	2	the	the	DT
cord-005453-4057qib7	10495	3	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10495	4	period	period	NN
cord-005453-4057qib7	10495	5	after	after	IN
cord-005453-4057qib7	10495	6	transplantation	transplantation	NN
cord-005453-4057qib7	10495	7	the	the	DT
cord-005453-4057qib7	10495	8	main	main	JJ
cord-005453-4057qib7	10495	9	risk	risk	NN
cord-005453-4057qib7	10495	10	of	of	IN
cord-005453-4057qib7	10495	11	fungal	fungal	JJ
cord-005453-4057qib7	10495	12	infection	infection	NN
cord-005453-4057qib7	10495	13	is	be	VBZ
cord-005453-4057qib7	10495	14	associated	associate	VBN
cord-005453-4057qib7	10495	15	with	with	IN
cord-005453-4057qib7	10495	16	candidiasis	candidiasi	NNS
cord-005453-4057qib7	10495	17	.	.	.
cord-005453-4057qib7	10496	1	The	the	DT
cord-005453-4057qib7	10496	2	greatest	great	JJS
cord-005453-4057qib7	10496	3	risk	risk	NN
cord-005453-4057qib7	10496	4	of	of	IN
cord-005453-4057qib7	10496	5	aspergillosis	aspergillosis	NN
cord-005453-4057qib7	10496	6	occurs	occur	VBZ
cord-005453-4057qib7	10496	7	later	later	RB
cord-005453-4057qib7	10496	8	and	and	CC
cord-005453-4057qib7	10496	9	have	have	VBP
cord-005453-4057qib7	10496	10	a	a	DT
cord-005453-4057qib7	10496	11	significant	significant	JJ
cord-005453-4057qib7	10496	12	relation	relation	NN
cord-005453-4057qib7	10496	13	with	with	IN
cord-005453-4057qib7	10496	14	GvHD	GvHD	NNP
cord-005453-4057qib7	10496	15	.	.	.
cord-005453-4057qib7	10497	1	Except	except	IN
cord-005453-4057qib7	10497	2	for	for	IN
cord-005453-4057qib7	10497	3	candida	candida	NN
cord-005453-4057qib7	10497	4	parapsilosis	parapsilosis	NNP
cord-005453-4057qib7	10497	5	the	the	DT
cord-005453-4057qib7	10497	6	main	main	JJ
cord-005453-4057qib7	10497	7	source	source	NN
cord-005453-4057qib7	10497	8	of	of	IN
cord-005453-4057qib7	10497	9	yeasts	yeast	NNS
cord-005453-4057qib7	10497	10	are	be	VBP
cord-005453-4057qib7	10497	11	the	the	DT
cord-005453-4057qib7	10497	12	GI	GI	NNP
cord-005453-4057qib7	10497	13	tract	tract	NN
cord-005453-4057qib7	10497	14	.	.	.
cord-005453-4057qib7	10498	1	The	the	DT
cord-005453-4057qib7	10498	2	main	main	JJ
cord-005453-4057qib7	10498	3	source	source	NN
cord-005453-4057qib7	10498	4	of	of	IN
cord-005453-4057qib7	10498	5	aspergillus	aspergillus	NN
cord-005453-4057qib7	10498	6	are	be	VBP
cord-005453-4057qib7	10498	7	aerosolized	aerosolize	VBN
cord-005453-4057qib7	10498	8	particles	particle	NNS
cord-005453-4057qib7	10498	9	retained	retain	VBN
cord-005453-4057qib7	10498	10	by	by	IN
cord-005453-4057qib7	10498	11	HEPA	HEPA	NNP
cord-005453-4057qib7	10498	12	filters	filter	NNS
cord-005453-4057qib7	10498	13	.	.	.
cord-005453-4057qib7	10499	1	In	in	IN
cord-005453-4057qib7	10499	2	patients	patient	NNS
cord-005453-4057qib7	10499	3	without	without	IN
cord-005453-4057qib7	10499	4	a	a	DT
cord-005453-4057qib7	10499	5	previous	previous	JJ
cord-005453-4057qib7	10499	6	episode	episode	NN
cord-005453-4057qib7	10499	7	of	of	IN
cord-005453-4057qib7	10499	8	fungal	fungal	JJ
cord-005453-4057qib7	10499	9	infection	infection	NN
cord-005453-4057qib7	10499	10	the	the	DT
cord-005453-4057qib7	10499	11	main	main	JJ
cord-005453-4057qib7	10499	12	risk	risk	NN
cord-005453-4057qib7	10499	13	of	of	IN
cord-005453-4057qib7	10499	14	filamentous	filamentous	JJ
cord-005453-4057qib7	10499	15	fungi	fungus	NNS
cord-005453-4057qib7	10499	16	occurs	occur	VBZ
cord-005453-4057qib7	10499	17	only	only	RB
cord-005453-4057qib7	10499	18	after	after	IN
cord-005453-4057qib7	10499	19	discharge	discharge	NN
cord-005453-4057qib7	10499	20	.	.	.
cord-005453-4057qib7	10500	1	We	-PRON-	PRP
cord-005453-4057qib7	10500	2	conclude	conclude	VBP
cord-005453-4057qib7	10500	3	that	that	IN
cord-005453-4057qib7	10500	4	fluconazole	fluconazole	NN
cord-005453-4057qib7	10500	5	alone	alone	RB
cord-005453-4057qib7	10500	6	or	or	CC
cord-005453-4057qib7	10500	7	followed	follow	VBN
cord-005453-4057qib7	10500	8	by	by	IN
cord-005453-4057qib7	10500	9	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10500	10	in	in	IN
cord-005453-4057qib7	10500	11	high	high	JJ
cord-005453-4057qib7	10500	12	risk	risk	NN
cord-005453-4057qib7	10500	13	patients	patient	NNS
cord-005453-4057qib7	10500	14	is	be	VBZ
cord-005453-4057qib7	10500	15	a	a	DT
cord-005453-4057qib7	10500	16	feasible	feasible	JJ
cord-005453-4057qib7	10500	17	and	and	CC
cord-005453-4057qib7	10500	18	effective	effective	JJ
cord-005453-4057qib7	10500	19	regimen	regimen	NN
cord-005453-4057qib7	10500	20	for	for	IN
cord-005453-4057qib7	10500	21	primary	primary	JJ
cord-005453-4057qib7	10500	22	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10500	23	,	,	,
cord-005453-4057qib7	10500	24	in	in	IN
cord-005453-4057qib7	10500	25	allogeneic	allogeneic	NN
cord-005453-4057qib7	10500	26	transplantation	transplantation	NN
cord-005453-4057qib7	10500	27	.	.	.
cord-005453-4057qib7	10501	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10501	2	Background	background	NN
cord-005453-4057qib7	10501	3	:	:	:
cord-005453-4057qib7	10501	4	BK	BK	NNP
cord-005453-4057qib7	10501	5	virus	virus	NN
cord-005453-4057qib7	10501	6	-	-	HYPH
cord-005453-4057qib7	10501	7	associated	associate	VBN
cord-005453-4057qib7	10501	8	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	10501	9	cystitis	cystitis	NN
cord-005453-4057qib7	10501	10	(	(	-LRB-
cord-005453-4057qib7	10501	11	BKV	BKV	NNP
cord-005453-4057qib7	10501	12	-	-	HYPH
cord-005453-4057qib7	10501	13	HC	HC	NNP
cord-005453-4057qib7	10501	14	)	)	-RRB-
cord-005453-4057qib7	10501	15	has	have	VBZ
cord-005453-4057qib7	10501	16	emerged	emerge	VBN
cord-005453-4057qib7	10501	17	as	as	IN
cord-005453-4057qib7	10501	18	a	a	DT
cord-005453-4057qib7	10501	19	serious	serious	JJ
cord-005453-4057qib7	10501	20	infection	infection	NN
cord-005453-4057qib7	10501	21	after	after	IN
cord-005453-4057qib7	10501	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10501	23	stem	stem	NN
cord-005453-4057qib7	10501	24	cell	cell	NN
cord-005453-4057qib7	10501	25	transplantation	transplantation	NN
cord-005453-4057qib7	10501	26	(	(	-LRB-
cord-005453-4057qib7	10501	27	HSCT	HSCT	NNP
cord-005453-4057qib7	10501	28	)	)	-RRB-
cord-005453-4057qib7	10501	29	.	.	.
cord-005453-4057qib7	10502	1	It	-PRON-	PRP
cord-005453-4057qib7	10502	2	is	be	VBZ
cord-005453-4057qib7	10502	3	characterized	characterize	VBN
cord-005453-4057qib7	10502	4	by	by	IN
cord-005453-4057qib7	10502	5	painful	painful	JJ
cord-005453-4057qib7	10502	6	hematuria	hematuria	NN
cord-005453-4057qib7	10502	7	due	due	IN
cord-005453-4057qib7	10502	8	to	to	IN
cord-005453-4057qib7	10502	9	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	10502	10	inflammation	inflammation	NN
cord-005453-4057qib7	10502	11	of	of	IN
cord-005453-4057qib7	10502	12	the	the	DT
cord-005453-4057qib7	10502	13	urinary	urinary	JJ
cord-005453-4057qib7	10502	14	bladder	bladder	NN
cord-005453-4057qib7	10502	15	mucosa	mucosa	NN
cord-005453-4057qib7	10502	16	,	,	,
cord-005453-4057qib7	10502	17	this	this	DT
cord-005453-4057qib7	10502	18	causes	cause	VBZ
cord-005453-4057qib7	10502	19	significant	significant	JJ
cord-005453-4057qib7	10502	20	morbidity	morbidity	NN
cord-005453-4057qib7	10502	21	,	,	,
cord-005453-4057qib7	10502	22	prolonged	prolonged	JJ
cord-005453-4057qib7	10502	23	hospital	hospital	NN
cord-005453-4057qib7	10502	24	care	care	NN
cord-005453-4057qib7	10502	25	with	with	IN
cord-005453-4057qib7	10502	26	extensive	extensive	JJ
cord-005453-4057qib7	10502	27	nursing	nursing	NN
cord-005453-4057qib7	10502	28	requirements	requirement	NNS
cord-005453-4057qib7	10502	29	and	and	CC
cord-005453-4057qib7	10502	30	increases	increase	NNS
cord-005453-4057qib7	10502	31	in	in	IN
cord-005453-4057qib7	10502	32	healthcare	healthcare	NN
cord-005453-4057qib7	10502	33	costs	cost	NNS
cord-005453-4057qib7	10502	34	.	.	.
cord-005453-4057qib7	10503	1	The	the	DT
cord-005453-4057qib7	10503	2	purpose	purpose	NN
cord-005453-4057qib7	10503	3	of	of	IN
cord-005453-4057qib7	10503	4	this	this	DT
cord-005453-4057qib7	10503	5	study	study	NN
cord-005453-4057qib7	10503	6	is	be	VBZ
cord-005453-4057qib7	10503	7	to	to	TO
cord-005453-4057qib7	10503	8	determine	determine	VB
cord-005453-4057qib7	10503	9	the	the	DT
cord-005453-4057qib7	10503	10	incidence	incidence	NN
cord-005453-4057qib7	10503	11	,	,	,
cord-005453-4057qib7	10503	12	risk	risk	NN
cord-005453-4057qib7	10503	13	factors	factor	NNS
cord-005453-4057qib7	10503	14	,	,	,
cord-005453-4057qib7	10503	15	and	and	CC
cord-005453-4057qib7	10503	16	duration	duration	NN
cord-005453-4057qib7	10503	17	of	of	IN
cord-005453-4057qib7	10503	18	treatment	treatment	NN
cord-005453-4057qib7	10503	19	in	in	IN
cord-005453-4057qib7	10503	20	our	-PRON-	PRP$
cord-005453-4057qib7	10503	21	center	center	NN
cord-005453-4057qib7	10503	22	.	.	.
cord-005453-4057qib7	10504	1	Methods	method	NNS
cord-005453-4057qib7	10504	2	:	:	:
cord-005453-4057qib7	10504	3	We	-PRON-	PRP
cord-005453-4057qib7	10504	4	performed	perform	VBD
cord-005453-4057qib7	10504	5	a	a	DT
cord-005453-4057qib7	10504	6	retrospective	retrospective	JJ
cord-005453-4057qib7	10504	7	review	review	NN
cord-005453-4057qib7	10504	8	of	of	IN
cord-005453-4057qib7	10504	9	HSCT	HSCT	NNP
cord-005453-4057qib7	10504	10	patients	patient	NNS
cord-005453-4057qib7	10504	11	at	at	IN
cord-005453-4057qib7	10504	12	Luis	Luis	NNP
cord-005453-4057qib7	10504	13	Calvo	Calvo	NNP
cord-005453-4057qib7	10504	14	Mackenna	Mackenna	NNP
cord-005453-4057qib7	10504	15	Children´s	Children´s	NNP
cord-005453-4057qib7	10504	16	Hospital	Hospital	NNP
cord-005453-4057qib7	10504	17	in	in	IN
cord-005453-4057qib7	10504	18	Santiago	Santiago	NNP
cord-005453-4057qib7	10504	19	,	,	,
cord-005453-4057qib7	10504	20	Chile	Chile	NNP
cord-005453-4057qib7	10504	21	diagnosed	diagnose	VBD
cord-005453-4057qib7	10504	22	with	with	IN
cord-005453-4057qib7	10504	23	BKV	BKV	NNP
cord-005453-4057qib7	10504	24	-	-	HYPH
cord-005453-4057qib7	10504	25	HC	HC	NNP
cord-005453-4057qib7	10504	26	,	,	,
cord-005453-4057qib7	10504	27	from	from	IN
cord-005453-4057qib7	10504	28	1st	1st	JJ
cord-005453-4057qib7	10504	29	January	January	NNP
cord-005453-4057qib7	10504	30	2016	2016	CD
cord-005453-4057qib7	10504	31	to	to	IN
cord-005453-4057qib7	10504	32	30th	30th	JJ
cord-005453-4057qib7	10504	33	November	November	NNP
cord-005453-4057qib7	10504	34	2018	2018	CD
cord-005453-4057qib7	10504	35	.	.	.
cord-005453-4057qib7	10505	1	We	-PRON-	PRP
cord-005453-4057qib7	10505	2	investigated	investigate	VBD
cord-005453-4057qib7	10505	3	the	the	DT
cord-005453-4057qib7	10505	4	incidence	incidence	NN
cord-005453-4057qib7	10505	5	,	,	,
cord-005453-4057qib7	10505	6	risk	risk	NN
cord-005453-4057qib7	10505	7	factors	factor	NNS
cord-005453-4057qib7	10505	8	and	and	CC
cord-005453-4057qib7	10505	9	duration	duration	NN
cord-005453-4057qib7	10505	10	of	of	IN
cord-005453-4057qib7	10505	11	treatment	treatment	NN
cord-005453-4057qib7	10505	12	of	of	IN
cord-005453-4057qib7	10505	13	BKV	BKV	NNP
cord-005453-4057qib7	10505	14	-	-	HYPH
cord-005453-4057qib7	10505	15	HC	HC	NNP
cord-005453-4057qib7	10505	16	in	in	IN
cord-005453-4057qib7	10505	17	paediatric	paediatric	JJ
cord-005453-4057qib7	10505	18	patients	patient	NNS
cord-005453-4057qib7	10505	19	undergoing	undergo	VBG
cord-005453-4057qib7	10505	20	HSCT	HSCT	NNP
cord-005453-4057qib7	10505	21	over	over	IN
cord-005453-4057qib7	10505	22	a	a	DT
cord-005453-4057qib7	10505	23	35	35	CD
cord-005453-4057qib7	10505	24	months	month	NNS
cord-005453-4057qib7	10505	25	period	period	NN
cord-005453-4057qib7	10505	26	.	.	.
cord-005453-4057qib7	10506	1	BKV	BKV	NNP
cord-005453-4057qib7	10506	2	-	-	HYPH
cord-005453-4057qib7	10506	3	HC	HC	NNP
cord-005453-4057qib7	10506	4	was	be	VBD
cord-005453-4057qib7	10506	5	defined	define	VBN
cord-005453-4057qib7	10506	6	as	as	IN
cord-005453-4057qib7	10506	7	BK	BK	NNP
cord-005453-4057qib7	10506	8	virus	virus	NN
cord-005453-4057qib7	10506	9	(	(	-LRB-
cord-005453-4057qib7	10506	10	BKV	bkv	NN
cord-005453-4057qib7	10506	11	)	)	-RRB-
cord-005453-4057qib7	10506	12	detection	detection	NN
cord-005453-4057qib7	10506	13	in	in	IN
cord-005453-4057qib7	10506	14	urine	urine	NN
cord-005453-4057qib7	10506	15	by	by	IN
cord-005453-4057qib7	10506	16	PCR	PCR	NNP
cord-005453-4057qib7	10506	17	testing	testing	NN
cord-005453-4057qib7	10506	18	in	in	IN
cord-005453-4057qib7	10506	19	association	association	NN
cord-005453-4057qib7	10506	20	with	with	IN
cord-005453-4057qib7	10506	21	clinical	clinical	JJ
cord-005453-4057qib7	10506	22	symptoms	symptom	NNS
cord-005453-4057qib7	10506	23	and	and	CC
cord-005453-4057qib7	10506	24	hematuria	hematuria	NN
cord-005453-4057qib7	10506	25	grade	grade	NN
cord-005453-4057qib7	10506	26	2	2	CD
cord-005453-4057qib7	10506	27	or	or	CC
cord-005453-4057qib7	10506	28	higher	high	JJR
cord-005453-4057qib7	10506	29	.	.	.
cord-005453-4057qib7	10507	1	Sixty	sixty	CD
cord-005453-4057qib7	10507	2	-	-	HYPH
cord-005453-4057qib7	10507	3	seven	seven	CD
cord-005453-4057qib7	10507	4	patients	patient	NNS
cord-005453-4057qib7	10507	5	were	be	VBD
cord-005453-4057qib7	10507	6	trasplanted	trasplante	VBN
cord-005453-4057qib7	10507	7	during	during	IN
cord-005453-4057qib7	10507	8	this	this	DT
cord-005453-4057qib7	10507	9	period	period	NN
cord-005453-4057qib7	10507	10	.	.	.
cord-005453-4057qib7	10508	1	Results	result	NNS
cord-005453-4057qib7	10508	2	:	:	:
cord-005453-4057qib7	10509	1	Eleven	eleven	CD
cord-005453-4057qib7	10509	2	patients	patient	NNS
cord-005453-4057qib7	10509	3	were	be	VBD
cord-005453-4057qib7	10509	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	10509	5	with	with	IN
cord-005453-4057qib7	10509	6	BKV	BKV	NNP
cord-005453-4057qib7	10509	7	-	-	HYPH
cord-005453-4057qib7	10509	8	HC	HC	NNP
cord-005453-4057qib7	10509	9	at	at	IN
cord-005453-4057qib7	10509	10	our	-PRON-	PRP$
cord-005453-4057qib7	10509	11	institution	institution	NN
cord-005453-4057qib7	10509	12	,	,	,
cord-005453-4057qib7	10509	13	only	only	RB
cord-005453-4057qib7	10509	14	one	one	CD
cord-005453-4057qib7	10509	15	with	with	IN
cord-005453-4057qib7	10509	16	BK	BK	NNP
cord-005453-4057qib7	10509	17	viremia	viremia	NN
cord-005453-4057qib7	10509	18	.	.	.
cord-005453-4057qib7	10510	1	The	the	DT
cord-005453-4057qib7	10510	2	cumulative	cumulative	JJ
cord-005453-4057qib7	10510	3	incidence	incidence	NN
cord-005453-4057qib7	10510	4	of	of	IN
cord-005453-4057qib7	10510	5	BKV	BKV	NNP
cord-005453-4057qib7	10510	6	-	-	HYPH
cord-005453-4057qib7	10510	7	HC	HC	NNP
cord-005453-4057qib7	10510	8	in	in	IN
cord-005453-4057qib7	10510	9	our	-PRON-	PRP$
cord-005453-4057qib7	10510	10	series	series	NN
cord-005453-4057qib7	10510	11	was	be	VBD
cord-005453-4057qib7	10510	12	16	16	CD
cord-005453-4057qib7	10510	13	%	%	NN
cord-005453-4057qib7	10510	14	.	.	.
cord-005453-4057qib7	10511	1	All	all	DT
cord-005453-4057qib7	10511	2	of	of	IN
cord-005453-4057qib7	10511	3	them	-PRON-	PRP
cord-005453-4057qib7	10511	4	were	be	VBD
cord-005453-4057qib7	10511	5	treated	treat	VBN
cord-005453-4057qib7	10511	6	with	with	IN
cord-005453-4057qib7	10511	7	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10511	8	.	.	.
cord-005453-4057qib7	10512	1	The	the	DT
cord-005453-4057qib7	10512	2	median	median	JJ
cord-005453-4057qib7	10512	3	age	age	NN
cord-005453-4057qib7	10512	4	at	at	IN
cord-005453-4057qib7	10512	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	10512	6	was	be	VBD
cord-005453-4057qib7	10512	7	9	9	CD
cord-005453-4057qib7	10512	8	years	year	NNS
cord-005453-4057qib7	10512	9	old	old	JJ
cord-005453-4057qib7	10513	1	(	(	-LRB-
cord-005453-4057qib7	10513	2	range	range	NN
cord-005453-4057qib7	10513	3	:	:	:
cord-005453-4057qib7	10513	4	3	3	CD
cord-005453-4057qib7	10513	5	-	-	SYM
cord-005453-4057qib7	10513	6	13	13	CD
cord-005453-4057qib7	10513	7	y.o	y.o	NNP
cord-005453-4057qib7	10513	8	.	.	NNP
cord-005453-4057qib7	10513	9	)	)	-RRB-
cord-005453-4057qib7	10513	10	.	.	.
cord-005453-4057qib7	10514	1	The	the	DT
cord-005453-4057qib7	10514	2	median	median	JJ
cord-005453-4057qib7	10514	3	time	time	NN
cord-005453-4057qib7	10514	4	from	from	IN
cord-005453-4057qib7	10514	5	HSCT	HSCT	NNP
cord-005453-4057qib7	10514	6	to	to	IN
cord-005453-4057qib7	10514	7	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	10514	8	cystitis	cystitis	NN
cord-005453-4057qib7	10514	9	(	(	-LRB-
cord-005453-4057qib7	10514	10	HC	HC	NNP
cord-005453-4057qib7	10514	11	)	)	-RRB-
cord-005453-4057qib7	10514	12	was	be	VBD
cord-005453-4057qib7	10514	13	40	40	CD
cord-005453-4057qib7	10514	14	days	day	NNS
cord-005453-4057qib7	10515	1	(	(	-LRB-
cord-005453-4057qib7	10515	2	range	range	NN
cord-005453-4057qib7	10515	3	:	:	:
cord-005453-4057qib7	10515	4	25	25	CD
cord-005453-4057qib7	10515	5	-	-	SYM
cord-005453-4057qib7	10515	6	240	240	CD
cord-005453-4057qib7	10515	7	days	day	NNS
cord-005453-4057qib7	10515	8	)	)	-RRB-
cord-005453-4057qib7	10515	9	,	,	,
cord-005453-4057qib7	10515	10	the	the	DT
cord-005453-4057qib7	10515	11	median	median	JJ
cord-005453-4057qib7	10515	12	length	length	NN
cord-005453-4057qib7	10515	13	of	of	IN
cord-005453-4057qib7	10515	14	treatment	treatment	NN
cord-005453-4057qib7	10515	15	was	be	VBD
cord-005453-4057qib7	10515	16	9	9	CD
cord-005453-4057qib7	10515	17	weeks	week	NNS
cord-005453-4057qib7	10516	1	(	(	-LRB-
cord-005453-4057qib7	10516	2	range	range	NN
cord-005453-4057qib7	10516	3	:	:	:
cord-005453-4057qib7	10516	4	2	2	CD
cord-005453-4057qib7	10516	5	-	-	SYM
cord-005453-4057qib7	10516	6	36	36	CD
cord-005453-4057qib7	10516	7	)	)	-RRB-
cord-005453-4057qib7	10516	8	.	.	.
cord-005453-4057qib7	10517	1	All	all	DT
cord-005453-4057qib7	10517	2	patients	patient	NNS
cord-005453-4057qib7	10517	3	received	receive	VBD
cord-005453-4057qib7	10517	4	myeloablative	myeloablative	JJ
cord-005453-4057qib7	10517	5	conditioning	conditioning	NN
cord-005453-4057qib7	10517	6	regimens	regimen	NNS
cord-005453-4057qib7	10517	7	and	and	CC
cord-005453-4057qib7	10517	8	used	use	VBN
cord-005453-4057qib7	10517	9	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	10517	10	(	(	-LRB-
cord-005453-4057qib7	10517	11	100	100	CD
cord-005453-4057qib7	10517	12	%	%	NN
cord-005453-4057qib7	10517	13	)	)	-RRB-
cord-005453-4057qib7	10517	14	;	;	:
cord-005453-4057qib7	10517	15	ten	ten	CD
cord-005453-4057qib7	10517	16	(	(	-LRB-
cord-005453-4057qib7	10517	17	90	90	CD
cord-005453-4057qib7	10517	18	%	%	NN
cord-005453-4057qib7	10517	19	)	)	-RRB-
cord-005453-4057qib7	10517	20	were	be	VBD
cord-005453-4057qib7	10517	21	unrelated	unrelated	JJ
cord-005453-4057qib7	10517	22	cord	cord	NN
cord-005453-4057qib7	10517	23	blood	blood	NN
cord-005453-4057qib7	10517	24	transplant	transplant	NN
cord-005453-4057qib7	10517	25	recipients	recipient	NNS
cord-005453-4057qib7	10517	26	and	and	CC
cord-005453-4057qib7	10517	27	nine	nine	CD
cord-005453-4057qib7	10517	28	(	(	-LRB-
cord-005453-4057qib7	10517	29	81	81	CD
cord-005453-4057qib7	10517	30	%	%	NN
cord-005453-4057qib7	10517	31	)	)	-RRB-
cord-005453-4057qib7	10517	32	used	use	VBD
cord-005453-4057qib7	10517	33	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	10517	34	globulin	globulin	NN
cord-005453-4057qib7	10517	35	.	.	.
cord-005453-4057qib7	10518	1	A	a	DT
cord-005453-4057qib7	10518	2	concomitant	concomitant	JJ
cord-005453-4057qib7	10518	3	viral	viral	JJ
cord-005453-4057qib7	10518	4	reactivation	reactivation	NN
cord-005453-4057qib7	10518	5	(	(	-LRB-
cord-005453-4057qib7	10518	6	CMV	CMV	NNP
cord-005453-4057qib7	10518	7	/	/	SYM
cord-005453-4057qib7	10518	8	VH6	VH6	NNP
cord-005453-4057qib7	10518	9	)	)	-RRB-
cord-005453-4057qib7	10518	10	was	be	VBD
cord-005453-4057qib7	10518	11	demonstrated	demonstrate	VBN
cord-005453-4057qib7	10518	12	in	in	IN
cord-005453-4057qib7	10518	13	six	six	CD
cord-005453-4057qib7	10518	14	(	(	-LRB-
cord-005453-4057qib7	10518	15	56	56	CD
cord-005453-4057qib7	10518	16	%	%	NN
cord-005453-4057qib7	10518	17	)	)	-RRB-
cord-005453-4057qib7	10518	18	patients	patient	NNS
cord-005453-4057qib7	10518	19	.	.	.
cord-005453-4057qib7	10519	1	No	no	DT
cord-005453-4057qib7	10519	2	patient	patient	NN
cord-005453-4057qib7	10519	3	died	die	VBD
cord-005453-4057qib7	10519	4	due	due	IN
cord-005453-4057qib7	10519	5	to	to	IN
cord-005453-4057qib7	10519	6	BKV	BKV	NNP
cord-005453-4057qib7	10519	7	-	-	HYPH
cord-005453-4057qib7	10519	8	HC	HC	NNP
cord-005453-4057qib7	10519	9	or	or	CC
cord-005453-4057qib7	10519	10	its	-PRON-	PRP$
cord-005453-4057qib7	10519	11	complications	complication	NNS
cord-005453-4057qib7	10519	12	,	,	,
cord-005453-4057qib7	10519	13	but	but	CC
cord-005453-4057qib7	10519	14	in	in	IN
cord-005453-4057qib7	10519	15	the	the	DT
cord-005453-4057qib7	10519	16	follow	follow	NN
cord-005453-4057qib7	10519	17	up	up	RP
cord-005453-4057qib7	10519	18	three	three	CD
cord-005453-4057qib7	10519	19	patients	patient	NNS
cord-005453-4057qib7	10519	20	died	die	VBD
cord-005453-4057qib7	10519	21	,	,	,
cord-005453-4057qib7	10519	22	one	one	CD
cord-005453-4057qib7	10519	23	in	in	IN
cord-005453-4057qib7	10519	24	relapse	relapse	NN
cord-005453-4057qib7	10519	25	and	and	CC
cord-005453-4057qib7	10519	26	two	two	CD
cord-005453-4057qib7	10519	27	of	of	IN
cord-005453-4057qib7	10519	28	other	other	JJ
cord-005453-4057qib7	10519	29	post	post	NN
cord-005453-4057qib7	10519	30	transplant´s	transplant´s	NNP
cord-005453-4057qib7	10519	31	complications	complication	NNS
cord-005453-4057qib7	10519	32	.	.	.
cord-005453-4057qib7	10520	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10520	2	:	:	:
cord-005453-4057qib7	10521	1	BKV	BKV	NNP
cord-005453-4057qib7	10521	2	-	-	HYPH
cord-005453-4057qib7	10521	3	HC	HC	NNP
cord-005453-4057qib7	10521	4	is	be	VBZ
cord-005453-4057qib7	10521	5	the	the	DT
cord-005453-4057qib7	10521	6	result	result	NN
cord-005453-4057qib7	10521	7	of	of	IN
cord-005453-4057qib7	10521	8	a	a	DT
cord-005453-4057qib7	10521	9	complex	complex	JJ
cord-005453-4057qib7	10521	10	interaction	interaction	NN
cord-005453-4057qib7	10521	11	between	between	IN
cord-005453-4057qib7	10521	12	patient	patient	JJ
cord-005453-4057qib7	10521	13	characteristics	characteristic	NNS
cord-005453-4057qib7	10521	14	,	,	,
cord-005453-4057qib7	10521	15	donor	donor	NN
cord-005453-4057qib7	10521	16	type	type	NN
cord-005453-4057qib7	10521	17	and	and	CC
cord-005453-4057qib7	10521	18	conditioning	conditioning	NN
cord-005453-4057qib7	10521	19	regimen	regimen	NN
cord-005453-4057qib7	10521	20	intensity	intensity	NN
cord-005453-4057qib7	10521	21	.	.	.
cord-005453-4057qib7	10522	1	These	these	DT
cord-005453-4057qib7	10522	2	patients	patient	NNS
cord-005453-4057qib7	10522	3	experienced	experience	VBD
cord-005453-4057qib7	10522	4	significant	significant	JJ
cord-005453-4057qib7	10522	5	morbidity	morbidity	NN
cord-005453-4057qib7	10522	6	and	and	CC
cord-005453-4057qib7	10522	7	prolonged	prolong	VBN
cord-005453-4057qib7	10522	8	treatment	treatment	NN
cord-005453-4057qib7	10522	9	.	.	.
cord-005453-4057qib7	10523	1	In	in	IN
cord-005453-4057qib7	10523	2	our	-PRON-	PRP$
cord-005453-4057qib7	10523	3	cohort	cohort	JJ
cord-005453-4057qib7	10523	4	BKV	BKV	NNP
cord-005453-4057qib7	10523	5	-	-	HYPH
cord-005453-4057qib7	10523	6	HC	HC	NNP
cord-005453-4057qib7	10523	7	of	of	IN
cord-005453-4057qib7	10523	8	all	all	DT
cord-005453-4057qib7	10523	9	patients	patient	NNS
cord-005453-4057qib7	10523	10	but	but	CC
cord-005453-4057qib7	10523	11	one	one	CD
cord-005453-4057qib7	10523	12	were	be	VBD
cord-005453-4057qib7	10523	13	transplanted	transplant	VBN
cord-005453-4057qib7	10523	14	with	with	IN
cord-005453-4057qib7	10523	15	an	an	DT
cord-005453-4057qib7	10523	16	unrelated	unrelated	JJ
cord-005453-4057qib7	10523	17	umbilical	umbilical	JJ
cord-005453-4057qib7	10523	18	cord	cord	NN
cord-005453-4057qib7	10523	19	blood	blood	NN
cord-005453-4057qib7	10523	20	unit	unit	NN
cord-005453-4057qib7	10523	21	,	,	,
cord-005453-4057qib7	10523	22	all	all	DT
cord-005453-4057qib7	10523	23	of	of	IN
cord-005453-4057qib7	10523	24	them	-PRON-	PRP
cord-005453-4057qib7	10523	25	received	receive	VBD
cord-005453-4057qib7	10523	26	myeloablative	myeloablative	JJ
cord-005453-4057qib7	10523	27	conditioning	conditioning	NN
cord-005453-4057qib7	10523	28	regimen	regimen	NN
cord-005453-4057qib7	10523	29	with	with	IN
cord-005453-4057qib7	10523	30	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	10523	31	and	and	CC
cord-005453-4057qib7	10523	32	most	most	JJS
cord-005453-4057qib7	10523	33	of	of	IN
cord-005453-4057qib7	10523	34	them	-PRON-	PRP
cord-005453-4057qib7	10523	35	received	receive	VBD
cord-005453-4057qib7	10523	36	anti	anti	JJ
cord-005453-4057qib7	10523	37	-	-	JJ
cord-005453-4057qib7	10523	38	thymocyte	thymocyte	JJ
cord-005453-4057qib7	10523	39	globulin	globulin	NN
cord-005453-4057qib7	10523	40	.	.	.
cord-005453-4057qib7	10524	1	We	-PRON-	PRP
cord-005453-4057qib7	10524	2	also	also	RB
cord-005453-4057qib7	10524	3	observed	observe	VBD
cord-005453-4057qib7	10524	4	frequently	frequently	RB
cord-005453-4057qib7	10524	5	co	co	VBD
cord-005453-4057qib7	10524	6	-	-	NN
cord-005453-4057qib7	10524	7	existence	existence	NN
cord-005453-4057qib7	10524	8	of	of	IN
cord-005453-4057qib7	10524	9	viral	viral	JJ
cord-005453-4057qib7	10524	10	infections	infection	NNS
cord-005453-4057qib7	10524	11	from	from	IN
cord-005453-4057qib7	10524	12	Herpes	Herpes	NNP
cord-005453-4057qib7	10524	13	family	family	NN
cord-005453-4057qib7	10524	14	as	as	IN
cord-005453-4057qib7	10524	15	CMV	CMV	NNP
cord-005453-4057qib7	10524	16	and	and	CC
cord-005453-4057qib7	10524	17	VH6	VH6	NNP
cord-005453-4057qib7	10524	18	.	.	.
cord-005453-4057qib7	10525	1	The	the	DT
cord-005453-4057qib7	10525	2	main	main	JJ
cord-005453-4057qib7	10525	3	limitations	limitation	NNS
cord-005453-4057qib7	10525	4	of	of	IN
cord-005453-4057qib7	10525	5	this	this	DT
cord-005453-4057qib7	10525	6	work	work	NN
cord-005453-4057qib7	10525	7	are	be	VBP
cord-005453-4057qib7	10525	8	its	-PRON-	PRP$
cord-005453-4057qib7	10525	9	retrospective	retrospective	JJ
cord-005453-4057qib7	10525	10	nature	nature	NN
cord-005453-4057qib7	10525	11	and	and	CC
cord-005453-4057qib7	10525	12	it´s	it´s	NN
cord-005453-4057qib7	10525	13	from	from	IN
cord-005453-4057qib7	10525	14	a	a	DT
cord-005453-4057qib7	10525	15	single	single	JJ
cord-005453-4057qib7	10525	16	center	center	NN
cord-005453-4057qib7	10525	17	.	.	.
cord-005453-4057qib7	10526	1	More	More	JJR
cord-005453-4057qib7	10526	2	studies	study	NNS
cord-005453-4057qib7	10526	3	are	be	VBP
cord-005453-4057qib7	10526	4	necessary	necessary	JJ
cord-005453-4057qib7	10526	5	to	to	TO
cord-005453-4057qib7	10526	6	better	better	RB
cord-005453-4057qib7	10526	7	understand	understand	VB
cord-005453-4057qib7	10526	8	the	the	DT
cord-005453-4057qib7	10526	9	epidemiology	epidemiology	NN
cord-005453-4057qib7	10526	10	and	and	CC
cord-005453-4057qib7	10526	11	risk	risk	NN
cord-005453-4057qib7	10526	12	factor	factor	NN
cord-005453-4057qib7	10526	13	associated	associate	VBN
cord-005453-4057qib7	10526	14	with	with	IN
cord-005453-4057qib7	10526	15	BKV	BKV	NNP
cord-005453-4057qib7	10526	16	-	-	HYPH
cord-005453-4057qib7	10526	17	HC	HC	NNP
cord-005453-4057qib7	10526	18	and	and	CC
cord-005453-4057qib7	10526	19	the	the	DT
cord-005453-4057qib7	10526	20	morbidities	morbidity	NNS
cord-005453-4057qib7	10526	21	associated	associate	VBN
cord-005453-4057qib7	10526	22	with	with	IN
cord-005453-4057qib7	10526	23	its	-PRON-	PRP$
cord-005453-4057qib7	10526	24	treatment	treatment	NN
cord-005453-4057qib7	10526	25	.	.	.
cord-005453-4057qib7	10527	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10527	2	:	:	:
cord-005453-4057qib7	10527	3	Nothing	nothing	NN
cord-005453-4057qib7	10527	4	to	to	TO
cord-005453-4057qib7	10527	5	declare	declare	VB
cord-005453-4057qib7	10527	6	How	how	WRB
cord-005453-4057qib7	10527	7	we	-PRON-	PRP
cord-005453-4057qib7	10527	8	manage	manage	VBP
cord-005453-4057qib7	10527	9	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10527	10	reactivation	reactivation	NN
cord-005453-4057qib7	10527	11	in	in	IN
cord-005453-4057qib7	10527	12	the	the	DT
cord-005453-4057qib7	10527	13	posttransplant	posttransplant	NN
cord-005453-4057qib7	10527	14	setting	set	VBG
cord-005453-4057qib7	10527	15	Oscar	Oscar	NNP
cord-005453-4057qib7	10527	16	Borsani	Borsani	NNP
cord-005453-4057qib7	10527	17	1	1	CD
cord-005453-4057qib7	10527	18	,	,	,
cord-005453-4057qib7	10527	19	Anna	Anna	NNP
cord-005453-4057qib7	10527	20	Amelia	Amelia	NNP
cord-005453-4057qib7	10527	21	Colombo	Colombo	NNP
cord-005453-4057qib7	10527	22	1	1	CD
cord-005453-4057qib7	10527	23	,	,	,
cord-005453-4057qib7	10527	24	Daniela	Daniela	NNP
cord-005453-4057qib7	10527	25	Caldera	Caldera	NNP
cord-005453-4057qib7	10527	26	1	1	CD
cord-005453-4057qib7	10527	27	,	,	,
cord-005453-4057qib7	10527	28	Paolo	Paolo	NNP
cord-005453-4057qib7	10527	29	Bernasconi	Bernasconi	NNP
cord-005453-4057qib7	10527	30	1	1	CD
cord-005453-4057qib7	10527	31	1	1	CD
cord-005453-4057qib7	10527	32	University	University	NNP
cord-005453-4057qib7	10527	33	of	of	IN
cord-005453-4057qib7	10527	34	Pavia	Pavia	NNP
cord-005453-4057qib7	10527	35	,	,	,
cord-005453-4057qib7	10527	36	San	San	NNP
cord-005453-4057qib7	10527	37	Matteo	Matteo	NNP
cord-005453-4057qib7	10527	38	Hospital	Hospital	NNP
cord-005453-4057qib7	10527	39	,	,	,
cord-005453-4057qib7	10527	40	Pavia	Pavia	NNP
cord-005453-4057qib7	10527	41	,	,	,
cord-005453-4057qib7	10527	42	Italy	Italy	NNP
cord-005453-4057qib7	10527	43	Background	Background	NNP
cord-005453-4057qib7	10527	44	:	:	:
cord-005453-4057qib7	10528	1	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10528	2	encephalitis	encephalitis	RB
cord-005453-4057qib7	10528	3	is	be	VBZ
cord-005453-4057qib7	10528	4	a	a	DT
cord-005453-4057qib7	10528	5	life	life	NN
cord-005453-4057qib7	10528	6	-	-	HYPH
cord-005453-4057qib7	10528	7	threatening	threaten	VBG
cord-005453-4057qib7	10528	8	complication	complication	NN
cord-005453-4057qib7	10528	9	in	in	IN
cord-005453-4057qib7	10528	10	the	the	DT
cord-005453-4057qib7	10528	11	post	post	JJ
cord-005453-4057qib7	10528	12	-	-	JJ
cord-005453-4057qib7	10528	13	transplant	transplant	JJ
cord-005453-4057qib7	10528	14	setting	setting	NN
cord-005453-4057qib7	10528	15	and	and	CC
cord-005453-4057qib7	10528	16	it	-PRON-	PRP
cord-005453-4057qib7	10528	17	develops	develop	VBZ
cord-005453-4057qib7	10528	18	in	in	IN
cord-005453-4057qib7	10528	19	about	about	RB
cord-005453-4057qib7	10528	20	1	1	CD
cord-005453-4057qib7	10528	21	%	%	NN
cord-005453-4057qib7	10528	22	of	of	IN
cord-005453-4057qib7	10528	23	patients	patient	NNS
cord-005453-4057qib7	10528	24	receiving	receive	VBG
cord-005453-4057qib7	10528	25	traditional	traditional	JJ
cord-005453-4057qib7	10528	26	HSCT	HSCT	NNP
cord-005453-4057qib7	10528	27	.	.	.
cord-005453-4057qib7	10529	1	Several	several	JJ
cord-005453-4057qib7	10529	2	risk	risk	NN
cord-005453-4057qib7	10529	3	factors	factor	NNS
cord-005453-4057qib7	10529	4	were	be	VBD
cord-005453-4057qib7	10529	5	described	describe	VBN
cord-005453-4057qib7	10529	6	.	.	.
cord-005453-4057qib7	10530	1	A	a	DT
cord-005453-4057qib7	10530	2	differential	differential	JJ
cord-005453-4057qib7	10530	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	10530	4	between	between	IN
cord-005453-4057qib7	10530	5	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10530	6	encephalitis	encephalitis	JJ
cord-005453-4057qib7	10530	7	and	and	CC
cord-005453-4057qib7	10530	8	other	other	JJ
cord-005453-4057qib7	10530	9	neurological	neurological	JJ
cord-005453-4057qib7	10530	10	complications	complication	NNS
cord-005453-4057qib7	10530	11	is	be	VBZ
cord-005453-4057qib7	10530	12	extremely	extremely	RB
cord-005453-4057qib7	10530	13	important	important	JJ
cord-005453-4057qib7	10530	14	but	but	CC
cord-005453-4057qib7	10530	15	often	often	RB
cord-005453-4057qib7	10530	16	not	not	RB
cord-005453-4057qib7	10530	17	-	-	HYPH
cord-005453-4057qib7	10530	18	easy	easy	JJ
cord-005453-4057qib7	10530	19	to	to	TO
cord-005453-4057qib7	10530	20	achieve	achieve	VB
cord-005453-4057qib7	10530	21	because	because	IN
cord-005453-4057qib7	10530	22	of	of	IN
cord-005453-4057qib7	10530	23	the	the	DT
cord-005453-4057qib7	10530	24	highly	highly	RB
cord-005453-4057qib7	10530	25	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	10530	26	clinical	clinical	JJ
cord-005453-4057qib7	10530	27	and	and	CC
cord-005453-4057qib7	10530	28	radiological	radiological	JJ
cord-005453-4057qib7	10530	29	features	feature	NNS
cord-005453-4057qib7	10530	30	and	and	CC
cord-005453-4057qib7	10530	31	complexity	complexity	NN
cord-005453-4057qib7	10530	32	of	of	IN
cord-005453-4057qib7	10530	33	interpretation	interpretation	NN
cord-005453-4057qib7	10530	34	,	,	,
cord-005453-4057qib7	10530	35	especially	especially	RB
cord-005453-4057qib7	10530	36	in	in	IN
cord-005453-4057qib7	10530	37	transplanted	transplanted	JJ
cord-005453-4057qib7	10530	38	patients	patient	NNS
cord-005453-4057qib7	10530	39	.	.	.
cord-005453-4057qib7	10531	1	Here	here	RB
cord-005453-4057qib7	10531	2	we	-PRON-	PRP
cord-005453-4057qib7	10531	3	described	describe	VBD
cord-005453-4057qib7	10531	4	vignettes	vignette	NNS
cord-005453-4057qib7	10531	5	that	that	WDT
cord-005453-4057qib7	10531	6	represent	represent	VBP
cord-005453-4057qib7	10531	7	and	and	CC
cord-005453-4057qib7	10531	8	highlight	highlight	VBP
cord-005453-4057qib7	10531	9	distinct	distinct	JJ
cord-005453-4057qib7	10531	10	problems	problem	NNS
cord-005453-4057qib7	10531	11	in	in	IN
cord-005453-4057qib7	10531	12	the	the	DT
cord-005453-4057qib7	10531	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	10531	14	and	and	CC
cord-005453-4057qib7	10531	15	management	management	NN
cord-005453-4057qib7	10531	16	of	of	IN
cord-005453-4057qib7	10531	17	transplanted	transplanted	JJ
cord-005453-4057qib7	10531	18	patients	patient	NNS
cord-005453-4057qib7	10531	19	with	with	IN
cord-005453-4057qib7	10531	20	suspected	suspect	VBN
cord-005453-4057qib7	10531	21	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10531	22	reactivation	reactivation	NN
cord-005453-4057qib7	10531	23	.	.	.
cord-005453-4057qib7	10532	1	Methods	method	NNS
cord-005453-4057qib7	10532	2	:	:	:
cord-005453-4057qib7	10532	3	We	-PRON-	PRP
cord-005453-4057qib7	10532	4	collected	collect	VBD
cord-005453-4057qib7	10532	5	the	the	DT
cord-005453-4057qib7	10532	6	clinical	clinical	JJ
cord-005453-4057qib7	10532	7	,	,	,
cord-005453-4057qib7	10532	8	laboratory	laboratory	NN
cord-005453-4057qib7	10532	9	and	and	CC
cord-005453-4057qib7	10532	10	radiological	radiological	JJ
cord-005453-4057qib7	10532	11	(	(	-LRB-
cord-005453-4057qib7	10532	12	electroencephalogram	electroencephalogram	NN
cord-005453-4057qib7	10532	13	,	,	,
cord-005453-4057qib7	10532	14	brain	brain	NN
cord-005453-4057qib7	10532	15	MRI	MRI	NNP
cord-005453-4057qib7	10532	16	and	and	CC
cord-005453-4057qib7	10532	17	brain	brain	NN
cord-005453-4057qib7	10532	18	CT	CT	NNP
cord-005453-4057qib7	10532	19	)	)	-RRB-
cord-005453-4057qib7	10532	20	data	datum	NNS
cord-005453-4057qib7	10532	21	of	of	IN
cord-005453-4057qib7	10532	22	transplanted	transplanted	JJ
cord-005453-4057qib7	10532	23	patients	patient	NNS
cord-005453-4057qib7	10532	24	who	who	WP
cord-005453-4057qib7	10532	25	developed	develop	VBD
cord-005453-4057qib7	10532	26	a	a	DT
cord-005453-4057qib7	10532	27	neurological	neurological	JJ
cord-005453-4057qib7	10532	28	syndrome	syndrome	NN
cord-005453-4057qib7	10532	29	suspected	suspect	VBN
cord-005453-4057qib7	10532	30	for	for	IN
cord-005453-4057qib7	10532	31	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10532	32	reactivation	reactivation	NN
cord-005453-4057qib7	10532	33	.	.	.
cord-005453-4057qib7	10533	1	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10533	2	was	be	VBD
cord-005453-4057qib7	10533	3	detected	detect	VBN
cord-005453-4057qib7	10533	4	on	on	IN
cord-005453-4057qib7	10533	5	serum	serum	NN
cord-005453-4057qib7	10533	6	and	and	CC
cord-005453-4057qib7	10533	7	CSF	CSF	NNP
cord-005453-4057qib7	10533	8	using	use	VBG
cord-005453-4057qib7	10533	9	RT	RT	NNP
cord-005453-4057qib7	10533	10	-	-	HYPH
cord-005453-4057qib7	10533	11	qPCR	qPCR	NNP
cord-005453-4057qib7	10533	12	.	.	.
cord-005453-4057qib7	10534	1	Results	result	NNS
cord-005453-4057qib7	10534	2	:	:	:
cord-005453-4057qib7	10534	3	1	1	LS
cord-005453-4057qib7	10534	4	)	)	-RRB-
cord-005453-4057qib7	10535	1	A	a	DT
cord-005453-4057qib7	10535	2	61-years	61-years	CD
cord-005453-4057qib7	10535	3	-	-	HYPH
cord-005453-4057qib7	10535	4	old	old	JJ
cord-005453-4057qib7	10535	5	patient	patient	NN
cord-005453-4057qib7	10535	6	developed	develop	VBD
cord-005453-4057qib7	10535	7	a	a	DT
cord-005453-4057qib7	10535	8	diffuse	diffuse	JJ
cord-005453-4057qib7	10535	9	erythema	erythema	NN
cord-005453-4057qib7	10535	10	and	and	CC
cord-005453-4057qib7	10535	11	subsequent	subsequent	JJ
cord-005453-4057qib7	10535	12	encephalitic	encephalitic	JJ
cord-005453-4057qib7	10535	13	syndrome	syndrome	NN
cord-005453-4057qib7	10535	14	following	follow	VBG
cord-005453-4057qib7	10535	15	HSCT	HSCT	NNP
cord-005453-4057qib7	10535	16	.	.	.
cord-005453-4057qib7	10536	1	The	the	DT
cord-005453-4057qib7	10536	2	brain	brain	NN
cord-005453-4057qib7	10536	3	MRI	MRI	NNP
cord-005453-4057qib7	10536	4	revealed	reveal	VBD
cord-005453-4057qib7	10536	5	clear	clear	JJ
cord-005453-4057qib7	10536	6	signs	sign	NNS
cord-005453-4057qib7	10536	7	of	of	IN
cord-005453-4057qib7	10536	8	limbic	limbic	JJ
cord-005453-4057qib7	10536	9	encephalitic	encephalitic	JJ
cord-005453-4057qib7	10536	10	and	and	CC
cord-005453-4057qib7	10536	11	searching	search	VBG
cord-005453-4057qib7	10536	12	for	for	IN
cord-005453-4057qib7	10536	13	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10536	14	on	on	IN
cord-005453-4057qib7	10536	15	serum	serum	NN
cord-005453-4057qib7	10536	16	and	and	CC
cord-005453-4057qib7	10536	17	CSF	CSF	NNP
cord-005453-4057qib7	10536	18	revealed	reveal	VBD
cord-005453-4057qib7	10536	19	150.000	150.000	CD
cord-005453-4057qib7	10536	20	copies	copy	NNS
cord-005453-4057qib7	10536	21	/	/	SYM
cord-005453-4057qib7	10536	22	mL	ml	NN
cord-005453-4057qib7	10536	23	and	and	CC
cord-005453-4057qib7	10536	24	220.000	220.000	CD
cord-005453-4057qib7	10536	25	copies	copy	NNS
cord-005453-4057qib7	10536	26	/	/	SYM
cord-005453-4057qib7	10536	27	ml	ml	NN
cord-005453-4057qib7	10536	28	respectively	respectively	RB
cord-005453-4057qib7	10536	29	.	.	.
cord-005453-4057qib7	10537	1	An	an	DT
cord-005453-4057qib7	10537	2	antiviral	antiviral	JJ
cord-005453-4057qib7	10537	3	therapy	therapy	NN
cord-005453-4057qib7	10537	4	was	be	VBD
cord-005453-4057qib7	10537	5	started	start	VBN
cord-005453-4057qib7	10537	6	but	but	CC
cord-005453-4057qib7	10537	7	no	no	DT
cord-005453-4057qib7	10537	8	clinical	clinical	JJ
cord-005453-4057qib7	10537	9	benefit	benefit	NN
cord-005453-4057qib7	10537	10	was	be	VBD
cord-005453-4057qib7	10537	11	achieved	achieve	VBN
cord-005453-4057qib7	10537	12	.	.	.
cord-005453-4057qib7	10538	1	2	2	LS
cord-005453-4057qib7	10538	2	)	)	-RRB-
cord-005453-4057qib7	10539	1	A	a	DT
cord-005453-4057qib7	10539	2	59-years	59-years	CD
cord-005453-4057qib7	10539	3	-	-	HYPH
cord-005453-4057qib7	10539	4	old	old	JJ
cord-005453-4057qib7	10539	5	patient	patient	NN
cord-005453-4057qib7	10539	6	developed	develop	VBD
cord-005453-4057qib7	10539	7	a	a	DT
cord-005453-4057qib7	10539	8	typical	typical	JJ
cord-005453-4057qib7	10539	9	neurological	neurological	JJ
cord-005453-4057qib7	10539	10	syndrome	syndrome	NN
cord-005453-4057qib7	10539	11	without	without	IN
cord-005453-4057qib7	10539	12	brain	brain	NN
cord-005453-4057qib7	10539	13	MRI	MRI	NNP
cord-005453-4057qib7	10539	14	findings	finding	NNS
cord-005453-4057qib7	10539	15	of	of	IN
cord-005453-4057qib7	10539	16	encephalitis	encephalitis	NN
cord-005453-4057qib7	10539	17	and	and	CC
cord-005453-4057qib7	10539	18	with	with	IN
cord-005453-4057qib7	10539	19	no	no	DT
cord-005453-4057qib7	10539	20	evidence	evidence	NN
cord-005453-4057qib7	10539	21	of	of	IN
cord-005453-4057qib7	10539	22	skin	skin	NN
cord-005453-4057qib7	10539	23	involvement	involvement	NN
cord-005453-4057qib7	10539	24	.	.	.
cord-005453-4057qib7	10540	1	The	the	DT
cord-005453-4057qib7	10540	2	lumbar	lumbar	NN
cord-005453-4057qib7	10540	3	puncture	puncture	NN
cord-005453-4057qib7	10540	4	and	and	CC
cord-005453-4057qib7	10540	5	CSF	CSF	NNP
cord-005453-4057qib7	10540	6	analysis	analysis	NN
cord-005453-4057qib7	10540	7	showed	show	VBD
cord-005453-4057qib7	10540	8	a	a	DT
cord-005453-4057qib7	10540	9	total	total	NN
cord-005453-4057qib7	10540	10	of	of	IN
cord-005453-4057qib7	10540	11	49.200	49.200	CD
cord-005453-4057qib7	10540	12	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10540	13	DNA	DNA	NNP
cord-005453-4057qib7	10540	14	copies	copy	NNS
cord-005453-4057qib7	10540	15	/	/	SYM
cord-005453-4057qib7	10540	16	mL.	mL.	NNP
cord-005453-4057qib7	10540	17	Antiviral	antiviral	JJ
cord-005453-4057qib7	10540	18	therapy	therapy	NN
cord-005453-4057qib7	10540	19	with	with	IN
cord-005453-4057qib7	10540	20	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10540	21	and	and	CC
cord-005453-4057qib7	10540	22	Foscarnet	Foscarnet	NNP
cord-005453-4057qib7	10540	23	was	be	VBD
cord-005453-4057qib7	10540	24	promptly	promptly	RB
cord-005453-4057qib7	10540	25	started	start	VBN
cord-005453-4057qib7	10540	26	with	with	IN
cord-005453-4057qib7	10540	27	clinical	clinical	JJ
cord-005453-4057qib7	10540	28	improvement	improvement	NN
cord-005453-4057qib7	10540	29	and	and	CC
cord-005453-4057qib7	10540	30	a	a	DT
cord-005453-4057qib7	10540	31	drastically	drastically	JJ
cord-005453-4057qib7	10540	32	reduction	reduction	NN
cord-005453-4057qib7	10540	33	of	of	IN
cord-005453-4057qib7	10540	34	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10540	35	DNA	DNA	NNP
cord-005453-4057qib7	10540	36	on	on	IN
cord-005453-4057qib7	10540	37	both	both	CC
cord-005453-4057qib7	10540	38	CSF	CSF	NNP
cord-005453-4057qib7	10540	39	and	and	CC
cord-005453-4057qib7	10540	40	serum	serum	NN
cord-005453-4057qib7	10540	41	.	.	.
cord-005453-4057qib7	10541	1	A	a	DT
cord-005453-4057qib7	10541	2	new	new	JJ
cord-005453-4057qib7	10541	3	brain	brain	NN
cord-005453-4057qib7	10542	1	MRI	MRI	NNP
cord-005453-4057qib7	10542	2	revealed	reveal	VBD
cord-005453-4057qib7	10542	3	an	an	DT
cord-005453-4057qib7	10542	4	acute	acute	JJ
cord-005453-4057qib7	10542	5	limbic	limbic	JJ
cord-005453-4057qib7	10542	6	encephalitis	encephalitis	RB
cord-005453-4057qib7	10542	7	.	.	.
cord-005453-4057qib7	10543	1	3	3	LS
cord-005453-4057qib7	10543	2	)	)	-RRB-
cord-005453-4057qib7	10544	1	A	a	DT
cord-005453-4057qib7	10544	2	slight	slight	JJ
cord-005453-4057qib7	10544	3	neurological	neurological	JJ
cord-005453-4057qib7	10544	4	syndrome	syndrome	NN
cord-005453-4057qib7	10544	5	consisting	consist	VBG
cord-005453-4057qib7	10544	6	of	of	IN
cord-005453-4057qib7	10544	7	confusion	confusion	NN
cord-005453-4057qib7	10544	8	and	and	CC
cord-005453-4057qib7	10544	9	amnesia	amnesia	NN
cord-005453-4057qib7	10544	10	developed	develop	VBN
cord-005453-4057qib7	10544	11	in	in	IN
cord-005453-4057qib7	10544	12	a	a	DT
cord-005453-4057qib7	10544	13	49-years	49-years	CD
cord-005453-4057qib7	10544	14	-	-	HYPH
cord-005453-4057qib7	10544	15	old	old	JJ
cord-005453-4057qib7	10544	16	-	-	HYPH
cord-005453-4057qib7	10544	17	patient	patient	NN
cord-005453-4057qib7	10544	18	.	.	.
cord-005453-4057qib7	10545	1	Brain	Brain	NNP
cord-005453-4057qib7	10545	2	MRI	MRI	NNP
cord-005453-4057qib7	10545	3	findings	finding	NNS
cord-005453-4057qib7	10545	4	were	be	VBD
cord-005453-4057qib7	10545	5	compatible	compatible	JJ
cord-005453-4057qib7	10545	6	with	with	IN
cord-005453-4057qib7	10545	7	a	a	DT
cord-005453-4057qib7	10545	8	Wernicke	Wernicke	NNP
cord-005453-4057qib7	10545	9	syndrome	syndrome	NN
cord-005453-4057qib7	10545	10	,	,	,
cord-005453-4057qib7	10545	11	but	but	CC
cord-005453-4057qib7	10545	12	no	no	DT
cord-005453-4057qib7	10545	13	improvement	improvement	NN
cord-005453-4057qib7	10545	14	of	of	IN
cord-005453-4057qib7	10545	15	neurologic	neurologic	JJ
cord-005453-4057qib7	10545	16	symptoms	symptom	NNS
cord-005453-4057qib7	10545	17	were	be	VBD
cord-005453-4057qib7	10545	18	obtained	obtain	VBN
cord-005453-4057qib7	10545	19	with	with	IN
cord-005453-4057qib7	10545	20	thiamine	thiamine	NN
cord-005453-4057qib7	10545	21	supplementation	supplementation	NN
cord-005453-4057qib7	10545	22	.	.	.
cord-005453-4057qib7	10546	1	CSF	CSF	NNP
cord-005453-4057qib7	10546	2	analysis	analysis	NN
cord-005453-4057qib7	10546	3	did	do	VBD
cord-005453-4057qib7	10546	4	not	not	RB
cord-005453-4057qib7	10546	5	revealed	reveal	VBN
cord-005453-4057qib7	10546	6	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10546	7	DNA	DNA	NNP
cord-005453-4057qib7	10546	8	,	,	,
cord-005453-4057qib7	10546	9	which	which	WDT
cord-005453-4057qib7	10546	10	was	be	VBD
cord-005453-4057qib7	10546	11	detected	detect	VBN
cord-005453-4057qib7	10546	12	at	at	IN
cord-005453-4057qib7	10546	13	low	low	JJ
cord-005453-4057qib7	10546	14	copies	copy	NNS
cord-005453-4057qib7	10546	15	number	number	NN
cord-005453-4057qib7	10546	16	on	on	IN
cord-005453-4057qib7	10546	17	serum	serum	NN
cord-005453-4057qib7	10546	18	analysis	analysis	NN
cord-005453-4057qib7	10546	19	.	.	.
cord-005453-4057qib7	10547	1	A	a	DT
cord-005453-4057qib7	10547	2	second	second	JJ
cord-005453-4057qib7	10547	3	brain	brain	NN
cord-005453-4057qib7	10547	4	MRI	MRI	NNP
cord-005453-4057qib7	10547	5	was	be	VBD
cord-005453-4057qib7	10547	6	conclusive	conclusive	JJ
cord-005453-4057qib7	10547	7	for	for	IN
cord-005453-4057qib7	10547	8	limbic	limbic	NN
cord-005453-4057qib7	10547	9	encephalitis	encephalitis	RB
cord-005453-4057qib7	10547	10	,	,	,
cord-005453-4057qib7	10547	11	so	so	IN
cord-005453-4057qib7	10547	12	an	an	DT
cord-005453-4057qib7	10547	13	antiviral	antiviral	JJ
cord-005453-4057qib7	10547	14	therapy	therapy	NN
cord-005453-4057qib7	10547	15	with	with	IN
cord-005453-4057qib7	10547	16	Foscavir	Foscavir	NNP
cord-005453-4057qib7	10547	17	was	be	VBD
cord-005453-4057qib7	10547	18	started	start	VBN
cord-005453-4057qib7	10547	19	and	and	CC
cord-005453-4057qib7	10547	20	radiological	radiological	JJ
cord-005453-4057qib7	10547	21	but	but	CC
cord-005453-4057qib7	10547	22	not	not	RB
cord-005453-4057qib7	10547	23	clinical	clinical	JJ
cord-005453-4057qib7	10547	24	improvement	improvement	NN
cord-005453-4057qib7	10547	25	was	be	VBD
cord-005453-4057qib7	10547	26	noted	note	VBN
cord-005453-4057qib7	10547	27	.	.	.
cord-005453-4057qib7	10548	1	The	the	DT
cord-005453-4057qib7	10548	2	patient	patient	NN
cord-005453-4057qib7	10548	3	died	die	VBD
cord-005453-4057qib7	10548	4	after	after	IN
cord-005453-4057qib7	10548	5	few	few	JJ
cord-005453-4057qib7	10548	6	days	day	NNS
cord-005453-4057qib7	10548	7	.	.	.
cord-005453-4057qib7	10549	1	4	4	LS
cord-005453-4057qib7	10549	2	)	)	-RRB-
cord-005453-4057qib7	10550	1	In	in	IN
cord-005453-4057qib7	10550	2	the	the	DT
cord-005453-4057qib7	10550	3	last	last	JJ
cord-005453-4057qib7	10550	4	case	case	NN
cord-005453-4057qib7	10550	5	we	-PRON-	PRP
cord-005453-4057qib7	10550	6	present	present	VBP
cord-005453-4057qib7	10550	7	a	a	DT
cord-005453-4057qib7	10550	8	52-years	52-years	CD
cord-005453-4057qib7	10550	9	-	-	HYPH
cord-005453-4057qib7	10550	10	old	old	JJ
cord-005453-4057qib7	10550	11	patient	patient	NN
cord-005453-4057qib7	10550	12	who	who	WP
cord-005453-4057qib7	10550	13	developed	develop	VBD
cord-005453-4057qib7	10550	14	a	a	DT
cord-005453-4057qib7	10550	15	clinical	clinical	JJ
cord-005453-4057qib7	10550	16	picture	picture	NN
cord-005453-4057qib7	10550	17	of	of	IN
cord-005453-4057qib7	10550	18	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	10550	19	(	(	-LRB-
cord-005453-4057qib7	10550	20	i.e.	i.e.	FW
cord-005453-4057qib7	10550	21	amnesia	amnesia	NN
cord-005453-4057qib7	10550	22	,	,	,
cord-005453-4057qib7	10550	23	ataxia	ataxia	NN
cord-005453-4057qib7	10550	24	,	,	,
cord-005453-4057qib7	10550	25	drowsiness	drowsiness	NN
cord-005453-4057qib7	10550	26	,	,	,
cord-005453-4057qib7	10550	27	weakness	weakness	NN
cord-005453-4057qib7	10550	28	,	,	,
cord-005453-4057qib7	10550	29	depression	depression	NN
cord-005453-4057qib7	10550	30	)	)	-RRB-
cord-005453-4057qib7	10550	31	with	with	IN
cord-005453-4057qib7	10550	32	rapid	rapid	JJ
cord-005453-4057qib7	10550	33	progression	progression	NN
cord-005453-4057qib7	10550	34	to	to	IN
cord-005453-4057qib7	10550	35	coma	coma	NN
cord-005453-4057qib7	10550	36	after	after	IN
cord-005453-4057qib7	10550	37	seventy	seventy	CD
cord-005453-4057qib7	10550	38	-	-	HYPH
cord-005453-4057qib7	10550	39	eight	eight	CD
cord-005453-4057qib7	10550	40	days	day	NNS
cord-005453-4057qib7	10550	41	from	from	IN
cord-005453-4057qib7	10550	42	HSCT	HSCT	NNP
cord-005453-4057qib7	10550	43	.	.	.
cord-005453-4057qib7	10551	1	A	a	DT
cord-005453-4057qib7	10551	2	brain	brain	NN
cord-005453-4057qib7	10551	3	MRI	MRI	NNP
cord-005453-4057qib7	10551	4	showed	show	VBD
cord-005453-4057qib7	10551	5	a	a	DT
cord-005453-4057qib7	10551	6	slight	slight	JJ
cord-005453-4057qib7	10551	7	contrast	contrast	NN
cord-005453-4057qib7	10551	8	enhancement	enhancement	NN
cord-005453-4057qib7	10551	9	in	in	IN
cord-005453-4057qib7	10551	10	parietal	parietal	JJ
cord-005453-4057qib7	10551	11	-	-	HYPH
cord-005453-4057qib7	10551	12	occipital	occipital	JJ
cord-005453-4057qib7	10551	13	regions	region	NNS
cord-005453-4057qib7	10551	14	.	.	.
cord-005453-4057qib7	10552	1	During	during	IN
cord-005453-4057qib7	10552	2	the	the	DT
cord-005453-4057qib7	10552	3	recovery	recovery	NN
cord-005453-4057qib7	10552	4	phase	phase	NN
cord-005453-4057qib7	10552	5	from	from	IN
cord-005453-4057qib7	10552	6	conditioning	conditioning	NN
cord-005453-4057qib7	10552	7	-	-	HYPH
cord-005453-4057qib7	10552	8	induced	induce	VBN
cord-005453-4057qib7	10552	9	cytopenia	cytopenia	NNP
cord-005453-4057qib7	10552	10	,	,	,
cord-005453-4057qib7	10552	11	an	an	DT
cord-005453-4057qib7	10552	12	increasing	increase	VBG
cord-005453-4057qib7	10552	13	in	in	IN
cord-005453-4057qib7	10552	14	serum	serum	NN
cord-005453-4057qib7	10552	15	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10552	16	DNA	DNA	NNP
cord-005453-4057qib7	10552	17	was	be	VBD
cord-005453-4057qib7	10552	18	detected	detect	VBN
cord-005453-4057qib7	10552	19	.	.	.
cord-005453-4057qib7	10553	1	Searching	search	VBG
cord-005453-4057qib7	10553	2	for	for	IN
cord-005453-4057qib7	10553	3	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10553	4	DNA	DNA	NNP
cord-005453-4057qib7	10553	5	on	on	IN
cord-005453-4057qib7	10553	6	donor	donor	NN
cord-005453-4057qib7	10553	7	's	's	POS
cord-005453-4057qib7	10553	8	follicles	follicle	NNS
cord-005453-4057qib7	10553	9	showed	show	VBD
cord-005453-4057qib7	10553	10	a	a	DT
cord-005453-4057qib7	10553	11	chromosomally	chromosomally	RB
cord-005453-4057qib7	10553	12	integrated	integrate	VBN
cord-005453-4057qib7	10553	13	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10553	14	(	(	-LRB-
cord-005453-4057qib7	10553	15	ciHHV-6	ciHHV-6	NNP
cord-005453-4057qib7	10553	16	)	)	-RRB-
cord-005453-4057qib7	10553	17	.	.	.
cord-005453-4057qib7	10554	1	Cyclosporin	Cyclosporin	NNP
cord-005453-4057qib7	10554	2	A	a	DT
cord-005453-4057qib7	10554	3	(	(	-LRB-
cord-005453-4057qib7	10554	4	CsA	csa	NN
cord-005453-4057qib7	10554	5	)	)	-RRB-
cord-005453-4057qib7	10554	6	was	be	VBD
cord-005453-4057qib7	10554	7	interrupted	interrupt	VBN
cord-005453-4057qib7	10554	8	and	and	CC
cord-005453-4057qib7	10554	9	neurological	neurological	JJ
cord-005453-4057qib7	10554	10	improvement	improvement	NN
cord-005453-4057qib7	10554	11	was	be	VBD
cord-005453-4057qib7	10554	12	observed	observe	VBN
cord-005453-4057qib7	10554	13	in	in	IN
cord-005453-4057qib7	10554	14	the	the	DT
cord-005453-4057qib7	10554	15	following	follow	VBG
cord-005453-4057qib7	10554	16	hours	hour	NNS
cord-005453-4057qib7	10554	17	:	:	:
cord-005453-4057qib7	10554	18	a	a	DT
cord-005453-4057qib7	10554	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	10554	20	of	of	IN
cord-005453-4057qib7	10554	21	PRES	PRES	NNP
cord-005453-4057qib7	10554	22	was	be	VBD
cord-005453-4057qib7	10554	23	made	make	VBN
cord-005453-4057qib7	10554	24	.	.	.
cord-005453-4057qib7	10555	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10555	2	:	:	:
cord-005453-4057qib7	10556	1	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10556	2	encephalitis	encephalitis	RB
cord-005453-4057qib7	10556	3	should	should	MD
cord-005453-4057qib7	10556	4	be	be	VB
cord-005453-4057qib7	10556	5	suspected	suspect	VBN
cord-005453-4057qib7	10556	6	in	in	IN
cord-005453-4057qib7	10556	7	transplanted	transplanted	JJ
cord-005453-4057qib7	10556	8	patients	patient	NNS
cord-005453-4057qib7	10556	9	with	with	IN
cord-005453-4057qib7	10556	10	a	a	DT
cord-005453-4057qib7	10556	11	clinical	clinical	JJ
cord-005453-4057qib7	10556	12	syndrome	syndrome	NN
cord-005453-4057qib7	10556	13	of	of	IN
cord-005453-4057qib7	10556	14	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	10556	15	.	.	.
cord-005453-4057qib7	10557	1	PCR	PCR	NNP
cord-005453-4057qib7	10557	2	detection	detection	NN
cord-005453-4057qib7	10557	3	of	of	IN
cord-005453-4057qib7	10557	4	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10557	5	DNA	DNA	NNP
cord-005453-4057qib7	10557	6	in	in	IN
cord-005453-4057qib7	10557	7	CSF	csf	NN
cord-005453-4057qib7	10557	8	associated	associate	VBN
cord-005453-4057qib7	10557	9	with	with	IN
cord-005453-4057qib7	10557	10	either	either	DT
cord-005453-4057qib7	10557	11	typical	typical	JJ
cord-005453-4057qib7	10557	12	brain	brain	NN
cord-005453-4057qib7	10557	13	MRI	MRI	NNP
cord-005453-4057qib7	10557	14	abnormalities	abnormality	NNS
cord-005453-4057qib7	10557	15	or	or	CC
cord-005453-4057qib7	10557	16	a	a	DT
cord-005453-4057qib7	10557	17	clinical	clinical	JJ
cord-005453-4057qib7	10557	18	diagnosis	diagnosis	NN
cord-005453-4057qib7	10557	19	of	of	IN
cord-005453-4057qib7	10557	20	nonspecific	nonspecific	JJ
cord-005453-4057qib7	10557	21	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	10557	22	must	must	MD
cord-005453-4057qib7	10557	23	lead	lead	VB
cord-005453-4057qib7	10557	24	to	to	IN
cord-005453-4057qib7	10557	25	the	the	DT
cord-005453-4057qib7	10557	26	urgent	urgent	JJ
cord-005453-4057qib7	10557	27	initiation	initiation	NN
cord-005453-4057qib7	10557	28	of	of	IN
cord-005453-4057qib7	10557	29	systemic	systemic	JJ
cord-005453-4057qib7	10557	30	antiviral	antiviral	JJ
cord-005453-4057qib7	10557	31	treatment	treatment	NN
cord-005453-4057qib7	10557	32	.	.	.
cord-005453-4057qib7	10558	1	If	if	IN
cord-005453-4057qib7	10558	2	an	an	DT
cord-005453-4057qib7	10558	3	increase	increase	NN
cord-005453-4057qib7	10558	4	of	of	IN
cord-005453-4057qib7	10558	5	both	both	DT
cord-005453-4057qib7	10558	6	serum	serum	NN
cord-005453-4057qib7	10558	7	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10558	8	DNA	DNA	NNP
cord-005453-4057qib7	10558	9	and	and	CC
cord-005453-4057qib7	10558	10	WBC	WBC	NNP
cord-005453-4057qib7	10558	11	is	be	VBZ
cord-005453-4057qib7	10558	12	detected	detect	VBN
cord-005453-4057qib7	10558	13	,	,	,
cord-005453-4057qib7	10558	14	a	a	DT
cord-005453-4057qib7	10558	15	ciHHV-6	ciHHV-6	NNP
cord-005453-4057qib7	10558	16	should	should	MD
cord-005453-4057qib7	10558	17	be	be	VB
cord-005453-4057qib7	10558	18	confirmed	confirm	VBN
cord-005453-4057qib7	10558	19	.	.	.
cord-005453-4057qib7	10559	1	PRES	PRES	NNP
cord-005453-4057qib7	10559	2	is	be	VBZ
cord-005453-4057qib7	10559	3	an	an	DT
cord-005453-4057qib7	10559	4	important	important	JJ
cord-005453-4057qib7	10559	5	differential	differential	JJ
cord-005453-4057qib7	10559	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	10559	7	in	in	IN
cord-005453-4057qib7	10559	8	transplanted	transplanted	JJ
cord-005453-4057qib7	10559	9	patients	patient	NNS
cord-005453-4057qib7	10559	10	which	which	WDT
cord-005453-4057qib7	10559	11	developed	develop	VBD
cord-005453-4057qib7	10559	12	an	an	DT
cord-005453-4057qib7	10559	13	encephalitic	encephalitic	JJ
cord-005453-4057qib7	10559	14	syndrome	syndrome	NN
cord-005453-4057qib7	10559	15	.	.	.
cord-005453-4057qib7	10560	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10560	2	:	:	:
cord-005453-4057qib7	10560	3	Nothing	nothing	NN
cord-005453-4057qib7	10560	4	to	to	TO
cord-005453-4057qib7	10560	5	declare	declare	VB
cord-005453-4057qib7	10560	6	Background	background	NN
cord-005453-4057qib7	10560	7	:	:	:
cord-005453-4057qib7	10561	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	10561	2	(	(	-LRB-
cord-005453-4057qib7	10561	3	CMV	CMV	NNP
cord-005453-4057qib7	10561	4	)	)	-RRB-
cord-005453-4057qib7	10561	5	infection	infection	NN
cord-005453-4057qib7	10561	6	is	be	VBZ
cord-005453-4057qib7	10561	7	a	a	DT
cord-005453-4057qib7	10561	8	major	major	JJ
cord-005453-4057qib7	10561	9	cause	cause	NN
cord-005453-4057qib7	10561	10	of	of	IN
cord-005453-4057qib7	10561	11	morbidity	morbidity	NN
cord-005453-4057qib7	10561	12	and	and	CC
cord-005453-4057qib7	10561	13	mortality	mortality	NN
cord-005453-4057qib7	10561	14	after	after	IN
cord-005453-4057qib7	10561	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10561	16	stem	stem	NN
cord-005453-4057qib7	10561	17	cell	cell	NN
cord-005453-4057qib7	10561	18	transplantation	transplantation	NN
cord-005453-4057qib7	10561	19	(	(	-LRB-
cord-005453-4057qib7	10561	20	HSCT	HSCT	NNP
cord-005453-4057qib7	10561	21	)	)	-RRB-
cord-005453-4057qib7	10561	22	.	.	.
cord-005453-4057qib7	10562	1	It	-PRON-	PRP
cord-005453-4057qib7	10562	2	causes	cause	VBZ
cord-005453-4057qib7	10562	3	end	end	NN
cord-005453-4057qib7	10562	4	-	-	HYPH
cord-005453-4057qib7	10562	5	organ	organ	NN
cord-005453-4057qib7	10562	6	disease	disease	NN
cord-005453-4057qib7	10562	7	,	,	,
cord-005453-4057qib7	10562	8	multi	multi	JJ
cord-005453-4057qib7	10562	9	-	-	JJ
cord-005453-4057qib7	10562	10	organ	organ	JJ
cord-005453-4057qib7	10562	11	dysfunction	dysfunction	NN
cord-005453-4057qib7	10562	12	syndrome	syndrome	NN
cord-005453-4057qib7	10562	13	,	,	,
cord-005453-4057qib7	10562	14	graft	graft	NN
cord-005453-4057qib7	10562	15	failure	failure	NN
cord-005453-4057qib7	10562	16	,	,	,
cord-005453-4057qib7	10562	17	increased	increase	VBN
cord-005453-4057qib7	10562	18	susceptibility	susceptibility	NN
cord-005453-4057qib7	10562	19	to	to	IN
cord-005453-4057qib7	10562	20	infections	infection	NNS
cord-005453-4057qib7	10562	21	and	and	CC
cord-005453-4057qib7	10562	22	GVHD	GVHD	NNP
cord-005453-4057qib7	10562	23	.	.	.
cord-005453-4057qib7	10563	1	Greatest	great	JJS
cord-005453-4057qib7	10563	2	risk	risk	NN
cord-005453-4057qib7	10563	3	of	of	IN
cord-005453-4057qib7	10563	4	CMV	CMV	NNP
cord-005453-4057qib7	10563	5	infection	infection	NN
cord-005453-4057qib7	10563	6	in	in	IN
cord-005453-4057qib7	10563	7	a	a	DT
cord-005453-4057qib7	10563	8	seropositive	seropositive	JJ
cord-005453-4057qib7	10563	9	host	host	NN
cord-005453-4057qib7	10563	10	is	be	VBZ
cord-005453-4057qib7	10563	11	the	the	DT
cord-005453-4057qib7	10563	12	reactivation	reactivation	NN
cord-005453-4057qib7	10563	13	of	of	IN
cord-005453-4057qib7	10563	14	latent	latent	JJ
cord-005453-4057qib7	10563	15	virus	virus	NN
cord-005453-4057qib7	10563	16	.	.	.
cord-005453-4057qib7	10564	1	Methods	method	NNS
cord-005453-4057qib7	10564	2	:	:	:
cord-005453-4057qib7	10565	1	A	a	DT
cord-005453-4057qib7	10565	2	prospective	prospective	JJ
cord-005453-4057qib7	10565	3	descriptive	descriptive	JJ
cord-005453-4057qib7	10565	4	study	study	NN
cord-005453-4057qib7	10565	5	performed	perform	VBN
cord-005453-4057qib7	10565	6	at	at	IN
cord-005453-4057qib7	10565	7	Armed	Armed	NNP
cord-005453-4057qib7	10565	8	Forces	Forces	NNPS
cord-005453-4057qib7	10565	9	Bone	Bone	NNP
cord-005453-4057qib7	10565	10	Marrow	Marrow	NNP
cord-005453-4057qib7	10565	11	Transplant	Transplant	NNP
cord-005453-4057qib7	10565	12	Centre	Centre	NNP
cord-005453-4057qib7	10565	13	,	,	,
cord-005453-4057qib7	10565	14	Rawalpindi	Rawalpindi	NNP
cord-005453-4057qib7	10565	15	,	,	,
cord-005453-4057qib7	10565	16	Pakistan	Pakistan	NNP
cord-005453-4057qib7	10565	17	from	from	IN
cord-005453-4057qib7	10565	18	Dec	Dec	NNP
cord-005453-4057qib7	10565	19	2016	2016	CD
cord-005453-4057qib7	10565	20	to	to	IN
cord-005453-4057qib7	10565	21	Sep	Sep	NNP
cord-005453-4057qib7	10565	22	2018	2018	CD
cord-005453-4057qib7	10565	23	.	.	.
cord-005453-4057qib7	10566	1	Hundred	hundred	CD
cord-005453-4057qib7	10566	2	consecutive	consecutive	JJ
cord-005453-4057qib7	10566	3	patients	patient	NNS
cord-005453-4057qib7	10566	4	who	who	WP
cord-005453-4057qib7	10566	5	underwent	undergo	VBD
cord-005453-4057qib7	10566	6	HSCT	HSCT	NNP
cord-005453-4057qib7	10566	7	were	be	VBD
cord-005453-4057qib7	10566	8	followed	follow	VBN
cord-005453-4057qib7	10566	9	with	with	IN
cord-005453-4057qib7	10566	10	weekly	weekly	JJ
cord-005453-4057qib7	10566	11	CMV	CMV	NNP
cord-005453-4057qib7	10566	12	DNA	DNA	NNP
cord-005453-4057qib7	10566	13	quantitative	quantitative	JJ
cord-005453-4057qib7	10566	14	PCR	pcr	NN
cord-005453-4057qib7	10566	15	from	from	IN
cord-005453-4057qib7	10566	16	engraftment	engraftment	NN
cord-005453-4057qib7	10566	17	till	till	IN
cord-005453-4057qib7	10566	18	day	day	NN
cord-005453-4057qib7	10566	19	100	100	CD
cord-005453-4057qib7	10566	20	for	for	IN
cord-005453-4057qib7	10566	21	CMV	CMV	NNP
cord-005453-4057qib7	10566	22	reactivation	reactivation	NN
cord-005453-4057qib7	10566	23	.	.	.
cord-005453-4057qib7	10567	1	Patients	patient	NNS
cord-005453-4057qib7	10567	2	in	in	IN
cord-005453-4057qib7	10567	3	whom	whom	WP
cord-005453-4057qib7	10567	4	CMV	CMV	NNP
cord-005453-4057qib7	10567	5	PCR	PCR	NNP
cord-005453-4057qib7	10567	6	showed	show	VBD
cord-005453-4057qib7	10567	7	more	more	JJR
cord-005453-4057qib7	10567	8	than	than	IN
cord-005453-4057qib7	10567	9	2000	2000	CD
cord-005453-4057qib7	10567	10	copies	copy	NNS
cord-005453-4057qib7	10567	11	/	/	SYM
cord-005453-4057qib7	10567	12	ml	ml	NNS
cord-005453-4057qib7	10567	13	were	be	VBD
cord-005453-4057qib7	10567	14	treated	treat	VBN
cord-005453-4057qib7	10567	15	with	with	IN
cord-005453-4057qib7	10567	16	antiviral	antiviral	JJ
cord-005453-4057qib7	10567	17	therapy	therapy	NN
cord-005453-4057qib7	10567	18	.	.	.
cord-005453-4057qib7	10568	1	Factors	factor	NNS
cord-005453-4057qib7	10568	2	associated	associate	VBN
cord-005453-4057qib7	10568	3	with	with	IN
cord-005453-4057qib7	10568	4	CMV	CMV	NNP
cord-005453-4057qib7	10568	5	reactivation	reactivation	NN
cord-005453-4057qib7	10568	6	,	,	,
cord-005453-4057qib7	10568	7	outcome	outcome	NN
cord-005453-4057qib7	10568	8	of	of	IN
cord-005453-4057qib7	10568	9	antiviral	antiviral	JJ
cord-005453-4057qib7	10568	10	therapy	therapy	NN
cord-005453-4057qib7	10568	11	and	and	CC
cord-005453-4057qib7	10568	12	effect	effect	NN
cord-005453-4057qib7	10568	13	of	of	IN
cord-005453-4057qib7	10568	14	CMV	CMV	NNP
cord-005453-4057qib7	10568	15	on	on	IN
cord-005453-4057qib7	10568	16	transplant	transplant	NN
cord-005453-4057qib7	10568	17	outcome	outcome	NN
cord-005453-4057qib7	10568	18	is	be	VBZ
cord-005453-4057qib7	10568	19	studied	study	VBN
cord-005453-4057qib7	10568	20	.	.	.
cord-005453-4057qib7	10569	1	Results	result	NNS
cord-005453-4057qib7	10569	2	:	:	:
cord-005453-4057qib7	10570	1	Out	out	IN
cord-005453-4057qib7	10570	2	of	of	IN
cord-005453-4057qib7	10570	3	100	100	CD
cord-005453-4057qib7	10570	4	cases	case	NNS
cord-005453-4057qib7	10570	5	,	,	,
cord-005453-4057qib7	10570	6	82	82	CD
cord-005453-4057qib7	10570	7	were	be	VBD
cord-005453-4057qib7	10570	8	HLA	HLA	NNP
cord-005453-4057qib7	10570	9	matched	match	VBN
cord-005453-4057qib7	10570	10	siblings	sibling	NNS
cord-005453-4057qib7	10570	11	,	,	,
cord-005453-4057qib7	10570	12	15	15	CD
cord-005453-4057qib7	10570	13	were	be	VBD
cord-005453-4057qib7	10570	14	matched	match	VBN
cord-005453-4057qib7	10571	1	family	family	NN
cord-005453-4057qib7	10571	2	donors	donor	NNS
cord-005453-4057qib7	10571	3	and	and	CC
cord-005453-4057qib7	10571	4	3	3	CD
cord-005453-4057qib7	10571	5	were	be	VBD
cord-005453-4057qib7	10571	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10571	7	transplants	transplant	NNS
cord-005453-4057qib7	10572	1	There	there	EX
cord-005453-4057qib7	10572	2	were	be	VBD
cord-005453-4057qib7	10572	3	66	66	CD
cord-005453-4057qib7	10572	4	males	male	NNS
cord-005453-4057qib7	10572	5	and	and	CC
cord-005453-4057qib7	10572	6	34	34	CD
cord-005453-4057qib7	10572	7	females	female	NNS
cord-005453-4057qib7	10572	8	.	.	.
cord-005453-4057qib7	10573	1	Mean	mean	JJ
cord-005453-4057qib7	10573	2	age	age	NN
cord-005453-4057qib7	10573	3	was	be	VBD
cord-005453-4057qib7	10573	4	11.9	11.9	CD
cord-005453-4057qib7	10573	5	±8.9	±8.9	JJ
cord-005453-4057qib7	10573	6	years	year	NNS
cord-005453-4057qib7	10573	7	.	.	.
cord-005453-4057qib7	10574	1	Fourty	fourty	CD
cord-005453-4057qib7	10574	2	-	-	HYPH
cord-005453-4057qib7	10574	3	two	two	CD
cord-005453-4057qib7	10574	4	transplants	transplant	NNS
cord-005453-4057qib7	10574	5	were	be	VBD
cord-005453-4057qib7	10574	6	done	do	VBN
cord-005453-4057qib7	10574	7	in	in	IN
cord-005453-4057qib7	10574	8	thalassemia	thalassemia	NN
cord-005453-4057qib7	10574	9	,	,	,
cord-005453-4057qib7	10574	10	35	35	CD
cord-005453-4057qib7	10574	11	in	in	IN
cord-005453-4057qib7	10574	12	aplasia	aplasia	NNP
cord-005453-4057qib7	10574	13	,	,	,
cord-005453-4057qib7	10574	14	09	09	CD
cord-005453-4057qib7	10574	15	in	in	IN
cord-005453-4057qib7	10574	16	leukemias	leukemia	NNS
cord-005453-4057qib7	10574	17	and	and	CC
cord-005453-4057qib7	10574	18	14	14	CD
cord-005453-4057qib7	10574	19	in	in	IN
cord-005453-4057qib7	10574	20	other	other	JJ
cord-005453-4057qib7	10574	21	hematological	hematological	JJ
cord-005453-4057qib7	10574	22	disorders	disorder	NNS
cord-005453-4057qib7	10574	23	and	and	CC
cord-005453-4057qib7	10574	24	immune	immune	JJ
cord-005453-4057qib7	10574	25	deficiencies	deficiency	NNS
cord-005453-4057qib7	10574	26	.	.	.
cord-005453-4057qib7	10575	1	Ninety	ninety	CD
cord-005453-4057qib7	10575	2	-	-	HYPH
cord-005453-4057qib7	10575	3	eight	eight	CD
cord-005453-4057qib7	10575	4	recipients	recipient	NNS
cord-005453-4057qib7	10575	5	and	and	CC
cord-005453-4057qib7	10575	6	all	all	PDT
cord-005453-4057qib7	10575	7	the	the	DT
cord-005453-4057qib7	10575	8	donors	donor	NNS
cord-005453-4057qib7	10575	9	were	be	VBD
cord-005453-4057qib7	10575	10	CMV	CMV	NNP
cord-005453-4057qib7	10575	11	seropositive	seropositive	JJ
cord-005453-4057qib7	10575	12	before	before	IN
cord-005453-4057qib7	10575	13	HSCT	HSCT	NNP
cord-005453-4057qib7	10575	14	.	.	.
cord-005453-4057qib7	10576	1	CMV	CMV	NNP
cord-005453-4057qib7	10576	2	reactivation	reactivation	NN
cord-005453-4057qib7	10576	3	was	be	VBD
cord-005453-4057qib7	10576	4	seen	see	VBN
cord-005453-4057qib7	10576	5	in	in	IN
cord-005453-4057qib7	10576	6	81	81	CD
cord-005453-4057qib7	10576	7	patients	patient	NNS
cord-005453-4057qib7	10576	8	and	and	CC
cord-005453-4057qib7	10576	9	42	42	CD
cord-005453-4057qib7	10576	10	of	of	IN
cord-005453-4057qib7	10576	11	them	-PRON-	PRP
cord-005453-4057qib7	10576	12	had	have	VBD
cord-005453-4057qib7	10576	13	CMV	CMV	NNP
cord-005453-4057qib7	10576	14	viral	viral	JJ
cord-005453-4057qib7	10576	15	load	load	NN
cord-005453-4057qib7	10577	1	more	more	JJR
cord-005453-4057qib7	10577	2	than	than	IN
cord-005453-4057qib7	10577	3	2000	2000	CD
cord-005453-4057qib7	10577	4	copies	copy	NNS
cord-005453-4057qib7	10577	5	/	/	SYM
cord-005453-4057qib7	10577	6	ml	ml	NN
cord-005453-4057qib7	10577	7	and	and	CC
cord-005453-4057qib7	10577	8	39	39	CD
cord-005453-4057qib7	10577	9	patients	patient	NNS
cord-005453-4057qib7	10577	10	had	have	VBD
cord-005453-4057qib7	10577	11	CMV	CMV	NNP
cord-005453-4057qib7	10577	12	viral	viral	JJ
cord-005453-4057qib7	10577	13	load	load	NN
cord-005453-4057qib7	10578	1	less	less	JJR
cord-005453-4057qib7	10578	2	than	than	IN
cord-005453-4057qib7	10578	3	2000	2000	CD
cord-005453-4057qib7	10578	4	copies	copy	NNS
cord-005453-4057qib7	10578	5	/	/	SYM
cord-005453-4057qib7	10578	6	ml	ml	NN
cord-005453-4057qib7	10578	7	.	.	.
cord-005453-4057qib7	10579	1	Nineteen	nineteen	CD
cord-005453-4057qib7	10579	2	patients	patient	NNS
cord-005453-4057qib7	10579	3	had	have	VBD
cord-005453-4057qib7	10579	4	no	no	DT
cord-005453-4057qib7	10579	5	CMV	CMV	NNP
cord-005453-4057qib7	10579	6	reactivation	reactivation	NN
cord-005453-4057qib7	10579	7	.	.	.
cord-005453-4057qib7	10580	1	Mean	mean	JJ
cord-005453-4057qib7	10580	2	time	time	NN
cord-005453-4057qib7	10580	3	to	to	IN
cord-005453-4057qib7	10580	4	reactivation	reactivation	NN
cord-005453-4057qib7	10580	5	since	since	IN
cord-005453-4057qib7	10580	6	transplant	transplant	NN
cord-005453-4057qib7	10580	7	was	be	VBD
cord-005453-4057qib7	10580	8	36±19	36±19	NNP
cord-005453-4057qib7	10580	9	days	day	NNS
cord-005453-4057qib7	10580	10	.	.	.
cord-005453-4057qib7	10581	1	Valganciclovir	Valganciclovir	NNP
cord-005453-4057qib7	10581	2	was	be	VBD
cord-005453-4057qib7	10581	3	given	give	VBN
cord-005453-4057qib7	10581	4	in	in	IN
cord-005453-4057qib7	10581	5	36	36	CD
cord-005453-4057qib7	10581	6	patients	patient	NNS
cord-005453-4057qib7	10581	7	due	due	JJ
cord-005453-4057qib7	10581	8	to	to	IN
cord-005453-4057qib7	10581	9	ease	ease	NN
cord-005453-4057qib7	10581	10	of	of	IN
cord-005453-4057qib7	10581	11	administration	administration	NN
cord-005453-4057qib7	10581	12	and	and	CC
cord-005453-4057qib7	10581	13	six	six	CD
cord-005453-4057qib7	10581	14	patients	patient	NNS
cord-005453-4057qib7	10581	15	were	be	VBD
cord-005453-4057qib7	10581	16	treated	treat	VBN
cord-005453-4057qib7	10581	17	with	with	IN
cord-005453-4057qib7	10581	18	ganciclovir	ganciclovir	NNS
cord-005453-4057qib7	10581	19	during	during	IN
cord-005453-4057qib7	10581	20	their	-PRON-	PRP$
cord-005453-4057qib7	10581	21	hospital	hospital	NN
cord-005453-4057qib7	10581	22	stay	stay	NN
cord-005453-4057qib7	10581	23	.	.	.
cord-005453-4057qib7	10582	1	Only	only	RB
cord-005453-4057qib7	10582	2	one	one	CD
cord-005453-4057qib7	10582	3	patient	patient	NN
cord-005453-4057qib7	10582	4	had	have	VBD
cord-005453-4057qib7	10582	5	resistant	resistant	JJ
cord-005453-4057qib7	10582	6	disease	disease	NN
cord-005453-4057qib7	10582	7	.	.	.
cord-005453-4057qib7	10583	1	Mean	mean	JJ
cord-005453-4057qib7	10583	2	time	time	NN
cord-005453-4057qib7	10583	3	to	to	TO
cord-005453-4057qib7	10583	4	clear	clear	JJ
cord-005453-4057qib7	10583	5	viremia	viremia	NN
cord-005453-4057qib7	10583	6	was	be	VBD
cord-005453-4057qib7	10583	7	20±12.8	20±12.8	CD
cord-005453-4057qib7	10583	8	days	day	NNS
cord-005453-4057qib7	10583	9	.	.	.
cord-005453-4057qib7	10584	1	The	the	DT
cord-005453-4057qib7	10584	2	patients	patient	NNS
cord-005453-4057qib7	10584	3	having	have	VBG
cord-005453-4057qib7	10584	4	viral	viral	JJ
cord-005453-4057qib7	10584	5	load	load	NN
cord-005453-4057qib7	10584	6	less	less	JJR
cord-005453-4057qib7	10584	7	than	than	IN
cord-005453-4057qib7	10584	8	2000	2000	CD
cord-005453-4057qib7	10584	9	copies	copy	NNS
cord-005453-4057qib7	10584	10	/	/	SYM
cord-005453-4057qib7	10584	11	ml	ml	NNS
cord-005453-4057qib7	10584	12	,	,	,
cord-005453-4057qib7	10584	13	subsequently	subsequently	RB
cord-005453-4057qib7	10584	14	cleared	clear	VBD
cord-005453-4057qib7	10584	15	CMV	CMV	NNP
cord-005453-4057qib7	10584	16	without	without	IN
cord-005453-4057qib7	10584	17	any	any	DT
cord-005453-4057qib7	10584	18	treatment	treatment	NN
cord-005453-4057qib7	10584	19	.	.	.
cord-005453-4057qib7	10585	1	Antiviral	antiviral	JJ
cord-005453-4057qib7	10585	2	agents	agent	NNS
cord-005453-4057qib7	10585	3	;	;	:
cord-005453-4057qib7	10585	4	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	10585	5	and	and	CC
cord-005453-4057qib7	10585	6	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	10585	7	were	be	VBD
cord-005453-4057qib7	10585	8	equally	equally	RB
cord-005453-4057qib7	10585	9	effective	effective	JJ
cord-005453-4057qib7	10585	10	for	for	IN
cord-005453-4057qib7	10585	11	treating	treat	VBG
cord-005453-4057qib7	10585	12	CMV	CMV	NNP
cord-005453-4057qib7	10585	13	infection	infection	NN
cord-005453-4057qib7	10585	14	with	with	IN
cord-005453-4057qib7	10585	15	99	99	CD
cord-005453-4057qib7	10585	16	%	%	NN
cord-005453-4057qib7	10585	17	efficacy	efficacy	NN
cord-005453-4057qib7	10585	18	,	,	,
cord-005453-4057qib7	10585	19	however	however	RB
cord-005453-4057qib7	10585	20	,	,	,
cord-005453-4057qib7	10585	21	more	more	RBR
cord-005453-4057qib7	10585	22	adverse	adverse	JJ
cord-005453-4057qib7	10585	23	effects	effect	NNS
cord-005453-4057qib7	10585	24	were	be	VBD
cord-005453-4057qib7	10585	25	seen	see	VBN
cord-005453-4057qib7	10585	26	with	with	IN
cord-005453-4057qib7	10585	27	ganciclovir	ganciclovir	NNS
cord-005453-4057qib7	10585	28	.	.	.
cord-005453-4057qib7	10586	1	Myelosuppression	Myelosuppression	NNP
cord-005453-4057qib7	10586	2	I	I	NNP
cord-005453-4057qib7	10586	3	-	-	HYPH
cord-005453-4057qib7	10586	4	III	III	NNP
cord-005453-4057qib7	10586	5	was	be	VBD
cord-005453-4057qib7	10586	6	seen	see	VBN
cord-005453-4057qib7	10586	7	in	in	IN
cord-005453-4057qib7	10586	8	24	24	CD
cord-005453-4057qib7	10586	9	%	%	NN
cord-005453-4057qib7	10586	10	patients	patient	NNS
cord-005453-4057qib7	10586	11	treated	treat	VBN
cord-005453-4057qib7	10586	12	with	with	IN
cord-005453-4057qib7	10586	13	valganciclovir	valganciclovir	NNS
cord-005453-4057qib7	10586	14	and	and	CC
cord-005453-4057qib7	10586	15	in	in	IN
cord-005453-4057qib7	10586	16	46	46	CD
cord-005453-4057qib7	10586	17	%	%	NN
cord-005453-4057qib7	10586	18	treated	treat	VBN
cord-005453-4057qib7	10586	19	with	with	IN
cord-005453-4057qib7	10586	20	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	10586	21	.	.	.
cord-005453-4057qib7	10587	1	Renal	renal	JJ
cord-005453-4057qib7	10587	2	impairment	impairment	NN
cord-005453-4057qib7	10588	1	I	-PRON-	PRP
cord-005453-4057qib7	10588	2	-	-	HYPH
cord-005453-4057qib7	10588	3	II	II	NNP
cord-005453-4057qib7	10588	4	was	be	VBD
cord-005453-4057qib7	10588	5	seen	see	VBN
cord-005453-4057qib7	10588	6	in	in	IN
cord-005453-4057qib7	10588	7	14	14	CD
cord-005453-4057qib7	10588	8	%	%	NN
cord-005453-4057qib7	10588	9	of	of	IN
cord-005453-4057qib7	10588	10	valganciclovir	valganciclovir	NNS
cord-005453-4057qib7	10588	11	and	and	CC
cord-005453-4057qib7	10588	12	20	20	CD
cord-005453-4057qib7	10588	13	%	%	NN
cord-005453-4057qib7	10588	14	of	of	IN
cord-005453-4057qib7	10588	15	ganciclovir	ganciclovir	NNS
cord-005453-4057qib7	10588	16	treated	treat	VBN
cord-005453-4057qib7	10588	17	patients	patient	NNS
cord-005453-4057qib7	10588	18	.	.	.
cord-005453-4057qib7	10589	1	Steroid	Steroid	NNP
cord-005453-4057qib7	10589	2	administration	administration	NN
cord-005453-4057qib7	10589	3	was	be	VBD
cord-005453-4057qib7	10589	4	strongly	strongly	RB
cord-005453-4057qib7	10589	5	associated	associate	VBN
cord-005453-4057qib7	10589	6	with	with	IN
cord-005453-4057qib7	10589	7	CMV	CMV	NNP
cord-005453-4057qib7	10589	8	reactivation	reactivation	NN
cord-005453-4057qib7	10589	9	(	(	-LRB-
cord-005453-4057qib7	10589	10	p	p	NN
cord-005453-4057qib7	10589	11	=	=	SYM
cord-005453-4057qib7	10589	12	0.003	0.003	CD
cord-005453-4057qib7	10589	13	)	)	-RRB-
cord-005453-4057qib7	10589	14	.	.	.
cord-005453-4057qib7	10590	1	No	no	DT
cord-005453-4057qib7	10590	2	statistically	statistically	RB
cord-005453-4057qib7	10590	3	significant	significant	JJ
cord-005453-4057qib7	10590	4	association	association	NN
cord-005453-4057qib7	10590	5	was	be	VBD
cord-005453-4057qib7	10590	6	found	find	VBN
cord-005453-4057qib7	10590	7	with	with	IN
cord-005453-4057qib7	10590	8	the	the	DT
cord-005453-4057qib7	10590	9	use	use	NN
cord-005453-4057qib7	10590	10	of	of	IN
cord-005453-4057qib7	10590	11	ATG	ATG	NNP
cord-005453-4057qib7	10590	12	,	,	,
cord-005453-4057qib7	10590	13	GVHD	GVHD	NNP
cord-005453-4057qib7	10590	14	,	,	,
cord-005453-4057qib7	10590	15	underlying	underlie	VBG
cord-005453-4057qib7	10590	16	disease	disease	NN
cord-005453-4057qib7	10590	17	,	,	,
cord-005453-4057qib7	10590	18	ABO	ABO	NNP
cord-005453-4057qib7	10590	19	or	or	CC
cord-005453-4057qib7	10590	20	gender	gender	NN
cord-005453-4057qib7	10590	21	mismatch	mismatch	NN
cord-005453-4057qib7	10590	22	.	.	.
cord-005453-4057qib7	10591	1	OS	OS	NNP
cord-005453-4057qib7	10591	2	was	be	VBD
cord-005453-4057qib7	10591	3	81.0	81.0	CD
cord-005453-4057qib7	10591	4	%	%	NN
cord-005453-4057qib7	10591	5	and	and	CC
cord-005453-4057qib7	10591	6	93.1	93.1	CD
cord-005453-4057qib7	10591	7	%	%	NN
cord-005453-4057qib7	10591	8	in	in	IN
cord-005453-4057qib7	10591	9	with	with	IN
cord-005453-4057qib7	10591	10	and	and	CC
cord-005453-4057qib7	10591	11	without	without	IN
cord-005453-4057qib7	10591	12	CMV	CMV	NNP
cord-005453-4057qib7	10591	13	Reactivation	Reactivation	NNP
cord-005453-4057qib7	10591	14	(	(	-LRB-
cord-005453-4057qib7	10591	15	p=0.1	p=0.1	NNP
cord-005453-4057qib7	10591	16	)	)	-RRB-
cord-005453-4057qib7	10591	17	and	and	CC
cord-005453-4057qib7	10591	18	DFS	DFS	NNP
cord-005453-4057qib7	10591	19	was	be	VBD
cord-005453-4057qib7	10591	20	83.3	83.3	CD
cord-005453-4057qib7	10591	21	%	%	NN
cord-005453-4057qib7	10591	22	and	and	CC
cord-005453-4057qib7	10591	23	96.6	96.6	CD
cord-005453-4057qib7	10591	24	%	%	NN
cord-005453-4057qib7	10591	25	in	in	IN
cord-005453-4057qib7	10591	26	with	with	IN
cord-005453-4057qib7	10591	27	and	and	CC
cord-005453-4057qib7	10591	28	without	without	IN
cord-005453-4057qib7	10592	1	CMV	CMV	NNP
cord-005453-4057qib7	10592	2	Reactivation	Reactivation	NNP
cord-005453-4057qib7	10592	3	(	(	-LRB-
cord-005453-4057qib7	10592	4	p=0.06	p=0.06	NNP
cord-005453-4057qib7	10592	5	)	)	-RRB-
cord-005453-4057qib7	10592	6	Conclusions	conclusion	NNS
cord-005453-4057qib7	10592	7	:	:	:
cord-005453-4057qib7	10593	1	CMV	CMV	NNP
cord-005453-4057qib7	10593	2	reactivation	reactivation	NN
cord-005453-4057qib7	10593	3	was	be	VBD
cord-005453-4057qib7	10593	4	seen	see	VBN
cord-005453-4057qib7	10593	5	in	in	IN
cord-005453-4057qib7	10593	6	81	81	CD
cord-005453-4057qib7	10593	7	%	%	NN
cord-005453-4057qib7	10593	8	of	of	IN
cord-005453-4057qib7	10593	9	the	the	DT
cord-005453-4057qib7	10593	10	transplant	transplant	NN
cord-005453-4057qib7	10593	11	recipients	recipient	NNS
cord-005453-4057qib7	10593	12	,	,	,
cord-005453-4057qib7	10593	13	this	this	DT
cord-005453-4057qib7	10593	14	is	be	VBZ
cord-005453-4057qib7	10593	15	higher	high	JJR
cord-005453-4057qib7	10593	16	compared	compare	VBN
cord-005453-4057qib7	10593	17	to	to	IN
cord-005453-4057qib7	10593	18	the	the	DT
cord-005453-4057qib7	10593	19	western	western	JJ
cord-005453-4057qib7	10593	20	world	world	NN
cord-005453-4057qib7	10593	21	due	due	JJ
cord-005453-4057qib7	10593	22	to	to	IN
cord-005453-4057qib7	10593	23	high	high	JJ
cord-005453-4057qib7	10593	24	CMV	CMV	NNP
cord-005453-4057qib7	10593	25	seropositivity	seropositivity	NN
cord-005453-4057qib7	10593	26	is	be	VBZ
cord-005453-4057qib7	10593	27	this	this	DT
cord-005453-4057qib7	10593	28	region	region	NN
cord-005453-4057qib7	10593	29	.	.	.
cord-005453-4057qib7	10594	1	Steroids	Steroids	NNP
cord-005453-4057qib7	10594	2	administration	administration	NN
cord-005453-4057qib7	10594	3	in	in	IN
cord-005453-4057qib7	10594	4	post	post	JJ
cord-005453-4057qib7	10594	5	-	-	JJ
cord-005453-4057qib7	10594	6	transplant	transplant	JJ
cord-005453-4057qib7	10594	7	period	period	NN
cord-005453-4057qib7	10594	8	significantly	significantly	RB
cord-005453-4057qib7	10594	9	increase	increase	VBP
cord-005453-4057qib7	10594	10	the	the	DT
cord-005453-4057qib7	10594	11	risk	risk	NN
cord-005453-4057qib7	10594	12	of	of	IN
cord-005453-4057qib7	10594	13	CMV	CMV	NNP
cord-005453-4057qib7	10594	14	reactivation	reactivation	NN
cord-005453-4057qib7	10594	15	.	.	.
cord-005453-4057qib7	10595	1	Preemptive	preemptive	JJ
cord-005453-4057qib7	10595	2	therapy	therapy	NN
cord-005453-4057qib7	10595	3	with	with	IN
cord-005453-4057qib7	10595	4	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	10595	5	effectively	effectively	RB
cord-005453-4057qib7	10595	6	treats	treat	VBZ
cord-005453-4057qib7	10595	7	CMV	CMV	NNP
cord-005453-4057qib7	10595	8	reactivation	reactivation	NN
cord-005453-4057qib7	10595	9	with	with	IN
cord-005453-4057qib7	10595	10	acceptable	acceptable	JJ
cord-005453-4057qib7	10595	11	side	side	NN
cord-005453-4057qib7	10595	12	effects	effect	NNS
cord-005453-4057qib7	10595	13	.	.	.
cord-005453-4057qib7	10596	1	Viral	viral	JJ
cord-005453-4057qib7	10596	2	threshold	threshold	NN
cord-005453-4057qib7	10596	3	for	for	IN
cord-005453-4057qib7	10596	4	treatment	treatment	NN
cord-005453-4057qib7	10596	5	should	should	MD
cord-005453-4057qib7	10596	6	be	be	VB
cord-005453-4057qib7	10596	7	decided	decide	VBN
cord-005453-4057qib7	10596	8	considering	consider	VBG
cord-005453-4057qib7	10596	9	the	the	DT
cord-005453-4057qib7	10596	10	regional	regional	JJ
cord-005453-4057qib7	10596	11	endemicity	endemicity	NN
cord-005453-4057qib7	10596	12	.	.	.
cord-005453-4057qib7	10597	1	CMV	CMV	NNP
cord-005453-4057qib7	10597	2	adversely	adversely	RB
cord-005453-4057qib7	10597	3	affects	affect	VBZ
cord-005453-4057qib7	10597	4	the	the	DT
cord-005453-4057qib7	10597	5	transplant	transplant	NN
cord-005453-4057qib7	10597	6	outcome	outcome	NN
cord-005453-4057qib7	10597	7	in	in	IN
cord-005453-4057qib7	10597	8	terms	term	NNS
cord-005453-4057qib7	10597	9	of	of	IN
cord-005453-4057qib7	10597	10	DFS	DFS	NNP
cord-005453-4057qib7	10597	11	and	and	CC
cord-005453-4057qib7	10597	12	OS	OS	NNP
cord-005453-4057qib7	10597	13	.	.	.
cord-005453-4057qib7	10598	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10598	2	:	:	:
cord-005453-4057qib7	10599	1	No	no	DT
cord-005453-4057qib7	10599	2	conflict	conflict	NN
cord-005453-4057qib7	10599	3	of	of	IN
cord-005453-4057qib7	10599	4	interest	interest	NN
cord-005453-4057qib7	10599	5	.	.	.
cord-005453-4057qib7	10600	1	Acute	acute	JJ
cord-005453-4057qib7	10600	2	nephritis	nephritis	NN
cord-005453-4057qib7	10600	3	requiring	require	VBG
cord-005453-4057qib7	10600	4	nephrectomy	nephrectomy	NN
cord-005453-4057qib7	10600	5	caused	cause	VBN
cord-005453-4057qib7	10600	6	by	by	IN
cord-005453-4057qib7	10600	7	adenovirus	adenovirus	NN
cord-005453-4057qib7	10600	8	(	(	-LRB-
cord-005453-4057qib7	10600	9	HADV	HADV	NNP
cord-005453-4057qib7	10600	10	)	)	-RRB-
cord-005453-4057qib7	10600	11	and	and	CC
cord-005453-4057qib7	10600	12	human	human	JJ
cord-005453-4057qib7	10600	13	polyomavirus	polyomavirus	NNP
cord-005453-4057qib7	10600	14	BK	BK	NNP
cord-005453-4057qib7	10600	15	(	(	-LRB-
cord-005453-4057qib7	10600	16	BKPYV	BKPYV	NNP
cord-005453-4057qib7	10600	17	)	)	-RRB-
cord-005453-4057qib7	10600	18	following	follow	VBG
cord-005453-4057qib7	10600	19	allogeneic	allogeneic	NN
cord-005453-4057qib7	10600	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10600	21	stem	stem	NN
cord-005453-4057qib7	10600	22	-	-	HYPH
cord-005453-4057qib7	10600	23	cell	cell	NN
cord-005453-4057qib7	10600	24	transplantation	transplantation	NN
cord-005453-4057qib7	10600	25	in	in	IN
cord-005453-4057qib7	10600	26	a	a	DT
cord-005453-4057qib7	10600	27	patient	patient	NN
cord-005453-4057qib7	10600	28	with	with	IN
cord-005453-4057qib7	10600	29	PH+	PH+	NNP
cord-005453-4057qib7	10601	1	all	all	DT
cord-005453-4057qib7	10601	2	Background	Background	NNP
cord-005453-4057qib7	10602	1	:	:	:
cord-005453-4057qib7	10602	2	Adenovirus	Adenovirus	NNP
cord-005453-4057qib7	10602	3	infection	infection	NN
cord-005453-4057qib7	10602	4	represents	represent	VBZ
cord-005453-4057qib7	10602	5	an	an	DT
cord-005453-4057qib7	10602	6	important	important	JJ
cord-005453-4057qib7	10602	7	cause	cause	NN
cord-005453-4057qib7	10602	8	of	of	IN
cord-005453-4057qib7	10602	9	morbidity	morbidity	NN
cord-005453-4057qib7	10602	10	and	and	CC
cord-005453-4057qib7	10602	11	mortality	mortality	NN
cord-005453-4057qib7	10602	12	after	after	IN
cord-005453-4057qib7	10602	13	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10602	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10602	15	stem	stem	NN
cord-005453-4057qib7	10602	16	cell	cell	NN
cord-005453-4057qib7	10602	17	transplantation	transplantation	NN
cord-005453-4057qib7	10602	18	(	(	-LRB-
cord-005453-4057qib7	10602	19	allo	allo	NN
cord-005453-4057qib7	10602	20	-	-	HYPH
cord-005453-4057qib7	10602	21	HSCT	HSCT	NNP
cord-005453-4057qib7	10602	22	)	)	-RRB-
cord-005453-4057qib7	10602	23	,	,	,
cord-005453-4057qib7	10602	24	with	with	IN
cord-005453-4057qib7	10602	25	no	no	DT
cord-005453-4057qib7	10602	26	established	establish	VBN
cord-005453-4057qib7	10602	27	therapy	therapy	NN
cord-005453-4057qib7	10602	28	.	.	.
cord-005453-4057qib7	10603	1	Although	although	IN
cord-005453-4057qib7	10603	2	different	different	JJ
cord-005453-4057qib7	10603	3	organs	organ	NNS
cord-005453-4057qib7	10603	4	may	may	MD
cord-005453-4057qib7	10603	5	be	be	VB
cord-005453-4057qib7	10603	6	affected	affect	VBN
cord-005453-4057qib7	10603	7	by	by	IN
cord-005453-4057qib7	10603	8	disseminated	disseminate	VBN
cord-005453-4057qib7	10603	9	HAdV	hadv	JJ
cord-005453-4057qib7	10603	10	infections	infection	NNS
cord-005453-4057qib7	10603	11	,	,	,
cord-005453-4057qib7	10603	12	kidney	kidney	NN
cord-005453-4057qib7	10603	13	involvement	involvement	NN
cord-005453-4057qib7	10603	14	has	have	VBZ
cord-005453-4057qib7	10603	15	been	be	VBN
cord-005453-4057qib7	10603	16	rarely	rarely	RB
cord-005453-4057qib7	10603	17	reported	report	VBN
cord-005453-4057qib7	10603	18	.	.	.
cord-005453-4057qib7	10604	1	Co	Co	NNS
cord-005453-4057qib7	10604	2	-	-	NN
cord-005453-4057qib7	10604	3	infection	infection	NN
cord-005453-4057qib7	10604	4	of	of	IN
cord-005453-4057qib7	10604	5	HAdV	hadv	NN
cord-005453-4057qib7	10604	6	and	and	CC
cord-005453-4057qib7	10604	7	BKPyV	bkpyv	NN
cord-005453-4057qib7	10604	8	are	be	VBP
cord-005453-4057qib7	10604	9	common	common	JJ
cord-005453-4057qib7	10604	10	complication	complication	NN
cord-005453-4057qib7	10604	11	in	in	IN
cord-005453-4057qib7	10604	12	patients	patient	NNS
cord-005453-4057qib7	10604	13	undergoing	undergo	VBG
cord-005453-4057qib7	10604	14	allo	allo	NN
cord-005453-4057qib7	10604	15	-	-	HYPH
cord-005453-4057qib7	10604	16	HSCT	HSCT	NNP
cord-005453-4057qib7	10604	17	,	,	,
cord-005453-4057qib7	10604	18	but	but	CC
cord-005453-4057qib7	10604	19	recent	recent	JJ
cord-005453-4057qib7	10604	20	studies	study	NNS
cord-005453-4057qib7	10604	21	demonstrate	demonstrate	VBP
cord-005453-4057qib7	10604	22	that	that	IN
cord-005453-4057qib7	10604	23	BKPyV	bkpyv	PRP
cord-005453-4057qib7	10604	24	may	may	MD
cord-005453-4057qib7	10604	25	facilitate	facilitate	VB
cord-005453-4057qib7	10604	26	the	the	DT
cord-005453-4057qib7	10604	27	replication	replication	NN
cord-005453-4057qib7	10604	28	of	of	IN
cord-005453-4057qib7	10604	29	HAdV	hadv	NN
cord-005453-4057qib7	10604	30	and	and	CC
cord-005453-4057qib7	10604	31	lead	lead	VB
cord-005453-4057qib7	10604	32	to	to	IN
cord-005453-4057qib7	10604	33	elevated	elevated	JJ
cord-005453-4057qib7	10604	34	viremia	viremia	NN
cord-005453-4057qib7	10604	35	with	with	IN
cord-005453-4057qib7	10604	36	increased	increase	VBN
cord-005453-4057qib7	10604	37	virulence	virulence	NN
cord-005453-4057qib7	10604	38	and	and	CC
cord-005453-4057qib7	10604	39	serious	serious	JJ
cord-005453-4057qib7	10604	40	clinical	clinical	JJ
cord-005453-4057qib7	10604	41	consequences	consequence	NNS
cord-005453-4057qib7	10604	42	.	.	.
cord-005453-4057qib7	10605	1	Here	here	RB
cord-005453-4057qib7	10605	2	we	-PRON-	PRP
cord-005453-4057qib7	10605	3	report	report	VBP
cord-005453-4057qib7	10605	4	a	a	DT
cord-005453-4057qib7	10605	5	case	case	NN
cord-005453-4057qib7	10605	6	of	of	IN
cord-005453-4057qib7	10605	7	an	an	DT
cord-005453-4057qib7	10605	8	adult	adult	NN
cord-005453-4057qib7	10605	9	patient	patient	NN
cord-005453-4057qib7	10605	10	who	who	WP
cord-005453-4057qib7	10605	11	required	require	VBD
cord-005453-4057qib7	10605	12	a	a	DT
cord-005453-4057qib7	10605	13	monolateral	monolateral	JJ
cord-005453-4057qib7	10605	14	nephrectomy	nephrectomy	NN
cord-005453-4057qib7	10605	15	due	due	IN
cord-005453-4057qib7	10605	16	to	to	IN
cord-005453-4057qib7	10605	17	HAdV	hadv	JJ
cord-005453-4057qib7	10605	18	pyelonephritis	pyelonephritis	NN
cord-005453-4057qib7	10605	19	as	as	IN
cord-005453-4057qib7	10605	20	an	an	DT
cord-005453-4057qib7	10605	21	early	early	JJ
cord-005453-4057qib7	10605	22	complication	complication	NN
cord-005453-4057qib7	10605	23	of	of	IN
cord-005453-4057qib7	10605	24	allo	allo	NN
cord-005453-4057qib7	10605	25	-	-	HYPH
cord-005453-4057qib7	10605	26	HSCT	HSCT	NNP
cord-005453-4057qib7	10605	27	for	for	IN
cord-005453-4057qib7	10605	28	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	10605	29	-	-	HYPH
cord-005453-4057qib7	10605	30	positive	positive	JJ
cord-005453-4057qib7	10605	31	acute	acute	JJ
cord-005453-4057qib7	10605	32	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	10605	33	leukemia	leukemia	NN
cord-005453-4057qib7	10606	1	(	(	-LRB-
cord-005453-4057qib7	10606	2	Ph+	Ph+	NNP
cord-005453-4057qib7	10606	3	ALL	all	DT
cord-005453-4057qib7	10606	4	)	)	-RRB-
cord-005453-4057qib7	10606	5	.	.	.
cord-005453-4057qib7	10607	1	Methods	method	NNS
cord-005453-4057qib7	10607	2	:	:	:
cord-005453-4057qib7	10607	3	In	in	IN
cord-005453-4057qib7	10607	4	September	September	NNP
cord-005453-4057qib7	10607	5	2014	2014	CD
cord-005453-4057qib7	10607	6	,	,	,
cord-005453-4057qib7	10607	7	an	an	DT
cord-005453-4057qib7	10607	8	ethiopian	ethiopian	JJ
cord-005453-4057qib7	10607	9	gentleman	gentleman	NN
cord-005453-4057qib7	10607	10	was	be	VBD
cord-005453-4057qib7	10607	11	diagnosed	diagnose	VBN
cord-005453-4057qib7	10607	12	with	with	IN
cord-005453-4057qib7	10607	13	Ph+	Ph+	NNP
cord-005453-4057qib7	10607	14	ALL	all	RB
cord-005453-4057qib7	10607	15	at	at	IN
cord-005453-4057qib7	10607	16	the	the	DT
cord-005453-4057qib7	10607	17	age	age	NN
cord-005453-4057qib7	10607	18	of	of	IN
cord-005453-4057qib7	10607	19	24	24	CD
cord-005453-4057qib7	10607	20	years	year	NNS
cord-005453-4057qib7	10607	21	.	.	.
cord-005453-4057qib7	10608	1	He	-PRON-	PRP
cord-005453-4057qib7	10608	2	was	be	VBD
cord-005453-4057qib7	10608	3	treated	treat	VBN
cord-005453-4057qib7	10608	4	with	with	IN
cord-005453-4057qib7	10608	5	polychemotherapy	polychemotherapy	NNP
cord-005453-4057qib7	10608	6	in	in	IN
cord-005453-4057qib7	10608	7	association	association	NNP
cord-005453-4057qib7	10608	8	with	with	IN
cord-005453-4057qib7	10608	9	the	the	DT
cord-005453-4057qib7	10608	10	tyrosin	tyrosin	NNP
cord-005453-4057qib7	10608	11	kinase	kinase	NNP
cord-005453-4057qib7	10608	12	inhibitor	inhibitor	NN
cord-005453-4057qib7	10608	13	imatinib	imatinib	NNP
cord-005453-4057qib7	10608	14	mesylate	mesylate	NNP
cord-005453-4057qib7	10608	15	achieving	achieve	VBG
cord-005453-4057qib7	10608	16	a	a	DT
cord-005453-4057qib7	10608	17	complete	complete	JJ
cord-005453-4057qib7	10608	18	remission	remission	NN
cord-005453-4057qib7	10608	19	(	(	-LRB-
cord-005453-4057qib7	10608	20	CR	CR	NNP
cord-005453-4057qib7	10608	21	)	)	-RRB-
cord-005453-4057qib7	10608	22	.	.	.
cord-005453-4057qib7	10609	1	One	one	CD
cord-005453-4057qib7	10609	2	year	year	NN
cord-005453-4057qib7	10609	3	later	later	RB
cord-005453-4057qib7	10609	4	,	,	,
cord-005453-4057qib7	10609	5	due	due	IN
cord-005453-4057qib7	10609	6	to	to	IN
cord-005453-4057qib7	10609	7	disease	disease	NN
cord-005453-4057qib7	10609	8	relapse	relapse	VB
cord-005453-4057qib7	10609	9	with	with	IN
cord-005453-4057qib7	10609	10	CNS	CNS	NNP
cord-005453-4057qib7	10609	11	involvement	involvement	NN
cord-005453-4057qib7	10609	12	,	,	,
cord-005453-4057qib7	10609	13	he	-PRON-	PRP
cord-005453-4057qib7	10609	14	was	be	VBD
cord-005453-4057qib7	10609	15	started	start	VBN
cord-005453-4057qib7	10609	16	on	on	IN
cord-005453-4057qib7	10609	17	vincristine	vincristine	NN
cord-005453-4057qib7	10609	18	and	and	CC
cord-005453-4057qib7	10609	19	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	10609	20	plus	plus	CC
cord-005453-4057qib7	10609	21	imatinib	imatinib	JJ
cord-005453-4057qib7	10609	22	treatment	treatment	NN
cord-005453-4057qib7	10609	23	and	and	CC
cord-005453-4057qib7	10609	24	in	in	IN
cord-005453-4057qib7	10609	25	April	April	NNP
cord-005453-4057qib7	10609	26	2017	2017	CD
cord-005453-4057qib7	10609	27	he	-PRON-	PRP
cord-005453-4057qib7	10609	28	was	be	VBD
cord-005453-4057qib7	10609	29	referred	refer	VBN
cord-005453-4057qib7	10609	30	to	to	IN
cord-005453-4057qib7	10609	31	our	-PRON-	PRP$
cord-005453-4057qib7	10609	32	BMT	BMT	NNP
cord-005453-4057qib7	10609	33	Center	Center	NNP
cord-005453-4057qib7	10609	34	from	from	IN
cord-005453-4057qib7	10609	35	Ethiopia	Ethiopia	NNP
cord-005453-4057qib7	10609	36	.	.	.
cord-005453-4057qib7	10610	1	Upon	upon	IN
cord-005453-4057qib7	10610	2	confirmation	confirmation	NN
cord-005453-4057qib7	10610	3	of	of	IN
cord-005453-4057qib7	10610	4	the	the	DT
cord-005453-4057qib7	10610	5	p210	p210	NN
cord-005453-4057qib7	10610	6	Ph+	Ph+	NNP
cord-005453-4057qib7	10610	7	B	B	NNP
cord-005453-4057qib7	10610	8	-	-	:
cord-005453-4057qib7	10610	9	ALL	all	DT
cord-005453-4057qib7	10610	10	diagnosis	diagnosis	NN
cord-005453-4057qib7	10610	11	,	,	,
cord-005453-4057qib7	10610	12	therapy	therapy	NN
cord-005453-4057qib7	10610	13	with	with	IN
cord-005453-4057qib7	10610	14	the	the	DT
cord-005453-4057qib7	10610	15	Scr	Scr	NNP
cord-005453-4057qib7	10610	16	/	/	SYM
cord-005453-4057qib7	10610	17	Abl	Abl	NNP
cord-005453-4057qib7	10610	18	dual	dual	JJ
cord-005453-4057qib7	10610	19	inhibitor	inhibitor	NN
cord-005453-4057qib7	10610	20	dasatinib	dasatinib	NN
cord-005453-4057qib7	10610	21	associated	associate	VBN
cord-005453-4057qib7	10610	22	to	to	IN
cord-005453-4057qib7	10610	23	intrathecal	intrathecal	JJ
cord-005453-4057qib7	10610	24	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10610	25	was	be	VBD
cord-005453-4057qib7	10610	26	started	start	VBN
cord-005453-4057qib7	10610	27	and	and	CC
cord-005453-4057qib7	10610	28	a	a	DT
cord-005453-4057qib7	10610	29	salvage	salvage	NN
cord-005453-4057qib7	10610	30	treatment	treatment	NN
cord-005453-4057qib7	10610	31	with	with	IN
cord-005453-4057qib7	10610	32	inotuzumab	inotuzumab	NNS
cord-005453-4057qib7	10610	33	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	10610	34	followed	follow	VBN
cord-005453-4057qib7	10610	35	by	by	IN
cord-005453-4057qib7	10610	36	an	an	DT
cord-005453-4057qib7	10610	37	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10610	38	HSCT	HSCT	NNP
cord-005453-4057qib7	10610	39	from	from	IN
cord-005453-4057qib7	10610	40	a	a	DT
cord-005453-4057qib7	10610	41	HLA	HLA	NNP
cord-005453-4057qib7	10610	42	-	-	HYPH
cord-005453-4057qib7	10610	43	identical	identical	JJ
cord-005453-4057qib7	10610	44	brother	brother	NN
cord-005453-4057qib7	10610	45	was	be	VBD
cord-005453-4057qib7	10610	46	planned	plan	VBN
cord-005453-4057qib7	10610	47	.	.	.
cord-005453-4057qib7	10611	1	Having	have	VBG
cord-005453-4057qib7	10611	2	achieved	achieve	VBN
cord-005453-4057qib7	10611	3	a	a	DT
cord-005453-4057qib7	10611	4	documented	document	VBN
cord-005453-4057qib7	10611	5	molecular	molecular	JJ
cord-005453-4057qib7	10611	6	CR	cr	NN
cord-005453-4057qib7	10611	7	disease	disease	NN
cord-005453-4057qib7	10611	8	status	status	NN
cord-005453-4057qib7	10611	9	,	,	,
cord-005453-4057qib7	10611	10	in	in	IN
cord-005453-4057qib7	10611	11	June	June	NNP
cord-005453-4057qib7	10611	12	2017	2017	CD
cord-005453-4057qib7	10611	13	the	the	DT
cord-005453-4057qib7	10611	14	patient	patient	NN
cord-005453-4057qib7	10611	15	underwent	undergo	VBD
cord-005453-4057qib7	10611	16	allo	allo	NN
cord-005453-4057qib7	10611	17	-	-	HYPH
cord-005453-4057qib7	10611	18	HSCT	HSCT	NNP
cord-005453-4057qib7	10611	19	following	follow	VBG
cord-005453-4057qib7	10611	20	the	the	DT
cord-005453-4057qib7	10611	21	fludarabine	fludarabine	NN
cord-005453-4057qib7	10611	22	-	-	HYPH
cord-005453-4057qib7	10611	23	melphalan	melphalan	NNP
cord-005453-4057qib7	10611	24	reduced	reduce	VBN
cord-005453-4057qib7	10611	25	-	-	HYPH
cord-005453-4057qib7	10611	26	intensity	intensity	NN
cord-005453-4057qib7	10611	27	conditioning	conditioning	NN
cord-005453-4057qib7	10611	28	regimen	regimen	NN
cord-005453-4057qib7	10611	29	.	.	.
cord-005453-4057qib7	10612	1	Graft	graft	NN
cord-005453-4057qib7	10612	2	-	-	HYPH
cord-005453-4057qib7	10612	3	versus	versus	IN
cord-005453-4057qib7	10612	4	-	-	HYPH
cord-005453-4057qib7	10612	5	host	host	NN
cord-005453-4057qib7	10612	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10612	7	included	include	VBD
cord-005453-4057qib7	10612	8	anti	anti	JJ
cord-005453-4057qib7	10612	9	-	-	JJ
cord-005453-4057qib7	10612	10	thymocyte	thymocyte	JJ
cord-005453-4057qib7	10612	11	globulin	globulin	NN
cord-005453-4057qib7	10612	12	,	,	,
cord-005453-4057qib7	10612	13	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	10612	14	and	and	CC
cord-005453-4057qib7	10612	15	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	10613	1	mofetil	mofetil	NNP
cord-005453-4057qib7	10613	2	Results	result	NNS
cord-005453-4057qib7	10614	1	:	:	:
cord-005453-4057qib7	10614	2	On	on	IN
cord-005453-4057qib7	10614	3	day	day	NN
cord-005453-4057qib7	10614	4	+24	+24	CD
cord-005453-4057qib7	10614	5	post	post	NN
cord-005453-4057qib7	10614	6	-	-	NN
cord-005453-4057qib7	10614	7	transplantation	transplantation	JJ
cord-005453-4057qib7	10614	8	the	the	DT
cord-005453-4057qib7	10614	9	patient	patient	NN
cord-005453-4057qib7	10614	10	developed	develop	VBD
cord-005453-4057qib7	10614	11	macro	macro	NN
cord-005453-4057qib7	10614	12	-	-	HYPH
cord-005453-4057qib7	10614	13	hematuria	hematuria	NN
cord-005453-4057qib7	10614	14	due	due	IN
cord-005453-4057qib7	10614	15	to	to	IN
cord-005453-4057qib7	10614	16	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	10614	17	cystitis	cystitis	NN
cord-005453-4057qib7	10614	18	and	and	CC
cord-005453-4057qib7	10614	19	a	a	DT
cord-005453-4057qib7	10614	20	CT	CT	NNP
cord-005453-4057qib7	10614	21	scan	scan	NN
cord-005453-4057qib7	10614	22	unveiled	unveil	VBD
cord-005453-4057qib7	10614	23	a	a	DT
cord-005453-4057qib7	10614	24	left	left	JJ
cord-005453-4057qib7	10614	25	pyelonephritis	pyelonephritis	NN
cord-005453-4057qib7	10614	26	with	with	IN
cord-005453-4057qib7	10614	27	marked	marked	JJ
cord-005453-4057qib7	10614	28	kidney	kidney	NN
cord-005453-4057qib7	10614	29	enlargement	enlargement	NN
cord-005453-4057qib7	10614	30	.	.	.
cord-005453-4057qib7	10615	1	Kidney	kidney	NN
cord-005453-4057qib7	10615	2	microbial	microbial	JJ
cord-005453-4057qib7	10615	3	investigations	investigation	NNS
cord-005453-4057qib7	10615	4	were	be	VBD
cord-005453-4057qib7	10615	5	all	all	DT
cord-005453-4057qib7	10615	6	negative	negative	JJ
cord-005453-4057qib7	10615	7	.	.	.
cord-005453-4057qib7	10616	1	At	at	IN
cord-005453-4057qib7	10616	2	the	the	DT
cord-005453-4057qib7	10616	3	same	same	JJ
cord-005453-4057qib7	10616	4	time	time	NN
cord-005453-4057qib7	10616	5	,	,	,
cord-005453-4057qib7	10616	6	HAdV	hadv	JJ
cord-005453-4057qib7	10616	7	viremia	viremia	NN
cord-005453-4057qib7	10616	8	with	with	IN
cord-005453-4057qib7	10616	9	very	very	RB
cord-005453-4057qib7	10616	10	high	high	JJ
cord-005453-4057qib7	10616	11	copy	copy	NN
cord-005453-4057qib7	10616	12	number	number	NN
cord-005453-4057qib7	10616	13	(	(	-LRB-
cord-005453-4057qib7	10616	14	>	>	NFP
cord-005453-4057qib7	10616	15	25000000	25000000	CD
cord-005453-4057qib7	10616	16	cp	cp	NNS
cord-005453-4057qib7	10616	17	/	/	SYM
cord-005453-4057qib7	10616	18	ml	ml	NN
cord-005453-4057qib7	10616	19	)	)	-RRB-
cord-005453-4057qib7	10616	20	was	be	VBD
cord-005453-4057qib7	10616	21	documented	document	VBN
cord-005453-4057qib7	10616	22	and	and	CC
cord-005453-4057qib7	10616	23	also	also	RB
cord-005453-4057qib7	10616	24	elevated	elevate	VBN
cord-005453-4057qib7	10616	25	BKPyV	bkpyv	NN
cord-005453-4057qib7	10616	26	(	(	-LRB-
cord-005453-4057qib7	10617	1	>	>	NFP
cord-005453-4057qib7	10617	2	25000000	25000000	CD
cord-005453-4057qib7	10617	3	cp	cp	NNS
cord-005453-4057qib7	10617	4	/	/	SYM
cord-005453-4057qib7	10617	5	ml	ml	NNP
cord-005453-4057qib7	10617	6	)	)	-RRB-
cord-005453-4057qib7	10617	7	viruria	viruria	NNP
cord-005453-4057qib7	10617	8	and	and	CC
cord-005453-4057qib7	10617	9	viremia	viremia	NNP
cord-005453-4057qib7	10617	10	(	(	-LRB-
cord-005453-4057qib7	10617	11	6400	6400	CD
cord-005453-4057qib7	10617	12	cp	cp	NN
cord-005453-4057qib7	10617	13	/	/	SYM
cord-005453-4057qib7	10617	14	ml	ml	NN
cord-005453-4057qib7	10617	15	)	)	-RRB-
cord-005453-4057qib7	10617	16	.	.	.
cord-005453-4057qib7	10618	1	The	the	DT
cord-005453-4057qib7	10618	2	genotyping	genotyping	NN
cord-005453-4057qib7	10618	3	of	of	IN
cord-005453-4057qib7	10618	4	HAdV	hadv	NN
cord-005453-4057qib7	10618	5	evidenced	evidenced	JJ
cord-005453-4057qib7	10618	6	serotype	serotype	NN
cord-005453-4057qib7	10618	7	B11	B11	NNP
cord-005453-4057qib7	10618	8	mainly	mainly	RB
cord-005453-4057qib7	10618	9	involved	involve	VBN
cord-005453-4057qib7	10618	10	in	in	IN
cord-005453-4057qib7	10618	11	infections	infection	NNS
cord-005453-4057qib7	10618	12	of	of	IN
cord-005453-4057qib7	10618	13	the	the	DT
cord-005453-4057qib7	10618	14	urinary	urinary	JJ
cord-005453-4057qib7	10618	15	tract	tract	NN
cord-005453-4057qib7	10618	16	.	.	.
cord-005453-4057qib7	10619	1	Treatment	treatment	NN
cord-005453-4057qib7	10619	2	with	with	IN
cord-005453-4057qib7	10619	3	cidofovir	cidofovir	NNS
cord-005453-4057qib7	10619	4	was	be	VBD
cord-005453-4057qib7	10619	5	immediately	immediately	RB
cord-005453-4057qib7	10619	6	started	start	VBN
cord-005453-4057qib7	10619	7	;	;	:
cord-005453-4057qib7	10619	8	nonetheless	nonetheless	RB
cord-005453-4057qib7	10619	9	,	,	,
cord-005453-4057qib7	10619	10	due	due	IN
cord-005453-4057qib7	10619	11	to	to	IN
cord-005453-4057qib7	10619	12	rapid	rapid	JJ
cord-005453-4057qib7	10619	13	clinical	clinical	JJ
cord-005453-4057qib7	10619	14	worsening	worsen	VBG
cord-005453-4057qib7	10619	15	despite	despite	IN
cord-005453-4057qib7	10619	16	maximal	maximal	JJ
cord-005453-4057qib7	10619	17	antibiotic	antibiotic	JJ
cord-005453-4057qib7	10619	18	therapy	therapy	NN
cord-005453-4057qib7	10619	19	,	,	,
cord-005453-4057qib7	10619	20	on	on	IN
cord-005453-4057qib7	10619	21	day	day	NN
cord-005453-4057qib7	10619	22	+50	+50	NN
cord-005453-4057qib7	10619	23	a	a	DT
cord-005453-4057qib7	10619	24	left	left	JJ
cord-005453-4057qib7	10619	25	nephrectomy	nephrectomy	NN
cord-005453-4057qib7	10619	26	was	be	VBD
cord-005453-4057qib7	10619	27	performed	perform	VBN
cord-005453-4057qib7	10619	28	,	,	,
cord-005453-4057qib7	10619	29	which	which	WDT
cord-005453-4057qib7	10619	30	led	lead	VBD
cord-005453-4057qib7	10619	31	to	to	IN
cord-005453-4057qib7	10619	32	a	a	DT
cord-005453-4057qib7	10619	33	subsequent	subsequent	JJ
cord-005453-4057qib7	10619	34	progressive	progressive	JJ
cord-005453-4057qib7	10619	35	resolution	resolution	NN
cord-005453-4057qib7	10619	36	of	of	IN
cord-005453-4057qib7	10619	37	the	the	DT
cord-005453-4057qib7	10619	38	clinical	clinical	JJ
cord-005453-4057qib7	10619	39	symptoms	symptom	NNS
cord-005453-4057qib7	10619	40	and	and	CC
cord-005453-4057qib7	10619	41	negativization	negativization	NN
cord-005453-4057qib7	10619	42	of	of	IN
cord-005453-4057qib7	10619	43	HAdV	HAdV	NNP
cord-005453-4057qib7	10619	44	and	and	CC
cord-005453-4057qib7	10619	45	BKPyV	BKPyV	NNP
cord-005453-4057qib7	10619	46	viremia	viremia	NN
cord-005453-4057qib7	10619	47	and	and	CC
cord-005453-4057qib7	10619	48	viruria	viruria	NNP
cord-005453-4057qib7	10619	49	.	.	.
cord-005453-4057qib7	10620	1	PCR	PCR	NNP
cord-005453-4057qib7	10620	2	Real	real	JJ
cord-005453-4057qib7	10620	3	time	time	NN
cord-005453-4057qib7	10620	4	performed	perform	VBN
cord-005453-4057qib7	10620	5	on	on	IN
cord-005453-4057qib7	10620	6	the	the	DT
cord-005453-4057qib7	10620	7	kidney	kidney	NN
cord-005453-4057qib7	10620	8	tissue	tissue	NN
cord-005453-4057qib7	10620	9	unveiled	unveil	VBD
cord-005453-4057qib7	10620	10	very	very	RB
cord-005453-4057qib7	10620	11	high	high	JJ
cord-005453-4057qib7	10620	12	concentration	concentration	NN
cord-005453-4057qib7	10620	13	of	of	IN
cord-005453-4057qib7	10620	14	HAdV	hadv	JJ
cord-005453-4057qib7	10620	15	copy	copy	NN
cord-005453-4057qib7	10620	16	number	number	NN
cord-005453-4057qib7	10620	17	.	.	.
cord-005453-4057qib7	10621	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10621	2	:	:	:
cord-005453-4057qib7	10622	1	Acute	acute	JJ
cord-005453-4057qib7	10622	2	pyelonephritis	pyelonephritis	NN
cord-005453-4057qib7	10622	3	due	due	IN
cord-005453-4057qib7	10622	4	to	to	IN
cord-005453-4057qib7	10622	5	disseminated	disseminate	VBN
cord-005453-4057qib7	10622	6	HAdV	hadv	JJ
cord-005453-4057qib7	10622	7	infection	infection	NN
cord-005453-4057qib7	10622	8	may	may	MD
cord-005453-4057qib7	10622	9	represent	represent	VB
cord-005453-4057qib7	10622	10	a	a	DT
cord-005453-4057qib7	10622	11	possible	possible	JJ
cord-005453-4057qib7	10622	12	cause	cause	NN
cord-005453-4057qib7	10622	13	of	of	IN
cord-005453-4057qib7	10622	14	severe	severe	JJ
cord-005453-4057qib7	10622	15	complication	complication	NN
cord-005453-4057qib7	10622	16	following	follow	VBG
cord-005453-4057qib7	10622	17	allo	allo	NN
cord-005453-4057qib7	10622	18	-	-	HYPH
cord-005453-4057qib7	10622	19	HSCT	HSCT	NNP
cord-005453-4057qib7	10622	20	.	.	.
cord-005453-4057qib7	10623	1	Monitoring	monitoring	NN
cord-005453-4057qib7	10623	2	of	of	IN
cord-005453-4057qib7	10623	3	HAdV	hadv	JJ
cord-005453-4057qib7	10623	4	copy	copy	NN
cord-005453-4057qib7	10623	5	number	number	NN
cord-005453-4057qib7	10623	6	is	be	VBZ
cord-005453-4057qib7	10623	7	helpful	helpful	JJ
cord-005453-4057qib7	10623	8	to	to	TO
cord-005453-4057qib7	10623	9	evaluate	evaluate	VB
cord-005453-4057qib7	10623	10	infection	infection	NN
cord-005453-4057qib7	10623	11	severity	severity	NN
cord-005453-4057qib7	10623	12	and	and	CC
cord-005453-4057qib7	10623	13	response	response	NN
cord-005453-4057qib7	10623	14	to	to	IN
cord-005453-4057qib7	10623	15	treatment	treatment	NN
cord-005453-4057qib7	10623	16	.	.	.
cord-005453-4057qib7	10624	1	Co	Co	NNS
cord-005453-4057qib7	10624	2	-	-	NN
cord-005453-4057qib7	10624	3	infection	infection	NN
cord-005453-4057qib7	10624	4	of	of	IN
cord-005453-4057qib7	10624	5	HAdV	hadv	NN
cord-005453-4057qib7	10624	6	and	and	CC
cord-005453-4057qib7	10624	7	BKPyV	bkpyv	NN
cord-005453-4057qib7	10624	8	in	in	IN
cord-005453-4057qib7	10624	9	immunocompromised	immunocompromised	JJ
cord-005453-4057qib7	10624	10	patients	patient	NNS
cord-005453-4057qib7	10624	11	should	should	MD
cord-005453-4057qib7	10624	12	be	be	VB
cord-005453-4057qib7	10624	13	always	always	RB
cord-005453-4057qib7	10624	14	considered	consider	VBN
cord-005453-4057qib7	10624	15	likely	likely	JJ
cord-005453-4057qib7	10624	16	to	to	TO
cord-005453-4057qib7	10624	17	worsen	worsen	VB
cord-005453-4057qib7	10624	18	clinical	clinical	JJ
cord-005453-4057qib7	10624	19	course	course	NN
cord-005453-4057qib7	10624	20	and	and	CC
cord-005453-4057qib7	10624	21	outcome	outcome	NN
cord-005453-4057qib7	10624	22	.	.	.
cord-005453-4057qib7	10625	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10625	2	:	:	:
cord-005453-4057qib7	10625	3	Nothing	nothing	NN
cord-005453-4057qib7	10625	4	to	to	TO
cord-005453-4057qib7	10625	5	declare	declare	VB
cord-005453-4057qib7	10625	6	Background	background	NN
cord-005453-4057qib7	10625	7	:	:	:
cord-005453-4057qib7	10626	1	Infection	infection	NN
cord-005453-4057qib7	10626	2	is	be	VBZ
cord-005453-4057qib7	10626	3	a	a	DT
cord-005453-4057qib7	10626	4	major	major	JJ
cord-005453-4057qib7	10626	5	cause	cause	NN
cord-005453-4057qib7	10626	6	of	of	IN
cord-005453-4057qib7	10626	7	morbidity	morbidity	NN
cord-005453-4057qib7	10626	8	and	and	CC
cord-005453-4057qib7	10626	9	mortality	mortality	NN
cord-005453-4057qib7	10626	10	in	in	IN
cord-005453-4057qib7	10626	11	patients	patient	NNS
cord-005453-4057qib7	10626	12	(	(	-LRB-
cord-005453-4057qib7	10626	13	pts	pts	NNP
cord-005453-4057qib7	10626	14	)	)	-RRB-
cord-005453-4057qib7	10626	15	receiving	receive	VBG
cord-005453-4057qib7	10626	16	an	an	DT
cord-005453-4057qib7	10626	17	allo	allo	NN
cord-005453-4057qib7	10626	18	-	-	HYPH
cord-005453-4057qib7	10626	19	HSCT	HSCT	NNP
cord-005453-4057qib7	10626	20	.	.	.
cord-005453-4057qib7	10627	1	Its	-PRON-	PRP$
cord-005453-4057qib7	10627	2	severity	severity	NN
cord-005453-4057qib7	10627	3	is	be	VBZ
cord-005453-4057qib7	10627	4	related	relate	VBN
cord-005453-4057qib7	10627	5	primarily	primarily	RB
cord-005453-4057qib7	10627	6	to	to	IN
cord-005453-4057qib7	10627	7	the	the	DT
cord-005453-4057qib7	10627	8	depth	depth	NN
cord-005453-4057qib7	10627	9	and	and	CC
cord-005453-4057qib7	10627	10	duration	duration	NN
cord-005453-4057qib7	10627	11	of	of	IN
cord-005453-4057qib7	10627	12	neutropenia	neutropenia	NN
cord-005453-4057qib7	10627	13	.	.	.
cord-005453-4057qib7	10628	1	Febrile	febrile	JJ
cord-005453-4057qib7	10628	2	neutropenia	neutropenia	NN
cord-005453-4057qib7	10628	3	(	(	-LRB-
cord-005453-4057qib7	10628	4	FN	FN	NNP
cord-005453-4057qib7	10628	5	)	)	-RRB-
cord-005453-4057qib7	10628	6	is	be	VBZ
cord-005453-4057qib7	10628	7	defined	define	VBN
cord-005453-4057qib7	10628	8	as	as	IN
cord-005453-4057qib7	10628	9	a	a	DT
cord-005453-4057qib7	10628	10	neutrophil	neutrophil	NN
cord-005453-4057qib7	10628	11	count	count	NN
cord-005453-4057qib7	10628	12	below	below	IN
cord-005453-4057qib7	10628	13	500	500	CD
cord-005453-4057qib7	10628	14	cells	cell	NNS
cord-005453-4057qib7	10628	15	/	/	SYM
cord-005453-4057qib7	10628	16	mm	mm	NNP
cord-005453-4057qib7	10628	17	3	3	CD
cord-005453-4057qib7	10628	18	and	and	CC
cord-005453-4057qib7	10628	19	a	a	DT
cord-005453-4057qib7	10628	20	fever	fever	NN
cord-005453-4057qib7	10628	21	≥	≥	CD
cord-005453-4057qib7	10628	22	38.3	38.3	CD
cord-005453-4057qib7	10628	23	°	°	NN
cord-005453-4057qib7	10628	24	C	c	NN
cord-005453-4057qib7	10628	25	at	at	IN
cord-005453-4057qib7	10628	26	a	a	DT
cord-005453-4057qib7	10628	27	single	single	JJ
cord-005453-4057qib7	10628	28	measurement	measurement	NN
cord-005453-4057qib7	10628	29	or≥	or≥	NNP
cord-005453-4057qib7	10628	30	38	38	CD
cord-005453-4057qib7	10628	31	°	°	NN
cord-005453-4057qib7	10628	32	C	C	NNP
cord-005453-4057qib7	10628	33	2	2	CD
cord-005453-4057qib7	10628	34	times	time	NNS
cord-005453-4057qib7	10628	35	at	at	IN
cord-005453-4057qib7	10628	36	one	one	CD
cord-005453-4057qib7	10628	37	hour	hour	NN
cord-005453-4057qib7	10628	38	intervals	interval	NNS
cord-005453-4057qib7	10628	39	.	.	.
cord-005453-4057qib7	10629	1	The	the	DT
cord-005453-4057qib7	10629	2	objective	objective	NN
cord-005453-4057qib7	10629	3	of	of	IN
cord-005453-4057qib7	10629	4	our	-PRON-	PRP$
cord-005453-4057qib7	10629	5	study	study	NN
cord-005453-4057qib7	10629	6	is	be	VBZ
cord-005453-4057qib7	10629	7	to	to	TO
cord-005453-4057qib7	10629	8	analyze	analyze	VB
cord-005453-4057qib7	10629	9	the	the	DT
cord-005453-4057qib7	10629	10	epidemiological	epidemiological	JJ
cord-005453-4057qib7	10629	11	,	,	,
cord-005453-4057qib7	10629	12	clinical	clinical	JJ
cord-005453-4057qib7	10629	13	,	,	,
cord-005453-4057qib7	10629	14	biological	biological	JJ
cord-005453-4057qib7	10629	15	characteristics	characteristic	NNS
cord-005453-4057qib7	10629	16	of	of	IN
cord-005453-4057qib7	10629	17	febrile	febrile	JJ
cord-005453-4057qib7	10629	18	episodes	episode	NNS
cord-005453-4057qib7	10629	19	(	(	-LRB-
cord-005453-4057qib7	10629	20	FE	FE	NNP
cord-005453-4057qib7	10629	21	)	)	-RRB-
cord-005453-4057qib7	10629	22	occurred	occur	VBD
cord-005453-4057qib7	10629	23	in	in	IN
cord-005453-4057qib7	10629	24	136	136	CD
cord-005453-4057qib7	10629	25	pts	pt	NNS
cord-005453-4057qib7	10629	26	who	who	WP
cord-005453-4057qib7	10629	27	benefited	benefit	VBD
cord-005453-4057qib7	10629	28	an	an	DT
cord-005453-4057qib7	10629	29	allo	allo	NN
cord-005453-4057qib7	10629	30	-	-	HYPH
cord-005453-4057qib7	10629	31	CSH	csh	NN
cord-005453-4057qib7	10629	32	over	over	IN
cord-005453-4057qib7	10629	33	a	a	DT
cord-005453-4057qib7	10629	34	period	period	NN
cord-005453-4057qib7	10629	35	of	of	IN
cord-005453-4057qib7	10629	36	2	2	CD
cord-005453-4057qib7	10629	37	years	year	NNS
cord-005453-4057qib7	10629	38	.	.	.
cord-005453-4057qib7	10630	1	Methods	method	NNS
cord-005453-4057qib7	10630	2	:	:	:
cord-005453-4057qib7	10630	3	From	from	IN
cord-005453-4057qib7	10630	4	January	January	NNP
cord-005453-4057qib7	10630	5	2016	2016	CD
cord-005453-4057qib7	10630	6	to	to	IN
cord-005453-4057qib7	10630	7	December	December	NNP
cord-005453-4057qib7	10630	8	2017	2017	CD
cord-005453-4057qib7	10630	9	,	,	,
cord-005453-4057qib7	10630	10	136	136	CD
cord-005453-4057qib7	10630	11	allo	allo	NN
cord-005453-4057qib7	10630	12	-	-	HYPH
cord-005453-4057qib7	10630	13	HSCT	HSCT	NNP
cord-005453-4057qib7	10630	14	were	be	VBD
cord-005453-4057qib7	10630	15	performed	perform	VBN
cord-005453-4057qib7	10630	16	in	in	IN
cord-005453-4057qib7	10630	17	136	136	CD
cord-005453-4057qib7	10630	18	pts	pt	NNS
cord-005453-4057qib7	10630	19	including	include	VBG
cord-005453-4057qib7	10630	20	106	106	CD
cord-005453-4057qib7	10630	21	sibling	sibling	NN
cord-005453-4057qib7	10630	22	-	-	HYPH
cord-005453-4057qib7	10630	23	HLA	HLA	NNP
cord-005453-4057qib7	10630	24	identical	identical	JJ
cord-005453-4057qib7	10630	25	,	,	,
cord-005453-4057qib7	10630	26	26	26	CD
cord-005453-4057qib7	10630	27	haplo	haplo	NN
cord-005453-4057qib7	10630	28	-	-	HYPH
cord-005453-4057qib7	10630	29	identical	identical	JJ
cord-005453-4057qib7	10630	30	and	and	CC
cord-005453-4057qib7	10630	31	04	04	CD
cord-005453-4057qib7	10630	32	phenoidentical	phenoidentical	JJ
cord-005453-4057qib7	10630	33	for	for	IN
cord-005453-4057qib7	10630	34	essentially	essentially	RB
cord-005453-4057qib7	10630	35	acute	acute	JJ
cord-005453-4057qib7	10630	36	leukemia	leukemia	NN
cord-005453-4057qib7	10630	37	(	(	-LRB-
cord-005453-4057qib7	10630	38	68	68	CD
cord-005453-4057qib7	10630	39	pts	pt	NNS
cord-005453-4057qib7	10630	40	,	,	,
cord-005453-4057qib7	10630	41	50	50	CD
cord-005453-4057qib7	10630	42	%	%	NN
cord-005453-4057qib7	10630	43	)	)	-RRB-
cord-005453-4057qib7	10630	44	,	,	,
cord-005453-4057qib7	10630	45	acquired	acquire	VBN
cord-005453-4057qib7	10630	46	and	and	CC
cord-005453-4057qib7	10630	47	congenital	congenital	JJ
cord-005453-4057qib7	10630	48	aplasia	aplasia	NNP
cord-005453-4057qib7	10630	49	(	(	-LRB-
cord-005453-4057qib7	10630	50	45	45	CD
cord-005453-4057qib7	10630	51	pts	pt	NNS
cord-005453-4057qib7	10630	52	,	,	,
cord-005453-4057qib7	10630	53	33	33	CD
cord-005453-4057qib7	10630	54	%	%	NN
cord-005453-4057qib7	10630	55	)	)	-RRB-
cord-005453-4057qib7	10630	56	.	.	.
cord-005453-4057qib7	10631	1	The	the	DT
cord-005453-4057qib7	10631	2	median	median	JJ
cord-005453-4057qib7	10631	3	age	age	NN
cord-005453-4057qib7	10631	4	is	be	VBZ
cord-005453-4057qib7	10631	5	22	22	CD
cord-005453-4057qib7	10631	6	years	year	NNS
cord-005453-4057qib7	10631	7	(	(	-LRB-
cord-005453-4057qib7	10631	8	3	3	CD
cord-005453-4057qib7	10631	9	-	-	SYM
cord-005453-4057qib7	10631	10	59	59	CD
cord-005453-4057qib7	10631	11	)	)	-RRB-
cord-005453-4057qib7	10631	12	and	and	CC
cord-005453-4057qib7	10631	13	sex	sex	NN
cord-005453-4057qib7	10631	14	-	-	HYPH
cord-005453-4057qib7	10631	15	ratio	ratio	NN
cord-005453-4057qib7	10631	16	(	(	-LRB-
cord-005453-4057qib7	10631	17	M	M	NNP
cord-005453-4057qib7	10631	18	/	/	SYM
cord-005453-4057qib7	10631	19	F	F	NNP
cord-005453-4057qib7	10631	20	)	)	-RRB-
cord-005453-4057qib7	10631	21	:	:	:
cord-005453-4057qib7	10632	1	1.72	1.72	CD
cord-005453-4057qib7	10632	2	.	.	.
cord-005453-4057qib7	10633	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10633	2	consisted	consist	VBD
cord-005453-4057qib7	10633	3	on	on	IN
cord-005453-4057qib7	10633	4	isolation	isolation	NN
cord-005453-4057qib7	10633	5	sterile	sterile	JJ
cord-005453-4057qib7	10633	6	room	room	NN
cord-005453-4057qib7	10633	7	with	with	IN
cord-005453-4057qib7	10633	8	laminar	laminar	JJ
cord-005453-4057qib7	10633	9	flow	flow	NN
cord-005453-4057qib7	10633	10	,	,	,
cord-005453-4057qib7	10633	11	digestive	digestive	JJ
cord-005453-4057qib7	10633	12	decontamination	decontamination	NN
cord-005453-4057qib7	10633	13	,	,	,
cord-005453-4057qib7	10633	14	fluconazole	fluconazole	NN
cord-005453-4057qib7	10633	15	and	and	CC
cord-005453-4057qib7	10633	16	Aciclovir	Aciclovir	NNP
cord-005453-4057qib7	10633	17	.	.	.
cord-005453-4057qib7	10634	1	Nine	nine	CD
cord-005453-4057qib7	10634	2	pts	pts	NN
cord-005453-4057qib7	10634	3	(	(	-LRB-
cord-005453-4057qib7	10634	4	6.6	6.6	CD
cord-005453-4057qib7	10634	5	%	%	NN
cord-005453-4057qib7	10634	6	)	)	-RRB-
cord-005453-4057qib7	10634	7	were	be	VBD
cord-005453-4057qib7	10634	8	infected	infect	VBN
cord-005453-4057qib7	10634	9	at	at	IN
cord-005453-4057qib7	10634	10	the	the	DT
cord-005453-4057qib7	10634	11	time	time	NN
cord-005453-4057qib7	10634	12	of	of	IN
cord-005453-4057qib7	10634	13	hospitalization	hospitalization	NN
cord-005453-4057qib7	10634	14	(	(	-LRB-
cord-005453-4057qib7	10634	15	cellulitis	cellulitis	NNP
cord-005453-4057qib7	10634	16	03	03	CD
cord-005453-4057qib7	10634	17	,	,	,
cord-005453-4057qib7	10634	18	pneumoniae	pneumoniae	NN
cord-005453-4057qib7	10634	19	02	02	CD
cord-005453-4057qib7	10634	20	,	,	,
cord-005453-4057qib7	10634	21	bacterial	bacterial	JJ
cord-005453-4057qib7	10634	22	angina	angina	NN
cord-005453-4057qib7	10634	23	01	01	CD
cord-005453-4057qib7	10634	24	,	,	,
cord-005453-4057qib7	10634	25	veinitis	veinitis	NNP
cord-005453-4057qib7	10634	26	01	01	CD
cord-005453-4057qib7	10634	27	,	,	,
cord-005453-4057qib7	10634	28	bronchial	bronchial	JJ
cord-005453-4057qib7	10634	29	pneumonia	pneumonia	NN
cord-005453-4057qib7	10634	30	01	01	CD
cord-005453-4057qib7	10634	31	,	,	,
cord-005453-4057qib7	10634	32	furuncle	furuncle	NNP
cord-005453-4057qib7	10634	33	cutaneous	cutaneous	JJ
cord-005453-4057qib7	10634	34	01	01	CD
cord-005453-4057qib7	10634	35	)	)	-RRB-
cord-005453-4057qib7	10634	36	requiring	require	VBG
cord-005453-4057qib7	10634	37	treatment	treatment	NN
cord-005453-4057qib7	10634	38	with	with	IN
cord-005453-4057qib7	10634	39	antibiotics	antibiotic	NNS
cord-005453-4057qib7	10634	40	.	.	.
cord-005453-4057qib7	10635	1	Conditioning	conditioning	NN
cord-005453-4057qib7	10635	2	regimen	regimen	NN
cord-005453-4057qib7	10635	3	is	be	VBZ
cord-005453-4057qib7	10635	4	myeloablative	myeloablative	JJ
cord-005453-4057qib7	10635	5	in	in	IN
cord-005453-4057qib7	10635	6	all	all	DT
cord-005453-4057qib7	10635	7	pts	pt	NNS
cord-005453-4057qib7	10635	8	.	.	.
cord-005453-4057qib7	10636	1	Anti	anti	JJ
cord-005453-4057qib7	10636	2	-	-	JJ
cord-005453-4057qib7	10636	3	thymocyte	thymocyte	JJ
cord-005453-4057qib7	10636	4	globulin	globulin	NN
cord-005453-4057qib7	10636	5	is	be	VBZ
cord-005453-4057qib7	10636	6	used	use	VBN
cord-005453-4057qib7	10636	7	in	in	IN
cord-005453-4057qib7	10636	8	61	61	CD
cord-005453-4057qib7	10636	9	pts	pt	NNS
cord-005453-4057qib7	10636	10	(	(	-LRB-
cord-005453-4057qib7	10636	11	44.8	44.8	CD
cord-005453-4057qib7	10636	12	%	%	NN
cord-005453-4057qib7	10636	13	)	)	-RRB-
cord-005453-4057qib7	10636	14	.	.	.
cord-005453-4057qib7	10637	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	10637	2	blood	blood	NN
cord-005453-4057qib7	10637	3	stem	stem	NN
cord-005453-4057qib7	10637	4	cells	cell	NNS
cord-005453-4057qib7	10637	5	(	(	-LRB-
cord-005453-4057qib7	10637	6	PBSC	PBSC	NNP
cord-005453-4057qib7	10637	7	)	)	-RRB-
cord-005453-4057qib7	10637	8	are	be	VBP
cord-005453-4057qib7	10637	9	used	use	VBN
cord-005453-4057qib7	10637	10	in	in	IN
cord-005453-4057qib7	10637	11	117	117	CD
cord-005453-4057qib7	10637	12	pts	pt	NNS
cord-005453-4057qib7	10637	13	(	(	-LRB-
cord-005453-4057qib7	10637	14	86	86	CD
cord-005453-4057qib7	10637	15	%	%	NN
cord-005453-4057qib7	10637	16	)	)	-RRB-
cord-005453-4057qib7	10637	17	with	with	IN
cord-005453-4057qib7	10637	18	an	an	DT
cord-005453-4057qib7	10637	19	average	average	JJ
cord-005453-4057qib7	10637	20	level	level	NN
cord-005453-4057qib7	10637	21	of	of	IN
cord-005453-4057qib7	10637	22	CD34	CD34	NNP
cord-005453-4057qib7	10637	23	+	+	CC
cord-005453-4057qib7	10637	24	cells	cell	NNS
cord-005453-4057qib7	10637	25	:	:	:
cord-005453-4057qib7	10637	26	7,5.10	7,5.10	CD
cord-005453-4057qib7	10637	27	6	6	CD
cord-005453-4057qib7	10638	1	/Kg	/Kg	.
cord-005453-4057qib7	10639	1	(	(	-LRB-
cord-005453-4057qib7	10639	2	2	2	CD
cord-005453-4057qib7	10639	3	.	.	.
cord-005453-4057qib7	10639	4	1	1	CD
cord-005453-4057qib7	10639	5	-	-	SYM
cord-005453-4057qib7	10639	6	19.8	19.8	CD
cord-005453-4057qib7	10639	7	)	)	-RRB-
cord-005453-4057qib7	10639	8	,	,	,
cord-005453-4057qib7	10639	9	bone	bone	NN
cord-005453-4057qib7	10639	10	marrow	marrow	NN
cord-005453-4057qib7	10639	11	(	(	-LRB-
cord-005453-4057qib7	10639	12	BM	BM	NNP
cord-005453-4057qib7	10639	13	)	)	-RRB-
cord-005453-4057qib7	10639	14	in	in	IN
cord-005453-4057qib7	10639	15	5	5	CD
cord-005453-4057qib7	10639	16	pts	pt	NNS
cord-005453-4057qib7	10639	17	with	with	IN
cord-005453-4057qib7	10639	18	a	a	DT
cord-005453-4057qib7	10639	19	mean	mean	JJ
cord-005453-4057qib7	10639	20	level	level	NN
cord-005453-4057qib7	10639	21	of	of	IN
cord-005453-4057qib7	10639	22	nucleated	nucleated	JJ
cord-005453-4057qib7	10639	23	cells	cell	NNS
cord-005453-4057qib7	10639	24	:	:	:
cord-005453-4057qib7	10639	25	3.4	3.4	CD
cord-005453-4057qib7	10639	26	X	x	SYM
cord-005453-4057qib7	10639	27	10	10	CD
cord-005453-4057qib7	10639	28	8	8	CD
cord-005453-4057qib7	10639	29	/Kg	/kg	NN
cord-005453-4057qib7	10639	30	(	(	-LRB-
cord-005453-4057qib7	10639	31	0.8	0.8	CD
cord-005453-4057qib7	10639	32	-	-	SYM
cord-005453-4057qib7	10639	33	3.6	3.6	CD
cord-005453-4057qib7	10639	34	)	)	-RRB-
cord-005453-4057qib7	10639	35	and	and	CC
cord-005453-4057qib7	10639	36	the	the	DT
cord-005453-4057qib7	10639	37	association	association	NN
cord-005453-4057qib7	10639	38	of	of	IN
cord-005453-4057qib7	10639	39	PBSC	PBSC	NNP
cord-005453-4057qib7	10639	40	-	-	HYPH
cord-005453-4057qib7	10639	41	BM	BM	NNP
cord-005453-4057qib7	10639	42	in	in	IN
cord-005453-4057qib7	10639	43	14	14	CD
cord-005453-4057qib7	10639	44	pts	pt	NNS
cord-005453-4057qib7	10639	45	(	(	-LRB-
cord-005453-4057qib7	10639	46	haplo	haplo	NN
cord-005453-4057qib7	10639	47	-	-	HYPH
cord-005453-4057qib7	10639	48	identical	identical	JJ
cord-005453-4057qib7	10639	49	)	)	-RRB-
cord-005453-4057qib7	10639	50	.	.	.
cord-005453-4057qib7	10640	1	At	at	IN
cord-005453-4057qib7	10640	2	each	each	DT
cord-005453-4057qib7	10640	3	FE	FE	NNP
cord-005453-4057qib7	10640	4	,	,	,
cord-005453-4057qib7	10640	5	are	be	VBP
cord-005453-4057qib7	10640	6	practiced	practice	VBN
cord-005453-4057qib7	10640	7	:	:	:
cord-005453-4057qib7	10641	1	chest	chest	NN
cord-005453-4057qib7	10641	2	x	x	NN
cord-005453-4057qib7	10641	3	-	-	NN
cord-005453-4057qib7	10641	4	ray	ray	NN
cord-005453-4057qib7	10641	5	,	,	,
cord-005453-4057qib7	10641	6	procalcitonin	procalcitonin	NNS
cord-005453-4057qib7	10641	7	test	test	NN
cord-005453-4057qib7	10641	8	,	,	,
cord-005453-4057qib7	10641	9	blood	blood	NN
cord-005453-4057qib7	10641	10	culture	culture	NN
cord-005453-4057qib7	10641	11	,	,	,
cord-005453-4057qib7	10641	12	microbiological	microbiological	JJ
cord-005453-4057qib7	10641	13	study	study	NN
cord-005453-4057qib7	10641	14	of	of	IN
cord-005453-4057qib7	10641	15	urine	urine	NN
cord-005453-4057qib7	10641	16	and	and	CC
cord-005453-4057qib7	10641	17	stool	stool	NN
cord-005453-4057qib7	10641	18	(	(	-LRB-
cord-005453-4057qib7	10641	19	if	if	IN
cord-005453-4057qib7	10641	20	diarrhea	diarrhea	NN
cord-005453-4057qib7	10641	21	)	)	-RRB-
cord-005453-4057qib7	10641	22	.	.	.
cord-005453-4057qib7	10642	1	Results	result	NNS
cord-005453-4057qib7	10642	2	:	:	:
cord-005453-4057qib7	10643	1	All	all	DT
cord-005453-4057qib7	10643	2	pts	pt	NNS
cord-005453-4057qib7	10643	3	showed	show	VBD
cord-005453-4057qib7	10643	4	aplasia	aplasia	NNP
cord-005453-4057qib7	10643	5	with	with	IN
cord-005453-4057qib7	10643	6	an	an	DT
cord-005453-4057qib7	10643	7	average	average	JJ
cord-005453-4057qib7	10643	8	duration	duration	NN
cord-005453-4057qib7	10643	9	of	of	IN
cord-005453-4057qib7	10643	10	16	16	CD
cord-005453-4057qib7	10643	11	days	day	NNS
cord-005453-4057qib7	10643	12	(	(	-LRB-
cord-005453-4057qib7	10643	13	6	6	CD
cord-005453-4057qib7	10643	14	-	-	SYM
cord-005453-4057qib7	10643	15	49	49	CD
cord-005453-4057qib7	10643	16	)	)	-RRB-
cord-005453-4057qib7	10643	17	,	,	,
cord-005453-4057qib7	10643	18	neutrophil	neutrophil	NN
cord-005453-4057qib7	10643	19	engraftment	engraftment	NN
cord-005453-4057qib7	10643	20	was	be	VBD
cord-005453-4057qib7	10643	21	observed	observe	VBN
cord-005453-4057qib7	10643	22	at	at	IN
cord-005453-4057qib7	10643	23	day	day	NN
cord-005453-4057qib7	10643	24	18	18	CD
cord-005453-4057qib7	10643	25	(	(	-LRB-
cord-005453-4057qib7	10643	26	9	9	CD
cord-005453-4057qib7	10643	27	-	-	SYM
cord-005453-4057qib7	10643	28	31	31	CD
cord-005453-4057qib7	10643	29	)	)	-RRB-
cord-005453-4057qib7	10643	30	.	.	.
cord-005453-4057qib7	10644	1	One	one	CD
cord-005453-4057qib7	10644	2	hundred	hundred	CD
cord-005453-4057qib7	10644	3	and	and	CC
cord-005453-4057qib7	10644	4	twenty	twenty	CD
cord-005453-4057qib7	10644	5	-	-	HYPH
cord-005453-4057qib7	10644	6	nine	nine	CD
cord-005453-4057qib7	10644	7	pts	pt	NNS
cord-005453-4057qib7	10644	8	(	(	-LRB-
cord-005453-4057qib7	10644	9	94.8	94.8	CD
cord-005453-4057qib7	10644	10	%	%	NN
cord-005453-4057qib7	10644	11	)	)	-RRB-
cord-005453-4057qib7	10644	12	presented	present	VBD
cord-005453-4057qib7	10644	13	205	205	CD
cord-005453-4057qib7	10644	14	FE	FE	NNP
cord-005453-4057qib7	10644	15	with	with	IN
cord-005453-4057qib7	10644	16	an	an	DT
cord-005453-4057qib7	10644	17	average	average	NN
cord-005453-4057qib7	10644	18	of	of	IN
cord-005453-4057qib7	10644	19	1.5	1.5	CD
cord-005453-4057qib7	10644	20	per	per	IN
cord-005453-4057qib7	10644	21	pt	pt	NN
cord-005453-4057qib7	10644	22	.	.	.
cord-005453-4057qib7	10645	1	Eleven	eleven	CD
cord-005453-4057qib7	10645	2	pts	pt	NNS
cord-005453-4057qib7	10645	3	(	(	-LRB-
cord-005453-4057qib7	10645	4	8	8	CD
cord-005453-4057qib7	10645	5	%	%	NN
cord-005453-4057qib7	10645	6	)	)	-RRB-
cord-005453-4057qib7	10645	7	had	have	VBD
cord-005453-4057qib7	10645	8	3	3	CD
cord-005453-4057qib7	10645	9	FE	FE	NNP
cord-005453-4057qib7	10645	10	or	or	CC
cord-005453-4057qib7	10645	11	more	more	JJR
cord-005453-4057qib7	10645	12	.	.	.
cord-005453-4057qib7	10646	1	Forty	forty	CD
cord-005453-4057qib7	10646	2	nine	nine	CD
cord-005453-4057qib7	10646	3	(	(	-LRB-
cord-005453-4057qib7	10646	4	23,9	23,9	CD
cord-005453-4057qib7	10646	5	%	%	NN
cord-005453-4057qib7	10646	6	)	)	-RRB-
cord-005453-4057qib7	10647	1	FE	FE	NNP
cord-005453-4057qib7	10647	2	are	be	VBP
cord-005453-4057qib7	10647	3	clinically	clinically	RB
cord-005453-4057qib7	10647	4	documented	document	VBN
cord-005453-4057qib7	10647	5	(	(	-LRB-
cord-005453-4057qib7	10647	6	digestive	digestive	JJ
cord-005453-4057qib7	10647	7	:	:	:
cord-005453-4057qib7	10647	8	19	19	CD
cord-005453-4057qib7	10647	9	,	,	,
cord-005453-4057qib7	10647	10	skin	skin	NN
cord-005453-4057qib7	10647	11	:	:	:
cord-005453-4057qib7	10647	12	14	14	CD
cord-005453-4057qib7	10647	13	,	,	,
cord-005453-4057qib7	10647	14	pulmonary	pulmonary	JJ
cord-005453-4057qib7	10647	15	:	:	:
cord-005453-4057qib7	10647	16	11	11	CD
cord-005453-4057qib7	10647	17	,	,	,
cord-005453-4057qib7	10647	18	urinary	urinary	JJ
cord-005453-4057qib7	10647	19	:	:	:
cord-005453-4057qib7	10647	20	03	03	CD
cord-005453-4057qib7	10648	1	,	,	,
cord-005453-4057qib7	10648	2	Oto	Oto	NNP
cord-005453-4057qib7	10648	3	-	-	HYPH
cord-005453-4057qib7	10648	4	Rhino	Rhino	NNP
cord-005453-4057qib7	10648	5	-	-	HYPH
cord-005453-4057qib7	10648	6	Laryngology	Laryngology	NNP
cord-005453-4057qib7	10648	7	:	:	:
cord-005453-4057qib7	10648	8	02	02	CD
cord-005453-4057qib7	10648	9	)	)	-RRB-
cord-005453-4057qib7	10648	10	.	.	.
cord-005453-4057qib7	10649	1	The	the	DT
cord-005453-4057qib7	10649	2	blood	blood	NN
cord-005453-4057qib7	10649	3	cultures	culture	NNS
cord-005453-4057qib7	10649	4	are	be	VBP
cord-005453-4057qib7	10649	5	made	make	VBN
cord-005453-4057qib7	10649	6	at	at	IN
cord-005453-4057qib7	10649	7	195	195	CD
cord-005453-4057qib7	10649	8	FE	FE	NNP
cord-005453-4057qib7	10649	9	,	,	,
cord-005453-4057qib7	10649	10	136	136	CD
cord-005453-4057qib7	10649	11	FE	FE	NNP
cord-005453-4057qib7	10649	12	are	be	VBP
cord-005453-4057qib7	10649	13	microbiologically	microbiologically	RB
cord-005453-4057qib7	10649	14	documented	document	VBN
cord-005453-4057qib7	10649	15	(	(	-LRB-
cord-005453-4057qib7	10649	16	66	66	CD
cord-005453-4057qib7	10649	17	%	%	NN
cord-005453-4057qib7	10649	18	):	):	NN
cord-005453-4057qib7	10649	19	gram	gram	JJ
cord-005453-4057qib7	10649	20	-	-	HYPH
cord-005453-4057qib7	10649	21	positive	positive	JJ
cord-005453-4057qib7	10649	22	bacteremia	bacteremia	NN
cord-005453-4057qib7	10649	23	in	in	IN
cord-005453-4057qib7	10649	24	77	77	CD
cord-005453-4057qib7	10649	25	%	%	NN
cord-005453-4057qib7	10649	26	(	(	-LRB-
cord-005453-4057qib7	10649	27	mainly	mainly	RB
cord-005453-4057qib7	10649	28	coagulase	coagulase	JJ
cord-005453-4057qib7	10649	29	negative	negative	JJ
cord-005453-4057qib7	10649	30	staphylococci	staphylococcus	NNS
cord-005453-4057qib7	10649	31	)	)	-RRB-
cord-005453-4057qib7	10649	32	and	and	CC
cord-005453-4057qib7	10649	33	gramnegative	gramnegative	JJ
cord-005453-4057qib7	10649	34	bacilli	bacilli	JJ
cord-005453-4057qib7	10649	35	in	in	IN
cord-005453-4057qib7	10649	36	23	23	CD
cord-005453-4057qib7	10649	37	%	%	NN
cord-005453-4057qib7	10649	38	of	of	IN
cord-005453-4057qib7	10649	39	cases	case	NNS
cord-005453-4057qib7	10649	40	.	.	.
cord-005453-4057qib7	10650	1	Procalcitonin	Procalcitonin	NNP
cord-005453-4057qib7	10650	2	test	test	NN
cord-005453-4057qib7	10650	3	performed	perform	VBN
cord-005453-4057qib7	10650	4	during	during	IN
cord-005453-4057qib7	10650	5	157	157	CD
cord-005453-4057qib7	10650	6	FE	FE	NNP
cord-005453-4057qib7	10650	7	:	:	:
cord-005453-4057qib7	10650	8	normal	normal	JJ
cord-005453-4057qib7	10650	9	(	(	-LRB-
cord-005453-4057qib7	10650	10	32	32	CD
cord-005453-4057qib7	10650	11	cases	case	NNS
cord-005453-4057qib7	10650	12	)	)	-RRB-
cord-005453-4057qib7	10650	13	,	,	,
cord-005453-4057qib7	10650	14	probable	probable	JJ
cord-005453-4057qib7	10650	15	infection	infection	NN
cord-005453-4057qib7	10650	16	(	(	-LRB-
cord-005453-4057qib7	10650	17	90	90	CD
cord-005453-4057qib7	10650	18	cases	case	NNS
cord-005453-4057qib7	10650	19	)	)	-RRB-
cord-005453-4057qib7	10650	20	,	,	,
cord-005453-4057qib7	10650	21	probable	probable	JJ
cord-005453-4057qib7	10650	22	sepsis	sepsis	NN
cord-005453-4057qib7	10650	23	(	(	-LRB-
cord-005453-4057qib7	10650	24	15	15	CD
cord-005453-4057qib7	10650	25	cases	case	NNS
cord-005453-4057qib7	10650	26	)	)	-RRB-
cord-005453-4057qib7	10650	27	,	,	,
cord-005453-4057qib7	10650	28	severe	severe	JJ
cord-005453-4057qib7	10650	29	sepsis	sepsis	NN
cord-005453-4057qib7	10650	30	(	(	-LRB-
cord-005453-4057qib7	10650	31	19	19	CD
cord-005453-4057qib7	10650	32	cases	case	NNS
cord-005453-4057qib7	10650	33	)	)	-RRB-
cord-005453-4057qib7	10650	34	and	and	CC
cord-005453-4057qib7	10650	35	septic	septic	JJ
cord-005453-4057qib7	10650	36	shock	shock	NN
cord-005453-4057qib7	10650	37	(	(	-LRB-
cord-005453-4057qib7	10650	38	one	one	CD
cord-005453-4057qib7	10650	39	case	case	NN
cord-005453-4057qib7	10650	40	)	)	-RRB-
cord-005453-4057qib7	10650	41	.	.	.
cord-005453-4057qib7	10651	1	Empirical	empirical	JJ
cord-005453-4057qib7	10651	2	double	double	JJ
cord-005453-4057qib7	10651	3	antibiotic	antibiotic	JJ
cord-005453-4057qib7	10651	4	therapy	therapy	NN
cord-005453-4057qib7	10651	5	is	be	VBZ
cord-005453-4057qib7	10651	6	initiated	initiate	VBN
cord-005453-4057qib7	10651	7	in	in	IN
cord-005453-4057qib7	10651	8	120	120	CD
cord-005453-4057qib7	10651	9	pts	pt	NNS
cord-005453-4057qib7	10651	10	without	without	IN
cord-005453-4057qib7	10651	11	waiting	wait	VBG
cord-005453-4057qib7	10651	12	for	for	IN
cord-005453-4057qib7	10651	13	the	the	DT
cord-005453-4057qib7	10651	14	results	result	NNS
cord-005453-4057qib7	10651	15	of	of	IN
cord-005453-4057qib7	10651	16	the	the	DT
cord-005453-4057qib7	10651	17	microbiological	microbiological	JJ
cord-005453-4057qib7	10651	18	study	study	NN
cord-005453-4057qib7	10651	19	.	.	.
cord-005453-4057qib7	10652	1	This	this	DT
cord-005453-4057qib7	10652	2	association	association	NN
cord-005453-4057qib7	10652	3	was	be	VBD
cord-005453-4057qib7	10652	4	sufficient	sufficient	JJ
cord-005453-4057qib7	10652	5	in	in	IN
cord-005453-4057qib7	10652	6	15	15	CD
cord-005453-4057qib7	10652	7	pts	pt	NNS
cord-005453-4057qib7	10652	8	(	(	-LRB-
cord-005453-4057qib7	10652	9	11	11	CD
cord-005453-4057qib7	10652	10	%	%	NN
cord-005453-4057qib7	10652	11	)	)	-RRB-
cord-005453-4057qib7	10652	12	.	.	.
cord-005453-4057qib7	10653	1	The	the	DT
cord-005453-4057qib7	10653	2	transition	transition	NN
cord-005453-4057qib7	10653	3	to	to	IN
cord-005453-4057qib7	10653	4	a	a	DT
cord-005453-4057qib7	10653	5	second	second	JJ
cord-005453-4057qib7	10653	6	line	line	NN
cord-005453-4057qib7	10653	7	was	be	VBD
cord-005453-4057qib7	10653	8	needed	need	VBN
cord-005453-4057qib7	10653	9	in	in	IN
cord-005453-4057qib7	10653	10	114	114	CD
cord-005453-4057qib7	10653	11	pts	pt	NNS
cord-005453-4057qib7	10653	12	(	(	-LRB-
cord-005453-4057qib7	10653	13	83.8	83.8	CD
cord-005453-4057qib7	10653	14	%	%	NN
cord-005453-4057qib7	10653	15	)	)	-RRB-
cord-005453-4057qib7	10653	16	and	and	CC
cord-005453-4057qib7	10653	17	third	third	JJ
cord-005453-4057qib7	10653	18	line	line	NN
cord-005453-4057qib7	10653	19	in	in	IN
cord-005453-4057qib7	10653	20	82	82	CD
cord-005453-4057qib7	10653	21	pts	pt	NNS
cord-005453-4057qib7	10653	22	(	(	-LRB-
cord-005453-4057qib7	10653	23	60	60	CD
cord-005453-4057qib7	10653	24	%	%	NN
cord-005453-4057qib7	10653	25	)	)	-RRB-
cord-005453-4057qib7	10653	26	.	.	.
cord-005453-4057qib7	10654	1	Antifungal	Antifungal	NNP
cord-005453-4057qib7	10654	2	is	be	VBZ
cord-005453-4057qib7	10654	3	added	add	VBN
cord-005453-4057qib7	10654	4	in	in	IN
cord-005453-4057qib7	10654	5	36	36	CD
cord-005453-4057qib7	10654	6	cases	case	NNS
cord-005453-4057qib7	10654	7	(	(	-LRB-
cord-005453-4057qib7	10654	8	27	27	CD
cord-005453-4057qib7	10654	9	%	%	NN
cord-005453-4057qib7	10654	10	)	)	-RRB-
cord-005453-4057qib7	10654	11	.	.	.
cord-005453-4057qib7	10655	1	Eight	eight	CD
cord-005453-4057qib7	10655	2	pts	pt	NNS
cord-005453-4057qib7	10655	3	benefited	benefit	VBN
cord-005453-4057qib7	10655	4	from	from	IN
cord-005453-4057qib7	10655	5	G	G	NNP
cord-005453-4057qib7	10655	6	-	-	HYPH
cord-005453-4057qib7	10655	7	CSF	CSF	NNP
cord-005453-4057qib7	10655	8	.	.	.
cord-005453-4057qib7	10656	1	The	the	DT
cord-005453-4057qib7	10656	2	evolution	evolution	NN
cord-005453-4057qib7	10656	3	is	be	VBZ
cord-005453-4057qib7	10656	4	favorable	favorable	JJ
cord-005453-4057qib7	10656	5	in	in	IN
cord-005453-4057qib7	10656	6	202	202	CD
cord-005453-4057qib7	10656	7	FE	FE	NNP
cord-005453-4057qib7	10656	8	(	(	-LRB-
cord-005453-4057qib7	10656	9	98.5	98.5	CD
cord-005453-4057qib7	10656	10	%	%	NN
cord-005453-4057qib7	10656	11	)	)	-RRB-
cord-005453-4057qib7	10656	12	,	,	,
cord-005453-4057qib7	10656	13	apyrexia	apyrexia	NNP
cord-005453-4057qib7	10656	14	obtained	obtain	VBN
cord-005453-4057qib7	10656	15	after	after	IN
cord-005453-4057qib7	10656	16	an	an	DT
cord-005453-4057qib7	10656	17	average	average	NN
cord-005453-4057qib7	10656	18	of	of	IN
cord-005453-4057qib7	10656	19	3.3	3.3	CD
cord-005453-4057qib7	10656	20	days	day	NNS
cord-005453-4057qib7	10656	21	.	.	.
cord-005453-4057qib7	10657	1	Three	three	CD
cord-005453-4057qib7	10657	2	pts	pt	NNS
cord-005453-4057qib7	10657	3	died	die	VBD
cord-005453-4057qib7	10657	4	(	(	-LRB-
cord-005453-4057qib7	10657	5	2	2	CD
cord-005453-4057qib7	10657	6	%	%	NN
cord-005453-4057qib7	10657	7	)	)	-RRB-
cord-005453-4057qib7	10657	8	by	by	IN
cord-005453-4057qib7	10657	9	severe	severe	JJ
cord-005453-4057qib7	10657	10	sepsis	sepsis	NN
cord-005453-4057qib7	10657	11	on	on	IN
cord-005453-4057qib7	10657	12	a	a	DT
cord-005453-4057qib7	10657	13	durable	durable	JJ
cord-005453-4057qib7	10657	14	aplasia	aplasia	NN
cord-005453-4057qib7	10657	15	,	,	,
cord-005453-4057qib7	10657	16	2	2	CD
cord-005453-4057qib7	10657	17	of	of	IN
cord-005453-4057qib7	10657	18	which	which	WDT
cord-005453-4057qib7	10657	19	had	have	VBD
cord-005453-4057qib7	10657	20	a	a	DT
cord-005453-4057qib7	10657	21	cellulitis	cellulitis	NN
cord-005453-4057qib7	10657	22	before	before	IN
cord-005453-4057qib7	10657	23	the	the	DT
cord-005453-4057qib7	10657	24	conditioning	conditioning	NN
cord-005453-4057qib7	10657	25	.	.	.
cord-005453-4057qib7	10658	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10658	2	:	:	:
cord-005453-4057qib7	10658	3	FE	fe	NN
cord-005453-4057qib7	10658	4	increase	increase	NN
cord-005453-4057qib7	10658	5	morbidity	morbidity	NN
cord-005453-4057qib7	10658	6	and	and	CC
cord-005453-4057qib7	10658	7	mortality	mortality	NN
cord-005453-4057qib7	10658	8	in	in	IN
cord-005453-4057qib7	10658	9	allo	allo	NN
cord-005453-4057qib7	10658	10	-	-	HYPH
cord-005453-4057qib7	10658	11	HSCT	HSCT	NNP
cord-005453-4057qib7	10658	12	so	so	IN
cord-005453-4057qib7	10658	13	prophylactic	prophylactic	JJ
cord-005453-4057qib7	10658	14	measures	measure	NNS
cord-005453-4057qib7	10658	15	are	be	VBP
cord-005453-4057qib7	10658	16	essential	essential	JJ
cord-005453-4057qib7	10658	17	.	.	.
cord-005453-4057qib7	10659	1	Empirical	empirical	JJ
cord-005453-4057qib7	10659	2	antibiotics	antibiotic	NNS
cord-005453-4057qib7	10659	3	treatment	treatment	NN
cord-005453-4057qib7	10659	4	has	have	VBZ
cord-005453-4057qib7	10659	5	to	to	TO
cord-005453-4057qib7	10659	6	be	be	VB
cord-005453-4057qib7	10659	7	instituted	institute	VBN
cord-005453-4057qib7	10659	8	very	very	RB
cord-005453-4057qib7	10659	9	quickly	quickly	RB
cord-005453-4057qib7	10659	10	in	in	IN
cord-005453-4057qib7	10659	11	the	the	DT
cord-005453-4057qib7	10659	12	absence	absence	NN
cord-005453-4057qib7	10659	13	of	of	IN
cord-005453-4057qib7	10659	14	documentation	documentation	NN
cord-005453-4057qib7	10659	15	.	.	.
cord-005453-4057qib7	10660	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10660	2	:	:	:
cord-005453-4057qib7	10660	3	Nothing	nothing	NN
cord-005453-4057qib7	10660	4	to	to	TO
cord-005453-4057qib7	10660	5	declare	declare	VB
cord-005453-4057qib7	10660	6	P472	P472	NNP
cord-005453-4057qib7	10660	7	Abstract	Abstract	NNP
cord-005453-4057qib7	10660	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	10660	9	.	.	.
cord-005453-4057qib7	10661	1	Atsushi	Atsushi	NNP
cord-005453-4057qib7	10661	2	Satake	Satake	NNP
cord-005453-4057qib7	10661	3	1	1	CD
cord-005453-4057qib7	10661	4	,	,	,
cord-005453-4057qib7	10661	5	Masaaki	Masaaki	NNP
cord-005453-4057qib7	10661	6	Hotta	Hotta	NNP
cord-005453-4057qib7	10661	7	1	1	CD
cord-005453-4057qib7	10661	8	,	,	,
cord-005453-4057qib7	10661	9	Ryo	Ryo	NNP
cord-005453-4057qib7	10661	10	Saito	Saito	NNP
cord-005453-4057qib7	10661	11	1	1	CD
cord-005453-4057qib7	10661	12	,	,	,
cord-005453-4057qib7	10661	13	Akiko	Akiko	NNP
cord-005453-4057qib7	10661	14	Konishi	Konishi	NNP
cord-005453-4057qib7	10661	15	1	1	CD
cord-005453-4057qib7	10661	16	,	,	,
cord-005453-4057qib7	10661	17	Hideaki	Hideaki	NNP
cord-005453-4057qib7	10661	18	Yoshimura	Yoshimura	NNP
cord-005453-4057qib7	10661	19	1	1	CD
cord-005453-4057qib7	10661	20	,	,	,
cord-005453-4057qib7	10661	21	Takahisa	Takahisa	NNP
cord-005453-4057qib7	10661	22	Nakanishi	Nakanishi	NNP
cord-005453-4057qib7	10661	23	1	1	CD
cord-005453-4057qib7	10661	24	,	,	,
cord-005453-4057qib7	10661	25	Shinya	Shinya	NNP
cord-005453-4057qib7	10661	26	Fujita	Fujita	NNP
cord-005453-4057qib7	10661	27	1	1	CD
cord-005453-4057qib7	10661	28	,	,	,
cord-005453-4057qib7	10661	29	Tomoki	Tomoki	NNP
cord-005453-4057qib7	10661	30	Ito	Ito	NNP
cord-005453-4057qib7	10661	31	1	1	CD
cord-005453-4057qib7	10661	32	,	,	,
cord-005453-4057qib7	10661	33	Kazuyoshi	Kazuyoshi	NNP
cord-005453-4057qib7	10661	34	Ishii	Ishii	NNP
cord-005453-4057qib7	10661	35	1	1	CD
cord-005453-4057qib7	10662	1	,	,	,
cord-005453-4057qib7	10662	2	Shosaku	Shosaku	NNP
cord-005453-4057qib7	10662	3	Nomura	Nomura	NNP
cord-005453-4057qib7	10662	4	1	1	CD
cord-005453-4057qib7	10662	5	1	1	CD
cord-005453-4057qib7	10662	6	Kansai	Kansai	NNP
cord-005453-4057qib7	10662	7	Medical	Medical	NNP
cord-005453-4057qib7	10662	8	University	University	NNP
cord-005453-4057qib7	10662	9	,	,	,
cord-005453-4057qib7	10662	10	Osaka	Osaka	NNP
cord-005453-4057qib7	10662	11	,	,	,
cord-005453-4057qib7	10662	12	Japan	Japan	NNP
cord-005453-4057qib7	10662	13	Background	Background	NNP
cord-005453-4057qib7	10662	14	:	:	:
cord-005453-4057qib7	10662	15	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	10662	16	(	(	-LRB-
cord-005453-4057qib7	10662	17	CMV	CMV	NNP
cord-005453-4057qib7	10662	18	)	)	-RRB-
cord-005453-4057qib7	10662	19	infection	infection	NN
cord-005453-4057qib7	10662	20	remains	remain	VBZ
cord-005453-4057qib7	10662	21	a	a	DT
cord-005453-4057qib7	10662	22	common	common	JJ
cord-005453-4057qib7	10662	23	complication	complication	NN
cord-005453-4057qib7	10662	24	after	after	IN
cord-005453-4057qib7	10662	25	allogeneic	allogeneic	JJ
cord-005453-4057qib7	10662	26	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10662	27	stem	stem	NN
cord-005453-4057qib7	10662	28	cell	cell	NN
cord-005453-4057qib7	10662	29	transplantation	transplantation	NN
cord-005453-4057qib7	10662	30	(	(	-LRB-
cord-005453-4057qib7	10662	31	aHSCT	aHSCT	NNP
cord-005453-4057qib7	10662	32	)	)	-RRB-
cord-005453-4057qib7	10662	33	,	,	,
cord-005453-4057qib7	10662	34	which	which	WDT
cord-005453-4057qib7	10662	35	results	result	VBZ
cord-005453-4057qib7	10662	36	in	in	IN
cord-005453-4057qib7	10662	37	increased	increase	VBN
cord-005453-4057qib7	10662	38	morbidity	morbidity	NN
cord-005453-4057qib7	10662	39	and	and	CC
cord-005453-4057qib7	10662	40	mortality	mortality	NN
cord-005453-4057qib7	10662	41	.	.	.
cord-005453-4057qib7	10663	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	10663	2	is	be	VBZ
cord-005453-4057qib7	10663	3	a	a	DT
cord-005453-4057qib7	10663	4	novel	novel	JJ
cord-005453-4057qib7	10663	5	anti	anti	AFX
cord-005453-4057qib7	10663	6	CMV	CMV	NNP
cord-005453-4057qib7	10663	7	drug	drug	NN
cord-005453-4057qib7	10663	8	that	that	WDT
cord-005453-4057qib7	10663	9	inhibits	inhibit	VBZ
cord-005453-4057qib7	10663	10	the	the	DT
cord-005453-4057qib7	10663	11	CMV	CMV	NNP
cord-005453-4057qib7	10663	12	-	-	HYPH
cord-005453-4057qib7	10663	13	terminase	terminase	NN
cord-005453-4057qib7	10663	14	complex	complex	NN
cord-005453-4057qib7	10663	15	.	.	.
cord-005453-4057qib7	10664	1	The	the	DT
cord-005453-4057qib7	10664	2	purpose	purpose	NN
cord-005453-4057qib7	10664	3	of	of	IN
cord-005453-4057qib7	10664	4	this	this	DT
cord-005453-4057qib7	10664	5	retrospective	retrospective	JJ
cord-005453-4057qib7	10664	6	study	study	NN
cord-005453-4057qib7	10664	7	is	be	VBZ
cord-005453-4057qib7	10664	8	to	to	TO
cord-005453-4057qib7	10664	9	elucidate	elucidate	VB
cord-005453-4057qib7	10664	10	the	the	DT
cord-005453-4057qib7	10664	11	efficacy	efficacy	NN
cord-005453-4057qib7	10664	12	and	and	CC
cord-005453-4057qib7	10664	13	safety	safety	NN
cord-005453-4057qib7	10664	14	of	of	IN
cord-005453-4057qib7	10664	15	CMV	CMV	NNP
cord-005453-4057qib7	10664	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10664	17	with	with	IN
cord-005453-4057qib7	10664	18	letermovir	letermovir	NNS
cord-005453-4057qib7	10664	19	early	early	RB
cord-005453-4057qib7	10664	20	after	after	IN
cord-005453-4057qib7	10664	21	aHSCT	ahsct	NN
cord-005453-4057qib7	10664	22	in	in	IN
cord-005453-4057qib7	10664	23	clinical	clinical	JJ
cord-005453-4057qib7	10664	24	practice	practice	NN
cord-005453-4057qib7	10664	25	.	.	.
cord-005453-4057qib7	10665	1	Methods	method	NNS
cord-005453-4057qib7	10665	2	:	:	:
cord-005453-4057qib7	10665	3	We	-PRON-	PRP
cord-005453-4057qib7	10665	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	10665	5	analyzed	analyze	VBD
cord-005453-4057qib7	10665	6	the	the	DT
cord-005453-4057qib7	10665	7	incidence	incidence	NN
cord-005453-4057qib7	10665	8	of	of	IN
cord-005453-4057qib7	10665	9	CMV	CMV	NNP
cord-005453-4057qib7	10665	10	infection	infection	NN
cord-005453-4057qib7	10665	11	,	,	,
cord-005453-4057qib7	10665	12	CMV	CMV	NNP
cord-005453-4057qib7	10665	13	disease	disease	NN
cord-005453-4057qib7	10665	14	,	,	,
cord-005453-4057qib7	10665	15	preemptive	preemptive	JJ
cord-005453-4057qib7	10665	16	therapy	therapy	NN
cord-005453-4057qib7	10665	17	,	,	,
cord-005453-4057qib7	10665	18	adverse	adverse	JJ
cord-005453-4057qib7	10665	19	events	event	NNS
cord-005453-4057qib7	10665	20	through	through	IN
cord-005453-4057qib7	10665	21	week	week	NN
cord-005453-4057qib7	10665	22	14	14	CD
cord-005453-4057qib7	10665	23	after	after	IN
cord-005453-4057qib7	10665	24	aHSCT	aHSCT	NNP
cord-005453-4057qib7	10665	25	,	,	,
cord-005453-4057qib7	10665	26	the	the	DT
cord-005453-4057qib7	10665	27	rates	rate	NNS
cord-005453-4057qib7	10665	28	of	of	IN
cord-005453-4057qib7	10665	29	engraftment	engraftment	NN
cord-005453-4057qib7	10665	30	and	and	CC
cord-005453-4057qib7	10665	31	overall	overall	JJ
cord-005453-4057qib7	10665	32	survival	survival	NN
cord-005453-4057qib7	10665	33	.	.	.
cord-005453-4057qib7	10666	1	All	all	DT
cord-005453-4057qib7	10666	2	patients	patient	NNS
cord-005453-4057qib7	10666	3	underwent	undergo	VBD
cord-005453-4057qib7	10666	4	aHSCT	ahsct	RB
cord-005453-4057qib7	10666	5	in	in	IN
cord-005453-4057qib7	10666	6	our	-PRON-	PRP$
cord-005453-4057qib7	10666	7	institution	institution	NN
cord-005453-4057qib7	10666	8	for	for	IN
cord-005453-4057qib7	10666	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10666	10	malignancies	malignancy	NNS
cord-005453-4057qib7	10666	11	between	between	IN
cord-005453-4057qib7	10666	12	May	May	NNP
cord-005453-4057qib7	10666	13	2018	2018	CD
cord-005453-4057qib7	10666	14	and	and	CC
cord-005453-4057qib7	10666	15	Nov	Nov	NNP
cord-005453-4057qib7	10666	16	2018	2018	CD
cord-005453-4057qib7	10666	17	.	.	.
cord-005453-4057qib7	10667	1	Data	datum	NNS
cord-005453-4057qib7	10667	2	collected	collect	VBN
cord-005453-4057qib7	10667	3	in	in	IN
cord-005453-4057qib7	10667	4	this	this	DT
cord-005453-4057qib7	10667	5	study	study	NN
cord-005453-4057qib7	10667	6	included	include	VBD
cord-005453-4057qib7	10667	7	patient	patient	NN
cord-005453-4057qib7	10667	8	's	's	POS
cord-005453-4057qib7	10667	9	characteristics	characteristic	NNS
cord-005453-4057qib7	10667	10	such	such	JJ
cord-005453-4057qib7	10667	11	as	as	IN
cord-005453-4057qib7	10667	12	age	age	NN
cord-005453-4057qib7	10667	13	,	,	,
cord-005453-4057qib7	10667	14	sex	sex	NN
cord-005453-4057qib7	10667	15	,	,	,
cord-005453-4057qib7	10667	16	disease	disease	NN
cord-005453-4057qib7	10667	17	status	status	NN
cord-005453-4057qib7	10667	18	,	,	,
cord-005453-4057qib7	10667	19	donor	donor	NN
cord-005453-4057qib7	10667	20	source	source	NN
cord-005453-4057qib7	10667	21	and	and	CC
cord-005453-4057qib7	10667	22	CMV	CMV	NNP
cord-005453-4057qib7	10667	23	disease	disease	NN
cord-005453-4057qib7	10667	24	risk	risk	NN
cord-005453-4057qib7	10667	25	.	.	.
cord-005453-4057qib7	10668	1	CMV	CMV	NNP
cord-005453-4057qib7	10668	2	infection	infection	NN
cord-005453-4057qib7	10668	3	was	be	VBD
cord-005453-4057qib7	10668	4	evaluated	evaluate	VBN
cord-005453-4057qib7	10668	5	by	by	IN
cord-005453-4057qib7	10668	6	CMV	CMV	NNP
cord-005453-4057qib7	10668	7	antigenemia	antigenemia	NN
cord-005453-4057qib7	10668	8	.	.	.
cord-005453-4057qib7	10669	1	This	this	DT
cord-005453-4057qib7	10669	2	study	study	NN
cord-005453-4057qib7	10669	3	was	be	VBD
cord-005453-4057qib7	10669	4	approved	approve	VBN
cord-005453-4057qib7	10669	5	by	by	IN
cord-005453-4057qib7	10669	6	the	the	DT
cord-005453-4057qib7	10669	7	Research	Research	NNP
cord-005453-4057qib7	10669	8	Ethics	Ethics	NNP
cord-005453-4057qib7	10669	9	Committee	Committee	NNP
cord-005453-4057qib7	10669	10	of	of	IN
cord-005453-4057qib7	10669	11	the	the	DT
cord-005453-4057qib7	10669	12	Faculty	Faculty	NNP
cord-005453-4057qib7	10669	13	of	of	IN
cord-005453-4057qib7	10669	14	Medicine	Medicine	NNP
cord-005453-4057qib7	10669	15	,	,	,
cord-005453-4057qib7	10669	16	Kansai	Kansai	NNP
cord-005453-4057qib7	10669	17	Medical	Medical	NNP
cord-005453-4057qib7	10669	18	University	University	NNP
cord-005453-4057qib7	10669	19	.	.	.
cord-005453-4057qib7	10670	1	Results	result	NNS
cord-005453-4057qib7	10670	2	:	:	:
cord-005453-4057qib7	10671	1	Thirteen	thirteen	CD
cord-005453-4057qib7	10671	2	patients	patient	NNS
cord-005453-4057qib7	10671	3	(	(	-LRB-
cord-005453-4057qib7	10671	4	male	male	JJ
cord-005453-4057qib7	10671	5	9	9	CD
cord-005453-4057qib7	10671	6	,	,	,
cord-005453-4057qib7	10671	7	female	female	JJ
cord-005453-4057qib7	10671	8	4	4	CD
cord-005453-4057qib7	10671	9	)	)	-RRB-
cord-005453-4057qib7	10671	10	underwent	undergo	VBD
cord-005453-4057qib7	10671	11	aHSCT	ahsct	NN
cord-005453-4057qib7	10671	12	and	and	CC
cord-005453-4057qib7	10671	13	received	receive	VBD
cord-005453-4057qib7	10671	14	CMV	CMV	NNP
cord-005453-4057qib7	10671	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10671	16	with	with	IN
cord-005453-4057qib7	10671	17	letermovir	letermovir	NNS
cord-005453-4057qib7	10671	18	.	.	.
cord-005453-4057qib7	10672	1	The	the	DT
cord-005453-4057qib7	10672	2	median	median	JJ
cord-005453-4057qib7	10672	3	age	age	NN
cord-005453-4057qib7	10672	4	was	be	VBD
cord-005453-4057qib7	10672	5	54	54	CD
cord-005453-4057qib7	10672	6	years	year	NNS
cord-005453-4057qib7	10672	7	(	(	-LRB-
cord-005453-4057qib7	10672	8	range	range	NN
cord-005453-4057qib7	10672	9	,	,	,
cord-005453-4057qib7	10672	10	18	18	CD
cord-005453-4057qib7	10672	11	-	-	SYM
cord-005453-4057qib7	10672	12	65	65	CD
cord-005453-4057qib7	10672	13	years	year	NNS
cord-005453-4057qib7	10672	14	)	)	-RRB-
cord-005453-4057qib7	10672	15	.	.	.
cord-005453-4057qib7	10673	1	Overall	overall	RB
cord-005453-4057qib7	10673	2	,	,	,
cord-005453-4057qib7	10673	3	10	10	CD
cord-005453-4057qib7	10673	4	of	of	IN
cord-005453-4057qib7	10673	5	13	13	CD
cord-005453-4057qib7	10673	6	patients	patient	NNS
cord-005453-4057qib7	10673	7	(	(	-LRB-
cord-005453-4057qib7	10673	8	76.9	76.9	CD
cord-005453-4057qib7	10673	9	%	%	NN
cord-005453-4057qib7	10673	10	)	)	-RRB-
cord-005453-4057qib7	10673	11	were	be	VBD
cord-005453-4057qib7	10673	12	considered	consider	VBN
cord-005453-4057qib7	10673	13	to	to	TO
cord-005453-4057qib7	10673	14	be	be	VB
cord-005453-4057qib7	10673	15	at	at	IN
cord-005453-4057qib7	10673	16	high	high	JJ
cord-005453-4057qib7	10673	17	risk	risk	NN
cord-005453-4057qib7	10673	18	for	for	IN
cord-005453-4057qib7	10673	19	CMV	CMV	NNP
cord-005453-4057qib7	10673	20	,	,	,
cord-005453-4057qib7	10673	21	including	include	VBG
cord-005453-4057qib7	10673	22	5	5	CD
cord-005453-4057qib7	10673	23	patients	patient	NNS
cord-005453-4057qib7	10673	24	(	(	-LRB-
cord-005453-4057qib7	10673	25	38.5	38.5	CD
cord-005453-4057qib7	10673	26	%	%	NN
cord-005453-4057qib7	10673	27	)	)	-RRB-
cord-005453-4057qib7	10673	28	with	with	IN
cord-005453-4057qib7	10673	29	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10673	30	donors	donor	NNS
cord-005453-4057qib7	10673	31	,	,	,
cord-005453-4057qib7	10673	32	and	and	CC
cord-005453-4057qib7	10673	33	1	1	CD
cord-005453-4057qib7	10673	34	(	(	-LRB-
cord-005453-4057qib7	10673	35	7.7	7.7	CD
cord-005453-4057qib7	10673	36	%	%	NN
cord-005453-4057qib7	10673	37	)	)	-RRB-
cord-005453-4057qib7	10673	38	with	with	IN
cord-005453-4057qib7	10673	39	mismatched	mismatched	JJ
cord-005453-4057qib7	10673	40	,	,	,
cord-005453-4057qib7	10673	41	unrelated	unrelated	JJ
cord-005453-4057qib7	10673	42	donors	donor	NNS
cord-005453-4057qib7	10673	43	.	.	.
cord-005453-4057qib7	10674	1	All	all	DT
cord-005453-4057qib7	10674	2	patients	patient	NNS
cord-005453-4057qib7	10674	3	began	begin	VBD
cord-005453-4057qib7	10674	4	letermovir	letermovir	NNS
cord-005453-4057qib7	10674	5	from	from	IN
cord-005453-4057qib7	10674	6	day	day	NN
cord-005453-4057qib7	10674	7	0	0	CD
cord-005453-4057qib7	10674	8	after	after	IN
cord-005453-4057qib7	10674	9	aHSCT	ahsct	NN
cord-005453-4057qib7	10674	10	,	,	,
cord-005453-4057qib7	10674	11	and	and	CC
cord-005453-4057qib7	10674	12	achieved	achieve	VBN
cord-005453-4057qib7	10674	13	engraftment	engraftment	NNP
cord-005453-4057qib7	10674	14	(	(	-LRB-
cord-005453-4057qib7	10674	15	median	median	NNP
cord-005453-4057qib7	10674	16	17	17	CD
cord-005453-4057qib7	10674	17	,	,	,
cord-005453-4057qib7	10674	18	13	13	CD
cord-005453-4057qib7	10674	19	-	-	SYM
cord-005453-4057qib7	10674	20	22	22	CD
cord-005453-4057qib7	10674	21	days	day	NNS
cord-005453-4057qib7	10674	22	)	)	-RRB-
cord-005453-4057qib7	10674	23	.	.	.
cord-005453-4057qib7	10675	1	No	no	DT
cord-005453-4057qib7	10675	2	patient	patient	NN
cord-005453-4057qib7	10675	3	developed	develop	VBD
cord-005453-4057qib7	10675	4	CMV	CMV	NNP
cord-005453-4057qib7	10675	5	disease	disease	NN
cord-005453-4057qib7	10675	6	and	and	CC
cord-005453-4057qib7	10675	7	required	require	VBN
cord-005453-4057qib7	10675	8	preemptive	preemptive	JJ
cord-005453-4057qib7	10675	9	therapy	therapy	NN
cord-005453-4057qib7	10675	10	.	.	.
cord-005453-4057qib7	10676	1	One	one	CD
cord-005453-4057qib7	10676	2	patient	patient	NN
cord-005453-4057qib7	10676	3	died	die	VBD
cord-005453-4057qib7	10676	4	of	of	IN
cord-005453-4057qib7	10676	5	treatment	treatment	NN
cord-005453-4057qib7	10676	6	-	-	HYPH
cord-005453-4057qib7	10676	7	related	relate	VBN
cord-005453-4057qib7	10676	8	mortality	mortality	NN
cord-005453-4057qib7	10676	9	,	,	,
cord-005453-4057qib7	10676	10	and	and	CC
cord-005453-4057qib7	10676	11	2	2	CD
cord-005453-4057qib7	10676	12	patients	patient	NNS
cord-005453-4057qib7	10676	13	died	die	VBD
cord-005453-4057qib7	10676	14	of	of	IN
cord-005453-4057qib7	10676	15	acute	acute	JJ
cord-005453-4057qib7	10676	16	GVHD	GVHD	NNP
cord-005453-4057qib7	10676	17	.	.	.
cord-005453-4057qib7	10677	1	Although	although	IN
cord-005453-4057qib7	10677	2	one	one	CD
cord-005453-4057qib7	10677	3	patient	patient	NN
cord-005453-4057qib7	10677	4	discontinued	discontinue	VBD
cord-005453-4057qib7	10677	5	letermovir	letermovir	NNS
cord-005453-4057qib7	10677	6	before	before	IN
cord-005453-4057qib7	10677	7	day	day	NN
cord-005453-4057qib7	10677	8	100	100	CD
cord-005453-4057qib7	10677	9	after	after	IN
cord-005453-4057qib7	10677	10	aHSCT	aHSCT	NNP
cord-005453-4057qib7	10677	11	because	because	IN
cord-005453-4057qib7	10677	12	letermovir	letermovir	NNP
cord-005453-4057qib7	10677	13	was	be	VBD
cord-005453-4057qib7	10677	14	suspected	suspect	VBN
cord-005453-4057qib7	10677	15	to	to	TO
cord-005453-4057qib7	10677	16	be	be	VB
cord-005453-4057qib7	10677	17	a	a	DT
cord-005453-4057qib7	10677	18	cause	cause	NN
cord-005453-4057qib7	10677	19	of	of	IN
cord-005453-4057qib7	10677	20	persistent	persistent	JJ
cord-005453-4057qib7	10677	21	nausea	nausea	NN
cord-005453-4057qib7	10677	22	,	,	,
cord-005453-4057qib7	10677	23	severe	severe	JJ
cord-005453-4057qib7	10677	24	adverse	adverse	JJ
cord-005453-4057qib7	10677	25	events	event	NNS
cord-005453-4057qib7	10677	26	were	be	VBD
cord-005453-4057qib7	10677	27	not	not	RB
cord-005453-4057qib7	10677	28	observed	observe	VBN
cord-005453-4057qib7	10677	29	.	.	.
cord-005453-4057qib7	10678	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10678	2	:	:	:
cord-005453-4057qib7	10679	1	It	-PRON-	PRP
cord-005453-4057qib7	10679	2	is	be	VBZ
cord-005453-4057qib7	10679	3	still	still	RB
cord-005453-4057qib7	10679	4	unknown	unknown	JJ
cord-005453-4057qib7	10679	5	whether	whether	IN
cord-005453-4057qib7	10679	6	CMV	CMV	NNP
cord-005453-4057qib7	10679	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10679	8	with	with	IN
cord-005453-4057qib7	10679	9	letermovir	letermovir	NNP
cord-005453-4057qib7	10679	10	improves	improve	VBZ
cord-005453-4057qib7	10679	11	OS	OS	NNP
cord-005453-4057qib7	10679	12	and	and	CC
cord-005453-4057qib7	10679	13	reduces	reduce	VBZ
cord-005453-4057qib7	10679	14	TRM	TRM	NNP
cord-005453-4057qib7	10679	15	;	;	:
cord-005453-4057qib7	10679	16	however	however	RB
cord-005453-4057qib7	10679	17	,	,	,
cord-005453-4057qib7	10679	18	our	-PRON-	PRP$
cord-005453-4057qib7	10679	19	data	datum	NNS
cord-005453-4057qib7	10679	20	suggests	suggest	VBZ
cord-005453-4057qib7	10679	21	that	that	IN
cord-005453-4057qib7	10679	22	CMV	CMV	NNP
cord-005453-4057qib7	10679	23	infection	infection	NN
cord-005453-4057qib7	10679	24	is	be	VBZ
cord-005453-4057qib7	10679	25	considerably	considerably	RB
cord-005453-4057qib7	10679	26	inhibited	inhibit	VBN
cord-005453-4057qib7	10679	27	by	by	IN
cord-005453-4057qib7	10679	28	administration	administration	NN
cord-005453-4057qib7	10679	29	of	of	IN
cord-005453-4057qib7	10679	30	letermovir	letermovir	NNP
cord-005453-4057qib7	10679	31	early	early	RB
cord-005453-4057qib7	10679	32	after	after	IN
cord-005453-4057qib7	10679	33	aHSCT	ahsct	NN
cord-005453-4057qib7	10679	34	.	.	.
cord-005453-4057qib7	10680	1	Clinical	clinical	JJ
cord-005453-4057qib7	10680	2	Trial	Trial	NNP
cord-005453-4057qib7	10680	3	Registry	Registry	NNP
cord-005453-4057qib7	10680	4	:	:	:
cord-005453-4057qib7	10681	1	Not	not	RB
cord-005453-4057qib7	10681	2	applicable	applicable	JJ
cord-005453-4057qib7	10681	3	.	.	.
cord-005453-4057qib7	10682	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10682	2	:	:	:
cord-005453-4057qib7	10683	1	The	the	DT
cord-005453-4057qib7	10683	2	authors	author	NNS
cord-005453-4057qib7	10683	3	declare	declare	VBP
cord-005453-4057qib7	10683	4	noconflicts	noconflict	NNS
cord-005453-4057qib7	10683	5	of	of	IN
cord-005453-4057qib7	10683	6	interest	interest	NN
cord-005453-4057qib7	10683	7	for	for	IN
cord-005453-4057qib7	10683	8	this	this	DT
cord-005453-4057qib7	10683	9	study	study	NN
cord-005453-4057qib7	10683	10	.	.	.
cord-005453-4057qib7	10684	1	Background	background	NN
cord-005453-4057qib7	10684	2	:	:	:
cord-005453-4057qib7	10684	3	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	10684	4	(	(	-LRB-
cord-005453-4057qib7	10684	5	CMV	CMV	NNP
cord-005453-4057qib7	10684	6	)	)	-RRB-
cord-005453-4057qib7	10684	7	is	be	VBZ
cord-005453-4057qib7	10684	8	cause	cause	NN
cord-005453-4057qib7	10684	9	of	of	IN
cord-005453-4057qib7	10684	10	increased	increase	VBN
cord-005453-4057qib7	10684	11	morbidity	morbidity	NN
cord-005453-4057qib7	10684	12	and	and	CC
cord-005453-4057qib7	10684	13	mortality	mortality	NN
cord-005453-4057qib7	10684	14	after	after	IN
cord-005453-4057qib7	10684	15	transplantation	transplantation	NN
cord-005453-4057qib7	10684	16	of	of	IN
cord-005453-4057qib7	10684	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10684	18	cells	cell	NNS
cord-005453-4057qib7	10684	19	.	.	.
cord-005453-4057qib7	10685	1	The	the	DT
cord-005453-4057qib7	10685	2	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	10685	3	of	of	IN
cord-005453-4057qib7	10685	4	CMV	CMV	NNP
cord-005453-4057qib7	10685	5	disease	disease	NN
cord-005453-4057qib7	10685	6	or	or	CC
cord-005453-4057qib7	10685	7	infection	infection	NN
cord-005453-4057qib7	10685	8	is	be	VBZ
cord-005453-4057qib7	10685	9	complex	complex	JJ
cord-005453-4057qib7	10685	10	with	with	IN
cord-005453-4057qib7	10685	11	multiple	multiple	JJ
cord-005453-4057qib7	10685	12	interactions	interaction	NNS
cord-005453-4057qib7	10685	13	with	with	IN
cord-005453-4057qib7	10685	14	the	the	DT
cord-005453-4057qib7	10685	15	immune	immune	JJ
cord-005453-4057qib7	10685	16	system	system	NN
cord-005453-4057qib7	10685	17	,	,	,
cord-005453-4057qib7	10685	18	mainly	mainly	RB
cord-005453-4057qib7	10685	19	in	in	IN
cord-005453-4057qib7	10685	20	acute	acute	JJ
cord-005453-4057qib7	10685	21	and	and	CC
cord-005453-4057qib7	10685	22	chronic	chronic	JJ
cord-005453-4057qib7	10685	23	graft	graft	NN
cord-005453-4057qib7	10685	24	-	-	HYPH
cord-005453-4057qib7	10685	25	versus	versus	IN
cord-005453-4057qib7	10685	26	-	-	HYPH
cord-005453-4057qib7	10685	27	host	host	NN
cord-005453-4057qib7	10685	28	disease	disease	NN
cord-005453-4057qib7	10685	29	(	(	-LRB-
cord-005453-4057qib7	10685	30	GVHD	GVHD	NNP
cord-005453-4057qib7	10685	31	)	)	-RRB-
cord-005453-4057qib7	10685	32	.	.	.
cord-005453-4057qib7	10686	1	The	the	DT
cord-005453-4057qib7	10686	2	aim	aim	NN
cord-005453-4057qib7	10686	3	of	of	IN
cord-005453-4057qib7	10686	4	this	this	DT
cord-005453-4057qib7	10686	5	study	study	NN
cord-005453-4057qib7	10686	6	is	be	VBZ
cord-005453-4057qib7	10686	7	to	to	TO
cord-005453-4057qib7	10686	8	analyze	analyze	VB
cord-005453-4057qib7	10686	9	the	the	DT
cord-005453-4057qib7	10686	10	risk	risk	NN
cord-005453-4057qib7	10686	11	factors	factor	NNS
cord-005453-4057qib7	10686	12	for	for	IN
cord-005453-4057qib7	10686	13	the	the	DT
cord-005453-4057qib7	10686	14	reactivation	reactivation	NN
cord-005453-4057qib7	10686	15	of	of	IN
cord-005453-4057qib7	10686	16	CMV	CMV	NNP
cord-005453-4057qib7	10686	17	in	in	IN
cord-005453-4057qib7	10686	18	patients	patient	NNS
cord-005453-4057qib7	10686	19	undergoing	undergo	VBG
cord-005453-4057qib7	10686	20	allogeneic	allogeneic	IN
cord-005453-4057qib7	10686	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10686	22	cell	cell	NN
cord-005453-4057qib7	10686	23	transplantation	transplantation	NN
cord-005453-4057qib7	10686	24	(	(	-LRB-
cord-005453-4057qib7	10686	25	HCT	HCT	NNP
cord-005453-4057qib7	10686	26	)	)	-RRB-
cord-005453-4057qib7	10686	27	.	.	.
cord-005453-4057qib7	10687	1	Methods	method	NNS
cord-005453-4057qib7	10687	2	:	:	:
cord-005453-4057qib7	10687	3	Prospective	prospective	JJ
cord-005453-4057qib7	10687	4	descriptive	descriptive	JJ
cord-005453-4057qib7	10687	5	study	study	NN
cord-005453-4057qib7	10687	6	of	of	IN
cord-005453-4057qib7	10687	7	the	the	DT
cord-005453-4057qib7	10687	8	risk	risk	NN
cord-005453-4057qib7	10687	9	factors	factor	NNS
cord-005453-4057qib7	10687	10	for	for	IN
cord-005453-4057qib7	10687	11	the	the	DT
cord-005453-4057qib7	10687	12	reactivation	reactivation	NN
cord-005453-4057qib7	10687	13	of	of	IN
cord-005453-4057qib7	10687	14	CMV	CMV	NNP
cord-005453-4057qib7	10687	15	in	in	IN
cord-005453-4057qib7	10687	16	the	the	DT
cord-005453-4057qib7	10687	17	described	describe	VBN
cord-005453-4057qib7	10687	18	population	population	NN
cord-005453-4057qib7	10687	19	.	.	.
cord-005453-4057qib7	10688	1	Univariate	univariate	JJ
cord-005453-4057qib7	10688	2	and	and	CC
cord-005453-4057qib7	10688	3	multivariate	multivariate	JJ
cord-005453-4057qib7	10688	4	analysis	analysis	NN
cord-005453-4057qib7	10688	5	of	of	IN
cord-005453-4057qib7	10688	6	the	the	DT
cord-005453-4057qib7	10688	7	predisposing	predisposing	JJ
cord-005453-4057qib7	10688	8	factors	factor	NNS
cord-005453-4057qib7	10688	9	were	be	VBD
cord-005453-4057qib7	10688	10	performed	perform	VBN
cord-005453-4057qib7	10688	11	:	:	:
cord-005453-4057qib7	10688	12	donor	donor	NN
cord-005453-4057qib7	10688	13	graft	graft	NN
cord-005453-4057qib7	10688	14	,	,	,
cord-005453-4057qib7	10688	15	treatment	treatment	NN
cord-005453-4057qib7	10688	16	with	with	IN
cord-005453-4057qib7	10688	17	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	10688	18	,	,	,
cord-005453-4057qib7	10688	19	use	use	NN
cord-005453-4057qib7	10688	20	of	of	IN
cord-005453-4057qib7	10688	21	antithymoglobin	antithymoglobin	NN
cord-005453-4057qib7	10688	22	,	,	,
cord-005453-4057qib7	10688	23	serologic	serologic	NN
cord-005453-4057qib7	10688	24	status	status	NN
cord-005453-4057qib7	10688	25	,	,	,
cord-005453-4057qib7	10688	26	conditioning	conditioning	NN
cord-005453-4057qib7	10688	27	regimen	regimen	NN
cord-005453-4057qib7	10688	28	and	and	CC
cord-005453-4057qib7	10688	29	the	the	DT
cord-005453-4057qib7	10688	30	presence	presence	NN
cord-005453-4057qib7	10688	31	of	of	IN
cord-005453-4057qib7	10688	32	GVHD	GVHD	NNP
cord-005453-4057qib7	10688	33	.	.	.
cord-005453-4057qib7	10689	1	Results	result	NNS
cord-005453-4057qib7	10689	2	:	:	:
cord-005453-4057qib7	10690	1	During	during	IN
cord-005453-4057qib7	10690	2	the	the	DT
cord-005453-4057qib7	10690	3	period	period	NN
cord-005453-4057qib7	10690	4	between	between	IN
cord-005453-4057qib7	10690	5	August	August	NNP
cord-005453-4057qib7	10690	6	2014	2014	CD
cord-005453-4057qib7	10690	7	until	until	IN
cord-005453-4057qib7	10690	8	January	January	NNP
cord-005453-4057qib7	10690	9	2017	2017	CD
cord-005453-4057qib7	10690	10	,	,	,
cord-005453-4057qib7	10690	11	71	71	CD
cord-005453-4057qib7	10690	12	patients	patient	NNS
cord-005453-4057qib7	10690	13	were	be	VBD
cord-005453-4057qib7	10690	14	evaluated	evaluate	VBN
cord-005453-4057qib7	10690	15	.	.	.
cord-005453-4057qib7	10691	1	42.25	42.25	CD
cord-005453-4057qib7	10691	2	%	%	NN
cord-005453-4057qib7	10691	3	(	(	-LRB-
cord-005453-4057qib7	10691	4	n:30	n:30	CD
cord-005453-4057qib7	10691	5	)	)	-RRB-
cord-005453-4057qib7	10691	6	had	have	VBD
cord-005453-4057qib7	10691	7	reactivation	reactivation	NN
cord-005453-4057qib7	10691	8	of	of	IN
cord-005453-4057qib7	10691	9	CMV	CMV	NNP
cord-005453-4057qib7	10691	10	.	.	.
cord-005453-4057qib7	10692	1	Average	average	JJ
cord-005453-4057qib7	10692	2	reactivation	reactivation	NN
cord-005453-4057qib7	10692	3	was	be	VBD
cord-005453-4057qib7	10692	4	58	58	CD
cord-005453-4057qib7	10692	5	days	day	NNS
cord-005453-4057qib7	10692	6	post	post	NN
cord-005453-4057qib7	10692	7	transplant	transplant	NN
cord-005453-4057qib7	10692	8	.	.	.
cord-005453-4057qib7	10693	1	Both	both	DT
cord-005453-4057qib7	10693	2	(	(	-LRB-
cord-005453-4057qib7	10693	3	recipient	recipient	NN
cord-005453-4057qib7	10693	4	and	and	CC
cord-005453-4057qib7	10693	5	the	the	DT
cord-005453-4057qib7	10693	6	donor	donor	NN
cord-005453-4057qib7	10693	7	)	)	-RRB-
cord-005453-4057qib7	10693	8	had	have	VBD
cord-005453-4057qib7	10693	9	positive	positive	JJ
cord-005453-4057qib7	10693	10	CMV	CMV	NNP
cord-005453-4057qib7	10693	11	IgG	igg	NN
cord-005453-4057qib7	10693	12	in	in	IN
cord-005453-4057qib7	10693	13	78.9	78.9	CD
cord-005453-4057qib7	10693	14	%	%	NN
cord-005453-4057qib7	10693	15	.	.	.
cord-005453-4057qib7	10694	1	In	in	IN
cord-005453-4057qib7	10694	2	the	the	DT
cord-005453-4057qib7	10694	3	univariate	univariate	JJ
cord-005453-4057qib7	10694	4	analysis	analysis	NN
cord-005453-4057qib7	10694	5	,	,	,
cord-005453-4057qib7	10694	6	the	the	DT
cord-005453-4057qib7	10694	7	reactivation	reactivation	NN
cord-005453-4057qib7	10694	8	of	of	IN
cord-005453-4057qib7	10694	9	CMV	CMV	NNP
cord-005453-4057qib7	10694	10	was	be	VBD
cord-005453-4057qib7	10694	11	associated	associate	VBN
cord-005453-4057qib7	10694	12	with	with	IN
cord-005453-4057qib7	10694	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10694	14	transplantation	transplantation	NN
cord-005453-4057qib7	10694	15	(	(	-LRB-
cord-005453-4057qib7	10694	16	p	p	NN
cord-005453-4057qib7	10694	17	:	:	:
cord-005453-4057qib7	10694	18	<	<	XX
cord-005453-4057qib7	10694	19	0.01	0.01	CD
cord-005453-4057qib7	10694	20	)	)	-RRB-
cord-005453-4057qib7	10694	21	,	,	,
cord-005453-4057qib7	10694	22	with	with	IN
cord-005453-4057qib7	10694	23	the	the	DT
cord-005453-4057qib7	10694	24	use	use	NN
cord-005453-4057qib7	10694	25	of	of	IN
cord-005453-4057qib7	10694	26	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	10694	27	(	(	-LRB-
cord-005453-4057qib7	10694	28	p	p	NN
cord-005453-4057qib7	10694	29	:	:	:
cord-005453-4057qib7	10694	30	<	<	XX
cord-005453-4057qib7	10694	31	0.01	0.01	CD
cord-005453-4057qib7	10694	32	)	)	-RRB-
cord-005453-4057qib7	10694	33	and	and	CC
cord-005453-4057qib7	10694	34	GVHD	GVHD	NNP
cord-005453-4057qib7	10694	35	(	(	-LRB-
cord-005453-4057qib7	10694	36	p	p	NN
cord-005453-4057qib7	10694	37	:	:	:
cord-005453-4057qib7	10694	38	<	<	XX
cord-005453-4057qib7	10694	39	0.01	0.01	CD
cord-005453-4057qib7	10694	40	)	)	-RRB-
cord-005453-4057qib7	10694	41	.	.	.
cord-005453-4057qib7	10695	1	In	in	IN
cord-005453-4057qib7	10695	2	the	the	DT
cord-005453-4057qib7	10695	3	multivariate	multivariate	JJ
cord-005453-4057qib7	10695	4	analysis	analysis	NN
cord-005453-4057qib7	10695	5	,	,	,
cord-005453-4057qib7	10695	6	the	the	DT
cord-005453-4057qib7	10695	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10695	8	transplant	transplant	NN
cord-005453-4057qib7	10695	9	maintained	maintain	VBD
cord-005453-4057qib7	10695	10	its	-PRON-	PRP$
cord-005453-4057qib7	10695	11	statistical	statistical	JJ
cord-005453-4057qib7	10695	12	significance	significance	NN
cord-005453-4057qib7	10695	13	in	in	IN
cord-005453-4057qib7	10695	14	comparison	comparison	NN
cord-005453-4057qib7	10695	15	with	with	IN
cord-005453-4057qib7	10695	16	the	the	DT
cord-005453-4057qib7	10695	17	related	relate	VBN
cord-005453-4057qib7	10695	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	10695	19	transplant	transplant	NN
cord-005453-4057qib7	10695	20	(	(	-LRB-
cord-005453-4057qib7	10695	21	p	p	NN
cord-005453-4057qib7	10695	22	:	:	:
cord-005453-4057qib7	10695	23	0.0012	0.0012	CD
cord-005453-4057qib7	10695	24	,	,	,
cord-005453-4057qib7	10695	25	OR:7.07	OR:7.07	NNP
cord-005453-4057qib7	10695	26	;	;	:
cord-005453-4057qib7	10695	27	IC95%:2.4	IC95%:2.4	NNPS
cord-005453-4057qib7	10695	28	-	-	HYPH
cord-005453-4057qib7	10695	29	20.6	20.6	CD
cord-005453-4057qib7	10695	30	)	)	-RRB-
cord-005453-4057qib7	10695	31	as	as	RB
cord-005453-4057qib7	10695	32	well	well	RB
cord-005453-4057qib7	10695	33	as	as	IN
cord-005453-4057qib7	10695	34	the	the	DT
cord-005453-4057qib7	10695	35	use	use	NN
cord-005453-4057qib7	10695	36	of	of	IN
cord-005453-4057qib7	10695	37	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	10695	38	(	(	-LRB-
cord-005453-4057qib7	10695	39	p	p	NN
cord-005453-4057qib7	10695	40	:	:	:
cord-005453-4057qib7	10695	41	0.0014	0.0014	CD
cord-005453-4057qib7	10695	42	,	,	,
cord-005453-4057qib7	10695	43	OR:9.25	OR:9.25	NNP
cord-005453-4057qib7	10695	44	;	;	:
cord-005453-4057qib7	10695	45	IC95%:2.6	ic95%:2.6	CD
cord-005453-4057qib7	10695	46	-	-	SYM
cord-005453-4057qib7	10695	47	32.4	32.4	CD
cord-005453-4057qib7	10695	48	)	)	-RRB-
cord-005453-4057qib7	10695	49	.	.	.
cord-005453-4057qib7	10696	1	100	100	CD
cord-005453-4057qib7	10696	2	%	%	NN
cord-005453-4057qib7	10696	3	of	of	IN
cord-005453-4057qib7	10696	4	patients	patient	NNS
cord-005453-4057qib7	10696	5	receiving	receive	VBG
cord-005453-4057qib7	10696	6	corticosteroid	corticosteroid	JJ
cord-005453-4057qib7	10696	7	treatment	treatment	NN
cord-005453-4057qib7	10696	8	had	have	VBD
cord-005453-4057qib7	10696	9	grade	grade	NN
cord-005453-4057qib7	10696	10	II	II	NNP
cord-005453-4057qib7	10696	11	/	/	SYM
cord-005453-4057qib7	10696	12	III	iii	CD
cord-005453-4057qib7	10696	13	GVHD	GVHD	NNP
cord-005453-4057qib7	10696	14	.	.	.
cord-005453-4057qib7	10697	1	The	the	DT
cord-005453-4057qib7	10697	2	serologicac	serologicac	NN
cord-005453-4057qib7	10697	3	status	status	NN
cord-005453-4057qib7	10697	4	,	,	,
cord-005453-4057qib7	10697	5	myeloablative	myeloablative	NNP
cord-005453-4057qib7	10697	6	conditioning	conditioning	NN
cord-005453-4057qib7	10697	7	regimen	regimen	NN
cord-005453-4057qib7	10697	8	and	and	CC
cord-005453-4057qib7	10697	9	the	the	DT
cord-005453-4057qib7	10697	10	use	use	NN
cord-005453-4057qib7	10697	11	of	of	IN
cord-005453-4057qib7	10697	12	ATG	ATG	NNP
cord-005453-4057qib7	10697	13	showed	show	VBD
cord-005453-4057qib7	10697	14	no	no	DT
cord-005453-4057qib7	10697	15	statistically	statistically	RB
cord-005453-4057qib7	10697	16	significant	significant	JJ
cord-005453-4057qib7	10697	17	association	association	NN
cord-005453-4057qib7	10697	18	.	.	.
cord-005453-4057qib7	10698	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10698	2	:	:	:
cord-005453-4057qib7	10699	1	In	in	IN
cord-005453-4057qib7	10699	2	patients	patient	NNS
cord-005453-4057qib7	10699	3	undergoing	undergo	VBG
cord-005453-4057qib7	10699	4	allogeneic	allogeneic	IN
cord-005453-4057qib7	10699	5	transplantation	transplantation	NN
cord-005453-4057qib7	10699	6	,	,	,
cord-005453-4057qib7	10699	7	were	be	VBD
cord-005453-4057qib7	10699	8	found	find	VBN
cord-005453-4057qib7	10699	9	as	as	IN
cord-005453-4057qib7	10699	10	risk	risk	NN
cord-005453-4057qib7	10699	11	factor	factor	NN
cord-005453-4057qib7	10699	12	to	to	IN
cord-005453-4057qib7	10699	13	reactivation	reactivation	NN
cord-005453-4057qib7	10699	14	,	,	,
cord-005453-4057qib7	10699	15	those	those	DT
cord-005453-4057qib7	10699	16	who	who	WP
cord-005453-4057qib7	10699	17	received	receive	VBD
cord-005453-4057qib7	10699	18	haploidentic	haploidentic	JJ
cord-005453-4057qib7	10699	19	transplantation	transplantation	NN
cord-005453-4057qib7	10699	20	and	and	CC
cord-005453-4057qib7	10699	21	treatment	treatment	NN
cord-005453-4057qib7	10699	22	with	with	IN
cord-005453-4057qib7	10699	23	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	10699	24	.	.	.
cord-005453-4057qib7	10700	1	Another	another	DT
cord-005453-4057qib7	10700	2	risk	risk	NN
cord-005453-4057qib7	10700	3	factor	factor	NN
cord-005453-4057qib7	10700	4	that	that	WDT
cord-005453-4057qib7	10700	5	showed	show	VBD
cord-005453-4057qib7	10700	6	greater	great	JJR
cord-005453-4057qib7	10700	7	reactivation	reactivation	NN
cord-005453-4057qib7	10700	8	was	be	VBD
cord-005453-4057qib7	10700	9	the	the	DT
cord-005453-4057qib7	10700	10	presence	presence	NN
cord-005453-4057qib7	10700	11	of	of	IN
cord-005453-4057qib7	10700	12	GVHD	GVHD	NNP
cord-005453-4057qib7	10700	13	.	.	.
cord-005453-4057qib7	10701	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10701	2	:	:	:
cord-005453-4057qib7	10701	3	nothing	nothing	NN
cord-005453-4057qib7	10701	4	to	to	TO
cord-005453-4057qib7	10701	5	declare	declare	VB
cord-005453-4057qib7	10701	6	Methods	method	NNS
cord-005453-4057qib7	10701	7	:	:	:
cord-005453-4057qib7	10702	1	A	a	DT
cord-005453-4057qib7	10702	2	37	37	CD
cord-005453-4057qib7	10702	3	y	y	NN
cord-005453-4057qib7	10702	4	/	/	SYM
cord-005453-4057qib7	10702	5	o	o	NN
cord-005453-4057qib7	10702	6	male	male	NN
cord-005453-4057qib7	10702	7	was	be	VBD
cord-005453-4057qib7	10702	8	referred	refer	VBN
cord-005453-4057qib7	10702	9	for	for	IN
cord-005453-4057qib7	10702	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	10702	11	transplant	transplant	NN
cord-005453-4057qib7	10702	12	following	follow	VBG
cord-005453-4057qib7	10702	13	3	3	CD
cord-005453-4057qib7	10702	14	cycles	cycle	NNS
cord-005453-4057qib7	10702	15	of	of	IN
cord-005453-4057qib7	10702	16	induction	induction	NN
cord-005453-4057qib7	10702	17	therapy	therapy	NN
cord-005453-4057qib7	10702	18	for	for	IN
cord-005453-4057qib7	10702	19	AML	AML	NNP
cord-005453-4057qib7	10702	20	with	with	IN
cord-005453-4057qib7	10702	21	complex	complex	JJ
cord-005453-4057qib7	10702	22	karyotype	karyotype	NN
cord-005453-4057qib7	10702	23	and	and	CC
cord-005453-4057qib7	10702	24	AXSL1	axsl1	NN
cord-005453-4057qib7	10702	25	mutation	mutation	NN
cord-005453-4057qib7	10702	26	having	have	VBG
cord-005453-4057qib7	10702	27	achieved	achieve	VBN
cord-005453-4057qib7	10702	28	complete	complete	JJ
cord-005453-4057qib7	10702	29	remission	remission	NN
cord-005453-4057qib7	10702	30	following	follow	VBG
cord-005453-4057qib7	10702	31	the	the	DT
cord-005453-4057qib7	10702	32	first	first	JJ
cord-005453-4057qib7	10702	33	cycle	cycle	NN
cord-005453-4057qib7	10702	34	of	of	IN
cord-005453-4057qib7	10702	35	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10702	36	.	.	.
cord-005453-4057qib7	10703	1	His	-PRON-	PRP$
cord-005453-4057qib7	10703	2	first	first	JJ
cord-005453-4057qib7	10703	3	induction	induction	NN
cord-005453-4057qib7	10703	4	cycle	cycle	NN
cord-005453-4057qib7	10703	5	was	be	VBD
cord-005453-4057qib7	10703	6	complicated	complicate	VBN
cord-005453-4057qib7	10703	7	by	by	IN
cord-005453-4057qib7	10703	8	a	a	DT
cord-005453-4057qib7	10703	9	perianal	perianal	JJ
cord-005453-4057qib7	10703	10	myeloid	myeloid	JJ
cord-005453-4057qib7	10703	11	sarcoma	sarcoma	NN
cord-005453-4057qib7	10703	12	which	which	WDT
cord-005453-4057qib7	10703	13	became	become	VBD
cord-005453-4057qib7	10703	14	infected	infected	JJ
cord-005453-4057qib7	10703	15	and	and	CC
cord-005453-4057qib7	10703	16	required	require	VBN
cord-005453-4057qib7	10703	17	surgical	surgical	JJ
cord-005453-4057qib7	10703	18	drainage	drainage	NN
cord-005453-4057qib7	10703	19	and	and	CC
cord-005453-4057qib7	10703	20	formation	formation	NN
cord-005453-4057qib7	10703	21	of	of	IN
cord-005453-4057qib7	10703	22	a	a	DT
cord-005453-4057qib7	10703	23	defunctioning	defunctione	VBG
cord-005453-4057qib7	10703	24	colostomy	colostomy	NN
cord-005453-4057qib7	10703	25	.	.	.
cord-005453-4057qib7	10704	1	Results	result	NNS
cord-005453-4057qib7	10704	2	:	:	:
cord-005453-4057qib7	10705	1	Following	follow	VBG
cord-005453-4057qib7	10705	2	2	2	CD
cord-005453-4057qib7	10705	3	allogeneic	allogeneic	NN
cord-005453-4057qib7	10705	4	transplants	transplant	NNS
cord-005453-4057qib7	10705	5	,	,	,
cord-005453-4057qib7	10705	6	the	the	DT
cord-005453-4057qib7	10705	7	first	first	JJ
cord-005453-4057qib7	10705	8	complicated	complicate	VBN
cord-005453-4057qib7	10705	9	by	by	IN
cord-005453-4057qib7	10705	10	secondary	secondary	JJ
cord-005453-4057qib7	10705	11	graft	graft	NN
cord-005453-4057qib7	10705	12	failure	failure	NN
cord-005453-4057qib7	10705	13	and	and	CC
cord-005453-4057qib7	10705	14	the	the	DT
cord-005453-4057qib7	10705	15	second	second	JJ
cord-005453-4057qib7	10705	16	by	by	IN
cord-005453-4057qib7	10705	17	primary	primary	JJ
cord-005453-4057qib7	10705	18	graft	graft	NN
cord-005453-4057qib7	10705	19	failure	failure	NN
cord-005453-4057qib7	10705	20	he	-PRON-	PRP
cord-005453-4057qib7	10705	21	presented	present	VBD
cord-005453-4057qib7	10705	22	with	with	IN
cord-005453-4057qib7	10705	23	two	two	CD
cord-005453-4057qib7	10705	24	skin	skin	NN
cord-005453-4057qib7	10705	25	lesions	lesion	NNS
cord-005453-4057qib7	10705	26	,	,	,
cord-005453-4057qib7	10705	27	with	with	IN
cord-005453-4057qib7	10705	28	a	a	DT
cord-005453-4057qib7	10705	29	third	third	JJ
cord-005453-4057qib7	10705	30	lesion	lesion	NN
cord-005453-4057qib7	10705	31	adjacent	adjacent	JJ
cord-005453-4057qib7	10705	32	to	to	IN
cord-005453-4057qib7	10705	33	his	-PRON-	PRP$
cord-005453-4057qib7	10705	34	stoma	stoma	NN
cord-005453-4057qib7	10705	35	developing	develop	VBG
cord-005453-4057qib7	10705	36	shortly	shortly	RB
cord-005453-4057qib7	10705	37	after	after	IN
cord-005453-4057qib7	10705	38	admission	admission	NN
cord-005453-4057qib7	10705	39	.	.	.
cord-005453-4057qib7	10706	1	All	all	DT
cord-005453-4057qib7	10706	2	lesions	lesion	NNS
cord-005453-4057qib7	10706	3	were	be	VBD
cord-005453-4057qib7	10706	4	erythematous	erythematous	JJ
cord-005453-4057qib7	10706	5	with	with	IN
cord-005453-4057qib7	10706	6	central	central	JJ
cord-005453-4057qib7	10706	7	necrosis	necrosis	NN
cord-005453-4057qib7	10706	8	and	and	CC
cord-005453-4057qib7	10706	9	progressed	progress	VBD
cord-005453-4057qib7	10706	10	rapidly	rapidly	RB
cord-005453-4057qib7	10706	11	in	in	IN
cord-005453-4057qib7	10706	12	size	size	NN
cord-005453-4057qib7	10706	13	over	over	IN
cord-005453-4057qib7	10706	14	48	48	CD
cord-005453-4057qib7	10706	15	hours	hour	NNS
cord-005453-4057qib7	10706	16	.	.	.
cord-005453-4057qib7	10707	1	Biopsy	biopsy	NN
cord-005453-4057qib7	10707	2	of	of	IN
cord-005453-4057qib7	10707	3	the	the	DT
cord-005453-4057qib7	10707	4	skin	skin	NN
cord-005453-4057qib7	10707	5	and	and	CC
cord-005453-4057qib7	10707	6	para	para	NNP
cord-005453-4057qib7	10707	7	-	-	HYPH
cord-005453-4057qib7	10707	8	stomal	stomal	JJ
cord-005453-4057qib7	10707	9	lesions	lesion	NNS
cord-005453-4057qib7	10707	10	revealed	reveal	VBD
cord-005453-4057qib7	10707	11	fungal	fungal	JJ
cord-005453-4057qib7	10707	12	mycelia	mycelium	NNS
cord-005453-4057qib7	10707	13	,	,	,
cord-005453-4057qib7	10707	14	with	with	IN
cord-005453-4057qib7	10707	15	culture	culture	NN
cord-005453-4057qib7	10707	16	subsequently	subsequently	RB
cord-005453-4057qib7	10707	17	identifying	identify	VBG
cord-005453-4057qib7	10707	18	Rhizopus	Rhizopus	NNP
cord-005453-4057qib7	10707	19	oryzae	oryzae	NN
cord-005453-4057qib7	10707	20	.	.	.
cord-005453-4057qib7	10708	1	Initial	initial	JJ
cord-005453-4057qib7	10708	2	treatment	treatment	NN
cord-005453-4057qib7	10708	3	was	be	VBD
cord-005453-4057qib7	10708	4	with	with	IN
cord-005453-4057qib7	10708	5	liposomal	liposomal	JJ
cord-005453-4057qib7	10708	6	amphotericin	amphotericin	NNS
cord-005453-4057qib7	10708	7	B	B	NNP
cord-005453-4057qib7	10708	8	5mg	5mg	NNP
cord-005453-4057qib7	10708	9	/	/	SYM
cord-005453-4057qib7	10708	10	kg	kg	NN
cord-005453-4057qib7	10708	11	/	/	SYM
cord-005453-4057qib7	10708	12	day	day	NN
cord-005453-4057qib7	10708	13	followed	follow	VBN
cord-005453-4057qib7	10708	14	by	by	IN
cord-005453-4057qib7	10708	15	dose	dose	NN
cord-005453-4057qib7	10708	16	escalation	escalation	NN
cord-005453-4057qib7	10708	17	to	to	IN
cord-005453-4057qib7	10708	18	10mg	10mg	NNP
cord-005453-4057qib7	10708	19	/	/	SYM
cord-005453-4057qib7	10708	20	kg	kg	NN
cord-005453-4057qib7	10708	21	/	/	SYM
cord-005453-4057qib7	10708	22	day	day	NN
cord-005453-4057qib7	10708	23	due	due	JJ
cord-005453-4057qib7	10708	24	to	to	IN
cord-005453-4057qib7	10708	25	the	the	DT
cord-005453-4057qib7	10708	26	development	development	NN
cord-005453-4057qib7	10708	27	of	of	IN
cord-005453-4057qib7	10708	28	new	new	JJ
cord-005453-4057qib7	10708	29	skin	skin	NN
cord-005453-4057qib7	10708	30	lesions	lesion	NNS
cord-005453-4057qib7	10708	31	.	.	.
cord-005453-4057qib7	10709	1	The	the	DT
cord-005453-4057qib7	10709	2	patient	patient	NN
cord-005453-4057qib7	10709	3	had	have	VBD
cord-005453-4057qib7	10709	4	been	be	VBN
cord-005453-4057qib7	10709	5	taking	take	VBG
cord-005453-4057qib7	10709	6	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10709	7	(	(	-LRB-
cord-005453-4057qib7	10709	8	tablet	tablet	NN
cord-005453-4057qib7	10709	9	)	)	-RRB-
cord-005453-4057qib7	10709	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10709	11	since	since	IN
cord-005453-4057qib7	10709	12	his	-PRON-	PRP$
cord-005453-4057qib7	10709	13	first	first	JJ
cord-005453-4057qib7	10709	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	10709	15	transplant	transplant	NN
cord-005453-4057qib7	10709	16	and	and	CC
cord-005453-4057qib7	10709	17	peripheral	peripheral	JJ
cord-005453-4057qib7	10709	18	blood	blood	NN
cord-005453-4057qib7	10709	19	drug	drug	NN
cord-005453-4057qib7	10709	20	levels	level	NNS
cord-005453-4057qib7	10709	21	checked	check	VBN
cord-005453-4057qib7	10709	22	at	at	IN
cord-005453-4057qib7	10709	23	the	the	DT
cord-005453-4057qib7	10709	24	time	time	NN
cord-005453-4057qib7	10709	25	of	of	IN
cord-005453-4057qib7	10709	26	admission	admission	NN
cord-005453-4057qib7	10709	27	were	be	VBD
cord-005453-4057qib7	10709	28	therapeutic	therapeutic	JJ
cord-005453-4057qib7	10709	29	confirming	confirming	NN
cord-005453-4057qib7	10709	30	that	that	IN
cord-005453-4057qib7	10709	31	this	this	DT
cord-005453-4057qib7	10709	32	was	be	VBD
cord-005453-4057qib7	10709	33	a	a	DT
cord-005453-4057qib7	10709	34	breakthrough	breakthrough	JJ
cord-005453-4057qib7	10709	35	fungal	fungal	NN
cord-005453-4057qib7	10709	36	infection	infection	NN
cord-005453-4057qib7	10709	37	.	.	.
cord-005453-4057qib7	10710	1	Consequently	consequently	RB
cord-005453-4057qib7	10710	2	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10710	3	was	be	VBD
cord-005453-4057qib7	10710	4	stopped	stop	VBN
cord-005453-4057qib7	10710	5	and	and	CC
cord-005453-4057qib7	10710	6	isavuconazole	isavuconazole	NNP
cord-005453-4057qib7	10710	7	added	add	VBD
cord-005453-4057qib7	10710	8	to	to	IN
cord-005453-4057qib7	10710	9	the	the	DT
cord-005453-4057qib7	10710	10	treatment	treatment	NN
cord-005453-4057qib7	10710	11	regimen	regimen	NN
cord-005453-4057qib7	10710	12	.	.	.
cord-005453-4057qib7	10711	1	Surgical	surgical	JJ
cord-005453-4057qib7	10711	2	assessment	assessment	NN
cord-005453-4057qib7	10711	3	was	be	VBD
cord-005453-4057qib7	10711	4	undertaken	undertake	VBN
cord-005453-4057qib7	10711	5	but	but	CC
cord-005453-4057qib7	10711	6	surgery	surgery	NN
cord-005453-4057qib7	10711	7	was	be	VBD
cord-005453-4057qib7	10711	8	deferred	defer	VBN
cord-005453-4057qib7	10711	9	on	on	IN
cord-005453-4057qib7	10711	10	the	the	DT
cord-005453-4057qib7	10711	11	basis	basis	NN
cord-005453-4057qib7	10711	12	of	of	IN
cord-005453-4057qib7	10711	13	high	high	JJ
cord-005453-4057qib7	10711	14	risk	risk	NN
cord-005453-4057qib7	10711	15	due	due	IN
cord-005453-4057qib7	10711	16	to	to	IN
cord-005453-4057qib7	10711	17	the	the	DT
cord-005453-4057qib7	10711	18	extent	extent	NN
cord-005453-4057qib7	10711	19	of	of	IN
cord-005453-4057qib7	10711	20	the	the	DT
cord-005453-4057qib7	10711	21	infection	infection	NN
cord-005453-4057qib7	10711	22	and	and	CC
cord-005453-4057qib7	10711	23	the	the	DT
cord-005453-4057qib7	10711	24	patient´s	patient´s	NNP
cord-005453-4057qib7	10711	25	profound	profound	JJ
cord-005453-4057qib7	10711	26	pancytopenia	pancytopenia	NNP
cord-005453-4057qib7	10711	27	.	.	.
cord-005453-4057qib7	10712	1	The	the	DT
cord-005453-4057qib7	10712	2	organism	organism	NN
cord-005453-4057qib7	10712	3	was	be	VBD
cord-005453-4057qib7	10712	4	tested	test	VBN
cord-005453-4057qib7	10712	5	for	for	IN
cord-005453-4057qib7	10712	6	in	in	FW
cord-005453-4057qib7	10712	7	vitro	vitro	FW
cord-005453-4057qib7	10712	8	susceptibilitiy	susceptibilitiy	NNP
cord-005453-4057qib7	10712	9	and	and	CC
cord-005453-4057qib7	10712	10	found	find	VBD
cord-005453-4057qib7	10712	11	to	to	TO
cord-005453-4057qib7	10712	12	be	be	VB
cord-005453-4057qib7	10712	13	resistant	resistant	JJ
cord-005453-4057qib7	10712	14	to	to	IN
cord-005453-4057qib7	10712	15	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10712	16	(	(	-LRB-
cord-005453-4057qib7	10712	17	MIC	mic	NN
cord-005453-4057qib7	10712	18	>	>	XX
cord-005453-4057qib7	10712	19	16mg	16mg	NN
cord-005453-4057qib7	10712	20	/	/	SYM
cord-005453-4057qib7	10712	21	l	l	NN
cord-005453-4057qib7	10712	22	)	)	-RRB-
cord-005453-4057qib7	10712	23	,	,	,
cord-005453-4057qib7	10712	24	with	with	IN
cord-005453-4057qib7	10712	25	borderline	borderline	JJ
cord-005453-4057qib7	10712	26	resistance	resistance	NN
cord-005453-4057qib7	10712	27	to	to	IN
cord-005453-4057qib7	10712	28	isavuconazole	isavuconazole	NNP
cord-005453-4057qib7	10712	29	(	(	-LRB-
cord-005453-4057qib7	10712	30	MIC	MIC	NNP
cord-005453-4057qib7	10712	31	16mg	16mg	NN
cord-005453-4057qib7	10712	32	/	/	SYM
cord-005453-4057qib7	10712	33	L	L	NNP
cord-005453-4057qib7	10712	34	)	)	-RRB-
cord-005453-4057qib7	10712	35	and	and	CC
cord-005453-4057qib7	10712	36	sensitive	sensitive	JJ
cord-005453-4057qib7	10712	37	to	to	IN
cord-005453-4057qib7	10712	38	Amphotericin	Amphotericin	NNP
cord-005453-4057qib7	10712	39	B	B	NNP
cord-005453-4057qib7	10712	40	(	(	-LRB-
cord-005453-4057qib7	10712	41	MIC	mic	NN
cord-005453-4057qib7	10712	42	0.25mg	0.25mg	CD
cord-005453-4057qib7	10712	43	/	/	SYM
cord-005453-4057qib7	10712	44	L	l	NN
cord-005453-4057qib7	10712	45	)	)	-RRB-
cord-005453-4057qib7	10712	46	(	(	-LRB-
cord-005453-4057qib7	10712	47	PHE	PHE	NNP
cord-005453-4057qib7	10712	48	Mycology	Mycology	NNP
cord-005453-4057qib7	10712	49	Reference	Reference	NNP
cord-005453-4057qib7	10712	50	Laboratory	Laboratory	NNP
cord-005453-4057qib7	10712	51	,	,	,
cord-005453-4057qib7	10712	52	England	England	NNP
cord-005453-4057qib7	10712	53	)	)	-RRB-
cord-005453-4057qib7	10712	54	.	.	.
cord-005453-4057qib7	10713	1	Isavuconazole	Isavuconazole	NNP
cord-005453-4057qib7	10713	2	was	be	VBD
cord-005453-4057qib7	10713	3	therefore	therefore	RB
cord-005453-4057qib7	10713	4	stopped	stop	VBN
cord-005453-4057qib7	10713	5	and	and	CC
cord-005453-4057qib7	10713	6	the	the	DT
cord-005453-4057qib7	10713	7	patient	patient	NN
cord-005453-4057qib7	10713	8	was	be	VBD
cord-005453-4057qib7	10713	9	managed	manage	VBN
cord-005453-4057qib7	10713	10	with	with	IN
cord-005453-4057qib7	10713	11	liposomal	liposomal	JJ
cord-005453-4057qib7	10713	12	amphotericin	amphotericin	NNS
cord-005453-4057qib7	10713	13	B	B	NNP
cord-005453-4057qib7	10713	14	along	along	IN
cord-005453-4057qib7	10713	15	with	with	IN
cord-005453-4057qib7	10713	16	daily	daily	JJ
cord-005453-4057qib7	10713	17	granulocyte	granulocyte	NN
cord-005453-4057qib7	10713	18	infusions	infusion	NNS
cord-005453-4057qib7	10713	19	.	.	.
cord-005453-4057qib7	10714	1	He	-PRON-	PRP
cord-005453-4057qib7	10714	2	underwent	undergo	VBD
cord-005453-4057qib7	10714	3	a	a	DT
cord-005453-4057qib7	10714	4	third	third	JJ
cord-005453-4057qib7	10714	5	allogeneic	allogeneic	NN
cord-005453-4057qib7	10714	6	transplant	transplant	NN
cord-005453-4057qib7	10714	7	using	use	VBG
cord-005453-4057qib7	10714	8	a	a	DT
cord-005453-4057qib7	10714	9	different	different	JJ
cord-005453-4057qib7	10714	10	unrelated	unrelated	JJ
cord-005453-4057qib7	10714	11	donor	donor	NN
cord-005453-4057qib7	10714	12	and	and	CC
cord-005453-4057qib7	10714	13	stable	stable	JJ
cord-005453-4057qib7	10714	14	engraftment	engraftment	NN
cord-005453-4057qib7	10714	15	was	be	VBD
cord-005453-4057qib7	10714	16	achieved	achieve	VBN
cord-005453-4057qib7	10714	17	.	.	.
cord-005453-4057qib7	10715	1	Post	post	JJ
cord-005453-4057qib7	10715	2	transplant	transplant	NN
cord-005453-4057qib7	10715	3	there	there	EX
cord-005453-4057qib7	10715	4	was	be	VBD
cord-005453-4057qib7	10715	5	initially	initially	RB
cord-005453-4057qib7	10715	6	an	an	DT
cord-005453-4057qib7	10715	7	increase	increase	NN
cord-005453-4057qib7	10715	8	in	in	IN
cord-005453-4057qib7	10715	9	the	the	DT
cord-005453-4057qib7	10715	10	size	size	NN
cord-005453-4057qib7	10715	11	of	of	IN
cord-005453-4057qib7	10715	12	the	the	DT
cord-005453-4057qib7	10715	13	para	para	NNP
cord-005453-4057qib7	10715	14	-	-	HYPH
cord-005453-4057qib7	10715	15	stomal	stomal	NNP
cord-005453-4057qib7	10715	16	lesion	lesion	NN
cord-005453-4057qib7	10715	17	,	,	,
cord-005453-4057qib7	10715	18	but	but	CC
cord-005453-4057qib7	10715	19	no	no	DT
cord-005453-4057qib7	10715	20	new	new	JJ
cord-005453-4057qib7	10715	21	skin	skin	NN
cord-005453-4057qib7	10715	22	lesions	lesion	NNS
cord-005453-4057qib7	10715	23	developed	develop	VBN
cord-005453-4057qib7	10715	24	.	.	.
cord-005453-4057qib7	10716	1	Following	follow	VBG
cord-005453-4057qib7	10716	2	engraftment	engraftment	NN
cord-005453-4057qib7	10716	3	he	-PRON-	PRP
cord-005453-4057qib7	10716	4	underwent	undergo	VBD
cord-005453-4057qib7	10716	5	resection	resection	NN
cord-005453-4057qib7	10716	6	of	of	IN
cord-005453-4057qib7	10716	7	the	the	DT
cord-005453-4057qib7	10716	8	stomal	stomal	NNP
cord-005453-4057qib7	10716	9	lesion	lesion	NN
cord-005453-4057qib7	10716	10	,	,	,
cord-005453-4057qib7	10716	11	with	with	IN
cord-005453-4057qib7	10716	12	primary	primary	JJ
cord-005453-4057qib7	10716	13	closure	closure	NN
cord-005453-4057qib7	10716	14	and	and	CC
cord-005453-4057qib7	10716	15	re	re	NN
cord-005453-4057qib7	10716	16	-	-	NN
cord-005453-4057qib7	10716	17	siting	siting	NN
cord-005453-4057qib7	10716	18	of	of	IN
cord-005453-4057qib7	10716	19	his	-PRON-	PRP$
cord-005453-4057qib7	10716	20	stoma	stoma	NN
cord-005453-4057qib7	10716	21	.	.	.
cord-005453-4057qib7	10717	1	Amphotericin	Amphotericin	NNP
cord-005453-4057qib7	10717	2	B	B	NNP
cord-005453-4057qib7	10717	3	was	be	VBD
cord-005453-4057qib7	10717	4	replaced	replace	VBN
cord-005453-4057qib7	10717	5	by	by	IN
cord-005453-4057qib7	10717	6	isavuconazole	isavuconazole	NNP
cord-005453-4057qib7	10717	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10717	8	on	on	IN
cord-005453-4057qib7	10717	9	discharge	discharge	NN
cord-005453-4057qib7	10717	10	and	and	CC
cord-005453-4057qib7	10717	11	he	-PRON-	PRP
cord-005453-4057qib7	10717	12	continues	continue	VBZ
cord-005453-4057qib7	10717	13	to	to	TO
cord-005453-4057qib7	10717	14	make	make	VB
cord-005453-4057qib7	10717	15	an	an	DT
cord-005453-4057qib7	10717	16	excellent	excellent	JJ
cord-005453-4057qib7	10717	17	recovery	recovery	NN
cord-005453-4057qib7	10717	18	.	.	.
cord-005453-4057qib7	10718	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10718	2	:	:	:
cord-005453-4057qib7	10719	1	Whilst	whilst	IN
cord-005453-4057qib7	10719	2	Aspergillus	aspergillus	NN
cord-005453-4057qib7	10719	3	species	specie	NNS
cord-005453-4057qib7	10719	4	remain	remain	VBP
cord-005453-4057qib7	10719	5	the	the	DT
cord-005453-4057qib7	10719	6	most	most	RBS
cord-005453-4057qib7	10719	7	common	common	JJ
cord-005453-4057qib7	10719	8	cause	cause	NN
cord-005453-4057qib7	10719	9	of	of	IN
cord-005453-4057qib7	10719	10	invasive	invasive	JJ
cord-005453-4057qib7	10719	11	fungal	fungal	JJ
cord-005453-4057qib7	10719	12	infections	infection	NNS
cord-005453-4057qib7	10719	13	in	in	IN
cord-005453-4057qib7	10719	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	10719	15	transplant	transplant	NN
cord-005453-4057qib7	10719	16	patients	patient	NNS
cord-005453-4057qib7	10719	17	,	,	,
cord-005453-4057qib7	10719	18	other	other	JJ
cord-005453-4057qib7	10719	19	species	specie	NNS
cord-005453-4057qib7	10719	20	including	include	VBG
cord-005453-4057qib7	10719	21	the	the	DT
cord-005453-4057qib7	10719	22	Mucorales	Mucorales	NNPS
cord-005453-4057qib7	10719	23	are	be	VBP
cord-005453-4057qib7	10719	24	seen	see	VBN
cord-005453-4057qib7	10719	25	,	,	,
cord-005453-4057qib7	10719	26	and	and	CC
cord-005453-4057qib7	10719	27	generally	generally	RB
cord-005453-4057qib7	10719	28	associated	associate	VBN
cord-005453-4057qib7	10719	29	with	with	IN
cord-005453-4057qib7	10719	30	poorer	poor	JJR
cord-005453-4057qib7	10719	31	outcomes	outcome	NNS
cord-005453-4057qib7	10719	32	.	.	.
cord-005453-4057qib7	10720	1	Whilst	whilst	IN
cord-005453-4057qib7	10720	2	there	there	EX
cord-005453-4057qib7	10720	3	are	be	VBP
cord-005453-4057qib7	10720	4	standardised	standardised	JJ
cord-005453-4057qib7	10720	5	methodologies	methodology	NNS
cord-005453-4057qib7	10720	6	for	for	IN
cord-005453-4057qib7	10720	7	susceptibility	susceptibility	NN
cord-005453-4057qib7	10720	8	testing	testing	NN
cord-005453-4057qib7	10720	9	,	,	,
cord-005453-4057qib7	10720	10	fungi	fungus	NNS
cord-005453-4057qib7	10720	11	specific	specific	JJ
cord-005453-4057qib7	10720	12	cut	cut	NN
cord-005453-4057qib7	10720	13	offs	off	NNS
cord-005453-4057qib7	10720	14	based	base	VBN
cord-005453-4057qib7	10720	15	on	on	IN
cord-005453-4057qib7	10720	16	clinical	clinical	JJ
cord-005453-4057qib7	10720	17	outcomes	outcome	NNS
cord-005453-4057qib7	10720	18	are	be	VBP
cord-005453-4057qib7	10720	19	only	only	RB
cord-005453-4057qib7	10720	20	available	available	JJ
cord-005453-4057qib7	10720	21	for	for	IN
cord-005453-4057qib7	10720	22	a	a	DT
cord-005453-4057qib7	10720	23	limited	limited	JJ
cord-005453-4057qib7	10720	24	number	number	NN
cord-005453-4057qib7	10720	25	of	of	IN
cord-005453-4057qib7	10720	26	species/	species/	CD
cord-005453-4057qib7	10720	27	antifungal	antifungal	JJ
cord-005453-4057qib7	10720	28	agents	agent	NNS
cord-005453-4057qib7	10720	29	.	.	.
cord-005453-4057qib7	10721	1	In	in	IN
cord-005453-4057qib7	10721	2	this	this	DT
cord-005453-4057qib7	10721	3	case	case	NN
cord-005453-4057qib7	10721	4	,	,	,
cord-005453-4057qib7	10721	5	susceptibility	susceptibility	NN
cord-005453-4057qib7	10721	6	testing	testing	NN
cord-005453-4057qib7	10721	7	demonstrated	demonstrate	VBD
cord-005453-4057qib7	10721	8	resistance	resistance	NN
cord-005453-4057qib7	10721	9	to	to	IN
cord-005453-4057qib7	10721	10	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10721	11	which	which	WDT
cord-005453-4057qib7	10721	12	was	be	VBD
cord-005453-4057qib7	10721	13	consistent	consistent	JJ
cord-005453-4057qib7	10721	14	with	with	IN
cord-005453-4057qib7	10721	15	the	the	DT
cord-005453-4057qib7	10721	16	clinical	clinical	JJ
cord-005453-4057qib7	10721	17	presentation	presentation	NN
cord-005453-4057qib7	10721	18	of	of	IN
cord-005453-4057qib7	10721	19	invasive	invasive	JJ
cord-005453-4057qib7	10721	20	infection	infection	NN
cord-005453-4057qib7	10721	21	despite	despite	IN
cord-005453-4057qib7	10721	22	therapeutic	therapeutic	JJ
cord-005453-4057qib7	10721	23	levels	level	NNS
cord-005453-4057qib7	10721	24	of	of	IN
cord-005453-4057qib7	10721	25	posaconazole	posaconazole	NN
cord-005453-4057qib7	10721	26	.	.	.
cord-005453-4057qib7	10722	1	It	-PRON-	PRP
cord-005453-4057qib7	10722	2	is	be	VBZ
cord-005453-4057qib7	10722	3	also	also	RB
cord-005453-4057qib7	10722	4	worth	worth	JJ
cord-005453-4057qib7	10722	5	noting	note	VBG
cord-005453-4057qib7	10722	6	that	that	IN
cord-005453-4057qib7	10722	7	an	an	DT
cord-005453-4057qib7	10722	8	estimated	estimate	VBN
cord-005453-4057qib7	10722	9	45	45	CD
cord-005453-4057qib7	10722	10	%	%	NN
cord-005453-4057qib7	10722	11	of	of	IN
cord-005453-4057qib7	10722	12	R.	R.	NNP
cord-005453-4057qib7	10722	13	oryzae	oryzae	NN
cord-005453-4057qib7	10722	14	isolates	isolate	VBZ
cord-005453-4057qib7	10722	15	in	in	IN
cord-005453-4057qib7	10722	16	the	the	DT
cord-005453-4057qib7	10722	17	UK	UK	NNP
cord-005453-4057qib7	10722	18	are	be	VBP
cord-005453-4057qib7	10722	19	resistant	resistant	JJ
cord-005453-4057qib7	10722	20	to	to	IN
cord-005453-4057qib7	10722	21	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10722	22	.	.	.
cord-005453-4057qib7	10723	1	Treatment	treatment	NN
cord-005453-4057qib7	10723	2	with	with	IN
cord-005453-4057qib7	10723	3	high	high	JJ
cord-005453-4057qib7	10723	4	dose	dose	NN
cord-005453-4057qib7	10723	5	Amphotericin	Amphotericin	NNP
cord-005453-4057qib7	10723	6	B	B	NNP
cord-005453-4057qib7	10723	7	resulted	result	VBD
cord-005453-4057qib7	10723	8	in	in	IN
cord-005453-4057qib7	10723	9	improvement	improvement	NN
cord-005453-4057qib7	10723	10	in	in	IN
cord-005453-4057qib7	10723	11	small	small	JJ
cord-005453-4057qib7	10723	12	skin	skin	NN
cord-005453-4057qib7	10723	13	lesions	lesion	NNS
cord-005453-4057qib7	10723	14	with	with	IN
cord-005453-4057qib7	10723	15	stabilisation	stabilisation	NN
cord-005453-4057qib7	10723	16	of	of	IN
cord-005453-4057qib7	10723	17	the	the	DT
cord-005453-4057qib7	10723	18	larger	large	JJR
cord-005453-4057qib7	10723	19	stomal	stomal	NNP
cord-005453-4057qib7	10723	20	lesion	lesion	NN
cord-005453-4057qib7	10723	21	until	until	IN
cord-005453-4057qib7	10723	22	count	count	NN
cord-005453-4057qib7	10723	23	recovery	recovery	NN
cord-005453-4057qib7	10723	24	allowed	allow	VBD
cord-005453-4057qib7	10723	25	surgical	surgical	JJ
cord-005453-4057qib7	10723	26	resection	resection	NN
cord-005453-4057qib7	10723	27	.	.	.
cord-005453-4057qib7	10724	1	Background	background	NN
cord-005453-4057qib7	10724	2	:	:	:
cord-005453-4057qib7	10725	1	Total	total	JJ
cord-005453-4057qib7	10725	2	depletion	depletion	NN
cord-005453-4057qib7	10725	3	of	of	IN
cord-005453-4057qib7	10725	4	innate	innate	JJ
cord-005453-4057qib7	10725	5	and	and	CC
cord-005453-4057qib7	10725	6	adaptive	adaptive	JJ
cord-005453-4057qib7	10725	7	immune	immune	JJ
cord-005453-4057qib7	10725	8	cell	cell	NN
cord-005453-4057qib7	10725	9	populations	population	NNS
cord-005453-4057qib7	10725	10	occurs	occur	VBZ
cord-005453-4057qib7	10725	11	after	after	IN
cord-005453-4057qib7	10725	12	intensive	intensive	JJ
cord-005453-4057qib7	10725	13	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10725	14	and	and	CC
cord-005453-4057qib7	10725	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10725	16	stem	stem	NN
cord-005453-4057qib7	10725	17	cell	cell	NN
cord-005453-4057qib7	10725	18	transplantation	transplantation	NN
cord-005453-4057qib7	10725	19	(	(	-LRB-
cord-005453-4057qib7	10725	20	HSCT	HSCT	NNP
cord-005453-4057qib7	10725	21	)	)	-RRB-
cord-005453-4057qib7	10725	22	.	.	.
cord-005453-4057qib7	10726	1	Both	both	DT
cord-005453-4057qib7	10726	2	T	t	NN
cord-005453-4057qib7	10726	3	and	and	CC
cord-005453-4057qib7	10726	4	B	b	NN
cord-005453-4057qib7	10726	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	10726	6	pools	pool	NNS
cord-005453-4057qib7	10726	7	are	be	VBP
cord-005453-4057qib7	10726	8	restored	restore	VBN
cord-005453-4057qib7	10726	9	slower	slow	RBR
cord-005453-4057qib7	10726	10	that	that	IN
cord-005453-4057qib7	10726	11	myelomonocytic	myelomonocytic	JJ
cord-005453-4057qib7	10726	12	populations	population	NNS
cord-005453-4057qib7	10726	13	.	.	.
cord-005453-4057qib7	10727	1	HSCT	HSCT	NNP
cord-005453-4057qib7	10727	2	patients	patient	NNS
cord-005453-4057qib7	10727	3	are	be	VBP
cord-005453-4057qib7	10727	4	at	at	IN
cord-005453-4057qib7	10727	5	high	high	JJ
cord-005453-4057qib7	10727	6	risk	risk	NN
cord-005453-4057qib7	10727	7	for	for	IN
cord-005453-4057qib7	10727	8	bacterial	bacterial	JJ
cord-005453-4057qib7	10727	9	and	and	CC
cord-005453-4057qib7	10727	10	viral	viral	JJ
cord-005453-4057qib7	10727	11	infections	infection	NNS
cord-005453-4057qib7	10727	12	at	at	IN
cord-005453-4057qib7	10727	13	early	early	JJ
cord-005453-4057qib7	10727	14	terms	term	NNS
cord-005453-4057qib7	10727	15	(	(	-LRB-
cord-005453-4057qib7	10727	16	<	<	NNP
cord-005453-4057qib7	10727	17	100	100	CD
cord-005453-4057qib7	10727	18	days	day	NNS
cord-005453-4057qib7	10727	19	)	)	-RRB-
cord-005453-4057qib7	10727	20	post	post	JJ
cord-005453-4057qib7	10727	21	-	-	NN
cord-005453-4057qib7	10727	22	transplant	transplant	NN
cord-005453-4057qib7	10727	23	.	.	.
cord-005453-4057qib7	10728	1	The	the	DT
cord-005453-4057qib7	10728	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	10728	3	of	of	IN
cord-005453-4057qib7	10728	4	the	the	DT
cord-005453-4057qib7	10728	5	immune	immune	JJ
cord-005453-4057qib7	10728	6	system	system	NN
cord-005453-4057qib7	10728	7	depends	depend	VBZ
cord-005453-4057qib7	10728	8	on	on	IN
cord-005453-4057qib7	10728	9	the	the	DT
cord-005453-4057qib7	10728	10	time	time	NN
cord-005453-4057qib7	10728	11	required	require	VBN
cord-005453-4057qib7	10728	12	for	for	IN
cord-005453-4057qib7	10728	13	stem	stem	NN
cord-005453-4057qib7	10728	14	cell	cell	NN
cord-005453-4057qib7	10728	15	recruitment	recruitment	NN
cord-005453-4057qib7	10728	16	,	,	,
cord-005453-4057qib7	10728	17	differentiation	differentiation	NN
cord-005453-4057qib7	10728	18	,	,	,
cord-005453-4057qib7	10728	19	expansion	expansion	NN
cord-005453-4057qib7	10728	20	,	,	,
cord-005453-4057qib7	10728	21	maturation	maturation	NN
cord-005453-4057qib7	10728	22	and	and	CC
cord-005453-4057qib7	10728	23	release	release	NN
cord-005453-4057qib7	10728	24	into	into	IN
cord-005453-4057qib7	10728	25	the	the	DT
cord-005453-4057qib7	10728	26	bloodstream	bloodstream	NN
cord-005453-4057qib7	10728	27	.	.	.
cord-005453-4057qib7	10729	1	Restoration	restoration	NN
cord-005453-4057qib7	10729	2	terms	term	NNS
cord-005453-4057qib7	10729	3	for	for	IN
cord-005453-4057qib7	10729	4	myeloid	myeloid	JJ
cord-005453-4057qib7	10729	5	cells	cell	NNS
cord-005453-4057qib7	10729	6	after	after	IN
cord-005453-4057qib7	10729	7	HSCT	HSCT	NNP
cord-005453-4057qib7	10729	8	are	be	VBP
cord-005453-4057qib7	10729	9	usually	usually	RB
cord-005453-4057qib7	10729	10	defined	define	VBN
cord-005453-4057qib7	10729	11	as	as	IN
cord-005453-4057qib7	10729	12	the	the	DT
cord-005453-4057qib7	10729	13	1st	1st	JJ
cord-005453-4057qib7	10729	14	day	day	NN
cord-005453-4057qib7	10729	15	with	with	IN
cord-005453-4057qib7	10729	16	neutrophil	neutrophil	NN
cord-005453-4057qib7	10729	17	count	count	NN
cord-005453-4057qib7	10729	18	of	of	IN
cord-005453-4057qib7	10729	19	≥	≥	CD
cord-005453-4057qib7	10729	20	0.5	0.5	CD
cord-005453-4057qib7	10729	21	x	x	SYM
cord-005453-4057qib7	10729	22	10	10	CD
cord-005453-4057qib7	10729	23	^	^	SYM
cord-005453-4057qib7	10729	24	9	9	CD
cord-005453-4057qib7	10729	25	/	/	SYM
cord-005453-4057qib7	10729	26	L	l	NN
cord-005453-4057qib7	10729	27	with	with	IN
cord-005453-4057qib7	10729	28	mean	mean	JJ
cord-005453-4057qib7	10729	29	recovery	recovery	NN
cord-005453-4057qib7	10729	30	terms	term	NNS
cord-005453-4057qib7	10729	31	of	of	IN
cord-005453-4057qib7	10729	32	12	12	CD
cord-005453-4057qib7	10729	33	to	to	TO
cord-005453-4057qib7	10729	34	20	20	CD
cord-005453-4057qib7	10729	35	days	day	NNS
cord-005453-4057qib7	10729	36	.	.	.
cord-005453-4057qib7	10730	1	High	high	JJ
cord-005453-4057qib7	10730	2	occurrence	occurrence	NN
cord-005453-4057qib7	10730	3	of	of	IN
cord-005453-4057qib7	10730	4	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	10730	5	(	(	-LRB-
cord-005453-4057qib7	10730	6	CMV	CMV	NNP
cord-005453-4057qib7	10730	7	)	)	-RRB-
cord-005453-4057qib7	10730	8	in	in	IN
cord-005453-4057qib7	10730	9	HSCT	HSCT	NNP
cord-005453-4057qib7	10730	10	patients	patient	NNS
cord-005453-4057qib7	10730	11	mostly	mostly	RB
cord-005453-4057qib7	10730	12	result	result	VBP
cord-005453-4057qib7	10730	13	from	from	IN
cord-005453-4057qib7	10730	14	reactivation	reactivation	NN
cord-005453-4057qib7	10730	15	of	of	IN
cord-005453-4057qib7	10730	16	a	a	DT
cord-005453-4057qib7	10730	17	latent	latent	JJ
cord-005453-4057qib7	10730	18	virus	virus	NN
cord-005453-4057qib7	10730	19	acquired	acquire	VBN
cord-005453-4057qib7	10730	20	in	in	IN
cord-005453-4057qib7	10730	21	early	early	JJ
cord-005453-4057qib7	10730	22	childhood	childhood	NN
cord-005453-4057qib7	10730	23	.	.	.
cord-005453-4057qib7	10731	1	However	however	RB
cord-005453-4057qib7	10731	2	,	,	,
cord-005453-4057qib7	10731	3	delayed	delay	VBN
cord-005453-4057qib7	10731	4	immune	immune	JJ
cord-005453-4057qib7	10731	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	10731	6	and	and	CC
cord-005453-4057qib7	10731	7	subsequent	subsequent	JJ
cord-005453-4057qib7	10731	8	infections	infection	NNS
cord-005453-4057qib7	10731	9	such	such	JJ
cord-005453-4057qib7	10731	10	as	as	IN
cord-005453-4057qib7	10731	11	CMV	CMV	NNP
cord-005453-4057qib7	10731	12	,	,	,
cord-005453-4057qib7	10731	13	adenovirus	adenovirus	NN
cord-005453-4057qib7	10731	14	(	(	-LRB-
cord-005453-4057qib7	10731	15	ADV	ADV	NNP
cord-005453-4057qib7	10731	16	)	)	-RRB-
cord-005453-4057qib7	10731	17	or	or	CC
cord-005453-4057qib7	10731	18	Herpes	Herpes	NNP
cord-005453-4057qib7	10731	19	6	6	CD
cord-005453-4057qib7	10732	1	(	(	-LRB-
cord-005453-4057qib7	10732	2	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10732	3	)	)	-RRB-
cord-005453-4057qib7	10732	4	diseases	disease	NNS
cord-005453-4057qib7	10732	5	are	be	VBP
cord-005453-4057qib7	10732	6	not	not	RB
cord-005453-4057qib7	10732	7	unusual	unusual	JJ
cord-005453-4057qib7	10732	8	and	and	CC
cord-005453-4057qib7	10732	9	still	still	RB
cord-005453-4057qib7	10732	10	constitute	constitute	VB
cord-005453-4057qib7	10732	11	a	a	DT
cord-005453-4057qib7	10732	12	major	major	JJ
cord-005453-4057qib7	10732	13	cause	cause	NN
cord-005453-4057qib7	10732	14	of	of	IN
cord-005453-4057qib7	10732	15	death	death	NN
cord-005453-4057qib7	10732	16	in	in	IN
cord-005453-4057qib7	10732	17	Peru	Peru	NNP
cord-005453-4057qib7	10732	18	.	.	.
cord-005453-4057qib7	10733	1	Methods	method	NNS
cord-005453-4057qib7	10733	2	:	:	:
cord-005453-4057qib7	10733	3	Peruvian	peruvian	JJ
cord-005453-4057qib7	10733	4	pediatric	pediatric	JJ
cord-005453-4057qib7	10733	5	patients	patient	NNS
cord-005453-4057qib7	10733	6	(	(	-LRB-
cord-005453-4057qib7	10733	7	n=22	n=22	NNP
cord-005453-4057qib7	10733	8	)	)	-RRB-
cord-005453-4057qib7	10733	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	10733	10	with	with	IN
cord-005453-4057qib7	10733	11	aplastic	aplastic	JJ
cord-005453-4057qib7	10733	12	anemia	anemia	NN
cord-005453-4057qib7	10733	13	,	,	,
cord-005453-4057qib7	10733	14	MDS	MDS	NNP
cord-005453-4057qib7	10733	15	,	,	,
cord-005453-4057qib7	10733	16	AML	AML	NNP
cord-005453-4057qib7	10733	17	or	or	CC
cord-005453-4057qib7	10733	18	ALL	all	DT
cord-005453-4057qib7	10733	19	underwent	undergo	VBD
cord-005453-4057qib7	10733	20	a	a	DT
cord-005453-4057qib7	10733	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10733	22	HSCT	HSCT	NNP
cord-005453-4057qib7	10733	23	performed	perform	VBN
cord-005453-4057qib7	10733	24	with	with	IN
cord-005453-4057qib7	10733	25	the	the	DT
cord-005453-4057qib7	10733	26	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	10733	27	device	device	NN
cord-005453-4057qib7	10733	28	.	.	.
cord-005453-4057qib7	10734	1	Patients	patient	NNS
cord-005453-4057qib7	10734	2	treated	treat	VBN
cord-005453-4057qib7	10734	3	were	be	VBD
cord-005453-4057qib7	10734	4	separated	separate	VBN
cord-005453-4057qib7	10734	5	in	in	IN
cord-005453-4057qib7	10734	6	two	two	CD
cord-005453-4057qib7	10734	7	groups	group	NNS
cord-005453-4057qib7	10734	8	.	.	.
cord-005453-4057qib7	10735	1	The	the	DT
cord-005453-4057qib7	10735	2	group	group	NN
cord-005453-4057qib7	10735	3	of	of	IN
cord-005453-4057qib7	10735	4	patients	patient	NNS
cord-005453-4057qib7	10735	5	who	who	WP
cord-005453-4057qib7	10735	6	received	receive	VBD
cord-005453-4057qib7	10735	7	viral	viral	JJ
cord-005453-4057qib7	10735	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10735	9	(	(	-LRB-
cord-005453-4057qib7	10735	10	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10735	11	)	)	-RRB-
cord-005453-4057qib7	10735	12	was	be	VBD
cord-005453-4057qib7	10735	13	compared	compare	VBN
cord-005453-4057qib7	10735	14	to	to	IN
cord-005453-4057qib7	10735	15	the	the	DT
cord-005453-4057qib7	10735	16	group	group	NN
cord-005453-4057qib7	10735	17	that	that	WDT
cord-005453-4057qib7	10735	18	did	do	VBD
cord-005453-4057qib7	10735	19	not	not	RB
cord-005453-4057qib7	10735	20	receive	receive	VB
cord-005453-4057qib7	10735	21	any	any	DT
cord-005453-4057qib7	10735	22	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10735	23	treatment	treatment	NN
cord-005453-4057qib7	10735	24	.	.	.
cord-005453-4057qib7	10736	1	Viral	viral	JJ
cord-005453-4057qib7	10736	2	reactivation	reactivation	NN
cord-005453-4057qib7	10736	3	was	be	VBD
cord-005453-4057qib7	10736	4	confirmed	confirm	VBN
cord-005453-4057qib7	10736	5	by	by	IN
cord-005453-4057qib7	10736	6	PCR	PCR	NNP
cord-005453-4057qib7	10736	7	test	test	NN
cord-005453-4057qib7	10736	8	twice	twice	PDT
cord-005453-4057qib7	10736	9	a	a	DT
cord-005453-4057qib7	10736	10	week	week	NN
cord-005453-4057qib7	10736	11	and	and	CC
cord-005453-4057qib7	10736	12	clinical	clinical	JJ
cord-005453-4057qib7	10736	13	signs	sign	NNS
cord-005453-4057qib7	10736	14	within	within	IN
cord-005453-4057qib7	10736	15	15	15	CD
cord-005453-4057qib7	10736	16	days	day	NNS
cord-005453-4057qib7	10736	17	after	after	IN
cord-005453-4057qib7	10736	18	HSCT	HSCT	NNP
cord-005453-4057qib7	10736	19	.	.	.
cord-005453-4057qib7	10737	1	Results	result	NNS
cord-005453-4057qib7	10737	2	:	:	:
cord-005453-4057qib7	10738	1	In	in	IN
cord-005453-4057qib7	10738	2	the	the	DT
cord-005453-4057qib7	10738	3	group	group	NN
cord-005453-4057qib7	10738	4	that	that	WDT
cord-005453-4057qib7	10738	5	didn´t	didn´t	NNP
cord-005453-4057qib7	10738	6	received	receive	VBD
cord-005453-4057qib7	10738	7	prophylactic	prophylactic	JJ
cord-005453-4057qib7	10738	8	treatment	treatment	NN
cord-005453-4057qib7	10738	9	,	,	,
cord-005453-4057qib7	10738	10	engraftment	engraftment	NN
cord-005453-4057qib7	10738	11	occurred	occur	VBD
cord-005453-4057qib7	10738	12	close	close	RB
cord-005453-4057qib7	10738	13	to	to	IN
cord-005453-4057qib7	10738	14	day	day	NN
cord-005453-4057qib7	10738	15	10	10	CD
cord-005453-4057qib7	10738	16	post	post	NN
cord-005453-4057qib7	10738	17	haplo	haplo	NN
cord-005453-4057qib7	10738	18	-	-	HYPH
cord-005453-4057qib7	10738	19	HSCT	HSCT	NNP
cord-005453-4057qib7	10738	20	and	and	CC
cord-005453-4057qib7	10738	21	none	none	NN
cord-005453-4057qib7	10738	22	of	of	IN
cord-005453-4057qib7	10738	23	the	the	DT
cord-005453-4057qib7	10738	24	patients	patient	NNS
cord-005453-4057qib7	10738	25	developed	develop	VBD
cord-005453-4057qib7	10738	26	GvHD	GvHD	NNP
cord-005453-4057qib7	10738	27	(	(	-LRB-
cord-005453-4057qib7	10738	28	graft	graft	NN
cord-005453-4057qib7	10738	29	versus	versus	IN
cord-005453-4057qib7	10738	30	host	host	NN
cord-005453-4057qib7	10738	31	disease	disease	NN
cord-005453-4057qib7	10738	32	)	)	-RRB-
cord-005453-4057qib7	10738	33	.	.	.
cord-005453-4057qib7	10739	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	10739	2	,	,	,
cord-005453-4057qib7	10739	3	incidences	incidence	NNS
cord-005453-4057qib7	10739	4	of	of	IN
cord-005453-4057qib7	10739	5	CMV	CMV	NNP
cord-005453-4057qib7	10739	6	,	,	,
cord-005453-4057qib7	10739	7	HHV-6	HHV-6	NNP
cord-005453-4057qib7	10739	8	and	and	CC
cord-005453-4057qib7	10739	9	BKV	BKV	NNP
cord-005453-4057qib7	10739	10	infections	infection	NNS
cord-005453-4057qib7	10739	11	before	before	IN
cord-005453-4057qib7	10739	12	day	day	NN
cord-005453-4057qib7	10740	1	15	15	CD
cord-005453-4057qib7	10740	2	post	post	NN
cord-005453-4057qib7	10740	3	haplo	haplo	NNP
cord-005453-4057qib7	10740	4	-	-	HYPH
cord-005453-4057qib7	10740	5	HSCT	HSCT	NNP
cord-005453-4057qib7	10740	6	were	be	VBD
cord-005453-4057qib7	10740	7	still	still	RB
cord-005453-4057qib7	10740	8	high	high	JJ
cord-005453-4057qib7	10740	9	.	.	.
cord-005453-4057qib7	10741	1	An	an	DT
cord-005453-4057qib7	10741	2	overall	overall	JJ
cord-005453-4057qib7	10741	3	survival	survival	NN
cord-005453-4057qib7	10741	4	(	(	-LRB-
cord-005453-4057qib7	10741	5	OS	OS	NNP
cord-005453-4057qib7	10741	6	)	)	-RRB-
cord-005453-4057qib7	10741	7	over	over	IN
cord-005453-4057qib7	10741	8	65	65	CD
cord-005453-4057qib7	10741	9	%	%	NN
cord-005453-4057qib7	10741	10	with	with	IN
cord-005453-4057qib7	10741	11	an	an	DT
cord-005453-4057qib7	10741	12	IC	IC	NNP
cord-005453-4057qib7	10741	13	95	95	CD
cord-005453-4057qib7	10741	14	%	%	NN
cord-005453-4057qib7	10741	15	was	be	VBD
cord-005453-4057qib7	10741	16	reached	reach	VBN
cord-005453-4057qib7	10741	17	at	at	IN
cord-005453-4057qib7	10741	18	the	the	DT
cord-005453-4057qib7	10741	19	end	end	NN
cord-005453-4057qib7	10741	20	of	of	IN
cord-005453-4057qib7	10741	21	the	the	DT
cord-005453-4057qib7	10741	22	first	first	JJ
cord-005453-4057qib7	10741	23	year	year	NN
cord-005453-4057qib7	10741	24	.	.	.
cord-005453-4057qib7	10742	1	On	on	IN
cord-005453-4057qib7	10742	2	the	the	DT
cord-005453-4057qib7	10742	3	other	other	JJ
cord-005453-4057qib7	10742	4	hand	hand	NN
cord-005453-4057qib7	10742	5	,	,	,
cord-005453-4057qib7	10742	6	the	the	DT
cord-005453-4057qib7	10742	7	group	group	NN
cord-005453-4057qib7	10742	8	of	of	IN
cord-005453-4057qib7	10742	9	patients	patient	NNS
cord-005453-4057qib7	10742	10	that	that	WDT
cord-005453-4057qib7	10742	11	received	receive	VBD
cord-005453-4057qib7	10742	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10742	13	with	with	IN
cord-005453-4057qib7	10742	14	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10742	15	did	do	VBD
cord-005453-4057qib7	10742	16	not	not	RB
cord-005453-4057qib7	10742	17	developed	develop	VBN
cord-005453-4057qib7	10742	18	GvHD	GvHD	NNP
cord-005453-4057qib7	10742	19	and	and	CC
cord-005453-4057qib7	10742	20	reached	reach	VBD
cord-005453-4057qib7	10742	21	the	the	DT
cord-005453-4057qib7	10742	22	engraftment	engraftment	NN
cord-005453-4057qib7	10742	23	close	close	JJ
cord-005453-4057qib7	10742	24	to	to	IN
cord-005453-4057qib7	10742	25	day	day	NN
cord-005453-4057qib7	10742	26	10	10	CD
cord-005453-4057qib7	10742	27	with	with	IN
cord-005453-4057qib7	10742	28	a	a	DT
cord-005453-4057qib7	10742	29	very	very	RB
cord-005453-4057qib7	10742	30	low	low	JJ
cord-005453-4057qib7	10742	31	viremia	viremia	NN
cord-005453-4057qib7	10742	32	incidence	incidence	NN
cord-005453-4057qib7	10742	33	after	after	IN
cord-005453-4057qib7	10742	34	the	the	DT
cord-005453-4057qib7	10742	35	first	first	JJ
cord-005453-4057qib7	10742	36	month	month	NN
cord-005453-4057qib7	10742	37	post	post	NN
cord-005453-4057qib7	10742	38	haplo	haplo	NNP
cord-005453-4057qib7	10742	39	-	-	HYPH
cord-005453-4057qib7	10742	40	HSCT	HSCT	NNP
cord-005453-4057qib7	10742	41	.	.	.
cord-005453-4057qib7	10743	1	All	all	DT
cord-005453-4057qib7	10743	2	viral	viral	JJ
cord-005453-4057qib7	10743	3	reactivations	reactivation	NNS
cord-005453-4057qib7	10743	4	were	be	VBD
cord-005453-4057qib7	10743	5	caused	cause	VBN
cord-005453-4057qib7	10743	6	by	by	IN
cord-005453-4057qib7	10743	7	CMV	CMV	NNP
cord-005453-4057qib7	10743	8	and	and	CC
cord-005453-4057qib7	10743	9	the	the	DT
cord-005453-4057qib7	10743	10	OS	OS	NNP
cord-005453-4057qib7	10743	11	was	be	VBD
cord-005453-4057qib7	10743	12	over	over	IN
cord-005453-4057qib7	10743	13	91	91	CD
cord-005453-4057qib7	10743	14	%	%	NN
cord-005453-4057qib7	10743	15	with	with	IN
cord-005453-4057qib7	10743	16	an	an	DT
cord-005453-4057qib7	10743	17	IC	IC	NNP
cord-005453-4057qib7	10743	18	95	95	CD
cord-005453-4057qib7	10743	19	%	%	NN
cord-005453-4057qib7	10743	20	at	at	IN
cord-005453-4057qib7	10743	21	the	the	DT
cord-005453-4057qib7	10743	22	end	end	NN
cord-005453-4057qib7	10743	23	of	of	IN
cord-005453-4057qib7	10743	24	the	the	DT
cord-005453-4057qib7	10743	25	first	first	JJ
cord-005453-4057qib7	10743	26	year	year	NN
cord-005453-4057qib7	10743	27	.	.	.
cord-005453-4057qib7	10744	1	Previous	previous	JJ
cord-005453-4057qib7	10744	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10744	3	to	to	IN
cord-005453-4057qib7	10744	4	both	both	CC
cord-005453-4057qib7	10744	5	the	the	DT
cord-005453-4057qib7	10744	6	donor	donor	NN
cord-005453-4057qib7	10744	7	and	and	CC
cord-005453-4057qib7	10744	8	the	the	DT
cord-005453-4057qib7	10744	9	receptor	receptor	NN
cord-005453-4057qib7	10744	10	with	with	IN
cord-005453-4057qib7	10744	11	Ganciclovir	Ganciclovir	NNP
cord-005453-4057qib7	10744	12	(	(	-LRB-
cord-005453-4057qib7	10744	13	5mg	5mg	NNP
cord-005453-4057qib7	10744	14	/	/	SYM
cord-005453-4057qib7	10744	15	kg	kg	NN
cord-005453-4057qib7	10744	16	)	)	-RRB-
cord-005453-4057qib7	10744	17	every	every	DT
cord-005453-4057qib7	10744	18	12	12	CD
cord-005453-4057qib7	10744	19	hours	hour	NNS
cord-005453-4057qib7	10744	20	before	before	RB
cord-005453-4057qib7	10744	21	and	and	CC
cord-005453-4057qib7	10744	22	during	during	IN
cord-005453-4057qib7	10744	23	the	the	DT
cord-005453-4057qib7	10744	24	conditioning	conditioning	NN
cord-005453-4057qib7	10744	25	regimen	regimen	NN
cord-005453-4057qib7	10744	26	has	have	VBZ
cord-005453-4057qib7	10744	27	allowed	allow	VBN
cord-005453-4057qib7	10744	28	a	a	DT
cord-005453-4057qib7	10744	29	better	well	JJR
cord-005453-4057qib7	10744	30	control	control	NN
cord-005453-4057qib7	10744	31	of	of	IN
cord-005453-4057qib7	10744	32	viral	viral	JJ
cord-005453-4057qib7	10744	33	reactivation	reactivation	NN
cord-005453-4057qib7	10744	34	.	.	.
cord-005453-4057qib7	10745	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10745	2	:	:	:
cord-005453-4057qib7	10746	1	The	the	DT
cord-005453-4057qib7	10746	2	attempts	attempt	NNS
cord-005453-4057qib7	10746	3	to	to	TO
cord-005453-4057qib7	10746	4	improve	improve	VB
cord-005453-4057qib7	10746	5	immune	immune	JJ
cord-005453-4057qib7	10746	6	function	function	NN
cord-005453-4057qib7	10746	7	and	and	CC
cord-005453-4057qib7	10746	8	reduce	reduce	VB
cord-005453-4057qib7	10746	9	nonrelapse	nonrelapse	JJ
cord-005453-4057qib7	10746	10	mortality	mortality	NN
cord-005453-4057qib7	10746	11	from	from	IN
cord-005453-4057qib7	10746	12	infectious	infectious	JJ
cord-005453-4057qib7	10746	13	complications	complication	NNS
cord-005453-4057qib7	10746	14	without	without	IN
cord-005453-4057qib7	10746	15	increasing	increase	VBG
cord-005453-4057qib7	10746	16	GvHD	GvHD	NNP
cord-005453-4057qib7	10746	17	have	have	VBP
cord-005453-4057qib7	10746	18	focused	focus	VBN
cord-005453-4057qib7	10746	19	on	on	IN
cord-005453-4057qib7	10746	20	a	a	DT
cord-005453-4057qib7	10746	21	partial	partial	JJ
cord-005453-4057qib7	10746	22	T	t	NN
cord-005453-4057qib7	10746	23	cell	cell	NN
cord-005453-4057qib7	10746	24	depleted	deplete	VBN
cord-005453-4057qib7	10746	25	graft	graft	NN
cord-005453-4057qib7	10746	26	,	,	,
cord-005453-4057qib7	10746	27	such	such	JJ
cord-005453-4057qib7	10746	28	as	as	IN
cord-005453-4057qib7	10746	29	T	T	NNP
cord-005453-4057qib7	10746	30	cell	cell	NN
cord-005453-4057qib7	10746	31	depletion	depletion	NN
cord-005453-4057qib7	10746	32	(	(	-LRB-
cord-005453-4057qib7	10746	33	TCR	TCR	NNP
cord-005453-4057qib7	10746	34	α	α	NNP
cord-005453-4057qib7	10746	35	/	/	SYM
cord-005453-4057qib7	10746	36	β	β	NN
cord-005453-4057qib7	10746	37	)	)	-RRB-
cord-005453-4057qib7	10746	38	.	.	.
cord-005453-4057qib7	10747	1	This	this	DT
cord-005453-4057qib7	10747	2	graft	graft	NN
cord-005453-4057qib7	10747	3	retains	retain	VBZ
cord-005453-4057qib7	10747	4	a	a	DT
cord-005453-4057qib7	10747	5	large	large	JJ
cord-005453-4057qib7	10747	6	numbers	number	NNS
cord-005453-4057qib7	10747	7	of	of	IN
cord-005453-4057qib7	10747	8	effector	effector	NN
cord-005453-4057qib7	10747	9	cells	cell	NNS
cord-005453-4057qib7	10747	10	,	,	,
cord-005453-4057qib7	10747	11	such	such	JJ
cord-005453-4057qib7	10747	12	as	as	IN
cord-005453-4057qib7	10747	13	TcR	TcR	NNP
cord-005453-4057qib7	10747	14	γ	γ	NNP
cord-005453-4057qib7	10747	15	/	/	SYM
cord-005453-4057qib7	10747	16	δ	δ	NN
cord-005453-4057qib7	10747	17	and	and	CC
cord-005453-4057qib7	10747	18	natural	natural	JJ
cord-005453-4057qib7	10747	19	killer	killer	NN
cord-005453-4057qib7	10747	20	cells	cell	NNS
cord-005453-4057qib7	10747	21	.	.	.
cord-005453-4057qib7	10748	1	However	however	RB
cord-005453-4057qib7	10748	2	,	,	,
cord-005453-4057qib7	10748	3	delayed	delay	VBN
cord-005453-4057qib7	10748	4	immune	immune	JJ
cord-005453-4057qib7	10748	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	10748	6	and	and	CC
cord-005453-4057qib7	10748	7	subsequent	subsequent	JJ
cord-005453-4057qib7	10748	8	infections	infection	NNS
cord-005453-4057qib7	10748	9	are	be	VBP
cord-005453-4057qib7	10748	10	a	a	DT
cord-005453-4057qib7	10748	11	big	big	JJ
cord-005453-4057qib7	10748	12	issue	issue	NN
cord-005453-4057qib7	10748	13	.	.	.
cord-005453-4057qib7	10749	1	A	a	DT
cord-005453-4057qib7	10749	2	novel	novel	JJ
cord-005453-4057qib7	10749	3	partial	partial	JJ
cord-005453-4057qib7	10749	4	T	t	NN
cord-005453-4057qib7	10749	5	cell	cell	NN
cord-005453-4057qib7	10749	6	depletion	depletion	NN
cord-005453-4057qib7	10749	7	strategy	strategy	NN
cord-005453-4057qib7	10749	8	such	such	JJ
cord-005453-4057qib7	10749	9	as	as	IN
cord-005453-4057qib7	10749	10	depleted	deplete	VBN
cord-005453-4057qib7	10749	11	naïve	naïve	JJ
cord-005453-4057qib7	10749	12	T	t	NN
cord-005453-4057qib7	10749	13	cells	cell	NNS
cord-005453-4057qib7	10749	14	(	(	-LRB-
cord-005453-4057qib7	10749	15	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	10749	16	T	T	NNP
cord-005453-4057qib7	10749	17	cells	cell	NNS
cord-005453-4057qib7	10749	18	)	)	-RRB-
cord-005453-4057qib7	10749	19	could	could	MD
cord-005453-4057qib7	10749	20	enhance	enhance	VB
cord-005453-4057qib7	10749	21	the	the	DT
cord-005453-4057qib7	10749	22	recovery	recovery	NN
cord-005453-4057qib7	10749	23	of	of	IN
cord-005453-4057qib7	10749	24	immune	immune	JJ
cord-005453-4057qib7	10749	25	function	function	NN
cord-005453-4057qib7	10749	26	after	after	IN
cord-005453-4057qib7	10749	27	haplo	haplo	NN
cord-005453-4057qib7	10749	28	-	-	HYPH
cord-005453-4057qib7	10749	29	HSCT	HSCT	NNP
cord-005453-4057qib7	10749	30	because	because	IN
cord-005453-4057qib7	10749	31	donor	donor	NN
cord-005453-4057qib7	10749	32	pathogen	pathogen	NN
cord-005453-4057qib7	10749	33	memory	memory	NN
cord-005453-4057qib7	10749	34	T	T	NNP
cord-005453-4057qib7	10749	35	cells	cell	NNS
cord-005453-4057qib7	10749	36	from	from	IN
cord-005453-4057qib7	10749	37	the	the	DT
cord-005453-4057qib7	10749	38	donor	donor	NN
cord-005453-4057qib7	10749	39	are	be	VBP
cord-005453-4057qib7	10749	40	retained	retain	VBN
cord-005453-4057qib7	10749	41	.	.	.
cord-005453-4057qib7	10750	1	It	-PRON-	PRP
cord-005453-4057qib7	10750	2	is	be	VBZ
cord-005453-4057qib7	10750	3	necessary	necessary	JJ
cord-005453-4057qib7	10750	4	to	to	TO
cord-005453-4057qib7	10750	5	increase	increase	VB
cord-005453-4057qib7	10750	6	the	the	DT
cord-005453-4057qib7	10750	7	studies	study	NNS
cord-005453-4057qib7	10750	8	and	and	CC
cord-005453-4057qib7	10750	9	the	the	DT
cord-005453-4057qib7	10750	10	database	database	NN
cord-005453-4057qib7	10750	11	to	to	TO
cord-005453-4057qib7	10750	12	set	set	VB
cord-005453-4057qib7	10750	13	the	the	DT
cord-005453-4057qib7	10750	14	scheme	scheme	NN
cord-005453-4057qib7	10750	15	of	of	IN
cord-005453-4057qib7	10750	16	previous	previous	JJ
cord-005453-4057qib7	10750	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10750	18	to	to	IN
cord-005453-4057qib7	10750	19	the	the	DT
cord-005453-4057qib7	10750	20	recipient	recipient	NN
cord-005453-4057qib7	10750	21	to	to	TO
cord-005453-4057qib7	10750	22	contain	contain	VB
cord-005453-4057qib7	10750	23	the	the	DT
cord-005453-4057qib7	10750	24	viral	viral	JJ
cord-005453-4057qib7	10750	25	reactivation	reactivation	NN
cord-005453-4057qib7	10750	26	and	and	CC
cord-005453-4057qib7	10750	27	to	to	TO
cord-005453-4057qib7	10750	28	help	help	VB
cord-005453-4057qib7	10750	29	a	a	DT
cord-005453-4057qib7	10750	30	rapid	rapid	JJ
cord-005453-4057qib7	10750	31	immune	immune	JJ
cord-005453-4057qib7	10750	32	reconstitution	reconstitution	NN
cord-005453-4057qib7	10750	33	.	.	.
cord-005453-4057qib7	10751	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10751	2	:	:	:
cord-005453-4057qib7	10751	3	No	no	DT
cord-005453-4057qib7	10751	4	conflict	conflict	NN
cord-005453-4057qib7	10751	5	of	of	IN
cord-005453-4057qib7	10751	6	interest	interest	NN
cord-005453-4057qib7	10751	7	is	be	VBZ
cord-005453-4057qib7	10751	8	declared	declare	VBN
cord-005453-4057qib7	10751	9	Information	Information	NNP
cord-005453-4057qib7	10751	10	was	be	VBD
cord-005453-4057qib7	10751	11	recovered	recover	VBN
cord-005453-4057qib7	10751	12	from	from	IN
cord-005453-4057qib7	10751	13	the	the	DT
cord-005453-4057qib7	10751	14	medical	medical	JJ
cord-005453-4057qib7	10751	15	records	record	NNS
cord-005453-4057qib7	10751	16	.	.	.
cord-005453-4057qib7	10752	1	Results	result	NNS
cord-005453-4057qib7	10752	2	:	:	:
cord-005453-4057qib7	10753	1	Thirty	thirty	CD
cord-005453-4057qib7	10753	2	-	-	HYPH
cord-005453-4057qib7	10753	3	four	four	CD
cord-005453-4057qib7	10753	4	patients	patient	NNS
cord-005453-4057qib7	10753	5	were	be	VBD
cord-005453-4057qib7	10753	6	included	include	VBN
cord-005453-4057qib7	10753	7	,	,	,
cord-005453-4057qib7	10753	8	of	of	IN
cord-005453-4057qib7	10753	9	them	-PRON-	PRP
cord-005453-4057qib7	10753	10	with	with	IN
cord-005453-4057qib7	10753	11	the	the	DT
cord-005453-4057qib7	10753	12	following	follow	VBG
cord-005453-4057qib7	10753	13	diagnoses	diagnosis	NNS
cord-005453-4057qib7	10753	14	:	:	:
cord-005453-4057qib7	10753	15	Acute	acute	JJ
cord-005453-4057qib7	10753	16	leukemia	leukemia	NN
cord-005453-4057qib7	10753	17	(	(	-LRB-
cord-005453-4057qib7	10753	18	27	27	CD
cord-005453-4057qib7	10753	19	)	)	-RRB-
cord-005453-4057qib7	10753	20	,	,	,
cord-005453-4057qib7	10753	21	granulocytic	granulocytic	JJ
cord-005453-4057qib7	10753	22	chronic	chronic	JJ
cord-005453-4057qib7	10753	23	leukemia	leukemia	NN
cord-005453-4057qib7	10753	24	(	(	-LRB-
cord-005453-4057qib7	10753	25	4	4	CD
cord-005453-4057qib7	10753	26	)	)	-RRB-
cord-005453-4057qib7	10753	27	,	,	,
cord-005453-4057qib7	10753	28	dendritic	dendritic	JJ
cord-005453-4057qib7	10753	29	cell	cell	NN
cord-005453-4057qib7	10753	30	neoplasia	neoplasia	NN
cord-005453-4057qib7	10753	31	(	(	-LRB-
cord-005453-4057qib7	10753	32	2	2	CD
cord-005453-4057qib7	10753	33	)	)	-RRB-
cord-005453-4057qib7	10753	34	,	,	,
cord-005453-4057qib7	10753	35	aplastic	aplastic	JJ
cord-005453-4057qib7	10753	36	anemia	anemia	NN
cord-005453-4057qib7	10753	37	(	(	-LRB-
cord-005453-4057qib7	10753	38	1	1	CD
cord-005453-4057qib7	10753	39	)	)	-RRB-
cord-005453-4057qib7	10753	40	.	.	.
cord-005453-4057qib7	10754	1	80	80	CD
cord-005453-4057qib7	10754	2	%	%	NN
cord-005453-4057qib7	10754	3	of	of	IN
cord-005453-4057qib7	10754	4	the	the	DT
cord-005453-4057qib7	10754	5	patients	patient	NNS
cord-005453-4057qib7	10754	6	received	receive	VBD
cord-005453-4057qib7	10754	7	a	a	DT
cord-005453-4057qib7	10754	8	transplant	transplant	NN
cord-005453-4057qib7	10754	9	from	from	IN
cord-005453-4057qib7	10754	10	an	an	DT
cord-005453-4057qib7	10754	11	identical	identical	JJ
cord-005453-4057qib7	10754	12	HLA	HLA	NNP
cord-005453-4057qib7	10754	13	donor	donor	NN
cord-005453-4057qib7	10754	14	and	and	CC
cord-005453-4057qib7	10754	15	20	20	CD
cord-005453-4057qib7	10754	16	%	%	NN
cord-005453-4057qib7	10754	17	received	receive	VBD
cord-005453-4057qib7	10754	18	a	a	DT
cord-005453-4057qib7	10754	19	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10754	20	transplant	transplant	NN
cord-005453-4057qib7	10754	21	.	.	.
cord-005453-4057qib7	10755	1	Mean	mean	JJ
cord-005453-4057qib7	10755	2	age	age	NN
cord-005453-4057qib7	10755	3	's	's	POS
cord-005453-4057qib7	10755	4	patients	patient	NNS
cord-005453-4057qib7	10755	5	was	be	VBD
cord-005453-4057qib7	10755	6	32	32	CD
cord-005453-4057qib7	10755	7	years	year	NNS
cord-005453-4057qib7	10755	8	(	(	-LRB-
cord-005453-4057qib7	10755	9	19	19	CD
cord-005453-4057qib7	10755	10	-	-	SYM
cord-005453-4057qib7	10755	11	57	57	CD
cord-005453-4057qib7	10755	12	)	)	-RRB-
cord-005453-4057qib7	10755	13	.	.	.
cord-005453-4057qib7	10756	1	Prophylaxis	Prophylaxis	NNP
cord-005453-4057qib7	10756	2	with	with	IN
cord-005453-4057qib7	10756	3	Posaconazole	Posaconazole	NNP
cord-005453-4057qib7	10756	4	was	be	VBD
cord-005453-4057qib7	10756	5	performed	perform	VBN
cord-005453-4057qib7	10756	6	on	on	IN
cord-005453-4057qib7	10756	7	44	44	CD
cord-005453-4057qib7	10756	8	%	%	NN
cord-005453-4057qib7	10756	9	of	of	IN
cord-005453-4057qib7	10756	10	the	the	DT
cord-005453-4057qib7	10756	11	patients	patient	NNS
cord-005453-4057qib7	10756	12	with	with	IN
cord-005453-4057qib7	10756	13	identical	identical	JJ
cord-005453-4057qib7	10756	14	HLA	HLA	NNP
cord-005453-4057qib7	10756	15	and	and	CC
cord-005453-4057qib7	10756	16	86	86	CD
cord-005453-4057qib7	10756	17	%	%	NN
cord-005453-4057qib7	10756	18	on	on	IN
cord-005453-4057qib7	10756	19	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10756	20	group	group	NN
cord-005453-4057qib7	10756	21	;	;	:
cord-005453-4057qib7	10756	22	the	the	DT
cord-005453-4057qib7	10756	23	rest	rest	NN
cord-005453-4057qib7	10756	24	of	of	IN
cord-005453-4057qib7	10756	25	the	the	DT
cord-005453-4057qib7	10756	26	patients	patient	NNS
cord-005453-4057qib7	10756	27	received	receive	VBD
cord-005453-4057qib7	10756	28	Fluconazole	Fluconazole	NNP
cord-005453-4057qib7	10756	29	.	.	.
cord-005453-4057qib7	10757	1	The	the	DT
cord-005453-4057qib7	10757	2	posaconazole	posaconazole	NN
cord-005453-4057qib7	10757	3	group	group	NN
cord-005453-4057qib7	10757	4	presented	present	VBD
cord-005453-4057qib7	10757	5	:	:	:
cord-005453-4057qib7	10757	6	Fever	fever	NN
cord-005453-4057qib7	10757	7	61	61	CD
cord-005453-4057qib7	10757	8	%	%	NN
cord-005453-4057qib7	10757	9	,	,	,
cord-005453-4057qib7	10757	10	mucositis	mucositis	NNP
cord-005453-4057qib7	10757	11	GI	GI	NNP
cord-005453-4057qib7	10757	12	-	-	HYPH
cord-005453-4057qib7	10757	13	II	II	NNP
cord-005453-4057qib7	10757	14	94	94	CD
cord-005453-4057qib7	10757	15	%	%	NN
cord-005453-4057qib7	10757	16	,	,	,
cord-005453-4057qib7	10757	17	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	10757	18	toxicity	toxicity	NN
cord-005453-4057qib7	10757	19	GI	GI	NNP
cord-005453-4057qib7	10757	20	-	-	HYPH
cord-005453-4057qib7	10757	21	II	II	NNP
cord-005453-4057qib7	10757	22	67	67	CD
cord-005453-4057qib7	10757	23	%	%	NN
cord-005453-4057qib7	10757	24	(	(	-LRB-
cord-005453-4057qib7	10757	25	p=	p=	NNP
cord-005453-4057qib7	10757	26	0.006	0.006	CD
cord-005453-4057qib7	10757	27	)	)	-RRB-
cord-005453-4057qib7	10757	28	,	,	,
cord-005453-4057qib7	10757	29	hepatic	hepatic	JJ
cord-005453-4057qib7	10757	30	toxicity	toxicity	NN
cord-005453-4057qib7	10757	31	11	11	CD
cord-005453-4057qib7	10757	32	%	%	NN
cord-005453-4057qib7	10757	33	,	,	,
cord-005453-4057qib7	10757	34	kidney	kidney	NN
cord-005453-4057qib7	10757	35	toxicity	toxicity	NN
cord-005453-4057qib7	10757	36	17	17	CD
cord-005453-4057qib7	10757	37	%	%	NN
cord-005453-4057qib7	10757	38	,	,	,
cord-005453-4057qib7	10757	39	oral	oral	JJ
cord-005453-4057qib7	10757	40	candidiasis	candidiasis	NN
cord-005453-4057qib7	10757	41	100	100	CD
cord-005453-4057qib7	10757	42	%	%	NN
cord-005453-4057qib7	10757	43	.	.	.
cord-005453-4057qib7	10758	1	During	during	IN
cord-005453-4057qib7	10758	2	this	this	DT
cord-005453-4057qib7	10758	3	period	period	NN
cord-005453-4057qib7	10758	4	none	none	NN
cord-005453-4057qib7	10758	5	of	of	IN
cord-005453-4057qib7	10758	6	the	the	DT
cord-005453-4057qib7	10758	7	patients	patient	NNS
cord-005453-4057qib7	10758	8	presented	present	VBD
cord-005453-4057qib7	10758	9	invasive	invasive	JJ
cord-005453-4057qib7	10758	10	fungal	fungal	JJ
cord-005453-4057qib7	10758	11	infection	infection	NN
cord-005453-4057qib7	10758	12	in	in	IN
cord-005453-4057qib7	10758	13	any	any	DT
cord-005453-4057qib7	10758	14	group	group	NN
cord-005453-4057qib7	10758	15	.	.	.
cord-005453-4057qib7	10759	1	There	there	EX
cord-005453-4057qib7	10759	2	were	be	VBD
cord-005453-4057qib7	10759	3	2	2	CD
cord-005453-4057qib7	10759	4	deceases	decease	NNS
cord-005453-4057qib7	10759	5	,	,	,
cord-005453-4057qib7	10759	6	one	one	CD
cord-005453-4057qib7	10759	7	on	on	IN
cord-005453-4057qib7	10759	8	each	each	DT
cord-005453-4057qib7	10759	9	group	group	NN
cord-005453-4057qib7	10759	10	and	and	CC
cord-005453-4057qib7	10759	11	none	none	NN
cord-005453-4057qib7	10759	12	related	relate	VBN
cord-005453-4057qib7	10759	13	to	to	IN
cord-005453-4057qib7	10759	14	a	a	DT
cord-005453-4057qib7	10759	15	fungal	fungal	JJ
cord-005453-4057qib7	10759	16	infection	infection	NN
cord-005453-4057qib7	10759	17	.	.	.
cord-005453-4057qib7	10760	1	The	the	DT
cord-005453-4057qib7	10760	2	overall	overall	JJ
cord-005453-4057qib7	10760	3	survival	survival	NN
cord-005453-4057qib7	10760	4	was	be	VBD
cord-005453-4057qib7	10760	5	of	of	IN
cord-005453-4057qib7	10760	6	the	the	DT
cord-005453-4057qib7	10760	7	92	92	CD
cord-005453-4057qib7	10760	8	%	%	NN
cord-005453-4057qib7	10760	9	versus	versus	IN
cord-005453-4057qib7	10760	10	93	93	CD
cord-005453-4057qib7	10760	11	%	%	NN
cord-005453-4057qib7	10760	12	on	on	IN
cord-005453-4057qib7	10760	13	the	the	DT
cord-005453-4057qib7	10760	14	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10760	15	group	group	NN
cord-005453-4057qib7	10760	16	and	and	CC
cord-005453-4057qib7	10760	17	the	the	DT
cord-005453-4057qib7	10760	18	fluconazole	fluconazole	NNP
cord-005453-4057qib7	10760	19	group	group	NN
cord-005453-4057qib7	10760	20	respectively	respectively	RB
cord-005453-4057qib7	10760	21	.	.	.
cord-005453-4057qib7	10761	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10761	2	:	:	:
cord-005453-4057qib7	10762	1	The	the	DT
cord-005453-4057qib7	10762	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10762	3	with	with	IN
cord-005453-4057qib7	10762	4	posaconazole	posaconazole	NNP
cord-005453-4057qib7	10762	5	and	and	CC
cord-005453-4057qib7	10762	6	fluconazole	fluconazole	NNP
cord-005453-4057qib7	10762	7	is	be	VBZ
cord-005453-4057qib7	10762	8	effective	effective	JJ
cord-005453-4057qib7	10762	9	on	on	IN
cord-005453-4057qib7	10762	10	the	the	DT
cord-005453-4057qib7	10762	11	prevention	prevention	NN
cord-005453-4057qib7	10762	12	of	of	IN
cord-005453-4057qib7	10762	13	invasive	invasive	JJ
cord-005453-4057qib7	10762	14	fungal	fungal	JJ
cord-005453-4057qib7	10762	15	infection	infection	NN
cord-005453-4057qib7	10762	16	on	on	IN
cord-005453-4057qib7	10762	17	the	the	DT
cord-005453-4057qib7	10762	18	first	first	JJ
cord-005453-4057qib7	10762	19	100	100	CD
cord-005453-4057qib7	10762	20	days	day	NNS
cord-005453-4057qib7	10762	21	.	.	.
cord-005453-4057qib7	10763	1	The	the	DT
cord-005453-4057qib7	10763	2	toxicity	toxicity	NN
cord-005453-4057qib7	10763	3	was	be	VBD
cord-005453-4057qib7	10763	4	similar	similar	JJ
cord-005453-4057qib7	10763	5	on	on	IN
cord-005453-4057qib7	10763	6	both	both	DT
cord-005453-4057qib7	10763	7	groups	group	NNS
cord-005453-4057qib7	10763	8	.	.	.
cord-005453-4057qib7	10764	1	Posaconazole	Posaconazole	NNP
cord-005453-4057qib7	10764	2	can	can	MD
cord-005453-4057qib7	10764	3	be	be	VB
cord-005453-4057qib7	10764	4	effective	effective	JJ
cord-005453-4057qib7	10764	5	on	on	IN
cord-005453-4057qib7	10764	6	the	the	DT
cord-005453-4057qib7	10764	7	prevention	prevention	NN
cord-005453-4057qib7	10764	8	of	of	IN
cord-005453-4057qib7	10764	9	the	the	DT
cord-005453-4057qib7	10764	10	haploidentical	haploidentical	JJ
cord-005453-4057qib7	10764	11	type	type	NN
cord-005453-4057qib7	10764	12	.	.	.
cord-005453-4057qib7	10765	1	Is	be	VBZ
cord-005453-4057qib7	10765	2	necessary	necessary	JJ
cord-005453-4057qib7	10765	3	to	to	TO
cord-005453-4057qib7	10765	4	continue	continue	VB
cord-005453-4057qib7	10765	5	following	follow	VBG
cord-005453-4057qib7	10765	6	the	the	DT
cord-005453-4057qib7	10765	7	patients	patient	NNS
cord-005453-4057qib7	10765	8	with	with	IN
cord-005453-4057qib7	10765	9	infection	infection	NN
cord-005453-4057qib7	10765	10	risk	risk	NN
cord-005453-4057qib7	10765	11	on	on	IN
cord-005453-4057qib7	10765	12	a	a	DT
cord-005453-4057qib7	10765	13	long	long	JJ
cord-005453-4057qib7	10765	14	-	-	HYPH
cord-005453-4057qib7	10765	15	term	term	NN
cord-005453-4057qib7	10765	16	period	period	NN
cord-005453-4057qib7	10765	17	associated	associate	VBN
cord-005453-4057qib7	10765	18	with	with	IN
cord-005453-4057qib7	10765	19	the	the	DT
cord-005453-4057qib7	10765	20	chronic	chronic	JJ
cord-005453-4057qib7	10765	21	GVHD	GVHD	NNP
cord-005453-4057qib7	10765	22	.	.	.
cord-005453-4057qib7	10766	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10766	2	:	:	:
cord-005453-4057qib7	10767	1	None	none	NN
cord-005453-4057qib7	10767	2	declared	declare	VBD
cord-005453-4057qib7	10767	3	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	10768	1	These	these	DT
cord-005453-4057qib7	10768	2	results	result	NNS
cord-005453-4057qib7	10768	3	open	open	VBP
cord-005453-4057qib7	10768	4	the	the	DT
cord-005453-4057qib7	10768	5	question	question	NN
cord-005453-4057qib7	10768	6	whether	whether	IN
cord-005453-4057qib7	10768	7	allo	allo	NN
cord-005453-4057qib7	10768	8	-	-	HYPH
cord-005453-4057qib7	10768	9	SCT	SCT	NNP
cord-005453-4057qib7	10768	10	should	should	MD
cord-005453-4057qib7	10768	11	still	still	RB
cord-005453-4057qib7	10768	12	be	be	VB
cord-005453-4057qib7	10768	13	offered	offer	VBN
cord-005453-4057qib7	10768	14	to	to	IN
cord-005453-4057qib7	10768	15	these	these	DT
cord-005453-4057qib7	10768	16	patients	patient	NNS
cord-005453-4057qib7	10768	17	.	.	.
cord-005453-4057qib7	10769	1	Methods	method	NNS
cord-005453-4057qib7	10769	2	:	:	:
cord-005453-4057qib7	10769	3	We	-PRON-	PRP
cord-005453-4057qib7	10769	4	aimed	aim	VBD
cord-005453-4057qib7	10769	5	to	to	TO
cord-005453-4057qib7	10769	6	define	define	VB
cord-005453-4057qib7	10769	7	the	the	DT
cord-005453-4057qib7	10769	8	role	role	NN
cord-005453-4057qib7	10769	9	of	of	IN
cord-005453-4057qib7	10769	10	allo	allo	NNP
cord-005453-4057qib7	10769	11	-	-	HYPH
cord-005453-4057qib7	10769	12	SCT	SCT	NNP
cord-005453-4057qib7	10769	13	in	in	IN
cord-005453-4057qib7	10769	14	refractory	refractory	JJ
cord-005453-4057qib7	10769	15	or	or	CC
cord-005453-4057qib7	10769	16	relapsing	relapse	VBG
cord-005453-4057qib7	10769	17	after	after	IN
cord-005453-4057qib7	10769	18	two	two	CD
cord-005453-4057qib7	10769	19	lines	line	NNS
cord-005453-4057qib7	10769	20	de	de	IN
cord-005453-4057qib7	10769	21	novo	novo	NNP
cord-005453-4057qib7	10769	22	or	or	CC
cord-005453-4057qib7	10769	23	transformed	transform	VBN
cord-005453-4057qib7	10769	24	DLBCL	DLBCL	NNP
cord-005453-4057qib7	10769	25	patients	patient	NNS
cord-005453-4057qib7	10769	26	,	,	,
cord-005453-4057qib7	10769	27	and	and	CC
cord-005453-4057qib7	10769	28	its	-PRON-	PRP$
cord-005453-4057qib7	10769	29	comparison	comparison	NN
cord-005453-4057qib7	10769	30	with	with	IN
cord-005453-4057qib7	10769	31	ZUMA-1	ZUMA-1	NNP
cord-005453-4057qib7	10769	32	CAR	CAR	NNP
cord-005453-4057qib7	10769	33	-	-	HYPH
cord-005453-4057qib7	10769	34	T	t	NN
cord-005453-4057qib7	10769	35	cells	cell	NNS
cord-005453-4057qib7	10769	36	trial	trial	NN
cord-005453-4057qib7	10769	37	(	(	-LRB-
cord-005453-4057qib7	10769	38	Neelapu	Neelapu	NNP
cord-005453-4057qib7	10769	39	et	et	NNP
cord-005453-4057qib7	10769	40	al	al	NNP
cord-005453-4057qib7	10769	41	NEJM	NEJM	NNP
cord-005453-4057qib7	10769	42	2017	2017	CD
cord-005453-4057qib7	10769	43	)	)	-RRB-
cord-005453-4057qib7	10769	44	.	.	.
cord-005453-4057qib7	10770	1	We	-PRON-	PRP
cord-005453-4057qib7	10770	2	analyse	analyse	VBP
cord-005453-4057qib7	10770	3	long	long	JJ
cord-005453-4057qib7	10770	4	-	-	HYPH
cord-005453-4057qib7	10770	5	term	term	NN
cord-005453-4057qib7	10770	6	allo	allo	NN
cord-005453-4057qib7	10770	7	-	-	HYPH
cord-005453-4057qib7	10770	8	SCT	SCT	NNP
cord-005453-4057qib7	10770	9	results	result	NNS
cord-005453-4057qib7	10770	10	in	in	IN
cord-005453-4057qib7	10770	11	40	40	CD
cord-005453-4057qib7	10770	12	de	de	NNP
cord-005453-4057qib7	10770	13	novo	novo	NNP
cord-005453-4057qib7	10770	14	(	(	-LRB-
cord-005453-4057qib7	10770	15	n=23	n=23	NNP
cord-005453-4057qib7	10770	16	)	)	-RRB-
cord-005453-4057qib7	10770	17	or	or	CC
cord-005453-4057qib7	10770	18	transformed	transform	VBN
cord-005453-4057qib7	10770	19	DLBCL	DLBCL	NNP
cord-005453-4057qib7	10770	20	(	(	-LRB-
cord-005453-4057qib7	10770	21	n=17	n=17	NNP
cord-005453-4057qib7	10770	22	)	)	-RRB-
cord-005453-4057qib7	10770	23	out	out	IN
cord-005453-4057qib7	10770	24	of	of	IN
cord-005453-4057qib7	10770	25	the	the	DT
cord-005453-4057qib7	10770	26	1000	1000	CD
cord-005453-4057qib7	10770	27	allo	allo	NN
cord-005453-4057qib7	10770	28	-	-	HYPH
cord-005453-4057qib7	10770	29	SCT	SCT	NNP
cord-005453-4057qib7	10770	30	performed	perform	VBN
cord-005453-4057qib7	10770	31	in	in	IN
cord-005453-4057qib7	10770	32	our	-PRON-	PRP$
cord-005453-4057qib7	10770	33	institution	institution	NN
cord-005453-4057qib7	10770	34	between	between	IN
cord-005453-4057qib7	10770	35	October	October	NNP
cord-005453-4057qib7	10770	36	1995	1995	CD
cord-005453-4057qib7	10770	37	to	to	IN
cord-005453-4057qib7	10770	38	October	October	NNP
cord-005453-4057qib7	10770	39	2018	2018	CD
cord-005453-4057qib7	10770	40	.	.	.
cord-005453-4057qib7	10771	1	Results	result	NNS
cord-005453-4057qib7	10771	2	:	:	:
cord-005453-4057qib7	10772	1	Patients	patient	NNS
cord-005453-4057qib7	10772	2	and	and	CC
cord-005453-4057qib7	10772	3	transplant	transplant	NN
cord-005453-4057qib7	10772	4	characteristics	characteristic	NNS
cord-005453-4057qib7	10772	5	are	be	VBP
cord-005453-4057qib7	10772	6	summarized	summarize	VBN
cord-005453-4057qib7	10772	7	in	in	IN
cord-005453-4057qib7	10772	8	Table	Table	NNP
cord-005453-4057qib7	10772	9	1	1	CD
cord-005453-4057qib7	10772	10	.	.	.
cord-005453-4057qib7	10773	1	Complete	complete	JJ
cord-005453-4057qib7	10773	2	response	response	NN
cord-005453-4057qib7	10773	3	(	(	-LRB-
cord-005453-4057qib7	10773	4	CR	cr	NN
cord-005453-4057qib7	10773	5	)	)	-RRB-
cord-005453-4057qib7	10773	6	at	at	IN
cord-005453-4057qib7	10773	7	100	100	CD
cord-005453-4057qib7	10773	8	days	day	NNS
cord-005453-4057qib7	10773	9	was	be	VBD
cord-005453-4057qib7	10773	10	67,5	67,5	CD
cord-005453-4057qib7	10773	11	%	%	NN
cord-005453-4057qib7	10773	12	and	and	CC
cord-005453-4057qib7	10773	13	83	83	CD
cord-005453-4057qib7	10773	14	%	%	NN
cord-005453-4057qib7	10773	15	of	of	IN
cord-005453-4057qib7	10773	16	them	-PRON-	PRP
cord-005453-4057qib7	10773	17	remain	remain	VBP
cord-005453-4057qib7	10773	18	in	in	IN
cord-005453-4057qib7	10773	19	CR	CR	NNP
cord-005453-4057qib7	10773	20	at	at	IN
cord-005453-4057qib7	10773	21	12	12	CD
cord-005453-4057qib7	10773	22	months	month	NNS
cord-005453-4057qib7	10773	23	.	.	.
cord-005453-4057qib7	10774	1	With	with	IN
cord-005453-4057qib7	10774	2	a	a	DT
cord-005453-4057qib7	10774	3	median	median	JJ
cord-005453-4057qib7	10774	4	follow	follow	NN
cord-005453-4057qib7	10774	5	-	-	HYPH
cord-005453-4057qib7	10774	6	up	up	NN
cord-005453-4057qib7	10774	7	of	of	IN
cord-005453-4057qib7	10774	8	46	46	CD
cord-005453-4057qib7	10774	9	months	month	NNS
cord-005453-4057qib7	10774	10	,	,	,
cord-005453-4057qib7	10774	11	5-year	5-year	CD
cord-005453-4057qib7	10774	12	progression	progression	NN
cord-005453-4057qib7	10774	13	-	-	HYPH
cord-005453-4057qib7	10774	14	free	free	JJ
cord-005453-4057qib7	10774	15	survival	survival	NN
cord-005453-4057qib7	10774	16	(	(	-LRB-
cord-005453-4057qib7	10774	17	PFS	PFS	NNP
cord-005453-4057qib7	10774	18	)	)	-RRB-
cord-005453-4057qib7	10774	19	was	be	VBD
cord-005453-4057qib7	10774	20	54	54	CD
cord-005453-4057qib7	10774	21	%	%	NN
cord-005453-4057qib7	10774	22	and	and	CC
cord-005453-4057qib7	10774	23	5-year	5-year	CD
cord-005453-4057qib7	10774	24	overall	overall	JJ
cord-005453-4057qib7	10774	25	survival	survival	NN
cord-005453-4057qib7	10774	26	(	(	-LRB-
cord-005453-4057qib7	10774	27	OS	OS	NNP
cord-005453-4057qib7	10774	28	)	)	-RRB-
cord-005453-4057qib7	10774	29	48	48	CD
cord-005453-4057qib7	10774	30	%	%	NN
cord-005453-4057qib7	10774	31	,	,	,
cord-005453-4057qib7	10774	32	with	with	IN
cord-005453-4057qib7	10774	33	a	a	DT
cord-005453-4057qib7	10774	34	3-year	3-year	CD
cord-005453-4057qib7	10774	35	transplant	transplant	NN
cord-005453-4057qib7	10774	36	-	-	HYPH
cord-005453-4057qib7	10774	37	related	relate	VBN
cord-005453-4057qib7	10774	38	mortality	mortality	NN
cord-005453-4057qib7	10774	39	of	of	IN
cord-005453-4057qib7	10774	40	18	18	CD
cord-005453-4057qib7	10774	41	%	%	NN
cord-005453-4057qib7	10774	42	.	.	.
cord-005453-4057qib7	10775	1	Refractoriness	Refractoriness	NNP
cord-005453-4057qib7	10775	2	at	at	IN
cord-005453-4057qib7	10775	3	the	the	DT
cord-005453-4057qib7	10775	4	time	time	NN
cord-005453-4057qib7	10775	5	of	of	IN
cord-005453-4057qib7	10775	6	the	the	DT
cord-005453-4057qib7	10775	7	transplant	transplant	NN
cord-005453-4057qib7	10775	8	was	be	VBD
cord-005453-4057qib7	10775	9	associated	associate	VBN
cord-005453-4057qib7	10775	10	with	with	IN
cord-005453-4057qib7	10775	11	a	a	DT
cord-005453-4057qib7	10775	12	poorer	poor	JJR
cord-005453-4057qib7	10775	13	prognosis	prognosis	NN
cord-005453-4057qib7	10775	14	,	,	,
cord-005453-4057qib7	10775	15	with	with	IN
cord-005453-4057qib7	10775	16	only	only	RB
cord-005453-4057qib7	10775	17	2	2	CD
cord-005453-4057qib7	10775	18	out	out	IN
cord-005453-4057qib7	10775	19	of	of	IN
cord-005453-4057qib7	10775	20	9	9	CD
cord-005453-4057qib7	10775	21	refractory	refractory	JJ
cord-005453-4057qib7	10775	22	patients	patient	NNS
cord-005453-4057qib7	10775	23	being	be	VBG
cord-005453-4057qib7	10775	24	long	long	JJ
cord-005453-4057qib7	10775	25	term	term	NN
cord-005453-4057qib7	10775	26	survivors	survivor	NNS
cord-005453-4057qib7	10775	27	(	(	-LRB-
cord-005453-4057qib7	10775	28	Figure	figure	NN
cord-005453-4057qib7	10775	29	1	1	CD
cord-005453-4057qib7	10775	30	)	)	-RRB-
cord-005453-4057qib7	10775	31	.	.	.
cord-005453-4057qib7	10776	1	Similar	similar	JJ
cord-005453-4057qib7	10776	2	results	result	NNS
cord-005453-4057qib7	10776	3	were	be	VBD
cord-005453-4057qib7	10776	4	reported	report	VBN
cord-005453-4057qib7	10776	5	for	for	IN
cord-005453-4057qib7	10776	6	ZUMA-1	zuma-1	CD
cord-005453-4057qib7	10776	7	trial	trial	NN
cord-005453-4057qib7	10776	8	,	,	,
cord-005453-4057qib7	10776	9	with	with	IN
cord-005453-4057qib7	10776	10	a	a	DT
cord-005453-4057qib7	10776	11	best	good	JJS
cord-005453-4057qib7	10776	12	response	response	NN
cord-005453-4057qib7	10776	13	of	of	IN
cord-005453-4057qib7	10776	14	55	55	CD
cord-005453-4057qib7	10776	15	%	%	NN
cord-005453-4057qib7	10776	16	CR	cr	NN
cord-005453-4057qib7	10776	17	retained	retain	VBN
cord-005453-4057qib7	10776	18	in	in	IN
cord-005453-4057qib7	10776	19	79	79	CD
cord-005453-4057qib7	10776	20	%	%	NN
cord-005453-4057qib7	10776	21	of	of	IN
cord-005453-4057qib7	10776	22	them	-PRON-	PRP
cord-005453-4057qib7	10776	23	at	at	IN
cord-005453-4057qib7	10776	24	12	12	CD
cord-005453-4057qib7	10776	25	months	month	NNS
cord-005453-4057qib7	10776	26	.	.	.
cord-005453-4057qib7	10777	1	With	with	IN
cord-005453-4057qib7	10777	2	a	a	DT
cord-005453-4057qib7	10777	3	median	median	JJ
cord-005453-4057qib7	10777	4	follow	follow	NN
cord-005453-4057qib7	10777	5	-	-	HYPH
cord-005453-4057qib7	10777	6	up	up	NN
cord-005453-4057qib7	10777	7	of	of	IN
cord-005453-4057qib7	10777	8	15	15	CD
cord-005453-4057qib7	10777	9	months	month	NNS
cord-005453-4057qib7	10777	10	,	,	,
cord-005453-4057qib7	10777	11	18-months	18-months	CD
cord-005453-4057qib7	10777	12	PFS	PFS	NNP
cord-005453-4057qib7	10777	13	was	be	VBD
cord-005453-4057qib7	10777	14	41	41	CD
cord-005453-4057qib7	10777	15	%	%	NN
cord-005453-4057qib7	10777	16	and	and	CC
cord-005453-4057qib7	10777	17	18-months	18-months	CD
cord-005453-4057qib7	10777	18	OS	OS	NNP
cord-005453-4057qib7	10777	19	53	53	CD
cord-005453-4057qib7	10777	20	%	%	NN
cord-005453-4057qib7	10777	21	.	.	.
cord-005453-4057qib7	10778	1	Patients	patient	NNS
cord-005453-4057qib7	10778	2	characteristics	characteristic	NNS
cord-005453-4057qib7	10778	3	did	do	VBD
cord-005453-4057qib7	10778	4	not	not	RB
cord-005453-4057qib7	10778	5	differ	differ	VB
cord-005453-4057qib7	10778	6	in	in	IN
cord-005453-4057qib7	10778	7	our	-PRON-	PRP$
cord-005453-4057qib7	10778	8	series	series	NN
cord-005453-4057qib7	10778	9	and	and	CC
cord-005453-4057qib7	10778	10	ZUMA-1	ZUMA-1	NNP
cord-005453-4057qib7	10778	11	,	,	,
cord-005453-4057qib7	10778	12	except	except	IN
cord-005453-4057qib7	10778	13	that	that	IN
cord-005453-4057qib7	10778	14	all	all	PDT
cord-005453-4057qib7	10778	15	the	the	DT
cord-005453-4057qib7	10778	16	patients	patient	NNS
cord-005453-4057qib7	10778	17	in	in	IN
cord-005453-4057qib7	10778	18	ZUMA-1	ZUMA-1	NNP
cord-005453-4057qib7	10778	19	were	be	VBD
cord-005453-4057qib7	10778	20	refractory	refractory	JJ
cord-005453-4057qib7	10778	21	prior	prior	RB
cord-005453-4057qib7	10778	22	to	to	IN
cord-005453-4057qib7	10778	23	therapy	therapy	NN
cord-005453-4057qib7	10778	24	(	(	-LRB-
cord-005453-4057qib7	10778	25	Table	table	NN
cord-005453-4057qib7	10778	26	1	1	CD
cord-005453-4057qib7	10778	27	)	)	-RRB-
cord-005453-4057qib7	10778	28	.	.	.
cord-005453-4057qib7	10779	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10779	2	:	:	:
cord-005453-4057qib7	10780	1	Although	although	IN
cord-005453-4057qib7	10780	2	very	very	RB
cord-005453-4057qib7	10780	3	few	few	JJ
cord-005453-4057qib7	10780	4	patients	patient	NNS
cord-005453-4057qib7	10780	5	with	with	IN
cord-005453-4057qib7	10780	6	de	de	NNP
cord-005453-4057qib7	10780	7	novo	novo	NNP
cord-005453-4057qib7	10780	8	or	or	CC
cord-005453-4057qib7	10780	9	transformed	transform	VBN
cord-005453-4057qib7	10780	10	DLBCL	DLBCL	NNS
cord-005453-4057qib7	10780	11	are	be	VBP
cord-005453-4057qib7	10780	12	offering	offer	VBG
cord-005453-4057qib7	10780	13	an	an	DT
cord-005453-4057qib7	10780	14	allo	allo	NN
cord-005453-4057qib7	10780	15	-	-	HYPH
cord-005453-4057qib7	10780	16	SCT	sct	NN
cord-005453-4057qib7	10780	17	(	(	-LRB-
cord-005453-4057qib7	10780	18	4	4	CD
cord-005453-4057qib7	10780	19	%	%	NN
cord-005453-4057qib7	10780	20	of	of	IN
cord-005453-4057qib7	10780	21	all	all	DT
cord-005453-4057qib7	10780	22	allo	allo	NN
cord-005453-4057qib7	10780	23	-	-	HYPH
cord-005453-4057qib7	10780	24	SCT	SCT	NNP
cord-005453-4057qib7	10780	25	)	)	-RRB-
cord-005453-4057qib7	10780	26	,	,	,
cord-005453-4057qib7	10780	27	this	this	DT
cord-005453-4057qib7	10780	28	is	be	VBZ
cord-005453-4057qib7	10780	29	a	a	DT
cord-005453-4057qib7	10780	30	curative	curative	JJ
cord-005453-4057qib7	10780	31	option	option	NN
cord-005453-4057qib7	10780	32	in	in	IN
cord-005453-4057qib7	10780	33	chemosensitive	chemosensitive	JJ
cord-005453-4057qib7	10780	34	patients	patient	NNS
cord-005453-4057qib7	10780	35	and	and	CC
cord-005453-4057qib7	10780	36	with	with	IN
cord-005453-4057qib7	10780	37	more	more	RBR
cord-005453-4057qib7	10780	38	mature	mature	JJ
cord-005453-4057qib7	10780	39	data	datum	NNS
cord-005453-4057qib7	10780	40	and	and	CC
cord-005453-4057qib7	10780	41	longer	long	RBR
cord-005453-4057qib7	10780	42	follow	follow	NN
cord-005453-4057qib7	10780	43	-	-	HYPH
cord-005453-4057qib7	10780	44	up	up	NN
cord-005453-4057qib7	10780	45	than	than	IN
cord-005453-4057qib7	10780	46	with	with	IN
cord-005453-4057qib7	10780	47	CAR	car	NN
cord-005453-4057qib7	10780	48	-	-	HYPH
cord-005453-4057qib7	10780	49	T	t	NN
cord-005453-4057qib7	10780	50	therapy	therapy	NN
cord-005453-4057qib7	10780	51	;	;	:
cord-005453-4057qib7	10780	52	for	for	IN
cord-005453-4057qib7	10780	53	these	these	DT
cord-005453-4057qib7	10780	54	reasons	reason	NNS
cord-005453-4057qib7	10780	55	,	,	,
cord-005453-4057qib7	10780	56	it	-PRON-	PRP
cord-005453-4057qib7	10780	57	should	should	MD
cord-005453-4057qib7	10780	58	still	still	RB
cord-005453-4057qib7	10780	59	be	be	VB
cord-005453-4057qib7	10780	60	offer	offer	NN
cord-005453-4057qib7	10780	61	to	to	IN
cord-005453-4057qib7	10780	62	these	these	DT
cord-005453-4057qib7	10780	63	poor	poor	JJ
cord-005453-4057qib7	10780	64	prognosis	prognosis	NN
cord-005453-4057qib7	10780	65	patients	patient	NNS
cord-005453-4057qib7	10780	66	.	.	.
cord-005453-4057qib7	10781	1	Moreover	moreover	RB
cord-005453-4057qib7	10781	2	,	,	,
cord-005453-4057qib7	10781	3	almost	almost	RB
cord-005453-4057qib7	10781	4	all	all	DT
cord-005453-4057qib7	10781	5	patients	patient	NNS
cord-005453-4057qib7	10781	6	have	have	VBP
cord-005453-4057qib7	10781	7	now	now	RB
cord-005453-4057qib7	10781	8	available	available	JJ
cord-005453-4057qib7	10781	9	donor	donor	NN
cord-005453-4057qib7	10781	10	,	,	,
cord-005453-4057qib7	10781	11	better	well	JJR
cord-005453-4057qib7	10781	12	graft	graft	NN
cord-005453-4057qib7	10781	13	-	-	HYPH
cord-005453-4057qib7	10781	14	versus	versus	IN
cord-005453-4057qib7	10781	15	-	-	HYPH
cord-005453-4057qib7	10781	16	host	host	NN
cord-005453-4057qib7	10781	17	disease	disease	NN
cord-005453-4057qib7	10781	18	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10781	19	will	will	MD
cord-005453-4057qib7	10781	20	decrease	decrease	VB
cord-005453-4057qib7	10781	21	TRM	TRM	NNP
cord-005453-4057qib7	10781	22	and	and	CC
cord-005453-4057qib7	10781	23	morbidity	morbidity	NN
cord-005453-4057qib7	10781	24	,	,	,
cord-005453-4057qib7	10781	25	and	and	CC
cord-005453-4057qib7	10781	26	new	new	JJ
cord-005453-4057qib7	10781	27	therapies	therapy	NNS
cord-005453-4057qib7	10781	28	will	will	MD
cord-005453-4057qib7	10781	29	make	make	VB
cord-005453-4057qib7	10781	30	more	more	JJR
cord-005453-4057qib7	10781	31	patients	patient	NNS
cord-005453-4057qib7	10781	32	in	in	IN
cord-005453-4057qib7	10781	33	sensitive	sensitive	JJ
cord-005453-4057qib7	10781	34	disease	disease	NN
cord-005453-4057qib7	10781	35	before	before	IN
cord-005453-4057qib7	10781	36	allo	allo	NNP
cord-005453-4057qib7	10781	37	-	-	HYPH
cord-005453-4057qib7	10781	38	SCT	SCT	NNP
cord-005453-4057qib7	10781	39	.	.	.
cord-005453-4057qib7	10782	1	Therefore	therefore	RB
cord-005453-4057qib7	10782	2	,	,	,
cord-005453-4057qib7	10782	3	allo	allo	NN
cord-005453-4057qib7	10782	4	-	-	HYPH
cord-005453-4057qib7	10782	5	SCT	SCT	NNP
cord-005453-4057qib7	10782	6	and	and	CC
cord-005453-4057qib7	10782	7	CAR	CAR	NNP
cord-005453-4057qib7	10782	8	-	-	HYPH
cord-005453-4057qib7	10782	9	T	t	NN
cord-005453-4057qib7	10782	10	cells	cell	NNS
cord-005453-4057qib7	10782	11	are	be	VBP
cord-005453-4057qib7	10782	12	strategies	strategy	NNS
cord-005453-4057qib7	10782	13	to	to	TO
cord-005453-4057qib7	10782	14	be	be	VB
cord-005453-4057qib7	10782	15	discussed	discuss	VBN
cord-005453-4057qib7	10782	16	in	in	IN
cord-005453-4057qib7	10782	17	every	every	DT
cord-005453-4057qib7	10782	18	young	young	JJ
cord-005453-4057qib7	10782	19	patient	patient	NN
cord-005453-4057qib7	10782	20	with	with	IN
cord-005453-4057qib7	10782	21	available	available	JJ
cord-005453-4057qib7	10782	22	donor	donor	NN
cord-005453-4057qib7	10782	23	.	.	.
cord-005453-4057qib7	10783	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10783	2	:	:	:
cord-005453-4057qib7	10783	3	Honoraria	Honoraria	NNP
cord-005453-4057qib7	10783	4	as	as	IN
cord-005453-4057qib7	10783	5	advisor	advisor	NN
cord-005453-4057qib7	10783	6	or	or	CC
cord-005453-4057qib7	10783	7	speaker	speaker	NN
cord-005453-4057qib7	10783	8	from	from	IN
cord-005453-4057qib7	10783	9	Gilead	Gilead	NNP
cord-005453-4057qib7	10784	1	(	(	-LRB-
cord-005453-4057qib7	10784	2	Methods	method	NNS
cord-005453-4057qib7	10784	3	:	:	:
cord-005453-4057qib7	10785	1	Consecutive	consecutive	JJ
cord-005453-4057qib7	10785	2	patients	patient	NNS
cord-005453-4057qib7	10785	3	transplanted	transplant	VBN
cord-005453-4057qib7	10785	4	for	for	IN
cord-005453-4057qib7	10785	5	HGBL	HGBL	NNP
cord-005453-4057qib7	10785	6	(	(	-LRB-
cord-005453-4057qib7	10785	7	excluding	exclude	VBG
cord-005453-4057qib7	10785	8	Burkitts	Burkitts	NNP
cord-005453-4057qib7	10785	9	lymphoma	lymphoma	NN
cord-005453-4057qib7	10785	10	)	)	-RRB-
cord-005453-4057qib7	10785	11	between	between	IN
cord-005453-4057qib7	10785	12	2007	2007	CD
cord-005453-4057qib7	10785	13	-	-	SYM
cord-005453-4057qib7	10785	14	2017	2017	CD
cord-005453-4057qib7	10785	15	in	in	IN
cord-005453-4057qib7	10785	16	the	the	DT
cord-005453-4057qib7	10785	17	EBMT	EBMT	NNP
cord-005453-4057qib7	10785	18	database	database	NN
cord-005453-4057qib7	10785	19	were	be	VBD
cord-005453-4057qib7	10785	20	included	include	VBN
cord-005453-4057qib7	10785	21	.	.	.
cord-005453-4057qib7	10786	1	Data	datum	NNS
cord-005453-4057qib7	10786	2	collected	collect	VBD
cord-005453-4057qib7	10786	3	included	include	VBN
cord-005453-4057qib7	10786	4	age	age	NN
cord-005453-4057qib7	10786	5	,	,	,
cord-005453-4057qib7	10786	6	sex	sex	NN
cord-005453-4057qib7	10786	7	,	,	,
cord-005453-4057qib7	10786	8	pathology	pathology	NN
cord-005453-4057qib7	10786	9	subtype	subtype	NN
cord-005453-4057qib7	10786	10	(	(	-LRB-
cord-005453-4057qib7	10786	11	HGBL	HGBL	NNP
cord-005453-4057qib7	10786	12	(	(	-LRB-
cord-005453-4057qib7	10786	13	including	include	VBG
cord-005453-4057qib7	10786	14	subtypes	subtype	NNS
cord-005453-4057qib7	10786	15	)	)	-RRB-
cord-005453-4057qib7	10786	16	,	,	,
cord-005453-4057qib7	10786	17	tFL	tFL	NNP
cord-005453-4057qib7	10786	18	,	,	,
cord-005453-4057qib7	10786	19	DHL	DHL	NNP
cord-005453-4057qib7	10786	20	)	)	-RRB-
cord-005453-4057qib7	10786	21	,	,	,
cord-005453-4057qib7	10786	22	disease	disease	NN
cord-005453-4057qib7	10786	23	status	status	NN
cord-005453-4057qib7	10786	24	at	at	IN
cord-005453-4057qib7	10786	25	SCT	SCT	NNP
cord-005453-4057qib7	10786	26	,	,	,
cord-005453-4057qib7	10786	27	conditioning	conditioning	NN
cord-005453-4057qib7	10786	28	(	(	-LRB-
cord-005453-4057qib7	10786	29	MA	MA	NNP
cord-005453-4057qib7	10786	30	vs	vs	IN
cord-005453-4057qib7	10786	31	BEAM	BEAM	NNP
cord-005453-4057qib7	10786	32	Cam	Cam	NNP
cord-005453-4057qib7	10786	33	vs	vs	IN
cord-005453-4057qib7	10786	34	Flu	Flu	NNP
cord-005453-4057qib7	10786	35	-	-	HYPH
cord-005453-4057qib7	10786	36	Mel	Mel	NNP
cord-005453-4057qib7	10786	37	-	-	HYPH
cord-005453-4057qib7	10786	38	Cam	Cam	NNP
cord-005453-4057qib7	10786	39	/	/	SYM
cord-005453-4057qib7	10786	40	ATG	ATG	NNP
cord-005453-4057qib7	10786	41	)	)	-RRB-
cord-005453-4057qib7	10786	42	,	,	,
cord-005453-4057qib7	10786	43	engraftment	engraftment	NN
cord-005453-4057qib7	10786	44	,	,	,
cord-005453-4057qib7	10786	45	day	day	NN
cord-005453-4057qib7	10786	46	100	100	CD
cord-005453-4057qib7	10786	47	outcome	outcome	NN
cord-005453-4057qib7	10786	48	,	,	,
cord-005453-4057qib7	10786	49	TRM	TRM	NNP
cord-005453-4057qib7	10786	50	,	,	,
cord-005453-4057qib7	10786	51	OS	OS	NNP
cord-005453-4057qib7	10786	52	and	and	CC
cord-005453-4057qib7	10786	53	PFS	PFS	NNP
cord-005453-4057qib7	10786	54	and	and	CC
cord-005453-4057qib7	10786	55	eligibility	eligibility	NN
cord-005453-4057qib7	10786	56	for	for	IN
cord-005453-4057qib7	10786	57	EMEA	EMEA	NNP
cord-005453-4057qib7	10786	58	licensed	licensed	JJ
cord-005453-4057qib7	10786	59	indication	indication	NN
cord-005453-4057qib7	10786	60	of	of	IN
cord-005453-4057qib7	10786	61	CAR	car	NN
cord-005453-4057qib7	10786	62	-	-	HYPH
cord-005453-4057qib7	10786	63	T	t	NN
cord-005453-4057qib7	10786	64	therapy	therapy	NN
cord-005453-4057qib7	10786	65	.	.	.
cord-005453-4057qib7	10787	1	Results	result	NNS
cord-005453-4057qib7	10787	2	:	:	:
cord-005453-4057qib7	10788	1	Fifty	fifty	CD
cord-005453-4057qib7	10788	2	patients	patient	NNS
cord-005453-4057qib7	10788	3	(	(	-LRB-
cord-005453-4057qib7	10788	4	29	29	CD
cord-005453-4057qib7	10788	5	M	M	NNP
cord-005453-4057qib7	10788	6	,	,	,
cord-005453-4057qib7	10788	7	21F	21F	NNP
cord-005453-4057qib7	10788	8	)	)	-RRB-
cord-005453-4057qib7	10788	9	with	with	IN
cord-005453-4057qib7	10788	10	a	a	DT
cord-005453-4057qib7	10788	11	median	median	JJ
cord-005453-4057qib7	10788	12	age	age	NN
cord-005453-4057qib7	10788	13	of	of	IN
cord-005453-4057qib7	10788	14	47	47	CD
cord-005453-4057qib7	10788	15	at	at	IN
cord-005453-4057qib7	10788	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	10788	17	and	and	CC
cord-005453-4057qib7	10788	18	50	50	CD
cord-005453-4057qib7	10788	19	at	at	IN
cord-005453-4057qib7	10788	20	SCT	SCT	NNP
cord-005453-4057qib7	10788	21	were	be	VBD
cord-005453-4057qib7	10788	22	included	include	VBN
cord-005453-4057qib7	10788	23	.	.	.
cord-005453-4057qib7	10789	1	The	the	DT
cord-005453-4057qib7	10789	2	subtypes	subtype	NNS
cord-005453-4057qib7	10789	3	included	include	VBD
cord-005453-4057qib7	10789	4	HGBL	HGBL	NNP
cord-005453-4057qib7	10789	5	(	(	-LRB-
cord-005453-4057qib7	10789	6	n=29	n=29	NNP
cord-005453-4057qib7	10789	7	)	)	-RRB-
cord-005453-4057qib7	10789	8	,	,	,
cord-005453-4057qib7	10789	9	tFL	tFL	NNP
cord-005453-4057qib7	10789	10	(	(	-LRB-
cord-005453-4057qib7	10789	11	n=11	n=11	NNP
cord-005453-4057qib7	10789	12	)	)	-RRB-
cord-005453-4057qib7	10789	13	and	and	CC
cord-005453-4057qib7	10789	14	DHL	DHL	NNP
cord-005453-4057qib7	10789	15	(	(	-LRB-
cord-005453-4057qib7	10789	16	n=10	n=10	NNP
cord-005453-4057qib7	10789	17	)	)	-RRB-
cord-005453-4057qib7	10789	18	.	.	.
cord-005453-4057qib7	10790	1	Indications	indication	NNS
cord-005453-4057qib7	10790	2	for	for	IN
cord-005453-4057qib7	10790	3	SCT	SCT	NNP
cord-005453-4057qib7	10790	4	were	be	VBD
cord-005453-4057qib7	10790	5	:	:	:
cord-005453-4057qib7	10790	6	primary	primary	JJ
cord-005453-4057qib7	10790	7	refractory	refractory	NN
cord-005453-4057qib7	10790	8	(	(	-LRB-
cord-005453-4057qib7	10790	9	n=17	n=17	NNP
cord-005453-4057qib7	10790	10	)	)	-RRB-
cord-005453-4057qib7	10790	11	,	,	,
cord-005453-4057qib7	10790	12	relapse	relapse	NN
cord-005453-4057qib7	10790	13	<	<	XX
cord-005453-4057qib7	10790	14	12	12	CD
cord-005453-4057qib7	10790	15	months	month	NNS
cord-005453-4057qib7	10790	16	after	after	IN
cord-005453-4057qib7	10790	17	primary	primary	JJ
cord-005453-4057qib7	10790	18	treatment	treatment	NN
cord-005453-4057qib7	10790	19	(	(	-LRB-
cord-005453-4057qib7	10790	20	n=12	n=12	NNP
cord-005453-4057qib7	10790	21	)	)	-RRB-
cord-005453-4057qib7	10790	22	,	,	,
cord-005453-4057qib7	10790	23	previous	previous	JJ
cord-005453-4057qib7	10790	24	autologous	autologous	JJ
cord-005453-4057qib7	10790	25	-	-	HYPH
cord-005453-4057qib7	10790	26	SCT	SCT	NNP
cord-005453-4057qib7	10790	27	(	(	-LRB-
cord-005453-4057qib7	10790	28	n=10	n=10	NNP
cord-005453-4057qib7	10790	29	)	)	-RRB-
cord-005453-4057qib7	10790	30	and	and	CC
cord-005453-4057qib7	10790	31	DHL	DHL	NNP
cord-005453-4057qib7	10790	32	(	(	-LRB-
cord-005453-4057qib7	10790	33	n=11	n=11	NNP
cord-005453-4057qib7	10790	34	)	)	-RRB-
cord-005453-4057qib7	10790	35	.	.	.
cord-005453-4057qib7	10791	1	The	the	DT
cord-005453-4057qib7	10791	2	median	median	JJ
cord-005453-4057qib7	10791	3	lines	line	NNS
cord-005453-4057qib7	10791	4	of	of	IN
cord-005453-4057qib7	10791	5	therapy	therapy	NN
cord-005453-4057qib7	10791	6	was	be	VBD
cord-005453-4057qib7	10791	7	4	4	CD
cord-005453-4057qib7	10792	1	(	(	-LRB-
cord-005453-4057qib7	10792	2	range	range	NN
cord-005453-4057qib7	10792	3	1	1	CD
cord-005453-4057qib7	10792	4	to	to	IN
cord-005453-4057qib7	10792	5	6	6	CD
cord-005453-4057qib7	10792	6	)	)	-RRB-
cord-005453-4057qib7	10792	7	.	.	.
cord-005453-4057qib7	10793	1	Conditioning	conditioning	NN
cord-005453-4057qib7	10793	2	used	use	VBN
cord-005453-4057qib7	10793	3	was	be	VBD
cord-005453-4057qib7	10794	1	CyTBI	cytbi	CD
cord-005453-4057qib7	10794	2	n=21	n=21	NN
cord-005453-4057qib7	10794	3	,	,	,
cord-005453-4057qib7	10794	4	Bu	Bu	NNP
cord-005453-4057qib7	10794	5	/	/	SYM
cord-005453-4057qib7	10794	6	Cy	Cy	NNP
cord-005453-4057qib7	10795	1	n=1	n=1	UH
cord-005453-4057qib7	10795	2	,	,	,
cord-005453-4057qib7	10795	3	Etop	Etop	NNP
cord-005453-4057qib7	10795	4	/	/	SYM
cord-005453-4057qib7	10795	5	TBI	TBI	NNP
cord-005453-4057qib7	10795	6	n=1	n=1	NN
cord-005453-4057qib7	10795	7	,	,	,
cord-005453-4057qib7	10795	8	FluBuCy	FluBuCy	NNPS
cord-005453-4057qib7	10795	9	n=1	n=1	CC
cord-005453-4057qib7	10795	10	,	,	.
cord-005453-4057qib7	10796	1	BEAMCam	beamcam	RB
cord-005453-4057qib7	10796	2	n=7	n=7	NNS
cord-005453-4057qib7	10796	3	,	,	,
cord-005453-4057qib7	10796	4	FMC	FMC	NNP
cord-005453-4057qib7	10796	5	/	/	SYM
cord-005453-4057qib7	10796	6	T	T	NNP
cord-005453-4057qib7	10796	7	,	,	,
cord-005453-4057qib7	10796	8	n=	n=	NNP
cord-005453-4057qib7	10796	9	19	19	CD
cord-005453-4057qib7	10796	10	.	.	.
cord-005453-4057qib7	10797	1	All	all	DT
cord-005453-4057qib7	10797	2	patients	patient	NNS
cord-005453-4057qib7	10797	3	engrafted	engraft	VBN
cord-005453-4057qib7	10797	4	with	with	IN
cord-005453-4057qib7	10797	5	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	10797	6	>	>	XX
cord-005453-4057qib7	10797	7	1.0	1.0	CD
cord-005453-4057qib7	10797	8	10	10	CD
cord-005453-4057qib7	10797	9	9	9	CD
cord-005453-4057qib7	10797	10	/L	/L	.
cord-005453-4057qib7	10797	11	at	at	IN
cord-005453-4057qib7	10797	12	median	median	JJ
cord-005453-4057qib7	10797	13	15	15	CD
cord-005453-4057qib7	10797	14	days	day	NNS
cord-005453-4057qib7	10797	15	and	and	CC
cord-005453-4057qib7	10797	16	platelets	platelet	NNS
cord-005453-4057qib7	10797	17	>	>	NFP
cord-005453-4057qib7	10797	18	20	20	CD
cord-005453-4057qib7	10797	19	10	10	CD
cord-005453-4057qib7	10797	20	9	9	CD
cord-005453-4057qib7	10797	21	/L	/L	.
cord-005453-4057qib7	10797	22	at	at	IN
cord-005453-4057qib7	10797	23	median	median	JJ
cord-005453-4057qib7	10797	24	17days	17days	CD
cord-005453-4057qib7	10797	25	.	.	.
cord-005453-4057qib7	10798	1	The	the	DT
cord-005453-4057qib7	10798	2	day	day	NN
cord-005453-4057qib7	10798	3	100	100	CD
cord-005453-4057qib7	10798	4	mortality	mortality	NN
cord-005453-4057qib7	10798	5	was	be	VBD
cord-005453-4057qib7	10798	6	8	8	CD
cord-005453-4057qib7	10798	7	%	%	NN
cord-005453-4057qib7	10798	8	(	(	-LRB-
cord-005453-4057qib7	10798	9	progressive	progressive	JJ
cord-005453-4057qib7	10798	10	disease	disease	NN
cord-005453-4057qib7	10798	11	4	4	CD
cord-005453-4057qib7	10798	12	%	%	NN
cord-005453-4057qib7	10798	13	,	,	,
cord-005453-4057qib7	10798	14	NRM	NRM	NNP
cord-005453-4057qib7	10798	15	4	4	CD
cord-005453-4057qib7	10798	16	%	%	NN
cord-005453-4057qib7	10798	17	)	)	-RRB-
cord-005453-4057qib7	10798	18	with	with	IN
cord-005453-4057qib7	10798	19	a	a	DT
cord-005453-4057qib7	10798	20	5	5	CD
cord-005453-4057qib7	10798	21	year	year	NN
cord-005453-4057qib7	10798	22	OS	os	NN
cord-005453-4057qib7	10798	23	of	of	IN
cord-005453-4057qib7	10798	24	56	56	CD
cord-005453-4057qib7	10798	25	%	%	NN
cord-005453-4057qib7	10798	26	and	and	CC
cord-005453-4057qib7	10798	27	mortality	mortality	NN
cord-005453-4057qib7	10798	28	due	due	IN
cord-005453-4057qib7	10798	29	to	to	IN
cord-005453-4057qib7	10798	30	progressive	progressive	JJ
cord-005453-4057qib7	10798	31	disease	disease	NN
cord-005453-4057qib7	10798	32	22	22	CD
cord-005453-4057qib7	10798	33	%	%	NN
cord-005453-4057qib7	10798	34	and	and	CC
cord-005453-4057qib7	10798	35	NRM	NRM	NNP
cord-005453-4057qib7	10798	36	16	16	CD
cord-005453-4057qib7	10798	37	%	%	NN
cord-005453-4057qib7	10798	38	.	.	.
cord-005453-4057qib7	10799	1	Disease	Disease	NNP
cord-005453-4057qib7	10799	2	subtype	subtype	NN
cord-005453-4057qib7	10799	3	influenced	influence	VBD
cord-005453-4057qib7	10799	4	outcome	outcome	NN
cord-005453-4057qib7	10799	5	with	with	IN
cord-005453-4057qib7	10799	6	an	an	DT
cord-005453-4057qib7	10799	7	OS	os	NN
cord-005453-4057qib7	10799	8	for	for	IN
cord-005453-4057qib7	10799	9	primary	primary	JJ
cord-005453-4057qib7	10799	10	refractory	refractory	JJ
cord-005453-4057qib7	10799	11	HGBL	HGBL	NNP
cord-005453-4057qib7	10799	12	,	,	,
cord-005453-4057qib7	10799	13	relapsed	relapse	VBN
cord-005453-4057qib7	10799	14	HGBL	HGBL	NNP
cord-005453-4057qib7	10799	15	,	,	,
cord-005453-4057qib7	10799	16	tFL	tFL	NNP
cord-005453-4057qib7	10799	17	and	and	CC
cord-005453-4057qib7	10799	18	DHL	DHL	NNP
cord-005453-4057qib7	10799	19	respectively	respectively	RB
cord-005453-4057qib7	10799	20	of	of	IN
cord-005453-4057qib7	10799	21	53	53	CD
cord-005453-4057qib7	10799	22	%	%	NN
cord-005453-4057qib7	10799	23	,	,	,
cord-005453-4057qib7	10799	24	58	58	CD
cord-005453-4057qib7	10799	25	%	%	NN
cord-005453-4057qib7	10799	26	,	,	,
cord-005453-4057qib7	10799	27	57	57	CD
cord-005453-4057qib7	10799	28	%	%	NN
cord-005453-4057qib7	10799	29	and	and	CC
cord-005453-4057qib7	10799	30	89	89	CD
cord-005453-4057qib7	10799	31	%	%	NN
cord-005453-4057qib7	10799	32	.	.	.
cord-005453-4057qib7	10800	1	23	23	CD
cord-005453-4057qib7	10800	2	patients	patient	NNS
cord-005453-4057qib7	10800	3	were	be	VBD
cord-005453-4057qib7	10800	4	eligible	eligible	JJ
cord-005453-4057qib7	10800	5	for	for	IN
cord-005453-4057qib7	10800	6	a	a	DT
cord-005453-4057qib7	10800	7	licensed	licensed	JJ
cord-005453-4057qib7	10800	8	CAR	car	NN
cord-005453-4057qib7	10800	9	-	-	HYPH
cord-005453-4057qib7	10800	10	T	t	NN
cord-005453-4057qib7	10800	11	product	product	NN
cord-005453-4057qib7	10800	12	.	.	.
cord-005453-4057qib7	10801	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10801	2	:	:	:
cord-005453-4057qib7	10802	1	The	the	DT
cord-005453-4057qib7	10802	2	outcome	outcome	NN
cord-005453-4057qib7	10802	3	of	of	IN
cord-005453-4057qib7	10802	4	these	these	DT
cord-005453-4057qib7	10802	5	high	high	JJ
cord-005453-4057qib7	10802	6	risk	risk	NN
cord-005453-4057qib7	10802	7	HGBL	HGBL	NNP
cord-005453-4057qib7	10802	8	patients	patient	NNS
cord-005453-4057qib7	10802	9	have	have	VBP
cord-005453-4057qib7	10802	10	an	an	DT
cord-005453-4057qib7	10802	11	acceptable	acceptable	JJ
cord-005453-4057qib7	10802	12	OS	os	NN
cord-005453-4057qib7	10802	13	of	of	IN
cord-005453-4057qib7	10802	14	56	56	CD
cord-005453-4057qib7	10802	15	%	%	NN
cord-005453-4057qib7	10802	16	,	,	,
cord-005453-4057qib7	10802	17	with	with	IN
cord-005453-4057qib7	10802	18	relapsed	relapse	VBN
cord-005453-4057qib7	10802	19	disease	disease	NN
cord-005453-4057qib7	10802	20	being	be	VBG
cord-005453-4057qib7	10802	21	the	the	DT
cord-005453-4057qib7	10802	22	commonest	common	JJS
cord-005453-4057qib7	10802	23	cause	cause	NN
cord-005453-4057qib7	10802	24	of	of	IN
cord-005453-4057qib7	10802	25	mortality	mortality	NN
cord-005453-4057qib7	10802	26	.	.	.
cord-005453-4057qib7	10803	1	Patients	patient	NNS
cord-005453-4057qib7	10803	2	with	with	IN
cord-005453-4057qib7	10803	3	DHL	DHL	NNP
cord-005453-4057qib7	10803	4	have	have	VBP
cord-005453-4057qib7	10803	5	a	a	DT
cord-005453-4057qib7	10803	6	particularly	particularly	RB
cord-005453-4057qib7	10803	7	good	good	JJ
cord-005453-4057qib7	10803	8	outcome	outcome	NN
cord-005453-4057qib7	10803	9	in	in	IN
cord-005453-4057qib7	10803	10	this	this	DT
cord-005453-4057qib7	10803	11	series	series	NN
cord-005453-4057qib7	10803	12	;	;	,
cord-005453-4057qib7	10803	13	recent	recent	JJ
cord-005453-4057qib7	10803	14	evidence	evidence	NN
cord-005453-4057qib7	10803	15	indicates	indicate	VBZ
cord-005453-4057qib7	10803	16	that	that	IN
cord-005453-4057qib7	10803	17	some	some	DT
cord-005453-4057qib7	10803	18	of	of	IN
cord-005453-4057qib7	10803	19	these	these	DT
cord-005453-4057qib7	10803	20	patients	patient	NNS
cord-005453-4057qib7	10803	21	with	with	IN
cord-005453-4057qib7	10803	22	a	a	DT
cord-005453-4057qib7	10803	23	non	non	JJ
cord-005453-4057qib7	10803	24	-	-	JJ
cord-005453-4057qib7	10803	25	immunoglobulin	immunoglobulin	JJ
cord-005453-4057qib7	10803	26	gene	gene	NN
cord-005453-4057qib7	10803	27	associated	associate	VBD
cord-005453-4057qib7	10803	28	MYC	MYC	NNP
cord-005453-4057qib7	10803	29	translocation	translocation	NN
cord-005453-4057qib7	10803	30	could	could	MD
cord-005453-4057qib7	10803	31	be	be	VB
cord-005453-4057qib7	10803	32	managed	manage	VBN
cord-005453-4057qib7	10803	33	more	more	RBR
cord-005453-4057qib7	10803	34	conservatively	conservatively	RB
cord-005453-4057qib7	10803	35	(	(	-LRB-
cord-005453-4057qib7	10803	36	ASH	ASH	NNP
cord-005453-4057qib7	10803	37	Sehn	Sehn	NNP
cord-005453-4057qib7	10803	38	)	)	-RRB-
cord-005453-4057qib7	10803	39	.	.	.
cord-005453-4057qib7	10804	1	The	the	DT
cord-005453-4057qib7	10804	2	outcomes	outcome	NNS
cord-005453-4057qib7	10804	3	achieved	achieve	VBN
cord-005453-4057qib7	10804	4	with	with	IN
cord-005453-4057qib7	10804	5	allogeneic	allogeneic	NN
cord-005453-4057qib7	10804	6	-	-	HYPH
cord-005453-4057qib7	10804	7	SCT	sct	NN
cord-005453-4057qib7	10804	8	in	in	IN
cord-005453-4057qib7	10804	9	this	this	DT
cord-005453-4057qib7	10804	10	series	series	NN
cord-005453-4057qib7	10804	11	will	will	MD
cord-005453-4057qib7	10804	12	provide	provide	VB
cord-005453-4057qib7	10804	13	a	a	DT
cord-005453-4057qib7	10804	14	baseline	baseline	NN
cord-005453-4057qib7	10804	15	for	for	IN
cord-005453-4057qib7	10804	16	outcome	outcome	NN
cord-005453-4057qib7	10804	17	assessment	assessment	NN
cord-005453-4057qib7	10804	18	with	with	IN
cord-005453-4057qib7	10804	19	a	a	DT
cord-005453-4057qib7	10804	20	CART	cart	NN
cord-005453-4057qib7	10804	21	program	program	NN
cord-005453-4057qib7	10804	22	.	.	.
cord-005453-4057qib7	10805	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10805	2	:	:	:
cord-005453-4057qib7	10806	1	Nothing	nothing	NN
cord-005453-4057qib7	10806	2	to	to	TO
cord-005453-4057qib7	10806	3	Declare	declare	VB
cord-005453-4057qib7	10806	4	Background	background	NN
cord-005453-4057qib7	10806	5	:	:	:
cord-005453-4057qib7	10806	6	Immune	immune	JJ
cord-005453-4057qib7	10806	7	checkpoint	checkpoint	NN
cord-005453-4057qib7	10806	8	inhibitors	inhibitor	NNS
cord-005453-4057qib7	10806	9	(	(	-LRB-
cord-005453-4057qib7	10806	10	ICI	ICI	NNP
cord-005453-4057qib7	10806	11	)	)	-RRB-
cord-005453-4057qib7	10806	12	allow	allow	VB
cord-005453-4057qib7	10806	13	to	to	TO
cord-005453-4057qib7	10806	14	achieve	achieve	VB
cord-005453-4057qib7	10806	15	a	a	DT
cord-005453-4057qib7	10806	16	durable	durable	JJ
cord-005453-4057qib7	10806	17	remission	remission	NN
cord-005453-4057qib7	10806	18	in	in	IN
cord-005453-4057qib7	10806	19	patients	patient	NNS
cord-005453-4057qib7	10806	20	with	with	IN
cord-005453-4057qib7	10806	21	resistant	resistant	JJ
cord-005453-4057qib7	10806	22	or	or	CC
cord-005453-4057qib7	10806	23	refractory	refractory	JJ
cord-005453-4057qib7	10806	24	(	(	-LRB-
cord-005453-4057qib7	10806	25	r	r	NN
cord-005453-4057qib7	10806	26	/	/	SYM
cord-005453-4057qib7	10806	27	r	r	NN
cord-005453-4057qib7	10806	28	)	)	-RRB-
cord-005453-4057qib7	10806	29	classical	classical	JJ
cord-005453-4057qib7	10806	30	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	10806	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	10806	32	.	.	.
cord-005453-4057qib7	10807	1	However	however	RB
cord-005453-4057qib7	10807	2	,	,	,
cord-005453-4057qib7	10807	3	the	the	DT
cord-005453-4057qib7	10807	4	information	information	NN
cord-005453-4057qib7	10807	5	about	about	IN
cord-005453-4057qib7	10807	6	optimal	optimal	JJ
cord-005453-4057qib7	10807	7	duration	duration	NN
cord-005453-4057qib7	10807	8	of	of	IN
cord-005453-4057qib7	10807	9	therapy	therapy	NN
cord-005453-4057qib7	10807	10	and	and	CC
cord-005453-4057qib7	10807	11	the	the	DT
cord-005453-4057qib7	10807	12	prognosis	prognosis	NN
cord-005453-4057qib7	10807	13	of	of	IN
cord-005453-4057qib7	10807	14	the	the	DT
cord-005453-4057qib7	10807	15	patients	patient	NNS
cord-005453-4057qib7	10807	16	after	after	IN
cord-005453-4057qib7	10807	17	ICI	ICI	NNP
cord-005453-4057qib7	10807	18	cessation	cessation	NN
cord-005453-4057qib7	10807	19	is	be	VBZ
cord-005453-4057qib7	10807	20	limited	limit	VBN
cord-005453-4057qib7	10807	21	(	(	-LRB-
cord-005453-4057qib7	10807	22	Manson	Manson	NNP
cord-005453-4057qib7	10807	23	,	,	,
cord-005453-4057qib7	10807	24	Blood	blood	NN
cord-005453-4057qib7	10807	25	2018	2018	CD
cord-005453-4057qib7	10807	26	)	)	-RRB-
cord-005453-4057qib7	10807	27	.	.	.
cord-005453-4057qib7	10808	1	Therefore	therefore	RB
cord-005453-4057qib7	10808	2	,	,	,
cord-005453-4057qib7	10808	3	the	the	DT
cord-005453-4057qib7	10808	4	optimal	optimal	JJ
cord-005453-4057qib7	10808	5	role	role	NN
cord-005453-4057qib7	10808	6	of	of	IN
cord-005453-4057qib7	10808	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10808	8	SCT	SCT	NNP
cord-005453-4057qib7	10808	9	(	(	-LRB-
cord-005453-4057qib7	10808	10	HSCT	HSCT	NNP
cord-005453-4057qib7	10808	11	)	)	-RRB-
cord-005453-4057qib7	10808	12	in	in	IN
cord-005453-4057qib7	10808	13	this	this	DT
cord-005453-4057qib7	10808	14	patient	patient	NN
cord-005453-4057qib7	10808	15	group	group	NN
cord-005453-4057qib7	10808	16	is	be	VBZ
cord-005453-4057qib7	10808	17	not	not	RB
cord-005453-4057qib7	10808	18	defined	define	VBN
cord-005453-4057qib7	10808	19	.	.	.
cord-005453-4057qib7	10809	1	Our	-PRON-	PRP$
cord-005453-4057qib7	10809	2	aim	aim	NN
cord-005453-4057qib7	10809	3	was	be	VBD
cord-005453-4057qib7	10809	4	to	to	TO
cord-005453-4057qib7	10809	5	determine	determine	VB
cord-005453-4057qib7	10809	6	remission	remission	NN
cord-005453-4057qib7	10809	7	duration	duration	NN
cord-005453-4057qib7	10809	8	in	in	IN
cord-005453-4057qib7	10809	9	patients	patient	NNS
cord-005453-4057qib7	10809	10	who	who	WP
cord-005453-4057qib7	10809	11	discontinued	discontinue	VBD
cord-005453-4057qib7	10809	12	ICI	ICI	NNP
cord-005453-4057qib7	10810	1	monotherapy	monotherapy	IN
cord-005453-4057qib7	10810	2	after	after	IN
cord-005453-4057qib7	10810	3	achieving	achieve	VBG
cord-005453-4057qib7	10810	4	complete	complete	JJ
cord-005453-4057qib7	10810	5	remission	remission	NN
cord-005453-4057qib7	10810	6	(	(	-LRB-
cord-005453-4057qib7	10810	7	CR	CR	NNP
cord-005453-4057qib7	10810	8	)	)	-RRB-
cord-005453-4057qib7	10810	9	.	.	.
cord-005453-4057qib7	10811	1	Methods	method	NNS
cord-005453-4057qib7	10811	2	:	:	:
cord-005453-4057qib7	10812	1	This	this	DT
cord-005453-4057qib7	10812	2	analysis	analysis	NN
cord-005453-4057qib7	10812	3	included	include	VBD
cord-005453-4057qib7	10812	4	20	20	CD
cord-005453-4057qib7	10812	5	patients	patient	NNS
cord-005453-4057qib7	10812	6	(	(	-LRB-
cord-005453-4057qib7	10812	7	5	5	CD
cord-005453-4057qib7	10812	8	male/15	male/15	NNP
cord-005453-4057qib7	10812	9	female	female	NN
cord-005453-4057qib7	10812	10	)	)	-RRB-
cord-005453-4057qib7	10812	11	aged	age	VBN
cord-005453-4057qib7	10812	12	19	19	CD
cord-005453-4057qib7	10812	13	to	to	IN
cord-005453-4057qib7	10812	14	47	47	CD
cord-005453-4057qib7	10813	1	(	(	-LRB-
cord-005453-4057qib7	10813	2	median	median	NN
cord-005453-4057qib7	10813	3	32	32	CD
cord-005453-4057qib7	10813	4	years	year	NNS
cord-005453-4057qib7	10813	5	)	)	-RRB-
cord-005453-4057qib7	10813	6	with	with	IN
cord-005453-4057qib7	10813	7	r	r	NNP
cord-005453-4057qib7	10813	8	/	/	SYM
cord-005453-4057qib7	10813	9	r	r	NN
cord-005453-4057qib7	10813	10	classical	classical	JJ
cord-005453-4057qib7	10813	11	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	10813	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	10813	13	who	who	WP
cord-005453-4057qib7	10813	14	were	be	VBD
cord-005453-4057qib7	10813	15	treated	treat	VBN
cord-005453-4057qib7	10813	16	with	with	IN
cord-005453-4057qib7	10813	17	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10813	18	(	(	-LRB-
cord-005453-4057qib7	10813	19	3	3	CD
cord-005453-4057qib7	10813	20	mg	mg	NNP
cord-005453-4057qib7	10813	21	/	/	SYM
cord-005453-4057qib7	10813	22	kg	kg	NN
cord-005453-4057qib7	10813	23	every	every	DT
cord-005453-4057qib7	10813	24	14	14	CD
cord-005453-4057qib7	10813	25	days	day	NNS
cord-005453-4057qib7	10813	26	)	)	-RRB-
cord-005453-4057qib7	10813	27	and	and	CC
cord-005453-4057qib7	10813	28	achieved	achieve	VBD
cord-005453-4057qib7	10813	29	CR	CR	NNP
cord-005453-4057qib7	10813	30	.	.	.
cord-005453-4057qib7	10814	1	Response	response	NN
cord-005453-4057qib7	10814	2	was	be	VBD
cord-005453-4057qib7	10814	3	assessed	assess	VBN
cord-005453-4057qib7	10814	4	by	by	IN
cord-005453-4057qib7	10815	1	positron	positron	NN
cord-005453-4057qib7	10815	2	-	-	HYPH
cord-005453-4057qib7	10815	3	emission	emission	NN
cord-005453-4057qib7	10815	4	tomography	tomography	NN
cord-005453-4057qib7	10815	5	/	/	SYM
cord-005453-4057qib7	10815	6	computed	compute	VBN
cord-005453-4057qib7	10815	7	tomography	tomography	NN
cord-005453-4057qib7	10815	8	(	(	-LRB-
cord-005453-4057qib7	10815	9	PET	PET	NNP
cord-005453-4057qib7	10815	10	/	/	SYM
cord-005453-4057qib7	10815	11	CT	CT	NNP
cord-005453-4057qib7	10815	12	)	)	-RRB-
cord-005453-4057qib7	10815	13	using	use	VBG
cord-005453-4057qib7	10815	14	LYRIC	LYRIC	NNP
cord-005453-4057qib7	10815	15	criteria	criterion	NNS
cord-005453-4057qib7	10815	16	every	every	DT
cord-005453-4057qib7	10815	17	3	3	CD
cord-005453-4057qib7	10815	18	month	month	NN
cord-005453-4057qib7	10815	19	.	.	.
cord-005453-4057qib7	10816	1	After	after	IN
cord-005453-4057qib7	10816	2	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10816	3	therapy	therapy	NN
cord-005453-4057qib7	10816	4	had	have	VBD
cord-005453-4057qib7	10816	5	been	be	VBN
cord-005453-4057qib7	10816	6	stopped	stop	VBN
cord-005453-4057qib7	10816	7	the	the	DT
cord-005453-4057qib7	10816	8	patients	patient	NNS
cord-005453-4057qib7	10816	9	received	receive	VBN
cord-005453-4057qib7	10817	1	no	no	DT
cord-005453-4057qib7	10817	2	other	other	JJ
cord-005453-4057qib7	10817	3	treatment	treatment	NN
cord-005453-4057qib7	10817	4	and	and	CC
cord-005453-4057qib7	10817	5	disease	disease	NN
cord-005453-4057qib7	10817	6	was	be	VBD
cord-005453-4057qib7	10817	7	assessed	assess	VBN
cord-005453-4057qib7	10817	8	every	every	DT
cord-005453-4057qib7	10817	9	3	3	CD
cord-005453-4057qib7	10817	10	months	month	NNS
cord-005453-4057qib7	10817	11	by	by	IN
cord-005453-4057qib7	10817	12	PET	PET	NNP
cord-005453-4057qib7	10817	13	/	/	SYM
cord-005453-4057qib7	10817	14	CT	CT	NNP
cord-005453-4057qib7	10817	15	.	.	.
cord-005453-4057qib7	10818	1	Median	median	JJ
cord-005453-4057qib7	10818	2	follow	follow	NN
cord-005453-4057qib7	10818	3	-	-	HYPH
cord-005453-4057qib7	10818	4	up	up	NN
cord-005453-4057qib7	10818	5	after	after	IN
cord-005453-4057qib7	10818	6	therapy	therapy	NN
cord-005453-4057qib7	10818	7	discontinuation	discontinuation	NN
cord-005453-4057qib7	10818	8	was	be	VBD
cord-005453-4057qib7	10818	9	20	20	CD
cord-005453-4057qib7	10818	10	(	(	-LRB-
cord-005453-4057qib7	10818	11	10	10	CD
cord-005453-4057qib7	10818	12	-	-	SYM
cord-005453-4057qib7	10818	13	21	21	CD
cord-005453-4057qib7	10818	14	)	)	-RRB-
cord-005453-4057qib7	10818	15	months	month	NNS
cord-005453-4057qib7	10818	16	.	.	.
cord-005453-4057qib7	10819	1	Results	result	NNS
cord-005453-4057qib7	10819	2	:	:	:
cord-005453-4057qib7	10820	1	At	at	IN
cord-005453-4057qib7	10820	2	the	the	DT
cord-005453-4057qib7	10820	3	moment	moment	NN
cord-005453-4057qib7	10820	4	of	of	IN
cord-005453-4057qib7	10820	5	therapy	therapy	NN
cord-005453-4057qib7	10820	6	initiation	initiation	NN
cord-005453-4057qib7	10820	7	14	14	CD
cord-005453-4057qib7	10820	8	(	(	-LRB-
cord-005453-4057qib7	10820	9	70	70	CD
cord-005453-4057qib7	10820	10	%	%	NN
cord-005453-4057qib7	10820	11	)	)	-RRB-
cord-005453-4057qib7	10820	12	patients	patient	NNS
cord-005453-4057qib7	10820	13	had	have	VBD
cord-005453-4057qib7	10820	14	stage	stage	NN
cord-005453-4057qib7	10820	15	4	4	CD
cord-005453-4057qib7	10820	16	disease	disease	NN
cord-005453-4057qib7	10820	17	,	,	,
cord-005453-4057qib7	10820	18	11	11	CD
cord-005453-4057qib7	10820	19	(	(	-LRB-
cord-005453-4057qib7	10820	20	55	55	CD
cord-005453-4057qib7	10820	21	%	%	NN
cord-005453-4057qib7	10820	22	)	)	-RRB-
cord-005453-4057qib7	10821	1	patients	patient	NNS
cord-005453-4057qib7	10821	2	had	have	VBD
cord-005453-4057qib7	10821	3	progressive	progressive	JJ
cord-005453-4057qib7	10821	4	disease	disease	NN
cord-005453-4057qib7	10821	5	(	(	-LRB-
cord-005453-4057qib7	10821	6	PD	PD	NNP
cord-005453-4057qib7	10821	7	)	)	-RRB-
cord-005453-4057qib7	10821	8	,	,	,
cord-005453-4057qib7	10821	9	4	4	CD
cord-005453-4057qib7	10821	10	(	(	-LRB-
cord-005453-4057qib7	10821	11	20	20	CD
cord-005453-4057qib7	10821	12	%	%	NN
cord-005453-4057qib7	10821	13	)	)	-RRB-
cord-005453-4057qib7	10821	14	patients	patient	NNS
cord-005453-4057qib7	10821	15	had	have	VBD
cord-005453-4057qib7	10821	16	stable	stable	JJ
cord-005453-4057qib7	10821	17	disease	disease	NN
cord-005453-4057qib7	10821	18	,	,	,
cord-005453-4057qib7	10821	19	3	3	CD
cord-005453-4057qib7	10821	20	(	(	-LRB-
cord-005453-4057qib7	10821	21	15	15	CD
cord-005453-4057qib7	10821	22	%	%	NN
cord-005453-4057qib7	10821	23	)	)	-RRB-
cord-005453-4057qib7	10822	1	patients	patient	NNS
cord-005453-4057qib7	10822	2	had	have	VBD
cord-005453-4057qib7	10822	3	partial	partial	JJ
cord-005453-4057qib7	10822	4	remission	remission	NN
cord-005453-4057qib7	10822	5	and	and	CC
cord-005453-4057qib7	10822	6	2	2	CD
cord-005453-4057qib7	10822	7	(	(	-LRB-
cord-005453-4057qib7	10822	8	10%)complete	10%)complete	JJ
cord-005453-4057qib7	10822	9	remission	remission	NN
cord-005453-4057qib7	10822	10	;	;	:
cord-005453-4057qib7	10822	11	12	12	CD
cord-005453-4057qib7	10822	12	(	(	-LRB-
cord-005453-4057qib7	10822	13	60	60	CD
cord-005453-4057qib7	10822	14	%	%	NN
cord-005453-4057qib7	10822	15	)	)	-RRB-
cord-005453-4057qib7	10823	1	patients	patient	NNS
cord-005453-4057qib7	10823	2	had	have	VBD
cord-005453-4057qib7	10823	3	B	b	NN
cord-005453-4057qib7	10823	4	-	-	HYPH
cord-005453-4057qib7	10823	5	symptoms	symptom	NNS
cord-005453-4057qib7	10823	6	and	and	CC
cord-005453-4057qib7	10823	7	ECOG	ECOG	NNP
cord-005453-4057qib7	10823	8	score	score	NN
cord-005453-4057qib7	10824	1	>	>	XX
cord-005453-4057qib7	10824	2	1	1	CD
cord-005453-4057qib7	10824	3	.	.	.
cord-005453-4057qib7	10825	1	The	the	DT
cord-005453-4057qib7	10825	2	median	median	JJ
cord-005453-4057qib7	10825	3	number	number	NN
cord-005453-4057qib7	10825	4	of	of	IN
cord-005453-4057qib7	10825	5	previous	previous	JJ
cord-005453-4057qib7	10825	6	therapy	therapy	NN
cord-005453-4057qib7	10825	7	lines	line	NNS
cord-005453-4057qib7	10825	8	was	be	VBD
cord-005453-4057qib7	10825	9	5	5	CD
cord-005453-4057qib7	10825	10	(	(	-LRB-
cord-005453-4057qib7	10825	11	3	3	CD
cord-005453-4057qib7	10825	12	)	)	-RRB-
cord-005453-4057qib7	10825	13	(	(	-LRB-
cord-005453-4057qib7	10825	14	4	4	LS
cord-005453-4057qib7	10825	15	)	)	-RRB-
cord-005453-4057qib7	10825	16	(	(	-LRB-
cord-005453-4057qib7	10825	17	5	5	LS
cord-005453-4057qib7	10825	18	)	)	-RRB-
cord-005453-4057qib7	10825	19	(	(	-LRB-
cord-005453-4057qib7	10825	20	6	6	LS
cord-005453-4057qib7	10825	21	)	)	-RRB-
cord-005453-4057qib7	10825	22	(	(	-LRB-
cord-005453-4057qib7	10825	23	7	7	LS
cord-005453-4057qib7	10825	24	)	)	-RRB-
cord-005453-4057qib7	10825	25	(	(	-LRB-
cord-005453-4057qib7	10825	26	8)	8)	NNP
cord-005453-4057qib7	10825	27	(	(	-LRB-
cord-005453-4057qib7	10825	28	9	9	CD
cord-005453-4057qib7	10825	29	)	)	-RRB-
cord-005453-4057qib7	10825	30	(	(	-LRB-
cord-005453-4057qib7	10825	31	10	10	CD
cord-005453-4057qib7	10825	32	)	)	-RRB-
cord-005453-4057qib7	10825	33	.	.	.
cord-005453-4057qib7	10826	1	Before	before	IN
cord-005453-4057qib7	10826	2	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10826	3	initiation	initiation	NN
cord-005453-4057qib7	10826	4	high	high	RB
cord-005453-4057qib7	10826	5	dose	dose	NN
cord-005453-4057qib7	10826	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10826	7	with	with	IN
cord-005453-4057qib7	10826	8	autologous	autologous	JJ
cord-005453-4057qib7	10826	9	SCT	SCT	NNP
cord-005453-4057qib7	10826	10	was	be	VBD
cord-005453-4057qib7	10826	11	performed	perform	VBN
cord-005453-4057qib7	10826	12	in	in	IN
cord-005453-4057qib7	10826	13	9	9	CD
cord-005453-4057qib7	10826	14	patients	patient	NNS
cord-005453-4057qib7	10826	15	(	(	-LRB-
cord-005453-4057qib7	10826	16	45	45	CD
cord-005453-4057qib7	10826	17	%	%	NN
cord-005453-4057qib7	10826	18	)	)	-RRB-
cord-005453-4057qib7	10826	19	and	and	CC
cord-005453-4057qib7	10826	20	8	8	CD
cord-005453-4057qib7	10826	21	(	(	-LRB-
cord-005453-4057qib7	10826	22	40	40	CD
cord-005453-4057qib7	10826	23	%	%	NN
cord-005453-4057qib7	10826	24	)	)	-RRB-
cord-005453-4057qib7	10826	25	received	receive	VBD
cord-005453-4057qib7	10826	26	brentuximab	brentuximab	NNP
cord-005453-4057qib7	10826	27	vedotin	vedotin	NNP
cord-005453-4057qib7	10826	28	.	.	.
cord-005453-4057qib7	10827	1	The	the	DT
cord-005453-4057qib7	10827	2	median	median	JJ
cord-005453-4057qib7	10827	3	number	number	NN
cord-005453-4057qib7	10827	4	of	of	IN
cord-005453-4057qib7	10827	5	nivolumab	nivolumab	JJ
cord-005453-4057qib7	10827	6	cycles	cycle	NNS
cord-005453-4057qib7	10827	7	was	be	VBD
cord-005453-4057qib7	10827	8	25	25	CD
cord-005453-4057qib7	10827	9	(	(	-LRB-
cord-005453-4057qib7	10827	10	18	18	CD
cord-005453-4057qib7	10827	11	-	-	SYM
cord-005453-4057qib7	10827	12	30	30	CD
cord-005453-4057qib7	10827	13	)	)	-RRB-
cord-005453-4057qib7	10827	14	.	.	.
cord-005453-4057qib7	10828	1	CR	CR	NNP
cord-005453-4057qib7	10828	2	was	be	VBD
cord-005453-4057qib7	10828	3	achieved	achieve	VBN
cord-005453-4057qib7	10828	4	after	after	IN
cord-005453-4057qib7	10828	5	median	median	NN
cord-005453-4057qib7	10828	6	of	of	IN
cord-005453-4057qib7	10828	7	6	6	CD
cord-005453-4057qib7	10828	8	(	(	-LRB-
cord-005453-4057qib7	10828	9	6	6	CD
cord-005453-4057qib7	10828	10	-	-	SYM
cord-005453-4057qib7	10828	11	18	18	CD
cord-005453-4057qib7	10828	12	)	)	-RRB-
cord-005453-4057qib7	10828	13	cycles	cycle	NNS
cord-005453-4057qib7	10828	14	.	.	.
cord-005453-4057qib7	10829	1	The	the	DT
cord-005453-4057qib7	10829	2	median	median	JJ
cord-005453-4057qib7	10829	3	duration	duration	NN
cord-005453-4057qib7	10829	4	of	of	IN
cord-005453-4057qib7	10829	5	therapy	therapy	NN
cord-005453-4057qib7	10829	6	after	after	IN
cord-005453-4057qib7	10829	7	achievement	achievement	NN
cord-005453-4057qib7	10829	8	of	of	IN
cord-005453-4057qib7	10829	9	CR	CR	NNP
cord-005453-4057qib7	10829	10	was	be	VBD
cord-005453-4057qib7	10829	11	7	7	CD
cord-005453-4057qib7	10829	12	(	(	-LRB-
cord-005453-4057qib7	10829	13	1	1	CD
cord-005453-4057qib7	10829	14	-	-	SYM
cord-005453-4057qib7	10829	15	15	15	CD
cord-005453-4057qib7	10829	16	)	)	-RRB-
cord-005453-4057qib7	10829	17	months	month	NNS
cord-005453-4057qib7	10829	18	.	.	.
cord-005453-4057qib7	10830	1	At	at	IN
cord-005453-4057qib7	10830	2	the	the	DT
cord-005453-4057qib7	10830	3	time	time	NN
cord-005453-4057qib7	10830	4	of	of	IN
cord-005453-4057qib7	10830	5	analysis	analysis	NN
cord-005453-4057qib7	10830	6	,	,	,
cord-005453-4057qib7	10830	7	all	all	DT
cord-005453-4057qib7	10830	8	patients	patient	NNS
cord-005453-4057qib7	10830	9	were	be	VBD
cord-005453-4057qib7	10830	10	alive	alive	JJ
cord-005453-4057qib7	10830	11	,	,	,
cord-005453-4057qib7	10830	12	8	8	CD
cord-005453-4057qib7	10830	13	(	(	-LRB-
cord-005453-4057qib7	10830	14	40	40	CD
cord-005453-4057qib7	10830	15	%	%	NN
cord-005453-4057qib7	10830	16	)	)	-RRB-
cord-005453-4057qib7	10831	1	out	out	IN
cord-005453-4057qib7	10831	2	of	of	IN
cord-005453-4057qib7	10831	3	20	20	CD
cord-005453-4057qib7	10831	4	patients	patient	NNS
cord-005453-4057qib7	10831	5	relapsed	relapse	VBN
cord-005453-4057qib7	10831	6	after	after	IN
cord-005453-4057qib7	10831	7	therapy	therapy	NN
cord-005453-4057qib7	10831	8	discontinuation	discontinuation	NN
cord-005453-4057qib7	10831	9	.	.	.
cord-005453-4057qib7	10832	1	The	the	DT
cord-005453-4057qib7	10832	2	median	median	JJ
cord-005453-4057qib7	10832	3	progression	progression	NN
cord-005453-4057qib7	10832	4	-	-	HYPH
cord-005453-4057qib7	10832	5	free	free	JJ
cord-005453-4057qib7	10832	6	survival	survival	NN
cord-005453-4057qib7	10832	7	(	(	-LRB-
cord-005453-4057qib7	10832	8	PFS	PFS	NNP
cord-005453-4057qib7	10832	9	)	)	-RRB-
cord-005453-4057qib7	10832	10	for	for	IN
cord-005453-4057qib7	10832	11	the	the	DT
cord-005453-4057qib7	10832	12	total	total	JJ
cord-005453-4057qib7	10832	13	group	group	NN
cord-005453-4057qib7	10832	14	was	be	VBD
cord-005453-4057qib7	10832	15	not	not	RB
cord-005453-4057qib7	10832	16	achieved	achieve	VBN
cord-005453-4057qib7	10832	17	.	.	.
cord-005453-4057qib7	10833	1	Among	among	IN
cord-005453-4057qib7	10833	2	patients	patient	NNS
cord-005453-4057qib7	10833	3	with	with	IN
cord-005453-4057qib7	10833	4	relapse	relapse	NN
cord-005453-4057qib7	10833	5	,	,	,
cord-005453-4057qib7	10833	6	the	the	DT
cord-005453-4057qib7	10833	7	median	median	JJ
cord-005453-4057qib7	10833	8	time	time	NN
cord-005453-4057qib7	10833	9	before	before	IN
cord-005453-4057qib7	10833	10	PD	PD	NNP
cord-005453-4057qib7	10833	11	was	be	VBD
cord-005453-4057qib7	10833	12	11	11	CD
cord-005453-4057qib7	10833	13	(	(	-LRB-
cord-005453-4057qib7	10833	14	5	5	CD
cord-005453-4057qib7	10833	15	-	-	SYM
cord-005453-4057qib7	10833	16	20	20	CD
cord-005453-4057qib7	10833	17	)	)	-RRB-
cord-005453-4057qib7	10833	18	months	month	NNS
cord-005453-4057qib7	10833	19	.	.	.
cord-005453-4057qib7	10834	1	After	after	IN
cord-005453-4057qib7	10834	2	relapse	relapse	NN
cord-005453-4057qib7	10834	3	all	all	DT
cord-005453-4057qib7	10834	4	patients	patient	NNS
cord-005453-4057qib7	10834	5	were	be	VBD
cord-005453-4057qib7	10834	6	retreated	retreat	VBN
cord-005453-4057qib7	10834	7	with	with	IN
cord-005453-4057qib7	10834	8	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10834	9	monotherapy	monotherapy	NN
cord-005453-4057qib7	10834	10	or	or	CC
cord-005453-4057qib7	10834	11	with	with	IN
cord-005453-4057qib7	10834	12	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10834	13	combination	combination	NN
cord-005453-4057qib7	10834	14	.	.	.
cord-005453-4057qib7	10835	1	One	one	CD
cord-005453-4057qib7	10835	2	patient	patient	NN
cord-005453-4057qib7	10835	3	achieved	achieve	VBD
cord-005453-4057qib7	10835	4	complete	complete	JJ
cord-005453-4057qib7	10835	5	remission	remission	NN
cord-005453-4057qib7	10835	6	;	;	:
cord-005453-4057qib7	10835	7	1	1	CD
cord-005453-4057qib7	10835	8	-partial	-partial	JJ
cord-005453-4057qib7	10835	9	remission	remission	NN
cord-005453-4057qib7	10835	10	;	;	:
cord-005453-4057qib7	10835	11	1	1	CD
cord-005453-4057qib7	10835	12	-indeterminate	-indeterminate	NN
cord-005453-4057qib7	10835	13	response	response	NN
cord-005453-4057qib7	10835	14	type	type	NN
cord-005453-4057qib7	10835	15	2	2	CD
cord-005453-4057qib7	10835	16	.	.	.
cord-005453-4057qib7	10836	1	Other	other	JJ
cord-005453-4057qib7	10836	2	patients	patient	NNS
cord-005453-4057qib7	10836	3	are	be	VBP
cord-005453-4057qib7	10836	4	continuing	continue	VBG
cord-005453-4057qib7	10836	5	the	the	DT
cord-005453-4057qib7	10836	6	therapy	therapy	NN
cord-005453-4057qib7	10836	7	and	and	CC
cord-005453-4057qib7	10836	8	their	-PRON-	PRP$
cord-005453-4057qib7	10836	9	response	response	NN
cord-005453-4057qib7	10836	10	has	have	VBZ
cord-005453-4057qib7	10836	11	not	not	RB
cord-005453-4057qib7	10836	12	yet	yet	RB
cord-005453-4057qib7	10836	13	been	be	VBN
cord-005453-4057qib7	10836	14	evaluated	evaluate	VBN
cord-005453-4057qib7	10836	15	.	.	.
cord-005453-4057qib7	10837	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10837	2	:	:	:
cord-005453-4057qib7	10837	3	While	while	IN
cord-005453-4057qib7	10837	4	complete	complete	JJ
cord-005453-4057qib7	10837	5	response	response	NN
cord-005453-4057qib7	10837	6	was	be	VBD
cord-005453-4057qib7	10837	7	maintained	maintain	VBN
cord-005453-4057qib7	10837	8	in	in	IN
cord-005453-4057qib7	10837	9	some	some	DT
cord-005453-4057qib7	10837	10	patients	patient	NNS
cord-005453-4057qib7	10837	11	at	at	IN
cord-005453-4057qib7	10837	12	median	median	NN
cord-005453-4057qib7	10837	13	follow	follow	VB
cord-005453-4057qib7	10837	14	up	up	IN
cord-005453-4057qib7	10837	15	of	of	IN
cord-005453-4057qib7	10837	16	20	20	CD
cord-005453-4057qib7	10837	17	months	month	NNS
cord-005453-4057qib7	10837	18	after	after	IN
cord-005453-4057qib7	10837	19	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10837	20	therapy	therapy	NNP
cord-005453-4057qib7	10837	21	cessation	cessation	NNP
cord-005453-4057qib7	10837	22	,	,	,
cord-005453-4057qib7	10837	23	the	the	DT
cord-005453-4057qib7	10837	24	PFS	PFS	NNP
cord-005453-4057qib7	10837	25	plateau	plateau	NN
cord-005453-4057qib7	10837	26	was	be	VBD
cord-005453-4057qib7	10837	27	not	not	RB
cord-005453-4057qib7	10837	28	reached	reach	VBN
cord-005453-4057qib7	10837	29	.	.	.
cord-005453-4057qib7	10838	1	We	-PRON-	PRP
cord-005453-4057qib7	10838	2	report	report	VBP
cord-005453-4057qib7	10838	3	that	that	IN
cord-005453-4057qib7	10838	4	patients	patient	NNS
cord-005453-4057qib7	10838	5	with	with	IN
cord-005453-4057qib7	10838	6	relapse	relapse	NN
cord-005453-4057qib7	10838	7	after	after	IN
cord-005453-4057qib7	10838	8	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10838	9	discontinuation	discontinuation	NN
cord-005453-4057qib7	10838	10	sustained	sustain	VBD
cord-005453-4057qib7	10838	11	sensitivity	sensitivity	NN
cord-005453-4057qib7	10838	12	to	to	IN
cord-005453-4057qib7	10838	13	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10838	14	and	and	CC
cord-005453-4057qib7	10838	15	achieved	achieve	VBD
cord-005453-4057qib7	10838	16	a	a	DT
cord-005453-4057qib7	10838	17	response	response	NN
cord-005453-4057qib7	10838	18	during	during	IN
cord-005453-4057qib7	10838	19	retreatment	retreatment	NN
cord-005453-4057qib7	10838	20	with	with	IN
cord-005453-4057qib7	10838	21	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10838	22	monotherapy	monotherapy	NN
cord-005453-4057qib7	10838	23	or	or	CC
cord-005453-4057qib7	10838	24	with	with	IN
cord-005453-4057qib7	10838	25	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10838	26	combination	combination	NN
cord-005453-4057qib7	10838	27	.	.	.
cord-005453-4057qib7	10839	1	In	in	IN
cord-005453-4057qib7	10839	2	patients	patient	NNS
cord-005453-4057qib7	10839	3	with	with	IN
cord-005453-4057qib7	10839	4	unsatisfactory	unsatisfactory	JJ
cord-005453-4057qib7	10839	5	response	response	NN
cord-005453-4057qib7	10839	6	to	to	IN
cord-005453-4057qib7	10839	7	nivolumab	nivolumab	NNP
cord-005453-4057qib7	10839	8	retreatment	retreatment	NN
cord-005453-4057qib7	10839	9	,	,	,
cord-005453-4057qib7	10839	10	HSCT	HSCT	NNP
cord-005453-4057qib7	10839	11	option	option	NN
cord-005453-4057qib7	10839	12	should	should	MD
cord-005453-4057qib7	10839	13	be	be	VB
cord-005453-4057qib7	10839	14	considered	consider	VBN
cord-005453-4057qib7	10839	15	.	.	.
cord-005453-4057qib7	10840	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10840	2	:	:	:
cord-005453-4057qib7	10840	3	Nothing	nothing	NN
cord-005453-4057qib7	10840	4	to	to	TO
cord-005453-4057qib7	10840	5	declare	declare	VB
cord-005453-4057qib7	10840	6	High	High	NNP
cord-005453-4057qib7	10840	7	dose	dose	NN
cord-005453-4057qib7	10840	8	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10840	9	with	with	IN
cord-005453-4057qib7	10840	10	autologous	autologous	JJ
cord-005453-4057qib7	10840	11	stem	stem	NN
cord-005453-4057qib7	10840	12	cell	cell	NN
cord-005453-4057qib7	10840	13	transplantation	transplantation	NN
cord-005453-4057qib7	10840	14	in	in	IN
cord-005453-4057qib7	10840	15	primary	primary	JJ
cord-005453-4057qib7	10840	16	central	central	JJ
cord-005453-4057qib7	10840	17	nervous	nervous	JJ
cord-005453-4057qib7	10840	18	system	system	NN
cord-005453-4057qib7	10840	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	10840	20	:	:	:
cord-005453-4057qib7	10841	1	Data	datum	NNS
cord-005453-4057qib7	10841	2	from	from	IN
cord-005453-4057qib7	10841	3	the	the	DT
cord-005453-4057qib7	10841	4	japan	japan	NNP
cord-005453-4057qib7	10841	5	society	society	NN
cord-005453-4057qib7	10841	6	for	for	IN
cord-005453-4057qib7	10841	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	10841	8	cell	cell	NN
cord-005453-4057qib7	10841	9	transplantation	transplantation	NN
cord-005453-4057qib7	10841	10	(	(	-LRB-
cord-005453-4057qib7	10841	11	JSHCT	JSHCT	NNP
cord-005453-4057qib7	10841	12	)	)	-RRB-
cord-005453-4057qib7	10841	13	registry	registry	NN
cord-005453-4057qib7	10841	14	Center	Center	NNP
cord-005453-4057qib7	10841	15	Hospital	Hospital	NNP
cord-005453-4057qib7	10841	16	,	,	,
cord-005453-4057qib7	10841	17	Tokyo	Tokyo	NNP
cord-005453-4057qib7	10841	18	,	,	,
cord-005453-4057qib7	10841	19	Japan	Japan	NNP
cord-005453-4057qib7	10841	20	,	,	,
cord-005453-4057qib7	10841	21	4	4	CD
cord-005453-4057qib7	10841	22	National	National	NNP
cord-005453-4057qib7	10841	23	Cancer	Cancer	NNP
cord-005453-4057qib7	10841	24	Institute	Institute	NNP
cord-005453-4057qib7	10841	25	,	,	,
cord-005453-4057qib7	10841	26	Bethesda	Bethesda	NNP
cord-005453-4057qib7	10841	27	,	,	,
cord-005453-4057qib7	10841	28	MD	MD	NNP
cord-005453-4057qib7	10841	29	,	,	,
cord-005453-4057qib7	10841	30	United	United	NNP
cord-005453-4057qib7	10841	31	States	States	NNP
cord-005453-4057qib7	10841	32	,	,	,
cord-005453-4057qib7	10841	33	5	5	CD
cord-005453-4057qib7	10841	34	Okayama	Okayama	NNP
cord-005453-4057qib7	10841	35	University	University	NNP
cord-005453-4057qib7	10841	36	Hospital	Hospital	NNP
cord-005453-4057qib7	10841	37	,	,	,
cord-005453-4057qib7	10841	38	Okayama	Okayama	NNP
cord-005453-4057qib7	10841	39	,	,	,
cord-005453-4057qib7	10841	40	Japan	Japan	NNP
cord-005453-4057qib7	10841	41	,	,	,
cord-005453-4057qib7	10841	42	6	6	CD
cord-005453-4057qib7	10841	43	Kanazawa	Kanazawa	NNP
cord-005453-4057qib7	10841	44	Medical	Medical	NNP
cord-005453-4057qib7	10841	45	University	University	NNP
cord-005453-4057qib7	10841	46	,	,	,
cord-005453-4057qib7	10841	47	Uchinada	Uchinada	NNP
cord-005453-4057qib7	10841	48	,	,	,
cord-005453-4057qib7	10841	49	Japan	Japan	NNP
cord-005453-4057qib7	10841	50	,	,	,
cord-005453-4057qib7	10841	51	7	7	CD
cord-005453-4057qib7	10841	52	Kyoto	Kyoto	NNP
cord-005453-4057qib7	10841	53	University	University	NNP
cord-005453-4057qib7	10841	54	,	,	,
cord-005453-4057qib7	10841	55	Kyoto	Kyoto	NNP
cord-005453-4057qib7	10841	56	,	,	,
cord-005453-4057qib7	10841	57	Japan	Japan	NNP
cord-005453-4057qib7	10841	58	,	,	,
cord-005453-4057qib7	10841	59	8	8	CD
cord-005453-4057qib7	10841	60	Aomori	Aomori	NNP
cord-005453-4057qib7	10841	61	Prefectural	Prefectural	NNP
cord-005453-4057qib7	10841	62	Central	Central	NNP
cord-005453-4057qib7	10841	63	Hospital	Hospital	NNP
cord-005453-4057qib7	10841	64	,	,	,
cord-005453-4057qib7	10841	65	Aomori	Aomori	NNP
cord-005453-4057qib7	10841	66	,	,	,
cord-005453-4057qib7	10841	67	Japan	Japan	NNP
cord-005453-4057qib7	10841	68	,	,	,
cord-005453-4057qib7	10841	69	9	9	CD
cord-005453-4057qib7	10841	70	Yamagata	Yamagata	NNP
cord-005453-4057qib7	10841	71	Unversity	Unversity	NNP
cord-005453-4057qib7	10841	72	School	School	NNP
cord-005453-4057qib7	10841	73	of	of	IN
cord-005453-4057qib7	10841	74	Medicine	Medicine	NNP
cord-005453-4057qib7	10841	75	,	,	,
cord-005453-4057qib7	10841	76	Yamagata	Yamagata	NNP
cord-005453-4057qib7	10841	77	,	,	,
cord-005453-4057qib7	10841	78	Japan	Japan	NNP
cord-005453-4057qib7	10841	79	,	,	,
cord-005453-4057qib7	10841	80	10	10	CD
cord-005453-4057qib7	10841	81	Tenri	Tenri	NNP
cord-005453-4057qib7	10841	82	Hospital	Hospital	NNP
cord-005453-4057qib7	10841	83	,	,	,
cord-005453-4057qib7	10841	84	Tenri	Tenri	NNP
cord-005453-4057qib7	10841	85	,	,	,
cord-005453-4057qib7	10841	86	Japan	Japan	NNP
cord-005453-4057qib7	10841	87	,	,	,
cord-005453-4057qib7	10841	88	11	11	CD
cord-005453-4057qib7	10841	89	Hiroshima	Hiroshima	NNP
cord-005453-4057qib7	10841	90	University	University	NNP
cord-005453-4057qib7	10841	91	,	,	,
cord-005453-4057qib7	10841	92	Hiroshima	Hiroshima	NNP
cord-005453-4057qib7	10841	93	,	,	,
cord-005453-4057qib7	10841	94	Japan	Japan	NNP
cord-005453-4057qib7	10841	95	,	,	,
cord-005453-4057qib7	10841	96	12	12	CD
cord-005453-4057qib7	10841	97	Japanese	Japanese	NNP
cord-005453-4057qib7	10841	98	Data	Data	NNPS
cord-005453-4057qib7	10841	99	Center	Center	NNP
cord-005453-4057qib7	10841	100	for	for	IN
cord-005453-4057qib7	10841	101	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	10841	102	Cell	Cell	NNP
cord-005453-4057qib7	10841	103	Transplantation	Transplantation	NNP
cord-005453-4057qib7	10841	104	,	,	,
cord-005453-4057qib7	10841	105	Nagoya	Nagoya	NNP
cord-005453-4057qib7	10841	106	,	,	,
cord-005453-4057qib7	10841	107	Japan	Japan	NNP
cord-005453-4057qib7	10841	108	,	,	,
cord-005453-4057qib7	10841	109	13	13	CD
cord-005453-4057qib7	10841	110	Nagoya	Nagoya	NNP
cord-005453-4057qib7	10841	111	University	University	NNP
cord-005453-4057qib7	10841	112	Graduate	Graduate	NNP
cord-005453-4057qib7	10841	113	School	School	NNP
cord-005453-4057qib7	10841	114	of	of	IN
cord-005453-4057qib7	10841	115	Medicine	Medicine	NNP
cord-005453-4057qib7	10841	116	,	,	,
cord-005453-4057qib7	10841	117	Nagoya	Nagoya	NNP
cord-005453-4057qib7	10841	118	,	,	,
cord-005453-4057qib7	10841	119	Japan	Japan	NNP
cord-005453-4057qib7	10841	120	,	,	,
cord-005453-4057qib7	10841	121	14	14	CD
cord-005453-4057qib7	10841	122	Shimane	Shimane	NNP
cord-005453-4057qib7	10841	123	University	University	NNP
cord-005453-4057qib7	10841	124	Hospital	Hospital	NNP
cord-005453-4057qib7	10841	125	,	,	,
cord-005453-4057qib7	10841	126	Izumo	Izumo	NNP
cord-005453-4057qib7	10841	127	,	,	,
cord-005453-4057qib7	10842	1	Japan	Japan	NNP
cord-005453-4057qib7	10842	2	Background	Background	NNP
cord-005453-4057qib7	10842	3	:	:	:
cord-005453-4057qib7	10842	4	High	high	JJ
cord-005453-4057qib7	10842	5	-	-	HYPH
cord-005453-4057qib7	10842	6	dose	dose	NN
cord-005453-4057qib7	10842	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10842	8	(	(	-LRB-
cord-005453-4057qib7	10842	9	HDT	HDT	NNP
cord-005453-4057qib7	10842	10	)	)	-RRB-
cord-005453-4057qib7	10842	11	with	with	IN
cord-005453-4057qib7	10842	12	autologous	autologous	JJ
cord-005453-4057qib7	10842	13	stem	stem	NN
cord-005453-4057qib7	10842	14	cell	cell	NN
cord-005453-4057qib7	10842	15	transplantation	transplantation	NN
cord-005453-4057qib7	10842	16	(	(	-LRB-
cord-005453-4057qib7	10842	17	ASCT	ASCT	NNP
cord-005453-4057qib7	10842	18	)	)	-RRB-
cord-005453-4057qib7	10842	19	has	have	VBZ
cord-005453-4057qib7	10842	20	been	be	VBN
cord-005453-4057qib7	10842	21	shown	show	VBN
cord-005453-4057qib7	10842	22	to	to	TO
cord-005453-4057qib7	10842	23	improve	improve	VB
cord-005453-4057qib7	10842	24	prognosis	prognosis	NN
cord-005453-4057qib7	10842	25	of	of	IN
cord-005453-4057qib7	10842	26	patients	patient	NNS
cord-005453-4057qib7	10842	27	with	with	IN
cord-005453-4057qib7	10842	28	central	central	JJ
cord-005453-4057qib7	10842	29	nervous	nervous	JJ
cord-005453-4057qib7	10842	30	system	system	NN
cord-005453-4057qib7	10842	31	(	(	-LRB-
cord-005453-4057qib7	10842	32	CNS	CNS	NNP
cord-005453-4057qib7	10842	33	)	)	-RRB-
cord-005453-4057qib7	10842	34	lymphoma	lymphoma	NN
cord-005453-4057qib7	10842	35	.	.	.
cord-005453-4057qib7	10843	1	Whereas	whereas	IN
cord-005453-4057qib7	10843	2	the	the	DT
cord-005453-4057qib7	10843	3	common	common	JJ
cord-005453-4057qib7	10843	4	regimen	regimen	NN
cord-005453-4057qib7	10843	5	of	of	IN
cord-005453-4057qib7	10843	6	HDT	HDT	NNP
cord-005453-4057qib7	10843	7	for	for	IN
cord-005453-4057qib7	10843	8	PCNSL	PCNSL	NNP
cord-005453-4057qib7	10843	9	in	in	IN
cord-005453-4057qib7	10843	10	the	the	DT
cord-005453-4057qib7	10843	11	Europe	Europe	NNP
cord-005453-4057qib7	10843	12	and	and	CC
cord-005453-4057qib7	10843	13	the	the	DT
cord-005453-4057qib7	10843	14	US	US	NNP
cord-005453-4057qib7	10843	15	is	be	VBZ
cord-005453-4057qib7	10843	16	thiotepa	thiotepa	RB
cord-005453-4057qib7	10843	17	-	-	HYPH
cord-005453-4057qib7	10843	18	based	base	VBN
cord-005453-4057qib7	10843	19	regimen	regimen	NN
cord-005453-4057qib7	10843	20	,	,	,
cord-005453-4057qib7	10843	21	e.g.	e.g.	RB
cord-005453-4057qib7	10843	22	BCNU	BCNU	NNP
cord-005453-4057qib7	10843	23	-	-	HYPH
cord-005453-4057qib7	10843	24	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	10843	25	,	,	,
cord-005453-4057qib7	10844	1	TBC	TBC	NNP
cord-005453-4057qib7	10844	2	(	(	-LRB-
cord-005453-4057qib7	10844	3	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	10844	4	-	-	HYPH
cord-005453-4057qib7	10844	5	Busulfan	Busulfan	NNP
cord-005453-4057qib7	10844	6	-	-	HYPH
cord-005453-4057qib7	10844	7	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	10844	8	)	)	-RRB-
cord-005453-4057qib7	10844	9	,	,	,
cord-005453-4057qib7	10844	10	thiotepa	thiotepa	RB
cord-005453-4057qib7	10844	11	-	-	HYPH
cord-005453-4057qib7	10844	12	based	base	VBN
cord-005453-4057qib7	10844	13	regimen	regimen	NN
cord-005453-4057qib7	10844	14	was	be	VBD
cord-005453-4057qib7	10844	15	only	only	RB
cord-005453-4057qib7	10844	16	available	available	JJ
cord-005453-4057qib7	10844	17	before	before	IN
cord-005453-4057qib7	10844	18	discontinuation	discontinuation	NN
cord-005453-4057qib7	10844	19	of	of	IN
cord-005453-4057qib7	10844	20	thiotepa	thiotepa	NNS
cord-005453-4057qib7	10844	21	in	in	IN
cord-005453-4057qib7	10844	22	2009	2009	CD
cord-005453-4057qib7	10844	23	in	in	IN
cord-005453-4057qib7	10844	24	Japan	Japan	NNP
cord-005453-4057qib7	10844	25	.	.	.
cord-005453-4057qib7	10845	1	We	-PRON-	PRP
cord-005453-4057qib7	10845	2	report	report	VBP
cord-005453-4057qib7	10845	3	the	the	DT
cord-005453-4057qib7	10845	4	results	result	NNS
cord-005453-4057qib7	10845	5	of	of	IN
cord-005453-4057qib7	10845	6	ASCT	ASCT	NNP
cord-005453-4057qib7	10845	7	for	for	IN
cord-005453-4057qib7	10845	8	PCNSL	PCNSL	NNP
cord-005453-4057qib7	10845	9	from	from	IN
cord-005453-4057qib7	10845	10	the	the	DT
cord-005453-4057qib7	10845	11	Japan	Japan	NNP
cord-005453-4057qib7	10845	12	Society	Society	NNP
cord-005453-4057qib7	10845	13	for	for	IN
cord-005453-4057qib7	10845	14	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	10845	15	Cell	Cell	NNP
cord-005453-4057qib7	10845	16	Transplantation	Transplantation	NNP
cord-005453-4057qib7	10845	17	(	(	-LRB-
cord-005453-4057qib7	10845	18	JSHCT	JSHCT	NNP
cord-005453-4057qib7	10845	19	)	)	-RRB-
cord-005453-4057qib7	10845	20	Registry	Registry	NNP
cord-005453-4057qib7	10845	21	.	.	.
cord-005453-4057qib7	10846	1	Methods	method	NNS
cord-005453-4057qib7	10846	2	:	:	:
cord-005453-4057qib7	10847	1	Data	datum	NNS
cord-005453-4057qib7	10847	2	from	from	IN
cord-005453-4057qib7	10847	3	the	the	DT
cord-005453-4057qib7	10847	4	JSHCT	JSHCT	NNP
cord-005453-4057qib7	10847	5	registry	registry	NN
cord-005453-4057qib7	10847	6	were	be	VBD
cord-005453-4057qib7	10847	7	retrospectively	retrospectively	RB
cord-005453-4057qib7	10847	8	analyzed	analyze	VBN
cord-005453-4057qib7	10847	9	.	.	.
cord-005453-4057qib7	10848	1	102	102	CD
cord-005453-4057qib7	10848	2	patients	patient	NNS
cord-005453-4057qib7	10848	3	with	with	IN
cord-005453-4057qib7	10848	4	PCNSL	PCNSL	NNP
cord-005453-4057qib7	10848	5	who	who	WP
cord-005453-4057qib7	10848	6	received	receive	VBD
cord-005453-4057qib7	10848	7	first	first	JJ
cord-005453-4057qib7	10848	8	HDT	HDT	NNP
cord-005453-4057qib7	10848	9	/	/	SYM
cord-005453-4057qib7	10848	10	ASCT	ASCT	NNP
cord-005453-4057qib7	10848	11	between	between	IN
cord-005453-4057qib7	10848	12	2006	2006	CD
cord-005453-4057qib7	10848	13	and	and	CC
cord-005453-4057qib7	10848	14	2015	2015	CD
cord-005453-4057qib7	10848	15	were	be	VBD
cord-005453-4057qib7	10848	16	evaluated	evaluate	VBN
cord-005453-4057qib7	10848	17	.	.	.
cord-005453-4057qib7	10849	1	Distribution	distribution	NN
cord-005453-4057qib7	10849	2	differences	difference	NNS
cord-005453-4057qib7	10849	3	of	of	IN
cord-005453-4057qib7	10849	4	clinical	clinical	JJ
cord-005453-4057qib7	10849	5	characteristics	characteristic	NNS
cord-005453-4057qib7	10849	6	between	between	IN
cord-005453-4057qib7	10849	7	groups	group	NNS
cord-005453-4057qib7	10849	8	were	be	VBD
cord-005453-4057qib7	10849	9	analyzed	analyze	VBN
cord-005453-4057qib7	10849	10	with	with	IN
cord-005453-4057qib7	10849	11	Fisher´s	fisher´s	JJ
cord-005453-4057qib7	10849	12	exact	exact	NN
cord-005453-4057qib7	10849	13	or	or	CC
cord-005453-4057qib7	10849	14	Mann	Mann	NNP
cord-005453-4057qib7	10849	15	-	-	HYPH
cord-005453-4057qib7	10849	16	Whitney	Whitney	NNP
cord-005453-4057qib7	10849	17	U	U	NNP
cord-005453-4057qib7	10849	18	tests	test	VBZ
cord-005453-4057qib7	10849	19	.	.	.
cord-005453-4057qib7	10850	1	Overall	overall	JJ
cord-005453-4057qib7	10850	2	survival	survival	NN
cord-005453-4057qib7	10850	3	(	(	-LRB-
cord-005453-4057qib7	10850	4	OS	OS	NNP
cord-005453-4057qib7	10850	5	)	)	-RRB-
cord-005453-4057qib7	10850	6	and	and	CC
cord-005453-4057qib7	10850	7	progression	progression	NN
cord-005453-4057qib7	10850	8	free	free	JJ
cord-005453-4057qib7	10850	9	survival	survival	NN
cord-005453-4057qib7	10850	10	(	(	-LRB-
cord-005453-4057qib7	10850	11	PFS	PFS	NNP
cord-005453-4057qib7	10850	12	)	)	-RRB-
cord-005453-4057qib7	10850	13	were	be	VBD
cord-005453-4057qib7	10850	14	calculated	calculate	VBN
cord-005453-4057qib7	10850	15	using	use	VBG
cord-005453-4057qib7	10850	16	Kaplan	Kaplan	NNP
cord-005453-4057qib7	10850	17	-	-	HYPH
cord-005453-4057qib7	10850	18	Meier	Meier	NNP
cord-005453-4057qib7	10850	19	method	method	NN
cord-005453-4057qib7	10850	20	.	.	.
cord-005453-4057qib7	10851	1	Two	two	CD
cord-005453-4057qib7	10851	2	-	-	HYPH
cord-005453-4057qib7	10851	3	group	group	NN
cord-005453-4057qib7	10851	4	analysis	analysis	NN
cord-005453-4057qib7	10851	5	of	of	IN
cord-005453-4057qib7	10851	6	the	the	DT
cord-005453-4057qib7	10851	7	cumulative	cumulative	JJ
cord-005453-4057qib7	10851	8	incidence	incidence	NN
cord-005453-4057qib7	10851	9	of	of	IN
cord-005453-4057qib7	10851	10	relapse	relapse	NN
cord-005453-4057qib7	10851	11	was	be	VBD
cord-005453-4057qib7	10851	12	conducted	conduct	VBN
cord-005453-4057qib7	10851	13	using	use	VBG
cord-005453-4057qib7	10851	14	the	the	DT
cord-005453-4057qib7	10851	15	Grey	Grey	NNP
cord-005453-4057qib7	10851	16	test	test	NN
cord-005453-4057qib7	10851	17	.	.	.
cord-005453-4057qib7	10852	1	Factors	factor	NNS
cord-005453-4057qib7	10852	2	were	be	VBD
cord-005453-4057qib7	10852	3	analyzed	analyze	VBN
cord-005453-4057qib7	10852	4	in	in	IN
cord-005453-4057qib7	10852	5	univariable	univariable	JJ
cord-005453-4057qib7	10852	6	analysis	analysis	NN
cord-005453-4057qib7	10852	7	,	,	,
cord-005453-4057qib7	10852	8	and	and	CC
cord-005453-4057qib7	10852	9	all	all	DT
cord-005453-4057qib7	10852	10	factors	factor	NNS
cord-005453-4057qib7	10852	11	with	with	IN
cord-005453-4057qib7	10852	12	P≤.1	P≤.1	NNS
cord-005453-4057qib7	10852	13	were	be	VBD
cord-005453-4057qib7	10852	14	retained	retain	VBN
cord-005453-4057qib7	10852	15	in	in	IN
cord-005453-4057qib7	10852	16	the	the	DT
cord-005453-4057qib7	10852	17	multivariable	multivariable	JJ
cord-005453-4057qib7	10852	18	model	model	NN
cord-005453-4057qib7	10852	19	.	.	.
cord-005453-4057qib7	10853	1	All	all	DT
cord-005453-4057qib7	10853	2	P	p	NN
cord-005453-4057qib7	10853	3	values	value	NNS
cord-005453-4057qib7	10853	4	were	be	VBD
cord-005453-4057qib7	10853	5	2	2	CD
cord-005453-4057qib7	10853	6	sided	sided	JJ
cord-005453-4057qib7	10853	7	,	,	,
cord-005453-4057qib7	10853	8	and	and	CC
cord-005453-4057qib7	10853	9	values	value	NNS
cord-005453-4057qib7	10853	10	were	be	VBD
cord-005453-4057qib7	10853	11	regarded	regard	VBN
cord-005453-4057qib7	10853	12	statistically	statistically	RB
cord-005453-4057qib7	10853	13	significant	significant	JJ
cord-005453-4057qib7	10853	14	if	if	IN
cord-005453-4057qib7	10853	15	P	p	NN
cord-005453-4057qib7	10853	16	<	<	XX
cord-005453-4057qib7	10853	17	.05	.05	NFP
cord-005453-4057qib7	10853	18	.	.	.
cord-005453-4057qib7	10854	1	Results	result	NNS
cord-005453-4057qib7	10854	2	:	:	:
cord-005453-4057qib7	10855	1	Median	median	JJ
cord-005453-4057qib7	10855	2	age	age	NN
cord-005453-4057qib7	10855	3	was	be	VBD
cord-005453-4057qib7	10855	4	54	54	CD
cord-005453-4057qib7	10855	5	months	month	NNS
cord-005453-4057qib7	10856	1	(	(	-LRB-
cord-005453-4057qib7	10856	2	range	range	NN
cord-005453-4057qib7	10856	3	20	20	CD
cord-005453-4057qib7	10856	4	-	-	SYM
cord-005453-4057qib7	10856	5	74	74	CD
cord-005453-4057qib7	10856	6	)	)	-RRB-
cord-005453-4057qib7	10856	7	with	with	IN
cord-005453-4057qib7	10856	8	15	15	CD
cord-005453-4057qib7	10856	9	patients	patient	NNS
cord-005453-4057qib7	10856	10	over	over	IN
cord-005453-4057qib7	10856	11	64	64	CD
cord-005453-4057qib7	10856	12	years	year	NNS
cord-005453-4057qib7	10856	13	of	of	IN
cord-005453-4057qib7	10856	14	age	age	NN
cord-005453-4057qib7	10856	15	;	;	:
cord-005453-4057qib7	10856	16	38	38	CD
cord-005453-4057qib7	10856	17	males	male	NNS
cord-005453-4057qib7	10856	18	and	and	CC
cord-005453-4057qib7	10856	19	64	64	CD
cord-005453-4057qib7	10856	20	females	female	NNS
cord-005453-4057qib7	10856	21	.	.	.
cord-005453-4057qib7	10857	1	ECOG	ECOG	NNP
cord-005453-4057qib7	10857	2	-	-	HYPH
cord-005453-4057qib7	10857	3	Performance	Performance	NNP
cord-005453-4057qib7	10857	4	Status	status	NN
cord-005453-4057qib7	10857	5	(	(	-LRB-
cord-005453-4057qib7	10857	6	PS	PS	NNP
cord-005453-4057qib7	10857	7	)	)	-RRB-
cord-005453-4057qib7	10857	8	at	at	IN
cord-005453-4057qib7	10857	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	10857	10	was	be	VBD
cord-005453-4057qib7	10857	11	better	well	JJR
cord-005453-4057qib7	10858	1	(	(	-LRB-
cord-005453-4057qib7	10858	2	PS0	PS0	NNP
cord-005453-4057qib7	10858	3	-	-	HYPH
cord-005453-4057qib7	10858	4	1	1	CD
cord-005453-4057qib7	10858	5	)	)	-RRB-
cord-005453-4057qib7	10859	1	in	in	IN
cord-005453-4057qib7	10859	2	86	86	CD
cord-005453-4057qib7	10859	3	patients	patient	NNS
cord-005453-4057qib7	10859	4	and	and	CC
cord-005453-4057qib7	10859	5	poor	poor	JJ
cord-005453-4057qib7	10859	6	(	(	-LRB-
cord-005453-4057qib7	10859	7	PS2	PS2	NNP
cord-005453-4057qib7	10859	8	-	-	HYPH
cord-005453-4057qib7	10859	9	4	4	CD
cord-005453-4057qib7	10859	10	)	)	-RRB-
cord-005453-4057qib7	10859	11	in	in	IN
cord-005453-4057qib7	10859	12	16	16	CD
cord-005453-4057qib7	10859	13	patients	patient	NNS
cord-005453-4057qib7	10859	14	.	.	.
cord-005453-4057qib7	10860	1	Serum	serum	NN
cord-005453-4057qib7	10860	2	lactate	lactate	NN
cord-005453-4057qib7	10860	3	dehydrogenase	dehydrogenase	NN
cord-005453-4057qib7	10860	4	(	(	-LRB-
cord-005453-4057qib7	10860	5	LDH	LDH	NNP
cord-005453-4057qib7	10860	6	)	)	-RRB-
cord-005453-4057qib7	10860	7	levels	level	NNS
cord-005453-4057qib7	10860	8	at	at	IN
cord-005453-4057qib7	10860	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	10860	10	were	be	VBD
cord-005453-4057qib7	10860	11	elevated	elevate	VBN
cord-005453-4057qib7	10860	12	in	in	IN
cord-005453-4057qib7	10860	13	17	17	CD
cord-005453-4057qib7	10860	14	patients	patient	NNS
cord-005453-4057qib7	10860	15	.	.	.
cord-005453-4057qib7	10861	1	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	10861	2	PS	PS	NNP
cord-005453-4057qib7	10861	3	and	and	CC
cord-005453-4057qib7	10861	4	Cerebrospinal	cerebrospinal	NN
cord-005453-4057qib7	10861	5	fluid	fluid	NN
cord-005453-4057qib7	10861	6	(	(	-LRB-
cord-005453-4057qib7	10861	7	CSF	CSF	NNP
cord-005453-4057qib7	10861	8	)	)	-RRB-
cord-005453-4057qib7	10861	9	protein	protein	NN
cord-005453-4057qib7	10861	10	concentration	concentration	NN
cord-005453-4057qib7	10861	11	at	at	IN
cord-005453-4057qib7	10861	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	10861	13	were	be	VBD
cord-005453-4057qib7	10861	14	not	not	RB
cord-005453-4057qib7	10861	15	collected	collect	VBN
cord-005453-4057qib7	10861	16	in	in	IN
cord-005453-4057qib7	10861	17	the	the	DT
cord-005453-4057qib7	10861	18	registry	registry	NN
cord-005453-4057qib7	10861	19	.	.	.
cord-005453-4057qib7	10862	1	71	71	CD
cord-005453-4057qib7	10862	2	patients	patient	NNS
cord-005453-4057qib7	10862	3	were	be	VBD
cord-005453-4057qib7	10862	4	in	in	IN
cord-005453-4057qib7	10862	5	complete	complete	JJ
cord-005453-4057qib7	10862	6	remission	remission	NN
cord-005453-4057qib7	10862	7	(	(	-LRB-
cord-005453-4057qib7	10862	8	CR	CR	NNP
cord-005453-4057qib7	10862	9	)	)	-RRB-
cord-005453-4057qib7	10862	10	,	,	,
cord-005453-4057qib7	10862	11	21	21	CD
cord-005453-4057qib7	10862	12	patients	patient	NNS
cord-005453-4057qib7	10862	13	were	be	VBD
cord-005453-4057qib7	10862	14	in	in	IN
cord-005453-4057qib7	10862	15	partial	partial	JJ
cord-005453-4057qib7	10862	16	response	response	NN
cord-005453-4057qib7	10862	17	(	(	-LRB-
cord-005453-4057qib7	10862	18	PR	PR	NNP
cord-005453-4057qib7	10862	19	)	)	-RRB-
cord-005453-4057qib7	10862	20	,	,	,
cord-005453-4057qib7	10862	21	and	and	CC
cord-005453-4057qib7	10862	22	7	7	CD
cord-005453-4057qib7	10862	23	patients	patient	NNS
cord-005453-4057qib7	10862	24	were	be	VBD
cord-005453-4057qib7	10862	25	stable	stable	JJ
cord-005453-4057qib7	10862	26	disease	disease	NN
cord-005453-4057qib7	10862	27	(	(	-LRB-
cord-005453-4057qib7	10862	28	SD	SD	NNP
cord-005453-4057qib7	10862	29	)	)	-RRB-
cord-005453-4057qib7	10862	30	or	or	CC
cord-005453-4057qib7	10862	31	progressive	progressive	JJ
cord-005453-4057qib7	10862	32	disease	disease	NN
cord-005453-4057qib7	10862	33	(	(	-LRB-
cord-005453-4057qib7	10862	34	PD	PD	NNP
cord-005453-4057qib7	10862	35	)	)	-RRB-
cord-005453-4057qib7	10862	36	at	at	IN
cord-005453-4057qib7	10862	37	the	the	DT
cord-005453-4057qib7	10862	38	time	time	NN
cord-005453-4057qib7	10862	39	of	of	IN
cord-005453-4057qib7	10862	40	HDT	HDT	NNP
cord-005453-4057qib7	10862	41	/	/	SYM
cord-005453-4057qib7	10862	42	ASCT	ASCT	NNP
cord-005453-4057qib7	10862	43	.	.	.
cord-005453-4057qib7	10863	1	After	after	IN
cord-005453-4057qib7	10863	2	HDT	HDT	NNP
cord-005453-4057qib7	10863	3	/	/	SYM
cord-005453-4057qib7	10863	4	ASCT	ASCT	NNP
cord-005453-4057qib7	10863	5	,	,	,
cord-005453-4057qib7	10863	6	additional	additional	JJ
cord-005453-4057qib7	10863	7	20	20	CD
cord-005453-4057qib7	10863	8	patients	patient	NNS
cord-005453-4057qib7	10863	9	achieved	achieve	VBD
cord-005453-4057qib7	10863	10	CR	CR	NNP
cord-005453-4057qib7	10863	11	.	.	.
cord-005453-4057qib7	10864	1	With	with	IN
cord-005453-4057qib7	10864	2	median	median	JJ
cord-005453-4057qib7	10864	3	follow	follow	NN
cord-005453-4057qib7	10864	4	-	-	HYPH
cord-005453-4057qib7	10864	5	up	up	NN
cord-005453-4057qib7	10864	6	period	period	NN
cord-005453-4057qib7	10864	7	of	of	IN
cord-005453-4057qib7	10864	8	44	44	CD
cord-005453-4057qib7	10864	9	months	month	NNS
cord-005453-4057qib7	10864	10	,	,	,
cord-005453-4057qib7	10864	11	the	the	DT
cord-005453-4057qib7	10864	12	5-year	5-year	CD
cord-005453-4057qib7	10864	13	OS	OS	NNP
cord-005453-4057qib7	10864	14	and	and	CC
cord-005453-4057qib7	10864	15	PFS	PFS	NNP
cord-005453-4057qib7	10864	16	were	be	VBD
cord-005453-4057qib7	10864	17	54.9	54.9	CD
cord-005453-4057qib7	10864	18	%	%	NN
cord-005453-4057qib7	10864	19	and	and	CC
cord-005453-4057qib7	10864	20	38.4	38.4	CD
cord-005453-4057qib7	10864	21	%	%	NN
cord-005453-4057qib7	10864	22	,	,	,
cord-005453-4057qib7	10864	23	respectively	respectively	RB
cord-005453-4057qib7	10864	24	.	.	.
cord-005453-4057qib7	10865	1	The	the	DT
cord-005453-4057qib7	10865	2	was	be	VBD
cord-005453-4057qib7	10865	3	no	no	DT
cord-005453-4057qib7	10865	4	significant	significant	JJ
cord-005453-4057qib7	10865	5	difference	difference	NN
cord-005453-4057qib7	10865	6	in	in	IN
cord-005453-4057qib7	10865	7	OS	OS	NNP
cord-005453-4057qib7	10865	8	and	and	CC
cord-005453-4057qib7	10865	9	PFS	PFS	NNP
cord-005453-4057qib7	10865	10	between	between	IN
cord-005453-4057qib7	10865	11	upfront	upfront	NN
cord-005453-4057qib7	10865	12	and	and	CC
cord-005453-4057qib7	10865	13	salvage	salvage	VB
cord-005453-4057qib7	10865	14	HDT	HDT	NNP
cord-005453-4057qib7	10865	15	/	/	SYM
cord-005453-4057qib7	10865	16	ASCT	ASCT	NNP
cord-005453-4057qib7	10865	17	.	.	.
cord-005453-4057qib7	10866	1	Since	since	IN
cord-005453-4057qib7	10866	2	thiotepa	thiotepa	NNP
cord-005453-4057qib7	10866	3	,	,	,
cord-005453-4057qib7	10866	4	a	a	DT
cord-005453-4057qib7	10866	5	key	key	JJ
cord-005453-4057qib7	10866	6	agent	agent	NN
cord-005453-4057qib7	10866	7	in	in	IN
cord-005453-4057qib7	10866	8	HDT	HDT	NNP
cord-005453-4057qib7	10866	9	/	/	SYM
cord-005453-4057qib7	10866	10	ASCT	ASCT	NNP
cord-005453-4057qib7	10866	11	for	for	IN
cord-005453-4057qib7	10866	12	PCNSL	PCNSL	NNP
cord-005453-4057qib7	10866	13	,	,	,
cord-005453-4057qib7	10866	14	has	have	VBZ
cord-005453-4057qib7	10866	15	been	be	VBN
cord-005453-4057qib7	10866	16	unavailable	unavailable	JJ
cord-005453-4057qib7	10866	17	after	after	IN
cord-005453-4057qib7	10866	18	the	the	DT
cord-005453-4057qib7	10866	19	discontinuation	discontinuation	NN
cord-005453-4057qib7	10866	20	in	in	IN
cord-005453-4057qib7	10866	21	Japan	Japan	NNP
cord-005453-4057qib7	10866	22	,	,	,
cord-005453-4057qib7	10866	23	the	the	DT
cord-005453-4057qib7	10866	24	HDT	HDT	NNP
cord-005453-4057qib7	10866	25	regimens	regimen	NNS
cord-005453-4057qib7	10866	26	used	use	VBN
cord-005453-4057qib7	10866	27	were	be	VBD
cord-005453-4057qib7	10866	28	not	not	RB
cord-005453-4057qib7	10866	29	uniform	uniform	JJ
cord-005453-4057qib7	10866	30	.	.	.
cord-005453-4057qib7	10867	1	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	10867	2	-	-	HYPH
cord-005453-4057qib7	10867	3	containing	contain	VBG
cord-005453-4057qib7	10867	4	HDT	HDT	NNP
cord-005453-4057qib7	10867	5	was	be	VBD
cord-005453-4057qib7	10867	6	received	receive	VBN
cord-005453-4057qib7	10867	7	by	by	IN
cord-005453-4057qib7	10867	8	16	16	CD
cord-005453-4057qib7	10867	9	out	out	IN
cord-005453-4057qib7	10867	10	of	of	IN
cord-005453-4057qib7	10867	11	32	32	CD
cord-005453-4057qib7	10867	12	patients	patient	NNS
cord-005453-4057qib7	10867	13	before	before	IN
cord-005453-4057qib7	10867	14	2010	2010	CD
cord-005453-4057qib7	10867	15	,	,	,
cord-005453-4057qib7	10867	16	but	but	CC
cord-005453-4057qib7	10867	17	by	by	IN
cord-005453-4057qib7	10867	18	2	2	CD
cord-005453-4057qib7	10867	19	out	out	IN
cord-005453-4057qib7	10867	20	of	of	IN
cord-005453-4057qib7	10867	21	70	70	CD
cord-005453-4057qib7	10867	22	patients	patient	NNS
cord-005453-4057qib7	10867	23	after	after	IN
cord-005453-4057qib7	10867	24	2011	2011	CD
cord-005453-4057qib7	10867	25	.	.	.
cord-005453-4057qib7	10868	1	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	10868	2	-	-	HYPH
cord-005453-4057qib7	10868	3	containing	contain	VBG
cord-005453-4057qib7	10868	4	HDT	HDT	NNP
cord-005453-4057qib7	10868	5	showed	show	VBD
cord-005453-4057qib7	10868	6	improved	improve	VBN
cord-005453-4057qib7	10868	7	PFS	PFS	NNP
cord-005453-4057qib7	10868	8	(	(	-LRB-
cord-005453-4057qib7	10868	9	P=.019	P=.019	NNP
cord-005453-4057qib7	10868	10	)	)	-RRB-
cord-005453-4057qib7	10868	11	,	,	,
cord-005453-4057qib7	10868	12	lower	low	JJR
cord-005453-4057qib7	10868	13	relapse	relapse	NN
cord-005453-4057qib7	10868	14	(	(	-LRB-
cord-005453-4057qib7	10868	15	P=.042	P=.042	NNP
cord-005453-4057qib7	10868	16	)	)	-RRB-
cord-005453-4057qib7	10868	17	and	and	CC
cord-005453-4057qib7	10868	18	a	a	DT
cord-005453-4057qib7	10868	19	trend	trend	NN
cord-005453-4057qib7	10868	20	toward	toward	IN
cord-005453-4057qib7	10868	21	a	a	DT
cord-005453-4057qib7	10868	22	survival	survival	NN
cord-005453-4057qib7	10868	23	benefit	benefit	NN
cord-005453-4057qib7	10868	24	.	.	.
cord-005453-4057qib7	10869	1	In	in	IN
cord-005453-4057qib7	10869	2	the	the	DT
cord-005453-4057qib7	10869	3	multivariate	multivariate	JJ
cord-005453-4057qib7	10869	4	analysis	analysis	NN
cord-005453-4057qib7	10869	5	,	,	,
cord-005453-4057qib7	10869	6	non	non	JJ
cord-005453-4057qib7	10869	7	-	-	JJ
cord-005453-4057qib7	10869	8	complete	complete	JJ
cord-005453-4057qib7	10869	9	remission	remission	NN
cord-005453-4057qib7	10869	10	at	at	IN
cord-005453-4057qib7	10869	11	HDT	HDT	NNP
cord-005453-4057qib7	10869	12	/	/	SYM
cord-005453-4057qib7	10869	13	ASCT	ASCT	NNP
cord-005453-4057qib7	10869	14	was	be	VBD
cord-005453-4057qib7	10869	15	an	an	DT
cord-005453-4057qib7	10869	16	independent	independent	JJ
cord-005453-4057qib7	10869	17	predictor	predictor	NN
cord-005453-4057qib7	10869	18	for	for	IN
cord-005453-4057qib7	10869	19	OS	OS	NNP
cord-005453-4057qib7	10869	20	(	(	-LRB-
cord-005453-4057qib7	10869	21	HR=2.40	HR=2.40	NNP
cord-005453-4057qib7	10869	22	,	,	,
cord-005453-4057qib7	10869	23	95%CI:1.25	95%ci:1.25	CD
cord-005453-4057qib7	10869	24	-	-	SYM
cord-005453-4057qib7	10869	25	4.58	4.58	CD
cord-005453-4057qib7	10869	26	,	,	,
cord-005453-4057qib7	10869	27	P=.008	p=.008	NN
cord-005453-4057qib7	10869	28	)	)	-RRB-
cord-005453-4057qib7	10869	29	and	and	CC
cord-005453-4057qib7	10869	30	thiotepacontaining	thiotepacontaine	VBG
cord-005453-4057qib7	10869	31	HDT	HDT	NNP
cord-005453-4057qib7	10869	32	remained	remain	VBD
cord-005453-4057qib7	10869	33	significant	significant	JJ
cord-005453-4057qib7	10869	34	for	for	IN
cord-005453-4057qib7	10869	35	PFS	PFS	NNP
cord-005453-4057qib7	10869	36	(	(	-LRB-
cord-005453-4057qib7	10869	37	HR=0.42	HR=0.42	NNP
cord-005453-4057qib7	10869	38	,	,	,
cord-005453-4057qib7	10869	39	95%CI:0.19	95%ci:0.19	CD
cord-005453-4057qib7	10869	40	-	-	SYM
cord-005453-4057qib7	10869	41	0.95	0.95	CD
cord-005453-4057qib7	10869	42	,	,	,
cord-005453-4057qib7	10869	43	P=.038	P=.038	NNP
cord-005453-4057qib7	10869	44	)	)	-RRB-
cord-005453-4057qib7	10869	45	.	.	.
cord-005453-4057qib7	10870	1	[	[	-LRB-
cord-005453-4057qib7	10870	2	[	[	-LRB-
cord-005453-4057qib7	10870	3	P481	P481	NNP
cord-005453-4057qib7	10870	4	Image	Image	NNP
cord-005453-4057qib7	10870	5	]	]	-RRB-
cord-005453-4057qib7	10870	6	1	1	CD
cord-005453-4057qib7	10870	7	.	.	.
cord-005453-4057qib7	10871	1	OS(A),PFS(B	os(a),pfs(b	LS
cord-005453-4057qib7	10871	2	)	)	-RRB-
cord-005453-4057qib7	10872	1	in	in	IN
cord-005453-4057qib7	10872	2	all	all	DT
cord-005453-4057qib7	10872	3	patients	patient	NNS
cord-005453-4057qib7	10872	4	(	(	-LRB-
cord-005453-4057qib7	10872	5	n=102	n=102	UH
cord-005453-4057qib7	10872	6	)	)	-RRB-
cord-005453-4057qib7	10872	7	and	and	CC
cord-005453-4057qib7	10872	8	cumulative	cumulative	JJ
cord-005453-4057qib7	10872	9	incidence	incidence	NN
cord-005453-4057qib7	10872	10	of	of	IN
cord-005453-4057qib7	10872	11	relapse	relapse	NN
cord-005453-4057qib7	10872	12	in	in	IN
cord-005453-4057qib7	10872	13	CR	CR	NNP
cord-005453-4057qib7	10872	14	patients	patient	NNS
cord-005453-4057qib7	10872	15	(	(	-LRB-
cord-005453-4057qib7	10872	16	C	C	NNP
cord-005453-4057qib7	10872	17	;	;	:
cord-005453-4057qib7	10872	18	n=91	n=91	NNP
cord-005453-4057qib7	10872	19	)	)	-RRB-
cord-005453-4057qib7	10873	1	]	]	-RRB-
cord-005453-4057qib7	10874	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10874	2	:	:	:
cord-005453-4057qib7	10875	1	Our	-PRON-	PRP$
cord-005453-4057qib7	10875	2	results	result	NNS
cord-005453-4057qib7	10875	3	confirm	confirm	VBP
cord-005453-4057qib7	10875	4	the	the	DT
cord-005453-4057qib7	10875	5	activity	activity	NN
cord-005453-4057qib7	10875	6	of	of	IN
cord-005453-4057qib7	10875	7	thiotepacontaining	thiotepacontaine	VBG
cord-005453-4057qib7	10875	8	regimen	regimen	NN
cord-005453-4057qib7	10875	9	for	for	IN
cord-005453-4057qib7	10875	10	HDT	HDT	NNP
cord-005453-4057qib7	10875	11	/	/	SYM
cord-005453-4057qib7	10875	12	ASCT	ASCT	NNP
cord-005453-4057qib7	10875	13	in	in	IN
cord-005453-4057qib7	10875	14	PCNSL	PCNSL	NNP
cord-005453-4057qib7	10875	15	patients	patient	NNS
cord-005453-4057qib7	10875	16	.	.	.
cord-005453-4057qib7	10876	1	Currently	currently	RB
cord-005453-4057qib7	10876	2	a	a	DT
cord-005453-4057qib7	10876	3	pharmaceutical	pharmaceutical	JJ
cord-005453-4057qib7	10876	4	company	company	NN
cord-005453-4057qib7	10876	5	re	re	NN
cord-005453-4057qib7	10876	6	-	-	VBN
cord-005453-4057qib7	10876	7	develops	develop	VBZ
cord-005453-4057qib7	10876	8	thiotepa	thiotepa	NNP
cord-005453-4057qib7	10876	9	for	for	IN
cord-005453-4057qib7	10876	10	new	new	JJ
cord-005453-4057qib7	10876	11	approval	approval	NN
cord-005453-4057qib7	10876	12	of	of	IN
cord-005453-4057qib7	10876	13	HDT	HDT	NNP
cord-005453-4057qib7	10876	14	/	/	SYM
cord-005453-4057qib7	10876	15	ASCT	ASCT	NNP
cord-005453-4057qib7	10876	16	in	in	IN
cord-005453-4057qib7	10876	17	pediatric	pediatric	JJ
cord-005453-4057qib7	10876	18	solid	solid	JJ
cord-005453-4057qib7	10876	19	cancer	cancer	NN
cord-005453-4057qib7	10876	20	and	and	CC
cord-005453-4057qib7	10876	21	adult	adult	NN
cord-005453-4057qib7	10876	22	lymphoma	lymphoma	NN
cord-005453-4057qib7	10876	23	in	in	IN
cord-005453-4057qib7	10876	24	Japan	Japan	NNP
cord-005453-4057qib7	10876	25	(	(	-LRB-
cord-005453-4057qib7	10876	26	JapicCTI-163433	JapicCTI-163433	NNP
cord-005453-4057qib7	10876	27	)	)	-RRB-
cord-005453-4057qib7	10876	28	.	.	.
cord-005453-4057qib7	10877	1	Further	further	JJ
cord-005453-4057qib7	10877	2	evaluation	evaluation	NN
cord-005453-4057qib7	10877	3	with	with	IN
cord-005453-4057qib7	10877	4	the	the	DT
cord-005453-4057qib7	10877	5	thiotepa	thiotepa	NNS
cord-005453-4057qib7	10877	6	by	by	IN
cord-005453-4057qib7	10877	7	prospective	prospective	JJ
cord-005453-4057qib7	10877	8	clinical	clinical	JJ
cord-005453-4057qib7	10877	9	trials	trial	NNS
cord-005453-4057qib7	10877	10	is	be	VBZ
cord-005453-4057qib7	10877	11	warranted	warrant	VBN
cord-005453-4057qib7	10877	12	.	.	.
cord-005453-4057qib7	10878	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10878	2	Background	background	NN
cord-005453-4057qib7	10878	3	:	:	:
cord-005453-4057qib7	10878	4	T	t	NN
cord-005453-4057qib7	10878	5	-	-	HYPH
cord-005453-4057qib7	10878	6	cell	cell	NN
cord-005453-4057qib7	10878	7	non	non	JJ
cord-005453-4057qib7	10878	8	-	-	JJ
cord-005453-4057qib7	10878	9	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	10878	10	lymphomas	lymphoma	NNS
cord-005453-4057qib7	10878	11	(	(	-LRB-
cord-005453-4057qib7	10878	12	T	T	NNP
cord-005453-4057qib7	10878	13	-	-	HYPH
cord-005453-4057qib7	10878	14	NHL	NHL	NNP
cord-005453-4057qib7	10878	15	)	)	-RRB-
cord-005453-4057qib7	10878	16	are	be	VBP
cord-005453-4057qib7	10878	17	rare	rare	JJ
cord-005453-4057qib7	10878	18	diseases	disease	NNS
cord-005453-4057qib7	10878	19	and	and	CC
cord-005453-4057qib7	10878	20	they	-PRON-	PRP
cord-005453-4057qib7	10878	21	are	be	VBP
cord-005453-4057qib7	10878	22	associated	associate	VBN
cord-005453-4057qib7	10878	23	with	with	IN
cord-005453-4057qib7	10878	24	worse	bad	JJR
cord-005453-4057qib7	10878	25	prognosis	prognosis	NN
cord-005453-4057qib7	10878	26	when	when	WRB
cord-005453-4057qib7	10878	27	compared	compare	VBN
cord-005453-4057qib7	10878	28	to	to	IN
cord-005453-4057qib7	10878	29	their	-PRON-	PRP$
cord-005453-4057qib7	10878	30	B	b	NN
cord-005453-4057qib7	10878	31	-	-	HYPH
cord-005453-4057qib7	10878	32	cell	cell	NN
cord-005453-4057qib7	10878	33	counterparts	counterpart	NNS
cord-005453-4057qib7	10878	34	.	.	.
cord-005453-4057qib7	10879	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	10879	2	stem	stem	VBP
cord-005453-4057qib7	10879	3	cell	cell	NN
cord-005453-4057qib7	10879	4	transplantation	transplantation	NN
cord-005453-4057qib7	10879	5	(	(	-LRB-
cord-005453-4057qib7	10879	6	allo	allo	FW
cord-005453-4057qib7	10879	7	-	-	HYPH
cord-005453-4057qib7	10879	8	SCT	SCT	NNP
cord-005453-4057qib7	10879	9	)	)	-RRB-
cord-005453-4057qib7	10879	10	may	may	MD
cord-005453-4057qib7	10879	11	have	have	VB
cord-005453-4057qib7	10879	12	a	a	DT
cord-005453-4057qib7	10879	13	curative	curative	JJ
cord-005453-4057qib7	10879	14	potential	potential	NN
cord-005453-4057qib7	10879	15	for	for	IN
cord-005453-4057qib7	10879	16	these	these	DT
cord-005453-4057qib7	10879	17	patients	patient	NNS
cord-005453-4057qib7	10879	18	due	due	JJ
cord-005453-4057qib7	10879	19	to	to	IN
cord-005453-4057qib7	10879	20	the	the	DT
cord-005453-4057qib7	10879	21	graft	graft	NN
cord-005453-4057qib7	10879	22	versus	versus	IN
cord-005453-4057qib7	10879	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	10879	24	effect	effect	NN
cord-005453-4057qib7	10879	25	.	.	.
cord-005453-4057qib7	10880	1	However	however	RB
cord-005453-4057qib7	10880	2	,	,	,
cord-005453-4057qib7	10880	3	data	datum	NNS
cord-005453-4057qib7	10880	4	is	be	VBZ
cord-005453-4057qib7	10880	5	limited	limit	VBN
cord-005453-4057qib7	10880	6	on	on	IN
cord-005453-4057qib7	10880	7	the	the	DT
cord-005453-4057qib7	10880	8	efficacy	efficacy	NN
cord-005453-4057qib7	10880	9	of	of	IN
cord-005453-4057qib7	10880	10	allo	allo	NNP
cord-005453-4057qib7	10880	11	-	-	HYPH
cord-005453-4057qib7	10880	12	SCT	SCT	NNP
cord-005453-4057qib7	10880	13	for	for	IN
cord-005453-4057qib7	10880	14	these	these	DT
cord-005453-4057qib7	10880	15	diseases	disease	NNS
cord-005453-4057qib7	10880	16	.	.	.
cord-005453-4057qib7	10881	1	Methods	method	NNS
cord-005453-4057qib7	10881	2	:	:	:
cord-005453-4057qib7	10881	3	We	-PRON-	PRP
cord-005453-4057qib7	10881	4	identified	identify	VBD
cord-005453-4057qib7	10881	5	53	53	CD
cord-005453-4057qib7	10881	6	patients	patient	NNS
cord-005453-4057qib7	10881	7	(	(	-LRB-
cord-005453-4057qib7	10881	8	32	32	CD
cord-005453-4057qib7	10881	9	%	%	NN
cord-005453-4057qib7	10881	10	females	female	NNS
cord-005453-4057qib7	10881	11	;	;	:
cord-005453-4057qib7	10881	12	median	median	JJ
cord-005453-4057qib7	10881	13	age	age	NN
cord-005453-4057qib7	10881	14	:	:	:
cord-005453-4057qib7	10881	15	43	43	CD
cord-005453-4057qib7	10881	16	y	y	NN
cord-005453-4057qib7	10881	17	;	;	:
cord-005453-4057qib7	10881	18	range,4	range,4	NNP
cord-005453-4057qib7	10881	19	-	-	HYPH
cord-005453-4057qib7	10881	20	67	67	CD
cord-005453-4057qib7	10881	21	)	)	-RRB-
cord-005453-4057qib7	10881	22	with	with	IN
cord-005453-4057qib7	10881	23	T	T	NNP
cord-005453-4057qib7	10881	24	-	-	HYPH
cord-005453-4057qib7	10881	25	NHL	NHL	NNP
cord-005453-4057qib7	10881	26	that	that	WDT
cord-005453-4057qib7	10881	27	underwent	undergo	VBD
cord-005453-4057qib7	10881	28	allo	allo	NN
cord-005453-4057qib7	10881	29	-	-	HYPH
cord-005453-4057qib7	10881	30	SCT	SCT	NNP
cord-005453-4057qib7	10881	31	at	at	IN
cord-005453-4057qib7	10881	32	University	University	NNP
cord-005453-4057qib7	10881	33	Hospital	Hospital	NNP
cord-005453-4057qib7	10881	34	Eppendorf	Eppendorf	NNP
cord-005453-4057qib7	10881	35	between	between	IN
cord-005453-4057qib7	10881	36	1992	1992	CD
cord-005453-4057qib7	10881	37	and	and	CC
cord-005453-4057qib7	10881	38	2017	2017	CD
cord-005453-4057qib7	10881	39	.	.	.
cord-005453-4057qib7	10882	1	Twenty	twenty	CD
cord-005453-4057qib7	10882	2	-	-	HYPH
cord-005453-4057qib7	10882	3	one	one	CD
cord-005453-4057qib7	10882	4	patients	patient	NNS
cord-005453-4057qib7	10882	5	(	(	-LRB-
cord-005453-4057qib7	10882	6	underwent	undergo	VBD
cord-005453-4057qib7	10882	7	allo	allo	NN
cord-005453-4057qib7	10882	8	-	-	HYPH
cord-005453-4057qib7	10882	9	SCT	SCT	NNP
cord-005453-4057qib7	10882	10	from	from	IN
cord-005453-4057qib7	10882	11	a	a	DT
cord-005453-4057qib7	10882	12	matched	match	VBN
cord-005453-4057qib7	10882	13	sibling	sibling	NN
cord-005453-4057qib7	10882	14	donor	donor	NN
cord-005453-4057qib7	10882	15	(	(	-LRB-
cord-005453-4057qib7	10882	16	MSD	MSD	NNP
cord-005453-4057qib7	10882	17	)	)	-RRB-
cord-005453-4057qib7	10882	18	and	and	CC
cord-005453-4057qib7	10882	19	32	32	CD
cord-005453-4057qib7	10882	20	(	(	-LRB-
cord-005453-4057qib7	10882	21	60	60	CD
cord-005453-4057qib7	10882	22	%	%	NN
cord-005453-4057qib7	10882	23	)	)	-RRB-
cord-005453-4057qib7	10882	24	from	from	IN
cord-005453-4057qib7	10882	25	a	a	DT
cord-005453-4057qib7	10882	26	matched	match	VBN
cord-005453-4057qib7	10882	27	unrelated	unrelated	JJ
cord-005453-4057qib7	10882	28	donor	donor	NN
cord-005453-4057qib7	10882	29	(	(	-LRB-
cord-005453-4057qib7	10882	30	MUD	mud	NN
cord-005453-4057qib7	10882	31	)	)	-RRB-
cord-005453-4057qib7	10882	32	.	.	.
cord-005453-4057qib7	10883	1	Sixteen	sixteen	CD
cord-005453-4057qib7	10883	2	patients	patient	NNS
cord-005453-4057qib7	10883	3	had	have	VBD
cord-005453-4057qib7	10883	4	PTCL	PTCL	NNS
cord-005453-4057qib7	10883	5	(	(	-LRB-
cord-005453-4057qib7	10883	6	30	30	CD
cord-005453-4057qib7	10883	7	%	%	NN
cord-005453-4057qib7	10883	8	)	)	-RRB-
cord-005453-4057qib7	10883	9	,	,	,
cord-005453-4057qib7	10883	10	n=8	n=8	NN
cord-005453-4057qib7	10883	11	(	(	-LRB-
cord-005453-4057qib7	10883	12	15	15	CD
cord-005453-4057qib7	10883	13	%	%	NN
cord-005453-4057qib7	10883	14	)	)	-RRB-
cord-005453-4057qib7	10883	15	anaplastic	anaplastic	JJ
cord-005453-4057qib7	10883	16	large	large	JJ
cord-005453-4057qib7	10883	17	-	-	HYPH
cord-005453-4057qib7	10883	18	cell	cell	NN
cord-005453-4057qib7	10883	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	10883	20	(	(	-LRB-
cord-005453-4057qib7	10883	21	ALCL	ALCL	NNP
cord-005453-4057qib7	10883	22	)	)	-RRB-
cord-005453-4057qib7	10883	23	,	,	,
cord-005453-4057qib7	10883	24	n=8	n=8	NN
cord-005453-4057qib7	10883	25	(	(	-LRB-
cord-005453-4057qib7	10883	26	15	15	CD
cord-005453-4057qib7	10883	27	%	%	NN
cord-005453-4057qib7	10883	28	)	)	-RRB-
cord-005453-4057qib7	10883	29	angioimmunoblastic	angioimmunoblastic	JJ
cord-005453-4057qib7	10883	30	large	large	JJ
cord-005453-4057qib7	10883	31	cell	cell	NN
cord-005453-4057qib7	10883	32	lymphoma	lymphoma	NN
cord-005453-4057qib7	10883	33	,	,	,
cord-005453-4057qib7	10883	34	n=8	n=8	NN
cord-005453-4057qib7	10883	35	(	(	-LRB-
cord-005453-4057qib7	10883	36	15	15	CD
cord-005453-4057qib7	10883	37	%	%	NN
cord-005453-4057qib7	10883	38	)	)	-RRB-
cord-005453-4057qib7	10883	39	adult	adult	NN
cord-005453-4057qib7	10883	40	T	t	NN
cord-005453-4057qib7	10883	41	-	-	HYPH
cord-005453-4057qib7	10883	42	cell	cell	NN
cord-005453-4057qib7	10883	43	leukemia	leukemia	NN
cord-005453-4057qib7	10883	44	/	/	SYM
cord-005453-4057qib7	10883	45	lymphoma	lymphoma	NN
cord-005453-4057qib7	10883	46	,	,	,
cord-005453-4057qib7	10883	47	n=5	n=5	JJ
cord-005453-4057qib7	10883	48	(	(	-LRB-
cord-005453-4057qib7	10883	49	9	9	CD
cord-005453-4057qib7	10883	50	%	%	NN
cord-005453-4057qib7	10883	51	)	)	-RRB-
cord-005453-4057qib7	10883	52	hepatosplenic	hepatosplenic	NNP
cord-005453-4057qib7	10883	53	gamma	gamma	NNP
cord-005453-4057qib7	10883	54	/	/	SYM
cord-005453-4057qib7	10883	55	delta	delta	NNP
cord-005453-4057qib7	10883	56	T	t	NN
cord-005453-4057qib7	10883	57	-	-	HYPH
cord-005453-4057qib7	10883	58	cell	cell	NN
cord-005453-4057qib7	10883	59	lymphoma	lymphoma	NN
cord-005453-4057qib7	10883	60	,	,	,
cord-005453-4057qib7	10883	61	n=4	n=4	JJ
cord-005453-4057qib7	10883	62	(	(	-LRB-
cord-005453-4057qib7	10883	63	8	8	CD
cord-005453-4057qib7	10883	64	%	%	NN
cord-005453-4057qib7	10883	65	)	)	-RRB-
cord-005453-4057qib7	10883	66	enteropathy	enteropathy	NNP
cord-005453-4057qib7	10883	67	associated	associate	VBD
cord-005453-4057qib7	10883	68	T	t	NN
cord-005453-4057qib7	10883	69	-	-	HYPH
cord-005453-4057qib7	10883	70	cell	cell	NN
cord-005453-4057qib7	10883	71	lymphoma	lymphoma	NN
cord-005453-4057qib7	10883	72	,	,	,
cord-005453-4057qib7	10883	73	n=2	n=2	NNS
cord-005453-4057qib7	10883	74	(	(	-LRB-
cord-005453-4057qib7	10883	75	4	4	CD
cord-005453-4057qib7	10883	76	%	%	NN
cord-005453-4057qib7	10883	77	)	)	-RRB-
cord-005453-4057qib7	10884	1	Tcell	tcell	JJ
cord-005453-4057qib7	10884	2	-	-	HYPH
cord-005453-4057qib7	10884	3	prolymphocytic	prolymphocytic	JJ
cord-005453-4057qib7	10884	4	leukemia	leukemia	NN
cord-005453-4057qib7	10884	5	,	,	,
cord-005453-4057qib7	10884	6	and	and	CC
cord-005453-4057qib7	10884	7	n=1	n=1	NN
cord-005453-4057qib7	10884	8	(	(	-LRB-
cord-005453-4057qib7	10884	9	2	2	CD
cord-005453-4057qib7	10884	10	%	%	NN
cord-005453-4057qib7	10884	11	)	)	-RRB-
cord-005453-4057qib7	10885	1	each	each	DT
cord-005453-4057qib7	10885	2	extranodal	extranodal	DT
cord-005453-4057qib7	10885	3	T	T	NNP
cord-005453-4057qib7	10885	4	/	/	SYM
cord-005453-4057qib7	10885	5	NK	nk	NN
cord-005453-4057qib7	10885	6	-	-	HYPH
cord-005453-4057qib7	10885	7	cell	cell	NN
cord-005453-4057qib7	10885	8	lymphoma	lymphoma	NN
cord-005453-4057qib7	10885	9	,	,	,
cord-005453-4057qib7	10885	10	cutaneous	cutaneous	JJ
cord-005453-4057qib7	10885	11	T	t	NN
cord-005453-4057qib7	10885	12	-	-	HYPH
cord-005453-4057qib7	10885	13	cell	cell	NN
cord-005453-4057qib7	10885	14	lymphoma	lymphoma	NN
cord-005453-4057qib7	10885	15	as	as	IN
cord-005453-4057qib7	10885	16	underlying	underlie	VBG
cord-005453-4057qib7	10885	17	diagnosis	diagnosis	NN
cord-005453-4057qib7	10885	18	.	.	.
cord-005453-4057qib7	10886	1	The	the	DT
cord-005453-4057qib7	10886	2	median	median	NN
cord-005453-4057qib7	10886	3	Ann	Ann	NNP
cord-005453-4057qib7	10886	4	Arbour	Arbour	NNP
cord-005453-4057qib7	10886	5	stage	stage	NN
cord-005453-4057qib7	10886	6	at	at	IN
cord-005453-4057qib7	10886	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	10886	8	was	be	VBD
cord-005453-4057qib7	10886	9	4	4	CD
cord-005453-4057qib7	10887	1	(	(	-LRB-
cord-005453-4057qib7	10887	2	range	range	NN
cord-005453-4057qib7	10887	3	,	,	,
cord-005453-4057qib7	10887	4	1	1	CD
cord-005453-4057qib7	10887	5	-	-	SYM
cord-005453-4057qib7	10887	6	4	4	CD
cord-005453-4057qib7	10887	7	)	)	-RRB-
cord-005453-4057qib7	10887	8	.	.	.
cord-005453-4057qib7	10888	1	Ten	ten	CD
cord-005453-4057qib7	10888	2	patients	patient	NNS
cord-005453-4057qib7	10888	3	(	(	-LRB-
cord-005453-4057qib7	10888	4	19	19	CD
cord-005453-4057qib7	10888	5	%	%	NN
cord-005453-4057qib7	10888	6	)	)	-RRB-
cord-005453-4057qib7	10888	7	had	have	VBD
cord-005453-4057qib7	10888	8	bone	bone	NN
cord-005453-4057qib7	10888	9	marrow	marrow	NN
cord-005453-4057qib7	10888	10	involvement	involvement	NN
cord-005453-4057qib7	10888	11	at	at	IN
cord-005453-4057qib7	10888	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	10888	13	.	.	.
cord-005453-4057qib7	10889	1	All	all	DT
cord-005453-4057qib7	10889	2	patients	patient	NNS
cord-005453-4057qib7	10889	3	were	be	VBD
cord-005453-4057qib7	10889	4	heavily	heavily	RB
cord-005453-4057qib7	10889	5	pretreated	pretreate	VBN
cord-005453-4057qib7	10889	6	,	,	,
cord-005453-4057qib7	10889	7	17	17	CD
cord-005453-4057qib7	10889	8	(	(	-LRB-
cord-005453-4057qib7	10889	9	32	32	CD
cord-005453-4057qib7	10889	10	%	%	NN
cord-005453-4057qib7	10889	11	)	)	-RRB-
cord-005453-4057qib7	10889	12	patients	patient	NNS
cord-005453-4057qib7	10889	13	relapsed	relapse	VBD
cord-005453-4057qib7	10889	14	post	post	JJ
cord-005453-4057qib7	10889	15	autologous	autologous	JJ
cord-005453-4057qib7	10889	16	stem	stem	NN
cord-005453-4057qib7	10889	17	cell	cell	NN
cord-005453-4057qib7	10889	18	transplant	transplant	NN
cord-005453-4057qib7	10889	19	(	(	-LRB-
cord-005453-4057qib7	10889	20	APSCT	APSCT	NNP
cord-005453-4057qib7	10889	21	)	)	-RRB-
cord-005453-4057qib7	10889	22	and	and	CC
cord-005453-4057qib7	10889	23	one	one	CD
cord-005453-4057qib7	10889	24	patient	patient	JJ
cord-005453-4057qib7	10889	25	post	post	FW
cord-005453-4057qib7	10889	26	allo	allo	FW
cord-005453-4057qib7	10889	27	-	-	HYPH
cord-005453-4057qib7	10889	28	SCT	SCT	NNP
cord-005453-4057qib7	10889	29	.	.	.
cord-005453-4057qib7	10890	1	Fifteen	fifteen	CD
cord-005453-4057qib7	10890	2	patients	patient	NNS
cord-005453-4057qib7	10890	3	(	(	-LRB-
cord-005453-4057qib7	10890	4	28	28	CD
cord-005453-4057qib7	10890	5	%	%	NN
cord-005453-4057qib7	10890	6	)	)	-RRB-
cord-005453-4057qib7	10890	7	were	be	VBD
cord-005453-4057qib7	10890	8	transplanted	transplant	VBN
cord-005453-4057qib7	10890	9	in	in	IN
cord-005453-4057qib7	10890	10	complete	complete	JJ
cord-005453-4057qib7	10890	11	remission	remission	NN
cord-005453-4057qib7	10890	12	(	(	-LRB-
cord-005453-4057qib7	10890	13	CR	cr	NN
cord-005453-4057qib7	10890	14	)	)	-RRB-
cord-005453-4057qib7	10890	15	(	(	-LRB-
cord-005453-4057qib7	10890	16	10	10	CD
cord-005453-4057qib7	10890	17	in	in	IN
cord-005453-4057qib7	10890	18	1	1	CD
cord-005453-4057qib7	10890	19	st	st	NNP
cord-005453-4057qib7	10890	20	CR	CR	NNP
cord-005453-4057qib7	10890	21	,	,	,
cord-005453-4057qib7	10890	22	2	2	CD
cord-005453-4057qib7	10890	23	in	in	IN
cord-005453-4057qib7	10890	24	2	2	CD
cord-005453-4057qib7	10890	25	nd	nd	NNP
cord-005453-4057qib7	10890	26	CR	CR	NNP
cord-005453-4057qib7	10890	27	)	)	-RRB-
cord-005453-4057qib7	10890	28	,	,	.
cord-005453-4057qib7	10891	1	n=13	n=13	NNP
cord-005453-4057qib7	10891	2	(	(	-LRB-
cord-005453-4057qib7	10891	3	25	25	CD
cord-005453-4057qib7	10891	4	%	%	NN
cord-005453-4057qib7	10891	5	)	)	-RRB-
cord-005453-4057qib7	10892	1	in	in	IN
cord-005453-4057qib7	10892	2	partial	partial	JJ
cord-005453-4057qib7	10892	3	remission	remission	NN
cord-005453-4057qib7	10892	4	(	(	-LRB-
cord-005453-4057qib7	10892	5	PR	PR	NNP
cord-005453-4057qib7	10892	6	)	)	-RRB-
cord-005453-4057qib7	10892	7	,	,	,
cord-005453-4057qib7	10892	8	and	and	CC
cord-005453-4057qib7	10892	9	n=21	n=21	NN
cord-005453-4057qib7	10892	10	(	(	-LRB-
cord-005453-4057qib7	10892	11	40	40	CD
cord-005453-4057qib7	10892	12	%	%	NN
cord-005453-4057qib7	10892	13	)	)	-RRB-
cord-005453-4057qib7	10892	14	with	with	IN
cord-005453-4057qib7	10892	15	advanced	advanced	JJ
cord-005453-4057qib7	10892	16	disease	disease	NN
cord-005453-4057qib7	10892	17	.	.	.
cord-005453-4057qib7	10893	1	Most	Most	JJS
cord-005453-4057qib7	10893	2	of	of	IN
cord-005453-4057qib7	10893	3	the	the	DT
cord-005453-4057qib7	10893	4	patients	patient	NNS
cord-005453-4057qib7	10893	5	received	receive	VBD
cord-005453-4057qib7	10893	6	myeloablative	myeloablative	JJ
cord-005453-4057qib7	10893	7	conditioning	conditioning	NN
cord-005453-4057qib7	10893	8	(	(	-LRB-
cord-005453-4057qib7	10893	9	91	91	CD
cord-005453-4057qib7	10893	10	%	%	NN
cord-005453-4057qib7	10893	11	)	)	-RRB-
cord-005453-4057qib7	10893	12	.	.	.
cord-005453-4057qib7	10894	1	Thirty	thirty	CD
cord-005453-4057qib7	10894	2	-	-	HYPH
cord-005453-4057qib7	10894	3	eight	eight	CD
cord-005453-4057qib7	10894	4	(	(	-LRB-
cord-005453-4057qib7	10894	5	72	72	CD
cord-005453-4057qib7	10894	6	%	%	NN
cord-005453-4057qib7	10894	7	)	)	-RRB-
cord-005453-4057qib7	10894	8	patients	patient	NNS
cord-005453-4057qib7	10894	9	received	receive	VBD
cord-005453-4057qib7	10894	10	Total	total	JJ
cord-005453-4057qib7	10894	11	body	body	NN
cord-005453-4057qib7	10894	12	irradiation	irradiation	NN
cord-005453-4057qib7	10894	13	based	base	VBN
cord-005453-4057qib7	10894	14	regimens	regimen	NNS
cord-005453-4057qib7	10894	15	and	and	CC
cord-005453-4057qib7	10894	16	15	15	CD
cord-005453-4057qib7	10894	17	(	(	-LRB-
cord-005453-4057qib7	10894	18	28	28	CD
cord-005453-4057qib7	10894	19	%	%	NN
cord-005453-4057qib7	10894	20	)	)	-RRB-
cord-005453-4057qib7	10894	21	received	receive	VBD
cord-005453-4057qib7	10894	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10894	23	based	base	VBN
cord-005453-4057qib7	10894	24	regimens	regimen	NNS
cord-005453-4057qib7	10894	25	.	.	.
cord-005453-4057qib7	10895	1	Twenty	twenty	CD
cord-005453-4057qib7	10895	2	patients	patient	NNS
cord-005453-4057qib7	10895	3	(	(	-LRB-
cord-005453-4057qib7	10895	4	38	38	CD
cord-005453-4057qib7	10895	5	%	%	NN
cord-005453-4057qib7	10895	6	)	)	-RRB-
cord-005453-4057qib7	10895	7	received	receive	VBD
cord-005453-4057qib7	10895	8	Anti	Anti	NNP
cord-005453-4057qib7	10895	9	-	-	NNP
cord-005453-4057qib7	10895	10	T	t	JJ
cord-005453-4057qib7	10895	11	-	-	HYPH
cord-005453-4057qib7	10895	12	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	10895	13	globulin	globulin	NN
cord-005453-4057qib7	10895	14	(	(	-LRB-
cord-005453-4057qib7	10895	15	ATLG	ATLG	NNP
cord-005453-4057qib7	10895	16	Neovii	Neovii	NNP
cord-005453-4057qib7	10895	17	)	)	-RRB-
cord-005453-4057qib7	10895	18	,	,	,
cord-005453-4057qib7	10895	19	and	and	CC
cord-005453-4057qib7	10895	20	most	most	JJS
cord-005453-4057qib7	10895	21	patients	patient	NNS
cord-005453-4057qib7	10895	22	(	(	-LRB-
cord-005453-4057qib7	10895	23	87	87	CD
cord-005453-4057qib7	10895	24	%	%	NN
cord-005453-4057qib7	10895	25	)	)	-RRB-
cord-005453-4057qib7	10895	26	received	receive	VBD
cord-005453-4057qib7	10895	27	G	G	NNP
cord-005453-4057qib7	10895	28	-	-	HYPH
cord-005453-4057qib7	10895	29	CSF	CSF	NNP
cord-005453-4057qib7	10895	30	mobilized	mobilize	VBD
cord-005453-4057qib7	10895	31	peripheral	peripheral	JJ
cord-005453-4057qib7	10895	32	stem	stem	NN
cord-005453-4057qib7	10895	33	cells	cell	NNS
cord-005453-4057qib7	10895	34	.	.	.
cord-005453-4057qib7	10896	1	Results	result	NNS
cord-005453-4057qib7	10896	2	:	:	:
cord-005453-4057qib7	10897	1	Overall	overall	RB
cord-005453-4057qib7	10897	2	,	,	,
cord-005453-4057qib7	10897	3	49	49	CD
cord-005453-4057qib7	10897	4	patients	patient	NNS
cord-005453-4057qib7	10897	5	(	(	-LRB-
cord-005453-4057qib7	10897	6	92	92	CD
cord-005453-4057qib7	10897	7	%	%	NN
cord-005453-4057qib7	10897	8	)	)	-RRB-
cord-005453-4057qib7	10897	9	had	have	VBD
cord-005453-4057qib7	10897	10	neutrophil	neutrophil	NN
cord-005453-4057qib7	10897	11	engraftment	engraftment	NN
cord-005453-4057qib7	10897	12	(	(	-LRB-
cord-005453-4057qib7	10897	13	median	median	JJ
cord-005453-4057qib7	10897	14	days	day	NNS
cord-005453-4057qib7	10897	15	:	:	:
cord-005453-4057qib7	10897	16	13	13	CD
cord-005453-4057qib7	10897	17	;	;	:
cord-005453-4057qib7	10897	18	range,9	range,9	NNS
cord-005453-4057qib7	10897	19	-	-	HYPH
cord-005453-4057qib7	10897	20	36	36	CD
cord-005453-4057qib7	10897	21	)	)	-RRB-
cord-005453-4057qib7	10897	22	.	.	.
cord-005453-4057qib7	10898	1	At	at	IN
cord-005453-4057qib7	10898	2	day	day	NN
cord-005453-4057qib7	10898	3	100	100	CD
cord-005453-4057qib7	10898	4	,	,	,
cord-005453-4057qib7	10898	5	the	the	DT
cord-005453-4057qib7	10898	6	cumulative	cumulative	JJ
cord-005453-4057qib7	10898	7	incidences	incidence	NNS
cord-005453-4057qib7	10898	8	of	of	IN
cord-005453-4057qib7	10898	9	grade	grade	NN
cord-005453-4057qib7	10898	10	II	II	NNP
cord-005453-4057qib7	10898	11	-	-	HYPH
cord-005453-4057qib7	10898	12	IV	IV	NNP
cord-005453-4057qib7	10898	13	and	and	CC
cord-005453-4057qib7	10898	14	grade	grade	NN
cord-005453-4057qib7	10898	15	III	III	NNP
cord-005453-4057qib7	10898	16	-	-	HYPH
cord-005453-4057qib7	10898	17	IV	IV	NNP
cord-005453-4057qib7	10898	18	acute	acute	JJ
cord-005453-4057qib7	10898	19	GVHD	GVHD	NNP
cord-005453-4057qib7	10898	20	were	be	VBD
cord-005453-4057qib7	10898	21	42	42	CD
cord-005453-4057qib7	10898	22	%	%	NN
cord-005453-4057qib7	10898	23	and	and	CC
cord-005453-4057qib7	10898	24	15	15	CD
cord-005453-4057qib7	10898	25	%	%	NN
cord-005453-4057qib7	10898	26	,	,	,
cord-005453-4057qib7	10898	27	respectively	respectively	RB
cord-005453-4057qib7	10898	28	.	.	.
cord-005453-4057qib7	10899	1	After	after	IN
cord-005453-4057qib7	10899	2	a	a	DT
cord-005453-4057qib7	10899	3	median	median	NN
cord-005453-4057qib7	10899	4	follow	follow	NN
cord-005453-4057qib7	10899	5	up	up	IN
cord-005453-4057qib7	10899	6	of	of	IN
cord-005453-4057qib7	10899	7	12	12	CD
cord-005453-4057qib7	10899	8	months	month	NNS
cord-005453-4057qib7	10899	9	(	(	-LRB-
cord-005453-4057qib7	10899	10	range	range	NN
cord-005453-4057qib7	10899	11	,	,	,
cord-005453-4057qib7	10899	12	1	1	CD
cord-005453-4057qib7	10899	13	-	-	SYM
cord-005453-4057qib7	10899	14	171	171	CD
cord-005453-4057qib7	10899	15	)	)	-RRB-
cord-005453-4057qib7	10899	16	the	the	DT
cord-005453-4057qib7	10899	17	cumulative	cumulative	JJ
cord-005453-4057qib7	10899	18	incidences	incidence	NNS
cord-005453-4057qib7	10899	19	of	of	IN
cord-005453-4057qib7	10899	20	chronic	chronic	JJ
cord-005453-4057qib7	10899	21	GVHD	GVHD	NNP
cord-005453-4057qib7	10899	22	was	be	VBD
cord-005453-4057qib7	10899	23	12	12	CD
cord-005453-4057qib7	10899	24	%	%	NN
cord-005453-4057qib7	10899	25	distributed	distribute	VBN
cord-005453-4057qib7	10899	26	evenly	evenly	RB
cord-005453-4057qib7	10899	27	between	between	IN
cord-005453-4057qib7	10899	28	limited	limited	JJ
cord-005453-4057qib7	10899	29	and	and	CC
cord-005453-4057qib7	10899	30	extensive	extensive	JJ
cord-005453-4057qib7	10899	31	.	.	.
cord-005453-4057qib7	10900	1	Twenty	twenty	CD
cord-005453-4057qib7	10900	2	nine	nine	CD
cord-005453-4057qib7	10900	3	patients	patient	NNS
cord-005453-4057qib7	10900	4	(	(	-LRB-
cord-005453-4057qib7	10900	5	55	55	CD
cord-005453-4057qib7	10900	6	%	%	NN
cord-005453-4057qib7	10900	7	)	)	-RRB-
cord-005453-4057qib7	10900	8	achieved	achieve	VBD
cord-005453-4057qib7	10900	9	CR	cr	NN
cord-005453-4057qib7	10900	10	after	after	IN
cord-005453-4057qib7	10900	11	allo	allo	NN
cord-005453-4057qib7	10900	12	-	-	HYPH
cord-005453-4057qib7	10900	13	SCT	SCT	NNP
cord-005453-4057qib7	10900	14	.	.	.
cord-005453-4057qib7	10901	1	Median	median	JJ
cord-005453-4057qib7	10901	2	overall	overall	JJ
cord-005453-4057qib7	10901	3	survival	survival	NN
cord-005453-4057qib7	10901	4	(	(	-LRB-
cord-005453-4057qib7	10901	5	OS	OS	NNP
cord-005453-4057qib7	10901	6	)	)	-RRB-
cord-005453-4057qib7	10901	7	and	and	CC
cord-005453-4057qib7	10901	8	disease	disease	NN
cord-005453-4057qib7	10901	9	free	free	JJ
cord-005453-4057qib7	10902	1	(	(	-LRB-
cord-005453-4057qib7	10902	2	PFS	PFS	NNP
cord-005453-4057qib7	10902	3	)	)	-RRB-
cord-005453-4057qib7	10902	4	survival	survival	NN
cord-005453-4057qib7	10902	5	were	be	VBD
cord-005453-4057qib7	10902	6	44	44	CD
cord-005453-4057qib7	10902	7	months	month	NNS
cord-005453-4057qib7	10902	8	and	and	CC
cord-005453-4057qib7	10902	9	12	12	CD
cord-005453-4057qib7	10902	10	months	month	NNS
cord-005453-4057qib7	10902	11	respectively	respectively	RB
cord-005453-4057qib7	10902	12	.	.	.
cord-005453-4057qib7	10903	1	The	the	DT
cord-005453-4057qib7	10903	2	3	3	CD
cord-005453-4057qib7	10903	3	year	year	NN
cord-005453-4057qib7	10903	4	OS	OS	NNP
cord-005453-4057qib7	10903	5	and	and	CC
cord-005453-4057qib7	10903	6	PFS	PFS	NNP
cord-005453-4057qib7	10903	7	were	be	VBD
cord-005453-4057qib7	10903	8	50	50	CD
cord-005453-4057qib7	10903	9	%	%	NN
cord-005453-4057qib7	10903	10	and	and	CC
cord-005453-4057qib7	10903	11	43	43	CD
cord-005453-4057qib7	10903	12	%	%	NN
cord-005453-4057qib7	10903	13	respectively	respectively	RB
cord-005453-4057qib7	10903	14	.	.	.
cord-005453-4057qib7	10904	1	Fourteen	fourteen	CD
cord-005453-4057qib7	10904	2	(	(	-LRB-
cord-005453-4057qib7	10904	3	26	26	CD
cord-005453-4057qib7	10904	4	%	%	NN
cord-005453-4057qib7	10904	5	;	;	:
cord-005453-4057qib7	10904	6	95	95	CD
cord-005453-4057qib7	10904	7	%	%	NN
cord-005453-4057qib7	10904	8	CI	CI	NNP
cord-005453-4057qib7	10904	9	[	[	-LRB-
cord-005453-4057qib7	10904	10	0.15	0.15	CD
cord-005453-4057qib7	10904	11	-	-	HYPH
cord-005453-4057qib7	10904	12	0.40	0.40	CD
cord-005453-4057qib7	10904	13	]	]	-RRB-
cord-005453-4057qib7	10904	14	)	)	-RRB-
cord-005453-4057qib7	10904	15	deaths	death	NNS
cord-005453-4057qib7	10904	16	were	be	VBD
cord-005453-4057qib7	10904	17	due	due	JJ
cord-005453-4057qib7	10904	18	to	to	IN
cord-005453-4057qib7	10904	19	non	non	JJ
cord-005453-4057qib7	10904	20	relapse	relapse	NN
cord-005453-4057qib7	10904	21	mortality	mortality	NN
cord-005453-4057qib7	10904	22	(	(	-LRB-
cord-005453-4057qib7	10904	23	NRM	NRM	NNP
cord-005453-4057qib7	10904	24	)	)	-RRB-
cord-005453-4057qib7	10904	25	and	and	CC
cord-005453-4057qib7	10904	26	15	15	CD
cord-005453-4057qib7	10904	27	patients	patient	NNS
cord-005453-4057qib7	10904	28	(	(	-LRB-
cord-005453-4057qib7	10904	29	28	28	CD
cord-005453-4057qib7	10904	30	%	%	NN
cord-005453-4057qib7	10904	31	;	;	:
cord-005453-4057qib7	10904	32	95	95	CD
cord-005453-4057qib7	10904	33	%	%	NN
cord-005453-4057qib7	10904	34	CI	CI	NNP
cord-005453-4057qib7	10904	35	[	[	-LRB-
cord-005453-4057qib7	10904	36	0.17	0.17	CD
cord-005453-4057qib7	10904	37	-	-	HYPH
cord-005453-4057qib7	10904	38	0.42	0.42	CD
cord-005453-4057qib7	10904	39	]	]	-RRB-
cord-005453-4057qib7	10904	40	)	)	-RRB-
cord-005453-4057qib7	10904	41	died	die	VBD
cord-005453-4057qib7	10904	42	due	due	IN
cord-005453-4057qib7	10904	43	to	to	IN
cord-005453-4057qib7	10904	44	disease	disease	NN
cord-005453-4057qib7	10904	45	progression	progression	NN
cord-005453-4057qib7	10904	46	.	.	.
cord-005453-4057qib7	10905	1	Patients	patient	NNS
cord-005453-4057qib7	10905	2	with	with	IN
cord-005453-4057qib7	10905	3	a	a	DT
cord-005453-4057qib7	10905	4	male	male	JJ
cord-005453-4057qib7	10905	5	donor	donor	NN
cord-005453-4057qib7	10905	6	had	have	VBD
cord-005453-4057qib7	10905	7	improved	improve	VBN
cord-005453-4057qib7	10905	8	OS	OS	NNP
cord-005453-4057qib7	10905	9	compared	compare	VBN
cord-005453-4057qib7	10905	10	to	to	IN
cord-005453-4057qib7	10905	11	those	those	DT
cord-005453-4057qib7	10905	12	with	with	IN
cord-005453-4057qib7	10905	13	a	a	DT
cord-005453-4057qib7	10905	14	female	female	JJ
cord-005453-4057qib7	10905	15	donor	donor	NN
cord-005453-4057qib7	10905	16	(	(	-LRB-
cord-005453-4057qib7	10905	17	3	3	CD
cord-005453-4057qib7	10905	18	year	year	NN
cord-005453-4057qib7	10905	19	OS	os	NN
cord-005453-4057qib7	10905	20	male	male	JJ
cord-005453-4057qib7	10905	21	56	56	CD
cord-005453-4057qib7	10905	22	%	%	NN
cord-005453-4057qib7	10905	23	,	,	,
cord-005453-4057qib7	10905	24	Female	female	JJ
cord-005453-4057qib7	10905	25	34	34	CD
cord-005453-4057qib7	10905	26	%	%	NN
cord-005453-4057qib7	10905	27	;	;	:
cord-005453-4057qib7	10905	28	p=0.038	p=0.038	NNP
cord-005453-4057qib7	10905	29	)	)	-RRB-
cord-005453-4057qib7	10905	30	.	.	.
cord-005453-4057qib7	10906	1	Patient	patient	JJ
cord-005453-4057qib7	10906	2	gender	gender	NN
cord-005453-4057qib7	10906	3	,	,	,
cord-005453-4057qib7	10906	4	disease	disease	NN
cord-005453-4057qib7	10906	5	subtype	subtype	NN
cord-005453-4057qib7	10906	6	,	,	,
cord-005453-4057qib7	10906	7	bone	bone	NN
cord-005453-4057qib7	10906	8	marrow	marrow	NN
cord-005453-4057qib7	10906	9	involvement	involvement	NN
cord-005453-4057qib7	10906	10	,	,	,
cord-005453-4057qib7	10906	11	type	type	NN
cord-005453-4057qib7	10906	12	of	of	IN
cord-005453-4057qib7	10906	13	allo	allo	NN
cord-005453-4057qib7	10906	14	-	-	HYPH
cord-005453-4057qib7	10906	15	SCT	SCT	NNP
cord-005453-4057qib7	10906	16	,	,	,
cord-005453-4057qib7	10906	17	donor	donor	NN
cord-005453-4057qib7	10906	18	,	,	,
cord-005453-4057qib7	10906	19	patient	patient	JJ
cord-005453-4057qib7	10906	20	CMV	CMV	NNP
cord-005453-4057qib7	10906	21	status	status	NN
cord-005453-4057qib7	10906	22	,	,	,
cord-005453-4057qib7	10906	23	ABO	ABO	NNP
cord-005453-4057qib7	10906	24	incompatibility	incompatibility	NN
cord-005453-4057qib7	10906	25	,	,	,
cord-005453-4057qib7	10906	26	disease	disease	NN
cord-005453-4057qib7	10906	27	stage	stage	NN
cord-005453-4057qib7	10906	28	at	at	IN
cord-005453-4057qib7	10906	29	diagnosis	diagnosis	NN
cord-005453-4057qib7	10906	30	,	,	,
cord-005453-4057qib7	10906	31	previous	previous	JJ
cord-005453-4057qib7	10906	32	transplant	transplant	NN
cord-005453-4057qib7	10906	33	,	,	,
cord-005453-4057qib7	10906	34	disease	disease	NN
cord-005453-4057qib7	10906	35	status	status	NN
cord-005453-4057qib7	10906	36	at	at	IN
cord-005453-4057qib7	10906	37	transplant	transplant	NN
cord-005453-4057qib7	10906	38	,	,	,
cord-005453-4057qib7	10906	39	conditioning	conditioning	NN
cord-005453-4057qib7	10906	40	regimen	regimen	NN
cord-005453-4057qib7	10906	41	,	,	,
cord-005453-4057qib7	10906	42	ATG	ATG	NNP
cord-005453-4057qib7	10906	43	and	and	CC
cord-005453-4057qib7	10906	44	stem	stem	NN
cord-005453-4057qib7	10906	45	cell	cell	NN
cord-005453-4057qib7	10906	46	source	source	NN
cord-005453-4057qib7	10906	47	had	have	VBD
cord-005453-4057qib7	10906	48	no	no	DT
cord-005453-4057qib7	10906	49	effect	effect	NN
cord-005453-4057qib7	10906	50	on	on	IN
cord-005453-4057qib7	10906	51	OS	OS	NNP
cord-005453-4057qib7	10906	52	,	,	,
cord-005453-4057qib7	10906	53	PFS	PFS	NNP
cord-005453-4057qib7	10906	54	,	,	,
cord-005453-4057qib7	10906	55	NRM	NRM	NNP
cord-005453-4057qib7	10906	56	,	,	,
cord-005453-4057qib7	10906	57	and	and	CC
cord-005453-4057qib7	10906	58	post	post	NN
cord-005453-4057qib7	10906	59	transplant	transplant	NN
cord-005453-4057qib7	10906	60	complications	complication	NNS
cord-005453-4057qib7	10906	61	.	.	.
cord-005453-4057qib7	10907	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10907	2	:	:	:
cord-005453-4057qib7	10908	1	Acknowledging	acknowledge	VBG
cord-005453-4057qib7	10908	2	the	the	DT
cord-005453-4057qib7	10908	3	retrospective	retrospective	JJ
cord-005453-4057qib7	10908	4	nature	nature	NN
cord-005453-4057qib7	10908	5	,	,	,
cord-005453-4057qib7	10908	6	our	-PRON-	PRP$
cord-005453-4057qib7	10908	7	study	study	NN
cord-005453-4057qib7	10908	8	shows	show	VBZ
cord-005453-4057qib7	10908	9	that	that	IN
cord-005453-4057qib7	10908	10	allo	allo	NNP
cord-005453-4057qib7	10908	11	-	-	HYPH
cord-005453-4057qib7	10908	12	SCT	SCT	NNP
cord-005453-4057qib7	10908	13	induces	induce	VBZ
cord-005453-4057qib7	10908	14	high	high	JJ
cord-005453-4057qib7	10908	15	rates	rate	NNS
cord-005453-4057qib7	10908	16	of	of	IN
cord-005453-4057qib7	10908	17	complete	complete	JJ
cord-005453-4057qib7	10908	18	remission	remission	NN
cord-005453-4057qib7	10908	19	,	,	,
cord-005453-4057qib7	10908	20	and	and	CC
cord-005453-4057qib7	10908	21	may	may	MD
cord-005453-4057qib7	10908	22	have	have	VB
cord-005453-4057qib7	10908	23	a	a	DT
cord-005453-4057qib7	10908	24	curative	curative	JJ
cord-005453-4057qib7	10908	25	potential	potential	NN
cord-005453-4057qib7	10908	26	even	even	RB
cord-005453-4057qib7	10908	27	in	in	IN
cord-005453-4057qib7	10908	28	diseases	disease	NNS
cord-005453-4057qib7	10908	29	relapsing	relapse	VBG
cord-005453-4057qib7	10908	30	post	post	JJ
cord-005453-4057qib7	10908	31	ASCT	ASCT	NNP
cord-005453-4057qib7	10908	32	.	.	.
cord-005453-4057qib7	10909	1	However	however	RB
cord-005453-4057qib7	10909	2	our	-PRON-	PRP$
cord-005453-4057qib7	10909	3	findings	finding	NNS
cord-005453-4057qib7	10909	4	need	need	VBP
cord-005453-4057qib7	10909	5	to	to	TO
cord-005453-4057qib7	10909	6	be	be	VB
cord-005453-4057qib7	10909	7	confirmed	confirm	VBN
cord-005453-4057qib7	10909	8	in	in	IN
cord-005453-4057qib7	10909	9	larger	large	JJR
cord-005453-4057qib7	10909	10	prospective	prospective	JJ
cord-005453-4057qib7	10909	11	studies	study	NNS
cord-005453-4057qib7	10909	12	.	.	.
cord-005453-4057qib7	10910	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10910	2	:	:	:
cord-005453-4057qib7	10910	3	No	no	DT
cord-005453-4057qib7	10910	4	funding	funding	NN
cord-005453-4057qib7	10910	5	,	,	,
cord-005453-4057qib7	10910	6	no	no	DT
cord-005453-4057qib7	10910	7	conflict	conflict	NN
cord-005453-4057qib7	10910	8	of	of	IN
cord-005453-4057qib7	10910	9	interest	interest	NN
cord-005453-4057qib7	10910	10	P483	P483	NNP
cord-005453-4057qib7	10910	11	Abstract	Abstract	NNP
cord-005453-4057qib7	10910	12	already	already	RB
cord-005453-4057qib7	10910	13	published	publish	VBN
cord-005453-4057qib7	10910	14	.	.	.
cord-005453-4057qib7	10911	1	At	at	IN
cord-005453-4057qib7	10911	2	-	-	HYPH
cord-005453-4057qib7	10911	3	home	home	NN
cord-005453-4057qib7	10911	4	autologous	autologous	JJ
cord-005453-4057qib7	10911	5	stem	stem	NN
cord-005453-4057qib7	10911	6	cell	cell	NN
cord-005453-4057qib7	10911	7	transplantation	transplantation	NN
cord-005453-4057qib7	10911	8	in	in	IN
cord-005453-4057qib7	10911	9	lymphoma	lymphoma	NN
cord-005453-4057qib7	10911	10	patients	patient	NNS
cord-005453-4057qib7	10911	11	:	:	:
cord-005453-4057qib7	10911	12	Clinical	clinical	JJ
cord-005453-4057qib7	10911	13	impact	impact	NN
cord-005453-4057qib7	10911	14	of	of	IN
cord-005453-4057qib7	10911	15	non	non	JJ
cord-005453-4057qib7	10911	16	-	-	JJ
cord-005453-4057qib7	10911	17	G	g	JJ
cord-005453-4057qib7	10911	18	-	-	HYPH
cord-005453-4057qib7	10911	19	CSF	CSF	NNP
cord-005453-4057qib7	10911	20	administration	administration	NN
cord-005453-4057qib7	10911	21	post	post	NN
cord-005453-4057qib7	10911	22	-	-	NN
cord-005453-4057qib7	10911	23	transplant	transplant	NN
cord-005453-4057qib7	10911	24	Background	background	NN
cord-005453-4057qib7	10911	25	:	:	:
cord-005453-4057qib7	10912	1	Severe	severe	JJ
cord-005453-4057qib7	10912	2	neutropenia	neutropenia	NN
cord-005453-4057qib7	10912	3	remains	remain	VBZ
cord-005453-4057qib7	10912	4	the	the	DT
cord-005453-4057qib7	10912	5	main	main	JJ
cord-005453-4057qib7	10912	6	cause	cause	NN
cord-005453-4057qib7	10912	7	of	of	IN
cord-005453-4057qib7	10912	8	morbidity	morbidity	NN
cord-005453-4057qib7	10912	9	and	and	CC
cord-005453-4057qib7	10912	10	mortality	mortality	NN
cord-005453-4057qib7	10912	11	after	after	IN
cord-005453-4057qib7	10912	12	autologous	autologous	JJ
cord-005453-4057qib7	10912	13	stem	stem	NN
cord-005453-4057qib7	10912	14	cell	cell	NN
cord-005453-4057qib7	10912	15	transplantation	transplantation	NN
cord-005453-4057qib7	10912	16	(	(	-LRB-
cord-005453-4057qib7	10912	17	ASCT	ASCT	NNP
cord-005453-4057qib7	10912	18	)	)	-RRB-
cord-005453-4057qib7	10912	19	.	.	.
cord-005453-4057qib7	10913	1	G	G	NNP
cord-005453-4057qib7	10913	2	-	-	HYPH
cord-005453-4057qib7	10913	3	CSF	CSF	NNP
cord-005453-4057qib7	10913	4	administration	administration	NN
cord-005453-4057qib7	10913	5	after	after	IN
cord-005453-4057qib7	10913	6	ASCT	ASCT	NNP
cord-005453-4057qib7	10913	7	is	be	VBZ
cord-005453-4057qib7	10913	8	a	a	DT
cord-005453-4057qib7	10913	9	common	common	JJ
cord-005453-4057qib7	10913	10	practice	practice	NN
cord-005453-4057qib7	10913	11	,	,	,
cord-005453-4057qib7	10913	12	performed	perform	VBN
cord-005453-4057qib7	10913	13	to	to	TO
cord-005453-4057qib7	10913	14	reduce	reduce	VB
cord-005453-4057qib7	10913	15	the	the	DT
cord-005453-4057qib7	10913	16	duration	duration	NN
cord-005453-4057qib7	10913	17	of	of	IN
cord-005453-4057qib7	10913	18	neutropenia	neutropenia	NN
cord-005453-4057qib7	10913	19	and	and	CC
cord-005453-4057qib7	10913	20	its	-PRON-	PRP$
cord-005453-4057qib7	10913	21	complications	complication	NNS
cord-005453-4057qib7	10913	22	.	.	.
cord-005453-4057qib7	10914	1	In	in	IN
cord-005453-4057qib7	10914	2	a	a	DT
cord-005453-4057qib7	10914	3	previous	previous	JJ
cord-005453-4057qib7	10914	4	work	work	NN
cord-005453-4057qib7	10914	5	in	in	IN
cord-005453-4057qib7	10914	6	patients	patient	NNS
cord-005453-4057qib7	10914	7	with	with	IN
cord-005453-4057qib7	10914	8	multiple	multiple	JJ
cord-005453-4057qib7	10914	9	myeloma	myeloma	NN
cord-005453-4057qib7	10914	10	managed	manage	VBN
cord-005453-4057qib7	10914	11	at	at	IN
cord-005453-4057qib7	10914	12	home	home	NN
cord-005453-4057qib7	10914	13	after	after	IN
cord-005453-4057qib7	10914	14	ASCT	ASCT	NNP
cord-005453-4057qib7	10914	15	,	,	,
cord-005453-4057qib7	10914	16	we	-PRON-	PRP
cord-005453-4057qib7	10914	17	did	do	VBD
cord-005453-4057qib7	10914	18	not	not	RB
cord-005453-4057qib7	10914	19	observe	observe	VB
cord-005453-4057qib7	10914	20	a	a	DT
cord-005453-4057qib7	10914	21	deleterious	deleterious	JJ
cord-005453-4057qib7	10914	22	clinical	clinical	JJ
cord-005453-4057qib7	10914	23	impact	impact	NN
cord-005453-4057qib7	10914	24	in	in	IN
cord-005453-4057qib7	10914	25	those	those	DT
cord-005453-4057qib7	10914	26	patients	patient	NNS
cord-005453-4057qib7	10914	27	that	that	WDT
cord-005453-4057qib7	10914	28	did	do	VBD
cord-005453-4057qib7	10914	29	not	not	RB
cord-005453-4057qib7	10914	30	receive	receive	VB
cord-005453-4057qib7	10914	31	G	G	NNP
cord-005453-4057qib7	10914	32	-	-	HYPH
cord-005453-4057qib7	10914	33	CSF	csf	NN
cord-005453-4057qib7	10914	34	post	post	NN
cord-005453-4057qib7	10914	35	-	-	NN
cord-005453-4057qib7	10914	36	transplant	transplant	NN
cord-005453-4057qib7	10914	37	(	(	-LRB-
cord-005453-4057qib7	10914	38	Martinez	Martinez	NNP
cord-005453-4057qib7	10914	39	-	-	HYPH
cord-005453-4057qib7	10914	40	Cibrian	Cibrian	NNP
cord-005453-4057qib7	10914	41	N.	N.	NNP
cord-005453-4057qib7	10914	42	et	et	NNP
cord-005453-4057qib7	10914	43	al	al	NNP
cord-005453-4057qib7	10914	44	,	,	,
cord-005453-4057qib7	10914	45	BMT	BMT	NNP
cord-005453-4057qib7	10914	46	2016	2016	CD
cord-005453-4057qib7	10914	47	)	)	-RRB-
cord-005453-4057qib7	10914	48	.	.	.
cord-005453-4057qib7	10915	1	Despite	despite	IN
cord-005453-4057qib7	10915	2	the	the	DT
cord-005453-4057qib7	10915	3	fact	fact	NN
cord-005453-4057qib7	10915	4	that	that	IN
cord-005453-4057qib7	10915	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	10915	6	patients	patient	NNS
cord-005453-4057qib7	10915	7	receive	receive	VBP
cord-005453-4057qib7	10915	8	a	a	DT
cord-005453-4057qib7	10915	9	more	more	RBR
cord-005453-4057qib7	10915	10	intensive	intensive	JJ
cord-005453-4057qib7	10915	11	conditioning	conditioning	NN
cord-005453-4057qib7	10915	12	regimen	regimen	NN
cord-005453-4057qib7	10915	13	that	that	IN
cord-005453-4057qib7	10915	14	multiple	multiple	JJ
cord-005453-4057qib7	10915	15	myeloma	myeloma	NN
cord-005453-4057qib7	10915	16	patients	patient	NNS
cord-005453-4057qib7	10915	17	,	,	,
cord-005453-4057qib7	10915	18	we	-PRON-	PRP
cord-005453-4057qib7	10915	19	hypothesized	hypothesize	VBD
cord-005453-4057qib7	10915	20	that	that	IN
cord-005453-4057qib7	10915	21	the	the	DT
cord-005453-4057qib7	10915	22	use	use	NN
cord-005453-4057qib7	10915	23	of	of	IN
cord-005453-4057qib7	10915	24	G	G	NNP
cord-005453-4057qib7	10915	25	-	-	HYPH
cord-005453-4057qib7	10915	26	CSF	CSF	NNP
cord-005453-4057qib7	10915	27	in	in	IN
cord-005453-4057qib7	10915	28	lymphoma	lymphoma	NN
cord-005453-4057qib7	10915	29	patients	patient	NNS
cord-005453-4057qib7	10915	30	managed	manage	VBD
cord-005453-4057qib7	10915	31	at	at	IN
cord-005453-4057qib7	10915	32	home	home	NN
cord-005453-4057qib7	10915	33	during	during	IN
cord-005453-4057qib7	10915	34	the	the	DT
cord-005453-4057qib7	10915	35	aplasia	aplasia	JJ
cord-005453-4057qib7	10915	36	phase	phase	NN
cord-005453-4057qib7	10915	37	of	of	IN
cord-005453-4057qib7	10915	38	ASCT	ASCT	NNP
cord-005453-4057qib7	10915	39	does	do	VBZ
cord-005453-4057qib7	10915	40	not	not	RB
cord-005453-4057qib7	10915	41	provide	provide	VB
cord-005453-4057qib7	10915	42	a	a	DT
cord-005453-4057qib7	10915	43	significant	significant	JJ
cord-005453-4057qib7	10915	44	clinical	clinical	JJ
cord-005453-4057qib7	10915	45	benefit	benefit	NN
cord-005453-4057qib7	10915	46	.	.	.
cord-005453-4057qib7	10916	1	Methods	method	NNS
cord-005453-4057qib7	10916	2	:	:	:
cord-005453-4057qib7	10917	1	93	93	CD
cord-005453-4057qib7	10917	2	lymphoma	lymphoma	NN
cord-005453-4057qib7	10917	3	patients	patient	NNS
cord-005453-4057qib7	10917	4	were	be	VBD
cord-005453-4057qib7	10917	5	managed	manage	VBN
cord-005453-4057qib7	10917	6	at	at	IN
cord-005453-4057qib7	10917	7	-	-	HYPH
cord-005453-4057qib7	10917	8	home	home	NN
cord-005453-4057qib7	10917	9	since	since	IN
cord-005453-4057qib7	10917	10	day	day	NN
cord-005453-4057qib7	10917	11	+1	+1	NNS
cord-005453-4057qib7	10917	12	of	of	IN
cord-005453-4057qib7	10917	13	ASCT	ASCT	NNP
cord-005453-4057qib7	10917	14	.	.	.
cord-005453-4057qib7	10918	1	Between	between	IN
cord-005453-4057qib7	10918	2	February	February	NNP
cord-005453-4057qib7	10918	3	2010	2010	CD
cord-005453-4057qib7	10918	4	and	and	CC
cord-005453-4057qib7	10918	5	July	July	NNP
cord-005453-4057qib7	10918	6	2016	2016	CD
cord-005453-4057qib7	10918	7	,	,	,
cord-005453-4057qib7	10918	8	68	68	CD
cord-005453-4057qib7	10918	9	patients	patient	NNS
cord-005453-4057qib7	10918	10	received	receive	VBN
cord-005453-4057qib7	10918	11	at	at	IN
cord-005453-4057qib7	10918	12	-	-	HYPH
cord-005453-4057qib7	10918	13	home	home	NN
cord-005453-4057qib7	10918	14	G	G	NNP
cord-005453-4057qib7	10918	15	-	-	HYPH
cord-005453-4057qib7	10918	16	CSF	CSF	NNP
cord-005453-4057qib7	10918	17	5	5	CD
cord-005453-4057qib7	10918	18	μg	μg	NNP
cord-005453-4057qib7	10918	19	/	/	SYM
cord-005453-4057qib7	10918	20	kg	kg	NN
cord-005453-4057qib7	10918	21	per	per	IN
cord-005453-4057qib7	10918	22	day	day	NN
cord-005453-4057qib7	10918	23	since	since	IN
cord-005453-4057qib7	10918	24	day	day	NN
cord-005453-4057qib7	10918	25	+7	+7	.
cord-005453-4057qib7	10918	26	until	until	IN
cord-005453-4057qib7	10918	27	their	-PRON-	PRP$
cord-005453-4057qib7	10918	28	ANC	ANC	NNP
cord-005453-4057qib7	10918	29	reached	reach	VBD
cord-005453-4057qib7	10918	30	1x10	1x10	CD
cord-005453-4057qib7	10918	31	9	9	CD
cord-005453-4057qib7	10918	32	/L	/L	.
cord-005453-4057qib7	10918	33	(	(	-LRB-
cord-005453-4057qib7	10918	34	G	G	NNP
cord-005453-4057qib7	10918	35	-	-	HYPH
cord-005453-4057qib7	10918	36	CSF	CSF	NNP
cord-005453-4057qib7	10918	37	group	group	NN
cord-005453-4057qib7	10918	38	)	)	-RRB-
cord-005453-4057qib7	10918	39	and	and	CC
cord-005453-4057qib7	10918	40	,	,	,
cord-005453-4057qib7	10918	41	since	since	IN
cord-005453-4057qib7	10918	42	August	August	NNP
cord-005453-4057qib7	10918	43	2016	2016	CD
cord-005453-4057qib7	10918	44	,	,	,
cord-005453-4057qib7	10918	45	25	25	CD
cord-005453-4057qib7	10918	46	patients	patient	NNS
cord-005453-4057qib7	10918	47	did	do	VBD
cord-005453-4057qib7	10918	48	not	not	RB
cord-005453-4057qib7	10918	49	receive	receive	VB
cord-005453-4057qib7	10918	50	G	G	NNP
cord-005453-4057qib7	10918	51	-	-	HYPH
cord-005453-4057qib7	10918	52	CSF	CSF	NNP
cord-005453-4057qib7	10918	53	(	(	-LRB-
cord-005453-4057qib7	10918	54	non	non	JJ
cord-005453-4057qib7	10918	55	-	-	JJ
cord-005453-4057qib7	10918	56	G	g	JJ
cord-005453-4057qib7	10918	57	-	-	HYPH
cord-005453-4057qib7	10918	58	CSF	CSF	NNP
cord-005453-4057qib7	10918	59	group	group	NN
cord-005453-4057qib7	10918	60	)	)	-RRB-
cord-005453-4057qib7	10918	61	.	.	.
cord-005453-4057qib7	10919	1	All	all	DT
cord-005453-4057qib7	10919	2	patients	patient	NNS
cord-005453-4057qib7	10919	3	were	be	VBD
cord-005453-4057qib7	10919	4	conditioned	condition	VBN
cord-005453-4057qib7	10919	5	with	with	IN
cord-005453-4057qib7	10919	6	BEAM	BEAM	NNP
cord-005453-4057qib7	10919	7	and	and	CC
cord-005453-4057qib7	10919	8	received	receive	VBD
cord-005453-4057qib7	10919	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10919	10	with	with	IN
cord-005453-4057qib7	10919	11	a	a	DT
cord-005453-4057qib7	10919	12	quinolone	quinolone	NN
cord-005453-4057qib7	10919	13	,	,	,
cord-005453-4057qib7	10919	14	fluconazole	fluconazole	NN
cord-005453-4057qib7	10919	15	,	,	,
cord-005453-4057qib7	10919	16	aerosolized	aerosolize	VBN
cord-005453-4057qib7	10919	17	pentamidine	pentamidine	NN
cord-005453-4057qib7	10919	18	and	and	CC
cord-005453-4057qib7	10919	19	low	low	JJ
cord-005453-4057qib7	10919	20	-	-	HYPH
cord-005453-4057qib7	10919	21	dose	dose	NN
cord-005453-4057qib7	10919	22	acyclovir	acyclovir	NN
cord-005453-4057qib7	10919	23	(	(	-LRB-
cord-005453-4057qib7	10919	24	HVS+	HVS+	NNP
cord-005453-4057qib7	10919	25	)	)	-RRB-
cord-005453-4057qib7	10919	26	.	.	.
cord-005453-4057qib7	10920	1	In	in	IN
cord-005453-4057qib7	10920	2	all	all	DT
cord-005453-4057qib7	10920	3	cases	case	NNS
cord-005453-4057qib7	10920	4	we	-PRON-	PRP
cord-005453-4057qib7	10920	5	added	add	VBD
cord-005453-4057qib7	10920	6	primary	primary	JJ
cord-005453-4057qib7	10920	7	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10920	8	with	with	IN
cord-005453-4057qib7	10920	9	piperacillin	piperacillin	NNP
cord-005453-4057qib7	10920	10	-	-	HYPH
cord-005453-4057qib7	10920	11	tazobactam	tazobactam	NNS
cord-005453-4057qib7	10920	12	4.5	4.5	CD
cord-005453-4057qib7	10920	13	g/8h	g/8h	NNP
cord-005453-4057qib7	10920	14	i.v	i.v	NNP
cord-005453-4057qib7	10920	15	.	.	NNP
cord-005453-4057qib7	10920	16	,	,	,
cord-005453-4057qib7	10920	17	using	use	VBG
cord-005453-4057qib7	10920	18	a	a	DT
cord-005453-4057qib7	10920	19	portable	portable	JJ
cord-005453-4057qib7	10920	20	intermittent	intermittent	JJ
cord-005453-4057qib7	10920	21	infusion	infusion	NN
cord-005453-4057qib7	10920	22	pump	pump	NN
cord-005453-4057qib7	10920	23	(	(	-LRB-
cord-005453-4057qib7	10920	24	IIP	IIP	NNP
cord-005453-4057qib7	10920	25	)	)	-RRB-
cord-005453-4057qib7	10920	26	,	,	,
cord-005453-4057qib7	10920	27	from	from	IN
cord-005453-4057qib7	10920	28	an	an	DT
cord-005453-4057qib7	10920	29	absolute	absolute	JJ
cord-005453-4057qib7	10920	30	neutrophil	neutrophil	NN
cord-005453-4057qib7	10920	31	count	count	NN
cord-005453-4057qib7	10920	32	(	(	-LRB-
cord-005453-4057qib7	10920	33	ANC	ANC	NNP
cord-005453-4057qib7	10920	34	)	)	-RRB-
cord-005453-4057qib7	10920	35	<	<	XX
cord-005453-4057qib7	10920	36	0.5x10	0.5x10	CD
cord-005453-4057qib7	10920	37	9	9	CD
cord-005453-4057qib7	10920	38	/L	/L	.
cord-005453-4057qib7	10920	39	until	until	IN
cord-005453-4057qib7	10920	40	the	the	DT
cord-005453-4057qib7	10920	41	first	first	JJ
cord-005453-4057qib7	10920	42	day	day	NN
cord-005453-4057qib7	10920	43	of	of	IN
cord-005453-4057qib7	10920	44	fever	fever	NN
cord-005453-4057qib7	10920	45	or	or	CC
cord-005453-4057qib7	10920	46	until	until	IN
cord-005453-4057qib7	10920	47	attaining	attain	VBG
cord-005453-4057qib7	10920	48	an	an	DT
cord-005453-4057qib7	10920	49	ANC	ANC	NNP
cord-005453-4057qib7	10920	50	of	of	IN
cord-005453-4057qib7	10920	51	1x10	1x10	CD
cord-005453-4057qib7	10920	52	9	9	CD
cord-005453-4057qib7	10921	1	/L.	/L.	.
cord-005453-4057qib7	10922	1	First	first	JJ
cord-005453-4057qib7	10922	2	-	-	HYPH
cord-005453-4057qib7	10922	3	line	line	NN
cord-005453-4057qib7	10922	4	therapy	therapy	NN
cord-005453-4057qib7	10922	5	at	at	IN
cord-005453-4057qib7	10922	6	home	home	NN
cord-005453-4057qib7	10922	7	of	of	IN
cord-005453-4057qib7	10922	8	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10922	9	fever	fever	NN
cord-005453-4057qib7	10922	10	(	(	-LRB-
cord-005453-4057qib7	10922	11	NF	NF	NNP
cord-005453-4057qib7	10922	12	)	)	-RRB-
cord-005453-4057qib7	10922	13	was	be	VBD
cord-005453-4057qib7	10922	14	refrigerated	refrigerate	VBN
cord-005453-4057qib7	10922	15	meropenem	meropenem	NNP
cord-005453-4057qib7	10922	16	1	1	CD
cord-005453-4057qib7	10922	17	g/8h	g/8h	NNP
cord-005453-4057qib7	10922	18	i.v	i.v	NNP
cord-005453-4057qib7	10922	19	using	use	VBG
cord-005453-4057qib7	10922	20	a	a	DT
cord-005453-4057qib7	10922	21	portable	portable	JJ
cord-005453-4057qib7	10922	22	IIP	IIP	NNP
cord-005453-4057qib7	10922	23	.	.	.
cord-005453-4057qib7	10923	1	Fever	fever	NN
cord-005453-4057qib7	10923	2	was	be	VBD
cord-005453-4057qib7	10923	3	an	an	DT
cord-005453-4057qib7	10923	4	indication	indication	NN
cord-005453-4057qib7	10923	5	of	of	IN
cord-005453-4057qib7	10923	6	immediate	immediate	JJ
cord-005453-4057qib7	10923	7	visit	visit	NN
cord-005453-4057qib7	10923	8	to	to	IN
cord-005453-4057qib7	10923	9	the	the	DT
cord-005453-4057qib7	10923	10	hospital	hospital	NN
cord-005453-4057qib7	10923	11	,	,	,
cord-005453-4057qib7	10923	12	and	and	CC
cord-005453-4057qib7	10923	13	those	those	DT
cord-005453-4057qib7	10923	14	patients	patient	NNS
cord-005453-4057qib7	10923	15	presenting	present	VBG
cord-005453-4057qib7	10923	16	with	with	IN
cord-005453-4057qib7	10923	17	focal	focal	JJ
cord-005453-4057qib7	10923	18	infection	infection	NN
cord-005453-4057qib7	10923	19	or	or	CC
cord-005453-4057qib7	10923	20	signs	sign	NNS
cord-005453-4057qib7	10923	21	of	of	IN
cord-005453-4057qib7	10923	22	severe	severe	JJ
cord-005453-4057qib7	10923	23	sepsis	sepsis	NN
cord-005453-4057qib7	10923	24	were	be	VBD
cord-005453-4057qib7	10923	25	admitted	admit	VBN
cord-005453-4057qib7	10923	26	.	.	.
cord-005453-4057qib7	10924	1	Other	other	JJ
cord-005453-4057qib7	10924	2	indications	indication	NNS
cord-005453-4057qib7	10924	3	for	for	IN
cord-005453-4057qib7	10924	4	readmission	readmission	NN
cord-005453-4057qib7	10924	5	were	be	VBD
cord-005453-4057qib7	10924	6	:	:	:
cord-005453-4057qib7	10924	7	willingness	willingness	NN
cord-005453-4057qib7	10924	8	of	of	IN
cord-005453-4057qib7	10924	9	the	the	DT
cord-005453-4057qib7	10924	10	patient	patient	NN
cord-005453-4057qib7	10924	11	or	or	CC
cord-005453-4057qib7	10924	12	caregiver	caregiver	NN
cord-005453-4057qib7	10924	13	;	;	,
cord-005453-4057qib7	10924	14	uncontrolled	uncontrolled	JJ
cord-005453-4057qib7	10924	15	nausea	nausea	NN
cord-005453-4057qib7	10924	16	,	,	,
cord-005453-4057qib7	10924	17	vomiting	vomiting	NN
cord-005453-4057qib7	10924	18	or	or	CC
cord-005453-4057qib7	10924	19	diarrhea	diarrhea	NN
cord-005453-4057qib7	10924	20	and	and	CC
cord-005453-4057qib7	10924	21	mucositis	mucositis	NNP
cord-005453-4057qib7	10924	22	requiring	require	VBG
cord-005453-4057qib7	10924	23	total	total	JJ
cord-005453-4057qib7	10924	24	parenteral	parenteral	JJ
cord-005453-4057qib7	10924	25	nutrition	nutrition	NN
cord-005453-4057qib7	10924	26	or	or	CC
cord-005453-4057qib7	10924	27	i.v	i.v	NNP
cord-005453-4057qib7	10924	28	.	.	NNP
cord-005453-4057qib7	10924	29	morphics	morphic	NNS
cord-005453-4057qib7	10924	30	.	.	.
cord-005453-4057qib7	10925	1	Results	result	NNS
cord-005453-4057qib7	10925	2	:	:	:
cord-005453-4057qib7	10926	1	The	the	DT
cord-005453-4057qib7	10926	2	main	main	JJ
cord-005453-4057qib7	10926	3	characteristics	characteristic	NNS
cord-005453-4057qib7	10926	4	of	of	IN
cord-005453-4057qib7	10926	5	the	the	DT
cord-005453-4057qib7	10926	6	patients	patient	NNS
cord-005453-4057qib7	10926	7	are	be	VBP
cord-005453-4057qib7	10926	8	shown	show	VBN
cord-005453-4057qib7	10926	9	in	in	IN
cord-005453-4057qib7	10926	10	table	table	NN
cord-005453-4057qib7	10926	11	1	1	CD
cord-005453-4057qib7	10926	12	.	.	.
cord-005453-4057qib7	10927	1	There	there	EX
cord-005453-4057qib7	10927	2	were	be	VBD
cord-005453-4057qib7	10927	3	no	no	DT
cord-005453-4057qib7	10927	4	differences	difference	NNS
cord-005453-4057qib7	10927	5	between	between	IN
cord-005453-4057qib7	10927	6	groups	group	NNS
cord-005453-4057qib7	10927	7	with	with	IN
cord-005453-4057qib7	10927	8	respect	respect	NN
cord-005453-4057qib7	10927	9	to	to	IN
cord-005453-4057qib7	10927	10	gender	gender	NN
cord-005453-4057qib7	10927	11	,	,	,
cord-005453-4057qib7	10927	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	10927	13	,	,	,
cord-005453-4057qib7	10927	14	stage	stage	NN
cord-005453-4057qib7	10927	15	of	of	IN
cord-005453-4057qib7	10927	16	disease	disease	NN
cord-005453-4057qib7	10927	17	,	,	,
cord-005453-4057qib7	10927	18	comorbidity	comorbidity	NN
cord-005453-4057qib7	10927	19	index	index	NN
cord-005453-4057qib7	10927	20	(	(	-LRB-
cord-005453-4057qib7	10927	21	HCT	HCT	NNP
cord-005453-4057qib7	10927	22	-	-	HYPH
cord-005453-4057qib7	10927	23	CI	CI	NNP
cord-005453-4057qib7	10927	24	)	)	-RRB-
cord-005453-4057qib7	10927	25	,	,	,
cord-005453-4057qib7	10927	26	source	source	NN
cord-005453-4057qib7	10927	27	of	of	IN
cord-005453-4057qib7	10927	28	stem	stem	NN
cord-005453-4057qib7	10927	29	cells	cell	NNS
cord-005453-4057qib7	10927	30	(	(	-LRB-
cord-005453-4057qib7	10927	31	peripheral	peripheral	JJ
cord-005453-4057qib7	10927	32	blood	blood	NN
cord-005453-4057qib7	10927	33	)	)	-RRB-
cord-005453-4057qib7	10927	34	and	and	CC
cord-005453-4057qib7	10927	35	CD34	CD34	NNP
cord-005453-4057qib7	10927	36	+	+	CC
cord-005453-4057qib7	10927	37	cell	cell	NN
cord-005453-4057qib7	10927	38	dose	dose	NN
cord-005453-4057qib7	10927	39	infused	infuse	VBN
cord-005453-4057qib7	10927	40	.	.	.
cord-005453-4057qib7	10928	1	The	the	DT
cord-005453-4057qib7	10928	2	median	median	NN
cord-005453-4057qib7	10928	3	(	(	-LRB-
cord-005453-4057qib7	10928	4	range	range	NN
cord-005453-4057qib7	10928	5	)	)	-RRB-
cord-005453-4057qib7	10928	6	age	age	NN
cord-005453-4057qib7	10928	7	(	(	-LRB-
cord-005453-4057qib7	10928	8	years	year	NNS
cord-005453-4057qib7	10928	9	)	)	-RRB-
cord-005453-4057qib7	10928	10	was	be	VBD
cord-005453-4057qib7	10928	11	44	44	CD
cord-005453-4057qib7	10928	12	(	(	-LRB-
cord-005453-4057qib7	10928	13	19	19	CD
cord-005453-4057qib7	10928	14	-	-	SYM
cord-005453-4057qib7	10928	15	71	71	CD
cord-005453-4057qib7	10928	16	)	)	-RRB-
cord-005453-4057qib7	10928	17	in	in	IN
cord-005453-4057qib7	10928	18	G	G	NNP
cord-005453-4057qib7	10928	19	-	-	HYPH
cord-005453-4057qib7	10928	20	CSF	CSF	NNP
cord-005453-4057qib7	10928	21	group	group	NN
cord-005453-4057qib7	10928	22	and	and	CC
cord-005453-4057qib7	10928	23	52	52	CD
cord-005453-4057qib7	10928	24	in	in	IN
cord-005453-4057qib7	10928	25	non	non	JJ
cord-005453-4057qib7	10928	26	-	-	JJ
cord-005453-4057qib7	10928	27	G	g	JJ
cord-005453-4057qib7	10928	28	-	-	HYPH
cord-005453-4057qib7	10928	29	CSF	csf	NN
cord-005453-4057qib7	10928	30	group	group	NN
cord-005453-4057qib7	10928	31	(	(	-LRB-
cord-005453-4057qib7	10928	32	p=0.03	p=0.03	NN
cord-005453-4057qib7	10928	33	)	)	-RRB-
cord-005453-4057qib7	10928	34	.	.	.
cord-005453-4057qib7	10929	1	Duration	duration	NN
cord-005453-4057qib7	10929	2	of	of	IN
cord-005453-4057qib7	10929	3	neutropenia	neutropenia	NN
cord-005453-4057qib7	10929	4	less	less	JJR
cord-005453-4057qib7	10929	5	than	than	IN
cord-005453-4057qib7	10929	6	0.5	0.5	CD
cord-005453-4057qib7	10929	7	x10	x10	CD
cord-005453-4057qib7	10929	8	9	9	CD
cord-005453-4057qib7	10929	9	/L	/L	,
cord-005453-4057qib7	10929	10	was	be	VBD
cord-005453-4057qib7	10929	11	significantly	significantly	RB
cord-005453-4057qib7	10929	12	longer	long	JJR
cord-005453-4057qib7	10929	13	in	in	IN
cord-005453-4057qib7	10929	14	non	non	JJ
cord-005453-4057qib7	10929	15	-	-	JJ
cord-005453-4057qib7	10929	16	G	g	JJ
cord-005453-4057qib7	10929	17	-	-	HYPH
cord-005453-4057qib7	10929	18	CSF	CSF	NNP
cord-005453-4057qib7	10929	19	group	group	NN
cord-005453-4057qib7	10929	20	,	,	,
cord-005453-4057qib7	10929	21	with	with	IN
cord-005453-4057qib7	10929	22	a	a	DT
cord-005453-4057qib7	10929	23	median	median	NN
cord-005453-4057qib7	10929	24	of	of	IN
cord-005453-4057qib7	10929	25	11	11	CD
cord-005453-4057qib7	10929	26	days	day	NNS
cord-005453-4057qib7	10929	27	(	(	-LRB-
cord-005453-4057qib7	10929	28	range	range	VBP
cord-005453-4057qib7	10929	29	6	6	CD
cord-005453-4057qib7	10929	30	-	-	SYM
cord-005453-4057qib7	10929	31	19	19	CD
cord-005453-4057qib7	10929	32	)	)	-RRB-
cord-005453-4057qib7	10929	33	,	,	,
cord-005453-4057qib7	10929	34	compared	compare	VBN
cord-005453-4057qib7	10929	35	with	with	IN
cord-005453-4057qib7	10929	36	8	8	CD
cord-005453-4057qib7	10929	37	(	(	-LRB-
cord-005453-4057qib7	10929	38	range	range	NNP
cord-005453-4057qib7	10929	39	6	6	CD
cord-005453-4057qib7	10929	40	-	-	SYM
cord-005453-4057qib7	10929	41	17	17	CD
cord-005453-4057qib7	10929	42	)	)	-RRB-
cord-005453-4057qib7	10929	43	in	in	IN
cord-005453-4057qib7	10929	44	G	G	NNP
cord-005453-4057qib7	10929	45	-	-	HYPH
cord-005453-4057qib7	10929	46	CSF	CSF	NNP
cord-005453-4057qib7	10929	47	group	group	NN
cord-005453-4057qib7	10929	48	(	(	-LRB-
cord-005453-4057qib7	10929	49	p	p	NN
cord-005453-4057qib7	10929	50	<	<	XX
cord-005453-4057qib7	10929	51	0.0001	0.0001	CD
cord-005453-4057qib7	10929	52	)	)	-RRB-
cord-005453-4057qib7	10929	53	.	.	.
cord-005453-4057qib7	10930	1	Severe	severe	JJ
cord-005453-4057qib7	10930	2	neutropenia	neutropenia	NN
cord-005453-4057qib7	10930	3	,	,	,
cord-005453-4057qib7	10930	4	less	less	JJR
cord-005453-4057qib7	10930	5	than	than	IN
cord-005453-4057qib7	10930	6	0.1x10	0.1x10	CD
cord-005453-4057qib7	10930	7	9	9	CD
cord-005453-4057qib7	10930	8	/L	/L	,
cord-005453-4057qib7	10930	9	,	,	,
cord-005453-4057qib7	10930	10	was	be	VBD
cord-005453-4057qib7	10930	11	also	also	RB
cord-005453-4057qib7	10930	12	longer	long	JJR
cord-005453-4057qib7	10930	13	in	in	IN
cord-005453-4057qib7	10930	14	the	the	DT
cord-005453-4057qib7	10930	15	non	non	JJ
cord-005453-4057qib7	10930	16	-	-	JJ
cord-005453-4057qib7	10930	17	G	g	JJ
cord-005453-4057qib7	10930	18	-	-	HYPH
cord-005453-4057qib7	10930	19	CSF	csf	NN
cord-005453-4057qib7	10930	20	group	group	NN
cord-005453-4057qib7	10930	21	(	(	-LRB-
cord-005453-4057qib7	10930	22	8	8	CD
cord-005453-4057qib7	10930	23	days	day	NNS
cord-005453-4057qib7	10930	24	(	(	-LRB-
cord-005453-4057qib7	10930	25	4	4	CD
cord-005453-4057qib7	10930	26	-	-	SYM
cord-005453-4057qib7	10930	27	11	11	CD
cord-005453-4057qib7	10930	28	)	)	-RRB-
cord-005453-4057qib7	10930	29	vs.	vs.	FW
cord-005453-4057qib7	10930	30	7	7	CD
cord-005453-4057qib7	10930	31	(	(	-LRB-
cord-005453-4057qib7	10930	32	5	5	CD
cord-005453-4057qib7	10930	33	-	-	SYM
cord-005453-4057qib7	10930	34	13	13	CD
cord-005453-4057qib7	10930	35	)	)	-RRB-
cord-005453-4057qib7	10930	36	;	;	:
cord-005453-4057qib7	10930	37	p=0.014	p=0.014	NNS
cord-005453-4057qib7	10930	38	)	)	-RRB-
cord-005453-4057qib7	10930	39	.	.	.
cord-005453-4057qib7	10931	1	No	no	DT
cord-005453-4057qib7	10931	2	differences	difference	NNS
cord-005453-4057qib7	10931	3	were	be	VBD
cord-005453-4057qib7	10931	4	observed	observe	VBN
cord-005453-4057qib7	10931	5	in	in	IN
cord-005453-4057qib7	10931	6	the	the	DT
cord-005453-4057qib7	10931	7	time	time	NN
cord-005453-4057qib7	10931	8	to	to	IN
cord-005453-4057qib7	10931	9	platelet	platelet	NN
cord-005453-4057qib7	10931	10	engraftment	engraftment	NN
cord-005453-4057qib7	10931	11	.	.	.
cord-005453-4057qib7	10932	1	G	G	NNP
cord-005453-4057qib7	10932	2	-	-	HYPH
cord-005453-4057qib7	10932	3	CSF	csf	NN
cord-005453-4057qib7	10932	4	post	post	JJ
cord-005453-4057qib7	10932	5	-	-	JJ
cord-005453-4057qib7	10932	6	transplant	transplant	JJ
cord-005453-4057qib7	10932	7	avoidance	avoidance	NN
cord-005453-4057qib7	10932	8	did	do	VBD
cord-005453-4057qib7	10932	9	not	not	RB
cord-005453-4057qib7	10932	10	influence	influence	VB
cord-005453-4057qib7	10932	11	the	the	DT
cord-005453-4057qib7	10932	12	incidence	incidence	NN
cord-005453-4057qib7	10932	13	of	of	IN
cord-005453-4057qib7	10932	14	neutropenic	neutropenic	JJ
cord-005453-4057qib7	10932	15	fever	fever	NN
cord-005453-4057qib7	10932	16	,	,	,
cord-005453-4057qib7	10932	17	the	the	DT
cord-005453-4057qib7	10932	18	first	first	JJ
cord-005453-4057qib7	10932	19	day	day	NN
cord-005453-4057qib7	10932	20	and	and	CC
cord-005453-4057qib7	10932	21	duration	duration	NN
cord-005453-4057qib7	10932	22	of	of	IN
cord-005453-4057qib7	10932	23	fever	fever	NN
cord-005453-4057qib7	10932	24	,	,	,
cord-005453-4057qib7	10932	25	the	the	DT
cord-005453-4057qib7	10932	26	incidence	incidence	NN
cord-005453-4057qib7	10932	27	and	and	CC
cord-005453-4057qib7	10932	28	severity	severity	NN
cord-005453-4057qib7	10932	29	of	of	IN
cord-005453-4057qib7	10932	30	oral	oral	JJ
cord-005453-4057qib7	10932	31	mucositis	mucositis	NN
cord-005453-4057qib7	10932	32	,	,	,
cord-005453-4057qib7	10932	33	bacterial	bacterial	JJ
cord-005453-4057qib7	10932	34	infections	infection	NNS
cord-005453-4057qib7	10932	35	documented	document	VBN
cord-005453-4057qib7	10932	36	and	and	CC
cord-005453-4057qib7	10932	37	number	number	NN
cord-005453-4057qib7	10932	38	of	of	IN
cord-005453-4057qib7	10932	39	readmissions	readmission	NNS
cord-005453-4057qib7	10932	40	.	.	.
cord-005453-4057qib7	10933	1	The	the	DT
cord-005453-4057qib7	10933	2	median	median	JJ
cord-005453-4057qib7	10933	3	duration	duration	NN
cord-005453-4057qib7	10933	4	of	of	IN
cord-005453-4057qib7	10933	5	the	the	DT
cord-005453-4057qib7	10933	6	whole	whole	JJ
cord-005453-4057qib7	10933	7	procedure	procedure	NN
cord-005453-4057qib7	10933	8	at	at	IN
cord-005453-4057qib7	10933	9	-	-	HYPH
cord-005453-4057qib7	10933	10	home	home	NN
cord-005453-4057qib7	10933	11	was	be	VBD
cord-005453-4057qib7	10933	12	1	1	CD
cord-005453-4057qib7	10933	13	day	day	NN
cord-005453-4057qib7	10933	14	shorter	short	JJR
cord-005453-4057qib7	10933	15	in	in	IN
cord-005453-4057qib7	10933	16	the	the	DT
cord-005453-4057qib7	10933	17	G	G	NNP
cord-005453-4057qib7	10933	18	-	-	HYPH
cord-005453-4057qib7	10933	19	CSF	CSF	NNP
cord-005453-4057qib7	10933	20	group	group	NN
cord-005453-4057qib7	10933	21	(	(	-LRB-
cord-005453-4057qib7	10933	22	14	14	CD
cord-005453-4057qib7	10933	23	vs.	vs.	NN
cord-005453-4057qib7	10933	24	15	15	CD
cord-005453-4057qib7	10933	25	days	day	NNS
cord-005453-4057qib7	10933	26	;	;	:
cord-005453-4057qib7	10933	27	p=0.12	p=0.12	NN
cord-005453-4057qib7	10933	28	)	)	-RRB-
cord-005453-4057qib7	10933	29	.	.	.
cord-005453-4057qib7	10934	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10934	2	:	:	:
cord-005453-4057qib7	10935	1	The	the	DT
cord-005453-4057qib7	10935	2	policy	policy	NN
cord-005453-4057qib7	10935	3	of	of	IN
cord-005453-4057qib7	10935	4	not	not	RB
cord-005453-4057qib7	10935	5	administering	administer	VBG
cord-005453-4057qib7	10935	6	G	G	NNP
cord-005453-4057qib7	10935	7	-	-	HYPH
cord-005453-4057qib7	10935	8	CSF	csf	NN
cord-005453-4057qib7	10935	9	post	post	NN
cord-005453-4057qib7	10935	10	-	-	JJ
cord-005453-4057qib7	10935	11	ASCT	asct	NN
cord-005453-4057qib7	10935	12	in	in	IN
cord-005453-4057qib7	10935	13	our	-PRON-	PRP$
cord-005453-4057qib7	10935	14	home	home	NN
cord-005453-4057qib7	10935	15	-	-	HYPH
cord-005453-4057qib7	10935	16	based	base	VBN
cord-005453-4057qib7	10935	17	program	program	NN
cord-005453-4057qib7	10935	18	for	for	IN
cord-005453-4057qib7	10935	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	10935	20	patients	patient	NNS
cord-005453-4057qib7	10935	21	,	,	,
cord-005453-4057qib7	10935	22	that	that	WDT
cord-005453-4057qib7	10935	23	include	include	VBP
cord-005453-4057qib7	10935	24	intensive	intensive	JJ
cord-005453-4057qib7	10935	25	bacterial	bacterial	JJ
cord-005453-4057qib7	10935	26	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10935	27	,	,	,
cord-005453-4057qib7	10935	28	did	do	VBD
cord-005453-4057qib7	10935	29	not	not	RB
cord-005453-4057qib7	10935	30	have	have	VB
cord-005453-4057qib7	10935	31	a	a	DT
cord-005453-4057qib7	10935	32	deleterious	deleterious	JJ
cord-005453-4057qib7	10935	33	impact	impact	NN
cord-005453-4057qib7	10935	34	on	on	IN
cord-005453-4057qib7	10935	35	the	the	DT
cord-005453-4057qib7	10935	36	main	main	JJ
cord-005453-4057qib7	10935	37	results	result	NNS
cord-005453-4057qib7	10935	38	reviewed	review	VBN
cord-005453-4057qib7	10935	39	,	,	,
cord-005453-4057qib7	10935	40	which	which	WDT
cord-005453-4057qib7	10935	41	suggests	suggest	VBZ
cord-005453-4057qib7	10935	42	that	that	IN
cord-005453-4057qib7	10935	43	elimination	elimination	NN
cord-005453-4057qib7	10935	44	of	of	IN
cord-005453-4057qib7	10935	45	its	-PRON-	PRP$
cord-005453-4057qib7	10935	46	use	use	NN
cord-005453-4057qib7	10935	47	can	can	MD
cord-005453-4057qib7	10935	48	be	be	VB
cord-005453-4057qib7	10935	49	achieved	achieve	VBN
cord-005453-4057qib7	10935	50	.	.	.
cord-005453-4057qib7	10936	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10937	1	The	the	DT
cord-005453-4057qib7	10937	2	aim	aim	NN
cord-005453-4057qib7	10937	3	of	of	IN
cord-005453-4057qib7	10937	4	this	this	DT
cord-005453-4057qib7	10937	5	study	study	NN
cord-005453-4057qib7	10937	6	was	be	VBD
cord-005453-4057qib7	10937	7	to	to	TO
cord-005453-4057qib7	10937	8	analyze	analyze	VB
cord-005453-4057qib7	10937	9	the	the	DT
cord-005453-4057qib7	10937	10	Spanish	spanish	JJ
cord-005453-4057qib7	10937	11	experience	experience	NN
cord-005453-4057qib7	10937	12	with	with	IN
cord-005453-4057qib7	10937	13	patients	patient	NNS
cord-005453-4057qib7	10937	14	diagnosed	diagnose	VBN
cord-005453-4057qib7	10937	15	of	of	IN
cord-005453-4057qib7	10937	16	NHL	NHL	NNP
cord-005453-4057qib7	10937	17	who	who	WP
cord-005453-4057qib7	10937	18	received	receive	VBD
cord-005453-4057qib7	10937	19	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	10937	20	with	with	IN
cord-005453-4057qib7	10937	21	Pt	Pt	NNP
cord-005453-4057qib7	10937	22	-	-	HYPH
cord-005453-4057qib7	10937	23	Cy	Cy	NNP
cord-005453-4057qib7	10937	24	.	.	.
cord-005453-4057qib7	10938	1	Methods	method	NNS
cord-005453-4057qib7	10938	2	:	:	:
cord-005453-4057qib7	10939	1	Sixty	sixty	CD
cord-005453-4057qib7	10939	2	patients	patient	NNS
cord-005453-4057qib7	10939	3	who	who	WP
cord-005453-4057qib7	10939	4	received	receive	VBD
cord-005453-4057qib7	10939	5	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	10939	6	with	with	IN
cord-005453-4057qib7	10939	7	Pt	Pt	NNP
cord-005453-4057qib7	10939	8	-	-	HYPH
cord-005453-4057qib7	10939	9	CY	CY	NNP
cord-005453-4057qib7	10939	10	in	in	IN
cord-005453-4057qib7	10939	11	17	17	CD
cord-005453-4057qib7	10939	12	Spanish	spanish	JJ
cord-005453-4057qib7	10939	13	centers	center	NNS
cord-005453-4057qib7	10939	14	from	from	IN
cord-005453-4057qib7	10939	15	2012	2012	CD
cord-005453-4057qib7	10939	16	to	to	IN
cord-005453-4057qib7	10939	17	2016	2016	CD
cord-005453-4057qib7	10939	18	were	be	VBD
cord-005453-4057qib7	10939	19	analyzed	analyze	VBN
cord-005453-4057qib7	10939	20	.	.	.
cord-005453-4057qib7	10940	1	Patients	patient	NNS
cord-005453-4057qib7	10940	2	were	be	VBD
cord-005453-4057qib7	10940	3	followed	follow	VBN
cord-005453-4057qib7	10940	4	-	-	HYPH
cord-005453-4057qib7	10940	5	up	up	NN
cord-005453-4057qib7	10940	6	until	until	IN
cord-005453-4057qib7	10940	7	2017	2017	CD
cord-005453-4057qib7	10940	8	.	.	.
cord-005453-4057qib7	10941	1	GVHD	GVHD	NNP
cord-005453-4057qib7	10941	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10941	3	consisted	consist	VBD
cord-005453-4057qib7	10941	4	in	in	IN
cord-005453-4057qib7	10941	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	10941	6	50	50	CD
cord-005453-4057qib7	10941	7	mg	mg	NNP
cord-005453-4057qib7	10941	8	/	/	SYM
cord-005453-4057qib7	10941	9	kg	kg	NNP
cord-005453-4057qib7	10941	10	/	/	SYM
cord-005453-4057qib7	10941	11	d	d	NN
cord-005453-4057qib7	10941	12	on	on	IN
cord-005453-4057qib7	10941	13	days	day	NNS
cord-005453-4057qib7	10941	14	+3	+3	NNP
cord-005453-4057qib7	10941	15	and	and	CC
cord-005453-4057qib7	10941	16	+4	+4	NNP
cord-005453-4057qib7	10941	17	,	,	,
cord-005453-4057qib7	10941	18	and	and	CC
cord-005453-4057qib7	10941	19	MMF	mmf	NN
cord-005453-4057qib7	10941	20	and	and	CC
cord-005453-4057qib7	10941	21	a	a	DT
cord-005453-4057qib7	10941	22	calcineurin	calcineurin	JJ
cord-005453-4057qib7	10941	23	inhibitor	inhibitor	NN
cord-005453-4057qib7	10941	24	from	from	IN
cord-005453-4057qib7	10941	25	day	day	NN
cord-005453-4057qib7	10941	26	+5	+5	NFP
cord-005453-4057qib7	10941	27	.	.	.
cord-005453-4057qib7	10942	1	Results	result	NNS
cord-005453-4057qib7	10942	2	:	:	:
cord-005453-4057qib7	10943	1	Patients	patient	NNS
cord-005453-4057qib7	10943	2	'	'	POS
cord-005453-4057qib7	10943	3	characteristics	characteristic	NNS
cord-005453-4057qib7	10943	4	are	be	VBP
cord-005453-4057qib7	10943	5	summarized	summarize	VBN
cord-005453-4057qib7	10943	6	on	on	IN
cord-005453-4057qib7	10943	7	Table	Table	NNP
cord-005453-4057qib7	10943	8	 	 	_SP
cord-005453-4057qib7	10943	9	1	1	CD
cord-005453-4057qib7	10943	10	.	.	.
cord-005453-4057qib7	10944	1	Median	median	JJ
cord-005453-4057qib7	10944	2	age	age	NN
cord-005453-4057qib7	10944	3	of	of	IN
cord-005453-4057qib7	10944	4	patients	patient	NNS
cord-005453-4057qib7	10944	5	was	be	VBD
cord-005453-4057qib7	10944	6	50	50	CD
cord-005453-4057qib7	10944	7	,	,	,
cord-005453-4057qib7	10944	8	75	75	CD
cord-005453-4057qib7	10944	9	%	%	NN
cord-005453-4057qib7	10944	10	male	male	NN
cord-005453-4057qib7	10944	11	,	,	,
cord-005453-4057qib7	10944	12	and	and	CC
cord-005453-4057qib7	10944	13	diagnosed	diagnose	VBN
cord-005453-4057qib7	10944	14	from	from	IN
cord-005453-4057qib7	10944	15	T	T	NNP
cord-005453-4057qib7	10944	16	cell	cell	NN
cord-005453-4057qib7	10944	17	lymphoma	lymphoma	NN
cord-005453-4057qib7	10944	18	(	(	-LRB-
cord-005453-4057qib7	10944	19	37	37	CD
cord-005453-4057qib7	10944	20	%	%	NN
cord-005453-4057qib7	10944	21	)	)	-RRB-
cord-005453-4057qib7	10944	22	.	.	.
cord-005453-4057qib7	10945	1	Most	Most	JJS
cord-005453-4057qib7	10945	2	of	of	IN
cord-005453-4057qib7	10945	3	them	-PRON-	PRP
cord-005453-4057qib7	10945	4	didn´t	didn´t	TO
cord-005453-4057qib7	10945	5	achieve	achieve	VB
cord-005453-4057qib7	10945	6	complete	complete	JJ
cord-005453-4057qib7	10945	7	response	response	NN
cord-005453-4057qib7	10945	8	prior	prior	RB
cord-005453-4057qib7	10945	9	to	to	IN
cord-005453-4057qib7	10945	10	transplant	transplant	NN
cord-005453-4057qib7	10945	11	(	(	-LRB-
cord-005453-4057qib7	10945	12	55	55	CD
cord-005453-4057qib7	10945	13	%	%	NN
cord-005453-4057qib7	10945	14	)	)	-RRB-
cord-005453-4057qib7	10945	15	,	,	,
cord-005453-4057qib7	10945	16	but	but	CC
cord-005453-4057qib7	10945	17	only	only	RB
cord-005453-4057qib7	10945	18	15	15	CD
cord-005453-4057qib7	10945	19	%	%	NN
cord-005453-4057qib7	10945	20	with	with	IN
cord-005453-4057qib7	10945	21	active	active	JJ
cord-005453-4057qib7	10945	22	disease	disease	NN
cord-005453-4057qib7	10945	23	.	.	.
cord-005453-4057qib7	10946	1	Up	up	IN
cord-005453-4057qib7	10946	2	to	to	TO
cord-005453-4057qib7	10946	3	63	63	CD
cord-005453-4057qib7	10946	4	%	%	NN
cord-005453-4057qib7	10946	5	of	of	IN
cord-005453-4057qib7	10946	6	patients	patient	NNS
cord-005453-4057qib7	10946	7	had	have	VBD
cord-005453-4057qib7	10946	8	received	receive	VBN
cord-005453-4057qib7	10946	9	previous	previous	JJ
cord-005453-4057qib7	10946	10	transplant	transplant	NN
cord-005453-4057qib7	10946	11	,	,	,
cord-005453-4057qib7	10946	12	from	from	IN
cord-005453-4057qib7	10946	13	which	which	WDT
cord-005453-4057qib7	10946	14	5	5	CD
cord-005453-4057qib7	10946	15	%	%	NN
cord-005453-4057qib7	10946	16	was	be	VBD
cord-005453-4057qib7	10946	17	an	an	DT
cord-005453-4057qib7	10946	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	10946	19	transplantation	transplantation	NN
cord-005453-4057qib7	10946	20	.	.	.
cord-005453-4057qib7	10947	1	Source	source	NN
cord-005453-4057qib7	10947	2	of	of	IN
cord-005453-4057qib7	10947	3	stem	stem	NN
cord-005453-4057qib7	10947	4	cells	cell	NNS
cord-005453-4057qib7	10947	5	was	be	VBD
cord-005453-4057qib7	10947	6	mainly	mainly	RB
cord-005453-4057qib7	10947	7	peripheral	peripheral	JJ
cord-005453-4057qib7	10947	8	blood	blood	NN
cord-005453-4057qib7	10947	9	(	(	-LRB-
cord-005453-4057qib7	10947	10	90	90	CD
cord-005453-4057qib7	10947	11	%	%	NN
cord-005453-4057qib7	10947	12	)	)	-RRB-
cord-005453-4057qib7	10947	13	,	,	,
cord-005453-4057qib7	10947	14	and	and	CC
cord-005453-4057qib7	10947	15	reduced	reduce	VBN
cord-005453-4057qib7	10947	16	intensity	intensity	NN
cord-005453-4057qib7	10947	17	conditioning	conditioning	NN
cord-005453-4057qib7	10947	18	was	be	VBD
cord-005453-4057qib7	10947	19	the	the	DT
cord-005453-4057qib7	10947	20	preferred	preferred	JJ
cord-005453-4057qib7	10947	21	(	(	-LRB-
cord-005453-4057qib7	10947	22	82	82	CD
cord-005453-4057qib7	10947	23	%	%	NN
cord-005453-4057qib7	10947	24	)	)	-RRB-
cord-005453-4057qib7	10947	25	regimen	regimen	NN
cord-005453-4057qib7	10947	26	.	.	.
cord-005453-4057qib7	10948	1	Donors	donor	NNS
cord-005453-4057qib7	10948	2	were	be	VBD
cord-005453-4057qib7	10948	3	43	43	CD
cord-005453-4057qib7	10948	4	%	%	NN
cord-005453-4057qib7	10948	5	siblings	sibling	NNS
cord-005453-4057qib7	10948	6	(	(	-LRB-
cord-005453-4057qib7	10948	7	26	26	CD
cord-005453-4057qib7	10948	8	)	)	-RRB-
cord-005453-4057qib7	10948	9	,	,	,
cord-005453-4057qib7	10948	10	38	38	CD
cord-005453-4057qib7	10948	11	%	%	NN
cord-005453-4057qib7	10948	12	offspring	offspring	NN
cord-005453-4057qib7	10948	13	(	(	-LRB-
cord-005453-4057qib7	10948	14	23	23	CD
cord-005453-4057qib7	10948	15	)	)	-RRB-
cord-005453-4057qib7	10948	16	,	,	,
cord-005453-4057qib7	10948	17	and	and	CC
cord-005453-4057qib7	10948	18	18	18	CD
cord-005453-4057qib7	10948	19	%	%	NN
cord-005453-4057qib7	10948	20	parents	parent	NNS
cord-005453-4057qib7	10948	21	(	(	-LRB-
cord-005453-4057qib7	10948	22	11	11	CD
cord-005453-4057qib7	10948	23	)	)	-RRB-
cord-005453-4057qib7	10948	24	.	.	.
cord-005453-4057qib7	10949	1	Median	median	JJ
cord-005453-4057qib7	10949	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	10949	3	and	and	CC
cord-005453-4057qib7	10949	4	platelet	platelet	NN
cord-005453-4057qib7	10949	5	engraftment	engraftment	NN
cord-005453-4057qib7	10949	6	was	be	VBD
cord-005453-4057qib7	10949	7	18	18	CD
cord-005453-4057qib7	10949	8	(	(	-LRB-
cord-005453-4057qib7	10949	9	16	16	CD
cord-005453-4057qib7	10949	10	-	-	SYM
cord-005453-4057qib7	10949	11	21	21	CD
cord-005453-4057qib7	10949	12	)	)	-RRB-
cord-005453-4057qib7	10949	13	and	and	CC
cord-005453-4057qib7	10949	14	28	28	CD
cord-005453-4057qib7	10949	15	(	(	-LRB-
cord-005453-4057qib7	10949	16	20	20	CD
cord-005453-4057qib7	10949	17	-	-	SYM
cord-005453-4057qib7	10949	18	42	42	CD
cord-005453-4057qib7	10949	19	)	)	-RRB-
cord-005453-4057qib7	10949	20	days	day	NNS
cord-005453-4057qib7	10949	21	,	,	,
cord-005453-4057qib7	10949	22	respectively	respectively	RB
cord-005453-4057qib7	10949	23	.	.	.
cord-005453-4057qib7	10950	1	Acute	acute	JJ
cord-005453-4057qib7	10950	2	GVHD	GVHD	NNP
cord-005453-4057qib7	10950	3	grade	grade	NN
cord-005453-4057qib7	10950	4	II	II	NNP
cord-005453-4057qib7	10950	5	-	-	HYPH
cord-005453-4057qib7	10950	6	IV	IV	NNP
cord-005453-4057qib7	10950	7	rate	rate	NN
cord-005453-4057qib7	10950	8	was	be	VBD
cord-005453-4057qib7	10950	9	55	55	CD
cord-005453-4057qib7	10950	10	%	%	NN
cord-005453-4057qib7	10950	11	,	,	,
cord-005453-4057qib7	10950	12	with	with	IN
cord-005453-4057qib7	10950	13	only	only	RB
cord-005453-4057qib7	10950	14	6	6	CD
cord-005453-4057qib7	10950	15	patients	patient	NNS
cord-005453-4057qib7	10950	16	developing	develop	VBG
cord-005453-4057qib7	10950	17	grade	grade	NN
cord-005453-4057qib7	10950	18	III	III	NNP
cord-005453-4057qib7	10950	19	-	-	HYPH
cord-005453-4057qib7	10950	20	IV	IV	NNP
cord-005453-4057qib7	10950	21	(	(	-LRB-
cord-005453-4057qib7	10950	22	10	10	CD
cord-005453-4057qib7	10950	23	%	%	NN
cord-005453-4057qib7	10950	24	)	)	-RRB-
cord-005453-4057qib7	10950	25	.	.	.
cord-005453-4057qib7	10951	1	Chronic	chronic	JJ
cord-005453-4057qib7	10951	2	GVHD	GVHD	NNP
cord-005453-4057qib7	10951	3	rate	rate	NN
cord-005453-4057qib7	10951	4	was	be	VBD
cord-005453-4057qib7	10951	5	17	17	CD
cord-005453-4057qib7	10951	6	%	%	NN
cord-005453-4057qib7	10951	7	,	,	,
cord-005453-4057qib7	10951	8	and	and	CC
cord-005453-4057qib7	10951	9	only	only	RB
cord-005453-4057qib7	10951	10	in	in	IN
cord-005453-4057qib7	10951	11	3	3	CD
cord-005453-4057qib7	10951	12	(	(	-LRB-
cord-005453-4057qib7	10951	13	5	5	CD
cord-005453-4057qib7	10951	14	%	%	NN
cord-005453-4057qib7	10951	15	)	)	-RRB-
cord-005453-4057qib7	10951	16	was	be	VBD
cord-005453-4057qib7	10951	17	extensive	extensive	JJ
cord-005453-4057qib7	10951	18	.	.	.
cord-005453-4057qib7	10952	1	Median	median	JJ
cord-005453-4057qib7	10952	2	follow	follow	NN
cord-005453-4057qib7	10952	3	-	-	HYPH
cord-005453-4057qib7	10952	4	up	up	NN
cord-005453-4057qib7	10952	5	was	be	VBD
cord-005453-4057qib7	10952	6	14	14	CD
cord-005453-4057qib7	10952	7	months	month	NNS
cord-005453-4057qib7	10952	8	.	.	.
cord-005453-4057qib7	10953	1	The	the	DT
cord-005453-4057qib7	10953	2	2-year	2-year	CD
cord-005453-4057qib7	10953	3	overall	overall	JJ
cord-005453-4057qib7	10953	4	survival	survival	NN
cord-005453-4057qib7	10953	5	and	and	CC
cord-005453-4057qib7	10953	6	event	event	NN
cord-005453-4057qib7	10953	7	free	free	JJ
cord-005453-4057qib7	10953	8	survival	survival	NN
cord-005453-4057qib7	10953	9	was	be	VBD
cord-005453-4057qib7	10953	10	43	43	CD
cord-005453-4057qib7	10953	11	%	%	NN
cord-005453-4057qib7	10953	12	and	and	CC
cord-005453-4057qib7	10953	13	39	39	CD
cord-005453-4057qib7	10953	14	%	%	NN
cord-005453-4057qib7	10953	15	,	,	,
cord-005453-4057qib7	10953	16	respectively	respectively	RB
cord-005453-4057qib7	10953	17	.	.	.
cord-005453-4057qib7	10954	1	The	the	DT
cord-005453-4057qib7	10954	2	2-year	2-year	CD
cord-005453-4057qib7	10954	3	cumulative	cumulative	JJ
cord-005453-4057qib7	10954	4	incidence	incidence	NN
cord-005453-4057qib7	10954	5	of	of	IN
cord-005453-4057qib7	10954	6	relapse	relapse	NN
cord-005453-4057qib7	10954	7	was	be	VBD
cord-005453-4057qib7	10954	8	14	14	CD
cord-005453-4057qib7	10954	9	%	%	NN
cord-005453-4057qib7	10954	10	and	and	CC
cord-005453-4057qib7	10954	11	2-year	2-year	CD
cord-005453-4057qib7	10954	12	cumulative	cumulative	JJ
cord-005453-4057qib7	10954	13	incidence	incidence	NN
cord-005453-4057qib7	10954	14	of	of	IN
cord-005453-4057qib7	10954	15	NRM	NRM	NNP
cord-005453-4057qib7	10954	16	was	be	VBD
cord-005453-4057qib7	10954	17	22	22	CD
cord-005453-4057qib7	10954	18	%	%	NN
cord-005453-4057qib7	10954	19	.	.	.
cord-005453-4057qib7	10955	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10955	2	:	:	:
cord-005453-4057qib7	10956	1	Relapsed	relapsed	JJ
cord-005453-4057qib7	10956	2	/	/	SYM
cord-005453-4057qib7	10956	3	refractory	refractory	JJ
cord-005453-4057qib7	10956	4	NHL	NHL	NNP
cord-005453-4057qib7	10956	5	are	be	VBP
cord-005453-4057qib7	10956	6	aggressive	aggressive	JJ
cord-005453-4057qib7	10956	7	entities	entity	NNS
cord-005453-4057qib7	10956	8	with	with	IN
cord-005453-4057qib7	10956	9	a	a	DT
cord-005453-4057qib7	10956	10	fatal	fatal	JJ
cord-005453-4057qib7	10956	11	course	course	NN
cord-005453-4057qib7	10956	12	in	in	IN
cord-005453-4057qib7	10956	13	a	a	DT
cord-005453-4057qib7	10956	14	short	short	JJ
cord-005453-4057qib7	10956	15	period	period	NN
cord-005453-4057qib7	10956	16	of	of	IN
cord-005453-4057qib7	10956	17	time	time	NN
cord-005453-4057qib7	10956	18	.	.	.
cord-005453-4057qib7	10957	1	HaploSCT	HaploSCT	NNP
cord-005453-4057qib7	10958	1	with	with	IN
cord-005453-4057qib7	10958	2	Pt	Pt	NNP
cord-005453-4057qib7	10958	3	-	-	HYPH
cord-005453-4057qib7	10958	4	Cy	Cy	NNP
cord-005453-4057qib7	10958	5	permit	permit	VB
cord-005453-4057qib7	10958	6	a	a	DT
cord-005453-4057qib7	10958	7	new	new	JJ
cord-005453-4057qib7	10958	8	treatment	treatment	NN
cord-005453-4057qib7	10958	9	option	option	NN
cord-005453-4057qib7	10958	10	among	among	IN
cord-005453-4057qib7	10958	11	these	these	DT
cord-005453-4057qib7	10958	12	patients	patient	NNS
cord-005453-4057qib7	10958	13	,	,	,
cord-005453-4057qib7	10958	14	with	with	IN
cord-005453-4057qib7	10958	15	acceptable	acceptable	JJ
cord-005453-4057qib7	10958	16	outcomes	outcome	NNS
cord-005453-4057qib7	10958	17	.	.	.
cord-005453-4057qib7	10959	1	More	More	JJR
cord-005453-4057qib7	10959	2	studies	study	NNS
cord-005453-4057qib7	10959	3	are	be	VBP
cord-005453-4057qib7	10959	4	needed	need	VBN
cord-005453-4057qib7	10959	5	with	with	IN
cord-005453-4057qib7	10959	6	a	a	DT
cord-005453-4057qib7	10959	7	larger	large	JJR
cord-005453-4057qib7	10959	8	cohort	cohort	NN
cord-005453-4057qib7	10959	9	of	of	IN
cord-005453-4057qib7	10959	10	patients	patient	NNS
cord-005453-4057qib7	10959	11	and	and	CC
cord-005453-4057qib7	10959	12	longer	long	RBR
cord-005453-4057qib7	10959	13	follow	follow	VB
cord-005453-4057qib7	10959	14	-	-	HYPH
cord-005453-4057qib7	10959	15	up	up	NN
cord-005453-4057qib7	10959	16	to	to	TO
cord-005453-4057qib7	10959	17	confirm	confirm	VB
cord-005453-4057qib7	10959	18	these	these	DT
cord-005453-4057qib7	10959	19	results	result	NNS
cord-005453-4057qib7	10959	20	.	.	.
cord-005453-4057qib7	10960	1	Disclosure	disclosure	NN
cord-005453-4057qib7	10960	2	:	:	:
cord-005453-4057qib7	10960	3	Nothing	nothing	NN
cord-005453-4057qib7	10960	4	to	to	TO
cord-005453-4057qib7	10960	5	disclose	disclose	VB
cord-005453-4057qib7	10960	6	.	.	.
cord-005453-4057qib7	10961	1	Higher	high	JJR
cord-005453-4057qib7	10961	2	SUV	SUV	NNP
cord-005453-4057qib7	10961	3	at	at	IN
cord-005453-4057qib7	10961	4	pre	pre	JJ
cord-005453-4057qib7	10961	5	-	-	NN
cord-005453-4057qib7	10961	6	transplant	transplant	NN
cord-005453-4057qib7	10961	7	and	and	CC
cord-005453-4057qib7	10961	8	day	day	NN
cord-005453-4057qib7	10961	9	100	100	CD
cord-005453-4057qib7	10962	1	posttransplant	posttransplant	NNP
cord-005453-4057qib7	10962	2	pet	pet	NNP
cord-005453-4057qib7	10962	3	scan	scan	NNP
cord-005453-4057qib7	10962	4	both	both	DT
cord-005453-4057qib7	10962	5	independently	independently	RB
cord-005453-4057qib7	10962	6	predict	predict	VBP
cord-005453-4057qib7	10962	7	inferior	inferior	JJ
cord-005453-4057qib7	10962	8	survival	survival	NN
cord-005453-4057qib7	10962	9	in	in	IN
cord-005453-4057qib7	10962	10	patients	patient	NNS
cord-005453-4057qib7	10962	11	with	with	IN
cord-005453-4057qib7	10962	12	diffuse	diffuse	JJ
cord-005453-4057qib7	10962	13	large	large	JJ
cord-005453-4057qib7	10962	14	B	b	NN
cord-005453-4057qib7	10962	15	cell	cell	NN
cord-005453-4057qib7	10962	16	lymphoma	lymphoma	NN
cord-005453-4057qib7	10962	17	Background	background	NN
cord-005453-4057qib7	10962	18	:	:	:
cord-005453-4057qib7	10963	1	Autologous	autologous	JJ
cord-005453-4057qib7	10963	2	stem	stem	NN
cord-005453-4057qib7	10963	3	cell	cell	NN
cord-005453-4057qib7	10963	4	transplant	transplant	NN
cord-005453-4057qib7	10963	5	(	(	-LRB-
cord-005453-4057qib7	10963	6	auto	auto	NN
cord-005453-4057qib7	10963	7	-	-	HYPH
cord-005453-4057qib7	10963	8	HCT	HCT	NNP
cord-005453-4057qib7	10963	9	)	)	-RRB-
cord-005453-4057qib7	10963	10	can	can	MD
cord-005453-4057qib7	10963	11	cure	cure	VB
cord-005453-4057qib7	10963	12	some	some	DT
cord-005453-4057qib7	10963	13	patients	patient	NNS
cord-005453-4057qib7	10963	14	with	with	IN
cord-005453-4057qib7	10963	15	relapsed	relapse	VBN
cord-005453-4057qib7	10963	16	diffuse	diffuse	JJ
cord-005453-4057qib7	10963	17	large	large	JJ
cord-005453-4057qib7	10963	18	B	b	NN
cord-005453-4057qib7	10963	19	-	-	HYPH
cord-005453-4057qib7	10963	20	cell	cell	NN
cord-005453-4057qib7	10963	21	lymphoma	lymphoma	NN
cord-005453-4057qib7	10963	22	(	(	-LRB-
cord-005453-4057qib7	10963	23	DLBCL	DLBCL	NNP
cord-005453-4057qib7	10963	24	)	)	-RRB-
cord-005453-4057qib7	10963	25	but	but	CC
cord-005453-4057qib7	10963	26	relapse	relapse	NN
cord-005453-4057qib7	10963	27	occurs	occur	VBZ
cord-005453-4057qib7	10963	28	in	in	IN
cord-005453-4057qib7	10963	29	about	about	RB
cord-005453-4057qib7	10963	30	50	50	CD
cord-005453-4057qib7	10963	31	%	%	NN
cord-005453-4057qib7	10963	32	of	of	IN
cord-005453-4057qib7	10963	33	patients	patient	NNS
cord-005453-4057qib7	10963	34	.	.	.
cord-005453-4057qib7	10964	1	While	while	IN
cord-005453-4057qib7	10964	2	our	-PRON-	PRP$
cord-005453-4057qib7	10964	3	center	center	NN
cord-005453-4057qib7	10964	4	and	and	CC
cord-005453-4057qib7	10964	5	others	other	NNS
cord-005453-4057qib7	10964	6	utilize	utilize	VBP
cord-005453-4057qib7	10964	7	routine	routine	JJ
cord-005453-4057qib7	10964	8	surveillance	surveillance	NN
cord-005453-4057qib7	10964	9	imaging	image	VBG
cord-005453-4057qib7	10964	10	post	post	JJ
cord-005453-4057qib7	10964	11	-	-	NN
cord-005453-4057qib7	10964	12	transplant	transplant	NN
cord-005453-4057qib7	10964	13	,	,	,
cord-005453-4057qib7	10964	14	the	the	DT
cord-005453-4057qib7	10964	15	utility	utility	NN
cord-005453-4057qib7	10964	16	in	in	IN
cord-005453-4057qib7	10964	17	this	this	DT
cord-005453-4057qib7	10964	18	setting	setting	NN
cord-005453-4057qib7	10964	19	is	be	VBZ
cord-005453-4057qib7	10964	20	unclear	unclear	JJ
cord-005453-4057qib7	10964	21	.	.	.
cord-005453-4057qib7	10965	1	Imaging	imaging	NN
cord-005453-4057qib7	10965	2	is	be	VBZ
cord-005453-4057qib7	10965	3	costly	costly	JJ
cord-005453-4057qib7	10965	4	and	and	CC
cord-005453-4057qib7	10965	5	exposes	expose	VBZ
cord-005453-4057qib7	10965	6	patients	patient	NNS
cord-005453-4057qib7	10965	7	to	to	IN
cord-005453-4057qib7	10965	8	radiation	radiation	NN
cord-005453-4057qib7	10965	9	.	.	.
cord-005453-4057qib7	10966	1	Novel	novel	JJ
cord-005453-4057qib7	10966	2	interventions	intervention	NNS
cord-005453-4057qib7	10966	3	are	be	VBP
cord-005453-4057qib7	10966	4	now	now	RB
cord-005453-4057qib7	10966	5	available	available	JJ
cord-005453-4057qib7	10966	6	for	for	IN
cord-005453-4057qib7	10966	7	patients	patient	NNS
cord-005453-4057qib7	10966	8	relapsing	relapse	VBG
cord-005453-4057qib7	10966	9	after	after	IN
cord-005453-4057qib7	10966	10	auto	auto	NN
cord-005453-4057qib7	10966	11	-	-	HYPH
cord-005453-4057qib7	10966	12	HCT	hct	NN
cord-005453-4057qib7	10966	13	making	make	VBG
cord-005453-4057qib7	10966	14	early	early	JJ
cord-005453-4057qib7	10966	15	disease	disease	NN
cord-005453-4057qib7	10966	16	recognition	recognition	NN
cord-005453-4057qib7	10966	17	crucial	crucial	JJ
cord-005453-4057qib7	10966	18	to	to	TO
cord-005453-4057qib7	10966	19	intervene	intervene	VB
cord-005453-4057qib7	10966	20	prior	prior	RB
cord-005453-4057qib7	10966	21	to	to	IN
cord-005453-4057qib7	10966	22	clinical	clinical	JJ
cord-005453-4057qib7	10966	23	progression	progression	NN
cord-005453-4057qib7	10966	24	.	.	.
cord-005453-4057qib7	10967	1	Hence	hence	RB
cord-005453-4057qib7	10967	2	,	,	,
cord-005453-4057qib7	10967	3	we	-PRON-	PRP
cord-005453-4057qib7	10967	4	studied	study	VBD
cord-005453-4057qib7	10967	5	impact	impact	NN
cord-005453-4057qib7	10967	6	of	of	IN
cord-005453-4057qib7	10967	7	post	post	JJ
cord-005453-4057qib7	10967	8	-	-	JJ
cord-005453-4057qib7	10967	9	auto	auto	JJ
cord-005453-4057qib7	10967	10	-	-	HYPH
cord-005453-4057qib7	10967	11	HCT	hct	NN
cord-005453-4057qib7	10967	12	surveillance	surveillance	NN
cord-005453-4057qib7	10967	13	(	(	-LRB-
cord-005453-4057qib7	10967	14	18)F	18)F	NNP
cord-005453-4057qib7	10967	15	-	-	HYPH
cord-005453-4057qib7	10967	16	FDG	FDG	NNP
cord-005453-4057qib7	10967	17	-	-	HYPH
cord-005453-4057qib7	10967	18	PET	PET	NNP
cord-005453-4057qib7	10967	19	CT	CT	NNP
cord-005453-4057qib7	10967	20	at	at	IN
cord-005453-4057qib7	10967	21	day	day	NN
cord-005453-4057qib7	10967	22	100	100	CD
cord-005453-4057qib7	10967	23	on	on	IN
cord-005453-4057qib7	10967	24	transplant	transplant	NN
cord-005453-4057qib7	10967	25	outcomes	outcome	NNS
cord-005453-4057qib7	10967	26	.	.	.
cord-005453-4057qib7	10968	1	Methods	method	NNS
cord-005453-4057qib7	10968	2	:	:	:
cord-005453-4057qib7	10968	3	We	-PRON-	PRP
cord-005453-4057qib7	10968	4	analyzed	analyze	VBD
cord-005453-4057qib7	10968	5	a	a	DT
cord-005453-4057qib7	10968	6	cohort	cohort	NN
cord-005453-4057qib7	10968	7	of	of	IN
cord-005453-4057qib7	10968	8	131	131	CD
cord-005453-4057qib7	10968	9	consecutive	consecutive	JJ
cord-005453-4057qib7	10968	10	auto	auto	NN
cord-005453-4057qib7	10968	11	-	-	HYPH
cord-005453-4057qib7	10968	12	HCT	hct	NN
cord-005453-4057qib7	10968	13	recipients	recipient	NNS
cord-005453-4057qib7	10968	14	with	with	IN
cord-005453-4057qib7	10968	15	relapsed	relapse	VBN
cord-005453-4057qib7	10968	16	/	/	SYM
cord-005453-4057qib7	10968	17	refractory	refractory	JJ
cord-005453-4057qib7	10968	18	DLBCL	DLBCL	NNP
cord-005453-4057qib7	10968	19	who	who	WP
cord-005453-4057qib7	10968	20	then	then	RB
cord-005453-4057qib7	10968	21	underwent	undergo	VBD
cord-005453-4057qib7	10968	22	pre	pre	JJ
cord-005453-4057qib7	10968	23	-	-	JJ
cord-005453-4057qib7	10968	24	transplant	transplant	JJ
cord-005453-4057qib7	10968	25	PET	PET	NNP
cord-005453-4057qib7	10968	26	/	/	SYM
cord-005453-4057qib7	10968	27	CT	CT	NNP
cord-005453-4057qib7	10968	28	and	and	CC
cord-005453-4057qib7	10968	29	surveillance	surveillance	NN
cord-005453-4057qib7	10968	30	PET	PET	NNP
cord-005453-4057qib7	10968	31	CT	CT	NNP
cord-005453-4057qib7	10968	32	at	at	IN
cord-005453-4057qib7	10968	33	day	day	NN
cord-005453-4057qib7	10968	34	100	100	CD
cord-005453-4057qib7	10968	35	(	(	-LRB-
cord-005453-4057qib7	10968	36	Interquartile	Interquartile	NNP
cord-005453-4057qib7	10968	37	range	range	NN
cord-005453-4057qib7	10968	38	(	(	-LRB-
cord-005453-4057qib7	10968	39	IQR	IQR	NNP
cord-005453-4057qib7	10968	40	)	)	-RRB-
cord-005453-4057qib7	10968	41	:	:	:
cord-005453-4057qib7	10968	42	97	97	CD
cord-005453-4057qib7	10968	43	-	-	SYM
cord-005453-4057qib7	10968	44	103	103	CD
cord-005453-4057qib7	10968	45	days	day	NNS
cord-005453-4057qib7	10968	46	)	)	-RRB-
cord-005453-4057qib7	10969	1	post	post	JJ
cord-005453-4057qib7	10969	2	-	-	NN
cord-005453-4057qib7	10969	3	HCT	HCT	NNP
cord-005453-4057qib7	10969	4	at	at	IN
cord-005453-4057qib7	10969	5	the	the	DT
cord-005453-4057qib7	10969	6	University	University	NNP
cord-005453-4057qib7	10969	7	of	of	IN
cord-005453-4057qib7	10969	8	Minnesota	Minnesota	NNP
cord-005453-4057qib7	10969	9	Medical	Medical	NNP
cord-005453-4057qib7	10969	10	Center	Center	NNP
cord-005453-4057qib7	10969	11	.	.	.
cord-005453-4057qib7	10970	1	Univariate	Univariate	NNP
cord-005453-4057qib7	10970	2	analysis	analysis	NN
cord-005453-4057qib7	10970	3	was	be	VBD
cord-005453-4057qib7	10970	4	performed	perform	VBN
cord-005453-4057qib7	10970	5	to	to	TO
cord-005453-4057qib7	10970	6	analyze	analyze	VB
cord-005453-4057qib7	10970	7	PET	pet	NN
cord-005453-4057qib7	10970	8	parameters	parameter	NNS
cord-005453-4057qib7	10970	9	including	include	VBG
cord-005453-4057qib7	10970	10	Deauville	Deauville	NNP
cord-005453-4057qib7	10970	11	score	score	NN
cord-005453-4057qib7	10970	12	(	(	-LRB-
cord-005453-4057qib7	10970	13	D	D	NNP
cord-005453-4057qib7	10970	14	)	)	-RRB-
cord-005453-4057qib7	10970	15	,	,	,
cord-005453-4057qib7	10970	16	standardized	standardized	JJ
cord-005453-4057qib7	10970	17	uptake	uptake	NN
cord-005453-4057qib7	10970	18	values	value	NNS
cord-005453-4057qib7	10970	19	(	(	-LRB-
cord-005453-4057qib7	10970	20	SUV	SUV	NNP
cord-005453-4057qib7	10970	21	)	)	-RRB-
cord-005453-4057qib7	10970	22	,	,	,
cord-005453-4057qib7	10970	23	total	total	JJ
cord-005453-4057qib7	10970	24	lesion	lesion	NN
cord-005453-4057qib7	10970	25	glycolysis	glycolysis	NN
cord-005453-4057qib7	10970	26	(	(	-LRB-
cord-005453-4057qib7	10970	27	TLG	TLG	NNP
cord-005453-4057qib7	10970	28	)	)	-RRB-
cord-005453-4057qib7	10970	29	and	and	CC
cord-005453-4057qib7	10970	30	total	total	JJ
cord-005453-4057qib7	10970	31	metabolic	metabolic	JJ
cord-005453-4057qib7	10970	32	tumor	tumor	NN
cord-005453-4057qib7	10970	33	volume	volume	NN
cord-005453-4057qib7	10970	34	(	(	-LRB-
cord-005453-4057qib7	10970	35	TMTV	TMTV	NNP
cord-005453-4057qib7	10970	36	)	)	-RRB-
cord-005453-4057qib7	10970	37	as	as	IN
cord-005453-4057qib7	10970	38	predictors	predictor	NNS
cord-005453-4057qib7	10970	39	of	of	IN
cord-005453-4057qib7	10970	40	relapse	relapse	NN
cord-005453-4057qib7	10970	41	and	and	CC
cord-005453-4057qib7	10970	42	survival	survival	NN
cord-005453-4057qib7	10970	43	after	after	IN
cord-005453-4057qib7	10970	44	auto	auto	NN
cord-005453-4057qib7	10970	45	-	-	HYPH
cord-005453-4057qib7	10970	46	HCT	hct	NN
cord-005453-4057qib7	10970	47	.	.	.
cord-005453-4057qib7	10971	1	In	in	IN
cord-005453-4057qib7	10971	2	addition	addition	NN
cord-005453-4057qib7	10971	3	,	,	,
cord-005453-4057qib7	10971	4	we	-PRON-	PRP
cord-005453-4057qib7	10971	5	assessed	assess	VBD
cord-005453-4057qib7	10971	6	outcomes	outcome	NNS
cord-005453-4057qib7	10971	7	of	of	IN
cord-005453-4057qib7	10971	8	patients	patient	NNS
cord-005453-4057qib7	10971	9	with	with	IN
cord-005453-4057qib7	10971	10	clinically	clinically	RB
cord-005453-4057qib7	10971	11	versus	versus	IN
cord-005453-4057qib7	10971	12	radiographically	radiographically	RB
cord-005453-4057qib7	10971	13	detected	detect	VBN
cord-005453-4057qib7	10971	14	relapsed	relapse	VBN
cord-005453-4057qib7	10971	15	DLBCL	DLBCL	NNP
cord-005453-4057qib7	10971	16	after	after	IN
cord-005453-4057qib7	10971	17	auto	auto	NN
cord-005453-4057qib7	10971	18	-	-	HYPH
cord-005453-4057qib7	10971	19	HCT	hct	NN
cord-005453-4057qib7	10971	20	.	.	.
cord-005453-4057qib7	10972	1	Other	other	JJ
cord-005453-4057qib7	10972	2	pre	pre	JJ
cord-005453-4057qib7	10972	3	-	-	JJ
cord-005453-4057qib7	10972	4	HCT	hct	JJ
cord-005453-4057qib7	10972	5	factors	factor	NNS
cord-005453-4057qib7	10972	6	analyzed	analyze	VBD
cord-005453-4057qib7	10972	7	included	include	VBN
cord-005453-4057qib7	10972	8	age	age	NN
cord-005453-4057qib7	10972	9	,	,	,
cord-005453-4057qib7	10972	10	gender	gender	NN
cord-005453-4057qib7	10972	11	,	,	,
cord-005453-4057qib7	10972	12	conditioning	conditioning	NN
cord-005453-4057qib7	10972	13	regimen	regimen	NN
cord-005453-4057qib7	10972	14	,	,	,
cord-005453-4057qib7	10972	15	performance	performance	NN
cord-005453-4057qib7	10972	16	status	status	NN
cord-005453-4057qib7	10972	17	,	,	,
cord-005453-4057qib7	10972	18	consolidation	consolidation	NN
cord-005453-4057qib7	10972	19	radiation	radiation	NN
cord-005453-4057qib7	10972	20	therapy	therapy	NN
cord-005453-4057qib7	10972	21	,	,	,
cord-005453-4057qib7	10972	22	TMTV	TMTV	NNP
cord-005453-4057qib7	10972	23	,	,	,
cord-005453-4057qib7	10972	24	SUV	SUV	NNP
cord-005453-4057qib7	10972	25	,	,	,
cord-005453-4057qib7	10972	26	TLG	TLG	NNP
cord-005453-4057qib7	10972	27	.	.	.
cord-005453-4057qib7	10973	1	Results	result	NNS
cord-005453-4057qib7	10973	2	:	:	:
cord-005453-4057qib7	10974	1	Five	five	CD
cord-005453-4057qib7	10974	2	-	-	HYPH
cord-005453-4057qib7	10974	3	year	year	NN
cord-005453-4057qib7	10974	4	cumulative	cumulative	JJ
cord-005453-4057qib7	10974	5	incidence	incidence	NN
cord-005453-4057qib7	10974	6	of	of	IN
cord-005453-4057qib7	10974	7	relapse	relapse	NN
cord-005453-4057qib7	10974	8	after	after	IN
cord-005453-4057qib7	10974	9	auto	auto	NN
cord-005453-4057qib7	10974	10	-	-	HYPH
cord-005453-4057qib7	10974	11	HCT	HCT	NNP
cord-005453-4057qib7	10974	12	was	be	VBD
cord-005453-4057qib7	10974	13	50	50	CD
cord-005453-4057qib7	10974	14	%	%	NN
cord-005453-4057qib7	10974	15	(	(	-LRB-
cord-005453-4057qib7	10974	16	95%CI	95%ci	CD
cord-005453-4057qib7	10974	17	39	39	CD
cord-005453-4057qib7	10974	18	to	to	IN
cord-005453-4057qib7	10974	19	59	59	CD
cord-005453-4057qib7	10974	20	)	)	-RRB-
cord-005453-4057qib7	10974	21	and	and	CC
cord-005453-4057qib7	10974	22	overall	overall	JJ
cord-005453-4057qib7	10974	23	survival	survival	NN
cord-005453-4057qib7	10974	24	(	(	-LRB-
cord-005453-4057qib7	10974	25	OS	OS	NNP
cord-005453-4057qib7	10974	26	)	)	-RRB-
cord-005453-4057qib7	10974	27	was	be	VBD
cord-005453-4057qib7	10974	28	51	51	CD
cord-005453-4057qib7	10974	29	%	%	NN
cord-005453-4057qib7	10974	30	(	(	-LRB-
cord-005453-4057qib7	10974	31	95	95	CD
cord-005453-4057qib7	10974	32	%	%	NN
cord-005453-4057qib7	10974	33	CI	CI	NNP
cord-005453-4057qib7	10974	34	41	41	CD
cord-005453-4057qib7	10974	35	to	to	IN
cord-005453-4057qib7	10974	36	63	63	CD
cord-005453-4057qib7	10974	37	)	)	-RRB-
cord-005453-4057qib7	10974	38	.	.	.
cord-005453-4057qib7	10975	1	Twelve	twelve	CD
cord-005453-4057qib7	10975	2	(	(	-LRB-
cord-005453-4057qib7	10975	3	9	9	CD
cord-005453-4057qib7	10975	4	%	%	NN
cord-005453-4057qib7	10975	5	)	)	-RRB-
cord-005453-4057qib7	10975	6	relapsed	relapse	VBN
cord-005453-4057qib7	10975	7	prior	prior	RB
cord-005453-4057qib7	10975	8	to	to	IN
cord-005453-4057qib7	10975	9	day	day	NN
cord-005453-4057qib7	10975	10	100	100	CD
cord-005453-4057qib7	10975	11	.	.	.
cord-005453-4057qib7	10976	1	D	d	NN
cord-005453-4057qib7	10976	2	-	-	HYPH
cord-005453-4057qib7	10976	3	score	score	NN
cord-005453-4057qib7	10976	4	for	for	IN
cord-005453-4057qib7	10976	5	91	91	CD
cord-005453-4057qib7	10976	6	patients	patient	NNS
cord-005453-4057qib7	10976	7	with	with	IN
cord-005453-4057qib7	10976	8	d100	d100	NNP
cord-005453-4057qib7	10976	9	PET	PET	NNP
cord-005453-4057qib7	10976	10	/	/	SYM
cord-005453-4057qib7	10976	11	CT	CT	NNP
cord-005453-4057qib7	10976	12	were	be	VBD
cord-005453-4057qib7	10976	13	D1	d1	NN
cord-005453-4057qib7	10976	14	(	(	-LRB-
cord-005453-4057qib7	10976	15	22	22	CD
cord-005453-4057qib7	10976	16	%	%	NN
cord-005453-4057qib7	10976	17	)	)	-RRB-
cord-005453-4057qib7	10976	18	,	,	,
cord-005453-4057qib7	10976	19	D2	d2	NN
cord-005453-4057qib7	10976	20	(	(	-LRB-
cord-005453-4057qib7	10976	21	55	55	CD
cord-005453-4057qib7	10976	22	%	%	NN
cord-005453-4057qib7	10976	23	)	)	-RRB-
cord-005453-4057qib7	10976	24	,	,	,
cord-005453-4057qib7	10976	25	D3	D3	NNP
cord-005453-4057qib7	10976	26	(	(	-LRB-
cord-005453-4057qib7	10976	27	0	0	CD
cord-005453-4057qib7	10976	28	%	%	NN
cord-005453-4057qib7	10976	29	)	)	-RRB-
cord-005453-4057qib7	10976	30	,	,	,
cord-005453-4057qib7	10976	31	D4	D4	NNP
cord-005453-4057qib7	10976	32	(	(	-LRB-
cord-005453-4057qib7	10976	33	10	10	CD
cord-005453-4057qib7	10976	34	%	%	NN
cord-005453-4057qib7	10976	35	)	)	-RRB-
cord-005453-4057qib7	10976	36	,	,	,
cord-005453-4057qib7	10976	37	D5	D5	NNP
cord-005453-4057qib7	10976	38	(	(	-LRB-
cord-005453-4057qib7	10976	39	13	13	CD
cord-005453-4057qib7	10976	40	%	%	NN
cord-005453-4057qib7	10976	41	)	)	-RRB-
cord-005453-4057qib7	10976	42	with	with	IN
cord-005453-4057qib7	10976	43	median	median	JJ
cord-005453-4057qib7	10976	44	survival	survival	NN
cord-005453-4057qib7	10976	45	in	in	IN
cord-005453-4057qib7	10976	46	years	year	NNS
cord-005453-4057qib7	10976	47	for	for	IN
cord-005453-4057qib7	10976	48	D1	d1	NN
cord-005453-4057qib7	10976	49	,	,	,
cord-005453-4057qib7	10976	50	D2	d2	NN
cord-005453-4057qib7	10976	51	,	,	,
cord-005453-4057qib7	10976	52	D4	d4	NN
cord-005453-4057qib7	10976	53	and	and	CC
cord-005453-4057qib7	10976	54	D5	d5	NN
cord-005453-4057qib7	10976	55	of	of	IN
cord-005453-4057qib7	10976	56	6.0	6.0	CD
cord-005453-4057qib7	10976	57	,	,	,
cord-005453-4057qib7	10976	58	6.8	6.8	CD
cord-005453-4057qib7	10976	59	,	,	,
cord-005453-4057qib7	10976	60	4.7	4.7	CD
cord-005453-4057qib7	10976	61	,	,	,
cord-005453-4057qib7	10976	62	and	and	CC
cord-005453-4057qib7	10976	63	1.2	1.2	CD
cord-005453-4057qib7	10976	64	,	,	,
cord-005453-4057qib7	10976	65	respectively	respectively	RB
cord-005453-4057qib7	10976	66	.	.	.
cord-005453-4057qib7	10977	1	Mean	mean	JJ
cord-005453-4057qib7	10977	2	SUV	SUV	NNP
cord-005453-4057qib7	10977	3	varied	vary	VBN
cord-005453-4057qib7	10977	4	from	from	IN
cord-005453-4057qib7	10977	5	1.53	1.53	CD
cord-005453-4057qib7	10977	6	(	(	-LRB-
cord-005453-4057qib7	10977	7	D1	d1	NN
cord-005453-4057qib7	10977	8	)	)	-RRB-
cord-005453-4057qib7	10977	9	to	to	IN
cord-005453-4057qib7	10977	10	17.9	17.9	CD
cord-005453-4057qib7	10977	11	(	(	-LRB-
cord-005453-4057qib7	10977	12	D5	D5	NNP
cord-005453-4057qib7	10977	13	)	)	-RRB-
cord-005453-4057qib7	10977	14	.	.	.
cord-005453-4057qib7	10978	1	SUV	SUV	NNP
cord-005453-4057qib7	10978	2	was	be	VBD
cord-005453-4057qib7	10978	3	predictive	predictive	JJ
cord-005453-4057qib7	10978	4	of	of	IN
cord-005453-4057qib7	10978	5	relapse	relapse	NN
cord-005453-4057qib7	10978	6	and	and	CC
cord-005453-4057qib7	10978	7	OS	os	NN
cord-005453-4057qib7	10978	8	.	.	.
cord-005453-4057qib7	10979	1	Risk	risk	NN
cord-005453-4057qib7	10979	2	of	of	IN
cord-005453-4057qib7	10979	3	relapse	relapse	NN
cord-005453-4057qib7	10979	4	increased	increase	VBD
cord-005453-4057qib7	10979	5	with	with	IN
cord-005453-4057qib7	10979	6	doubling	double	VBG
cord-005453-4057qib7	10979	7	of	of	IN
cord-005453-4057qib7	10979	8	SUV	SUV	NNP
cord-005453-4057qib7	10979	9	;	;	:
cord-005453-4057qib7	10979	10	2-fold	2-fold	CD
cord-005453-4057qib7	10979	11	higher	high	JJR
cord-005453-4057qib7	10979	12	SUV	SUV	NNP
cord-005453-4057qib7	10979	13	increased	increase	VBD
cord-005453-4057qib7	10979	14	HR	hr	NN
cord-005453-4057qib7	10979	15	by	by	IN
cord-005453-4057qib7	10979	16	1.77	1.77	CD
cord-005453-4057qib7	10979	17	(	(	-LRB-
cord-005453-4057qib7	10979	18	95%CI	95%ci	CD
cord-005453-4057qib7	10979	19	1.34	1.34	CD
cord-005453-4057qib7	10979	20	-	-	HYPH
cord-005453-4057qib7	10979	21	2.33	2.33	CD
cord-005453-4057qib7	10979	22	;	;	:
cord-005453-4057qib7	10979	23	p=	p=	NN
cord-005453-4057qib7	10979	24	0.01	0.01	CD
cord-005453-4057qib7	10979	25	)	)	-RRB-
cord-005453-4057qib7	10979	26	.	.	.
cord-005453-4057qib7	10980	1	Mortality	mortality	NN
cord-005453-4057qib7	10980	2	increased	increase	VBD
cord-005453-4057qib7	10980	3	with	with	IN
cord-005453-4057qib7	10980	4	doubling	double	VBG
cord-005453-4057qib7	10980	5	of	of	IN
cord-005453-4057qib7	10980	6	SUV	suv	NN
cord-005453-4057qib7	10980	7	in	in	IN
cord-005453-4057qib7	10980	8	both	both	DT
cord-005453-4057qib7	10980	9	pre	pre	JJ
cord-005453-4057qib7	10980	10	-	-	JJ
cord-005453-4057qib7	10980	11	HCT	hct	JJ
cord-005453-4057qib7	10980	12	(	(	-LRB-
cord-005453-4057qib7	10980	13	2-fold	2-fold	CD
cord-005453-4057qib7	10980	14	increase	increase	NN
cord-005453-4057qib7	10980	15	in	in	IN
cord-005453-4057qib7	10980	16	SUV	SUV	NNP
cord-005453-4057qib7	10980	17	associated	associate	VBN
cord-005453-4057qib7	10980	18	with	with	IN
cord-005453-4057qib7	10980	19	HR	hr	NN
cord-005453-4057qib7	10980	20	1.46	1.46	CD
cord-005453-4057qib7	10980	21	[	[	-LRB-
cord-005453-4057qib7	10980	22	95	95	CD
cord-005453-4057qib7	10980	23	%	%	NN
cord-005453-4057qib7	10980	24	CI	CI	NNP
cord-005453-4057qib7	10980	25	1.1	1.1	CD
cord-005453-4057qib7	10980	26	to	to	IN
cord-005453-4057qib7	10980	27	1.8	1.8	CD
cord-005453-4057qib7	10980	28	]	]	-RRB-
cord-005453-4057qib7	10980	29	;	;	:
cord-005453-4057qib7	10980	30	p=0.01	p=0.01	NNP
cord-005453-4057qib7	10980	31	)	)	-RRB-
cord-005453-4057qib7	10980	32	as	as	RB
cord-005453-4057qib7	10980	33	well	well	RB
cord-005453-4057qib7	10980	34	as	as	IN
cord-005453-4057qib7	10980	35	post	post	JJ
cord-005453-4057qib7	10980	36	-	-	JJ
cord-005453-4057qib7	10980	37	HCT	hct	JJ
cord-005453-4057qib7	10980	38	PET	pet	NN
cord-005453-4057qib7	10981	1	(	(	-LRB-
cord-005453-4057qib7	10981	2	HR	HR	NNP
cord-005453-4057qib7	10981	3	1.7	1.7	CD
cord-005453-4057qib7	10981	4	[	[	-LRB-
cord-005453-4057qib7	10981	5	95	95	CD
cord-005453-4057qib7	10981	6	%	%	NN
cord-005453-4057qib7	10981	7	CI	CI	NNP
cord-005453-4057qib7	10982	1	1.3	1.3	CD
cord-005453-4057qib7	10982	2	to	to	IN
cord-005453-4057qib7	10982	3	2.3	2.3	CD
cord-005453-4057qib7	10982	4	]	]	-RRB-
cord-005453-4057qib7	10982	5	;	;	:
cord-005453-4057qib7	10982	6	p=0	p=0	NNP
cord-005453-4057qib7	10982	7	)	)	-RRB-
cord-005453-4057qib7	10982	8	irrespective	irrespective	RB
cord-005453-4057qib7	10982	9	of	of	IN
cord-005453-4057qib7	10982	10	the	the	DT
cord-005453-4057qib7	10982	11	bulk	bulk	NN
cord-005453-4057qib7	10982	12	of	of	IN
cord-005453-4057qib7	10982	13	tumor	tumor	NN
cord-005453-4057qib7	10982	14	.	.	.
cord-005453-4057qib7	10983	1	In	in	IN
cord-005453-4057qib7	10983	2	addition	addition	NN
cord-005453-4057qib7	10983	3	,	,	,
cord-005453-4057qib7	10983	4	risk	risk	NN
cord-005453-4057qib7	10983	5	of	of	IN
cord-005453-4057qib7	10983	6	death	death	NN
cord-005453-4057qib7	10983	7	was	be	VBD
cord-005453-4057qib7	10983	8	4	4	CD
cord-005453-4057qib7	10983	9	times	time	NNS
cord-005453-4057qib7	10983	10	higher	high	JJR
cord-005453-4057qib7	10983	11	in	in	IN
cord-005453-4057qib7	10983	12	D5	D5	NNP
cord-005453-4057qib7	10983	13	patients	patient	NNS
cord-005453-4057qib7	10983	14	relative	relative	JJ
cord-005453-4057qib7	10983	15	to	to	IN
cord-005453-4057qib7	10983	16	D1	d1	NN
cord-005453-4057qib7	10983	17	(	(	-LRB-
cord-005453-4057qib7	10983	18	HR	hr	NN
cord-005453-4057qib7	10983	19	4.10	4.10	CD
cord-005453-4057qib7	10983	20	[	[	-LRB-
cord-005453-4057qib7	10983	21	95	95	CD
cord-005453-4057qib7	10983	22	%	%	NN
cord-005453-4057qib7	10983	23	CI	ci	NN
cord-005453-4057qib7	10983	24	=	=	SYM
cord-005453-4057qib7	10983	25	1.56	1.56	CD
cord-005453-4057qib7	10983	26	to	to	IN
cord-005453-4057qib7	10983	27	10.77	10.77	CD
cord-005453-4057qib7	10983	28	]	]	-RRB-
cord-005453-4057qib7	10983	29	;	;	:
cord-005453-4057qib7	10983	30	p≤0.01	p≤0.01	LS
cord-005453-4057qib7	10983	31	)	)	-RRB-
cord-005453-4057qib7	10983	32	.	.	.
cord-005453-4057qib7	10984	1	Patients	patient	NNS
cord-005453-4057qib7	10984	2	with	with	IN
cord-005453-4057qib7	10984	3	D5	D5	NNP
cord-005453-4057qib7	10984	4	(	(	-LRB-
cord-005453-4057qib7	10984	5	n=12	n=12	NNP
cord-005453-4057qib7	10984	6	)	)	-RRB-
cord-005453-4057qib7	10984	7	had	have	VBD
cord-005453-4057qib7	10984	8	higher	high	JJR
cord-005453-4057qib7	10984	9	TMTV	TMTV	NNS
cord-005453-4057qib7	10984	10	(	(	-LRB-
cord-005453-4057qib7	10984	11	137	137	CD
cord-005453-4057qib7	10984	12	cm	cm	NNS
cord-005453-4057qib7	10984	13	3	3	CD
cord-005453-4057qib7	10984	14	)	)	-RRB-
cord-005453-4057qib7	10984	15	compared	compare	VBN
cord-005453-4057qib7	10984	16	to	to	IN
cord-005453-4057qib7	10984	17	D4	D4	NNP
cord-005453-4057qib7	10984	18	(	(	-LRB-
cord-005453-4057qib7	10984	19	n=9	n=9	NN
cord-005453-4057qib7	10984	20	,	,	,
cord-005453-4057qib7	10984	21	TMTV	TMTV	NNP
cord-005453-4057qib7	10984	22	12.5	12.5	CD
cord-005453-4057qib7	10984	23	cm	cm	NNS
cord-005453-4057qib7	10984	24	3	3	CD
cord-005453-4057qib7	10984	25	)	)	-RRB-
cord-005453-4057qib7	10984	26	.	.	.
cord-005453-4057qib7	10985	1	The	the	DT
cord-005453-4057qib7	10985	2	hazard	hazard	NN
cord-005453-4057qib7	10985	3	ratio	ratio	NN
cord-005453-4057qib7	10985	4	for	for	IN
cord-005453-4057qib7	10985	5	death	death	NN
cord-005453-4057qib7	10985	6	following	follow	VBG
cord-005453-4057qib7	10985	7	relapse	relapse	NN
cord-005453-4057qib7	10985	8	was	be	VBD
cord-005453-4057qib7	10985	9	2-fold	2-fold	CD
cord-005453-4057qib7	10985	10	higher	high	JJR
cord-005453-4057qib7	10985	11	(	(	-LRB-
cord-005453-4057qib7	10985	12	HR	HR	NNP
cord-005453-4057qib7	10985	13	1.8	1.8	CD
cord-005453-4057qib7	10985	14	[	[	-LRB-
cord-005453-4057qib7	10985	15	95	95	CD
cord-005453-4057qib7	10985	16	%	%	NN
cord-005453-4057qib7	10985	17	CI	CI	NNP
cord-005453-4057qib7	10985	18	0.9	0.9	CD
cord-005453-4057qib7	10985	19	to	to	IN
cord-005453-4057qib7	10985	20	3.4	3.4	CD
cord-005453-4057qib7	10985	21	]	]	-RRB-
cord-005453-4057qib7	10985	22	;	;	:
cord-005453-4057qib7	10985	23	p=0.08	p=0.08	NNP
cord-005453-4057qib7	10985	24	)	)	-RRB-
cord-005453-4057qib7	10985	25	if	if	IN
cord-005453-4057qib7	10985	26	relapse	relapse	NN
cord-005453-4057qib7	10985	27	was	be	VBD
cord-005453-4057qib7	10985	28	detected	detect	VBN
cord-005453-4057qib7	10985	29	clinically	clinically	RB
cord-005453-4057qib7	10985	30	versus	versus	IN
cord-005453-4057qib7	10985	31	only	only	RB
cord-005453-4057qib7	10985	32	radiographically	radiographically	RB
cord-005453-4057qib7	10985	33	over	over	IN
cord-005453-4057qib7	10985	34	a	a	DT
cord-005453-4057qib7	10985	35	median	median	JJ
cord-005453-4057qib7	10985	36	follow	follow	NN
cord-005453-4057qib7	10985	37	-	-	HYPH
cord-005453-4057qib7	10985	38	up	up	RP
cord-005453-4057qib7	10985	39	time	time	NN
cord-005453-4057qib7	10985	40	period	period	NN
cord-005453-4057qib7	10985	41	of	of	IN
cord-005453-4057qib7	10985	42	3.3	3.3	CD
cord-005453-4057qib7	10985	43	years	year	NNS
cord-005453-4057qib7	10985	44	.	.	.
cord-005453-4057qib7	10986	1	Other	other	JJ
cord-005453-4057qib7	10986	2	pretransplant	pretransplant	JJ
cord-005453-4057qib7	10986	3	patient	patient	NN
cord-005453-4057qib7	10986	4	and	and	CC
cord-005453-4057qib7	10986	5	disease	disease	NN
cord-005453-4057qib7	10986	6	characteristics	characteristic	NNS
cord-005453-4057qib7	10986	7	did	do	VBD
cord-005453-4057qib7	10986	8	not	not	RB
cord-005453-4057qib7	10986	9	significantly	significantly	RB
cord-005453-4057qib7	10986	10	influenced	influence	VBN
cord-005453-4057qib7	10986	11	the	the	DT
cord-005453-4057qib7	10986	12	outcomes	outcome	NNS
cord-005453-4057qib7	10986	13	.	.	.
cord-005453-4057qib7	10987	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	10987	2	:	:	:
cord-005453-4057qib7	10988	1	In	in	IN
cord-005453-4057qib7	10988	2	patients	patient	NNS
cord-005453-4057qib7	10988	3	with	with	IN
cord-005453-4057qib7	10988	4	R	r	NN
cord-005453-4057qib7	10988	5	/	/	SYM
cord-005453-4057qib7	10988	6	R	r	NN
cord-005453-4057qib7	10988	7	DLBCL	DLBCL	NNP
cord-005453-4057qib7	10988	8	undergoing	undergo	VBG
cord-005453-4057qib7	10988	9	auto	auto	NN
cord-005453-4057qib7	10988	10	-	-	HYPH
cord-005453-4057qib7	10988	11	HCT	hct	NN
cord-005453-4057qib7	10988	12	,	,	,
cord-005453-4057qib7	10988	13	surveillance	surveillance	NN
cord-005453-4057qib7	10988	14	PET	PET	NNP
cord-005453-4057qib7	10988	15	/	/	SYM
cord-005453-4057qib7	10988	16	CT	CT	NNP
cord-005453-4057qib7	10988	17	at	at	IN
cord-005453-4057qib7	10988	18	day	day	NN
cord-005453-4057qib7	10988	19	100	100	CD
cord-005453-4057qib7	10988	20	identified	identify	VBN
cord-005453-4057qib7	10988	21	patients	patient	NNS
cord-005453-4057qib7	10988	22	with	with	IN
cord-005453-4057qib7	10988	23	poor	poor	JJ
cord-005453-4057qib7	10988	24	survival~1	survival~1	NNP
cord-005453-4057qib7	10988	25	year	year	NN
cord-005453-4057qib7	10988	26	.	.	.
cord-005453-4057qib7	10989	1	Higher	high	JJR
cord-005453-4057qib7	10989	2	SUV	SUV	NNP
cord-005453-4057qib7	10989	3	in	in	IN
cord-005453-4057qib7	10989	4	both	both	DT
cord-005453-4057qib7	10989	5	pre	pre	JJ
cord-005453-4057qib7	10989	6	-	-	NN
cord-005453-4057qib7	10989	7	transplant	transplant	NN
cord-005453-4057qib7	10989	8	as	as	RB
cord-005453-4057qib7	10989	9	well	well	RB
cord-005453-4057qib7	10989	10	as	as	IN
cord-005453-4057qib7	10989	11	post	post	JJ
cord-005453-4057qib7	10989	12	-	-	JJ
cord-005453-4057qib7	10989	13	HCT	hct	JJ
cord-005453-4057qib7	10989	14	PET	pet	NN
cord-005453-4057qib7	10989	15	was	be	VBD
cord-005453-4057qib7	10989	16	predictive	predictive	JJ
cord-005453-4057qib7	10989	17	of	of	IN
cord-005453-4057qib7	10989	18	increased	increase	VBN
cord-005453-4057qib7	10989	19	mortality	mortality	NN
cord-005453-4057qib7	10989	20	.	.	.
cord-005453-4057qib7	10990	1	These	these	DT
cord-005453-4057qib7	10990	2	patients	patient	NNS
cord-005453-4057qib7	10990	3	may	may	MD
cord-005453-4057qib7	10990	4	benefit	benefit	VB
cord-005453-4057qib7	10990	5	from	from	IN
cord-005453-4057qib7	10990	6	novel	novel	JJ
cord-005453-4057qib7	10990	7	treatments	treatment	NNS
cord-005453-4057qib7	10990	8	.	.	.
cord-005453-4057qib7	10991	1	[	[	-LRB-
cord-005453-4057qib7	10991	2	There	there	EX
cord-005453-4057qib7	10991	3	are	be	VBP
cord-005453-4057qib7	10991	4	concerns	concern	NNS
cord-005453-4057qib7	10991	5	about	about	IN
cord-005453-4057qib7	10991	6	the	the	DT
cord-005453-4057qib7	10991	7	risks	risk	NNS
cord-005453-4057qib7	10991	8	of	of	IN
cord-005453-4057qib7	10991	9	nivolumab	nivolumab	JJ
cord-005453-4057qib7	10991	10	treatment	treatment	NN
cord-005453-4057qib7	10991	11	before	before	RB
cord-005453-4057qib7	10991	12	and	and	CC
cord-005453-4057qib7	10991	13	after	after	IN
cord-005453-4057qib7	10991	14	allo	allo	NN
cord-005453-4057qib7	10991	15	-	-	HYPH
cord-005453-4057qib7	10991	16	HSCT	HSCT	NNP
cord-005453-4057qib7	10991	17	,	,	,
cord-005453-4057qib7	10991	18	due	due	IN
cord-005453-4057qib7	10991	19	to	to	IN
cord-005453-4057qib7	10991	20	the	the	DT
cord-005453-4057qib7	10991	21	risk	risk	NN
cord-005453-4057qib7	10991	22	of	of	IN
cord-005453-4057qib7	10991	23	heavy	heavy	JJ
cord-005453-4057qib7	10991	24	GVHD	GVHD	NNP
cord-005453-4057qib7	10991	25	,	,	,
cord-005453-4057qib7	10991	26	thus	thus	RB
cord-005453-4057qib7	10991	27	the	the	DT
cord-005453-4057qib7	10991	28	place	place	NN
cord-005453-4057qib7	10991	29	of	of	IN
cord-005453-4057qib7	10991	30	immune	immune	JJ
cord-005453-4057qib7	10991	31	checkpoints	checkpoint	NNS
cord-005453-4057qib7	10991	32	inhibitors	inhibitor	NNS
cord-005453-4057qib7	10991	33	is	be	VBZ
cord-005453-4057qib7	10991	34	not	not	RB
cord-005453-4057qib7	10991	35	yet	yet	RB
cord-005453-4057qib7	10991	36	defined	define	VBN
cord-005453-4057qib7	10991	37	.	.	.
cord-005453-4057qib7	10992	1	This	this	DT
cord-005453-4057qib7	10992	2	report	report	NN
cord-005453-4057qib7	10992	3	include	include	VBP
cord-005453-4057qib7	10992	4	analysis	analysis	NN
cord-005453-4057qib7	10992	5	of	of	IN
cord-005453-4057qib7	10992	6	our	-PRON-	PRP$
cord-005453-4057qib7	10992	7	center	center	NN
cord-005453-4057qib7	10992	8	experience	experience	NN
cord-005453-4057qib7	10992	9	of	of	IN
cord-005453-4057qib7	10992	10	nivolumab	nivolumab	JJ
cord-005453-4057qib7	10992	11	treatment	treatment	NN
cord-005453-4057qib7	10992	12	in	in	IN
cord-005453-4057qib7	10992	13	patients	patient	NNS
cord-005453-4057qib7	10992	14	with	with	IN
cord-005453-4057qib7	10992	15	r	r	NN
cord-005453-4057qib7	10992	16	/	/	SYM
cord-005453-4057qib7	10992	17	r	r	NN
cord-005453-4057qib7	10992	18	HL	HL	NNP
cord-005453-4057qib7	10992	19	before	before	RB
cord-005453-4057qib7	10992	20	and	and	CC
cord-005453-4057qib7	10992	21	after	after	IN
cord-005453-4057qib7	10992	22	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	10992	23	.	.	.
cord-005453-4057qib7	10993	1	Methods	method	NNS
cord-005453-4057qib7	10993	2	:	:	:
cord-005453-4057qib7	10993	3	We	-PRON-	PRP
cord-005453-4057qib7	10993	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	10993	5	evaluated	evaluate	VBD
cord-005453-4057qib7	10993	6	the	the	DT
cord-005453-4057qib7	10993	7	results	result	NNS
cord-005453-4057qib7	10993	8	of	of	IN
cord-005453-4057qib7	10993	9	alloHSCT	allohsct	NN
cord-005453-4057qib7	10993	10	in	in	IN
cord-005453-4057qib7	10993	11	86	86	CD
cord-005453-4057qib7	10993	12	patients	patient	NNS
cord-005453-4057qib7	10993	13	with	with	IN
cord-005453-4057qib7	10993	14	r	r	NN
cord-005453-4057qib7	10993	15	/	/	SYM
cord-005453-4057qib7	10993	16	r	r	NN
cord-005453-4057qib7	10993	17	cHL	chl	NN
cord-005453-4057qib7	10993	18	who	who	WP
cord-005453-4057qib7	10993	19	had	have	VBD
cord-005453-4057qib7	10993	20	undergone	undergo	VBN
cord-005453-4057qib7	10993	21	transplant	transplant	NN
cord-005453-4057qib7	10993	22	from	from	IN
cord-005453-4057qib7	10993	23	2002	2002	CD
cord-005453-4057qib7	10993	24	to	to	IN
cord-005453-4057qib7	10993	25	2018	2018	CD
cord-005453-4057qib7	10993	26	.	.	.
cord-005453-4057qib7	10994	1	The	the	DT
cord-005453-4057qib7	10994	2	analysis	analysis	NN
cord-005453-4057qib7	10994	3	included	include	VBD
cord-005453-4057qib7	10994	4	patients	patient	NNS
cord-005453-4057qib7	10994	5	received	receive	VBD
cord-005453-4057qib7	10994	6	the	the	DT
cord-005453-4057qib7	10994	7	FluBe	flube	NN
cord-005453-4057qib7	10994	8	conditioning	conditioning	NN
cord-005453-4057qib7	10994	9	and	and	CC
cord-005453-4057qib7	10994	10	PTCy	PTCy	NNS
cord-005453-4057qib7	10994	11	GVHD	GVHD	NNP
cord-005453-4057qib7	10994	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	10994	13	.	.	.
cord-005453-4057qib7	10995	1	In	in	IN
cord-005453-4057qib7	10995	2	group	group	NN
cord-005453-4057qib7	10995	3	A	a	DT
cord-005453-4057qib7	10995	4	patients	patient	NNS
cord-005453-4057qib7	10995	5	(	(	-LRB-
cord-005453-4057qib7	10995	6	n=20	n=20	NN
cord-005453-4057qib7	10995	7	)	)	-RRB-
cord-005453-4057qib7	10995	8	received	receive	VBD
cord-005453-4057qib7	10995	9	bridge	bridge	NN
cord-005453-4057qib7	10995	10	therapy	therapy	NN
cord-005453-4057qib7	10995	11	with	with	IN
cord-005453-4057qib7	10995	12	Nivоlumab	Nivоlumab	NNP
cord-005453-4057qib7	10995	13	and	and	CC
cord-005453-4057qib7	10995	14	in	in	IN
cord-005453-4057qib7	10995	15	group	group	NN
cord-005453-4057qib7	10995	16	B	b	NN
cord-005453-4057qib7	10995	17	patients	patient	NNS
cord-005453-4057qib7	10995	18	(	(	-LRB-
cord-005453-4057qib7	10995	19	n=34	n=34	NNP
cord-005453-4057qib7	10995	20	)	)	-RRB-
cord-005453-4057qib7	10995	21	received	receive	VBD
cord-005453-4057qib7	10995	22	bridge	bridge	NN
cord-005453-4057qib7	10995	23	therapy	therapy	NN
cord-005453-4057qib7	10995	24	with	with	IN
cord-005453-4057qib7	10995	25	Brentuximab	Brentuximab	NNP
cord-005453-4057qib7	10995	26	vedotin	vedotin	NNP
cord-005453-4057qib7	10995	27	or	or	CC
cord-005453-4057qib7	10995	28	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	10995	29	-	-	HYPH
cord-005453-4057qib7	10995	30	based	base	VBN
cord-005453-4057qib7	10995	31	bridges	bridge	NNS
cord-005453-4057qib7	10995	32	.	.	.
cord-005453-4057qib7	10996	1	Time	time	NN
cord-005453-4057qib7	10996	2	from	from	IN
cord-005453-4057qib7	10996	3	the	the	DT
cord-005453-4057qib7	10996	4	last	last	JJ
cord-005453-4057qib7	10996	5	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	10996	6	administration	administration	NN
cord-005453-4057qib7	10996	7	to	to	IN
cord-005453-4057qib7	10996	8	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	10996	9	was	be	VBD
cord-005453-4057qib7	10996	10	at	at	IN
cord-005453-4057qib7	10996	11	least	least	JJS
cord-005453-4057qib7	10996	12	2	2	CD
cord-005453-4057qib7	10996	13	months	month	NNS
cord-005453-4057qib7	10996	14	.	.	.
cord-005453-4057qib7	10997	1	Results	result	NNS
cord-005453-4057qib7	10997	2	:	:	:
cord-005453-4057qib7	10998	1	At	at	IN
cord-005453-4057qib7	10998	2	the	the	DT
cord-005453-4057qib7	10998	3	time	time	NN
cord-005453-4057qib7	10998	4	of	of	IN
cord-005453-4057qib7	10998	5	analysis	analysis	NN
cord-005453-4057qib7	10998	6	,	,	,
cord-005453-4057qib7	10998	7	median	median	JJ
cord-005453-4057qib7	10998	8	follow	follow	NN
cord-005453-4057qib7	10998	9	-	-	HYPH
cord-005453-4057qib7	10998	10	up	up	NN
cord-005453-4057qib7	10998	11	was	be	VBD
cord-005453-4057qib7	10998	12	12	12	CD
cord-005453-4057qib7	10998	13	(	(	-LRB-
cord-005453-4057qib7	10998	14	1	1	CD
cord-005453-4057qib7	10998	15	-	-	SYM
cord-005453-4057qib7	10998	16	20	20	CD
cord-005453-4057qib7	10998	17	)	)	-RRB-
cord-005453-4057qib7	10998	18	months	month	NNS
cord-005453-4057qib7	10998	19	for	for	IN
cord-005453-4057qib7	10998	20	group	group	NN
cord-005453-4057qib7	10998	21	A	A	NNP
cord-005453-4057qib7	10998	22	,	,	,
cord-005453-4057qib7	10998	23	and	and	CC
cord-005453-4057qib7	10998	24	15	15	CD
cord-005453-4057qib7	10998	25	(	(	-LRB-
cord-005453-4057qib7	10998	26	1	1	CD
cord-005453-4057qib7	10998	27	-	-	SYM
cord-005453-4057qib7	10998	28	64	64	CD
cord-005453-4057qib7	10998	29	)	)	-RRB-
cord-005453-4057qib7	10998	30	months	month	NNS
cord-005453-4057qib7	10998	31	for	for	IN
cord-005453-4057qib7	10998	32	group	group	NN
cord-005453-4057qib7	10999	1	B.	B.	NNP
cord-005453-4057qib7	10999	2	There	there	EX
cord-005453-4057qib7	10999	3	was	be	VBD
cord-005453-4057qib7	10999	4	no	no	DT
cord-005453-4057qib7	10999	5	difference	difference	NN
cord-005453-4057qib7	10999	6	in	in	IN
cord-005453-4057qib7	10999	7	two	two	CD
cord-005453-4057qib7	10999	8	-	-	HYPH
cord-005453-4057qib7	10999	9	year	year	NN
cord-005453-4057qib7	10999	10	OS	os	NN
cord-005453-4057qib7	10999	11	(	(	-LRB-
cord-005453-4057qib7	10999	12	p=0,39	p=0,39	NNP
cord-005453-4057qib7	10999	13	)	)	-RRB-
cord-005453-4057qib7	10999	14	with	with	IN
cord-005453-4057qib7	10999	15	significantly	significantly	RB
cord-005453-4057qib7	10999	16	better	well	JJR
cord-005453-4057qib7	10999	17	EFS	EFS	NNP
cord-005453-4057qib7	10999	18	(	(	-LRB-
cord-005453-4057qib7	10999	19	p=0,025	p=0,025	NNP
cord-005453-4057qib7	10999	20	)	)	-RRB-
cord-005453-4057qib7	10999	21	for	for	IN
cord-005453-4057qib7	10999	22	group	group	NN
cord-005453-4057qib7	10999	23	A	A	NNP
cord-005453-4057qib7	10999	24	versus	versus	IN
cord-005453-4057qib7	10999	25	group	group	NN
cord-005453-4057qib7	10999	26	B	b	NN
cord-005453-4057qib7	10999	27	:	:	:
cord-005453-4057qib7	10999	28	95	95	CD
cord-005453-4057qib7	10999	29	%	%	NN
cord-005453-4057qib7	10999	30	and	and	CC
cord-005453-4057qib7	10999	31	95	95	CD
cord-005453-4057qib7	10999	32	%	%	NN
cord-005453-4057qib7	10999	33	vs	vs	IN
cord-005453-4057qib7	10999	34	85,3	85,3	CD
cord-005453-4057qib7	10999	35	%	%	NN
cord-005453-4057qib7	10999	36	and	and	CC
cord-005453-4057qib7	10999	37	62	62	CD
cord-005453-4057qib7	10999	38	%	%	NN
cord-005453-4057qib7	10999	39	respectively	respectively	RB
cord-005453-4057qib7	10999	40	.	.	.
cord-005453-4057qib7	11000	1	Relapse	relapse	NN
cord-005453-4057qib7	11000	2	incidence	incidence	NN
cord-005453-4057qib7	11000	3	was	be	VBD
cord-005453-4057qib7	11000	4	0	0	CD
cord-005453-4057qib7	11000	5	%	%	NN
cord-005453-4057qib7	11000	6	for	for	IN
cord-005453-4057qib7	11000	7	group	group	NN
cord-005453-4057qib7	11000	8	A	A	NNP
cord-005453-4057qib7	11000	9	versus	versus	IN
cord-005453-4057qib7	11000	10	26,5	26,5	CD
cord-005453-4057qib7	11000	11	%	%	NN
cord-005453-4057qib7	11000	12	in	in	IN
cord-005453-4057qib7	11000	13	group	group	NN
cord-005453-4057qib7	11000	14	B	B	NNP
cord-005453-4057qib7	11000	15	(	(	-LRB-
cord-005453-4057qib7	11000	16	p=0,025	p=0,025	NNP
cord-005453-4057qib7	11000	17	)	)	-RRB-
cord-005453-4057qib7	11000	18	.	.	.
cord-005453-4057qib7	11001	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	11001	2	incidence	incidence	NN
cord-005453-4057qib7	11001	3	of	of	IN
cord-005453-4057qib7	11001	4	non	non	JJ
cord-005453-4057qib7	11001	5	-	-	JJ
cord-005453-4057qib7	11001	6	relapse	relapse	JJ
cord-005453-4057qib7	11001	7	mortality	mortality	NN
cord-005453-4057qib7	11001	8	at	at	IN
cord-005453-4057qib7	11001	9	2	2	CD
cord-005453-4057qib7	11001	10	years	year	NNS
cord-005453-4057qib7	11001	11	was	be	VBD
cord-005453-4057qib7	11001	12	5,0	5,0	CD
cord-005453-4057qib7	11001	13	%	%	NN
cord-005453-4057qib7	11001	14	and	and	CC
cord-005453-4057qib7	11001	15	13,8	13,8	CD
cord-005453-4057qib7	11001	16	%	%	NN
cord-005453-4057qib7	11001	17	in	in	IN
cord-005453-4057qib7	11001	18	group	group	NN
cord-005453-4057qib7	11001	19	A	a	NN
cord-005453-4057qib7	11001	20	and	and	CC
cord-005453-4057qib7	11001	21	group	group	NN
cord-005453-4057qib7	11001	22	B	b	NN
cord-005453-4057qib7	11001	23	,	,	,
cord-005453-4057qib7	11001	24	respectively	respectively	RB
cord-005453-4057qib7	11001	25	(	(	-LRB-
cord-005453-4057qib7	11001	26	p=0,631	p=0,631	NNP
cord-005453-4057qib7	11001	27	)	)	-RRB-
cord-005453-4057qib7	11001	28	.	.	.
cord-005453-4057qib7	11002	1	There	there	EX
cord-005453-4057qib7	11002	2	was	be	VBD
cord-005453-4057qib7	11002	3	no	no	DT
cord-005453-4057qib7	11002	4	difference	difference	NN
cord-005453-4057qib7	11002	5	in	in	IN
cord-005453-4057qib7	11002	6	grade	grade	NN
cord-005453-4057qib7	11002	7	II	II	NNP
cord-005453-4057qib7	11002	8	-	-	HYPH
cord-005453-4057qib7	11002	9	IV	IV	NNP
cord-005453-4057qib7	11002	10	(	(	-LRB-
cord-005453-4057qib7	11002	11	44	44	CD
cord-005453-4057qib7	11002	12	%	%	NN
cord-005453-4057qib7	11002	13	vs	vs	IN
cord-005453-4057qib7	11002	14	27	27	CD
cord-005453-4057qib7	11002	15	%	%	NN
cord-005453-4057qib7	11002	16	,	,	,
cord-005453-4057qib7	11002	17	p=0.23	p=0.23	NNP
cord-005453-4057qib7	11002	18	)	)	-RRB-
cord-005453-4057qib7	11002	19	and	and	CC
cord-005453-4057qib7	11002	20	grade	grade	NN
cord-005453-4057qib7	11002	21	III	III	NNP
cord-005453-4057qib7	11002	22	-	-	HYPH
cord-005453-4057qib7	11002	23	IV	IV	NNP
cord-005453-4057qib7	11002	24	(	(	-LRB-
cord-005453-4057qib7	11002	25	22	22	CD
cord-005453-4057qib7	11002	26	%	%	NN
cord-005453-4057qib7	11002	27	vs	vs	IN
cord-005453-4057qib7	11002	28	13	13	CD
cord-005453-4057qib7	11002	29	%	%	NN
cord-005453-4057qib7	11002	30	,	,	,
cord-005453-4057qib7	11002	31	p=0.3	p=0.3	NNP
cord-005453-4057qib7	11002	32	)	)	-RRB-
cord-005453-4057qib7	11002	33	aGVHD	aGVHD	NNP
cord-005453-4057qib7	11002	34	,	,	,
cord-005453-4057qib7	11002	35	as	as	RB
cord-005453-4057qib7	11002	36	well	well	RB
cord-005453-4057qib7	11002	37	as	as	IN
cord-005453-4057qib7	11002	38	extensive	extensive	JJ
cord-005453-4057qib7	11002	39	chronic	chronic	JJ
cord-005453-4057qib7	11002	40	GVHD	GVHD	NNP
cord-005453-4057qib7	11002	41	(	(	-LRB-
cord-005453-4057qib7	11002	42	21	21	CD
cord-005453-4057qib7	11002	43	%	%	NN
cord-005453-4057qib7	11002	44	vs	vs	IN
cord-005453-4057qib7	11002	45	28	28	CD
cord-005453-4057qib7	11002	46	%	%	NN
cord-005453-4057qib7	11002	47	,	,	,
cord-005453-4057qib7	11002	48	p=0,83	p=0,83	NNP
cord-005453-4057qib7	11002	49	)	)	-RRB-
cord-005453-4057qib7	11002	50	in	in	IN
cord-005453-4057qib7	11002	51	groups	group	NNS
cord-005453-4057qib7	11002	52	A	A	NNP
cord-005453-4057qib7	11002	53	and	and	CC
cord-005453-4057qib7	11002	54	B	b	NN
cord-005453-4057qib7	11002	55	,	,	,
cord-005453-4057qib7	11002	56	respectively	respectively	RB
cord-005453-4057qib7	11002	57	.	.	.
cord-005453-4057qib7	11003	1	Ten	ten	CD
cord-005453-4057qib7	11003	2	patients	patient	NNS
cord-005453-4057qib7	11003	3	with	with	IN
cord-005453-4057qib7	11003	4	relapse	relapse	NN
cord-005453-4057qib7	11003	5	after	after	IN
cord-005453-4057qib7	11003	6	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11003	7	were	be	VBD
cord-005453-4057qib7	11003	8	treated	treat	VBN
cord-005453-4057qib7	11003	9	with	with	IN
cord-005453-4057qib7	11003	10	different	different	JJ
cord-005453-4057qib7	11003	11	doses	dose	NNS
cord-005453-4057qib7	11003	12	(	(	-LRB-
cord-005453-4057qib7	11003	13	0,5	0,5	CD
cord-005453-4057qib7	11003	14	-	-	SYM
cord-005453-4057qib7	11003	15	3	3	CD
cord-005453-4057qib7	11003	16	mg	mg	NNP
cord-005453-4057qib7	11003	17	/	/	SYM
cord-005453-4057qib7	11003	18	kg	kg	NNP
cord-005453-4057qib7	11003	19	)	)	-RRB-
cord-005453-4057qib7	11003	20	of	of	IN
cord-005453-4057qib7	11003	21	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11003	22	in	in	IN
cord-005453-4057qib7	11003	23	CIC725	CIC725	NNP
cord-005453-4057qib7	11003	24	center	center	NN
cord-005453-4057qib7	11003	25	.	.	.
cord-005453-4057qib7	11004	1	At	at	IN
cord-005453-4057qib7	11004	2	the	the	DT
cord-005453-4057qib7	11004	3	median	median	NN
cord-005453-4057qib7	11004	4	follow	follow	NN
cord-005453-4057qib7	11004	5	up	up	IN
cord-005453-4057qib7	11004	6	of	of	IN
cord-005453-4057qib7	11004	7	16	16	CD
cord-005453-4057qib7	11004	8	mo	mo	NN
cord-005453-4057qib7	11004	9	(	(	-LRB-
cord-005453-4057qib7	11004	10	0,6	0,6	CD
cord-005453-4057qib7	11004	11	-	-	SYM
cord-005453-4057qib7	11004	12	28	28	CD
cord-005453-4057qib7	11004	13	)	)	-RRB-
cord-005453-4057qib7	11004	14	all	all	DT
cord-005453-4057qib7	11004	15	patients	patient	NNS
cord-005453-4057qib7	11004	16	remain	remain	VBP
cord-005453-4057qib7	11004	17	alive	alive	JJ
cord-005453-4057qib7	11004	18	.	.	.
cord-005453-4057qib7	11005	1	The	the	DT
cord-005453-4057qib7	11005	2	objective	objective	JJ
cord-005453-4057qib7	11005	3	response	response	NN
cord-005453-4057qib7	11005	4	to	to	IN
cord-005453-4057qib7	11005	5	therapy	therapy	NN
cord-005453-4057qib7	11005	6	was	be	VBD
cord-005453-4057qib7	11005	7	assessed	assess	VBN
cord-005453-4057qib7	11005	8	in	in	IN
cord-005453-4057qib7	11005	9	7	7	CD
cord-005453-4057qib7	11005	10	patients	patient	NNS
cord-005453-4057qib7	11005	11	noted	note	VBN
cord-005453-4057qib7	11005	12	in	in	IN
cord-005453-4057qib7	11005	13	all	all	DT
cord-005453-4057qib7	11005	14	patients	patient	NNS
cord-005453-4057qib7	11005	15	(	(	-LRB-
cord-005453-4057qib7	11005	16	100	100	CD
cord-005453-4057qib7	11005	17	%	%	NN
cord-005453-4057qib7	11005	18	)	)	-RRB-
cord-005453-4057qib7	11005	19	,	,	,
cord-005453-4057qib7	11005	20	disregard	disregard	VB
cord-005453-4057qib7	11005	21	the	the	DT
cord-005453-4057qib7	11005	22	dose	dose	NN
cord-005453-4057qib7	11005	23	of	of	IN
cord-005453-4057qib7	11005	24	the	the	DT
cord-005453-4057qib7	11005	25	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11005	26	:	:	:
cord-005453-4057qib7	11006	1	CR	CR	NNP
cord-005453-4057qib7	11006	2	in	in	IN
cord-005453-4057qib7	11006	3	29	29	CD
cord-005453-4057qib7	11006	4	%	%	NN
cord-005453-4057qib7	11006	5	,	,	,
cord-005453-4057qib7	11006	6	and	and	CC
cord-005453-4057qib7	11006	7	PR	PR	NNP
cord-005453-4057qib7	11006	8	in	in	IN
cord-005453-4057qib7	11006	9	71	71	CD
cord-005453-4057qib7	11006	10	%	%	NN
cord-005453-4057qib7	11006	11	.	.	.
cord-005453-4057qib7	11007	1	The	the	DT
cord-005453-4057qib7	11007	2	response	response	NN
cord-005453-4057qib7	11007	3	was	be	VBD
cord-005453-4057qib7	11007	4	lost	lose	VBN
cord-005453-4057qib7	11007	5	in	in	IN
cord-005453-4057qib7	11007	6	four	four	CD
cord-005453-4057qib7	11007	7	patients	patient	NNS
cord-005453-4057qib7	11007	8	,	,	,
cord-005453-4057qib7	11007	9	which	which	WDT
cord-005453-4057qib7	11007	10	required	require	VBD
cord-005453-4057qib7	11007	11	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11007	12	retreatment	retreatment	NN
cord-005453-4057qib7	11007	13	.	.	.
cord-005453-4057qib7	11008	1	None	none	NN
cord-005453-4057qib7	11008	2	of	of	IN
cord-005453-4057qib7	11008	3	the	the	DT
cord-005453-4057qib7	11008	4	patients	patient	NNS
cord-005453-4057qib7	11008	5	developed	develop	VBD
cord-005453-4057qib7	11008	6	GVHD	GVHD	NNP
cord-005453-4057qib7	11008	7	after	after	IN
cord-005453-4057qib7	11008	8	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11008	9	administration	administration	NN
cord-005453-4057qib7	11008	10	.	.	.
cord-005453-4057qib7	11009	1	In	in	IN
cord-005453-4057qib7	11009	2	this	this	DT
cord-005453-4057qib7	11009	3	analysis	analysis	NN
cord-005453-4057qib7	11009	4	,	,	,
cord-005453-4057qib7	11009	5	there	there	EX
cord-005453-4057qib7	11009	6	was	be	VBD
cord-005453-4057qib7	11009	7	also	also	RB
cord-005453-4057qib7	11009	8	no	no	DT
cord-005453-4057qib7	11009	9	correlation	correlation	NN
cord-005453-4057qib7	11009	10	between	between	IN
cord-005453-4057qib7	11009	11	dose	dose	NN
cord-005453-4057qib7	11009	12	of	of	IN
cord-005453-4057qib7	11009	13	nivolumab	nivolumab	NNS
cord-005453-4057qib7	11009	14	and	and	CC
cord-005453-4057qib7	11009	15	incidence	incidence	NN
cord-005453-4057qib7	11009	16	and	and	CC
cord-005453-4057qib7	11009	17	severity	severity	NN
cord-005453-4057qib7	11009	18	of	of	IN
cord-005453-4057qib7	11009	19	adverse	adverse	JJ
cord-005453-4057qib7	11009	20	events	event	NNS
cord-005453-4057qib7	11009	21	.	.	.
cord-005453-4057qib7	11010	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11010	2	:	:	:
cord-005453-4057qib7	11010	3	AlloHSCT	AlloHSCT	NNP
cord-005453-4057qib7	11010	4	in	in	IN
cord-005453-4057qib7	11010	5	combination	combination	NN
cord-005453-4057qib7	11010	6	with	with	IN
cord-005453-4057qib7	11010	7	immune	immune	JJ
cord-005453-4057qib7	11010	8	checkpoints	checkpoint	NNS
cord-005453-4057qib7	11011	1	inhibitors	inhibitor	NNS
cord-005453-4057qib7	11011	2	is	be	VBZ
cord-005453-4057qib7	11011	3	a	a	DT
cord-005453-4057qib7	11011	4	good	good	JJ
cord-005453-4057qib7	11011	5	option	option	NN
cord-005453-4057qib7	11011	6	for	for	IN
cord-005453-4057qib7	11011	7	patients	patient	NNS
cord-005453-4057qib7	11011	8	with	with	IN
cord-005453-4057qib7	11011	9	r	r	NN
cord-005453-4057qib7	11011	10	/	/	SYM
cord-005453-4057qib7	11011	11	r	r	NN
cord-005453-4057qib7	11011	12	cHL	chl	NN
cord-005453-4057qib7	11011	13	.	.	.
cord-005453-4057qib7	11012	1	Consideration	consideration	NN
cord-005453-4057qib7	11012	2	for	for	IN
cord-005453-4057qib7	11012	3	immune	immune	NN
cord-005453-4057qib7	11012	4	-	-	HYPH
cord-005453-4057qib7	11012	5	mediated	mediate	VBN
cord-005453-4057qib7	11012	6	toxicities	toxicity	NNS
cord-005453-4057qib7	11012	7	and	and	CC
cord-005453-4057qib7	11012	8	the	the	DT
cord-005453-4057qib7	11012	9	potential	potential	NN
cord-005453-4057qib7	11012	10	for	for	IN
cord-005453-4057qib7	11012	11	increased	increase	VBN
cord-005453-4057qib7	11012	12	graft	graft	NN
cord-005453-4057qib7	11012	13	-	-	HYPH
cord-005453-4057qib7	11012	14	versus	versus	IN
cord-005453-4057qib7	11012	15	-	-	HYPH
cord-005453-4057qib7	11012	16	host	host	NN
cord-005453-4057qib7	11012	17	disease	disease	NN
cord-005453-4057qib7	11012	18	remain	remain	VBP
cord-005453-4057qib7	11012	19	important	important	JJ
cord-005453-4057qib7	11012	20	.	.	.
cord-005453-4057qib7	11013	1	Early	early	JJ
cord-005453-4057qib7	11013	2	data	datum	NNS
cord-005453-4057qib7	11013	3	suggest	suggest	VBP
cord-005453-4057qib7	11013	4	that	that	IN
cord-005453-4057qib7	11013	5	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11013	6	may	may	MD
cord-005453-4057qib7	11013	7	be	be	VB
cord-005453-4057qib7	11013	8	an	an	DT
cord-005453-4057qib7	11013	9	efficient	efficient	JJ
cord-005453-4057qib7	11013	10	therapy	therapy	NN
cord-005453-4057qib7	11013	11	in	in	IN
cord-005453-4057qib7	11013	12	patients	patient	NNS
cord-005453-4057qib7	11013	13	with	with	IN
cord-005453-4057qib7	11013	14	r	r	NN
cord-005453-4057qib7	11013	15	/	/	SYM
cord-005453-4057qib7	11013	16	r	r	NN
cord-005453-4057qib7	11013	17	cHL	chl	NN
cord-005453-4057qib7	11013	18	relapse	relapse	NN
cord-005453-4057qib7	11013	19	after	after	IN
cord-005453-4057qib7	11013	20	allo	allo	NN
cord-005453-4057qib7	11013	21	-	-	HYPH
cord-005453-4057qib7	11013	22	HSCT	HSCT	NNP
cord-005453-4057qib7	11013	23	.	.	.
cord-005453-4057qib7	11014	1	Further	further	JJ
cord-005453-4057qib7	11014	2	research	research	NN
cord-005453-4057qib7	11014	3	needed	need	VBN
cord-005453-4057qib7	11014	4	.	.	.
cord-005453-4057qib7	11015	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11015	2	:	:	:
cord-005453-4057qib7	11016	1	The	the	DT
cord-005453-4057qib7	11016	2	authors	author	NNS
cord-005453-4057qib7	11016	3	declare	declare	VBP
cord-005453-4057qib7	11016	4	no	no	DT
cord-005453-4057qib7	11016	5	conflicts	conflict	NNS
cord-005453-4057qib7	11016	6	of	of	IN
cord-005453-4057qib7	11016	7	interest	interest	NN
cord-005453-4057qib7	11016	8	.	.	.
cord-005453-4057qib7	11017	1	Background	background	NN
cord-005453-4057qib7	11017	2	:	:	:
cord-005453-4057qib7	11018	1	Transformation	transformation	NN
cord-005453-4057qib7	11018	2	to	to	TO
cord-005453-4057qib7	11018	3	diffuse	diffuse	VB
cord-005453-4057qib7	11018	4	large	large	JJ
cord-005453-4057qib7	11018	5	B	b	NN
cord-005453-4057qib7	11018	6	-	-	HYPH
cord-005453-4057qib7	11018	7	cell	cell	NN
cord-005453-4057qib7	11018	8	lymphoma	lymphoma	NN
cord-005453-4057qib7	11018	9	(	(	-LRB-
cord-005453-4057qib7	11018	10	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11018	11	)	)	-RRB-
cord-005453-4057qib7	11018	12	is	be	VBZ
cord-005453-4057qib7	11018	13	considered	consider	VBN
cord-005453-4057qib7	11018	14	to	to	TO
cord-005453-4057qib7	11018	15	be	be	VB
cord-005453-4057qib7	11018	16	one	one	CD
cord-005453-4057qib7	11018	17	of	of	IN
cord-005453-4057qib7	11018	18	the	the	DT
cord-005453-4057qib7	11018	19	most	most	RBS
cord-005453-4057qib7	11018	20	unfavourable	unfavourable	JJ
cord-005453-4057qib7	11018	21	events	event	NNS
cord-005453-4057qib7	11018	22	of	of	IN
cord-005453-4057qib7	11018	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	11018	24	natural	natural	JJ
cord-005453-4057qib7	11018	25	history	history	NN
cord-005453-4057qib7	11018	26	with	with	IN
cord-005453-4057qib7	11018	27	poorer	poor	JJR
cord-005453-4057qib7	11018	28	outcome	outcome	NN
cord-005453-4057qib7	11018	29	as	as	IN
cord-005453-4057qib7	11018	30	compared	compare	VBN
cord-005453-4057qib7	11018	31	to	to	IN
cord-005453-4057qib7	11018	32	de	de	NNP
cord-005453-4057qib7	11018	33	novo	novo	NNP
cord-005453-4057qib7	11018	34	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11018	35	(	(	-LRB-
cord-005453-4057qib7	11018	36	Alonso	Alonso	NNP
cord-005453-4057qib7	11018	37	-	-	HYPH
cord-005453-4057qib7	11018	38	Álvarez	Álvarez	NNP
cord-005453-4057qib7	11018	39	et	et	FW
cord-005453-4057qib7	11018	40	al	al	NNP
cord-005453-4057qib7	11018	41	,	,	,
cord-005453-4057qib7	11018	42	BJH	BJH	NNP
cord-005453-4057qib7	11018	43	2017	2017	CD
cord-005453-4057qib7	11018	44	)	)	-RRB-
cord-005453-4057qib7	11018	45	.	.	.
cord-005453-4057qib7	11019	1	In	in	IN
cord-005453-4057qib7	11019	2	patients	patient	NNS
cord-005453-4057qib7	11019	3	suitable	suitable	JJ
cord-005453-4057qib7	11019	4	for	for	IN
cord-005453-4057qib7	11019	5	salvage	salvage	NN
cord-005453-4057qib7	11019	6	therapy	therapy	NN
cord-005453-4057qib7	11019	7	,	,	,
cord-005453-4057qib7	11019	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11019	9	stem	stem	NN
cord-005453-4057qib7	11019	10	-	-	HYPH
cord-005453-4057qib7	11019	11	cell	cell	NN
cord-005453-4057qib7	11019	12	transplantation	transplantation	NN
cord-005453-4057qib7	11019	13	(	(	-LRB-
cord-005453-4057qib7	11019	14	SCT	SCT	NNP
cord-005453-4057qib7	11019	15	)	)	-RRB-
cord-005453-4057qib7	11019	16	could	could	MD
cord-005453-4057qib7	11019	17	be	be	VB
cord-005453-4057qib7	11019	18	an	an	DT
cord-005453-4057qib7	11019	19	option	option	NN
cord-005453-4057qib7	11019	20	,	,	,
cord-005453-4057qib7	11019	21	although	although	IN
cord-005453-4057qib7	11019	22	its	-PRON-	PRP$
cord-005453-4057qib7	11019	23	role	role	NN
cord-005453-4057qib7	11019	24	is	be	VBZ
cord-005453-4057qib7	11019	25	not	not	RB
cord-005453-4057qib7	11019	26	well	well	RB
cord-005453-4057qib7	11019	27	stablished	stablishe	VBN
cord-005453-4057qib7	11019	28	.	.	.
cord-005453-4057qib7	11020	1	We	-PRON-	PRP
cord-005453-4057qib7	11020	2	analyse	analyse	VBP
cord-005453-4057qib7	11020	3	indication	indication	NN
cord-005453-4057qib7	11020	4	and	and	CC
cord-005453-4057qib7	11020	5	outcome	outcome	NN
cord-005453-4057qib7	11020	6	after	after	IN
cord-005453-4057qib7	11020	7	transplant	transplant	NN
cord-005453-4057qib7	11020	8	in	in	IN
cord-005453-4057qib7	11020	9	transformed	transform	VBN
cord-005453-4057qib7	11020	10	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11020	11	at	at	IN
cord-005453-4057qib7	11020	12	a	a	DT
cord-005453-4057qib7	11020	13	single	single	JJ
cord-005453-4057qib7	11020	14	Reference	reference	NN
cord-005453-4057qib7	11020	15	Transplant	Transplant	NNP
cord-005453-4057qib7	11020	16	Unit	Unit	NNP
cord-005453-4057qib7	11020	17	.	.	.
cord-005453-4057qib7	11021	1	Methods	method	NNS
cord-005453-4057qib7	11021	2	:	:	:
cord-005453-4057qib7	11022	1	Out	out	IN
cord-005453-4057qib7	11022	2	of	of	IN
cord-005453-4057qib7	11022	3	2565	2565	CD
cord-005453-4057qib7	11022	4	total	total	NN
cord-005453-4057qib7	11022	5	of	of	IN
cord-005453-4057qib7	11022	6	transplants	transplant	NNS
cord-005453-4057qib7	11022	7	performed	perform	VBN
cord-005453-4057qib7	11022	8	at	at	IN
cord-005453-4057qib7	11022	9	our	-PRON-	PRP$
cord-005453-4057qib7	11022	10	Unit	Unit	NNP
cord-005453-4057qib7	11022	11	between	between	IN
cord-005453-4057qib7	11022	12	1995	1995	CD
cord-005453-4057qib7	11022	13	and	and	CC
cord-005453-4057qib7	11022	14	2018	2018	CD
cord-005453-4057qib7	11022	15	-1564	-1564	VBP
cord-005453-4057qib7	11022	16	autologous	autologous	JJ
cord-005453-4057qib7	11022	17	and	and	CC
cord-005453-4057qib7	11022	18	1001	1001	CD
cord-005453-4057qib7	11022	19	allogeneic-51	allogeneic-51	CD
cord-005453-4057qib7	11022	20	were	be	VBD
cord-005453-4057qib7	11022	21	DLBCL	dlbcl	RB
cord-005453-4057qib7	11022	22	transformed	transform	VBN
cord-005453-4057qib7	11022	23	from	from	IN
cord-005453-4057qib7	11022	24	an	an	DT
cord-005453-4057qib7	11022	25	indolent	indolent	JJ
cord-005453-4057qib7	11022	26	NHL	NHL	NNP
cord-005453-4057qib7	11022	27	.	.	.
cord-005453-4057qib7	11023	1	Of	of	IN
cord-005453-4057qib7	11023	2	them	-PRON-	PRP
cord-005453-4057qib7	11023	3	,	,	,
cord-005453-4057qib7	11023	4	36	36	CD
cord-005453-4057qib7	11023	5	received	receive	VBD
cord-005453-4057qib7	11023	6	an	an	DT
cord-005453-4057qib7	11023	7	autologous	autologous	JJ
cord-005453-4057qib7	11023	8	SCT	SCT	NNP
cord-005453-4057qib7	11023	9	(	(	-LRB-
cord-005453-4057qib7	11023	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11023	11	)	)	-RRB-
cord-005453-4057qib7	11023	12	and	and	CC
cord-005453-4057qib7	11023	13	15	15	CD
cord-005453-4057qib7	11023	14	an	an	DT
cord-005453-4057qib7	11023	15	allogeneic	allogeneic	NN
cord-005453-4057qib7	11023	16	SCT	sct	NN
cord-005453-4057qib7	11023	17	(	(	-LRB-
cord-005453-4057qib7	11023	18	allo	allo	NN
cord-005453-4057qib7	11023	19	-	-	HYPH
cord-005453-4057qib7	11023	20	SCT	SCT	NNP
cord-005453-4057qib7	11023	21	)	)	-RRB-
cord-005453-4057qib7	11023	22	.	.	.
cord-005453-4057qib7	11024	1	Results	result	NNS
cord-005453-4057qib7	11024	2	:	:	:
cord-005453-4057qib7	11025	1	Median	median	JJ
cord-005453-4057qib7	11025	2	age	age	NN
cord-005453-4057qib7	11025	3	was	be	VBD
cord-005453-4057qib7	11025	4	60	60	CD
cord-005453-4057qib7	11025	5	years	year	NNS
cord-005453-4057qib7	11025	6	old	old	JJ
cord-005453-4057qib7	11025	7	(	(	-LRB-
cord-005453-4057qib7	11025	8	range	range	VBP
cord-005453-4057qib7	11025	9	40	40	CD
cord-005453-4057qib7	11025	10	-	-	SYM
cord-005453-4057qib7	11025	11	69	69	CD
cord-005453-4057qib7	11025	12	)	)	-RRB-
cord-005453-4057qib7	11025	13	and	and	CC
cord-005453-4057qib7	11025	14	52	52	CD
cord-005453-4057qib7	11025	15	(	(	-LRB-
cord-005453-4057qib7	11025	16	range	range	NN
cord-005453-4057qib7	11025	17	35	35	CD
cord-005453-4057qib7	11025	18	-	-	SYM
cord-005453-4057qib7	11025	19	65	65	CD
cord-005453-4057qib7	11025	20	)	)	-RRB-
cord-005453-4057qib7	11025	21	for	for	IN
cord-005453-4057qib7	11025	22	patients	patient	NNS
cord-005453-4057qib7	11025	23	receiving	receive	VBG
cord-005453-4057qib7	11025	24	ASCT	ASCT	NNP
cord-005453-4057qib7	11025	25	and	and	CC
cord-005453-4057qib7	11025	26	allo	allo	NN
cord-005453-4057qib7	11025	27	-	-	HYPH
cord-005453-4057qib7	11025	28	SCT	SCT	NNP
cord-005453-4057qib7	11025	29	,	,	,
cord-005453-4057qib7	11025	30	respectively	respectively	RB
cord-005453-4057qib7	11025	31	.	.	.
cord-005453-4057qib7	11026	1	All	all	DT
cord-005453-4057qib7	11026	2	ASCT	ASCT	NNP
cord-005453-4057qib7	11026	3	received	receive	VBD
cord-005453-4057qib7	11026	4	BEAM	BEAM	NNP
cord-005453-4057qib7	11026	5	as	as	IN
cord-005453-4057qib7	11026	6	a	a	DT
cord-005453-4057qib7	11026	7	conditioning	conditioning	NN
cord-005453-4057qib7	11026	8	regimen	regimen	NN
cord-005453-4057qib7	11026	9	and	and	CC
cord-005453-4057qib7	11026	10	most	most	JJS
cord-005453-4057qib7	11026	11	of	of	IN
cord-005453-4057qib7	11026	12	the	the	DT
cord-005453-4057qib7	11026	13	patients	patient	NNS
cord-005453-4057qib7	11026	14	in	in	IN
cord-005453-4057qib7	11026	15	the	the	DT
cord-005453-4057qib7	11026	16	allo	allo	NNP
cord-005453-4057qib7	11026	17	-	-	HYPH
cord-005453-4057qib7	11026	18	SCT	SCT	NNP
cord-005453-4057qib7	11026	19	group	group	NN
cord-005453-4057qib7	11026	20	received	receive	VBD
cord-005453-4057qib7	11026	21	a	a	DT
cord-005453-4057qib7	11026	22	fludarabine	fludarabine	NN
cord-005453-4057qib7	11026	23	/	/	SYM
cord-005453-4057qib7	11026	24	melphalan	melphalan	NN
cord-005453-4057qib7	11026	25	combination	combination	NN
cord-005453-4057qib7	11026	26	(	(	-LRB-
cord-005453-4057qib7	11026	27	73	73	CD
cord-005453-4057qib7	11026	28	%	%	NN
cord-005453-4057qib7	11026	29	)	)	-RRB-
cord-005453-4057qib7	11026	30	.	.	.
cord-005453-4057qib7	11027	1	GVHD	GVHD	NNP
cord-005453-4057qib7	11027	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11027	3	consisted	consist	VBD
cord-005453-4057qib7	11027	4	on	on	IN
cord-005453-4057qib7	11027	5	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	11027	6	/	/	SYM
cord-005453-4057qib7	11027	7	sirolimus	sirolimus	NN
cord-005453-4057qib7	11027	8	combination	combination	NN
cord-005453-4057qib7	11027	9	in	in	IN
cord-005453-4057qib7	11027	10	87	87	CD
cord-005453-4057qib7	11027	11	%	%	NN
cord-005453-4057qib7	11027	12	and	and	CC
cord-005453-4057qib7	11027	13	calcioneurin	calcioneurin	NNP
cord-005453-4057qib7	11027	14	plus	plus	CC
cord-005453-4057qib7	11027	15	methotrexate	methotrexate	NNP
cord-005453-4057qib7	11027	16	in	in	IN
cord-005453-4057qib7	11027	17	13	13	CD
cord-005453-4057qib7	11027	18	%	%	NN
cord-005453-4057qib7	11027	19	.	.	.
cord-005453-4057qib7	11028	1	Regarding	regard	VBG
cord-005453-4057qib7	11028	2	transplant	transplant	NN
cord-005453-4057qib7	11028	3	disease	disease	NN
cord-005453-4057qib7	11028	4	status	status	NN
cord-005453-4057qib7	11028	5	,	,	,
cord-005453-4057qib7	11028	6	28	28	CD
cord-005453-4057qib7	11028	7	(	(	-LRB-
cord-005453-4057qib7	11028	8	78	78	CD
cord-005453-4057qib7	11028	9	%	%	NN
cord-005453-4057qib7	11028	10	)	)	-RRB-
cord-005453-4057qib7	11028	11	of	of	IN
cord-005453-4057qib7	11028	12	the	the	DT
cord-005453-4057qib7	11028	13	ASCT	ASCT	NNP
cord-005453-4057qib7	11028	14	patients	patient	NNS
cord-005453-4057qib7	11028	15	were	be	VBD
cord-005453-4057qib7	11028	16	transplanted	transplant	VBN
cord-005453-4057qib7	11028	17	in	in	IN
cord-005453-4057qib7	11028	18	complete	complete	JJ
cord-005453-4057qib7	11028	19	response	response	NN
cord-005453-4057qib7	11028	20	(	(	-LRB-
cord-005453-4057qib7	11028	21	CR	CR	NNP
cord-005453-4057qib7	11028	22	)	)	-RRB-
cord-005453-4057qib7	11028	23	.	.	.
cord-005453-4057qib7	11029	1	In	in	IN
cord-005453-4057qib7	11029	2	the	the	DT
cord-005453-4057qib7	11029	3	allo	allo	NNP
cord-005453-4057qib7	11029	4	-	-	HYPH
cord-005453-4057qib7	11029	5	SCT	SCT	NNP
cord-005453-4057qib7	11029	6	group	group	NN
cord-005453-4057qib7	11029	7	,	,	,
cord-005453-4057qib7	11029	8	11	11	CD
cord-005453-4057qib7	11029	9	(	(	-LRB-
cord-005453-4057qib7	11029	10	73	73	CD
cord-005453-4057qib7	11029	11	%	%	NN
cord-005453-4057qib7	11029	12	)	)	-RRB-
cord-005453-4057qib7	11029	13	patients	patient	NNS
cord-005453-4057qib7	11029	14	had	have	VBD
cord-005453-4057qib7	11029	15	received	receive	VBN
cord-005453-4057qib7	11029	16	three	three	CD
cord-005453-4057qib7	11029	17	or	or	CC
cord-005453-4057qib7	11029	18	more	more	JJR
cord-005453-4057qib7	11029	19	treatment	treatment	NN
cord-005453-4057qib7	11029	20	lines	line	NNS
cord-005453-4057qib7	11029	21	before	before	IN
cord-005453-4057qib7	11029	22	transplant	transplant	NN
cord-005453-4057qib7	11029	23	and	and	CC
cord-005453-4057qib7	11029	24	13	13	CD
cord-005453-4057qib7	11029	25	patients	patient	NNS
cord-005453-4057qib7	11029	26	(	(	-LRB-
cord-005453-4057qib7	11029	27	87	87	CD
cord-005453-4057qib7	11029	28	%	%	NN
cord-005453-4057qib7	11029	29	)	)	-RRB-
cord-005453-4057qib7	11029	30	had	have	VBD
cord-005453-4057qib7	11029	31	received	receive	VBN
cord-005453-4057qib7	11029	32	a	a	DT
cord-005453-4057qib7	11029	33	previous	previous	JJ
cord-005453-4057qib7	11029	34	ASCT	ASCT	NNP
cord-005453-4057qib7	11029	35	,	,	,
cord-005453-4057qib7	11029	36	being	be	VBG
cord-005453-4057qib7	11029	37	11	11	CD
cord-005453-4057qib7	11029	38	(	(	-LRB-
cord-005453-4057qib7	11029	39	73	73	CD
cord-005453-4057qib7	11029	40	%	%	NN
cord-005453-4057qib7	11029	41	)	)	-RRB-
cord-005453-4057qib7	11029	42	in	in	IN
cord-005453-4057qib7	11029	43	CR	CR	NNP
cord-005453-4057qib7	11029	44	,	,	,
cord-005453-4057qib7	11029	45	3	3	CD
cord-005453-4057qib7	11029	46	in	in	IN
cord-005453-4057qib7	11029	47	partial	partial	JJ
cord-005453-4057qib7	11029	48	response	response	NN
cord-005453-4057qib7	11029	49	(	(	-LRB-
cord-005453-4057qib7	11029	50	PR	PR	NNP
cord-005453-4057qib7	11029	51	)	)	-RRB-
cord-005453-4057qib7	11029	52	and	and	CC
cord-005453-4057qib7	11029	53	1	1	CD
cord-005453-4057qib7	11029	54	in	in	IN
cord-005453-4057qib7	11029	55	progressive	progressive	JJ
cord-005453-4057qib7	11029	56	disease	disease	NN
cord-005453-4057qib7	11029	57	.	.	.
cord-005453-4057qib7	11030	1	Transplant	transplant	NN
cord-005453-4057qib7	11030	2	related	relate	VBN
cord-005453-4057qib7	11030	3	mortality	mortality	NN
cord-005453-4057qib7	11030	4	(	(	-LRB-
cord-005453-4057qib7	11030	5	TRM	TRM	NNP
cord-005453-4057qib7	11030	6	)	)	-RRB-
cord-005453-4057qib7	11030	7	was	be	VBD
cord-005453-4057qib7	11030	8	5.6	5.6	CD
cord-005453-4057qib7	11030	9	%	%	NN
cord-005453-4057qib7	11030	10	in	in	IN
cord-005453-4057qib7	11030	11	the	the	DT
cord-005453-4057qib7	11030	12	ASCT	ASCT	NNP
cord-005453-4057qib7	11030	13	and	and	CC
cord-005453-4057qib7	11030	14	27	27	CD
cord-005453-4057qib7	11030	15	%	%	NN
cord-005453-4057qib7	11031	1	In	in	IN
cord-005453-4057qib7	11031	2	the	the	DT
cord-005453-4057qib7	11031	3	allo	allo	NNP
cord-005453-4057qib7	11031	4	-	-	HYPH
cord-005453-4057qib7	11031	5	SCT	sct	NN
cord-005453-4057qib7	11031	6	group	group	NN
cord-005453-4057qib7	11031	7	.	.	.
cord-005453-4057qib7	11032	1	Overall	overall	JJ
cord-005453-4057qib7	11032	2	survival	survival	NN
cord-005453-4057qib7	11032	3	(	(	-LRB-
cord-005453-4057qib7	11032	4	OS	OS	NNP
cord-005453-4057qib7	11032	5	)	)	-RRB-
cord-005453-4057qib7	11032	6	and	and	CC
cord-005453-4057qib7	11032	7	progression	progression	NN
cord-005453-4057qib7	11032	8	-	-	HYPH
cord-005453-4057qib7	11032	9	free	free	JJ
cord-005453-4057qib7	11032	10	-	-	HYPH
cord-005453-4057qib7	11032	11	survival	survival	NN
cord-005453-4057qib7	11032	12	(	(	-LRB-
cord-005453-4057qib7	11032	13	PFS	PFS	NNP
cord-005453-4057qib7	11032	14	)	)	-RRB-
cord-005453-4057qib7	11032	15	at	at	IN
cord-005453-4057qib7	11032	16	25	25	CD
cord-005453-4057qib7	11032	17	months	month	NNS
cord-005453-4057qib7	11032	18	were	be	VBD
cord-005453-4057qib7	11032	19	94	94	CD
cord-005453-4057qib7	11032	20	%	%	NN
cord-005453-4057qib7	11032	21	(	(	-LRB-
cord-005453-4057qib7	11032	22	OS	OS	NNP
cord-005453-4057qib7	11032	23	)	)	-RRB-
cord-005453-4057qib7	11032	24	,	,	,
cord-005453-4057qib7	11032	25	76	76	CD
cord-005453-4057qib7	11032	26	%	%	NN
cord-005453-4057qib7	11032	27	(	(	-LRB-
cord-005453-4057qib7	11032	28	PFS	PFS	NNP
cord-005453-4057qib7	11032	29	)	)	-RRB-
cord-005453-4057qib7	11032	30	for	for	IN
cord-005453-4057qib7	11032	31	patients	patient	NNS
cord-005453-4057qib7	11032	32	receiving	receive	VBG
cord-005453-4057qib7	11032	33	ASCT	ASCT	NNP
cord-005453-4057qib7	11032	34	and	and	CC
cord-005453-4057qib7	11032	35	63	63	CD
cord-005453-4057qib7	11032	36	%	%	NN
cord-005453-4057qib7	11032	37	(	(	-LRB-
cord-005453-4057qib7	11032	38	OS	OS	NNP
cord-005453-4057qib7	11032	39	)	)	-RRB-
cord-005453-4057qib7	11032	40	and	and	CC
cord-005453-4057qib7	11032	41	56	56	CD
cord-005453-4057qib7	11032	42	%	%	NN
cord-005453-4057qib7	11032	43	(	(	-LRB-
cord-005453-4057qib7	11032	44	PFS	PFS	NNP
cord-005453-4057qib7	11032	45	)	)	-RRB-
cord-005453-4057qib7	11032	46	for	for	IN
cord-005453-4057qib7	11032	47	allo	allo	NN
cord-005453-4057qib7	11032	48	-	-	HYPH
cord-005453-4057qib7	11032	49	SCT	SCT	NNP
cord-005453-4057qib7	11032	50	.	.	.
cord-005453-4057qib7	11033	1	With	with	IN
cord-005453-4057qib7	11033	2	a	a	DT
cord-005453-4057qib7	11033	3	median	median	NN
cord-005453-4057qib7	11033	4	follow	follow	NN
cord-005453-4057qib7	11033	5	up	up	IN
cord-005453-4057qib7	11033	6	of	of	IN
cord-005453-4057qib7	11033	7	57	57	CD
cord-005453-4057qib7	11033	8	months	month	NNS
cord-005453-4057qib7	11033	9	for	for	IN
cord-005453-4057qib7	11033	10	patients	patient	NNS
cord-005453-4057qib7	11033	11	receiving	receive	VBG
cord-005453-4057qib7	11033	12	an	an	DT
cord-005453-4057qib7	11033	13	ASCT	ASCT	NNP
cord-005453-4057qib7	11033	14	,	,	,
cord-005453-4057qib7	11033	15	21	21	CD
cord-005453-4057qib7	11033	16	(	(	-LRB-
cord-005453-4057qib7	11033	17	58	58	CD
cord-005453-4057qib7	11033	18	%	%	NN
cord-005453-4057qib7	11033	19	)	)	-RRB-
cord-005453-4057qib7	11033	20	remain	remain	VBP
cord-005453-4057qib7	11033	21	in	in	IN
cord-005453-4057qib7	11033	22	CR	CR	NNP
cord-005453-4057qib7	11033	23	.	.	.
cord-005453-4057qib7	11034	1	In	in	IN
cord-005453-4057qib7	11034	2	the	the	DT
cord-005453-4057qib7	11034	3	allo	allo	NNP
cord-005453-4057qib7	11034	4	-	-	HYPH
cord-005453-4057qib7	11034	5	SCT	SCT	NNP
cord-005453-4057qib7	11034	6	group	group	NN
cord-005453-4057qib7	11034	7	median	median	NN
cord-005453-4057qib7	11034	8	follow	follow	VBP
cord-005453-4057qib7	11034	9	up	up	RP
cord-005453-4057qib7	11034	10	is	be	VBZ
cord-005453-4057qib7	11034	11	24	24	CD
cord-005453-4057qib7	11034	12	months	month	NNS
cord-005453-4057qib7	11034	13	for	for	IN
cord-005453-4057qib7	11034	14	the	the	DT
cord-005453-4057qib7	11034	15	whole	whole	JJ
cord-005453-4057qib7	11034	16	group	group	NN
cord-005453-4057qib7	11034	17	and	and	CC
cord-005453-4057qib7	11034	18	50	50	CD
cord-005453-4057qib7	11034	19	months	month	NNS
cord-005453-4057qib7	11034	20	for	for	IN
cord-005453-4057qib7	11034	21	alive	alive	JJ
cord-005453-4057qib7	11034	22	patients	patient	NNS
cord-005453-4057qib7	11034	23	;	;	:
cord-005453-4057qib7	11034	24	9	9	CD
cord-005453-4057qib7	11034	25	patients	patient	NNS
cord-005453-4057qib7	11034	26	are	be	VBP
cord-005453-4057qib7	11034	27	alive	alive	JJ
cord-005453-4057qib7	11034	28	and	and	CC
cord-005453-4057qib7	11034	29	disease	disease	NN
cord-005453-4057qib7	11034	30	free	free	JJ
cord-005453-4057qib7	11034	31	and	and	CC
cord-005453-4057qib7	11034	32	6	6	CD
cord-005453-4057qib7	11034	33	have	have	VBP
cord-005453-4057qib7	11034	34	died	die	VBN
cord-005453-4057qib7	11034	35	,	,	,
cord-005453-4057qib7	11034	36	4	4	CD
cord-005453-4057qib7	11034	37	due	due	IN
cord-005453-4057qib7	11034	38	to	to	IN
cord-005453-4057qib7	11034	39	TRM	TRM	NNP
cord-005453-4057qib7	11034	40	(	(	-LRB-
cord-005453-4057qib7	11034	41	28	28	CD
cord-005453-4057qib7	11034	42	%	%	NN
cord-005453-4057qib7	11034	43	)	)	-RRB-
cord-005453-4057qib7	11034	44	.	.	.
cord-005453-4057qib7	11035	1	Regarding	regard	VBG
cord-005453-4057qib7	11035	2	progression	progression	NN
cord-005453-4057qib7	11035	3	,	,	,
cord-005453-4057qib7	11035	4	12	12	CD
cord-005453-4057qib7	11035	5	(	(	-LRB-
cord-005453-4057qib7	11035	6	33	33	CD
cord-005453-4057qib7	11035	7	%	%	NN
cord-005453-4057qib7	11035	8	)	)	-RRB-
cord-005453-4057qib7	11035	9	have	have	VBP
cord-005453-4057qib7	11035	10	progressed	progress	VBN
cord-005453-4057qib7	11035	11	after	after	IN
cord-005453-4057qib7	11035	12	autologous	autologous	JJ
cord-005453-4057qib7	11035	13	transplant	transplant	NN
cord-005453-4057qib7	11035	14	and	and	CC
cord-005453-4057qib7	11035	15	2	2	CD
cord-005453-4057qib7	11035	16	after	after	IN
cord-005453-4057qib7	11035	17	allo	allo	NN
cord-005453-4057qib7	11035	18	-	-	HYPH
cord-005453-4057qib7	11035	19	SCT	SCT	NNP
cord-005453-4057qib7	11035	20	.	.	.
cord-005453-4057qib7	11036	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11036	2	:	:	:
cord-005453-4057qib7	11037	1	Indication	indication	NN
cord-005453-4057qib7	11037	2	for	for	IN
cord-005453-4057qib7	11037	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11037	4	SCT	SCT	NNP
cord-005453-4057qib7	11037	5	in	in	IN
cord-005453-4057qib7	11037	6	transformed	transform	VBN
cord-005453-4057qib7	11037	7	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11037	8	is	be	VBZ
cord-005453-4057qib7	11037	9	stablished	stablishe	VBN
cord-005453-4057qib7	11037	10	in	in	IN
cord-005453-4057qib7	11037	11	few	few	JJ
cord-005453-4057qib7	11037	12	patients	patient	NNS
cord-005453-4057qib7	11037	13	.	.	.
cord-005453-4057qib7	11038	1	Only	only	RB
cord-005453-4057qib7	11038	2	2	2	CD
cord-005453-4057qib7	11038	3	%	%	NN
cord-005453-4057qib7	11038	4	of	of	IN
cord-005453-4057qib7	11038	5	the	the	DT
cord-005453-4057qib7	11038	6	patients	patient	NNS
cord-005453-4057qib7	11038	7	in	in	IN
cord-005453-4057qib7	11038	8	our	-PRON-	PRP$
cord-005453-4057qib7	11038	9	transplant	transplant	NN
cord-005453-4057qib7	11038	10	Unit	Unit	NNP
cord-005453-4057qib7	11038	11	receive	receive	VB
cord-005453-4057qib7	11038	12	a	a	DT
cord-005453-4057qib7	11038	13	transplant	transplant	NN
cord-005453-4057qib7	11038	14	due	due	IN
cord-005453-4057qib7	11038	15	to	to	IN
cord-005453-4057qib7	11038	16	transformed	transform	VBN
cord-005453-4057qib7	11038	17	lymphoma	lymphoma	NN
cord-005453-4057qib7	11038	18	,	,	,
cord-005453-4057qib7	11038	19	corresponding	correspond	VBG
cord-005453-4057qib7	11038	20	to	to	IN
cord-005453-4057qib7	11038	21	a	a	DT
cord-005453-4057qib7	11038	22	2.3	2.3	CD
cord-005453-4057qib7	11038	23	%	%	NN
cord-005453-4057qib7	11038	24	of	of	IN
cord-005453-4057qib7	11038	25	autologous	autologous	JJ
cord-005453-4057qib7	11038	26	activity	activity	NN
cord-005453-4057qib7	11038	27	and	and	CC
cord-005453-4057qib7	11038	28	1.5	1.5	CD
cord-005453-4057qib7	11038	29	%	%	NN
cord-005453-4057qib7	11038	30	of	of	IN
cord-005453-4057qib7	11038	31	allogeneic	allogeneic	NN
cord-005453-4057qib7	11038	32	activity	activity	NN
cord-005453-4057qib7	11038	33	.	.	.
cord-005453-4057qib7	11039	1	According	accord	VBG
cord-005453-4057qib7	11039	2	to	to	IN
cord-005453-4057qib7	11039	3	our	-PRON-	PRP$
cord-005453-4057qib7	11039	4	results	result	NNS
cord-005453-4057qib7	11039	5	transplant	transplant	NN
cord-005453-4057qib7	11039	6	should	should	MD
cord-005453-4057qib7	11039	7	be	be	VB
cord-005453-4057qib7	11039	8	considered	consider	VBN
cord-005453-4057qib7	11039	9	a	a	DT
cord-005453-4057qib7	11039	10	curative	curative	JJ
cord-005453-4057qib7	11039	11	option	option	NN
cord-005453-4057qib7	11039	12	.	.	.
cord-005453-4057qib7	11040	1	Most	Most	JJS
cord-005453-4057qib7	11040	2	of	of	IN
cord-005453-4057qib7	11040	3	our	-PRON-	PRP$
cord-005453-4057qib7	11040	4	patients	patient	NNS
cord-005453-4057qib7	11040	5	were	be	VBD
cord-005453-4057qib7	11040	6	transplanted	transplant	VBN
cord-005453-4057qib7	11040	7	in	in	IN
cord-005453-4057qib7	11040	8	CR	CR	NNP
cord-005453-4057qib7	11040	9	,	,	,
cord-005453-4057qib7	11040	10	so	so	RB
cord-005453-4057qib7	11040	11	new	new	JJ
cord-005453-4057qib7	11040	12	agents	agent	NNS
cord-005453-4057qib7	11040	13	trying	try	VBG
cord-005453-4057qib7	11040	14	to	to	TO
cord-005453-4057qib7	11040	15	reach	reach	VB
cord-005453-4057qib7	11040	16	best	good	JJS
cord-005453-4057qib7	11040	17	response	response	NN
cord-005453-4057qib7	11040	18	before	before	IN
cord-005453-4057qib7	11040	19	transplant	transplant	NN
cord-005453-4057qib7	11040	20	should	should	MD
cord-005453-4057qib7	11040	21	be	be	VB
cord-005453-4057qib7	11040	22	considered	consider	VBN
cord-005453-4057qib7	11040	23	.	.	.
cord-005453-4057qib7	11041	1	[	[	-LRB-
cord-005453-4057qib7	11041	2	[	[	-LRB-
cord-005453-4057qib7	11041	3	P488	P488	NNP
cord-005453-4057qib7	11041	4	Image	image	NN
cord-005453-4057qib7	11041	5	]	]	-RRB-
cord-005453-4057qib7	11041	6	1	1	CD
cord-005453-4057qib7	11041	7	.	.	.
cord-005453-4057qib7	11041	8	 	 	_SP
cord-005453-4057qib7	11042	1	Eva	Eva	NNP
cord-005453-4057qib7	11042	2	Konirova	Konirova	NNP
cord-005453-4057qib7	11042	3	1	1	CD
cord-005453-4057qib7	11042	4	,	,	,
cord-005453-4057qib7	11042	5	Antonin	Antonin	NNP
cord-005453-4057qib7	11042	6	Vitek	Vitek	NNP
cord-005453-4057qib7	11042	7	2	2	CD
cord-005453-4057qib7	11042	8	,	,	,
cord-005453-4057qib7	11042	9	Marta	Marta	NNP
cord-005453-4057qib7	11042	10	Krejci	Krejci	NNP
cord-005453-4057qib7	11042	11	3	3	CD
cord-005453-4057qib7	11042	12	,	,	,
cord-005453-4057qib7	11042	13	Edgar	Edgar	NNP
cord-005453-4057qib7	11042	14	Faber	Faber	NNP
cord-005453-4057qib7	11042	15	4	4	CD
cord-005453-4057qib7	11042	16	,	,	,
cord-005453-4057qib7	11042	17	Katerina	Katerina	NNP
cord-005453-4057qib7	11042	18	Steinerova	Steinerova	NNP
cord-005453-4057qib7	11042	19	5	5	CD
cord-005453-4057qib7	11042	20	,	,	,
cord-005453-4057qib7	11042	21	David	David	NNP
cord-005453-4057qib7	11042	22	Belada	Belada	NNP
cord-005453-4057qib7	11042	23	6	6	CD
cord-005453-4057qib7	11042	24	,	,	,
cord-005453-4057qib7	11042	25	Jan	Jan	NNP
cord-005453-4057qib7	11042	26	Novak	Novak	NNP
cord-005453-4057qib7	11042	27	7	7	CD
cord-005453-4057qib7	11042	28	,	,	,
cord-005453-4057qib7	11042	29	Juraj	Juraj	NNP
cord-005453-4057qib7	11042	30	Duras	Duras	NNP
cord-005453-4057qib7	11042	31	8	8	CD
cord-005453-4057qib7	11042	32	,	,	,
cord-005453-4057qib7	11042	33	Petr	Petr	NNP
cord-005453-4057qib7	11042	34	Sedlacek	Sedlacek	NNP
cord-005453-4057qib7	11042	35	9	9	CD
cord-005453-4057qib7	11042	36	,	,	,
cord-005453-4057qib7	11042	37	Veronika	Veronika	NNP
cord-005453-4057qib7	11042	38	Valkova	Valkova	NNP
cord-005453-4057qib7	11042	39	2	2	CD
cord-005453-4057qib7	11042	40	,	,	,
cord-005453-4057qib7	11042	41	Andrea	Andrea	NNP
cord-005453-4057qib7	11042	42	Janikova	Janikova	NNP
cord-005453-4057qib7	11042	43	3	3	CD
cord-005453-4057qib7	11042	44	,	,	,
cord-005453-4057qib7	11042	45	Ludek	Ludek	NNP
cord-005453-4057qib7	11042	46	Raida	Raida	NNP
cord-005453-4057qib7	11042	47	4	4	CD
cord-005453-4057qib7	11042	48	,	,	,
cord-005453-4057qib7	11042	49	Pavel	Pavel	NNP
cord-005453-4057qib7	11042	50	Jindra	Jindra	NNP
cord-005453-4057qib7	11042	51	5	5	CD
cord-005453-4057qib7	11042	52	,	,	,
cord-005453-4057qib7	11042	53	Pavel	Pavel	NNP
cord-005453-4057qib7	11042	54	Zak	Zak	NNP
cord-005453-4057qib7	11042	55	6	6	CD
cord-005453-4057qib7	11042	56	,	,	,
cord-005453-4057qib7	11042	57	Tomas	Tomas	NNP
cord-005453-4057qib7	11042	58	Kozak	Kozak	NNP
cord-005453-4057qib7	11042	59	10	10	CD
cord-005453-4057qib7	11042	60	,	,	,
cord-005453-4057qib7	11042	61	Marie	Marie	NNP
cord-005453-4057qib7	11042	62	Trnkova	Trnkova	NNP
cord-005453-4057qib7	11042	63	1	1	CD
cord-005453-4057qib7	11042	64	,	,	,
cord-005453-4057qib7	11042	65	Michal	Michal	NNP
cord-005453-4057qib7	11042	66	Karas	Karas	NNP
cord-005453-4057qib7	11042	67	5	5	CD
cord-005453-4057qib7	11042	68	,	,	,
cord-005453-4057qib7	11042	69	Marek	Marek	NNP
cord-005453-4057qib7	11042	70	Trneny	Trneny	NNP
cord-005453-4057qib7	11042	71	1	1	CD
cord-005453-4057qib7	11042	72	management	management	NN
cord-005453-4057qib7	11042	73	.	.	.
cord-005453-4057qib7	11043	1	However	however	RB
cord-005453-4057qib7	11043	2	,	,	,
cord-005453-4057qib7	11043	3	differences	difference	NNS
cord-005453-4057qib7	11043	4	in	in	IN
cord-005453-4057qib7	11043	5	patient	patient	NN
cord-005453-4057qib7	11043	6	's	's	POS
cord-005453-4057qib7	11043	7	characteristics	characteristic	NNS
cord-005453-4057qib7	11043	8	as	as	RB
cord-005453-4057qib7	11043	9	well	well	RB
cord-005453-4057qib7	11043	10	as	as	IN
cord-005453-4057qib7	11043	11	frequency	frequency	NN
cord-005453-4057qib7	11043	12	of	of	IN
cord-005453-4057qib7	11043	13	HSCT	HSCT	NNP
cord-005453-4057qib7	11043	14	indication	indication	NN
cord-005453-4057qib7	11043	15	in	in	IN
cord-005453-4057qib7	11043	16	different	different	JJ
cord-005453-4057qib7	11043	17	lymphoma	lymphoma	NN
cord-005453-4057qib7	11043	18	subtypes	subtype	NNS
cord-005453-4057qib7	11043	19	have	have	VBP
cord-005453-4057qib7	11043	20	been	be	VBN
cord-005453-4057qib7	11043	21	observed	observe	VBN
cord-005453-4057qib7	11043	22	in	in	IN
cord-005453-4057qib7	11043	23	the	the	DT
cord-005453-4057qib7	11043	24	last	last	JJ
cord-005453-4057qib7	11043	25	decade	decade	NN
cord-005453-4057qib7	11043	26	.	.	.
cord-005453-4057qib7	11044	1	The	the	DT
cord-005453-4057qib7	11044	2	aim	aim	NN
cord-005453-4057qib7	11044	3	of	of	IN
cord-005453-4057qib7	11044	4	this	this	DT
cord-005453-4057qib7	11044	5	study	study	NN
cord-005453-4057qib7	11044	6	was	be	VBD
cord-005453-4057qib7	11044	7	retrospective	retrospective	JJ
cord-005453-4057qib7	11044	8	analysis	analysis	NN
cord-005453-4057qib7	11044	9	of	of	IN
cord-005453-4057qib7	11044	10	HSCT	HSCT	NNP
cord-005453-4057qib7	11044	11	for	for	IN
cord-005453-4057qib7	11044	12	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11044	13	in	in	IN
cord-005453-4057qib7	11044	14	Czech	Czech	NNP
cord-005453-4057qib7	11044	15	Republic	Republic	NNP
cord-005453-4057qib7	11044	16	.	.	.
cord-005453-4057qib7	11045	1	Methods	method	NNS
cord-005453-4057qib7	11045	2	:	:	:
cord-005453-4057qib7	11046	1	Data	datum	NNS
cord-005453-4057qib7	11046	2	of	of	IN
cord-005453-4057qib7	11046	3	adult	adult	NN
cord-005453-4057qib7	11046	4	patients	patient	NNS
cord-005453-4057qib7	11046	5	transplanted	transplant	VBN
cord-005453-4057qib7	11046	6	between	between	IN
cord-005453-4057qib7	11046	7	years	year	NNS
cord-005453-4057qib7	11046	8	1993	1993	CD
cord-005453-4057qib7	11046	9	-	-	SYM
cord-005453-4057qib7	11046	10	2016	2016	CD
cord-005453-4057qib7	11046	11	were	be	VBD
cord-005453-4057qib7	11046	12	retrospectively	retrospectively	RB
cord-005453-4057qib7	11046	13	analyzed	analyze	VBN
cord-005453-4057qib7	11046	14	using	use	VBG
cord-005453-4057qib7	11046	15	EBMT	EBMT	NNP
cord-005453-4057qib7	11046	16	database	database	NN
cord-005453-4057qib7	11046	17	.	.	.
cord-005453-4057qib7	11047	1	Results	result	NNS
cord-005453-4057qib7	11047	2	:	:	:
cord-005453-4057qib7	11048	1	Between	between	IN
cord-005453-4057qib7	11048	2	1993	1993	CD
cord-005453-4057qib7	11048	3	and	and	CC
cord-005453-4057qib7	11048	4	2016	2016	CD
cord-005453-4057qib7	11048	5	,	,	,
cord-005453-4057qib7	11048	6	2816	2816	CD
cord-005453-4057qib7	11048	7	autologous	autologous	JJ
cord-005453-4057qib7	11048	8	HSCT	HSCT	NNP
cord-005453-4057qib7	11048	9	(	(	-LRB-
cord-005453-4057qib7	11048	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11048	11	)	)	-RRB-
cord-005453-4057qib7	11048	12	were	be	VBD
cord-005453-4057qib7	11048	13	performed	perform	VBN
cord-005453-4057qib7	11048	14	in	in	IN
cord-005453-4057qib7	11048	15	2651	2651	CD
cord-005453-4057qib7	11048	16	patients	patient	NNS
cord-005453-4057qib7	11048	17	(	(	-LRB-
cord-005453-4057qib7	11048	18	1511	1511	CD
cord-005453-4057qib7	11048	19	men	man	NNS
cord-005453-4057qib7	11048	20	,	,	,
cord-005453-4057qib7	11048	21	57	57	CD
cord-005453-4057qib7	11048	22	%	%	NN
cord-005453-4057qib7	11048	23	)	)	-RRB-
cord-005453-4057qib7	11048	24	with	with	IN
cord-005453-4057qib7	11048	25	different	different	JJ
cord-005453-4057qib7	11048	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	11048	27	subtypes	subtype	NNS
cord-005453-4057qib7	11048	28	.	.	.
cord-005453-4057qib7	11049	1	The	the	DT
cord-005453-4057qib7	11049	2	median	median	JJ
cord-005453-4057qib7	11049	3	age	age	NN
cord-005453-4057qib7	11049	4	was	be	VBD
cord-005453-4057qib7	11049	5	49	49	CD
cord-005453-4057qib7	11049	6	years	year	NNS
cord-005453-4057qib7	11050	1	(	(	-LRB-
cord-005453-4057qib7	11050	2	range	range	NNP
cord-005453-4057qib7	11050	3	18	18	CD
cord-005453-4057qib7	11050	4	-	-	SYM
cord-005453-4057qib7	11050	5	75	75	CD
cord-005453-4057qib7	11050	6	)	)	-RRB-
cord-005453-4057qib7	11050	7	.	.	.
cord-005453-4057qib7	11051	1	Out	out	IN
cord-005453-4057qib7	11051	2	of	of	IN
cord-005453-4057qib7	11051	3	these	these	DT
cord-005453-4057qib7	11051	4	,	,	,
cord-005453-4057qib7	11051	5	2078	2078	CD
cord-005453-4057qib7	11051	6	(	(	-LRB-
cord-005453-4057qib7	11051	7	78	78	CD
cord-005453-4057qib7	11051	8	%	%	NN
cord-005453-4057qib7	11051	9	)	)	-RRB-
cord-005453-4057qib7	11051	10	were	be	VBD
cord-005453-4057qib7	11051	11	patients	patient	NNS
cord-005453-4057qib7	11051	12	with	with	IN
cord-005453-4057qib7	11051	13	non	non	JJ
cord-005453-4057qib7	11051	14	-	-	JJ
cord-005453-4057qib7	11051	15	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	11051	16	lymphoma	lymphoma	NN
cord-005453-4057qib7	11051	17	(	(	-LRB-
cord-005453-4057qib7	11051	18	NHL	NHL	NNP
cord-005453-4057qib7	11051	19	)	)	-RRB-
cord-005453-4057qib7	11051	20	,	,	,
cord-005453-4057qib7	11051	21	569	569	CD
cord-005453-4057qib7	11051	22	(	(	-LRB-
cord-005453-4057qib7	11051	23	21	21	CD
cord-005453-4057qib7	11051	24	%	%	NN
cord-005453-4057qib7	11051	25	)	)	-RRB-
cord-005453-4057qib7	11051	26	with	with	IN
cord-005453-4057qib7	11051	27	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11051	28	lymphoma	lymphoma	NN
cord-005453-4057qib7	11051	29	(	(	-LRB-
cord-005453-4057qib7	11051	30	HL	HL	NNP
cord-005453-4057qib7	11051	31	)	)	-RRB-
cord-005453-4057qib7	11051	32	.	.	.
cord-005453-4057qib7	11052	1	The	the	DT
cord-005453-4057qib7	11052	2	NHL	NHL	NNP
cord-005453-4057qib7	11052	3	group	group	NN
cord-005453-4057qib7	11052	4	comprised	comprise	VBN
cord-005453-4057qib7	11052	5	of	of	IN
cord-005453-4057qib7	11052	6	diffuse	diffuse	JJ
cord-005453-4057qib7	11052	7	large	large	JJ
cord-005453-4057qib7	11052	8	B	b	NN
cord-005453-4057qib7	11052	9	-	-	HYPH
cord-005453-4057qib7	11052	10	cell	cell	NN
cord-005453-4057qib7	11052	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11052	12	(	(	-LRB-
cord-005453-4057qib7	11052	13	DLBCL	dlbcl	RB
cord-005453-4057qib7	11052	14	,	,	,
cord-005453-4057qib7	11052	15	36	36	CD
cord-005453-4057qib7	11052	16	%	%	NN
cord-005453-4057qib7	11052	17	)	)	-RRB-
cord-005453-4057qib7	11052	18	,	,	,
cord-005453-4057qib7	11052	19	follicular	follicular	JJ
cord-005453-4057qib7	11052	20	lymphoma	lymphoma	NN
cord-005453-4057qib7	11052	21	(	(	-LRB-
cord-005453-4057qib7	11052	22	FL	FL	NNP
cord-005453-4057qib7	11052	23	,	,	,
cord-005453-4057qib7	11052	24	18	18	CD
cord-005453-4057qib7	11052	25	%	%	NN
cord-005453-4057qib7	11052	26	)	)	-RRB-
cord-005453-4057qib7	11052	27	,	,	,
cord-005453-4057qib7	11052	28	mantle	mantle	NN
cord-005453-4057qib7	11052	29	cell	cell	NN
cord-005453-4057qib7	11052	30	lymphoma	lymphoma	NN
cord-005453-4057qib7	11052	31	(	(	-LRB-
cord-005453-4057qib7	11052	32	MCL	MCL	NNP
cord-005453-4057qib7	11052	33	,	,	,
cord-005453-4057qib7	11052	34	16	16	CD
cord-005453-4057qib7	11052	35	%	%	NN
cord-005453-4057qib7	11052	36	)	)	-RRB-
cord-005453-4057qib7	11052	37	and	and	CC
cord-005453-4057qib7	11052	38	T	T	NNP
cord-005453-4057qib7	11052	39	-	-	HYPH
cord-005453-4057qib7	11052	40	NHL	NHL	NNP
cord-005453-4057qib7	11052	41	(	(	-LRB-
cord-005453-4057qib7	11052	42	9	9	CD
cord-005453-4057qib7	11052	43	%	%	NN
cord-005453-4057qib7	11052	44	)	)	-RRB-
cord-005453-4057qib7	11052	45	.	.	.
cord-005453-4057qib7	11053	1	The	the	DT
cord-005453-4057qib7	11053	2	frequency	frequency	NN
cord-005453-4057qib7	11053	3	of	of	IN
cord-005453-4057qib7	11053	4	ASCT	ASCT	NNP
cord-005453-4057qib7	11053	5	in	in	IN
cord-005453-4057qib7	11053	6	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11053	7	increased	increase	VBD
cord-005453-4057qib7	11053	8	from	from	IN
cord-005453-4057qib7	11053	9	1993	1993	CD
cord-005453-4057qib7	11053	10	to	to	IN
cord-005453-4057qib7	11053	11	2000	2000	CD
cord-005453-4057qib7	11053	12	and	and	CC
cord-005453-4057qib7	11053	13	has	have	VBZ
cord-005453-4057qib7	11053	14	been	be	VBN
cord-005453-4057qib7	11053	15	constant	constant	JJ
cord-005453-4057qib7	11053	16	since	since	IN
cord-005453-4057qib7	11053	17	2000	2000	CD
cord-005453-4057qib7	11053	18	(	(	-LRB-
cord-005453-4057qib7	11053	19	120	120	CD
cord-005453-4057qib7	11053	20	-	-	SYM
cord-005453-4057qib7	11053	21	130	130	CD
cord-005453-4057qib7	11053	22	transplants	transplant	NNS
cord-005453-4057qib7	11053	23	per	per	IN
cord-005453-4057qib7	11053	24	year	year	NN
cord-005453-4057qib7	11053	25	)	)	-RRB-
cord-005453-4057qib7	11053	26	.	.	.
cord-005453-4057qib7	11054	1	Differences	difference	NNS
cord-005453-4057qib7	11054	2	in	in	IN
cord-005453-4057qib7	11054	3	frequency	frequency	NN
cord-005453-4057qib7	11054	4	of	of	IN
cord-005453-4057qib7	11054	5	ASCT	ASCT	NNP
cord-005453-4057qib7	11054	6	were	be	VBD
cord-005453-4057qib7	11054	7	observed	observe	VBN
cord-005453-4057qib7	11054	8	among	among	IN
cord-005453-4057qib7	11054	9	lymphoma	lymphoma	NN
cord-005453-4057qib7	11054	10	subtypes	subtype	NNS
cord-005453-4057qib7	11055	1	-decreasing	-decrease	VBG
cord-005453-4057qib7	11055	2	numbers	number	NNS
cord-005453-4057qib7	11055	3	of	of	IN
cord-005453-4057qib7	11055	4	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11055	5	and	and	CC
cord-005453-4057qib7	11055	6	FL	FL	NNP
cord-005453-4057qib7	11055	7	and	and	CC
cord-005453-4057qib7	11055	8	increasing	increase	VBG
cord-005453-4057qib7	11055	9	numbers	number	NNS
cord-005453-4057qib7	11055	10	of	of	IN
cord-005453-4057qib7	11055	11	T	T	NNP
cord-005453-4057qib7	11055	12	-	-	HYPH
cord-005453-4057qib7	11055	13	NHL	NHL	NNP
cord-005453-4057qib7	11055	14	and	and	CC
cord-005453-4057qib7	11055	15	MCL	MCL	NNP
cord-005453-4057qib7	11055	16	,	,	,
cord-005453-4057qib7	11055	17	with	with	IN
cord-005453-4057qib7	11055	18	ASCT	ASCT	NNP
cord-005453-4057qib7	11055	19	as	as	IN
cord-005453-4057qib7	11055	20	part	part	NN
cord-005453-4057qib7	11055	21	of	of	IN
cord-005453-4057qib7	11055	22	the	the	DT
cord-005453-4057qib7	11055	23	induction	induction	NN
cord-005453-4057qib7	11055	24	therapy	therapy	NN
cord-005453-4057qib7	11055	25	.	.	.
cord-005453-4057qib7	11056	1	Between	between	IN
cord-005453-4057qib7	11056	2	1996	1996	CD
cord-005453-4057qib7	11056	3	and	and	CC
cord-005453-4057qib7	11056	4	2016	2016	CD
cord-005453-4057qib7	11056	5	a	a	DT
cord-005453-4057qib7	11056	6	total	total	NN
cord-005453-4057qib7	11056	7	of	of	IN
cord-005453-4057qib7	11056	8	329	329	CD
cord-005453-4057qib7	11056	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	11056	10	HSCT	HSCT	NNP
cord-005453-4057qib7	11056	11	(	(	-LRB-
cord-005453-4057qib7	11056	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11056	13	)	)	-RRB-
cord-005453-4057qib7	11056	14	were	be	VBD
cord-005453-4057qib7	11056	15	performed	perform	VBN
cord-005453-4057qib7	11056	16	in	in	IN
cord-005453-4057qib7	11056	17	319	319	CD
cord-005453-4057qib7	11056	18	patients	patient	NNS
cord-005453-4057qib7	11056	19	(	(	-LRB-
cord-005453-4057qib7	11056	20	200	200	CD
cord-005453-4057qib7	11056	21	men	man	NNS
cord-005453-4057qib7	11056	22	,	,	,
cord-005453-4057qib7	11056	23	63	63	CD
cord-005453-4057qib7	11056	24	%	%	NN
cord-005453-4057qib7	11056	25	)	)	-RRB-
cord-005453-4057qib7	11056	26	.	.	.
cord-005453-4057qib7	11057	1	Median	median	JJ
cord-005453-4057qib7	11057	2	age	age	NN
cord-005453-4057qib7	11057	3	was	be	VBD
cord-005453-4057qib7	11057	4	46	46	CD
cord-005453-4057qib7	11057	5	years	year	NNS
cord-005453-4057qib7	11058	1	(	(	-LRB-
cord-005453-4057qib7	11058	2	range	range	NNP
cord-005453-4057qib7	11058	3	19	19	CD
cord-005453-4057qib7	11058	4	-	-	SYM
cord-005453-4057qib7	11058	5	66	66	CD
cord-005453-4057qib7	11058	6	)	)	-RRB-
cord-005453-4057qib7	11058	7	.	.	.
cord-005453-4057qib7	11059	1	Out	out	IN
cord-005453-4057qib7	11059	2	of	of	IN
cord-005453-4057qib7	11059	3	these	these	DT
cord-005453-4057qib7	11059	4	257	257	CD
cord-005453-4057qib7	11059	5	(	(	-LRB-
cord-005453-4057qib7	11059	6	81	81	CD
cord-005453-4057qib7	11059	7	%	%	NN
cord-005453-4057qib7	11059	8	)	)	-RRB-
cord-005453-4057qib7	11059	9	were	be	VBD
cord-005453-4057qib7	11059	10	patients	patient	NNS
cord-005453-4057qib7	11059	11	with	with	IN
cord-005453-4057qib7	11059	12	NHL	NHL	NNP
cord-005453-4057qib7	11059	13	,	,	,
cord-005453-4057qib7	11059	14	61	61	CD
cord-005453-4057qib7	11059	15	(	(	-LRB-
cord-005453-4057qib7	11059	16	18	18	CD
cord-005453-4057qib7	11059	17	%	%	NN
cord-005453-4057qib7	11059	18	)	)	-RRB-
cord-005453-4057qib7	11059	19	HL	HL	NNP
cord-005453-4057qib7	11059	20	.	.	.
cord-005453-4057qib7	11060	1	The	the	DT
cord-005453-4057qib7	11060	2	most	most	RBS
cord-005453-4057qib7	11060	3	common	common	JJ
cord-005453-4057qib7	11060	4	NHL	NHL	NNP
cord-005453-4057qib7	11060	5	subtypes	subtype	NNS
cord-005453-4057qib7	11060	6	were	be	VBD
cord-005453-4057qib7	11060	7	FL	FL	NNP
cord-005453-4057qib7	11060	8	(	(	-LRB-
cord-005453-4057qib7	11060	9	27	27	CD
cord-005453-4057qib7	11060	10	%	%	NN
cord-005453-4057qib7	11060	11	)	)	-RRB-
cord-005453-4057qib7	11060	12	,	,	,
cord-005453-4057qib7	11060	13	MCL	MCL	NNP
cord-005453-4057qib7	11060	14	(	(	-LRB-
cord-005453-4057qib7	11060	15	22	22	CD
cord-005453-4057qib7	11060	16	%	%	NN
cord-005453-4057qib7	11060	17	)	)	-RRB-
cord-005453-4057qib7	11060	18	,	,	,
cord-005453-4057qib7	11060	19	T	T	NNP
cord-005453-4057qib7	11060	20	-	-	HYPH
cord-005453-4057qib7	11060	21	NHL	NHL	NNP
cord-005453-4057qib7	11060	22	(	(	-LRB-
cord-005453-4057qib7	11060	23	22	22	CD
cord-005453-4057qib7	11060	24	%	%	NN
cord-005453-4057qib7	11060	25	)	)	-RRB-
cord-005453-4057qib7	11060	26	and	and	CC
cord-005453-4057qib7	11060	27	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11060	28	(	(	-LRB-
cord-005453-4057qib7	11060	29	16	16	CD
cord-005453-4057qib7	11060	30	%	%	NN
cord-005453-4057qib7	11060	31	)	)	-RRB-
cord-005453-4057qib7	11060	32	.	.	.
cord-005453-4057qib7	11061	1	In	in	IN
cord-005453-4057qib7	11061	2	the	the	DT
cord-005453-4057qib7	11061	3	last	last	JJ
cord-005453-4057qib7	11061	4	10	10	CD
cord-005453-4057qib7	11061	5	years	year	NNS
cord-005453-4057qib7	11061	6	the	the	DT
cord-005453-4057qib7	11061	7	number	number	NN
cord-005453-4057qib7	11061	8	of	of	IN
cord-005453-4057qib7	11061	9	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11061	10	for	for	IN
cord-005453-4057qib7	11061	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11061	12	is	be	VBZ
cord-005453-4057qib7	11061	13	fluctuating	fluctuate	VBG
cord-005453-4057qib7	11061	14	around	around	IN
cord-005453-4057qib7	11061	15	20	20	CD
cord-005453-4057qib7	11061	16	per	per	IN
cord-005453-4057qib7	11061	17	year	year	NN
cord-005453-4057qib7	11061	18	.	.	.
cord-005453-4057qib7	11062	1	The	the	DT
cord-005453-4057qib7	11062	2	median	median	JJ
cord-005453-4057qib7	11062	3	age	age	NN
cord-005453-4057qib7	11062	4	at	at	IN
cord-005453-4057qib7	11062	5	ASCT	ASCT	NNP
cord-005453-4057qib7	11062	6	was	be	VBD
cord-005453-4057qib7	11062	7	significantly	significantly	RB
cord-005453-4057qib7	11062	8	higher	high	JJR
cord-005453-4057qib7	11062	9	in	in	IN
cord-005453-4057qib7	11062	10	the	the	DT
cord-005453-4057qib7	11062	11	years	year	NNS
cord-005453-4057qib7	11062	12	2010	2010	CD
cord-005453-4057qib7	11062	13	-	-	SYM
cord-005453-4057qib7	11062	14	2016	2016	CD
cord-005453-4057qib7	11062	15	vs	vs	IN
cord-005453-4057qib7	11062	16	1993	1993	CD
cord-005453-4057qib7	11062	17	-	-	SYM
cord-005453-4057qib7	11062	18	2000	2000	CD
cord-005453-4057qib7	11062	19	[	[	-LRB-
cord-005453-4057qib7	11062	20	54.5	54.5	CD
cord-005453-4057qib7	11062	21	(	(	-LRB-
cord-005453-4057qib7	11062	22	18.1	18.1	CD
cord-005453-4057qib7	11062	23	-	-	HYPH
cord-005453-4057qib7	11062	24	74.8	74.8	CD
cord-005453-4057qib7	11062	25	)	)	-RRB-
cord-005453-4057qib7	11062	26	vs.	vs.	FW
cord-005453-4057qib7	11062	27	40.9	40.9	CD
cord-005453-4057qib7	11062	28	(	(	-LRB-
cord-005453-4057qib7	11062	29	18.6	18.6	CD
cord-005453-4057qib7	11062	30	-	-	HYPH
cord-005453-4057qib7	11062	31	72.5	72.5	NNP
cord-005453-4057qib7	11062	32	)	)	-RRB-
cord-005453-4057qib7	11062	33	,	,	,
cord-005453-4057qib7	11062	34	p	p	NN
cord-005453-4057qib7	11062	35	<	<	XX
cord-005453-4057qib7	11062	36	0.0001	0.0001	CD
cord-005453-4057qib7	11062	37	,	,	,
cord-005453-4057qib7	11062	38	fig	fig	NN
cord-005453-4057qib7	11062	39	1	1	CD
cord-005453-4057qib7	11062	40	]	]	-RRB-
cord-005453-4057qib7	11062	41	,	,	,
cord-005453-4057qib7	11062	42	while	while	IN
cord-005453-4057qib7	11062	43	the	the	DT
cord-005453-4057qib7	11062	44	increase	increase	NN
cord-005453-4057qib7	11062	45	at	at	IN
cord-005453-4057qib7	11062	46	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11062	47	[	[	-LRB-
cord-005453-4057qib7	11062	48	46.5	46.5	CD
cord-005453-4057qib7	11062	49	(	(	-LRB-
cord-005453-4057qib7	11062	50	21.3	21.3	CD
cord-005453-4057qib7	11062	51	-	-	HYPH
cord-005453-4057qib7	11062	52	65.5	65.5	CD
cord-005453-4057qib7	11062	53	)	)	-RRB-
cord-005453-4057qib7	11062	54	vs	vs	IN
cord-005453-4057qib7	11062	55	41.6(20.3	41.6(20.3	NNP
cord-005453-4057qib7	11062	56	-	-	HYPH
cord-005453-4057qib7	11062	57	64.5	64.5	CD
cord-005453-4057qib7	11062	58	)	)	-RRB-
cord-005453-4057qib7	11062	59	]	]	-RRB-
cord-005453-4057qib7	11062	60	did	do	VBD
cord-005453-4057qib7	11062	61	not	not	RB
cord-005453-4057qib7	11062	62	reach	reach	VB
cord-005453-4057qib7	11062	63	statistical	statistical	JJ
cord-005453-4057qib7	11062	64	significance	significance	NN
cord-005453-4057qib7	11062	65	(	(	-LRB-
cord-005453-4057qib7	11062	66	p=0.07	p=0.07	NNP
cord-005453-4057qib7	11062	67	)	)	-RRB-
cord-005453-4057qib7	11062	68	.	.	.
cord-005453-4057qib7	11063	1	With	with	IN
cord-005453-4057qib7	11063	2	median	median	NN
cord-005453-4057qib7	11063	3	follow	follow	VB
cord-005453-4057qib7	11063	4	up	up	RP
cord-005453-4057qib7	11063	5	for	for	IN
cord-005453-4057qib7	11063	6	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11063	7	,	,	,
cord-005453-4057qib7	11063	8	5	5	CD
cord-005453-4057qib7	11063	9	y	y	NN
cord-005453-4057qib7	11063	10	probability	probability	NN
cord-005453-4057qib7	11063	11	OS	OS	NNP
cord-005453-4057qib7	11063	12	for	for	IN
cord-005453-4057qib7	11063	13	patient	patient	NN
cord-005453-4057qib7	11063	14	transplanted	transplant	VBN
cord-005453-4057qib7	11063	15	in	in	IN
cord-005453-4057qib7	11063	16	the	the	DT
cord-005453-4057qib7	11063	17	later	later	JJ
cord-005453-4057qib7	11063	18	period	period	NN
cord-005453-4057qib7	11063	19	2010	2010	CD
cord-005453-4057qib7	11063	20	-	-	SYM
cord-005453-4057qib7	11063	21	2016	2016	CD
cord-005453-4057qib7	11063	22	was	be	VBD
cord-005453-4057qib7	11063	23	in	in	IN
cord-005453-4057qib7	11063	24	relapsed	relapse	VBN
cord-005453-4057qib7	11063	25	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11063	26	25.7	25.7	CD
cord-005453-4057qib7	11063	27	%	%	NN
cord-005453-4057qib7	11063	28	,	,	,
cord-005453-4057qib7	11063	29	in	in	IN
cord-005453-4057qib7	11063	30	FL	FL	NNP
cord-005453-4057qib7	11063	31	77.4	77.4	CD
cord-005453-4057qib7	11063	32	%	%	NN
cord-005453-4057qib7	11063	33	,	,	,
cord-005453-4057qib7	11063	34	in	in	IN
cord-005453-4057qib7	11063	35	HL	HL	NNP
cord-005453-4057qib7	11063	36	51.0	51.0	CD
cord-005453-4057qib7	11063	37	%	%	NN
cord-005453-4057qib7	11063	38	and	and	CC
cord-005453-4057qib7	11063	39	in	in	IN
cord-005453-4057qib7	11063	40	MCL	MCL	NNP
cord-005453-4057qib7	11063	41	45.7	45.7	CD
cord-005453-4057qib7	11063	42	%	%	NN
cord-005453-4057qib7	11063	43	,	,	,
cord-005453-4057qib7	11063	44	5	5	CD
cord-005453-4057qib7	11063	45	y	y	NN
cord-005453-4057qib7	11063	46	OS	os	NN
cord-005453-4057qib7	11063	47	for	for	IN
cord-005453-4057qib7	11063	48	ASCT	ASCT	NNP
cord-005453-4057qib7	11063	49	as	as	IN
cord-005453-4057qib7	11063	50	part	part	NN
cord-005453-4057qib7	11063	51	of	of	IN
cord-005453-4057qib7	11063	52	first	first	JJ
cord-005453-4057qib7	11063	53	line	line	NN
cord-005453-4057qib7	11063	54	therapy	therapy	NN
cord-005453-4057qib7	11063	55	in	in	IN
cord-005453-4057qib7	11063	56	the	the	DT
cord-005453-4057qib7	11063	57	same	same	JJ
cord-005453-4057qib7	11063	58	period	period	NN
cord-005453-4057qib7	11064	1	was	be	VBD
cord-005453-4057qib7	11064	2	in	in	IN
cord-005453-4057qib7	11064	3	MCL	MCL	NNP
cord-005453-4057qib7	11064	4	78.1	78.1	CD
cord-005453-4057qib7	11064	5	%	%	NN
cord-005453-4057qib7	11064	6	and	and	CC
cord-005453-4057qib7	11064	7	in	in	IN
cord-005453-4057qib7	11064	8	T	T	NNP
cord-005453-4057qib7	11064	9	-	-	HYPH
cord-005453-4057qib7	11064	10	NHL	NHL	NNP
cord-005453-4057qib7	11064	11	48.2	48.2	CD
cord-005453-4057qib7	11064	12	%	%	NN
cord-005453-4057qib7	11064	13	.	.	.
cord-005453-4057qib7	11065	1	OS	OS	NNP
cord-005453-4057qib7	11065	2	was	be	VBD
cord-005453-4057qib7	11065	3	significantly	significantly	RB
cord-005453-4057qib7	11065	4	better	well	JJR
cord-005453-4057qib7	11065	5	in	in	IN
cord-005453-4057qib7	11065	6	all	all	DT
cord-005453-4057qib7	11065	7	patients	patient	NNS
cord-005453-4057qib7	11065	8	who	who	WP
cord-005453-4057qib7	11065	9	underwent	undergo	VBD
cord-005453-4057qib7	11065	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11065	11	in	in	IN
cord-005453-4057qib7	11065	12	the	the	DT
cord-005453-4057qib7	11065	13	years	year	NNS
cord-005453-4057qib7	11065	14	2010	2010	CD
cord-005453-4057qib7	11065	15	-	-	SYM
cord-005453-4057qib7	11065	16	2016	2016	CD
cord-005453-4057qib7	11065	17	vs	vs	IN
cord-005453-4057qib7	11065	18	1993	1993	CD
cord-005453-4057qib7	11065	19	-	-	SYM
cord-005453-4057qib7	11065	20	2000	2000	CD
cord-005453-4057qib7	11065	21	(	(	-LRB-
cord-005453-4057qib7	11065	22	70.%	70.%	CD
cord-005453-4057qib7	11065	23	vs.	vs.	IN
cord-005453-4057qib7	11065	24	57	57	CD
cord-005453-4057qib7	11065	25	.5	.5	CD
cord-005453-4057qib7	11065	26	%	%	NN
cord-005453-4057qib7	11065	27	,	,	,
cord-005453-4057qib7	11065	28	p	p	NN
cord-005453-4057qib7	11065	29	<	<	XX
cord-005453-4057qib7	11065	30	0.0001	0.0001	CD
cord-005453-4057qib7	11065	31	)	)	-RRB-
cord-005453-4057qib7	11065	32	and	and	CC
cord-005453-4057qib7	11065	33	there	there	EX
cord-005453-4057qib7	11065	34	was	be	VBD
cord-005453-4057qib7	11065	35	a	a	DT
cord-005453-4057qib7	11065	36	trend	trend	NN
cord-005453-4057qib7	11065	37	towards	towards	IN
cord-005453-4057qib7	11065	38	better	well	JJR
cord-005453-4057qib7	11065	39	OS	os	NN
cord-005453-4057qib7	11065	40	in	in	IN
cord-005453-4057qib7	11065	41	patients	patient	NNS
cord-005453-4057qib7	11065	42	after	after	IN
cord-005453-4057qib7	11065	43	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11065	44	(	(	-LRB-
cord-005453-4057qib7	11065	45	with	with	IN
cord-005453-4057qib7	11065	46	44.7	44.7	CD
cord-005453-4057qib7	11065	47	%	%	NN
cord-005453-4057qib7	11065	48	vs	vs	IN
cord-005453-4057qib7	11065	49	23.5	23.5	CD
cord-005453-4057qib7	11065	50	%	%	NN
cord-005453-4057qib7	11065	51	,	,	,
cord-005453-4057qib7	11065	52	p=0.1084	p=0.1084	''
cord-005453-4057qib7	11065	53	)	)	-RRB-
cord-005453-4057qib7	11066	1	(	(	-LRB-
cord-005453-4057qib7	11066	2	fig	fig	NNP
cord-005453-4057qib7	11066	3	2	2	CD
cord-005453-4057qib7	11066	4	)	)	-RRB-
cord-005453-4057qib7	11066	5	.	.	.
cord-005453-4057qib7	11067	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11067	2	:	:	:
cord-005453-4057qib7	11068	1	HSCT	HSCT	NNP
cord-005453-4057qib7	11068	2	remains	remain	VBZ
cord-005453-4057qib7	11068	3	important	important	JJ
cord-005453-4057qib7	11068	4	treatment	treatment	NN
cord-005453-4057qib7	11068	5	modality	modality	NN
cord-005453-4057qib7	11068	6	for	for	IN
cord-005453-4057qib7	11068	7	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11068	8	in	in	IN
cord-005453-4057qib7	11068	9	the	the	DT
cord-005453-4057qib7	11068	10	era	era	NN
cord-005453-4057qib7	11068	11	of	of	IN
cord-005453-4057qib7	11068	12	targeted	targeted	JJ
cord-005453-4057qib7	11068	13	antibody	antibody	NN
cord-005453-4057qib7	11068	14	and	and	CC
cord-005453-4057qib7	11068	15	molecular	molecular	JJ
cord-005453-4057qib7	11068	16	therapy	therapy	NN
cord-005453-4057qib7	11068	17	and	and	CC
cord-005453-4057qib7	11068	18	we	-PRON-	PRP
cord-005453-4057qib7	11068	19	can	can	MD
cord-005453-4057qib7	11068	20	transplant	transplant	VB
cord-005453-4057qib7	11068	21	older	old	JJR
cord-005453-4057qib7	11068	22	patients	patient	NNS
cord-005453-4057qib7	11068	23	due	due	JJ
cord-005453-4057qib7	11068	24	to	to	IN
cord-005453-4057qib7	11068	25	better	well	JJR
cord-005453-4057qib7	11068	26	supportive	supportive	JJ
cord-005453-4057qib7	11068	27	treatment	treatment	NN
cord-005453-4057qib7	11068	28	.	.	.
cord-005453-4057qib7	11069	1	Acknowledgment	acknowledgment	NN
cord-005453-4057qib7	11069	2	:	:	:
cord-005453-4057qib7	11069	3	PROGRESS	PROGRESS	NNP
cord-005453-4057qib7	11069	4	Q28	Q28	NNP
cord-005453-4057qib7	11069	5	-	-	HYPH
cord-005453-4057qib7	11069	6	9	9	CD
cord-005453-4057qib7	11069	7	UK	UK	NNP
cord-005453-4057qib7	11069	8	from	from	IN
cord-005453-4057qib7	11069	9	the	the	DT
cord-005453-4057qib7	11069	10	Czech	Czech	NNP
cord-005453-4057qib7	11069	11	Ministry	Ministry	NNP
cord-005453-4057qib7	11069	12	of	of	IN
cord-005453-4057qib7	11069	13	Education	Education	NNP
cord-005453-4057qib7	11069	14	Youth	Youth	NNP
cord-005453-4057qib7	11069	15	and	and	CC
cord-005453-4057qib7	11069	16	Sports	Sports	NNPS
cord-005453-4057qib7	11069	17	Disclosure	Disclosure	NNP
cord-005453-4057qib7	11069	18	:	:	:
cord-005453-4057qib7	11069	19	Nothing	nothing	NN
cord-005453-4057qib7	11069	20	to	to	TO
cord-005453-4057qib7	11069	21	declare	declare	VB
cord-005453-4057qib7	11069	22	Background	background	NN
cord-005453-4057qib7	11069	23	:	:	:
cord-005453-4057qib7	11069	24	Disease	Disease	NNP
cord-005453-4057qib7	11069	25	chemosensitivity	chemosensitivity	NN
cord-005453-4057qib7	11069	26	to	to	TO
cord-005453-4057qib7	11069	27	salvage	salvage	VB
cord-005453-4057qib7	11069	28	treatment	treatment	NN
cord-005453-4057qib7	11069	29	has	have	VBZ
cord-005453-4057qib7	11069	30	been	be	VBN
cord-005453-4057qib7	11069	31	proven	prove	VBN
cord-005453-4057qib7	11069	32	to	to	TO
cord-005453-4057qib7	11069	33	be	be	VB
cord-005453-4057qib7	11069	34	a	a	DT
cord-005453-4057qib7	11069	35	major	major	JJ
cord-005453-4057qib7	11069	36	predictive	predictive	JJ
cord-005453-4057qib7	11069	37	factor	factor	NN
cord-005453-4057qib7	11069	38	for	for	IN
cord-005453-4057qib7	11069	39	a	a	DT
cord-005453-4057qib7	11069	40	favorable	favorable	JJ
cord-005453-4057qib7	11069	41	outcome	outcome	NN
cord-005453-4057qib7	11069	42	after	after	IN
cord-005453-4057qib7	11069	43	autologous	autologous	JJ
cord-005453-4057qib7	11069	44	stem	stem	NN
cord-005453-4057qib7	11069	45	cell	cell	NN
cord-005453-4057qib7	11069	46	transplantation	transplantation	NN
cord-005453-4057qib7	11069	47	(	(	-LRB-
cord-005453-4057qib7	11069	48	ASCT	ASCT	NNP
cord-005453-4057qib7	11069	49	)	)	-RRB-
cord-005453-4057qib7	11069	50	for	for	IN
cord-005453-4057qib7	11069	51	patients	patient	NNS
cord-005453-4057qib7	11069	52	with	with	IN
cord-005453-4057qib7	11069	53	refractory	refractory	JJ
cord-005453-4057qib7	11069	54	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11069	55	.	.	.
cord-005453-4057qib7	11070	1	Therefore	therefore	RB
cord-005453-4057qib7	11070	2	the	the	DT
cord-005453-4057qib7	11070	3	importance	importance	NN
cord-005453-4057qib7	11070	4	of	of	IN
cord-005453-4057qib7	11070	5	effective	effective	JJ
cord-005453-4057qib7	11070	6	and	and	CC
cord-005453-4057qib7	11070	7	safe	safe	JJ
cord-005453-4057qib7	11070	8	salvageregimens	salvageregimen	NNS
cord-005453-4057qib7	11070	9	is	be	VBZ
cord-005453-4057qib7	11070	10	indisputable	indisputable	JJ
cord-005453-4057qib7	11070	11	.	.	.
cord-005453-4057qib7	11071	1	Methods	method	NNS
cord-005453-4057qib7	11071	2	:	:	:
cord-005453-4057qib7	11072	1	We	-PRON-	PRP
cord-005453-4057qib7	11072	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	11072	3	compared	compare	VBD
cord-005453-4057qib7	11072	4	the	the	DT
cord-005453-4057qib7	11072	5	outcomes	outcome	NNS
cord-005453-4057qib7	11072	6	in	in	IN
cord-005453-4057qib7	11072	7	terms	term	NNS
cord-005453-4057qib7	11072	8	of	of	IN
cord-005453-4057qib7	11072	9	safety	safety	NN
cord-005453-4057qib7	11072	10	and	and	CC
cord-005453-4057qib7	11072	11	efficacy	efficacy	NN
cord-005453-4057qib7	11072	12	,	,	,
cord-005453-4057qib7	11072	13	in	in	IN
cord-005453-4057qib7	11072	14	67	67	CD
cord-005453-4057qib7	11072	15	(	(	-LRB-
cord-005453-4057qib7	11072	16	HL:36	HL:36	NNP
cord-005453-4057qib7	11072	17	,	,	,
cord-005453-4057qib7	11072	18	NHL:31	NHL:31	NNP
cord-005453-4057qib7	11072	19	)	)	-RRB-
cord-005453-4057qib7	11072	20	patients	patient	NNS
cord-005453-4057qib7	11072	21	,	,	,
cord-005453-4057qib7	11072	22	with	with	IN
cord-005453-4057qib7	11072	23	a	a	DT
cord-005453-4057qib7	11072	24	median	median	JJ
cord-005453-4057qib7	11072	25	age	age	NN
cord-005453-4057qib7	11072	26	of	of	IN
cord-005453-4057qib7	11072	27	34.5(16	34.5(16	CD
cord-005453-4057qib7	11072	28	-	-	SYM
cord-005453-4057qib7	11072	29	75	75	CD
cord-005453-4057qib7	11072	30	)	)	-RRB-
cord-005453-4057qib7	11072	31	years	year	NNS
cord-005453-4057qib7	11072	32	,	,	,
cord-005453-4057qib7	11072	33	who	who	WP
cord-005453-4057qib7	11072	34	received	receive	VBD
cord-005453-4057qib7	11072	35	as	as	IN
cord-005453-4057qib7	11072	36	1	1	CD
cord-005453-4057qib7	11072	37	st	st	NNP
cord-005453-4057qib7	11072	38	salvage	salvage	NN
cord-005453-4057qib7	11072	39	either	either	CC
cord-005453-4057qib7	11072	40	DICEP	DICEP	NNP
cord-005453-4057qib7	11073	1	[	[	-LRB-
cord-005453-4057qib7	11073	2	Cyclophoshamide	Cyclophoshamide	NNP
cord-005453-4057qib7	11073	3	(	(	-LRB-
cord-005453-4057qib7	11073	4	1750	1750	CD
cord-005453-4057qib7	11073	5	mg	mg	NNP
cord-005453-4057qib7	11073	6	/	/	SYM
cord-005453-4057qib7	11073	7	m	m	NNP
cord-005453-4057qib7	11073	8	2	2	CD
cord-005453-4057qib7	11073	9	)	)	-RRB-
cord-005453-4057qib7	11073	10	,	,	,
cord-005453-4057qib7	11073	11	Etoposide	Etoposide	NNP
cord-005453-4057qib7	11073	12	(	(	-LRB-
cord-005453-4057qib7	11073	13	350mg	350mg	NNP
cord-005453-4057qib7	11073	14	/	/	SYM
cord-005453-4057qib7	11073	15	m	m	NNP
cord-005453-4057qib7	11073	16	2	2	CD
cord-005453-4057qib7	11073	17	)	)	-RRB-
cord-005453-4057qib7	11073	18	,	,	.
cord-005453-4057qib7	11074	1	Cisplatin	cisplatin	NN
cord-005453-4057qib7	11074	2	(	(	-LRB-
cord-005453-4057qib7	11074	3	35	35	CD
cord-005453-4057qib7	11074	4	mg/	mg/	NN
cord-005453-4057qib7	11074	5	m	m	NNP
cord-005453-4057qib7	11074	6	2	2	CD
cord-005453-4057qib7	11074	7	)	)	-RRB-
cord-005453-4057qib7	11074	8	,	,	,
cord-005453-4057qib7	11074	9	days	day	NNS
cord-005453-4057qib7	11074	10	1	1	CD
cord-005453-4057qib7	11074	11	-	-	SYM
cord-005453-4057qib7	11074	12	3	3	CD
cord-005453-4057qib7	11074	13	,	,	,
cord-005453-4057qib7	11074	14	(	(	-LRB-
cord-005453-4057qib7	11074	15	n=23	n=23	NN
cord-005453-4057qib7	11074	16	)	)	-RRB-
cord-005453-4057qib7	11074	17	]	]	-RRB-
cord-005453-4057qib7	11074	18	or	or	CC
cord-005453-4057qib7	11074	19	the	the	DT
cord-005453-4057qib7	11074	20	widely	widely	RB
cord-005453-4057qib7	11074	21	used	use	VBN
cord-005453-4057qib7	11074	22	regimen	regimen	NN
cord-005453-4057qib7	11074	23	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11074	24	(	(	-LRB-
cord-005453-4057qib7	11074	25	n=44	n=44	NNP
cord-005453-4057qib7	11074	26	)	)	-RRB-
cord-005453-4057qib7	11074	27	.	.	.
cord-005453-4057qib7	11075	1	Rituximab	Rituximab	NNP
cord-005453-4057qib7	11075	2	was	be	VBD
cord-005453-4057qib7	11075	3	additionally	additionally	RB
cord-005453-4057qib7	11075	4	given	give	VBN
cord-005453-4057qib7	11075	5	to	to	IN
cord-005453-4057qib7	11075	6	all	all	DT
cord-005453-4057qib7	11075	7	CD-20	CD-20	NNP
cord-005453-4057qib7	11075	8	positive	positive	JJ
cord-005453-4057qib7	11075	9	lymphoma	lymphoma	NN
cord-005453-4057qib7	11075	10	patients	patient	NNS
cord-005453-4057qib7	11075	11	.	.	.
cord-005453-4057qib7	11076	1	The	the	DT
cord-005453-4057qib7	11076	2	statistical	statistical	JJ
cord-005453-4057qib7	11076	3	analysis	analysis	NN
cord-005453-4057qib7	11076	4	based	base	VBN
cord-005453-4057qib7	11076	5	on	on	IN
cord-005453-4057qib7	11076	6	the	the	DT
cord-005453-4057qib7	11076	7	independent	independent	JJ
cord-005453-4057qib7	11076	8	T	t	NN
cord-005453-4057qib7	11076	9	-	-	HYPH
cord-005453-4057qib7	11076	10	test	test	NN
cord-005453-4057qib7	11076	11	,	,	,
cord-005453-4057qib7	11076	12	Kaplan	Kaplan	NNP
cord-005453-4057qib7	11076	13	Meir	Meir	NNP
cord-005453-4057qib7	11076	14	method	method	NN
cord-005453-4057qib7	11076	15	and	and	CC
cord-005453-4057qib7	11076	16	logrank	logrank	NN
cord-005453-4057qib7	11076	17	test	test	NN
cord-005453-4057qib7	11076	18	.	.	.
cord-005453-4057qib7	11077	1	Results	result	NNS
cord-005453-4057qib7	11077	2	:	:	:
cord-005453-4057qib7	11078	1	The	the	DT
cord-005453-4057qib7	11078	2	reason	reason	NN
cord-005453-4057qib7	11078	3	for	for	IN
cord-005453-4057qib7	11078	4	salvage	salvage	NN
cord-005453-4057qib7	11078	5	treatment	treatment	NN
cord-005453-4057qib7	11078	6	was	be	VBD
cord-005453-4057qib7	11078	7	primary	primary	JJ
cord-005453-4057qib7	11078	8	induction	induction	NN
cord-005453-4057qib7	11078	9	failure	failure	NN
cord-005453-4057qib7	11078	10	(	(	-LRB-
cord-005453-4057qib7	11078	11	PIF	PIF	NNP
cord-005453-4057qib7	11078	12	,	,	,
cord-005453-4057qib7	11078	13	n=34	n=34	NNP
cord-005453-4057qib7	11078	14	)	)	-RRB-
cord-005453-4057qib7	11078	15	,	,	,
cord-005453-4057qib7	11078	16	early	early	JJ
cord-005453-4057qib7	11078	17	relapse	relapse	NN
cord-005453-4057qib7	11078	18	(	(	-LRB-
cord-005453-4057qib7	11078	19	<	<	NNP
cord-005453-4057qib7	11078	20	12	12	CD
cord-005453-4057qib7	11078	21	months	month	NNS
cord-005453-4057qib7	11078	22	post	post	NN
cord-005453-4057qib7	11078	23	induction	induction	NN
cord-005453-4057qib7	11078	24	-	-	HYPH
cord-005453-4057qib7	11078	25	remission	remission	NN
cord-005453-4057qib7	11078	26	therapy	therapy	NN
cord-005453-4057qib7	11078	27	n=14	n=14	NNP
cord-005453-4057qib7	11078	28	)	)	-RRB-
cord-005453-4057qib7	11078	29	and	and	CC
cord-005453-4057qib7	11078	30	late	late	JJ
cord-005453-4057qib7	11078	31	relapsed	relapsed	JJ
cord-005453-4057qib7	11078	32	disease	disease	NN
cord-005453-4057qib7	11078	33	(	(	-LRB-
cord-005453-4057qib7	11078	34	n=19	n=19	NN
cord-005453-4057qib7	11078	35	)	)	-RRB-
cord-005453-4057qib7	11078	36	.	.	.
cord-005453-4057qib7	11079	1	More	more	RBR
cord-005453-4057qib7	11079	2	specifically	specifically	RB
cord-005453-4057qib7	11079	3	,	,	,
cord-005453-4057qib7	11079	4	19/23	19/23	CD
cord-005453-4057qib7	11079	5	patients	patient	NNS
cord-005453-4057qib7	11079	6	(	(	-LRB-
cord-005453-4057qib7	11079	7	83	83	CD
cord-005453-4057qib7	11079	8	%	%	NN
cord-005453-4057qib7	11079	9	)	)	-RRB-
cord-005453-4057qib7	11079	10	in	in	IN
cord-005453-4057qib7	11079	11	the	the	DT
cord-005453-4057qib7	11079	12	DICEP	DICEP	NNP
cord-005453-4057qib7	11079	13	-	-	HYPH
cord-005453-4057qib7	11079	14	group	group	NN
cord-005453-4057qib7	11079	15	,	,	,
cord-005453-4057qib7	11079	16	and	and	CC
cord-005453-4057qib7	11079	17	29/44	29/44	CD
cord-005453-4057qib7	11079	18	patients	patient	NNS
cord-005453-4057qib7	11079	19	(	(	-LRB-
cord-005453-4057qib7	11079	20	65	65	CD
cord-005453-4057qib7	11079	21	%	%	NN
cord-005453-4057qib7	11079	22	)	)	-RRB-
cord-005453-4057qib7	11079	23	in	in	IN
cord-005453-4057qib7	11079	24	the	the	DT
cord-005453-4057qib7	11079	25	ESHAPgroup	eshapgroup	NN
cord-005453-4057qib7	11079	26	were	be	VBD
cord-005453-4057qib7	11079	27	assessed	assess	VBN
cord-005453-4057qib7	11079	28	with	with	IN
cord-005453-4057qib7	11079	29	PIF	PIF	NNP
cord-005453-4057qib7	11079	30	or	or	CC
cord-005453-4057qib7	11079	31	early	early	JJ
cord-005453-4057qib7	11079	32	relapsed	relapse	VBN
cord-005453-4057qib7	11079	33	disease	disease	NN
cord-005453-4057qib7	11079	34	,	,	,
cord-005453-4057qib7	11079	35	however	however	RB
cord-005453-4057qib7	11079	36	this	this	DT
cord-005453-4057qib7	11079	37	difference	difference	NN
cord-005453-4057qib7	11079	38	was	be	VBD
cord-005453-4057qib7	11079	39	not	not	RB
cord-005453-4057qib7	11079	40	statistically	statistically	RB
cord-005453-4057qib7	11079	41	significant	significant	JJ
cord-005453-4057qib7	11079	42	.	.	.
cord-005453-4057qib7	11080	1	Both	both	DT
cord-005453-4057qib7	11080	2	regimens	regimen	NNS
cord-005453-4057qib7	11080	3	were	be	VBD
cord-005453-4057qib7	11080	4	well	well	RB
cord-005453-4057qib7	11080	5	tolerated	tolerate	VBN
cord-005453-4057qib7	11080	6	and	and	CC
cord-005453-4057qib7	11080	7	no	no	DT
cord-005453-4057qib7	11080	8	major	major	JJ
cord-005453-4057qib7	11080	9	organ	organ	NN
cord-005453-4057qib7	11080	10	toxicities	toxicity	NNS
cord-005453-4057qib7	11080	11	were	be	VBD
cord-005453-4057qib7	11080	12	noticed	notice	VBN
cord-005453-4057qib7	11080	13	.	.	.
cord-005453-4057qib7	11081	1	Eleven	eleven	CD
cord-005453-4057qib7	11081	2	patients	patient	NNS
cord-005453-4057qib7	11081	3	(	(	-LRB-
cord-005453-4057qib7	11081	4	48	48	CD
cord-005453-4057qib7	11081	5	%	%	NN
cord-005453-4057qib7	11081	6	)	)	-RRB-
cord-005453-4057qib7	11081	7	from	from	IN
cord-005453-4057qib7	11081	8	the	the	DT
cord-005453-4057qib7	11081	9	DICEP	DICEP	NNP
cord-005453-4057qib7	11081	10	-	-	HYPH
cord-005453-4057qib7	11081	11	group	group	NN
cord-005453-4057qib7	11081	12	,	,	,
cord-005453-4057qib7	11081	13	while	while	IN
cord-005453-4057qib7	11081	14	only	only	RB
cord-005453-4057qib7	11081	15	4(10	4(10	CD
cord-005453-4057qib7	11081	16	%	%	NN
cord-005453-4057qib7	11081	17	)	)	-RRB-
cord-005453-4057qib7	11081	18	from	from	IN
cord-005453-4057qib7	11081	19	the	the	DT
cord-005453-4057qib7	11081	20	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11081	21	-	-	HYPH
cord-005453-4057qib7	11081	22	group	group	NN
cord-005453-4057qib7	11081	23	developed	develop	VBD
cord-005453-4057qib7	11081	24	febrile	febrile	JJ
cord-005453-4057qib7	11081	25	infections	infection	NNS
cord-005453-4057qib7	11081	26	.	.	.
cord-005453-4057qib7	11082	1	All	all	DT
cord-005453-4057qib7	11082	2	patients	patient	NNS
cord-005453-4057qib7	11082	3	were	be	VBD
cord-005453-4057qib7	11082	4	successfully	successfully	RB
cord-005453-4057qib7	11082	5	managed	manage	VBN
cord-005453-4057qib7	11082	6	with	with	IN
cord-005453-4057qib7	11082	7	the	the	DT
cord-005453-4057qib7	11082	8	appropriate	appropriate	JJ
cord-005453-4057qib7	11082	9	treatment	treatment	NN
cord-005453-4057qib7	11082	10	and	and	CC
cord-005453-4057qib7	11082	11	only	only	RB
cord-005453-4057qib7	11082	12	one	one	CD
cord-005453-4057qib7	11082	13	,	,	,
cord-005453-4057qib7	11082	14	from	from	IN
cord-005453-4057qib7	11082	15	the	the	DT
cord-005453-4057qib7	11082	16	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11082	17	-	-	HYPH
cord-005453-4057qib7	11082	18	group	group	NN
cord-005453-4057qib7	11082	19	,	,	,
cord-005453-4057qib7	11082	20	required	require	VBN
cord-005453-4057qib7	11082	21	for	for	IN
cord-005453-4057qib7	11082	22	short	short	JJ
cord-005453-4057qib7	11082	23	period	period	NN
cord-005453-4057qib7	11082	24	admission	admission	NN
cord-005453-4057qib7	11082	25	to	to	IN
cord-005453-4057qib7	11082	26	the	the	DT
cord-005453-4057qib7	11082	27	intensive	intensive	JJ
cord-005453-4057qib7	11082	28	care	care	NN
cord-005453-4057qib7	11082	29	unit	unit	NN
cord-005453-4057qib7	11082	30	.	.	.
cord-005453-4057qib7	11083	1	After	after	IN
cord-005453-4057qib7	11083	2	1	1	CD
cord-005453-4057qib7	11083	3	cycle	cycle	NN
cord-005453-4057qib7	11083	4	of	of	IN
cord-005453-4057qib7	11083	5	DICEP	DICEP	NNP
cord-005453-4057qib7	11083	6	and	and	CC
cord-005453-4057qib7	11083	7	2	2	CD
cord-005453-4057qib7	11083	8	cycles	cycle	NNS
cord-005453-4057qib7	11083	9	of	of	IN
cord-005453-4057qib7	11083	10	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11084	1	the	the	DT
cord-005453-4057qib7	11084	2	disease	disease	NN
cord-005453-4057qib7	11084	3	response	response	NN
cord-005453-4057qib7	11084	4	was	be	VBD
cord-005453-4057qib7	11084	5	re	re	VBN
cord-005453-4057qib7	11084	6	-	-	VBN
cord-005453-4057qib7	11084	7	assessed	assess	VBN
cord-005453-4057qib7	11084	8	by	by	IN
cord-005453-4057qib7	11084	9	PET	PET	NNP
cord-005453-4057qib7	11084	10	/	/	SYM
cord-005453-4057qib7	11084	11	CT	CT	NNP
cord-005453-4057qib7	11084	12	scan	scan	NN
cord-005453-4057qib7	11084	13	.	.	.
cord-005453-4057qib7	11085	1	The	the	DT
cord-005453-4057qib7	11085	2	overall	overall	JJ
cord-005453-4057qib7	11085	3	response	response	NN
cord-005453-4057qib7	11085	4	rate	rate	NN
cord-005453-4057qib7	11085	5	(	(	-LRB-
cord-005453-4057qib7	11085	6	>	>	NFP
cord-005453-4057qib7	11085	7	50	50	CD
cord-005453-4057qib7	11085	8	%	%	NN
cord-005453-4057qib7	11085	9	tumor	tumor	NN
cord-005453-4057qib7	11085	10	reduction	reduction	NN
cord-005453-4057qib7	11085	11	)	)	-RRB-
cord-005453-4057qib7	11085	12	was	be	VBD
cord-005453-4057qib7	11085	13	significantly	significantly	RB
cord-005453-4057qib7	11085	14	superior	superior	JJ
cord-005453-4057qib7	11085	15	for	for	IN
cord-005453-4057qib7	11085	16	the	the	DT
cord-005453-4057qib7	11085	17	DICEP	DICEP	NNP
cord-005453-4057qib7	11085	18	-	-	HYPH
cord-005453-4057qib7	11085	19	regimen	regimen	NN
cord-005453-4057qib7	11085	20	,	,	,
cord-005453-4057qib7	11085	21	reaching	reach	VBG
cord-005453-4057qib7	11085	22	92	92	CD
cord-005453-4057qib7	11085	23	%	%	NN
cord-005453-4057qib7	11085	24	(	(	-LRB-
cord-005453-4057qib7	11085	25	21/23	21/23	CD
cord-005453-4057qib7	11085	26	patients	patient	NNS
cord-005453-4057qib7	11085	27	)	)	-RRB-
cord-005453-4057qib7	11085	28	vs.	vs.	IN
cord-005453-4057qib7	11085	29	64	64	CD
cord-005453-4057qib7	11085	30	%	%	NN
cord-005453-4057qib7	11085	31	(	(	-LRB-
cord-005453-4057qib7	11085	32	27/44	27/44	CD
cord-005453-4057qib7	11085	33	patients	patient	NNS
cord-005453-4057qib7	11085	34	)	)	-RRB-
cord-005453-4057qib7	11085	35	for	for	IN
cord-005453-4057qib7	11085	36	ESHAPregimen	ESHAPregimen	NNP
cord-005453-4057qib7	11085	37	(	(	-LRB-
cord-005453-4057qib7	11085	38	p=0,003	p=0,003	NN
cord-005453-4057qib7	11085	39	)	)	-RRB-
cord-005453-4057qib7	11085	40	.	.	.
cord-005453-4057qib7	11086	1	Eleven	eleven	CD
cord-005453-4057qib7	11086	2	patients	patient	NNS
cord-005453-4057qib7	11086	3	(	(	-LRB-
cord-005453-4057qib7	11086	4	48	48	CD
cord-005453-4057qib7	11086	5	%	%	NN
cord-005453-4057qib7	11086	6	)	)	-RRB-
cord-005453-4057qib7	11086	7	from	from	IN
cord-005453-4057qib7	11086	8	the	the	DT
cord-005453-4057qib7	11086	9	DICEP	DICEP	NNP
cord-005453-4057qib7	11086	10	-	-	HYPH
cord-005453-4057qib7	11086	11	group	group	NN
cord-005453-4057qib7	11086	12	and	and	CC
cord-005453-4057qib7	11086	13	14(30	14(30	CD
cord-005453-4057qib7	11086	14	%	%	NN
cord-005453-4057qib7	11086	15	)	)	-RRB-
cord-005453-4057qib7	11086	16	from	from	IN
cord-005453-4057qib7	11086	17	the	the	DT
cord-005453-4057qib7	11086	18	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11086	19	-	-	HYPH
cord-005453-4057qib7	11086	20	group	group	NN
cord-005453-4057qib7	11086	21	achieved	achieve	VBD
cord-005453-4057qib7	11086	22	complete	complete	JJ
cord-005453-4057qib7	11086	23	metabolic	metabolic	JJ
cord-005453-4057qib7	11086	24	remission	remission	NN
cord-005453-4057qib7	11086	25	according	accord	VBG
cord-005453-4057qib7	11086	26	to	to	IN
cord-005453-4057qib7	11086	27	PET/	PET/	NNP
cord-005453-4057qib7	11086	28	CT	CT	NNP
cord-005453-4057qib7	11086	29	criteria	criterion	NNS
cord-005453-4057qib7	11086	30	(	(	-LRB-
cord-005453-4057qib7	11086	31	p	p	NN
cord-005453-4057qib7	11086	32	=	=	SYM
cord-005453-4057qib7	11086	33	ns	ns	NNP
cord-005453-4057qib7	11086	34	)	)	-RRB-
cord-005453-4057qib7	11086	35	.	.	.
cord-005453-4057qib7	11087	1	The	the	DT
cord-005453-4057qib7	11087	2	median	median	JJ
cord-005453-4057qib7	11087	3	hospitalization	hospitalization	NN
cord-005453-4057qib7	11087	4	period	period	NN
cord-005453-4057qib7	11087	5	was	be	VBD
cord-005453-4057qib7	11087	6	20(5	20(5	CD
cord-005453-4057qib7	11087	7	-	-	SYM
cord-005453-4057qib7	11087	8	25	25	CD
cord-005453-4057qib7	11087	9	)	)	-RRB-
cord-005453-4057qib7	11087	10	days	day	NNS
cord-005453-4057qib7	11087	11	for	for	IN
cord-005453-4057qib7	11087	12	the	the	DT
cord-005453-4057qib7	11087	13	DICEP	DICEP	NNP
cord-005453-4057qib7	11087	14	-	-	HYPH
cord-005453-4057qib7	11087	15	group	group	NN
cord-005453-4057qib7	11087	16	compared	compare	VBN
cord-005453-4057qib7	11087	17	to	to	IN
cord-005453-4057qib7	11087	18	10(10	10(10	CD
cord-005453-4057qib7	11087	19	-	-	SYM
cord-005453-4057qib7	11087	20	19	19	CD
cord-005453-4057qib7	11087	21	)	)	-RRB-
cord-005453-4057qib7	11087	22	days	day	NNS
cord-005453-4057qib7	11087	23	for	for	IN
cord-005453-4057qib7	11087	24	the	the	DT
cord-005453-4057qib7	11087	25	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11087	26	-	-	HYPH
cord-005453-4057qib7	11087	27	group	group	NN
cord-005453-4057qib7	11087	28	.	.	.
cord-005453-4057qib7	11088	1	However	however	RB
cord-005453-4057qib7	11088	2	,	,	,
cord-005453-4057qib7	11088	3	for	for	IN
cord-005453-4057qib7	11088	4	the	the	DT
cord-005453-4057qib7	11088	5	ESHAPgroup	eshapgroup	NN
cord-005453-4057qib7	11088	6	,	,	,
cord-005453-4057qib7	11088	7	an	an	DT
cord-005453-4057qib7	11088	8	additional	additional	JJ
cord-005453-4057qib7	11088	9	median	median	NN
cord-005453-4057qib7	11088	10	of	of	IN
cord-005453-4057qib7	11088	11	20(6	20(6	CD
cord-005453-4057qib7	11088	12	-	-	SYM
cord-005453-4057qib7	11088	13	33	33	CD
cord-005453-4057qib7	11088	14	)	)	-RRB-
cord-005453-4057qib7	11088	15	hospitalization	hospitalization	NN
cord-005453-4057qib7	11088	16	days	day	NNS
cord-005453-4057qib7	11088	17	were	be	VBD
cord-005453-4057qib7	11088	18	required	require	VBN
cord-005453-4057qib7	11088	19	,	,	,
cord-005453-4057qib7	11088	20	since	since	IN
cord-005453-4057qib7	11088	21	12	12	CD
cord-005453-4057qib7	11088	22	of	of	IN
cord-005453-4057qib7	11088	23	the	the	DT
cord-005453-4057qib7	11088	24	non	non	NNS
cord-005453-4057qib7	11088	25	-	-	NNS
cord-005453-4057qib7	11088	26	responders	responder	NNS
cord-005453-4057qib7	11088	27	patients	patient	NNS
cord-005453-4057qib7	11088	28	received	receive	VBD
cord-005453-4057qib7	11088	29	a	a	DT
cord-005453-4057qib7	11088	30	2	2	CD
cord-005453-4057qib7	11088	31	nd	nd	NNP
cord-005453-4057qib7	11088	32	salvage	salvage	NN
cord-005453-4057qib7	11088	33	before	before	IN
cord-005453-4057qib7	11088	34	ASCT	ASCT	NNP
cord-005453-4057qib7	11088	35	.	.	.
cord-005453-4057qib7	11089	1	The	the	DT
cord-005453-4057qib7	11089	2	mobilization	mobilization	NN
cord-005453-4057qib7	11089	3	and	and	CC
cord-005453-4057qib7	11089	4	stem	stem	NN
cord-005453-4057qib7	11089	5	cell	cell	NN
cord-005453-4057qib7	11089	6	collection	collection	NN
cord-005453-4057qib7	11089	7	was	be	VBD
cord-005453-4057qib7	11089	8	successful	successful	JJ
cord-005453-4057qib7	11089	9	for	for	IN
cord-005453-4057qib7	11089	10	both	both	DT
cord-005453-4057qib7	11089	11	groups	group	NNS
cord-005453-4057qib7	11089	12	,	,	,
cord-005453-4057qib7	11089	13	though	though	IN
cord-005453-4057qib7	11089	14	significant	significant	JJ
cord-005453-4057qib7	11089	15	higher	high	JJR
cord-005453-4057qib7	11089	16	number	number	NN
cord-005453-4057qib7	11089	17	of	of	IN
cord-005453-4057qib7	11089	18	CD34	CD34	NNP
cord-005453-4057qib7	11089	19	+	+	CC
cord-005453-4057qib7	11089	20	cells	cell	NNS
cord-005453-4057qib7	11089	21	were	be	VBD
cord-005453-4057qib7	11089	22	collected	collect	VBN
cord-005453-4057qib7	11089	23	in	in	IN
cord-005453-4057qib7	11089	24	the	the	DT
cord-005453-4057qib7	11089	25	DICEP	DICEP	NNP
cord-005453-4057qib7	11089	26	-	-	HYPH
cord-005453-4057qib7	11089	27	group	group	NN
cord-005453-4057qib7	11089	28	(	(	-LRB-
cord-005453-4057qib7	11089	29	17.2x10	17.2x10	CD
cord-005453-4057qib7	11089	30	3	3	CD
cord-005453-4057qib7	11089	31	/kg	/kg	.
cord-005453-4057qib7	11089	32	vs.	vs.	FW
cord-005453-4057qib7	11089	33	5.4x10	5.4x10	CD
cord-005453-4057qib7	11089	34	3	3	CD
cord-005453-4057qib7	11090	1	/kg	/kg	NFP
cord-005453-4057qib7	11090	2	,	,	,
cord-005453-4057qib7	11090	3	p=0,001	p=0,001	NNP
cord-005453-4057qib7	11090	4	)	)	-RRB-
cord-005453-4057qib7	11090	5	.	.	.
cord-005453-4057qib7	11091	1	All	all	DT
cord-005453-4057qib7	11091	2	but	but	IN
cord-005453-4057qib7	11091	3	two	two	CD
cord-005453-4057qib7	11091	4	patients	patient	NNS
cord-005453-4057qib7	11091	5	(	(	-LRB-
cord-005453-4057qib7	11091	6	due	due	IN
cord-005453-4057qib7	11091	7	to	to	IN
cord-005453-4057qib7	11091	8	refractory	refractory	JJ
cord-005453-4057qib7	11091	9	disease	disease	NN
cord-005453-4057qib7	11091	10	)	)	-RRB-
cord-005453-4057qib7	11091	11	underwent	undergo	VBD
cord-005453-4057qib7	11091	12	ASCT	ASCT	NNP
cord-005453-4057qib7	11091	13	.	.	.
cord-005453-4057qib7	11092	1	Noticeably	noticeably	RB
cord-005453-4057qib7	11092	2	,	,	,
cord-005453-4057qib7	11092	3	the	the	DT
cord-005453-4057qib7	11092	4	median	median	JJ
cord-005453-4057qib7	11092	5	period	period	NN
cord-005453-4057qib7	11092	6	from	from	IN
cord-005453-4057qib7	11092	7	1	1	CD
cord-005453-4057qib7	11092	8	st	st	NNP
cord-005453-4057qib7	11092	9	salvage	salvage	NN
cord-005453-4057qib7	11092	10	treatment	treatment	NN
cord-005453-4057qib7	11092	11	to	to	IN
cord-005453-4057qib7	11092	12	ASCT	ASCT	NNP
cord-005453-4057qib7	11092	13	was	be	VBD
cord-005453-4057qib7	11092	14	significantly	significantly	RB
cord-005453-4057qib7	11092	15	shorter	short	JJR
cord-005453-4057qib7	11092	16	for	for	IN
cord-005453-4057qib7	11092	17	the	the	DT
cord-005453-4057qib7	11092	18	DICEPgroup	dicepgroup	NN
cord-005453-4057qib7	11092	19	(	(	-LRB-
cord-005453-4057qib7	11092	20	64	64	CD
cord-005453-4057qib7	11092	21	vs.	vs.	IN
cord-005453-4057qib7	11092	22	128	128	CD
cord-005453-4057qib7	11092	23	days	day	NNS
cord-005453-4057qib7	11092	24	,	,	,
cord-005453-4057qib7	11092	25	p=0,013	p=0,013	NNP
cord-005453-4057qib7	11092	26	)	)	-RRB-
cord-005453-4057qib7	11092	27	,	,	,
cord-005453-4057qib7	11092	28	apparently	apparently	RB
cord-005453-4057qib7	11092	29	because	because	IN
cord-005453-4057qib7	11092	30	12	12	CD
cord-005453-4057qib7	11092	31	non	non	NNS
cord-005453-4057qib7	11092	32	-	-	NNS
cord-005453-4057qib7	11092	33	responders	responder	NNS
cord-005453-4057qib7	11092	34	patients	patient	NNS
cord-005453-4057qib7	11092	35	from	from	IN
cord-005453-4057qib7	11092	36	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11092	37	-	-	HYPH
cord-005453-4057qib7	11092	38	group	group	NN
cord-005453-4057qib7	11092	39	treated	treat	VBN
cord-005453-4057qib7	11092	40	with	with	IN
cord-005453-4057qib7	11092	41	a	a	DT
cord-005453-4057qib7	11092	42	2	2	CD
cord-005453-4057qib7	11092	43	nd	nd	NNP
cord-005453-4057qib7	11092	44	salvage	salvage	NN
cord-005453-4057qib7	11092	45	.	.	.
cord-005453-4057qib7	11093	1	The	the	DT
cord-005453-4057qib7	11093	2	3-years	3-years	CD
cord-005453-4057qib7	11093	3	overall	overall	JJ
cord-005453-4057qib7	11093	4	and	and	CC
cord-005453-4057qib7	11093	5	progression	progression	NN
cord-005453-4057qib7	11093	6	free	free	JJ
cord-005453-4057qib7	11093	7	survival	survival	NN
cord-005453-4057qib7	11093	8	were	be	VBD
cord-005453-4057qib7	11093	9	similar	similar	JJ
cord-005453-4057qib7	11093	10	for	for	IN
cord-005453-4057qib7	11093	11	DICEP	DICEP	NNP
cord-005453-4057qib7	11093	12	-	-	:
cord-005453-4057qib7	11093	13	and	and	CC
cord-005453-4057qib7	11093	14	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11093	15	-	-	HYPH
cord-005453-4057qib7	11093	16	groups	group	NNS
cord-005453-4057qib7	11093	17	(	(	-LRB-
cord-005453-4057qib7	11093	18	95	95	CD
cord-005453-4057qib7	11093	19	%	%	NN
cord-005453-4057qib7	11093	20	vs.	vs.	IN
cord-005453-4057qib7	11093	21	88	88	CD
cord-005453-4057qib7	11093	22	%	%	NN
cord-005453-4057qib7	11093	23	and	and	CC
cord-005453-4057qib7	11093	24	70	70	CD
cord-005453-4057qib7	11093	25	%	%	NN
cord-005453-4057qib7	11093	26	vs	vs	IN
cord-005453-4057qib7	11093	27	80	80	CD
cord-005453-4057qib7	11093	28	%	%	NN
cord-005453-4057qib7	11093	29	respectively	respectively	RB
cord-005453-4057qib7	11093	30	)	)	-RRB-
cord-005453-4057qib7	11093	31	.	.	.
cord-005453-4057qib7	11094	1	Two	two	CD
cord-005453-4057qib7	11094	2	heavily	heavily	RB
cord-005453-4057qib7	11094	3	pretreated	pretreate	VBD
cord-005453-4057qib7	11094	4	patients	patient	NNS
cord-005453-4057qib7	11094	5	from	from	IN
cord-005453-4057qib7	11094	6	the	the	DT
cord-005453-4057qib7	11094	7	ESHAP	ESHAP	NNP
cord-005453-4057qib7	11094	8	-	-	HYPH
cord-005453-4057qib7	11094	9	group	group	NN
cord-005453-4057qib7	11094	10	developed	develop	VBD
cord-005453-4057qib7	11094	11	secondary	secondary	JJ
cord-005453-4057qib7	11094	12	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	11094	13	syndrome	syndrome	NN
cord-005453-4057qib7	11094	14	post	post	NN
cord-005453-4057qib7	11094	15	ASCT	ASCT	NNP
cord-005453-4057qib7	11094	16	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	11094	17	:	:	:
cord-005453-4057qib7	11095	1	In	in	IN
cord-005453-4057qib7	11095	2	our	-PRON-	PRP$
cord-005453-4057qib7	11095	3	series	series	NN
cord-005453-4057qib7	11095	4	of	of	IN
cord-005453-4057qib7	11095	5	patients	patient	NNS
cord-005453-4057qib7	11095	6	both	both	DT
cord-005453-4057qib7	11095	7	regimens	regimen	NNS
cord-005453-4057qib7	11095	8	proved	prove	VBD
cord-005453-4057qib7	11095	9	to	to	TO
cord-005453-4057qib7	11095	10	be	be	VB
cord-005453-4057qib7	11095	11	safe	safe	JJ
cord-005453-4057qib7	11095	12	.	.	.
cord-005453-4057qib7	11096	1	Interestingly	interestingly	RB
cord-005453-4057qib7	11096	2	,	,	,
cord-005453-4057qib7	11096	3	despite	despite	IN
cord-005453-4057qib7	11096	4	the	the	DT
cord-005453-4057qib7	11096	5	fact	fact	NN
cord-005453-4057qib7	11096	6	that	that	IN
cord-005453-4057qib7	11096	7	more	more	JJR
cord-005453-4057qib7	11096	8	patients	patient	NNS
cord-005453-4057qib7	11096	9	in	in	IN
cord-005453-4057qib7	11096	10	DICEP	DICEP	NNP
cord-005453-4057qib7	11096	11	-	-	HYPH
cord-005453-4057qib7	11096	12	group	group	NN
cord-005453-4057qib7	11096	13	had	have	VBD
cord-005453-4057qib7	11096	14	poor	poor	JJ
cord-005453-4057qib7	11096	15	risk	risk	NN
cord-005453-4057qib7	11096	16	disease	disease	NN
cord-005453-4057qib7	11097	1	the	the	DT
cord-005453-4057qib7	11097	2	DICEPregiment	dicepregiment	NN
cord-005453-4057qib7	11097	3	was	be	VBD
cord-005453-4057qib7	11097	4	significantly	significantly	RB
cord-005453-4057qib7	11097	5	more	more	RBR
cord-005453-4057qib7	11097	6	effective	effective	JJ
cord-005453-4057qib7	11097	7	,	,	,
cord-005453-4057qib7	11097	8	resulting	result	VBG
cord-005453-4057qib7	11097	9	thus	thus	RB
cord-005453-4057qib7	11097	10	in	in	IN
cord-005453-4057qib7	11097	11	an	an	DT
cord-005453-4057qib7	11097	12	earlier	early	JJR
cord-005453-4057qib7	11097	13	ASCT	ASCT	NNP
cord-005453-4057qib7	11097	14	,	,	,
cord-005453-4057qib7	11097	15	less	less	JJR
cord-005453-4057qib7	11097	16	exposure	exposure	NN
cord-005453-4057qib7	11097	17	to	to	IN
cord-005453-4057qib7	11097	18	chemotherapeutic	chemotherapeutic	JJ
cord-005453-4057qib7	11097	19	agents	agent	NNS
cord-005453-4057qib7	11097	20	,	,	,
cord-005453-4057qib7	11097	21	that	that	WDT
cord-005453-4057qib7	11097	22	might	may	MD
cord-005453-4057qib7	11097	23	led	lead	VBD
cord-005453-4057qib7	11097	24	in	in	IN
cord-005453-4057qib7	11097	25	less	less	JJR
cord-005453-4057qib7	11097	26	long	long	JJ
cord-005453-4057qib7	11097	27	-	-	HYPH
cord-005453-4057qib7	11097	28	term	term	NN
cord-005453-4057qib7	11097	29	toxicity	toxicity	NN
cord-005453-4057qib7	11097	30	.	.	.
cord-005453-4057qib7	11098	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	11098	2	,	,	,
cord-005453-4057qib7	11098	3	prospective	prospective	JJ
cord-005453-4057qib7	11098	4	trials	trial	NNS
cord-005453-4057qib7	11098	5	with	with	IN
cord-005453-4057qib7	11098	6	large	large	JJ
cord-005453-4057qib7	11098	7	series	series	NN
cord-005453-4057qib7	11098	8	of	of	IN
cord-005453-4057qib7	11098	9	patients	patient	NNS
cord-005453-4057qib7	11098	10	are	be	VBP
cord-005453-4057qib7	11098	11	needed	need	VBN
cord-005453-4057qib7	11098	12	to	to	TO
cord-005453-4057qib7	11098	13	define	define	VB
cord-005453-4057qib7	11098	14	the	the	DT
cord-005453-4057qib7	11098	15	role	role	NN
cord-005453-4057qib7	11098	16	of	of	IN
cord-005453-4057qib7	11098	17	DICEP	DICEP	NNP
cord-005453-4057qib7	11098	18	in	in	IN
cord-005453-4057qib7	11098	19	the	the	DT
cord-005453-4057qib7	11098	20	salvage	salvage	NN
cord-005453-4057qib7	11098	21	treatment	treatment	NN
cord-005453-4057qib7	11098	22	setting	setting	NN
cord-005453-4057qib7	11098	23	.	.	.
cord-005453-4057qib7	11099	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11099	2	:	:	:
cord-005453-4057qib7	11099	3	no	no	DT
cord-005453-4057qib7	11099	4	conflict	conflict	NN
cord-005453-4057qib7	11099	5	of	of	IN
cord-005453-4057qib7	11099	6	interest	interest	NN
cord-005453-4057qib7	11099	7	Background	background	NN
cord-005453-4057qib7	11099	8	:	:	:
cord-005453-4057qib7	11100	1	Although	although	IN
cord-005453-4057qib7	11100	2	autologous	autologous	JJ
cord-005453-4057qib7	11100	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11100	4	stem	stem	NN
cord-005453-4057qib7	11100	5	cell	cell	NN
cord-005453-4057qib7	11100	6	transplantation	transplantation	NN
cord-005453-4057qib7	11100	7	(	(	-LRB-
cord-005453-4057qib7	11100	8	auto	auto	NN
cord-005453-4057qib7	11100	9	-	-	HYPH
cord-005453-4057qib7	11100	10	HSCT	HSCT	NNP
cord-005453-4057qib7	11100	11	)	)	-RRB-
cord-005453-4057qib7	11100	12	is	be	VBZ
cord-005453-4057qib7	11100	13	one	one	CD
cord-005453-4057qib7	11100	14	of	of	IN
cord-005453-4057qib7	11100	15	the	the	DT
cord-005453-4057qib7	11100	16	best	good	JJS
cord-005453-4057qib7	11100	17	curative	curative	JJ
cord-005453-4057qib7	11100	18	strategies	strategy	NNS
cord-005453-4057qib7	11100	19	for	for	IN
cord-005453-4057qib7	11100	20	patients	patient	NNS
cord-005453-4057qib7	11100	21	with	with	IN
cord-005453-4057qib7	11100	22	chemosensitive	chemosensitive	JJ
cord-005453-4057qib7	11100	23	T	t	NN
cord-005453-4057qib7	11100	24	-	-	HYPH
cord-005453-4057qib7	11100	25	cell	cell	NN
cord-005453-4057qib7	11100	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	11100	27	,	,	,
cord-005453-4057qib7	11100	28	major	major	JJ
cord-005453-4057qib7	11100	29	limitation	limitation	NN
cord-005453-4057qib7	11100	30	remains	remain	VBZ
cord-005453-4057qib7	11100	31	a	a	DT
cord-005453-4057qib7	11100	32	tumor	tumor	NN
cord-005453-4057qib7	11100	33	contaminated	contaminate	VBN
cord-005453-4057qib7	11100	34	graft	graft	NN
cord-005453-4057qib7	11100	35	-	-	HYPH
cord-005453-4057qib7	11100	36	related	relate	VBN
cord-005453-4057qib7	11100	37	relapse	relapse	NN
cord-005453-4057qib7	11100	38	or	or	CC
cord-005453-4057qib7	11100	39	residual	residual	JJ
cord-005453-4057qib7	11100	40	disease	disease	NN
cord-005453-4057qib7	11100	41	after	after	IN
cord-005453-4057qib7	11100	42	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11100	43	.	.	.
cord-005453-4057qib7	11101	1	Several	several	JJ
cord-005453-4057qib7	11101	2	purging	purging	NN
cord-005453-4057qib7	11101	3	methods	method	NNS
cord-005453-4057qib7	11101	4	were	be	VBD
cord-005453-4057qib7	11101	5	introduced	introduce	VBN
cord-005453-4057qib7	11101	6	in	in	IN
cord-005453-4057qib7	11101	7	auto	auto	NN
cord-005453-4057qib7	11101	8	-	-	HYPH
cord-005453-4057qib7	11101	9	HSCT	HSCT	NNP
cord-005453-4057qib7	11101	10	for	for	IN
cord-005453-4057qib7	11101	11	these	these	DT
cord-005453-4057qib7	11101	12	limitations	limitation	NNS
cord-005453-4057qib7	11101	13	,	,	,
cord-005453-4057qib7	11101	14	however	however	RB
cord-005453-4057qib7	11101	15	there	there	EX
cord-005453-4057qib7	11101	16	are	be	VBP
cord-005453-4057qib7	11101	17	few	few	JJ
cord-005453-4057qib7	11101	18	studies	study	NNS
cord-005453-4057qib7	11101	19	of	of	IN
cord-005453-4057qib7	11101	20	ex	ex	NNP
cord-005453-4057qib7	11101	21	vivo	vivo	NN
cord-005453-4057qib7	11101	22	purging	purging	NN
cord-005453-4057qib7	11101	23	of	of	IN
cord-005453-4057qib7	11101	24	the	the	DT
cord-005453-4057qib7	11101	25	autograft	autograft	NN
cord-005453-4057qib7	11101	26	in	in	IN
cord-005453-4057qib7	11101	27	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11101	28	,	,	,
cord-005453-4057qib7	11101	29	especially	especially	RB
cord-005453-4057qib7	11101	30	T	t	NN
cord-005453-4057qib7	11101	31	-	-	HYPH
cord-005453-4057qib7	11101	32	cell	cell	NN
cord-005453-4057qib7	11101	33	lymphoma	lymphoma	NN
cord-005453-4057qib7	11101	34	.	.	.
cord-005453-4057qib7	11102	1	Therefore	therefore	RB
cord-005453-4057qib7	11102	2	,	,	,
cord-005453-4057qib7	11102	3	we	-PRON-	PRP
cord-005453-4057qib7	11102	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	11102	5	analyzed	analyze	VBD
cord-005453-4057qib7	11102	6	59	59	CD
cord-005453-4057qib7	11102	7	consecutive	consecutive	JJ
cord-005453-4057qib7	11102	8	T	t	NN
cord-005453-4057qib7	11102	9	-	-	HYPH
cord-005453-4057qib7	11102	10	cell	cell	NN
cord-005453-4057qib7	11102	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11102	12	patients	patient	NNS
cord-005453-4057qib7	11102	13	receiving	receive	VBG
cord-005453-4057qib7	11102	14	auto	auto	NN
cord-005453-4057qib7	11102	15	-	-	HYPH
cord-005453-4057qib7	11102	16	HSCT	HSCT	NNP
cord-005453-4057qib7	11102	17	with	with	IN
cord-005453-4057qib7	11102	18	/	/	SYM
cord-005453-4057qib7	11102	19	without	without	IN
cord-005453-4057qib7	11102	20	ex	ex	FW
cord-005453-4057qib7	11102	21	vivo	vivo	NN
cord-005453-4057qib7	11102	22	purging	purging	NN
cord-005453-4057qib7	11102	23	.	.	.
cord-005453-4057qib7	11103	1	Methods	method	NNS
cord-005453-4057qib7	11103	2	:	:	:
cord-005453-4057qib7	11104	1	Among	among	IN
cord-005453-4057qib7	11104	2	them	-PRON-	PRP
cord-005453-4057qib7	11104	3	,	,	,
cord-005453-4057qib7	11104	4	33	33	CD
cord-005453-4057qib7	11104	5	patients	patient	NNS
cord-005453-4057qib7	11104	6	underwent	undergo	VBD
cord-005453-4057qib7	11104	7	autograft	autograft	NN
cord-005453-4057qib7	11104	8	manipulation	manipulation	NN
cord-005453-4057qib7	11104	9	with	with	IN
cord-005453-4057qib7	11104	10	ex	ex	FW
cord-005453-4057qib7	11104	11	vivo	vivo	NN
cord-005453-4057qib7	11104	12	purging	purge	VBG
cord-005453-4057qib7	11104	13	by	by	IN
cord-005453-4057qib7	11104	14	CD34	CD34	NNP
cord-005453-4057qib7	11104	15	+	+	CC
cord-005453-4057qib7	11104	16	cells	cell	NNS
cord-005453-4057qib7	11104	17	selection	selection	NN
cord-005453-4057qib7	11104	18	using	use	VBG
cord-005453-4057qib7	11104	19	a	a	DT
cord-005453-4057qib7	11104	20	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	11104	21	device	device	NN
cord-005453-4057qib7	11104	22	.	.	.
cord-005453-4057qib7	11105	1	Results	result	NNS
cord-005453-4057qib7	11105	2	:	:	:
cord-005453-4057qib7	11106	1	With	with	IN
cord-005453-4057qib7	11106	2	median	median	JJ
cord-005453-4057qib7	11106	3	follow	follow	NN
cord-005453-4057qib7	11106	4	-	-	HYPH
cord-005453-4057qib7	11106	5	up	up	NN
cord-005453-4057qib7	11106	6	duration	duration	NN
cord-005453-4057qib7	11106	7	of	of	IN
cord-005453-4057qib7	11106	8	42	42	CD
cord-005453-4057qib7	11106	9	months	month	NNS
cord-005453-4057qib7	11106	10	(	(	-LRB-
cord-005453-4057qib7	11106	11	range	range	NN
cord-005453-4057qib7	11106	12	,	,	,
cord-005453-4057qib7	11106	13	6	6	CD
cord-005453-4057qib7	11106	14	-	-	SYM
cord-005453-4057qib7	11106	15	121	121	CD
cord-005453-4057qib7	11106	16	months	month	NNS
cord-005453-4057qib7	11106	17	)	)	-RRB-
cord-005453-4057qib7	11106	18	,	,	,
cord-005453-4057qib7	11106	19	3-year	3-year	JJ
cord-005453-4057qib7	11106	20	overall	overall	JJ
cord-005453-4057qib7	11106	21	survival	survival	NN
cord-005453-4057qib7	11106	22	(	(	-LRB-
cord-005453-4057qib7	11106	23	OS	os	NN
cord-005453-4057qib7	11106	24	;	;	:
cord-005453-4057qib7	11106	25	73.8	73.8	CD
cord-005453-4057qib7	11106	26	%	%	NN
cord-005453-4057qib7	11106	27	vs.	vs.	NN
cord-005453-4057qib7	11106	28	49.0	49.0	CD
cord-005453-4057qib7	11106	29	%	%	NN
cord-005453-4057qib7	11106	30	,	,	,
cord-005453-4057qib7	11106	31	p=0.017	p=0.017	NNS
cord-005453-4057qib7	11106	32	)	)	-RRB-
cord-005453-4057qib7	11106	33	and	and	CC
cord-005453-4057qib7	11106	34	3-year	3-year	CD
cord-005453-4057qib7	11106	35	progression	progression	NN
cord-005453-4057qib7	11106	36	-	-	HYPH
cord-005453-4057qib7	11106	37	free	free	JJ
cord-005453-4057qib7	11106	38	survival	survival	NN
cord-005453-4057qib7	11106	39	(	(	-LRB-
cord-005453-4057qib7	11106	40	PFS	PFS	NNP
cord-005453-4057qib7	11106	41	;	;	:
cord-005453-4057qib7	11106	42	75.8	75.8	CD
cord-005453-4057qib7	11106	43	%	%	NN
cord-005453-4057qib7	11106	44	vs.	vs.	CC
cord-005453-4057qib7	11106	45	52.4	52.4	CD
cord-005453-4057qib7	11106	46	%	%	NN
cord-005453-4057qib7	11106	47	,	,	,
cord-005453-4057qib7	11106	48	p=0.039	p=0.039	JJ
cord-005453-4057qib7	11106	49	)	)	-RRB-
cord-005453-4057qib7	11106	50	in	in	IN
cord-005453-4057qib7	11106	51	a	a	DT
cord-005453-4057qib7	11106	52	purged	purge	VBN
cord-005453-4057qib7	11106	53	and	and	CC
cord-005453-4057qib7	11106	54	unpurged	unpurged	JJ
cord-005453-4057qib7	11106	55	group	group	NN
cord-005453-4057qib7	11106	56	,	,	,
cord-005453-4057qib7	11106	57	respectively	respectively	RB
cord-005453-4057qib7	11106	58	.	.	.
cord-005453-4057qib7	11107	1	Transplant	transplant	NN
cord-005453-4057qib7	11107	2	-	-	HYPH
cord-005453-4057qib7	11107	3	related	relate	VBN
cord-005453-4057qib7	11107	4	mortality	mortality	NN
cord-005453-4057qib7	11107	5	was	be	VBD
cord-005453-4057qib7	11107	6	observed	observe	VBN
cord-005453-4057qib7	11107	7	in	in	IN
cord-005453-4057qib7	11107	8	both	both	DT
cord-005453-4057qib7	11107	9	groups	group	NNS
cord-005453-4057qib7	11107	10	(	(	-LRB-
cord-005453-4057qib7	11107	11	2	2	CD
cord-005453-4057qib7	11107	12	patients	patient	NNS
cord-005453-4057qib7	11107	13	of	of	IN
cord-005453-4057qib7	11107	14	a	a	DT
cord-005453-4057qib7	11107	15	purged	purge	VBN
cord-005453-4057qib7	11107	16	group	group	NN
cord-005453-4057qib7	11107	17	and	and	CC
cord-005453-4057qib7	11107	18	1	1	CD
cord-005453-4057qib7	11107	19	patient	patient	NN
cord-005453-4057qib7	11107	20	of	of	IN
cord-005453-4057qib7	11107	21	an	an	DT
cord-005453-4057qib7	11107	22	unpurged	unpurged	JJ
cord-005453-4057qib7	11107	23	group	group	NN
cord-005453-4057qib7	11107	24	)	)	-RRB-
cord-005453-4057qib7	11107	25	.	.	.
cord-005453-4057qib7	11108	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	11108	2	(	(	-LRB-
cord-005453-4057qib7	11108	3	10	10	CD
cord-005453-4057qib7	11108	4	vs.	vs.	NN
cord-005453-4057qib7	11108	5	9	9	CD
cord-005453-4057qib7	11108	6	days	day	NNS
cord-005453-4057qib7	11108	7	,	,	,
cord-005453-4057qib7	11108	8	p=0.240	p=0.240	NNP
cord-005453-4057qib7	11108	9	)	)	-RRB-
cord-005453-4057qib7	11109	1	and	and	CC
cord-005453-4057qib7	11109	2	platelet	platelet	NN
cord-005453-4057qib7	11109	3	(	(	-LRB-
cord-005453-4057qib7	11109	4	30	30	CD
cord-005453-4057qib7	11109	5	vs.	vs.	NN
cord-005453-4057qib7	11109	6	24	24	CD
cord-005453-4057qib7	11109	7	days	day	NNS
cord-005453-4057qib7	11109	8	,	,	,
cord-005453-4057qib7	11109	9	p=0.055	p=0.055	NN
cord-005453-4057qib7	11109	10	)	)	-RRB-
cord-005453-4057qib7	11109	11	recovery	recovery	NN
cord-005453-4057qib7	11109	12	were	be	VBD
cord-005453-4057qib7	11109	13	similar	similar	JJ
cord-005453-4057qib7	11109	14	in	in	IN
cord-005453-4057qib7	11109	15	both	both	DT
cord-005453-4057qib7	11109	16	group	group	NN
cord-005453-4057qib7	11109	17	and	and	CC
cord-005453-4057qib7	11109	18	there	there	EX
cord-005453-4057qib7	11109	19	was	be	VBD
cord-005453-4057qib7	11109	20	no	no	DT
cord-005453-4057qib7	11109	21	engraftment	engraftment	NN
cord-005453-4057qib7	11109	22	failure	failure	NN
cord-005453-4057qib7	11109	23	.	.	.
cord-005453-4057qib7	11110	1	On	on	IN
cord-005453-4057qib7	11110	2	subgroup	subgroup	NN
cord-005453-4057qib7	11110	3	analysis	analysis	NN
cord-005453-4057qib7	11110	4	according	accord	VBG
cord-005453-4057qib7	11110	5	to	to	IN
cord-005453-4057qib7	11110	6	upfront	upfront	NN
cord-005453-4057qib7	11110	7	and	and	CC
cord-005453-4057qib7	11110	8	salvage	salvage	VB
cord-005453-4057qib7	11110	9	auto	auto	NN
cord-005453-4057qib7	11110	10	-	-	HYPH
cord-005453-4057qib7	11110	11	HSCT	HSCT	NNP
cord-005453-4057qib7	11110	12	,	,	,
cord-005453-4057qib7	11110	13	while	while	IN
cord-005453-4057qib7	11110	14	survival	survival	NN
cord-005453-4057qib7	11110	15	outcomes	outcome	NNS
cord-005453-4057qib7	11110	16	were	be	VBD
cord-005453-4057qib7	11110	17	improved	improve	VBN
cord-005453-4057qib7	11110	18	by	by	IN
cord-005453-4057qib7	11110	19	stem	stem	NN
cord-005453-4057qib7	11110	20	cell	cell	NN
cord-005453-4057qib7	11110	21	purging	purge	VBG
cord-005453-4057qib7	11110	22	in	in	IN
cord-005453-4057qib7	11110	23	the	the	DT
cord-005453-4057qib7	11110	24	upfront	upfront	JJ
cord-005453-4057qib7	11110	25	auto	auto	NN
cord-005453-4057qib7	11110	26	-	-	HYPH
cord-005453-4057qib7	11110	27	HSCT	HSCT	NNP
cord-005453-4057qib7	11110	28	(	(	-LRB-
cord-005453-4057qib7	11110	29	OS	OS	NNP
cord-005453-4057qib7	11110	30	with	with	IN
cord-005453-4057qib7	11110	31	p=0.039	p=0.039	JJ
cord-005453-4057qib7	11110	32	and	and	CC
cord-005453-4057qib7	11110	33	PFS	PFS	NNP
cord-005453-4057qib7	11110	34	with	with	IN
cord-005453-4057qib7	11110	35	p=0.047	p=0.047	NNS
cord-005453-4057qib7	11110	36	)	)	-RRB-
cord-005453-4057qib7	11110	37	,	,	,
cord-005453-4057qib7	11110	38	there	there	EX
cord-005453-4057qib7	11110	39	were	be	VBD
cord-005453-4057qib7	11110	40	no	no	DT
cord-005453-4057qib7	11110	41	different	different	JJ
cord-005453-4057qib7	11110	42	survival	survival	NN
cord-005453-4057qib7	11110	43	outcomes	outcome	NNS
cord-005453-4057qib7	11110	44	in	in	IN
cord-005453-4057qib7	11110	45	salvage	salvage	NN
cord-005453-4057qib7	11110	46	auto	auto	NN
cord-005453-4057qib7	11110	47	-	-	HYPH
cord-005453-4057qib7	11110	48	HSCT	HSCT	NNP
cord-005453-4057qib7	11110	49	.	.	.
cord-005453-4057qib7	11111	1	The	the	DT
cord-005453-4057qib7	11111	2	unmanageable	unmanageable	JJ
cord-005453-4057qib7	11111	3	late	late	JJ
cord-005453-4057qib7	11111	4	-	-	HYPH
cord-005453-4057qib7	11111	5	infectious	infectious	JJ
cord-005453-4057qib7	11111	6	complications	complication	NNS
cord-005453-4057qib7	11111	7	were	be	VBD
cord-005453-4057qib7	11111	8	few	few	JJ
cord-005453-4057qib7	11111	9	in	in	IN
cord-005453-4057qib7	11111	10	both	both	DT
cord-005453-4057qib7	11111	11	groups	group	NNS
cord-005453-4057qib7	11111	12	except	except	IN
cord-005453-4057qib7	11111	13	for	for	IN
cord-005453-4057qib7	11111	14	predominantly	predominantly	RB
cord-005453-4057qib7	11111	15	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	11111	16	reactivation	reactivation	NN
cord-005453-4057qib7	11111	17	in	in	IN
cord-005453-4057qib7	11111	18	a	a	DT
cord-005453-4057qib7	11111	19	purged	purge	VBN
cord-005453-4057qib7	11111	20	group	group	NN
cord-005453-4057qib7	11111	21	(	(	-LRB-
cord-005453-4057qib7	11111	22	3	3	CD
cord-005453-4057qib7	11111	23	vs.	vs.	NN
cord-005453-4057qib7	11111	24	1	1	CD
cord-005453-4057qib7	11111	25	patient	patient	NN
cord-005453-4057qib7	11111	26	)	)	-RRB-
cord-005453-4057qib7	11111	27	.	.	.
cord-005453-4057qib7	11112	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11112	2	:	:	:
cord-005453-4057qib7	11113	1	Although	although	IN
cord-005453-4057qib7	11113	2	cohort	cohort	NN
cord-005453-4057qib7	11113	3	was	be	VBD
cord-005453-4057qib7	11113	4	a	a	DT
cord-005453-4057qib7	11113	5	small	small	JJ
cord-005453-4057qib7	11113	6	number	number	NN
cord-005453-4057qib7	11113	7	,	,	,
cord-005453-4057qib7	11113	8	ex	ex	NN
cord-005453-4057qib7	11113	9	vivo	vivo	NN
cord-005453-4057qib7	11113	10	graft	graft	NN
cord-005453-4057qib7	11113	11	-	-	HYPH
cord-005453-4057qib7	11113	12	purging	purging	NN
cord-005453-4057qib7	11113	13	method	method	NN
cord-005453-4057qib7	11113	14	was	be	VBD
cord-005453-4057qib7	11113	15	feasible	feasible	JJ
cord-005453-4057qib7	11113	16	and	and	CC
cord-005453-4057qib7	11113	17	safe	safe	JJ
cord-005453-4057qib7	11113	18	in	in	IN
cord-005453-4057qib7	11113	19	T	t	NN
cord-005453-4057qib7	11113	20	-	-	HYPH
cord-005453-4057qib7	11113	21	cell	cell	NN
cord-005453-4057qib7	11113	22	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11113	23	.	.	.
cord-005453-4057qib7	11114	1	And	and	CC
cord-005453-4057qib7	11114	2	this	this	DT
cord-005453-4057qib7	11114	3	purging	purge	VBG
cord-005453-4057qib7	11114	4	strategy	strategy	NN
cord-005453-4057qib7	11114	5	observed	observe	VBD
cord-005453-4057qib7	11114	6	the	the	DT
cord-005453-4057qib7	11114	7	more	more	RBR
cord-005453-4057qib7	11114	8	favorable	favorable	JJ
cord-005453-4057qib7	11114	9	survival	survival	NN
cord-005453-4057qib7	11114	10	outcomes	outcome	NNS
cord-005453-4057qib7	11114	11	in	in	IN
cord-005453-4057qib7	11114	12	the	the	DT
cord-005453-4057qib7	11114	13	upfront	upfront	JJ
cord-005453-4057qib7	11114	14	auto	auto	NN
cord-005453-4057qib7	11114	15	-	-	HYPH
cord-005453-4057qib7	11114	16	HSCT	HSCT	NNP
cord-005453-4057qib7	11114	17	than	than	IN
cord-005453-4057qib7	11114	18	salvage	salvage	NN
cord-005453-4057qib7	11114	19	setting	setting	NN
cord-005453-4057qib7	11114	20	.	.	.
cord-005453-4057qib7	11115	1	Therefore	therefore	RB
cord-005453-4057qib7	11115	2	,	,	,
cord-005453-4057qib7	11115	3	further	further	JJ
cord-005453-4057qib7	11115	4	randomized	randomized	JJ
cord-005453-4057qib7	11115	5	studies	study	NNS
cord-005453-4057qib7	11115	6	are	be	VBP
cord-005453-4057qib7	11115	7	needed	need	VBN
cord-005453-4057qib7	11115	8	to	to	TO
cord-005453-4057qib7	11115	9	determine	determine	VB
cord-005453-4057qib7	11115	10	the	the	DT
cord-005453-4057qib7	11115	11	firm	firm	JJ
cord-005453-4057qib7	11115	12	efficacy	efficacy	NN
cord-005453-4057qib7	11115	13	of	of	IN
cord-005453-4057qib7	11115	14	CD34	CD34	NNP
cord-005453-4057qib7	11115	15	+	+	CC
cord-005453-4057qib7	11115	16	purification	purification	NN
cord-005453-4057qib7	11115	17	with	with	IN
cord-005453-4057qib7	11115	18	the	the	DT
cord-005453-4057qib7	11115	19	large	large	JJ
cord-005453-4057qib7	11115	20	number	number	NN
cord-005453-4057qib7	11115	21	of	of	IN
cord-005453-4057qib7	11115	22	patients	patient	NNS
cord-005453-4057qib7	11115	23	in	in	IN
cord-005453-4057qib7	11115	24	auto	auto	NN
cord-005453-4057qib7	11115	25	-	-	HYPH
cord-005453-4057qib7	11115	26	HSCT	HSCT	NNP
cord-005453-4057qib7	11115	27	for	for	IN
cord-005453-4057qib7	11115	28	T	T	NNP
cord-005453-4057qib7	11115	29	cell	cell	NN
cord-005453-4057qib7	11115	30	-	-	HYPH
cord-005453-4057qib7	11115	31	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11115	32	.	.	.
cord-005453-4057qib7	11116	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11116	2	:	:	:
cord-005453-4057qib7	11116	3	Nothing	nothing	NN
cord-005453-4057qib7	11116	4	to	to	TO
cord-005453-4057qib7	11116	5	declare	declare	VB
cord-005453-4057qib7	11116	6	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	11116	7	-	-	HYPH
cord-005453-4057qib7	11116	8	based	base	VBN
cord-005453-4057qib7	11116	9	regimens	regimen	NNS
cord-005453-4057qib7	11116	10	in	in	IN
cord-005453-4057qib7	11116	11	relapsed	relapsed	JJ
cord-005453-4057qib7	11116	12	or	or	CC
cord-005453-4057qib7	11116	13	refractory	refractory	JJ
cord-005453-4057qib7	11116	14	non	non	AFX
cord-005453-4057qib7	11116	15	hodgkin	hodgkin	NNP
cord-005453-4057qib7	11116	16	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11116	17	:	:	:
cord-005453-4057qib7	11116	18	The	the	DT
cord-005453-4057qib7	11116	19	role	role	NN
cord-005453-4057qib7	11116	20	of	of	IN
cord-005453-4057qib7	11116	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11116	22	stem	stem	NN
cord-005453-4057qib7	11116	23	cells	cell	NNS
cord-005453-4057qib7	11116	24	transplantation	transplantation	NN
cord-005453-4057qib7	11116	25	Methods	method	NNS
cord-005453-4057qib7	11117	1	:	:	:
cord-005453-4057qib7	11117	2	We	-PRON-	PRP
cord-005453-4057qib7	11117	3	analyzed	analyze	VBD
cord-005453-4057qib7	11117	4	data	datum	NNS
cord-005453-4057qib7	11117	5	of	of	IN
cord-005453-4057qib7	11117	6	18	18	CD
cord-005453-4057qib7	11117	7	patients	patient	NNS
cord-005453-4057qib7	11117	8	with	with	IN
cord-005453-4057qib7	11117	9	r	r	NN
cord-005453-4057qib7	11117	10	/	/	SYM
cord-005453-4057qib7	11117	11	r	r	NN
cord-005453-4057qib7	11117	12	NHL	NHL	NNP
cord-005453-4057qib7	11117	13	,	,	,
cord-005453-4057qib7	11117	14	among	among	IN
cord-005453-4057qib7	11117	15	them	-PRON-	PRP
cord-005453-4057qib7	11117	16	n11	n11	NN
cord-005453-4057qib7	11117	17	with	with	IN
cord-005453-4057qib7	11117	18	Diffuse	diffuse	JJ
cord-005453-4057qib7	11117	19	large	large	JJ
cord-005453-4057qib7	11117	20	B	b	NN
cord-005453-4057qib7	11117	21	-	-	HYPH
cord-005453-4057qib7	11117	22	cell	cell	NN
cord-005453-4057qib7	11117	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	11117	24	(	(	-LRB-
cord-005453-4057qib7	11117	25	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11117	26	)	)	-RRB-
cord-005453-4057qib7	11117	27	,	,	,
cord-005453-4057qib7	11117	28	n5	n5	NNP
cord-005453-4057qib7	11117	29	with	with	IN
cord-005453-4057qib7	11117	30	Primary	primary	JJ
cord-005453-4057qib7	11117	31	mediastinal	mediastinal	JJ
cord-005453-4057qib7	11117	32	B	b	NN
cord-005453-4057qib7	11117	33	-	-	HYPH
cord-005453-4057qib7	11117	34	cell	cell	NN
cord-005453-4057qib7	11117	35	lymphoma	lymphoma	NN
cord-005453-4057qib7	11117	36	(	(	-LRB-
cord-005453-4057qib7	11117	37	PMBCL	PMBCL	NNP
cord-005453-4057qib7	11117	38	)	)	-RRB-
cord-005453-4057qib7	11117	39	,	,	,
cord-005453-4057qib7	11117	40	n1	n1	NNP
cord-005453-4057qib7	11117	41	with	with	IN
cord-005453-4057qib7	11117	42	Gray	Gray	NNP
cord-005453-4057qib7	11117	43	zone	zone	NN
cord-005453-4057qib7	11117	44	lymphoma	lymphoma	NN
cord-005453-4057qib7	11117	45	(	(	-LRB-
cord-005453-4057qib7	11117	46	GZL	GZL	NNP
cord-005453-4057qib7	11117	47	)	)	-RRB-
cord-005453-4057qib7	11117	48	and	and	CC
cord-005453-4057qib7	11117	49	n1	n1	NNP
cord-005453-4057qib7	11117	50	with	with	IN
cord-005453-4057qib7	11117	51	Gamma	Gamma	NNP
cord-005453-4057qib7	11117	52	-	-	HYPH
cord-005453-4057qib7	11117	53	Delta	Delta	NNP
cord-005453-4057qib7	11117	54	peripheral	peripheral	JJ
cord-005453-4057qib7	11117	55	T	t	NN
cord-005453-4057qib7	11117	56	-	-	HYPH
cord-005453-4057qib7	11117	57	cell	cell	NN
cord-005453-4057qib7	11117	58	lymphoma	lymphoma	NN
cord-005453-4057qib7	11117	59	(	(	-LRB-
cord-005453-4057qib7	11117	60	PTCL	PTCL	NNP
cord-005453-4057qib7	11117	61	)	)	-RRB-
cord-005453-4057qib7	11117	62	,	,	,
cord-005453-4057qib7	11117	63	who	who	WP
cord-005453-4057qib7	11117	64	received	receive	VBD
cord-005453-4057qib7	11117	65	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11117	66	-	-	HYPH
cord-005453-4057qib7	11117	67	based	base	VBN
cord-005453-4057qib7	11117	68	regimens	regimen	NNS
cord-005453-4057qib7	11117	69	.	.	.
cord-005453-4057qib7	11118	1	The	the	DT
cord-005453-4057qib7	11118	2	median	median	JJ
cord-005453-4057qib7	11118	3	age	age	NN
cord-005453-4057qib7	11118	4	was	be	VBD
cord-005453-4057qib7	11118	5	37	37	CD
cord-005453-4057qib7	11118	6	years	year	NNS
cord-005453-4057qib7	11118	7	(	(	-LRB-
cord-005453-4057qib7	11118	8	range	range	NN
cord-005453-4057qib7	11118	9	,	,	,
cord-005453-4057qib7	11118	10	18	18	CD
cord-005453-4057qib7	11118	11	-64	-64	NN
cord-005453-4057qib7	11118	12	years	year	NNS
cord-005453-4057qib7	11118	13	)	)	-RRB-
cord-005453-4057qib7	11118	14	.	.	.
cord-005453-4057qib7	11119	1	Most	Most	JJS
cord-005453-4057qib7	11119	2	of	of	IN
cord-005453-4057qib7	11119	3	the	the	DT
cord-005453-4057qib7	11119	4	patients	patient	NNS
cord-005453-4057qib7	11119	5	n14	n14	NNP
cord-005453-4057qib7	11119	6	(	(	-LRB-
cord-005453-4057qib7	11119	7	78	78	CD
cord-005453-4057qib7	11119	8	%	%	NN
cord-005453-4057qib7	11119	9	)	)	-RRB-
cord-005453-4057qib7	11119	10	had	have	VBD
cord-005453-4057qib7	11119	11	a	a	DT
cord-005453-4057qib7	11119	12	primary	primary	JJ
cord-005453-4057qib7	11119	13	chemoresistant	chemoresistant	JJ
cord-005453-4057qib7	11119	14	disease	disease	NN
cord-005453-4057qib7	11119	15	,	,	.
cord-005453-4057qib7	11120	1	the	the	DT
cord-005453-4057qib7	11120	2	rest	rest	NN
cord-005453-4057qib7	11120	3	patients	patient	NNS
cord-005453-4057qib7	11120	4	n4	n4	NNP
cord-005453-4057qib7	11120	5	(	(	-LRB-
cord-005453-4057qib7	11120	6	22	22	CD
cord-005453-4057qib7	11120	7	%	%	NN
cord-005453-4057qib7	11120	8	)	)	-RRB-
cord-005453-4057qib7	11120	9	had	have	VBD
cord-005453-4057qib7	11120	10	a	a	DT
cord-005453-4057qib7	11120	11	relapse	relapse	NN
cord-005453-4057qib7	11120	12	.	.	.
cord-005453-4057qib7	11121	1	The	the	DT
cord-005453-4057qib7	11121	2	median	median	NN
cord-005453-4057qib7	11121	3	of	of	IN
cord-005453-4057qib7	11121	4	lines	line	NNS
cord-005453-4057qib7	11121	5	of	of	IN
cord-005453-4057qib7	11121	6	prior	prior	JJ
cord-005453-4057qib7	11121	7	therapy	therapy	NN
cord-005453-4057qib7	11121	8	was	be	VBD
cord-005453-4057qib7	11121	9	3	3	CD
cord-005453-4057qib7	11121	10	lines	line	NNS
cord-005453-4057qib7	11121	11	(	(	-LRB-
cord-005453-4057qib7	11121	12	range	range	NN
cord-005453-4057qib7	11121	13	,	,	,
cord-005453-4057qib7	11121	14	2	2	CD
cord-005453-4057qib7	11121	15	-	-	SYM
cord-005453-4057qib7	11121	16	6	6	CD
cord-005453-4057qib7	11121	17	lines	line	NNS
cord-005453-4057qib7	11121	18	)	)	-RRB-
cord-005453-4057qib7	11121	19	.	.	.
cord-005453-4057qib7	11122	1	All	all	DT
cord-005453-4057qib7	11122	2	sixteen	sixteen	CD
cord-005453-4057qib7	11122	3	patients	patient	NNS
cord-005453-4057qib7	11122	4	with	with	IN
cord-005453-4057qib7	11122	5	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11122	6	and	and	CC
cord-005453-4057qib7	11122	7	PMBCL	PMBCL	NNP
cord-005453-4057qib7	11122	8	received	receive	VBD
cord-005453-4057qib7	11122	9	1	1	CD
cord-005453-4057qib7	11122	10	-3	-3	NNP
cord-005453-4057qib7	11122	11	cycles	cycle	NNS
cord-005453-4057qib7	11122	12	of	of	IN
cord-005453-4057qib7	11122	13	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11122	14	in	in	IN
cord-005453-4057qib7	11122	15	combination	combination	NN
cord-005453-4057qib7	11122	16	with	with	IN
cord-005453-4057qib7	11122	17	bendamustine	bendamustine	NNP
cord-005453-4057qib7	11122	18	,	,	,
cord-005453-4057qib7	11122	19	gemcitabine	gemcitabine	NNP
cord-005453-4057qib7	11122	20	and	and	CC
cord-005453-4057qib7	11122	21	rituximab	rituximab	NN
cord-005453-4057qib7	11122	22	(	(	-LRB-
cord-005453-4057qib7	11122	23	BeGeRN	BeGeRN	NNP
cord-005453-4057qib7	11122	24	)	)	-RRB-
cord-005453-4057qib7	11122	25	.	.	.
cord-005453-4057qib7	11123	1	The	the	DT
cord-005453-4057qib7	11123	2	patient	patient	NN
cord-005453-4057qib7	11123	3	with	with	IN
cord-005453-4057qib7	11123	4	GZL	GZL	NNP
cord-005453-4057qib7	11123	5	received	receive	VBD
cord-005453-4057qib7	11123	6	5	5	CD
cord-005453-4057qib7	11123	7	cycles	cycle	NNS
cord-005453-4057qib7	11123	8	of	of	IN
cord-005453-4057qib7	11123	9	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11123	10	in	in	IN
cord-005453-4057qib7	11123	11	combination	combination	NN
cord-005453-4057qib7	11123	12	with	with	IN
cord-005453-4057qib7	11123	13	brentuximab	brentuximab	NNP
cord-005453-4057qib7	11123	14	vedotin	vedotin	NNP
cord-005453-4057qib7	11123	15	and	and	CC
cord-005453-4057qib7	11123	16	EPOCH	epoch	NN
cord-005453-4057qib7	11123	17	.	.	.
cord-005453-4057qib7	11124	1	And	and	CC
cord-005453-4057qib7	11124	2	the	the	DT
cord-005453-4057qib7	11124	3	patient	patient	NN
cord-005453-4057qib7	11124	4	with	with	IN
cord-005453-4057qib7	11124	5	PTCL	PTCL	NNP
cord-005453-4057qib7	11124	6	received	receive	VBD
cord-005453-4057qib7	11124	7	10	10	CD
cord-005453-4057qib7	11124	8	cycles	cycle	NNS
cord-005453-4057qib7	11124	9	of	of	IN
cord-005453-4057qib7	11124	10	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11124	11	monotherapy	monotherapy	NN
cord-005453-4057qib7	11124	12	.	.	.
cord-005453-4057qib7	11125	1	Results	result	NNS
cord-005453-4057qib7	11125	2	:	:	:
cord-005453-4057qib7	11126	1	At	at	IN
cord-005453-4057qib7	11126	2	median	median	NN
cord-005453-4057qib7	11126	3	follow	follow	VB
cord-005453-4057qib7	11126	4	up	up	RB
cord-005453-4057qib7	11126	5	8	8	CD
cord-005453-4057qib7	11126	6	months	month	NNS
cord-005453-4057qib7	11126	7	(	(	-LRB-
cord-005453-4057qib7	11126	8	3	3	CD
cord-005453-4057qib7	11126	9	-	-	SYM
cord-005453-4057qib7	11126	10	16	16	CD
cord-005453-4057qib7	11126	11	)	)	-RRB-
cord-005453-4057qib7	11126	12	objective	objective	JJ
cord-005453-4057qib7	11126	13	response	response	NN
cord-005453-4057qib7	11126	14	(	(	-LRB-
cord-005453-4057qib7	11126	15	OR	OR	NNP
cord-005453-4057qib7	11126	16	)	)	-RRB-
cord-005453-4057qib7	11126	17	after	after	IN
cord-005453-4057qib7	11126	18	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11126	19	-	-	HYPH
cord-005453-4057qib7	11126	20	based	base	VBN
cord-005453-4057qib7	11126	21	regimens	regimen	NNS
cord-005453-4057qib7	11126	22	was	be	VBD
cord-005453-4057qib7	11126	23	noted	note	VBN
cord-005453-4057qib7	11126	24	in	in	IN
cord-005453-4057qib7	11126	25	n10	n10	NN
cord-005453-4057qib7	11126	26	(	(	-LRB-
cord-005453-4057qib7	11126	27	56	56	CD
cord-005453-4057qib7	11126	28	%	%	NN
cord-005453-4057qib7	11126	29	)	)	-RRB-
cord-005453-4057qib7	11126	30	patients	patient	NNS
cord-005453-4057qib7	11126	31	,	,	,
cord-005453-4057qib7	11126	32	complete	complete	JJ
cord-005453-4057qib7	11126	33	response	response	NN
cord-005453-4057qib7	11126	34	(	(	-LRB-
cord-005453-4057qib7	11126	35	CR	CR	NNP
cord-005453-4057qib7	11126	36	)	)	-RRB-
cord-005453-4057qib7	11126	37	and	and	CC
cord-005453-4057qib7	11126	38	partial	partial	JJ
cord-005453-4057qib7	11126	39	response	response	NN
cord-005453-4057qib7	11126	40	(	(	-LRB-
cord-005453-4057qib7	11126	41	PR	PR	NNP
cord-005453-4057qib7	11126	42	)	)	-RRB-
cord-005453-4057qib7	11126	43	in	in	IN
cord-005453-4057qib7	11126	44	n9	n9	NNP
cord-005453-4057qib7	11126	45	(	(	-LRB-
cord-005453-4057qib7	11126	46	50	50	CD
cord-005453-4057qib7	11126	47	%	%	NN
cord-005453-4057qib7	11126	48	)	)	-RRB-
cord-005453-4057qib7	11126	49	and	and	CC
cord-005453-4057qib7	11126	50	n1	n1	NNP
cord-005453-4057qib7	11126	51	(	(	-LRB-
cord-005453-4057qib7	11126	52	6	6	CD
cord-005453-4057qib7	11126	53	%	%	NN
cord-005453-4057qib7	11126	54	)	)	-RRB-
cord-005453-4057qib7	11126	55	patients	patient	NNS
cord-005453-4057qib7	11126	56	,	,	,
cord-005453-4057qib7	11126	57	respectively	respectively	RB
cord-005453-4057qib7	11126	58	.	.	.
cord-005453-4057qib7	11127	1	CR	CR	NNP
cord-005453-4057qib7	11127	2	observed	observe	VBD
cord-005453-4057qib7	11127	3	in	in	IN
cord-005453-4057qib7	11127	4	n4	n4	CD
cord-005453-4057qib7	11127	5	patients	patient	NNS
cord-005453-4057qib7	11127	6	with	with	IN
cord-005453-4057qib7	11127	7	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11127	8	,	,	,
cord-005453-4057qib7	11127	9	n3	n3	NN
cord-005453-4057qib7	11127	10	with	with	IN
cord-005453-4057qib7	11127	11	PMBCL	PMBCL	NNP
cord-005453-4057qib7	11127	12	,	,	,
cord-005453-4057qib7	11127	13	n1	n1	NNP
cord-005453-4057qib7	11127	14	with	with	IN
cord-005453-4057qib7	11127	15	GZL	GZL	NNP
cord-005453-4057qib7	11127	16	,	,	,
cord-005453-4057qib7	11127	17	n1	n1	NNP
cord-005453-4057qib7	11127	18	with	with	IN
cord-005453-4057qib7	11127	19	PTCL	PTCL	NNP
cord-005453-4057qib7	11127	20	.	.	.
cord-005453-4057qib7	11128	1	And	and	CC
cord-005453-4057qib7	11128	2	PR	PR	NNP
cord-005453-4057qib7	11128	3	observed	observe	VBD
cord-005453-4057qib7	11128	4	in	in	IN
cord-005453-4057qib7	11128	5	1	1	CD
cord-005453-4057qib7	11128	6	patient	patient	NN
cord-005453-4057qib7	11128	7	with	with	IN
cord-005453-4057qib7	11128	8	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11128	9	.	.	.
cord-005453-4057qib7	11129	1	Two	two	CD
cord-005453-4057qib7	11129	2	responding	respond	VBG
cord-005453-4057qib7	11129	3	patients	patient	NNS
cord-005453-4057qib7	11129	4	with	with	IN
cord-005453-4057qib7	11129	5	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11129	6	underwent	undergo	VBN
cord-005453-4057qib7	11129	7	auto	auto	NN
cord-005453-4057qib7	11129	8	-	-	HYPH
cord-005453-4057qib7	11129	9	HSCT	HSCT	NNP
cord-005453-4057qib7	11129	10	.	.	.
cord-005453-4057qib7	11130	1	And	and	CC
cord-005453-4057qib7	11130	2	four	four	CD
cord-005453-4057qib7	11130	3	responding	respond	VBG
cord-005453-4057qib7	11130	4	patients	patient	NNS
cord-005453-4057qib7	11130	5	(	(	-LRB-
cord-005453-4057qib7	11130	6	n1	n1	NNP
cord-005453-4057qib7	11130	7	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11130	8	,	,	,
cord-005453-4057qib7	11130	9	n1	n1	NNP
cord-005453-4057qib7	11130	10	PMBCL	PMBCL	NNP
cord-005453-4057qib7	11130	11	,	,	,
cord-005453-4057qib7	11130	12	n1	n1	NNP
cord-005453-4057qib7	11130	13	GZL	GZL	NNP
cord-005453-4057qib7	11130	14	,	,	,
cord-005453-4057qib7	11130	15	n1	n1	NNP
cord-005453-4057qib7	11130	16	PTCL	PTCL	NNP
cord-005453-4057qib7	11130	17	)	)	-RRB-
cord-005453-4057qib7	11130	18	received	receive	VBD
cord-005453-4057qib7	11130	19	allogeneic	allogeneic	JJ
cord-005453-4057qib7	11130	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11130	21	stem	stem	NN
cord-005453-4057qib7	11130	22	cells	cell	NNS
cord-005453-4057qib7	11130	23	transplantation	transplantation	NN
cord-005453-4057qib7	11130	24	(	(	-LRB-
cord-005453-4057qib7	11130	25	allo	allo	NN
cord-005453-4057qib7	11130	26	-	-	HYPH
cord-005453-4057qib7	11130	27	HSCT	HSCT	NNP
cord-005453-4057qib7	11130	28	)	)	-RRB-
cord-005453-4057qib7	11130	29	.	.	.
cord-005453-4057qib7	11131	1	The	the	DT
cord-005453-4057qib7	11131	2	median	median	JJ
cord-005453-4057qib7	11131	3	duration	duration	NN
cord-005453-4057qib7	11131	4	of	of	IN
cord-005453-4057qib7	11131	5	response	response	NN
cord-005453-4057qib7	11131	6	for	for	IN
cord-005453-4057qib7	11131	7	all	all	DT
cord-005453-4057qib7	11131	8	n10	n10	CD
cord-005453-4057qib7	11131	9	patients	patient	NNS
cord-005453-4057qib7	11131	10	with	with	IN
cord-005453-4057qib7	11131	11	OR	or	CC
cord-005453-4057qib7	11131	12	was	be	VBD
cord-005453-4057qib7	11131	13	5	5	CD
cord-005453-4057qib7	11132	1	(	(	-LRB-
cord-005453-4057qib7	11132	2	range	range	NN
cord-005453-4057qib7	11132	3	:	:	:
cord-005453-4057qib7	11132	4	3	3	CD
cord-005453-4057qib7	11132	5	-	-	SYM
cord-005453-4057qib7	11132	6	16	16	CD
cord-005453-4057qib7	11132	7	+	+	SYM
cord-005453-4057qib7	11132	8	)	)	-RRB-
cord-005453-4057qib7	11132	9	months	month	NNS
cord-005453-4057qib7	11132	10	.	.	.
cord-005453-4057qib7	11133	1	Among	among	IN
cord-005453-4057qib7	11133	2	n4	n4	NN
cord-005453-4057qib7	11133	3	patients	patient	NNS
cord-005453-4057qib7	11133	4	who	who	WP
cord-005453-4057qib7	11133	5	achieved	achieve	VBD
cord-005453-4057qib7	11133	6	OR	or	CC
cord-005453-4057qib7	11133	7	without	without	IN
cord-005453-4057qib7	11133	8	HSCT	HSCT	NNP
cord-005453-4057qib7	11133	9	,	,	,
cord-005453-4057qib7	11133	10	only	only	RB
cord-005453-4057qib7	11133	11	n1	n1	NNP
cord-005453-4057qib7	11133	12	remain	remain	VBP
cord-005453-4057qib7	11133	13	in	in	IN
cord-005453-4057qib7	11133	14	CR	CR	NNP
cord-005453-4057qib7	11133	15	.	.	.
cord-005453-4057qib7	11134	1	Two	two	CD
cord-005453-4057qib7	11134	2	patients	patient	NNS
cord-005453-4057qib7	11134	3	who	who	WP
cord-005453-4057qib7	11134	4	received	receive	VBD
cord-005453-4057qib7	11134	5	auto	auto	NN
cord-005453-4057qib7	11134	6	-	-	HYPH
cord-005453-4057qib7	11134	7	HSCT	HSCT	NNP
cord-005453-4057qib7	11134	8	had	have	VBD
cord-005453-4057qib7	11134	9	a	a	DT
cord-005453-4057qib7	11134	10	relapse	relapse	NN
cord-005453-4057qib7	11134	11	.	.	.
cord-005453-4057qib7	11135	1	One	one	CD
cord-005453-4057qib7	11135	2	patient	patient	NN
cord-005453-4057qib7	11135	3	with	with	IN
cord-005453-4057qib7	11135	4	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11135	5	improved	improve	VBN
cord-005453-4057qib7	11135	6	the	the	DT
cord-005453-4057qib7	11135	7	response	response	NN
cord-005453-4057qib7	11135	8	after	after	IN
cord-005453-4057qib7	11135	9	allo	allo	NN
cord-005453-4057qib7	11135	10	-	-	HYPH
cord-005453-4057qib7	11135	11	HSCT	HSCT	NNP
cord-005453-4057qib7	11135	12	from	from	IN
cord-005453-4057qib7	11135	13	PR	PR	NNP
cord-005453-4057qib7	11135	14	to	to	IN
cord-005453-4057qib7	11135	15	CR	CR	NNP
cord-005453-4057qib7	11135	16	,	,	,
cord-005453-4057qib7	11135	17	and	and	CC
cord-005453-4057qib7	11135	18	all	all	DT
cord-005453-4057qib7	11135	19	four	four	CD
cord-005453-4057qib7	11135	20	patients	patient	NNS
cord-005453-4057qib7	11135	21	with	with	IN
cord-005453-4057qib7	11135	22	allo	allo	NN
cord-005453-4057qib7	11135	23	-	-	HYPH
cord-005453-4057qib7	11135	24	HSCT	HSCT	NNP
cord-005453-4057qib7	11135	25	remain	remain	VBP
cord-005453-4057qib7	11135	26	in	in	IN
cord-005453-4057qib7	11135	27	CR	CR	NNP
cord-005453-4057qib7	11135	28	.	.	.
cord-005453-4057qib7	11136	1	The	the	DT
cord-005453-4057qib7	11136	2	probabilities	probability	NNS
cord-005453-4057qib7	11136	3	of	of	IN
cord-005453-4057qib7	11136	4	1-year	1-year	CD
cord-005453-4057qib7	11136	5	OS	OS	NNP
cord-005453-4057qib7	11136	6	and	and	CC
cord-005453-4057qib7	11136	7	PFS	PFS	NNP
cord-005453-4057qib7	11136	8	rates	rate	NNS
cord-005453-4057qib7	11136	9	were	be	VBD
cord-005453-4057qib7	11136	10	49	49	CD
cord-005453-4057qib7	11136	11	%	%	NN
cord-005453-4057qib7	11136	12	and	and	CC
cord-005453-4057qib7	11136	13	31	31	CD
cord-005453-4057qib7	11136	14	%	%	NN
cord-005453-4057qib7	11136	15	,	,	,
cord-005453-4057qib7	11136	16	respectively	respectively	RB
cord-005453-4057qib7	11136	17	.	.	.
cord-005453-4057qib7	11137	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11137	2	:	:	:
cord-005453-4057qib7	11138	1	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	11138	2	-	-	HYPH
cord-005453-4057qib7	11138	3	based	base	VBN
cord-005453-4057qib7	11138	4	regimens	regimen	NNS
cord-005453-4057qib7	11138	5	can	can	MD
cord-005453-4057qib7	11138	6	lead	lead	VB
cord-005453-4057qib7	11138	7	to	to	IN
cord-005453-4057qib7	11138	8	an	an	DT
cord-005453-4057qib7	11138	9	objective	objective	JJ
cord-005453-4057qib7	11138	10	response	response	NN
cord-005453-4057qib7	11138	11	in	in	IN
cord-005453-4057qib7	11138	12	56	56	CD
cord-005453-4057qib7	11138	13	%	%	NN
cord-005453-4057qib7	11138	14	patients	patient	NNS
cord-005453-4057qib7	11138	15	with	with	IN
cord-005453-4057qib7	11138	16	r	r	NN
cord-005453-4057qib7	11138	17	/	/	SYM
cord-005453-4057qib7	11138	18	r	r	NN
cord-005453-4057qib7	11138	19	NHL	NHL	NNP
cord-005453-4057qib7	11138	20	.	.	.
cord-005453-4057qib7	11139	1	However	however	RB
cord-005453-4057qib7	11139	2	,	,	,
cord-005453-4057qib7	11139	3	the	the	DT
cord-005453-4057qib7	11139	4	durability	durability	NN
cord-005453-4057qib7	11139	5	of	of	IN
cord-005453-4057qib7	11139	6	response	response	NN
cord-005453-4057qib7	11139	7	to	to	IN
cord-005453-4057qib7	11139	8	therapy	therapy	NN
cord-005453-4057qib7	11139	9	is	be	VBZ
cord-005453-4057qib7	11139	10	not	not	RB
cord-005453-4057qib7	11139	11	long	long	JJ
cord-005453-4057qib7	11139	12	.	.	.
cord-005453-4057qib7	11140	1	Nivolumab	Nivolumab	NNP
cord-005453-4057qib7	11140	2	-	-	HYPH
cord-005453-4057qib7	11140	3	based	base	VBN
cord-005453-4057qib7	11140	4	regimens	regimen	NNS
cord-005453-4057qib7	11140	5	can	can	MD
cord-005453-4057qib7	11140	6	be	be	VB
cord-005453-4057qib7	11140	7	used	use	VBN
cord-005453-4057qib7	11140	8	as	as	IN
cord-005453-4057qib7	11140	9	bridge	bridge	NN
cord-005453-4057qib7	11140	10	to	to	IN
cord-005453-4057qib7	11140	11	allo	allo	NN
cord-005453-4057qib7	11140	12	-	-	HYPH
cord-005453-4057qib7	11140	13	HSCT	HSCT	NNP
cord-005453-4057qib7	11140	14	Disclosure	Disclosure	NNP
cord-005453-4057qib7	11140	15	:	:	:
cord-005453-4057qib7	11140	16	There	there	EX
cord-005453-4057qib7	11140	17	are	be	VBP
cord-005453-4057qib7	11140	18	no	no	DT
cord-005453-4057qib7	11140	19	conflicts	conflict	NNS
cord-005453-4057qib7	11140	20	of	of	IN
cord-005453-4057qib7	11140	21	interest	interest	NN
cord-005453-4057qib7	11140	22	to	to	TO
cord-005453-4057qib7	11140	23	disclose	disclose	VB
cord-005453-4057qib7	11140	24	Background	background	NN
cord-005453-4057qib7	11140	25	:	:	:
cord-005453-4057qib7	11140	26	Patients	patient	NNS
cord-005453-4057qib7	11140	27	with	with	IN
cord-005453-4057qib7	11140	28	aggressive	aggressive	JJ
cord-005453-4057qib7	11140	29	non	non	JJ
cord-005453-4057qib7	11140	30	-	-	JJ
cord-005453-4057qib7	11140	31	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	11140	32	lymphoma	lymphoma	NN
cord-005453-4057qib7	11140	33	(	(	-LRB-
cord-005453-4057qib7	11140	34	NHL	NHL	NNP
cord-005453-4057qib7	11140	35	)	)	-RRB-
cord-005453-4057qib7	11140	36	who	who	WP
cord-005453-4057qib7	11140	37	relapse	relapse	VBP
cord-005453-4057qib7	11140	38	after	after	IN
cord-005453-4057qib7	11140	39	autologous	autologous	JJ
cord-005453-4057qib7	11140	40	stem	stem	NN
cord-005453-4057qib7	11140	41	cell	cell	NN
cord-005453-4057qib7	11140	42	transplantation	transplantation	NN
cord-005453-4057qib7	11140	43	have	have	VBP
cord-005453-4057qib7	11140	44	a	a	DT
cord-005453-4057qib7	11140	45	dismal	dismal	JJ
cord-005453-4057qib7	11140	46	outcome	outcome	NN
cord-005453-4057qib7	11140	47	and	and	CC
cord-005453-4057qib7	11140	48	could	could	MD
cord-005453-4057qib7	11140	49	benefit	benefit	VB
cord-005453-4057qib7	11140	50	from	from	IN
cord-005453-4057qib7	11140	51	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11140	52	,	,	,
cord-005453-4057qib7	11140	53	allogeneic	allogeneic	NN
cord-005453-4057qib7	11140	54	stem	stem	NN
cord-005453-4057qib7	11140	55	cell	cell	NN
cord-005453-4057qib7	11140	56	transplantation	transplantation	NN
cord-005453-4057qib7	11140	57	or	or	CC
cord-005453-4057qib7	11140	58	experimental	experimental	JJ
cord-005453-4057qib7	11140	59	treatments	treatment	NNS
cord-005453-4057qib7	11140	60	.	.	.
cord-005453-4057qib7	11141	1	Systemic	systemic	JJ
cord-005453-4057qib7	11141	2	inflammatory	inflammatory	JJ
cord-005453-4057qib7	11141	3	parameters	parameter	NNS
cord-005453-4057qib7	11141	4	at	at	IN
cord-005453-4057qib7	11141	5	diagnosis	diagnosis	NN
cord-005453-4057qib7	11141	6	have	have	VBP
cord-005453-4057qib7	11141	7	demonstrated	demonstrate	VBN
cord-005453-4057qib7	11141	8	to	to	TO
cord-005453-4057qib7	11141	9	be	be	VB
cord-005453-4057qib7	11141	10	useful	useful	JJ
cord-005453-4057qib7	11141	11	to	to	TO
cord-005453-4057qib7	11141	12	predict	predict	VB
cord-005453-4057qib7	11141	13	lymphoma	lymphoma	NN
cord-005453-4057qib7	11141	14	evolution	evolution	NN
cord-005453-4057qib7	11141	15	.	.	.
cord-005453-4057qib7	11142	1	Methods	method	NNS
cord-005453-4057qib7	11142	2	:	:	:
cord-005453-4057qib7	11142	3	We	-PRON-	PRP
cord-005453-4057qib7	11142	4	conducted	conduct	VBD
cord-005453-4057qib7	11142	5	a	a	DT
cord-005453-4057qib7	11142	6	retrospective	retrospective	JJ
cord-005453-4057qib7	11142	7	review	review	NN
cord-005453-4057qib7	11142	8	of	of	IN
cord-005453-4057qib7	11142	9	patients	patient	NNS
cord-005453-4057qib7	11142	10	with	with	IN
cord-005453-4057qib7	11142	11	aggressive	aggressive	JJ
cord-005453-4057qib7	11142	12	NHL	NHL	NNP
cord-005453-4057qib7	11142	13	who	who	WP
cord-005453-4057qib7	11142	14	underwent	undergo	VBD
cord-005453-4057qib7	11142	15	autologous	autologous	JJ
cord-005453-4057qib7	11142	16	stem	stem	NN
cord-005453-4057qib7	11142	17	cell	cell	NN
cord-005453-4057qib7	11142	18	transplantation	transplantation	NN
cord-005453-4057qib7	11142	19	(	(	-LRB-
cord-005453-4057qib7	11142	20	ASTC	ASTC	NNP
cord-005453-4057qib7	11142	21	)	)	-RRB-
cord-005453-4057qib7	11142	22	to	to	TO
cord-005453-4057qib7	11142	23	evaluate	evaluate	VB
cord-005453-4057qib7	11142	24	the	the	DT
cord-005453-4057qib7	11142	25	relationship	relationship	NN
cord-005453-4057qib7	11142	26	between	between	IN
cord-005453-4057qib7	11142	27	LDH	LDH	NNP
cord-005453-4057qib7	11142	28	,	,	,
cord-005453-4057qib7	11142	29	β2-microglobulin	β2-microglobulin	XX
cord-005453-4057qib7	11142	30	,	,	,
cord-005453-4057qib7	11142	31	inflammatory	inflammatory	JJ
cord-005453-4057qib7	11142	32	parameters	parameter	NNS
cord-005453-4057qib7	11142	33	(	(	-LRB-
cord-005453-4057qib7	11142	34	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11142	35	(	(	-LRB-
cord-005453-4057qib7	11142	36	ALC	ALC	NNP
cord-005453-4057qib7	11142	37	)	)	-RRB-
cord-005453-4057qib7	11142	38	and	and	CC
cord-005453-4057qib7	11142	39	monocyte	monocyte	NNP
cord-005453-4057qib7	11142	40	count	count	NNP
cord-005453-4057qib7	11142	41	(	(	-LRB-
cord-005453-4057qib7	11142	42	AMC	AMC	NNP
cord-005453-4057qib7	11142	43	)	)	-RRB-
cord-005453-4057qib7	11142	44	,	,	,
cord-005453-4057qib7	11142	45	ferritin	ferritin	NN
cord-005453-4057qib7	11142	46	or	or	CC
cord-005453-4057qib7	11142	47	C	c	NN
cord-005453-4057qib7	11142	48	-	-	HYPH
cord-005453-4057qib7	11142	49	reactive	reactive	JJ
cord-005453-4057qib7	11142	50	protein	protein	NN
cord-005453-4057qib7	11142	51	)	)	-RRB-
cord-005453-4057qib7	11142	52	and	and	CC
cord-005453-4057qib7	11142	53	imaging	image	VBG
cord-005453-4057qib7	11142	54	techniques	technique	NNS
cord-005453-4057qib7	11142	55	before	before	IN
cord-005453-4057qib7	11142	56	and	and	CC
cord-005453-4057qib7	11142	57	on	on	IN
cord-005453-4057qib7	11142	58	day	day	NN
cord-005453-4057qib7	11142	59	+100	+100	HYPH
cord-005453-4057qib7	11142	60	post	post	NN
cord-005453-4057qib7	11142	61	-	-	JJ
cord-005453-4057qib7	11142	62	ASTC	ASTC	NNP
cord-005453-4057qib7	11142	63	and	and	CC
cord-005453-4057qib7	11142	64	progression	progression	NN
cord-005453-4057qib7	11142	65	free	free	JJ
cord-005453-4057qib7	11142	66	survival	survival	NN
cord-005453-4057qib7	11142	67	(	(	-LRB-
cord-005453-4057qib7	11142	68	PFS	PFS	NNP
cord-005453-4057qib7	11142	69	)	)	-RRB-
cord-005453-4057qib7	11142	70	,	,	,
cord-005453-4057qib7	11142	71	as	as	RB
cord-005453-4057qib7	11142	72	well	well	RB
cord-005453-4057qib7	11142	73	as	as	IN
cord-005453-4057qib7	11142	74	the	the	DT
cord-005453-4057qib7	11142	75	role	role	NN
cord-005453-4057qib7	11142	76	of	of	IN
cord-005453-4057qib7	11142	77	residual	residual	JJ
cord-005453-4057qib7	11142	78	disease	disease	NN
cord-005453-4057qib7	11142	79	directed	direct	VBD
cord-005453-4057qib7	11142	80	radiotherapy	radiotherapy	NNP
cord-005453-4057qib7	11142	81	(	(	-LRB-
cord-005453-4057qib7	11142	82	RT	RT	NNP
cord-005453-4057qib7	11142	83	)	)	-RRB-
cord-005453-4057qib7	11142	84	.	.	.
cord-005453-4057qib7	11143	1	Results	result	NNS
cord-005453-4057qib7	11143	2	:	:	:
cord-005453-4057qib7	11144	1	One	one	CD
cord-005453-4057qib7	11144	2	hundred	hundred	CD
cord-005453-4057qib7	11144	3	and	and	CC
cord-005453-4057qib7	11144	4	sixty	sixty	CD
cord-005453-4057qib7	11144	5	patients	patient	NNS
cord-005453-4057qib7	11144	6	with	with	IN
cord-005453-4057qib7	11144	7	aggressive	aggressive	JJ
cord-005453-4057qib7	11144	8	NHL	NHL	NNP
cord-005453-4057qib7	11144	9	received	receive	VBD
cord-005453-4057qib7	11144	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11144	11	as	as	IN
cord-005453-4057qib7	11144	12	consolidation	consolidation	NN
cord-005453-4057qib7	11144	13	treatment	treatment	NN
cord-005453-4057qib7	11144	14	in	in	IN
cord-005453-4057qib7	11144	15	our	-PRON-	PRP$
cord-005453-4057qib7	11144	16	center	center	NN
cord-005453-4057qib7	11144	17	between	between	IN
cord-005453-4057qib7	11144	18	2000	2000	CD
cord-005453-4057qib7	11144	19	and	and	CC
cord-005453-4057qib7	11144	20	2017	2017	CD
cord-005453-4057qib7	11144	21	.	.	.
cord-005453-4057qib7	11145	1	The	the	DT
cord-005453-4057qib7	11145	2	most	most	RBS
cord-005453-4057qib7	11145	3	common	common	JJ
cord-005453-4057qib7	11145	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	11145	5	was	be	VBD
cord-005453-4057qib7	11145	6	diffuse	diffuse	JJ
cord-005453-4057qib7	11145	7	large	large	JJ
cord-005453-4057qib7	11145	8	B	b	NN
cord-005453-4057qib7	11145	9	-	-	HYPH
cord-005453-4057qib7	11145	10	cell	cell	NN
cord-005453-4057qib7	11145	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11145	12	(	(	-LRB-
cord-005453-4057qib7	11145	13	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11145	14	)	)	-RRB-
cord-005453-4057qib7	11145	15	.	.	.
cord-005453-4057qib7	11146	1	One	one	CD
cord-005453-4057qib7	11146	2	hundred	hundred	CD
cord-005453-4057qib7	11146	3	and	and	CC
cord-005453-4057qib7	11146	4	nine	nine	CD
cord-005453-4057qib7	11146	5	patients	patient	NNS
cord-005453-4057qib7	11146	6	received	receive	VBD
cord-005453-4057qib7	11146	7	upfront	upfront	JJ
cord-005453-4057qib7	11146	8	ASCT	ASCT	NNP
cord-005453-4057qib7	11146	9	for	for	IN
cord-005453-4057qib7	11146	10	high	high	JJ
cord-005453-4057qib7	11146	11	risk	risk	NN
cord-005453-4057qib7	11146	12	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11146	13	(	(	-LRB-
cord-005453-4057qib7	11146	14	defined	define	VBN
cord-005453-4057qib7	11146	15	as	as	IN
cord-005453-4057qib7	11146	16	age	age	NN
cord-005453-4057qib7	11146	17	-	-	HYPH
cord-005453-4057qib7	11146	18	adjusted	adjust	VBN
cord-005453-4057qib7	11146	19	IPI	IPI	NNP
cord-005453-4057qib7	11146	20	2	2	CD
cord-005453-4057qib7	11146	21	-	-	HYPH
cord-005453-4057qib7	11146	22	3)(n=28	3)(n=28	CD
cord-005453-4057qib7	11146	23	)	)	-RRB-
cord-005453-4057qib7	11146	24	or	or	CC
cord-005453-4057qib7	11146	25	for	for	IN
cord-005453-4057qib7	11146	26	having	have	VBG
cord-005453-4057qib7	11146	27	received	receive	VBN
cord-005453-4057qib7	11146	28	two	two	CD
cord-005453-4057qib7	11146	29	or	or	CC
cord-005453-4057qib7	11146	30	more	more	JJR
cord-005453-4057qib7	11146	31	lines	line	NNS
cord-005453-4057qib7	11146	32	to	to	TO
cord-005453-4057qib7	11146	33	obtain	obtain	VB
cord-005453-4057qib7	11146	34	first	first	JJ
cord-005453-4057qib7	11146	35	complete	complete	JJ
cord-005453-4057qib7	11146	36	remission	remission	NN
cord-005453-4057qib7	11146	37	(	(	-LRB-
cord-005453-4057qib7	11146	38	n=28	n=28	RB
cord-005453-4057qib7	11146	39	)	)	-RRB-
cord-005453-4057qib7	11146	40	,	,	,
cord-005453-4057qib7	11146	41	for	for	IN
cord-005453-4057qib7	11146	42	T	t	NN
cord-005453-4057qib7	11146	43	-	-	HYPH
cord-005453-4057qib7	11146	44	cell	cell	NN
cord-005453-4057qib7	11146	45	lymphoma	lymphoma	NN
cord-005453-4057qib7	11146	46	(	(	-LRB-
cord-005453-4057qib7	11146	47	n=27	n=27	NNP
cord-005453-4057qib7	11146	48	)	)	-RRB-
cord-005453-4057qib7	11146	49	and	and	CC
cord-005453-4057qib7	11146	50	for	for	IN
cord-005453-4057qib7	11146	51	mantle	mantle	NN
cord-005453-4057qib7	11146	52	cell	cell	NN
cord-005453-4057qib7	11146	53	lymphoma	lymphoma	NN
cord-005453-4057qib7	11146	54	(	(	-LRB-
cord-005453-4057qib7	11146	55	n=26	n=26	RB
cord-005453-4057qib7	11146	56	)	)	-RRB-
cord-005453-4057qib7	11146	57	.	.	.
cord-005453-4057qib7	11147	1	The	the	DT
cord-005453-4057qib7	11147	2	rest	rest	NN
cord-005453-4057qib7	11147	3	was	be	VBD
cord-005453-4057qib7	11147	4	performed	perform	VBN
cord-005453-4057qib7	11147	5	in	in	IN
cord-005453-4057qib7	11147	6	relapsed	relapsed	JJ
cord-005453-4057qib7	11147	7	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11147	8	.	.	.
cord-005453-4057qib7	11148	1	Forty	forty	CD
cord-005453-4057qib7	11148	2	-	-	HYPH
cord-005453-4057qib7	11148	3	seven	seven	CD
cord-005453-4057qib7	11148	4	patients	patient	NNS
cord-005453-4057qib7	11148	5	(	(	-LRB-
cord-005453-4057qib7	11148	6	29	29	CD
cord-005453-4057qib7	11148	7	%	%	NN
cord-005453-4057qib7	11148	8	)	)	-RRB-
cord-005453-4057qib7	11148	9	relapsed	relapse	VBN
cord-005453-4057qib7	11148	10	and	and	CC
cord-005453-4057qib7	11148	11	PFS	PFS	NNP
cord-005453-4057qib7	11148	12	was	be	VBD
cord-005453-4057qib7	11148	13	110	110	CD
cord-005453-4057qib7	11148	14	months	month	NNS
cord-005453-4057qib7	11148	15	.	.	.
cord-005453-4057qib7	11149	1	Pretransplant	pretransplant	JJ
cord-005453-4057qib7	11149	2	response	response	NN
cord-005453-4057qib7	11149	3	was	be	VBD
cord-005453-4057qib7	11149	4	evaluated	evaluate	VBN
cord-005453-4057qib7	11149	5	with	with	IN
cord-005453-4057qib7	11149	6	CT	CT	NNP
cord-005453-4057qib7	11149	7	scan	scan	NN
cord-005453-4057qib7	11149	8	in	in	IN
cord-005453-4057qib7	11149	9	66	66	CD
cord-005453-4057qib7	11149	10	patients	patient	NNS
cord-005453-4057qib7	11149	11	(	(	-LRB-
cord-005453-4057qib7	11149	12	11	11	CD
cord-005453-4057qib7	11149	13	of	of	IN
cord-005453-4057qib7	11149	14	this	this	DT
cord-005453-4057qib7	11149	15	with	with	IN
cord-005453-4057qib7	11149	16	partial	partial	JJ
cord-005453-4057qib7	11149	17	remission	remission	NN
cord-005453-4057qib7	11149	18	(	(	-LRB-
cord-005453-4057qib7	11149	19	CT	CT	NNP
cord-005453-4057qib7	11149	20	-	-	HYPH
cord-005453-4057qib7	11149	21	PR	PR	NNP
cord-005453-4057qib7	11149	22	)	)	-RRB-
cord-005453-4057qib7	11149	23	and	and	CC
cord-005453-4057qib7	11149	24	94	94	CD
cord-005453-4057qib7	11149	25	patients	patient	NNS
cord-005453-4057qib7	11149	26	were	be	VBD
cord-005453-4057qib7	11149	27	evaluated	evaluate	VBN
cord-005453-4057qib7	11149	28	with	with	IN
cord-005453-4057qib7	11149	29	FDGPET	FDGPET	NNP
cord-005453-4057qib7	11149	30	/	/	SYM
cord-005453-4057qib7	11149	31	CT	CT	NNP
cord-005453-4057qib7	11149	32	(	(	-LRB-
cord-005453-4057qib7	11149	33	27	27	CD
cord-005453-4057qib7	11149	34	were	be	VBD
cord-005453-4057qib7	11150	1	pretransplant	pretransplant	JJ
cord-005453-4057qib7	11150	2	positive	positive	JJ
cord-005453-4057qib7	11150	3	(	(	-LRB-
cord-005453-4057qib7	11150	4	PET1	PET1	NNP
cord-005453-4057qib7	11150	5	)	)	-RRB-
cord-005453-4057qib7	11150	6	;	;	:
cord-005453-4057qib7	11150	7	of	of	IN
cord-005453-4057qib7	11150	8	these	these	DT
cord-005453-4057qib7	11150	9	,	,	,
cord-005453-4057qib7	11150	10	18	18	CD
cord-005453-4057qib7	11150	11	patients	patient	NNS
cord-005453-4057qib7	11150	12	maintained	maintain	VBD
cord-005453-4057qib7	11150	13	positivity	positivity	NN
cord-005453-4057qib7	11150	14	at	at	IN
cord-005453-4057qib7	11150	15	day	day	NN
cord-005453-4057qib7	11150	16	100	100	CD
cord-005453-4057qib7	11150	17	after	after	IN
cord-005453-4057qib7	11150	18	ASTC	ASTC	NNP
cord-005453-4057qib7	11150	19	(	(	-LRB-
cord-005453-4057qib7	11150	20	PET2	PET2	NNP
cord-005453-4057qib7	11150	21	)	)	-RRB-
cord-005453-4057qib7	11150	22	.	.	.
cord-005453-4057qib7	11151	1	PFS	PFS	NNP
cord-005453-4057qib7	11151	2	in	in	IN
cord-005453-4057qib7	11151	3	patients	patient	NNS
cord-005453-4057qib7	11151	4	with	with	IN
cord-005453-4057qib7	11151	5	CT	CT	NNP
cord-005453-4057qib7	11151	6	-	-	HYPH
cord-005453-4057qib7	11151	7	PR	PR	NNP
cord-005453-4057qib7	11151	8	was	be	VBD
cord-005453-4057qib7	11151	9	46	46	CD
cord-005453-4057qib7	11151	10	months	month	NNS
cord-005453-4057qib7	11151	11	,	,	,
cord-005453-4057qib7	11151	12	in	in	IN
cord-005453-4057qib7	11151	13	PET1	PET1	NNP
cord-005453-4057qib7	11151	14	positive	positive	JJ
cord-005453-4057qib7	11151	15	ones	one	NNS
cord-005453-4057qib7	11151	16	99	99	CD
cord-005453-4057qib7	11151	17	months	month	NNS
cord-005453-4057qib7	11151	18	and	and	CC
cord-005453-4057qib7	11151	19	in	in	IN
cord-005453-4057qib7	11151	20	PET2	PET2	NNP
cord-005453-4057qib7	11151	21	positive	positive	JJ
cord-005453-4057qib7	11151	22	ones	one	NNS
cord-005453-4057qib7	11151	23	21	21	CD
cord-005453-4057qib7	11151	24	months	month	NNS
cord-005453-4057qib7	11151	25	.	.	.
cord-005453-4057qib7	11152	1	Univariate	Univariate	NNP
cord-005453-4057qib7	11152	2	analysis	analysis	NN
cord-005453-4057qib7	11152	3	showed	show	VBD
cord-005453-4057qib7	11152	4	PET2	PET2	NNP
cord-005453-4057qib7	11152	5	positivity	positivity	NN
cord-005453-4057qib7	11152	6	as	as	IN
cord-005453-4057qib7	11152	7	the	the	DT
cord-005453-4057qib7	11152	8	most	most	RBS
cord-005453-4057qib7	11152	9	accurate	accurate	JJ
cord-005453-4057qib7	11152	10	predictor	predictor	NN
cord-005453-4057qib7	11152	11	of	of	IN
cord-005453-4057qib7	11152	12	relapse	relapse	NN
cord-005453-4057qib7	11152	13	(	(	-LRB-
cord-005453-4057qib7	11152	14	HR	HR	NNP
cord-005453-4057qib7	11152	15	3,13	3,13	NNP
cord-005453-4057qib7	11152	16	,	,	,
cord-005453-4057qib7	11152	17	p=0,004	p=0,004	NNP
cord-005453-4057qib7	11152	18	)	)	-RRB-
cord-005453-4057qib7	11152	19	followed	follow	VBN
cord-005453-4057qib7	11152	20	by	by	IN
cord-005453-4057qib7	11152	21	AMC	AMC	NNP
cord-005453-4057qib7	11152	22	at	at	IN
cord-005453-4057qib7	11152	23	day	day	NN
cord-005453-4057qib7	11152	24	+100	+100	NNP
cord-005453-4057qib7	11152	25	(	(	-LRB-
cord-005453-4057qib7	11152	26	HR	HR	NNP
cord-005453-4057qib7	11152	27	1,002	1,002	CD
cord-005453-4057qib7	11152	28	,	,	,
cord-005453-4057qib7	11152	29	p=0,13	p=0,13	NNP
cord-005453-4057qib7	11152	30	)	)	-RRB-
cord-005453-4057qib7	11152	31	,	,	,
cord-005453-4057qib7	11152	32	albumin	albumin	NN
cord-005453-4057qib7	11152	33	at	at	IN
cord-005453-4057qib7	11152	34	day	day	NN
cord-005453-4057qib7	11152	35	+100	+100	NNS
cord-005453-4057qib7	11152	36	(	(	-LRB-
cord-005453-4057qib7	11152	37	HR	HR	NNP
cord-005453-4057qib7	11152	38	0,93	0,93	NN
cord-005453-4057qib7	11152	39	,	,	,
cord-005453-4057qib7	11152	40	p=0,03	p=0,03	NNP
cord-005453-4057qib7	11152	41	)	)	-RRB-
cord-005453-4057qib7	11152	42	,	,	,
cord-005453-4057qib7	11152	43	LDH	LDH	NNP
cord-005453-4057qib7	11152	44	at	at	IN
cord-005453-4057qib7	11152	45	day	day	NN
cord-005453-4057qib7	11152	46	+100	+100	NNP
cord-005453-4057qib7	11152	47	(	(	-LRB-
cord-005453-4057qib7	11152	48	HR	HR	NNP
cord-005453-4057qib7	11152	49	1,002	1,002	CD
cord-005453-4057qib7	11152	50	,	,	,
cord-005453-4057qib7	11152	51	p	p	NN
cord-005453-4057qib7	11152	52	<	<	XX
cord-005453-4057qib7	11152	53	0,001	0,001	CD
cord-005453-4057qib7	11152	54	)	)	-RRB-
cord-005453-4057qib7	11152	55	and	and	CC
cord-005453-4057qib7	11152	56	pretransplant	pretransplant	VB
cord-005453-4057qib7	11152	57	ALC	ALC	NNP
cord-005453-4057qib7	11152	58	/	/	SYM
cord-005453-4057qib7	11152	59	AMC	AMC	NNP
cord-005453-4057qib7	11152	60	ratio	ratio	NN
cord-005453-4057qib7	11152	61	(	(	-LRB-
cord-005453-4057qib7	11152	62	HR	HR	NNP
cord-005453-4057qib7	11152	63	1,068	1,068	CD
cord-005453-4057qib7	11152	64	p=0,008	p=0,008	NNP
cord-005453-4057qib7	11152	65	)	)	-RRB-
cord-005453-4057qib7	11152	66	.	.	.
cord-005453-4057qib7	11153	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	11153	2	analysis	analysis	NN
cord-005453-4057qib7	11153	3	only	only	RB
cord-005453-4057qib7	11153	4	demonstrated	demonstrate	VBD
cord-005453-4057qib7	11153	5	an	an	DT
cord-005453-4057qib7	11153	6	association	association	NN
cord-005453-4057qib7	11153	7	with	with	IN
cord-005453-4057qib7	11153	8	PET2	PET2	NNP
cord-005453-4057qib7	11153	9	positivity	positivity	NN
cord-005453-4057qib7	11153	10	(	(	-LRB-
cord-005453-4057qib7	11153	11	HR	HR	NNP
cord-005453-4057qib7	11153	12	7,78	7,78	CD
cord-005453-4057qib7	11153	13	)	)	-RRB-
cord-005453-4057qib7	11154	1	p	p	NN
cord-005453-4057qib7	11154	2	<	<	XX
cord-005453-4057qib7	11154	3	001	001	CD
cord-005453-4057qib7	11154	4	and	and	CC
cord-005453-4057qib7	11154	5	LDH	LDH	NNP
cord-005453-4057qib7	11154	6	in	in	IN
cord-005453-4057qib7	11154	7	day	day	NN
cord-005453-4057qib7	11154	8	+100	+100	NNS
cord-005453-4057qib7	11154	9	(	(	-LRB-
cord-005453-4057qib7	11154	10	HR	HR	NNP
cord-005453-4057qib7	11154	11	1,008	1,008	CD
cord-005453-4057qib7	11154	12	)	)	-RRB-
cord-005453-4057qib7	11154	13	p=0,003	p=0,003	VBP
cord-005453-4057qib7	11154	14	with	with	IN
cord-005453-4057qib7	11154	15	PFS	PFS	NNP
cord-005453-4057qib7	11154	16	.	.	.
cord-005453-4057qib7	11155	1	Five	five	CD
cord-005453-4057qib7	11155	2	and	and	CC
cord-005453-4057qib7	11155	3	ten	ten	CD
cord-005453-4057qib7	11155	4	years	year	NNS
cord-005453-4057qib7	11155	5	overall	overall	JJ
cord-005453-4057qib7	11155	6	survival	survival	NN
cord-005453-4057qib7	11155	7	were	be	VBD
cord-005453-4057qib7	11155	8	61	61	CD
cord-005453-4057qib7	11155	9	%	%	NN
cord-005453-4057qib7	11155	10	and	and	CC
cord-005453-4057qib7	11155	11	37	37	CD
cord-005453-4057qib7	11155	12	%	%	NN
cord-005453-4057qib7	11155	13	in	in	IN
cord-005453-4057qib7	11155	14	PET2	PET2	NNP
cord-005453-4057qib7	11155	15	negative	negative	JJ
cord-005453-4057qib7	11155	16	patients	patient	NNS
cord-005453-4057qib7	11155	17	vs	vs	IN
cord-005453-4057qib7	11155	18	25	25	CD
cord-005453-4057qib7	11155	19	and	and	CC
cord-005453-4057qib7	11155	20	5	5	CD
cord-005453-4057qib7	11155	21	%	%	NN
cord-005453-4057qib7	11155	22	in	in	IN
cord-005453-4057qib7	11155	23	PET2	PET2	NNP
cord-005453-4057qib7	11155	24	positive	positive	JJ
cord-005453-4057qib7	11155	25	ones	one	NNS
cord-005453-4057qib7	11156	1	(	(	-LRB-
cord-005453-4057qib7	11156	2	p	p	NN
cord-005453-4057qib7	11156	3	<	<	XX
cord-005453-4057qib7	11156	4	0,01	0,01	NN
cord-005453-4057qib7	11156	5	)	)	-RRB-
cord-005453-4057qib7	11156	6	.	.	.
cord-005453-4057qib7	11157	1	Eight	eight	CD
cord-005453-4057qib7	11157	2	out	out	IN
cord-005453-4057qib7	11157	3	of	of	IN
cord-005453-4057qib7	11157	4	19	19	CD
cord-005453-4057qib7	11157	5	patients	patient	NNS
cord-005453-4057qib7	11157	6	with	with	IN
cord-005453-4057qib7	11157	7	PET2	PET2	NNP
cord-005453-4057qib7	11157	8	positivity	positivity	NN
cord-005453-4057qib7	11157	9	did	do	VBD
cord-005453-4057qib7	11157	10	not	not	RB
cord-005453-4057qib7	11157	11	relapse	relapse	VB
cord-005453-4057qib7	11157	12	.	.	.
cord-005453-4057qib7	11158	1	Salvage	salvage	NN
cord-005453-4057qib7	11158	2	radiation	radiation	NN
cord-005453-4057qib7	11158	3	therapy	therapy	NN
cord-005453-4057qib7	11158	4	was	be	VBD
cord-005453-4057qib7	11158	5	used	use	VBN
cord-005453-4057qib7	11158	6	in	in	IN
cord-005453-4057qib7	11158	7	7	7	CD
cord-005453-4057qib7	11158	8	patients	patient	NNS
cord-005453-4057qib7	11158	9	with	with	IN
cord-005453-4057qib7	11158	10	positive	positive	JJ
cord-005453-4057qib7	11158	11	residual	residual	JJ
cord-005453-4057qib7	11158	12	mass	mass	NN
cord-005453-4057qib7	11158	13	and	and	CC
cord-005453-4057qib7	11158	14	5	5	CD
cord-005453-4057qib7	11158	15	of	of	IN
cord-005453-4057qib7	11158	16	them	-PRON-	PRP
cord-005453-4057qib7	11158	17	did	do	VBD
cord-005453-4057qib7	11158	18	not	not	RB
cord-005453-4057qib7	11158	19	relapse	relapse	VB
cord-005453-4057qib7	11158	20	.	.	.
cord-005453-4057qib7	11159	1	Two	two	CD
cord-005453-4057qib7	11159	2	patients	patient	NNS
cord-005453-4057qib7	11159	3	relapsed	relapse	VBD
cord-005453-4057qib7	11159	4	:	:	:
cord-005453-4057qib7	11160	1	one	one	CD
cord-005453-4057qib7	11160	2	patient	patient	NN
cord-005453-4057qib7	11160	3	had	have	VBD
cord-005453-4057qib7	11160	4	residual	residual	JJ
cord-005453-4057qib7	11160	5	mass	mass	NN
cord-005453-4057qib7	11160	6	and	and	CC
cord-005453-4057qib7	11160	7	another	another	DT
cord-005453-4057qib7	11160	8	had	have	VBD
cord-005453-4057qib7	11160	9	remote	remote	JJ
cord-005453-4057qib7	11160	10	affectation	affectation	NN
cord-005453-4057qib7	11160	11	from	from	IN
cord-005453-4057qib7	11160	12	primary	primary	JJ
cord-005453-4057qib7	11160	13	site	site	NN
cord-005453-4057qib7	11160	14	and	and	CC
cord-005453-4057qib7	11160	15	could	could	MD
cord-005453-4057qib7	11160	16	be	be	VB
cord-005453-4057qib7	11160	17	considered	consider	VBN
cord-005453-4057qib7	11160	18	as	as	IN
cord-005453-4057qib7	11160	19	progression	progression	NN
cord-005453-4057qib7	11160	20	before	before	IN
cord-005453-4057qib7	11160	21	day	day	NN
cord-005453-4057qib7	11160	22	+100	+100	NNS
cord-005453-4057qib7	11160	23	.	.	.
cord-005453-4057qib7	11161	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11161	2	:	:	:
cord-005453-4057qib7	11162	1	Post	Post	NNP
cord-005453-4057qib7	11162	2	ASCT	ASCT	NNP
cord-005453-4057qib7	11163	1	FDGPET/	FDGPET/	NNP
cord-005453-4057qib7	11163	2	CT	CT	NNP
cord-005453-4057qib7	11163	3	is	be	VBZ
cord-005453-4057qib7	11163	4	superior	superior	JJ
cord-005453-4057qib7	11163	5	to	to	IN
cord-005453-4057qib7	11163	6	conventional	conventional	JJ
cord-005453-4057qib7	11163	7	CT	CT	NNP
cord-005453-4057qib7	11163	8	in	in	IN
cord-005453-4057qib7	11163	9	predicting	predict	VBG
cord-005453-4057qib7	11163	10	outcome	outcome	NN
cord-005453-4057qib7	11163	11	in	in	IN
cord-005453-4057qib7	11163	12	aggressive	aggressive	JJ
cord-005453-4057qib7	11163	13	lymphoma	lymphoma	NN
cord-005453-4057qib7	11163	14	after	after	IN
cord-005453-4057qib7	11163	15	ASTC	ASTC	NNP
cord-005453-4057qib7	11163	16	.	.	.
cord-005453-4057qib7	11164	1	Pre	pre	JJ
cord-005453-4057qib7	11164	2	and	and	CC
cord-005453-4057qib7	11164	3	post	post	VB
cord-005453-4057qib7	11164	4	ASCT	asct	JJ
cord-005453-4057qib7	11164	5	systemic	systemic	JJ
cord-005453-4057qib7	11164	6	inflammatory	inflammatory	JJ
cord-005453-4057qib7	11164	7	parameters	parameter	NNS
cord-005453-4057qib7	11164	8	did	do	VBD
cord-005453-4057qib7	11164	9	n't	not	RB
cord-005453-4057qib7	11164	10	help	help	NN
cord-005453-4057qib7	11164	11	to	to	TO
cord-005453-4057qib7	11164	12	improve	improve	VB
cord-005453-4057qib7	11164	13	the	the	DT
cord-005453-4057qib7	11164	14	relapse	relapse	NN
cord-005453-4057qib7	11164	15	risk	risk	NN
cord-005453-4057qib7	11164	16	prediction	prediction	NN
cord-005453-4057qib7	11164	17	.	.	.
cord-005453-4057qib7	11165	1	Addition	addition	NN
cord-005453-4057qib7	11165	2	of	of	IN
cord-005453-4057qib7	11165	3	consolidative	consolidative	JJ
cord-005453-4057qib7	11165	4	RT	RT	NNP
cord-005453-4057qib7	11165	5	after	after	IN
cord-005453-4057qib7	11165	6	ASTC	ASTC	NNP
cord-005453-4057qib7	11165	7	has	have	VBZ
cord-005453-4057qib7	11165	8	demonstrated	demonstrate	VBN
cord-005453-4057qib7	11165	9	improvement	improvement	NN
cord-005453-4057qib7	11165	10	in	in	IN
cord-005453-4057qib7	11165	11	PFS	PFS	NNP
cord-005453-4057qib7	11165	12	in	in	IN
cord-005453-4057qib7	11165	13	patients	patient	NNS
cord-005453-4057qib7	11165	14	with	with	IN
cord-005453-4057qib7	11165	15	PET	pet	JJ
cord-005453-4057qib7	11165	16	positivity	positivity	NN
cord-005453-4057qib7	11165	17	.	.	.
cord-005453-4057qib7	11166	1	It	-PRON-	PRP
cord-005453-4057qib7	11166	2	would	would	MD
cord-005453-4057qib7	11166	3	be	be	VB
cord-005453-4057qib7	11166	4	neccesary	neccesary	JJ
cord-005453-4057qib7	11166	5	to	to	TO
cord-005453-4057qib7	11166	6	develop	develop	VB
cord-005453-4057qib7	11166	7	randomized	randomized	JJ
cord-005453-4057qib7	11166	8	trials	trial	NNS
cord-005453-4057qib7	11166	9	to	to	TO
cord-005453-4057qib7	11166	10	assess	assess	VB
cord-005453-4057qib7	11166	11	the	the	DT
cord-005453-4057qib7	11166	12	role	role	NN
cord-005453-4057qib7	11166	13	of	of	IN
cord-005453-4057qib7	11166	14	RT	RT	NNP
cord-005453-4057qib7	11166	15	in	in	IN
cord-005453-4057qib7	11166	16	residual	residual	JJ
cord-005453-4057qib7	11166	17	disease	disease	NN
cord-005453-4057qib7	11166	18	in	in	IN
cord-005453-4057qib7	11166	19	advanced	advanced	JJ
cord-005453-4057qib7	11166	20	aggressive	aggressive	JJ
cord-005453-4057qib7	11166	21	NHL	NHL	NNP
cord-005453-4057qib7	11166	22	with	with	IN
cord-005453-4057qib7	11166	23	insufficient	insufficient	JJ
cord-005453-4057qib7	11166	24	response	response	NN
cord-005453-4057qib7	11166	25	to	to	IN
cord-005453-4057qib7	11166	26	systemic	systemic	JJ
cord-005453-4057qib7	11166	27	treatment	treatment	NN
cord-005453-4057qib7	11166	28	with	with	IN
cord-005453-4057qib7	11166	29	PET	pet	JJ
cord-005453-4057qib7	11166	30	response	response	NN
cord-005453-4057qib7	11166	31	evaluation	evaluation	NN
cord-005453-4057qib7	11166	32	.	.	.
cord-005453-4057qib7	11167	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11167	2	:	:	:
cord-005453-4057qib7	11167	3	Nothing	nothing	NN
cord-005453-4057qib7	11167	4	to	to	TO
cord-005453-4057qib7	11167	5	declare	declare	VB
cord-005453-4057qib7	11167	6	Long	long	JJ
cord-005453-4057qib7	11167	7	term	term	NN
cord-005453-4057qib7	11167	8	outcome	outcome	NN
cord-005453-4057qib7	11167	9	of	of	IN
cord-005453-4057qib7	11167	10	patients	patient	NNS
cord-005453-4057qib7	11167	11	with	with	IN
cord-005453-4057qib7	11167	12	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11167	13	malignancy	malignancy	NN
cord-005453-4057qib7	11167	14	who	who	WP
cord-005453-4057qib7	11167	15	underwent	undergo	VBD
cord-005453-4057qib7	11167	16	high	high	JJ
cord-005453-4057qib7	11167	17	dose	dose	NN
cord-005453-4057qib7	11168	1	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11168	2	followed	follow	VBD
cord-005453-4057qib7	11168	3	autologous	autologous	JJ
cord-005453-4057qib7	11168	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11168	5	cell	cell	NN
cord-005453-4057qib7	11168	6	transplantation	transplantation	NN
cord-005453-4057qib7	11168	7	at	at	IN
cord-005453-4057qib7	11168	8	a	a	DT
cord-005453-4057qib7	11168	9	single	single	JJ
cord-005453-4057qib7	11168	10	institution	institution	NN
cord-005453-4057qib7	11168	11	over	over	IN
cord-005453-4057qib7	11168	12	20	20	CD
cord-005453-4057qib7	11168	13	years	year	NNS
cord-005453-4057qib7	11168	14	Joanna	Joanna	NNP
cord-005453-4057qib7	11168	15	Romejko	Romejko	NNP
cord-005453-4057qib7	11168	16	-	-	HYPH
cord-005453-4057qib7	11168	17	Jarosinska	Jarosinska	NNP
cord-005453-4057qib7	11168	18	1	1	CD
cord-005453-4057qib7	11168	19	,	,	,
cord-005453-4057qib7	11168	20	Ewa	Ewa	NNP
cord-005453-4057qib7	11168	21	Paszkiewicz	Paszkiewicz	NNP
cord-005453-4057qib7	11168	22	-	-	HYPH
cord-005453-4057qib7	11168	23	Kozik	Kozik	NNP
cord-005453-4057qib7	11168	24	1	1	CD
cord-005453-4057qib7	11168	25	,	,	,
cord-005453-4057qib7	11168	26	Lukasz	Lukasz	NNP
cord-005453-4057qib7	11168	27	Targonski	Targonski	NNP
cord-005453-4057qib7	11168	28	1	1	CD
cord-005453-4057qib7	11168	29	,	,	,
cord-005453-4057qib7	11168	30	Lidia	Lidia	NNP
cord-005453-4057qib7	11168	31	Popławska	Popławska	NNP
cord-005453-4057qib7	11168	32	1	1	CD
cord-005453-4057qib7	11168	33	,	,	,
cord-005453-4057qib7	11168	34	Jan	Jan	NNP
cord-005453-4057qib7	11168	35	Walewski	Walewski	NNP
cord-005453-4057qib7	11168	36	1	1	CD
cord-005453-4057qib7	11168	37	Background	Background	NNP
cord-005453-4057qib7	11168	38	:	:	:
cord-005453-4057qib7	11169	1	High	high	JJ
cord-005453-4057qib7	11169	2	dose	dose	NN
cord-005453-4057qib7	11169	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11169	4	(	(	-LRB-
cord-005453-4057qib7	11169	5	HDT	HDT	NNP
cord-005453-4057qib7	11169	6	)	)	-RRB-
cord-005453-4057qib7	11169	7	and	and	CC
cord-005453-4057qib7	11169	8	autologous	autologous	JJ
cord-005453-4057qib7	11169	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11169	10	cell	cell	NN
cord-005453-4057qib7	11169	11	transplantation	transplantation	NN
cord-005453-4057qib7	11169	12	(	(	-LRB-
cord-005453-4057qib7	11169	13	auto	auto	NN
cord-005453-4057qib7	11169	14	-	-	HYPH
cord-005453-4057qib7	11169	15	HCT	HCT	NNP
cord-005453-4057qib7	11169	16	)	)	-RRB-
cord-005453-4057qib7	11169	17	is	be	VBZ
cord-005453-4057qib7	11169	18	a	a	DT
cord-005453-4057qib7	11169	19	standard	standard	NN
cord-005453-4057qib7	11169	20	of	of	IN
cord-005453-4057qib7	11169	21	care	care	NN
cord-005453-4057qib7	11169	22	for	for	IN
cord-005453-4057qib7	11169	23	relapsed	relapsed	JJ
cord-005453-4057qib7	11169	24	/	/	SYM
cord-005453-4057qib7	11169	25	refractory	refractory	JJ
cord-005453-4057qib7	11169	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	11169	27	patients	patient	NNS
cord-005453-4057qib7	11169	28	(	(	-LRB-
cord-005453-4057qib7	11169	29	pts	pts	NNP
cord-005453-4057qib7	11169	30	)	)	-RRB-
cord-005453-4057qib7	11169	31	or	or	CC
cord-005453-4057qib7	11169	32	it	-PRON-	PRP
cord-005453-4057qib7	11169	33	is	be	VBZ
cord-005453-4057qib7	11169	34	used	use	VBN
cord-005453-4057qib7	11169	35	as	as	IN
cord-005453-4057qib7	11169	36	a	a	DT
cord-005453-4057qib7	11169	37	consolidation	consolidation	NN
cord-005453-4057qib7	11169	38	for	for	IN
cord-005453-4057qib7	11169	39	myeloma	myeloma	NN
cord-005453-4057qib7	11169	40	and	and	CC
cord-005453-4057qib7	11169	41	high	high	JJ
cord-005453-4057qib7	11169	42	risk	risk	NN
cord-005453-4057qib7	11169	43	lymphoma	lymphoma	NN
cord-005453-4057qib7	11169	44	patients	patient	NNS
cord-005453-4057qib7	11169	45	in	in	IN
cord-005453-4057qib7	11169	46	first	first	JJ
cord-005453-4057qib7	11169	47	line	line	NN
cord-005453-4057qib7	11169	48	treatment	treatment	NN
cord-005453-4057qib7	11169	49	.	.	.
cord-005453-4057qib7	11170	1	We	-PRON-	PRP
cord-005453-4057qib7	11170	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	11170	3	evaluated	evaluate	VBD
cord-005453-4057qib7	11170	4	long	long	JJ
cord-005453-4057qib7	11170	5	-	-	HYPH
cord-005453-4057qib7	11170	6	term	term	NN
cord-005453-4057qib7	11170	7	outcome	outcome	NN
cord-005453-4057qib7	11170	8	including	include	VBG
cord-005453-4057qib7	11170	9	late	late	JJ
cord-005453-4057qib7	11170	10	effects	effect	NNS
cord-005453-4057qib7	11170	11	and	and	CC
cord-005453-4057qib7	11170	12	risk	risk	NN
cord-005453-4057qib7	11170	13	factors	factor	NNS
cord-005453-4057qib7	11170	14	in	in	IN
cord-005453-4057qib7	11170	15	patients	patient	NNS
cord-005453-4057qib7	11170	16	with	with	IN
cord-005453-4057qib7	11170	17	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11170	18	malignancy	malignancy	NN
cord-005453-4057qib7	11170	19	who	who	WP
cord-005453-4057qib7	11170	20	underwent	undergo	VBD
cord-005453-4057qib7	11170	21	auto	auto	NN
cord-005453-4057qib7	11170	22	-	-	HYPH
cord-005453-4057qib7	11170	23	HCT	hct	NN
cord-005453-4057qib7	11170	24	.	.	.
cord-005453-4057qib7	11171	1	Methods	method	NNS
cord-005453-4057qib7	11171	2	:	:	:
cord-005453-4057qib7	11172	1	We	-PRON-	PRP
cord-005453-4057qib7	11172	2	collected	collect	VBD
cord-005453-4057qib7	11172	3	data	datum	NNS
cord-005453-4057qib7	11172	4	from	from	IN
cord-005453-4057qib7	11172	5	926	926	CD
cord-005453-4057qib7	11172	6	consecutive	consecutive	JJ
cord-005453-4057qib7	11172	7	patients	patient	NNS
cord-005453-4057qib7	11172	8	with	with	IN
cord-005453-4057qib7	11172	9	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11172	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	11172	11	(	(	-LRB-
cord-005453-4057qib7	11172	12	HL	HL	NNP
cord-005453-4057qib7	11172	13	)	)	-RRB-
cord-005453-4057qib7	11172	14	(	(	-LRB-
cord-005453-4057qib7	11172	15	n=326	n=326	NNP
cord-005453-4057qib7	11172	16	)	)	-RRB-
cord-005453-4057qib7	11172	17	,	,	,
cord-005453-4057qib7	11172	18	aggressive	aggressive	JJ
cord-005453-4057qib7	11172	19	B	b	NN
cord-005453-4057qib7	11172	20	lymphoma	lymphoma	NN
cord-005453-4057qib7	11172	21	(	(	-LRB-
cord-005453-4057qib7	11172	22	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11172	23	)	)	-RRB-
cord-005453-4057qib7	11172	24	(	(	-LRB-
cord-005453-4057qib7	11172	25	n=186	n=186	NNP
cord-005453-4057qib7	11172	26	)	)	-RRB-
cord-005453-4057qib7	11172	27	,	,	,
cord-005453-4057qib7	11172	28	myeloma	myeloma	NN
cord-005453-4057qib7	11172	29	(	(	-LRB-
cord-005453-4057qib7	11172	30	n=199	n=199	NNP
cord-005453-4057qib7	11172	31	)	)	-RRB-
cord-005453-4057qib7	11172	32	,	,	,
cord-005453-4057qib7	11172	33	indolent	indolent	JJ
cord-005453-4057qib7	11172	34	lymphoma	lymphoma	NN
cord-005453-4057qib7	11172	35	(	(	-LRB-
cord-005453-4057qib7	11172	36	n=30	n=30	NNP
cord-005453-4057qib7	11172	37	)	)	-RRB-
cord-005453-4057qib7	11172	38	,	,	,
cord-005453-4057qib7	11172	39	mantle	mantle	NN
cord-005453-4057qib7	11172	40	cell	cell	NN
cord-005453-4057qib7	11172	41	lymphoma	lymphoma	NN
cord-005453-4057qib7	11172	42	(	(	-LRB-
cord-005453-4057qib7	11172	43	n=122	n=122	NNP
cord-005453-4057qib7	11172	44	)	)	-RRB-
cord-005453-4057qib7	11172	45	and	and	CC
cord-005453-4057qib7	11172	46	peripheral	peripheral	JJ
cord-005453-4057qib7	11172	47	T	T	NNP
cord-005453-4057qib7	11172	48	cell	cell	NN
cord-005453-4057qib7	11172	49	lymphoma	lymphoma	NN
cord-005453-4057qib7	11172	50	(	(	-LRB-
cord-005453-4057qib7	11172	51	n=63	n=63	NNP
cord-005453-4057qib7	11172	52	)	)	-RRB-
cord-005453-4057qib7	11172	53	who	who	WP
cord-005453-4057qib7	11172	54	underwent	undergo	VBD
cord-005453-4057qib7	11172	55	auto	auto	NN
cord-005453-4057qib7	11172	56	-	-	HYPH
cord-005453-4057qib7	11172	57	HCT	hct	NN
cord-005453-4057qib7	11172	58	at	at	IN
cord-005453-4057qib7	11172	59	our	-PRON-	PRP$
cord-005453-4057qib7	11172	60	institution	institution	NN
cord-005453-4057qib7	11172	61	between	between	IN
cord-005453-4057qib7	11172	62	1997	1997	CD
cord-005453-4057qib7	11172	63	and	and	CC
cord-005453-4057qib7	11172	64	2017	2017	CD
cord-005453-4057qib7	11172	65	.	.	.
cord-005453-4057qib7	11173	1	At	at	IN
cord-005453-4057qib7	11173	2	transplant	transplant	NN
cord-005453-4057qib7	11173	3	median	median	NN
cord-005453-4057qib7	11173	4	(	(	-LRB-
cord-005453-4057qib7	11173	5	range	range	NN
cord-005453-4057qib7	11173	6	)	)	-RRB-
cord-005453-4057qib7	11173	7	age	age	NN
cord-005453-4057qib7	11173	8	was	be	VBD
cord-005453-4057qib7	11173	9	46	46	CD
cord-005453-4057qib7	11174	1	(	(	-LRB-
cord-005453-4057qib7	11174	2	17	17	CD
cord-005453-4057qib7	11174	3	-	-	SYM
cord-005453-4057qib7	11174	4	71	71	CD
cord-005453-4057qib7	11174	5	)	)	-RRB-
cord-005453-4057qib7	11174	6	years	year	NNS
cord-005453-4057qib7	11174	7	,	,	,
cord-005453-4057qib7	11174	8	clinical	clinical	JJ
cord-005453-4057qib7	11174	9	stage	stage	NN
cord-005453-4057qib7	11174	10	III	III	NNP
cord-005453-4057qib7	11174	11	/	/	SYM
cord-005453-4057qib7	11174	12	IV	IV	NNP
cord-005453-4057qib7	11174	13	was	be	VBD
cord-005453-4057qib7	11174	14	found	find	VBN
cord-005453-4057qib7	11174	15	in	in	IN
cord-005453-4057qib7	11174	16	499	499	CD
cord-005453-4057qib7	11174	17	of	of	IN
cord-005453-4057qib7	11174	18	lymphoma	lymphoma	NN
cord-005453-4057qib7	11174	19	pts	pts	NN
cord-005453-4057qib7	11174	20	,	,	,
cord-005453-4057qib7	11174	21	complete	complete	JJ
cord-005453-4057qib7	11174	22	remission	remission	NN
cord-005453-4057qib7	11174	23	,	,	,
cord-005453-4057qib7	11174	24	partial	partial	JJ
cord-005453-4057qib7	11174	25	remission	remission	NN
cord-005453-4057qib7	11174	26	and	and	CC
cord-005453-4057qib7	11174	27	stable/	stable/	CD
cord-005453-4057qib7	11174	28	progressive	progressive	JJ
cord-005453-4057qib7	11174	29	disease	disease	NN
cord-005453-4057qib7	11174	30	occurred	occur	VBD
cord-005453-4057qib7	11174	31	in	in	IN
cord-005453-4057qib7	11174	32	462(50	462(50	CD
cord-005453-4057qib7	11174	33	%	%	NN
cord-005453-4057qib7	11174	34	)	)	-RRB-
cord-005453-4057qib7	11174	35	,	,	,
cord-005453-4057qib7	11174	36	397	397	CD
cord-005453-4057qib7	11174	37	(	(	-LRB-
cord-005453-4057qib7	11174	38	43	43	CD
cord-005453-4057qib7	11174	39	%	%	NN
cord-005453-4057qib7	11174	40	)	)	-RRB-
cord-005453-4057qib7	11174	41	,	,	,
cord-005453-4057qib7	11174	42	67	67	CD
cord-005453-4057qib7	11174	43	(	(	-LRB-
cord-005453-4057qib7	11174	44	7	7	CD
cord-005453-4057qib7	11174	45	%	%	NN
cord-005453-4057qib7	11174	46	)	)	-RRB-
cord-005453-4057qib7	11174	47	pts	pt	NNS
cord-005453-4057qib7	11174	48	,	,	,
cord-005453-4057qib7	11174	49	respectively	respectively	RB
cord-005453-4057qib7	11174	50	.	.	.
cord-005453-4057qib7	11175	1	BEAM	BEAM	NNP
cord-005453-4057qib7	11175	2	regimen	regimen	NN
cord-005453-4057qib7	11175	3	was	be	VBD
cord-005453-4057qib7	11175	4	used	use	VBN
cord-005453-4057qib7	11175	5	in	in	IN
cord-005453-4057qib7	11175	6	549	549	CD
cord-005453-4057qib7	11175	7	pts	pt	NNS
cord-005453-4057qib7	11175	8	(	(	-LRB-
cord-005453-4057qib7	11175	9	59	59	CD
cord-005453-4057qib7	11175	10	%	%	NN
cord-005453-4057qib7	11175	11	)	)	-RRB-
cord-005453-4057qib7	11175	12	,	,	,
cord-005453-4057qib7	11175	13	Mel200	mel200	NN
cord-005453-4057qib7	11175	14	in	in	IN
cord-005453-4057qib7	11175	15	200	200	CD
cord-005453-4057qib7	11175	16	pts	pt	NNS
cord-005453-4057qib7	11175	17	(	(	-LRB-
cord-005453-4057qib7	11175	18	23	23	CD
cord-005453-4057qib7	11175	19	%	%	NN
cord-005453-4057qib7	11175	20	)	)	-RRB-
cord-005453-4057qib7	11175	21	and	and	CC
cord-005453-4057qib7	11175	22	other	other	JJ
cord-005453-4057qib7	11175	23	myeloablative	myeloablative	JJ
cord-005453-4057qib7	11175	24	regimens	regimen	NNS
cord-005453-4057qib7	11175	25	in	in	IN
cord-005453-4057qib7	11175	26	177	177	CD
cord-005453-4057qib7	11175	27	pts	pt	NNS
cord-005453-4057qib7	11175	28	(	(	-LRB-
cord-005453-4057qib7	11175	29	18	18	CD
cord-005453-4057qib7	11175	30	%	%	NN
cord-005453-4057qib7	11175	31	)	)	-RRB-
cord-005453-4057qib7	11175	32	.	.	.
cord-005453-4057qib7	11176	1	Results	result	NNS
cord-005453-4057qib7	11176	2	62	62	CD
cord-005453-4057qib7	11176	3	%	%	NN
cord-005453-4057qib7	11176	4	)	)	-RRB-
cord-005453-4057qib7	11176	5	]	]	-RRB-
cord-005453-4057qib7	11176	6	,	,	,
cord-005453-4057qib7	11176	7	respectively	respectively	RB
cord-005453-4057qib7	11176	8	.	.	.
cord-005453-4057qib7	11177	1	Partial	partial	JJ
cord-005453-4057qib7	11177	2	remission	remission	NN
cord-005453-4057qib7	11177	3	or	or	CC
cord-005453-4057qib7	11177	4	stable	stable	JJ
cord-005453-4057qib7	11177	5	disease	disease	NN
cord-005453-4057qib7	11177	6	at	at	IN
cord-005453-4057qib7	11177	7	transplant	transplant	NN
cord-005453-4057qib7	11177	8	,	,	,
cord-005453-4057qib7	11177	9	clinical	clinical	JJ
cord-005453-4057qib7	11177	10	stage	stage	NN
cord-005453-4057qib7	11177	11	III	III	NNP
cord-005453-4057qib7	11177	12	or	or	CC
cord-005453-4057qib7	11177	13	IV	IV	NNP
cord-005453-4057qib7	11177	14	,	,	,
cord-005453-4057qib7	11177	15	and	and	CC
cord-005453-4057qib7	11177	16	age	age	NN
cord-005453-4057qib7	11177	17	more	more	JJR
cord-005453-4057qib7	11177	18	than	than	IN
cord-005453-4057qib7	11177	19	60	60	CD
cord-005453-4057qib7	11177	20	,	,	,
cord-005453-4057qib7	11177	21	were	be	VBD
cord-005453-4057qib7	11177	22	identified	identify	VBN
cord-005453-4057qib7	11177	23	as	as	IN
cord-005453-4057qib7	11177	24	risk	risk	NN
cord-005453-4057qib7	11177	25	factors	factor	NNS
cord-005453-4057qib7	11177	26	associated	associate	VBN
cord-005453-4057qib7	11177	27	with	with	IN
cord-005453-4057qib7	11177	28	inferior	inferior	JJ
cord-005453-4057qib7	11177	29	OS	OS	NNP
cord-005453-4057qib7	11177	30	and	and	CC
cord-005453-4057qib7	11177	31	PFS	PFS	NNP
cord-005453-4057qib7	11177	32	in	in	IN
cord-005453-4057qib7	11177	33	univariate	univariate	JJ
cord-005453-4057qib7	11177	34	and	and	CC
cord-005453-4057qib7	11177	35	multivariate	multivariate	JJ
cord-005453-4057qib7	11177	36	analysis	analysis	NN
cord-005453-4057qib7	11177	37	.	.	.
cord-005453-4057qib7	11178	1	Histopathologic	Histopathologic	NNP
cord-005453-4057qib7	11178	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	11178	3	was	be	VBD
cord-005453-4057qib7	11178	4	not	not	RB
cord-005453-4057qib7	11178	5	a	a	DT
cord-005453-4057qib7	11178	6	risk	risk	NN
cord-005453-4057qib7	11178	7	factor	factor	NN
cord-005453-4057qib7	11178	8	for	for	IN
cord-005453-4057qib7	11178	9	OS	OS	NNP
cord-005453-4057qib7	11178	10	and	and	CC
cord-005453-4057qib7	11178	11	PFS	PFS	NNP
cord-005453-4057qib7	11178	12	(	(	-LRB-
cord-005453-4057qib7	11178	13	p	p	NN
cord-005453-4057qib7	11178	14	=	=	SYM
cord-005453-4057qib7	11178	15	NS	NS	NNP
cord-005453-4057qib7	11178	16	)	)	-RRB-
cord-005453-4057qib7	11178	17	.	.	.
cord-005453-4057qib7	11179	1	The	the	DT
cord-005453-4057qib7	11179	2	outcome	outcome	NN
cord-005453-4057qib7	11179	3	of	of	IN
cord-005453-4057qib7	11179	4	patients	patient	NNS
cord-005453-4057qib7	11179	5	who	who	WP
cord-005453-4057qib7	11179	6	underwent	undergo	VBD
cord-005453-4057qib7	11179	7	auto	auto	NN
cord-005453-4057qib7	11179	8	-	-	HYPH
cord-005453-4057qib7	11179	9	HCT	hct	NN
cord-005453-4057qib7	11179	10	between	between	IN
cord-005453-4057qib7	11179	11	1997	1997	CD
cord-005453-4057qib7	11179	12	-	-	SYM
cord-005453-4057qib7	11179	13	2003	2003	CD
cord-005453-4057qib7	11179	14	was	be	VBD
cord-005453-4057qib7	11179	15	inferior	inferior	JJ
cord-005453-4057qib7	11179	16	to	to	IN
cord-005453-4057qib7	11179	17	the	the	DT
cord-005453-4057qib7	11179	18	outcome	outcome	NN
cord-005453-4057qib7	11179	19	of	of	IN
cord-005453-4057qib7	11179	20	patients	patient	NNS
cord-005453-4057qib7	11179	21	treated	treat	VBN
cord-005453-4057qib7	11179	22	in	in	IN
cord-005453-4057qib7	11179	23	2004	2004	CD
cord-005453-4057qib7	11179	24	-	-	SYM
cord-005453-4057qib7	11179	25	2010	2010	CD
cord-005453-4057qib7	11179	26	or	or	CC
cord-005453-4057qib7	11179	27	2011	2011	CD
cord-005453-4057qib7	11179	28	-	-	SYM
cord-005453-4057qib7	11179	29	2017	2017	CD
cord-005453-4057qib7	11179	30	.	.	.
cord-005453-4057qib7	11180	1	5-	5-	CD
cord-005453-4057qib7	11180	2	year	year	NN
cord-005453-4057qib7	11180	3	OS	OS	NNP
cord-005453-4057qib7	11180	4	was	be	VBD
cord-005453-4057qib7	11180	5	53	53	CD
cord-005453-4057qib7	11180	6	%	%	NN
cord-005453-4057qib7	11180	7	,	,	,
cord-005453-4057qib7	11180	8	68	68	CD
cord-005453-4057qib7	11180	9	%	%	NN
cord-005453-4057qib7	11180	10	,	,	,
cord-005453-4057qib7	11180	11	73%(p	73%(p	CD
cord-005453-4057qib7	11180	12	<	<	XX
cord-005453-4057qib7	11180	13	0.001	0.001	CD
cord-005453-4057qib7	11180	14	)	)	-RRB-
cord-005453-4057qib7	11180	15	and	and	CC
cord-005453-4057qib7	11180	16	5	5	CD
cord-005453-4057qib7	11180	17	year	year	NN
cord-005453-4057qib7	11180	18	PFS	PFS	NNP
cord-005453-4057qib7	11180	19	was	be	VBD
cord-005453-4057qib7	11180	20	43	43	CD
cord-005453-4057qib7	11180	21	%	%	NN
cord-005453-4057qib7	11180	22	,	,	,
cord-005453-4057qib7	11180	23	54	54	CD
cord-005453-4057qib7	11180	24	%	%	NN
cord-005453-4057qib7	11180	25	,	,	,
cord-005453-4057qib7	11180	26	55	55	CD
cord-005453-4057qib7	11180	27	%	%	NN
cord-005453-4057qib7	11180	28	(	(	-LRB-
cord-005453-4057qib7	11180	29	p	p	NN
cord-005453-4057qib7	11180	30	<	<	XX
cord-005453-4057qib7	11180	31	0.01	0.01	CD
cord-005453-4057qib7	11180	32	)	)	-RRB-
cord-005453-4057qib7	11180	33	,	,	,
cord-005453-4057qib7	11180	34	respectively	respectively	RB
cord-005453-4057qib7	11180	35	.	.	.
cord-005453-4057qib7	11181	1	We	-PRON-	PRP
cord-005453-4057qib7	11181	2	recorded	record	VBD
cord-005453-4057qib7	11181	3	37	37	CD
cord-005453-4057qib7	11181	4	(	(	-LRB-
cord-005453-4057qib7	11181	5	4	4	CD
cord-005453-4057qib7	11181	6	%	%	NN
cord-005453-4057qib7	11181	7	)	)	-RRB-
cord-005453-4057qib7	11181	8	cases	case	NNS
cord-005453-4057qib7	11181	9	of	of	IN
cord-005453-4057qib7	11181	10	second	second	JJ
cord-005453-4057qib7	11181	11	primary	primary	JJ
cord-005453-4057qib7	11181	12	cancer	cancer	NN
cord-005453-4057qib7	11181	13	(	(	-LRB-
cord-005453-4057qib7	11181	14	18	18	CD
cord-005453-4057qib7	11181	15	solid	solid	JJ
cord-005453-4057qib7	11181	16	tumors	tumor	NNS
cord-005453-4057qib7	11181	17	and	and	CC
cord-005453-4057qib7	11181	18	19	19	CD
cord-005453-4057qib7	11181	19	hematologic	hematologic	JJ
cord-005453-4057qib7	11181	20	cancers	cancer	NNS
cord-005453-4057qib7	11181	21	)	)	-RRB-
cord-005453-4057qib7	11181	22	.	.	.
cord-005453-4057qib7	11182	1	Acute	acute	JJ
cord-005453-4057qib7	11182	2	cardiotoxicity	cardiotoxicity	NN
cord-005453-4057qib7	11182	3	occurred	occur	VBD
cord-005453-4057qib7	11182	4	in	in	IN
cord-005453-4057qib7	11182	5	5	5	CD
cord-005453-4057qib7	11182	6	patients	patient	NNS
cord-005453-4057qib7	11182	7	from	from	IN
cord-005453-4057qib7	11182	8	1	1	CD
cord-005453-4057qib7	11182	9	to	to	IN
cord-005453-4057qib7	11182	10	15	15	CD
cord-005453-4057qib7	11182	11	years	year	NNS
cord-005453-4057qib7	11182	12	after	after	IN
cord-005453-4057qib7	11182	13	transplant	transplant	NN
cord-005453-4057qib7	11182	14	,	,	,
cord-005453-4057qib7	11182	15	and	and	CC
cord-005453-4057qib7	11182	16	required	require	VBD
cord-005453-4057qib7	11182	17	heart	heart	NN
cord-005453-4057qib7	11182	18	transplant	transplant	NN
cord-005453-4057qib7	11182	19	in	in	IN
cord-005453-4057qib7	11182	20	2	2	CD
cord-005453-4057qib7	11182	21	patients	patient	NNS
cord-005453-4057qib7	11182	22	.	.	.
cord-005453-4057qib7	11183	1	326	326	CD
cord-005453-4057qib7	11183	2	patients	patient	NNS
cord-005453-4057qib7	11183	3	(	(	-LRB-
cord-005453-4057qib7	11183	4	35	35	CD
cord-005453-4057qib7	11183	5	%	%	NN
cord-005453-4057qib7	11183	6	)	)	-RRB-
cord-005453-4057qib7	11183	7	died	die	VBD
cord-005453-4057qib7	11183	8	.	.	.
cord-005453-4057qib7	11184	1	The	the	DT
cord-005453-4057qib7	11184	2	main	main	JJ
cord-005453-4057qib7	11184	3	causes	cause	NNS
cord-005453-4057qib7	11184	4	of	of	IN
cord-005453-4057qib7	11184	5	death	death	NN
cord-005453-4057qib7	11184	6	were	be	VBD
cord-005453-4057qib7	11184	7	progressive	progressive	JJ
cord-005453-4057qib7	11184	8	disease	disease	NN
cord-005453-4057qib7	11184	9	in	in	IN
cord-005453-4057qib7	11184	10	271	271	CD
cord-005453-4057qib7	11184	11	pts	pt	NNS
cord-005453-4057qib7	11184	12	(	(	-LRB-
cord-005453-4057qib7	11184	13	89	89	CD
cord-005453-4057qib7	11184	14	%	%	NN
cord-005453-4057qib7	11184	15	)	)	-RRB-
cord-005453-4057qib7	11184	16	,	,	,
cord-005453-4057qib7	11184	17	second	second	JJ
cord-005453-4057qib7	11184	18	primary	primary	JJ
cord-005453-4057qib7	11184	19	malignancy	malignancy	NN
cord-005453-4057qib7	11184	20	in	in	IN
cord-005453-4057qib7	11184	21	22	22	CD
cord-005453-4057qib7	11184	22	pts	pt	NNS
cord-005453-4057qib7	11184	23	(	(	-LRB-
cord-005453-4057qib7	11184	24	6.7	6.7	CD
cord-005453-4057qib7	11184	25	%	%	NN
cord-005453-4057qib7	11184	26	)	)	-RRB-
cord-005453-4057qib7	11185	1	Treatment	treatment	NN
cord-005453-4057qib7	11185	2	related	related	JJ
cord-005453-4057qib7	11185	3	mortality	mortality	NN
cord-005453-4057qib7	11185	4	was	be	VBD
cord-005453-4057qib7	11185	5	0.8	0.8	CD
cord-005453-4057qib7	11185	6	%	%	NN
cord-005453-4057qib7	11185	7	(	(	-LRB-
cord-005453-4057qib7	11185	8	8	8	CD
cord-005453-4057qib7	11185	9	pts	pt	NNS
cord-005453-4057qib7	11185	10	)	)	-RRB-
cord-005453-4057qib7	11185	11	,	,	,
cord-005453-4057qib7	11185	12	and	and	CC
cord-005453-4057qib7	11185	13	mortality	mortality	NN
cord-005453-4057qib7	11185	14	within	within	IN
cord-005453-4057qib7	11185	15	100	100	CD
cord-005453-4057qib7	11185	16	days	day	NNS
cord-005453-4057qib7	11185	17	was	be	VBD
cord-005453-4057qib7	11185	18	22	22	CD
cord-005453-4057qib7	11185	19	(	(	-LRB-
cord-005453-4057qib7	11185	20	2,4	2,4	CD
cord-005453-4057qib7	11185	21	%	%	NN
cord-005453-4057qib7	11185	22	)	)	-RRB-
cord-005453-4057qib7	11185	23	.	.	.
cord-005453-4057qib7	11186	1	[	[	-LRB-
cord-005453-4057qib7	11186	2	[	[	-LRB-
cord-005453-4057qib7	11186	3	P494	p494	CD
cord-005453-4057qib7	11186	4	Image	image	NN
cord-005453-4057qib7	11186	5	]	]	-RRB-
cord-005453-4057qib7	11186	6	1	1	CD
cord-005453-4057qib7	11186	7	.	.	.
cord-005453-4057qib7	11187	1	PFS	PFS	NNP
cord-005453-4057qib7	11187	2	and	and	CC
cord-005453-4057qib7	11187	3	OS	OS	NNP
cord-005453-4057qib7	11187	4	in	in	IN
cord-005453-4057qib7	11187	5	patients	patient	NNS
cord-005453-4057qib7	11187	6	underwent	undergo	VBD
cord-005453-4057qib7	11187	7	HDT	HDT	NNP
cord-005453-4057qib7	11187	8	and	and	CC
cord-005453-4057qib7	11187	9	auto	auto	NN
cord-005453-4057qib7	11187	10	-	-	HYPH
cord-005453-4057qib7	11187	11	HCT	HCT	NNP
cord-005453-4057qib7	11187	12	1997	1997	CD
cord-005453-4057qib7	11187	13	-2003	-2003	RBR
cord-005453-4057qib7	11187	14	,	,	,
cord-005453-4057qib7	11187	15	2004	2004	CD
cord-005453-4057qib7	11187	16	-2010	-2010	NN
cord-005453-4057qib7	11187	17	,	,	,
cord-005453-4057qib7	11187	18	2011	2011	CD
cord-005453-4057qib7	11187	19	-2017	-2017	.
cord-005453-4057qib7	11188	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11188	2	:	:	:
cord-005453-4057qib7	11188	3	More	More	JJR
cord-005453-4057qib7	11188	4	than	than	IN
cord-005453-4057qib7	11188	5	45	45	CD
cord-005453-4057qib7	11188	6	%	%	NN
cord-005453-4057qib7	11188	7	of	of	IN
cord-005453-4057qib7	11188	8	patients	patient	NNS
cord-005453-4057qib7	11188	9	who	who	WP
cord-005453-4057qib7	11188	10	underwent	undergo	VBD
cord-005453-4057qib7	11188	11	HDT	HDT	NNP
cord-005453-4057qib7	11188	12	and	and	CC
cord-005453-4057qib7	11188	13	auto	auto	NN
cord-005453-4057qib7	11188	14	-	-	HYPH
cord-005453-4057qib7	11188	15	HCT	HCT	NNP
cord-005453-4057qib7	11188	16	had	have	VBD
cord-005453-4057qib7	11188	17	long	long	JJ
cord-005453-4057qib7	11188	18	term	term	NN
cord-005453-4057qib7	11188	19	survival	survival	NN
cord-005453-4057qib7	11188	20	without	without	IN
cord-005453-4057qib7	11188	21	progressive	progressive	JJ
cord-005453-4057qib7	11188	22	disease	disease	NN
cord-005453-4057qib7	11188	23	.	.	.
cord-005453-4057qib7	11189	1	Older	old	JJR
cord-005453-4057qib7	11189	2	age	age	NN
cord-005453-4057qib7	11189	3	,	,	,
cord-005453-4057qib7	11189	4	non	non	JJ
cord-005453-4057qib7	11189	5	-	-	JJ
cord-005453-4057qib7	11189	6	complete	complete	JJ
cord-005453-4057qib7	11189	7	remission	remission	NN
cord-005453-4057qib7	11189	8	at	at	IN
cord-005453-4057qib7	11189	9	transplant	transplant	NN
cord-005453-4057qib7	11189	10	,	,	,
cord-005453-4057qib7	11189	11	advanced	advanced	JJ
cord-005453-4057qib7	11189	12	stage	stage	NN
cord-005453-4057qib7	11189	13	are	be	VBP
cord-005453-4057qib7	11189	14	associated	associate	VBN
cord-005453-4057qib7	11189	15	with	with	IN
cord-005453-4057qib7	11189	16	poor	poor	JJ
cord-005453-4057qib7	11189	17	outcome	outcome	NN
cord-005453-4057qib7	11189	18	.	.	.
cord-005453-4057qib7	11190	1	Patients	patient	NNS
cord-005453-4057qib7	11190	2	recently	recently	RB
cord-005453-4057qib7	11190	3	transplanted	transplant	VBN
cord-005453-4057qib7	11190	4	had	have	VBD
cord-005453-4057qib7	11190	5	a	a	DT
cord-005453-4057qib7	11190	6	better	well	JJR
cord-005453-4057qib7	11190	7	outcome	outcome	NN
cord-005453-4057qib7	11190	8	than	than	IN
cord-005453-4057qib7	11190	9	patients	patient	NNS
cord-005453-4057qib7	11190	10	transplanted	transplant	VBN
cord-005453-4057qib7	11190	11	before	before	IN
cord-005453-4057qib7	11190	12	2004	2004	CD
cord-005453-4057qib7	11190	13	.	.	.
cord-005453-4057qib7	11191	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11191	2	:	:	:
cord-005453-4057qib7	11191	3	Nothing	nothing	NN
cord-005453-4057qib7	11191	4	to	to	TO
cord-005453-4057qib7	11191	5	declare	declare	VB
cord-005453-4057qib7	11191	6	Outcomes	outcome	NNS
cord-005453-4057qib7	11191	7	after	after	IN
cord-005453-4057qib7	11191	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11191	9	and	and	CC
cord-005453-4057qib7	11191	10	matched	match	VBD
cord-005453-4057qib7	11191	11	related	relate	VBN
cord-005453-4057qib7	11191	12	HSCT	HSCT	NNP
cord-005453-4057qib7	11191	13	in	in	IN
cord-005453-4057qib7	11191	14	lymphoma	lymphoma	NN
cord-005453-4057qib7	11191	15	do	do	VBP
cord-005453-4057qib7	11191	16	not	not	RB
cord-005453-4057qib7	11191	17	differ	differ	VB
cord-005453-4057qib7	11191	18	significantly	significantly	RB
cord-005453-4057qib7	11191	19	:	:	:
cord-005453-4057qib7	11191	20	A	a	DT
cord-005453-4057qib7	11191	21	single	single	JJ
cord-005453-4057qib7	11191	22	center	center	NN
cord-005453-4057qib7	11191	23	study	study	NN
cord-005453-4057qib7	11191	24	Nadira	Nadira	NNP
cord-005453-4057qib7	11191	25	Durakovic	Durakovic	NNP
cord-005453-4057qib7	11191	26	1,2	1,2	CD
cord-005453-4057qib7	11191	27	,	,	,
cord-005453-4057qib7	11191	28	Zinaida	Zinaida	NNP
cord-005453-4057qib7	11191	29	Perić	Perić	NNP
cord-005453-4057qib7	11191	30	1,2	1,2	CD
cord-005453-4057qib7	11191	31	,	,	,
cord-005453-4057qib7	11191	32	Lana	Lana	NNP
cord-005453-4057qib7	11191	33	Desnica	Desnica	NNP
cord-005453-4057qib7	11191	34	2	2	CD
cord-005453-4057qib7	11191	35	,	,	,
cord-005453-4057qib7	11191	36	Ranka	Ranka	NNP
cord-005453-4057qib7	11191	37	Serventi	Serventi	NNP
cord-005453-4057qib7	11191	38	-	-	HYPH
cord-005453-4057qib7	11191	39	Seiwerth	Seiwerth	NNP
cord-005453-4057qib7	11191	40	2	2	CD
cord-005453-4057qib7	11191	41	,	,	,
cord-005453-4057qib7	11191	42	Sandra	Sandra	NNP
cord-005453-4057qib7	11191	43	Bašić	Bašić	NNP
cord-005453-4057qib7	11191	44	Kinda	Kinda	NNP
cord-005453-4057qib7	11191	45	2	2	CD
cord-005453-4057qib7	11191	46	,	,	,
cord-005453-4057qib7	11191	47	Ivo	Ivo	NNP
cord-005453-4057qib7	11191	48	Radman	Radman	NNP
cord-005453-4057qib7	11191	49	-	-	HYPH
cord-005453-4057qib7	11191	50	Livaja	Livaja	NNP
cord-005453-4057qib7	11191	51	2	2	CD
cord-005453-4057qib7	11191	52	,	,	,
cord-005453-4057qib7	11191	53	Alen	Alen	NNP
cord-005453-4057qib7	11191	54	Ostojić	Ostojić	NNP
cord-005453-4057qib7	11191	55	2	2	CD
cord-005453-4057qib7	11191	56	,	,	,
cord-005453-4057qib7	11191	57	Ante	Ante	NNP
cord-005453-4057qib7	11191	58	Vulić	Vulić	NNP
cord-005453-4057qib7	11191	59	2	2	CD
cord-005453-4057qib7	11191	60	,	,	,
cord-005453-4057qib7	11191	61	Dražen	Dražen	NNP
cord-005453-4057qib7	11191	62	Pulanić	Pulanić	NNP
cord-005453-4057qib7	11191	63	1,2	1,2	CD
cord-005453-4057qib7	11191	64	,	,	,
cord-005453-4057qib7	11191	65	Pavle	Pavle	NNP
cord-005453-4057qib7	11191	66	Rončević	Rončević	NNP
cord-005453-4057qib7	11191	67	2	2	CD
cord-005453-4057qib7	11191	68	,	,	,
cord-005453-4057qib7	11191	69	Zorana	Zorana	NNP
cord-005453-4057qib7	11191	70	Grubić	Grubić	NNP
cord-005453-4057qib7	11191	71	2	2	CD
cord-005453-4057qib7	11191	72	,	,	,
cord-005453-4057qib7	11191	73	Igor	Igor	NNP
cord-005453-4057qib7	11191	74	Aurer	Aurer	NNP
cord-005453-4057qib7	11191	75	1,2	1,2	CD
cord-005453-4057qib7	11191	76	,	,	,
cord-005453-4057qib7	11191	77	Radovan	Radovan	NNP
cord-005453-4057qib7	11191	78	Vrhovac	Vrhovac	NNP
cord-005453-4057qib7	11191	79	1,2	1,2	CD
cord-005453-4057qib7	11191	80	1	1	CD
cord-005453-4057qib7	11191	81	University	University	NNP
cord-005453-4057qib7	11191	82	of	of	IN
cord-005453-4057qib7	11191	83	Zagreb	Zagreb	NNP
cord-005453-4057qib7	11191	84	,	,	,
cord-005453-4057qib7	11191	85	School	School	NNP
cord-005453-4057qib7	11191	86	of	of	IN
cord-005453-4057qib7	11191	87	Medicine	Medicine	NNP
cord-005453-4057qib7	11191	88	,	,	,
cord-005453-4057qib7	11191	89	Internal	Internal	NNP
cord-005453-4057qib7	11191	90	Medicine	Medicine	NNP
cord-005453-4057qib7	11191	91	,	,	,
cord-005453-4057qib7	11191	92	Zagreb	Zagreb	NNP
cord-005453-4057qib7	11191	93	,	,	,
cord-005453-4057qib7	11191	94	Croatia	Croatia	NNP
cord-005453-4057qib7	11191	95	,	,	,
cord-005453-4057qib7	11191	96	2	2	CD
cord-005453-4057qib7	11191	97	UHC	UHC	NNP
cord-005453-4057qib7	11191	98	Zagreb	Zagreb	NNP
cord-005453-4057qib7	11191	99	,	,	,
cord-005453-4057qib7	11191	100	Zagreb	Zagreb	NNP
cord-005453-4057qib7	11191	101	,	,	,
cord-005453-4057qib7	11192	1	Croatia	Croatia	NNP
cord-005453-4057qib7	11192	2	Background	Background	NNP
cord-005453-4057qib7	11192	3	:	:	:
cord-005453-4057qib7	11193	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	11193	2	HSCT	HSCT	NNP
cord-005453-4057qib7	11193	3	still	still	RB
cord-005453-4057qib7	11193	4	offers	offer	VBZ
cord-005453-4057qib7	11193	5	patients	patient	NNS
cord-005453-4057qib7	11193	6	with	with	IN
cord-005453-4057qib7	11193	7	relapsed	relapse	VBN
cord-005453-4057qib7	11193	8	/	/	SYM
cord-005453-4057qib7	11193	9	refractory	refractory	JJ
cord-005453-4057qib7	11193	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	11193	11	the	the	DT
cord-005453-4057qib7	11193	12	best	good	JJS
cord-005453-4057qib7	11193	13	chance	chance	NN
cord-005453-4057qib7	11193	14	of	of	IN
cord-005453-4057qib7	11193	15	long	long	JJ
cord-005453-4057qib7	11193	16	-	-	HYPH
cord-005453-4057qib7	11193	17	term	term	NN
cord-005453-4057qib7	11193	18	survival	survival	NN
cord-005453-4057qib7	11193	19	.	.	.
cord-005453-4057qib7	11194	1	In	in	IN
cord-005453-4057qib7	11194	2	most	most	RBS
cord-005453-4057qib7	11194	3	such	such	JJ
cord-005453-4057qib7	11194	4	patients	patient	NNS
cord-005453-4057qib7	11194	5	timing	timing	NN
cord-005453-4057qib7	11194	6	of	of	IN
cord-005453-4057qib7	11194	7	HSCT	HSCT	NNP
cord-005453-4057qib7	11194	8	is	be	VBZ
cord-005453-4057qib7	11194	9	crucial	crucial	JJ
cord-005453-4057qib7	11194	10	,	,	,
cord-005453-4057qib7	11194	11	therefore	therefore	RB
cord-005453-4057qib7	11194	12	a	a	DT
cord-005453-4057qib7	11194	13	related	related	JJ
cord-005453-4057qib7	11194	14	donor	donor	NN
cord-005453-4057qib7	11194	15	is	be	VBZ
cord-005453-4057qib7	11194	16	preferred	prefer	VBN
cord-005453-4057qib7	11194	17	.	.	.
cord-005453-4057qib7	11195	1	We	-PRON-	PRP
cord-005453-4057qib7	11195	2	analyzed	analyze	VBD
cord-005453-4057qib7	11195	3	acute	acute	JJ
cord-005453-4057qib7	11195	4	and	and	CC
cord-005453-4057qib7	11195	5	chronic	chronic	JJ
cord-005453-4057qib7	11195	6	GVHD	GVHD	NNP
cord-005453-4057qib7	11195	7	incidence	incidence	NN
cord-005453-4057qib7	11195	8	,	,	,
cord-005453-4057qib7	11195	9	relapse	relapse	NN
cord-005453-4057qib7	11195	10	and	and	CC
cord-005453-4057qib7	11195	11	overall	overall	JJ
cord-005453-4057qib7	11195	12	survival	survival	NN
cord-005453-4057qib7	11195	13	,	,	,
cord-005453-4057qib7	11195	14	but	but	CC
cord-005453-4057qib7	11195	15	also	also	RB
cord-005453-4057qib7	11195	16	time	time	NN
cord-005453-4057qib7	11195	17	to	to	IN
cord-005453-4057qib7	11195	18	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	11195	19	(	(	-LRB-
cord-005453-4057qib7	11195	20	IS	be	VBZ
cord-005453-4057qib7	11195	21	)	)	-RRB-
cord-005453-4057qib7	11195	22	discontinuation	discontinuation	NN
cord-005453-4057qib7	11195	23	and	and	CC
cord-005453-4057qib7	11195	24	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11195	25	recovery	recovery	NN
cord-005453-4057qib7	11195	26	comparing	compare	VBG
cord-005453-4057qib7	11195	27	transplantation	transplantation	NN
cord-005453-4057qib7	11195	28	using	use	VBG
cord-005453-4057qib7	11195	29	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11195	30	(	(	-LRB-
cord-005453-4057qib7	11195	31	haplo	haplo	NNP
cord-005453-4057qib7	11195	32	)	)	-RRB-
cord-005453-4057qib7	11195	33	and	and	CC
cord-005453-4057qib7	11195	34	matched	match	VBD
cord-005453-4057qib7	11195	35	related	related	JJ
cord-005453-4057qib7	11195	36	donors	donor	NNS
cord-005453-4057qib7	11195	37	(	(	-LRB-
cord-005453-4057qib7	11195	38	MRD	MRD	NNP
cord-005453-4057qib7	11195	39	)	)	-RRB-
cord-005453-4057qib7	11195	40	in	in	IN
cord-005453-4057qib7	11195	41	single	single	JJ
cord-005453-4057qib7	11195	42	center	center	NN
cord-005453-4057qib7	11195	43	in	in	IN
cord-005453-4057qib7	11195	44	this	this	DT
cord-005453-4057qib7	11195	45	indication	indication	NN
cord-005453-4057qib7	11195	46	.	.	.
cord-005453-4057qib7	11196	1	Methods	method	NNS
cord-005453-4057qib7	11196	2	:	:	:
cord-005453-4057qib7	11196	3	In	in	IN
cord-005453-4057qib7	11196	4	the	the	DT
cord-005453-4057qib7	11196	5	time	time	NN
cord-005453-4057qib7	11196	6	period	period	NN
cord-005453-4057qib7	11196	7	between	between	IN
cord-005453-4057qib7	11196	8	5/2011	5/2011	CD
cord-005453-4057qib7	11196	9	and	and	CC
cord-005453-4057qib7	11196	10	5/2018	5/2018	CD
cord-005453-4057qib7	11196	11	at	at	IN
cord-005453-4057qib7	11196	12	UHC	UHC	NNP
cord-005453-4057qib7	11196	13	Zagreb	Zagreb	NNP
cord-005453-4057qib7	11196	14	,	,	,
cord-005453-4057qib7	11196	15	Croatia	Croatia	NNP
cord-005453-4057qib7	11196	16	,	,	,
cord-005453-4057qib7	11196	17	10	10	CD
cord-005453-4057qib7	11196	18	MRD	MRD	NNP
cord-005453-4057qib7	11196	19	and	and	CC
cord-005453-4057qib7	11196	20	13	13	CD
cord-005453-4057qib7	11196	21	haplo	haplo	NN
cord-005453-4057qib7	11196	22	transplantations	transplantation	NNS
cord-005453-4057qib7	11196	23	in	in	IN
cord-005453-4057qib7	11196	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	11196	25	were	be	VBD
cord-005453-4057qib7	11196	26	done	do	VBN
cord-005453-4057qib7	11196	27	,	,	,
cord-005453-4057qib7	11196	28	15	15	CD
cord-005453-4057qib7	11196	29	for	for	IN
cord-005453-4057qib7	11196	30	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11196	31	and	and	CC
cord-005453-4057qib7	11196	32	8	8	CD
cord-005453-4057qib7	11196	33	for	for	IN
cord-005453-4057qib7	11196	34	NHL	NHL	NNP
cord-005453-4057qib7	11196	35	.	.	.
cord-005453-4057qib7	11197	1	All	all	DT
cord-005453-4057qib7	11197	2	patients	patient	NNS
cord-005453-4057qib7	11197	3	transplanted	transplant	VBN
cord-005453-4057qib7	11197	4	from	from	IN
cord-005453-4057qib7	11197	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11197	6	donors	donor	NNS
cord-005453-4057qib7	11197	7	received	receive	VBD
cord-005453-4057qib7	11197	8	PTCY	PTCY	NNP
cord-005453-4057qib7	11197	9	.	.	.
cord-005453-4057qib7	11198	1	Data	datum	NNS
cord-005453-4057qib7	11198	2	were	be	VBD
cord-005453-4057qib7	11198	3	computed	compute	VBN
cord-005453-4057qib7	11198	4	using	use	VBG
cord-005453-4057qib7	11198	5	the	the	DT
cord-005453-4057qib7	11198	6	R	r	NN
cord-005453-4057qib7	11198	7	package	package	NN
cord-005453-4057qib7	11198	8	.	.	.
cord-005453-4057qib7	11199	1	The	the	DT
cord-005453-4057qib7	11199	2	probability	probability	NN
cord-005453-4057qib7	11199	3	of	of	IN
cord-005453-4057qib7	11199	4	GVHD	GVHD	NNP
cord-005453-4057qib7	11199	5	was	be	VBD
cord-005453-4057qib7	11199	6	calculated	calculate	VBN
cord-005453-4057qib7	11199	7	using	use	VBG
cord-005453-4057qib7	11199	8	the	the	DT
cord-005453-4057qib7	11199	9	cumulative	cumulative	JJ
cord-005453-4057qib7	11199	10	incidence	incidence	NN
cord-005453-4057qib7	11199	11	method	method	NN
cord-005453-4057qib7	11199	12	and	and	CC
cord-005453-4057qib7	11199	13	subgroups	subgroup	NNS
cord-005453-4057qib7	11199	14	were	be	VBD
cord-005453-4057qib7	11199	15	compared	compare	VBN
cord-005453-4057qib7	11199	16	using	use	VBG
cord-005453-4057qib7	11199	17	the	the	DT
cord-005453-4057qib7	11199	18	Gray	gray	JJ
cord-005453-4057qib7	11199	19	test	test	NN
cord-005453-4057qib7	11199	20	.	.	.
cord-005453-4057qib7	11200	1	Results	result	NNS
cord-005453-4057qib7	11200	2	:	:	:
cord-005453-4057qib7	11201	1	Median	median	JJ
cord-005453-4057qib7	11201	2	age	age	NN
cord-005453-4057qib7	11201	3	was	be	VBD
cord-005453-4057qib7	11201	4	38	38	CD
cord-005453-4057qib7	11201	5	(	(	-LRB-
cord-005453-4057qib7	11201	6	19	19	CD
cord-005453-4057qib7	11201	7	-	-	SYM
cord-005453-4057qib7	11201	8	62	62	CD
cord-005453-4057qib7	11201	9	)	)	-RRB-
cord-005453-4057qib7	11201	10	years	year	NNS
cord-005453-4057qib7	11201	11	;	;	:
cord-005453-4057qib7	11201	12	36	36	CD
cord-005453-4057qib7	11201	13	(	(	-LRB-
cord-005453-4057qib7	11201	14	19	19	CD
cord-005453-4057qib7	11201	15	-	-	SYM
cord-005453-4057qib7	11201	16	62	62	CD
cord-005453-4057qib7	11201	17	)	)	-RRB-
cord-005453-4057qib7	11201	18	in	in	IN
cord-005453-4057qib7	11201	19	haplo	haplo	NNP
cord-005453-4057qib7	11201	20	and	and	CC
cord-005453-4057qib7	11201	21	41	41	CD
cord-005453-4057qib7	11201	22	(	(	-LRB-
cord-005453-4057qib7	11201	23	25	25	CD
cord-005453-4057qib7	11201	24	-	-	SYM
cord-005453-4057qib7	11201	25	56	56	CD
cord-005453-4057qib7	11201	26	)	)	-RRB-
cord-005453-4057qib7	11201	27	in	in	IN
cord-005453-4057qib7	11201	28	MRD	MRD	NNP
cord-005453-4057qib7	11201	29	group	group	NN
cord-005453-4057qib7	11201	30	.	.	.
cord-005453-4057qib7	11202	1	Four	four	CD
cord-005453-4057qib7	11202	2	patients	patient	NNS
cord-005453-4057qib7	11202	3	were	be	VBD
cord-005453-4057qib7	11202	4	in	in	IN
cord-005453-4057qib7	11202	5	PR	PR	NNP
cord-005453-4057qib7	11202	6	and	and	CC
cord-005453-4057qib7	11202	7	9	9	CD
cord-005453-4057qib7	11202	8	in	in	IN
cord-005453-4057qib7	11202	9	CR	CR	NNP
cord-005453-4057qib7	11202	10	in	in	IN
cord-005453-4057qib7	11202	11	haplo	haplo	NNP
cord-005453-4057qib7	11202	12	group	group	NN
cord-005453-4057qib7	11202	13	,	,	,
cord-005453-4057qib7	11202	14	while	while	IN
cord-005453-4057qib7	11202	15	in	in	IN
cord-005453-4057qib7	11202	16	MRD	MRD	NNP
cord-005453-4057qib7	11202	17	group	group	NN
cord-005453-4057qib7	11202	18	5	5	CD
cord-005453-4057qib7	11202	19	patients	patient	NNS
cord-005453-4057qib7	11202	20	were	be	VBD
cord-005453-4057qib7	11202	21	in	in	IN
cord-005453-4057qib7	11202	22	CR	CR	NNP
cord-005453-4057qib7	11202	23	and	and	CC
cord-005453-4057qib7	11202	24	5	5	CD
cord-005453-4057qib7	11202	25	in	in	IN
cord-005453-4057qib7	11202	26	PR	PR	NNP
cord-005453-4057qib7	11202	27	.	.	.
cord-005453-4057qib7	11203	1	In	in	IN
cord-005453-4057qib7	11203	2	haplo	haplo	NNP
cord-005453-4057qib7	11203	3	group	group	NN
cord-005453-4057qib7	11203	4	12	12	CD
cord-005453-4057qib7	11203	5	patients	patient	NNS
cord-005453-4057qib7	11203	6	(	(	-LRB-
cord-005453-4057qib7	11203	7	92	92	CD
cord-005453-4057qib7	11203	8	%	%	NN
cord-005453-4057qib7	11203	9	)	)	-RRB-
cord-005453-4057qib7	11203	10	received	receive	VBD
cord-005453-4057qib7	11203	11	bone	bone	NN
cord-005453-4057qib7	11203	12	marrow	marrow	NN
cord-005453-4057qib7	11203	13	(	(	-LRB-
cord-005453-4057qib7	11203	14	BM	BM	NNP
cord-005453-4057qib7	11203	15	)	)	-RRB-
cord-005453-4057qib7	11203	16	and	and	CC
cord-005453-4057qib7	11203	17	only	only	RB
cord-005453-4057qib7	11203	18	1	1	CD
cord-005453-4057qib7	11203	19	(	(	-LRB-
cord-005453-4057qib7	11203	20	8	8	CD
cord-005453-4057qib7	11203	21	%	%	NN
cord-005453-4057qib7	11203	22	)	)	-RRB-
cord-005453-4057qib7	11203	23	peripheral	peripheral	JJ
cord-005453-4057qib7	11203	24	blood	blood	NN
cord-005453-4057qib7	11203	25	stem	stem	NN
cord-005453-4057qib7	11203	26	cells	cell	NNS
cord-005453-4057qib7	11203	27	(	(	-LRB-
cord-005453-4057qib7	11203	28	PBSC	PBSC	NNP
cord-005453-4057qib7	11203	29	)	)	-RRB-
cord-005453-4057qib7	11203	30	.	.	.
cord-005453-4057qib7	11204	1	In	in	IN
cord-005453-4057qib7	11204	2	MRD	MRD	NNP
cord-005453-4057qib7	11204	3	group	group	NN
cord-005453-4057qib7	11204	4	all	all	DT
cord-005453-4057qib7	11204	5	patients	patient	NNS
cord-005453-4057qib7	11204	6	received	receive	VBD
cord-005453-4057qib7	11204	7	PBSC	PBSC	NNP
cord-005453-4057qib7	11204	8	.	.	.
cord-005453-4057qib7	11205	1	All	all	DT
cord-005453-4057qib7	11205	2	patients	patient	NNS
cord-005453-4057qib7	11205	3	in	in	IN
cord-005453-4057qib7	11205	4	haplo	haplo	NNP
cord-005453-4057qib7	11205	5	group	group	NN
cord-005453-4057qib7	11205	6	received	receive	VBD
cord-005453-4057qib7	11205	7	NMA	NMA	NNP
cord-005453-4057qib7	11205	8	(	(	-LRB-
cord-005453-4057qib7	11205	9	"	"	``
cord-005453-4057qib7	11205	10	Baltimore	Baltimore	NNP
cord-005453-4057qib7	11205	11	"	"	''
cord-005453-4057qib7	11205	12	)	)	-RRB-
cord-005453-4057qib7	11206	1	conditioning	conditioning	NN
cord-005453-4057qib7	11206	2	with	with	IN
cord-005453-4057qib7	11206	3	PTCY	PTCY	NNP
cord-005453-4057qib7	11206	4	while	while	IN
cord-005453-4057qib7	11206	5	in	in	IN
cord-005453-4057qib7	11206	6	MRD	MRD	NNP
cord-005453-4057qib7	11206	7	group	group	NN
cord-005453-4057qib7	11206	8	9	9	CD
cord-005453-4057qib7	11206	9	patients	patient	NNS
cord-005453-4057qib7	11206	10	(	(	-LRB-
cord-005453-4057qib7	11206	11	90	90	CD
cord-005453-4057qib7	11206	12	%	%	NN
cord-005453-4057qib7	11206	13	)	)	-RRB-
cord-005453-4057qib7	11206	14	received	receive	VBD
cord-005453-4057qib7	11206	15	Flu	Flu	NNP
cord-005453-4057qib7	11206	16	-	-	HYPH
cord-005453-4057qib7	11206	17	Bu2ATG	Bu2ATG	NNP
cord-005453-4057qib7	11206	18	,	,	,
cord-005453-4057qib7	11206	19	and	and	CC
cord-005453-4057qib7	11206	20	only	only	RB
cord-005453-4057qib7	11206	21	one	one	CD
cord-005453-4057qib7	11206	22	received	receive	VBN
cord-005453-4057qib7	11206	23	FluTBI	flutbi	NN
cord-005453-4057qib7	11206	24	as	as	IN
cord-005453-4057qib7	11206	25	conditioning	conditioning	NN
cord-005453-4057qib7	11206	26	protocol	protocol	NN
cord-005453-4057qib7	11206	27	.	.	.
cord-005453-4057qib7	11207	1	In	in	IN
cord-005453-4057qib7	11207	2	haplo	haplo	NN
cord-005453-4057qib7	11207	3	group	group	NN
cord-005453-4057qib7	11207	4	85	85	CD
cord-005453-4057qib7	11207	5	%	%	NN
cord-005453-4057qib7	11207	6	patients	patient	NNS
cord-005453-4057qib7	11207	7	were	be	VBD
cord-005453-4057qib7	11207	8	previously	previously	RB
cord-005453-4057qib7	11207	9	treated	treat	VBN
cord-005453-4057qib7	11207	10	with	with	IN
cord-005453-4057qib7	11207	11	autologus	autologus	JJ
cord-005453-4057qib7	11207	12	transplantation	transplantation	NN
cord-005453-4057qib7	11207	13	,	,	,
cord-005453-4057qib7	11207	14	80	80	CD
cord-005453-4057qib7	11207	15	%	%	NN
cord-005453-4057qib7	11207	16	in	in	IN
cord-005453-4057qib7	11207	17	MRD	MRD	NNP
cord-005453-4057qib7	11207	18	group	group	NN
cord-005453-4057qib7	11207	19	.	.	.
cord-005453-4057qib7	11208	1	There	there	EX
cord-005453-4057qib7	11208	2	was	be	VBD
cord-005453-4057qib7	11208	3	no	no	DT
cord-005453-4057qib7	11208	4	significant	significant	JJ
cord-005453-4057qib7	11208	5	difference	difference	NN
cord-005453-4057qib7	11208	6	in	in	IN
cord-005453-4057qib7	11208	7	time	time	NN
cord-005453-4057qib7	11208	8	to	to	IN
cord-005453-4057qib7	11208	9	IS	be	VBZ
cord-005453-4057qib7	11208	10	discontinuation	discontinuation	NN
cord-005453-4057qib7	11208	11	,	,	,
cord-005453-4057qib7	11208	12	149	149	CD
cord-005453-4057qib7	11208	13	and	and	CC
cord-005453-4057qib7	11208	14	155	155	CD
cord-005453-4057qib7	11208	15	days	day	NNS
cord-005453-4057qib7	11208	16	in	in	IN
cord-005453-4057qib7	11208	17	haplo	haplo	NNP
cord-005453-4057qib7	11208	18	and	and	CC
cord-005453-4057qib7	11208	19	MRD	MRD	NNP
cord-005453-4057qib7	11208	20	group	group	NN
cord-005453-4057qib7	11208	21	,	,	,
cord-005453-4057qib7	11208	22	respectively	respectively	RB
cord-005453-4057qib7	11208	23	.	.	.
cord-005453-4057qib7	11209	1	Patients	patient	NNS
cord-005453-4057qib7	11209	2	after	after	IN
cord-005453-4057qib7	11209	3	haplo	haplo	NNP
cord-005453-4057qib7	11209	4	recovered	recover	VBD
cord-005453-4057qib7	11209	5	slower	slow	RBR
cord-005453-4057qib7	11209	6	,	,	,
cord-005453-4057qib7	11209	7	recovering	recover	VBG
cord-005453-4057qib7	11209	8	ANC	ANC	NNP
cord-005453-4057qib7	11209	9	after	after	IN
cord-005453-4057qib7	11209	10	22.6	22.6	CD
cord-005453-4057qib7	11209	11	days	day	NNS
cord-005453-4057qib7	11209	12	(	(	-LRB-
cord-005453-4057qib7	11209	13	95	95	CD
cord-005453-4057qib7	11209	14	%	%	NN
cord-005453-4057qib7	11209	15	CI	CI	NNP
cord-005453-4057qib7	11209	16	,	,	,
cord-005453-4057qib7	11209	17	17.7	17.7	CD
cord-005453-4057qib7	11209	18	-	-	HYPH
cord-005453-4057qib7	11209	19	27.4	27.4	CD
cord-005453-4057qib7	11209	20	)	)	-RRB-
cord-005453-4057qib7	11209	21	and	and	CC
cord-005453-4057qib7	11209	22	16.5	16.5	CD
cord-005453-4057qib7	11209	23	(	(	-LRB-
cord-005453-4057qib7	11209	24	95	95	CD
cord-005453-4057qib7	11209	25	%	%	NN
cord-005453-4057qib7	11209	26	CI	CI	NNP
cord-005453-4057qib7	11209	27	,	,	,
cord-005453-4057qib7	11209	28	13.9	13.9	CD
cord-005453-4057qib7	11209	29	-	-	SYM
cord-005453-4057qib7	11209	30	19	19	CD
cord-005453-4057qib7	11209	31	)	)	-RRB-
cord-005453-4057qib7	11209	32	(	(	-LRB-
cord-005453-4057qib7	11209	33	p=0.04	p=0.04	NN
cord-005453-4057qib7	11209	34	)	)	-RRB-
cord-005453-4057qib7	11209	35	and	and	CC
cord-005453-4057qib7	11209	36	recovering	recover	VBG
cord-005453-4057qib7	11209	37	platelets	platelet	NNS
cord-005453-4057qib7	11209	38	after	after	IN
cord-005453-4057qib7	11209	39	34.6	34.6	CD
cord-005453-4057qib7	11209	40	days	day	NNS
cord-005453-4057qib7	11209	41	(	(	-LRB-
cord-005453-4057qib7	11209	42	95	95	CD
cord-005453-4057qib7	11209	43	%	%	NN
cord-005453-4057qib7	11209	44	CI	CI	NNP
cord-005453-4057qib7	11209	45	,	,	,
cord-005453-4057qib7	11209	46	15.5	15.5	CD
cord-005453-4057qib7	11209	47	-	-	SYM
cord-005453-4057qib7	11209	48	53.7	53.7	CD
cord-005453-4057qib7	11209	49	)	)	-RRB-
cord-005453-4057qib7	11209	50	and	and	CC
cord-005453-4057qib7	11209	51	10.8	10.8	CD
cord-005453-4057qib7	11209	52	(	(	-LRB-
cord-005453-4057qib7	11209	53	95	95	CD
cord-005453-4057qib7	11209	54	%	%	NN
cord-005453-4057qib7	11209	55	CI	ci	NN
cord-005453-4057qib7	11209	56	,	,	,
cord-005453-4057qib7	11209	57	9.2	9.2	CD
cord-005453-4057qib7	11209	58	-	-	HYPH
cord-005453-4057qib7	11209	59	12.4	12.4	CD
cord-005453-4057qib7	11209	60	)	)	-RRB-
cord-005453-4057qib7	11209	61	(	(	-LRB-
cord-005453-4057qib7	11209	62	p	p	NN
cord-005453-4057qib7	11209	63	<	<	XX
cord-005453-4057qib7	11209	64	0.01	0.01	CD
cord-005453-4057qib7	11209	65	)	)	-RRB-
cord-005453-4057qib7	11209	66	in	in	IN
cord-005453-4057qib7	11209	67	haplo	haplo	NNP
cord-005453-4057qib7	11209	68	and	and	CC
cord-005453-4057qib7	11209	69	MRD	MRD	NNP
cord-005453-4057qib7	11209	70	group	group	NN
cord-005453-4057qib7	11209	71	.	.	.
cord-005453-4057qib7	11210	1	With	with	IN
cord-005453-4057qib7	11210	2	a	a	DT
cord-005453-4057qib7	11210	3	median	median	NN
cord-005453-4057qib7	11210	4	follow	follow	NN
cord-005453-4057qib7	11210	5	up	up	IN
cord-005453-4057qib7	11210	6	of	of	IN
cord-005453-4057qib7	11210	7	469	469	CD
cord-005453-4057qib7	11210	8	days	day	NNS
cord-005453-4057qib7	11210	9	,	,	,
cord-005453-4057qib7	11210	10	overall	overall	JJ
cord-005453-4057qib7	11210	11	survival	survival	NN
cord-005453-4057qib7	11210	12	was	be	VBD
cord-005453-4057qib7	11210	13	83	83	CD
cord-005453-4057qib7	11210	14	%	%	NN
cord-005453-4057qib7	11210	15	(	(	-LRB-
cord-005453-4057qib7	11210	16	95	95	CD
cord-005453-4057qib7	11210	17	%	%	NN
cord-005453-4057qib7	11210	18	CI	CI	NNP
cord-005453-4057qib7	11210	19	,	,	,
cord-005453-4057qib7	11210	20	63	63	CD
cord-005453-4057qib7	11210	21	-	-	SYM
cord-005453-4057qib7	11210	22	100	100	CD
cord-005453-4057qib7	11210	23	)	)	-RRB-
cord-005453-4057qib7	11210	24	in	in	IN
cord-005453-4057qib7	11210	25	haplo	haplo	NNP
cord-005453-4057qib7	11210	26	and	and	CC
cord-005453-4057qib7	11210	27	80	80	CD
cord-005453-4057qib7	11210	28	%	%	NN
cord-005453-4057qib7	11210	29	(	(	-LRB-
cord-005453-4057qib7	11210	30	95	95	CD
cord-005453-4057qib7	11210	31	%	%	NN
cord-005453-4057qib7	11210	32	CI	CI	NNP
cord-005453-4057qib7	11210	33	,	,	,
cord-005453-4057qib7	11210	34	59	59	CD
cord-005453-4057qib7	11210	35	-	-	SYM
cord-005453-4057qib7	11210	36	100	100	CD
cord-005453-4057qib7	11210	37	)	)	-RRB-
cord-005453-4057qib7	11210	38	in	in	IN
cord-005453-4057qib7	11210	39	MRD	MRD	NNP
cord-005453-4057qib7	11210	40	group	group	NN
cord-005453-4057qib7	11210	41	.	.	.
cord-005453-4057qib7	11211	1	TRM	TRM	NNP
cord-005453-4057qib7	11211	2	was	be	VBD
cord-005453-4057qib7	11211	3	8	8	CD
cord-005453-4057qib7	11211	4	%	%	NN
cord-005453-4057qib7	11211	5	in	in	IN
cord-005453-4057qib7	11211	6	haplo	haplo	NN
cord-005453-4057qib7	11211	7	and	and	CC
cord-005453-4057qib7	11211	8	20	20	CD
cord-005453-4057qib7	11211	9	%	%	NN
cord-005453-4057qib7	11211	10	in	in	IN
cord-005453-4057qib7	11211	11	MRD	MRD	NNP
cord-005453-4057qib7	11211	12	group	group	NN
cord-005453-4057qib7	11211	13	.	.	.
cord-005453-4057qib7	11212	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	11212	2	incidence	incidence	NN
cord-005453-4057qib7	11212	3	of	of	IN
cord-005453-4057qib7	11212	4	aGVHD	aGVHD	NNP
cord-005453-4057qib7	11212	5	II	II	NNP
cord-005453-4057qib7	11212	6	-	-	HYPH
cord-005453-4057qib7	11212	7	IV	IV	NNP
cord-005453-4057qib7	11212	8	was	be	VBD
cord-005453-4057qib7	11212	9	31	31	CD
cord-005453-4057qib7	11212	10	%	%	NN
cord-005453-4057qib7	11212	11	(	(	-LRB-
cord-005453-4057qib7	11212	12	95	95	CD
cord-005453-4057qib7	11212	13	%	%	NN
cord-005453-4057qib7	11212	14	CI	ci	NN
cord-005453-4057qib7	11212	15	,	,	,
cord-005453-4057qib7	11212	16	9	9	CD
cord-005453-4057qib7	11212	17	-	-	SYM
cord-005453-4057qib7	11212	18	56	56	CD
cord-005453-4057qib7	11212	19	)	)	-RRB-
cord-005453-4057qib7	11212	20	and	and	CC
cord-005453-4057qib7	11212	21	32	32	CD
cord-005453-4057qib7	11212	22	%	%	NN
cord-005453-4057qib7	11212	23	(	(	-LRB-
cord-005453-4057qib7	11212	24	95	95	CD
cord-005453-4057qib7	11212	25	%	%	NN
cord-005453-4057qib7	11212	26	CI	CI	NNP
cord-005453-4057qib7	11212	27	,	,	,
cord-005453-4057qib7	11212	28	in	in	IN
cord-005453-4057qib7	11212	29	haplo	haplo	NNP
cord-005453-4057qib7	11212	30	and	and	CC
cord-005453-4057qib7	11212	31	MRD	MRD	NNP
cord-005453-4057qib7	11212	32	group	group	NN
cord-005453-4057qib7	11212	33	,	,	,
cord-005453-4057qib7	11212	34	respectively	respectively	RB
cord-005453-4057qib7	11212	35	(	(	-LRB-
cord-005453-4057qib7	11212	36	p=0.84	p=0.84	NNP
cord-005453-4057qib7	11212	37	)	)	-RRB-
cord-005453-4057qib7	11212	38	.	.	.
cord-005453-4057qib7	11213	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	11213	2	incidence	incidence	NN
cord-005453-4057qib7	11213	3	of	of	IN
cord-005453-4057qib7	11213	4	cGVHD	cGVHD	NNP
cord-005453-4057qib7	11213	5	requiring	require	VBG
cord-005453-4057qib7	11213	6	treatment	treatment	NN
cord-005453-4057qib7	11213	7	was	be	VBD
cord-005453-4057qib7	11213	8	22	22	CD
cord-005453-4057qib7	11213	9	%	%	NN
cord-005453-4057qib7	11213	10	(	(	-LRB-
cord-005453-4057qib7	11213	11	95	95	CD
cord-005453-4057qib7	11213	12	%	%	NN
cord-005453-4057qib7	11213	13	CI	CI	NNP
cord-005453-4057qib7	11213	14	,	,	,
cord-005453-4057qib7	11213	15	and	and	CC
cord-005453-4057qib7	11213	16	MRD	MRD	NNP
cord-005453-4057qib7	11213	17	20	20	CD
cord-005453-4057qib7	11213	18	%	%	NN
cord-005453-4057qib7	11213	19	(	(	-LRB-
cord-005453-4057qib7	11213	20	95	95	CD
cord-005453-4057qib7	11213	21	%	%	NN
cord-005453-4057qib7	11213	22	CI	ci	NN
cord-005453-4057qib7	11213	23	,	,	,
cord-005453-4057qib7	11213	24	0	0	CD
cord-005453-4057qib7	11213	25	-	-	SYM
cord-005453-4057qib7	11213	26	62	62	CD
cord-005453-4057qib7	11213	27	)	)	-RRB-
cord-005453-4057qib7	11213	28	in	in	IN
cord-005453-4057qib7	11213	29	haplo	haplo	NNP
cord-005453-4057qib7	11213	30	and	and	CC
cord-005453-4057qib7	11213	31	MRD	MRD	NNP
cord-005453-4057qib7	11213	32	group	group	NN
cord-005453-4057qib7	11213	33	,	,	,
cord-005453-4057qib7	11213	34	respectively	respectively	RB
cord-005453-4057qib7	11213	35	(	(	-LRB-
cord-005453-4057qib7	11213	36	p=0.46	p=0.46	NNP
cord-005453-4057qib7	11213	37	)	)	-RRB-
cord-005453-4057qib7	11213	38	.	.	.
cord-005453-4057qib7	11214	1	All	all	DT
cord-005453-4057qib7	11214	2	cases	case	NNS
cord-005453-4057qib7	11214	3	of	of	IN
cord-005453-4057qib7	11214	4	cGVHD	cGVHD	NNP
cord-005453-4057qib7	11214	5	developed	develop	VBN
cord-005453-4057qib7	11214	6	after	after	IN
cord-005453-4057qib7	11214	7	DLI	DLI	NNP
cord-005453-4057qib7	11214	8	.	.	.
cord-005453-4057qib7	11215	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	11215	2	incidence	incidence	NN
cord-005453-4057qib7	11215	3	of	of	IN
cord-005453-4057qib7	11215	4	relapse	relapse	NN
cord-005453-4057qib7	11215	5	was	be	VBD
cord-005453-4057qib7	11215	6	32	32	CD
cord-005453-4057qib7	11215	7	%	%	NN
cord-005453-4057qib7	11215	8	(	(	-LRB-
cord-005453-4057qib7	11215	9	95	95	CD
cord-005453-4057qib7	11215	10	%	%	NN
cord-005453-4057qib7	11215	11	CI	ci	NN
cord-005453-4057qib7	11215	12	,	,	,
cord-005453-4057qib7	11215	13	9	9	CD
cord-005453-4057qib7	11215	14	-	-	SYM
cord-005453-4057qib7	11215	15	58	58	CD
cord-005453-4057qib7	11215	16	)	)	-RRB-
cord-005453-4057qib7	11215	17	and	and	CC
cord-005453-4057qib7	11215	18	38	38	CD
cord-005453-4057qib7	11215	19	%	%	NN
cord-005453-4057qib7	11215	20	(	(	-LRB-
cord-005453-4057qib7	11215	21	95	95	CD
cord-005453-4057qib7	11215	22	%	%	NN
cord-005453-4057qib7	11215	23	CI	CI	NNP
cord-005453-4057qib7	11215	24	,	,	,
cord-005453-4057qib7	11215	25	7	7	CD
cord-005453-4057qib7	11215	26	-	-	SYM
cord-005453-4057qib7	11215	27	72	72	CD
cord-005453-4057qib7	11215	28	)	)	-RRB-
cord-005453-4057qib7	11215	29	for	for	IN
cord-005453-4057qib7	11215	30	haplo	haplo	NNP
cord-005453-4057qib7	11215	31	and	and	CC
cord-005453-4057qib7	11215	32	MRD	MRD	NNP
cord-005453-4057qib7	11215	33	group	group	NN
cord-005453-4057qib7	11215	34	,	,	,
cord-005453-4057qib7	11215	35	respectively	respectively	RB
cord-005453-4057qib7	11215	36	(	(	-LRB-
cord-005453-4057qib7	11215	37	p=0.77	p=0.77	NNP
cord-005453-4057qib7	11215	38	)	)	-RRB-
cord-005453-4057qib7	11215	39	.	.	.
cord-005453-4057qib7	11216	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11216	2	:	:	:
cord-005453-4057qib7	11217	1	We	-PRON-	PRP
cord-005453-4057qib7	11217	2	found	find	VBD
cord-005453-4057qib7	11217	3	no	no	DT
cord-005453-4057qib7	11217	4	significant	significant	JJ
cord-005453-4057qib7	11217	5	difference	difference	NN
cord-005453-4057qib7	11217	6	in	in	IN
cord-005453-4057qib7	11217	7	overall	overall	JJ
cord-005453-4057qib7	11217	8	survival	survival	NN
cord-005453-4057qib7	11217	9	,	,	,
cord-005453-4057qib7	11217	10	relapse	relapse	NN
cord-005453-4057qib7	11217	11	incidence	incidence	NN
cord-005453-4057qib7	11217	12	,	,	,
cord-005453-4057qib7	11217	13	aGVHD	aGVHD	NNP
cord-005453-4057qib7	11217	14	and	and	CC
cord-005453-4057qib7	11217	15	cGVHD	cGVHD	NNP
cord-005453-4057qib7	11217	16	incidence	incidence	NN
cord-005453-4057qib7	11217	17	between	between	IN
cord-005453-4057qib7	11217	18	these	these	DT
cord-005453-4057qib7	11217	19	two	two	CD
cord-005453-4057qib7	11217	20	groups	group	NNS
cord-005453-4057qib7	11217	21	.	.	.
cord-005453-4057qib7	11218	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11218	2	recovery	recovery	NN
cord-005453-4057qib7	11218	3	was	be	VBD
cord-005453-4057qib7	11218	4	slower	slow	JJR
cord-005453-4057qib7	11218	5	after	after	IN
cord-005453-4057qib7	11218	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11218	7	transplantation	transplantation	NN
cord-005453-4057qib7	11218	8	,	,	,
cord-005453-4057qib7	11218	9	but	but	CC
cord-005453-4057qib7	11218	10	it	-PRON-	PRP
cord-005453-4057qib7	11218	11	did	do	VBD
cord-005453-4057qib7	11218	12	not	not	RB
cord-005453-4057qib7	11218	13	influence	influence	VB
cord-005453-4057qib7	11218	14	TRM	TRM	NNP
cord-005453-4057qib7	11218	15	as	as	IN
cord-005453-4057qib7	11218	16	it	-PRON-	PRP
cord-005453-4057qib7	11218	17	was	be	VBD
cord-005453-4057qib7	11218	18	higher	high	JJR
cord-005453-4057qib7	11218	19	after	after	IN
cord-005453-4057qib7	11218	20	MRD	MRD	NNP
cord-005453-4057qib7	11218	21	.	.	.
cord-005453-4057qib7	11219	1	Even	even	RB
cord-005453-4057qib7	11219	2	though	though	IN
cord-005453-4057qib7	11219	3	limited	limit	VBN
cord-005453-4057qib7	11219	4	in	in	IN
cord-005453-4057qib7	11219	5	number	number	NN
cord-005453-4057qib7	11219	6	,	,	,
cord-005453-4057qib7	11219	7	this	this	DT
cord-005453-4057qib7	11219	8	data	datum	NNS
cord-005453-4057qib7	11219	9	contribute	contribute	VBP
cord-005453-4057qib7	11219	10	to	to	IN
cord-005453-4057qib7	11219	11	the	the	DT
cord-005453-4057qib7	11219	12	growing	grow	VBG
cord-005453-4057qib7	11219	13	body	body	NN
cord-005453-4057qib7	11219	14	of	of	IN
cord-005453-4057qib7	11219	15	evidence	evidence	NN
cord-005453-4057qib7	11219	16	that	that	IN
cord-005453-4057qib7	11219	17	use	use	NN
cord-005453-4057qib7	11219	18	of	of	IN
cord-005453-4057qib7	11219	19	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11219	20	donors	donor	NNS
cord-005453-4057qib7	11219	21	,	,	,
cord-005453-4057qib7	11219	22	particularly	particularly	RB
cord-005453-4057qib7	11219	23	in	in	IN
cord-005453-4057qib7	11219	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	11219	25	setting	setting	NN
cord-005453-4057qib7	11219	26	,	,	,
cord-005453-4057qib7	11219	27	is	be	VBZ
cord-005453-4057qib7	11219	28	as	as	RB
cord-005453-4057qib7	11219	29	worthy	worthy	JJ
cord-005453-4057qib7	11219	30	as	as	IN
cord-005453-4057qib7	11219	31	using	use	VBG
cord-005453-4057qib7	11219	32	matched	match	VBN
cord-005453-4057qib7	11219	33	related	related	JJ
cord-005453-4057qib7	11219	34	donors	donor	NNS
cord-005453-4057qib7	11219	35	and	and	CC
cord-005453-4057qib7	11219	36	should	should	MD
cord-005453-4057qib7	11219	37	be	be	VB
cord-005453-4057qib7	11219	38	at	at	IN
cord-005453-4057qib7	11219	39	least	least	JJS
cord-005453-4057qib7	11219	40	second	second	JJ
cord-005453-4057qib7	11219	41	choice	choice	NN
cord-005453-4057qib7	11219	42	in	in	IN
cord-005453-4057qib7	11219	43	donor	donor	NN
cord-005453-4057qib7	11219	44	selection	selection	NN
cord-005453-4057qib7	11219	45	,	,	,
cord-005453-4057qib7	11219	46	and	and	CC
cord-005453-4057qib7	11219	47	in	in	IN
cord-005453-4057qib7	11219	48	older	old	JJR
cord-005453-4057qib7	11219	49	patients	patient	NNS
cord-005453-4057qib7	11219	50	(	(	-LRB-
cord-005453-4057qib7	11219	51	with	with	IN
cord-005453-4057qib7	11219	52	older	old	JJR
cord-005453-4057qib7	11219	53	donors	donor	NNS
cord-005453-4057qib7	11219	54	)	)	-RRB-
cord-005453-4057qib7	11219	55	probably	probably	RB
cord-005453-4057qib7	11219	56	the	the	DT
cord-005453-4057qib7	11219	57	first	first	JJ
cord-005453-4057qib7	11219	58	one	one	CD
cord-005453-4057qib7	11219	59	.	.	.
cord-005453-4057qib7	11220	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11220	2	:	:	:
cord-005453-4057qib7	11220	3	Nothing	nothing	NN
cord-005453-4057qib7	11220	4	to	to	TO
cord-005453-4057qib7	11220	5	declare	declare	VB
cord-005453-4057qib7	11220	6	.	.	.
cord-005453-4057qib7	11221	1	Adjuvant	adjuvant	NN
cord-005453-4057qib7	11221	2	involved	involve	VBN
cord-005453-4057qib7	11221	3	field	field	NN
cord-005453-4057qib7	11221	4	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11221	5	post	post	JJ
cord-005453-4057qib7	11221	6	autologous	autologous	JJ
cord-005453-4057qib7	11221	7	stem	stem	NN
cord-005453-4057qib7	11221	8	cell	cell	NN
cord-005453-4057qib7	11221	9	transplantation	transplantation	NN
cord-005453-4057qib7	11221	10	for	for	IN
cord-005453-4057qib7	11221	11	refractory	refractory	JJ
cord-005453-4057qib7	11221	12	/	/	SYM
cord-005453-4057qib7	11221	13	relapsed	relapse	VBN
cord-005453-4057qib7	11221	14	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11222	1	results	result	NNS
cord-005453-4057qib7	11222	2	in	in	IN
cord-005453-4057qib7	11222	3	favorable	favorable	JJ
cord-005453-4057qib7	11222	4	outcome	outcome	NN
cord-005453-4057qib7	11222	5	with	with	IN
cord-005453-4057qib7	11222	6	low	low	JJ
cord-005453-4057qib7	11222	7	toxicity	toxicity	NN
cord-005453-4057qib7	11222	8	:	:	:
cord-005453-4057qib7	11222	9	A	a	DT
cord-005453-4057qib7	11222	10	single	single	JJ
cord-005453-4057qib7	11222	11	center	center	NN
cord-005453-4057qib7	11222	12	experience	experience	NN
cord-005453-4057qib7	11223	1	Background	background	NN
cord-005453-4057qib7	11223	2	:	:	:
cord-005453-4057qib7	11224	1	Involved	involve	VBN
cord-005453-4057qib7	11224	2	field	field	NN
cord-005453-4057qib7	11224	3	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11224	4	(	(	-LRB-
cord-005453-4057qib7	11224	5	IFRT	IFRT	NNP
cord-005453-4057qib7	11224	6	)	)	-RRB-
cord-005453-4057qib7	11224	7	to	to	IN
cord-005453-4057qib7	11224	8	previous	previous	JJ
cord-005453-4057qib7	11224	9	bulky	bulky	JJ
cord-005453-4057qib7	11224	10	or	or	CC
cord-005453-4057qib7	11224	11	localized	localized	JJ
cord-005453-4057qib7	11224	12	residual	residual	JJ
cord-005453-4057qib7	11224	13	disease	disease	NN
cord-005453-4057qib7	11224	14	,	,	,
cord-005453-4057qib7	11224	15	is	be	VBZ
cord-005453-4057qib7	11224	16	a	a	DT
cord-005453-4057qib7	11224	17	widely	widely	RB
cord-005453-4057qib7	11224	18	used	use	VBN
cord-005453-4057qib7	11224	19	treatment	treatment	NN
cord-005453-4057qib7	11224	20	approach	approach	NN
cord-005453-4057qib7	11224	21	to	to	TO
cord-005453-4057qib7	11224	22	minimize	minimize	VB
cord-005453-4057qib7	11224	23	the	the	DT
cord-005453-4057qib7	11224	24	risk	risk	NN
cord-005453-4057qib7	11224	25	of	of	IN
cord-005453-4057qib7	11224	26	relapse	relapse	NN
cord-005453-4057qib7	11224	27	post	post	JJ
cord-005453-4057qib7	11224	28	autologous	autologous	JJ
cord-005453-4057qib7	11224	29	stem	stem	NN
cord-005453-4057qib7	11224	30	cell	cell	NN
cord-005453-4057qib7	11224	31	transplantation	transplantation	NN
cord-005453-4057qib7	11224	32	(	(	-LRB-
cord-005453-4057qib7	11224	33	ASCT	ASCT	NNP
cord-005453-4057qib7	11224	34	)	)	-RRB-
cord-005453-4057qib7	11224	35	.	.	.
cord-005453-4057qib7	11225	1	However	however	RB
cord-005453-4057qib7	11225	2	,	,	,
cord-005453-4057qib7	11225	3	the	the	DT
cord-005453-4057qib7	11225	4	proper	proper	JJ
cord-005453-4057qib7	11225	5	time	time	NN
cord-005453-4057qib7	11225	6	for	for	IN
cord-005453-4057qib7	11225	7	irradiation	irradiation	NN
cord-005453-4057qib7	11225	8	treatment	treatment	NN
cord-005453-4057qib7	11225	9	remains	remain	VBZ
cord-005453-4057qib7	11225	10	controversial	controversial	JJ
cord-005453-4057qib7	11225	11	.	.	.
cord-005453-4057qib7	11226	1	Adjuvant	Adjuvant	NNP
cord-005453-4057qib7	11226	2	IFRT	IFRT	NNP
cord-005453-4057qib7	11226	3	(	(	-LRB-
cord-005453-4057qib7	11226	4	adj	adj	NNP
cord-005453-4057qib7	11226	5	-	-	HYPH
cord-005453-4057qib7	11226	6	IFRT	IFRT	NNP
cord-005453-4057qib7	11226	7	)	)	-RRB-
cord-005453-4057qib7	11226	8	in	in	IN
cord-005453-4057qib7	11226	9	pre	pre	JJ
cord-005453-4057qib7	11226	10	-	-	JJ
cord-005453-4057qib7	11226	11	ASCT	asct	JJ
cord-005453-4057qib7	11226	12	period	period	NN
cord-005453-4057qib7	11226	13	could	could	MD
cord-005453-4057qib7	11226	14	cause	cause	VB
cord-005453-4057qib7	11226	15	undesirable	undesirable	JJ
cord-005453-4057qib7	11226	16	toxicity	toxicity	NN
cord-005453-4057qib7	11226	17	which	which	WDT
cord-005453-4057qib7	11226	18	might	may	MD
cord-005453-4057qib7	11226	19	delays	delay	NNS
cord-005453-4057qib7	11226	20	or	or	CC
cord-005453-4057qib7	11226	21	even	even	RB
cord-005453-4057qib7	11226	22	cancel	cancel	VB
cord-005453-4057qib7	11226	23	the	the	DT
cord-005453-4057qib7	11226	24	ASCT	ASCT	NNP
cord-005453-4057qib7	11226	25	resulting	result	VBG
cord-005453-4057qib7	11226	26	in	in	IN
cord-005453-4057qib7	11226	27	increased	increase	VBN
cord-005453-4057qib7	11226	28	risk	risk	NN
cord-005453-4057qib7	11226	29	of	of	IN
cord-005453-4057qib7	11226	30	relapse	relapse	NN
cord-005453-4057qib7	11226	31	,	,	,
cord-005453-4057qib7	11226	32	or	or	CC
cord-005453-4057qib7	11226	33	could	could	MD
cord-005453-4057qib7	11226	34	affect	affect	VB
cord-005453-4057qib7	11226	35	the	the	DT
cord-005453-4057qib7	11226	36	marrow	marrow	NN
cord-005453-4057qib7	11226	37	environmental	environmental	JJ
cord-005453-4057qib7	11226	38	and	and	CC
cord-005453-4057qib7	11226	39	marrow	marrow	NN
cord-005453-4057qib7	11226	40	niche	niche	NN
cord-005453-4057qib7	11226	41	resulting	result	VBG
cord-005453-4057qib7	11226	42	thus	thus	RB
cord-005453-4057qib7	11226	43	in	in	IN
cord-005453-4057qib7	11226	44	impaired	impaired	JJ
cord-005453-4057qib7	11226	45	engraftment	engraftment	NN
cord-005453-4057qib7	11226	46	.	.	.
cord-005453-4057qib7	11227	1	On	on	IN
cord-005453-4057qib7	11227	2	the	the	DT
cord-005453-4057qib7	11227	3	other	other	JJ
cord-005453-4057qib7	11227	4	hand	hand	NN
cord-005453-4057qib7	11227	5	,	,	,
cord-005453-4057qib7	11227	6	the	the	DT
cord-005453-4057qib7	11227	7	ajd	ajd	NNP
cord-005453-4057qib7	11227	8	-	-	HYPH
cord-005453-4057qib7	11227	9	IFTR	IFTR	NNP
cord-005453-4057qib7	11227	10	in	in	IN
cord-005453-4057qib7	11227	11	the	the	DT
cord-005453-4057qib7	11227	12	early	early	JJ
cord-005453-4057qib7	11227	13	post	post	JJ
cord-005453-4057qib7	11227	14	-	-	JJ
cord-005453-4057qib7	11227	15	ASCT	asct	JJ
cord-005453-4057qib7	11227	16	period	period	NN
cord-005453-4057qib7	11227	17	,	,	,
cord-005453-4057qib7	11227	18	upon	upon	IN
cord-005453-4057qib7	11227	19	marrow	marrow	NN
cord-005453-4057qib7	11227	20	recovery	recovery	NN
cord-005453-4057qib7	11227	21	,	,	,
cord-005453-4057qib7	11227	22	offers	offer	VBZ
cord-005453-4057qib7	11227	23	a	a	DT
cord-005453-4057qib7	11227	24	potential	potential	JJ
cord-005453-4057qib7	11227	25	advantage	advantage	NN
cord-005453-4057qib7	11227	26	by	by	IN
cord-005453-4057qib7	11227	27	delivering	deliver	VBG
cord-005453-4057qib7	11227	28	irradiation	irradiation	NN
cord-005453-4057qib7	11227	29	after	after	IN
cord-005453-4057qib7	11227	30	sufficient	sufficient	JJ
cord-005453-4057qib7	11227	31	disease	disease	NN
cord-005453-4057qib7	11227	32	response	response	NN
cord-005453-4057qib7	11227	33	,	,	,
cord-005453-4057qib7	11227	34	without	without	IN
cord-005453-4057qib7	11227	35	affecting	affect	VBG
cord-005453-4057qib7	11227	36	the	the	DT
cord-005453-4057qib7	11227	37	engraftment	engraftment	NN
cord-005453-4057qib7	11227	38	.	.	.
cord-005453-4057qib7	11228	1	In	in	IN
cord-005453-4057qib7	11228	2	this	this	DT
cord-005453-4057qib7	11228	3	retrospective	retrospective	JJ
cord-005453-4057qib7	11228	4	study	study	NN
cord-005453-4057qib7	11228	5	we	-PRON-	PRP
cord-005453-4057qib7	11228	6	evaluated	evaluate	VBD
cord-005453-4057qib7	11228	7	the	the	DT
cord-005453-4057qib7	11228	8	safety	safety	NN
cord-005453-4057qib7	11228	9	and	and	CC
cord-005453-4057qib7	11228	10	efficacy	efficacy	NN
cord-005453-4057qib7	11228	11	of	of	IN
cord-005453-4057qib7	11228	12	the	the	DT
cord-005453-4057qib7	11228	13	IFRT	IFRT	NNP
cord-005453-4057qib7	11228	14	as	as	IN
cord-005453-4057qib7	11228	15	adjuvant	adjuvant	JJ
cord-005453-4057qib7	11228	16	treatment	treatment	NN
cord-005453-4057qib7	11228	17	in	in	IN
cord-005453-4057qib7	11228	18	patients	patient	NNS
cord-005453-4057qib7	11228	19	who	who	WP
cord-005453-4057qib7	11228	20	had	have	VBD
cord-005453-4057qib7	11228	21	previously	previously	RB
cord-005453-4057qib7	11228	22	treated	treat	VBN
cord-005453-4057qib7	11228	23	with	with	IN
cord-005453-4057qib7	11228	24	ASCT	ASCT	NNP
cord-005453-4057qib7	11228	25	for	for	IN
cord-005453-4057qib7	11228	26	relapsed	relapsed	JJ
cord-005453-4057qib7	11228	27	or	or	CC
cord-005453-4057qib7	11228	28	refractory	refractory	JJ
cord-005453-4057qib7	11228	29	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11228	30	.	.	.
cord-005453-4057qib7	11229	1	Methods	method	NNS
cord-005453-4057qib7	11229	2	:	:	:
cord-005453-4057qib7	11229	3	Twenty	twenty	CD
cord-005453-4057qib7	11229	4	-	-	HYPH
cord-005453-4057qib7	11229	5	three	three	CD
cord-005453-4057qib7	11229	6	patients	patient	NNS
cord-005453-4057qib7	11229	7	(	(	-LRB-
cord-005453-4057qib7	11229	8	Hodgkin=14	Hodgkin=14	NNP
cord-005453-4057qib7	11229	9	,	,	,
cord-005453-4057qib7	11229	10	Non	non	JJ
cord-005453-4057qib7	11229	11	-	-	NN
cord-005453-4057qib7	11229	12	Hodgkin=9	hodgkin=9	JJ
cord-005453-4057qib7	11229	13	)	)	-RRB-
cord-005453-4057qib7	11229	14	,	,	,
cord-005453-4057qib7	11229	15	aged	age	VBN
cord-005453-4057qib7	11229	16	of	of	IN
cord-005453-4057qib7	11229	17	34(16	34(16	CD
cord-005453-4057qib7	11229	18	-	-	SYM
cord-005453-4057qib7	11229	19	76	76	CD
cord-005453-4057qib7	11229	20	)	)	-RRB-
cord-005453-4057qib7	11229	21	years	year	NNS
cord-005453-4057qib7	11229	22	,	,	,
cord-005453-4057qib7	11229	23	underwent	undergo	VBD
cord-005453-4057qib7	11229	24	ASCT	ASCT	NNP
cord-005453-4057qib7	11229	25	,	,	,
cord-005453-4057qib7	11229	26	for	for	IN
cord-005453-4057qib7	11229	27	primary	primary	JJ
cord-005453-4057qib7	11229	28	refractory	refractory	NN
cord-005453-4057qib7	11229	29	(	(	-LRB-
cord-005453-4057qib7	11229	30	n=15	n=15	NNP
cord-005453-4057qib7	11229	31	)	)	-RRB-
cord-005453-4057qib7	11229	32	or	or	CC
cord-005453-4057qib7	11229	33	relapsed	relapse	VBN
cord-005453-4057qib7	11229	34	(	(	-LRB-
cord-005453-4057qib7	11229	35	n=8	n=8	NN
cord-005453-4057qib7	11229	36	)	)	-RRB-
cord-005453-4057qib7	11229	37	disease	disease	NN
cord-005453-4057qib7	11229	38	.	.	.
cord-005453-4057qib7	11230	1	Patients	patient	NNS
cord-005453-4057qib7	11230	2	who	who	WP
cord-005453-4057qib7	11230	3	had	have	VBD
cord-005453-4057qib7	11230	4	bulky	bulky	JJ
cord-005453-4057qib7	11230	5	disease	disease	NN
cord-005453-4057qib7	11230	6	at	at	IN
cord-005453-4057qib7	11230	7	the	the	DT
cord-005453-4057qib7	11230	8	time	time	NN
cord-005453-4057qib7	11230	9	of	of	IN
cord-005453-4057qib7	11230	10	relapse	relapse	NN
cord-005453-4057qib7	11230	11	or	or	CC
cord-005453-4057qib7	11230	12	those	those	DT
cord-005453-4057qib7	11230	13	with	with	IN
cord-005453-4057qib7	11230	14	residual	residual	JJ
cord-005453-4057qib7	11230	15	mass	mass	JJ
cord-005453-4057qib7	11230	16	post	post	NN
cord-005453-4057qib7	11230	17	salvage	salvage	NN
cord-005453-4057qib7	11230	18	treatment	treatment	NN
cord-005453-4057qib7	11230	19	,	,	,
cord-005453-4057qib7	11230	20	were	be	VBD
cord-005453-4057qib7	11230	21	considered	consider	VBN
cord-005453-4057qib7	11230	22	as	as	IN
cord-005453-4057qib7	11230	23	candidates	candidate	NNS
cord-005453-4057qib7	11230	24	for	for	IN
cord-005453-4057qib7	11230	25	adj	adj	JJ
cord-005453-4057qib7	11230	26	-	-	HYPH
cord-005453-4057qib7	11230	27	IFRT	IFRT	NNP
cord-005453-4057qib7	11230	28	,	,	,
cord-005453-4057qib7	11230	29	early	early	RB
cord-005453-4057qib7	11230	30	(	(	-LRB-
cord-005453-4057qib7	11230	31	within	within	IN
cord-005453-4057qib7	11230	32	2	2	CD
cord-005453-4057qib7	11230	33	-	-	SYM
cord-005453-4057qib7	11230	34	3	3	CD
cord-005453-4057qib7	11230	35	months	month	NNS
cord-005453-4057qib7	11230	36	)	)	-RRB-
cord-005453-4057qib7	11230	37	after	after	IN
cord-005453-4057qib7	11230	38	documentation	documentation	NN
cord-005453-4057qib7	11230	39	of	of	IN
cord-005453-4057qib7	11230	40	autologous	autologous	JJ
cord-005453-4057qib7	11230	41	stem	stem	NN
cord-005453-4057qib7	11230	42	cells	cell	NNS
cord-005453-4057qib7	11230	43	engraftment	engraftment	NN
cord-005453-4057qib7	11230	44	.	.	.
cord-005453-4057qib7	11231	1	All	all	DT
cord-005453-4057qib7	11231	2	patients	patient	NNS
cord-005453-4057qib7	11231	3	proceeded	proceed	VBD
cord-005453-4057qib7	11231	4	to	to	IN
cord-005453-4057qib7	11231	5	ASCT	ASCT	NNP
cord-005453-4057qib7	11231	6	with	with	IN
cord-005453-4057qib7	11231	7	chemosensitive	chemosensitive	JJ
cord-005453-4057qib7	11231	8	disease	disease	NN
cord-005453-4057qib7	11231	9	after	after	IN
cord-005453-4057qib7	11231	10	a	a	DT
cord-005453-4057qib7	11231	11	median	median	NN
cord-005453-4057qib7	11231	12	of	of	IN
cord-005453-4057qib7	11231	13	2	2	CD
cord-005453-4057qib7	11231	14	lines	line	NNS
cord-005453-4057qib7	11231	15	of	of	IN
cord-005453-4057qib7	11231	16	salvage	salvage	NN
cord-005453-4057qib7	11231	17	therapy	therapy	NN
cord-005453-4057qib7	11231	18	.	.	.
cord-005453-4057qib7	11232	1	At	at	IN
cord-005453-4057qib7	11232	2	the	the	DT
cord-005453-4057qib7	11232	3	time	time	NN
cord-005453-4057qib7	11232	4	of	of	IN
cord-005453-4057qib7	11232	5	ASCT	ASCT	NNP
cord-005453-4057qib7	11232	6	20	20	CD
cord-005453-4057qib7	11232	7	patients	patient	NNS
cord-005453-4057qib7	11232	8	(	(	-LRB-
cord-005453-4057qib7	11232	9	80	80	CD
cord-005453-4057qib7	11232	10	%	%	NN
cord-005453-4057qib7	11232	11	)	)	-RRB-
cord-005453-4057qib7	11232	12	had	have	VBD
cord-005453-4057qib7	11232	13	residual	residual	JJ
cord-005453-4057qib7	11232	14	disease	disease	NN
cord-005453-4057qib7	11232	15	while	while	IN
cord-005453-4057qib7	11232	16	4(20	4(20	CD
cord-005453-4057qib7	11232	17	%	%	NN
cord-005453-4057qib7	11232	18	)	)	-RRB-
cord-005453-4057qib7	11232	19	evaluated	evaluate	VBN
cord-005453-4057qib7	11232	20	to	to	TO
cord-005453-4057qib7	11232	21	be	be	VB
cord-005453-4057qib7	11232	22	in	in	IN
cord-005453-4057qib7	11232	23	complete	complete	JJ
cord-005453-4057qib7	11232	24	remission	remission	NN
cord-005453-4057qib7	11232	25	.	.	.
cord-005453-4057qib7	11233	1	The	the	DT
cord-005453-4057qib7	11233	2	preparative	preparative	JJ
cord-005453-4057qib7	11233	3	regimens	regimen	NNS
cord-005453-4057qib7	11233	4	were	be	VBD
cord-005453-4057qib7	11233	5	:	:	:
cord-005453-4057qib7	11233	6	single	single	JJ
cord-005453-4057qib7	11233	7	-	-	HYPH
cord-005453-4057qib7	11233	8	agent	agent	NN
cord-005453-4057qib7	11233	9	Melphalan	Melphalan	NNP
cord-005453-4057qib7	11233	10	(	(	-LRB-
cord-005453-4057qib7	11233	11	n=9	n=9	NN
cord-005453-4057qib7	11233	12	)	)	-RRB-
cord-005453-4057qib7	11233	13	,	,	,
cord-005453-4057qib7	11233	14	Busulfan	Busulfan	NNP
cord-005453-4057qib7	11233	15	-	-	HYPH
cord-005453-4057qib7	11233	16	Etoposide	Etoposide	NNP
cord-005453-4057qib7	11233	17	-	-	HYPH
cord-005453-4057qib7	11233	18	Melphalan	Melphalan	NNP
cord-005453-4057qib7	11233	19	(	(	-LRB-
cord-005453-4057qib7	11233	20	n=7	n=7	NNS
cord-005453-4057qib7	11233	21	)	)	-RRB-
cord-005453-4057qib7	11233	22	,	,	,
cord-005453-4057qib7	11233	23	BEAM	BEAM	NNP
cord-005453-4057qib7	11233	24	(	(	-LRB-
cord-005453-4057qib7	11233	25	n=5	n=5	NNP
cord-005453-4057qib7	11233	26	)	)	-RRB-
cord-005453-4057qib7	11233	27	and	and	CC
cord-005453-4057qib7	11233	28	Bendamustin	Bendamustin	NNP
cord-005453-4057qib7	11233	29	-	-	HYPH
cord-005453-4057qib7	11233	30	Etoposide	Etoposide	NNP
cord-005453-4057qib7	11233	31	-	-	HYPH
cord-005453-4057qib7	11233	32	Cytarabine	Cytarabine	NNP
cord-005453-4057qib7	11233	33	-	-	HYPH
cord-005453-4057qib7	11233	34	Melphalan	Melphalan	NNP
cord-005453-4057qib7	11233	35	(	(	-LRB-
cord-005453-4057qib7	11233	36	n=3	n=3	NN
cord-005453-4057qib7	11233	37	)	)	-RRB-
cord-005453-4057qib7	11233	38	.	.	.
cord-005453-4057qib7	11234	1	Filgrastim	Filgrastim	NNP
cord-005453-4057qib7	11234	2	was	be	VBD
cord-005453-4057qib7	11234	3	given	give	VBN
cord-005453-4057qib7	11234	4	till	till	IN
cord-005453-4057qib7	11234	5	neutrophills	neutrophills	NNP
cord-005453-4057qib7	11234	6	recovery	recovery	NN
cord-005453-4057qib7	11234	7	,	,	,
cord-005453-4057qib7	11234	8	while	while	IN
cord-005453-4057qib7	11234	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11234	10	against	against	IN
cord-005453-4057qib7	11234	11	bacteria	bacteria	NNS
cord-005453-4057qib7	11234	12	,	,	,
cord-005453-4057qib7	11234	13	fungus	fungus	NN
cord-005453-4057qib7	11234	14	,	,	,
cord-005453-4057qib7	11234	15	viruses	virus	NNS
cord-005453-4057qib7	11234	16	and	and	CC
cord-005453-4057qib7	11234	17	PCP	PCP	NNP
cord-005453-4057qib7	11234	18	were	be	VBD
cord-005453-4057qib7	11234	19	administered	administer	VBN
cord-005453-4057qib7	11234	20	till	till	IN
cord-005453-4057qib7	11234	21	the	the	DT
cord-005453-4057qib7	11234	22	completion	completion	NN
cord-005453-4057qib7	11234	23	of	of	IN
cord-005453-4057qib7	11234	24	adj	adj	JJ
cord-005453-4057qib7	11234	25	-	-	HYPH
cord-005453-4057qib7	11234	26	IFRT	IFRT	NNP
cord-005453-4057qib7	11234	27	.	.	.
cord-005453-4057qib7	11235	1	Results	result	NNS
cord-005453-4057qib7	11235	2	:	:	:
cord-005453-4057qib7	11236	1	All	all	DT
cord-005453-4057qib7	11236	2	patients	patient	NNS
cord-005453-4057qib7	11236	3	engrafted	engraft	VBD
cord-005453-4057qib7	11236	4	promptly	promptly	RB
cord-005453-4057qib7	11236	5	and	and	CC
cord-005453-4057qib7	11236	6	successfully	successfully	RB
cord-005453-4057qib7	11236	7	.	.	.
cord-005453-4057qib7	11237	1	No	no	DT
cord-005453-4057qib7	11237	2	patient	patient	NN
cord-005453-4057qib7	11237	3	experienced	experience	VBD
cord-005453-4057qib7	11237	4	any	any	DT
cord-005453-4057qib7	11237	5	severe	severe	JJ
cord-005453-4057qib7	11237	6	toxicity	toxicity	NN
cord-005453-4057qib7	11237	7	or	or	CC
cord-005453-4057qib7	11237	8	active	active	JJ
cord-005453-4057qib7	11237	9	infection	infection	NN
cord-005453-4057qib7	11237	10	before	before	IN
cord-005453-4057qib7	11237	11	adj	adj	JJ
cord-005453-4057qib7	11237	12	-	-	HYPH
cord-005453-4057qib7	11237	13	IFTR	IFTR	NNP
cord-005453-4057qib7	11237	14	.	.	.
cord-005453-4057qib7	11238	1	Though	though	IN
cord-005453-4057qib7	11238	2	our	-PRON-	PRP$
cord-005453-4057qib7	11238	3	plan	plan	NN
cord-005453-4057qib7	11238	4	was	be	VBD
cord-005453-4057qib7	11238	5	to	to	TO
cord-005453-4057qib7	11238	6	proceed	proceed	VB
cord-005453-4057qib7	11238	7	with	with	IN
cord-005453-4057qib7	11238	8	adj	adj	JJ
cord-005453-4057qib7	11238	9	-	-	HYPH
cord-005453-4057qib7	11238	10	IFRT	ifrt	NN
cord-005453-4057qib7	11238	11	within	within	IN
cord-005453-4057qib7	11238	12	3	3	CD
cord-005453-4057qib7	11238	13	months	month	NNS
cord-005453-4057qib7	11238	14	post	post	NN
cord-005453-4057qib7	11238	15	ASCT	ASCT	NNP
cord-005453-4057qib7	11238	16	,	,	,
cord-005453-4057qib7	11238	17	finally	finally	RB
cord-005453-4057qib7	11238	18	it	-PRON-	PRP
cord-005453-4057qib7	11238	19	was	be	VBD
cord-005453-4057qib7	11238	20	delivered	deliver	VBN
cord-005453-4057qib7	11238	21	after	after	IN
cord-005453-4057qib7	11238	22	a	a	DT
cord-005453-4057qib7	11238	23	median	median	NN
cord-005453-4057qib7	11238	24	of	of	IN
cord-005453-4057qib7	11238	25	4.5	4.5	CD
cord-005453-4057qib7	11238	26	(	(	-LRB-
cord-005453-4057qib7	11238	27	2	2	CD
cord-005453-4057qib7	11238	28	-	-	SYM
cord-005453-4057qib7	11238	29	7	7	CD
cord-005453-4057qib7	11238	30	)	)	-RRB-
cord-005453-4057qib7	11238	31	months	month	NNS
cord-005453-4057qib7	11238	32	;	;	:
cord-005453-4057qib7	11238	33	the	the	DT
cord-005453-4057qib7	11238	34	median	median	JJ
cord-005453-4057qib7	11238	35	radiation	radiation	NN
cord-005453-4057qib7	11238	36	dose	dose	NN
cord-005453-4057qib7	11238	37	was	be	VBD
cord-005453-4057qib7	11238	38	30(24	30(24	CD
cord-005453-4057qib7	11238	39	-	-	SYM
cord-005453-4057qib7	11238	40	36	36	CD
cord-005453-4057qib7	11239	1	)	)	-RRB-
cord-005453-4057qib7	11239	2	Gy	Gy	NNP
cord-005453-4057qib7	11239	3	.	.	.
cord-005453-4057qib7	11240	1	Ten	ten	CD
cord-005453-4057qib7	11240	2	patients	patient	NNS
cord-005453-4057qib7	11240	3	received	receive	VBD
cord-005453-4057qib7	11240	4	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11240	5	in	in	IN
cord-005453-4057qib7	11240	6	the	the	DT
cord-005453-4057qib7	11240	7	mediastinum	mediastinum	NN
cord-005453-4057qib7	11240	8	,	,	,
cord-005453-4057qib7	11240	9	9	9	CD
cord-005453-4057qib7	11240	10	in	in	IN
cord-005453-4057qib7	11240	11	the	the	DT
cord-005453-4057qib7	11240	12	abdomen	abdomen	NN
cord-005453-4057qib7	11240	13	/	/	SYM
cord-005453-4057qib7	11240	14	pelvis/	pelvis/	JJ
cord-005453-4057qib7	11240	15	inguinal	inguinal	JJ
cord-005453-4057qib7	11240	16	area	area	NN
cord-005453-4057qib7	11240	17	3	3	CD
cord-005453-4057qib7	11240	18	in	in	IN
cord-005453-4057qib7	11240	19	the	the	DT
cord-005453-4057qib7	11240	20	neck	neck	NN
cord-005453-4057qib7	11240	21	,	,	,
cord-005453-4057qib7	11240	22	and	and	CC
cord-005453-4057qib7	11240	23	1	1	CD
cord-005453-4057qib7	11240	24	in	in	IN
cord-005453-4057qib7	11240	25	the	the	DT
cord-005453-4057qib7	11240	26	left	left	JJ
cord-005453-4057qib7	11240	27	leg	leg	NN
cord-005453-4057qib7	11240	28	.	.	.
cord-005453-4057qib7	11241	1	The	the	DT
cord-005453-4057qib7	11241	2	adj	adj	JJ
cord-005453-4057qib7	11241	3	-	-	HYPH
cord-005453-4057qib7	11241	4	IFRT	IFRT	NNP
cord-005453-4057qib7	11241	5	was	be	VBD
cord-005453-4057qib7	11241	6	well	well	RB
cord-005453-4057qib7	11241	7	tolerated	tolerate	VBN
cord-005453-4057qib7	11241	8	.	.	.
cord-005453-4057qib7	11242	1	No	no	DT
cord-005453-4057qib7	11242	2	patient	patient	NN
cord-005453-4057qib7	11242	3	experienced	experience	VBD
cord-005453-4057qib7	11242	4	toxicity	toxicity	NN
cord-005453-4057qib7	11242	5	grade	grade	NN
cord-005453-4057qib7	11242	6	>	>	XX
cord-005453-4057qib7	11243	1	3	3	LS
cord-005453-4057qib7	11244	1	and	and	CC
cord-005453-4057qib7	11244	2	none	none	NN
cord-005453-4057qib7	11244	3	required	require	VBD
cord-005453-4057qib7	11244	4	hospitalization	hospitalization	NN
cord-005453-4057qib7	11244	5	.	.	.
cord-005453-4057qib7	11245	1	Currently	currently	RB
cord-005453-4057qib7	11245	2	,	,	,
cord-005453-4057qib7	11245	3	after	after	IN
cord-005453-4057qib7	11245	4	a	a	DT
cord-005453-4057qib7	11245	5	median	median	JJ
cord-005453-4057qib7	11245	6	follow	follow	NN
cord-005453-4057qib7	11245	7	-	-	HYPH
cord-005453-4057qib7	11245	8	up	up	NN
cord-005453-4057qib7	11245	9	of	of	IN
cord-005453-4057qib7	11245	10	2(2	2(2	NNP
cord-005453-4057qib7	11245	11	-	-	SYM
cord-005453-4057qib7	11245	12	5	5	CD
cord-005453-4057qib7	11245	13	)	)	-RRB-
cord-005453-4057qib7	11245	14	years	year	NNS
cord-005453-4057qib7	11245	15	,	,	,
cord-005453-4057qib7	11245	16	19/23	19/23	CD
cord-005453-4057qib7	11245	17	patients	patient	NNS
cord-005453-4057qib7	11245	18	are	be	VBP
cord-005453-4057qib7	11245	19	alive	alive	JJ
cord-005453-4057qib7	11245	20	and	and	CC
cord-005453-4057qib7	11245	21	well	well	RB
cord-005453-4057qib7	11245	22	;	;	:
cord-005453-4057qib7	11245	23	the	the	DT
cord-005453-4057qib7	11245	24	5-years	5-years	CD
cord-005453-4057qib7	11245	25	overall	overall	JJ
cord-005453-4057qib7	11245	26	and	and	CC
cord-005453-4057qib7	11245	27	progression	progression	NN
cord-005453-4057qib7	11245	28	free	free	JJ
cord-005453-4057qib7	11245	29	survival	survival	NN
cord-005453-4057qib7	11245	30	rates	rate	NNS
cord-005453-4057qib7	11245	31	are	be	VBP
cord-005453-4057qib7	11245	32	75	75	CD
cord-005453-4057qib7	11245	33	%	%	NN
cord-005453-4057qib7	11245	34	and	and	CC
cord-005453-4057qib7	11245	35	55	55	CD
cord-005453-4057qib7	11245	36	%	%	NN
cord-005453-4057qib7	11245	37	respectively	respectively	RB
cord-005453-4057qib7	11245	38	.	.	.
cord-005453-4057qib7	11246	1	Four	four	CD
cord-005453-4057qib7	11246	2	patients	patient	NNS
cord-005453-4057qib7	11246	3	died	die	VBD
cord-005453-4057qib7	11246	4	;	;	:
cord-005453-4057qib7	11246	5	2	2	CD
cord-005453-4057qib7	11246	6	due	due	JJ
cord-005453-4057qib7	11246	7	to	to	IN
cord-005453-4057qib7	11246	8	relapsed	relapse	VBN
cord-005453-4057qib7	11246	9	disease	disease	NN
cord-005453-4057qib7	11246	10	and	and	CC
cord-005453-4057qib7	11246	11	2	2	CD
cord-005453-4057qib7	11246	12	heavily	heavily	RB
cord-005453-4057qib7	11246	13	pretreated	pretreate	VBN
cord-005453-4057qib7	11246	14	patients	patient	NNS
cord-005453-4057qib7	11246	15	due	due	JJ
cord-005453-4057qib7	11246	16	to	to	IN
cord-005453-4057qib7	11247	1	secondary	secondary	JJ
cord-005453-4057qib7	11247	2	myelodyspalstic	myelodyspalstic	JJ
cord-005453-4057qib7	11247	3	syndrome	syndrome	NN
cord-005453-4057qib7	11247	4	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	11247	5	:	:	:
cord-005453-4057qib7	11248	1	In	in	IN
cord-005453-4057qib7	11248	2	our	-PRON-	PRP$
cord-005453-4057qib7	11248	3	study	study	NN
cord-005453-4057qib7	11248	4	,	,	,
cord-005453-4057qib7	11248	5	the	the	DT
cord-005453-4057qib7	11248	6	adj	adj	JJ
cord-005453-4057qib7	11248	7	-	-	HYPH
cord-005453-4057qib7	11248	8	IFRT	ifrt	NN
cord-005453-4057qib7	11248	9	in	in	IN
cord-005453-4057qib7	11248	10	the	the	DT
cord-005453-4057qib7	11248	11	early	early	JJ
cord-005453-4057qib7	11248	12	post	post	JJ
cord-005453-4057qib7	11248	13	transplant	transplant	NN
cord-005453-4057qib7	11248	14	period	period	NN
cord-005453-4057qib7	11248	15	demonstrated	demonstrate	VBD
cord-005453-4057qib7	11248	16	a	a	DT
cord-005453-4057qib7	11248	17	safe	safe	JJ
cord-005453-4057qib7	11248	18	and	and	CC
cord-005453-4057qib7	11248	19	well	well	RB
cord-005453-4057qib7	11248	20	-	-	HYPH
cord-005453-4057qib7	11248	21	tolerated	tolerate	VBN
cord-005453-4057qib7	11248	22	profile	profile	NN
cord-005453-4057qib7	11248	23	.	.	.
cord-005453-4057qib7	11249	1	Taking	take	VBG
cord-005453-4057qib7	11249	2	into	into	IN
cord-005453-4057qib7	11249	3	consideration	consideration	NN
cord-005453-4057qib7	11249	4	the	the	DT
cord-005453-4057qib7	11249	5	poor	poor	JJ
cord-005453-4057qib7	11249	6	risk	risk	NN
cord-005453-4057qib7	11249	7	status	status	NN
cord-005453-4057qib7	11249	8	of	of	IN
cord-005453-4057qib7	11249	9	our	-PRON-	PRP$
cord-005453-4057qib7	11249	10	patients	patient	NNS
cord-005453-4057qib7	11249	11	(	(	-LRB-
cord-005453-4057qib7	11249	12	residual	residual	JJ
cord-005453-4057qib7	11249	13	disease	disease	NN
cord-005453-4057qib7	11249	14	post	post	NN
cord-005453-4057qib7	11249	15	salvage	salvage	NN
cord-005453-4057qib7	11249	16	regimen	regimen	NN
cord-005453-4057qib7	11249	17	or	or	CC
cord-005453-4057qib7	11249	18	bulky	bulky	JJ
cord-005453-4057qib7	11249	19	disease	disease	NN
cord-005453-4057qib7	11249	20	at	at	IN
cord-005453-4057qib7	11249	21	the	the	DT
cord-005453-4057qib7	11249	22	time	time	NN
cord-005453-4057qib7	11249	23	of	of	IN
cord-005453-4057qib7	11249	24	relapse	relapse	NN
cord-005453-4057qib7	11249	25	)	)	-RRB-
cord-005453-4057qib7	11249	26	,	,	,
cord-005453-4057qib7	11249	27	the	the	DT
cord-005453-4057qib7	11249	28	promising	promising	JJ
cord-005453-4057qib7	11249	29	overall	overall	NN
cord-005453-4057qib7	11249	30	and	and	CC
cord-005453-4057qib7	11249	31	progression	progression	NN
cord-005453-4057qib7	11249	32	free	free	JJ
cord-005453-4057qib7	11249	33	survival	survival	NN
cord-005453-4057qib7	11249	34	rates	rate	NNS
cord-005453-4057qib7	11249	35	suggested	suggest	VBD
cord-005453-4057qib7	11249	36	that	that	IN
cord-005453-4057qib7	11249	37	adj	adj	JJ
cord-005453-4057qib7	11249	38	-	-	HYPH
cord-005453-4057qib7	11249	39	IFRT	IFRT	NNP
cord-005453-4057qib7	11249	40	post	post	NN
cord-005453-4057qib7	11249	41	ASCT	ASCT	NNP
cord-005453-4057qib7	11249	42	is	be	VBZ
cord-005453-4057qib7	11249	43	also	also	RB
cord-005453-4057qib7	11249	44	an	an	DT
cord-005453-4057qib7	11249	45	effective	effective	JJ
cord-005453-4057qib7	11249	46	approach	approach	NN
cord-005453-4057qib7	11249	47	.	.	.
cord-005453-4057qib7	11250	1	Well	well	UH
cord-005453-4057qib7	11250	2	designed	design	VBN
cord-005453-4057qib7	11250	3	trials	trial	NNS
cord-005453-4057qib7	11250	4	are	be	VBP
cord-005453-4057qib7	11250	5	needed	need	VBN
cord-005453-4057qib7	11250	6	to	to	TO
cord-005453-4057qib7	11250	7	clarify	clarify	VB
cord-005453-4057qib7	11250	8	the	the	DT
cord-005453-4057qib7	11250	9	role	role	NN
cord-005453-4057qib7	11250	10	and	and	CC
cord-005453-4057qib7	11250	11	the	the	DT
cord-005453-4057qib7	11250	12	appropriate	appropriate	JJ
cord-005453-4057qib7	11250	13	time	time	NN
cord-005453-4057qib7	11250	14	of	of	IN
cord-005453-4057qib7	11250	15	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11250	16	in	in	IN
cord-005453-4057qib7	11250	17	the	the	DT
cord-005453-4057qib7	11250	18	ASCT	ASCT	NNP
cord-005453-4057qib7	11250	19	setting	set	VBG
cord-005453-4057qib7	11250	20	Disclosure	Disclosure	NNP
cord-005453-4057qib7	11250	21	:	:	:
cord-005453-4057qib7	11250	22	No	no	DT
cord-005453-4057qib7	11250	23	conflict	conflict	NN
cord-005453-4057qib7	11250	24	of	of	IN
cord-005453-4057qib7	11250	25	interest	interest	NN
cord-005453-4057qib7	11250	26	Adverse	adverse	JJ
cord-005453-4057qib7	11250	27	prognostic	prognostic	JJ
cord-005453-4057qib7	11250	28	impact	impact	NN
cord-005453-4057qib7	11250	29	of	of	IN
cord-005453-4057qib7	11250	30	pre	pre	JJ
cord-005453-4057qib7	11250	31	-	-	JJ
cord-005453-4057qib7	11250	32	transplant	transplant	JJ
cord-005453-4057qib7	11250	33	neutrophil/	neutrophil/	ADD
cord-005453-4057qib7	11250	34	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11250	35	ratio	ratio	NN
cord-005453-4057qib7	11250	36	in	in	IN
cord-005453-4057qib7	11250	37	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	11250	38	disorders	disorder	NNS
cord-005453-4057qib7	11250	39	Background	Background	NNP
cord-005453-4057qib7	11250	40	:	:	:
cord-005453-4057qib7	11250	41	BrentuximabVedotin(BV	brentuximabvedotin(bv	RB
cord-005453-4057qib7	11250	42	)	)	-RRB-
cord-005453-4057qib7	11251	1	is	be	VBZ
cord-005453-4057qib7	11251	2	a	a	DT
cord-005453-4057qib7	11251	3	chimeric	chimeric	JJ
cord-005453-4057qib7	11251	4	anti	anti	JJ
cord-005453-4057qib7	11251	5	CD30	CD30	NNP
cord-005453-4057qib7	11251	6	IgG1	igg1	NN
cord-005453-4057qib7	11251	7	antibody	antibody	NN
cord-005453-4057qib7	11251	8	,	,	,
cord-005453-4057qib7	11251	9	conjugated	conjugate	VBN
cord-005453-4057qib7	11251	10	to	to	IN
cord-005453-4057qib7	11251	11	synthetic	synthetic	JJ
cord-005453-4057qib7	11251	12	antitubulinmomomethylauristatin	antitubulinmomomethylauristatin	NNS
cord-005453-4057qib7	11251	13	.	.	.
cord-005453-4057qib7	11252	1	BV	BV	NNP
cord-005453-4057qib7	11252	2	is	be	VBZ
cord-005453-4057qib7	11252	3	approved	approve	VBN
cord-005453-4057qib7	11252	4	for	for	IN
cord-005453-4057qib7	11252	5	the	the	DT
cord-005453-4057qib7	11252	6	treatment	treatment	NN
cord-005453-4057qib7	11252	7	of	of	IN
cord-005453-4057qib7	11252	8	classical	classical	JJ
cord-005453-4057qib7	11252	9	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11252	10	lymphoma	lymphoma	NN
cord-005453-4057qib7	11252	11	(	(	-LRB-
cord-005453-4057qib7	11252	12	HL	HL	NNP
cord-005453-4057qib7	11252	13	)	)	-RRB-
cord-005453-4057qib7	11252	14	in	in	IN
cord-005453-4057qib7	11252	15	relapse	relapse	NN
cord-005453-4057qib7	11252	16	either	either	CC
cord-005453-4057qib7	11252	17	after	after	IN
cord-005453-4057qib7	11252	18	autologous	autologous	JJ
cord-005453-4057qib7	11252	19	stem	stem	NN
cord-005453-4057qib7	11252	20	cell	cell	NN
cord-005453-4057qib7	11252	21	transplantation	transplantation	NN
cord-005453-4057qib7	11252	22	(	(	-LRB-
cord-005453-4057qib7	11252	23	ASCT	ASCT	NNP
cord-005453-4057qib7	11252	24	)	)	-RRB-
cord-005453-4057qib7	11252	25	or	or	CC
cord-005453-4057qib7	11252	26	after	after	IN
cord-005453-4057qib7	11252	27	two	two	CD
cord-005453-4057qib7	11252	28	lines	line	NNS
cord-005453-4057qib7	11252	29	of	of	IN
cord-005453-4057qib7	11252	30	combination	combination	NN
cord-005453-4057qib7	11252	31	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11252	32	in	in	IN
cord-005453-4057qib7	11252	33	transplant	transplant	NN
cord-005453-4057qib7	11252	34	ineligible	ineligible	JJ
cord-005453-4057qib7	11252	35	patients	patient	NNS
cord-005453-4057qib7	11252	36	.	.	.
cord-005453-4057qib7	11253	1	The	the	DT
cord-005453-4057qib7	11253	2	AETHERA	AETHERA	NNP
cord-005453-4057qib7	11253	3	trial	trial	NN
cord-005453-4057qib7	11253	4	revealed	reveal	VBD
cord-005453-4057qib7	11253	5	increased	increase	VBN
cord-005453-4057qib7	11253	6	PFS	PFS	NNP
cord-005453-4057qib7	11253	7	when	when	WRB
cord-005453-4057qib7	11253	8	BV	BV	NNP
cord-005453-4057qib7	11253	9	is	be	VBZ
cord-005453-4057qib7	11253	10	used	use	VBN
cord-005453-4057qib7	11253	11	as	as	IN
cord-005453-4057qib7	11253	12	maintenance	maintenance	NN
cord-005453-4057qib7	11253	13	therapy	therapy	NN
cord-005453-4057qib7	11253	14	for	for	IN
cord-005453-4057qib7	11253	15	16	16	CD
cord-005453-4057qib7	11253	16	cycles	cycle	NNS
cord-005453-4057qib7	11253	17	in	in	IN
cord-005453-4057qib7	11253	18	high	high	JJ
cord-005453-4057qib7	11253	19	risk	risk	NN
cord-005453-4057qib7	11253	20	patients	patient	NNS
cord-005453-4057qib7	11253	21	after	after	IN
cord-005453-4057qib7	11253	22	ASCT	ASCT	NNP
cord-005453-4057qib7	11253	23	.	.	.
cord-005453-4057qib7	11254	1	However	however	RB
cord-005453-4057qib7	11254	2	,	,	,
cord-005453-4057qib7	11254	3	this	this	DT
cord-005453-4057qib7	11254	4	schedule	schedule	NN
cord-005453-4057qib7	11254	5	is	be	VBZ
cord-005453-4057qib7	11254	6	associated	associate	VBN
cord-005453-4057qib7	11254	7	with	with	IN
cord-005453-4057qib7	11254	8	a	a	DT
cord-005453-4057qib7	11254	9	high	high	JJ
cord-005453-4057qib7	11254	10	cost	cost	NN
cord-005453-4057qib7	11254	11	and	and	CC
cord-005453-4057qib7	11254	12	significant	significant	JJ
cord-005453-4057qib7	11254	13	toxicity	toxicity	NN
cord-005453-4057qib7	11254	14	particularly	particularly	RB
cord-005453-4057qib7	11254	15	in	in	IN
cord-005453-4057qib7	11254	16	term	term	NN
cord-005453-4057qib7	11254	17	of	of	IN
cord-005453-4057qib7	11254	18	peripheral	peripheral	JJ
cord-005453-4057qib7	11254	19	neuropathy	neuropathy	NN
cord-005453-4057qib7	11254	20	.	.	.
cord-005453-4057qib7	11255	1	Our	-PRON-	PRP$
cord-005453-4057qib7	11255	2	primary	primary	JJ
cord-005453-4057qib7	11255	3	objective	objective	NN
cord-005453-4057qib7	11255	4	is	be	VBZ
cord-005453-4057qib7	11255	5	to	to	TO
cord-005453-4057qib7	11255	6	assess	assess	VB
cord-005453-4057qib7	11255	7	the	the	DT
cord-005453-4057qib7	11255	8	efficacy	efficacy	NN
cord-005453-4057qib7	11255	9	of	of	IN
cord-005453-4057qib7	11255	10	4	4	CD
cord-005453-4057qib7	11255	11	cycles	cycle	NNS
cord-005453-4057qib7	11255	12	Brentuximab	Brentuximab	NNP
cord-005453-4057qib7	11255	13	as	as	IN
cord-005453-4057qib7	11255	14	consolidation	consolidation	NN
cord-005453-4057qib7	11255	15	therapy	therapy	NN
cord-005453-4057qib7	11255	16	after	after	IN
cord-005453-4057qib7	11255	17	ASCT	ASCT	NNP
cord-005453-4057qib7	11255	18	for	for	IN
cord-005453-4057qib7	11255	19	relapsed	relapse	VBN
cord-005453-4057qib7	11255	20	/	/	SYM
cord-005453-4057qib7	11255	21	refractory	refractory	NN
cord-005453-4057qib7	11255	22	(	(	-LRB-
cord-005453-4057qib7	11255	23	R	r	NN
cord-005453-4057qib7	11255	24	/	/	SYM
cord-005453-4057qib7	11255	25	R	r	NN
cord-005453-4057qib7	11255	26	)	)	-RRB-
cord-005453-4057qib7	11255	27	HL	HL	NNP
cord-005453-4057qib7	11255	28	.	.	.
cord-005453-4057qib7	11256	1	Secondary	secondary	JJ
cord-005453-4057qib7	11256	2	objectives	objective	NNS
cord-005453-4057qib7	11256	3	include	include	VBP
cord-005453-4057qib7	11256	4	side	side	NN
cord-005453-4057qib7	11256	5	effects	effect	NNS
cord-005453-4057qib7	11256	6	,	,	,
cord-005453-4057qib7	11256	7	progression	progression	NN
cord-005453-4057qib7	11256	8	free	free	JJ
cord-005453-4057qib7	11256	9	survival	survival	NN
cord-005453-4057qib7	11256	10	(	(	-LRB-
cord-005453-4057qib7	11256	11	PFS	PFS	NNP
cord-005453-4057qib7	11256	12	)	)	-RRB-
cord-005453-4057qib7	11256	13	,	,	,
cord-005453-4057qib7	11256	14	and	and	CC
cord-005453-4057qib7	11256	15	overall	overall	JJ
cord-005453-4057qib7	11256	16	Survival	Survival	NNP
cord-005453-4057qib7	11256	17	(	(	-LRB-
cord-005453-4057qib7	11256	18	OS	OS	NNP
cord-005453-4057qib7	11256	19	)	)	-RRB-
cord-005453-4057qib7	11256	20	.	.	.
cord-005453-4057qib7	11257	1	Methods	method	NNS
cord-005453-4057qib7	11257	2	:	:	:
cord-005453-4057qib7	11257	3	This	this	DT
cord-005453-4057qib7	11257	4	is	be	VBZ
cord-005453-4057qib7	11257	5	a	a	DT
cord-005453-4057qib7	11257	6	retrospective	retrospective	JJ
cord-005453-4057qib7	11257	7	single	single	JJ
cord-005453-4057qib7	11257	8	center	center	NN
cord-005453-4057qib7	11257	9	analysis	analysis	NN
cord-005453-4057qib7	11257	10	approved	approve	VBN
cord-005453-4057qib7	11257	11	by	by	IN
cord-005453-4057qib7	11257	12	the	the	DT
cord-005453-4057qib7	11257	13	IRB	IRB	NNP
cord-005453-4057qib7	11257	14	of	of	IN
cord-005453-4057qib7	11257	15	the	the	DT
cord-005453-4057qib7	11257	16	American	American	NNP
cord-005453-4057qib7	11257	17	University	University	NNP
cord-005453-4057qib7	11257	18	of	of	IN
cord-005453-4057qib7	11257	19	Beirut	Beirut	NNP
cord-005453-4057qib7	11257	20	Medical	Medical	NNP
cord-005453-4057qib7	11257	21	Center	Center	NNP
cord-005453-4057qib7	11257	22	.	.	.
cord-005453-4057qib7	11258	1	We	-PRON-	PRP
cord-005453-4057qib7	11258	2	included	include	VBD
cord-005453-4057qib7	11258	3	in	in	IN
cord-005453-4057qib7	11258	4	this	this	DT
cord-005453-4057qib7	11258	5	study	study	NN
cord-005453-4057qib7	11258	6	consecutive	consecutive	JJ
cord-005453-4057qib7	11258	7	patients	patient	NNS
cord-005453-4057qib7	11258	8	with	with	IN
cord-005453-4057qib7	11258	9	R	r	NN
cord-005453-4057qib7	11258	10	/	/	SYM
cord-005453-4057qib7	11258	11	R	r	NN
cord-005453-4057qib7	11258	12	HL	HL	NNP
cord-005453-4057qib7	11258	13	who	who	WP
cord-005453-4057qib7	11258	14	underwent	undergo	VBD
cord-005453-4057qib7	11258	15	ASCT	ASCT	NNP
cord-005453-4057qib7	11258	16	between	between	IN
cord-005453-4057qib7	11258	17	2014	2014	CD
cord-005453-4057qib7	11258	18	and	and	CC
cord-005453-4057qib7	11258	19	2018	2018	CD
cord-005453-4057qib7	11258	20	,	,	,
cord-005453-4057qib7	11258	21	and	and	CC
cord-005453-4057qib7	11258	22	received	receive	VBD
cord-005453-4057qib7	11258	23	BV	BV	NNP
cord-005453-4057qib7	11258	24	consolidation	consolidation	NN
cord-005453-4057qib7	11258	25	post	post	NN
cord-005453-4057qib7	11258	26	-	-	JJ
cord-005453-4057qib7	11258	27	ASCT	ASCT	NNP
cord-005453-4057qib7	11258	28	.	.	.
cord-005453-4057qib7	11259	1	Results	result	NNS
cord-005453-4057qib7	11259	2	:	:	:
cord-005453-4057qib7	11260	1	We	-PRON-	PRP
cord-005453-4057qib7	11260	2	identified	identify	VBD
cord-005453-4057qib7	11260	3	18	18	CD
cord-005453-4057qib7	11260	4	consecutive	consecutive	JJ
cord-005453-4057qib7	11260	5	adult	adult	NN
cord-005453-4057qib7	11260	6	patients	patient	NNS
cord-005453-4057qib7	11260	7	with	with	IN
cord-005453-4057qib7	11260	8	R	r	NN
cord-005453-4057qib7	11260	9	/	/	SYM
cord-005453-4057qib7	11260	10	R	r	NN
cord-005453-4057qib7	11260	11	HL	HL	NNP
cord-005453-4057qib7	11260	12	treated	treat	VBN
cord-005453-4057qib7	11260	13	with	with	IN
cord-005453-4057qib7	11260	14	BV	BV	NNP
cord-005453-4057qib7	11260	15	1.8	1.8	CD
cord-005453-4057qib7	11260	16	mg	mg	CD
cord-005453-4057qib7	11261	1	/kg	/kg	NFP
cord-005453-4057qib7	11261	2	IV	IV	NNP
cord-005453-4057qib7	11262	1	every	every	DT
cord-005453-4057qib7	11262	2	3	3	CD
cord-005453-4057qib7	11262	3	weeks	week	NNS
cord-005453-4057qib7	11262	4	as	as	IN
cord-005453-4057qib7	11262	5	consolidation	consolidation	NN
cord-005453-4057qib7	11262	6	therapy	therapy	NN
cord-005453-4057qib7	11262	7	after	after	IN
cord-005453-4057qib7	11262	8	ASCT	ASCT	NNP
cord-005453-4057qib7	11262	9	.	.	.
cord-005453-4057qib7	11263	1	The	the	DT
cord-005453-4057qib7	11263	2	indications	indication	NNS
cord-005453-4057qib7	11263	3	for	for	IN
cord-005453-4057qib7	11263	4	BV	BV	NNP
cord-005453-4057qib7	11263	5	consolidation	consolidation	NN
cord-005453-4057qib7	11263	6	was	be	VBD
cord-005453-4057qib7	11263	7	primary	primary	JJ
cord-005453-4057qib7	11263	8	refractory	refractory	JJ
cord-005453-4057qib7	11263	9	disease	disease	NN
cord-005453-4057qib7	11263	10	in	in	IN
cord-005453-4057qib7	11263	11	11	11	CD
cord-005453-4057qib7	11263	12	patients	patient	NNS
cord-005453-4057qib7	11263	13	(	(	-LRB-
cord-005453-4057qib7	11263	14	61	61	CD
cord-005453-4057qib7	11263	15	%	%	NN
cord-005453-4057qib7	11263	16	)	)	-RRB-
cord-005453-4057qib7	11263	17	,	,	,
cord-005453-4057qib7	11263	18	early	early	JJ
cord-005453-4057qib7	11263	19	relapse	relapse	NN
cord-005453-4057qib7	11263	20	in	in	IN
cord-005453-4057qib7	11263	21	6	6	CD
cord-005453-4057qib7	11263	22	patients	patient	NNS
cord-005453-4057qib7	11263	23	(	(	-LRB-
cord-005453-4057qib7	11263	24	33	33	CD
cord-005453-4057qib7	11263	25	%	%	NN
cord-005453-4057qib7	11263	26	)	)	-RRB-
cord-005453-4057qib7	11263	27	(	(	-LRB-
cord-005453-4057qib7	11263	28	after	after	IN
cord-005453-4057qib7	11263	29	a	a	DT
cord-005453-4057qib7	11263	30	median	median	JJ
cord-005453-4057qib7	11263	31	time	time	NN
cord-005453-4057qib7	11263	32	of	of	IN
cord-005453-4057qib7	11263	33	10	10	CD
cord-005453-4057qib7	11263	34	months	month	NNS
cord-005453-4057qib7	11263	35	;	;	:
cord-005453-4057qib7	11263	36	range	range	NN
cord-005453-4057qib7	11263	37	,	,	,
cord-005453-4057qib7	11263	38	3	3	CD
cord-005453-4057qib7	11263	39	-	-	SYM
cord-005453-4057qib7	11263	40	11	11	CD
cord-005453-4057qib7	11263	41	)	)	-RRB-
cord-005453-4057qib7	11263	42	andextranodalinvolvement	andextranodalinvolvement	VBP
cord-005453-4057qib7	11263	43	in	in	IN
cord-005453-4057qib7	11263	44	one	one	CD
cord-005453-4057qib7	11263	45	patient	patient	NN
cord-005453-4057qib7	11263	46	(	(	-LRB-
cord-005453-4057qib7	11263	47	6	6	CD
cord-005453-4057qib7	11263	48	%	%	NN
cord-005453-4057qib7	11263	49	)	)	-RRB-
cord-005453-4057qib7	11263	50	.	.	.
cord-005453-4057qib7	11264	1	The	the	DT
cord-005453-4057qib7	11264	2	median	median	JJ
cord-005453-4057qib7	11264	3	number	number	NN
cord-005453-4057qib7	11264	4	of	of	IN
cord-005453-4057qib7	11264	5	lines	line	NNS
cord-005453-4057qib7	11264	6	of	of	IN
cord-005453-4057qib7	11264	7	therapy	therapy	NN
cord-005453-4057qib7	11264	8	pre	pre	JJ
cord-005453-4057qib7	11264	9	-	-	NNP
cord-005453-4057qib7	11264	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11264	11	was	be	VBD
cord-005453-4057qib7	11264	12	3	3	CD
cord-005453-4057qib7	11265	1	(	(	-LRB-
cord-005453-4057qib7	11265	2	range	range	NN
cord-005453-4057qib7	11265	3	,	,	,
cord-005453-4057qib7	11265	4	2	2	CD
cord-005453-4057qib7	11265	5	-	-	SYM
cord-005453-4057qib7	11265	6	5	5	CD
cord-005453-4057qib7	11265	7	)	)	-RRB-
cord-005453-4057qib7	11265	8	.	.	.
cord-005453-4057qib7	11266	1	The	the	DT
cord-005453-4057qib7	11266	2	median	median	JJ
cord-005453-4057qib7	11266	3	time	time	NN
cord-005453-4057qib7	11266	4	to	to	IN
cord-005453-4057qib7	11266	5	BV	BV	NNP
cord-005453-4057qib7	11266	6	initiation	initiation	NN
cord-005453-4057qib7	11266	7	post	post	JJ
cord-005453-4057qib7	11266	8	-	-	JJ
cord-005453-4057qib7	11266	9	ASCT	ASCT	NNP
cord-005453-4057qib7	11266	10	was	be	VBD
cord-005453-4057qib7	11266	11	76	76	CD
cord-005453-4057qib7	11266	12	days	day	NNS
cord-005453-4057qib7	11266	13	(	(	-LRB-
cord-005453-4057qib7	11266	14	range	range	NN
cord-005453-4057qib7	11266	15	,	,	,
cord-005453-4057qib7	11266	16	35	35	CD
cord-005453-4057qib7	11266	17	-	-	SYM
cord-005453-4057qib7	11266	18	188	188	CD
cord-005453-4057qib7	11266	19	)	)	-RRB-
cord-005453-4057qib7	11266	20	.	.	.
cord-005453-4057qib7	11267	1	Patients	patient	NNS
cord-005453-4057qib7	11267	2	received	receive	VBD
cord-005453-4057qib7	11267	3	a	a	DT
cord-005453-4057qib7	11267	4	median	median	NN
cord-005453-4057qib7	11267	5	of	of	IN
cord-005453-4057qib7	11267	6	4	4	CD
cord-005453-4057qib7	11267	7	cycles	cycle	NNS
cord-005453-4057qib7	11267	8	(	(	-LRB-
cord-005453-4057qib7	11267	9	range	range	VBP
cord-005453-4057qib7	11267	10	,	,	,
cord-005453-4057qib7	11267	11	3	3	CD
cord-005453-4057qib7	11267	12	-	-	SYM
cord-005453-4057qib7	11267	13	4	4	CD
cord-005453-4057qib7	11267	14	)	)	-RRB-
cord-005453-4057qib7	11267	15	of	of	IN
cord-005453-4057qib7	11267	16	BV	BV	NNP
cord-005453-4057qib7	11267	17	post	post	NNP
cord-005453-4057qib7	11267	18	-	-	JJ
cord-005453-4057qib7	11267	19	ASCT	ASCT	NNP
cord-005453-4057qib7	11267	20	.	.	.
cord-005453-4057qib7	11268	1	After	after	IN
cord-005453-4057qib7	11268	2	a	a	DT
cord-005453-4057qib7	11268	3	median	median	NN
cord-005453-4057qib7	11268	4	follow	follow	NN
cord-005453-4057qib7	11268	5	up	up	IN
cord-005453-4057qib7	11268	6	of	of	IN
cord-005453-4057qib7	11268	7	30	30	CD
cord-005453-4057qib7	11268	8	months	month	NNS
cord-005453-4057qib7	11268	9	(	(	-LRB-
cord-005453-4057qib7	11268	10	range	range	NN
cord-005453-4057qib7	11268	11	,	,	,
cord-005453-4057qib7	11268	12	8	8	CD
cord-005453-4057qib7	11268	13	-	-	SYM
cord-005453-4057qib7	11268	14	50	50	CD
cord-005453-4057qib7	11268	15	)	)	-RRB-
cord-005453-4057qib7	11268	16	,	,	,
cord-005453-4057qib7	11268	17	five	five	CD
cord-005453-4057qib7	11268	18	(	(	-LRB-
cord-005453-4057qib7	11268	19	28	28	CD
cord-005453-4057qib7	11268	20	%	%	NN
cord-005453-4057qib7	11268	21	)	)	-RRB-
cord-005453-4057qib7	11268	22	patients	patient	NNS
cord-005453-4057qib7	11268	23	relapsed	relapse	VBN
cord-005453-4057qib7	11268	24	after	after	IN
cord-005453-4057qib7	11268	25	ASCT	ASCT	NNP
cord-005453-4057qib7	11268	26	.	.	.
cord-005453-4057qib7	11269	1	The	the	DT
cord-005453-4057qib7	11269	2	median	median	JJ
cord-005453-4057qib7	11269	3	time	time	NN
cord-005453-4057qib7	11269	4	to	to	TO
cord-005453-4057qib7	11269	5	relapse	relapse	NN
cord-005453-4057qib7	11269	6	was	be	VBD
cord-005453-4057qib7	11269	7	7	7	CD
cord-005453-4057qib7	11269	8	months	month	NNS
cord-005453-4057qib7	11269	9	(	(	-LRB-
cord-005453-4057qib7	11269	10	range	range	NN
cord-005453-4057qib7	11269	11	,	,	,
cord-005453-4057qib7	11269	12	4	4	CD
cord-005453-4057qib7	11269	13	-	-	SYM
cord-005453-4057qib7	11269	14	21	21	CD
cord-005453-4057qib7	11269	15	)	)	-RRB-
cord-005453-4057qib7	11269	16	.	.	.
cord-005453-4057qib7	11270	1	Median	median	JJ
cord-005453-4057qib7	11270	2	PFS	PFS	NNP
cord-005453-4057qib7	11270	3	and	and	CC
cord-005453-4057qib7	11270	4	OS	OS	NNP
cord-005453-4057qib7	11270	5	were	be	VBD
cord-005453-4057qib7	11270	6	not	not	RB
cord-005453-4057qib7	11270	7	reached	reach	VBN
cord-005453-4057qib7	11270	8	.	.	.
cord-005453-4057qib7	11271	1	We	-PRON-	PRP
cord-005453-4057qib7	11271	2	did	do	VBD
cord-005453-4057qib7	11271	3	not	not	RB
cord-005453-4057qib7	11271	4	observe	observe	VB
cord-005453-4057qib7	11271	5	any	any	DT
cord-005453-4057qib7	11271	6	significant	significant	JJ
cord-005453-4057qib7	11271	7	toxicities	toxicity	NNS
cord-005453-4057qib7	11271	8	during	during	IN
cord-005453-4057qib7	11271	9	or	or	CC
cord-005453-4057qib7	11271	10	after	after	IN
cord-005453-4057qib7	11271	11	therapy	therapy	NN
cord-005453-4057qib7	11271	12	.	.	.
cord-005453-4057qib7	11272	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11272	2	:	:	:
cord-005453-4057qib7	11272	3	4	4	CD
cord-005453-4057qib7	11272	4	cycles	cycle	NNS
cord-005453-4057qib7	11272	5	of	of	IN
cord-005453-4057qib7	11272	6	BV	BV	NNP
cord-005453-4057qib7	11272	7	consolidation	consolidation	NN
cord-005453-4057qib7	11272	8	after	after	IN
cord-005453-4057qib7	11272	9	ASCT	ASCT	NNP
cord-005453-4057qib7	11272	10	seem	seem	VBP
cord-005453-4057qib7	11272	11	to	to	TO
cord-005453-4057qib7	11272	12	be	be	VB
cord-005453-4057qib7	11272	13	safe	safe	JJ
cord-005453-4057qib7	11272	14	and	and	CC
cord-005453-4057qib7	11272	15	effective	effective	JJ
cord-005453-4057qib7	11272	16	in	in	IN
cord-005453-4057qib7	11272	17	preventing	prevent	VBG
cord-005453-4057qib7	11272	18	relapse	relapse	NN
cord-005453-4057qib7	11273	1	,	,	,
cord-005453-4057qib7	11273	2	however	however	RB
cord-005453-4057qib7	11273	3	our	-PRON-	PRP$
cord-005453-4057qib7	11273	4	findings	finding	NNS
cord-005453-4057qib7	11273	5	need	need	VBP
cord-005453-4057qib7	11273	6	to	to	TO
cord-005453-4057qib7	11273	7	be	be	VB
cord-005453-4057qib7	11273	8	confirmed	confirm	VBN
cord-005453-4057qib7	11273	9	with	with	IN
cord-005453-4057qib7	11273	10	larger	large	JJR
cord-005453-4057qib7	11273	11	prospective	prospective	JJ
cord-005453-4057qib7	11273	12	studies	study	NNS
cord-005453-4057qib7	11273	13	.	.	.
cord-005453-4057qib7	11274	1	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11274	2	or	or	CC
cord-005453-4057qib7	11274	3	who	who	WP
cord-005453-4057qib7	11274	4	progress	progress	VBP
cord-005453-4057qib7	11274	5	after	after	IN
cord-005453-4057qib7	11274	6	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	11274	7	is	be	VBZ
cord-005453-4057qib7	11274	8	poor	poor	JJ
cord-005453-4057qib7	11274	9	.	.	.
cord-005453-4057qib7	11275	1	Despite	despite	IN
cord-005453-4057qib7	11275	2	introduction	introduction	NN
cord-005453-4057qib7	11275	3	of	of	IN
cord-005453-4057qib7	11275	4	novel	novel	JJ
cord-005453-4057qib7	11275	5	agents	agent	NNS
cord-005453-4057qib7	11275	6	like	like	IN
cord-005453-4057qib7	11275	7	brentuximab	brentuximab	NNP
cord-005453-4057qib7	11275	8	vedotin	vedotin	NNP
cord-005453-4057qib7	11275	9	(	(	-LRB-
cord-005453-4057qib7	11275	10	BV	BV	NNP
cord-005453-4057qib7	11275	11	)	)	-RRB-
cord-005453-4057qib7	11275	12	or	or	CC
cord-005453-4057qib7	11275	13	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11275	14	,	,	,
cord-005453-4057qib7	11275	15	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11275	16	appears	appear	VBZ
cord-005453-4057qib7	11275	17	the	the	DT
cord-005453-4057qib7	11275	18	most	most	RBS
cord-005453-4057qib7	11275	19	effective	effective	JJ
cord-005453-4057qib7	11275	20	treatment	treatment	NN
cord-005453-4057qib7	11275	21	option	option	NN
cord-005453-4057qib7	11275	22	with	with	IN
cord-005453-4057qib7	11275	23	curative	curative	JJ
cord-005453-4057qib7	11275	24	potential	potential	NN
cord-005453-4057qib7	11275	25	.	.	.
cord-005453-4057qib7	11276	1	The	the	DT
cord-005453-4057qib7	11276	2	goal	goal	NN
cord-005453-4057qib7	11276	3	of	of	IN
cord-005453-4057qib7	11276	4	this	this	DT
cord-005453-4057qib7	11276	5	study	study	NN
cord-005453-4057qib7	11276	6	was	be	VBD
cord-005453-4057qib7	11276	7	to	to	TO
cord-005453-4057qib7	11276	8	evaluate	evaluate	VB
cord-005453-4057qib7	11276	9	efficacy	efficacy	NN
cord-005453-4057qib7	11276	10	of	of	IN
cord-005453-4057qib7	11276	11	alloHSCT	allohsct	NN
cord-005453-4057qib7	11276	12	for	for	IN
cord-005453-4057qib7	11276	13	HL	HL	NNP
cord-005453-4057qib7	11276	14	,	,	,
cord-005453-4057qib7	11276	15	including	include	VBG
cord-005453-4057qib7	11276	16	patients	patient	NNS
cord-005453-4057qib7	11276	17	pre	pre	VB
cord-005453-4057qib7	11276	18	-	-	VBN
cord-005453-4057qib7	11276	19	treated	treat	VBN
cord-005453-4057qib7	11276	20	with	with	IN
cord-005453-4057qib7	11276	21	novel	novel	JJ
cord-005453-4057qib7	11276	22	agents	agent	NNS
cord-005453-4057qib7	11276	23	.	.	.
cord-005453-4057qib7	11277	1	Methods	method	NNS
cord-005453-4057qib7	11277	2	:	:	:
cord-005453-4057qib7	11278	1	Between	between	IN
cord-005453-4057qib7	11278	2	years	year	NNS
cord-005453-4057qib7	11278	3	2012	2012	CD
cord-005453-4057qib7	11278	4	-	-	SYM
cord-005453-4057qib7	11278	5	2018	2018	CD
cord-005453-4057qib7	11278	6	,	,	,
cord-005453-4057qib7	11278	7	45	45	CD
cord-005453-4057qib7	11278	8	patients	patient	NNS
cord-005453-4057qib7	11278	9	(	(	-LRB-
cord-005453-4057qib7	11278	10	including	include	VBG
cord-005453-4057qib7	11278	11	23	23	CD
cord-005453-4057qib7	11278	12	males	male	NNS
cord-005453-4057qib7	11278	13	)	)	-RRB-
cord-005453-4057qib7	11278	14	with	with	IN
cord-005453-4057qib7	11278	15	HL	HL	NNP
cord-005453-4057qib7	11278	16	were	be	VBD
cord-005453-4057qib7	11278	17	treated	treat	VBN
cord-005453-4057qib7	11278	18	with	with	IN
cord-005453-4057qib7	11278	19	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11278	20	in	in	IN
cord-005453-4057qib7	11278	21	MSC	MSC	NNP
cord-005453-4057qib7	11278	22	Institute	Institute	NNP
cord-005453-4057qib7	11278	23	of	of	IN
cord-005453-4057qib7	11278	24	Oncology	Oncology	NNP
cord-005453-4057qib7	11278	25	in	in	IN
cord-005453-4057qib7	11278	26	Gliwice	Gliwice	NNP
cord-005453-4057qib7	11278	27	,	,	,
cord-005453-4057qib7	11278	28	Poland	Poland	NNP
cord-005453-4057qib7	11278	29	.	.	.
cord-005453-4057qib7	11279	1	Median	median	JJ
cord-005453-4057qib7	11279	2	age	age	NN
cord-005453-4057qib7	11279	3	was	be	VBD
cord-005453-4057qib7	11279	4	32	32	CD
cord-005453-4057qib7	11279	5	(	(	-LRB-
cord-005453-4057qib7	11279	6	19	19	CD
cord-005453-4057qib7	11279	7	-	-	SYM
cord-005453-4057qib7	11279	8	57	57	CD
cord-005453-4057qib7	11279	9	)	)	-RRB-
cord-005453-4057qib7	11279	10	years	year	NNS
cord-005453-4057qib7	11279	11	.	.	.
cord-005453-4057qib7	11280	1	Median	median	JJ
cord-005453-4057qib7	11280	2	lines	line	NNS
cord-005453-4057qib7	11280	3	of	of	IN
cord-005453-4057qib7	11280	4	preceding	precede	VBG
cord-005453-4057qib7	11280	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11280	6	was	be	VBD
cord-005453-4057qib7	11280	7	4	4	CD
cord-005453-4057qib7	11280	8	(	(	-LRB-
cord-005453-4057qib7	11280	9	2	2	CD
cord-005453-4057qib7	11280	10	-	-	SYM
cord-005453-4057qib7	11280	11	8	8	CD
cord-005453-4057qib7	11280	12	)	)	-RRB-
cord-005453-4057qib7	11280	13	;	;	:
cord-005453-4057qib7	11281	1	34	34	CD
cord-005453-4057qib7	11281	2	(	(	-LRB-
cord-005453-4057qib7	11281	3	76	76	CD
cord-005453-4057qib7	11281	4	%	%	NN
cord-005453-4057qib7	11281	5	)	)	-RRB-
cord-005453-4057qib7	11281	6	patients	patient	NNS
cord-005453-4057qib7	11281	7	had	have	VBD
cord-005453-4057qib7	11281	8	been	be	VBN
cord-005453-4057qib7	11281	9	pre	pre	VBN
cord-005453-4057qib7	11281	10	-	-	VBN
cord-005453-4057qib7	11281	11	treated	treat	VBN
cord-005453-4057qib7	11282	1	with	with	IN
cord-005453-4057qib7	11282	2	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	11282	3	,	,	,
cord-005453-4057qib7	11282	4	24	24	CD
cord-005453-4057qib7	11282	5	(	(	-LRB-
cord-005453-4057qib7	11282	6	53	53	CD
cord-005453-4057qib7	11282	7	%	%	NN
cord-005453-4057qib7	11282	8	)	)	-RRB-
cord-005453-4057qib7	11282	9	with	with	IN
cord-005453-4057qib7	11282	10	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11282	11	,	,	,
cord-005453-4057qib7	11282	12	17	17	CD
cord-005453-4057qib7	11282	13	(	(	-LRB-
cord-005453-4057qib7	11282	14	38	38	CD
cord-005453-4057qib7	11282	15	%	%	NN
cord-005453-4057qib7	11282	16	)	)	-RRB-
cord-005453-4057qib7	11282	17	with	with	IN
cord-005453-4057qib7	11282	18	BV	BV	NNP
cord-005453-4057qib7	11282	19	,	,	,
cord-005453-4057qib7	11282	20	7	7	CD
cord-005453-4057qib7	11282	21	(	(	-LRB-
cord-005453-4057qib7	11282	22	16	16	CD
cord-005453-4057qib7	11282	23	%	%	NN
cord-005453-4057qib7	11282	24	)	)	-RRB-
cord-005453-4057qib7	11283	1	-with	-with	HYPH
cord-005453-4057qib7	11283	2	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11283	3	.	.	.
cord-005453-4057qib7	11284	1	Disease	disease	NN
cord-005453-4057qib7	11284	2	status	status	NN
cord-005453-4057qib7	11284	3	at	at	IN
cord-005453-4057qib7	11284	4	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11284	5	was	be	VBD
cord-005453-4057qib7	11284	6	as	as	IN
cord-005453-4057qib7	11284	7	follows	follow	VBZ
cord-005453-4057qib7	11284	8	:	:	:
cord-005453-4057qib7	11284	9	CR-19	CR-19	NNP
cord-005453-4057qib7	11284	10	,	,	,
cord-005453-4057qib7	11284	11	PR-10	PR-10	NNP
cord-005453-4057qib7	11284	12	,	,	,
cord-005453-4057qib7	11284	13	NR-16	NR-16	NNP
cord-005453-4057qib7	11284	14	.	.	.
cord-005453-4057qib7	11285	1	Patients	patient	NNS
cord-005453-4057qib7	11285	2	were	be	VBD
cord-005453-4057qib7	11285	3	treated	treat	VBN
cord-005453-4057qib7	11285	4	with	with	IN
cord-005453-4057qib7	11285	5	HSCT	HSCT	NNP
cord-005453-4057qib7	11285	6	from	from	IN
cord-005453-4057qib7	11285	7	either	either	DT
cord-005453-4057qib7	11285	8	HLA	HLA	NNP
cord-005453-4057qib7	11285	9	-	-	HYPH
cord-005453-4057qib7	11285	10	matched	match	VBN
cord-005453-4057qib7	11285	11	sibling	sibling	NN
cord-005453-4057qib7	11285	12	donor	donor	NN
cord-005453-4057qib7	11285	13	(	(	-LRB-
cord-005453-4057qib7	11285	14	MSD	MSD	NNP
cord-005453-4057qib7	11285	15	,	,	,
cord-005453-4057qib7	11285	16	n=21	n=21	NN
cord-005453-4057qib7	11285	17	)	)	-RRB-
cord-005453-4057qib7	11285	18	,	,	,
cord-005453-4057qib7	11285	19	unrelated	unrelated	JJ
cord-005453-4057qib7	11285	20	donor	donor	NN
cord-005453-4057qib7	11285	21	(	(	-LRB-
cord-005453-4057qib7	11285	22	URD	URD	NNP
cord-005453-4057qib7	11285	23	,	,	,
cord-005453-4057qib7	11285	24	n=18	n=18	NN
cord-005453-4057qib7	11285	25	)	)	-RRB-
cord-005453-4057qib7	11285	26	or	or	CC
cord-005453-4057qib7	11285	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11285	28	donor	donor	NN
cord-005453-4057qib7	11285	29	(	(	-LRB-
cord-005453-4057qib7	11285	30	n=6	n=6	NNP
cord-005453-4057qib7	11285	31	)	)	-RRB-
cord-005453-4057qib7	11285	32	.	.	.
cord-005453-4057qib7	11286	1	Conditioning	conditioning	NN
cord-005453-4057qib7	11286	2	was	be	VBD
cord-005453-4057qib7	11286	3	myeloablative	myeloablative	JJ
cord-005453-4057qib7	11286	4	in	in	IN
cord-005453-4057qib7	11286	5	21	21	CD
cord-005453-4057qib7	11286	6	(	(	-LRB-
cord-005453-4057qib7	11286	7	47	47	CD
cord-005453-4057qib7	11286	8	%	%	NN
cord-005453-4057qib7	11286	9	)	)	-RRB-
cord-005453-4057qib7	11286	10	cases	case	NNS
cord-005453-4057qib7	11286	11	.	.	.
cord-005453-4057qib7	11287	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	11287	2	blood	blood	NN
cord-005453-4057qib7	11287	3	was	be	VBD
cord-005453-4057qib7	11287	4	used	use	VBN
cord-005453-4057qib7	11287	5	as	as	IN
cord-005453-4057qib7	11287	6	a	a	DT
cord-005453-4057qib7	11287	7	source	source	NN
cord-005453-4057qib7	11287	8	of	of	IN
cord-005453-4057qib7	11287	9	stem	stem	NN
cord-005453-4057qib7	11287	10	cells	cell	NNS
cord-005453-4057qib7	11287	11	.	.	.
cord-005453-4057qib7	11288	1	Results	result	NNS
cord-005453-4057qib7	11288	2	:	:	:
cord-005453-4057qib7	11289	1	All	all	DT
cord-005453-4057qib7	11289	2	but	but	IN
cord-005453-4057qib7	11289	3	one	one	CD
cord-005453-4057qib7	11289	4	patient	patient	NN
cord-005453-4057qib7	11289	5	engrafted	engraft	VBN
cord-005453-4057qib7	11289	6	with	with	IN
cord-005453-4057qib7	11289	7	median	median	JJ
cord-005453-4057qib7	11289	8	time	time	NN
cord-005453-4057qib7	11289	9	of	of	IN
cord-005453-4057qib7	11289	10	neutrophil	neutrophil	NN
cord-005453-4057qib7	11289	11	recovery	recovery	NN
cord-005453-4057qib7	11289	12	of	of	IN
cord-005453-4057qib7	11289	13	14	14	CD
cord-005453-4057qib7	11289	14	(	(	-LRB-
cord-005453-4057qib7	11289	15	9	9	CD
cord-005453-4057qib7	11289	16	-	-	SYM
cord-005453-4057qib7	11289	17	20	20	CD
cord-005453-4057qib7	11289	18	)	)	-RRB-
cord-005453-4057qib7	11289	19	days	day	NNS
cord-005453-4057qib7	11289	20	.	.	.
cord-005453-4057qib7	11290	1	The	the	DT
cord-005453-4057qib7	11290	2	incidence	incidence	NN
cord-005453-4057qib7	11290	3	of	of	IN
cord-005453-4057qib7	11290	4	grade	grade	NN
cord-005453-4057qib7	11290	5	2	2	CD
cord-005453-4057qib7	11290	6	-	-	SYM
cord-005453-4057qib7	11290	7	4	4	CD
cord-005453-4057qib7	11290	8	and	and	CC
cord-005453-4057qib7	11290	9	grade	grade	NN
cord-005453-4057qib7	11290	10	3	3	CD
cord-005453-4057qib7	11290	11	-	-	SYM
cord-005453-4057qib7	11290	12	4	4	CD
cord-005453-4057qib7	11290	13	acute	acute	JJ
cord-005453-4057qib7	11290	14	GVHD	GVHD	NNP
cord-005453-4057qib7	11290	15	was	be	VBD
cord-005453-4057qib7	11290	16	16	16	CD
cord-005453-4057qib7	11290	17	%	%	NN
cord-005453-4057qib7	11290	18	and	and	CC
cord-005453-4057qib7	11290	19	11	11	CD
cord-005453-4057qib7	11290	20	%	%	NN
cord-005453-4057qib7	11290	21	,	,	,
cord-005453-4057qib7	11290	22	respectively	respectively	RB
cord-005453-4057qib7	11290	23	,	,	,
cord-005453-4057qib7	11290	24	while	while	IN
cord-005453-4057qib7	11290	25	the	the	DT
cord-005453-4057qib7	11290	26	incidence	incidence	NN
cord-005453-4057qib7	11290	27	of	of	IN
cord-005453-4057qib7	11290	28	chronic	chronic	JJ
cord-005453-4057qib7	11290	29	GvHD	gvhd	NN
cord-005453-4057qib7	11290	30	was	be	VBD
cord-005453-4057qib7	11290	31	43	43	CD
cord-005453-4057qib7	11290	32	%	%	NN
cord-005453-4057qib7	11290	33	.	.	.
cord-005453-4057qib7	11291	1	The	the	DT
cord-005453-4057qib7	11291	2	probabilities	probability	NNS
cord-005453-4057qib7	11291	3	of	of	IN
cord-005453-4057qib7	11291	4	OS	OS	NNP
cord-005453-4057qib7	11291	5	and	and	CC
cord-005453-4057qib7	11291	6	PFS	PFS	NNP
cord-005453-4057qib7	11291	7	at	at	IN
cord-005453-4057qib7	11291	8	2	2	CD
cord-005453-4057qib7	11291	9	years	year	NNS
cord-005453-4057qib7	11291	10	were	be	VBD
cord-005453-4057qib7	11291	11	54	54	CD
cord-005453-4057qib7	11291	12	%	%	NN
cord-005453-4057qib7	11291	13	(	(	-LRB-
cord-005453-4057qib7	11291	14	+	+	CC
cord-005453-4057qib7	11291	15	/-12	/-12	.
cord-005453-4057qib7	11291	16	%	%	NN
cord-005453-4057qib7	11291	17	)	)	-RRB-
cord-005453-4057qib7	11291	18	and	and	CC
cord-005453-4057qib7	11291	19	55	55	CD
cord-005453-4057qib7	11291	20	%	%	NN
cord-005453-4057qib7	11291	21	(	(	-LRB-
cord-005453-4057qib7	11291	22	+	+	CC
cord-005453-4057qib7	11291	23	/-8	/-8	CD
cord-005453-4057qib7	11291	24	%	%	NN
cord-005453-4057qib7	11291	25	)	)	-RRB-
cord-005453-4057qib7	11291	26	,	,	,
cord-005453-4057qib7	11291	27	respectively	respectively	RB
cord-005453-4057qib7	11291	28	.	.	.
cord-005453-4057qib7	11292	1	The	the	DT
cord-005453-4057qib7	11292	2	incidences	incidence	NNS
cord-005453-4057qib7	11292	3	of	of	IN
cord-005453-4057qib7	11292	4	progression	progression	NN
cord-005453-4057qib7	11292	5	and	and	CC
cord-005453-4057qib7	11292	6	transplant	transplant	NN
cord-005453-4057qib7	11292	7	-	-	HYPH
cord-005453-4057qib7	11292	8	related	relate	VBN
cord-005453-4057qib7	11292	9	mortality	mortality	NN
cord-005453-4057qib7	11292	10	were	be	VBD
cord-005453-4057qib7	11292	11	31	31	CD
cord-005453-4057qib7	11292	12	%	%	NN
cord-005453-4057qib7	11292	13	and	and	CC
cord-005453-4057qib7	11292	14	14	14	CD
cord-005453-4057qib7	11292	15	%	%	NN
cord-005453-4057qib7	11292	16	,	,	,
cord-005453-4057qib7	11292	17	respectively	respectively	RB
cord-005453-4057qib7	11292	18	.	.	.
cord-005453-4057qib7	11293	1	The	the	DT
cord-005453-4057qib7	11293	2	2y	2y	CD
cord-005453-4057qib7	11293	3	PFS	PFS	NNP
cord-005453-4057qib7	11293	4	rates	rate	NNS
cord-005453-4057qib7	11293	5	were	be	VBD
cord-005453-4057qib7	11293	6	42	42	CD
cord-005453-4057qib7	11293	7	%	%	NN
cord-005453-4057qib7	11293	8	for	for	IN
cord-005453-4057qib7	11293	9	MSD	MSD	NNP
cord-005453-4057qib7	11293	10	,	,	,
cord-005453-4057qib7	11293	11	72	72	CD
cord-005453-4057qib7	11293	12	%	%	NN
cord-005453-4057qib7	11293	13	for	for	IN
cord-005453-4057qib7	11293	14	URD	URD	NNP
cord-005453-4057qib7	11293	15	and	and	CC
cord-005453-4057qib7	11293	16	62	62	CD
cord-005453-4057qib7	11293	17	%	%	NN
cord-005453-4057qib7	11293	18	for	for	IN
cord-005453-4057qib7	11293	19	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11293	20	donors	donor	NNS
cord-005453-4057qib7	11293	21	.	.	.
cord-005453-4057qib7	11294	1	In	in	IN
cord-005453-4057qib7	11294	2	a	a	DT
cord-005453-4057qib7	11294	3	univariate	univariate	JJ
cord-005453-4057qib7	11294	4	analysis	analysis	NN
cord-005453-4057qib7	11294	5	PFS	PFS	NNP
cord-005453-4057qib7	11294	6	was	be	VBD
cord-005453-4057qib7	11294	7	affected	affect	VBN
cord-005453-4057qib7	11294	8	by	by	IN
cord-005453-4057qib7	11294	9	recipient	recipient	NN
cord-005453-4057qib7	11294	10	gender	gender	NN
cord-005453-4057qib7	11294	11	(	(	-LRB-
cord-005453-4057qib7	11294	12	female	female	JJ
cord-005453-4057qib7	11294	13	-75	-75	CD
cord-005453-4057qib7	11294	14	%	%	NN
cord-005453-4057qib7	11294	15	,	,	,
cord-005453-4057qib7	11294	16	male	male	JJ
cord-005453-4057qib7	11294	17	-38	-38	NNP
cord-005453-4057qib7	11294	18	%	%	NN
cord-005453-4057qib7	11294	19	,	,	,
cord-005453-4057qib7	11294	20	p=0.009	p=0.009	NN
cord-005453-4057qib7	11294	21	)	)	-RRB-
cord-005453-4057qib7	11294	22	and	and	CC
cord-005453-4057qib7	11294	23	disease	disease	NN
cord-005453-4057qib7	11294	24	status	status	NN
cord-005453-4057qib7	11294	25	at	at	IN
cord-005453-4057qib7	11294	26	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11294	27	(	(	-LRB-
cord-005453-4057qib7	11294	28	CR	CR	NNP
cord-005453-4057qib7	11294	29	-78	-78	NN
cord-005453-4057qib7	11294	30	%	%	NN
cord-005453-4057qib7	11294	31	,	,	,
cord-005453-4057qib7	11294	32	PR	PR	NNP
cord-005453-4057qib7	11294	33	-47	-47	CD
cord-005453-4057qib7	11294	34	%	%	NN
cord-005453-4057qib7	11294	35	,	,	,
cord-005453-4057qib7	11294	36	NR	NR	NNP
cord-005453-4057qib7	11294	37	-38	-38	NNP
cord-005453-4057qib7	11294	38	%	%	NN
cord-005453-4057qib7	11294	39	,	,	,
cord-005453-4057qib7	11294	40	p=0.09	p=0.09	NNP
cord-005453-4057qib7	11294	41	)	)	-RRB-
cord-005453-4057qib7	11294	42	.	.	.
cord-005453-4057qib7	11295	1	In	in	IN
cord-005453-4057qib7	11295	2	a	a	DT
cord-005453-4057qib7	11295	3	multivariate	multivariate	JJ
cord-005453-4057qib7	11295	4	model	model	NN
cord-005453-4057qib7	11295	5	the	the	DT
cord-005453-4057qib7	11295	6	disease	disease	NN
cord-005453-4057qib7	11295	7	status	status	NN
cord-005453-4057qib7	11295	8	other	other	JJ
cord-005453-4057qib7	11295	9	than	than	IN
cord-005453-4057qib7	11295	10	CR	CR	NNP
cord-005453-4057qib7	11295	11	was	be	VBD
cord-005453-4057qib7	11295	12	the	the	DT
cord-005453-4057qib7	11295	13	only	only	JJ
cord-005453-4057qib7	11295	14	factor	factor	NN
cord-005453-4057qib7	11295	15	associated	associate	VBN
cord-005453-4057qib7	11295	16	with	with	IN
cord-005453-4057qib7	11295	17	increased	increase	VBN
cord-005453-4057qib7	11295	18	risk	risk	NN
cord-005453-4057qib7	11295	19	of	of	IN
cord-005453-4057qib7	11295	20	treatment	treatment	NN
cord-005453-4057qib7	11295	21	failure	failure	NN
cord-005453-4057qib7	11295	22	(	(	-LRB-
cord-005453-4057qib7	11295	23	reverse	reverse	JJ
cord-005453-4057qib7	11295	24	PFS	PFS	NNP
cord-005453-4057qib7	11295	25	)	)	-RRB-
cord-005453-4057qib7	11296	1	-HR=3.13	-hr=3.13	NN
cord-005453-4057qib7	11296	2	,	,	,
cord-005453-4057qib7	11296	3	95%CI	95%ci	CD
cord-005453-4057qib7	11296	4	1.45	1.45	CD
cord-005453-4057qib7	11296	5	-	-	HYPH
cord-005453-4057qib7	11296	6	6.76	6.76	CD
cord-005453-4057qib7	11296	7	,	,	,
cord-005453-4057qib7	11296	8	p=0.004	p=0.004	NNP
cord-005453-4057qib7	11296	9	.	.	.
cord-005453-4057qib7	11297	1	Neither	neither	DT
cord-005453-4057qib7	11297	2	donor	donor	NN
cord-005453-4057qib7	11297	3	type	type	NN
cord-005453-4057qib7	11297	4	nor	nor	CC
cord-005453-4057qib7	11297	5	conditioning	conditioning	NN
cord-005453-4057qib7	11297	6	affected	affect	VBN
cord-005453-4057qib7	11297	7	long	long	JJ
cord-005453-4057qib7	11297	8	-	-	HYPH
cord-005453-4057qib7	11297	9	term	term	NN
cord-005453-4057qib7	11297	10	outcome	outcome	NN
cord-005453-4057qib7	11297	11	.	.	.
cord-005453-4057qib7	11298	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11298	2	:	:	:
cord-005453-4057qib7	11299	1	Results	result	NNS
cord-005453-4057qib7	11299	2	of	of	IN
cord-005453-4057qib7	11299	3	alloHSCT	allohsct	NN
cord-005453-4057qib7	11299	4	for	for	IN
cord-005453-4057qib7	11299	5	patients	patient	NNS
cord-005453-4057qib7	11299	6	with	with	IN
cord-005453-4057qib7	11299	7	relapsed	relapse	VBN
cord-005453-4057qib7	11299	8	/	/	SYM
cord-005453-4057qib7	11299	9	refractory	refractory	JJ
cord-005453-4057qib7	11299	10	HL	HL	NNP
cord-005453-4057qib7	11299	11	are	be	VBP
cord-005453-4057qib7	11299	12	determined	determine	VBN
cord-005453-4057qib7	11299	13	by	by	IN
cord-005453-4057qib7	11299	14	disease	disease	NN
cord-005453-4057qib7	11299	15	status	status	NN
cord-005453-4057qib7	11299	16	at	at	IN
cord-005453-4057qib7	11299	17	transplantation	transplantation	NN
cord-005453-4057qib7	11299	18	.	.	.
cord-005453-4057qib7	11300	1	Efforts	effort	NNS
cord-005453-4057qib7	11300	2	should	should	MD
cord-005453-4057qib7	11300	3	be	be	VB
cord-005453-4057qib7	11300	4	done	do	VBN
cord-005453-4057qib7	11300	5	to	to	TO
cord-005453-4057qib7	11300	6	reduce	reduce	VB
cord-005453-4057qib7	11300	7	tumour	tumour	NN
cord-005453-4057qib7	11300	8	burden	burden	NN
cord-005453-4057qib7	11300	9	before	before	IN
cord-005453-4057qib7	11300	10	transplantation	transplantation	NN
cord-005453-4057qib7	11300	11	,	,	,
cord-005453-4057qib7	11300	12	optimally	optimally	RB
cord-005453-4057qib7	11300	13	to	to	TO
cord-005453-4057qib7	11300	14	achieve	achieve	VB
cord-005453-4057qib7	11300	15	CR	CR	NNP
cord-005453-4057qib7	11300	16	.	.	.
cord-005453-4057qib7	11301	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11301	2	:	:	:
cord-005453-4057qib7	11301	3	Nothing	nothing	NN
cord-005453-4057qib7	11301	4	to	to	TO
cord-005453-4057qib7	11301	5	declare	declare	VB
cord-005453-4057qib7	11301	6	Background	background	NN
cord-005453-4057qib7	11301	7	:	:	:
cord-005453-4057qib7	11301	8	Brentuximab	Brentuximab	NNP
cord-005453-4057qib7	11301	9	vedotin	vedotin	NNP
cord-005453-4057qib7	11301	10	(	(	-LRB-
cord-005453-4057qib7	11301	11	BV	BV	NNP
cord-005453-4057qib7	11301	12	)	)	-RRB-
cord-005453-4057qib7	11301	13	,	,	,
cord-005453-4057qib7	11301	14	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11301	15	and	and	CC
cord-005453-4057qib7	11301	16	pembrolizumab	pembrolizumab	NNP
cord-005453-4057qib7	11301	17	have	have	VBP
cord-005453-4057qib7	11301	18	been	be	VBN
cord-005453-4057qib7	11301	19	assigned	assign	VBN
cord-005453-4057qib7	11301	20	to	to	IN
cord-005453-4057qib7	11301	21	chemorefractory	chemorefractory	JJ
cord-005453-4057qib7	11301	22	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11301	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	11301	24	treatment	treatment	NN
cord-005453-4057qib7	11301	25	.	.	.
cord-005453-4057qib7	11302	1	Impact	impact	NN
cord-005453-4057qib7	11302	2	of	of	IN
cord-005453-4057qib7	11302	3	these	these	DT
cord-005453-4057qib7	11302	4	agents	agent	NNS
cord-005453-4057qib7	11302	5	on	on	IN
cord-005453-4057qib7	11302	6	disease	disease	NN
cord-005453-4057qib7	11302	7	-	-	HYPH
cord-005453-4057qib7	11302	8	free	free	JJ
cord-005453-4057qib7	11302	9	-	-	HYPH
cord-005453-4057qib7	11302	10	survival	survival	NN
cord-005453-4057qib7	11302	11	after	after	IN
cord-005453-4057qib7	11302	12	autologous	autologous	JJ
cord-005453-4057qib7	11302	13	stem	stem	NN
cord-005453-4057qib7	11302	14	cell	cell	NN
cord-005453-4057qib7	11302	15	transplantation	transplantation	NN
cord-005453-4057qib7	11302	16	(	(	-LRB-
cord-005453-4057qib7	11302	17	ASCT	ASCT	NNP
cord-005453-4057qib7	11302	18	)	)	-RRB-
cord-005453-4057qib7	11302	19	remains	remain	VBZ
cord-005453-4057qib7	11302	20	under	under	IN
cord-005453-4057qib7	11302	21	investigation	investigation	NN
cord-005453-4057qib7	11302	22	.	.	.
cord-005453-4057qib7	11303	1	Aim	Aim	NNP
cord-005453-4057qib7	11303	2	of	of	IN
cord-005453-4057qib7	11303	3	the	the	DT
cord-005453-4057qib7	11303	4	study	study	NN
cord-005453-4057qib7	11303	5	is	be	VBZ
cord-005453-4057qib7	11303	6	to	to	TO
cord-005453-4057qib7	11303	7	compare	compare	VB
cord-005453-4057qib7	11303	8	BV	BV	NNP
cord-005453-4057qib7	11303	9	-	-	:
cord-005453-4057qib7	11303	10	and	and	CC
cord-005453-4057qib7	11303	11	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11303	12	-	-	HYPH
cord-005453-4057qib7	11303	13	treated	treat	VBN
cord-005453-4057qib7	11303	14	patients	patient	NNS
cord-005453-4057qib7	11303	15	with	with	IN
cord-005453-4057qib7	11303	16	a	a	DT
cord-005453-4057qib7	11303	17	control	control	NN
cord-005453-4057qib7	11303	18	group	group	NN
cord-005453-4057qib7	11303	19	.	.	.
cord-005453-4057qib7	11304	1	Methods	method	NNS
cord-005453-4057qib7	11304	2	:	:	:
cord-005453-4057qib7	11304	3	Clinical	clinical	JJ
cord-005453-4057qib7	11304	4	characteristics	characteristic	NNS
cord-005453-4057qib7	11304	5	and	and	CC
cord-005453-4057qib7	11304	6	outcomes	outcome	NNS
cord-005453-4057qib7	11304	7	of	of	IN
cord-005453-4057qib7	11304	8	chemo	chemo	NN
cord-005453-4057qib7	11304	9	refractory	refractory	JJ
cord-005453-4057qib7	11304	10	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11304	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11304	12	patients	patient	NNS
cord-005453-4057qib7	11304	13	who	who	WP
cord-005453-4057qib7	11304	14	underwent	undergo	VBD
cord-005453-4057qib7	11304	15	ASCT	ASCT	NNP
cord-005453-4057qib7	11304	16	during	during	IN
cord-005453-4057qib7	11304	17	2011	2011	CD
cord-005453-4057qib7	11304	18	-	-	SYM
cord-005453-4057qib7	11304	19	2017	2017	CD
cord-005453-4057qib7	11304	20	.	.	.
cord-005453-4057qib7	11305	1	Results	result	NNS
cord-005453-4057qib7	11305	2	:	:	:
cord-005453-4057qib7	11306	1	A	a	DT
cord-005453-4057qib7	11306	2	total	total	NN
cord-005453-4057qib7	11306	3	of	of	IN
cord-005453-4057qib7	11306	4	56	56	CD
cord-005453-4057qib7	11306	5	patients	patient	NNS
cord-005453-4057qib7	11306	6	(	(	-LRB-
cord-005453-4057qib7	11306	7	33	33	CD
cord-005453-4057qib7	11306	8	men	man	NNS
cord-005453-4057qib7	11306	9	;	;	:
cord-005453-4057qib7	11306	10	21	21	CD
cord-005453-4057qib7	11306	11	women	woman	NNS
cord-005453-4057qib7	11306	12	,	,	,
cord-005453-4057qib7	11306	13	median	median	JJ
cord-005453-4057qib7	11306	14	age	age	NN
cord-005453-4057qib7	11306	15	37	37	CD
cord-005453-4057qib7	11306	16	years	year	NNS
cord-005453-4057qib7	11306	17	old	old	JJ
cord-005453-4057qib7	11306	18	,	,	,
cord-005453-4057qib7	11306	19	19	19	CD
cord-005453-4057qib7	11306	20	-	-	SYM
cord-005453-4057qib7	11306	21	65	65	CD
cord-005453-4057qib7	11306	22	)	)	-RRB-
cord-005453-4057qib7	11306	23	were	be	VBD
cord-005453-4057qib7	11306	24	treated	treat	VBN
cord-005453-4057qib7	11306	25	with	with	IN
cord-005453-4057qib7	11306	26	BV	BV	NNP
cord-005453-4057qib7	11306	27	:	:	:
cord-005453-4057qib7	11306	28	24	24	CD
cord-005453-4057qib7	11306	29	pre	pre	JJ
cord-005453-4057qib7	11306	30	-	-	NN
cord-005453-4057qib7	11306	31	transplant	transplant	NN
cord-005453-4057qib7	11306	32	,	,	,
cord-005453-4057qib7	11306	33	30	30	CD
cord-005453-4057qib7	11306	34	post	post	NN
cord-005453-4057qib7	11306	35	-	-	JJ
cord-005453-4057qib7	11306	36	transplant	transplant	NN
cord-005453-4057qib7	11306	37	and	and	CC
cord-005453-4057qib7	11306	38	7	7	CD
cord-005453-4057qib7	11306	39	pre	pre	JJ
cord-005453-4057qib7	11306	40	-	-	NN
cord-005453-4057qib7	11306	41	and	and	CC
cord-005453-4057qib7	11306	42	posttransplant	posttransplant	NN
cord-005453-4057qib7	11306	43	.	.	.
cord-005453-4057qib7	11307	1	Pre	pre	JJ
cord-005453-4057qib7	11307	2	-	-	JJ
cord-005453-4057qib7	11307	3	transplant	transplant	NN
cord-005453-4057qib7	11307	4	BV	BV	NNP
cord-005453-4057qib7	11307	5	patients	patient	NNS
cord-005453-4057qib7	11307	6	had	have	VBD
cord-005453-4057qib7	11307	7	primary	primary	JJ
cord-005453-4057qib7	11307	8	refractory	refractory	JJ
cord-005453-4057qib7	11307	9	disease	disease	NN
cord-005453-4057qib7	11307	10	or	or	CC
cord-005453-4057qib7	11307	11	early	early	JJ
cord-005453-4057qib7	11307	12	relapse	relapse	NN
cord-005453-4057qib7	11307	13	in	in	IN
cord-005453-4057qib7	11307	14	the	the	DT
cord-005453-4057qib7	11307	15	majority	majority	NN
cord-005453-4057qib7	11307	16	(	(	-LRB-
cord-005453-4057qib7	11307	17	92	92	CD
cord-005453-4057qib7	11307	18	%	%	NN
cord-005453-4057qib7	11307	19	)	)	-RRB-
cord-005453-4057qib7	11307	20	.	.	.
cord-005453-4057qib7	11308	1	Post	post	JJ
cord-005453-4057qib7	11308	2	-	-	JJ
cord-005453-4057qib7	11308	3	transplant	transplant	NN
cord-005453-4057qib7	11308	4	treatment	treatment	NN
cord-005453-4057qib7	11308	5	occurred	occur	VBD
cord-005453-4057qib7	11308	6	in	in	IN
cord-005453-4057qib7	11308	7	the	the	DT
cord-005453-4057qib7	11308	8	context	context	NN
cord-005453-4057qib7	11308	9	of	of	IN
cord-005453-4057qib7	11308	10	relapsed	relapse	VBN
cord-005453-4057qib7	11308	11	/	/	SYM
cord-005453-4057qib7	11308	12	refractory	refractory	JJ
cord-005453-4057qib7	11308	13	disease	disease	NN
cord-005453-4057qib7	11308	14	in	in	IN
cord-005453-4057qib7	11308	15	27	27	CD
cord-005453-4057qib7	11308	16	patients	patient	NNS
cord-005453-4057qib7	11308	17	;	;	:
cord-005453-4057qib7	11308	18	12	12	CD
cord-005453-4057qib7	11308	19	(	(	-LRB-
cord-005453-4057qib7	11308	20	40	40	CD
cord-005453-4057qib7	11308	21	%	%	NN
cord-005453-4057qib7	11308	22	)	)	-RRB-
cord-005453-4057qib7	11308	23	had	have	VBD
cord-005453-4057qib7	11308	24	an	an	DT
cord-005453-4057qib7	11308	25	allogeneic	allogeneic	NN
cord-005453-4057qib7	11308	26	stem	stem	NN
cord-005453-4057qib7	11308	27	cell	cell	NN
cord-005453-4057qib7	11308	28	transplant	transplant	NN
cord-005453-4057qib7	11308	29	.	.	.
cord-005453-4057qib7	11309	1	Among	among	IN
cord-005453-4057qib7	11309	2	them	-PRON-	PRP
cord-005453-4057qib7	11309	3	,	,	,
cord-005453-4057qib7	11309	4	6	6	CD
cord-005453-4057qib7	11309	5	had	have	VBD
cord-005453-4057qib7	11309	6	additional	additional	JJ
cord-005453-4057qib7	11309	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11309	8	and	and	CC
cord-005453-4057qib7	11309	9	2	2	CD
cord-005453-4057qib7	11309	10	nivolumab	nivolumab	NNS
cord-005453-4057qib7	11309	11	,	,	,
cord-005453-4057qib7	11309	12	gaining	gain	VBG
cord-005453-4057qib7	11309	13	a	a	DT
cord-005453-4057qib7	11309	14	complete	complete	JJ
cord-005453-4057qib7	11309	15	metabolic	metabolic	JJ
cord-005453-4057qib7	11309	16	response	response	NN
cord-005453-4057qib7	11309	17	.	.	.
cord-005453-4057qib7	11310	1	In	in	IN
cord-005453-4057qib7	11310	2	the	the	DT
cord-005453-4057qib7	11310	3	15	15	CD
cord-005453-4057qib7	11310	4	rest	rest	NN
cord-005453-4057qib7	11310	5	of	of	IN
cord-005453-4057qib7	11310	6	patients	patient	NNS
cord-005453-4057qib7	11310	7	,	,	,
cord-005453-4057qib7	11310	8	change	change	NN
cord-005453-4057qib7	11310	9	of	of	IN
cord-005453-4057qib7	11310	10	treatment	treatment	NN
cord-005453-4057qib7	11310	11	due	due	IN
cord-005453-4057qib7	11310	12	to	to	IN
cord-005453-4057qib7	11310	13	eventual	eventual	JJ
cord-005453-4057qib7	11310	14	BV	BV	NNP
cord-005453-4057qib7	11310	15	failure	failure	NN
cord-005453-4057qib7	11310	16	occurred	occur	VBD
cord-005453-4057qib7	11310	17	.	.	.
cord-005453-4057qib7	11311	1	BV	BV	NNP
cord-005453-4057qib7	11311	2	was	be	VBD
cord-005453-4057qib7	11311	3	administered	administer	VBN
cord-005453-4057qib7	11311	4	as	as	IN
cord-005453-4057qib7	11311	5	a	a	DT
cord-005453-4057qib7	11311	6	maintenance	maintenance	NN
cord-005453-4057qib7	11311	7	treatment	treatment	NN
cord-005453-4057qib7	11311	8	in	in	IN
cord-005453-4057qib7	11311	9	10	10	CD
cord-005453-4057qib7	11311	10	patients	patient	NNS
cord-005453-4057qib7	11311	11	.	.	.
cord-005453-4057qib7	11312	1	In	in	IN
cord-005453-4057qib7	11312	2	six	six	CD
cord-005453-4057qib7	11312	3	of	of	IN
cord-005453-4057qib7	11312	4	them	-PRON-	PRP
cord-005453-4057qib7	11312	5	BV	BV	NNP
cord-005453-4057qib7	11312	6	had	have	VBD
cord-005453-4057qib7	11312	7	already	already	RB
cord-005453-4057qib7	11312	8	been	be	VBN
cord-005453-4057qib7	11312	9	administered	administer	VBN
cord-005453-4057qib7	11312	10	pre	pre	JJ
cord-005453-4057qib7	11312	11	-	-	NN
cord-005453-4057qib7	11312	12	transplant	transplant	NN
cord-005453-4057qib7	11312	13	as	as	RB
cord-005453-4057qib7	11312	14	well	well	RB
cord-005453-4057qib7	11312	15	.	.	.
cord-005453-4057qib7	11313	1	Out	out	IN
cord-005453-4057qib7	11313	2	of	of	IN
cord-005453-4057qib7	11313	3	maintenance	maintenance	NN
cord-005453-4057qib7	11313	4	treatment	treatment	NN
cord-005453-4057qib7	11313	5	patients	patient	NNS
cord-005453-4057qib7	11313	6	,	,	,
cord-005453-4057qib7	11313	7	2	2	CD
cord-005453-4057qib7	11313	8	relapsed	relapse	VBD
cord-005453-4057qib7	11313	9	and	and	CC
cord-005453-4057qib7	11313	10	subsequently	subsequently	RB
cord-005453-4057qib7	11313	11	received	receive	VBD
cord-005453-4057qib7	11313	12	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11313	13	.	.	.
cord-005453-4057qib7	11314	1	Two	two	CD
cord-005453-4057qib7	11314	2	patients	patient	NNS
cord-005453-4057qib7	11314	3	died	die	VBD
cord-005453-4057qib7	11314	4	due	due	JJ
cord-005453-4057qib7	11314	5	to	to	IN
cord-005453-4057qib7	11314	6	prior	prior	JJ
cord-005453-4057qib7	11314	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11314	8	complications	complication	NNS
cord-005453-4057qib7	11314	9	,	,	,
cord-005453-4057qib7	11314	10	whereas	whereas	IN
cord-005453-4057qib7	11314	11	13	13	CD
cord-005453-4057qib7	11314	12	are	be	VBP
cord-005453-4057qib7	11314	13	currently	currently	RB
cord-005453-4057qib7	11314	14	on	on	IN
cord-005453-4057qib7	11314	15	nivolumab	nivolumab	JJ
cord-005453-4057qib7	11314	16	treatment	treatment	NN
cord-005453-4057qib7	11314	17	.	.	.
cord-005453-4057qib7	11315	1	PET	pet	NN
cord-005453-4057qib7	11315	2	-	-	HYPH
cord-005453-4057qib7	11315	3	based	base	VBN
cord-005453-4057qib7	11315	4	response	response	NN
cord-005453-4057qib7	11315	5	was	be	VBD
cord-005453-4057qib7	11315	6	available	available	JJ
cord-005453-4057qib7	11315	7	in	in	IN
cord-005453-4057qib7	11315	8	6	6	CD
cord-005453-4057qib7	11315	9	patients	patient	NNS
cord-005453-4057qib7	11315	10	,	,	,
cord-005453-4057qib7	11315	11	4	4	LS
cord-005453-4057qib7	11315	12	having	have	VBG
cord-005453-4057qib7	11315	13	a	a	DT
cord-005453-4057qib7	11315	14	complete	complete	JJ
cord-005453-4057qib7	11315	15	metabolic	metabolic	JJ
cord-005453-4057qib7	11315	16	response	response	NN
cord-005453-4057qib7	11315	17	(	(	-LRB-
cord-005453-4057qib7	11315	18	CMR	CMR	NNP
cord-005453-4057qib7	11315	19	)	)	-RRB-
cord-005453-4057qib7	11315	20	and	and	CC
cord-005453-4057qib7	11315	21	2	2	CD
cord-005453-4057qib7	11315	22	a	a	DT
cord-005453-4057qib7	11315	23	partial	partial	JJ
cord-005453-4057qib7	11315	24	metabolic	metabolic	JJ
cord-005453-4057qib7	11315	25	response	response	NN
cord-005453-4057qib7	11315	26	.	.	.
cord-005453-4057qib7	11316	1	Stable	stable	JJ
cord-005453-4057qib7	11316	2	disease	disease	NN
cord-005453-4057qib7	11316	3	was	be	VBD
cord-005453-4057qib7	11316	4	achieved	achieve	VBN
cord-005453-4057qib7	11316	5	by	by	IN
cord-005453-4057qib7	11316	6	CTbased	ctbased	JJ
cord-005453-4057qib7	11316	7	response	response	NN
cord-005453-4057qib7	11316	8	in	in	IN
cord-005453-4057qib7	11316	9	the	the	DT
cord-005453-4057qib7	11316	10	rest	rest	NN
cord-005453-4057qib7	11316	11	patients	patient	NNS
cord-005453-4057qib7	11316	12	.	.	.
cord-005453-4057qib7	11317	1	No	no	DT
cord-005453-4057qib7	11317	2	major	major	JJ
cord-005453-4057qib7	11317	3	toxicities	toxicity	NNS
cord-005453-4057qib7	11317	4	were	be	VBD
cord-005453-4057qib7	11317	5	observed	observe	VBN
cord-005453-4057qib7	11317	6	.	.	.
cord-005453-4057qib7	11318	1	One	one	CD
cord-005453-4057qib7	11318	2	patient	patient	NN
cord-005453-4057qib7	11318	3	presented	present	VBN
cord-005453-4057qib7	11318	4	with	with	IN
cord-005453-4057qib7	11318	5	grade	grade	NN
cord-005453-4057qib7	11318	6	2	2	CD
cord-005453-4057qib7	11318	7	asymptomatic	asymptomatic	JJ
cord-005453-4057qib7	11318	8	hypothyroidism	hypothyroidism	NN
cord-005453-4057qib7	11318	9	and	and	CC
cord-005453-4057qib7	11318	10	one	one	CD
cord-005453-4057qib7	11318	11	with	with	IN
cord-005453-4057qib7	11318	12	grade	grade	NN
cord-005453-4057qib7	11318	13	3	3	CD
cord-005453-4057qib7	11318	14	anemia	anemia	NN
cord-005453-4057qib7	11318	15	attributed	attribute	VBN
cord-005453-4057qib7	11318	16	to	to	IN
cord-005453-4057qib7	11318	17	non	non	JJ
cord-005453-4057qib7	11318	18	-	-	JJ
cord-005453-4057qib7	11318	19	inflammatory	inflammatory	JJ
cord-005453-4057qib7	11318	20	upper	upper	JJ
cord-005453-4057qib7	11318	21	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	11318	22	blood	blood	NN
cord-005453-4057qib7	11318	23	loss	loss	NN
cord-005453-4057qib7	11318	24	.	.	.
cord-005453-4057qib7	11319	1	In	in	IN
cord-005453-4057qib7	11319	2	total	total	JJ
cord-005453-4057qib7	11319	3	,	,	,
cord-005453-4057qib7	11319	4	20	20	CD
cord-005453-4057qib7	11319	5	patients	patient	NNS
cord-005453-4057qib7	11319	6	received	receive	VBD
cord-005453-4057qib7	11319	7	anti	anti	JJ
cord-005453-4057qib7	11319	8	-	-	JJ
cord-005453-4057qib7	11319	9	PD1	pd1	JJ
cord-005453-4057qib7	11319	10	treatment	treatment	NN
cord-005453-4057qib7	11319	11	,	,	,
cord-005453-4057qib7	11319	12	all	all	DT
cord-005453-4057qib7	11319	13	post	post	NN
cord-005453-4057qib7	11319	14	BV	BV	NNP
cord-005453-4057qib7	11319	15	failure	failure	NN
cord-005453-4057qib7	11319	16	.	.	.
cord-005453-4057qib7	11320	1	With	with	IN
cord-005453-4057qib7	11320	2	a	a	DT
cord-005453-4057qib7	11320	3	median	median	JJ
cord-005453-4057qib7	11320	4	follow	follow	NN
cord-005453-4057qib7	11320	5	-	-	HYPH
cord-005453-4057qib7	11320	6	up	up	NN
cord-005453-4057qib7	11320	7	of	of	IN
cord-005453-4057qib7	11320	8	34.3	34.3	CD
cord-005453-4057qib7	11320	9	(	(	-LRB-
cord-005453-4057qib7	11320	10	1.5	1.5	CD
cord-005453-4057qib7	11320	11	-	-	SYM
cord-005453-4057qib7	11320	12	202	202	CD
cord-005453-4057qib7	11320	13	.2	.2	CD
cord-005453-4057qib7	11320	14	)	)	-RRB-
cord-005453-4057qib7	11320	15	months	month	NNS
cord-005453-4057qib7	11320	16	,	,	,
cord-005453-4057qib7	11320	17	5-year	5-year	CD
cord-005453-4057qib7	11320	18	overall	overall	JJ
cord-005453-4057qib7	11320	19	survival	survival	NN
cord-005453-4057qib7	11320	20	(	(	-LRB-
cord-005453-4057qib7	11320	21	OS	OS	NNP
cord-005453-4057qib7	11320	22	)	)	-RRB-
cord-005453-4057qib7	11320	23	was	be	VBD
cord-005453-4057qib7	11320	24	65.9	65.9	CD
cord-005453-4057qib7	11320	25	%	%	NN
cord-005453-4057qib7	11320	26	in	in	IN
cord-005453-4057qib7	11320	27	patients	patient	NNS
cord-005453-4057qib7	11320	28	treated	treat	VBN
cord-005453-4057qib7	11320	29	only	only	RB
cord-005453-4057qib7	11320	30	with	with	IN
cord-005453-4057qib7	11320	31	BV	BV	NNP
cord-005453-4057qib7	11320	32	compared	compare	VBN
cord-005453-4057qib7	11320	33	to	to	IN
cord-005453-4057qib7	11320	34	78.2	78.2	CD
cord-005453-4057qib7	11320	35	%	%	NN
cord-005453-4057qib7	11320	36	in	in	IN
cord-005453-4057qib7	11320	37	patients	patient	NNS
cord-005453-4057qib7	11320	38	treated	treat	VBN
cord-005453-4057qib7	11320	39	with	with	IN
cord-005453-4057qib7	11320	40	additional	additional	JJ
cord-005453-4057qib7	11320	41	anti	anti	JJ
cord-005453-4057qib7	11320	42	-	-	JJ
cord-005453-4057qib7	11320	43	PD1	pd1	JJ
cord-005453-4057qib7	11320	44	treatment	treatment	NN
cord-005453-4057qib7	11320	45	(	(	-LRB-
cord-005453-4057qib7	11320	46	p=0.356	p=0.356	VB
cord-005453-4057qib7	11320	47	,	,	,
cord-005453-4057qib7	11320	48	Figure	figure	NN
cord-005453-4057qib7	11320	49	)	)	-RRB-
cord-005453-4057qib7	11320	50	.	.	.
cord-005453-4057qib7	11321	1	Median	median	JJ
cord-005453-4057qib7	11321	2	OS	os	NN
cord-005453-4057qib7	11321	3	for	for	IN
cord-005453-4057qib7	11321	4	patients	patient	NNS
cord-005453-4057qib7	11321	5	treated	treat	VBN
cord-005453-4057qib7	11321	6	only	only	RB
cord-005453-4057qib7	11321	7	with	with	IN
cord-005453-4057qib7	11321	8	BV	BV	NNP
cord-005453-4057qib7	11321	9	was	be	VBD
cord-005453-4057qib7	11321	10	113.5	113.5	CD
cord-005453-4057qib7	11321	11	months	month	NNS
cord-005453-4057qib7	11321	12	,	,	,
cord-005453-4057qib7	11321	13	whereas	whereas	IN
cord-005453-4057qib7	11321	14	median	median	JJ
cord-005453-4057qib7	11321	15	OS	OS	NNP
cord-005453-4057qib7	11321	16	has	have	VBZ
cord-005453-4057qib7	11321	17	not	not	RB
cord-005453-4057qib7	11321	18	been	be	VBN
cord-005453-4057qib7	11321	19	reached	reach	VBN
cord-005453-4057qib7	11321	20	for	for	IN
cord-005453-4057qib7	11321	21	patients	patient	NNS
cord-005453-4057qib7	11321	22	that	that	WDT
cord-005453-4057qib7	11321	23	received	receive	VBD
cord-005453-4057qib7	11321	24	anti	anti	JJ
cord-005453-4057qib7	11321	25	-	-	JJ
cord-005453-4057qib7	11321	26	PD1	pd1	JJ
cord-005453-4057qib7	11321	27	treatment	treatment	NN
cord-005453-4057qib7	11321	28	.	.	.
cord-005453-4057qib7	11322	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11322	2	:	:	:
cord-005453-4057qib7	11322	3	BV	BV	NNP
cord-005453-4057qib7	11322	4	pre	pre	VBD
cord-005453-4057qib7	11322	5	or	or	CC
cord-005453-4057qib7	11322	6	post	post	JJ
cord-005453-4057qib7	11322	7	-	-	JJ
cord-005453-4057qib7	11322	8	transplant	transplant	JJ
cord-005453-4057qib7	11322	9	and	and	CC
cord-005453-4057qib7	11322	10	anti	anti	JJ
cord-005453-4057qib7	11322	11	-	-	JJ
cord-005453-4057qib7	11322	12	PD1	pd1	JJ
cord-005453-4057qib7	11322	13	treatment	treatment	NN
cord-005453-4057qib7	11322	14	post	post	NN
cord-005453-4057qib7	11322	15	-	-	NN
cord-005453-4057qib7	11322	16	transplant	transplant	NN
cord-005453-4057qib7	11322	17	after	after	IN
cord-005453-4057qib7	11322	18	BV	BV	NNP
cord-005453-4057qib7	11322	19	failure	failure	NN
cord-005453-4057qib7	11322	20	have	have	VBP
cord-005453-4057qib7	11322	21	outstanding	outstanding	JJ
cord-005453-4057qib7	11322	22	results	result	NNS
cord-005453-4057qib7	11322	23	in	in	IN
cord-005453-4057qib7	11322	24	chemo	chemo	NN
cord-005453-4057qib7	11322	25	refractory	refractory	JJ
cord-005453-4057qib7	11322	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	11322	27	patients	patient	NNS
cord-005453-4057qib7	11322	28	.	.	.
cord-005453-4057qib7	11323	1	Treatment	treatment	NN
cord-005453-4057qib7	11323	2	sequence	sequence	NN
cord-005453-4057qib7	11323	3	in	in	IN
cord-005453-4057qib7	11323	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	11323	5	transplantation	transplantation	NN
cord-005453-4057qib7	11324	1	eligible	eligible	JJ
cord-005453-4057qib7	11324	2	patients	patient	NNS
cord-005453-4057qib7	11324	3	remains	remain	VBZ
cord-005453-4057qib7	11324	4	to	to	TO
cord-005453-4057qib7	11324	5	be	be	VB
cord-005453-4057qib7	11324	6	further	further	RB
cord-005453-4057qib7	11324	7	studied	study	VBN
cord-005453-4057qib7	11324	8	.	.	.
cord-005453-4057qib7	11325	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11325	2	:	:	:
cord-005453-4057qib7	11325	3	Nothing	nothing	NN
cord-005453-4057qib7	11325	4	to	to	TO
cord-005453-4057qib7	11325	5	declare	declare	VB
cord-005453-4057qib7	11325	6	Background	background	NN
cord-005453-4057qib7	11325	7	:	:	:
cord-005453-4057qib7	11325	8	Allogeneic	allogeneic	NN
cord-005453-4057qib7	11325	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11325	10	cell	cell	NN
cord-005453-4057qib7	11325	11	transplantation	transplantation	NN
cord-005453-4057qib7	11325	12	(	(	-LRB-
cord-005453-4057qib7	11325	13	allo	allo	NN
cord-005453-4057qib7	11325	14	-	-	HYPH
cord-005453-4057qib7	11325	15	HCT	HCT	NNP
cord-005453-4057qib7	11325	16	)	)	-RRB-
cord-005453-4057qib7	11325	17	with	with	IN
cord-005453-4057qib7	11325	18	reduced	reduce	VBN
cord-005453-4057qib7	11325	19	-	-	HYPH
cord-005453-4057qib7	11325	20	intensity	intensity	NN
cord-005453-4057qib7	11325	21	conditioning	conditioning	NN
cord-005453-4057qib7	11325	22	(	(	-LRB-
cord-005453-4057qib7	11325	23	RIC	RIC	NNP
cord-005453-4057qib7	11325	24	)	)	-RRB-
cord-005453-4057qib7	11325	25	has	have	VBZ
cord-005453-4057qib7	11325	26	been	be	VBN
cord-005453-4057qib7	11325	27	used	use	VBN
cord-005453-4057qib7	11325	28	in	in	IN
cord-005453-4057qib7	11325	29	heavily	heavily	RB
cord-005453-4057qib7	11325	30	pretreated	pretreate	VBN
cord-005453-4057qib7	11325	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	11325	32	patients	patient	NNS
cord-005453-4057qib7	11325	33	with	with	IN
cord-005453-4057qib7	11325	34	the	the	DT
cord-005453-4057qib7	11325	35	promise	promise	NN
cord-005453-4057qib7	11325	36	of	of	IN
cord-005453-4057qib7	11325	37	decreased	decrease	VBN
cord-005453-4057qib7	11325	38	treatment	treatment	NN
cord-005453-4057qib7	11325	39	-	-	HYPH
cord-005453-4057qib7	11325	40	related	relate	VBN
cord-005453-4057qib7	11325	41	mortality	mortality	NN
cord-005453-4057qib7	11325	42	.	.	.
cord-005453-4057qib7	11326	1	Despite	despite	IN
cord-005453-4057qib7	11326	2	improvements	improvement	NNS
cord-005453-4057qib7	11326	3	in	in	IN
cord-005453-4057qib7	11326	4	outcomes	outcome	NNS
cord-005453-4057qib7	11326	5	of	of	IN
cord-005453-4057qib7	11326	6	patients	patient	NNS
cord-005453-4057qib7	11326	7	with	with	IN
cord-005453-4057qib7	11326	8	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11326	9	neoplasms	neoplasm	NNS
cord-005453-4057qib7	11326	10	,	,	,
cord-005453-4057qib7	11326	11	several	several	JJ
cord-005453-4057qib7	11326	12	new	new	JJ
cord-005453-4057qib7	11326	13	agents	agent	NNS
cord-005453-4057qib7	11326	14	emerge	emerge	VBP
cord-005453-4057qib7	11326	15	as	as	IN
cord-005453-4057qib7	11326	16	potential	potential	JJ
cord-005453-4057qib7	11326	17	therapies	therapy	NNS
cord-005453-4057qib7	11326	18	.	.	.
cord-005453-4057qib7	11327	1	Therefore	therefore	RB
cord-005453-4057qib7	11327	2	,	,	,
cord-005453-4057qib7	11327	3	we	-PRON-	PRP
cord-005453-4057qib7	11327	4	aimed	aim	VBD
cord-005453-4057qib7	11327	5	to	to	TO
cord-005453-4057qib7	11327	6	describe	describe	VB
cord-005453-4057qib7	11327	7	our	-PRON-	PRP$
cord-005453-4057qib7	11327	8	long	long	JJ
cord-005453-4057qib7	11327	9	-	-	HYPH
cord-005453-4057qib7	11327	10	term	term	NN
cord-005453-4057qib7	11327	11	experience	experience	NN
cord-005453-4057qib7	11327	12	in	in	IN
cord-005453-4057qib7	11327	13	patients	patient	NNS
cord-005453-4057qib7	11327	14	with	with	IN
cord-005453-4057qib7	11327	15	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11327	16	(	(	-LRB-
cord-005453-4057qib7	11327	17	HL	HL	NNP
cord-005453-4057qib7	11327	18	)	)	-RRB-
cord-005453-4057qib7	11327	19	,	,	,
cord-005453-4057qib7	11327	20	non	non	JJ
cord-005453-4057qib7	11327	21	-	-	JJ
cord-005453-4057qib7	11327	22	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11327	23	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11327	24	(	(	-LRB-
cord-005453-4057qib7	11327	25	NHL	NHL	NNP
cord-005453-4057qib7	11327	26	)	)	-RRB-
cord-005453-4057qib7	11327	27	and	and	CC
cord-005453-4057qib7	11327	28	chronic	chronic	JJ
cord-005453-4057qib7	11327	29	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	11327	30	leukemia	leukemia	NN
cord-005453-4057qib7	11327	31	(	(	-LRB-
cord-005453-4057qib7	11327	32	CLL	CLL	NNP
cord-005453-4057qib7	11327	33	)	)	-RRB-
cord-005453-4057qib7	11327	34	post	post	NN
cord-005453-4057qib7	11327	35	allo	allo	NN
cord-005453-4057qib7	11327	36	-	-	HYPH
cord-005453-4057qib7	11327	37	HCT	HCT	NNP
cord-005453-4057qib7	11327	38	.	.	.
cord-005453-4057qib7	11328	1	Methods	method	NNS
cord-005453-4057qib7	11328	2	:	:	:
cord-005453-4057qib7	11328	3	In	in	IN
cord-005453-4057qib7	11328	4	this	this	DT
cord-005453-4057qib7	11328	5	retrospective	retrospective	JJ
cord-005453-4057qib7	11328	6	study	study	NN
cord-005453-4057qib7	11328	7	,	,	,
cord-005453-4057qib7	11328	8	we	-PRON-	PRP
cord-005453-4057qib7	11328	9	enrolled	enrol	VBD
cord-005453-4057qib7	11328	10	consecutive	consecutive	JJ
cord-005453-4057qib7	11328	11	patients	patient	NNS
cord-005453-4057qib7	11328	12	who	who	WP
cord-005453-4057qib7	11328	13	underwent	undergo	VBD
cord-005453-4057qib7	11328	14	allo	allo	NN
cord-005453-4057qib7	11328	15	-	-	HYPH
cord-005453-4057qib7	11328	16	HCT	hct	NN
cord-005453-4057qib7	11328	17	for	for	IN
cord-005453-4057qib7	11328	18	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11328	19	neoplasms	neoplasm	NNS
cord-005453-4057qib7	11328	20	in	in	IN
cord-005453-4057qib7	11328	21	our	-PRON-	PRP$
cord-005453-4057qib7	11328	22	institution	institution	NN
cord-005453-4057qib7	11328	23	(	(	-LRB-
cord-005453-4057qib7	11328	24	2001	2001	CD
cord-005453-4057qib7	11328	25	)	)	-RRB-
cord-005453-4057qib7	11328	26	(	(	-LRB-
cord-005453-4057qib7	11328	27	2002	2002	CD
cord-005453-4057qib7	11328	28	)	)	-RRB-
cord-005453-4057qib7	11329	1	(	(	-LRB-
cord-005453-4057qib7	11329	2	2003	2003	CD
cord-005453-4057qib7	11329	3	)	)	-RRB-
cord-005453-4057qib7	11330	1	(	(	-LRB-
cord-005453-4057qib7	11330	2	2004	2004	CD
cord-005453-4057qib7	11330	3	)	)	-RRB-
cord-005453-4057qib7	11331	1	(	(	-LRB-
cord-005453-4057qib7	11331	2	2005	2005	CD
cord-005453-4057qib7	11331	3	)	)	-RRB-
cord-005453-4057qib7	11332	1	(	(	-LRB-
cord-005453-4057qib7	11332	2	2006	2006	CD
cord-005453-4057qib7	11332	3	)	)	-RRB-
cord-005453-4057qib7	11333	1	(	(	-LRB-
cord-005453-4057qib7	11333	2	2007	2007	CD
cord-005453-4057qib7	11333	3	)	)	-RRB-
cord-005453-4057qib7	11334	1	(	(	-LRB-
cord-005453-4057qib7	11334	2	2008	2008	CD
cord-005453-4057qib7	11334	3	)	)	-RRB-
cord-005453-4057qib7	11335	1	(	(	-LRB-
cord-005453-4057qib7	11335	2	2009	2009	CD
cord-005453-4057qib7	11335	3	)	)	-RRB-
cord-005453-4057qib7	11336	1	(	(	-LRB-
cord-005453-4057qib7	11336	2	2010	2010	CD
cord-005453-4057qib7	11336	3	)	)	-RRB-
cord-005453-4057qib7	11337	1	(	(	-LRB-
cord-005453-4057qib7	11337	2	2011	2011	CD
cord-005453-4057qib7	11337	3	)	)	-RRB-
cord-005453-4057qib7	11338	1	(	(	-LRB-
cord-005453-4057qib7	11338	2	2012	2012	CD
cord-005453-4057qib7	11338	3	)	)	-RRB-
cord-005453-4057qib7	11339	1	(	(	-LRB-
cord-005453-4057qib7	11339	2	2013	2013	CD
cord-005453-4057qib7	11339	3	)	)	-RRB-
cord-005453-4057qib7	11340	1	(	(	-LRB-
cord-005453-4057qib7	11340	2	2014	2014	CD
cord-005453-4057qib7	11340	3	)	)	-RRB-
cord-005453-4057qib7	11340	4	(	(	-LRB-
cord-005453-4057qib7	11340	5	2015	2015	CD
cord-005453-4057qib7	11340	6	)	)	-RRB-
cord-005453-4057qib7	11340	7	(	(	-LRB-
cord-005453-4057qib7	11340	8	2016	2016	CD
cord-005453-4057qib7	11340	9	)	)	-RRB-
cord-005453-4057qib7	11340	10	(	(	-LRB-
cord-005453-4057qib7	11340	11	2017	2017	CD
cord-005453-4057qib7	11340	12	)	)	-RRB-
cord-005453-4057qib7	11340	13	(	(	-LRB-
cord-005453-4057qib7	11340	14	2018	2018	CD
cord-005453-4057qib7	11340	15	)	)	-RRB-
cord-005453-4057qib7	11340	16	.	.	.
cord-005453-4057qib7	11341	1	Results	result	NNS
cord-005453-4057qib7	11341	2	:	:	:
cord-005453-4057qib7	11342	1	In	in	IN
cord-005453-4057qib7	11342	2	total	total	NN
cord-005453-4057qib7	11342	3	,	,	,
cord-005453-4057qib7	11342	4	50	50	CD
cord-005453-4057qib7	11342	5	patients	patient	NNS
cord-005453-4057qib7	11342	6	(	(	-LRB-
cord-005453-4057qib7	11342	7	male	male	JJ
cord-005453-4057qib7	11342	8	:	:	:
cord-005453-4057qib7	11342	9	female=35:25	female=35:25	CD
cord-005453-4057qib7	11342	10	)	)	-RRB-
cord-005453-4057qib7	11342	11	aged	age	VBN
cord-005453-4057qib7	11342	12	36	36	CD
cord-005453-4057qib7	11342	13	(	(	-LRB-
cord-005453-4057qib7	11342	14	15	15	CD
cord-005453-4057qib7	11342	15	-	-	SYM
cord-005453-4057qib7	11342	16	64	64	CD
cord-005453-4057qib7	11342	17	)	)	-RRB-
cord-005453-4057qib7	11342	18	years	year	NNS
cord-005453-4057qib7	11342	19	,	,	,
cord-005453-4057qib7	11342	20	underwent	undergo	VBD
cord-005453-4057qib7	11342	21	allo	allo	NN
cord-005453-4057qib7	11342	22	-	-	HYPH
cord-005453-4057qib7	11342	23	HCT	hct	NN
cord-005453-4057qib7	11342	24	for	for	IN
cord-005453-4057qib7	11342	25	HL	HL	NNP
cord-005453-4057qib7	11342	26	(	(	-LRB-
cord-005453-4057qib7	11342	27	n=24	n=24	NNP
cord-005453-4057qib7	11342	28	)	)	-RRB-
cord-005453-4057qib7	11342	29	,	,	,
cord-005453-4057qib7	11342	30	NHL	NHL	NNP
cord-005453-4057qib7	11342	31	(	(	-LRB-
cord-005453-4057qib7	11342	32	n=21	n=21	NNP
cord-005453-4057qib7	11342	33	)	)	-RRB-
cord-005453-4057qib7	11342	34	and	and	CC
cord-005453-4057qib7	11342	35	CLL	CLL	NNP
cord-005453-4057qib7	11342	36	(	(	-LRB-
cord-005453-4057qib7	11342	37	n=5	n=5	NNP
cord-005453-4057qib7	11342	38	)	)	-RRB-
cord-005453-4057qib7	11342	39	.	.	.
cord-005453-4057qib7	11343	1	The	the	DT
cord-005453-4057qib7	11343	2	majority	majority	NN
cord-005453-4057qib7	11343	3	of	of	IN
cord-005453-4057qib7	11343	4	patients	patient	NNS
cord-005453-4057qib7	11343	5	were	be	VBD
cord-005453-4057qib7	11343	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	11343	7	at	at	IN
cord-005453-4057qib7	11343	8	stage	stage	NN
cord-005453-4057qib7	11343	9	IV	IV	NNP
cord-005453-4057qib7	11343	10	(	(	-LRB-
cord-005453-4057qib7	11343	11	48	48	CD
cord-005453-4057qib7	11343	12	%	%	NN
cord-005453-4057qib7	11343	13	)	)	-RRB-
cord-005453-4057qib7	11343	14	;	;	:
cord-005453-4057qib7	11343	15	34	34	CD
cord-005453-4057qib7	11343	16	%	%	NN
cord-005453-4057qib7	11343	17	had	have	VBD
cord-005453-4057qib7	11343	18	bone	bone	NN
cord-005453-4057qib7	11343	19	marrow	marrow	NN
cord-005453-4057qib7	11343	20	involvement	involvement	NN
cord-005453-4057qib7	11343	21	and	and	CC
cord-005453-4057qib7	11343	22	66	66	CD
cord-005453-4057qib7	11343	23	%	%	NN
cord-005453-4057qib7	11343	24	had	have	VBD
cord-005453-4057qib7	11343	25	undergone	undergo	VBN
cord-005453-4057qib7	11343	26	autologous	autologous	JJ
cord-005453-4057qib7	11343	27	HCT	hct	NN
cord-005453-4057qib7	11343	28	.	.	.
cord-005453-4057qib7	11344	1	Most	Most	JJS
cord-005453-4057qib7	11344	2	patients	patient	NNS
cord-005453-4057qib7	11344	3	were	be	VBD
cord-005453-4057qib7	11344	4	heavily	heavily	RB
cord-005453-4057qib7	11344	5	pretreated	pretreate	VBN
cord-005453-4057qib7	11344	6	(	(	-LRB-
cord-005453-4057qib7	11344	7	median	median	NN
cord-005453-4057qib7	11344	8	lines=4	lines=4	NNS
cord-005453-4057qib7	11344	9	,	,	,
cord-005453-4057qib7	11344	10	range	range	VBP
cord-005453-4057qib7	11344	11	1	1	CD
cord-005453-4057qib7	11344	12	-	-	SYM
cord-005453-4057qib7	11344	13	11	11	CD
cord-005453-4057qib7	11344	14	)	)	-RRB-
cord-005453-4057qib7	11344	15	,	,	,
cord-005453-4057qib7	11344	16	21	21	CD
cord-005453-4057qib7	11344	17	of	of	IN
cord-005453-4057qib7	11344	18	them	-PRON-	PRP
cord-005453-4057qib7	11344	19	had	have	VBD
cord-005453-4057qib7	11344	20	received	receive	VBN
cord-005453-4057qib7	11344	21	more	more	JJR
cord-005453-4057qib7	11344	22	than	than	IN
cord-005453-4057qib7	11344	23	4	4	CD
cord-005453-4057qib7	11344	24	treatment	treatment	NN
cord-005453-4057qib7	11344	25	lines	line	NNS
cord-005453-4057qib7	11344	26	and	and	CC
cord-005453-4057qib7	11344	27	at	at	IN
cord-005453-4057qib7	11344	28	the	the	DT
cord-005453-4057qib7	11344	29	time	time	NN
cord-005453-4057qib7	11344	30	of	of	IN
cord-005453-4057qib7	11344	31	transplantation	transplantation	NN
cord-005453-4057qib7	11344	32	only	only	RB
cord-005453-4057qib7	11344	33	14	14	CD
cord-005453-4057qib7	11344	34	had	have	VBD
cord-005453-4057qib7	11344	35	complete	complete	JJ
cord-005453-4057qib7	11344	36	response	response	NN
cord-005453-4057qib7	11344	37	,	,	,
cord-005453-4057qib7	11344	38	while	while	IN
cord-005453-4057qib7	11344	39	9	9	CD
cord-005453-4057qib7	11344	40	had	have	VBD
cord-005453-4057qib7	11344	41	partial	partial	JJ
cord-005453-4057qib7	11344	42	response	response	NN
cord-005453-4057qib7	11344	43	and	and	CC
cord-005453-4057qib7	11344	44	27	27	CD
cord-005453-4057qib7	11344	45	were	be	VBD
cord-005453-4057qib7	11344	46	refractory	refractory	JJ
cord-005453-4057qib7	11344	47	.	.	.
cord-005453-4057qib7	11345	1	According	accord	VBG
cord-005453-4057qib7	11345	2	to	to	IN
cord-005453-4057qib7	11345	3	Disease	Disease	NNP
cord-005453-4057qib7	11345	4	-	-	HYPH
cord-005453-4057qib7	11345	5	Risk	Risk	NNP
cord-005453-4057qib7	11345	6	Index	Index	NNP
cord-005453-4057qib7	11345	7	(	(	-LRB-
cord-005453-4057qib7	11345	8	DRI	DRI	NNP
cord-005453-4057qib7	11345	9	)	)	-RRB-
cord-005453-4057qib7	11345	10	,	,	,
cord-005453-4057qib7	11345	11	patients	patient	NNS
cord-005453-4057qib7	11345	12	were	be	VBD
cord-005453-4057qib7	11345	13	stratified	stratify	VBN
cord-005453-4057qib7	11345	14	at	at	IN
cord-005453-4057qib7	11345	15	low	low	JJ
cord-005453-4057qib7	11345	16	(	(	-LRB-
cord-005453-4057qib7	11345	17	n=11	n=11	NNP
cord-005453-4057qib7	11345	18	,	,	,
cord-005453-4057qib7	11345	19	23.4	23.4	CD
cord-005453-4057qib7	11345	20	%	%	NN
cord-005453-4057qib7	11345	21	)	)	-RRB-
cord-005453-4057qib7	11345	22	,	,	,
cord-005453-4057qib7	11345	23	intermediate	intermediate	JJ
cord-005453-4057qib7	11345	24	(	(	-LRB-
cord-005453-4057qib7	11345	25	n=12	n=12	NNP
cord-005453-4057qib7	11345	26	,	,	,
cord-005453-4057qib7	11345	27	25.5	25.5	CD
cord-005453-4057qib7	11345	28	%	%	NN
cord-005453-4057qib7	11345	29	)	)	-RRB-
cord-005453-4057qib7	11345	30	,	,	,
cord-005453-4057qib7	11345	31	high	high	JJ
cord-005453-4057qib7	11345	32	(	(	-LRB-
cord-005453-4057qib7	11345	33	n=20	n=20	NN
cord-005453-4057qib7	11345	34	,	,	,
cord-005453-4057qib7	11345	35	42.6	42.6	CD
cord-005453-4057qib7	11345	36	%	%	NN
cord-005453-4057qib7	11345	37	)	)	-RRB-
cord-005453-4057qib7	11345	38	or	or	CC
cord-005453-4057qib7	11345	39	very	very	RB
cord-005453-4057qib7	11345	40	high	high	JJ
cord-005453-4057qib7	11345	41	(	(	-LRB-
cord-005453-4057qib7	11345	42	n=4	n=4	JJ
cord-005453-4057qib7	11345	43	,	,	,
cord-005453-4057qib7	11345	44	8.5	8.5	CD
cord-005453-4057qib7	11345	45	%	%	NN
cord-005453-4057qib7	11345	46	)	)	-RRB-
cord-005453-4057qib7	11345	47	category	category	NN
cord-005453-4057qib7	11345	48	.	.	.
cord-005453-4057qib7	11346	1	Among	among	IN
cord-005453-4057qib7	11346	2	patients	patient	NNS
cord-005453-4057qib7	11346	3	with	with	IN
cord-005453-4057qib7	11346	4	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11346	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	11346	6	,	,	,
cord-005453-4057qib7	11346	7	Brentuximab	Brentuximab	NNP
cord-005453-4057qib7	11346	8	vedotin	vedotin	NNP
cord-005453-4057qib7	11346	9	was	be	VBD
cord-005453-4057qib7	11346	10	administrated	administrate	VBN
cord-005453-4057qib7	11346	11	in	in	IN
cord-005453-4057qib7	11346	12	7	7	CD
cord-005453-4057qib7	11346	13	and	and	CC
cord-005453-4057qib7	11346	14	4	4	CD
cord-005453-4057qib7	11346	15	of	of	IN
cord-005453-4057qib7	11346	16	them	-PRON-	PRP
cord-005453-4057qib7	11346	17	were	be	VBD
cord-005453-4057qib7	11346	18	effectively	effectively	RB
cord-005453-4057qib7	11346	19	bridged	bridge	VBN
cord-005453-4057qib7	11346	20	to	to	IN
cord-005453-4057qib7	11346	21	allo	allo	NN
cord-005453-4057qib7	11346	22	-	-	HYPH
cord-005453-4057qib7	11346	23	HCT	hct	NN
cord-005453-4057qib7	11346	24	.	.	.
cord-005453-4057qib7	11347	1	All	all	DT
cord-005453-4057qib7	11347	2	patients	patient	NNS
cord-005453-4057qib7	11347	3	received	receive	VBD
cord-005453-4057qib7	11347	4	RIC	RIC	NNP
cord-005453-4057qib7	11347	5	,	,	,
cord-005453-4057qib7	11347	6	mainly	mainly	RB
cord-005453-4057qib7	11347	7	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	11347	8	(	(	-LRB-
cord-005453-4057qib7	11347	9	150mg/	150mg/	CD
cord-005453-4057qib7	11347	10	m	m	CD
cord-005453-4057qib7	11347	11	2	2	CD
cord-005453-4057qib7	11347	12	)	)	-RRB-
cord-005453-4057qib7	11347	13	-Cyclophosphamide	-Cyclophosphamide	.
cord-005453-4057qib7	11348	1	(	(	-LRB-
cord-005453-4057qib7	11348	2	2g/	2g/	CD
cord-005453-4057qib7	11348	3	m	m	CD
cord-005453-4057qib7	11348	4	2	2	CD
cord-005453-4057qib7	11348	5	)	)	-RRB-
cord-005453-4057qib7	11348	6	in	in	IN
cord-005453-4057qib7	11348	7	CLL	CLL	NNP
cord-005453-4057qib7	11348	8	and	and	CC
cord-005453-4057qib7	11348	9	NHL	NHL	NNP
cord-005453-4057qib7	11348	10	and	and	CC
cord-005453-4057qib7	11348	11	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	11348	12	(	(	-LRB-
cord-005453-4057qib7	11348	13	10mg	10mg	NNP
cord-005453-4057qib7	11348	14	/	/	SYM
cord-005453-4057qib7	11348	15	kg)-Fludarabine	kg)-Fludarabine	NNP
cord-005453-4057qib7	11348	16	(	(	-LRB-
cord-005453-4057qib7	11348	17	120	120	CD
cord-005453-4057qib7	11348	18	mg	mg	NNP
cord-005453-4057qib7	11348	19	/	/	SYM
cord-005453-4057qib7	11348	20	m	m	NN
cord-005453-4057qib7	11348	21	2	2	CD
cord-005453-4057qib7	11348	22	)	)	-RRB-
cord-005453-4057qib7	11349	1	-Cyclophosphamide	-cyclophosphamide	RB
cord-005453-4057qib7	11350	1	(	(	-LRB-
cord-005453-4057qib7	11350	2	60mg	60mg	NNP
cord-005453-4057qib7	11350	3	/	/	SYM
cord-005453-4057qib7	11350	4	kg	kg	NNP
cord-005453-4057qib7	11350	5	)	)	-RRB-
cord-005453-4057qib7	11350	6	in	in	IN
cord-005453-4057qib7	11350	7	HL	HL	NNP
cord-005453-4057qib7	11350	8	from	from	IN
cord-005453-4057qib7	11350	9	matched	match	VBN
cord-005453-4057qib7	11350	10	sibling	sibling	NN
cord-005453-4057qib7	11350	11	(	(	-LRB-
cord-005453-4057qib7	11350	12	n=27	n=27	NNP
cord-005453-4057qib7	11350	13	)	)	-RRB-
cord-005453-4057qib7	11350	14	,	,	,
cord-005453-4057qib7	11350	15	matched	match	VBN
cord-005453-4057qib7	11350	16	(	(	-LRB-
cord-005453-4057qib7	11350	17	n=15	n=15	NNP
cord-005453-4057qib7	11350	18	)	)	-RRB-
cord-005453-4057qib7	11350	19	or	or	CC
cord-005453-4057qib7	11350	20	mismatched	mismatch	VBN
cord-005453-4057qib7	11350	21	unrelated	unrelated	JJ
cord-005453-4057qib7	11350	22	(	(	-LRB-
cord-005453-4057qib7	11350	23	n=8	n=8	NN
cord-005453-4057qib7	11350	24	)	)	-RRB-
cord-005453-4057qib7	11350	25	donors	donor	NNS
cord-005453-4057qib7	11350	26	.	.	.
cord-005453-4057qib7	11351	1	Graft	graft	NN
cord-005453-4057qib7	11351	2	-	-	HYPH
cord-005453-4057qib7	11351	3	versus	versus	IN
cord-005453-4057qib7	11351	4	-	-	HYPH
cord-005453-4057qib7	11351	5	host	host	NN
cord-005453-4057qib7	11351	6	disease	disease	NN
cord-005453-4057qib7	11351	7	(	(	-LRB-
cord-005453-4057qib7	11351	8	GVHD	GVHD	NNP
cord-005453-4057qib7	11351	9	)	)	-RRB-
cord-005453-4057qib7	11351	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11351	11	consisted	consist	VBD
cord-005453-4057qib7	11351	12	of	of	IN
cord-005453-4057qib7	11351	13	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	11351	14	or	or	CC
cord-005453-4057qib7	11351	15	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	11351	16	and	and	CC
cord-005453-4057qib7	11351	17	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	11351	18	mofetil	mofetil	NNP
cord-005453-4057qib7	11351	19	or	or	CC
cord-005453-4057qib7	11351	20	short	short	JJ
cord-005453-4057qib7	11351	21	-	-	HYPH
cord-005453-4057qib7	11351	22	term	term	NN
cord-005453-4057qib7	11351	23	methotrexate	methotrexate	NNP
cord-005453-4057qib7	11351	24	and	and	CC
cord-005453-4057qib7	11351	25	additional	additional	JJ
cord-005453-4057qib7	11351	26	low	low	JJ
cord-005453-4057qib7	11351	27	-	-	HYPH
cord-005453-4057qib7	11351	28	dose	dose	NN
cord-005453-4057qib7	11351	29	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	11351	30	globulin	globulin	NN
cord-005453-4057qib7	11351	31	(	(	-LRB-
cord-005453-4057qib7	11351	32	5mg	5mg	NNP
cord-005453-4057qib7	11351	33	/	/	SYM
cord-005453-4057qib7	11351	34	kg	kg	NNP
cord-005453-4057qib7	11351	35	)	)	-RRB-
cord-005453-4057qib7	11351	36	in	in	IN
cord-005453-4057qib7	11351	37	unrelated	unrelated	JJ
cord-005453-4057qib7	11351	38	donors	donor	NNS
cord-005453-4057qib7	11351	39	.	.	.
cord-005453-4057qib7	11352	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	11352	2	blood	blood	NN
cord-005453-4057qib7	11352	3	was	be	VBD
cord-005453-4057qib7	11352	4	the	the	DT
cord-005453-4057qib7	11352	5	main	main	JJ
cord-005453-4057qib7	11352	6	cell	cell	NN
cord-005453-4057qib7	11352	7	source	source	NN
cord-005453-4057qib7	11352	8	(	(	-LRB-
cord-005453-4057qib7	11352	9	48/50	48/50	CD
cord-005453-4057qib7	11352	10	)	)	-RRB-
cord-005453-4057qib7	11352	11	and	and	CC
cord-005453-4057qib7	11352	12	median	median	JJ
cord-005453-4057qib7	11352	13	number	number	NN
cord-005453-4057qib7	11352	14	of	of	IN
cord-005453-4057qib7	11352	15	CD34	CD34	NNP
cord-005453-4057qib7	11352	16	+	+	CC
cord-005453-4057qib7	11352	17	cells	cell	NNS
cord-005453-4057qib7	11352	18	infused	infuse	VBN
cord-005453-4057qib7	11352	19	was	be	VBD
cord-005453-4057qib7	11352	20	6.37x10	6.37x10	CD
cord-005453-4057qib7	11352	21	6	6	CD
cord-005453-4057qib7	11353	1	/kg	/kg	NFP
cord-005453-4057qib7	11353	2	(	(	-LRB-
cord-005453-4057qib7	11353	3	1.33	1.33	CD
cord-005453-4057qib7	11353	4	-	-	SYM
cord-005453-4057qib7	11353	5	14.5	14.5	CD
cord-005453-4057qib7	11353	6	)	)	-RRB-
cord-005453-4057qib7	11353	7	.	.	.
cord-005453-4057qib7	11354	1	Two	two	CD
cord-005453-4057qib7	11354	2	patients	patient	NNS
cord-005453-4057qib7	11354	3	succumbed	succumb	VBD
cord-005453-4057qib7	11354	4	to	to	IN
cord-005453-4057qib7	11354	5	advanced	advanced	JJ
cord-005453-4057qib7	11354	6	underlying	underlying	JJ
cord-005453-4057qib7	11354	7	disease	disease	NN
cord-005453-4057qib7	11354	8	before	before	IN
cord-005453-4057qib7	11354	9	engraftment	engraftment	NN
cord-005453-4057qib7	11354	10	;	;	:
cord-005453-4057qib7	11354	11	while	while	IN
cord-005453-4057qib7	11354	12	the	the	DT
cord-005453-4057qib7	11354	13	other	other	JJ
cord-005453-4057qib7	11354	14	engrafted	engraft	VBD
cord-005453-4057qib7	11354	15	successfully	successfully	RB
cord-005453-4057qib7	11354	16	.	.	.
cord-005453-4057qib7	11355	1	Median	median	JJ
cord-005453-4057qib7	11355	2	time	time	NN
cord-005453-4057qib7	11355	3	until	until	IN
cord-005453-4057qib7	11355	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	11355	5	and	and	CC
cord-005453-4057qib7	11355	6	platelet	platelet	NN
cord-005453-4057qib7	11355	7	engraftment	engraftment	NN
cord-005453-4057qib7	11355	8	was	be	VBD
cord-005453-4057qib7	11355	9	10	10	CD
cord-005453-4057qib7	11355	10	and	and	CC
cord-005453-4057qib7	11355	11	12	12	CD
cord-005453-4057qib7	11355	12	days	day	NNS
cord-005453-4057qib7	11355	13	respectively	respectively	RB
cord-005453-4057qib7	11355	14	.	.	.
cord-005453-4057qib7	11356	1	Eighteen	eighteen	CD
cord-005453-4057qib7	11356	2	patients	patient	NNS
cord-005453-4057qib7	11356	3	(	(	-LRB-
cord-005453-4057qib7	11356	4	36.7	36.7	CD
cord-005453-4057qib7	11356	5	%	%	NN
cord-005453-4057qib7	11356	6	)	)	-RRB-
cord-005453-4057qib7	11356	7	developed	develop	VBN
cord-005453-4057qib7	11356	8	acute	acute	JJ
cord-005453-4057qib7	11356	9	GVHD	GVHD	NNP
cord-005453-4057qib7	11356	10	(	(	-LRB-
cord-005453-4057qib7	11356	11	grade	grade	NN
cord-005453-4057qib7	11356	12	III	III	NNP
cord-005453-4057qib7	11356	13	-	-	HYPH
cord-005453-4057qib7	11356	14	IV	IV	NNP
cord-005453-4057qib7	11356	15	,	,	,
cord-005453-4057qib7	11356	16	n=5	n=5	JJ
cord-005453-4057qib7	11356	17	)	)	-RRB-
cord-005453-4057qib7	11356	18	,	,	,
cord-005453-4057qib7	11356	19	steroid	steroid	NN
cord-005453-4057qib7	11356	20	sensitive	sensitive	JJ
cord-005453-4057qib7	11356	21	in	in	IN
cord-005453-4057qib7	11356	22	10	10	CD
cord-005453-4057qib7	11356	23	(	(	-LRB-
cord-005453-4057qib7	11356	24	62.5	62.5	CD
cord-005453-4057qib7	11356	25	%	%	NN
cord-005453-4057qib7	11356	26	)	)	-RRB-
cord-005453-4057qib7	11356	27	and	and	CC
cord-005453-4057qib7	11356	28	11	11	CD
cord-005453-4057qib7	11356	29	relapsed	relapse	VBD
cord-005453-4057qib7	11356	30	.	.	.
cord-005453-4057qib7	11357	1	One	one	CD
cord-005453-4057qib7	11357	2	-	-	HYPH
cord-005453-4057qib7	11357	3	year	year	NN
cord-005453-4057qib7	11357	4	cumulative	cumulative	JJ
cord-005453-4057qib7	11357	5	incidence	incidence	NN
cord-005453-4057qib7	11357	6	(	(	-LRB-
cord-005453-4057qib7	11357	7	CI	CI	NNP
cord-005453-4057qib7	11357	8	)	)	-RRB-
cord-005453-4057qib7	11357	9	of	of	IN
cord-005453-4057qib7	11357	10	extensive	extensive	JJ
cord-005453-4057qib7	11357	11	chronic	chronic	JJ
cord-005453-4057qib7	11357	12	GVHD	GVHD	NNP
cord-005453-4057qib7	11357	13	was	be	VBD
cord-005453-4057qib7	11357	14	78.2	78.2	CD
cord-005453-4057qib7	11357	15	%	%	NN
cord-005453-4057qib7	11357	16	,	,	,
cord-005453-4057qib7	11357	17	and	and	CC
cord-005453-4057qib7	11357	18	13	13	CD
cord-005453-4057qib7	11357	19	patients	patient	NNS
cord-005453-4057qib7	11357	20	required	require	VBD
cord-005453-4057qib7	11357	21	more	more	JJR
cord-005453-4057qib7	11357	22	than	than	IN
cord-005453-4057qib7	11357	23	one	one	CD
cord-005453-4057qib7	11357	24	additional	additional	JJ
cord-005453-4057qib7	11357	25	line	line	NN
cord-005453-4057qib7	11357	26	of	of	IN
cord-005453-4057qib7	11357	27	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	11357	28	(	(	-LRB-
cord-005453-4057qib7	11357	29	range	range	NNP
cord-005453-4057qib7	11357	30	1	1	CD
cord-005453-4057qib7	11357	31	-	-	SYM
cord-005453-4057qib7	11357	32	5	5	CD
cord-005453-4057qib7	11357	33	)	)	-RRB-
cord-005453-4057qib7	11357	34	.	.	.
cord-005453-4057qib7	11358	1	Ten	ten	CD
cord-005453-4057qib7	11358	2	patients	patient	NNS
cord-005453-4057qib7	11358	3	presented	present	VBD
cord-005453-4057qib7	11358	4	CMV	CMV	NNP
cord-005453-4057qib7	11358	5	reactivation	reactivation	NN
cord-005453-4057qib7	11358	6	successfully	successfully	RB
cord-005453-4057qib7	11358	7	treated	treat	VBN
cord-005453-4057qib7	11358	8	with	with	IN
cord-005453-4057qib7	11358	9	antiviral	antiviral	JJ
cord-005453-4057qib7	11358	10	medication	medication	NN
cord-005453-4057qib7	11358	11	and	and	CC
cord-005453-4057qib7	11358	12	1	1	CD
cord-005453-4057qib7	11358	13	patient	patient	NN
cord-005453-4057qib7	11358	14	died	die	VBD
cord-005453-4057qib7	11358	15	from	from	IN
cord-005453-4057qib7	11358	16	HSV7	HSV7	NNP
cord-005453-4057qib7	11358	17	encephalitis	encephalitis	NNP
cord-005453-4057qib7	11358	18	.	.	.
cord-005453-4057qib7	11359	1	With	with	IN
cord-005453-4057qib7	11359	2	a	a	DT
cord-005453-4057qib7	11359	3	median	median	JJ
cord-005453-4057qib7	11359	4	follow	follow	NN
cord-005453-4057qib7	11359	5	of	of	IN
cord-005453-4057qib7	11359	6	3	3	CD
cord-005453-4057qib7	11359	7	years	year	NNS
cord-005453-4057qib7	11359	8	(	(	-LRB-
cord-005453-4057qib7	11359	9	1	1	CD
cord-005453-4057qib7	11359	10	-	-	SYM
cord-005453-4057qib7	11359	11	16	16	CD
cord-005453-4057qib7	11359	12	years	year	NNS
cord-005453-4057qib7	11359	13	)	)	-RRB-
cord-005453-4057qib7	11359	14	,	,	,
cord-005453-4057qib7	11359	15	10-year	10-year	CD
cord-005453-4057qib7	11359	16	OS	os	NN
cord-005453-4057qib7	11359	17	was	be	VBD
cord-005453-4057qib7	11359	18	40.4	40.4	CD
cord-005453-4057qib7	11359	19	%	%	NN
cord-005453-4057qib7	11359	20	,	,	,
cord-005453-4057qib7	11359	21	10-year	10-year	CD
cord-005453-4057qib7	11359	22	non	non	JJ
cord-005453-4057qib7	11359	23	-	-	JJ
cord-005453-4057qib7	11359	24	relapse	relapse	JJ
cord-005453-4057qib7	11359	25	mortality	mortality	NN
cord-005453-4057qib7	11359	26	CI	CI	NNP
cord-005453-4057qib7	11359	27	23.4	23.4	CD
cord-005453-4057qib7	11359	28	%	%	NN
cord-005453-4057qib7	11359	29	and	and	CC
cord-005453-4057qib7	11359	30	10year	10year	JJ
cord-005453-4057qib7	11359	31	DFS	DFS	NNP
cord-005453-4057qib7	11359	32	32	32	CD
cord-005453-4057qib7	11359	33	%	%	NN
cord-005453-4057qib7	11359	34	.	.	.
cord-005453-4057qib7	11360	1	There	there	EX
cord-005453-4057qib7	11360	2	was	be	VBD
cord-005453-4057qib7	11360	3	no	no	DT
cord-005453-4057qib7	11360	4	difference	difference	NN
cord-005453-4057qib7	11360	5	in	in	IN
cord-005453-4057qib7	11360	6	survival	survival	NN
cord-005453-4057qib7	11360	7	according	accord	VBG
cord-005453-4057qib7	11360	8	to	to	IN
cord-005453-4057qib7	11360	9	original	original	JJ
cord-005453-4057qib7	11360	10	disease	disease	NN
cord-005453-4057qib7	11360	11	(	(	-LRB-
cord-005453-4057qib7	11360	12	5-year	5-year	CD
cord-005453-4057qib7	11360	13	OS	os	NN
cord-005453-4057qib7	11360	14	for	for	IN
cord-005453-4057qib7	11360	15	NHL=60.2	NHL=60.2	NNP
cord-005453-4057qib7	11360	16	%	%	NN
cord-005453-4057qib7	11360	17	,	,	,
cord-005453-4057qib7	11360	18	HL=46.7	hl=46.7	UH
cord-005453-4057qib7	11360	19	%	%	NN
cord-005453-4057qib7	11360	20	,	,	,
cord-005453-4057qib7	11360	21	CLL=31%%	CLL=31%%	NNS
cord-005453-4057qib7	11360	22	,	,	,
cord-005453-4057qib7	11360	23	p=0.67	p=0.67	NNP
cord-005453-4057qib7	11360	24	)	)	-RRB-
cord-005453-4057qib7	11360	25	.	.	.
cord-005453-4057qib7	11361	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	11361	2	analysis	analysis	NN
cord-005453-4057qib7	11361	3	revealed	reveal	VBD
cord-005453-4057qib7	11361	4	high	high	JJ
cord-005453-4057qib7	11361	5	and	and	CC
cord-005453-4057qib7	11361	6	very	very	RB
cord-005453-4057qib7	11361	7	high	high	JJ
cord-005453-4057qib7	11361	8	DRI	dri	NN
cord-005453-4057qib7	11361	9	as	as	IN
cord-005453-4057qib7	11361	10	the	the	DT
cord-005453-4057qib7	11361	11	single	single	JJ
cord-005453-4057qib7	11361	12	predicting	predict	VBG
cord-005453-4057qib7	11361	13	factor	factor	NN
cord-005453-4057qib7	11361	14	of	of	IN
cord-005453-4057qib7	11361	15	OS	OS	NNP
cord-005453-4057qib7	11361	16	(	(	-LRB-
cord-005453-4057qib7	11361	17	HR	HR	NNP
cord-005453-4057qib7	11361	18	9.69	9.69	CD
cord-005453-4057qib7	11361	19	,	,	,
cord-005453-4057qib7	11361	20	CI	CI	NNP
cord-005453-4057qib7	11361	21	1.55	1.55	CD
cord-005453-4057qib7	11361	22	-	-	HYPH
cord-005453-4057qib7	11361	23	60.55	60.55	CD
cord-005453-4057qib7	11361	24	,	,	,
cord-005453-4057qib7	11361	25	p=0.015	p=0.015	NNPS
cord-005453-4057qib7	11361	26	)	)	-RRB-
cord-005453-4057qib7	11361	27	,	,	,
cord-005453-4057qib7	11361	28	when	when	WRB
cord-005453-4057qib7	11361	29	assessing	assess	VBG
cord-005453-4057qib7	11361	30	impact	impact	NN
cord-005453-4057qib7	11361	31	of	of	IN
cord-005453-4057qib7	11361	32	disease	disease	NN
cord-005453-4057qib7	11361	33	,	,	,
cord-005453-4057qib7	11361	34	DRI	DRI	NNP
cord-005453-4057qib7	11361	35	,	,	,
cord-005453-4057qib7	11361	36	prior	prior	JJ
cord-005453-4057qib7	11361	37	treatment	treatment	NN
cord-005453-4057qib7	11361	38	lines	line	NNS
cord-005453-4057qib7	11361	39	,	,	,
cord-005453-4057qib7	11361	40	gender	gender	NN
cord-005453-4057qib7	11361	41	and	and	CC
cord-005453-4057qib7	11361	42	bone	bone	NN
cord-005453-4057qib7	11361	43	marrow	marrow	NN
cord-005453-4057qib7	11361	44	infiltration	infiltration	NN
cord-005453-4057qib7	11361	45	at	at	IN
cord-005453-4057qib7	11361	46	diagnosis	diagnosis	NN
cord-005453-4057qib7	11361	47	.	.	.
cord-005453-4057qib7	11362	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11362	2	:	:	:
cord-005453-4057qib7	11363	1	Our	-PRON-	PRP$
cord-005453-4057qib7	11363	2	data	datum	NNS
cord-005453-4057qib7	11363	3	suggest	suggest	VBP
cord-005453-4057qib7	11363	4	that	that	IN
cord-005453-4057qib7	11363	5	RIC	RIC	NNP
cord-005453-4057qib7	11363	6	allo	allo	NNP
cord-005453-4057qib7	11363	7	-	-	HYPH
cord-005453-4057qib7	11363	8	HCT	HCT	NNP
cord-005453-4057qib7	11363	9	provides	provide	VBZ
cord-005453-4057qib7	11363	10	encouraging	encourage	VBG
cord-005453-4057qib7	11363	11	survival	survival	NN
cord-005453-4057qib7	11363	12	rates	rate	NNS
cord-005453-4057qib7	11363	13	,	,	,
cord-005453-4057qib7	11363	14	potentially	potentially	RB
cord-005453-4057qib7	11363	15	offering	offer	VBG
cord-005453-4057qib7	11363	16	the	the	DT
cord-005453-4057qib7	11363	17	chance	chance	NN
cord-005453-4057qib7	11363	18	of	of	IN
cord-005453-4057qib7	11363	19	cure	cure	NN
cord-005453-4057qib7	11363	20	,	,	,
cord-005453-4057qib7	11363	21	with	with	IN
cord-005453-4057qib7	11363	22	acceptable	acceptable	JJ
cord-005453-4057qib7	11363	23	long	long	JJ
cord-005453-4057qib7	11363	24	-	-	HYPH
cord-005453-4057qib7	11363	25	term	term	NN
cord-005453-4057qib7	11363	26	mortality	mortality	NN
cord-005453-4057qib7	11363	27	in	in	IN
cord-005453-4057qib7	11363	28	selected	select	VBN
cord-005453-4057qib7	11363	29	high	high	JJ
cord-005453-4057qib7	11363	30	-	-	HYPH
cord-005453-4057qib7	11363	31	risk	risk	NN
cord-005453-4057qib7	11363	32	patients	patient	NNS
cord-005453-4057qib7	11363	33	with	with	IN
cord-005453-4057qib7	11363	34	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11363	35	neoplasms	neoplasm	NNS
cord-005453-4057qib7	11363	36	.	.	.
cord-005453-4057qib7	11364	1	DRI	DRI	NNP
cord-005453-4057qib7	11364	2	that	that	WDT
cord-005453-4057qib7	11364	3	is	be	VBZ
cord-005453-4057qib7	11364	4	mainly	mainly	RB
cord-005453-4057qib7	11364	5	associated	associate	VBN
cord-005453-4057qib7	11364	6	with	with	IN
cord-005453-4057qib7	11364	7	disease	disease	NN
cord-005453-4057qib7	11364	8	stage	stage	NN
cord-005453-4057qib7	11364	9	at	at	IN
cord-005453-4057qib7	11364	10	transplant	transplant	NN
cord-005453-4057qib7	11364	11	independently	independently	RB
cord-005453-4057qib7	11364	12	affects	affect	VBZ
cord-005453-4057qib7	11364	13	survival	survival	NN
cord-005453-4057qib7	11364	14	.	.	.
cord-005453-4057qib7	11365	1	Therefore	therefore	RB
cord-005453-4057qib7	11365	2	,	,	,
cord-005453-4057qib7	11365	3	continued	continue	VBN
cord-005453-4057qib7	11365	4	efforts	effort	NNS
cord-005453-4057qib7	11365	5	are	be	VBP
cord-005453-4057qib7	11365	6	necessary	necessary	JJ
cord-005453-4057qib7	11365	7	for	for	IN
cord-005453-4057qib7	11365	8	clinical	clinical	JJ
cord-005453-4057qib7	11365	9	application	application	NN
cord-005453-4057qib7	11365	10	of	of	IN
cord-005453-4057qib7	11365	11	novel	novel	JJ
cord-005453-4057qib7	11365	12	agents	agent	NNS
cord-005453-4057qib7	11365	13	aiming	aim	VBG
cord-005453-4057qib7	11365	14	to	to	TO
cord-005453-4057qib7	11365	15	lower	lower	VB
cord-005453-4057qib7	11365	16	disease	disease	NN
cord-005453-4057qib7	11365	17	stage	stage	NN
cord-005453-4057qib7	11365	18	pre	pre	JJ
cord-005453-4057qib7	11365	19	-	-	NN
cord-005453-4057qib7	11365	20	transplant	transplant	NN
cord-005453-4057qib7	11365	21	.	.	.
cord-005453-4057qib7	11366	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11366	2	:	:	:
cord-005453-4057qib7	11366	3	Nothing	nothing	NN
cord-005453-4057qib7	11366	4	to	to	TO
cord-005453-4057qib7	11366	5	declare	declare	VB
cord-005453-4057qib7	11366	6	Results	result	NNS
cord-005453-4057qib7	11366	7	:	:	:
cord-005453-4057qib7	11367	1	Six	six	CD
cord-005453-4057qib7	11367	2	pts	pt	NNS
cord-005453-4057qib7	11367	3	were	be	VBD
cord-005453-4057qib7	11367	4	identified	identify	VBN
cord-005453-4057qib7	11367	5	,	,	,
cord-005453-4057qib7	11367	6	with	with	IN
cord-005453-4057qib7	11367	7	a	a	DT
cord-005453-4057qib7	11367	8	median	median	JJ
cord-005453-4057qib7	11367	9	age	age	NN
cord-005453-4057qib7	11367	10	of	of	IN
cord-005453-4057qib7	11367	11	30	30	CD
cord-005453-4057qib7	11367	12	years	year	NNS
cord-005453-4057qib7	11367	13	at	at	IN
cord-005453-4057qib7	11367	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	11367	15	:	:	:
cord-005453-4057qib7	11367	16	five	five	CD
cord-005453-4057qib7	11367	17	with	with	IN
cord-005453-4057qib7	11367	18	HL	HL	NNP
cord-005453-4057qib7	11367	19	nodular	nodular	JJ
cord-005453-4057qib7	11367	20	sclerosis	sclerosis	NN
cord-005453-4057qib7	11367	21	and	and	CC
cord-005453-4057qib7	11367	22	1	1	CD
cord-005453-4057qib7	11367	23	with	with	IN
cord-005453-4057qib7	11367	24	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11367	25	depletion	depletion	NN
cord-005453-4057qib7	11367	26	.	.	.
cord-005453-4057qib7	11368	1	The	the	DT
cord-005453-4057qib7	11368	2	median	median	JJ
cord-005453-4057qib7	11368	3	number	number	NN
cord-005453-4057qib7	11368	4	of	of	IN
cord-005453-4057qib7	11368	5	therapeutic	therapeutic	JJ
cord-005453-4057qib7	11368	6	lines	line	NNS
cord-005453-4057qib7	11368	7	prior	prior	RB
cord-005453-4057qib7	11368	8	to	to	IN
cord-005453-4057qib7	11368	9	allo	allo	NN
cord-005453-4057qib7	11368	10	-	-	HYPH
cord-005453-4057qib7	11368	11	HSCT	HSCT	NNP
cord-005453-4057qib7	11368	12	was	be	VBD
cord-005453-4057qib7	11368	13	5	5	CD
cord-005453-4057qib7	11368	14	[	[	-LRB-
cord-005453-4057qib7	11368	15	4	4	CD
cord-005453-4057qib7	11368	16	-	-	SYM
cord-005453-4057qib7	11368	17	10	10	CD
cord-005453-4057qib7	11368	18	]	]	-RRB-
cord-005453-4057qib7	11368	19	;	;	:
cord-005453-4057qib7	11368	20	four	four	CD
cord-005453-4057qib7	11368	21	pts	pt	NNS
cord-005453-4057qib7	11368	22	were	be	VBD
cord-005453-4057qib7	11368	23	previously	previously	RB
cord-005453-4057qib7	11368	24	treated	treat	VBN
cord-005453-4057qib7	11368	25	with	with	IN
cord-005453-4057qib7	11368	26	Brentuximaband	Brentuximaband	NNP
cord-005453-4057qib7	11368	27	two	two	CD
cord-005453-4057qib7	11368	28	pts	pt	NNS
cord-005453-4057qib7	11368	29	had	have	VBD
cord-005453-4057qib7	11368	30	been	be	VBN
cord-005453-4057qib7	11368	31	submitted	submit	VBN
cord-005453-4057qib7	11368	32	to	to	IN
cord-005453-4057qib7	11368	33	high	high	JJ
cord-005453-4057qib7	11368	34	dose	dose	NN
cord-005453-4057qib7	11368	35	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11368	36	with	with	IN
cord-005453-4057qib7	11368	37	autologous	autologous	JJ
cord-005453-4057qib7	11368	38	bone	bone	NN
cord-005453-4057qib7	11368	39	marrow	marrow	NN
cord-005453-4057qib7	11368	40	support	support	NN
cord-005453-4057qib7	11368	41	.	.	.
cord-005453-4057qib7	11369	1	At	at	IN
cord-005453-4057qib7	11369	2	the	the	DT
cord-005453-4057qib7	11369	3	time	time	NN
cord-005453-4057qib7	11369	4	of	of	IN
cord-005453-4057qib7	11369	5	allo	allo	NN
cord-005453-4057qib7	11369	6	-	-	HYPH
cord-005453-4057qib7	11369	7	HSCT	HSCT	NNP
cord-005453-4057qib7	11369	8	,	,	,
cord-005453-4057qib7	11369	9	4	4	CD
cord-005453-4057qib7	11369	10	pts	pt	NNS
cord-005453-4057qib7	11369	11	had	have	VBD
cord-005453-4057qib7	11369	12	progressive	progressive	JJ
cord-005453-4057qib7	11369	13	disease	disease	NN
cord-005453-4057qib7	11369	14	(	(	-LRB-
cord-005453-4057qib7	11369	15	DP	DP	NNP
cord-005453-4057qib7	11369	16	)	)	-RRB-
cord-005453-4057qib7	11369	17	,	,	,
cord-005453-4057qib7	11369	18	1	1	CD
cord-005453-4057qib7	11369	19	was	be	VBD
cord-005453-4057qib7	11369	20	in	in	IN
cord-005453-4057qib7	11369	21	partial	partial	JJ
cord-005453-4057qib7	11369	22	response	response	NN
cord-005453-4057qib7	11369	23	and	and	CC
cord-005453-4057qib7	11369	24	1	1	CD
cord-005453-4057qib7	11369	25	in	in	IN
cord-005453-4057qib7	11369	26	complete	complete	JJ
cord-005453-4057qib7	11369	27	response	response	NN
cord-005453-4057qib7	11369	28	(	(	-LRB-
cord-005453-4057qib7	11369	29	CR	CR	NNP
cord-005453-4057qib7	11369	30	)	)	-RRB-
cord-005453-4057qib7	11369	31	.	.	.
cord-005453-4057qib7	11370	1	Five	five	CD
cord-005453-4057qib7	11370	2	allo	allo	NN
cord-005453-4057qib7	11370	3	-	-	HYPH
cord-005453-4057qib7	11370	4	HSCT	HSCT	NNP
cord-005453-4057qib7	11370	5	were	be	VBD
cord-005453-4057qib7	11370	6	performed	perform	VBN
cord-005453-4057qib7	11370	7	with	with	IN
cord-005453-4057qib7	11370	8	a	a	DT
cord-005453-4057qib7	11370	9	related	related	JJ
cord-005453-4057qib7	11370	10	donor	donor	NN
cord-005453-4057qib7	11370	11	,	,	,
cord-005453-4057qib7	11370	12	4	4	CD
cord-005453-4057qib7	11370	13	of	of	IN
cord-005453-4057qib7	11370	14	wich	wich	WP
cord-005453-4057qib7	11370	15	were	be	VBD
cord-005453-4057qib7	11370	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11370	17	(	(	-LRB-
cord-005453-4057qib7	11370	18	2	2	CD
cord-005453-4057qib7	11370	19	parents	parent	NNS
cord-005453-4057qib7	11370	20	,	,	,
cord-005453-4057qib7	11370	21	1	1	CD
cord-005453-4057qib7	11370	22	sibling	sibling	NN
cord-005453-4057qib7	11370	23	and	and	CC
cord-005453-4057qib7	11370	24	1	1	CD
cord-005453-4057qib7	11370	25	descendant	descendant	NN
cord-005453-4057qib7	11370	26	)	)	-RRB-
cord-005453-4057qib7	11370	27	and	and	CC
cord-005453-4057qib7	11370	28	1	1	CD
cord-005453-4057qib7	11370	29	with	with	IN
cord-005453-4057qib7	11370	30	an	an	DT
cord-005453-4057qib7	11370	31	unrelated	unrelated	JJ
cord-005453-4057qib7	11370	32	donor	donor	NN
cord-005453-4057qib7	11370	33	(	(	-LRB-
cord-005453-4057qib7	11370	34	10/10	10/10	CD
cord-005453-4057qib7	11370	35	)	)	-RRB-
cord-005453-4057qib7	11370	36	.	.	.
cord-005453-4057qib7	11371	1	Prophylaxis	Prophylaxis	NNP
cord-005453-4057qib7	11371	2	for	for	IN
cord-005453-4057qib7	11371	3	GvHD	GvHD	NNP
cord-005453-4057qib7	11371	4	was	be	VBD
cord-005453-4057qib7	11371	5	performed	perform	VBN
cord-005453-4057qib7	11371	6	with	with	IN
cord-005453-4057qib7	11371	7	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	11371	8	and	and	CC
cord-005453-4057qib7	11371	9	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	11371	10	mofetil	mofetil	NNP
cord-005453-4057qib7	11371	11	(	(	-LRB-
cord-005453-4057qib7	11371	12	with	with	IN
cord-005453-4057qib7	11371	13	post	post	JJ
cord-005453-4057qib7	11371	14	-	-	JJ
cord-005453-4057qib7	11371	15	transplant	transplant	JJ
cord-005453-4057qib7	11371	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	11371	17	in	in	IN
cord-005453-4057qib7	11371	18	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11371	19	allo	allo	NN
cord-005453-4057qib7	11371	20	-	-	HYPH
cord-005453-4057qib7	11371	21	HSCT	HSCT	NNP
cord-005453-4057qib7	11371	22	)	)	-RRB-
cord-005453-4057qib7	11371	23	.	.	.
cord-005453-4057qib7	11372	1	On	on	IN
cord-005453-4057qib7	11372	2	day	day	NN
cord-005453-4057qib7	11372	3	+100	+100	NNS
cord-005453-4057qib7	11372	4	evaluations	evaluation	NNS
cord-005453-4057qib7	11372	5	,	,	,
cord-005453-4057qib7	11372	6	5	5	CD
cord-005453-4057qib7	11372	7	pts	pt	NNS
cord-005453-4057qib7	11372	8	had	have	VBD
cord-005453-4057qib7	11372	9	a	a	DT
cord-005453-4057qib7	11372	10	CR	cr	NN
cord-005453-4057qib7	11372	11	and	and	CC
cord-005453-4057qib7	11372	12	1	1	CD
cord-005453-4057qib7	11372	13	patient	patient	NN
cord-005453-4057qib7	11372	14	(	(	-LRB-
cord-005453-4057qib7	11372	15	pt	pt	NN
cord-005453-4057qib7	11372	16	)	)	-RRB-
cord-005453-4057qib7	11372	17	had	have	VBD
cord-005453-4057qib7	11372	18	DP	dp	NN
cord-005453-4057qib7	11372	19	.	.	.
cord-005453-4057qib7	11373	1	The	the	DT
cord-005453-4057qib7	11373	2	median	median	JJ
cord-005453-4057qib7	11373	3	time	time	NN
cord-005453-4057qib7	11373	4	to	to	TO
cord-005453-4057qib7	11373	5	relapse	relapse	VB
cord-005453-4057qib7	11373	6	after	after	IN
cord-005453-4057qib7	11373	7	allo	allo	NN
cord-005453-4057qib7	11373	8	-	-	HYPH
cord-005453-4057qib7	11373	9	HSCT	HSCT	NNP
cord-005453-4057qib7	11373	10	was	be	VBD
cord-005453-4057qib7	11373	11	of	of	IN
cord-005453-4057qib7	11373	12	12	12	CD
cord-005453-4057qib7	11373	13	months	month	NNS
cord-005453-4057qib7	11373	14	.	.	.
cord-005453-4057qib7	11374	1	At	at	IN
cord-005453-4057qib7	11374	2	the	the	DT
cord-005453-4057qib7	11374	3	time	time	NN
cord-005453-4057qib7	11374	4	of	of	IN
cord-005453-4057qib7	11374	5	initiation	initiation	NN
cord-005453-4057qib7	11374	6	of	of	IN
cord-005453-4057qib7	11374	7	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11374	8	,	,	,
cord-005453-4057qib7	11374	9	5	5	CD
cord-005453-4057qib7	11374	10	pts	pt	NNS
cord-005453-4057qib7	11374	11	were	be	VBD
cord-005453-4057qib7	11374	12	under	under	IN
cord-005453-4057qib7	11374	13	steroid	steroid	NN
cord-005453-4057qib7	11374	14	therapy	therapy	NN
cord-005453-4057qib7	11374	15	for	for	IN
cord-005453-4057qib7	11374	16	disease	disease	NNP
cord-005453-4057qib7	11374	17	control	control	NN
cord-005453-4057qib7	11374	18	,	,	,
cord-005453-4057qib7	11374	19	without	without	IN
cord-005453-4057qib7	11374	20	other	other	JJ
cord-005453-4057qib7	11374	21	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	11374	22	therapy	therapy	NN
cord-005453-4057qib7	11374	23	.	.	.
cord-005453-4057qib7	11375	1	The	the	DT
cord-005453-4057qib7	11375	2	median	median	JJ
cord-005453-4057qib7	11375	3	time	time	NN
cord-005453-4057qib7	11375	4	between	between	IN
cord-005453-4057qib7	11375	5	allo	allo	NN
cord-005453-4057qib7	11375	6	-	-	HYPH
cord-005453-4057qib7	11375	7	HSCT	HSCT	NNP
cord-005453-4057qib7	11375	8	and	and	CC
cord-005453-4057qib7	11375	9	the	the	DT
cord-005453-4057qib7	11375	10	beginning	beginning	NN
cord-005453-4057qib7	11375	11	of	of	IN
cord-005453-4057qib7	11375	12	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11375	13	was	be	VBD
cord-005453-4057qib7	11375	14	16	16	CD
cord-005453-4057qib7	11375	15	months	month	NNS
cord-005453-4057qib7	11375	16	.	.	.
cord-005453-4057qib7	11376	1	The	the	DT
cord-005453-4057qib7	11376	2	initial	initial	JJ
cord-005453-4057qib7	11376	3	dose	dose	NN
cord-005453-4057qib7	11376	4	was	be	VBD
cord-005453-4057qib7	11376	5	1	1	CD
cord-005453-4057qib7	11376	6	mg	mg	NNP
cord-005453-4057qib7	11376	7	/	/	SYM
cord-005453-4057qib7	11376	8	kg	kg	NNP
cord-005453-4057qib7	11376	9	(	(	-LRB-
cord-005453-4057qib7	11376	10	associated	associate	VBN
cord-005453-4057qib7	11376	11	with	with	IN
cord-005453-4057qib7	11376	12	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	11376	13	therapy	therapy	NN
cord-005453-4057qib7	11376	14	)	)	-RRB-
cord-005453-4057qib7	11376	15	,	,	,
cord-005453-4057qib7	11376	16	escalated	escalate	VBD
cord-005453-4057qib7	11376	17	up	up	RP
cord-005453-4057qib7	11376	18	to	to	TO
cord-005453-4057qib7	11376	19	3	3	CD
cord-005453-4057qib7	11376	20	mg	mg	NNP
cord-005453-4057qib7	11376	21	/	/	SYM
cord-005453-4057qib7	11376	22	kg	kg	NNP
cord-005453-4057qib7	11376	23	biweekly	biweekly	NN
cord-005453-4057qib7	11376	24	,	,	,
cord-005453-4057qib7	11376	25	according	accord	VBG
cord-005453-4057qib7	11376	26	to	to	IN
cord-005453-4057qib7	11376	27	patient	patient	NN
cord-005453-4057qib7	11376	28	's	's	POS
cord-005453-4057qib7	11376	29	tolerance	tolerance	NN
cord-005453-4057qib7	11376	30	.	.	.
cord-005453-4057qib7	11377	1	After	after	IN
cord-005453-4057qib7	11377	2	the	the	DT
cord-005453-4057qib7	11377	3	start	start	NN
cord-005453-4057qib7	11377	4	of	of	IN
cord-005453-4057qib7	11377	5	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11377	6	,	,	,
cord-005453-4057qib7	11377	7	3	3	CD
cord-005453-4057qib7	11377	8	patients	patient	NNS
cord-005453-4057qib7	11377	9	,	,	,
cord-005453-4057qib7	11377	10	with	with	IN
cord-005453-4057qib7	11377	11	previous	previous	JJ
cord-005453-4057qib7	11377	12	GvHD	GvHD	NNP
cord-005453-4057qib7	11377	13	manifestations	manifestation	NNS
cord-005453-4057qib7	11377	14	,	,	,
cord-005453-4057qib7	11377	15	presented	present	VBD
cord-005453-4057qib7	11377	16	a	a	DT
cord-005453-4057qib7	11377	17	worsening	worsening	NN
cord-005453-4057qib7	11377	18	of	of	IN
cord-005453-4057qib7	11377	19	the	the	DT
cord-005453-4057qib7	11377	20	cutaneous	cutaneous	JJ
cord-005453-4057qib7	11377	21	GvHD	GvHD	NNP
cord-005453-4057qib7	11377	22	,	,	,
cord-005453-4057qib7	11377	23	which	which	WDT
cord-005453-4057qib7	11377	24	required	require	VBD
cord-005453-4057qib7	11377	25	an	an	DT
cord-005453-4057qib7	11377	26	escalation	escalation	NN
cord-005453-4057qib7	11377	27	of	of	IN
cord-005453-4057qib7	11377	28	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	11377	29	therapy	therapy	NN
cord-005453-4057qib7	11377	30	.	.	.
cord-005453-4057qib7	11378	1	As	as	IN
cord-005453-4057qib7	11378	2	toxicity	toxicity	NN
cord-005453-4057qib7	11378	3	,	,	,
cord-005453-4057qib7	11378	4	1	1	CD
cord-005453-4057qib7	11378	5	pt	pt	NN
cord-005453-4057qib7	11378	6	had	have	VBD
cord-005453-4057qib7	11378	7	a	a	DT
cord-005453-4057qib7	11378	8	grade	grade	NN
cord-005453-4057qib7	11378	9	4	4	CD
cord-005453-4057qib7	11378	10	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	11378	11	,	,	,
cord-005453-4057qib7	11378	12	1	1	CD
cord-005453-4057qib7	11378	13	pt	pt	NN
cord-005453-4057qib7	11378	14	had	have	VBD
cord-005453-4057qib7	11378	15	a	a	DT
cord-005453-4057qib7	11378	16	grade	grade	NN
cord-005453-4057qib7	11378	17	4	4	CD
cord-005453-4057qib7	11378	18	encephalitis	encephalitis	NN
cord-005453-4057qib7	11378	19	/	/	SYM
cord-005453-4057qib7	11378	20	hypophysitis	hypophysitis	NNP
cord-005453-4057qib7	11378	21	,	,	,
cord-005453-4057qib7	11378	22	1	1	CD
cord-005453-4057qib7	11378	23	pt	pt	NN
cord-005453-4057qib7	11378	24	had	have	VBD
cord-005453-4057qib7	11378	25	a	a	DT
cord-005453-4057qib7	11378	26	grade	grade	NN
cord-005453-4057qib7	11378	27	4	4	CD
cord-005453-4057qib7	11378	28	pancreatitis	pancreatitis	NN
cord-005453-4057qib7	11378	29	,	,	,
cord-005453-4057qib7	11378	30	2	2	CD
cord-005453-4057qib7	11378	31	pts	pt	NNS
cord-005453-4057qib7	11378	32	had	have	VBD
cord-005453-4057qib7	11378	33	headache	headache	NN
cord-005453-4057qib7	11378	34	(	(	-LRB-
cord-005453-4057qib7	11378	35	grade	grade	NN
cord-005453-4057qib7	11378	36	1	1	CD
cord-005453-4057qib7	11378	37	and	and	CC
cord-005453-4057qib7	11378	38	3	3	CD
cord-005453-4057qib7	11378	39	)	)	-RRB-
cord-005453-4057qib7	11378	40	,	,	,
cord-005453-4057qib7	11378	41	2	2	CD
cord-005453-4057qib7	11378	42	pts	pt	NNS
cord-005453-4057qib7	11378	43	had	have	VBD
cord-005453-4057qib7	11378	44	a	a	DT
cord-005453-4057qib7	11378	45	grade	grade	NN
cord-005453-4057qib7	11378	46	2	2	CD
cord-005453-4057qib7	11378	47	-	-	SYM
cord-005453-4057qib7	11378	48	3	3	CD
cord-005453-4057qib7	11378	49	cutaneous	cutaneous	JJ
cord-005453-4057qib7	11378	50	reation	reation	NN
cord-005453-4057qib7	11378	51	.	.	.
cord-005453-4057qib7	11379	1	With	with	IN
cord-005453-4057qib7	11379	2	a	a	DT
cord-005453-4057qib7	11379	3	median	median	JJ
cord-005453-4057qib7	11379	4	follow	follow	NN
cord-005453-4057qib7	11379	5	-	-	HYPH
cord-005453-4057qib7	11379	6	up	up	NN
cord-005453-4057qib7	11379	7	of	of	IN
cord-005453-4057qib7	11379	8	13	13	CD
cord-005453-4057qib7	11379	9	months	month	NNS
cord-005453-4057qib7	11379	10	since	since	IN
cord-005453-4057qib7	11379	11	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11379	12	treatment	treatment	NN
cord-005453-4057qib7	11379	13	,	,	,
cord-005453-4057qib7	11379	14	the	the	DT
cord-005453-4057qib7	11379	15	overall	overall	JJ
cord-005453-4057qib7	11379	16	response	response	NN
cord-005453-4057qib7	11379	17	rate	rate	NN
cord-005453-4057qib7	11379	18	was	be	VBD
cord-005453-4057qib7	11379	19	100	100	CD
cord-005453-4057qib7	11379	20	%	%	NN
cord-005453-4057qib7	11379	21	:	:	:
cord-005453-4057qib7	11379	22	1	1	CD
cord-005453-4057qib7	11379	23	pt	pt	NN
cord-005453-4057qib7	11379	24	obtained	obtain	VBD
cord-005453-4057qib7	11379	25	CR	CR	NNP
cord-005453-4057qib7	11379	26	and	and	CC
cord-005453-4057qib7	11379	27	5	5	CD
cord-005453-4057qib7	11379	28	pts	pts	NN
cord-005453-4057qib7	11379	29	partial	partial	JJ
cord-005453-4057qib7	11379	30	remission	remission	NN
cord-005453-4057qib7	11379	31	.	.	.
cord-005453-4057qib7	11380	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	11380	2	,	,	,
cord-005453-4057qib7	11380	3	there	there	EX
cord-005453-4057qib7	11380	4	were	be	VBD
cord-005453-4057qib7	11380	5	2	2	CD
cord-005453-4057qib7	11380	6	deaths	death	NNS
cord-005453-4057qib7	11380	7	after	after	IN
cord-005453-4057qib7	11380	8	the	the	DT
cord-005453-4057qib7	11380	9	onset	onset	NN
cord-005453-4057qib7	11380	10	of	of	IN
cord-005453-4057qib7	11380	11	nivolumab	nivolumab	NNP
cord-005453-4057qib7	11380	12	:	:	:
cord-005453-4057qib7	11380	13	1	1	CD
cord-005453-4057qib7	11380	14	pt	pt	NN
cord-005453-4057qib7	11380	15	at	at	IN
cord-005453-4057qib7	11380	16	4	4	CD
cord-005453-4057qib7	11380	17	monts	mont	NNS
cord-005453-4057qib7	11380	18	with	with	IN
cord-005453-4057qib7	11380	19	DP	DP	NNP
cord-005453-4057qib7	11380	20	and	and	CC
cord-005453-4057qib7	11380	21	another	another	DT
cord-005453-4057qib7	11380	22	one	one	CD
cord-005453-4057qib7	11380	23	due	due	IN
cord-005453-4057qib7	11380	24	to	to	IN
cord-005453-4057qib7	11380	25	acute	acute	JJ
cord-005453-4057qib7	11380	26	myocardial	myocardial	JJ
cord-005453-4057qib7	11380	27	infarction	infarction	NN
cord-005453-4057qib7	11380	28	at	at	IN
cord-005453-4057qib7	11380	29	16	16	CD
cord-005453-4057qib7	11380	30	months	month	NNS
cord-005453-4057qib7	11380	31	.	.	.
cord-005453-4057qib7	11381	1	At	at	IN
cord-005453-4057qib7	11381	2	the	the	DT
cord-005453-4057qib7	11381	3	time	time	NN
cord-005453-4057qib7	11381	4	of	of	IN
cord-005453-4057qib7	11381	5	analysis	analysis	NN
cord-005453-4057qib7	11381	6	,	,	,
cord-005453-4057qib7	11381	7	3	3	CD
cord-005453-4057qib7	11381	8	pts	pt	NNS
cord-005453-4057qib7	11381	9	maintained	maintain	VBD
cord-005453-4057qib7	11381	10	response	response	NN
cord-005453-4057qib7	11381	11	under	under	IN
cord-005453-4057qib7	11381	12	nivolumab	nivolumab	JJ
cord-005453-4057qib7	11381	13	treatment	treatment	NN
cord-005453-4057qib7	11381	14	(	(	-LRB-
cord-005453-4057qib7	11381	15	median	median	JJ
cord-005453-4057qib7	11381	16	cycles	cycle	NNS
cord-005453-4057qib7	11381	17	26	26	CD
cord-005453-4057qib7	11381	18	)	)	-RRB-
cord-005453-4057qib7	11381	19	and	and	CC
cord-005453-4057qib7	11381	20	1	1	CD
cord-005453-4057qib7	11381	21	pt	pt	NN
cord-005453-4057qib7	11381	22	had	have	VBD
cord-005453-4057qib7	11381	23	therapy	therapy	NN
cord-005453-4057qib7	11381	24	suspended	suspend	VBN
cord-005453-4057qib7	11381	25	because	because	IN
cord-005453-4057qib7	11381	26	of	of	IN
cord-005453-4057qib7	11381	27	toxicity	toxicity	NN
cord-005453-4057qib7	11381	28	.	.	.
cord-005453-4057qib7	11382	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11382	2	:	:	:
cord-005453-4057qib7	11383	1	These	these	DT
cord-005453-4057qib7	11383	2	results	result	NNS
cord-005453-4057qib7	11383	3	demonstrate	demonstrate	VBP
cord-005453-4057qib7	11383	4	the	the	DT
cord-005453-4057qib7	11383	5	high	high	JJ
cord-005453-4057qib7	11383	6	probability	probability	NN
cord-005453-4057qib7	11383	7	of	of	IN
cord-005453-4057qib7	11383	8	achieving	achieve	VBG
cord-005453-4057qib7	11383	9	response	response	NN
cord-005453-4057qib7	11383	10	with	with	IN
cord-005453-4057qib7	11383	11	nivolumab	nivolumab	JJ
cord-005453-4057qib7	11383	12	treatment	treatment	NN
cord-005453-4057qib7	11383	13	in	in	IN
cord-005453-4057qib7	11383	14	patients	patient	NNS
cord-005453-4057qib7	11383	15	with	with	IN
cord-005453-4057qib7	11383	16	RR	RR	NNP
cord-005453-4057qib7	11383	17	-	-	HYPH
cord-005453-4057qib7	11383	18	HL	HL	NNP
cord-005453-4057qib7	11383	19	relapsing	relapse	VBG
cord-005453-4057qib7	11383	20	after	after	IN
cord-005453-4057qib7	11383	21	allo	allo	NN
cord-005453-4057qib7	11383	22	-	-	HYPH
cord-005453-4057qib7	11383	23	HSCT	HSCT	NNP
cord-005453-4057qib7	11383	24	,	,	,
cord-005453-4057qib7	11383	25	but	but	CC
cord-005453-4057qib7	11383	26	adverse	adverse	JJ
cord-005453-4057qib7	11383	27	events	event	NNS
cord-005453-4057qib7	11383	28	of	of	IN
cord-005453-4057qib7	11383	29	grade	grade	NN
cord-005453-4057qib7	11383	30	4	4	CD
cord-005453-4057qib7	11383	31	were	be	VBD
cord-005453-4057qib7	11383	32	frequent	frequent	JJ
cord-005453-4057qib7	11383	33	in	in	IN
cord-005453-4057qib7	11383	34	this	this	DT
cord-005453-4057qib7	11383	35	small	small	JJ
cord-005453-4057qib7	11383	36	group	group	NN
cord-005453-4057qib7	11383	37	,	,	,
cord-005453-4057qib7	11383	38	and	and	CC
cord-005453-4057qib7	11383	39	the	the	DT
cord-005453-4057qib7	11383	40	treatment	treatment	NN
cord-005453-4057qib7	11383	41	toxicity	toxicity	NN
cord-005453-4057qib7	11383	42	was	be	VBD
cord-005453-4057qib7	11383	43	significant	significant	JJ
cord-005453-4057qib7	11383	44	.	.	.
cord-005453-4057qib7	11384	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11384	2	:	:	:
cord-005453-4057qib7	11384	3	Nothing	nothing	NN
cord-005453-4057qib7	11384	4	to	to	TO
cord-005453-4057qib7	11384	5	declare	declare	VB
cord-005453-4057qib7	11384	6	Background	background	NN
cord-005453-4057qib7	11384	7	:	:	:
cord-005453-4057qib7	11385	1	Intravascular	Intravascular	VBN
cord-005453-4057qib7	11385	2	large	large	JJ
cord-005453-4057qib7	11385	3	B	b	NN
cord-005453-4057qib7	11385	4	-	-	HYPH
cord-005453-4057qib7	11385	5	cell	cell	NN
cord-005453-4057qib7	11385	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	11385	7	(	(	-LRB-
cord-005453-4057qib7	11385	8	IVLBCL	IVLBCL	NNP
cord-005453-4057qib7	11385	9	)	)	-RRB-
cord-005453-4057qib7	11385	10	is	be	VBZ
cord-005453-4057qib7	11385	11	a	a	DT
cord-005453-4057qib7	11385	12	rare	rare	JJ
cord-005453-4057qib7	11385	13	form	form	NN
cord-005453-4057qib7	11385	14	of	of	IN
cord-005453-4057qib7	11385	15	large	large	JJ
cord-005453-4057qib7	11385	16	B	b	NN
cord-005453-4057qib7	11385	17	-	-	HYPH
cord-005453-4057qib7	11385	18	cell	cell	NN
cord-005453-4057qib7	11385	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	11385	20	with	with	IN
cord-005453-4057qib7	11385	21	pathological	pathological	JJ
cord-005453-4057qib7	11385	22	findings	finding	NNS
cord-005453-4057qib7	11385	23	of	of	IN
cord-005453-4057qib7	11385	24	intravascular	intravascular	JJ
cord-005453-4057qib7	11385	25	proliferation	proliferation	NN
cord-005453-4057qib7	11386	1	and/or	and/or	CC
cord-005453-4057qib7	11386	2	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	11386	3	involvement	involvement	NN
cord-005453-4057qib7	11386	4	of	of	IN
cord-005453-4057qib7	11386	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	11386	6	cells	cell	NNS
cord-005453-4057qib7	11386	7	.	.	.
cord-005453-4057qib7	11387	1	According	accord	VBG
cord-005453-4057qib7	11387	2	to	to	IN
cord-005453-4057qib7	11387	3	their	-PRON-	PRP$
cord-005453-4057qib7	11387	4	geographic	geographic	JJ
cord-005453-4057qib7	11387	5	distribution	distribution	NN
cord-005453-4057qib7	11387	6	,	,	,
cord-005453-4057qib7	11387	7	IVLBCL	IVLBCL	NNP
cord-005453-4057qib7	11387	8	could	could	MD
cord-005453-4057qib7	11387	9	be	be	VB
cord-005453-4057qib7	11387	10	dichotomized	dichotomize	VBN
cord-005453-4057qib7	11387	11	into	into	IN
cord-005453-4057qib7	11387	12	Asian	asian	JJ
cord-005453-4057qib7	11387	13	and	and	CC
cord-005453-4057qib7	11387	14	Western	western	JJ
cord-005453-4057qib7	11387	15	variants	variant	NNS
cord-005453-4057qib7	11387	16	.	.	.
cord-005453-4057qib7	11388	1	Compared	compare	VBN
cord-005453-4057qib7	11388	2	with	with	IN
cord-005453-4057qib7	11388	3	the	the	DT
cord-005453-4057qib7	11388	4	Western	western	JJ
cord-005453-4057qib7	11388	5	variant	variant	NN
cord-005453-4057qib7	11388	6	,	,	,
cord-005453-4057qib7	11388	7	where	where	WRB
cord-005453-4057qib7	11388	8	skin	skin	NN
cord-005453-4057qib7	11388	9	involvement	involvement	NN
cord-005453-4057qib7	11388	10	was	be	VBD
cord-005453-4057qib7	11388	11	common	common	JJ
cord-005453-4057qib7	11388	12	,	,	,
cord-005453-4057qib7	11388	13	the	the	DT
cord-005453-4057qib7	11388	14	Asian	asian	JJ
cord-005453-4057qib7	11388	15	variant	variant	NN
cord-005453-4057qib7	11388	16	was	be	VBD
cord-005453-4057qib7	11388	17	reported	report	VBN
cord-005453-4057qib7	11388	18	to	to	TO
cord-005453-4057qib7	11388	19	involve	involve	VB
cord-005453-4057qib7	11388	20	more	more	JJR
cord-005453-4057qib7	11388	21	frequently	frequently	RB
cord-005453-4057qib7	11388	22	the	the	DT
cord-005453-4057qib7	11388	23	liver	liver	NN
cord-005453-4057qib7	11388	24	,	,	,
cord-005453-4057qib7	11388	25	spleen	spleen	NN
cord-005453-4057qib7	11388	26	and	and	CC
cord-005453-4057qib7	11388	27	bone	bone	NN
cord-005453-4057qib7	11388	28	marrow	marrow	NN
cord-005453-4057qib7	11388	29	,	,	,
cord-005453-4057qib7	11388	30	and	and	CC
cord-005453-4057qib7	11388	31	hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	11388	32	lymphohistiocytosis	lymphohistiocytosis	NNP
cord-005453-4057qib7	11388	33	is	be	VBZ
cord-005453-4057qib7	11388	34	more	more	RBR
cord-005453-4057qib7	11388	35	common	common	JJ
cord-005453-4057qib7	11388	36	in	in	IN
cord-005453-4057qib7	11388	37	Asian	asian	JJ
cord-005453-4057qib7	11388	38	variant	variant	NN
cord-005453-4057qib7	11388	39	.	.	.
cord-005453-4057qib7	11389	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	11389	2	of	of	IN
cord-005453-4057qib7	11389	3	IVLBL	IVLBL	NNP
cord-005453-4057qib7	11389	4	is	be	VBZ
cord-005453-4057qib7	11389	5	still	still	RB
cord-005453-4057qib7	11389	6	difficult	difficult	JJ
cord-005453-4057qib7	11389	7	because	because	IN
cord-005453-4057qib7	11389	8	of	of	IN
cord-005453-4057qib7	11389	9	the	the	DT
cord-005453-4057qib7	11389	10	lack	lack	NN
cord-005453-4057qib7	11389	11	of	of	IN
cord-005453-4057qib7	11389	12	overt	overt	JJ
cord-005453-4057qib7	11389	13	lymphadenopathy	lymphadenopathy	JJ
cord-005453-4057qib7	11389	14	and	and	CC
cord-005453-4057qib7	11389	15	peripheral	peripheral	JJ
cord-005453-4057qib7	11389	16	blood	blood	NN
cord-005453-4057qib7	11389	17	involvement	involvement	NN
cord-005453-4057qib7	11389	18	.	.	.
cord-005453-4057qib7	11390	1	Thus	thus	RB
cord-005453-4057qib7	11390	2	,	,	,
cord-005453-4057qib7	11390	3	timely	timely	RB
cord-005453-4057qib7	11390	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	11390	5	and	and	CC
cord-005453-4057qib7	11390	6	immediate	immediate	JJ
cord-005453-4057qib7	11390	7	treatment	treatment	NN
cord-005453-4057qib7	11390	8	remain	remain	VBP
cord-005453-4057qib7	11390	9	as	as	IN
cord-005453-4057qib7	11390	10	a	a	DT
cord-005453-4057qib7	11390	11	challenge	challenge	NN
cord-005453-4057qib7	11390	12	to	to	TO
cord-005453-4057qib7	11390	13	improve	improve	VB
cord-005453-4057qib7	11390	14	outcomes	outcome	NNS
cord-005453-4057qib7	11390	15	for	for	IN
cord-005453-4057qib7	11390	16	patients	patient	NNS
cord-005453-4057qib7	11390	17	with	with	IN
cord-005453-4057qib7	11390	18	the	the	DT
cord-005453-4057qib7	11390	19	Asian	asian	JJ
cord-005453-4057qib7	11390	20	variant	variant	NN
cord-005453-4057qib7	11390	21	.	.	.
cord-005453-4057qib7	11391	1	Therefore	therefore	RB
cord-005453-4057qib7	11391	2	,	,	,
cord-005453-4057qib7	11391	3	we	-PRON-	PRP
cord-005453-4057qib7	11391	4	analyzed	analyze	VBD
cord-005453-4057qib7	11391	5	the	the	DT
cord-005453-4057qib7	11391	6	clinical	clinical	JJ
cord-005453-4057qib7	11391	7	features	feature	NNS
cord-005453-4057qib7	11391	8	and	and	CC
cord-005453-4057qib7	11391	9	treatment	treatment	NN
cord-005453-4057qib7	11391	10	outcomes	outcome	NNS
cord-005453-4057qib7	11391	11	of	of	IN
cord-005453-4057qib7	11391	12	patients	patient	NNS
cord-005453-4057qib7	11391	13	with	with	IN
cord-005453-4057qib7	11391	14	the	the	DT
cord-005453-4057qib7	11391	15	Asian	asian	JJ
cord-005453-4057qib7	11391	16	variant	variant	NN
cord-005453-4057qib7	11391	17	of	of	IN
cord-005453-4057qib7	11391	18	IVLBCL	IVLBCL	NNP
cord-005453-4057qib7	11391	19	.	.	.
cord-005453-4057qib7	11392	1	Methods	method	NNS
cord-005453-4057qib7	11393	1	:	:	:
cord-005453-4057qib7	11393	2	We	-PRON-	PRP
cord-005453-4057qib7	11393	3	analyzed	analyze	VBD
cord-005453-4057qib7	11393	4	46	46	CD
cord-005453-4057qib7	11393	5	patients	patient	NNS
cord-005453-4057qib7	11393	6	who	who	WP
cord-005453-4057qib7	11393	7	were	be	VBD
cord-005453-4057qib7	11393	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	11393	9	with	with	IN
cord-005453-4057qib7	11393	10	IVLBCL	IVLBCL	NNP
cord-005453-4057qib7	11393	11	between	between	IN
cord-005453-4057qib7	11393	12	2001	2001	CD
cord-005453-4057qib7	11393	13	and	and	CC
cord-005453-4057qib7	11393	14	2018	2018	CD
cord-005453-4057qib7	11393	15	.	.	.
cord-005453-4057qib7	11394	1	All	all	DT
cord-005453-4057qib7	11394	2	patients	patient	NNS
cord-005453-4057qib7	11394	3	were	be	VBD
cord-005453-4057qib7	11394	4	treated	treat	VBN
cord-005453-4057qib7	11394	5	with	with	IN
cord-005453-4057qib7	11394	6	rituximab	rituximab	NN
cord-005453-4057qib7	11394	7	,	,	,
cord-005453-4057qib7	11394	8	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	11394	9	,	,	,
cord-005453-4057qib7	11394	10	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	11394	11	,	,	,
cord-005453-4057qib7	11394	12	vincristine	vincristine	NN
cord-005453-4057qib7	11394	13	,	,	,
cord-005453-4057qib7	11394	14	and	and	CC
cord-005453-4057qib7	11394	15	prednisone	prednisone	NNP
cord-005453-4057qib7	11394	16	(	(	-LRB-
cord-005453-4057qib7	11394	17	R	r	NN
cord-005453-4057qib7	11394	18	-	-	HYPH
cord-005453-4057qib7	11394	19	CHOP	CHOP	NNP
cord-005453-4057qib7	11394	20	)	)	-RRB-
cord-005453-4057qib7	11394	21	.	.	.
cord-005453-4057qib7	11395	1	Results	result	NNS
cord-005453-4057qib7	11395	2	:	:	:
cord-005453-4057qib7	11396	1	Forty	forty	CD
cord-005453-4057qib7	11396	2	-	-	HYPH
cord-005453-4057qib7	11396	3	six	six	CD
cord-005453-4057qib7	11396	4	patients	patient	NNS
cord-005453-4057qib7	11396	5	were	be	VBD
cord-005453-4057qib7	11396	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	11396	7	with	with	IN
cord-005453-4057qib7	11396	8	IVLBCL	IVLBCL	NNP
cord-005453-4057qib7	11396	9	,	,	,
cord-005453-4057qib7	11396	10	and	and	CC
cord-005453-4057qib7	11396	11	their	-PRON-	PRP$
cord-005453-4057qib7	11396	12	median	median	JJ
cord-005453-4057qib7	11396	13	age	age	NN
cord-005453-4057qib7	11396	14	at	at	IN
cord-005453-4057qib7	11396	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	11396	16	was	be	VBD
cord-005453-4057qib7	11396	17	62	62	CD
cord-005453-4057qib7	11396	18	years	year	NNS
cord-005453-4057qib7	11396	19	(	(	-LRB-
cord-005453-4057qib7	11396	20	range	range	NN
cord-005453-4057qib7	11396	21	:	:	:
cord-005453-4057qib7	11396	22	34	34	CD
cord-005453-4057qib7	11396	23	-	-	SYM
cord-005453-4057qib7	11396	24	82	82	CD
cord-005453-4057qib7	11396	25	years	year	NNS
cord-005453-4057qib7	11396	26	)	)	-RRB-
cord-005453-4057qib7	11396	27	.	.	.
cord-005453-4057qib7	11397	1	Male	male	JJ
cord-005453-4057qib7	11397	2	patients	patient	NNS
cord-005453-4057qib7	11397	3	predominated	predominate	VBD
cord-005453-4057qib7	11397	4	(	(	-LRB-
cord-005453-4057qib7	11397	5	n=26	n=26	RB
cord-005453-4057qib7	11397	6	,	,	,
cord-005453-4057qib7	11397	7	57	57	CD
cord-005453-4057qib7	11397	8	%	%	NN
cord-005453-4057qib7	11397	9	)	)	-RRB-
cord-005453-4057qib7	11397	10	,	,	,
cord-005453-4057qib7	11397	11	and	and	CC
cord-005453-4057qib7	11397	12	B	b	NN
cord-005453-4057qib7	11397	13	symptoms	symptom	NNS
cord-005453-4057qib7	11397	14	were	be	VBD
cord-005453-4057qib7	11397	15	present	present	JJ
cord-005453-4057qib7	11397	16	in	in	IN
cord-005453-4057qib7	11397	17	31	31	CD
cord-005453-4057qib7	11397	18	patients	patient	NNS
cord-005453-4057qib7	11397	19	(	(	-LRB-
cord-005453-4057qib7	11397	20	78	78	CD
cord-005453-4057qib7	11397	21	%	%	NN
cord-005453-4057qib7	11397	22	)	)	-RRB-
cord-005453-4057qib7	11397	23	.	.	.
cord-005453-4057qib7	11398	1	Hepatomegaly	Hepatomegaly	NNP
cord-005453-4057qib7	11398	2	and/or	and/or	CC
cord-005453-4057qib7	11398	3	splenomegaly	splenomegaly	NNS
cord-005453-4057qib7	11398	4	were	be	VBD
cord-005453-4057qib7	11398	5	observed	observe	VBN
cord-005453-4057qib7	11398	6	in	in	IN
cord-005453-4057qib7	11398	7	26	26	CD
cord-005453-4057qib7	11398	8	patients	patient	NNS
cord-005453-4057qib7	11398	9	(	(	-LRB-
cord-005453-4057qib7	11398	10	57	57	CD
cord-005453-4057qib7	11398	11	%	%	NN
cord-005453-4057qib7	11398	12	)	)	-RRB-
cord-005453-4057qib7	11398	13	,	,	,
cord-005453-4057qib7	11398	14	whereas	whereas	IN
cord-005453-4057qib7	11398	15	lymphadenopathy	lymphadenopathy	JJ
cord-005453-4057qib7	11398	16	was	be	VBD
cord-005453-4057qib7	11398	17	less	less	RBR
cord-005453-4057qib7	11398	18	common	common	JJ
cord-005453-4057qib7	11398	19	(	(	-LRB-
cord-005453-4057qib7	11398	20	n	n	NN
cord-005453-4057qib7	11398	21	=	=	SYM
cord-005453-4057qib7	11398	22	22	22	CD
cord-005453-4057qib7	11398	23	,	,	,
cord-005453-4057qib7	11398	24	48	48	CD
cord-005453-4057qib7	11398	25	%	%	NN
cord-005453-4057qib7	11398	26	)	)	-RRB-
cord-005453-4057qib7	11398	27	.	.	.
cord-005453-4057qib7	11399	1	Bone	bone	NN
cord-005453-4057qib7	11399	2	marrow	marrow	NN
cord-005453-4057qib7	11399	3	and	and	CC
cord-005453-4057qib7	11399	4	liver	liver	NN
cord-005453-4057qib7	11399	5	were	be	VBD
cord-005453-4057qib7	11399	6	the	the	DT
cord-005453-4057qib7	11399	7	most	most	RBS
cord-005453-4057qib7	11399	8	commonly	commonly	RB
cord-005453-4057qib7	11399	9	involved	involve	VBN
cord-005453-4057qib7	11399	10	extranodal	extranodal	JJ
cord-005453-4057qib7	11399	11	organs	organ	NNS
cord-005453-4057qib7	11399	12	(	(	-LRB-
cord-005453-4057qib7	11399	13	54	54	CD
cord-005453-4057qib7	11399	14	%	%	NN
cord-005453-4057qib7	11399	15	,	,	,
cord-005453-4057qib7	11399	16	and	and	CC
cord-005453-4057qib7	11399	17	48	48	CD
cord-005453-4057qib7	11399	18	%	%	NN
cord-005453-4057qib7	11399	19	,	,	,
cord-005453-4057qib7	11399	20	respectively	respectively	RB
cord-005453-4057qib7	11399	21	)	)	-RRB-
cord-005453-4057qib7	11399	22	and	and	CC
cord-005453-4057qib7	11399	23	were	be	VBD
cord-005453-4057qib7	11399	24	the	the	DT
cord-005453-4057qib7	11399	25	most	most	RBS
cord-005453-4057qib7	11399	26	common	common	JJ
cord-005453-4057qib7	11399	27	sites	site	NNS
cord-005453-4057qib7	11399	28	of	of	IN
cord-005453-4057qib7	11399	29	biopsy	biopsy	NN
cord-005453-4057qib7	11399	30	for	for	IN
cord-005453-4057qib7	11399	31	diagnosis	diagnosis	NN
cord-005453-4057qib7	11399	32	in	in	IN
cord-005453-4057qib7	11399	33	this	this	DT
cord-005453-4057qib7	11399	34	study	study	NN
cord-005453-4057qib7	11399	35	.	.	.
cord-005453-4057qib7	11400	1	All	all	DT
cord-005453-4057qib7	11400	2	patients	patient	NNS
cord-005453-4057qib7	11400	3	received	receive	VBD
cord-005453-4057qib7	11400	4	R	r	NN
cord-005453-4057qib7	11400	5	-	-	HYPH
cord-005453-4057qib7	11400	6	CHOP	chop	NN
cord-005453-4057qib7	11400	7	as	as	IN
cord-005453-4057qib7	11400	8	a	a	DT
cord-005453-4057qib7	11400	9	first	first	JJ
cord-005453-4057qib7	11400	10	-	-	HYPH
cord-005453-4057qib7	11400	11	line	line	NN
cord-005453-4057qib7	11400	12	treatment	treatment	NN
cord-005453-4057qib7	11400	13	after	after	IN
cord-005453-4057qib7	11400	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	11400	15	with	with	IN
cord-005453-4057qib7	11400	16	a	a	DT
cord-005453-4057qib7	11400	17	median	median	JJ
cord-005453-4057qib7	11400	18	number	number	NN
cord-005453-4057qib7	11400	19	of	of	IN
cord-005453-4057qib7	11400	20	six	six	CD
cord-005453-4057qib7	11400	21	cycles	cycle	NNS
cord-005453-4057qib7	11400	22	(	(	-LRB-
cord-005453-4057qib7	11400	23	range	range	VBP
cord-005453-4057qib7	11400	24	one	one	CD
cord-005453-4057qib7	11400	25	to	to	IN
cord-005453-4057qib7	11400	26	eight	eight	CD
cord-005453-4057qib7	11400	27	)	)	-RRB-
cord-005453-4057qib7	11400	28	.	.	.
cord-005453-4057qib7	11401	1	At	at	IN
cord-005453-4057qib7	11401	2	the	the	DT
cord-005453-4057qib7	11401	3	end	end	NN
cord-005453-4057qib7	11401	4	of	of	IN
cord-005453-4057qib7	11401	5	treatment	treatment	NN
cord-005453-4057qib7	11401	6	,	,	,
cord-005453-4057qib7	11401	7	31	31	CD
cord-005453-4057qib7	11401	8	patients	patient	NNS
cord-005453-4057qib7	11401	9	achieved	achieve	VBD
cord-005453-4057qib7	11401	10	a	a	DT
cord-005453-4057qib7	11401	11	complete	complete	JJ
cord-005453-4057qib7	11401	12	response	response	NN
cord-005453-4057qib7	11401	13	(	(	-LRB-
cord-005453-4057qib7	11401	14	CR	CR	NNP
cord-005453-4057qib7	11401	15	)	)	-RRB-
cord-005453-4057qib7	11401	16	,	,	,
cord-005453-4057qib7	11401	17	whereas	whereas	IN
cord-005453-4057qib7	11401	18	eight	eight	CD
cord-005453-4057qib7	11401	19	patients	patient	NNS
cord-005453-4057qib7	11401	20	showed	show	VBD
cord-005453-4057qib7	11401	21	progression	progression	NN
cord-005453-4057qib7	11401	22	.	.	.
cord-005453-4057qib7	11402	1	Six	six	CD
cord-005453-4057qib7	11402	2	patients	patient	NNS
cord-005453-4057qib7	11402	3	died	die	VBD
cord-005453-4057qib7	11402	4	after	after	IN
cord-005453-4057qib7	11402	5	the	the	DT
cord-005453-4057qib7	11402	6	first	first	JJ
cord-005453-4057qib7	11402	7	or	or	CC
cord-005453-4057qib7	11402	8	second	second	JJ
cord-005453-4057qib7	11402	9	cycle	cycle	NN
cord-005453-4057qib7	11402	10	of	of	IN
cord-005453-4057qib7	11402	11	R	r	NN
cord-005453-4057qib7	11402	12	-	-	HYPH
cord-005453-4057qib7	11402	13	CHOP	chop	NN
cord-005453-4057qib7	11402	14	,	,	,
cord-005453-4057qib7	11402	15	and	and	CC
cord-005453-4057qib7	11402	16	the	the	DT
cord-005453-4057qib7	11402	17	causes	cause	NNS
cord-005453-4057qib7	11402	18	of	of	IN
cord-005453-4057qib7	11402	19	death	death	NN
cord-005453-4057qib7	11402	20	were	be	VBD
cord-005453-4057qib7	11402	21	treatment	treatment	NN
cord-005453-4057qib7	11402	22	-	-	HYPH
cord-005453-4057qib7	11402	23	related	relate	VBN
cord-005453-4057qib7	11402	24	adverse	adverse	JJ
cord-005453-4057qib7	11402	25	events	event	NNS
cord-005453-4057qib7	11402	26	including	include	VBG
cord-005453-4057qib7	11402	27	cytopenia	cytopenia	NNP
cord-005453-4057qib7	11402	28	,	,	,
cord-005453-4057qib7	11402	29	infectious	infectious	JJ
cord-005453-4057qib7	11402	30	complications	complication	NNS
cord-005453-4057qib7	11402	31	,	,	,
cord-005453-4057qib7	11402	32	and	and	CC
cord-005453-4057qib7	11402	33	pulmonary	pulmonary	JJ
cord-005453-4057qib7	11402	34	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	11402	35	.	.	.
cord-005453-4057qib7	11403	1	Upfront	Upfront	NNP
cord-005453-4057qib7	11403	2	ASCT	ASCT	NNP
cord-005453-4057qib7	11403	3	was	be	VBD
cord-005453-4057qib7	11403	4	done	do	VBN
cord-005453-4057qib7	11403	5	for	for	IN
cord-005453-4057qib7	11403	6	two	two	CD
cord-005453-4057qib7	11403	7	patients	patient	NNS
cord-005453-4057qib7	11403	8	including	include	VBG
cord-005453-4057qib7	11403	9	one	one	CD
cord-005453-4057qib7	11403	10	patient	patient	NN
cord-005453-4057qib7	11403	11	with	with	IN
cord-005453-4057qib7	11403	12	CNS	CNS	NNP
cord-005453-4057qib7	11403	13	involvement	involvement	NN
cord-005453-4057qib7	11403	14	at	at	IN
cord-005453-4057qib7	11403	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	11403	16	,	,	,
cord-005453-4057qib7	11403	17	and	and	CC
cord-005453-4057qib7	11403	18	these	these	DT
cord-005453-4057qib7	11403	19	patients	patient	NNS
cord-005453-4057qib7	11403	20	were	be	VBD
cord-005453-4057qib7	11403	21	still	still	RB
cord-005453-4057qib7	11403	22	alive	alive	JJ
cord-005453-4057qib7	11403	23	at	at	IN
cord-005453-4057qib7	11403	24	the	the	DT
cord-005453-4057qib7	11403	25	time	time	NN
cord-005453-4057qib7	11403	26	of	of	IN
cord-005453-4057qib7	11403	27	analysis	analysis	NN
cord-005453-4057qib7	11403	28	without	without	IN
cord-005453-4057qib7	11403	29	evidence	evidence	NN
cord-005453-4057qib7	11403	30	of	of	IN
cord-005453-4057qib7	11403	31	relapse	relapse	NN
cord-005453-4057qib7	11403	32	.	.	.
cord-005453-4057qib7	11404	1	On	on	IN
cord-005453-4057qib7	11404	2	the	the	DT
cord-005453-4057qib7	11404	3	other	other	JJ
cord-005453-4057qib7	11404	4	hand	hand	NN
cord-005453-4057qib7	11404	5	,	,	,
cord-005453-4057qib7	11404	6	the	the	DT
cord-005453-4057qib7	11404	7	outcome	outcome	NN
cord-005453-4057qib7	11404	8	of	of	IN
cord-005453-4057qib7	11404	9	six	six	CD
cord-005453-4057qib7	11404	10	patients	patient	NNS
cord-005453-4057qib7	11404	11	undergoing	undergo	VBG
cord-005453-4057qib7	11404	12	salvage	salvage	NN
cord-005453-4057qib7	11404	13	ASCT	ASCT	NNP
cord-005453-4057qib7	11404	14	after	after	IN
cord-005453-4057qib7	11404	15	relapse	relapse	NN
cord-005453-4057qib7	11404	16	was	be	VBD
cord-005453-4057qib7	11404	17	poor	poor	JJ
cord-005453-4057qib7	11404	18	;	;	:
cord-005453-4057qib7	11404	19	thus	thus	RB
cord-005453-4057qib7	11404	20	,	,	,
cord-005453-4057qib7	11404	21	only	only	RB
cord-005453-4057qib7	11404	22	one	one	CD
cord-005453-4057qib7	11404	23	patient	patient	NN
cord-005453-4057qib7	11404	24	was	be	VBD
cord-005453-4057qib7	11404	25	alive	alive	JJ
cord-005453-4057qib7	11404	26	.	.	.
cord-005453-4057qib7	11405	1	Likewise	likewise	RB
cord-005453-4057qib7	11405	2	,	,	,
cord-005453-4057qib7	11405	3	patients	patient	NNS
cord-005453-4057qib7	11405	4	with	with	IN
cord-005453-4057qib7	11405	5	disease	disease	NN
cord-005453-4057qib7	11405	6	progression	progression	NN
cord-005453-4057qib7	11405	7	at	at	IN
cord-005453-4057qib7	11405	8	the	the	DT
cord-005453-4057qib7	11405	9	end	end	NN
cord-005453-4057qib7	11405	10	of	of	IN
cord-005453-4057qib7	11405	11	treatment	treatment	NN
cord-005453-4057qib7	11405	12	with	with	IN
cord-005453-4057qib7	11405	13	R	r	NN
cord-005453-4057qib7	11405	14	-	-	HYPH
cord-005453-4057qib7	11405	15	CHOP	CHOP	NNP
cord-005453-4057qib7	11405	16	showed	show	VBD
cord-005453-4057qib7	11405	17	dismal	dismal	JJ
cord-005453-4057qib7	11405	18	prognoses	prognosis	NNS
cord-005453-4057qib7	11405	19	even	even	RB
cord-005453-4057qib7	11405	20	after	after	IN
cord-005453-4057qib7	11405	21	salvage	salvage	NN
cord-005453-4057qib7	11405	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11405	23	except	except	IN
cord-005453-4057qib7	11405	24	for	for	IN
cord-005453-4057qib7	11405	25	one	one	CD
cord-005453-4057qib7	11405	26	.	.	.
cord-005453-4057qib7	11406	1	At	at	IN
cord-005453-4057qib7	11406	2	a	a	DT
cord-005453-4057qib7	11406	3	median	median	JJ
cord-005453-4057qib7	11406	4	follow	follow	NN
cord-005453-4057qib7	11406	5	-	-	HYPH
cord-005453-4057qib7	11406	6	up	up	NN
cord-005453-4057qib7	11406	7	of	of	IN
cord-005453-4057qib7	11406	8	47.0	47.0	CD
cord-005453-4057qib7	11406	9	months	month	NNS
cord-005453-4057qib7	11406	10	(	(	-LRB-
cord-005453-4057qib7	11406	11	95	95	CD
cord-005453-4057qib7	11406	12	%	%	NN
cord-005453-4057qib7	11406	13	confidence	confidence	NN
cord-005453-4057qib7	11406	14	interval	interval	NN
cord-005453-4057qib7	11406	15	,	,	,
cord-005453-4057qib7	11406	16	CI	CI	NNP
cord-005453-4057qib7	11406	17	25.0	25.0	CD
cord-005453-4057qib7	11406	18	-	-	HYPH
cord-005453-4057qib7	11406	19	69.0	69.0	CD
cord-005453-4057qib7	11406	20	)	)	-RRB-
cord-005453-4057qib7	11406	21	,	,	,
cord-005453-4057qib7	11406	22	the	the	DT
cord-005453-4057qib7	11406	23	median	median	JJ
cord-005453-4057qib7	11406	24	overall	overall	JJ
cord-005453-4057qib7	11406	25	survival	survival	NN
cord-005453-4057qib7	11406	26	was	be	VBD
cord-005453-4057qib7	11406	27	45.0	45.0	CD
cord-005453-4057qib7	11406	28	months	month	NNS
cord-005453-4057qib7	11406	29	(	(	-LRB-
cord-005453-4057qib7	11406	30	95	95	CD
cord-005453-4057qib7	11406	31	%	%	NN
cord-005453-4057qib7	11406	32	CI	CI	NNP
cord-005453-4057qib7	11406	33	25.8	25.8	CD
cord-005453-4057qib7	11406	34	-	-	HYPH
cord-005453-4057qib7	11406	35	64.2	64.2	CD
cord-005453-4057qib7	11406	36	)	)	-RRB-
cord-005453-4057qib7	11406	37	.	.	.
cord-005453-4057qib7	11407	1	The	the	DT
cord-005453-4057qib7	11407	2	treatment	treatment	NN
cord-005453-4057qib7	11407	3	outcome	outcome	NN
cord-005453-4057qib7	11407	4	of	of	IN
cord-005453-4057qib7	11407	5	patients	patient	NNS
cord-005453-4057qib7	11407	6	with	with	IN
cord-005453-4057qib7	11407	7	the	the	DT
cord-005453-4057qib7	11407	8	Asian	asian	JJ
cord-005453-4057qib7	11407	9	variant	variant	NN
cord-005453-4057qib7	11407	10	of	of	IN
cord-005453-4057qib7	11407	11	IVLBCL	IVLBCL	NNP
cord-005453-4057qib7	11407	12	is	be	VBZ
cord-005453-4057qib7	11407	13	still	still	RB
cord-005453-4057qib7	11407	14	not	not	RB
cord-005453-4057qib7	11407	15	satisfactory	satisfactory	JJ
cord-005453-4057qib7	11407	16	.	.	.
cord-005453-4057qib7	11408	1	Although	although	IN
cord-005453-4057qib7	11408	2	upfront	upfront	JJ
cord-005453-4057qib7	11408	3	autologous	autologous	JJ
cord-005453-4057qib7	11408	4	stem	stem	NN
cord-005453-4057qib7	11408	5	cell	cell	NN
cord-005453-4057qib7	11408	6	transplantation	transplantation	NN
cord-005453-4057qib7	11408	7	might	may	MD
cord-005453-4057qib7	11408	8	be	be	VB
cord-005453-4057qib7	11408	9	effective	effective	JJ
cord-005453-4057qib7	11408	10	for	for	IN
cord-005453-4057qib7	11408	11	selected	select	VBN
cord-005453-4057qib7	11408	12	patients	patient	NNS
cord-005453-4057qib7	11408	13	at	at	IN
cord-005453-4057qib7	11408	14	high	high	JJ
cord-005453-4057qib7	11408	15	-	-	HYPH
cord-005453-4057qib7	11408	16	risk	risk	NN
cord-005453-4057qib7	11408	17	of	of	IN
cord-005453-4057qib7	11408	18	relapse	relapse	NN
cord-005453-4057qib7	11408	19	,	,	,
cord-005453-4057qib7	11408	20	its	-PRON-	PRP$
cord-005453-4057qib7	11408	21	role	role	NN
cord-005453-4057qib7	11408	22	is	be	VBZ
cord-005453-4057qib7	11408	23	still	still	RB
cord-005453-4057qib7	11408	24	not	not	RB
cord-005453-4057qib7	11408	25	clear	clear	JJ
cord-005453-4057qib7	11408	26	,	,	,
cord-005453-4057qib7	11408	27	either	either	RB
cord-005453-4057qib7	11408	28	.	.	.
cord-005453-4057qib7	11409	1	Thus	thus	RB
cord-005453-4057qib7	11409	2	,	,	,
cord-005453-4057qib7	11409	3	further	further	JJ
cord-005453-4057qib7	11409	4	study	study	NN
cord-005453-4057qib7	11409	5	should	should	MD
cord-005453-4057qib7	11409	6	be	be	VB
cord-005453-4057qib7	11409	7	warranted	warrant	VBN
cord-005453-4057qib7	11409	8	to	to	TO
cord-005453-4057qib7	11409	9	develop	develop	VB
cord-005453-4057qib7	11409	10	more	more	JJR
cord-005453-4057qib7	11409	11	effective	effective	JJ
cord-005453-4057qib7	11409	12	strategies	strategy	NNS
cord-005453-4057qib7	11409	13	for	for	IN
cord-005453-4057qib7	11409	14	diagnosis	diagnosis	NN
cord-005453-4057qib7	11409	15	and	and	CC
cord-005453-4057qib7	11409	16	treatment	treatment	NN
cord-005453-4057qib7	11409	17	.	.	.
cord-005453-4057qib7	11410	1	Clinical	clinical	JJ
cord-005453-4057qib7	11410	2	Trial	Trial	NNP
cord-005453-4057qib7	11410	3	Registry	Registry	NNP
cord-005453-4057qib7	11410	4	:	:	:
cord-005453-4057qib7	11411	1	Not	not	RB
cord-005453-4057qib7	11411	2	applicable	applicable	JJ
cord-005453-4057qib7	11411	3	Disclosure	disclosure	NN
cord-005453-4057qib7	11411	4	:	:	:
cord-005453-4057qib7	11411	5	Nothing	nothing	NN
cord-005453-4057qib7	11411	6	to	to	TO
cord-005453-4057qib7	11411	7	disclare	disclare	VB
cord-005453-4057qib7	11411	8	 	 	_SP
cord-005453-4057qib7	11411	9	Background	Background	NNP
cord-005453-4057qib7	11411	10	:	:	:
cord-005453-4057qib7	11411	11	Peripheral	Peripheral	NNP
cord-005453-4057qib7	11411	12	T	t	NN
cord-005453-4057qib7	11411	13	-	-	HYPH
cord-005453-4057qib7	11411	14	cell	cell	NN
cord-005453-4057qib7	11411	15	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11411	16	(	(	-LRB-
cord-005453-4057qib7	11411	17	PTCLs	ptcl	NNS
cord-005453-4057qib7	11411	18	)	)	-RRB-
cord-005453-4057qib7	11411	19	are	be	VBP
cord-005453-4057qib7	11411	20	about	about	RB
cord-005453-4057qib7	11411	21	10	10	CD
cord-005453-4057qib7	11411	22	%	%	NN
cord-005453-4057qib7	11411	23	of	of	IN
cord-005453-4057qib7	11411	24	non	non	JJ
cord-005453-4057qib7	11411	25	-	-	JJ
cord-005453-4057qib7	11411	26	Hodgkin´s	hodgkin´s	JJ
cord-005453-4057qib7	11411	27	lymphomas	lymphoma	NNS
cord-005453-4057qib7	11411	28	usually	usually	RB
cord-005453-4057qib7	11411	29	with	with	IN
cord-005453-4057qib7	11411	30	an	an	DT
cord-005453-4057qib7	11411	31	aggressive	aggressive	JJ
cord-005453-4057qib7	11411	32	clinical	clinical	JJ
cord-005453-4057qib7	11411	33	course	course	NN
cord-005453-4057qib7	11411	34	and	and	CC
cord-005453-4057qib7	11411	35	unfavorable	unfavorable	JJ
cord-005453-4057qib7	11411	36	prognosis	prognosis	NN
cord-005453-4057qib7	11411	37	.	.	.
cord-005453-4057qib7	11412	1	Given	give	VBN
cord-005453-4057qib7	11412	2	their	-PRON-	PRP$
cord-005453-4057qib7	11412	3	heterogeneity	heterogeneity	NN
cord-005453-4057qib7	11412	4	,	,	,
cord-005453-4057qib7	11412	5	consensus	consensus	NN
cord-005453-4057qib7	11412	6	on	on	IN
cord-005453-4057qib7	11412	7	the	the	DT
cord-005453-4057qib7	11412	8	best	good	JJS
cord-005453-4057qib7	11412	9	first	first	JJ
cord-005453-4057qib7	11412	10	-	-	HYPH
cord-005453-4057qib7	11412	11	line	line	NN
cord-005453-4057qib7	11412	12	treatment	treatment	NN
cord-005453-4057qib7	11412	13	and	and	CC
cord-005453-4057qib7	11412	14	the	the	DT
cord-005453-4057qib7	11412	15	role	role	NN
cord-005453-4057qib7	11412	16	of	of	IN
cord-005453-4057qib7	11412	17	autologous	autologous	JJ
cord-005453-4057qib7	11412	18	/	/	SYM
cord-005453-4057qib7	11412	19	allogeneic	allogeneic	IN
cord-005453-4057qib7	11412	20	(	(	-LRB-
cord-005453-4057qib7	11412	21	ASCT	ASCT	NNP
cord-005453-4057qib7	11412	22	/	/	SYM
cord-005453-4057qib7	11412	23	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11412	24	)	)	-RRB-
cord-005453-4057qib7	11412	25	stem	stem	NN
cord-005453-4057qib7	11412	26	cell	cell	NN
cord-005453-4057qib7	11412	27	transplantation	transplantation	NN
cord-005453-4057qib7	11412	28	as	as	IN
cord-005453-4057qib7	11412	29	consolidation	consolidation	NN
cord-005453-4057qib7	11412	30	is	be	VBZ
cord-005453-4057qib7	11412	31	controversial	controversial	JJ
cord-005453-4057qib7	11412	32	.	.	.
cord-005453-4057qib7	11413	1	Methods	method	NNS
cord-005453-4057qib7	11413	2	:	:	:
cord-005453-4057qib7	11414	1	We	-PRON-	PRP
cord-005453-4057qib7	11414	2	evaluated	evaluate	VBD
cord-005453-4057qib7	11414	3	the	the	DT
cord-005453-4057qib7	11414	4	overall	overall	JJ
cord-005453-4057qib7	11414	5	survival	survival	NN
cord-005453-4057qib7	11414	6	(	(	-LRB-
cord-005453-4057qib7	11414	7	OS	OS	NNP
cord-005453-4057qib7	11414	8	)	)	-RRB-
cord-005453-4057qib7	11414	9	,	,	,
cord-005453-4057qib7	11414	10	progression	progression	NN
cord-005453-4057qib7	11414	11	-	-	HYPH
cord-005453-4057qib7	11414	12	free	free	JJ
cord-005453-4057qib7	11414	13	survival	survival	NN
cord-005453-4057qib7	11414	14	(	(	-LRB-
cord-005453-4057qib7	11414	15	PFS	PFS	NNP
cord-005453-4057qib7	11414	16	)	)	-RRB-
cord-005453-4057qib7	11414	17	and	and	CC
cord-005453-4057qib7	11414	18	toxicities	toxicity	NNS
cord-005453-4057qib7	11414	19	of	of	IN
cord-005453-4057qib7	11414	20	a	a	DT
cord-005453-4057qib7	11414	21	cohort	cohort	NN
cord-005453-4057qib7	11414	22	of	of	IN
cord-005453-4057qib7	11414	23	patients	patient	NNS
cord-005453-4057qib7	11414	24	with	with	IN
cord-005453-4057qib7	11414	25	PTCLs	ptcl	NNS
cord-005453-4057qib7	11414	26	submitted	submit	VBN
cord-005453-4057qib7	11414	27	to	to	IN
cord-005453-4057qib7	11414	28	ASCT	ASCT	NNP
cord-005453-4057qib7	11414	29	/	/	SYM
cord-005453-4057qib7	11414	30	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11414	31	intensification	intensification	NN
cord-005453-4057qib7	11414	32	at	at	IN
cord-005453-4057qib7	11414	33	our	-PRON-	PRP$
cord-005453-4057qib7	11414	34	institution	institution	NN
cord-005453-4057qib7	11414	35	between	between	IN
cord-005453-4057qib7	11414	36	January	January	NNP
cord-005453-4057qib7	11414	37	2000	2000	CD
cord-005453-4057qib7	11414	38	and	and	CC
cord-005453-4057qib7	11414	39	July	July	NNP
cord-005453-4057qib7	11414	40	2018	2018	CD
cord-005453-4057qib7	11414	41	.	.	.
cord-005453-4057qib7	11415	1	OS	OS	NNP
cord-005453-4057qib7	11415	2	was	be	VBD
cord-005453-4057qib7	11415	3	calculated	calculate	VBN
cord-005453-4057qib7	11415	4	from	from	IN
cord-005453-4057qib7	11415	5	the	the	DT
cord-005453-4057qib7	11415	6	date	date	NN
cord-005453-4057qib7	11415	7	of	of	IN
cord-005453-4057qib7	11415	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	11415	9	until	until	IN
cord-005453-4057qib7	11415	10	death	death	NN
cord-005453-4057qib7	11415	11	.	.	.
cord-005453-4057qib7	11416	1	PFS	PFS	NNP
cord-005453-4057qib7	11416	2	was	be	VBD
cord-005453-4057qib7	11416	3	measured	measure	VBN
cord-005453-4057qib7	11416	4	from	from	IN
cord-005453-4057qib7	11416	5	transplant	transplant	NN
cord-005453-4057qib7	11416	6	until	until	IN
cord-005453-4057qib7	11416	7	relapse	relapse	NN
cord-005453-4057qib7	11416	8	,	,	,
cord-005453-4057qib7	11416	9	progressive	progressive	JJ
cord-005453-4057qib7	11416	10	disease	disease	NN
cord-005453-4057qib7	11416	11	or	or	CC
cord-005453-4057qib7	11416	12	last	last	JJ
cord-005453-4057qib7	11416	13	follow	follow	NN
cord-005453-4057qib7	11416	14	-	-	HYPH
cord-005453-4057qib7	11416	15	up	up	NN
cord-005453-4057qib7	11416	16	.	.	.
cord-005453-4057qib7	11417	1	OS	OS	NNP
cord-005453-4057qib7	11417	2	and	and	CC
cord-005453-4057qib7	11417	3	PFS	PFS	NNP
cord-005453-4057qib7	11417	4	rates	rate	NNS
cord-005453-4057qib7	11417	5	were	be	VBD
cord-005453-4057qib7	11417	6	estimated	estimate	VBN
cord-005453-4057qib7	11417	7	using	use	VBG
cord-005453-4057qib7	11417	8	the	the	DT
cord-005453-4057qib7	11417	9	Kaplan	Kaplan	NNP
cord-005453-4057qib7	11417	10	-	-	HYPH
cord-005453-4057qib7	11417	11	Meier	Meier	NNP
cord-005453-4057qib7	11417	12	method	method	NN
cord-005453-4057qib7	11417	13	and	and	CC
cord-005453-4057qib7	11417	14	compared	compare	VBN
cord-005453-4057qib7	11417	15	with	with	IN
cord-005453-4057qib7	11417	16	the	the	DT
cord-005453-4057qib7	11417	17	Log	Log	NNP
cord-005453-4057qib7	11417	18	-	-	HYPH
cord-005453-4057qib7	11417	19	Rank	Rank	NNP
cord-005453-4057qib7	11417	20	test	test	NN
cord-005453-4057qib7	11417	21	.	.	.
cord-005453-4057qib7	11418	1	Results	result	NNS
cord-005453-4057qib7	11418	2	:	:	:
cord-005453-4057qib7	11419	1	Twenty	twenty	CD
cord-005453-4057qib7	11419	2	-	-	HYPH
cord-005453-4057qib7	11419	3	six	six	CD
cord-005453-4057qib7	11419	4	patients	patient	NNS
cord-005453-4057qib7	11419	5	were	be	VBD
cord-005453-4057qib7	11419	6	identified	identify	VBN
cord-005453-4057qib7	11419	7	,	,	,
cord-005453-4057qib7	11419	8	16	16	CD
cord-005453-4057qib7	11419	9	female	female	JJ
cord-005453-4057qib7	11419	10	(	(	-LRB-
cord-005453-4057qib7	11419	11	61	61	CD
cord-005453-4057qib7	11419	12	%	%	NN
cord-005453-4057qib7	11419	13	)	)	-RRB-
cord-005453-4057qib7	11419	14	,	,	,
cord-005453-4057qib7	11419	15	median	median	JJ
cord-005453-4057qib7	11419	16	age	age	NN
cord-005453-4057qib7	11419	17	was	be	VBD
cord-005453-4057qib7	11419	18	46	46	CD
cord-005453-4057qib7	11419	19	years	year	NNS
cord-005453-4057qib7	11420	1	(	(	-LRB-
cord-005453-4057qib7	11420	2	range	range	NN
cord-005453-4057qib7	11420	3	:	:	:
cord-005453-4057qib7	11420	4	22	22	CD
cord-005453-4057qib7	11420	5	to	to	IN
cord-005453-4057qib7	11420	6	62	62	CD
cord-005453-4057qib7	11420	7	)	)	-RRB-
cord-005453-4057qib7	11420	8	.	.	.
cord-005453-4057qib7	11421	1	Ninetytwo	Ninetytwo	NNP
cord-005453-4057qib7	11421	2	percent	percent	NN
cord-005453-4057qib7	11421	3	of	of	IN
cord-005453-4057qib7	11421	4	patients	patient	NNS
cord-005453-4057qib7	11421	5	presented	present	VBN
cord-005453-4057qib7	11421	6	with	with	IN
cord-005453-4057qib7	11421	7	advanced	advanced	JJ
cord-005453-4057qib7	11421	8	-	-	HYPH
cord-005453-4057qib7	11421	9	stage	stage	NN
cord-005453-4057qib7	11421	10	disease	disease	NN
cord-005453-4057qib7	11421	11	at	at	IN
cord-005453-4057qib7	11421	12	diagnosis	diagnosis	NN
cord-005453-4057qib7	11421	13	(	(	-LRB-
cord-005453-4057qib7	11421	14	Ann	Ann	NNP
cord-005453-4057qib7	11421	15	Arbor	Arbor	NNP
cord-005453-4057qib7	11421	16	stage	stage	NN
cord-005453-4057qib7	11421	17	III	III	NNP
cord-005453-4057qib7	11421	18	or	or	CC
cord-005453-4057qib7	11421	19	IV	IV	NNP
cord-005453-4057qib7	11421	20	)	)	-RRB-
cord-005453-4057qib7	11421	21	,	,	,
cord-005453-4057qib7	11421	22	38	38	CD
cord-005453-4057qib7	11421	23	%	%	NN
cord-005453-4057qib7	11421	24	with	with	IN
cord-005453-4057qib7	11421	25	B	b	NN
cord-005453-4057qib7	11421	26	symptoms	symptom	NNS
cord-005453-4057qib7	11421	27	.	.	.
cord-005453-4057qib7	11422	1	According	accord	VBG
cord-005453-4057qib7	11422	2	to	to	IN
cord-005453-4057qib7	11422	3	the	the	DT
cord-005453-4057qib7	11422	4	2016	2016	CD
cord-005453-4057qib7	11422	5	WHO	who	WP
cord-005453-4057qib7	11422	6	classification	classification	NN
cord-005453-4057qib7	11422	7	,	,	,
cord-005453-4057qib7	11422	8	histologic	histologic	JJ
cord-005453-4057qib7	11422	9	PTCL	PTCL	NNS
cord-005453-4057qib7	11422	10	subtypes	subtype	NNS
cord-005453-4057qib7	11422	11	included	include	VBN
cord-005453-4057qib7	11422	12	angioimmunoblastic	angioimmunoblastic	JJ
cord-005453-4057qib7	11422	13	Tcell	Tcell	NNP
cord-005453-4057qib7	11422	14	lymphoma	lymphoma	NN
cord-005453-4057qib7	11422	15	(	(	-LRB-
cord-005453-4057qib7	11422	16	n	n	NN
cord-005453-4057qib7	11422	17	=	=	SYM
cord-005453-4057qib7	11422	18	12	12	CD
cord-005453-4057qib7	11422	19	)	)	-RRB-
cord-005453-4057qib7	11422	20	;	;	:
cord-005453-4057qib7	11422	21	PTCL	PTCL	NNP
cord-005453-4057qib7	11422	22	not	not	RB
cord-005453-4057qib7	11422	23	otherwise	otherwise	RB
cord-005453-4057qib7	11422	24	specified	specify	VBN
cord-005453-4057qib7	11422	25	(	(	-LRB-
cord-005453-4057qib7	11422	26	n	n	NN
cord-005453-4057qib7	11422	27	=	=	SYM
cord-005453-4057qib7	11422	28	6	6	CD
cord-005453-4057qib7	11422	29	)	)	-RRB-
cord-005453-4057qib7	11422	30	;	;	,
cord-005453-4057qib7	11422	31	anaplastic	anaplastic	JJ
cord-005453-4057qib7	11422	32	large	large	JJ
cord-005453-4057qib7	11422	33	cell	cell	NN
cord-005453-4057qib7	11422	34	lymphoma	lymphoma	NN
cord-005453-4057qib7	11422	35	,	,	,
cord-005453-4057qib7	11422	36	ALK	ALK	NNP
cord-005453-4057qib7	11422	37	-	-	HYPH
cord-005453-4057qib7	11422	38	negative	negative	JJ
cord-005453-4057qib7	11422	39	(	(	-LRB-
cord-005453-4057qib7	11422	40	n	n	NN
cord-005453-4057qib7	11422	41	=	=	SYM
cord-005453-4057qib7	11422	42	5	5	CD
cord-005453-4057qib7	11422	43	)	)	-RRB-
cord-005453-4057qib7	11422	44	;	;	,
cord-005453-4057qib7	11422	45	anaplastic	anaplastic	JJ
cord-005453-4057qib7	11422	46	large	large	JJ
cord-005453-4057qib7	11422	47	cell	cell	NN
cord-005453-4057qib7	11422	48	lymphoma	lymphoma	NN
cord-005453-4057qib7	11422	49	,	,	,
cord-005453-4057qib7	11422	50	ALK	ALK	NNP
cord-005453-4057qib7	11422	51	-	-	HYPH
cord-005453-4057qib7	11422	52	positive	positive	JJ
cord-005453-4057qib7	11422	53	(	(	-LRB-
cord-005453-4057qib7	11422	54	n	n	NN
cord-005453-4057qib7	11422	55	=	=	SYM
cord-005453-4057qib7	11422	56	1	1	CD
cord-005453-4057qib7	11422	57	)	)	-RRB-
cord-005453-4057qib7	11422	58	;	;	,
cord-005453-4057qib7	11422	59	nodal	nodal	JJ
cord-005453-4057qib7	11422	60	peripheral	peripheral	JJ
cord-005453-4057qib7	11422	61	T	t	NN
cord-005453-4057qib7	11422	62	-	-	HYPH
cord-005453-4057qib7	11422	63	cell	cell	NN
cord-005453-4057qib7	11422	64	lymphoma	lymphoma	NN
cord-005453-4057qib7	11422	65	with	with	IN
cord-005453-4057qib7	11422	66	TFH	TFH	NNP
cord-005453-4057qib7	11422	67	phenotype	phenotype	NN
cord-005453-4057qib7	11422	68	(	(	-LRB-
cord-005453-4057qib7	11422	69	n	n	NN
cord-005453-4057qib7	11422	70	=	=	SYM
cord-005453-4057qib7	11422	71	2	2	CD
cord-005453-4057qib7	11422	72	)	)	-RRB-
cord-005453-4057qib7	11422	73	.	.	.
cord-005453-4057qib7	11423	1	Extranodal	Extranodal	NNP
cord-005453-4057qib7	11423	2	NK	NK	NNP
cord-005453-4057qib7	11423	3	/	/	SYM
cord-005453-4057qib7	11423	4	T	t	NN
cord-005453-4057qib7	11423	5	-	-	HYPH
cord-005453-4057qib7	11423	6	cell	cell	NN
cord-005453-4057qib7	11423	7	lymphoma	lymphoma	NN
cord-005453-4057qib7	11423	8	,	,	,
cord-005453-4057qib7	11423	9	nasal	nasal	NN
cord-005453-4057qib7	11423	10	type	type	NN
cord-005453-4057qib7	11423	11	and	and	CC
cord-005453-4057qib7	11423	12	primary	primary	JJ
cord-005453-4057qib7	11423	13	cutaneous	cutaneous	JJ
cord-005453-4057qib7	11423	14	subtypes	subtype	NNS
cord-005453-4057qib7	11423	15	were	be	VBD
cord-005453-4057qib7	11423	16	excluded	exclude	VBN
cord-005453-4057qib7	11423	17	.	.	.
cord-005453-4057qib7	11424	1	The	the	DT
cord-005453-4057qib7	11424	2	ageadjusted	ageadjusted	JJ
cord-005453-4057qib7	11424	3	IPI	IPI	NNP
cord-005453-4057qib7	11424	4	(	(	-LRB-
cord-005453-4057qib7	11424	5	aaIPI	aaipi	UH
cord-005453-4057qib7	11424	6	)	)	-RRB-
cord-005453-4057qib7	11424	7	was	be	VBD
cord-005453-4057qib7	11424	8	low	low	JJ
cord-005453-4057qib7	11424	9	/	/	SYM
cord-005453-4057qib7	11424	10	intermediate	intermediate	JJ
cord-005453-4057qib7	11424	11	low	low	NN
cord-005453-4057qib7	11424	12	in	in	IN
cord-005453-4057qib7	11424	13	15	15	CD
cord-005453-4057qib7	11424	14	patients	patient	NNS
cord-005453-4057qib7	11424	15	(	(	-LRB-
cord-005453-4057qib7	11424	16	57	57	CD
cord-005453-4057qib7	11424	17	%	%	NN
cord-005453-4057qib7	11424	18	)	)	-RRB-
cord-005453-4057qib7	11424	19	and	and	CC
cord-005453-4057qib7	11424	20	intermediate	intermediate	JJ
cord-005453-4057qib7	11424	21	high	high	JJ
cord-005453-4057qib7	11424	22	/	/	SYM
cord-005453-4057qib7	11424	23	high	high	JJ
cord-005453-4057qib7	11424	24	in	in	IN
cord-005453-4057qib7	11424	25	11	11	CD
cord-005453-4057qib7	11424	26	patients	patient	NNS
cord-005453-4057qib7	11424	27	(	(	-LRB-
cord-005453-4057qib7	11424	28	43	43	CD
cord-005453-4057qib7	11424	29	%	%	NN
cord-005453-4057qib7	11424	30	)	)	-RRB-
cord-005453-4057qib7	11424	31	.	.	.
cord-005453-4057qib7	11425	1	Twenty	twenty	CD
cord-005453-4057qib7	11425	2	-	-	HYPH
cord-005453-4057qib7	11425	3	seven	seven	CD
cord-005453-4057qib7	11425	4	transplants	transplant	NNS
cord-005453-4057qib7	11425	5	were	be	VBD
cord-005453-4057qib7	11425	6	performed	perform	VBN
cord-005453-4057qib7	11425	7	(	(	-LRB-
cord-005453-4057qib7	11425	8	19	19	CD
cord-005453-4057qib7	11425	9	ASCT	ASCT	NNP
cord-005453-4057qib7	11425	10	,	,	,
cord-005453-4057qib7	11425	11	8	8	CD
cord-005453-4057qib7	11425	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11425	13	)	)	-RRB-
cord-005453-4057qib7	11425	14	;	;	:
cord-005453-4057qib7	11425	15	18	18	CD
cord-005453-4057qib7	11425	16	were	be	VBD
cord-005453-4057qib7	11425	17	consolidation	consolidation	NN
cord-005453-4057qib7	11425	18	in	in	IN
cord-005453-4057qib7	11425	19	1st	1st	JJ
cord-005453-4057qib7	11425	20	response	response	NN
cord-005453-4057qib7	11425	21	(	(	-LRB-
cord-005453-4057qib7	11425	22	16	16	CD
cord-005453-4057qib7	11425	23	ASCT	ASCT	NNP
cord-005453-4057qib7	11425	24	and	and	CC
cord-005453-4057qib7	11425	25	2	2	CD
cord-005453-4057qib7	11425	26	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11425	27	)	)	-RRB-
cord-005453-4057qib7	11425	28	with	with	IN
cord-005453-4057qib7	11425	29	16	16	CD
cord-005453-4057qib7	11425	30	in	in	IN
cord-005453-4057qib7	11425	31	Complete	complete	JJ
cord-005453-4057qib7	11425	32	Remission	remission	NN
cord-005453-4057qib7	11425	33	(	(	-LRB-
cord-005453-4057qib7	11425	34	CR	CR	NNP
cord-005453-4057qib7	11425	35	)	)	-RRB-
cord-005453-4057qib7	11425	36	and	and	CC
cord-005453-4057qib7	11425	37	2	2	CD
cord-005453-4057qib7	11425	38	in	in	IN
cord-005453-4057qib7	11425	39	Partial	partial	JJ
cord-005453-4057qib7	11425	40	Remission	Remission	NNP
cord-005453-4057qib7	11425	41	(	(	-LRB-
cord-005453-4057qib7	11425	42	PR	PR	NNP
cord-005453-4057qib7	11425	43	)	)	-RRB-
cord-005453-4057qib7	11425	44	.	.	.
cord-005453-4057qib7	11426	1	Nine	nine	CD
cord-005453-4057qib7	11426	2	transplants	transplant	NNS
cord-005453-4057qib7	11426	3	were	be	VBD
cord-005453-4057qib7	11426	4	performed	perform	VBN
cord-005453-4057qib7	11426	5	as	as	IN
cord-005453-4057qib7	11426	6	consolidation	consolidation	NN
cord-005453-4057qib7	11426	7	of	of	IN
cord-005453-4057qib7	11426	8	2	2	CD
cord-005453-4057qib7	11426	9	nd	nd	NNP
cord-005453-4057qib7	11426	10	response	response	NN
cord-005453-4057qib7	11426	11	(	(	-LRB-
cord-005453-4057qib7	11426	12	3	3	CD
cord-005453-4057qib7	11426	13	ASCT	ASCT	NNP
cord-005453-4057qib7	11426	14	and	and	CC
cord-005453-4057qib7	11426	15	6	6	CD
cord-005453-4057qib7	11426	16	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11426	17	)	)	-RRB-
cord-005453-4057qib7	11426	18	with	with	IN
cord-005453-4057qib7	11426	19	4	4	CD
cord-005453-4057qib7	11426	20	in	in	IN
cord-005453-4057qib7	11426	21	CR	CR	NNP
cord-005453-4057qib7	11426	22	and	and	CC
cord-005453-4057qib7	11426	23	5	5	CD
cord-005453-4057qib7	11426	24	PR	pr	NN
cord-005453-4057qib7	11426	25	.	.	.
cord-005453-4057qib7	11427	1	In	in	IN
cord-005453-4057qib7	11427	2	1	1	CD
cord-005453-4057qib7	11427	3	patient	patient	NN
cord-005453-4057qib7	11427	4	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11427	5	was	be	VBD
cord-005453-4057qib7	11427	6	performed	perform	VBN
cord-005453-4057qib7	11427	7	after	after	IN
cord-005453-4057qib7	11427	8	ASCT	ASCT	NNP
cord-005453-4057qib7	11427	9	,	,	,
cord-005453-4057qib7	11427	10	due	due	JJ
cord-005453-4057qib7	11427	11	to	to	IN
cord-005453-4057qib7	11427	12	early	early	JJ
cord-005453-4057qib7	11427	13	relapse	relapse	NN
cord-005453-4057qib7	11427	14	(	(	-LRB-
cord-005453-4057qib7	11427	15	<	<	NNP
cord-005453-4057qib7	11427	16	12	12	CD
cord-005453-4057qib7	11427	17	months	month	NNS
cord-005453-4057qib7	11427	18	)	)	-RRB-
cord-005453-4057qib7	11427	19	.	.	.
cord-005453-4057qib7	11428	1	BEAM	BEAM	NNP
cord-005453-4057qib7	11428	2	regimen	regimen	NN
cord-005453-4057qib7	11428	3	was	be	VBD
cord-005453-4057qib7	11428	4	used	use	VBN
cord-005453-4057qib7	11428	5	in	in	IN
cord-005453-4057qib7	11428	6	ASCT	ASCT	NNP
cord-005453-4057qib7	11428	7	as	as	IN
cord-005453-4057qib7	11428	8	conditioning	conditioning	NN
cord-005453-4057qib7	11428	9	and	and	CC
cord-005453-4057qib7	11428	10	FluMEL	flumel	NN
cord-005453-4057qib7	11428	11	in	in	IN
cord-005453-4057qib7	11428	12	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11428	13	.	.	.
cord-005453-4057qib7	11429	1	All	all	DT
cord-005453-4057qib7	11429	2	patients	patient	NNS
cord-005453-4057qib7	11429	3	engrafted	engraft	VBD
cord-005453-4057qib7	11429	4	,	,	,
cord-005453-4057qib7	11429	5	the	the	DT
cord-005453-4057qib7	11429	6	median	median	JJ
cord-005453-4057qib7	11429	7	time	time	NN
cord-005453-4057qib7	11429	8	to	to	IN
cord-005453-4057qib7	11429	9	leukocyte	leukocyte	NN
cord-005453-4057qib7	11429	10	recovery	recovery	NN
cord-005453-4057qib7	11430	1	>	>	XX
cord-005453-4057qib7	11431	1	1,000	1,000	CD
cord-005453-4057qib7	11432	1	/μL	/μL	:
cord-005453-4057qib7	11432	2	was	be	VBD
cord-005453-4057qib7	11432	3	14	14	CD
cord-005453-4057qib7	11432	4	days	day	NNS
cord-005453-4057qib7	11432	5	(	(	-LRB-
cord-005453-4057qib7	11432	6	range	range	NN
cord-005453-4057qib7	11432	7	,	,	,
cord-005453-4057qib7	11432	8	11	11	CD
cord-005453-4057qib7	11432	9	to	to	TO
cord-005453-4057qib7	11432	10	25	25	CD
cord-005453-4057qib7	11432	11	)	)	-RRB-
cord-005453-4057qib7	11432	12	.	.	.
cord-005453-4057qib7	11433	1	Four	four	CD
cord-005453-4057qib7	11433	2	of	of	IN
cord-005453-4057qib7	11433	3	the	the	DT
cord-005453-4057qib7	11433	4	8	8	CD
cord-005453-4057qib7	11433	5	pts	pts	NN
cord-005453-4057qib7	11433	6	(	(	-LRB-
cord-005453-4057qib7	11433	7	50	50	CD
cord-005453-4057qib7	11433	8	%	%	NN
cord-005453-4057qib7	11433	9	)	)	-RRB-
cord-005453-4057qib7	11433	10	,	,	,
cord-005453-4057qib7	11433	11	submitted	submit	VBN
cord-005453-4057qib7	11433	12	to	to	IN
cord-005453-4057qib7	11433	13	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11433	14	had	have	VBD
cord-005453-4057qib7	11433	15	chronic	chronic	JJ
cord-005453-4057qib7	11433	16	graft	graft	NN
cord-005453-4057qib7	11433	17	versus	versus	IN
cord-005453-4057qib7	11433	18	host	host	NN
cord-005453-4057qib7	11433	19	disease	disease	NN
cord-005453-4057qib7	11433	20	which	which	WDT
cord-005453-4057qib7	11433	21	was	be	VBD
cord-005453-4057qib7	11433	22	the	the	DT
cord-005453-4057qib7	11433	23	most	most	RBS
cord-005453-4057qib7	11433	24	relevant	relevant	JJ
cord-005453-4057qib7	11433	25	complication	complication	NN
cord-005453-4057qib7	11433	26	of	of	IN
cord-005453-4057qib7	11433	27	this	this	DT
cord-005453-4057qib7	11433	28	analysis	analysis	NN
cord-005453-4057qib7	11433	29	.	.	.
cord-005453-4057qib7	11434	1	Considering	consider	VBG
cord-005453-4057qib7	11434	2	the	the	DT
cord-005453-4057qib7	11434	3	whole	whole	JJ
cord-005453-4057qib7	11434	4	cohort	cohort	NN
cord-005453-4057qib7	11434	5	,	,	,
cord-005453-4057qib7	11434	6	the	the	DT
cord-005453-4057qib7	11434	7	median	median	JJ
cord-005453-4057qib7	11434	8	follow	follow	NN
cord-005453-4057qib7	11434	9	-	-	HYPH
cord-005453-4057qib7	11434	10	up	up	NN
cord-005453-4057qib7	11434	11	was	be	VBD
cord-005453-4057qib7	11434	12	50.5	50.5	CD
cord-005453-4057qib7	11434	13	months	month	NNS
cord-005453-4057qib7	11434	14	(	(	-LRB-
cord-005453-4057qib7	11434	15	range	range	NN
cord-005453-4057qib7	11434	16	,	,	,
cord-005453-4057qib7	11434	17	2	2	CD
cord-005453-4057qib7	11434	18	to	to	IN
cord-005453-4057qib7	11434	19	217	217	CD
cord-005453-4057qib7	11434	20	)	)	-RRB-
cord-005453-4057qib7	11434	21	.	.	.
cord-005453-4057qib7	11435	1	The	the	DT
cord-005453-4057qib7	11435	2	estimated	estimate	VBN
cord-005453-4057qib7	11435	3	5-year	5-year	CD
cord-005453-4057qib7	11435	4	OS	OS	NNP
cord-005453-4057qib7	11435	5	and	and	CC
cord-005453-4057qib7	11435	6	PFS	PFS	NNP
cord-005453-4057qib7	11435	7	were	be	VBD
cord-005453-4057qib7	11435	8	77	77	CD
cord-005453-4057qib7	11435	9	%	%	NN
cord-005453-4057qib7	11435	10	and	and	CC
cord-005453-4057qib7	11435	11	39	39	CD
cord-005453-4057qib7	11435	12	%	%	NN
cord-005453-4057qib7	11435	13	,	,	,
cord-005453-4057qib7	11435	14	respectively	respectively	RB
cord-005453-4057qib7	11435	15	.	.	.
cord-005453-4057qib7	11436	1	Seven	seven	CD
cord-005453-4057qib7	11436	2	patients	patient	NNS
cord-005453-4057qib7	11436	3	relapsed	relapse	VBD
cord-005453-4057qib7	11436	4	(	(	-LRB-
cord-005453-4057qib7	11436	5	6	6	CD
cord-005453-4057qib7	11436	6	early	early	JJ
cord-005453-4057qib7	11436	7	)	)	-RRB-
cord-005453-4057qib7	11436	8	all	all	DT
cord-005453-4057qib7	11436	9	after	after	IN
cord-005453-4057qib7	11436	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11436	11	,	,	,
cord-005453-4057qib7	11436	12	there	there	EX
cord-005453-4057qib7	11436	13	were	be	VBD
cord-005453-4057qib7	11436	14	no	no	DT
cord-005453-4057qib7	11436	15	relapses	relapse	NNS
cord-005453-4057qib7	11436	16	after	after	IN
cord-005453-4057qib7	11436	17	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11436	18	,	,	,
cord-005453-4057qib7	11436	19	however	however	RB
cord-005453-4057qib7	11436	20	,	,	,
cord-005453-4057qib7	11436	21	the	the	DT
cord-005453-4057qib7	11436	22	results	result	NNS
cord-005453-4057qib7	11436	23	were	be	VBD
cord-005453-4057qib7	11436	24	not	not	RB
cord-005453-4057qib7	11436	25	statistically	statistically	RB
cord-005453-4057qib7	11436	26	significant	significant	JJ
cord-005453-4057qib7	11436	27	between	between	IN
cord-005453-4057qib7	11436	28	the	the	DT
cord-005453-4057qib7	11436	29	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11436	30	and	and	CC
cord-005453-4057qib7	11436	31	ASCT	ASCT	NNP
cord-005453-4057qib7	11436	32	groups	group	NNS
cord-005453-4057qib7	11436	33	;	;	:
cord-005453-4057qib7	11436	34	the	the	DT
cord-005453-4057qib7	11436	35	5-year	5-year	CD
cord-005453-4057qib7	11436	36	OS	OS	NNP
cord-005453-4057qib7	11436	37	rates	rate	NNS
cord-005453-4057qib7	11436	38	were	be	VBD
cord-005453-4057qib7	11436	39	87	87	CD
cord-005453-4057qib7	11436	40	%	%	NN
cord-005453-4057qib7	11436	41	and	and	CC
cord-005453-4057qib7	11436	42	62	62	CD
cord-005453-4057qib7	11436	43	%	%	NN
cord-005453-4057qib7	11436	44	(	(	-LRB-
cord-005453-4057qib7	11436	45	p	p	NN
cord-005453-4057qib7	11436	46	=	=	SYM
cord-005453-4057qib7	11436	47	0,16	0,16	NN
cord-005453-4057qib7	11436	48	)	)	-RRB-
cord-005453-4057qib7	11437	1	and	and	CC
cord-005453-4057qib7	11437	2	the	the	DT
cord-005453-4057qib7	11437	3	5year	5year	JJ
cord-005453-4057qib7	11437	4	PFS	PFS	NNP
cord-005453-4057qib7	11437	5	rates	rate	NNS
cord-005453-4057qib7	11437	6	were	be	VBD
cord-005453-4057qib7	11437	7	85	85	CD
cord-005453-4057qib7	11437	8	%	%	NN
cord-005453-4057qib7	11437	9	and	and	CC
cord-005453-4057qib7	11437	10	59	59	CD
cord-005453-4057qib7	11437	11	%	%	NN
cord-005453-4057qib7	11437	12	(	(	-LRB-
cord-005453-4057qib7	11437	13	p	p	NN
cord-005453-4057qib7	11437	14	=	=	SYM
cord-005453-4057qib7	11437	15	0,26	0,26	CD
cord-005453-4057qib7	11437	16	)	)	-RRB-
cord-005453-4057qib7	11437	17	respectively	respectively	RB
cord-005453-4057qib7	11437	18	.	.	.
cord-005453-4057qib7	11438	1	For	for	IN
cord-005453-4057qib7	11438	2	the	the	DT
cord-005453-4057qib7	11438	3	all	all	DT
cord-005453-4057qib7	11438	4	patients	patient	NNS
cord-005453-4057qib7	11438	5	treatment	treatment	NN
cord-005453-4057qib7	11438	6	-	-	HYPH
cord-005453-4057qib7	11438	7	related	relate	VBN
cord-005453-4057qib7	11438	8	mortality	mortality	NN
cord-005453-4057qib7	11438	9	(	(	-LRB-
cord-005453-4057qib7	11438	10	TRM	TRM	NNP
cord-005453-4057qib7	11438	11	)	)	-RRB-
cord-005453-4057qib7	11438	12	was	be	VBD
cord-005453-4057qib7	11438	13	3,7	3,7	CD
cord-005453-4057qib7	11438	14	%	%	NN
cord-005453-4057qib7	11438	15	;	;	:
cord-005453-4057qib7	11438	16	7	7	CD
cord-005453-4057qib7	11438	17	patients	patient	NNS
cord-005453-4057qib7	11438	18	died	die	VBD
cord-005453-4057qib7	11438	19	,	,	,
cord-005453-4057qib7	11438	20	6	6	CD
cord-005453-4057qib7	11438	21	with	with	IN
cord-005453-4057qib7	11438	22	progressive	progressive	JJ
cord-005453-4057qib7	11438	23	disease	disease	NN
cord-005453-4057qib7	11438	24	(	(	-LRB-
cord-005453-4057qib7	11438	25	ASCT	ASCT	NNP
cord-005453-4057qib7	11438	26	)	)	-RRB-
cord-005453-4057qib7	11438	27	and	and	CC
cord-005453-4057qib7	11438	28	1	1	CD
cord-005453-4057qib7	11438	29	for	for	IN
cord-005453-4057qib7	11438	30	hepatic	hepatic	JJ
cord-005453-4057qib7	11438	31	toxicity	toxicity	NN
cord-005453-4057qib7	11438	32	(	(	-LRB-
cord-005453-4057qib7	11438	33	alloSCT	alloSCT	NNP
cord-005453-4057qib7	11438	34	)	)	-RRB-
cord-005453-4057qib7	11438	35	before	before	IN
cord-005453-4057qib7	11438	36	D+100	D+100	NNS
cord-005453-4057qib7	11438	37	.	.	.
cord-005453-4057qib7	11439	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11439	2	:	:	:
cord-005453-4057qib7	11440	1	The	the	DT
cord-005453-4057qib7	11440	2	results	result	NNS
cord-005453-4057qib7	11440	3	of	of	IN
cord-005453-4057qib7	11440	4	this	this	DT
cord-005453-4057qib7	11440	5	retrospective	retrospective	JJ
cord-005453-4057qib7	11440	6	study	study	NN
cord-005453-4057qib7	11440	7	,	,	,
cord-005453-4057qib7	11440	8	taking	take	VBG
cord-005453-4057qib7	11440	9	into	into	IN
cord-005453-4057qib7	11440	10	account	account	NN
cord-005453-4057qib7	11440	11	the	the	DT
cord-005453-4057qib7	11440	12	adverse	adverse	JJ
cord-005453-4057qib7	11440	13	risk	risk	NN
cord-005453-4057qib7	11440	14	profile	profile	NN
cord-005453-4057qib7	11440	15	of	of	IN
cord-005453-4057qib7	11440	16	the	the	DT
cord-005453-4057qib7	11440	17	population	population	NN
cord-005453-4057qib7	11440	18	,	,	,
cord-005453-4057qib7	11440	19	suggest	suggest	VBP
cord-005453-4057qib7	11440	20	that	that	IN
cord-005453-4057qib7	11440	21	autologous	autologous	JJ
cord-005453-4057qib7	11440	22	/	/	SYM
cord-005453-4057qib7	11440	23	allogeneic	allogeneic	IN
cord-005453-4057qib7	11440	24	stem	stem	NN
cord-005453-4057qib7	11440	25	cell	cell	NN
cord-005453-4057qib7	11440	26	transplantation	transplantation	NN
cord-005453-4057qib7	11440	27	as	as	IN
cord-005453-4057qib7	11440	28	an	an	DT
cord-005453-4057qib7	11440	29	effective	effective	JJ
cord-005453-4057qib7	11440	30	and	and	CC
cord-005453-4057qib7	11440	31	safe	safe	JJ
cord-005453-4057qib7	11440	32	option	option	NN
cord-005453-4057qib7	11440	33	for	for	IN
cord-005453-4057qib7	11440	34	the	the	DT
cord-005453-4057qib7	11440	35	consolidation	consolidation	NN
cord-005453-4057qib7	11440	36	of	of	IN
cord-005453-4057qib7	11440	37	patients	patient	NNS
cord-005453-4057qib7	11440	38	with	with	IN
cord-005453-4057qib7	11440	39	PTCLs	ptcl	NNS
cord-005453-4057qib7	11440	40	.	.	.
cord-005453-4057qib7	11441	1	These	these	DT
cord-005453-4057qib7	11441	2	results	result	NNS
cord-005453-4057qib7	11441	3	need	need	VBP
cord-005453-4057qib7	11441	4	to	to	TO
cord-005453-4057qib7	11441	5	be	be	VB
cord-005453-4057qib7	11441	6	validated	validate	VBN
cord-005453-4057qib7	11441	7	in	in	IN
cord-005453-4057qib7	11441	8	prospective	prospective	JJ
cord-005453-4057qib7	11441	9	studies	study	NNS
cord-005453-4057qib7	11441	10	,	,	,
cord-005453-4057qib7	11441	11	including	include	VBG
cord-005453-4057qib7	11441	12	a	a	DT
cord-005453-4057qib7	11441	13	larger	large	JJR
cord-005453-4057qib7	11441	14	number	number	NN
cord-005453-4057qib7	11441	15	of	of	IN
cord-005453-4057qib7	11441	16	patients	patient	NNS
cord-005453-4057qib7	11441	17	.	.	.
cord-005453-4057qib7	11442	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11442	2	Background	background	NN
cord-005453-4057qib7	11442	3	:	:	:
cord-005453-4057qib7	11443	1	Autologous	autologous	JJ
cord-005453-4057qib7	11443	2	stem	stem	NN
cord-005453-4057qib7	11443	3	cell	cell	NN
cord-005453-4057qib7	11443	4	transplantation	transplantation	NN
cord-005453-4057qib7	11443	5	is	be	VBZ
cord-005453-4057qib7	11443	6	used	use	VBN
cord-005453-4057qib7	11443	7	as	as	IN
cord-005453-4057qib7	11443	8	consolidation	consolidation	NN
cord-005453-4057qib7	11443	9	therapy	therapy	NN
cord-005453-4057qib7	11443	10	in	in	IN
cord-005453-4057qib7	11443	11	relapsed	relapse	VBN
cord-005453-4057qib7	11443	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	11443	13	patients	patient	NNS
cord-005453-4057qib7	11443	14	.	.	.
cord-005453-4057qib7	11444	1	However	however	RB
cord-005453-4057qib7	11444	2	,	,	,
cord-005453-4057qib7	11444	3	outcome	outcome	NN
cord-005453-4057qib7	11444	4	of	of	IN
cord-005453-4057qib7	11444	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	11444	6	patients	patient	NNS
cord-005453-4057qib7	11444	7	relapsing	relapse	VBG
cord-005453-4057qib7	11444	8	after	after	IN
cord-005453-4057qib7	11444	9	autologous	autologous	JJ
cord-005453-4057qib7	11444	10	stem	stem	NN
cord-005453-4057qib7	11444	11	cell	cell	NN
cord-005453-4057qib7	11444	12	transplantation	transplantation	NN
cord-005453-4057qib7	11444	13	is	be	VBZ
cord-005453-4057qib7	11444	14	poor	poor	JJ
cord-005453-4057qib7	11444	15	and	and	CC
cord-005453-4057qib7	11444	16	allogeneic	allogeneic	IN
cord-005453-4057qib7	11444	17	stem	stem	NN
cord-005453-4057qib7	11444	18	cell	cell	NN
cord-005453-4057qib7	11444	19	transplantation	transplantation	NN
cord-005453-4057qib7	11444	20	which	which	WDT
cord-005453-4057qib7	11444	21	can	can	MD
cord-005453-4057qib7	11444	22	be	be	VB
cord-005453-4057qib7	11444	23	curative	curative	JJ
cord-005453-4057qib7	11444	24	is	be	VBZ
cord-005453-4057qib7	11444	25	used	use	VBN
cord-005453-4057qib7	11444	26	in	in	IN
cord-005453-4057qib7	11444	27	the	the	DT
cord-005453-4057qib7	11444	28	transplant	transplant	NN
cord-005453-4057qib7	11444	29	eligible	eligible	JJ
cord-005453-4057qib7	11444	30	patients	patient	NNS
cord-005453-4057qib7	11444	31	in	in	IN
cord-005453-4057qib7	11444	32	this	this	DT
cord-005453-4057qib7	11444	33	setting	setting	NN
cord-005453-4057qib7	11444	34	.	.	.
cord-005453-4057qib7	11445	1	Besides	besides	RB
cord-005453-4057qib7	11445	2	,	,	,
cord-005453-4057qib7	11445	3	allogeneic	allogeneic	IN
cord-005453-4057qib7	11445	4	stem	stem	NN
cord-005453-4057qib7	11445	5	cell	cell	NN
cord-005453-4057qib7	11445	6	transplantation	transplantation	NN
cord-005453-4057qib7	11445	7	can	can	MD
cord-005453-4057qib7	11445	8	be	be	VB
cord-005453-4057qib7	11445	9	an	an	DT
cord-005453-4057qib7	11445	10	option	option	NN
cord-005453-4057qib7	11445	11	before	before	IN
cord-005453-4057qib7	11445	12	autologous	autologous	JJ
cord-005453-4057qib7	11445	13	stem	stem	NN
cord-005453-4057qib7	11445	14	cell	cell	NN
cord-005453-4057qib7	11445	15	transplantation	transplantation	NN
cord-005453-4057qib7	11445	16	in	in	IN
cord-005453-4057qib7	11445	17	some	some	DT
cord-005453-4057qib7	11445	18	high	high	JJ
cord-005453-4057qib7	11445	19	risk	risk	NN
cord-005453-4057qib7	11445	20	patients	patient	NNS
cord-005453-4057qib7	11445	21	.	.	.
cord-005453-4057qib7	11446	1	In	in	IN
cord-005453-4057qib7	11446	2	this	this	DT
cord-005453-4057qib7	11446	3	study	study	NN
cord-005453-4057qib7	11446	4	,	,	,
cord-005453-4057qib7	11446	5	we	-PRON-	PRP
cord-005453-4057qib7	11446	6	aimed	aim	VBD
cord-005453-4057qib7	11446	7	to	to	TO
cord-005453-4057qib7	11446	8	compare	compare	VB
cord-005453-4057qib7	11446	9	the	the	DT
cord-005453-4057qib7	11446	10	survival	survival	NN
cord-005453-4057qib7	11446	11	rates	rate	NNS
cord-005453-4057qib7	11446	12	of	of	IN
cord-005453-4057qib7	11446	13	lymphoma	lymphoma	NN
cord-005453-4057qib7	11446	14	patients	patient	NNS
cord-005453-4057qib7	11446	15	older	old	JJR
cord-005453-4057qib7	11446	16	than	than	IN
cord-005453-4057qib7	11446	17	60	60	CD
cord-005453-4057qib7	11446	18	years	year	NNS
cord-005453-4057qib7	11446	19	of	of	IN
cord-005453-4057qib7	11446	20	age	age	NN
cord-005453-4057qib7	11446	21	and	and	CC
cord-005453-4057qib7	11446	22	patients	patient	NNS
cord-005453-4057qib7	11446	23	aged	aged	JJ
cord-005453-4057qib7	11446	24	50	50	CD
cord-005453-4057qib7	11446	25	-	-	SYM
cord-005453-4057qib7	11446	26	60	60	CD
cord-005453-4057qib7	11446	27	who	who	WP
cord-005453-4057qib7	11446	28	had	have	VBD
cord-005453-4057qib7	11446	29	undergone	undergo	VBN
cord-005453-4057qib7	11446	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	11446	31	transplantation	transplantation	NN
cord-005453-4057qib7	11446	32	in	in	IN
cord-005453-4057qib7	11446	33	our	-PRON-	PRP$
cord-005453-4057qib7	11446	34	center	center	NN
cord-005453-4057qib7	11446	35	.	.	.
cord-005453-4057qib7	11447	1	Methods	method	NNS
cord-005453-4057qib7	11447	2	:	:	:
cord-005453-4057qib7	11447	3	We	-PRON-	PRP
cord-005453-4057qib7	11447	4	collected	collect	VBD
cord-005453-4057qib7	11447	5	the	the	DT
cord-005453-4057qib7	11447	6	data	datum	NNS
cord-005453-4057qib7	11447	7	of	of	IN
cord-005453-4057qib7	11447	8	lymphoma	lymphoma	NN
cord-005453-4057qib7	11447	9	patients	patient	NNS
cord-005453-4057qib7	11447	10	older	old	JJR
cord-005453-4057qib7	11447	11	than	than	IN
cord-005453-4057qib7	11447	12	50	50	CD
cord-005453-4057qib7	11447	13	years	year	NNS
cord-005453-4057qib7	11447	14	of	of	IN
cord-005453-4057qib7	11447	15	age	age	NN
cord-005453-4057qib7	11447	16	who	who	WP
cord-005453-4057qib7	11447	17	had	have	VBD
cord-005453-4057qib7	11447	18	undergone	undergo	VBN
cord-005453-4057qib7	11447	19	allogeneic	allogeneic	NN
cord-005453-4057qib7	11447	20	transplantation	transplantation	NN
cord-005453-4057qib7	11447	21	in	in	IN
cord-005453-4057qib7	11447	22	our	-PRON-	PRP$
cord-005453-4057qib7	11447	23	center	center	NN
cord-005453-4057qib7	11447	24	and	and	CC
cord-005453-4057qib7	11447	25	analyzed	analyze	VBD
cord-005453-4057qib7	11447	26	the	the	DT
cord-005453-4057qib7	11447	27	results	result	NNS
cord-005453-4057qib7	11447	28	by	by	IN
cord-005453-4057qib7	11447	29	grouping	group	VBG
cord-005453-4057qib7	11447	30	them	-PRON-	PRP
cord-005453-4057qib7	11447	31	into	into	IN
cord-005453-4057qib7	11447	32	2	2	CD
cord-005453-4057qib7	11447	33	,	,	,
cord-005453-4057qib7	11447	34	namely	namely	RB
cord-005453-4057qib7	11447	35	the	the	DT
cord-005453-4057qib7	11447	36	ones	one	NNS
cord-005453-4057qib7	11447	37	between	between	IN
cord-005453-4057qib7	11447	38	50	50	CD
cord-005453-4057qib7	11447	39	-	-	SYM
cord-005453-4057qib7	11447	40	60	60	CD
cord-005453-4057qib7	11447	41	years	year	NNS
cord-005453-4057qib7	11447	42	of	of	IN
cord-005453-4057qib7	11447	43	age	age	NN
cord-005453-4057qib7	11447	44	and	and	CC
cord-005453-4057qib7	11447	45	the	the	DT
cord-005453-4057qib7	11447	46	ones	one	NNS
cord-005453-4057qib7	11447	47	over	over	IN
cord-005453-4057qib7	11447	48	60	60	CD
cord-005453-4057qib7	11447	49	years	year	NNS
cord-005453-4057qib7	11447	50	of	of	IN
cord-005453-4057qib7	11447	51	age	age	NN
cord-005453-4057qib7	11447	52	.	.	.
cord-005453-4057qib7	11448	1	[	[	-LRB-
cord-005453-4057qib7	11448	2	[	[	-LRB-
cord-005453-4057qib7	11448	3	P506	P506	NNP
cord-005453-4057qib7	11448	4	Image	image	NN
cord-005453-4057qib7	11448	5	]	]	-RRB-
cord-005453-4057qib7	11448	6	1	1	CD
cord-005453-4057qib7	11448	7	.	.	.
cord-005453-4057qib7	11449	1	Figure	figure	NN
cord-005453-4057qib7	11449	2	1	1	CD
cord-005453-4057qib7	11449	3	Results	result	NNS
cord-005453-4057qib7	11450	1	:	:	:
cord-005453-4057qib7	11450	2	There	there	EX
cord-005453-4057qib7	11450	3	were	be	VBD
cord-005453-4057qib7	11450	4	42	42	CD
cord-005453-4057qib7	11450	5	patients	patient	NNS
cord-005453-4057qib7	11450	6	over	over	IN
cord-005453-4057qib7	11450	7	the	the	DT
cord-005453-4057qib7	11450	8	age	age	NN
cord-005453-4057qib7	11450	9	of	of	IN
cord-005453-4057qib7	11450	10	50	50	CD
cord-005453-4057qib7	11450	11	who	who	WP
cord-005453-4057qib7	11450	12	had	have	VBD
cord-005453-4057qib7	11450	13	undergone	undergo	VBN
cord-005453-4057qib7	11450	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	11450	15	stem	stem	NN
cord-005453-4057qib7	11450	16	cell	cell	NN
cord-005453-4057qib7	11450	17	trasplantation	trasplantation	NN
cord-005453-4057qib7	11450	18	with	with	IN
cord-005453-4057qib7	11450	19	the	the	DT
cord-005453-4057qib7	11450	20	diagnosis	diagnosis	NN
cord-005453-4057qib7	11450	21	of	of	IN
cord-005453-4057qib7	11450	22	lmphoma	lmphoma	NNP
cord-005453-4057qib7	11450	23	between	between	IN
cord-005453-4057qib7	11450	24	2011	2011	CD
cord-005453-4057qib7	11450	25	and	and	CC
cord-005453-4057qib7	11450	26	2018	2018	CD
cord-005453-4057qib7	11450	27	.	.	.
cord-005453-4057qib7	11451	1	18	18	CD
cord-005453-4057qib7	11451	2	of	of	IN
cord-005453-4057qib7	11451	3	these	these	DT
cord-005453-4057qib7	11451	4	patients	patient	NNS
cord-005453-4057qib7	11451	5	were	be	VBD
cord-005453-4057qib7	11451	6	over	over	IN
cord-005453-4057qib7	11451	7	60	60	CD
cord-005453-4057qib7	11451	8	years	year	NNS
cord-005453-4057qib7	11451	9	of	of	IN
cord-005453-4057qib7	11451	10	age	age	NN
cord-005453-4057qib7	11451	11	.	.	.
cord-005453-4057qib7	11452	1	37	37	CD
cord-005453-4057qib7	11452	2	patients	patient	NNS
cord-005453-4057qib7	11452	3	had	have	VBD
cord-005453-4057qib7	11452	4	Non	Non	NNP
cord-005453-4057qib7	11452	5	-	-	JJ
cord-005453-4057qib7	11452	6	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11452	7	lymphoma	lymphoma	NN
cord-005453-4057qib7	11452	8	and	and	CC
cord-005453-4057qib7	11452	9	5	5	CD
cord-005453-4057qib7	11452	10	patients	patient	NNS
cord-005453-4057qib7	11452	11	had	have	VBD
cord-005453-4057qib7	11452	12	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11452	13	lymphoma	lymphoma	NN
cord-005453-4057qib7	11452	14	.	.	.
cord-005453-4057qib7	11453	1	The	the	DT
cord-005453-4057qib7	11453	2	characteristics	characteristic	NNS
cord-005453-4057qib7	11453	3	of	of	IN
cord-005453-4057qib7	11453	4	the	the	DT
cord-005453-4057qib7	11453	5	patients	patient	NNS
cord-005453-4057qib7	11453	6	are	be	VBP
cord-005453-4057qib7	11453	7	summarized	summarize	VBN
cord-005453-4057qib7	11453	8	in	in	IN
cord-005453-4057qib7	11453	9	Table	Table	NNP
cord-005453-4057qib7	11453	10	 	 	_SP
cord-005453-4057qib7	11453	11	1	1	CD
cord-005453-4057qib7	11453	12	.	.	.
cord-005453-4057qib7	11454	1	Patients	patient	NNS
cord-005453-4057qib7	11454	2	'	'	POS
cord-005453-4057qib7	11454	3	comorbidity	comorbidity	NN
cord-005453-4057qib7	11454	4	indexes	index	NNS
cord-005453-4057qib7	11454	5	were	be	VBD
cord-005453-4057qib7	11454	6	calculated	calculate	VBN
cord-005453-4057qib7	11454	7	with	with	IN
cord-005453-4057qib7	11454	8	Augmented	Augmented	NNP
cord-005453-4057qib7	11454	9	HCT	HCT	NNP
cord-005453-4057qib7	11454	10	-	-	HYPH
cord-005453-4057qib7	11454	11	CI	CI	NNP
cord-005453-4057qib7	11454	12	which	which	WDT
cord-005453-4057qib7	11454	13	includes	include	VBZ
cord-005453-4057qib7	11454	14	patients	patient	NNS
cord-005453-4057qib7	11454	15	'	'	POS
cord-005453-4057qib7	11454	16	pretransplant	pretransplant	JJ
cord-005453-4057qib7	11454	17	ferritin	ferritin	NN
cord-005453-4057qib7	11454	18	,	,	,
cord-005453-4057qib7	11454	19	albümin	albümin	NNP
cord-005453-4057qib7	11454	20	and	and	CC
cord-005453-4057qib7	11454	21	thrombocyte	thrombocyte	NNP
cord-005453-4057qib7	11454	22	counts	count	VBZ
cord-005453-4057qib7	11454	23	as	as	IN
cord-005453-4057qib7	11454	24	a	a	DT
cord-005453-4057qib7	11454	25	variable	variable	NN
cord-005453-4057qib7	11454	26	.	.	.
cord-005453-4057qib7	11455	1	No	no	DT
cord-005453-4057qib7	11455	2	difference	difference	NN
cord-005453-4057qib7	11455	3	could	could	MD
cord-005453-4057qib7	11455	4	be	be	VB
cord-005453-4057qib7	11455	5	found	find	VBN
cord-005453-4057qib7	11455	6	between	between	IN
cord-005453-4057qib7	11455	7	groups	group	NNS
cord-005453-4057qib7	11455	8	regarding	regard	VBG
cord-005453-4057qib7	11455	9	neutrophil	neutrophil	NN
cord-005453-4057qib7	11455	10	and	and	CC
cord-005453-4057qib7	11455	11	platelet	platelet	NN
cord-005453-4057qib7	11455	12	engraftment	engraftment	NN
cord-005453-4057qib7	11455	13	times	time	NNS
cord-005453-4057qib7	11455	14	and	and	CC
cord-005453-4057qib7	11455	15	comorbidity	comorbidity	NN
cord-005453-4057qib7	11455	16	indexes	index	NNS
cord-005453-4057qib7	11455	17	.	.	.
cord-005453-4057qib7	11456	1	However	however	RB
cord-005453-4057qib7	11456	2	,	,	,
cord-005453-4057qib7	11456	3	acute	acute	JJ
cord-005453-4057qib7	11456	4	graft	graft	NN
cord-005453-4057qib7	11456	5	versus	versus	IN
cord-005453-4057qib7	11456	6	rate	rate	NN
cord-005453-4057qib7	11456	7	and	and	CC
cord-005453-4057qib7	11456	8	documented	document	VBD
cord-005453-4057qib7	11456	9	bacterial	bacterial	JJ
cord-005453-4057qib7	11456	10	infection	infection	NN
cord-005453-4057qib7	11456	11	rate	rate	NN
cord-005453-4057qib7	11456	12	during	during	IN
cord-005453-4057qib7	11456	13	the	the	DT
cord-005453-4057qib7	11456	14	hospitalization	hospitalization	NN
cord-005453-4057qib7	11456	15	period	period	NN
cord-005453-4057qib7	11456	16	were	be	VBD
cord-005453-4057qib7	11456	17	higher	high	JJR
cord-005453-4057qib7	11456	18	in	in	IN
cord-005453-4057qib7	11456	19	the	the	DT
cord-005453-4057qib7	11456	20	50	50	CD
cord-005453-4057qib7	11456	21	-	-	SYM
cord-005453-4057qib7	11456	22	60	60	CD
cord-005453-4057qib7	11456	23	years	year	NNS
cord-005453-4057qib7	11456	24	age	age	NN
cord-005453-4057qib7	11456	25	group	group	NN
cord-005453-4057qib7	11456	26	(	(	-LRB-
cord-005453-4057qib7	11456	27	p=0,01	p=0,01	NN
cord-005453-4057qib7	11456	28	)	)	-RRB-
cord-005453-4057qib7	11456	29	.	.	.
cord-005453-4057qib7	11457	1	100	100	CD
cord-005453-4057qib7	11457	2	day	day	NN
cord-005453-4057qib7	11457	3	mortality	mortality	NN
cord-005453-4057qib7	11457	4	rate	rate	NN
cord-005453-4057qib7	11457	5	and	and	CC
cord-005453-4057qib7	11457	6	non	non	JJ
cord-005453-4057qib7	11457	7	-	-	JJ
cord-005453-4057qib7	11457	8	relapse	relapse	JJ
cord-005453-4057qib7	11457	9	mortality	mortality	NN
cord-005453-4057qib7	11457	10	rate	rate	NN
cord-005453-4057qib7	11457	11	were	be	VBD
cord-005453-4057qib7	11457	12	not	not	RB
cord-005453-4057qib7	11457	13	different	different	JJ
cord-005453-4057qib7	11457	14	between	between	IN
cord-005453-4057qib7	11457	15	groups	group	NNS
cord-005453-4057qib7	11457	16	.	.	.
cord-005453-4057qib7	11458	1	More	more	RBR
cord-005453-4057qib7	11458	2	importantly	importantly	RB
cord-005453-4057qib7	11458	3	,	,	,
cord-005453-4057qib7	11458	4	Progression	progression	NN
cord-005453-4057qib7	11458	5	free	free	JJ
cord-005453-4057qib7	11458	6	survival(PFS	survival(pfs	RB
cord-005453-4057qib7	11458	7	)	)	-RRB-
cord-005453-4057qib7	11458	8	and	and	CC
cord-005453-4057qib7	11458	9	overall	overall	RB
cord-005453-4057qib7	11458	10	survival(OS	survival(os	JJ
cord-005453-4057qib7	11458	11	)	)	-RRB-
cord-005453-4057qib7	11459	1	of	of	IN
cord-005453-4057qib7	11459	2	patients	patient	NNS
cord-005453-4057qib7	11459	3	in	in	IN
cord-005453-4057qib7	11459	4	the	the	DT
cord-005453-4057qib7	11459	5	50	50	CD
cord-005453-4057qib7	11459	6	-	-	SYM
cord-005453-4057qib7	11459	7	60	60	CD
cord-005453-4057qib7	11459	8	years	year	NNS
cord-005453-4057qib7	11459	9	age	age	NN
cord-005453-4057qib7	11459	10	group	group	NN
cord-005453-4057qib7	11459	11	and	and	CC
cord-005453-4057qib7	11459	12	over	over	IN
cord-005453-4057qib7	11459	13	60	60	CD
cord-005453-4057qib7	11459	14	years	year	NNS
cord-005453-4057qib7	11459	15	of	of	IN
cord-005453-4057qib7	11459	16	age	age	NN
cord-005453-4057qib7	11459	17	group	group	NN
cord-005453-4057qib7	11459	18	were	be	VBD
cord-005453-4057qib7	11459	19	not	not	RB
cord-005453-4057qib7	11459	20	different	different	JJ
cord-005453-4057qib7	11459	21	(	(	-LRB-
cord-005453-4057qib7	11459	22	p=0,45	p=0,45	NNP
cord-005453-4057qib7	11459	23	)	)	-RRB-
cord-005453-4057qib7	11460	1	(	(	-LRB-
cord-005453-4057qib7	11460	2	Figure	figure	NN
cord-005453-4057qib7	11460	3	1	1	CD
cord-005453-4057qib7	11460	4	)	)	-RRB-
cord-005453-4057qib7	11460	5	Conclusions	conclusion	NNS
cord-005453-4057qib7	11460	6	:	:	:
cord-005453-4057qib7	11461	1	In	in	IN
cord-005453-4057qib7	11461	2	the	the	DT
cord-005453-4057qib7	11461	3	present	present	JJ
cord-005453-4057qib7	11461	4	study	study	NN
cord-005453-4057qib7	11461	5	,	,	,
cord-005453-4057qib7	11461	6	although	although	IN
cord-005453-4057qib7	11461	7	the	the	DT
cord-005453-4057qib7	11461	8	number	number	NN
cord-005453-4057qib7	11461	9	of	of	IN
cord-005453-4057qib7	11461	10	patients	patient	NNS
cord-005453-4057qib7	11461	11	is	be	VBZ
cord-005453-4057qib7	11461	12	low	low	JJ
cord-005453-4057qib7	11461	13	,	,	,
cord-005453-4057qib7	11461	14	we	-PRON-	PRP
cord-005453-4057qib7	11461	15	showed	show	VBD
cord-005453-4057qib7	11461	16	that	that	IN
cord-005453-4057qib7	11461	17	lymphoma	lymphoma	NN
cord-005453-4057qib7	11461	18	patients	patient	NNS
cord-005453-4057qib7	11461	19	over	over	IN
cord-005453-4057qib7	11461	20	60	60	CD
cord-005453-4057qib7	11461	21	years	year	NNS
cord-005453-4057qib7	11461	22	of	of	IN
cord-005453-4057qib7	11461	23	age	age	NN
cord-005453-4057qib7	11461	24	have	have	VBP
cord-005453-4057qib7	11461	25	similar	similar	JJ
cord-005453-4057qib7	11461	26	outcomes	outcome	NNS
cord-005453-4057qib7	11461	27	and	and	CC
cord-005453-4057qib7	11461	28	transplant	transplant	NN
cord-005453-4057qib7	11461	29	related	relate	VBN
cord-005453-4057qib7	11461	30	toxicity	toxicity	NN
cord-005453-4057qib7	11461	31	as	as	IN
cord-005453-4057qib7	11461	32	the	the	DT
cord-005453-4057qib7	11461	33	patients	patient	NNS
cord-005453-4057qib7	11461	34	between	between	IN
cord-005453-4057qib7	11461	35	50	50	CD
cord-005453-4057qib7	11461	36	to	to	TO
cord-005453-4057qib7	11461	37	60	60	CD
cord-005453-4057qib7	11461	38	years	year	NNS
cord-005453-4057qib7	11461	39	of	of	IN
cord-005453-4057qib7	11461	40	age	age	NN
cord-005453-4057qib7	11461	41	.	.	.
cord-005453-4057qib7	11462	1	PFS	PFS	NNP
cord-005453-4057qib7	11462	2	and	and	CC
cord-005453-4057qib7	11462	3	OS	OS	NNP
cord-005453-4057qib7	11462	4	were	be	VBD
cord-005453-4057qib7	11462	5	very	very	RB
cord-005453-4057qib7	11462	6	close	close	JJ
cord-005453-4057qib7	11462	7	in	in	IN
cord-005453-4057qib7	11462	8	this	this	DT
cord-005453-4057qib7	11462	9	study	study	NN
cord-005453-4057qib7	11462	10	.	.	.
cord-005453-4057qib7	11463	1	We	-PRON-	PRP
cord-005453-4057qib7	11463	2	think	think	VBP
cord-005453-4057qib7	11463	3	that	that	IN
cord-005453-4057qib7	11463	4	this	this	DT
cord-005453-4057qib7	11463	5	may	may	MD
cord-005453-4057qib7	11463	6	be	be	VB
cord-005453-4057qib7	11463	7	due	due	JJ
cord-005453-4057qib7	11463	8	to	to	IN
cord-005453-4057qib7	11463	9	low	low	JJ
cord-005453-4057qib7	11463	10	relapse	relapse	NN
cord-005453-4057qib7	11463	11	rate	rate	NN
cord-005453-4057qib7	11463	12	in	in	IN
cord-005453-4057qib7	11463	13	the	the	DT
cord-005453-4057qib7	11463	14	patients	patient	NNS
cord-005453-4057qib7	11463	15	and	and	CC
cord-005453-4057qib7	11463	16	high	high	JJ
cord-005453-4057qib7	11463	17	mortality	mortality	NN
cord-005453-4057qib7	11463	18	rate	rate	NN
cord-005453-4057qib7	11463	19	in	in	IN
cord-005453-4057qib7	11463	20	relapsing	relapse	VBG
cord-005453-4057qib7	11463	21	patients	patient	NNS
cord-005453-4057qib7	11463	22	.	.	.
cord-005453-4057qib7	11464	1	In	in	IN
cord-005453-4057qib7	11464	2	conclusion	conclusion	NN
cord-005453-4057qib7	11464	3	,	,	,
cord-005453-4057qib7	11464	4	allogeneic	allogeneic	IN
cord-005453-4057qib7	11464	5	stem	stem	NN
cord-005453-4057qib7	11464	6	cell	cell	NN
cord-005453-4057qib7	11464	7	transplantation	transplantation	NN
cord-005453-4057qib7	11464	8	which	which	WDT
cord-005453-4057qib7	11464	9	has	have	VBZ
cord-005453-4057qib7	11464	10	a	a	DT
cord-005453-4057qib7	11464	11	curative	curative	JJ
cord-005453-4057qib7	11464	12	potential	potential	NN
cord-005453-4057qib7	11464	13	may	may	MD
cord-005453-4057qib7	11464	14	be	be	VB
cord-005453-4057qib7	11464	15	employed	employ	VBN
cord-005453-4057qib7	11464	16	in	in	IN
cord-005453-4057qib7	11464	17	transplant	transplant	NN
cord-005453-4057qib7	11464	18	eligible	eligible	JJ
cord-005453-4057qib7	11464	19	elderly	elderly	JJ
cord-005453-4057qib7	11464	20	lymphoma	lymphoma	NN
cord-005453-4057qib7	11464	21	patients	patient	NNS
cord-005453-4057qib7	11464	22	Disclosure	Disclosure	NNP
cord-005453-4057qib7	11464	23	:	:	:
cord-005453-4057qib7	11464	24	Nothing	nothing	NN
cord-005453-4057qib7	11464	25	to	to	TO
cord-005453-4057qib7	11464	26	declare	declare	VB
cord-005453-4057qib7	11464	27	Background	background	NN
cord-005453-4057qib7	11464	28	:	:	:
cord-005453-4057qib7	11464	29	Follicular	follicular	JJ
cord-005453-4057qib7	11464	30	Lymphoma	Lymphoma	NNP
cord-005453-4057qib7	11464	31	(	(	-LRB-
cord-005453-4057qib7	11464	32	FL	FL	NNP
cord-005453-4057qib7	11464	33	)	)	-RRB-
cord-005453-4057qib7	11464	34	histologic	histologic	JJ
cord-005453-4057qib7	11464	35	transformation	transformation	NN
cord-005453-4057qib7	11464	36	consist	consist	VBP
cord-005453-4057qib7	11464	37	on	on	IN
cord-005453-4057qib7	11464	38	the	the	DT
cord-005453-4057qib7	11464	39	development	development	NN
cord-005453-4057qib7	11464	40	of	of	IN
cord-005453-4057qib7	11464	41	an	an	DT
cord-005453-4057qib7	11464	42	aggressive	aggressive	JJ
cord-005453-4057qib7	11464	43	lymphoma	lymphoma	NN
cord-005453-4057qib7	11464	44	,	,	,
cord-005453-4057qib7	11464	45	usually	usually	RB
cord-005453-4057qib7	11464	46	a	a	DT
cord-005453-4057qib7	11464	47	diffuse	diffuse	JJ
cord-005453-4057qib7	11464	48	large	large	JJ
cord-005453-4057qib7	11464	49	B	b	NN
cord-005453-4057qib7	11464	50	cell	cell	NN
cord-005453-4057qib7	11464	51	lymphoma	lymphoma	NN
cord-005453-4057qib7	11464	52	(	(	-LRB-
cord-005453-4057qib7	11464	53	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11464	54	)	)	-RRB-
cord-005453-4057qib7	11464	55	.	.	.
cord-005453-4057qib7	11465	1	Histological	histological	JJ
cord-005453-4057qib7	11465	2	transformation	transformation	NN
cord-005453-4057qib7	11465	3	has	have	VBZ
cord-005453-4057qib7	11465	4	been	be	VBN
cord-005453-4057qib7	11465	5	considered	consider	VBN
cord-005453-4057qib7	11465	6	to	to	TO
cord-005453-4057qib7	11465	7	have	have	VB
cord-005453-4057qib7	11465	8	poor	poor	JJ
cord-005453-4057qib7	11465	9	prognosis	prognosis	NN
cord-005453-4057qib7	11465	10	.	.	.
cord-005453-4057qib7	11466	1	In	in	IN
cord-005453-4057qib7	11466	2	pre	pre	JJ
cord-005453-4057qib7	11466	3	-	-	JJ
cord-005453-4057qib7	11466	4	rituximab	rituximab	JJ
cord-005453-4057qib7	11466	5	era	era	NN
cord-005453-4057qib7	11466	6	median	median	NN
cord-005453-4057qib7	11466	7	OS	os	NN
cord-005453-4057qib7	11466	8	ranged	range	VBD
cord-005453-4057qib7	11466	9	between	between	IN
cord-005453-4057qib7	11466	10	1	1	CD
cord-005453-4057qib7	11466	11	and	and	CC
cord-005453-4057qib7	11466	12	2	2	CD
cord-005453-4057qib7	11466	13	years	year	NNS
cord-005453-4057qib7	11466	14	,	,	,
cord-005453-4057qib7	11466	15	however	however	RB
cord-005453-4057qib7	11466	16	,	,	,
cord-005453-4057qib7	11466	17	in	in	IN
cord-005453-4057qib7	11466	18	recent	recent	JJ
cord-005453-4057qib7	11466	19	series	series	NN
cord-005453-4057qib7	11466	20	of	of	IN
cord-005453-4057qib7	11466	21	patients	patient	NNS
cord-005453-4057qib7	11466	22	treated	treat	VBN
cord-005453-4057qib7	11466	23	with	with	IN
cord-005453-4057qib7	11466	24	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11466	25	plus	plus	CC
cord-005453-4057qib7	11466	26	rituximab	rituximab	NN
cord-005453-4057qib7	11466	27	,	,	,
cord-005453-4057qib7	11466	28	the	the	DT
cord-005453-4057qib7	11466	29	outcome	outcome	NN
cord-005453-4057qib7	11466	30	of	of	IN
cord-005453-4057qib7	11466	31	transformed	transform	VBN
cord-005453-4057qib7	11466	32	FL	FL	NNP
cord-005453-4057qib7	11466	33	has	have	VBZ
cord-005453-4057qib7	11466	34	improved	improve	VBN
cord-005453-4057qib7	11466	35	,	,	,
cord-005453-4057qib7	11466	36	especially	especially	RB
cord-005453-4057qib7	11466	37	in	in	IN
cord-005453-4057qib7	11466	38	those	those	DT
cord-005453-4057qib7	11466	39	that	that	WDT
cord-005453-4057qib7	11466	40	receive	receive	VBP
cord-005453-4057qib7	11466	41	Autologous	autologous	JJ
cord-005453-4057qib7	11466	42	stem	stem	NN
cord-005453-4057qib7	11466	43	cell	cell	NN
cord-005453-4057qib7	11466	44	transplantation	transplantation	NN
cord-005453-4057qib7	11466	45	(	(	-LRB-
cord-005453-4057qib7	11466	46	ASCT	ASCT	NNP
cord-005453-4057qib7	11466	47	)	)	-RRB-
cord-005453-4057qib7	11466	48	,	,	,
cord-005453-4057qib7	11466	49	who	who	WP
cord-005453-4057qib7	11466	50	reach	reach	VBP
cord-005453-4057qib7	11466	51	5-year	5-year	CD
cord-005453-4057qib7	11466	52	OS	os	NN
cord-005453-4057qib7	11466	53	up	up	IN
cord-005453-4057qib7	11466	54	to	to	TO
cord-005453-4057qib7	11466	55	75	75	CD
cord-005453-4057qib7	11466	56	%	%	NN
cord-005453-4057qib7	11466	57	in	in	IN
cord-005453-4057qib7	11466	58	some	some	DT
cord-005453-4057qib7	11466	59	series	series	NN
cord-005453-4057qib7	11466	60	.	.	.
cord-005453-4057qib7	11467	1	Methods	method	NNS
cord-005453-4057qib7	11467	2	:	:	:
cord-005453-4057qib7	11467	3	We	-PRON-	PRP
cord-005453-4057qib7	11467	4	have	have	VBP
cord-005453-4057qib7	11467	5	retrospectively	retrospectively	RB
cord-005453-4057qib7	11467	6	studied	study	VBN
cord-005453-4057qib7	11467	7	19	19	CD
cord-005453-4057qib7	11467	8	consecutive	consecutive	JJ
cord-005453-4057qib7	11467	9	patients	patient	NNS
cord-005453-4057qib7	11467	10	undergoing	undergo	VBG
cord-005453-4057qib7	11467	11	ASCT	ASCT	NNP
cord-005453-4057qib7	11467	12	for	for	IN
cord-005453-4057qib7	11467	13	transformed	transform	VBN
cord-005453-4057qib7	11467	14	FL	FL	NNP
cord-005453-4057qib7	11467	15	between	between	IN
cord-005453-4057qib7	11467	16	2006	2006	CD
cord-005453-4057qib7	11467	17	and	and	CC
cord-005453-4057qib7	11467	18	2015	2015	CD
cord-005453-4057qib7	11467	19	in	in	IN
cord-005453-4057qib7	11467	20	a	a	DT
cord-005453-4057qib7	11467	21	tertiary	tertiary	JJ
cord-005453-4057qib7	11467	22	center	center	NN
cord-005453-4057qib7	11467	23	in	in	IN
cord-005453-4057qib7	11467	24	the	the	DT
cord-005453-4057qib7	11467	25	Basque	Basque	NNP
cord-005453-4057qib7	11467	26	Country	Country	NNP
cord-005453-4057qib7	11467	27	,	,	,
cord-005453-4057qib7	11467	28	Spain	Spain	NNP
cord-005453-4057qib7	11467	29	.	.	.
cord-005453-4057qib7	11468	1	Patients	patient	NNS
cord-005453-4057qib7	11468	2	were	be	VBD
cord-005453-4057qib7	11468	3	considered	consider	VBN
cord-005453-4057qib7	11468	4	to	to	TO
cord-005453-4057qib7	11468	5	have	have	VB
cord-005453-4057qib7	11468	6	a	a	DT
cord-005453-4057qib7	11468	7	transformed	transform	VBN
cord-005453-4057qib7	11468	8	FL	FL	NNP
cord-005453-4057qib7	11468	9	if	if	IN
cord-005453-4057qib7	11468	10	they	-PRON-	PRP
cord-005453-4057qib7	11468	11	were	be	VBD
cord-005453-4057qib7	11468	12	diagnosed	diagnose	VBN
cord-005453-4057qib7	11468	13	of	of	IN
cord-005453-4057qib7	11468	14	a	a	DT
cord-005453-4057qib7	11468	15	DLBCL	dlbcl	NN
cord-005453-4057qib7	11468	16	and	and	CC
cord-005453-4057qib7	11468	17	they	-PRON-	PRP
cord-005453-4057qib7	11468	18	have	have	VBP
cord-005453-4057qib7	11468	19	previous	previous	JJ
cord-005453-4057qib7	11468	20	history	history	NN
cord-005453-4057qib7	11468	21	of	of	IN
cord-005453-4057qib7	11468	22	FL	FL	NNP
cord-005453-4057qib7	11468	23	or	or	CC
cord-005453-4057qib7	11468	24	histological	histological	JJ
cord-005453-4057qib7	11468	25	evidence	evidence	NN
cord-005453-4057qib7	11468	26	of	of	IN
cord-005453-4057qib7	11468	27	a	a	DT
cord-005453-4057qib7	11468	28	FL	FL	NNP
cord-005453-4057qib7	11468	29	in	in	IN
cord-005453-4057qib7	11468	30	another	another	DT
cord-005453-4057qib7	11468	31	location	location	NN
cord-005453-4057qib7	11468	32	.	.	.
cord-005453-4057qib7	11469	1	These	these	DT
cord-005453-4057qib7	11469	2	patients	patient	NNS
cord-005453-4057qib7	11469	3	were	be	VBD
cord-005453-4057qib7	11469	4	compared	compare	VBN
cord-005453-4057qib7	11469	5	to	to	IN
cord-005453-4057qib7	11469	6	a	a	DT
cord-005453-4057qib7	11469	7	retrospective	retrospective	JJ
cord-005453-4057qib7	11469	8	cohort	cohort	NN
cord-005453-4057qib7	11469	9	of	of	IN
cord-005453-4057qib7	11469	10	38	38	CD
cord-005453-4057qib7	11469	11	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11469	12	patients	patient	NNS
cord-005453-4057qib7	11469	13	with	with	IN
cord-005453-4057qib7	11469	14	high	high	JJ
cord-005453-4057qib7	11469	15	IPI	IPI	NNP
cord-005453-4057qib7	11469	16	or	or	CC
cord-005453-4057qib7	11469	17	stage	stage	NN
cord-005453-4057qib7	11469	18	that	that	WDT
cord-005453-4057qib7	11469	19	received	receive	VBD
cord-005453-4057qib7	11469	20	ASCT	ASCT	NNP
cord-005453-4057qib7	11469	21	in	in	IN
cord-005453-4057qib7	11469	22	first	first	JJ
cord-005453-4057qib7	11469	23	remission	remission	NN
cord-005453-4057qib7	11469	24	according	accord	VBG
cord-005453-4057qib7	11469	25	to	to	IN
cord-005453-4057qib7	11469	26	our	-PRON-	PRP$
cord-005453-4057qib7	11469	27	institution	institution	NN
cord-005453-4057qib7	11469	28	strategy	strategy	NN
cord-005453-4057qib7	11469	29	.	.	.
cord-005453-4057qib7	11470	1	PFS	PFS	NNP
cord-005453-4057qib7	11470	2	and	and	CC
cord-005453-4057qib7	11470	3	OS	OS	NNP
cord-005453-4057qib7	11470	4	were	be	VBD
cord-005453-4057qib7	11470	5	calculated	calculate	VBN
cord-005453-4057qib7	11470	6	from	from	IN
cord-005453-4057qib7	11470	7	the	the	DT
cord-005453-4057qib7	11470	8	time	time	NN
cord-005453-4057qib7	11470	9	of	of	IN
cord-005453-4057qib7	11470	10	the	the	DT
cord-005453-4057qib7	11470	11	ASCT	ASCT	NNP
cord-005453-4057qib7	11470	12	.	.	.
cord-005453-4057qib7	11471	1	In	in	IN
cord-005453-4057qib7	11471	2	the	the	DT
cord-005453-4057qib7	11471	3	case	case	NN
cord-005453-4057qib7	11471	4	of	of	IN
cord-005453-4057qib7	11471	5	transformed	transform	VBN
cord-005453-4057qib7	11471	6	FL	FL	NNP
cord-005453-4057qib7	11471	7	,	,	,
cord-005453-4057qib7	11471	8	both	both	CC
cord-005453-4057qib7	11471	9	relapses	relapse	NNS
cord-005453-4057qib7	11471	10	of	of	IN
cord-005453-4057qib7	11471	11	the	the	DT
cord-005453-4057qib7	11471	12	aggressive	aggressive	JJ
cord-005453-4057qib7	11471	13	or	or	CC
cord-005453-4057qib7	11471	14	indolent	indolent	JJ
cord-005453-4057qib7	11471	15	lymphoma	lymphoma	NN
cord-005453-4057qib7	11471	16	were	be	VBD
cord-005453-4057qib7	11471	17	considered	consider	VBN
cord-005453-4057qib7	11471	18	.	.	.
cord-005453-4057qib7	11472	1	Survival	survival	NN
cord-005453-4057qib7	11472	2	analysis	analysis	NN
cord-005453-4057qib7	11472	3	was	be	VBD
cord-005453-4057qib7	11472	4	performed	perform	VBN
cord-005453-4057qib7	11472	5	with	with	IN
cord-005453-4057qib7	11472	6	Kaplan	Kaplan	NNP
cord-005453-4057qib7	11472	7	-	-	HYPH
cord-005453-4057qib7	11472	8	Meyer	Meyer	NNP
cord-005453-4057qib7	11472	9	estimator	estimator	NN
cord-005453-4057qib7	11472	10	Results	result	VBZ
cord-005453-4057qib7	11472	11	:	:	:
cord-005453-4057qib7	11472	12	A	a	DT
cord-005453-4057qib7	11472	13	total	total	NN
cord-005453-4057qib7	11472	14	of	of	IN
cord-005453-4057qib7	11472	15	19	19	CD
cord-005453-4057qib7	11472	16	transformed	transform	VBN
cord-005453-4057qib7	11472	17	FL	FL	NNP
cord-005453-4057qib7	11472	18	and	and	CC
cord-005453-4057qib7	11472	19	38	38	CD
cord-005453-4057qib7	11472	20	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11472	21	patients	patient	NNS
cord-005453-4057qib7	11472	22	were	be	VBD
cord-005453-4057qib7	11472	23	studied	study	VBN
cord-005453-4057qib7	11472	24	,	,	,
cord-005453-4057qib7	11472	25	with	with	IN
cord-005453-4057qib7	11472	26	a	a	DT
cord-005453-4057qib7	11472	27	median	median	NN
cord-005453-4057qib7	11472	28	follow	follow	NN
cord-005453-4057qib7	11472	29	up	up	IN
cord-005453-4057qib7	11472	30	of	of	IN
cord-005453-4057qib7	11472	31	41.4	41.4	CD
cord-005453-4057qib7	11472	32	and	and	CC
cord-005453-4057qib7	11472	33	51.7	51.7	CD
cord-005453-4057qib7	11472	34	months	month	NNS
cord-005453-4057qib7	11472	35	respectively	respectively	RB
cord-005453-4057qib7	11472	36	.	.	.
cord-005453-4057qib7	11473	1	Patient	patient	JJ
cord-005453-4057qib7	11473	2	characteristics	characteristic	NNS
cord-005453-4057qib7	11473	3	are	be	VBP
cord-005453-4057qib7	11473	4	described	describe	VBN
cord-005453-4057qib7	11473	5	in	in	IN
cord-005453-4057qib7	11473	6	table	table	NN
cord-005453-4057qib7	11473	7	1	1	CD
cord-005453-4057qib7	11473	8	.	.	.
cord-005453-4057qib7	11474	1	3-year	3-year	JJ
cord-005453-4057qib7	11474	2	PFS	PFS	NNP
cord-005453-4057qib7	11474	3	was	be	VBD
cord-005453-4057qib7	11474	4	68	68	CD
cord-005453-4057qib7	11474	5	%	%	NN
cord-005453-4057qib7	11474	6	in	in	IN
cord-005453-4057qib7	11474	7	transformed	transform	VBN
cord-005453-4057qib7	11474	8	FL	FL	NNP
cord-005453-4057qib7	11474	9	and	and	CC
cord-005453-4057qib7	11474	10	81	81	CD
cord-005453-4057qib7	11474	11	%	%	NN
cord-005453-4057qib7	11474	12	in	in	IN
cord-005453-4057qib7	11474	13	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11474	14	,	,	,
cord-005453-4057qib7	11474	15	and	and	CC
cord-005453-4057qib7	11474	16	3-year	3-year	JJ
cord-005453-4057qib7	11474	17	OS	os	NN
cord-005453-4057qib7	11474	18	was	be	VBD
cord-005453-4057qib7	11474	19	81	81	CD
cord-005453-4057qib7	11474	20	%	%	NN
cord-005453-4057qib7	11474	21	and	and	CC
cord-005453-4057qib7	11474	22	84	84	CD
cord-005453-4057qib7	11474	23	%	%	NN
cord-005453-4057qib7	11474	24	,	,	,
cord-005453-4057qib7	11474	25	respectively	respectively	RB
cord-005453-4057qib7	11474	26	(	(	-LRB-
cord-005453-4057qib7	11474	27	picture	picture	NN
cord-005453-4057qib7	11474	28	1	1	CD
cord-005453-4057qib7	11474	29	)	)	-RRB-
cord-005453-4057qib7	11474	30	.	.	.
cord-005453-4057qib7	11475	1	There	there	EX
cord-005453-4057qib7	11475	2	were	be	VBD
cord-005453-4057qib7	11475	3	no	no	DT
cord-005453-4057qib7	11475	4	significant	significant	JJ
cord-005453-4057qib7	11475	5	differences	difference	NNS
cord-005453-4057qib7	11475	6	in	in	IN
cord-005453-4057qib7	11475	7	PFS	PFS	NNP
cord-005453-4057qib7	11475	8	or	or	CC
cord-005453-4057qib7	11475	9	OS	OS	NNP
cord-005453-4057qib7	11475	10	between	between	IN
cord-005453-4057qib7	11475	11	this	this	DT
cord-005453-4057qib7	11475	12	two	two	CD
cord-005453-4057qib7	11475	13	groups	group	NNS
cord-005453-4057qib7	11475	14	(	(	-LRB-
cord-005453-4057qib7	11475	15	p	p	NN
cord-005453-4057qib7	11475	16	=	=	SYM
cord-005453-4057qib7	11475	17	0.44	0.44	CD
cord-005453-4057qib7	11475	18	)	)	-RRB-
cord-005453-4057qib7	11475	19	.	.	.
cord-005453-4057qib7	11476	1	In	in	IN
cord-005453-4057qib7	11476	2	both	both	DT
cord-005453-4057qib7	11476	3	groups	group	NNS
cord-005453-4057qib7	11476	4	all	all	DT
cord-005453-4057qib7	11476	5	relapses	relapse	NNS
cord-005453-4057qib7	11476	6	occurred	occur	VBD
cord-005453-4057qib7	11476	7	in	in	IN
cord-005453-4057qib7	11476	8	the	the	DT
cord-005453-4057qib7	11476	9	first	first	JJ
cord-005453-4057qib7	11476	10	three	three	CD
cord-005453-4057qib7	11476	11	years	year	NNS
cord-005453-4057qib7	11476	12	after	after	IN
cord-005453-4057qib7	11476	13	ASCT	ASCT	NNP
cord-005453-4057qib7	11476	14	.	.	.
cord-005453-4057qib7	11477	1	Among	among	IN
cord-005453-4057qib7	11477	2	the	the	DT
cord-005453-4057qib7	11477	3	patients	patient	NNS
cord-005453-4057qib7	11477	4	with	with	IN
cord-005453-4057qib7	11477	5	transformed	transform	VBN
cord-005453-4057qib7	11477	6	FL	FL	NNP
cord-005453-4057qib7	11477	7	6	6	CD
cord-005453-4057qib7	11477	8	relapses	relapse	NNS
cord-005453-4057qib7	11477	9	were	be	VBD
cord-005453-4057qib7	11477	10	observed	observe	VBN
cord-005453-4057qib7	11477	11	.	.	.
cord-005453-4057qib7	11478	1	Five	five	CD
cord-005453-4057qib7	11478	2	of	of	IN
cord-005453-4057qib7	11478	3	them	-PRON-	PRP
cord-005453-4057qib7	11478	4	(	(	-LRB-
cord-005453-4057qib7	11478	5	83	83	CD
cord-005453-4057qib7	11478	6	%	%	NN
cord-005453-4057qib7	11478	7	)	)	-RRB-
cord-005453-4057qib7	11478	8	were	be	VBD
cord-005453-4057qib7	11478	9	aggressive	aggressive	JJ
cord-005453-4057qib7	11478	10	relapses	relapse	NNS
cord-005453-4057qib7	11478	11	,	,	,
cord-005453-4057qib7	11478	12	while	while	IN
cord-005453-4057qib7	11478	13	only	only	RB
cord-005453-4057qib7	11478	14	one	one	CD
cord-005453-4057qib7	11478	15	patient	patient	NN
cord-005453-4057qib7	11478	16	presented	present	VBD
cord-005453-4057qib7	11478	17	relapse	relapse	NN
cord-005453-4057qib7	11478	18	as	as	IN
cord-005453-4057qib7	11478	19	an	an	DT
cord-005453-4057qib7	11478	20	indolent	indolent	JJ
cord-005453-4057qib7	11478	21	lymphoma	lymphoma	NN
cord-005453-4057qib7	11478	22	(	(	-LRB-
cord-005453-4057qib7	11478	23	FL	FL	NNP
cord-005453-4057qib7	11478	24	histological	histological	JJ
cord-005453-4057qib7	11478	25	grade	grade	NN
cord-005453-4057qib7	11478	26	3A	3a	NN
cord-005453-4057qib7	11478	27	with	with	IN
cord-005453-4057qib7	11478	28	an	an	DT
cord-005453-4057qib7	11478	29	aggressive	aggressive	JJ
cord-005453-4057qib7	11478	30	clinical	clinical	JJ
cord-005453-4057qib7	11478	31	course	course	NN
cord-005453-4057qib7	11478	32	)	)	-RRB-
cord-005453-4057qib7	11478	33	.	.	.
cord-005453-4057qib7	11479	1	[	[	-LRB-
cord-005453-4057qib7	11479	2	[	[	-LRB-
cord-005453-4057qib7	11479	3	P507	P507	NNP
cord-005453-4057qib7	11479	4	Image	image	NN
cord-005453-4057qib7	11479	5	]	]	-RRB-
cord-005453-4057qib7	11479	6	1	1	CD
cord-005453-4057qib7	11479	7	.	.	.
cord-005453-4057qib7	11480	1	Image	image	NN
cord-005453-4057qib7	11480	2	1	1	CD
cord-005453-4057qib7	11480	3	:	:	:
cord-005453-4057qib7	11480	4	Transformed	transform	VBN
cord-005453-4057qib7	11480	5	FL	FL	NNP
cord-005453-4057qib7	11480	6	and	and	CC
cord-005453-4057qib7	11480	7	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11480	8	PFS	PFS	NNP
cord-005453-4057qib7	11480	9	after	after	IN
cord-005453-4057qib7	11480	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11480	11	]	]	-RRB-
cord-005453-4057qib7	11481	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11481	2	:	:	:
cord-005453-4057qib7	11481	3	In	in	IN
cord-005453-4057qib7	11481	4	our	-PRON-	PRP$
cord-005453-4057qib7	11481	5	experience	experience	NN
cord-005453-4057qib7	11481	6	,	,	,
cord-005453-4057qib7	11481	7	ASCT	ASCT	NNP
cord-005453-4057qib7	11481	8	in	in	IN
cord-005453-4057qib7	11481	9	transformed	transform	VBN
cord-005453-4057qib7	11481	10	FL	FL	NNP
cord-005453-4057qib7	11481	11	offers	offer	VBZ
cord-005453-4057qib7	11481	12	good	good	JJ
cord-005453-4057qib7	11481	13	results	result	NNS
cord-005453-4057qib7	11481	14	,	,	,
cord-005453-4057qib7	11481	15	similar	similar	JJ
cord-005453-4057qib7	11481	16	to	to	IN
cord-005453-4057qib7	11481	17	those	those	DT
cord-005453-4057qib7	11481	18	in	in	IN
cord-005453-4057qib7	11481	19	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11481	20	.	.	.
cord-005453-4057qib7	11482	1	FL	FL	NNP
cord-005453-4057qib7	11482	2	presents	present	VBZ
cord-005453-4057qib7	11482	3	a	a	DT
cord-005453-4057qib7	11482	4	natural	natural	JJ
cord-005453-4057qib7	11482	5	course	course	NN
cord-005453-4057qib7	11482	6	akin	akin	JJ
cord-005453-4057qib7	11482	7	to	to	IN
cord-005453-4057qib7	11482	8	that	that	DT
cord-005453-4057qib7	11482	9	of	of	IN
cord-005453-4057qib7	11482	10	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11482	11	,	,	,
cord-005453-4057qib7	11482	12	with	with	IN
cord-005453-4057qib7	11482	13	relapses	relapse	NNS
cord-005453-4057qib7	11482	14	occurring	occur	VBG
cord-005453-4057qib7	11482	15	early	early	RB
cord-005453-4057qib7	11482	16	and	and	CC
cord-005453-4057qib7	11482	17	survival	survival	NN
cord-005453-4057qib7	11482	18	reaching	reach	VBG
cord-005453-4057qib7	11482	19	a	a	DT
cord-005453-4057qib7	11482	20	plateau	plateau	NN
cord-005453-4057qib7	11482	21	.	.	.
cord-005453-4057qib7	11483	1	This	this	DT
cord-005453-4057qib7	11483	2	data	data	NN
cord-005453-4057qib7	11483	3	suggests	suggest	VBZ
cord-005453-4057qib7	11483	4	that	that	IN
cord-005453-4057qib7	11483	5	some	some	DT
cord-005453-4057qib7	11483	6	patients	patient	NNS
cord-005453-4057qib7	11483	7	with	with	IN
cord-005453-4057qib7	11483	8	transformed	transform	VBN
cord-005453-4057qib7	11483	9	FL	FL	NNP
cord-005453-4057qib7	11483	10	can	can	MD
cord-005453-4057qib7	11483	11	be	be	VB
cord-005453-4057qib7	11483	12	cured	cure	VBN
cord-005453-4057qib7	11483	13	after	after	IN
cord-005453-4057qib7	11483	14	ASCT	ASCT	NNP
cord-005453-4057qib7	11483	15	.	.	.
cord-005453-4057qib7	11484	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11484	2	:	:	:
cord-005453-4057qib7	11484	3	Nothing	nothing	NN
cord-005453-4057qib7	11484	4	to	to	TO
cord-005453-4057qib7	11484	5	declare	declare	VB
cord-005453-4057qib7	11484	6	.	.	.
cord-005453-4057qib7	11485	1	Safety	safety	NN
cord-005453-4057qib7	11485	2	and	and	CC
cord-005453-4057qib7	11485	3	efficacy	efficacy	NN
cord-005453-4057qib7	11485	4	of	of	IN
cord-005453-4057qib7	11485	5	intensive	intensive	JJ
cord-005453-4057qib7	11485	6	preconditioning	preconditioning	NN
cord-005453-4057qib7	11485	7	regimen	regimen	NN
cord-005453-4057qib7	11485	8	containing	contain	VBG
cord-005453-4057qib7	11485	9	cladribine	cladribine	NN
cord-005453-4057qib7	11485	10	in	in	IN
cord-005453-4057qib7	11485	11	autologous	autologous	JJ
cord-005453-4057qib7	11485	12	peripheral	peripheral	JJ
cord-005453-4057qib7	11485	13	blood	blood	NN
cord-005453-4057qib7	11485	14	stem	stem	NN
cord-005453-4057qib7	11485	15	cell	cell	NN
cord-005453-4057qib7	11485	16	transplantation	transplantation	NN
cord-005453-4057qib7	11485	17	of	of	IN
cord-005453-4057qib7	11485	18	refractory	refractory	JJ
cord-005453-4057qib7	11485	19	and	and	CC
cord-005453-4057qib7	11485	20	relapsed	relapse	VBD
cord-005453-4057qib7	11485	21	young	young	JJ
cord-005453-4057qib7	11485	22	highly	highly	RB
cord-005453-4057qib7	11485	23	invasive	invasive	JJ
cord-005453-4057qib7	11485	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	11485	25	Background	background	NN
cord-005453-4057qib7	11485	26	:	:	:
cord-005453-4057qib7	11485	27	Autologous	autologous	JJ
cord-005453-4057qib7	11485	28	peripheral	peripheral	JJ
cord-005453-4057qib7	11485	29	blood	blood	NN
cord-005453-4057qib7	11485	30	stem	stem	NN
cord-005453-4057qib7	11485	31	cell	cell	NN
cord-005453-4057qib7	11485	32	transplantation	transplantation	NN
cord-005453-4057qib7	11485	33	(	(	-LRB-
cord-005453-4057qib7	11485	34	APBSCT	APBSCT	NNP
cord-005453-4057qib7	11485	35	)	)	-RRB-
cord-005453-4057qib7	11485	36	is	be	VBZ
cord-005453-4057qib7	11485	37	one	one	CD
cord-005453-4057qib7	11485	38	of	of	IN
cord-005453-4057qib7	11485	39	the	the	DT
cord-005453-4057qib7	11485	40	main	main	JJ
cord-005453-4057qib7	11485	41	treatments	treatment	NNS
cord-005453-4057qib7	11485	42	for	for	IN
cord-005453-4057qib7	11485	43	patients	patient	NNS
cord-005453-4057qib7	11485	44	with	with	IN
cord-005453-4057qib7	11485	45	non	non	JJ
cord-005453-4057qib7	11485	46	-	-	JJ
cord-005453-4057qib7	11485	47	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11485	48	's	's	POS
cord-005453-4057qib7	11485	49	lymphoma	lymphoma	NN
cord-005453-4057qib7	11485	50	(	(	-LRB-
cord-005453-4057qib7	11485	51	NHL	NHL	NNP
cord-005453-4057qib7	11485	52	)	)	-RRB-
cord-005453-4057qib7	11485	53	.	.	.
cord-005453-4057qib7	11486	1	Effective	effective	JJ
cord-005453-4057qib7	11486	2	and	and	CC
cord-005453-4057qib7	11486	3	safe	safe	JJ
cord-005453-4057qib7	11486	4	conditioning	conditioning	NN
cord-005453-4057qib7	11486	5	regimens	regimen	NNS
cord-005453-4057qib7	11486	6	can	can	MD
cord-005453-4057qib7	11486	7	improve	improve	VB
cord-005453-4057qib7	11486	8	the	the	DT
cord-005453-4057qib7	11486	9	cure	cure	NN
cord-005453-4057qib7	11486	10	rate	rate	NN
cord-005453-4057qib7	11486	11	of	of	IN
cord-005453-4057qib7	11486	12	NHL	NHL	NNP
cord-005453-4057qib7	11486	13	.	.	.
cord-005453-4057qib7	11487	1	BEAM	beam	NN
cord-005453-4057qib7	11487	2	is	be	VBZ
cord-005453-4057qib7	11487	3	the	the	DT
cord-005453-4057qib7	11487	4	most	most	RBS
cord-005453-4057qib7	11487	5	common	common	JJ
cord-005453-4057qib7	11487	6	pretreatment	pretreatment	NN
cord-005453-4057qib7	11487	7	scheme	scheme	NN
cord-005453-4057qib7	11487	8	,	,	,
cord-005453-4057qib7	11487	9	but	but	CC
cord-005453-4057qib7	11487	10	for	for	IN
cord-005453-4057qib7	11487	11	refractory	refractory	JJ
cord-005453-4057qib7	11487	12	and	and	CC
cord-005453-4057qib7	11487	13	relapsed	relapse	VBD
cord-005453-4057qib7	11487	14	young	young	JJ
cord-005453-4057qib7	11487	15	highly	highly	RB
cord-005453-4057qib7	11487	16	invasive	invasive	JJ
cord-005453-4057qib7	11487	17	lymphoma	lymphoma	NN
cord-005453-4057qib7	11487	18	,	,	,
cord-005453-4057qib7	11487	19	especially	especially	RB
cord-005453-4057qib7	11487	20	for	for	IN
cord-005453-4057qib7	11487	21	dual	dual	JJ
cord-005453-4057qib7	11487	22	-	-	HYPH
cord-005453-4057qib7	11487	23	expression	expression	NN
cord-005453-4057qib7	11487	24	DLBCL	dlbcl	NN
cord-005453-4057qib7	11487	25	,	,	,
cord-005453-4057qib7	11487	26	pretreatment	pretreatment	NN
cord-005453-4057qib7	11487	27	needs	need	VBZ
cord-005453-4057qib7	11487	28	to	to	TO
cord-005453-4057qib7	11487	29	be	be	VB
cord-005453-4057qib7	11487	30	strengthened	strengthen	VBN
cord-005453-4057qib7	11487	31	.	.	.
cord-005453-4057qib7	11488	1	Studies	study	NNS
cord-005453-4057qib7	11488	2	have	have	VBP
cord-005453-4057qib7	11488	3	shown	show	VBN
cord-005453-4057qib7	11488	4	that	that	IN
cord-005453-4057qib7	11488	5	the	the	DT
cord-005453-4057qib7	11488	6	Cladribine	Cladribine	NNP
cord-005453-4057qib7	11488	7	(	(	-LRB-
cord-005453-4057qib7	11488	8	Clad)+Gemcitabine	clad)+gemcitabine	UH
cord-005453-4057qib7	11488	9	(	(	-LRB-
cord-005453-4057qib7	11488	10	Gem)+Busulfan	Gem)+Busulfan	NNP
cord-005453-4057qib7	11488	11	(	(	-LRB-
cord-005453-4057qib7	11488	12	Bu	Bu	NNP
cord-005453-4057qib7	11488	13	)	)	-RRB-
cord-005453-4057qib7	11488	14	combination	combination	NN
cord-005453-4057qib7	11488	15	provides	provide	VBZ
cord-005453-4057qib7	11488	16	synergistic	synergistic	JJ
cord-005453-4057qib7	11488	17	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	11488	18	in	in	IN
cord-005453-4057qib7	11488	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	11488	20	cell	cell	NN
cord-005453-4057qib7	11488	21	lines	line	NNS
cord-005453-4057qib7	11488	22	.	.	.
cord-005453-4057qib7	11489	1	We	-PRON-	PRP
cord-005453-4057qib7	11489	2	evaluated	evaluate	VBD
cord-005453-4057qib7	11489	3	the	the	DT
cord-005453-4057qib7	11489	4	the	the	DT
cord-005453-4057qib7	11489	5	safety	safety	NN
cord-005453-4057qib7	11489	6	and	and	CC
cord-005453-4057qib7	11489	7	short	short	JJ
cord-005453-4057qib7	11489	8	-	-	HYPH
cord-005453-4057qib7	11489	9	term	term	NN
cord-005453-4057qib7	11489	10	efficacy	efficacy	NN
cord-005453-4057qib7	11489	11	of	of	IN
cord-005453-4057qib7	11489	12	intensive	intensive	JJ
cord-005453-4057qib7	11489	13	preconditioning	preconditioning	NN
cord-005453-4057qib7	11489	14	regimen	regimen	NN
cord-005453-4057qib7	11489	15	containing	contain	VBG
cord-005453-4057qib7	11489	16	cladribine	cladribine	NNP
cord-005453-4057qib7	11489	17	(	(	-LRB-
cord-005453-4057qib7	11489	18	Clad+GEM+BU	Clad+GEM+BU	NNP
cord-005453-4057qib7	11489	19	)	)	-RRB-
cord-005453-4057qib7	11489	20	for	for	IN
cord-005453-4057qib7	11489	21	refractory	refractory	JJ
cord-005453-4057qib7	11489	22	and	and	CC
cord-005453-4057qib7	11489	23	relapsed	relapse	VBD
cord-005453-4057qib7	11489	24	young	young	JJ
cord-005453-4057qib7	11489	25	highly	highly	RB
cord-005453-4057qib7	11489	26	invasive	invasive	JJ
cord-005453-4057qib7	11489	27	lymphoma	lymphoma	NN
cord-005453-4057qib7	11489	28	undergoing	undergo	VBG
cord-005453-4057qib7	11489	29	APBSCT	APBSCT	NNP
cord-005453-4057qib7	11489	30	.	.	.
cord-005453-4057qib7	11490	1	Methods	method	NNS
cord-005453-4057qib7	11490	2	:	:	:
cord-005453-4057qib7	11491	1	Ten	ten	CD
cord-005453-4057qib7	11491	2	patients	patient	NNS
cord-005453-4057qib7	11491	3	with	with	IN
cord-005453-4057qib7	11491	4	NHL	NHL	NNP
cord-005453-4057qib7	11491	5	received	receive	VBD
cord-005453-4057qib7	11491	6	APBSCT	APBSCT	NNP
cord-005453-4057qib7	11491	7	.	.	.
cord-005453-4057qib7	11492	1	CA)CTX+	CA)CTX+	NNP
cord-005453-4057qib7	11492	2	Ara	Ara	NNP
cord-005453-4057qib7	11492	3	-	-	HYPH
cord-005453-4057qib7	11492	4	C	C	NNP
cord-005453-4057qib7	11492	5	)	)	-RRB-
cord-005453-4057qib7	11492	6	therapy	therapy	NN
cord-005453-4057qib7	11492	7	followed	follow	VBN
cord-005453-4057qib7	11492	8	by	by	IN
cord-005453-4057qib7	11492	9	G	G	NNP
cord-005453-4057qib7	11492	10	-	-	HYPH
cord-005453-4057qib7	11492	11	CSF	CSF	NNP
cord-005453-4057qib7	11492	12	was	be	VBD
cord-005453-4057qib7	11492	13	used	use	VBN
cord-005453-4057qib7	11492	14	for	for	IN
cord-005453-4057qib7	11492	15	PBSC	PBSC	NNP
cord-005453-4057qib7	11492	16	mobilization	mobilization	NN
cord-005453-4057qib7	11492	17	.	.	.
cord-005453-4057qib7	11493	1	Sevenr	Sevenr	NNP
cord-005453-4057qib7	11493	2	patients	patient	NNS
cord-005453-4057qib7	11493	3	received	receive	VBD
cord-005453-4057qib7	11493	4	conditioning	conditioning	NN
cord-005453-4057qib7	11493	5	regimens	regimen	NNS
cord-005453-4057qib7	11493	6	of	of	IN
cord-005453-4057qib7	11493	7	BEAM(BEAM	beam(beam	JJ
cord-005453-4057qib7	11493	8	group	group	NN
cord-005453-4057qib7	11493	9	)	)	-RRB-
cord-005453-4057qib7	11493	10	:	:	:
cord-005453-4057qib7	11493	11	BCNU	BCNU	NNP
cord-005453-4057qib7	11493	12	300mg/	300mg/	CD
cord-005453-4057qib7	11493	13	m	m	CD
cord-005453-4057qib7	11493	14	2	2	CD
cord-005453-4057qib7	11493	15	·	·	NFP
cord-005453-4057qib7	11494	1	d	d	NNP
cord-005453-4057qib7	11494	2	-1	-1	NNP
cord-005453-4057qib7	11494	3	×1d	×1d	NNP
cord-005453-4057qib7	11494	4	(	(	-LRB-
cord-005453-4057qib7	11494	5	-7d	-7d	:
cord-005453-4057qib7	11494	6	)	)	-RRB-
cord-005453-4057qib7	11494	7	,	,	.
cord-005453-4057qib7	11495	1	VP16	VP16	NNP
cord-005453-4057qib7	11495	2	100mg	100mg	NNP
cord-005453-4057qib7	11495	3	/	/	SYM
cord-005453-4057qib7	11495	4	m	m	NN
cord-005453-4057qib7	11495	5	2	2	CD
cord-005453-4057qib7	11495	6	·	·	NFP
cord-005453-4057qib7	11495	7	Q12h×4d	q12h×4d	XX
cord-005453-4057qib7	11495	8	(	(	-LRB-
cord-005453-4057qib7	11495	9	-6d--3d	-6d--3d	NNP
cord-005453-4057qib7	11495	10	)	)	-RRB-
cord-005453-4057qib7	11495	11	,	,	.
cord-005453-4057qib7	11496	1	Ara	Ara	NNP
cord-005453-4057qib7	11496	2	-	-	HYPH
cord-005453-4057qib7	11496	3	C	C	NNP
cord-005453-4057qib7	11496	4	200mg	200mg	NNP
cord-005453-4057qib7	11496	5	/	/	SYM
cord-005453-4057qib7	11496	6	m	m	NN
cord-005453-4057qib7	11496	7	2	2	CD
cord-005453-4057qib7	11496	8	·	·	NFP
cord-005453-4057qib7	11496	9	q12h×4	q12h×4	NNP
cord-005453-4057qib7	11496	10	d	d	XX
cord-005453-4057qib7	11496	11	(	(	-LRB-
cord-005453-4057qib7	11497	1	-6d--3d	-6d--3d	NN
cord-005453-4057qib7	11497	2	)	)	-RRB-
cord-005453-4057qib7	11497	3	,	,	,
cord-005453-4057qib7	11497	4	Mel	Mel	NNP
cord-005453-4057qib7	11497	5	140mg	140mg	NNP
cord-005453-4057qib7	11497	6	/	/	SYM
cord-005453-4057qib7	11497	7	m	m	NN
cord-005453-4057qib7	11497	8	2	2	CD
cord-005453-4057qib7	11497	9	·	·	NFP
cord-005453-4057qib7	11497	10	d	d	NN
cord-005453-4057qib7	11497	11	-1	-1	NN
cord-005453-4057qib7	11497	12	×1d	×1d	NNP
cord-005453-4057qib7	11497	13	(	(	-LRB-
cord-005453-4057qib7	11497	14	-2d	-2d	NFP
cord-005453-4057qib7	11497	15	)	)	-RRB-
cord-005453-4057qib7	11497	16	.	.	.
cord-005453-4057qib7	11498	1	Three	three	CD
cord-005453-4057qib7	11498	2	patients	patient	NNS
cord-005453-4057qib7	11498	3	received	receive	VBD
cord-005453-4057qib7	11498	4	intensive	intensive	JJ
cord-005453-4057qib7	11498	5	preconditioning	preconditioning	NN
cord-005453-4057qib7	11498	6	regimen	regimen	NN
cord-005453-4057qib7	11498	7	containing	contain	VBG
cord-005453-4057qib7	11498	8	cladribine	cladribine	NNP
cord-005453-4057qib7	11498	9	(	(	-LRB-
cord-005453-4057qib7	11498	10	CLGB	CLGB	NNP
cord-005453-4057qib7	11498	11	group	group	NN
cord-005453-4057qib7	11498	12	)	)	-RRB-
cord-005453-4057qib7	11498	13	:	:	:
cord-005453-4057qib7	11499	1	CLad	CLad	NNP
cord-005453-4057qib7	11499	2	5	5	CD
cord-005453-4057qib7	11499	3	mg	mg	NN
cord-005453-4057qib7	11500	1	/m	/m	NNP
cord-005453-4057qib7	11500	2	2	2	LS
cord-005453-4057qib7	11500	3	·	·	NFP
cord-005453-4057qib7	11500	4	d	d	NN
cord-005453-4057qib7	11500	5	-1	-1	NNP
cord-005453-4057qib7	11501	1	×5d	×5d	NNP
cord-005453-4057qib7	11501	2	(	(	-LRB-
cord-005453-4057qib7	11501	3	-6d--2d	-6d--2d	NNP
cord-005453-4057qib7	11501	4	)	)	-RRB-
cord-005453-4057qib7	11501	5	,	,	.
cord-005453-4057qib7	11502	1	GEM2500mg	GEM2500mg	NNP
cord-005453-4057qib7	11502	2	/	/	SYM
cord-005453-4057qib7	11502	3	m	m	NN
cord-005453-4057qib7	11502	4	2	2	CD
cord-005453-4057qib7	11502	5	·	·	NFP
cord-005453-4057qib7	11502	6	d	d	NN
cord-005453-4057qib7	11502	7	-1	-1	NNP
cord-005453-4057qib7	11502	8	×2d	×2d	NNP
cord-005453-4057qib7	11502	9	(	(	-LRB-
cord-005453-4057qib7	11502	10	-6d	-6d	UH
cord-005453-4057qib7	11502	11	,	,	,
cord-005453-4057qib7	11502	12	-2d	-2d	NNP
cord-005453-4057qib7	11502	13	)	)	-RRB-
cord-005453-4057qib7	11502	14	,	,	.
cord-005453-4057qib7	11503	1	BU0.8mg	BU0.8mg	NNP
cord-005453-4057qib7	11503	2	/	/	SYM
cord-005453-4057qib7	11503	3	Kg	Kg	NNP
cord-005453-4057qib7	11503	4	Q6h×4d	Q6h×4d	NNP
cord-005453-4057qib7	11503	5	(	(	-LRB-
cord-005453-4057qib7	11503	6	-6d--3d	-6d--3d	NNP
cord-005453-4057qib7	11503	7	)	)	-RRB-
cord-005453-4057qib7	11503	8	.	.	.
cord-005453-4057qib7	11504	1	Follow	follow	VB
cord-005453-4057qib7	11504	2	-	-	HYPH
cord-005453-4057qib7	11504	3	up	up	RP
cord-005453-4057qib7	11504	4	date	date	NN
cord-005453-4057qib7	11504	5	expires	expire	VBZ
cord-005453-4057qib7	11504	6	on	on	IN
cord-005453-4057qib7	11504	7	December	December	NNP
cord-005453-4057qib7	11504	8	1	1	CD
cord-005453-4057qib7	11504	9	,	,	,
cord-005453-4057qib7	11504	10	2018	2018	CD
cord-005453-4057qib7	11504	11	.	.	.
cord-005453-4057qib7	11505	1	Results	result	NNS
cord-005453-4057qib7	11505	2	:	:	:
cord-005453-4057qib7	11506	1	The	the	DT
cord-005453-4057qib7	11506	2	age	age	NN
cord-005453-4057qib7	11506	3	of	of	IN
cord-005453-4057qib7	11506	4	3	3	CD
cord-005453-4057qib7	11506	5	patients	patient	NNS
cord-005453-4057qib7	11506	6	in	in	IN
cord-005453-4057qib7	11506	7	CLGB	CLGB	NNP
cord-005453-4057qib7	11506	8	group	group	NN
cord-005453-4057qib7	11506	9	was	be	VBD
cord-005453-4057qib7	11506	10	41	41	CD
cord-005453-4057qib7	11506	11	,	,	,
cord-005453-4057qib7	11506	12	12	12	CD
cord-005453-4057qib7	11506	13	and	and	CC
cord-005453-4057qib7	11506	14	50	50	CD
cord-005453-4057qib7	11506	15	years	year	NNS
cord-005453-4057qib7	11506	16	,	,	,
cord-005453-4057qib7	11506	17	respectively	respectively	RB
cord-005453-4057qib7	11506	18	.	.	.
cord-005453-4057qib7	11507	1	Two	two	CD
cord-005453-4057qib7	11507	2	patients	patient	NNS
cord-005453-4057qib7	11507	3	were	be	VBD
cord-005453-4057qib7	11507	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	11507	5	as	as	IN
cord-005453-4057qib7	11507	6	diffuse	diffuse	JJ
cord-005453-4057qib7	11507	7	large	large	JJ
cord-005453-4057qib7	11507	8	B	b	NN
cord-005453-4057qib7	11507	9	-	-	HYPH
cord-005453-4057qib7	11507	10	cell	cell	NN
cord-005453-4057qib7	11507	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11507	12	with	with	IN
cord-005453-4057qib7	11507	13	double	double	JJ
cord-005453-4057qib7	11507	14	expression	expression	NN
cord-005453-4057qib7	11507	15	and	and	CC
cord-005453-4057qib7	11507	16	one	one	NN
cord-005453-4057qib7	11507	17	was	be	VBD
cord-005453-4057qib7	11507	18	diffuse	diffuse	JJ
cord-005453-4057qib7	11507	19	large	large	JJ
cord-005453-4057qib7	11507	20	B	b	NN
cord-005453-4057qib7	11507	21	-	-	HYPH
cord-005453-4057qib7	11507	22	cell	cell	NN
cord-005453-4057qib7	11507	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	11507	24	with	with	IN
cord-005453-4057qib7	11507	25	two	two	CD
cord-005453-4057qib7	11507	26	recurrences	recurrence	NNS
cord-005453-4057qib7	11507	27	.	.	.
cord-005453-4057qib7	11508	1	The	the	DT
cord-005453-4057qib7	11508	2	patients	patient	NNS
cord-005453-4057qib7	11508	3	of	of	IN
cord-005453-4057qib7	11508	4	BEAM	BEAM	NNP
cord-005453-4057qib7	11508	5	group	group	NN
cord-005453-4057qib7	11508	6	were	be	VBD
cord-005453-4057qib7	11508	7	all	all	DT
cord-005453-4057qib7	11508	8	high	high	JJ
cord-005453-4057qib7	11508	9	-	-	HYPH
cord-005453-4057qib7	11508	10	risk	risk	NN
cord-005453-4057qib7	11508	11	,	,	,
cord-005453-4057qib7	11508	12	relapsed	relapsed	JJ
cord-005453-4057qib7	11508	13	and	and	CC
cord-005453-4057qib7	11508	14	refractory	refractory	JJ
cord-005453-4057qib7	11508	15	NHL.All	NHL.All	NNP
cord-005453-4057qib7	11508	16	patients	patient	NNS
cord-005453-4057qib7	11508	17	were	be	VBD
cord-005453-4057qib7	11508	18	successfully	successfully	RB
cord-005453-4057qib7	11508	19	engrafted	engraft	VBN
cord-005453-4057qib7	11508	20	after	after	IN
cord-005453-4057qib7	11508	21	infusing	infuse	VBG
cord-005453-4057qib7	11508	22	APBSC	APBSC	NNS
cord-005453-4057qib7	11508	23	.	.	.
cord-005453-4057qib7	11509	1	The	the	DT
cord-005453-4057qib7	11509	2	average	average	JJ
cord-005453-4057qib7	11509	3	lowest	low	JJS
cord-005453-4057qib7	11509	4	leukocyte	leukocyte	NN
cord-005453-4057qib7	11509	5	in	in	IN
cord-005453-4057qib7	11509	6	CLGB	CLGB	NNP
cord-005453-4057qib7	11509	7	group	group	NN
cord-005453-4057qib7	11509	8	and	and	CC
cord-005453-4057qib7	11509	9	BEAM	BEAM	NNP
cord-005453-4057qib7	11509	10	group	group	NN
cord-005453-4057qib7	11509	11	were	be	VBD
cord-005453-4057qib7	11509	12	(	(	-LRB-
cord-005453-4057qib7	11509	13	0.023	0.023	CD
cord-005453-4057qib7	11509	14	±0.023	±0.023	NN
cord-005453-4057qib7	11509	15	)	)	-RRB-
cord-005453-4057qib7	11510	1	×10	×10	NNS
cord-005453-4057qib7	11510	2	9	9	CD
cord-005453-4057qib7	11510	3	/L	/L	,
cord-005453-4057qib7	11510	4	VS	VS	NNP
cord-005453-4057qib7	11510	5	(	(	-LRB-
cord-005453-4057qib7	11510	6	0.237±0.2033)×10	0.237±0.2033)×10	CD
cord-005453-4057qib7	11510	7	9	9	CD
cord-005453-4057qib7	11510	8	/L	/l	CD
cord-005453-4057qib7	11510	9	,	,	,
cord-005453-4057qib7	11510	10	respectively	respectively	RB
cord-005453-4057qib7	11510	11	.	.	.
cord-005453-4057qib7	11511	1	The	the	DT
cord-005453-4057qib7	11511	2	average	average	JJ
cord-005453-4057qib7	11511	3	lowest	low	JJS
cord-005453-4057qib7	11511	4	leukocyte	leukocyte	NN
cord-005453-4057qib7	11511	5	in	in	IN
cord-005453-4057qib7	11511	6	CLGB	CLGB	NNP
cord-005453-4057qib7	11511	7	group	group	NN
cord-005453-4057qib7	11511	8	was	be	VBD
cord-005453-4057qib7	11511	9	lower	low	JJR
cord-005453-4057qib7	11511	10	than	than	IN
cord-005453-4057qib7	11511	11	that	that	DT
cord-005453-4057qib7	11511	12	in	in	IN
cord-005453-4057qib7	11511	13	BEAM	BEAM	NNP
cord-005453-4057qib7	11511	14	group	group	NN
cord-005453-4057qib7	11511	15	.	.	.
cord-005453-4057qib7	11512	1	The	the	DT
cord-005453-4057qib7	11512	2	average	average	JJ
cord-005453-4057qib7	11512	3	time	time	NN
cord-005453-4057qib7	11512	4	to	to	IN
cord-005453-4057qib7	11512	5	ANC	ANC	NNP
cord-005453-4057qib7	11512	6	<	<	XX
cord-005453-4057qib7	11512	7	0.5×109	0.5×109	ADD
cord-005453-4057qib7	11513	1	/	/	NFP
cord-005453-4057qib7	11514	1	L	L	NNP
cord-005453-4057qib7	11514	2	in	in	IN
cord-005453-4057qib7	11514	3	CLGB	CLGB	NNP
cord-005453-4057qib7	11514	4	group	group	NN
cord-005453-4057qib7	11514	5	and	and	CC
cord-005453-4057qib7	11514	6	BEAM	BEAM	NNP
cord-005453-4057qib7	11514	7	group	group	NN
cord-005453-4057qib7	11514	8	were	be	VBD
cord-005453-4057qib7	11514	9	1.33d	1.33d	CD
cord-005453-4057qib7	11514	10	±1.53d	±1.53d	NN
cord-005453-4057qib7	11514	11	VS	VS	NNP
cord-005453-4057qib7	11514	12	3.57d±2.07d	3.57d±2.07d	CD
cord-005453-4057qib7	11514	13	.	.	.
cord-005453-4057qib7	11515	1	The	the	DT
cord-005453-4057qib7	11515	2	average	average	JJ
cord-005453-4057qib7	11515	3	time	time	NN
cord-005453-4057qib7	11515	4	to	to	IN
cord-005453-4057qib7	11515	5	ANC≥0.5×10	anc≥0.5×10	NN
cord-005453-4057qib7	11515	6	9	9	CD
cord-005453-4057qib7	11515	7	/L	/L	.
cord-005453-4057qib7	11515	8	in	in	IN
cord-005453-4057qib7	11515	9	CLGB	CLGB	NNP
cord-005453-4057qib7	11515	10	group	group	NN
cord-005453-4057qib7	11515	11	and	and	CC
cord-005453-4057qib7	11515	12	BEAM	BEAM	NNP
cord-005453-4057qib7	11515	13	group	group	NN
cord-005453-4057qib7	11515	14	were	be	VBD
cord-005453-4057qib7	11515	15	9.0d±1.0d	9.0d±1.0d	CD
cord-005453-4057qib7	11515	16	VS	VS	NNP
cord-005453-4057qib7	11515	17	10.0d±2.6d	10.0d±2.6d	CD
cord-005453-4057qib7	11515	18	;	;	:
cord-005453-4057qib7	11515	19	The	the	DT
cord-005453-4057qib7	11515	20	average	average	JJ
cord-005453-4057qib7	11515	21	time	time	NN
cord-005453-4057qib7	11515	22	to	to	IN
cord-005453-4057qib7	11515	23	PLT≥20×10	PLT≥20×10	NNP
cord-005453-4057qib7	11515	24	9	9	CD
cord-005453-4057qib7	11515	25	/L	/l	CD
cord-005453-4057qib7	11515	26	of	of	IN
cord-005453-4057qib7	11515	27	CLGB	CLGB	NNP
cord-005453-4057qib7	11515	28	group	group	NN
cord-005453-4057qib7	11515	29	was	be	VBD
cord-005453-4057qib7	11515	30	not	not	RB
cord-005453-4057qib7	11515	31	different	different	JJ
cord-005453-4057qib7	11515	32	to	to	IN
cord-005453-4057qib7	11515	33	that	that	DT
cord-005453-4057qib7	11515	34	of	of	IN
cord-005453-4057qib7	11515	35	BEAM	BEAM	NNP
cord-005453-4057qib7	11515	36	group	group	NN
cord-005453-4057qib7	11515	37	(	(	-LRB-
cord-005453-4057qib7	11515	38	8.0d±1.0d	8.0d±1.0d	IN
cord-005453-4057qib7	11515	39	VS	VS	NNP
cord-005453-4057qib7	11515	40	9.6d±2.2d	9.6d±2.2d	CD
cord-005453-4057qib7	11515	41	)	)	-RRB-
cord-005453-4057qib7	11516	1	the	the	DT
cord-005453-4057qib7	11516	2	average	average	JJ
cord-005453-4057qib7	11516	3	time	time	NN
cord-005453-4057qib7	11516	4	of	of	IN
cord-005453-4057qib7	11516	5	neutropenia	neutropenia	NN
cord-005453-4057qib7	11516	6	was	be	VBD
cord-005453-4057qib7	11516	7	n't	not	RB
cord-005453-4057qib7	11516	8	significantly	significantly	RB
cord-005453-4057qib7	11516	9	different	different	JJ
cord-005453-4057qib7	11516	10	in	in	IN
cord-005453-4057qib7	11516	11	two	two	CD
cord-005453-4057qib7	11516	12	groups	group	NNS
cord-005453-4057qib7	11516	13	(	(	-LRB-
cord-005453-4057qib7	11516	14	8.33d±3.1d	8.33d±3.1d	CD
cord-005453-4057qib7	11516	15	VS	VS	NNP
cord-005453-4057qib7	11516	16	8.0d±2.1d	8.0d±2.1d	NN
cord-005453-4057qib7	11516	17	)	)	-RRB-
cord-005453-4057qib7	11516	18	.	.	.
cord-005453-4057qib7	11517	1	The	the	DT
cord-005453-4057qib7	11517	2	adverse	adverse	JJ
cord-005453-4057qib7	11517	3	reactions	reaction	NNS
cord-005453-4057qib7	11517	4	of	of	IN
cord-005453-4057qib7	11517	5	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	11517	6	tract	tract	NN
cord-005453-4057qib7	11517	7	and	and	CC
cord-005453-4057qib7	11517	8	oral	oral	JJ
cord-005453-4057qib7	11517	9	mucosa	mucosa	NN
cord-005453-4057qib7	11517	10	were	be	VBD
cord-005453-4057qib7	11517	11	close	close	JJ
cord-005453-4057qib7	11517	12	in	in	IN
cord-005453-4057qib7	11517	13	tow	tow	NN
cord-005453-4057qib7	11517	14	groups	group	NNS
cord-005453-4057qib7	11517	15	.	.	.
cord-005453-4057qib7	11518	1	VOD	VOD	NNP
cord-005453-4057qib7	11518	2	,	,	,
cord-005453-4057qib7	11518	3	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	11518	4	cystitis	cystitis	NN
cord-005453-4057qib7	11518	5	,	,	,
cord-005453-4057qib7	11518	6	pretreatment	pretreatment	NN
cord-005453-4057qib7	11518	7	-	-	HYPH
cord-005453-4057qib7	11518	8	related	relate	VBN
cord-005453-4057qib7	11518	9	interstitial	interstitial	JJ
cord-005453-4057qib7	11518	10	pneumonia	pneumonia	NN
cord-005453-4057qib7	11518	11	,	,	,
cord-005453-4057qib7	11518	12	Liver	liver	NN
cord-005453-4057qib7	11518	13	and	and	CC
cord-005453-4057qib7	11518	14	kidney	kidney	NN
cord-005453-4057qib7	11518	15	dysfunction	dysfunction	NN
cord-005453-4057qib7	11518	16	were	be	VBD
cord-005453-4057qib7	11518	17	not	not	RB
cord-005453-4057qib7	11518	18	happened	happen	VBN
cord-005453-4057qib7	11518	19	in	in	IN
cord-005453-4057qib7	11518	20	tow	tow	NN
cord-005453-4057qib7	11518	21	groups	group	NNS
cord-005453-4057qib7	11518	22	.	.	.
cord-005453-4057qib7	11519	1	The	the	DT
cord-005453-4057qib7	11519	2	rate	rate	NN
cord-005453-4057qib7	11519	3	of	of	IN
cord-005453-4057qib7	11519	4	infectious	infectious	JJ
cord-005453-4057qib7	11519	5	fever	fever	NN
cord-005453-4057qib7	11519	6	was	be	VBD
cord-005453-4057qib7	11519	7	close	close	JJ
cord-005453-4057qib7	11519	8	in	in	IN
cord-005453-4057qib7	11519	9	two	two	CD
cord-005453-4057qib7	11519	10	groups	group	NNS
cord-005453-4057qib7	11519	11	(	(	-LRB-
cord-005453-4057qib7	11519	12	2/3	2/3	CD
cord-005453-4057qib7	11519	13	VS	VS	NNP
cord-005453-4057qib7	11519	14	4/7	4/7	CD
cord-005453-4057qib7	11519	15	)	)	-RRB-
cord-005453-4057qib7	11519	16	.	.	.
cord-005453-4057qib7	11520	1	The	the	DT
cord-005453-4057qib7	11520	2	median	median	JJ
cord-005453-4057qib7	11520	3	followup	followup	JJ
cord-005453-4057qib7	11520	4	period	period	NN
cord-005453-4057qib7	11520	5	in	in	IN
cord-005453-4057qib7	11520	6	BEAM	BEAM	NNP
cord-005453-4057qib7	11520	7	group	group	NN
cord-005453-4057qib7	11520	8	was	be	VBD
cord-005453-4057qib7	11520	9	9	9	CD
cord-005453-4057qib7	11520	10	(	(	-LRB-
cord-005453-4057qib7	11520	11	1~19	1~19	CD
cord-005453-4057qib7	11520	12	)	)	-RRB-
cord-005453-4057qib7	11520	13	months	month	NNS
cord-005453-4057qib7	11520	14	.	.	.
cord-005453-4057qib7	11521	1	In	in	IN
cord-005453-4057qib7	11521	2	the	the	DT
cord-005453-4057qib7	11521	3	BEAM	BEAM	NNP
cord-005453-4057qib7	11521	4	group	group	NN
cord-005453-4057qib7	11521	5	,	,	,
cord-005453-4057qib7	11521	6	a	a	DT
cord-005453-4057qib7	11521	7	patient	patient	NN
cord-005453-4057qib7	11521	8	died	die	VBD
cord-005453-4057qib7	11521	9	20	20	CD
cord-005453-4057qib7	11521	10	days	day	NNS
cord-005453-4057qib7	11521	11	after	after	IN
cord-005453-4057qib7	11521	12	transplantation	transplantation	NN
cord-005453-4057qib7	11521	13	,	,	,
cord-005453-4057qib7	11521	14	because	because	IN
cord-005453-4057qib7	11521	15	he	-PRON-	PRP
cord-005453-4057qib7	11521	16	was	be	VBD
cord-005453-4057qib7	11521	17	diagnosed	diagnose	VBN
cord-005453-4057qib7	11521	18	with	with	IN
cord-005453-4057qib7	11521	19	recurrent	recurrent	JJ
cord-005453-4057qib7	11521	20	NKT	NKT	NNP
cord-005453-4057qib7	11521	21	cell	cell	NN
cord-005453-4057qib7	11521	22	lymphoma	lymphoma	NN
cord-005453-4057qib7	11521	23	and	and	CC
cord-005453-4057qib7	11521	24	intracranial	intracranial	JJ
cord-005453-4057qib7	11521	25	infection	infection	NN
cord-005453-4057qib7	11521	26	caused	cause	VBN
cord-005453-4057qib7	11521	27	by	by	IN
cord-005453-4057qib7	11521	28	severe	severe	JJ
cord-005453-4057qib7	11521	29	sinus	sinus	NN
cord-005453-4057qib7	11521	30	infection	infection	NN
cord-005453-4057qib7	11521	31	.	.	.
cord-005453-4057qib7	11522	1	Another	another	DT
cord-005453-4057qib7	11522	2	case	case	NN
cord-005453-4057qib7	11522	3	of	of	IN
cord-005453-4057qib7	11522	4	BEAM	BEAM	NNP
cord-005453-4057qib7	11522	5	group	group	NN
cord-005453-4057qib7	11522	6	was	be	VBD
cord-005453-4057qib7	11522	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	11522	8	as	as	IN
cord-005453-4057qib7	11522	9	double	double	RB
cord-005453-4057qib7	11522	10	-	-	HYPH
cord-005453-4057qib7	11522	11	expressed	express	VBN
cord-005453-4057qib7	11522	12	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11522	13	,	,	,
cord-005453-4057qib7	11522	14	which	which	WDT
cord-005453-4057qib7	11522	15	relapsed	relapse	VBD
cord-005453-4057qib7	11522	16	3	3	CD
cord-005453-4057qib7	11522	17	months	month	NNS
cord-005453-4057qib7	11522	18	after	after	IN
cord-005453-4057qib7	11522	19	transplantation	transplantation	NN
cord-005453-4057qib7	11522	20	.	.	.
cord-005453-4057qib7	11523	1	The	the	DT
cord-005453-4057qib7	11523	2	remaining	remain	VBG
cord-005453-4057qib7	11523	3	patients	patient	NNS
cord-005453-4057qib7	11523	4	in	in	IN
cord-005453-4057qib7	11523	5	EBMT	EBMT	NNP
cord-005453-4057qib7	11523	6	group	group	NN
cord-005453-4057qib7	11523	7	survived	survive	VBD
cord-005453-4057qib7	11523	8	disease	disease	NN
cord-005453-4057qib7	11523	9	-	-	HYPH
cord-005453-4057qib7	11523	10	free	free	JJ
cord-005453-4057qib7	11523	11	.	.	.
cord-005453-4057qib7	11524	1	The	the	DT
cord-005453-4057qib7	11524	2	follow	follow	VB
cord-005453-4057qib7	11524	3	-	-	HYPH
cord-005453-4057qib7	11524	4	up	up	NN
cord-005453-4057qib7	11524	5	time	time	NN
cord-005453-4057qib7	11524	6	of	of	IN
cord-005453-4057qib7	11524	7	3	3	CD
cord-005453-4057qib7	11524	8	patients	patient	NNS
cord-005453-4057qib7	11524	9	in	in	IN
cord-005453-4057qib7	11524	10	CLGB	CLGB	NNP
cord-005453-4057qib7	11524	11	group	group	NN
cord-005453-4057qib7	11524	12	were	be	VBD
cord-005453-4057qib7	11524	13	2	2	CD
cord-005453-4057qib7	11524	14	months	month	NNS
cord-005453-4057qib7	11524	15	,	,	,
cord-005453-4057qib7	11524	16	3	3	CD
cord-005453-4057qib7	11524	17	months	month	NNS
cord-005453-4057qib7	11524	18	and	and	CC
cord-005453-4057qib7	11524	19	9	9	CD
cord-005453-4057qib7	11524	20	months	month	NNS
cord-005453-4057qib7	11524	21	respectively	respectively	RB
cord-005453-4057qib7	11524	22	.	.	.
cord-005453-4057qib7	11525	1	All	all	DT
cord-005453-4057qib7	11525	2	patients	patient	NNS
cord-005453-4057qib7	11525	3	survived	survive	VBD
cord-005453-4057qib7	11525	4	without	without	IN
cord-005453-4057qib7	11525	5	disease	disease	NN
cord-005453-4057qib7	11525	6	.	.	.
cord-005453-4057qib7	11526	1	However	however	RB
cord-005453-4057qib7	11526	2	,	,	,
cord-005453-4057qib7	11526	3	the	the	DT
cord-005453-4057qib7	11526	4	follow	follow	NN
cord-005453-4057qib7	11526	5	-	-	HYPH
cord-005453-4057qib7	11526	6	up	up	NN
cord-005453-4057qib7	11526	7	time	time	NN
cord-005453-4057qib7	11526	8	is	be	VBZ
cord-005453-4057qib7	11526	9	short	short	JJ
cord-005453-4057qib7	11526	10	and	and	CC
cord-005453-4057qib7	11526	11	needs	need	VBZ
cord-005453-4057qib7	11526	12	long	long	JJ
cord-005453-4057qib7	11526	13	-	-	HYPH
cord-005453-4057qib7	11526	14	term	term	NN
cord-005453-4057qib7	11526	15	follow	follow	NN
cord-005453-4057qib7	11526	16	-	-	HYPH
cord-005453-4057qib7	11526	17	up	up	NN
cord-005453-4057qib7	11526	18	.	.	.
cord-005453-4057qib7	11527	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11527	2	:	:	:
cord-005453-4057qib7	11528	1	The	the	DT
cord-005453-4057qib7	11528	2	treatment	treatment	NN
cord-005453-4057qib7	11528	3	of	of	IN
cord-005453-4057qib7	11528	4	intensive	intensive	JJ
cord-005453-4057qib7	11528	5	preconditioning	preconditioning	NN
cord-005453-4057qib7	11528	6	regimen	regimen	NN
cord-005453-4057qib7	11528	7	containing	contain	VBG
cord-005453-4057qib7	11528	8	Cladribine	Cladribine	NNP
cord-005453-4057qib7	11528	9	(	(	-LRB-
cord-005453-4057qib7	11528	10	CLGB	CLGB	NNP
cord-005453-4057qib7	11528	11	)	)	-RRB-
cord-005453-4057qib7	11528	12	for	for	IN
cord-005453-4057qib7	11528	13	refractory	refractory	JJ
cord-005453-4057qib7	11528	14	and	and	CC
cord-005453-4057qib7	11528	15	relapsed	relapse	VBD
cord-005453-4057qib7	11528	16	young	young	JJ
cord-005453-4057qib7	11528	17	highly	highly	RB
cord-005453-4057qib7	11528	18	invasive	invasive	JJ
cord-005453-4057qib7	11528	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	11528	20	undergoing	undergo	VBG
cord-005453-4057qib7	11528	21	APBSCT	APBSCT	NNP
cord-005453-4057qib7	11528	22	is	be	VBZ
cord-005453-4057qib7	11528	23	safe	safe	JJ
cord-005453-4057qib7	11528	24	.	.	.
cord-005453-4057qib7	11529	1	The	the	DT
cord-005453-4057qib7	11529	2	time	time	NN
cord-005453-4057qib7	11529	3	of	of	IN
cord-005453-4057qib7	11529	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11529	5	reconstruction	reconstruction	NN
cord-005453-4057qib7	11529	6	is	be	VBZ
cord-005453-4057qib7	11529	7	short	short	JJ
cord-005453-4057qib7	11529	8	,	,	,
cord-005453-4057qib7	11529	9	and	and	CC
cord-005453-4057qib7	11529	10	the	the	DT
cord-005453-4057qib7	11529	11	adverse	adverse	JJ
cord-005453-4057qib7	11529	12	effects	effect	NNS
cord-005453-4057qib7	11529	13	is	be	VBZ
cord-005453-4057qib7	11529	14	tolerable	tolerable	JJ
cord-005453-4057qib7	11529	15	for	for	IN
cord-005453-4057qib7	11529	16	patients	patient	NNS
cord-005453-4057qib7	11529	17	with	with	IN
cord-005453-4057qib7	11529	18	refractory	refractory	JJ
cord-005453-4057qib7	11529	19	and	and	CC
cord-005453-4057qib7	11529	20	relapsed	relapse	VBD
cord-005453-4057qib7	11529	21	young	young	JJ
cord-005453-4057qib7	11529	22	highly	highly	RB
cord-005453-4057qib7	11529	23	invasive	invasive	JJ
cord-005453-4057qib7	11529	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	11529	25	.	.	.
cord-005453-4057qib7	11530	1	The	the	DT
cord-005453-4057qib7	11530	2	current	current	JJ
cord-005453-4057qib7	11530	3	short	short	JJ
cord-005453-4057qib7	11530	4	-	-	HYPH
cord-005453-4057qib7	11530	5	term	term	NN
cord-005453-4057qib7	11530	6	outcome	outcome	NN
cord-005453-4057qib7	11530	7	is	be	VBZ
cord-005453-4057qib7	11530	8	good	good	JJ
cord-005453-4057qib7	11530	9	,	,	,
cord-005453-4057qib7	11530	10	but	but	CC
cord-005453-4057qib7	11530	11	the	the	DT
cord-005453-4057qib7	11530	12	long	long	JJ
cord-005453-4057qib7	11530	13	-	-	HYPH
cord-005453-4057qib7	11530	14	term	term	NN
cord-005453-4057qib7	11530	15	effect	effect	NN
cord-005453-4057qib7	11530	16	need	need	VBP
cord-005453-4057qib7	11530	17	a	a	DT
cord-005453-4057qib7	11530	18	longer	long	JJR
cord-005453-4057qib7	11530	19	time	time	NN
cord-005453-4057qib7	11530	20	to	to	TO
cord-005453-4057qib7	11530	21	follow	follow	VB
cord-005453-4057qib7	11530	22	-	-	HYPH
cord-005453-4057qib7	11530	23	up	up	NN
cord-005453-4057qib7	11530	24	.	.	.
cord-005453-4057qib7	11531	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11531	2	:	:	:
cord-005453-4057qib7	11532	1	This	this	DT
cord-005453-4057qib7	11532	2	work	work	NN
cord-005453-4057qib7	11532	3	was	be	VBD
cord-005453-4057qib7	11532	4	supported	support	VBN
cord-005453-4057qib7	11532	5	by	by	IN
cord-005453-4057qib7	11532	6	National	National	NNP
cord-005453-4057qib7	11532	7	Nature	Nature	NNP
cord-005453-4057qib7	11532	8	Sciences	Sciences	NNPS
cord-005453-4057qib7	11532	9	Found	find	VBN
cord-005453-4057qib7	11532	10	of	of	IN
cord-005453-4057qib7	11532	11	China	China	NNP
cord-005453-4057qib7	11532	12	(	(	-LRB-
cord-005453-4057qib7	11532	13	81300417	81300417	CD
cord-005453-4057qib7	11532	14	)	)	-RRB-
cord-005453-4057qib7	11532	15	.	.	.
cord-005453-4057qib7	11533	1	There	there	EX
cord-005453-4057qib7	11533	2	is	be	VBZ
cord-005453-4057qib7	11533	3	no	no	DT
cord-005453-4057qib7	11533	4	disclosure	disclosure	NN
cord-005453-4057qib7	11533	5	of	of	IN
cord-005453-4057qib7	11533	6	conflict	conflict	NN
cord-005453-4057qib7	11533	7	of	of	IN
cord-005453-4057qib7	11533	8	interest	interest	NN
cord-005453-4057qib7	11533	9	.	.	.
cord-005453-4057qib7	11534	1	The	the	DT
cord-005453-4057qib7	11534	2	all	all	DT
cord-005453-4057qib7	11534	3	authors	author	NNS
cord-005453-4057qib7	11534	4	name	name	VBP
cord-005453-4057qib7	11534	5	:	:	:
cord-005453-4057qib7	11535	1	Xiang	Xiang	NNP
cord-005453-4057qib7	11535	2	-	-	HYPH
cord-005453-4057qib7	11535	3	Li	Li	NNP
cord-005453-4057qib7	11535	4	Chen	Chen	NNP
cord-005453-4057qib7	11535	5	,	,	,
cord-005453-4057qib7	11535	6	Yu	Yu	NNP
cord-005453-4057qib7	11535	7	-	-	HYPH
cord-005453-4057qib7	11535	8	Zhu	Zhu	NNP
cord-005453-4057qib7	11535	9	Zang	Zang	NNP
cord-005453-4057qib7	11535	10	,	,	,
cord-005453-4057qib7	11535	11	Wen	Wen	NNP
cord-005453-4057qib7	11535	12	-	-	HYPH
cord-005453-4057qib7	11535	13	Hui	Hui	NNP
cord-005453-4057qib7	11535	14	Zhang	Zhang	NNP
cord-005453-4057qib7	11535	15	,	,	,
cord-005453-4057qib7	11535	16	Yin	Yin	NNP
cord-005453-4057qib7	11535	17	Zhang	Zhang	NNP
cord-005453-4057qib7	11535	18	,	,	,
cord-005453-4057qib7	11535	19	Zhong	Zhong	NNP
cord-005453-4057qib7	11535	20	-	-	HYPH
cord-005453-4057qib7	11535	21	Wen	Wen	NNP
cord-005453-4057qib7	11535	22	Liu	Liu	NNP
cord-005453-4057qib7	11535	23	,	,	,
cord-005453-4057qib7	11535	24	Ping	Ping	NNP
cord-005453-4057qib7	11535	25	-	-	HYPH
cord-005453-4057qib7	11535	26	Chong	Chong	NNP
cord-005453-4057qib7	11535	27	Lei	Lei	NNP
cord-005453-4057qib7	11535	28	,	,	,
cord-005453-4057qib7	11535	29	Jing	Jing	NNP
cord-005453-4057qib7	11535	30	Yang	Yang	NNP
cord-005453-4057qib7	11535	31	,	,	,
cord-005453-4057qib7	11535	32	Yu	Yu	NNP
cord-005453-4057qib7	11535	33	-	-	HYPH
cord-005453-4057qib7	11535	34	Qing	Qing	NNP
cord-005453-4057qib7	11535	35	Chen	Chen	NNP
cord-005453-4057qib7	11535	36	,	,	,
cord-005453-4057qib7	11535	37	Kai	Kai	NNP
cord-005453-4057qib7	11535	38	Sun	Sun	NNP
cord-005453-4057qib7	11535	39	.	.	.
cord-005453-4057qib7	11536	1	Background	background	NN
cord-005453-4057qib7	11536	2	:	:	:
cord-005453-4057qib7	11537	1	Small	small	JJ
cord-005453-4057qib7	11537	2	part	part	NN
cord-005453-4057qib7	11537	3	of	of	IN
cord-005453-4057qib7	11537	4	children	child	NNS
cord-005453-4057qib7	11537	5	with	with	IN
cord-005453-4057qib7	11537	6	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11537	7	Disease	Disease	NNP
cord-005453-4057qib7	11537	8	(	(	-LRB-
cord-005453-4057qib7	11537	9	HD	HD	NNP
cord-005453-4057qib7	11537	10	)	)	-RRB-
cord-005453-4057qib7	11537	11	demonstrate	demonstrate	VB
cord-005453-4057qib7	11537	12	initial	initial	JJ
cord-005453-4057qib7	11537	13	resistance	resistance	NN
cord-005453-4057qib7	11537	14	to	to	IN
cord-005453-4057qib7	11537	15	the	the	DT
cord-005453-4057qib7	11537	16	standard	standard	NN
cord-005453-4057qib7	11537	17	and	and	CC
cord-005453-4057qib7	11537	18	even	even	RB
cord-005453-4057qib7	11537	19	"	"	``
cord-005453-4057qib7	11537	20	salvage	salvage	VB
cord-005453-4057qib7	11537	21	"	"	''
cord-005453-4057qib7	11537	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11537	23	and	and	CC
cord-005453-4057qib7	11537	24	need	need	VB
cord-005453-4057qib7	11537	25	innovative	innovative	JJ
cord-005453-4057qib7	11537	26	drugs	drug	NNS
cord-005453-4057qib7	11537	27	for	for	IN
cord-005453-4057qib7	11537	28	the	the	DT
cord-005453-4057qib7	11537	29	treatment	treatment	NN
cord-005453-4057qib7	11537	30	.	.	.
cord-005453-4057qib7	11538	1	Methods	method	NNS
cord-005453-4057qib7	11538	2	:	:	:
cord-005453-4057qib7	11538	3	A	a	DT
cord-005453-4057qib7	11538	4	15-year	15-year	JJ
cord-005453-4057qib7	11538	5	girl	girl	NN
cord-005453-4057qib7	11538	6	was	be	VBD
cord-005453-4057qib7	11538	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	11538	8	with	with	IN
cord-005453-4057qib7	11538	9	classical	classical	JJ
cord-005453-4057qib7	11538	10	HD	hd	NN
cord-005453-4057qib7	11538	11	(	(	-LRB-
cord-005453-4057qib7	11538	12	nodular	nodular	JJ
cord-005453-4057qib7	11538	13	sclerosis)corresponding	sclerosis)corresponding	NNP
cord-005453-4057qib7	11538	14	to	to	TO
cord-005453-4057qib7	11538	15	stage	stage	NN
cord-005453-4057qib7	11538	16	II	II	NNP
cord-005453-4057qib7	11538	17	E	e	NN
cord-005453-4057qib7	11538	18	B	b	NN
cord-005453-4057qib7	11538	19	(	(	-LRB-
cord-005453-4057qib7	11538	20	fever	fever	NN
cord-005453-4057qib7	11538	21	>	>	XX
cord-005453-4057qib7	11538	22	38	38	CD
cord-005453-4057qib7	11538	23	°	°	NN
cord-005453-4057qib7	11538	24	C	c	NN
cord-005453-4057qib7	11538	25	)	)	-RRB-
cord-005453-4057qib7	11538	26	in	in	IN
cord-005453-4057qib7	11538	27	April	April	NNP
cord-005453-4057qib7	11538	28	2016.After	2016.after	CD
cord-005453-4057qib7	11539	1	two	two	CD
cord-005453-4057qib7	11539	2	cycles	cycle	NNS
cord-005453-4057qib7	11539	3	of	of	IN
cord-005453-4057qib7	11539	4	OEPA	OEPA	NNP
cord-005453-4057qib7	11539	5	(	(	-LRB-
cord-005453-4057qib7	11539	6	vincristine	vincristine	NN
cord-005453-4057qib7	11539	7	,	,	,
cord-005453-4057qib7	11539	8	etoposide	etoposide	RB
cord-005453-4057qib7	11539	9	,	,	,
cord-005453-4057qib7	11539	10	prednisone	prednisone	NN
cord-005453-4057qib7	11539	11	and	and	CC
cord-005453-4057qib7	11539	12	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	11539	13	)	)	-RRB-
cord-005453-4057qib7	11539	14	and	and	CC
cord-005453-4057qib7	11539	15	next	next	JJ
cord-005453-4057qib7	11539	16	two	two	CD
cord-005453-4057qib7	11539	17	cycles	cycle	NNS
cord-005453-4057qib7	11539	18	COPP	COPP	NNP
cord-005453-4057qib7	11539	19	(	(	-LRB-
cord-005453-4057qib7	11539	20	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	11539	21	,	,	,
cord-005453-4057qib7	11539	22	vincristine	vincristine	NN
cord-005453-4057qib7	11539	23	,	,	,
cord-005453-4057qib7	11539	24	prednisone	prednisone	NN
cord-005453-4057qib7	11539	25	and	and	CC
cord-005453-4057qib7	11539	26	procarbazine	procarbazine	NN
cord-005453-4057qib7	11539	27	)	)	-RRB-
cord-005453-4057qib7	11540	1	the	the	DT
cord-005453-4057qib7	11540	2	patient	patient	NN
cord-005453-4057qib7	11540	3	again	again	RB
cord-005453-4057qib7	11540	4	had	have	VBD
cord-005453-4057qib7	11540	5	progressive	progressive	JJ
cord-005453-4057qib7	11540	6	disease	disease	NN
cord-005453-4057qib7	11540	7	.	.	.
cord-005453-4057qib7	11541	1	As	as	IN
cord-005453-4057qib7	11541	2	the	the	DT
cord-005453-4057qib7	11541	3	patient	patient	NN
cord-005453-4057qib7	11541	4	achieved	achieve	VBD
cord-005453-4057qib7	11541	5	a	a	DT
cord-005453-4057qib7	11541	6	partial	partial	JJ
cord-005453-4057qib7	11541	7	response	response	NN
cord-005453-4057qib7	11541	8	(	(	-LRB-
cord-005453-4057qib7	11541	9	PR	PR	NNP
cord-005453-4057qib7	11541	10	)	)	-RRB-
cord-005453-4057qib7	11541	11	after	after	IN
cord-005453-4057qib7	11541	12	"	"	``
cord-005453-4057qib7	11541	13	Salvage"therapy	Salvage"therapy	NNP
cord-005453-4057qib7	11541	14	with	with	IN
cord-005453-4057qib7	11541	15	two	two	CD
cord-005453-4057qib7	11541	16	cycles	cycle	NNS
cord-005453-4057qib7	11541	17	of	of	IN
cord-005453-4057qib7	11541	18	IGEV	IGEV	NNP
cord-005453-4057qib7	11541	19	(	(	-LRB-
cord-005453-4057qib7	11541	20	ifosfamide	ifosfamide	NNP
cord-005453-4057qib7	11541	21	,	,	,
cord-005453-4057qib7	11541	22	gemcitabine	gemcitabine	NNP
cord-005453-4057qib7	11541	23	,	,	,
cord-005453-4057qib7	11541	24	vinorelbine	vinorelbine	NNP
cord-005453-4057qib7	11541	25	,	,	,
cord-005453-4057qib7	11541	26	and	and	CC
cord-005453-4057qib7	11541	27	prednisone	prednisone	NNP
cord-005453-4057qib7	11541	28	)	)	-RRB-
cord-005453-4057qib7	11541	29	,	,	,
cord-005453-4057qib7	11541	30	she	-PRON-	PRP
cord-005453-4057qib7	11541	31	received	receive	VBD
cord-005453-4057qib7	11541	32	auto	auto	NN
cord-005453-4057qib7	11541	33	-	-	HYPH
cord-005453-4057qib7	11541	34	SCT	SCT	NNP
cord-005453-4057qib7	11541	35	in	in	IN
cord-005453-4057qib7	11541	36	February	February	NNP
cord-005453-4057qib7	11541	37	2017	2017	CD
cord-005453-4057qib7	11541	38	(	(	-LRB-
cord-005453-4057qib7	11541	39	patient	patient	JJ
cord-005453-4057qib7	11541	40	status	status	NN
cord-005453-4057qib7	11541	41	before	before	IN
cord-005453-4057qib7	11541	42	auto	auto	NN
cord-005453-4057qib7	11541	43	-	-	HYPH
cord-005453-4057qib7	11541	44	SCT	SCT	NNP
cord-005453-4057qib7	11541	45	was	be	VBD
cord-005453-4057qib7	11541	46	PR	PR	NNP
cord-005453-4057qib7	11541	47	)	)	-RRB-
cord-005453-4057qib7	11541	48	.	.	.
cord-005453-4057qib7	11542	1	We	-PRON-	PRP
cord-005453-4057qib7	11542	2	used	use	VBD
cord-005453-4057qib7	11542	3	CCNU	CCNU	NNP
cord-005453-4057qib7	11542	4	-	-	HYPH
cord-005453-4057qib7	11542	5	containing	contain	VBG
cord-005453-4057qib7	11542	6	conditioning	conditioning	NN
cord-005453-4057qib7	11542	7	regimen	regimen	NN
cord-005453-4057qib7	11542	8	CEM	CEM	NNP
cord-005453-4057qib7	11542	9	:	:	:
cord-005453-4057qib7	11543	1	Lomustine	Lomustine	NNP
cord-005453-4057qib7	11543	2	(	(	-LRB-
cord-005453-4057qib7	11543	3	CCNU	CCNU	NNP
cord-005453-4057qib7	11543	4	)	)	-RRB-
cord-005453-4057qib7	11544	1	300	300	CD
cord-005453-4057qib7	11545	1	mg	mg	NNP
cord-005453-4057qib7	11545	2	/	/	SYM
cord-005453-4057qib7	11545	3	m	m	NNP
cord-005453-4057qib7	11545	4	2	2	CD
cord-005453-4057qib7	11545	5	+	+	CC
cord-005453-4057qib7	11546	1	Etoposide	etoposide	RB
cord-005453-4057qib7	11546	2	1200	1200	CD
cord-005453-4057qib7	11547	1	mg	mg	NNP
cord-005453-4057qib7	11547	2	/	/	SYM
cord-005453-4057qib7	11547	3	m	m	NN
cord-005453-4057qib7	11547	4	2	2	CD
cord-005453-4057qib7	11548	1	+	+	CC
cord-005453-4057qib7	11548	2	Melphalan	Melphalan	NNP
cord-005453-4057qib7	11548	3	180	180	CD
cord-005453-4057qib7	11548	4	mg	mg	NNP
cord-005453-4057qib7	11548	5	/	/	SYM
cord-005453-4057qib7	11548	6	m	m	NN
cord-005453-4057qib7	11548	7	2	2	CD
cord-005453-4057qib7	11548	8	.	.	.
cord-005453-4057qib7	11549	1	At	at	IN
cord-005453-4057qib7	11549	2	Day	day	NN
cord-005453-4057qib7	11549	3	+90	+90	CD
cord-005453-4057qib7	11549	4	after	after	IN
cord-005453-4057qib7	11549	5	auto	auto	NN
cord-005453-4057qib7	11549	6	-	-	HYPH
cord-005453-4057qib7	11549	7	SCT	SCT	NNP
cord-005453-4057qib7	11549	8	,	,	,
cord-005453-4057qib7	11549	9	the	the	DT
cord-005453-4057qib7	11549	10	patient	patient	NN
cord-005453-4057qib7	11549	11	again	again	RB
cord-005453-4057qib7	11549	12	demonstrated	demonstrate	VBD
cord-005453-4057qib7	11549	13	progression	progression	NN
cord-005453-4057qib7	11549	14	of	of	IN
cord-005453-4057qib7	11549	15	the	the	DT
cord-005453-4057qib7	11549	16	disease	disease	NN
cord-005453-4057qib7	11549	17	:	:	:
cord-005453-4057qib7	11550	1	PET	PET	NNP
cord-005453-4057qib7	11550	2	/	/	SYM
cord-005453-4057qib7	11550	3	CT	CT	NNP
cord-005453-4057qib7	11550	4	-	-	HYPH
cord-005453-4057qib7	11550	5	examination	examination	NN
cord-005453-4057qib7	11550	6	showed	show	VBD
cord-005453-4057qib7	11550	7	mediastinal	mediastinal	JJ
cord-005453-4057qib7	11550	8	tumor	tumor	NN
cord-005453-4057qib7	11550	9	mass	mass	NN
cord-005453-4057qib7	11550	10	enlargement	enlargement	NN
cord-005453-4057qib7	11550	11	with	with	IN
cord-005453-4057qib7	11550	12	increased	increase	VBN
cord-005453-4057qib7	11550	13	left	left	JJ
cord-005453-4057qib7	11550	14	lung	lung	NN
cord-005453-4057qib7	11550	15	nodule	nodule	NN
cord-005453-4057qib7	11550	16	simultaneously	simultaneously	RB
cord-005453-4057qib7	11550	17	to	to	IN
cord-005453-4057qib7	11550	18	short	short	JJ
cord-005453-4057qib7	11550	19	metabolic	metabolic	JJ
cord-005453-4057qib7	11550	20	activity	activity	NN
cord-005453-4057qib7	11550	21	.	.	.
cord-005453-4057qib7	11551	1	Patient	Patient	NNP
cord-005453-4057qib7	11551	2	was	be	VBD
cord-005453-4057qib7	11551	3	under	under	IN
cord-005453-4057qib7	11551	4	observation	observation	NN
cord-005453-4057qib7	11551	5	.	.	.
cord-005453-4057qib7	11552	1	At	at	IN
cord-005453-4057qib7	11552	2	Day	day	NN
cord-005453-4057qib7	11552	3	+140	+140	XX
cord-005453-4057qib7	11552	4	the	the	DT
cord-005453-4057qib7	11552	5	disease	disease	NN
cord-005453-4057qib7	11552	6	had	have	VBD
cord-005453-4057qib7	11552	7	relapsed	relapse	VBN
cord-005453-4057qib7	11552	8	and	and	CC
cord-005453-4057qib7	11552	9	progressed	progress	VBN
cord-005453-4057qib7	11552	10	-examination	-examination	NN
cord-005453-4057qib7	11552	11	by	by	IN
cord-005453-4057qib7	11552	12	PET	PET	NNP
cord-005453-4057qib7	11552	13	/	/	SYM
cord-005453-4057qib7	11552	14	CT	CT	NNP
cord-005453-4057qib7	11552	15	demonstrated	demonstrate	VBD
cord-005453-4057qib7	11552	16	multifocal	multifocal	JJ
cord-005453-4057qib7	11552	17	progressive	progressive	JJ
cord-005453-4057qib7	11552	18	disease	disease	NN
cord-005453-4057qib7	11552	19	with	with	IN
cord-005453-4057qib7	11552	20	multiple	multiple	JJ
cord-005453-4057qib7	11552	21	pulmonary	pulmonary	JJ
cord-005453-4057qib7	11552	22	lesions	lesion	NNS
cord-005453-4057qib7	11552	23	and	and	CC
cord-005453-4057qib7	11552	24	increased	increase	VBN
cord-005453-4057qib7	11552	25	metabolism	metabolism	NN
cord-005453-4057qib7	11552	26	in	in	IN
cord-005453-4057qib7	11552	27	comparison	comparison	NN
cord-005453-4057qib7	11552	28	with	with	IN
cord-005453-4057qib7	11552	29	the	the	DT
cord-005453-4057qib7	11552	30	previous	previous	JJ
cord-005453-4057qib7	11552	31	PET	PET	NNP
cord-005453-4057qib7	11552	32	/	/	SYM
cord-005453-4057qib7	11552	33	CT	CT	NNP
cord-005453-4057qib7	11552	34	scan	scan	NN
cord-005453-4057qib7	11552	35	.	.	.
cord-005453-4057qib7	11553	1	In	in	IN
cord-005453-4057qib7	11553	2	July	July	NNP
cord-005453-4057qib7	11553	3	-	-	HYPH
cord-005453-4057qib7	11553	4	October	October	NNP
cord-005453-4057qib7	11553	5	2017	2017	CD
cord-005453-4057qib7	11553	6	,	,	,
cord-005453-4057qib7	11553	7	the	the	DT
cord-005453-4057qib7	11553	8	patient	patient	NN
cord-005453-4057qib7	11553	9	had	have	VBD
cord-005453-4057qib7	11553	10	Salvage	salvage	NN
cord-005453-4057qib7	11553	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11553	12	with	with	IN
cord-005453-4057qib7	11553	13	a	a	DT
cord-005453-4057qib7	11553	14	combination	combination	NN
cord-005453-4057qib7	11553	15	of	of	IN
cord-005453-4057qib7	11553	16	Brentuximab	Brentuximab	NNP
cord-005453-4057qib7	11553	17	vedotin	vedotin	NNP
cord-005453-4057qib7	11553	18	(	(	-LRB-
cord-005453-4057qib7	11553	19	BV	BV	NNP
cord-005453-4057qib7	11553	20	)	)	-RRB-
cord-005453-4057qib7	11553	21	(	(	-LRB-
cord-005453-4057qib7	11553	22	BV	BV	NNP
cord-005453-4057qib7	11553	23	DHAP	DHAP	NNP
cord-005453-4057qib7	11553	24	(	(	-LRB-
cord-005453-4057qib7	11553	25	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	11553	26	,	,	,
cord-005453-4057qib7	11553	27	cytarabine	cytarabine	NN
cord-005453-4057qib7	11553	28	,	,	,
cord-005453-4057qib7	11553	29	cisplatin	cisplatin	NN
cord-005453-4057qib7	11553	30	)	)	-RRB-
cord-005453-4057qib7	11553	31	+	+	SYM
cord-005453-4057qib7	11553	32	BV	BV	NNP
cord-005453-4057qib7	11553	33	(	(	-LRB-
cord-005453-4057qib7	11553	34	without	without	IN
cord-005453-4057qib7	11553	35	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11553	36	due	due	IN
cord-005453-4057qib7	11553	37	to	to	IN
cord-005453-4057qib7	11553	38	suspected	suspect	VBN
cord-005453-4057qib7	11553	39	invasive	invasive	JJ
cord-005453-4057qib7	11553	40	mycosis	mycosi	NNS
cord-005453-4057qib7	11553	41	)	)	-RRB-
cord-005453-4057qib7	11553	42	+	+	SYM
cord-005453-4057qib7	11553	43	BV	BV	NNP
cord-005453-4057qib7	11553	44	DHAP	DHAP	NNP
cord-005453-4057qib7	11553	45	)	)	-RRB-
cord-005453-4057qib7	11553	46	,	,	,
cord-005453-4057qib7	11553	47	however	however	RB
cord-005453-4057qib7	11553	48	,	,	,
cord-005453-4057qib7	11553	49	only	only	JJ
cord-005453-4057qib7	11553	50	partial	partial	JJ
cord-005453-4057qib7	11553	51	PET	pet	NN
cord-005453-4057qib7	11553	52	-	-	HYPH
cord-005453-4057qib7	11553	53	positive	positive	JJ
cord-005453-4057qib7	11553	54	remission	remission	NN
cord-005453-4057qib7	11553	55	was	be	VBD
cord-005453-4057qib7	11553	56	achieved	achieve	VBN
cord-005453-4057qib7	11553	57	.	.	.
cord-005453-4057qib7	11554	1	Because	because	IN
cord-005453-4057qib7	11554	2	of	of	IN
cord-005453-4057qib7	11554	3	many	many	JJ
cord-005453-4057qib7	11554	4	times	time	NNS
cord-005453-4057qib7	11554	5	relapsed	relapsed	JJ
cord-005453-4057qib7	11554	6	and	and	CC
cord-005453-4057qib7	11554	7	progressed	progress	VBD
cord-005453-4057qib7	11554	8	disease	disease	NN
cord-005453-4057qib7	11554	9	Pembrolizumab	Pembrolizumab	NNP
cord-005453-4057qib7	11554	10	therapy	therapy	NN
cord-005453-4057qib7	11554	11	was	be	VBD
cord-005453-4057qib7	11554	12	started	start	VBN
cord-005453-4057qib7	11554	13	in	in	IN
cord-005453-4057qib7	11554	14	October	October	NNP
cord-005453-4057qib7	11554	15	2017	2017	CD
cord-005453-4057qib7	11555	1	:	:	:
cord-005453-4057qib7	11555	2	2	2	CD
cord-005453-4057qib7	11555	3	mg	mg	NNP
cord-005453-4057qib7	11555	4	/	/	SYM
cord-005453-4057qib7	11555	5	kg	kg	NNP
cord-005453-4057qib7	11555	6	every	every	DT
cord-005453-4057qib7	11555	7	three	three	CD
cord-005453-4057qib7	11555	8	weeks	week	NNS
cord-005453-4057qib7	11556	1	four	four	CD
cord-005453-4057qib7	11556	2	cycles	cycle	NNS
cord-005453-4057qib7	11556	3	totally	totally	RB
cord-005453-4057qib7	11556	4	.	.	.
cord-005453-4057qib7	11557	1	Toxic	toxic	JJ
cord-005453-4057qib7	11557	2	effects	effect	NNS
cord-005453-4057qib7	11557	3	and	and	CC
cord-005453-4057qib7	11557	4	serious	serious	JJ
cord-005453-4057qib7	11557	5	complications	complication	NNS
cord-005453-4057qib7	11557	6	during	during	IN
cord-005453-4057qib7	11557	7	and	and	CC
cord-005453-4057qib7	11557	8	after	after	IN
cord-005453-4057qib7	11557	9	therapy	therapy	NN
cord-005453-4057qib7	11557	10	by	by	IN
cord-005453-4057qib7	11557	11	Pembrolizumab	Pembrolizumab	NNP
cord-005453-4057qib7	11557	12	were	be	VBD
cord-005453-4057qib7	11557	13	not	not	RB
cord-005453-4057qib7	11557	14	observed	observe	VBN
cord-005453-4057qib7	11557	15	.	.	.
cord-005453-4057qib7	11558	1	In	in	IN
cord-005453-4057qib7	11558	2	February	February	NNP
cord-005453-4057qib7	11558	3	2018	2018	CD
cord-005453-4057qib7	11558	4	,	,	,
cord-005453-4057qib7	11558	5	after	after	IN
cord-005453-4057qib7	11558	6	Pembrolizumab	Pembrolizumab	NNP
cord-005453-4057qib7	11558	7	#	#	$
cord-005453-4057qib7	11558	8	4	4	CD
cord-005453-4057qib7	11558	9	,	,	,
cord-005453-4057qib7	11558	10	the	the	DT
cord-005453-4057qib7	11558	11	patient	patient	NN
cord-005453-4057qib7	11558	12	showed	show	VBD
cord-005453-4057qib7	11558	13	complete	complete	JJ
cord-005453-4057qib7	11558	14	metabolic	metabolic	JJ
cord-005453-4057qib7	11558	15	remission	remission	NN
cord-005453-4057qib7	11558	16	of	of	IN
cord-005453-4057qib7	11558	17	the	the	DT
cord-005453-4057qib7	11558	18	disease	disease	NN
cord-005453-4057qib7	11558	19	by	by	IN
cord-005453-4057qib7	11558	20	control	control	NNP
cord-005453-4057qib7	11558	21	PET	PET	NNP
cord-005453-4057qib7	11558	22	-	-	HYPH
cord-005453-4057qib7	11558	23	CT	CT	NNP
cord-005453-4057qib7	11558	24	.	.	.
cord-005453-4057qib7	11559	1	In	in	IN
cord-005453-4057qib7	11559	2	April	April	NNP
cord-005453-4057qib7	11559	3	2018	2018	CD
cord-005453-4057qib7	11559	4	,	,	,
cord-005453-4057qib7	11559	5	the	the	DT
cord-005453-4057qib7	11559	6	patient	patient	NN
cord-005453-4057qib7	11559	7	received	receive	VBD
cord-005453-4057qib7	11559	8	haplo	haplo	NNP
cord-005453-4057qib7	11559	9	-	-	HYPH
cord-005453-4057qib7	11559	10	SCT	SCT	NNP
cord-005453-4057qib7	11559	11	with	with	IN
cord-005453-4057qib7	11559	12	post	post	JJ
cord-005453-4057qib7	11559	13	-	-	JJ
cord-005453-4057qib7	11559	14	transplant	transplant	JJ
cord-005453-4057qib7	11559	15	HD	hd	NN
cord-005453-4057qib7	11559	16	-	-	HYPH
cord-005453-4057qib7	11559	17	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	11559	18	.	.	.
cord-005453-4057qib7	11560	1	We	-PRON-	PRP
cord-005453-4057qib7	11560	2	used	use	VBD
cord-005453-4057qib7	11560	3	conditioning	conditioning	NN
cord-005453-4057qib7	11560	4	modes	mode	NNS
cord-005453-4057qib7	11560	5	with	with	IN
cord-005453-4057qib7	11560	6	reduced	reduce	VBN
cord-005453-4057qib7	11560	7	toxicity	toxicity	NN
cord-005453-4057qib7	11560	8	(	(	-LRB-
cord-005453-4057qib7	11561	1	Fludarabin	Fludarabin	NNP
cord-005453-4057qib7	11561	2	150mg	150mg	NNP
cord-005453-4057qib7	11561	3	/	/	SYM
cord-005453-4057qib7	11561	4	m	m	NN
cord-005453-4057qib7	11561	5	2	2	CD
cord-005453-4057qib7	11561	6	+	+	SYM
cord-005453-4057qib7	11561	7	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	11561	8	42g	42g	NNS
cord-005453-4057qib7	11561	9	/	/	SYM
cord-005453-4057qib7	11561	10	m	m	CD
cord-005453-4057qib7	11561	11	2	2	CD
cord-005453-4057qib7	11561	12	)	)	-RRB-
cord-005453-4057qib7	11561	13	,	,	,
cord-005453-4057qib7	11561	14	high	high	JJ
cord-005453-4057qib7	11561	15	doses	dose	NNS
cord-005453-4057qib7	11561	16	of	of	IN
cord-005453-4057qib7	11561	17	Cy	Cy	NNP
cord-005453-4057qib7	11561	18	(	(	-LRB-
cord-005453-4057qib7	11561	19	50	50	CD
cord-005453-4057qib7	11561	20	mg	mg	NNP
cord-005453-4057qib7	11561	21	/	/	SYM
cord-005453-4057qib7	11561	22	kg	kg	NNP
cord-005453-4057qib7	11561	23	)	)	-RRB-
cord-005453-4057qib7	11561	24	on	on	IN
cord-005453-4057qib7	11561	25	days	day	NNS
cord-005453-4057qib7	11561	26	+3	+3	NNP
cord-005453-4057qib7	11561	27	and	and	CC
cord-005453-4057qib7	11561	28	+4	+4	NN
cord-005453-4057qib7	11561	29	.	.	.
cord-005453-4057qib7	11562	1	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	11562	2	and	and	CC
cord-005453-4057qib7	11562	3	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	11562	4	mofetil	mofetil	NNP
cord-005453-4057qib7	11562	5	started	start	VBD
cord-005453-4057qib7	11562	6	on	on	IN
cord-005453-4057qib7	11562	7	day	day	NN
cord-005453-4057qib7	11562	8	+5	+5	NFP
cord-005453-4057qib7	11562	9	.	.	.
cord-005453-4057qib7	11563	1	MMF	MMF	NNP
cord-005453-4057qib7	11563	2	was	be	VBD
cord-005453-4057qib7	11563	3	terminated	terminate	VBN
cord-005453-4057qib7	11563	4	on	on	IN
cord-005453-4057qib7	11563	5	day	day	NN
cord-005453-4057qib7	11563	6	35	35	CD
cord-005453-4057qib7	11563	7	,	,	,
cord-005453-4057qib7	11563	8	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	11563	9	-on	-on	.
cord-005453-4057qib7	11563	10	day	day	NN
cord-005453-4057qib7	11563	11	180	180	CD
cord-005453-4057qib7	11563	12	.	.	.
cord-005453-4057qib7	11564	1	Patient	Patient	NNP
cord-005453-4057qib7	11564	2	did	do	VBD
cord-005453-4057qib7	11564	3	not	not	RB
cord-005453-4057qib7	11564	4	have	have	VB
cord-005453-4057qib7	11564	5	acute	acute	JJ
cord-005453-4057qib7	11564	6	and	and	CC
cord-005453-4057qib7	11564	7	chronic	chronic	JJ
cord-005453-4057qib7	11564	8	GVHD	GVHD	NNP
cord-005453-4057qib7	11564	9	.	.	.
cord-005453-4057qib7	11565	1	Results	result	NNS
cord-005453-4057qib7	11565	2	:	:	:
cord-005453-4057qib7	11566	1	At	at	IN
cord-005453-4057qib7	11566	2	the	the	DT
cord-005453-4057qib7	11566	3	moment	moment	NN
cord-005453-4057qib7	11566	4	the	the	DT
cord-005453-4057qib7	11566	5	patient	patient	NN
cord-005453-4057qib7	11566	6	is	be	VBZ
cord-005453-4057qib7	11566	7	alive	alive	JJ
cord-005453-4057qib7	11566	8	and	and	CC
cord-005453-4057qib7	11566	9	still	still	RB
cord-005453-4057qib7	11566	10	in	in	IN
cord-005453-4057qib7	11566	11	PET	pet	NN
cord-005453-4057qib7	11566	12	-	-	HYPH
cord-005453-4057qib7	11566	13	negative	negative	JJ
cord-005453-4057qib7	11566	14	CR	cr	NN
cord-005453-4057qib7	11566	15	with	with	IN
cord-005453-4057qib7	11566	16	duration	duration	NN
cord-005453-4057qib7	11566	17	more	more	JJR
cord-005453-4057qib7	11566	18	than	than	IN
cord-005453-4057qib7	11566	19	9	9	CD
cord-005453-4057qib7	11566	20	mo	mo	NN
cord-005453-4057qib7	11566	21	.	.	.
cord-005453-4057qib7	11567	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11567	2	:	:	:
cord-005453-4057qib7	11568	1	Pembrolizumab	Pembrolizumab	NNP
cord-005453-4057qib7	11568	2	has	have	VBZ
cord-005453-4057qib7	11568	3	demonstrated	demonstrate	VBN
cord-005453-4057qib7	11568	4	high	high	JJ
cord-005453-4057qib7	11568	5	activity	activity	NN
cord-005453-4057qib7	11568	6	against	against	IN
cord-005453-4057qib7	11568	7	resistant	resistant	JJ
cord-005453-4057qib7	11568	8	HD	hd	NN
cord-005453-4057qib7	11568	9	even	even	RB
cord-005453-4057qib7	11568	10	after	after	IN
cord-005453-4057qib7	11568	11	post	post	JJ
cord-005453-4057qib7	11568	12	-	-	JJ
cord-005453-4057qib7	11568	13	auto	auto	JJ
cord-005453-4057qib7	11568	14	-	-	HYPH
cord-005453-4057qib7	11568	15	SCT	sct	NN
cord-005453-4057qib7	11568	16	progression	progression	NN
cord-005453-4057qib7	11568	17	with	with	IN
cord-005453-4057qib7	11568	18	good	good	JJ
cord-005453-4057qib7	11568	19	tolerability	tolerability	NN
cord-005453-4057qib7	11568	20	for	for	IN
cord-005453-4057qib7	11568	21	the	the	DT
cord-005453-4057qib7	11568	22	sick	sick	JJ
cord-005453-4057qib7	11568	23	child	child	NN
cord-005453-4057qib7	11568	24	.	.	.
cord-005453-4057qib7	11569	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11569	2	:	:	:
cord-005453-4057qib7	11569	3	Nothing	nothing	NN
cord-005453-4057qib7	11569	4	to	to	TO
cord-005453-4057qib7	11569	5	declare	declare	VB
cord-005453-4057qib7	11569	6	P510	P510	NNP
cord-005453-4057qib7	11569	7	High	High	NNP
cord-005453-4057qib7	11569	8	dose	dose	NN
cord-005453-4057qib7	11569	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11569	10	followed	follow	VBN
cord-005453-4057qib7	11569	11	by	by	IN
cord-005453-4057qib7	11569	12	autolougous	autolougous	JJ
cord-005453-4057qib7	11569	13	peripheral	peripheral	JJ
cord-005453-4057qib7	11569	14	blood	blood	NN
cord-005453-4057qib7	11569	15	stem	stem	NN
cord-005453-4057qib7	11569	16	cell	cell	NN
cord-005453-4057qib7	11569	17	transplantation	transplantation	NN
cord-005453-4057qib7	11569	18	(	(	-LRB-
cord-005453-4057qib7	11569	19	ASCT	ASCT	NNP
cord-005453-4057qib7	11569	20	)	)	-RRB-
cord-005453-4057qib7	11569	21	in	in	IN
cord-005453-4057qib7	11569	22	diffuse	diffuse	JJ
cord-005453-4057qib7	11569	23	large	large	JJ
cord-005453-4057qib7	11569	24	B	b	NN
cord-005453-4057qib7	11569	25	cell	cell	NN
cord-005453-4057qib7	11569	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	11569	27	(	(	-LRB-
cord-005453-4057qib7	11569	28	DLBCL	DLBCL	NNP
cord-005453-4057qib7	11569	29	)	)	-RRB-
cord-005453-4057qib7	11570	1	Median	median	JJ
cord-005453-4057qib7	11570	2	age	age	NN
cord-005453-4057qib7	11570	3	is	be	VBZ
cord-005453-4057qib7	11570	4	38,9	38,9	CD
cord-005453-4057qib7	11570	5	years	year	NNS
cord-005453-4057qib7	11570	6	(	(	-LRB-
cord-005453-4057qib7	11570	7	14	14	CD
cord-005453-4057qib7	11570	8	to	to	TO
cord-005453-4057qib7	11570	9	67	67	CD
cord-005453-4057qib7	11570	10	)	)	-RRB-
cord-005453-4057qib7	11570	11	and	and	CC
cord-005453-4057qib7	11570	12	sex	sex	NN
cord-005453-4057qib7	11570	13	ratio	ratio	NN
cord-005453-4057qib7	11570	14	(	(	-LRB-
cord-005453-4057qib7	11570	15	M	M	NNP
cord-005453-4057qib7	11570	16	/	/	SYM
cord-005453-4057qib7	11570	17	F	F	NNP
cord-005453-4057qib7	11570	18	)	)	-RRB-
cord-005453-4057qib7	11570	19	1.14	1.14	CD
cord-005453-4057qib7	11570	20	;	;	:
cord-005453-4057qib7	11570	21	Ann	Ann	NNP
cord-005453-4057qib7	11570	22	Arbor	Arbor	NNP
cord-005453-4057qib7	11570	23	stage	stage	NN
cord-005453-4057qib7	11570	24	III	III	NNP
cord-005453-4057qib7	11570	25	-	-	HYPH
cord-005453-4057qib7	11570	26	IV	IV	NNP
cord-005453-4057qib7	11570	27	:	:	:
cord-005453-4057qib7	11570	28	104	104	CD
cord-005453-4057qib7	11570	29	pts	pt	NNS
cord-005453-4057qib7	11570	30	.	.	.
cord-005453-4057qib7	11571	1	Before	before	IN
cord-005453-4057qib7	11571	2	HDT	HDT	NNP
cord-005453-4057qib7	11571	3	induction	induction	NN
cord-005453-4057qib7	11571	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11571	5	(	(	-LRB-
cord-005453-4057qib7	11571	6	CHOP	chop	NN
cord-005453-4057qib7	11571	7	,	,	,
cord-005453-4057qib7	11571	8	C2H2OPA	C2H2OPA	NNP
cord-005453-4057qib7	11571	9	)	)	-RRB-
cord-005453-4057qib7	11571	10	was	be	VBD
cord-005453-4057qib7	11571	11	instituted	institute	VBN
cord-005453-4057qib7	11571	12	and	and	CC
cord-005453-4057qib7	11571	13	associated	associate	VBN
cord-005453-4057qib7	11571	14	with	with	IN
cord-005453-4057qib7	11571	15	Rituximab	Rituximab	NNP
cord-005453-4057qib7	11571	16	in	in	IN
cord-005453-4057qib7	11571	17	100	100	CD
cord-005453-4057qib7	11571	18	pts	pt	NNS
cord-005453-4057qib7	11571	19	(	(	-LRB-
cord-005453-4057qib7	11571	20	66,6	66,6	CD
cord-005453-4057qib7	11571	21	%	%	NN
cord-005453-4057qib7	11571	22	)	)	-RRB-
cord-005453-4057qib7	11571	23	,	,	,
cord-005453-4057qib7	11571	24	49	49	CD
cord-005453-4057qib7	11571	25	pts	pt	NNS
cord-005453-4057qib7	11571	26	(	(	-LRB-
cord-005453-4057qib7	11571	27	32,7	32,7	CD
cord-005453-4057qib7	11571	28	%	%	NN
cord-005453-4057qib7	11571	29	)	)	-RRB-
cord-005453-4057qib7	11571	30	received	receive	VBD
cord-005453-4057qib7	11571	31	more	more	JJR
cord-005453-4057qib7	11571	32	than	than	IN
cord-005453-4057qib7	11571	33	2	2	CD
cord-005453-4057qib7	11571	34	treatment	treatment	NN
cord-005453-4057qib7	11571	35	lines	line	NNS
cord-005453-4057qib7	11571	36	and	and	CC
cord-005453-4057qib7	11571	37	16	16	CD
cord-005453-4057qib7	11571	38	pts	pt	NNS
cord-005453-4057qib7	11571	39	(	(	-LRB-
cord-005453-4057qib7	11571	40	10,7	10,7	CD
cord-005453-4057qib7	11571	41	%	%	NN
cord-005453-4057qib7	11571	42	)	)	-RRB-
cord-005453-4057qib7	11571	43	received	receive	VBD
cord-005453-4057qib7	11571	44	complementary	complementary	JJ
cord-005453-4057qib7	11571	45	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	11571	46	.	.	.
cord-005453-4057qib7	11572	1	Transplant	transplant	NN
cord-005453-4057qib7	11572	2	disease	disease	NN
cord-005453-4057qib7	11572	3	status	status	NN
cord-005453-4057qib7	11572	4	before	before	IN
cord-005453-4057qib7	11572	5	HDT	HDT	NNP
cord-005453-4057qib7	11572	6	was	be	VBD
cord-005453-4057qib7	11572	7	complete	complete	JJ
cord-005453-4057qib7	11572	8	remission	remission	NN
cord-005453-4057qib7	11572	9	(	(	-LRB-
cord-005453-4057qib7	11572	10	CR	CR	NNP
cord-005453-4057qib7	11572	11	)	)	-RRB-
cord-005453-4057qib7	11572	12	in	in	IN
cord-005453-4057qib7	11572	13	93	93	CD
cord-005453-4057qib7	11572	14	pts	pt	NNS
cord-005453-4057qib7	11572	15	,	,	,
cord-005453-4057qib7	11572	16	partial	partial	JJ
cord-005453-4057qib7	11572	17	remission	remission	NN
cord-005453-4057qib7	11572	18	in	in	IN
cord-005453-4057qib7	11572	19	55	55	CD
cord-005453-4057qib7	11572	20	pts	pt	NNS
cord-005453-4057qib7	11572	21	(	(	-LRB-
cord-005453-4057qib7	11572	22	RP	RP	NNP
cord-005453-4057qib7	11572	23	)	)	-RRB-
cord-005453-4057qib7	11572	24	and	and	CC
cord-005453-4057qib7	11572	25	disease	disease	NN
cord-005453-4057qib7	11572	26	progression	progression	NN
cord-005453-4057qib7	11572	27	in	in	IN
cord-005453-4057qib7	11572	28	2	2	CD
cord-005453-4057qib7	11572	29	pts	pt	NNS
cord-005453-4057qib7	11572	30	.	.	.
cord-005453-4057qib7	11573	1	The	the	DT
cord-005453-4057qib7	11573	2	delay	delay	NN
cord-005453-4057qib7	11573	3	from	from	IN
cord-005453-4057qib7	11573	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	11573	5	to	to	IN
cord-005453-4057qib7	11573	6	HDT	HDT	NNP
cord-005453-4057qib7	11573	7	is	be	VBZ
cord-005453-4057qib7	11573	8	11,7	11,7	CD
cord-005453-4057qib7	11573	9	months	month	NNS
cord-005453-4057qib7	11573	10	(	(	-LRB-
cord-005453-4057qib7	11573	11	4	4	CD
cord-005453-4057qib7	11573	12	-	-	SYM
cord-005453-4057qib7	11573	13	103	103	CD
cord-005453-4057qib7	11573	14	)	)	-RRB-
cord-005453-4057qib7	11573	15	.	.	.
cord-005453-4057qib7	11574	1	The	the	DT
cord-005453-4057qib7	11574	2	HDT	HDT	NNP
cord-005453-4057qib7	11574	3	protocols	protocol	NNS
cord-005453-4057qib7	11574	4	used	use	VBN
cord-005453-4057qib7	11574	5	are	be	VBP
cord-005453-4057qib7	11574	6	:	:	:
cord-005453-4057qib7	11574	7	Tutshka	tutshka	NN
cord-005453-4057qib7	11574	8	:	:	:
cord-005453-4057qib7	11574	9	87	87	CD
cord-005453-4057qib7	11574	10	pts	pt	NNS
cord-005453-4057qib7	11574	11	,	,	,
cord-005453-4057qib7	11574	12	Tutshka+VP16	Tutshka+VP16	NNP
cord-005453-4057qib7	11574	13	:	:	:
cord-005453-4057qib7	11574	14	42	42	CD
cord-005453-4057qib7	11574	15	pts	pt	NNS
cord-005453-4057qib7	11574	16	,	,	,
cord-005453-4057qib7	11574	17	BAM	BAM	NNP
cord-005453-4057qib7	11574	18	12	12	CD
cord-005453-4057qib7	11574	19	(	(	-LRB-
cord-005453-4057qib7	11574	20	Busulfan	Busulfan	NNP
cord-005453-4057qib7	11574	21	+	+	CC
cord-005453-4057qib7	11574	22	Cytarabine+Melphalan	cytarabine+melphalan	NN
cord-005453-4057qib7	11574	23	)	)	-RRB-
cord-005453-4057qib7	11575	1	:	:	:
cord-005453-4057qib7	11575	2	16	16	CD
cord-005453-4057qib7	11575	3	pts	pt	NNS
cord-005453-4057qib7	11575	4	et	et	FW
cord-005453-4057qib7	11575	5	BEAM	beam	NN
cord-005453-4057qib7	11575	6	:	:	:
cord-005453-4057qib7	11575	7	5	5	CD
cord-005453-4057qib7	11575	8	pts	pt	NNS
cord-005453-4057qib7	11575	9	.	.	.
cord-005453-4057qib7	11576	1	All	all	DT
cord-005453-4057qib7	11576	2	pts	pt	NNS
cord-005453-4057qib7	11576	3	received	receive	VBD
cord-005453-4057qib7	11576	4	,	,	,
cord-005453-4057qib7	11576	5	after	after	IN
cord-005453-4057qib7	11576	6	thawing	thawing	NN
cord-005453-4057qib7	11576	7	,	,	,
cord-005453-4057qib7	11576	8	mobilized	mobilize	VBD
cord-005453-4057qib7	11576	9	PBSC	PBSC	NNP
cord-005453-4057qib7	11576	10	obtained	obtain	VBN
cord-005453-4057qib7	11576	11	by	by	IN
cord-005453-4057qib7	11576	12	G	G	NNP
cord-005453-4057qib7	11576	13	-	-	HYPH
cord-005453-4057qib7	11576	14	CSF	csf	NN
cord-005453-4057qib7	11576	15	mobilization	mobilization	NN
cord-005453-4057qib7	11576	16	(	(	-LRB-
cord-005453-4057qib7	11576	17	15μg	15μg	NNP
cord-005453-4057qib7	11576	18	/	/	SYM
cord-005453-4057qib7	11576	19	Kg	Kg	NNP
cord-005453-4057qib7	11576	20	/	/	SYM
cord-005453-4057qib7	11576	21	d	d	NN
cord-005453-4057qib7	11576	22	,	,	,
cord-005453-4057qib7	11576	23	5	5	CD
cord-005453-4057qib7	11576	24	days	day	NNS
cord-005453-4057qib7	11576	25	)	)	-RRB-
cord-005453-4057qib7	11576	26	alone	alone	RB
cord-005453-4057qib7	11576	27	and	and	CC
cord-005453-4057qib7	11576	28	froze	freeze	VBD
cord-005453-4057qib7	11576	29	in	in	IN
cord-005453-4057qib7	11576	30	liquid	liquid	JJ
cord-005453-4057qib7	11576	31	nitrogen	nitrogen	NN
cord-005453-4057qib7	11576	32	.	.	.
cord-005453-4057qib7	11577	1	The	the	DT
cord-005453-4057qib7	11577	2	median	median	JJ
cord-005453-4057qib7	11577	3	rate	rate	NN
cord-005453-4057qib7	11577	4	CD34	CD34	NNP
cord-005453-4057qib7	11578	1	+	+	CC
cord-005453-4057qib7	11578	2	cells	cell	NNS
cord-005453-4057qib7	11578	3	infused	infuse	VBN
cord-005453-4057qib7	11578	4	is	be	VBZ
cord-005453-4057qib7	11578	5	3,6	3,6	CD
cord-005453-4057qib7	11578	6	x	x	SYM
cord-005453-4057qib7	11578	7	10	10	CD
cord-005453-4057qib7	11578	8	6	6	CD
cord-005453-4057qib7	11579	1	/Kg	/Kg	.
cord-005453-4057qib7	11580	1	(	(	-LRB-
cord-005453-4057qib7	11580	2	0	0	CD
cord-005453-4057qib7	11580	3	.	.	.
cord-005453-4057qib7	11580	4	87	87	CD
cord-005453-4057qib7	11580	5	-	-	SYM
cord-005453-4057qib7	11580	6	17.36	17.36	CD
cord-005453-4057qib7	11580	7	)	)	-RRB-
cord-005453-4057qib7	11580	8	.	.	.
cord-005453-4057qib7	11581	1	The	the	DT
cord-005453-4057qib7	11581	2	median	median	JJ
cord-005453-4057qib7	11581	3	follow	follow	NN
cord-005453-4057qib7	11581	4	-	-	HYPH
cord-005453-4057qib7	11581	5	up	up	NN
cord-005453-4057qib7	11581	6	at	at	IN
cord-005453-4057qib7	11581	7	12/31/2017	12/31/2017	CD
cord-005453-4057qib7	11581	8	is	be	VBZ
cord-005453-4057qib7	11581	9	67	67	CD
cord-005453-4057qib7	11581	10	months	month	NNS
cord-005453-4057qib7	11581	11	.	.	.
cord-005453-4057qib7	11582	1	Results	result	NNS
cord-005453-4057qib7	11582	2	:	:	:
cord-005453-4057qib7	11582	3	the	the	DT
cord-005453-4057qib7	11582	4	median	median	JJ
cord-005453-4057qib7	11582	5	time	time	NN
cord-005453-4057qib7	11582	6	to	to	TO
cord-005453-4057qib7	11582	7	graft	graft	VB
cord-005453-4057qib7	11582	8	(	(	-LRB-
cord-005453-4057qib7	11582	9	PNC	PNC	NNP
cord-005453-4057qib7	11582	10	>	>	XX
cord-005453-4057qib7	11582	11	0.5	0.5	CD
cord-005453-4057qib7	11582	12	x	x	SYM
cord-005453-4057qib7	11582	13	10	10	CD
cord-005453-4057qib7	11582	14	9	9	CD
cord-005453-4057qib7	11582	15	/l	/l	NN
cord-005453-4057qib7	11582	16	)	)	-RRB-
cord-005453-4057qib7	11582	17	was	be	VBD
cord-005453-4057qib7	11582	18	13	13	CD
cord-005453-4057qib7	11582	19	days	day	NNS
cord-005453-4057qib7	11582	20	(	(	-LRB-
cord-005453-4057qib7	11582	21	9	9	CD
cord-005453-4057qib7	11582	22	-	-	SYM
cord-005453-4057qib7	11582	23	18	18	CD
cord-005453-4057qib7	11582	24	)	)	-RRB-
cord-005453-4057qib7	11582	25	.	.	.
cord-005453-4057qib7	11583	1	Ten	ten	CD
cord-005453-4057qib7	11583	2	early	early	JJ
cord-005453-4057qib7	11583	3	deaths	death	NNS
cord-005453-4057qib7	11583	4	were	be	VBD
cord-005453-4057qib7	11583	5	observed	observe	VBN
cord-005453-4057qib7	11583	6	including	include	VBG
cord-005453-4057qib7	11583	7	8	8	CD
cord-005453-4057qib7	11583	8	infection	infection	NN
cord-005453-4057qib7	11583	9	(	(	-LRB-
cord-005453-4057qib7	11583	10	TRM	TRM	NNP
cord-005453-4057qib7	11583	11	:	:	:
cord-005453-4057qib7	11583	12	6,6	6,6	CD
cord-005453-4057qib7	11583	13	%	%	NN
cord-005453-4057qib7	11583	14	)	)	-RRB-
cord-005453-4057qib7	11583	15	and	and	CC
cord-005453-4057qib7	11583	16	3	3	CD
cord-005453-4057qib7	11583	17	in	in	IN
cord-005453-4057qib7	11583	18	disease	disease	NN
cord-005453-4057qib7	11583	19	progression	progression	NN
cord-005453-4057qib7	11583	20	at	at	IN
cord-005453-4057qib7	11583	21	3	3	CD
cord-005453-4057qib7	11583	22	months	month	NNS
cord-005453-4057qib7	11583	23	.	.	.
cord-005453-4057qib7	11584	1	After	after	IN
cord-005453-4057qib7	11584	2	3	3	CD
cord-005453-4057qib7	11584	3	months	month	NNS
cord-005453-4057qib7	11584	4	of	of	IN
cord-005453-4057qib7	11584	5	HDT	HDT	NNP
cord-005453-4057qib7	11584	6	137	137	CD
cord-005453-4057qib7	11584	7	pts	pt	NNS
cord-005453-4057qib7	11584	8	are	be	VBP
cord-005453-4057qib7	11584	9	assessable	assessable	JJ
cord-005453-4057qib7	11584	10	including	include	VBG
cord-005453-4057qib7	11584	11	128	128	CD
cord-005453-4057qib7	11584	12	pts	pt	NNS
cord-005453-4057qib7	11584	13	in	in	IN
cord-005453-4057qib7	11584	14	CR	CR	NNP
cord-005453-4057qib7	11584	15	(	(	-LRB-
cord-005453-4057qib7	11584	16	93,4	93,4	CD
cord-005453-4057qib7	11584	17	%	%	NN
cord-005453-4057qib7	11584	18	)	)	-RRB-
cord-005453-4057qib7	11584	19	and	and	CC
cord-005453-4057qib7	11584	20	9	9	CD
cord-005453-4057qib7	11584	21	pts	pt	NNS
cord-005453-4057qib7	11584	22	in	in	IN
cord-005453-4057qib7	11584	23	PR	PR	NNP
cord-005453-4057qib7	11584	24	(	(	-LRB-
cord-005453-4057qib7	11584	25	6,6	6,6	CD
cord-005453-4057qib7	11584	26	%	%	NN
cord-005453-4057qib7	11584	27	)	)	-RRB-
cord-005453-4057qib7	11584	28	.	.	.
cord-005453-4057qib7	11585	1	Relapse	relapse	NN
cord-005453-4057qib7	11585	2	was	be	VBD
cord-005453-4057qib7	11585	3	observed	observe	VBN
cord-005453-4057qib7	11585	4	in	in	IN
cord-005453-4057qib7	11585	5	31	31	CD
cord-005453-4057qib7	11585	6	pts	pt	NNS
cord-005453-4057qib7	11585	7	(	(	-LRB-
cord-005453-4057qib7	11585	8	22.6	22.6	CD
cord-005453-4057qib7	11585	9	%	%	NN
cord-005453-4057qib7	11585	10	)	)	-RRB-
cord-005453-4057qib7	11585	11	and	and	CC
cord-005453-4057qib7	11585	12	it	-PRON-	PRP
cord-005453-4057qib7	11585	13	was	be	VBD
cord-005453-4057qib7	11585	14	earlier	early	JJR
cord-005453-4057qib7	11585	15	relapse	relapse	NN
cord-005453-4057qib7	11585	16	in	in	IN
cord-005453-4057qib7	11585	17	a	a	DT
cord-005453-4057qib7	11585	18	period	period	NN
cord-005453-4057qib7	11585	19	of	of	IN
cord-005453-4057qib7	11585	20	24	24	CD
cord-005453-4057qib7	11585	21	months	month	NNS
cord-005453-4057qib7	11585	22	in	in	IN
cord-005453-4057qib7	11585	23	15	15	CD
cord-005453-4057qib7	11585	24	pts	pt	NNS
cord-005453-4057qib7	11585	25	(	(	-LRB-
cord-005453-4057qib7	11585	26	48	48	CD
cord-005453-4057qib7	11585	27	%	%	NN
cord-005453-4057qib7	11585	28	)	)	-RRB-
cord-005453-4057qib7	11585	29	.	.	.
cord-005453-4057qib7	11586	1	Deaths	death	NNS
cord-005453-4057qib7	11586	2	were	be	VBD
cord-005453-4057qib7	11586	3	among	among	IN
cord-005453-4057qib7	11586	4	39/150	39/150	CD
cord-005453-4057qib7	11586	5	pts	pt	NNS
cord-005453-4057qib7	11586	6	(	(	-LRB-
cord-005453-4057qib7	11586	7	26	26	CD
cord-005453-4057qib7	11586	8	%	%	NN
cord-005453-4057qib7	11586	9	)	)	-RRB-
cord-005453-4057qib7	11586	10	.	.	.
cord-005453-4057qib7	11587	1	Persistent	persistent	JJ
cord-005453-4057qib7	11587	2	CR	CR	NNP
cord-005453-4057qib7	11587	3	was	be	VBD
cord-005453-4057qib7	11587	4	achieved	achieve	VBN
cord-005453-4057qib7	11587	5	in	in	IN
cord-005453-4057qib7	11587	6	112/137	112/137	CD
cord-005453-4057qib7	11587	7	pts	pt	NNS
cord-005453-4057qib7	11587	8	(	(	-LRB-
cord-005453-4057qib7	11587	9	81,8	81,8	CD
cord-005453-4057qib7	11587	10	%	%	NN
cord-005453-4057qib7	11587	11	)	)	-RRB-
cord-005453-4057qib7	11587	12	including	include	VBG
cord-005453-4057qib7	11587	13	23/30	23/30	CD
cord-005453-4057qib7	11587	14	(	(	-LRB-
cord-005453-4057qib7	11587	15	76,6	76,6	CD
cord-005453-4057qib7	11587	16	%	%	NN
cord-005453-4057qib7	11587	17	)	)	-RRB-
cord-005453-4057qib7	11587	18	MLCL	MLCL	NNP
cord-005453-4057qib7	11587	19	and	and	CC
cord-005453-4057qib7	11587	20	89/107	89/107	CD
cord-005453-4057qib7	11587	21	(	(	-LRB-
cord-005453-4057qib7	11587	22	83,1	83,1	CD
cord-005453-4057qib7	11587	23	%	%	NN
cord-005453-4057qib7	11587	24	)	)	-RRB-
cord-005453-4057qib7	11588	1	others	other	NNS
cord-005453-4057qib7	11588	2	DLBCL	dlbcl	VBP
cord-005453-4057qib7	11588	3	.	.	.
cord-005453-4057qib7	11589	1	The	the	DT
cord-005453-4057qib7	11589	2	overall	overall	JJ
cord-005453-4057qib7	11589	3	survival	survival	NN
cord-005453-4057qib7	11589	4	(	(	-LRB-
cord-005453-4057qib7	11589	5	OS	OS	NNP
cord-005453-4057qib7	11589	6	)	)	-RRB-
cord-005453-4057qib7	11589	7	and	and	CC
cord-005453-4057qib7	11589	8	event	event	VB
cord-005453-4057qib7	11589	9	free	free	JJ
cord-005453-4057qib7	11589	10	survival	survival	NN
cord-005453-4057qib7	11589	11	(	(	-LRB-
cord-005453-4057qib7	11589	12	EFS	EFS	NNP
cord-005453-4057qib7	11589	13	)	)	-RRB-
cord-005453-4057qib7	11589	14	at	at	IN
cord-005453-4057qib7	11589	15	10	10	CD
cord-005453-4057qib7	11589	16	years	year	NNS
cord-005453-4057qib7	11589	17	are	be	VBP
cord-005453-4057qib7	11589	18	respectively	respectively	RB
cord-005453-4057qib7	11589	19	68	68	CD
cord-005453-4057qib7	11589	20	%	%	NN
cord-005453-4057qib7	11589	21	and	and	CC
cord-005453-4057qib7	11589	22	64	64	CD
cord-005453-4057qib7	11589	23	%	%	NN
cord-005453-4057qib7	11589	24	.	.	.
cord-005453-4057qib7	11590	1	The	the	DT
cord-005453-4057qib7	11590	2	OS	OS	NNP
cord-005453-4057qib7	11590	3	and	and	CC
cord-005453-4057qib7	11590	4	EFS	EFS	NNP
cord-005453-4057qib7	11590	5	are	be	VBP
cord-005453-4057qib7	11590	6	better	well	JJR
cord-005453-4057qib7	11590	7	in	in	IN
cord-005453-4057qib7	11590	8	patients	patient	NNS
cord-005453-4057qib7	11590	9	who	who	WP
cord-005453-4057qib7	11590	10	received	receive	VBD
cord-005453-4057qib7	11590	11	Rituximab	Rituximab	NNP
cord-005453-4057qib7	11590	12	in	in	IN
cord-005453-4057qib7	11590	13	initial	initial	JJ
cord-005453-4057qib7	11590	14	therapy	therapy	NN
cord-005453-4057qib7	11590	15	:	:	:
cord-005453-4057qib7	11590	16	OS	OS	NNP
cord-005453-4057qib7	11590	17	(	(	-LRB-
cord-005453-4057qib7	11590	18	79	79	CD
cord-005453-4057qib7	11590	19	%	%	NN
cord-005453-4057qib7	11590	20	vs	vs	IN
cord-005453-4057qib7	11590	21	54	54	CD
cord-005453-4057qib7	11590	22	%	%	NN
cord-005453-4057qib7	11590	23	;	;	:
cord-005453-4057qib7	11590	24	p	p	NN
cord-005453-4057qib7	11590	25	<	<	XX
cord-005453-4057qib7	11590	26	0,001	0,001	CD
cord-005453-4057qib7	11590	27	)	)	-RRB-
cord-005453-4057qib7	11590	28	et	et	FW
cord-005453-4057qib7	11590	29	EFS	EFS	NNP
cord-005453-4057qib7	11590	30	(	(	-LRB-
cord-005453-4057qib7	11590	31	79	79	CD
cord-005453-4057qib7	11590	32	%	%	NN
cord-005453-4057qib7	11590	33	vs	vs	IN
cord-005453-4057qib7	11590	34	46	46	CD
cord-005453-4057qib7	11590	35	%	%	NN
cord-005453-4057qib7	11590	36	;	;	.
cord-005453-4057qib7	11591	1	p	p	LS
cord-005453-4057qib7	11591	2	<	<	XX
cord-005453-4057qib7	11591	3	0,001	0,001	CD
cord-005453-4057qib7	11591	4	)	)	-RRB-
cord-005453-4057qib7	11591	5	.	.	.
cord-005453-4057qib7	11592	1	Herein	herein	RB
cord-005453-4057qib7	11592	2	,	,	,
cord-005453-4057qib7	11592	3	we	-PRON-	PRP
cord-005453-4057qib7	11592	4	present	present	VBP
cord-005453-4057qib7	11592	5	one	one	CD
cord-005453-4057qib7	11592	6	patient	patient	NN
cord-005453-4057qib7	11592	7	with	with	IN
cord-005453-4057qib7	11592	8	refractory	refractory	JJ
cord-005453-4057qib7	11592	9	MCL	MCL	NNP
cord-005453-4057qib7	11592	10	,	,	,
cord-005453-4057qib7	11592	11	who	who	WP
cord-005453-4057qib7	11592	12	were	be	VBD
cord-005453-4057qib7	11592	13	insensitive	insensitive	JJ
cord-005453-4057qib7	11592	14	to	to	IN
cord-005453-4057qib7	11592	15	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11592	16	and	and	CC
cord-005453-4057qib7	11592	17	then	then	RB
cord-005453-4057qib7	11592	18	experienced	experience	VBD
cord-005453-4057qib7	11592	19	a	a	DT
cord-005453-4057qib7	11592	20	dramatic	dramatic	JJ
cord-005453-4057qib7	11592	21	improvement	improvement	NN
cord-005453-4057qib7	11592	22	with	with	IN
cord-005453-4057qib7	11592	23	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	11592	24	mono	mono	NN
cord-005453-4057qib7	11592	25	-	-	HYPH
cord-005453-4057qib7	11592	26	therapy	therapy	NN
cord-005453-4057qib7	11592	27	but	but	CC
cord-005453-4057qib7	11592	28	later	later	RB
cord-005453-4057qib7	11592	29	developed	develop	VBD
cord-005453-4057qib7	11592	30	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	11592	31	resistance	resistance	NN
cord-005453-4057qib7	11592	32	,	,	,
cord-005453-4057qib7	11592	33	ultimately	ultimately	RB
cord-005453-4057qib7	11592	34	resulting	result	VBG
cord-005453-4057qib7	11592	35	in	in	IN
cord-005453-4057qib7	11592	36	the	the	DT
cord-005453-4057qib7	11592	37	deterioration	deterioration	NN
cord-005453-4057qib7	11592	38	of	of	IN
cord-005453-4057qib7	11592	39	disease	disease	NN
cord-005453-4057qib7	11592	40	and	and	CC
cord-005453-4057qib7	11592	41	death	death	NN
cord-005453-4057qib7	11592	42	.	.	.
cord-005453-4057qib7	11593	1	Methods	method	NNS
cord-005453-4057qib7	11593	2	:	:	:
cord-005453-4057qib7	11593	3	We	-PRON-	PRP
cord-005453-4057qib7	11593	4	give	give	VBP
cord-005453-4057qib7	11593	5	the	the	DT
cord-005453-4057qib7	11593	6	patient	patient	NN
cord-005453-4057qib7	11593	7	several	several	JJ
cord-005453-4057qib7	11593	8	examinations	examination	NNS
cord-005453-4057qib7	11593	9	including	include	VBG
cord-005453-4057qib7	11593	10	Ultrasound	ultrasound	NN
cord-005453-4057qib7	11593	11	,	,	,
cord-005453-4057qib7	11593	12	bone	bone	NN
cord-005453-4057qib7	11593	13	marrow	marrow	NN
cord-005453-4057qib7	11593	14	biopsy	biopsy	NN
cord-005453-4057qib7	11593	15	,	,	,
cord-005453-4057qib7	11593	16	lymph	lymph	NN
cord-005453-4057qib7	11593	17	node	node	NN
cord-005453-4057qib7	11593	18	biopsy	biopsy	NN
cord-005453-4057qib7	11593	19	,	,	,
cord-005453-4057qib7	11593	20	Exome	Exome	NNP
cord-005453-4057qib7	11593	21	Sequencing	Sequencing	NNP
cord-005453-4057qib7	11593	22	,	,	,
cord-005453-4057qib7	11593	23	Sanger	Sanger	NNP
cord-005453-4057qib7	11593	24	sequencing	sequencing	NN
cord-005453-4057qib7	11593	25	,	,	,
cord-005453-4057qib7	11593	26	and	and	CC
cord-005453-4057qib7	11593	27	so	so	RB
cord-005453-4057qib7	11593	28	on	on	RB
cord-005453-4057qib7	11593	29	.	.	.
cord-005453-4057qib7	11594	1	For	for	IN
cord-005453-4057qib7	11594	2	the	the	DT
cord-005453-4057qib7	11594	3	treatment	treatment	NN
cord-005453-4057qib7	11594	4	of	of	IN
cord-005453-4057qib7	11594	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	11594	6	,	,	,
cord-005453-4057qib7	11594	7	the	the	DT
cord-005453-4057qib7	11594	8	patient	patient	NN
cord-005453-4057qib7	11594	9	received	receive	VBD
cord-005453-4057qib7	11594	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11594	11	,	,	,
cord-005453-4057qib7	11594	12	including	include	VBG
cord-005453-4057qib7	11594	13	1	1	CD
cord-005453-4057qib7	11594	14	course	course	NN
cord-005453-4057qib7	11594	15	of	of	IN
cord-005453-4057qib7	11594	16	CHOP(cyclophosphamide	CHOP(cyclophosphamide	NNP
cord-005453-4057qib7	11594	17	1.3	1.3	CD
cord-005453-4057qib7	11594	18	g	g	NN
cord-005453-4057qib7	11594	19	day	day	NN
cord-005453-4057qib7	11594	20	1	1	CD
cord-005453-4057qib7	11594	21	,	,	,
cord-005453-4057qib7	11595	1	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	11595	2	40	40	CD
cord-005453-4057qib7	11595	3	mg	mg	NNP
cord-005453-4057qib7	11595	4	day	day	NN
cord-005453-4057qib7	11595	5	1,Vinorelbine	1,vinorelbine	CD
cord-005453-4057qib7	11595	6	40	40	CD
cord-005453-4057qib7	11595	7	mg	mg	NNP
cord-005453-4057qib7	11595	8	day	day	NN
cord-005453-4057qib7	11595	9	1	1	CD
cord-005453-4057qib7	11595	10	,	,	,
cord-005453-4057qib7	11595	11	and	and	CC
cord-005453-4057qib7	11595	12	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	11595	13	15	15	CD
cord-005453-4057qib7	11595	14	mg	mg	NN
cord-005453-4057qib7	11595	15	from	from	IN
cord-005453-4057qib7	11595	16	day	day	NN
cord-005453-4057qib7	11595	17	1	1	CD
cord-005453-4057qib7	11595	18	to	to	IN
cord-005453-4057qib7	11595	19	5	5	CD
cord-005453-4057qib7	11595	20	)	)	-RRB-
cord-005453-4057qib7	11595	21	and	and	CC
cord-005453-4057qib7	11595	22	1	1	CD
cord-005453-4057qib7	11595	23	course	course	NN
cord-005453-4057qib7	11595	24	of	of	IN
cord-005453-4057qib7	11595	25	R	r	NN
cord-005453-4057qib7	11595	26	-	-	HYPH
cord-005453-4057qib7	11595	27	DHAP	DHAP	NNP
cord-005453-4057qib7	11595	28	(	(	-LRB-
cord-005453-4057qib7	11595	29	rituximab	rituximab	RB
cord-005453-4057qib7	11595	30	600	600	CD
cord-005453-4057qib7	11595	31	mg	mg	NNS
cord-005453-4057qib7	11595	32	day0	day0	NN
cord-005453-4057qib7	11595	33	,	,	,
cord-005453-4057qib7	11595	34	cytarabine	cytarabine	RB
cord-005453-4057qib7	11595	35	2	2	CD
cord-005453-4057qib7	11595	36	g	g	NN
cord-005453-4057qib7	11595	37	q12	q12	NN
cord-005453-4057qib7	11595	38	day	day	NN
cord-005453-4057qib7	11595	39	1	1	CD
cord-005453-4057qib7	11595	40	,	,	,
cord-005453-4057qib7	11596	1	Cisplatin	cisplatin	NN
cord-005453-4057qib7	11596	2	100	100	CD
cord-005453-4057qib7	11596	3	mg	mg	NNP
cord-005453-4057qib7	11596	4	day	day	NN
cord-005453-4057qib7	11596	5	1,dexamethasone	1,dexamethasone	CD
cord-005453-4057qib7	11596	6	20	20	CD
cord-005453-4057qib7	11596	7	mg	mg	RB
cord-005453-4057qib7	11596	8	from	from	IN
cord-005453-4057qib7	11596	9	day	day	NN
cord-005453-4057qib7	11596	10	1	1	CD
cord-005453-4057qib7	11596	11	to	to	IN
cord-005453-4057qib7	11596	12	5)in	5)in	CD
cord-005453-4057qib7	11596	13	succession	succession	NN
cord-005453-4057qib7	11596	14	.	.	.
cord-005453-4057qib7	11597	1	Because	because	IN
cord-005453-4057qib7	11597	2	of	of	IN
cord-005453-4057qib7	11597	3	the	the	DT
cord-005453-4057qib7	11597	4	failure	failure	NN
cord-005453-4057qib7	11597	5	to	to	TO
cord-005453-4057qib7	11597	6	control	control	VB
cord-005453-4057qib7	11597	7	disease	disease	NN
cord-005453-4057qib7	11597	8	progression	progression	NN
cord-005453-4057qib7	11597	9	,	,	,
cord-005453-4057qib7	11597	10	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	11598	1	560	560	CD
cord-005453-4057qib7	11598	2	mg	mg	NN
cord-005453-4057qib7	11598	3	qd	qd	NNP
cord-005453-4057qib7	11598	4	was	be	VBD
cord-005453-4057qib7	11598	5	used	use	VBN
cord-005453-4057qib7	11598	6	until	until	IN
cord-005453-4057qib7	11598	7	the	the	DT
cord-005453-4057qib7	11598	8	patient	patient	NN
cord-005453-4057qib7	11598	9	died	die	VBD
cord-005453-4057qib7	11598	10	.	.	.
cord-005453-4057qib7	11599	1	Results	result	NNS
cord-005453-4057qib7	11599	2	:	:	:
cord-005453-4057qib7	11600	1	The	the	DT
cord-005453-4057qib7	11600	2	64-year	64-year	JJ
cord-005453-4057qib7	11600	3	-	-	HYPH
cord-005453-4057qib7	11600	4	old	old	JJ
cord-005453-4057qib7	11600	5	man	man	NN
cord-005453-4057qib7	11600	6	initially	initially	RB
cord-005453-4057qib7	11600	7	referred	refer	VBD
cord-005453-4057qib7	11600	8	to	to	IN
cord-005453-4057qib7	11600	9	our	-PRON-	PRP$
cord-005453-4057qib7	11600	10	hospital	hospital	NN
cord-005453-4057qib7	11600	11	for	for	IN
cord-005453-4057qib7	11600	12	complaints	complaint	NNS
cord-005453-4057qib7	11600	13	of	of	IN
cord-005453-4057qib7	11600	14	abdominal	abdominal	JJ
cord-005453-4057qib7	11600	15	pain	pain	NN
cord-005453-4057qib7	11600	16	and	and	CC
cord-005453-4057qib7	11600	17	distention	distention	NN
cord-005453-4057qib7	11600	18	over	over	IN
cord-005453-4057qib7	11600	19	2	2	CD
cord-005453-4057qib7	11600	20	months	month	NNS
cord-005453-4057qib7	11600	21	.	.	.
cord-005453-4057qib7	11601	1	Ultrasound	ultrasound	NN
cord-005453-4057qib7	11601	2	showed	show	VBD
cord-005453-4057qib7	11601	3	splenomegaly	splenomegaly	JJ
cord-005453-4057qib7	11601	4	and	and	CC
cord-005453-4057qib7	11601	5	multiple	multiple	JJ
cord-005453-4057qib7	11601	6	enlarged	enlarged	JJ
cord-005453-4057qib7	11601	7	retroperitoneal	retroperitoneal	JJ
cord-005453-4057qib7	11601	8	lymph	lymph	NN
cord-005453-4057qib7	11601	9	nodes	node	NNS
cord-005453-4057qib7	11601	10	.	.	.
cord-005453-4057qib7	11602	1	Excisional	Excisional	NNP
cord-005453-4057qib7	11602	2	biopsy	biopsy	NN
cord-005453-4057qib7	11602	3	conducted	conduct	VBN
cord-005453-4057qib7	11602	4	on	on	IN
cord-005453-4057qib7	11602	5	the	the	DT
cord-005453-4057qib7	11602	6	right	right	JJ
cord-005453-4057qib7	11602	7	neck	neck	NN
cord-005453-4057qib7	11602	8	lymph	lymph	NN
cord-005453-4057qib7	11602	9	node	node	NN
cord-005453-4057qib7	11602	10	revealed	reveal	VBD
cord-005453-4057qib7	11602	11	the	the	DT
cord-005453-4057qib7	11602	12	presence	presence	NN
cord-005453-4057qib7	11602	13	of	of	IN
cord-005453-4057qib7	11602	14	malignant	malignant	JJ
cord-005453-4057qib7	11602	15	cells	cell	NNS
cord-005453-4057qib7	11602	16	.	.	.
cord-005453-4057qib7	11603	1	Immunohistochemically	immunohistochemically	RB
cord-005453-4057qib7	11603	2	,	,	,
cord-005453-4057qib7	11603	3	the	the	DT
cord-005453-4057qib7	11603	4	neoplastic	neoplastic	JJ
cord-005453-4057qib7	11603	5	cells	cell	NNS
cord-005453-4057qib7	11603	6	were	be	VBD
cord-005453-4057qib7	11603	7	positive	positive	JJ
cord-005453-4057qib7	11603	8	for	for	IN
cord-005453-4057qib7	11603	9	Bcl2	Bcl2	NNP
cord-005453-4057qib7	11603	10	,	,	,
cord-005453-4057qib7	11603	11	Bcl6,CD20	Bcl6,CD20	NNP
cord-005453-4057qib7	11603	12	,	,	,
cord-005453-4057qib7	11603	13	CD5	CD5	NNP
cord-005453-4057qib7	11603	14	,	,	,
cord-005453-4057qib7	11603	15	CD79a	CD79a	NNP
cord-005453-4057qib7	11603	16	,	,	,
cord-005453-4057qib7	11603	17	CD43	CD43	NNP
cord-005453-4057qib7	11603	18	,	,	,
cord-005453-4057qib7	11603	19	Ki-67(50	ki-67(50	NN
cord-005453-4057qib7	11603	20	%	%	NN
cord-005453-4057qib7	11603	21	)	)	-RRB-
cord-005453-4057qib7	11603	22	,	,	,
cord-005453-4057qib7	11603	23	SOX11	SOX11	NNP
cord-005453-4057qib7	11603	24	,	,	,
cord-005453-4057qib7	11603	25	CD21	CD21	NNP
cord-005453-4057qib7	11603	26	(	(	-LRB-
cord-005453-4057qib7	11603	27	FDC	FDC	NNP
cord-005453-4057qib7	11603	28	)	)	-RRB-
cord-005453-4057qib7	11603	29	and	and	CC
cord-005453-4057qib7	11603	30	Cyclin	Cyclin	NNP
cord-005453-4057qib7	11603	31	D1	D1	NNP
cord-005453-4057qib7	11603	32	and	and	CC
cord-005453-4057qib7	11603	33	negative	negative	JJ
cord-005453-4057qib7	11603	34	for	for	IN
cord-005453-4057qib7	11603	35	CD10	CD10	NNP
cord-005453-4057qib7	11603	36	,	,	,
cord-005453-4057qib7	11603	37	CD23	CD23	NNP
cord-005453-4057qib7	11603	38	and	and	CC
cord-005453-4057qib7	11603	39	CD3	CD3	NNP
cord-005453-4057qib7	11603	40	;	;	:
cord-005453-4057qib7	11603	41	Fluorescence	Fluorescence	NNP
cord-005453-4057qib7	11603	42	In	in	IN
cord-005453-4057qib7	11603	43	Situ	Situ	NNP
cord-005453-4057qib7	11603	44	Hybridization(FISH	Hybridization(FISH	NNP
cord-005453-4057qib7	11603	45	)	)	-RRB-
cord-005453-4057qib7	11603	46	showed	show	VBD
cord-005453-4057qib7	11603	47	IGH/	igh/	NN
cord-005453-4057qib7	11603	48	CCND1,t(11;14	ccnd1,t(11;14	NN
cord-005453-4057qib7	11603	49	)	)	-RRB-
cord-005453-4057qib7	11604	1	90%.Thus	90%.thus	LS
cord-005453-4057qib7	11604	2	a	a	DT
cord-005453-4057qib7	11604	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	11604	4	of	of	IN
cord-005453-4057qib7	11604	5	MCL	MCL	NNP
cord-005453-4057qib7	11604	6	was	be	VBD
cord-005453-4057qib7	11604	7	confirmed	confirm	VBN
cord-005453-4057qib7	11604	8	.	.	.
cord-005453-4057qib7	11605	1	2	2	LS
cord-005453-4057qib7	11605	2	course	course	NN
cord-005453-4057qib7	11605	3	of	of	IN
cord-005453-4057qib7	11605	4	therapeutic	therapeutic	JJ
cord-005453-4057qib7	11605	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11605	6	were	be	VBD
cord-005453-4057qib7	11605	7	applied	apply	VBN
cord-005453-4057qib7	11605	8	to	to	IN
cord-005453-4057qib7	11605	9	the	the	DT
cord-005453-4057qib7	11605	10	patient	patient	NN
cord-005453-4057qib7	11605	11	but	but	CC
cord-005453-4057qib7	11605	12	he	-PRON-	PRP
cord-005453-4057qib7	11605	13	did	do	VBD
cord-005453-4057qib7	11605	14	not	not	RB
cord-005453-4057qib7	11605	15	respond	respond	VB
cord-005453-4057qib7	11605	16	well	well	RB
cord-005453-4057qib7	11605	17	.	.	.
cord-005453-4057qib7	11606	1	He	-PRON-	PRP
cord-005453-4057qib7	11606	2	suffered	suffer	VBD
cord-005453-4057qib7	11606	3	recurrent	recurrent	JJ
cord-005453-4057qib7	11606	4	fever	fever	NN
cord-005453-4057qib7	11606	5	,	,	,
cord-005453-4057qib7	11606	6	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	11606	7	,	,	,
cord-005453-4057qib7	11606	8	left	leave	VBD
cord-005453-4057qib7	11606	9	abdominal	abdominal	JJ
cord-005453-4057qib7	11606	10	pain	pain	NN
cord-005453-4057qib7	11606	11	,	,	,
cord-005453-4057qib7	11606	12	splenomegaly	splenomegaly	NN
cord-005453-4057qib7	11606	13	and	and	CC
cord-005453-4057qib7	11606	14	multiple	multiple	JJ
cord-005453-4057qib7	11606	15	enlarged	enlarged	JJ
cord-005453-4057qib7	11606	16	lymph	lymph	NN
cord-005453-4057qib7	11606	17	nodes	node	NNS
cord-005453-4057qib7	11606	18	.	.	.
cord-005453-4057qib7	11607	1	Then	then	RB
cord-005453-4057qib7	11607	2	he	-PRON-	PRP
cord-005453-4057qib7	11607	3	received	receive	VBD
cord-005453-4057qib7	11607	4	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	11607	5	mono	mono	NN
cord-005453-4057qib7	11607	6	-	-	HYPH
cord-005453-4057qib7	11607	7	therapy	therapy	NN
cord-005453-4057qib7	11607	8	,	,	,
cord-005453-4057qib7	11607	9	and	and	CC
cord-005453-4057qib7	11607	10	experienced	experience	VBD
cord-005453-4057qib7	11607	11	a	a	DT
cord-005453-4057qib7	11607	12	dramatic	dramatic	JJ
cord-005453-4057qib7	11607	13	improvement	improvement	NN
cord-005453-4057qib7	11607	14	as	as	IN
cord-005453-4057qib7	11607	15	his	-PRON-	PRP$
cord-005453-4057qib7	11607	16	body	body	NN
cord-005453-4057qib7	11607	17	temperature	temperature	NN
cord-005453-4057qib7	11607	18	was	be	VBD
cord-005453-4057qib7	11607	19	controlled	control	VBN
cord-005453-4057qib7	11607	20	,	,	,
cord-005453-4057qib7	11607	21	his	-PRON-	PRP$
cord-005453-4057qib7	11607	22	hemogram	hemogram	NN
cord-005453-4057qib7	11607	23	became	become	VBD
cord-005453-4057qib7	11607	24	normal	normal	JJ
cord-005453-4057qib7	11607	25	and	and	CC
cord-005453-4057qib7	11607	26	his	-PRON-	PRP$
cord-005453-4057qib7	11607	27	spleen	spleen	NNS
cord-005453-4057qib7	11607	28	and	and	CC
cord-005453-4057qib7	11607	29	lymph	lymph	NN
cord-005453-4057qib7	11607	30	node	node	NN
cord-005453-4057qib7	11607	31	tapered	taper	VBN
cord-005453-4057qib7	11607	32	.	.	.
cord-005453-4057qib7	11608	1	After	after	IN
cord-005453-4057qib7	11608	2	about	about	RB
cord-005453-4057qib7	11608	3	6	6	CD
cord-005453-4057qib7	11608	4	months	month	NNS
cord-005453-4057qib7	11608	5	response	response	NN
cord-005453-4057qib7	11608	6	of	of	IN
cord-005453-4057qib7	11608	7	ibrutinib	ibrutinib	NNP
cord-005453-4057qib7	11608	8	,	,	,
cord-005453-4057qib7	11608	9	the	the	DT
cord-005453-4057qib7	11608	10	disease	disease	NN
cord-005453-4057qib7	11608	11	deteriorated	deteriorate	VBD
cord-005453-4057qib7	11608	12	rapidly	rapidly	RB
cord-005453-4057qib7	11608	13	and	and	CC
cord-005453-4057qib7	11608	14	he	-PRON-	PRP
cord-005453-4057qib7	11608	15	died	die	VBD
cord-005453-4057qib7	11608	16	very	very	RB
cord-005453-4057qib7	11608	17	soon	soon	RB
cord-005453-4057qib7	11608	18	.	.	.
cord-005453-4057qib7	11609	1	Exome	Exome	NNP
cord-005453-4057qib7	11609	2	sequencing	sequencing	NN
cord-005453-4057qib7	11609	3	from	from	IN
cord-005453-4057qib7	11609	4	the	the	DT
cord-005453-4057qib7	11609	5	patient	patient	JJ
cord-005453-4057qib7	11609	6	peripheral	peripheral	JJ
cord-005453-4057qib7	11609	7	blood	blood	NN
cord-005453-4057qib7	11609	8	at	at	IN
cord-005453-4057qib7	11609	9	this	this	DT
cord-005453-4057qib7	11609	10	time	time	NN
cord-005453-4057qib7	11609	11	detected	detect	VBD
cord-005453-4057qib7	11609	12	one	one	CD
cord-005453-4057qib7	11609	13	missense	missense	JJ
cord-005453-4057qib7	11609	14	mutation	mutation	NN
cord-005453-4057qib7	11609	15	in	in	IN
cord-005453-4057qib7	11609	16	exon	exon	NN
cord-005453-4057qib7	11609	17	5	5	CD
cord-005453-4057qib7	11609	18	of	of	IN
cord-005453-4057qib7	11609	19	TP53	TP53	NNP
cord-005453-4057qib7	11609	20	at	at	IN
cord-005453-4057qib7	11609	21	nucleotide	nucleotide	JJ
cord-005453-4057qib7	11609	22	524	524	CD
cord-005453-4057qib7	11609	23	G	g	NN
cord-005453-4057qib7	11610	1	>	>	XX
cord-005453-4057qib7	11611	1	A	a	DT
cord-005453-4057qib7	11611	2	,	,	,
cord-005453-4057qib7	11611	3	resulting	result	VBG
cord-005453-4057qib7	11611	4	in	in	IN
cord-005453-4057qib7	11611	5	an	an	DT
cord-005453-4057qib7	11611	6	Argnine	Argnine	NNP
cord-005453-4057qib7	11611	7	to	to	IN
cord-005453-4057qib7	11611	8	Histidine	Histidine	NNP
cord-005453-4057qib7	11611	9	change	change	NN
cord-005453-4057qib7	11611	10	at	at	IN
cord-005453-4057qib7	11611	11	amino	amino	NN
cord-005453-4057qib7	11611	12	acid	acid	NN
cord-005453-4057qib7	11611	13	175	175	CD
cord-005453-4057qib7	11612	1	(	(	-LRB-
cord-005453-4057qib7	11612	2	p	p	NN
cord-005453-4057qib7	11612	3	.	.	.
cord-005453-4057qib7	11612	4	Arg175His	Arg175His	''
cord-005453-4057qib7	11612	5	)	)	-RRB-
cord-005453-4057qib7	11612	6	.	.	.
cord-005453-4057qib7	11613	1	But	but	CC
cord-005453-4057qib7	11613	2	Sanger	Sanger	NNP
cord-005453-4057qib7	11613	3	sequencing	sequencing	NN
cord-005453-4057qib7	11613	4	of	of	IN
cord-005453-4057qib7	11613	5	the	the	DT
cord-005453-4057qib7	11613	6	patient	patient	NN
cord-005453-4057qib7	11613	7	bone	bone	NN
cord-005453-4057qib7	11613	8	marrow	marrow	NN
cord-005453-4057qib7	11613	9	FFPE	FFPE	NNP
cord-005453-4057qib7	11613	10	sample	sample	NN
cord-005453-4057qib7	11613	11	at	at	IN
cord-005453-4057qib7	11613	12	the	the	DT
cord-005453-4057qib7	11613	13	time	time	NN
cord-005453-4057qib7	11613	14	of	of	IN
cord-005453-4057qib7	11613	15	original	original	JJ
cord-005453-4057qib7	11613	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	11613	17	did	do	VBD
cord-005453-4057qib7	11613	18	not	not	RB
cord-005453-4057qib7	11613	19	detect	detect	VB
cord-005453-4057qib7	11613	20	this	this	DT
cord-005453-4057qib7	11613	21	mutation	mutation	NN
cord-005453-4057qib7	11613	22	.	.	.
cord-005453-4057qib7	11614	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11614	2	:	:	:
cord-005453-4057qib7	11615	1	Thus	thus	RB
cord-005453-4057qib7	11615	2	,	,	,
cord-005453-4057qib7	11615	3	our	-PRON-	PRP$
cord-005453-4057qib7	11615	4	study	study	NN
cord-005453-4057qib7	11615	5	reported	report	VBD
cord-005453-4057qib7	11615	6	a	a	DT
cord-005453-4057qib7	11615	7	TP53	TP53	NNP
cord-005453-4057qib7	11615	8	R175H	r175h	NN
cord-005453-4057qib7	11615	9	mutation	mutation	NN
cord-005453-4057qib7	11615	10	MCL	mcl	NN
cord-005453-4057qib7	11615	11	patient	patient	NN
cord-005453-4057qib7	11615	12	who	who	WP
cord-005453-4057qib7	11615	13	developed	develop	VBD
cord-005453-4057qib7	11615	14	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	11615	15	resistance	resistance	NN
cord-005453-4057qib7	11615	16	and	and	CC
cord-005453-4057qib7	11615	17	progressed	progress	VBD
cord-005453-4057qib7	11615	18	aggresively	aggresively	RB
cord-005453-4057qib7	11615	19	,	,	,
cord-005453-4057qib7	11615	20	which	which	WDT
cord-005453-4057qib7	11615	21	may	may	MD
cord-005453-4057qib7	11615	22	open	open	VB
cord-005453-4057qib7	11615	23	new	new	JJ
cord-005453-4057qib7	11615	24	insight	insight	NN
cord-005453-4057qib7	11615	25	for	for	IN
cord-005453-4057qib7	11615	26	future	future	JJ
cord-005453-4057qib7	11615	27	effort	effort	NN
cord-005453-4057qib7	11615	28	for	for	IN
cord-005453-4057qib7	11615	29	alternative	alternative	JJ
cord-005453-4057qib7	11615	30	therapeutic	therapeutic	JJ
cord-005453-4057qib7	11615	31	strategies	strategy	NNS
cord-005453-4057qib7	11615	32	in	in	IN
cord-005453-4057qib7	11615	33	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	11615	34	-	-	HYPH
cord-005453-4057qib7	11615	35	refractory	refractory	JJ
cord-005453-4057qib7	11615	36	MCL	mcl	NN
cord-005453-4057qib7	11615	37	.	.	.
cord-005453-4057qib7	11616	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11616	2	:	:	:
cord-005453-4057qib7	11616	3	Nothing	nothing	NN
cord-005453-4057qib7	11616	4	to	to	TO
cord-005453-4057qib7	11616	5	declare	declare	VB
cord-005453-4057qib7	11616	6	.	.	.
cord-005453-4057qib7	11617	1	Minimal	minimal	JJ
cord-005453-4057qib7	11617	2	residual	residual	JJ
cord-005453-4057qib7	11617	3	disease	disease	NN
cord-005453-4057qib7	11617	4	,	,	,
cord-005453-4057qib7	11617	5	tolerance	tolerance	NN
cord-005453-4057qib7	11617	6	,	,	,
cord-005453-4057qib7	11617	7	chimerism	chimerism	NN
cord-005453-4057qib7	11617	8	and	and	CC
cord-005453-4057qib7	11617	9	immune	immune	JJ
cord-005453-4057qib7	11617	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	11617	11	Peripheral	peripheral	JJ
cord-005453-4057qib7	11617	12	blood	blood	NN
cord-005453-4057qib7	11617	13	samples	sample	NNS
cord-005453-4057qib7	11617	14	were	be	VBD
cord-005453-4057qib7	11617	15	obtained	obtain	VBN
cord-005453-4057qib7	11617	16	for	for	IN
cord-005453-4057qib7	11617	17	routine	routine	JJ
cord-005453-4057qib7	11617	18	analysis	analysis	NN
cord-005453-4057qib7	11617	19	at	at	IN
cord-005453-4057qib7	11617	20	several	several	JJ
cord-005453-4057qib7	11617	21	time	time	NN
cord-005453-4057qib7	11617	22	points	point	NNS
cord-005453-4057qib7	11617	23	after	after	IN
cord-005453-4057qib7	11617	24	HSCT	HSCT	NNP
cord-005453-4057qib7	11617	25	.	.	.
cord-005453-4057qib7	11618	1	All	all	DT
cord-005453-4057qib7	11618	2	available	available	JJ
cord-005453-4057qib7	11618	3	blood	blood	NN
cord-005453-4057qib7	11618	4	samples	sample	NNS
cord-005453-4057qib7	11618	5	between	between	IN
cord-005453-4057qib7	11618	6	0.5	0.5	CD
cord-005453-4057qib7	11618	7	and	and	CC
cord-005453-4057qib7	11618	8	2	2	CD
cord-005453-4057qib7	11618	9	years	year	NNS
cord-005453-4057qib7	11618	10	were	be	VBD
cord-005453-4057qib7	11618	11	used	use	VBN
cord-005453-4057qib7	11618	12	in	in	IN
cord-005453-4057qib7	11618	13	the	the	DT
cord-005453-4057qib7	11618	14	analysis	analysis	NN
cord-005453-4057qib7	11618	15	.	.	.
cord-005453-4057qib7	11619	1	To	to	TO
cord-005453-4057qib7	11619	2	assess	assess	VB
cord-005453-4057qib7	11619	3	changes	change	NNS
cord-005453-4057qib7	11619	4	in	in	IN
cord-005453-4057qib7	11619	5	the	the	DT
cord-005453-4057qib7	11619	6	CD19+B	CD19+B	NNP
cord-005453-4057qib7	11619	7	and	and	CC
cord-005453-4057qib7	11619	8	CD19	CD19	NNP
cord-005453-4057qib7	11619	9	+	+	CC
cord-005453-4057qib7	11619	10	CD27+memory	cd27+memory	NN
cord-005453-4057qib7	11619	11	B	b	NN
cord-005453-4057qib7	11619	12	cell	cell	NN
cord-005453-4057qib7	11619	13	counts	count	VBZ
cord-005453-4057qib7	11619	14	over	over	IN
cord-005453-4057qib7	11619	15	time	time	NN
cord-005453-4057qib7	11619	16	while	while	IN
cord-005453-4057qib7	11619	17	accounting	account	VBG
cord-005453-4057qib7	11619	18	for	for	IN
cord-005453-4057qib7	11619	19	the	the	DT
cord-005453-4057qib7	11619	20	correlation	correlation	NN
cord-005453-4057qib7	11619	21	between	between	IN
cord-005453-4057qib7	11619	22	the	the	DT
cord-005453-4057qib7	11619	23	repeated	repeat	VBN
cord-005453-4057qib7	11619	24	measurements	measurement	NNS
cord-005453-4057qib7	11619	25	of	of	IN
cord-005453-4057qib7	11619	26	each	each	DT
cord-005453-4057qib7	11619	27	patient	patient	NN
cord-005453-4057qib7	11619	28	,	,	,
cord-005453-4057qib7	11619	29	we	-PRON-	PRP
cord-005453-4057qib7	11619	30	used	use	VBD
cord-005453-4057qib7	11619	31	linear	linear	JJ
cord-005453-4057qib7	11619	32	mixed	mixed	JJ
cord-005453-4057qib7	11619	33	-	-	HYPH
cord-005453-4057qib7	11619	34	effects	effect	NNS
cord-005453-4057qib7	11619	35	models	model	NNS
cord-005453-4057qib7	11619	36	.	.	.
cord-005453-4057qib7	11620	1	Wilcoxon	Wilcoxon	NNP
cord-005453-4057qib7	11620	2	rank	rank	NN
cord-005453-4057qib7	11620	3	test	test	NN
cord-005453-4057qib7	11620	4	,	,	,
cord-005453-4057qib7	11620	5	Kruskal	Kruskal	NNP
cord-005453-4057qib7	11620	6	-	-	HYPH
cord-005453-4057qib7	11620	7	Wallis	Wallis	NNP
cord-005453-4057qib7	11620	8	test	test	NN
cord-005453-4057qib7	11620	9	and	and	CC
cord-005453-4057qib7	11620	10	linear	linear	JJ
cord-005453-4057qib7	11620	11	regression	regression	NN
cord-005453-4057qib7	11620	12	were	be	VBD
cord-005453-4057qib7	11620	13	used	use	VBN
cord-005453-4057qib7	11620	14	for	for	IN
cord-005453-4057qib7	11620	15	univariate	univariate	JJ
cord-005453-4057qib7	11620	16	analysis	analysis	NN
cord-005453-4057qib7	11620	17	.	.	.
cord-005453-4057qib7	11621	1	Results	result	NNS
cord-005453-4057qib7	11621	2	:	:	:
cord-005453-4057qib7	11622	1	At	at	IN
cord-005453-4057qib7	11622	2	one	one	CD
cord-005453-4057qib7	11622	3	year	year	NN
cord-005453-4057qib7	11622	4	after	after	IN
cord-005453-4057qib7	11622	5	HSCT	HSCT	NNP
cord-005453-4057qib7	11622	6	,	,	,
cord-005453-4057qib7	11622	7	univariate	univariate	JJ
cord-005453-4057qib7	11622	8	analysis	analysis	NN
cord-005453-4057qib7	11622	9	showed	show	VBD
cord-005453-4057qib7	11622	10	that	that	IN
cord-005453-4057qib7	11622	11	patients	patient	NNS
cord-005453-4057qib7	11622	12	transplanted	transplant	VBN
cord-005453-4057qib7	11622	13	with	with	IN
cord-005453-4057qib7	11622	14	a	a	DT
cord-005453-4057qib7	11622	15	CB	CB	NNP
cord-005453-4057qib7	11622	16	graft	graft	NN
cord-005453-4057qib7	11622	17	compared	compare	VBN
cord-005453-4057qib7	11622	18	to	to	IN
cord-005453-4057qib7	11622	19	BM	BM	NNP
cord-005453-4057qib7	11622	20	and	and	CC
cord-005453-4057qib7	11622	21	PBSC	PBSC	NNP
cord-005453-4057qib7	11622	22	had	have	VBD
cord-005453-4057qib7	11622	23	a	a	DT
cord-005453-4057qib7	11622	24	significantly	significantly	RB
cord-005453-4057qib7	11622	25	higher	high	JJR
cord-005453-4057qib7	11622	26	absolute	absolute	JJ
cord-005453-4057qib7	11622	27	number	number	NN
cord-005453-4057qib7	11622	28	of	of	IN
cord-005453-4057qib7	11622	29	B	b	NN
cord-005453-4057qib7	11622	30	cells	cell	NNS
cord-005453-4057qib7	11622	31	(	(	-LRB-
cord-005453-4057qib7	11622	32	median	median	NN
cord-005453-4057qib7	11622	33	BM=	BM=	NNP
cord-005453-4057qib7	11622	34	501	501	CD
cord-005453-4057qib7	11622	35	,	,	,
cord-005453-4057qib7	11622	36	median	median	NN
cord-005453-4057qib7	11622	37	CB=1402	cb=1402	NN
cord-005453-4057qib7	11622	38	,	,	,
cord-005453-4057qib7	11622	39	median	median	JJ
cord-005453-4057qib7	11622	40	PBSC=502	pbsc=502	NN
cord-005453-4057qib7	11622	41	cells/	cells/	CD
cord-005453-4057qib7	11623	1	μl	μl	UH
cord-005453-4057qib7	11623	2	,	,	,
cord-005453-4057qib7	11623	3	P=1.4e-5	P=1.4e-5	NNP
cord-005453-4057qib7	11623	4	)	)	-RRB-
cord-005453-4057qib7	11624	1	and	and	CC
cord-005453-4057qib7	11624	2	memory	memory	NN
cord-005453-4057qib7	11624	3	B	b	NN
cord-005453-4057qib7	11624	4	cells	cell	NNS
cord-005453-4057qib7	11624	5	(	(	-LRB-
cord-005453-4057qib7	11624	6	median	median	JJ
cord-005453-4057qib7	11624	7	BM=	BM=	NNP
cord-005453-4057qib7	11624	8	26	26	CD
cord-005453-4057qib7	11624	9	,	,	,
cord-005453-4057qib7	11624	10	median	median	NN
cord-005453-4057qib7	11624	11	CB=75	CB=75	NNP
cord-005453-4057qib7	11624	12	,	,	,
cord-005453-4057qib7	11624	13	median	median	JJ
cord-005453-4057qib7	11624	14	PBSC=23	PBSC=23	NNP
cord-005453-4057qib7	11624	15	cells/	cells/	CD
cord-005453-4057qib7	11625	1	μl	μl	UH
cord-005453-4057qib7	11625	2	,	,	,
cord-005453-4057qib7	11625	3	.	.	.
cord-005453-4057qib7	11626	1	Recipients	recipient	NNS
cord-005453-4057qib7	11626	2	with	with	IN
cord-005453-4057qib7	11626	3	age	age	NN
cord-005453-4057qib7	11626	4	under	under	IN
cord-005453-4057qib7	11626	5	5	5	CD
cord-005453-4057qib7	11626	6	years	year	NNS
cord-005453-4057qib7	11626	7	had	have	VBD
cord-005453-4057qib7	11626	8	significantly	significantly	RB
cord-005453-4057qib7	11626	9	higher	high	JJR
cord-005453-4057qib7	11626	10	absolute	absolute	JJ
cord-005453-4057qib7	11626	11	numbers	number	NNS
cord-005453-4057qib7	11626	12	of	of	IN
cord-005453-4057qib7	11626	13	B	b	NN
cord-005453-4057qib7	11626	14	(	(	-LRB-
cord-005453-4057qib7	11626	15	median=919	median=919	NNP
cord-005453-4057qib7	11626	16	,	,	,
cord-005453-4057qib7	11626	17	median=473	median=473	NN
cord-005453-4057qib7	11626	18	cells/	cells/	CD
cord-005453-4057qib7	11627	1	μl	μl	UH
cord-005453-4057qib7	11627	2	,	,	,
cord-005453-4057qib7	11627	3	P=2.9e-4	p=2.9e-4	ADD
cord-005453-4057qib7	11627	4	)	)	-RRB-
cord-005453-4057qib7	11627	5	and	and	CC
cord-005453-4057qib7	11627	6	memory	memory	NN
cord-005453-4057qib7	11627	7	B	b	NN
cord-005453-4057qib7	11627	8	cells	cell	NNS
cord-005453-4057qib7	11627	9	(	(	-LRB-
cord-005453-4057qib7	11627	10	median=54	median=54	NNP
cord-005453-4057qib7	11627	11	,	,	,
cord-005453-4057qib7	11627	12	median=22	median=22	NNP
cord-005453-4057qib7	11627	13	cells	cell	NNS
cord-005453-4057qib7	11627	14	/	/	SYM
cord-005453-4057qib7	11627	15	μl	μl	NN
cord-005453-4057qib7	11627	16	,	,	,
cord-005453-4057qib7	11627	17	P=2.7e-5	p=2.7e-5	NN
cord-005453-4057qib7	11627	18	)	)	-RRB-
cord-005453-4057qib7	11628	1	than	than	IN
cord-005453-4057qib7	11628	2	above	above	IN
cord-005453-4057qib7	11628	3	5	5	CD
cord-005453-4057qib7	11628	4	years	year	NNS
cord-005453-4057qib7	11628	5	.	.	.
cord-005453-4057qib7	11629	1	Increase	increase	VB
cord-005453-4057qib7	11629	2	in	in	IN
cord-005453-4057qib7	11629	3	donor	donor	NN
cord-005453-4057qib7	11629	4	age	age	NN
cord-005453-4057qib7	11629	5	was	be	VBD
cord-005453-4057qib7	11629	6	associated	associate	VBN
cord-005453-4057qib7	11629	7	with	with	IN
cord-005453-4057qib7	11629	8	a	a	DT
cord-005453-4057qib7	11629	9	decreasing	decrease	VBG
cord-005453-4057qib7	11629	10	effect	effect	NN
cord-005453-4057qib7	11629	11	on	on	IN
cord-005453-4057qib7	11629	12	B	b	NN
cord-005453-4057qib7	11629	13	cell	cell	NN
cord-005453-4057qib7	11630	1	(	(	-LRB-
cord-005453-4057qib7	11630	2	R	r	NN
cord-005453-4057qib7	11630	3	2	2	CD
cord-005453-4057qib7	11630	4	=	=	SYM
cord-005453-4057qib7	11630	5	0.35	0.35	CD
cord-005453-4057qib7	11630	6	,	,	,
cord-005453-4057qib7	11630	7	P=5.9e-14	P=5.9e-14	NNP
cord-005453-4057qib7	11630	8	)	)	-RRB-
cord-005453-4057qib7	11630	9	and	and	CC
cord-005453-4057qib7	11630	10	memory	memory	NN
cord-005453-4057qib7	11630	11	B	b	NN
cord-005453-4057qib7	11630	12	cell	cell	NN
cord-005453-4057qib7	11630	13	(	(	-LRB-
cord-005453-4057qib7	11630	14	R	r	NN
cord-005453-4057qib7	11630	15	2	2	CD
cord-005453-4057qib7	11630	16	=	=	SYM
cord-005453-4057qib7	11630	17	0.25	0.25	CD
cord-005453-4057qib7	11630	18	,	,	,
cord-005453-4057qib7	11630	19	P=2.1e-8	p=2.1e-8	CD
cord-005453-4057qib7	11630	20	)	)	-RRB-
cord-005453-4057qib7	11630	21	reconstitution	reconstitution	NN
cord-005453-4057qib7	11630	22	as	as	IN
cord-005453-4057qib7	11630	23	determined	determine	VBN
cord-005453-4057qib7	11630	24	in	in	IN
cord-005453-4057qib7	11630	25	regression	regression	NN
cord-005453-4057qib7	11630	26	analysis	analysis	NN
cord-005453-4057qib7	11630	27	.	.	.
cord-005453-4057qib7	11631	1	Following	follow	VBG
cord-005453-4057qib7	11631	2	univariate	univariate	JJ
cord-005453-4057qib7	11631	3	analysis	analysis	NN
cord-005453-4057qib7	11631	4	,	,	,
cord-005453-4057qib7	11631	5	we	-PRON-	PRP
cord-005453-4057qib7	11631	6	analysed	analyse	VBD
cord-005453-4057qib7	11631	7	these	these	DT
cord-005453-4057qib7	11631	8	factors	factor	NNS
cord-005453-4057qib7	11631	9	in	in	IN
cord-005453-4057qib7	11631	10	a	a	DT
cord-005453-4057qib7	11631	11	mixed	mixed	JJ
cord-005453-4057qib7	11631	12	effects	effect	NNS
cord-005453-4057qib7	11631	13	model	model	NN
cord-005453-4057qib7	11631	14	to	to	TO
cord-005453-4057qib7	11631	15	assess	assess	VB
cord-005453-4057qib7	11631	16	the	the	DT
cord-005453-4057qib7	11631	17	relation	relation	NN
cord-005453-4057qib7	11631	18	with	with	IN
cord-005453-4057qib7	11631	19	differences	difference	NNS
cord-005453-4057qib7	11631	20	in	in	IN
cord-005453-4057qib7	11631	21	B	b	NN
cord-005453-4057qib7	11631	22	cell	cell	NN
cord-005453-4057qib7	11631	23	or	or	CC
cord-005453-4057qib7	11631	24	memory	memory	NN
cord-005453-4057qib7	11631	25	B	b	NN
cord-005453-4057qib7	11631	26	cell	cell	NN
cord-005453-4057qib7	11631	27	numbers	number	NNS
cord-005453-4057qib7	11631	28	0.5	0.5	CD
cord-005453-4057qib7	11631	29	-	-	HYPH
cord-005453-4057qib7	11631	30	2	2	CD
cord-005453-4057qib7	11631	31	years	year	NNS
cord-005453-4057qib7	11631	32	after	after	IN
cord-005453-4057qib7	11631	33	HSCT	HSCT	NNP
cord-005453-4057qib7	11631	34	.	.	.
cord-005453-4057qib7	11632	1	In	in	IN
cord-005453-4057qib7	11632	2	our	-PRON-	PRP$
cord-005453-4057qib7	11632	3	analysis	analysis	NN
cord-005453-4057qib7	11632	4	we	-PRON-	PRP
cord-005453-4057qib7	11632	5	found	find	VBD
cord-005453-4057qib7	11632	6	significant	significant	JJ
cord-005453-4057qib7	11632	7	decreasing	decrease	VBG
cord-005453-4057qib7	11632	8	B	b	NN
cord-005453-4057qib7	11632	9	cell	cell	NN
cord-005453-4057qib7	11632	10	and	and	CC
cord-005453-4057qib7	11632	11	memory	memory	NN
cord-005453-4057qib7	11632	12	B	b	NN
cord-005453-4057qib7	11632	13	cell	cell	NN
cord-005453-4057qib7	11632	14	numbers	number	NNS
cord-005453-4057qib7	11632	15	with	with	IN
cord-005453-4057qib7	11632	16	increasing	increase	VBG
cord-005453-4057qib7	11632	17	donor	donor	NN
cord-005453-4057qib7	11632	18	age	age	NN
cord-005453-4057qib7	11632	19	corrected	correct	VBD
cord-005453-4057qib7	11632	20	for	for	IN
cord-005453-4057qib7	11632	21	recipient	recipient	NN
cord-005453-4057qib7	11632	22	age	age	NN
cord-005453-4057qib7	11632	23	and	and	CC
cord-005453-4057qib7	11632	24	source	source	NN
cord-005453-4057qib7	11632	25	(	(	-LRB-
cord-005453-4057qib7	11632	26	both	both	DT
cord-005453-4057qib7	11632	27	P	p	NN
cord-005453-4057qib7	11632	28	<	<	XX
cord-005453-4057qib7	11632	29	0.001	0.001	CD
cord-005453-4057qib7	11632	30	)	)	-RRB-
cord-005453-4057qib7	11632	31	.	.	.
cord-005453-4057qib7	11633	1	Increasing	increase	VBG
cord-005453-4057qib7	11633	2	recipient	recipient	NN
cord-005453-4057qib7	11633	3	age	age	NN
cord-005453-4057qib7	11633	4	also	also	RB
cord-005453-4057qib7	11633	5	showed	show	VBD
cord-005453-4057qib7	11633	6	a	a	DT
cord-005453-4057qib7	11633	7	significant	significant	JJ
cord-005453-4057qib7	11633	8	decrease	decrease	NN
cord-005453-4057qib7	11633	9	in	in	IN
cord-005453-4057qib7	11634	1	B	b	NN
cord-005453-4057qib7	11634	2	cell	cell	NN
cord-005453-4057qib7	11634	3	and	and	CC
cord-005453-4057qib7	11634	4	memory	memory	NN
cord-005453-4057qib7	11634	5	B	b	NN
cord-005453-4057qib7	11634	6	cell	cell	NN
cord-005453-4057qib7	11634	7	numbers	number	NNS
cord-005453-4057qib7	11634	8	(	(	-LRB-
cord-005453-4057qib7	11634	9	both	both	DT
cord-005453-4057qib7	11634	10	P	p	NN
cord-005453-4057qib7	11634	11	<	<	XX
cord-005453-4057qib7	11634	12	0.001	0.001	CD
cord-005453-4057qib7	11634	13	)	)	-RRB-
cord-005453-4057qib7	11634	14	but	but	CC
cord-005453-4057qib7	11635	1	there	there	EX
cord-005453-4057qib7	11635	2	was	be	VBD
cord-005453-4057qib7	11635	3	no	no	DT
cord-005453-4057qib7	11635	4	significant	significant	JJ
cord-005453-4057qib7	11635	5	influence	influence	NN
cord-005453-4057qib7	11635	6	of	of	IN
cord-005453-4057qib7	11635	7	donor	donor	NN
cord-005453-4057qib7	11635	8	source	source	NN
cord-005453-4057qib7	11635	9	(	(	-LRB-
cord-005453-4057qib7	11635	10	Figure	figure	NN
cord-005453-4057qib7	11635	11	1	1	CD
cord-005453-4057qib7	11635	12	)	)	-RRB-
cord-005453-4057qib7	11635	13	.	.	.
cord-005453-4057qib7	11636	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11636	2	:	:	:
cord-005453-4057qib7	11637	1	B	b	NN
cord-005453-4057qib7	11637	2	cell	cell	NN
cord-005453-4057qib7	11637	3	and	and	CC
cord-005453-4057qib7	11637	4	memory	memory	NN
cord-005453-4057qib7	11637	5	B	b	NN
cord-005453-4057qib7	11637	6	cell	cell	NN
cord-005453-4057qib7	11637	7	numbers	number	NNS
cord-005453-4057qib7	11637	8	after	after	IN
cord-005453-4057qib7	11637	9	HSCT	HSCT	NNP
cord-005453-4057qib7	11637	10	are	be	VBP
cord-005453-4057qib7	11637	11	influenced	influence	VBN
cord-005453-4057qib7	11637	12	by	by	IN
cord-005453-4057qib7	11637	13	donor	donor	NN
cord-005453-4057qib7	11637	14	and	and	CC
cord-005453-4057qib7	11637	15	recipient	recipient	NN
cord-005453-4057qib7	11637	16	age	age	NN
cord-005453-4057qib7	11637	17	but	but	CC
cord-005453-4057qib7	11637	18	not	not	RB
cord-005453-4057qib7	11637	19	by	by	IN
cord-005453-4057qib7	11637	20	donor	donor	NN
cord-005453-4057qib7	11637	21	source	source	NN
cord-005453-4057qib7	11637	22	.	.	.
cord-005453-4057qib7	11638	1	Older	old	JJR
cord-005453-4057qib7	11638	2	donors	donor	NNS
cord-005453-4057qib7	11638	3	and	and	CC
cord-005453-4057qib7	11638	4	recipients	recipient	NNS
cord-005453-4057qib7	11638	5	show	show	VBP
cord-005453-4057qib7	11638	6	a	a	DT
cord-005453-4057qib7	11638	7	decrease	decrease	NN
cord-005453-4057qib7	11638	8	in	in	IN
cord-005453-4057qib7	11638	9	B	b	NN
cord-005453-4057qib7	11638	10	cells	cell	NNS
cord-005453-4057qib7	11638	11	and	and	CC
cord-005453-4057qib7	11638	12	memory	memory	NN
cord-005453-4057qib7	11638	13	B	b	NN
cord-005453-4057qib7	11638	14	cells	cell	NNS
cord-005453-4057qib7	11638	15	numbers	number	NNS
cord-005453-4057qib7	11638	16	0.5	0.5	CD
cord-005453-4057qib7	11638	17	-	-	HYPH
cord-005453-4057qib7	11638	18	2	2	CD
cord-005453-4057qib7	11638	19	years	year	NNS
cord-005453-4057qib7	11638	20	after	after	IN
cord-005453-4057qib7	11638	21	HSCT	HSCT	NNP
cord-005453-4057qib7	11638	22	.	.	.
cord-005453-4057qib7	11639	1	[	[	-LRB-
cord-005453-4057qib7	11639	2	[	[	-LRB-
cord-005453-4057qib7	11639	3	P512	P512	NNP
cord-005453-4057qib7	11639	4	Image	Image	NNP
cord-005453-4057qib7	11639	5	]	]	-RRB-
cord-005453-4057qib7	11639	6	1	1	CD
cord-005453-4057qib7	11639	7	.	.	.
cord-005453-4057qib7	11640	1	Figure	figure	NN
cord-005453-4057qib7	11640	2	1	1	CD
cord-005453-4057qib7	11640	3	.	.	.
cord-005453-4057qib7	11641	1	B	b	NN
cord-005453-4057qib7	11641	2	cell	cell	NN
cord-005453-4057qib7	11641	3	development	development	NN
cord-005453-4057qib7	11641	4	and	and	CC
cord-005453-4057qib7	11641	5	donor	donor	NN
cord-005453-4057qib7	11641	6	age	age	NN
cord-005453-4057qib7	11641	7	.	.	.
cord-005453-4057qib7	11642	1	Green	Green	NNP
cord-005453-4057qib7	11642	2	shows	show	VBZ
cord-005453-4057qib7	11642	3	CB	CB	NNP
cord-005453-4057qib7	11642	4	,	,	,
cord-005453-4057qib7	11642	5	red	red	JJ
cord-005453-4057qib7	11642	6	BM	BM	NNP
cord-005453-4057qib7	11642	7	,	,	,
cord-005453-4057qib7	11642	8	blue	blue	JJ
cord-005453-4057qib7	11642	9	PBSC	PBSC	NNP
cord-005453-4057qib7	11642	10	at	at	IN
cord-005453-4057qib7	11642	11	mean	mean	JJ
cord-005453-4057qib7	11642	12	donor	donor	NN
cord-005453-4057qib7	11642	13	age	age	NN
cord-005453-4057qib7	11642	14	.	.	.
cord-005453-4057qib7	11642	15	]	]	-RRB-
cord-005453-4057qib7	11643	1	1	1	CD
cord-005453-4057qib7	11643	2	Copenhagen	Copenhagen	NNP
cord-005453-4057qib7	11643	3	University	University	NNP
cord-005453-4057qib7	11643	4	Hospital	Hospital	NNP
cord-005453-4057qib7	11643	5	Rigshospitalet	Rigshospitalet	NNP
cord-005453-4057qib7	11643	6	,	,	,
cord-005453-4057qib7	11643	7	Copenhagen	Copenhagen	NNP
cord-005453-4057qib7	11643	8	,	,	,
cord-005453-4057qib7	11643	9	Denmark	Denmark	NNP
cord-005453-4057qib7	11643	10	,	,	,
cord-005453-4057qib7	11643	11	2	2	CD
cord-005453-4057qib7	11643	12	Leiden	Leiden	NNP
cord-005453-4057qib7	11643	13	University	University	NNP
cord-005453-4057qib7	11643	14	Medical	Medical	NNP
cord-005453-4057qib7	11643	15	Center	Center	NNP
cord-005453-4057qib7	11643	16	,	,	,
cord-005453-4057qib7	11643	17	Leiden	Leiden	NNP
cord-005453-4057qib7	11643	18	,	,	,
cord-005453-4057qib7	11644	1	Netherlands	Netherlands	NNP
cord-005453-4057qib7	11644	2	Background	Background	NNP
cord-005453-4057qib7	11644	3	:	:	:
cord-005453-4057qib7	11645	1	The	the	DT
cord-005453-4057qib7	11645	2	outcome	outcome	NN
cord-005453-4057qib7	11645	3	of	of	IN
cord-005453-4057qib7	11645	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	11645	5	HSCT	HSCT	NNP
cord-005453-4057qib7	11645	6	is	be	VBZ
cord-005453-4057qib7	11645	7	challenged	challenge	VBN
cord-005453-4057qib7	11645	8	by	by	IN
cord-005453-4057qib7	11645	9	a	a	DT
cord-005453-4057qib7	11645	10	delayed	delayed	JJ
cord-005453-4057qib7	11645	11	and	and	CC
cord-005453-4057qib7	11645	12	long	long	RB
cord-005453-4057qib7	11645	13	-	-	HYPH
cord-005453-4057qib7	11645	14	lasting	last	VBG
cord-005453-4057qib7	11645	15	imbalanced	imbalanced	JJ
cord-005453-4057qib7	11645	16	T	t	NN
cord-005453-4057qib7	11645	17	-	-	HYPH
cord-005453-4057qib7	11645	18	cell	cell	NN
cord-005453-4057qib7	11645	19	reconstitution	reconstitution	NN
cord-005453-4057qib7	11645	20	increasing	increase	VBG
cord-005453-4057qib7	11645	21	the	the	DT
cord-005453-4057qib7	11645	22	risk	risk	NN
cord-005453-4057qib7	11645	23	of	of	IN
cord-005453-4057qib7	11645	24	acute	acute	JJ
cord-005453-4057qib7	11645	25	GvHD	gvhd	NN
cord-005453-4057qib7	11645	26	,	,	,
cord-005453-4057qib7	11645	27	infections	infection	NNS
cord-005453-4057qib7	11645	28	and	and	CC
cord-005453-4057qib7	11645	29	disease	disease	NN
cord-005453-4057qib7	11645	30	progression	progression	NN
cord-005453-4057qib7	11645	31	.	.	.
cord-005453-4057qib7	11646	1	Although	although	IN
cord-005453-4057qib7	11646	2	the	the	DT
cord-005453-4057qib7	11646	3	role	role	NN
cord-005453-4057qib7	11646	4	of	of	IN
cord-005453-4057qib7	11646	5	differentially	differentially	RB
cord-005453-4057qib7	11646	6	and	and	CC
cord-005453-4057qib7	11646	7	functionally	functionally	RB
cord-005453-4057qib7	11646	8	distinct	distinct	JJ
cord-005453-4057qib7	11646	9	T	t	NN
cord-005453-4057qib7	11646	10	-	-	HYPH
cord-005453-4057qib7	11646	11	cell	cell	NN
cord-005453-4057qib7	11646	12	subsets	subset	NNS
cord-005453-4057qib7	11646	13	in	in	IN
cord-005453-4057qib7	11646	14	the	the	DT
cord-005453-4057qib7	11646	15	development	development	NN
cord-005453-4057qib7	11646	16	of	of	IN
cord-005453-4057qib7	11646	17	complications	complication	NNS
cord-005453-4057qib7	11646	18	has	have	VBZ
cord-005453-4057qib7	11646	19	been	be	VBN
cord-005453-4057qib7	11646	20	addressed	address	VBN
cord-005453-4057qib7	11646	21	,	,	,
cord-005453-4057qib7	11646	22	little	little	JJ
cord-005453-4057qib7	11646	23	is	be	VBZ
cord-005453-4057qib7	11646	24	known	know	VBN
cord-005453-4057qib7	11646	25	about	about	IN
cord-005453-4057qib7	11646	26	the	the	DT
cord-005453-4057qib7	11646	27	factors	factor	NNS
cord-005453-4057qib7	11646	28	controlling	control	VBG
cord-005453-4057qib7	11646	29	their	-PRON-	PRP$
cord-005453-4057qib7	11646	30	recovery	recovery	NN
cord-005453-4057qib7	11646	31	.	.	.
cord-005453-4057qib7	11647	1	In	in	IN
cord-005453-4057qib7	11647	2	this	this	DT
cord-005453-4057qib7	11647	3	study	study	NN
cord-005453-4057qib7	11647	4	,	,	,
cord-005453-4057qib7	11647	5	we	-PRON-	PRP
cord-005453-4057qib7	11647	6	investigated	investigate	VBD
cord-005453-4057qib7	11647	7	the	the	DT
cord-005453-4057qib7	11647	8	impact	impact	NN
cord-005453-4057qib7	11647	9	of	of	IN
cord-005453-4057qib7	11647	10	immuneregulating	immuneregulate	VBG
cord-005453-4057qib7	11647	11	and	and	CC
cord-005453-4057qib7	11647	12	homeostatic	homeostatic	JJ
cord-005453-4057qib7	11647	13	cytokines	cytokine	NNS
cord-005453-4057qib7	11647	14	on	on	IN
cord-005453-4057qib7	11647	15	the	the	DT
cord-005453-4057qib7	11647	16	reconstitution	reconstitution	NN
cord-005453-4057qib7	11647	17	of	of	IN
cord-005453-4057qib7	11647	18	functionally	functionally	RB
cord-005453-4057qib7	11647	19	distinct	distinct	JJ
cord-005453-4057qib7	11647	20	T	t	NN
cord-005453-4057qib7	11647	21	-	-	HYPH
cord-005453-4057qib7	11647	22	cell	cell	NN
cord-005453-4057qib7	11647	23	subsets	subset	NNS
cord-005453-4057qib7	11647	24	and	and	CC
cord-005453-4057qib7	11647	25	associated	associate	VBN
cord-005453-4057qib7	11647	26	clinical	clinical	JJ
cord-005453-4057qib7	11647	27	outcomes	outcome	NNS
cord-005453-4057qib7	11647	28	.	.	.
cord-005453-4057qib7	11648	1	Methods	method	NNS
cord-005453-4057qib7	11648	2	:	:	:
cord-005453-4057qib7	11648	3	We	-PRON-	PRP
cord-005453-4057qib7	11648	4	included	include	VBD
cord-005453-4057qib7	11648	5	80	80	CD
cord-005453-4057qib7	11648	6	children	child	NNS
cord-005453-4057qib7	11648	7	undergoing	undergo	VBG
cord-005453-4057qib7	11648	8	allogeneic	allogeneic	IN
cord-005453-4057qib7	11648	9	HSCT	HSCT	NNP
cord-005453-4057qib7	11648	10	for	for	IN
cord-005453-4057qib7	11648	11	ALL	all	DT
cord-005453-4057qib7	11648	12	(	(	-LRB-
cord-005453-4057qib7	11648	13	n=46	n=46	JJ
cord-005453-4057qib7	11648	14	)	)	-RRB-
cord-005453-4057qib7	11648	15	or	or	CC
cord-005453-4057qib7	11648	16	AML	AML	NNP
cord-005453-4057qib7	11648	17	(	(	-LRB-
cord-005453-4057qib7	11648	18	n=34	n=34	NNP
cord-005453-4057qib7	11648	19	)	)	-RRB-
cord-005453-4057qib7	11648	20	with	with	IN
cord-005453-4057qib7	11648	21	a	a	DT
cord-005453-4057qib7	11648	22	median	median	JJ
cord-005453-4057qib7	11648	23	age	age	NN
cord-005453-4057qib7	11648	24	of	of	IN
cord-005453-4057qib7	11648	25	8.3	8.3	CD
cord-005453-4057qib7	11648	26	years	year	NNS
cord-005453-4057qib7	11649	1	(	(	-LRB-
cord-005453-4057qib7	11649	2	range	range	NN
cord-005453-4057qib7	11649	3	:	:	:
cord-005453-4057qib7	11649	4	0.8	0.8	CD
cord-005453-4057qib7	11649	5	-	-	HYPH
cord-005453-4057qib7	11649	6	17.8	17.8	CD
cord-005453-4057qib7	11649	7	)	)	-RRB-
cord-005453-4057qib7	11649	8	.	.	.
cord-005453-4057qib7	11650	1	Donors	donor	NNS
cord-005453-4057qib7	11650	2	were	be	VBD
cord-005453-4057qib7	11650	3	either	either	CC
cord-005453-4057qib7	11650	4	MRD	MRD	NNP
cord-005453-4057qib7	11650	5	(	(	-LRB-
cord-005453-4057qib7	11650	6	n=21	n=21	NNP
cord-005453-4057qib7	11650	7	)	)	-RRB-
cord-005453-4057qib7	11650	8	,	,	,
cord-005453-4057qib7	11650	9	MUD	MUD	NNP
cord-005453-4057qib7	11650	10	(	(	-LRB-
cord-005453-4057qib7	11650	11	n=45	n=45	NNS
cord-005453-4057qib7	11650	12	)	)	-RRB-
cord-005453-4057qib7	11650	13	or	or	CC
cord-005453-4057qib7	11650	14	MMUD	MMUD	NNP
cord-005453-4057qib7	11650	15	(	(	-LRB-
cord-005453-4057qib7	11650	16	n=14	n=14	NNP
cord-005453-4057qib7	11650	17	)	)	-RRB-
cord-005453-4057qib7	11650	18	.	.	.
cord-005453-4057qib7	11651	1	BM	BM	NNP
cord-005453-4057qib7	11651	2	(	(	-LRB-
cord-005453-4057qib7	11651	3	n=70	n=70	NNP
cord-005453-4057qib7	11651	4	)	)	-RRB-
cord-005453-4057qib7	11651	5	or	or	CC
cord-005453-4057qib7	11651	6	PB	PB	NNP
cord-005453-4057qib7	11651	7	(	(	-LRB-
cord-005453-4057qib7	11651	8	n=10	n=10	NNP
cord-005453-4057qib7	11651	9	)	)	-RRB-
cord-005453-4057qib7	11651	10	were	be	VBD
cord-005453-4057qib7	11651	11	used	use	VBN
cord-005453-4057qib7	11651	12	as	as	IN
cord-005453-4057qib7	11651	13	stem	stem	NN
cord-005453-4057qib7	11651	14	cell	cell	NN
cord-005453-4057qib7	11651	15	source	source	NN
cord-005453-4057qib7	11651	16	.	.	.
cord-005453-4057qib7	11652	1	Conditioning	conditioning	NN
cord-005453-4057qib7	11652	2	regimens	regimen	NNS
cord-005453-4057qib7	11652	3	were	be	VBD
cord-005453-4057qib7	11652	4	based	base	VBN
cord-005453-4057qib7	11652	5	on	on	IN
cord-005453-4057qib7	11652	6	TBI	TBI	NNP
cord-005453-4057qib7	11652	7	(	(	-LRB-
cord-005453-4057qib7	11652	8	n=25	n=25	NNP
cord-005453-4057qib7	11652	9	)	)	-RRB-
cord-005453-4057qib7	11652	10	or	or	CC
cord-005453-4057qib7	11652	11	highdose	highdose	NN
cord-005453-4057qib7	11652	12	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11652	13	alone	alone	JJ
cord-005453-4057qib7	11652	14	(	(	-LRB-
cord-005453-4057qib7	11652	15	n=55	n=55	NNP
cord-005453-4057qib7	11652	16	)	)	-RRB-
cord-005453-4057qib7	11652	17	and	and	CC
cord-005453-4057qib7	11652	18	included	include	VBD
cord-005453-4057qib7	11652	19	ATG	ATG	NNP
cord-005453-4057qib7	11652	20	in	in	IN
cord-005453-4057qib7	11652	21	58	58	CD
cord-005453-4057qib7	11652	22	patients	patient	NNS
cord-005453-4057qib7	11652	23	.	.	.
cord-005453-4057qib7	11653	1	Thirty	thirty	CD
cord-005453-4057qib7	11653	2	age	age	NN
cord-005453-4057qib7	11653	3	-	-	HYPH
cord-005453-4057qib7	11653	4	matched	match	VBN
cord-005453-4057qib7	11653	5	healthy	healthy	JJ
cord-005453-4057qib7	11653	6	children	child	NNS
cord-005453-4057qib7	11653	7	were	be	VBD
cord-005453-4057qib7	11653	8	included	include	VBN
cord-005453-4057qib7	11653	9	as	as	IN
cord-005453-4057qib7	11653	10	controls	control	NNS
cord-005453-4057qib7	11653	11	.	.	.
cord-005453-4057qib7	11654	1	Cytokines	Cytokines	NNP
cord-005453-4057qib7	11654	2	(	(	-LRB-
cord-005453-4057qib7	11654	3	IL-7	IL-7	NNP
cord-005453-4057qib7	11654	4	,	,	,
cord-005453-4057qib7	11654	5	IL-15	IL-15	NNP
cord-005453-4057qib7	11654	6	,	,	,
cord-005453-4057qib7	11654	7	IL-18	IL-18	NNP
cord-005453-4057qib7	11654	8	,	,	,
cord-005453-4057qib7	11654	9	SCF	SCF	NNP
cord-005453-4057qib7	11654	10	,	,	,
cord-005453-4057qib7	11654	11	IL-6	IL-6	NNP
cord-005453-4057qib7	11654	12	,	,	,
cord-005453-4057qib7	11654	13	IL-2	IL-2	NNP
cord-005453-4057qib7	11654	14	and	and	CC
cord-005453-4057qib7	11654	15	TNFα	TNFα	NNP
cord-005453-4057qib7	11654	16	)	)	-RRB-
cord-005453-4057qib7	11654	17	and	and	CC
cord-005453-4057qib7	11654	18	active	active	JJ
cord-005453-4057qib7	11654	19	ATG	ATG	NNP
cord-005453-4057qib7	11654	20	in	in	IN
cord-005453-4057qib7	11654	21	plasma	plasma	NN
cord-005453-4057qib7	11654	22	were	be	VBD
cord-005453-4057qib7	11654	23	longitudinally	longitudinally	RB
cord-005453-4057qib7	11654	24	measured	measure	VBN
cord-005453-4057qib7	11654	25	from	from	IN
cord-005453-4057qib7	11654	26	before	before	IN
cord-005453-4057qib7	11654	27	conditioning	conditioning	NN
cord-005453-4057qib7	11654	28	until	until	IN
cord-005453-4057qib7	11654	29	3	3	CD
cord-005453-4057qib7	11654	30	months	month	NNS
cord-005453-4057qib7	11654	31	after	after	IN
cord-005453-4057qib7	11654	32	HSCT	HSCT	NNP
cord-005453-4057qib7	11654	33	(	(	-LRB-
cord-005453-4057qib7	11654	34	n=80	n=80	NNP
cord-005453-4057qib7	11654	35	)	)	-RRB-
cord-005453-4057qib7	11654	36	along	along	IN
cord-005453-4057qib7	11654	37	with	with	IN
cord-005453-4057qib7	11654	38	an	an	DT
cord-005453-4057qib7	11654	39	extended	extended	JJ
cord-005453-4057qib7	11654	40	phenotyping	phenotyping	NN
cord-005453-4057qib7	11654	41	of	of	IN
cord-005453-4057qib7	11654	42	T	t	NN
cord-005453-4057qib7	11654	43	-	-	HYPH
cord-005453-4057qib7	11654	44	cell	cell	NN
cord-005453-4057qib7	11654	45	maturation	maturation	NN
cord-005453-4057qib7	11654	46	and	and	CC
cord-005453-4057qib7	11654	47	differentiation	differentiation	NN
cord-005453-4057qib7	11654	48	by	by	IN
cord-005453-4057qib7	11654	49	flow	flow	NN
cord-005453-4057qib7	11654	50	cytometry	cytometry	NN
cord-005453-4057qib7	11654	51	(	(	-LRB-
cord-005453-4057qib7	11654	52	n=41	n=41	RB
cord-005453-4057qib7	11654	53	)	)	-RRB-
cord-005453-4057qib7	11654	54	.	.	.
cord-005453-4057qib7	11655	1	Results	result	NNS
cord-005453-4057qib7	11655	2	:	:	:
cord-005453-4057qib7	11656	1	The	the	DT
cord-005453-4057qib7	11656	2	homeostatic	homeostatic	JJ
cord-005453-4057qib7	11656	3	cytokines	cytokine	NNS
cord-005453-4057qib7	11656	4	IL-7	IL-7	NNP
cord-005453-4057qib7	11656	5	and	and	CC
cord-005453-4057qib7	11656	6	IL-15	IL-15	NNP
cord-005453-4057qib7	11656	7	increased	increase	VBD
cord-005453-4057qib7	11656	8	from	from	IN
cord-005453-4057qib7	11656	9	pre	pre	JJ
cord-005453-4057qib7	11656	10	-	-	JJ
cord-005453-4057qib7	11656	11	conditioning	conditioning	NN
cord-005453-4057qib7	11656	12	to	to	TO
cord-005453-4057qib7	11656	13	peak	peak	VB
cord-005453-4057qib7	11656	14	1	1	CD
cord-005453-4057qib7	11656	15	-	-	SYM
cord-005453-4057qib7	11656	16	2	2	CD
cord-005453-4057qib7	11656	17	weeks	week	NNS
cord-005453-4057qib7	11656	18	post	post	NN
cord-005453-4057qib7	11656	19	-	-	JJ
cord-005453-4057qib7	11656	20	HSCT	HSCT	NNP
cord-005453-4057qib7	11656	21	and	and	CC
cord-005453-4057qib7	11656	22	gradually	gradually	RB
cord-005453-4057qib7	11656	23	declined	decline	VBD
cord-005453-4057qib7	11656	24	thereafter	thereafter	RB
cord-005453-4057qib7	11656	25	.	.	.
cord-005453-4057qib7	11657	1	IL-6	IL-6	NNP
cord-005453-4057qib7	11657	2	levels	level	NNS
cord-005453-4057qib7	11657	3	were	be	VBD
cord-005453-4057qib7	11657	4	shortly	shortly	RB
cord-005453-4057qib7	11657	5	elevated	elevate	VBN
cord-005453-4057qib7	11657	6	,	,	,
cord-005453-4057qib7	11657	7	while	while	IN
cord-005453-4057qib7	11657	8	IL-18	IL-18	NNP
cord-005453-4057qib7	11657	9	and	and	CC
cord-005453-4057qib7	11657	10	SCF	SCF	NNP
cord-005453-4057qib7	11657	11	remained	remain	VBD
cord-005453-4057qib7	11657	12	relatively	relatively	RB
cord-005453-4057qib7	11657	13	stable	stable	JJ
cord-005453-4057qib7	11657	14	,	,	,
cord-005453-4057qib7	11657	15	and	and	CC
cord-005453-4057qib7	11657	16	IL-2	IL-2	NNP
cord-005453-4057qib7	11657	17	and	and	CC
cord-005453-4057qib7	11657	18	TNF	TNF	NNP
cord-005453-4057qib7	11657	19	-	-	HYPH
cord-005453-4057qib7	11657	20	α	α	NNP
cord-005453-4057qib7	11657	21	levels	level	NNS
cord-005453-4057qib7	11657	22	were	be	VBD
cord-005453-4057qib7	11657	23	below	below	IN
cord-005453-4057qib7	11657	24	threshold	threshold	NN
cord-005453-4057qib7	11657	25	of	of	IN
cord-005453-4057qib7	11657	26	detection	detection	NN
cord-005453-4057qib7	11657	27	at	at	IN
cord-005453-4057qib7	11657	28	all	all	DT
cord-005453-4057qib7	11657	29	time	time	NN
cord-005453-4057qib7	11657	30	points	point	NNS
cord-005453-4057qib7	11657	31	.	.	.
cord-005453-4057qib7	11658	1	The	the	DT
cord-005453-4057qib7	11658	2	early	early	JJ
cord-005453-4057qib7	11658	3	rise	rise	NN
cord-005453-4057qib7	11658	4	of	of	IN
cord-005453-4057qib7	11658	5	IL-7	IL-7	NNP
cord-005453-4057qib7	11658	6	and	and	CC
cord-005453-4057qib7	11658	7	IL-15	IL-15	NNP
cord-005453-4057qib7	11658	8	was	be	VBD
cord-005453-4057qib7	11658	9	strongly	strongly	RB
cord-005453-4057qib7	11658	10	associated	associate	VBN
cord-005453-4057qib7	11658	11	with	with	IN
cord-005453-4057qib7	11658	12	the	the	DT
cord-005453-4057qib7	11658	13	degree	degree	NN
cord-005453-4057qib7	11658	14	of	of	IN
cord-005453-4057qib7	11658	15	T	t	NN
cord-005453-4057qib7	11658	16	-	-	HYPH
cord-005453-4057qib7	11658	17	cell	cell	NN
cord-005453-4057qib7	11658	18	depletion	depletion	NN
cord-005453-4057qib7	11658	19	by	by	IN
cord-005453-4057qib7	11658	20	ATG	ATG	NNP
cord-005453-4057qib7	11658	21	,	,	,
cord-005453-4057qib7	11658	22	while	while	IN
cord-005453-4057qib7	11658	23	IL-15	IL-15	NNP
cord-005453-4057qib7	11658	24	also	also	RB
cord-005453-4057qib7	11658	25	correlated	correlate	VBD
cord-005453-4057qib7	11658	26	with	with	IN
cord-005453-4057qib7	11658	27	markers	marker	NNS
cord-005453-4057qib7	11658	28	of	of	IN
cord-005453-4057qib7	11658	29	systemic	systemic	JJ
cord-005453-4057qib7	11658	30	inflammation	inflammation	NN
cord-005453-4057qib7	11658	31	.	.	.
cord-005453-4057qib7	11659	1	IL-7	IL-7	NNP
cord-005453-4057qib7	11659	2	and	and	CC
cord-005453-4057qib7	11659	3	IL-15	IL-15	NNP
cord-005453-4057qib7	11659	4	levels	level	NNS
cord-005453-4057qib7	11659	5	were	be	VBD
cord-005453-4057qib7	11659	6	significantly	significantly	RB
cord-005453-4057qib7	11659	7	higher	high	JJR
cord-005453-4057qib7	11659	8	in	in	IN
cord-005453-4057qib7	11659	9	children	child	NNS
cord-005453-4057qib7	11659	10	treated	treat	VBN
cord-005453-4057qib7	11659	11	with	with	IN
cord-005453-4057qib7	11659	12	ATG	ATG	NNP
cord-005453-4057qib7	11659	13	(	(	-LRB-
cord-005453-4057qib7	11659	14	P	p	NN
cord-005453-4057qib7	11659	15	<	<	XX
cord-005453-4057qib7	11659	16	0.001	0.001	CD
cord-005453-4057qib7	11659	17	)	)	-RRB-
cord-005453-4057qib7	11659	18	and	and	CC
cord-005453-4057qib7	11659	19	correlated	correlate	VBD
cord-005453-4057qib7	11659	20	with	with	IN
cord-005453-4057qib7	11659	21	both	both	DT
cord-005453-4057qib7	11659	22	longer	long	JJR
cord-005453-4057qib7	11659	23	exposure	exposure	NN
cord-005453-4057qib7	11659	24	to	to	IN
cord-005453-4057qib7	11659	25	ATG	ATG	NNP
cord-005453-4057qib7	11659	26	(	(	-LRB-
cord-005453-4057qib7	11659	27	P	p	NN
cord-005453-4057qib7	11659	28	<	<	XX
cord-005453-4057qib7	11659	29	0.001	0.001	CD
cord-005453-4057qib7	11659	30	)	)	-RRB-
cord-005453-4057qib7	11659	31	and	and	CC
cord-005453-4057qib7	11659	32	increased	increase	VBN
cord-005453-4057qib7	11659	33	levels	level	NNS
cord-005453-4057qib7	11659	34	of	of	IN
cord-005453-4057qib7	11659	35	active	active	JJ
cord-005453-4057qib7	11659	36	ATG	ATG	NNP
cord-005453-4057qib7	11659	37	(	(	-LRB-
cord-005453-4057qib7	11659	38	day	day	NN
cord-005453-4057qib7	11659	39	+21	+21	CD
cord-005453-4057qib7	11659	40	:	:	:
cord-005453-4057qib7	11659	41	IL-7	IL-7	NNP
cord-005453-4057qib7	11660	1	:	:	:
cord-005453-4057qib7	11660	2	r=0.71	r=0.71	NNP
cord-005453-4057qib7	11660	3	,	,	,
cord-005453-4057qib7	11660	4	P	p	NN
cord-005453-4057qib7	11660	5	<	<	XX
cord-005453-4057qib7	11660	6	0.0001	0.0001	CD
cord-005453-4057qib7	11660	7	;	;	:
cord-005453-4057qib7	11660	8	IL-15	il-15	RB
cord-005453-4057qib7	11660	9	:	:	:
cord-005453-4057qib7	11660	10	r=0.61	r=0.61	NNP
cord-005453-4057qib7	11660	11	,	,	,
cord-005453-4057qib7	11660	12	P	p	NN
cord-005453-4057qib7	11660	13	<	<	XX
cord-005453-4057qib7	11660	14	0.0001	0.0001	CD
cord-005453-4057qib7	11660	15	)	)	-RRB-
cord-005453-4057qib7	11660	16	,	,	,
cord-005453-4057qib7	11660	17	indicating	indicate	VBG
cord-005453-4057qib7	11660	18	that	that	IN
cord-005453-4057qib7	11660	19	high	high	JJ
cord-005453-4057qib7	11660	20	levels	level	NNS
cord-005453-4057qib7	11660	21	of	of	IN
cord-005453-4057qib7	11660	22	these	these	DT
cord-005453-4057qib7	11660	23	cytokines	cytokine	NNS
cord-005453-4057qib7	11660	24	reflected	reflect	VBD
cord-005453-4057qib7	11660	25	more	more	RBR
cord-005453-4057qib7	11660	26	pronounced	pronounced	JJ
cord-005453-4057qib7	11660	27	T	t	NN
cord-005453-4057qib7	11660	28	-	-	HYPH
cord-005453-4057qib7	11660	29	cell	cell	NN
cord-005453-4057qib7	11660	30	depletion	depletion	NN
cord-005453-4057qib7	11660	31	during	during	IN
cord-005453-4057qib7	11660	32	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	11660	33	.	.	.
cord-005453-4057qib7	11661	1	Higher	high	JJR
cord-005453-4057qib7	11661	2	circulating	circulate	VBG
cord-005453-4057qib7	11661	3	levels	level	NNS
cord-005453-4057qib7	11661	4	of	of	IN
cord-005453-4057qib7	11661	5	IL-7	IL-7	NNP
cord-005453-4057qib7	11661	6	and	and	CC
cord-005453-4057qib7	11661	7	IL-15	IL-15	NNP
cord-005453-4057qib7	11661	8	were	be	VBD
cord-005453-4057qib7	11661	9	associated	associate	VBN
cord-005453-4057qib7	11661	10	with	with	IN
cord-005453-4057qib7	11661	11	a	a	DT
cord-005453-4057qib7	11661	12	slow	slow	JJ
cord-005453-4057qib7	11661	13	recovery	recovery	NN
cord-005453-4057qib7	11661	14	of	of	IN
cord-005453-4057qib7	11661	15	CD3	CD3	NNP
cord-005453-4057qib7	11661	16	+	+	CC
cord-005453-4057qib7	11661	17	,	,	,
cord-005453-4057qib7	11661	18	CD4	CD4	NNP
cord-005453-4057qib7	11661	19	+	+	CC
cord-005453-4057qib7	11661	20	and	and	CC
cord-005453-4057qib7	11661	21	CD8	CD8	NNP
cord-005453-4057qib7	11661	22	+	+	CC
cord-005453-4057qib7	11661	23	T	t	NN
cord-005453-4057qib7	11661	24	-	-	HYPH
cord-005453-4057qib7	11661	25	cell	cell	NN
cord-005453-4057qib7	11661	26	counts	count	NNS
cord-005453-4057qib7	11661	27	at	at	IN
cord-005453-4057qib7	11661	28	day	day	NN
cord-005453-4057qib7	11661	29	+30	+30	CD
cord-005453-4057qib7	11661	30	and	and	CC
cord-005453-4057qib7	11661	31	+60	+60	NNP
cord-005453-4057qib7	11661	32	post	post	NN
cord-005453-4057qib7	11661	33	-	-	JJ
cord-005453-4057qib7	11661	34	HSCT	HSCT	NNP
cord-005453-4057qib7	11661	35	(	(	-LRB-
cord-005453-4057qib7	11661	36	P	p	NN
cord-005453-4057qib7	11661	37	<	<	XX
cord-005453-4057qib7	11661	38	0.05	0.05	CD
cord-005453-4057qib7	11661	39	)	)	-RRB-
cord-005453-4057qib7	11661	40	,	,	,
cord-005453-4057qib7	11661	41	while	while	IN
cord-005453-4057qib7	11661	42	the	the	DT
cord-005453-4057qib7	11661	43	remaining	remain	VBG
cord-005453-4057qib7	11661	44	cytokines	cytokine	NNS
cord-005453-4057qib7	11661	45	did	do	VBD
cord-005453-4057qib7	11661	46	not	not	RB
cord-005453-4057qib7	11661	47	correlate	correlate	VB
cord-005453-4057qib7	11661	48	with	with	IN
cord-005453-4057qib7	11661	49	immune	immune	JJ
cord-005453-4057qib7	11661	50	reconstitution	reconstitution	NN
cord-005453-4057qib7	11661	51	.	.	.
cord-005453-4057qib7	11662	1	Looking	look	VBG
cord-005453-4057qib7	11662	2	into	into	IN
cord-005453-4057qib7	11662	3	T	t	NN
cord-005453-4057qib7	11662	4	-	-	HYPH
cord-005453-4057qib7	11662	5	cell	cell	NN
cord-005453-4057qib7	11662	6	subpopulations	subpopulation	NNS
cord-005453-4057qib7	11662	7	,	,	,
cord-005453-4057qib7	11662	8	increased	increase	VBN
cord-005453-4057qib7	11662	9	levels	level	NNS
cord-005453-4057qib7	11662	10	of	of	IN
cord-005453-4057qib7	11662	11	IL-7	IL-7	NNP
cord-005453-4057qib7	11662	12	and	and	CC
cord-005453-4057qib7	11662	13	IL-15	IL-15	NNP
cord-005453-4057qib7	11662	14	during	during	IN
cord-005453-4057qib7	11662	15	the	the	DT
cord-005453-4057qib7	11662	16	first	first	JJ
cord-005453-4057qib7	11662	17	month	month	NN
cord-005453-4057qib7	11662	18	post	post	NN
cord-005453-4057qib7	11662	19	-	-	NN
cord-005453-4057qib7	11662	20	transplant	transplant	NN
cord-005453-4057qib7	11662	21	were	be	VBD
cord-005453-4057qib7	11662	22	associated	associate	VBN
cord-005453-4057qib7	11662	23	with	with	IN
cord-005453-4057qib7	11662	24	lower	low	JJR
cord-005453-4057qib7	11662	25	numbers	number	NNS
cord-005453-4057qib7	11662	26	of	of	IN
cord-005453-4057qib7	11662	27	naïve	naïve	JJ
cord-005453-4057qib7	11662	28	T	t	NN
cord-005453-4057qib7	11662	29	cells	cell	NNS
cord-005453-4057qib7	11662	30	and	and	CC
cord-005453-4057qib7	11662	31	correlated	correlate	VBD
cord-005453-4057qib7	11662	32	with	with	IN
cord-005453-4057qib7	11662	33	an	an	DT
cord-005453-4057qib7	11662	34	increased	increase	VBN
cord-005453-4057qib7	11662	35	proportion	proportion	NN
cord-005453-4057qib7	11662	36	of	of	IN
cord-005453-4057qib7	11662	37	CD4	CD4	NNP
cord-005453-4057qib7	11662	38	+	+	CC
cord-005453-4057qib7	11663	1	and	and	CC
cord-005453-4057qib7	11663	2	CD8	CD8	NNP
cord-005453-4057qib7	11663	3	+	+	CC
cord-005453-4057qib7	11663	4	effector	effector	NN
cord-005453-4057qib7	11663	5	memory	memory	NN
cord-005453-4057qib7	11663	6	cells	cell	NNS
cord-005453-4057qib7	11663	7	(	(	-LRB-
cord-005453-4057qib7	11663	8	Figure	figure	NN
cord-005453-4057qib7	11663	9	)	)	-RRB-
cord-005453-4057qib7	11663	10	.	.	.
cord-005453-4057qib7	11664	1	No	no	DT
cord-005453-4057qib7	11664	2	differential	differential	JJ
cord-005453-4057qib7	11664	3	effect	effect	NN
cord-005453-4057qib7	11664	4	of	of	IN
cord-005453-4057qib7	11664	5	cytokines	cytokine	NNS
cord-005453-4057qib7	11664	6	on	on	IN
cord-005453-4057qib7	11664	7	polarization	polarization	NN
cord-005453-4057qib7	11664	8	of	of	IN
cord-005453-4057qib7	11664	9	CD4	CD4	NNP
cord-005453-4057qib7	11664	10	+	+	CC
cord-005453-4057qib7	11664	11	T	T	NNP
cord-005453-4057qib7	11664	12	cells	cell	NNS
cord-005453-4057qib7	11664	13	into	into	IN
cord-005453-4057qib7	11664	14	Th1	th1	NN
cord-005453-4057qib7	11664	15	,	,	,
cord-005453-4057qib7	11664	16	Th2	th2	CD
cord-005453-4057qib7	11664	17	,	,	,
cord-005453-4057qib7	11664	18	Th17	Th17	NNP
cord-005453-4057qib7	11665	1	cells	cell	NNS
cord-005453-4057qib7	11665	2	or	or	CC
cord-005453-4057qib7	11665	3	Treg	Treg	NNP
cord-005453-4057qib7	11665	4	cells	cell	NNS
cord-005453-4057qib7	11665	5	was	be	VBD
cord-005453-4057qib7	11665	6	found	find	VBN
cord-005453-4057qib7	11665	7	.	.	.
cord-005453-4057qib7	11666	1	In	in	IN
cord-005453-4057qib7	11666	2	ATG	ATG	NNP
cord-005453-4057qib7	11666	3	-	-	HYPH
cord-005453-4057qib7	11666	4	treated	treat	VBN
cord-005453-4057qib7	11666	5	patients	patient	NNS
cord-005453-4057qib7	11666	6	,	,	,
cord-005453-4057qib7	11666	7	IL-7	IL-7	NNP
cord-005453-4057qib7	11666	8	and	and	CC
cord-005453-4057qib7	11666	9	IL-15	IL-15	NNP
cord-005453-4057qib7	11666	10	levels	level	NNS
cord-005453-4057qib7	11666	11	at	at	IN
cord-005453-4057qib7	11666	12	day	day	NN
cord-005453-4057qib7	11666	13	+14	+14	CD
cord-005453-4057qib7	11666	14	were	be	VBD
cord-005453-4057qib7	11666	15	significantly	significantly	RB
cord-005453-4057qib7	11666	16	lower	low	JJR
cord-005453-4057qib7	11666	17	in	in	IN
cord-005453-4057qib7	11666	18	patients	patient	NNS
cord-005453-4057qib7	11666	19	developing	develop	VBG
cord-005453-4057qib7	11666	20	acute	acute	JJ
cord-005453-4057qib7	11666	21	GvHD	GvHD	NNP
cord-005453-4057qib7	11666	22	grade	grade	NN
cord-005453-4057qib7	11666	23	II	II	NNP
cord-005453-4057qib7	11666	24	-	-	HYPH
cord-005453-4057qib7	11666	25	IV	IV	NNP
cord-005453-4057qib7	11666	26	(	(	-LRB-
cord-005453-4057qib7	11666	27	P=0.0007	P=0.0007	NNP
cord-005453-4057qib7	11666	28	and	and	CC
cord-005453-4057qib7	11666	29	P=0.0007	P=0.0007	NNP
cord-005453-4057qib7	11666	30	,	,	,
cord-005453-4057qib7	11666	31	respectively	respectively	RB
cord-005453-4057qib7	11666	32	)	)	-RRB-
cord-005453-4057qib7	11666	33	.	.	.
cord-005453-4057qib7	11667	1	In	in	IN
cord-005453-4057qib7	11667	2	the	the	DT
cord-005453-4057qib7	11667	3	total	total	JJ
cord-005453-4057qib7	11667	4	cohort	cohort	NN
cord-005453-4057qib7	11667	5	,	,	,
cord-005453-4057qib7	11667	6	increased	increase	VBD
cord-005453-4057qib7	11667	7	IL-7	IL-7	NNP
cord-005453-4057qib7	11667	8	levels	level	NNS
cord-005453-4057qib7	11667	9	were	be	VBD
cord-005453-4057qib7	11667	10	associated	associate	VBN
cord-005453-4057qib7	11667	11	with	with	IN
cord-005453-4057qib7	11667	12	a	a	DT
cord-005453-4057qib7	11667	13	reactivation	reactivation	NN
cord-005453-4057qib7	11667	14	of	of	IN
cord-005453-4057qib7	11667	15	EBV	EBV	NNP
cord-005453-4057qib7	11667	16	(	(	-LRB-
cord-005453-4057qib7	11667	17	P=0.040	P=0.040	NNP
cord-005453-4057qib7	11667	18	)	)	-RRB-
cord-005453-4057qib7	11667	19	.	.	.
cord-005453-4057qib7	11668	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11668	2	:	:	:
cord-005453-4057qib7	11669	1	These	these	DT
cord-005453-4057qib7	11669	2	findings	finding	NNS
cord-005453-4057qib7	11669	3	suggest	suggest	VBP
cord-005453-4057qib7	11669	4	that	that	IN
cord-005453-4057qib7	11669	5	quantification	quantification	NN
cord-005453-4057qib7	11669	6	of	of	IN
cord-005453-4057qib7	11669	7	IL-7	IL-7	NNP
cord-005453-4057qib7	11669	8	and	and	CC
cord-005453-4057qib7	11669	9	IL-15	IL-15	NNP
cord-005453-4057qib7	11669	10	can	can	MD
cord-005453-4057qib7	11669	11	be	be	VB
cord-005453-4057qib7	11669	12	indicative	indicative	JJ
cord-005453-4057qib7	11669	13	for	for	IN
cord-005453-4057qib7	11669	14	the	the	DT
cord-005453-4057qib7	11669	15	degree	degree	NN
cord-005453-4057qib7	11669	16	of	of	IN
cord-005453-4057qib7	11669	17	T	t	NN
cord-005453-4057qib7	11669	18	-	-	HYPH
cord-005453-4057qib7	11669	19	cell	cell	NN
cord-005453-4057qib7	11669	20	depletion	depletion	NN
cord-005453-4057qib7	11669	21	during	during	IN
cord-005453-4057qib7	11669	22	the	the	DT
cord-005453-4057qib7	11669	23	first	first	JJ
cord-005453-4057qib7	11669	24	weeks	week	NNS
cord-005453-4057qib7	11669	25	after	after	IN
cord-005453-4057qib7	11669	26	HSCT	HSCT	NNP
cord-005453-4057qib7	11669	27	and	and	CC
cord-005453-4057qib7	11669	28	predictive	predictive	JJ
cord-005453-4057qib7	11669	29	of	of	IN
cord-005453-4057qib7	11669	30	complications	complication	NNS
cord-005453-4057qib7	11669	31	.	.	.
cord-005453-4057qib7	11670	1	Overall	overall	RB
cord-005453-4057qib7	11670	2	,	,	,
cord-005453-4057qib7	11670	3	these	these	DT
cord-005453-4057qib7	11670	4	results	result	NNS
cord-005453-4057qib7	11670	5	indicate	indicate	VBP
cord-005453-4057qib7	11670	6	that	that	IN
cord-005453-4057qib7	11670	7	the	the	DT
cord-005453-4057qib7	11670	8	lymphopenia	lymphopenia	NNP
cord-005453-4057qib7	11670	9	-	-	HYPH
cord-005453-4057qib7	11670	10	induced	induce	VBN
cord-005453-4057qib7	11670	11	elevation	elevation	NN
cord-005453-4057qib7	11670	12	of	of	IN
cord-005453-4057qib7	11670	13	IL-7	IL-7	NNP
cord-005453-4057qib7	11670	14	and	and	CC
cord-005453-4057qib7	11670	15	IL-15	IL-15	NNP
cord-005453-4057qib7	11670	16	is	be	VBZ
cord-005453-4057qib7	11670	17	a	a	DT
cord-005453-4057qib7	11670	18	major	major	JJ
cord-005453-4057qib7	11670	19	driver	driver	NN
cord-005453-4057qib7	11670	20	of	of	IN
cord-005453-4057qib7	11670	21	the	the	DT
cord-005453-4057qib7	11670	22	initial	initial	JJ
cord-005453-4057qib7	11670	23	expansion	expansion	NN
cord-005453-4057qib7	11670	24	of	of	IN
cord-005453-4057qib7	11670	25	donor	donor	NN
cord-005453-4057qib7	11670	26	T	t	NN
cord-005453-4057qib7	11670	27	-	-	HYPH
cord-005453-4057qib7	11670	28	cells	cell	NNS
cord-005453-4057qib7	11670	29	.	.	.
cord-005453-4057qib7	11671	1	Background	background	NN
cord-005453-4057qib7	11671	2	:	:	:
cord-005453-4057qib7	11672	1	Mathematical	mathematical	JJ
cord-005453-4057qib7	11672	2	kinetic	kinetic	JJ
cord-005453-4057qib7	11672	3	models	model	NNS
cord-005453-4057qib7	11672	4	were	be	VBD
cord-005453-4057qib7	11672	5	adopted	adopt	VBN
cord-005453-4057qib7	11672	6	to	to	TO
cord-005453-4057qib7	11672	7	study	study	VB
cord-005453-4057qib7	11672	8	immune	immune	JJ
cord-005453-4057qib7	11672	9	cell	cell	NN
cord-005453-4057qib7	11672	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	11672	11	after	after	IN
cord-005453-4057qib7	11672	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	11672	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11672	14	stem	stem	NN
cord-005453-4057qib7	11672	15	cell	cell	NN
cord-005453-4057qib7	11672	16	transplantation	transplantation	NN
cord-005453-4057qib7	11672	17	(	(	-LRB-
cord-005453-4057qib7	11672	18	allo	allo	NN
cord-005453-4057qib7	11672	19	-	-	HYPH
cord-005453-4057qib7	11672	20	HSCT	HSCT	NNP
cord-005453-4057qib7	11672	21	)	)	-RRB-
cord-005453-4057qib7	11672	22	.	.	.
cord-005453-4057qib7	11673	1	The	the	DT
cord-005453-4057qib7	11673	2	associations	association	NNS
cord-005453-4057qib7	11673	3	between	between	IN
cord-005453-4057qib7	11673	4	acute	acute	JJ
cord-005453-4057qib7	11673	5	graft	graft	NN
cord-005453-4057qib7	11673	6	-	-	HYPH
cord-005453-4057qib7	11673	7	versus	versus	IN
cord-005453-4057qib7	11673	8	-	-	HYPH
cord-005453-4057qib7	11673	9	host	host	NN
cord-005453-4057qib7	11673	10	disease	disease	NN
cord-005453-4057qib7	11673	11	(	(	-LRB-
cord-005453-4057qib7	11673	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	11673	13	)	)	-RRB-
cord-005453-4057qib7	11673	14	,	,	,
cord-005453-4057qib7	11673	15	relapse	relapse	NN
cord-005453-4057qib7	11673	16	and	and	CC
cord-005453-4057qib7	11673	17	the	the	DT
cord-005453-4057qib7	11673	18	immune	immune	JJ
cord-005453-4057qib7	11673	19	cell	cell	NN
cord-005453-4057qib7	11673	20	reconstitution	reconstitution	NN
cord-005453-4057qib7	11673	21	kinetic	kinetic	JJ
cord-005453-4057qib7	11673	22	models	model	NNS
cord-005453-4057qib7	11673	23	were	be	VBD
cord-005453-4057qib7	11673	24	explored	explore	VBN
cord-005453-4057qib7	11673	25	.	.	.
cord-005453-4057qib7	11674	1	Methods	method	NNS
cord-005453-4057qib7	11674	2	:	:	:
cord-005453-4057qib7	11674	3	From	from	IN
cord-005453-4057qib7	11674	4	June	June	NNP
cord-005453-4057qib7	11674	5	1	1	CD
cord-005453-4057qib7	11674	6	,	,	,
cord-005453-4057qib7	11674	7	2011	2011	CD
cord-005453-4057qib7	11674	8	to	to	IN
cord-005453-4057qib7	11674	9	May	May	NNP
cord-005453-4057qib7	11674	10	31	31	CD
cord-005453-4057qib7	11674	11	,	,	,
cord-005453-4057qib7	11674	12	2015	2015	CD
cord-005453-4057qib7	11674	13	,	,	,
cord-005453-4057qib7	11674	14	sixty	sixty	CD
cord-005453-4057qib7	11674	15	-	-	HYPH
cord-005453-4057qib7	11674	16	five	five	CD
cord-005453-4057qib7	11674	17	patients	patient	NNS
cord-005453-4057qib7	11674	18	with	with	IN
cord-005453-4057qib7	11674	19	hematological	hematological	JJ
cord-005453-4057qib7	11674	20	malignancies	malignancy	NNS
cord-005453-4057qib7	11674	21	after	after	IN
cord-005453-4057qib7	11674	22	allo	allo	NN
cord-005453-4057qib7	11674	23	-	-	HYPH
cord-005453-4057qib7	11674	24	HSCT	HSCT	NNP
cord-005453-4057qib7	11674	25	were	be	VBD
cord-005453-4057qib7	11674	26	recruited	recruit	VBN
cord-005453-4057qib7	11674	27	.	.	.
cord-005453-4057qib7	11675	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	11675	2	blood	blood	NN
cord-005453-4057qib7	11675	3	was	be	VBD
cord-005453-4057qib7	11675	4	collected	collect	VBN
cord-005453-4057qib7	11675	5	on	on	IN
cord-005453-4057qib7	11675	6	+14	+14	CD
cord-005453-4057qib7	11675	7	day	day	NN
cord-005453-4057qib7	11675	8	,	,	,
cord-005453-4057qib7	11675	9	+28	+28	NNP
cord-005453-4057qib7	11675	10	day	day	NN
cord-005453-4057qib7	11675	11	,	,	,
cord-005453-4057qib7	11675	12	+42	+42	NNP
cord-005453-4057qib7	11675	13	day	day	NN
cord-005453-4057qib7	11675	14	and	and	CC
cord-005453-4057qib7	11675	15	in	in	IN
cord-005453-4057qib7	11675	16	+2	+2	CD
cord-005453-4057qib7	11675	17	month	month	NN
cord-005453-4057qib7	11675	18	,	,	,
cord-005453-4057qib7	11675	19	+3	+3	NNP
cord-005453-4057qib7	11675	20	month	month	NN
cord-005453-4057qib7	11675	21	,	,	,
cord-005453-4057qib7	11675	22	+6	+6	CD
cord-005453-4057qib7	11675	23	month	month	NN
cord-005453-4057qib7	11675	24	,	,	,
cord-005453-4057qib7	11675	25	+9	+9	CD
cord-005453-4057qib7	11675	26	month	month	NN
cord-005453-4057qib7	11675	27	,	,	,
cord-005453-4057qib7	11676	1	+12	+12	CD
cord-005453-4057qib7	11676	2	month	month	NN
cord-005453-4057qib7	11676	3	,	,	,
cord-005453-4057qib7	11676	4	+18	+18	CD
cord-005453-4057qib7	11676	5	month	month	NN
cord-005453-4057qib7	11676	6	,	,	,
cord-005453-4057qib7	11677	1	+24	+24	NNP
cord-005453-4057qib7	11677	2	month	month	NN
cord-005453-4057qib7	11677	3	.	.	.
cord-005453-4057qib7	11678	1	Lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11678	2	subsets	subset	NNS
cord-005453-4057qib7	11678	3	were	be	VBD
cord-005453-4057qib7	11678	4	determined	determine	VBN
cord-005453-4057qib7	11678	5	by	by	IN
cord-005453-4057qib7	11678	6	flow	flow	NN
cord-005453-4057qib7	11678	7	cytometry	cytometry	NN
cord-005453-4057qib7	11678	8	,	,	,
cord-005453-4057qib7	11678	9	including	include	VBG
cord-005453-4057qib7	11678	10	in	in	IN
cord-005453-4057qib7	11678	11	total	total	JJ
cord-005453-4057qib7	11678	12	T	t	NN
cord-005453-4057qib7	11678	13	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11678	14	(	(	-LRB-
cord-005453-4057qib7	11678	15	CD3	CD3	NNP
cord-005453-4057qib7	11678	16	+	+	SYM
cord-005453-4057qib7	11678	17	)	)	-RRB-
cord-005453-4057qib7	11678	18	,	,	,
cord-005453-4057qib7	11678	19	helper	helper	NN
cord-005453-4057qib7	11678	20	T	t	NN
cord-005453-4057qib7	11678	21	cells	cell	NNS
cord-005453-4057qib7	11678	22	(	(	-LRB-
cord-005453-4057qib7	11678	23	CD3	CD3	NNP
cord-005453-4057qib7	11678	24	+	+	CC
cord-005453-4057qib7	11678	25	CD4	CD4	NNP
cord-005453-4057qib7	11678	26	+	+	CC
cord-005453-4057qib7	11678	27	)	)	-RRB-
cord-005453-4057qib7	11678	28	,	,	,
cord-005453-4057qib7	11678	29	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	11678	30	T	t	NN
cord-005453-4057qib7	11678	31	cells	cell	NNS
cord-005453-4057qib7	11678	32	(	(	-LRB-
cord-005453-4057qib7	11678	33	CD3	CD3	NNP
cord-005453-4057qib7	11678	34	+	+	CC
cord-005453-4057qib7	11678	35	CD8	CD8	NNP
cord-005453-4057qib7	11678	36	+	+	SYM
cord-005453-4057qib7	11678	37	)	)	-RRB-
cord-005453-4057qib7	11678	38	,	,	,
cord-005453-4057qib7	11678	39	CD4	CD4	NNP
cord-005453-4057qib7	11678	40	/	/	SYM
cord-005453-4057qib7	11678	41	CD8	CD8	NNP
cord-005453-4057qib7	11678	42	ratio	ratio	NN
cord-005453-4057qib7	11678	43	,	,	,
cord-005453-4057qib7	11678	44	nature	nature	NN
cord-005453-4057qib7	11678	45	killer	killer	NN
cord-005453-4057qib7	11678	46	(	(	-LRB-
cord-005453-4057qib7	11678	47	NK	NK	NNP
cord-005453-4057qib7	11678	48	)	)	-RRB-
cord-005453-4057qib7	11678	49	cells	cell	NNS
cord-005453-4057qib7	11678	50	(	(	-LRB-
cord-005453-4057qib7	11678	51	CD3	CD3	NNP
cord-005453-4057qib7	11678	52	-CD56	-cd56	NN
cord-005453-4057qib7	11679	1	+	+	LS
cord-005453-4057qib7	11679	2	)	)	-RRB-
cord-005453-4057qib7	11679	3	,	,	,
cord-005453-4057qib7	11679	4	NKT	NKT	NNP
cord-005453-4057qib7	11679	5	cells	cell	NNS
cord-005453-4057qib7	11679	6	(	(	-LRB-
cord-005453-4057qib7	11679	7	CD3	CD3	NNP
cord-005453-4057qib7	11679	8	+	+	CC
cord-005453-4057qib7	11679	9	CD56	CD56	NNP
cord-005453-4057qib7	11680	1	+	+	LS
cord-005453-4057qib7	11680	2	)	)	-RRB-
cord-005453-4057qib7	11680	3	,	,	,
cord-005453-4057qib7	11680	4	B	b	NN
cord-005453-4057qib7	11680	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11680	6	(	(	-LRB-
cord-005453-4057qib7	11680	7	CD19	CD19	NNP
cord-005453-4057qib7	11680	8	+	+	CC
cord-005453-4057qib7	11680	9	)	)	-RRB-
cord-005453-4057qib7	11680	10	,	,	,
cord-005453-4057qib7	11680	11	naive	naive	JJ
cord-005453-4057qib7	11680	12	T	t	NN
cord-005453-4057qib7	11680	13	cells	cell	NNS
cord-005453-4057qib7	11680	14	(	(	-LRB-
cord-005453-4057qib7	11680	15	CD3	CD3	NNP
cord-005453-4057qib7	11680	16	+	+	CC
cord-005453-4057qib7	11680	17	HLA	HLA	NNP
cord-005453-4057qib7	11680	18	-	-	HYPH
cord-005453-4057qib7	11680	19	DR	DR	NNP
cord-005453-4057qib7	11680	20	+	+	CC
cord-005453-4057qib7	11680	21	)	)	-RRB-
cord-005453-4057qib7	11680	22	,	,	,
cord-005453-4057qib7	11680	23	static	static	JJ
cord-005453-4057qib7	11680	24	T	t	NN
cord-005453-4057qib7	11680	25	cells	cell	NNS
cord-005453-4057qib7	11680	26	(	(	-LRB-
cord-005453-4057qib7	11680	27	CD3	CD3	NNP
cord-005453-4057qib7	11680	28	+	+	CC
cord-005453-4057qib7	11680	29	HLA	HLA	NNP
cord-005453-4057qib7	11680	30	-	-	HYPH
cord-005453-4057qib7	11680	31	DR	DR	NNP
cord-005453-4057qib7	11680	32	-	-	,
cord-005453-4057qib7	11680	33	)	)	-RRB-
cord-005453-4057qib7	11680	34	,	,	,
cord-005453-4057qib7	11680	35	and	and	CC
cord-005453-4057qib7	11680	36	regulatory	regulatory	JJ
cord-005453-4057qib7	11680	37	T	t	NN
cord-005453-4057qib7	11680	38	cells	cell	NNS
cord-005453-4057qib7	11680	39	(	(	-LRB-
cord-005453-4057qib7	11680	40	CD4	CD4	NNP
cord-005453-4057qib7	11680	41	+	+	CC
cord-005453-4057qib7	11681	1	CD25	cd25	JJ
cord-005453-4057qib7	11681	2	high	high	RB
cord-005453-4057qib7	11682	1	Foxp3	foxp3	JJ
cord-005453-4057qib7	11682	2	+	+	CC
cord-005453-4057qib7	11682	3	)	)	-RRB-
cord-005453-4057qib7	11682	4	.	.	.
cord-005453-4057qib7	11683	1	Mathematical	mathematical	JJ
cord-005453-4057qib7	11683	2	kinetic	kinetic	JJ
cord-005453-4057qib7	11683	3	models	model	NNS
cord-005453-4057qib7	11683	4	were	be	VBD
cord-005453-4057qib7	11683	5	calculated	calculate	VBN
cord-005453-4057qib7	11683	6	for	for	IN
cord-005453-4057qib7	11683	7	immune	immune	JJ
cord-005453-4057qib7	11683	8	cell	cell	NN
cord-005453-4057qib7	11683	9	reconstitution	reconstitution	NN
cord-005453-4057qib7	11683	10	with	with	IN
cord-005453-4057qib7	11683	11	SPSS	SPSS	NNP
cord-005453-4057qib7	11683	12	.	.	.
cord-005453-4057qib7	11684	1	Results	result	NNS
cord-005453-4057qib7	11684	2	:	:	:
cord-005453-4057qib7	11685	1	After	after	IN
cord-005453-4057qib7	11685	2	allo	allo	NN
cord-005453-4057qib7	11685	3	-	-	HYPH
cord-005453-4057qib7	11685	4	HSCT	HSCT	NNP
cord-005453-4057qib7	11685	5	,	,	,
cord-005453-4057qib7	11685	6	a	a	DT
cord-005453-4057qib7	11685	7	logarithmic	logarithmic	JJ
cord-005453-4057qib7	11685	8	curve	curve	NN
cord-005453-4057qib7	11685	9	model	model	NN
cord-005453-4057qib7	11685	10	was	be	VBD
cord-005453-4057qib7	11685	11	observed	observe	VBN
cord-005453-4057qib7	11685	12	for	for	IN
cord-005453-4057qib7	11685	13	CD3	CD3	NNP
cord-005453-4057qib7	11685	14	+	+	CC
cord-005453-4057qib7	11685	15	T	T	NNP
cord-005453-4057qib7	11685	16	cells	cell	NNS
cord-005453-4057qib7	11685	17	.	.	.
cord-005453-4057qib7	11686	1	Cubic	cubic	JJ
cord-005453-4057qib7	11686	2	curve	curve	NN
cord-005453-4057qib7	11686	3	models	model	NNS
cord-005453-4057qib7	11686	4	were	be	VBD
cord-005453-4057qib7	11686	5	observed	observe	VBN
cord-005453-4057qib7	11686	6	for	for	IN
cord-005453-4057qib7	11686	7	CD3	CD3	NNP
cord-005453-4057qib7	11686	8	+	+	SYM
cord-005453-4057qib7	11686	9	CD4	CD4	NNP
cord-005453-4057qib7	11686	10	+	+	CC
cord-005453-4057qib7	11686	11	T	t	NN
cord-005453-4057qib7	11686	12	cells	cell	NNS
cord-005453-4057qib7	11686	13	,	,	,
cord-005453-4057qib7	11686	14	CD4	CD4	NNP
cord-005453-4057qib7	11686	15	+	+	CC
cord-005453-4057qib7	11687	1	CD25	CD25	NNP
cord-005453-4057qib7	11688	1	high+	high+	NNP
cord-005453-4057qib7	11688	2	Foxp3	Foxp3	NNP
cord-005453-4057qib7	11688	3	+	+	CC
cord-005453-4057qib7	11688	4	T	T	NNP
cord-005453-4057qib7	11688	5	cell	cell	NN
cord-005453-4057qib7	11688	6	,	,	,
cord-005453-4057qib7	11688	7	CD3	CD3	NNP
cord-005453-4057qib7	11688	8	+	+	CC
cord-005453-4057qib7	11688	9	HLA	HLA	NNP
cord-005453-4057qib7	11688	10	-	-	HYPH
cord-005453-4057qib7	11688	11	DR	DR	NNP
cord-005453-4057qib7	11688	12	-T	-T	:
cord-005453-4057qib7	11688	13	cells	cell	NNS
cord-005453-4057qib7	11688	14	,	,	,
cord-005453-4057qib7	11688	15	CD3	CD3	NNP
cord-005453-4057qib7	11688	16	+	+	CC
cord-005453-4057qib7	11688	17	CD56	CD56	NNP
cord-005453-4057qib7	11688	18	+	+	SYM
cord-005453-4057qib7	11688	19	NKT	NKT	NNP
cord-005453-4057qib7	11688	20	cells	cell	NNS
cord-005453-4057qib7	11688	21	,	,	,
cord-005453-4057qib7	11688	22	CD19	CD19	NNP
cord-005453-4057qib7	11688	23	+	+	CC
cord-005453-4057qib7	11688	24	B	b	NN
cord-005453-4057qib7	11688	25	cells	cell	NNS
cord-005453-4057qib7	11688	26	.	.	.
cord-005453-4057qib7	11689	1	CD3	CD3	NNP
cord-005453-4057qib7	11689	2	+	+	CC
cord-005453-4057qib7	11689	3	CD8	CD8	NNP
cord-005453-4057qib7	11689	4	+	+	CC
cord-005453-4057qib7	11689	5	T	T	NNP
cord-005453-4057qib7	11689	6	cells	cell	NNS
cord-005453-4057qib7	11689	7	,	,	,
cord-005453-4057qib7	11689	8	CD3	CD3	NNP
cord-005453-4057qib7	11689	9	+	+	CC
cord-005453-4057qib7	11689	10	HLA	HLA	NNP
cord-005453-4057qib7	11689	11	-	-	HYPH
cord-005453-4057qib7	11689	12	DR	DR	NNP
cord-005453-4057qib7	11689	13	+	+	CC
cord-005453-4057qib7	11689	14	T	t	NN
cord-005453-4057qib7	11689	15	cells	cell	NNS
cord-005453-4057qib7	11689	16	,	,	,
cord-005453-4057qib7	11689	17	and	and	CC
cord-005453-4057qib7	11689	18	CD3	CD3	NNP
cord-005453-4057qib7	11689	19	-CD56	-cd56	NN
cord-005453-4057qib7	11690	1	+	+	CC
cord-005453-4057qib7	11691	1	NK	NK	NNP
cord-005453-4057qib7	11691	2	cells	cell	NNS
cord-005453-4057qib7	11691	3	showed	show	VBD
cord-005453-4057qib7	11691	4	S	s	NN
cord-005453-4057qib7	11691	5	type	type	NN
cord-005453-4057qib7	11691	6	curve	curve	NN
cord-005453-4057qib7	11691	7	models	model	NNS
cord-005453-4057qib7	11691	8	.	.	.
cord-005453-4057qib7	11692	1	Considering	consider	VBG
cord-005453-4057qib7	11692	2	T	t	NN
cord-005453-4057qib7	11692	3	cells	cell	NNS
cord-005453-4057qib7	11692	4	were	be	VBD
cord-005453-4057qib7	11692	5	the	the	DT
cord-005453-4057qib7	11692	6	major	major	JJ
cord-005453-4057qib7	11692	7	mediators	mediator	NNS
cord-005453-4057qib7	11692	8	for	for	IN
cord-005453-4057qib7	11692	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	11692	10	and	and	CC
cord-005453-4057qib7	11692	11	graft	graft	NN
cord-005453-4057qib7	11692	12	-	-	HYPH
cord-005453-4057qib7	11692	13	versusleukemia	versusleukemia	NN
cord-005453-4057qib7	11692	14	effect	effect	NN
cord-005453-4057qib7	11692	15	after	after	IN
cord-005453-4057qib7	11692	16	allo	allo	NN
cord-005453-4057qib7	11692	17	-	-	HYPH
cord-005453-4057qib7	11692	18	HSCT	HSCT	NNP
cord-005453-4057qib7	11692	19	.	.	.
cord-005453-4057qib7	11693	1	With	with	IN
cord-005453-4057qib7	11693	2	established	establish	VBN
cord-005453-4057qib7	11693	3	immune	immune	JJ
cord-005453-4057qib7	11693	4	cell	cell	NN
cord-005453-4057qib7	11693	5	kinetic	kinetic	JJ
cord-005453-4057qib7	11693	6	models	model	NNS
cord-005453-4057qib7	11693	7	,	,	,
cord-005453-4057qib7	11693	8	we	-PRON-	PRP
cord-005453-4057qib7	11693	9	found	find	VBD
cord-005453-4057qib7	11693	10	that	that	IN
cord-005453-4057qib7	11693	11	different	different	JJ
cord-005453-4057qib7	11693	12	curve	curve	NN
cord-005453-4057qib7	11693	13	models	model	NNS
cord-005453-4057qib7	11693	14	were	be	VBD
cord-005453-4057qib7	11693	15	observed	observe	VBN
cord-005453-4057qib7	11693	16	between	between	IN
cord-005453-4057qib7	11693	17	patients	patient	NNS
cord-005453-4057qib7	11693	18	with	with	IN
cord-005453-4057qib7	11693	19	and	and	CC
cord-005453-4057qib7	11693	20	without	without	IN
cord-005453-4057qib7	11693	21	aGVHD	agvhd	NN
cord-005453-4057qib7	11693	22	after	after	IN
cord-005453-4057qib7	11693	23	allo	allo	NN
cord-005453-4057qib7	11693	24	-	-	HYPH
cord-005453-4057qib7	11693	25	HSCT	HSCT	NNP
cord-005453-4057qib7	11693	26	.	.	.
cord-005453-4057qib7	11694	1	Although	although	IN
cord-005453-4057qib7	11694	2	the	the	DT
cord-005453-4057qib7	11694	3	kinetic	kinetic	JJ
cord-005453-4057qib7	11694	4	models	model	NNS
cord-005453-4057qib7	11694	5	were	be	VBD
cord-005453-4057qib7	11694	6	almost	almost	RB
cord-005453-4057qib7	11694	7	the	the	DT
cord-005453-4057qib7	11694	8	same	same	JJ
cord-005453-4057qib7	11694	9	for	for	IN
cord-005453-4057qib7	11694	10	leukemia	leukemia	NN
cord-005453-4057qib7	11694	11	-	-	HYPH
cord-005453-4057qib7	11694	12	free	free	JJ
cord-005453-4057qib7	11694	13	and	and	CC
cord-005453-4057qib7	11694	14	relapsed	relapsed	JJ
cord-005453-4057qib7	11694	15	patients	patient	NNS
cord-005453-4057qib7	11694	16	in	in	IN
cord-005453-4057qib7	11694	17	the	the	DT
cord-005453-4057qib7	11694	18	first	first	JJ
cord-005453-4057qib7	11694	19	3	3	CD
cord-005453-4057qib7	11694	20	months	month	NNS
cord-005453-4057qib7	11694	21	after	after	IN
cord-005453-4057qib7	11694	22	allo	allo	NN
cord-005453-4057qib7	11694	23	-	-	HYPH
cord-005453-4057qib7	11694	24	HSCT	HSCT	NNP
cord-005453-4057qib7	11694	25	,	,	,
cord-005453-4057qib7	11694	26	significantly	significantly	RB
cord-005453-4057qib7	11694	27	different	different	JJ
cord-005453-4057qib7	11694	28	kinetic	kinetic	JJ
cord-005453-4057qib7	11694	29	curves	curve	NNS
cord-005453-4057qib7	11694	30	could	could	MD
cord-005453-4057qib7	11694	31	be	be	VB
cord-005453-4057qib7	11694	32	observed	observe	VBN
cord-005453-4057qib7	11694	33	thereafter	thereafter	RB
cord-005453-4057qib7	11694	34	.	.	.
cord-005453-4057qib7	11695	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11695	2	:	:	:
cord-005453-4057qib7	11696	1	The	the	DT
cord-005453-4057qib7	11696	2	immune	immune	JJ
cord-005453-4057qib7	11696	3	cell	cell	NN
cord-005453-4057qib7	11696	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	11696	5	showed	show	VBD
cord-005453-4057qib7	11696	6	different	different	JJ
cord-005453-4057qib7	11696	7	mathematical	mathematical	JJ
cord-005453-4057qib7	11696	8	curve	curve	NN
cord-005453-4057qib7	11696	9	models	model	NNS
cord-005453-4057qib7	11696	10	after	after	IN
cord-005453-4057qib7	11696	11	allo	allo	NN
cord-005453-4057qib7	11696	12	-	-	HYPH
cord-005453-4057qib7	11696	13	HSCT	HSCT	NNP
cord-005453-4057qib7	11696	14	.	.	.
cord-005453-4057qib7	11697	1	Kinetic	kinetic	JJ
cord-005453-4057qib7	11697	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	11697	3	model	model	NN
cord-005453-4057qib7	11697	4	of	of	IN
cord-005453-4057qib7	11697	5	certain	certain	JJ
cord-005453-4057qib7	11697	6	immune	immune	JJ
cord-005453-4057qib7	11697	7	cell	cell	NN
cord-005453-4057qib7	11697	8	was	be	VBD
cord-005453-4057qib7	11697	9	associated	associate	VBN
cord-005453-4057qib7	11697	10	with	with	IN
cord-005453-4057qib7	11697	11	aGVHD	agvhd	NN
cord-005453-4057qib7	11697	12	and	and	CC
cord-005453-4057qib7	11697	13	relapse	relapse	NN
cord-005453-4057qib7	11697	14	.	.	.
cord-005453-4057qib7	11698	1	Hence	hence	RB
cord-005453-4057qib7	11698	2	,	,	,
cord-005453-4057qib7	11698	3	mathematical	mathematical	JJ
cord-005453-4057qib7	11698	4	kinetic	kinetic	JJ
cord-005453-4057qib7	11698	5	models	model	NNS
cord-005453-4057qib7	11698	6	of	of	IN
cord-005453-4057qib7	11698	7	immune	immune	JJ
cord-005453-4057qib7	11698	8	cell	cell	NN
cord-005453-4057qib7	11698	9	reconstitution	reconstitution	NN
cord-005453-4057qib7	11698	10	may	may	MD
cord-005453-4057qib7	11698	11	be	be	VB
cord-005453-4057qib7	11698	12	potential	potential	JJ
cord-005453-4057qib7	11698	13	indictor	indictor	NN
cord-005453-4057qib7	11698	14	for	for	IN
cord-005453-4057qib7	11698	15	predicting	predict	VBG
cord-005453-4057qib7	11698	16	aGVHD	agvhd	NN
cord-005453-4057qib7	11698	17	and	and	CC
cord-005453-4057qib7	11698	18	relapse	relapse	VB
cord-005453-4057qib7	11698	19	after	after	IN
cord-005453-4057qib7	11698	20	allo	allo	NN
cord-005453-4057qib7	11698	21	-	-	HYPH
cord-005453-4057qib7	11698	22	HSCT	HSCT	NNP
cord-005453-4057qib7	11698	23	.	.	.
cord-005453-4057qib7	11699	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11699	2	:	:	:
cord-005453-4057qib7	11699	3	Nothing	nothing	NN
cord-005453-4057qib7	11699	4	to	to	TO
cord-005453-4057qib7	11699	5	declare	declare	VB
cord-005453-4057qib7	11699	6	Lineage	Lineage	NNP
cord-005453-4057qib7	11699	7	specific	specific	JJ
cord-005453-4057qib7	11699	8	chimerism	chimerism	NN
cord-005453-4057qib7	11699	9	analysis	analysis	NN
cord-005453-4057qib7	11699	10	in	in	IN
cord-005453-4057qib7	11699	11	pediatric	pediatric	JJ
cord-005453-4057qib7	11699	12	patients	patient	NNS
cord-005453-4057qib7	11699	13	following	follow	VBG
cord-005453-4057qib7	11699	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	11699	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11699	16	cell	cell	NN
cord-005453-4057qib7	11699	17	transplantation	transplantation	NN
cord-005453-4057qib7	11699	18	(	(	-LRB-
cord-005453-4057qib7	11699	19	HCT	HCT	NNP
cord-005453-4057qib7	11699	20	Background	background	NN
cord-005453-4057qib7	11699	21	:	:	:
cord-005453-4057qib7	11700	1	The	the	DT
cord-005453-4057qib7	11700	2	outcome	outcome	NN
cord-005453-4057qib7	11700	3	of	of	IN
cord-005453-4057qib7	11700	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	11700	5	HCT	hct	NN
cord-005453-4057qib7	11700	6	is	be	VBZ
cord-005453-4057qib7	11700	7	dependent	dependent	JJ
cord-005453-4057qib7	11700	8	on	on	IN
cord-005453-4057qib7	11700	9	several	several	JJ
cord-005453-4057qib7	11700	10	variables	variable	NNS
cord-005453-4057qib7	11700	11	that	that	WDT
cord-005453-4057qib7	11700	12	include	include	VBP
cord-005453-4057qib7	11700	13	patient	patient	JJ
cord-005453-4057qib7	11700	14	age	age	NN
cord-005453-4057qib7	11700	15	,	,	,
cord-005453-4057qib7	11700	16	disease	disease	NN
cord-005453-4057qib7	11700	17	and	and	CC
cord-005453-4057qib7	11700	18	stage	stage	NN
cord-005453-4057qib7	11700	19	,	,	,
cord-005453-4057qib7	11700	20	cytoreduction	cytoreduction	NN
cord-005453-4057qib7	11700	21	,	,	,
cord-005453-4057qib7	11700	22	graft	graft	NN
cord-005453-4057qib7	11700	23	,	,	,
cord-005453-4057qib7	11700	24	graft	graft	NN
cord-005453-4057qib7	11700	25	manipulation	manipulation	NN
cord-005453-4057qib7	11700	26	,	,	,
cord-005453-4057qib7	11700	27	and	and	CC
cord-005453-4057qib7	11700	28	graft	graft	NN
cord-005453-4057qib7	11700	29	versus	versus	IN
cord-005453-4057qib7	11700	30	host	host	NN
cord-005453-4057qib7	11700	31	disease	disease	NN
cord-005453-4057qib7	11700	32	(	(	-LRB-
cord-005453-4057qib7	11700	33	GvHD	GvHD	NNP
cord-005453-4057qib7	11700	34	)	)	-RRB-
cord-005453-4057qib7	11700	35	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11700	36	.	.	.
cord-005453-4057qib7	11701	1	One	one	CD
cord-005453-4057qib7	11701	2	aspect	aspect	NN
cord-005453-4057qib7	11701	3	of	of	IN
cord-005453-4057qib7	11701	4	HCT	hct	NN
cord-005453-4057qib7	11701	5	that	that	WDT
cord-005453-4057qib7	11701	6	remains	remain	VBZ
cord-005453-4057qib7	11701	7	poorly	poorly	RB
cord-005453-4057qib7	11701	8	defined	define	VBN
cord-005453-4057qib7	11701	9	and	and	CC
cord-005453-4057qib7	11701	10	studied	study	VBN
cord-005453-4057qib7	11701	11	is	be	VBZ
cord-005453-4057qib7	11701	12	the	the	DT
cord-005453-4057qib7	11701	13	donor/	donor/	CD
cord-005453-4057qib7	11701	14	host	host	NN
cord-005453-4057qib7	11701	15	(	(	-LRB-
cord-005453-4057qib7	11701	16	D	d	NN
cord-005453-4057qib7	11701	17	/	/	SYM
cord-005453-4057qib7	11701	18	H	h	NN
cord-005453-4057qib7	11701	19	)	)	-RRB-
cord-005453-4057qib7	11701	20	chimerism	chimerism	NN
cord-005453-4057qib7	11701	21	post	post	NN
cord-005453-4057qib7	11701	22	HCT	hct	NN
cord-005453-4057qib7	11701	23	.	.	.
cord-005453-4057qib7	11702	1	Since	since	IN
cord-005453-4057qib7	11702	2	2010	2010	CD
cord-005453-4057qib7	11702	3	,	,	,
cord-005453-4057qib7	11702	4	we	-PRON-	PRP
cord-005453-4057qib7	11702	5	followed	follow	VBD
cord-005453-4057qib7	11702	6	patients	patient	NNS
cord-005453-4057qib7	11702	7	with	with	IN
cord-005453-4057qib7	11702	8	D	D	NNP
cord-005453-4057qib7	11702	9	/	/	SYM
cord-005453-4057qib7	11702	10	H	h	NN
cord-005453-4057qib7	11702	11	lineage	lineage	NN
cord-005453-4057qib7	11702	12	specific	specific	JJ
cord-005453-4057qib7	11702	13	chimerism	chimerism	NN
cord-005453-4057qib7	11702	14	post	post	NN
cord-005453-4057qib7	11702	15	HCT	hct	NN
cord-005453-4057qib7	11702	16	.	.	.
cord-005453-4057qib7	11703	1	Analyses	analysis	NNS
cord-005453-4057qib7	11703	2	were	be	VBD
cord-005453-4057qib7	11703	3	performed	perform	VBN
cord-005453-4057qib7	11703	4	by	by	IN
cord-005453-4057qib7	11703	5	short	short	JJ
cord-005453-4057qib7	11703	6	tandem	tandem	NN
cord-005453-4057qib7	11703	7	repeat	repeat	NN
cord-005453-4057qib7	11703	8	(	(	-LRB-
cord-005453-4057qib7	11704	1	STR	STR	NNP
cord-005453-4057qib7	11704	2	)	)	-RRB-
cord-005453-4057qib7	11704	3	polymorphism	polymorphism	NN
cord-005453-4057qib7	11704	4	analysis	analysis	NN
cord-005453-4057qib7	11704	5	at	at	IN
cord-005453-4057qib7	11704	6	the	the	DT
cord-005453-4057qib7	11704	7	American	American	NNP
cord-005453-4057qib7	11704	8	Red	Red	NNP
cord-005453-4057qib7	11704	9	Cross	Cross	NNP
cord-005453-4057qib7	11704	10	Blood	Blood	NNP
cord-005453-4057qib7	11704	11	Services	Services	NNP
cord-005453-4057qib7	11704	12	(	(	-LRB-
cord-005453-4057qib7	11704	13	Philadelphia	Philadelphia	NNP
cord-005453-4057qib7	11704	14	,	,	,
cord-005453-4057qib7	11704	15	PA	PA	NNP
cord-005453-4057qib7	11704	16	)	)	-RRB-
cord-005453-4057qib7	11704	17	.	.	.
cord-005453-4057qib7	11705	1	Studies	study	NNS
cord-005453-4057qib7	11705	2	were	be	VBD
cord-005453-4057qib7	11705	3	performed	perform	VBN
cord-005453-4057qib7	11705	4	on	on	IN
cord-005453-4057qib7	11705	5	blood	blood	NN
cord-005453-4057qib7	11705	6	total	total	JJ
cord-005453-4057qib7	11705	7	leukocytes	leukocyte	NNS
cord-005453-4057qib7	11705	8	,	,	,
cord-005453-4057qib7	11705	9	myeloid	myeloid	NN
cord-005453-4057qib7	11705	10	/	/	SYM
cord-005453-4057qib7	11705	11	neutrophil	neutrophil	NN
cord-005453-4057qib7	11705	12	Cells	cell	NNS
cord-005453-4057qib7	11705	13	,	,	,
cord-005453-4057qib7	11705	14	T	t	NN
cord-005453-4057qib7	11705	15	-	-	HYPH
cord-005453-4057qib7	11705	16	cells	cell	NNS
cord-005453-4057qib7	11705	17	,	,	,
cord-005453-4057qib7	11705	18	Bcells	Bcells	NNP
cord-005453-4057qib7	11705	19	,	,	,
cord-005453-4057qib7	11705	20	and	and	CC
cord-005453-4057qib7	11705	21	NK	nk	NN
cord-005453-4057qib7	11705	22	-	-	HYPH
cord-005453-4057qib7	11705	23	cells	cell	NNS
cord-005453-4057qib7	11705	24	.	.	.
cord-005453-4057qib7	11706	1	Methods	method	NNS
cord-005453-4057qib7	11706	2	:	:	:
cord-005453-4057qib7	11706	3	In	in	IN
cord-005453-4057qib7	11706	4	this	this	DT
cord-005453-4057qib7	11706	5	retrospective	retrospective	JJ
cord-005453-4057qib7	11706	6	study	study	NN
cord-005453-4057qib7	11706	7	,	,	,
cord-005453-4057qib7	11706	8	the	the	DT
cord-005453-4057qib7	11706	9	charts	chart	NNS
cord-005453-4057qib7	11706	10	of	of	IN
cord-005453-4057qib7	11706	11	154	154	CD
cord-005453-4057qib7	11706	12	consecutive	consecutive	JJ
cord-005453-4057qib7	11706	13	patients	patient	NNS
cord-005453-4057qib7	11706	14	who	who	WP
cord-005453-4057qib7	11706	15	underwent	undergo	VBD
cord-005453-4057qib7	11706	16	allogeneic	allogeneic	JJ
cord-005453-4057qib7	11706	17	HCT	hct	NN
cord-005453-4057qib7	11706	18	between	between	IN
cord-005453-4057qib7	11706	19	January	January	NNP
cord-005453-4057qib7	11706	20	2010	2010	CD
cord-005453-4057qib7	11706	21	to	to	IN
cord-005453-4057qib7	11706	22	June	June	NNP
cord-005453-4057qib7	11706	23	2015	2015	CD
cord-005453-4057qib7	11706	24	on	on	IN
cord-005453-4057qib7	11706	25	the	the	DT
cord-005453-4057qib7	11706	26	Pediatric	Pediatric	NNP
cord-005453-4057qib7	11706	27	Bone	Bone	NNP
cord-005453-4057qib7	11706	28	Marrow	Marrow	NNP
cord-005453-4057qib7	11706	29	Transplant	Transplant	NNP
cord-005453-4057qib7	11706	30	Service	Service	NNP
cord-005453-4057qib7	11706	31	at	at	IN
cord-005453-4057qib7	11706	32	MSKCC	MSKCC	NNS
cord-005453-4057qib7	11706	33	were	be	VBD
cord-005453-4057qib7	11706	34	retrospectively	retrospectively	RB
cord-005453-4057qib7	11706	35	reviewed	review	VBN
cord-005453-4057qib7	11706	36	.	.	.
cord-005453-4057qib7	11707	1	Lineage	lineage	NN
cord-005453-4057qib7	11707	2	specific	specific	JJ
cord-005453-4057qib7	11707	3	donor	donor	NN
cord-005453-4057qib7	11707	4	chimerism	chimerism	NN
cord-005453-4057qib7	11707	5	post	post	NN
cord-005453-4057qib7	11707	6	HCT	HCT	NNP
cord-005453-4057qib7	11707	7	was	be	VBD
cord-005453-4057qib7	11707	8	studied	study	VBN
cord-005453-4057qib7	11707	9	including	include	VBG
cord-005453-4057qib7	11707	10	D	d	NN
cord-005453-4057qib7	11707	11	/	/	SYM
cord-005453-4057qib7	11707	12	H	h	NN
cord-005453-4057qib7	11707	13	chimerism	chimerism	NN
cord-005453-4057qib7	11707	14	trend	trend	NN
cord-005453-4057qib7	11707	15	,	,	,
cord-005453-4057qib7	11707	16	and	and	CC
cord-005453-4057qib7	11707	17	factors	factor	NNS
cord-005453-4057qib7	11707	18	with	with	IN
cord-005453-4057qib7	11707	19	potential	potential	JJ
cord-005453-4057qib7	11707	20	impact	impact	NN
cord-005453-4057qib7	11707	21	on	on	IN
cord-005453-4057qib7	11707	22	chimerism	chimerism	NN
cord-005453-4057qib7	11707	23	including	include	VBG
cord-005453-4057qib7	11707	24	:	:	:
cord-005453-4057qib7	11707	25	age	age	NN
cord-005453-4057qib7	11707	26	,	,	,
cord-005453-4057qib7	11707	27	disease	disease	NN
cord-005453-4057qib7	11707	28	,	,	,
cord-005453-4057qib7	11707	29	graft	graft	NN
cord-005453-4057qib7	11707	30	source	source	NN
cord-005453-4057qib7	11707	31	,	,	,
cord-005453-4057qib7	11707	32	and	and	CC
cord-005453-4057qib7	11707	33	T	t	NN
cord-005453-4057qib7	11707	34	-	-	HYPH
cord-005453-4057qib7	11707	35	cell	cell	NN
cord-005453-4057qib7	11707	36	depletion	depletion	NN
cord-005453-4057qib7	11707	37	(	(	-LRB-
cord-005453-4057qib7	11707	38	TCD	TCD	NNP
cord-005453-4057qib7	11707	39	)	)	-RRB-
cord-005453-4057qib7	11707	40	.	.	.
cord-005453-4057qib7	11708	1	Preliminary	preliminary	JJ
cord-005453-4057qib7	11708	2	analyzes	analyze	VBZ
cord-005453-4057qib7	11708	3	performed	perform	VBN
cord-005453-4057qib7	11708	4	on	on	IN
cord-005453-4057qib7	11708	5	this	this	DT
cord-005453-4057qib7	11708	6	cohort	cohort	NN
cord-005453-4057qib7	11708	7	included	include	VBD
cord-005453-4057qib7	11708	8	Wilcoxon	Wilcoxon	NNP
cord-005453-4057qib7	11708	9	Rank	Rank	NNP
cord-005453-4057qib7	11708	10	Test	Test	NNP
cord-005453-4057qib7	11708	11	and	and	CC
cord-005453-4057qib7	11708	12	cox	cox	NNP
cord-005453-4057qib7	11708	13	proportional	proportional	JJ
cord-005453-4057qib7	11708	14	hazard	hazard	NN
cord-005453-4057qib7	11708	15	analyses	analysis	NNS
cord-005453-4057qib7	11708	16	.	.	.
cord-005453-4057qib7	11709	1	Results	result	NNS
cord-005453-4057qib7	11709	2	:	:	:
cord-005453-4057qib7	11709	3	137	137	CD
cord-005453-4057qib7	11709	4	patients	patient	NNS
cord-005453-4057qib7	11709	5	were	be	VBD
cord-005453-4057qib7	11709	6	selected	select	VBN
cord-005453-4057qib7	11709	7	based	base	VBN
cord-005453-4057qib7	11709	8	on	on	IN
cord-005453-4057qib7	11709	9	the	the	DT
cord-005453-4057qib7	11709	10	number	number	NN
cord-005453-4057qib7	11709	11	of	of	IN
cord-005453-4057qib7	11709	12	analyses	analysis	NNS
cord-005453-4057qib7	11709	13	.	.	.
cord-005453-4057qib7	11710	1	The	the	DT
cord-005453-4057qib7	11710	2	median	median	JJ
cord-005453-4057qib7	11710	3	age	age	NN
cord-005453-4057qib7	11710	4	was	be	VBD
cord-005453-4057qib7	11710	5	11.3	11.3	CD
cord-005453-4057qib7	11710	6	years	year	NNS
cord-005453-4057qib7	11710	7	.	.	.
cord-005453-4057qib7	11711	1	Patients	patient	NNS
cord-005453-4057qib7	11711	2	had	have	VBD
cord-005453-4057qib7	11711	3	hematologic	hematologic	JJ
cord-005453-4057qib7	11711	4	malignancies	malignancy	NNS
cord-005453-4057qib7	11711	5	(	(	-LRB-
cord-005453-4057qib7	11711	6	N=95	N=95	NNP
cord-005453-4057qib7	11711	7	)	)	-RRB-
cord-005453-4057qib7	11711	8	or	or	CC
cord-005453-4057qib7	11711	9	non	non	JJ
cord-005453-4057qib7	11711	10	-	-	JJ
cord-005453-4057qib7	11711	11	malignant	malignant	JJ
cord-005453-4057qib7	11711	12	hematologic	hematologic	JJ
cord-005453-4057qib7	11711	13	diseases	disease	NNS
cord-005453-4057qib7	11711	14	(	(	-LRB-
cord-005453-4057qib7	11711	15	N=27	N=27	NNP
cord-005453-4057qib7	11711	16	)	)	-RRB-
cord-005453-4057qib7	11711	17	,	,	,
cord-005453-4057qib7	11711	18	or	or	CC
cord-005453-4057qib7	11711	19	immune	immune	JJ
cord-005453-4057qib7	11711	20	disorders	disorder	NNS
cord-005453-4057qib7	11711	21	(	(	-LRB-
cord-005453-4057qib7	11711	22	N=15	N=15	NNP
cord-005453-4057qib7	11711	23	)	)	-RRB-
cord-005453-4057qib7	11711	24	.	.	.
cord-005453-4057qib7	11712	1	Cytoreduction	Cytoreduction	NNP
cord-005453-4057qib7	11712	2	included	include	VBD
cord-005453-4057qib7	11712	3	TBI-(N=42	TBI-(N=42	NNP
cord-005453-4057qib7	11712	4	)	)	-RRB-
cord-005453-4057qib7	11712	5	,	,	,
cord-005453-4057qib7	11712	6	or	or	CC
cord-005453-4057qib7	11712	7	chemotherapybased	chemotherapybase	VBN
cord-005453-4057qib7	11712	8	regiments	regiment	NNS
cord-005453-4057qib7	11712	9	(	(	-LRB-
cord-005453-4057qib7	11712	10	N=98	N=98	NNP
cord-005453-4057qib7	11712	11	)	)	-RRB-
cord-005453-4057qib7	11712	12	.	.	.
cord-005453-4057qib7	11713	1	Patients	patient	NNS
cord-005453-4057qib7	11713	2	were	be	VBD
cord-005453-4057qib7	11713	3	recipients	recipient	NNS
cord-005453-4057qib7	11713	4	of	of	IN
cord-005453-4057qib7	11713	5	T	t	NN
cord-005453-4057qib7	11713	6	-	-	HYPH
cord-005453-4057qib7	11713	7	cell	cell	NN
cord-005453-4057qib7	11713	8	depleted	deplete	VBN
cord-005453-4057qib7	11713	9	marrow	marrow	NN
cord-005453-4057qib7	11713	10	or	or	CC
cord-005453-4057qib7	11713	11	peripheral	peripheral	JJ
cord-005453-4057qib7	11713	12	blood	blood	NN
cord-005453-4057qib7	11713	13	grafts	graft	NNS
cord-005453-4057qib7	11713	14	(	(	-LRB-
cord-005453-4057qib7	11713	15	N=101	N=101	NNP
cord-005453-4057qib7	11713	16	)	)	-RRB-
cord-005453-4057qib7	11713	17	,	,	,
cord-005453-4057qib7	11713	18	unmodified	unmodified	JJ
cord-005453-4057qib7	11713	19	marrow	marrow	NN
cord-005453-4057qib7	11713	20	or	or	CC
cord-005453-4057qib7	11713	21	peripheral	peripheral	JJ
cord-005453-4057qib7	11713	22	blood	blood	NN
cord-005453-4057qib7	11713	23	grafts	graft	NNS
cord-005453-4057qib7	11713	24	(	(	-LRB-
cord-005453-4057qib7	11713	25	N=28	N=28	NNP
cord-005453-4057qib7	11713	26	)	)	-RRB-
cord-005453-4057qib7	11713	27	or	or	CC
cord-005453-4057qib7	11713	28	cord	cord	NN
cord-005453-4057qib7	11713	29	blood	blood	NN
cord-005453-4057qib7	11713	30	grafts	graft	NNS
cord-005453-4057qib7	11713	31	(	(	-LRB-
cord-005453-4057qib7	11713	32	N=8	N=8	NNP
cord-005453-4057qib7	11713	33	)	)	-RRB-
cord-005453-4057qib7	11713	34	.	.	.
cord-005453-4057qib7	11714	1	Full	full	JJ
cord-005453-4057qib7	11714	2	donor	donor	NN
cord-005453-4057qib7	11714	3	chimerism	chimerism	NN
cord-005453-4057qib7	11714	4	of	of	IN
cord-005453-4057qib7	11714	5	myeloid	myeloid	NN
cord-005453-4057qib7	11714	6	cells	cell	NNS
cord-005453-4057qib7	11714	7	,	,	,
cord-005453-4057qib7	11714	8	B	b	NN
cord-005453-4057qib7	11714	9	-	-	HYPH
cord-005453-4057qib7	11714	10	cells	cell	NNS
cord-005453-4057qib7	11714	11	and	and	CC
cord-005453-4057qib7	11714	12	NKcells	nkcell	NNS
cord-005453-4057qib7	11714	13	,	,	,
cord-005453-4057qib7	11714	14	but	but	CC
cord-005453-4057qib7	11714	15	not	not	RB
cord-005453-4057qib7	11714	16	T	t	NN
cord-005453-4057qib7	11714	17	-	-	HYPH
cord-005453-4057qib7	11714	18	cells	cell	NNS
cord-005453-4057qib7	11714	19	occurred	occur	VBD
cord-005453-4057qib7	11714	20	early	early	JJ
cord-005453-4057qib7	11714	21	post	post	NN
cord-005453-4057qib7	11714	22	-	-	NN
cord-005453-4057qib7	11714	23	transplant	transplant	NN
cord-005453-4057qib7	11714	24	.	.	.
cord-005453-4057qib7	11715	1	There	there	EX
cord-005453-4057qib7	11715	2	was	be	VBD
cord-005453-4057qib7	11715	3	no	no	DT
cord-005453-4057qib7	11715	4	difference	difference	NN
cord-005453-4057qib7	11715	5	in	in	IN
cord-005453-4057qib7	11715	6	the	the	DT
cord-005453-4057qib7	11715	7	percentage	percentage	NN
cord-005453-4057qib7	11715	8	of	of	IN
cord-005453-4057qib7	11715	9	total	total	JJ
cord-005453-4057qib7	11715	10	donor	donor	NN
cord-005453-4057qib7	11715	11	leukocytes	leukocyte	NNS
cord-005453-4057qib7	11715	12	at	at	IN
cord-005453-4057qib7	11715	13	3	3	CD
cord-005453-4057qib7	11715	14	months	month	NNS
cord-005453-4057qib7	11715	15	vs.	vs.	IN
cord-005453-4057qib7	11715	16	12	12	CD
cord-005453-4057qib7	11715	17	months	month	NNS
cord-005453-4057qib7	11716	1	post	post	NNP
cord-005453-4057qib7	11716	2	HSCT	HSCT	NNP
cord-005453-4057qib7	11716	3	(	(	-LRB-
cord-005453-4057qib7	11716	4	n=30	n=30	NNP
cord-005453-4057qib7	11716	5	)	)	-RRB-
cord-005453-4057qib7	11716	6	,	,	,
cord-005453-4057qib7	11716	7	while	while	IN
cord-005453-4057qib7	11716	8	the	the	DT
cord-005453-4057qib7	11716	9	median	median	NN
cord-005453-4057qib7	11716	10	of	of	IN
cord-005453-4057qib7	11716	11	donor	donor	NN
cord-005453-4057qib7	11716	12	T	t	NN
cord-005453-4057qib7	11716	13	-	-	HYPH
cord-005453-4057qib7	11716	14	cell	cell	NN
cord-005453-4057qib7	11716	15	chimerism	chimerism	NN
cord-005453-4057qib7	11716	16	was	be	VBD
cord-005453-4057qib7	11716	17	51	51	CD
cord-005453-4057qib7	11716	18	%	%	NN
cord-005453-4057qib7	11716	19	at	at	IN
cord-005453-4057qib7	11716	20	3	3	CD
cord-005453-4057qib7	11716	21	months	month	NNS
cord-005453-4057qib7	11716	22	and	and	CC
cord-005453-4057qib7	11716	23	91	91	CD
cord-005453-4057qib7	11716	24	%	%	NN
cord-005453-4057qib7	11716	25	at	at	IN
cord-005453-4057qib7	11716	26	12	12	CD
cord-005453-4057qib7	11716	27	months	month	NNS
cord-005453-4057qib7	11717	1	post	post	NNP
cord-005453-4057qib7	11717	2	HSCT	HSCT	NNP
cord-005453-4057qib7	11717	3	(	(	-LRB-
cord-005453-4057qib7	11717	4	p	p	NN
cord-005453-4057qib7	11717	5	<	<	XX
cord-005453-4057qib7	11717	6	0.0001	0.0001	CD
cord-005453-4057qib7	11717	7	,	,	,
cord-005453-4057qib7	11717	8	N=42	N=42	NNP
cord-005453-4057qib7	11717	9	)	)	-RRB-
cord-005453-4057qib7	11717	10	.	.	.
cord-005453-4057qib7	11718	1	Figure	figure	NN
cord-005453-4057qib7	11718	2	1	1	CD
cord-005453-4057qib7	11718	3	shows	show	VBZ
cord-005453-4057qib7	11718	4	the	the	DT
cord-005453-4057qib7	11718	5	impact	impact	NN
cord-005453-4057qib7	11718	6	of	of	IN
cord-005453-4057qib7	11718	7	different	different	JJ
cord-005453-4057qib7	11718	8	factors	factor	NNS
cord-005453-4057qib7	11718	9	including	include	VBG
cord-005453-4057qib7	11718	10	:	:	:
cord-005453-4057qib7	11718	11	(	(	-LRB-
cord-005453-4057qib7	11718	12	A	a	NN
cord-005453-4057qib7	11718	13	)	)	-RRB-
cord-005453-4057qib7	11718	14	the	the	DT
cord-005453-4057qib7	11718	15	use	use	NN
cord-005453-4057qib7	11718	16	of	of	IN
cord-005453-4057qib7	11718	17	TBI	TBI	NNP
cord-005453-4057qib7	11718	18	-	-	:
cord-005453-4057qib7	11718	19	or	or	CC
cord-005453-4057qib7	11718	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11718	21	-	-	HYPH
cord-005453-4057qib7	11718	22	based	base	VBN
cord-005453-4057qib7	11718	23	regimens	regimen	NNS
cord-005453-4057qib7	11718	24	,	,	,
cord-005453-4057qib7	11718	25	(	(	-LRB-
cord-005453-4057qib7	11718	26	B	b	NN
cord-005453-4057qib7	11718	27	)	)	-RRB-
cord-005453-4057qib7	11718	28	age	age	NN
cord-005453-4057qib7	11718	29	(	(	-LRB-
cord-005453-4057qib7	11718	30	<	<	XX
cord-005453-4057qib7	11718	31	or	or	CC
cord-005453-4057qib7	11718	32	>	>	XX
cord-005453-4057qib7	11718	33	3	3	CD
cord-005453-4057qib7	11718	34	years	year	NNS
cord-005453-4057qib7	11718	35	)	)	-RRB-
cord-005453-4057qib7	11718	36	,	,	,
cord-005453-4057qib7	11718	37	and	and	CC
cord-005453-4057qib7	11718	38	(	(	-LRB-
cord-005453-4057qib7	11718	39	C	c	NN
cord-005453-4057qib7	11718	40	)	)	-RRB-
cord-005453-4057qib7	11718	41	type	type	NN
cord-005453-4057qib7	11718	42	of	of	IN
cord-005453-4057qib7	11718	43	graft	graft	NN
cord-005453-4057qib7	11718	44	(	(	-LRB-
cord-005453-4057qib7	11718	45	T	t	NN
cord-005453-4057qib7	11718	46	-	-	HYPH
cord-005453-4057qib7	11718	47	cell	cell	NN
cord-005453-4057qib7	11718	48	depleted	deplete	VBN
cord-005453-4057qib7	11718	49	Vs	Vs	NNP
cord-005453-4057qib7	11718	50	unmodified	unmodified	JJ
cord-005453-4057qib7	11718	51	Vs	Vs	NNP
cord-005453-4057qib7	11718	52	Cord	Cord	NNP
cord-005453-4057qib7	11718	53	Blood	blood	NN
cord-005453-4057qib7	11718	54	)	)	-RRB-
cord-005453-4057qib7	11718	55	.	.	.
cord-005453-4057qib7	11719	1	Donor	donor	NN
cord-005453-4057qib7	11719	2	total	total	JJ
cord-005453-4057qib7	11719	3	leukocytes	leukocyte	NNS
cord-005453-4057qib7	11719	4	chimerism	chimerism	NN
cord-005453-4057qib7	11719	5	was	be	VBD
cord-005453-4057qib7	11719	6	significantly	significantly	RB
cord-005453-4057qib7	11719	7	lower	low	JJR
cord-005453-4057qib7	11719	8	at	at	IN
cord-005453-4057qib7	11719	9	12	12	CD
cord-005453-4057qib7	11719	10	months	month	NNS
cord-005453-4057qib7	11719	11	as	as	IN
cord-005453-4057qib7	11719	12	compared	compare	VBN
cord-005453-4057qib7	11719	13	to	to	IN
cord-005453-4057qib7	11719	14	3	3	CD
cord-005453-4057qib7	11719	15	months	month	NNS
cord-005453-4057qib7	11719	16	for	for	IN
cord-005453-4057qib7	11719	17	patients	patient	NNS
cord-005453-4057qib7	11719	18	<	<	XX
cord-005453-4057qib7	11719	19	3	3	CD
cord-005453-4057qib7	11719	20	years	year	NNS
cord-005453-4057qib7	11719	21	of	of	IN
cord-005453-4057qib7	11719	22	age	age	NN
cord-005453-4057qib7	11719	23	(	(	-LRB-
cord-005453-4057qib7	11719	24	p=0.012	p=0.012	NNP
cord-005453-4057qib7	11719	25	)	)	-RRB-
cord-005453-4057qib7	11719	26	.	.	.
cord-005453-4057qib7	11720	1	For	for	IN
cord-005453-4057qib7	11720	2	most	most	JJS
cord-005453-4057qib7	11720	3	grafts	graft	NNS
cord-005453-4057qib7	11720	4	,	,	,
cord-005453-4057qib7	11720	5	full	full	JJ
cord-005453-4057qib7	11720	6	donor	donor	NN
cord-005453-4057qib7	11720	7	chimerism	chimerism	NN
cord-005453-4057qib7	11720	8	of	of	IN
cord-005453-4057qib7	11720	9	T	t	NN
cord-005453-4057qib7	11720	10	-	-	HYPH
cord-005453-4057qib7	11720	11	cells	cell	NNS
cord-005453-4057qib7	11720	12	occurred	occur	VBD
cord-005453-4057qib7	11720	13	early	early	RB
cord-005453-4057qib7	11720	14	,	,	,
cord-005453-4057qib7	11720	15	while	while	IN
cord-005453-4057qib7	11720	16	for	for	IN
cord-005453-4057qib7	11720	17	T	t	NN
cord-005453-4057qib7	11720	18	-	-	HYPH
cord-005453-4057qib7	11720	19	cell	cell	NN
cord-005453-4057qib7	11720	20	depleted	deplete	VBN
cord-005453-4057qib7	11720	21	transplants	transplant	NNS
cord-005453-4057qib7	11720	22	,	,	,
cord-005453-4057qib7	11720	23	it	-PRON-	PRP
cord-005453-4057qib7	11720	24	took	take	VBD
cord-005453-4057qib7	11720	25	up	up	RP
cord-005453-4057qib7	11720	26	to	to	IN
cord-005453-4057qib7	11720	27	one	one	CD
cord-005453-4057qib7	11720	28	year	year	NN
cord-005453-4057qib7	11720	29	to	to	TO
cord-005453-4057qib7	11720	30	complete	complete	VB
cord-005453-4057qib7	11720	31	.	.	.
cord-005453-4057qib7	11721	1	Cord	cord	NN
cord-005453-4057qib7	11721	2	blood	blood	NN
cord-005453-4057qib7	11721	3	grafts	graft	NNS
cord-005453-4057qib7	11721	4	were	be	VBD
cord-005453-4057qib7	11721	5	associated	associate	VBN
cord-005453-4057qib7	11721	6	with	with	IN
cord-005453-4057qib7	11721	7	high	high	JJ
cord-005453-4057qib7	11721	8	T	t	NN
cord-005453-4057qib7	11721	9	-	-	HYPH
cord-005453-4057qib7	11721	10	cell	cell	NN
cord-005453-4057qib7	11721	11	donor	donor	NN
cord-005453-4057qib7	11721	12	chimerism	chimerism	NN
cord-005453-4057qib7	11721	13	throughout	throughout	IN
cord-005453-4057qib7	11721	14	the	the	DT
cord-005453-4057qib7	11721	15	post	post	JJ
cord-005453-4057qib7	11721	16	-	-	JJ
cord-005453-4057qib7	11721	17	transplant	transplant	JJ
cord-005453-4057qib7	11721	18	period	period	NN
cord-005453-4057qib7	11721	19	.	.	.
cord-005453-4057qib7	11722	1	There	there	EX
cord-005453-4057qib7	11722	2	was	be	VBD
cord-005453-4057qib7	11722	3	a	a	DT
cord-005453-4057qib7	11722	4	significant	significant	JJ
cord-005453-4057qib7	11722	5	difference	difference	NN
cord-005453-4057qib7	11722	6	in	in	IN
cord-005453-4057qib7	11722	7	the	the	DT
cord-005453-4057qib7	11722	8	%	%	NN
cord-005453-4057qib7	11722	9	donor	donor	NN
cord-005453-4057qib7	11722	10	T	t	NN
cord-005453-4057qib7	11722	11	-	-	HYPH
cord-005453-4057qib7	11722	12	cells	cell	NNS
cord-005453-4057qib7	11722	13	at	at	IN
cord-005453-4057qib7	11722	14	3	3	CD
cord-005453-4057qib7	11722	15	and	and	CC
cord-005453-4057qib7	11722	16	12	12	CD
cord-005453-4057qib7	11722	17	months	month	NNS
cord-005453-4057qib7	11722	18	post	post	NN
cord-005453-4057qib7	11722	19	HCT	hct	NN
cord-005453-4057qib7	11722	20	when	when	WRB
cord-005453-4057qib7	11722	21	comparing	compare	VBG
cord-005453-4057qib7	11722	22	T	t	NN
cord-005453-4057qib7	11722	23	-	-	HYPH
cord-005453-4057qib7	11722	24	cell	cell	NN
cord-005453-4057qib7	11722	25	depleted	deplete	VBN
cord-005453-4057qib7	11722	26	and	and	CC
cord-005453-4057qib7	11722	27	unmodified	unmodified	JJ
cord-005453-4057qib7	11722	28	grafts	graft	NNS
cord-005453-4057qib7	11722	29	(	(	-LRB-
cord-005453-4057qib7	11722	30	p=0.015	p=0.015	NNP
cord-005453-4057qib7	11722	31	)	)	-RRB-
cord-005453-4057qib7	11722	32	.	.	.
cord-005453-4057qib7	11723	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11723	2	:	:	:
cord-005453-4057qib7	11724	1	This	this	DT
cord-005453-4057qib7	11724	2	preliminary	preliminary	JJ
cord-005453-4057qib7	11724	3	analysis	analysis	NN
cord-005453-4057qib7	11724	4	of	of	IN
cord-005453-4057qib7	11724	5	lineage	lineage	NN
cord-005453-4057qib7	11724	6	specific	specific	JJ
cord-005453-4057qib7	11724	7	chimerism	chimerism	NN
cord-005453-4057qib7	11724	8	post	post	JJ
cord-005453-4057qib7	11724	9	-	-	JJ
cord-005453-4057qib7	11724	10	transplant	transplant	NN
cord-005453-4057qib7	11724	11	showed	show	VBD
cord-005453-4057qib7	11724	12	that	that	IN
cord-005453-4057qib7	11724	13	donor	donor	NN
cord-005453-4057qib7	11724	14	Tcells	Tcells	NNP
cord-005453-4057qib7	11724	15	may	may	MD
cord-005453-4057qib7	11724	16	take	take	VB
cord-005453-4057qib7	11724	17	one	one	CD
cord-005453-4057qib7	11724	18	year	year	NN
cord-005453-4057qib7	11724	19	to	to	TO
cord-005453-4057qib7	11724	20	fully	fully	RB
cord-005453-4057qib7	11724	21	recover	recover	VB
cord-005453-4057qib7	11724	22	post	post	NN
cord-005453-4057qib7	11724	23	-	-	JJ
cord-005453-4057qib7	11724	24	transplant	transplant	NN
cord-005453-4057qib7	11724	25	,	,	,
cord-005453-4057qib7	11724	26	mostly	mostly	RB
cord-005453-4057qib7	11724	27	following	follow	VBG
cord-005453-4057qib7	11724	28	T	t	NN
cord-005453-4057qib7	11724	29	-	-	HYPH
cord-005453-4057qib7	11724	30	cell	cell	NN
cord-005453-4057qib7	11724	31	depleted	deplete	VBN
cord-005453-4057qib7	11724	32	grafts	graft	NNS
cord-005453-4057qib7	11724	33	,	,	,
cord-005453-4057qib7	11724	34	without	without	IN
cord-005453-4057qib7	11724	35	intervention	intervention	NN
cord-005453-4057qib7	11724	36	.	.	.
cord-005453-4057qib7	11725	1	Cord	cord	NN
cord-005453-4057qib7	11725	2	blood	blood	NN
cord-005453-4057qib7	11725	3	grafts	graft	NNS
cord-005453-4057qib7	11725	4	were	be	VBD
cord-005453-4057qib7	11725	5	associated	associate	VBN
cord-005453-4057qib7	11725	6	with	with	IN
cord-005453-4057qib7	11725	7	high	high	JJ
cord-005453-4057qib7	11725	8	donor	donor	NN
cord-005453-4057qib7	11725	9	chimerism	chimerism	NN
cord-005453-4057qib7	11725	10	throughout	throughout	IN
cord-005453-4057qib7	11725	11	the	the	DT
cord-005453-4057qib7	11725	12	post	post	JJ
cord-005453-4057qib7	11725	13	-	-	JJ
cord-005453-4057qib7	11725	14	transplant	transplant	JJ
cord-005453-4057qib7	11725	15	period	period	NN
cord-005453-4057qib7	11725	16	.	.	.
cord-005453-4057qib7	11726	1	Lastly	lastly	RB
cord-005453-4057qib7	11726	2	,	,	,
cord-005453-4057qib7	11726	3	factors	factor	NNS
cord-005453-4057qib7	11726	4	associated	associate	VBN
cord-005453-4057qib7	11726	5	with	with	IN
cord-005453-4057qib7	11726	6	loss	loss	NN
cord-005453-4057qib7	11726	7	of	of	IN
cord-005453-4057qib7	11726	8	donor	donor	NN
cord-005453-4057qib7	11726	9	chimerism	chimerism	NN
cord-005453-4057qib7	11726	10	posttransplant	posttransplant	NN
cord-005453-4057qib7	11726	11	were	be	VBD
cord-005453-4057qib7	11726	12	younger	young	JJR
cord-005453-4057qib7	11726	13	age	age	NN
cord-005453-4057qib7	11726	14	and	and	CC
cord-005453-4057qib7	11726	15	non	non	JJ
cord-005453-4057qib7	11726	16	-	-	JJ
cord-005453-4057qib7	11726	17	malignant	malignant	JJ
cord-005453-4057qib7	11726	18	disorders	disorder	NNS
cord-005453-4057qib7	11726	19	.	.	.
cord-005453-4057qib7	11727	1	More	More	JJR
cord-005453-4057qib7	11727	2	in	in	IN
cord-005453-4057qib7	11727	3	-	-	HYPH
cord-005453-4057qib7	11727	4	depth	depth	NN
cord-005453-4057qib7	11727	5	analyses	analysis	NNS
cord-005453-4057qib7	11727	6	are	be	VBP
cord-005453-4057qib7	11727	7	being	be	VBG
cord-005453-4057qib7	11727	8	performed	perform	VBN
cord-005453-4057qib7	11727	9	including	include	VBG
cord-005453-4057qib7	11727	10	the	the	DT
cord-005453-4057qib7	11727	11	relation	relation	NN
cord-005453-4057qib7	11727	12	of	of	IN
cord-005453-4057qib7	11727	13	chimerism	chimerism	NN
cord-005453-4057qib7	11727	14	and	and	CC
cord-005453-4057qib7	11727	15	HCT	hct	NN
cord-005453-4057qib7	11727	16	outcome	outcome	NN
cord-005453-4057qib7	11727	17	.	.	.
cord-005453-4057qib7	11728	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11728	2	:	:	:
cord-005453-4057qib7	11729	1	Eileen	Eileen	NNP
cord-005453-4057qib7	11729	2	Nicoletti	Nicoletti	NNP
cord-005453-4057qib7	11730	1	-Employee	-Employee	NNP
cord-005453-4057qib7	11730	2	Rocket	Rocket	NNP
cord-005453-4057qib7	11730	3	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	11730	4	,	,	,
cord-005453-4057qib7	11730	5	Susan	Susan	NNP
cord-005453-4057qib7	11730	6	Prockop	Prockop	NNP
cord-005453-4057qib7	11731	1	-Investigator	-Investigator	NNP
cord-005453-4057qib7	11732	1	Atara	Atara	NNP
cord-005453-4057qib7	11732	2	Biotherapeutics	Biotherapeutics	NNPS
cord-005453-4057qib7	11732	3	-Research	-Research	:
cord-005453-4057qib7	11732	4	funding	funding	NN
cord-005453-4057qib7	11732	5	,	,	,
cord-005453-4057qib7	11732	6	Susan	Susan	NNP
cord-005453-4057qib7	11732	7	Prockop	Prockop	NNP
cord-005453-4057qib7	11733	1	-Mesoblast	-mesoblast	RB
cord-005453-4057qib7	11734	1	-Research	-Research	:
cord-005453-4057qib7	11734	2	funding	funding	NN
cord-005453-4057qib7	11734	3	,	,	,
cord-005453-4057qib7	11734	4	Nancy	Nancy	NNP
cord-005453-4057qib7	11734	5	Kernan	Kernan	NNP
cord-005453-4057qib7	11735	1	-Gentium	-gentium	LS
cord-005453-4057qib7	11735	2	-support	-support	XX
cord-005453-4057qib7	11735	3	;	;	:
cord-005453-4057qib7	11735	4	Jazz	Jazz	NNP
cord-005453-4057qib7	11735	5	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	11735	6	-Support	-Support	NNP
cord-005453-4057qib7	11735	7	,	,	,
cord-005453-4057qib7	11735	8	Richard	Richard	NNP
cord-005453-4057qib7	11735	9	O´Reilly	o´reilly	RB
cord-005453-4057qib7	11735	10	-Atara	-Atara	.
cord-005453-4057qib7	11735	11	Biotherapeutics	Biotherapeutics	NNPS
cord-005453-4057qib7	11735	12	-Royalty	-royalty	RB
cord-005453-4057qib7	11735	13	,	,	,
cord-005453-4057qib7	11735	14	Consultancy	Consultancy	NNP
cord-005453-4057qib7	11735	15	and	and	CC
cord-005453-4057qib7	11735	16	Research	Research	NNP
cord-005453-4057qib7	11735	17	,	,	,
cord-005453-4057qib7	11736	1	Jaap	Jaap	NNP
cord-005453-4057qib7	11736	2	Jan	Jan	NNP
cord-005453-4057qib7	11736	3	Boelens	Boelens	NNP
cord-005453-4057qib7	11736	4	-Bluebird	-Bluebird	VBZ
cord-005453-4057qib7	11736	5	Bio	Bio	NNP
cord-005453-4057qib7	11737	1	-Consultancy	-Consultancy	NNP
cord-005453-4057qib7	11737	2	,	,	,
cord-005453-4057qib7	11737	3	Avrobio	Avrobio	NNP
cord-005453-4057qib7	11737	4	-Consultancy	-Consultancy	NNP
cord-005453-4057qib7	11738	1	;	;	:
cord-005453-4057qib7	11738	2	Jaap	Jaap	NNP
cord-005453-4057qib7	11738	3	Jan	Jan	NNP
cord-005453-4057qib7	11738	4	Boelens	Boelens	NNP
cord-005453-4057qib7	11739	1	-Chimerix	-Chimerix	.
cord-005453-4057qib7	11740	1	-Consultancy	-Consultancy	NNP
cord-005453-4057qib7	11741	1	;	;	:
cord-005453-4057qib7	11741	2	Magenta	Magenta	NNP
cord-005453-4057qib7	11741	3	-Consultancy	-Consultancy	NNP
cord-005453-4057qib7	11741	4	Background	Background	NNP
cord-005453-4057qib7	11741	5	:	:	:
cord-005453-4057qib7	11742	1	The	the	DT
cord-005453-4057qib7	11742	2	success	success	NN
cord-005453-4057qib7	11742	3	of	of	IN
cord-005453-4057qib7	11742	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11742	5	stem	stem	NN
cord-005453-4057qib7	11742	6	cell	cell	NN
cord-005453-4057qib7	11742	7	transplantation	transplantation	NN
cord-005453-4057qib7	11742	8	(	(	-LRB-
cord-005453-4057qib7	11742	9	HSCT	HSCT	NNP
cord-005453-4057qib7	11742	10	)	)	-RRB-
cord-005453-4057qib7	11742	11	lies	lie	VBZ
cord-005453-4057qib7	11742	12	with	with	IN
cord-005453-4057qib7	11742	13	the	the	DT
cord-005453-4057qib7	11742	14	ability	ability	NN
cord-005453-4057qib7	11742	15	of	of	IN
cord-005453-4057qib7	11742	16	the	the	DT
cord-005453-4057qib7	11742	17	engrafted	engraft	VBN
cord-005453-4057qib7	11742	18	immune	immune	JJ
cord-005453-4057qib7	11742	19	system	system	NN
cord-005453-4057qib7	11742	20	to	to	TO
cord-005453-4057qib7	11742	21	remove	remove	VB
cord-005453-4057qib7	11742	22	residual	residual	JJ
cord-005453-4057qib7	11742	23	leukemia	leukemia	NN
cord-005453-4057qib7	11742	24	cells	cell	NNS
cord-005453-4057qib7	11742	25	via	via	IN
cord-005453-4057qib7	11742	26	a	a	DT
cord-005453-4057qib7	11742	27	graft	graft	NN
cord-005453-4057qib7	11742	28	-	-	HYPH
cord-005453-4057qib7	11742	29	versus	versus	IN
cord-005453-4057qib7	11742	30	-	-	HYPH
cord-005453-4057qib7	11742	31	leukemia	leukemia	NN
cord-005453-4057qib7	11742	32	effect	effect	NN
cord-005453-4057qib7	11742	33	.	.	.
cord-005453-4057qib7	11743	1	Despite	despite	IN
cord-005453-4057qib7	11743	2	this	this	DT
cord-005453-4057qib7	11743	3	,	,	,
cord-005453-4057qib7	11743	4	relapse	relapse	NN
cord-005453-4057qib7	11743	5	remains	remain	VBZ
cord-005453-4057qib7	11743	6	the	the	DT
cord-005453-4057qib7	11743	7	major	major	JJ
cord-005453-4057qib7	11743	8	cause	cause	NN
cord-005453-4057qib7	11743	9	of	of	IN
cord-005453-4057qib7	11743	10	mortality	mortality	NN
cord-005453-4057qib7	11743	11	among	among	IN
cord-005453-4057qib7	11743	12	patients	patient	NNS
cord-005453-4057qib7	11743	13	receiving	receive	VBG
cord-005453-4057qib7	11743	14	HSCT	HSCT	NNP
cord-005453-4057qib7	11743	15	.	.	.
cord-005453-4057qib7	11744	1	One	one	CD
cord-005453-4057qib7	11744	2	of	of	IN
cord-005453-4057qib7	11744	3	the	the	DT
cord-005453-4057qib7	11744	4	immune	immune	JJ
cord-005453-4057qib7	11744	5	evasion	evasion	NN
cord-005453-4057qib7	11744	6	mechanisms	mechanism	NNS
cord-005453-4057qib7	11744	7	of	of	IN
cord-005453-4057qib7	11744	8	leukemic	leukemic	JJ
cord-005453-4057qib7	11744	9	cells	cell	NNS
cord-005453-4057qib7	11744	10	to	to	TO
cord-005453-4057qib7	11744	11	escape	escape	VB
cord-005453-4057qib7	11744	12	from	from	IN
cord-005453-4057qib7	11744	13	donor	donor	NN
cord-005453-4057qib7	11744	14	T	t	NN
cord-005453-4057qib7	11744	15	cell	cell	NN
cord-005453-4057qib7	11744	16	recognition	recognition	NN
cord-005453-4057qib7	11744	17	in	in	IN
cord-005453-4057qib7	11744	18	haplo	haplo	NNP
cord-005453-4057qib7	11744	19	-	-	HYPH
cord-005453-4057qib7	11744	20	HSCT	HSCT	NNP
cord-005453-4057qib7	11744	21	is	be	VBZ
cord-005453-4057qib7	11744	22	the	the	DT
cord-005453-4057qib7	11744	23	genomic	genomic	JJ
cord-005453-4057qib7	11744	24	loss	loss	NN
cord-005453-4057qib7	11744	25	of	of	IN
cord-005453-4057qib7	11744	26	the	the	DT
cord-005453-4057qib7	11744	27	patient	patient	JJ
cord-005453-4057qib7	11744	28	specific	specific	JJ
cord-005453-4057qib7	11744	29	HLA	HLA	NNP
cord-005453-4057qib7	11744	30	.	.	.
cord-005453-4057qib7	11745	1	It	-PRON-	PRP
cord-005453-4057qib7	11745	2	has	have	VBZ
cord-005453-4057qib7	11745	3	been	be	VBN
cord-005453-4057qib7	11745	4	described	describe	VBN
cord-005453-4057qib7	11745	5	in	in	IN
cord-005453-4057qib7	11745	6	20	20	CD
cord-005453-4057qib7	11745	7	-	-	SYM
cord-005453-4057qib7	11745	8	30	30	CD
cord-005453-4057qib7	11745	9	%	%	NN
cord-005453-4057qib7	11745	10	of	of	IN
cord-005453-4057qib7	11745	11	acute	acute	JJ
cord-005453-4057qib7	11745	12	myeloid	myeloid	NN
cord-005453-4057qib7	11745	13	leukemia	leukemia	NN
cord-005453-4057qib7	11745	14	(	(	-LRB-
cord-005453-4057qib7	11745	15	AML	AML	NNP
cord-005453-4057qib7	11745	16	)	)	-RRB-
cord-005453-4057qib7	11745	17	and	and	CC
cord-005453-4057qib7	11745	18	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	11745	19	syndrome	syndrome	NN
cord-005453-4057qib7	11745	20	(	(	-LRB-
cord-005453-4057qib7	11745	21	MDS	MDS	NNP
cord-005453-4057qib7	11745	22	)	)	-RRB-
cord-005453-4057qib7	11745	23	relapses	relapse	NNS
cord-005453-4057qib7	11745	24	after	after	IN
cord-005453-4057qib7	11745	25	haplo	haplo	NN
cord-005453-4057qib7	11745	26	-	-	HYPH
cord-005453-4057qib7	11745	27	HSCT	HSCT	NNP
cord-005453-4057qib7	11745	28	.	.	.
cord-005453-4057qib7	11746	1	The	the	DT
cord-005453-4057qib7	11746	2	aim	aim	NN
cord-005453-4057qib7	11746	3	of	of	IN
cord-005453-4057qib7	11746	4	this	this	DT
cord-005453-4057qib7	11746	5	study	study	NN
cord-005453-4057qib7	11746	6	was	be	VBD
cord-005453-4057qib7	11746	7	to	to	TO
cord-005453-4057qib7	11746	8	analyze	analyze	VB
cord-005453-4057qib7	11746	9	HLA	HLA	NNP
cord-005453-4057qib7	11746	10	loss	loss	NN
cord-005453-4057qib7	11746	11	in	in	IN
cord-005453-4057qib7	11746	12	a	a	DT
cord-005453-4057qib7	11746	13	large	large	JJ
cord-005453-4057qib7	11746	14	cohort	cohort	NN
cord-005453-4057qib7	11746	15	of	of	IN
cord-005453-4057qib7	11746	16	patients	patient	NNS
cord-005453-4057qib7	11746	17	who	who	WP
cord-005453-4057qib7	11746	18	relapsed	relapse	VBD
cord-005453-4057qib7	11746	19	after	after	IN
cord-005453-4057qib7	11746	20	T	t	NN
cord-005453-4057qib7	11746	21	-	-	HYPH
cord-005453-4057qib7	11746	22	cell	cell	NN
cord-005453-4057qib7	11746	23	replete	replete	JJ
cord-005453-4057qib7	11746	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11746	25	transplantation	transplantation	NN
cord-005453-4057qib7	11746	26	with	with	IN
cord-005453-4057qib7	11746	27	posttransplant	posttransplant	NN
cord-005453-4057qib7	11746	28	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	11746	29	.	.	.
cord-005453-4057qib7	11747	1	Methods	method	NNS
cord-005453-4057qib7	11747	2	:	:	:
cord-005453-4057qib7	11748	1	From	from	IN
cord-005453-4057qib7	11748	2	December	December	NNP
cord-005453-4057qib7	11748	3	2007	2007	CD
cord-005453-4057qib7	11748	4	to	to	IN
cord-005453-4057qib7	11748	5	September	September	NNP
cord-005453-4057qib7	11748	6	2018	2018	CD
cord-005453-4057qib7	11748	7	,	,	,
cord-005453-4057qib7	11748	8	180	180	CD
cord-005453-4057qib7	11748	9	patients	patient	NNS
cord-005453-4057qib7	11748	10	with	with	IN
cord-005453-4057qib7	11748	11	hematological	hematological	JJ
cord-005453-4057qib7	11748	12	malignancies	malignancy	NNS
cord-005453-4057qib7	11748	13	who	who	WP
cord-005453-4057qib7	11748	14	received	receive	VBD
cord-005453-4057qib7	11748	15	a	a	DT
cord-005453-4057qib7	11748	16	haplo	haplo	NN
cord-005453-4057qib7	11748	17	-	-	HYPH
cord-005453-4057qib7	11748	18	HSCT	HSCT	NNP
cord-005453-4057qib7	11748	19	were	be	VBD
cord-005453-4057qib7	11748	20	recruited	recruit	VBN
cord-005453-4057qib7	11748	21	.	.	.
cord-005453-4057qib7	11749	1	Among	among	IN
cord-005453-4057qib7	11749	2	them	-PRON-	PRP
cord-005453-4057qib7	11749	3	,	,	,
cord-005453-4057qib7	11749	4	31	31	CD
cord-005453-4057qib7	11749	5	patients	patient	NNS
cord-005453-4057qib7	11749	6	presented	present	VBD
cord-005453-4057qib7	11749	7	a	a	DT
cord-005453-4057qib7	11749	8	relapse	relapse	NN
cord-005453-4057qib7	11749	9	after	after	IN
cord-005453-4057qib7	11749	10	haplo	haplo	NN
cord-005453-4057qib7	11749	11	-	-	HYPH
cord-005453-4057qib7	11749	12	HSCT	HSCT	NNP
cord-005453-4057qib7	11749	13	.	.	.
cord-005453-4057qib7	11750	1	HLA	HLA	NNP
cord-005453-4057qib7	11750	2	typing	typing	NN
cord-005453-4057qib7	11750	3	was	be	VBD
cord-005453-4057qib7	11750	4	performed	perform	VBN
cord-005453-4057qib7	11750	5	by	by	IN
cord-005453-4057qib7	11750	6	real	real	JJ
cord-005453-4057qib7	11750	7	-	-	HYPH
cord-005453-4057qib7	11750	8	time	time	NN
cord-005453-4057qib7	11750	9	PCR	PCR	NNP
cord-005453-4057qib7	11750	10	using	use	VBG
cord-005453-4057qib7	11750	11	HLA	HLA	NNP
cord-005453-4057qib7	11750	12	-	-	HYPH
cord-005453-4057qib7	11750	13	KMR	KMR	NNP
cord-005453-4057qib7	11750	14	kit	kit	NN
cord-005453-4057qib7	11750	15	(	(	-LRB-
cord-005453-4057qib7	11750	16	GenDX	gendx	NN
cord-005453-4057qib7	11750	17	,	,	,
cord-005453-4057qib7	11750	18	Netherlands).Nine	Netherlands).Nine	NNP
cord-005453-4057qib7	11750	19	patients	patient	NNS
cord-005453-4057qib7	11750	20	were	be	VBD
cord-005453-4057qib7	11750	21	excluded	exclude	VBN
cord-005453-4057qib7	11750	22	from	from	IN
cord-005453-4057qib7	11750	23	the	the	DT
cord-005453-4057qib7	11750	24	analysis	analysis	NN
cord-005453-4057qib7	11750	25	because	because	IN
cord-005453-4057qib7	11750	26	the	the	DT
cord-005453-4057qib7	11750	27	kit	kit	NN
cord-005453-4057qib7	11750	28	employed	employ	VBN
cord-005453-4057qib7	11750	29	did	do	VBD
cord-005453-4057qib7	11750	30	not	not	RB
cord-005453-4057qib7	11750	31	include	include	VB
cord-005453-4057qib7	11750	32	the	the	DT
cord-005453-4057qib7	11750	33	recipientspecific	recipientspecific	NNP
cord-005453-4057qib7	11750	34	HLA	HLA	NNP
cord-005453-4057qib7	11750	35	.	.	.
cord-005453-4057qib7	11751	1	Thus	thus	RB
cord-005453-4057qib7	11751	2	,	,	,
cord-005453-4057qib7	11751	3	a	a	DT
cord-005453-4057qib7	11751	4	total	total	NN
cord-005453-4057qib7	11751	5	of	of	IN
cord-005453-4057qib7	11751	6	22	22	CD
cord-005453-4057qib7	11751	7	relapse	relapse	NN
cord-005453-4057qib7	11751	8	cases	case	NNS
cord-005453-4057qib7	11751	9	were	be	VBD
cord-005453-4057qib7	11751	10	analyzed	analyze	VBN
cord-005453-4057qib7	11751	11	.	.	.
cord-005453-4057qib7	11752	1	The	the	DT
cord-005453-4057qib7	11752	2	analysis	analysis	NN
cord-005453-4057qib7	11752	3	of	of	IN
cord-005453-4057qib7	11752	4	chimerism	chimerism	NN
cord-005453-4057qib7	11752	5	was	be	VBD
cord-005453-4057qib7	11752	6	carried	carry	VBN
cord-005453-4057qib7	11752	7	out	out	RP
cord-005453-4057qib7	11752	8	using	use	VBG
cord-005453-4057qib7	11752	9	short	short	JJ
cord-005453-4057qib7	11752	10	tandem	tandem	NN
cord-005453-4057qib7	11752	11	repeat	repeat	NN
cord-005453-4057qib7	11752	12	PCR	pcr	NN
cord-005453-4057qib7	11752	13	amplification	amplification	NN
cord-005453-4057qib7	11752	14	(	(	-LRB-
cord-005453-4057qib7	11752	15	AmpFlSTR	AmpFlSTR	NNP
cord-005453-4057qib7	11753	1	SGM	SGM	NNP
cord-005453-4057qib7	11753	2	Plus	Plus	NNP
cord-005453-4057qib7	11753	3	,	,	,
cord-005453-4057qib7	11753	4	Thermo	Thermo	NNP
cord-005453-4057qib7	11753	5	Fisher	Fisher	NNP
cord-005453-4057qib7	11753	6	,	,	,
cord-005453-4057qib7	11753	7	USA	USA	NNP
cord-005453-4057qib7	11753	8	)	)	-RRB-
cord-005453-4057qib7	11753	9	with	with	IN
cord-005453-4057qib7	11753	10	a	a	DT
cord-005453-4057qib7	11753	11	sensitivity	sensitivity	NN
cord-005453-4057qib7	11753	12	of	of	IN
cord-005453-4057qib7	11753	13	1	1	CD
cord-005453-4057qib7	11753	14	%	%	NN
cord-005453-4057qib7	11753	15	.	.	.
cord-005453-4057qib7	11754	1	Results	result	NNS
cord-005453-4057qib7	11754	2	:	:	:
cord-005453-4057qib7	11755	1	Genomic	genomic	JJ
cord-005453-4057qib7	11755	2	loss	loss	NN
cord-005453-4057qib7	11755	3	of	of	IN
cord-005453-4057qib7	11755	4	the	the	DT
cord-005453-4057qib7	11755	5	patient	patient	NN
cord-005453-4057qib7	11755	6	HLA	HLA	NNP
cord-005453-4057qib7	11755	7	occurred	occur	VBD
cord-005453-4057qib7	11755	8	in	in	IN
cord-005453-4057qib7	11755	9	6/	6/	CD
cord-005453-4057qib7	11755	10	22	22	CD
cord-005453-4057qib7	11755	11	patients	patient	NNS
cord-005453-4057qib7	11755	12	(	(	-LRB-
cord-005453-4057qib7	11755	13	27	27	CD
cord-005453-4057qib7	11755	14	%	%	NN
cord-005453-4057qib7	11755	15	)	)	-RRB-
cord-005453-4057qib7	11756	1	(	(	-LRB-
cord-005453-4057qib7	11756	2	Table	table	NN
cord-005453-4057qib7	11756	3	1	1	CD
cord-005453-4057qib7	11756	4	)	)	-RRB-
cord-005453-4057qib7	11756	5	.	.	.
cord-005453-4057qib7	11757	1	These	these	DT
cord-005453-4057qib7	11757	2	patients	patient	NNS
cord-005453-4057qib7	11757	3	presented	present	VBD
cord-005453-4057qib7	11757	4	different	different	JJ
cord-005453-4057qib7	11757	5	hematological	hematological	JJ
cord-005453-4057qib7	11757	6	neoplasms	neoplasm	NNS
cord-005453-4057qib7	11757	7	.	.	.
cord-005453-4057qib7	11758	1	Interestingly	interestingly	RB
cord-005453-4057qib7	11758	2	,	,	,
cord-005453-4057qib7	11758	3	4	4	CD
cord-005453-4057qib7	11758	4	patients	patient	NNS
cord-005453-4057qib7	11758	5	presented	present	VBN
cord-005453-4057qib7	11758	6	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11758	7	neoplasm	neoplasm	NN
cord-005453-4057qib7	11758	8	(	(	-LRB-
cord-005453-4057qib7	11758	9	1	1	CD
cord-005453-4057qib7	11758	10	acute	acute	JJ
cord-005453-4057qib7	11758	11	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	11758	12	leukemia	leukemia	NN
cord-005453-4057qib7	11758	13	(	(	-LRB-
cord-005453-4057qib7	11758	14	ALL	ALL	NNP
cord-005453-4057qib7	11758	15	-	-	HYPH
cord-005453-4057qib7	11758	16	T	T	NNP
cord-005453-4057qib7	11758	17	)	)	-RRB-
cord-005453-4057qib7	11758	18	,	,	,
cord-005453-4057qib7	11758	19	1	1	CD
cord-005453-4057qib7	11758	20	dentritic	dentritic	JJ
cord-005453-4057qib7	11758	21	cell	cell	NN
cord-005453-4057qib7	11758	22	leukemia	leukemia	NN
cord-005453-4057qib7	11758	23	(	(	-LRB-
cord-005453-4057qib7	11758	24	DCL	DCL	NNP
cord-005453-4057qib7	11758	25	)	)	-RRB-
cord-005453-4057qib7	11758	26	and	and	CC
cord-005453-4057qib7	11758	27	2	2	CD
cord-005453-4057qib7	11758	28	hodking´s	hodking´s	CD
cord-005453-4057qib7	11758	29	lymphoma	lymphoma	NN
cord-005453-4057qib7	11758	30	(	(	-LRB-
cord-005453-4057qib7	11758	31	HL	HL	NNP
cord-005453-4057qib7	11758	32	)	)	-RRB-
cord-005453-4057qib7	11758	33	)	)	-RRB-
cord-005453-4057qib7	11758	34	.	.	.
cord-005453-4057qib7	11759	1	HLA	HLA	NNP
cord-005453-4057qib7	11759	2	loss	loss	NN
cord-005453-4057qib7	11759	3	relapses	relapse	NNS
cord-005453-4057qib7	11759	4	occurred	occur	VBD
cord-005453-4057qib7	11759	5	later	later	RB
cord-005453-4057qib7	11759	6	than	than	IN
cord-005453-4057qib7	11759	7	classical	classical	JJ
cord-005453-4057qib7	11759	8	relapses	relapse	NNS
cord-005453-4057qib7	11759	9	(	(	-LRB-
cord-005453-4057qib7	11759	10	370	370	CD
cord-005453-4057qib7	11759	11	vs.166	vs.166	NNP
cord-005453-4057qib7	11759	12	days	day	NNS
cord-005453-4057qib7	11759	13	)	)	-RRB-
cord-005453-4057qib7	11759	14	.	.	.
cord-005453-4057qib7	11760	1	Regarding	regard	VBG
cord-005453-4057qib7	11760	2	the	the	DT
cord-005453-4057qib7	11760	3	treatment	treatment	NN
cord-005453-4057qib7	11760	4	received	receive	VBN
cord-005453-4057qib7	11760	5	(	(	-LRB-
cord-005453-4057qib7	11760	6	Table	table	NN
cord-005453-4057qib7	11760	7	1	1	CD
cord-005453-4057qib7	11760	8	)	)	-RRB-
cord-005453-4057qib7	11760	9	,	,	,
cord-005453-4057qib7	11760	10	four	four	CD
cord-005453-4057qib7	11760	11	patients	patient	NNS
cord-005453-4057qib7	11760	12	were	be	VBD
cord-005453-4057qib7	11760	13	studied	study	VBN
cord-005453-4057qib7	11760	14	retrospectively	retrospectively	RB
cord-005453-4057qib7	11760	15	.	.	.
cord-005453-4057qib7	11761	1	Three	three	CD
cord-005453-4057qib7	11761	2	of	of	IN
cord-005453-4057qib7	11761	3	them	-PRON-	PRP
cord-005453-4057qib7	11761	4	were	be	VBD
cord-005453-4057qib7	11761	5	treated	treat	VBN
cord-005453-4057qib7	11761	6	with	with	IN
cord-005453-4057qib7	11761	7	donor	donor	NN
cord-005453-4057qib7	11761	8	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11761	9	infusions	infusion	NNS
cord-005453-4057qib7	11761	10	(	(	-LRB-
cord-005453-4057qib7	11761	11	DLIs	DLIs	NNP
cord-005453-4057qib7	11761	12	)	)	-RRB-
cord-005453-4057qib7	11761	13	+	+	CC
cord-005453-4057qib7	11761	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11761	15	or	or	CC
cord-005453-4057qib7	11761	16	other	other	JJ
cord-005453-4057qib7	11761	17	drugs	drug	NNS
cord-005453-4057qib7	11761	18	at	at	IN
cord-005453-4057qib7	11761	19	the	the	DT
cord-005453-4057qib7	11761	20	time	time	NN
cord-005453-4057qib7	11761	21	of	of	IN
cord-005453-4057qib7	11761	22	the	the	DT
cord-005453-4057qib7	11761	23	relapse	relapse	NN
cord-005453-4057qib7	11761	24	.	.	.
cord-005453-4057qib7	11762	1	The	the	DT
cord-005453-4057qib7	11762	2	other	other	JJ
cord-005453-4057qib7	11762	3	patient	patient	NN
cord-005453-4057qib7	11762	4	did	do	VBD
cord-005453-4057qib7	11762	5	not	not	RB
cord-005453-4057qib7	11762	6	receive	receive	VB
cord-005453-4057qib7	11762	7	any	any	DT
cord-005453-4057qib7	11762	8	treatment	treatment	NN
cord-005453-4057qib7	11762	9	.	.	.
cord-005453-4057qib7	11763	1	In	in	IN
cord-005453-4057qib7	11763	2	the	the	DT
cord-005453-4057qib7	11763	3	end	end	NN
cord-005453-4057qib7	11763	4	,	,	,
cord-005453-4057qib7	11763	5	all	all	DT
cord-005453-4057qib7	11763	6	4	4	CD
cord-005453-4057qib7	11763	7	patients	patient	NNS
cord-005453-4057qib7	11763	8	died	die	VBD
cord-005453-4057qib7	11763	9	from	from	IN
cord-005453-4057qib7	11763	10	disease	disease	NN
cord-005453-4057qib7	11763	11	progression	progression	NN
cord-005453-4057qib7	11763	12	.	.	.
cord-005453-4057qib7	11764	1	Prospectively	prospectively	RB
cord-005453-4057qib7	11764	2	,	,	,
cord-005453-4057qib7	11764	3	we	-PRON-	PRP
cord-005453-4057qib7	11764	4	detected	detect	VBD
cord-005453-4057qib7	11764	5	HLA	HLA	NNP
cord-005453-4057qib7	11764	6	loss	loss	NN
cord-005453-4057qib7	11764	7	at	at	IN
cord-005453-4057qib7	11764	8	relapse	relapse	NN
cord-005453-4057qib7	11764	9	in	in	IN
cord-005453-4057qib7	11764	10	other	other	JJ
cord-005453-4057qib7	11764	11	two	two	CD
cord-005453-4057qib7	11764	12	patients	patient	NNS
cord-005453-4057qib7	11764	13	.	.	.
cord-005453-4057qib7	11765	1	At	at	IN
cord-005453-4057qib7	11765	2	the	the	DT
cord-005453-4057qib7	11765	3	moment	moment	NN
cord-005453-4057qib7	11765	4	of	of	IN
cord-005453-4057qib7	11765	5	relapse	relapse	NN
cord-005453-4057qib7	11765	6	,	,	,
cord-005453-4057qib7	11765	7	the	the	DT
cord-005453-4057qib7	11765	8	first	first	JJ
cord-005453-4057qib7	11765	9	case	case	NN
cord-005453-4057qib7	11765	10	received	receive	VBD
cord-005453-4057qib7	11765	11	brentuximab	brentuximab	NNS
cord-005453-4057qib7	11765	12	+	+	CC
cord-005453-4057qib7	11765	13	Haplo	Haplo	NNP
cord-005453-4057qib7	11765	14	-	-	HYPH
cord-005453-4057qib7	11765	15	HSCT	HSCT	NNP
cord-005453-4057qib7	11765	16	from	from	IN
cord-005453-4057qib7	11765	17	alternative	alternative	JJ
cord-005453-4057qib7	11765	18	donor	donor	NN
cord-005453-4057qib7	11765	19	and	and	CC
cord-005453-4057qib7	11765	20	the	the	DT
cord-005453-4057qib7	11765	21	other	other	JJ
cord-005453-4057qib7	11765	22	case	case	NN
cord-005453-4057qib7	11765	23	received	receive	VBD
cord-005453-4057qib7	11765	24	daratumumab	daratumumab	NNP
cord-005453-4057qib7	11765	25	+	+	CC
cord-005453-4057qib7	11765	26	Haplo	Haplo	NNP
cord-005453-4057qib7	11765	27	-	-	HYPH
cord-005453-4057qib7	11765	28	HSCT	HSCT	NNP
cord-005453-4057qib7	11765	29	(	(	-LRB-
cord-005453-4057qib7	11765	30	pending	pende	VBG
cord-005453-4057qib7	11765	31	)	)	-RRB-
cord-005453-4057qib7	11765	32	.	.	.
cord-005453-4057qib7	11766	1	Both	both	DT
cord-005453-4057qib7	11766	2	patients	patient	NNS
cord-005453-4057qib7	11766	3	are	be	VBP
cord-005453-4057qib7	11766	4	alive	alive	JJ
cord-005453-4057qib7	11766	5	,	,	,
cord-005453-4057qib7	11766	6	the	the	DT
cord-005453-4057qib7	11766	7	first	first	JJ
cord-005453-4057qib7	11766	8	one	one	CD
cord-005453-4057qib7	11766	9	in	in	IN
cord-005453-4057qib7	11766	10	complete	complete	JJ
cord-005453-4057qib7	11766	11	remission	remission	NN
cord-005453-4057qib7	11766	12	(	(	-LRB-
cord-005453-4057qib7	11766	13	CR	CR	NNP
cord-005453-4057qib7	11766	14	)	)	-RRB-
cord-005453-4057qib7	11766	15	and	and	CC
cord-005453-4057qib7	11766	16	the	the	DT
cord-005453-4057qib7	11766	17	second	second	JJ
cord-005453-4057qib7	11766	18	one	one	CD
cord-005453-4057qib7	11766	19	in	in	IN
cord-005453-4057qib7	11766	20	partial	partial	JJ
cord-005453-4057qib7	11766	21	remission	remission	NN
cord-005453-4057qib7	11766	22	(	(	-LRB-
cord-005453-4057qib7	11766	23	PR	PR	NNP
cord-005453-4057qib7	11766	24	)	)	-RRB-
cord-005453-4057qib7	11766	25	.	.	.
cord-005453-4057qib7	11767	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11767	2	:	:	:
cord-005453-4057qib7	11768	1	The	the	DT
cord-005453-4057qib7	11768	2	frequency	frequency	NN
cord-005453-4057qib7	11768	3	of	of	IN
cord-005453-4057qib7	11768	4	HLA	HLA	NNP
cord-005453-4057qib7	11768	5	loss	loss	NN
cord-005453-4057qib7	11768	6	at	at	IN
cord-005453-4057qib7	11768	7	relapse	relapse	NN
cord-005453-4057qib7	11768	8	is	be	VBZ
cord-005453-4057qib7	11768	9	similar	similar	JJ
cord-005453-4057qib7	11768	10	in	in	IN
cord-005453-4057qib7	11768	11	our	-PRON-	PRP$
cord-005453-4057qib7	11768	12	cohort	cohort	NN
cord-005453-4057qib7	11768	13	to	to	IN
cord-005453-4057qib7	11768	14	what	what	WP
cord-005453-4057qib7	11768	15	is	be	VBZ
cord-005453-4057qib7	11768	16	described	describe	VBN
cord-005453-4057qib7	11768	17	in	in	IN
cord-005453-4057qib7	11768	18	the	the	DT
cord-005453-4057qib7	11768	19	literature	literature	NN
cord-005453-4057qib7	11768	20	.	.	.
cord-005453-4057qib7	11769	1	HLA	HLA	NNP
cord-005453-4057qib7	11769	2	loss	loss	NN
cord-005453-4057qib7	11769	3	has	have	VBZ
cord-005453-4057qib7	11769	4	been	be	VBN
cord-005453-4057qib7	11769	5	identified	identify	VBN
cord-005453-4057qib7	11769	6	in	in	IN
cord-005453-4057qib7	11769	7	patients	patient	NNS
cord-005453-4057qib7	11769	8	with	with	IN
cord-005453-4057qib7	11769	9	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11769	10	neoplasms	neoplasm	NNS
cord-005453-4057qib7	11769	11	,	,	,
cord-005453-4057qib7	11769	12	while	while	IN
cord-005453-4057qib7	11769	13	this	this	DT
cord-005453-4057qib7	11769	14	mechanism	mechanism	NN
cord-005453-4057qib7	11769	15	has	have	VBZ
cord-005453-4057qib7	11769	16	not	not	RB
cord-005453-4057qib7	11769	17	been	be	VBN
cord-005453-4057qib7	11769	18	previously	previously	RB
cord-005453-4057qib7	11769	19	described	describe	VBN
cord-005453-4057qib7	11769	20	in	in	IN
cord-005453-4057qib7	11769	21	such	such	JJ
cord-005453-4057qib7	11769	22	diseases	disease	NNS
cord-005453-4057qib7	11769	23	.	.	.
cord-005453-4057qib7	11770	1	The	the	DT
cord-005453-4057qib7	11770	2	analysis	analysis	NN
cord-005453-4057qib7	11770	3	of	of	IN
cord-005453-4057qib7	11770	4	this	this	DT
cord-005453-4057qib7	11770	5	immune	immune	JJ
cord-005453-4057qib7	11770	6	evasion	evasion	NN
cord-005453-4057qib7	11770	7	mechanism	mechanism	NN
cord-005453-4057qib7	11770	8	should	should	MD
cord-005453-4057qib7	11770	9	be	be	VB
cord-005453-4057qib7	11770	10	implemented	implement	VBN
cord-005453-4057qib7	11770	11	in	in	IN
cord-005453-4057qib7	11770	12	the	the	DT
cord-005453-4057qib7	11770	13	routine	routine	JJ
cord-005453-4057qib7	11770	14	screening	screening	NN
cord-005453-4057qib7	11770	15	of	of	IN
cord-005453-4057qib7	11770	16	patients	patient	NNS
cord-005453-4057qib7	11770	17	transplanted	transplant	VBN
cord-005453-4057qib7	11770	18	from	from	IN
cord-005453-4057qib7	11770	19	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11770	20	donors	donor	NNS
cord-005453-4057qib7	11770	21	in	in	IN
cord-005453-4057qib7	11770	22	order	order	NN
cord-005453-4057qib7	11770	23	to	to	TO
cord-005453-4057qib7	11770	24	design	design	VB
cord-005453-4057qib7	11770	25	effective	effective	JJ
cord-005453-4057qib7	11770	26	rescue	rescue	NN
cord-005453-4057qib7	11770	27	strategies	strategy	NNS
cord-005453-4057qib7	11770	28	.	.	.
cord-005453-4057qib7	11771	1	These	these	DT
cord-005453-4057qib7	11771	2	treatments	treatment	NNS
cord-005453-4057qib7	11771	3	should	should	MD
cord-005453-4057qib7	11771	4	not	not	RB
cord-005453-4057qib7	11771	5	be	be	VB
cord-005453-4057qib7	11771	6	based	base	VBN
cord-005453-4057qib7	11771	7	on	on	IN
cord-005453-4057qib7	11771	8	DLIs	dli	NNS
cord-005453-4057qib7	11771	9	or	or	CC
cord-005453-4057qib7	11771	10	second	second	JJ
cord-005453-4057qib7	11771	11	transplantation	transplantation	NN
cord-005453-4057qib7	11771	12	with	with	IN
cord-005453-4057qib7	11771	13	the	the	DT
cord-005453-4057qib7	11771	14	same	same	JJ
cord-005453-4057qib7	11771	15	donor	donor	NN
cord-005453-4057qib7	11771	16	,	,	,
cord-005453-4057qib7	11771	17	instead	instead	RB
cord-005453-4057qib7	11771	18	,	,	,
cord-005453-4057qib7	11771	19	alternative	alternative	JJ
cord-005453-4057qib7	11771	20	donors	donor	NNS
cord-005453-4057qib7	11771	21	should	should	MD
cord-005453-4057qib7	11771	22	be	be	VB
cord-005453-4057qib7	11771	23	used	use	VBN
cord-005453-4057qib7	11771	24	.	.	.
cord-005453-4057qib7	11772	1	Background	background	NN
cord-005453-4057qib7	11772	2	:	:	:
cord-005453-4057qib7	11773	1	An	an	DT
cord-005453-4057qib7	11773	2	adequate	adequate	JJ
cord-005453-4057qib7	11773	3	immune	immune	JJ
cord-005453-4057qib7	11773	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	11773	5	(	(	-LRB-
cord-005453-4057qib7	11773	6	IR	IR	NNP
cord-005453-4057qib7	11773	7	)	)	-RRB-
cord-005453-4057qib7	11773	8	is	be	VBZ
cord-005453-4057qib7	11773	9	crucial	crucial	JJ
cord-005453-4057qib7	11773	10	to	to	TO
cord-005453-4057qib7	11773	11	reduce	reduce	VB
cord-005453-4057qib7	11773	12	transplant	transplant	NN
cord-005453-4057qib7	11773	13	toxicity	toxicity	NN
cord-005453-4057qib7	11773	14	,	,	,
cord-005453-4057qib7	11773	15	relapse	relapse	NN
cord-005453-4057qib7	11773	16	rate	rate	NN
cord-005453-4057qib7	11773	17	and	and	CC
cord-005453-4057qib7	11773	18	mortality	mortality	NN
cord-005453-4057qib7	11773	19	after	after	IN
cord-005453-4057qib7	11773	20	allogeneic	allogeneic	NN
cord-005453-4057qib7	11773	21	stem	stem	NN
cord-005453-4057qib7	11773	22	cell	cell	NN
cord-005453-4057qib7	11773	23	transplantation	transplantation	NN
cord-005453-4057qib7	11773	24	(	(	-LRB-
cord-005453-4057qib7	11773	25	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11773	26	)	)	-RRB-
cord-005453-4057qib7	11773	27	.	.	.
cord-005453-4057qib7	11774	1	The	the	DT
cord-005453-4057qib7	11774	2	aim	aim	NN
cord-005453-4057qib7	11774	3	of	of	IN
cord-005453-4057qib7	11774	4	this	this	DT
cord-005453-4057qib7	11774	5	,	,	,
cord-005453-4057qib7	11774	6	single	single	JJ
cord-005453-4057qib7	11774	7	center	center	NN
cord-005453-4057qib7	11774	8	retrospective	retrospective	JJ
cord-005453-4057qib7	11774	9	study	study	NN
cord-005453-4057qib7	11774	10	was	be	VBD
cord-005453-4057qib7	11774	11	to	to	TO
cord-005453-4057qib7	11774	12	investigate	investigate	VB
cord-005453-4057qib7	11774	13	the	the	DT
cord-005453-4057qib7	11774	14	correlation	correlation	NN
cord-005453-4057qib7	11774	15	between	between	IN
cord-005453-4057qib7	11774	16	the	the	DT
cord-005453-4057qib7	11774	17	recovery	recovery	NN
cord-005453-4057qib7	11774	18	of	of	IN
cord-005453-4057qib7	11774	19	different	different	JJ
cord-005453-4057qib7	11774	20	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11774	21	subpopulations	subpopulation	NNS
cord-005453-4057qib7	11774	22	with	with	IN
cord-005453-4057qib7	11774	23	the	the	DT
cord-005453-4057qib7	11774	24	main	main	JJ
cord-005453-4057qib7	11774	25	transplant	transplant	NN
cord-005453-4057qib7	11774	26	outcomes	outcome	NNS
cord-005453-4057qib7	11774	27	,	,	,
cord-005453-4057qib7	11774	28	including	include	VBG
cord-005453-4057qib7	11774	29	overall	overall	JJ
cord-005453-4057qib7	11774	30	survival	survival	NN
cord-005453-4057qib7	11774	31	(	(	-LRB-
cord-005453-4057qib7	11774	32	OS	OS	NNP
cord-005453-4057qib7	11774	33	)	)	-RRB-
cord-005453-4057qib7	11774	34	,	,	,
cord-005453-4057qib7	11774	35	disease	disease	NNP
cord-005453-4057qib7	11774	36	free	free	JJ
cord-005453-4057qib7	11774	37	survival	survival	NN
cord-005453-4057qib7	11774	38	(	(	-LRB-
cord-005453-4057qib7	11774	39	DFS	DFS	NNP
cord-005453-4057qib7	11774	40	)	)	-RRB-
cord-005453-4057qib7	11774	41	and	and	CC
cord-005453-4057qib7	11774	42	non	non	JJ
cord-005453-4057qib7	11774	43	-	-	JJ
cord-005453-4057qib7	11774	44	relapse	relapse	JJ
cord-005453-4057qib7	11774	45	mortality	mortality	NN
cord-005453-4057qib7	11774	46	(	(	-LRB-
cord-005453-4057qib7	11774	47	NRM	NRM	NNP
cord-005453-4057qib7	11774	48	)	)	-RRB-
cord-005453-4057qib7	11774	49	.	.	.
cord-005453-4057qib7	11775	1	Methods	method	NNS
cord-005453-4057qib7	11775	2	:	:	:
cord-005453-4057qib7	11775	3	We	-PRON-	PRP
cord-005453-4057qib7	11775	4	analyzed	analyze	VBD
cord-005453-4057qib7	11775	5	the	the	DT
cord-005453-4057qib7	11775	6	IR	IR	NNP
cord-005453-4057qib7	11775	7	of	of	IN
cord-005453-4057qib7	11775	8	177	177	CD
cord-005453-4057qib7	11775	9	adult	adult	NN
cord-005453-4057qib7	11775	10	patients	patient	NNS
cord-005453-4057qib7	11775	11	(	(	-LRB-
cord-005453-4057qib7	11775	12	AML	AML	NNP
cord-005453-4057qib7	11775	13	n=62	n=62	NN
cord-005453-4057qib7	11775	14	,	,	,
cord-005453-4057qib7	11775	15	ALL	all	DT
cord-005453-4057qib7	11775	16	n=41	n=41	NN
cord-005453-4057qib7	11775	17	,	,	,
cord-005453-4057qib7	11775	18	MDS	MDS	NNP
cord-005453-4057qib7	11775	19	n=	n=	NNP
cord-005453-4057qib7	11775	20	24	24	CD
cord-005453-4057qib7	11775	21	,	,	,
cord-005453-4057qib7	11775	22	NHL	NHL	NNP
cord-005453-4057qib7	11775	23	n=9	n=9	NN
cord-005453-4057qib7	11775	24	,	,	,
cord-005453-4057qib7	11775	25	HD	HD	NNP
cord-005453-4057qib7	11775	26	n=2	n=2	NNS
cord-005453-4057qib7	11775	27	,	,	,
cord-005453-4057qib7	11775	28	CLL	CLL	NNP
cord-005453-4057qib7	11775	29	n=4	n=4	NNS
cord-005453-4057qib7	11775	30	,	,	,
cord-005453-4057qib7	11775	31	CML	CML	NNP
cord-005453-4057qib7	11775	32	n=7	n=7	NNS
cord-005453-4057qib7	11775	33	,	,	,
cord-005453-4057qib7	11775	34	MM	MM	NNP
cord-005453-4057qib7	11775	35	,	,	,
cord-005453-4057qib7	11775	36	n=11	n=11	NNP
cord-005453-4057qib7	11775	37	,	,	,
cord-005453-4057qib7	11775	38	MPN	MPN	NNP
cord-005453-4057qib7	11775	39	n=10	n=10	NNP
cord-005453-4057qib7	11775	40	)	)	-RRB-
cord-005453-4057qib7	11775	41	who	who	WP
cord-005453-4057qib7	11775	42	underwent	undergo	VBD
cord-005453-4057qib7	11775	43	(	(	-LRB-
cord-005453-4057qib7	11775	44	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11775	45	)	)	-RRB-
cord-005453-4057qib7	11775	46	between	between	IN
cord-005453-4057qib7	11775	47	January	January	NNP
cord-005453-4057qib7	11775	48	2013	2013	CD
cord-005453-4057qib7	11775	49	and	and	CC
cord-005453-4057qib7	11775	50	March	March	NNP
cord-005453-4057qib7	11775	51	2017	2017	CD
cord-005453-4057qib7	11775	52	.	.	.
cord-005453-4057qib7	11776	1	Median	median	JJ
cord-005453-4057qib7	11776	2	age	age	NN
cord-005453-4057qib7	11776	3	at	at	IN
cord-005453-4057qib7	11776	4	transplant	transplant	NN
cord-005453-4057qib7	11776	5	was	be	VBD
cord-005453-4057qib7	11776	6	52	52	CD
cord-005453-4057qib7	11776	7	years	year	NNS
cord-005453-4057qib7	11777	1	(	(	-LRB-
cord-005453-4057qib7	11777	2	range	range	NNP
cord-005453-4057qib7	11777	3	17	17	CD
cord-005453-4057qib7	11777	4	.	.	.
cord-005453-4057qib7	11778	1	3	3	LS
cord-005453-4057qib7	11778	2	-	-	SYM
cord-005453-4057qib7	11778	3	71.3	71.3	CD
cord-005453-4057qib7	11778	4	)	)	-RRB-
cord-005453-4057qib7	11778	5	with	with	IN
cord-005453-4057qib7	11778	6	male	male	JJ
cord-005453-4057qib7	11778	7	/	/	SYM
cord-005453-4057qib7	11778	8	female	female	JJ
cord-005453-4057qib7	11778	9	ratio	ratio	NN
cord-005453-4057qib7	11778	10	of	of	IN
cord-005453-4057qib7	11778	11	62	62	CD
cord-005453-4057qib7	11778	12	%	%	NN
cord-005453-4057qib7	11778	13	.	.	.
cord-005453-4057qib7	11779	1	Donors	donor	NNS
cord-005453-4057qib7	11779	2	were	be	VBD
cord-005453-4057qib7	11779	3	HLAidentical	hlaidentical	JJ
cord-005453-4057qib7	11779	4	siblings	sibling	NNS
cord-005453-4057qib7	11779	5	(	(	-LRB-
cord-005453-4057qib7	11779	6	n=39	n=39	NNP
cord-005453-4057qib7	11779	7	,	,	,
cord-005453-4057qib7	11779	8	22	22	CD
cord-005453-4057qib7	11779	9	%	%	NN
cord-005453-4057qib7	11779	10	)	)	-RRB-
cord-005453-4057qib7	11779	11	,	,	,
cord-005453-4057qib7	11779	12	family	family	NN
cord-005453-4057qib7	11779	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11779	14	(	(	-LRB-
cord-005453-4057qib7	11779	15	n=11	n=11	NNP
cord-005453-4057qib7	11779	16	,	,	,
cord-005453-4057qib7	11779	17	6	6	CD
cord-005453-4057qib7	11779	18	%	%	NN
cord-005453-4057qib7	11779	19	)	)	-RRB-
cord-005453-4057qib7	11779	20	,	,	,
cord-005453-4057qib7	11779	21	matched	match	VBN
cord-005453-4057qib7	11779	22	unrelated	unrelated	JJ
cord-005453-4057qib7	11779	23	(	(	-LRB-
cord-005453-4057qib7	11779	24	109	109	CD
cord-005453-4057qib7	11779	25	,	,	,
cord-005453-4057qib7	11779	26	62	62	CD
cord-005453-4057qib7	11779	27	%	%	NN
cord-005453-4057qib7	11779	28	)	)	-RRB-
cord-005453-4057qib7	11779	29	,	,	,
cord-005453-4057qib7	11779	30	mismatched	mismatch	VBN
cord-005453-4057qib7	11779	31	unrelated	unrelated	JJ
cord-005453-4057qib7	11779	32	(	(	-LRB-
cord-005453-4057qib7	11779	33	n=11	n=11	FW
cord-005453-4057qib7	11779	34	,	,	,
cord-005453-4057qib7	11779	35	6	6	CD
cord-005453-4057qib7	11779	36	%	%	NN
cord-005453-4057qib7	11779	37	)	)	-RRB-
cord-005453-4057qib7	11779	38	and	and	CC
cord-005453-4057qib7	11779	39	cord	cord	NN
cord-005453-4057qib7	11779	40	blood	blood	NN
cord-005453-4057qib7	11779	41	units	unit	NNS
cord-005453-4057qib7	11779	42	(	(	-LRB-
cord-005453-4057qib7	11779	43	n=7	n=7	NNS
cord-005453-4057qib7	11779	44	,	,	,
cord-005453-4057qib7	11779	45	4	4	CD
cord-005453-4057qib7	11779	46	%	%	NN
cord-005453-4057qib7	11779	47	)	)	-RRB-
cord-005453-4057qib7	11779	48	.	.	.
cord-005453-4057qib7	11780	1	The	the	DT
cord-005453-4057qib7	11780	2	stem	stem	NN
cord-005453-4057qib7	11780	3	cell	cell	NN
cord-005453-4057qib7	11780	4	source	source	NN
cord-005453-4057qib7	11780	5	was	be	VBD
cord-005453-4057qib7	11780	6	the	the	DT
cord-005453-4057qib7	11780	7	bone	bone	NN
cord-005453-4057qib7	11780	8	marrow	marrow	NN
cord-005453-4057qib7	11780	9	(	(	-LRB-
cord-005453-4057qib7	11780	10	BM	BM	NNP
cord-005453-4057qib7	11780	11	)	)	-RRB-
cord-005453-4057qib7	11780	12	in	in	IN
cord-005453-4057qib7	11780	13	30	30	CD
cord-005453-4057qib7	11780	14	patients	patient	NNS
cord-005453-4057qib7	11780	15	(	(	-LRB-
cord-005453-4057qib7	11780	16	17	17	CD
cord-005453-4057qib7	11780	17	%	%	NN
cord-005453-4057qib7	11780	18	)	)	-RRB-
cord-005453-4057qib7	11780	19	,	,	,
cord-005453-4057qib7	11780	20	the	the	DT
cord-005453-4057qib7	11780	21	cord	cord	NN
cord-005453-4057qib7	11780	22	blood	blood	NN
cord-005453-4057qib7	11780	23	in	in	IN
cord-005453-4057qib7	11780	24	7	7	CD
cord-005453-4057qib7	11780	25	(	(	-LRB-
cord-005453-4057qib7	11780	26	4	4	CD
cord-005453-4057qib7	11780	27	%	%	NN
cord-005453-4057qib7	11780	28	)	)	-RRB-
cord-005453-4057qib7	11780	29	and	and	CC
cord-005453-4057qib7	11780	30	G	G	NNP
cord-005453-4057qib7	11780	31	-	-	HYPH
cord-005453-4057qib7	11780	32	CSF	CSF	NNP
cord-005453-4057qib7	11780	33	mobilized	mobilize	VBD
cord-005453-4057qib7	11780	34	peripheral	peripheral	JJ
cord-005453-4057qib7	11780	35	blood	blood	NN
cord-005453-4057qib7	11780	36	in	in	IN
cord-005453-4057qib7	11780	37	140	140	CD
cord-005453-4057qib7	11780	38	(	(	-LRB-
cord-005453-4057qib7	11780	39	79	79	CD
cord-005453-4057qib7	11780	40	%	%	NN
cord-005453-4057qib7	11780	41	)	)	-RRB-
cord-005453-4057qib7	11780	42	.	.	.
cord-005453-4057qib7	11781	1	The	the	DT
cord-005453-4057qib7	11781	2	conditioning	conditioning	NN
cord-005453-4057qib7	11781	3	regimen	regimen	NN
cord-005453-4057qib7	11781	4	was	be	VBD
cord-005453-4057qib7	11781	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	11781	6	in	in	IN
cord-005453-4057qib7	11781	7	99(56	99(56	CD
cord-005453-4057qib7	11781	8	%	%	NN
cord-005453-4057qib7	11781	9	)	)	-RRB-
cord-005453-4057qib7	11781	10	transplant	transplant	NN
cord-005453-4057qib7	11781	11	,	,	,
cord-005453-4057qib7	11781	12	reduced	reduced	JJ
cord-005453-4057qib7	11781	13	intensity	intensity	NN
cord-005453-4057qib7	11781	14	in	in	IN
cord-005453-4057qib7	11781	15	75	75	CD
cord-005453-4057qib7	11781	16	(	(	-LRB-
cord-005453-4057qib7	11781	17	42	42	CD
cord-005453-4057qib7	11781	18	%	%	NN
cord-005453-4057qib7	11781	19	)	)	-RRB-
cord-005453-4057qib7	11781	20	and	and	CC
cord-005453-4057qib7	11781	21	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	11781	22	in	in	IN
cord-005453-4057qib7	11781	23	3	3	CD
cord-005453-4057qib7	11781	24	(	(	-LRB-
cord-005453-4057qib7	11781	25	2	2	CD
cord-005453-4057qib7	11781	26	%	%	NN
cord-005453-4057qib7	11781	27	)	)	-RRB-
cord-005453-4057qib7	11781	28	.	.	.
cord-005453-4057qib7	11782	1	GVHD	GVHD	NNP
cord-005453-4057qib7	11782	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11782	3	was	be	VBD
cord-005453-4057qib7	11782	4	based	base	VBN
cord-005453-4057qib7	11782	5	on	on	IN
cord-005453-4057qib7	11782	6	calcineurin	calcineurin	NNP
cord-005453-4057qib7	11782	7	inhibitors	inhibitor	NNS
cord-005453-4057qib7	11782	8	in	in	IN
cord-005453-4057qib7	11782	9	combination	combination	NN
cord-005453-4057qib7	11782	10	with	with	IN
cord-005453-4057qib7	11782	11	Methotrexate	Methotrexate	NNP
cord-005453-4057qib7	11782	12	or	or	CC
cord-005453-4057qib7	11782	13	Mofetil	Mofetil	NNP
cord-005453-4057qib7	11782	14	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	11782	15	.	.	.
cord-005453-4057qib7	11783	1	Antilymphocytes	Antilymphocytes	NNPS
cord-005453-4057qib7	11783	2	Immunoglobulins	Immunoglobulins	NNP
cord-005453-4057qib7	11783	3	was	be	VBD
cord-005453-4057qib7	11783	4	used	use	VBN
cord-005453-4057qib7	11783	5	in	in	IN
cord-005453-4057qib7	11783	6	145	145	CD
cord-005453-4057qib7	11783	7	patients	patient	NNS
cord-005453-4057qib7	11783	8	(	(	-LRB-
cord-005453-4057qib7	11783	9	81	81	CD
cord-005453-4057qib7	11783	10	%	%	NN
cord-005453-4057qib7	11783	11	)	)	-RRB-
cord-005453-4057qib7	11783	12	(	(	-LRB-
cord-005453-4057qib7	11783	13	Anti	Anti	NNP
cord-005453-4057qib7	11783	14	Thymocytes	Thymocytes	NNP
cord-005453-4057qib7	11783	15	Globulin	Globulin	NNP
cord-005453-4057qib7	11783	16	,	,	,
cord-005453-4057qib7	11783	17	ATG	ATG	NNP
cord-005453-4057qib7	11783	18	Sanofi	Sanofi	NNP
cord-005453-4057qib7	11783	19	-	-	HYPH
cord-005453-4057qib7	11783	20	Genzyme	Genzyme	NNP
cord-005453-4057qib7	11783	21	in	in	IN
cord-005453-4057qib7	11783	22	114	114	CD
cord-005453-4057qib7	11783	23	or	or	CC
cord-005453-4057qib7	11783	24	Anti	Anti	NNP
cord-005453-4057qib7	11783	25	T	T	NNP
cord-005453-4057qib7	11783	26	-	-	HYPH
cord-005453-4057qib7	11783	27	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11783	28	globulin	globulin	NN
cord-005453-4057qib7	11783	29	,	,	,
cord-005453-4057qib7	11783	30	ATLG	ATLG	NNP
cord-005453-4057qib7	11783	31	-Neovii	-neovii	VBP
cord-005453-4057qib7	11783	32	Biotech	Biotech	NNP
cord-005453-4057qib7	11783	33	,	,	,
cord-005453-4057qib7	11783	34	in	in	IN
cord-005453-4057qib7	11783	35	31	31	CD
cord-005453-4057qib7	11783	36	)	)	-RRB-
cord-005453-4057qib7	11783	37	.	.	.
cord-005453-4057qib7	11784	1	The	the	DT
cord-005453-4057qib7	11784	2	peripheral	peripheral	JJ
cord-005453-4057qib7	11784	3	blood	blood	NN
cord-005453-4057qib7	11784	4	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11784	5	subsets	subset	NNS
cord-005453-4057qib7	11784	6	(	(	-LRB-
cord-005453-4057qib7	11784	7	CD3	CD3	NNP
cord-005453-4057qib7	11784	8	+	+	CC
cord-005453-4057qib7	11784	9	,	,	,
cord-005453-4057qib7	11784	10	CD3+CD4	cd3+cd4	CD
cord-005453-4057qib7	11784	11	+	+	CC
cord-005453-4057qib7	11784	12	,	,	,
cord-005453-4057qib7	11784	13	CD3+CD8	CD3+CD8	NNP
cord-005453-4057qib7	11784	14	+	+	SYM
cord-005453-4057qib7	11784	15	,	,	,
cord-005453-4057qib7	11784	16	CD19	CD19	NNP
cord-005453-4057qib7	11784	17	+	+	CC
cord-005453-4057qib7	11784	18	(	(	-LRB-
cord-005453-4057qib7	11784	19	B	b	NN
cord-005453-4057qib7	11784	20	cells	cell	NNS
cord-005453-4057qib7	11784	21	)	)	-RRB-
cord-005453-4057qib7	11784	22	and	and	CC
cord-005453-4057qib7	11784	23	CD16+CD56	CD16+CD56	NNP
cord-005453-4057qib7	11784	24	+	+	CC
cord-005453-4057qib7	11785	1	(	(	-LRB-
cord-005453-4057qib7	11785	2	NK	NK	NNP
cord-005453-4057qib7	11785	3	)	)	-RRB-
cord-005453-4057qib7	11785	4	were	be	VBD
cord-005453-4057qib7	11785	5	analyzed	analyze	VBN
cord-005453-4057qib7	11785	6	by	by	IN
cord-005453-4057qib7	11785	7	flow	flow	NN
cord-005453-4057qib7	11785	8	cytometry	cytometry	NN
cord-005453-4057qib7	11785	9	at	at	IN
cord-005453-4057qib7	11785	10	1	1	CD
cord-005453-4057qib7	11785	11	,	,	,
cord-005453-4057qib7	11785	12	2	2	CD
cord-005453-4057qib7	11785	13	,	,	,
cord-005453-4057qib7	11785	14	3	3	CD
cord-005453-4057qib7	11785	15	,	,	,
cord-005453-4057qib7	11785	16	6	6	CD
cord-005453-4057qib7	11785	17	,	,	,
cord-005453-4057qib7	11785	18	12	12	CD
cord-005453-4057qib7	11785	19	and	and	CC
cord-005453-4057qib7	11785	20	24	24	CD
cord-005453-4057qib7	11785	21	months	month	NNS
cord-005453-4057qib7	11785	22	after	after	IN
cord-005453-4057qib7	11785	23	HSCT	HSCT	NNP
cord-005453-4057qib7	11785	24	.	.	.
cord-005453-4057qib7	11786	1	Post	post	JJ
cord-005453-4057qib7	11786	2	-	-	JJ
cord-005453-4057qib7	11786	3	transplant	transplant	NN
cord-005453-4057qib7	11786	4	engraftment	engraftment	NN
cord-005453-4057qib7	11786	5	was	be	VBD
cord-005453-4057qib7	11786	6	molecularly	molecularly	RB
cord-005453-4057qib7	11786	7	determined	determine	VBN
cord-005453-4057qib7	11786	8	by	by	IN
cord-005453-4057qib7	11786	9	VNTR	VNTR	NNP
cord-005453-4057qib7	11786	10	analysis	analysis	NN
cord-005453-4057qib7	11786	11	.	.	.
cord-005453-4057qib7	11787	1	Results	result	NNS
cord-005453-4057qib7	11787	2	:	:	:
cord-005453-4057qib7	11788	1	As	as	IN
cord-005453-4057qib7	11788	2	detailed	detailed	JJ
cord-005453-4057qib7	11788	3	in	in	IN
cord-005453-4057qib7	11788	4	Table	table	NN
cord-005453-4057qib7	11788	5	1	1	CD
cord-005453-4057qib7	11788	6	the	the	DT
cord-005453-4057qib7	11788	7	proportion	proportion	NN
cord-005453-4057qib7	11788	8	of	of	IN
cord-005453-4057qib7	11788	9	full	full	JJ
cord-005453-4057qib7	11788	10	donor	donor	NN
cord-005453-4057qib7	11788	11	chimerism	chimerism	NN
cord-005453-4057qib7	11788	12	analyzed	analyze	VBN
cord-005453-4057qib7	11788	13	in	in	IN
cord-005453-4057qib7	11788	14	the	the	DT
cord-005453-4057qib7	11788	15	peripheral	peripheral	JJ
cord-005453-4057qib7	11788	16	blood	blood	NN
cord-005453-4057qib7	11788	17	T	t	NN
cord-005453-4057qib7	11788	18	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11788	19	improved	improve	VBN
cord-005453-4057qib7	11788	20	progressively	progressively	RB
cord-005453-4057qib7	11788	21	after	after	IN
cord-005453-4057qib7	11788	22	transplantation	transplantation	NN
cord-005453-4057qib7	11788	23	and	and	CC
cord-005453-4057qib7	11788	24	the	the	DT
cord-005453-4057qib7	11788	25	same	same	JJ
cord-005453-4057qib7	11788	26	pattern	pattern	NN
cord-005453-4057qib7	11788	27	was	be	VBD
cord-005453-4057qib7	11788	28	observed	observe	VBN
cord-005453-4057qib7	11788	29	when	when	WRB
cord-005453-4057qib7	11788	30	the	the	DT
cord-005453-4057qib7	11788	31	chimeric	chimeric	JJ
cord-005453-4057qib7	11788	32	status	status	NN
cord-005453-4057qib7	11788	33	was	be	VBD
cord-005453-4057qib7	11788	34	measured	measure	VBN
cord-005453-4057qib7	11788	35	in	in	IN
cord-005453-4057qib7	11788	36	bone	bone	NN
cord-005453-4057qib7	11788	37	marrow	marrow	NN
cord-005453-4057qib7	11788	38	mononuclear	mononuclear	NN
cord-005453-4057qib7	11788	39	cells	cell	NNS
cord-005453-4057qib7	11788	40	.	.	.
cord-005453-4057qib7	11789	1	To	to	TO
cord-005453-4057qib7	11789	2	favor	favor	VB
cord-005453-4057qib7	11789	3	the	the	DT
cord-005453-4057qib7	11789	4	achievement	achievement	NN
cord-005453-4057qib7	11789	5	of	of	IN
cord-005453-4057qib7	11789	6	a	a	DT
cord-005453-4057qib7	11789	7	full	full	JJ
cord-005453-4057qib7	11789	8	donor	donor	NN
cord-005453-4057qib7	11789	9	chimerism	chimerism	NN
cord-005453-4057qib7	11789	10	,	,	,
cord-005453-4057qib7	11789	11	DLI	DLI	NNP
cord-005453-4057qib7	11789	12	were	be	VBD
cord-005453-4057qib7	11789	13	performed	perform	VBN
cord-005453-4057qib7	11789	14	in	in	IN
cord-005453-4057qib7	11789	15	26	26	CD
cord-005453-4057qib7	11789	16	patients	patient	NNS
cord-005453-4057qib7	11789	17	starting	start	VBG
cord-005453-4057qib7	11789	18	at	at	IN
cord-005453-4057qib7	11789	19	the	the	DT
cord-005453-4057qib7	11789	20	median	median	NN
cord-005453-4057qib7	11789	21	of	of	IN
cord-005453-4057qib7	11789	22	96	96	CD
cord-005453-4057qib7	11789	23	days	day	NNS
cord-005453-4057qib7	11789	24	after	after	IN
cord-005453-4057qib7	11789	25	transplant	transplant	NN
cord-005453-4057qib7	11789	26	(	(	-LRB-
cord-005453-4057qib7	11789	27	range:34	range:34	NN
cord-005453-4057qib7	11789	28	-	-	HYPH
cord-005453-4057qib7	11789	29	447	447	CD
cord-005453-4057qib7	11789	30	)	)	-RRB-
cord-005453-4057qib7	11789	31	.	.	.
cord-005453-4057qib7	11790	1	With	with	IN
cord-005453-4057qib7	11790	2	a	a	DT
cord-005453-4057qib7	11790	3	median	median	JJ
cord-005453-4057qib7	11790	4	follow	follow	NN
cord-005453-4057qib7	11790	5	-	-	HYPH
cord-005453-4057qib7	11790	6	up	up	RP
cord-005453-4057qib7	11790	7	observation	observation	NN
cord-005453-4057qib7	11790	8	of	of	IN
cord-005453-4057qib7	11790	9	25	25	CD
cord-005453-4057qib7	11790	10	months	month	NNS
cord-005453-4057qib7	11790	11	(	(	-LRB-
cord-005453-4057qib7	11790	12	range	range	VBP
cord-005453-4057qib7	11790	13	7	7	CD
cord-005453-4057qib7	11790	14	-	-	SYM
cord-005453-4057qib7	11790	15	61	61	CD
cord-005453-4057qib7	11790	16	)	)	-RRB-
cord-005453-4057qib7	11790	17	,	,	,
cord-005453-4057qib7	11790	18	the	the	DT
cord-005453-4057qib7	11790	19	one	one	CD
cord-005453-4057qib7	11790	20	year	year	NN
cord-005453-4057qib7	11790	21	OS	OS	NNP
cord-005453-4057qib7	11790	22	and	and	CC
cord-005453-4057qib7	11790	23	NRM	NRM	NNP
cord-005453-4057qib7	11790	24	was	be	VBD
cord-005453-4057qib7	11790	25	88	88	CD
cord-005453-4057qib7	11790	26	%	%	NN
cord-005453-4057qib7	11790	27	and	and	CC
cord-005453-4057qib7	11790	28	5	5	CD
cord-005453-4057qib7	11790	29	%	%	NN
cord-005453-4057qib7	11790	30	,	,	,
cord-005453-4057qib7	11790	31	respectively	respectively	RB
cord-005453-4057qib7	11790	32	.	.	.
cord-005453-4057qib7	11791	1	At	at	IN
cord-005453-4057qib7	11791	2	6	6	CD
cord-005453-4057qib7	11791	3	months	month	NNS
cord-005453-4057qib7	11791	4	after	after	IN
cord-005453-4057qib7	11791	5	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11791	6	,	,	,
cord-005453-4057qib7	11791	7	the	the	DT
cord-005453-4057qib7	11791	8	achievement	achievement	NN
cord-005453-4057qib7	11791	9	of	of	IN
cord-005453-4057qib7	11791	10	values	value	NNS
cord-005453-4057qib7	11791	11	higher	high	JJR
cord-005453-4057qib7	11791	12	than	than	IN
cord-005453-4057qib7	11791	13	75	75	CD
cord-005453-4057qib7	11791	14	,	,	,
cord-005453-4057qib7	11791	15	175	175	CD
cord-005453-4057qib7	11791	16	and	and	CC
cord-005453-4057qib7	11791	17	65	65	CD
cord-005453-4057qib7	11791	18	/μL	/μL	:
cord-005453-4057qib7	11791	19	for	for	IN
cord-005453-4057qib7	11791	20	CD4	CD4	NNP
cord-005453-4057qib7	11791	21	+	+	CC
cord-005453-4057qib7	11791	22	,	,	,
cord-005453-4057qib7	11791	23	CD8	CD8	NNP
cord-005453-4057qib7	11791	24	+	+	CC
cord-005453-4057qib7	11791	25	and	and	CC
cord-005453-4057qib7	11791	26	NK	NK	NNP
cord-005453-4057qib7	11791	27	cells	cell	NNS
cord-005453-4057qib7	11791	28	,	,	,
cord-005453-4057qib7	11791	29	respectively	respectively	RB
cord-005453-4057qib7	11791	30	was	be	VBD
cord-005453-4057qib7	11791	31	significantly	significantly	RB
cord-005453-4057qib7	11791	32	associated	associate	VBN
cord-005453-4057qib7	11791	33	to	to	IN
cord-005453-4057qib7	11791	34	a	a	DT
cord-005453-4057qib7	11791	35	better	well	JJR
cord-005453-4057qib7	11791	36	OS	os	NN
cord-005453-4057qib7	11791	37	(	(	-LRB-
cord-005453-4057qib7	11791	38	Figure	figure	NN
cord-005453-4057qib7	11791	39	1	1	CD
cord-005453-4057qib7	11791	40	)	)	-RRB-
cord-005453-4057qib7	11791	41	,	,	,
cord-005453-4057qib7	11791	42	DFS	DFS	NNP
cord-005453-4057qib7	11791	43	(	(	-LRB-
cord-005453-4057qib7	11791	44	P	p	NN
cord-005453-4057qib7	11791	45	=	=	SYM
cord-005453-4057qib7	11791	46	0.05	0.05	CD
cord-005453-4057qib7	11791	47	)	)	-RRB-
cord-005453-4057qib7	11791	48	,	,	,
cord-005453-4057qib7	11791	49	and	and	CC
cord-005453-4057qib7	11791	50	to	to	IN
cord-005453-4057qib7	11791	51	a	a	DT
cord-005453-4057qib7	11791	52	lower	low	JJR
cord-005453-4057qib7	11791	53	NRM	NRM	NNP
cord-005453-4057qib7	11791	54	(	(	-LRB-
cord-005453-4057qib7	11791	55	P	p	NN
cord-005453-4057qib7	11791	56	<	<	XX
cord-005453-4057qib7	11791	57	0.001	0.001	CD
cord-005453-4057qib7	11791	58	for	for	IN
cord-005453-4057qib7	11791	59	CD4	CD4	NNP
cord-005453-4057qib7	11791	60	+	+	CC
cord-005453-4057qib7	11791	61	and	and	CC
cord-005453-4057qib7	11791	62	CD8	CD8	NNP
cord-005453-4057qib7	11791	63	+	+	SYM
cord-005453-4057qib7	11791	64	,	,	,
cord-005453-4057qib7	11791	65	P=	P=	NNP
cord-005453-4057qib7	11791	66	0.0034	0.0034	CD
cord-005453-4057qib7	11791	67	for	for	IN
cord-005453-4057qib7	11791	68	NK	NK	NNP
cord-005453-4057qib7	11791	69	)	)	-RRB-
cord-005453-4057qib7	11791	70	.	.	.
cord-005453-4057qib7	11792	1	A	a	DT
cord-005453-4057qib7	11792	2	better	well	JJR
cord-005453-4057qib7	11792	3	lymphoid	lymphoid	JJ
cord-005453-4057qib7	11792	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	11792	5	was	be	VBD
cord-005453-4057qib7	11792	6	observed	observe	VBN
cord-005453-4057qib7	11792	7	after	after	IN
cord-005453-4057qib7	11792	8	the	the	DT
cord-005453-4057qib7	11792	9	use	use	NN
cord-005453-4057qib7	11792	10	of	of	IN
cord-005453-4057qib7	11792	11	either	either	CC
cord-005453-4057qib7	11792	12	a	a	DT
cord-005453-4057qib7	11792	13	sibling	sibling	NN
cord-005453-4057qib7	11792	14	or	or	CC
cord-005453-4057qib7	11792	15	a	a	DT
cord-005453-4057qib7	11792	16	haplo	haplo	NN
cord-005453-4057qib7	11792	17	donor	donor	NN
cord-005453-4057qib7	11792	18	than	than	IN
cord-005453-4057qib7	11792	19	a	a	DT
cord-005453-4057qib7	11792	20	matched	match	VBN
cord-005453-4057qib7	11792	21	unrelated	unrelated	JJ
cord-005453-4057qib7	11792	22	or	or	CC
cord-005453-4057qib7	11792	23	cord	cord	NN
cord-005453-4057qib7	11792	24	blood	blood	NN
cord-005453-4057qib7	11792	25	donors	donor	NNS
cord-005453-4057qib7	11792	26	.	.	.
cord-005453-4057qib7	11793	1	The	the	DT
cord-005453-4057qib7	11793	2	use	use	NN
cord-005453-4057qib7	11793	3	of	of	IN
cord-005453-4057qib7	11793	4	ATG	ATG	NNP
cord-005453-4057qib7	11793	5	was	be	VBD
cord-005453-4057qib7	11793	6	significantly	significantly	RB
cord-005453-4057qib7	11793	7	associated	associate	VBN
cord-005453-4057qib7	11793	8	with	with	IN
cord-005453-4057qib7	11793	9	a	a	DT
cord-005453-4057qib7	11793	10	delayed	delay	VBN
cord-005453-4057qib7	11793	11	CD4	CD4	NNP
cord-005453-4057qib7	11793	12	+	+	CC
cord-005453-4057qib7	11793	13	recovery	recovery	NN
cord-005453-4057qib7	11793	14	but	but	CC
cord-005453-4057qib7	11793	15	with	with	IN
cord-005453-4057qib7	11793	16	a	a	DT
cord-005453-4057qib7	11793	17	faster	fast	JJR
cord-005453-4057qib7	11793	18	NK	NK	NNP
cord-005453-4057qib7	11793	19	cells	cell	NNS
cord-005453-4057qib7	11793	20	reconstitution	reconstitution	NN
cord-005453-4057qib7	11793	21	.	.	.
cord-005453-4057qib7	11794	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11794	2	:	:	:
cord-005453-4057qib7	11795	1	At	at	IN
cord-005453-4057qib7	11795	2	six	six	CD
cord-005453-4057qib7	11795	3	months	month	NNS
cord-005453-4057qib7	11795	4	after	after	IN
cord-005453-4057qib7	11795	5	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	11795	6	,	,	,
cord-005453-4057qib7	11795	7	recovery	recovery	NN
cord-005453-4057qib7	11795	8	of	of	IN
cord-005453-4057qib7	11795	9	CD4	CD4	NNP
cord-005453-4057qib7	11795	10	+	+	CC
cord-005453-4057qib7	11795	11	and	and	CC
cord-005453-4057qib7	11795	12	NK	NK	NNP
cord-005453-4057qib7	11795	13	cells	cell	NNS
cord-005453-4057qib7	11795	14	predicts	predict	VBZ
cord-005453-4057qib7	11795	15	survival	survival	NN
cord-005453-4057qib7	11795	16	.	.	.
cord-005453-4057qib7	11796	1	Monitoring	monitoring	NN
cord-005453-4057qib7	11796	2	of	of	IN
cord-005453-4057qib7	11796	3	immune	immune	JJ
cord-005453-4057qib7	11796	4	recovery	recovery	NN
cord-005453-4057qib7	11796	5	may	may	MD
cord-005453-4057qib7	11796	6	help	help	VB
cord-005453-4057qib7	11796	7	to	to	TO
cord-005453-4057qib7	11796	8	guide	guide	VB
cord-005453-4057qib7	11796	9	pre	pre	VB
cord-005453-4057qib7	11796	10	and	and	CC
cord-005453-4057qib7	11796	11	post	post	JJ
cord-005453-4057qib7	11796	12	-	-	JJ
cord-005453-4057qib7	11796	13	transplant	transplant	JJ
cord-005453-4057qib7	11796	14	treatment	treatment	NN
cord-005453-4057qib7	11796	15	strategies	strategy	NNS
cord-005453-4057qib7	11796	16	.	.	.
cord-005453-4057qib7	11797	1	Days	day	NNS
cord-005453-4057qib7	11797	2	infections	infection	NNS
cord-005453-4057qib7	11797	3	and	and	CC
cord-005453-4057qib7	11797	4	disease	disease	NN
cord-005453-4057qib7	11797	5	control	control	NN
cord-005453-4057qib7	11797	6	.	.	.
cord-005453-4057qib7	11798	1	Several	several	JJ
cord-005453-4057qib7	11798	2	groups	group	NNS
cord-005453-4057qib7	11798	3	have	have	VBP
cord-005453-4057qib7	11798	4	demonstrated	demonstrate	VBN
cord-005453-4057qib7	11798	5	the	the	DT
cord-005453-4057qib7	11798	6	independent	independent	JJ
cord-005453-4057qib7	11798	7	prognostic	prognostic	JJ
cord-005453-4057qib7	11798	8	value	value	NN
cord-005453-4057qib7	11798	9	of	of	IN
cord-005453-4057qib7	11798	10	different	different	JJ
cord-005453-4057qib7	11798	11	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11798	12	subpopulations	subpopulation	NNS
cord-005453-4057qib7	11798	13	in	in	IN
cord-005453-4057qib7	11798	14	HSCT	HSCT	NNP
cord-005453-4057qib7	11798	15	outcomes	outcome	NNS
cord-005453-4057qib7	11798	16	.	.	.
cord-005453-4057qib7	11799	1	Posttransplant	Posttransplant	NNP
cord-005453-4057qib7	11799	2	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	11800	1	(	(	-LRB-
cord-005453-4057qib7	11800	2	PT	PT	NNP
cord-005453-4057qib7	11800	3	-	-	HYPH
cord-005453-4057qib7	11800	4	Cy	Cy	NNP
cord-005453-4057qib7	11800	5	)	)	-RRB-
cord-005453-4057qib7	11800	6	effectively	effectively	RB
cord-005453-4057qib7	11800	7	prevents	prevent	VBZ
cord-005453-4057qib7	11800	8	GVHD	GVHD	NNP
cord-005453-4057qib7	11800	9	after	after	IN
cord-005453-4057qib7	11800	10	HLA	HLA	NNP
cord-005453-4057qib7	11800	11	-	-	HYPH
cord-005453-4057qib7	11800	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11800	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11800	14	stem	stem	NN
cord-005453-4057qib7	11800	15	cell	cell	NN
cord-005453-4057qib7	11800	16	transplantation	transplantation	NN
cord-005453-4057qib7	11800	17	(	(	-LRB-
cord-005453-4057qib7	11800	18	Haplo	Haplo	NNP
cord-005453-4057qib7	11800	19	)	)	-RRB-
cord-005453-4057qib7	11800	20	.	.	.
cord-005453-4057qib7	11801	1	The	the	DT
cord-005453-4057qib7	11801	2	use	use	NN
cord-005453-4057qib7	11801	3	of	of	IN
cord-005453-4057qib7	11801	4	PT	PT	NNP
cord-005453-4057qib7	11801	5	-	-	HYPH
cord-005453-4057qib7	11801	6	Cy	Cy	NNP
cord-005453-4057qib7	11801	7	in	in	IN
cord-005453-4057qib7	11801	8	HLA	HLA	NNP
cord-005453-4057qib7	11801	9	matched	match	VBN
cord-005453-4057qib7	11801	10	related	relate	VBN
cord-005453-4057qib7	11801	11	(	(	-LRB-
cord-005453-4057qib7	11801	12	MRD	MRD	NNP
cord-005453-4057qib7	11801	13	)	)	-RRB-
cord-005453-4057qib7	11801	14	or	or	CC
cord-005453-4057qib7	11801	15	unrelated	unrelated	JJ
cord-005453-4057qib7	11801	16	(	(	-LRB-
cord-005453-4057qib7	11801	17	MUD	mud	NN
cord-005453-4057qib7	11801	18	)	)	-RRB-
cord-005453-4057qib7	11801	19	donors	donor	NNS
cord-005453-4057qib7	11801	20	HSCT	HSCT	NNP
cord-005453-4057qib7	11801	21	,	,	,
cord-005453-4057qib7	11801	22	although	although	IN
cord-005453-4057qib7	11801	23	less	less	RBR
cord-005453-4057qib7	11801	24	explored	explore	VBN
cord-005453-4057qib7	11801	25	,	,	,
cord-005453-4057qib7	11801	26	has	have	VBZ
cord-005453-4057qib7	11801	27	also	also	RB
cord-005453-4057qib7	11801	28	been	be	VBN
cord-005453-4057qib7	11801	29	introduced	introduce	VBN
cord-005453-4057qib7	11801	30	.	.	.
cord-005453-4057qib7	11802	1	The	the	DT
cord-005453-4057qib7	11802	2	aim	aim	NN
cord-005453-4057qib7	11802	3	of	of	IN
cord-005453-4057qib7	11802	4	this	this	DT
cord-005453-4057qib7	11802	5	study	study	NN
cord-005453-4057qib7	11802	6	was	be	VBD
cord-005453-4057qib7	11802	7	to	to	TO
cord-005453-4057qib7	11802	8	compare	compare	VB
cord-005453-4057qib7	11802	9	the	the	DT
cord-005453-4057qib7	11802	10	early	early	JJ
cord-005453-4057qib7	11802	11	immune	immune	JJ
cord-005453-4057qib7	11802	12	reconstitution	reconstitution	NN
cord-005453-4057qib7	11802	13	after	after	IN
cord-005453-4057qib7	11802	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	11802	15	HSCT	HSCT	NNP
cord-005453-4057qib7	11802	16	from	from	IN
cord-005453-4057qib7	11802	17	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11802	18	and	and	CC
cord-005453-4057qib7	11802	19	HLA	HLA	NNP
cord-005453-4057qib7	11802	20	-	-	HYPH
cord-005453-4057qib7	11802	21	matched	match	VBN
cord-005453-4057qib7	11802	22	donors	donor	NNS
cord-005453-4057qib7	11802	23	using	use	VBG
cord-005453-4057qib7	11802	24	PT	PT	NNP
cord-005453-4057qib7	11802	25	-	-	HYPH
cord-005453-4057qib7	11802	26	Cy	Cy	NNP
cord-005453-4057qib7	11802	27	.	.	.
cord-005453-4057qib7	11803	1	Methods	method	NNS
cord-005453-4057qib7	11803	2	:	:	:
cord-005453-4057qib7	11804	1	One	one	CD
cord-005453-4057qib7	11804	2	hundred	hundred	CD
cord-005453-4057qib7	11804	3	and	and	CC
cord-005453-4057qib7	11804	4	sixty	sixty	CD
cord-005453-4057qib7	11804	5	-	-	HYPH
cord-005453-4057qib7	11804	6	four	four	CD
cord-005453-4057qib7	11804	7	HSCT	HSCT	NNP
cord-005453-4057qib7	11804	8	performed	perform	VBN
cord-005453-4057qib7	11804	9	in	in	IN
cord-005453-4057qib7	11804	10	our	-PRON-	PRP$
cord-005453-4057qib7	11804	11	center	center	NN
cord-005453-4057qib7	11804	12	were	be	VBD
cord-005453-4057qib7	11804	13	analyzed	analyze	VBN
cord-005453-4057qib7	11804	14	:	:	:
cord-005453-4057qib7	11804	15	125	125	CD
cord-005453-4057qib7	11804	16	Haplo	Haplo	NNP
cord-005453-4057qib7	11804	17	performed	perform	VBN
cord-005453-4057qib7	11804	18	between	between	IN
cord-005453-4057qib7	11804	19	2011	2011	CD
cord-005453-4057qib7	11804	20	and	and	CC
cord-005453-4057qib7	11804	21	2017	2017	CD
cord-005453-4057qib7	11804	22	and	and	CC
cord-005453-4057qib7	11804	23	39	39	CD
cord-005453-4057qib7	11804	24	HSCT	HSCT	NNP
cord-005453-4057qib7	11804	25	from	from	IN
cord-005453-4057qib7	11804	26	HLA	HLA	NNP
cord-005453-4057qib7	11804	27	-	-	HYPH
cord-005453-4057qib7	11804	28	identical	identical	JJ
cord-005453-4057qib7	11804	29	donors	donor	NNS
cord-005453-4057qib7	11804	30	(	(	-LRB-
cord-005453-4057qib7	11804	31	19	19	CD
cord-005453-4057qib7	11804	32	consecutive	consecutive	JJ
cord-005453-4057qib7	11804	33	MRD	MRD	NNP
cord-005453-4057qib7	11804	34	SCT	SCT	NNP
cord-005453-4057qib7	11804	35	performed	perform	VBN
cord-005453-4057qib7	11804	36	with	with	IN
cord-005453-4057qib7	11804	37	PT	PT	NNP
cord-005453-4057qib7	11804	38	-	-	HYPH
cord-005453-4057qib7	11804	39	Cy	Cy	NNP
cord-005453-4057qib7	11804	40	between	between	IN
cord-005453-4057qib7	11804	41	2016	2016	CD
cord-005453-4057qib7	11804	42	and	and	CC
cord-005453-4057qib7	11804	43	2017	2017	CD
cord-005453-4057qib7	11804	44	and	and	CC
cord-005453-4057qib7	11804	45	20	20	CD
cord-005453-4057qib7	11804	46	MUD	mud	NN
cord-005453-4057qib7	11804	47	SCT	SCT	NNP
cord-005453-4057qib7	11804	48	with	with	IN
cord-005453-4057qib7	11804	49	PT	PT	NNP
cord-005453-4057qib7	11804	50	-	-	HYPH
cord-005453-4057qib7	11804	51	CY	CY	NNP
cord-005453-4057qib7	11804	52	between	between	IN
cord-005453-4057qib7	11804	53	2014	2014	CD
cord-005453-4057qib7	11804	54	and	and	CC
cord-005453-4057qib7	11804	55	2017	2017	CD
cord-005453-4057qib7	11804	56	)	)	-RRB-
cord-005453-4057qib7	11804	57	.	.	.
cord-005453-4057qib7	11805	1	PT	PT	NNP
cord-005453-4057qib7	11805	2	-	-	HYPH
cord-005453-4057qib7	11805	3	Cy	Cy	NNP
cord-005453-4057qib7	11805	4	was	be	VBD
cord-005453-4057qib7	11805	5	administered	administer	VBN
cord-005453-4057qib7	11805	6	at	at	IN
cord-005453-4057qib7	11805	7	50mg	50mg	CD
cord-005453-4057qib7	11805	8	/	/	SYM
cord-005453-4057qib7	11805	9	kg	kg	NN
cord-005453-4057qib7	11805	10	/	/	SYM
cord-005453-4057qib7	11805	11	d	d	NN
cord-005453-4057qib7	11805	12	in	in	IN
cord-005453-4057qib7	11805	13	days	day	NNS
cord-005453-4057qib7	11805	14	+3	+3	NNP
cord-005453-4057qib7	11805	15	and	and	CC
cord-005453-4057qib7	11805	16	+4	+4	NNP
cord-005453-4057qib7	11805	17	postransplant	postransplant	NN
cord-005453-4057qib7	11805	18	,	,	,
cord-005453-4057qib7	11805	19	followed	follow	VBN
cord-005453-4057qib7	11805	20	by	by	IN
cord-005453-4057qib7	11805	21	MMF	MMF	NNP
cord-005453-4057qib7	11805	22	10mg	10mg	NNP
cord-005453-4057qib7	11805	23	/	/	SYM
cord-005453-4057qib7	11805	24	kg/	kg/	NNP
cord-005453-4057qib7	11805	25	d	d	NNP
cord-005453-4057qib7	11805	26	and	and	CC
cord-005453-4057qib7	11805	27	a	a	DT
cord-005453-4057qib7	11805	28	calcineurin	calcineurin	JJ
cord-005453-4057qib7	11805	29	inhibitor	inhibitor	NN
cord-005453-4057qib7	11806	1	(	(	-LRB-
cord-005453-4057qib7	11806	2	Ciclosporina	Ciclosporina	NNP
cord-005453-4057qib7	11806	3	A	A	NNP
cord-005453-4057qib7	11806	4	or	or	CC
cord-005453-4057qib7	11806	5	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	11806	6	)	)	-RRB-
cord-005453-4057qib7	11806	7	from	from	IN
cord-005453-4057qib7	11806	8	day	day	NN
cord-005453-4057qib7	11806	9	+5	+5	NFP
cord-005453-4057qib7	11806	10	ahead	ahead	RB
cord-005453-4057qib7	11806	11	.	.	.
cord-005453-4057qib7	11807	1	We	-PRON-	PRP
cord-005453-4057qib7	11807	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	11807	3	compared	compare	VBD
cord-005453-4057qib7	11807	4	early	early	JJ
cord-005453-4057qib7	11807	5	immune	immune	JJ
cord-005453-4057qib7	11807	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	11807	7	at	at	IN
cord-005453-4057qib7	11807	8	day	day	NN
cord-005453-4057qib7	11807	9	+30	+30	CD
cord-005453-4057qib7	11807	10	and	and	CC
cord-005453-4057qib7	11807	11	day	day	NN
cord-005453-4057qib7	11807	12	+90	+90	CD
cord-005453-4057qib7	11807	13	among	among	IN
cord-005453-4057qib7	11807	14	these	these	DT
cord-005453-4057qib7	11807	15	three	three	CD
cord-005453-4057qib7	11807	16	populations	population	NNS
cord-005453-4057qib7	11807	17	.	.	.
cord-005453-4057qib7	11808	1	Early	early	RB
cord-005453-4057qib7	11808	2	IR	IR	NNP
cord-005453-4057qib7	11808	3	was	be	VBD
cord-005453-4057qib7	11808	4	assessed	assess	VBN
cord-005453-4057qib7	11808	5	through	through	IN
cord-005453-4057qib7	11808	6	the	the	DT
cord-005453-4057qib7	11808	7	analysis	analysis	NN
cord-005453-4057qib7	11808	8	of	of	IN
cord-005453-4057qib7	11808	9	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11808	10	subpopulations	subpopulation	NNS
cord-005453-4057qib7	11808	11	including	include	VBG
cord-005453-4057qib7	11808	12	total	total	JJ
cord-005453-4057qib7	11808	13	T	t	NN
cord-005453-4057qib7	11808	14	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11808	15	CD3	CD3	NNP
cord-005453-4057qib7	11808	16	+	+	CC
cord-005453-4057qib7	11808	17	,	,	,
cord-005453-4057qib7	11808	18	CD4	CD4	NNP
cord-005453-4057qib7	11808	19	+	+	CC
cord-005453-4057qib7	11808	20	and	and	CC
cord-005453-4057qib7	11808	21	CD8+subpopulations	cd8+subpopulation	NNS
cord-005453-4057qib7	11808	22	,	,	,
cord-005453-4057qib7	11808	23	NK	NK	NNP
cord-005453-4057qib7	11808	24	CD3-CD56	cd3-cd56	NN
cord-005453-4057qib7	11808	25	+	+	CC
cord-005453-4057qib7	11808	26	cells	cell	NNS
cord-005453-4057qib7	11808	27	,	,	,
cord-005453-4057qib7	11808	28	CD56	cd56	NN
cord-005453-4057qib7	11808	29	+	+	CC
cord-005453-4057qib7	11808	30	bright	bright	JJ
cord-005453-4057qib7	11808	31	immature	immature	JJ
cord-005453-4057qib7	11808	32	subpopulation	subpopulation	NN
cord-005453-4057qib7	11808	33	and	and	CC
cord-005453-4057qib7	11808	34	total	total	NN
cord-005453-4057qib7	11808	35	B	b	NN
cord-005453-4057qib7	11808	36	CD19	CD19	NNP
cord-005453-4057qib7	11809	1	+	+	CC
cord-005453-4057qib7	11809	2	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11809	3	..	..	.
cord-005453-4057qib7	11810	1	Lymphocytes	lymphocytes	NN
cord-005453-4057qib7	11810	2	subpopulations	subpopulation	NNS
cord-005453-4057qib7	11810	3	were	be	VBD
cord-005453-4057qib7	11810	4	determined	determine	VBN
cord-005453-4057qib7	11810	5	by	by	IN
cord-005453-4057qib7	11810	6	multiparametric	multiparametric	JJ
cord-005453-4057qib7	11810	7	flow	flow	NN
cord-005453-4057qib7	11810	8	cytometry	cytometry	NN
cord-005453-4057qib7	11810	9	(	(	-LRB-
cord-005453-4057qib7	11810	10	FC500	FC500	NNP
cord-005453-4057qib7	11810	11	and	and	CC
cord-005453-4057qib7	11810	12	Navios	Navios	NNP
cord-005453-4057qib7	11810	13	,	,	,
cord-005453-4057qib7	11810	14	Beckman	Beckman	NNP
cord-005453-4057qib7	11810	15	Coulter	Coulter	NNP
cord-005453-4057qib7	11810	16	®	®	POS
cord-005453-4057qib7	11810	17	)	)	-RRB-
cord-005453-4057qib7	11810	18	.	.	.
cord-005453-4057qib7	11811	1	Results	result	NNS
cord-005453-4057qib7	11811	2	:	:	:
cord-005453-4057qib7	11812	1	All	all	DT
cord-005453-4057qib7	11812	2	patients	patient	NNS
cord-005453-4057qib7	11812	3	,	,	,
cord-005453-4057qib7	11812	4	but	but	CC
cord-005453-4057qib7	11812	5	1	1	CD
cord-005453-4057qib7	11812	6	MUD	mud	NN
cord-005453-4057qib7	11812	7	and	and	CC
cord-005453-4057qib7	11812	8	1	1	CD
cord-005453-4057qib7	11812	9	Haplo	Haplo	NNP
cord-005453-4057qib7	11812	10	,	,	,
cord-005453-4057qib7	11812	11	received	receive	VBD
cord-005453-4057qib7	11812	12	PB	PB	NNP
cord-005453-4057qib7	11812	13	as	as	IN
cord-005453-4057qib7	11812	14	stem	stem	NN
cord-005453-4057qib7	11812	15	cell	cell	NN
cord-005453-4057qib7	11812	16	source	source	NN
cord-005453-4057qib7	11812	17	.	.	.
cord-005453-4057qib7	11813	1	46	46	CD
cord-005453-4057qib7	11813	2	patients	patient	NNS
cord-005453-4057qib7	11813	3	received	receive	VBD
cord-005453-4057qib7	11813	4	prior	prior	JJ
cord-005453-4057qib7	11813	5	transplant	transplant	NN
cord-005453-4057qib7	11813	6	in	in	IN
cord-005453-4057qib7	11813	7	Haplo	Haplo	NNP
cord-005453-4057qib7	11813	8	group	group	NN
cord-005453-4057qib7	11813	9	.	.	.
cord-005453-4057qib7	11814	1	Patient´s	patient´s	JJ
cord-005453-4057qib7	11814	2	characteristics	characteristic	NNS
cord-005453-4057qib7	11814	3	are	be	VBP
cord-005453-4057qib7	11814	4	shown	show	VBN
cord-005453-4057qib7	11814	5	in	in	IN
cord-005453-4057qib7	11814	6	table	table	NN
cord-005453-4057qib7	11814	7	1	1	CD
cord-005453-4057qib7	11814	8	.	.	.
cord-005453-4057qib7	11815	1	Patients	patient	NNS
cord-005453-4057qib7	11815	2	who	who	WP
cord-005453-4057qib7	11815	3	received	receive	VBD
cord-005453-4057qib7	11815	4	HSCT	HSCT	NNP
cord-005453-4057qib7	11815	5	from	from	IN
cord-005453-4057qib7	11815	6	MRD	MRD	NNP
cord-005453-4057qib7	11815	7	showed	show	VBD
cord-005453-4057qib7	11815	8	the	the	DT
cord-005453-4057qib7	11815	9	fastest	fast	JJS
cord-005453-4057qib7	11815	10	IR	IR	NNP
cord-005453-4057qib7	11815	11	,	,	,
cord-005453-4057qib7	11815	12	with	with	IN
cord-005453-4057qib7	11815	13	statistically	statistically	RB
cord-005453-4057qib7	11815	14	significant	significant	JJ
cord-005453-4057qib7	11815	15	differences	difference	NNS
cord-005453-4057qib7	11815	16	compared	compare	VBN
cord-005453-4057qib7	11815	17	to	to	IN
cord-005453-4057qib7	11815	18	Haplo	Haplo	NNP
cord-005453-4057qib7	11815	19	in	in	IN
cord-005453-4057qib7	11815	20	almost	almost	RB
cord-005453-4057qib7	11815	21	all	all	DT
cord-005453-4057qib7	11815	22	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11815	23	populations	population	NNS
cord-005453-4057qib7	11815	24	at	at	IN
cord-005453-4057qib7	11815	25	day	day	NN
cord-005453-4057qib7	11815	26	+30	+30	CD
cord-005453-4057qib7	11815	27	(	(	-LRB-
cord-005453-4057qib7	11815	28	CD3	CD3	NNP
cord-005453-4057qib7	11815	29	+	+	CC
cord-005453-4057qib7	11815	30	,	,	,
cord-005453-4057qib7	11815	31	CD4	CD4	NNP
cord-005453-4057qib7	11815	32	+	+	CC
cord-005453-4057qib7	11815	33	,	,	,
cord-005453-4057qib7	11815	34	CD8	CD8	NNP
cord-005453-4057qib7	11815	35	+	+	CC
cord-005453-4057qib7	11815	36	and	and	CC
cord-005453-4057qib7	11815	37	NK	NK	NNP
cord-005453-4057qib7	11815	38	cells	cell	NNS
cord-005453-4057qib7	11815	39	)	)	-RRB-
cord-005453-4057qib7	11815	40	,	,	,
cord-005453-4057qib7	11815	41	and	and	CC
cord-005453-4057qib7	11815	42	also	also	RB
cord-005453-4057qib7	11815	43	in	in	IN
cord-005453-4057qib7	11815	44	CD3	CD3	NNP
cord-005453-4057qib7	11816	1	+	+	CC
cord-005453-4057qib7	11816	2	,	,	,
cord-005453-4057qib7	11816	3	CD8	CD8	NNP
cord-005453-4057qib7	11816	4	+	+	CC
cord-005453-4057qib7	11816	5	and	and	CC
cord-005453-4057qib7	11816	6	B	b	NN
cord-005453-4057qib7	11816	7	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11816	8	at	at	IN
cord-005453-4057qib7	11816	9	day	day	NN
cord-005453-4057qib7	11816	10	+90	+90	CD
cord-005453-4057qib7	11816	11	.	.	.
cord-005453-4057qib7	11817	1	Comparison	comparison	NN
cord-005453-4057qib7	11817	2	between	between	IN
cord-005453-4057qib7	11817	3	Haplo	Haplo	NNP
cord-005453-4057qib7	11817	4	and	and	CC
cord-005453-4057qib7	11817	5	MUD	MUD	NNP
cord-005453-4057qib7	11817	6	HSCT	HSCT	NNP
cord-005453-4057qib7	11817	7	showed	show	VBD
cord-005453-4057qib7	11817	8	better	well	JJR
cord-005453-4057qib7	11817	9	IR	IR	NNP
cord-005453-4057qib7	11817	10	among	among	IN
cord-005453-4057qib7	11817	11	Haplo	Haplo	NNP
cord-005453-4057qib7	11817	12	,	,	,
cord-005453-4057qib7	11817	13	demonstrated	demonstrate	VBN
cord-005453-4057qib7	11817	14	by	by	IN
cord-005453-4057qib7	11817	15	higher	high	JJR
cord-005453-4057qib7	11817	16	counts	count	NNS
cord-005453-4057qib7	11817	17	in	in	IN
cord-005453-4057qib7	11817	18	CD3+,CD4	CD3+,CD4	NNP
cord-005453-4057qib7	11818	1	+	+	CC
cord-005453-4057qib7	11818	2	,	,	,
cord-005453-4057qib7	11818	3	CD8	CD8	NNP
cord-005453-4057qib7	11818	4	+	+	CC
cord-005453-4057qib7	11818	5	and	and	CC
cord-005453-4057qib7	11818	6	NK	NK	NNP
cord-005453-4057qib7	11818	7	cell	cell	NN
cord-005453-4057qib7	11818	8	counts	count	VBZ
cord-005453-4057qib7	11818	9	at	at	IN
cord-005453-4057qib7	11818	10	day	day	NN
cord-005453-4057qib7	11818	11	+30	+30	CD
cord-005453-4057qib7	11818	12	.	.	.
cord-005453-4057qib7	11819	1	No	no	DT
cord-005453-4057qib7	11819	2	differences	difference	NNS
cord-005453-4057qib7	11819	3	were	be	VBD
cord-005453-4057qib7	11819	4	seen	see	VBN
cord-005453-4057qib7	11819	5	at	at	IN
cord-005453-4057qib7	11819	6	day	day	NN
cord-005453-4057qib7	11819	7	+90	+90	CD
cord-005453-4057qib7	11819	8	.	.	.
cord-005453-4057qib7	11820	1	(	(	-LRB-
cord-005453-4057qib7	11820	2	Figure	figure	NN
cord-005453-4057qib7	11820	3	1	1	CD
cord-005453-4057qib7	11820	4	)	)	-RRB-
cord-005453-4057qib7	11820	5	.	.	.
cord-005453-4057qib7	11821	1	Percentage	percentage	NN
cord-005453-4057qib7	11821	2	of	of	IN
cord-005453-4057qib7	11821	3	immature	immature	JJ
cord-005453-4057qib7	11821	4	CD56	CD56	NNP
cord-005453-4057qib7	11821	5	bright	bright	JJ
cord-005453-4057qib7	11821	6	NK	NK	NNP
cord-005453-4057qib7	11821	7	cells	cell	NNS
cord-005453-4057qib7	11821	8	was	be	VBD
cord-005453-4057qib7	11821	9	higher	high	JJR
cord-005453-4057qib7	11821	10	in	in	IN
cord-005453-4057qib7	11821	11	MUD	mud	NN
cord-005453-4057qib7	11821	12	HSCT	HSCT	NNP
cord-005453-4057qib7	11821	13	at	at	IN
cord-005453-4057qib7	11821	14	+30	+30	CD
cord-005453-4057qib7	11821	15	,	,	,
cord-005453-4057qib7	11821	16	with	with	IN
cord-005453-4057qib7	11821	17	no	no	DT
cord-005453-4057qib7	11821	18	differences	difference	NNS
cord-005453-4057qib7	11821	19	between	between	IN
cord-005453-4057qib7	11821	20	Haplo	Haplo	NNP
cord-005453-4057qib7	11821	21	and	and	CC
cord-005453-4057qib7	11821	22	MRD	MRD	NNP
cord-005453-4057qib7	11821	23	HSCT	HSCT	NNP
cord-005453-4057qib7	11821	24	.	.	.
cord-005453-4057qib7	11822	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11822	2	:	:	:
cord-005453-4057qib7	11823	1	In	in	IN
cord-005453-4057qib7	11823	2	our	-PRON-	PRP$
cord-005453-4057qib7	11823	3	cohort	cohort	NN
cord-005453-4057qib7	11823	4	of	of	IN
cord-005453-4057qib7	11823	5	patients	patient	NNS
cord-005453-4057qib7	11823	6	with	with	IN
cord-005453-4057qib7	11823	7	PT	PT	NNP
cord-005453-4057qib7	11823	8	-	-	HYPH
cord-005453-4057qib7	11823	9	CY	CY	NNP
cord-005453-4057qib7	11823	10	based	base	VBN
cord-005453-4057qib7	11823	11	GVHD	GVHD	NNP
cord-005453-4057qib7	11823	12	prophylaxis	prophylaxis	JJ
cord-005453-4057qib7	11823	13	regimen	regimen	NN
cord-005453-4057qib7	11823	14	,	,	,
cord-005453-4057qib7	11823	15	those	those	DT
cord-005453-4057qib7	11823	16	who	who	WP
cord-005453-4057qib7	11823	17	received	receive	VBD
cord-005453-4057qib7	11823	18	HSCT	HSCT	NNP
cord-005453-4057qib7	11823	19	from	from	IN
cord-005453-4057qib7	11823	20	MRD	MRD	NNP
cord-005453-4057qib7	11823	21	showed	show	VBD
cord-005453-4057qib7	11823	22	the	the	DT
cord-005453-4057qib7	11823	23	earliest	early	JJS
cord-005453-4057qib7	11823	24	immune	immune	JJ
cord-005453-4057qib7	11823	25	reconstitution	reconstitution	NN
cord-005453-4057qib7	11823	26	compared	compare	VBN
cord-005453-4057qib7	11823	27	to	to	IN
cord-005453-4057qib7	11823	28	Haplo	Haplo	NNP
cord-005453-4057qib7	11823	29	and	and	CC
cord-005453-4057qib7	11823	30	MUD	MUD	NNP
cord-005453-4057qib7	11823	31	at	at	IN
cord-005453-4057qib7	11823	32	day	day	NN
cord-005453-4057qib7	11823	33	+30	+30	CD
cord-005453-4057qib7	11823	34	and	and	CC
cord-005453-4057qib7	11823	35	+90	+90	NN
cord-005453-4057qib7	11823	36	.	.	.
cord-005453-4057qib7	11824	1	Haplo	Haplo	NNP
cord-005453-4057qib7	11824	2	showed	show	VBD
cord-005453-4057qib7	11824	3	better	well	JJR
cord-005453-4057qib7	11824	4	IR	IR	NNP
cord-005453-4057qib7	11824	5	compared	compare	VBN
cord-005453-4057qib7	11824	6	to	to	IN
cord-005453-4057qib7	11824	7	MUD	mud	NN
cord-005453-4057qib7	11824	8	at	at	IN
cord-005453-4057qib7	11824	9	day	day	NN
cord-005453-4057qib7	11824	10	+30	+30	CD
cord-005453-4057qib7	11824	11	.	.	.
cord-005453-4057qib7	11825	1	NK	NK	NNP
cord-005453-4057qib7	11825	2	maturation	maturation	NN
cord-005453-4057qib7	11825	3	at	at	IN
cord-005453-4057qib7	11825	4	day	day	NN
cord-005453-4057qib7	11825	5	+30	+30	CD
cord-005453-4057qib7	11825	6	was	be	VBD
cord-005453-4057qib7	11825	7	a	a	DT
cord-005453-4057qib7	11825	8	little	little	JJ
cord-005453-4057qib7	11825	9	better	well	JJR
cord-005453-4057qib7	11825	10	among	among	IN
cord-005453-4057qib7	11825	11	Haplo	Haplo	NNP
cord-005453-4057qib7	11825	12	and	and	CC
cord-005453-4057qib7	11825	13	MRD	MRD	NNP
cord-005453-4057qib7	11825	14	HSCT	HSCT	NNP
cord-005453-4057qib7	11825	15	recipients	recipient	NNS
cord-005453-4057qib7	11825	16	than	than	IN
cord-005453-4057qib7	11825	17	MUD	mud	NN
cord-005453-4057qib7	11825	18	HSCT	HSCT	NNP
cord-005453-4057qib7	11825	19	patients	patient	NNS
cord-005453-4057qib7	11825	20	.	.	.
cord-005453-4057qib7	11826	1	In	in	IN
cord-005453-4057qib7	11826	2	our	-PRON-	PRP$
cord-005453-4057qib7	11826	3	experience	experience	NN
cord-005453-4057qib7	11826	4	,	,	,
cord-005453-4057qib7	11826	5	using	use	VBG
cord-005453-4057qib7	11826	6	mostly	mostly	RB
cord-005453-4057qib7	11826	7	PBSC	PBSC	NNP
cord-005453-4057qib7	11826	8	as	as	IN
cord-005453-4057qib7	11826	9	graft	graft	NN
cord-005453-4057qib7	11826	10	source	source	NN
cord-005453-4057qib7	11826	11	,	,	,
cord-005453-4057qib7	11826	12	type	type	NN
cord-005453-4057qib7	11826	13	of	of	IN
cord-005453-4057qib7	11826	14	donor	donor	NN
cord-005453-4057qib7	11826	15	influenced	influence	VBN
cord-005453-4057qib7	11826	16	early	early	JJ
cord-005453-4057qib7	11826	17	IR	IR	NNP
cord-005453-4057qib7	11826	18	in	in	IN
cord-005453-4057qib7	11826	19	PT	PT	NNP
cord-005453-4057qib7	11826	20	-	-	HYPH
cord-005453-4057qib7	11826	21	Cy	Cy	NNP
cord-005453-4057qib7	11826	22	based	base	VBN
cord-005453-4057qib7	11826	23	HSCT	HSCT	NNP
cord-005453-4057qib7	11826	24	,	,	,
cord-005453-4057qib7	11826	25	Background	background	NN
cord-005453-4057qib7	11826	26	:	:	:
cord-005453-4057qib7	11826	27	Cell	cell	NN
cord-005453-4057qib7	11826	28	-	-	HYPH
cord-005453-4057qib7	11826	29	free	free	JJ
cord-005453-4057qib7	11826	30	DNA	dna	NN
cord-005453-4057qib7	11826	31	(	(	-LRB-
cord-005453-4057qib7	11826	32	cfDNA	cfDNA	VBG
cord-005453-4057qib7	11826	33	)	)	-RRB-
cord-005453-4057qib7	11826	34	isolated	isolate	VBN
cord-005453-4057qib7	11826	35	from	from	IN
cord-005453-4057qib7	11826	36	plasma	plasma	NN
cord-005453-4057qib7	11826	37	or	or	CC
cord-005453-4057qib7	11826	38	serum	serum	NN
cord-005453-4057qib7	11826	39	has	have	VBZ
cord-005453-4057qib7	11826	40	received	receive	VBN
cord-005453-4057qib7	11826	41	increasing	increase	VBG
cord-005453-4057qib7	11826	42	interest	interest	NN
cord-005453-4057qib7	11826	43	for	for	IN
cord-005453-4057qib7	11826	44	diagnostic	diagnostic	JJ
cord-005453-4057qib7	11826	45	applications	application	NNS
cord-005453-4057qib7	11826	46	.	.	.
cord-005453-4057qib7	11827	1	However	however	RB
cord-005453-4057qib7	11827	2	,	,	,
cord-005453-4057qib7	11827	3	the	the	DT
cord-005453-4057qib7	11827	4	reported	report	VBN
cord-005453-4057qib7	11827	5	clinical	clinical	JJ
cord-005453-4057qib7	11827	6	usefulness	usefulness	NN
cord-005453-4057qib7	11827	7	of	of	IN
cord-005453-4057qib7	11827	8	cfDNA	cfdna	RB
cord-005453-4057qib7	11827	9	in	in	IN
cord-005453-4057qib7	11827	10	patients	patient	NNS
cord-005453-4057qib7	11827	11	undergoing	undergo	VBG
cord-005453-4057qib7	11827	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	11827	13	cell	cell	NN
cord-005453-4057qib7	11827	14	transplantation	transplantation	NN
cord-005453-4057qib7	11827	15	(	(	-LRB-
cord-005453-4057qib7	11827	16	HSCT	HSCT	NNP
cord-005453-4057qib7	11827	17	)	)	-RRB-
cord-005453-4057qib7	11827	18	is	be	VBZ
cord-005453-4057qib7	11827	19	scarce	scarce	JJ
cord-005453-4057qib7	11827	20	.	.	.
cord-005453-4057qib7	11828	1	Methods	method	NNS
cord-005453-4057qib7	11828	2	:	:	:
cord-005453-4057qib7	11828	3	The	the	DT
cord-005453-4057qib7	11828	4	chimeric	chimeric	JJ
cord-005453-4057qib7	11828	5	status	status	NN
cord-005453-4057qib7	11828	6	both	both	CC
cord-005453-4057qib7	11828	7	in	in	IN
cord-005453-4057qib7	11828	8	peripheral	peripheral	JJ
cord-005453-4057qib7	11828	9	blood	blood	NN
cord-005453-4057qib7	11828	10	and	and	CC
cord-005453-4057qib7	11828	11	in	in	IN
cord-005453-4057qib7	11828	12	cfDNA	cfdna	RB
cord-005453-4057qib7	11828	13	obtained	obtain	VBN
cord-005453-4057qib7	11828	14	from	from	IN
cord-005453-4057qib7	11828	15	plasma	plasma	NN
cord-005453-4057qib7	11828	16	was	be	VBD
cord-005453-4057qib7	11828	17	investigated	investigate	VBN
cord-005453-4057qib7	11828	18	in	in	IN
cord-005453-4057qib7	11828	19	110	110	CD
cord-005453-4057qib7	11828	20	patients	patient	NNS
cord-005453-4057qib7	11828	21	undergoing	undergo	VBG
cord-005453-4057qib7	11828	22	HSCT	HSCT	NNP
cord-005453-4057qib7	11828	23	.	.	.
cord-005453-4057qib7	11829	1	DNA	DNA	NNP
cord-005453-4057qib7	11829	2	and	and	CC
cord-005453-4057qib7	11829	3	RNA	RNA	NNP
cord-005453-4057qib7	11829	4	were	be	VBD
cord-005453-4057qib7	11829	5	isolated	isolate	VBN
cord-005453-4057qib7	11829	6	from	from	IN
cord-005453-4057qib7	11829	7	plasma	plasma	NN
cord-005453-4057qib7	11829	8	within	within	IN
cord-005453-4057qib7	11829	9	four	four	CD
cord-005453-4057qib7	11829	10	hours	hour	NNS
cord-005453-4057qib7	11829	11	of	of	IN
cord-005453-4057qib7	11829	12	blood	blood	NN
cord-005453-4057qib7	11829	13	draw	draw	NN
cord-005453-4057qib7	11829	14	.	.	.
cord-005453-4057qib7	11830	1	Patients	patient	NNS
cord-005453-4057qib7	11830	2	were	be	VBD
cord-005453-4057qib7	11830	3	evaluated	evaluate	VBN
cord-005453-4057qib7	11830	4	for	for	IN
cord-005453-4057qib7	11830	5	chimerism	chimerism	NN
cord-005453-4057qib7	11830	6	at	at	IN
cord-005453-4057qib7	11830	7	day	day	NN
cord-005453-4057qib7	11830	8	+30	+30	CD
cord-005453-4057qib7	11830	9	,	,	,
cord-005453-4057qib7	11830	10	+100	+100	NNP
cord-005453-4057qib7	11830	11	and	and	CC
cord-005453-4057qib7	11830	12	+365	+365	NNP
cord-005453-4057qib7	11830	13	post	post	NN
cord-005453-4057qib7	11830	14	-	-	NN
cord-005453-4057qib7	11830	15	transplant	transplant	NN
cord-005453-4057qib7	11830	16	.	.	.
cord-005453-4057qib7	11831	1	A	a	DT
cord-005453-4057qib7	11831	2	panel	panel	NN
cord-005453-4057qib7	11831	3	of	of	IN
cord-005453-4057qib7	11831	4	seven	seven	CD
cord-005453-4057qib7	11831	5	microsatellites	microsatellite	NNS
cord-005453-4057qib7	11831	6	was	be	VBD
cord-005453-4057qib7	11831	7	amplified	amplify	VBN
cord-005453-4057qib7	11831	8	by	by	IN
cord-005453-4057qib7	11831	9	PCR	PCR	NNP
cord-005453-4057qib7	11831	10	for	for	IN
cord-005453-4057qib7	11831	11	chimerism	chimerism	NN
cord-005453-4057qib7	11831	12	detection	detection	NN
cord-005453-4057qib7	11831	13	and	and	CC
cord-005453-4057qib7	11831	14	PCR	PCR	NNP
cord-005453-4057qib7	11831	15	products	product	NNS
cord-005453-4057qib7	11831	16	were	be	VBD
cord-005453-4057qib7	11831	17	analysed	analyse	VBN
cord-005453-4057qib7	11831	18	by	by	IN
cord-005453-4057qib7	11831	19	capillary	capillary	JJ
cord-005453-4057qib7	11831	20	electrophoresis	electrophoresis	NN
cord-005453-4057qib7	11831	21	.	.	.
cord-005453-4057qib7	11832	1	For	for	IN
cord-005453-4057qib7	11832	2	further	further	JJ
cord-005453-4057qib7	11832	3	cfDNA	cfDNA	JJR
cord-005453-4057qib7	11832	4	characterization	characterization	NN
cord-005453-4057qib7	11832	5	the	the	DT
cord-005453-4057qib7	11832	6	micro	micro	NNP
cord-005453-4057qib7	11832	7	RNA	RNA	NNP
cord-005453-4057qib7	11832	8	(	(	-LRB-
cord-005453-4057qib7	11832	9	miRNA	miRNA	NNP
cord-005453-4057qib7	11832	10	)	)	-RRB-
cord-005453-4057qib7	11832	11	200c	200c	NNP
cord-005453-4057qib7	11832	12	was	be	VBD
cord-005453-4057qib7	11832	13	analysed	analyse	VBN
cord-005453-4057qib7	11832	14	using	use	VBG
cord-005453-4057qib7	11832	15	digital	digital	JJ
cord-005453-4057qib7	11832	16	PCR	PCR	NNP
cord-005453-4057qib7	11832	17	.	.	.
cord-005453-4057qib7	11833	1	Mutations	mutation	NNS
cord-005453-4057qib7	11833	2	frequently	frequently	RB
cord-005453-4057qib7	11833	3	used	use	VBD
cord-005453-4057qib7	11833	4	for	for	IN
cord-005453-4057qib7	11833	5	minimal	minimal	JJ
cord-005453-4057qib7	11833	6	residual	residual	JJ
cord-005453-4057qib7	11833	7	disease	disease	NN
cord-005453-4057qib7	11833	8	assessment	assessment	NN
cord-005453-4057qib7	11833	9	such	such	JJ
cord-005453-4057qib7	11833	10	as	as	IN
cord-005453-4057qib7	11833	11	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	11833	12	,	,	,
cord-005453-4057qib7	11833	13	NPM1	NPM1	NNP
cord-005453-4057qib7	11833	14	and	and	CC
cord-005453-4057qib7	11833	15	JAK2	JAK2	NNP
cord-005453-4057qib7	11833	16	were	be	VBD
cord-005453-4057qib7	11833	17	also	also	RB
cord-005453-4057qib7	11833	18	investigated	investigate	VBN
cord-005453-4057qib7	11833	19	in	in	IN
cord-005453-4057qib7	11833	20	cfDNA	cfdna	ADD
cord-005453-4057qib7	11833	21	.	.	.
cord-005453-4057qib7	11834	1	Results	result	NNS
cord-005453-4057qib7	11834	2	:	:	:
cord-005453-4057qib7	11835	1	The	the	DT
cord-005453-4057qib7	11835	2	mean	mean	NN
cord-005453-4057qib7	11835	3	cfDNA	cfdna	JJ
cord-005453-4057qib7	11835	4	concentration	concentration	NN
cord-005453-4057qib7	11835	5	in	in	IN
cord-005453-4057qib7	11835	6	transplanted	transplanted	JJ
cord-005453-4057qib7	11835	7	patients	patient	NNS
cord-005453-4057qib7	11835	8	was	be	VBD
cord-005453-4057qib7	11835	9	469	469	CD
cord-005453-4057qib7	11835	10	ng	ng	NNP
cord-005453-4057qib7	11835	11	/	/	SYM
cord-005453-4057qib7	11835	12	ml	ml	XX
cord-005453-4057qib7	11835	13	,	,	,
cord-005453-4057qib7	11835	14	while	while	IN
cord-005453-4057qib7	11835	15	in	in	IN
cord-005453-4057qib7	11835	16	healthy	healthy	JJ
cord-005453-4057qib7	11835	17	donors	donor	NNS
cord-005453-4057qib7	11835	18	used	use	VBN
cord-005453-4057qib7	11835	19	as	as	IN
cord-005453-4057qib7	11835	20	control	control	NN
cord-005453-4057qib7	11835	21	group	group	NN
cord-005453-4057qib7	11835	22	(	(	-LRB-
cord-005453-4057qib7	11835	23	n=20	n=20	NNP
cord-005453-4057qib7	11835	24	)	)	-RRB-
cord-005453-4057qib7	11835	25	was	be	VBD
cord-005453-4057qib7	11835	26	119	119	CD
cord-005453-4057qib7	11835	27	ng	ng	NN
cord-005453-4057qib7	11835	28	/	/	SYM
cord-005453-4057qib7	11835	29	ml	ml	NN
cord-005453-4057qib7	11835	30	.	.	.
cord-005453-4057qib7	11836	1	The	the	DT
cord-005453-4057qib7	11836	2	mean	mean	NN
cord-005453-4057qib7	11836	3	cfDNA	cfdna	JJ
cord-005453-4057qib7	11836	4	concentration	concentration	NN
cord-005453-4057qib7	11836	5	difference	difference	NN
cord-005453-4057qib7	11836	6	between	between	IN
cord-005453-4057qib7	11836	7	both	both	DT
cord-005453-4057qib7	11836	8	groups	group	NNS
cord-005453-4057qib7	11836	9	reached	reach	VBD
cord-005453-4057qib7	11836	10	statistical	statistical	JJ
cord-005453-4057qib7	11836	11	significance	significance	NN
cord-005453-4057qib7	11836	12	(	(	-LRB-
cord-005453-4057qib7	11836	13	p=	p=	NNP
cord-005453-4057qib7	11836	14	0.0197	0.0197	CD
cord-005453-4057qib7	11836	15	)	)	-RRB-
cord-005453-4057qib7	11836	16	.	.	.
cord-005453-4057qib7	11837	1	When	when	WRB
cord-005453-4057qib7	11837	2	analysing	analyse	VBG
cord-005453-4057qib7	11837	3	cfDNA	cfdna	RB
cord-005453-4057qib7	11837	4	from	from	IN
cord-005453-4057qib7	11837	5	transplanted	transplanted	JJ
cord-005453-4057qib7	11837	6	patients	patient	NNS
cord-005453-4057qib7	11837	7	and	and	CC
cord-005453-4057qib7	11837	8	in	in	IN
cord-005453-4057qib7	11837	9	the	the	DT
cord-005453-4057qib7	11837	10	control	control	NN
cord-005453-4057qib7	11837	11	group	group	NN
cord-005453-4057qib7	11837	12	we	-PRON-	PRP
cord-005453-4057qib7	11837	13	could	could	MD
cord-005453-4057qib7	11837	14	not	not	RB
cord-005453-4057qib7	11837	15	detect	detect	VB
cord-005453-4057qib7	11837	16	DNA	dna	NN
cord-005453-4057qib7	11837	17	fragments	fragment	NNS
cord-005453-4057qib7	11837	18	larger	large	JJR
cord-005453-4057qib7	11837	19	than	than	IN
cord-005453-4057qib7	11837	20	400	400	CD
cord-005453-4057qib7	11837	21	bp	bp	NNS
cord-005453-4057qib7	11837	22	and	and	CC
cord-005453-4057qib7	11838	1	the	the	DT
cord-005453-4057qib7	11838	2	size	size	NN
cord-005453-4057qib7	11838	3	range	range	NN
cord-005453-4057qib7	11838	4	of	of	IN
cord-005453-4057qib7	11838	5	the	the	DT
cord-005453-4057qib7	11838	6	analysed	analyse	VBN
cord-005453-4057qib7	11838	7	fragments	fragment	NNS
cord-005453-4057qib7	11838	8	was	be	VBD
cord-005453-4057qib7	11838	9	between	between	IN
cord-005453-4057qib7	11838	10	80	80	CD
cord-005453-4057qib7	11838	11	and	and	CC
cord-005453-4057qib7	11838	12	200	200	CD
cord-005453-4057qib7	11838	13	bp	bp	NNS
cord-005453-4057qib7	11838	14	.	.	.
cord-005453-4057qib7	11839	1	In	in	IN
cord-005453-4057qib7	11839	2	41	41	CD
cord-005453-4057qib7	11839	3	out	out	IN
cord-005453-4057qib7	11839	4	of	of	IN
cord-005453-4057qib7	11839	5	110	110	CD
cord-005453-4057qib7	11839	6	patients	patient	NNS
cord-005453-4057qib7	11839	7	a	a	DT
cord-005453-4057qib7	11839	8	mixture	mixture	NN
cord-005453-4057qib7	11839	9	of	of	IN
cord-005453-4057qib7	11839	10	donor	donor	NN
cord-005453-4057qib7	11839	11	and	and	CC
cord-005453-4057qib7	11839	12	recipient	recipient	NN
cord-005453-4057qib7	11839	13	cfDNA	cfDNA	.
cord-005453-4057qib7	11840	1	(	(	-LRB-
cord-005453-4057qib7	11840	2	MC	MC	NNP
cord-005453-4057qib7	11840	3	)	)	-RRB-
cord-005453-4057qib7	11840	4	was	be	VBD
cord-005453-4057qib7	11840	5	detected	detect	VBN
cord-005453-4057qib7	11840	6	.	.	.
cord-005453-4057qib7	11841	1	With	with	IN
cord-005453-4057qib7	11841	2	the	the	DT
cord-005453-4057qib7	11841	3	exception	exception	NN
cord-005453-4057qib7	11841	4	of	of	IN
cord-005453-4057qib7	11841	5	three	three	CD
cord-005453-4057qib7	11841	6	patients	patient	NNS
cord-005453-4057qib7	11841	7	relapsing	relapse	VBG
cord-005453-4057qib7	11841	8	after	after	IN
cord-005453-4057qib7	11841	9	transplant	transplant	NN
cord-005453-4057qib7	11841	10	in	in	IN
cord-005453-4057qib7	11841	11	which	which	WDT
cord-005453-4057qib7	11841	12	MC	MC	NNP
cord-005453-4057qib7	11841	13	was	be	VBD
cord-005453-4057qib7	11841	14	detected	detect	VBN
cord-005453-4057qib7	11841	15	both	both	CC
cord-005453-4057qib7	11841	16	in	in	IN
cord-005453-4057qib7	11841	17	peripheral	peripheral	JJ
cord-005453-4057qib7	11841	18	blood	blood	NN
cord-005453-4057qib7	11841	19	and	and	CC
cord-005453-4057qib7	11841	20	plasma	plasma	NN
cord-005453-4057qib7	11841	21	in	in	IN
cord-005453-4057qib7	11841	22	the	the	DT
cord-005453-4057qib7	11841	23	rest	rest	NN
cord-005453-4057qib7	11841	24	of	of	IN
cord-005453-4057qib7	11841	25	the	the	DT
cord-005453-4057qib7	11841	26	patients	patient	NNS
cord-005453-4057qib7	11841	27	(	(	-LRB-
cord-005453-4057qib7	11841	28	n=38	n=38	RB
cord-005453-4057qib7	11841	29	)	)	-RRB-
cord-005453-4057qib7	11842	1	MC	MC	NNP
cord-005453-4057qib7	11842	2	was	be	VBD
cord-005453-4057qib7	11842	3	detected	detect	VBN
cord-005453-4057qib7	11842	4	only	only	RB
cord-005453-4057qib7	11842	5	in	in	IN
cord-005453-4057qib7	11842	6	plasma	plasma	NN
cord-005453-4057qib7	11842	7	.	.	.
cord-005453-4057qib7	11843	1	The	the	DT
cord-005453-4057qib7	11843	2	mean	mean	JJ
cord-005453-4057qib7	11843	3	percentage	percentage	NN
cord-005453-4057qib7	11843	4	of	of	IN
cord-005453-4057qib7	11843	5	recipient	recipient	NN
cord-005453-4057qib7	11843	6	cfDNA	cfdna	RB
cord-005453-4057qib7	11843	7	in	in	IN
cord-005453-4057qib7	11843	8	the	the	DT
cord-005453-4057qib7	11843	9	plasma	plasma	NN
cord-005453-4057qib7	11843	10	samples	sample	NNS
cord-005453-4057qib7	11843	11	was	be	VBD
cord-005453-4057qib7	11843	12	18	18	CD
cord-005453-4057qib7	11843	13	%	%	NN
cord-005453-4057qib7	11843	14	(	(	-LRB-
cord-005453-4057qib7	11843	15	range	range	NN
cord-005453-4057qib7	11843	16	:	:	:
cord-005453-4057qib7	11843	17	1	1	CD
cord-005453-4057qib7	11843	18	-	-	SYM
cord-005453-4057qib7	11843	19	81	81	CD
cord-005453-4057qib7	11843	20	%	%	NN
cord-005453-4057qib7	11843	21	)	)	-RRB-
cord-005453-4057qib7	11843	22	.	.	.
cord-005453-4057qib7	11844	1	All	all	PDT
cord-005453-4057qib7	11844	2	the	the	DT
cord-005453-4057qib7	11844	3	patients	patient	NNS
cord-005453-4057qib7	11844	4	with	with	IN
cord-005453-4057qib7	11844	5	acute	acute	JJ
cord-005453-4057qib7	11844	6	GvHD	GvHD	NNP
cord-005453-4057qib7	11844	7	(	(	-LRB-
cord-005453-4057qib7	11844	8	aGvHD	agvhd	NN
cord-005453-4057qib7	11844	9	)	)	-RRB-
cord-005453-4057qib7	11844	10	(	(	-LRB-
cord-005453-4057qib7	11844	11	grade	grade	NN
cord-005453-4057qib7	11844	12	:	:	:
cord-005453-4057qib7	11844	13	I	I	NNP
cord-005453-4057qib7	11844	14	-	-	HYPH
cord-005453-4057qib7	11844	15	IV	IV	NNP
cord-005453-4057qib7	11844	16	)	)	-RRB-
cord-005453-4057qib7	11844	17	(	(	-LRB-
cord-005453-4057qib7	11844	18	n=15	n=15	NNP
cord-005453-4057qib7	11844	19	)	)	-RRB-
cord-005453-4057qib7	11844	20	showed	show	VBD
cord-005453-4057qib7	11844	21	MC	MC	NNP
cord-005453-4057qib7	11844	22	in	in	IN
cord-005453-4057qib7	11844	23	plasma	plasma	NN
cord-005453-4057qib7	11844	24	at	at	IN
cord-005453-4057qib7	11844	25	least	least	JJS
cord-005453-4057qib7	11844	26	in	in	IN
cord-005453-4057qib7	11844	27	one	one	CD
cord-005453-4057qib7	11844	28	of	of	IN
cord-005453-4057qib7	11844	29	the	the	DT
cord-005453-4057qib7	11844	30	time	time	NN
cord-005453-4057qib7	11844	31	-	-	HYPH
cord-005453-4057qib7	11844	32	point	point	NN
cord-005453-4057qib7	11844	33	tested	test	VBN
cord-005453-4057qib7	11844	34	.	.	.
cord-005453-4057qib7	11845	1	No	no	DT
cord-005453-4057qib7	11845	2	significant	significant	JJ
cord-005453-4057qib7	11845	3	difference	difference	NN
cord-005453-4057qib7	11845	4	was	be	VBD
cord-005453-4057qib7	11845	5	found	find	VBN
cord-005453-4057qib7	11845	6	in	in	IN
cord-005453-4057qib7	11845	7	the	the	DT
cord-005453-4057qib7	11845	8	mean	mean	JJ
cord-005453-4057qib7	11845	9	recipient	recipient	NN
cord-005453-4057qib7	11845	10	cfDNA	cfdna	JJ
cord-005453-4057qib7	11845	11	percentage	percentage	NN
cord-005453-4057qib7	11845	12	in	in	IN
cord-005453-4057qib7	11845	13	patients	patient	NNS
cord-005453-4057qib7	11845	14	with	with	IN
cord-005453-4057qib7	11845	15	aGvHD	aGvHD	.
cord-005453-4057qib7	11845	16	grade	grade	NN
cord-005453-4057qib7	11845	17	I	I	NNP
cord-005453-4057qib7	11845	18	-	-	HYPH
cord-005453-4057qib7	11845	19	II	II	NNP
cord-005453-4057qib7	11845	20	when	when	WRB
cord-005453-4057qib7	11845	21	compared	compare	VBN
cord-005453-4057qib7	11845	22	with	with	IN
cord-005453-4057qib7	11845	23	grade	grade	NN
cord-005453-4057qib7	11845	24	III	III	NNP
cord-005453-4057qib7	11845	25	-	-	HYPH
cord-005453-4057qib7	11845	26	IV	IV	NNP
cord-005453-4057qib7	11845	27	.	.	.
cord-005453-4057qib7	11846	1	Meanwhile	meanwhile	RB
cord-005453-4057qib7	11846	2	in	in	IN
cord-005453-4057qib7	11846	3	the	the	DT
cord-005453-4057qib7	11846	4	group	group	NN
cord-005453-4057qib7	11846	5	of	of	IN
cord-005453-4057qib7	11846	6	patients	patient	NNS
cord-005453-4057qib7	11846	7	with	with	IN
cord-005453-4057qib7	11846	8	chronic	chronic	JJ
cord-005453-4057qib7	11846	9	GvHD	GvHD	NNP
cord-005453-4057qib7	11846	10	(	(	-LRB-
cord-005453-4057qib7	11847	1	n=42	n=42	NNP
cord-005453-4057qib7	11847	2	)	)	-RRB-
cord-005453-4057qib7	11847	3	MC	MC	NNP
cord-005453-4057qib7	11847	4	in	in	IN
cord-005453-4057qib7	11847	5	plasma	plasma	NN
cord-005453-4057qib7	11847	6	was	be	VBD
cord-005453-4057qib7	11847	7	detected	detect	VBN
cord-005453-4057qib7	11847	8	in	in	IN
cord-005453-4057qib7	11847	9	13	13	CD
cord-005453-4057qib7	11847	10	patients	patient	NNS
cord-005453-4057qib7	11847	11	.	.	.
cord-005453-4057qib7	11848	1	In	in	IN
cord-005453-4057qib7	11848	2	those	those	DT
cord-005453-4057qib7	11848	3	patients	patient	NNS
cord-005453-4057qib7	11848	4	with	with	IN
cord-005453-4057qib7	11848	5	clinical	clinical	JJ
cord-005453-4057qib7	11848	6	improvement	improvement	NN
cord-005453-4057qib7	11848	7	of	of	IN
cord-005453-4057qib7	11848	8	aGvHD	agvhd	NN
cord-005453-4057qib7	11848	9	(	(	-LRB-
cord-005453-4057qib7	11848	10	n=6	n=6	NNP
cord-005453-4057qib7	11848	11	)	)	-RRB-
cord-005453-4057qib7	11848	12	a	a	DT
cord-005453-4057qib7	11848	13	decrease	decrease	NN
cord-005453-4057qib7	11848	14	in	in	IN
cord-005453-4057qib7	11848	15	the	the	DT
cord-005453-4057qib7	11848	16	percentage	percentage	NN
cord-005453-4057qib7	11848	17	of	of	IN
cord-005453-4057qib7	11848	18	recipient	recipient	NN
cord-005453-4057qib7	11848	19	cfDNA	cfDNA	NNPS
cord-005453-4057qib7	11848	20	was	be	VBD
cord-005453-4057qib7	11848	21	observed	observe	VBN
cord-005453-4057qib7	11848	22	during	during	IN
cord-005453-4057qib7	11848	23	treatment	treatment	NN
cord-005453-4057qib7	11848	24	.	.	.
cord-005453-4057qib7	11849	1	In	in	IN
cord-005453-4057qib7	11849	2	patients	patient	NNS
cord-005453-4057qib7	11849	3	without	without	IN
cord-005453-4057qib7	11849	4	improvement	improvement	NN
cord-005453-4057qib7	11849	5	or	or	CC
cord-005453-4057qib7	11849	6	even	even	RB
cord-005453-4057qib7	11849	7	aGvHD	agvhd	NN
cord-005453-4057qib7	11849	8	worsening	worsen	VBG
cord-005453-4057qib7	11849	9	(	(	-LRB-
cord-005453-4057qib7	11849	10	n=5	n=5	JJ
cord-005453-4057qib7	11849	11	)	)	-RRB-
cord-005453-4057qib7	11849	12	stable	stable	JJ
cord-005453-4057qib7	11849	13	or	or	CC
cord-005453-4057qib7	11849	14	increasing	increase	VBG
cord-005453-4057qib7	11849	15	recipient	recipient	NN
cord-005453-4057qib7	11849	16	cfDNA	cfdna	JJ
cord-005453-4057qib7	11849	17	percentage	percentage	NN
cord-005453-4057qib7	11849	18	was	be	VBD
cord-005453-4057qib7	11849	19	detected	detect	VBN
cord-005453-4057qib7	11849	20	.	.	.
cord-005453-4057qib7	11850	1	Since	since	IN
cord-005453-4057qib7	11850	2	recipient	recipient	NN
cord-005453-4057qib7	11850	3	cfDNA	cfdna	EX
cord-005453-4057qib7	11850	4	can	can	MD
cord-005453-4057qib7	11850	5	be	be	VB
cord-005453-4057qib7	11850	6	detected	detect	VBN
cord-005453-4057qib7	11850	7	in	in	IN
cord-005453-4057qib7	11850	8	patients	patient	NNS
cord-005453-4057qib7	11850	9	without	without	IN
cord-005453-4057qib7	11850	10	transplant	transplant	NN
cord-005453-4057qib7	11850	11	-	-	HYPH
cord-005453-4057qib7	11850	12	related	relate	VBN
cord-005453-4057qib7	11850	13	complications	complication	NNS
cord-005453-4057qib7	11850	14	we	-PRON-	PRP
cord-005453-4057qib7	11850	15	analysed	analyse	VBD
cord-005453-4057qib7	11850	16	the	the	DT
cord-005453-4057qib7	11850	17	miRNA	miRNA	NNP
cord-005453-4057qib7	11850	18	200c	200c	CD
cord-005453-4057qib7	11850	19	expression	expression	NN
cord-005453-4057qib7	11850	20	in	in	IN
cord-005453-4057qib7	11850	21	all	all	DT
cord-005453-4057qib7	11850	22	patients	patient	NNS
cord-005453-4057qib7	11850	23	with	with	IN
cord-005453-4057qib7	11850	24	recipient	recipient	NN
cord-005453-4057qib7	11850	25	cfDNA	cfdna	RB
cord-005453-4057qib7	11850	26	.	.	.
cord-005453-4057qib7	11851	1	A	a	DT
cord-005453-4057qib7	11851	2	significant	significant	JJ
cord-005453-4057qib7	11851	3	difference	difference	NN
cord-005453-4057qib7	11851	4	was	be	VBD
cord-005453-4057qib7	11851	5	found	find	VBN
cord-005453-4057qib7	11851	6	in	in	IN
cord-005453-4057qib7	11851	7	the	the	DT
cord-005453-4057qib7	11851	8	miRNA	miRNA	NNP
cord-005453-4057qib7	11851	9	200c	200c	CD
cord-005453-4057qib7	11851	10	expression	expression	NN
cord-005453-4057qib7	11851	11	in	in	IN
cord-005453-4057qib7	11851	12	patients	patient	NNS
cord-005453-4057qib7	11851	13	with	with	IN
cord-005453-4057qib7	11851	14	aGvHD	agvhd	NN
cord-005453-4057qib7	11851	15	(	(	-LRB-
cord-005453-4057qib7	11851	16	mean	mean	VB
cord-005453-4057qib7	11851	17	miRNA	miRNA	NNP
cord-005453-4057qib7	11851	18	200c	200c	NNP
cord-005453-4057qib7	11851	19	:	:	:
cord-005453-4057qib7	11852	1	9.7	9.7	CD
cord-005453-4057qib7	11852	2	miRNA	miRNA	NNP
cord-005453-4057qib7	11852	3	200c	200c	NNP
cord-005453-4057qib7	11852	4	copies/10	copies/10	NNP
cord-005453-4057qib7	11852	5	4	4	CD
cord-005453-4057qib7	11852	6	U6	U6	NNP
cord-005453-4057qib7	11852	7	copies	copy	NNS
cord-005453-4057qib7	11852	8	)	)	-RRB-
cord-005453-4057qib7	11852	9	when	when	WRB
cord-005453-4057qib7	11852	10	compared	compare	VBN
cord-005453-4057qib7	11852	11	with	with	IN
cord-005453-4057qib7	11852	12	patients	patient	NNS
cord-005453-4057qib7	11852	13	without	without	IN
cord-005453-4057qib7	11852	14	GvHD	GvHD	NNP
cord-005453-4057qib7	11852	15	(	(	-LRB-
cord-005453-4057qib7	11852	16	mean	mean	VB
cord-005453-4057qib7	11852	17	miRNA	miRNA	NNP
cord-005453-4057qib7	11852	18	200c	200c	NNP
cord-005453-4057qib7	11852	19	:	:	:
cord-005453-4057qib7	11853	1	35.4	35.4	CD
cord-005453-4057qib7	11853	2	miRNA	miRNA	NNP
cord-005453-4057qib7	11853	3	copies/10	copies/10	NNP
cord-005453-4057qib7	11853	4	4	4	CD
cord-005453-4057qib7	11853	5	U6	U6	NNP
cord-005453-4057qib7	11853	6	copies	copy	NNS
cord-005453-4057qib7	11853	7	)	)	-RRB-
cord-005453-4057qib7	11853	8	.	.	.
cord-005453-4057qib7	11854	1	In	in	IN
cord-005453-4057qib7	11854	2	those	those	DT
cord-005453-4057qib7	11854	3	patients	patient	NNS
cord-005453-4057qib7	11854	4	with	with	IN
cord-005453-4057qib7	11854	5	extramedullary	extramedullary	JJ
cord-005453-4057qib7	11854	6	AML	AML	NNP
cord-005453-4057qib7	11854	7	relapse	relapse	NN
cord-005453-4057qib7	11854	8	(	(	-LRB-
cord-005453-4057qib7	11854	9	n=3	n=3	NN
cord-005453-4057qib7	11854	10	)	)	-RRB-
cord-005453-4057qib7	11854	11	frequent	frequent	JJ
cord-005453-4057qib7	11854	12	mutations	mutation	NNS
cord-005453-4057qib7	11854	13	(	(	-LRB-
cord-005453-4057qib7	11854	14	FLT3-ITD	flt3-itd	VB
cord-005453-4057qib7	11854	15	,	,	,
cord-005453-4057qib7	11854	16	NPM1	NPM1	NNP
cord-005453-4057qib7	11854	17	)	)	-RRB-
cord-005453-4057qib7	11855	1	were	be	VBD
cord-005453-4057qib7	11855	2	only	only	RB
cord-005453-4057qib7	11855	3	detected	detect	VBN
cord-005453-4057qib7	11855	4	in	in	IN
cord-005453-4057qib7	11855	5	the	the	DT
cord-005453-4057qib7	11855	6	cfDNA	cfdna	JJ
cord-005453-4057qib7	11855	7	fraction	fraction	NN
cord-005453-4057qib7	11855	8	.	.	.
cord-005453-4057qib7	11856	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11856	2	:	:	:
cord-005453-4057qib7	11857	1	Longitudinal	longitudinal	JJ
cord-005453-4057qib7	11857	2	analysis	analysis	NN
cord-005453-4057qib7	11857	3	of	of	IN
cord-005453-4057qib7	11857	4	cfDNA	cfDNA	NNP
cord-005453-4057qib7	11857	5	represents	represent	VBZ
cord-005453-4057qib7	11857	6	a	a	DT
cord-005453-4057qib7	11857	7	useful	useful	JJ
cord-005453-4057qib7	11857	8	complementary	complementary	JJ
cord-005453-4057qib7	11857	9	tool	tool	NN
cord-005453-4057qib7	11857	10	in	in	IN
cord-005453-4057qib7	11857	11	particular	particular	JJ
cord-005453-4057qib7	11857	12	for	for	IN
cord-005453-4057qib7	11857	13	those	those	DT
cord-005453-4057qib7	11857	14	patients	patient	NNS
cord-005453-4057qib7	11857	15	with	with	IN
cord-005453-4057qib7	11857	16	clinical	clinical	JJ
cord-005453-4057qib7	11857	17	complications	complication	NNS
cord-005453-4057qib7	11857	18	after	after	IN
cord-005453-4057qib7	11857	19	HSCT	HSCT	NNP
cord-005453-4057qib7	11857	20	.	.	.
cord-005453-4057qib7	11858	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11858	2	:	:	:
cord-005453-4057qib7	11858	3	Nothing	nothing	NN
cord-005453-4057qib7	11858	4	to	to	TO
cord-005453-4057qib7	11858	5	declare	declare	VB
cord-005453-4057qib7	11858	6	Comparison	comparison	NN
cord-005453-4057qib7	11858	7	of	of	IN
cord-005453-4057qib7	11858	8	the	the	DT
cord-005453-4057qib7	11858	9	impact	impact	NN
cord-005453-4057qib7	11858	10	of	of	IN
cord-005453-4057qib7	11858	11	ATG	ATG	NNP
cord-005453-4057qib7	11858	12	/	/	SYM
cord-005453-4057qib7	11858	13	PT	PT	NNP
cord-005453-4057qib7	11858	14	-	-	HYPH
cord-005453-4057qib7	11858	15	CY	CY	NNP
cord-005453-4057qib7	11858	16	-	-	HYPH
cord-005453-4057qib7	11858	17	based	base	VBN
cord-005453-4057qib7	11858	18	and	and	CC
cord-005453-4057qib7	11858	19	TCR	TCR	NNP
cord-005453-4057qib7	11858	20	αβ	αβ	NN
cord-005453-4057qib7	11858	21	-	-	HYPH
cord-005453-4057qib7	11858	22	depletion	depletion	NN
cord-005453-4057qib7	11858	23	as	as	IN
cord-005453-4057qib7	11858	24	GVHD	GVHD	NNP
cord-005453-4057qib7	11858	25	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11858	26	regimens	regimen	NNS
cord-005453-4057qib7	11858	27	on	on	IN
cord-005453-4057qib7	11858	28	the	the	DT
cord-005453-4057qib7	11858	29	recovery	recovery	NN
cord-005453-4057qib7	11858	30	of	of	IN
cord-005453-4057qib7	11858	31	memory	memory	NN
cord-005453-4057qib7	11858	32	T	t	NN
cord-005453-4057qib7	11858	33	-	-	HYPH
cord-005453-4057qib7	11858	34	cell	cell	NN
cord-005453-4057qib7	11858	35	compartment	compartment	NN
cord-005453-4057qib7	11858	36	Background	background	NN
cord-005453-4057qib7	11858	37	:	:	:
cord-005453-4057qib7	11859	1	Over	over	IN
cord-005453-4057qib7	11859	2	recent	recent	JJ
cord-005453-4057qib7	11859	3	years	year	NNS
cord-005453-4057qib7	11859	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	11859	5	and	and	CC
cord-005453-4057qib7	11859	6	HLAmismatched	hlamismatched	JJ
cord-005453-4057qib7	11859	7	donors	donor	NNS
cord-005453-4057qib7	11859	8	have	have	VBP
cord-005453-4057qib7	11859	9	been	be	VBN
cord-005453-4057qib7	11859	10	increasingly	increasingly	RB
cord-005453-4057qib7	11859	11	adopted	adopt	VBN
cord-005453-4057qib7	11859	12	as	as	IN
cord-005453-4057qib7	11859	13	a	a	DT
cord-005453-4057qib7	11859	14	valid	valid	JJ
cord-005453-4057qib7	11859	15	donor	donor	NN
cord-005453-4057qib7	11859	16	source	source	NN
cord-005453-4057qib7	11859	17	.	.	.
cord-005453-4057qib7	11860	1	Modern	modern	JJ
cord-005453-4057qib7	11860	2	graft	graft	NN
cord-005453-4057qib7	11860	3	-	-	HYPH
cord-005453-4057qib7	11860	4	versus	versus	IN
cord-005453-4057qib7	11860	5	-	-	HYPH
cord-005453-4057qib7	11860	6	host	host	NN
cord-005453-4057qib7	11860	7	disease	disease	NN
cord-005453-4057qib7	11860	8	(	(	-LRB-
cord-005453-4057qib7	11861	1	GVHD	GVHD	NNP
cord-005453-4057qib7	11861	2	)	)	-RRB-
cord-005453-4057qib7	11861	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11861	4	regimens	regimen	NNS
cord-005453-4057qib7	11861	5	such	such	JJ
cord-005453-4057qib7	11861	6	as	as	IN
cord-005453-4057qib7	11861	7	drug	drug	NN
cord-005453-4057qib7	11861	8	-	-	HYPH
cord-005453-4057qib7	11861	9	based	base	VBN
cord-005453-4057qib7	11861	10	(	(	-LRB-
cord-005453-4057qib7	11861	11	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	11861	12	globulin	globulin	NN
cord-005453-4057qib7	11861	13	(	(	-LRB-
cord-005453-4057qib7	11861	14	ATG	ATG	NNP
cord-005453-4057qib7	11861	15	)	)	-RRB-
cord-005453-4057qib7	11861	16	,	,	,
cord-005453-4057qib7	11861	17	post	post	JJ
cord-005453-4057qib7	11861	18	-	-	JJ
cord-005453-4057qib7	11861	19	transplant	transplant	NN
cord-005453-4057qib7	11861	20	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	11861	21	(	(	-LRB-
cord-005453-4057qib7	11861	22	PT	PT	NNP
cord-005453-4057qib7	11861	23	-	-	HYPH
cord-005453-4057qib7	11861	24	Cy	Cy	NNP
cord-005453-4057qib7	11861	25	)	)	-RRB-
cord-005453-4057qib7	11861	26	)	)	-RRB-
cord-005453-4057qib7	11861	27	or	or	CC
cord-005453-4057qib7	11861	28	graft	graft	NN
cord-005453-4057qib7	11861	29	-	-	HYPH
cord-005453-4057qib7	11861	30	manipulated	manipulate	VBN
cord-005453-4057qib7	11861	31	(	(	-LRB-
cord-005453-4057qib7	11861	32	TCR	TCR	NNP
cord-005453-4057qib7	11861	33	αβ	αβ	NN
cord-005453-4057qib7	11861	34	-	-	HYPH
cord-005453-4057qib7	11861	35	depletion	depletion	NN
cord-005453-4057qib7	11861	36	)	)	-RRB-
cord-005453-4057qib7	11861	37	demonstrate	demonstrate	VB
cord-005453-4057qib7	11861	38	effective	effective	JJ
cord-005453-4057qib7	11861	39	prevention	prevention	NN
cord-005453-4057qib7	11861	40	of	of	IN
cord-005453-4057qib7	11861	41	GVHD	GVHD	NNP
cord-005453-4057qib7	11861	42	.	.	.
cord-005453-4057qib7	11862	1	Here	here	RB
cord-005453-4057qib7	11862	2	we	-PRON-	PRP
cord-005453-4057qib7	11862	3	report	report	VBP
cord-005453-4057qib7	11862	4	our	-PRON-	PRP$
cord-005453-4057qib7	11862	5	data	datum	NNS
cord-005453-4057qib7	11862	6	about	about	IN
cord-005453-4057qib7	11862	7	an	an	DT
cord-005453-4057qib7	11862	8	influence	influence	NN
cord-005453-4057qib7	11862	9	of	of	IN
cord-005453-4057qib7	11862	10	different	different	JJ
cord-005453-4057qib7	11862	11	GVHD	GVHD	NNP
cord-005453-4057qib7	11862	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11862	13	regimens	regimen	NNS
cord-005453-4057qib7	11862	14	after	after	IN
cord-005453-4057qib7	11862	15	allo	allo	NN
cord-005453-4057qib7	11862	16	-	-	HYPH
cord-005453-4057qib7	11862	17	HSCT	HSCT	NNP
cord-005453-4057qib7	11862	18	with	with	IN
cord-005453-4057qib7	11862	19	PBSC	PBSC	NNP
cord-005453-4057qib7	11862	20	as	as	IN
cord-005453-4057qib7	11862	21	a	a	DT
cord-005453-4057qib7	11862	22	graft	graft	NN
cord-005453-4057qib7	11862	23	source	source	NN
cord-005453-4057qib7	11862	24	on	on	IN
cord-005453-4057qib7	11862	25	CD8	CD8	NNP
cord-005453-4057qib7	11862	26	+	+	CC
cord-005453-4057qib7	11862	27	memory	memory	NN
cord-005453-4057qib7	11862	28	T	T	NNP
cord-005453-4057qib7	11862	29	-	-	HYPH
cord-005453-4057qib7	11862	30	cells	cell	NNS
cord-005453-4057qib7	11862	31	recovery	recovery	NN
cord-005453-4057qib7	11862	32	.	.	.
cord-005453-4057qib7	11863	1	Methods	method	NNS
cord-005453-4057qib7	11863	2	:	:	:
cord-005453-4057qib7	11863	3	Our	-PRON-	PRP$
cord-005453-4057qib7	11863	4	study	study	NN
cord-005453-4057qib7	11863	5	comprised	comprise	VBD
cord-005453-4057qib7	11863	6	32	32	CD
cord-005453-4057qib7	11863	7	leukemia	leukemia	NN
cord-005453-4057qib7	11863	8	patients	patient	NNS
cord-005453-4057qib7	11863	9	who	who	WP
cord-005453-4057qib7	11863	10	underwent	undergo	VBD
cord-005453-4057qib7	11863	11	allo	allo	NN
cord-005453-4057qib7	11863	12	-	-	HYPH
cord-005453-4057qib7	11863	13	HSCT	HSCT	NNP
cord-005453-4057qib7	11863	14	with	with	IN
cord-005453-4057qib7	11863	15	PBSC	PBSC	NNP
cord-005453-4057qib7	11863	16	as	as	IN
cord-005453-4057qib7	11863	17	a	a	DT
cord-005453-4057qib7	11863	18	graft	graft	NN
cord-005453-4057qib7	11863	19	source	source	NN
cord-005453-4057qib7	11863	20	in	in	IN
cord-005453-4057qib7	11863	21	National	National	NNP
cord-005453-4057qib7	11863	22	Research	Research	NNP
cord-005453-4057qib7	11863	23	Center	Center	NNP
cord-005453-4057qib7	11863	24	for	for	IN
cord-005453-4057qib7	11863	25	Hematology	Hematology	NNP
cord-005453-4057qib7	11863	26	,	,	,
cord-005453-4057qib7	11863	27	Moscow	Moscow	NNP
cord-005453-4057qib7	11863	28	,	,	,
cord-005453-4057qib7	11863	29	Russia	Russia	NNP
cord-005453-4057qib7	11863	30	.	.	.
cord-005453-4057qib7	11864	1	Detailed	detailed	JJ
cord-005453-4057qib7	11864	2	patients	patient	NNS
cord-005453-4057qib7	11864	3	characteristics	characteristic	NNS
cord-005453-4057qib7	11864	4	are	be	VBP
cord-005453-4057qib7	11864	5	presented	present	VBN
cord-005453-4057qib7	11864	6	in	in	IN
cord-005453-4057qib7	11864	7	Table	Table	NNP
cord-005453-4057qib7	11864	8	1	1	CD
cord-005453-4057qib7	11864	9	.	.	.
cord-005453-4057qib7	11865	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	11865	2	blood	blood	NN
cord-005453-4057qib7	11865	3	samples	sample	NNS
cord-005453-4057qib7	11865	4	were	be	VBD
cord-005453-4057qib7	11865	5	collected	collect	VBN
cord-005453-4057qib7	11865	6	on	on	IN
cord-005453-4057qib7	11865	7	day	day	NN
cord-005453-4057qib7	11865	8	+30	+30	CD
cord-005453-4057qib7	11865	9	,	,	,
cord-005453-4057qib7	11865	10	+60	+60	NNP
cord-005453-4057qib7	11865	11	and	and	CC
cord-005453-4057qib7	11865	12	+90	+90	NN
cord-005453-4057qib7	11865	13	after	after	IN
cord-005453-4057qib7	11865	14	allo	allo	NN
cord-005453-4057qib7	11865	15	-	-	HYPH
cord-005453-4057qib7	11865	16	HSCT	HSCT	NNP
cord-005453-4057qib7	11865	17	.	.	.
cord-005453-4057qib7	11866	1	Flow	flow	NN
cord-005453-4057qib7	11866	2	cytometry	cytometry	NN
cord-005453-4057qib7	11866	3	analysis	analysis	NN
cord-005453-4057qib7	11866	4	was	be	VBD
cord-005453-4057qib7	11866	5	performed	perform	VBN
cord-005453-4057qib7	11866	6	on	on	IN
cord-005453-4057qib7	11866	7	BD	BD	NNP
cord-005453-4057qib7	11866	8	FACS	FACS	NNP
cord-005453-4057qib7	11866	9	Canto	Canto	NNP
cord-005453-4057qib7	11866	10	II	II	NNP
cord-005453-4057qib7	11867	1	(	(	-LRB-
cord-005453-4057qib7	11867	2	Becton	Becton	NNP
cord-005453-4057qib7	11867	3	Dickinson	Dickinson	NNP
cord-005453-4057qib7	11867	4	,	,	,
cord-005453-4057qib7	11867	5	USA	USA	NNP
cord-005453-4057qib7	11867	6	)	)	-RRB-
cord-005453-4057qib7	11867	7	to	to	TO
cord-005453-4057qib7	11867	8	define	define	VB
cord-005453-4057qib7	11867	9	T	t	NN
cord-005453-4057qib7	11867	10	-	-	HYPH
cord-005453-4057qib7	11867	11	memory	memory	NN
cord-005453-4057qib7	11867	12	subsets	subset	NNS
cord-005453-4057qib7	11867	13	:	:	:
cord-005453-4057qib7	11867	14	T	t	NN
cord-005453-4057qib7	11867	15	-	-	HYPH
cord-005453-4057qib7	11867	16	naive	naive	JJ
cord-005453-4057qib7	11867	17	and	and	CC
cord-005453-4057qib7	11867	18	T	t	NN
cord-005453-4057qib7	11867	19	-	-	HYPH
cord-005453-4057qib7	11867	20	stem	stem	NN
cord-005453-4057qib7	11867	21	cell	cell	NN
cord-005453-4057qib7	11867	22	memory	memory	NN
cord-005453-4057qib7	11868	1	(	(	-LRB-
cord-005453-4057qib7	11868	2	Tnv+Tscm	Tnv+Tscm	NNP
cord-005453-4057qib7	11868	3	)	)	-RRB-
cord-005453-4057qib7	11869	1	-CD8+CD45R0-CCR7	-CD8+CD45R0-CCR7	.
cord-005453-4057qib7	11870	1	+	+	CC
cord-005453-4057qib7	11871	1	CD28	CD28	NNP
cord-005453-4057qib7	11872	1	+	+	CC
cord-005453-4057qib7	11872	2	;	;	:
cord-005453-4057qib7	11872	3	T	t	JJ
cord-005453-4057qib7	11872	4	-	-	HYPH
cord-005453-4057qib7	11872	5	central	central	JJ
cord-005453-4057qib7	11872	6	memory	memory	NN
cord-005453-4057qib7	11872	7	(	(	-LRB-
cord-005453-4057qib7	11872	8	Tcm	Tcm	NNP
cord-005453-4057qib7	11872	9	)	)	-RRB-
cord-005453-4057qib7	11872	10	-CD8+CD45R0	-CD8+CD45R0	:
cord-005453-4057qib7	11872	11	+	+	CC
cord-005453-4057qib7	11872	12	CCR7+CD28	CCR7+CD28	NNP
cord-005453-4057qib7	11872	13	+	+	CC
cord-005453-4057qib7	11872	14	;	;	:
cord-005453-4057qib7	11872	15	T	t	JJ
cord-005453-4057qib7	11872	16	-	-	HYPH
cord-005453-4057qib7	11872	17	transitional	transitional	JJ
cord-005453-4057qib7	11872	18	memory	memory	NN
cord-005453-4057qib7	11872	19	(	(	-LRB-
cord-005453-4057qib7	11872	20	Ttm	Ttm	NNP
cord-005453-4057qib7	11872	21	)	)	-RRB-
cord-005453-4057qib7	11872	22	-CD8	-CD8	.
cord-005453-4057qib7	11873	1	+	+	CC
cord-005453-4057qib7	11874	1	CD45R0+CCR7-CD28	CD45R0+CCR7-CD28	NNP
cord-005453-4057qib7	11875	1	+	+	CC
cord-005453-4057qib7	11875	2	;	;	:
cord-005453-4057qib7	11875	3	T	t	NN
cord-005453-4057qib7	11875	4	-	-	HYPH
cord-005453-4057qib7	11875	5	effector	effector	NN
cord-005453-4057qib7	11875	6	memory	memory	NN
cord-005453-4057qib7	11875	7	(	(	-LRB-
cord-005453-4057qib7	11875	8	Tem	Tem	NNP
cord-005453-4057qib7	11875	9	)	)	-RRB-
cord-005453-4057qib7	11875	10	-CD8+CD45R0+CCR7-CD28-	-cd8+cd45r0+ccr7-cd28-	NN
cord-005453-4057qib7	11875	11	;	;	:
cord-005453-4057qib7	11875	12	T	t	NN
cord-005453-4057qib7	11875	13	-	-	HYPH
cord-005453-4057qib7	11875	14	terminal	terminal	NN
cord-005453-4057qib7	11875	15	effector	effector	NN
cord-005453-4057qib7	11875	16	(	(	-LRB-
cord-005453-4057qib7	11875	17	Tte	Tte	NNP
cord-005453-4057qib7	11875	18	)	)	-RRB-
cord-005453-4057qib7	11875	19	-CD8+CD45R0-CCR7-CD28-	-cd8+cd45r0-ccr7-cd28-	ADD
cord-005453-4057qib7	11875	20	.	.	.
cord-005453-4057qib7	11876	1	Sysmex	Sysmex	NNP
cord-005453-4057qib7	11876	2	XE-2100	XE-2100	NNS
cord-005453-4057qib7	11876	3	was	be	VBD
cord-005453-4057qib7	11876	4	used	use	VBN
cord-005453-4057qib7	11876	5	to	to	TO
cord-005453-4057qib7	11876	6	calculate	calculate	VB
cord-005453-4057qib7	11876	7	absolute	absolute	JJ
cord-005453-4057qib7	11876	8	count	count	NN
cord-005453-4057qib7	11876	9	of	of	IN
cord-005453-4057qib7	11876	10	different	different	JJ
cord-005453-4057qib7	11876	11	T	t	NN
cord-005453-4057qib7	11876	12	-	-	HYPH
cord-005453-4057qib7	11876	13	memory	memory	NN
cord-005453-4057qib7	11876	14	cell	cell	NN
cord-005453-4057qib7	11876	15	subsets	subset	NNS
cord-005453-4057qib7	11876	16	.	.	.
cord-005453-4057qib7	11877	1	Mann	Mann	NNP
cord-005453-4057qib7	11877	2	-	-	HYPH
cord-005453-4057qib7	11877	3	Whitney	Whitney	NNP
cord-005453-4057qib7	11877	4	U	U	NNP
cord-005453-4057qib7	11877	5	test	test	NN
cord-005453-4057qib7	11877	6	was	be	VBD
cord-005453-4057qib7	11877	7	used	use	VBN
cord-005453-4057qib7	11877	8	for	for	IN
cord-005453-4057qib7	11877	9	nonparametric	nonparametric	JJ
cord-005453-4057qib7	11877	10	data	datum	NNS
cord-005453-4057qib7	11877	11	analysis	analysis	NN
cord-005453-4057qib7	11877	12	.	.	.
cord-005453-4057qib7	11878	1	A	a	DT
cord-005453-4057qib7	11878	2	p	p	NN
cord-005453-4057qib7	11878	3	-	-	HYPH
cord-005453-4057qib7	11878	4	value	value	NN
cord-005453-4057qib7	11878	5	less	less	JJR
cord-005453-4057qib7	11878	6	than	than	IN
cord-005453-4057qib7	11878	7	0.05	0.05	CD
cord-005453-4057qib7	11878	8	was	be	VBD
cord-005453-4057qib7	11878	9	considered	consider	VBN
cord-005453-4057qib7	11878	10	as	as	RB
cord-005453-4057qib7	11878	11	significant	significant	JJ
cord-005453-4057qib7	11878	12	.	.	.
cord-005453-4057qib7	11879	1	Results	result	NNS
cord-005453-4057qib7	11879	2	:	:	:
cord-005453-4057qib7	11879	3	Results	result	NNS
cord-005453-4057qib7	11879	4	of	of	IN
cord-005453-4057qib7	11879	5	Mann	Mann	NNP
cord-005453-4057qib7	11879	6	-	-	HYPH
cord-005453-4057qib7	11879	7	Whitney	Whitney	NNP
cord-005453-4057qib7	11879	8	U	U	NNP
cord-005453-4057qib7	11879	9	test	test	NN
cord-005453-4057qib7	11879	10	(	(	-LRB-
cord-005453-4057qib7	11879	11	calculated	calculate	VBN
cord-005453-4057qib7	11879	12	pvalues	pvalues	NNP
cord-005453-4057qib7	11879	13	)	)	-RRB-
cord-005453-4057qib7	11880	1	to	to	TO
cord-005453-4057qib7	11880	2	compare	compare	VB
cord-005453-4057qib7	11880	3	absolute	absolute	JJ
cord-005453-4057qib7	11880	4	number	number	NN
cord-005453-4057qib7	11880	5	of	of	IN
cord-005453-4057qib7	11880	6	T	t	NN
cord-005453-4057qib7	11880	7	-	-	HYPH
cord-005453-4057qib7	11880	8	memory	memory	NN
cord-005453-4057qib7	11880	9	cell	cell	NN
cord-005453-4057qib7	11880	10	subsets	subset	NNS
cord-005453-4057qib7	11880	11	in	in	IN
cord-005453-4057qib7	11880	12	terms	term	NNS
cord-005453-4057qib7	11880	13	of	of	IN
cord-005453-4057qib7	11880	14	different	different	JJ
cord-005453-4057qib7	11880	15	GVHD	GVHD	NNP
cord-005453-4057qib7	11880	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11880	17	regimens	regimen	NNS
cord-005453-4057qib7	11880	18	are	be	VBP
cord-005453-4057qib7	11880	19	presented	present	VBN
cord-005453-4057qib7	11880	20	in	in	IN
cord-005453-4057qib7	11880	21	Figure	figure	NN
cord-005453-4057qib7	11880	22	1	1	CD
cord-005453-4057qib7	11880	23	.	.	.
cord-005453-4057qib7	11881	1	During	during	IN
cord-005453-4057qib7	11881	2	all	all	DT
cord-005453-4057qib7	11881	3	follow	follow	VB
cord-005453-4057qib7	11881	4	-	-	HYPH
cord-005453-4057qib7	11881	5	up	up	NN
cord-005453-4057qib7	11881	6	period	period	NN
cord-005453-4057qib7	11881	7	the	the	DT
cord-005453-4057qib7	11881	8	number	number	NN
cord-005453-4057qib7	11881	9	of	of	IN
cord-005453-4057qib7	11881	10	Tnv+scm	Tnv+scm	NNP
cord-005453-4057qib7	11881	11	and	and	CC
cord-005453-4057qib7	11881	12	Tcm	Tcm	NNP
cord-005453-4057qib7	11881	13	remains	remain	VBZ
cord-005453-4057qib7	11881	14	significantly	significantly	RB
cord-005453-4057qib7	11881	15	reduced	reduce	VBN
cord-005453-4057qib7	11881	16	after	after	IN
cord-005453-4057qib7	11881	17	ATG+PT	ATG+PT	NNP
cord-005453-4057qib7	11881	18	-	-	HYPH
cord-005453-4057qib7	11881	19	Cy	Cy	NNP
cord-005453-4057qib7	11881	20	or	or	CC
cord-005453-4057qib7	11881	21	TCR	TCR	NNP
cord-005453-4057qib7	11881	22	αβ	αβ	NN
cord-005453-4057qib7	11881	23	-	-	HYPH
cord-005453-4057qib7	11881	24	depletion	depletion	NN
cord-005453-4057qib7	11881	25	compared	compare	VBN
cord-005453-4057qib7	11881	26	to	to	IN
cord-005453-4057qib7	11881	27	ATG	ATG	NNP
cord-005453-4057qib7	11881	28	-	-	HYPH
cord-005453-4057qib7	11881	29	based	base	VBN
cord-005453-4057qib7	11881	30	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	11881	31	regimen	regimen	NN
cord-005453-4057qib7	11881	32	.	.	.
cord-005453-4057qib7	11882	1	On	on	IN
cord-005453-4057qib7	11882	2	day	day	NN
cord-005453-4057qib7	11882	3	+30	+30	CD
cord-005453-4057qib7	11882	4	we	-PRON-	PRP
cord-005453-4057qib7	11882	5	observe	observe	VBP
cord-005453-4057qib7	11882	6	no	no	DT
cord-005453-4057qib7	11882	7	difference	difference	NN
cord-005453-4057qib7	11882	8	in	in	IN
cord-005453-4057qib7	11882	9	the	the	DT
cord-005453-4057qib7	11882	10	number	number	NN
cord-005453-4057qib7	11882	11	of	of	IN
cord-005453-4057qib7	11882	12	Tnv+scm	Tnv+scm	NNP
cord-005453-4057qib7	11882	13	and	and	CC
cord-005453-4057qib7	11882	14	Tcm	Tcm	NNP
cord-005453-4057qib7	11882	15	cells	cell	NNS
cord-005453-4057qib7	11882	16	after	after	IN
cord-005453-4057qib7	11882	17	ATG+PT	ATG+PT	NNP
cord-005453-4057qib7	11882	18	-	-	HYPH
cord-005453-4057qib7	11882	19	Cy	Cy	NNP
cord-005453-4057qib7	11882	20	or	or	CC
cord-005453-4057qib7	11882	21	TCR	TCR	NNP
cord-005453-4057qib7	11882	22	αβ	αβ	NN
cord-005453-4057qib7	11882	23	-	-	HYPH
cord-005453-4057qib7	11882	24	depletion	depletion	NN
cord-005453-4057qib7	11882	25	.	.	.
cord-005453-4057qib7	11883	1	Terminally	terminally	RB
cord-005453-4057qib7	11883	2	differentiated	differentiate	VBN
cord-005453-4057qib7	11883	3	CD8	CD8	NNP
cord-005453-4057qib7	11883	4	+	+	CC
cord-005453-4057qib7	11883	5	cells	cell	NNS
cord-005453-4057qib7	11883	6	(	(	-LRB-
cord-005453-4057qib7	11884	1	Ttm	Ttm	NNP
cord-005453-4057qib7	11884	2	,	,	,
cord-005453-4057qib7	11884	3	Tem	Tem	NNP
cord-005453-4057qib7	11884	4	,	,	,
cord-005453-4057qib7	11884	5	Tte	Tte	NNP
cord-005453-4057qib7	11884	6	)	)	-RRB-
cord-005453-4057qib7	11884	7	count	count	NN
cord-005453-4057qib7	11884	8	is	be	VBZ
cord-005453-4057qib7	11884	9	significantly	significantly	RB
cord-005453-4057qib7	11884	10	lowered	lower	VBN
cord-005453-4057qib7	11884	11	in	in	IN
cord-005453-4057qib7	11884	12	TCR	TCR	NNP
cord-005453-4057qib7	11884	13	αβ	αβ	NN
cord-005453-4057qib7	11884	14	-	-	HYPH
cord-005453-4057qib7	11884	15	depletion	depletion	NN
cord-005453-4057qib7	11884	16	patients	patient	NNS
cord-005453-4057qib7	11884	17	group	group	NN
cord-005453-4057qib7	11884	18	in	in	IN
cord-005453-4057qib7	11884	19	comparison	comparison	NN
cord-005453-4057qib7	11884	20	to	to	IN
cord-005453-4057qib7	11884	21	ATG+PT	ATG+PT	NNP
cord-005453-4057qib7	11884	22	-	-	HYPH
cord-005453-4057qib7	11884	23	Cy	Cy	NNP
cord-005453-4057qib7	11884	24	.	.	.
cord-005453-4057qib7	11885	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	11885	2	recovery	recovery	NN
cord-005453-4057qib7	11885	3	of	of	IN
cord-005453-4057qib7	11885	4	Tnv+scm	Tnv+scm	NNP
cord-005453-4057qib7	11885	5	and	and	CC
cord-005453-4057qib7	11885	6	Tcm	Tcm	NNP
cord-005453-4057qib7	11885	7	after	after	IN
cord-005453-4057qib7	11885	8	PT	PT	NNP
cord-005453-4057qib7	11885	9	-	-	HYPH
cord-005453-4057qib7	11885	10	Cy	Cy	NNP
cord-005453-4057qib7	11885	11	is	be	VBZ
cord-005453-4057qib7	11885	12	faster	fast	JJR
cord-005453-4057qib7	11885	13	than	than	IN
cord-005453-4057qib7	11885	14	after	after	IN
cord-005453-4057qib7	11885	15	TCR	TCR	NNP
cord-005453-4057qib7	11885	16	αβ	αβ	NN
cord-005453-4057qib7	11885	17	-	-	HYPH
cord-005453-4057qib7	11885	18	depletion	depletion	NN
cord-005453-4057qib7	11885	19	.	.	.
cord-005453-4057qib7	11886	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11886	2	:	:	:
cord-005453-4057qib7	11887	1	According	accord	VBG
cord-005453-4057qib7	11887	2	to	to	IN
cord-005453-4057qib7	11887	3	our	-PRON-	PRP$
cord-005453-4057qib7	11887	4	data	datum	NNS
cord-005453-4057qib7	11887	5	the	the	DT
cord-005453-4057qib7	11887	6	mechanism	mechanism	NN
cord-005453-4057qib7	11887	7	of	of	IN
cord-005453-4057qib7	11887	8	PT	PT	NNP
cord-005453-4057qib7	11887	9	-	-	HYPH
cord-005453-4057qib7	11887	10	Cy	Cy	NNP
cord-005453-4057qib7	11887	11	is	be	VBZ
cord-005453-4057qib7	11887	12	seems	seem	VBZ
cord-005453-4057qib7	11887	13	to	to	TO
cord-005453-4057qib7	11887	14	be	be	VB
cord-005453-4057qib7	11887	15	more	more	RBR
cord-005453-4057qib7	11887	16	selective	selective	JJ
cord-005453-4057qib7	11887	17	compared	compare	VBN
cord-005453-4057qib7	11887	18	to	to	IN
cord-005453-4057qib7	11887	19	TCR	TCR	NNP
cord-005453-4057qib7	11887	20	αβ	αβ	NN
cord-005453-4057qib7	11887	21	-	-	HYPH
cord-005453-4057qib7	11887	22	depletion	depletion	NN
cord-005453-4057qib7	11887	23	due	due	IN
cord-005453-4057qib7	11887	24	to	to	IN
cord-005453-4057qib7	11887	25	its	-PRON-	PRP$
cord-005453-4057qib7	11887	26	transient	transient	JJ
cord-005453-4057qib7	11887	27	impact	impact	NN
cord-005453-4057qib7	11887	28	just	just	RB
cord-005453-4057qib7	11887	29	on	on	IN
cord-005453-4057qib7	11887	30	Tnv+scm	Tnv+scm	NNP
cord-005453-4057qib7	11887	31	and	and	CC
cord-005453-4057qib7	11887	32	Tcm	Tcm	NNP
cord-005453-4057qib7	11887	33	without	without	IN
cord-005453-4057qib7	11887	34	affecting	affect	VBG
cord-005453-4057qib7	11887	35	on	on	IN
cord-005453-4057qib7	11887	36	the	the	DT
cord-005453-4057qib7	11887	37	effector	effector	JJ
cord-005453-4057qib7	11887	38	pool	pool	NN
cord-005453-4057qib7	11887	39	.	.	.
cord-005453-4057qib7	11888	1	Through	through	IN
cord-005453-4057qib7	11888	2	this	this	DT
cord-005453-4057qib7	11888	3	it	-PRON-	PRP
cord-005453-4057qib7	11888	4	may	may	MD
cord-005453-4057qib7	11888	5	lead	lead	VB
cord-005453-4057qib7	11888	6	to	to	IN
cord-005453-4057qib7	11888	7	delayed	delay	VBN
cord-005453-4057qib7	11888	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	11888	9	of	of	IN
cord-005453-4057qib7	11888	10	adaptive	adaptive	JJ
cord-005453-4057qib7	11888	11	immunity	immunity	NN
cord-005453-4057qib7	11888	12	after	after	IN
cord-005453-4057qib7	11888	13	TCR	TCR	NNP
cord-005453-4057qib7	11888	14	αβ	αβ	NN
cord-005453-4057qib7	11888	15	-	-	HYPH
cord-005453-4057qib7	11888	16	depletion	depletion	NN
cord-005453-4057qib7	11888	17	compared	compare	VBN
cord-005453-4057qib7	11888	18	to	to	IN
cord-005453-4057qib7	11888	19	using	use	VBG
cord-005453-4057qib7	11888	20	PT	PT	NNP
cord-005453-4057qib7	11888	21	-	-	HYPH
cord-005453-4057qib7	11888	22	Cy	Cy	NNP
cord-005453-4057qib7	11888	23	.	.	.
cord-005453-4057qib7	11889	1	Clinical	clinical	JJ
cord-005453-4057qib7	11889	2	relevance	relevance	NN
cord-005453-4057qib7	11889	3	of	of	IN
cord-005453-4057qib7	11889	4	the	the	DT
cord-005453-4057qib7	11889	5	quantitative	quantitative	JJ
cord-005453-4057qib7	11889	6	characteristics	characteristic	NNS
cord-005453-4057qib7	11889	7	of	of	IN
cord-005453-4057qib7	11889	8	immune	immune	JJ
cord-005453-4057qib7	11889	9	recovery	recovery	NN
cord-005453-4057qib7	11889	10	in	in	IN
cord-005453-4057qib7	11889	11	the	the	DT
cord-005453-4057qib7	11889	12	context	context	NN
cord-005453-4057qib7	11889	13	of	of	IN
cord-005453-4057qib7	11889	14	different	different	JJ
cord-005453-4057qib7	11889	15	approaches	approach	NNS
cord-005453-4057qib7	11889	16	to	to	IN
cord-005453-4057qib7	11889	17	GVHD	GVHD	NNP
cord-005453-4057qib7	11889	18	prevention	prevention	NN
cord-005453-4057qib7	11889	19	remains	remain	VBZ
cord-005453-4057qib7	11889	20	to	to	TO
cord-005453-4057qib7	11889	21	be	be	VB
cord-005453-4057qib7	11889	22	established	establish	VBN
cord-005453-4057qib7	11889	23	.	.	.
cord-005453-4057qib7	11890	1	Background	background	NN
cord-005453-4057qib7	11890	2	:	:	:
cord-005453-4057qib7	11891	1	Immune	immune	JJ
cord-005453-4057qib7	11891	2	effector	effector	NN
cord-005453-4057qib7	11891	3	cells	cell	NNS
cord-005453-4057qib7	11891	4	,	,	,
cord-005453-4057qib7	11891	5	belonging	belong	VBG
cord-005453-4057qib7	11891	6	to	to	IN
cord-005453-4057qib7	11891	7	either	either	CC
cord-005453-4057qib7	11891	8	innate	innate	JJ
cord-005453-4057qib7	11891	9	or	or	CC
cord-005453-4057qib7	11891	10	acquired	acquire	VBN
cord-005453-4057qib7	11891	11	immunity	immunity	NN
cord-005453-4057qib7	11891	12	,	,	,
cord-005453-4057qib7	11891	13	play	play	VB
cord-005453-4057qib7	11891	14	a	a	DT
cord-005453-4057qib7	11891	15	key	key	JJ
cord-005453-4057qib7	11891	16	role	role	NN
cord-005453-4057qib7	11891	17	on	on	IN
cord-005453-4057qib7	11891	18	preventing	prevent	VBG
cord-005453-4057qib7	11891	19	disease	disease	NN
cord-005453-4057qib7	11891	20	relapse	relapse	NN
cord-005453-4057qib7	11891	21	after	after	IN
cord-005453-4057qib7	11891	22	allogeneic	allogeneic	JJ
cord-005453-4057qib7	11891	23	Haematopoietic	Haematopoietic	NNP
cord-005453-4057qib7	11891	24	Stem	Stem	NNP
cord-005453-4057qib7	11891	25	Cell	Cell	NNP
cord-005453-4057qib7	11891	26	Transplantation	transplantation	NN
cord-005453-4057qib7	11891	27	(	(	-LRB-
cord-005453-4057qib7	11891	28	HSCT	HSCT	NNP
cord-005453-4057qib7	11891	29	)	)	-RRB-
cord-005453-4057qib7	11891	30	.	.	.
cord-005453-4057qib7	11892	1	Most	Most	JJS
cord-005453-4057qib7	11892	2	of	of	IN
cord-005453-4057qib7	11892	3	known	know	VBN
cord-005453-4057qib7	11892	4	immune	immune	JJ
cord-005453-4057qib7	11892	5	effector	effector	NN
cord-005453-4057qib7	11892	6	are	be	VBP
cord-005453-4057qib7	11892	7	CD3	CD3	NNP
cord-005453-4057qib7	11892	8	+	+	SYM
cord-005453-4057qib7	11892	9	CD8	CD8	NNP
cord-005453-4057qib7	11892	10	+	+	CC
cord-005453-4057qib7	11892	11	T	T	NNP
cord-005453-4057qib7	11892	12	-	-	HYPH
cord-005453-4057qib7	11892	13	cells	cell	NNS
cord-005453-4057qib7	11892	14	and	and	CC
cord-005453-4057qib7	11892	15	CD3	CD3	NNP
cord-005453-4057qib7	11892	16	-CD56	-cd56	NN
cord-005453-4057qib7	11892	17	+	+	NNP
cord-005453-4057qib7	11892	18	Natural	Natural	NNP
cord-005453-4057qib7	11892	19	Killer	Killer	NNP
cord-005453-4057qib7	11892	20	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11892	21	,	,	,
cord-005453-4057qib7	11892	22	while	while	IN
cord-005453-4057qib7	11892	23	CD3	CD3	NNP
cord-005453-4057qib7	11892	24	+	+	SYM
cord-005453-4057qib7	11892	25	CD4	CD4	NNP
cord-005453-4057qib7	11892	26	+	+	CC
cord-005453-4057qib7	11892	27	cells	cell	NNS
cord-005453-4057qib7	11892	28	act	act	VBP
cord-005453-4057qib7	11892	29	as	as	IN
cord-005453-4057qib7	11892	30	modulatory	modulatory	JJ
cord-005453-4057qib7	11892	31	and	and	CC
cord-005453-4057qib7	11892	32	regulatory	regulatory	JJ
cord-005453-4057qib7	11892	33	cells	cell	NNS
cord-005453-4057qib7	11892	34	.	.	.
cord-005453-4057qib7	11893	1	The	the	DT
cord-005453-4057qib7	11893	2	early	early	JJ
cord-005453-4057qib7	11893	3	post	post	JJ
cord-005453-4057qib7	11893	4	-	-	JJ
cord-005453-4057qib7	11893	5	HSCT	hsct	JJ
cord-005453-4057qib7	11893	6	ratio	ratio	NN
cord-005453-4057qib7	11893	7	between	between	IN
cord-005453-4057qib7	11893	8	these	these	DT
cord-005453-4057qib7	11893	9	cellular	cellular	JJ
cord-005453-4057qib7	11893	10	subsets	subset	NNS
cord-005453-4057qib7	11893	11	may	may	MD
cord-005453-4057qib7	11893	12	be	be	VB
cord-005453-4057qib7	11893	13	an	an	DT
cord-005453-4057qib7	11893	14	indicator	indicator	NN
cord-005453-4057qib7	11893	15	of	of	IN
cord-005453-4057qib7	11893	16	Graft	Graft	NNP
cord-005453-4057qib7	11893	17	vs	vs	IN
cord-005453-4057qib7	11893	18	-	-	HYPH
cord-005453-4057qib7	11893	19	Tumor	tumor	NN
cord-005453-4057qib7	11893	20	(	(	-LRB-
cord-005453-4057qib7	11893	21	GVT	GVT	NNP
cord-005453-4057qib7	11893	22	)	)	-RRB-
cord-005453-4057qib7	11893	23	effect	effect	NN
cord-005453-4057qib7	11893	24	.	.	.
cord-005453-4057qib7	11894	1	Methods	method	NNS
cord-005453-4057qib7	11894	2	:	:	:
cord-005453-4057qib7	11894	3	We	-PRON-	PRP
cord-005453-4057qib7	11894	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	11894	5	revised	revise	VBD
cord-005453-4057qib7	11894	6	the	the	DT
cord-005453-4057qib7	11894	7	immune	immune	JJ
cord-005453-4057qib7	11894	8	recovery	recovery	NN
cord-005453-4057qib7	11894	9	of	of	IN
cord-005453-4057qib7	11894	10	117	117	CD
cord-005453-4057qib7	11894	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	11894	12	HSCT	HSCT	NNP
cord-005453-4057qib7	11894	13	performed	perform	VBN
cord-005453-4057qib7	11894	14	at	at	IN
cord-005453-4057qib7	11894	15	our	-PRON-	PRP$
cord-005453-4057qib7	11894	16	Institution	Institution	NNP
cord-005453-4057qib7	11894	17	from	from	IN
cord-005453-4057qib7	11894	18	2013	2013	CD
cord-005453-4057qib7	11894	19	to	to	IN
cord-005453-4057qib7	11894	20	2017	2017	CD
cord-005453-4057qib7	11894	21	,	,	,
cord-005453-4057qib7	11894	22	analysed	analyse	VBN
cord-005453-4057qib7	11894	23	on	on	IN
cord-005453-4057qib7	11894	24	peripheral	peripheral	JJ
cord-005453-4057qib7	11894	25	blood	blood	NN
cord-005453-4057qib7	11894	26	by	by	IN
cord-005453-4057qib7	11894	27	multiparametric	multiparametric	JJ
cord-005453-4057qib7	11894	28	flow	flow	NN
cord-005453-4057qib7	11894	29	cytometry	cytometry	NN
cord-005453-4057qib7	11894	30	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11894	31	subpopulations	subpopulation	NNS
cord-005453-4057qib7	11894	32	panel	panel	NN
cord-005453-4057qib7	11894	33	.	.	.
cord-005453-4057qib7	11895	1	DIagnosis	DIagnosis	NNP
cord-005453-4057qib7	11895	2	were	be	VBD
cord-005453-4057qib7	11895	3	Acute	acute	JJ
cord-005453-4057qib7	11895	4	Leukemias	Leukemias	NNPS
cord-005453-4057qib7	11895	5	(	(	-LRB-
cord-005453-4057qib7	11895	6	69	69	CD
cord-005453-4057qib7	11895	7	%	%	NN
cord-005453-4057qib7	11895	8	)	)	-RRB-
cord-005453-4057qib7	11895	9	,	,	,
cord-005453-4057qib7	11895	10	Chronic	Chronic	NNP
cord-005453-4057qib7	11895	11	Myeloproliferative	Myeloproliferative	NNP
cord-005453-4057qib7	11895	12	Neoplasms	Neoplasms	NNP
cord-005453-4057qib7	11895	13	(	(	-LRB-
cord-005453-4057qib7	11895	14	10	10	CD
cord-005453-4057qib7	11895	15	%	%	NN
cord-005453-4057qib7	11895	16	)	)	-RRB-
cord-005453-4057qib7	11895	17	,	,	,
cord-005453-4057qib7	11895	18	Lymphomas	lymphoma	NNS
cord-005453-4057qib7	11895	19	(	(	-LRB-
cord-005453-4057qib7	11895	20	10	10	CD
cord-005453-4057qib7	11895	21	%	%	NN
cord-005453-4057qib7	11895	22	)	)	-RRB-
cord-005453-4057qib7	11895	23	,	,	,
cord-005453-4057qib7	11895	24	Myelodysplastic	Myelodysplastic	NNP
cord-005453-4057qib7	11895	25	Syndromes	syndrome	NNS
cord-005453-4057qib7	11895	26	(	(	-LRB-
cord-005453-4057qib7	11895	27	5	5	CD
cord-005453-4057qib7	11895	28	%	%	NN
cord-005453-4057qib7	11895	29	)	)	-RRB-
cord-005453-4057qib7	11895	30	,	,	,
cord-005453-4057qib7	11895	31	Multiple	Multiple	NNP
cord-005453-4057qib7	11895	32	Myeloma	Myeloma	NNP
cord-005453-4057qib7	11895	33	(	(	-LRB-
cord-005453-4057qib7	11895	34	3	3	CD
cord-005453-4057qib7	11895	35	%	%	NN
cord-005453-4057qib7	11895	36	)	)	-RRB-
cord-005453-4057qib7	11895	37	and	and	CC
cord-005453-4057qib7	11895	38	Severe	severe	JJ
cord-005453-4057qib7	11895	39	Aplastic	Aplastic	NNP
cord-005453-4057qib7	11895	40	Anemia	anemia	NN
cord-005453-4057qib7	11895	41	(	(	-LRB-
cord-005453-4057qib7	11895	42	3	3	CD
cord-005453-4057qib7	11895	43	%	%	NN
cord-005453-4057qib7	11895	44	)	)	-RRB-
cord-005453-4057qib7	11895	45	.	.	.
cord-005453-4057qib7	11896	1	We	-PRON-	PRP
cord-005453-4057qib7	11896	2	established	establish	VBD
cord-005453-4057qib7	11896	3	2	2	CD
cord-005453-4057qib7	11896	4	early	early	JJ
cord-005453-4057qib7	11896	5	time	time	NN
cord-005453-4057qib7	11896	6	-	-	HYPH
cord-005453-4057qib7	11896	7	points	point	NNS
cord-005453-4057qib7	11896	8	of	of	IN
cord-005453-4057qib7	11896	9	evaluation	evaluation	NN
cord-005453-4057qib7	11896	10	,	,	,
cord-005453-4057qib7	11896	11	30	30	CD
cord-005453-4057qib7	11896	12	and	and	CC
cord-005453-4057qib7	11896	13	60	60	CD
cord-005453-4057qib7	11896	14	days	day	NNS
cord-005453-4057qib7	11896	15	from	from	IN
cord-005453-4057qib7	11896	16	the	the	DT
cord-005453-4057qib7	11896	17	graft	graft	NN
cord-005453-4057qib7	11896	18	infusion	infusion	NN
cord-005453-4057qib7	11896	19	,	,	,
cord-005453-4057qib7	11896	20	to	to	TO
cord-005453-4057qib7	11896	21	analyse	analyse	VB
cord-005453-4057qib7	11896	22	the	the	DT
cord-005453-4057qib7	11896	23	differences	difference	NNS
cord-005453-4057qib7	11896	24	in	in	IN
cord-005453-4057qib7	11896	25	disease	disease	NN
cord-005453-4057qib7	11896	26	free	free	JJ
cord-005453-4057qib7	11896	27	survival	survival	NN
cord-005453-4057qib7	11896	28	(	(	-LRB-
cord-005453-4057qib7	11896	29	DFS	DFS	NNP
cord-005453-4057qib7	11896	30	)	)	-RRB-
cord-005453-4057qib7	11896	31	and	and	CC
cord-005453-4057qib7	11896	32	overall	overall	JJ
cord-005453-4057qib7	11896	33	survival	survival	NN
cord-005453-4057qib7	11896	34	(	(	-LRB-
cord-005453-4057qib7	11896	35	OS	OS	NNP
cord-005453-4057qib7	11896	36	)	)	-RRB-
cord-005453-4057qib7	11896	37	between	between	IN
cord-005453-4057qib7	11896	38	patients	patient	NNS
cord-005453-4057qib7	11896	39	according	accord	VBG
cord-005453-4057qib7	11896	40	to	to	IN
cord-005453-4057qib7	11896	41	the	the	DT
cord-005453-4057qib7	11896	42	CD3	CD3	NNP
cord-005453-4057qib7	11896	43	+	+	SYM
cord-005453-4057qib7	11896	44	CD8	CD8	NNP
cord-005453-4057qib7	11896	45	+	+	CC
cord-005453-4057qib7	11897	1	x	x	SYM
cord-005453-4057qib7	11897	2	CD3	CD3	NNP
cord-005453-4057qib7	11897	3	-CD56	-cd56	NN
cord-005453-4057qib7	11898	1	+	+	CC
cord-005453-4057qib7	11898	2	/	/	SYM
cord-005453-4057qib7	11898	3	CD3	CD3	NNP
cord-005453-4057qib7	11898	4	+	+	CC
cord-005453-4057qib7	11898	5	CD4	CD4	NNP
cord-005453-4057qib7	11898	6	+	+	CC
cord-005453-4057qib7	11898	7	ratio	ratio	NN
cord-005453-4057qib7	11898	8	.	.	.
cord-005453-4057qib7	11899	1	Results	result	NNS
cord-005453-4057qib7	11899	2	:	:	:
cord-005453-4057qib7	11900	1	Median	median	JJ
cord-005453-4057qib7	11900	2	ratio	ratio	NN
cord-005453-4057qib7	11900	3	at	at	IN
cord-005453-4057qib7	11900	4	+60	+60	CD
cord-005453-4057qib7	11900	5	days	day	NNS
cord-005453-4057qib7	11900	6	was	be	VBD
cord-005453-4057qib7	11900	7	of	of	IN
cord-005453-4057qib7	11900	8	0,5667	0,5667	CD
cord-005453-4057qib7	11900	9	.	.	.
cord-005453-4057qib7	11901	1	At	at	IN
cord-005453-4057qib7	11901	2	this	this	DT
cord-005453-4057qib7	11901	3	time	time	NN
cord-005453-4057qib7	11901	4	point	point	NN
cord-005453-4057qib7	11901	5	,	,	,
cord-005453-4057qib7	11901	6	patients	patient	NNS
cord-005453-4057qib7	11901	7	who	who	WP
cord-005453-4057qib7	11901	8	showed	show	VBD
cord-005453-4057qib7	11901	9	the	the	DT
cord-005453-4057qib7	11901	10	ratio	ratio	NN
cord-005453-4057qib7	11901	11	higher	high	JJR
cord-005453-4057qib7	11901	12	than	than	IN
cord-005453-4057qib7	11901	13	the	the	DT
cord-005453-4057qib7	11901	14	median	median	NN
cord-005453-4057qib7	11901	15	had	have	VBD
cord-005453-4057qib7	11901	16	both	both	CC
cord-005453-4057qib7	11901	17	a	a	DT
cord-005453-4057qib7	11901	18	better	well	JJR
cord-005453-4057qib7	11901	19	DFS	DFS	NNP
cord-005453-4057qib7	11901	20	(	(	-LRB-
cord-005453-4057qib7	11901	21	median	median	JJ
cord-005453-4057qib7	11901	22	DFS	DFS	NNP
cord-005453-4057qib7	11901	23	time	time	NN
cord-005453-4057qib7	11901	24	not	not	RB
cord-005453-4057qib7	11901	25	reached	reach	VBN
cord-005453-4057qib7	11901	26	vs	vs	IN
cord-005453-4057qib7	11901	27	12	12	CD
cord-005453-4057qib7	11901	28	months	month	NNS
cord-005453-4057qib7	11901	29	;	;	:
cord-005453-4057qib7	11901	30	p	p	NN
cord-005453-4057qib7	11901	31	=	=	SYM
cord-005453-4057qib7	11901	32	0,018	0,018	CD
cord-005453-4057qib7	11901	33	)	)	-RRB-
cord-005453-4057qib7	11902	1	(	(	-LRB-
cord-005453-4057qib7	11902	2	Figure	figure	NN
cord-005453-4057qib7	11902	3	1	1	CD
cord-005453-4057qib7	11902	4	)	)	-RRB-
cord-005453-4057qib7	11902	5	and	and	CC
cord-005453-4057qib7	11902	6	OS	OS	NNP
cord-005453-4057qib7	11902	7	(	(	-LRB-
cord-005453-4057qib7	11902	8	median	median	JJ
cord-005453-4057qib7	11902	9	OS	OS	NNP
cord-005453-4057qib7	11902	10	time	time	NN
cord-005453-4057qib7	11902	11	not	not	RB
cord-005453-4057qib7	11902	12	reached	reach	VBN
cord-005453-4057qib7	11902	13	vs	vs	IN
cord-005453-4057qib7	11902	14	13	13	CD
cord-005453-4057qib7	11902	15	months	month	NNS
cord-005453-4057qib7	11902	16	;	;	:
cord-005453-4057qib7	11902	17	p	p	NN
cord-005453-4057qib7	11902	18	=	=	SYM
cord-005453-4057qib7	11902	19	0,014	0,014	CD
cord-005453-4057qib7	11902	20	)	)	-RRB-
cord-005453-4057qib7	11902	21	.	.	.
cord-005453-4057qib7	11903	1	Likewise	likewise	RB
cord-005453-4057qib7	11903	2	,	,	,
cord-005453-4057qib7	11903	3	ratio	ratio	NN
cord-005453-4057qib7	11903	4	at	at	IN
cord-005453-4057qib7	11903	5	+30	+30	CD
cord-005453-4057qib7	11903	6	showed	show	VBD
cord-005453-4057qib7	11903	7	an	an	DT
cord-005453-4057qib7	11903	8	advantage	advantage	NN
cord-005453-4057qib7	11903	9	on	on	IN
cord-005453-4057qib7	11903	10	DFS	DFS	NNP
cord-005453-4057qib7	11903	11	(	(	-LRB-
cord-005453-4057qib7	11903	12	p	p	NN
cord-005453-4057qib7	11903	13	=	=	SYM
cord-005453-4057qib7	11903	14	0,027	0,027	CD
cord-005453-4057qib7	11903	15	)	)	-RRB-
cord-005453-4057qib7	11903	16	,	,	,
cord-005453-4057qib7	11903	17	and	and	CC
cord-005453-4057qib7	11903	18	not	not	RB
cord-005453-4057qib7	11903	19	on	on	IN
cord-005453-4057qib7	11903	20	OS	OS	NNP
cord-005453-4057qib7	11903	21	(	(	-LRB-
cord-005453-4057qib7	11903	22	p	p	NN
cord-005453-4057qib7	11903	23	=	=	SYM
cord-005453-4057qib7	11903	24	0,06	0,06	CD
cord-005453-4057qib7	11903	25	)	)	-RRB-
cord-005453-4057qib7	11903	26	.	.	.
cord-005453-4057qib7	11904	1	Other	other	JJ
cord-005453-4057qib7	11904	2	factors	factor	NNS
cord-005453-4057qib7	11904	3	possibly	possibly	RB
cord-005453-4057qib7	11904	4	affecting	affect	VBG
cord-005453-4057qib7	11904	5	both	both	CC
cord-005453-4057qib7	11904	6	DFS	DFS	NNP
cord-005453-4057qib7	11904	7	and	and	CC
cord-005453-4057qib7	11904	8	OS	OS	NNP
cord-005453-4057qib7	11904	9	were	be	VBD
cord-005453-4057qib7	11904	10	analysed	analyse	VBN
cord-005453-4057qib7	11904	11	in	in	IN
cord-005453-4057qib7	11904	12	univariate	univariate	JJ
cord-005453-4057qib7	11904	13	analysis	analysis	NN
cord-005453-4057qib7	11904	14	,	,	,
cord-005453-4057qib7	11904	15	such	such	JJ
cord-005453-4057qib7	11904	16	as	as	IN
cord-005453-4057qib7	11904	17	the	the	DT
cord-005453-4057qib7	11904	18	use	use	NN
cord-005453-4057qib7	11904	19	of	of	IN
cord-005453-4057qib7	11904	20	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	11904	21	globulin	globulin	NN
cord-005453-4057qib7	11904	22	(	(	-LRB-
cord-005453-4057qib7	11904	23	ATG	ATG	NNP
cord-005453-4057qib7	11904	24	)	)	-RRB-
cord-005453-4057qib7	11904	25	,	,	,
cord-005453-4057qib7	11904	26	conditioning	conditioning	NN
cord-005453-4057qib7	11904	27	regimen	regimen	NN
cord-005453-4057qib7	11904	28	intensity	intensity	NN
cord-005453-4057qib7	11904	29	,	,	,
cord-005453-4057qib7	11904	30	graft	graft	NN
cord-005453-4057qib7	11904	31	source	source	NN
cord-005453-4057qib7	11904	32	,	,	,
cord-005453-4057qib7	11904	33	HLA	HLA	NNP
cord-005453-4057qib7	11904	34	-	-	HYPH
cord-005453-4057qib7	11904	35	matching	matching	NN
cord-005453-4057qib7	11904	36	and	and	CC
cord-005453-4057qib7	11904	37	disease	disease	NN
cord-005453-4057qib7	11904	38	status	status	NN
cord-005453-4057qib7	11904	39	at	at	IN
cord-005453-4057qib7	11904	40	HSCT	HSCT	NNP
cord-005453-4057qib7	11904	41	,	,	,
cord-005453-4057qib7	11904	42	the	the	DT
cord-005453-4057qib7	11904	43	latter	latter	JJ
cord-005453-4057qib7	11904	44	being	be	VBG
cord-005453-4057qib7	11904	45	the	the	DT
cord-005453-4057qib7	11904	46	only	only	JJ
cord-005453-4057qib7	11904	47	variable	variable	NN
cord-005453-4057qib7	11904	48	with	with	IN
cord-005453-4057qib7	11904	49	a	a	DT
cord-005453-4057qib7	11904	50	significantly	significantly	RB
cord-005453-4057qib7	11904	51	detrimental	detrimental	JJ
cord-005453-4057qib7	11904	52	impact	impact	NN
cord-005453-4057qib7	11904	53	on	on	IN
cord-005453-4057qib7	11904	54	both	both	CC
cord-005453-4057qib7	11904	55	OS	OS	NNP
cord-005453-4057qib7	11904	56	and	and	CC
cord-005453-4057qib7	11904	57	DFS	DFS	NNP
cord-005453-4057qib7	11904	58	.	.	.
cord-005453-4057qib7	11905	1	Disease	disease	NN
cord-005453-4057qib7	11905	2	status	status	NN
cord-005453-4057qib7	11905	3	was	be	VBD
cord-005453-4057qib7	11905	4	confirmed	confirm	VBN
cord-005453-4057qib7	11905	5	an	an	DT
cord-005453-4057qib7	11905	6	independent	independent	JJ
cord-005453-4057qib7	11905	7	valriable	valriable	NN
cord-005453-4057qib7	11905	8	associated	associate	VBN
cord-005453-4057qib7	11905	9	with	with	IN
cord-005453-4057qib7	11905	10	both	both	DT
cord-005453-4057qib7	11905	11	DFS	DFS	NNP
cord-005453-4057qib7	11905	12	and	and	CC
cord-005453-4057qib7	11905	13	OS	OS	NNP
cord-005453-4057qib7	11905	14	as	as	RB
cord-005453-4057qib7	11905	15	well	well	RB
cord-005453-4057qib7	11905	16	as	as	IN
cord-005453-4057qib7	11905	17	+60	+60	CD
cord-005453-4057qib7	11905	18	ratio	ratio	NN
cord-005453-4057qib7	11905	19	both	both	CC
cord-005453-4057qib7	11905	20	on	on	IN
cord-005453-4057qib7	11905	21	DFS	DFS	NNP
cord-005453-4057qib7	11905	22	(	(	-LRB-
cord-005453-4057qib7	11905	23	Hazard	Hazard	NNP
cord-005453-4057qib7	11905	24	Ratio	Ratio	NNP
cord-005453-4057qib7	11905	25	[	[	-LRB-
cord-005453-4057qib7	11905	26	HR	HR	NNP
cord-005453-4057qib7	11905	27	]	]	-RRB-
cord-005453-4057qib7	11905	28	-2,721	-2,721	.
cord-005453-4057qib7	11906	1	;	;	:
cord-005453-4057qib7	11906	2	p	p	NN
cord-005453-4057qib7	11906	3	=	=	SYM
cord-005453-4057qib7	11906	4	0,015	0,015	CD
cord-005453-4057qib7	11906	5	)	)	-RRB-
cord-005453-4057qib7	11907	1	and	and	CC
cord-005453-4057qib7	11907	2	OS	OS	NNP
cord-005453-4057qib7	11907	3	(	(	-LRB-
cord-005453-4057qib7	11907	4	HR	HR	NNP
cord-005453-4057qib7	11907	5	2,627	2,627	CD
cord-005453-4057qib7	11907	6	;	;	:
cord-005453-4057qib7	11907	7	p	p	NN
cord-005453-4057qib7	11907	8	=	=	SYM
cord-005453-4057qib7	11907	9	0,022	0,022	CD
cord-005453-4057qib7	11907	10	)	)	-RRB-
cord-005453-4057qib7	11907	11	.	.	.
cord-005453-4057qib7	11908	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11908	2	:	:	:
cord-005453-4057qib7	11909	1	Our	-PRON-	PRP$
cord-005453-4057qib7	11909	2	data	datum	NNS
cord-005453-4057qib7	11909	3	show	show	VBP
cord-005453-4057qib7	11909	4	that	that	IN
cord-005453-4057qib7	11909	5	CD3	CD3	NNP
cord-005453-4057qib7	11909	6	+	+	SYM
cord-005453-4057qib7	11909	7	CD8	CD8	NNP
cord-005453-4057qib7	11909	8	+	+	CC
cord-005453-4057qib7	11909	9	x	x	SYM
cord-005453-4057qib7	11909	10	CD3	CD3	NNP
cord-005453-4057qib7	11909	11	-CD56	-cd56	NN
cord-005453-4057qib7	11909	12	+	+	NNP
cord-005453-4057qib7	11909	13	/	/	SYM
cord-005453-4057qib7	11909	14	CD3	CD3	NNP
cord-005453-4057qib7	11910	1	+	+	CC
cord-005453-4057qib7	11911	1	CD4	CD4	NNP
cord-005453-4057qib7	11911	2	+	+	CC
cord-005453-4057qib7	11911	3	ratio	ratio	NN
cord-005453-4057qib7	11911	4	assessed	assess	VBN
cord-005453-4057qib7	11911	5	at	at	IN
cord-005453-4057qib7	11911	6	+60	+60	NNP
cord-005453-4057qib7	11911	7	is	be	VBZ
cord-005453-4057qib7	11911	8	and	and	CC
cord-005453-4057qib7	11911	9	independent	independent	JJ
cord-005453-4057qib7	11911	10	predictor	predictor	NN
cord-005453-4057qib7	11911	11	of	of	IN
cord-005453-4057qib7	11911	12	transplant	transplant	NN
cord-005453-4057qib7	11911	13	outcome	outcome	NN
cord-005453-4057qib7	11911	14	,	,	,
cord-005453-4057qib7	11911	15	possibly	possibly	RB
cord-005453-4057qib7	11911	16	representing	represent	VBG
cord-005453-4057qib7	11911	17	a	a	DT
cord-005453-4057qib7	11911	18	row	row	NN
cord-005453-4057qib7	11911	19	indicator	indicator	NN
cord-005453-4057qib7	11911	20	of	of	IN
cord-005453-4057qib7	11911	21	anti	anti	JJ
cord-005453-4057qib7	11911	22	-	-	JJ
cord-005453-4057qib7	11911	23	leukemic	leukemic	JJ
cord-005453-4057qib7	11911	24	immune	immune	JJ
cord-005453-4057qib7	11911	25	surveillance	surveillance	NN
cord-005453-4057qib7	11911	26	.	.	.
cord-005453-4057qib7	11912	1	The	the	DT
cord-005453-4057qib7	11912	2	integration	integration	NN
cord-005453-4057qib7	11912	3	of	of	IN
cord-005453-4057qib7	11912	4	this	this	DT
cord-005453-4057qib7	11912	5	index	index	NN
cord-005453-4057qib7	11912	6	with	with	IN
cord-005453-4057qib7	11912	7	other	other	JJ
cord-005453-4057qib7	11912	8	known	know	VBN
cord-005453-4057qib7	11912	9	outcome	outcome	NN
cord-005453-4057qib7	11912	10	predictors	predictor	NNS
cord-005453-4057qib7	11912	11	may	may	MD
cord-005453-4057qib7	11912	12	help	help	VB
cord-005453-4057qib7	11912	13	in	in	IN
cord-005453-4057qib7	11912	14	improving	improve	VBG
cord-005453-4057qib7	11912	15	the	the	DT
cord-005453-4057qib7	11912	16	management	management	NN
cord-005453-4057qib7	11912	17	of	of	IN
cord-005453-4057qib7	11912	18	post	post	JJ
cord-005453-4057qib7	11912	19	-	-	JJ
cord-005453-4057qib7	11912	20	transplant	transplant	JJ
cord-005453-4057qib7	11912	21	phase	phase	NN
cord-005453-4057qib7	11912	22	.	.	.
cord-005453-4057qib7	11913	1	[	[	-LRB-
cord-005453-4057qib7	11913	2	[	[	-LRB-
cord-005453-4057qib7	11913	3	P524	P524	NNP
cord-005453-4057qib7	11913	4	Image	image	NN
cord-005453-4057qib7	11913	5	]	]	-RRB-
cord-005453-4057qib7	11913	6	1	1	CD
cord-005453-4057qib7	11913	7	.	.	.
cord-005453-4057qib7	11914	1	Figure	figure	NN
cord-005453-4057qib7	11914	2	1	1	CD
cord-005453-4057qib7	11914	3	Background	background	NN
cord-005453-4057qib7	11914	4	:	:	:
cord-005453-4057qib7	11915	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	11915	2	stem	stem	VBP
cord-005453-4057qib7	11915	3	cell	cell	NN
cord-005453-4057qib7	11915	4	transplantation	transplantation	NN
cord-005453-4057qib7	11915	5	(	(	-LRB-
cord-005453-4057qib7	11915	6	alo	alo	NNP
cord-005453-4057qib7	11915	7	-	-	HYPH
cord-005453-4057qib7	11915	8	HSCT	HSCT	NNP
cord-005453-4057qib7	11915	9	)	)	-RRB-
cord-005453-4057qib7	11915	10	is	be	VBZ
cord-005453-4057qib7	11915	11	a	a	DT
cord-005453-4057qib7	11915	12	curative	curative	JJ
cord-005453-4057qib7	11915	13	treatment	treatment	NN
cord-005453-4057qib7	11916	1	but	but	CC
cord-005453-4057qib7	11916	2	it	-PRON-	PRP
cord-005453-4057qib7	11916	3	is	be	VBZ
cord-005453-4057qib7	11916	4	associated	associate	VBN
cord-005453-4057qib7	11916	5	with	with	IN
cord-005453-4057qib7	11916	6	lifethreatening	lifethreatening	JJ
cord-005453-4057qib7	11916	7	complications	complication	NNS
cord-005453-4057qib7	11916	8	.	.	.
cord-005453-4057qib7	11917	1	Most	Most	JJS
cord-005453-4057qib7	11917	2	deaths	death	NNS
cord-005453-4057qib7	11917	3	are	be	VBP
cord-005453-4057qib7	11917	4	due	due	JJ
cord-005453-4057qib7	11917	5	to	to	IN
cord-005453-4057qib7	11917	6	relapse	relapse	NN
cord-005453-4057qib7	11917	7	,	,	,
cord-005453-4057qib7	11917	8	graft	graft	NN
cord-005453-4057qib7	11917	9	versus	versus	IN
cord-005453-4057qib7	11917	10	host	host	NN
cord-005453-4057qib7	11917	11	disease	disease	NN
cord-005453-4057qib7	11917	12	(	(	-LRB-
cord-005453-4057qib7	11917	13	GvHD	GvHD	NNP
cord-005453-4057qib7	11917	14	)	)	-RRB-
cord-005453-4057qib7	11917	15	and	and	CC
cord-005453-4057qib7	11917	16	infection	infection	NN
cord-005453-4057qib7	11917	17	.	.	.
cord-005453-4057qib7	11918	1	The	the	DT
cord-005453-4057qib7	11918	2	pattern	pattern	NN
cord-005453-4057qib7	11918	3	and	and	CC
cord-005453-4057qib7	11918	4	quality	quality	NN
cord-005453-4057qib7	11918	5	of	of	IN
cord-005453-4057qib7	11918	6	the	the	DT
cord-005453-4057qib7	11918	7	immune	immune	JJ
cord-005453-4057qib7	11918	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	11918	9	(	(	-LRB-
cord-005453-4057qib7	11918	10	IR	IR	NNP
cord-005453-4057qib7	11918	11	)	)	-RRB-
cord-005453-4057qib7	11918	12	after	after	IN
cord-005453-4057qib7	11918	13	transplantation	transplantation	NN
cord-005453-4057qib7	11918	14	may	may	MD
cord-005453-4057qib7	11918	15	affect	affect	VB
cord-005453-4057qib7	11918	16	these	these	DT
cord-005453-4057qib7	11918	17	outcomes	outcome	NNS
cord-005453-4057qib7	11918	18	.	.	.
cord-005453-4057qib7	11919	1	However	however	RB
cord-005453-4057qib7	11919	2	,	,	,
cord-005453-4057qib7	11919	3	there	there	EX
cord-005453-4057qib7	11919	4	are	be	VBP
cord-005453-4057qib7	11919	5	limited	limited	JJ
cord-005453-4057qib7	11919	6	data	datum	NNS
cord-005453-4057qib7	11919	7	on	on	IN
cord-005453-4057qib7	11919	8	the	the	DT
cord-005453-4057qib7	11919	9	association	association	NN
cord-005453-4057qib7	11919	10	of	of	IN
cord-005453-4057qib7	11919	11	the	the	DT
cord-005453-4057qib7	11919	12	quality	quality	NN
cord-005453-4057qib7	11919	13	of	of	IN
cord-005453-4057qib7	11919	14	the	the	DT
cord-005453-4057qib7	11919	15	IR	IR	NNP
cord-005453-4057qib7	11919	16	and	and	CC
cord-005453-4057qib7	11919	17	either	either	CC
cord-005453-4057qib7	11919	18	the	the	DT
cord-005453-4057qib7	11919	19	development	development	NN
cord-005453-4057qib7	11919	20	of	of	IN
cord-005453-4057qib7	11919	21	GVHD	GVHD	NNP
cord-005453-4057qib7	11919	22	and	and	CC
cord-005453-4057qib7	11919	23	survival	survival	NN
cord-005453-4057qib7	11919	24	.	.	.
cord-005453-4057qib7	11920	1	Methods	method	NNS
cord-005453-4057qib7	11920	2	:	:	:
cord-005453-4057qib7	11920	3	Eighty	eighty	CD
cord-005453-4057qib7	11920	4	-	-	HYPH
cord-005453-4057qib7	11920	5	five	five	CD
cord-005453-4057qib7	11920	6	patients	patient	NNS
cord-005453-4057qib7	11920	7	who	who	WP
cord-005453-4057qib7	11920	8	received	receive	VBD
cord-005453-4057qib7	11920	9	a	a	DT
cord-005453-4057qib7	11920	10	non	non	JJ
cord-005453-4057qib7	11920	11	T	t	NN
cord-005453-4057qib7	11920	12	-	-	HYPH
cord-005453-4057qib7	11920	13	cell	cell	NN
cord-005453-4057qib7	11920	14	depleted	deplete	VBN
cord-005453-4057qib7	11920	15	alo	alo	NNP
cord-005453-4057qib7	11920	16	-	-	HYPH
cord-005453-4057qib7	11920	17	HSCT	HSCT	NNP
cord-005453-4057qib7	11920	18	in	in	IN
cord-005453-4057qib7	11920	19	our	-PRON-	PRP$
cord-005453-4057qib7	11920	20	center	center	NN
cord-005453-4057qib7	11920	21	from	from	IN
cord-005453-4057qib7	11920	22	2011	2011	CD
cord-005453-4057qib7	11920	23	to	to	IN
cord-005453-4057qib7	11920	24	2014	2014	CD
cord-005453-4057qib7	11920	25	were	be	VBD
cord-005453-4057qib7	11920	26	prospectively	prospectively	RB
cord-005453-4057qib7	11920	27	studied	study	VBN
cord-005453-4057qib7	11920	28	.	.	.
cord-005453-4057qib7	11921	1	Most	Most	JJS
cord-005453-4057qib7	11921	2	patients	patient	NNS
cord-005453-4057qib7	11921	3	received	receive	VBD
cord-005453-4057qib7	11921	4	HLA	HLA	NNP
cord-005453-4057qib7	11921	5	-	-	HYPH
cord-005453-4057qib7	11921	6	identical	identical	JJ
cord-005453-4057qib7	11921	7	grafts	graft	NNS
cord-005453-4057qib7	11921	8	.	.	.
cord-005453-4057qib7	11922	1	Total	total	JJ
cord-005453-4057qib7	11922	2	CD4	CD4	NNP
cord-005453-4057qib7	11922	3	+	+	CC
cord-005453-4057qib7	11922	4	and	and	CC
cord-005453-4057qib7	11922	5	CD8	CD8	NNP
cord-005453-4057qib7	11922	6	+	+	CC
cord-005453-4057qib7	11922	7	T	T	NNP
cord-005453-4057qib7	11922	8	cells	cell	NNS
cord-005453-4057qib7	11922	9	,	,	,
cord-005453-4057qib7	11923	1	CCR7+CD4	CCR7+CD4	NNP
cord-005453-4057qib7	11923	2	+	+	CC
cord-005453-4057qib7	11924	1	and	and	CC
cord-005453-4057qib7	11924	2	CCR7+CD8	CCR7+CD8	NNP
cord-005453-4057qib7	11925	1	+	+	JJ
cord-005453-4057qib7	11925	2	(	(	-LRB-
cord-005453-4057qib7	11925	3	which	which	WDT
cord-005453-4057qib7	11925	4	include	include	VBP
cord-005453-4057qib7	11925	5	both	both	DT
cord-005453-4057qib7	11925	6	naïve	naïve	JJ
cord-005453-4057qib7	11925	7	and	and	CC
cord-005453-4057qib7	11925	8	central	central	JJ
cord-005453-4057qib7	11925	9	memory	memory	NN
cord-005453-4057qib7	11925	10	T	T	NNP
cord-005453-4057qib7	11925	11	cells	cell	NNS
cord-005453-4057qib7	11925	12	)	)	-RRB-
cord-005453-4057qib7	11925	13	and	and	CC
cord-005453-4057qib7	11925	14	naïve	naïve	JJ
cord-005453-4057qib7	11925	15	CCR7+CD62L+	CCR7+CD62L+	NNS
cord-005453-4057qib7	11925	16	T	t	NN
cord-005453-4057qib7	11925	17	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11925	18	were	be	VBD
cord-005453-4057qib7	11925	19	quantified	quantify	VBN
cord-005453-4057qib7	11925	20	by	by	IN
cord-005453-4057qib7	11925	21	flow	flow	NN
cord-005453-4057qib7	11925	22	cytometry	cytometry	NN
cord-005453-4057qib7	11925	23	.	.	.
cord-005453-4057qib7	11926	1	Data	datum	NNS
cord-005453-4057qib7	11926	2	were	be	VBD
cord-005453-4057qib7	11926	3	collected	collect	VBN
cord-005453-4057qib7	11926	4	at	at	IN
cord-005453-4057qib7	11926	5	days	day	NNS
cord-005453-4057qib7	11926	6	+30	+30	CD
cord-005453-4057qib7	11926	7	,	,	,
cord-005453-4057qib7	11926	8	+60	+60	NNP
cord-005453-4057qib7	11926	9	,	,	,
cord-005453-4057qib7	11926	10	+90	+90	CD
cord-005453-4057qib7	11926	11	,	,	,
cord-005453-4057qib7	11926	12	+180	+180	NNP
cord-005453-4057qib7	11926	13	and	and	CC
cord-005453-4057qib7	11926	14	+360	+360	NNP
cord-005453-4057qib7	11926	15	after	after	IN
cord-005453-4057qib7	11926	16	alo	alo	JJ
cord-005453-4057qib7	11926	17	-	-	HYPH
cord-005453-4057qib7	11926	18	HSCT	HSCT	NNP
cord-005453-4057qib7	11926	19	.	.	.
cord-005453-4057qib7	11927	1	The	the	DT
cord-005453-4057qib7	11927	2	association	association	NN
cord-005453-4057qib7	11927	3	between	between	IN
cord-005453-4057qib7	11927	4	IR	IR	NNP
cord-005453-4057qib7	11927	5	and	and	CC
cord-005453-4057qib7	11927	6	the	the	DT
cord-005453-4057qib7	11927	7	GVHD	GVHD	NNP
cord-005453-4057qib7	11927	8	was	be	VBD
cord-005453-4057qib7	11927	9	studied	study	VBN
cord-005453-4057qib7	11927	10	through	through	IN
cord-005453-4057qib7	11927	11	an	an	DT
cord-005453-4057qib7	11927	12	ANOVA	anova	NN
cord-005453-4057qib7	11927	13	.	.	.
cord-005453-4057qib7	11928	1	For	for	IN
cord-005453-4057qib7	11928	2	the	the	DT
cord-005453-4057qib7	11928	3	multivariate	multivariate	JJ
cord-005453-4057qib7	11928	4	analysis	analysis	NN
cord-005453-4057qib7	11928	5	,	,	,
cord-005453-4057qib7	11928	6	a	a	DT
cord-005453-4057qib7	11928	7	logistic	logistic	JJ
cord-005453-4057qib7	11928	8	regression	regression	NN
cord-005453-4057qib7	11928	9	was	be	VBD
cord-005453-4057qib7	11928	10	performed	perform	VBN
cord-005453-4057qib7	11928	11	including	include	VBG
cord-005453-4057qib7	11928	12	those	those	DT
cord-005453-4057qib7	11928	13	confusing	confuse	VBG
cord-005453-4057qib7	11928	14	clinical	clinical	JJ
cord-005453-4057qib7	11928	15	variables	variable	NNS
cord-005453-4057qib7	11928	16	that	that	WDT
cord-005453-4057qib7	11928	17	were	be	VBD
cord-005453-4057qib7	11928	18	significant	significant	JJ
cord-005453-4057qib7	11928	19	in	in	IN
cord-005453-4057qib7	11928	20	the	the	DT
cord-005453-4057qib7	11928	21	univariate	univariate	JJ
cord-005453-4057qib7	11928	22	analysis	analysis	NN
cord-005453-4057qib7	11928	23	(	(	-LRB-
cord-005453-4057qib7	11928	24	p≤0.10	p≤0.10	NN
cord-005453-4057qib7	11928	25	)	)	-RRB-
cord-005453-4057qib7	11928	26	.	.	.
cord-005453-4057qib7	11929	1	The	the	DT
cord-005453-4057qib7	11929	2	study	study	NN
cord-005453-4057qib7	11929	3	of	of	IN
cord-005453-4057qib7	11929	4	overall	overall	JJ
cord-005453-4057qib7	11929	5	survival	survival	NN
cord-005453-4057qib7	11929	6	(	(	-LRB-
cord-005453-4057qib7	11929	7	OS	OS	NNP
cord-005453-4057qib7	11929	8	)	)	-RRB-
cord-005453-4057qib7	11929	9	versus	versus	IN
cord-005453-4057qib7	11929	10	IR	IR	NNP
cord-005453-4057qib7	11929	11	was	be	VBD
cord-005453-4057qib7	11929	12	performed	perform	VBN
cord-005453-4057qib7	11929	13	with	with	IN
cord-005453-4057qib7	11929	14	a	a	DT
cord-005453-4057qib7	11929	15	cox	cox	NNP
cord-005453-4057qib7	11929	16	regression	regression	NN
cord-005453-4057qib7	11929	17	model	model	NN
cord-005453-4057qib7	11929	18	.	.	.
cord-005453-4057qib7	11930	1	Results	result	NNS
cord-005453-4057qib7	11930	2	:	:	:
cord-005453-4057qib7	11931	1	Total	total	JJ
cord-005453-4057qib7	11931	2	CD3	CD3	NNP
cord-005453-4057qib7	11931	3	+	+	CC
cord-005453-4057qib7	11931	4	T	t	NN
cord-005453-4057qib7	11931	5	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	11931	6	reached	reach	VBD
cord-005453-4057qib7	11931	7	normal	normal	JJ
cord-005453-4057qib7	11931	8	numbers	number	NNS
cord-005453-4057qib7	11931	9	within	within	IN
cord-005453-4057qib7	11931	10	the	the	DT
cord-005453-4057qib7	11931	11	first	first	JJ
cord-005453-4057qib7	11931	12	two	two	CD
cord-005453-4057qib7	11931	13	months	month	NNS
cord-005453-4057qib7	11931	14	.	.	.
cord-005453-4057qib7	11932	1	Median	median	JJ
cord-005453-4057qib7	11932	2	T	T	NNP
cord-005453-4057qib7	11932	3	CD8	CD8	NNP
cord-005453-4057qib7	11932	4	+	+	CC
cord-005453-4057qib7	11932	5	count	count	NN
cord-005453-4057qib7	11932	6	was	be	VBD
cord-005453-4057qib7	11933	1	263	263	CD
cord-005453-4057qib7	11933	2	cells	cell	NNS
cord-005453-4057qib7	11933	3	/	/	SYM
cord-005453-4057qib7	11933	4	ul	ul	NN
cord-005453-4057qib7	11933	5	after	after	IN
cord-005453-4057qib7	11933	6	one	one	CD
cord-005453-4057qib7	11933	7	month	month	NN
cord-005453-4057qib7	11933	8	,	,	,
cord-005453-4057qib7	11933	9	which	which	WDT
cord-005453-4057qib7	11933	10	is	be	VBZ
cord-005453-4057qib7	11933	11	within	within	IN
cord-005453-4057qib7	11933	12	the	the	DT
cord-005453-4057qib7	11933	13	normal	normal	JJ
cord-005453-4057qib7	11933	14	range	range	NN
cord-005453-4057qib7	11933	15	.	.	.
cord-005453-4057qib7	11934	1	Conversely	conversely	RB
cord-005453-4057qib7	11934	2	,	,	,
cord-005453-4057qib7	11934	3	it	-PRON-	PRP
cord-005453-4057qib7	11934	4	took	take	VBD
cord-005453-4057qib7	11934	5	nearly	nearly	RB
cord-005453-4057qib7	11934	6	one	one	CD
cord-005453-4057qib7	11934	7	year	year	NN
cord-005453-4057qib7	11934	8	to	to	TO
cord-005453-4057qib7	11934	9	get	get	VB
cord-005453-4057qib7	11934	10	normal	normal	JJ
cord-005453-4057qib7	11934	11	counts	count	NNS
cord-005453-4057qib7	11934	12	of	of	IN
cord-005453-4057qib7	11934	13	CD4	CD4	NNP
cord-005453-4057qib7	11934	14	+	+	CC
cord-005453-4057qib7	11934	15	T	t	NN
cord-005453-4057qib7	11934	16	cells	cell	NNS
cord-005453-4057qib7	11934	17	(	(	-LRB-
cord-005453-4057qib7	11934	18	542	542	CD
cord-005453-4057qib7	11934	19	cells	cell	NNS
cord-005453-4057qib7	11934	20	/	/	SYM
cord-005453-4057qib7	11934	21	ul	ul	NN
cord-005453-4057qib7	11934	22	)	)	-RRB-
cord-005453-4057qib7	11934	23	.	.	.
cord-005453-4057qib7	11935	1	The	the	DT
cord-005453-4057qib7	11935	2	only	only	JJ
cord-005453-4057qib7	11935	3	two	two	CD
cord-005453-4057qib7	11935	4	clinical	clinical	JJ
cord-005453-4057qib7	11935	5	parameters	parameter	NNS
cord-005453-4057qib7	11935	6	conditioning	condition	VBG
cord-005453-4057qib7	11935	7	a	a	DT
cord-005453-4057qib7	11935	8	worse	bad	JJR
cord-005453-4057qib7	11935	9	recovery	recovery	NN
cord-005453-4057qib7	11935	10	of	of	IN
cord-005453-4057qib7	11935	11	the	the	DT
cord-005453-4057qib7	11935	12	CD4	CD4	NNP
cord-005453-4057qib7	11935	13	+	+	CC
cord-005453-4057qib7	11935	14	T	t	NN
cord-005453-4057qib7	11935	15	cells	cell	NNS
cord-005453-4057qib7	11935	16	were	be	VBD
cord-005453-4057qib7	11935	17	the	the	DT
cord-005453-4057qib7	11935	18	previous	previous	JJ
cord-005453-4057qib7	11935	19	alosensitization	alosensitization	NN
cord-005453-4057qib7	11935	20	of	of	IN
cord-005453-4057qib7	11935	21	the	the	DT
cord-005453-4057qib7	11935	22	donor	donor	NN
cord-005453-4057qib7	11935	23	and	and	CC
cord-005453-4057qib7	11935	24	the	the	DT
cord-005453-4057qib7	11935	25	sex	sex	NN
cord-005453-4057qib7	11935	26	,	,	,
cord-005453-4057qib7	11935	27	being	be	VBG
cord-005453-4057qib7	11935	28	female	female	JJ
cord-005453-4057qib7	11935	29	donor	donor	NN
cord-005453-4057qib7	11935	30	and	and	CC
cord-005453-4057qib7	11935	31	male	male	NN
cord-005453-4057qib7	11935	32	recipient	recipient	NN
cord-005453-4057qib7	11935	33	the	the	DT
cord-005453-4057qib7	11935	34	worst	bad	JJS
cord-005453-4057qib7	11935	35	combination	combination	NN
cord-005453-4057qib7	11935	36	for	for	IN
cord-005453-4057qib7	11935	37	the	the	DT
cord-005453-4057qib7	11935	38	IR	IR	NNP
cord-005453-4057qib7	11935	39	.	.	.
cord-005453-4057qib7	11936	1	No	no	DT
cord-005453-4057qib7	11936	2	parameters	parameter	NNS
cord-005453-4057qib7	11936	3	influenced	influence	VBD
cord-005453-4057qib7	11936	4	the	the	DT
cord-005453-4057qib7	11936	5	quality	quality	NN
cord-005453-4057qib7	11936	6	of	of	IN
cord-005453-4057qib7	11936	7	the	the	DT
cord-005453-4057qib7	11936	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	11936	9	of	of	IN
cord-005453-4057qib7	11936	10	CD8	CD8	NNP
cord-005453-4057qib7	11936	11	+	+	CC
cord-005453-4057qib7	11936	12	T	T	NNP
cord-005453-4057qib7	11936	13	cells	cell	NNS
cord-005453-4057qib7	11936	14	.	.	.
cord-005453-4057qib7	11937	1	Of	of	IN
cord-005453-4057qib7	11937	2	note	note	NN
cord-005453-4057qib7	11937	3	,	,	,
cord-005453-4057qib7	11937	4	the	the	DT
cord-005453-4057qib7	11937	5	age	age	NN
cord-005453-4057qib7	11937	6	or	or	CC
cord-005453-4057qib7	11937	7	the	the	DT
cord-005453-4057qib7	11937	8	HLA	HLA	NNP
cord-005453-4057qib7	11937	9	status	status	NN
cord-005453-4057qib7	11937	10	did	do	VBD
cord-005453-4057qib7	11937	11	not	not	RB
cord-005453-4057qib7	11937	12	influence	influence	VB
cord-005453-4057qib7	11937	13	the	the	DT
cord-005453-4057qib7	11937	14	quality	quality	NN
cord-005453-4057qib7	11937	15	of	of	IN
cord-005453-4057qib7	11937	16	the	the	DT
cord-005453-4057qib7	11937	17	IR	IR	NNP
cord-005453-4057qib7	11937	18	.	.	.
cord-005453-4057qib7	11938	1	When	when	WRB
cord-005453-4057qib7	11938	2	the	the	DT
cord-005453-4057qib7	11938	3	patients	patient	NNS
cord-005453-4057qib7	11938	4	were	be	VBD
cord-005453-4057qib7	11938	5	divided	divide	VBN
cord-005453-4057qib7	11938	6	into	into	IN
cord-005453-4057qib7	11938	7	GVHD	GVHD	NNP
cord-005453-4057qib7	11938	8	and	and	CC
cord-005453-4057qib7	11938	9	no	no	DT
cord-005453-4057qib7	11938	10	GVHD	GVHD	NNP
cord-005453-4057qib7	11938	11	,	,	,
cord-005453-4057qib7	11938	12	we	-PRON-	PRP
cord-005453-4057qib7	11938	13	found	find	VBD
cord-005453-4057qib7	11938	14	no	no	DT
cord-005453-4057qib7	11938	15	differences	difference	NNS
cord-005453-4057qib7	11938	16	in	in	IN
cord-005453-4057qib7	11938	17	the	the	DT
cord-005453-4057qib7	11938	18	recovery	recovery	NN
cord-005453-4057qib7	11938	19	of	of	IN
cord-005453-4057qib7	11938	20	either	either	CC
cord-005453-4057qib7	11938	21	the	the	DT
cord-005453-4057qib7	11938	22	proportion	proportion	NN
cord-005453-4057qib7	11938	23	or	or	CC
cord-005453-4057qib7	11938	24	absolute	absolute	JJ
cord-005453-4057qib7	11938	25	count	count	NN
cord-005453-4057qib7	11938	26	of	of	IN
cord-005453-4057qib7	11938	27	every	every	DT
cord-005453-4057qib7	11938	28	T	T	NNP
cord-005453-4057qib7	11938	29	cell	cell	NN
cord-005453-4057qib7	11938	30	subpopulation	subpopulation	NN
cord-005453-4057qib7	11938	31	,	,	,
cord-005453-4057qib7	11938	32	including	include	VBG
cord-005453-4057qib7	11938	33	total	total	JJ
cord-005453-4057qib7	11938	34	T	t	NN
cord-005453-4057qib7	11938	35	cells	cell	NNS
cord-005453-4057qib7	11938	36	as	as	RB
cord-005453-4057qib7	11938	37	well	well	RB
cord-005453-4057qib7	11938	38	as	as	IN
cord-005453-4057qib7	11938	39	naïve	naïve	JJ
cord-005453-4057qib7	11938	40	/	/	SYM
cord-005453-4057qib7	11938	41	central	central	JJ
cord-005453-4057qib7	11938	42	memory	memory	NN
cord-005453-4057qib7	11938	43	T	T	NNP
cord-005453-4057qib7	11938	44	cells	cell	NNS
cord-005453-4057qib7	11938	45	,	,	,
cord-005453-4057qib7	11938	46	both	both	CC
cord-005453-4057qib7	11938	47	CD4	CD4	NNP
cord-005453-4057qib7	11938	48	+	+	CC
cord-005453-4057qib7	11938	49	and	and	CC
cord-005453-4057qib7	11938	50	CD8	CD8	NNP
cord-005453-4057qib7	11938	51	+	+	CC
cord-005453-4057qib7	11938	52	.	.	.
cord-005453-4057qib7	11939	1	Finally	finally	RB
cord-005453-4057qib7	11939	2	,	,	,
cord-005453-4057qib7	11939	3	a	a	DT
cord-005453-4057qib7	11939	4	multivariant	multivariant	JJ
cord-005453-4057qib7	11939	5	analysis	analysis	NN
cord-005453-4057qib7	11939	6	confirmed	confirm	VBD
cord-005453-4057qib7	11939	7	that	that	IN
cord-005453-4057qib7	11939	8	the	the	DT
cord-005453-4057qib7	11939	9	absolute	absolute	JJ
cord-005453-4057qib7	11939	10	counts	count	NNS
cord-005453-4057qib7	11939	11	of	of	IN
cord-005453-4057qib7	11939	12	CD4+CCR7	cd4+ccr7	NN
cord-005453-4057qib7	11939	13	+	+	CC
cord-005453-4057qib7	11939	14	T	t	NN
cord-005453-4057qib7	11939	15	cells	cell	NNS
cord-005453-4057qib7	11939	16	at	at	IN
cord-005453-4057qib7	11939	17	day	day	NN
cord-005453-4057qib7	11939	18	+90	+90	NFP
cord-005453-4057qib7	11939	19	as	as	RB
cord-005453-4057qib7	11939	20	well	well	RB
cord-005453-4057qib7	11939	21	as	as	IN
cord-005453-4057qib7	11939	22	the	the	DT
cord-005453-4057qib7	11939	23	absolute	absolute	JJ
cord-005453-4057qib7	11939	24	counts	count	NNS
cord-005453-4057qib7	11939	25	of	of	IN
cord-005453-4057qib7	11939	26	both	both	DT
cord-005453-4057qib7	11939	27	CD4+CCR7	cd4+ccr7	NN
cord-005453-4057qib7	11939	28	+	+	CC
cord-005453-4057qib7	11939	29	T	t	NN
cord-005453-4057qib7	11939	30	cells	cell	NNS
cord-005453-4057qib7	11939	31	and	and	CC
cord-005453-4057qib7	11939	32	naïve	naïve	JJ
cord-005453-4057qib7	11939	33	CD4+CCR7+CD62L+	CD4+CCR7+CD62L+	NNS
cord-005453-4057qib7	11939	34	at	at	IN
cord-005453-4057qib7	11939	35	day	day	NN
cord-005453-4057qib7	11939	36	+180	+180	NNP
cord-005453-4057qib7	11939	37	were	be	VBD
cord-005453-4057qib7	11939	38	associated	associate	VBN
cord-005453-4057qib7	11939	39	with	with	IN
cord-005453-4057qib7	11939	40	better	well	JJR
cord-005453-4057qib7	11939	41	OS	OS	NNP
cord-005453-4057qib7	11939	42	.	.	.
cord-005453-4057qib7	11940	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11940	2	:	:	:
cord-005453-4057qib7	11941	1	In	in	IN
cord-005453-4057qib7	11941	2	conclusion	conclusion	NN
cord-005453-4057qib7	11941	3	,	,	,
cord-005453-4057qib7	11941	4	neither	neither	CC
cord-005453-4057qib7	11941	5	the	the	DT
cord-005453-4057qib7	11941	6	development	development	NN
cord-005453-4057qib7	11941	7	of	of	IN
cord-005453-4057qib7	11941	8	GVHD	GVHD	NNP
cord-005453-4057qib7	11941	9	nor	nor	CC
cord-005453-4057qib7	11941	10	other	other	JJ
cord-005453-4057qib7	11941	11	relevant	relevant	JJ
cord-005453-4057qib7	11941	12	parameters	parameter	NNS
cord-005453-4057qib7	11941	13	seem	seem	VBP
cord-005453-4057qib7	11941	14	to	to	TO
cord-005453-4057qib7	11941	15	play	play	VB
cord-005453-4057qib7	11941	16	a	a	DT
cord-005453-4057qib7	11941	17	determinant	determinant	JJ
cord-005453-4057qib7	11941	18	role	role	NN
cord-005453-4057qib7	11941	19	in	in	IN
cord-005453-4057qib7	11941	20	the	the	DT
cord-005453-4057qib7	11941	21	quality	quality	NN
cord-005453-4057qib7	11941	22	of	of	IN
cord-005453-4057qib7	11941	23	the	the	DT
cord-005453-4057qib7	11941	24	IR	IR	NNP
cord-005453-4057qib7	11941	25	.	.	.
cord-005453-4057qib7	11942	1	To	to	IN
cord-005453-4057qib7	11942	2	our	-PRON-	PRP$
cord-005453-4057qib7	11942	3	knowledge	knowledge	NN
cord-005453-4057qib7	11942	4	this	this	DT
cord-005453-4057qib7	11942	5	is	be	VBZ
cord-005453-4057qib7	11942	6	the	the	DT
cord-005453-4057qib7	11942	7	first	first	JJ
cord-005453-4057qib7	11942	8	study	study	NN
cord-005453-4057qib7	11942	9	which	which	WDT
cord-005453-4057qib7	11942	10	demonstrate	demonstrate	VBP
cord-005453-4057qib7	11942	11	a	a	DT
cord-005453-4057qib7	11942	12	clear	clear	JJ
cord-005453-4057qib7	11942	13	association	association	NN
cord-005453-4057qib7	11942	14	between	between	IN
cord-005453-4057qib7	11942	15	the	the	DT
cord-005453-4057qib7	11942	16	recovery	recovery	NN
cord-005453-4057qib7	11942	17	of	of	IN
cord-005453-4057qib7	11942	18	naïve	naïve	JJ
cord-005453-4057qib7	11942	19	CD4	CD4	NNP
cord-005453-4057qib7	11942	20	+	+	CC
cord-005453-4057qib7	11942	21	T	t	NN
cord-005453-4057qib7	11942	22	cells	cell	NNS
cord-005453-4057qib7	11942	23	measured	measure	VBN
cord-005453-4057qib7	11942	24	by	by	IN
cord-005453-4057qib7	11942	25	flow	flow	NN
cord-005453-4057qib7	11942	26	cytometry	cytometry	NN
cord-005453-4057qib7	11942	27	and	and	CC
cord-005453-4057qib7	11942	28	the	the	DT
cord-005453-4057qib7	11942	29	OS	OS	NNP
cord-005453-4057qib7	11942	30	.	.	.
cord-005453-4057qib7	11943	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11943	2	:	:	:
cord-005453-4057qib7	11943	3	Nothing	nothing	NN
cord-005453-4057qib7	11943	4	to	to	TO
cord-005453-4057qib7	11943	5	declare	declare	VB
cord-005453-4057qib7	11943	6	P526	p526	CD
cord-005453-4057qib7	11943	7	Abstract	Abstract	NNP
cord-005453-4057qib7	11943	8	already	already	RB
cord-005453-4057qib7	11943	9	published	publish	VBN
cord-005453-4057qib7	11943	10	.	.	.
cord-005453-4057qib7	11944	1	Azacitidine	Azacitidine	NNP
cord-005453-4057qib7	11944	2	(	(	-LRB-
cord-005453-4057qib7	11944	3	AZA	AZA	NNP
cord-005453-4057qib7	11944	4	)	)	-RRB-
cord-005453-4057qib7	11944	5	for	for	IN
cord-005453-4057qib7	11944	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11944	7	or	or	CC
cord-005453-4057qib7	11944	8	pre	pre	JJ
cord-005453-4057qib7	11944	9	-	-	JJ
cord-005453-4057qib7	11944	10	emptive	emptive	JJ
cord-005453-4057qib7	11944	11	therapy	therapy	NN
cord-005453-4057qib7	11944	12	for	for	IN
cord-005453-4057qib7	11944	13	myeloid	myeloid	JJ
cord-005453-4057qib7	11944	14	neoplasms	neoplasm	NNS
cord-005453-4057qib7	11944	15	after	after	IN
cord-005453-4057qib7	11944	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	11944	17	stem	stem	NN
cord-005453-4057qib7	11944	18	cell	cell	NN
cord-005453-4057qib7	11944	19	transplantation	transplantation	NN
cord-005453-4057qib7	11944	20	whom	whom	WP
cord-005453-4057qib7	11944	21	21	21	CD
cord-005453-4057qib7	11944	22	were	be	VBD
cord-005453-4057qib7	11944	23	treated	treat	VBN
cord-005453-4057qib7	11944	24	prophylactically	prophylactically	RB
cord-005453-4057qib7	11944	25	and	and	CC
cord-005453-4057qib7	11944	26	11	11	CD
cord-005453-4057qib7	11944	27	preemptively	preemptively	RB
cord-005453-4057qib7	11944	28	.	.	.
cord-005453-4057qib7	11945	1	Median	median	JJ
cord-005453-4057qib7	11945	2	age	age	NN
cord-005453-4057qib7	11945	3	was	be	VBD
cord-005453-4057qib7	11945	4	55	55	CD
cord-005453-4057qib7	11945	5	years	year	NNS
cord-005453-4057qib7	11946	1	[	[	-LRB-
cord-005453-4057qib7	11946	2	range	range	NN
cord-005453-4057qib7	11946	3	,	,	,
cord-005453-4057qib7	11946	4	15	15	CD
cord-005453-4057qib7	11946	5	-	-	SYM
cord-005453-4057qib7	11946	6	69	69	CD
cord-005453-4057qib7	11946	7	]	]	-RRB-
cord-005453-4057qib7	11946	8	and	and	CC
cord-005453-4057qib7	11946	9	all	all	DT
cord-005453-4057qib7	11946	10	patients	patient	NNS
cord-005453-4057qib7	11946	11	had	have	VBD
cord-005453-4057qib7	11946	12	a	a	DT
cord-005453-4057qib7	11946	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	11946	14	of	of	IN
cord-005453-4057qib7	11946	15	AML	AML	NNP
cord-005453-4057qib7	11946	16	or	or	CC
cord-005453-4057qib7	11946	17	high	high	JJ
cord-005453-4057qib7	11946	18	-	-	HYPH
cord-005453-4057qib7	11946	19	risk	risk	NN
cord-005453-4057qib7	11946	20	MDS	MDS	NNP
cord-005453-4057qib7	11946	21	.	.	.
cord-005453-4057qib7	11947	1	Prophylactic	prophylactic	JJ
cord-005453-4057qib7	11947	2	treatment	treatment	NN
cord-005453-4057qib7	11947	3	consisted	consist	VBD
cord-005453-4057qib7	11947	4	of	of	IN
cord-005453-4057qib7	11947	5	AZA	AZA	NNP
cord-005453-4057qib7	11947	6	32	32	CD
cord-005453-4057qib7	11948	1	mg	mg	NNP
cord-005453-4057qib7	11948	2	/	/	SYM
cord-005453-4057qib7	11948	3	m	m	NNP
cord-005453-4057qib7	11948	4	2	2	CD
cord-005453-4057qib7	11948	5	for	for	IN
cord-005453-4057qib7	11948	6	5	5	CD
cord-005453-4057qib7	11948	7	days	day	NNS
cord-005453-4057qib7	11948	8	in	in	IN
cord-005453-4057qib7	11948	9	cycles	cycle	NNS
cord-005453-4057qib7	11948	10	of	of	IN
cord-005453-4057qib7	11948	11	28	28	CD
cord-005453-4057qib7	11948	12	days	day	NNS
cord-005453-4057qib7	11948	13	.	.	.
cord-005453-4057qib7	11949	1	In	in	IN
cord-005453-4057qib7	11949	2	the	the	DT
cord-005453-4057qib7	11949	3	pre	pre	JJ
cord-005453-4057qib7	11949	4	-	-	JJ
cord-005453-4057qib7	11949	5	emptive	emptive	JJ
cord-005453-4057qib7	11949	6	setting	setting	NN
cord-005453-4057qib7	11949	7	,	,	,
cord-005453-4057qib7	11949	8	5	5	CD
cord-005453-4057qib7	11949	9	patients	patient	NNS
cord-005453-4057qib7	11949	10	received	receive	VBD
cord-005453-4057qib7	11949	11	75	75	CD
cord-005453-4057qib7	11949	12	mg	mg	NNP
cord-005453-4057qib7	11949	13	/	/	SYM
cord-005453-4057qib7	11949	14	m	m	NNP
cord-005453-4057qib7	11949	15	2	2	CD
cord-005453-4057qib7	11949	16	for	for	IN
cord-005453-4057qib7	11949	17	7	7	CD
cord-005453-4057qib7	11949	18	days	day	NNS
cord-005453-4057qib7	11949	19	per	per	IN
cord-005453-4057qib7	11949	20	cycle	cycle	NN
cord-005453-4057qib7	11949	21	and	and	CC
cord-005453-4057qib7	11949	22	6	6	CD
cord-005453-4057qib7	11949	23	patients	patient	NNS
cord-005453-4057qib7	11949	24	75	75	CD
cord-005453-4057qib7	11949	25	mg	mg	NNP
cord-005453-4057qib7	11949	26	/	/	SYM
cord-005453-4057qib7	11949	27	m	m	NN
cord-005453-4057qib7	11949	28	2	2	CD
cord-005453-4057qib7	11949	29	for	for	IN
cord-005453-4057qib7	11949	30	5	5	CD
cord-005453-4057qib7	11949	31	days	day	NNS
cord-005453-4057qib7	11949	32	per	per	IN
cord-005453-4057qib7	11949	33	cycle	cycle	NN
cord-005453-4057qib7	11949	34	.	.	.
cord-005453-4057qib7	11950	1	A	a	DT
cord-005453-4057qib7	11950	2	median	median	NN
cord-005453-4057qib7	11950	3	of	of	IN
cord-005453-4057qib7	11950	4	6	6	CD
cord-005453-4057qib7	11950	5	cycles	cycle	NNS
cord-005453-4057qib7	11950	6	[	[	-LRB-
cord-005453-4057qib7	11950	7	range	range	NN
cord-005453-4057qib7	11950	8	,	,	,
cord-005453-4057qib7	11950	9	[	[	-LRB-
cord-005453-4057qib7	11950	10	1	1	CD
cord-005453-4057qib7	11950	11	]	]	-RRB-
cord-005453-4057qib7	11950	12	[	[	-LRB-
cord-005453-4057qib7	11950	13	2	2	CD
cord-005453-4057qib7	11950	14	]	]	-RRB-
cord-005453-4057qib7	11950	15	[	[	-LRB-
cord-005453-4057qib7	11950	16	3	3	CD
cord-005453-4057qib7	11950	17	]	]	-RRB-
cord-005453-4057qib7	11950	18	[	[	-LRB-
cord-005453-4057qib7	11950	19	4	4	CD
cord-005453-4057qib7	11950	20	]	]	-RRB-
cord-005453-4057qib7	11950	21	[	[	-LRB-
cord-005453-4057qib7	11950	22	5	5	CD
cord-005453-4057qib7	11950	23	]	]	-RRB-
cord-005453-4057qib7	11950	24	[	[	-LRB-
cord-005453-4057qib7	11950	25	6	6	CD
cord-005453-4057qib7	11950	26	]	]	-RRB-
cord-005453-4057qib7	11950	27	[	[	-LRB-
cord-005453-4057qib7	11950	28	7	7	CD
cord-005453-4057qib7	11950	29	]	]	-RRB-
cord-005453-4057qib7	11950	30	[	[	-LRB-
cord-005453-4057qib7	11950	31	8	8	CD
cord-005453-4057qib7	11950	32	]	]	-RRB-
cord-005453-4057qib7	11950	33	[	[	-LRB-
cord-005453-4057qib7	11950	34	9	9	CD
cord-005453-4057qib7	11950	35	]	]	-RRB-
cord-005453-4057qib7	11950	36	[	[	-LRB-
cord-005453-4057qib7	11950	37	10	10	CD
cord-005453-4057qib7	11950	38	]	]	-RRB-
cord-005453-4057qib7	11950	39	[	[	-LRB-
cord-005453-4057qib7	11950	40	11	11	CD
cord-005453-4057qib7	11950	41	]	]	-RRB-
cord-005453-4057qib7	11950	42	[	[	-LRB-
cord-005453-4057qib7	11950	43	12	12	CD
cord-005453-4057qib7	11950	44	]	]	-RRB-
cord-005453-4057qib7	11950	45	[	[	-LRB-
cord-005453-4057qib7	11950	46	13	13	CD
cord-005453-4057qib7	11950	47	]	]	-RRB-
cord-005453-4057qib7	11950	48	[	[	-LRB-
cord-005453-4057qib7	11950	49	14	14	CD
cord-005453-4057qib7	11950	50	]	]	-RRB-
cord-005453-4057qib7	11950	51	[	[	-LRB-
cord-005453-4057qib7	11950	52	15	15	CD
cord-005453-4057qib7	11950	53	]	]	-RRB-
cord-005453-4057qib7	11950	54	[	[	-LRB-
cord-005453-4057qib7	11950	55	16	16	CD
cord-005453-4057qib7	11950	56	]	]	-RRB-
cord-005453-4057qib7	11950	57	[	[	-LRB-
cord-005453-4057qib7	11950	58	17	17	CD
cord-005453-4057qib7	11950	59	]	]	-RRB-
cord-005453-4057qib7	11950	60	[	[	-LRB-
cord-005453-4057qib7	11950	61	18	18	CD
cord-005453-4057qib7	11950	62	]	]	-RRB-
cord-005453-4057qib7	11950	63	was	be	VBD
cord-005453-4057qib7	11950	64	administered	administer	VBN
cord-005453-4057qib7	11950	65	in	in	IN
cord-005453-4057qib7	11950	66	the	the	DT
cord-005453-4057qib7	11950	67	prophylactic	prophylactic	JJ
cord-005453-4057qib7	11950	68	group	group	NN
cord-005453-4057qib7	11950	69	and	and	CC
cord-005453-4057qib7	11950	70	of	of	IN
cord-005453-4057qib7	11950	71	4	4	CD
cord-005453-4057qib7	11950	72	cycles	cycle	NNS
cord-005453-4057qib7	11950	73	[	[	-LRB-
cord-005453-4057qib7	11950	74	range	range	NN
cord-005453-4057qib7	11950	75	,	,	,
cord-005453-4057qib7	11950	76	4	4	CD
cord-005453-4057qib7	11950	77	-	-	SYM
cord-005453-4057qib7	11950	78	22	22	CD
cord-005453-4057qib7	11950	79	]	]	-RRB-
cord-005453-4057qib7	11950	80	in	in	IN
cord-005453-4057qib7	11950	81	the	the	DT
cord-005453-4057qib7	11950	82	pre	pre	JJ
cord-005453-4057qib7	11950	83	-	-	JJ
cord-005453-4057qib7	11950	84	emptive	emptive	JJ
cord-005453-4057qib7	11950	85	group	group	NN
cord-005453-4057qib7	11950	86	.	.	.
cord-005453-4057qib7	11951	1	Ten	ten	CD
cord-005453-4057qib7	11951	2	patients	patient	NNS
cord-005453-4057qib7	11951	3	also	also	RB
cord-005453-4057qib7	11951	4	received	receive	VBD
cord-005453-4057qib7	11951	5	at	at	IN
cord-005453-4057qib7	11951	6	least	least	JJS
cord-005453-4057qib7	11951	7	one	one	CD
cord-005453-4057qib7	11951	8	DLI	DLI	NNP
cord-005453-4057qib7	11951	9	after	after	IN
cord-005453-4057qib7	11951	10	the	the	DT
cord-005453-4057qib7	11951	11	third	third	JJ
cord-005453-4057qib7	11951	12	AZA	AZA	NNP
cord-005453-4057qib7	11951	13	cycle	cycle	NN
cord-005453-4057qib7	11951	14	:	:	:
cord-005453-4057qib7	11951	15	8	8	CD
cord-005453-4057qib7	11951	16	patients	patient	NNS
cord-005453-4057qib7	11951	17	in	in	IN
cord-005453-4057qib7	11951	18	the	the	DT
cord-005453-4057qib7	11951	19	prophylactic	prophylactic	JJ
cord-005453-4057qib7	11951	20	group	group	NN
cord-005453-4057qib7	11951	21	and	and	CC
cord-005453-4057qib7	11951	22	2	2	CD
cord-005453-4057qib7	11951	23	patients	patient	NNS
cord-005453-4057qib7	11951	24	in	in	IN
cord-005453-4057qib7	11951	25	the	the	DT
cord-005453-4057qib7	11951	26	pre	pre	JJ
cord-005453-4057qib7	11951	27	-	-	JJ
cord-005453-4057qib7	11951	28	emptive	emptive	JJ
cord-005453-4057qib7	11951	29	one	one	CD
cord-005453-4057qib7	11951	30	.	.	.
cord-005453-4057qib7	11952	1	Results	result	NNS
cord-005453-4057qib7	11952	2	:	:	:
cord-005453-4057qib7	11953	1	During	during	IN
cord-005453-4057qib7	11953	2	follow	follow	NN
cord-005453-4057qib7	11953	3	-	-	HYPH
cord-005453-4057qib7	11953	4	up	up	NN
cord-005453-4057qib7	11953	5	,	,	,
cord-005453-4057qib7	11953	6	10	10	CD
cord-005453-4057qib7	11953	7	patients	patient	NNS
cord-005453-4057qib7	11953	8	had	have	VBD
cord-005453-4057qib7	11953	9	significant	significant	JJ
cord-005453-4057qib7	11953	10	delays	delay	NNS
cord-005453-4057qib7	11953	11	in	in	IN
cord-005453-4057qib7	11953	12	treatment	treatment	NN
cord-005453-4057qib7	11953	13	plan	plan	NN
cord-005453-4057qib7	11953	14	due	due	JJ
cord-005453-4057qib7	11953	15	to	to	IN
cord-005453-4057qib7	11953	16	transitory	transitory	JJ
cord-005453-4057qib7	11953	17	mild	mild	JJ
cord-005453-4057qib7	11953	18	complications	complication	NNS
cord-005453-4057qib7	11953	19	.	.	.
cord-005453-4057qib7	11954	1	However	however	RB
cord-005453-4057qib7	11954	2	,	,	,
cord-005453-4057qib7	11954	3	15	15	CD
cord-005453-4057qib7	11954	4	%	%	NN
cord-005453-4057qib7	11954	5	of	of	IN
cord-005453-4057qib7	11954	6	patients	patient	NNS
cord-005453-4057qib7	11954	7	(	(	-LRB-
cord-005453-4057qib7	11954	8	n=5	n=5	NNP
cord-005453-4057qib7	11954	9	)	)	-RRB-
cord-005453-4057qib7	11954	10	presented	present	VBD
cord-005453-4057qib7	11954	11	infectious	infectious	JJ
cord-005453-4057qib7	11954	12	complications	complication	NNS
cord-005453-4057qib7	11954	13	requiring	require	VBG
cord-005453-4057qib7	11954	14	hospitalisation	hospitalisation	NN
cord-005453-4057qib7	11954	15	and	and	CC
cord-005453-4057qib7	11954	16	40	40	CD
cord-005453-4057qib7	11954	17	%	%	NN
cord-005453-4057qib7	11954	18	of	of	IN
cord-005453-4057qib7	11954	19	patients	patient	NNS
cord-005453-4057qib7	11954	20	(	(	-LRB-
cord-005453-4057qib7	11954	21	n=10	n=10	NNP
cord-005453-4057qib7	11954	22	in	in	IN
cord-005453-4057qib7	11954	23	the	the	DT
cord-005453-4057qib7	11954	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11954	25	group	group	NN
cord-005453-4057qib7	11954	26	and	and	CC
cord-005453-4057qib7	11954	27	3	3	CD
cord-005453-4057qib7	11954	28	in	in	IN
cord-005453-4057qib7	11954	29	the	the	DT
cord-005453-4057qib7	11954	30	pre	pre	JJ
cord-005453-4057qib7	11954	31	-	-	JJ
cord-005453-4057qib7	11954	32	emptive	emptive	JJ
cord-005453-4057qib7	11954	33	group	group	NN
cord-005453-4057qib7	11954	34	)	)	-RRB-
cord-005453-4057qib7	11954	35	presented	present	VBD
cord-005453-4057qib7	11954	36	some	some	DT
cord-005453-4057qib7	11954	37	form	form	NN
cord-005453-4057qib7	11954	38	of	of	IN
cord-005453-4057qib7	11954	39	GvHD	GvHD	NNP
cord-005453-4057qib7	11954	40	.	.	.
cord-005453-4057qib7	11955	1	In	in	IN
cord-005453-4057qib7	11955	2	patients	patient	NNS
cord-005453-4057qib7	11955	3	who	who	WP
cord-005453-4057qib7	11955	4	developed	develop	VBD
cord-005453-4057qib7	11955	5	GvHD	GvHD	NNP
cord-005453-4057qib7	11955	6	,	,	,
cord-005453-4057qib7	11955	7	3	3	CD
cord-005453-4057qib7	11955	8	had	have	VBD
cord-005453-4057qib7	11955	9	to	to	TO
cord-005453-4057qib7	11955	10	discontinue	discontinue	VB
cord-005453-4057qib7	11955	11	treatment	treatment	NN
cord-005453-4057qib7	11955	12	(	(	-LRB-
cord-005453-4057qib7	11955	13	all	all	DT
cord-005453-4057qib7	11955	14	in	in	IN
cord-005453-4057qib7	11955	15	the	the	DT
cord-005453-4057qib7	11955	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11955	17	group	group	NN
cord-005453-4057qib7	11955	18	)	)	-RRB-
cord-005453-4057qib7	11955	19	;	;	:
cord-005453-4057qib7	11955	20	also	also	RB
cord-005453-4057qib7	11955	21	8	8	CD
cord-005453-4057qib7	11955	22	patients	patient	NNS
cord-005453-4057qib7	11955	23	discontinued	discontinue	VBD
cord-005453-4057qib7	11955	24	treatment	treatment	NN
cord-005453-4057qib7	11955	25	due	due	IN
cord-005453-4057qib7	11955	26	to	to	IN
cord-005453-4057qib7	11955	27	disease	disease	NN
cord-005453-4057qib7	11955	28	progression	progression	NN
cord-005453-4057qib7	11955	29	.	.	.
cord-005453-4057qib7	11956	1	The	the	DT
cord-005453-4057qib7	11956	2	overall	overall	JJ
cord-005453-4057qib7	11956	3	drop	drop	NN
cord-005453-4057qib7	11956	4	-	-	HYPH
cord-005453-4057qib7	11956	5	out	out	RP
cord-005453-4057qib7	11956	6	rate	rate	NN
cord-005453-4057qib7	11956	7	was	be	VBD
cord-005453-4057qib7	11956	8	37.5	37.5	CD
cord-005453-4057qib7	11956	9	%	%	NN
cord-005453-4057qib7	11956	10	(	(	-LRB-
cord-005453-4057qib7	11956	11	n=12	n=12	NNP
cord-005453-4057qib7	11956	12	)	)	-RRB-
cord-005453-4057qib7	11956	13	.	.	.
cord-005453-4057qib7	11957	1	Survival	survival	NN
cord-005453-4057qib7	11957	2	was	be	VBD
cord-005453-4057qib7	11957	3	analysed	analyse	VBN
cord-005453-4057qib7	11957	4	from	from	IN
cord-005453-4057qib7	11957	5	initiation	initiation	NN
cord-005453-4057qib7	11957	6	of	of	IN
cord-005453-4057qib7	11957	7	treatment	treatment	NN
cord-005453-4057qib7	11957	8	with	with	IN
cord-005453-4057qib7	11957	9	AZA	AZA	NNP
cord-005453-4057qib7	11957	10	and	and	CC
cord-005453-4057qib7	11957	11	median	median	JJ
cord-005453-4057qib7	11957	12	follow	follow	NN
cord-005453-4057qib7	11957	13	-	-	HYPH
cord-005453-4057qib7	11957	14	up	up	NN
cord-005453-4057qib7	11957	15	was	be	VBD
cord-005453-4057qib7	11957	16	16	16	CD
cord-005453-4057qib7	11957	17	months	month	NNS
cord-005453-4057qib7	11957	18	.	.	.
cord-005453-4057qib7	11958	1	One	one	CD
cord-005453-4057qib7	11958	2	-	-	HYPH
cord-005453-4057qib7	11958	3	year	year	NN
cord-005453-4057qib7	11958	4	EFS	efs	NN
cord-005453-4057qib7	11958	5	was	be	VBD
cord-005453-4057qib7	11958	6	95	95	CD
cord-005453-4057qib7	11958	7	%	%	NN
cord-005453-4057qib7	11958	8	in	in	IN
cord-005453-4057qib7	11958	9	the	the	DT
cord-005453-4057qib7	11958	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11958	11	group	group	NN
cord-005453-4057qib7	11958	12	,	,	,
cord-005453-4057qib7	11958	13	with	with	IN
cord-005453-4057qib7	11958	14	only	only	RB
cord-005453-4057qib7	11958	15	one	one	CD
cord-005453-4057qib7	11958	16	patient	patient	NN
cord-005453-4057qib7	11958	17	relapsing	relapse	VBG
cord-005453-4057qib7	11958	18	and	and	CC
cord-005453-4057qib7	11958	19	no	no	DT
cord-005453-4057qib7	11958	20	deaths	death	NNS
cord-005453-4057qib7	11958	21	.	.	.
cord-005453-4057qib7	11959	1	In	in	IN
cord-005453-4057qib7	11959	2	the	the	DT
cord-005453-4057qib7	11959	3	pre	pre	JJ
cord-005453-4057qib7	11959	4	-	-	JJ
cord-005453-4057qib7	11959	5	emptive	emptive	JJ
cord-005453-4057qib7	11959	6	group	group	NN
cord-005453-4057qib7	11959	7	,	,	,
cord-005453-4057qib7	11959	8	the	the	DT
cord-005453-4057qib7	11959	9	1-year	1-year	CD
cord-005453-4057qib7	11959	10	EFS	EFS	NNP
cord-005453-4057qib7	11959	11	was	be	VBD
cord-005453-4057qib7	11959	12	45	45	CD
cord-005453-4057qib7	11959	13	%	%	NN
cord-005453-4057qib7	11959	14	and	and	CC
cord-005453-4057qib7	11959	15	the	the	DT
cord-005453-4057qib7	11959	16	median	median	JJ
cord-005453-4057qib7	11959	17	EFS	efs	NN
cord-005453-4057qib7	11959	18	was	be	VBD
cord-005453-4057qib7	11959	19	6	6	CD
cord-005453-4057qib7	11959	20	months	month	NNS
cord-005453-4057qib7	11959	21	;	;	:
cord-005453-4057qib7	11960	1	1-year	1-year	CD
cord-005453-4057qib7	11960	2	OS	OS	NNP
cord-005453-4057qib7	11960	3	was	be	VBD
cord-005453-4057qib7	11960	4	70	70	CD
cord-005453-4057qib7	11960	5	%	%	NN
cord-005453-4057qib7	11960	6	and	and	CC
cord-005453-4057qib7	11960	7	median	median	JJ
cord-005453-4057qib7	11960	8	OS	OS	NNP
cord-005453-4057qib7	11960	9	was	be	VBD
cord-005453-4057qib7	11960	10	24	24	CD
cord-005453-4057qib7	11960	11	months	month	NNS
cord-005453-4057qib7	11960	12	.	.	.
cord-005453-4057qib7	11961	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11961	2	:	:	:
cord-005453-4057qib7	11962	1	We	-PRON-	PRP
cord-005453-4057qib7	11962	2	conclude	conclude	VBP
cord-005453-4057qib7	11962	3	that	that	IN
cord-005453-4057qib7	11962	4	post	post	JJ
cord-005453-4057qib7	11962	5	-	-	JJ
cord-005453-4057qib7	11962	6	transplant	transplant	JJ
cord-005453-4057qib7	11962	7	AZA	AZA	NNP
cord-005453-4057qib7	11962	8	treatment	treatment	NN
cord-005453-4057qib7	11962	9	is	be	VBZ
cord-005453-4057qib7	11962	10	a	a	DT
cord-005453-4057qib7	11962	11	well	well	RB
cord-005453-4057qib7	11962	12	-	-	HYPH
cord-005453-4057qib7	11962	13	tolerated	tolerate	VBN
cord-005453-4057qib7	11962	14	therapy	therapy	NN
cord-005453-4057qib7	11962	15	,	,	,
cord-005453-4057qib7	11962	16	but	but	CC
cord-005453-4057qib7	11962	17	the	the	DT
cord-005453-4057qib7	11962	18	incidence	incidence	NN
cord-005453-4057qib7	11962	19	of	of	IN
cord-005453-4057qib7	11962	20	side	side	NN
cord-005453-4057qib7	11962	21	effects	effect	NNS
cord-005453-4057qib7	11962	22	remains	remain	VBZ
cord-005453-4057qib7	11962	23	discordant	discordant	JJ
cord-005453-4057qib7	11962	24	in	in	IN
cord-005453-4057qib7	11962	25	the	the	DT
cord-005453-4057qib7	11962	26	literature	literature	NN
cord-005453-4057qib7	11962	27	.	.	.
cord-005453-4057qib7	11963	1	Results	result	NNS
cord-005453-4057qib7	11963	2	in	in	IN
cord-005453-4057qib7	11963	3	the	the	DT
cord-005453-4057qib7	11963	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11963	5	group	group	NN
cord-005453-4057qib7	11963	6	are	be	VBP
cord-005453-4057qib7	11963	7	excellent	excellent	JJ
cord-005453-4057qib7	11963	8	,	,	,
cord-005453-4057qib7	11963	9	but	but	CC
cord-005453-4057qib7	11963	10	patients	patient	NNS
cord-005453-4057qib7	11963	11	with	with	IN
cord-005453-4057qib7	11963	12	positive	positive	JJ
cord-005453-4057qib7	11963	13	minimal	minimal	JJ
cord-005453-4057qib7	11963	14	residual	residual	JJ
cord-005453-4057qib7	11963	15	disease	disease	NN
cord-005453-4057qib7	11963	16	treated	treat	VBN
cord-005453-4057qib7	11963	17	pre	pre	NNP
cord-005453-4057qib7	11963	18	-	-	NN
cord-005453-4057qib7	11963	19	emptively	emptively	NNP
cord-005453-4057qib7	11963	20	had	have	VBD
cord-005453-4057qib7	11963	21	a	a	DT
cord-005453-4057qib7	11963	22	lower	low	JJR
cord-005453-4057qib7	11963	23	outcome	outcome	NN
cord-005453-4057qib7	11963	24	with	with	IN
cord-005453-4057qib7	11963	25	only	only	JJ
cord-005453-4057qib7	11963	26	stabilisation	stabilisation	NN
cord-005453-4057qib7	11963	27	of	of	IN
cord-005453-4057qib7	11963	28	the	the	DT
cord-005453-4057qib7	11963	29	disease	disease	NN
cord-005453-4057qib7	11963	30	.	.	.
cord-005453-4057qib7	11964	1	Randomised	randomised	JJ
cord-005453-4057qib7	11964	2	prospective	prospective	JJ
cord-005453-4057qib7	11964	3	trials	trial	NNS
cord-005453-4057qib7	11964	4	are	be	VBP
cord-005453-4057qib7	11964	5	needed	need	VBN
cord-005453-4057qib7	11964	6	to	to	TO
cord-005453-4057qib7	11964	7	define	define	VB
cord-005453-4057qib7	11964	8	patients	patient	NNS
cord-005453-4057qib7	11964	9	who	who	WP
cord-005453-4057qib7	11964	10	would	would	MD
cord-005453-4057qib7	11964	11	benefit	benefit	VB
cord-005453-4057qib7	11964	12	the	the	DT
cord-005453-4057qib7	11964	13	most	most	JJS
cord-005453-4057qib7	11964	14	from	from	IN
cord-005453-4057qib7	11964	15	this	this	DT
cord-005453-4057qib7	11964	16	treatment	treatment	NN
cord-005453-4057qib7	11964	17	and	and	CC
cord-005453-4057qib7	11964	18	at	at	IN
cord-005453-4057qib7	11964	19	what	what	WP
cord-005453-4057qib7	11964	20	timing	timing	NN
cord-005453-4057qib7	11964	21	,	,	,
cord-005453-4057qib7	11964	22	dosage	dosage	NN
cord-005453-4057qib7	11964	23	and	and	CC
cord-005453-4057qib7	11964	24	duration	duration	NN
cord-005453-4057qib7	11964	25	of	of	IN
cord-005453-4057qib7	11964	26	treatment	treatment	NN
cord-005453-4057qib7	11964	27	.	.	.
cord-005453-4057qib7	11965	1	Disclosure	disclosure	NN
cord-005453-4057qib7	11965	2	:	:	:
cord-005453-4057qib7	11965	3	Nothing	nothing	NN
cord-005453-4057qib7	11965	4	to	to	TO
cord-005453-4057qib7	11965	5	declare	declare	VB
cord-005453-4057qib7	11965	6	.	.	.
cord-005453-4057qib7	11966	1	Abstract	Abstract	NNP
cord-005453-4057qib7	11966	2	already	already	RB
cord-005453-4057qib7	11966	3	published	publish	VBN
cord-005453-4057qib7	11966	4	.	.	.
cord-005453-4057qib7	11967	1	Results	result	NNS
cord-005453-4057qib7	11967	2	:	:	:
cord-005453-4057qib7	11968	1	All	all	DT
cord-005453-4057qib7	11968	2	subjects	subject	NNS
cord-005453-4057qib7	11968	3	experienced	experience	VBD
cord-005453-4057qib7	11968	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	11968	5	engraftment	engraftment	NN
cord-005453-4057qib7	11968	6	at	at	IN
cord-005453-4057qib7	11968	7	a	a	DT
cord-005453-4057qib7	11968	8	median	median	NN
cord-005453-4057qib7	11968	9	of	of	IN
cord-005453-4057qib7	11968	10	17	17	CD
cord-005453-4057qib7	11968	11	days	day	NNS
cord-005453-4057qib7	11968	12	(	(	-LRB-
cord-005453-4057qib7	11968	13	range	range	NNP
cord-005453-4057qib7	11968	14	14	14	CD
cord-005453-4057qib7	11968	15	-	-	SYM
cord-005453-4057qib7	11968	16	20	20	CD
cord-005453-4057qib7	11968	17	)	)	-RRB-
cord-005453-4057qib7	11968	18	and	and	CC
cord-005453-4057qib7	11968	19	demonstrated	demonstrate	VBD
cord-005453-4057qib7	11968	20	full	full	JJ
cord-005453-4057qib7	11968	21	donor	donor	NN
cord-005453-4057qib7	11968	22	myeloid	myeloid	NN
cord-005453-4057qib7	11968	23	chimerism	chimerism	NN
cord-005453-4057qib7	11968	24	.	.	.
cord-005453-4057qib7	11969	1	M	M	NNP
cord-005453-4057qib7	11969	2	-	-	HYPH
cord-005453-4057qib7	11969	3	MDSC	MDSC	NNP
cord-005453-4057qib7	11969	4	and	and	CC
cord-005453-4057qib7	11969	5	PMN	PMN	NNP
cord-005453-4057qib7	11969	6	-	-	HYPH
cord-005453-4057qib7	11969	7	MDSC	MDSC	NNP
cord-005453-4057qib7	11969	8	recovery	recovery	NN
cord-005453-4057qib7	11969	9	peaked	peak	VBD
cord-005453-4057qib7	11969	10	at	at	IN
cord-005453-4057qib7	11969	11	a	a	DT
cord-005453-4057qib7	11969	12	median	median	NN
cord-005453-4057qib7	11969	13	of	of	IN
cord-005453-4057qib7	11969	14	22	22	CD
cord-005453-4057qib7	11969	15	days	day	NNS
cord-005453-4057qib7	11969	16	posttransplant	posttransplant	NNP
cord-005453-4057qib7	11969	17	.	.	.
cord-005453-4057qib7	11970	1	The	the	DT
cord-005453-4057qib7	11970	2	median	median	JJ
cord-005453-4057qib7	11970	3	peak	peak	NN
cord-005453-4057qib7	11970	4	absolute	absolute	JJ
cord-005453-4057qib7	11970	5	M	M	NNP
cord-005453-4057qib7	11970	6	-	-	HYPH
cord-005453-4057qib7	11970	7	MDSC	MDSC	NNP
cord-005453-4057qib7	11970	8	count	count	NN
cord-005453-4057qib7	11970	9	was	be	VBD
cord-005453-4057qib7	11970	10	9,828	9,828	CD
cord-005453-4057qib7	11970	11	cell	cell	NN
cord-005453-4057qib7	11970	12	/	/	SYM
cord-005453-4057qib7	11970	13	mL	ml	NN
cord-005453-4057qib7	11970	14	(	(	-LRB-
cord-005453-4057qib7	11970	15	range	range	NN
cord-005453-4057qib7	11970	16	9,180	9,180	CD
cord-005453-4057qib7	11970	17	-	-	HYPH
cord-005453-4057qib7	11970	18	41,120	41,120	CD
cord-005453-4057qib7	11970	19	/	/	SYM
cord-005453-4057qib7	11970	20	mL	ml	NN
cord-005453-4057qib7	11970	21	)	)	-RRB-
cord-005453-4057qib7	11970	22	representing	represent	VBG
cord-005453-4057qib7	11970	23	a	a	DT
cord-005453-4057qib7	11970	24	range	range	NN
cord-005453-4057qib7	11970	25	of	of	IN
cord-005453-4057qib7	11970	26	1.5	1.5	CD
cord-005453-4057qib7	11970	27	%	%	NN
cord-005453-4057qib7	11970	28	to	to	IN
cord-005453-4057qib7	11970	29	4.8	4.8	CD
cord-005453-4057qib7	11970	30	%	%	NN
cord-005453-4057qib7	11970	31	of	of	IN
cord-005453-4057qib7	11970	32	PBMCs	pbmc	NNS
cord-005453-4057qib7	11970	33	.	.	.
cord-005453-4057qib7	11971	1	The	the	DT
cord-005453-4057qib7	11971	2	PMN	PMN	NNP
cord-005453-4057qib7	11971	3	-	-	HYPH
cord-005453-4057qib7	11971	4	MDSC	MDSC	NNP
cord-005453-4057qib7	11971	5	peak	peak	NN
cord-005453-4057qib7	11971	6	was	be	VBD
cord-005453-4057qib7	11971	7	more	more	RBR
cord-005453-4057qib7	11971	8	robust	robust	JJ
cord-005453-4057qib7	11971	9	,	,	,
cord-005453-4057qib7	11971	10	with	with	IN
cord-005453-4057qib7	11971	11	a	a	DT
cord-005453-4057qib7	11971	12	median	median	JJ
cord-005453-4057qib7	11971	13	absolute	absolute	JJ
cord-005453-4057qib7	11971	14	peak	peak	NN
cord-005453-4057qib7	11971	15	of	of	IN
cord-005453-4057qib7	11971	16	103,730	103,730	CD
cord-005453-4057qib7	11971	17	cells	cell	NNS
cord-005453-4057qib7	11971	18	/	/	SYM
cord-005453-4057qib7	11971	19	mL	ml	NN
cord-005453-4057qib7	11972	1	(	(	-LRB-
cord-005453-4057qib7	11972	2	range	range	NN
cord-005453-4057qib7	11972	3	11,330	11,330	CD
cord-005453-4057qib7	11972	4	-	-	HYPH
cord-005453-4057qib7	11972	5	676,800	676,800	CD
cord-005453-4057qib7	11972	6	/	/	SYM
cord-005453-4057qib7	11972	7	mL	ml	NN
cord-005453-4057qib7	11972	8	)	)	-RRB-
cord-005453-4057qib7	11972	9	representing	represent	VBG
cord-005453-4057qib7	11972	10	a	a	DT
cord-005453-4057qib7	11972	11	median	median	NN
cord-005453-4057qib7	11972	12	of	of	IN
cord-005453-4057qib7	11972	13	25.3	25.3	CD
cord-005453-4057qib7	11972	14	%	%	NN
cord-005453-4057qib7	11972	15	of	of	IN
cord-005453-4057qib7	11972	16	PBMCs	pbmc	NNS
cord-005453-4057qib7	11972	17	(	(	-LRB-
cord-005453-4057qib7	11972	18	range	range	VB
cord-005453-4057qib7	11972	19	10	10	CD
cord-005453-4057qib7	11972	20	.	.	.
cord-005453-4057qib7	11973	1	3	3	LS
cord-005453-4057qib7	11973	2	-	-	SYM
cord-005453-4057qib7	11973	3	44.2	44.2	CD
cord-005453-4057qib7	11973	4	%	%	NN
cord-005453-4057qib7	11973	5	)	)	-RRB-
cord-005453-4057qib7	11973	6	.	.	.
cord-005453-4057qib7	11974	1	Of	of	IN
cord-005453-4057qib7	11974	2	note	note	NN
cord-005453-4057qib7	11974	3	,	,	,
cord-005453-4057qib7	11974	4	the	the	DT
cord-005453-4057qib7	11974	5	one	one	CD
cord-005453-4057qib7	11974	6	patient	patient	NN
cord-005453-4057qib7	11974	7	who	who	WP
cord-005453-4057qib7	11974	8	developed	develop	VBD
cord-005453-4057qib7	11974	9	severe	severe	JJ
cord-005453-4057qib7	11974	10	,	,	,
cord-005453-4057qib7	11974	11	life	life	NN
cord-005453-4057qib7	11974	12	-	-	HYPH
cord-005453-4057qib7	11974	13	threatening	threaten	VBG
cord-005453-4057qib7	11974	14	GVHD	GVHD	NNP
cord-005453-4057qib7	11974	15	had	have	VBD
cord-005453-4057qib7	11974	16	the	the	DT
cord-005453-4057qib7	11974	17	lowest	low	JJS
cord-005453-4057qib7	11974	18	absolute	absolute	JJ
cord-005453-4057qib7	11974	19	and	and	CC
cord-005453-4057qib7	11974	20	relative	relative	JJ
cord-005453-4057qib7	11974	21	PMN	PMN	NNP
cord-005453-4057qib7	11974	22	-	-	HYPH
cord-005453-4057qib7	11974	23	MDSC	MDSC	NNP
cord-005453-4057qib7	11974	24	recovery	recovery	NN
cord-005453-4057qib7	11974	25	(	(	-LRB-
cord-005453-4057qib7	11974	26	11,330	11,330	CD
cord-005453-4057qib7	11974	27	cells	cell	NNS
cord-005453-4057qib7	11974	28	/	/	SYM
cord-005453-4057qib7	11974	29	mL	ml	NN
cord-005453-4057qib7	11974	30	and	and	CC
cord-005453-4057qib7	11974	31	10.3	10.3	CD
cord-005453-4057qib7	11974	32	%	%	NN
cord-005453-4057qib7	11974	33	of	of	IN
cord-005453-4057qib7	11974	34	total	total	JJ
cord-005453-4057qib7	11974	35	PBMCs	pbmc	NNS
cord-005453-4057qib7	11974	36	)	)	-RRB-
cord-005453-4057qib7	11974	37	.	.	.
cord-005453-4057qib7	11975	1	Recovery	recovery	NN
cord-005453-4057qib7	11975	2	of	of	IN
cord-005453-4057qib7	11975	3	M	M	NNP
cord-005453-4057qib7	11975	4	-	-	HYPH
cord-005453-4057qib7	11975	5	and	and	CC
cord-005453-4057qib7	11975	6	PMN	PMN	NNP
cord-005453-4057qib7	11975	7	-	-	HYPH
cord-005453-4057qib7	11975	8	MDSCs	MDSCs	NNP
cord-005453-4057qib7	11975	9	occurred	occur	VBD
cord-005453-4057qib7	11975	10	at	at	IN
cord-005453-4057qib7	11975	11	a	a	DT
cord-005453-4057qib7	11975	12	similar	similar	JJ
cord-005453-4057qib7	11975	13	tempo	tempo	NN
cord-005453-4057qib7	11975	14	and	and	CC
cord-005453-4057qib7	11975	15	magnitude	magnitude	NN
cord-005453-4057qib7	11975	16	in	in	IN
cord-005453-4057qib7	11975	17	two	two	CD
cord-005453-4057qib7	11975	18	recipients	recipient	NNS
cord-005453-4057qib7	11975	19	of	of	IN
cord-005453-4057qib7	11975	20	standard	standard	JJ
cord-005453-4057qib7	11975	21	GVHD	GVHD	NNP
cord-005453-4057qib7	11975	22	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11975	23	(	(	-LRB-
cord-005453-4057qib7	11975	24	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	11975	25	/	/	SYM
cord-005453-4057qib7	11975	26	methotrexate	methotrexate	NNP
cord-005453-4057qib7	11975	27	)	)	-RRB-
cord-005453-4057qib7	11975	28	.	.	.
cord-005453-4057qib7	11976	1	However	however	RB
cord-005453-4057qib7	11976	2	,	,	,
cord-005453-4057qib7	11976	3	while	while	IN
cord-005453-4057qib7	11976	4	MDSCs	mdsc	NNS
cord-005453-4057qib7	11976	5	isolated	isolate	VBN
cord-005453-4057qib7	11976	6	from	from	IN
cord-005453-4057qib7	11976	7	PTCy	PTCy	NNS
cord-005453-4057qib7	11976	8	recipients	recipient	NNS
cord-005453-4057qib7	11976	9	exhibited	exhibit	VBD
cord-005453-4057qib7	11976	10	clear	clear	JJ
cord-005453-4057qib7	11976	11	T	t	NN
cord-005453-4057qib7	11976	12	-	-	HYPH
cord-005453-4057qib7	11976	13	cell	cell	NN
cord-005453-4057qib7	11976	14	suppressive	suppressive	JJ
cord-005453-4057qib7	11976	15	capacity	capacity	NN
cord-005453-4057qib7	11976	16	,	,	,
cord-005453-4057qib7	11976	17	those	those	DT
cord-005453-4057qib7	11976	18	from	from	IN
cord-005453-4057qib7	11976	19	the	the	DT
cord-005453-4057qib7	11976	20	comparison	comparison	NN
cord-005453-4057qib7	11976	21	patients	patient	NNS
cord-005453-4057qib7	11976	22	did	do	VBD
cord-005453-4057qib7	11976	23	not	not	RB
cord-005453-4057qib7	11976	24	(	(	-LRB-
cord-005453-4057qib7	11976	25	see	see	VB
cord-005453-4057qib7	11976	26	Figure	figure	NN
cord-005453-4057qib7	11976	27	)	)	-RRB-
cord-005453-4057qib7	11976	28	.	.	.
cord-005453-4057qib7	11977	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	11977	2	:	:	:
cord-005453-4057qib7	11978	1	MDSCs	mdsc	NNS
cord-005453-4057qib7	11978	2	recover	recover	VB
cord-005453-4057qib7	11978	3	rapidly	rapidly	RB
cord-005453-4057qib7	11978	4	and	and	CC
cord-005453-4057qib7	11978	5	robustly	robustly	RB
cord-005453-4057qib7	11978	6	after	after	IN
cord-005453-4057qib7	11978	7	alloHCT	allohct	XX
cord-005453-4057qib7	11978	8	using	use	VBG
cord-005453-4057qib7	11978	9	PTCy	PTCy	NNS
cord-005453-4057qib7	11978	10	as	as	IN
cord-005453-4057qib7	11978	11	GVHD	GVHD	NNP
cord-005453-4057qib7	11978	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	11978	13	,	,	,
cord-005453-4057qib7	11978	14	and	and	CC
cord-005453-4057qib7	11978	15	may	may	MD
cord-005453-4057qib7	11978	16	play	play	VB
cord-005453-4057qib7	11978	17	a	a	DT
cord-005453-4057qib7	11978	18	role	role	NN
cord-005453-4057qib7	11978	19	in	in	IN
cord-005453-4057qib7	11978	20	mitigating	mitigate	VBG
cord-005453-4057qib7	11978	21	GVHD	GVHD	NNP
cord-005453-4057qib7	11978	22	risk	risk	NN
cord-005453-4057qib7	11978	23	by	by	IN
cord-005453-4057qib7	11978	24	mediating	mediate	VBG
cord-005453-4057qib7	11978	25	T	T	NNP
cord-005453-4057qib7	11978	26	-	-	HYPH
cord-005453-4057qib7	11978	27	cell	cell	NN
cord-005453-4057qib7	11978	28	suppression	suppression	NN
cord-005453-4057qib7	11978	29	.	.	.
cord-005453-4057qib7	11979	1	This	this	DT
cord-005453-4057qib7	11979	2	may	may	MD
cord-005453-4057qib7	11979	3	be	be	VB
cord-005453-4057qib7	11979	4	a	a	DT
cord-005453-4057qib7	11979	5	mechanism	mechanism	NN
cord-005453-4057qib7	11979	6	by	by	IN
cord-005453-4057qib7	11979	7	which	which	WDT
cord-005453-4057qib7	11979	8	PTCy	PTCy	VBZ
cord-005453-4057qib7	11979	9	results	result	NNS
cord-005453-4057qib7	11979	10	in	in	IN
cord-005453-4057qib7	11979	11	donor	donor	NN
cord-005453-4057qib7	11979	12	-	-	HYPH
cord-005453-4057qib7	11979	13	recipient	recipient	NN
cord-005453-4057qib7	11979	14	tolerance	tolerance	NN
cord-005453-4057qib7	11979	15	.	.	.
cord-005453-4057qib7	11980	1	Background	background	NN
cord-005453-4057qib7	11980	2	:	:	:
cord-005453-4057qib7	11981	1	High	high	JJ
cord-005453-4057qib7	11981	2	dose	dose	NN
cord-005453-4057qib7	11981	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	11981	4	followed	follow	VBN
cord-005453-4057qib7	11981	5	by	by	IN
cord-005453-4057qib7	11981	6	autologous	autologous	JJ
cord-005453-4057qib7	11981	7	stem	stem	NN
cord-005453-4057qib7	11981	8	cell	cell	NN
cord-005453-4057qib7	11981	9	transplantation	transplantation	NN
cord-005453-4057qib7	11981	10	(	(	-LRB-
cord-005453-4057qib7	11981	11	ASCT	ASCT	NNP
cord-005453-4057qib7	11981	12	)	)	-RRB-
cord-005453-4057qib7	11981	13	offers	offer	VBZ
cord-005453-4057qib7	11981	14	a	a	DT
cord-005453-4057qib7	11981	15	cure	cure	NN
cord-005453-4057qib7	11981	16	in	in	IN
cord-005453-4057qib7	11981	17	the	the	DT
cord-005453-4057qib7	11981	18	upfront	upfront	NN
cord-005453-4057qib7	11981	19	and	and	CC
cord-005453-4057qib7	11981	20	relapsed	relapse	VBD
cord-005453-4057qib7	11981	21	setting	setting	NN
cord-005453-4057qib7	11981	22	in	in	IN
cord-005453-4057qib7	11981	23	both	both	DT
cord-005453-4057qib7	11981	24	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	11981	25	(	(	-LRB-
cord-005453-4057qib7	11981	26	HL	HL	NNP
cord-005453-4057qib7	11981	27	)	)	-RRB-
cord-005453-4057qib7	11981	28	and	and	CC
cord-005453-4057qib7	11981	29	non	non	JJ
cord-005453-4057qib7	11981	30	-	-	JJ
cord-005453-4057qib7	11981	31	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	11981	32	lymphoma	lymphoma	NN
cord-005453-4057qib7	11981	33	(	(	-LRB-
cord-005453-4057qib7	11981	34	NHL	NHL	NNP
cord-005453-4057qib7	11981	35	)	)	-RRB-
cord-005453-4057qib7	11981	36	.	.	.
cord-005453-4057qib7	11982	1	ASCT	ASCT	NNP
cord-005453-4057qib7	11982	2	also	also	RB
cord-005453-4057qib7	11982	3	remains	remain	VBZ
cord-005453-4057qib7	11982	4	standard	standard	NN
cord-005453-4057qib7	11982	5	of	of	IN
cord-005453-4057qib7	11982	6	care	care	NN
cord-005453-4057qib7	11982	7	in	in	IN
cord-005453-4057qib7	11982	8	previously	previously	RB
cord-005453-4057qib7	11982	9	untreated	untreated	JJ
cord-005453-4057qib7	11982	10	multiple	multiple	JJ
cord-005453-4057qib7	11982	11	myeloma	myeloma	NN
cord-005453-4057qib7	11982	12	(	(	-LRB-
cord-005453-4057qib7	11982	13	MM	MM	NNP
cord-005453-4057qib7	11982	14	)	)	-RRB-
cord-005453-4057qib7	11982	15	patients	patient	NNS
cord-005453-4057qib7	11982	16	after	after	IN
cord-005453-4057qib7	11982	17	induction	induction	NN
cord-005453-4057qib7	11982	18	therapy	therapy	NN
cord-005453-4057qib7	11982	19	,	,	,
cord-005453-4057qib7	11982	20	if	if	IN
cord-005453-4057qib7	11982	21	eligible	eligible	JJ
cord-005453-4057qib7	11982	22	.	.	.
cord-005453-4057qib7	11983	1	The	the	DT
cord-005453-4057qib7	11983	2	availability	availability	NN
cord-005453-4057qib7	11983	3	of	of	IN
cord-005453-4057qib7	11983	4	new	new	JJ
cord-005453-4057qib7	11983	5	cellular	cellular	JJ
cord-005453-4057qib7	11983	6	or	or	CC
cord-005453-4057qib7	11983	7	other	other	JJ
cord-005453-4057qib7	11983	8	immune	immune	JJ
cord-005453-4057qib7	11983	9	therapies	therapy	NNS
cord-005453-4057qib7	11983	10	that	that	WDT
cord-005453-4057qib7	11983	11	can	can	MD
cord-005453-4057qib7	11983	12	be	be	VB
cord-005453-4057qib7	11983	13	used	use	VBN
cord-005453-4057qib7	11983	14	after	after	IN
cord-005453-4057qib7	11983	15	ASCT	ASCT	NNP
cord-005453-4057qib7	11983	16	underscores	underscore	VBZ
cord-005453-4057qib7	11983	17	the	the	DT
cord-005453-4057qib7	11983	18	potential	potential	JJ
cord-005453-4057qib7	11983	19	importance	importance	NN
cord-005453-4057qib7	11983	20	of	of	IN
cord-005453-4057qib7	11983	21	monitoring	monitor	VBG
cord-005453-4057qib7	11983	22	immune	immune	JJ
cord-005453-4057qib7	11983	23	reconstitution	reconstitution	NN
cord-005453-4057qib7	11983	24	after	after	IN
cord-005453-4057qib7	11983	25	ASCT	ASCT	NNP
cord-005453-4057qib7	11983	26	.	.	.
cord-005453-4057qib7	11984	1	Methods	method	NNS
cord-005453-4057qib7	11984	2	:	:	:
cord-005453-4057qib7	11985	1	Immune	immune	JJ
cord-005453-4057qib7	11985	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	11985	3	panels	panel	NNS
cord-005453-4057qib7	11985	4	(	(	-LRB-
cord-005453-4057qib7	11985	5	IRP	IRP	NNP
cord-005453-4057qib7	11985	6	)	)	-RRB-
cord-005453-4057qib7	11985	7	were	be	VBD
cord-005453-4057qib7	11985	8	evaluated	evaluate	VBN
cord-005453-4057qib7	11985	9	retrospectively	retrospectively	RB
cord-005453-4057qib7	11985	10	in	in	IN
cord-005453-4057qib7	11985	11	all	all	DT
cord-005453-4057qib7	11985	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	11985	13	and	and	CC
cord-005453-4057qib7	11985	14	MM	MM	NNP
cord-005453-4057qib7	11985	15	patients	patient	NNS
cord-005453-4057qib7	11985	16	over	over	IN
cord-005453-4057qib7	11985	17	a	a	DT
cord-005453-4057qib7	11985	18	5-year	5-year	CD
cord-005453-4057qib7	11985	19	span	span	NN
cord-005453-4057qib7	11985	20	(	(	-LRB-
cord-005453-4057qib7	11985	21	2012	2012	CD
cord-005453-4057qib7	11985	22	-	-	SYM
cord-005453-4057qib7	11985	23	2017	2017	CD
cord-005453-4057qib7	11985	24	)	)	-RRB-
cord-005453-4057qib7	11985	25	whom	whom	WP
cord-005453-4057qib7	11985	26	underwent	undergo	VBD
cord-005453-4057qib7	11985	27	ASCT	ASCT	NNP
cord-005453-4057qib7	11985	28	at	at	IN
cord-005453-4057qib7	11985	29	our	-PRON-	PRP$
cord-005453-4057qib7	11985	30	institution	institution	NN
cord-005453-4057qib7	11985	31	.	.	.
cord-005453-4057qib7	11986	1	Patients	patient	NNS
cord-005453-4057qib7	11986	2	were	be	VBD
cord-005453-4057qib7	11986	3	included	include	VBN
cord-005453-4057qib7	11986	4	if	if	IN
cord-005453-4057qib7	11986	5	they	-PRON-	PRP
cord-005453-4057qib7	11986	6	had	have	VBD
cord-005453-4057qib7	11986	7	a	a	DT
cord-005453-4057qib7	11986	8	pre	pre	JJ
cord-005453-4057qib7	11986	9	-	-	JJ
cord-005453-4057qib7	11986	10	ASCT	ASCT	NNP
cord-005453-4057qib7	11986	11	measured	measure	VBN
cord-005453-4057qib7	11986	12	within	within	IN
cord-005453-4057qib7	11986	13	30	30	CD
cord-005453-4057qib7	11986	14	days	day	NNS
cord-005453-4057qib7	11986	15	of	of	IN
cord-005453-4057qib7	11986	16	ASCT	ASCT	NNP
cord-005453-4057qib7	11986	17	and	and	CC
cord-005453-4057qib7	11986	18	two	two	CD
cord-005453-4057qib7	11986	19	other	other	JJ
cord-005453-4057qib7	11986	20	IRP	IRP	NNP
cord-005453-4057qib7	11986	21	at	at	IN
cord-005453-4057qib7	11986	22	any	any	DT
cord-005453-4057qib7	11986	23	of	of	IN
cord-005453-4057qib7	11986	24	the	the	DT
cord-005453-4057qib7	11986	25	following	follow	VBG
cord-005453-4057qib7	11986	26	timepoints	timepoint	NNS
cord-005453-4057qib7	11986	27	(	(	-LRB-
cord-005453-4057qib7	11986	28	1	1	CD
cord-005453-4057qib7	11986	29	)	)	-RRB-
cord-005453-4057qib7	11986	30	day	day	NN
cord-005453-4057qib7	11986	31	30	30	CD
cord-005453-4057qib7	11986	32	-	-	SYM
cord-005453-4057qib7	11986	33	45	45	CD
cord-005453-4057qib7	11986	34	,	,	,
cord-005453-4057qib7	11986	35	(	(	-LRB-
cord-005453-4057qib7	11986	36	2	2	LS
cord-005453-4057qib7	11986	37	)	)	-RRB-
cord-005453-4057qib7	11986	38	day	day	NN
cord-005453-4057qib7	11986	39	60	60	CD
cord-005453-4057qib7	11986	40	-	-	SYM
cord-005453-4057qib7	11986	41	90	90	CD
cord-005453-4057qib7	11986	42	,	,	,
cord-005453-4057qib7	11986	43	and	and	CC
cord-005453-4057qib7	11986	44	(	(	-LRB-
cord-005453-4057qib7	11986	45	3	3	LS
cord-005453-4057qib7	11986	46	)	)	-RRB-
cord-005453-4057qib7	11986	47	at	at	IN
cord-005453-4057qib7	11986	48	1-year	1-year	CD
cord-005453-4057qib7	11986	49	post	post	JJ
cord-005453-4057qib7	11986	50	-	-	JJ
cord-005453-4057qib7	11986	51	ASCT	asct	JJ
cord-005453-4057qib7	11986	52	.	.	.
cord-005453-4057qib7	11987	1	Patients	patient	NNS
cord-005453-4057qib7	11987	2	in	in	IN
cord-005453-4057qib7	11987	3	the	the	DT
cord-005453-4057qib7	11987	4	lymphoma	lymphoma	NN
cord-005453-4057qib7	11987	5	cohort	cohort	NN
cord-005453-4057qib7	11987	6	had	have	VBD
cord-005453-4057qib7	11987	7	their	-PRON-	PRP$
cord-005453-4057qib7	11987	8	IRP	IRP	NNP
cord-005453-4057qib7	11987	9	excluded	exclude	VBN
cord-005453-4057qib7	11987	10	if	if	IN
cord-005453-4057qib7	11987	11	they	-PRON-	PRP
cord-005453-4057qib7	11987	12	had	have	VBD
cord-005453-4057qib7	11987	13	additional	additional	JJ
cord-005453-4057qib7	11987	14	treatment	treatment	NN
cord-005453-4057qib7	11987	15	within	within	IN
cord-005453-4057qib7	11987	16	the	the	DT
cord-005453-4057qib7	11987	17	first	first	JJ
cord-005453-4057qib7	11987	18	year	year	NN
cord-005453-4057qib7	11987	19	post	post	NN
cord-005453-4057qib7	11987	20	-	-	JJ
cord-005453-4057qib7	11987	21	ASCT	asct	JJ
cord-005453-4057qib7	11987	22	(	(	-LRB-
cord-005453-4057qib7	11987	23	other	other	JJ
cord-005453-4057qib7	11987	24	than	than	IN
cord-005453-4057qib7	11987	25	maintenance	maintenance	NN
cord-005453-4057qib7	11987	26	rituximab	rituximab	NNP
cord-005453-4057qib7	11987	27	)	)	-RRB-
cord-005453-4057qib7	11987	28	.	.	.
cord-005453-4057qib7	11988	1	Mononuclear	Mononuclear	NNP
cord-005453-4057qib7	11988	2	cells	cell	NNS
cord-005453-4057qib7	11988	3	from	from	IN
cord-005453-4057qib7	11988	4	peripheral	peripheral	JJ
cord-005453-4057qib7	11988	5	blood	blood	NN
cord-005453-4057qib7	11988	6	were	be	VBD
cord-005453-4057qib7	11988	7	analyzed	analyze	VBN
cord-005453-4057qib7	11988	8	by	by	IN
cord-005453-4057qib7	11988	9	flow	flow	NN
cord-005453-4057qib7	11988	10	cytometry	cytometry	NN
cord-005453-4057qib7	11988	11	for	for	IN
cord-005453-4057qib7	11988	12	assessment	assessment	NN
cord-005453-4057qib7	11988	13	of	of	IN
cord-005453-4057qib7	11988	14	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	11988	15	phenotype	phenotype	NN
cord-005453-4057qib7	11988	16	and	and	CC
cord-005453-4057qib7	11988	17	numbers	number	NNS
cord-005453-4057qib7	11988	18	.	.	.
cord-005453-4057qib7	11989	1	Absolute	absolute	JJ
cord-005453-4057qib7	11989	2	values	value	NNS
cord-005453-4057qib7	11989	3	were	be	VBD
cord-005453-4057qib7	11989	4	compared	compare	VBN
cord-005453-4057qib7	11989	5	using	use	VBG
cord-005453-4057qib7	11989	6	the	the	DT
cord-005453-4057qib7	11989	7	Mann	Mann	NNP
cord-005453-4057qib7	11989	8	-	-	HYPH
cord-005453-4057qib7	11989	9	Whitney	Whitney	NNP
cord-005453-4057qib7	11989	10	U	U	NNP
cord-005453-4057qib7	11989	11	test	test	NN
cord-005453-4057qib7	11989	12	.	.	.
cord-005453-4057qib7	11990	1	Results	result	NNS
cord-005453-4057qib7	11990	2	:	:	:
cord-005453-4057qib7	11991	1	The	the	DT
cord-005453-4057qib7	11991	2	data	datum	NNS
cord-005453-4057qib7	11991	3	on	on	IN
cord-005453-4057qib7	11991	4	78	78	CD
cord-005453-4057qib7	11991	5	patients	patient	NNS
cord-005453-4057qib7	11991	6	were	be	VBD
cord-005453-4057qib7	11991	7	available	available	JJ
cord-005453-4057qib7	11991	8	for	for	IN
cord-005453-4057qib7	11991	9	analysis	analysis	NN
cord-005453-4057qib7	11991	10	(	(	-LRB-
cord-005453-4057qib7	11991	11	50	50	CD
cord-005453-4057qib7	11991	12	MM	MM	NNP
cord-005453-4057qib7	11991	13	,	,	,
cord-005453-4057qib7	11991	14	24	24	CD
cord-005453-4057qib7	11991	15	NHL	NHL	NNP
cord-005453-4057qib7	11991	16	,	,	,
cord-005453-4057qib7	11991	17	4	4	CD
cord-005453-4057qib7	11991	18	HL	HL	NNP
cord-005453-4057qib7	11991	19	)	)	-RRB-
cord-005453-4057qib7	11991	20	.	.	.
cord-005453-4057qib7	11992	1	All	all	DT
cord-005453-4057qib7	11992	2	lymphoma	lymphoma	NN
cord-005453-4057qib7	11992	3	patients	patient	NNS
cord-005453-4057qib7	11992	4	were	be	VBD
cord-005453-4057qib7	11992	5	conditioned	condition	VBN
cord-005453-4057qib7	11992	6	with	with	IN
cord-005453-4057qib7	11992	7	BEAM	BEAM	NNP
cord-005453-4057qib7	11992	8	.	.	.
cord-005453-4057qib7	11993	1	All	all	DT
cord-005453-4057qib7	11993	2	MM	MM	NNP
cord-005453-4057qib7	11993	3	patients	patient	NNS
cord-005453-4057qib7	11993	4	were	be	VBD
cord-005453-4057qib7	11993	5	conditioned	condition	VBN
cord-005453-4057qib7	11993	6	with	with	IN
cord-005453-4057qib7	11993	7	a	a	DT
cord-005453-4057qib7	11993	8	standard	standard	JJ
cord-005453-4057qib7	11993	9	high	high	JJ
cord-005453-4057qib7	11993	10	dose	dose	NN
cord-005453-4057qib7	11993	11	melphalan	melphalan	NNP
cord-005453-4057qib7	11993	12	regimen	regimen	NN
cord-005453-4057qib7	11993	13	.	.	.
cord-005453-4057qib7	11994	1	The	the	DT
cord-005453-4057qib7	11994	2	median	median	JJ
cord-005453-4057qib7	11994	3	pre	pre	JJ
cord-005453-4057qib7	11994	4	-	-	JJ
cord-005453-4057qib7	11994	5	ASCT	asct	JJ
cord-005453-4057qib7	11994	6	absolute	absolute	JJ
cord-005453-4057qib7	11994	7	CD3	CD3	NNP
cord-005453-4057qib7	11994	8	counts	count	VBZ
cord-005453-4057qib7	11994	9	in	in	IN
cord-005453-4057qib7	11994	10	the	the	DT
cord-005453-4057qib7	11994	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	11994	12	cohort	cohort	NN
cord-005453-4057qib7	11994	13	were	be	VBD
cord-005453-4057qib7	11994	14	significantly	significantly	RB
cord-005453-4057qib7	11994	15	lower	low	JJR
cord-005453-4057qib7	11994	16	than	than	IN
cord-005453-4057qib7	11994	17	the	the	DT
cord-005453-4057qib7	11994	18	MM	MM	NNP
cord-005453-4057qib7	11994	19	cohort	cohort	NN
cord-005453-4057qib7	11994	20	at	at	IN
cord-005453-4057qib7	11994	21	1709	1709	CD
cord-005453-4057qib7	11994	22	cells	cell	NNS
cord-005453-4057qib7	11995	1	/	/	NFP
cord-005453-4057qib7	11996	1	μL	μL	.
cord-005453-4057qib7	11997	1	vs	vs	IN
cord-005453-4057qib7	11997	2	3309	3309	CD
cord-005453-4057qib7	11997	3	cells/	cells/	CD
cord-005453-4057qib7	11998	1	μL	μL	NNP
cord-005453-4057qib7	11998	2	,	,	,
cord-005453-4057qib7	11999	1	respectively	respectively	RB
cord-005453-4057qib7	11999	2	(	(	-LRB-
cord-005453-4057qib7	11999	3	P=0.049	P=0.049	NNP
cord-005453-4057qib7	11999	4	)	)	-RRB-
cord-005453-4057qib7	11999	5	.	.	.
cord-005453-4057qib7	12000	1	However	however	RB
cord-005453-4057qib7	12000	2	,	,	,
cord-005453-4057qib7	12000	3	the	the	DT
cord-005453-4057qib7	12000	4	MM	MM	NNP
cord-005453-4057qib7	12000	5	cohort	cohort	NN
cord-005453-4057qib7	12000	6	exhibited	exhibit	VBD
cord-005453-4057qib7	12000	7	a	a	DT
cord-005453-4057qib7	12000	8	greater	great	JJR
cord-005453-4057qib7	12000	9	percent	percent	NN
cord-005453-4057qib7	12000	10	reduction	reduction	NN
cord-005453-4057qib7	12000	11	in	in	IN
cord-005453-4057qib7	12000	12	CD3	CD3	NNP
cord-005453-4057qib7	12000	13	cells	cell	NNS
cord-005453-4057qib7	12000	14	on	on	IN
cord-005453-4057qib7	12000	15	day	day	NN
cord-005453-4057qib7	12000	16	30	30	CD
cord-005453-4057qib7	12000	17	at	at	IN
cord-005453-4057qib7	12000	18	85.3	85.3	CD
cord-005453-4057qib7	12000	19	%	%	NN
cord-005453-4057qib7	12000	20	vs	vs	IN
cord-005453-4057qib7	12000	21	63.5	63.5	CD
cord-005453-4057qib7	12000	22	%	%	NN
cord-005453-4057qib7	12000	23	,	,	,
cord-005453-4057qib7	12000	24	respectively	respectively	RB
cord-005453-4057qib7	12000	25	which	which	WDT
cord-005453-4057qib7	12000	26	continued	continue	VBD
cord-005453-4057qib7	12000	27	through	through	IN
cord-005453-4057qib7	12000	28	day	day	NN
cord-005453-4057qib7	12000	29	365	365	CD
cord-005453-4057qib7	12000	30	at	at	IN
cord-005453-4057qib7	12000	31	79.8	79.8	CD
cord-005453-4057qib7	12000	32	%	%	NN
cord-005453-4057qib7	12000	33	vs	vs	IN
cord-005453-4057qib7	12000	34	70.3	70.3	CD
cord-005453-4057qib7	12000	35	%	%	NN
cord-005453-4057qib7	12000	36	,	,	,
cord-005453-4057qib7	12000	37	respectively	respectively	RB
cord-005453-4057qib7	12000	38	.	.	.
cord-005453-4057qib7	12001	1	This	this	DT
cord-005453-4057qib7	12001	2	led	lead	VBD
cord-005453-4057qib7	12001	3	to	to	IN
cord-005453-4057qib7	12001	4	nonsignificant	nonsignificant	JJ
cord-005453-4057qib7	12001	5	changes	change	NNS
cord-005453-4057qib7	12001	6	in	in	IN
cord-005453-4057qib7	12001	7	absolute	absolute	JJ
cord-005453-4057qib7	12001	8	CD3	CD3	NNP
cord-005453-4057qib7	12001	9	count	count	NN
cord-005453-4057qib7	12001	10	by	by	IN
cord-005453-4057qib7	12001	11	day	day	NN
cord-005453-4057qib7	12001	12	365	365	CD
cord-005453-4057qib7	12001	13	at	at	IN
cord-005453-4057qib7	12001	14	667	667	CD
cord-005453-4057qib7	12001	15	cells/	cells/	CD
cord-005453-4057qib7	12002	1	μL	μL	.
cord-005453-4057qib7	12003	1	vs	vs	IN
cord-005453-4057qib7	12003	2	507	507	CD
cord-005453-4057qib7	12003	3	cells	cell	NNS
cord-005453-4057qib7	12003	4	/	/	SYM
cord-005453-4057qib7	12003	5	μL	μl	NN
cord-005453-4057qib7	12003	6	,	,	,
cord-005453-4057qib7	12003	7	respectively	respectively	RB
cord-005453-4057qib7	12003	8	(	(	-LRB-
cord-005453-4057qib7	12003	9	P=0.39	p=0.39	NN
cord-005453-4057qib7	12003	10	)	)	-RRB-
cord-005453-4057qib7	12003	11	(	(	-LRB-
cord-005453-4057qib7	12003	12	figure	figure	NN
cord-005453-4057qib7	12003	13	1	1	CD
cord-005453-4057qib7	12003	14	)	)	-RRB-
cord-005453-4057qib7	12003	15	.	.	.
cord-005453-4057qib7	12004	1	The	the	DT
cord-005453-4057qib7	12004	2	median	median	JJ
cord-005453-4057qib7	12004	3	absolute	absolute	JJ
cord-005453-4057qib7	12004	4	CD4	CD4	NNP
cord-005453-4057qib7	12004	5	count	count	NN
cord-005453-4057qib7	12004	6	pre	pre	JJ
cord-005453-4057qib7	12004	7	-	-	JJ
cord-005453-4057qib7	12004	8	ASCT	ASCT	NNP
cord-005453-4057qib7	12004	9	for	for	IN
cord-005453-4057qib7	12004	10	MM	MM	NNP
cord-005453-4057qib7	12004	11	and	and	CC
cord-005453-4057qib7	12004	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	12004	13	cohorts	cohort	NNS
cord-005453-4057qib7	12004	14	were	be	VBD
cord-005453-4057qib7	12004	15	2101	2101	CD
cord-005453-4057qib7	12004	16	cells/	cells/	CD
cord-005453-4057qib7	12005	1	μL	μL	NNP
cord-005453-4057qib7	12005	2	and	and	CC
cord-005453-4057qib7	12005	3	863	863	CD
cord-005453-4057qib7	12005	4	cells/	cells/	CD
cord-005453-4057qib7	12006	1	μL	μL	NNP
cord-005453-4057qib7	12006	2	,	,	,
cord-005453-4057qib7	12007	1	respectively	respectively	RB
cord-005453-4057qib7	12007	2	(	(	-LRB-
cord-005453-4057qib7	12007	3	P=0.007	p=0.007	NN
cord-005453-4057qib7	12007	4	)	)	-RRB-
cord-005453-4057qib7	12007	5	.	.	.
cord-005453-4057qib7	12008	1	Similarly	similarly	RB
cord-005453-4057qib7	12008	2	,	,	,
cord-005453-4057qib7	12008	3	a	a	DT
cord-005453-4057qib7	12008	4	greater	great	JJR
cord-005453-4057qib7	12008	5	percent	percent	NN
cord-005453-4057qib7	12008	6	reduction	reduction	NN
cord-005453-4057qib7	12008	7	in	in	IN
cord-005453-4057qib7	12008	8	CD4	CD4	NNP
cord-005453-4057qib7	12008	9	cells	cell	NNS
cord-005453-4057qib7	12008	10	led	lead	VBD
cord-005453-4057qib7	12008	11	to	to	IN
cord-005453-4057qib7	12008	12	comparable	comparable	JJ
cord-005453-4057qib7	12008	13	absolute	absolute	JJ
cord-005453-4057qib7	12008	14	counts	count	NNS
cord-005453-4057qib7	12008	15	on	on	IN
cord-005453-4057qib7	12008	16	day	day	NN
cord-005453-4057qib7	12008	17	365	365	CD
cord-005453-4057qib7	12008	18	at	at	IN
cord-005453-4057qib7	12008	19	310	310	CD
cord-005453-4057qib7	12008	20	cells/	cells/	CD
cord-005453-4057qib7	12009	1	μL	μL	.
cord-005453-4057qib7	12010	1	vs	vs	IN
cord-005453-4057qib7	12010	2	298	298	CD
cord-005453-4057qib7	12010	3	cells	cell	NNS
cord-005453-4057qib7	12010	4	/	/	SYM
cord-005453-4057qib7	12010	5	μL	μl	NN
cord-005453-4057qib7	12010	6	,	,	,
cord-005453-4057qib7	12010	7	respectively	respectively	RB
cord-005453-4057qib7	12010	8	(	(	-LRB-
cord-005453-4057qib7	12010	9	P=0.322	P=0.322	NNP
cord-005453-4057qib7	12010	10	)	)	-RRB-
cord-005453-4057qib7	12010	11	.	.	.
cord-005453-4057qib7	12011	1	The	the	DT
cord-005453-4057qib7	12011	2	failure	failure	NN
cord-005453-4057qib7	12011	3	of	of	IN
cord-005453-4057qib7	12011	4	post	post	JJ
cord-005453-4057qib7	12011	5	-	-	JJ
cord-005453-4057qib7	12011	6	ASCT	asct	JJ
cord-005453-4057qib7	12011	7	CD3	cd3	NN
cord-005453-4057qib7	12011	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	12011	9	to	to	TO
cord-005453-4057qib7	12011	10	pre	pre	JJ
cord-005453-4057qib7	12011	11	-	-	JJ
cord-005453-4057qib7	12011	12	ASCT	asct	JJ
cord-005453-4057qib7	12011	13	levels	level	NNS
cord-005453-4057qib7	12011	14	was	be	VBD
cord-005453-4057qib7	12011	15	driven	drive	VBN
cord-005453-4057qib7	12011	16	by	by	IN
cord-005453-4057qib7	12011	17	lack	lack	NN
cord-005453-4057qib7	12011	18	of	of	IN
cord-005453-4057qib7	12011	19	CD4	CD4	NNP
cord-005453-4057qib7	12011	20	+	+	CC
cord-005453-4057qib7	12011	21	cell	cell	NN
cord-005453-4057qib7	12011	22	recovery	recovery	NN
cord-005453-4057qib7	12011	23	,	,	,
cord-005453-4057qib7	12011	24	namely	namely	RB
cord-005453-4057qib7	12011	25	CD4+CD45RA+	CD4+CD45RA+	NNP
cord-005453-4057qib7	12011	26	cells	cell	NNS
cord-005453-4057qib7	12011	27	with	with	IN
cord-005453-4057qib7	12011	28	a	a	DT
cord-005453-4057qib7	12011	29	median	median	NN
cord-005453-4057qib7	12011	30	of	of	IN
cord-005453-4057qib7	12011	31	21	21	CD
cord-005453-4057qib7	12011	32	cells/	cells/	CD
cord-005453-4057qib7	12012	1	μL	μL	NNP
cord-005453-4057qib7	12012	2	and	and	CC
cord-005453-4057qib7	12012	3	20	20	CD
cord-005453-4057qib7	12012	4	cells/	cells/	CD
cord-005453-4057qib7	12013	1	μL	μL	.
cord-005453-4057qib7	12014	1	in	in	IN
cord-005453-4057qib7	12014	2	the	the	DT
cord-005453-4057qib7	12014	3	MM	MM	NNP
cord-005453-4057qib7	12014	4	and	and	CC
cord-005453-4057qib7	12014	5	lymphoma	lymphoma	NN
cord-005453-4057qib7	12014	6	cohorts	cohort	NNS
cord-005453-4057qib7	12014	7	,	,	,
cord-005453-4057qib7	12014	8	respectively	respectively	RB
cord-005453-4057qib7	12014	9	at	at	IN
cord-005453-4057qib7	12014	10	day	day	NN
cord-005453-4057qib7	12014	11	365	365	CD
cord-005453-4057qib7	12014	12	(	(	-LRB-
cord-005453-4057qib7	12014	13	figures	figure	NNS
cord-005453-4057qib7	12014	14	2	2	CD
cord-005453-4057qib7	12014	15	and	and	CC
cord-005453-4057qib7	12014	16	3	3	CD
cord-005453-4057qib7	12014	17	)	)	-RRB-
cord-005453-4057qib7	12014	18	.	.	.
cord-005453-4057qib7	12015	1	This	this	DT
cord-005453-4057qib7	12015	2	led	lead	VBD
cord-005453-4057qib7	12015	3	to	to	IN
cord-005453-4057qib7	12015	4	markedly	markedly	RB
cord-005453-4057qib7	12015	5	diminished	diminish	VBN
cord-005453-4057qib7	12015	6	CD4	CD4	NNP
cord-005453-4057qib7	12015	7	:	:	:
cord-005453-4057qib7	12015	8	CD8	CD8	NNP
cord-005453-4057qib7	12015	9	ratios	ratio	NNS
cord-005453-4057qib7	12015	10	through	through	IN
cord-005453-4057qib7	12015	11	day	day	NN
cord-005453-4057qib7	12015	12	365	365	CD
cord-005453-4057qib7	12015	13	(	(	-LRB-
cord-005453-4057qib7	12015	14	figure	figure	NN
cord-005453-4057qib7	12015	15	4	4	CD
cord-005453-4057qib7	12015	16	)	)	-RRB-
cord-005453-4057qib7	12015	17	.	.	.
cord-005453-4057qib7	12016	1	[	[	-LRB-
cord-005453-4057qib7	12016	2	[	[	-LRB-
cord-005453-4057qib7	12016	3	P531	p531	CD
cord-005453-4057qib7	12016	4	Image	image	NN
cord-005453-4057qib7	12016	5	]	]	-RRB-
cord-005453-4057qib7	12016	6	1	1	CD
cord-005453-4057qib7	12016	7	.	.	.
cord-005453-4057qib7	12017	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12017	2	:	:	:
cord-005453-4057qib7	12018	1	Impaired	impaired	JJ
cord-005453-4057qib7	12018	2	T	t	NN
cord-005453-4057qib7	12018	3	-	-	HYPH
cord-005453-4057qib7	12018	4	cell	cell	NN
cord-005453-4057qib7	12018	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	12018	6	in	in	IN
cord-005453-4057qib7	12018	7	both	both	DT
cord-005453-4057qib7	12018	8	lymphoma	lymphoma	NN
cord-005453-4057qib7	12018	9	and	and	CC
cord-005453-4057qib7	12018	10	MM	MM	NNP
cord-005453-4057qib7	12018	11	continues	continue	VBZ
cord-005453-4057qib7	12018	12	through	through	IN
cord-005453-4057qib7	12018	13	1-year	1-year	CD
cord-005453-4057qib7	12018	14	post	post	JJ
cord-005453-4057qib7	12018	15	-	-	JJ
cord-005453-4057qib7	12018	16	ASCT	asct	JJ
cord-005453-4057qib7	12018	17	.	.	.
cord-005453-4057qib7	12019	1	As	as	IN
cord-005453-4057qib7	12019	2	shown	show	VBN
cord-005453-4057qib7	12019	3	,	,	,
cord-005453-4057qib7	12019	4	a	a	DT
cord-005453-4057qib7	12019	5	larger	large	JJR
cord-005453-4057qib7	12019	6	percent	percent	NN
cord-005453-4057qib7	12019	7	reduction	reduction	NN
cord-005453-4057qib7	12019	8	in	in	IN
cord-005453-4057qib7	12019	9	median	median	JJ
cord-005453-4057qib7	12019	10	CD3	CD3	NNP
cord-005453-4057qib7	12019	11	and	and	CC
cord-005453-4057qib7	12019	12	CD4	CD4	NNP
cord-005453-4057qib7	12019	13	counts	count	VBZ
cord-005453-4057qib7	12019	14	through	through	IN
cord-005453-4057qib7	12019	15	day	day	NN
cord-005453-4057qib7	12019	16	365	365	CD
cord-005453-4057qib7	12019	17	was	be	VBD
cord-005453-4057qib7	12019	18	appreciated	appreciate	VBN
cord-005453-4057qib7	12019	19	in	in	IN
cord-005453-4057qib7	12019	20	MM	MM	NNP
cord-005453-4057qib7	12019	21	compared	compare	VBN
cord-005453-4057qib7	12019	22	to	to	IN
cord-005453-4057qib7	12019	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	12019	24	leading	lead	VBG
cord-005453-4057qib7	12019	25	to	to	IN
cord-005453-4057qib7	12019	26	the	the	DT
cord-005453-4057qib7	12019	27	nonsignificant	nonsignificant	JJ
cord-005453-4057qib7	12019	28	differences	difference	NNS
cord-005453-4057qib7	12019	29	in	in	IN
cord-005453-4057qib7	12019	30	the	the	DT
cord-005453-4057qib7	12019	31	post	post	JJ
cord-005453-4057qib7	12019	32	-	-	JJ
cord-005453-4057qib7	12019	33	ASCT	asct	JJ
cord-005453-4057qib7	12019	34	absolute	absolute	JJ
cord-005453-4057qib7	12019	35	counts	count	NNS
cord-005453-4057qib7	12019	36	despite	despite	IN
cord-005453-4057qib7	12019	37	significantly	significantly	RB
cord-005453-4057qib7	12019	38	higher	high	JJR
cord-005453-4057qib7	12019	39	pre	pre	JJ
cord-005453-4057qib7	12019	40	-	-	JJ
cord-005453-4057qib7	12019	41	ASCT	asct	JJ
cord-005453-4057qib7	12019	42	counts	count	NNS
cord-005453-4057qib7	12019	43	in	in	IN
cord-005453-4057qib7	12019	44	the	the	DT
cord-005453-4057qib7	12019	45	MM	MM	NNP
cord-005453-4057qib7	12019	46	cohort	cohort	NN
cord-005453-4057qib7	12019	47	.	.	.
cord-005453-4057qib7	12020	1	Impaired	impaired	JJ
cord-005453-4057qib7	12020	2	recovery	recovery	NN
cord-005453-4057qib7	12020	3	of	of	IN
cord-005453-4057qib7	12020	4	CD4	CD4	NNP
cord-005453-4057qib7	12020	5	T	T	NNP
cord-005453-4057qib7	12020	6	-	-	HYPH
cord-005453-4057qib7	12020	7	cells	cell	NNS
cord-005453-4057qib7	12020	8	may	may	MD
cord-005453-4057qib7	12020	9	increase	increase	VB
cord-005453-4057qib7	12020	10	the	the	DT
cord-005453-4057qib7	12020	11	risk	risk	NN
cord-005453-4057qib7	12020	12	of	of	IN
cord-005453-4057qib7	12020	13	opportunistic	opportunistic	JJ
cord-005453-4057qib7	12020	14	infections	infection	NNS
cord-005453-4057qib7	12020	15	,	,	,
cord-005453-4057qib7	12020	16	decrease	decrease	VB
cord-005453-4057qib7	12020	17	the	the	DT
cord-005453-4057qib7	12020	18	response	response	NN
cord-005453-4057qib7	12020	19	to	to	IN
cord-005453-4057qib7	12020	20	vaccination	vaccination	NN
cord-005453-4057qib7	12020	21	and	and	CC
cord-005453-4057qib7	12020	22	lead	lead	VB
cord-005453-4057qib7	12020	23	to	to	IN
cord-005453-4057qib7	12020	24	ineffective	ineffective	JJ
cord-005453-4057qib7	12020	25	anti	anti	JJ
cord-005453-4057qib7	12020	26	-	-	JJ
cord-005453-4057qib7	12020	27	tumor	tumor	JJ
cord-005453-4057qib7	12020	28	response	response	NN
cord-005453-4057qib7	12020	29	.	.	.
cord-005453-4057qib7	12021	1	Further	further	JJ
cord-005453-4057qib7	12021	2	prospective	prospective	JJ
cord-005453-4057qib7	12021	3	and	and	CC
cord-005453-4057qib7	12021	4	larger	large	JJR
cord-005453-4057qib7	12021	5	retrospective	retrospective	JJ
cord-005453-4057qib7	12021	6	studies	study	NNS
cord-005453-4057qib7	12021	7	like	like	IN
cord-005453-4057qib7	12021	8	this	this	DT
cord-005453-4057qib7	12021	9	should	should	MD
cord-005453-4057qib7	12021	10	continue	continue	VB
cord-005453-4057qib7	12021	11	in	in	IN
cord-005453-4057qib7	12021	12	the	the	DT
cord-005453-4057qib7	12021	13	modern	modern	JJ
cord-005453-4057qib7	12021	14	-	-	HYPH
cord-005453-4057qib7	12021	15	era	era	NN
cord-005453-4057qib7	12021	16	as	as	IN
cord-005453-4057qib7	12021	17	they	-PRON-	PRP
cord-005453-4057qib7	12021	18	may	may	MD
cord-005453-4057qib7	12021	19	help	help	VB
cord-005453-4057qib7	12021	20	predict	predict	VB
cord-005453-4057qib7	12021	21	responses	response	NNS
cord-005453-4057qib7	12021	22	to	to	IN
cord-005453-4057qib7	12021	23	further	further	JJ
cord-005453-4057qib7	12021	24	interventions	intervention	NNS
cord-005453-4057qib7	12021	25	requiring	require	VBG
cord-005453-4057qib7	12021	26	a	a	DT
cord-005453-4057qib7	12021	27	robust	robust	JJ
cord-005453-4057qib7	12021	28	T	t	NN
cord-005453-4057qib7	12021	29	-	-	HYPH
cord-005453-4057qib7	12021	30	cell	cell	NN
cord-005453-4057qib7	12021	31	repertoire	repertoire	NN
cord-005453-4057qib7	12021	32	for	for	IN
cord-005453-4057qib7	12021	33	maximal	maximal	JJ
cord-005453-4057qib7	12021	34	efficacy	efficacy	NN
cord-005453-4057qib7	12021	35	such	such	JJ
cord-005453-4057qib7	12021	36	as	as	IN
cord-005453-4057qib7	12021	37	CAR	car	NN
cord-005453-4057qib7	12021	38	-	-	HYPH
cord-005453-4057qib7	12021	39	T	t	NN
cord-005453-4057qib7	12021	40	cell	cell	NN
cord-005453-4057qib7	12021	41	and	and	CC
cord-005453-4057qib7	12021	42	BiTE	bite	NN
cord-005453-4057qib7	12021	43	therapies	therapy	NNS
cord-005453-4057qib7	12021	44	.	.	.
cord-005453-4057qib7	12022	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12022	2	:	:	:
cord-005453-4057qib7	12023	1	Nothing	nothing	NN
cord-005453-4057qib7	12023	2	to	to	TO
cord-005453-4057qib7	12023	3	declare	declare	VB
cord-005453-4057qib7	12023	4	P532	P532	NNP
cord-005453-4057qib7	12023	5	Peri	Peri	NNP
cord-005453-4057qib7	12023	6	-	-	HYPH
cord-005453-4057qib7	12023	7	transplant	transplant	NN
cord-005453-4057qib7	12023	8	detection	detection	NN
cord-005453-4057qib7	12023	9	of	of	IN
cord-005453-4057qib7	12023	10	measurable	measurable	JJ
cord-005453-4057qib7	12023	11	residual	residual	JJ
cord-005453-4057qib7	12023	12	disease	disease	NN
cord-005453-4057qib7	12023	13	by	by	IN
cord-005453-4057qib7	12023	14	multicolor	multicolor	JJ
cord-005453-4057qib7	12023	15	flow	flow	NN
cord-005453-4057qib7	12023	16	cytometry	cytometry	NN
cord-005453-4057qib7	12023	17	is	be	VBZ
cord-005453-4057qib7	12023	18	highly	highly	RB
cord-005453-4057qib7	12023	19	predictive	predictive	JJ
cord-005453-4057qib7	12023	20	for	for	IN
cord-005453-4057qib7	12023	21	relapse	relapse	NN
cord-005453-4057qib7	12023	22	in	in	IN
cord-005453-4057qib7	12023	23	acute	acute	JJ
cord-005453-4057qib7	12023	24	myeloid	myeloid	JJ
cord-005453-4057qib7	12023	25	leukemia	leukemia	NN
cord-005453-4057qib7	12023	26	patients	patient	NNS
cord-005453-4057qib7	12024	1	Background	background	NN
cord-005453-4057qib7	12024	2	:	:	:
cord-005453-4057qib7	12025	1	Presence	presence	NN
cord-005453-4057qib7	12025	2	of	of	IN
cord-005453-4057qib7	12025	3	measurable	measurable	JJ
cord-005453-4057qib7	12025	4	residual	residual	JJ
cord-005453-4057qib7	12025	5	disease	disease	NN
cord-005453-4057qib7	12025	6	(	(	-LRB-
cord-005453-4057qib7	12025	7	MRD	MRD	NNP
cord-005453-4057qib7	12025	8	)	)	-RRB-
cord-005453-4057qib7	12025	9	prior	prior	RB
cord-005453-4057qib7	12025	10	to	to	IN
cord-005453-4057qib7	12025	11	allo	allo	NNP
cord-005453-4057qib7	12025	12	-	-	HYPH
cord-005453-4057qib7	12025	13	SCT	SCT	NNP
cord-005453-4057qib7	12025	14	has	have	VBZ
cord-005453-4057qib7	12025	15	been	be	VBN
cord-005453-4057qib7	12025	16	shown	show	VBN
cord-005453-4057qib7	12025	17	to	to	TO
cord-005453-4057qib7	12025	18	be	be	VB
cord-005453-4057qib7	12025	19	predictive	predictive	JJ
cord-005453-4057qib7	12025	20	for	for	IN
cord-005453-4057qib7	12025	21	survival	survival	NN
cord-005453-4057qib7	12025	22	in	in	IN
cord-005453-4057qib7	12025	23	patients	patient	NNS
cord-005453-4057qib7	12025	24	in	in	IN
cord-005453-4057qib7	12025	25	hematological	hematological	JJ
cord-005453-4057qib7	12025	26	CR	cr	NN
cord-005453-4057qib7	12025	27	of	of	IN
cord-005453-4057qib7	12025	28	AML	AML	NNP
cord-005453-4057qib7	12025	29	.	.	.
cord-005453-4057qib7	12026	1	In	in	IN
cord-005453-4057qib7	12026	2	this	this	DT
cord-005453-4057qib7	12026	3	study	study	NN
cord-005453-4057qib7	12026	4	we	-PRON-	PRP
cord-005453-4057qib7	12026	5	analyzed	analyze	VBD
cord-005453-4057qib7	12026	6	the	the	DT
cord-005453-4057qib7	12026	7	impact	impact	NN
cord-005453-4057qib7	12026	8	of	of	IN
cord-005453-4057qib7	12026	9	MRD	MRD	NNP
cord-005453-4057qib7	12026	10	in	in	IN
cord-005453-4057qib7	12026	11	such	such	JJ
cord-005453-4057qib7	12026	12	patients	patient	NNS
cord-005453-4057qib7	12026	13	measured	measure	VBN
cord-005453-4057qib7	12026	14	by	by	IN
cord-005453-4057qib7	12026	15	8-color	8-color	CD
cord-005453-4057qib7	12026	16	multiparameter	multiparameter	NNP
cord-005453-4057qib7	12026	17	flow	flow	NN
cord-005453-4057qib7	12026	18	cytometry	cytometry	NN
cord-005453-4057qib7	12026	19	(	(	-LRB-
cord-005453-4057qib7	12026	20	MFC	MFC	NNP
cord-005453-4057qib7	12026	21	)	)	-RRB-
cord-005453-4057qib7	12026	22	prior	prior	RB
cord-005453-4057qib7	12026	23	to	to	IN
cord-005453-4057qib7	12026	24	and	and	CC
cord-005453-4057qib7	12026	25	on	on	IN
cord-005453-4057qib7	12026	26	day	day	NN
cord-005453-4057qib7	12026	27	+100	+100	HYPH
cord-005453-4057qib7	12026	28	post	post	NN
cord-005453-4057qib7	12026	29	-	-	NN
cord-005453-4057qib7	12026	30	transplant	transplant	NN
cord-005453-4057qib7	12026	31	.	.	.
cord-005453-4057qib7	12027	1	Methods	method	NNS
cord-005453-4057qib7	12027	2	:	:	:
cord-005453-4057qib7	12027	3	The	the	DT
cord-005453-4057qib7	12027	4	bone	bone	NN
cord-005453-4057qib7	12027	5	marrow	marrow	NN
cord-005453-4057qib7	12027	6	samples	sample	NNS
cord-005453-4057qib7	12027	7	immediately	immediately	RB
cord-005453-4057qib7	12027	8	prior	prior	RB
cord-005453-4057qib7	12027	9	to	to	IN
cord-005453-4057qib7	12027	10	allo	allo	NNP
cord-005453-4057qib7	12027	11	-	-	HYPH
cord-005453-4057qib7	12027	12	SCT	SCT	NNP
cord-005453-4057qib7	12027	13	and	and	CC
cord-005453-4057qib7	12027	14	on	on	IN
cord-005453-4057qib7	12027	15	day	day	NN
cord-005453-4057qib7	12027	16	+100	+100	HYPH
cord-005453-4057qib7	12027	17	post	post	NN
cord-005453-4057qib7	12027	18	-	-	NN
cord-005453-4057qib7	12027	19	transplant	transplant	NN
cord-005453-4057qib7	12027	20	were	be	VBD
cord-005453-4057qib7	12027	21	retrospectively	retrospectively	RB
cord-005453-4057qib7	12027	22	analyzed	analyze	VBN
cord-005453-4057qib7	12027	23	.	.	.
cord-005453-4057qib7	12028	1	MRD	MRD	NNP
cord-005453-4057qib7	12028	2	evaluation	evaluation	NN
cord-005453-4057qib7	12028	3	was	be	VBD
cord-005453-4057qib7	12028	4	carried	carry	VBN
cord-005453-4057qib7	12028	5	out	out	RP
cord-005453-4057qib7	12028	6	with	with	IN
cord-005453-4057qib7	12028	7	antibodies	antibody	NNS
cord-005453-4057qib7	12028	8	against	against	IN
cord-005453-4057qib7	12028	9	:	:	:
cord-005453-4057qib7	12029	1	(	(	-LRB-
cord-005453-4057qib7	12029	2	1	1	LS
cord-005453-4057qib7	12029	3	)	)	-RRB-
cord-005453-4057qib7	12029	4	Results	result	NNS
cord-005453-4057qib7	12029	5	:	:	:
cord-005453-4057qib7	12030	1	A	a	DT
cord-005453-4057qib7	12030	2	number	number	NN
cord-005453-4057qib7	12030	3	of	of	IN
cord-005453-4057qib7	12030	4	55	55	CD
cord-005453-4057qib7	12030	5	AML	AML	NNP
cord-005453-4057qib7	12030	6	patients	patient	NNS
cord-005453-4057qib7	12030	7	(	(	-LRB-
cord-005453-4057qib7	12030	8	male	male	JJ
cord-005453-4057qib7	12030	9	,	,	,
cord-005453-4057qib7	12030	10	n=35	n=35	RB
cord-005453-4057qib7	12030	11	)	)	-RRB-
cord-005453-4057qib7	12030	12	with	with	IN
cord-005453-4057qib7	12030	13	median	median	JJ
cord-005453-4057qib7	12030	14	age	age	NN
cord-005453-4057qib7	12030	15	of	of	IN
cord-005453-4057qib7	12030	16	57	57	CD
cord-005453-4057qib7	12030	17	years	year	NNS
cord-005453-4057qib7	12030	18	(	(	-LRB-
cord-005453-4057qib7	12030	19	23	23	CD
cord-005453-4057qib7	12030	20	-	-	SYM
cord-005453-4057qib7	12030	21	77	77	CD
cord-005453-4057qib7	12030	22	)	)	-RRB-
cord-005453-4057qib7	12030	23	in	in	IN
cord-005453-4057qib7	12030	24	hematological	hematological	JJ
cord-005453-4057qib7	12030	25	CR	cr	NN
cord-005453-4057qib7	12030	26	prior	prior	RB
cord-005453-4057qib7	12030	27	to	to	IN
cord-005453-4057qib7	12030	28	allo	allo	NNP
cord-005453-4057qib7	12030	29	-	-	HYPH
cord-005453-4057qib7	12030	30	SCT	SCT	NNP
cord-005453-4057qib7	12030	31	were	be	VBD
cord-005453-4057qib7	12030	32	enrolled	enrol	VBN
cord-005453-4057qib7	12030	33	in	in	IN
cord-005453-4057qib7	12030	34	the	the	DT
cord-005453-4057qib7	12030	35	study	study	NN
cord-005453-4057qib7	12030	36	.	.	.
cord-005453-4057qib7	12031	1	We	-PRON-	PRP
cord-005453-4057qib7	12031	2	observed	observe	VBD
cord-005453-4057qib7	12031	3	lower	low	JJR
cord-005453-4057qib7	12031	4	survival	survival	NN
cord-005453-4057qib7	12031	5	in	in	IN
cord-005453-4057qib7	12031	6	patients	patient	NNS
cord-005453-4057qib7	12031	7	with	with	IN
cord-005453-4057qib7	12031	8	MRD	MRD	NNP
cord-005453-4057qib7	12031	9	by	by	IN
cord-005453-4057qib7	12031	10	MFC	MFC	NNP
cord-005453-4057qib7	12031	11	pre	pre	NN
cord-005453-4057qib7	12031	12	-	-	NN
cord-005453-4057qib7	12031	13	transplant	transplant	JJ
cord-005453-4057qib7	12031	14	(	(	-LRB-
cord-005453-4057qib7	12031	15	2y	2y	NNP
cord-005453-4057qib7	12031	16	OS	OS	NNP
cord-005453-4057qib7	12031	17	:	:	:
cord-005453-4057qib7	12031	18	61	61	CD
cord-005453-4057qib7	12031	19	%	%	NN
cord-005453-4057qib7	12031	20	(	(	-LRB-
cord-005453-4057qib7	12031	21	41	41	CD
cord-005453-4057qib7	12031	22	-	-	SYM
cord-005453-4057qib7	12031	23	81	81	CD
cord-005453-4057qib7	12031	24	%	%	NN
cord-005453-4057qib7	12031	25	)	)	-RRB-
cord-005453-4057qib7	12031	26	vs.	vs.	NN
cord-005453-4057qib7	12031	27	92	92	CD
cord-005453-4057qib7	12031	28	%	%	NN
cord-005453-4057qib7	12031	29	(	(	-LRB-
cord-005453-4057qib7	12031	30	82	82	CD
cord-005453-4057qib7	12031	31	-	-	SYM
cord-005453-4057qib7	12031	32	100	100	CD
cord-005453-4057qib7	12031	33	%	%	NN
cord-005453-4057qib7	12031	34	)	)	-RRB-
cord-005453-4057qib7	12031	35	,	,	,
cord-005453-4057qib7	12031	36	p=0.018	p=0.018	NNP
cord-005453-4057qib7	12031	37	)	)	-RRB-
cord-005453-4057qib7	12031	38	due	due	JJ
cord-005453-4057qib7	12031	39	to	to	IN
cord-005453-4057qib7	12031	40	increased	increase	VBN
cord-005453-4057qib7	12031	41	relapse	relapse	NN
cord-005453-4057qib7	12031	42	incidence	incidence	NN
cord-005453-4057qib7	12031	43	(	(	-LRB-
cord-005453-4057qib7	12031	44	35	35	CD
cord-005453-4057qib7	12031	45	%	%	NN
cord-005453-4057qib7	12031	46	(	(	-LRB-
cord-005453-4057qib7	12031	47	17	17	CD
cord-005453-4057qib7	12031	48	-	-	SYM
cord-005453-4057qib7	12031	49	53	53	CD
cord-005453-4057qib7	12031	50	%	%	NN
cord-005453-4057qib7	12031	51	)	)	-RRB-
cord-005453-4057qib7	12031	52	vs.	vs.	IN
cord-005453-4057qib7	12031	53	8	8	CD
cord-005453-4057qib7	12031	54	%	%	NN
cord-005453-4057qib7	12031	55	(	(	-LRB-
cord-005453-4057qib7	12031	56	0	0	CD
cord-005453-4057qib7	12031	57	-	-	SYM
cord-005453-4057qib7	12031	58	18	18	CD
cord-005453-4057qib7	12031	59	%	%	NN
cord-005453-4057qib7	12031	60	)	)	-RRB-
cord-005453-4057qib7	12031	61	,	,	,
cord-005453-4057qib7	12031	62	p=0.009	p=0.009	NN
cord-005453-4057qib7	12031	63	)	)	-RRB-
cord-005453-4057qib7	12031	64	.	.	.
cord-005453-4057qib7	12032	1	In	in	IN
cord-005453-4057qib7	12032	2	multivariate	multivariate	JJ
cord-005453-4057qib7	12032	3	analysis	analysis	NN
cord-005453-4057qib7	12032	4	,	,	,
cord-005453-4057qib7	12032	5	MRD	MRD	NNP
cord-005453-4057qib7	12032	6	pos	pos	NNP
cord-005453-4057qib7	12032	7	prior	prior	RB
cord-005453-4057qib7	12032	8	to	to	IN
cord-005453-4057qib7	12032	9	allo	allo	NNP
cord-005453-4057qib7	12032	10	-	-	HYPH
cord-005453-4057qib7	12032	11	SCT	SCT	NNP
cord-005453-4057qib7	12032	12	has	have	VBZ
cord-005453-4057qib7	12032	13	strong	strong	JJ
cord-005453-4057qib7	12032	14	significant	significant	JJ
cord-005453-4057qib7	12032	15	impact	impact	NN
cord-005453-4057qib7	12032	16	on	on	IN
cord-005453-4057qib7	12032	17	OS	OS	NNP
cord-005453-4057qib7	12032	18	(	(	-LRB-
cord-005453-4057qib7	12032	19	HR	HR	NNP
cord-005453-4057qib7	12032	20	6.5	6.5	CD
cord-005453-4057qib7	12032	21	(	(	-LRB-
cord-005453-4057qib7	12032	22	1.5	1.5	CD
cord-005453-4057qib7	12032	23	-30	-30	CD
cord-005453-4057qib7	12032	24	)	)	-RRB-
cord-005453-4057qib7	12032	25	,	,	,
cord-005453-4057qib7	12032	26	p=0.015	p=0.015	NNP
cord-005453-4057qib7	12032	27	)	)	-RRB-
cord-005453-4057qib7	12032	28	.	.	.
cord-005453-4057qib7	12033	1	Of	of	IN
cord-005453-4057qib7	12033	2	55	55	CD
cord-005453-4057qib7	12033	3	patients	patient	NNS
cord-005453-4057qib7	12033	4	,	,	,
cord-005453-4057qib7	12033	5	a	a	DT
cord-005453-4057qib7	12033	6	sample	sample	NN
cord-005453-4057qib7	12033	7	both	both	CC
cord-005453-4057qib7	12033	8	before	before	IN
cord-005453-4057qib7	12033	9	and	and	CC
cord-005453-4057qib7	12033	10	on	on	IN
cord-005453-4057qib7	12033	11	day	day	NN
cord-005453-4057qib7	12033	12	+100	+100	NNS
cord-005453-4057qib7	12033	13	after	after	IN
cord-005453-4057qib7	12033	14	transplantation	transplantation	NN
cord-005453-4057qib7	12033	15	was	be	VBD
cord-005453-4057qib7	12033	16	available	available	JJ
cord-005453-4057qib7	12033	17	in	in	IN
cord-005453-4057qib7	12033	18	33	33	CD
cord-005453-4057qib7	12033	19	patients	patient	NNS
cord-005453-4057qib7	12033	20	.	.	.
cord-005453-4057qib7	12034	1	Of	of	IN
cord-005453-4057qib7	12034	2	those	those	DT
cord-005453-4057qib7	12034	3	33	33	CD
cord-005453-4057qib7	12034	4	patients	patient	NNS
cord-005453-4057qib7	12034	5	,	,	,
cord-005453-4057qib7	12034	6	15	15	CD
cord-005453-4057qib7	12034	7	(	(	-LRB-
cord-005453-4057qib7	12034	8	46	46	CD
cord-005453-4057qib7	12034	9	%	%	NN
cord-005453-4057qib7	12034	10	)	)	-RRB-
cord-005453-4057qib7	12034	11	were	be	VBD
cord-005453-4057qib7	12034	12	MRD	MRD	NNP
cord-005453-4057qib7	12034	13	negative	negative	JJ
cord-005453-4057qib7	12034	14	prior	prior	RB
cord-005453-4057qib7	12034	15	to	to	IN
cord-005453-4057qib7	12034	16	transplant	transplant	NN
cord-005453-4057qib7	12034	17	and	and	CC
cord-005453-4057qib7	12034	18	on	on	IN
cord-005453-4057qib7	12034	19	day	day	NN
cord-005453-4057qib7	12034	20	+100	+100	NNS
cord-005453-4057qib7	12034	21	(	(	-LRB-
cord-005453-4057qib7	12034	22	MRD	MRD	NNP
cord-005453-4057qib7	12034	23	neg	neg	NNP
cord-005453-4057qib7	12034	24	/	/	SYM
cord-005453-4057qib7	12034	25	neg	neg	NNP
cord-005453-4057qib7	12034	26	)	)	-RRB-
cord-005453-4057qib7	12034	27	;	;	:
cord-005453-4057qib7	12034	28	14	14	CD
cord-005453-4057qib7	12034	29	(	(	-LRB-
cord-005453-4057qib7	12034	30	42	42	CD
cord-005453-4057qib7	12034	31	%	%	NN
cord-005453-4057qib7	12034	32	)	)	-RRB-
cord-005453-4057qib7	12034	33	patients	patient	NNS
cord-005453-4057qib7	12034	34	were	be	VBD
cord-005453-4057qib7	12034	35	MRD	MRD	NNP
cord-005453-4057qib7	12034	36	positive	positive	JJ
cord-005453-4057qib7	12034	37	prior	prior	RB
cord-005453-4057qib7	12034	38	to	to	IN
cord-005453-4057qib7	12034	39	transplant	transplant	NN
cord-005453-4057qib7	12034	40	and	and	CC
cord-005453-4057qib7	12034	41	negative	negative	JJ
cord-005453-4057qib7	12034	42	at	at	IN
cord-005453-4057qib7	12034	43	day	day	NN
cord-005453-4057qib7	12034	44	+100	+100	.
cord-005453-4057qib7	12035	1	(	(	-LRB-
cord-005453-4057qib7	12035	2	MRD	MRD	NNP
cord-005453-4057qib7	12035	3	pos	pos	NNP
cord-005453-4057qib7	12035	4	/	/	SYM
cord-005453-4057qib7	12035	5	neg	neg	NNP
cord-005453-4057qib7	12035	6	)	)	-RRB-
cord-005453-4057qib7	12035	7	;	;	:
cord-005453-4057qib7	12035	8	and	and	CC
cord-005453-4057qib7	12035	9	4	4	CD
cord-005453-4057qib7	12035	10	(	(	-LRB-
cord-005453-4057qib7	12035	11	12	12	CD
cord-005453-4057qib7	12035	12	%	%	NN
cord-005453-4057qib7	12035	13	)	)	-RRB-
cord-005453-4057qib7	12035	14	patients	patient	NNS
cord-005453-4057qib7	12035	15	were	be	VBD
cord-005453-4057qib7	12035	16	MRD	MRD	NNP
cord-005453-4057qib7	12035	17	positive	positive	JJ
cord-005453-4057qib7	12035	18	at	at	IN
cord-005453-4057qib7	12035	19	both	both	DT
cord-005453-4057qib7	12035	20	timepoints	timepoint	NNS
cord-005453-4057qib7	12035	21	(	(	-LRB-
cord-005453-4057qib7	12035	22	MRD	MRD	NNP
cord-005453-4057qib7	12035	23	pos	pos	NNP
cord-005453-4057qib7	12035	24	/	/	SYM
cord-005453-4057qib7	12035	25	pos	pos	NNP
cord-005453-4057qib7	12035	26	)	)	-RRB-
cord-005453-4057qib7	12035	27	.	.	.
cord-005453-4057qib7	12036	1	DFS	DFS	NNP
cord-005453-4057qib7	12036	2	and	and	CC
cord-005453-4057qib7	12036	3	OS	OS	NNP
cord-005453-4057qib7	12036	4	for	for	IN
cord-005453-4057qib7	12036	5	these	these	DT
cord-005453-4057qib7	12036	6	three	three	CD
cord-005453-4057qib7	12036	7	groups	group	NNS
cord-005453-4057qib7	12036	8	were	be	VBD
cord-005453-4057qib7	12036	9	as	as	IN
cord-005453-4057qib7	12036	10	follow	follow	NN
cord-005453-4057qib7	12036	11	:	:	:
cord-005453-4057qib7	12037	1	2y	2y	NNP
cord-005453-4057qib7	12037	2	DFS	DFS	NNP
cord-005453-4057qib7	12037	3	:	:	:
cord-005453-4057qib7	12038	1	MRD	MRD	NNP
cord-005453-4057qib7	12038	2	neg	neg	NNP
cord-005453-4057qib7	12038	3	/	/	SYM
cord-005453-4057qib7	12038	4	neg	neg	NN
cord-005453-4057qib7	12038	5	:	:	:
cord-005453-4057qib7	12038	6	93	93	CD
cord-005453-4057qib7	12038	7	%	%	NN
cord-005453-4057qib7	12038	8	(	(	-LRB-
cord-005453-4057qib7	12038	9	80	80	CD
cord-005453-4057qib7	12038	10	-	-	SYM
cord-005453-4057qib7	12038	11	100	100	CD
cord-005453-4057qib7	12038	12	%	%	NN
cord-005453-4057qib7	12038	13	)	)	-RRB-
cord-005453-4057qib7	12038	14	,	,	,
cord-005453-4057qib7	12038	15	MRD	MRD	NNP
cord-005453-4057qib7	12038	16	pos	pos	NNP
cord-005453-4057qib7	12038	17	/	/	SYM
cord-005453-4057qib7	12038	18	neg	neg	NN
cord-005453-4057qib7	12038	19	:	:	:
cord-005453-4057qib7	12038	20	78	78	CD
cord-005453-4057qib7	12038	21	%	%	NN
cord-005453-4057qib7	12038	22	(	(	-LRB-
cord-005453-4057qib7	12038	23	56	56	CD
cord-005453-4057qib7	12038	24	-	-	SYM
cord-005453-4057qib7	12038	25	100	100	CD
cord-005453-4057qib7	12038	26	%	%	NN
cord-005453-4057qib7	12038	27	)	)	-RRB-
cord-005453-4057qib7	12038	28	;	;	:
cord-005453-4057qib7	12038	29	MRD	MRD	NNP
cord-005453-4057qib7	12038	30	pos	pos	NNP
cord-005453-4057qib7	12038	31	/	/	SYM
cord-005453-4057qib7	12038	32	pos	pos	NN
cord-005453-4057qib7	12038	33	:	:	:
cord-005453-4057qib7	12038	34	25	25	CD
cord-005453-4057qib7	12038	35	%	%	NN
cord-005453-4057qib7	12038	36	(	(	-LRB-
cord-005453-4057qib7	12038	37	0	0	CD
cord-005453-4057qib7	12038	38	-	-	SYM
cord-005453-4057qib7	12038	39	75	75	CD
cord-005453-4057qib7	12038	40	%	%	NN
cord-005453-4057qib7	12038	41	,	,	,
cord-005453-4057qib7	12038	42	p=0.006	p=0.006	NNP
cord-005453-4057qib7	12038	43	)	)	-RRB-
cord-005453-4057qib7	12038	44	;	;	:
cord-005453-4057qib7	12038	45	2y	2y	NNP
cord-005453-4057qib7	12038	46	OS	OS	NNP
cord-005453-4057qib7	12038	47	:	:	:
cord-005453-4057qib7	12039	1	MRD	MRD	NNP
cord-005453-4057qib7	12039	2	neg	neg	NNP
cord-005453-4057qib7	12039	3	/	/	SYM
cord-005453-4057qib7	12039	4	neg	neg	NNP
cord-005453-4057qib7	12039	5	:	:	:
cord-005453-4057qib7	12039	6	100	100	CD
cord-005453-4057qib7	12039	7	%	%	NN
cord-005453-4057qib7	12039	8	;	;	:
cord-005453-4057qib7	12039	9	MRD	MRD	NNP
cord-005453-4057qib7	12039	10	pos	pos	NNP
cord-005453-4057qib7	12039	11	/	/	SYM
cord-005453-4057qib7	12039	12	neg	neg	NN
cord-005453-4057qib7	12039	13	:	:	:
cord-005453-4057qib7	12039	14	93	93	CD
cord-005453-4057qib7	12039	15	%	%	NN
cord-005453-4057qib7	12039	16	(	(	-LRB-
cord-005453-4057qib7	12039	17	79	79	CD
cord-005453-4057qib7	12039	18	-	-	SYM
cord-005453-4057qib7	12039	19	100	100	CD
cord-005453-4057qib7	12039	20	%	%	NN
cord-005453-4057qib7	12039	21	)	)	-RRB-
cord-005453-4057qib7	12039	22	;	;	:
cord-005453-4057qib7	12039	23	MRD	MRD	NNP
cord-005453-4057qib7	12039	24	pos	pos	NNP
cord-005453-4057qib7	12039	25	/	/	SYM
cord-005453-4057qib7	12039	26	pos	pos	NN
cord-005453-4057qib7	12039	27	:	:	:
cord-005453-4057qib7	12039	28	25	25	CD
cord-005453-4057qib7	12039	29	%	%	NN
cord-005453-4057qib7	12039	30	(	(	-LRB-
cord-005453-4057qib7	12039	31	0	0	CD
cord-005453-4057qib7	12039	32	-	-	SYM
cord-005453-4057qib7	12039	33	75	75	CD
cord-005453-4057qib7	12039	34	%	%	NN
cord-005453-4057qib7	12039	35	,	,	,
cord-005453-4057qib7	12039	36	p	p	NN
cord-005453-4057qib7	12039	37	<	<	XX
cord-005453-4057qib7	12039	38	0.001	0.001	CD
cord-005453-4057qib7	12039	39	)	)	-RRB-
cord-005453-4057qib7	12039	40	.	.	.
cord-005453-4057qib7	12040	1	Upon	upon	IN
cord-005453-4057qib7	12040	2	multivariate	multivariate	JJ
cord-005453-4057qib7	12040	3	analysis	analysis	NN
cord-005453-4057qib7	12040	4	,	,	,
cord-005453-4057qib7	12040	5	the	the	DT
cord-005453-4057qib7	12040	6	MRD	MRD	NNP
cord-005453-4057qib7	12040	7	status	status	NN
cord-005453-4057qib7	12040	8	prior	prior	RB
cord-005453-4057qib7	12040	9	to	to	IN
cord-005453-4057qib7	12040	10	transplant	transplant	NN
cord-005453-4057qib7	12040	11	and	and	CC
cord-005453-4057qib7	12040	12	on	on	IN
cord-005453-4057qib7	12040	13	day	day	NN
cord-005453-4057qib7	12040	14	+100	+100	NNP
cord-005453-4057qib7	12040	15	showed	show	VBD
cord-005453-4057qib7	12040	16	strong	strong	JJ
cord-005453-4057qib7	12040	17	significant	significant	JJ
cord-005453-4057qib7	12040	18	impact	impact	NN
cord-005453-4057qib7	12040	19	on	on	IN
cord-005453-4057qib7	12040	20	DFS	DFS	NNP
cord-005453-4057qib7	12040	21	(	(	-LRB-
cord-005453-4057qib7	12040	22	HR	HR	NNP
cord-005453-4057qib7	12040	23	3.6	3.6	CD
cord-005453-4057qib7	12040	24	(	(	-LRB-
cord-005453-4057qib7	12040	25	1.3	1.3	CD
cord-005453-4057qib7	12040	26	-9.9	-9.9	NFP
cord-005453-4057qib7	12040	27	)	)	-RRB-
cord-005453-4057qib7	12040	28	,	,	,
cord-005453-4057qib7	12040	29	p=0.01	p=0.01	NNP
cord-005453-4057qib7	12040	30	)	)	-RRB-
cord-005453-4057qib7	12040	31	and	and	CC
cord-005453-4057qib7	12040	32	OS	OS	NNP
cord-005453-4057qib7	12040	33	)	)	-RRB-
cord-005453-4057qib7	12040	34	,	,	,
cord-005453-4057qib7	12040	35	p=0.017	p=0.017	NNS
cord-005453-4057qib7	12040	36	)	)	-RRB-
cord-005453-4057qib7	12040	37	.	.	.
cord-005453-4057qib7	12041	1	We	-PRON-	PRP
cord-005453-4057qib7	12041	2	did	do	VBD
cord-005453-4057qib7	12041	3	not	not	RB
cord-005453-4057qib7	12041	4	observe	observe	VB
cord-005453-4057qib7	12041	5	any	any	DT
cord-005453-4057qib7	12041	6	significant	significant	JJ
cord-005453-4057qib7	12041	7	impact	impact	NN
cord-005453-4057qib7	12041	8	of	of	IN
cord-005453-4057qib7	12041	9	other	other	JJ
cord-005453-4057qib7	12041	10	factors	factor	NNS
cord-005453-4057qib7	12041	11	included	include	VBN
cord-005453-4057qib7	12041	12	in	in	IN
cord-005453-4057qib7	12041	13	the	the	DT
cord-005453-4057qib7	12041	14	multivariate	multivariate	JJ
cord-005453-4057qib7	12041	15	analysis	analysis	NN
cord-005453-4057qib7	12041	16	(	(	-LRB-
cord-005453-4057qib7	12041	17	patient	patient	NN
cord-005453-4057qib7	12041	18	's	's	POS
cord-005453-4057qib7	12041	19	age	age	NN
cord-005453-4057qib7	12041	20	,	,	,
cord-005453-4057qib7	12041	21	patient	patient	NNP
cord-005453-4057qib7	12041	22	's	's	POS
cord-005453-4057qib7	12041	23	sex	sex	NN
cord-005453-4057qib7	12041	24	,	,	,
cord-005453-4057qib7	12041	25	and	and	CC
cord-005453-4057qib7	12041	26	recipient/	recipient/	JJ
cord-005453-4057qib7	12041	27	donor	donor	NN
cord-005453-4057qib7	12041	28	sex	sex	NN
cord-005453-4057qib7	12041	29	constellation	constellation	NN
cord-005453-4057qib7	12041	30	)	)	-RRB-
cord-005453-4057qib7	12041	31	.	.	.
cord-005453-4057qib7	12042	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12042	2	:	:	:
cord-005453-4057qib7	12043	1	MRD	MRD	NNP
cord-005453-4057qib7	12043	2	positivity	positivity	NN
cord-005453-4057qib7	12043	3	prior	prior	RB
cord-005453-4057qib7	12043	4	to	to	IN
cord-005453-4057qib7	12043	5	allotransplant	allotransplant	JJ
cord-005453-4057qib7	12043	6	and	and	CC
cord-005453-4057qib7	12043	7	at	at	IN
cord-005453-4057qib7	12043	8	day	day	NN
cord-005453-4057qib7	12043	9	+100	+100	NNS
cord-005453-4057qib7	12043	10	by	by	IN
cord-005453-4057qib7	12043	11	MFC	MFC	NNP
cord-005453-4057qib7	12043	12	is	be	VBZ
cord-005453-4057qib7	12043	13	highly	highly	RB
cord-005453-4057qib7	12043	14	predictive	predictive	JJ
cord-005453-4057qib7	12043	15	for	for	IN
cord-005453-4057qib7	12043	16	survival	survival	NN
cord-005453-4057qib7	12043	17	after	after	IN
cord-005453-4057qib7	12043	18	allo	allo	NN
cord-005453-4057qib7	12043	19	-	-	HYPH
cord-005453-4057qib7	12043	20	SCT	SCT	NNP
cord-005453-4057qib7	12043	21	.	.	.
cord-005453-4057qib7	12044	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12044	2	:	:	:
cord-005453-4057qib7	12044	3	Nothing	nothing	NN
cord-005453-4057qib7	12044	4	to	to	TO
cord-005453-4057qib7	12044	5	declaire	declaire	VB
cord-005453-4057qib7	12044	6	Background	background	NN
cord-005453-4057qib7	12044	7	:	:	:
cord-005453-4057qib7	12045	1	Immune	immune	JJ
cord-005453-4057qib7	12045	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	12045	3	is	be	VBZ
cord-005453-4057qib7	12045	4	a	a	DT
cord-005453-4057qib7	12045	5	critical	critical	JJ
cord-005453-4057qib7	12045	6	factor	factor	NN
cord-005453-4057qib7	12045	7	for	for	IN
cord-005453-4057qib7	12045	8	risk	risk	NN
cord-005453-4057qib7	12045	9	assessment	assessment	NN
cord-005453-4057qib7	12045	10	of	of	IN
cord-005453-4057qib7	12045	11	life	life	NN
cord-005453-4057qib7	12045	12	threatening	threaten	VBG
cord-005453-4057qib7	12045	13	infections	infection	NNS
cord-005453-4057qib7	12045	14	and	and	CC
cord-005453-4057qib7	12045	15	long	long	JJ
cord-005453-4057qib7	12045	16	-	-	HYPH
cord-005453-4057qib7	12045	17	term	term	NN
cord-005453-4057qib7	12045	18	survival	survival	NN
cord-005453-4057qib7	12045	19	in	in	IN
cord-005453-4057qib7	12045	20	patients	patient	NNS
cord-005453-4057qib7	12045	21	undergoing	undergo	VBG
cord-005453-4057qib7	12045	22	allogeneic	allogeneic	IN
cord-005453-4057qib7	12045	23	cell	cell	NN
cord-005453-4057qib7	12045	24	transplantation	transplantation	NN
cord-005453-4057qib7	12045	25	(	(	-LRB-
cord-005453-4057qib7	12045	26	HSCT	HSCT	NNP
cord-005453-4057qib7	12045	27	)	)	-RRB-
cord-005453-4057qib7	12045	28	.	.	.
cord-005453-4057qib7	12046	1	Methods	method	NNS
cord-005453-4057qib7	12046	2	:	:	:
cord-005453-4057qib7	12046	3	Immune	immune	JJ
cord-005453-4057qib7	12046	4	cell	cell	NN
cord-005453-4057qib7	12046	5	subsets	subset	NNS
cord-005453-4057qib7	12046	6	(	(	-LRB-
cord-005453-4057qib7	12046	7	CD19	CD19	NNP
cord-005453-4057qib7	12046	8	,	,	,
cord-005453-4057qib7	12046	9	CD4	CD4	NNP
cord-005453-4057qib7	12046	10	,	,	,
cord-005453-4057qib7	12046	11	CD8	CD8	NNP
cord-005453-4057qib7	12046	12	,	,	,
cord-005453-4057qib7	12046	13	CD56	CD56	NNP
cord-005453-4057qib7	12046	14	,	,	,
cord-005453-4057qib7	12046	15	CD25+CD127-	cd25+cd127-	NN
cord-005453-4057qib7	12046	16	)	)	-RRB-
cord-005453-4057qib7	12046	17	were	be	VBD
cord-005453-4057qib7	12046	18	quantified	quantify	VBN
cord-005453-4057qib7	12046	19	by	by	IN
cord-005453-4057qib7	12046	20	flow	flow	NN
cord-005453-4057qib7	12046	21	cytometry	cytometry	NN
cord-005453-4057qib7	12046	22	.	.	.
cord-005453-4057qib7	12047	1	TREC	TREC	NNP
cord-005453-4057qib7	12047	2	and	and	CC
cord-005453-4057qib7	12047	3	KREC	KREC	NNP
cord-005453-4057qib7	12047	4	were	be	VBD
cord-005453-4057qib7	12047	5	quantified	quantify	VBN
cord-005453-4057qib7	12047	6	simultaneously	simultaneously	RB
cord-005453-4057qib7	12047	7	using	use	VBG
cord-005453-4057qib7	12047	8	droplet	droplet	NN
cord-005453-4057qib7	12047	9	digital	digital	JJ
cord-005453-4057qib7	12047	10	PCR	PCR	NNP
cord-005453-4057qib7	12047	11	(	(	-LRB-
cord-005453-4057qib7	12047	12	dPCR	dPCR	NNP
cord-005453-4057qib7	12047	13	)	)	-RRB-
cord-005453-4057qib7	12047	14	.	.	.
cord-005453-4057qib7	12048	1	A	a	DT
cord-005453-4057qib7	12048	2	total	total	NN
cord-005453-4057qib7	12048	3	of	of	IN
cord-005453-4057qib7	12048	4	31	31	CD
cord-005453-4057qib7	12048	5	patients	patient	NNS
cord-005453-4057qib7	12048	6	were	be	VBD
cord-005453-4057qib7	12048	7	evaluated	evaluate	VBN
cord-005453-4057qib7	12048	8	.	.	.
cord-005453-4057qib7	12049	1	Mean	mean	JJ
cord-005453-4057qib7	12049	2	age	age	NN
cord-005453-4057qib7	12049	3	at	at	IN
cord-005453-4057qib7	12049	4	transplant	transplant	NN
cord-005453-4057qib7	12049	5	was	be	VBD
cord-005453-4057qib7	12049	6	56	56	CD
cord-005453-4057qib7	12049	7	years	year	NNS
cord-005453-4057qib7	12050	1	(	(	-LRB-
cord-005453-4057qib7	12050	2	range	range	NN
cord-005453-4057qib7	12050	3	:	:	:
cord-005453-4057qib7	12050	4	18	18	CD
cord-005453-4057qib7	12050	5	-	-	SYM
cord-005453-4057qib7	12050	6	74	74	CD
cord-005453-4057qib7	12050	7	years	year	NNS
cord-005453-4057qib7	12050	8	)	)	-RRB-
cord-005453-4057qib7	12051	1	Samples	sample	NNS
cord-005453-4057qib7	12051	2	were	be	VBD
cord-005453-4057qib7	12051	3	obtained	obtain	VBN
cord-005453-4057qib7	12051	4	before	before	IN
cord-005453-4057qib7	12051	5	HSCT	HSCT	NNP
cord-005453-4057qib7	12051	6	and	and	CC
cord-005453-4057qib7	12051	7	at	at	IN
cord-005453-4057qib7	12051	8	day	day	NN
cord-005453-4057qib7	12051	9	30	30	CD
cord-005453-4057qib7	12051	10	,	,	,
cord-005453-4057qib7	12051	11	100	100	CD
cord-005453-4057qib7	12051	12	and	and	CC
cord-005453-4057qib7	12051	13	365	365	CD
cord-005453-4057qib7	12051	14	after	after	IN
cord-005453-4057qib7	12051	15	HSCT	HSCT	NNP
cord-005453-4057qib7	12051	16	.	.	.
cord-005453-4057qib7	12052	1	Results	result	NNS
cord-005453-4057qib7	12052	2	:	:	:
cord-005453-4057qib7	12053	1	Absolute	absolute	JJ
cord-005453-4057qib7	12053	2	numbers	number	NNS
cord-005453-4057qib7	12053	3	of	of	IN
cord-005453-4057qib7	12053	4	CD3	CD3	NNP
cord-005453-4057qib7	12053	5	and	and	CC
cord-005453-4057qib7	12053	6	CD19	CD19	NNP
cord-005453-4057qib7	12053	7	cells	cell	NNS
cord-005453-4057qib7	12053	8	remained	remain	VBD
cord-005453-4057qib7	12053	9	below	below	IN
cord-005453-4057qib7	12053	10	pre	pre	JJ
cord-005453-4057qib7	12053	11	-	-	JJ
cord-005453-4057qib7	12053	12	transplant	transplant	JJ
cord-005453-4057qib7	12053	13	levels	level	NNS
cord-005453-4057qib7	12053	14	until	until	IN
cord-005453-4057qib7	12053	15	day	day	NN
cord-005453-4057qib7	12053	16	100	100	CD
cord-005453-4057qib7	12053	17	,	,	,
cord-005453-4057qib7	12053	18	increasing	increase	VBG
cord-005453-4057qib7	12053	19	further	far	RBR
cord-005453-4057qib7	12053	20	and	and	CC
cord-005453-4057qib7	12053	21	eventually	eventually	RB
cord-005453-4057qib7	12053	22	reaching	reach	VBG
cord-005453-4057qib7	12053	23	pre	pre	JJ
cord-005453-4057qib7	12053	24	-	-	JJ
cord-005453-4057qib7	12053	25	transplant	transplant	JJ
cord-005453-4057qib7	12053	26	levels	level	NNS
cord-005453-4057qib7	12053	27	one	one	CD
cord-005453-4057qib7	12053	28	year	year	NN
cord-005453-4057qib7	12053	29	after	after	IN
cord-005453-4057qib7	12053	30	HSCT	HSCT	NNP
cord-005453-4057qib7	12053	31	.	.	.
cord-005453-4057qib7	12054	1	Absolute	absolute	JJ
cord-005453-4057qib7	12054	2	counts	count	NNS
cord-005453-4057qib7	12054	3	of	of	IN
cord-005453-4057qib7	12054	4	CD4	CD4	NNP
cord-005453-4057qib7	12054	5	and	and	CC
cord-005453-4057qib7	12054	6	CD25+CD127-cells	CD25+CD127-cells	NNP
cord-005453-4057qib7	12054	7	remained	remain	VBD
cord-005453-4057qib7	12054	8	below	below	IN
cord-005453-4057qib7	12054	9	pre	pre	JJ
cord-005453-4057qib7	12054	10	-	-	JJ
cord-005453-4057qib7	12054	11	transplant	transplant	JJ
cord-005453-4057qib7	12054	12	levels	level	NNS
cord-005453-4057qib7	12054	13	beyond	beyond	IN
cord-005453-4057qib7	12054	14	one	one	CD
cord-005453-4057qib7	12054	15	year	year	NN
cord-005453-4057qib7	12054	16	after	after	IN
cord-005453-4057qib7	12054	17	HSCT	HSCT	NNP
cord-005453-4057qib7	12054	18	.	.	.
cord-005453-4057qib7	12055	1	CD56	cd56	NN
cord-005453-4057qib7	12055	2	cells	cell	NNS
cord-005453-4057qib7	12055	3	were	be	VBD
cord-005453-4057qib7	12055	4	characterized	characterize	VBN
cord-005453-4057qib7	12055	5	by	by	IN
cord-005453-4057qib7	12055	6	fast	fast	JJ
cord-005453-4057qib7	12055	7	reconstitution	reconstitution	NN
cord-005453-4057qib7	12055	8	kinetics	kinetics	NN
cord-005453-4057qib7	12055	9	,	,	,
cord-005453-4057qib7	12055	10	reaching	reach	VBG
cord-005453-4057qib7	12055	11	pre	pre	JJ
cord-005453-4057qib7	12055	12	-	-	JJ
cord-005453-4057qib7	12055	13	transplant	transplant	JJ
cord-005453-4057qib7	12055	14	levels	level	NNS
cord-005453-4057qib7	12055	15	already	already	RB
cord-005453-4057qib7	12055	16	at	at	IN
cord-005453-4057qib7	12055	17	day	day	NN
cord-005453-4057qib7	12055	18	30	30	CD
cord-005453-4057qib7	12055	19	.	.	.
cord-005453-4057qib7	12056	1	B	b	NN
cord-005453-4057qib7	12056	2	cells	cell	NNS
cord-005453-4057qib7	12056	3	correlated	correlate	VBN
cord-005453-4057qib7	12056	4	with	with	IN
cord-005453-4057qib7	12056	5	KREC	KREC	NNP
cord-005453-4057qib7	12056	6	levels	level	NNS
cord-005453-4057qib7	12056	7	at	at	IN
cord-005453-4057qib7	12056	8	all	all	DT
cord-005453-4057qib7	12056	9	time	time	NN
cord-005453-4057qib7	12056	10	-	-	HYPH
cord-005453-4057qib7	12056	11	points	point	NNS
cord-005453-4057qib7	12056	12	tested	test	VBN
cord-005453-4057qib7	12056	13	,	,	,
cord-005453-4057qib7	12056	14	whereas	whereas	IN
cord-005453-4057qib7	12056	15	T	t	NN
cord-005453-4057qib7	12056	16	cells	cell	NNS
cord-005453-4057qib7	12056	17	correlated	correlate	VBN
cord-005453-4057qib7	12056	18	with	with	IN
cord-005453-4057qib7	12056	19	TREC	TREC	NNP
cord-005453-4057qib7	12056	20	levels	level	NNS
cord-005453-4057qib7	12056	21	only	only	RB
cord-005453-4057qib7	12056	22	one	one	CD
cord-005453-4057qib7	12056	23	year	year	NN
cord-005453-4057qib7	12056	24	after	after	IN
cord-005453-4057qib7	12056	25	transplantation	transplantation	NN
cord-005453-4057qib7	12056	26	.	.	.
cord-005453-4057qib7	12057	1	When	when	WRB
cord-005453-4057qib7	12057	2	we	-PRON-	PRP
cord-005453-4057qib7	12057	3	compared	compare	VBD
cord-005453-4057qib7	12057	4	cell	cell	NN
cord-005453-4057qib7	12057	5	subsets	subset	NNS
cord-005453-4057qib7	12057	6	,	,	,
cord-005453-4057qib7	12057	7	TREC	TREC	NNP
cord-005453-4057qib7	12057	8	,	,	,
cord-005453-4057qib7	12057	9	KREC	KREC	NNP
cord-005453-4057qib7	12057	10	levels	level	NNS
cord-005453-4057qib7	12057	11	and	and	CC
cord-005453-4057qib7	12057	12	the	the	DT
cord-005453-4057qib7	12057	13	reconstitution	reconstitution	NN
cord-005453-4057qib7	12057	14	kinetics	kinetics	NN
cord-005453-4057qib7	12057	15	thereof	thereof	RB
cord-005453-4057qib7	12057	16	between	between	IN
cord-005453-4057qib7	12057	17	patients	patient	NNS
cord-005453-4057qib7	12057	18	with	with	IN
cord-005453-4057qib7	12057	19	reduced	reduce	VBN
cord-005453-4057qib7	12057	20	intensity	intensity	NN
cord-005453-4057qib7	12057	21	conditioning	conditioning	NN
cord-005453-4057qib7	12057	22	(	(	-LRB-
cord-005453-4057qib7	12057	23	n=26	n=26	RB
cord-005453-4057qib7	12057	24	)	)	-RRB-
cord-005453-4057qib7	12057	25	or	or	CC
cord-005453-4057qib7	12057	26	full	full	JJ
cord-005453-4057qib7	12057	27	conditioning	conditioning	NN
cord-005453-4057qib7	12057	28	(	(	-LRB-
cord-005453-4057qib7	12057	29	n=5	n=5	JJ
cord-005453-4057qib7	12057	30	)	)	-RRB-
cord-005453-4057qib7	12057	31	no	no	DT
cord-005453-4057qib7	12057	32	significant	significant	JJ
cord-005453-4057qib7	12057	33	differences	difference	NNS
cord-005453-4057qib7	12057	34	were	be	VBD
cord-005453-4057qib7	12057	35	observed	observe	VBN
cord-005453-4057qib7	12057	36	.	.	.
cord-005453-4057qib7	12058	1	Patients	patient	NNS
cord-005453-4057qib7	12058	2	with	with	IN
cord-005453-4057qib7	12058	3	pre	pre	JJ
cord-005453-4057qib7	12058	4	-	-	JJ
cord-005453-4057qib7	12058	5	transplant	transplant	JJ
cord-005453-4057qib7	12058	6	TREC	TREC	NNP
cord-005453-4057qib7	12058	7	levels	level	NNS
cord-005453-4057qib7	12058	8	above	above	IN
cord-005453-4057qib7	12058	9	the	the	DT
cord-005453-4057qib7	12058	10	mean	mean	NN
cord-005453-4057qib7	12058	11	(	(	-LRB-
cord-005453-4057qib7	12058	12	200	200	CD
cord-005453-4057qib7	12058	13	TREC	TREC	NNP
cord-005453-4057qib7	12058	14	copies	copy	NNS
cord-005453-4057qib7	12058	15	/	/	SYM
cord-005453-4057qib7	12058	16	ml	ml	NN
cord-005453-4057qib7	12058	17	blood	blood	NN
cord-005453-4057qib7	12058	18	)	)	-RRB-
cord-005453-4057qib7	12058	19	showed	show	VBD
cord-005453-4057qib7	12058	20	higher	high	JJR
cord-005453-4057qib7	12058	21	TREC	TREC	NNP
cord-005453-4057qib7	12058	22	levels	level	NNS
cord-005453-4057qib7	12058	23	and	and	CC
cord-005453-4057qib7	12058	24	a	a	DT
cord-005453-4057qib7	12058	25	faster	fast	JJR
cord-005453-4057qib7	12058	26	T	t	NN
cord-005453-4057qib7	12058	27	-	-	HYPH
cord-005453-4057qib7	12058	28	cell	cell	NN
cord-005453-4057qib7	12058	29	reconstitution	reconstitution	NN
cord-005453-4057qib7	12058	30	after	after	IN
cord-005453-4057qib7	12058	31	HSCT	HSCT	NNP
cord-005453-4057qib7	12058	32	suggesting	suggest	VBG
cord-005453-4057qib7	12058	33	that	that	IN
cord-005453-4057qib7	12058	34	Tcell	Tcell	NNP
cord-005453-4057qib7	12058	35	reconstitution	reconstitution	NN
cord-005453-4057qib7	12058	36	can	can	MD
cord-005453-4057qib7	12058	37	be	be	VB
cord-005453-4057qib7	12058	38	predicted	predict	VBN
cord-005453-4057qib7	12058	39	by	by	IN
cord-005453-4057qib7	12058	40	analysing	analyse	VBG
cord-005453-4057qib7	12058	41	thymic	thymic	JJ
cord-005453-4057qib7	12058	42	functionality	functionality	NN
cord-005453-4057qib7	12058	43	before	before	IN
cord-005453-4057qib7	12058	44	transplantation	transplantation	NN
cord-005453-4057qib7	12058	45	.	.	.
cord-005453-4057qib7	12059	1	Indeed	indeed	RB
cord-005453-4057qib7	12059	2	,	,	,
cord-005453-4057qib7	12059	3	in	in	IN
cord-005453-4057qib7	12059	4	patients	patient	NNS
cord-005453-4057qib7	12059	5	with	with	IN
cord-005453-4057qib7	12059	6	a	a	DT
cord-005453-4057qib7	12059	7	pre	pre	JJ
cord-005453-4057qib7	12059	8	-	-	JJ
cord-005453-4057qib7	12059	9	transplant	transplant	JJ
cord-005453-4057qib7	12059	10	TREC	TREC	NNP
cord-005453-4057qib7	12059	11	above	above	IN
cord-005453-4057qib7	12059	12	200	200	CD
cord-005453-4057qib7	12059	13	TREC	TREC	NNP
cord-005453-4057qib7	12059	14	copies/	copies/	XX
cord-005453-4057qib7	12060	1	ml	ml	LS
cord-005453-4057qib7	12060	2	blood	blood	NN
cord-005453-4057qib7	12060	3	,	,	,
cord-005453-4057qib7	12060	4	the	the	DT
cord-005453-4057qib7	12060	5	positive	positive	JJ
cord-005453-4057qib7	12060	6	predictive	predictive	JJ
cord-005453-4057qib7	12060	7	value	value	NN
cord-005453-4057qib7	12060	8	for	for	IN
cord-005453-4057qib7	12060	9	an	an	DT
cord-005453-4057qib7	12060	10	efficient	efficient	JJ
cord-005453-4057qib7	12060	11	T	t	NN
cord-005453-4057qib7	12060	12	-	-	HYPH
cord-005453-4057qib7	12060	13	cell	cell	NN
cord-005453-4057qib7	12060	14	reconstitution	reconstitution	NN
cord-005453-4057qib7	12060	15	was	be	VBD
cord-005453-4057qib7	12060	16	0.889	0.889	CD
cord-005453-4057qib7	12060	17	(	(	-LRB-
cord-005453-4057qib7	12060	18	p=0.012	p=0.012	NNP
cord-005453-4057qib7	12060	19	)	)	-RRB-
cord-005453-4057qib7	12060	20	.	.	.
cord-005453-4057qib7	12061	1	We	-PRON-	PRP
cord-005453-4057qib7	12061	2	analysed	analyse	VBD
cord-005453-4057qib7	12061	3	the	the	DT
cord-005453-4057qib7	12061	4	recovery	recovery	NN
cord-005453-4057qib7	12061	5	kinetics	kinetic	NNS
cord-005453-4057qib7	12061	6	of	of	IN
cord-005453-4057qib7	12061	7	the	the	DT
cord-005453-4057qib7	12061	8	cell	cell	NN
cord-005453-4057qib7	12061	9	subsets	subset	NNS
cord-005453-4057qib7	12061	10	,	,	,
cord-005453-4057qib7	12061	11	TREC	TREC	NNP
cord-005453-4057qib7	12061	12	and	and	CC
cord-005453-4057qib7	12061	13	KREC	KREC	NNP
cord-005453-4057qib7	12061	14	levels	level	NNS
cord-005453-4057qib7	12061	15	in	in	IN
cord-005453-4057qib7	12061	16	patients	patient	NNS
cord-005453-4057qib7	12061	17	with	with	IN
cord-005453-4057qib7	12061	18	and	and	CC
cord-005453-4057qib7	12061	19	without	without	IN
cord-005453-4057qib7	12061	20	transplant	transplant	NN
cord-005453-4057qib7	12061	21	-	-	HYPH
cord-005453-4057qib7	12061	22	related	relate	VBN
cord-005453-4057qib7	12061	23	complications	complication	NNS
cord-005453-4057qib7	12061	24	.	.	.
cord-005453-4057qib7	12062	1	Patients	patient	NNS
cord-005453-4057qib7	12062	2	with	with	IN
cord-005453-4057qib7	12062	3	either	either	DT
cord-005453-4057qib7	12062	4	acute	acute	JJ
cord-005453-4057qib7	12062	5	graft	graft	NN
cord-005453-4057qib7	12062	6	-	-	HYPH
cord-005453-4057qib7	12062	7	versus	versus	IN
cord-005453-4057qib7	12062	8	-	-	HYPH
cord-005453-4057qib7	12062	9	host	host	NN
cord-005453-4057qib7	12062	10	disease	disease	NN
cord-005453-4057qib7	12062	11	or	or	CC
cord-005453-4057qib7	12062	12	severe	severe	JJ
cord-005453-4057qib7	12062	13	infections	infection	NNS
cord-005453-4057qib7	12062	14	showed	show	VBD
cord-005453-4057qib7	12062	15	a	a	DT
cord-005453-4057qib7	12062	16	slower	slow	JJR
cord-005453-4057qib7	12062	17	TREC	trec	JJ
cord-005453-4057qib7	12062	18	reconstitution	reconstitution	NN
cord-005453-4057qib7	12062	19	when	when	WRB
cord-005453-4057qib7	12062	20	compared	compare	VBN
cord-005453-4057qib7	12062	21	with	with	IN
cord-005453-4057qib7	12062	22	patients	patient	NNS
cord-005453-4057qib7	12062	23	without	without	IN
cord-005453-4057qib7	12062	24	complications	complication	NNS
cord-005453-4057qib7	12062	25	.	.	.
cord-005453-4057qib7	12063	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12063	2	:	:	:
cord-005453-4057qib7	12064	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12064	2	data	datum	NNS
cord-005453-4057qib7	12064	3	suggest	suggest	VBP
cord-005453-4057qib7	12064	4	that	that	IN
cord-005453-4057qib7	12064	5	the	the	DT
cord-005453-4057qib7	12064	6	analysis	analysis	NN
cord-005453-4057qib7	12064	7	of	of	IN
cord-005453-4057qib7	12064	8	immune	immune	JJ
cord-005453-4057qib7	12064	9	cell	cell	NN
cord-005453-4057qib7	12064	10	subsets	subset	NNS
cord-005453-4057qib7	12064	11	together	together	RB
cord-005453-4057qib7	12064	12	with	with	IN
cord-005453-4057qib7	12064	13	TREC	TREC	NNP
cord-005453-4057qib7	12064	14	and	and	CC
cord-005453-4057qib7	12064	15	KREC	KREC	NNP
cord-005453-4057qib7	12064	16	quantification	quantification	NN
cord-005453-4057qib7	12064	17	can	can	MD
cord-005453-4057qib7	12064	18	be	be	VB
cord-005453-4057qib7	12064	19	used	use	VBN
cord-005453-4057qib7	12064	20	to	to	TO
cord-005453-4057qib7	12064	21	evaluate	evaluate	VB
cord-005453-4057qib7	12064	22	the	the	DT
cord-005453-4057qib7	12064	23	immune	immune	JJ
cord-005453-4057qib7	12064	24	reconstitution	reconstitution	NN
cord-005453-4057qib7	12064	25	process	process	NN
cord-005453-4057qib7	12064	26	after	after	IN
cord-005453-4057qib7	12064	27	HSCT	HSCT	NNP
cord-005453-4057qib7	12064	28	.	.	.
cord-005453-4057qib7	12065	1	Pre	pre	JJ
cord-005453-4057qib7	12065	2	-	-	JJ
cord-005453-4057qib7	12065	3	transplant	transplant	JJ
cord-005453-4057qib7	12065	4	TREC	TREC	NNP
cord-005453-4057qib7	12065	5	levels	level	NNS
cord-005453-4057qib7	12065	6	allow	allow	VBP
cord-005453-4057qib7	12065	7	T	t	NN
cord-005453-4057qib7	12065	8	-	-	HYPH
cord-005453-4057qib7	12065	9	cell	cell	NN
cord-005453-4057qib7	12065	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	12065	11	efficiency	efficiency	NN
cord-005453-4057qib7	12065	12	prediction	prediction	NN
cord-005453-4057qib7	12065	13	after	after	IN
cord-005453-4057qib7	12065	14	HSCT	HSCT	NNP
cord-005453-4057qib7	12065	15	.	.	.
cord-005453-4057qib7	12066	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12066	2	:	:	:
cord-005453-4057qib7	12066	3	Nothing	nothing	NN
cord-005453-4057qib7	12066	4	to	to	TO
cord-005453-4057qib7	12066	5	declare	declare	VB
cord-005453-4057qib7	12066	6	Background	background	NN
cord-005453-4057qib7	12066	7	:	:	:
cord-005453-4057qib7	12066	8	Falling	fall	VBG
cord-005453-4057qib7	12066	9	donor	donor	NN
cord-005453-4057qib7	12066	10	/	/	SYM
cord-005453-4057qib7	12066	11	mixed	mix	VBN
cord-005453-4057qib7	12066	12	chimerism	chimerism	NN
cord-005453-4057qib7	12066	13	after	after	IN
cord-005453-4057qib7	12066	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	12066	15	haematopoetic	haematopoetic	JJ
cord-005453-4057qib7	12066	16	stem	stem	NN
cord-005453-4057qib7	12066	17	cell	cell	NN
cord-005453-4057qib7	12066	18	transplant	transplant	NN
cord-005453-4057qib7	12066	19	(	(	-LRB-
cord-005453-4057qib7	12066	20	SCT	SCT	NNP
cord-005453-4057qib7	12066	21	)	)	-RRB-
cord-005453-4057qib7	12066	22	is	be	VBZ
cord-005453-4057qib7	12066	23	associated	associate	VBN
cord-005453-4057qib7	12066	24	with	with	IN
cord-005453-4057qib7	12066	25	an	an	DT
cord-005453-4057qib7	12066	26	increased	increase	VBN
cord-005453-4057qib7	12066	27	risk	risk	NN
cord-005453-4057qib7	12066	28	of	of	IN
cord-005453-4057qib7	12066	29	relapse	relapse	NN
cord-005453-4057qib7	12066	30	and	and	CC
cord-005453-4057qib7	12066	31	the	the	DT
cord-005453-4057qib7	12066	32	potential	potential	NN
cord-005453-4057qib7	12066	33	for	for	IN
cord-005453-4057qib7	12066	34	graft	graft	NN
cord-005453-4057qib7	12066	35	rejection	rejection	NN
cord-005453-4057qib7	12066	36	.	.	.
cord-005453-4057qib7	12067	1	Donor	donor	NN
cord-005453-4057qib7	12067	2	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	12067	3	infusions	infusion	NNS
cord-005453-4057qib7	12067	4	(	(	-LRB-
cord-005453-4057qib7	12067	5	DLI	DLI	NNP
cord-005453-4057qib7	12067	6	)	)	-RRB-
cord-005453-4057qib7	12067	7	are	be	VBP
cord-005453-4057qib7	12067	8	often	often	RB
cord-005453-4057qib7	12067	9	administered	administer	VBN
cord-005453-4057qib7	12067	10	in	in	IN
cord-005453-4057qib7	12067	11	patients	patient	NNS
cord-005453-4057qib7	12067	12	with	with	IN
cord-005453-4057qib7	12067	13	mixed	mixed	JJ
cord-005453-4057qib7	12067	14	chimerism	chimerism	NN
cord-005453-4057qib7	12067	15	to	to	TO
cord-005453-4057qib7	12067	16	achieve	achieve	VB
cord-005453-4057qib7	12067	17	full	full	JJ
cord-005453-4057qib7	12067	18	donor	donor	NN
cord-005453-4057qib7	12067	19	chimerism	chimerism	NN
cord-005453-4057qib7	12067	20	but	but	CC
cord-005453-4057qib7	12067	21	there	there	EX
cord-005453-4057qib7	12067	22	is	be	VBZ
cord-005453-4057qib7	12067	23	little	little	JJ
cord-005453-4057qib7	12067	24	data	datum	NNS
cord-005453-4057qib7	12067	25	on	on	IN
cord-005453-4057qib7	12067	26	long	long	JJ
cord-005453-4057qib7	12067	27	term	term	NN
cord-005453-4057qib7	12067	28	outcomes	outcome	NNS
cord-005453-4057qib7	12067	29	for	for	IN
cord-005453-4057qib7	12067	30	DLI	DLI	NNP
cord-005453-4057qib7	12067	31	given	give	VBN
cord-005453-4057qib7	12067	32	for	for	IN
cord-005453-4057qib7	12067	33	persistent	persistent	JJ
cord-005453-4057qib7	12067	34	mixed	mixed	JJ
cord-005453-4057qib7	12067	35	chimerism	chimerism	NN
cord-005453-4057qib7	12067	36	.	.	.
cord-005453-4057qib7	12068	1	Methods	method	NNS
cord-005453-4057qib7	12068	2	:	:	:
cord-005453-4057qib7	12069	1	A	a	DT
cord-005453-4057qib7	12069	2	retrospective	retrospective	JJ
cord-005453-4057qib7	12069	3	analysis	analysis	NN
cord-005453-4057qib7	12069	4	of	of	IN
cord-005453-4057qib7	12069	5	all	all	DT
cord-005453-4057qib7	12069	6	patients	patient	NNS
cord-005453-4057qib7	12069	7	administered	administer	VBD
cord-005453-4057qib7	12069	8	DLI	DLI	NNP
cord-005453-4057qib7	12069	9	for	for	IN
cord-005453-4057qib7	12069	10	mixed	mixed	JJ
cord-005453-4057qib7	12069	11	chimerism	chimerism	NN
cord-005453-4057qib7	12069	12	between	between	IN
cord-005453-4057qib7	12069	13	2008	2008	CD
cord-005453-4057qib7	12069	14	to	to	IN
cord-005453-4057qib7	12069	15	January	January	NNP
cord-005453-4057qib7	12069	16	2017	2017	CD
cord-005453-4057qib7	12069	17	was	be	VBD
cord-005453-4057qib7	12069	18	performed	perform	VBN
cord-005453-4057qib7	12069	19	.	.	.
cord-005453-4057qib7	12070	1	All	all	DT
cord-005453-4057qib7	12070	2	patients	patient	NNS
cord-005453-4057qib7	12070	3	were	be	VBD
cord-005453-4057qib7	12070	4	transplanted	transplant	VBN
cord-005453-4057qib7	12070	5	at	at	IN
cord-005453-4057qib7	12070	6	the	the	DT
cord-005453-4057qib7	12070	7	University	University	NNP
cord-005453-4057qib7	12070	8	Hospital	Hospital	NNP
cord-005453-4057qib7	12070	9	of	of	IN
cord-005453-4057qib7	12070	10	Wales	Wales	NNP
cord-005453-4057qib7	12070	11	within	within	IN
cord-005453-4057qib7	12070	12	the	the	DT
cord-005453-4057qib7	12070	13	South	South	NNP
cord-005453-4057qib7	12070	14	Wales	Wales	NNP
cord-005453-4057qib7	12070	15	Blood	Blood	NNP
cord-005453-4057qib7	12070	16	and	and	CC
cord-005453-4057qib7	12070	17	Marrow	Marrow	NNP
cord-005453-4057qib7	12070	18	Transplant	Transplant	NNP
cord-005453-4057qib7	12070	19	(	(	-LRB-
cord-005453-4057qib7	12070	20	SWBMT	SWBMT	NNP
cord-005453-4057qib7	12070	21	)	)	-RRB-
cord-005453-4057qib7	12070	22	Programme	Programme	NNP
cord-005453-4057qib7	12070	23	.	.	.
cord-005453-4057qib7	12071	1	Patients	patient	NNS
cord-005453-4057qib7	12071	2	were	be	VBD
cord-005453-4057qib7	12071	3	identified	identify	VBN
cord-005453-4057qib7	12071	4	by	by	IN
cord-005453-4057qib7	12071	5	the	the	DT
cord-005453-4057qib7	12071	6	SWBMT	SWBMT	NNP
cord-005453-4057qib7	12071	7	database	database	NN
cord-005453-4057qib7	12071	8	and	and	CC
cord-005453-4057qib7	12071	9	additional	additional	JJ
cord-005453-4057qib7	12071	10	outcome	outcome	NN
cord-005453-4057qib7	12071	11	data	datum	NNS
cord-005453-4057qib7	12071	12	gathered	gather	VBN
cord-005453-4057qib7	12071	13	by	by	IN
cord-005453-4057qib7	12071	14	review	review	NN
cord-005453-4057qib7	12071	15	of	of	IN
cord-005453-4057qib7	12071	16	patients	patient	NNS
cord-005453-4057qib7	12071	17	'	'	POS
cord-005453-4057qib7	12071	18	medical	medical	JJ
cord-005453-4057qib7	12071	19	records	record	NNS
cord-005453-4057qib7	12071	20	.	.	.
cord-005453-4057qib7	12072	1	Results	result	NNS
cord-005453-4057qib7	12072	2	:	:	:
cord-005453-4057qib7	12073	1	58	58	CD
cord-005453-4057qib7	12073	2	patients	patient	NNS
cord-005453-4057qib7	12073	3	were	be	VBD
cord-005453-4057qib7	12073	4	treated	treat	VBN
cord-005453-4057qib7	12073	5	with	with	IN
cord-005453-4057qib7	12073	6	111	111	CD
cord-005453-4057qib7	12073	7	donor	donor	NN
cord-005453-4057qib7	12073	8	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	12073	9	infusions	infusion	NNS
cord-005453-4057qib7	12073	10	between	between	IN
cord-005453-4057qib7	12073	11	2008	2008	CD
cord-005453-4057qib7	12073	12	and	and	CC
cord-005453-4057qib7	12073	13	January	January	NNP
cord-005453-4057qib7	12073	14	2017	2017	CD
cord-005453-4057qib7	12073	15	.	.	.
cord-005453-4057qib7	12074	1	Thirty	thirty	CD
cord-005453-4057qib7	12074	2	one	one	CD
cord-005453-4057qib7	12074	3	patients	patient	NNS
cord-005453-4057qib7	12074	4	treated	treat	VBN
cord-005453-4057qib7	12074	5	for	for	IN
cord-005453-4057qib7	12074	6	relapse	relapse	NN
cord-005453-4057qib7	12074	7	(	(	-LRB-
cord-005453-4057qib7	12074	8	with	with	IN
cord-005453-4057qib7	12074	9	or	or	CC
cord-005453-4057qib7	12074	10	without	without	IN
cord-005453-4057qib7	12074	11	mixed	mixed	JJ
cord-005453-4057qib7	12074	12	chimerism	chimerism	NN
cord-005453-4057qib7	12074	13	)	)	-RRB-
cord-005453-4057qib7	12074	14	were	be	VBD
cord-005453-4057qib7	12074	15	excluded	exclude	VBN
cord-005453-4057qib7	12074	16	as	as	IN
cord-005453-4057qib7	12074	17	was	be	VBD
cord-005453-4057qib7	12074	18	a	a	DT
cord-005453-4057qib7	12074	19	further	further	JJ
cord-005453-4057qib7	12074	20	patient	patient	NN
cord-005453-4057qib7	12074	21	with	with	IN
cord-005453-4057qib7	12074	22	a	a	DT
cord-005453-4057qib7	12074	23	mismatched	mismatched	JJ
cord-005453-4057qib7	12074	24	donor	donor	NN
cord-005453-4057qib7	12074	25	.	.	.
cord-005453-4057qib7	12075	1	The	the	DT
cord-005453-4057qib7	12075	2	rest	rest	NN
cord-005453-4057qib7	12075	3	were	be	VBD
cord-005453-4057qib7	12075	4	10/10	10/10	CD
cord-005453-4057qib7	12075	5	match	match	NN
cord-005453-4057qib7	12075	6	.	.	.
cord-005453-4057qib7	12076	1	Twenty	twenty	CD
cord-005453-4057qib7	12076	2	six	six	CD
cord-005453-4057qib7	12076	3	patients	patient	NNS
cord-005453-4057qib7	12076	4	received	receive	VBD
cord-005453-4057qib7	12076	5	a	a	DT
cord-005453-4057qib7	12076	6	total	total	NN
cord-005453-4057qib7	12076	7	of	of	IN
cord-005453-4057qib7	12076	8	54	54	CD
cord-005453-4057qib7	12076	9	donor	donor	NN
cord-005453-4057qib7	12076	10	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	12076	11	infusions	infusion	NNS
cord-005453-4057qib7	12076	12	for	for	IN
cord-005453-4057qib7	12076	13	mixed	mixed	JJ
cord-005453-4057qib7	12076	14	chimerism	chimerism	NN
cord-005453-4057qib7	12076	15	alone	alone	RB
cord-005453-4057qib7	12076	16	.	.	.
cord-005453-4057qib7	12077	1	The	the	DT
cord-005453-4057qib7	12077	2	median	median	JJ
cord-005453-4057qib7	12077	3	age	age	NN
cord-005453-4057qib7	12077	4	was	be	VBD
cord-005453-4057qib7	12077	5	63	63	CD
cord-005453-4057qib7	12077	6	years	year	NNS
cord-005453-4057qib7	12078	1	(	(	-LRB-
cord-005453-4057qib7	12078	2	range	range	NN
cord-005453-4057qib7	12078	3	:	:	:
cord-005453-4057qib7	12078	4	27	27	CD
cord-005453-4057qib7	12078	5	-	-	SYM
cord-005453-4057qib7	12078	6	71	71	CD
cord-005453-4057qib7	12078	7	)	)	-RRB-
cord-005453-4057qib7	12078	8	with	with	IN
cord-005453-4057qib7	12078	9	65	65	CD
cord-005453-4057qib7	12078	10	%	%	NN
cord-005453-4057qib7	12078	11	women	woman	NNS
cord-005453-4057qib7	12078	12	.	.	.
cord-005453-4057qib7	12079	1	Fourteen	fourteen	CD
cord-005453-4057qib7	12079	2	(	(	-LRB-
cord-005453-4057qib7	12079	3	54	54	CD
cord-005453-4057qib7	12079	4	%	%	NN
cord-005453-4057qib7	12079	5	)	)	-RRB-
cord-005453-4057qib7	12079	6	of	of	IN
cord-005453-4057qib7	12079	7	the	the	DT
cord-005453-4057qib7	12079	8	patients	patient	NNS
cord-005453-4057qib7	12079	9	had	have	VBD
cord-005453-4057qib7	12079	10	sibling	sibling	NN
cord-005453-4057qib7	12079	11	donor	donor	NN
cord-005453-4057qib7	12079	12	transplants	transplant	NNS
cord-005453-4057qib7	12079	13	and	and	CC
cord-005453-4057qib7	12079	14	twelve	twelve	CD
cord-005453-4057qib7	12079	15	(	(	-LRB-
cord-005453-4057qib7	12079	16	46	46	CD
cord-005453-4057qib7	12079	17	%	%	NN
cord-005453-4057qib7	12079	18	)	)	-RRB-
cord-005453-4057qib7	12079	19	from	from	IN
cord-005453-4057qib7	12079	20	matched	match	VBN
cord-005453-4057qib7	12079	21	unrelated	unrelated	JJ
cord-005453-4057qib7	12079	22	donors	donor	NNS
cord-005453-4057qib7	12079	23	.	.	.
cord-005453-4057qib7	12080	1	Indications	indication	NNS
cord-005453-4057qib7	12080	2	for	for	IN
cord-005453-4057qib7	12080	3	transplant	transplant	NN
cord-005453-4057qib7	12080	4	were	be	VBD
cord-005453-4057qib7	12080	5	:	:	:
cord-005453-4057qib7	12080	6	for	for	IN
cord-005453-4057qib7	12080	7	AML	AML	NNP
cord-005453-4057qib7	12080	8	or	or	CC
cord-005453-4057qib7	12080	9	sAML	saml	NN
cord-005453-4057qib7	12081	1	(	(	-LRB-
cord-005453-4057qib7	12081	2	n=16	n=16	NNP
cord-005453-4057qib7	12081	3	)	)	-RRB-
cord-005453-4057qib7	12081	4	,	,	,
cord-005453-4057qib7	12081	5	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	12081	6	(	(	-LRB-
cord-005453-4057qib7	12081	7	n=4	n=4	NNP
cord-005453-4057qib7	12081	8	)	)	-RRB-
cord-005453-4057qib7	12081	9	,	,	,
cord-005453-4057qib7	12081	10	MDS	MDS	NNP
cord-005453-4057qib7	12081	11	(	(	-LRB-
cord-005453-4057qib7	12081	12	n=3	n=3	NN
cord-005453-4057qib7	12081	13	)	)	-RRB-
cord-005453-4057qib7	12081	14	,	,	,
cord-005453-4057qib7	12081	15	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	12081	16	lymphoma	lymphoma	NN
cord-005453-4057qib7	12081	17	(	(	-LRB-
cord-005453-4057qib7	12081	18	n=1	n=1	CD
cord-005453-4057qib7	12081	19	)	)	-RRB-
cord-005453-4057qib7	12081	20	,	,	,
cord-005453-4057qib7	12081	21	non	non	JJ
cord-005453-4057qib7	12081	22	-	-	JJ
cord-005453-4057qib7	12081	23	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	12081	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	12081	25	(	(	-LRB-
cord-005453-4057qib7	12081	26	n=1	n=1	FW
cord-005453-4057qib7	12081	27	)	)	-RRB-
cord-005453-4057qib7	12081	28	and	and	CC
cord-005453-4057qib7	12081	29	ALL	all	DT
cord-005453-4057qib7	12081	30	(	(	-LRB-
cord-005453-4057qib7	12081	31	n=1	n=1	JJ
cord-005453-4057qib7	12081	32	)	)	-RRB-
cord-005453-4057qib7	12081	33	.	.	.
cord-005453-4057qib7	12082	1	Escalating	escalate	VBG
cord-005453-4057qib7	12082	2	doses	dose	NNS
cord-005453-4057qib7	12082	3	of	of	IN
cord-005453-4057qib7	12082	4	donor	donor	NN
cord-005453-4057qib7	12082	5	CD3	cd3	NN
cord-005453-4057qib7	12083	1	+	+	CC
cord-005453-4057qib7	12083	2	T	t	NN
cord-005453-4057qib7	12083	3	cells	cell	NNS
cord-005453-4057qib7	12083	4	were	be	VBD
cord-005453-4057qib7	12083	5	administered	administer	VBN
cord-005453-4057qib7	12083	6	commencing	commence	VBG
cord-005453-4057qib7	12083	7	at	at	IN
cord-005453-4057qib7	12083	8	5×10	5×10	CD
cord-005453-4057qib7	12083	9	5	5	CD
cord-005453-4057qib7	12083	10	/kg	/kg	NN
cord-005453-4057qib7	12083	11	to	to	IN
cord-005453-4057qib7	12083	12	5×10	5×10	CD
cord-005453-4057qib7	12083	13	6	6	CD
cord-005453-4057qib7	12083	14	/kg	/kg	.
cord-005453-4057qib7	12083	15	then	then	RB
cord-005453-4057qib7	12083	16	increased	increase	VBN
cord-005453-4057qib7	12083	17	at	at	IN
cord-005453-4057qib7	12083	18	half	half	JJ
cord-005453-4057qib7	12083	19	log	log	NN
cord-005453-4057qib7	12083	20	increments	increment	NNS
cord-005453-4057qib7	12083	21	according	accord	VBG
cord-005453-4057qib7	12083	22	to	to	IN
cord-005453-4057qib7	12083	23	chimerism	chimerism	NN
cord-005453-4057qib7	12083	24	results	result	NNS
cord-005453-4057qib7	12083	25	until	until	IN
cord-005453-4057qib7	12083	26	full	full	JJ
cord-005453-4057qib7	12083	27	donor	donor	NN
cord-005453-4057qib7	12083	28	chimerism	chimerism	NN
cord-005453-4057qib7	12083	29	was	be	VBD
cord-005453-4057qib7	12083	30	achieved	achieve	VBN
cord-005453-4057qib7	12083	31	.	.	.
cord-005453-4057qib7	12084	1	The	the	DT
cord-005453-4057qib7	12084	2	median	median	JJ
cord-005453-4057qib7	12084	3	number	number	NN
cord-005453-4057qib7	12084	4	of	of	IN
cord-005453-4057qib7	12084	5	doses	dose	NNS
cord-005453-4057qib7	12084	6	administered	administer	VBN
cord-005453-4057qib7	12084	7	was	be	VBD
cord-005453-4057qib7	12084	8	2	2	CD
cord-005453-4057qib7	12085	1	(	(	-LRB-
cord-005453-4057qib7	12085	2	range	range	NNP
cord-005453-4057qib7	12085	3	1	1	CD
cord-005453-4057qib7	12085	4	-	-	SYM
cord-005453-4057qib7	12085	5	5	5	CD
cord-005453-4057qib7	12085	6	)	)	-RRB-
cord-005453-4057qib7	12085	7	.	.	.
cord-005453-4057qib7	12086	1	The	the	DT
cord-005453-4057qib7	12086	2	median	median	JJ
cord-005453-4057qib7	12086	3	interval	interval	NN
cord-005453-4057qib7	12086	4	was	be	VBD
cord-005453-4057qib7	12086	5	94	94	CD
cord-005453-4057qib7	12086	6	days	day	NNS
cord-005453-4057qib7	12086	7	(	(	-LRB-
cord-005453-4057qib7	12086	8	range	range	VBP
cord-005453-4057qib7	12086	9	48	48	CD
cord-005453-4057qib7	12086	10	-	-	SYM
cord-005453-4057qib7	12086	11	408	408	CD
cord-005453-4057qib7	12086	12	)	)	-RRB-
cord-005453-4057qib7	12086	13	.	.	.
cord-005453-4057qib7	12087	1	The	the	DT
cord-005453-4057qib7	12087	2	median	median	JJ
cord-005453-4057qib7	12087	3	dose	dose	NN
cord-005453-4057qib7	12087	4	was	be	VBD
cord-005453-4057qib7	12087	5	1×10	1×10	CD
cord-005453-4057qib7	12087	6	6	6	CD
cord-005453-4057qib7	12087	7	/	/	SYM
cord-005453-4057qib7	12087	8	kg	kg	NN
cord-005453-4057qib7	12088	1	(	(	-LRB-
cord-005453-4057qib7	12088	2	range	range	VBP
cord-005453-4057qib7	12088	3	5×10	5×10	CD
cord-005453-4057qib7	12088	4	5	5	CD
cord-005453-4057qib7	12088	5	-6×10	-6×10	NNP
cord-005453-4057qib7	12088	6	7	7	CD
cord-005453-4057qib7	12088	7	)	)	-RRB-
cord-005453-4057qib7	12088	8	.	.	.
cord-005453-4057qib7	12089	1	Seventeen	seventeen	CD
cord-005453-4057qib7	12089	2	patients	patient	NNS
cord-005453-4057qib7	12089	3	(	(	-LRB-
cord-005453-4057qib7	12089	4	65	65	CD
cord-005453-4057qib7	12089	5	%	%	NN
cord-005453-4057qib7	12089	6	)	)	-RRB-
cord-005453-4057qib7	12089	7	achieved	achieve	VBN
cord-005453-4057qib7	12089	8	full	full	JJ
cord-005453-4057qib7	12089	9	donor	donor	NN
cord-005453-4057qib7	12089	10	chimerism	chimerism	NN
cord-005453-4057qib7	12089	11	and	and	CC
cord-005453-4057qib7	12089	12	remained	remain	VBD
cord-005453-4057qib7	12089	13	so	so	RB
cord-005453-4057qib7	12089	14	until	until	IN
cord-005453-4057qib7	12089	15	most	most	JJS
cord-005453-4057qib7	12089	16	recent	recent	JJ
cord-005453-4057qib7	12089	17	follow	follow	VBP
cord-005453-4057qib7	12089	18	up	up	RP
cord-005453-4057qib7	12089	19	(	(	-LRB-
cord-005453-4057qib7	12089	20	median	median	NN
cord-005453-4057qib7	12089	21	25	25	CD
cord-005453-4057qib7	12089	22	months	month	NNS
cord-005453-4057qib7	12089	23	,	,	,
cord-005453-4057qib7	12090	1	range	range	NNP
cord-005453-4057qib7	12090	2	12	12	CD
cord-005453-4057qib7	12090	3	-	-	SYM
cord-005453-4057qib7	12090	4	64	64	CD
cord-005453-4057qib7	12090	5	)	)	-RRB-
cord-005453-4057qib7	12090	6	.	.	.
cord-005453-4057qib7	12091	1	One	one	CD
cord-005453-4057qib7	12091	2	patient	patient	NN
cord-005453-4057qib7	12091	3	continued	continue	VBD
cord-005453-4057qib7	12091	4	to	to	TO
cord-005453-4057qib7	12091	5	receive	receive	VB
cord-005453-4057qib7	12091	6	DLI	DLI	NNP
cord-005453-4057qib7	12091	7	after	after	IN
cord-005453-4057qib7	12091	8	the	the	DT
cord-005453-4057qib7	12091	9	study	study	NN
cord-005453-4057qib7	12091	10	period	period	NN
cord-005453-4057qib7	12091	11	and	and	CC
cord-005453-4057qib7	12091	12	later	later	RB
cord-005453-4057qib7	12091	13	reverted	revert	VBN
cord-005453-4057qib7	12091	14	to	to	IN
cord-005453-4057qib7	12091	15	full	full	JJ
cord-005453-4057qib7	12091	16	donor	donor	NN
cord-005453-4057qib7	12091	17	.	.	.
cord-005453-4057qib7	12092	1	Two	two	CD
cord-005453-4057qib7	12092	2	patients	patient	NNS
cord-005453-4057qib7	12092	3	had	have	VBD
cord-005453-4057qib7	12092	4	ongoing	ongoing	JJ
cord-005453-4057qib7	12092	5	mixed	mixed	JJ
cord-005453-4057qib7	12092	6	chimerism	chimerism	NN
cord-005453-4057qib7	12092	7	with	with	IN
cord-005453-4057qib7	12092	8	no	no	DT
cord-005453-4057qib7	12092	9	evidence	evidence	NN
cord-005453-4057qib7	12092	10	of	of	IN
cord-005453-4057qib7	12092	11	relapse	relapse	NN
cord-005453-4057qib7	12092	12	.	.	.
cord-005453-4057qib7	12093	1	Two	two	CD
cord-005453-4057qib7	12093	2	patients	patient	NNS
cord-005453-4057qib7	12093	3	relapsed	relapse	VBD
cord-005453-4057qib7	12093	4	;	;	:
cord-005453-4057qib7	12093	5	one	one	CD
cord-005453-4057qib7	12093	6	of	of	IN
cord-005453-4057qib7	12093	7	whom	whom	WP
cord-005453-4057qib7	12093	8	later	later	RB
cord-005453-4057qib7	12093	9	achieved	achieve	VBD
cord-005453-4057qib7	12093	10	remission	remission	NN
cord-005453-4057qib7	12093	11	.	.	.
cord-005453-4057qib7	12094	1	There	there	EX
cord-005453-4057qib7	12094	2	were	be	VBD
cord-005453-4057qib7	12094	3	six	six	CD
cord-005453-4057qib7	12094	4	cases	case	NNS
cord-005453-4057qib7	12094	5	of	of	IN
cord-005453-4057qib7	12094	6	GvHD	GvHD	NNP
cord-005453-4057qib7	12094	7	;	;	:
cord-005453-4057qib7	12094	8	acute	acute	JJ
cord-005453-4057qib7	12094	9	GvHD	GvHD	NNP
cord-005453-4057qib7	12094	10	(	(	-LRB-
cord-005453-4057qib7	12095	1	grade	grade	NN
cord-005453-4057qib7	12095	2	II	II	NNP
cord-005453-4057qib7	12095	3	n=2	n=2	NNS
cord-005453-4057qib7	12095	4	,	,	,
cord-005453-4057qib7	12095	5	grade	grade	NN
cord-005453-4057qib7	12095	6	III	iii	CD
cord-005453-4057qib7	12095	7	n=1	n=1	NN
cord-005453-4057qib7	12095	8	)	)	-RRB-
cord-005453-4057qib7	12095	9	and	and	CC
cord-005453-4057qib7	12095	10	2	2	CD
cord-005453-4057qib7	12095	11	cases	case	NNS
cord-005453-4057qib7	12095	12	of	of	IN
cord-005453-4057qib7	12095	13	chronic	chronic	JJ
cord-005453-4057qib7	12095	14	extensive	extensive	JJ
cord-005453-4057qib7	12095	15	GvHD	gvhd	NN
cord-005453-4057qib7	12095	16	.	.	.
cord-005453-4057qib7	12096	1	One	one	CD
cord-005453-4057qib7	12096	2	patient	patient	NN
cord-005453-4057qib7	12096	3	had	have	VBD
cord-005453-4057qib7	12096	4	GvHD	GvHD	NNP
cord-005453-4057qib7	12096	5	features	feature	NNS
cord-005453-4057qib7	12096	6	consistent	consistent	JJ
cord-005453-4057qib7	12096	7	with	with	IN
cord-005453-4057qib7	12096	8	overlap	overlap	NN
cord-005453-4057qib7	12096	9	syndrome	syndrome	NN
cord-005453-4057qib7	12096	10	.	.	.
cord-005453-4057qib7	12097	1	A	a	DT
cord-005453-4057qib7	12097	2	total	total	NN
cord-005453-4057qib7	12097	3	of	of	IN
cord-005453-4057qib7	12097	4	five	five	CD
cord-005453-4057qib7	12097	5	patients	patient	NNS
cord-005453-4057qib7	12097	6	died	die	VBD
cord-005453-4057qib7	12097	7	,	,	,
cord-005453-4057qib7	12097	8	four	four	CD
cord-005453-4057qib7	12097	9	due	due	JJ
cord-005453-4057qib7	12097	10	to	to	IN
cord-005453-4057qib7	12097	11	infection	infection	NN
cord-005453-4057qib7	12097	12	(	(	-LRB-
cord-005453-4057qib7	12097	13	one	one	CD
cord-005453-4057qib7	12097	14	in	in	IN
cord-005453-4057qib7	12097	15	a	a	DT
cord-005453-4057qib7	12097	16	patient	patient	NN
cord-005453-4057qib7	12097	17	with	with	IN
cord-005453-4057qib7	12097	18	GvHD	GvHD	NNP
cord-005453-4057qib7	12097	19	)	)	-RRB-
cord-005453-4057qib7	12097	20	and	and	CC
cord-005453-4057qib7	12097	21	one	one	CD
cord-005453-4057qib7	12097	22	due	due	IN
cord-005453-4057qib7	12097	23	to	to	IN
cord-005453-4057qib7	12097	24	cardiac	cardiac	JJ
cord-005453-4057qib7	12097	25	toxicity	toxicity	NN
cord-005453-4057qib7	12097	26	from	from	IN
cord-005453-4057qib7	12097	27	previous	previous	JJ
cord-005453-4057qib7	12097	28	treatment	treatment	NN
cord-005453-4057qib7	12097	29	(	(	-LRB-
cord-005453-4057qib7	12097	30	confirmed	confirm	VBN
cord-005453-4057qib7	12097	31	on	on	IN
cord-005453-4057qib7	12097	32	post	post	JJ
cord-005453-4057qib7	12097	33	-	-	JJ
cord-005453-4057qib7	12097	34	mortem	mortem	JJ
cord-005453-4057qib7	12097	35	)	)	-RRB-
cord-005453-4057qib7	12097	36	.	.	.
cord-005453-4057qib7	12098	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12098	2	:	:	:
cord-005453-4057qib7	12099	1	The	the	DT
cord-005453-4057qib7	12099	2	results	result	NNS
cord-005453-4057qib7	12099	3	of	of	IN
cord-005453-4057qib7	12099	4	our	-PRON-	PRP$
cord-005453-4057qib7	12099	5	single	single	JJ
cord-005453-4057qib7	12099	6	centre	centre	NN
cord-005453-4057qib7	12099	7	study	study	NN
cord-005453-4057qib7	12099	8	help	help	NN
cord-005453-4057qib7	12099	9	reinforce	reinforce	VB
cord-005453-4057qib7	12099	10	the	the	DT
cord-005453-4057qib7	12099	11	evidence	evidence	NN
cord-005453-4057qib7	12099	12	for	for	IN
cord-005453-4057qib7	12099	13	DLI	DLI	NNP
cord-005453-4057qib7	12099	14	in	in	IN
cord-005453-4057qib7	12099	15	establishing	establish	VBG
cord-005453-4057qib7	12099	16	full	full	JJ
cord-005453-4057qib7	12099	17	donor	donor	NN
cord-005453-4057qib7	12099	18	chimerism	chimerism	NN
cord-005453-4057qib7	12099	19	when	when	WRB
cord-005453-4057qib7	12099	20	mixed	mixed	JJ
cord-005453-4057qib7	12099	21	chimerism	chimerism	NN
cord-005453-4057qib7	12099	22	is	be	VBZ
cord-005453-4057qib7	12099	23	detected	detect	VBN
cord-005453-4057qib7	12099	24	in	in	IN
cord-005453-4057qib7	12099	25	the	the	DT
cord-005453-4057qib7	12099	26	absence	absence	NN
cord-005453-4057qib7	12099	27	of	of	IN
cord-005453-4057qib7	12099	28	relapse	relapse	NN
cord-005453-4057qib7	12099	29	.	.	.
cord-005453-4057qib7	12100	1	Incremental	incremental	JJ
cord-005453-4057qib7	12100	2	DLI	DLI	NNP
cord-005453-4057qib7	12100	3	dosing	dosing	NN
cord-005453-4057qib7	12100	4	is	be	VBZ
cord-005453-4057qib7	12100	5	an	an	DT
cord-005453-4057qib7	12100	6	effective	effective	JJ
cord-005453-4057qib7	12100	7	strategy	strategy	NN
cord-005453-4057qib7	12100	8	and	and	CC
cord-005453-4057qib7	12100	9	associated	associate	VBN
cord-005453-4057qib7	12100	10	with	with	IN
cord-005453-4057qib7	12100	11	a	a	DT
cord-005453-4057qib7	12100	12	low	low	JJ
cord-005453-4057qib7	12100	13	relapse	relapse	NN
cord-005453-4057qib7	12100	14	rate	rate	NN
cord-005453-4057qib7	12100	15	.	.	.
cord-005453-4057qib7	12101	1	Caution	caution	NN
cord-005453-4057qib7	12101	2	should	should	MD
cord-005453-4057qib7	12101	3	still	still	RB
cord-005453-4057qib7	12101	4	be	be	VB
cord-005453-4057qib7	12101	5	given	give	VBN
cord-005453-4057qib7	12101	6	to	to	IN
cord-005453-4057qib7	12101	7	the	the	DT
cord-005453-4057qib7	12101	8	risk	risk	NN
cord-005453-4057qib7	12101	9	of	of	IN
cord-005453-4057qib7	12101	10	GvHD	GvHD	NNP
cord-005453-4057qib7	12101	11	following	follow	VBG
cord-005453-4057qib7	12101	12	DLI	DLI	NNP
cord-005453-4057qib7	12101	13	,	,	,
cord-005453-4057qib7	12101	14	however	however	RB
cord-005453-4057qib7	12101	15	the	the	DT
cord-005453-4057qib7	12101	16	risk	risk	NN
cord-005453-4057qib7	12101	17	appears	appear	VBZ
cord-005453-4057qib7	12101	18	to	to	TO
cord-005453-4057qib7	12101	19	be	be	VB
cord-005453-4057qib7	12101	20	low	low	JJ
cord-005453-4057qib7	12101	21	in	in	IN
cord-005453-4057qib7	12101	22	this	this	DT
cord-005453-4057qib7	12101	23	study	study	NN
cord-005453-4057qib7	12101	24	.	.	.
cord-005453-4057qib7	12102	1	Larger	large	JJR
cord-005453-4057qib7	12102	2	prospective	prospective	JJ
cord-005453-4057qib7	12102	3	studies	study	NNS
cord-005453-4057qib7	12102	4	are	be	VBP
cord-005453-4057qib7	12102	5	ongoing	ongoing	JJ
cord-005453-4057qib7	12102	6	to	to	TO
cord-005453-4057qib7	12102	7	address	address	VB
cord-005453-4057qib7	12102	8	the	the	DT
cord-005453-4057qib7	12102	9	optimal	optimal	JJ
cord-005453-4057qib7	12102	10	dosing	dosing	NN
cord-005453-4057qib7	12102	11	strategy	strategy	NN
cord-005453-4057qib7	12102	12	for	for	IN
cord-005453-4057qib7	12102	13	DLI	DLI	NNP
cord-005453-4057qib7	12102	14	post	post	NN
cord-005453-4057qib7	12102	15	-	-	NN
cord-005453-4057qib7	12102	16	transplant	transplant	NN
cord-005453-4057qib7	12102	17	.	.	.
cord-005453-4057qib7	12103	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12103	2	:	:	:
cord-005453-4057qib7	12103	3	Nothing	nothing	NN
cord-005453-4057qib7	12103	4	to	to	TO
cord-005453-4057qib7	12103	5	declare	declare	VB
cord-005453-4057qib7	12103	6	Hypomethylating	Hypomethylating	NNP
cord-005453-4057qib7	12103	7	agents	agent	NNS
cord-005453-4057qib7	12103	8	for	for	IN
cord-005453-4057qib7	12103	9	the	the	DT
cord-005453-4057qib7	12103	10	treatment	treatment	NN
cord-005453-4057qib7	12103	11	of	of	IN
cord-005453-4057qib7	12103	12	relapsed	relapsed	JJ
cord-005453-4057qib7	12103	13	acute	acute	JJ
cord-005453-4057qib7	12103	14	myeloid	myeloid	NN
cord-005453-4057qib7	12103	15	leukemia	leukemia	NN
cord-005453-4057qib7	12103	16	after	after	IN
cord-005453-4057qib7	12103	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	12103	18	blood	blood	NN
cord-005453-4057qib7	12103	19	stem	stem	NN
cord-005453-4057qib7	12103	20	cell	cell	NN
cord-005453-4057qib7	12103	21	transplantation	transplantation	NN
cord-005453-4057qib7	12103	22	:	:	:
cord-005453-4057qib7	12103	23	A	a	DT
cord-005453-4057qib7	12103	24	single	single	JJ
cord-005453-4057qib7	12103	25	center	center	NN
cord-005453-4057qib7	12103	26	experience	experience	NN
cord-005453-4057qib7	12103	27	Mariarita	Mariarita	NNP
cord-005453-4057qib7	12103	28	Sciume	Sciume	NNP
cord-005453-4057qib7	12103	29	1	1	CD
cord-005453-4057qib7	12103	30	,	,	,
cord-005453-4057qib7	12103	31	Giorgia	Giorgia	NNP
cord-005453-4057qib7	12103	32	Saporiti	Saporiti	NNP
cord-005453-4057qib7	12103	33	1	1	CD
cord-005453-4057qib7	12103	34	,	,	,
cord-005453-4057qib7	12103	35	Elena	Elena	NNP
cord-005453-4057qib7	12103	36	Tagliaferri	Tagliaferri	NNP
cord-005453-4057qib7	12103	37	1	1	CD
cord-005453-4057qib7	12103	38	,	,	,
cord-005453-4057qib7	12103	39	Nicola	Nicola	NNP
cord-005453-4057qib7	12103	40	Fracchiolla	Fracchiolla	NNP
cord-005453-4057qib7	12103	41	1	1	CD
cord-005453-4057qib7	12103	42	,	,	,
cord-005453-4057qib7	12103	43	Federica	Federica	NNP
cord-005453-4057qib7	12103	44	Grifoni	Grifoni	NNP
cord-005453-4057qib7	12103	45	1	1	CD
cord-005453-4057qib7	12103	46	,	,	,
cord-005453-4057qib7	12103	47	Giorgia	Giorgia	NNP
cord-005453-4057qib7	12103	48	Levati	Levati	NNP
cord-005453-4057qib7	12103	49	1	1	CD
cord-005453-4057qib7	12103	50	,	,	,
cord-005453-4057qib7	12103	51	Luca	Luca	NNP
cord-005453-4057qib7	12103	52	Baldini	Baldini	NNP
cord-005453-4057qib7	12103	53	1	1	CD
cord-005453-4057qib7	12103	54	,	,	,
cord-005453-4057qib7	12103	55	Francesco	Francesco	NNP
cord-005453-4057qib7	12103	56	Onida	Onida	NNP
cord-005453-4057qib7	12103	57	1	1	CD
cord-005453-4057qib7	12103	58	the	the	DT
cord-005453-4057qib7	12103	59	post	post	JJ
cord-005453-4057qib7	12103	60	-	-	JJ
cord-005453-4057qib7	12103	61	transplant	transplant	JJ
cord-005453-4057qib7	12103	62	period	period	NN
cord-005453-4057qib7	12103	63	with	with	IN
cord-005453-4057qib7	12103	64	well	well	RB
cord-005453-4057qib7	12103	65	-	-	HYPH
cord-005453-4057qib7	12103	66	balanced	balance	VBN
cord-005453-4057qib7	12103	67	profile	profile	NN
cord-005453-4057qib7	12103	68	of	of	IN
cord-005453-4057qib7	12103	69	good	good	JJ
cord-005453-4057qib7	12103	70	efficacy	efficacy	NN
cord-005453-4057qib7	12103	71	and	and	CC
cord-005453-4057qib7	12103	72	moderate	moderate	JJ
cord-005453-4057qib7	12103	73	toxicity	toxicity	NN
cord-005453-4057qib7	12103	74	.	.	.
cord-005453-4057qib7	12104	1	We	-PRON-	PRP
cord-005453-4057qib7	12104	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	12104	3	evaluated	evaluate	VBD
cord-005453-4057qib7	12104	4	the	the	DT
cord-005453-4057qib7	12104	5	safety	safety	NN
cord-005453-4057qib7	12104	6	and	and	CC
cord-005453-4057qib7	12104	7	efficacy	efficacy	NN
cord-005453-4057qib7	12104	8	of	of	IN
cord-005453-4057qib7	12104	9	HMA	HMA	NNP
cord-005453-4057qib7	12104	10	+	+	CC
cord-005453-4057qib7	12104	11	/-DLI	/-DLI	.
cord-005453-4057qib7	12105	1	in	in	IN
cord-005453-4057qib7	12105	2	a	a	DT
cord-005453-4057qib7	12105	3	reallife	reallife	JJ
cord-005453-4057qib7	12105	4	cohort	cohort	NN
cord-005453-4057qib7	12105	5	of	of	IN
cord-005453-4057qib7	12105	6	AML	AML	NNP
cord-005453-4057qib7	12105	7	patients	patient	NNS
cord-005453-4057qib7	12105	8	relapsing	relapse	VBG
cord-005453-4057qib7	12105	9	after	after	IN
cord-005453-4057qib7	12105	10	allo	allo	NN
cord-005453-4057qib7	12105	11	-	-	HYPH
cord-005453-4057qib7	12105	12	SCT	SCT	NNP
cord-005453-4057qib7	12105	13	.	.	.
cord-005453-4057qib7	12106	1	Methods	method	NNS
cord-005453-4057qib7	12106	2	:	:	:
cord-005453-4057qib7	12107	1	Data	datum	NNS
cord-005453-4057qib7	12107	2	from	from	IN
cord-005453-4057qib7	12107	3	all	all	DT
cord-005453-4057qib7	12107	4	patients	patient	NNS
cord-005453-4057qib7	12107	5	with	with	IN
cord-005453-4057qib7	12107	6	AML	AML	NNP
cord-005453-4057qib7	12107	7	who	who	WP
cord-005453-4057qib7	12107	8	underwent	undergo	VBD
cord-005453-4057qib7	12107	9	allo	allo	NNP
cord-005453-4057qib7	12107	10	-	-	HYPH
cord-005453-4057qib7	12107	11	SCT	SCT	NNP
cord-005453-4057qib7	12107	12	at	at	IN
cord-005453-4057qib7	12107	13	our	-PRON-	PRP$
cord-005453-4057qib7	12107	14	Institution	Institution	NNP
cord-005453-4057qib7	12107	15	in	in	IN
cord-005453-4057qib7	12107	16	the	the	DT
cord-005453-4057qib7	12107	17	last	last	JJ
cord-005453-4057qib7	12107	18	6	6	CD
cord-005453-4057qib7	12107	19	years	year	NNS
cord-005453-4057qib7	12107	20	and	and	CC
cord-005453-4057qib7	12107	21	subsequently	subsequently	RB
cord-005453-4057qib7	12107	22	received	receive	VBD
cord-005453-4057qib7	12107	23	HMA	HMA	NNP
cord-005453-4057qib7	12107	24	as	as	IN
cord-005453-4057qib7	12107	25	a	a	DT
cord-005453-4057qib7	12107	26	salvage	salvage	NN
cord-005453-4057qib7	12107	27	treatment	treatment	NN
cord-005453-4057qib7	12107	28	for	for	IN
cord-005453-4057qib7	12107	29	disease	disease	NN
cord-005453-4057qib7	12107	30	recurrence	recurrence	NN
cord-005453-4057qib7	12107	31	or	or	CC
cord-005453-4057qib7	12107	32	preemptively	preemptively	RB
cord-005453-4057qib7	12107	33	for	for	IN
cord-005453-4057qib7	12107	34	loss	loss	NN
cord-005453-4057qib7	12107	35	of	of	IN
cord-005453-4057qib7	12107	36	complete	complete	JJ
cord-005453-4057qib7	12107	37	donor	donor	NN
cord-005453-4057qib7	12107	38	chimerism	chimerism	NN
cord-005453-4057qib7	12107	39	were	be	VBD
cord-005453-4057qib7	12107	40	collected	collect	VBN
cord-005453-4057qib7	12107	41	.	.	.
cord-005453-4057qib7	12108	1	Results	result	NNS
cord-005453-4057qib7	12108	2	:	:	:
cord-005453-4057qib7	12109	1	Eleven	eleven	CD
cord-005453-4057qib7	12109	2	patients	patient	NNS
cord-005453-4057qib7	12109	3	with	with	IN
cord-005453-4057qib7	12109	4	a	a	DT
cord-005453-4057qib7	12109	5	median	median	JJ
cord-005453-4057qib7	12109	6	age	age	NN
cord-005453-4057qib7	12109	7	of	of	IN
cord-005453-4057qib7	12109	8	64	64	CD
cord-005453-4057qib7	12109	9	years	year	NNS
cord-005453-4057qib7	12109	10	(	(	-LRB-
cord-005453-4057qib7	12109	11	range	range	NN
cord-005453-4057qib7	12109	12	41	41	CD
cord-005453-4057qib7	12109	13	-	-	SYM
cord-005453-4057qib7	12109	14	66	66	CD
cord-005453-4057qib7	12109	15	)	)	-RRB-
cord-005453-4057qib7	12109	16	were	be	VBD
cord-005453-4057qib7	12109	17	identified	identify	VBN
cord-005453-4057qib7	12109	18	;	;	:
cord-005453-4057qib7	12109	19	median	median	JJ
cord-005453-4057qib7	12109	20	time	time	NN
cord-005453-4057qib7	12109	21	between	between	IN
cord-005453-4057qib7	12109	22	allo	allo	NN
cord-005453-4057qib7	12109	23	-	-	HYPH
cord-005453-4057qib7	12109	24	SCT	sct	NN
cord-005453-4057qib7	12109	25	and	and	CC
cord-005453-4057qib7	12109	26	time	time	NN
cord-005453-4057qib7	12109	27	to	to	IN
cord-005453-4057qib7	12109	28	HMA	HMA	NNP
cord-005453-4057qib7	12109	29	therapy	therapy	NN
cord-005453-4057qib7	12109	30	was	be	VBD
cord-005453-4057qib7	12109	31	10	10	CD
cord-005453-4057qib7	12109	32	months	month	NNS
cord-005453-4057qib7	12110	1	(	(	-LRB-
cord-005453-4057qib7	12110	2	range	range	NNP
cord-005453-4057qib7	12110	3	4	4	CD
cord-005453-4057qib7	12110	4	-	-	SYM
cord-005453-4057qib7	12110	5	42	42	CD
cord-005453-4057qib7	12110	6	)	)	-RRB-
cord-005453-4057qib7	12110	7	.	.	.
cord-005453-4057qib7	12111	1	According	accord	VBG
cord-005453-4057qib7	12111	2	to	to	IN
cord-005453-4057qib7	12111	3	ELN	ELN	NNP
cord-005453-4057qib7	12111	4	genetic	genetic	JJ
cord-005453-4057qib7	12111	5	risk	risk	NN
cord-005453-4057qib7	12111	6	stratification	stratification	NN
cord-005453-4057qib7	12111	7	,	,	,
cord-005453-4057qib7	12111	8	2	2	CD
cord-005453-4057qib7	12111	9	patients	patient	NNS
cord-005453-4057qib7	12111	10	were	be	VBD
cord-005453-4057qib7	12111	11	classified	classify	VBN
cord-005453-4057qib7	12111	12	in	in	IN
cord-005453-4057qib7	12111	13	the	the	DT
cord-005453-4057qib7	12111	14	favorable	favorable	JJ
cord-005453-4057qib7	12111	15	group	group	NN
cord-005453-4057qib7	12111	16	,	,	,
cord-005453-4057qib7	12111	17	3	3	CD
cord-005453-4057qib7	12111	18	in	in	IN
cord-005453-4057qib7	12111	19	the	the	DT
cord-005453-4057qib7	12111	20	intermediate	intermediate	NN
cord-005453-4057qib7	12111	21	-	-	:
cord-005453-4057qib7	12111	22	I	i	NN
cord-005453-4057qib7	12111	23	,	,	,
cord-005453-4057qib7	12111	24	2	2	CD
cord-005453-4057qib7	12111	25	in	in	IN
cord-005453-4057qib7	12111	26	the	the	DT
cord-005453-4057qib7	12111	27	intermediate	intermediate	JJ
cord-005453-4057qib7	12111	28	-	-	HYPH
cord-005453-4057qib7	12111	29	II	II	NNP
cord-005453-4057qib7	12111	30	and	and	CC
cord-005453-4057qib7	12111	31	4	4	CD
cord-005453-4057qib7	12111	32	in	in	IN
cord-005453-4057qib7	12111	33	the	the	DT
cord-005453-4057qib7	12111	34	adverse	adverse	JJ
cord-005453-4057qib7	12111	35	one	one	CD
cord-005453-4057qib7	12111	36	.	.	.
cord-005453-4057qib7	12112	1	Six	six	CD
cord-005453-4057qib7	12112	2	patients	patient	NNS
cord-005453-4057qib7	12112	3	were	be	VBD
cord-005453-4057qib7	12112	4	treated	treat	VBN
cord-005453-4057qib7	12112	5	with	with	IN
cord-005453-4057qib7	12112	6	AZA	AZA	NNP
cord-005453-4057qib7	12112	7	,	,	,
cord-005453-4057qib7	12112	8	whereas	whereas	IN
cord-005453-4057qib7	12112	9	the	the	DT
cord-005453-4057qib7	12112	10	remaining	remain	VBG
cord-005453-4057qib7	12112	11	5	5	CD
cord-005453-4057qib7	12112	12	patients	patient	NNS
cord-005453-4057qib7	12112	13	with	with	IN
cord-005453-4057qib7	12112	14	DAC	DAC	NNP
cord-005453-4057qib7	12112	15	.	.	.
cord-005453-4057qib7	12113	1	The	the	DT
cord-005453-4057qib7	12113	2	cycles	cycle	NNS
cord-005453-4057qib7	12113	3	were	be	VBD
cord-005453-4057qib7	12113	4	repeated	repeat	VBN
cord-005453-4057qib7	12113	5	every	every	DT
cord-005453-4057qib7	12113	6	28	28	CD
cord-005453-4057qib7	12113	7	days	day	NNS
cord-005453-4057qib7	12113	8	.	.	.
cord-005453-4057qib7	12114	1	Ten	ten	CD
cord-005453-4057qib7	12114	2	patients	patient	NNS
cord-005453-4057qib7	12114	3	(	(	-LRB-
cord-005453-4057qib7	12114	4	91	91	CD
cord-005453-4057qib7	12114	5	%	%	NN
cord-005453-4057qib7	12114	6	)	)	-RRB-
cord-005453-4057qib7	12114	7	started	start	VBD
cord-005453-4057qib7	12114	8	HMA	HMA	NNP
cord-005453-4057qib7	12114	9	for	for	IN
cord-005453-4057qib7	12114	10	morphological	morphological	JJ
cord-005453-4057qib7	12114	11	AML	AML	NNP
cord-005453-4057qib7	12114	12	relapse	relapse	NN
cord-005453-4057qib7	12114	13	,	,	,
cord-005453-4057qib7	12114	14	while	while	IN
cord-005453-4057qib7	12114	15	one	one	CD
cord-005453-4057qib7	12114	16	patient	patient	NN
cord-005453-4057qib7	12114	17	received	receive	VBD
cord-005453-4057qib7	12114	18	AZA	AZA	NNP
cord-005453-4057qib7	12114	19	as	as	IN
cord-005453-4057qib7	12114	20	a	a	DT
cord-005453-4057qib7	12114	21	sequential	sequential	JJ
cord-005453-4057qib7	12114	22	treatment	treatment	NN
cord-005453-4057qib7	12114	23	after	after	IN
cord-005453-4057qib7	12114	24	DLI	DLI	NNP
cord-005453-4057qib7	12114	25	administered	administer	VBD
cord-005453-4057qib7	12114	26	for	for	IN
cord-005453-4057qib7	12114	27	loss	loss	NN
cord-005453-4057qib7	12114	28	of	of	IN
cord-005453-4057qib7	12114	29	complete	complete	JJ
cord-005453-4057qib7	12114	30	donor	donor	NN
cord-005453-4057qib7	12114	31	chimerism	chimerism	NN
cord-005453-4057qib7	12114	32	.	.	.
cord-005453-4057qib7	12115	1	Median	median	JJ
cord-005453-4057qib7	12115	2	number	number	NN
cord-005453-4057qib7	12115	3	of	of	IN
cord-005453-4057qib7	12115	4	cycles	cycle	NNS
cord-005453-4057qib7	12115	5	was	be	VBD
cord-005453-4057qib7	12115	6	3	3	CD
cord-005453-4057qib7	12116	1	(	(	-LRB-
cord-005453-4057qib7	12116	2	range	range	NN
cord-005453-4057qib7	12116	3	1	1	CD
cord-005453-4057qib7	12116	4	-20	-20	CD
cord-005453-4057qib7	12116	5	)	)	-RRB-
cord-005453-4057qib7	12116	6	.	.	.
cord-005453-4057qib7	12117	1	Treatment	treatment	NN
cord-005453-4057qib7	12117	2	strategy	strategy	NN
cord-005453-4057qib7	12117	3	included	include	VBD
cord-005453-4057qib7	12117	4	combination	combination	NN
cord-005453-4057qib7	12117	5	with	with	IN
cord-005453-4057qib7	12117	6	DLI	DLI	NNP
cord-005453-4057qib7	12117	7	in	in	IN
cord-005453-4057qib7	12117	8	5	5	CD
cord-005453-4057qib7	12117	9	patients	patient	NNS
cord-005453-4057qib7	12117	10	(	(	-LRB-
cord-005453-4057qib7	12117	11	2	2	CD
cord-005453-4057qib7	12117	12	in	in	IN
cord-005453-4057qib7	12117	13	the	the	DT
cord-005453-4057qib7	12117	14	DAC	DAC	NNP
cord-005453-4057qib7	12117	15	cohort	cohort	NN
cord-005453-4057qib7	12117	16	,	,	,
cord-005453-4057qib7	12117	17	3	3	CD
cord-005453-4057qib7	12117	18	in	in	IN
cord-005453-4057qib7	12117	19	the	the	DT
cord-005453-4057qib7	12117	20	AZA	AZA	NNP
cord-005453-4057qib7	12117	21	cohort	cohort	NN
cord-005453-4057qib7	12117	22	)	)	-RRB-
cord-005453-4057qib7	12117	23	,	,	,
cord-005453-4057qib7	12117	24	while	while	IN
cord-005453-4057qib7	12117	25	in	in	IN
cord-005453-4057qib7	12117	26	one	one	CD
cord-005453-4057qib7	12117	27	case	case	NN
cord-005453-4057qib7	12117	28	of	of	IN
cord-005453-4057qib7	12117	29	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	12117	30	+	+	CC
cord-005453-4057qib7	12117	31	AML	AML	NNP
cord-005453-4057qib7	12117	32	sorafenib	sorafenib	NNP
cord-005453-4057qib7	12117	33	was	be	VBD
cord-005453-4057qib7	12117	34	also	also	RB
cord-005453-4057qib7	12117	35	associated	associate	VBN
cord-005453-4057qib7	12117	36	to	to	IN
cord-005453-4057qib7	12117	37	DAC	DAC	NNP
cord-005453-4057qib7	12117	38	and	and	CC
cord-005453-4057qib7	12117	39	DLI	DLI	NNP
cord-005453-4057qib7	12117	40	.	.	.
cord-005453-4057qib7	12118	1	No	no	DT
cord-005453-4057qib7	12118	2	grade	grade	NN
cord-005453-4057qib7	12118	3	3/4	3/4	CD
cord-005453-4057qib7	12118	4	toxicities	toxicity	NNS
cord-005453-4057qib7	12118	5	and	and	CC
cord-005453-4057qib7	12118	6	no	no	DT
cord-005453-4057qib7	12118	7	acute	acute	JJ
cord-005453-4057qib7	12118	8	GvHD	gvhd	NN
cord-005453-4057qib7	12118	9	occurred	occur	VBD
cord-005453-4057qib7	12118	10	.	.	.
cord-005453-4057qib7	12119	1	A	a	DT
cord-005453-4057qib7	12119	2	clinically	clinically	RB
cord-005453-4057qib7	12119	3	significant	significant	JJ
cord-005453-4057qib7	12119	4	response	response	NN
cord-005453-4057qib7	12119	5	was	be	VBD
cord-005453-4057qib7	12119	6	observed	observe	VBN
cord-005453-4057qib7	12119	7	in	in	IN
cord-005453-4057qib7	12119	8	four	four	CD
cord-005453-4057qib7	12119	9	patients	patient	NNS
cord-005453-4057qib7	12119	10	(	(	-LRB-
cord-005453-4057qib7	12119	11	36	36	CD
cord-005453-4057qib7	12119	12	%	%	NN
cord-005453-4057qib7	12119	13	)	)	-RRB-
cord-005453-4057qib7	12119	14	,	,	,
cord-005453-4057qib7	12119	15	all	all	DT
cord-005453-4057qib7	12119	16	receiving	receive	VBG
cord-005453-4057qib7	12119	17	at	at	IN
cord-005453-4057qib7	12119	18	least	least	JJS
cord-005453-4057qib7	12119	19	4	4	CD
cord-005453-4057qib7	12119	20	cycles	cycle	NNS
cord-005453-4057qib7	12119	21	of	of	IN
cord-005453-4057qib7	12119	22	HMA	HMA	NNP
cord-005453-4057qib7	12119	23	therapy	therapy	NN
cord-005453-4057qib7	12119	24	;	;	:
cord-005453-4057qib7	12119	25	in	in	IN
cord-005453-4057qib7	12119	26	particular	particular	JJ
cord-005453-4057qib7	12119	27	,	,	,
cord-005453-4057qib7	12119	28	a	a	DT
cord-005453-4057qib7	12119	29	complete	complete	JJ
cord-005453-4057qib7	12119	30	remission	remission	NN
cord-005453-4057qib7	12119	31	(	(	-LRB-
cord-005453-4057qib7	12119	32	CR	CR	NNP
cord-005453-4057qib7	12119	33	)	)	-RRB-
cord-005453-4057qib7	12119	34	was	be	VBD
cord-005453-4057qib7	12119	35	achieved	achieve	VBN
cord-005453-4057qib7	12119	36	in	in	IN
cord-005453-4057qib7	12119	37	3/10	3/10	CD
cord-005453-4057qib7	12119	38	patients	patient	NNS
cord-005453-4057qib7	12119	39	treated	treat	VBN
cord-005453-4057qib7	12119	40	for	for	IN
cord-005453-4057qib7	12119	41	morphological	morphological	JJ
cord-005453-4057qib7	12119	42	relapse	relapse	NN
cord-005453-4057qib7	12119	43	,	,	,
cord-005453-4057qib7	12119	44	including	include	VBG
cord-005453-4057qib7	12119	45	the	the	DT
cord-005453-4057qib7	12119	46	one	one	NN
cord-005453-4057qib7	12119	47	who	who	WP
cord-005453-4057qib7	12119	48	received	receive	VBD
cord-005453-4057qib7	12119	49	the	the	DT
cord-005453-4057qib7	12119	50	DAC	DAC	NNP
cord-005453-4057qib7	12119	51	/	/	SYM
cord-005453-4057qib7	12119	52	DLI	DLI	NNP
cord-005453-4057qib7	12119	53	/	/	SYM
cord-005453-4057qib7	12119	54	sorafenib	sorafenib	NNP
cord-005453-4057qib7	12119	55	combination	combination	NNP
cord-005453-4057qib7	12119	56	and	and	CC
cord-005453-4057qib7	12119	57	one	one	CD
cord-005453-4057qib7	12119	58	(	(	-LRB-
cord-005453-4057qib7	12119	59	favorable	favorable	JJ
cord-005453-4057qib7	12119	60	ELN	ELN	NNP
cord-005453-4057qib7	12119	61	risk	risk	NN
cord-005453-4057qib7	12119	62	)	)	-RRB-
cord-005453-4057qib7	12119	63	who	who	WP
cord-005453-4057qib7	12119	64	received	receive	VBD
cord-005453-4057qib7	12119	65	AZA	AZA	NNP
cord-005453-4057qib7	12119	66	alone	alone	JJ
cord-005453-4057qib7	12119	67	(	(	-LRB-
cord-005453-4057qib7	12119	68	not	not	RB
cord-005453-4057qib7	12119	69	eligible	eligible	JJ
cord-005453-4057qib7	12119	70	for	for	IN
cord-005453-4057qib7	12119	71	DLI	DLI	NNP
cord-005453-4057qib7	12119	72	due	due	IN
cord-005453-4057qib7	12119	73	to	to	IN
cord-005453-4057qib7	12119	74	a	a	DT
cord-005453-4057qib7	12119	75	concomitant	concomitant	JJ
cord-005453-4057qib7	12119	76	lateonset	lateonset	NN
cord-005453-4057qib7	12119	77	cutaneous	cutaneous	JJ
cord-005453-4057qib7	12119	78	grade	grade	NN
cord-005453-4057qib7	12119	79	2	2	CD
cord-005453-4057qib7	12119	80	GvHD	GvHD	NNP
cord-005453-4057qib7	12119	81	)	)	-RRB-
cord-005453-4057qib7	12119	82	.	.	.
cord-005453-4057qib7	12120	1	Of	of	IN
cord-005453-4057qib7	12120	2	interest	interest	NN
cord-005453-4057qib7	12120	3	,	,	,
cord-005453-4057qib7	12120	4	the	the	DT
cord-005453-4057qib7	12120	5	latter	latter	JJ
cord-005453-4057qib7	12120	6	patient	patient	NN
cord-005453-4057qib7	12120	7	also	also	RB
cord-005453-4057qib7	12120	8	displayed	display	VBD
cord-005453-4057qib7	12120	9	a	a	DT
cord-005453-4057qib7	12120	10	resolution	resolution	NN
cord-005453-4057qib7	12120	11	of	of	IN
cord-005453-4057qib7	12120	12	the	the	DT
cord-005453-4057qib7	12120	13	cutaneous	cutaneous	JJ
cord-005453-4057qib7	12120	14	GvHD	gvhd	NN
cord-005453-4057qib7	12120	15	.	.	.
cord-005453-4057qib7	12121	1	Full	full	JJ
cord-005453-4057qib7	12121	2	donor	donor	NN
cord-005453-4057qib7	12121	3	chimerism	chimerism	NN
cord-005453-4057qib7	12121	4	recovery	recovery	NN
cord-005453-4057qib7	12121	5	with	with	IN
cord-005453-4057qib7	12121	6	no	no	DT
cord-005453-4057qib7	12121	7	GvHD	gvhd	NN
cord-005453-4057qib7	12121	8	was	be	VBD
cord-005453-4057qib7	12121	9	observed	observe	VBN
cord-005453-4057qib7	12121	10	in	in	IN
cord-005453-4057qib7	12121	11	the	the	DT
cord-005453-4057qib7	12121	12	patient	patient	NN
cord-005453-4057qib7	12121	13	who	who	WP
cord-005453-4057qib7	12121	14	received	receive	VBD
cord-005453-4057qib7	12121	15	AZA	AZA	NNP
cord-005453-4057qib7	12121	16	for	for	IN
cord-005453-4057qib7	12121	17	the	the	DT
cord-005453-4057qib7	12121	18	progressive	progressive	JJ
cord-005453-4057qib7	12121	19	donor	donor	NN
cord-005453-4057qib7	12121	20	chimerism	chimerism	NN
cord-005453-4057qib7	12121	21	loss	loss	NN
cord-005453-4057qib7	12121	22	not	not	RB
cord-005453-4057qib7	12121	23	responding	respond	VBG
cord-005453-4057qib7	12121	24	to	to	IN
cord-005453-4057qib7	12121	25	DLI	DLI	NNP
cord-005453-4057qib7	12121	26	alone	alone	JJ
cord-005453-4057qib7	12121	27	.	.	.
cord-005453-4057qib7	12122	1	With	with	IN
cord-005453-4057qib7	12122	2	a	a	DT
cord-005453-4057qib7	12122	3	median	median	JJ
cord-005453-4057qib7	12122	4	follow	follow	NN
cord-005453-4057qib7	12122	5	-	-	HYPH
cord-005453-4057qib7	12122	6	up	up	NN
cord-005453-4057qib7	12122	7	of	of	IN
cord-005453-4057qib7	12122	8	7	7	CD
cord-005453-4057qib7	12122	9	months	month	NNS
cord-005453-4057qib7	12122	10	(	(	-LRB-
cord-005453-4057qib7	12122	11	range	range	VBP
cord-005453-4057qib7	12122	12	4	4	CD
cord-005453-4057qib7	12122	13	-	-	SYM
cord-005453-4057qib7	12122	14	29	29	CD
cord-005453-4057qib7	12122	15	)	)	-RRB-
cord-005453-4057qib7	12122	16	,	,	,
cord-005453-4057qib7	12122	17	the	the	DT
cord-005453-4057qib7	12122	18	median	median	JJ
cord-005453-4057qib7	12122	19	OS	OS	NNP
cord-005453-4057qib7	12122	20	from	from	IN
cord-005453-4057qib7	12122	21	HMA	HMA	NNP
cord-005453-4057qib7	12122	22	treatment	treatment	NN
cord-005453-4057qib7	12122	23	in	in	IN
cord-005453-4057qib7	12122	24	responding	respond	VBG
cord-005453-4057qib7	12122	25	patients	patient	NNS
cord-005453-4057qib7	12122	26	was	be	VBD
cord-005453-4057qib7	12122	27	16	16	CD
cord-005453-4057qib7	12122	28	months	month	NNS
cord-005453-4057qib7	12123	1	(	(	-LRB-
cord-005453-4057qib7	12123	2	range	range	NNP
cord-005453-4057qib7	12123	3	4	4	CD
cord-005453-4057qib7	12123	4	-	-	SYM
cord-005453-4057qib7	12123	5	29	29	CD
cord-005453-4057qib7	12123	6	)	)	-RRB-
cord-005453-4057qib7	12123	7	;	;	:
cord-005453-4057qib7	12123	8	at	at	IN
cord-005453-4057qib7	12123	9	the	the	DT
cord-005453-4057qib7	12123	10	time	time	NN
cord-005453-4057qib7	12123	11	of	of	IN
cord-005453-4057qib7	12123	12	data	datum	NNS
cord-005453-4057qib7	12123	13	collection	collection	NN
cord-005453-4057qib7	12123	14	responses	response	NNS
cord-005453-4057qib7	12123	15	were	be	VBD
cord-005453-4057qib7	12123	16	maintained	maintain	VBN
cord-005453-4057qib7	12123	17	in	in	IN
cord-005453-4057qib7	12123	18	all	all	DT
cord-005453-4057qib7	12123	19	four	four	CD
cord-005453-4057qib7	12123	20	patients	patient	NNS
cord-005453-4057qib7	12123	21	.	.	.
cord-005453-4057qib7	12124	1	Seven	seven	CD
cord-005453-4057qib7	12124	2	patients	patient	NNS
cord-005453-4057qib7	12124	3	had	have	VBD
cord-005453-4057qib7	12124	4	died	die	VBN
cord-005453-4057qib7	12124	5	,	,	,
cord-005453-4057qib7	12124	6	six	six	CD
cord-005453-4057qib7	12124	7	from	from	IN
cord-005453-4057qib7	12124	8	AML	AML	NNP
cord-005453-4057qib7	12124	9	progression	progression	NN
cord-005453-4057qib7	12124	10	and	and	CC
cord-005453-4057qib7	12124	11	one	one	CD
cord-005453-4057qib7	12124	12	for	for	IN
cord-005453-4057qib7	12124	13	severe	severe	JJ
cord-005453-4057qib7	12124	14	intestinal	intestinal	JJ
cord-005453-4057qib7	12124	15	GvHD	gvhd	NN
cord-005453-4057qib7	12124	16	occurring	occur	VBG
cord-005453-4057qib7	12124	17	after	after	IN
cord-005453-4057qib7	12124	18	failure	failure	NN
cord-005453-4057qib7	12124	19	of	of	IN
cord-005453-4057qib7	12124	20	DLI+AZA	dli+aza	NN
cord-005453-4057qib7	12124	21	and	and	CC
cord-005453-4057qib7	12124	22	a	a	DT
cord-005453-4057qib7	12124	23	following	follow	VBG
cord-005453-4057qib7	12124	24	salvage	salvage	NN
cord-005453-4057qib7	12124	25	induction	induction	NN
cord-005453-4057qib7	12124	26	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12124	27	treatment	treatment	NN
cord-005453-4057qib7	12124	28	.	.	.
cord-005453-4057qib7	12125	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12125	2	:	:	:
cord-005453-4057qib7	12126	1	Although	although	IN
cord-005453-4057qib7	12126	2	arising	arise	VBG
cord-005453-4057qib7	12126	3	from	from	IN
cord-005453-4057qib7	12126	4	a	a	DT
cord-005453-4057qib7	12126	5	limited	limited	JJ
cord-005453-4057qib7	12126	6	number	number	NN
cord-005453-4057qib7	12126	7	of	of	IN
cord-005453-4057qib7	12126	8	patients	patient	NNS
cord-005453-4057qib7	12126	9	,	,	,
cord-005453-4057qib7	12126	10	our	-PRON-	PRP$
cord-005453-4057qib7	12126	11	real	real	JJ
cord-005453-4057qib7	12126	12	-	-	HYPH
cord-005453-4057qib7	12126	13	life	life	NN
cord-005453-4057qib7	12126	14	experience	experience	NN
cord-005453-4057qib7	12126	15	of	of	IN
cord-005453-4057qib7	12126	16	treatment	treatment	NN
cord-005453-4057qib7	12126	17	with	with	IN
cord-005453-4057qib7	12126	18	HMAs	hma	NNS
cord-005453-4057qib7	12126	19	+	+	CC
cord-005453-4057qib7	12126	20	/-DLI	/-DLI	.
cord-005453-4057qib7	12127	1	in	in	IN
cord-005453-4057qib7	12127	2	AML	AML	NNP
cord-005453-4057qib7	12127	3	patients	patient	NNS
cord-005453-4057qib7	12127	4	relapsing	relapse	VBG
cord-005453-4057qib7	12127	5	after	after	IN
cord-005453-4057qib7	12127	6	allo	allo	NN
cord-005453-4057qib7	12127	7	-	-	HYPH
cord-005453-4057qib7	12127	8	SCT	SCT	NNP
cord-005453-4057qib7	12127	9	showed	show	VBD
cord-005453-4057qib7	12127	10	a	a	DT
cord-005453-4057qib7	12127	11	general	general	JJ
cord-005453-4057qib7	12127	12	very	very	RB
cord-005453-4057qib7	12127	13	good	good	JJ
cord-005453-4057qib7	12127	14	safety	safety	NN
cord-005453-4057qib7	12127	15	profile	profile	NN
cord-005453-4057qib7	12127	16	and	and	CC
cord-005453-4057qib7	12127	17	promising	promising	JJ
cord-005453-4057qib7	12127	18	antileukemic	antileukemic	JJ
cord-005453-4057qib7	12127	19	activity	activity	NN
cord-005453-4057qib7	12127	20	,	,	,
cord-005453-4057qib7	12127	21	altogether	altogether	RB
cord-005453-4057qib7	12127	22	suggesting	suggest	VBG
cord-005453-4057qib7	12127	23	a	a	DT
cord-005453-4057qib7	12127	24	facilitation	facilitation	NN
cord-005453-4057qib7	12127	25	of	of	IN
cord-005453-4057qib7	12127	26	the	the	DT
cord-005453-4057qib7	12127	27	graftversus	graftversus	NN
cord-005453-4057qib7	12127	28	-	-	HYPH
cord-005453-4057qib7	12127	29	leukemia	leukemia	NN
cord-005453-4057qib7	12127	30	effect	effect	NN
cord-005453-4057qib7	12127	31	(	(	-LRB-
cord-005453-4057qib7	12127	32	GvL	gvl	NN
cord-005453-4057qib7	12127	33	)	)	-RRB-
cord-005453-4057qib7	12127	34	associated	associate	VBN
cord-005453-4057qib7	12127	35	to	to	IN
cord-005453-4057qib7	12127	36	a	a	DT
cord-005453-4057qib7	12127	37	possible	possible	JJ
cord-005453-4057qib7	12127	38	suppression	suppression	NN
cord-005453-4057qib7	12127	39	of	of	IN
cord-005453-4057qib7	12127	40	the	the	DT
cord-005453-4057qib7	12127	41	GvH	gvh	JJ
cord-005453-4057qib7	12127	42	reaction	reaction	NN
cord-005453-4057qib7	12127	43	.	.	.
cord-005453-4057qib7	12128	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12128	2	:	:	:
cord-005453-4057qib7	12128	3	Nothing	nothing	NN
cord-005453-4057qib7	12128	4	to	to	TO
cord-005453-4057qib7	12128	5	declare	declare	VB
cord-005453-4057qib7	12128	6	Conclusions	conclusion	NNS
cord-005453-4057qib7	12128	7	:	:	:
cord-005453-4057qib7	12128	8	In	in	IN
cord-005453-4057qib7	12128	9	this	this	DT
cord-005453-4057qib7	12128	10	study	study	NN
cord-005453-4057qib7	12128	11	,	,	,
cord-005453-4057qib7	12128	12	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	12128	13	cell	cell	NN
cord-005453-4057qib7	12128	14	count	count	NN
cord-005453-4057qib7	12128	15	and	and	CC
cord-005453-4057qib7	12128	16	IgG	IgG	NNP
cord-005453-4057qib7	12128	17	value	value	NN
cord-005453-4057qib7	12128	18	had	have	VBD
cord-005453-4057qib7	12128	19	recovered	recover	VBN
cord-005453-4057qib7	12128	20	about	about	RB
cord-005453-4057qib7	12128	21	15	15	CD
cord-005453-4057qib7	12128	22	months	month	NNS
cord-005453-4057qib7	12128	23	after	after	IN
cord-005453-4057qib7	12128	24	SCT	SCT	NNP
cord-005453-4057qib7	12128	25	.	.	.
cord-005453-4057qib7	12129	1	In	in	IN
cord-005453-4057qib7	12129	2	our	-PRON-	PRP$
cord-005453-4057qib7	12129	3	institute	institute	NN
cord-005453-4057qib7	12129	4	,	,	,
cord-005453-4057qib7	12129	5	we	-PRON-	PRP
cord-005453-4057qib7	12129	6	have	have	VBP
cord-005453-4057qib7	12129	7	achieved	achieve	VBN
cord-005453-4057qib7	12129	8	a	a	DT
cord-005453-4057qib7	12129	9	low	low	JJ
cord-005453-4057qib7	12129	10	incidence	incidence	NN
cord-005453-4057qib7	12129	11	of	of	IN
cord-005453-4057qib7	12129	12	infection	infection	NN
cord-005453-4057qib7	12129	13	by	by	IN
cord-005453-4057qib7	12129	14	education	education	NN
cord-005453-4057qib7	12129	15	and	and	CC
cord-005453-4057qib7	12129	16	medication	medication	NN
cord-005453-4057qib7	12129	17	for	for	IN
cord-005453-4057qib7	12129	18	patients	patient	NNS
cord-005453-4057qib7	12129	19	until	until	IN
cord-005453-4057qib7	12129	20	recovery	recovery	NN
cord-005453-4057qib7	12129	21	of	of	IN
cord-005453-4057qib7	12129	22	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	12129	23	cell	cell	NN
cord-005453-4057qib7	12129	24	count	count	NN
cord-005453-4057qib7	12129	25	and	and	CC
cord-005453-4057qib7	12130	1	IgG.	IgG.	NNP
cord-005453-4057qib7	12131	1	However	however	RB
cord-005453-4057qib7	12131	2	,	,	,
cord-005453-4057qib7	12131	3	we	-PRON-	PRP
cord-005453-4057qib7	12131	4	found	find	VBD
cord-005453-4057qib7	12131	5	a	a	DT
cord-005453-4057qib7	12131	6	higher	high	JJR
cord-005453-4057qib7	12131	7	incidence	incidence	NN
cord-005453-4057qib7	12131	8	of	of	IN
cord-005453-4057qib7	12131	9	infection	infection	NN
cord-005453-4057qib7	12131	10	after	after	IN
cord-005453-4057qib7	12131	11	recovery	recovery	NN
cord-005453-4057qib7	12131	12	of	of	IN
cord-005453-4057qib7	12131	13	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	12131	14	cell	cell	NN
cord-005453-4057qib7	12131	15	count	count	NN
cord-005453-4057qib7	12131	16	and	and	CC
cord-005453-4057qib7	12132	1	IgG.	IgG.	NNP
cord-005453-4057qib7	12133	1	At	at	IN
cord-005453-4057qib7	12133	2	12	12	CD
cord-005453-4057qib7	12133	3	-	-	SYM
cord-005453-4057qib7	12133	4	15	15	CD
cord-005453-4057qib7	12133	5	months	month	NNS
cord-005453-4057qib7	12133	6	after	after	IN
cord-005453-4057qib7	12133	7	SCT	SCT	NNP
cord-005453-4057qib7	12133	8	,	,	,
cord-005453-4057qib7	12133	9	administration	administration	NN
cord-005453-4057qib7	12133	10	of	of	IN
cord-005453-4057qib7	12133	11	prophylactic	prophylactic	JJ
cord-005453-4057qib7	12133	12	medications	medication	NNS
cord-005453-4057qib7	12133	13	such	such	JJ
cord-005453-4057qib7	12133	14	as	as	IN
cord-005453-4057qib7	12133	15	sulfamethoxazole	sulfamethoxazole	NNP
cord-005453-4057qib7	12133	16	-	-	HYPH
cord-005453-4057qib7	12133	17	trimethoprim	trimethoprim	NNP
cord-005453-4057qib7	12133	18	were	be	VBD
cord-005453-4057qib7	12133	19	terminated	terminate	VBN
cord-005453-4057qib7	12133	20	and	and	CC
cord-005453-4057qib7	12133	21	social	social	JJ
cord-005453-4057qib7	12133	22	comeback	comeback	NN
cord-005453-4057qib7	12133	23	such	such	JJ
cord-005453-4057qib7	12133	24	as	as	IN
cord-005453-4057qib7	12133	25	return	return	NN
cord-005453-4057qib7	12133	26	to	to	IN
cord-005453-4057qib7	12133	27	school	school	NN
cord-005453-4057qib7	12133	28	or	or	CC
cord-005453-4057qib7	12133	29	work	work	NN
cord-005453-4057qib7	12133	30	were	be	VBD
cord-005453-4057qib7	12133	31	achieved	achieve	VBN
cord-005453-4057qib7	12133	32	in	in	IN
cord-005453-4057qib7	12133	33	most	most	JJS
cord-005453-4057qib7	12133	34	patients	patient	NNS
cord-005453-4057qib7	12133	35	.	.	.
cord-005453-4057qib7	12134	1	It	-PRON-	PRP
cord-005453-4057qib7	12134	2	is	be	VBZ
cord-005453-4057qib7	12134	3	possible	possible	JJ
cord-005453-4057qib7	12134	4	that	that	IN
cord-005453-4057qib7	12134	5	the	the	DT
cord-005453-4057qib7	12134	6	high	high	JJ
cord-005453-4057qib7	12134	7	incidence	incidence	NN
cord-005453-4057qib7	12134	8	of	of	IN
cord-005453-4057qib7	12134	9	community	community	NN
cord-005453-4057qib7	12134	10	-	-	HYPH
cord-005453-4057qib7	12134	11	acquired	acquire	VBN
cord-005453-4057qib7	12134	12	infection	infection	NN
cord-005453-4057qib7	12134	13	was	be	VBD
cord-005453-4057qib7	12134	14	associated	associate	VBN
cord-005453-4057qib7	12134	15	with	with	IN
cord-005453-4057qib7	12134	16	their	-PRON-	PRP$
cord-005453-4057qib7	12134	17	comeback	comeback	NN
cord-005453-4057qib7	12134	18	.	.	.
cord-005453-4057qib7	12135	1	Thus	thus	RB
cord-005453-4057qib7	12135	2	,	,	,
cord-005453-4057qib7	12135	3	we	-PRON-	PRP
cord-005453-4057qib7	12135	4	should	should	MD
cord-005453-4057qib7	12135	5	consider	consider	VB
cord-005453-4057qib7	12135	6	additional	additional	JJ
cord-005453-4057qib7	12135	7	prevention	prevention	NN
cord-005453-4057qib7	12135	8	of	of	IN
cord-005453-4057qib7	12135	9	infection	infection	NN
cord-005453-4057qib7	12135	10	for	for	IN
cord-005453-4057qib7	12135	11	patients	patient	NNS
cord-005453-4057qib7	12135	12	in	in	IN
cord-005453-4057qib7	12135	13	this	this	DT
cord-005453-4057qib7	12135	14	period	period	NN
cord-005453-4057qib7	12135	15	and	and	CC
cord-005453-4057qib7	12135	16	further	further	JJ
cord-005453-4057qib7	12135	17	evaluation	evaluation	NN
cord-005453-4057qib7	12135	18	of	of	IN
cord-005453-4057qib7	12135	19	immunological	immunological	JJ
cord-005453-4057qib7	12135	20	markers	marker	NNS
cord-005453-4057qib7	12135	21	is	be	VBZ
cord-005453-4057qib7	12135	22	needed	need	VBN
cord-005453-4057qib7	12135	23	.	.	.
cord-005453-4057qib7	12136	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12136	2	:	:	:
cord-005453-4057qib7	12136	3	No	no	DT
cord-005453-4057qib7	12136	4	potential	potential	JJ
cord-005453-4057qib7	12136	5	conflicts	conflict	NNS
cord-005453-4057qib7	12136	6	of	of	IN
cord-005453-4057qib7	12136	7	interest	interest	NN
cord-005453-4057qib7	12136	8	were	be	VBD
cord-005453-4057qib7	12136	9	disclosed	disclose	VBN
cord-005453-4057qib7	12136	10	.	.	.
cord-005453-4057qib7	12137	1	Effect	effect	NN
cord-005453-4057qib7	12137	2	of	of	IN
cord-005453-4057qib7	12137	3	minimal	minimal	JJ
cord-005453-4057qib7	12137	4	residual	residual	JJ
cord-005453-4057qib7	12137	5	disease	disease	NN
cord-005453-4057qib7	12137	6	before	before	IN
cord-005453-4057qib7	12137	7	transplantation	transplantation	NN
cord-005453-4057qib7	12137	8	on	on	IN
cord-005453-4057qib7	12137	9	the	the	DT
cord-005453-4057qib7	12137	10	outcome	outcome	NN
cord-005453-4057qib7	12137	11	of	of	IN
cord-005453-4057qib7	12137	12	haplo	haplo	NN
cord-005453-4057qib7	12137	13	-	-	HYPH
cord-005453-4057qib7	12137	14	identical	identical	JJ
cord-005453-4057qib7	12137	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12137	16	stem	stem	NN
cord-005453-4057qib7	12137	17	cell	cell	NN
cord-005453-4057qib7	12137	18	transplantation	transplantation	NN
cord-005453-4057qib7	12137	19	for	for	IN
cord-005453-4057qib7	12137	20	high	high	JJ
cord-005453-4057qib7	12137	21	-	-	HYPH
cord-005453-4057qib7	12137	22	risk	risk	NN
cord-005453-4057qib7	12137	23	acute	acute	JJ
cord-005453-4057qib7	12137	24	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	12137	25	leukemia	leukemia	NN
cord-005453-4057qib7	12137	26	Yehui	Yehui	NNP
cord-005453-4057qib7	12137	27	Tan	Tan	NNP
cord-005453-4057qib7	12137	28	1	1	CD
cord-005453-4057qib7	12137	29	,	,	,
cord-005453-4057qib7	12137	30	Sujun	Sujun	NNP
cord-005453-4057qib7	12137	31	Gao	Gao	NNP
cord-005453-4057qib7	12137	32	1	1	CD
cord-005453-4057qib7	12137	33	,	,	,
cord-005453-4057qib7	12137	34	Xiaoliang	Xiaoliang	NNP
cord-005453-4057qib7	12137	35	Liu	Liu	NNP
cord-005453-4057qib7	12137	36	1	1	CD
cord-005453-4057qib7	12137	37	,	,	,
cord-005453-4057qib7	12137	38	Long	Long	NNP
cord-005453-4057qib7	12137	39	Su	Su	NNP
cord-005453-4057qib7	12137	40	1	1	CD
cord-005453-4057qib7	12137	41	,	,	,
cord-005453-4057qib7	12137	42	Wei	Wei	NNP
cord-005453-4057qib7	12137	43	Han	Han	NNP
cord-005453-4057qib7	12137	44	1	1	CD
cord-005453-4057qib7	12137	45	,	,	,
cord-005453-4057qib7	12137	46	Yu	Yu	NNP
cord-005453-4057qib7	12137	47	Liu	Liu	NNP
cord-005453-4057qib7	12137	48	1	1	CD
cord-005453-4057qib7	12137	49	,	,	,
cord-005453-4057qib7	12137	50	Yangzhi	Yangzhi	NNP
cord-005453-4057qib7	12137	51	Zhao	Zhao	NNP
cord-005453-4057qib7	12137	52	1	1	CD
cord-005453-4057qib7	12137	53	Background	background	NN
cord-005453-4057qib7	12137	54	:	:	:
cord-005453-4057qib7	12138	1	To	to	TO
cord-005453-4057qib7	12138	2	analyze	analyze	VB
cord-005453-4057qib7	12138	3	the	the	DT
cord-005453-4057qib7	12138	4	effect	effect	NN
cord-005453-4057qib7	12138	5	of	of	IN
cord-005453-4057qib7	12138	6	haploid	haploid	JJ
cord-005453-4057qib7	12138	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12138	8	stem	stem	NN
cord-005453-4057qib7	12138	9	cell	cell	NN
cord-005453-4057qib7	12138	10	transplantation	transplantation	NN
cord-005453-4057qib7	12138	11	(	(	-LRB-
cord-005453-4057qib7	12138	12	HID	HID	NNP
cord-005453-4057qib7	12138	13	-	-	HYPH
cord-005453-4057qib7	12138	14	HSCT	HSCT	NNP
cord-005453-4057qib7	12138	15	)	)	-RRB-
cord-005453-4057qib7	12138	16	on	on	IN
cord-005453-4057qib7	12138	17	high	high	JJ
cord-005453-4057qib7	12138	18	-	-	HYPH
cord-005453-4057qib7	12138	19	risk	risk	NN
cord-005453-4057qib7	12138	20	acute	acute	JJ
cord-005453-4057qib7	12138	21	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	12138	22	leukemia	leukemia	NN
cord-005453-4057qib7	12138	23	(	(	-LRB-
cord-005453-4057qib7	12138	24	ALL	all	DT
cord-005453-4057qib7	12138	25	)	)	-RRB-
cord-005453-4057qib7	12138	26	,	,	,
cord-005453-4057qib7	12138	27	and	and	CC
cord-005453-4057qib7	12138	28	to	to	TO
cord-005453-4057qib7	12138	29	explore	explore	VB
cord-005453-4057qib7	12138	30	the	the	DT
cord-005453-4057qib7	12138	31	effect	effect	NN
cord-005453-4057qib7	12138	32	of	of	IN
cord-005453-4057qib7	12138	33	minimal	minimal	JJ
cord-005453-4057qib7	12138	34	residual	residual	JJ
cord-005453-4057qib7	12138	35	disease	disease	NN
cord-005453-4057qib7	12138	36	(	(	-LRB-
cord-005453-4057qib7	12138	37	MRD	MRD	NNP
cord-005453-4057qib7	12138	38	)	)	-RRB-
cord-005453-4057qib7	12138	39	before	before	IN
cord-005453-4057qib7	12138	40	transplant	transplant	NN
cord-005453-4057qib7	12138	41	on	on	IN
cord-005453-4057qib7	12138	42	the	the	DT
cord-005453-4057qib7	12138	43	prognosis	prognosis	NN
cord-005453-4057qib7	12138	44	.	.	.
cord-005453-4057qib7	12139	1	Methods	method	NNS
cord-005453-4057qib7	12139	2	:	:	:
cord-005453-4057qib7	12139	3	A	a	DT
cord-005453-4057qib7	12139	4	retrospective	retrospective	JJ
cord-005453-4057qib7	12139	5	analysis	analysis	NN
cord-005453-4057qib7	12139	6	was	be	VBD
cord-005453-4057qib7	12139	7	made	make	VBN
cord-005453-4057qib7	12139	8	on	on	IN
cord-005453-4057qib7	12139	9	39	39	CD
cord-005453-4057qib7	12139	10	high	high	JJ
cord-005453-4057qib7	12139	11	risk	risk	NN
cord-005453-4057qib7	12139	12	ALL	all	DT
cord-005453-4057qib7	12139	13	patients	patient	NNS
cord-005453-4057qib7	12139	14	accepted	accept	VBD
cord-005453-4057qib7	12139	15	HID	HID	NNP
cord-005453-4057qib7	12139	16	-	-	HYPH
cord-005453-4057qib7	12139	17	HSCT	HSCT	NNP
cord-005453-4057qib7	12139	18	in	in	IN
cord-005453-4057qib7	12139	19	our	-PRON-	PRP$
cord-005453-4057qib7	12139	20	hospital	hospital	NN
cord-005453-4057qib7	12139	21	from	from	IN
cord-005453-4057qib7	12139	22	January	January	NNP
cord-005453-4057qib7	12139	23	2013	2013	CD
cord-005453-4057qib7	12139	24	to	to	IN
cord-005453-4057qib7	12139	25	January	January	NNP
cord-005453-4057qib7	12139	26	2018	2018	CD
cord-005453-4057qib7	12139	27	.	.	.
cord-005453-4057qib7	12140	1	The	the	DT
cord-005453-4057qib7	12140	2	clinical	clinical	JJ
cord-005453-4057qib7	12140	3	features	feature	NNS
cord-005453-4057qib7	12140	4	,	,	,
cord-005453-4057qib7	12140	5	stem	stem	NN
cord-005453-4057qib7	12140	6	cell	cell	NN
cord-005453-4057qib7	12140	7	implantation	implantation	NN
cord-005453-4057qib7	12140	8	,	,	,
cord-005453-4057qib7	12140	9	complications	complication	NNS
cord-005453-4057qib7	12140	10	,	,	,
cord-005453-4057qib7	12140	11	survival	survival	NN
cord-005453-4057qib7	12140	12	and	and	CC
cord-005453-4057qib7	12140	13	recurrence	recurrence	NN
cord-005453-4057qib7	12140	14	were	be	VBD
cord-005453-4057qib7	12140	15	compared	compare	VBN
cord-005453-4057qib7	12140	16	between	between	IN
cord-005453-4057qib7	12140	17	pre	pre	JJ
cord-005453-4057qib7	12140	18	-	-	JJ
cord-005453-4057qib7	12140	19	transplant	transplant	NN
cord-005453-4057qib7	12140	20	MRD	MRD	NNP
cord-005453-4057qib7	12140	21	+	+	SYM
cord-005453-4057qib7	12140	22	and	and	CC
cord-005453-4057qib7	12140	23	MRDpatients	mrdpatient	NNS
cord-005453-4057qib7	12140	24	.	.	.
cord-005453-4057qib7	12141	1	Results	result	NNS
cord-005453-4057qib7	12141	2	:	:	:
cord-005453-4057qib7	12142	1	All	all	PDT
cord-005453-4057qib7	12142	2	the	the	DT
cord-005453-4057qib7	12142	3	39	39	CD
cord-005453-4057qib7	12142	4	patients	patient	NNS
cord-005453-4057qib7	12142	5	got	get	VBD
cord-005453-4057qib7	12142	6	successfully	successfully	RB
cord-005453-4057qib7	12142	7	implanted	implant	VBN
cord-005453-4057qib7	12142	8	.	.	.
cord-005453-4057qib7	12143	1	The	the	DT
cord-005453-4057qib7	12143	2	overall	overall	JJ
cord-005453-4057qib7	12143	3	survival	survival	NN
cord-005453-4057qib7	12143	4	(	(	-LRB-
cord-005453-4057qib7	12143	5	OS	OS	NNP
cord-005453-4057qib7	12143	6	)	)	-RRB-
cord-005453-4057qib7	12143	7	was	be	VBD
cord-005453-4057qib7	12143	8	54.67	54.67	CD
cord-005453-4057qib7	12143	9	%	%	NN
cord-005453-4057qib7	12143	10	,	,	,
cord-005453-4057qib7	12143	11	the	the	DT
cord-005453-4057qib7	12143	12	disease	disease	NN
cord-005453-4057qib7	12143	13	free	free	JJ
cord-005453-4057qib7	12143	14	survival	survival	NN
cord-005453-4057qib7	12143	15	(	(	-LRB-
cord-005453-4057qib7	12143	16	DFS	DFS	NNP
cord-005453-4057qib7	12143	17	)	)	-RRB-
cord-005453-4057qib7	12143	18	was	be	VBD
cord-005453-4057qib7	12143	19	40.96	40.96	CD
cord-005453-4057qib7	12143	20	%	%	NN
cord-005453-4057qib7	12143	21	,	,	,
cord-005453-4057qib7	12143	22	the	the	DT
cord-005453-4057qib7	12143	23	incidence	incidence	NN
cord-005453-4057qib7	12143	24	of	of	IN
cord-005453-4057qib7	12143	25	acute	acute	JJ
cord-005453-4057qib7	12143	26	graft	graft	NN
cord-005453-4057qib7	12143	27	versus	versus	IN
cord-005453-4057qib7	12143	28	host	host	NN
cord-005453-4057qib7	12143	29	disease	disease	NN
cord-005453-4057qib7	12143	30	(	(	-LRB-
cord-005453-4057qib7	12143	31	aGVHD	aGVHD	NNP
cord-005453-4057qib7	12143	32	)	)	-RRB-
cord-005453-4057qib7	12143	33	was	be	VBD
cord-005453-4057qib7	12143	34	53.8	53.8	CD
cord-005453-4057qib7	12143	35	%	%	NN
cord-005453-4057qib7	12143	36	,	,	,
cord-005453-4057qib7	12143	37	including	include	VBG
cord-005453-4057qib7	12143	38	23.1	23.1	CD
cord-005453-4057qib7	12143	39	%	%	NN
cord-005453-4057qib7	12143	40	II	II	NNP
cord-005453-4057qib7	12143	41	~	~	NFP
cord-005453-4057qib7	12143	42	IV	IV	NNP
cord-005453-4057qib7	12143	43	degree	degree	NN
cord-005453-4057qib7	12143	44	aGVHD	agvhd	NN
cord-005453-4057qib7	12143	45	and	and	CC
cord-005453-4057qib7	12143	46	2.6	2.6	CD
cord-005453-4057qib7	12143	47	%	%	NN
cord-005453-4057qib7	12143	48	III	iii	CD
cord-005453-4057qib7	12144	1	~IV	~IV	NFP
cord-005453-4057qib7	12144	2	degree	degree	NN
cord-005453-4057qib7	12144	3	aGVHD	aGVHD	NNP
cord-005453-4057qib7	12144	4	.	.	.
cord-005453-4057qib7	12145	1	There	there	EX
cord-005453-4057qib7	12145	2	was	be	VBD
cord-005453-4057qib7	12145	3	no	no	DT
cord-005453-4057qib7	12145	4	significant	significant	JJ
cord-005453-4057qib7	12145	5	difference	difference	NN
cord-005453-4057qib7	12145	6	in	in	IN
cord-005453-4057qib7	12145	7	stem	stem	NN
cord-005453-4057qib7	12145	8	cell	cell	NN
cord-005453-4057qib7	12145	9	implantation	implantation	NN
cord-005453-4057qib7	12145	10	,	,	,
cord-005453-4057qib7	12145	11	GVHD	GVHD	NNP
cord-005453-4057qib7	12145	12	,	,	,
cord-005453-4057qib7	12145	13	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	12145	14	and	and	CC
cord-005453-4057qib7	12145	15	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	12145	16	cystitis	cystitis	NN
cord-005453-4057qib7	12145	17	between	between	IN
cord-005453-4057qib7	12145	18	MRD	MRD	NNP
cord-005453-4057qib7	12145	19	+	+	SYM
cord-005453-4057qib7	12145	20	and	and	CC
cord-005453-4057qib7	12145	21	MRDpatients	mrdpatient	NNS
cord-005453-4057qib7	12145	22	.	.	.
cord-005453-4057qib7	12146	1	DFS	DFS	NNP
cord-005453-4057qib7	12146	2	and	and	CC
cord-005453-4057qib7	12146	3	OS	OS	NNP
cord-005453-4057qib7	12146	4	in	in	IN
cord-005453-4057qib7	12146	5	MRD	MRD	NNP
cord-005453-4057qib7	12146	6	+	+	CC
cord-005453-4057qib7	12146	7	patients	patient	NNS
cord-005453-4057qib7	12146	8	were	be	VBD
cord-005453-4057qib7	12146	9	significantly	significantly	RB
cord-005453-4057qib7	12146	10	lower	low	JJR
cord-005453-4057qib7	12146	11	than	than	IN
cord-005453-4057qib7	12146	12	those	those	DT
cord-005453-4057qib7	12146	13	in	in	IN
cord-005453-4057qib7	12146	14	MRD	MRD	NNP
cord-005453-4057qib7	12146	15	-patients	-patients	NNP
cord-005453-4057qib7	12146	16	,	,	,
cord-005453-4057qib7	12146	17	and	and	CC
cord-005453-4057qib7	12146	18	the	the	DT
cord-005453-4057qib7	12146	19	cumulative	cumulative	JJ
cord-005453-4057qib7	12146	20	RR	rr	NN
cord-005453-4057qib7	12146	21	rate	rate	NN
cord-005453-4057qib7	12146	22	increased	increase	VBD
cord-005453-4057qib7	12146	23	significantly	significantly	RB
cord-005453-4057qib7	12146	24	,	,	,
cord-005453-4057qib7	12146	25	there	there	EX
cord-005453-4057qib7	12146	26	was	be	VBD
cord-005453-4057qib7	12146	27	no	no	DT
cord-005453-4057qib7	12146	28	significant	significant	JJ
cord-005453-4057qib7	12146	29	difference	difference	NN
cord-005453-4057qib7	12146	30	in	in	IN
cord-005453-4057qib7	12146	31	cumulative	cumulative	JJ
cord-005453-4057qib7	12146	32	TRM	TRM	NNP
cord-005453-4057qib7	12146	33	.	.	.
cord-005453-4057qib7	12147	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12147	2	:	:	:
cord-005453-4057qib7	12147	3	HID	HID	NNP
cord-005453-4057qib7	12147	4	-	-	HYPH
cord-005453-4057qib7	12147	5	HSCT	HSCT	NNP
cord-005453-4057qib7	12147	6	was	be	VBD
cord-005453-4057qib7	12147	7	an	an	DT
cord-005453-4057qib7	12147	8	effective	effective	JJ
cord-005453-4057qib7	12147	9	method	method	NN
cord-005453-4057qib7	12147	10	to	to	TO
cord-005453-4057qib7	12147	11	treat	treat	VB
cord-005453-4057qib7	12147	12	high	high	JJ
cord-005453-4057qib7	12147	13	risk	risk	NN
cord-005453-4057qib7	12147	14	ALL	all	DT
cord-005453-4057qib7	12147	15	,	,	,
cord-005453-4057qib7	12147	16	but	but	CC
cord-005453-4057qib7	12147	17	MRD	MRD	NNP
cord-005453-4057qib7	12147	18	+	+	SYM
cord-005453-4057qib7	12147	19	patients	patient	NNS
cord-005453-4057qib7	12147	20	had	have	VBD
cord-005453-4057qib7	12147	21	high	high	JJ
cord-005453-4057qib7	12147	22	recurrence	recurrence	NN
cord-005453-4057qib7	12147	23	rate	rate	NN
cord-005453-4057qib7	12147	24	and	and	CC
cord-005453-4057qib7	12147	25	poor	poor	JJ
cord-005453-4057qib7	12147	26	prognosis	prognosis	NN
cord-005453-4057qib7	12147	27	.	.	.
cord-005453-4057qib7	12148	1	Strategy	Strategy	NNP
cord-005453-4057qib7	12148	2	Adjustment	Adjustment	NNP
cord-005453-4057qib7	12148	3	should	should	MD
cord-005453-4057qib7	12148	4	be	be	VB
cord-005453-4057qib7	12148	5	considered	consider	VBN
cord-005453-4057qib7	12148	6	to	to	TO
cord-005453-4057qib7	12148	7	reduce	reduce	VB
cord-005453-4057qib7	12148	8	tumor	tumor	NN
cord-005453-4057qib7	12148	9	residual	residual	JJ
cord-005453-4057qib7	12148	10	and	and	CC
cord-005453-4057qib7	12148	11	the	the	DT
cord-005453-4057qib7	12148	12	transplantation	transplantation	NN
cord-005453-4057qib7	12148	13	strategy	strategy	NN
cord-005453-4057qib7	12148	14	should	should	MD
cord-005453-4057qib7	12148	15	be	be	VB
cord-005453-4057qib7	12148	16	optimized	optimize	VBN
cord-005453-4057qib7	12148	17	for	for	IN
cord-005453-4057qib7	12148	18	these	these	DT
cord-005453-4057qib7	12148	19	kind	kind	NN
cord-005453-4057qib7	12148	20	of	of	IN
cord-005453-4057qib7	12148	21	high	high	JJ
cord-005453-4057qib7	12148	22	risk	risk	NN
cord-005453-4057qib7	12148	23	patients	patient	NNS
cord-005453-4057qib7	12148	24	,	,	,
cord-005453-4057qib7	12148	25	so	so	IN
cord-005453-4057qib7	12148	26	as	as	IN
cord-005453-4057qib7	12148	27	to	to	TO
cord-005453-4057qib7	12148	28	improve	improve	VB
cord-005453-4057qib7	12148	29	survival	survival	NN
cord-005453-4057qib7	12148	30	rate	rate	NN
cord-005453-4057qib7	12148	31	.	.	.
cord-005453-4057qib7	12149	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12149	2	:	:	:
cord-005453-4057qib7	12149	3	Nothing	nothing	NN
cord-005453-4057qib7	12149	4	to	to	TO
cord-005453-4057qib7	12149	5	declare	declare	VB
cord-005453-4057qib7	12149	6	Background	background	NN
cord-005453-4057qib7	12149	7	:	:	:
cord-005453-4057qib7	12150	1	Lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12150	2	are	be	VBP
cord-005453-4057qib7	12150	3	responsible	responsible	JJ
cord-005453-4057qib7	12150	4	for	for	IN
cord-005453-4057qib7	12150	5	the	the	DT
cord-005453-4057qib7	12150	6	cellular	cellular	JJ
cord-005453-4057qib7	12150	7	and	and	CC
cord-005453-4057qib7	12150	8	humoral	humoral	JJ
cord-005453-4057qib7	12150	9	immunity	immunity	NN
cord-005453-4057qib7	12150	10	and	and	CC
cord-005453-4057qib7	12150	11	,	,	,
cord-005453-4057qib7	12150	12	consequently	consequently	RB
cord-005453-4057qib7	12150	13	,	,	,
cord-005453-4057qib7	12150	14	its	-PRON-	PRP$
cord-005453-4057qib7	12150	15	recovery	recovery	NN
cord-005453-4057qib7	12150	16	after	after	IN
cord-005453-4057qib7	12150	17	allo	allo	NN
cord-005453-4057qib7	12150	18	-	-	HYPH
cord-005453-4057qib7	12150	19	HSCT	HSCT	NNP
cord-005453-4057qib7	12150	20	might	may	MD
cord-005453-4057qib7	12150	21	be	be	VB
cord-005453-4057qib7	12150	22	linked	link	VBN
cord-005453-4057qib7	12150	23	with	with	IN
cord-005453-4057qib7	12150	24	the	the	DT
cord-005453-4057qib7	12150	25	survival	survival	NN
cord-005453-4057qib7	12150	26	after	after	IN
cord-005453-4057qib7	12150	27	the	the	DT
cord-005453-4057qib7	12150	28	procedure	procedure	NN
cord-005453-4057qib7	12150	29	.	.	.
cord-005453-4057qib7	12151	1	The	the	DT
cord-005453-4057qib7	12151	2	aim	aim	NN
cord-005453-4057qib7	12151	3	of	of	IN
cord-005453-4057qib7	12151	4	this	this	DT
cord-005453-4057qib7	12151	5	study	study	NN
cord-005453-4057qib7	12151	6	was	be	VBD
cord-005453-4057qib7	12151	7	to	to	TO
cord-005453-4057qib7	12151	8	analyze	analyze	VB
cord-005453-4057qib7	12151	9	this	this	DT
cord-005453-4057qib7	12151	10	hypothesis	hypothesis	NN
cord-005453-4057qib7	12151	11	in	in	IN
cord-005453-4057qib7	12151	12	our	-PRON-	PRP$
cord-005453-4057qib7	12151	13	series	series	NN
cord-005453-4057qib7	12151	14	of	of	IN
cord-005453-4057qib7	12151	15	patients	patient	NNS
cord-005453-4057qib7	12151	16	.	.	.
cord-005453-4057qib7	12152	1	Methods	method	NNS
cord-005453-4057qib7	12152	2	:	:	:
cord-005453-4057qib7	12152	3	All	all	PDT
cord-005453-4057qib7	12152	4	the	the	DT
cord-005453-4057qib7	12152	5	209	209	CD
cord-005453-4057qib7	12152	6	allo	allo	NN
cord-005453-4057qib7	12152	7	-	-	HYPH
cord-005453-4057qib7	12152	8	HSCT	HSCT	NNP
cord-005453-4057qib7	12152	9	performed	perform	VBD
cord-005453-4057qib7	12152	10	in	in	IN
cord-005453-4057qib7	12152	11	our	-PRON-	PRP$
cord-005453-4057qib7	12152	12	center	center	NN
cord-005453-4057qib7	12152	13	from	from	IN
cord-005453-4057qib7	12152	14	January	January	NNP
cord-005453-4057qib7	12152	15	2015	2015	CD
cord-005453-4057qib7	12152	16	through	through	IN
cord-005453-4057qib7	12152	17	July	July	NNP
cord-005453-4057qib7	12152	18	2018	2018	CD
cord-005453-4057qib7	12152	19	were	be	VBD
cord-005453-4057qib7	12152	20	included	include	VBN
cord-005453-4057qib7	12152	21	in	in	IN
cord-005453-4057qib7	12152	22	the	the	DT
cord-005453-4057qib7	12152	23	analysis	analysis	NN
cord-005453-4057qib7	12152	24	.	.	.
cord-005453-4057qib7	12153	1	Median	median	JJ
cord-005453-4057qib7	12153	2	age	age	NN
cord-005453-4057qib7	12153	3	was	be	VBD
cord-005453-4057qib7	12153	4	52	52	CD
cord-005453-4057qib7	12153	5	years	year	NNS
cord-005453-4057qib7	12154	1	(	(	-LRB-
cord-005453-4057qib7	12154	2	range	range	NN
cord-005453-4057qib7	12154	3	:	:	:
cord-005453-4057qib7	12154	4	7	7	CD
cord-005453-4057qib7	12154	5	-	-	SYM
cord-005453-4057qib7	12154	6	69	69	CD
cord-005453-4057qib7	12154	7	)	)	-RRB-
cord-005453-4057qib7	12154	8	.	.	.
cord-005453-4057qib7	12155	1	122	122	CD
cord-005453-4057qib7	12155	2	pts	pt	NNS
cord-005453-4057qib7	12155	3	were	be	VBD
cord-005453-4057qib7	12155	4	male	male	JJ
cord-005453-4057qib7	12155	5	(	(	-LRB-
cord-005453-4057qib7	12155	6	58,4	58,4	CD
cord-005453-4057qib7	12155	7	%	%	NN
cord-005453-4057qib7	12155	8	)	)	-RRB-
cord-005453-4057qib7	12155	9	and	and	CC
cord-005453-4057qib7	12155	10	87	87	CD
cord-005453-4057qib7	12155	11	were	be	VBD
cord-005453-4057qib7	12155	12	female	female	JJ
cord-005453-4057qib7	12155	13	(	(	-LRB-
cord-005453-4057qib7	12155	14	41,6	41,6	CD
cord-005453-4057qib7	12155	15	%	%	NN
cord-005453-4057qib7	12155	16	)	)	-RRB-
cord-005453-4057qib7	12155	17	.	.	.
cord-005453-4057qib7	12156	1	Baseline	baseline	JJ
cord-005453-4057qib7	12156	2	diseases	disease	NNS
cord-005453-4057qib7	12156	3	were	be	VBD
cord-005453-4057qib7	12156	4	:	:	:
cord-005453-4057qib7	12156	5	69	69	CD
cord-005453-4057qib7	12156	6	AML	AML	NNP
cord-005453-4057qib7	12156	7	,	,	,
cord-005453-4057qib7	12156	8	49	49	CD
cord-005453-4057qib7	12156	9	LPD	LPD	NNP
cord-005453-4057qib7	12156	10	,	,	,
cord-005453-4057qib7	12156	11	31	31	CD
cord-005453-4057qib7	12156	12	MDS	MDS	NNP
cord-005453-4057qib7	12156	13	,	,	,
cord-005453-4057qib7	12156	14	28	28	CD
cord-005453-4057qib7	12156	15	ALL	all	DT
cord-005453-4057qib7	12156	16	,	,	,
cord-005453-4057qib7	12156	17	16	16	CD
cord-005453-4057qib7	12156	18	MPD	MPD	NNP
cord-005453-4057qib7	12156	19	,	,	,
cord-005453-4057qib7	12156	20	10	10	CD
cord-005453-4057qib7	12156	21	MM	mm	NN
cord-005453-4057qib7	12156	22	,	,	,
cord-005453-4057qib7	12156	23	and	and	CC
cord-005453-4057qib7	12156	24	6	6	CD
cord-005453-4057qib7	12156	25	BMF	bmf	NN
cord-005453-4057qib7	12156	26	.	.	.
cord-005453-4057qib7	12157	1	Donor	donor	NN
cord-005453-4057qib7	12157	2	was	be	VBD
cord-005453-4057qib7	12157	3	unrelated	unrelated	JJ
cord-005453-4057qib7	12157	4	in	in	IN
cord-005453-4057qib7	12157	5	113	113	CD
cord-005453-4057qib7	12157	6	(	(	-LRB-
cord-005453-4057qib7	12157	7	54,1	54,1	CD
cord-005453-4057qib7	12157	8	%	%	NN
cord-005453-4057qib7	12157	9	)	)	-RRB-
cord-005453-4057qib7	12157	10	,	,	,
cord-005453-4057qib7	12157	11	and	and	CC
cord-005453-4057qib7	12157	12	was	be	VBD
cord-005453-4057qib7	12157	13	family	family	NN
cord-005453-4057qib7	12157	14	in	in	IN
cord-005453-4057qib7	12157	15	96	96	CD
cord-005453-4057qib7	12157	16	cases	case	NNS
cord-005453-4057qib7	12157	17	(	(	-LRB-
cord-005453-4057qib7	12157	18	45,9	45,9	CD
cord-005453-4057qib7	12157	19	%	%	NN
cord-005453-4057qib7	12157	20	)	)	-RRB-
cord-005453-4057qib7	12157	21	(	(	-LRB-
cord-005453-4057qib7	12157	22	including	include	VBG
cord-005453-4057qib7	12157	23	31	31	CD
cord-005453-4057qib7	12157	24	haplo	haplo	NN
cord-005453-4057qib7	12157	25	-	-	HYPH
cord-005453-4057qib7	12157	26	identical	identical	JJ
cord-005453-4057qib7	12157	27	)	)	-RRB-
cord-005453-4057qib7	12157	28	.	.	.
cord-005453-4057qib7	12158	1	Stem	stem	JJ
cord-005453-4057qib7	12158	2	cell	cell	NN
cord-005453-4057qib7	12158	3	source	source	NN
cord-005453-4057qib7	12158	4	was	be	VBD
cord-005453-4057qib7	12158	5	PB	PB	NNP
cord-005453-4057qib7	12158	6	in	in	IN
cord-005453-4057qib7	12158	7	195	195	CD
cord-005453-4057qib7	12158	8	(	(	-LRB-
cord-005453-4057qib7	12158	9	93	93	CD
cord-005453-4057qib7	12158	10	,	,	,
cord-005453-4057qib7	12158	11	3	3	CD
cord-005453-4057qib7	12158	12	%	%	NN
cord-005453-4057qib7	12158	13	)	)	-RRB-
cord-005453-4057qib7	12158	14	and	and	CC
cord-005453-4057qib7	12158	15	BM	BM	NNP
cord-005453-4057qib7	12158	16	in	in	IN
cord-005453-4057qib7	12158	17	14	14	CD
cord-005453-4057qib7	12158	18	pts	pt	NNS
cord-005453-4057qib7	12158	19	(	(	-LRB-
cord-005453-4057qib7	12158	20	6,7	6,7	CD
cord-005453-4057qib7	12158	21	%	%	NN
cord-005453-4057qib7	12158	22	)	)	-RRB-
cord-005453-4057qib7	12158	23	.	.	.
cord-005453-4057qib7	12159	1	Conditioning	conditioning	NN
cord-005453-4057qib7	12159	2	regimen	regimen	NN
cord-005453-4057qib7	12159	3	was	be	VBD
cord-005453-4057qib7	12159	4	reduced	reduce	VBN
cord-005453-4057qib7	12159	5	in	in	IN
cord-005453-4057qib7	12159	6	111	111	CD
cord-005453-4057qib7	12159	7	procedures	procedure	NNS
cord-005453-4057qib7	12159	8	(	(	-LRB-
cord-005453-4057qib7	12159	9	53,1	53,1	CD
cord-005453-4057qib7	12159	10	%	%	NN
cord-005453-4057qib7	12159	11	)	)	-RRB-
cord-005453-4057qib7	12159	12	and	and	CC
cord-005453-4057qib7	12159	13	intensive	intensive	JJ
cord-005453-4057qib7	12159	14	in	in	IN
cord-005453-4057qib7	12159	15	98	98	CD
cord-005453-4057qib7	12159	16	(	(	-LRB-
cord-005453-4057qib7	12159	17	46,9	46,9	CD
cord-005453-4057qib7	12159	18	%	%	NN
cord-005453-4057qib7	12159	19	)	)	-RRB-
cord-005453-4057qib7	12159	20	(	(	-LRB-
cord-005453-4057qib7	12159	21	including	include	VBG
cord-005453-4057qib7	12159	22	just	just	RB
cord-005453-4057qib7	12159	23	one	one	CD
cord-005453-4057qib7	12159	24	non	non	JJ
cord-005453-4057qib7	12159	25	-	-	JJ
cord-005453-4057qib7	12159	26	myeloablative	myeloablative	JJ
cord-005453-4057qib7	12159	27	)	)	-RRB-
cord-005453-4057qib7	12159	28	.	.	.
cord-005453-4057qib7	12160	1	Overall	overall	JJ
cord-005453-4057qib7	12160	2	mortalities	mortality	NNS
cord-005453-4057qib7	12160	3	at	at	IN
cord-005453-4057qib7	12160	4	days	day	NNS
cord-005453-4057qib7	12160	5	+100	+100	NNS
cord-005453-4057qib7	12160	6	and	and	CC
cord-005453-4057qib7	12160	7	+365	+365	NNP
cord-005453-4057qib7	12161	1	(	(	-LRB-
cord-005453-4057qib7	12161	2	the	the	DT
cord-005453-4057qib7	12161	3	latter	latter	JJ
cord-005453-4057qib7	12161	4	in	in	IN
cord-005453-4057qib7	12161	5	patients	patient	NNS
cord-005453-4057qib7	12161	6	with	with	IN
cord-005453-4057qib7	12161	7	follow	follow	VB
cord-005453-4057qib7	12161	8	-	-	HYPH
cord-005453-4057qib7	12161	9	up	up	NN
cord-005453-4057qib7	12161	10	superior	superior	JJ
cord-005453-4057qib7	12161	11	to	to	IN
cord-005453-4057qib7	12161	12	1	1	CD
cord-005453-4057qib7	12161	13	year	year	NN
cord-005453-4057qib7	12161	14	)	)	-RRB-
cord-005453-4057qib7	12161	15	were	be	VBD
cord-005453-4057qib7	12161	16	9,1	9,1	CD
cord-005453-4057qib7	12161	17	%	%	NN
cord-005453-4057qib7	12161	18	and	and	CC
cord-005453-4057qib7	12161	19	24,9	24,9	CD
cord-005453-4057qib7	12161	20	%	%	NN
cord-005453-4057qib7	12161	21	,	,	,
cord-005453-4057qib7	12161	22	respectively	respectively	RB
cord-005453-4057qib7	12161	23	.	.	.
cord-005453-4057qib7	12162	1	Median	median	JJ
cord-005453-4057qib7	12162	2	follow	follow	NN
cord-005453-4057qib7	12162	3	-	-	HYPH
cord-005453-4057qib7	12162	4	up	up	NN
cord-005453-4057qib7	12162	5	was	be	VBD
cord-005453-4057qib7	12162	6	25	25	CD
cord-005453-4057qib7	12162	7	months	month	NNS
cord-005453-4057qib7	12163	1	(	(	-LRB-
cord-005453-4057qib7	12163	2	range	range	NN
cord-005453-4057qib7	12163	3	:	:	:
cord-005453-4057qib7	12163	4	4	4	CD
cord-005453-4057qib7	12163	5	-	-	SYM
cord-005453-4057qib7	12163	6	47	47	CD
cord-005453-4057qib7	12163	7	)	)	-RRB-
cord-005453-4057qib7	12163	8	.	.	.
cord-005453-4057qib7	12164	1	Evolution	evolution	NN
cord-005453-4057qib7	12164	2	of	of	IN
cord-005453-4057qib7	12164	3	absolute	absolute	JJ
cord-005453-4057qib7	12164	4	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	12164	5	counts	count	NNS
cord-005453-4057qib7	12164	6	(	(	-LRB-
cord-005453-4057qib7	12164	7	ALC	ALC	NNP
cord-005453-4057qib7	12164	8	)	)	-RRB-
cord-005453-4057qib7	12164	9	and	and	CC
cord-005453-4057qib7	12164	10	subpopulations	subpopulation	NNS
cord-005453-4057qib7	12164	11	at	at	IN
cord-005453-4057qib7	12164	12	pre	pre	JJ
cord-005453-4057qib7	12164	13	-	-	JJ
cord-005453-4057qib7	12164	14	HSCT	HSCT	NNP
cord-005453-4057qib7	12164	15	and	and	CC
cord-005453-4057qib7	12164	16	during	during	IN
cord-005453-4057qib7	12164	17	the	the	DT
cord-005453-4057qib7	12164	18	first	first	JJ
cord-005453-4057qib7	12164	19	year	year	NN
cord-005453-4057qib7	12164	20	after	after	IN
cord-005453-4057qib7	12164	21	allo	allo	NN
cord-005453-4057qib7	12164	22	-	-	HYPH
cord-005453-4057qib7	12164	23	HSCT	HSCT	NNP
cord-005453-4057qib7	12164	24	were	be	VBD
cord-005453-4057qib7	12164	25	analyzed	analyze	VBN
cord-005453-4057qib7	12164	26	.	.	.
cord-005453-4057qib7	12165	1	Results	result	NNS
cord-005453-4057qib7	12165	2	:	:	:
cord-005453-4057qib7	12166	1	As	as	IN
cord-005453-4057qib7	12166	2	shown	show	VBN
cord-005453-4057qib7	12166	3	in	in	IN
cord-005453-4057qib7	12166	4	table	table	NN
cord-005453-4057qib7	12166	5	1	1	CD
cord-005453-4057qib7	12166	6	,	,	,
cord-005453-4057qib7	12166	7	ALC	ALC	NNP
cord-005453-4057qib7	12166	8	and	and	CC
cord-005453-4057qib7	12166	9	CD4	CD4	NNP
cord-005453-4057qib7	12166	10	+	+	CC
cord-005453-4057qib7	12166	11	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12166	12	decreased	decrease	VBD
cord-005453-4057qib7	12166	13	after	after	IN
cord-005453-4057qib7	12166	14	conditioning	conditioning	NN
cord-005453-4057qib7	12166	15	therapy	therapy	NN
cord-005453-4057qib7	12166	16	,	,	,
cord-005453-4057qib7	12166	17	and	and	CC
cord-005453-4057qib7	12166	18	recovered	recover	VBD
cord-005453-4057qib7	12166	19	progressively	progressively	RB
cord-005453-4057qib7	12166	20	during	during	IN
cord-005453-4057qib7	12166	21	the	the	DT
cord-005453-4057qib7	12166	22	post	post	JJ
cord-005453-4057qib7	12166	23	-	-	JJ
cord-005453-4057qib7	12166	24	HSCT	hsct	JJ
cord-005453-4057qib7	12166	25	period	period	NN
cord-005453-4057qib7	12166	26	.	.	.
cord-005453-4057qib7	12167	1	At	at	IN
cord-005453-4057qib7	12167	2	day	day	NN
cord-005453-4057qib7	12167	3	+365	+365	NNP
cord-005453-4057qib7	12167	4	,	,	,
cord-005453-4057qib7	12167	5	majority	majority	NN
cord-005453-4057qib7	12167	6	of	of	IN
cord-005453-4057qib7	12167	7	patients	patient	NNS
cord-005453-4057qib7	12167	8	had	have	VBD
cord-005453-4057qib7	12167	9	>	>	$
cord-005453-4057qib7	12167	10	1000	1000	CD
cord-005453-4057qib7	12167	11	ALC	alc	NN
cord-005453-4057qib7	12167	12	/	/	SYM
cord-005453-4057qib7	12167	13	mcL	mcl	NN
cord-005453-4057qib7	12167	14	,	,	,
cord-005453-4057qib7	12167	15	clearly	clearly	RB
cord-005453-4057qib7	12167	16	improved	improve	VBN
cord-005453-4057qib7	12167	17	compared	compare	VBN
cord-005453-4057qib7	12167	18	to	to	IN
cord-005453-4057qib7	12167	19	admission	admission	NN
cord-005453-4057qib7	12167	20	values	value	NNS
cord-005453-4057qib7	12167	21	.	.	.
cord-005453-4057qib7	12168	1	CD4	CD4	NNP
cord-005453-4057qib7	12168	2	+	+	CC
cord-005453-4057qib7	12168	3	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12168	4	at	at	IN
cord-005453-4057qib7	12168	5	day	day	NN
cord-005453-4057qib7	12168	6	+100	+100	NNP
cord-005453-4057qib7	12168	7	was	be	VBD
cord-005453-4057qib7	12168	8	still	still	RB
cord-005453-4057qib7	12168	9	very	very	RB
cord-005453-4057qib7	12168	10	low	low	JJ
cord-005453-4057qib7	12168	11	,	,	,
cord-005453-4057qib7	12168	12	but	but	CC
cord-005453-4057qib7	12168	13	at	at	IN
cord-005453-4057qib7	12168	14	day	day	NN
cord-005453-4057qib7	12168	15	+365	+365	XX
cord-005453-4057qib7	12168	16	around	around	RB
cord-005453-4057qib7	12169	1	half	half	NN
cord-005453-4057qib7	12169	2	of	of	IN
cord-005453-4057qib7	12169	3	the	the	DT
cord-005453-4057qib7	12169	4	series	series	NN
cord-005453-4057qib7	12169	5	had	have	VBD
cord-005453-4057qib7	12169	6	200	200	CD
cord-005453-4057qib7	12169	7	-	-	SYM
cord-005453-4057qib7	12169	8	500	500	CD
cord-005453-4057qib7	12169	9	/	/	SYM
cord-005453-4057qib7	12169	10	mcL.	mcl.	NN
cord-005453-4057qib7	12170	1	We	-PRON-	PRP
cord-005453-4057qib7	12170	2	found	find	VBD
cord-005453-4057qib7	12170	3	a	a	DT
cord-005453-4057qib7	12170	4	strong	strong	JJ
cord-005453-4057qib7	12170	5	link	link	NN
cord-005453-4057qib7	12170	6	between	between	IN
cord-005453-4057qib7	12170	7	ALC	ALC	NNP
cord-005453-4057qib7	12170	8	,	,	,
cord-005453-4057qib7	12170	9	CD4	CD4	NNP
cord-005453-4057qib7	12170	10	+	+	CC
cord-005453-4057qib7	12170	11	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12170	12	,	,	,
cord-005453-4057qib7	12170	13	and	and	CC
cord-005453-4057qib7	12171	1	CD19	CD19	NNP
cord-005453-4057qib7	12171	2	+	+	CC
cord-005453-4057qib7	12171	3	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12171	4	at	at	IN
cord-005453-4057qib7	12171	5	days	day	NNS
cord-005453-4057qib7	12171	6	+30	+30	CD
cord-005453-4057qib7	12171	7	and	and	CC
cord-005453-4057qib7	12171	8	day	day	NN
cord-005453-4057qib7	12171	9	+100	+100	NNS
cord-005453-4057qib7	12171	10	with	with	IN
cord-005453-4057qib7	12171	11	overall	overall	JJ
cord-005453-4057qib7	12171	12	survival	survival	NN
cord-005453-4057qib7	12171	13	at	at	IN
cord-005453-4057qib7	12171	14	day	day	NN
cord-005453-4057qib7	12171	15	+365	+365	NNP
cord-005453-4057qib7	12171	16	of	of	IN
cord-005453-4057qib7	12171	17	the	the	DT
cord-005453-4057qib7	12171	18	series	series	NN
cord-005453-4057qib7	12171	19	(	(	-LRB-
cord-005453-4057qib7	12171	20	table	table	NN
cord-005453-4057qib7	12171	21	2	2	CD
cord-005453-4057qib7	12171	22	)	)	-RRB-
cord-005453-4057qib7	12171	23	.	.	.
cord-005453-4057qib7	12172	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12172	2	:	:	:
cord-005453-4057qib7	12173	1	In	in	IN
cord-005453-4057qib7	12173	2	our	-PRON-	PRP$
cord-005453-4057qib7	12173	3	series	series	NN
cord-005453-4057qib7	12173	4	,	,	,
cord-005453-4057qib7	12173	5	immunity	immunity	NN
cord-005453-4057qib7	12173	6	recovery	recovery	NN
cord-005453-4057qib7	12173	7	was	be	VBD
cord-005453-4057qib7	12173	8	a	a	DT
cord-005453-4057qib7	12173	9	late	late	JJ
cord-005453-4057qib7	12173	10	event	event	NN
cord-005453-4057qib7	12173	11	for	for	IN
cord-005453-4057qib7	12173	12	majority	majority	NN
cord-005453-4057qib7	12173	13	of	of	IN
cord-005453-4057qib7	12173	14	patients	patient	NNS
cord-005453-4057qib7	12173	15	undergoing	undergo	VBG
cord-005453-4057qib7	12173	16	allo	allo	NN
cord-005453-4057qib7	12173	17	-	-	HYPH
cord-005453-4057qib7	12173	18	HSCT	HSCT	NNP
cord-005453-4057qib7	12173	19	.	.	.
cord-005453-4057qib7	12174	1	In	in	IN
cord-005453-4057qib7	12174	2	addition	addition	NN
cord-005453-4057qib7	12174	3	,	,	,
cord-005453-4057qib7	12174	4	in	in	IN
cord-005453-4057qib7	12174	5	our	-PRON-	PRP$
cord-005453-4057qib7	12174	6	experience	experience	NN
cord-005453-4057qib7	12174	7	,	,	,
cord-005453-4057qib7	12174	8	the	the	DT
cord-005453-4057qib7	12174	9	precocity	precocity	NN
cord-005453-4057qib7	12174	10	and	and	CC
cord-005453-4057qib7	12174	11	quality	quality	NN
cord-005453-4057qib7	12174	12	of	of	IN
cord-005453-4057qib7	12174	13	the	the	DT
cord-005453-4057qib7	12174	14	ALC	ALC	NNP
cord-005453-4057qib7	12174	15	,	,	,
cord-005453-4057qib7	12174	16	CD4	CD4	NNP
cord-005453-4057qib7	12174	17	+	+	CC
cord-005453-4057qib7	12174	18	,	,	,
cord-005453-4057qib7	12174	19	and	and	CC
cord-005453-4057qib7	12174	20	CD19	CD19	NNP
cord-005453-4057qib7	12174	21	+	+	CC
cord-005453-4057qib7	12174	22	cells	cell	NNS
cord-005453-4057qib7	12174	23	recovery	recovery	NN
cord-005453-4057qib7	12174	24	was	be	VBD
cord-005453-4057qib7	12174	25	clearly	clearly	RB
cord-005453-4057qib7	12174	26	linked	link	VBN
cord-005453-4057qib7	12174	27	with	with	IN
cord-005453-4057qib7	12174	28	long	long	JJ
cord-005453-4057qib7	12174	29	-	-	HYPH
cord-005453-4057qib7	12174	30	term	term	NN
cord-005453-4057qib7	12174	31	survival	survival	NN
cord-005453-4057qib7	12174	32	.	.	.
cord-005453-4057qib7	12175	1	Background	background	NN
cord-005453-4057qib7	12175	2	:	:	:
cord-005453-4057qib7	12176	1	The	the	DT
cord-005453-4057qib7	12176	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	12176	3	of	of	IN
cord-005453-4057qib7	12176	4	T	T	NNP
cord-005453-4057qib7	12176	5	and	and	CC
cord-005453-4057qib7	12176	6	Natural	Natural	NNP
cord-005453-4057qib7	12176	7	Killer	Killer	NNP
cord-005453-4057qib7	12176	8	(	(	-LRB-
cord-005453-4057qib7	12176	9	NK	NK	NNP
cord-005453-4057qib7	12176	10	)	)	-RRB-
cord-005453-4057qib7	12176	11	cells	cell	NNS
cord-005453-4057qib7	12176	12	after	after	IN
cord-005453-4057qib7	12176	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12176	14	stem	stem	NN
cord-005453-4057qib7	12176	15	cell	cell	NN
cord-005453-4057qib7	12176	16	transplantation	transplantation	NN
cord-005453-4057qib7	12176	17	(	(	-LRB-
cord-005453-4057qib7	12176	18	HSCT	HSCT	NNP
cord-005453-4057qib7	12176	19	)	)	-RRB-
cord-005453-4057qib7	12176	20	strongly	strongly	RB
cord-005453-4057qib7	12176	21	influences	influence	VBZ
cord-005453-4057qib7	12176	22	the	the	DT
cord-005453-4057qib7	12176	23	outcome	outcome	NN
cord-005453-4057qib7	12176	24	of	of	IN
cord-005453-4057qib7	12176	25	HSCT	HSCT	NNP
cord-005453-4057qib7	12176	26	including	include	VBG
cord-005453-4057qib7	12176	27	viral	viral	JJ
cord-005453-4057qib7	12176	28	infection	infection	NN
cord-005453-4057qib7	12176	29	and	and	CC
cord-005453-4057qib7	12176	30	graft	graft	NN
cord-005453-4057qib7	12176	31	versus	versus	IN
cord-005453-4057qib7	12176	32	-	-	HYPH
cord-005453-4057qib7	12176	33	host	host	NN
cord-005453-4057qib7	12176	34	disease	disease	NN
cord-005453-4057qib7	12176	35	(	(	-LRB-
cord-005453-4057qib7	12176	36	GVHD	GVHD	NNP
cord-005453-4057qib7	12176	37	)	)	-RRB-
cord-005453-4057qib7	12176	38	.	.	.
cord-005453-4057qib7	12177	1	The	the	DT
cord-005453-4057qib7	12177	2	purpose	purpose	NN
cord-005453-4057qib7	12177	3	of	of	IN
cord-005453-4057qib7	12177	4	this	this	DT
cord-005453-4057qib7	12177	5	study	study	NN
cord-005453-4057qib7	12177	6	was	be	VBD
cord-005453-4057qib7	12177	7	to	to	TO
cord-005453-4057qib7	12177	8	investigate	investigate	VB
cord-005453-4057qib7	12177	9	the	the	DT
cord-005453-4057qib7	12177	10	clinical	clinical	JJ
cord-005453-4057qib7	12177	11	efficacy	efficacy	NN
cord-005453-4057qib7	12177	12	of	of	IN
cord-005453-4057qib7	12177	13	immune	immune	JJ
cord-005453-4057qib7	12177	14	reconstitution	reconstitution	NN
cord-005453-4057qib7	12177	15	including	include	VBG
cord-005453-4057qib7	12177	16	T	T	NNP
cord-005453-4057qib7	12177	17	and	and	CC
cord-005453-4057qib7	12177	18	NK	NK	NNP
cord-005453-4057qib7	12177	19	cells	cell	NNS
cord-005453-4057qib7	12177	20	after	after	IN
cord-005453-4057qib7	12177	21	HSCT	HSCT	NNP
cord-005453-4057qib7	12177	22	in	in	IN
cord-005453-4057qib7	12177	23	children	child	NNS
cord-005453-4057qib7	12177	24	.	.	.
cord-005453-4057qib7	12178	1	Methods	method	NNS
cord-005453-4057qib7	12179	1	:	:	:
cord-005453-4057qib7	12179	2	We	-PRON-	PRP
cord-005453-4057qib7	12179	3	reviewed	review	VBD
cord-005453-4057qib7	12179	4	the	the	DT
cord-005453-4057qib7	12179	5	records	record	NNS
cord-005453-4057qib7	12179	6	of	of	IN
cord-005453-4057qib7	12179	7	30	30	CD
cord-005453-4057qib7	12179	8	patients	patient	NNS
cord-005453-4057qib7	12179	9	who	who	WP
cord-005453-4057qib7	12179	10	undergoing	undergo	VBG
cord-005453-4057qib7	12179	11	allogeneic	allogeneic	IN
cord-005453-4057qib7	12179	12	HSCT	HSCT	NNP
cord-005453-4057qib7	12179	13	in	in	IN
cord-005453-4057qib7	12179	14	Department	Department	NNP
cord-005453-4057qib7	12179	15	of	of	IN
cord-005453-4057qib7	12179	16	Pediatrics	Pediatrics	NNP
cord-005453-4057qib7	12179	17	,	,	,
cord-005453-4057qib7	12179	18	Pusan	Pusan	NNP
cord-005453-4057qib7	12179	19	National	National	NNP
cord-005453-4057qib7	12179	20	University	University	NNP
cord-005453-4057qib7	12179	21	Children	Children	NNP
cord-005453-4057qib7	12179	22	's	's	POS
cord-005453-4057qib7	12179	23	Hospital	Hospital	NNP
cord-005453-4057qib7	12179	24	,	,	,
cord-005453-4057qib7	12179	25	from	from	IN
cord-005453-4057qib7	12179	26	January	January	NNP
cord-005453-4057qib7	12179	27	2013	2013	CD
cord-005453-4057qib7	12179	28	to	to	IN
cord-005453-4057qib7	12179	29	July	July	NNP
cord-005453-4057qib7	12179	30	2017	2017	CD
cord-005453-4057qib7	12179	31	.	.	.
cord-005453-4057qib7	12180	1	The	the	DT
cord-005453-4057qib7	12180	2	counts	count	NNS
cord-005453-4057qib7	12180	3	of	of	IN
cord-005453-4057qib7	12180	4	T	t	NN
cord-005453-4057qib7	12180	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	12180	6	subsets	subset	NNS
cord-005453-4057qib7	12180	7	and	and	CC
cord-005453-4057qib7	12180	8	NK	NK	NNP
cord-005453-4057qib7	12180	9	cells	cell	NNS
cord-005453-4057qib7	12180	10	was	be	VBD
cord-005453-4057qib7	12180	11	monitored	monitor	VBN
cord-005453-4057qib7	12180	12	in	in	IN
cord-005453-4057qib7	12180	13	peripheral	peripheral	JJ
cord-005453-4057qib7	12180	14	blood	blood	NN
cord-005453-4057qib7	12180	15	by	by	IN
cord-005453-4057qib7	12180	16	flow	flow	NN
cord-005453-4057qib7	12180	17	cytometric	cytometric	NN
cord-005453-4057qib7	12180	18	technique	technique	NN
cord-005453-4057qib7	12180	19	during	during	IN
cord-005453-4057qib7	12180	20	1	1	CD
cord-005453-4057qib7	12180	21	,	,	,
cord-005453-4057qib7	12180	22	3	3	CD
cord-005453-4057qib7	12180	23	,	,	,
cord-005453-4057qib7	12180	24	6	6	CD
cord-005453-4057qib7	12180	25	,	,	,
cord-005453-4057qib7	12180	26	and	and	CC
cord-005453-4057qib7	12180	27	12	12	CD
cord-005453-4057qib7	12180	28	months	month	NNS
cord-005453-4057qib7	12180	29	post	post	NN
cord-005453-4057qib7	12180	30	-	-	JJ
cord-005453-4057qib7	12180	31	HSCT	HSCT	NNP
cord-005453-4057qib7	12180	32	.	.	.
cord-005453-4057qib7	12181	1	Blood	blood	NN
cord-005453-4057qib7	12181	2	samples	sample	NNS
cord-005453-4057qib7	12181	3	for	for	IN
cord-005453-4057qib7	12181	4	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	12181	5	(	(	-LRB-
cord-005453-4057qib7	12181	6	CMV	CMV	NNP
cord-005453-4057qib7	12181	7	)	)	-RRB-
cord-005453-4057qib7	12181	8	and	and	CC
cord-005453-4057qib7	12181	9	Epstein	Epstein	NNP
cord-005453-4057qib7	12181	10	-	-	HYPH
cord-005453-4057qib7	12181	11	Barr	Barr	NNP
cord-005453-4057qib7	12181	12	virus	virus	NN
cord-005453-4057qib7	12181	13	(	(	-LRB-
cord-005453-4057qib7	12181	14	EBV	EBV	NNP
cord-005453-4057qib7	12181	15	)	)	-RRB-
cord-005453-4057qib7	12181	16	monitoring	monitoring	NN
cord-005453-4057qib7	12181	17	were	be	VBD
cord-005453-4057qib7	12181	18	tested	test	VBN
cord-005453-4057qib7	12181	19	by	by	IN
cord-005453-4057qib7	12181	20	real	real	JJ
cord-005453-4057qib7	12181	21	-	-	HYPH
cord-005453-4057qib7	12181	22	time	time	NN
cord-005453-4057qib7	12181	23	PCR	pcr	NN
cord-005453-4057qib7	12181	24	assay	assay	NN
cord-005453-4057qib7	12181	25	.	.	.
cord-005453-4057qib7	12182	1	Results	result	NNS
cord-005453-4057qib7	12182	2	:	:	:
cord-005453-4057qib7	12183	1	For	for	IN
cord-005453-4057qib7	12183	2	total	total	NN
cord-005453-4057qib7	12183	3	of	of	IN
cord-005453-4057qib7	12183	4	30	30	CD
cord-005453-4057qib7	12183	5	patients	patient	NNS
cord-005453-4057qib7	12183	6	,	,	,
cord-005453-4057qib7	12183	7	the	the	DT
cord-005453-4057qib7	12183	8	mean	mean	JJ
cord-005453-4057qib7	12183	9	age	age	NN
cord-005453-4057qib7	12183	10	was	be	VBD
cord-005453-4057qib7	12183	11	9.1	9.1	CD
cord-005453-4057qib7	12183	12	years	year	NNS
cord-005453-4057qib7	12183	13	(	(	-LRB-
cord-005453-4057qib7	12183	14	range	range	NN
cord-005453-4057qib7	12183	15	,	,	,
cord-005453-4057qib7	12183	16	9	9	CD
cord-005453-4057qib7	12183	17	months-19	months-19	CD
cord-005453-4057qib7	12183	18	years	year	NNS
cord-005453-4057qib7	12183	19	)	)	-RRB-
cord-005453-4057qib7	12183	20	,	,	,
cord-005453-4057qib7	12183	21	16	16	CD
cord-005453-4057qib7	12183	22	of	of	IN
cord-005453-4057qib7	12183	23	the	the	DT
cord-005453-4057qib7	12183	24	patients	patient	NNS
cord-005453-4057qib7	12183	25	were	be	VBD
cord-005453-4057qib7	12184	1	boys	boy	NNS
cord-005453-4057qib7	12184	2	and	and	CC
cord-005453-4057qib7	12184	3	14	14	CD
cord-005453-4057qib7	12184	4	was	be	VBD
cord-005453-4057qib7	12184	5	girl	girl	NN
cord-005453-4057qib7	12184	6	.	.	.
cord-005453-4057qib7	12185	1	Out	out	IN
cord-005453-4057qib7	12185	2	of	of	IN
cord-005453-4057qib7	12185	3	a	a	DT
cord-005453-4057qib7	12185	4	total	total	JJ
cord-005453-4057qib7	12185	5	30	30	CD
cord-005453-4057qib7	12185	6	patients	patient	NNS
cord-005453-4057qib7	12185	7	without	without	IN
cord-005453-4057qib7	12185	8	pre	pre	JJ
cord-005453-4057qib7	12185	9	-	-	JJ
cord-005453-4057qib7	12185	10	HSCT	HSCT	NNP
cord-005453-4057qib7	12185	11	CMV	CMV	NNP
cord-005453-4057qib7	12185	12	viremia	viremia	NN
cord-005453-4057qib7	12185	13	or	or	CC
cord-005453-4057qib7	12185	14	CMV	CMV	NNP
cord-005453-4057qib7	12185	15	infection	infection	NN
cord-005453-4057qib7	12185	16	,	,	,
cord-005453-4057qib7	12185	17	10	10	CD
cord-005453-4057qib7	12185	18	(	(	-LRB-
cord-005453-4057qib7	12185	19	33.3	33.3	CD
cord-005453-4057qib7	12185	20	%	%	NN
cord-005453-4057qib7	12185	21	)	)	-RRB-
cord-005453-4057qib7	12185	22	recipients	recipient	NNS
cord-005453-4057qib7	12185	23	experienced	experience	VBD
cord-005453-4057qib7	12185	24	CMV	CMV	NNP
cord-005453-4057qib7	12185	25	infection	infection	NN
cord-005453-4057qib7	12185	26	.	.	.
cord-005453-4057qib7	12186	1	The	the	DT
cord-005453-4057qib7	12186	2	number	number	NN
cord-005453-4057qib7	12186	3	of	of	IN
cord-005453-4057qib7	12186	4	CD8	CD8	NNP
cord-005453-4057qib7	12186	5	+	+	CC
cord-005453-4057qib7	12186	6	T	T	NNP
cord-005453-4057qib7	12186	7	cells	cell	NNS
cord-005453-4057qib7	12186	8	in	in	IN
cord-005453-4057qib7	12186	9	3	3	CD
cord-005453-4057qib7	12186	10	and	and	CC
cord-005453-4057qib7	12186	11	6	6	CD
cord-005453-4057qib7	12186	12	months	month	NNS
cord-005453-4057qib7	12186	13	post	post	NN
cord-005453-4057qib7	12186	14	-	-	JJ
cord-005453-4057qib7	12186	15	HSCT	HSCT	NNP
cord-005453-4057qib7	12186	16	was	be	VBD
cord-005453-4057qib7	12186	17	significantly	significantly	RB
cord-005453-4057qib7	12186	18	higher	high	JJR
cord-005453-4057qib7	12186	19	in	in	IN
cord-005453-4057qib7	12186	20	patients	patient	NNS
cord-005453-4057qib7	12186	21	with	with	IN
cord-005453-4057qib7	12186	22	CMV	CMV	NNP
cord-005453-4057qib7	12186	23	reactivation	reactivation	NN
cord-005453-4057qib7	12186	24	compared	compare	VBN
cord-005453-4057qib7	12186	25	to	to	IN
cord-005453-4057qib7	12186	26	patients	patient	NNS
cord-005453-4057qib7	12186	27	without	without	IN
cord-005453-4057qib7	12186	28	(	(	-LRB-
cord-005453-4057qib7	12186	29	median	median	JJ
cord-005453-4057qib7	12186	30	1066.11/	1066.11/	CD
cord-005453-4057qib7	12187	1	μL	μL	.
cord-005453-4057qib7	12188	1	vs.	vs.	FW
cord-005453-4057qib7	12189	1	979.0	979.0	CD
cord-005453-4057qib7	12189	2	/	/	SYM
cord-005453-4057qib7	12189	3	μL	μL	NNP
cord-005453-4057qib7	12189	4	,	,	,
cord-005453-4057qib7	12189	5	P=0.004	p=0.004	NN
cord-005453-4057qib7	12189	6	,	,	,
cord-005453-4057qib7	12189	7	and	and	CC
cord-005453-4057qib7	12189	8	1047.45/	1047.45/	CD
cord-005453-4057qib7	12190	1	μL	μL	.
cord-005453-4057qib7	12191	1	vs.	vs.	FW
cord-005453-4057qib7	12191	2	551.44	551.44	CD
cord-005453-4057qib7	12192	1	/μL	/μL	NFP
cord-005453-4057qib7	12192	2	,	,	,
cord-005453-4057qib7	12192	3	P=0.002	P=0.002	NNP
cord-005453-4057qib7	12192	4	)	)	-RRB-
cord-005453-4057qib7	12192	5	.	.	.
cord-005453-4057qib7	12193	1	In	in	IN
cord-005453-4057qib7	12193	2	6	6	CD
cord-005453-4057qib7	12193	3	(	(	-LRB-
cord-005453-4057qib7	12193	4	20	20	CD
cord-005453-4057qib7	12193	5	%	%	NN
cord-005453-4057qib7	12193	6	)	)	-RRB-
cord-005453-4057qib7	12193	7	recipients	recipient	NNS
cord-005453-4057qib7	12193	8	presented	present	VBD
cord-005453-4057qib7	12193	9	acute	acute	JJ
cord-005453-4057qib7	12193	10	GVHD	GVHD	NNP
cord-005453-4057qib7	12193	11	,	,	,
cord-005453-4057qib7	12193	12	the	the	DT
cord-005453-4057qib7	12193	13	number	number	NN
cord-005453-4057qib7	12193	14	of	of	IN
cord-005453-4057qib7	12193	15	CD4	CD4	NNP
cord-005453-4057qib7	12193	16	+	+	CC
cord-005453-4057qib7	12193	17	T	T	NNP
cord-005453-4057qib7	12193	18	cells	cell	NNS
cord-005453-4057qib7	12193	19	in	in	IN
cord-005453-4057qib7	12193	20	1	1	CD
cord-005453-4057qib7	12193	21	and	and	CC
cord-005453-4057qib7	12193	22	3	3	CD
cord-005453-4057qib7	12193	23	months	month	NNS
cord-005453-4057qib7	12193	24	post	post	JJ
cord-005453-4057qib7	12193	25	-	-	JJ
cord-005453-4057qib7	12193	26	HSCT	HSCT	NNP
cord-005453-4057qib7	12193	27	was	be	VBD
cord-005453-4057qib7	12193	28	significantly	significantly	RB
cord-005453-4057qib7	12193	29	lower	low	JJR
cord-005453-4057qib7	12193	30	in	in	IN
cord-005453-4057qib7	12193	31	patients	patient	NNS
cord-005453-4057qib7	12193	32	with	with	IN
cord-005453-4057qib7	12193	33	acute	acute	JJ
cord-005453-4057qib7	12193	34	GVHD	GVHD	NNP
cord-005453-4057qib7	12193	35	compared	compare	VBN
cord-005453-4057qib7	12193	36	to	to	IN
cord-005453-4057qib7	12193	37	patients	patient	NNS
cord-005453-4057qib7	12193	38	without	without	IN
cord-005453-4057qib7	12193	39	(	(	-LRB-
cord-005453-4057qib7	12193	40	median	median	NN
cord-005453-4057qib7	12193	41	239.13/	239.13/	CD
cord-005453-4057qib7	12194	1	μL	μL	.
cord-005453-4057qib7	12195	1	vs.	vs.	FW
cord-005453-4057qib7	12196	1	365.0	365.0	CD
cord-005453-4057qib7	12196	2	/	/	SYM
cord-005453-4057qib7	12196	3	μL	μL	NNP
cord-005453-4057qib7	12196	4	,	,	,
cord-005453-4057qib7	12196	5	P=0.045	p=0.045	NN
cord-005453-4057qib7	12196	6	,	,	,
cord-005453-4057qib7	12196	7	and	and	CC
cord-005453-4057qib7	12197	1	165.2	165.2	CD
cord-005453-4057qib7	12197	2	/	/	SYM
cord-005453-4057qib7	12197	3	μL	μl	NN
cord-005453-4057qib7	12197	4	vs.	vs.	IN
cord-005453-4057qib7	12197	5	344.27	344.27	CD
cord-005453-4057qib7	12197	6	/	/	SYM
cord-005453-4057qib7	12197	7	μL	μL	NNP
cord-005453-4057qib7	12197	8	,	,	,
cord-005453-4057qib7	12197	9	P=0.035	p=0.035	NN
cord-005453-4057qib7	12197	10	)	)	-RRB-
cord-005453-4057qib7	12197	11	.	.	.
cord-005453-4057qib7	12198	1	The	the	DT
cord-005453-4057qib7	12198	2	number	number	NN
cord-005453-4057qib7	12198	3	of	of	IN
cord-005453-4057qib7	12198	4	NK	NK	NNP
cord-005453-4057qib7	12198	5	cells	cell	NNS
cord-005453-4057qib7	12198	6	in	in	IN
cord-005453-4057qib7	12198	7	1	1	CD
cord-005453-4057qib7	12198	8	months	month	NNS
cord-005453-4057qib7	12198	9	post	post	NN
cord-005453-4057qib7	12198	10	-	-	JJ
cord-005453-4057qib7	12198	11	HSCT	HSCT	NNP
cord-005453-4057qib7	12198	12	was	be	VBD
cord-005453-4057qib7	12198	13	significantly	significantly	RB
cord-005453-4057qib7	12198	14	lower	low	JJR
cord-005453-4057qib7	12198	15	in	in	IN
cord-005453-4057qib7	12198	16	patients	patient	NNS
cord-005453-4057qib7	12198	17	with	with	IN
cord-005453-4057qib7	12198	18	CMV	CMV	NNP
cord-005453-4057qib7	12198	19	reactivation	reactivation	NN
cord-005453-4057qib7	12198	20	and	and	CC
cord-005453-4057qib7	12198	21	acute	acute	JJ
cord-005453-4057qib7	12198	22	GVHD	GVHD	NNP
cord-005453-4057qib7	12198	23	compared	compare	VBN
cord-005453-4057qib7	12198	24	to	to	IN
cord-005453-4057qib7	12198	25	patients	patient	NNS
cord-005453-4057qib7	12198	26	without	without	IN
cord-005453-4057qib7	12198	27	(	(	-LRB-
cord-005453-4057qib7	12199	1	258.5	258.5	CD
cord-005453-4057qib7	12199	2	/	/	SYM
cord-005453-4057qib7	12199	3	μL	μl	NN
cord-005453-4057qib7	12199	4	vs.	vs.	IN
cord-005453-4057qib7	12199	5	501.67	501.67	CD
cord-005453-4057qib7	12200	1	/μL	/μL	NFP
cord-005453-4057qib7	12200	2	,	,	,
cord-005453-4057qib7	12200	3	P=0.004	P=0.004	NNP
cord-005453-4057qib7	12200	4	,	,	,
cord-005453-4057qib7	12200	5	and	and	CC
cord-005453-4057qib7	12200	6	162.5	162.5	CD
cord-005453-4057qib7	12201	1	/μL	/μL	NFP
cord-005453-4057qib7	12201	2	vs.	vs.	IN
cord-005453-4057qib7	12201	3	464.88/	464.88/	CD
cord-005453-4057qib7	12202	1	μL	μL	NNP
cord-005453-4057qib7	12202	2	,	,	,
cord-005453-4057qib7	12202	3	P=0.027	p=0.027	RB
cord-005453-4057qib7	12202	4	,	,	,
cord-005453-4057qib7	12202	5	respectively	respectively	RB
cord-005453-4057qib7	12202	6	)	)	-RRB-
cord-005453-4057qib7	12202	7	.	.	.
cord-005453-4057qib7	12203	1	In	in	IN
cord-005453-4057qib7	12203	2	multivariable	multivariable	JJ
cord-005453-4057qib7	12203	3	analysis	analysis	NN
cord-005453-4057qib7	12203	4	,	,	,
cord-005453-4057qib7	12203	5	acute	acute	JJ
cord-005453-4057qib7	12203	6	GVHD	GVHD	NNP
cord-005453-4057qib7	12203	7	was	be	VBD
cord-005453-4057qib7	12203	8	shown	show	VBN
cord-005453-4057qib7	12203	9	to	to	TO
cord-005453-4057qib7	12203	10	be	be	VB
cord-005453-4057qib7	12203	11	the	the	DT
cord-005453-4057qib7	12203	12	decisive	decisive	JJ
cord-005453-4057qib7	12203	13	factor	factor	NN
cord-005453-4057qib7	12203	14	influencing	influence	VBG
cord-005453-4057qib7	12203	15	total	total	JJ
cord-005453-4057qib7	12203	16	T	t	NN
cord-005453-4057qib7	12203	17	cells	cell	NNS
cord-005453-4057qib7	12203	18	(	(	-LRB-
cord-005453-4057qib7	12203	19	P=0.028	p=0.028	NN
cord-005453-4057qib7	12203	20	)	)	-RRB-
cord-005453-4057qib7	12203	21	and	and	CC
cord-005453-4057qib7	12203	22	CMV	CMV	NNP
cord-005453-4057qib7	12203	23	reactivation	reactivation	NN
cord-005453-4057qib7	12203	24	was	be	VBD
cord-005453-4057qib7	12203	25	independently	independently	RB
cord-005453-4057qib7	12203	26	associated	associate	VBN
cord-005453-4057qib7	12203	27	with	with	IN
cord-005453-4057qib7	12203	28	CD8	CD8	NNP
cord-005453-4057qib7	12203	29	+	+	CC
cord-005453-4057qib7	12203	30	T	T	NNP
cord-005453-4057qib7	12203	31	cells	cell	NNS
cord-005453-4057qib7	12203	32	(	(	-LRB-
cord-005453-4057qib7	12203	33	P=0.026	P=0.026	NNP
cord-005453-4057qib7	12203	34	)	)	-RRB-
cord-005453-4057qib7	12203	35	.	.	.
cord-005453-4057qib7	12204	1	The	the	DT
cord-005453-4057qib7	12204	2	CD4	CD4	NNP
cord-005453-4057qib7	12204	3	+	+	CC
cord-005453-4057qib7	12204	4	T	t	NN
cord-005453-4057qib7	12204	5	cells	cell	NNS
cord-005453-4057qib7	12204	6	counts	count	NNS
cord-005453-4057qib7	12204	7	were	be	VBD
cord-005453-4057qib7	12204	8	associated	associate	VBN
cord-005453-4057qib7	12204	9	with	with	IN
cord-005453-4057qib7	12204	10	prior	prior	JJ
cord-005453-4057qib7	12204	11	HSCT	HSCT	NNP
cord-005453-4057qib7	12204	12	history	history	NN
cord-005453-4057qib7	12204	13	and	and	CC
cord-005453-4057qib7	12204	14	acute	acute	JJ
cord-005453-4057qib7	12204	15	GVHD	GVHD	NNP
cord-005453-4057qib7	12204	16	(	(	-LRB-
cord-005453-4057qib7	12204	17	P=0.042	P=0.042	NNP
cord-005453-4057qib7	12204	18	and	and	CC
cord-005453-4057qib7	12204	19	P=0.038	P=0.038	NNP
cord-005453-4057qib7	12204	20	)	)	-RRB-
cord-005453-4057qib7	12204	21	,	,	,
cord-005453-4057qib7	12204	22	and	and	CC
cord-005453-4057qib7	12204	23	the	the	DT
cord-005453-4057qib7	12204	24	CD8	CD8	NNP
cord-005453-4057qib7	12204	25	+	+	CC
cord-005453-4057qib7	12204	26	T	T	NNP
cord-005453-4057qib7	12204	27	cells	cell	NNS
cord-005453-4057qib7	12204	28	counts	count	NNS
cord-005453-4057qib7	12204	29	were	be	VBD
cord-005453-4057qib7	12204	30	also	also	RB
cord-005453-4057qib7	12204	31	significantly	significantly	RB
cord-005453-4057qib7	12204	32	associated	associate	VBN
cord-005453-4057qib7	12204	33	with	with	IN
cord-005453-4057qib7	12204	34	donor	donor	NN
cord-005453-4057qib7	12204	35	type	type	NN
cord-005453-4057qib7	12204	36	(	(	-LRB-
cord-005453-4057qib7	12204	37	P=0.016	P=0.016	NNP
cord-005453-4057qib7	12204	38	)	)	-RRB-
cord-005453-4057qib7	12204	39	.	.	.
cord-005453-4057qib7	12205	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12205	2	:	:	:
cord-005453-4057qib7	12206	1	Overall	overall	RB
cord-005453-4057qib7	12206	2	,	,	,
cord-005453-4057qib7	12206	3	our	-PRON-	PRP$
cord-005453-4057qib7	12206	4	study	study	NN
cord-005453-4057qib7	12206	5	documents	document	NNS
cord-005453-4057qib7	12206	6	that	that	WDT
cord-005453-4057qib7	12206	7	immune	immune	JJ
cord-005453-4057qib7	12206	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	12206	9	of	of	IN
cord-005453-4057qib7	12206	10	CD4	CD4	NNP
cord-005453-4057qib7	12206	11	+	+	CC
cord-005453-4057qib7	12206	12	,	,	,
cord-005453-4057qib7	12206	13	CD8	CD8	NNP
cord-005453-4057qib7	12206	14	+	+	CC
cord-005453-4057qib7	12206	15	T	T	NNP
cord-005453-4057qib7	12206	16	cells	cell	NNS
cord-005453-4057qib7	12206	17	and	and	CC
cord-005453-4057qib7	12206	18	NK	NK	NNP
cord-005453-4057qib7	12206	19	cells	cell	NNS
cord-005453-4057qib7	12206	20	is	be	VBZ
cord-005453-4057qib7	12206	21	strongly	strongly	RB
cord-005453-4057qib7	12206	22	associated	associate	VBN
cord-005453-4057qib7	12206	23	with	with	IN
cord-005453-4057qib7	12206	24	CMV	CMV	NNP
cord-005453-4057qib7	12206	25	reactivation	reactivation	NN
cord-005453-4057qib7	12206	26	and	and	CC
cord-005453-4057qib7	12206	27	acute	acute	JJ
cord-005453-4057qib7	12206	28	GVHD	GVHD	NNP
cord-005453-4057qib7	12206	29	.	.	.
cord-005453-4057qib7	12207	1	Additionally	additionally	RB
cord-005453-4057qib7	12207	2	,	,	,
cord-005453-4057qib7	12207	3	we	-PRON-	PRP
cord-005453-4057qib7	12207	4	show	show	VBP
cord-005453-4057qib7	12207	5	that	that	IN
cord-005453-4057qib7	12207	6	acute	acute	JJ
cord-005453-4057qib7	12207	7	GVHD	GVHD	NNP
cord-005453-4057qib7	12207	8	is	be	VBZ
cord-005453-4057qib7	12207	9	influenced	influence	VBN
cord-005453-4057qib7	12207	10	by	by	IN
cord-005453-4057qib7	12207	11	lack	lack	NN
cord-005453-4057qib7	12207	12	of	of	IN
cord-005453-4057qib7	12207	13	sufficient	sufficient	JJ
cord-005453-4057qib7	12207	14	numbers	number	NNS
cord-005453-4057qib7	12207	15	of	of	IN
cord-005453-4057qib7	12207	16	NK	NK	NNP
cord-005453-4057qib7	12207	17	cells	cell	NNS
cord-005453-4057qib7	12207	18	as	as	RB
cord-005453-4057qib7	12207	19	well	well	RB
cord-005453-4057qib7	12207	20	as	as	IN
cord-005453-4057qib7	12207	21	CD4	CD4	NNP
cord-005453-4057qib7	12207	22	+	+	CC
cord-005453-4057qib7	12207	23	T	T	NNP
cord-005453-4057qib7	12207	24	cells	cell	NNS
cord-005453-4057qib7	12207	25	early	early	RB
cord-005453-4057qib7	12207	26	after	after	IN
cord-005453-4057qib7	12207	27	SCT	SCT	NNP
cord-005453-4057qib7	12207	28	.	.	.
cord-005453-4057qib7	12208	1	CD8	CD8	NNP
cord-005453-4057qib7	12208	2	+	+	CC
cord-005453-4057qib7	12208	3	T	T	NNP
cord-005453-4057qib7	12208	4	cells	cell	NNS
cord-005453-4057qib7	12208	5	,	,	,
cord-005453-4057qib7	12208	6	on	on	IN
cord-005453-4057qib7	12208	7	the	the	DT
cord-005453-4057qib7	12208	8	other	other	JJ
cord-005453-4057qib7	12208	9	hand	hand	NN
cord-005453-4057qib7	12208	10	,	,	,
cord-005453-4057qib7	12208	11	significantly	significantly	RB
cord-005453-4057qib7	12208	12	increase	increase	VBP
cord-005453-4057qib7	12208	13	after	after	IN
cord-005453-4057qib7	12208	14	CMV	cmv	NN
cord-005453-4057qib7	12208	15	-	-	HYPH
cord-005453-4057qib7	12208	16	reactivation	reactivation	NN
cord-005453-4057qib7	12208	17	and	and	CC
cord-005453-4057qib7	12208	18	most	most	RBS
cord-005453-4057qib7	12208	19	likely	likely	RB
cord-005453-4057qib7	12208	20	play	play	VBP
cord-005453-4057qib7	12208	21	an	an	DT
cord-005453-4057qib7	12208	22	important	important	JJ
cord-005453-4057qib7	12208	23	role	role	NN
cord-005453-4057qib7	12208	24	in	in	IN
cord-005453-4057qib7	12208	25	reactivation	reactivation	NN
cord-005453-4057qib7	12208	26	.	.	.
cord-005453-4057qib7	12209	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12209	2	:	:	:
cord-005453-4057qib7	12209	3	Nothing	nothing	NN
cord-005453-4057qib7	12209	4	to	to	TO
cord-005453-4057qib7	12209	5	declare	declare	VB
cord-005453-4057qib7	12209	6	Background	background	NN
cord-005453-4057qib7	12209	7	:	:	:
cord-005453-4057qib7	12209	8	Curative	curative	JJ
cord-005453-4057qib7	12209	9	effect	effect	NN
cord-005453-4057qib7	12209	10	of	of	IN
cord-005453-4057qib7	12209	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	12209	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12209	13	stem	stem	NN
cord-005453-4057qib7	12209	14	cell	cell	NN
cord-005453-4057qib7	12209	15	transplantation	transplantation	NN
cord-005453-4057qib7	12209	16	(	(	-LRB-
cord-005453-4057qib7	12209	17	allo	allo	NN
cord-005453-4057qib7	12209	18	-	-	HYPH
cord-005453-4057qib7	12209	19	HSCT	HSCT	NNP
cord-005453-4057qib7	12209	20	)	)	-RRB-
cord-005453-4057qib7	12209	21	depends	depend	VBZ
cord-005453-4057qib7	12209	22	on	on	IN
cord-005453-4057qib7	12209	23	the	the	DT
cord-005453-4057qib7	12209	24	alloreactive	alloreactive	JJ
cord-005453-4057qib7	12209	25	T	t	NN
cord-005453-4057qib7	12209	26	-	-	HYPH
cord-005453-4057qib7	12209	27	cell	cell	NN
cord-005453-4057qib7	12209	28	immune	immune	JJ
cord-005453-4057qib7	12209	29	response	response	NN
cord-005453-4057qib7	12209	30	toward	toward	IN
cord-005453-4057qib7	12209	31	residual	residual	JJ
cord-005453-4057qib7	12209	32	malignant	malignant	JJ
cord-005453-4057qib7	12209	33	cells	cell	NNS
cord-005453-4057qib7	12210	1	-graft	-graft	NN
cord-005453-4057qib7	12210	2	-	-	HYPH
cord-005453-4057qib7	12210	3	versus	versus	IN
cord-005453-4057qib7	12210	4	-	-	HYPH
cord-005453-4057qib7	12210	5	leukemia	leukemia	NN
cord-005453-4057qib7	12210	6	reaction	reaction	NN
cord-005453-4057qib7	12210	7	.	.	.
cord-005453-4057qib7	12211	1	However	however	RB
cord-005453-4057qib7	12211	2	,	,	,
cord-005453-4057qib7	12211	3	alloreactive	alloreactive	JJ
cord-005453-4057qib7	12211	4	population	population	NN
cord-005453-4057qib7	12211	5	has	have	VBZ
cord-005453-4057qib7	12211	6	not	not	RB
cord-005453-4057qib7	12211	7	been	be	VBN
cord-005453-4057qib7	12211	8	phenotypically	phenotypically	RB
cord-005453-4057qib7	12211	9	defined	define	VBN
cord-005453-4057qib7	12211	10	.	.	.
cord-005453-4057qib7	12212	1	Recent	recent	JJ
cord-005453-4057qib7	12212	2	studies	study	NNS
cord-005453-4057qib7	12212	3	suggest	suggest	VBP
cord-005453-4057qib7	12212	4	that	that	IN
cord-005453-4057qib7	12212	5	alloreactive	alloreactive	NNP
cord-005453-4057qib7	12212	6	T	T	NNP
cord-005453-4057qib7	12212	7	cells	cell	NNS
cord-005453-4057qib7	12212	8	express	express	VBP
cord-005453-4057qib7	12212	9	both	both	DT
cord-005453-4057qib7	12212	10	costimulatory	costimulatory	JJ
cord-005453-4057qib7	12212	11	and	and	CC
cord-005453-4057qib7	12212	12	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12212	13	receptors	receptor	NNS
cord-005453-4057qib7	12212	14	simultaneously	simultaneously	RB
cord-005453-4057qib7	12212	15	.	.	.
cord-005453-4057qib7	12213	1	Exhaustion	exhaustion	NN
cord-005453-4057qib7	12213	2	caused	cause	VBN
cord-005453-4057qib7	12213	3	by	by	IN
cord-005453-4057qib7	12213	4	the	the	DT
cord-005453-4057qib7	12213	5	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12213	6	signaling	signaling	NN
cord-005453-4057qib7	12213	7	dampens	dampen	VBZ
cord-005453-4057qib7	12213	8	Tcell	Tcell	NNP
cord-005453-4057qib7	12213	9	functionality	functionality	NN
cord-005453-4057qib7	12213	10	,	,	,
cord-005453-4057qib7	12213	11	which	which	WDT
cord-005453-4057qib7	12213	12	could	could	MD
cord-005453-4057qib7	12213	13	lead	lead	VB
cord-005453-4057qib7	12213	14	to	to	IN
cord-005453-4057qib7	12213	15	the	the	DT
cord-005453-4057qib7	12213	16	disease	disease	NN
cord-005453-4057qib7	12213	17	relapse	relapse	VB
cord-005453-4057qib7	12213	18	.	.	.
cord-005453-4057qib7	12214	1	Here	here	RB
cord-005453-4057qib7	12214	2	we	-PRON-	PRP
cord-005453-4057qib7	12214	3	aimed	aim	VBD
cord-005453-4057qib7	12214	4	to	to	TO
cord-005453-4057qib7	12214	5	investigate	investigate	VB
cord-005453-4057qib7	12214	6	the	the	DT
cord-005453-4057qib7	12214	7	expression	expression	NN
cord-005453-4057qib7	12214	8	of	of	IN
cord-005453-4057qib7	12214	9	costimulatory	costimulatory	NN
cord-005453-4057qib7	12214	10	and	and	CC
cord-005453-4057qib7	12214	11	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12214	12	receptors	receptor	NNS
cord-005453-4057qib7	12214	13	on	on	IN
cord-005453-4057qib7	12214	14	antigen	antigen	NN
cord-005453-4057qib7	12214	15	-	-	HYPH
cord-005453-4057qib7	12214	16	experienced	experience	VBN
cord-005453-4057qib7	12214	17	T	T	NNP
cord-005453-4057qib7	12214	18	cells	cell	NNS
cord-005453-4057qib7	12214	19	after	after	IN
cord-005453-4057qib7	12214	20	transplantation	transplantation	NN
cord-005453-4057qib7	12214	21	,	,	,
cord-005453-4057qib7	12214	22	to	to	TO
cord-005453-4057qib7	12214	23	isolate	isolate	VB
cord-005453-4057qib7	12214	24	subpopulation	subpopulation	NN
cord-005453-4057qib7	12214	25	specific	specific	JJ
cord-005453-4057qib7	12214	26	for	for	IN
cord-005453-4057qib7	12214	27	allo	allo	NN
cord-005453-4057qib7	12214	28	-	-	HYPH
cord-005453-4057qib7	12214	29	HSCT	HSCT	NNP
cord-005453-4057qib7	12214	30	patients	patient	NNS
cord-005453-4057qib7	12214	31	and	and	CC
cord-005453-4057qib7	12214	32	analyze	analyze	VB
cord-005453-4057qib7	12214	33	their	-PRON-	PRP$
cord-005453-4057qib7	12214	34	T	t	NN
cord-005453-4057qib7	12214	35	-	-	HYPH
cord-005453-4057qib7	12214	36	cell	cell	NN
cord-005453-4057qib7	12214	37	receptor	receptor	NN
cord-005453-4057qib7	12214	38	(	(	-LRB-
cord-005453-4057qib7	12214	39	TCR	TCR	NNP
cord-005453-4057qib7	12214	40	)	)	-RRB-
cord-005453-4057qib7	12214	41	repertoire	repertoire	NN
cord-005453-4057qib7	12214	42	.	.	.
cord-005453-4057qib7	12215	1	Methods	method	NNS
cord-005453-4057qib7	12215	2	:	:	:
cord-005453-4057qib7	12215	3	Expression	expression	NN
cord-005453-4057qib7	12215	4	of	of	IN
cord-005453-4057qib7	12215	5	coinhibitory	coinhibitory	NNP
cord-005453-4057qib7	12215	6	and	and	CC
cord-005453-4057qib7	12215	7	costimulatory	costimulatory	NNP
cord-005453-4057qib7	12215	8	molecules	molecule	NNS
cord-005453-4057qib7	12215	9	on	on	IN
cord-005453-4057qib7	12215	10	PBMCs	pbmcs	JJ
cord-005453-4057qib7	12215	11	patients	patient	NNS
cord-005453-4057qib7	12215	12	at	at	IN
cord-005453-4057qib7	12215	13	various	various	JJ
cord-005453-4057qib7	12215	14	time	time	NN
cord-005453-4057qib7	12215	15	points	point	NNS
cord-005453-4057qib7	12215	16	after	after	IN
cord-005453-4057qib7	12215	17	allo	allo	NN
cord-005453-4057qib7	12215	18	-	-	HYPH
cord-005453-4057qib7	12215	19	HSCT	HSCT	NNP
cord-005453-4057qib7	12215	20	was	be	VBD
cord-005453-4057qib7	12215	21	analyzed	analyze	VBN
cord-005453-4057qib7	12215	22	for	for	IN
cord-005453-4057qib7	12215	23	expression	expression	NN
cord-005453-4057qib7	12215	24	of	of	IN
cord-005453-4057qib7	12215	25	:	:	:
cord-005453-4057qib7	12215	26	CD3	CD3	NNP
cord-005453-4057qib7	12215	27	,	,	,
cord-005453-4057qib7	12215	28	CD8	CD8	NNP
cord-005453-4057qib7	12215	29	,	,	,
cord-005453-4057qib7	12215	30	CD4	CD4	NNP
cord-005453-4057qib7	12215	31	,	,	,
cord-005453-4057qib7	12215	32	CD45RA	CD45RA	NNP
cord-005453-4057qib7	12215	33	,	,	,
cord-005453-4057qib7	12215	34	CCR7	CCR7	NNP
cord-005453-4057qib7	12215	35	,	,	,
cord-005453-4057qib7	12215	36	CD95	CD95	NNP
cord-005453-4057qib7	12215	37	,	,	,
cord-005453-4057qib7	12215	38	CD27	CD27	NNP
cord-005453-4057qib7	12215	39	,	,	,
cord-005453-4057qib7	12215	40	CD28	CD28	NNP
cord-005453-4057qib7	12215	41	,	,	,
cord-005453-4057qib7	12215	42	KLRG1	klrg1	XX
cord-005453-4057qib7	12215	43	,	,	,
cord-005453-4057qib7	12215	44	TIGIT	TIGIT	NNP
cord-005453-4057qib7	12215	45	,	,	,
cord-005453-4057qib7	12215	46	PD1	PD1	NNP
cord-005453-4057qib7	12215	47	,	,	,
cord-005453-4057qib7	12215	48	CD137	CD137	NNP
cord-005453-4057qib7	12215	49	and	and	CC
cord-005453-4057qib7	12215	50	OX40	OX40	NNP
cord-005453-4057qib7	12215	51	by	by	IN
cord-005453-4057qib7	12215	52	flow	flow	NN
cord-005453-4057qib7	12215	53	cytometry	cytometry	NN
cord-005453-4057qib7	12215	54	and	and	CC
cord-005453-4057qib7	12215	55	compared	compare	VBN
cord-005453-4057qib7	12215	56	to	to	IN
cord-005453-4057qib7	12215	57	healthy	healthy	JJ
cord-005453-4057qib7	12215	58	donors	donor	NNS
cord-005453-4057qib7	12215	59	.	.	.
cord-005453-4057qib7	12216	1	CD3+CD8+CD95-CD27	CD3+CD8+CD95-CD27	NNP
cord-005453-4057qib7	12216	2	+	+	.
cord-005453-4057qib7	12217	1	CD28+PD1+TIGIT+	CD28+PD1+TIGIT+	NNP
cord-005453-4057qib7	12217	2	fraction	fraction	NNP
cord-005453-4057qib7	12217	3	and	and	CC
cord-005453-4057qib7	12217	4	CD3	CD3	NNP
cord-005453-4057qib7	12217	5	+	+	CC
cord-005453-4057qib7	12217	6	CD8	CD8	NNP
cord-005453-4057qib7	12218	1	+	+	CC
cord-005453-4057qib7	12219	1	control	control	NN
cord-005453-4057qib7	12219	2	fractions	fraction	NNS
cord-005453-4057qib7	12219	3	were	be	VBD
cord-005453-4057qib7	12219	4	separated	separate	VBN
cord-005453-4057qib7	12219	5	on	on	IN
cord-005453-4057qib7	12219	6	FACS	FACS	NNP
cord-005453-4057qib7	12219	7	Aria	Aria	NNP
cord-005453-4057qib7	12219	8	II	II	NNP
cord-005453-4057qib7	12219	9	cell	cell	NN
cord-005453-4057qib7	12219	10	sorter	sorter	NN
cord-005453-4057qib7	12219	11	.	.	.
cord-005453-4057qib7	12220	1	Double	double	JJ
cord-005453-4057qib7	12220	2	barcoded	barcoded	JJ
cord-005453-4057qib7	12220	3	cDNA	cdna	NN
cord-005453-4057qib7	12220	4	libraries	library	NNS
cord-005453-4057qib7	12220	5	of	of	IN
cord-005453-4057qib7	12220	6	TCR	TCR	NNP
cord-005453-4057qib7	12220	7	beta	beta	NN
cord-005453-4057qib7	12220	8	-	-	HYPH
cord-005453-4057qib7	12220	9	chains	chain	NNS
cord-005453-4057qib7	12220	10	for	for	IN
cord-005453-4057qib7	12220	11	both	both	DT
cord-005453-4057qib7	12220	12	fractions	fraction	NNS
cord-005453-4057qib7	12220	13	were	be	VBD
cord-005453-4057qib7	12220	14	prepared	prepare	VBN
cord-005453-4057qib7	12220	15	and	and	CC
cord-005453-4057qib7	12220	16	analyzed	analyze	VBN
cord-005453-4057qib7	12220	17	by	by	IN
cord-005453-4057qib7	12220	18	sequencing	sequence	VBG
cord-005453-4057qib7	12220	19	on	on	IN
cord-005453-4057qib7	12220	20	Illumina	Illumina	NNP
cord-005453-4057qib7	12220	21	platform	platform	NN
cord-005453-4057qib7	12220	22	.	.	.
cord-005453-4057qib7	12221	1	Sequencing	sequencing	NN
cord-005453-4057qib7	12221	2	results	result	NNS
cord-005453-4057qib7	12221	3	were	be	VBD
cord-005453-4057qib7	12221	4	processed	process	VBN
cord-005453-4057qib7	12221	5	by	by	IN
cord-005453-4057qib7	12221	6	MiGEC	MiGEC	NNP
cord-005453-4057qib7	12221	7	,	,	,
cord-005453-4057qib7	12221	8	MiXCR	MiXCR	NNP
cord-005453-4057qib7	12221	9	and	and	CC
cord-005453-4057qib7	12221	10	VDJTools	vdjtool	VBZ
cord-005453-4057qib7	12221	11	software	software	NN
cord-005453-4057qib7	12221	12	.	.	.
cord-005453-4057qib7	12222	1	Enriched	enriched	JJ
cord-005453-4057qib7	12222	2	clones	clone	NNS
cord-005453-4057qib7	12222	3	were	be	VBD
cord-005453-4057qib7	12222	4	identified	identify	VBN
cord-005453-4057qib7	12222	5	by	by	IN
cord-005453-4057qib7	12222	6	Fisher	Fisher	NNP
cord-005453-4057qib7	12222	7	's	's	POS
cord-005453-4057qib7	12222	8	exact	exact	JJ
cord-005453-4057qib7	12222	9	test	test	NN
cord-005453-4057qib7	12222	10	(	(	-LRB-
cord-005453-4057qib7	12222	11	p>10	p>10	NN
cord-005453-4057qib7	12222	12	-10	-10	CD
cord-005453-4057qib7	12222	13	)	)	-RRB-
cord-005453-4057qib7	12222	14	.	.	.
cord-005453-4057qib7	12223	1	Results	result	NNS
cord-005453-4057qib7	12223	2	:	:	:
cord-005453-4057qib7	12224	1	We	-PRON-	PRP
cord-005453-4057qib7	12224	2	did	do	VBD
cord-005453-4057qib7	12224	3	not	not	RB
cord-005453-4057qib7	12224	4	find	find	VB
cord-005453-4057qib7	12224	5	any	any	DT
cord-005453-4057qib7	12224	6	significant	significant	JJ
cord-005453-4057qib7	12224	7	differences	difference	NNS
cord-005453-4057qib7	12224	8	between	between	IN
cord-005453-4057qib7	12224	9	patients	patient	NNS
cord-005453-4057qib7	12224	10	after	after	IN
cord-005453-4057qib7	12224	11	allo	allo	NN
cord-005453-4057qib7	12224	12	-	-	HYPH
cord-005453-4057qib7	12224	13	HSCT	HSCT	NNP
cord-005453-4057qib7	12224	14	and	and	CC
cord-005453-4057qib7	12224	15	healthy	healthy	JJ
cord-005453-4057qib7	12224	16	donors	donor	NNS
cord-005453-4057qib7	12224	17	in	in	IN
cord-005453-4057qib7	12224	18	single	single	JJ
cord-005453-4057qib7	12224	19	marker	marker	NN
cord-005453-4057qib7	12224	20	's	's	POS
cord-005453-4057qib7	12224	21	expression	expression	NN
cord-005453-4057qib7	12224	22	,	,	,
cord-005453-4057qib7	12224	23	but	but	CC
cord-005453-4057qib7	12224	24	,	,	,
cord-005453-4057qib7	12224	25	when	when	WRB
cord-005453-4057qib7	12224	26	considering	consider	VBG
cord-005453-4057qib7	12224	27	coexpression	coexpression	NN
cord-005453-4057qib7	12224	28	of	of	IN
cord-005453-4057qib7	12224	29	co	co	JJ
cord-005453-4057qib7	12224	30	-	-	JJ
cord-005453-4057qib7	12224	31	stimulatory	stimulatory	JJ
cord-005453-4057qib7	12224	32	and	and	CC
cord-005453-4057qib7	12224	33	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12224	34	molecules	molecule	NNS
cord-005453-4057qib7	12224	35	on	on	IN
cord-005453-4057qib7	12224	36	T	t	NN
cord-005453-4057qib7	12224	37	cells	cell	NNS
cord-005453-4057qib7	12224	38	we	-PRON-	PRP
cord-005453-4057qib7	12224	39	found	find	VBD
cord-005453-4057qib7	12224	40	that	that	IN
cord-005453-4057qib7	12224	41	CD3+CD8+CD95-CD27+CD28	CD3+CD8+CD95-CD27+CD28	NNP
cord-005453-4057qib7	12224	42	+	+	SYM
cord-005453-4057qib7	12224	43	PD1+TIGIT+	pd1+tigit+	NN
cord-005453-4057qib7	12224	44	subpopulation	subpopulation	NN
cord-005453-4057qib7	12224	45	was	be	VBD
cord-005453-4057qib7	12224	46	significantly	significantly	RB
cord-005453-4057qib7	12224	47	increased	increase	VBN
cord-005453-4057qib7	12224	48	in	in	IN
cord-005453-4057qib7	12224	49	allo	allo	NN
cord-005453-4057qib7	12224	50	-	-	HYPH
cord-005453-4057qib7	12224	51	HSCT	HSCT	NNP
cord-005453-4057qib7	12224	52	patients	patient	NNS
cord-005453-4057qib7	12224	53	.	.	.
cord-005453-4057qib7	12225	1	Moreover	moreover	RB
cord-005453-4057qib7	12225	2	it	-PRON-	PRP
cord-005453-4057qib7	12225	3	increased	increase	VBD
cord-005453-4057qib7	12225	4	with	with	IN
cord-005453-4057qib7	12225	5	the	the	DT
cord-005453-4057qib7	12225	6	time	time	NN
cord-005453-4057qib7	12225	7	since	since	IN
cord-005453-4057qib7	12225	8	the	the	DT
cord-005453-4057qib7	12225	9	transplantation	transplantation	NN
cord-005453-4057qib7	12225	10	(	(	-LRB-
cord-005453-4057qib7	12225	11	Fig	Fig	NNP
cord-005453-4057qib7	12225	12	.	.	.
cord-005453-4057qib7	12225	13	1	1	CD
cord-005453-4057qib7	12225	14	)	)	-RRB-
cord-005453-4057qib7	12225	15	.	.	.
cord-005453-4057qib7	12226	1	This	this	DT
cord-005453-4057qib7	12226	2	population	population	NN
cord-005453-4057qib7	12226	3	was	be	VBD
cord-005453-4057qib7	12226	4	isolated	isolate	VBN
cord-005453-4057qib7	12226	5	by	by	IN
cord-005453-4057qib7	12226	6	cell	cell	NN
cord-005453-4057qib7	12226	7	sorting	sorting	NN
cord-005453-4057qib7	12226	8	and	and	CC
cord-005453-4057qib7	12226	9	alongside	alongside	RB
cord-005453-4057qib7	12226	10	with	with	IN
cord-005453-4057qib7	12226	11	total	total	JJ
cord-005453-4057qib7	12226	12	CD8	CD8	NNP
cord-005453-4057qib7	12226	13	+	+	CC
cord-005453-4057qib7	12226	14	fraction	fraction	NN
cord-005453-4057qib7	12226	15	subjected	subject	VBN
cord-005453-4057qib7	12226	16	to	to	IN
cord-005453-4057qib7	12226	17	TCR	TCR	NNP
cord-005453-4057qib7	12226	18	beta	beta	JJ
cord-005453-4057qib7	12226	19	-	-	HYPH
cord-005453-4057qib7	12226	20	chain	chain	NN
cord-005453-4057qib7	12226	21	repertoire	repertoire	NN
cord-005453-4057qib7	12226	22	sequencing	sequencing	NN
cord-005453-4057qib7	12226	23	.	.	.
cord-005453-4057qib7	12227	1	The	the	DT
cord-005453-4057qib7	12227	2	population	population	NN
cord-005453-4057qib7	12227	3	contained	contain	VBD
cord-005453-4057qib7	12227	4	clones	clone	NNS
cord-005453-4057qib7	12227	5	significantly	significantly	RB
cord-005453-4057qib7	12227	6	enriched	enrich	VBN
cord-005453-4057qib7	12227	7	compared	compare	VBN
cord-005453-4057qib7	12227	8	with	with	IN
cord-005453-4057qib7	12227	9	CD8	CD8	NNP
cord-005453-4057qib7	12227	10	+	+	CC
cord-005453-4057qib7	12227	11	fraction	fraction	NN
cord-005453-4057qib7	12227	12	representing	represent	VBG
cord-005453-4057qib7	12227	13	potentially	potentially	RB
cord-005453-4057qib7	12227	14	alloreactive	alloreactive	JJ
cord-005453-4057qib7	12227	15	cells	cell	NNS
cord-005453-4057qib7	12227	16	.	.	.
cord-005453-4057qib7	12228	1	This	this	DT
cord-005453-4057qib7	12228	2	hypothesis	hypothesis	NN
cord-005453-4057qib7	12228	3	is	be	VBZ
cord-005453-4057qib7	12228	4	further	further	RB
cord-005453-4057qib7	12228	5	supported	support	VBN
cord-005453-4057qib7	12228	6	by	by	IN
cord-005453-4057qib7	12228	7	the	the	DT
cord-005453-4057qib7	12228	8	notion	notion	NN
cord-005453-4057qib7	12228	9	that	that	IN
cord-005453-4057qib7	12228	10	the	the	DT
cord-005453-4057qib7	12228	11	level	level	NN
cord-005453-4057qib7	12228	12	of	of	IN
cord-005453-4057qib7	12228	13	expression	expression	NN
cord-005453-4057qib7	12228	14	of	of	IN
cord-005453-4057qib7	12228	15	CD27	CD27	NNP
cord-005453-4057qib7	12228	16	and	and	CC
cord-005453-4057qib7	12228	17	CD28	CD28	NNP
cord-005453-4057qib7	12228	18	co	co	VBD
cord-005453-4057qib7	12228	19	-	-	JJ
cord-005453-4057qib7	12228	20	stimulatory	stimulatory	JJ
cord-005453-4057qib7	12228	21	molecules	molecule	NNS
cord-005453-4057qib7	12228	22	is	be	VBZ
cord-005453-4057qib7	12228	23	lower	low	JJR
cord-005453-4057qib7	12228	24	in	in	IN
cord-005453-4057qib7	12228	25	the	the	DT
cord-005453-4057qib7	12228	26	group	group	NN
cord-005453-4057qib7	12228	27	of	of	IN
cord-005453-4057qib7	12228	28	patients	patient	NNS
cord-005453-4057qib7	12228	29	who	who	WP
cord-005453-4057qib7	12228	30	subsequently	subsequently	RB
cord-005453-4057qib7	12228	31	relapsed	relapse	VBD
cord-005453-4057qib7	12228	32	,	,	,
cord-005453-4057qib7	12228	33	compared	compare	VBN
cord-005453-4057qib7	12228	34	with	with	IN
cord-005453-4057qib7	12228	35	the	the	DT
cord-005453-4057qib7	12228	36	patients	patient	NNS
cord-005453-4057qib7	12228	37	with	with	IN
cord-005453-4057qib7	12228	38	complete	complete	JJ
cord-005453-4057qib7	12228	39	remission	remission	NN
cord-005453-4057qib7	12228	40	,	,	,
cord-005453-4057qib7	12228	41	while	while	IN
cord-005453-4057qib7	12228	42	the	the	DT
cord-005453-4057qib7	12228	43	expression	expression	NN
cord-005453-4057qib7	12228	44	of	of	IN
cord-005453-4057qib7	12228	45	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12228	46	receptors	receptor	NNS
cord-005453-4057qib7	12228	47	was	be	VBD
cord-005453-4057qib7	12228	48	high	high	JJ
cord-005453-4057qib7	12228	49	in	in	IN
cord-005453-4057qib7	12228	50	both	both	DT
cord-005453-4057qib7	12228	51	groups	group	NNS
cord-005453-4057qib7	12228	52	.	.	.
cord-005453-4057qib7	12229	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12229	2	:	:	:
cord-005453-4057qib7	12230	1	According	accord	VBG
cord-005453-4057qib7	12230	2	to	to	IN
cord-005453-4057qib7	12230	3	our	-PRON-	PRP$
cord-005453-4057qib7	12230	4	data	data	NN
cord-005453-4057qib7	12230	5	patients	patient	NNS
cord-005453-4057qib7	12230	6	after	after	IN
cord-005453-4057qib7	12230	7	allo	allo	NN
cord-005453-4057qib7	12230	8	-	-	HYPH
cord-005453-4057qib7	12230	9	HSCT	HSCT	NNP
cord-005453-4057qib7	12230	10	have	have	VBP
cord-005453-4057qib7	12230	11	a	a	DT
cord-005453-4057qib7	12230	12	phenotypically	phenotypically	RB
cord-005453-4057qib7	12230	13	distinct	distinct	JJ
cord-005453-4057qib7	12230	14	T	t	NN
cord-005453-4057qib7	12230	15	-	-	HYPH
cord-005453-4057qib7	12230	16	cell	cell	NN
cord-005453-4057qib7	12230	17	population	population	NN
cord-005453-4057qib7	12230	18	characterized	characterize	VBN
cord-005453-4057qib7	12230	19	by	by	IN
cord-005453-4057qib7	12230	20	simultaneous	simultaneous	JJ
cord-005453-4057qib7	12230	21	expression	expression	NN
cord-005453-4057qib7	12230	22	of	of	IN
cord-005453-4057qib7	12230	23	costimulatory	costimulatory	NN
cord-005453-4057qib7	12230	24	and	and	CC
cord-005453-4057qib7	12230	25	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12230	26	markers	marker	NNS
cord-005453-4057qib7	12230	27	.	.	.
cord-005453-4057qib7	12231	1	This	this	DT
cord-005453-4057qib7	12231	2	population	population	NN
cord-005453-4057qib7	12231	3	contains	contain	VBZ
cord-005453-4057qib7	12231	4	specifically	specifically	RB
cord-005453-4057qib7	12231	5	enriched	enrich	VBN
cord-005453-4057qib7	12231	6	clones	clone	NNS
cord-005453-4057qib7	12231	7	,	,	,
cord-005453-4057qib7	12231	8	which	which	WDT
cord-005453-4057qib7	12231	9	may	may	MD
cord-005453-4057qib7	12231	10	be	be	VB
cord-005453-4057qib7	12231	11	specific	specific	JJ
cord-005453-4057qib7	12231	12	for	for	IN
cord-005453-4057qib7	12231	13	alloantigens	alloantigens	NNP
cord-005453-4057qib7	12231	14	.	.	.
cord-005453-4057qib7	12232	1	Further	further	JJ
cord-005453-4057qib7	12232	2	functional	functional	JJ
cord-005453-4057qib7	12232	3	assays	assay	NNS
cord-005453-4057qib7	12232	4	are	be	VBP
cord-005453-4057qib7	12232	5	needed	need	VBN
cord-005453-4057qib7	12232	6	to	to	TO
cord-005453-4057qib7	12232	7	confirm	confirm	VB
cord-005453-4057qib7	12232	8	the	the	DT
cord-005453-4057qib7	12232	9	alloreactive	alloreactive	JJ
cord-005453-4057qib7	12232	10	potential	potential	NN
cord-005453-4057qib7	12232	11	of	of	IN
cord-005453-4057qib7	12232	12	this	this	DT
cord-005453-4057qib7	12232	13	subpopulation	subpopulation	NN
cord-005453-4057qib7	12232	14	.	.	.
cord-005453-4057qib7	12233	1	Besides	besides	IN
cord-005453-4057qib7	12233	2	low	low	JJ
cord-005453-4057qib7	12233	3	expression	expression	NN
cord-005453-4057qib7	12233	4	of	of	IN
cord-005453-4057qib7	12233	5	costimulatory	costimulatory	NN
cord-005453-4057qib7	12233	6	molecules	molecule	NNS
cord-005453-4057qib7	12233	7	combined	combine	VBN
cord-005453-4057qib7	12233	8	with	with	IN
cord-005453-4057qib7	12233	9	high	high	JJ
cord-005453-4057qib7	12233	10	expression	expression	NN
cord-005453-4057qib7	12233	11	of	of	IN
cord-005453-4057qib7	12233	12	inhibitory	inhibitory	JJ
cord-005453-4057qib7	12233	13	receptors	receptor	NNS
cord-005453-4057qib7	12233	14	on	on	IN
cord-005453-4057qib7	12233	15	antigen	antigen	NN
cord-005453-4057qib7	12233	16	-	-	HYPH
cord-005453-4057qib7	12233	17	experienced	experience	VBN
cord-005453-4057qib7	12233	18	T	t	NN
cord-005453-4057qib7	12233	19	-	-	HYPH
cord-005453-4057qib7	12233	20	cells	cell	NNS
cord-005453-4057qib7	12233	21	of	of	IN
cord-005453-4057qib7	12233	22	patients	patient	NNS
cord-005453-4057qib7	12233	23	after	after	IN
cord-005453-4057qib7	12233	24	allo	allo	NN
cord-005453-4057qib7	12233	25	-	-	HYPH
cord-005453-4057qib7	12233	26	HSCT	HSCT	NNP
cord-005453-4057qib7	12233	27	might	may	MD
cord-005453-4057qib7	12233	28	be	be	VB
cord-005453-4057qib7	12233	29	associated	associate	VBN
cord-005453-4057qib7	12233	30	with	with	IN
cord-005453-4057qib7	12233	31	a	a	DT
cord-005453-4057qib7	12233	32	disease	disease	NN
cord-005453-4057qib7	12233	33	relapse	relapse	NN
cord-005453-4057qib7	12233	34	.	.	.
cord-005453-4057qib7	12234	1	Fondazione	Fondazione	NNP
cord-005453-4057qib7	12234	2	MBBM	MBBM	NNP
cord-005453-4057qib7	12234	3	,	,	,
cord-005453-4057qib7	12234	4	Monza	Monza	NNP
cord-005453-4057qib7	12234	5	,	,	,
cord-005453-4057qib7	12234	6	Italy	Italy	NNP
cord-005453-4057qib7	12234	7	,	,	,
cord-005453-4057qib7	12234	8	3	3	CD
cord-005453-4057qib7	12234	9	Ospedale	Ospedale	NNP
cord-005453-4057qib7	12234	10	San	San	NNP
cord-005453-4057qib7	12234	11	Gerardo	Gerardo	NNP
cord-005453-4057qib7	12234	12	,	,	,
cord-005453-4057qib7	12234	13	Laboratorio	Laboratorio	NNP
cord-005453-4057qib7	12234	14	Stefano	Stefano	NNP
cord-005453-4057qib7	12234	15	Verri	Verri	NNP
cord-005453-4057qib7	12234	16	,	,	,
cord-005453-4057qib7	12234	17	Monza	Monza	NNP
cord-005453-4057qib7	12234	18	,	,	,
cord-005453-4057qib7	12234	19	Italy	Italy	NNP
cord-005453-4057qib7	12234	20	Background	Background	NNP
cord-005453-4057qib7	12234	21	:	:	:
cord-005453-4057qib7	12234	22	Poor	poor	JJ
cord-005453-4057qib7	12234	23	graft	graft	NN
cord-005453-4057qib7	12234	24	function	function	NN
cord-005453-4057qib7	12234	25	(	(	-LRB-
cord-005453-4057qib7	12234	26	PGF	PGF	NNP
cord-005453-4057qib7	12234	27	)	)	-RRB-
cord-005453-4057qib7	12234	28	is	be	VBZ
cord-005453-4057qib7	12234	29	a	a	DT
cord-005453-4057qib7	12234	30	severe	severe	JJ
cord-005453-4057qib7	12234	31	complication	complication	NN
cord-005453-4057qib7	12234	32	after	after	IN
cord-005453-4057qib7	12234	33	HSCT	HSCT	NNP
cord-005453-4057qib7	12234	34	,	,	,
cord-005453-4057qib7	12234	35	with	with	IN
cord-005453-4057qib7	12234	36	a	a	DT
cord-005453-4057qib7	12234	37	high	high	JJ
cord-005453-4057qib7	12234	38	risk	risk	NN
cord-005453-4057qib7	12234	39	of	of	IN
cord-005453-4057qib7	12234	40	morbidity	morbidity	NN
cord-005453-4057qib7	12234	41	and	and	CC
cord-005453-4057qib7	12234	42	mortality	mortality	NN
cord-005453-4057qib7	12234	43	,	,	,
cord-005453-4057qib7	12234	44	mainly	mainly	RB
cord-005453-4057qib7	12234	45	due	due	IN
cord-005453-4057qib7	12234	46	to	to	IN
cord-005453-4057qib7	12234	47	infections	infection	NNS
cord-005453-4057qib7	12234	48	.	.	.
cord-005453-4057qib7	12235	1	Donor	Donor	NNP
cord-005453-4057qib7	12235	2	CD34	CD34	NNP
cord-005453-4057qib7	12235	3	+	+	CC
cord-005453-4057qib7	12235	4	SCB	SCB	NNP
cord-005453-4057qib7	12235	5	seems	seem	VBZ
cord-005453-4057qib7	12235	6	to	to	TO
cord-005453-4057qib7	12235	7	offer	offer	VB
cord-005453-4057qib7	12235	8	high	high	JJ
cord-005453-4057qib7	12235	9	chances	chance	NNS
cord-005453-4057qib7	12235	10	of	of	IN
cord-005453-4057qib7	12235	11	haematological	haematological	NN
cord-005453-4057qib7	12235	12	recovery	recovery	NN
cord-005453-4057qib7	12235	13	,	,	,
cord-005453-4057qib7	12235	14	not	not	RB
cord-005453-4057qib7	12235	15	jeopardized	jeopardize	VBN
cord-005453-4057qib7	12235	16	by	by	IN
cord-005453-4057qib7	12235	17	GvHD	GvHD	NNP
cord-005453-4057qib7	12235	18	.	.	.
cord-005453-4057qib7	12236	1	However	however	RB
cord-005453-4057qib7	12236	2	,	,	,
cord-005453-4057qib7	12236	3	pediatric	pediatric	JJ
cord-005453-4057qib7	12236	4	reports	report	NNS
cord-005453-4057qib7	12236	5	remain	remain	VBP
cord-005453-4057qib7	12236	6	scarce	scarce	JJ
cord-005453-4057qib7	12236	7	.	.	.
cord-005453-4057qib7	12237	1	Methods	method	NNS
cord-005453-4057qib7	12237	2	:	:	:
cord-005453-4057qib7	12237	3	19	19	CD
cord-005453-4057qib7	12237	4	out	out	IN
cord-005453-4057qib7	12237	5	of	of	IN
cord-005453-4057qib7	12237	6	215	215	CD
cord-005453-4057qib7	12237	7	patients	patient	NNS
cord-005453-4057qib7	12237	8	undergoing	undergo	VBG
cord-005453-4057qib7	12237	9	transplantation	transplantation	NN
cord-005453-4057qib7	12237	10	in	in	IN
cord-005453-4057qib7	12237	11	our	-PRON-	PRP$
cord-005453-4057qib7	12237	12	pediatric	pediatric	JJ
cord-005453-4057qib7	12237	13	unit	unit	NN
cord-005453-4057qib7	12237	14	from	from	IN
cord-005453-4057qib7	12237	15	2012	2012	CD
cord-005453-4057qib7	12237	16	to	to	IN
cord-005453-4057qib7	12237	17	2018	2018	CD
cord-005453-4057qib7	12237	18	have	have	VBP
cord-005453-4057qib7	12237	19	been	be	VBN
cord-005453-4057qib7	12237	20	retrospectively	retrospectively	RB
cord-005453-4057qib7	12237	21	evaluated	evaluate	VBN
cord-005453-4057qib7	12237	22	for	for	IN
cord-005453-4057qib7	12237	23	at	at	RB
cord-005453-4057qib7	12237	24	least	least	JJS
cord-005453-4057qib7	12237	25	2	2	CD
cord-005453-4057qib7	12237	26	line	line	NN
cord-005453-4057qib7	12237	27	persistent	persistent	JJ
cord-005453-4057qib7	12237	28	cytopenia	cytopenia	NNS
cord-005453-4057qib7	12237	29	(	(	-LRB-
cord-005453-4057qib7	12237	30	Hb	Hb	NNP
cord-005453-4057qib7	12237	31	<	<	XX
cord-005453-4057qib7	12237	32	9.5g	9.5g	CD
cord-005453-4057qib7	12237	33	/	/	SYM
cord-005453-4057qib7	12237	34	dl	dl	NN
cord-005453-4057qib7	12237	35	,	,	,
cord-005453-4057qib7	12237	36	PLT	PLT	NNP
cord-005453-4057qib7	12237	37	<	<	XX
cord-005453-4057qib7	12237	38	30000	30000	CD
cord-005453-4057qib7	12237	39	/	/	SYM
cord-005453-4057qib7	12237	40	mmc	mmc	NN
cord-005453-4057qib7	12237	41	,	,	,
cord-005453-4057qib7	12237	42	N	N	NNP
cord-005453-4057qib7	12237	43	<	<	XX
cord-005453-4057qib7	12237	44	1000/	1000/	CD
cord-005453-4057qib7	12237	45	mmc	mmc	NNS
cord-005453-4057qib7	12237	46	)	)	-RRB-
cord-005453-4057qib7	12237	47	and/or	and/or	CC
cord-005453-4057qib7	12237	48	transfusion	transfusion	NN
cord-005453-4057qib7	12237	49	-	-	HYPH
cord-005453-4057qib7	12237	50	dependency	dependency	NN
cord-005453-4057qib7	12237	51	beyond	beyond	IN
cord-005453-4057qib7	12237	52	3	3	CD
cord-005453-4057qib7	12237	53	months	month	NNS
cord-005453-4057qib7	12237	54	after	after	IN
cord-005453-4057qib7	12237	55	HSCT	HSCT	NNP
cord-005453-4057qib7	12237	56	in	in	IN
cord-005453-4057qib7	12237	57	the	the	DT
cord-005453-4057qib7	12237	58	presence	presence	NN
cord-005453-4057qib7	12237	59	of	of	IN
cord-005453-4057qib7	12237	60	full	full	JJ
cord-005453-4057qib7	12237	61	donor	donor	NN
cord-005453-4057qib7	12237	62	chimerism	chimerism	NN
cord-005453-4057qib7	12237	63	.	.	.
cord-005453-4057qib7	12238	1	Bone	bone	NN
cord-005453-4057qib7	12238	2	marrow	marrow	NN
cord-005453-4057qib7	12238	3	cellularity	cellularity	NN
cord-005453-4057qib7	12238	4	was	be	VBD
cord-005453-4057qib7	12238	5	evaluated	evaluate	VBN
cord-005453-4057qib7	12238	6	through	through	IN
cord-005453-4057qib7	12238	7	biopsy	biopsy	NN
cord-005453-4057qib7	12238	8	as	as	IN
cord-005453-4057qib7	12238	9	further	further	JJ
cord-005453-4057qib7	12238	10	indicator	indicator	NN
cord-005453-4057qib7	12238	11	of	of	IN
cord-005453-4057qib7	12238	12	PGF	PGF	NNP
cord-005453-4057qib7	12238	13	.	.	.
cord-005453-4057qib7	12239	1	(	(	-LRB-
cord-005453-4057qib7	12239	2	1/8	1/8	CD
cord-005453-4057qib7	12239	3	)	)	-RRB-
cord-005453-4057qib7	12239	4	to	to	TO
cord-005453-4057qib7	12239	5	donate	donate	VB
cord-005453-4057qib7	12239	6	or	or	CC
cord-005453-4057qib7	12239	7	medical	medical	JJ
cord-005453-4057qib7	12239	8	decision	decision	NN
cord-005453-4057qib7	12239	9	(	(	-LRB-
cord-005453-4057qib7	12239	10	7/8	7/8	CD
cord-005453-4057qib7	12239	11	)	)	-RRB-
cord-005453-4057qib7	12239	12	.	.	.
cord-005453-4057qib7	12240	1	Bone	bone	NN
cord-005453-4057qib7	12240	2	marrow	marrow	NN
cord-005453-4057qib7	12240	3	cellularity	cellularity	NN
cord-005453-4057qib7	12240	4	was	be	VBD
cord-005453-4057qib7	12240	5	<	<	XX
cord-005453-4057qib7	12240	6	5	5	CD
cord-005453-4057qib7	12240	7	%	%	NN
cord-005453-4057qib7	12240	8	in	in	IN
cord-005453-4057qib7	12240	9	50	50	CD
cord-005453-4057qib7	12240	10	%	%	NN
cord-005453-4057qib7	12240	11	of	of	IN
cord-005453-4057qib7	12240	12	the	the	DT
cord-005453-4057qib7	12240	13	patients	patient	NNS
cord-005453-4057qib7	12240	14	who	who	WP
cord-005453-4057qib7	12240	15	underwent	undergo	VBD
cord-005453-4057qib7	12240	16	SCB	SCB	NNP
cord-005453-4057qib7	12240	17	for	for	IN
cord-005453-4057qib7	12240	18	which	which	WDT
cord-005453-4057qib7	12240	19	the	the	DT
cord-005453-4057qib7	12240	20	histology	histology	NN
cord-005453-4057qib7	12240	21	was	be	VBD
cord-005453-4057qib7	12240	22	available	available	JJ
cord-005453-4057qib7	12240	23	(	(	-LRB-
cord-005453-4057qib7	12240	24	8	8	CD
cord-005453-4057qib7	12240	25	cases	case	NNS
cord-005453-4057qib7	12240	26	)	)	-RRB-
cord-005453-4057qib7	12240	27	,	,	,
cord-005453-4057qib7	12240	28	and	and	CC
cord-005453-4057qib7	12240	29	25	25	CD
cord-005453-4057qib7	12240	30	%	%	NN
cord-005453-4057qib7	12240	31	in	in	IN
cord-005453-4057qib7	12240	32	those	those	DT
cord-005453-4057qib7	12240	33	who	who	WP
cord-005453-4057qib7	12240	34	have	have	VBP
cord-005453-4057qib7	12240	35	not	not	RB
cord-005453-4057qib7	12240	36	been	be	VBN
cord-005453-4057qib7	12240	37	treated	treat	VBN
cord-005453-4057qib7	12240	38	(	(	-LRB-
cord-005453-4057qib7	12240	39	2/8	2/8	CD
cord-005453-4057qib7	12240	40	)	)	-RRB-
cord-005453-4057qib7	12240	41	.	.	.
cord-005453-4057qib7	12241	1	At	at	IN
cord-005453-4057qib7	12241	2	30	30	CD
cord-005453-4057qib7	12241	3	days	day	NNS
cord-005453-4057qib7	12241	4	after	after	IN
cord-005453-4057qib7	12241	5	SCB	SCB	NNP
cord-005453-4057qib7	12241	6	10/11	10/11	CD
cord-005453-4057qib7	12241	7	(	(	-LRB-
cord-005453-4057qib7	12241	8	91	91	CD
cord-005453-4057qib7	12241	9	%	%	NN
cord-005453-4057qib7	12241	10	)	)	-RRB-
cord-005453-4057qib7	12241	11	patients	patient	NNS
cord-005453-4057qib7	12241	12	had	have	VBD
cord-005453-4057qib7	12241	13	hematological	hematological	JJ
cord-005453-4057qib7	12241	14	response	response	NN
cord-005453-4057qib7	12241	15	,	,	,
cord-005453-4057qib7	12241	16	which	which	WDT
cord-005453-4057qib7	12241	17	was	be	VBD
cord-005453-4057qib7	12241	18	complete	complete	JJ
cord-005453-4057qib7	12241	19	in	in	IN
cord-005453-4057qib7	12241	20	46	46	CD
cord-005453-4057qib7	12241	21	%	%	NN
cord-005453-4057qib7	12241	22	and	and	CC
cord-005453-4057qib7	12241	23	partial	partial	JJ
cord-005453-4057qib7	12241	24	in	in	IN
cord-005453-4057qib7	12241	25	45	45	CD
cord-005453-4057qib7	12241	26	%	%	NN
cord-005453-4057qib7	12241	27	of	of	IN
cord-005453-4057qib7	12241	28	the	the	DT
cord-005453-4057qib7	12241	29	patients	patient	NNS
cord-005453-4057qib7	12241	30	.	.	.
cord-005453-4057qib7	12242	1	Only	only	RB
cord-005453-4057qib7	12242	2	1	1	CD
cord-005453-4057qib7	12242	3	patient	patient	NN
cord-005453-4057qib7	12242	4	had	have	VBD
cord-005453-4057qib7	12242	5	no	no	DT
cord-005453-4057qib7	12242	6	response	response	NN
cord-005453-4057qib7	12242	7	.	.	.
cord-005453-4057qib7	12243	1	The	the	DT
cord-005453-4057qib7	12243	2	infusion	infusion	NN
cord-005453-4057qib7	12243	3	was	be	VBD
cord-005453-4057qib7	12243	4	always	always	RB
cord-005453-4057qib7	12243	5	well	well	RB
cord-005453-4057qib7	12243	6	tolerated	tolerate	VBN
cord-005453-4057qib7	12243	7	with	with	IN
cord-005453-4057qib7	12243	8	no	no	DT
cord-005453-4057qib7	12243	9	adverse	adverse	JJ
cord-005453-4057qib7	12243	10	events	event	NNS
cord-005453-4057qib7	12243	11	,	,	,
cord-005453-4057qib7	12243	12	and	and	CC
cord-005453-4057qib7	12243	13	no	no	DT
cord-005453-4057qib7	12243	14	worsening	worsening	NN
cord-005453-4057qib7	12243	15	of	of	IN
cord-005453-4057qib7	12243	16	GvHD	GvHD	NNP
cord-005453-4057qib7	12243	17	.	.	.
cord-005453-4057qib7	12244	1	Haematological	Haematological	NNP
cord-005453-4057qib7	12244	2	recovery	recovery	NN
cord-005453-4057qib7	12244	3	occurred	occur	VBD
cord-005453-4057qib7	12244	4	spontaneously	spontaneously	RB
cord-005453-4057qib7	12244	5	at	at	IN
cord-005453-4057qib7	12244	6	30	30	CD
cord-005453-4057qib7	12244	7	days	day	NNS
cord-005453-4057qib7	12244	8	after	after	IN
cord-005453-4057qib7	12244	9	bone	bone	NN
cord-005453-4057qib7	12244	10	marrow	marrow	NN
cord-005453-4057qib7	12244	11	biopsy	biopsy	NN
cord-005453-4057qib7	12244	12	in	in	IN
cord-005453-4057qib7	12244	13	a	a	DT
cord-005453-4057qib7	12244	14	significantly	significantly	RB
cord-005453-4057qib7	12244	15	lower	low	JJR
cord-005453-4057qib7	12244	16	proportion	proportion	NN
cord-005453-4057qib7	12244	17	of	of	IN
cord-005453-4057qib7	12244	18	patients	patient	NNS
cord-005453-4057qib7	12244	19	(	(	-LRB-
cord-005453-4057qib7	12244	20	2/8	2/8	CD
cord-005453-4057qib7	12244	21	,	,	,
cord-005453-4057qib7	12244	22	25	25	CD
cord-005453-4057qib7	12244	23	%	%	NN
cord-005453-4057qib7	12244	24	,	,	,
cord-005453-4057qib7	12244	25	p	p	NN
cord-005453-4057qib7	12244	26	<	<	XX
cord-005453-4057qib7	12244	27	0.05	0.05	CD
cord-005453-4057qib7	12244	28	)	)	-RRB-
cord-005453-4057qib7	12244	29	within	within	IN
cord-005453-4057qib7	12244	30	the	the	DT
cord-005453-4057qib7	12244	31	non	non	JJ
cord-005453-4057qib7	12244	32	-	-	JJ
cord-005453-4057qib7	12244	33	SCB	SCB	NNP
cord-005453-4057qib7	12244	34	group	group	NN
cord-005453-4057qib7	12244	35	.	.	.
cord-005453-4057qib7	12245	1	In	in	IN
cord-005453-4057qib7	12245	2	two	two	CD
cord-005453-4057qib7	12245	3	cases	case	NNS
cord-005453-4057qib7	12245	4	platelets	platelet	NNS
cord-005453-4057qib7	12245	5	engraftment	engraftment	NN
cord-005453-4057qib7	12245	6	was	be	VBD
cord-005453-4057qib7	12245	7	significantly	significantly	RB
cord-005453-4057qib7	12245	8	delayed	delay	VBN
cord-005453-4057qib7	12245	9	,	,	,
cord-005453-4057qib7	12245	10	up	up	IN
cord-005453-4057qib7	12245	11	to	to	IN
cord-005453-4057qib7	12245	12	one	one	CD
cord-005453-4057qib7	12245	13	year	year	NN
cord-005453-4057qib7	12245	14	after	after	IN
cord-005453-4057qib7	12245	15	bone	bone	NN
cord-005453-4057qib7	12245	16	marrow	marrow	NN
cord-005453-4057qib7	12245	17	biopsy	biopsy	NN
cord-005453-4057qib7	12245	18	and	and	CC
cord-005453-4057qib7	12245	19	in	in	IN
cord-005453-4057qib7	12245	20	one	one	CD
cord-005453-4057qib7	12245	21	case	case	NN
cord-005453-4057qib7	12245	22	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	12245	23	persists	persist	VBZ
cord-005453-4057qib7	12245	24	and	and	CC
cord-005453-4057qib7	12245	25	the	the	DT
cord-005453-4057qib7	12245	26	patient	patient	NN
cord-005453-4057qib7	12245	27	is	be	VBZ
cord-005453-4057qib7	12245	28	still	still	RB
cord-005453-4057qib7	12245	29	receiving	receive	VBG
cord-005453-4057qib7	12245	30	thrombopoietin	thrombopoietin	NNP
cord-005453-4057qib7	12245	31	agonists	agonist	NNS
cord-005453-4057qib7	12245	32	and	and	CC
cord-005453-4057qib7	12245	33	red	red	JJ
cord-005453-4057qib7	12245	34	blood	blood	NN
cord-005453-4057qib7	12245	35	cells	cell	NNS
cord-005453-4057qib7	12245	36	transfusions	transfusion	NNS
cord-005453-4057qib7	12245	37	at	at	IN
cord-005453-4057qib7	12245	38	9	9	CD
cord-005453-4057qib7	12245	39	months	month	NNS
cord-005453-4057qib7	12245	40	after	after	IN
cord-005453-4057qib7	12245	41	bone	bone	NN
cord-005453-4057qib7	12245	42	marrow	marrow	NN
cord-005453-4057qib7	12245	43	biopsy	biopsy	NN
cord-005453-4057qib7	12245	44	.	.	.
cord-005453-4057qib7	12246	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12246	2	:	:	:
cord-005453-4057qib7	12247	1	A	a	DT
cord-005453-4057qib7	12247	2	stem	stem	NN
cord-005453-4057qib7	12247	3	cell	cell	NN
cord-005453-4057qib7	12247	4	boost	boost	NN
cord-005453-4057qib7	12247	5	matched	match	VBD
cord-005453-4057qib7	12247	6	the	the	DT
cord-005453-4057qib7	12247	7	goal	goal	NN
cord-005453-4057qib7	12247	8	to	to	TO
cord-005453-4057qib7	12247	9	yield	yield	VB
cord-005453-4057qib7	12247	10	count	count	NN
cord-005453-4057qib7	12247	11	recovery	recovery	NN
cord-005453-4057qib7	12247	12	in	in	IN
cord-005453-4057qib7	12247	13	our	-PRON-	PRP$
cord-005453-4057qib7	12247	14	cohort	cohort	NN
cord-005453-4057qib7	12247	15	.	.	.
cord-005453-4057qib7	12248	1	Viral	viral	JJ
cord-005453-4057qib7	12248	2	infections	infection	NNS
cord-005453-4057qib7	12248	3	and	and	CC
cord-005453-4057qib7	12248	4	GvHD	GvHD	NNP
cord-005453-4057qib7	12248	5	may	may	MD
cord-005453-4057qib7	12248	6	be	be	VB
cord-005453-4057qib7	12248	7	possible	possible	JJ
cord-005453-4057qib7	12248	8	risk	risk	NN
cord-005453-4057qib7	12248	9	factors	factor	NNS
cord-005453-4057qib7	12248	10	for	for	IN
cord-005453-4057qib7	12248	11	PGF.Bilinear	PGF.Bilinear	NNP
cord-005453-4057qib7	12248	12	or	or	CC
cord-005453-4057qib7	12248	13	trilinear	trilinear	NN
cord-005453-4057qib7	12248	14	cytopenia	cytopenia	NNP
cord-005453-4057qib7	12248	15	with	with	IN
cord-005453-4057qib7	12248	16	transfusion	transfusion	NN
cord-005453-4057qib7	12248	17	dependency	dependency	NN
cord-005453-4057qib7	12248	18	and	and	CC
cord-005453-4057qib7	12248	19	BOM	BOM	NNP
cord-005453-4057qib7	12248	20	cellularity	cellularity	NNP
cord-005453-4057qib7	12248	21	<	<	XX
cord-005453-4057qib7	12248	22	5	5	CD
cord-005453-4057qib7	12248	23	%	%	NN
cord-005453-4057qib7	12248	24	and	and	CC
cord-005453-4057qib7	12248	25	full	full	JJ
cord-005453-4057qib7	12248	26	donor	donor	NN
cord-005453-4057qib7	12248	27	chimerism	chimerism	NN
cord-005453-4057qib7	12248	28	are	be	VBP
cord-005453-4057qib7	12248	29	good	good	JJ
cord-005453-4057qib7	12248	30	indications	indication	NNS
cord-005453-4057qib7	12248	31	for	for	IN
cord-005453-4057qib7	12248	32	SCB	SCB	NNP
cord-005453-4057qib7	12248	33	,	,	,
cord-005453-4057qib7	12248	34	that	that	WDT
cord-005453-4057qib7	12248	35	can	can	MD
cord-005453-4057qib7	12248	36	provide	provide	VB
cord-005453-4057qib7	12248	37	a	a	DT
cord-005453-4057qib7	12248	38	significantly	significantly	RB
cord-005453-4057qib7	12248	39	earlier	early	JJR
cord-005453-4057qib7	12248	40	hematological	hematological	JJ
cord-005453-4057qib7	12248	41	reconstitution	reconstitution	NN
cord-005453-4057qib7	12248	42	,	,	,
cord-005453-4057qib7	12248	43	without	without	IN
cord-005453-4057qib7	12248	44	risks	risk	NNS
cord-005453-4057qib7	12248	45	of	of	IN
cord-005453-4057qib7	12248	46	GvHD	GvHD	NNP
cord-005453-4057qib7	12248	47	.	.	.
cord-005453-4057qib7	12249	1	Due	due	IN
cord-005453-4057qib7	12249	2	to	to	IN
cord-005453-4057qib7	12249	3	the	the	DT
cord-005453-4057qib7	12249	4	proved	prove	VBN
cord-005453-4057qib7	12249	5	early	early	JJ
cord-005453-4057qib7	12249	6	efficacy	efficacy	NN
cord-005453-4057qib7	12249	7	and	and	CC
cord-005453-4057qib7	12249	8	safety	safety	NN
cord-005453-4057qib7	12249	9	of	of	IN
cord-005453-4057qib7	12249	10	CD34	CD34	NNP
cord-005453-4057qib7	12249	11	+	+	CC
cord-005453-4057qib7	12249	12	stem	stem	NN
cord-005453-4057qib7	12249	13	cell	cell	NN
cord-005453-4057qib7	12249	14	infusion	infusion	NN
cord-005453-4057qib7	12249	15	,	,	,
cord-005453-4057qib7	12249	16	we	-PRON-	PRP
cord-005453-4057qib7	12249	17	suggest	suggest	VBP
cord-005453-4057qib7	12249	18	that	that	IN
cord-005453-4057qib7	12249	19	this	this	DT
cord-005453-4057qib7	12249	20	procedure	procedure	NN
cord-005453-4057qib7	12249	21	should	should	MD
cord-005453-4057qib7	12249	22	be	be	VB
cord-005453-4057qib7	12249	23	taken	take	VBN
cord-005453-4057qib7	12249	24	in	in	IN
cord-005453-4057qib7	12249	25	consideration	consideration	NN
cord-005453-4057qib7	12249	26	in	in	IN
cord-005453-4057qib7	12249	27	children	child	NNS
cord-005453-4057qib7	12249	28	with	with	IN
cord-005453-4057qib7	12249	29	severe	severe	JJ
cord-005453-4057qib7	12249	30	bone	bone	NN
cord-005453-4057qib7	12249	31	marrow	marrow	NN
cord-005453-4057qib7	12249	32	hypoplasia	hypoplasia	NN
cord-005453-4057qib7	12249	33	and	and	CC
cord-005453-4057qib7	12249	34	persistent	persistent	JJ
cord-005453-4057qib7	12249	35	cytopenia	cytopenia	NNS
cord-005453-4057qib7	12249	36	after	after	IN
cord-005453-4057qib7	12249	37	HSCT	HSCT	NNP
cord-005453-4057qib7	12249	38	.	.	.
cord-005453-4057qib7	12250	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12250	2	Background	background	NN
cord-005453-4057qib7	12250	3	:	:	:
cord-005453-4057qib7	12251	1	As	as	IN
cord-005453-4057qib7	12251	2	allogeneic	allogeneic	IN
cord-005453-4057qib7	12251	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12251	4	stem	stem	NN
cord-005453-4057qib7	12251	5	cell	cell	NN
cord-005453-4057qib7	12251	6	transplantation	transplantation	NN
cord-005453-4057qib7	12251	7	(	(	-LRB-
cord-005453-4057qib7	12251	8	HSCT	HSCT	NNP
cord-005453-4057qib7	12251	9	)	)	-RRB-
cord-005453-4057qib7	12251	10	is	be	VBZ
cord-005453-4057qib7	12251	11	sometimes	sometimes	RB
cord-005453-4057qib7	12251	12	performed	perform	VBN
cord-005453-4057qib7	12251	13	despite	despite	IN
cord-005453-4057qib7	12251	14	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	12251	15	's	's	POS
cord-005453-4057qib7	12251	16	antigens	antigen	NNS
cord-005453-4057qib7	12251	17	incompatibility	incompatibility	NN
cord-005453-4057qib7	12251	18	and	and	CC
cord-005453-4057qib7	12251	19	mismatch	mismatch	NN
cord-005453-4057qib7	12251	20	,	,	,
cord-005453-4057qib7	12251	21	it	-PRON-	PRP
cord-005453-4057qib7	12251	22	is	be	VBZ
cord-005453-4057qib7	12251	23	essential	essential	JJ
cord-005453-4057qib7	12251	24	to	to	TO
cord-005453-4057qib7	12251	25	carefully	carefully	RB
cord-005453-4057qib7	12251	26	track	track	VB
cord-005453-4057qib7	12251	27	patients	patient	NNS
cord-005453-4057qib7	12251	28	'	'	POS
cord-005453-4057qib7	12251	29	genotypes	genotype	NNS
cord-005453-4057qib7	12251	30	after	after	IN
cord-005453-4057qib7	12251	31	it	-PRON-	PRP
cord-005453-4057qib7	12251	32	.	.	.
cord-005453-4057qib7	12252	1	Methods	method	NNS
cord-005453-4057qib7	12252	2	:	:	:
cord-005453-4057qib7	12252	3	For	for	IN
cord-005453-4057qib7	12252	4	the	the	DT
cord-005453-4057qib7	12252	5	study	study	NN
cord-005453-4057qib7	12252	6	we	-PRON-	PRP
cord-005453-4057qib7	12252	7	used	use	VBD
cord-005453-4057qib7	12252	8	erythrocytes	erythrocyte	NNS
cord-005453-4057qib7	12252	9	(	(	-LRB-
cord-005453-4057qib7	12252	10	N=189	N=189	NNP
cord-005453-4057qib7	12252	11	)	)	-RRB-
cord-005453-4057qib7	12252	12	and	and	CC
cord-005453-4057qib7	12252	13	DNA	DNA	NNP
cord-005453-4057qib7	12252	14	(	(	-LRB-
cord-005453-4057qib7	12252	15	N=20	N=20	NNP
cord-005453-4057qib7	12252	16	)	)	-RRB-
cord-005453-4057qib7	12252	17	from	from	IN
cord-005453-4057qib7	12252	18	patients	patient	NNS
cord-005453-4057qib7	12252	19	undergoing	undergo	VBG
cord-005453-4057qib7	12252	20	ABO	ABO	NNP
cord-005453-4057qib7	12252	21	-	-	:
cord-005453-4057qib7	12252	22	or	or	CC
cord-005453-4057qib7	12252	23	Rhesus	Rhesus	NNP
cord-005453-4057qib7	12252	24	-	-	HYPH
cord-005453-4057qib7	12252	25	mismatch	mismatch	NN
cord-005453-4057qib7	12252	26	HSCT	HSCT	NNP
cord-005453-4057qib7	12252	27	and	and	CC
cord-005453-4057qib7	12252	28	their	-PRON-	PRP$
cord-005453-4057qib7	12252	29	donors	donor	NNS
cord-005453-4057qib7	12252	30	.	.	.
cord-005453-4057qib7	12253	1	We	-PRON-	PRP
cord-005453-4057qib7	12253	2	used	use	VBD
cord-005453-4057qib7	12253	3	posttransplant	posttransplant	NNP
cord-005453-4057qib7	12253	4	no	no	DT
cord-005453-4057qib7	12253	5	transfused	transfuse	VBN
cord-005453-4057qib7	12253	6	patients	patient	NNS
cord-005453-4057qib7	12253	7	on	on	IN
cord-005453-4057qib7	12253	8	the	the	DT
cord-005453-4057qib7	12253	9	periods	period	NNS
cord-005453-4057qib7	12253	10	according	accord	VBG
cord-005453-4057qib7	12253	11	transplant	transplant	NN
cord-005453-4057qib7	12253	12	protocol	protocol	NN
cord-005453-4057qib7	12253	13	by	by	IN
cord-005453-4057qib7	12253	14	hemagglutination	hemagglutination	NN
cord-005453-4057qib7	12253	15	methods	method	NNS
cord-005453-4057qib7	12253	16	in	in	IN
cord-005453-4057qib7	12253	17	plate	plate	NN
cord-005453-4057qib7	12253	18	and	and	CC
cord-005453-4057qib7	12253	19	tube	tube	NN
cord-005453-4057qib7	12253	20	using	use	VBG
cord-005453-4057qib7	12253	21	monoclonal	monoclonal	JJ
cord-005453-4057qib7	12253	22	antibodies	antibody	NNS
cord-005453-4057qib7	12253	23	to	to	IN
cord-005453-4057qib7	12253	24	ABO	ABO	NNP
cord-005453-4057qib7	12253	25	and	and	CC
cord-005453-4057qib7	12253	26	Rhesus	Rhesus	NNP
cord-005453-4057qib7	12253	27	antigens	antigen	NNS
cord-005453-4057qib7	12253	28	(	(	-LRB-
cord-005453-4057qib7	12253	29	Hematolog	Hematolog	NNP
cord-005453-4057qib7	12253	30	,	,	,
cord-005453-4057qib7	12253	31	Russia	Russia	NNP
cord-005453-4057qib7	12253	32	)	)	-RRB-
cord-005453-4057qib7	12253	33	.	.	.
cord-005453-4057qib7	12254	1	We	-PRON-	PRP
cord-005453-4057qib7	12254	2	extracted	extract	VBD
cord-005453-4057qib7	12254	3	DNA	DNA	NNP
cord-005453-4057qib7	12254	4	with	with	IN
cord-005453-4057qib7	12254	5	DNA	dna	NN
cord-005453-4057qib7	12254	6	kit	kit	NN
cord-005453-4057qib7	12254	7	(	(	-LRB-
cord-005453-4057qib7	12254	8	BAG	bag	NN
cord-005453-4057qib7	12254	9	,	,	,
cord-005453-4057qib7	12254	10	Germany	Germany	NNP
cord-005453-4057qib7	12254	11	)	)	-RRB-
cord-005453-4057qib7	12254	12	and	and	CC
cord-005453-4057qib7	12254	13	conducted	conduct	VBD
cord-005453-4057qib7	12254	14	PCR	PCR	NNP
cord-005453-4057qib7	12254	15	-	-	HYPH
cord-005453-4057qib7	12254	16	SSP	SSP	NNP
cord-005453-4057qib7	12254	17	with	with	IN
cord-005453-4057qib7	12254	18	kits	kit	NNS
cord-005453-4057qib7	12254	19	ABO	ABO	NNP
cord-005453-4057qib7	12254	20	-	-	HYPH
cord-005453-4057qib7	12254	21	Type	Type	NNP
cord-005453-4057qib7	12254	22	,	,	,
cord-005453-4057qib7	12254	23	RH	RH	NNP
cord-005453-4057qib7	12254	24	-	-	HYPH
cord-005453-4057qib7	12254	25	Type	Type	NNP
cord-005453-4057qib7	12254	26	(	(	-LRB-
cord-005453-4057qib7	12254	27	BAG	bag	NN
cord-005453-4057qib7	12254	28	,	,	,
cord-005453-4057qib7	12254	29	Germany	Germany	NNP
cord-005453-4057qib7	12254	30	)	)	-RRB-
cord-005453-4057qib7	12254	31	.	.	.
cord-005453-4057qib7	12255	1	Chimerism	chimerism	NN
cord-005453-4057qib7	12255	2	was	be	VBD
cord-005453-4057qib7	12255	3	assessed	assess	VBN
cord-005453-4057qib7	12255	4	by	by	IN
cord-005453-4057qib7	12255	5	the	the	DT
cord-005453-4057qib7	12255	6	STR	STR	NNP
cord-005453-4057qib7	12255	7	-	-	HYPH
cord-005453-4057qib7	12255	8	PCR	PCR	NNP
cord-005453-4057qib7	12255	9	analysis	analysis	NN
cord-005453-4057qib7	12255	10	with	with	IN
cord-005453-4057qib7	12255	11	COrDIS	COrDIS	NNP
cord-005453-4057qib7	12255	12	Plus	Plus	NNP
cord-005453-4057qib7	12255	13	multiplex	multiplex	JJ
cord-005453-4057qib7	12255	14	kit	kit	NN
cord-005453-4057qib7	12255	15	for	for	IN
cord-005453-4057qib7	12255	16	amplification	amplification	NN
cord-005453-4057qib7	12255	17	of	of	IN
cord-005453-4057qib7	12255	18	19	19	CD
cord-005453-4057qib7	12255	19	polymorphic	polymorphic	JJ
cord-005453-4057qib7	12255	20	STRmarkers	strmarker	NNS
cord-005453-4057qib7	12255	21	and	and	CC
cord-005453-4057qib7	12255	22	amelogenin	amelogenin	NNP
cord-005453-4057qib7	12255	23	loci	locus	NNS
cord-005453-4057qib7	12255	24	.	.	.
cord-005453-4057qib7	12256	1	The	the	DT
cord-005453-4057qib7	12256	2	fragment	fragment	NN
cord-005453-4057qib7	12256	3	analysis	analysis	NN
cord-005453-4057qib7	12256	4	was	be	VBD
cord-005453-4057qib7	12256	5	performed	perform	VBN
cord-005453-4057qib7	12256	6	on	on	IN
cord-005453-4057qib7	12256	7	a	a	DT
cord-005453-4057qib7	12256	8	3130	3130	CD
cord-005453-4057qib7	12256	9	Genetic	Genetic	NNP
cord-005453-4057qib7	12256	10	Analyzer	Analyzer	NNP
cord-005453-4057qib7	12256	11	.	.	.
cord-005453-4057qib7	12257	1	Informative	informative	JJ
cord-005453-4057qib7	12257	2	loci	locus	NNS
cord-005453-4057qib7	12257	3	were	be	VBD
cord-005453-4057qib7	12257	4	chosen	choose	VBN
cord-005453-4057qib7	12257	5	by	by	IN
cord-005453-4057qib7	12257	6	comparison	comparison	NN
cord-005453-4057qib7	12257	7	of	of	IN
cord-005453-4057qib7	12257	8	pretransplant	pretransplant	JJ
cord-005453-4057qib7	12257	9	patient	patient	NN
cord-005453-4057qib7	12257	10	's	's	POS
cord-005453-4057qib7	12257	11	and	and	CC
cord-005453-4057qib7	12257	12	donor	donor	NN
cord-005453-4057qib7	12257	13	's	's	POS
cord-005453-4057qib7	12257	14	DNA	dna	NN
cord-005453-4057qib7	12257	15	.	.	.
cord-005453-4057qib7	12258	1	The	the	DT
cord-005453-4057qib7	12258	2	percentage	percentage	NN
cord-005453-4057qib7	12258	3	of	of	IN
cord-005453-4057qib7	12258	4	donor	donor	NN
cord-005453-4057qib7	12258	5	chimerism	chimerism	NN
cord-005453-4057qib7	12258	6	was	be	VBD
cord-005453-4057qib7	12258	7	calculated	calculate	VBN
cord-005453-4057qib7	12258	8	using	use	VBG
cord-005453-4057qib7	12258	9	standard	standard	JJ
cord-005453-4057qib7	12258	10	formula	formula	NN
cord-005453-4057qib7	12258	11	.	.	.
cord-005453-4057qib7	12259	1	Precise	precise	JJ
cord-005453-4057qib7	12259	2	RHCE	RHCE	NNP
cord-005453-4057qib7	12259	3	and	and	CC
cord-005453-4057qib7	12259	4	ABO	ABO	NNP
cord-005453-4057qib7	12259	5	genotypes	genotype	NNS
cord-005453-4057qib7	12259	6	were	be	VBD
cord-005453-4057qib7	12259	7	determined	determine	VBN
cord-005453-4057qib7	12259	8	by	by	IN
cord-005453-4057qib7	12259	9	direct	direct	JJ
cord-005453-4057qib7	12259	10	Sanger	Sanger	NNP
cord-005453-4057qib7	12259	11	sequencing	sequencing	NN
cord-005453-4057qib7	12259	12	.	.	.
cord-005453-4057qib7	12260	1	We	-PRON-	PRP
cord-005453-4057qib7	12260	2	revealed	reveal	VBD
cord-005453-4057qib7	12260	3	3	3	CD
cord-005453-4057qib7	12260	4	patients	patient	NNS
cord-005453-4057qib7	12260	5	with	with	IN
cord-005453-4057qib7	12260	6	unexpected	unexpected	JJ
cord-005453-4057qib7	12260	7	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	12260	8	ABO	ABO	NNP
cord-005453-4057qib7	12260	9	,	,	,
cord-005453-4057qib7	12260	10	Rhesus	Rhesus	NNP
cord-005453-4057qib7	12260	11	phenotypes	phenotype	NNS
cord-005453-4057qib7	12260	12	and	and	CC
cord-005453-4057qib7	12260	13	genotypes	genotype	NNS
cord-005453-4057qib7	12260	14	after	after	IN
cord-005453-4057qib7	12260	15	HSCT	HSCT	NNP
cord-005453-4057qib7	12260	16	on	on	IN
cord-005453-4057qib7	12260	17	+30	+30	NNP
cord-005453-4057qib7	12260	18	(	(	-LRB-
cord-005453-4057qib7	12260	19	2	2	CD
cord-005453-4057qib7	12260	20	patients	patient	NNS
cord-005453-4057qib7	12260	21	)	)	-RRB-
cord-005453-4057qib7	12260	22	and	and	CC
cord-005453-4057qib7	12260	23	+160	+160	NNP
cord-005453-4057qib7	12260	24	days	day	NNS
cord-005453-4057qib7	12260	25	(	(	-LRB-
cord-005453-4057qib7	12260	26	all	all	DT
cord-005453-4057qib7	12260	27	patients	patient	NNS
cord-005453-4057qib7	12260	28	)	)	-RRB-
cord-005453-4057qib7	12260	29	.	.	.
cord-005453-4057qib7	12261	1	Chimerism	chimerism	NN
cord-005453-4057qib7	12261	2	analyses	analysis	NNS
cord-005453-4057qib7	12261	3	on	on	IN
cord-005453-4057qib7	12261	4	STR	STR	NNP
cord-005453-4057qib7	12261	5	showed	show	VBD
cord-005453-4057qib7	12261	6	in	in	IN
cord-005453-4057qib7	12262	1	A.E.Kh	a.e.kh	RB
cord-005453-4057qib7	12262	2	.	.	.
cord-005453-4057qib7	12263	1	and	and	CC
cord-005453-4057qib7	12263	2	G.L.V.	G.L.V.	NNP
cord-005453-4057qib7	12263	3	patients	patient	NNS
cord-005453-4057qib7	12263	4	99	99	CD
cord-005453-4057qib7	12263	5	%	%	NN
cord-005453-4057qib7	12263	6	of	of	IN
cord-005453-4057qib7	12263	7	donor	donor	NN
cord-005453-4057qib7	12263	8	's	's	POS
cord-005453-4057qib7	12263	9	DNA	dna	NN
cord-005453-4057qib7	12263	10	and	and	CC
cord-005453-4057qib7	12263	11	less	less	JJR
cord-005453-4057qib7	12263	12	than	than	IN
cord-005453-4057qib7	12263	13	1	1	CD
cord-005453-4057qib7	12263	14	%	%	NN
cord-005453-4057qib7	12263	15	of	of	IN
cord-005453-4057qib7	12263	16	recipient	recipient	NN
cord-005453-4057qib7	12263	17	's	's	POS
cord-005453-4057qib7	12263	18	one	one	CD
cord-005453-4057qib7	12263	19	.	.	.
cord-005453-4057qib7	12264	1	B.N.A.	B.N.A.	NNP
cord-005453-4057qib7	12264	2	patient	patient	NN
cord-005453-4057qib7	12264	3	was	be	VBD
cord-005453-4057qib7	12264	4	relapsed	relapse	VBN
cord-005453-4057qib7	12264	5	and	and	CC
cord-005453-4057qib7	12264	6	chimerism	chimerism	NN
cord-005453-4057qib7	12264	7	analysis	analysis	NN
cord-005453-4057qib7	12264	8	revealed	reveal	VBD
cord-005453-4057qib7	12264	9	95	95	CD
cord-005453-4057qib7	12264	10	%	%	NN
cord-005453-4057qib7	12264	11	of	of	IN
cord-005453-4057qib7	12264	12	recipient	recipient	NN
cord-005453-4057qib7	12264	13	's	's	POS
cord-005453-4057qib7	12264	14	DNA	dna	NN
cord-005453-4057qib7	12264	15	and	and	CC
cord-005453-4057qib7	12264	16	5	5	CD
cord-005453-4057qib7	12264	17	%	%	NN
cord-005453-4057qib7	12264	18	of	of	IN
cord-005453-4057qib7	12264	19	donor	donor	NN
cord-005453-4057qib7	12264	20	's	's	POS
cord-005453-4057qib7	12264	21	one	one	CD
cord-005453-4057qib7	12264	22	.	.	.
cord-005453-4057qib7	12265	1	Using	use	VBG
cord-005453-4057qib7	12265	2	serological	serological	JJ
cord-005453-4057qib7	12265	3	methods	method	NNS
cord-005453-4057qib7	12265	4	and	and	CC
cord-005453-4057qib7	12265	5	PCR	PCR	NNP
cord-005453-4057qib7	12265	6	-	-	HYPH
cord-005453-4057qib7	12265	7	SSP	SSP	NNP
cord-005453-4057qib7	12266	1	we	-PRON-	PRP
cord-005453-4057qib7	12266	2	revealed	reveal	VBD
cord-005453-4057qib7	12266	3	genotypes	genotype	NNS
cord-005453-4057qib7	12266	4	ABO	ABO	NNP
cord-005453-4057qib7	12266	5	*	*	NFP
cord-005453-4057qib7	12266	6	A1B1	A1B1	NNP
cord-005453-4057qib7	12266	7	;	;	:
cord-005453-4057qib7	12266	8	RHD+	RHD+	NNP
cord-005453-4057qib7	12266	9	;	;	:
cord-005453-4057qib7	12266	10	RHCE	RHCE	NNP
cord-005453-4057qib7	12266	11	*	*	NFP
cord-005453-4057qib7	12266	12	CcEe	CcEe	NNP
cord-005453-4057qib7	12266	13	in	in	IN
cord-005453-4057qib7	12266	14	patient	patient	NN
cord-005453-4057qib7	12266	15	A.	a.	NN
cord-005453-4057qib7	12266	16	E.Kh	E.Kh	NNP
cord-005453-4057qib7	12266	17	.	.	.
cord-005453-4057qib7	12267	1	before	before	IN
cord-005453-4057qib7	12267	2	HSCT	HSCT	NNP
cord-005453-4057qib7	12267	3	,	,	,
cord-005453-4057qib7	12267	4	ABO	ABO	NNP
cord-005453-4057qib7	12267	5	*	*	NFP
cord-005453-4057qib7	12267	6	A2O1	A2O1	NNP
cord-005453-4057qib7	12267	7	;	;	:
cord-005453-4057qib7	12267	8	RHD+	RHD+	NNP
cord-005453-4057qib7	12267	9	;	;	:
cord-005453-4057qib7	12267	10	RHCE	RHCE	NNP
cord-005453-4057qib7	12268	1	*	*	NFP
cord-005453-4057qib7	12268	2	Ccee	Ccee	NNP
cord-005453-4057qib7	12268	3	in	in	IN
cord-005453-4057qib7	12268	4	her	-PRON-	PRP$
cord-005453-4057qib7	12268	5	donor	donor	NN
cord-005453-4057qib7	12268	6	,	,	,
cord-005453-4057qib7	12268	7	and	and	CC
cord-005453-4057qib7	12268	8	ABO	ABO	NNP
cord-005453-4057qib7	12268	9	*	*	NFP
cord-005453-4057qib7	12268	10	A1A2	A1A2	NNP
cord-005453-4057qib7	12268	11	;	;	:
cord-005453-4057qib7	12268	12	RHD+	RHD+	NNP
cord-005453-4057qib7	12268	13	;	;	:
cord-005453-4057qib7	12268	14	RHCE	RHCE	NNP
cord-005453-4057qib7	12269	1	*	*	NFP
cord-005453-4057qib7	12269	2	Ccee	Ccee	NNP
cord-005453-4057qib7	12269	3	on	on	RP
cord-005453-4057qib7	12269	4	+30d	+30d	NN
cord-005453-4057qib7	12269	5	after	after	IN
cord-005453-4057qib7	12269	6	HSCT	HSCT	NNP
cord-005453-4057qib7	12269	7	.	.	.
cord-005453-4057qib7	12270	1	Genotype	Genotype	NNP
cord-005453-4057qib7	12270	2	A1A2	A1A2	NNP
cord-005453-4057qib7	12270	3	was	be	VBD
cord-005453-4057qib7	12270	4	no	no	DT
cord-005453-4057qib7	12270	5	recipient	recipient	NN
cord-005453-4057qib7	12270	6	's	's	POS
cord-005453-4057qib7	12270	7	neither	neither	DT
cord-005453-4057qib7	12270	8	donor	donor	NN
cord-005453-4057qib7	12270	9	's	's	POS
cord-005453-4057qib7	12270	10	origin	origin	NN
cord-005453-4057qib7	12270	11	.	.	.
cord-005453-4057qib7	12271	1	Direct	direct	JJ
cord-005453-4057qib7	12271	2	sequencing	sequencing	NN
cord-005453-4057qib7	12271	3	did	do	VBD
cord-005453-4057qib7	12271	4	not	not	RB
cord-005453-4057qib7	12271	5	prove	prove	VB
cord-005453-4057qib7	12271	6	this	this	DT
cord-005453-4057qib7	12271	7	genotype	genotype	NN
cord-005453-4057qib7	12271	8	,	,	,
cord-005453-4057qib7	12271	9	but	but	CC
cord-005453-4057qib7	12271	10	revealed	reveal	VBD
cord-005453-4057qib7	12271	11	donor	donor	NN
cord-005453-4057qib7	12271	12	's	's	POS
cord-005453-4057qib7	12271	13	one	one	CD
cord-005453-4057qib7	12271	14	.	.	.
cord-005453-4057qib7	12272	1	On	on	IN
cord-005453-4057qib7	12272	2	+160d	+160d	JJ
cord-005453-4057qib7	12272	3	serological	serological	JJ
cord-005453-4057qib7	12272	4	methods	method	NNS
cord-005453-4057qib7	12272	5	and	and	CC
cord-005453-4057qib7	12272	6	PCR	PCR	NNP
cord-005453-4057qib7	12272	7	-	-	HYPH
cord-005453-4057qib7	12272	8	SSP	SSP	NNP
cord-005453-4057qib7	12272	9	also	also	RB
cord-005453-4057qib7	12272	10	revealed	reveal	VBD
cord-005453-4057qib7	12272	11	donor	donor	NN
cord-005453-4057qib7	12272	12	's	's	POS
cord-005453-4057qib7	12272	13	genotype	genotype	NN
cord-005453-4057qib7	12272	14	in	in	IN
cord-005453-4057qib7	12272	15	this	this	DT
cord-005453-4057qib7	12272	16	patient	patient	NN
cord-005453-4057qib7	12272	17	.	.	.
cord-005453-4057qib7	12273	1	Patient	Patient	NNP
cord-005453-4057qib7	12273	2	B.N.A.	B.N.A.	NNP
cord-005453-4057qib7	12273	3	had	have	VBD
cord-005453-4057qib7	12273	4	genotypes	genotype	NNS
cord-005453-4057qib7	12273	5	ABO	ABO	NNP
cord-005453-4057qib7	12274	1	*	*	NFP
cord-005453-4057qib7	12274	2	O01	O01	NNP
cord-005453-4057qib7	12274	3	/	/	SYM
cord-005453-4057qib7	12274	4	O01	O01	NNP
cord-005453-4057qib7	12274	5	;	;	:
cord-005453-4057qib7	12274	6	RHD+	RHD+	NNP
cord-005453-4057qib7	12274	7	;	;	:
cord-005453-4057qib7	12274	8	RHCE	RHCE	NNP
cord-005453-4057qib7	12275	1	*	*	NFP
cord-005453-4057qib7	12275	2	C	C	NNP
cord-005453-4057qib7	12275	3	w	w	NNP
cord-005453-4057qib7	12275	4	cEe	cEe	NNP
cord-005453-4057qib7	12275	5	before	before	IN
cord-005453-4057qib7	12275	6	HSCT	HSCT	NNP
cord-005453-4057qib7	12275	7	,	,	,
cord-005453-4057qib7	12275	8	her	-PRON-	PRP$
cord-005453-4057qib7	12275	9	donor	donor	NN
cord-005453-4057qib7	12276	1	-ABO	-ABO	.
cord-005453-4057qib7	12277	1	*	*	NFP
cord-005453-4057qib7	12277	2	B1O1	B1O1	NNP
cord-005453-4057qib7	12277	3	;	;	:
cord-005453-4057qib7	12277	4	RHD	RHD	NNP
cord-005453-4057qib7	12277	5	+	+	CC
cord-005453-4057qib7	12277	6	;	;	:
cord-005453-4057qib7	12277	7	RHCE	RHCE	NNP
cord-005453-4057qib7	12277	8	*	*	NFP
cord-005453-4057qib7	12277	9	Ccee	Ccee	NNP
cord-005453-4057qib7	12277	10	.	.	.
cord-005453-4057qib7	12278	1	On	on	IN
cord-005453-4057qib7	12278	2	+160d	+160d	PDT
cord-005453-4057qib7	12278	3	this	this	DT
cord-005453-4057qib7	12278	4	patient	patient	NN
cord-005453-4057qib7	12278	5	relapsed	relapse	VBD
cord-005453-4057qib7	12278	6	,	,	,
cord-005453-4057qib7	12278	7	but	but	CC
cord-005453-4057qib7	12278	8	Rhesus	Rhesus	NNP
cord-005453-4057qib7	12278	9	genotype	genotype	NN
cord-005453-4057qib7	12278	10	has	have	VBZ
cord-005453-4057qib7	12278	11	been	be	VBN
cord-005453-4057qib7	12278	12	detected	detect	VBN
cord-005453-4057qib7	12278	13	as	as	IN
cord-005453-4057qib7	12278	14	RHD+	RHD+	NNP
cord-005453-4057qib7	12278	15	;	;	:
cord-005453-4057qib7	12278	16	RHCE	RHCE	NNP
cord-005453-4057qib7	12279	1	*	*	NFP
cord-005453-4057qib7	12279	2	C	C	NNP
cord-005453-4057qib7	12279	3	wcee	wcee	NN
cord-005453-4057qib7	12279	4	(	(	-LRB-
cord-005453-4057qib7	12279	5	lack	lack	NN
cord-005453-4057qib7	12279	6	E	e	NN
cord-005453-4057qib7	12279	7	gene	gene	NN
cord-005453-4057qib7	12279	8	)	)	-RRB-
cord-005453-4057qib7	12279	9	.	.	.
cord-005453-4057qib7	12280	1	Direct	direct	JJ
cord-005453-4057qib7	12280	2	sequencing	sequencing	NN
cord-005453-4057qib7	12280	3	revealed	reveal	VBD
cord-005453-4057qib7	12280	4	gene	gene	NN
cord-005453-4057qib7	12280	5	RHCE*Ee	rhce*ee	NN
cord-005453-4057qib7	12280	6	.	.	.
cord-005453-4057qib7	12281	1	ABO	ABO	NNP
cord-005453-4057qib7	12281	2	genotype	genotype	NN
cord-005453-4057qib7	12281	3	was	be	VBD
cord-005453-4057qib7	12281	4	recipient	recipient	NN
cord-005453-4057qib7	12281	5	's	's	POS
cord-005453-4057qib7	12281	6	origin	origin	NN
cord-005453-4057qib7	12281	7	-O1O1	-o1o1	XX
cord-005453-4057qib7	12281	8	.	.	.
cord-005453-4057qib7	12282	1	In	in	IN
cord-005453-4057qib7	12282	2	patient	patient	NN
cord-005453-4057qib7	12282	3	G.L.V.	G.L.V.	NNP
cord-005453-4057qib7	12282	4	using	use	VBG
cord-005453-4057qib7	12282	5	serological	serological	JJ
cord-005453-4057qib7	12282	6	and	and	CC
cord-005453-4057qib7	12282	7	PCR	PCR	NNP
cord-005453-4057qib7	12282	8	-	-	HYPH
cord-005453-4057qib7	12282	9	SSP	SSP	NNP
cord-005453-4057qib7	12282	10	methods	method	NNS
cord-005453-4057qib7	12282	11	we	-PRON-	PRP
cord-005453-4057qib7	12282	12	determined	determine	VBD
cord-005453-4057qib7	12282	13	genotypes	genotype	NNS
cord-005453-4057qib7	12282	14	ABO	ABO	NNP
cord-005453-4057qib7	12282	15	*	*	NFP
cord-005453-4057qib7	12282	16	O01	O01	NNP
cord-005453-4057qib7	12282	17	/	/	SYM
cord-005453-4057qib7	12282	18	O01	O01	NNP
cord-005453-4057qib7	12282	19	;	;	:
cord-005453-4057qib7	12282	20	RHD	RHD	NNP
cord-005453-4057qib7	12282	21	+	+	CC
cord-005453-4057qib7	12282	22	;	;	:
cord-005453-4057qib7	12282	23	RHCE	RHCE	NNP
cord-005453-4057qib7	12282	24	*	*	NFP
cord-005453-4057qib7	12282	25	CCee	CCee	NNP
cord-005453-4057qib7	12282	26	genotype	genotype	NN
cord-005453-4057qib7	12282	27	before	before	IN
cord-005453-4057qib7	12282	28	HSCT	HSCT	NNP
cord-005453-4057qib7	12282	29	,	,	,
cord-005453-4057qib7	12282	30	and	and	CC
cord-005453-4057qib7	12282	31	ABO	ABO	NNP
cord-005453-4057qib7	12282	32	*	*	NFP
cord-005453-4057qib7	12282	33	A1/	A1/	NNP
cord-005453-4057qib7	12282	34	O01	O01	NNP
cord-005453-4057qib7	12282	35	;	;	:
cord-005453-4057qib7	12282	36	RHD+	RHD+	NNP
cord-005453-4057qib7	12282	37	;	;	:
cord-005453-4057qib7	12282	38	RHCE	RHCE	NNP
cord-005453-4057qib7	12282	39	*	*	NFP
cord-005453-4057qib7	12282	40	CcEe	CcEe	NNP
cord-005453-4057qib7	12282	41	genotype	genotype	NN
cord-005453-4057qib7	12282	42	in	in	IN
cord-005453-4057qib7	12282	43	her	-PRON-	PRP$
cord-005453-4057qib7	12282	44	HSC	HSC	NNP
cord-005453-4057qib7	12282	45	donor	donor	NN
cord-005453-4057qib7	12282	46	.	.	.
cord-005453-4057qib7	12283	1	On	on	IN
cord-005453-4057qib7	12283	2	+30d	+30d	NN
cord-005453-4057qib7	12283	3	patient	patient	NN
cord-005453-4057qib7	12283	4	had	have	VBD
cord-005453-4057qib7	12283	5	unexpected	unexpected	JJ
cord-005453-4057qib7	12283	6	genotype	genotype	NN
cord-005453-4057qib7	12283	7	ABO	ABO	NNP
cord-005453-4057qib7	12283	8	*	*	NFP
cord-005453-4057qib7	12284	1	O01	O01	NNP
cord-005453-4057qib7	12284	2	/	/	SYM
cord-005453-4057qib7	12284	3	O01	O01	NNP
cord-005453-4057qib7	12284	4	(	(	-LRB-
cord-005453-4057qib7	12284	5	a	a	DT
cord-005453-4057qib7	12284	6	lack	lack	NN
cord-005453-4057qib7	12284	7	of	of	IN
cord-005453-4057qib7	12284	8	A	a	DT
cord-005453-4057qib7	12284	9	antigen	antigen	NN
cord-005453-4057qib7	12284	10	)	)	-RRB-
cord-005453-4057qib7	12284	11	;	;	:
cord-005453-4057qib7	12284	12	RHCE	RHCE	NNP
cord-005453-4057qib7	12284	13	*	*	NFP
cord-005453-4057qib7	12285	1	Ccee	Ccee	NNP
cord-005453-4057qib7	12285	2	(	(	-LRB-
cord-005453-4057qib7	12285	3	a	a	DT
cord-005453-4057qib7	12285	4	lack	lack	NN
cord-005453-4057qib7	12285	5	of	of	IN
cord-005453-4057qib7	12285	6	E	e	NN
cord-005453-4057qib7	12285	7	antigen	antigen	NN
cord-005453-4057qib7	12285	8	)	)	-RRB-
cord-005453-4057qib7	12285	9	.	.	.
cord-005453-4057qib7	12286	1	In	in	IN
cord-005453-4057qib7	12286	2	order	order	NN
cord-005453-4057qib7	12286	3	to	to	TO
cord-005453-4057qib7	12286	4	explain	explain	VB
cord-005453-4057qib7	12286	5	unexpected	unexpected	JJ
cord-005453-4057qib7	12286	6	patient	patient	NN
cord-005453-4057qib7	12286	7	's	's	POS
cord-005453-4057qib7	12286	8	genotypes	genotype	NNS
cord-005453-4057qib7	12286	9	after	after	IN
cord-005453-4057qib7	12286	10	HSCT	HSCT	NNP
cord-005453-4057qib7	12286	11	we	-PRON-	PRP
cord-005453-4057qib7	12286	12	sequenced	sequence	VBD
cord-005453-4057qib7	12286	13	her	-PRON-	PRP$
cord-005453-4057qib7	12286	14	RHCE	RHCE	NNP
cord-005453-4057qib7	12286	15	and	and	CC
cord-005453-4057qib7	12286	16	ABO	ABO	NNP
cord-005453-4057qib7	12286	17	genes	gene	NNS
cord-005453-4057qib7	12286	18	and	and	CC
cord-005453-4057qib7	12286	19	found	find	VBD
cord-005453-4057qib7	12286	20	donor	donor	NN
cord-005453-4057qib7	12286	21	's	's	POS
cord-005453-4057qib7	12286	22	genotype	genotype	NN
cord-005453-4057qib7	12286	23	CcEe	CcEe	NNP
cord-005453-4057qib7	12286	24	;	;	:
cord-005453-4057qib7	12286	25	A1O1	A1O1	NNP
cord-005453-4057qib7	12286	26	that	that	WDT
cord-005453-4057qib7	12286	27	was	be	VBD
cord-005453-4057qib7	12286	28	in	in	IN
cord-005453-4057qib7	12286	29	agreement	agreement	NN
cord-005453-4057qib7	12286	30	with	with	IN
cord-005453-4057qib7	12286	31	results	result	NNS
cord-005453-4057qib7	12286	32	of	of	IN
cord-005453-4057qib7	12286	33	STR	STR	NNP
cord-005453-4057qib7	12286	34	analysis	analysis	NN
cord-005453-4057qib7	12286	35	.	.	.
cord-005453-4057qib7	12287	1	To	to	TO
cord-005453-4057qib7	12287	2	resolve	resolve	VB
cord-005453-4057qib7	12287	3	discrepancies	discrepancy	NNS
cord-005453-4057qib7	12287	4	between	between	IN
cord-005453-4057qib7	12287	5	serological	serological	JJ
cord-005453-4057qib7	12287	6	,	,	,
cord-005453-4057qib7	12287	7	PCR	PCR	NNP
cord-005453-4057qib7	12287	8	-	-	HYPH
cord-005453-4057qib7	12287	9	SSP	SSP	NNP
cord-005453-4057qib7	12287	10	and	and	CC
cord-005453-4057qib7	12287	11	sequencing	sequence	VBG
cord-005453-4057qib7	12287	12	analysis	analysis	NN
cord-005453-4057qib7	12287	13	data	datum	NNS
cord-005453-4057qib7	12287	14	we	-PRON-	PRP
cord-005453-4057qib7	12287	15	sequenced	sequence	VBD
cord-005453-4057qib7	12287	16	patient	patient	NN
cord-005453-4057qib7	12287	17	's	's	POS
cord-005453-4057qib7	12287	18	RHCE	RHCE	NNP
cord-005453-4057qib7	12287	19	cDNA	cdna	NN
cord-005453-4057qib7	12287	20	and	and	CC
cord-005453-4057qib7	12287	21	observed	observe	VBD
cord-005453-4057qib7	12287	22	only	only	RB
cord-005453-4057qib7	12287	23	Ce	Ce	NNP
cord-005453-4057qib7	12287	24	allele	allele	NN
cord-005453-4057qib7	12287	25	.	.	.
cord-005453-4057qib7	12288	1	At	at	IN
cord-005453-4057qib7	12288	2	present	present	JJ
cord-005453-4057qib7	12288	3	time	time	NN
cord-005453-4057qib7	12288	4	the	the	DT
cord-005453-4057qib7	12288	5	molecular	molecular	JJ
cord-005453-4057qib7	12288	6	basis	basis	NN
cord-005453-4057qib7	12288	7	of	of	IN
cord-005453-4057qib7	12288	8	selective	selective	JJ
cord-005453-4057qib7	12288	9	inactivation	inactivation	NN
cord-005453-4057qib7	12288	10	one	one	CD
cord-005453-4057qib7	12288	11	of	of	IN
cord-005453-4057qib7	12288	12	the	the	DT
cord-005453-4057qib7	12288	13	two	two	CD
cord-005453-4057qib7	12288	14	RHCE	RHCE	NNP
cord-005453-4057qib7	12288	15	alleles	allele	NNS
cord-005453-4057qib7	12288	16	is	be	VBZ
cord-005453-4057qib7	12288	17	not	not	RB
cord-005453-4057qib7	12288	18	clear	clear	JJ
cord-005453-4057qib7	12288	19	.	.	.
cord-005453-4057qib7	12289	1	On	on	IN
cord-005453-4057qib7	12289	2	+160d	+160d	JJ
cord-005453-4057qib7	12289	3	patient	patient	NN
cord-005453-4057qib7	12289	4	had	have	VBD
cord-005453-4057qib7	12289	5	donor	donor	NN
cord-005453-4057qib7	12289	6	's	's	POS
cord-005453-4057qib7	12289	7	genotype	genotype	NN
cord-005453-4057qib7	12289	8	.	.	.
cord-005453-4057qib7	12290	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12290	2	:	:	:
cord-005453-4057qib7	12291	1	What	what	WDT
cord-005453-4057qib7	12291	2	kind	kind	NN
cord-005453-4057qib7	12291	3	of	of	IN
cord-005453-4057qib7	12291	4	mechanisms	mechanism	NNS
cord-005453-4057qib7	12291	5	led	lead	VBN
cord-005453-4057qib7	12291	6	to	to	IN
cord-005453-4057qib7	12291	7	discrepancies	discrepancy	NNS
cord-005453-4057qib7	12291	8	between	between	IN
cord-005453-4057qib7	12291	9	results	result	NNS
cord-005453-4057qib7	12291	10	obtained	obtain	VBN
cord-005453-4057qib7	12291	11	by	by	IN
cord-005453-4057qib7	12291	12	different	different	JJ
cord-005453-4057qib7	12291	13	laboratory	laboratory	NN
cord-005453-4057qib7	12291	14	methods	method	NNS
cord-005453-4057qib7	12291	15	are	be	VBP
cord-005453-4057qib7	12291	16	still	still	RB
cord-005453-4057qib7	12291	17	not	not	RB
cord-005453-4057qib7	12291	18	clear	clear	JJ
cord-005453-4057qib7	12291	19	.	.	.
cord-005453-4057qib7	12292	1	An	an	DT
cord-005453-4057qib7	12292	2	interesting	interesting	JJ
cord-005453-4057qib7	12292	3	case	case	NN
cord-005453-4057qib7	12292	4	of	of	IN
cord-005453-4057qib7	12292	5	expression	expression	NN
cord-005453-4057qib7	12292	6	of	of	IN
cord-005453-4057qib7	12292	7	only	only	RB
cord-005453-4057qib7	12292	8	one	one	CD
cord-005453-4057qib7	12292	9	RHCE	RHCE	NNP
cord-005453-4057qib7	12292	10	allele	allele	NN
cord-005453-4057qib7	12292	11	in	in	IN
cord-005453-4057qib7	12292	12	patient	patient	NN
cord-005453-4057qib7	12292	13	G.L.V.	G.L.V.	NNP
cord-005453-4057qib7	12292	14	allows	allow	VBZ
cord-005453-4057qib7	12292	15	us	-PRON-	PRP
cord-005453-4057qib7	12292	16	to	to	TO
cord-005453-4057qib7	12292	17	suggest	suggest	VB
cord-005453-4057qib7	12292	18	involvement	involvement	NN
cord-005453-4057qib7	12292	19	of	of	IN
cord-005453-4057qib7	12292	20	some	some	DT
cord-005453-4057qib7	12292	21	epigenetic	epigenetic	JJ
cord-005453-4057qib7	12292	22	mechanisms	mechanism	NNS
cord-005453-4057qib7	12292	23	like	like	IN
cord-005453-4057qib7	12292	24	DNA	dna	NN
cord-005453-4057qib7	12292	25	methylation	methylation	NNS
cord-005453-4057qib7	12292	26	or	or	CC
cord-005453-4057qib7	12292	27	histone	histone	NN
cord-005453-4057qib7	12292	28	modification	modification	NN
cord-005453-4057qib7	12292	29	in	in	IN
cord-005453-4057qib7	12292	30	this	this	DT
cord-005453-4057qib7	12292	31	process	process	NN
cord-005453-4057qib7	12292	32	.	.	.
cord-005453-4057qib7	12293	1	Clinical	clinical	JJ
cord-005453-4057qib7	12293	2	Background	background	NN
cord-005453-4057qib7	12293	3	:	:	:
cord-005453-4057qib7	12294	1	In	in	IN
cord-005453-4057qib7	12294	2	relapsed	relapsed	JJ
cord-005453-4057qib7	12294	3	patients	patient	NNS
cord-005453-4057qib7	12294	4	with	with	IN
cord-005453-4057qib7	12294	5	acute	acute	JJ
cord-005453-4057qib7	12294	6	B	b	NN
cord-005453-4057qib7	12294	7	-lymphoblastic	-lymphoblastic	CD
cord-005453-4057qib7	12295	1	leukemia	leukemia	NN
cord-005453-4057qib7	12295	2	(	(	-LRB-
cord-005453-4057qib7	12295	3	ALL	ALL	NNP
cord-005453-4057qib7	12295	4	-	-	HYPH
cord-005453-4057qib7	12295	5	B	b	NN
cord-005453-4057qib7	12295	6	)	)	-RRB-
cord-005453-4057qib7	12295	7	who	who	WP
cord-005453-4057qib7	12295	8	achieved	achieve	VBD
cord-005453-4057qib7	12295	9	complete	complete	JJ
cord-005453-4057qib7	12295	10	remission	remission	NN
cord-005453-4057qib7	12295	11	(	(	-LRB-
cord-005453-4057qib7	12295	12	CR	CR	NNP
cord-005453-4057qib7	12295	13	)	)	-RRB-
cord-005453-4057qib7	12295	14	after	after	IN
cord-005453-4057qib7	12295	15	re	re	NN
cord-005453-4057qib7	12295	16	-	-	NN
cord-005453-4057qib7	12295	17	induction	induction	NN
cord-005453-4057qib7	12295	18	therapy	therapy	NN
cord-005453-4057qib7	12295	19	,	,	,
cord-005453-4057qib7	12295	20	minimal	minimal	JJ
cord-005453-4057qib7	12295	21	residual	residual	JJ
cord-005453-4057qib7	12295	22	disease	disease	NN
cord-005453-4057qib7	12295	23	(	(	-LRB-
cord-005453-4057qib7	12295	24	MRD	MRD	NNP
cord-005453-4057qib7	12295	25	;	;	:
cord-005453-4057qib7	12295	26	≥10	≥10	NNP
cord-005453-4057qib7	12295	27	-3	-3	NNP
cord-005453-4057qib7	12295	28	ALL	ALL	NNP
cord-005453-4057qib7	12295	29	-	-	HYPH
cord-005453-4057qib7	12295	30	B	b	NN
cord-005453-4057qib7	12295	31	cells	cell	NNS
cord-005453-4057qib7	12295	32	/	/	SYM
cord-005453-4057qib7	12295	33	ul	ul	NN
cord-005453-4057qib7	12295	34	)	)	-RRB-
cord-005453-4057qib7	12295	35	is	be	VBZ
cord-005453-4057qib7	12295	36	often	often	RB
cord-005453-4057qib7	12295	37	detected	detect	VBN
cord-005453-4057qib7	12295	38	.	.	.
cord-005453-4057qib7	12296	1	According	accord	VBG
cord-005453-4057qib7	12296	2	to	to	IN
cord-005453-4057qib7	12296	3	available	available	JJ
cord-005453-4057qib7	12296	4	data	datum	NNS
cord-005453-4057qib7	12296	5	,	,	,
cord-005453-4057qib7	12296	6	such	such	JJ
cord-005453-4057qib7	12296	7	condition	condition	NN
cord-005453-4057qib7	12296	8	varies	vary	VBZ
cord-005453-4057qib7	12296	9	from	from	IN
cord-005453-4057qib7	12296	10	30	30	CD
cord-005453-4057qib7	12296	11	%	%	NN
cord-005453-4057qib7	12296	12	to	to	IN
cord-005453-4057qib7	12296	13	even	even	RB
cord-005453-4057qib7	12296	14	50	50	CD
cord-005453-4057qib7	12296	15	%	%	NN
cord-005453-4057qib7	12296	16	of	of	IN
cord-005453-4057qib7	12296	17	cases	case	NNS
cord-005453-4057qib7	12296	18	,	,	,
cord-005453-4057qib7	12296	19	as	as	IN
cord-005453-4057qib7	12296	20	assessed	assess	VBN
cord-005453-4057qib7	12296	21	by	by	IN
cord-005453-4057qib7	12296	22	PCR	PCR	NNP
cord-005453-4057qib7	12296	23	or	or	CC
cord-005453-4057qib7	12296	24	flow	flow	VB
cord-005453-4057qib7	12296	25	cytometry	cytometry	NN
cord-005453-4057qib7	12296	26	(	(	-LRB-
cord-005453-4057qib7	12296	27	FC	FC	NNP
cord-005453-4057qib7	12296	28	)	)	-RRB-
cord-005453-4057qib7	12296	29	,	,	,
cord-005453-4057qib7	12296	30	while	while	IN
cord-005453-4057qib7	12296	31	the	the	DT
cord-005453-4057qib7	12296	32	presence	presence	NN
cord-005453-4057qib7	12296	33	of	of	IN
cord-005453-4057qib7	12296	34	MRD	MRD	NNP
cord-005453-4057qib7	12296	35	is	be	VBZ
cord-005453-4057qib7	12296	36	the	the	DT
cord-005453-4057qib7	12296	37	most	most	RBS
cord-005453-4057qib7	12296	38	important	important	JJ
cord-005453-4057qib7	12296	39	risk	risk	NN
cord-005453-4057qib7	12296	40	factor	factor	NN
cord-005453-4057qib7	12296	41	for	for	IN
cord-005453-4057qib7	12296	42	ALL	all	DT
cord-005453-4057qib7	12296	43	recurrence	recurrence	NN
cord-005453-4057qib7	12296	44	.	.	.
cord-005453-4057qib7	12297	1	In	in	IN
cord-005453-4057qib7	12297	2	this	this	DT
cord-005453-4057qib7	12297	3	abstract	abstract	NN
cord-005453-4057qib7	12297	4	,	,	,
cord-005453-4057qib7	12297	5	we	-PRON-	PRP
cord-005453-4057qib7	12297	6	describe	describe	VBP
cord-005453-4057qib7	12297	7	our	-PRON-	PRP$
cord-005453-4057qib7	12297	8	experience	experience	NN
cord-005453-4057qib7	12297	9	with	with	IN
cord-005453-4057qib7	12297	10	bridging	bridge	VBG
cord-005453-4057qib7	12297	11	therapy	therapy	NN
cord-005453-4057qib7	12297	12	using	use	VBG
cord-005453-4057qib7	12297	13	blinatumomab	blinatumomab	JJ
cord-005453-4057qib7	12297	14	infusion	infusion	NN
cord-005453-4057qib7	12297	15	after	after	IN
cord-005453-4057qib7	12297	16	re	re	NN
cord-005453-4057qib7	12297	17	-	-	NN
cord-005453-4057qib7	12297	18	induction	induction	JJ
cord-005453-4057qib7	12297	19	regimens	regimen	NNS
cord-005453-4057qib7	12297	20	and	and	CC
cord-005453-4057qib7	12297	21	before	before	IN
cord-005453-4057qib7	12297	22	the	the	DT
cord-005453-4057qib7	12297	23	planned	plan	VBN
cord-005453-4057qib7	12297	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	12297	25	stem	stem	NN
cord-005453-4057qib7	12297	26	cell	cell	NN
cord-005453-4057qib7	12297	27	transplantation	transplantation	NN
cord-005453-4057qib7	12297	28	(	(	-LRB-
cord-005453-4057qib7	12297	29	allo	allo	FW
cord-005453-4057qib7	12297	30	-	-	HYPH
cord-005453-4057qib7	12297	31	SCT	SCT	NNP
cord-005453-4057qib7	12297	32	)	)	-RRB-
cord-005453-4057qib7	12297	33	.	.	.
cord-005453-4057qib7	12298	1	The	the	DT
cord-005453-4057qib7	12298	2	procedure	procedure	NN
cord-005453-4057qib7	12298	3	was	be	VBD
cord-005453-4057qib7	12298	4	performed	perform	VBN
cord-005453-4057qib7	12298	5	in	in	IN
cord-005453-4057qib7	12298	6	three	three	CD
cord-005453-4057qib7	12298	7	young	young	JJ
cord-005453-4057qib7	12298	8	men	man	NNS
cord-005453-4057qib7	12298	9	suffering	suffer	VBG
cord-005453-4057qib7	12298	10	from	from	IN
cord-005453-4057qib7	12298	11	relapsed	relapse	VBN
cord-005453-4057qib7	12298	12	Ph	Ph	NNP
cord-005453-4057qib7	12298	13	(	(	-LRB-
cord-005453-4057qib7	12298	14	-	-	:
cord-005453-4057qib7	12298	15	)	)	-RRB-
cord-005453-4057qib7	12298	16	ALL	ALL	NNP
cord-005453-4057qib7	12298	17	-	-	HYPH
cord-005453-4057qib7	12298	18	B	b	NN
cord-005453-4057qib7	12298	19	at	at	IN
cord-005453-4057qib7	12298	20	the	the	DT
cord-005453-4057qib7	12298	21	age	age	NN
cord-005453-4057qib7	12298	22	of	of	IN
cord-005453-4057qib7	12298	23	19	19	CD
cord-005453-4057qib7	12298	24	,	,	,
cord-005453-4057qib7	12298	25	22	22	CD
cord-005453-4057qib7	12298	26	and	and	CC
cord-005453-4057qib7	12298	27	34	34	CD
cord-005453-4057qib7	12298	28	years	year	NNS
cord-005453-4057qib7	12298	29	.	.	.
cord-005453-4057qib7	12299	1	In	in	IN
cord-005453-4057qib7	12299	2	the	the	DT
cord-005453-4057qib7	12299	3	first	first	JJ
cord-005453-4057qib7	12299	4	case	case	NN
cord-005453-4057qib7	12299	5	(	(	-LRB-
cord-005453-4057qib7	12299	6	19yo	19yo	NNP
cord-005453-4057qib7	12299	7	)	)	-RRB-
cord-005453-4057qib7	12299	8	,	,	,
cord-005453-4057qib7	12299	9	relapse	relapse	VB
cord-005453-4057qib7	12299	10	with	with	IN
cord-005453-4057qib7	12299	11	previous	previous	JJ
cord-005453-4057qib7	12299	12	MRD	MRD	NNP
cord-005453-4057qib7	12299	13	accounting	account	VBG
cord-005453-4057qib7	12299	14	for	for	IN
cord-005453-4057qib7	12299	15	2.7	2.7	CD
cord-005453-4057qib7	12299	16	%	%	NN
cord-005453-4057qib7	12299	17	occurred	occur	VBD
cord-005453-4057qib7	12299	18	15	15	CD
cord-005453-4057qib7	12299	19	months	month	NNS
cord-005453-4057qib7	12299	20	after	after	IN
cord-005453-4057qib7	12299	21	CR1	CR1	NNP
cord-005453-4057qib7	12299	22	MRD	MRD	NNP
cord-005453-4057qib7	12299	23	neg	neg	NNP
cord-005453-4057qib7	12299	24	.	.	.
cord-005453-4057qib7	12300	1	In	in	IN
cord-005453-4057qib7	12300	2	the	the	DT
cord-005453-4057qib7	12300	3	next	next	JJ
cord-005453-4057qib7	12300	4	patient	patient	NN
cord-005453-4057qib7	12300	5	(	(	-LRB-
cord-005453-4057qib7	12300	6	22yo	22yo	JJ
cord-005453-4057qib7	12300	7	)	)	-RRB-
cord-005453-4057qib7	12301	1	the	the	DT
cord-005453-4057qib7	12301	2	second	second	JJ
cord-005453-4057qib7	12301	3	relapse	relapse	NN
cord-005453-4057qib7	12301	4	with	with	IN
cord-005453-4057qib7	12301	5	central	central	JJ
cord-005453-4057qib7	12301	6	nervous	nervous	JJ
cord-005453-4057qib7	12301	7	system	system	NN
cord-005453-4057qib7	12302	1	(	(	-LRB-
cord-005453-4057qib7	12302	2	CNS	CNS	NNP
cord-005453-4057qib7	12302	3	)	)	-RRB-
cord-005453-4057qib7	12302	4	involvement	involvement	NN
cord-005453-4057qib7	12302	5	occurred	occur	VBD
cord-005453-4057qib7	12302	6	5	5	CD
cord-005453-4057qib7	12302	7	months	month	NNS
cord-005453-4057qib7	12302	8	after	after	IN
cord-005453-4057qib7	12302	9	allo	allo	NN
cord-005453-4057qib7	12302	10	-	-	HYPH
cord-005453-4057qib7	12302	11	SCT	SCT	NNP
cord-005453-4057qib7	12302	12	performed	perform	VBN
cord-005453-4057qib7	12302	13	in	in	IN
cord-005453-4057qib7	12302	14	CR2	CR2	NNP
cord-005453-4057qib7	12302	15	(	(	-LRB-
cord-005453-4057qib7	12302	16	26	26	CD
cord-005453-4057qib7	12302	17	months	month	NNS
cord-005453-4057qib7	12302	18	after	after	IN
cord-005453-4057qib7	12302	19	CR1	CR1	NNP
cord-005453-4057qib7	12302	20	,	,	,
cord-005453-4057qib7	12302	21	MRD	MRD	NNP
cord-005453-4057qib7	12302	22	neg	neg	NNP
cord-005453-4057qib7	12302	23	)	)	-RRB-
cord-005453-4057qib7	12302	24	,	,	,
cord-005453-4057qib7	12302	25	while	while	IN
cord-005453-4057qib7	12302	26	in	in	IN
cord-005453-4057qib7	12302	27	the	the	DT
cord-005453-4057qib7	12302	28	third	third	JJ
cord-005453-4057qib7	12302	29	patient	patient	NN
cord-005453-4057qib7	12302	30	(	(	-LRB-
cord-005453-4057qib7	12302	31	34yo	34yo	JJ
cord-005453-4057qib7	12302	32	)	)	-RRB-
cord-005453-4057qib7	12302	33	,	,	,
cord-005453-4057qib7	12302	34	recurrence	recurrence	NN
cord-005453-4057qib7	12302	35	with	with	IN
cord-005453-4057qib7	12302	36	CNS	CNS	NNP
cord-005453-4057qib7	12302	37	and	and	CC
cord-005453-4057qib7	12302	38	testis	testis	NN
cord-005453-4057qib7	12302	39	involvement	involvement	NN
cord-005453-4057qib7	12302	40	occurred	occur	VBD
cord-005453-4057qib7	12302	41	12	12	CD
cord-005453-4057qib7	12302	42	years	year	NNS
cord-005453-4057qib7	12302	43	after	after	IN
cord-005453-4057qib7	12302	44	CR1	CR1	NNP
cord-005453-4057qib7	12302	45	(	(	-LRB-
cord-005453-4057qib7	12302	46	MRD	MRD	NNP
cord-005453-4057qib7	12302	47	neg	neg	NNP
cord-005453-4057qib7	12302	48	)	)	-RRB-
cord-005453-4057qib7	12302	49	.	.	.
cord-005453-4057qib7	12303	1	All	all	DT
cord-005453-4057qib7	12303	2	patients	patient	NNS
cord-005453-4057qib7	12303	3	underwent	undergo	VBD
cord-005453-4057qib7	12303	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12303	5	(	(	-LRB-
cord-005453-4057qib7	12303	6	FLAM	FLAM	NNP
cord-005453-4057qib7	12303	7	,	,	,
cord-005453-4057qib7	12303	8	HyperCVAD	HyperCVAD	NNP
cord-005453-4057qib7	12303	9	and	and	CC
cord-005453-4057qib7	12303	10	DNR	DNR	NNP
cord-005453-4057qib7	12303	11	/	/	SYM
cord-005453-4057qib7	12303	12	VCR	VCR	NNP
cord-005453-4057qib7	12303	13	/	/	SYM
cord-005453-4057qib7	12303	14	PegAsp	PegAsp	NNP
cord-005453-4057qib7	12303	15	/	/	SYM
cord-005453-4057qib7	12303	16	Dexa	Dexa	NNP
cord-005453-4057qib7	12303	17	regimens	regimen	NNS
cord-005453-4057qib7	12303	18	respectively	respectively	RB
cord-005453-4057qib7	12303	19	)	)	-RRB-
cord-005453-4057qib7	12303	20	followed	follow	VBN
cord-005453-4057qib7	12303	21	by	by	IN
cord-005453-4057qib7	12303	22	one	one	CD
cord-005453-4057qib7	12303	23	cycle	cycle	NN
cord-005453-4057qib7	12303	24	of	of	IN
cord-005453-4057qib7	12303	25	blinatumomab	blinatumomab	NN
cord-005453-4057qib7	12303	26	(	(	-LRB-
cord-005453-4057qib7	12303	27	at	at	IN
cord-005453-4057qib7	12303	28	a	a	DT
cord-005453-4057qib7	12303	29	dose	dose	NN
cord-005453-4057qib7	12303	30	of	of	IN
cord-005453-4057qib7	12303	31	9mcg	9mcg	CD
cord-005453-4057qib7	12303	32	/	/	SYM
cord-005453-4057qib7	12303	33	d	d	NN
cord-005453-4057qib7	12303	34	on	on	IN
cord-005453-4057qib7	12303	35	days	day	NNS
cord-005453-4057qib7	12303	36	1	1	CD
cord-005453-4057qib7	12303	37	-	-	SYM
cord-005453-4057qib7	12303	38	7	7	CD
cord-005453-4057qib7	12303	39	,	,	,
cord-005453-4057qib7	12303	40	followed	follow	VBN
cord-005453-4057qib7	12303	41	by	by	IN
cord-005453-4057qib7	12303	42	28mcg	28mcg	CD
cord-005453-4057qib7	12303	43	/	/	SYM
cord-005453-4057qib7	12303	44	d	d	NN
cord-005453-4057qib7	12303	45	on	on	IN
cord-005453-4057qib7	12303	46	days	day	NNS
cord-005453-4057qib7	12303	47	8	8	CD
cord-005453-4057qib7	12303	48	-	-	SYM
cord-005453-4057qib7	12303	49	28	28	CD
cord-005453-4057qib7	12303	50	in	in	IN
cord-005453-4057qib7	12303	51	a	a	DT
cord-005453-4057qib7	12303	52	continuous	continuous	JJ
cord-005453-4057qib7	12303	53	infusion	infusion	NN
cord-005453-4057qib7	12303	54	)	)	-RRB-
cord-005453-4057qib7	12303	55	and	and	CC
cord-005453-4057qib7	12303	56	allo	allo	NN
cord-005453-4057qib7	12303	57	-	-	HYPH
cord-005453-4057qib7	12303	58	SCT	SCT	NNP
cord-005453-4057qib7	12303	59	(	(	-LRB-
cord-005453-4057qib7	12303	60	using	use	VBG
cord-005453-4057qib7	12303	61	Eto	Eto	NNP
cord-005453-4057qib7	12303	62	/	/	SYM
cord-005453-4057qib7	12303	63	Cy	Cy	NNP
cord-005453-4057qib7	12303	64	/	/	SYM
cord-005453-4057qib7	12303	65	TBI	TBI	NNP
cord-005453-4057qib7	12303	66	/	/	SYM
cord-005453-4057qib7	12303	67	ATG/	atg/	JJ
cord-005453-4057qib7	12303	68	conditioning	conditioning	NN
cord-005453-4057qib7	12303	69	regimen	regimen	NN
cord-005453-4057qib7	12303	70	for	for	IN
cord-005453-4057qib7	12303	71	Ist	Ist	NNP
cord-005453-4057qib7	12303	72	and	and	CC
cord-005453-4057qib7	12303	73	IIIrd	IIIrd	NNP
cord-005453-4057qib7	12303	74	patient	patient	NN
cord-005453-4057qib7	12303	75	and	and	CC
cord-005453-4057qib7	12303	76	BuCy2	BuCy2	NNS
cord-005453-4057qib7	12303	77	for	for	IN
cord-005453-4057qib7	12303	78	IInd	IInd	NNP
cord-005453-4057qib7	12303	79	patient	patient	JJ
cord-005453-4057qib7	12303	80	;	;	:
cord-005453-4057qib7	12303	81	using	use	VBG
cord-005453-4057qib7	12303	82	matched	match	VBN
cord-005453-4057qib7	12303	83	unrelated	unrelated	JJ
cord-005453-4057qib7	12303	84	donor	donor	NN
cord-005453-4057qib7	12303	85	(	(	-LRB-
cord-005453-4057qib7	12303	86	MUD	mud	NN
cord-005453-4057qib7	12303	87	,	,	,
cord-005453-4057qib7	12303	88	Ist	Ist	NNP
cord-005453-4057qib7	12303	89	and	and	CC
cord-005453-4057qib7	12303	90	IIIrd	IIIrd	NNP
cord-005453-4057qib7	12303	91	patient	patient	JJ
cord-005453-4057qib7	12303	92	)	)	-RRB-
cord-005453-4057qib7	12303	93	or	or	CC
cord-005453-4057qib7	12303	94	matched	match	VBN
cord-005453-4057qib7	12303	95	related	related	JJ
cord-005453-4057qib7	12303	96	donor	donor	NN
cord-005453-4057qib7	12303	97	(	(	-LRB-
cord-005453-4057qib7	12303	98	IInd	IInd	NNP
cord-005453-4057qib7	12303	99	patient	patient	NN
cord-005453-4057qib7	12303	100	)	)	-RRB-
cord-005453-4057qib7	12303	101	)	)	-RRB-
cord-005453-4057qib7	12303	102	.	.	.
cord-005453-4057qib7	12304	1	MRD	MRD	NNP
cord-005453-4057qib7	12304	2	status	status	NN
cord-005453-4057qib7	12304	3	was	be	VBD
cord-005453-4057qib7	12304	4	assessed	assess	VBN
cord-005453-4057qib7	12304	5	after	after	IN
cord-005453-4057qib7	12304	6	each	each	DT
cord-005453-4057qib7	12304	7	cycle	cycle	NN
cord-005453-4057qib7	12304	8	of	of	IN
cord-005453-4057qib7	12304	9	blinatumomab	blinatumomab	NN
cord-005453-4057qib7	12304	10	by	by	IN
cord-005453-4057qib7	12304	11	FC	FC	NNP
cord-005453-4057qib7	12304	12	.	.	.
cord-005453-4057qib7	12305	1	Results	result	NNS
cord-005453-4057qib7	12305	2	:	:	:
cord-005453-4057qib7	12306	1	All	all	DT
cord-005453-4057qib7	12306	2	patients	patient	NNS
cord-005453-4057qib7	12306	3	achieved	achieve	VBD
cord-005453-4057qib7	12306	4	CR	CR	NNP
cord-005453-4057qib7	12306	5	MRD	MRD	NNP
cord-005453-4057qib7	12306	6	pos	pos	NN
cord-005453-4057qib7	12306	7	after	after	IN
cord-005453-4057qib7	12306	8	reinduction	reinduction	NN
cord-005453-4057qib7	12306	9	therapy	therapy	NN
cord-005453-4057qib7	12306	10	followed	follow	VBN
cord-005453-4057qib7	12306	11	by	by	IN
cord-005453-4057qib7	12306	12	clearance	clearance	NN
cord-005453-4057qib7	12306	13	of	of	IN
cord-005453-4057qib7	12306	14	MRD	MRD	NNP
cord-005453-4057qib7	12306	15	after	after	IN
cord-005453-4057qib7	12306	16	blinatumomab	blinatumomab	NNP
cord-005453-4057qib7	12306	17	course	course	NN
cord-005453-4057qib7	12306	18	(	(	-LRB-
cord-005453-4057qib7	12306	19	Tab	Tab	NNP
cord-005453-4057qib7	12306	20	.	.	.
cord-005453-4057qib7	12306	21	1	1	CD
cord-005453-4057qib7	12306	22	)	)	-RRB-
cord-005453-4057qib7	12306	23	.	.	.
cord-005453-4057qib7	12307	1	The	the	DT
cord-005453-4057qib7	12307	2	second	second	JJ
cord-005453-4057qib7	12307	3	patient	patient	NN
cord-005453-4057qib7	12307	4	,	,	,
cord-005453-4057qib7	12307	5	due	due	IN
cord-005453-4057qib7	12307	6	to	to	IN
cord-005453-4057qib7	12307	7	positive	positive	JJ
cord-005453-4057qib7	12307	8	MRD	MRD	NNP
cord-005453-4057qib7	12307	9	6	6	CD
cord-005453-4057qib7	12307	10	months	month	NNS
cord-005453-4057qib7	12307	11	after	after	IN
cord-005453-4057qib7	12307	12	allo	allo	NN
cord-005453-4057qib7	12307	13	-	-	HYPH
cord-005453-4057qib7	12307	14	SCT	SCT	NNP
cord-005453-4057qib7	12307	15	received	receive	VBD
cord-005453-4057qib7	12307	16	4	4	CD
cord-005453-4057qib7	12307	17	donor	donor	NN
cord-005453-4057qib7	12307	18	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	12307	19	infusions	infusion	NNS
cord-005453-4057qib7	12307	20	additionally	additionally	RB
cord-005453-4057qib7	12307	21	.	.	.
cord-005453-4057qib7	12308	1	During	during	IN
cord-005453-4057qib7	12308	2	the	the	DT
cord-005453-4057qib7	12308	3	administration	administration	NN
cord-005453-4057qib7	12308	4	of	of	IN
cord-005453-4057qib7	12308	5	blinatumomab	blinatumomab	NNP
cord-005453-4057qib7	12308	6	,	,	,
cord-005453-4057qib7	12308	7	no	no	DT
cord-005453-4057qib7	12308	8	adverse	adverse	JJ
cord-005453-4057qib7	12308	9	events	event	NNS
cord-005453-4057qib7	12308	10	(	(	-LRB-
cord-005453-4057qib7	12308	11	AEs	AEs	NNP
cord-005453-4057qib7	12308	12	)	)	-RRB-
cord-005453-4057qib7	12308	13	were	be	VBD
cord-005453-4057qib7	12308	14	observed	observe	VBN
cord-005453-4057qib7	12308	15	in	in	IN
cord-005453-4057qib7	12308	16	grade	grade	NN
cord-005453-4057qib7	12308	17	3	3	CD
cord-005453-4057qib7	12308	18	or	or	CC
cord-005453-4057qib7	12308	19	4	4	CD
cord-005453-4057qib7	12308	20	.	.	.
cord-005453-4057qib7	12309	1	One	one	CD
cord-005453-4057qib7	12309	2	patient	patient	NN
cord-005453-4057qib7	12309	3	developed	develop	VBD
cord-005453-4057qib7	12309	4	cytokine	cytokine	NN
cord-005453-4057qib7	12309	5	release	release	NN
cord-005453-4057qib7	12309	6	syndrome	syndrome	NN
cord-005453-4057qib7	12309	7	in	in	IN
cord-005453-4057qib7	12309	8	grade	grade	NN
cord-005453-4057qib7	12309	9	1	1	CD
cord-005453-4057qib7	12309	10	.	.	.
cord-005453-4057qib7	12310	1	The	the	DT
cord-005453-4057qib7	12310	2	progression	progression	NN
cord-005453-4057qib7	12310	3	free	free	JJ
cord-005453-4057qib7	12310	4	survival	survival	NN
cord-005453-4057qib7	12310	5	,	,	,
cord-005453-4057qib7	12310	6	time	time	NN
cord-005453-4057qib7	12310	7	to	to	IN
cord-005453-4057qib7	12310	8	positive	positive	JJ
cord-005453-4057qib7	12310	9	MRD	MRD	NNP
cord-005453-4057qib7	12310	10	and	and	CC
cord-005453-4057qib7	12310	11	follow	follow	VB
cord-005453-4057qib7	12310	12	up	up	RP
cord-005453-4057qib7	12310	13	are	be	VBP
cord-005453-4057qib7	12310	14	presented	present	VBN
cord-005453-4057qib7	12310	15	in	in	IN
cord-005453-4057qib7	12310	16	Tab	Tab	NNP
cord-005453-4057qib7	12310	17	1	1	CD
cord-005453-4057qib7	12310	18	.	.	.
cord-005453-4057qib7	12311	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12311	2	:	:	:
cord-005453-4057qib7	12312	1	The	the	DT
cord-005453-4057qib7	12312	2	use	use	NN
cord-005453-4057qib7	12312	3	of	of	IN
cord-005453-4057qib7	12312	4	blinatumomab	blinatumomab	NN
cord-005453-4057qib7	12312	5	as	as	IN
cord-005453-4057qib7	12312	6	a	a	DT
cord-005453-4057qib7	12312	7	bridging	bridge	VBG
cord-005453-4057qib7	12312	8	therapy	therapy	NN
cord-005453-4057qib7	12312	9	between	between	IN
cord-005453-4057qib7	12312	10	re	re	NN
cord-005453-4057qib7	12312	11	-	-	NN
cord-005453-4057qib7	12312	12	induction	induction	JJ
cord-005453-4057qib7	12312	13	regimens	regimen	NNS
cord-005453-4057qib7	12312	14	and	and	CC
cord-005453-4057qib7	12312	15	allo	allo	NN
cord-005453-4057qib7	12312	16	-	-	HYPH
cord-005453-4057qib7	12312	17	SCT	sct	NN
cord-005453-4057qib7	12312	18	in	in	IN
cord-005453-4057qib7	12312	19	patients	patient	NNS
cord-005453-4057qib7	12312	20	with	with	IN
cord-005453-4057qib7	12312	21	ALL	all	DT
cord-005453-4057qib7	12312	22	-	-	HYPH
cord-005453-4057qib7	12312	23	B	B	NNP
cord-005453-4057qib7	12312	24	and	and	CC
cord-005453-4057qib7	12312	25	MRD	MRD	NNP
cord-005453-4057qib7	12312	26	pos	pos	NNP
cord-005453-4057qib7	12312	27	appears	appear	VBZ
cord-005453-4057qib7	12312	28	to	to	TO
cord-005453-4057qib7	12312	29	be	be	VB
cord-005453-4057qib7	12312	30	safe	safe	JJ
cord-005453-4057qib7	12312	31	and	and	CC
cord-005453-4057qib7	12312	32	leads	lead	VBZ
cord-005453-4057qib7	12312	33	to	to	IN
cord-005453-4057qib7	12312	34	the	the	DT
cord-005453-4057qib7	12312	35	clearance	clearance	NN
cord-005453-4057qib7	12312	36	of	of	IN
cord-005453-4057qib7	12312	37	MRD	MRD	NNP
cord-005453-4057qib7	12312	38	which	which	WDT
cord-005453-4057qib7	12312	39	may	may	MD
cord-005453-4057qib7	12312	40	be	be	VB
cord-005453-4057qib7	12312	41	crucial	crucial	JJ
cord-005453-4057qib7	12312	42	in	in	IN
cord-005453-4057qib7	12312	43	OS	OS	NNP
cord-005453-4057qib7	12312	44	and	and	CC
cord-005453-4057qib7	12312	45	PFS	PFS	NNP
cord-005453-4057qib7	12312	46	prolongation	prolongation	NN
cord-005453-4057qib7	12312	47	after	after	IN
cord-005453-4057qib7	12312	48	following	follow	VBG
cord-005453-4057qib7	12312	49	allo	allo	NN
cord-005453-4057qib7	12312	50	-	-	HYPH
cord-005453-4057qib7	12312	51	SCT	sct	NN
cord-005453-4057qib7	12312	52	.	.	.
cord-005453-4057qib7	12313	1	Future	future	JJ
cord-005453-4057qib7	12313	2	studies	study	NNS
cord-005453-4057qib7	12313	3	on	on	IN
cord-005453-4057qib7	12313	4	larger	large	JJR
cord-005453-4057qib7	12313	5	groups	group	NNS
cord-005453-4057qib7	12313	6	of	of	IN
cord-005453-4057qib7	12313	7	patients	patient	NNS
cord-005453-4057qib7	12313	8	are	be	VBP
cord-005453-4057qib7	12313	9	necessary	necessary	JJ
cord-005453-4057qib7	12313	10	to	to	TO
cord-005453-4057qib7	12313	11	confirm	confirm	VB
cord-005453-4057qib7	12313	12	this	this	DT
cord-005453-4057qib7	12313	13	thesis	thesis	NN
cord-005453-4057qib7	12313	14	.	.	.
cord-005453-4057qib7	12314	1	Background	background	NN
cord-005453-4057qib7	12314	2	:	:	:
cord-005453-4057qib7	12315	1	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	12315	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12315	3	stem	stem	NN
cord-005453-4057qib7	12315	4	cell	cell	NN
cord-005453-4057qib7	12315	5	transplantation	transplantation	NN
cord-005453-4057qib7	12315	6	(	(	-LRB-
cord-005453-4057qib7	12315	7	HSCT	HSCT	NNP
cord-005453-4057qib7	12315	8	)	)	-RRB-
cord-005453-4057qib7	12315	9	is	be	VBZ
cord-005453-4057qib7	12315	10	considered	consider	VBN
cord-005453-4057qib7	12315	11	an	an	DT
cord-005453-4057qib7	12315	12	alternative	alternative	JJ
cord-005453-4057qib7	12315	13	treatment	treatment	NN
cord-005453-4057qib7	12315	14	for	for	IN
cord-005453-4057qib7	12315	15	hematologic	hematologic	JJ
cord-005453-4057qib7	12315	16	malignancies	malignancy	NNS
cord-005453-4057qib7	12315	17	in	in	IN
cord-005453-4057qib7	12315	18	patients	patient	NNS
cord-005453-4057qib7	12315	19	who	who	WP
cord-005453-4057qib7	12315	20	do	do	VBP
cord-005453-4057qib7	12315	21	not	not	RB
cord-005453-4057qib7	12315	22	have	have	VB
cord-005453-4057qib7	12315	23	an	an	DT
cord-005453-4057qib7	12315	24	HLA	HLA	NNP
cord-005453-4057qib7	12315	25	-	-	HYPH
cord-005453-4057qib7	12315	26	identical	identical	JJ
cord-005453-4057qib7	12315	27	sibling	sibling	NN
cord-005453-4057qib7	12315	28	donor	donor	NN
cord-005453-4057qib7	12315	29	[	[	-LRB-
cord-005453-4057qib7	12315	30	1	1	CD
cord-005453-4057qib7	12315	31	]	]	-RRB-
cord-005453-4057qib7	12315	32	.	.	.
cord-005453-4057qib7	12316	1	Since	since	IN
cord-005453-4057qib7	12316	2	infections	infection	NNS
cord-005453-4057qib7	12316	3	and	and	CC
cord-005453-4057qib7	12316	4	disease	disease	NN
cord-005453-4057qib7	12316	5	relapse	relapse	NN
cord-005453-4057qib7	12316	6	resulting	result	VBG
cord-005453-4057qib7	12316	7	from	from	IN
cord-005453-4057qib7	12316	8	delayed	delay	VBN
cord-005453-4057qib7	12316	9	immune	immune	JJ
cord-005453-4057qib7	12316	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	12316	11	(	(	-LRB-
cord-005453-4057qib7	12316	12	IR	IR	NNP
cord-005453-4057qib7	12316	13	)	)	-RRB-
cord-005453-4057qib7	12316	14	are	be	VBP
cord-005453-4057qib7	12316	15	the	the	DT
cord-005453-4057qib7	12316	16	most	most	RBS
cord-005453-4057qib7	12316	17	common	common	JJ
cord-005453-4057qib7	12316	18	causes	cause	NNS
cord-005453-4057qib7	12316	19	of	of	IN
cord-005453-4057qib7	12316	20	mortality	mortality	NN
cord-005453-4057qib7	12316	21	among	among	IN
cord-005453-4057qib7	12316	22	patients	patient	NNS
cord-005453-4057qib7	12316	23	undergoing	undergo	VBG
cord-005453-4057qib7	12316	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	12316	25	-	-	HYPH
cord-005453-4057qib7	12316	26	HSCT	HSCT	NNP
cord-005453-4057qib7	12316	27	[	[	-LRB-
cord-005453-4057qib7	12316	28	2	2	CD
cord-005453-4057qib7	12316	29	]	]	-RRB-
cord-005453-4057qib7	12316	30	,	,	,
cord-005453-4057qib7	12316	31	timely	timely	RB
cord-005453-4057qib7	12316	32	IR	IR	NNP
cord-005453-4057qib7	12316	33	is	be	VBZ
cord-005453-4057qib7	12316	34	essential	essential	JJ
cord-005453-4057qib7	12316	35	in	in	IN
cord-005453-4057qib7	12316	36	the	the	DT
cord-005453-4057qib7	12316	37	recovery	recovery	NN
cord-005453-4057qib7	12316	38	and	and	CC
cord-005453-4057qib7	12316	39	survival	survival	NN
cord-005453-4057qib7	12316	40	of	of	IN
cord-005453-4057qib7	12316	41	these	these	DT
cord-005453-4057qib7	12316	42	patients	patient	NNS
cord-005453-4057qib7	12316	43	.	.	.
cord-005453-4057qib7	12317	1	The	the	DT
cord-005453-4057qib7	12317	2	aim	aim	NN
cord-005453-4057qib7	12317	3	of	of	IN
cord-005453-4057qib7	12317	4	this	this	DT
cord-005453-4057qib7	12317	5	study	study	NN
cord-005453-4057qib7	12317	6	is	be	VBZ
cord-005453-4057qib7	12317	7	to	to	TO
cord-005453-4057qib7	12317	8	describe	describe	VB
cord-005453-4057qib7	12317	9	the	the	DT
cord-005453-4057qib7	12317	10	evolution	evolution	NN
cord-005453-4057qib7	12317	11	of	of	IN
cord-005453-4057qib7	12317	12	IR	IR	NNP
cord-005453-4057qib7	12317	13	after	after	IN
cord-005453-4057qib7	12317	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	12317	15	-	-	HYPH
cord-005453-4057qib7	12317	16	HSCT	HSCT	NNP
cord-005453-4057qib7	12317	17	and	and	CC
cord-005453-4057qib7	12317	18	to	to	TO
cord-005453-4057qib7	12317	19	estimate	estimate	VB
cord-005453-4057qib7	12317	20	survival	survival	NN
cord-005453-4057qib7	12317	21	rates	rate	NNS
cord-005453-4057qib7	12317	22	in	in	IN
cord-005453-4057qib7	12317	23	patients	patient	NNS
cord-005453-4057qib7	12317	24	with	with	IN
cord-005453-4057qib7	12317	25	delayed	delay	VBN
cord-005453-4057qib7	12317	26	vs.	vs.	IN
cord-005453-4057qib7	12317	27	adequate	adequate	JJ
cord-005453-4057qib7	12317	28	reconstitution	reconstitution	NN
cord-005453-4057qib7	12317	29	in	in	IN
cord-005453-4057qib7	12317	30	a	a	DT
cord-005453-4057qib7	12317	31	single	single	JJ
cord-005453-4057qib7	12317	32	center	center	NN
cord-005453-4057qib7	12317	33	in	in	IN
cord-005453-4057qib7	12317	34	Colombia	Colombia	NNP
cord-005453-4057qib7	12317	35	,	,	,
cord-005453-4057qib7	12317	36	South	South	NNP
cord-005453-4057qib7	12317	37	America	America	NNP
cord-005453-4057qib7	12317	38	.	.	.
cord-005453-4057qib7	12318	1	Methods	method	NNS
cord-005453-4057qib7	12318	2	:	:	:
cord-005453-4057qib7	12319	1	A	a	DT
cord-005453-4057qib7	12319	2	retrospective	retrospective	JJ
cord-005453-4057qib7	12319	3	cohort	cohort	NN
cord-005453-4057qib7	12319	4	study	study	NN
cord-005453-4057qib7	12319	5	was	be	VBD
cord-005453-4057qib7	12319	6	conducted	conduct	VBN
cord-005453-4057qib7	12319	7	on	on	IN
cord-005453-4057qib7	12319	8	26	26	CD
cord-005453-4057qib7	12319	9	consecutive	consecutive	JJ
cord-005453-4057qib7	12319	10	adult	adult	NN
cord-005453-4057qib7	12319	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	12319	12	-	-	HYPH
cord-005453-4057qib7	12319	13	HSCT	HSCT	NNP
cord-005453-4057qib7	12319	14	recipients	recipient	NNS
cord-005453-4057qib7	12319	15	at	at	IN
cord-005453-4057qib7	12319	16	a	a	DT
cord-005453-4057qib7	12319	17	tertiary	tertiary	JJ
cord-005453-4057qib7	12319	18	referral	referral	NN
cord-005453-4057qib7	12319	19	center	center	NN
cord-005453-4057qib7	12319	20	.	.	.
cord-005453-4057qib7	12320	1	CD4+cells	CD4+cells	NNP
cord-005453-4057qib7	12320	2	,	,	,
cord-005453-4057qib7	12320	3	CD8+cells	CD8+cells	NNPS
cord-005453-4057qib7	12320	4	,	,	,
cord-005453-4057qib7	12320	5	CD3+cells	CD3+cells	NNP
cord-005453-4057qib7	12320	6	,	,	,
cord-005453-4057qib7	12320	7	and	and	CC
cord-005453-4057qib7	12320	8	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	12320	9	levels	level	NNS
cord-005453-4057qib7	12320	10	were	be	VBD
cord-005453-4057qib7	12320	11	monitored	monitor	VBN
cord-005453-4057qib7	12320	12	before	before	IN
cord-005453-4057qib7	12320	13	HSCT	HSCT	NNP
cord-005453-4057qib7	12320	14	,	,	,
cord-005453-4057qib7	12320	15	at	at	IN
cord-005453-4057qib7	12320	16	first	first	JJ
cord-005453-4057qib7	12320	17	month	month	NN
cord-005453-4057qib7	12320	18	,	,	,
cord-005453-4057qib7	12320	19	and	and	CC
cord-005453-4057qib7	12320	20	then	then	RB
cord-005453-4057qib7	12320	21	every	every	DT
cord-005453-4057qib7	12320	22	three	three	CD
cord-005453-4057qib7	12320	23	months	month	NNS
cord-005453-4057qib7	12320	24	for	for	IN
cord-005453-4057qib7	12320	25	the	the	DT
cord-005453-4057qib7	12320	26	first	first	JJ
cord-005453-4057qib7	12320	27	two	two	CD
cord-005453-4057qib7	12320	28	years	year	NNS
cord-005453-4057qib7	12320	29	post	post	NN
cord-005453-4057qib7	12320	30	-	-	NN
cord-005453-4057qib7	12320	31	transplantation	transplantation	NN
cord-005453-4057qib7	12320	32	.	.	.
cord-005453-4057qib7	12321	1	Descriptive	descriptive	JJ
cord-005453-4057qib7	12321	2	statistics	statistic	NNS
cord-005453-4057qib7	12321	3	were	be	VBD
cord-005453-4057qib7	12321	4	used	use	VBN
cord-005453-4057qib7	12321	5	to	to	TO
cord-005453-4057qib7	12321	6	analyze	analyze	VB
cord-005453-4057qib7	12321	7	patient	patient	NN
cord-005453-4057qib7	12321	8	's	's	POS
cord-005453-4057qib7	12321	9	clinical	clinical	JJ
cord-005453-4057qib7	12321	10	characteristics	characteristic	NNS
cord-005453-4057qib7	12321	11	.	.	.
cord-005453-4057qib7	12322	1	The	the	DT
cord-005453-4057qib7	12322	2	Kaplan	Kaplan	NNP
cord-005453-4057qib7	12322	3	-	-	HYPH
cord-005453-4057qib7	12322	4	Meier	Meier	NNP
cord-005453-4057qib7	12322	5	method	method	NN
cord-005453-4057qib7	12322	6	was	be	VBD
cord-005453-4057qib7	12322	7	used	use	VBN
cord-005453-4057qib7	12322	8	to	to	TO
cord-005453-4057qib7	12322	9	assess	assess	VB
cord-005453-4057qib7	12322	10	overall	overall	JJ
cord-005453-4057qib7	12322	11	survival	survival	NN
cord-005453-4057qib7	12322	12	(	(	-LRB-
cord-005453-4057qib7	12322	13	OS	OS	NNP
cord-005453-4057qib7	12322	14	)	)	-RRB-
cord-005453-4057qib7	12322	15	and	and	CC
cord-005453-4057qib7	12322	16	relapse	relapse	NN
cord-005453-4057qib7	12322	17	-	-	HYPH
cord-005453-4057qib7	12322	18	free	free	JJ
cord-005453-4057qib7	12322	19	survival	survival	NN
cord-005453-4057qib7	12322	20	(	(	-LRB-
cord-005453-4057qib7	12322	21	RFS	RFS	NNP
cord-005453-4057qib7	12322	22	)	)	-RRB-
cord-005453-4057qib7	12322	23	rates	rate	NNS
cord-005453-4057qib7	12322	24	.	.	.
cord-005453-4057qib7	12323	1	Results	result	NNS
cord-005453-4057qib7	12323	2	:	:	:
cord-005453-4057qib7	12324	1	Twenty	twenty	CD
cord-005453-4057qib7	12324	2	-	-	HYPH
cord-005453-4057qib7	12324	3	six	six	CD
cord-005453-4057qib7	12324	4	patients	patient	NNS
cord-005453-4057qib7	12324	5	were	be	VBD
cord-005453-4057qib7	12324	6	included	include	VBN
cord-005453-4057qib7	12324	7	(	(	-LRB-
cord-005453-4057qib7	12324	8	50	50	CD
cord-005453-4057qib7	12324	9	%	%	NN
cord-005453-4057qib7	12324	10	were	be	VBD
cord-005453-4057qib7	12324	11	male	male	JJ
cord-005453-4057qib7	12324	12	)	)	-RRB-
cord-005453-4057qib7	12324	13	,	,	,
cord-005453-4057qib7	12324	14	with	with	IN
cord-005453-4057qib7	12324	15	a	a	DT
cord-005453-4057qib7	12324	16	median	median	JJ
cord-005453-4057qib7	12324	17	age	age	NN
cord-005453-4057qib7	12324	18	of	of	IN
cord-005453-4057qib7	12324	19	25.5	25.5	CD
cord-005453-4057qib7	12324	20	years	year	NNS
cord-005453-4057qib7	12325	1	(	(	-LRB-
cord-005453-4057qib7	12325	2	range	range	NNP
cord-005453-4057qib7	12325	3	16	16	CD
cord-005453-4057qib7	12325	4	-	-	SYM
cord-005453-4057qib7	12325	5	59	59	CD
cord-005453-4057qib7	12325	6	)	)	-RRB-
cord-005453-4057qib7	12325	7	.	.	.
cord-005453-4057qib7	12326	1	The	the	DT
cord-005453-4057qib7	12326	2	most	most	RBS
cord-005453-4057qib7	12326	3	common	common	JJ
cord-005453-4057qib7	12326	4	indication	indication	NN
cord-005453-4057qib7	12326	5	for	for	IN
cord-005453-4057qib7	12326	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	12326	7	HSCT	HSCT	NNP
cord-005453-4057qib7	12326	8	was	be	VBD
cord-005453-4057qib7	12326	9	acute	acute	JJ
cord-005453-4057qib7	12326	10	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	12326	11	leukemia	leukemia	NN
cord-005453-4057qib7	12326	12	(	(	-LRB-
cord-005453-4057qib7	12326	13	n=21	n=21	NNP
cord-005453-4057qib7	12326	14	,	,	,
cord-005453-4057qib7	12326	15	80.8	80.8	CD
cord-005453-4057qib7	12326	16	%	%	NN
cord-005453-4057qib7	12326	17	)	)	-RRB-
cord-005453-4057qib7	12326	18	,	,	,
cord-005453-4057qib7	12326	19	followed	follow	VBN
cord-005453-4057qib7	12326	20	by	by	IN
cord-005453-4057qib7	12326	21	non	non	JJ
cord-005453-4057qib7	12326	22	-	-	JJ
cord-005453-4057qib7	12326	23	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	12326	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	12326	25	(	(	-LRB-
cord-005453-4057qib7	12326	26	n=3	n=3	NN
cord-005453-4057qib7	12326	27	,	,	,
cord-005453-4057qib7	12326	28	11	11	CD
cord-005453-4057qib7	12326	29	.5	.5	CD
cord-005453-4057qib7	12326	30	%	%	NN
cord-005453-4057qib7	12326	31	)	)	-RRB-
cord-005453-4057qib7	12326	32	and	and	CC
cord-005453-4057qib7	12326	33	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	12326	34	syndrome	syndrome	NN
cord-005453-4057qib7	12326	35	(	(	-LRB-
cord-005453-4057qib7	12326	36	n=2	n=2	NNS
cord-005453-4057qib7	12326	37	,	,	,
cord-005453-4057qib7	12326	38	7.7	7.7	CD
cord-005453-4057qib7	12326	39	%	%	NN
cord-005453-4057qib7	12326	40	)	)	-RRB-
cord-005453-4057qib7	12326	41	.	.	.
cord-005453-4057qib7	12327	1	All	all	DT
cord-005453-4057qib7	12327	2	patients	patient	NNS
cord-005453-4057qib7	12327	3	received	receive	VBD
cord-005453-4057qib7	12327	4	GvHD	GvHD	NNP
cord-005453-4057qib7	12327	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	12327	6	therapy	therapy	NN
cord-005453-4057qib7	12327	7	with	with	IN
cord-005453-4057qib7	12327	8	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12327	9	,	,	,
cord-005453-4057qib7	12327	10	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	12327	11	,	,	,
cord-005453-4057qib7	12327	12	and	and	CC
cord-005453-4057qib7	12327	13	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	12327	14	mofetil	mofetil	NNP
cord-005453-4057qib7	12327	15	.	.	.
cord-005453-4057qib7	12328	1	Fifteen	fifteen	CD
cord-005453-4057qib7	12328	2	patients	patient	NNS
cord-005453-4057qib7	12328	3	(	(	-LRB-
cord-005453-4057qib7	12328	4	57.7	57.7	CD
cord-005453-4057qib7	12328	5	%	%	NN
cord-005453-4057qib7	12328	6	)	)	-RRB-
cord-005453-4057qib7	12328	7	presented	present	VBD
cord-005453-4057qib7	12328	8	cytomegalovirus	cytomegalovirus	JJ
cord-005453-4057qib7	12328	9	reactivation	reactivation	NN
cord-005453-4057qib7	12328	10	(	(	-LRB-
cord-005453-4057qib7	12328	11	25/26	25/26	CD
cord-005453-4057qib7	12328	12	at	at	IN
cord-005453-4057qib7	12328	13	risk	risk	NN
cord-005453-4057qib7	12328	14	)	)	-RRB-
cord-005453-4057qib7	12328	15	,	,	,
cord-005453-4057qib7	12328	16	5	5	CD
cord-005453-4057qib7	12328	17	patients	patient	NNS
cord-005453-4057qib7	12328	18	(	(	-LRB-
cord-005453-4057qib7	12328	19	19.2	19.2	CD
cord-005453-4057qib7	12328	20	%	%	NN
cord-005453-4057qib7	12328	21	)	)	-RRB-
cord-005453-4057qib7	12328	22	Epstein	Epstein	NNP
cord-005453-4057qib7	12328	23	-	-	HYPH
cord-005453-4057qib7	12328	24	Barr	Barr	NNP
cord-005453-4057qib7	12328	25	virus	virus	NN
cord-005453-4057qib7	12328	26	reactivation	reactivation	NN
cord-005453-4057qib7	12328	27	,	,	,
cord-005453-4057qib7	12328	28	and	and	CC
cord-005453-4057qib7	12328	29	4	4	CD
cord-005453-4057qib7	12328	30	patients	patient	NNS
cord-005453-4057qib7	12328	31	(	(	-LRB-
cord-005453-4057qib7	12328	32	15.4	15.4	CD
cord-005453-4057qib7	12328	33	%	%	NN
cord-005453-4057qib7	12328	34	)	)	-RRB-
cord-005453-4057qib7	12328	35	developed	develop	VBD
cord-005453-4057qib7	12328	36	adenovirus	adenovirus	NN
cord-005453-4057qib7	12328	37	infection	infection	NN
cord-005453-4057qib7	12328	38	.	.	.
cord-005453-4057qib7	12329	1	Median	median	JJ
cord-005453-4057qib7	12329	2	time	time	NN
cord-005453-4057qib7	12329	3	to	to	IN
cord-005453-4057qib7	12329	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	12329	5	engraftment	engraftment	NN
cord-005453-4057qib7	12330	1	(	(	-LRB-
cord-005453-4057qib7	12330	2	neutrophils>0.5×10	neutrophils>0.5×10	NNP
cord-005453-4057qib7	12330	3	9	9	CD
cord-005453-4057qib7	12330	4	/L	/L	.
cord-005453-4057qib7	12330	5	)	)	-RRB-
cord-005453-4057qib7	12330	6	was	be	VBD
cord-005453-4057qib7	12330	7	15	15	CD
cord-005453-4057qib7	12330	8	days	day	NNS
cord-005453-4057qib7	12330	9	(	(	-LRB-
cord-005453-4057qib7	12330	10	range12	range12	NNP
cord-005453-4057qib7	12330	11	-	-	HYPH
cord-005453-4057qib7	12330	12	29	29	CD
cord-005453-4057qib7	12330	13	)	)	-RRB-
cord-005453-4057qib7	12330	14	for	for	IN
cord-005453-4057qib7	12330	15	the	the	DT
cord-005453-4057qib7	12330	16	23	23	CD
cord-005453-4057qib7	12330	17	patients	patient	NNS
cord-005453-4057qib7	12330	18	recipients	recipient	NNS
cord-005453-4057qib7	12330	19	of	of	IN
cord-005453-4057qib7	12330	20	peripheral	peripheral	JJ
cord-005453-4057qib7	12330	21	blood	blood	NN
cord-005453-4057qib7	12330	22	progenitor	progenitor	NN
cord-005453-4057qib7	12330	23	cells	cell	NNS
cord-005453-4057qib7	12330	24	(	(	-LRB-
cord-005453-4057qib7	12330	25	PBPCs	pbpc	NNS
cord-005453-4057qib7	12330	26	)	)	-RRB-
cord-005453-4057qib7	12330	27	and	and	CC
cord-005453-4057qib7	12330	28	21	21	CD
cord-005453-4057qib7	12330	29	days	day	NNS
cord-005453-4057qib7	12330	30	(	(	-LRB-
cord-005453-4057qib7	12330	31	range20	range20	NNP
cord-005453-4057qib7	12330	32	-	-	HYPH
cord-005453-4057qib7	12330	33	27	27	CD
cord-005453-4057qib7	12330	34	)	)	-RRB-
cord-005453-4057qib7	12330	35	for	for	IN
cord-005453-4057qib7	12330	36	the	the	DT
cord-005453-4057qib7	12330	37	three	three	CD
cord-005453-4057qib7	12330	38	remaining	remain	VBG
cord-005453-4057qib7	12330	39	bone	bone	NN
cord-005453-4057qib7	12330	40	marrow	marrow	NN
cord-005453-4057qib7	12330	41	recipients	recipient	NNS
cord-005453-4057qib7	12330	42	.	.	.
cord-005453-4057qib7	12331	1	Platelet	platelet	NN
cord-005453-4057qib7	12331	2	engraftment	engraftment	NN
cord-005453-4057qib7	12331	3	,	,	,
cord-005453-4057qib7	12331	4	defined	define	VBN
cord-005453-4057qib7	12331	5	as	as	IN
cord-005453-4057qib7	12331	6	>	>	XX
cord-005453-4057qib7	12331	7	20,000	20,000	CD
cord-005453-4057qib7	12331	8	platelets/	platelets/	SYM
cord-005453-4057qib7	12331	9	mm	mm	NN
cord-005453-4057qib7	12331	10	3	3	CD
cord-005453-4057qib7	12331	11	Background	Background	NNP
cord-005453-4057qib7	12331	12	:	:	:
cord-005453-4057qib7	12331	13	Daratumumab	Daratumumab	NNP
cord-005453-4057qib7	12331	14	is	be	VBZ
cord-005453-4057qib7	12331	15	a	a	DT
cord-005453-4057qib7	12331	16	human	human	JJ
cord-005453-4057qib7	12331	17	monoclonal	monoclonal	JJ
cord-005453-4057qib7	12331	18	antibody	antibody	NN
cord-005453-4057qib7	12331	19	directed	direct	VBN
cord-005453-4057qib7	12331	20	against	against	IN
cord-005453-4057qib7	12331	21	the	the	DT
cord-005453-4057qib7	12331	22	glycoprotein	glycoprotein	NN
cord-005453-4057qib7	12331	23	CD38	CD38	NNP
cord-005453-4057qib7	12331	24	that	that	WDT
cord-005453-4057qib7	12331	25	is	be	VBZ
cord-005453-4057qib7	12331	26	overexpressed	overexpresse	VBN
cord-005453-4057qib7	12331	27	on	on	IN
cord-005453-4057qib7	12331	28	the	the	DT
cord-005453-4057qib7	12331	29	surface	surface	NN
cord-005453-4057qib7	12331	30	of	of	IN
cord-005453-4057qib7	12331	31	plasma	plasma	NN
cord-005453-4057qib7	12331	32	cells	cell	NNS
cord-005453-4057qib7	12331	33	in	in	IN
cord-005453-4057qib7	12331	34	multiple	multiple	JJ
cord-005453-4057qib7	12331	35	myeloma	myeloma	NN
cord-005453-4057qib7	12331	36	patients	patient	NNS
cord-005453-4057qib7	12331	37	.	.	.
cord-005453-4057qib7	12332	1	It	-PRON-	PRP
cord-005453-4057qib7	12332	2	is	be	VBZ
cord-005453-4057qib7	12332	3	approved	approve	VBN
cord-005453-4057qib7	12332	4	as	as	IN
cord-005453-4057qib7	12332	5	second	second	JJ
cord-005453-4057qib7	12332	6	line	line	NN
cord-005453-4057qib7	12332	7	therapy	therapy	NN
cord-005453-4057qib7	12332	8	either	either	CC
cord-005453-4057qib7	12332	9	as	as	IN
cord-005453-4057qib7	12332	10	single	single	JJ
cord-005453-4057qib7	12332	11	agent	agent	NN
cord-005453-4057qib7	12332	12	therapy	therapy	NN
cord-005453-4057qib7	12332	13	or	or	CC
cord-005453-4057qib7	12332	14	in	in	IN
cord-005453-4057qib7	12332	15	combination	combination	NN
cord-005453-4057qib7	12332	16	with	with	IN
cord-005453-4057qib7	12332	17	lenalidomide	lenalidomide	NN
cord-005453-4057qib7	12332	18	or	or	CC
cord-005453-4057qib7	12332	19	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12332	20	for	for	IN
cord-005453-4057qib7	12332	21	the	the	DT
cord-005453-4057qib7	12332	22	treatment	treatment	NN
cord-005453-4057qib7	12332	23	of	of	IN
cord-005453-4057qib7	12332	24	patients	patient	NNS
cord-005453-4057qib7	12332	25	with	with	IN
cord-005453-4057qib7	12332	26	relapsed	relapse	VBN
cord-005453-4057qib7	12332	27	/	/	SYM
cord-005453-4057qib7	12332	28	refractory	refractory	JJ
cord-005453-4057qib7	12332	29	multiple	multiple	JJ
cord-005453-4057qib7	12332	30	myeloma	myeloma	NN
cord-005453-4057qib7	12332	31	.	.	.
cord-005453-4057qib7	12333	1	Despite	despite	IN
cord-005453-4057qib7	12333	2	the	the	DT
cord-005453-4057qib7	12333	3	curative	curative	JJ
cord-005453-4057qib7	12333	4	potential	potential	NN
cord-005453-4057qib7	12333	5	of	of	IN
cord-005453-4057qib7	12333	6	an	an	DT
cord-005453-4057qib7	12333	7	allo	allo	NN
cord-005453-4057qib7	12333	8	-	-	HYPH
cord-005453-4057qib7	12333	9	SCT	SCT	NNP
cord-005453-4057qib7	12333	10	,	,	,
cord-005453-4057qib7	12333	11	the	the	DT
cord-005453-4057qib7	12333	12	high	high	JJ
cord-005453-4057qib7	12333	13	relapse	relapse	NN
cord-005453-4057qib7	12333	14	rate	rate	NN
cord-005453-4057qib7	12333	15	remains	remain	VBZ
cord-005453-4057qib7	12333	16	a	a	DT
cord-005453-4057qib7	12333	17	clinical	clinical	JJ
cord-005453-4057qib7	12333	18	problem	problem	NN
cord-005453-4057qib7	12333	19	.	.	.
cord-005453-4057qib7	12334	1	Data	datum	NNS
cord-005453-4057qib7	12334	2	addressing	address	VBG
cord-005453-4057qib7	12334	3	the	the	DT
cord-005453-4057qib7	12334	4	choice	choice	NN
cord-005453-4057qib7	12334	5	of	of	IN
cord-005453-4057qib7	12334	6	an	an	DT
cord-005453-4057qib7	12334	7	optimal	optimal	JJ
cord-005453-4057qib7	12334	8	salvage	salvage	NN
cord-005453-4057qib7	12334	9	therapy	therapy	NN
cord-005453-4057qib7	12334	10	regime	regime	NN
cord-005453-4057qib7	12334	11	for	for	IN
cord-005453-4057qib7	12334	12	these	these	DT
cord-005453-4057qib7	12334	13	heavily	heavily	RB
cord-005453-4057qib7	12334	14	pre	pre	JJ
cord-005453-4057qib7	12334	15	-	-	JJ
cord-005453-4057qib7	12334	16	treated	treat	VBN
cord-005453-4057qib7	12334	17	patients	patient	NNS
cord-005453-4057qib7	12334	18	is	be	VBZ
cord-005453-4057qib7	12334	19	missing	miss	VBG
cord-005453-4057qib7	12334	20	.	.	.
cord-005453-4057qib7	12335	1	Methods	method	NNS
cord-005453-4057qib7	12335	2	:	:	:
cord-005453-4057qib7	12336	1	From	from	IN
cord-005453-4057qib7	12336	2	April	April	NNP
cord-005453-4057qib7	12336	3	2016	2016	CD
cord-005453-4057qib7	12336	4	till	till	IN
cord-005453-4057qib7	12336	5	November	November	NNP
cord-005453-4057qib7	12336	6	2018	2018	CD
cord-005453-4057qib7	12336	7	a	a	DT
cord-005453-4057qib7	12336	8	total	total	NN
cord-005453-4057qib7	12336	9	of	of	IN
cord-005453-4057qib7	12336	10	22	22	CD
cord-005453-4057qib7	12336	11	patients	patient	NNS
cord-005453-4057qib7	12336	12	(	(	-LRB-
cord-005453-4057qib7	12336	13	male	male	NNP
cord-005453-4057qib7	12336	14	,	,	,
cord-005453-4057qib7	12336	15	n=10	n=10	NNP
cord-005453-4057qib7	12336	16	)	)	-RRB-
cord-005453-4057qib7	12336	17	with	with	IN
cord-005453-4057qib7	12336	18	the	the	DT
cord-005453-4057qib7	12336	19	median	median	JJ
cord-005453-4057qib7	12336	20	age	age	NN
cord-005453-4057qib7	12336	21	of	of	IN
cord-005453-4057qib7	12336	22	64	64	CD
cord-005453-4057qib7	12336	23	years	year	NNS
cord-005453-4057qib7	12336	24	(	(	-LRB-
cord-005453-4057qib7	12336	25	40	40	CD
cord-005453-4057qib7	12336	26	-	-	SYM
cord-005453-4057qib7	12336	27	72	72	CD
cord-005453-4057qib7	12336	28	)	)	-RRB-
cord-005453-4057qib7	12336	29	received	receive	VBD
cord-005453-4057qib7	12336	30	daratumumab	daratumumab	NNP
cord-005453-4057qib7	12336	31	as	as	IN
cord-005453-4057qib7	12336	32	a	a	DT
cord-005453-4057qib7	12336	33	salvage	salvage	NN
cord-005453-4057qib7	12336	34	therapy	therapy	NN
cord-005453-4057qib7	12336	35	for	for	IN
cord-005453-4057qib7	12336	36	relapse	relapse	NN
cord-005453-4057qib7	12336	37	of	of	IN
cord-005453-4057qib7	12336	38	multiple	multiple	JJ
cord-005453-4057qib7	12336	39	myeloma	myeloma	NN
cord-005453-4057qib7	12336	40	after	after	IN
cord-005453-4057qib7	12336	41	allo	allo	NN
cord-005453-4057qib7	12336	42	-	-	HYPH
cord-005453-4057qib7	12336	43	SCT	SCT	NNP
cord-005453-4057qib7	12336	44	at	at	IN
cord-005453-4057qib7	12336	45	the	the	DT
cord-005453-4057qib7	12336	46	University	University	NNP
cord-005453-4057qib7	12336	47	of	of	IN
cord-005453-4057qib7	12336	48	Hamburg	Hamburg	NNP
cord-005453-4057qib7	12336	49	.	.	.
cord-005453-4057qib7	12337	1	Prior	prior	RB
cord-005453-4057qib7	12337	2	to	to	IN
cord-005453-4057qib7	12337	3	allo	allo	NN
cord-005453-4057qib7	12337	4	-	-	HYPH
cord-005453-4057qib7	12337	5	SCT	SCT	NNP
cord-005453-4057qib7	12337	6	all	all	DT
cord-005453-4057qib7	12337	7	but	but	CC
cord-005453-4057qib7	12337	8	one	one	CD
cord-005453-4057qib7	12337	9	patient	patient	NN
cord-005453-4057qib7	12337	10	had	have	VBD
cord-005453-4057qib7	12337	11	received	receive	VBN
cord-005453-4057qib7	12337	12	an	an	DT
cord-005453-4057qib7	12337	13	autograft	autograft	NN
cord-005453-4057qib7	12337	14	,	,	,
cord-005453-4057qib7	12337	15	9	9	CD
cord-005453-4057qib7	12337	16	patients	patient	NNS
cord-005453-4057qib7	12337	17	even	even	RB
cord-005453-4057qib7	12337	18	≥2	≥2	NNP
cord-005453-4057qib7	12337	19	autografts	autografts	NNP
cord-005453-4057qib7	12337	20	and	and	CC
cord-005453-4057qib7	12337	21	4	4	CD
cord-005453-4057qib7	12337	22	patients	patient	NNS
cord-005453-4057qib7	12337	23	also	also	RB
cord-005453-4057qib7	12337	24	a	a	DT
cord-005453-4057qib7	12337	25	1	1	CD
cord-005453-4057qib7	12337	26	.	.	.
cord-005453-4057qib7	12337	27	allograft	allograft	NN
cord-005453-4057qib7	12337	28	.	.	.
cord-005453-4057qib7	12338	1	The	the	DT
cord-005453-4057qib7	12338	2	median	median	JJ
cord-005453-4057qib7	12338	3	number	number	NN
cord-005453-4057qib7	12338	4	of	of	IN
cord-005453-4057qib7	12338	5	salvage	salvage	NN
cord-005453-4057qib7	12338	6	lines	line	NNS
cord-005453-4057qib7	12338	7	post	post	JJ
cord-005453-4057qib7	12338	8	-	-	NN
cord-005453-4057qib7	12338	9	transplant	transplant	JJ
cord-005453-4057qib7	12338	10	and	and	CC
cord-005453-4057qib7	12338	11	prior	prior	RB
cord-005453-4057qib7	12338	12	to	to	IN
cord-005453-4057qib7	12338	13	first	first	JJ
cord-005453-4057qib7	12338	14	daratumumab	daratumumab	JJ
cord-005453-4057qib7	12338	15	infusion	infusion	NN
cord-005453-4057qib7	12338	16	was	be	VBD
cord-005453-4057qib7	12338	17	2	2	CD
cord-005453-4057qib7	12338	18	(	(	-LRB-
cord-005453-4057qib7	12338	19	0	0	CD
cord-005453-4057qib7	12338	20	-	-	SYM
cord-005453-4057qib7	12338	21	4	4	CD
cord-005453-4057qib7	12338	22	)	)	-RRB-
cord-005453-4057qib7	12338	23	.	.	.
cord-005453-4057qib7	12339	1	These	these	DT
cord-005453-4057qib7	12339	2	salvage	salvage	NN
cord-005453-4057qib7	12339	3	regimens	regimen	NNS
cord-005453-4057qib7	12339	4	included	include	VBD
cord-005453-4057qib7	12339	5	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	12339	6	,	,	,
cord-005453-4057qib7	12339	7	etoposide	etoposide	RB
cord-005453-4057qib7	12339	8	,	,	,
cord-005453-4057qib7	12339	9	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12339	10	,	,	,
cord-005453-4057qib7	12339	11	lenalidomide	lenalidomide	NNP
cord-005453-4057qib7	12339	12	,	,	,
cord-005453-4057qib7	12339	13	pomalidomide	pomalidomide	NNP
cord-005453-4057qib7	12339	14	and	and	CC
cord-005453-4057qib7	12339	15	carfilzomib	carfilzomib	NNP
cord-005453-4057qib7	12339	16	.	.	.
cord-005453-4057qib7	12340	1	Daratumumab	Daratumumab	NNP
cord-005453-4057qib7	12340	2	was	be	VBD
cord-005453-4057qib7	12340	3	started	start	VBN
cord-005453-4057qib7	12340	4	at	at	IN
cord-005453-4057qib7	12340	5	a	a	DT
cord-005453-4057qib7	12340	6	median	median	NN
cord-005453-4057qib7	12340	7	of	of	IN
cord-005453-4057qib7	12340	8	19	19	CD
cord-005453-4057qib7	12340	9	months	month	NNS
cord-005453-4057qib7	12340	10	(	(	-LRB-
cord-005453-4057qib7	12340	11	0	0	CD
cord-005453-4057qib7	12340	12	-	-	SYM
cord-005453-4057qib7	12340	13	43	43	CD
cord-005453-4057qib7	12340	14	)	)	-RRB-
cord-005453-4057qib7	12340	15	after	after	IN
cord-005453-4057qib7	12340	16	relapse/	relapse/	NN
cord-005453-4057qib7	12340	17	progress	progress	NN
cord-005453-4057qib7	12340	18	and	and	CC
cord-005453-4057qib7	12340	19	initiated	initiate	VBD
cord-005453-4057qib7	12340	20	as	as	IN
cord-005453-4057qib7	12340	21	single	single	JJ
cord-005453-4057qib7	12340	22	agent	agent	NN
cord-005453-4057qib7	12340	23	therapy	therapy	NN
cord-005453-4057qib7	12340	24	in	in	IN
cord-005453-4057qib7	12340	25	all	all	DT
cord-005453-4057qib7	12340	26	patients	patient	NNS
cord-005453-4057qib7	12340	27	.	.	.
cord-005453-4057qib7	12341	1	Concomitantly	concomitantly	RB
cord-005453-4057qib7	12341	2	,	,	,
cord-005453-4057qib7	12341	3	14	14	CD
cord-005453-4057qib7	12341	4	patients	patient	NNS
cord-005453-4057qib7	12341	5	received	receive	VBN
cord-005453-4057qib7	12341	6	either	either	CC
cord-005453-4057qib7	12341	7	an	an	DT
cord-005453-4057qib7	12341	8	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	12341	9	drug	drug	NN
cord-005453-4057qib7	12341	10	(	(	-LRB-
cord-005453-4057qib7	12341	11	lenalidomid	lenalidomid	NNP
cord-005453-4057qib7	12341	12	,	,	,
cord-005453-4057qib7	12341	13	n=10	n=10	NNP
cord-005453-4057qib7	12341	14	;	;	:
cord-005453-4057qib7	12341	15	pomalidomid	pomalidomid	NNP
cord-005453-4057qib7	12341	16	,	,	,
cord-005453-4057qib7	12341	17	n=1	n=1	CD
cord-005453-4057qib7	12341	18	)	)	-RRB-
cord-005453-4057qib7	12341	19	or	or	CC
cord-005453-4057qib7	12341	20	a	a	DT
cord-005453-4057qib7	12341	21	proteasome	proteasome	VBN
cord-005453-4057qib7	12341	22	inhibitor	inhibitor	NN
cord-005453-4057qib7	12341	23	(	(	-LRB-
cord-005453-4057qib7	12341	24	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12341	25	,	,	,
cord-005453-4057qib7	12341	26	n=3	n=3	NN
cord-005453-4057qib7	12341	27	)	)	-RRB-
cord-005453-4057qib7	12341	28	during	during	IN
cord-005453-4057qib7	12341	29	a	a	DT
cord-005453-4057qib7	12341	30	later	later	JJ
cord-005453-4057qib7	12341	31	course	course	NN
cord-005453-4057qib7	12341	32	of	of	IN
cord-005453-4057qib7	12341	33	daratumumab	daratumumab	VBN
cord-005453-4057qib7	12341	34	infusions	infusion	NNS
cord-005453-4057qib7	12341	35	.	.	.
cord-005453-4057qib7	12342	1	Combination	combination	NN
cord-005453-4057qib7	12342	2	therapy	therapy	NN
cord-005453-4057qib7	12342	3	was	be	VBD
cord-005453-4057qib7	12342	4	initiated	initiate	VBN
cord-005453-4057qib7	12342	5	when	when	WRB
cord-005453-4057qib7	12342	6	a	a	DT
cord-005453-4057qib7	12342	7	slow	slow	JJ
cord-005453-4057qib7	12342	8	rise	rise	NN
cord-005453-4057qib7	12342	9	of	of	IN
cord-005453-4057qib7	12342	10	paraprotein	paraprotein	NNP
cord-005453-4057qib7	12342	11	and/or	and/or	CC
cord-005453-4057qib7	12342	12	free	free	JJ
cord-005453-4057qib7	12342	13	light	light	JJ
cord-005453-4057qib7	12342	14	chains	chain	NNS
cord-005453-4057qib7	12342	15	or	or	CC
cord-005453-4057qib7	12342	16	no	no	DT
cord-005453-4057qib7	12342	17	response	response	NN
cord-005453-4057qib7	12342	18	to	to	IN
cord-005453-4057qib7	12342	19	monotherapy	monotherapy	NN
cord-005453-4057qib7	12342	20	was	be	VBD
cord-005453-4057qib7	12342	21	observed	observe	VBN
cord-005453-4057qib7	12342	22	(	(	-LRB-
cord-005453-4057qib7	12342	23	median	median	NN
cord-005453-4057qib7	12342	24	at	at	IN
cord-005453-4057qib7	12342	25	the	the	DT
cord-005453-4057qib7	12342	26	11	11	CD
cord-005453-4057qib7	12342	27	th	th	XX
cord-005453-4057qib7	12342	28	Infusion	Infusion	NNP
cord-005453-4057qib7	12342	29	)	)	-RRB-
cord-005453-4057qib7	12342	30	.	.	.
cord-005453-4057qib7	12343	1	Results	result	NNS
cord-005453-4057qib7	12343	2	:	:	:
cord-005453-4057qib7	12344	1	The	the	DT
cord-005453-4057qib7	12344	2	median	median	JJ
cord-005453-4057qib7	12344	3	number	number	NN
cord-005453-4057qib7	12344	4	of	of	IN
cord-005453-4057qib7	12344	5	infusions	infusion	NNS
cord-005453-4057qib7	12344	6	was	be	VBD
cord-005453-4057qib7	12344	7	14	14	CD
cord-005453-4057qib7	12344	8	.	.	.
cord-005453-4057qib7	12345	1	Twenty	twenty	CD
cord-005453-4057qib7	12345	2	adverse	adverse	JJ
cord-005453-4057qib7	12345	3	reactions	reaction	NNS
cord-005453-4057qib7	12345	4	were	be	VBD
cord-005453-4057qib7	12345	5	observed	observe	VBN
cord-005453-4057qib7	12345	6	in	in	IN
cord-005453-4057qib7	12345	7	13	13	CD
cord-005453-4057qib7	12345	8	of	of	IN
cord-005453-4057qib7	12345	9	22	22	CD
cord-005453-4057qib7	12345	10	(	(	-LRB-
cord-005453-4057qib7	12345	11	59	59	CD
cord-005453-4057qib7	12345	12	%	%	NN
cord-005453-4057qib7	12345	13	)	)	-RRB-
cord-005453-4057qib7	12345	14	patients	patient	NNS
cord-005453-4057qib7	12345	15	:	:	:
cord-005453-4057qib7	12345	16	dyspnea	dyspnea	NNP
cord-005453-4057qib7	12345	17	(	(	-LRB-
cord-005453-4057qib7	12345	18	n=5	n=5	NNP
cord-005453-4057qib7	12345	19	)	)	-RRB-
cord-005453-4057qib7	12345	20	,	,	.
cord-005453-4057qib7	12346	1	bronchospasm	bronchospasm	JJ
cord-005453-4057qib7	12346	2	(	(	-LRB-
cord-005453-4057qib7	12346	3	n=2	n=2	NNS
cord-005453-4057qib7	12346	4	)	)	-RRB-
cord-005453-4057qib7	12347	1	shivering	shiver	VBG
cord-005453-4057qib7	12347	2	(	(	-LRB-
cord-005453-4057qib7	12347	3	n=3	n=3	NN
cord-005453-4057qib7	12347	4	)	)	-RRB-
cord-005453-4057qib7	12347	5	,	,	,
cord-005453-4057qib7	12347	6	cough	cough	NN
cord-005453-4057qib7	12347	7	(	(	-LRB-
cord-005453-4057qib7	12347	8	n=2	n=2	NNS
cord-005453-4057qib7	12347	9	)	)	-RRB-
cord-005453-4057qib7	12347	10	,	,	,
cord-005453-4057qib7	12347	11	musculoskeletal	musculoskeletal	JJ
cord-005453-4057qib7	12347	12	pain	pain	NN
cord-005453-4057qib7	12347	13	(	(	-LRB-
cord-005453-4057qib7	12347	14	n=4	n=4	NNP
cord-005453-4057qib7	12347	15	)	)	-RRB-
cord-005453-4057qib7	12347	16	,	,	,
cord-005453-4057qib7	12347	17	acute	acute	JJ
cord-005453-4057qib7	12347	18	coronary	coronary	JJ
cord-005453-4057qib7	12347	19	syndrome	syndrome	NN
cord-005453-4057qib7	12347	20	(	(	-LRB-
cord-005453-4057qib7	12347	21	n=1	n=1	CD
cord-005453-4057qib7	12347	22	)	)	-RRB-
cord-005453-4057qib7	12347	23	,	,	,
cord-005453-4057qib7	12347	24	skin	skin	NN
cord-005453-4057qib7	12347	25	rush	rush	NN
cord-005453-4057qib7	12347	26	(	(	-LRB-
cord-005453-4057qib7	12347	27	n=1	n=1	FW
cord-005453-4057qib7	12347	28	)	)	-RRB-
cord-005453-4057qib7	12347	29	,	,	,
cord-005453-4057qib7	12347	30	facial	facial	JJ
cord-005453-4057qib7	12347	31	edema	edema	NN
cord-005453-4057qib7	12347	32	(	(	-LRB-
cord-005453-4057qib7	12347	33	n=1	n=1	FW
cord-005453-4057qib7	12347	34	)	)	-RRB-
cord-005453-4057qib7	12347	35	,	,	,
cord-005453-4057qib7	12347	36	pressure	pressure	NN
cord-005453-4057qib7	12347	37	on	on	IN
cord-005453-4057qib7	12347	38	eyes	eye	NNS
cord-005453-4057qib7	12347	39	(	(	-LRB-
cord-005453-4057qib7	12347	40	n=1	n=1	NN
cord-005453-4057qib7	12347	41	)	)	-RRB-
cord-005453-4057qib7	12347	42	.	.	.
cord-005453-4057qib7	12348	1	All	all	DT
cord-005453-4057qib7	12348	2	adverse	adverse	JJ
cord-005453-4057qib7	12348	3	reactions	reaction	NNS
cord-005453-4057qib7	12348	4	appeared	appear	VBD
cord-005453-4057qib7	12348	5	during	during	IN
cord-005453-4057qib7	12348	6	the	the	DT
cord-005453-4057qib7	12348	7	first	first	JJ
cord-005453-4057qib7	12348	8	infusion	infusion	NN
cord-005453-4057qib7	12348	9	and	and	CC
cord-005453-4057qib7	12348	10	were	be	VBD
cord-005453-4057qib7	12348	11	mostly	mostly	RB
cord-005453-4057qib7	12348	12	mild	mild	JJ
cord-005453-4057qib7	12348	13	or	or	CC
cord-005453-4057qib7	12348	14	moderate	moderate	JJ
cord-005453-4057qib7	12348	15	(	(	-LRB-
cord-005453-4057qib7	12348	16	CTC	CTC	NNP
cord-005453-4057qib7	12348	17	1	1	CD
cord-005453-4057qib7	12348	18	-	-	SYM
cord-005453-4057qib7	12348	19	2	2	CD
cord-005453-4057qib7	12348	20	,	,	,
cord-005453-4057qib7	12348	21	n=19	n=19	NN
cord-005453-4057qib7	12348	22	)	)	-RRB-
cord-005453-4057qib7	12348	23	.	.	.
cord-005453-4057qib7	12349	1	Tolerance	tolerance	NN
cord-005453-4057qib7	12349	2	of	of	IN
cord-005453-4057qib7	12349	3	the	the	DT
cord-005453-4057qib7	12349	4	following	follow	VBG
cord-005453-4057qib7	12349	5	infusions	infusion	NNS
cord-005453-4057qib7	12349	6	improved	improve	VBN
cord-005453-4057qib7	12349	7	and	and	CC
cord-005453-4057qib7	12349	8	in	in	IN
cord-005453-4057qib7	12349	9	none	none	NN
cord-005453-4057qib7	12349	10	of	of	IN
cord-005453-4057qib7	12349	11	the	the	DT
cord-005453-4057qib7	12349	12	cases	case	NNS
cord-005453-4057qib7	12349	13	therapy	therapy	NN
cord-005453-4057qib7	12349	14	had	have	VBD
cord-005453-4057qib7	12349	15	to	to	TO
cord-005453-4057qib7	12349	16	be	be	VB
cord-005453-4057qib7	12349	17	stopped	stop	VBN
cord-005453-4057qib7	12349	18	due	due	JJ
cord-005453-4057qib7	12349	19	to	to	IN
cord-005453-4057qib7	12349	20	adverse	adverse	JJ
cord-005453-4057qib7	12349	21	events	event	NNS
cord-005453-4057qib7	12349	22	.	.	.
cord-005453-4057qib7	12350	1	Three	three	CD
cord-005453-4057qib7	12350	2	patients	patient	NNS
cord-005453-4057qib7	12350	3	developed	develop	VBD
cord-005453-4057qib7	12350	4	late	late	JJ
cord-005453-4057qib7	12350	5	onset	onset	NN
cord-005453-4057qib7	12350	6	infections	infection	NNS
cord-005453-4057qib7	12350	7	(	(	-LRB-
cord-005453-4057qib7	12350	8	pneumonia	pneumonia	NN
cord-005453-4057qib7	12350	9	,	,	,
cord-005453-4057qib7	12350	10	n=2	n=2	NNS
cord-005453-4057qib7	12350	11	;	;	:
cord-005453-4057qib7	12350	12	urinary	urinary	JJ
cord-005453-4057qib7	12350	13	tract	tract	NN
cord-005453-4057qib7	12350	14	infection	infection	NN
cord-005453-4057qib7	12350	15	,	,	,
cord-005453-4057qib7	12350	16	n=1	n=1	CD
cord-005453-4057qib7	12350	17	)	)	-RRB-
cord-005453-4057qib7	12350	18	followed	follow	VBN
cord-005453-4057qib7	12350	19	by	by	IN
cord-005453-4057qib7	12350	20	temporarily	temporarily	RB
cord-005453-4057qib7	12350	21	therapy	therapy	NN
cord-005453-4057qib7	12350	22	interruption	interruption	NN
cord-005453-4057qib7	12350	23	.	.	.
cord-005453-4057qib7	12351	1	With	with	IN
cord-005453-4057qib7	12351	2	a	a	DT
cord-005453-4057qib7	12351	3	median	median	JJ
cord-005453-4057qib7	12351	4	follow	follow	NN
cord-005453-4057qib7	12351	5	-	-	HYPH
cord-005453-4057qib7	12351	6	up	up	NN
cord-005453-4057qib7	12351	7	of	of	IN
cord-005453-4057qib7	12351	8	14	14	CD
cord-005453-4057qib7	12351	9	months	month	NNS
cord-005453-4057qib7	12351	10	after	after	IN
cord-005453-4057qib7	12351	11	the	the	DT
cord-005453-4057qib7	12351	12	first	first	JJ
cord-005453-4057qib7	12351	13	administration	administration	NN
cord-005453-4057qib7	12351	14	20	20	CD
cord-005453-4057qib7	12351	15	of	of	IN
cord-005453-4057qib7	12351	16	22	22	CD
cord-005453-4057qib7	12351	17	patients	patient	NNS
cord-005453-4057qib7	12351	18	remain	remain	VBP
cord-005453-4057qib7	12351	19	alive	alive	JJ
cord-005453-4057qib7	12351	20	.9	.9	CD
cord-005453-4057qib7	12351	21	%	%	NN
cord-005453-4057qib7	12351	22	)	)	-RRB-
cord-005453-4057qib7	12351	23	.	.	.
cord-005453-4057qib7	12352	1	One	one	CD
cord-005453-4057qib7	12352	2	patient	patient	NN
cord-005453-4057qib7	12352	3	died	die	VBD
cord-005453-4057qib7	12352	4	due	due	IN
cord-005453-4057qib7	12352	5	to	to	IN
cord-005453-4057qib7	12352	6	progress	progress	NN
cord-005453-4057qib7	12352	7	of	of	IN
cord-005453-4057qib7	12352	8	myeloma	myeloma	NN
cord-005453-4057qib7	12352	9	and	and	CC
cord-005453-4057qib7	12352	10	another	another	DT
cord-005453-4057qib7	12352	11	died	die	VBD
cord-005453-4057qib7	12352	12	due	due	JJ
cord-005453-4057qib7	12352	13	to	to	IN
cord-005453-4057qib7	12352	14	severe	severe	JJ
cord-005453-4057qib7	12352	15	infection	infection	NN
cord-005453-4057qib7	12352	16	/	/	SYM
cord-005453-4057qib7	12352	17	sepsis	sepsis	NN
cord-005453-4057qib7	12352	18	.	.	.
cord-005453-4057qib7	12353	1	15	15	CD
cord-005453-4057qib7	12353	2	of	of	IN
cord-005453-4057qib7	12353	3	22	22	CD
cord-005453-4057qib7	12353	4	patients	patient	NNS
cord-005453-4057qib7	12353	5	responded	respond	VBD
cord-005453-4057qib7	12353	6	(	(	-LRB-
cord-005453-4057qib7	12353	7	68	68	CD
cord-005453-4057qib7	12353	8	%	%	NN
cord-005453-4057qib7	12353	9	;	;	:
cord-005453-4057qib7	12353	10	PR	PR	NNP
cord-005453-4057qib7	12353	11	,	,	,
cord-005453-4057qib7	12353	12	n=5	n=5	JJ
cord-005453-4057qib7	12353	13	;	;	:
cord-005453-4057qib7	12353	14	vgPR	vgpr	NN
cord-005453-4057qib7	12353	15	,	,	,
cord-005453-4057qib7	12353	16	n=8	n=8	NN
cord-005453-4057qib7	12353	17	;	;	:
cord-005453-4057qib7	12353	18	CR	cr	NN
cord-005453-4057qib7	12353	19	,	,	,
cord-005453-4057qib7	12353	20	n=2	n=2	NNS
cord-005453-4057qib7	12353	21	)	)	-RRB-
cord-005453-4057qib7	12353	22	to	to	IN
cord-005453-4057qib7	12353	23	the	the	DT
cord-005453-4057qib7	12353	24	therapy	therapy	NN
cord-005453-4057qib7	12353	25	with	with	IN
cord-005453-4057qib7	12353	26	daratumumab	daratumumab	NNP
cord-005453-4057qib7	12353	27	.	.	.
cord-005453-4057qib7	12354	1	The	the	DT
cord-005453-4057qib7	12354	2	responses	response	NNS
cord-005453-4057qib7	12354	3	(	(	-LRB-
cord-005453-4057qib7	12354	4	decrease	decrease	NN
cord-005453-4057qib7	12354	5	of	of	IN
cord-005453-4057qib7	12354	6	paraprotein	paraprotein	NNP
cord-005453-4057qib7	12354	7	and/or	and/or	CC
cord-005453-4057qib7	12354	8	free	free	JJ
cord-005453-4057qib7	12354	9	light	light	JJ
cord-005453-4057qib7	12354	10	chains	chain	NNS
cord-005453-4057qib7	12354	11	≥50	≥50	DT
cord-005453-4057qib7	12354	12	%	%	NN
cord-005453-4057qib7	12354	13	)	)	-RRB-
cord-005453-4057qib7	12354	14	occurred	occur	VBD
cord-005453-4057qib7	12354	15	at	at	IN
cord-005453-4057qib7	12354	16	a	a	DT
cord-005453-4057qib7	12354	17	median	median	NN
cord-005453-4057qib7	12354	18	of	of	IN
cord-005453-4057qib7	12354	19	7	7	CD
cord-005453-4057qib7	12354	20	days	day	NNS
cord-005453-4057qib7	12354	21	(	(	-LRB-
cord-005453-4057qib7	12354	22	4	4	CD
cord-005453-4057qib7	12354	23	-	-	SYM
cord-005453-4057qib7	12354	24	372	372	CD
cord-005453-4057qib7	12354	25	)	)	-RRB-
cord-005453-4057qib7	12354	26	after	after	IN
cord-005453-4057qib7	12354	27	the	the	DT
cord-005453-4057qib7	12354	28	first	first	JJ
cord-005453-4057qib7	12354	29	administration	administration	NN
cord-005453-4057qib7	12354	30	and	and	CC
cord-005453-4057qib7	12354	31	lasted	last	VBD
cord-005453-4057qib7	12354	32	for	for	IN
cord-005453-4057qib7	12354	33	5.0	5.0	CD
cord-005453-4057qib7	12354	34	months	month	NNS
cord-005453-4057qib7	12354	35	(	(	-LRB-
cord-005453-4057qib7	12354	36	0.5	0.5	CD
cord-005453-4057qib7	12354	37	-	-	SYM
cord-005453-4057qib7	12354	38	26.6	26.6	CD
cord-005453-4057qib7	12354	39	)	)	-RRB-
cord-005453-4057qib7	12354	40	.	.	.
cord-005453-4057qib7	12355	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12355	2	:	:	:
cord-005453-4057qib7	12356	1	Daratumumab	Daratumumab	NNP
cord-005453-4057qib7	12356	2	shows	show	VBZ
cord-005453-4057qib7	12356	3	an	an	DT
cord-005453-4057qib7	12356	4	encouraging	encourage	VBG
cord-005453-4057qib7	12356	5	efficacy	efficacy	NN
cord-005453-4057qib7	12356	6	and	and	CC
cord-005453-4057qib7	12356	7	acceptable	acceptable	JJ
cord-005453-4057qib7	12356	8	toxicity	toxicity	NN
cord-005453-4057qib7	12356	9	profile	profile	NN
cord-005453-4057qib7	12356	10	in	in	IN
cord-005453-4057qib7	12356	11	patients	patient	NNS
cord-005453-4057qib7	12356	12	with	with	IN
cord-005453-4057qib7	12356	13	relapsed	relapse	VBN
cord-005453-4057qib7	12356	14	/	/	SYM
cord-005453-4057qib7	12356	15	refractory	refractory	JJ
cord-005453-4057qib7	12356	16	myeloma	myeloma	NN
cord-005453-4057qib7	12356	17	after	after	IN
cord-005453-4057qib7	12356	18	allo	allo	NN
cord-005453-4057qib7	12356	19	-	-	HYPH
cord-005453-4057qib7	12356	20	SCT	SCT	NNP
cord-005453-4057qib7	12356	21	.	.	.
cord-005453-4057qib7	12357	1	Further	further	JJ
cord-005453-4057qib7	12357	2	studies	study	NNS
cord-005453-4057qib7	12357	3	are	be	VBP
cord-005453-4057qib7	12357	4	needed	need	VBN
cord-005453-4057qib7	12357	5	to	to	TO
cord-005453-4057qib7	12357	6	investigate	investigate	VB
cord-005453-4057qib7	12357	7	the	the	DT
cord-005453-4057qib7	12357	8	role	role	NN
cord-005453-4057qib7	12357	9	of	of	IN
cord-005453-4057qib7	12357	10	the	the	DT
cord-005453-4057qib7	12357	11	combination	combination	NN
cord-005453-4057qib7	12357	12	therapy	therapy	NN
cord-005453-4057qib7	12357	13	with	with	IN
cord-005453-4057qib7	12357	14	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	12357	15	drugs	drug	NNS
cord-005453-4057qib7	12357	16	or	or	CC
cord-005453-4057qib7	12357	17	proteasome	proteasome	NN
cord-005453-4057qib7	12357	18	inhibitors	inhibitor	NNS
cord-005453-4057qib7	12357	19	in	in	IN
cord-005453-4057qib7	12357	20	this	this	DT
cord-005453-4057qib7	12357	21	setting	setting	NN
cord-005453-4057qib7	12357	22	.	.	.
cord-005453-4057qib7	12358	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12358	2	:	:	:
cord-005453-4057qib7	12358	3	Nothing	nothing	NN
cord-005453-4057qib7	12358	4	to	to	TO
cord-005453-4057qib7	12358	5	declare	declare	VB
cord-005453-4057qib7	12358	6	P546	P546	NNP
cord-005453-4057qib7	12359	1	Clonal	Clonal	NNP
cord-005453-4057qib7	12359	2	plasma	plasma	NN
cord-005453-4057qib7	12359	3	cell	cell	NN
cord-005453-4057qib7	12359	4	detection	detection	NN
cord-005453-4057qib7	12359	5	by	by	IN
cord-005453-4057qib7	12359	6	high	high	JJ
cord-005453-4057qib7	12359	7	sensitive	sensitive	JJ
cord-005453-4057qib7	12359	8	flow	flow	NN
cord-005453-4057qib7	12359	9	cytometry	cytometry	NN
cord-005453-4057qib7	12359	10	in	in	IN
cord-005453-4057qib7	12359	11	aphaeresis	aphaeresis	NN
cord-005453-4057qib7	12359	12	product	product	NN
cord-005453-4057qib7	12359	13	is	be	VBZ
cord-005453-4057qib7	12359	14	poor	poor	JJ
cord-005453-4057qib7	12359	15	prognostic	prognostic	JJ
cord-005453-4057qib7	12359	16	and	and	CC
cord-005453-4057qib7	12359	17	not	not	RB
cord-005453-4057qib7	12359	18	increased	increase	VBN
cord-005453-4057qib7	12359	19	by	by	IN
cord-005453-4057qib7	12359	20	use	use	NN
cord-005453-4057qib7	12359	21	of	of	IN
cord-005453-4057qib7	12359	22	plerixafor	plerixafor	NN
cord-005453-4057qib7	12359	23	alone	alone	RB
cord-005453-4057qib7	12359	24	Background	background	NN
cord-005453-4057qib7	12359	25	:	:	:
cord-005453-4057qib7	12360	1	In	in	IN
cord-005453-4057qib7	12360	2	an	an	DT
cord-005453-4057qib7	12360	3	earlier	early	JJR
cord-005453-4057qib7	12360	4	from	from	IN
cord-005453-4057qib7	12360	5	our	-PRON-	PRP$
cord-005453-4057qib7	12360	6	center	center	NN
cord-005453-4057qib7	12360	7	we	-PRON-	PRP
cord-005453-4057qib7	12360	8	have	have	VBP
cord-005453-4057qib7	12360	9	demonstrated	demonstrate	VBN
cord-005453-4057qib7	12360	10	that	that	IN
cord-005453-4057qib7	12360	11	residual	residual	JJ
cord-005453-4057qib7	12360	12	clonal	clonal	JJ
cord-005453-4057qib7	12360	13	plasma	plasma	NN
cord-005453-4057qib7	12360	14	cells	cell	NNS
cord-005453-4057qib7	12360	15	(	(	-LRB-
cord-005453-4057qib7	12360	16	cPC	cPC	NNP
cord-005453-4057qib7	12360	17	)	)	-RRB-
cord-005453-4057qib7	12360	18	decrease	decrease	VB
cord-005453-4057qib7	12360	19	both	both	DT
cord-005453-4057qib7	12360	20	overall	overall	JJ
cord-005453-4057qib7	12360	21	survival	survival	NN
cord-005453-4057qib7	12360	22	(	(	-LRB-
cord-005453-4057qib7	12360	23	OS	OS	NNP
cord-005453-4057qib7	12360	24	)	)	-RRB-
cord-005453-4057qib7	12360	25	and	and	CC
cord-005453-4057qib7	12360	26	disease	disease	NNP
cord-005453-4057qib7	12360	27	free	free	JJ
cord-005453-4057qib7	12360	28	survival	survival	NN
cord-005453-4057qib7	12360	29	(	(	-LRB-
cord-005453-4057qib7	12360	30	DFS	DFS	NNP
cord-005453-4057qib7	12360	31	)	)	-RRB-
cord-005453-4057qib7	12361	1	(	(	-LRB-
cord-005453-4057qib7	12361	2	ASH	ASH	NNP
cord-005453-4057qib7	12361	3	2018).Plerixafor	2018).plerixafor	CD
cord-005453-4057qib7	12361	4	is	be	VBZ
cord-005453-4057qib7	12361	5	a	a	DT
cord-005453-4057qib7	12361	6	selective	selective	JJ
cord-005453-4057qib7	12361	7	antagonist	antagonist	NN
cord-005453-4057qib7	12361	8	of	of	IN
cord-005453-4057qib7	12361	9	CXC4	CXC4	NNP
cord-005453-4057qib7	12361	10	chemokine	chemokine	NN
cord-005453-4057qib7	12361	11	receptor	receptor	NN
cord-005453-4057qib7	12361	12	(	(	-LRB-
cord-005453-4057qib7	12361	13	CXCR4	CXCR4	NNP
cord-005453-4057qib7	12361	14	)	)	-RRB-
cord-005453-4057qib7	12361	15	and	and	CC
cord-005453-4057qib7	12361	16	able	able	JJ
cord-005453-4057qib7	12361	17	to	to	TO
cord-005453-4057qib7	12361	18	mobilize	mobilize	VB
cord-005453-4057qib7	12361	19	human	human	JJ
cord-005453-4057qib7	12361	20	peripheral	peripheral	JJ
cord-005453-4057qib7	12361	21	blood	blood	NN
cord-005453-4057qib7	12361	22	stem	stem	NN
cord-005453-4057qib7	12361	23	cell	cell	NN
cord-005453-4057qib7	12361	24	(	(	-LRB-
cord-005453-4057qib7	12361	25	PBSCs	pbsc	NNS
cord-005453-4057qib7	12361	26	)	)	-RRB-
cord-005453-4057qib7	12361	27	by	by	IN
cord-005453-4057qib7	12361	28	acting	act	VBG
cord-005453-4057qib7	12361	29	synergistically	synergistically	RB
cord-005453-4057qib7	12361	30	with	with	IN
cord-005453-4057qib7	12361	31	G	G	NNP
cord-005453-4057qib7	12361	32	-	-	HYPH
cord-005453-4057qib7	12361	33	CSF.The	CSF.The	NNP
cord-005453-4057qib7	12361	34	purpose	purpose	NN
cord-005453-4057qib7	12361	35	of	of	IN
cord-005453-4057qib7	12361	36	this	this	DT
cord-005453-4057qib7	12361	37	study	study	NN
cord-005453-4057qib7	12361	38	was	be	VBD
cord-005453-4057qib7	12361	39	to	to	TO
cord-005453-4057qib7	12361	40	evaluate	evaluate	VB
cord-005453-4057qib7	12361	41	the	the	DT
cord-005453-4057qib7	12361	42	safety	safety	NN
cord-005453-4057qib7	12361	43	and	and	CC
cord-005453-4057qib7	12361	44	efficacy	efficacy	NN
cord-005453-4057qib7	12361	45	of	of	IN
cord-005453-4057qib7	12361	46	plerixafor	plerixafor	NN
cord-005453-4057qib7	12361	47	in	in	IN
cord-005453-4057qib7	12361	48	myeloma	myeloma	NN
cord-005453-4057qib7	12361	49	patients	patient	NNS
cord-005453-4057qib7	12361	50	who	who	WP
cord-005453-4057qib7	12361	51	were	be	VBD
cord-005453-4057qib7	12361	52	proven	prove	VBN
cord-005453-4057qib7	12361	53	poor	poor	JJ
cord-005453-4057qib7	12361	54	mobilizers	mobilizer	NNS
cord-005453-4057qib7	12361	55	and	and	CC
cord-005453-4057qib7	12361	56	specifically	specifically	RB
cord-005453-4057qib7	12361	57	to	to	TO
cord-005453-4057qib7	12361	58	assess	assess	VB
cord-005453-4057qib7	12361	59	the	the	DT
cord-005453-4057qib7	12361	60	flow	flow	NN
cord-005453-4057qib7	12361	61	cytometric	cytometric	NN
cord-005453-4057qib7	12361	62	measurement	measurement	NN
cord-005453-4057qib7	12361	63	of	of	IN
cord-005453-4057qib7	12361	64	residual	residual	JJ
cord-005453-4057qib7	12361	65	clonal	clonal	JJ
cord-005453-4057qib7	12361	66	plasma	plasma	NN
cord-005453-4057qib7	12361	67	cells	cell	NNS
cord-005453-4057qib7	12361	68	in	in	IN
cord-005453-4057qib7	12361	69	the	the	DT
cord-005453-4057qib7	12361	70	apheresis	apheresis	NN
cord-005453-4057qib7	12361	71	products	product	NNS
cord-005453-4057qib7	12361	72	.	.	.
cord-005453-4057qib7	12362	1	Methods	method	NNS
cord-005453-4057qib7	12362	2	:	:	:
cord-005453-4057qib7	12362	3	Patients	patient	NNS
cord-005453-4057qib7	12362	4	with	with	IN
cord-005453-4057qib7	12362	5	a	a	DT
cord-005453-4057qib7	12362	6	diagnosis	diagnosis	NN
cord-005453-4057qib7	12362	7	of	of	IN
cord-005453-4057qib7	12362	8	MM	MM	NNP
cord-005453-4057qib7	12362	9	who	who	WP
cord-005453-4057qib7	12362	10	underwent	undergo	VBD
cord-005453-4057qib7	12362	11	auto	auto	NN
cord-005453-4057qib7	12362	12	HSCT	HSCT	NNP
cord-005453-4057qib7	12362	13	at	at	IN
cord-005453-4057qib7	12362	14	our	-PRON-	PRP$
cord-005453-4057qib7	12362	15	center	center	NN
cord-005453-4057qib7	12362	16	between	between	IN
cord-005453-4057qib7	12362	17	January	January	NNP
cord-005453-4057qib7	12362	18	2008-November	2008-november	CD
cord-005453-4057qib7	12362	19	2018	2018	CD
cord-005453-4057qib7	12362	20	were	be	VBD
cord-005453-4057qib7	12362	21	retrospectively	retrospectively	RB
cord-005453-4057qib7	12362	22	analyzed	analyze	VBN
cord-005453-4057qib7	12362	23	.	.	.
cord-005453-4057qib7	12363	1	Out	out	IN
cord-005453-4057qib7	12363	2	of	of	IN
cord-005453-4057qib7	12363	3	164	164	CD
cord-005453-4057qib7	12363	4	patients	patient	NNS
cord-005453-4057qib7	12363	5	,	,	,
cord-005453-4057qib7	12363	6	16	16	CD
cord-005453-4057qib7	12363	7	patients	patient	NNS
cord-005453-4057qib7	12363	8	received	receive	VBD
cord-005453-4057qib7	12363	9	plerixafor	plerixafor	NN
cord-005453-4057qib7	12363	10	as	as	IN
cord-005453-4057qib7	12363	11	mobilization	mobilization	NN
cord-005453-4057qib7	12363	12	regimen	regimen	NN
cord-005453-4057qib7	12363	13	due	due	IN
cord-005453-4057qib7	12363	14	to	to	IN
cord-005453-4057qib7	12363	15	poor	poor	JJ
cord-005453-4057qib7	12363	16	mobilization	mobilization	NN
cord-005453-4057qib7	12363	17	with	with	IN
cord-005453-4057qib7	12363	18	G	g	NN
cord-005453-4057qib7	12363	19	-	-	HYPH
cord-005453-4057qib7	12363	20	CSF.PBSC	CSF.PBSC	NNS
cord-005453-4057qib7	12363	21	grafts	graft	NNS
cord-005453-4057qib7	12363	22	were	be	VBD
cord-005453-4057qib7	12363	23	tested	test	VBN
cord-005453-4057qib7	12363	24	for	for	IN
cord-005453-4057qib7	12363	25	the	the	DT
cord-005453-4057qib7	12363	26	presence	presence	NN
cord-005453-4057qib7	12363	27	of	of	IN
cord-005453-4057qib7	12363	28	clonal	clonal	JJ
cord-005453-4057qib7	12363	29	PCs	pc	NNS
cord-005453-4057qib7	12363	30	(	(	-LRB-
cord-005453-4057qib7	12363	31	cPC	cPC	NNP
cord-005453-4057qib7	12363	32	)	)	-RRB-
cord-005453-4057qib7	12363	33	and	and	CC
cord-005453-4057qib7	12363	34	the	the	DT
cord-005453-4057qib7	12363	35	number	number	NN
cord-005453-4057qib7	12363	36	of	of	IN
cord-005453-4057qib7	12363	37	normal	normal	JJ
cord-005453-4057qib7	12363	38	PCs	pc	NNS
cord-005453-4057qib7	12363	39	(	(	-LRB-
cord-005453-4057qib7	12363	40	NPC	NPC	NNP
cord-005453-4057qib7	12363	41	)	)	-RRB-
cord-005453-4057qib7	12363	42	by	by	IN
cord-005453-4057qib7	12363	43	multi	multi	JJ
cord-005453-4057qib7	12363	44	-	-	JJ
cord-005453-4057qib7	12363	45	parameter	parameter	JJ
cord-005453-4057qib7	12363	46	flow	flow	NN
cord-005453-4057qib7	12363	47	cytometry	cytometry	NN
cord-005453-4057qib7	12363	48	(	(	-LRB-
cord-005453-4057qib7	12363	49	FCM).The	fcm).the	CD
cord-005453-4057qib7	12363	50	acquisition	acquisition	NN
cord-005453-4057qib7	12363	51	of	of	IN
cord-005453-4057qib7	12363	52	the	the	DT
cord-005453-4057qib7	12363	53	cells	cell	NNS
cord-005453-4057qib7	12363	54	was	be	VBD
cord-005453-4057qib7	12363	55	performed	perform	VBN
cord-005453-4057qib7	12363	56	using	use	VBG
cord-005453-4057qib7	12363	57	the	the	DT
cord-005453-4057qib7	12363	58	Navios	Navios	NNPS
cord-005453-4057qib7	12363	59	Flow	Flow	NNP
cord-005453-4057qib7	12363	60	cytometer	cytometer	NN
cord-005453-4057qib7	12363	61	BeckmanCoulter	BeckmanCoulter	NNP
cord-005453-4057qib7	12363	62	)	)	-RRB-
cord-005453-4057qib7	12363	63	.Upon	.Upon	.
cord-005453-4057qib7	12364	1	the	the	DT
cord-005453-4057qib7	12364	2	daily	daily	JJ
cord-005453-4057qib7	12364	3	checks	check	NNS
cord-005453-4057qib7	12364	4	of	of	IN
cord-005453-4057qib7	12364	5	the	the	DT
cord-005453-4057qib7	12364	6	instrument	instrument	NN
cord-005453-4057qib7	12364	7	,	,	,
cord-005453-4057qib7	12364	8	3x10	3x10	CD
cord-005453-4057qib7	12364	9	6	6	CD
cord-005453-4057qib7	12364	10	cells	cell	NNS
cord-005453-4057qib7	12364	11	for	for	IN
cord-005453-4057qib7	12364	12	each	each	DT
cord-005453-4057qib7	12364	13	sample	sample	NN
cord-005453-4057qib7	12364	14	were	be	VBD
cord-005453-4057qib7	12364	15	acquired	acquire	VBN
cord-005453-4057qib7	12364	16	and	and	CC
cord-005453-4057qib7	12364	17	the	the	DT
cord-005453-4057qib7	12364	18	collected	collect	VBN
cord-005453-4057qib7	12364	19	data	datum	NNS
cord-005453-4057qib7	12364	20	was	be	VBD
cord-005453-4057qib7	12364	21	analyzed	analyze	VBN
cord-005453-4057qib7	12364	22	using	use	VBG
cord-005453-4057qib7	12364	23	the	the	DT
cord-005453-4057qib7	12364	24	Kaluza	Kaluza	NNP
cord-005453-4057qib7	12364	25	software	software	NN
cord-005453-4057qib7	12364	26	(	(	-LRB-
cord-005453-4057qib7	12364	27	BeckmanCoulter	BeckmanCoulter	NNP
cord-005453-4057qib7	12364	28	,	,	,
cord-005453-4057qib7	12364	29	USA	USA	NNP
cord-005453-4057qib7	12364	30	)	)	-RRB-
cord-005453-4057qib7	12364	31	.	.	.
cord-005453-4057qib7	12365	1	Results	result	NNS
cord-005453-4057qib7	12365	2	:	:	:
cord-005453-4057qib7	12366	1	Patient	patient	JJ
cord-005453-4057qib7	12366	2	demographics	demographic	NNS
cord-005453-4057qib7	12366	3	are	be	VBP
cord-005453-4057qib7	12366	4	shown	show	VBN
cord-005453-4057qib7	12366	5	in	in	IN
cord-005453-4057qib7	12366	6	Table	table	NN
cord-005453-4057qib7	12367	1	1	1	LS
cord-005453-4057qib7	12367	2	.The	.the	CD
cord-005453-4057qib7	12367	3	majority	majority	NN
cord-005453-4057qib7	12367	4	of	of	IN
cord-005453-4057qib7	12367	5	patients	patient	NNS
cord-005453-4057qib7	12367	6	were	be	VBD
cord-005453-4057qib7	12368	1	male	male	JJ
cord-005453-4057qib7	12368	2	and	and	CC
cord-005453-4057qib7	12368	3	median	median	JJ
cord-005453-4057qib7	12368	4	age	age	NN
cord-005453-4057qib7	12368	5	was	be	VBD
cord-005453-4057qib7	12368	6	62	62	CD
cord-005453-4057qib7	12368	7	years	year	NNS
cord-005453-4057qib7	12368	8	in	in	IN
cord-005453-4057qib7	12368	9	the	the	DT
cord-005453-4057qib7	12368	10	plerixafor	plerixafor	NN
cord-005453-4057qib7	12368	11	group	group	NN
cord-005453-4057qib7	12368	12	.	.	.
cord-005453-4057qib7	12369	1	The	the	DT
cord-005453-4057qib7	12369	2	median	median	JJ
cord-005453-4057qib7	12369	3	interval	interval	NN
cord-005453-4057qib7	12369	4	from	from	IN
cord-005453-4057qib7	12369	5	time	time	NN
cord-005453-4057qib7	12369	6	of	of	IN
cord-005453-4057qib7	12369	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	12369	8	to	to	IN
cord-005453-4057qib7	12369	9	mobilization	mobilization	NN
cord-005453-4057qib7	12369	10	and	and	CC
cord-005453-4057qib7	12369	11	follow	follow	NN
cord-005453-4057qib7	12369	12	-	-	HYPH
cord-005453-4057qib7	12369	13	up	up	NN
cord-005453-4057qib7	12369	14	from	from	IN
cord-005453-4057qib7	12369	15	mobilization	mobilization	NN
cord-005453-4057qib7	12369	16	were	be	VBD
cord-005453-4057qib7	12369	17	3.3	3.3	CD
cord-005453-4057qib7	12369	18	months	month	NNS
cord-005453-4057qib7	12369	19	and	and	CC
cord-005453-4057qib7	12369	20	14.3	14.3	CD
cord-005453-4057qib7	12369	21	months	month	NNS
cord-005453-4057qib7	12369	22	in	in	IN
cord-005453-4057qib7	12369	23	plerixafor	plerixafor	NN
cord-005453-4057qib7	12369	24	group	group	NN
cord-005453-4057qib7	12369	25	,	,	,
cord-005453-4057qib7	12369	26	respectively	respectively	RB
cord-005453-4057qib7	12369	27	.	.	.
cord-005453-4057qib7	12370	1	cPC	cPC	NNP
cord-005453-4057qib7	12370	2	contamination	contamination	NN
cord-005453-4057qib7	12370	3	in	in	IN
cord-005453-4057qib7	12370	4	the	the	DT
cord-005453-4057qib7	12370	5	PBSC	PBSC	NNP
cord-005453-4057qib7	12370	6	grafts	graft	NNS
cord-005453-4057qib7	12370	7	was	be	VBD
cord-005453-4057qib7	12370	8	detectable	detectable	JJ
cord-005453-4057qib7	12370	9	in	in	IN
cord-005453-4057qib7	12370	10	32	32	CD
cord-005453-4057qib7	12370	11	and	and	CC
cord-005453-4057qib7	12370	12	7	7	CD
cord-005453-4057qib7	12370	13	patients	patient	NNS
cord-005453-4057qib7	12370	14	with	with	IN
cord-005453-4057qib7	12370	15	counts	count	NNS
cord-005453-4057qib7	12370	16	ranging	range	VBG
cord-005453-4057qib7	12370	17	between	between	IN
cord-005453-4057qib7	12370	18	0	0	CD
cord-005453-4057qib7	12370	19	-	-	HYPH
cord-005453-4057qib7	12370	20	8.7x10	8.7x10	CD
cord-005453-4057qib7	12370	21	-5	-5	CD
cord-005453-4057qib7	12370	22	and	and	CC
cord-005453-4057qib7	12370	23	0	0	CD
cord-005453-4057qib7	12370	24	-	-	HYPH
cord-005453-4057qib7	12370	25	0.1x10	0.1x10	CD
cord-005453-4057qib7	12370	26	-5	-5	CD
cord-005453-4057qib7	12370	27	in	in	IN
cord-005453-4057qib7	12370	28	G	G	NNP
cord-005453-4057qib7	12370	29	-	-	HYPH
cord-005453-4057qib7	12370	30	CSF	csf	NN
cord-005453-4057qib7	12370	31	alone	alone	RB
cord-005453-4057qib7	12370	32	and	and	CC
cord-005453-4057qib7	12370	33	G	g	NN
cord-005453-4057qib7	12370	34	-	-	HYPH
cord-005453-4057qib7	12370	35	CSF+Plerixafor	csf+plerixafor	NN
cord-005453-4057qib7	12370	36	groups	group	NNS
cord-005453-4057qib7	12370	37	,	,	,
cord-005453-4057qib7	12370	38	respectively	respectively	RB
cord-005453-4057qib7	12370	39	(	(	-LRB-
cord-005453-4057qib7	12370	40	p=0.116).There	p=0.116).there	EX
cord-005453-4057qib7	12370	41	were	be	VBD
cord-005453-4057qib7	12370	42	no	no	DT
cord-005453-4057qib7	12370	43	significant	significant	JJ
cord-005453-4057qib7	12370	44	differences	difference	NNS
cord-005453-4057qib7	12370	45	in	in	IN
cord-005453-4057qib7	12370	46	the	the	DT
cord-005453-4057qib7	12370	47	proportion	proportion	NN
cord-005453-4057qib7	12370	48	of	of	IN
cord-005453-4057qib7	12370	49	the	the	DT
cord-005453-4057qib7	12370	50	patients	patient	NNS
cord-005453-4057qib7	12370	51	with	with	IN
cord-005453-4057qib7	12370	52	graft	graft	NN
cord-005453-4057qib7	12370	53	contamination	contamination	NN
cord-005453-4057qib7	12370	54	between	between	IN
cord-005453-4057qib7	12370	55	subtypes	subtype	NNS
cord-005453-4057qib7	12370	56	of	of	IN
cord-005453-4057qib7	12370	57	MM	MM	NNP
cord-005453-4057qib7	12370	58	in	in	IN
cord-005453-4057qib7	12370	59	both	both	DT
cord-005453-4057qib7	12370	60	groups	group	NNS
cord-005453-4057qib7	12370	61	.	.	.
cord-005453-4057qib7	12371	1	One	one	CD
cord-005453-4057qib7	12371	2	hundred	hundred	CD
cord-005453-4057qib7	12372	1	(	(	-LRB-
cord-005453-4057qib7	12372	2	GCSF	GCSF	NNP
cord-005453-4057qib7	12372	3	/	/	SYM
cord-005453-4057qib7	12372	4	plerixafor;93/7	plerixafor;93/7	NNP
cord-005453-4057qib7	12372	5	)	)	-RRB-
cord-005453-4057qib7	12372	6	patients	patient	NNS
cord-005453-4057qib7	12372	7	had	have	VBD
cord-005453-4057qib7	12372	8	pre	pre	JJ
cord-005453-4057qib7	12372	9	-	-	JJ
cord-005453-4057qib7	12372	10	ASCT	asct	JJ
cord-005453-4057qib7	12372	11	PET	PET	NNP
cord-005453-4057qib7	12372	12	-	-	HYPH
cord-005453-4057qib7	12372	13	CT	CT	NNP
cord-005453-4057qib7	12372	14	imaging	imaging	NN
cord-005453-4057qib7	12372	15	done	do	VBN
cord-005453-4057qib7	12372	16	with	with	IN
cord-005453-4057qib7	12372	17	71	71	CD
cord-005453-4057qib7	12373	1	(	(	-LRB-
cord-005453-4057qib7	12373	2	GCSF	GCSF	NNP
cord-005453-4057qib7	12373	3	/	/	SYM
cord-005453-4057qib7	12373	4	plerixafor;64/7	plerixafor;64/7	NNP
cord-005453-4057qib7	12373	5	)	)	-RRB-
cord-005453-4057qib7	12373	6	have	have	VBP
cord-005453-4057qib7	12373	7	active	active	JJ
cord-005453-4057qib7	12373	8	lesion	lesion	NN
cord-005453-4057qib7	12373	9	at	at	IN
cord-005453-4057qib7	12373	10	the	the	DT
cord-005453-4057qib7	12373	11	time	time	NN
cord-005453-4057qib7	12373	12	of	of	IN
cord-005453-4057qib7	12373	13	mobilization	mobilization	NN
cord-005453-4057qib7	12373	14	.	.	.
cord-005453-4057qib7	12374	1	Statistically	statistically	RB
cord-005453-4057qib7	12374	2	significant	significant	JJ
cord-005453-4057qib7	12374	3	association	association	NN
cord-005453-4057qib7	12374	4	could	could	MD
cord-005453-4057qib7	12374	5	not	not	RB
cord-005453-4057qib7	12374	6	be	be	VB
cord-005453-4057qib7	12374	7	demonstrated	demonstrate	VBN
cord-005453-4057qib7	12374	8	between	between	IN
cord-005453-4057qib7	12374	9	the	the	DT
cord-005453-4057qib7	12374	10	disease	disease	NN
cord-005453-4057qib7	12374	11	<	<	XX
cord-005453-4057qib7	12374	12	CR	CR	NNP
cord-005453-4057qib7	12374	13	status	status	NN
cord-005453-4057qib7	12374	14	at	at	IN
cord-005453-4057qib7	12374	15	mobilization	mobilization	NN
cord-005453-4057qib7	12374	16	and	and	CC
cord-005453-4057qib7	12374	17	the	the	DT
cord-005453-4057qib7	12374	18	number	number	NN
cord-005453-4057qib7	12374	19	of	of	IN
cord-005453-4057qib7	12374	20	APC	APC	NNP
cord-005453-4057qib7	12374	21	in	in	IN
cord-005453-4057qib7	12374	22	the	the	DT
cord-005453-4057qib7	12374	23	apheresis	apheresis	NN
cord-005453-4057qib7	12374	24	product	product	NN
cord-005453-4057qib7	12374	25	in	in	IN
cord-005453-4057qib7	12374	26	both	both	DT
cord-005453-4057qib7	12374	27	groups	group	NNS
cord-005453-4057qib7	12374	28	(	(	-LRB-
cord-005453-4057qib7	12374	29	p>0.05).Twelve	p>0.05).twelve	NN
cord-005453-4057qib7	12374	30	of	of	IN
cord-005453-4057qib7	12374	31	16	16	CD
cord-005453-4057qib7	12374	32	patients	patient	NNS
cord-005453-4057qib7	12374	33	from	from	IN
cord-005453-4057qib7	12374	34	plerixafor	plerixafor	NN
cord-005453-4057qib7	12374	35	treatment	treatment	NN
cord-005453-4057qib7	12374	36	arm	arm	NN
cord-005453-4057qib7	12374	37	proceeded	proceed	VBD
cord-005453-4057qib7	12374	38	to	to	IN
cord-005453-4057qib7	12374	39	transplantation	transplantation	NN
cord-005453-4057qib7	12374	40	within	within	IN
cord-005453-4057qib7	12374	41	median	median	NN
cord-005453-4057qib7	12374	42	9.5	9.5	CD
cord-005453-4057qib7	12374	43	months	month	NNS
cord-005453-4057qib7	12374	44	.	.	.
cord-005453-4057qib7	12375	1	The	the	DT
cord-005453-4057qib7	12375	2	best	good	JJS
cord-005453-4057qib7	12375	3	overall	overall	JJ
cord-005453-4057qib7	12375	4	response	response	NN
cord-005453-4057qib7	12375	5	to	to	IN
cord-005453-4057qib7	12375	6	induction	induction	NN
cord-005453-4057qib7	12375	7	treatment	treatment	NN
cord-005453-4057qib7	12375	8	is	be	VBZ
cord-005453-4057qib7	12375	9	shown	show	VBN
cord-005453-4057qib7	12375	10	in	in	IN
cord-005453-4057qib7	12375	11	Table	table	NN
cord-005453-4057qib7	12375	12	1	1	CD
cord-005453-4057qib7	12375	13	.Thirtyfour	.thirtyfour	CD
cord-005453-4057qib7	12375	14	patients	patient	NNS
cord-005453-4057qib7	12375	15	from	from	IN
cord-005453-4057qib7	12375	16	the	the	DT
cord-005453-4057qib7	12375	17	G	G	NNP
cord-005453-4057qib7	12375	18	-	-	HYPH
cord-005453-4057qib7	12375	19	CSF	CSF	NNP
cord-005453-4057qib7	12375	20	alone	alone	RB
cord-005453-4057qib7	12375	21	arm	arm	NN
cord-005453-4057qib7	12375	22	and	and	CC
cord-005453-4057qib7	12375	23	2	2	CD
cord-005453-4057qib7	12375	24	patients	patient	NNS
cord-005453-4057qib7	12375	25	from	from	IN
cord-005453-4057qib7	12375	26	the	the	DT
cord-005453-4057qib7	12375	27	G	g	NN
cord-005453-4057qib7	12375	28	-	-	HYPH
cord-005453-4057qib7	12375	29	CSF+plerixafor	csf+plerixafor	NN
cord-005453-4057qib7	12375	30	arm	arm	NN
cord-005453-4057qib7	12375	31	died	die	VBD
cord-005453-4057qib7	12375	32	during	during	IN
cord-005453-4057qib7	12375	33	the	the	DT
cord-005453-4057qib7	12375	34	follow	follow	NN
cord-005453-4057qib7	12375	35	-	-	HYPH
cord-005453-4057qib7	12375	36	up	up	NN
cord-005453-4057qib7	12375	37	(	(	-LRB-
cord-005453-4057qib7	12375	38	p=0.52).Disease	p=0.52).disease	UH
cord-005453-4057qib7	12375	39	progression	progression	NN
cord-005453-4057qib7	12375	40	was	be	VBD
cord-005453-4057qib7	12375	41	seen	see	VBN
cord-005453-4057qib7	12375	42	in	in	IN
cord-005453-4057qib7	12375	43	48	48	CD
cord-005453-4057qib7	12375	44	patients	patient	NNS
cord-005453-4057qib7	12375	45	from	from	IN
cord-005453-4057qib7	12375	46	G	G	NNP
cord-005453-4057qib7	12375	47	-	-	HYPH
cord-005453-4057qib7	12375	48	CSF	CSF	NNP
cord-005453-4057qib7	12375	49	alone	alone	RB
cord-005453-4057qib7	12375	50	group	group	NN
cord-005453-4057qib7	12375	51	and	and	CC
cord-005453-4057qib7	12375	52	6	6	CD
cord-005453-4057qib7	12375	53	patients	patient	NNS
cord-005453-4057qib7	12375	54	from	from	IN
cord-005453-4057qib7	12375	55	G	g	NN
cord-005453-4057qib7	12375	56	-	-	HYPH
cord-005453-4057qib7	12375	57	CSF+plerixafor	csf+plerixafor	NN
cord-005453-4057qib7	12375	58	group	group	NN
cord-005453-4057qib7	12375	59	of	of	IN
cord-005453-4057qib7	12375	60	the	the	DT
cord-005453-4057qib7	12376	1	study(p=0.56).Estimated	study(p=0.56).Estimated	NNP
cord-005453-4057qib7	12376	2	mean	mean	NNP
cord-005453-4057qib7	12376	3	OS	OS	NNP
cord-005453-4057qib7	12376	4	was	be	VBD
cord-005453-4057qib7	12376	5	better	well	JJR
cord-005453-4057qib7	12376	6	among	among	IN
cord-005453-4057qib7	12376	7	patients	patient	NNS
cord-005453-4057qib7	12376	8	w/o	without	IN
cord-005453-4057qib7	12376	9	aPC	aPC	NNP
cord-005453-4057qib7	12376	10	contamination	contamination	NN
cord-005453-4057qib7	12376	11	in	in	IN
cord-005453-4057qib7	12376	12	plerixafor	plerixafor	NNP
cord-005453-4057qib7	12376	13	group	group	NN
cord-005453-4057qib7	12376	14	,	,	,
cord-005453-4057qib7	12376	15	respectively	respectively	RB
cord-005453-4057qib7	12376	16	(	(	-LRB-
cord-005453-4057qib7	12376	17	38.9±5.3mos	38.9±5.3mos	NNP
cord-005453-4057qib7	12376	18	vs	vs	IN
cord-005453-4057qib7	12376	19	16.8mos	16.8mos	CD
cord-005453-4057qib7	12376	20	;	;	:
cord-005453-4057qib7	12376	21	p=0.52	p=0.52	NNP
cord-005453-4057qib7	12376	22	)	)	-RRB-
cord-005453-4057qib7	12376	23	.	.	.
cord-005453-4057qib7	12377	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12377	2	:	:	:
cord-005453-4057qib7	12378	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12378	2	results	result	NNS
cord-005453-4057qib7	12378	3	on	on	IN
cord-005453-4057qib7	12378	4	164	164	CD
cord-005453-4057qib7	12378	5	and	and	CC
cord-005453-4057qib7	12378	6	few	few	JJ
cord-005453-4057qib7	12378	7	plerixafor	plerixafor	NN
cord-005453-4057qib7	12379	1	used	use	VBN
cord-005453-4057qib7	12379	2	patients	patient	NNS
cord-005453-4057qib7	12379	3	show	show	VB
cord-005453-4057qib7	12379	4	that	that	IN
cord-005453-4057qib7	12379	5	clonal	clonal	JJ
cord-005453-4057qib7	12379	6	plasma	plasma	NN
cord-005453-4057qib7	12379	7	cells	cell	NNS
cord-005453-4057qib7	12379	8	are	be	VBP
cord-005453-4057qib7	12379	9	detectable	detectable	JJ
cord-005453-4057qib7	12379	10	by	by	IN
cord-005453-4057qib7	12379	11	multiparametric	multiparametric	JJ
cord-005453-4057qib7	12379	12	flow	flow	NN
cord-005453-4057qib7	12379	13	more	more	RBR
cord-005453-4057qib7	12379	14	frequently	frequently	RB
cord-005453-4057qib7	12379	15	when	when	WRB
cord-005453-4057qib7	12379	16	patients	patient	NNS
cord-005453-4057qib7	12379	17	are	be	VBP
cord-005453-4057qib7	12379	18	poor	poor	JJ
cord-005453-4057qib7	12379	19	mobilizers	mobilizer	NNS
cord-005453-4057qib7	12379	20	and	and	CC
cord-005453-4057qib7	12379	21	require	require	VB
cord-005453-4057qib7	12379	22	plerixafor	plerixafor	NN
cord-005453-4057qib7	12379	23	.	.	.
cord-005453-4057qib7	12380	1	The	the	DT
cord-005453-4057qib7	12380	2	clonal	clonal	JJ
cord-005453-4057qib7	12380	3	PC	pc	NN
cord-005453-4057qib7	12380	4	contamination	contamination	NN
cord-005453-4057qib7	12380	5	can	can	MD
cord-005453-4057qib7	12380	6	be	be	VB
cord-005453-4057qib7	12380	7	attributed	attribute	VBN
cord-005453-4057qib7	12380	8	to	to	IN
cord-005453-4057qib7	12380	9	the	the	DT
cord-005453-4057qib7	12380	10	myeloma	myeloma	NN
cord-005453-4057qib7	12380	11	biology	biology	NN
cord-005453-4057qib7	12380	12	as	as	IN
cord-005453-4057qib7	12380	13	manifested	manifest	VBN
cord-005453-4057qib7	12380	14	by	by	IN
cord-005453-4057qib7	12380	15	higher	high	JJR
cord-005453-4057qib7	12380	16	number	number	NN
cord-005453-4057qib7	12380	17	of	of	IN
cord-005453-4057qib7	12380	18	lines	line	NNS
cord-005453-4057qib7	12380	19	induction	induction	NN
cord-005453-4057qib7	12380	20	regimens	regimen	NNS
cord-005453-4057qib7	12380	21	and	and	CC
cord-005453-4057qib7	12380	22	PET	pet	JJ
cord-005453-4057qib7	12380	23	positivity	positivity	NN
cord-005453-4057qib7	12380	24	among	among	IN
cord-005453-4057qib7	12380	25	the	the	DT
cord-005453-4057qib7	12380	26	plerixafor	plerixafor	NN
cord-005453-4057qib7	12380	27	-	-	HYPH
cord-005453-4057qib7	12380	28	required	require	VBN
cord-005453-4057qib7	12380	29	patients	patient	NNS
cord-005453-4057qib7	12380	30	.	.	.
cord-005453-4057qib7	12381	1	The	the	DT
cord-005453-4057qib7	12381	2	overall	overall	JJ
cord-005453-4057qib7	12381	3	and	and	CC
cord-005453-4057qib7	12381	4	disease	disease	NN
cord-005453-4057qib7	12381	5	survival	survival	NN
cord-005453-4057qib7	12381	6	was	be	VBD
cord-005453-4057qib7	12381	7	impaired	impair	VBN
cord-005453-4057qib7	12381	8	by	by	IN
cord-005453-4057qib7	12381	9	residual	residual	JJ
cord-005453-4057qib7	12381	10	clonal	clonal	JJ
cord-005453-4057qib7	12381	11	PCs	pc	NNS
cord-005453-4057qib7	12381	12	in	in	IN
cord-005453-4057qib7	12381	13	the	the	DT
cord-005453-4057qib7	12381	14	graft	graft	NN
cord-005453-4057qib7	12381	15	but	but	CC
cord-005453-4057qib7	12381	16	not	not	RB
cord-005453-4057qib7	12381	17	by	by	IN
cord-005453-4057qib7	12381	18	plerixafor	plerixafor	NN
cord-005453-4057qib7	12381	19	per	per	FW
cord-005453-4057qib7	12381	20	se	se	FW
cord-005453-4057qib7	12381	21	.	.	.
cord-005453-4057qib7	12382	1	Neither	neither	DT
cord-005453-4057qib7	12382	2	was	be	VBD
cord-005453-4057qib7	12382	3	the	the	DT
cord-005453-4057qib7	12382	4	content	content	NN
cord-005453-4057qib7	12382	5	of	of	IN
cord-005453-4057qib7	12382	6	clonal	clonal	JJ
cord-005453-4057qib7	12382	7	PCs	pc	NNS
cord-005453-4057qib7	12382	8	differed	differ	VBD
cord-005453-4057qib7	12382	9	from	from	IN
cord-005453-4057qib7	12382	10	others	other	NNS
cord-005453-4057qib7	12382	11	.	.	.
cord-005453-4057qib7	12383	1	Thus	thus	RB
cord-005453-4057qib7	12383	2	the	the	DT
cord-005453-4057qib7	12383	3	CXCR4	CXCR4	NNS
cord-005453-4057qib7	12383	4	shared	share	VBN
cord-005453-4057qib7	12383	5	by	by	IN
cord-005453-4057qib7	12383	6	HSC	HSC	NNP
cord-005453-4057qib7	12383	7	and	and	CC
cord-005453-4057qib7	12383	8	myeloma	myeloma	NN
cord-005453-4057qib7	12383	9	cells	cell	NNS
cord-005453-4057qib7	12383	10	do	do	VBP
cord-005453-4057qib7	12383	11	not	not	RB
cord-005453-4057qib7	12383	12	cause	cause	VB
cord-005453-4057qib7	12383	13	a	a	DT
cord-005453-4057qib7	12383	14	myeloma	myeloma	NN
cord-005453-4057qib7	12383	15	mobilization	mobilization	NN
cord-005453-4057qib7	12383	16	.	.	.
cord-005453-4057qib7	12384	1	Clinical	clinical	JJ
cord-005453-4057qib7	12384	2	Trial	Trial	NNP
cord-005453-4057qib7	12384	3	Registry	Registry	NNP
cord-005453-4057qib7	12384	4	:	:	:
cord-005453-4057qib7	12385	1	-Disclosure	-disclosure	UH
cord-005453-4057qib7	12385	2	:	:	:
cord-005453-4057qib7	12385	3	nothing	nothing	NN
cord-005453-4057qib7	12385	4	to	to	TO
cord-005453-4057qib7	12385	5	declare	declare	VB
cord-005453-4057qib7	12385	6	Prognostic	prognostic	JJ
cord-005453-4057qib7	12385	7	factors	factor	NNS
cord-005453-4057qib7	12385	8	for	for	IN
cord-005453-4057qib7	12385	9	overall	overall	JJ
cord-005453-4057qib7	12385	10	survival	survival	NN
cord-005453-4057qib7	12385	11	after	after	IN
cord-005453-4057qib7	12385	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	12385	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12385	14	cell	cell	NN
cord-005453-4057qib7	12385	15	transplantation	transplantation	NN
cord-005453-4057qib7	12385	16	in	in	IN
cord-005453-4057qib7	12385	17	multiple	multiple	JJ
cord-005453-4057qib7	12385	18	myeloma	myeloma	NN
cord-005453-4057qib7	12385	19	patients	patient	NNS
cord-005453-4057qib7	12386	1	All	all	DT
cord-005453-4057qib7	12386	2	factors	factor	NNS
cord-005453-4057qib7	12386	3	with	with	IN
cord-005453-4057qib7	12386	4	significant	significant	JJ
cord-005453-4057qib7	12386	5	influence	influence	NN
cord-005453-4057qib7	12386	6	on	on	IN
cord-005453-4057qib7	12386	7	pts	pts	NN
cord-005453-4057qib7	12386	8	survival	survival	NN
cord-005453-4057qib7	12386	9	were	be	VBD
cord-005453-4057qib7	12386	10	included	include	VBN
cord-005453-4057qib7	12386	11	multivariate	multivariate	JJ
cord-005453-4057qib7	12386	12	analysis	analysis	NN
cord-005453-4057qib7	12386	13	(	(	-LRB-
cord-005453-4057qib7	12386	14	Cox	Cox	NNP
cord-005453-4057qib7	12386	15	regression	regression	NN
cord-005453-4057qib7	12386	16	model	model	NN
cord-005453-4057qib7	12386	17	)	)	-RRB-
cord-005453-4057qib7	12386	18	but	but	CC
cord-005453-4057qib7	12386	19	only	only	RB
cord-005453-4057qib7	12386	20	re	re	NN
cord-005453-4057qib7	12386	21	-	-	NN
cord-005453-4057qib7	12386	22	admission	admission	NN
cord-005453-4057qib7	12386	23	in	in	IN
cord-005453-4057qib7	12386	24	the	the	DT
cord-005453-4057qib7	12386	25	first	first	JJ
cord-005453-4057qib7	12386	26	365	365	CD
cord-005453-4057qib7	12386	27	days	day	NNS
cord-005453-4057qib7	12386	28	demonstrated	demonstrate	VBD
cord-005453-4057qib7	12386	29	impact	impact	NN
cord-005453-4057qib7	12386	30	on	on	IN
cord-005453-4057qib7	12386	31	OS	OS	NNP
cord-005453-4057qib7	12386	32	(	(	-LRB-
cord-005453-4057qib7	12386	33	HR	HR	NNP
cord-005453-4057qib7	12386	34	4	4	CD
cord-005453-4057qib7	12386	35	,	,	,
cord-005453-4057qib7	12386	36	082	082	CD
cord-005453-4057qib7	12386	37	;	;	:
cord-005453-4057qib7	12386	38	p=0	p=0	NNP
cord-005453-4057qib7	12386	39	,	,	,
cord-005453-4057qib7	12386	40	005	005	CD
cord-005453-4057qib7	12386	41	)	)	-RRB-
cord-005453-4057qib7	12386	42	.	.	.
cord-005453-4057qib7	12387	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12387	2	:	:	:
cord-005453-4057qib7	12388	1	We	-PRON-	PRP
cord-005453-4057qib7	12388	2	analyzed	analyze	VBD
cord-005453-4057qib7	12388	3	risk	risk	NN
cord-005453-4057qib7	12388	4	factors	factor	NNS
cord-005453-4057qib7	12388	5	for	for	IN
cord-005453-4057qib7	12388	6	survival	survival	NN
cord-005453-4057qib7	12388	7	in	in	IN
cord-005453-4057qib7	12388	8	MM	MM	NNP
cord-005453-4057qib7	12388	9	pts	pts	NNP
cord-005453-4057qib7	12388	10	who	who	WP
cord-005453-4057qib7	12388	11	received	receive	VBD
cord-005453-4057qib7	12388	12	allo	allo	NN
cord-005453-4057qib7	12388	13	-	-	HYPH
cord-005453-4057qib7	12388	14	HCT	hct	NN
cord-005453-4057qib7	12388	15	.	.	.
cord-005453-4057qib7	12389	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12389	2	study	study	NN
cord-005453-4057qib7	12389	3	identified	identify	VBD
cord-005453-4057qib7	12389	4	disease	disease	NN
cord-005453-4057qib7	12389	5	-	-	HYPH
cord-005453-4057qib7	12389	6	related	relate	VBN
cord-005453-4057qib7	12389	7	risk	risk	NN
cord-005453-4057qib7	12389	8	factors	factor	NNS
cord-005453-4057qib7	12389	9	like	like	IN
cord-005453-4057qib7	12389	10	ISS	ISS	NNP
cord-005453-4057qib7	12389	11	and	and	CC
cord-005453-4057qib7	12389	12	transplantationrelated	transplantationrelate	VBN
cord-005453-4057qib7	12389	13	factors	factor	NNS
cord-005453-4057qib7	12389	14	such	such	JJ
cord-005453-4057qib7	12389	15	as	as	IN
cord-005453-4057qib7	12389	16	HCT	HCT	NNP
cord-005453-4057qib7	12389	17	-	-	HYPH
cord-005453-4057qib7	12389	18	CI	CI	NNP
cord-005453-4057qib7	12389	19	and	and	CC
cord-005453-4057qib7	12389	20	PAM	PAM	NNP
cord-005453-4057qib7	12389	21	,	,	,
cord-005453-4057qib7	12389	22	hospital	hospital	NN
cord-005453-4057qib7	12389	23	readmission	readmission	NN
cord-005453-4057qib7	12389	24	,	,	,
cord-005453-4057qib7	12389	25	days	day	NNS
cord-005453-4057qib7	12389	26	of	of	IN
cord-005453-4057qib7	12389	27	hospitalization	hospitalization	NN
cord-005453-4057qib7	12389	28	and	and	CC
cord-005453-4057qib7	12389	29	CMV	CMV	NNP
cord-005453-4057qib7	12389	30	reactivation	reactivation	NN
cord-005453-4057qib7	12389	31	that	that	WDT
cord-005453-4057qib7	12389	32	were	be	VBD
cord-005453-4057qib7	12389	33	associated	associate	VBN
cord-005453-4057qib7	12389	34	with	with	IN
cord-005453-4057qib7	12389	35	worse	bad	JJR
cord-005453-4057qib7	12389	36	long	long	JJ
cord-005453-4057qib7	12389	37	-	-	HYPH
cord-005453-4057qib7	12389	38	term	term	NN
cord-005453-4057qib7	12389	39	survival	survival	NN
cord-005453-4057qib7	12389	40	.	.	.
cord-005453-4057qib7	12390	1	In	in	IN
cord-005453-4057qib7	12390	2	our	-PRON-	PRP$
cord-005453-4057qib7	12390	3	series	series	NN
cord-005453-4057qib7	12390	4	,	,	,
cord-005453-4057qib7	12390	5	the	the	DT
cord-005453-4057qib7	12390	6	most	most	RBS
cord-005453-4057qib7	12390	7	frequent	frequent	JJ
cord-005453-4057qib7	12390	8	death	death	NN
cord-005453-4057qib7	12390	9	and	and	CC
cord-005453-4057qib7	12390	10	re	re	NN
cord-005453-4057qib7	12390	11	-	-	NN
cord-005453-4057qib7	12390	12	admission	admission	NN
cord-005453-4057qib7	12390	13	cause	cause	NN
cord-005453-4057qib7	12390	14	was	be	VBD
cord-005453-4057qib7	12390	15	infection	infection	NN
cord-005453-4057qib7	12390	16	,	,	,
cord-005453-4057qib7	12390	17	so	so	IN
cord-005453-4057qib7	12390	18	focusing	focus	VBG
cord-005453-4057qib7	12390	19	the	the	DT
cord-005453-4057qib7	12390	20	efforts	effort	NNS
cord-005453-4057qib7	12390	21	in	in	IN
cord-005453-4057qib7	12390	22	reduction	reduction	NN
cord-005453-4057qib7	12390	23	of	of	IN
cord-005453-4057qib7	12390	24	infection	infection	NN
cord-005453-4057qib7	12390	25	could	could	MD
cord-005453-4057qib7	12390	26	have	have	VB
cord-005453-4057qib7	12390	27	a	a	DT
cord-005453-4057qib7	12390	28	beneficial	beneficial	JJ
cord-005453-4057qib7	12390	29	impact	impact	NN
cord-005453-4057qib7	12390	30	on	on	IN
cord-005453-4057qib7	12390	31	improvement	improvement	NN
cord-005453-4057qib7	12390	32	of	of	IN
cord-005453-4057qib7	12390	33	survival	survival	NN
cord-005453-4057qib7	12390	34	in	in	IN
cord-005453-4057qib7	12390	35	MM	MM	NNP
cord-005453-4057qib7	12390	36	undergoing	undergo	VBG
cord-005453-4057qib7	12390	37	allo	allo	NN
cord-005453-4057qib7	12390	38	-	-	HYPH
cord-005453-4057qib7	12390	39	HCT	hct	NN
cord-005453-4057qib7	12390	40	.	.	.
cord-005453-4057qib7	12391	1	[	[	-LRB-
cord-005453-4057qib7	12391	2	[	[	-LRB-
cord-005453-4057qib7	12391	3	P547	p547	CD
cord-005453-4057qib7	12391	4	Image	image	NN
cord-005453-4057qib7	12391	5	]	]	-RRB-
cord-005453-4057qib7	12391	6	1	1	CD
cord-005453-4057qib7	12391	7	.	.	.
cord-005453-4057qib7	12392	1	Figure	figure	NN
cord-005453-4057qib7	12392	2	1	1	CD
cord-005453-4057qib7	12392	3	]	]	-RRB-
cord-005453-4057qib7	12393	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12393	2	:	:	:
cord-005453-4057qib7	12393	3	There	there	EX
cord-005453-4057qib7	12393	4	is	be	VBZ
cord-005453-4057qib7	12393	5	no	no	DT
cord-005453-4057qib7	12393	6	disclosure	disclosure	NN
cord-005453-4057qib7	12393	7	.	.	.
cord-005453-4057qib7	12394	1	Novel	novel	NN
cord-005453-4057qib7	12394	2	protocol	protocol	NN
cord-005453-4057qib7	12394	3	for	for	IN
cord-005453-4057qib7	12394	4	autologous	autologous	JJ
cord-005453-4057qib7	12394	5	hsct	hsct	NN
cord-005453-4057qib7	12394	6	in	in	IN
cord-005453-4057qib7	12394	7	multiple	multiple	JJ
cord-005453-4057qib7	12394	8	myeloma	myeloma	NN
cord-005453-4057qib7	12394	9	:	:	:
cord-005453-4057qib7	12394	10	Ambulatory	ambulatory	JJ
cord-005453-4057qib7	12394	11	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	12394	12	and	and	CC
cord-005453-4057qib7	12394	13	transplantation	transplantation	NN
cord-005453-4057qib7	12394	14	of	of	IN
cord-005453-4057qib7	12394	15	fresh	fresh	JJ
cord-005453-4057qib7	12394	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12394	17	stem	stem	NN
cord-005453-4057qib7	12394	18	cells	cell	NNS
cord-005453-4057qib7	12394	19	with	with	IN
cord-005453-4057qib7	12394	20	backup	backup	JJ
cord-005453-4057qib7	12394	21	storage	storage	NN
cord-005453-4057qib7	12394	22	Background	background	NN
cord-005453-4057qib7	12394	23	:	:	:
cord-005453-4057qib7	12394	24	Autologous	autologous	JJ
cord-005453-4057qib7	12394	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12394	26	stem	stem	NN
cord-005453-4057qib7	12394	27	cell	cell	NN
cord-005453-4057qib7	12394	28	transplantation	transplantation	NN
cord-005453-4057qib7	12394	29	(	(	-LRB-
cord-005453-4057qib7	12394	30	AHSCT	AHSCT	NNP
cord-005453-4057qib7	12394	31	)	)	-RRB-
cord-005453-4057qib7	12395	1	after	after	IN
cord-005453-4057qib7	12395	2	melphalan	melphalan	NNP
cord-005453-4057qib7	12395	3	conditioning	conditioning	NNP
cord-005453-4057qib7	12395	4	is	be	VBZ
cord-005453-4057qib7	12395	5	still	still	RB
cord-005453-4057qib7	12395	6	a	a	DT
cord-005453-4057qib7	12395	7	part	part	NN
cord-005453-4057qib7	12395	8	of	of	IN
cord-005453-4057qib7	12395	9	standard	standard	JJ
cord-005453-4057qib7	12395	10	treatment	treatment	NN
cord-005453-4057qib7	12395	11	of	of	IN
cord-005453-4057qib7	12395	12	multiple	multiple	JJ
cord-005453-4057qib7	12395	13	myeloma	myeloma	NN
cord-005453-4057qib7	12395	14	patients	patient	NNS
cord-005453-4057qib7	12395	15	.	.	.
cord-005453-4057qib7	12396	1	Traditional	traditional	JJ
cord-005453-4057qib7	12396	2	transplantation	transplantation	NN
cord-005453-4057qib7	12396	3	of	of	IN
cord-005453-4057qib7	12396	4	frozen	frozen	JJ
cord-005453-4057qib7	12396	5	stem	stem	NN
cord-005453-4057qib7	12396	6	cells	cell	NNS
cord-005453-4057qib7	12396	7	poses	pose	VBZ
cord-005453-4057qib7	12396	8	additional	additional	JJ
cord-005453-4057qib7	12396	9	risk	risk	NN
cord-005453-4057qib7	12396	10	for	for	IN
cord-005453-4057qib7	12396	11	the	the	DT
cord-005453-4057qib7	12396	12	patients	patient	NNS
cord-005453-4057qib7	12396	13	connected	connect	VBN
cord-005453-4057qib7	12396	14	with	with	IN
cord-005453-4057qib7	12396	15	DMSO	DMSO	NNP
cord-005453-4057qib7	12396	16	and	and	CC
cord-005453-4057qib7	12396	17	central	central	JJ
cord-005453-4057qib7	12396	18	venous	venous	JJ
cord-005453-4057qib7	12396	19	catheter	catheter	NN
cord-005453-4057qib7	12396	20	.	.	.
cord-005453-4057qib7	12397	1	The	the	DT
cord-005453-4057qib7	12397	2	transplantation	transplantation	NN
cord-005453-4057qib7	12397	3	of	of	IN
cord-005453-4057qib7	12397	4	fresh	fresh	JJ
cord-005453-4057qib7	12397	5	cells	cell	NNS
cord-005453-4057qib7	12397	6	is	be	VBZ
cord-005453-4057qib7	12397	7	an	an	DT
cord-005453-4057qib7	12397	8	option	option	NN
cord-005453-4057qib7	12397	9	-however	-however	TO
cord-005453-4057qib7	12397	10	,	,	,
cord-005453-4057qib7	12397	11	most	most	JJS
cord-005453-4057qib7	12397	12	mobilization	mobilization	NN
cord-005453-4057qib7	12397	13	protocols	protocol	NNS
cord-005453-4057qib7	12397	14	are	be	VBP
cord-005453-4057qib7	12397	15	either	either	RB
cord-005453-4057qib7	12397	16	low	low	RB
cord-005453-4057qib7	12397	17	-	-	HYPH
cord-005453-4057qib7	12397	18	efficient	efficient	JJ
cord-005453-4057qib7	12397	19	(	(	-LRB-
cord-005453-4057qib7	12397	20	G	G	NNP
cord-005453-4057qib7	12397	21	-	-	HYPH
cord-005453-4057qib7	12397	22	CSF	CSF	NNP
cord-005453-4057qib7	12397	23	)	)	-RRB-
cord-005453-4057qib7	12397	24	,	,	,
cord-005453-4057qib7	12397	25	expensive	expensive	JJ
cord-005453-4057qib7	12397	26	(	(	-LRB-
cord-005453-4057qib7	12397	27	G	G	NNP
cord-005453-4057qib7	12397	28	-	-	HYPH
cord-005453-4057qib7	12397	29	CSF	csf	NN
cord-005453-4057qib7	12397	30	+	+	CC
cord-005453-4057qib7	12397	31	plerixafor	plerixafor	NN
cord-005453-4057qib7	12397	32	)	)	-RRB-
cord-005453-4057qib7	12397	33	or	or	CC
cord-005453-4057qib7	12397	34	toxic	toxic	JJ
cord-005453-4057qib7	12397	35	(	(	-LRB-
cord-005453-4057qib7	12397	36	standard	standard	JJ
cord-005453-4057qib7	12397	37	dose	dose	JJ
cord-005453-4057qib7	12397	38	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	12397	39	)	)	-RRB-
cord-005453-4057qib7	12397	40	to	to	TO
cord-005453-4057qib7	12397	41	directly	directly	RB
cord-005453-4057qib7	12397	42	proceed	proceed	VB
cord-005453-4057qib7	12397	43	to	to	IN
cord-005453-4057qib7	12397	44	transplantation	transplantation	NN
cord-005453-4057qib7	12397	45	in	in	IN
cord-005453-4057qib7	12397	46	this	this	DT
cord-005453-4057qib7	12397	47	fragile	fragile	JJ
cord-005453-4057qib7	12397	48	group	group	NN
cord-005453-4057qib7	12397	49	of	of	IN
cord-005453-4057qib7	12397	50	patients	patient	NNS
cord-005453-4057qib7	12397	51	.	.	.
cord-005453-4057qib7	12398	1	We	-PRON-	PRP
cord-005453-4057qib7	12398	2	describe	describe	VBP
cord-005453-4057qib7	12398	3	here	here	RB
cord-005453-4057qib7	12398	4	the	the	DT
cord-005453-4057qib7	12398	5	novel	novel	JJ
cord-005453-4057qib7	12398	6	combination	combination	NN
cord-005453-4057qib7	12398	7	of	of	IN
cord-005453-4057qib7	12398	8	ambulatory	ambulatory	JJ
cord-005453-4057qib7	12398	9	mobilization	mobilization	NN
cord-005453-4057qib7	12398	10	with	with	IN
cord-005453-4057qib7	12398	11	very	very	RB
cord-005453-4057qib7	12398	12	low	low	JJ
cord-005453-4057qib7	12398	13	doses	dose	NNS
cord-005453-4057qib7	12398	14	of	of	IN
cord-005453-4057qib7	12398	15	Ara	Ara	NNP
cord-005453-4057qib7	12398	16	-	-	HYPH
cord-005453-4057qib7	12398	17	C	C	NNP
cord-005453-4057qib7	12398	18	and	and	CC
cord-005453-4057qib7	12398	19	G	G	NNP
cord-005453-4057qib7	12398	20	-	-	HYPH
cord-005453-4057qib7	12398	21	CSF	csf	NN
cord-005453-4057qib7	12398	22	connected	connect	VBN
cord-005453-4057qib7	12398	23	with	with	IN
cord-005453-4057qib7	12398	24	direct	direct	JJ
cord-005453-4057qib7	12398	25	AHSCT	AHSCT	NNP
cord-005453-4057qib7	12398	26	with	with	IN
cord-005453-4057qib7	12398	27	fresh	fresh	JJ
cord-005453-4057qib7	12398	28	cells	cell	NNS
cord-005453-4057qib7	12398	29	.	.	.
cord-005453-4057qib7	12399	1	Methods	method	NNS
cord-005453-4057qib7	12399	2	:	:	:
cord-005453-4057qib7	12400	1	The	the	DT
cord-005453-4057qib7	12400	2	prospectively	prospectively	RB
cord-005453-4057qib7	12400	3	collected	collect	VBN
cord-005453-4057qib7	12400	4	database	database	NN
cord-005453-4057qib7	12400	5	of	of	IN
cord-005453-4057qib7	12400	6	patients	patient	NNS
cord-005453-4057qib7	12400	7	after	after	IN
cord-005453-4057qib7	12400	8	AHSCT	AHSCT	NNP
cord-005453-4057qib7	12400	9	was	be	VBD
cord-005453-4057qib7	12400	10	searched	search	VBN
cord-005453-4057qib7	12400	11	for	for	IN
cord-005453-4057qib7	12400	12	patients	patient	NNS
cord-005453-4057qib7	12400	13	who	who	WP
cord-005453-4057qib7	12400	14	underwent	undergo	VBD
cord-005453-4057qib7	12400	15	AHSCT	AHSCT	NNP
cord-005453-4057qib7	12400	16	after	after	IN
cord-005453-4057qib7	12400	17	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	12400	18	with	with	IN
cord-005453-4057qib7	12400	19	Ara	Ara	NNP
cord-005453-4057qib7	12400	20	-	-	HYPH
cord-005453-4057qib7	12400	21	C	C	NNP
cord-005453-4057qib7	12400	22	and	and	CC
cord-005453-4057qib7	12400	23	transplantation	transplantation	NN
cord-005453-4057qib7	12400	24	with	with	IN
cord-005453-4057qib7	12400	25	fresh	fresh	JJ
cord-005453-4057qib7	12400	26	cells	cell	NNS
cord-005453-4057qib7	12400	27	(	(	-LRB-
cord-005453-4057qib7	12400	28	FC	FC	NNP
cord-005453-4057qib7	12400	29	)	)	-RRB-
cord-005453-4057qib7	12400	30	and	and	CC
cord-005453-4057qib7	12400	31	compared	compare	VBN
cord-005453-4057qib7	12400	32	with	with	IN
cord-005453-4057qib7	12400	33	control	control	NN
cord-005453-4057qib7	12400	34	group	group	NN
cord-005453-4057qib7	12400	35	of	of	IN
cord-005453-4057qib7	12400	36	consecutive	consecutive	JJ
cord-005453-4057qib7	12400	37	patients	patient	NNS
cord-005453-4057qib7	12400	38	transplanted	transplant	VBN
cord-005453-4057qib7	12400	39	with	with	IN
cord-005453-4057qib7	12400	40	standard	standard	JJ
cord-005453-4057qib7	12400	41	protocol	protocol	NN
cord-005453-4057qib7	12400	42	(	(	-LRB-
cord-005453-4057qib7	12400	43	SP	SP	NNP
cord-005453-4057qib7	12400	44	)	)	-RRB-
cord-005453-4057qib7	12400	45	(	(	-LRB-
cord-005453-4057qib7	12400	46	transplantation	transplantation	NN
cord-005453-4057qib7	12400	47	with	with	IN
cord-005453-4057qib7	12400	48	frozen	frozen	JJ
cord-005453-4057qib7	12400	49	cells	cell	NNS
cord-005453-4057qib7	12400	50	)	)	-RRB-
cord-005453-4057qib7	12400	51	between	between	IN
cord-005453-4057qib7	12400	52	July	July	NNP
cord-005453-4057qib7	12400	53	2016	2016	CD
cord-005453-4057qib7	12400	54	and	and	CC
cord-005453-4057qib7	12400	55	October	October	NNP
cord-005453-4057qib7	12400	56	2018	2018	CD
cord-005453-4057qib7	12400	57	.	.	.
cord-005453-4057qib7	12401	1	Protocol	protocol	NN
cord-005453-4057qib7	12401	2	of	of	IN
cord-005453-4057qib7	12401	3	ambulatory	ambulatory	JJ
cord-005453-4057qib7	12401	4	mobilization	mobilization	NN
cord-005453-4057qib7	12401	5	was	be	VBD
cord-005453-4057qib7	12401	6	:	:	:
cord-005453-4057qib7	12401	7	400mg	400mg	NNP
cord-005453-4057qib7	12401	8	/	/	SYM
cord-005453-4057qib7	12401	9	m²	m²	NNP
cord-005453-4057qib7	12401	10	of	of	IN
cord-005453-4057qib7	12401	11	AraC	AraC	NNP
cord-005453-4057qib7	12401	12	on	on	IN
cord-005453-4057qib7	12401	13	days	day	NNS
cord-005453-4057qib7	12401	14	+1	+1	NFP
cord-005453-4057qib7	12401	15	and	and	CC
cord-005453-4057qib7	12401	16	+2	+2	NN
cord-005453-4057qib7	12401	17	and	and	CC
cord-005453-4057qib7	12401	18	G	G	NNP
cord-005453-4057qib7	12401	19	-	-	HYPH
cord-005453-4057qib7	12401	20	CSF	CSF	NNP
cord-005453-4057qib7	12401	21	at	at	IN
cord-005453-4057qib7	12401	22	the	the	DT
cord-005453-4057qib7	12401	23	dose	dose	NN
cord-005453-4057qib7	12401	24	5	5	CD
cord-005453-4057qib7	12401	25	μg	μg	NNP
cord-005453-4057qib7	12401	26	/	/	SYM
cord-005453-4057qib7	12401	27	kg	kg	NNP
cord-005453-4057qib7	12401	28	/	/	SYM
cord-005453-4057qib7	12401	29	day	day	NN
cord-005453-4057qib7	12401	30	from	from	IN
cord-005453-4057qib7	12401	31	day	day	NN
cord-005453-4057qib7	12401	32	+5	+5	NFP
cord-005453-4057qib7	12401	33	and	and	CC
cord-005453-4057qib7	12401	34	escalated	escalate	VBD
cord-005453-4057qib7	12401	35	to	to	IN
cord-005453-4057qib7	12401	36	10	10	CD
cord-005453-4057qib7	12401	37	μg/	μg/	NN
cord-005453-4057qib7	12402	1	kg	kg	NNP
cord-005453-4057qib7	12402	2	/	/	SYM
cord-005453-4057qib7	12402	3	day	day	NN
cord-005453-4057qib7	12402	4	split	split	VBD
cord-005453-4057qib7	12402	5	into	into	IN
cord-005453-4057qib7	12402	6	two	two	CD
cord-005453-4057qib7	12402	7	doses	dose	NNS
cord-005453-4057qib7	12402	8	+10	+10	CD
cord-005453-4057qib7	12402	9	to	to	IN
cord-005453-4057qib7	12402	10	+13	+13	NN
cord-005453-4057qib7	12403	1	,	,	,
cord-005453-4057qib7	12403	2	apheresis	apheresis	NN
cord-005453-4057qib7	12403	3	started	start	VBD
cord-005453-4057qib7	12403	4	on	on	IN
cord-005453-4057qib7	12403	5	day	day	NN
cord-005453-4057qib7	12403	6	+14	+14	CD
cord-005453-4057qib7	12403	7	(	(	-LRB-
cord-005453-4057qib7	12403	8	or	or	CC
cord-005453-4057qib7	12403	9	later	later	RB
cord-005453-4057qib7	12403	10	)	)	-RRB-
cord-005453-4057qib7	12403	11	and	and	CC
cord-005453-4057qib7	12403	12	finished	finish	VBD
cord-005453-4057qib7	12403	13	when	when	WRB
cord-005453-4057qib7	12403	14	at	at	RB
cord-005453-4057qib7	12403	15	least	least	JJS
cord-005453-4057qib7	12403	16	7.5	7.5	CD
cord-005453-4057qib7	12403	17	x	x	SYM
cord-005453-4057qib7	12403	18	10e6	10e6	CD
cord-005453-4057qib7	12403	19	CD34	CD34	NNP
cord-005453-4057qib7	12403	20	+	+	CC
cord-005453-4057qib7	12403	21	positive	positive	JJ
cord-005453-4057qib7	12403	22	cells	cell	NNS
cord-005453-4057qib7	12403	23	were	be	VBD
cord-005453-4057qib7	12403	24	collected	collect	VBN
cord-005453-4057qib7	12403	25	.	.	.
cord-005453-4057qib7	12404	1	The	the	DT
cord-005453-4057qib7	12404	2	collected	collect	VBN
cord-005453-4057qib7	12404	3	cells	cell	NNS
cord-005453-4057qib7	12404	4	were	be	VBD
cord-005453-4057qib7	12404	5	split	split	VBN
cord-005453-4057qib7	12404	6	in	in	IN
cord-005453-4057qib7	12404	7	three	three	CD
cord-005453-4057qib7	12404	8	equal	equal	JJ
cord-005453-4057qib7	12404	9	parts:1	parts:1	NN
cord-005453-4057qib7	12404	10	)	)	-RRB-
cord-005453-4057qib7	12404	11	for	for	IN
cord-005453-4057qib7	12404	12	use	use	NN
cord-005453-4057qib7	12404	13	as	as	IN
cord-005453-4057qib7	12404	14	fresh	fresh	JJ
cord-005453-4057qib7	12404	15	transplant	transplant	NN
cord-005453-4057qib7	12404	16	2	2	CD
cord-005453-4057qib7	12404	17	)	)	-RRB-
cord-005453-4057qib7	12404	18	frozen	freeze	VBN
cord-005453-4057qib7	12404	19	for	for	IN
cord-005453-4057qib7	12404	20	possible	possible	JJ
cord-005453-4057qib7	12404	21	2	2	CD
cord-005453-4057qib7	12404	22	nd	nd	NNP
cord-005453-4057qib7	12404	23	transplant	transplant	NN
cord-005453-4057qib7	12404	24	3	3	CD
cord-005453-4057qib7	12404	25	)	)	-RRB-
cord-005453-4057qib7	12404	26	frozen	freeze	VBN
cord-005453-4057qib7	12404	27	as	as	IN
cord-005453-4057qib7	12404	28	backup	backup	NN
cord-005453-4057qib7	12404	29	.	.	.
cord-005453-4057qib7	12405	1	Results	result	NNS
cord-005453-4057qib7	12405	2	:	:	:
cord-005453-4057qib7	12406	1	There	there	EX
cord-005453-4057qib7	12406	2	were	be	VBD
cord-005453-4057qib7	12406	3	48	48	CD
cord-005453-4057qib7	12406	4	transplantations	transplantation	NNS
cord-005453-4057qib7	12406	5	with	with	IN
cord-005453-4057qib7	12406	6	fresh	fresh	JJ
cord-005453-4057qib7	12406	7	cells	cell	NNS
cord-005453-4057qib7	12406	8	and	and	CC
cord-005453-4057qib7	12406	9	49	49	CD
cord-005453-4057qib7	12406	10	transplantations	transplantation	NNS
cord-005453-4057qib7	12406	11	with	with	IN
cord-005453-4057qib7	12406	12	frozen	frozen	JJ
cord-005453-4057qib7	12406	13	cells	cell	NNS
cord-005453-4057qib7	12406	14	compared	compare	VBN
cord-005453-4057qib7	12406	15	.	.	.
cord-005453-4057qib7	12407	1	Both	both	DT
cord-005453-4057qib7	12407	2	groups	group	NNS
cord-005453-4057qib7	12407	3	had	have	VBD
cord-005453-4057qib7	12407	4	same	same	JJ
cord-005453-4057qib7	12407	5	mobilization	mobilization	NN
cord-005453-4057qib7	12407	6	protocol	protocol	NN
cord-005453-4057qib7	12407	7	-ambulatory	-ambulatory	.
cord-005453-4057qib7	12408	1	low	low	JJ
cord-005453-4057qib7	12408	2	dose	dose	NN
cord-005453-4057qib7	12408	3	ARA	ARA	NNP
cord-005453-4057qib7	12408	4	-	-	HYPH
cord-005453-4057qib7	12408	5	C.	C.	NNP
cord-005453-4057qib7	12409	1	The	the	DT
cord-005453-4057qib7	12409	2	median	median	JJ
cord-005453-4057qib7	12409	3	age	age	NN
cord-005453-4057qib7	12409	4	and	and	CC
cord-005453-4057qib7	12409	5	number	number	NN
cord-005453-4057qib7	12409	6	of	of	IN
cord-005453-4057qib7	12409	7	transplanted	transplanted	JJ
cord-005453-4057qib7	12409	8	cells	cell	NNS
cord-005453-4057qib7	12409	9	was	be	VBD
cord-005453-4057qib7	12409	10	similar	similar	JJ
cord-005453-4057qib7	12409	11	in	in	IN
cord-005453-4057qib7	12409	12	both	both	DT
cord-005453-4057qib7	12409	13	groups	group	NNS
cord-005453-4057qib7	12410	1	(	(	-LRB-
cord-005453-4057qib7	12410	2	56	56	CD
cord-005453-4057qib7	12410	3	vs	vs	IN
cord-005453-4057qib7	12410	4	57	57	CD
cord-005453-4057qib7	12410	5	,	,	,
cord-005453-4057qib7	12410	6	p=0.99	p=0.99	NN
cord-005453-4057qib7	12410	7	;	;	:
cord-005453-4057qib7	12410	8	5.2	5.2	CD
cord-005453-4057qib7	12410	9	vs	vs	IN
cord-005453-4057qib7	12410	10	5.3	5.3	CD
cord-005453-4057qib7	12410	11	CD34+/KG	CD34+/KG	NNP
cord-005453-4057qib7	12410	12	,	,	,
cord-005453-4057qib7	12410	13	p=0.97	p=0.97	NNP
cord-005453-4057qib7	12410	14	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	12410	15	:	:	:
cord-005453-4057qib7	12411	1	We	-PRON-	PRP
cord-005453-4057qib7	12411	2	present	present	VBP
cord-005453-4057qib7	12411	3	novel	novel	JJ
cord-005453-4057qib7	12411	4	approach	approach	NN
cord-005453-4057qib7	12411	5	that	that	WDT
cord-005453-4057qib7	12411	6	allows	allow	VBZ
cord-005453-4057qib7	12411	7	direct	direct	JJ
cord-005453-4057qib7	12411	8	AHSCT	AHSCT	NNP
cord-005453-4057qib7	12411	9	after	after	IN
cord-005453-4057qib7	12411	10	chemo	chemo	NN
cord-005453-4057qib7	12411	11	mobilization	mobilization	NN
cord-005453-4057qib7	12411	12	in	in	IN
cord-005453-4057qib7	12411	13	all	all	DT
cord-005453-4057qib7	12411	14	patients	patient	NNS
cord-005453-4057qib7	12411	15	who	who	WP
cord-005453-4057qib7	12411	16	are	be	VBP
cord-005453-4057qib7	12411	17	treated	treat	VBN
cord-005453-4057qib7	12411	18	with	with	IN
cord-005453-4057qib7	12411	19	melphalan	melphalan	NNP
cord-005453-4057qib7	12411	20	.	.	.
cord-005453-4057qib7	12412	1	We	-PRON-	PRP
cord-005453-4057qib7	12412	2	show	show	VBP
cord-005453-4057qib7	12412	3	that	that	IN
cord-005453-4057qib7	12412	4	it	-PRON-	PRP
cord-005453-4057qib7	12412	5	is	be	VBZ
cord-005453-4057qib7	12412	6	not	not	RB
cord-005453-4057qib7	12412	7	only	only	RB
cord-005453-4057qib7	12412	8	feasible	feasible	JJ
cord-005453-4057qib7	12412	9	to	to	TO
cord-005453-4057qib7	12412	10	do	do	VB
cord-005453-4057qib7	12412	11	AHSCT	AHSCT	NNP
cord-005453-4057qib7	12412	12	directly	directly	RB
cord-005453-4057qib7	12412	13	after	after	IN
cord-005453-4057qib7	12412	14	chemomobilization	chemomobilization	NN
cord-005453-4057qib7	12412	15	but	but	CC
cord-005453-4057qib7	12412	16	also	also	RB
cord-005453-4057qib7	12412	17	the	the	DT
cord-005453-4057qib7	12412	18	results	result	NNS
cord-005453-4057qib7	12412	19	may	may	MD
cord-005453-4057qib7	12412	20	favour	favour	VB
cord-005453-4057qib7	12412	21	this	this	DT
cord-005453-4057qib7	12412	22	approach	approach	NN
cord-005453-4057qib7	12412	23	when	when	WRB
cord-005453-4057qib7	12412	24	compared	compare	VBN
cord-005453-4057qib7	12412	25	with	with	IN
cord-005453-4057qib7	12412	26	current	current	JJ
cord-005453-4057qib7	12412	27	standard	standard	NN
cord-005453-4057qib7	12412	28	.	.	.
cord-005453-4057qib7	12413	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12413	2	:	:	:
cord-005453-4057qib7	12413	3	Nothing	nothing	NN
cord-005453-4057qib7	12413	4	to	to	TO
cord-005453-4057qib7	12413	5	declare	declare	VB
cord-005453-4057qib7	12413	6	Background	background	NN
cord-005453-4057qib7	12413	7	:	:	:
cord-005453-4057qib7	12414	1	High	high	JJ
cord-005453-4057qib7	12414	2	dose	dose	NN
cord-005453-4057qib7	12414	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12414	4	followed	follow	VBN
cord-005453-4057qib7	12414	5	by	by	IN
cord-005453-4057qib7	12414	6	autologous	autologous	JJ
cord-005453-4057qib7	12414	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12414	8	cell	cell	NN
cord-005453-4057qib7	12414	9	transplantation	transplantation	NN
cord-005453-4057qib7	12414	10	(	(	-LRB-
cord-005453-4057qib7	12414	11	HSCT	HSCT	NNP
cord-005453-4057qib7	12414	12	)	)	-RRB-
cord-005453-4057qib7	12414	13	is	be	VBZ
cord-005453-4057qib7	12414	14	considered	consider	VBN
cord-005453-4057qib7	12414	15	,	,	,
cord-005453-4057qib7	12414	16	since	since	IN
cord-005453-4057qib7	12414	17	the	the	DT
cord-005453-4057qib7	12414	18	nineties	ninety	NNS
cord-005453-4057qib7	12414	19	,	,	,
cord-005453-4057qib7	12414	20	the	the	DT
cord-005453-4057qib7	12414	21	standard	standard	NN
cord-005453-4057qib7	12414	22	of	of	IN
cord-005453-4057qib7	12414	23	care	care	NN
cord-005453-4057qib7	12414	24	for	for	IN
cord-005453-4057qib7	12414	25	patients	patient	NNS
cord-005453-4057qib7	12414	26	aged	age	VBN
cord-005453-4057qib7	12414	27	less	less	JJR
cord-005453-4057qib7	12414	28	than	than	IN
cord-005453-4057qib7	12414	29	70	70	CD
cord-005453-4057qib7	12414	30	-	-	SYM
cord-005453-4057qib7	12414	31	75	75	CD
cord-005453-4057qib7	12414	32	years	year	NNS
cord-005453-4057qib7	12414	33	old	old	JJ
cord-005453-4057qib7	12414	34	with	with	IN
cord-005453-4057qib7	12414	35	newly	newly	RB
cord-005453-4057qib7	12414	36	diagnosed	diagnose	VBN
cord-005453-4057qib7	12414	37	multiple	multiple	JJ
cord-005453-4057qib7	12414	38	myeloma	myeloma	NN
cord-005453-4057qib7	12414	39	(	(	-LRB-
cord-005453-4057qib7	12414	40	MM	MM	NNP
cord-005453-4057qib7	12414	41	)	)	-RRB-
cord-005453-4057qib7	12414	42	.	.	.
cord-005453-4057qib7	12415	1	However	however	RB
cord-005453-4057qib7	12415	2	,	,	,
cord-005453-4057qib7	12415	3	the	the	DT
cord-005453-4057qib7	12415	4	optimal	optimal	JJ
cord-005453-4057qib7	12415	5	induction	induction	NN
cord-005453-4057qib7	12415	6	treatment	treatment	NN
cord-005453-4057qib7	12415	7	prior	prior	RB
cord-005453-4057qib7	12415	8	to	to	IN
cord-005453-4057qib7	12415	9	HSCT	HSCT	NNP
cord-005453-4057qib7	12415	10	to	to	TO
cord-005453-4057qib7	12415	11	reduce	reduce	VB
cord-005453-4057qib7	12415	12	the	the	DT
cord-005453-4057qib7	12415	13	tumor	tumor	NN
cord-005453-4057qib7	12415	14	burden	burden	NN
cord-005453-4057qib7	12415	15	has	have	VBZ
cord-005453-4057qib7	12415	16	changed	change	VBN
cord-005453-4057qib7	12415	17	during	during	IN
cord-005453-4057qib7	12415	18	the	the	DT
cord-005453-4057qib7	12415	19	last	last	JJ
cord-005453-4057qib7	12415	20	few	few	JJ
cord-005453-4057qib7	12415	21	years	year	NNS
cord-005453-4057qib7	12415	22	.	.	.
cord-005453-4057qib7	12416	1	Improved	improve	VBN
cord-005453-4057qib7	12416	2	regimens	regimen	NNS
cord-005453-4057qib7	12416	3	have	have	VBP
cord-005453-4057qib7	12416	4	shown	show	VBN
cord-005453-4057qib7	12416	5	to	to	TO
cord-005453-4057qib7	12416	6	be	be	VB
cord-005453-4057qib7	12416	7	able	able	JJ
cord-005453-4057qib7	12416	8	to	to	TO
cord-005453-4057qib7	12416	9	increase	increase	VB
cord-005453-4057qib7	12416	10	the	the	DT
cord-005453-4057qib7	12416	11	quality	quality	NN
cord-005453-4057qib7	12416	12	of	of	IN
cord-005453-4057qib7	12416	13	the	the	DT
cord-005453-4057qib7	12416	14	pre	pre	JJ
cord-005453-4057qib7	12416	15	-	-	JJ
cord-005453-4057qib7	12416	16	HSCT	hsct	JJ
cord-005453-4057qib7	12416	17	response	response	NN
cord-005453-4057qib7	12416	18	,	,	,
cord-005453-4057qib7	12416	19	which	which	WDT
cord-005453-4057qib7	12416	20	might	may	MD
cord-005453-4057qib7	12416	21	subsequently	subsequently	RB
cord-005453-4057qib7	12416	22	impact	impact	VB
cord-005453-4057qib7	12416	23	on	on	IN
cord-005453-4057qib7	12416	24	the	the	DT
cord-005453-4057qib7	12416	25	post	post	JJ
cord-005453-4057qib7	12416	26	-	-	JJ
cord-005453-4057qib7	12416	27	HSCT	hsct	JJ
cord-005453-4057qib7	12416	28	response	response	NN
cord-005453-4057qib7	12416	29	,	,	,
cord-005453-4057qib7	12416	30	which	which	WDT
cord-005453-4057qib7	12416	31	has	have	VBZ
cord-005453-4057qib7	12416	32	been	be	VBN
cord-005453-4057qib7	12416	33	proved	prove	VBN
cord-005453-4057qib7	12416	34	to	to	TO
cord-005453-4057qib7	12416	35	be	be	VB
cord-005453-4057qib7	12416	36	associated	associate	VBN
cord-005453-4057qib7	12416	37	with	with	IN
cord-005453-4057qib7	12416	38	a	a	DT
cord-005453-4057qib7	12416	39	longer	long	JJR
cord-005453-4057qib7	12416	40	PFS	PFS	NNP
cord-005453-4057qib7	12416	41	.	.	.
cord-005453-4057qib7	12417	1	We	-PRON-	PRP
cord-005453-4057qib7	12417	2	recently	recently	RB
cord-005453-4057qib7	12417	3	changed	change	VBD
cord-005453-4057qib7	12417	4	the	the	DT
cord-005453-4057qib7	12417	5	induction	induction	NN
cord-005453-4057qib7	12417	6	therapy	therapy	NN
cord-005453-4057qib7	12417	7	for	for	IN
cord-005453-4057qib7	12417	8	pts	pts	NN
cord-005453-4057qib7	12417	9	candidates	candidate	NNS
cord-005453-4057qib7	12417	10	to	to	IN
cord-005453-4057qib7	12417	11	HSCT	HSCT	NNP
cord-005453-4057qib7	12417	12	.	.	.
cord-005453-4057qib7	12418	1	In	in	IN
cord-005453-4057qib7	12418	2	this	this	DT
cord-005453-4057qib7	12418	3	analysis	analysis	NN
cord-005453-4057qib7	12418	4	,	,	,
cord-005453-4057qib7	12418	5	we	-PRON-	PRP
cord-005453-4057qib7	12418	6	aimed	aim	VBD
cord-005453-4057qib7	12418	7	to	to	TO
cord-005453-4057qib7	12418	8	check	check	VB
cord-005453-4057qib7	12418	9	if	if	IN
cord-005453-4057qib7	12418	10	newer	new	JJR
cord-005453-4057qib7	12418	11	regimens	regimen	NNS
cord-005453-4057qib7	12418	12	impacted	impact	VBN
cord-005453-4057qib7	12418	13	on	on	IN
cord-005453-4057qib7	12418	14	pretransplant	pretransplant	JJ
cord-005453-4057qib7	12418	15	responses	response	NNS
cord-005453-4057qib7	12418	16	,	,	,
cord-005453-4057qib7	12418	17	and	and	CC
cord-005453-4057qib7	12418	18	how	how	WRB
cord-005453-4057qib7	12418	19	auto	auto	NN
cord-005453-4057qib7	12418	20	-	-	HYPH
cord-005453-4057qib7	12418	21	HSCT	HSCT	NNP
cord-005453-4057qib7	12418	22	changed	change	VBD
cord-005453-4057qib7	12418	23	the	the	DT
cord-005453-4057qib7	12418	24	pre	pre	JJ
cord-005453-4057qib7	12418	25	-	-	JJ
cord-005453-4057qib7	12418	26	HSCT	hsct	JJ
cord-005453-4057qib7	12418	27	status	status	NN
cord-005453-4057qib7	12418	28	.	.	.
cord-005453-4057qib7	12419	1	Methods	method	NNS
cord-005453-4057qib7	12419	2	:	:	:
cord-005453-4057qib7	12419	3	All	all	PDT
cord-005453-4057qib7	12419	4	the	the	DT
cord-005453-4057qib7	12419	5	117	117	CD
cord-005453-4057qib7	12419	6	auto	auto	NN
cord-005453-4057qib7	12419	7	-	-	HYPH
cord-005453-4057qib7	12419	8	HSCT	HSCT	NNP
cord-005453-4057qib7	12419	9	for	for	IN
cord-005453-4057qib7	12419	10	99	99	CD
cord-005453-4057qib7	12419	11	MM	MM	NNP
cord-005453-4057qib7	12419	12	patients	patient	NNS
cord-005453-4057qib7	12419	13	performed	perform	VBN
cord-005453-4057qib7	12419	14	in	in	IN
cord-005453-4057qib7	12419	15	our	-PRON-	PRP$
cord-005453-4057qib7	12419	16	center	center	NN
cord-005453-4057qib7	12419	17	from	from	IN
cord-005453-4057qib7	12419	18	January	January	NNP
cord-005453-4057qib7	12419	19	2014	2014	CD
cord-005453-4057qib7	12419	20	through	through	IN
cord-005453-4057qib7	12419	21	August	August	NNP
cord-005453-4057qib7	12419	22	2018	2018	CD
cord-005453-4057qib7	12419	23	were	be	VBD
cord-005453-4057qib7	12419	24	included	include	VBN
cord-005453-4057qib7	12419	25	in	in	IN
cord-005453-4057qib7	12419	26	the	the	DT
cord-005453-4057qib7	12419	27	analysis	analysis	NN
cord-005453-4057qib7	12419	28	.	.	.
cord-005453-4057qib7	12420	1	Median	median	JJ
cord-005453-4057qib7	12420	2	age	age	NN
cord-005453-4057qib7	12420	3	was	be	VBD
cord-005453-4057qib7	12420	4	60	60	CD
cord-005453-4057qib7	12420	5	years	year	NNS
cord-005453-4057qib7	12421	1	(	(	-LRB-
cord-005453-4057qib7	12421	2	range	range	NN
cord-005453-4057qib7	12421	3	:	:	:
cord-005453-4057qib7	12421	4	38	38	CD
cord-005453-4057qib7	12421	5	-	-	SYM
cord-005453-4057qib7	12421	6	76	76	CD
cord-005453-4057qib7	12421	7	)	)	-RRB-
cord-005453-4057qib7	12421	8	.	.	.
cord-005453-4057qib7	12422	1	54	54	CD
cord-005453-4057qib7	12422	2	pts	pt	NNS
cord-005453-4057qib7	12422	3	were	be	VBD
cord-005453-4057qib7	12422	4	male	male	JJ
cord-005453-4057qib7	12422	5	and	and	CC
cord-005453-4057qib7	12422	6	45	45	CD
cord-005453-4057qib7	12422	7	were	be	VBD
cord-005453-4057qib7	12422	8	female	female	JJ
cord-005453-4057qib7	12422	9	.	.	.
cord-005453-4057qib7	12423	1	Durie	Durie	NNP
cord-005453-4057qib7	12423	2	-	-	HYPH
cord-005453-4057qib7	12423	3	Salmon	Salmon	NNP
cord-005453-4057qib7	12423	4	stage	stage	NN
cord-005453-4057qib7	12423	5	was	be	VBD
cord-005453-4057qib7	12423	6	distributed	distribute	VBN
cord-005453-4057qib7	12423	7	as	as	IN
cord-005453-4057qib7	12423	8	follows	follow	VBZ
cord-005453-4057qib7	12423	9	:	:	:
cord-005453-4057qib7	12423	10	I	-PRON-	PRP
cord-005453-4057qib7	12423	11	(	(	-LRB-
cord-005453-4057qib7	12423	12	9.4	9.4	CD
cord-005453-4057qib7	12423	13	%	%	NN
cord-005453-4057qib7	12423	14	)	)	-RRB-
cord-005453-4057qib7	12423	15	,	,	,
cord-005453-4057qib7	12423	16	II	II	NNP
cord-005453-4057qib7	12423	17	(	(	-LRB-
cord-005453-4057qib7	12423	18	37.6	37.6	CD
cord-005453-4057qib7	12423	19	%	%	NN
cord-005453-4057qib7	12423	20	)	)	-RRB-
cord-005453-4057qib7	12423	21	and	and	CC
cord-005453-4057qib7	12423	22	III	III	NNP
cord-005453-4057qib7	12423	23	(	(	-LRB-
cord-005453-4057qib7	12423	24	53	53	CD
cord-005453-4057qib7	12423	25	%	%	NN
cord-005453-4057qib7	12423	26	)	)	-RRB-
cord-005453-4057qib7	12423	27	;	;	:
cord-005453-4057qib7	12423	28	13	13	CD
cord-005453-4057qib7	12423	29	%	%	NN
cord-005453-4057qib7	12423	30	had	have	VBD
cord-005453-4057qib7	12423	31	creatinine	creatinine	NN
cord-005453-4057qib7	12424	1	>	>	XX
cord-005453-4057qib7	12425	1	2	2	CD
cord-005453-4057qib7	12425	2	mg	mg	NNP
cord-005453-4057qib7	12425	3	/	/	SYM
cord-005453-4057qib7	12425	4	dL.	dl.	NN
cord-005453-4057qib7	12425	5	ISS	ISS	NNP
cord-005453-4057qib7	12425	6	was	be	VBD
cord-005453-4057qib7	12425	7	:	:	:
cord-005453-4057qib7	12425	8	1	1	CD
cord-005453-4057qib7	12425	9	(	(	-LRB-
cord-005453-4057qib7	12425	10	41	41	CD
cord-005453-4057qib7	12425	11	%	%	NN
cord-005453-4057qib7	12425	12	)	)	-RRB-
cord-005453-4057qib7	12425	13	,	,	,
cord-005453-4057qib7	12425	14	2	2	CD
cord-005453-4057qib7	12425	15	(	(	-LRB-
cord-005453-4057qib7	12425	16	28.2	28.2	CD
cord-005453-4057qib7	12425	17	%	%	NN
cord-005453-4057qib7	12425	18	)	)	-RRB-
cord-005453-4057qib7	12425	19	,	,	,
cord-005453-4057qib7	12425	20	and	and	CC
cord-005453-4057qib7	12425	21	3	3	CD
cord-005453-4057qib7	12425	22	(	(	-LRB-
cord-005453-4057qib7	12425	23	30.8	30.8	CD
cord-005453-4057qib7	12425	24	%	%	NN
cord-005453-4057qib7	12425	25	)	)	-RRB-
cord-005453-4057qib7	12425	26	.	.	.
cord-005453-4057qib7	12426	1	Type	type	NN
cord-005453-4057qib7	12426	2	of	of	IN
cord-005453-4057qib7	12426	3	monoclonal	monoclonal	JJ
cord-005453-4057qib7	12426	4	component	component	NN
cord-005453-4057qib7	12426	5	was	be	VBD
cord-005453-4057qib7	12426	6	:	:	:
cord-005453-4057qib7	12426	7	IgG	IgG	NNP
cord-005453-4057qib7	12426	8	(	(	-LRB-
cord-005453-4057qib7	12426	9	51.3	51.3	CD
cord-005453-4057qib7	12426	10	%	%	NN
cord-005453-4057qib7	12426	11	)	)	-RRB-
cord-005453-4057qib7	12426	12	,	,	,
cord-005453-4057qib7	12426	13	light	light	JJ
cord-005453-4057qib7	12426	14	chains	chain	NNS
cord-005453-4057qib7	12426	15	(	(	-LRB-
cord-005453-4057qib7	12426	16	23.9	23.9	CD
cord-005453-4057qib7	12426	17	%	%	NN
cord-005453-4057qib7	12426	18	)	)	-RRB-
cord-005453-4057qib7	12426	19	,	,	,
cord-005453-4057qib7	12426	20	IgA	IgA	NNP
cord-005453-4057qib7	12426	21	(	(	-LRB-
cord-005453-4057qib7	12426	22	22.2	22.2	CD
cord-005453-4057qib7	12426	23	%	%	NN
cord-005453-4057qib7	12426	24	)	)	-RRB-
cord-005453-4057qib7	12426	25	,	,	,
cord-005453-4057qib7	12426	26	and	and	CC
cord-005453-4057qib7	12426	27	non	non	JJ
cord-005453-4057qib7	12426	28	-	-	JJ
cord-005453-4057qib7	12426	29	secretory	secretory	JJ
cord-005453-4057qib7	12426	30	(	(	-LRB-
cord-005453-4057qib7	12426	31	2.6	2.6	CD
cord-005453-4057qib7	12426	32	%	%	NN
cord-005453-4057qib7	12426	33	)	)	-RRB-
cord-005453-4057qib7	12426	34	.	.	.
cord-005453-4057qib7	12427	1	51.3	51.3	CD
cord-005453-4057qib7	12427	2	%	%	NN
cord-005453-4057qib7	12427	3	had	have	VBD
cord-005453-4057qib7	12427	4	Bence	Bence	NNP
cord-005453-4057qib7	12427	5	Jones	Jones	NNP
cord-005453-4057qib7	12427	6	proteinuria	proteinuria	NN
cord-005453-4057qib7	12427	7	.	.	.
cord-005453-4057qib7	12428	1	Conditioning	conditioning	NN
cord-005453-4057qib7	12428	2	regimen	regimen	NN
cord-005453-4057qib7	12428	3	was	be	VBD
cord-005453-4057qib7	12428	4	Melphalan	Melphalan	NNP
cord-005453-4057qib7	12428	5	200	200	CD
cord-005453-4057qib7	12429	1	mg	mg	NNP
cord-005453-4057qib7	12429	2	/	/	SYM
cord-005453-4057qib7	12429	3	m	m	NNP
cord-005453-4057qib7	12429	4	2	2	CD
cord-005453-4057qib7	12429	5	in	in	IN
cord-005453-4057qib7	12429	6	106	106	CD
cord-005453-4057qib7	12429	7	(	(	-LRB-
cord-005453-4057qib7	12429	8	90.6	90.6	CD
cord-005453-4057qib7	12429	9	%	%	NN
cord-005453-4057qib7	12429	10	)	)	-RRB-
cord-005453-4057qib7	12429	11	,	,	,
cord-005453-4057qib7	12429	12	Melphalan	Melphalan	NNP
cord-005453-4057qib7	12429	13	100	100	CD
cord-005453-4057qib7	12429	14	-	-	SYM
cord-005453-4057qib7	12429	15	140	140	CD
cord-005453-4057qib7	12430	1	mg	mg	NNP
cord-005453-4057qib7	12430	2	/	/	SYM
cord-005453-4057qib7	12430	3	m	m	NNP
cord-005453-4057qib7	12430	4	2	2	CD
cord-005453-4057qib7	12430	5	in	in	IN
cord-005453-4057qib7	12430	6	9	9	CD
cord-005453-4057qib7	12430	7	(	(	-LRB-
cord-005453-4057qib7	12430	8	7.7	7.7	CD
cord-005453-4057qib7	12430	9	%	%	NN
cord-005453-4057qib7	12430	10	)	)	-RRB-
cord-005453-4057qib7	12430	11	,	,	,
cord-005453-4057qib7	12430	12	and	and	CC
cord-005453-4057qib7	12430	13	other	other	JJ
cord-005453-4057qib7	12430	14	in	in	IN
cord-005453-4057qib7	12430	15	2	2	CD
cord-005453-4057qib7	12430	16	(	(	-LRB-
cord-005453-4057qib7	12430	17	1.7	1.7	CD
cord-005453-4057qib7	12430	18	%	%	NN
cord-005453-4057qib7	12430	19	)	)	-RRB-
cord-005453-4057qib7	12430	20	.	.	.
cord-005453-4057qib7	12431	1	Results	result	NNS
cord-005453-4057qib7	12431	2	:	:	:
cord-005453-4057qib7	12432	1	Pre	pre	JJ
cord-005453-4057qib7	12432	2	-	-	JJ
cord-005453-4057qib7	12432	3	transplant	transplant	NN
cord-005453-4057qib7	12432	4	therapy	therapy	NN
cord-005453-4057qib7	12432	5	was	be	VBD
cord-005453-4057qib7	12432	6	:	:	:
cord-005453-4057qib7	12432	7	VCD	VCD	NNP
cord-005453-4057qib7	12432	8	in	in	IN
cord-005453-4057qib7	12432	9	60	60	CD
cord-005453-4057qib7	12432	10	(	(	-LRB-
cord-005453-4057qib7	12432	11	mostly	mostly	RB
cord-005453-4057qib7	12432	12	in	in	IN
cord-005453-4057qib7	12432	13	2014	2014	CD
cord-005453-4057qib7	12432	14	-	-	SYM
cord-005453-4057qib7	12432	15	6	6	CD
cord-005453-4057qib7	12432	16	)	)	-RRB-
cord-005453-4057qib7	12432	17	,	,	.
cord-005453-4057qib7	12433	1	VTD	VTD	NNP
cord-005453-4057qib7	12433	2	/	/	SYM
cord-005453-4057qib7	12433	3	VRD	VRD	NNP
cord-005453-4057qib7	12433	4	/	/	SYM
cord-005453-4057qib7	12433	5	KRD	KRD	NNP
cord-005453-4057qib7	12433	6	in	in	IN
cord-005453-4057qib7	12433	7	34	34	CD
cord-005453-4057qib7	12433	8	(	(	-LRB-
cord-005453-4057qib7	12433	9	mostly	mostly	RB
cord-005453-4057qib7	12433	10	in	in	IN
cord-005453-4057qib7	12433	11	2017	2017	CD
cord-005453-4057qib7	12433	12	-	-	SYM
cord-005453-4057qib7	12433	13	8	8	CD
cord-005453-4057qib7	12433	14	)	)	-RRB-
cord-005453-4057qib7	12433	15	,	,	,
cord-005453-4057qib7	12433	16	and	and	CC
cord-005453-4057qib7	12433	17	others	other	NNS
cord-005453-4057qib7	12433	18	in	in	IN
cord-005453-4057qib7	12433	19	23	23	CD
cord-005453-4057qib7	12433	20	cases	case	NNS
cord-005453-4057qib7	12433	21	.	.	.
cord-005453-4057qib7	12434	1	Status	status	NN
cord-005453-4057qib7	12434	2	of	of	IN
cord-005453-4057qib7	12434	3	the	the	DT
cord-005453-4057qib7	12434	4	disease	disease	NN
cord-005453-4057qib7	12434	5	at	at	IN
cord-005453-4057qib7	12434	6	transplant	transplant	NN
cord-005453-4057qib7	12434	7	was	be	VBD
cord-005453-4057qib7	12434	8	:	:	:
cord-005453-4057qib7	12434	9	CR	CR	NNP
cord-005453-4057qib7	12434	10	/	/	SYM
cord-005453-4057qib7	12434	11	VGPR	VGPR	NNP
cord-005453-4057qib7	12434	12	in	in	IN
cord-005453-4057qib7	12434	13	75	75	CD
cord-005453-4057qib7	12434	14	,	,	,
cord-005453-4057qib7	12434	15	PR	PR	NNP
cord-005453-4057qib7	12434	16	in	in	IN
cord-005453-4057qib7	12434	17	35	35	CD
cord-005453-4057qib7	12434	18	,	,	,
cord-005453-4057qib7	12434	19	and	and	CC
cord-005453-4057qib7	12434	20	SD	SD	NNP
cord-005453-4057qib7	12434	21	in	in	IN
cord-005453-4057qib7	12434	22	7	7	CD
cord-005453-4057qib7	12434	23	.	.	.
cord-005453-4057qib7	12435	1	Distribution	distribution	NN
cord-005453-4057qib7	12435	2	of	of	IN
cord-005453-4057qib7	12435	3	pretransplant	pretransplant	JJ
cord-005453-4057qib7	12435	4	response	response	NN
cord-005453-4057qib7	12435	5	based	base	VBN
cord-005453-4057qib7	12435	6	on	on	IN
cord-005453-4057qib7	12435	7	the	the	DT
cord-005453-4057qib7	12435	8	type	type	NN
cord-005453-4057qib7	12435	9	of	of	IN
cord-005453-4057qib7	12435	10	induction	induction	NN
cord-005453-4057qib7	12435	11	is	be	VBZ
cord-005453-4057qib7	12435	12	shown	show	VBN
cord-005453-4057qib7	12435	13	in	in	IN
cord-005453-4057qib7	12435	14	table	table	NN
cord-005453-4057qib7	12435	15	1	1	CD
cord-005453-4057qib7	12435	16	.	.	.
cord-005453-4057qib7	12436	1	Peri	peri	NN
cord-005453-4057qib7	12436	2	-	-	HYPH
cord-005453-4057qib7	12436	3	transplant	transplant	NN
cord-005453-4057qib7	12436	4	mortality	mortality	NN
cord-005453-4057qib7	12436	5	was	be	VBD
cord-005453-4057qib7	12436	6	0	0	CD
cord-005453-4057qib7	12436	7	%	%	NN
cord-005453-4057qib7	12436	8	.	.	.
cord-005453-4057qib7	12437	1	Day	day	NN
cord-005453-4057qib7	12437	2	+100	+100	NNS
cord-005453-4057qib7	12437	3	mortality	mortality	NN
cord-005453-4057qib7	12437	4	was	be	VBD
cord-005453-4057qib7	12437	5	1.7	1.7	CD
cord-005453-4057qib7	12437	6	%	%	NN
cord-005453-4057qib7	12437	7	(	(	-LRB-
cord-005453-4057qib7	12437	8	2	2	CD
cord-005453-4057qib7	12437	9	pts	pts	CD
cord-005453-4057qib7	12437	10	)	)	-RRB-
cord-005453-4057qib7	12437	11	,	,	,
cord-005453-4057qib7	12437	12	due	due	IN
cord-005453-4057qib7	12437	13	to	to	IN
cord-005453-4057qib7	12437	14	progressive	progressive	JJ
cord-005453-4057qib7	12437	15	disease	disease	NN
cord-005453-4057qib7	12437	16	.	.	.
cord-005453-4057qib7	12438	1	As	as	IN
cord-005453-4057qib7	12438	2	shown	show	VBN
cord-005453-4057qib7	12438	3	in	in	IN
cord-005453-4057qib7	12438	4	table	table	NN
cord-005453-4057qib7	12438	5	2	2	CD
cord-005453-4057qib7	12438	6	,	,	,
cord-005453-4057qib7	12438	7	all	all	DT
cord-005453-4057qib7	12438	8	patients	patient	NNS
cord-005453-4057qib7	12438	9	(	(	-LRB-
cord-005453-4057qib7	12438	10	14/14	14/14	CD
cord-005453-4057qib7	12438	11	)	)	-RRB-
cord-005453-4057qib7	12438	12	who	who	WP
cord-005453-4057qib7	12438	13	obtained	obtain	VBD
cord-005453-4057qib7	12438	14	CR	CR	NNP
cord-005453-4057qib7	12438	15	pre	pre	JJ
cord-005453-4057qib7	12438	16	-	-	JJ
cord-005453-4057qib7	12438	17	HSCT	HSCT	NNP
cord-005453-4057qib7	12438	18	,	,	,
cord-005453-4057qib7	12438	19	maintained	maintain	VBD
cord-005453-4057qib7	12438	20	the	the	DT
cord-005453-4057qib7	12438	21	response	response	NN
cord-005453-4057qib7	12438	22	at	at	IN
cord-005453-4057qib7	12438	23	day	day	NN
cord-005453-4057qib7	12438	24	+100	+100	NFP
cord-005453-4057qib7	12438	25	post	post	NN
cord-005453-4057qib7	12438	26	-	-	JJ
cord-005453-4057qib7	12438	27	HSCT	HSCT	NNP
cord-005453-4057qib7	12438	28	.	.	.
cord-005453-4057qib7	12439	1	Among	among	IN
cord-005453-4057qib7	12439	2	the	the	DT
cord-005453-4057qib7	12439	3	patients	patient	NNS
cord-005453-4057qib7	12439	4	in	in	IN
cord-005453-4057qib7	12439	5	VGPR	VGPR	NNP
cord-005453-4057qib7	12439	6	at	at	IN
cord-005453-4057qib7	12439	7	HSCT	HSCT	NNP
cord-005453-4057qib7	12439	8	,	,	,
cord-005453-4057qib7	12439	9	20	20	CD
cord-005453-4057qib7	12439	10	(	(	-LRB-
cord-005453-4057qib7	12439	11	32.8	32.8	CD
cord-005453-4057qib7	12439	12	%	%	NN
cord-005453-4057qib7	12439	13	)	)	-RRB-
cord-005453-4057qib7	12439	14	became	become	VBD
cord-005453-4057qib7	12439	15	into	into	IN
cord-005453-4057qib7	12439	16	CR	CR	NNP
cord-005453-4057qib7	12439	17	,	,	,
cord-005453-4057qib7	12439	18	and	and	CC
cord-005453-4057qib7	12439	19	37	37	CD
cord-005453-4057qib7	12439	20	(	(	-LRB-
cord-005453-4057qib7	12439	21	60.7	60.7	CD
cord-005453-4057qib7	12439	22	%	%	NN
cord-005453-4057qib7	12439	23	)	)	-RRB-
cord-005453-4057qib7	12439	24	maintained	maintain	VBD
cord-005453-4057qib7	12439	25	the	the	DT
cord-005453-4057qib7	12439	26	response	response	NN
cord-005453-4057qib7	12439	27	.	.	.
cord-005453-4057qib7	12440	1	The	the	DT
cord-005453-4057qib7	12440	2	CR	cr	NN
cord-005453-4057qib7	12440	3	rate	rate	NN
cord-005453-4057qib7	12440	4	at	at	IN
cord-005453-4057qib7	12440	5	post	post	JJ
cord-005453-4057qib7	12440	6	-	-	JJ
cord-005453-4057qib7	12440	7	HSCT	HSCT	NNP
cord-005453-4057qib7	12440	8	increased	increase	VBD
cord-005453-4057qib7	12440	9	264	264	CD
cord-005453-4057qib7	12440	10	%	%	NN
cord-005453-4057qib7	12440	11	compared	compare	VBN
cord-005453-4057qib7	12440	12	to	to	IN
cord-005453-4057qib7	12440	13	pre	pre	JJ
cord-005453-4057qib7	12440	14	-	-	JJ
cord-005453-4057qib7	12440	15	HSCT	HSCT	NNP
cord-005453-4057qib7	12440	16	(	(	-LRB-
cord-005453-4057qib7	12440	17	37	37	CD
cord-005453-4057qib7	12440	18	versus	versus	IN
cord-005453-4057qib7	12440	19	14	14	CD
cord-005453-4057qib7	12440	20	pts	pt	NNS
cord-005453-4057qib7	12440	21	)	)	-RRB-
cord-005453-4057qib7	12440	22	.	.	.
cord-005453-4057qib7	12441	1	Altogether	altogether	RB
cord-005453-4057qib7	12441	2	,	,	,
cord-005453-4057qib7	12441	3	after	after	IN
cord-005453-4057qib7	12441	4	HSCT	HSCT	NNP
cord-005453-4057qib7	12441	5	44	44	CD
cord-005453-4057qib7	12441	6	pts	pt	NNS
cord-005453-4057qib7	12441	7	(	(	-LRB-
cord-005453-4057qib7	12441	8	37.6	37.6	CD
cord-005453-4057qib7	12441	9	%	%	NN
cord-005453-4057qib7	12441	10	)	)	-RRB-
cord-005453-4057qib7	12441	11	improved	improve	VBN
cord-005453-4057qib7	12441	12	and	and	CC
cord-005453-4057qib7	12441	13	65	65	CD
cord-005453-4057qib7	12441	14	(	(	-LRB-
cord-005453-4057qib7	12441	15	55.6	55.6	CD
cord-005453-4057qib7	12441	16	%	%	NN
cord-005453-4057qib7	12441	17	)	)	-RRB-
cord-005453-4057qib7	12441	18	maintained	maintain	VBD
cord-005453-4057qib7	12441	19	the	the	DT
cord-005453-4057qib7	12441	20	pre	pre	JJ
cord-005453-4057qib7	12441	21	-	-	JJ
cord-005453-4057qib7	12441	22	HSCT	hsct	JJ
cord-005453-4057qib7	12441	23	response	response	NN
cord-005453-4057qib7	12441	24	.	.	.
cord-005453-4057qib7	12442	1	During	during	IN
cord-005453-4057qib7	12442	2	the	the	DT
cord-005453-4057qib7	12442	3	last	last	JJ
cord-005453-4057qib7	12442	4	period	period	NN
cord-005453-4057qib7	12442	5	of	of	IN
cord-005453-4057qib7	12442	6	time	time	NN
cord-005453-4057qib7	12442	7	,	,	,
cord-005453-4057qib7	12442	8	37	37	CD
cord-005453-4057qib7	12442	9	pts	pt	NNS
cord-005453-4057qib7	12442	10	started	start	VBD
cord-005453-4057qib7	12442	11	on	on	IN
cord-005453-4057qib7	12442	12	post	post	JJ
cord-005453-4057qib7	12442	13	-	-	JJ
cord-005453-4057qib7	12442	14	HSCT	hsct	JJ
cord-005453-4057qib7	12442	15	maintenance	maintenance	NN
cord-005453-4057qib7	12442	16	/	/	SYM
cord-005453-4057qib7	12442	17	consolidation	consolidation	NN
cord-005453-4057qib7	12442	18	,	,	,
cord-005453-4057qib7	12442	19	mainly	mainly	RB
cord-005453-4057qib7	12442	20	with	with	IN
cord-005453-4057qib7	12442	21	lenalidomide	lenalidomide	NN
cord-005453-4057qib7	12442	22	.	.	.
cord-005453-4057qib7	12443	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12443	2	:	:	:
cord-005453-4057qib7	12444	1	1	1	LS
cord-005453-4057qib7	12444	2	)	)	-RRB-
cord-005453-4057qib7	12444	3	With	with	IN
cord-005453-4057qib7	12444	4	the	the	DT
cord-005453-4057qib7	12444	5	new	new	JJ
cord-005453-4057qib7	12444	6	chemotherapeutic	chemotherapeutic	JJ
cord-005453-4057qib7	12444	7	schemes	scheme	NNS
cord-005453-4057qib7	12444	8	,	,	,
cord-005453-4057qib7	12444	9	76.5	76.5	CD
cord-005453-4057qib7	12444	10	%	%	NN
cord-005453-4057qib7	12444	11	of	of	IN
cord-005453-4057qib7	12444	12	patients	patient	NNS
cord-005453-4057qib7	12444	13	underwent	undergo	VBD
cord-005453-4057qib7	12444	14	HSCT	HSCT	NNP
cord-005453-4057qib7	12444	15	in	in	IN
cord-005453-4057qib7	12444	16	CR	CR	NNP
cord-005453-4057qib7	12444	17	or	or	CC
cord-005453-4057qib7	12444	18	VGPR	VGPR	NNP
cord-005453-4057qib7	12444	19	;	;	:
cord-005453-4057qib7	12445	1	2	2	LS
cord-005453-4057qib7	12445	2	)	)	-RRB-
cord-005453-4057qib7	12445	3	Majority	majority	NN
cord-005453-4057qib7	12445	4	of	of	IN
cord-005453-4057qib7	12445	5	pts	pts	NNP
cord-005453-4057qib7	12445	6	(	(	-LRB-
cord-005453-4057qib7	12445	7	93.2	93.2	CD
cord-005453-4057qib7	12445	8	%	%	NN
cord-005453-4057qib7	12445	9	)	)	-RRB-
cord-005453-4057qib7	12445	10	consolidated	consolidate	VBN
cord-005453-4057qib7	12445	11	or	or	CC
cord-005453-4057qib7	12445	12	improved	improve	VBD
cord-005453-4057qib7	12445	13	the	the	DT
cord-005453-4057qib7	12445	14	pre	pre	JJ
cord-005453-4057qib7	12445	15	-	-	JJ
cord-005453-4057qib7	12445	16	HSCT	hsct	JJ
cord-005453-4057qib7	12445	17	response	response	NN
cord-005453-4057qib7	12446	1	;	;	:
cord-005453-4057qib7	12446	2	3	3	LS
cord-005453-4057qib7	12446	3	)	)	-RRB-
cord-005453-4057qib7	12446	4	CR	cr	NN
cord-005453-4057qib7	12446	5	increased	increase	VBD
cord-005453-4057qib7	12446	6	substantially	substantially	RB
cord-005453-4057qib7	12446	7	(	(	-LRB-
cord-005453-4057qib7	12446	8	2.64	2.64	CD
cord-005453-4057qib7	12446	9	times	time	NNS
cord-005453-4057qib7	12446	10	)	)	-RRB-
cord-005453-4057qib7	12446	11	after	after	IN
cord-005453-4057qib7	12446	12	transplant	transplant	NN
cord-005453-4057qib7	12446	13	;	;	:
cord-005453-4057qib7	12446	14	4	4	LS
cord-005453-4057qib7	12446	15	)	)	-RRB-
cord-005453-4057qib7	12446	16	Optimized	optimize	VBN
cord-005453-4057qib7	12446	17	induction	induction	NN
cord-005453-4057qib7	12446	18	regimens	regimen	NNS
cord-005453-4057qib7	12446	19	,	,	,
cord-005453-4057qib7	12446	20	along	along	IN
cord-005453-4057qib7	12446	21	with	with	IN
cord-005453-4057qib7	12446	22	auto	auto	NN
cord-005453-4057qib7	12446	23	-	-	HYPH
cord-005453-4057qib7	12446	24	HSCT	HSCT	NNP
cord-005453-4057qib7	12446	25	followed	follow	VBD
cord-005453-4057qib7	12446	26	by	by	IN
cord-005453-4057qib7	12446	27	the	the	DT
cord-005453-4057qib7	12446	28	recently	recently	RB
cord-005453-4057qib7	12446	29	licensed	license	VBN
cord-005453-4057qib7	12446	30	use	use	NN
cord-005453-4057qib7	12446	31	of	of	IN
cord-005453-4057qib7	12446	32	maintenance	maintenance	NN
cord-005453-4057qib7	12446	33	therapy	therapy	NN
cord-005453-4057qib7	12446	34	with	with	IN
cord-005453-4057qib7	12446	35	lenalidomide	lenalidomide	NN
cord-005453-4057qib7	12446	36	,	,	,
cord-005453-4057qib7	12446	37	might	may	MD
cord-005453-4057qib7	12446	38	result	result	VB
cord-005453-4057qib7	12446	39	in	in	IN
cord-005453-4057qib7	12446	40	a	a	DT
cord-005453-4057qib7	12446	41	better	well	JJR
cord-005453-4057qib7	12446	42	PFS	PFS	NNP
cord-005453-4057qib7	12446	43	of	of	IN
cord-005453-4057qib7	12446	44	patients	patient	NNS
cord-005453-4057qib7	12446	45	with	with	IN
cord-005453-4057qib7	12446	46	MM	MM	NNP
cord-005453-4057qib7	12446	47	.	.	.
cord-005453-4057qib7	12447	1	Background	background	NN
cord-005453-4057qib7	12447	2	:	:	:
cord-005453-4057qib7	12448	1	Autologous	autologous	JJ
cord-005453-4057qib7	12448	2	stem	stem	NN
cord-005453-4057qib7	12448	3	cell	cell	NN
cord-005453-4057qib7	12448	4	transplantation	transplantation	NN
cord-005453-4057qib7	12448	5	(	(	-LRB-
cord-005453-4057qib7	12448	6	ASCT	ASCT	NNP
cord-005453-4057qib7	12448	7	)	)	-RRB-
cord-005453-4057qib7	12448	8	is	be	VBZ
cord-005453-4057qib7	12448	9	commonly	commonly	RB
cord-005453-4057qib7	12448	10	used	use	VBN
cord-005453-4057qib7	12448	11	in	in	IN
cord-005453-4057qib7	12448	12	treatment	treatment	NN
cord-005453-4057qib7	12448	13	of	of	IN
cord-005453-4057qib7	12448	14	patients	patient	NNS
cord-005453-4057qib7	12448	15	over	over	IN
cord-005453-4057qib7	12448	16	65	65	CD
cord-005453-4057qib7	12448	17	years	year	NNS
cord-005453-4057qib7	12448	18	with	with	IN
cord-005453-4057qib7	12448	19	multiple	multiple	JJ
cord-005453-4057qib7	12448	20	myeloma	myeloma	NN
cord-005453-4057qib7	12448	21	(	(	-LRB-
cord-005453-4057qib7	12448	22	MM	MM	NNP
cord-005453-4057qib7	12448	23	)	)	-RRB-
cord-005453-4057qib7	12448	24	,	,	,
cord-005453-4057qib7	12448	25	however	however	RB
cord-005453-4057qib7	12448	26	the	the	DT
cord-005453-4057qib7	12448	27	safety	safety	NN
cord-005453-4057qib7	12448	28	and	and	CC
cord-005453-4057qib7	12448	29	efficacy	efficacy	NN
cord-005453-4057qib7	12448	30	of	of	IN
cord-005453-4057qib7	12448	31	this	this	DT
cord-005453-4057qib7	12448	32	procedure	procedure	NN
cord-005453-4057qib7	12448	33	is	be	VBZ
cord-005453-4057qib7	12448	34	debatable	debatable	JJ
cord-005453-4057qib7	12448	35	.	.	.
cord-005453-4057qib7	12449	1	Methods	method	NNS
cord-005453-4057qib7	12449	2	:	:	:
cord-005453-4057qib7	12449	3	We	-PRON-	PRP
cord-005453-4057qib7	12449	4	conducted	conduct	VBD
cord-005453-4057qib7	12449	5	a	a	DT
cord-005453-4057qib7	12449	6	retrospective	retrospective	JJ
cord-005453-4057qib7	12449	7	review	review	NN
cord-005453-4057qib7	12449	8	of	of	IN
cord-005453-4057qib7	12449	9	MM	MM	NNP
cord-005453-4057qib7	12449	10	patients	patient	NNS
cord-005453-4057qib7	12449	11	who	who	WP
cord-005453-4057qib7	12449	12	underwent	undergo	VBD
cord-005453-4057qib7	12449	13	ASCT	ASCT	NNP
cord-005453-4057qib7	12449	14	from	from	IN
cord-005453-4057qib7	12449	15	2013	2013	CD
cord-005453-4057qib7	12449	16	to	to	IN
cord-005453-4057qib7	12449	17	2018	2018	CD
cord-005453-4057qib7	12449	18	at	at	IN
cord-005453-4057qib7	12449	19	our	-PRON-	PRP$
cord-005453-4057qib7	12449	20	institution	institution	NN
cord-005453-4057qib7	12449	21	.	.	.
cord-005453-4057qib7	12450	1	The	the	DT
cord-005453-4057qib7	12450	2	purpose	purpose	NN
cord-005453-4057qib7	12450	3	of	of	IN
cord-005453-4057qib7	12450	4	this	this	DT
cord-005453-4057qib7	12450	5	retrospective	retrospective	JJ
cord-005453-4057qib7	12450	6	study	study	NN
cord-005453-4057qib7	12450	7	was	be	VBD
cord-005453-4057qib7	12450	8	to	to	TO
cord-005453-4057qib7	12450	9	compare	compare	VB
cord-005453-4057qib7	12450	10	the	the	DT
cord-005453-4057qib7	12450	11	100-day	100-day	JJ
cord-005453-4057qib7	12450	12	mortality	mortality	NN
cord-005453-4057qib7	12450	13	,	,	,
cord-005453-4057qib7	12450	14	time	time	NN
cord-005453-4057qib7	12450	15	to	to	IN
cord-005453-4057qib7	12450	16	engraftment	engraftment	NN
cord-005453-4057qib7	12450	17	,	,	,
cord-005453-4057qib7	12450	18	and	and	CC
cord-005453-4057qib7	12450	19	incidence	incidence	NN
cord-005453-4057qib7	12450	20	of	of	IN
cord-005453-4057qib7	12450	21	grade	grade	NN
cord-005453-4057qib7	12450	22	1	1	CD
cord-005453-4057qib7	12450	23	-	-	SYM
cord-005453-4057qib7	12450	24	4	4	CD
cord-005453-4057qib7	12450	25	toxicities	toxicity	NNS
cord-005453-4057qib7	12450	26	in	in	IN
cord-005453-4057qib7	12450	27	elderly	elderly	JJ
cord-005453-4057qib7	12450	28	MM	MM	NNP
cord-005453-4057qib7	12450	29	patients	patient	NNS
cord-005453-4057qib7	12450	30	with	with	IN
cord-005453-4057qib7	12450	31	younger	young	JJR
cord-005453-4057qib7	12450	32	patients	patient	NNS
cord-005453-4057qib7	12450	33	taking	take	VBG
cord-005453-4057qib7	12450	34	into	into	IN
cord-005453-4057qib7	12450	35	account	account	NN
cord-005453-4057qib7	12450	36	comorbidity	comorbidity	NN
cord-005453-4057qib7	12450	37	information	information	NN
cord-005453-4057qib7	12450	38	.	.	.
cord-005453-4057qib7	12451	1	Other	other	JJ
cord-005453-4057qib7	12451	2	secondary	secondary	JJ
cord-005453-4057qib7	12451	3	end	end	NN
cord-005453-4057qib7	12451	4	points	point	NNS
cord-005453-4057qib7	12451	5	measured	measure	VBN
cord-005453-4057qib7	12451	6	were	be	VBD
cord-005453-4057qib7	12451	7	overall	overall	JJ
cord-005453-4057qib7	12451	8	survival	survival	NN
cord-005453-4057qib7	12451	9	(	(	-LRB-
cord-005453-4057qib7	12451	10	OS	OS	NNP
cord-005453-4057qib7	12451	11	)	)	-RRB-
cord-005453-4057qib7	12451	12	and	and	CC
cord-005453-4057qib7	12451	13	progression	progression	NN
cord-005453-4057qib7	12451	14	-	-	HYPH
cord-005453-4057qib7	12451	15	free	free	JJ
cord-005453-4057qib7	12451	16	survival	survival	NN
cord-005453-4057qib7	12451	17	(	(	-LRB-
cord-005453-4057qib7	12451	18	PFS	PFS	NNP
cord-005453-4057qib7	12451	19	)	)	-RRB-
cord-005453-4057qib7	12451	20	.	.	.
cord-005453-4057qib7	12452	1	Results	result	NNS
cord-005453-4057qib7	12452	2	:	:	:
cord-005453-4057qib7	12453	1	A	a	DT
cord-005453-4057qib7	12453	2	total	total	NN
cord-005453-4057qib7	12453	3	of	of	IN
cord-005453-4057qib7	12453	4	95	95	CD
cord-005453-4057qib7	12453	5	patients	patient	NNS
cord-005453-4057qib7	12453	6	were	be	VBD
cord-005453-4057qib7	12453	7	analysed	analyse	VBN
cord-005453-4057qib7	12453	8	and	and	CC
cord-005453-4057qib7	12453	9	categorized	categorize	VBN
cord-005453-4057qib7	12453	10	by	by	IN
cord-005453-4057qib7	12453	11	age	age	NN
cord-005453-4057qib7	12453	12	as	as	IN
cord-005453-4057qib7	12453	13	young	young	JJ
cord-005453-4057qib7	12453	14	patients	patient	NNS
cord-005453-4057qib7	12453	15	(	(	-LRB-
cord-005453-4057qib7	12453	16	37	37	CD
cord-005453-4057qib7	12453	17	to	to	TO
cord-005453-4057qib7	12453	18	64	64	CD
cord-005453-4057qib7	12453	19	y	y	NN
cord-005453-4057qib7	12453	20	;	;	:
cord-005453-4057qib7	12453	21	n=70	n=70	NNP
cord-005453-4057qib7	12453	22	)	)	-RRB-
cord-005453-4057qib7	12453	23	or	or	CC
cord-005453-4057qib7	12453	24	elderly	elderly	JJ
cord-005453-4057qib7	12453	25	(	(	-LRB-
cord-005453-4057qib7	12453	26	65	65	CD
cord-005453-4057qib7	12453	27	to	to	TO
cord-005453-4057qib7	12453	28	71	71	CD
cord-005453-4057qib7	12453	29	y	y	NN
cord-005453-4057qib7	12453	30	;	;	:
cord-005453-4057qib7	12454	1	n=25	n=25	NNP
cord-005453-4057qib7	12454	2	)	)	-RRB-
cord-005453-4057qib7	12454	3	.	.	.
cord-005453-4057qib7	12455	1	The	the	DT
cord-005453-4057qib7	12455	2	compared	compare	VBN
cord-005453-4057qib7	12455	3	groups	group	NNS
cord-005453-4057qib7	12455	4	did	do	VBD
cord-005453-4057qib7	12455	5	not	not	RB
cord-005453-4057qib7	12455	6	differ	differ	VB
cord-005453-4057qib7	12455	7	in	in	IN
cord-005453-4057qib7	12455	8	terms	term	NNS
cord-005453-4057qib7	12455	9	of	of	IN
cord-005453-4057qib7	12455	10	gender	gender	NN
cord-005453-4057qib7	12455	11	,	,	,
cord-005453-4057qib7	12455	12	ECOG	ECOG	NNP
cord-005453-4057qib7	12455	13	,	,	,
cord-005453-4057qib7	12455	14	HCT	hct	NN
cord-005453-4057qib7	12455	15	-	-	HYPH
cord-005453-4057qib7	12455	16	specific	specific	JJ
cord-005453-4057qib7	12455	17	comorbidity	comorbidity	NN
cord-005453-4057qib7	12455	18	index	index	NN
cord-005453-4057qib7	12455	19	(	(	-LRB-
cord-005453-4057qib7	12455	20	HCT	HCT	NNP
cord-005453-4057qib7	12455	21	-	-	HYPH
cord-005453-4057qib7	12455	22	CI	CI	NNP
cord-005453-4057qib7	12455	23	)	)	-RRB-
cord-005453-4057qib7	12455	24	,	,	,
cord-005453-4057qib7	12455	25	and	and	CC
cord-005453-4057qib7	12455	26	disease	disease	NN
cord-005453-4057qib7	12455	27	status	status	NN
cord-005453-4057qib7	12455	28	at	at	IN
cord-005453-4057qib7	12455	29	ASCT	ASCT	NNP
cord-005453-4057qib7	12455	30	.	.	.
cord-005453-4057qib7	12456	1	Melphalan	Melphalan	NNP
cord-005453-4057qib7	12456	2	in	in	IN
cord-005453-4057qib7	12456	3	a	a	DT
cord-005453-4057qib7	12456	4	dose	dose	NN
cord-005453-4057qib7	12456	5	of	of	IN
cord-005453-4057qib7	12456	6	200	200	CD
cord-005453-4057qib7	12456	7	mg	mg	NNP
cord-005453-4057qib7	12456	8	/	/	SYM
cord-005453-4057qib7	12456	9	m	m	NNP
cord-005453-4057qib7	12456	10	2	2	CD
cord-005453-4057qib7	12456	11	was	be	VBD
cord-005453-4057qib7	12456	12	used	use	VBN
cord-005453-4057qib7	12456	13	as	as	IN
cord-005453-4057qib7	12456	14	preparative	preparative	JJ
cord-005453-4057qib7	12456	15	regimen	regimen	NN
cord-005453-4057qib7	12456	16	in	in	IN
cord-005453-4057qib7	12456	17	65	65	CD
cord-005453-4057qib7	12456	18	%	%	NN
cord-005453-4057qib7	12456	19	of	of	IN
cord-005453-4057qib7	12456	20	younger	young	JJR
cord-005453-4057qib7	12456	21	patients	patient	NNS
cord-005453-4057qib7	12456	22	,	,	,
cord-005453-4057qib7	12456	23	and	and	CC
cord-005453-4057qib7	12456	24	in	in	IN
cord-005453-4057qib7	12456	25	43	43	CD
cord-005453-4057qib7	12456	26	%	%	NN
cord-005453-4057qib7	12456	27	of	of	IN
cord-005453-4057qib7	12456	28	the	the	DT
cord-005453-4057qib7	12456	29	elderly	elderly	JJ
cord-005453-4057qib7	12456	30	(	(	-LRB-
cord-005453-4057qib7	12456	31	p=	p=	NNP
cord-005453-4057qib7	12456	32	0.18	0.18	CD
cord-005453-4057qib7	12456	33	)	)	-RRB-
cord-005453-4057qib7	12456	34	.	.	.
cord-005453-4057qib7	12457	1	The	the	DT
cord-005453-4057qib7	12457	2	remaining	remain	VBG
cord-005453-4057qib7	12457	3	patients	patient	NNS
cord-005453-4057qib7	12457	4	received	receive	VBD
cord-005453-4057qib7	12457	5	140	140	CD
cord-005453-4057qib7	12457	6	mg	mg	NNP
cord-005453-4057qib7	12457	7	/	/	SYM
cord-005453-4057qib7	12457	8	m2	m2	NNP
cord-005453-4057qib7	12457	9	of	of	IN
cord-005453-4057qib7	12457	10	melphalan	melphalan	NNP
cord-005453-4057qib7	12457	11	or	or	CC
cord-005453-4057qib7	12457	12	lower	low	JJR
cord-005453-4057qib7	12457	13	dose	dose	NN
cord-005453-4057qib7	12457	14	(	(	-LRB-
cord-005453-4057qib7	12458	1	range	range	NNP
cord-005453-4057qib7	12458	2	,	,	,
cord-005453-4057qib7	12458	3	100	100	CD
cord-005453-4057qib7	12458	4	-	-	SYM
cord-005453-4057qib7	12458	5	140	140	CD
cord-005453-4057qib7	12458	6	mg	mg	NNP
cord-005453-4057qib7	12458	7	/	/	SYM
cord-005453-4057qib7	12458	8	m	m	NNP
cord-005453-4057qib7	12458	9	2	2	CD
cord-005453-4057qib7	12458	10	)	)	-RRB-
cord-005453-4057qib7	12458	11	due	due	IN
cord-005453-4057qib7	12458	12	to	to	IN
cord-005453-4057qib7	12458	13	HCT	HCT	NNP
cord-005453-4057qib7	12458	14	-	-	HYPH
cord-005453-4057qib7	12458	15	CI	ci	NN
cord-005453-4057qib7	12459	1	>	>	XX
cord-005453-4057qib7	12459	2	2	2	CD
cord-005453-4057qib7	12459	3	or	or	CC
cord-005453-4057qib7	12459	4	age	age	NN
cord-005453-4057qib7	12459	5	,	,	,
cord-005453-4057qib7	12459	6	on	on	IN
cord-005453-4057qib7	12459	7	the	the	DT
cord-005453-4057qib7	12459	8	physician	physician	NN
cord-005453-4057qib7	12459	9	discretion	discretion	NN
cord-005453-4057qib7	12459	10	.	.	.
cord-005453-4057qib7	12460	1	In	in	IN
cord-005453-4057qib7	12460	2	the	the	DT
cord-005453-4057qib7	12460	3	whole	whole	JJ
cord-005453-4057qib7	12460	4	study	study	NN
cord-005453-4057qib7	12460	5	group	group	NN
cord-005453-4057qib7	12460	6	there	there	EX
cord-005453-4057qib7	12460	7	were	be	VBD
cord-005453-4057qib7	12460	8	no	no	DT
cord-005453-4057qib7	12460	9	transplant	transplant	NN
cord-005453-4057qib7	12460	10	related	relate	VBN
cord-005453-4057qib7	12460	11	deaths	death	NNS
cord-005453-4057qib7	12460	12	within	within	IN
cord-005453-4057qib7	12460	13	the	the	DT
cord-005453-4057qib7	12460	14	first	first	JJ
cord-005453-4057qib7	12460	15	100	100	CD
cord-005453-4057qib7	12460	16	days	day	NNS
cord-005453-4057qib7	12460	17	of	of	IN
cord-005453-4057qib7	12460	18	ASCT	ASCT	NNP
cord-005453-4057qib7	12460	19	.	.	.
cord-005453-4057qib7	12461	1	Stratifying	stratify	VBG
cord-005453-4057qib7	12461	2	by	by	IN
cord-005453-4057qib7	12461	3	age	age	NN
cord-005453-4057qib7	12461	4	,	,	,
cord-005453-4057qib7	12461	5	there	there	EX
cord-005453-4057qib7	12461	6	was	be	VBD
cord-005453-4057qib7	12461	7	no	no	DT
cord-005453-4057qib7	12461	8	statistically	statistically	RB
cord-005453-4057qib7	12461	9	significant	significant	JJ
cord-005453-4057qib7	12461	10	difference	difference	NN
cord-005453-4057qib7	12461	11	concerning	concern	VBG
cord-005453-4057qib7	12461	12	febrile	febrile	JJ
cord-005453-4057qib7	12461	13	neutropenia	neutropenia	NN
cord-005453-4057qib7	12461	14	(	(	-LRB-
cord-005453-4057qib7	12461	15	FN	FN	NNP
cord-005453-4057qib7	12461	16	)	)	-RRB-
cord-005453-4057qib7	12461	17	incidence	incidence	NN
cord-005453-4057qib7	12461	18	,	,	,
cord-005453-4057qib7	12461	19	which	which	WDT
cord-005453-4057qib7	12461	20	was	be	VBD
cord-005453-4057qib7	12461	21	observed	observe	VBN
cord-005453-4057qib7	12461	22	in	in	IN
cord-005453-4057qib7	12461	23	14	14	CD
cord-005453-4057qib7	12461	24	%	%	NN
cord-005453-4057qib7	12461	25	of	of	IN
cord-005453-4057qib7	12461	26	younger	young	JJR
cord-005453-4057qib7	12461	27	patients	patient	NNS
cord-005453-4057qib7	12461	28	,	,	,
cord-005453-4057qib7	12461	29	and	and	CC
cord-005453-4057qib7	12461	30	17	17	CD
cord-005453-4057qib7	12461	31	%	%	NN
cord-005453-4057qib7	12461	32	of	of	IN
cord-005453-4057qib7	12461	33	elderly	elderly	JJ
cord-005453-4057qib7	12461	34	.	.	.
cord-005453-4057qib7	12462	1	In	in	IN
cord-005453-4057qib7	12462	2	contrast	contrast	NN
cord-005453-4057qib7	12462	3	,	,	,
cord-005453-4057qib7	12462	4	FN	FN	NNP
cord-005453-4057qib7	12462	5	was	be	VBD
cord-005453-4057qib7	12462	6	observed	observe	VBN
cord-005453-4057qib7	12462	7	more	more	RBR
cord-005453-4057qib7	12462	8	frequently	frequently	RB
cord-005453-4057qib7	12462	9	in	in	IN
cord-005453-4057qib7	12462	10	patients	patient	NNS
cord-005453-4057qib7	12462	11	with	with	IN
cord-005453-4057qib7	12462	12	HCT	HCT	NNP
cord-005453-4057qib7	12462	13	-	-	HYPH
cord-005453-4057qib7	12462	14	CI	ci	NN
cord-005453-4057qib7	12462	15	>	>	XX
cord-005453-4057qib7	12462	16	2	2	CD
cord-005453-4057qib7	12462	17	(	(	-LRB-
cord-005453-4057qib7	12462	18	38	38	CD
cord-005453-4057qib7	12462	19	%	%	NN
cord-005453-4057qib7	12462	20	vs	vs	IN
cord-005453-4057qib7	12462	21	12	12	CD
cord-005453-4057qib7	12462	22	%	%	NN
cord-005453-4057qib7	12462	23	,	,	,
cord-005453-4057qib7	12462	24	p=0.05	p=0.05	NNP
cord-005453-4057qib7	12462	25	)	)	-RRB-
cord-005453-4057qib7	12462	26	.	.	.
cord-005453-4057qib7	12463	1	Grade	grade	NN
cord-005453-4057qib7	12463	2	1	1	CD
cord-005453-4057qib7	12463	3	-	-	SYM
cord-005453-4057qib7	12463	4	2	2	CD
cord-005453-4057qib7	12463	5	infections	infection	NNS
cord-005453-4057qib7	12463	6	were	be	VBD
cord-005453-4057qib7	12463	7	more	more	RBR
cord-005453-4057qib7	12463	8	frequent	frequent	JJ
cord-005453-4057qib7	12463	9	in	in	IN
cord-005453-4057qib7	12463	10	older	old	JJR
cord-005453-4057qib7	12463	11	patients	patient	NNS
cord-005453-4057qib7	12463	12	(	(	-LRB-
cord-005453-4057qib7	12463	13	35	35	CD
cord-005453-4057qib7	12463	14	%	%	NN
cord-005453-4057qib7	12463	15	vs	vs	IN
cord-005453-4057qib7	12463	16	5	5	CD
cord-005453-4057qib7	12463	17	%	%	NN
cord-005453-4057qib7	12463	18	,	,	,
cord-005453-4057qib7	12463	19	p=	p=	NNP
cord-005453-4057qib7	12463	20	0.005	0.005	CD
cord-005453-4057qib7	12463	21	)	)	-RRB-
cord-005453-4057qib7	12463	22	,	,	,
cord-005453-4057qib7	12463	23	but	but	CC
cord-005453-4057qib7	12463	24	no	no	DT
cord-005453-4057qib7	12463	25	difference	difference	NN
cord-005453-4057qib7	12463	26	was	be	VBD
cord-005453-4057qib7	12463	27	found	find	VBN
cord-005453-4057qib7	12463	28	in	in	IN
cord-005453-4057qib7	12463	29	grade	grade	NN
cord-005453-4057qib7	12463	30	3	3	CD
cord-005453-4057qib7	12463	31	-	-	SYM
cord-005453-4057qib7	12463	32	4	4	CD
cord-005453-4057qib7	12463	33	infections	infection	NNS
cord-005453-4057qib7	12463	34	incidence	incidence	NN
cord-005453-4057qib7	12463	35	rate	rate	NN
cord-005453-4057qib7	12463	36	such	such	JJ
cord-005453-4057qib7	12463	37	as	as	IN
cord-005453-4057qib7	12463	38	pneumonia	pneumonia	NN
cord-005453-4057qib7	12463	39	,	,	,
cord-005453-4057qib7	12463	40	uroinfections	uroinfection	NNS
cord-005453-4057qib7	12463	41	and	and	CC
cord-005453-4057qib7	12463	42	neutropenic	neutropenic	JJ
cord-005453-4057qib7	12463	43	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	12463	44	(	(	-LRB-
cord-005453-4057qib7	12463	45	25	25	CD
cord-005453-4057qib7	12463	46	%	%	NN
cord-005453-4057qib7	12463	47	vs	vs	IN
cord-005453-4057qib7	12463	48	35	35	CD
cord-005453-4057qib7	12463	49	%	%	NN
cord-005453-4057qib7	12463	50	,	,	,
cord-005453-4057qib7	12463	51	p=0.52	p=0.52	NNP
cord-005453-4057qib7	12463	52	)	)	-RRB-
cord-005453-4057qib7	12463	53	,	,	,
cord-005453-4057qib7	12463	54	nor	nor	CC
cord-005453-4057qib7	12463	55	grade	grade	NN
cord-005453-4057qib7	12463	56	1	1	CD
cord-005453-4057qib7	12463	57	-	-	SYM
cord-005453-4057qib7	12463	58	2	2	CD
cord-005453-4057qib7	12463	59	and	and	CC
cord-005453-4057qib7	12463	60	3	3	CD
cord-005453-4057qib7	12463	61	-	-	SYM
cord-005453-4057qib7	12463	62	4	4	CD
cord-005453-4057qib7	12463	63	noninfectious	noninfectious	JJ
cord-005453-4057qib7	12463	64	toxicities	toxicity	NNS
cord-005453-4057qib7	12463	65	(	(	-LRB-
cord-005453-4057qib7	12463	66	50	50	CD
cord-005453-4057qib7	12463	67	%	%	NN
cord-005453-4057qib7	12463	68	vs	vs	IN
cord-005453-4057qib7	12463	69	38	38	CD
cord-005453-4057qib7	12463	70	%	%	NN
cord-005453-4057qib7	12463	71	,	,	,
cord-005453-4057qib7	12463	72	p=0.31	p=0.31	NNP
cord-005453-4057qib7	12463	73	,	,	,
cord-005453-4057qib7	12463	74	and	and	CC
cord-005453-4057qib7	12463	75	4	4	CD
cord-005453-4057qib7	12463	76	%	%	NN
cord-005453-4057qib7	12463	77	vs	vs	IN
cord-005453-4057qib7	12463	78	21	21	CD
cord-005453-4057qib7	12463	79	%	%	NN
cord-005453-4057qib7	12463	80	,	,	,
cord-005453-4057qib7	12463	81	p=0.06	p=0.06	JJ
cord-005453-4057qib7	12463	82	,	,	,
cord-005453-4057qib7	12463	83	respectively	respectively	RB
cord-005453-4057qib7	12463	84	)	)	-RRB-
cord-005453-4057qib7	12463	85	.	.	.
cord-005453-4057qib7	12464	1	The	the	DT
cord-005453-4057qib7	12464	2	median	median	JJ
cord-005453-4057qib7	12464	3	time	time	NN
cord-005453-4057qib7	12464	4	to	to	IN
cord-005453-4057qib7	12464	5	granulocyte	granulocyte	NNP
cord-005453-4057qib7	12464	6	engraftment	engraftment	NNP
cord-005453-4057qib7	12464	7	was	be	VBD
cord-005453-4057qib7	12464	8	11	11	CD
cord-005453-4057qib7	12464	9	days	day	NNS
cord-005453-4057qib7	12464	10	(	(	-LRB-
cord-005453-4057qib7	12464	11	range	range	NN
cord-005453-4057qib7	12464	12	,	,	,
cord-005453-4057qib7	12464	13	9	9	CD
cord-005453-4057qib7	12464	14	-	-	SYM
cord-005453-4057qib7	12464	15	19	19	CD
cord-005453-4057qib7	12464	16	days	day	NNS
cord-005453-4057qib7	12464	17	)	)	-RRB-
cord-005453-4057qib7	12464	18	in	in	IN
cord-005453-4057qib7	12464	19	elderly	elderly	JJ
cord-005453-4057qib7	12464	20	and	and	CC
cord-005453-4057qib7	12464	21	was	be	VBD
cord-005453-4057qib7	12464	22	comparable	comparable	JJ
cord-005453-4057qib7	12464	23	with	with	IN
cord-005453-4057qib7	12464	24	younger	young	JJR
cord-005453-4057qib7	12464	25	patients	patient	NNS
cord-005453-4057qib7	12464	26	.	.	.
cord-005453-4057qib7	12465	1	The	the	DT
cord-005453-4057qib7	12465	2	time	time	NN
cord-005453-4057qib7	12465	3	to	to	IN
cord-005453-4057qib7	12465	4	platelet	platelet	NN
cord-005453-4057qib7	12465	5	recovery	recovery	NN
cord-005453-4057qib7	12465	6	was	be	VBD
cord-005453-4057qib7	12465	7	also	also	RB
cord-005453-4057qib7	12465	8	similar	similar	JJ
cord-005453-4057qib7	12465	9	.	.	.
cord-005453-4057qib7	12466	1	After	after	IN
cord-005453-4057qib7	12466	2	the	the	DT
cord-005453-4057qib7	12466	3	median	median	JJ
cord-005453-4057qib7	12466	4	follow	follow	NN
cord-005453-4057qib7	12466	5	-	-	HYPH
cord-005453-4057qib7	12466	6	up	up	NN
cord-005453-4057qib7	12466	7	of	of	IN
cord-005453-4057qib7	12466	8	12	12	CD
cord-005453-4057qib7	12466	9	months	month	NNS
cord-005453-4057qib7	12466	10	for	for	IN
cord-005453-4057qib7	12466	11	survivors	survivor	NNS
cord-005453-4057qib7	12466	12	,	,	,
cord-005453-4057qib7	12466	13	OS	OS	NNP
cord-005453-4057qib7	12466	14	at	at	IN
cord-005453-4057qib7	12466	15	18	18	CD
cord-005453-4057qib7	12466	16	months	month	NNS
cord-005453-4057qib7	12466	17	was	be	VBD
cord-005453-4057qib7	12466	18	94	94	CD
cord-005453-4057qib7	12466	19	%	%	NN
cord-005453-4057qib7	12466	20	in	in	IN
cord-005453-4057qib7	12466	21	both	both	DT
cord-005453-4057qib7	12466	22	groups	group	NNS
cord-005453-4057qib7	12466	23	.	.	.
cord-005453-4057qib7	12467	1	PFS	PFS	NNP
cord-005453-4057qib7	12467	2	at	at	IN
cord-005453-4057qib7	12467	3	18	18	CD
cord-005453-4057qib7	12467	4	moths	moth	NNS
cord-005453-4057qib7	12467	5	was	be	VBD
cord-005453-4057qib7	12467	6	65	65	CD
cord-005453-4057qib7	12467	7	%	%	NN
cord-005453-4057qib7	12467	8	for	for	IN
cord-005453-4057qib7	12467	9	younger	young	JJR
cord-005453-4057qib7	12467	10	patients	patient	NNS
cord-005453-4057qib7	12467	11	,	,	,
cord-005453-4057qib7	12467	12	and	and	CC
cord-005453-4057qib7	12467	13	55	55	CD
cord-005453-4057qib7	12467	14	%	%	NN
cord-005453-4057qib7	12467	15	for	for	IN
cord-005453-4057qib7	12467	16	elderly	elderly	JJ
cord-005453-4057qib7	12467	17	(	(	-LRB-
cord-005453-4057qib7	12467	18	p=0.86).However	p=0.86).however	UH
cord-005453-4057qib7	12467	19	,	,	,
cord-005453-4057qib7	12467	20	the	the	DT
cord-005453-4057qib7	12467	21	association	association	NN
cord-005453-4057qib7	12467	22	between	between	IN
cord-005453-4057qib7	12467	23	PFS	PFS	NNP
cord-005453-4057qib7	12467	24	and	and	CC
cord-005453-4057qib7	12467	25	the	the	DT
cord-005453-4057qib7	12467	26	dose	dose	NN
cord-005453-4057qib7	12467	27	of	of	IN
cord-005453-4057qib7	12467	28	melphalan	melphalan	NNP
cord-005453-4057qib7	12467	29	used	use	VBN
cord-005453-4057qib7	12467	30	in	in	IN
cord-005453-4057qib7	12467	31	conditioning	conditioning	NN
cord-005453-4057qib7	12467	32	was	be	VBD
cord-005453-4057qib7	12467	33	observed	observe	VBN
cord-005453-4057qib7	12467	34	.	.	.
cord-005453-4057qib7	12468	1	PFS	PFS	NNP
cord-005453-4057qib7	12468	2	probability	probability	NN
cord-005453-4057qib7	12468	3	at	at	IN
cord-005453-4057qib7	12468	4	18	18	CD
cord-005453-4057qib7	12468	5	months	month	NNS
cord-005453-4057qib7	12468	6	for	for	IN
cord-005453-4057qib7	12468	7	patients	patient	NNS
cord-005453-4057qib7	12468	8	conditioned	condition	VBN
cord-005453-4057qib7	12468	9	with	with	IN
cord-005453-4057qib7	12468	10	the	the	DT
cord-005453-4057qib7	12468	11	dose	dose	NN
cord-005453-4057qib7	12468	12	of	of	IN
cord-005453-4057qib7	12468	13	200	200	CD
cord-005453-4057qib7	12468	14	mg	mg	NNP
cord-005453-4057qib7	12468	15	/	/	SYM
cord-005453-4057qib7	12468	16	m	m	NNP
cord-005453-4057qib7	12468	17	2	2	CD
cord-005453-4057qib7	12468	18	,	,	,
cord-005453-4057qib7	12468	19	140	140	CD
cord-005453-4057qib7	12468	20	mg	mg	NNP
cord-005453-4057qib7	12468	21	/	/	SYM
cord-005453-4057qib7	12468	22	m	m	NNP
cord-005453-4057qib7	12468	23	2	2	CD
cord-005453-4057qib7	12468	24	and	and	CC
cord-005453-4057qib7	12468	25	100	100	CD
cord-005453-4057qib7	12469	1	mg	mg	NNP
cord-005453-4057qib7	12469	2	/	/	SYM
cord-005453-4057qib7	12469	3	m	m	NNP
cord-005453-4057qib7	12469	4	2	2	CD
cord-005453-4057qib7	12469	5	was	be	VBD
cord-005453-4057qib7	12469	6	71	71	CD
cord-005453-4057qib7	12469	7	%	%	NN
cord-005453-4057qib7	12469	8	,	,	,
cord-005453-4057qib7	12469	9	58	58	CD
cord-005453-4057qib7	12469	10	%	%	NN
cord-005453-4057qib7	12469	11	and	and	CC
cord-005453-4057qib7	12469	12	21	21	CD
cord-005453-4057qib7	12469	13	%	%	NN
cord-005453-4057qib7	12469	14	,	,	,
cord-005453-4057qib7	12469	15	respectively	respectively	RB
cord-005453-4057qib7	12469	16	(	(	-LRB-
cord-005453-4057qib7	12469	17	p=0.012	p=0.012	NNP
cord-005453-4057qib7	12469	18	)	)	-RRB-
cord-005453-4057qib7	12469	19	.	.	.
cord-005453-4057qib7	12470	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12470	2	:	:	:
cord-005453-4057qib7	12471	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12471	2	data	datum	NNS
cord-005453-4057qib7	12471	3	show	show	VBP
cord-005453-4057qib7	12471	4	that	that	IN
cord-005453-4057qib7	12471	5	ASCT	ASCT	NNP
cord-005453-4057qib7	12471	6	in	in	IN
cord-005453-4057qib7	12471	7	transplant	transplant	NN
cord-005453-4057qib7	12471	8	eligible	eligible	JJ
cord-005453-4057qib7	12471	9	MM	MM	NNP
cord-005453-4057qib7	12471	10	patients	patient	NNS
cord-005453-4057qib7	12472	1	≥	≥	CD
cord-005453-4057qib7	12473	1	65	65	CD
cord-005453-4057qib7	12473	2	years	year	NNS
cord-005453-4057qib7	12473	3	of	of	IN
cord-005453-4057qib7	12473	4	age	age	NN
cord-005453-4057qib7	12473	5	is	be	VBZ
cord-005453-4057qib7	12473	6	safe	safe	JJ
cord-005453-4057qib7	12473	7	and	and	CC
cord-005453-4057qib7	12473	8	provides	provide	VBZ
cord-005453-4057qib7	12473	9	similar	similar	JJ
cord-005453-4057qib7	12473	10	outcomes	outcome	NNS
cord-005453-4057qib7	12473	11	as	as	IN
cord-005453-4057qib7	12473	12	seen	see	VBN
cord-005453-4057qib7	12473	13	in	in	IN
cord-005453-4057qib7	12473	14	younger	young	JJR
cord-005453-4057qib7	12473	15	patients	patient	NNS
cord-005453-4057qib7	12473	16	.	.	.
cord-005453-4057qib7	12474	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12474	2	:	:	:
cord-005453-4057qib7	12475	1	Nothing	nothing	NN
cord-005453-4057qib7	12475	2	to	to	TO
cord-005453-4057qib7	12475	3	declare	declare	VB
cord-005453-4057qib7	12475	4	Is	be	VBZ
cord-005453-4057qib7	12475	5	mobilization	mobilization	NN
cord-005453-4057qib7	12475	6	with	with	IN
cord-005453-4057qib7	12475	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12475	8	effect	effect	NN
cord-005453-4057qib7	12475	9	response	response	NN
cord-005453-4057qib7	12475	10	in	in	IN
cord-005453-4057qib7	12475	11	the	the	DT
cord-005453-4057qib7	12475	12	multiple	multiple	JJ
cord-005453-4057qib7	12475	13	myeloma	myeloma	NN
cord-005453-4057qib7	12475	14	?	?	.
cord-005453-4057qib7	12476	1	Background	background	NN
cord-005453-4057qib7	12476	2	:	:	:
cord-005453-4057qib7	12477	1	High	high	JJ
cord-005453-4057qib7	12477	2	dose	dose	NN
cord-005453-4057qib7	12477	3	melphalan	melphalan	NN
cord-005453-4057qib7	12477	4	therapy	therapy	NN
cord-005453-4057qib7	12477	5	with	with	IN
cord-005453-4057qib7	12477	6	autologous	autologous	JJ
cord-005453-4057qib7	12477	7	stem	stem	NN
cord-005453-4057qib7	12477	8	cell	cell	NN
cord-005453-4057qib7	12477	9	support	support	NN
cord-005453-4057qib7	12477	10	is	be	VBZ
cord-005453-4057qib7	12477	11	a	a	DT
cord-005453-4057qib7	12477	12	standart	standart	JJ
cord-005453-4057qib7	12477	13	approach	approach	NN
cord-005453-4057qib7	12477	14	in	in	IN
cord-005453-4057qib7	12477	15	symptomatic	symptomatic	JJ
cord-005453-4057qib7	12477	16	multiple	multiple	JJ
cord-005453-4057qib7	12477	17	myeloma	myeloma	NN
cord-005453-4057qib7	12477	18	patients	patient	NNS
cord-005453-4057qib7	12477	19	.	.	.
cord-005453-4057qib7	12478	1	Response	response	NN
cord-005453-4057qib7	12478	2	rates	rate	NNS
cord-005453-4057qib7	12478	3	increased	increase	VBD
cord-005453-4057qib7	12478	4	with	with	IN
cord-005453-4057qib7	12478	5	the	the	DT
cord-005453-4057qib7	12478	6	novel	novel	JJ
cord-005453-4057qib7	12478	7	anti	anti	JJ
cord-005453-4057qib7	12478	8	myeloma	myeloma	NN
cord-005453-4057qib7	12478	9	agents	agent	NNS
cord-005453-4057qib7	12478	10	and	and	CC
cord-005453-4057qib7	12478	11	the	the	DT
cord-005453-4057qib7	12478	12	use	use	NN
cord-005453-4057qib7	12478	13	of	of	IN
cord-005453-4057qib7	12478	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12478	15	for	for	IN
cord-005453-4057qib7	12478	16	stem	stem	NN
cord-005453-4057qib7	12478	17	cell	cell	NN
cord-005453-4057qib7	12478	18	mobilization	mobilization	NN
cord-005453-4057qib7	12478	19	should	should	MD
cord-005453-4057qib7	12478	20	be	be	VB
cord-005453-4057qib7	12478	21	questioned	question	VBN
cord-005453-4057qib7	12478	22	.	.	.
cord-005453-4057qib7	12479	1	The	the	DT
cord-005453-4057qib7	12479	2	purpose	purpose	NN
cord-005453-4057qib7	12479	3	of	of	IN
cord-005453-4057qib7	12479	4	this	this	DT
cord-005453-4057qib7	12479	5	study	study	NN
cord-005453-4057qib7	12479	6	is	be	VBZ
cord-005453-4057qib7	12479	7	to	to	TO
cord-005453-4057qib7	12479	8	determine	determine	VB
cord-005453-4057qib7	12479	9	the	the	DT
cord-005453-4057qib7	12479	10	effect	effect	NN
cord-005453-4057qib7	12479	11	of	of	IN
cord-005453-4057qib7	12479	12	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12479	13	used	use	VBN
cord-005453-4057qib7	12479	14	during	during	IN
cord-005453-4057qib7	12479	15	stem	stem	NN
cord-005453-4057qib7	12479	16	cell	cell	NN
cord-005453-4057qib7	12479	17	collection	collection	NN
cord-005453-4057qib7	12479	18	on	on	IN
cord-005453-4057qib7	12479	19	disease	disease	NN
cord-005453-4057qib7	12479	20	response	response	NN
cord-005453-4057qib7	12479	21	and	and	CC
cord-005453-4057qib7	12479	22	transplantation	transplantation	NN
cord-005453-4057qib7	12479	23	results	result	NNS
cord-005453-4057qib7	12479	24	.	.	.
cord-005453-4057qib7	12480	1	Methods	method	NNS
cord-005453-4057qib7	12480	2	:	:	:
cord-005453-4057qib7	12480	3	We	-PRON-	PRP
cord-005453-4057qib7	12480	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	12480	5	collect	collect	VBP
cord-005453-4057qib7	12480	6	data	datum	NNS
cord-005453-4057qib7	12480	7	from	from	IN
cord-005453-4057qib7	12480	8	270	270	CD
cord-005453-4057qib7	12480	9	myeloma	myeloma	NN
cord-005453-4057qib7	12480	10	patients	patient	NNS
cord-005453-4057qib7	12480	11	who	who	WP
cord-005453-4057qib7	12480	12	underwent	undergo	VBD
cord-005453-4057qib7	12480	13	autologous	autologous	JJ
cord-005453-4057qib7	12480	14	stem	stem	NN
cord-005453-4057qib7	12480	15	cell	cell	NN
cord-005453-4057qib7	12480	16	transplantation	transplantation	NN
cord-005453-4057qib7	12480	17	(	(	-LRB-
cord-005453-4057qib7	12480	18	ASCT	ASCT	NNP
cord-005453-4057qib7	12480	19	)	)	-RRB-
cord-005453-4057qib7	12480	20	in	in	IN
cord-005453-4057qib7	12480	21	Ankara	Ankara	NNP
cord-005453-4057qib7	12480	22	University	University	NNP
cord-005453-4057qib7	12480	23	Medicine	Medicine	NNP
cord-005453-4057qib7	12480	24	Faculty	Faculty	NNP
cord-005453-4057qib7	12480	25	,	,	,
cord-005453-4057qib7	12480	26	blood	blood	NN
cord-005453-4057qib7	12480	27	and	and	CC
cord-005453-4057qib7	12480	28	bone	bone	NN
cord-005453-4057qib7	12480	29	marrow	marrow	NN
cord-005453-4057qib7	12480	30	transplantation	transplantation	NN
cord-005453-4057qib7	12480	31	unit	unit	NN
cord-005453-4057qib7	12480	32	between	between	IN
cord-005453-4057qib7	12480	33	January	January	NNP
cord-005453-4057qib7	12480	34	2012	2012	CD
cord-005453-4057qib7	12480	35	and	and	CC
cord-005453-4057qib7	12480	36	November	November	NNP
cord-005453-4057qib7	12480	37	2018	2018	CD
cord-005453-4057qib7	12480	38	.	.	.
cord-005453-4057qib7	12481	1	51	51	CD
cord-005453-4057qib7	12481	2	patients	patient	NNS
cord-005453-4057qib7	12481	3	who	who	WP
cord-005453-4057qib7	12481	4	received	receive	VBD
cord-005453-4057qib7	12481	5	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	12481	6	protocol	protocol	NN
cord-005453-4057qib7	12481	7	for	for	IN
cord-005453-4057qib7	12481	8	stem	stem	NN
cord-005453-4057qib7	12481	9	cell	cell	NN
cord-005453-4057qib7	12481	10	mobilization	mobilization	NN
cord-005453-4057qib7	12481	11	were	be	VBD
cord-005453-4057qib7	12481	12	included	include	VBN
cord-005453-4057qib7	12481	13	in	in	IN
cord-005453-4057qib7	12481	14	the	the	DT
cord-005453-4057qib7	12481	15	study	study	NN
cord-005453-4057qib7	12481	16	.	.	.
cord-005453-4057qib7	12482	1	Disease	disease	NN
cord-005453-4057qib7	12482	2	response	response	NN
cord-005453-4057qib7	12482	3	were	be	VBD
cord-005453-4057qib7	12482	4	determined	determine	VBN
cord-005453-4057qib7	12482	5	according	accord	VBG
cord-005453-4057qib7	12482	6	to	to	IN
cord-005453-4057qib7	12482	7	International	International	NNP
cord-005453-4057qib7	12482	8	Myeloma	Myeloma	NNP
cord-005453-4057qib7	12482	9	Study	Study	NNP
cord-005453-4057qib7	12482	10	Group	Group	NNP
cord-005453-4057qib7	12482	11	(	(	-LRB-
cord-005453-4057qib7	12482	12	IMWG	IMWG	NNP
cord-005453-4057qib7	12482	13	)	)	-RRB-
cord-005453-4057qib7	12482	14	criteria	criterion	NNS
cord-005453-4057qib7	12482	15	before	before	IN
cord-005453-4057qib7	12482	16	and	and	CC
cord-005453-4057qib7	12482	17	after	after	IN
cord-005453-4057qib7	12482	18	the	the	DT
cord-005453-4057qib7	12482	19	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12482	20	.	.	.
cord-005453-4057qib7	12483	1	Transplant	transplant	NN
cord-005453-4057qib7	12483	2	responses	response	NNS
cord-005453-4057qib7	12483	3	and	and	CC
cord-005453-4057qib7	12483	4	their	-PRON-	PRP$
cord-005453-4057qib7	12483	5	effects	effect	NNS
cord-005453-4057qib7	12483	6	on	on	IN
cord-005453-4057qib7	12483	7	survival	survival	NN
cord-005453-4057qib7	12483	8	were	be	VBD
cord-005453-4057qib7	12483	9	also	also	RB
cord-005453-4057qib7	12483	10	indicated	indicate	VBN
cord-005453-4057qib7	12483	11	.	.	.
cord-005453-4057qib7	12484	1	Results	result	NNS
cord-005453-4057qib7	12484	2	:	:	:
cord-005453-4057qib7	12485	1	After	after	IN
cord-005453-4057qib7	12485	2	the	the	DT
cord-005453-4057qib7	12485	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	12485	4	of	of	IN
cord-005453-4057qib7	12485	5	MM	MM	NNP
cord-005453-4057qib7	12485	6	,	,	,
cord-005453-4057qib7	12485	7	51	51	CD
cord-005453-4057qib7	12485	8	patients	patient	NNS
cord-005453-4057qib7	12485	9	(	(	-LRB-
cord-005453-4057qib7	12485	10	male/	male/	CD
cord-005453-4057qib7	12485	11	female	female	NN
cord-005453-4057qib7	12485	12	:	:	:
cord-005453-4057qib7	12485	13	32/19	32/19	CD
cord-005453-4057qib7	12485	14	;	;	:
cord-005453-4057qib7	12485	15	median	median	JJ
cord-005453-4057qib7	12485	16	age	age	NN
cord-005453-4057qib7	12485	17	:	:	:
cord-005453-4057qib7	12485	18	59	59	CD
cord-005453-4057qib7	12485	19	years	year	NNS
cord-005453-4057qib7	12485	20	(	(	-LRB-
cord-005453-4057qib7	12485	21	between	between	IN
cord-005453-4057qib7	12485	22	40	40	CD
cord-005453-4057qib7	12485	23	-	-	SYM
cord-005453-4057qib7	12485	24	74	74	CD
cord-005453-4057qib7	12485	25	years	year	NNS
cord-005453-4057qib7	12485	26	)	)	-RRB-
cord-005453-4057qib7	12485	27	)	)	-RRB-
cord-005453-4057qib7	12485	28	with	with	IN
cord-005453-4057qib7	12485	29	median	median	JJ
cord-005453-4057qib7	12485	30	follow	follow	NN
cord-005453-4057qib7	12485	31	-	-	HYPH
cord-005453-4057qib7	12485	32	up	up	NN
cord-005453-4057qib7	12485	33	of	of	IN
cord-005453-4057qib7	12485	34	59.1	59.1	CD
cord-005453-4057qib7	12485	35	months	month	NNS
cord-005453-4057qib7	12485	36	(	(	-LRB-
cord-005453-4057qib7	12485	37	between	between	IN
cord-005453-4057qib7	12485	38	7,6	7,6	CD
cord-005453-4057qib7	12485	39	-185,8	-185,8	HYPH
cord-005453-4057qib7	12485	40	months	month	NNS
cord-005453-4057qib7	12485	41	)	)	-RRB-
cord-005453-4057qib7	12485	42	underwent	undergo	VBD
cord-005453-4057qib7	12485	43	ASCT	ASCT	NNP
cord-005453-4057qib7	12485	44	at	at	IN
cord-005453-4057qib7	12485	45	a	a	DT
cord-005453-4057qib7	12485	46	mean	mean	NN
cord-005453-4057qib7	12485	47	of	of	IN
cord-005453-4057qib7	12485	48	21,7	21,7	CD
cord-005453-4057qib7	12485	49	±6,2	±6,2	NNS
cord-005453-4057qib7	12485	50	months	month	NNS
cord-005453-4057qib7	12485	51	..	..	.
cord-005453-4057qib7	12486	1	Forty	forty	CD
cord-005453-4057qib7	12486	2	-	-	HYPH
cord-005453-4057qib7	12486	3	one	one	CD
cord-005453-4057qib7	12486	4	patients	patient	NNS
cord-005453-4057qib7	12486	5	were	be	VBD
cord-005453-4057qib7	12486	6	evaluated	evaluate	VBN
cord-005453-4057qib7	12486	7	before	before	IN
cord-005453-4057qib7	12486	8	and	and	CC
cord-005453-4057qib7	12486	9	after	after	IN
cord-005453-4057qib7	12486	10	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	12486	11	(	(	-LRB-
cord-005453-4057qib7	12486	12	table	table	NN
cord-005453-4057qib7	12486	13	1	1	CD
cord-005453-4057qib7	12486	14	)	)	-RRB-
cord-005453-4057qib7	12486	15	.	.	.
cord-005453-4057qib7	12487	1	In	in	IN
cord-005453-4057qib7	12487	2	69	69	CD
cord-005453-4057qib7	12487	3	%	%	NN
cord-005453-4057qib7	12487	4	of	of	IN
cord-005453-4057qib7	12487	5	the	the	DT
cord-005453-4057qib7	12487	6	patients	patient	NNS
cord-005453-4057qib7	12487	7	,	,	,
cord-005453-4057qib7	12487	8	the	the	DT
cord-005453-4057qib7	12487	9	disease	disease	NN
cord-005453-4057qib7	12487	10	response	response	NN
cord-005453-4057qib7	12487	11	was	be	VBD
cord-005453-4057qib7	12487	12	not	not	RB
cord-005453-4057qib7	12487	13	altered	alter	VBN
cord-005453-4057qib7	12487	14	by	by	IN
cord-005453-4057qib7	12487	15	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	12487	16	therapy	therapy	NN
cord-005453-4057qib7	12487	17	,	,	,
cord-005453-4057qib7	12487	18	and	and	CC
cord-005453-4057qib7	12487	19	22	22	CD
cord-005453-4057qib7	12487	20	%	%	NN
cord-005453-4057qib7	12487	21	of	of	IN
cord-005453-4057qib7	12487	22	the	the	DT
cord-005453-4057qib7	12487	23	patients	patient	NNS
cord-005453-4057qib7	12487	24	improved	improve	VBD
cord-005453-4057qib7	12487	25	their	-PRON-	PRP$
cord-005453-4057qib7	12487	26	response	response	NN
cord-005453-4057qib7	12487	27	status	status	NN
cord-005453-4057qib7	12487	28	.	.	.
cord-005453-4057qib7	12488	1	Post	post	JJ
cord-005453-4057qib7	12488	2	-	-	JJ
cord-005453-4057qib7	12488	3	transplant	transplant	JJ
cord-005453-4057qib7	12488	4	response	response	NN
cord-005453-4057qib7	12488	5	rates	rate	NNS
cord-005453-4057qib7	12488	6	of	of	IN
cord-005453-4057qib7	12488	7	patients	patient	NNS
cord-005453-4057qib7	12488	8	who	who	WP
cord-005453-4057qib7	12488	9	underwent	undergo	VBD
cord-005453-4057qib7	12488	10	stem	stem	NN
cord-005453-4057qib7	12488	11	cell	cell	NN
cord-005453-4057qib7	12488	12	mobilization	mobilization	NN
cord-005453-4057qib7	12488	13	with	with	IN
cord-005453-4057qib7	12488	14	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12488	15	are	be	VBP
cord-005453-4057qib7	12488	16	also	also	RB
cord-005453-4057qib7	12488	17	shown	show	VBN
cord-005453-4057qib7	12488	18	in	in	IN
cord-005453-4057qib7	12488	19	table-1	table-1	NNP
cord-005453-4057qib7	12488	20	.	.	.
cord-005453-4057qib7	12489	1	The	the	DT
cord-005453-4057qib7	12489	2	mean	mean	JJ
cord-005453-4057qib7	12489	3	survival	survival	NN
cord-005453-4057qib7	12489	4	of	of	IN
cord-005453-4057qib7	12489	5	the	the	DT
cord-005453-4057qib7	12489	6	patients	patient	NNS
cord-005453-4057qib7	12489	7	was	be	VBD
cord-005453-4057qib7	12489	8	52,7	52,7	CD
cord-005453-4057qib7	12489	9	±4,8	±4,8	NN
cord-005453-4057qib7	12489	10	months	month	NNS
cord-005453-4057qib7	12489	11	.	.	.
cord-005453-4057qib7	12490	1	When	when	WRB
cord-005453-4057qib7	12490	2	patients	patient	NNS
cord-005453-4057qib7	12490	3	were	be	VBD
cord-005453-4057qib7	12490	4	grouped	group	VBN
cord-005453-4057qib7	12490	5	according	accord	VBG
cord-005453-4057qib7	12490	6	to	to	IN
cord-005453-4057qib7	12490	7	changes	change	NNS
cord-005453-4057qib7	12490	8	in	in	IN
cord-005453-4057qib7	12490	9	response	response	NN
cord-005453-4057qib7	12490	10	status	status	NN
cord-005453-4057qib7	12490	11	before	before	IN
cord-005453-4057qib7	12490	12	and	and	CC
cord-005453-4057qib7	12490	13	after	after	IN
cord-005453-4057qib7	12490	14	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	12490	15	;	;	:
cord-005453-4057qib7	12490	16	there	there	EX
cord-005453-4057qib7	12490	17	was	be	VBD
cord-005453-4057qib7	12490	18	no	no	DT
cord-005453-4057qib7	12490	19	statistical	statistical	JJ
cord-005453-4057qib7	12490	20	difference	difference	NN
cord-005453-4057qib7	12490	21	between	between	IN
cord-005453-4057qib7	12490	22	mean	mean	JJ
cord-005453-4057qib7	12490	23	calculated	calculate	VBN
cord-005453-4057qib7	12490	24	survival	survival	NN
cord-005453-4057qib7	12490	25	(	(	-LRB-
cord-005453-4057qib7	12490	26	improved	improved	JJ
cord-005453-4057qib7	12490	27	response	response	NN
cord-005453-4057qib7	12490	28	,	,	,
cord-005453-4057qib7	12490	29	disease	disease	NN
cord-005453-4057qib7	12490	30	progression	progression	NN
cord-005453-4057qib7	12490	31	and	and	CC
cord-005453-4057qib7	12490	32	stable	stable	JJ
cord-005453-4057qib7	12490	33	disease	disease	NN
cord-005453-4057qib7	12490	34	;	;	:
cord-005453-4057qib7	12490	35	59,3±9,0	59,3±9,0	CD
cord-005453-4057qib7	12490	36	months	month	NNS
cord-005453-4057qib7	12490	37	,	,	,
cord-005453-4057qib7	12490	38	22,7±14,7	22,7±14,7	CD
cord-005453-4057qib7	12490	39	months	month	NNS
cord-005453-4057qib7	12490	40	and	and	CC
cord-005453-4057qib7	12490	41	46,4±5,0	46,4±5,0	CD
cord-005453-4057qib7	12490	42	months	month	NNS
cord-005453-4057qib7	12490	43	respectively	respectively	RB
cord-005453-4057qib7	12490	44	,	,	,
cord-005453-4057qib7	12490	45	p=0.425	p=0.425	NNP
cord-005453-4057qib7	12490	46	)	)	-RRB-
cord-005453-4057qib7	12490	47	(	(	-LRB-
cord-005453-4057qib7	12490	48	Figure-1	Figure-1	NNP
cord-005453-4057qib7	12490	49	)	)	-RRB-
cord-005453-4057qib7	12490	50	.	.	.
cord-005453-4057qib7	12491	1	The	the	DT
cord-005453-4057qib7	12491	2	rates	rate	NNS
cord-005453-4057qib7	12491	3	of	of	IN
cord-005453-4057qib7	12491	4	1-year	1-year	CD
cord-005453-4057qib7	12491	5	and	and	CC
cord-005453-4057qib7	12491	6	3-year	3-year	CD
cord-005453-4057qib7	12491	7	overall	overall	JJ
cord-005453-4057qib7	12491	8	survival	survival	NN
cord-005453-4057qib7	12491	9	(	(	-LRB-
cord-005453-4057qib7	12491	10	OS	OS	NNP
cord-005453-4057qib7	12491	11	)	)	-RRB-
cord-005453-4057qib7	12491	12	of	of	IN
cord-005453-4057qib7	12491	13	the	the	DT
cord-005453-4057qib7	12491	14	patients	patient	NNS
cord-005453-4057qib7	12491	15	with	with	IN
cord-005453-4057qib7	12491	16	no	no	DT
cord-005453-4057qib7	12491	17	response	response	NN
cord-005453-4057qib7	12491	18	to	to	IN
cord-005453-4057qib7	12491	19	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	12491	20	treatment	treatment	NN
cord-005453-4057qib7	12491	21	were	be	VBD
cord-005453-4057qib7	12491	22	as	as	IN
cord-005453-4057qib7	12491	23	follows	follow	VBZ
cord-005453-4057qib7	12491	24	;	;	:
cord-005453-4057qib7	12491	25	74,2%±7,9	74,2%±7,9	CD
cord-005453-4057qib7	12491	26	%	%	NN
cord-005453-4057qib7	12491	27	and	and	CC
cord-005453-4057qib7	12491	28	70,5%±8,3	70,5%±8,3	CD
cord-005453-4057qib7	12491	29	%	%	NN
cord-005453-4057qib7	12491	30	respectively	respectively	RB
cord-005453-4057qib7	12491	31	.	.	.
cord-005453-4057qib7	12492	1	Thirteen	thirteen	CD
cord-005453-4057qib7	12492	2	patients	patient	NNS
cord-005453-4057qib7	12492	3	who	who	WP
cord-005453-4057qib7	12492	4	were	be	VBD
cord-005453-4057qib7	12492	5	followed	follow	VBN
cord-005453-4057qib7	12492	6	up	up	RP
cord-005453-4057qib7	12492	7	median	median	NN
cord-005453-4057qib7	12492	8	27	27	CD
cord-005453-4057qib7	12492	9	months	month	NNS
cord-005453-4057qib7	12492	10	after	after	IN
cord-005453-4057qib7	12492	11	transplantation	transplantation	NN
cord-005453-4057qib7	12492	12	died	die	VBD
cord-005453-4057qib7	12492	13	at	at	IN
cord-005453-4057qib7	12492	14	an	an	DT
cord-005453-4057qib7	12492	15	average	average	NN
cord-005453-4057qib7	12492	16	of	of	IN
cord-005453-4057qib7	12492	17	3,4±2,5	3,4±2,5	CD
cord-005453-4057qib7	12492	18	months	month	NNS
cord-005453-4057qib7	12492	19	;	;	:
cord-005453-4057qib7	12492	20	6	6	CD
cord-005453-4057qib7	12492	21	of	of	IN
cord-005453-4057qib7	12492	22	these	these	DT
cord-005453-4057qib7	12492	23	deaths	death	NNS
cord-005453-4057qib7	12492	24	were	be	VBD
cord-005453-4057qib7	12492	25	caused	cause	VBN
cord-005453-4057qib7	12492	26	by	by	IN
cord-005453-4057qib7	12492	27	the	the	DT
cord-005453-4057qib7	12492	28	infection	infection	NN
cord-005453-4057qib7	12492	29	after	after	IN
cord-005453-4057qib7	12492	30	transplantation	transplantation	NN
cord-005453-4057qib7	12492	31	.	.	.
cord-005453-4057qib7	12493	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12493	2	:	:	:
cord-005453-4057qib7	12494	1	In	in	IN
cord-005453-4057qib7	12494	2	our	-PRON-	PRP$
cord-005453-4057qib7	12494	3	study	study	NN
cord-005453-4057qib7	12494	4	,	,	,
cord-005453-4057qib7	12494	5	it	-PRON-	PRP
cord-005453-4057qib7	12494	6	was	be	VBD
cord-005453-4057qib7	12494	7	observed	observe	VBN
cord-005453-4057qib7	12494	8	that	that	IN
cord-005453-4057qib7	12494	9	the	the	DT
cord-005453-4057qib7	12494	10	use	use	NN
cord-005453-4057qib7	12494	11	of	of	IN
cord-005453-4057qib7	12494	12	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12494	13	for	for	IN
cord-005453-4057qib7	12494	14	CD34	CD34	NNP
cord-005453-4057qib7	12494	15	+	+	CC
cord-005453-4057qib7	12494	16	stem	stem	NN
cord-005453-4057qib7	12494	17	cell	cell	NN
cord-005453-4057qib7	12494	18	mobilization	mobilization	NN
cord-005453-4057qib7	12494	19	did	do	VBD
cord-005453-4057qib7	12494	20	not	not	RB
cord-005453-4057qib7	12494	21	change	change	VB
cord-005453-4057qib7	12494	22	the	the	DT
cord-005453-4057qib7	12494	23	disease	disease	NN
cord-005453-4057qib7	12494	24	response	response	NN
cord-005453-4057qib7	12494	25	rates	rate	NNS
cord-005453-4057qib7	12494	26	by	by	IN
cord-005453-4057qib7	12494	27	69	69	CD
cord-005453-4057qib7	12494	28	%	%	NN
cord-005453-4057qib7	12494	29	.	.	.
cord-005453-4057qib7	12495	1	The	the	DT
cord-005453-4057qib7	12495	2	posttransplant	posttransplant	NN
cord-005453-4057qib7	12495	3	survival	survival	NN
cord-005453-4057qib7	12495	4	rates	rate	NNS
cord-005453-4057qib7	12495	5	of	of	IN
cord-005453-4057qib7	12495	6	MM	MM	NNP
cord-005453-4057qib7	12495	7	patients	patient	NNS
cord-005453-4057qib7	12495	8	who	who	WP
cord-005453-4057qib7	12495	9	had	have	VBD
cord-005453-4057qib7	12495	10	progressive	progressive	JJ
cord-005453-4057qib7	12495	11	disease	disease	NN
cord-005453-4057qib7	12495	12	after	after	IN
cord-005453-4057qib7	12495	13	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12495	14	use	use	NN
cord-005453-4057qib7	12495	15	were	be	VBD
cord-005453-4057qib7	12495	16	lower	low	JJR
cord-005453-4057qib7	12495	17	.	.	.
cord-005453-4057qib7	12496	1	However	however	RB
cord-005453-4057qib7	12496	2	,	,	,
cord-005453-4057qib7	12496	3	these	these	DT
cord-005453-4057qib7	12496	4	results	result	NNS
cord-005453-4057qib7	12496	5	warranted	warrant	VBN
cord-005453-4057qib7	12496	6	confirmed	confirm	VBN
cord-005453-4057qib7	12496	7	by	by	IN
cord-005453-4057qib7	12496	8	randomized	randomized	JJ
cord-005453-4057qib7	12496	9	controlled	control	VBN
cord-005453-4057qib7	12496	10	trials	trial	NNS
cord-005453-4057qib7	12496	11	.	.	.
cord-005453-4057qib7	12497	1	Clinical	clinical	JJ
cord-005453-4057qib7	12497	2	Trial	Trial	NNP
cord-005453-4057qib7	12497	3	Registry	Registry	NNP
cord-005453-4057qib7	12497	4	:	:	:
cord-005453-4057qib7	12498	1	-Disclosure	-disclosure	UH
cord-005453-4057qib7	12498	2	:	:	:
cord-005453-4057qib7	12498	3	Nothing	nothing	NN
cord-005453-4057qib7	12498	4	to	to	TO
cord-005453-4057qib7	12498	5	declare	declare	VB
cord-005453-4057qib7	12498	6	Results	result	NNS
cord-005453-4057qib7	12498	7	of	of	IN
cord-005453-4057qib7	12498	8	a	a	DT
cord-005453-4057qib7	12498	9	single	single	JJ
cord-005453-4057qib7	12498	10	center	center	NN
cord-005453-4057qib7	12498	11	experience	experience	NN
cord-005453-4057qib7	12498	12	:	:	:
cord-005453-4057qib7	12498	13	An	an	DT
cord-005453-4057qib7	12498	14	attempt	attempt	NN
cord-005453-4057qib7	12498	15	to	to	TO
cord-005453-4057qib7	12498	16	augment	augment	VB
cord-005453-4057qib7	12498	17	conditioning	conditioning	NN
cord-005453-4057qib7	12498	18	regimen	regimen	NN
cord-005453-4057qib7	12498	19	in	in	IN
cord-005453-4057qib7	12498	20	first	first	JJ
cord-005453-4057qib7	12498	21	autologous	autologous	JJ
cord-005453-4057qib7	12498	22	stem	stem	NN
cord-005453-4057qib7	12498	23	cell	cell	NN
cord-005453-4057qib7	12498	24	transplantation	transplantation	NN
cord-005453-4057qib7	12498	25	treatment	treatment	NN
cord-005453-4057qib7	12498	26	of	of	IN
cord-005453-4057qib7	12498	27	multiple	multiple	JJ
cord-005453-4057qib7	12498	28	myeloma	myeloma	NN
cord-005453-4057qib7	12498	29	(	(	-LRB-
cord-005453-4057qib7	12498	30	MM	MM	NNP
cord-005453-4057qib7	12498	31	)	)	-RRB-
cord-005453-4057qib7	12498	32	continues	continue	VBZ
cord-005453-4057qib7	12498	33	to	to	TO
cord-005453-4057qib7	12498	34	evolve	evolve	VB
cord-005453-4057qib7	12498	35	in	in	IN
cord-005453-4057qib7	12498	36	the	the	DT
cord-005453-4057qib7	12498	37	era	era	NN
cord-005453-4057qib7	12498	38	of	of	IN
cord-005453-4057qib7	12498	39	novel	novel	JJ
cord-005453-4057qib7	12498	40	agents	agent	NNS
cord-005453-4057qib7	12498	41	.	.	.
cord-005453-4057qib7	12499	1	The	the	DT
cord-005453-4057qib7	12499	2	addition	addition	NN
cord-005453-4057qib7	12499	3	of	of	IN
cord-005453-4057qib7	12499	4	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12499	5	to	to	TO
cord-005453-4057qib7	12499	6	highdose	highdose	VB
cord-005453-4057qib7	12499	7	melphalan	melphalan	NNP
cord-005453-4057qib7	12499	8	(	(	-LRB-
cord-005453-4057qib7	12499	9	Bor	Bor	NNP
cord-005453-4057qib7	12499	10	-	-	HYPH
cord-005453-4057qib7	12499	11	HDM	HDM	NNP
cord-005453-4057qib7	12499	12	)	)	-RRB-
cord-005453-4057qib7	12499	13	has	have	VBZ
cord-005453-4057qib7	12499	14	been	be	VBN
cord-005453-4057qib7	12499	15	reported	report	VBN
cord-005453-4057qib7	12499	16	by	by	IN
cord-005453-4057qib7	12499	17	several	several	JJ
cord-005453-4057qib7	12499	18	groups	group	NNS
cord-005453-4057qib7	12499	19	,	,	,
cord-005453-4057qib7	12499	20	and	and	CC
cord-005453-4057qib7	12499	21	it	-PRON-	PRP
cord-005453-4057qib7	12499	22	has	have	VBZ
cord-005453-4057qib7	12499	23	been	be	VBN
cord-005453-4057qib7	12499	24	outcome	outcome	VBN
cord-005453-4057qib7	12499	25	and	and	CC
cord-005453-4057qib7	12499	26	toxicity	toxicity	NN
cord-005453-4057qib7	12499	27	profile	profile	NN
cord-005453-4057qib7	12499	28	is	be	VBZ
cord-005453-4057qib7	12499	29	comparable	comparable	JJ
cord-005453-4057qib7	12499	30	to	to	IN
cord-005453-4057qib7	12499	31	high	high	JJ
cord-005453-4057qib7	12499	32	dose	dose	NN
cord-005453-4057qib7	12499	33	melphalan	melphalan	NN
cord-005453-4057qib7	12499	34	(	(	-LRB-
cord-005453-4057qib7	12499	35	HDM	HDM	NNP
cord-005453-4057qib7	12499	36	)	)	-RRB-
cord-005453-4057qib7	12499	37	alone	alone	RB
cord-005453-4057qib7	12499	38	.	.	.
cord-005453-4057qib7	12500	1	The	the	DT
cord-005453-4057qib7	12500	2	aim	aim	NN
cord-005453-4057qib7	12500	3	of	of	IN
cord-005453-4057qib7	12500	4	this	this	DT
cord-005453-4057qib7	12500	5	retrospective	retrospective	JJ
cord-005453-4057qib7	12500	6	study	study	NN
cord-005453-4057qib7	12500	7	was	be	VBD
cord-005453-4057qib7	12500	8	to	to	TO
cord-005453-4057qib7	12500	9	evaluate	evaluate	VB
cord-005453-4057qib7	12500	10	the	the	DT
cord-005453-4057qib7	12500	11	outcome	outcome	NN
cord-005453-4057qib7	12500	12	of	of	IN
cord-005453-4057qib7	12500	13	the	the	DT
cord-005453-4057qib7	12500	14	BOR	BOR	NNP
cord-005453-4057qib7	12500	15	-	-	HYPH
cord-005453-4057qib7	12500	16	HDM	HDM	NNP
cord-005453-4057qib7	12500	17	conditioning	conditioning	NN
cord-005453-4057qib7	12500	18	regimen	regimen	NN
cord-005453-4057qib7	12500	19	on	on	IN
cord-005453-4057qib7	12500	20	overall	overall	JJ
cord-005453-4057qib7	12500	21	response	response	NN
cord-005453-4057qib7	12500	22	for	for	IN
cord-005453-4057qib7	12500	23	patients	patient	NNS
cord-005453-4057qib7	12500	24	with	with	IN
cord-005453-4057qib7	12500	25	MM	MM	NNP
cord-005453-4057qib7	12500	26	undergoing	undergo	VBG
cord-005453-4057qib7	12500	27	first	first	JJ
cord-005453-4057qib7	12500	28	single	single	JJ
cord-005453-4057qib7	12500	29	ASCT	asct	NN
cord-005453-4057qib7	12500	30	at	at	IN
cord-005453-4057qib7	12500	31	our	-PRON-	PRP$
cord-005453-4057qib7	12500	32	institution	institution	NN
cord-005453-4057qib7	12500	33	.	.	.
cord-005453-4057qib7	12501	1	Methods	method	NNS
cord-005453-4057qib7	12501	2	:	:	:
cord-005453-4057qib7	12502	1	This	this	DT
cord-005453-4057qib7	12502	2	retrospective	retrospective	JJ
cord-005453-4057qib7	12502	3	single	single	JJ
cord-005453-4057qib7	12502	4	center	center	NN
cord-005453-4057qib7	12502	5	study	study	NN
cord-005453-4057qib7	12502	6	reviewed	review	VBD
cord-005453-4057qib7	12502	7	136	136	CD
cord-005453-4057qib7	12502	8	consecutive	consecutive	JJ
cord-005453-4057qib7	12502	9	myeloma	myeloma	NN
cord-005453-4057qib7	12502	10	patients	patient	NNS
cord-005453-4057qib7	12502	11	who	who	WP
cord-005453-4057qib7	12502	12	had	have	VBD
cord-005453-4057qib7	12502	13	received	receive	VBN
cord-005453-4057qib7	12502	14	the	the	DT
cord-005453-4057qib7	12502	15	first	first	JJ
cord-005453-4057qib7	12502	16	ASCT	ASCT	NNP
cord-005453-4057qib7	12502	17	either	either	CC
cord-005453-4057qib7	12502	18	with	with	IN
cord-005453-4057qib7	12502	19	Bor	Bor	NNP
cord-005453-4057qib7	12502	20	-	-	HYPH
cord-005453-4057qib7	12502	21	HDM	HDM	NNP
cord-005453-4057qib7	12502	22	(	(	-LRB-
cord-005453-4057qib7	12502	23	n=15	n=15	NNP
cord-005453-4057qib7	12502	24	,	,	,
cord-005453-4057qib7	12502	25	M	M	NNP
cord-005453-4057qib7	12502	26	/	/	SYM
cord-005453-4057qib7	12502	27	F=	F=	NNP
cord-005453-4057qib7	12502	28	11/4	11/4	CD
cord-005453-4057qib7	12502	29	)	)	-RRB-
cord-005453-4057qib7	12502	30	or	or	CC
cord-005453-4057qib7	12502	31	single	single	JJ
cord-005453-4057qib7	12502	32	agent	agent	NN
cord-005453-4057qib7	12502	33	HDM	HDM	NNP
cord-005453-4057qib7	12502	34	(	(	-LRB-
cord-005453-4057qib7	12502	35	n=121	n=121	NNP
cord-005453-4057qib7	12502	36	,	,	,
cord-005453-4057qib7	12502	37	M	M	NNP
cord-005453-4057qib7	12502	38	/	/	SYM
cord-005453-4057qib7	12502	39	F=	F=	NNP
cord-005453-4057qib7	12502	40	76/45	76/45	CD
cord-005453-4057qib7	12502	41	)	)	-RRB-
cord-005453-4057qib7	12502	42	conditioning	conditioning	NN
cord-005453-4057qib7	12502	43	regimen	regimen	NN
cord-005453-4057qib7	12502	44	.	.	.
cord-005453-4057qib7	12503	1	In	in	IN
cord-005453-4057qib7	12503	2	the	the	DT
cord-005453-4057qib7	12503	3	single	single	JJ
cord-005453-4057qib7	12503	4	agent	agent	NN
cord-005453-4057qib7	12503	5	HDM	HDM	NNP
cord-005453-4057qib7	12503	6	conditioning	conditioning	NN
cord-005453-4057qib7	12503	7	regimen	regimen	NN
cord-005453-4057qib7	12503	8	,	,	,
cord-005453-4057qib7	12503	9	melphalan	melphalan	NNP
cord-005453-4057qib7	12503	10	was	be	VBD
cord-005453-4057qib7	12503	11	administered	administer	VBN
cord-005453-4057qib7	12503	12	intravenously	intravenously	RB
cord-005453-4057qib7	12503	13	at	at	IN
cord-005453-4057qib7	12503	14	a	a	DT
cord-005453-4057qib7	12503	15	total	total	JJ
cord-005453-4057qib7	12503	16	dose	dose	NN
cord-005453-4057qib7	12503	17	of	of	IN
cord-005453-4057qib7	12503	18	200	200	CD
cord-005453-4057qib7	12503	19	mg	mg	NNP
cord-005453-4057qib7	12503	20	/	/	SYM
cord-005453-4057qib7	12503	21	m2	m2	NNP
cord-005453-4057qib7	12503	22	on	on	IN
cord-005453-4057qib7	12503	23	day	day	NN
cord-005453-4057qib7	12503	24	-3	-3	NNP
cord-005453-4057qib7	12504	1	and	and	CC
cord-005453-4057qib7	12504	2	-2	-2	CD
cord-005453-4057qib7	12504	3	and	and	CC
cord-005453-4057qib7	12504	4	stem	stem	NN
cord-005453-4057qib7	12504	5	cells	cell	NNS
cord-005453-4057qib7	12504	6	were	be	VBD
cord-005453-4057qib7	12504	7	infused	infuse	VBN
cord-005453-4057qib7	12504	8	on	on	IN
cord-005453-4057qib7	12504	9	day	day	NN
cord-005453-4057qib7	12504	10	0	0	CD
cord-005453-4057qib7	12504	11	.	.	.
cord-005453-4057qib7	12505	1	In	in	IN
cord-005453-4057qib7	12505	2	the	the	DT
cord-005453-4057qib7	12505	3	Bor	Bor	NNP
cord-005453-4057qib7	12505	4	-	-	HYPH
cord-005453-4057qib7	12505	5	HDM	HDM	NNP
cord-005453-4057qib7	12505	6	group	group	NN
cord-005453-4057qib7	12505	7	,	,	,
cord-005453-4057qib7	12505	8	melphalan	melphalan	NNP
cord-005453-4057qib7	12505	9	200mg	200mg	NNP
cord-005453-4057qib7	12505	10	/	/	SYM
cord-005453-4057qib7	12505	11	m	m	NNP
cord-005453-4057qib7	12505	12	2	2	CD
cord-005453-4057qib7	12505	13	was	be	VBD
cord-005453-4057qib7	12505	14	administered	administer	VBN
cord-005453-4057qib7	12505	15	on	on	IN
cord-005453-4057qib7	12505	16	day	day	NN
cord-005453-4057qib7	12505	17	-2	-2	CD
cord-005453-4057qib7	12505	18	.	.	.
cord-005453-4057qib7	12506	1	Bortezomib	Bortezomib	NNP
cord-005453-4057qib7	12506	2	was	be	VBD
cord-005453-4057qib7	12506	3	administered	administer	VBN
cord-005453-4057qib7	12506	4	intravenously	intravenously	RB
cord-005453-4057qib7	12506	5	at	at	IN
cord-005453-4057qib7	12506	6	a	a	DT
cord-005453-4057qib7	12506	7	dose	dose	NN
cord-005453-4057qib7	12506	8	of	of	IN
cord-005453-4057qib7	12506	9	1	1	CD
cord-005453-4057qib7	12506	10	mg	mg	NNP
cord-005453-4057qib7	12506	11	/	/	SYM
cord-005453-4057qib7	12506	12	m	m	NNP
cord-005453-4057qib7	12506	13	2	2	CD
cord-005453-4057qib7	12506	14	on	on	IN
cord-005453-4057qib7	12506	15	day	day	NN
cord-005453-4057qib7	12506	16	's	's	POS
cord-005453-4057qib7	12506	17	-6	-6	NNP
cord-005453-4057qib7	12506	18	,	,	,
cord-005453-4057qib7	12506	19	-3	-3	NNP
cord-005453-4057qib7	12506	20	,	,	,
cord-005453-4057qib7	12506	21	+1	+1	NNP
cord-005453-4057qib7	12506	22	,	,	,
cord-005453-4057qib7	12506	23	and	and	CC
cord-005453-4057qib7	12506	24	+4	+4	NFP
cord-005453-4057qib7	12506	25	as	as	IN
cord-005453-4057qib7	12506	26	described	describe	VBN
cord-005453-4057qib7	12506	27	in	in	IN
cord-005453-4057qib7	12506	28	a	a	DT
cord-005453-4057qib7	12506	29	phase	phase	NN
cord-005453-4057qib7	12506	30	2	2	CD
cord-005453-4057qib7	12506	31	study	study	NN
cord-005453-4057qib7	12506	32	by	by	IN
cord-005453-4057qib7	12506	33	Intergroupe	Intergroupe	NNP
cord-005453-4057qib7	12506	34	Francophone	Francophone	NNP
cord-005453-4057qib7	12506	35	du	du	NNP
cord-005453-4057qib7	12506	36	Myeĺome	Myeĺome	NNP
cord-005453-4057qib7	12506	37	(	(	-LRB-
cord-005453-4057qib7	12506	38	IFM	IFM	NNP
cord-005453-4057qib7	12506	39	)	)	-RRB-
cord-005453-4057qib7	12506	40	.	.	.
cord-005453-4057qib7	12507	1	Results	result	NNS
cord-005453-4057qib7	12507	2	:	:	:
cord-005453-4057qib7	12508	1	All	all	DT
cord-005453-4057qib7	12508	2	consecutive	consecutive	JJ
cord-005453-4057qib7	12508	3	patients	patient	NNS
cord-005453-4057qib7	12508	4	who	who	WP
cord-005453-4057qib7	12508	5	underwent	undergo	VBD
cord-005453-4057qib7	12508	6	single	single	JJ
cord-005453-4057qib7	12508	7	ASCT	ASCT	NNP
cord-005453-4057qib7	12508	8	from	from	IN
cord-005453-4057qib7	12508	9	January	January	NNP
cord-005453-4057qib7	12508	10	2010	2010	CD
cord-005453-4057qib7	12508	11	to	to	IN
cord-005453-4057qib7	12508	12	March	March	NNP
cord-005453-4057qib7	12508	13	2018	2018	CD
cord-005453-4057qib7	12508	14	using	use	VBG
cord-005453-4057qib7	12508	15	Bor	Bor	NNP
cord-005453-4057qib7	12508	16	-	-	HYPH
cord-005453-4057qib7	12508	17	HDM	HDM	NNP
cord-005453-4057qib7	12508	18	as	as	IN
cord-005453-4057qib7	12508	19	conditioning	conditioning	NN
cord-005453-4057qib7	12508	20	or	or	CC
cord-005453-4057qib7	12508	21	HDM	HDM	NNP
cord-005453-4057qib7	12508	22	were	be	VBD
cord-005453-4057qib7	12508	23	evaluated	evaluate	VBN
cord-005453-4057qib7	12508	24	.	.	.
cord-005453-4057qib7	12509	1	Conditioning	conditioning	NN
cord-005453-4057qib7	12509	2	regimen	regimen	NN
cord-005453-4057qib7	12509	3	was	be	VBD
cord-005453-4057qib7	12509	4	HDM	HDM	NNP
cord-005453-4057qib7	12509	5	in	in	IN
cord-005453-4057qib7	12509	6	121	121	CD
cord-005453-4057qib7	12509	7	patients	patient	NNS
cord-005453-4057qib7	12509	8	and	and	CC
cord-005453-4057qib7	12509	9	Bor	Bor	NNP
cord-005453-4057qib7	12509	10	-	-	HYPH
cord-005453-4057qib7	12509	11	HDM	HDM	NNP
cord-005453-4057qib7	12509	12	in	in	IN
cord-005453-4057qib7	12509	13	15	15	CD
cord-005453-4057qib7	12509	14	patients	patient	NNS
cord-005453-4057qib7	12509	15	.	.	.
cord-005453-4057qib7	12510	1	Median	median	JJ
cord-005453-4057qib7	12510	2	age	age	NN
cord-005453-4057qib7	12510	3	was	be	VBD
cord-005453-4057qib7	12510	4	significantly	significantly	RB
cord-005453-4057qib7	12510	5	lower	low	JJR
cord-005453-4057qib7	12510	6	in	in	IN
cord-005453-4057qib7	12510	7	Bor	Bor	NNP
cord-005453-4057qib7	12510	8	-	-	HYPH
cord-005453-4057qib7	12510	9	HDM	HDM	NNP
cord-005453-4057qib7	12510	10	conditioned	condition	VBD
cord-005453-4057qib7	12510	11	ASCT	ASCT	NNP
cord-005453-4057qib7	12510	12	compared	compare	VBN
cord-005453-4057qib7	12510	13	to	to	IN
cord-005453-4057qib7	12510	14	HDM	HDM	NNP
cord-005453-4057qib7	12510	15	group	group	NN
cord-005453-4057qib7	12510	16	(	(	-LRB-
cord-005453-4057qib7	12510	17	62	62	CD
cord-005453-4057qib7	12510	18	years	year	NNS
cord-005453-4057qib7	12510	19	vs	vs	IN
cord-005453-4057qib7	12510	20	52	52	CD
cord-005453-4057qib7	12510	21	years	year	NNS
cord-005453-4057qib7	12510	22	,	,	,
cord-005453-4057qib7	12510	23	p=000	p=000	NNP
cord-005453-4057qib7	12510	24	)	)	-RRB-
cord-005453-4057qib7	12510	25	.	.	.
cord-005453-4057qib7	12511	1	There	there	EX
cord-005453-4057qib7	12511	2	was	be	VBD
cord-005453-4057qib7	12511	3	no	no	DT
cord-005453-4057qib7	12511	4	significant	significant	JJ
cord-005453-4057qib7	12511	5	difference	difference	NN
cord-005453-4057qib7	12511	6	for	for	IN
cord-005453-4057qib7	12511	7	MM	MM	NNP
cord-005453-4057qib7	12511	8	subtype	subtype	NN
cord-005453-4057qib7	12511	9	,	,	,
cord-005453-4057qib7	12511	10	ISS	ISS	NNP
cord-005453-4057qib7	12511	11	stage	stage	NN
cord-005453-4057qib7	12511	12	at	at	IN
cord-005453-4057qib7	12511	13	diagnosis	diagnosis	NN
cord-005453-4057qib7	12511	14	,	,	,
cord-005453-4057qib7	12511	15	prior	prior	JJ
cord-005453-4057qib7	12511	16	treatment	treatment	NN
cord-005453-4057qib7	12511	17	line	line	NN
cord-005453-4057qib7	12511	18	among	among	IN
cord-005453-4057qib7	12511	19	HDM	HDM	NNP
cord-005453-4057qib7	12511	20	vs	vs	IN
cord-005453-4057qib7	12511	21	Bor	Bor	NNP
cord-005453-4057qib7	12511	22	-	-	HYPH
cord-005453-4057qib7	12511	23	HDM	HDM	NNP
cord-005453-4057qib7	12511	24	cohorts	cohort	NNS
cord-005453-4057qib7	12511	25	(	(	-LRB-
cord-005453-4057qib7	12511	26	p>0.5	p>0.5	NNP
cord-005453-4057qib7	12511	27	)	)	-RRB-
cord-005453-4057qib7	12511	28	.	.	.
cord-005453-4057qib7	12512	1	After	after	IN
cord-005453-4057qib7	12512	2	a	a	DT
cord-005453-4057qib7	12512	3	median	median	NN
cord-005453-4057qib7	12512	4	of	of	IN
cord-005453-4057qib7	12512	5	4	4	CD
cord-005453-4057qib7	12512	6	cycles	cycle	NNS
cord-005453-4057qib7	12512	7	of	of	IN
cord-005453-4057qib7	12512	8	induction	induction	NN
cord-005453-4057qib7	12512	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12512	10	,	,	,
cord-005453-4057qib7	12512	11	patients	patient	NNS
cord-005453-4057qib7	12512	12	in	in	IN
cord-005453-4057qib7	12512	13	the	the	DT
cord-005453-4057qib7	12512	14	Bor	Bor	NNP
cord-005453-4057qib7	12512	15	-	-	HYPH
cord-005453-4057qib7	12512	16	HD	HD	NNP
cord-005453-4057qib7	12512	17	exhibited	exhibit	VBD
cord-005453-4057qib7	12512	18	≥VGPR	≥vgpr	NN
cord-005453-4057qib7	12512	19	of	of	IN
cord-005453-4057qib7	12512	20	53.8	53.8	CD
cord-005453-4057qib7	12512	21	%	%	NN
cord-005453-4057qib7	12512	22	(	(	-LRB-
cord-005453-4057qib7	12512	23	n=7	n=7	NN
cord-005453-4057qib7	12512	24	)	)	-RRB-
cord-005453-4057qib7	12512	25	compared	compare	VBN
cord-005453-4057qib7	12512	26	to	to	IN
cord-005453-4057qib7	12512	27	56.7	56.7	CD
cord-005453-4057qib7	12512	28	%	%	NN
cord-005453-4057qib7	12512	29	(	(	-LRB-
cord-005453-4057qib7	12512	30	n=51	n=51	NNP
cord-005453-4057qib7	12512	31	)	)	-RRB-
cord-005453-4057qib7	12512	32	in	in	IN
cord-005453-4057qib7	12512	33	the	the	DT
cord-005453-4057qib7	12512	34	HDM	HDM	NNP
cord-005453-4057qib7	12512	35	group	group	NN
cord-005453-4057qib7	12512	36	(	(	-LRB-
cord-005453-4057qib7	12512	37	p=	p=	NNP
cord-005453-4057qib7	12512	38	p>0.5	p>0.5	NNP
cord-005453-4057qib7	12512	39	)	)	-RRB-
cord-005453-4057qib7	12512	40	.	.	.
cord-005453-4057qib7	12513	1	Pre	pre	JJ
cord-005453-4057qib7	12513	2	-	-	JJ
cord-005453-4057qib7	12513	3	ASCT	asct	JJ
cord-005453-4057qib7	12513	4	immune	immune	JJ
cord-005453-4057qib7	12513	5	response	response	NN
cord-005453-4057qib7	12513	6	(	(	-LRB-
cord-005453-4057qib7	12513	7	IF	if	NN
cord-005453-4057qib7	12513	8	(	(	-LRB-
cord-005453-4057qib7	12513	9	-	-	:
cord-005453-4057qib7	12513	10	)	)	-RRB-
cord-005453-4057qib7	12513	11	)	)	-RRB-
cord-005453-4057qib7	12513	12	was	be	VBD
cord-005453-4057qib7	12513	13	reported	report	VBN
cord-005453-4057qib7	12513	14	in	in	IN
cord-005453-4057qib7	12513	15	22.3	22.3	CD
cord-005453-4057qib7	12513	16	%	%	NN
cord-005453-4057qib7	12513	17	of	of	IN
cord-005453-4057qib7	12513	18	patients	patient	NNS
cord-005453-4057qib7	12513	19	treated	treat	VBN
cord-005453-4057qib7	12513	20	with	with	IN
cord-005453-4057qib7	12513	21	HDM	HDM	NNP
cord-005453-4057qib7	12513	22	,	,	,
cord-005453-4057qib7	12513	23	higher	high	JJR
cord-005453-4057qib7	12513	24	than	than	IN
cord-005453-4057qib7	12513	25	that	that	DT
cord-005453-4057qib7	12513	26	seen	see	VBN
cord-005453-4057qib7	12513	27	in	in	IN
cord-005453-4057qib7	12513	28	the	the	DT
cord-005453-4057qib7	12513	29	Bor	Bor	NNP
cord-005453-4057qib7	12513	30	-	-	HYPH
cord-005453-4057qib7	12513	31	HDM	HDM	NNP
cord-005453-4057qib7	12513	32	group	group	NN
cord-005453-4057qib7	12513	33	(	(	-LRB-
cord-005453-4057qib7	12513	34	6.7	6.7	CD
cord-005453-4057qib7	12513	35	%	%	NN
cord-005453-4057qib7	12513	36	)	)	-RRB-
cord-005453-4057qib7	12514	1	(	(	-LRB-
cord-005453-4057qib7	12514	2	p=0.3	p=0.3	NNP
cord-005453-4057qib7	12514	3	)	)	-RRB-
cord-005453-4057qib7	12514	4	.	.	.
cord-005453-4057qib7	12515	1	Nine	nine	CD
cord-005453-4057qib7	12515	2	(	(	-LRB-
cord-005453-4057qib7	12515	3	69.2	69.2	CD
cord-005453-4057qib7	12515	4	%	%	NN
cord-005453-4057qib7	12515	5	)	)	-RRB-
cord-005453-4057qib7	12515	6	patients	patient	NNS
cord-005453-4057qib7	12515	7	achieved	achieve	VBD
cord-005453-4057qib7	12515	8	post	post	JJ
cord-005453-4057qib7	12515	9	-	-	JJ
cord-005453-4057qib7	12515	10	ASCT	asct	JJ
cord-005453-4057qib7	12515	11	immune	immune	JJ
cord-005453-4057qib7	12515	12	response	response	NN
cord-005453-4057qib7	12515	13	(	(	-LRB-
cord-005453-4057qib7	12515	14	IF	if	NN
cord-005453-4057qib7	12515	15	(	(	-LRB-
cord-005453-4057qib7	12515	16	-	-	:
cord-005453-4057qib7	12515	17	)	)	-RRB-
cord-005453-4057qib7	12515	18	)	)	-RRB-
cord-005453-4057qib7	12516	1	≥VGPR	≥vgpr	NN
cord-005453-4057qib7	12516	2	compared	compare	VBN
cord-005453-4057qib7	12516	3	to	to	IN
cord-005453-4057qib7	12516	4	92	92	CD
cord-005453-4057qib7	12516	5	(	(	-LRB-
cord-005453-4057qib7	12516	6	78.6	78.6	CD
cord-005453-4057qib7	12516	7	%	%	NN
cord-005453-4057qib7	12516	8	)	)	-RRB-
cord-005453-4057qib7	12516	9	in	in	IN
cord-005453-4057qib7	12516	10	the	the	DT
cord-005453-4057qib7	12516	11	HDM	HDM	NNP
cord-005453-4057qib7	12516	12	group	group	NN
cord-005453-4057qib7	12516	13	.	.	.
cord-005453-4057qib7	12517	1	At	at	IN
cord-005453-4057qib7	12517	2	the	the	DT
cord-005453-4057qib7	12517	3	time	time	NN
cord-005453-4057qib7	12517	4	of	of	IN
cord-005453-4057qib7	12517	5	this	this	DT
cord-005453-4057qib7	12517	6	analysis	analysis	NN
cord-005453-4057qib7	12517	7	,	,	,
cord-005453-4057qib7	12517	8	ten	ten	CD
cord-005453-4057qib7	12517	9	patients	patient	NNS
cord-005453-4057qib7	12517	10	in	in	IN
cord-005453-4057qib7	12517	11	the	the	DT
cord-005453-4057qib7	12517	12	Bor	Bor	NNP
cord-005453-4057qib7	12517	13	-	-	HYPH
cord-005453-4057qib7	12517	14	HDM	HDM	NNP
cord-005453-4057qib7	12517	15	group	group	NN
cord-005453-4057qib7	12517	16	and	and	CC
cord-005453-4057qib7	12517	17	87	87	CD
cord-005453-4057qib7	12517	18	in	in	IN
cord-005453-4057qib7	12517	19	the	the	DT
cord-005453-4057qib7	12517	20	HDM	HDM	NNP
cord-005453-4057qib7	12517	21	group	group	NN
cord-005453-4057qib7	12517	22	had	have	VBD
cord-005453-4057qib7	12517	23	already	already	RB
cord-005453-4057qib7	12517	24	died	die	VBN
cord-005453-4057qib7	12517	25	,	,	,
cord-005453-4057qib7	12517	26	respectively	respectively	RB
cord-005453-4057qib7	12517	27	(	(	-LRB-
cord-005453-4057qib7	12517	28	p>0.5	p>0.5	NNP
cord-005453-4057qib7	12517	29	)	)	-RRB-
cord-005453-4057qib7	12517	30	.	.	.
cord-005453-4057qib7	12518	1	A	a	DT
cord-005453-4057qib7	12518	2	total	total	NN
cord-005453-4057qib7	12518	3	of	of	IN
cord-005453-4057qib7	12518	4	5	5	CD
cord-005453-4057qib7	12518	5	(	(	-LRB-
cord-005453-4057qib7	12518	6	45.5	45.5	CD
cord-005453-4057qib7	12518	7	%	%	NN
cord-005453-4057qib7	12518	8	)	)	-RRB-
cord-005453-4057qib7	12518	9	patients	patient	NNS
cord-005453-4057qib7	12518	10	in	in	IN
cord-005453-4057qib7	12518	11	the	the	DT
cord-005453-4057qib7	12518	12	Bor	Bor	NNP
cord-005453-4057qib7	12518	13	-	-	HYPH
cord-005453-4057qib7	12518	14	HDM	HDM	NNP
cord-005453-4057qib7	12518	15	group	group	NN
cord-005453-4057qib7	12518	16	and	and	CC
cord-005453-4057qib7	12518	17	50	50	CD
cord-005453-4057qib7	12518	18	(	(	-LRB-
cord-005453-4057qib7	12518	19	44.2	44.2	CD
cord-005453-4057qib7	12518	20	%	%	NN
cord-005453-4057qib7	12518	21	)	)	-RRB-
cord-005453-4057qib7	12518	22	patients	patient	NNS
cord-005453-4057qib7	12518	23	in	in	IN
cord-005453-4057qib7	12518	24	HDM	HDM	NNP
cord-005453-4057qib7	12518	25	group	group	NN
cord-005453-4057qib7	12518	26	had	have	VBD
cord-005453-4057qib7	12518	27	already	already	RB
cord-005453-4057qib7	12518	28	progressed	progress	VBN
cord-005453-4057qib7	12518	29	(	(	-LRB-
cord-005453-4057qib7	12518	30	p>0.5	p>0.5	NNP
cord-005453-4057qib7	12518	31	)	)	-RRB-
cord-005453-4057qib7	12518	32	.	.	.
cord-005453-4057qib7	12519	1	Estimated	estimate	VBN
cord-005453-4057qib7	12519	2	mean	mean	VBP
cord-005453-4057qib7	12519	3	OS	OS	NNP
cord-005453-4057qib7	12519	4	and	and	CC
cord-005453-4057qib7	12519	5	PFS	PFS	NNP
cord-005453-4057qib7	12519	6	was	be	VBD
cord-005453-4057qib7	12519	7	shorter	short	JJR
cord-005453-4057qib7	12519	8	for	for	IN
cord-005453-4057qib7	12519	9	group	group	NN
cord-005453-4057qib7	12519	10	treated	treat	VBN
cord-005453-4057qib7	12519	11	with	with	IN
cord-005453-4057qib7	12519	12	Bor	Bor	NNP
cord-005453-4057qib7	12519	13	-	-	HYPH
cord-005453-4057qib7	12519	14	HDM	HDM	NNP
cord-005453-4057qib7	12519	15	;	;	:
cord-005453-4057qib7	12519	16	48.2±6.9	48.2±6.9	CD
cord-005453-4057qib7	12519	17	mos	mos	NN
cord-005453-4057qib7	12519	18	and	and	CC
cord-005453-4057qib7	12519	19	40.2±8.5	40.2±8.5	CD
cord-005453-4057qib7	12519	20	mos	mos	NNP
cord-005453-4057qib7	12519	21	vs.	vs.	FW
cord-005453-4057qib7	12519	22	76.7±3.9	76.7±3.9	NNP
cord-005453-4057qib7	12519	23	mos	mos	NNP
cord-005453-4057qib7	12519	24	and	and	CC
cord-005453-4057qib7	12519	25	67.3±3.8	67.3±3.8	CD
cord-005453-4057qib7	12519	26	mos	mos	NN
cord-005453-4057qib7	12519	27	,	,	,
cord-005453-4057qib7	12519	28	respectively	respectively	RB
cord-005453-4057qib7	12519	29	(	(	-LRB-
cord-005453-4057qib7	12519	30	p>0.5	p>0.5	NNP
cord-005453-4057qib7	12519	31	)	)	-RRB-
cord-005453-4057qib7	12519	32	(	(	-LRB-
cord-005453-4057qib7	12519	33	Figure-1	Figure-1	NNP
cord-005453-4057qib7	12519	34	)	)	-RRB-
cord-005453-4057qib7	12519	35	.	.	.
cord-005453-4057qib7	12520	1	We	-PRON-	PRP
cord-005453-4057qib7	12520	2	could	could	MD
cord-005453-4057qib7	12520	3	not	not	RB
cord-005453-4057qib7	12520	4	demonstrate	demonstrate	VB
cord-005453-4057qib7	12520	5	the	the	DT
cord-005453-4057qib7	12520	6	impact	impact	NN
cord-005453-4057qib7	12520	7	of	of	IN
cord-005453-4057qib7	12520	8	pre	pre	JJ
cord-005453-4057qib7	12520	9	or	or	CC
cord-005453-4057qib7	12520	10	post	post	JJ
cord-005453-4057qib7	12520	11	transplant	transplant	NN
cord-005453-4057qib7	12520	12	≥VGPR	≥vgpr	NN
cord-005453-4057qib7	12520	13	immune	immune	JJ
cord-005453-4057qib7	12520	14	response	response	NN
cord-005453-4057qib7	12520	15	on	on	IN
cord-005453-4057qib7	12520	16	survival	survival	NN
cord-005453-4057qib7	12520	17	and	and	CC
cord-005453-4057qib7	12520	18	disease	disease	NN
cord-005453-4057qib7	12520	19	free	free	JJ
cord-005453-4057qib7	12520	20	survival	survival	NN
cord-005453-4057qib7	12520	21	.	.	.
cord-005453-4057qib7	12521	1	There	there	EX
cord-005453-4057qib7	12521	2	was	be	VBD
cord-005453-4057qib7	12521	3	no	no	DT
cord-005453-4057qib7	12521	4	engraftment	engraftment	NN
cord-005453-4057qib7	12521	5	failure	failure	NN
cord-005453-4057qib7	12521	6	observed	observe	VBN
cord-005453-4057qib7	12521	7	on	on	IN
cord-005453-4057qib7	12521	8	either	either	DT
cord-005453-4057qib7	12521	9	treatment	treatment	NN
cord-005453-4057qib7	12521	10	group	group	NN
cord-005453-4057qib7	12521	11	and	and	CC
cord-005453-4057qib7	12521	12	no	no	DT
cord-005453-4057qib7	12521	13	worsening	worsen	VBG
cord-005453-4057qib7	12521	14	peripheral	peripheral	JJ
cord-005453-4057qib7	12521	15	neuropathy	neuropathy	NN
cord-005453-4057qib7	12521	16	was	be	VBD
cord-005453-4057qib7	12521	17	developed	develop	VBN
cord-005453-4057qib7	12521	18	in	in	IN
cord-005453-4057qib7	12521	19	the	the	DT
cord-005453-4057qib7	12521	20	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12521	21	arm	arm	NN
cord-005453-4057qib7	12521	22	.	.	.
cord-005453-4057qib7	12522	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12522	2	:	:	:
cord-005453-4057qib7	12523	1	This	this	DT
cord-005453-4057qib7	12523	2	single	single	JJ
cord-005453-4057qib7	12523	3	center	center	NN
cord-005453-4057qib7	12523	4	experience	experience	NN
cord-005453-4057qib7	12523	5	on	on	IN
cord-005453-4057qib7	12523	6	a	a	DT
cord-005453-4057qib7	12523	7	small	small	JJ
cord-005453-4057qib7	12523	8	patient	patient	JJ
cord-005453-4057qib7	12523	9	pool	pool	NN
cord-005453-4057qib7	12523	10	was	be	VBD
cord-005453-4057qib7	12523	11	able	able	JJ
cord-005453-4057qib7	12523	12	to	to	TO
cord-005453-4057qib7	12523	13	repeat	repeat	VB
cord-005453-4057qib7	12523	14	the	the	DT
cord-005453-4057qib7	12523	15	prospective	prospective	JJ
cord-005453-4057qib7	12523	16	randomized	randomized	JJ
cord-005453-4057qib7	12523	17	study	study	NN
cord-005453-4057qib7	12523	18	results	result	NNS
cord-005453-4057qib7	12523	19	of	of	IN
cord-005453-4057qib7	12523	20	IFM	IFM	NNP
cord-005453-4057qib7	12523	21	.	.	.
cord-005453-4057qib7	12524	1	Further	further	JJ
cord-005453-4057qib7	12524	2	studies	study	NNS
cord-005453-4057qib7	12524	3	are	be	VBP
cord-005453-4057qib7	12524	4	warranted	warrant	VBN
cord-005453-4057qib7	12524	5	to	to	TO
cord-005453-4057qib7	12524	6	explore	explore	VB
cord-005453-4057qib7	12524	7	this	this	DT
cord-005453-4057qib7	12524	8	regimen	regimen	NN
cord-005453-4057qib7	12524	9	,	,	,
cord-005453-4057qib7	12524	10	especially	especially	RB
cord-005453-4057qib7	12524	11	when	when	WRB
cord-005453-4057qib7	12524	12	induction	induction	NN
cord-005453-4057qib7	12524	13	treatment	treatment	NN
cord-005453-4057qib7	12524	14	with	with	IN
cord-005453-4057qib7	12524	15	novel	novel	JJ
cord-005453-4057qib7	12524	16	agents	agent	NNS
cord-005453-4057qib7	12524	17	are	be	VBP
cord-005453-4057qib7	12524	18	employed	employ	VBN
cord-005453-4057qib7	12524	19	,	,	,
cord-005453-4057qib7	12524	20	with	with	IN
cord-005453-4057qib7	12524	21	special	special	JJ
cord-005453-4057qib7	12524	22	emphasis	emphasis	NN
cord-005453-4057qib7	12524	23	on	on	IN
cord-005453-4057qib7	12524	24	the	the	DT
cord-005453-4057qib7	12524	25	high	high	JJ
cord-005453-4057qib7	12524	26	-	-	HYPH
cord-005453-4057qib7	12524	27	risk	risk	NN
cord-005453-4057qib7	12524	28	myeloma	myeloma	NN
cord-005453-4057qib7	12524	29	patients	patient	NNS
cord-005453-4057qib7	12524	30	where	where	WRB
cord-005453-4057qib7	12524	31	response	response	NN
cord-005453-4057qib7	12524	32	rates	rate	NNS
cord-005453-4057qib7	12524	33	are	be	VBP
cord-005453-4057qib7	12524	34	good	good	JJ
cord-005453-4057qib7	12524	35	but	but	CC
cord-005453-4057qib7	12524	36	sustainability	sustainability	NN
cord-005453-4057qib7	12524	37	remains	remain	VBZ
cord-005453-4057qib7	12524	38	an	an	DT
cord-005453-4057qib7	12524	39	issue	issue	NN
cord-005453-4057qib7	12524	40	.	.	.
cord-005453-4057qib7	12525	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12525	2	:	:	:
cord-005453-4057qib7	12525	3	Nothing	nothing	NN
cord-005453-4057qib7	12525	4	to	to	TO
cord-005453-4057qib7	12525	5	disclosure	disclosure	VB
cord-005453-4057qib7	12525	6	The	the	DT
cord-005453-4057qib7	12525	7	efficacy	efficacy	NN
cord-005453-4057qib7	12525	8	and	and	CC
cord-005453-4057qib7	12525	9	safety	safety	NN
cord-005453-4057qib7	12525	10	of	of	IN
cord-005453-4057qib7	12525	11	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12525	12	plus	plus	CC
cord-005453-4057qib7	12525	13	busulfan/	busulfan/	NNP
cord-005453-4057qib7	12525	14	melphalan	melphalan	NNP
cord-005453-4057qib7	12525	15	as	as	IN
cord-005453-4057qib7	12525	16	conditioning	conditioning	NN
cord-005453-4057qib7	12525	17	regimen	regimen	NN
cord-005453-4057qib7	12525	18	in	in	IN
cord-005453-4057qib7	12525	19	multiple	multiple	JJ
cord-005453-4057qib7	12525	20	myeloma	myeloma	NN
cord-005453-4057qib7	12525	21	undergoing	undergo	VBG
cord-005453-4057qib7	12525	22	autologous	autologous	JJ
cord-005453-4057qib7	12525	23	stem	stem	NN
cord-005453-4057qib7	12525	24	cell	cell	NN
cord-005453-4057qib7	12525	25	transplantation	transplantation	NN
cord-005453-4057qib7	12525	26	:	:	:
cord-005453-4057qib7	12526	1	PHASE	phase	NN
cord-005453-4057qib7	12526	2	1/2	1/2	CD
cord-005453-4057qib7	12526	3	study	study	NN
cord-005453-4057qib7	12526	4	Background	background	NN
cord-005453-4057qib7	12526	5	:	:	:
cord-005453-4057qib7	12526	6	Bortezomib	Bortezomib	NNP
cord-005453-4057qib7	12526	7	have	have	VBP
cord-005453-4057qib7	12526	8	a	a	DT
cord-005453-4057qib7	12526	9	powerful	powerful	JJ
cord-005453-4057qib7	12526	10	antimyeloma	antimyeloma	NN
cord-005453-4057qib7	12526	11	activity	activity	NN
cord-005453-4057qib7	12526	12	and	and	CC
cord-005453-4057qib7	12526	13	was	be	VBD
cord-005453-4057qib7	12526	14	regarded	regard	VBN
cord-005453-4057qib7	12526	15	as	as	IN
cord-005453-4057qib7	12526	16	backbone	backbone	NN
cord-005453-4057qib7	12526	17	of	of	IN
cord-005453-4057qib7	12526	18	therapy	therapy	NN
cord-005453-4057qib7	12526	19	in	in	IN
cord-005453-4057qib7	12526	20	the	the	DT
cord-005453-4057qib7	12526	21	past	past	JJ
cord-005453-4057qib7	12526	22	decade	decade	NN
cord-005453-4057qib7	12526	23	but	but	CC
cord-005453-4057qib7	12526	24	its	-PRON-	PRP$
cord-005453-4057qib7	12526	25	safety	safety	NN
cord-005453-4057qib7	12526	26	and	and	CC
cord-005453-4057qib7	12526	27	efficacy	efficacy	NN
cord-005453-4057qib7	12526	28	as	as	IN
cord-005453-4057qib7	12526	29	a	a	DT
cord-005453-4057qib7	12526	30	part	part	NN
cord-005453-4057qib7	12526	31	of	of	IN
cord-005453-4057qib7	12526	32	busulfan/	busulfan/	ADD
cord-005453-4057qib7	12526	33	melphalan	melphalan	NNP
cord-005453-4057qib7	12526	34	conditioning	conditioning	NN
cord-005453-4057qib7	12526	35	regimen	regimen	NN
cord-005453-4057qib7	12526	36	of	of	IN
cord-005453-4057qib7	12526	37	autologous	autologous	JJ
cord-005453-4057qib7	12526	38	stem	stem	NN
cord-005453-4057qib7	12526	39	cell	cell	NN
cord-005453-4057qib7	12526	40	transplantation	transplantation	NN
cord-005453-4057qib7	12526	41	is	be	VBZ
cord-005453-4057qib7	12526	42	yet	yet	RB
cord-005453-4057qib7	12526	43	to	to	TO
cord-005453-4057qib7	12526	44	be	be	VB
cord-005453-4057qib7	12526	45	shown	show	VBN
cord-005453-4057qib7	12526	46	.	.	.
cord-005453-4057qib7	12527	1	Methods	method	NNS
cord-005453-4057qib7	12527	2	:	:	:
cord-005453-4057qib7	12528	1	A	a	DT
cord-005453-4057qib7	12528	2	phase	phase	NN
cord-005453-4057qib7	12528	3	1/2	1/2	CD
cord-005453-4057qib7	12528	4	trial	trial	NN
cord-005453-4057qib7	12528	5	to	to	TO
cord-005453-4057qib7	12528	6	explore	explore	VB
cord-005453-4057qib7	12528	7	the	the	DT
cord-005453-4057qib7	12528	8	safety	safety	NN
cord-005453-4057qib7	12528	9	and	and	CC
cord-005453-4057qib7	12528	10	activity	activity	NN
cord-005453-4057qib7	12528	11	of	of	IN
cord-005453-4057qib7	12528	12	a	a	DT
cord-005453-4057qib7	12528	13	bortezomib	bortezomib	NN
cord-005453-4057qib7	12528	14	on	on	IN
cord-005453-4057qib7	12528	15	days	day	NNS
cord-005453-4057qib7	12528	16	-6	-6	NNP
cord-005453-4057qib7	12528	17	,	,	,
cord-005453-4057qib7	12528	18	-3	-3	NNP
cord-005453-4057qib7	12528	19	,	,	,
cord-005453-4057qib7	12528	20	and	and	CC
cord-005453-4057qib7	12528	21	+1	+1	LS
cord-005453-4057qib7	12528	22	added	add	VBD
cord-005453-4057qib7	12528	23	to	to	IN
cord-005453-4057qib7	12528	24	a	a	DT
cord-005453-4057qib7	12528	25	conditioning	conditioning	NN
cord-005453-4057qib7	12528	26	regimen	regimen	NN
cord-005453-4057qib7	12528	27	with	with	IN
cord-005453-4057qib7	12528	28	busulfan	busulfan	NNP
cord-005453-4057qib7	12528	29	and	and	CC
cord-005453-4057qib7	12528	30	melphalan	melphalan	NNP
cord-005453-4057qib7	12528	31	(	(	-LRB-
cord-005453-4057qib7	12528	32	BuMel	BuMel	NNP
cord-005453-4057qib7	12528	33	,	,	,
cord-005453-4057qib7	12528	34	3.2	3.2	CD
cord-005453-4057qib7	12528	35	mg	mg	NNP
cord-005453-4057qib7	12528	36	/	/	SYM
cord-005453-4057qib7	12528	37	kg	kg	NNP
cord-005453-4057qib7	12528	38	/	/	SYM
cord-005453-4057qib7	12528	39	day	day	NN
cord-005453-4057qib7	12528	40	and	and	CC
cord-005453-4057qib7	12528	41	busulfan	busulfan	NN
cord-005453-4057qib7	12528	42	during	during	IN
cord-005453-4057qib7	12528	43	day	day	NN
cord-005453-4057qib7	12528	44	-5	-5	NNP
cord-005453-4057qib7	12529	1	and	and	CC
cord-005453-4057qib7	12529	2	-3	-3	NNP
cord-005453-4057qib7	12529	3	,	,	,
cord-005453-4057qib7	12529	4	140	140	CD
cord-005453-4057qib7	12529	5	mg/	mg/	NN
cord-005453-4057qib7	12529	6	m	m	CD
cord-005453-4057qib7	12529	7	2	2	CD
cord-005453-4057qib7	12529	8	/day	/day	CD
cord-005453-4057qib7	12529	9	of	of	IN
cord-005453-4057qib7	12529	10	melphalan	melphalan	NNP
cord-005453-4057qib7	12529	11	on	on	IN
cord-005453-4057qib7	12529	12	the	the	DT
cord-005453-4057qib7	12529	13	day	day	NN
cord-005453-4057qib7	12529	14	-2	-2	CD
cord-005453-4057qib7	12529	15	)	)	-RRB-
cord-005453-4057qib7	12529	16	,	,	,
cord-005453-4057qib7	12529	17	in	in	IN
cord-005453-4057qib7	12529	18	multiple	multiple	JJ
cord-005453-4057qib7	12529	19	myeloma	myeloma	NN
cord-005453-4057qib7	12529	20	(	(	-LRB-
cord-005453-4057qib7	12529	21	MM	MM	NNP
cord-005453-4057qib7	12529	22	)	)	-RRB-
cord-005453-4057qib7	12529	23	patients	patient	NNS
cord-005453-4057qib7	12529	24	who	who	WP
cord-005453-4057qib7	12529	25	received	receive	VBD
cord-005453-4057qib7	12529	26	autologous	autologous	JJ
cord-005453-4057qib7	12529	27	stem	stem	NN
cord-005453-4057qib7	12529	28	cell	cell	NN
cord-005453-4057qib7	12529	29	transplantation	transplantation	NN
cord-005453-4057qib7	12529	30	following	follow	VBG
cord-005453-4057qib7	12529	31	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12529	32	-	-	HYPH
cord-005453-4057qib7	12529	33	based	base	VBN
cord-005453-4057qib7	12529	34	induction	induction	NN
cord-005453-4057qib7	12529	35	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12529	36	.	.	.
cord-005453-4057qib7	12530	1	In	in	IN
cord-005453-4057qib7	12530	2	Phase	phase	NN
cord-005453-4057qib7	12530	3	1	1	CD
cord-005453-4057qib7	12530	4	,	,	,
cord-005453-4057qib7	12530	5	escalating	escalate	VBG
cord-005453-4057qib7	12530	6	doses	dose	NNS
cord-005453-4057qib7	12530	7	(	(	-LRB-
cord-005453-4057qib7	12530	8	0.7	0.7	CD
cord-005453-4057qib7	12530	9	,	,	,
cord-005453-4057qib7	12530	10	1.0	1.0	CD
cord-005453-4057qib7	12530	11	,	,	,
cord-005453-4057qib7	12530	12	and	and	CC
cord-005453-4057qib7	12530	13	1.3	1.3	CD
cord-005453-4057qib7	12530	14	mg	mg	NNP
cord-005453-4057qib7	12530	15	/	/	SYM
cord-005453-4057qib7	12530	16	m	m	NNP
cord-005453-4057qib7	12530	17	2	2	CD
cord-005453-4057qib7	12530	18	)	)	-RRB-
cord-005453-4057qib7	12530	19	of	of	IN
cord-005453-4057qib7	12530	20	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12530	21	with	with	IN
cord-005453-4057qib7	12530	22	BuMel	BuMel	NNP
cord-005453-4057qib7	12530	23	were	be	VBD
cord-005453-4057qib7	12530	24	administered	administer	VBN
cord-005453-4057qib7	12530	25	in	in	IN
cord-005453-4057qib7	12530	26	each	each	DT
cord-005453-4057qib7	12530	27	group	group	NN
cord-005453-4057qib7	12530	28	with	with	IN
cord-005453-4057qib7	12530	29	three	three	CD
cord-005453-4057qib7	12530	30	patients	patient	NNS
cord-005453-4057qib7	12530	31	.	.	.
cord-005453-4057qib7	12531	1	With	with	IN
cord-005453-4057qib7	12531	2	determined	determined	JJ
cord-005453-4057qib7	12531	3	maximum	maximum	NN
cord-005453-4057qib7	12531	4	tolerated	tolerate	VBN
cord-005453-4057qib7	12531	5	dose	dose	NN
cord-005453-4057qib7	12531	6	of	of	IN
cord-005453-4057qib7	12531	7	bortzomib	bortzomib	NNP
cord-005453-4057qib7	12531	8	at	at	IN
cord-005453-4057qib7	12531	9	a	a	DT
cord-005453-4057qib7	12531	10	1.3mg	1.3mg	CD
cord-005453-4057qib7	12531	11	/	/	SYM
cord-005453-4057qib7	12531	12	m	m	CD
cord-005453-4057qib7	12531	13	2	2	CD
cord-005453-4057qib7	12531	14	/day	/day	CD
cord-005453-4057qib7	12531	15	,	,	,
cord-005453-4057qib7	12531	16	cohort	cohort	NN
cord-005453-4057qib7	12531	17	with	with	IN
cord-005453-4057qib7	12531	18	41	41	CD
cord-005453-4057qib7	12531	19	patients	patient	NNS
cord-005453-4057qib7	12531	20	were	be	VBD
cord-005453-4057qib7	12531	21	analyzed	analyze	VBN
cord-005453-4057qib7	12531	22	for	for	IN
cord-005453-4057qib7	12531	23	Phase	phase	NN
cord-005453-4057qib7	12531	24	2	2	CD
cord-005453-4057qib7	12531	25	.	.	.
cord-005453-4057qib7	12532	1	Results	result	NNS
cord-005453-4057qib7	12532	2	:	:	:
cord-005453-4057qib7	12533	1	In	in	IN
cord-005453-4057qib7	12533	2	Phase	phase	NN
cord-005453-4057qib7	12533	3	1	1	CD
cord-005453-4057qib7	12533	4	,	,	,
cord-005453-4057qib7	12533	5	no	no	DT
cord-005453-4057qib7	12533	6	dose	dose	NN
cord-005453-4057qib7	12533	7	limiting	limit	VBG
cord-005453-4057qib7	12533	8	toxicity	toxicity	NN
cord-005453-4057qib7	12533	9	was	be	VBD
cord-005453-4057qib7	12533	10	observed	observe	VBN
cord-005453-4057qib7	12533	11	at	at	IN
cord-005453-4057qib7	12533	12	a	a	DT
cord-005453-4057qib7	12533	13	1.3mg	1.3mg	CD
cord-005453-4057qib7	12533	14	/	/	SYM
cord-005453-4057qib7	12533	15	m	m	NN
cord-005453-4057qib7	12533	16	2	2	CD
cord-005453-4057qib7	12533	17	/day	/day	CD
cord-005453-4057qib7	12533	18	of	of	IN
cord-005453-4057qib7	12533	19	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12533	20	.	.	.
cord-005453-4057qib7	12534	1	In	in	IN
cord-005453-4057qib7	12534	2	Phase	phase	NN
cord-005453-4057qib7	12534	3	2	2	CD
cord-005453-4057qib7	12534	4	,	,	,
cord-005453-4057qib7	12534	5	overall	overall	JJ
cord-005453-4057qib7	12534	6	responses	response	NNS
cord-005453-4057qib7	12534	7	at	at	IN
cord-005453-4057qib7	12534	8	3	3	CD
cord-005453-4057qib7	12534	9	months	month	NNS
cord-005453-4057qib7	12534	10	was	be	VBD
cord-005453-4057qib7	12534	11	shown	show	VBN
cord-005453-4057qib7	12534	12	as	as	IN
cord-005453-4057qib7	12534	13	75	75	CD
cord-005453-4057qib7	12534	14	%	%	NN
cord-005453-4057qib7	12534	15	of	of	IN
cord-005453-4057qib7	12534	16	very	very	RB
cord-005453-4057qib7	12534	17	good	good	JJ
cord-005453-4057qib7	12534	18	partial	partial	JJ
cord-005453-4057qib7	12534	19	response	response	NN
cord-005453-4057qib7	12534	20	(	(	-LRB-
cord-005453-4057qib7	12534	21	VGPR	VGPR	NNP
cord-005453-4057qib7	12534	22	)	)	-RRB-
cord-005453-4057qib7	12534	23	or	or	CC
cord-005453-4057qib7	12534	24	better	well	JJR
cord-005453-4057qib7	12534	25	and	and	CC
cord-005453-4057qib7	12534	26	55	55	CD
cord-005453-4057qib7	12534	27	%	%	NN
cord-005453-4057qib7	12534	28	of	of	IN
cord-005453-4057qib7	12534	29	complete	complete	JJ
cord-005453-4057qib7	12534	30	response	response	NN
cord-005453-4057qib7	12534	31	(	(	-LRB-
cord-005453-4057qib7	12534	32	CR	CR	NNP
cord-005453-4057qib7	12534	33	)	)	-RRB-
cord-005453-4057qib7	12534	34	,	,	,
cord-005453-4057qib7	12534	35	whereas	whereas	IN
cord-005453-4057qib7	12534	36	post	post	JJ
cord-005453-4057qib7	12534	37	-	-	JJ
cord-005453-4057qib7	12534	38	transplant	transplant	JJ
cord-005453-4057qib7	12534	39	overall	overall	RB
cord-005453-4057qib7	12534	40	best	good	JJS
cord-005453-4057qib7	12534	41	response	response	NN
cord-005453-4057qib7	12534	42	included	include	VBD
cord-005453-4057qib7	12534	43	83	83	CD
cord-005453-4057qib7	12534	44	%	%	NN
cord-005453-4057qib7	12534	45	of	of	IN
cord-005453-4057qib7	12534	46	VGPR	vgpr	NN
cord-005453-4057qib7	12534	47	or	or	CC
cord-005453-4057qib7	12534	48	better	well	JJR
cord-005453-4057qib7	12534	49	,	,	,
cord-005453-4057qib7	12534	50	and	and	CC
cord-005453-4057qib7	12534	51	68	68	CD
cord-005453-4057qib7	12534	52	%	%	NN
cord-005453-4057qib7	12534	53	of	of	IN
cord-005453-4057qib7	12534	54	CR	cr	NN
cord-005453-4057qib7	12534	55	,	,	,
cord-005453-4057qib7	12534	56	respectively	respectively	RB
cord-005453-4057qib7	12534	57	.	.	.
cord-005453-4057qib7	12535	1	With	with	IN
cord-005453-4057qib7	12535	2	median	median	JJ
cord-005453-4057qib7	12535	3	follow	follow	NN
cord-005453-4057qib7	12535	4	-	-	HYPH
cord-005453-4057qib7	12535	5	up	up	NN
cord-005453-4057qib7	12535	6	duration	duration	NN
cord-005453-4057qib7	12535	7	of	of	IN
cord-005453-4057qib7	12535	8	31.4	31.4	CD
cord-005453-4057qib7	12535	9	months	month	NNS
cord-005453-4057qib7	12535	10	,	,	,
cord-005453-4057qib7	12535	11	median	median	JJ
cord-005453-4057qib7	12535	12	progression	progression	NN
cord-005453-4057qib7	12535	13	-	-	HYPH
cord-005453-4057qib7	12535	14	free	free	JJ
cord-005453-4057qib7	12535	15	survival	survival	NN
cord-005453-4057qib7	12535	16	(	(	-LRB-
cord-005453-4057qib7	12535	17	PFS	PFS	NNP
cord-005453-4057qib7	12535	18	)	)	-RRB-
cord-005453-4057qib7	12535	19	was	be	VBD
cord-005453-4057qib7	12535	20	26.8	26.8	CD
cord-005453-4057qib7	12535	21	months	month	NNS
cord-005453-4057qib7	12535	22	.	.	.
cord-005453-4057qib7	12536	1	The	the	DT
cord-005453-4057qib7	12536	2	probabilities	probability	NNS
cord-005453-4057qib7	12536	3	of	of	IN
cord-005453-4057qib7	12536	4	2	2	CD
cord-005453-4057qib7	12536	5	years	year	NNS
cord-005453-4057qib7	12536	6	-	-	:
cord-005453-4057qib7	12536	7	PFS	PFS	NNP
cord-005453-4057qib7	12536	8	and	and	CC
cord-005453-4057qib7	12536	9	overall	overall	JJ
cord-005453-4057qib7	12536	10	survival	survival	NN
cord-005453-4057qib7	12536	11	(	(	-LRB-
cord-005453-4057qib7	12536	12	OS	OS	NNP
cord-005453-4057qib7	12536	13	)	)	-RRB-
cord-005453-4057qib7	12536	14	were	be	VBD
cord-005453-4057qib7	12536	15	56.5	56.5	CD
cord-005453-4057qib7	12536	16	%	%	NN
cord-005453-4057qib7	12536	17	and	and	CC
cord-005453-4057qib7	12536	18	not	not	RB
cord-005453-4057qib7	12536	19	estimable	estimable	JJ
cord-005453-4057qib7	12536	20	,	,	,
cord-005453-4057qib7	12536	21	respectively	respectively	RB
cord-005453-4057qib7	12536	22	.	.	.
cord-005453-4057qib7	12537	1	Especially	especially	RB
cord-005453-4057qib7	12537	2	,	,	,
cord-005453-4057qib7	12537	3	high	high	JJ
cord-005453-4057qib7	12537	4	-	-	HYPH
cord-005453-4057qib7	12537	5	risk	risk	NN
cord-005453-4057qib7	12537	6	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	12537	7	were	be	VBD
cord-005453-4057qib7	12537	8	associated	associate	VBN
cord-005453-4057qib7	12537	9	adverse	adverse	JJ
cord-005453-4057qib7	12537	10	survival	survival	NN
cord-005453-4057qib7	12537	11	outcome	outcome	NN
cord-005453-4057qib7	12537	12	compared	compare	VBN
cord-005453-4057qib7	12537	13	to	to	IN
cord-005453-4057qib7	12537	14	standard	standard	JJ
cord-005453-4057qib7	12537	15	-	-	HYPH
cord-005453-4057qib7	12537	16	risk	risk	NN
cord-005453-4057qib7	12537	17	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	12537	18	,	,	,
cord-005453-4057qib7	12537	19	respectively	respectively	RB
cord-005453-4057qib7	12537	20	(	(	-LRB-
cord-005453-4057qib7	12537	21	PFS	PFS	NNP
cord-005453-4057qib7	12537	22	,	,	,
cord-005453-4057qib7	12537	23	12.2	12.2	CD
cord-005453-4057qib7	12537	24	vs.	vs.	IN
cord-005453-4057qib7	12537	25	35.7	35.7	CD
cord-005453-4057qib7	12537	26	months	month	NNS
cord-005453-4057qib7	12537	27	,	,	,
cord-005453-4057qib7	12537	28	p=0.039	p=0.039	JJ
cord-005453-4057qib7	12537	29	;	;	:
cord-005453-4057qib7	12537	30	OS	OS	NNP
cord-005453-4057qib7	12537	31	,	,	,
cord-005453-4057qib7	12537	32	26.7	26.7	CD
cord-005453-4057qib7	12537	33	vs.	vs.	IN
cord-005453-4057qib7	12537	34	73.3	73.3	CD
cord-005453-4057qib7	12537	35	months	month	NNS
cord-005453-4057qib7	12537	36	,	,	,
cord-005453-4057qib7	12537	37	p=0.086	p=0.086	NNPS
cord-005453-4057qib7	12537	38	)	)	-RRB-
cord-005453-4057qib7	12537	39	.	.	.
cord-005453-4057qib7	12538	1	With	with	IN
cord-005453-4057qib7	12538	2	median	median	JJ
cord-005453-4057qib7	12538	3	11	11	CD
cord-005453-4057qib7	12538	4	days	day	NNS
cord-005453-4057qib7	12538	5	and	and	CC
cord-005453-4057qib7	12538	6	10	10	CD
cord-005453-4057qib7	12538	7	days	day	NNS
cord-005453-4057qib7	12538	8	for	for	IN
cord-005453-4057qib7	12538	9	neutrophil	neutrophil	NN
cord-005453-4057qib7	12538	10	and	and	CC
cord-005453-4057qib7	12538	11	platelet	platelet	NN
cord-005453-4057qib7	12538	12	engraftments	engraftment	NNS
cord-005453-4057qib7	12538	13	,	,	,
cord-005453-4057qib7	12538	14	any	any	DT
cord-005453-4057qib7	12538	15	graft	graft	NN
cord-005453-4057qib7	12538	16	failure	failure	NN
cord-005453-4057qib7	12538	17	or	or	CC
cord-005453-4057qib7	12538	18	delayed	delay	VBN
cord-005453-4057qib7	12538	19	engraft	engraft	NN
cord-005453-4057qib7	12538	20	was	be	VBD
cord-005453-4057qib7	12538	21	not	not	RB
cord-005453-4057qib7	12538	22	observed	observe	VBN
cord-005453-4057qib7	12538	23	.	.	.
cord-005453-4057qib7	12539	1	The	the	DT
cord-005453-4057qib7	12539	2	common	common	JJ
cord-005453-4057qib7	12539	3	grade	grade	NN
cord-005453-4057qib7	12539	4	3	3	CD
cord-005453-4057qib7	12539	5	or	or	CC
cord-005453-4057qib7	12539	6	severe	severe	JJ
cord-005453-4057qib7	12539	7	non	non	JJ
cord-005453-4057qib7	12539	8	-	-	JJ
cord-005453-4057qib7	12539	9	hematological	hematological	JJ
cord-005453-4057qib7	12539	10	adverse	adverse	JJ
cord-005453-4057qib7	12539	11	events	event	NNS
cord-005453-4057qib7	12539	12	included	include	VBD
cord-005453-4057qib7	12539	13	neutropenic	neutropenic	JJ
cord-005453-4057qib7	12539	14	fever	fever	NN
cord-005453-4057qib7	12539	15	(	(	-LRB-
cord-005453-4057qib7	12539	16	73.2	73.2	CD
cord-005453-4057qib7	12539	17	%	%	NN
cord-005453-4057qib7	12539	18	)	)	-RRB-
cord-005453-4057qib7	12539	19	and	and	CC
cord-005453-4057qib7	12539	20	stomatitis	stomatitis	NN
cord-005453-4057qib7	12539	21	(	(	-LRB-
cord-005453-4057qib7	12539	22	14.6	14.6	CD
cord-005453-4057qib7	12539	23	%	%	NN
cord-005453-4057qib7	12539	24	)	)	-RRB-
cord-005453-4057qib7	12539	25	.	.	.
cord-005453-4057qib7	12540	1	Except	except	IN
cord-005453-4057qib7	12540	2	three	three	CD
cord-005453-4057qib7	12540	3	cases	case	NNS
cord-005453-4057qib7	12540	4	with	with	IN
cord-005453-4057qib7	12540	5	transplant	transplant	NN
cord-005453-4057qib7	12540	6	-	-	HYPH
cord-005453-4057qib7	12540	7	related	relate	VBN
cord-005453-4057qib7	12540	8	mortality	mortality	NN
cord-005453-4057qib7	12540	9	due	due	IN
cord-005453-4057qib7	12540	10	to	to	IN
cord-005453-4057qib7	12540	11	sepsis	sepsis	NN
cord-005453-4057qib7	12540	12	,	,	,
cord-005453-4057qib7	12540	13	other	other	JJ
cord-005453-4057qib7	12540	14	adverse	adverse	JJ
cord-005453-4057qib7	12540	15	events	event	NNS
cord-005453-4057qib7	12540	16	were	be	VBD
cord-005453-4057qib7	12540	17	manageable	manageable	JJ
cord-005453-4057qib7	12540	18	.	.	.
cord-005453-4057qib7	12541	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12541	2	:	:	:
cord-005453-4057qib7	12542	1	These	these	DT
cord-005453-4057qib7	12542	2	results	result	NNS
cord-005453-4057qib7	12542	3	demonstrate	demonstrate	VBP
cord-005453-4057qib7	12542	4	that	that	IN
cord-005453-4057qib7	12542	5	bortezomib	bortezomib	NNP
cord-005453-4057qib7	12542	6	is	be	VBZ
cord-005453-4057qib7	12542	7	safe	safe	JJ
cord-005453-4057qib7	12542	8	and	and	CC
cord-005453-4057qib7	12542	9	can	can	MD
cord-005453-4057qib7	12542	10	be	be	VB
cord-005453-4057qib7	12542	11	a	a	DT
cord-005453-4057qib7	12542	12	part	part	NN
cord-005453-4057qib7	12542	13	of	of	IN
cord-005453-4057qib7	12542	14	conditioning	conditioning	NN
cord-005453-4057qib7	12542	15	regimen	regimen	NN
cord-005453-4057qib7	12542	16	in	in	IN
cord-005453-4057qib7	12542	17	combination	combination	NN
cord-005453-4057qib7	12542	18	with	with	IN
cord-005453-4057qib7	12542	19	BuMel	BuMel	NNP
cord-005453-4057qib7	12542	20	,	,	,
cord-005453-4057qib7	12542	21	for	for	IN
cord-005453-4057qib7	12542	22	patients	patient	NNS
cord-005453-4057qib7	12542	23	with	with	IN
cord-005453-4057qib7	12542	24	transplanteligible	transplanteligible	JJ
cord-005453-4057qib7	12542	25	multiple	multiple	JJ
cord-005453-4057qib7	12542	26	myeloma	myeloma	NN
cord-005453-4057qib7	12542	27	.	.	.
cord-005453-4057qib7	12543	1	Clinical	clinical	JJ
cord-005453-4057qib7	12543	2	Background	background	NN
cord-005453-4057qib7	12543	3	:	:	:
cord-005453-4057qib7	12544	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	12544	2	stem	stem	NN
cord-005453-4057qib7	12544	3	-	-	HYPH
cord-005453-4057qib7	12544	4	cell	cell	NN
cord-005453-4057qib7	12544	5	transplantation	transplantation	NN
cord-005453-4057qib7	12544	6	(	(	-LRB-
cord-005453-4057qib7	12544	7	allo	allo	FW
cord-005453-4057qib7	12544	8	-	-	HYPH
cord-005453-4057qib7	12544	9	SCT	SCT	NNP
cord-005453-4057qib7	12544	10	)	)	-RRB-
cord-005453-4057qib7	12544	11	is	be	VBZ
cord-005453-4057qib7	12544	12	one	one	CD
cord-005453-4057qib7	12544	13	of	of	IN
cord-005453-4057qib7	12544	14	treatment	treatment	NN
cord-005453-4057qib7	12544	15	option	option	NN
cord-005453-4057qib7	12544	16	for	for	IN
cord-005453-4057qib7	12544	17	patients	patient	NNS
cord-005453-4057qib7	12544	18	with	with	IN
cord-005453-4057qib7	12544	19	multiple	multiple	JJ
cord-005453-4057qib7	12544	20	myeloma	myeloma	NN
cord-005453-4057qib7	12544	21	(	(	-LRB-
cord-005453-4057qib7	12544	22	MM	MM	NNP
cord-005453-4057qib7	12544	23	)	)	-RRB-
cord-005453-4057qib7	12544	24	refractory	refractory	JJ
cord-005453-4057qib7	12544	25	to	to	IN
cord-005453-4057qib7	12544	26	novel	novel	JJ
cord-005453-4057qib7	12544	27	agents	agent	NNS
cord-005453-4057qib7	12544	28	.	.	.
cord-005453-4057qib7	12545	1	The	the	DT
cord-005453-4057qib7	12545	2	reports	report	NNS
cord-005453-4057qib7	12545	3	on	on	IN
cord-005453-4057qib7	12545	4	allo	allo	NN
cord-005453-4057qib7	12545	5	-	-	HYPH
cord-005453-4057qib7	12545	6	SCT	SCT	NNP
cord-005453-4057qib7	12545	7	for	for	IN
cord-005453-4057qib7	12545	8	MM	MM	NNP
cord-005453-4057qib7	12545	9	are	be	VBP
cord-005453-4057qib7	12545	10	limited	limited	JJ
cord-005453-4057qib7	12545	11	and	and	CC
cord-005453-4057qib7	12545	12	it	-PRON-	PRP
cord-005453-4057qib7	12545	13	is	be	VBZ
cord-005453-4057qib7	12545	14	an	an	DT
cord-005453-4057qib7	12545	15	important	important	JJ
cord-005453-4057qib7	12545	16	issue	issue	NN
cord-005453-4057qib7	12545	17	to	to	TO
cord-005453-4057qib7	12545	18	argue	argue	VB
cord-005453-4057qib7	12545	19	appropriate	appropriate	JJ
cord-005453-4057qib7	12545	20	conditioning	conditioning	NN
cord-005453-4057qib7	12545	21	regimens	regimen	NNS
cord-005453-4057qib7	12545	22	and	and	CC
cord-005453-4057qib7	12545	23	stem	stem	NN
cord-005453-4057qib7	12545	24	-	-	HYPH
cord-005453-4057qib7	12545	25	cell	cell	NN
cord-005453-4057qib7	12545	26	sources	source	NNS
cord-005453-4057qib7	12545	27	,	,	,
cord-005453-4057qib7	12545	28	and	and	CC
cord-005453-4057qib7	12545	29	patient	patient	JJ
cord-005453-4057qib7	12545	30	population	population	NN
cord-005453-4057qib7	12545	31	who	who	WP
cord-005453-4057qib7	12545	32	will	will	MD
cord-005453-4057qib7	12545	33	benefit	benefit	VB
cord-005453-4057qib7	12545	34	from	from	IN
cord-005453-4057qib7	12545	35	allo	allo	NN
cord-005453-4057qib7	12545	36	-	-	HYPH
cord-005453-4057qib7	12545	37	SCT	SCT	NNP
cord-005453-4057qib7	12545	38	.	.	.
cord-005453-4057qib7	12546	1	Methods	method	NNS
cord-005453-4057qib7	12546	2	:	:	:
cord-005453-4057qib7	12547	1	We	-PRON-	PRP
cord-005453-4057qib7	12547	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	12547	3	analyzed	analyze	VBD
cord-005453-4057qib7	12547	4	25	25	CD
cord-005453-4057qib7	12547	5	consecutive	consecutive	JJ
cord-005453-4057qib7	12547	6	patients	patient	NNS
cord-005453-4057qib7	12547	7	who	who	WP
cord-005453-4057qib7	12547	8	received	receive	VBD
cord-005453-4057qib7	12547	9	allo	allo	NN
cord-005453-4057qib7	12547	10	-	-	HYPH
cord-005453-4057qib7	12547	11	SCT	SCT	NNP
cord-005453-4057qib7	12547	12	for	for	IN
cord-005453-4057qib7	12547	13	relapsed	relapsed	JJ
cord-005453-4057qib7	12547	14	and	and	CC
cord-005453-4057qib7	12547	15	refractory	refractory	JJ
cord-005453-4057qib7	12547	16	multiple	multiple	JJ
cord-005453-4057qib7	12547	17	myeloma	myeloma	NN
cord-005453-4057qib7	12547	18	(	(	-LRB-
cord-005453-4057qib7	12547	19	RRMM	RRMM	NNP
cord-005453-4057qib7	12547	20	)	)	-RRB-
cord-005453-4057qib7	12547	21	between	between	IN
cord-005453-4057qib7	12547	22	Oct	Oct	NNP
cord-005453-4057qib7	12547	23	2009	2009	CD
cord-005453-4057qib7	12547	24	and	and	CC
cord-005453-4057qib7	12547	25	July	July	NNP
cord-005453-4057qib7	12547	26	2018	2018	CD
cord-005453-4057qib7	12547	27	at	at	IN
cord-005453-4057qib7	12547	28	Japanese	japanese	JJ
cord-005453-4057qib7	12547	29	Red	Red	NNP
cord-005453-4057qib7	12547	30	Cross	Cross	NNP
cord-005453-4057qib7	12547	31	Medical	Medical	NNP
cord-005453-4057qib7	12547	32	Center	Center	NNP
cord-005453-4057qib7	12547	33	.	.	.
cord-005453-4057qib7	12548	1	Characteristics	characteristic	NNS
cord-005453-4057qib7	12548	2	of	of	IN
cord-005453-4057qib7	12548	3	patients	patient	NNS
cord-005453-4057qib7	12548	4	,	,	,
cord-005453-4057qib7	12548	5	progression	progression	NN
cord-005453-4057qib7	12548	6	-	-	HYPH
cord-005453-4057qib7	12548	7	free	free	JJ
cord-005453-4057qib7	12548	8	survival	survival	NN
cord-005453-4057qib7	12548	9	(	(	-LRB-
cord-005453-4057qib7	12548	10	PFS	PFS	NNP
cord-005453-4057qib7	12548	11	)	)	-RRB-
cord-005453-4057qib7	12548	12	,	,	,
cord-005453-4057qib7	12548	13	and	and	CC
cord-005453-4057qib7	12548	14	overall	overall	JJ
cord-005453-4057qib7	12548	15	survival	survival	NN
cord-005453-4057qib7	12548	16	(	(	-LRB-
cord-005453-4057qib7	12548	17	OS	OS	NNP
cord-005453-4057qib7	12548	18	)	)	-RRB-
cord-005453-4057qib7	12548	19	were	be	VBD
cord-005453-4057qib7	12548	20	analyzed	analyze	VBN
cord-005453-4057qib7	12548	21	.	.	.
cord-005453-4057qib7	12549	1	Results	result	NNS
cord-005453-4057qib7	12549	2	:	:	:
cord-005453-4057qib7	12550	1	Median	median	JJ
cord-005453-4057qib7	12550	2	age	age	NN
cord-005453-4057qib7	12550	3	at	at	IN
cord-005453-4057qib7	12550	4	allo	allo	NN
cord-005453-4057qib7	12550	5	-	-	HYPH
cord-005453-4057qib7	12550	6	SCT	SCT	NNP
cord-005453-4057qib7	12550	7	was	be	VBD
cord-005453-4057qib7	12550	8	47	47	CD
cord-005453-4057qib7	12550	9	(	(	-LRB-
cord-005453-4057qib7	12550	10	range	range	NNP
cord-005453-4057qib7	12550	11	31	31	CD
cord-005453-4057qib7	12550	12	-	-	SYM
cord-005453-4057qib7	12550	13	61	61	CD
cord-005453-4057qib7	12550	14	)	)	-RRB-
cord-005453-4057qib7	12550	15	.	.	.
cord-005453-4057qib7	12551	1	Twelve	twelve	CD
cord-005453-4057qib7	12551	2	patients	patient	NNS
cord-005453-4057qib7	12551	3	were	be	VBD
cord-005453-4057qib7	12551	4	male	male	JJ
cord-005453-4057qib7	12551	5	and	and	CC
cord-005453-4057qib7	12551	6	13	13	CD
cord-005453-4057qib7	12551	7	were	be	VBD
cord-005453-4057qib7	12551	8	female	female	JJ
cord-005453-4057qib7	12551	9	.	.	.
cord-005453-4057qib7	12552	1	Myeloma	myeloma	NN
cord-005453-4057qib7	12552	2	type	type	NN
cord-005453-4057qib7	12552	3	were	be	VBD
cord-005453-4057qib7	12552	4	IgG:14	IgG:14	VBN
cord-005453-4057qib7	12552	5	,	,	,
cord-005453-4057qib7	12552	6	IgA	IgA	NNP
cord-005453-4057qib7	12552	7	:	:	:
cord-005453-4057qib7	12552	8	3	3	CD
cord-005453-4057qib7	12552	9	,	,	,
cord-005453-4057qib7	12552	10	IgD	IgD	NNP
cord-005453-4057qib7	12552	11	:	:	:
cord-005453-4057qib7	12552	12	2	2	CD
cord-005453-4057qib7	12552	13	,	,	,
cord-005453-4057qib7	12552	14	and	and	CC
cord-005453-4057qib7	12552	15	Bence	Bence	NNP
cord-005453-4057qib7	12552	16	-	-	HYPH
cord-005453-4057qib7	12552	17	Jones	Jones	NNP
cord-005453-4057qib7	12552	18	:	:	:
cord-005453-4057qib7	12552	19	6	6	CD
cord-005453-4057qib7	12552	20	.	.	.
cord-005453-4057qib7	12553	1	Stem	stem	NN
cord-005453-4057qib7	12553	2	-	-	HYPH
cord-005453-4057qib7	12553	3	cell	cell	NN
cord-005453-4057qib7	12553	4	sources	source	NNS
cord-005453-4057qib7	12553	5	were	be	VBD
cord-005453-4057qib7	12553	6	peripheral	peripheral	JJ
cord-005453-4057qib7	12553	7	blood	blood	NN
cord-005453-4057qib7	12553	8	from	from	IN
cord-005453-4057qib7	12553	9	HLAmatched	hlamatche	VBN
cord-005453-4057qib7	12553	10	related	related	JJ
cord-005453-4057qib7	12553	11	donor	donor	NN
cord-005453-4057qib7	12553	12	(	(	-LRB-
cord-005453-4057qib7	12553	13	rPBSCT	rPBSCT	NNP
cord-005453-4057qib7	12553	14	)	)	-RRB-
cord-005453-4057qib7	12553	15	:	:	:
cord-005453-4057qib7	12553	16	6	6	CD
cord-005453-4057qib7	12553	17	,	,	,
cord-005453-4057qib7	12553	18	bone	bone	NN
cord-005453-4057qib7	12553	19	mallow	mallow	NN
cord-005453-4057qib7	12553	20	from	from	IN
cord-005453-4057qib7	12553	21	HLA	HLA	NNP
cord-005453-4057qib7	12553	22	-	-	HYPH
cord-005453-4057qib7	12553	23	matched	match	VBN
cord-005453-4057qib7	12553	24	unrelated	unrelated	JJ
cord-005453-4057qib7	12553	25	donor	donor	NN
cord-005453-4057qib7	12553	26	(	(	-LRB-
cord-005453-4057qib7	12553	27	MUD	mud	NN
cord-005453-4057qib7	12553	28	)	)	-RRB-
cord-005453-4057qib7	12553	29	:	:	:
cord-005453-4057qib7	12553	30	4	4	CD
cord-005453-4057qib7	12553	31	,	,	,
cord-005453-4057qib7	12553	32	bone	bone	NN
cord-005453-4057qib7	12553	33	marrow	marrow	NN
cord-005453-4057qib7	12553	34	from	from	IN
cord-005453-4057qib7	12553	35	HLA	HLA	NNP
cord-005453-4057qib7	12553	36	-	-	HYPH
cord-005453-4057qib7	12553	37	mismatched	mismatched	JJ
cord-005453-4057qib7	12553	38	donor	donor	NN
cord-005453-4057qib7	12553	39	(	(	-LRB-
cord-005453-4057qib7	12553	40	MMUD	MMUD	NNP
cord-005453-4057qib7	12553	41	)	)	-RRB-
cord-005453-4057qib7	12553	42	:	:	:
cord-005453-4057qib7	12553	43	7	7	CD
cord-005453-4057qib7	12553	44	,	,	,
cord-005453-4057qib7	12553	45	and	and	CC
cord-005453-4057qib7	12553	46	cord	cord	NN
cord-005453-4057qib7	12553	47	blood	blood	NN
cord-005453-4057qib7	12553	48	(	(	-LRB-
cord-005453-4057qib7	12553	49	CB	CB	NNP
cord-005453-4057qib7	12553	50	)	)	-RRB-
cord-005453-4057qib7	12553	51	:	:	:
cord-005453-4057qib7	12554	1	8	8	CD
cord-005453-4057qib7	12554	2	.	.	.
cord-005453-4057qib7	12555	1	Twenty	twenty	CD
cord-005453-4057qib7	12555	2	-	-	HYPH
cord-005453-4057qib7	12555	3	three	three	CD
cord-005453-4057qib7	12555	4	of	of	IN
cord-005453-4057qib7	12555	5	25	25	CD
cord-005453-4057qib7	12555	6	patients	patient	NNS
cord-005453-4057qib7	12555	7	received	receive	VBN
cord-005453-4057qib7	12555	8	Flu	Flu	NNP
cord-005453-4057qib7	12555	9	/	/	SYM
cord-005453-4057qib7	12555	10	Mel	Mel	NNP
cord-005453-4057qib7	12555	11	-	-	HYPH
cord-005453-4057qib7	12555	12	base	base	NN
cord-005453-4057qib7	12555	13	,	,	,
cord-005453-4057qib7	12555	14	one	one	CD
cord-005453-4057qib7	12555	15	patient	patient	NN
cord-005453-4057qib7	12555	16	received	receive	VBD
cord-005453-4057qib7	12555	17	Bu	Bu	NNP
cord-005453-4057qib7	12555	18	/	/	SYM
cord-005453-4057qib7	12555	19	Mel	Mel	NNP
cord-005453-4057qib7	12555	20	-	-	HYPH
cord-005453-4057qib7	12555	21	based	base	VBN
cord-005453-4057qib7	12555	22	,	,	,
cord-005453-4057qib7	12555	23	and	and	CC
cord-005453-4057qib7	12555	24	one	one	CD
cord-005453-4057qib7	12555	25	patient	patient	NN
cord-005453-4057qib7	12555	26	received	receive	VBN
cord-005453-4057qib7	12555	27	etoposide	etoposide	JJ
cord-005453-4057qib7	12555	28	/	/	SYM
cord-005453-4057qib7	12555	29	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	12555	30	-	-	HYPH
cord-005453-4057qib7	12555	31	based	base	VBN
cord-005453-4057qib7	12555	32	conditioning	conditioning	NN
cord-005453-4057qib7	12555	33	regimens	regimen	NNS
cord-005453-4057qib7	12555	34	.	.	.
cord-005453-4057qib7	12556	1	Twenty	twenty	CD
cord-005453-4057qib7	12556	2	-	-	HYPH
cord-005453-4057qib7	12556	3	two	two	CD
cord-005453-4057qib7	12556	4	patients	patient	NNS
cord-005453-4057qib7	12556	5	who	who	WP
cord-005453-4057qib7	12556	6	transplanted	transplant	VBD
cord-005453-4057qib7	12556	7	after	after	IN
cord-005453-4057qib7	12556	8	2012	2012	CD
cord-005453-4057qib7	12556	9	received	receive	VBD
cord-005453-4057qib7	12556	10	8Gy	8gy	NN
cord-005453-4057qib7	12556	11	of	of	IN
cord-005453-4057qib7	12556	12	total	total	JJ
cord-005453-4057qib7	12556	13	body	body	NN
cord-005453-4057qib7	12556	14	irradiation	irradiation	NN
cord-005453-4057qib7	12556	15	(	(	-LRB-
cord-005453-4057qib7	12556	16	TBI	TBI	NNP
cord-005453-4057qib7	12556	17	)	)	-RRB-
cord-005453-4057qib7	12556	18	.	.	.
cord-005453-4057qib7	12557	1	Responses	response	NNS
cord-005453-4057qib7	12557	2	before	before	IN
cord-005453-4057qib7	12557	3	allo	allo	NNP
cord-005453-4057qib7	12557	4	-	-	HYPH
cord-005453-4057qib7	12557	5	SCT	SCT	NNP
cord-005453-4057qib7	12557	6	were	be	VBD
cord-005453-4057qib7	12557	7	CR	cr	NN
cord-005453-4057qib7	12557	8	:	:	:
cord-005453-4057qib7	12557	9	8	8	CD
cord-005453-4057qib7	12557	10	,	,	,
cord-005453-4057qib7	12557	11	VGPR	VGPR	NNP
cord-005453-4057qib7	12557	12	:	:	:
cord-005453-4057qib7	12557	13	6	6	CD
cord-005453-4057qib7	12557	14	,	,	,
cord-005453-4057qib7	12557	15	PR	PR	NNP
cord-005453-4057qib7	12557	16	:	:	:
cord-005453-4057qib7	12557	17	6	6	CD
cord-005453-4057qib7	12557	18	,	,	,
cord-005453-4057qib7	12557	19	SD	sd	NN
cord-005453-4057qib7	12557	20	:	:	:
cord-005453-4057qib7	12557	21	5	5	CD
cord-005453-4057qib7	12557	22	.	.	.
cord-005453-4057qib7	12558	1	Five	five	CD
cord-005453-4057qib7	12558	2	-	-	HYPH
cord-005453-4057qib7	12558	3	year	year	NN
cord-005453-4057qib7	12558	4	PFS	PFS	NNP
cord-005453-4057qib7	12558	5	was	be	VBD
cord-005453-4057qib7	12558	6	22	22	CD
cord-005453-4057qib7	12558	7	%	%	NN
cord-005453-4057qib7	12558	8	(	(	-LRB-
cord-005453-4057qib7	12558	9	95%CI	95%ci	CD
cord-005453-4057qib7	12558	10	:	:	SYM
cord-005453-4057qib7	12558	11	6	6	CD
cord-005453-4057qib7	12558	12	-	-	SYM
cord-005453-4057qib7	12558	13	45	45	CD
cord-005453-4057qib7	12558	14	)	)	-RRB-
cord-005453-4057qib7	12558	15	and	and	CC
cord-005453-4057qib7	12558	16	5-year	5-year	CD
cord-005453-4057qib7	12558	17	OS	OS	NNP
cord-005453-4057qib7	12558	18	was	be	VBD
cord-005453-4057qib7	12558	19	42	42	CD
cord-005453-4057qib7	12558	20	%	%	NN
cord-005453-4057qib7	12558	21	(	(	-LRB-
cord-005453-4057qib7	12558	22	95%CI	95%ci	CD
cord-005453-4057qib7	12558	23	:	:	:
cord-005453-4057qib7	12558	24	16	16	CD
cord-005453-4057qib7	12558	25	-	-	SYM
cord-005453-4057qib7	12558	26	66	66	CD
cord-005453-4057qib7	12558	27	)	)	-RRB-
cord-005453-4057qib7	12558	28	.	.	.
cord-005453-4057qib7	12559	1	Ten	ten	CD
cord-005453-4057qib7	12559	2	patients	patient	NNS
cord-005453-4057qib7	12559	3	died	die	VBD
cord-005453-4057qib7	12559	4	during	during	IN
cord-005453-4057qib7	12559	5	observation	observation	NN
cord-005453-4057qib7	12559	6	period	period	NN
cord-005453-4057qib7	12559	7	and	and	CC
cord-005453-4057qib7	12559	8	causes	cause	NNS
cord-005453-4057qib7	12559	9	of	of	IN
cord-005453-4057qib7	12559	10	death	death	NN
cord-005453-4057qib7	12559	11	were	be	VBD
cord-005453-4057qib7	12559	12	primary	primary	JJ
cord-005453-4057qib7	12559	13	disease	disease	NN
cord-005453-4057qib7	12559	14	:	:	:
cord-005453-4057qib7	12559	15	8	8	CD
cord-005453-4057qib7	12559	16	and	and	CC
cord-005453-4057qib7	12559	17	treatment	treatment	NN
cord-005453-4057qib7	12559	18	-	-	HYPH
cord-005453-4057qib7	12559	19	related	relate	VBN
cord-005453-4057qib7	12559	20	mortality	mortality	NN
cord-005453-4057qib7	12559	21	:	:	:
cord-005453-4057qib7	12559	22	2	2	CD
cord-005453-4057qib7	12559	23	.	.	.
cord-005453-4057qib7	12560	1	Patients	patient	NNS
cord-005453-4057qib7	12560	2	with	with	IN
cord-005453-4057qib7	12560	3	VGPR	VGPR	NNP
cord-005453-4057qib7	12560	4	or	or	CC
cord-005453-4057qib7	12560	5	better	well	JJR
cord-005453-4057qib7	12560	6	before	before	IN
cord-005453-4057qib7	12560	7	allo	allo	NNP
cord-005453-4057qib7	12560	8	-	-	HYPH
cord-005453-4057qib7	12560	9	SCT	SCT	NNP
cord-005453-4057qib7	12560	10	showed	show	VBD
cord-005453-4057qib7	12560	11	significantly	significantly	RB
cord-005453-4057qib7	12560	12	better	well	JJR
cord-005453-4057qib7	12560	13	PFS	PFS	NNP
cord-005453-4057qib7	12560	14	(	(	-LRB-
cord-005453-4057qib7	12560	15	p=0.04	p=0.04	NNP
cord-005453-4057qib7	12560	16	)	)	-RRB-
cord-005453-4057qib7	12560	17	and	and	CC
cord-005453-4057qib7	12560	18	OS	OS	NNP
cord-005453-4057qib7	12560	19	(	(	-LRB-
cord-005453-4057qib7	12560	20	p=0.011	p=0.011	NNP
cord-005453-4057qib7	12560	21	)	)	-RRB-
cord-005453-4057qib7	12560	22	as	as	IN
cord-005453-4057qib7	12560	23	compared	compare	VBN
cord-005453-4057qib7	12560	24	with	with	IN
cord-005453-4057qib7	12560	25	others	other	NNS
cord-005453-4057qib7	12560	26	.	.	.
cord-005453-4057qib7	12561	1	Female	female	JJ
cord-005453-4057qib7	12561	2	recipients	recipient	NNS
cord-005453-4057qib7	12561	3	showed	show	VBD
cord-005453-4057qib7	12561	4	significantly	significantly	RB
cord-005453-4057qib7	12561	5	better	well	JJR
cord-005453-4057qib7	12561	6	PFS	PFS	NNP
cord-005453-4057qib7	12561	7	(	(	-LRB-
cord-005453-4057qib7	12561	8	p=0.0034	p=0.0034	NNP
cord-005453-4057qib7	12561	9	)	)	-RRB-
cord-005453-4057qib7	12561	10	and	and	CC
cord-005453-4057qib7	12561	11	OS	OS	NNP
cord-005453-4057qib7	12561	12	(	(	-LRB-
cord-005453-4057qib7	12561	13	p=0.035	p=0.035	NNP
cord-005453-4057qib7	12561	14	)	)	-RRB-
cord-005453-4057qib7	12562	1	as	as	IN
cord-005453-4057qib7	12562	2	compared	compare	VBN
cord-005453-4057qib7	12562	3	with	with	IN
cord-005453-4057qib7	12562	4	male	male	JJ
cord-005453-4057qib7	12562	5	recipients	recipient	NNS
cord-005453-4057qib7	12562	6	.	.	.
cord-005453-4057qib7	12563	1	Recipients	recipient	NNS
cord-005453-4057qib7	12563	2	of	of	IN
cord-005453-4057qib7	12563	3	MMUD	MMUD	NNP
cord-005453-4057qib7	12563	4	showed	show	VBD
cord-005453-4057qib7	12563	5	significantly	significantly	RB
cord-005453-4057qib7	12563	6	better	well	JJR
cord-005453-4057qib7	12563	7	PFS	PFS	NNP
cord-005453-4057qib7	12563	8	(	(	-LRB-
cord-005453-4057qib7	12563	9	p=0.0034	p=0.0034	NN
cord-005453-4057qib7	12563	10	)	)	-RRB-
cord-005453-4057qib7	12563	11	.	.	.
cord-005453-4057qib7	12564	1	Among	among	IN
cord-005453-4057qib7	12564	2	15	15	CD
cord-005453-4057qib7	12564	3	patients	patient	NNS
cord-005453-4057qib7	12564	4	surviving	survive	VBG
cord-005453-4057qib7	12564	5	,	,	,
cord-005453-4057qib7	12564	6	10	10	CD
cord-005453-4057qib7	12564	7	patients	patient	NNS
cord-005453-4057qib7	12564	8	received	receive	VBD
cord-005453-4057qib7	12564	9	treatments	treatment	NNS
cord-005453-4057qib7	12564	10	including	include	VBG
cord-005453-4057qib7	12564	11	maintenance	maintenance	NN
cord-005453-4057qib7	12564	12	therapy	therapy	NN
cord-005453-4057qib7	12564	13	.	.	.
cord-005453-4057qib7	12565	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12565	2	:	:	:
cord-005453-4057qib7	12566	1	The	the	DT
cord-005453-4057qib7	12566	2	reason	reason	NN
cord-005453-4057qib7	12566	3	for	for	IN
cord-005453-4057qib7	12566	4	better	well	JJR
cord-005453-4057qib7	12566	5	PFS	PFS	NNP
cord-005453-4057qib7	12566	6	and	and	CC
cord-005453-4057qib7	12566	7	OS	OS	NNP
cord-005453-4057qib7	12566	8	in	in	IN
cord-005453-4057qib7	12566	9	female	female	JJ
cord-005453-4057qib7	12566	10	recipients	recipient	NNS
cord-005453-4057qib7	12566	11	is	be	VBZ
cord-005453-4057qib7	12566	12	unknown	unknown	JJ
cord-005453-4057qib7	12566	13	.	.	.
cord-005453-4057qib7	12567	1	It	-PRON-	PRP
cord-005453-4057qib7	12567	2	is	be	VBZ
cord-005453-4057qib7	12567	3	interesting	interesting	JJ
cord-005453-4057qib7	12567	4	that	that	IN
cord-005453-4057qib7	12567	5	recipients	recipient	NNS
cord-005453-4057qib7	12567	6	of	of	IN
cord-005453-4057qib7	12567	7	MMUD	MMUD	NNP
cord-005453-4057qib7	12567	8	showed	show	VBD
cord-005453-4057qib7	12567	9	better	well	JJR
cord-005453-4057qib7	12567	10	PFS	PFS	NNP
cord-005453-4057qib7	12567	11	,	,	,
cord-005453-4057qib7	12567	12	suggesting	suggest	VBG
cord-005453-4057qib7	12567	13	graft	graft	NN
cord-005453-4057qib7	12567	14	-	-	HYPH
cord-005453-4057qib7	12567	15	versusmyeloma	versusmyeloma	NN
cord-005453-4057qib7	12567	16	effects	effect	NNS
cord-005453-4057qib7	12567	17	.	.	.
cord-005453-4057qib7	12568	1	Allo	Allo	NNP
cord-005453-4057qib7	12568	2	-	-	HYPH
cord-005453-4057qib7	12568	3	SCT	SCT	NNP
cord-005453-4057qib7	12568	4	can	can	MD
cord-005453-4057qib7	12568	5	be	be	VB
cord-005453-4057qib7	12568	6	an	an	DT
cord-005453-4057qib7	12568	7	effective	effective	JJ
cord-005453-4057qib7	12568	8	treatment	treatment	NN
cord-005453-4057qib7	12568	9	option	option	NN
cord-005453-4057qib7	12568	10	if	if	IN
cord-005453-4057qib7	12568	11	patients	patient	NNS
cord-005453-4057qib7	12568	12	and	and	CC
cord-005453-4057qib7	12568	13	stem	stem	NN
cord-005453-4057qib7	12568	14	-	-	HYPH
cord-005453-4057qib7	12568	15	cell	cell	NN
cord-005453-4057qib7	12568	16	sources	source	NNS
cord-005453-4057qib7	12568	17	are	be	VBP
cord-005453-4057qib7	12568	18	appropriately	appropriately	RB
cord-005453-4057qib7	12568	19	selected	select	VBN
cord-005453-4057qib7	12568	20	.	.	.
cord-005453-4057qib7	12569	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12569	2	:	:	:
cord-005453-4057qib7	12570	1	authors	author	NNS
cord-005453-4057qib7	12570	2	declare	declare	VBP
cord-005453-4057qib7	12570	3	that	that	IN
cord-005453-4057qib7	12570	4	there	there	EX
cord-005453-4057qib7	12570	5	are	be	VBP
cord-005453-4057qib7	12570	6	no	no	DT
cord-005453-4057qib7	12570	7	conflicts	conflict	NNS
cord-005453-4057qib7	12570	8	of	of	IN
cord-005453-4057qib7	12570	9	interest	interest	NN
cord-005453-4057qib7	12570	10	.	.	.
cord-005453-4057qib7	12571	1	Second	second	JJ
cord-005453-4057qib7	12571	2	autologous	autologous	JJ
cord-005453-4057qib7	12571	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12571	4	stem	stem	NN
cord-005453-4057qib7	12571	5	cell	cell	NN
cord-005453-4057qib7	12571	6	tranpslant	tranpslant	NN
cord-005453-4057qib7	12571	7	versus	versus	FW
cord-005453-4057qib7	12571	8	chemoimmunotherapy	chemoimmunotherapy	NNP
cord-005453-4057qib7	12571	9	in	in	IN
cord-005453-4057qib7	12571	10	relapsed	relapse	VBN
cord-005453-4057qib7	12571	11	multiple	multiple	JJ
cord-005453-4057qib7	12571	12	myeloma	myeloma	NN
cord-005453-4057qib7	12571	13	after	after	IN
cord-005453-4057qib7	12571	14	first	first	JJ
cord-005453-4057qib7	12571	15	transplantation	transplantation	NN
cord-005453-4057qib7	12571	16	:	:	:
cord-005453-4057qib7	12572	1	Single	single	JJ
cord-005453-4057qib7	12572	2	center	center	NN
cord-005453-4057qib7	12572	3	data	datum	NNS
cord-005453-4057qib7	12572	4	Background	background	NN
cord-005453-4057qib7	12572	5	:	:	:
cord-005453-4057qib7	12573	1	Combination	combination	NN
cord-005453-4057qib7	12573	2	therapy	therapy	NN
cord-005453-4057qib7	12573	3	,	,	,
cord-005453-4057qib7	12573	4	mostly	mostly	RB
cord-005453-4057qib7	12573	5	triple	triple	JJ
cord-005453-4057qib7	12573	6	,	,	,
cord-005453-4057qib7	12573	7	followed	follow	VBN
cord-005453-4057qib7	12573	8	by	by	IN
cord-005453-4057qib7	12573	9	autologous	autologous	JJ
cord-005453-4057qib7	12573	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12573	11	stem	stem	NN
cord-005453-4057qib7	12573	12	cell	cell	NN
cord-005453-4057qib7	12573	13	transplantation	transplantation	NN
cord-005453-4057qib7	12573	14	(	(	-LRB-
cord-005453-4057qib7	12573	15	auto	auto	NN
cord-005453-4057qib7	12573	16	-	-	HYPH
cord-005453-4057qib7	12573	17	HCT	HCT	NNP
cord-005453-4057qib7	12573	18	)	)	-RRB-
cord-005453-4057qib7	12573	19	is	be	VBZ
cord-005453-4057qib7	12573	20	widely	widely	RB
cord-005453-4057qib7	12573	21	accepted	accept	VBN
cord-005453-4057qib7	12573	22	as	as	IN
cord-005453-4057qib7	12573	23	the	the	DT
cord-005453-4057qib7	12573	24	first	first	JJ
cord-005453-4057qib7	12573	25	-	-	HYPH
cord-005453-4057qib7	12573	26	line	line	NN
cord-005453-4057qib7	12573	27	standard	standard	JJ
cord-005453-4057qib7	12573	28	therapy	therapy	NN
cord-005453-4057qib7	12573	29	for	for	IN
cord-005453-4057qib7	12573	30	multiple	multiple	JJ
cord-005453-4057qib7	12573	31	myeloma	myeloma	NN
cord-005453-4057qib7	12573	32	(	(	-LRB-
cord-005453-4057qib7	12573	33	MM	MM	NNP
cord-005453-4057qib7	12573	34	)	)	-RRB-
cord-005453-4057qib7	12573	35	.	.	.
cord-005453-4057qib7	12574	1	Despite	despite	IN
cord-005453-4057qib7	12574	2	the	the	DT
cord-005453-4057qib7	12574	3	availability	availability	NN
cord-005453-4057qib7	12574	4	of	of	IN
cord-005453-4057qib7	12574	5	agents	agent	NNS
cord-005453-4057qib7	12574	6	such	such	JJ
cord-005453-4057qib7	12574	7	as	as	IN
cord-005453-4057qib7	12574	8	new	new	JJ
cord-005453-4057qib7	12574	9	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	12574	10	drugs	drug	NNS
cord-005453-4057qib7	12574	11	(	(	-LRB-
cord-005453-4057qib7	12574	12	IMIDs	IMIDs	NNP
cord-005453-4057qib7	12574	13	)	)	-RRB-
cord-005453-4057qib7	12574	14	,	,	,
cord-005453-4057qib7	12574	15	proteasome	proteasome	NN
cord-005453-4057qib7	12574	16	inhibitors	inhibitor	NNS
cord-005453-4057qib7	12574	17	(	(	-LRB-
cord-005453-4057qib7	12574	18	PIs	PIs	NNP
cord-005453-4057qib7	12574	19	)	)	-RRB-
cord-005453-4057qib7	12574	20	,	,	,
cord-005453-4057qib7	12574	21	histone	histone	NN
cord-005453-4057qib7	12574	22	-	-	HYPH
cord-005453-4057qib7	12574	23	deacetylase	deacetylase	NN
cord-005453-4057qib7	12574	24	inhibitors	inhibitor	NNS
cord-005453-4057qib7	12574	25	and	and	CC
cord-005453-4057qib7	12574	26	antibodies	antibody	NNS
cord-005453-4057qib7	12574	27	,	,	,
cord-005453-4057qib7	12574	28	it	-PRON-	PRP
cord-005453-4057qib7	12574	29	is	be	VBZ
cord-005453-4057qib7	12574	30	still	still	RB
cord-005453-4057qib7	12574	31	possible	possible	JJ
cord-005453-4057qib7	12574	32	to	to	TO
cord-005453-4057qib7	12574	33	achieve	achieve	VB
cord-005453-4057qib7	12574	34	longer	long	JJR
cord-005453-4057qib7	12574	35	and	and	CC
cord-005453-4057qib7	12574	36	deeper	deep	JJR
cord-005453-4057qib7	12574	37	responses	response	NNS
cord-005453-4057qib7	12574	38	,	,	,
cord-005453-4057qib7	12574	39	however	however	RB
cord-005453-4057qib7	12574	40	,	,	,
cord-005453-4057qib7	12574	41	multiple	multiple	JJ
cord-005453-4057qib7	12574	42	myeloma	myeloma	NN
cord-005453-4057qib7	12574	43	is	be	VBZ
cord-005453-4057qib7	12574	44	still	still	RB
cord-005453-4057qib7	12574	45	not	not	RB
cord-005453-4057qib7	12574	46	cured	cure	VBN
cord-005453-4057qib7	12574	47	and	and	CC
cord-005453-4057qib7	12574	48	relapse	relapse	NN
cord-005453-4057qib7	12574	49	is	be	VBZ
cord-005453-4057qib7	12574	50	inevitable	inevitable	JJ
cord-005453-4057qib7	12574	51	.	.	.
cord-005453-4057qib7	12575	1	The	the	DT
cord-005453-4057qib7	12575	2	availability	availability	NN
cord-005453-4057qib7	12575	3	of	of	IN
cord-005453-4057qib7	12575	4	these	these	DT
cord-005453-4057qib7	12575	5	novel	novel	JJ
cord-005453-4057qib7	12575	6	agents	agent	NNS
cord-005453-4057qib7	12575	7	has	have	VBZ
cord-005453-4057qib7	12575	8	increased	increase	VBN
cord-005453-4057qib7	12575	9	questions	question	NNS
cord-005453-4057qib7	12575	10	for	for	IN
cord-005453-4057qib7	12575	11	determining	determine	VBG
cord-005453-4057qib7	12575	12	optimal	optimal	JJ
cord-005453-4057qib7	12575	13	treatment	treatment	NN
cord-005453-4057qib7	12575	14	of	of	IN
cord-005453-4057qib7	12575	15	patients	patient	NNS
cord-005453-4057qib7	12575	16	with	with	IN
cord-005453-4057qib7	12575	17	relapse	relapse	NN
cord-005453-4057qib7	12575	18	after	after	IN
cord-005453-4057qib7	12575	19	the	the	DT
cord-005453-4057qib7	12575	20	first	first	JJ
cord-005453-4057qib7	12575	21	auto	auto	NN
cord-005453-4057qib7	12575	22	-	-	HYPH
cord-005453-4057qib7	12575	23	HCT	hct	NN
cord-005453-4057qib7	12575	24	.	.	.
cord-005453-4057qib7	12576	1	Methods	method	NNS
cord-005453-4057qib7	12576	2	:	:	:
cord-005453-4057qib7	12576	3	We	-PRON-	PRP
cord-005453-4057qib7	12576	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	12576	5	analyzed	analyze	VBD
cord-005453-4057qib7	12576	6	60	60	CD
cord-005453-4057qib7	12576	7	patients	patient	NNS
cord-005453-4057qib7	12576	8	who	who	WP
cord-005453-4057qib7	12576	9	relapsed	relapse	VBD
cord-005453-4057qib7	12576	10	according	accord	VBG
cord-005453-4057qib7	12576	11	to	to	IN
cord-005453-4057qib7	12576	12	International	International	NNP
cord-005453-4057qib7	12576	13	Myeloma	Myeloma	NNP
cord-005453-4057qib7	12576	14	Working	Working	NNP
cord-005453-4057qib7	12576	15	Group	Group	NNP
cord-005453-4057qib7	12576	16	(	(	-LRB-
cord-005453-4057qib7	12576	17	IMWG	IMWG	NNP
cord-005453-4057qib7	12576	18	)	)	-RRB-
cord-005453-4057qib7	12576	19	criteria	criterion	NNS
cord-005453-4057qib7	12576	20	after	after	IN
cord-005453-4057qib7	12576	21	1st	1st	JJ
cord-005453-4057qib7	12576	22	auto	auto	NN
cord-005453-4057qib7	12576	23	-	-	HYPH
cord-005453-4057qib7	12576	24	HCT	hct	NN
cord-005453-4057qib7	12576	25	.	.	.
cord-005453-4057qib7	12577	1	First	first	JJ
cord-005453-4057qib7	12577	2	group	group	NN
cord-005453-4057qib7	12577	3	[	[	-LRB-
cord-005453-4057qib7	12577	4	salvage	salvage	NN
cord-005453-4057qib7	12577	5	chemotherapy(CT	chemotherapy(CT	NNS
cord-005453-4057qib7	12577	6	)	)	-RRB-
cord-005453-4057qib7	12577	7	]	]	-RRB-
cord-005453-4057qib7	12578	1	(	(	-LRB-
cord-005453-4057qib7	12578	2	n=27	n=27	NNP
cord-005453-4057qib7	12578	3	)	)	-RRB-
cord-005453-4057qib7	12578	4	was	be	VBD
cord-005453-4057qib7	12578	5	treated	treat	VBN
cord-005453-4057qib7	12578	6	with	with	IN
cord-005453-4057qib7	12578	7	only	only	RB
cord-005453-4057qib7	12578	8	chemoimmunotherapy	chemoimmunotherapy	NN
cord-005453-4057qib7	12578	9	because	because	IN
cord-005453-4057qib7	12578	10	of	of	IN
cord-005453-4057qib7	12578	11	early	early	JJ
cord-005453-4057qib7	12578	12	relapse	relapse	NN
cord-005453-4057qib7	12578	13	or	or	CC
cord-005453-4057qib7	12578	14	refractory	refractory	JJ
cord-005453-4057qib7	12578	15	first	first	JJ
cord-005453-4057qib7	12578	16	auto	auto	NN
cord-005453-4057qib7	12578	17	-	-	HYPH
cord-005453-4057qib7	12578	18	SCT	SCT	NNP
cord-005453-4057qib7	12578	19	(	(	-LRB-
cord-005453-4057qib7	12578	20	within	within	IN
cord-005453-4057qib7	12578	21	6	6	CD
cord-005453-4057qib7	12578	22	months	month	NNS
cord-005453-4057qib7	12578	23	)	)	-RRB-
cord-005453-4057qib7	12578	24	,	,	,
cord-005453-4057qib7	12578	25	ineligible	ineligible	JJ
cord-005453-4057qib7	12578	26	to	to	IN
cord-005453-4057qib7	12578	27	second	second	JJ
cord-005453-4057qib7	12578	28	transplantation	transplantation	NN
cord-005453-4057qib7	12578	29	because	because	IN
cord-005453-4057qib7	12578	30	of	of	IN
cord-005453-4057qib7	12578	31	co	co	NN
cord-005453-4057qib7	12578	32	-	-	NN
cord-005453-4057qib7	12578	33	morbidity	morbidity	JJ
cord-005453-4057qib7	12578	34	,	,	,
cord-005453-4057qib7	12578	35	unwillingness	unwillingness	NN
cord-005453-4057qib7	12578	36	to	to	IN
cord-005453-4057qib7	12578	37	transplant	transplant	NN
cord-005453-4057qib7	12578	38	.	.	.
cord-005453-4057qib7	12579	1	Second	second	JJ
cord-005453-4057qib7	12579	2	group	group	NN
cord-005453-4057qib7	12579	3	(	(	-LRB-
cord-005453-4057qib7	12579	4	n=33	n=33	NN
cord-005453-4057qib7	12579	5	)	)	-RRB-
cord-005453-4057qib7	12579	6	(	(	-LRB-
cord-005453-4057qib7	12579	7	salvage	salvage	NN
cord-005453-4057qib7	12579	8	transplantion	transplantion	NN
cord-005453-4057qib7	12579	9	)	)	-RRB-
cord-005453-4057qib7	12579	10	was	be	VBD
cord-005453-4057qib7	12579	11	treated	treat	VBN
cord-005453-4057qib7	12579	12	with	with	IN
cord-005453-4057qib7	12579	13	second	second	JJ
cord-005453-4057qib7	12579	14	auto	auto	NN
cord-005453-4057qib7	12579	15	-	-	HYPH
cord-005453-4057qib7	12579	16	HCT	hct	NN
cord-005453-4057qib7	12579	17	as	as	IN
cord-005453-4057qib7	12579	18	a	a	DT
cord-005453-4057qib7	12579	19	salvage	salvage	NN
cord-005453-4057qib7	12579	20	therapy	therapy	NN
cord-005453-4057qib7	12579	21	.	.	.
cord-005453-4057qib7	12580	1	Consolidation	consolidation	NN
cord-005453-4057qib7	12580	2	and	and	CC
cord-005453-4057qib7	12580	3	long	long	JJ
cord-005453-4057qib7	12580	4	term	term	NN
cord-005453-4057qib7	12580	5	maintenance	maintenance	NN
cord-005453-4057qib7	12580	6	treatments	treatment	NNS
cord-005453-4057qib7	12580	7	were	be	VBD
cord-005453-4057qib7	12580	8	used	use	VBN
cord-005453-4057qib7	12580	9	in	in	IN
cord-005453-4057qib7	12580	10	both	both	DT
cord-005453-4057qib7	12580	11	groups	group	NNS
cord-005453-4057qib7	12580	12	.	.	.
cord-005453-4057qib7	12581	1	Results	result	NNS
cord-005453-4057qib7	12581	2	:	:	:
cord-005453-4057qib7	12582	1	There	there	EX
cord-005453-4057qib7	12582	2	was	be	VBD
cord-005453-4057qib7	12582	3	no	no	DT
cord-005453-4057qib7	12582	4	difference	difference	NN
cord-005453-4057qib7	12582	5	in	in	IN
cord-005453-4057qib7	12582	6	sex	sex	NN
cord-005453-4057qib7	12582	7	and	and	CC
cord-005453-4057qib7	12582	8	age	age	NN
cord-005453-4057qib7	12582	9	between	between	IN
cord-005453-4057qib7	12582	10	salvage	salvage	NN
cord-005453-4057qib7	12582	11	CT	CT	NNP
cord-005453-4057qib7	12582	12	and	and	CC
cord-005453-4057qib7	12582	13	auto	auto	NN
cord-005453-4057qib7	12582	14	-	-	HYPH
cord-005453-4057qib7	12582	15	SCT	SCT	NNP
cord-005453-4057qib7	12582	16	groups	group	NNS
cord-005453-4057qib7	12583	1	[	[	-LRB-
cord-005453-4057qib7	12583	2	Female	female	JJ
cord-005453-4057qib7	12583	3	/	/	SYM
cord-005453-4057qib7	12583	4	male	male	NN
cord-005453-4057qib7	12583	5	:	:	.
cord-005453-4057qib7	12584	1	11	11	CD
cord-005453-4057qib7	12584	2	vs	vs	IN
cord-005453-4057qib7	12584	3	13/	13/	CD
cord-005453-4057qib7	12584	4	16	16	CD
cord-005453-4057qib7	12584	5	vs	vs	IN
cord-005453-4057qib7	12584	6	20	20	CD
cord-005453-4057qib7	12584	7	;	;	,
cord-005453-4057qib7	12584	8	]	]	-RRB-
cord-005453-4057qib7	12584	9	.	.	.
cord-005453-4057qib7	12585	1	The	the	DT
cord-005453-4057qib7	12585	2	best	good	JJS
cord-005453-4057qib7	12585	3	response	response	NN
cord-005453-4057qib7	12585	4	after	after	IN
cord-005453-4057qib7	12585	5	salvage	salvage	NN
cord-005453-4057qib7	12585	6	auto	auto	NN
cord-005453-4057qib7	12585	7	-	-	HYPH
cord-005453-4057qib7	12585	8	SCT	SCT	NNP
cord-005453-4057qib7	12585	9	was	be	VBD
cord-005453-4057qib7	12585	10	complete	complete	JJ
cord-005453-4057qib7	12585	11	remission	remission	NN
cord-005453-4057qib7	12585	12	(	(	-LRB-
cord-005453-4057qib7	12585	13	CR	CR	NNP
cord-005453-4057qib7	12585	14	)	)	-RRB-
cord-005453-4057qib7	12585	15	in	in	IN
cord-005453-4057qib7	12585	16	62,5	62,5	CD
cord-005453-4057qib7	12585	17	%	%	NN
cord-005453-4057qib7	12585	18	,	,	,
cord-005453-4057qib7	12585	19	partial	partial	JJ
cord-005453-4057qib7	12585	20	remission	remission	NN
cord-005453-4057qib7	12585	21	(	(	-LRB-
cord-005453-4057qib7	12585	22	PR	PR	NNP
cord-005453-4057qib7	12585	23	)	)	-RRB-
cord-005453-4057qib7	12585	24	in	in	IN
cord-005453-4057qib7	12585	25	15,6	15,6	CD
cord-005453-4057qib7	12585	26	%	%	NN
cord-005453-4057qib7	12585	27	patients	patient	NNS
cord-005453-4057qib7	12585	28	,	,	,
cord-005453-4057qib7	12585	29	while	while	IN
cord-005453-4057qib7	12585	30	CR	CR	NNP
cord-005453-4057qib7	12585	31	in	in	IN
cord-005453-4057qib7	12585	32	44	44	CD
cord-005453-4057qib7	12585	33	%	%	NN
cord-005453-4057qib7	12585	34	,	,	,
cord-005453-4057qib7	12585	35	PR	PR	NNP
cord-005453-4057qib7	12585	36	in	in	IN
cord-005453-4057qib7	12585	37	14,8	14,8	CD
cord-005453-4057qib7	12585	38	%	%	NN
cord-005453-4057qib7	12585	39	patients	patient	NNS
cord-005453-4057qib7	12585	40	treated	treat	VBN
cord-005453-4057qib7	12585	41	with	with	IN
cord-005453-4057qib7	12585	42	salvage	salvage	NN
cord-005453-4057qib7	12585	43	CT	CT	NNP
cord-005453-4057qib7	12585	44	.	.	.
cord-005453-4057qib7	12586	1	Progression	progression	NN
cord-005453-4057qib7	12586	2	free	free	JJ
cord-005453-4057qib7	12586	3	survival	survival	NN
cord-005453-4057qib7	12586	4	(	(	-LRB-
cord-005453-4057qib7	12586	5	PFS	PFS	NNP
cord-005453-4057qib7	12586	6	)	)	-RRB-
cord-005453-4057qib7	12586	7	were	be	VBD
cord-005453-4057qib7	12586	8	significantly	significantly	RB
cord-005453-4057qib7	12586	9	better	well	JJR
cord-005453-4057qib7	12586	10	in	in	IN
cord-005453-4057qib7	12586	11	second	second	JJ
cord-005453-4057qib7	12586	12	transplant	transplant	NN
cord-005453-4057qib7	12586	13	group	group	NN
cord-005453-4057qib7	12586	14	(	(	-LRB-
cord-005453-4057qib7	12586	15	PFS	PFS	NNP
cord-005453-4057qib7	12586	16	;	;	:
cord-005453-4057qib7	12586	17	71	71	CD
cord-005453-4057qib7	12586	18	%	%	NN
cord-005453-4057qib7	12586	19	on	on	IN
cord-005453-4057qib7	12586	20	the	the	DT
cord-005453-4057qib7	12586	21	first	first	JJ
cord-005453-4057qib7	12586	22	year	year	NN
cord-005453-4057qib7	12586	23	;	;	:
cord-005453-4057qib7	12586	24	46,9	46,9	CD
cord-005453-4057qib7	12586	25	%	%	NN
cord-005453-4057qib7	12586	26	on	on	IN
cord-005453-4057qib7	12586	27	the	the	DT
cord-005453-4057qib7	12586	28	second	second	JJ
cord-005453-4057qib7	12586	29	year	year	NN
cord-005453-4057qib7	12586	30	after	after	IN
cord-005453-4057qib7	12586	31	transplant	transplant	NN
cord-005453-4057qib7	12586	32	vs	vs	IN
cord-005453-4057qib7	12586	33	59	59	CD
cord-005453-4057qib7	12586	34	%	%	NN
cord-005453-4057qib7	12586	35	on	on	IN
cord-005453-4057qib7	12586	36	the	the	DT
cord-005453-4057qib7	12586	37	first	first	JJ
cord-005453-4057qib7	12586	38	year	year	NN
cord-005453-4057qib7	12586	39	;	;	:
cord-005453-4057qib7	12586	40	17	17	CD
cord-005453-4057qib7	12586	41	%	%	NN
cord-005453-4057qib7	12586	42	on	on	IN
cord-005453-4057qib7	12586	43	the	the	DT
cord-005453-4057qib7	12586	44	second	second	JJ
cord-005453-4057qib7	12586	45	year	year	NN
cord-005453-4057qib7	12586	46	after	after	IN
cord-005453-4057qib7	12586	47	the	the	DT
cord-005453-4057qib7	12586	48	salvage	salvage	NN
cord-005453-4057qib7	12586	49	therapy	therapy	NN
cord-005453-4057qib7	12586	50	in	in	IN
cord-005453-4057qib7	12586	51	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12586	52	patients)[p	patients)[p	CD
cord-005453-4057qib7	12586	53	:	:	:
cord-005453-4057qib7	12586	54	0,001	0,001	CD
cord-005453-4057qib7	12586	55	]	]	-RRB-
cord-005453-4057qib7	12586	56	.	.	.
cord-005453-4057qib7	12587	1	Overall	overall	JJ
cord-005453-4057qib7	12587	2	survival	survival	NN
cord-005453-4057qib7	12587	3	(	(	-LRB-
cord-005453-4057qib7	12587	4	OS	OS	NNP
cord-005453-4057qib7	12587	5	)	)	-RRB-
cord-005453-4057qib7	12587	6	in	in	IN
cord-005453-4057qib7	12587	7	salvage	salvage	NN
cord-005453-4057qib7	12587	8	auto	auto	NN
cord-005453-4057qib7	12587	9	-	-	HYPH
cord-005453-4057qib7	12587	10	SCT	SCT	NNP
cord-005453-4057qib7	12587	11	group	group	NN
cord-005453-4057qib7	12587	12	was	be	VBD
cord-005453-4057qib7	12587	13	longer	long	JJR
cord-005453-4057qib7	12587	14	than	than	IN
cord-005453-4057qib7	12587	15	salvage	salvage	VB
cord-005453-4057qib7	12587	16	CT	CT	NNP
cord-005453-4057qib7	12587	17	(	(	-LRB-
cord-005453-4057qib7	12588	1	42,3	42,3	CD
cord-005453-4057qib7	12588	2	%	%	NN
cord-005453-4057qib7	12588	3	23.7	23.7	CD
cord-005453-4057qib7	12588	4	%	%	NN
cord-005453-4057qib7	12588	5	)	)	-RRB-
cord-005453-4057qib7	12588	6	,	,	,
cord-005453-4057qib7	12588	7	although	although	IN
cord-005453-4057qib7	12588	8	it	-PRON-	PRP
cord-005453-4057qib7	12588	9	did	do	VBD
cord-005453-4057qib7	12588	10	not	not	RB
cord-005453-4057qib7	12588	11	reach	reach	VB
cord-005453-4057qib7	12588	12	a	a	DT
cord-005453-4057qib7	12588	13	statistical	statistical	JJ
cord-005453-4057qib7	12588	14	significance	significance	NN
cord-005453-4057qib7	12588	15	(	(	-LRB-
cord-005453-4057qib7	12588	16	p>0.05	p>0.05	NNP
cord-005453-4057qib7	12588	17	)	)	-RRB-
cord-005453-4057qib7	12588	18	.	.	.
cord-005453-4057qib7	12589	1	Time	time	NN
cord-005453-4057qib7	12589	2	to	to	IN
cord-005453-4057qib7	12589	3	achieving	achieve	VBG
cord-005453-4057qib7	12589	4	the	the	DT
cord-005453-4057qib7	12589	5	best	good	JJS
cord-005453-4057qib7	12589	6	response	response	NN
cord-005453-4057qib7	12589	7	after	after	IN
cord-005453-4057qib7	12589	8	salvage	salvage	NN
cord-005453-4057qib7	12589	9	auto	auto	NN
cord-005453-4057qib7	12589	10	-	-	HYPH
cord-005453-4057qib7	12589	11	SCT	sct	NN
cord-005453-4057qib7	12589	12	and	and	CC
cord-005453-4057qib7	12589	13	salvage	salvage	NN
cord-005453-4057qib7	12589	14	CT	CT	NNP
cord-005453-4057qib7	12589	15	was	be	VBD
cord-005453-4057qib7	12589	16	1	1	CD
cord-005453-4057qib7	12589	17	(	(	-LRB-
cord-005453-4057qib7	12589	18	0	0	CD
cord-005453-4057qib7	12589	19	-	-	SYM
cord-005453-4057qib7	12589	20	9	9	CD
cord-005453-4057qib7	12589	21	)	)	-RRB-
cord-005453-4057qib7	12589	22	month	month	NN
cord-005453-4057qib7	12589	23	versus	versus	IN
cord-005453-4057qib7	12589	24	6,5(2	6,5(2	NNP
cord-005453-4057qib7	12589	25	-	-	SYM
cord-005453-4057qib7	12589	26	15	15	CD
cord-005453-4057qib7	12589	27	)	)	-RRB-
cord-005453-4057qib7	12589	28	months	month	NNS
cord-005453-4057qib7	12589	29	[	[	-LRB-
cord-005453-4057qib7	12589	30	p:0,02	p:0,02	NN
cord-005453-4057qib7	12589	31	]	]	-RRB-
cord-005453-4057qib7	12589	32	.	.	.
cord-005453-4057qib7	12590	1	Grade	grade	NN
cord-005453-4057qib7	12590	2	3	3	CD
cord-005453-4057qib7	12590	3	or	or	CC
cord-005453-4057qib7	12590	4	4	4	CD
cord-005453-4057qib7	12590	5	nonhematological	nonhematological	JJ
cord-005453-4057qib7	12590	6	toxicities	toxicity	NNS
cord-005453-4057qib7	12590	7	were	be	VBD
cord-005453-4057qib7	12590	8	similar	similar	JJ
cord-005453-4057qib7	12590	9	(	(	-LRB-
cord-005453-4057qib7	12590	10	auto	auto	NN
cord-005453-4057qib7	12590	11	-	-	HYPH
cord-005453-4057qib7	12590	12	SCT	SCT	NNP
cord-005453-4057qib7	12590	13	19	19	CD
cord-005453-4057qib7	12590	14	%	%	NN
cord-005453-4057qib7	12590	15	,	,	,
cord-005453-4057qib7	12590	16	salvage	salvage	NN
cord-005453-4057qib7	12590	17	CT	CT	NNP
cord-005453-4057qib7	12590	18	13	13	CD
cord-005453-4057qib7	12590	19	%	%	NN
cord-005453-4057qib7	12590	20	)	)	-RRB-
cord-005453-4057qib7	12590	21	in	in	IN
cord-005453-4057qib7	12590	22	both	both	DT
cord-005453-4057qib7	12590	23	groups	group	NNS
cord-005453-4057qib7	12590	24	.	.	.
cord-005453-4057qib7	12591	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12591	2	:	:	:
cord-005453-4057qib7	12592	1	Salvage	salvage	NN
cord-005453-4057qib7	12592	2	auto	auto	NN
cord-005453-4057qib7	12592	3	-	-	HYPH
cord-005453-4057qib7	12592	4	HCT	HCT	NNP
cord-005453-4057qib7	12592	5	may	may	MD
cord-005453-4057qib7	12592	6	provides	provide	VBZ
cord-005453-4057qib7	12592	7	longer	long	JJR
cord-005453-4057qib7	12592	8	progression	progression	NN
cord-005453-4057qib7	12592	9	free	free	JJ
cord-005453-4057qib7	12592	10	survival	survival	NN
cord-005453-4057qib7	12592	11	with	with	IN
cord-005453-4057qib7	12592	12	similar	similar	JJ
cord-005453-4057qib7	12592	13	toxicity	toxicity	NN
cord-005453-4057qib7	12592	14	profile	profile	NN
cord-005453-4057qib7	12592	15	according	accord	VBG
cord-005453-4057qib7	12592	16	to	to	IN
cord-005453-4057qib7	12592	17	chemoimmunotherapy	chemoimmunotherapy	NNP
cord-005453-4057qib7	12592	18	especially	especially	RB
cord-005453-4057qib7	12592	19	in	in	IN
cord-005453-4057qib7	12592	20	patients	patient	NNS
cord-005453-4057qib7	12592	21	with	with	IN
cord-005453-4057qib7	12592	22	sensitive	sensitive	JJ
cord-005453-4057qib7	12592	23	to	to	IN
cord-005453-4057qib7	12592	24	first	first	JJ
cord-005453-4057qib7	12592	25	auto	auto	NN
cord-005453-4057qib7	12592	26	-	-	HYPH
cord-005453-4057qib7	12592	27	SCT	SCT	NNP
cord-005453-4057qib7	12592	28	.	.	.
cord-005453-4057qib7	12593	1	It	-PRON-	PRP
cord-005453-4057qib7	12593	2	is	be	VBZ
cord-005453-4057qib7	12593	3	suggested	suggest	VBN
cord-005453-4057qib7	12593	4	that	that	IN
cord-005453-4057qib7	12593	5	earlier	early	JJR
cord-005453-4057qib7	12593	6	and	and	CC
cord-005453-4057qib7	12593	7	better	well	JJR
cord-005453-4057qib7	12593	8	responses	response	NNS
cord-005453-4057qib7	12593	9	,	,	,
cord-005453-4057qib7	12593	10	long	long	JJ
cord-005453-4057qib7	12593	11	-	-	HYPH
cord-005453-4057qib7	12593	12	term	term	NN
cord-005453-4057qib7	12593	13	progression	progression	NN
cord-005453-4057qib7	12593	14	free	free	JJ
cord-005453-4057qib7	12593	15	survival	survival	NN
cord-005453-4057qib7	12593	16	can	can	MD
cord-005453-4057qib7	12593	17	be	be	VB
cord-005453-4057qib7	12593	18	achieved	achieve	VBN
cord-005453-4057qib7	12593	19	with	with	IN
cord-005453-4057qib7	12593	20	salvage	salvage	NN
cord-005453-4057qib7	12593	21	auto	auto	NN
cord-005453-4057qib7	12593	22	-	-	HYPH
cord-005453-4057qib7	12593	23	SCT	SCT	NNP
cord-005453-4057qib7	12593	24	.	.	.
cord-005453-4057qib7	12594	1	We	-PRON-	PRP
cord-005453-4057qib7	12594	2	believe	believe	VBP
cord-005453-4057qib7	12594	3	that	that	IN
cord-005453-4057qib7	12594	4	there	there	EX
cord-005453-4057qib7	12594	5	will	will	MD
cord-005453-4057qib7	12594	6	be	be	VB
cord-005453-4057qib7	12594	7	statistical	statistical	JJ
cord-005453-4057qib7	12594	8	significance	significance	NN
cord-005453-4057qib7	12594	9	in	in	IN
cord-005453-4057qib7	12594	10	OS	OS	NNP
cord-005453-4057qib7	12594	11	such	such	JJ
cord-005453-4057qib7	12594	12	as	as	IN
cord-005453-4057qib7	12594	13	PFS	PFS	NNP
cord-005453-4057qib7	12594	14	by	by	IN
cord-005453-4057qib7	12594	15	increasing	increase	VBG
cord-005453-4057qib7	12594	16	the	the	DT
cord-005453-4057qib7	12594	17	number	number	NN
cord-005453-4057qib7	12594	18	of	of	IN
cord-005453-4057qib7	12594	19	patients	patient	NNS
cord-005453-4057qib7	12594	20	.	.	.
cord-005453-4057qib7	12595	1	The	the	DT
cord-005453-4057qib7	12595	2	authors	author	NNS
cord-005453-4057qib7	12595	3	believe	believe	VBP
cord-005453-4057qib7	12595	4	that	that	IN
cord-005453-4057qib7	12595	5	large	large	JJ
cord-005453-4057qib7	12595	6	scale	scale	NN
cord-005453-4057qib7	12595	7	randomized	randomize	VBN
cord-005453-4057qib7	12595	8	clinical	clinical	JJ
cord-005453-4057qib7	12595	9	trials	trial	NNS
cord-005453-4057qib7	12595	10	are	be	VBP
cord-005453-4057qib7	12595	11	needed	need	VBN
cord-005453-4057qib7	12595	12	for	for	IN
cord-005453-4057qib7	12595	13	optimal	optimal	JJ
cord-005453-4057qib7	12595	14	treatment	treatment	NN
cord-005453-4057qib7	12595	15	of	of	IN
cord-005453-4057qib7	12595	16	relapsing	relapse	VBG
cord-005453-4057qib7	12595	17	multiple	multiple	JJ
cord-005453-4057qib7	12595	18	myeloma	myeloma	NN
cord-005453-4057qib7	12595	19	after	after	IN
cord-005453-4057qib7	12595	20	first	first	JJ
cord-005453-4057qib7	12595	21	auto	auto	NN
cord-005453-4057qib7	12595	22	-	-	HYPH
cord-005453-4057qib7	12595	23	SCT	SCT	NNP
cord-005453-4057qib7	12595	24	.	.	.
cord-005453-4057qib7	12596	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12596	2	:	:	:
cord-005453-4057qib7	12596	3	Nothing	nothing	NN
cord-005453-4057qib7	12596	4	to	to	TO
cord-005453-4057qib7	12596	5	declare	declare	VB
cord-005453-4057qib7	12596	6	Background	background	NN
cord-005453-4057qib7	12596	7	:	:	:
cord-005453-4057qib7	12597	1	One	one	CD
cord-005453-4057qib7	12597	2	of	of	IN
cord-005453-4057qib7	12597	3	the	the	DT
cord-005453-4057qib7	12597	4	conditions	condition	NNS
cord-005453-4057qib7	12597	5	for	for	IN
cord-005453-4057qib7	12597	6	successful	successful	JJ
cord-005453-4057qib7	12597	7	transplantation	transplantation	NN
cord-005453-4057qib7	12597	8	of	of	IN
cord-005453-4057qib7	12597	9	autologous	autologous	JJ
cord-005453-4057qib7	12597	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12597	11	stem	stem	NN
cord-005453-4057qib7	12597	12	cells	cell	NNS
cord-005453-4057qib7	12597	13	(	(	-LRB-
cord-005453-4057qib7	12597	14	auto	auto	NN
cord-005453-4057qib7	12597	15	-	-	HYPH
cord-005453-4057qib7	12597	16	HSCT	HSCT	NNP
cord-005453-4057qib7	12597	17	)	)	-RRB-
cord-005453-4057qib7	12597	18	in	in	IN
cord-005453-4057qib7	12597	19	patients	patient	NNS
cord-005453-4057qib7	12597	20	with	with	IN
cord-005453-4057qib7	12597	21	multiple	multiple	JJ
cord-005453-4057qib7	12597	22	myeloma	myeloma	NN
cord-005453-4057qib7	12597	23	(	(	-LRB-
cord-005453-4057qib7	12597	24	MM	MM	NNP
cord-005453-4057qib7	12597	25	)	)	-RRB-
cord-005453-4057qib7	12597	26	is	be	VBZ
cord-005453-4057qib7	12597	27	the	the	DT
cord-005453-4057qib7	12597	28	timely	timely	JJ
cord-005453-4057qib7	12597	29	recovery	recovery	NN
cord-005453-4057qib7	12597	30	of	of	IN
cord-005453-4057qib7	12597	31	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	12597	32	,	,	,
cord-005453-4057qib7	12597	33	which	which	WDT
cord-005453-4057qib7	12597	34	is	be	VBZ
cord-005453-4057qib7	12597	35	associated	associate	VBN
cord-005453-4057qib7	12597	36	with	with	IN
cord-005453-4057qib7	12597	37	the	the	DT
cord-005453-4057qib7	12597	38	quantitative	quantitative	JJ
cord-005453-4057qib7	12597	39	and	and	CC
cord-005453-4057qib7	12597	40	qualitative	qualitative	JJ
cord-005453-4057qib7	12597	41	characteristics	characteristic	NNS
cord-005453-4057qib7	12597	42	of	of	IN
cord-005453-4057qib7	12597	43	the	the	DT
cord-005453-4057qib7	12597	44	graft	graft	NN
cord-005453-4057qib7	12597	45	.	.	.
cord-005453-4057qib7	12598	1	One	one	CD
cord-005453-4057qib7	12598	2	of	of	IN
cord-005453-4057qib7	12598	3	the	the	DT
cord-005453-4057qib7	12598	4	key	key	JJ
cord-005453-4057qib7	12598	5	indicators	indicator	NNS
cord-005453-4057qib7	12598	6	is	be	VBZ
cord-005453-4057qib7	12598	7	the	the	DT
cord-005453-4057qib7	12598	8	content	content	NN
cord-005453-4057qib7	12598	9	of	of	IN
cord-005453-4057qib7	12598	10	CD34	CD34	NNP
cord-005453-4057qib7	12598	11	+	+	CC
cord-005453-4057qib7	12598	12	cells	cell	NNS
cord-005453-4057qib7	12598	13	in	in	IN
cord-005453-4057qib7	12598	14	the	the	DT
cord-005453-4057qib7	12598	15	autograft	autograft	NN
cord-005453-4057qib7	12598	16	,	,	,
cord-005453-4057qib7	12598	17	which	which	WDT
cord-005453-4057qib7	12598	18	depends	depend	VBZ
cord-005453-4057qib7	12598	19	on	on	IN
cord-005453-4057qib7	12598	20	many	many	JJ
cord-005453-4057qib7	12598	21	factors	factor	NNS
cord-005453-4057qib7	12598	22	.	.	.
cord-005453-4057qib7	12599	1	Some	some	DT
cord-005453-4057qib7	12599	2	of	of	IN
cord-005453-4057qib7	12599	3	them	-PRON-	PRP
cord-005453-4057qib7	12599	4	are	be	VBP
cord-005453-4057qib7	12599	5	due	due	JJ
cord-005453-4057qib7	12599	6	to	to	IN
cord-005453-4057qib7	12599	7	previous	previous	JJ
cord-005453-4057qib7	12599	8	treatment	treatment	NN
cord-005453-4057qib7	12599	9	,	,	,
cord-005453-4057qib7	12599	10	others	other	NNS
cord-005453-4057qib7	12599	11	are	be	VBP
cord-005453-4057qib7	12599	12	directly	directly	RB
cord-005453-4057qib7	12599	13	related	relate	VBN
cord-005453-4057qib7	12599	14	to	to	IN
cord-005453-4057qib7	12599	15	the	the	DT
cord-005453-4057qib7	12599	16	patient	patient	NN
cord-005453-4057qib7	12599	17	:	:	:
cord-005453-4057qib7	12599	18	age	age	NN
cord-005453-4057qib7	12599	19	,	,	,
cord-005453-4057qib7	12599	20	stage	stage	NN
cord-005453-4057qib7	12599	21	of	of	IN
cord-005453-4057qib7	12599	22	the	the	DT
cord-005453-4057qib7	12599	23	disease	disease	NN
cord-005453-4057qib7	12599	24	,	,	,
cord-005453-4057qib7	12599	25	features	feature	NNS
cord-005453-4057qib7	12599	26	of	of	IN
cord-005453-4057qib7	12599	27	the	the	DT
cord-005453-4057qib7	12599	28	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12599	29	stem	stem	NN
cord-005453-4057qib7	12599	30	cells	cell	NNS
cord-005453-4057qib7	12599	31	(	(	-LRB-
cord-005453-4057qib7	12599	32	HSC	HSC	NNP
cord-005453-4057qib7	12599	33	)	)	-RRB-
cord-005453-4057qib7	12599	34	microenvironment	microenvironment	NN
cord-005453-4057qib7	12599	35	.	.	.
cord-005453-4057qib7	12600	1	The	the	DT
cord-005453-4057qib7	12600	2	aim	aim	NN
cord-005453-4057qib7	12600	3	of	of	IN
cord-005453-4057qib7	12600	4	the	the	DT
cord-005453-4057qib7	12600	5	study	study	NN
cord-005453-4057qib7	12600	6	was	be	VBD
cord-005453-4057qib7	12600	7	to	to	TO
cord-005453-4057qib7	12600	8	assess	assess	VB
cord-005453-4057qib7	12600	9	the	the	DT
cord-005453-4057qib7	12600	10	influence	influence	NN
cord-005453-4057qib7	12600	11	of	of	IN
cord-005453-4057qib7	12600	12	the	the	DT
cord-005453-4057qib7	12600	13	immune	immune	JJ
cord-005453-4057qib7	12600	14	response	response	NN
cord-005453-4057qib7	12600	15	genes	gene	NNS
cord-005453-4057qib7	12600	16	on	on	IN
cord-005453-4057qib7	12600	17	the	the	DT
cord-005453-4057qib7	12600	18	autograft	autograft	NN
cord-005453-4057qib7	12600	19	cellularity	cellularity	NN
cord-005453-4057qib7	12600	20	in	in	IN
cord-005453-4057qib7	12600	21	patients	patient	NNS
cord-005453-4057qib7	12600	22	with	with	IN
cord-005453-4057qib7	12600	23	MM	MM	NNP
cord-005453-4057qib7	12600	24	.	.	.
cord-005453-4057qib7	12601	1	Methods	method	NNS
cord-005453-4057qib7	12601	2	:	:	:
cord-005453-4057qib7	12601	3	А	а	JJ
cord-005453-4057qib7	12601	4	retrospective	retrospective	JJ
cord-005453-4057qib7	12601	5	analysis	analysis	NN
cord-005453-4057qib7	12601	6	of	of	IN
cord-005453-4057qib7	12601	7	the	the	DT
cord-005453-4057qib7	12601	8	genotyping	genotyping	NN
cord-005453-4057qib7	12601	9	results	result	NNS
cord-005453-4057qib7	12601	10	was	be	VBD
cord-005453-4057qib7	12601	11	performed	perform	VBN
cord-005453-4057qib7	12601	12	.	.	.
cord-005453-4057qib7	12602	1	Evaluation	evaluation	NN
cord-005453-4057qib7	12602	2	of	of	IN
cord-005453-4057qib7	12602	3	21	21	CD
cord-005453-4057qib7	12602	4	loci	locus	NNS
cord-005453-4057qib7	12602	5	in	in	IN
cord-005453-4057qib7	12602	6	15	15	CD
cord-005453-4057qib7	12602	7	genes	gene	NNS
cord-005453-4057qib7	12602	8	immune	immune	VBP
cord-005453-4057qib7	12602	9	response	response	NN
cord-005453-4057qib7	12602	10	and	and	CC
cord-005453-4057qib7	12602	11	harvesting	harvesting	NN
cord-005453-4057qib7	12602	12	of	of	IN
cord-005453-4057qib7	12602	13	autologous	autologous	JJ
cord-005453-4057qib7	12602	14	HSC	HSC	NNP
cord-005453-4057qib7	12602	15	in	in	IN
cord-005453-4057qib7	12602	16	78	78	CD
cord-005453-4057qib7	12602	17	patients	patient	NNS
cord-005453-4057qib7	12602	18	with	with	IN
cord-005453-4057qib7	12602	19	MM	MM	NNP
cord-005453-4057qib7	12602	20	has	have	VBZ
cord-005453-4057qib7	12602	21	been	be	VBN
cord-005453-4057qib7	12602	22	made	make	VBN
cord-005453-4057qib7	12602	23	.	.	.
cord-005453-4057qib7	12603	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12603	2	stem	stem	NN
cord-005453-4057qib7	12603	3	cell	cell	NN
cord-005453-4057qib7	12603	4	mobilization	mobilization	NN
cord-005453-4057qib7	12603	5	regimen	regimen	NN
cord-005453-4057qib7	12603	6	included	include	VBD
cord-005453-4057qib7	12603	7	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12603	8	4	4	CD
cord-005453-4057qib7	12603	9	g	g	NN
cord-005453-4057qib7	12603	10	/	/	SYM
cord-005453-4057qib7	12603	11	m	m	NN
cord-005453-4057qib7	12603	12	2	2	CD
cord-005453-4057qib7	12603	13	with	with	IN
cord-005453-4057qib7	12603	14	granulocyte	granulocyte	NN
cord-005453-4057qib7	12603	15	colony	colony	NN
cord-005453-4057qib7	12603	16	-	-	HYPH
cord-005453-4057qib7	12603	17	stimulating	stimulate	VBG
cord-005453-4057qib7	12603	18	factor	factor	NN
cord-005453-4057qib7	12603	19	.	.	.
cord-005453-4057qib7	12604	1	Genotyping	genotype	VBG
cord-005453-4057qib7	12604	2	of	of	IN
cord-005453-4057qib7	12604	3	the	the	DT
cord-005453-4057qib7	12604	4	immune	immune	JJ
cord-005453-4057qib7	12604	5	response	response	NN
cord-005453-4057qib7	12604	6	genes	gene	NNS
cord-005453-4057qib7	12604	7	polymorphic	polymorphic	JJ
cord-005453-4057qib7	12604	8	regions	region	NNS
cord-005453-4057qib7	12604	9	was	be	VBD
cord-005453-4057qib7	12604	10	carried	carry	VBN
cord-005453-4057qib7	12604	11	out	out	RP
cord-005453-4057qib7	12604	12	by	by	IN
cord-005453-4057qib7	12604	13	the	the	DT
cord-005453-4057qib7	12604	14	polymerase	polymerase	NN
cord-005453-4057qib7	12604	15	chain	chain	NN
cord-005453-4057qib7	12604	16	reaction	reaction	NN
cord-005453-4057qib7	12604	17	with	with	IN
cord-005453-4057qib7	12604	18	allelespecific	allelespecific	JJ
cord-005453-4057qib7	12604	19	primers	primer	NNS
cord-005453-4057qib7	12604	20	.	.	.
cord-005453-4057qib7	12605	1	The	the	DT
cord-005453-4057qib7	12605	2	number	number	NN
cord-005453-4057qib7	12605	3	of	of	IN
cord-005453-4057qib7	12605	4	CD34	CD34	NNP
cord-005453-4057qib7	12605	5	+	+	CC
cord-005453-4057qib7	12605	6	cells	cell	NNS
cord-005453-4057qib7	12605	7	was	be	VBD
cord-005453-4057qib7	12605	8	counted	count	VBN
cord-005453-4057qib7	12605	9	on	on	IN
cord-005453-4057qib7	12605	10	a	a	DT
cord-005453-4057qib7	12605	11	6-color	6-color	CD
cord-005453-4057qib7	12605	12	FACS	FACS	NNP
cord-005453-4057qib7	12605	13	Canto	Canto	NNP
cord-005453-4057qib7	12605	14	II	II	NNP
cord-005453-4057qib7	12605	15	flow	flow	NN
cord-005453-4057qib7	12605	16	cytometer	cytometer	NN
cord-005453-4057qib7	12605	17	.	.	.
cord-005453-4057qib7	12606	1	Results	result	NNS
cord-005453-4057qib7	12606	2	:	:	:
cord-005453-4057qib7	12607	1	According	accord	VBG
cord-005453-4057qib7	12607	2	to	to	IN
cord-005453-4057qib7	12607	3	the	the	DT
cord-005453-4057qib7	12607	4	results	result	NNS
cord-005453-4057qib7	12607	5	of	of	IN
cord-005453-4057qib7	12607	6	the	the	DT
cord-005453-4057qib7	12607	7	autologous	autologous	JJ
cord-005453-4057qib7	12607	8	transplant	transplant	NN
cord-005453-4057qib7	12607	9	harvesting	harvesting	NN
cord-005453-4057qib7	12607	10	,	,	,
cord-005453-4057qib7	12607	11	two	two	CD
cord-005453-4057qib7	12607	12	groups	group	NNS
cord-005453-4057qib7	12607	13	of	of	IN
cord-005453-4057qib7	12607	14	patients	patient	NNS
cord-005453-4057qib7	12607	15	were	be	VBD
cord-005453-4057qib7	12607	16	identified	identify	VBN
cord-005453-4057qib7	12607	17	.	.	.
cord-005453-4057qib7	12608	1	First	first	RB
cord-005453-4057qib7	12608	2	included	include	VBD
cord-005453-4057qib7	12608	3	65	65	CD
cord-005453-4057qib7	12608	4	patients	patient	NNS
cord-005453-4057qib7	12608	5	with	with	IN
cord-005453-4057qib7	12608	6	an	an	DT
cord-005453-4057qib7	12608	7	autograft	autograft	NN
cord-005453-4057qib7	12608	8	cellularity	cellularity	NN
cord-005453-4057qib7	12608	9	of	of	IN
cord-005453-4057qib7	12608	10	more	more	JJR
cord-005453-4057qib7	12608	11	than	than	IN
cord-005453-4057qib7	12608	12	2×10	2×10	CD
cord-005453-4057qib7	12608	13	6	6	CD
cord-005453-4057qib7	12608	14	/kg	/kg	CD
cord-005453-4057qib7	12608	15	body	body	NN
cord-005453-4057qib7	12608	16	weight	weight	NN
cord-005453-4057qib7	12608	17	.	.	.
cord-005453-4057qib7	12609	1	The	the	DT
cord-005453-4057qib7	12609	2	second	second	JJ
cord-005453-4057qib7	12609	3	group	group	NN
cord-005453-4057qib7	12609	4	consisted	consist	VBD
cord-005453-4057qib7	12609	5	of	of	IN
cord-005453-4057qib7	12609	6	13	13	CD
cord-005453-4057qib7	12609	7	patients	patient	NNS
cord-005453-4057qib7	12609	8	examined	examine	VBN
cord-005453-4057qib7	12609	9	with	with	IN
cord-005453-4057qib7	12609	10	the	the	DT
cord-005453-4057qib7	12609	11	number	number	NN
cord-005453-4057qib7	12609	12	of	of	IN
cord-005453-4057qib7	12609	13	CD34	CD34	NNP
cord-005453-4057qib7	12609	14	+	+	CC
cord-005453-4057qib7	12609	15	cells	cell	NNS
cord-005453-4057qib7	12609	16	in	in	IN
cord-005453-4057qib7	12609	17	the	the	DT
cord-005453-4057qib7	12609	18	autograft	autograft	NN
cord-005453-4057qib7	12609	19	≤2×10	≤2×10	NNP
cord-005453-4057qib7	12609	20	6	6	CD
cord-005453-4057qib7	12609	21	/kg	/kg	NFP
cord-005453-4057qib7	12609	22	of	of	IN
cord-005453-4057qib7	12609	23	the	the	DT
cord-005453-4057qib7	12609	24	patient	patient	NN
cord-005453-4057qib7	12609	25	's	's	POS
cord-005453-4057qib7	12609	26	body	body	NN
cord-005453-4057qib7	12609	27	weight	weight	NN
cord-005453-4057qib7	12609	28	.	.	.
cord-005453-4057qib7	12610	1	Comparing	compare	VBG
cord-005453-4057qib7	12610	2	the	the	DT
cord-005453-4057qib7	12610	3	identified	identify	VBN
cord-005453-4057qib7	12610	4	haplotypes	haplotype	NNS
cord-005453-4057qib7	12610	5	of	of	IN
cord-005453-4057qib7	12610	6	the	the	DT
cord-005453-4057qib7	12610	7	immune	immune	JJ
cord-005453-4057qib7	12610	8	response	response	NN
cord-005453-4057qib7	12610	9	genes	gene	NNS
cord-005453-4057qib7	12610	10	with	with	IN
cord-005453-4057qib7	12610	11	the	the	DT
cord-005453-4057qib7	12610	12	cellularity	cellularity	NN
cord-005453-4057qib7	12610	13	of	of	IN
cord-005453-4057qib7	12610	14	the	the	DT
cord-005453-4057qib7	12610	15	transplantation	transplantation	NN
cord-005453-4057qib7	12610	16	material	material	NN
cord-005453-4057qib7	12610	17	,	,	,
cord-005453-4057qib7	12610	18	it	-PRON-	PRP
cord-005453-4057qib7	12610	19	was	be	VBD
cord-005453-4057qib7	12610	20	found	find	VBN
cord-005453-4057qib7	12610	21	that	that	IN
cord-005453-4057qib7	12610	22	the	the	DT
cord-005453-4057qib7	12610	23	presence	presence	NN
cord-005453-4057qib7	12610	24	of	of	IN
cord-005453-4057qib7	12610	25	the	the	DT
cord-005453-4057qib7	12610	26	mutant	mutant	JJ
cord-005453-4057qib7	12610	27	allele	allele	NN
cord-005453-4057qib7	12610	28	in	in	IN
cord-005453-4057qib7	12610	29	the	the	DT
cord-005453-4057qib7	12610	30	homo	homo	NN
cord-005453-4057qib7	12610	31	-	-	HYPH
cord-005453-4057qib7	12610	32	and	and	CC
cord-005453-4057qib7	12610	33	heterozygous	heterozygous	JJ
cord-005453-4057qib7	12610	34	haplotypes	haplotype	NNS
cord-005453-4057qib7	12610	35	of	of	IN
cord-005453-4057qib7	12610	36	the	the	DT
cord-005453-4057qib7	12610	37	IL1β	IL1β	NNP
cord-005453-4057qib7	12610	38	gene	gene	NN
cord-005453-4057qib7	12610	39	(	(	-LRB-
cord-005453-4057qib7	12610	40	T-511C	T-511C	NNP
cord-005453-4057qib7	12610	41	)	)	-RRB-
cord-005453-4057qib7	12610	42	increased	increase	VBD
cord-005453-4057qib7	12610	43	the	the	DT
cord-005453-4057qib7	12610	44	chances	chance	NNS
cord-005453-4057qib7	12610	45	of	of	IN
cord-005453-4057qib7	12610	46	harvesting	harvest	VBG
cord-005453-4057qib7	12610	47	cellular	cellular	JJ
cord-005453-4057qib7	12610	48	material	material	NN
cord-005453-4057qib7	12610	49	with	with	IN
cord-005453-4057qib7	12610	50	a	a	DT
cord-005453-4057qib7	12610	51	higher	high	JJR
cord-005453-4057qib7	12610	52	content	content	NN
cord-005453-4057qib7	12610	53	of	of	IN
cord-005453-4057qib7	12610	54	CD34	CD34	NNP
cord-005453-4057qib7	12610	55	+	+	CC
cord-005453-4057qib7	12610	56	cells	cell	NNS
cord-005453-4057qib7	12610	57	in	in	IN
cord-005453-4057qib7	12610	58	4	4	CD
cord-005453-4057qib7	12610	59	times	time	NNS
cord-005453-4057qib7	12610	60	(	(	-LRB-
cord-005453-4057qib7	12610	61	χ2=5.04	χ2=5.04	NFP
cord-005453-4057qib7	12610	62	,	,	,
cord-005453-4057qib7	12610	63	p=0.02	p=0.02	NNP
cord-005453-4057qib7	12610	64	)	)	-RRB-
cord-005453-4057qib7	12610	65	,	,	,
cord-005453-4057qib7	12610	66	and	and	CC
cord-005453-4057qib7	12610	67	the	the	DT
cord-005453-4057qib7	12610	68	carriage	carriage	NN
cord-005453-4057qib7	12610	69	of	of	IN
cord-005453-4057qib7	12610	70	the	the	DT
cord-005453-4057qib7	12610	71	wild	wild	JJ
cord-005453-4057qib7	12610	72	type	type	NN
cord-005453-4057qib7	12610	73	allele	allele	NN
cord-005453-4057qib7	12610	74	in	in	IN
cord-005453-4057qib7	12610	75	the	the	DT
cord-005453-4057qib7	12610	76	homo	homo	NN
cord-005453-4057qib7	12610	77	-	-	HYPH
cord-005453-4057qib7	12610	78	and	and	CC
cord-005453-4057qib7	12610	79	heterozygous	heterozygous	JJ
cord-005453-4057qib7	12610	80	state	state	NN
cord-005453-4057qib7	12610	81	of	of	IN
cord-005453-4057qib7	12610	82	the	the	DT
cord-005453-4057qib7	12610	83	TLR2	TLR2	NNP
cord-005453-4057qib7	12610	84	(	(	-LRB-
cord-005453-4057qib7	12610	85	Arg753Gln	arg753gln	NN
cord-005453-4057qib7	12610	86	)	)	-RRB-
cord-005453-4057qib7	12610	87	gene	gene	NN
cord-005453-4057qib7	12610	88	is	be	VBZ
cord-005453-4057qib7	12610	89	more	more	JJR
cord-005453-4057qib7	12610	90	than	than	IN
cord-005453-4057qib7	12610	91	in	in	IN
cord-005453-4057qib7	12610	92	15	15	CD
cord-005453-4057qib7	12610	93	times	time	NNS
cord-005453-4057qib7	12610	94	(	(	-LRB-
cord-005453-4057qib7	12610	95	χ2=5.06	χ2=5.06	NNP
cord-005453-4057qib7	12610	96	,	,	,
cord-005453-4057qib7	12610	97	p=0.02	p=0.02	NNP
cord-005453-4057qib7	12610	98	)	)	-RRB-
cord-005453-4057qib7	12610	99	.	.	.
cord-005453-4057qib7	12611	1	Currently	currently	RB
cord-005453-4057qib7	12611	2	,	,	,
cord-005453-4057qib7	12611	3	it	-PRON-	PRP
cord-005453-4057qib7	12611	4	has	have	VBZ
cord-005453-4057qib7	12611	5	been	be	VBN
cord-005453-4057qib7	12611	6	shown	show	VBN
cord-005453-4057qib7	12611	7	that	that	IN
cord-005453-4057qib7	12611	8	single	single	JJ
cord-005453-4057qib7	12611	9	nucleotide	nucleotide	NN
cord-005453-4057qib7	12611	10	or	or	CC
cord-005453-4057qib7	12611	11	amino	amino	NN
cord-005453-4057qib7	12611	12	acid	acid	NN
cord-005453-4057qib7	12611	13	substitutions	substitution	NNS
cord-005453-4057qib7	12611	14	in	in	IN
cord-005453-4057qib7	12611	15	genes	gene	NNS
cord-005453-4057qib7	12611	16	can	can	MD
cord-005453-4057qib7	12611	17	lead	lead	VB
cord-005453-4057qib7	12611	18	to	to	IN
cord-005453-4057qib7	12611	19	changes	change	NNS
cord-005453-4057qib7	12611	20	in	in	IN
cord-005453-4057qib7	12611	21	the	the	DT
cord-005453-4057qib7	12611	22	expression	expression	NN
cord-005453-4057qib7	12611	23	pattern	pattern	NN
cord-005453-4057qib7	12611	24	of	of	IN
cord-005453-4057qib7	12611	25	their	-PRON-	PRP$
cord-005453-4057qib7	12611	26	final	final	JJ
cord-005453-4057qib7	12611	27	products	product	NNS
cord-005453-4057qib7	12611	28	:	:	:
cord-005453-4057qib7	12611	29	increased	increase	VBN
cord-005453-4057qib7	12611	30	secretion	secretion	NN
cord-005453-4057qib7	12611	31	of	of	IN
cord-005453-4057qib7	12611	32	interleukin	interleukin	NN
cord-005453-4057qib7	12611	33	1β	1β	CD
cord-005453-4057qib7	12611	34	(	(	-LRB-
cord-005453-4057qib7	12611	35	IL-1β	il-1β	NN
cord-005453-4057qib7	12611	36	)	)	-RRB-
cord-005453-4057qib7	12611	37	or	or	CC
cord-005453-4057qib7	12611	38	changes	change	NNS
cord-005453-4057qib7	12611	39	in	in	IN
cord-005453-4057qib7	12611	40	the	the	DT
cord-005453-4057qib7	12611	41	spatial	spatial	JJ
cord-005453-4057qib7	12611	42	configuration	configuration	NN
cord-005453-4057qib7	12611	43	and	and	CC
cord-005453-4057qib7	12611	44	functionality	functionality	NN
cord-005453-4057qib7	12611	45	of	of	IN
cord-005453-4057qib7	12611	46	the	the	DT
cord-005453-4057qib7	12611	47	receptors	receptor	NNS
cord-005453-4057qib7	12611	48	(	(	-LRB-
cord-005453-4057qib7	12611	49	TLR2	TLR2	NNP
cord-005453-4057qib7	12611	50	)	)	-RRB-
cord-005453-4057qib7	12611	51	.	.	.
cord-005453-4057qib7	12612	1	Thus	thus	RB
cord-005453-4057qib7	12612	2	,	,	,
cord-005453-4057qib7	12612	3	in	in	IN
cord-005453-4057qib7	12612	4	the	the	DT
cord-005453-4057qib7	12612	5	presence	presence	NN
cord-005453-4057qib7	12612	6	of	of	IN
cord-005453-4057qib7	12612	7	mutations	mutation	NNS
cord-005453-4057qib7	12612	8	in	in	IN
cord-005453-4057qib7	12612	9	the	the	DT
cord-005453-4057qib7	12612	10	IL1β	IL1β	NNP
cord-005453-4057qib7	12612	11	gene	gene	NN
cord-005453-4057qib7	12612	12	,	,	,
cord-005453-4057qib7	12612	13	the	the	DT
cord-005453-4057qib7	12612	14	enhanced	enhanced	JJ
cord-005453-4057qib7	12612	15	synthesis	synthesis	NN
cord-005453-4057qib7	12612	16	of	of	IN
cord-005453-4057qib7	12612	17	IL-1β	il-1β	JJ
cord-005453-4057qib7	12612	18	influences	influence	NNS
cord-005453-4057qib7	12612	19	on	on	IN
cord-005453-4057qib7	12612	20	fibroblasts	fibroblast	NNS
cord-005453-4057qib7	12612	21	,	,	,
cord-005453-4057qib7	12612	22	immunocompetent	immunocompetent	JJ
cord-005453-4057qib7	12612	23	,	,	,
cord-005453-4057qib7	12612	24	endothelial	endothelial	JJ
cord-005453-4057qib7	12612	25	,	,	,
cord-005453-4057qib7	12612	26	epithelial	epithelial	JJ
cord-005453-4057qib7	12612	27	and	and	CC
cord-005453-4057qib7	12612	28	other	other	JJ
cord-005453-4057qib7	12612	29	cells	cell	NNS
cord-005453-4057qib7	12612	30	,	,	,
cord-005453-4057qib7	12612	31	by	by	IN
cord-005453-4057qib7	12612	32	activating	activate	VBG
cord-005453-4057qib7	12612	33	hemopoiesis	hemopoiesis	NNP
cord-005453-4057qib7	12612	34	.	.	.
cord-005453-4057qib7	12613	1	In	in	IN
cord-005453-4057qib7	12613	2	turn	turn	NN
cord-005453-4057qib7	12613	3	,	,	,
cord-005453-4057qib7	12613	4	the	the	DT
cord-005453-4057qib7	12613	5	mutational	mutational	JJ
cord-005453-4057qib7	12613	6	status	status	NN
cord-005453-4057qib7	12613	7	of	of	IN
cord-005453-4057qib7	12613	8	the	the	DT
cord-005453-4057qib7	12613	9	Arg753Gln	arg753gln	CD
cord-005453-4057qib7	12613	10	locus	locus	NN
cord-005453-4057qib7	12613	11	located	locate	VBN
cord-005453-4057qib7	12613	12	within	within	IN
cord-005453-4057qib7	12613	13	the	the	DT
cord-005453-4057qib7	12613	14	TIR	TIR	NNP
cord-005453-4057qib7	12613	15	domain	domain	NN
cord-005453-4057qib7	12613	16	of	of	IN
cord-005453-4057qib7	12613	17	the	the	DT
cord-005453-4057qib7	12613	18	TLR2	TLR2	NNP
cord-005453-4057qib7	12613	19	receptor	receptor	NN
cord-005453-4057qib7	12613	20	in	in	IN
cord-005453-4057qib7	12613	21	the	the	DT
cord-005453-4057qib7	12613	22	cytosol	cytosol	NN
cord-005453-4057qib7	12613	23	,	,	,
cord-005453-4057qib7	12613	24	determines	determine	VBZ
cord-005453-4057qib7	12613	25	the	the	DT
cord-005453-4057qib7	12613	26	spatial	spatial	JJ
cord-005453-4057qib7	12613	27	configuration	configuration	NN
cord-005453-4057qib7	12613	28	of	of	IN
cord-005453-4057qib7	12613	29	the	the	DT
cord-005453-4057qib7	12613	30	TLR2	TLR2	NNP
cord-005453-4057qib7	12613	31	acting	acting	NN
cord-005453-4057qib7	12613	32	as	as	IN
cord-005453-4057qib7	12613	33	a	a	DT
cord-005453-4057qib7	12613	34	co	co	JJ
cord-005453-4057qib7	12613	35	-	-	JJ
cord-005453-4057qib7	12613	36	stimulatory	stimulatory	JJ
cord-005453-4057qib7	12613	37	receptor	receptor	NN
cord-005453-4057qib7	12613	38	of	of	IN
cord-005453-4057qib7	12613	39	CD4	CD4	NNP
cord-005453-4057qib7	12613	40	+	+	CC
cord-005453-4057qib7	12613	41	cells	cell	NNS
cord-005453-4057qib7	12613	42	,	,	,
cord-005453-4057qib7	12613	43	which	which	WDT
cord-005453-4057qib7	12613	44	ensure	ensure	VBP
cord-005453-4057qib7	12613	45	the	the	DT
cord-005453-4057qib7	12613	46	engraftment	engraftment	NN
cord-005453-4057qib7	12613	47	of	of	IN
cord-005453-4057qib7	12613	48	the	the	DT
cord-005453-4057qib7	12613	49	graft	graft	NN
cord-005453-4057qib7	12613	50	.	.	.
cord-005453-4057qib7	12614	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12614	2	:	:	:
cord-005453-4057qib7	12615	1	Identified	identify	VBN
cord-005453-4057qib7	12615	2	haplotypical	haplotypical	NN
cord-005453-4057qib7	12615	3	features	feature	NNS
cord-005453-4057qib7	12615	4	of	of	IN
cord-005453-4057qib7	12615	5	the	the	DT
cord-005453-4057qib7	12615	6	IL1β	IL1β	NNP
cord-005453-4057qib7	12615	7	and	and	CC
cord-005453-4057qib7	12615	8	TLR2	TLR2	NNP
cord-005453-4057qib7	12615	9	genes	gene	NNS
cord-005453-4057qib7	12615	10	in	in	IN
cord-005453-4057qib7	12615	11	patients	patient	NNS
cord-005453-4057qib7	12615	12	with	with	IN
cord-005453-4057qib7	12615	13	MM	MM	NNP
cord-005453-4057qib7	12615	14	may	may	MD
cord-005453-4057qib7	12615	15	act	act	VB
cord-005453-4057qib7	12615	16	as	as	IN
cord-005453-4057qib7	12615	17	predictors	predictor	NNS
cord-005453-4057qib7	12615	18	of	of	IN
cord-005453-4057qib7	12615	19	the	the	DT
cord-005453-4057qib7	12615	20	response	response	NN
cord-005453-4057qib7	12615	21	effectiveness	effectiveness	NN
cord-005453-4057qib7	12615	22	to	to	IN
cord-005453-4057qib7	12615	23	mobilization	mobilization	NN
cord-005453-4057qib7	12615	24	of	of	IN
cord-005453-4057qib7	12615	25	HSCs	hscs	NN
cord-005453-4057qib7	12615	26	in	in	IN
cord-005453-4057qib7	12615	27	their	-PRON-	PRP$
cord-005453-4057qib7	12615	28	carriers	carrier	NNS
cord-005453-4057qib7	12615	29	,	,	,
cord-005453-4057qib7	12615	30	which	which	WDT
cord-005453-4057qib7	12615	31	may	may	MD
cord-005453-4057qib7	12615	32	contribute	contribute	VB
cord-005453-4057qib7	12615	33	to	to	IN
cord-005453-4057qib7	12615	34	the	the	DT
cord-005453-4057qib7	12615	35	mobilization	mobilization	NN
cord-005453-4057qib7	12615	36	regimen	regimen	NN
cord-005453-4057qib7	12615	37	optimization	optimization	NN
cord-005453-4057qib7	12615	38	and	and	CC
cord-005453-4057qib7	12615	39	will	will	MD
cord-005453-4057qib7	12615	40	contribute	contribute	VB
cord-005453-4057qib7	12615	41	to	to	IN
cord-005453-4057qib7	12615	42	harvesting	harvest	VBG
cord-005453-4057qib7	12615	43	the	the	DT
cord-005453-4057qib7	12615	44	optimal	optimal	JJ
cord-005453-4057qib7	12615	45	cellularity	cellularity	NN
cord-005453-4057qib7	12615	46	of	of	IN
cord-005453-4057qib7	12615	47	an	an	DT
cord-005453-4057qib7	12615	48	autologous	autologous	JJ
cord-005453-4057qib7	12615	49	graft	graft	NN
cord-005453-4057qib7	12615	50	.	.	.
cord-005453-4057qib7	12616	1	Clinical	clinical	JJ
cord-005453-4057qib7	12616	2	Trial	Trial	NNP
cord-005453-4057qib7	12616	3	Registry	Registry	NNP
cord-005453-4057qib7	12616	4	:	:	:
cord-005453-4057qib7	12616	5	None	none	NN
cord-005453-4057qib7	12616	6	.	.	.
cord-005453-4057qib7	12617	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12617	2	:	:	:
cord-005453-4057qib7	12618	1	Authors	author	NNS
cord-005453-4057qib7	12618	2	declare	declare	VBP
cord-005453-4057qib7	12618	3	no	no	DT
cord-005453-4057qib7	12618	4	conflict	conflict	NN
cord-005453-4057qib7	12618	5	of	of	IN
cord-005453-4057qib7	12618	6	interest	interest	NN
cord-005453-4057qib7	12618	7	.	.	.
cord-005453-4057qib7	12619	1	Differentiating	differentiate	VBG
cord-005453-4057qib7	12619	2	diffuse	diffuse	NN
cord-005453-4057qib7	12619	3	from	from	IN
cord-005453-4057qib7	12619	4	focal	focal	JJ
cord-005453-4057qib7	12619	5	pattern	pattern	NN
cord-005453-4057qib7	12619	6	on	on	IN
cord-005453-4057qib7	12619	7	computed	compute	VBN
cord-005453-4057qib7	12619	8	tomography	tomography	NN
cord-005453-4057qib7	12619	9	:	:	:
cord-005453-4057qib7	12619	10	Added	add	VBN
cord-005453-4057qib7	12619	11	values	value	NNS
cord-005453-4057qib7	12619	12	of	of	IN
cord-005453-4057qib7	12619	13	a	a	DT
cord-005453-4057qib7	12619	14	radiomics	radiomic	NNS
cord-005453-4057qib7	12619	15	approach	approach	NN
cord-005453-4057qib7	12619	16	Background	background	NN
cord-005453-4057qib7	12619	17	:	:	:
cord-005453-4057qib7	12620	1	Focal	focal	JJ
cord-005453-4057qib7	12620	2	pattern	pattern	NN
cord-005453-4057qib7	12620	3	in	in	IN
cord-005453-4057qib7	12620	4	multiple	multiple	JJ
cord-005453-4057qib7	12620	5	myeloma	myeloma	NN
cord-005453-4057qib7	12620	6	(	(	-LRB-
cord-005453-4057qib7	12620	7	MM	MM	NNP
cord-005453-4057qib7	12620	8	)	)	-RRB-
cord-005453-4057qib7	12620	9	seems	seem	VBZ
cord-005453-4057qib7	12620	10	to	to	TO
cord-005453-4057qib7	12620	11	be	be	VB
cord-005453-4057qib7	12620	12	related	relate	VBN
cord-005453-4057qib7	12620	13	to	to	IN
cord-005453-4057qib7	12620	14	poorer	poor	JJR
cord-005453-4057qib7	12620	15	survival	survival	NN
cord-005453-4057qib7	12620	16	and	and	CC
cord-005453-4057qib7	12620	17	differentiation	differentiation	NN
cord-005453-4057qib7	12620	18	from	from	IN
cord-005453-4057qib7	12620	19	diffuse	diffuse	JJ
cord-005453-4057qib7	12620	20	to	to	IN
cord-005453-4057qib7	12620	21	focal	focal	JJ
cord-005453-4057qib7	12620	22	pattern	pattern	NN
cord-005453-4057qib7	12620	23	on	on	IN
cord-005453-4057qib7	12620	24	computed	compute	VBN
cord-005453-4057qib7	12620	25	tomography	tomography	NN
cord-005453-4057qib7	12620	26	(	(	-LRB-
cord-005453-4057qib7	12620	27	CT	CT	NNP
cord-005453-4057qib7	12620	28	)	)	-RRB-
cord-005453-4057qib7	12620	29	has	have	VBZ
cord-005453-4057qib7	12620	30	inter	inter	JJ
cord-005453-4057qib7	12620	31	-	-	JJ
cord-005453-4057qib7	12620	32	reader	reader	JJ
cord-005453-4057qib7	12620	33	variability	variability	NN
cord-005453-4057qib7	12620	34	.	.	.
cord-005453-4057qib7	12621	1	Therefore	therefore	RB
cord-005453-4057qib7	12621	2	the	the	DT
cord-005453-4057qib7	12621	3	purpose	purpose	NN
cord-005453-4057qib7	12621	4	of	of	IN
cord-005453-4057qib7	12621	5	this	this	DT
cord-005453-4057qib7	12621	6	study	study	NN
cord-005453-4057qib7	12621	7	is	be	VBZ
cord-005453-4057qib7	12621	8	to	to	TO
cord-005453-4057qib7	12621	9	assess	assess	VB
cord-005453-4057qib7	12621	10	if	if	IN
cord-005453-4057qib7	12621	11	a	a	DT
cord-005453-4057qib7	12621	12	Radiomic	Radiomic	NNP
cord-005453-4057qib7	12621	13	approach	approach	NN
cord-005453-4057qib7	12621	14	could	could	MD
cord-005453-4057qib7	12621	15	help	help	VB
cord-005453-4057qib7	12621	16	radiologists	radiologist	NNS
cord-005453-4057qib7	12621	17	in	in	IN
cord-005453-4057qib7	12621	18	differentiating	differentiate	VBG
cord-005453-4057qib7	12621	19	diffuse	diffuse	NN
cord-005453-4057qib7	12621	20	from	from	IN
cord-005453-4057qib7	12621	21	focal	focal	JJ
cord-005453-4057qib7	12621	22	patterns	pattern	NNS
cord-005453-4057qib7	12621	23	.	.	.
cord-005453-4057qib7	12622	1	Methods	method	NNS
cord-005453-4057qib7	12622	2	:	:	:
cord-005453-4057qib7	12622	3	We	-PRON-	PRP
cord-005453-4057qib7	12622	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	12622	5	reviewed	review	VBD
cord-005453-4057qib7	12622	6	imaging	image	VBG
cord-005453-4057qib7	12622	7	data	datum	NNS
cord-005453-4057qib7	12622	8	of	of	IN
cord-005453-4057qib7	12622	9	70	70	CD
cord-005453-4057qib7	12622	10	patients	patient	NNS
cord-005453-4057qib7	12622	11	with	with	IN
cord-005453-4057qib7	12622	12	MM	MM	NNP
cord-005453-4057qib7	12622	13	between	between	IN
cord-005453-4057qib7	12622	14	January	January	NNP
cord-005453-4057qib7	12622	15	2013	2013	CD
cord-005453-4057qib7	12622	16	and	and	CC
cord-005453-4057qib7	12622	17	September	September	NNP
cord-005453-4057qib7	12622	18	2018	2018	CD
cord-005453-4057qib7	12622	19	of	of	IN
cord-005453-4057qib7	12622	20	whom	whom	WP
cord-005453-4057qib7	12622	21	61(27	61(27	CD
cord-005453-4057qib7	12622	22	men	man	NNS
cord-005453-4057qib7	12622	23	and	and	CC
cord-005453-4057qib7	12622	24	34	34	CD
cord-005453-4057qib7	12622	25	women	woman	NNS
cord-005453-4057qib7	12622	26	;	;	:
cord-005453-4057qib7	12622	27	mean	mean	VB
cord-005453-4057qib7	12622	28	age	age	NN
cord-005453-4057qib7	12622	29	54.2	54.2	CD
cord-005453-4057qib7	12622	30	±3.7	±3.7	NNS
cord-005453-4057qib7	12622	31	)	)	-RRB-
cord-005453-4057qib7	12622	32	with	with	IN
cord-005453-4057qib7	12622	33	CT	CT	NNP
cord-005453-4057qib7	12622	34	,	,	,
cord-005453-4057qib7	12622	35	PET	PET	NNP
cord-005453-4057qib7	12622	36	-	-	HYPH
cord-005453-4057qib7	12622	37	CT	CT	NNP
cord-005453-4057qib7	12622	38	or	or	CC
cord-005453-4057qib7	12622	39	MRI	MRI	NNP
cord-005453-4057qib7	12622	40	available	available	JJ
cord-005453-4057qib7	12622	41	before	before	IN
cord-005453-4057qib7	12622	42	bone	bone	NN
cord-005453-4057qib7	12622	43	marrow	marrow	NN
cord-005453-4057qib7	12622	44	transplant	transplant	NN
cord-005453-4057qib7	12622	45	.	.	.
cord-005453-4057qib7	12623	1	Two	two	CD
cord-005453-4057qib7	12623	2	general	general	JJ
cord-005453-4057qib7	12623	3	radiologist	radiologist	NN
cord-005453-4057qib7	12623	4	evaluated	evaluate	VBN
cord-005453-4057qib7	12623	5	in	in	IN
cord-005453-4057qib7	12623	6	consensus	consensus	NN
cord-005453-4057qib7	12623	7	only	only	RB
cord-005453-4057qib7	12623	8	CT	CT	NNP
cord-005453-4057qib7	12623	9	images	image	NNS
cord-005453-4057qib7	12623	10	to	to	TO
cord-005453-4057qib7	12623	11	define	define	VB
cord-005453-4057qib7	12623	12	a	a	DT
cord-005453-4057qib7	12623	13	focal	focal	NN
cord-005453-4057qib7	12623	14	(	(	-LRB-
cord-005453-4057qib7	12623	15	at	at	RB
cord-005453-4057qib7	12623	16	least	least	RBS
cord-005453-4057qib7	12623	17	one	one	CD
cord-005453-4057qib7	12623	18	lytic	lytic	JJ
cord-005453-4057qib7	12623	19	lesion	lesion	NN
cord-005453-4057qib7	12623	20	>	>	XX
cord-005453-4057qib7	12623	21	5	5	CD
cord-005453-4057qib7	12623	22	mm	mm	NN
cord-005453-4057qib7	12623	23	in	in	IN
cord-005453-4057qib7	12623	24	diameter	diameter	NN
cord-005453-4057qib7	12623	25	)	)	-RRB-
cord-005453-4057qib7	12623	26	or	or	CC
cord-005453-4057qib7	12623	27	a	a	DT
cord-005453-4057qib7	12623	28	diffuse	diffuse	NN
cord-005453-4057qib7	12623	29	(	(	-LRB-
cord-005453-4057qib7	12623	30	lesions	lesion	NNS
cord-005453-4057qib7	12623	31	<	<	XX
cord-005453-4057qib7	12623	32	5	5	CD
cord-005453-4057qib7	12623	33	mm	mm	NNP
cord-005453-4057qib7	12623	34	,	,	,
cord-005453-4057qib7	12623	35	not	not	RB
cord-005453-4057qib7	12623	36	osteoporosis	osteoporosis	NN
cord-005453-4057qib7	12623	37	)	)	-RRB-
cord-005453-4057qib7	12623	38	pattern	pattern	NN
cord-005453-4057qib7	12623	39	.	.	.
cord-005453-4057qib7	12624	1	Radiomic	radiomic	JJ
cord-005453-4057qib7	12624	2	analysis	analysis	NN
cord-005453-4057qib7	12624	3	on	on	IN
cord-005453-4057qib7	12624	4	CT	CT	NNP
cord-005453-4057qib7	12624	5	thinslice	thinslice	NN
cord-005453-4057qib7	12624	6	images	image	NNS
cord-005453-4057qib7	12624	7	was	be	VBD
cord-005453-4057qib7	12624	8	then	then	RB
cord-005453-4057qib7	12624	9	applied	apply	VBN
cord-005453-4057qib7	12624	10	with	with	IN
cord-005453-4057qib7	12624	11	regions	region	NNS
cord-005453-4057qib7	12624	12	of	of	IN
cord-005453-4057qib7	12624	13	interest	interest	NN
cord-005453-4057qib7	12624	14	(	(	-LRB-
cord-005453-4057qib7	12624	15	ROIs	ROIs	NNP
cord-005453-4057qib7	12624	16	)	)	-RRB-
cord-005453-4057qib7	12624	17	done	do	VBN
cord-005453-4057qib7	12624	18	by	by	IN
cord-005453-4057qib7	12624	19	one	one	CD
cord-005453-4057qib7	12624	20	Researcher	Researcher	NNP
cord-005453-4057qib7	12624	21	not	not	RB
cord-005453-4057qib7	12624	22	expert	expert	VB
cord-005453-4057qib7	12624	23	in	in	IN
cord-005453-4057qib7	12624	24	Medical	Medical	NNP
cord-005453-4057qib7	12624	25	Imaging	Imaging	NNP
cord-005453-4057qib7	12624	26	or	or	CC
cord-005453-4057qib7	12624	27	MM	MM	NNP
cord-005453-4057qib7	12624	28	blindly	blindly	RB
cord-005453-4057qib7	12624	29	to	to	IN
cord-005453-4057qib7	12624	30	the	the	DT
cord-005453-4057qib7	12624	31	condition	condition	NN
cord-005453-4057qib7	12624	32	of	of	IN
cord-005453-4057qib7	12624	33	the	the	DT
cord-005453-4057qib7	12624	34	patients	patient	NNS
cord-005453-4057qib7	12624	35	.	.	.
cord-005453-4057qib7	12625	1	The	the	DT
cord-005453-4057qib7	12625	2	reference	reference	NN
cord-005453-4057qib7	12625	3	standard	standard	NN
cord-005453-4057qib7	12625	4	to	to	TO
cord-005453-4057qib7	12625	5	differentiate	differentiate	VB
cord-005453-4057qib7	12625	6	diffuse	diffuse	NN
cord-005453-4057qib7	12625	7	from	from	IN
cord-005453-4057qib7	12625	8	focal	focal	JJ
cord-005453-4057qib7	12625	9	pattern	pattern	NN
cord-005453-4057qib7	12625	10	was	be	VBD
cord-005453-4057qib7	12625	11	done	do	VBN
cord-005453-4057qib7	12625	12	by	by	IN
cord-005453-4057qib7	12625	13	radiological	radiological	JJ
cord-005453-4057qib7	12625	14	evaluation	evaluation	NN
cord-005453-4057qib7	12625	15	of	of	IN
cord-005453-4057qib7	12625	16	two	two	CD
cord-005453-4057qib7	12625	17	expert	expert	JJ
cord-005453-4057qib7	12625	18	musculosketal	musculosketal	JJ
cord-005453-4057qib7	12625	19	radiologists	radiologist	NNS
cord-005453-4057qib7	12625	20	blinded	blind	VBD
cord-005453-4057qib7	12625	21	to	to	IN
cord-005453-4057qib7	12625	22	the	the	DT
cord-005453-4057qib7	12625	23	clinical	clinical	JJ
cord-005453-4057qib7	12625	24	data	datum	NNS
cord-005453-4057qib7	12625	25	reviewing	review	VBG
cord-005453-4057qib7	12625	26	CT	CT	NNP
cord-005453-4057qib7	12625	27	,	,	,
cord-005453-4057qib7	12625	28	MRI	MRI	NNP
cord-005453-4057qib7	12625	29	and	and	CC
cord-005453-4057qib7	12625	30	PET	PET	NNP
cord-005453-4057qib7	12625	31	-	-	HYPH
cord-005453-4057qib7	12625	32	CT	CT	NNP
cord-005453-4057qib7	12625	33	images	image	NNS
cord-005453-4057qib7	12625	34	.	.	.
cord-005453-4057qib7	12626	1	N=104	N=104	NNP
cord-005453-4057qib7	12626	2	Radiomics	Radiomics	NNP
cord-005453-4057qib7	12626	3	features	feature	NNS
cord-005453-4057qib7	12626	4	were	be	VBD
cord-005453-4057qib7	12626	5	extracted	extract	VBN
cord-005453-4057qib7	12626	6	and	and	CC
cord-005453-4057qib7	12626	7	evaluated	evaluate	VBN
cord-005453-4057qib7	12626	8	with	with	IN
cord-005453-4057qib7	12626	9	an	an	DT
cord-005453-4057qib7	12626	10	open	open	JJ
cord-005453-4057qib7	12626	11	source	source	NN
cord-005453-4057qib7	12626	12	software	software	NN
cord-005453-4057qib7	12626	13	.	.	.
cord-005453-4057qib7	12627	1	Mann	Mann	NNP
cord-005453-4057qib7	12627	2	-	-	HYPH
cord-005453-4057qib7	12627	3	Whitney	Whitney	NNP
cord-005453-4057qib7	12627	4	U	U	NNP
cord-005453-4057qib7	12627	5	test	test	VBP
cord-005453-4057qib7	12627	6	for	for	IN
cord-005453-4057qib7	12627	7	unpaired	unpaired	JJ
cord-005453-4057qib7	12627	8	data	datum	NNS
cord-005453-4057qib7	12627	9	with	with	IN
cord-005453-4057qib7	12627	10	1000	1000	CD
cord-005453-4057qib7	12627	11	bootstraps	bootstraps	NN
cord-005453-4057qib7	12627	12	samples	sample	NNS
cord-005453-4057qib7	12627	13	was	be	VBD
cord-005453-4057qib7	12627	14	used	use	VBN
cord-005453-4057qib7	12627	15	to	to	TO
cord-005453-4057qib7	12627	16	compare	compare	VB
cord-005453-4057qib7	12627	17	Radiomics	Radiomics	NNP
cord-005453-4057qib7	12627	18	features	feature	NNS
cord-005453-4057qib7	12627	19	of	of	IN
cord-005453-4057qib7	12627	20	diffuse	diffuse	JJ
cord-005453-4057qib7	12627	21	and	and	CC
cord-005453-4057qib7	12627	22	focal	focal	JJ
cord-005453-4057qib7	12627	23	patterns	pattern	NNS
cord-005453-4057qib7	12627	24	and	and	CC
cord-005453-4057qib7	12627	25	then	then	RB
cord-005453-4057qib7	12627	26	feature	feature	VBP
cord-005453-4057qib7	12627	27	reduction	reduction	NN
cord-005453-4057qib7	12627	28	was	be	VBD
cord-005453-4057qib7	12627	29	done	do	VBN
cord-005453-4057qib7	12627	30	to	to	TO
cord-005453-4057qib7	12627	31	avoid	avoid	VB
cord-005453-4057qib7	12627	32	over	over	RB
cord-005453-4057qib7	12627	33	-	-	HYPH
cord-005453-4057qib7	12627	34	fitting	fitting	NN
cord-005453-4057qib7	12627	35	.	.	.
cord-005453-4057qib7	12628	1	Receiver	Receiver	NNP
cord-005453-4057qib7	12628	2	Operator	Operator	NNP
cord-005453-4057qib7	12628	3	Characteristic	Characteristic	NNP
cord-005453-4057qib7	12628	4	(	(	-LRB-
cord-005453-4057qib7	12628	5	ROC	ROC	NNP
cord-005453-4057qib7	12628	6	)	)	-RRB-
cord-005453-4057qib7	12628	7	analysis	analysis	NN
cord-005453-4057qib7	12628	8	with	with	IN
cord-005453-4057qib7	12628	9	area	area	NN
cord-005453-4057qib7	12628	10	under	under	IN
cord-005453-4057qib7	12628	11	the	the	DT
cord-005453-4057qib7	12628	12	curve	curve	NN
cord-005453-4057qib7	12628	13	was	be	VBD
cord-005453-4057qib7	12628	14	done	do	VBN
cord-005453-4057qib7	12628	15	to	to	TO
cord-005453-4057qib7	12628	16	compare	compare	VB
cord-005453-4057qib7	12628	17	Radiologists	Radiologists	NNPS
cord-005453-4057qib7	12628	18	and	and	CC
cord-005453-4057qib7	12628	19	Radiomics	Radiomics	NNP
cord-005453-4057qib7	12628	20	evaluation	evaluation	NN
cord-005453-4057qib7	12628	21	against	against	IN
cord-005453-4057qib7	12628	22	reference	reference	NN
cord-005453-4057qib7	12628	23	standard	standard	NN
cord-005453-4057qib7	12628	24	.	.	.
cord-005453-4057qib7	12629	1	Reading	read	VBG
cord-005453-4057qib7	12629	2	time	time	NN
cord-005453-4057qib7	12629	3	to	to	TO
cord-005453-4057qib7	12629	4	perform	perform	VB
cord-005453-4057qib7	12629	5	Radiomic	Radiomic	NNP
cord-005453-4057qib7	12629	6	analysis	analysis	NN
cord-005453-4057qib7	12629	7	was	be	VBD
cord-005453-4057qib7	12629	8	also	also	RB
cord-005453-4057qib7	12629	9	estimated	estimate	VBN
cord-005453-4057qib7	12629	10	.	.	.
cord-005453-4057qib7	12630	1	Results	result	NNS
cord-005453-4057qib7	12630	2	:	:	:
cord-005453-4057qib7	12631	1	The	the	DT
cord-005453-4057qib7	12631	2	pathological	pathological	JJ
cord-005453-4057qib7	12631	3	group	group	NN
cord-005453-4057qib7	12631	4	included	include	VBD
cord-005453-4057qib7	12631	5	:	:	:
cord-005453-4057qib7	12631	6	22	22	CD
cord-005453-4057qib7	12631	7	diffuse	diffuse	NN
cord-005453-4057qib7	12631	8	and	and	CC
cord-005453-4057qib7	12631	9	39	39	CD
cord-005453-4057qib7	12631	10	focal	focal	JJ
cord-005453-4057qib7	12631	11	patterns	pattern	NNS
cord-005453-4057qib7	12631	12	.	.	.
cord-005453-4057qib7	12632	1	After	after	IN
cord-005453-4057qib7	12632	2	feature	feature	NN
cord-005453-4057qib7	12632	3	reduction	reduction	NN
cord-005453-4057qib7	12632	4	,	,	,
cord-005453-4057qib7	12632	5	9	9	CD
cord-005453-4057qib7	12632	6	features	feature	NNS
cord-005453-4057qib7	12632	7	were	be	VBD
cord-005453-4057qib7	12632	8	different	different	JJ
cord-005453-4057qib7	12632	9	(	(	-LRB-
cord-005453-4057qib7	12632	10	p	p	NN
cord-005453-4057qib7	12632	11	<	<	XX
cord-005453-4057qib7	12632	12	0.05	0.05	CD
cord-005453-4057qib7	12632	13	)	)	-RRB-
cord-005453-4057qib7	12632	14	in	in	IN
cord-005453-4057qib7	12632	15	the	the	DT
cord-005453-4057qib7	12632	16	diffuse	diffuse	JJ
cord-005453-4057qib7	12632	17	and	and	CC
cord-005453-4057qib7	12632	18	focal	focal	JJ
cord-005453-4057qib7	12632	19	patterns	pattern	NNS
cord-005453-4057qib7	12632	20	(	(	-LRB-
cord-005453-4057qib7	12632	21	n=2/9	n=2/9	VBP
cord-005453-4057qib7	12632	22	features	feature	NNS
cord-005453-4057qib7	12632	23	were	be	VBD
cord-005453-4057qib7	12632	24	Shape	shape	NN
cord-005453-4057qib7	12632	25	-	-	HYPH
cord-005453-4057qib7	12632	26	based	base	VBN
cord-005453-4057qib7	12632	27	:	:	:
cord-005453-4057qib7	12632	28	MajorAxisLength	majoraxislength	NN
cord-005453-4057qib7	12632	29	and	and	CC
cord-005453-4057qib7	12632	30	Sphericity	sphericity	NN
cord-005453-4057qib7	12632	31	;	;	:
cord-005453-4057qib7	12632	32	n=7/9	n=7/9	ADD
cord-005453-4057qib7	12632	33	were	be	VBD
cord-005453-4057qib7	12632	34	Gray	Gray	NNP
cord-005453-4057qib7	12632	35	Level	Level	NNP
cord-005453-4057qib7	12632	36	Run	Run	NNP
cord-005453-4057qib7	12632	37	Length	length	NN
cord-005453-4057qib7	12632	38	Matrix	Matrix	NNP
cord-005453-4057qib7	12632	39	(	(	-LRB-
cord-005453-4057qib7	12632	40	Glrlm	Glrlm	NNP
cord-005453-4057qib7	12632	41	)	)	-RRB-
cord-005453-4057qib7	12632	42	)	)	-RRB-
cord-005453-4057qib7	12632	43	.	.	.
cord-005453-4057qib7	12633	1	150mg	150mg	NNP
cord-005453-4057qib7	12633	2	/	/	SYM
cord-005453-4057qib7	12633	3	kg	kg	NNP
cord-005453-4057qib7	12633	4	)	)	-RRB-
cord-005453-4057qib7	12633	5	.	.	.
cord-005453-4057qib7	12634	1	A	a	DT
cord-005453-4057qib7	12634	2	number	number	NN
cord-005453-4057qib7	12634	3	of	of	IN
cord-005453-4057qib7	12634	4	eleven	eleven	CD
cord-005453-4057qib7	12634	5	patients	patient	NNS
cord-005453-4057qib7	12634	6	did	do	VBD
cord-005453-4057qib7	12634	7	not	not	RB
cord-005453-4057qib7	12634	8	receive	receive	VB
cord-005453-4057qib7	12634	9	any	any	DT
cord-005453-4057qib7	12634	10	additional	additional	JJ
cord-005453-4057qib7	12634	11	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	12634	12	except	except	IN
cord-005453-4057qib7	12634	13	of	of	IN
cord-005453-4057qib7	12634	14	post	post	JJ
cord-005453-4057qib7	12634	15	-	-	JJ
cord-005453-4057qib7	12634	16	Cy	Cy	NNP
cord-005453-4057qib7	12634	17	.	.	.
cord-005453-4057qib7	12635	1	Results	result	NNS
cord-005453-4057qib7	12635	2	:	:	:
cord-005453-4057qib7	12636	1	After	after	IN
cord-005453-4057qib7	12636	2	a	a	DT
cord-005453-4057qib7	12636	3	median	median	NN
cord-005453-4057qib7	12636	4	follow	follow	NN
cord-005453-4057qib7	12636	5	up	up	IN
cord-005453-4057qib7	12636	6	of	of	IN
cord-005453-4057qib7	12636	7	11.4	11.4	CD
cord-005453-4057qib7	12636	8	months	month	NNS
cord-005453-4057qib7	12636	9	(	(	-LRB-
cord-005453-4057qib7	12636	10	range	range	VBP
cord-005453-4057qib7	12636	11	3.3	3.3	CD
cord-005453-4057qib7	12636	12	-34.5	-34.5	NFP
cord-005453-4057qib7	12636	13	)	)	-RRB-
cord-005453-4057qib7	12637	1	28	28	CD
cord-005453-4057qib7	12637	2	patients	patient	NNS
cord-005453-4057qib7	12637	3	were	be	VBD
cord-005453-4057qib7	12637	4	alive	alive	JJ
cord-005453-4057qib7	12637	5	.	.	.
cord-005453-4057qib7	12638	1	The	the	DT
cord-005453-4057qib7	12638	2	2-year	2-year	CD
cord-005453-4057qib7	12638	3	probabilities	probability	NNS
cord-005453-4057qib7	12638	4	of	of	IN
cord-005453-4057qib7	12638	5	PFS	PFS	NNP
cord-005453-4057qib7	12638	6	and	and	CC
cord-005453-4057qib7	12638	7	OS	OS	NNP
cord-005453-4057qib7	12638	8	were	be	VBD
cord-005453-4057qib7	12638	9	42	42	CD
cord-005453-4057qib7	12638	10	%	%	NN
cord-005453-4057qib7	12638	11	(	(	-LRB-
cord-005453-4057qib7	12638	12	21	21	CD
cord-005453-4057qib7	12638	13	-	-	SYM
cord-005453-4057qib7	12638	14	63	63	CD
cord-005453-4057qib7	12638	15	%	%	NN
cord-005453-4057qib7	12638	16	)	)	-RRB-
cord-005453-4057qib7	12638	17	and	and	CC
cord-005453-4057qib7	12638	18	65	65	CD
cord-005453-4057qib7	12638	19	%	%	NN
cord-005453-4057qib7	12638	20	(	(	-LRB-
cord-005453-4057qib7	12638	21	47	47	CD
cord-005453-4057qib7	12638	22	-	-	SYM
cord-005453-4057qib7	12638	23	83%).The	83%).the	CD
cord-005453-4057qib7	12638	24	cumulative	cumulative	JJ
cord-005453-4057qib7	12638	25	incidences	incidence	NNS
cord-005453-4057qib7	12638	26	(	(	-LRB-
cord-005453-4057qib7	12638	27	CIs	CIs	NNP
cord-005453-4057qib7	12638	28	)	)	-RRB-
cord-005453-4057qib7	12638	29	of	of	IN
cord-005453-4057qib7	12638	30	relapse	relapse	NN
cord-005453-4057qib7	12638	31	and	and	CC
cord-005453-4057qib7	12639	1	NRM	NRM	NNP
cord-005453-4057qib7	12639	2	at	at	IN
cord-005453-4057qib7	12639	3	2	2	CD
cord-005453-4057qib7	12639	4	years	year	NNS
cord-005453-4057qib7	12639	5	were	be	VBD
cord-005453-4057qib7	12639	6	28	28	CD
cord-005453-4057qib7	12639	7	%	%	NN
cord-005453-4057qib7	12639	8	(	(	-LRB-
cord-005453-4057qib7	12639	9	11	11	CD
cord-005453-4057qib7	12639	10	-	-	SYM
cord-005453-4057qib7	12639	11	45	45	CD
cord-005453-4057qib7	12639	12	%	%	NN
cord-005453-4057qib7	12639	13	)	)	-RRB-
cord-005453-4057qib7	12639	14	and	and	CC
cord-005453-4057qib7	12639	15	22	22	CD
cord-005453-4057qib7	12639	16	%	%	NN
cord-005453-4057qib7	12639	17	(	(	-LRB-
cord-005453-4057qib7	12639	18	8	8	CD
cord-005453-4057qib7	12639	19	-	-	SYM
cord-005453-4057qib7	12639	20	36	36	CD
cord-005453-4057qib7	12639	21	%	%	NN
cord-005453-4057qib7	12639	22	)	)	-RRB-
cord-005453-4057qib7	12639	23	,	,	,
cord-005453-4057qib7	12639	24	respectively	respectively	RB
cord-005453-4057qib7	12639	25	.	.	.
cord-005453-4057qib7	12640	1	Lower	low	JJR
cord-005453-4057qib7	12640	2	serum	serum	NN
cord-005453-4057qib7	12640	3	albumin	albumin	NN
cord-005453-4057qib7	12640	4	level	level	NN
cord-005453-4057qib7	12640	5	at	at	IN
cord-005453-4057qib7	12640	6	transplantation	transplantation	NN
cord-005453-4057qib7	12640	7	(	(	-LRB-
cord-005453-4057qib7	12640	8	≤36	≤36	NNP
cord-005453-4057qib7	12640	9	g	g	NN
cord-005453-4057qib7	12640	10	/	/	SYM
cord-005453-4057qib7	12640	11	dL	dl	NN
cord-005453-4057qib7	12640	12	)	)	-RRB-
cord-005453-4057qib7	12640	13	was	be	VBD
cord-005453-4057qib7	12640	14	associated	associate	VBN
cord-005453-4057qib7	12640	15	with	with	IN
cord-005453-4057qib7	12640	16	increased	increase	VBN
cord-005453-4057qib7	12640	17	relapses	relapse	NNS
cord-005453-4057qib7	12640	18	(	(	-LRB-
cord-005453-4057qib7	12640	19	HR	HR	NNP
cord-005453-4057qib7	12640	20	3.8	3.8	CD
cord-005453-4057qib7	12640	21	(	(	-LRB-
cord-005453-4057qib7	12640	22	1.2	1.2	CD
cord-005453-4057qib7	12640	23	-	-	SYM
cord-005453-4057qib7	12640	24	12.7	12.7	CD
cord-005453-4057qib7	12640	25	)	)	-RRB-
cord-005453-4057qib7	12640	26	,	,	,
cord-005453-4057qib7	12640	27	p=0.028	p=0.028	NN
cord-005453-4057qib7	12640	28	)	)	-RRB-
cord-005453-4057qib7	12640	29	and	and	CC
cord-005453-4057qib7	12640	30	NRM	NRM	NNP
cord-005453-4057qib7	12640	31	(	(	-LRB-
cord-005453-4057qib7	12640	32	HR	HR	NNP
cord-005453-4057qib7	12640	33	7.9	7.9	CD
cord-005453-4057qib7	12640	34	(	(	-LRB-
cord-005453-4057qib7	12640	35	2	2	CD
cord-005453-4057qib7	12640	36	-	-	SYM
cord-005453-4057qib7	12640	37	30	30	CD
cord-005453-4057qib7	12640	38	)	)	-RRB-
cord-005453-4057qib7	12640	39	,	,	,
cord-005453-4057qib7	12640	40	p=0.0026	p=0.0026	NNP
cord-005453-4057qib7	12640	41	)	)	-RRB-
cord-005453-4057qib7	12640	42	and	and	CC
cord-005453-4057qib7	12640	43	resulted	result	VBD
cord-005453-4057qib7	12640	44	in	in	IN
cord-005453-4057qib7	12640	45	poorer	poor	JJR
cord-005453-4057qib7	12640	46	PFS	PFS	NNP
cord-005453-4057qib7	12640	47	)	)	-RRB-
cord-005453-4057qib7	12640	48	,	,	,
cord-005453-4057qib7	12640	49	p=0.001	p=0.001	NNP
cord-005453-4057qib7	12640	50	)	)	-RRB-
cord-005453-4057qib7	12640	51	and	and	CC
cord-005453-4057qib7	12640	52	OS	OS	NNP
cord-005453-4057qib7	12640	53	)	)	-RRB-
cord-005453-4057qib7	12640	54	,	,	,
cord-005453-4057qib7	12640	55	p=0.048	p=0.048	NNP
cord-005453-4057qib7	12640	56	)	)	-RRB-
cord-005453-4057qib7	12640	57	.	.	.
cord-005453-4057qib7	12641	1	MMUD	MMUD	NNP
cord-005453-4057qib7	12641	2	and	and	CC
cord-005453-4057qib7	12641	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	12641	4	donors	donor	NNS
cord-005453-4057qib7	12641	5	were	be	VBD
cord-005453-4057qib7	12641	6	associated	associate	VBN
cord-005453-4057qib7	12641	7	with	with	IN
cord-005453-4057qib7	12641	8	poorer	poor	JJR
cord-005453-4057qib7	12641	9	NRM	NRM	NNP
cord-005453-4057qib7	12641	10	(	(	-LRB-
cord-005453-4057qib7	12641	11	HR	HR	NNP
cord-005453-4057qib7	12641	12	6.2	6.2	CD
cord-005453-4057qib7	12641	13	(	(	-LRB-
cord-005453-4057qib7	12641	14	1.9	1.9	CD
cord-005453-4057qib7	12641	15	-	-	SYM
cord-005453-4057qib7	12641	16	20.3	20.3	CD
cord-005453-4057qib7	12641	17	)	)	-RRB-
cord-005453-4057qib7	12641	18	,	,	,
cord-005453-4057qib7	12641	19	p=0.0027	p=0.0027	NNP
cord-005453-4057qib7	12641	20	)	)	-RRB-
cord-005453-4057qib7	12641	21	,	,	,
cord-005453-4057qib7	12641	22	and	and	CC
cord-005453-4057qib7	12641	23	resulted	result	VBD
cord-005453-4057qib7	12641	24	in	in	IN
cord-005453-4057qib7	12641	25	decreased	decrease	VBN
cord-005453-4057qib7	12641	26	PFS	PFS	NNP
cord-005453-4057qib7	12641	27	)	)	-RRB-
cord-005453-4057qib7	12641	28	,	,	,
cord-005453-4057qib7	12641	29	p=0.001	p=0.001	NNP
cord-005453-4057qib7	12641	30	)	)	-RRB-
cord-005453-4057qib7	12641	31	.	.	.
cord-005453-4057qib7	12642	1	The	the	DT
cord-005453-4057qib7	12642	2	high	high	JJ
cord-005453-4057qib7	12642	3	-	-	HYPH
cord-005453-4057qib7	12642	4	risk	risk	NN
cord-005453-4057qib7	12642	5	cytogenetic	cytogenetic	NN
cord-005453-4057qib7	12642	6	at	at	IN
cord-005453-4057qib7	12642	7	diagnosis	diagnosis	NN
cord-005453-4057qib7	12642	8	showed	show	VBD
cord-005453-4057qib7	12642	9	no	no	DT
cord-005453-4057qib7	12642	10	impact	impact	NN
cord-005453-4057qib7	12642	11	on	on	IN
cord-005453-4057qib7	12642	12	survival	survival	NN
cord-005453-4057qib7	12642	13	.	.	.
cord-005453-4057qib7	12643	1	The	the	DT
cord-005453-4057qib7	12643	2	CIs	ci	NNS
cord-005453-4057qib7	12643	3	of	of	IN
cord-005453-4057qib7	12643	4	acute	acute	JJ
cord-005453-4057qib7	12643	5	(	(	-LRB-
cord-005453-4057qib7	12643	6	grade	grade	NN
cord-005453-4057qib7	12643	7	II	II	NNP
cord-005453-4057qib7	12643	8	-	-	HYPH
cord-005453-4057qib7	12643	9	IV	IV	NNP
cord-005453-4057qib7	12643	10	)	)	-RRB-
cord-005453-4057qib7	12643	11	at	at	IN
cord-005453-4057qib7	12643	12	day	day	NN
cord-005453-4057qib7	12643	13	+100	+100	NNS
cord-005453-4057qib7	12643	14	and	and	CC
cord-005453-4057qib7	12643	15	chronic	chronic	JJ
cord-005453-4057qib7	12643	16	GvHD	gvhd	NN
cord-005453-4057qib7	12643	17	at	at	IN
cord-005453-4057qib7	12643	18	2	2	CD
cord-005453-4057qib7	12643	19	years	year	NNS
cord-005453-4057qib7	12643	20	were	be	VBD
cord-005453-4057qib7	12643	21	26	26	CD
cord-005453-4057qib7	12643	22	%	%	NN
cord-005453-4057qib7	12643	23	(	(	-LRB-
cord-005453-4057qib7	12643	24	10	10	CD
cord-005453-4057qib7	12643	25	-	-	SYM
cord-005453-4057qib7	12643	26	42	42	CD
cord-005453-4057qib7	12643	27	%	%	NN
cord-005453-4057qib7	12643	28	)	)	-RRB-
cord-005453-4057qib7	12643	29	and	and	CC
cord-005453-4057qib7	12643	30	48	48	CD
cord-005453-4057qib7	12643	31	%	%	NN
cord-005453-4057qib7	12643	32	(	(	-LRB-
cord-005453-4057qib7	12643	33	26	26	CD
cord-005453-4057qib7	12643	34	-	-	SYM
cord-005453-4057qib7	12643	35	70	70	CD
cord-005453-4057qib7	12643	36	%	%	NN
cord-005453-4057qib7	12643	37	)	)	-RRB-
cord-005453-4057qib7	12643	38	,	,	,
cord-005453-4057qib7	12643	39	respectively	respectively	RB
cord-005453-4057qib7	12643	40	.	.	.
cord-005453-4057qib7	12644	1	Absence	absence	NN
cord-005453-4057qib7	12644	2	of	of	IN
cord-005453-4057qib7	12644	3	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	12644	4	medication	medication	NN
cord-005453-4057qib7	12644	5	beside	beside	IN
cord-005453-4057qib7	12644	6	post	post	NNP
cord-005453-4057qib7	12644	7	-	-	NNP
cord-005453-4057qib7	12644	8	Cy	Cy	NNP
cord-005453-4057qib7	12644	9	was	be	VBD
cord-005453-4057qib7	12644	10	associated	associate	VBN
cord-005453-4057qib7	12644	11	with	with	IN
cord-005453-4057qib7	12644	12	poorer	poor	JJR
cord-005453-4057qib7	12644	13	OS	OS	NNP
cord-005453-4057qib7	12644	14	)	)	-RRB-
cord-005453-4057qib7	12644	15	,	,	,
cord-005453-4057qib7	12644	16	p=0.01	p=0.01	NNP
cord-005453-4057qib7	12644	17	)	)	-RRB-
cord-005453-4057qib7	12644	18	.	.	.
cord-005453-4057qib7	12645	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12645	2	:	:	:
cord-005453-4057qib7	12646	1	The	the	DT
cord-005453-4057qib7	12646	2	conditioning	conditioning	NN
cord-005453-4057qib7	12646	3	with	with	IN
cord-005453-4057qib7	12646	4	BU	BU	NNP
cord-005453-4057qib7	12646	5	,	,	,
cord-005453-4057qib7	12646	6	TT	TT	NNP
cord-005453-4057qib7	12646	7	and	and	CC
cord-005453-4057qib7	12646	8	post	post	AFX
cord-005453-4057qib7	12646	9	-	-	JJ
cord-005453-4057qib7	12646	10	Cy	Cy	NNP
cord-005453-4057qib7	12646	11	leads	lead	VBZ
cord-005453-4057qib7	12646	12	to	to	IN
cord-005453-4057qib7	12646	13	a	a	DT
cord-005453-4057qib7	12646	14	favorable	favorable	JJ
cord-005453-4057qib7	12646	15	PFS	PFS	NNP
cord-005453-4057qib7	12646	16	and	and	CC
cord-005453-4057qib7	12646	17	OS	OS	NNP
cord-005453-4057qib7	12646	18	due	due	JJ
cord-005453-4057qib7	12646	19	to	to	IN
cord-005453-4057qib7	12646	20	low	low	JJ
cord-005453-4057qib7	12646	21	incidences	incidence	NNS
cord-005453-4057qib7	12646	22	of	of	IN
cord-005453-4057qib7	12646	23	relapse	relapse	NN
cord-005453-4057qib7	12646	24	and	and	CC
cord-005453-4057qib7	12646	25	NRM	NRM	NNP
cord-005453-4057qib7	12646	26	for	for	IN
cord-005453-4057qib7	12646	27	patients	patient	NNS
cord-005453-4057qib7	12646	28	with	with	IN
cord-005453-4057qib7	12646	29	multiple	multiple	JJ
cord-005453-4057qib7	12646	30	myeloma	myeloma	NN
cord-005453-4057qib7	12646	31	relapsing	relapse	VBG
cord-005453-4057qib7	12646	32	after	after	IN
cord-005453-4057qib7	12646	33	autografting	autografte	VBG
cord-005453-4057qib7	12646	34	.	.	.
cord-005453-4057qib7	12647	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12647	2	:	:	:
cord-005453-4057qib7	12647	3	Nothing	nothing	NN
cord-005453-4057qib7	12647	4	to	to	TO
cord-005453-4057qib7	12647	5	declare	declare	VB
cord-005453-4057qib7	12647	6	Methods	method	NNS
cord-005453-4057qib7	12647	7	:	:	:
cord-005453-4057qib7	12647	8	Between	between	IN
cord-005453-4057qib7	12647	9	January	January	NNP
cord-005453-4057qib7	12647	10	2011	2011	CD
cord-005453-4057qib7	12647	11	and	and	CC
cord-005453-4057qib7	12647	12	May	May	NNP
cord-005453-4057qib7	12647	13	2017	2017	CD
cord-005453-4057qib7	12647	14	,	,	,
cord-005453-4057qib7	12647	15	we	-PRON-	PRP
cord-005453-4057qib7	12647	16	included	include	VBD
cord-005453-4057qib7	12647	17	51	51	CD
cord-005453-4057qib7	12647	18	patients	patient	NNS
cord-005453-4057qib7	12647	19	with	with	IN
cord-005453-4057qib7	12647	20	MM	MM	NNP
cord-005453-4057qib7	12647	21	who	who	WP
cord-005453-4057qib7	12647	22	underwent	undergo	VBD
cord-005453-4057qib7	12647	23	ASCT	ASCT	NNP
cord-005453-4057qib7	12647	24	and	and	CC
cord-005453-4057qib7	12647	25	received	receive	VBD
cord-005453-4057qib7	12647	26	Bortezomib	Bortezomib	NNP
cord-005453-4057qib7	12647	27	/	/	SYM
cord-005453-4057qib7	12647	28	Lenalidomide	Lenalidomide	NNP
cord-005453-4057qib7	12647	29	/	/	SYM
cord-005453-4057qib7	12647	30	Dexamethasone	Dexamethasone	NNP
cord-005453-4057qib7	12647	31	(	(	-LRB-
cord-005453-4057qib7	12647	32	VRD	VRD	NNP
cord-005453-4057qib7	12647	33	)	)	-RRB-
cord-005453-4057qib7	12647	34	consolidation	consolidation	NN
cord-005453-4057qib7	12647	35	and	and	CC
cord-005453-4057qib7	12647	36	maintenance	maintenance	NN
cord-005453-4057qib7	12647	37	therapy	therapy	NN
cord-005453-4057qib7	12647	38	,	,	,
cord-005453-4057qib7	12647	39	mainly	mainly	RB
cord-005453-4057qib7	12647	40	lenalidomide(R	lenalidomide(r	JJ
cord-005453-4057qib7	12647	41	)	)	-RRB-
cord-005453-4057qib7	12648	1	10mg	10mg	NNP
cord-005453-4057qib7	12648	2	/	/	SYM
cord-005453-4057qib7	12648	3	day	day	NN
cord-005453-4057qib7	12648	4	for	for	IN
cord-005453-4057qib7	12648	5	21	21	CD
cord-005453-4057qib7	12648	6	days	day	NNS
cord-005453-4057qib7	12648	7	every	every	DT
cord-005453-4057qib7	12648	8	28	28	CD
cord-005453-4057qib7	12648	9	days	day	NNS
cord-005453-4057qib7	12648	10	.	.	.
cord-005453-4057qib7	12649	1	Results	result	NNS
cord-005453-4057qib7	12649	2	:	:	:
cord-005453-4057qib7	12650	1	The	the	DT
cord-005453-4057qib7	12650	2	median	median	JJ
cord-005453-4057qib7	12650	3	age	age	NN
cord-005453-4057qib7	12650	4	at	at	IN
cord-005453-4057qib7	12650	5	transplant	transplant	NN
cord-005453-4057qib7	12650	6	was	be	VBD
cord-005453-4057qib7	12650	7	55	55	CD
cord-005453-4057qib7	12650	8	years	year	NNS
cord-005453-4057qib7	12650	9	(	(	-LRB-
cord-005453-4057qib7	12650	10	46	46	CD
cord-005453-4057qib7	12650	11	-	-	SYM
cord-005453-4057qib7	12650	12	75	75	CD
cord-005453-4057qib7	12650	13	)	)	-RRB-
cord-005453-4057qib7	12650	14	.	.	.
cord-005453-4057qib7	12651	1	Forty	forty	CD
cord-005453-4057qib7	12651	2	-	-	HYPH
cord-005453-4057qib7	12651	3	six	six	CD
cord-005453-4057qib7	12651	4	(	(	-LRB-
cord-005453-4057qib7	12651	5	90	90	CD
cord-005453-4057qib7	12651	6	%	%	NN
cord-005453-4057qib7	12651	7	)	)	-RRB-
cord-005453-4057qib7	12651	8	of	of	IN
cord-005453-4057qib7	12651	9	patients	patient	NNS
cord-005453-4057qib7	12651	10	received	receive	VBD
cord-005453-4057qib7	12651	11	R	r	NN
cord-005453-4057qib7	12651	12	maintenance	maintenance	NN
cord-005453-4057qib7	12651	13	,	,	,
cord-005453-4057qib7	12651	14	3	3	CD
cord-005453-4057qib7	12651	15	patients	patient	NNS
cord-005453-4057qib7	12651	16	received	receive	VBD
cord-005453-4057qib7	12651	17	VRD	VRD	NNP
cord-005453-4057qib7	12651	18	maintenance	maintenance	NN
cord-005453-4057qib7	12651	19	for	for	IN
cord-005453-4057qib7	12651	20	higher	high	JJR
cord-005453-4057qib7	12651	21	risk	risk	NN
cord-005453-4057qib7	12651	22	features	feature	NNS
cord-005453-4057qib7	12651	23	.	.	.
cord-005453-4057qib7	12652	1	Median	median	JJ
cord-005453-4057qib7	12652	2	duration	duration	NN
cord-005453-4057qib7	12652	3	of	of	IN
cord-005453-4057qib7	12652	4	R	r	NN
cord-005453-4057qib7	12652	5	maintenance	maintenance	NN
cord-005453-4057qib7	12652	6	was	be	VBD
cord-005453-4057qib7	12652	7	22	22	CD
cord-005453-4057qib7	12652	8	months	month	NNS
cord-005453-4057qib7	12652	9	.	.	.
cord-005453-4057qib7	12653	1	R	r	NN
cord-005453-4057qib7	12653	2	dose	dose	NN
cord-005453-4057qib7	12653	3	was	be	VBD
cord-005453-4057qib7	12653	4	changed	change	VBN
cord-005453-4057qib7	12653	5	for	for	IN
cord-005453-4057qib7	12653	6	toxicity	toxicity	NN
cord-005453-4057qib7	12653	7	(	(	-LRB-
cord-005453-4057qib7	12653	8	grade	grade	NN
cord-005453-4057qib7	12653	9	I	I	NNP
cord-005453-4057qib7	12653	10	-	-	HYPH
cord-005453-4057qib7	12653	11	II	II	NNP
cord-005453-4057qib7	12653	12	)	)	-RRB-
cord-005453-4057qib7	12653	13	in	in	IN
cord-005453-4057qib7	12653	14	17	17	CD
cord-005453-4057qib7	12653	15	(	(	-LRB-
cord-005453-4057qib7	12653	16	33	33	CD
cord-005453-4057qib7	12653	17	%	%	NN
cord-005453-4057qib7	12653	18	)	)	-RRB-
cord-005453-4057qib7	12653	19	patients	patient	NNS
cord-005453-4057qib7	12653	20	.	.	.
cord-005453-4057qib7	12654	1	Twenty	twenty	CD
cord-005453-4057qib7	12654	2	-	-	HYPH
cord-005453-4057qib7	12654	3	nine	nine	CD
cord-005453-4057qib7	12654	4	(	(	-LRB-
cord-005453-4057qib7	12654	5	57	57	CD
cord-005453-4057qib7	12654	6	%	%	NN
cord-005453-4057qib7	12654	7	)	)	-RRB-
cord-005453-4057qib7	12654	8	patients	patient	NNS
cord-005453-4057qib7	12654	9	relapsed	relapse	VBD
cord-005453-4057qib7	12654	10	:	:	:
cord-005453-4057qib7	12654	11	13	13	CD
cord-005453-4057qib7	12654	12	(	(	-LRB-
cord-005453-4057qib7	12654	13	25	25	CD
cord-005453-4057qib7	12654	14	%	%	NN
cord-005453-4057qib7	12654	15	)	)	-RRB-
cord-005453-4057qib7	12654	16	patients	patient	NNS
cord-005453-4057qib7	12654	17	were	be	VBD
cord-005453-4057qib7	12654	18	shifted	shift	VBN
cord-005453-4057qib7	12654	19	to	to	IN
cord-005453-4057qib7	12654	20	different	different	JJ
cord-005453-4057qib7	12654	21	treatment	treatment	NN
cord-005453-4057qib7	12654	22	protocols	protocol	NNS
cord-005453-4057qib7	12654	23	(	(	-LRB-
cord-005453-4057qib7	12654	24	treatment	treatment	NN
cord-005453-4057qib7	12654	25	change	change	NN
cord-005453-4057qib7	12654	26	)	)	-RRB-
cord-005453-4057qib7	12654	27	.	.	.
cord-005453-4057qib7	12655	1	6	6	CD
cord-005453-4057qib7	12655	2	patients	patient	NNS
cord-005453-4057qib7	12655	3	(	(	-LRB-
cord-005453-4057qib7	12655	4	11	11	CD
cord-005453-4057qib7	12655	5	%	%	NN
cord-005453-4057qib7	12655	6	)	)	-RRB-
cord-005453-4057qib7	12655	7	were	be	VBD
cord-005453-4057qib7	12655	8	kept	keep	VBN
cord-005453-4057qib7	12655	9	on	on	IN
cord-005453-4057qib7	12655	10	the	the	DT
cord-005453-4057qib7	12655	11	same	same	JJ
cord-005453-4057qib7	12655	12	R	r	NN
cord-005453-4057qib7	12655	13	maintenance	maintenance	NN
cord-005453-4057qib7	12655	14	(	(	-LRB-
cord-005453-4057qib7	12655	15	observation	observation	NN
cord-005453-4057qib7	12655	16	group	group	NN
cord-005453-4057qib7	12655	17	)	)	-RRB-
cord-005453-4057qib7	12655	18	and	and	CC
cord-005453-4057qib7	12655	19	10	10	CD
cord-005453-4057qib7	12655	20	(	(	-LRB-
cord-005453-4057qib7	12655	21	20	20	CD
cord-005453-4057qib7	12655	22	%	%	NN
cord-005453-4057qib7	12655	23	)	)	-RRB-
cord-005453-4057qib7	12655	24	patients	patient	NNS
cord-005453-4057qib7	12655	25	had	have	VBD
cord-005453-4057qib7	12655	26	increased	increase	VBN
cord-005453-4057qib7	12655	27	lenalidomide	lenalidomide	RB
cord-005453-4057qib7	12655	28	dose	dose	NN
cord-005453-4057qib7	12655	29	with	with	IN
cord-005453-4057qib7	12655	30	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	12655	31	(	(	-LRB-
cord-005453-4057qib7	12655	32	R/	R/	NNP
cord-005453-4057qib7	12655	33	D	D	NNP
cord-005453-4057qib7	12655	34	group	group	NN
cord-005453-4057qib7	12655	35	)	)	-RRB-
cord-005453-4057qib7	12655	36	.	.	.
cord-005453-4057qib7	12656	1	6	6	CD
cord-005453-4057qib7	12656	2	patients	patient	NNS
cord-005453-4057qib7	12656	3	(	(	-LRB-
cord-005453-4057qib7	12656	4	37	37	CD
cord-005453-4057qib7	12656	5	%	%	NN
cord-005453-4057qib7	12656	6	)	)	-RRB-
cord-005453-4057qib7	12656	7	of	of	IN
cord-005453-4057qib7	12656	8	the	the	DT
cord-005453-4057qib7	12656	9	last	last	JJ
cord-005453-4057qib7	12656	10	2	2	CD
cord-005453-4057qib7	12656	11	groups	group	NNS
cord-005453-4057qib7	12656	12	required	require	VBD
cord-005453-4057qib7	12656	13	change	change	NN
cord-005453-4057qib7	12656	14	of	of	IN
cord-005453-4057qib7	12656	15	treatment	treatment	NN
cord-005453-4057qib7	12656	16	later	later	RB
cord-005453-4057qib7	12656	17	.	.	.
cord-005453-4057qib7	12657	1	The	the	DT
cord-005453-4057qib7	12657	2	median	median	NN
cord-005453-4057qib7	12657	3	follow	follow	VBP
cord-005453-4057qib7	12657	4	up	up	RP
cord-005453-4057qib7	12657	5	was	be	VBD
cord-005453-4057qib7	12657	6	38	38	CD
cord-005453-4057qib7	12657	7	months	month	NNS
cord-005453-4057qib7	12657	8	.	.	.
cord-005453-4057qib7	12658	1	Median	median	JJ
cord-005453-4057qib7	12658	2	TNT	TNT	NNP
cord-005453-4057qib7	12658	3	was	be	VBD
cord-005453-4057qib7	12658	4	32	32	CD
cord-005453-4057qib7	12658	5	months	month	NNS
cord-005453-4057qib7	12658	6	(	(	-LRB-
cord-005453-4057qib7	12658	7	7	7	CD
cord-005453-4057qib7	12658	8	-	-	SYM
cord-005453-4057qib7	12658	9	62	62	CD
cord-005453-4057qib7	12658	10	)	)	-RRB-
cord-005453-4057qib7	12658	11	.	.	.
cord-005453-4057qib7	12659	1	At	at	IN
cord-005453-4057qib7	12659	2	2	2	CD
cord-005453-4057qib7	12659	3	years	year	NNS
cord-005453-4057qib7	12659	4	,	,	,
cord-005453-4057qib7	12659	5	the	the	DT
cord-005453-4057qib7	12659	6	estimated	estimate	VBN
cord-005453-4057qib7	12659	7	PFS	PFS	NNP
cord-005453-4057qib7	12659	8	and	and	CC
cord-005453-4057qib7	12659	9	OS	OS	NNP
cord-005453-4057qib7	12659	10	were	be	VBD
cord-005453-4057qib7	12659	11	39	39	CD
cord-005453-4057qib7	12659	12	%	%	NN
cord-005453-4057qib7	12659	13	and	and	CC
cord-005453-4057qib7	12659	14	97.5	97.5	CD
cord-005453-4057qib7	12659	15	%	%	NN
cord-005453-4057qib7	12659	16	respectively	respectively	RB
cord-005453-4057qib7	12659	17	.	.	.
cord-005453-4057qib7	12660	1	The	the	DT
cord-005453-4057qib7	12660	2	median	median	JJ
cord-005453-4057qib7	12660	3	OS	OS	NNP
cord-005453-4057qib7	12660	4	and	and	CC
cord-005453-4057qib7	12660	5	PFS2	PFS2	NNP
cord-005453-4057qib7	12660	6	(	(	-LRB-
cord-005453-4057qib7	12660	7	from	from	IN
cord-005453-4057qib7	12660	8	change	change	NN
cord-005453-4057qib7	12660	9	of	of	IN
cord-005453-4057qib7	12660	10	therapy	therapy	NN
cord-005453-4057qib7	12660	11	)	)	-RRB-
cord-005453-4057qib7	12660	12	were	be	VBD
cord-005453-4057qib7	12660	13	54	54	CD
cord-005453-4057qib7	12660	14	and	and	CC
cord-005453-4057qib7	12660	15	29	29	CD
cord-005453-4057qib7	12660	16	months	month	NNS
cord-005453-4057qib7	12660	17	for	for	IN
cord-005453-4057qib7	12660	18	patients	patient	NNS
cord-005453-4057qib7	12660	19	in	in	IN
cord-005453-4057qib7	12660	20	the	the	DT
cord-005453-4057qib7	12660	21	observation	observation	NN
cord-005453-4057qib7	12660	22	group	group	NN
cord-005453-4057qib7	12660	23	,	,	,
cord-005453-4057qib7	12660	24	versus	versus	IN
cord-005453-4057qib7	12660	25	52	52	CD
cord-005453-4057qib7	12660	26	and	and	CC
cord-005453-4057qib7	12660	27	27	27	CD
cord-005453-4057qib7	12660	28	months	month	NNS
cord-005453-4057qib7	12660	29	in	in	IN
cord-005453-4057qib7	12660	30	the	the	DT
cord-005453-4057qib7	12660	31	R	r	NN
cord-005453-4057qib7	12660	32	/	/	SYM
cord-005453-4057qib7	12660	33	D	d	NN
cord-005453-4057qib7	12660	34	group	group	NN
cord-005453-4057qib7	12660	35	,	,	,
cord-005453-4057qib7	12660	36	and	and	CC
cord-005453-4057qib7	12660	37	45	45	CD
cord-005453-4057qib7	12660	38	and	and	CC
cord-005453-4057qib7	12660	39	33	33	CD
cord-005453-4057qib7	12660	40	months	month	NNS
cord-005453-4057qib7	12660	41	with	with	IN
cord-005453-4057qib7	12660	42	treatment	treatment	NN
cord-005453-4057qib7	12660	43	change	change	NN
cord-005453-4057qib7	12660	44	,	,	,
cord-005453-4057qib7	12660	45	respectively	respectively	RB
cord-005453-4057qib7	12660	46	.	.	.
cord-005453-4057qib7	12661	1	No	no	DT
cord-005453-4057qib7	12661	2	statistically	statistically	RB
cord-005453-4057qib7	12661	3	significant	significant	JJ
cord-005453-4057qib7	12661	4	difference	difference	NN
cord-005453-4057qib7	12661	5	was	be	VBD
cord-005453-4057qib7	12661	6	noted	note	VBN
cord-005453-4057qib7	12661	7	.	.	.
cord-005453-4057qib7	12662	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12662	2	:	:	:
cord-005453-4057qib7	12663	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12663	2	small	small	JJ
cord-005453-4057qib7	12663	3	monocentric	monocentric	JJ
cord-005453-4057qib7	12663	4	study	study	NN
cord-005453-4057qib7	12663	5	is	be	VBZ
cord-005453-4057qib7	12663	6	limited	limit	VBN
cord-005453-4057qib7	12663	7	by	by	IN
cord-005453-4057qib7	12663	8	its	-PRON-	PRP$
cord-005453-4057qib7	12663	9	retrospective	retrospective	JJ
cord-005453-4057qib7	12663	10	design	design	NN
cord-005453-4057qib7	12663	11	and	and	CC
cord-005453-4057qib7	12663	12	small	small	JJ
cord-005453-4057qib7	12663	13	sample	sample	NN
cord-005453-4057qib7	12663	14	size	size	NN
cord-005453-4057qib7	12663	15	.	.	.
cord-005453-4057qib7	12664	1	However	however	RB
cord-005453-4057qib7	12664	2	,	,	,
cord-005453-4057qib7	12664	3	it	-PRON-	PRP
cord-005453-4057qib7	12664	4	suggests	suggest	VBZ
cord-005453-4057qib7	12664	5	that	that	IN
cord-005453-4057qib7	12664	6	increasing	increase	VBG
cord-005453-4057qib7	12664	7	lenalidomide	lenalidomide	JJ
cord-005453-4057qib7	12664	8	dose	dose	NN
cord-005453-4057qib7	12664	9	as	as	RB
cord-005453-4057qib7	12664	10	well	well	RB
cord-005453-4057qib7	12664	11	as	as	IN
cord-005453-4057qib7	12664	12	adding	add	VBG
cord-005453-4057qib7	12664	13	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	12664	14	in	in	IN
cord-005453-4057qib7	12664	15	selected	select	VBN
cord-005453-4057qib7	12664	16	patients	patient	NNS
cord-005453-4057qib7	12664	17	can	can	MD
cord-005453-4057qib7	12664	18	postpone	postpone	VB
cord-005453-4057qib7	12664	19	change	change	NN
cord-005453-4057qib7	12664	20	to	to	IN
cord-005453-4057qib7	12664	21	different	different	JJ
cord-005453-4057qib7	12664	22	lines	line	NNS
cord-005453-4057qib7	12664	23	of	of	IN
cord-005453-4057qib7	12664	24	treatment	treatment	NN
cord-005453-4057qib7	12664	25	without	without	IN
cord-005453-4057qib7	12664	26	affecting	affect	VBG
cord-005453-4057qib7	12664	27	survival	survival	NN
cord-005453-4057qib7	12664	28	.	.	.
cord-005453-4057qib7	12665	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12665	2	:	:	:
cord-005453-4057qib7	12665	3	Nothing	nothing	NN
cord-005453-4057qib7	12665	4	to	to	TO
cord-005453-4057qib7	12665	5	declare	declare	VB
cord-005453-4057qib7	12665	6	Can	Can	MD
cord-005453-4057qib7	12665	7	the	the	DT
cord-005453-4057qib7	12665	8	drugs	drug	NNS
cord-005453-4057qib7	12665	9	used	use	VBN
cord-005453-4057qib7	12665	10	before	before	IN
cord-005453-4057qib7	12665	11	autologous	autologous	JJ
cord-005453-4057qib7	12665	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12665	13	stem	stem	NN
cord-005453-4057qib7	12665	14	cell	cell	NN
cord-005453-4057qib7	12665	15	transplantation	transplantation	NN
cord-005453-4057qib7	12665	16	have	have	VBP
cord-005453-4057qib7	12665	17	impact	impact	NN
cord-005453-4057qib7	12665	18	on	on	IN
cord-005453-4057qib7	12665	19	CMV	CMV	NNP
cord-005453-4057qib7	12665	20	reactivation	reactivation	NN
cord-005453-4057qib7	12665	21	that	that	WDT
cord-005453-4057qib7	12665	22	results	result	VBZ
cord-005453-4057qib7	12665	23	in	in	IN
cord-005453-4057qib7	12665	24	decreased	decrease	VBN
cord-005453-4057qib7	12665	25	os	os	NN
cord-005453-4057qib7	12665	26	in	in	IN
cord-005453-4057qib7	12665	27	myeloma	myeloma	NN
cord-005453-4057qib7	12665	28	patients	patient	NNS
cord-005453-4057qib7	12665	29	after	after	IN
cord-005453-4057qib7	12665	30	ASCT	ASCT	NNP
cord-005453-4057qib7	12665	31	?	?	.
cord-005453-4057qib7	12666	1	more	more	RBR
cord-005453-4057qib7	12666	2	intensive	intensive	JJ
cord-005453-4057qib7	12666	3	treatment	treatment	NN
cord-005453-4057qib7	12666	4	regimens	regimen	NNS
cord-005453-4057qib7	12666	5	,	,	,
cord-005453-4057qib7	12666	6	such	such	JJ
cord-005453-4057qib7	12666	7	as	as	IN
cord-005453-4057qib7	12666	8	proteasome	proteasome	NN
cord-005453-4057qib7	12666	9	inhibitors	inhibitor	NNS
cord-005453-4057qib7	12666	10	(	(	-LRB-
cord-005453-4057qib7	12666	11	PI	PI	NNP
cord-005453-4057qib7	12666	12	)	)	-RRB-
cord-005453-4057qib7	12666	13	and/or	and/or	CC
cord-005453-4057qib7	12666	14	immunomodulatory	immunomodulatory	NNP
cord-005453-4057qib7	12666	15	(	(	-LRB-
cord-005453-4057qib7	12666	16	IMID	IMID	NNP
cord-005453-4057qib7	12666	17	)	)	-RRB-
cord-005453-4057qib7	12666	18	agents	agent	NNS
cord-005453-4057qib7	12666	19	.	.	.
cord-005453-4057qib7	12667	1	We	-PRON-	PRP
cord-005453-4057qib7	12667	2	performed	perform	VBD
cord-005453-4057qib7	12667	3	a	a	DT
cord-005453-4057qib7	12667	4	retrospective	retrospective	JJ
cord-005453-4057qib7	12667	5	,	,	,
cord-005453-4057qib7	12667	6	single	single	JJ
cord-005453-4057qib7	12667	7	center	center	NN
cord-005453-4057qib7	12667	8	study	study	NN
cord-005453-4057qib7	12667	9	to	to	TO
cord-005453-4057qib7	12667	10	evaluate	evaluate	VB
cord-005453-4057qib7	12667	11	the	the	DT
cord-005453-4057qib7	12667	12	incidence	incidence	NN
cord-005453-4057qib7	12667	13	,	,	,
cord-005453-4057qib7	12667	14	risk	risk	NN
cord-005453-4057qib7	12667	15	factors	factor	NNS
cord-005453-4057qib7	12667	16	,	,	,
cord-005453-4057qib7	12667	17	and	and	CC
cord-005453-4057qib7	12667	18	outcomes	outcome	NNS
cord-005453-4057qib7	12667	19	of	of	IN
cord-005453-4057qib7	12667	20	CMV	CMV	NNP
cord-005453-4057qib7	12667	21	infection	infection	NN
cord-005453-4057qib7	12667	22	in	in	IN
cord-005453-4057qib7	12667	23	patients	patient	NNS
cord-005453-4057qib7	12667	24	with	with	IN
cord-005453-4057qib7	12667	25	MM	MM	NNP
cord-005453-4057qib7	12667	26	who	who	WP
cord-005453-4057qib7	12667	27	underwent	undergo	VBD
cord-005453-4057qib7	12667	28	ASCT	ASCT	NNP
cord-005453-4057qib7	12667	29	with	with	IN
cord-005453-4057qib7	12667	30	a	a	DT
cord-005453-4057qib7	12667	31	high	high	JJ
cord-005453-4057qib7	12667	32	-	-	HYPH
cord-005453-4057qib7	12667	33	dose	dose	NN
cord-005453-4057qib7	12667	34	melphalan	melphalan	NN
cord-005453-4057qib7	12667	35	-	-	HYPH
cord-005453-4057qib7	12667	36	based	base	VBN
cord-005453-4057qib7	12667	37	regimen	regimen	NN
cord-005453-4057qib7	12667	38	.	.	.
cord-005453-4057qib7	12668	1	Methods	method	NNS
cord-005453-4057qib7	12668	2	:	:	:
cord-005453-4057qib7	12669	1	This	this	DT
cord-005453-4057qib7	12669	2	study	study	NN
cord-005453-4057qib7	12669	3	involved	involve	VBD
cord-005453-4057qib7	12669	4	a	a	DT
cord-005453-4057qib7	12669	5	retrospective	retrospective	JJ
cord-005453-4057qib7	12669	6	review	review	NN
cord-005453-4057qib7	12669	7	of	of	IN
cord-005453-4057qib7	12669	8	all	all	DT
cord-005453-4057qib7	12669	9	patients	patient	NNS
cord-005453-4057qib7	12669	10	with	with	IN
cord-005453-4057qib7	12669	11	who	who	WP
cord-005453-4057qib7	12669	12	underwent	undergo	VBD
cord-005453-4057qib7	12669	13	ASCT	ASCT	NNP
cord-005453-4057qib7	12669	14	between	between	IN
cord-005453-4057qib7	12669	15	January	January	NNP
cord-005453-4057qib7	12669	16	2015	2015	CD
cord-005453-4057qib7	12669	17	and	and	CC
cord-005453-4057qib7	12669	18	November	November	NNP
cord-005453-4057qib7	12669	19	2018	2018	CD
cord-005453-4057qib7	12669	20	at	at	IN
cord-005453-4057qib7	12669	21	our	-PRON-	PRP$
cord-005453-4057qib7	12669	22	stem	stem	NN
cord-005453-4057qib7	12669	23	cell	cell	NN
cord-005453-4057qib7	12669	24	transplantation	transplantation	NN
cord-005453-4057qib7	12669	25	center	center	NN
cord-005453-4057qib7	12669	26	.	.	.
cord-005453-4057qib7	12670	1	A	a	DT
cord-005453-4057qib7	12670	2	total	total	NN
cord-005453-4057qib7	12670	3	of	of	IN
cord-005453-4057qib7	12670	4	144	144	CD
cord-005453-4057qib7	12670	5	consecutive	consecutive	JJ
cord-005453-4057qib7	12670	6	adult	adult	NN
cord-005453-4057qib7	12670	7	patients	patient	NNS
cord-005453-4057qib7	12670	8	with	with	IN
cord-005453-4057qib7	12670	9	a	a	DT
cord-005453-4057qib7	12670	10	diagnosis	diagnosis	NN
cord-005453-4057qib7	12670	11	of	of	IN
cord-005453-4057qib7	12670	12	MM	MM	NNP
cord-005453-4057qib7	12670	13	(	(	-LRB-
cord-005453-4057qib7	12670	14	median	median	JJ
cord-005453-4057qib7	12670	15	age	age	NN
cord-005453-4057qib7	12670	16	at	at	IN
cord-005453-4057qib7	12670	17	diagnosis	diagnosis	NN
cord-005453-4057qib7	12670	18	:	:	:
cord-005453-4057qib7	12670	19	58	58	CD
cord-005453-4057qib7	12670	20	,	,	,
cord-005453-4057qib7	12670	21	range	range	NN
cord-005453-4057qib7	12670	22	:	:	:
cord-005453-4057qib7	12670	23	35	35	CD
cord-005453-4057qib7	12670	24	-	-	SYM
cord-005453-4057qib7	12670	25	77	77	CD
cord-005453-4057qib7	12670	26	)	)	-RRB-
cord-005453-4057qib7	12670	27	underwent	undergo	VBD
cord-005453-4057qib7	12670	28	ASCT	ASCT	NNP
cord-005453-4057qib7	12670	29	following	follow	VBG
cord-005453-4057qib7	12670	30	induction	induction	NN
cord-005453-4057qib7	12670	31	treatment	treatment	NN
cord-005453-4057qib7	12670	32	with	with	IN
cord-005453-4057qib7	12670	33	novel	novel	JJ
cord-005453-4057qib7	12670	34	agents	agent	NNS
cord-005453-4057qib7	12670	35	(	(	-LRB-
cord-005453-4057qib7	12670	36	PIs	pi	NNS
cord-005453-4057qib7	12670	37	and/or	and/or	CC
cord-005453-4057qib7	12670	38	IMIDs	IMIDs	NNP
cord-005453-4057qib7	12670	39	)	)	-RRB-
cord-005453-4057qib7	12670	40	.	.	.
cord-005453-4057qib7	12671	1	All	all	DT
cord-005453-4057qib7	12671	2	patients	patient	NNS
cord-005453-4057qib7	12671	3	received	receive	VBD
cord-005453-4057qib7	12671	4	antiviral	antiviral	JJ
cord-005453-4057qib7	12671	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	12671	6	with	with	IN
cord-005453-4057qib7	12671	7	acyclovir	acyclovir	NNP
cord-005453-4057qib7	12671	8	600	600	CD
cord-005453-4057qib7	12671	9	mg	mg	NNP
cord-005453-4057qib7	12671	10	/	/	SYM
cord-005453-4057qib7	12671	11	day	day	NN
cord-005453-4057qib7	12671	12	(	(	-LRB-
cord-005453-4057qib7	12671	13	n=104	n=104	NNP
cord-005453-4057qib7	12671	14	)	)	-RRB-
cord-005453-4057qib7	12671	15	or	or	CC
cord-005453-4057qib7	12671	16	valaganciclovir	valaganciclovir	VBZ
cord-005453-4057qib7	12671	17	1000	1000	CD
cord-005453-4057qib7	12671	18	mg	mg	NNP
cord-005453-4057qib7	12671	19	/	/	SYM
cord-005453-4057qib7	12671	20	day	day	NN
cord-005453-4057qib7	12671	21	(	(	-LRB-
cord-005453-4057qib7	12671	22	n=36	n=36	NNS
cord-005453-4057qib7	12671	23	)	)	-RRB-
cord-005453-4057qib7	12671	24	.	.	.
cord-005453-4057qib7	12672	1	Results	result	NNS
cord-005453-4057qib7	12672	2	:	:	:
cord-005453-4057qib7	12673	1	Baseline	baseline	JJ
cord-005453-4057qib7	12673	2	patient	patient	JJ
cord-005453-4057qib7	12673	3	characteristics	characteristic	NNS
cord-005453-4057qib7	12673	4	,	,	,
cord-005453-4057qib7	12673	5	according	accord	VBG
cord-005453-4057qib7	12673	6	to	to	IN
cord-005453-4057qib7	12673	7	induction	induction	NN
cord-005453-4057qib7	12673	8	treatment	treatment	NN
cord-005453-4057qib7	12673	9	,	,	,
cord-005453-4057qib7	12673	10	are	be	VBP
cord-005453-4057qib7	12673	11	summarized	summarize	VBN
cord-005453-4057qib7	12673	12	in	in	IN
cord-005453-4057qib7	12673	13	Table-	Table-	NNP
cord-005453-4057qib7	12673	14	1	1	CD
cord-005453-4057qib7	12673	15	.	.	.
cord-005453-4057qib7	12674	1	One	one	CD
cord-005453-4057qib7	12674	2	hundred	hundred	CD
cord-005453-4057qib7	12674	3	-	-	HYPH
cord-005453-4057qib7	12674	4	five	five	CD
cord-005453-4057qib7	12674	5	of	of	IN
cord-005453-4057qib7	12674	6	the	the	DT
cord-005453-4057qib7	12674	7	144	144	CD
cord-005453-4057qib7	12674	8	patients	patient	NNS
cord-005453-4057qib7	12674	9	(	(	-LRB-
cord-005453-4057qib7	12674	10	97.2	97.2	CD
cord-005453-4057qib7	12674	11	%	%	NN
cord-005453-4057qib7	12674	12	)	)	-RRB-
cord-005453-4057qib7	12674	13	were	be	VBD
cord-005453-4057qib7	12674	14	CMV	CMV	NNP
cord-005453-4057qib7	12674	15	IgGpositive	IgGpositive	NNP
cord-005453-4057qib7	12674	16	before	before	IN
cord-005453-4057qib7	12674	17	ASCT	ASCT	NNP
cord-005453-4057qib7	12674	18	.	.	.
cord-005453-4057qib7	12675	1	Overall	overall	RB
cord-005453-4057qib7	12675	2	,	,	,
cord-005453-4057qib7	12675	3	14.6	14.6	CD
cord-005453-4057qib7	12675	4	%	%	NN
cord-005453-4057qib7	12675	5	(	(	-LRB-
cord-005453-4057qib7	12675	6	n=21	n=21	NNP
cord-005453-4057qib7	12675	7	)	)	-RRB-
cord-005453-4057qib7	12675	8	of	of	IN
cord-005453-4057qib7	12675	9	CMVseropositive	CMVseropositive	NNP
cord-005453-4057qib7	12675	10	patients	patient	NNS
cord-005453-4057qib7	12675	11	developed	develop	VBD
cord-005453-4057qib7	12675	12	at	at	IN
cord-005453-4057qib7	12675	13	least	least	JJS
cord-005453-4057qib7	12675	14	one	one	CD
cord-005453-4057qib7	12675	15	episode	episode	NN
cord-005453-4057qib7	12675	16	of	of	IN
cord-005453-4057qib7	12675	17	CMV	CMV	NNP
cord-005453-4057qib7	12675	18	viremia	viremia	NN
cord-005453-4057qib7	12675	19	(	(	-LRB-
cord-005453-4057qib7	12675	20	CMV	CMV	NNP
cord-005453-4057qib7	12675	21	DNA	DNA	NNP
cord-005453-4057qib7	12675	22	>	>	XX
cord-005453-4057qib7	12675	23	100	100	CD
cord-005453-4057qib7	12675	24	copies	copy	NNS
cord-005453-4057qib7	12675	25	/	/	SYM
cord-005453-4057qib7	12675	26	ml	ml	NN
cord-005453-4057qib7	12675	27	)	)	-RRB-
cord-005453-4057qib7	12675	28	after	after	IN
cord-005453-4057qib7	12675	29	a	a	DT
cord-005453-4057qib7	12675	30	median	median	JJ
cord-005453-4057qib7	12675	31	24	24	CD
cord-005453-4057qib7	12675	32	months	month	NNS
cord-005453-4057qib7	12675	33	(	(	-LRB-
cord-005453-4057qib7	12675	34	range	range	NN
cord-005453-4057qib7	12675	35	;	;	:
cord-005453-4057qib7	12675	36	3	3	CD
cord-005453-4057qib7	12675	37	-	-	SYM
cord-005453-4057qib7	12675	38	48	48	CD
cord-005453-4057qib7	12675	39	mos	mo	NNS
cord-005453-4057qib7	12675	40	)	)	-RRB-
cord-005453-4057qib7	12675	41	follow	follow	NN
cord-005453-4057qib7	12675	42	-	-	HYPH
cord-005453-4057qib7	12675	43	up	up	NN
cord-005453-4057qib7	12675	44	.	.	.
cord-005453-4057qib7	12676	1	Persistent	persistent	JJ
cord-005453-4057qib7	12676	2	CMV	CMV	NNP
cord-005453-4057qib7	12676	3	viremia	viremia	NN
cord-005453-4057qib7	12676	4	(	(	-LRB-
cord-005453-4057qib7	12676	5	detectable	detectable	JJ
cord-005453-4057qib7	12676	6	CMV	CMV	NNP
cord-005453-4057qib7	12676	7	DNA	dna	NN
cord-005453-4057qib7	12676	8	load	load	NN
cord-005453-4057qib7	12676	9	in	in	IN
cord-005453-4057qib7	12676	10	more	more	JJR
cord-005453-4057qib7	12676	11	than	than	IN
cord-005453-4057qib7	12676	12	2	2	CD
cord-005453-4057qib7	12676	13	sequential	sequential	JJ
cord-005453-4057qib7	12676	14	plasma	plasma	NN
cord-005453-4057qib7	12676	15	specimens	specimen	NNS
cord-005453-4057qib7	12676	16	)	)	-RRB-
cord-005453-4057qib7	12676	17	occurred	occur	VBD
cord-005453-4057qib7	12676	18	in	in	IN
cord-005453-4057qib7	12676	19	4.9	4.9	CD
cord-005453-4057qib7	12676	20	%	%	NN
cord-005453-4057qib7	12676	21	(	(	-LRB-
cord-005453-4057qib7	12676	22	7	7	CD
cord-005453-4057qib7	12676	23	of	of	IN
cord-005453-4057qib7	12676	24	144	144	CD
cord-005453-4057qib7	12676	25	)	)	-RRB-
cord-005453-4057qib7	12676	26	of	of	IN
cord-005453-4057qib7	12676	27	the	the	DT
cord-005453-4057qib7	12676	28	seropositive	seropositive	JJ
cord-005453-4057qib7	12676	29	ASCT	ASCT	NNP
cord-005453-4057qib7	12676	30	recipients	recipient	NNS
cord-005453-4057qib7	12676	31	and	and	CC
cord-005453-4057qib7	12676	32	all	all	DT
cord-005453-4057qib7	12676	33	of	of	IN
cord-005453-4057qib7	12676	34	them	-PRON-	PRP
cord-005453-4057qib7	12676	35	were	be	VBD
cord-005453-4057qib7	12676	36	preventive	preventive	JJ
cord-005453-4057qib7	12676	37	treated	treat	VBN
cord-005453-4057qib7	12676	38	with	with	IN
cord-005453-4057qib7	12676	39	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	12676	40	(	(	-LRB-
cord-005453-4057qib7	12676	41	n=5	n=5	NNP
cord-005453-4057qib7	12676	42	)	)	-RRB-
cord-005453-4057qib7	12676	43	or	or	CC
cord-005453-4057qib7	12676	44	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	12676	45	(	(	-LRB-
cord-005453-4057qib7	12676	46	n=2	n=2	NNS
cord-005453-4057qib7	12676	47	)	)	-RRB-
cord-005453-4057qib7	12676	48	.	.	.
cord-005453-4057qib7	12677	1	The	the	DT
cord-005453-4057qib7	12677	2	time	time	NN
cord-005453-4057qib7	12677	3	from	from	IN
cord-005453-4057qib7	12677	4	stem	stem	NN
cord-005453-4057qib7	12677	5	cell	cell	NN
cord-005453-4057qib7	12677	6	infusion	infusion	NN
cord-005453-4057qib7	12677	7	to	to	IN
cord-005453-4057qib7	12677	8	the	the	DT
cord-005453-4057qib7	12677	9	development	development	NN
cord-005453-4057qib7	12677	10	of	of	IN
cord-005453-4057qib7	12677	11	CMV	CMV	NNP
cord-005453-4057qib7	12677	12	viremia	viremia	NN
cord-005453-4057qib7	12677	13	ranged	range	VBD
cord-005453-4057qib7	12677	14	from	from	IN
cord-005453-4057qib7	12677	15	3	3	CD
cord-005453-4057qib7	12677	16	days	day	NNS
cord-005453-4057qib7	12677	17	to	to	IN
cord-005453-4057qib7	12677	18	48	48	CD
cord-005453-4057qib7	12677	19	days	day	NNS
cord-005453-4057qib7	12677	20	.	.	.
cord-005453-4057qib7	12678	1	None	none	NN
cord-005453-4057qib7	12678	2	of	of	IN
cord-005453-4057qib7	12678	3	the	the	DT
cord-005453-4057qib7	12678	4	patients	patient	NNS
cord-005453-4057qib7	12678	5	with	with	IN
cord-005453-4057qib7	12678	6	untreated	untreated	JJ
cord-005453-4057qib7	12678	7	viremia	viremia	NN
cord-005453-4057qib7	12678	8	developed	develop	VBD
cord-005453-4057qib7	12678	9	identifiable	identifiable	JJ
cord-005453-4057qib7	12678	10	CMV	CMV	NNP
cord-005453-4057qib7	12678	11	sequelae	sequela	NNS
cord-005453-4057qib7	12678	12	.	.	.
cord-005453-4057qib7	12679	1	No	no	DT
cord-005453-4057qib7	12679	2	case	case	NN
cord-005453-4057qib7	12679	3	of	of	IN
cord-005453-4057qib7	12679	4	primary	primary	JJ
cord-005453-4057qib7	12679	5	infection	infection	NN
cord-005453-4057qib7	12679	6	in	in	IN
cord-005453-4057qib7	12679	7	seronegative	seronegative	JJ
cord-005453-4057qib7	12679	8	patients	patient	NNS
cord-005453-4057qib7	12679	9	at	at	IN
cord-005453-4057qib7	12679	10	transplant	transplant	NN
cord-005453-4057qib7	12679	11	was	be	VBD
cord-005453-4057qib7	12679	12	observed	observe	VBN
cord-005453-4057qib7	12679	13	.	.	.
cord-005453-4057qib7	12680	1	Adding	add	VBG
cord-005453-4057qib7	12680	2	to	to	IN
cord-005453-4057qib7	12680	3	that	that	DT
cord-005453-4057qib7	12680	4	none	none	NN
cord-005453-4057qib7	12680	5	of	of	IN
cord-005453-4057qib7	12680	6	the	the	DT
cord-005453-4057qib7	12680	7	patients	patient	NNS
cord-005453-4057qib7	12680	8	developed	develop	VBD
cord-005453-4057qib7	12680	9	CMV	CMV	NNP
cord-005453-4057qib7	12680	10	disease	disease	NN
cord-005453-4057qib7	12680	11	post	post	NN
cord-005453-4057qib7	12680	12	ASCT	ASCT	NNP
cord-005453-4057qib7	12680	13	.	.	.
cord-005453-4057qib7	12681	1	If	if	IN
cord-005453-4057qib7	12681	2	we	-PRON-	PRP
cord-005453-4057qib7	12681	3	analyzed	analyze	VBD
cord-005453-4057qib7	12681	4	the	the	DT
cord-005453-4057qib7	12681	5	subgroups	subgroup	NNS
cord-005453-4057qib7	12681	6	of	of	IN
cord-005453-4057qib7	12681	7	patients	patient	NNS
cord-005453-4057qib7	12681	8	according	accord	VBG
cord-005453-4057qib7	12681	9	to	to	IN
cord-005453-4057qib7	12681	10	induction	induction	NN
cord-005453-4057qib7	12681	11	therapy	therapy	NN
cord-005453-4057qib7	12681	12	(	(	-LRB-
cord-005453-4057qib7	12681	13	PI	pi	NN
cord-005453-4057qib7	12681	14	-	-	HYPH
cord-005453-4057qib7	12681	15	based	base	VBN
cord-005453-4057qib7	12681	16	,	,	,
cord-005453-4057qib7	12681	17	IMIDs	IMIDs	NNP
cord-005453-4057qib7	12681	18	,	,	,
cord-005453-4057qib7	12681	19	PI+IMID	PI+IMID	NNP
cord-005453-4057qib7	12681	20	)	)	-RRB-
cord-005453-4057qib7	12681	21	,	,	,
cord-005453-4057qib7	12681	22	the	the	DT
cord-005453-4057qib7	12681	23	incidence	incidence	NN
cord-005453-4057qib7	12681	24	of	of	IN
cord-005453-4057qib7	12681	25	post	post	JJ
cord-005453-4057qib7	12681	26	-	-	JJ
cord-005453-4057qib7	12681	27	ASCT	asct	JJ
cord-005453-4057qib7	12681	28	CMV	CMV	NNP
cord-005453-4057qib7	12681	29	reactivation	reactivation	NN
cord-005453-4057qib7	12681	30	was	be	VBD
cord-005453-4057qib7	12681	31	higher	high	JJR
cord-005453-4057qib7	12681	32	but	but	CC
cord-005453-4057qib7	12681	33	not	not	RB
cord-005453-4057qib7	12681	34	statistically	statistically	RB
cord-005453-4057qib7	12681	35	significant	significant	JJ
cord-005453-4057qib7	12681	36	,	,	,
cord-005453-4057qib7	12681	37	in	in	IN
cord-005453-4057qib7	12681	38	patients	patient	NNS
cord-005453-4057qib7	12681	39	who	who	WP
cord-005453-4057qib7	12681	40	received	receive	VBD
cord-005453-4057qib7	12681	41	only	only	RB
cord-005453-4057qib7	12681	42	PI	PI	NNP
cord-005453-4057qib7	12681	43	vs	vs	IN
cord-005453-4057qib7	12681	44	PI+IMID	PI+IMID	NNP
cord-005453-4057qib7	12681	45	(	(	-LRB-
cord-005453-4057qib7	12681	46	13	13	CD
cord-005453-4057qib7	12681	47	(	(	-LRB-
cord-005453-4057qib7	12681	48	61.9	61.9	CD
cord-005453-4057qib7	12681	49	%	%	NN
cord-005453-4057qib7	12681	50	)	)	-RRB-
cord-005453-4057qib7	12681	51	vs	vs	IN
cord-005453-4057qib7	12681	52	8	8	CD
cord-005453-4057qib7	12681	53	(	(	-LRB-
cord-005453-4057qib7	12681	54	38.1	38.1	CD
cord-005453-4057qib7	12681	55	%	%	NN
cord-005453-4057qib7	12681	56	)	)	-RRB-
cord-005453-4057qib7	12681	57	;	;	:
cord-005453-4057qib7	12681	58	p=1.00	p=1.00	NNP
cord-005453-4057qib7	12681	59	)	)	-RRB-
cord-005453-4057qib7	12681	60	.	.	.
cord-005453-4057qib7	12682	1	In	in	IN
cord-005453-4057qib7	12682	2	univariate	univariate	JJ
cord-005453-4057qib7	12682	3	analysis	analysis	NN
cord-005453-4057qib7	12682	4	,	,	,
cord-005453-4057qib7	12682	5	we	-PRON-	PRP
cord-005453-4057qib7	12682	6	could	could	MD
cord-005453-4057qib7	12682	7	not	not	RB
cord-005453-4057qib7	12682	8	demonstrate	demonstrate	VB
cord-005453-4057qib7	12682	9	the	the	DT
cord-005453-4057qib7	12682	10	importance	importance	NN
cord-005453-4057qib7	12682	11	of	of	IN
cord-005453-4057qib7	12682	12	induction	induction	NN
cord-005453-4057qib7	12682	13	therapy	therapy	NN
cord-005453-4057qib7	12682	14	with	with	IN
cord-005453-4057qib7	12682	15	novel	novel	JJ
cord-005453-4057qib7	12682	16	agents	agent	NNS
cord-005453-4057qib7	12682	17	the	the	DT
cord-005453-4057qib7	12682	18	occurrence	occurrence	NN
cord-005453-4057qib7	12682	19	of	of	IN
cord-005453-4057qib7	12682	20	a	a	DT
cord-005453-4057qib7	12682	21	post	post	JJ
cord-005453-4057qib7	12682	22	-	-	JJ
cord-005453-4057qib7	12682	23	ASCT	asct	JJ
cord-005453-4057qib7	12682	24	CMV	CMV	NNP
cord-005453-4057qib7	12682	25	reactivation	reactivation	NN
cord-005453-4057qib7	12682	26	requiring	require	VBG
cord-005453-4057qib7	12682	27	antiviral	antiviral	JJ
cord-005453-4057qib7	12682	28	treatment	treatment	NN
cord-005453-4057qib7	12682	29	.	.	.
cord-005453-4057qib7	12683	1	However	however	RB
cord-005453-4057qib7	12683	2	,	,	,
cord-005453-4057qib7	12683	3	statistically	statistically	RB
cord-005453-4057qib7	12683	4	significant	significant	JJ
cord-005453-4057qib7	12683	5	association	association	NN
cord-005453-4057qib7	12683	6	found	find	VBD
cord-005453-4057qib7	12683	7	between	between	IN
cord-005453-4057qib7	12683	8	the	the	DT
cord-005453-4057qib7	12683	9	disease	disease	NN
cord-005453-4057qib7	12683	10	<	<	XX
cord-005453-4057qib7	12683	11	VGPR	vgpr	NN
cord-005453-4057qib7	12683	12	status	status	NN
cord-005453-4057qib7	12683	13	at	at	IN
cord-005453-4057qib7	12683	14	ASCT	ASCT	NNP
cord-005453-4057qib7	12683	15	and	and	CC
cord-005453-4057qib7	12683	16	CMV	CMV	NNP
cord-005453-4057qib7	12683	17	reactivation	reactivation	NN
cord-005453-4057qib7	12683	18	(	(	-LRB-
cord-005453-4057qib7	12683	19	61.1	61.1	CD
cord-005453-4057qib7	12683	20	%	%	NN
cord-005453-4057qib7	12683	21	vs.	vs.	NN
cord-005453-4057qib7	12683	22	38.9	38.9	CD
cord-005453-4057qib7	12683	23	%	%	NN
cord-005453-4057qib7	12683	24	;	;	:
cord-005453-4057qib7	12683	25	p=0.035	p=0.035	NNP
cord-005453-4057qib7	12683	26	)	)	-RRB-
cord-005453-4057qib7	12683	27	.	.	.
cord-005453-4057qib7	12684	1	After	after	IN
cord-005453-4057qib7	12684	2	a	a	DT
cord-005453-4057qib7	12684	3	median	median	JJ
cord-005453-4057qib7	12684	4	follow	follow	NN
cord-005453-4057qib7	12684	5	-	-	HYPH
cord-005453-4057qib7	12684	6	up	up	NN
cord-005453-4057qib7	12684	7	14.3	14.3	CD
cord-005453-4057qib7	12684	8	months	month	NNS
cord-005453-4057qib7	12684	9	(	(	-LRB-
cord-005453-4057qib7	12684	10	range	range	NN
cord-005453-4057qib7	12684	11	;	;	:
cord-005453-4057qib7	12684	12	1	1	CD
cord-005453-4057qib7	12684	13	-	-	SYM
cord-005453-4057qib7	12684	14	45.9	45.9	CD
cord-005453-4057qib7	12684	15	months	month	NNS
cord-005453-4057qib7	12684	16	)	)	-RRB-
cord-005453-4057qib7	12684	17	,	,	,
cord-005453-4057qib7	12684	18	there	there	EX
cord-005453-4057qib7	12684	19	was	be	VBD
cord-005453-4057qib7	12684	20	no	no	DT
cord-005453-4057qib7	12684	21	significant	significant	JJ
cord-005453-4057qib7	12684	22	impact	impact	NN
cord-005453-4057qib7	12684	23	on	on	IN
cord-005453-4057qib7	12684	24	PFS	PFS	NNP
cord-005453-4057qib7	12684	25	,	,	,
cord-005453-4057qib7	12684	26	however	however	WRB
cord-005453-4057qib7	12684	27	there	there	EX
cord-005453-4057qib7	12684	28	was	be	VBD
cord-005453-4057qib7	12684	29	significant	significant	JJ
cord-005453-4057qib7	12684	30	decrease	decrease	NN
cord-005453-4057qib7	12684	31	in	in	IN
cord-005453-4057qib7	12684	32	estimated	estimate	VBN
cord-005453-4057qib7	12684	33	mean	mean	NN
cord-005453-4057qib7	12684	34	OS	OS	NNP
cord-005453-4057qib7	12684	35	who	who	WP
cord-005453-4057qib7	12684	36	had	have	VBD
cord-005453-4057qib7	12684	37	CMV	CMV	NNP
cord-005453-4057qib7	12684	38	reactivation	reactivation	NN
cord-005453-4057qib7	12684	39	when	when	WRB
cord-005453-4057qib7	12684	40	compared	compare	VBN
cord-005453-4057qib7	12684	41	to	to	IN
cord-005453-4057qib7	12684	42	those	those	DT
cord-005453-4057qib7	12684	43	without	without	IN
cord-005453-4057qib7	12684	44	CMV	CMV	NNP
cord-005453-4057qib7	12684	45	reactivation	reactivation	NN
cord-005453-4057qib7	12684	46	(	(	-LRB-
cord-005453-4057qib7	12684	47	34.1±4.5	34.1±4.5	CD
cord-005453-4057qib7	12684	48	vs.	vs.	NN
cord-005453-4057qib7	12684	49	41.9±1.3	41.9±1.3	CD
cord-005453-4057qib7	12684	50	;	;	:
cord-005453-4057qib7	12684	51	p=0.002	p=0.002	ADD
cord-005453-4057qib7	12684	52	)	)	-RRB-
cord-005453-4057qib7	12684	53	(	(	-LRB-
cord-005453-4057qib7	12684	54	Figure-1	Figure-1	NNP
cord-005453-4057qib7	12684	55	)	)	-RRB-
cord-005453-4057qib7	12684	56	.	.	.
cord-005453-4057qib7	12685	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12685	2	:	:	:
cord-005453-4057qib7	12686	1	CMV	CMV	NNP
cord-005453-4057qib7	12686	2	establishes	establish	VBZ
cord-005453-4057qib7	12686	3	lifelong	lifelong	JJ
cord-005453-4057qib7	12686	4	latency	latency	NN
cord-005453-4057qib7	12686	5	within	within	IN
cord-005453-4057qib7	12686	6	host	host	NN
cord-005453-4057qib7	12686	7	cells	cell	NNS
cord-005453-4057qib7	12686	8	and	and	CC
cord-005453-4057qib7	12686	9	in	in	IN
cord-005453-4057qib7	12686	10	the	the	DT
cord-005453-4057qib7	12686	11	setting	setting	NN
cord-005453-4057qib7	12686	12	of	of	IN
cord-005453-4057qib7	12686	13	impaired	impaired	JJ
cord-005453-4057qib7	12686	14	cellular	cellular	JJ
cord-005453-4057qib7	12686	15	immunity	immunity	NN
cord-005453-4057qib7	12686	16	;	;	:
cord-005453-4057qib7	12686	17	CMV	CMV	NNP
cord-005453-4057qib7	12686	18	may	may	MD
cord-005453-4057qib7	12686	19	reactivate	reactivate	VB
cord-005453-4057qib7	12686	20	from	from	IN
cord-005453-4057qib7	12686	21	latency	latency	NN
cord-005453-4057qib7	12686	22	,	,	,
cord-005453-4057qib7	12686	23	disseminate	disseminate	VB
cord-005453-4057qib7	12686	24	,	,	,
cord-005453-4057qib7	12686	25	and	and	CC
cord-005453-4057qib7	12686	26	directly	directly	RB
cord-005453-4057qib7	12686	27	cause	cause	VB
cord-005453-4057qib7	12686	28	life	life	NN
cord-005453-4057qib7	12686	29	-	-	HYPH
cord-005453-4057qib7	12686	30	threatening	threaten	VBG
cord-005453-4057qib7	12686	31	disease	disease	NN
cord-005453-4057qib7	12686	32	.	.	.
cord-005453-4057qib7	12687	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12687	2	data	data	NN
cord-005453-4057qib7	12687	3	suggests	suggest	VBZ
cord-005453-4057qib7	12687	4	that	that	IN
cord-005453-4057qib7	12687	5	MM	MM	NNP
cord-005453-4057qib7	12687	6	patients	patient	NNS
cord-005453-4057qib7	12687	7	treated	treat	VBN
cord-005453-4057qib7	12687	8	with	with	IN
cord-005453-4057qib7	12687	9	PI	pi	NN
cord-005453-4057qib7	12687	10	-	-	HYPH
cord-005453-4057qib7	12687	11	based	base	VBN
cord-005453-4057qib7	12687	12	induction	induction	NN
cord-005453-4057qib7	12687	13	regimens	regimen	NNS
cord-005453-4057qib7	12687	14	and	and	CC
cord-005453-4057qib7	12687	15	immunological	immunological	JJ
cord-005453-4057qib7	12687	16	response	response	NN
cord-005453-4057qib7	12687	17	<	<	XX
cord-005453-4057qib7	12687	18	VGPR	VGPR	NNP
cord-005453-4057qib7	12687	19	at	at	IN
cord-005453-4057qib7	12687	20	time	time	NN
cord-005453-4057qib7	12687	21	of	of	IN
cord-005453-4057qib7	12687	22	ASCT	ASCT	NNP
cord-005453-4057qib7	12687	23	seem	seem	VBP
cord-005453-4057qib7	12687	24	to	to	TO
cord-005453-4057qib7	12687	25	have	have	VB
cord-005453-4057qib7	12687	26	higher	high	JJR
cord-005453-4057qib7	12687	27	risk	risk	NN
cord-005453-4057qib7	12687	28	of	of	IN
cord-005453-4057qib7	12687	29	developing	develop	VBG
cord-005453-4057qib7	12687	30	symptomatic	symptomatic	JJ
cord-005453-4057qib7	12687	31	CMV	CMV	NNP
cord-005453-4057qib7	12687	32	reactivation	reactivation	NN
cord-005453-4057qib7	12687	33	.	.	.
cord-005453-4057qib7	12688	1	However	however	RB
cord-005453-4057qib7	12688	2	,	,	,
cord-005453-4057qib7	12688	3	further	further	JJ
cord-005453-4057qib7	12688	4	studies	study	NNS
cord-005453-4057qib7	12688	5	on	on	IN
cord-005453-4057qib7	12688	6	a	a	DT
cord-005453-4057qib7	12688	7	large	large	JJ
cord-005453-4057qib7	12688	8	number	number	NN
cord-005453-4057qib7	12688	9	of	of	IN
cord-005453-4057qib7	12688	10	patients	patient	NNS
cord-005453-4057qib7	12688	11	are	be	VBP
cord-005453-4057qib7	12688	12	warranted	warrant	VBN
cord-005453-4057qib7	12688	13	to	to	TO
cord-005453-4057qib7	12688	14	clarify	clarify	VB
cord-005453-4057qib7	12688	15	these	these	DT
cord-005453-4057qib7	12688	16	findings	finding	NNS
cord-005453-4057qib7	12688	17	.	.	.
cord-005453-4057qib7	12689	1	Clinical	clinical	JJ
cord-005453-4057qib7	12689	2	Background	background	NN
cord-005453-4057qib7	12689	3	:	:	:
cord-005453-4057qib7	12689	4	High	high	JJ
cord-005453-4057qib7	12689	5	-	-	HYPH
cord-005453-4057qib7	12689	6	dose	dose	NN
cord-005453-4057qib7	12689	7	therapy	therapy	NN
cord-005453-4057qib7	12689	8	followed	follow	VBN
cord-005453-4057qib7	12689	9	by	by	IN
cord-005453-4057qib7	12689	10	autologous	autologous	JJ
cord-005453-4057qib7	12689	11	stem	stem	NN
cord-005453-4057qib7	12689	12	cell	cell	NN
cord-005453-4057qib7	12689	13	transplantation	transplantation	NN
cord-005453-4057qib7	12689	14	(	(	-LRB-
cord-005453-4057qib7	12689	15	ASCT	ASCT	NNP
cord-005453-4057qib7	12689	16	)	)	-RRB-
cord-005453-4057qib7	12689	17	has	have	VBZ
cord-005453-4057qib7	12689	18	been	be	VBN
cord-005453-4057qib7	12689	19	shown	show	VBN
cord-005453-4057qib7	12689	20	to	to	TO
cord-005453-4057qib7	12689	21	prolong	prolong	VB
cord-005453-4057qib7	12689	22	survival	survival	NN
cord-005453-4057qib7	12689	23	in	in	IN
cord-005453-4057qib7	12689	24	patients	patient	NNS
cord-005453-4057qib7	12689	25	with	with	IN
cord-005453-4057qib7	12689	26	multiple	multiple	JJ
cord-005453-4057qib7	12689	27	myeloma	myeloma	NN
cord-005453-4057qib7	12689	28	(	(	-LRB-
cord-005453-4057qib7	12689	29	MM	MM	NNP
cord-005453-4057qib7	12689	30	)	)	-RRB-
cord-005453-4057qib7	12689	31	in	in	IN
cord-005453-4057qib7	12689	32	randomized	randomized	JJ
cord-005453-4057qib7	12689	33	trials	trial	NNS
cord-005453-4057qib7	12689	34	.	.	.
cord-005453-4057qib7	12690	1	However	however	RB
cord-005453-4057qib7	12690	2	,	,	,
cord-005453-4057qib7	12690	3	these	these	DT
cord-005453-4057qib7	12690	4	trials	trial	NNS
cord-005453-4057qib7	12690	5	only	only	RB
cord-005453-4057qib7	12690	6	include	include	VBP
cord-005453-4057qib7	12690	7	patients	patient	NNS
cord-005453-4057qib7	12690	8	aged	age	VBN
cord-005453-4057qib7	12690	9	<	<	XX
cord-005453-4057qib7	12690	10	65	65	CD
cord-005453-4057qib7	12690	11	years	year	NNS
cord-005453-4057qib7	12690	12	.	.	.
cord-005453-4057qib7	12691	1	Data	datum	NNS
cord-005453-4057qib7	12691	2	regarding	regard	VBG
cord-005453-4057qib7	12691	3	safety	safety	NN
cord-005453-4057qib7	12691	4	and	and	CC
cord-005453-4057qib7	12691	5	outcomes	outcome	NNS
cord-005453-4057qib7	12691	6	in	in	IN
cord-005453-4057qib7	12691	7	this	this	DT
cord-005453-4057qib7	12691	8	patient	patient	JJ
cord-005453-4057qib7	12691	9	population	population	NN
cord-005453-4057qib7	12691	10	is	be	VBZ
cord-005453-4057qib7	12691	11	lacking	lack	VBG
cord-005453-4057qib7	12691	12	.	.	.
cord-005453-4057qib7	12692	1	Methods	method	NNS
cord-005453-4057qib7	12692	2	:	:	:
cord-005453-4057qib7	12693	1	The	the	DT
cord-005453-4057qib7	12693	2	aim	aim	NN
cord-005453-4057qib7	12693	3	of	of	IN
cord-005453-4057qib7	12693	4	this	this	DT
cord-005453-4057qib7	12693	5	study	study	NN
cord-005453-4057qib7	12693	6	was	be	VBD
cord-005453-4057qib7	12693	7	to	to	TO
cord-005453-4057qib7	12693	8	compare	compare	VB
cord-005453-4057qib7	12693	9	safety	safety	NN
cord-005453-4057qib7	12693	10	profile	profile	NN
cord-005453-4057qib7	12693	11	and	and	CC
cord-005453-4057qib7	12693	12	outcomes	outcome	NNS
cord-005453-4057qib7	12693	13	in	in	IN
cord-005453-4057qib7	12693	14	MM	MM	NNP
cord-005453-4057qib7	12693	15	patients	patient	NNS
cord-005453-4057qib7	12693	16	younger	young	JJR
cord-005453-4057qib7	12693	17	and	and	CC
cord-005453-4057qib7	12693	18	older	old	JJR
cord-005453-4057qib7	12693	19	than	than	IN
cord-005453-4057qib7	12693	20	65	65	CD
cord-005453-4057qib7	12693	21	years	year	NNS
cord-005453-4057qib7	12693	22	-	-	HYPH
cord-005453-4057qib7	12693	23	old	old	JJ
cord-005453-4057qib7	12693	24	who	who	WP
cord-005453-4057qib7	12693	25	underwent	undergo	VBD
cord-005453-4057qib7	12693	26	ASCT	ASCT	NNP
cord-005453-4057qib7	12693	27	in	in	IN
cord-005453-4057qib7	12693	28	our	-PRON-	PRP$
cord-005453-4057qib7	12693	29	Unit	Unit	NNP
cord-005453-4057qib7	12693	30	from	from	IN
cord-005453-4057qib7	12693	31	July	July	NNP
cord-005453-4057qib7	12693	32	2014	2014	CD
cord-005453-4057qib7	12693	33	to	to	IN
cord-005453-4057qib7	12693	34	October	October	NNP
cord-005453-4057qib7	12693	35	2018	2018	CD
cord-005453-4057qib7	12693	36	.	.	.
cord-005453-4057qib7	12694	1	Patient	Patient	NNP
cord-005453-4057qib7	12694	2	's	's	POS
cord-005453-4057qib7	12694	3	demographics	demographic	NNS
cord-005453-4057qib7	12694	4	,	,	,
cord-005453-4057qib7	12694	5	clinical	clinical	JJ
cord-005453-4057qib7	12694	6	characteristics	characteristic	NNS
cord-005453-4057qib7	12694	7	,	,	,
cord-005453-4057qib7	12694	8	transplant	transplant	NN
cord-005453-4057qib7	12694	9	related	relate	VBN
cord-005453-4057qib7	12694	10	variables	variable	NNS
cord-005453-4057qib7	12694	11	and	and	CC
cord-005453-4057qib7	12694	12	probability	probability	NN
cord-005453-4057qib7	12694	13	of	of	IN
cord-005453-4057qib7	12694	14	admission	admission	NN
cord-005453-4057qib7	12694	15	to	to	IN
cord-005453-4057qib7	12694	16	the	the	DT
cord-005453-4057qib7	12694	17	Intensive	Intensive	NNP
cord-005453-4057qib7	12694	18	Care	Care	NNP
cord-005453-4057qib7	12694	19	Unit	Unit	NNP
cord-005453-4057qib7	12694	20	(	(	-LRB-
cord-005453-4057qib7	12694	21	ICU	ICU	NNP
cord-005453-4057qib7	12694	22	)	)	-RRB-
cord-005453-4057qib7	12694	23	were	be	VBD
cord-005453-4057qib7	12694	24	analyzed	analyze	VBN
cord-005453-4057qib7	12694	25	.	.	.
cord-005453-4057qib7	12695	1	Patients	patient	NNS
cord-005453-4057qib7	12695	2	aged	age	VBN
cord-005453-4057qib7	12695	3	<	<	XX
cord-005453-4057qib7	12695	4	65	65	CD
cord-005453-4057qib7	12695	5	and	and	CC
cord-005453-4057qib7	12695	6	≥65	≥65	NNP
cord-005453-4057qib7	12695	7	years	year	NNS
cord-005453-4057qib7	12695	8	-	-	HYPH
cord-005453-4057qib7	12695	9	old	old	JJ
cord-005453-4057qib7	12695	10	would	would	MD
cord-005453-4057qib7	12695	11	be	be	VB
cord-005453-4057qib7	12695	12	called	call	VBN
cord-005453-4057qib7	12695	13	M1	M1	NNP
cord-005453-4057qib7	12695	14	and	and	CC
cord-005453-4057qib7	12695	15	M2	M2	NNP
cord-005453-4057qib7	12695	16	,	,	,
cord-005453-4057qib7	12695	17	respectively	respectively	RB
cord-005453-4057qib7	12695	18	,	,	,
cord-005453-4057qib7	12695	19	from	from	IN
cord-005453-4057qib7	12695	20	now	now	RB
cord-005453-4057qib7	12695	21	on	on	RB
cord-005453-4057qib7	12695	22	.	.	.
cord-005453-4057qib7	12696	1	Sorror	Sorror	NNP
cord-005453-4057qib7	12696	2	index	index	NN
cord-005453-4057qib7	12696	3	was	be	VBD
cord-005453-4057qib7	12696	4	used	use	VBN
cord-005453-4057qib7	12696	5	to	to	TO
cord-005453-4057qib7	12696	6	estimate	estimate	VB
cord-005453-4057qib7	12696	7	risk	risk	NN
cord-005453-4057qib7	12696	8	of	of	IN
cord-005453-4057qib7	12696	9	mortality	mortality	NN
cord-005453-4057qib7	12696	10	in	in	IN
cord-005453-4057qib7	12696	11	the	the	DT
cord-005453-4057qib7	12696	12	two	two	CD
cord-005453-4057qib7	12696	13	cohorts	cohort	NNS
cord-005453-4057qib7	12696	14	.	.	.
cord-005453-4057qib7	12697	1	Results	result	NNS
cord-005453-4057qib7	12697	2	:	:	:
cord-005453-4057qib7	12698	1	A	a	DT
cord-005453-4057qib7	12698	2	hundred	hundred	CD
cord-005453-4057qib7	12698	3	and	and	CC
cord-005453-4057qib7	12698	4	eleven	eleven	CD
cord-005453-4057qib7	12698	5	patients	patient	NNS
cord-005453-4057qib7	12698	6	with	with	IN
cord-005453-4057qib7	12698	7	MM	MM	NNP
cord-005453-4057qib7	12698	8	underwent	undergo	VBD
cord-005453-4057qib7	12698	9	ASCT	ASCT	NNP
cord-005453-4057qib7	12698	10	in	in	IN
cord-005453-4057qib7	12698	11	the	the	DT
cord-005453-4057qib7	12698	12	study	study	NN
cord-005453-4057qib7	12698	13	period	period	NN
cord-005453-4057qib7	12698	14	.	.	.
cord-005453-4057qib7	12699	1	Median	median	JJ
cord-005453-4057qib7	12699	2	age	age	NN
cord-005453-4057qib7	12699	3	was	be	VBD
cord-005453-4057qib7	12699	4	60.9	60.9	CD
cord-005453-4057qib7	12699	5	years	year	NNS
cord-005453-4057qib7	12699	6	-	-	HYPH
cord-005453-4057qib7	12699	7	old	old	JJ
cord-005453-4057qib7	12699	8	(	(	-LRB-
cord-005453-4057qib7	12699	9	range	range	NN
cord-005453-4057qib7	12699	10	35	35	CD
cord-005453-4057qib7	12699	11	-	-	SYM
cord-005453-4057qib7	12699	12	73	73	CD
cord-005453-4057qib7	12699	13	)	)	-RRB-
cord-005453-4057qib7	12699	14	and	and	CC
cord-005453-4057qib7	12699	15	53.2	53.2	CD
cord-005453-4057qib7	12699	16	%	%	NN
cord-005453-4057qib7	12699	17	were	be	VBD
cord-005453-4057qib7	12699	18	male	male	JJ
cord-005453-4057qib7	12699	19	.	.	.
cord-005453-4057qib7	12700	1	Thirtythree	Thirtythree	NNP
cord-005453-4057qib7	12700	2	(	(	-LRB-
cord-005453-4057qib7	12700	3	28,8	28,8	CD
cord-005453-4057qib7	12700	4	%	%	NN
cord-005453-4057qib7	12700	5	)	)	-RRB-
cord-005453-4057qib7	12700	6	patients	patient	NNS
cord-005453-4057qib7	12700	7	were	be	VBD
cord-005453-4057qib7	12700	8	≥	≥	CD
cord-005453-4057qib7	12700	9	65	65	CD
cord-005453-4057qib7	12700	10	years	year	NNS
cord-005453-4057qib7	12700	11	.	.	.
cord-005453-4057qib7	12701	1	The	the	DT
cord-005453-4057qib7	12701	2	probability	probability	NN
cord-005453-4057qib7	12701	3	of	of	IN
cord-005453-4057qib7	12701	4	having	have	VBG
cord-005453-4057qib7	12701	5	a	a	DT
cord-005453-4057qib7	12701	6	high	high	JJ
cord-005453-4057qib7	12701	7	risk	risk	NN
cord-005453-4057qib7	12701	8	comorbidity	comorbidity	NN
cord-005453-4057qib7	12701	9	index	index	NN
cord-005453-4057qib7	12701	10	was	be	VBD
cord-005453-4057qib7	12701	11	similar	similar	JJ
cord-005453-4057qib7	12701	12	in	in	IN
cord-005453-4057qib7	12701	13	both	both	DT
cord-005453-4057qib7	12701	14	groups	group	NNS
cord-005453-4057qib7	12701	15	(	(	-LRB-
cord-005453-4057qib7	12701	16	M1	M1	NNP
cord-005453-4057qib7	12701	17	11,7	11,7	CD
cord-005453-4057qib7	12702	1	vsM2	vsm2	RB
cord-005453-4057qib7	12702	2	12,1	12,1	CD
cord-005453-4057qib7	12702	3	%	%	NN
cord-005453-4057qib7	12702	4	)	)	-RRB-
cord-005453-4057qib7	12702	5	.	.	.
cord-005453-4057qib7	12703	1	The	the	DT
cord-005453-4057qib7	12703	2	median	median	JJ
cord-005453-4057qib7	12703	3	cells	cell	NNS
cord-005453-4057qib7	12703	4	obtained	obtain	VBN
cord-005453-4057qib7	12703	5	in	in	IN
cord-005453-4057qib7	12703	6	the	the	DT
cord-005453-4057qib7	12703	7	apheresis	apheresis	NN
cord-005453-4057qib7	12703	8	procedure	procedure	NN
cord-005453-4057qib7	12703	9	was	be	VBD
cord-005453-4057qib7	12703	10	5.35	5.35	CD
cord-005453-4057qib7	12703	11	x10	x10	NN
cord-005453-4057qib7	12703	12	6	6	CD
cord-005453-4057qib7	12703	13	(	(	-LRB-
cord-005453-4057qib7	12703	14	1,70	1,70	NNP
cord-005453-4057qib7	12703	15	-	-	HYPH
cord-005453-4057qib7	12703	16	15.92	15.92	CD
cord-005453-4057qib7	12703	17	)	)	-RRB-
cord-005453-4057qib7	12703	18	in	in	IN
cord-005453-4057qib7	12703	19	M1	M1	NNP
cord-005453-4057qib7	12703	20	compared	compare	VBN
cord-005453-4057qib7	12703	21	to	to	IN
cord-005453-4057qib7	12703	22	3.77	3.77	CD
cord-005453-4057qib7	12703	23	x10	x10	NN
cord-005453-4057qib7	12703	24	6	6	CD
cord-005453-4057qib7	12703	25	(	(	-LRB-
cord-005453-4057qib7	12703	26	1.96	1.96	CD
cord-005453-4057qib7	12703	27	-	-	SYM
cord-005453-4057qib7	12703	28	10	10	CD
cord-005453-4057qib7	12703	29	-	-	SYM
cord-005453-4057qib7	12703	30	48	48	CD
cord-005453-4057qib7	12703	31	)	)	-RRB-
cord-005453-4057qib7	12703	32	in	in	IN
cord-005453-4057qib7	12703	33	M2	M2	NNP
cord-005453-4057qib7	12703	34	.	.	.
cord-005453-4057qib7	12704	1	There	there	EX
cord-005453-4057qib7	12704	2	were	be	VBD
cord-005453-4057qib7	12704	3	no	no	DT
cord-005453-4057qib7	12704	4	differences	difference	NNS
cord-005453-4057qib7	12704	5	in	in	IN
cord-005453-4057qib7	12704	6	median	median	JJ
cord-005453-4057qib7	12704	7	admission	admission	NN
cord-005453-4057qib7	12704	8	lenght	lenght	NN
cord-005453-4057qib7	12704	9	between	between	IN
cord-005453-4057qib7	12704	10	the	the	DT
cord-005453-4057qib7	12704	11	2	2	CD
cord-005453-4057qib7	12704	12	cohorts	cohort	NNS
cord-005453-4057qib7	12704	13	(	(	-LRB-
cord-005453-4057qib7	12704	14	M1:19	m1:19	$
cord-005453-4057qib7	12704	15	days	day	NNS
cord-005453-4057qib7	12704	16	vs	vs	IN
cord-005453-4057qib7	12704	17	M2	M2	NNP
cord-005453-4057qib7	12704	18	:	:	:
cord-005453-4057qib7	12704	19	20	20	CD
cord-005453-4057qib7	12704	20	days	day	NNS
cord-005453-4057qib7	12704	21	)	)	-RRB-
cord-005453-4057qib7	12704	22	.	.	.
cord-005453-4057qib7	12705	1	Median	median	JJ
cord-005453-4057qib7	12705	2	days	day	NNS
cord-005453-4057qib7	12705	3	for	for	IN
cord-005453-4057qib7	12705	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	12705	5	recovery	recovery	NN
cord-005453-4057qib7	12705	6	above	above	IN
cord-005453-4057qib7	12705	7	1000	1000	CD
cord-005453-4057qib7	12705	8	was	be	VBD
cord-005453-4057qib7	12705	9	12	12	CD
cord-005453-4057qib7	12705	10	days	day	NNS
cord-005453-4057qib7	12705	11	in	in	IN
cord-005453-4057qib7	12705	12	both	both	DT
cord-005453-4057qib7	12705	13	groups	group	NNS
cord-005453-4057qib7	12705	14	with	with	IN
cord-005453-4057qib7	12705	15	a	a	DT
cord-005453-4057qib7	12705	16	wider	wide	JJR
cord-005453-4057qib7	12705	17	range	range	NN
cord-005453-4057qib7	12705	18	in	in	IN
cord-005453-4057qib7	12705	19	M1	M1	NNP
cord-005453-4057qib7	12705	20	(	(	-LRB-
cord-005453-4057qib7	12705	21	11	11	CD
cord-005453-4057qib7	12705	22	-	-	SYM
cord-005453-4057qib7	12705	23	23	23	CD
cord-005453-4057qib7	12705	24	)	)	-RRB-
cord-005453-4057qib7	12705	25	compared	compare	VBN
cord-005453-4057qib7	12705	26	to	to	IN
cord-005453-4057qib7	12705	27	M2	M2	NNP
cord-005453-4057qib7	12705	28	(	(	-LRB-
cord-005453-4057qib7	12705	29	11	11	CD
cord-005453-4057qib7	12705	30	-	-	SYM
cord-005453-4057qib7	12705	31	15	15	CD
cord-005453-4057qib7	12705	32	)	)	-RRB-
cord-005453-4057qib7	12705	33	.	.	.
cord-005453-4057qib7	12706	1	No	no	DT
cord-005453-4057qib7	12706	2	differences	difference	NNS
cord-005453-4057qib7	12706	3	were	be	VBD
cord-005453-4057qib7	12706	4	found	find	VBN
cord-005453-4057qib7	12706	5	in	in	IN
cord-005453-4057qib7	12706	6	platelet	platelet	NN
cord-005453-4057qib7	12706	7	recovery	recovery	NN
cord-005453-4057qib7	12706	8	above	above	IN
cord-005453-4057qib7	12706	9	100.000	100.000	CD
cord-005453-4057qib7	12706	10	(	(	-LRB-
cord-005453-4057qib7	12706	11	M1	M1	NNP
cord-005453-4057qib7	12706	12	20	20	CD
cord-005453-4057qib7	12706	13	days	day	NNS
cord-005453-4057qib7	12706	14	vs	vs	IN
cord-005453-4057qib7	12706	15	M2	M2	NNP
cord-005453-4057qib7	12706	16	21	21	CD
cord-005453-4057qib7	12706	17	days	day	NNS
cord-005453-4057qib7	12706	18	)	)	-RRB-
cord-005453-4057qib7	12706	19	.	.	.
cord-005453-4057qib7	12707	1	Median	median	JJ
cord-005453-4057qib7	12707	2	packed	pack	VBD
cord-005453-4057qib7	12707	3	red	red	JJ
cord-005453-4057qib7	12707	4	blood	blood	NN
cord-005453-4057qib7	12707	5	cells	cell	NNS
cord-005453-4057qib7	12707	6	and	and	CC
cord-005453-4057qib7	12707	7	platelets	platelet	NNS
cord-005453-4057qib7	12707	8	transfusions	transfusion	NNS
cord-005453-4057qib7	12707	9	were	be	VBD
cord-005453-4057qib7	12707	10	1	1	CD
cord-005453-4057qib7	12707	11	(	(	-LRB-
cord-005453-4057qib7	12707	12	0	0	CD
cord-005453-4057qib7	12707	13	-	-	SYM
cord-005453-4057qib7	12707	14	6	6	CD
cord-005453-4057qib7	12707	15	)	)	-RRB-
cord-005453-4057qib7	12707	16	and	and	CC
cord-005453-4057qib7	12707	17	3	3	CD
cord-005453-4057qib7	12707	18	(	(	-LRB-
cord-005453-4057qib7	12707	19	0	0	CD
cord-005453-4057qib7	12707	20	-	-	SYM
cord-005453-4057qib7	12707	21	16	16	CD
cord-005453-4057qib7	12707	22	)	)	-RRB-
cord-005453-4057qib7	12707	23	,	,	,
cord-005453-4057qib7	12707	24	respectively	respectively	RB
cord-005453-4057qib7	12707	25	,	,	,
cord-005453-4057qib7	12707	26	in	in	IN
cord-005453-4057qib7	12707	27	M1	M1	NNP
cord-005453-4057qib7	12707	28	.	.	.
cord-005453-4057qib7	12708	1	In	in	IN
cord-005453-4057qib7	12708	2	M2	M2	NNP
cord-005453-4057qib7	12708	3	cohort	cohort	NN
cord-005453-4057qib7	12708	4	,	,	,
cord-005453-4057qib7	12708	5	they	-PRON-	PRP
cord-005453-4057qib7	12708	6	were	be	VBD
cord-005453-4057qib7	12708	7	2	2	CD
cord-005453-4057qib7	12708	8	(	(	-LRB-
cord-005453-4057qib7	12708	9	0	0	CD
cord-005453-4057qib7	12708	10	-	-	SYM
cord-005453-4057qib7	12708	11	5	5	CD
cord-005453-4057qib7	12708	12	)	)	-RRB-
cord-005453-4057qib7	12708	13	and	and	CC
cord-005453-4057qib7	12708	14	4	4	LS
cord-005453-4057qib7	12708	15	(	(	-LRB-
cord-005453-4057qib7	12708	16	0	0	CD
cord-005453-4057qib7	12708	17	-	-	SYM
cord-005453-4057qib7	12708	18	14	14	CD
cord-005453-4057qib7	12708	19	)	)	-RRB-
cord-005453-4057qib7	12708	20	,	,	,
cord-005453-4057qib7	12708	21	respectively	respectively	RB
cord-005453-4057qib7	12708	22	.	.	.
cord-005453-4057qib7	12709	1	The	the	DT
cord-005453-4057qib7	12709	2	incidence	incidence	NN
cord-005453-4057qib7	12709	3	of	of	IN
cord-005453-4057qib7	12709	4	grade	grade	NN
cord-005453-4057qib7	12709	5	3	3	CD
cord-005453-4057qib7	12709	6	-	-	SYM
cord-005453-4057qib7	12709	7	4	4	CD
cord-005453-4057qib7	12709	8	mucositis	mucositis	NN
cord-005453-4057qib7	12709	9	in	in	IN
cord-005453-4057qib7	12709	10	M1	M1	NNP
cord-005453-4057qib7	12709	11	and	and	CC
cord-005453-4057qib7	12709	12	M2	M2	NNP
cord-005453-4057qib7	12709	13	was	be	VBD
cord-005453-4057qib7	12709	14	50.6	50.6	CD
cord-005453-4057qib7	12709	15	%	%	NN
cord-005453-4057qib7	12709	16	and	and	CC
cord-005453-4057qib7	12709	17	44.1	44.1	CD
cord-005453-4057qib7	12709	18	%	%	NN
cord-005453-4057qib7	12709	19	,	,	,
cord-005453-4057qib7	12709	20	respectively	respectively	RB
cord-005453-4057qib7	12709	21	.	.	.
cord-005453-4057qib7	12710	1	There	there	EX
cord-005453-4057qib7	12710	2	were	be	VBD
cord-005453-4057qib7	12710	3	no	no	DT
cord-005453-4057qib7	12710	4	statistically	statistically	RB
cord-005453-4057qib7	12710	5	significant	significant	JJ
cord-005453-4057qib7	12710	6	differences	difference	NNS
cord-005453-4057qib7	12710	7	in	in	IN
cord-005453-4057qib7	12710	8	terms	term	NNS
cord-005453-4057qib7	12710	9	of	of	IN
cord-005453-4057qib7	12710	10	using	use	VBG
cord-005453-4057qib7	12710	11	morphine	morphine	NN
cord-005453-4057qib7	12710	12	for	for	IN
cord-005453-4057qib7	12710	13	pain	pain	NN
cord-005453-4057qib7	12710	14	control	control	NN
cord-005453-4057qib7	12710	15	between	between	IN
cord-005453-4057qib7	12710	16	the	the	DT
cord-005453-4057qib7	12710	17	two	two	CD
cord-005453-4057qib7	12710	18	cohorts	cohort	NNS
cord-005453-4057qib7	12710	19	(	(	-LRB-
cord-005453-4057qib7	12710	20	M1	M1	NNP
cord-005453-4057qib7	12710	21	,	,	,
cord-005453-4057qib7	12710	22	63,4	63,4	CD
cord-005453-4057qib7	12710	23	%	%	NN
cord-005453-4057qib7	12710	24	vsM2	vsm2	NN
cord-005453-4057qib7	12710	25	,	,	,
cord-005453-4057qib7	12710	26	58,8	58,8	CD
cord-005453-4057qib7	12710	27	%	%	NN
cord-005453-4057qib7	12710	28	)	)	-RRB-
cord-005453-4057qib7	12710	29	.	.	.
cord-005453-4057qib7	12711	1	None	none	NN
cord-005453-4057qib7	12711	2	patient	patient	NN
cord-005453-4057qib7	12711	3	requiered	requiere	VBD
cord-005453-4057qib7	12711	4	total	total	JJ
cord-005453-4057qib7	12711	5	parenteral	parenteral	JJ
cord-005453-4057qib7	12711	6	nutrition	nutrition	NN
cord-005453-4057qib7	12711	7	(	(	-LRB-
cord-005453-4057qib7	12711	8	TPN	TPN	NNP
cord-005453-4057qib7	12711	9	)	)	-RRB-
cord-005453-4057qib7	12711	10	in	in	IN
cord-005453-4057qib7	12711	11	group	group	NN
cord-005453-4057qib7	12711	12	M2	M2	NNP
cord-005453-4057qib7	12711	13	and	and	CC
cord-005453-4057qib7	12711	14	only	only	RB
cord-005453-4057qib7	12711	15	one	one	CD
cord-005453-4057qib7	12711	16	in	in	IN
cord-005453-4057qib7	12711	17	group	group	NN
cord-005453-4057qib7	12711	18	M1	M1	NNP
cord-005453-4057qib7	12711	19	.	.	.
cord-005453-4057qib7	12712	1	The	the	DT
cord-005453-4057qib7	12712	2	incidence	incidence	NN
cord-005453-4057qib7	12712	3	of	of	IN
cord-005453-4057qib7	12712	4	ICU	ICU	NNP
cord-005453-4057qib7	12712	5	admission	admission	NN
cord-005453-4057qib7	12712	6	was	be	VBD
cord-005453-4057qib7	12712	7	1.5	1.5	CD
cord-005453-4057qib7	12712	8	times	time	NNS
cord-005453-4057qib7	12712	9	higher	high	JJR
cord-005453-4057qib7	12712	10	in	in	IN
cord-005453-4057qib7	12712	11	patients	patient	NNS
cord-005453-4057qib7	12712	12	aged	age	VBN
cord-005453-4057qib7	12712	13	≥65	≥65	NNP
cord-005453-4057qib7	12712	14	than	than	IN
cord-005453-4057qib7	12712	15	in	in	IN
cord-005453-4057qib7	12712	16	patients	patient	NNS
cord-005453-4057qib7	12712	17	<	<	XX
cord-005453-4057qib7	12712	18	65	65	CD
cord-005453-4057qib7	12712	19	years	year	NNS
cord-005453-4057qib7	12712	20	-	-	HYPH
cord-005453-4057qib7	12712	21	old	old	JJ
cord-005453-4057qib7	12712	22	6,1	6,1	CD
cord-005453-4057qib7	12712	23	%	%	NN
cord-005453-4057qib7	12712	24	vs3,9	vs3,9	NNP
cord-005453-4057qib7	12712	25	%	%	NN
cord-005453-4057qib7	12712	26	)	)	-RRB-
cord-005453-4057qib7	12712	27	,	,	,
cord-005453-4057qib7	12712	28	but	but	CC
cord-005453-4057qib7	12712	29	differences	difference	NNS
cord-005453-4057qib7	12712	30	were	be	VBD
cord-005453-4057qib7	12712	31	not	not	RB
cord-005453-4057qib7	12712	32	statistically	statistically	RB
cord-005453-4057qib7	12712	33	significant	significant	JJ
cord-005453-4057qib7	12712	34	(	(	-LRB-
cord-005453-4057qib7	12712	35	p	p	NN
cord-005453-4057qib7	12712	36	=	=	SYM
cord-005453-4057qib7	12712	37	0.52	0.52	CD
cord-005453-4057qib7	12712	38	)	)	-RRB-
cord-005453-4057qib7	12712	39	.	.	.
cord-005453-4057qib7	12713	1	There	there	EX
cord-005453-4057qib7	12713	2	were	be	VBD
cord-005453-4057qib7	12713	3	no	no	DT
cord-005453-4057qib7	12713	4	deaths	death	NNS
cord-005453-4057qib7	12713	5	during	during	IN
cord-005453-4057qib7	12713	6	the	the	DT
cord-005453-4057qib7	12713	7	transplant	transplant	NN
cord-005453-4057qib7	12713	8	procedure	procedure	NN
cord-005453-4057qib7	12713	9	in	in	IN
cord-005453-4057qib7	12713	10	any	any	DT
cord-005453-4057qib7	12713	11	of	of	IN
cord-005453-4057qib7	12713	12	the	the	DT
cord-005453-4057qib7	12713	13	2	2	CD
cord-005453-4057qib7	12713	14	cohorts	cohort	NNS
cord-005453-4057qib7	12713	15	Conclusions	conclusion	NNS
cord-005453-4057qib7	12713	16	:	:	:
cord-005453-4057qib7	12713	17	1	1	LS
cord-005453-4057qib7	12713	18	)	)	-RRB-
cord-005453-4057qib7	12714	1	In	in	IN
cord-005453-4057qib7	12714	2	our	-PRON-	PRP$
cord-005453-4057qib7	12714	3	series	series	NN
cord-005453-4057qib7	12714	4	,	,	,
cord-005453-4057qib7	12714	5	high	high	JJ
cord-005453-4057qib7	12714	6	-	-	HYPH
cord-005453-4057qib7	12714	7	dose	dose	NN
cord-005453-4057qib7	12714	8	therapy	therapy	NN
cord-005453-4057qib7	12714	9	followed	follow	VBN
cord-005453-4057qib7	12714	10	by	by	IN
cord-005453-4057qib7	12714	11	autologous	autologous	JJ
cord-005453-4057qib7	12714	12	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12714	13	cell	cell	NN
cord-005453-4057qib7	12714	14	transplantation	transplantation	NN
cord-005453-4057qib7	12714	15	in	in	IN
cord-005453-4057qib7	12714	16	MM	MM	NNP
cord-005453-4057qib7	12714	17	patients	patient	NNS
cord-005453-4057qib7	12714	18	aged	age	VBN
cord-005453-4057qib7	12714	19	≥65	≥65	PRP
cord-005453-4057qib7	12714	20	was	be	VBD
cord-005453-4057qib7	12714	21	feasible	feasible	JJ
cord-005453-4057qib7	12714	22	.	.	.
cord-005453-4057qib7	12715	1	2	2	LS
cord-005453-4057qib7	12715	2	)	)	-RRB-
cord-005453-4057qib7	12716	1	Transplant	transplant	NN
cord-005453-4057qib7	12716	2	procedure	procedure	NN
cord-005453-4057qib7	12716	3	in	in	IN
cord-005453-4057qib7	12716	4	older	old	JJR
cord-005453-4057qib7	12716	5	patients	patient	NNS
cord-005453-4057qib7	12716	6	was	be	VBD
cord-005453-4057qib7	12716	7	as	as	RB
cord-005453-4057qib7	12716	8	safe	safe	JJ
cord-005453-4057qib7	12716	9	as	as	IN
cord-005453-4057qib7	12716	10	in	in	IN
cord-005453-4057qib7	12716	11	patients	patient	NNS
cord-005453-4057qib7	12716	12	<	<	XX
cord-005453-4057qib7	12716	13	65	65	CD
cord-005453-4057qib7	12716	14	years	year	NNS
cord-005453-4057qib7	12716	15	-	-	HYPH
cord-005453-4057qib7	12716	16	old	old	JJ
cord-005453-4057qib7	12716	17	.	.	.
cord-005453-4057qib7	12717	1	3	3	LS
cord-005453-4057qib7	12717	2	)	)	-RRB-
cord-005453-4057qib7	12718	1	No	no	DT
cord-005453-4057qib7	12718	2	differences	difference	NNS
cord-005453-4057qib7	12718	3	were	be	VBD
cord-005453-4057qib7	12718	4	found	find	VBN
cord-005453-4057qib7	12718	5	in	in	IN
cord-005453-4057qib7	12718	6	terms	term	NNS
cord-005453-4057qib7	12718	7	of	of	IN
cord-005453-4057qib7	12718	8	graft	graft	NN
cord-005453-4057qib7	12718	9	,	,	,
cord-005453-4057qib7	12718	10	transfusion	transfusion	NN
cord-005453-4057qib7	12718	11	support	support	NN
cord-005453-4057qib7	12718	12	,	,	,
cord-005453-4057qib7	12718	13	transplant	transplant	NN
cord-005453-4057qib7	12718	14	related	relate	VBN
cord-005453-4057qib7	12718	15	complications	complication	NNS
cord-005453-4057qib7	12718	16	and	and	CC
cord-005453-4057qib7	12718	17	length	length	NN
cord-005453-4057qib7	12718	18	of	of	IN
cord-005453-4057qib7	12718	19	admission	admission	NN
cord-005453-4057qib7	12718	20	.	.	.
cord-005453-4057qib7	12719	1	4	4	LS
cord-005453-4057qib7	12719	2	)	)	-RRB-
cord-005453-4057qib7	12720	1	Age	age	NN
cord-005453-4057qib7	12720	2	should	should	MD
cord-005453-4057qib7	12720	3	not	not	RB
cord-005453-4057qib7	12720	4	be	be	VB
cord-005453-4057qib7	12720	5	a	a	DT
cord-005453-4057qib7	12720	6	limiting	limit	VBG
cord-005453-4057qib7	12720	7	factor	factor	NN
cord-005453-4057qib7	12720	8	in	in	IN
cord-005453-4057qib7	12720	9	considering	consider	VBG
cord-005453-4057qib7	12720	10	the	the	DT
cord-005453-4057qib7	12720	11	modality	modality	NN
cord-005453-4057qib7	12720	12	of	of	IN
cord-005453-4057qib7	12720	13	ASCT	ASCT	NNP
cord-005453-4057qib7	12720	14	in	in	IN
cord-005453-4057qib7	12720	15	this	this	DT
cord-005453-4057qib7	12720	16	patient	patient	JJ
cord-005453-4057qib7	12720	17	population	population	NN
cord-005453-4057qib7	12720	18	Disclosure	disclosure	NN
cord-005453-4057qib7	12720	19	:	:	:
cord-005453-4057qib7	12720	20	Nothing	nothing	NN
cord-005453-4057qib7	12720	21	to	to	TO
cord-005453-4057qib7	12720	22	declare	declare	VB
cord-005453-4057qib7	12720	23	The	the	DT
cord-005453-4057qib7	12720	24	correlation	correlation	NN
cord-005453-4057qib7	12720	25	between	between	IN
cord-005453-4057qib7	12720	26	the	the	DT
cord-005453-4057qib7	12720	27	kinetics	kinetic	NNS
cord-005453-4057qib7	12720	28	of	of	IN
cord-005453-4057qib7	12720	29	peripheral	peripheral	JJ
cord-005453-4057qib7	12720	30	blood	blood	NN
cord-005453-4057qib7	12720	31	counts	count	NNS
cord-005453-4057qib7	12720	32	and	and	CC
cord-005453-4057qib7	12720	33	the	the	DT
cord-005453-4057qib7	12720	34	response	response	NN
cord-005453-4057qib7	12720	35	to	to	IN
cord-005453-4057qib7	12720	36	treatment	treatment	NN
cord-005453-4057qib7	12720	37	after	after	IN
cord-005453-4057qib7	12720	38	high	high	JJ
cord-005453-4057qib7	12720	39	-	-	HYPH
cord-005453-4057qib7	12720	40	dose	dose	NN
cord-005453-4057qib7	12720	41	melphalan	melphalan	NN
cord-005453-4057qib7	12720	42	with	with	IN
cord-005453-4057qib7	12720	43	stem	stem	NN
cord-005453-4057qib7	12720	44	cell	cell	NN
cord-005453-4057qib7	12720	45	support	support	NN
cord-005453-4057qib7	12720	46	in	in	IN
cord-005453-4057qib7	12720	47	multiple	multiple	JJ
cord-005453-4057qib7	12720	48	myeloma	myeloma	NN
cord-005453-4057qib7	12720	49	patients	patient	NNS
cord-005453-4057qib7	12721	1	Background	background	NN
cord-005453-4057qib7	12721	2	:	:	:
cord-005453-4057qib7	12722	1	The	the	DT
cord-005453-4057qib7	12722	2	long	long	JJ
cord-005453-4057qib7	12722	3	-	-	HYPH
cord-005453-4057qib7	12722	4	term	term	NN
cord-005453-4057qib7	12722	5	survival	survival	NN
cord-005453-4057qib7	12722	6	of	of	IN
cord-005453-4057qib7	12722	7	MM	MM	NNP
cord-005453-4057qib7	12722	8	patients	patient	NNS
cord-005453-4057qib7	12722	9	has	have	VBZ
cord-005453-4057qib7	12722	10	dramatically	dramatically	RB
cord-005453-4057qib7	12722	11	increased	increase	VBN
cord-005453-4057qib7	12722	12	in	in	IN
cord-005453-4057qib7	12722	13	the	the	DT
cord-005453-4057qib7	12722	14	last	last	JJ
cord-005453-4057qib7	12722	15	20	20	CD
cord-005453-4057qib7	12722	16	years	year	NNS
cord-005453-4057qib7	12722	17	,	,	,
cord-005453-4057qib7	12722	18	particularly	particularly	RB
cord-005453-4057qib7	12722	19	for	for	IN
cord-005453-4057qib7	12722	20	younger	young	JJR
cord-005453-4057qib7	12722	21	patients	patient	NNS
cord-005453-4057qib7	12722	22	.	.	.
cord-005453-4057qib7	12723	1	This	this	DT
cord-005453-4057qib7	12723	2	is	be	VBZ
cord-005453-4057qib7	12723	3	attributable	attributable	JJ
cord-005453-4057qib7	12723	4	in	in	IN
cord-005453-4057qib7	12723	5	part	part	NN
cord-005453-4057qib7	12723	6	to	to	IN
cord-005453-4057qib7	12723	7	the	the	DT
cord-005453-4057qib7	12723	8	introduction	introduction	NN
cord-005453-4057qib7	12723	9	and	and	CC
cord-005453-4057qib7	12723	10	development	development	NN
cord-005453-4057qib7	12723	11	of	of	IN
cord-005453-4057qib7	12723	12	high	high	JJ
cord-005453-4057qib7	12723	13	dose	dose	NN
cord-005453-4057qib7	12723	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12723	15	with	with	IN
cord-005453-4057qib7	12723	16	melphalan	melphalan	NNP
cord-005453-4057qib7	12723	17	with	with	IN
cord-005453-4057qib7	12723	18	stem	stem	NN
cord-005453-4057qib7	12723	19	cell	cell	NN
cord-005453-4057qib7	12723	20	support	support	NN
cord-005453-4057qib7	12723	21	(	(	-LRB-
cord-005453-4057qib7	12723	22	HDM	HDM	NNP
cord-005453-4057qib7	12723	23	-	-	HYPH
cord-005453-4057qib7	12723	24	ASCT	ASCT	NNP
cord-005453-4057qib7	12723	25	)	)	-RRB-
cord-005453-4057qib7	12723	26	.	.	.
cord-005453-4057qib7	12724	1	Currently	currently	RB
cord-005453-4057qib7	12724	2	,	,	,
cord-005453-4057qib7	12724	3	frontline	frontline	JJ
cord-005453-4057qib7	12724	4	ASCT	ASCT	NNP
cord-005453-4057qib7	12724	5	is	be	VBZ
cord-005453-4057qib7	12724	6	still	still	RB
cord-005453-4057qib7	12724	7	considered	consider	VBN
cord-005453-4057qib7	12724	8	the	the	DT
cord-005453-4057qib7	12724	9	standard	standard	NN
cord-005453-4057qib7	12724	10	of	of	IN
cord-005453-4057qib7	12724	11	care	care	NN
cord-005453-4057qib7	12724	12	for	for	IN
cord-005453-4057qib7	12724	13	all	all	DT
cord-005453-4057qib7	12724	14	eligible	eligible	JJ
cord-005453-4057qib7	12724	15	patients	patient	NNS
cord-005453-4057qib7	12724	16	.	.	.
cord-005453-4057qib7	12725	1	Many	many	JJ
cord-005453-4057qib7	12725	2	prognostic	prognostic	JJ
cord-005453-4057qib7	12725	3	factors	factor	NNS
cord-005453-4057qib7	12725	4	pre	pre	VBP
cord-005453-4057qib7	12725	5	and	and	CC
cord-005453-4057qib7	12725	6	post	post	JJ
cord-005453-4057qib7	12725	7	transplantation	transplantation	NN
cord-005453-4057qib7	12725	8	have	have	VBP
cord-005453-4057qib7	12725	9	been	be	VBN
cord-005453-4057qib7	12725	10	identified	identify	VBN
cord-005453-4057qib7	12725	11	,	,	,
cord-005453-4057qib7	12725	12	e.g.	e.g.	RB
cord-005453-4057qib7	12725	13	:	:	:
cord-005453-4057qib7	12725	14	age	age	NN
cord-005453-4057qib7	12725	15	,	,	,
cord-005453-4057qib7	12725	16	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	12725	17	,	,	,
cord-005453-4057qib7	12725	18	cytogenitcs	cytogenitc	NNS
cord-005453-4057qib7	12725	19	,	,	,
cord-005453-4057qib7	12725	20	response	response	NN
cord-005453-4057qib7	12725	21	to	to	IN
cord-005453-4057qib7	12725	22	treatment	treatment	NN
cord-005453-4057qib7	12725	23	and	and	CC
cord-005453-4057qib7	12725	24	disease	disease	NN
cord-005453-4057qib7	12725	25	status	status	NN
cord-005453-4057qib7	12725	26	prior	prior	RB
cord-005453-4057qib7	12725	27	to	to	IN
cord-005453-4057qib7	12725	28	and	and	CC
cord-005453-4057qib7	12725	29	post	post	VB
cord-005453-4057qib7	12725	30	transplantation	transplantation	NN
cord-005453-4057qib7	12725	31	.	.	.
cord-005453-4057qib7	12726	1	To	to	IN
cord-005453-4057qib7	12726	2	our	-PRON-	PRP$
cord-005453-4057qib7	12726	3	knowledge	knowledge	NN
cord-005453-4057qib7	12726	4	there	there	EX
cord-005453-4057qib7	12726	5	is	be	VBZ
cord-005453-4057qib7	12726	6	no	no	DT
cord-005453-4057qib7	12726	7	data	data	NN
cord-005453-4057qib7	12726	8	correlating	correlate	VBG
cord-005453-4057qib7	12726	9	between	between	IN
cord-005453-4057qib7	12726	10	kinetics	kinetic	NNS
cord-005453-4057qib7	12726	11	of	of	IN
cord-005453-4057qib7	12726	12	counts	count	NNS
cord-005453-4057qib7	12726	13	response	response	NN
cord-005453-4057qib7	12726	14	to	to	IN
cord-005453-4057qib7	12726	15	melphalan	melphalan	NNP
cord-005453-4057qib7	12726	16	and	and	CC
cord-005453-4057qib7	12726	17	prognosis	prognosis	NN
cord-005453-4057qib7	12726	18	.	.	.
cord-005453-4057qib7	12727	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12727	2	aim	aim	NN
cord-005453-4057qib7	12727	3	was	be	VBD
cord-005453-4057qib7	12727	4	to	to	TO
cord-005453-4057qib7	12727	5	assess	assess	VB
cord-005453-4057qib7	12727	6	the	the	DT
cord-005453-4057qib7	12727	7	prognostic	prognostic	JJ
cord-005453-4057qib7	12727	8	significance	significance	NN
cord-005453-4057qib7	12727	9	of	of	IN
cord-005453-4057qib7	12727	10	the	the	DT
cord-005453-4057qib7	12727	11	neutrophil	neutrophil	NN
cord-005453-4057qib7	12727	12	and	and	CC
cord-005453-4057qib7	12727	13	platelets	platelet	NNS
cord-005453-4057qib7	12727	14	decaying	decay	VBG
cord-005453-4057qib7	12727	15	counts	count	NNS
cord-005453-4057qib7	12727	16	after	after	IN
cord-005453-4057qib7	12727	17	high	high	JJ
cord-005453-4057qib7	12727	18	dose	dose	NN
cord-005453-4057qib7	12727	19	melphalan	melphalan	NN
cord-005453-4057qib7	12727	20	.	.	.
cord-005453-4057qib7	12728	1	Methods	method	NNS
cord-005453-4057qib7	12728	2	-we	-we	:
cord-005453-4057qib7	12728	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	12728	4	analyzed	analyze	VBD
cord-005453-4057qib7	12728	5	our	-PRON-	PRP$
cord-005453-4057qib7	12728	6	cohort	cohort	NN
cord-005453-4057qib7	12728	7	of	of	IN
cord-005453-4057qib7	12728	8	159	159	CD
cord-005453-4057qib7	12728	9	multiple	multiple	JJ
cord-005453-4057qib7	12728	10	myeloma	myeloma	NN
cord-005453-4057qib7	12728	11	patients	patient	NNS
cord-005453-4057qib7	12728	12	who	who	WP
cord-005453-4057qib7	12728	13	underwent	undergo	VBD
cord-005453-4057qib7	12728	14	HDM	HDM	NNP
cord-005453-4057qib7	12728	15	-	-	HYPH
cord-005453-4057qib7	12728	16	ASCT	ASCT	NNP
cord-005453-4057qib7	12728	17	at	at	IN
cord-005453-4057qib7	12728	18	the	the	DT
cord-005453-4057qib7	12728	19	Hadassah	Hadassah	NNP
cord-005453-4057qib7	12728	20	medical	medical	JJ
cord-005453-4057qib7	12728	21	center	center	NN
cord-005453-4057qib7	12728	22	bone	bone	NN
cord-005453-4057qib7	12728	23	marrow	marrow	NN
cord-005453-4057qib7	12728	24	transplant	transplant	NN
cord-005453-4057qib7	12728	25	department	department	NN
cord-005453-4057qib7	12728	26	,	,	,
cord-005453-4057qib7	12728	27	between	between	IN
cord-005453-4057qib7	12728	28	the	the	DT
cord-005453-4057qib7	12728	29	years	year	NNS
cord-005453-4057qib7	12728	30	2007	2007	CD
cord-005453-4057qib7	12728	31	-	-	SYM
cord-005453-4057qib7	12728	32	2015	2015	CD
cord-005453-4057qib7	12728	33	.	.	.
cord-005453-4057qib7	12729	1	The	the	DT
cord-005453-4057qib7	12729	2	kinetics	kinetic	NNS
cord-005453-4057qib7	12729	3	of	of	IN
cord-005453-4057qib7	12729	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	12729	5	and	and	CC
cord-005453-4057qib7	12729	6	platelet	platelet	NN
cord-005453-4057qib7	12729	7	decay	decay	NN
cord-005453-4057qib7	12729	8	during	during	IN
cord-005453-4057qib7	12729	9	the	the	DT
cord-005453-4057qib7	12729	10	first	first	JJ
cord-005453-4057qib7	12729	11	two	two	CD
cord-005453-4057qib7	12729	12	weeks	week	NNS
cord-005453-4057qib7	12729	13	after	after	IN
cord-005453-4057qib7	12729	14	melphalan	melphalan	NNP
cord-005453-4057qib7	12729	15	administration	administration	NNP
cord-005453-4057qib7	12729	16	was	be	VBD
cord-005453-4057qib7	12729	17	fitted	fit	VBN
cord-005453-4057qib7	12729	18	using	use	VBG
cord-005453-4057qib7	12729	19	linear	linear	JJ
cord-005453-4057qib7	12729	20	and	and	CC
cord-005453-4057qib7	12729	21	exponential	exponential	JJ
cord-005453-4057qib7	12729	22	mathematical	mathematical	JJ
cord-005453-4057qib7	12729	23	models	model	NNS
cord-005453-4057qib7	12729	24	.	.	.
cord-005453-4057qib7	12730	1	Methods	method	NNS
cord-005453-4057qib7	12730	2	:	:	:
cord-005453-4057qib7	12730	3	we	-PRON-	PRP
cord-005453-4057qib7	12730	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	12730	5	analyzed	analyze	VBD
cord-005453-4057qib7	12730	6	our	-PRON-	PRP$
cord-005453-4057qib7	12730	7	cohort	cohort	NN
cord-005453-4057qib7	12730	8	of	of	IN
cord-005453-4057qib7	12730	9	159	159	CD
cord-005453-4057qib7	12730	10	multiple	multiple	JJ
cord-005453-4057qib7	12730	11	myeloma	myeloma	NN
cord-005453-4057qib7	12730	12	patients	patient	NNS
cord-005453-4057qib7	12730	13	who	who	WP
cord-005453-4057qib7	12730	14	underwent	undergo	VBD
cord-005453-4057qib7	12730	15	HDM	HDM	NNP
cord-005453-4057qib7	12730	16	-	-	HYPH
cord-005453-4057qib7	12730	17	ASCT	ASCT	NNP
cord-005453-4057qib7	12730	18	at	at	IN
cord-005453-4057qib7	12730	19	the	the	DT
cord-005453-4057qib7	12730	20	Hadassah	Hadassah	NNP
cord-005453-4057qib7	12730	21	medical	medical	JJ
cord-005453-4057qib7	12730	22	center	center	NN
cord-005453-4057qib7	12730	23	bone	bone	NN
cord-005453-4057qib7	12730	24	marrow	marrow	NN
cord-005453-4057qib7	12730	25	transplant	transplant	NN
cord-005453-4057qib7	12730	26	department	department	NN
cord-005453-4057qib7	12730	27	,	,	,
cord-005453-4057qib7	12730	28	between	between	IN
cord-005453-4057qib7	12730	29	the	the	DT
cord-005453-4057qib7	12730	30	years	year	NNS
cord-005453-4057qib7	12730	31	2007	2007	CD
cord-005453-4057qib7	12730	32	-	-	SYM
cord-005453-4057qib7	12730	33	2015	2015	CD
cord-005453-4057qib7	12730	34	.	.	.
cord-005453-4057qib7	12731	1	The	the	DT
cord-005453-4057qib7	12731	2	kinetics	kinetic	NNS
cord-005453-4057qib7	12731	3	of	of	IN
cord-005453-4057qib7	12731	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	12731	5	and	and	CC
cord-005453-4057qib7	12731	6	platelet	platelet	NN
cord-005453-4057qib7	12731	7	decay	decay	NN
cord-005453-4057qib7	12731	8	during	during	IN
cord-005453-4057qib7	12731	9	the	the	DT
cord-005453-4057qib7	12731	10	first	first	JJ
cord-005453-4057qib7	12731	11	two	two	CD
cord-005453-4057qib7	12731	12	weeks	week	NNS
cord-005453-4057qib7	12731	13	after	after	IN
cord-005453-4057qib7	12731	14	melphalan	melphalan	NNP
cord-005453-4057qib7	12731	15	administration	administration	NNP
cord-005453-4057qib7	12731	16	was	be	VBD
cord-005453-4057qib7	12731	17	fitted	fit	VBN
cord-005453-4057qib7	12731	18	using	use	VBG
cord-005453-4057qib7	12731	19	linear	linear	JJ
cord-005453-4057qib7	12731	20	and	and	CC
cord-005453-4057qib7	12731	21	exponential	exponential	JJ
cord-005453-4057qib7	12731	22	mathematical	mathematical	JJ
cord-005453-4057qib7	12731	23	models	model	NNS
cord-005453-4057qib7	12731	24	.	.	.
cord-005453-4057qib7	12732	1	Results	result	NNS
cord-005453-4057qib7	12732	2	:	:	:
cord-005453-4057qib7	12733	1	Factors	factor	NNS
cord-005453-4057qib7	12733	2	associated	associate	VBN
cord-005453-4057qib7	12733	3	with	with	IN
cord-005453-4057qib7	12733	4	prolonged	prolonged	JJ
cord-005453-4057qib7	12733	5	OS	os	NN
cord-005453-4057qib7	12733	6	in	in	IN
cord-005453-4057qib7	12733	7	univariate	univariate	JJ
cord-005453-4057qib7	12733	8	analysis	analysis	NN
cord-005453-4057qib7	12733	9	were	be	VBD
cord-005453-4057qib7	12733	10	:	:	:
cord-005453-4057qib7	12734	1	ISS	ISS	NNP
cord-005453-4057qib7	12734	2	stage	stage	NN
cord-005453-4057qib7	12734	3	1(p=0.024	1(p=0.024	NNP
cord-005453-4057qib7	12734	4	)	)	-RRB-
cord-005453-4057qib7	12734	5	,	,	,
cord-005453-4057qib7	12734	6	≤2	≤2	NNP
cord-005453-4057qib7	12734	7	lines	line	NNS
cord-005453-4057qib7	12734	8	of	of	IN
cord-005453-4057qib7	12734	9	treatment	treatment	NN
cord-005453-4057qib7	12734	10	prior	prior	RB
cord-005453-4057qib7	12734	11	to	to	IN
cord-005453-4057qib7	12734	12	ASCT(p	ASCT(p	NNP
cord-005453-4057qib7	12734	13	<	<	XX
cord-005453-4057qib7	12734	14	0.001	0.001	CD
cord-005453-4057qib7	12734	15	)	)	-RRB-
cord-005453-4057qib7	12734	16	,	,	,
cord-005453-4057qib7	12734	17	favorable	favorable	JJ
cord-005453-4057qib7	12734	18	cytogenetics(p=0.004	cytogenetics(p=0.004	NNP
cord-005453-4057qib7	12734	19	)	)	-RRB-
cord-005453-4057qib7	12734	20	,	,	,
cord-005453-4057qib7	12734	21	response	response	NN
cord-005453-4057qib7	12734	22	to	to	IN
cord-005453-4057qib7	12734	23	treatment	treatment	NN
cord-005453-4057qib7	12734	24	(	(	-LRB-
cord-005453-4057qib7	12734	25	PR	pr	NN
cord-005453-4057qib7	12734	26	or	or	CC
cord-005453-4057qib7	12734	27	better	well	JJR
cord-005453-4057qib7	12734	28	,	,	,
cord-005453-4057qib7	12734	29	p=0.046	p=0.046	NNS
cord-005453-4057qib7	12734	30	)	)	-RRB-
cord-005453-4057qib7	12734	31	and	and	CC
cord-005453-4057qib7	12734	32	rapid	rapid	JJ
cord-005453-4057qib7	12734	33	linear	linear	JJ
cord-005453-4057qib7	12734	34	neutrophil	neutrophil	NN
cord-005453-4057qib7	12734	35	decay	decay	NN
cord-005453-4057qib7	12734	36	(	(	-LRB-
cord-005453-4057qib7	12734	37	p	p	NN
cord-005453-4057qib7	12734	38	=	=	SYM
cord-005453-4057qib7	12734	39	0.046	0.046	CD
cord-005453-4057qib7	12734	40	)	)	-RRB-
cord-005453-4057qib7	12734	41	.	.	.
cord-005453-4057qib7	12735	1	In	in	IN
cord-005453-4057qib7	12735	2	multivariate	multivariate	JJ
cord-005453-4057qib7	12735	3	analysis	analysis	NN
cord-005453-4057qib7	12735	4	,	,	,
cord-005453-4057qib7	12735	5	only	only	RB
cord-005453-4057qib7	12735	6	≤2	≤2	NNP
cord-005453-4057qib7	12735	7	lines	line	NNS
cord-005453-4057qib7	12735	8	of	of	IN
cord-005453-4057qib7	12735	9	treatment	treatment	NN
cord-005453-4057qib7	12735	10	before	before	IN
cord-005453-4057qib7	12735	11	HDM	HDM	NNP
cord-005453-4057qib7	12735	12	-	-	HYPH
cord-005453-4057qib7	12735	13	ASCT	ASCT	NNP
cord-005453-4057qib7	12735	14	and	and	CC
cord-005453-4057qib7	12735	15	rapid	rapid	JJ
cord-005453-4057qib7	12735	16	linear	linear	JJ
cord-005453-4057qib7	12735	17	neutrophils	neutrophil	NNS
cord-005453-4057qib7	12735	18	count	count	VBP
cord-005453-4057qib7	12735	19	decay	decay	NN
cord-005453-4057qib7	12735	20	remained	remain	VBD
cord-005453-4057qib7	12735	21	statistically	statistically	RB
cord-005453-4057qib7	12735	22	significant	significant	JJ
cord-005453-4057qib7	12735	23	for	for	IN
cord-005453-4057qib7	12735	24	OS	os	NN
cord-005453-4057qib7	12735	25	prolongation	prolongation	NN
cord-005453-4057qib7	12735	26	.	.	.
cord-005453-4057qib7	12736	1	No	no	DT
cord-005453-4057qib7	12736	2	predictive	predictive	JJ
cord-005453-4057qib7	12736	3	threshold	threshold	NN
cord-005453-4057qib7	12736	4	value	value	NN
cord-005453-4057qib7	12736	5	of	of	IN
cord-005453-4057qib7	12736	6	the	the	DT
cord-005453-4057qib7	12736	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	12736	8	decay	decay	NN
cord-005453-4057qib7	12736	9	incline	incline	NN
cord-005453-4057qib7	12736	10	was	be	VBD
cord-005453-4057qib7	12736	11	found	find	VBN
cord-005453-4057qib7	12736	12	.	.	.
cord-005453-4057qib7	12737	1	Improved	Improved	NNP
cord-005453-4057qib7	12737	2	PFS	PFS	NNP
cord-005453-4057qib7	12737	3	was	be	VBD
cord-005453-4057qib7	12737	4	associated	associate	VBN
cord-005453-4057qib7	12737	5	with	with	IN
cord-005453-4057qib7	12737	6	≤2	≤2	NNP
cord-005453-4057qib7	12737	7	lines	line	NNS
cord-005453-4057qib7	12737	8	of	of	IN
cord-005453-4057qib7	12737	9	treatment	treatment	NN
cord-005453-4057qib7	12737	10	prior	prior	RB
cord-005453-4057qib7	12737	11	to	to	IN
cord-005453-4057qib7	12737	12	ASCT	ASCT	NNP
cord-005453-4057qib7	12737	13	,	,	,
cord-005453-4057qib7	12737	14	and	and	CC
cord-005453-4057qib7	12737	15	the	the	DT
cord-005453-4057qib7	12737	16	response	response	NN
cord-005453-4057qib7	12737	17	status	status	NN
cord-005453-4057qib7	12737	18	after	after	IN
cord-005453-4057qib7	12737	19	HDM	HDM	NNP
cord-005453-4057qib7	12737	20	-	-	HYPH
cord-005453-4057qib7	12737	21	ASCT	ASCT	NNP
cord-005453-4057qib7	12737	22	(	(	-LRB-
cord-005453-4057qib7	12737	23	p=0.003	p=0.003	NNP
cord-005453-4057qib7	12737	24	,	,	,
cord-005453-4057qib7	12737	25	p=0.019	p=0.019	NNP
cord-005453-4057qib7	12737	26	)	)	-RRB-
cord-005453-4057qib7	12737	27	.	.	.
cord-005453-4057qib7	12738	1	Additionally	additionally	RB
cord-005453-4057qib7	12738	2	,	,	,
cord-005453-4057qib7	12738	3	toxicity	toxicity	NN
cord-005453-4057qib7	12738	4	evaluation	evaluation	NN
cord-005453-4057qib7	12738	5	showed	show	VBD
cord-005453-4057qib7	12738	6	prolonged	prolonged	JJ
cord-005453-4057qib7	12738	7	neutropenia	neutropenia	NN
cord-005453-4057qib7	12738	8	to	to	TO
cord-005453-4057qib7	12738	9	be	be	VB
cord-005453-4057qib7	12738	10	associated	associate	VBN
cord-005453-4057qib7	12738	11	with	with	IN
cord-005453-4057qib7	12738	12	inferior	inferior	JJ
cord-005453-4057qib7	12738	13	OS	os	NN
cord-005453-4057qib7	12738	14	(	(	-LRB-
cord-005453-4057qib7	12738	15	HR	hr	NN
cord-005453-4057qib7	12738	16	=	=	SYM
cord-005453-4057qib7	12738	17	1.139	1.139	CD
cord-005453-4057qib7	12738	18	,	,	,
cord-005453-4057qib7	12738	19	p=0.03	p=0.03	NN
cord-005453-4057qib7	12738	20	)	)	-RRB-
cord-005453-4057qib7	12738	21	and	and	CC
cord-005453-4057qib7	12738	22	rapid	rapid	JJ
cord-005453-4057qib7	12738	23	exponential	exponential	JJ
cord-005453-4057qib7	12738	24	decay	decay	NN
cord-005453-4057qib7	12738	25	of	of	IN
cord-005453-4057qib7	12738	26	neutrophil	neutrophil	NN
cord-005453-4057qib7	12738	27	counts	count	NNS
cord-005453-4057qib7	12738	28	to	to	TO
cord-005453-4057qib7	12738	29	correlate	correlate	VB
cord-005453-4057qib7	12738	30	with	with	IN
cord-005453-4057qib7	12738	31	higher	high	JJR
cord-005453-4057qib7	12738	32	incidence	incidence	NN
cord-005453-4057qib7	12738	33	of	of	IN
cord-005453-4057qib7	12738	34	mucositis	mucositis	NNP
cord-005453-4057qib7	12738	35	(	(	-LRB-
cord-005453-4057qib7	12738	36	p	p	NN
cord-005453-4057qib7	12738	37	=	=	SYM
cord-005453-4057qib7	12738	38	0.013	0.013	CD
cord-005453-4057qib7	12738	39	)	)	-RRB-
cord-005453-4057qib7	12738	40	.	.	.
cord-005453-4057qib7	12739	1	Fast	fast	JJ
cord-005453-4057qib7	12739	2	platelet	platelet	NN
cord-005453-4057qib7	12739	3	decay	decay	NN
cord-005453-4057qib7	12739	4	was	be	VBD
cord-005453-4057qib7	12739	5	associated	associate	VBN
cord-005453-4057qib7	12739	6	with	with	IN
cord-005453-4057qib7	12739	7	delayed	delayed	JJ
cord-005453-4057qib7	12739	8	platelet	platelet	NN
cord-005453-4057qib7	12739	9	engraftment	engraftment	NN
cord-005453-4057qib7	12739	10	(	(	-LRB-
cord-005453-4057qib7	12739	11	p	p	NN
cord-005453-4057qib7	12739	12	<	<	XX
cord-005453-4057qib7	12739	13	0.01	0.01	CD
cord-005453-4057qib7	12739	14	)	)	-RRB-
cord-005453-4057qib7	12740	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12740	2	:	:	:
cord-005453-4057qib7	12740	3	We	-PRON-	PRP
cord-005453-4057qib7	12740	4	have	have	VBP
cord-005453-4057qib7	12740	5	shown	show	VBN
cord-005453-4057qib7	12740	6	that	that	IN
cord-005453-4057qib7	12740	7	rapid	rapid	JJ
cord-005453-4057qib7	12740	8	linear	linear	JJ
cord-005453-4057qib7	12740	9	decay	decay	NN
cord-005453-4057qib7	12740	10	in	in	IN
cord-005453-4057qib7	12740	11	neutrophil	neutrophil	NN
cord-005453-4057qib7	12740	12	counts	count	NNS
cord-005453-4057qib7	12740	13	predicts	predict	VBZ
cord-005453-4057qib7	12740	14	better	well	JJR
cord-005453-4057qib7	12740	15	OS	os	NN
cord-005453-4057qib7	12740	16	without	without	IN
cord-005453-4057qib7	12740	17	a	a	DT
cord-005453-4057qib7	12740	18	significant	significant	JJ
cord-005453-4057qib7	12740	19	benefit	benefit	NN
cord-005453-4057qib7	12740	20	in	in	IN
cord-005453-4057qib7	12740	21	PFS	PFS	NNP
cord-005453-4057qib7	12740	22	in	in	IN
cord-005453-4057qib7	12740	23	MM	MM	NNP
cord-005453-4057qib7	12740	24	patients	patient	NNS
cord-005453-4057qib7	12740	25	undergoing	undergo	VBG
cord-005453-4057qib7	12740	26	HDM	HDM	NNP
cord-005453-4057qib7	12740	27	-	-	HYPH
cord-005453-4057qib7	12740	28	ASCT	ASCT	NNP
cord-005453-4057qib7	12740	29	.	.	.
cord-005453-4057qib7	12741	1	This	this	DT
cord-005453-4057qib7	12741	2	discrepancy	discrepancy	NN
cord-005453-4057qib7	12741	3	might	may	MD
cord-005453-4057qib7	12741	4	reflect	reflect	VB
cord-005453-4057qib7	12741	5	the	the	DT
cord-005453-4057qib7	12741	6	problematic	problematic	JJ
cord-005453-4057qib7	12741	7	estimation	estimation	NN
cord-005453-4057qib7	12741	8	in	in	IN
cord-005453-4057qib7	12741	9	a	a	DT
cord-005453-4057qib7	12741	10	retrospective	retrospective	JJ
cord-005453-4057qib7	12741	11	analysis	analysis	NN
cord-005453-4057qib7	12741	12	of	of	IN
cord-005453-4057qib7	12741	13	PFS	PFS	NNP
cord-005453-4057qib7	12741	14	.	.	.
cord-005453-4057qib7	12742	1	Rapid	rapid	JJ
cord-005453-4057qib7	12742	2	decrease	decrease	NN
cord-005453-4057qib7	12742	3	in	in	IN
cord-005453-4057qib7	12742	4	neutrophils	neutrophil	NNS
cord-005453-4057qib7	12742	5	and	and	CC
cord-005453-4057qib7	12742	6	platelet	platelet	NN
cord-005453-4057qib7	12742	7	counts	count	NNS
cord-005453-4057qib7	12742	8	was	be	VBD
cord-005453-4057qib7	12742	9	associated	associate	VBN
cord-005453-4057qib7	12742	10	with	with	IN
cord-005453-4057qib7	12742	11	more	more	JJR
cord-005453-4057qib7	12742	12	toxicity	toxicity	NN
cord-005453-4057qib7	12742	13	:	:	:
cord-005453-4057qib7	12742	14	higher	high	JJR
cord-005453-4057qib7	12742	15	mucositis	mucositis	JJ
cord-005453-4057qib7	12742	16	rate	rate	NN
cord-005453-4057qib7	12742	17	and	and	CC
cord-005453-4057qib7	12742	18	delayed	delay	VBN
cord-005453-4057qib7	12742	19	engraftment	engraftment	NN
cord-005453-4057qib7	12742	20	,	,	,
cord-005453-4057qib7	12742	21	respectively	respectively	RB
cord-005453-4057qib7	12742	22	.	.	.
cord-005453-4057qib7	12743	1	Therefore	therefore	RB
cord-005453-4057qib7	12743	2	a	a	DT
cord-005453-4057qib7	12743	3	rapid	rapid	JJ
cord-005453-4057qib7	12743	4	decay	decay	NN
cord-005453-4057qib7	12743	5	of	of	IN
cord-005453-4057qib7	12743	6	blood	blood	NN
cord-005453-4057qib7	12743	7	counts	count	NNS
cord-005453-4057qib7	12743	8	after	after	IN
cord-005453-4057qib7	12743	9	HDM	HDM	NNP
cord-005453-4057qib7	12743	10	-	-	HYPH
cord-005453-4057qib7	12743	11	ASCT	ASCT	NNP
cord-005453-4057qib7	12743	12	appears	appear	VBZ
cord-005453-4057qib7	12743	13	to	to	TO
cord-005453-4057qib7	12743	14	be	be	VB
cord-005453-4057qib7	12743	15	an	an	DT
cord-005453-4057qib7	12743	16	in	in	IN
cord-005453-4057qib7	12743	17	-	-	HYPH
cord-005453-4057qib7	12743	18	vivo	vivo	NN
cord-005453-4057qib7	12743	19	phamacodynamic	phamacodynamic	JJ
cord-005453-4057qib7	12743	20	marker	marker	NN
cord-005453-4057qib7	12743	21	of	of	IN
cord-005453-4057qib7	12743	22	higher	high	JJR
cord-005453-4057qib7	12743	23	efficacy	efficacy	NN
cord-005453-4057qib7	12743	24	and	and	CC
cord-005453-4057qib7	12743	25	toxicity	toxicity	NN
cord-005453-4057qib7	12743	26	of	of	IN
cord-005453-4057qib7	12743	27	melphalan	melphalan	NNP
cord-005453-4057qib7	12743	28	.	.	.
cord-005453-4057qib7	12744	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12744	2	:	:	:
cord-005453-4057qib7	12744	3	Nothing	nothing	NN
cord-005453-4057qib7	12744	4	to	to	TO
cord-005453-4057qib7	12744	5	declare	declare	VB
cord-005453-4057qib7	12744	6	P564	p564	NN
cord-005453-4057qib7	12745	1	Do	do	VBP
cord-005453-4057qib7	12745	2	we	-PRON-	PRP
cord-005453-4057qib7	12745	3	need	need	VB
cord-005453-4057qib7	12745	4	to	to	TO
cord-005453-4057qib7	12745	5	freeze	freeze	VB
cord-005453-4057qib7	12745	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12745	7	cells	cell	NNS
cord-005453-4057qib7	12745	8	for	for	IN
cord-005453-4057qib7	12745	9	autotransplants	autotransplant	NNS
cord-005453-4057qib7	12745	10	in	in	IN
cord-005453-4057qib7	12745	11	patients	patient	NNS
cord-005453-4057qib7	12745	12	with	with	IN
cord-005453-4057qib7	12745	13	myeloma	myeloma	NN
cord-005453-4057qib7	12745	14	conditioned	condition	VBN
cord-005453-4057qib7	12745	15	with	with	IN
cord-005453-4057qib7	12745	16	melphalan	melphalan	NNP
cord-005453-4057qib7	12745	17	?	?	.
cord-005453-4057qib7	12746	1	Daniel	Daniel	NNP
cord-005453-4057qib7	12746	2	Garcia	Garcia	NNP
cord-005453-4057qib7	12746	3	Belmonte	Belmonte	NNP
cord-005453-4057qib7	12746	4	1	1	CD
cord-005453-4057qib7	12746	5	,	,	,
cord-005453-4057qib7	12747	1	Beatriz	Beatriz	NNP
cord-005453-4057qib7	12747	2	Aguado	Aguado	NNP
cord-005453-4057qib7	12747	3	Bueno	Bueno	NNP
cord-005453-4057qib7	12747	4	1	1	CD
cord-005453-4057qib7	12747	5	,	,	,
cord-005453-4057qib7	12747	6	Miguel	Miguel	NNP
cord-005453-4057qib7	12747	7	Herrero	Herrero	NNP
cord-005453-4057qib7	12747	8	Coderch	Coderch	NNP
cord-005453-4057qib7	12747	9	1	1	CD
cord-005453-4057qib7	12747	10	,	,	,
cord-005453-4057qib7	12747	11	Rafael	Rafael	NNP
cord-005453-4057qib7	12747	12	de	de	NNP
cord-005453-4057qib7	12747	13	la	la	NNP
cord-005453-4057qib7	12747	14	Camara	Camara	NNP
cord-005453-4057qib7	12747	15	1	1	CD
cord-005453-4057qib7	12747	16	Background	Background	NNP
cord-005453-4057qib7	12747	17	:	:	:
cord-005453-4057qib7	12748	1	Multiple	multiple	JJ
cord-005453-4057qib7	12748	2	myeloma	myeloma	NN
cord-005453-4057qib7	12748	3	(	(	-LRB-
cord-005453-4057qib7	12748	4	MM	MM	NNP
cord-005453-4057qib7	12748	5	)	)	-RRB-
cord-005453-4057qib7	12748	6	is	be	VBZ
cord-005453-4057qib7	12748	7	the	the	DT
cord-005453-4057qib7	12748	8	most	most	RBS
cord-005453-4057qib7	12748	9	frequent	frequent	JJ
cord-005453-4057qib7	12748	10	indication	indication	NN
cord-005453-4057qib7	12748	11	of	of	IN
cord-005453-4057qib7	12748	12	auto	auto	NN
cord-005453-4057qib7	12748	13	-	-	HYPH
cord-005453-4057qib7	12748	14	HSCT	HSCT	NNP
cord-005453-4057qib7	12748	15	,	,	,
cord-005453-4057qib7	12748	16	representing	represent	VBG
cord-005453-4057qib7	12748	17	51	51	CD
cord-005453-4057qib7	12748	18	%	%	NN
cord-005453-4057qib7	12748	19	of	of	IN
cord-005453-4057qib7	12748	20	all	all	DT
cord-005453-4057qib7	12748	21	auto	auto	NN
cord-005453-4057qib7	12748	22	-	-	HYPH
cord-005453-4057qib7	12748	23	HSCT	HSCT	NNP
cord-005453-4057qib7	12748	24	in	in	IN
cord-005453-4057qib7	12748	25	2016	2016	CD
cord-005453-4057qib7	12749	1	(	(	-LRB-
cord-005453-4057qib7	12749	2	Passweg	Passweg	NNP
cord-005453-4057qib7	12749	3	JR	JR	NNP
cord-005453-4057qib7	12749	4	.	.	.
cord-005453-4057qib7	12750	1	BMT	BMT	NNP
cord-005453-4057qib7	12750	2	2018	2018	CD
cord-005453-4057qib7	12750	3	;	;	:
cord-005453-4057qib7	12750	4	53:1139	53:1139	CD
cord-005453-4057qib7	12750	5	-	-	SYM
cord-005453-4057qib7	12750	6	48	48	CD
cord-005453-4057qib7	12750	7	)	)	-RRB-
cord-005453-4057qib7	12750	8	.	.	.
cord-005453-4057qib7	12751	1	Nearly	nearly	RB
cord-005453-4057qib7	12751	2	all	all	DT
cord-005453-4057qib7	12751	3	are	be	VBP
cord-005453-4057qib7	12751	4	performed	perform	VBN
cord-005453-4057qib7	12751	5	with	with	IN
cord-005453-4057qib7	12751	6	peripheral	peripheral	JJ
cord-005453-4057qib7	12751	7	blood	blood	NN
cord-005453-4057qib7	12751	8	progenitor	progenitor	NN
cord-005453-4057qib7	12751	9	cells	cell	NNS
cord-005453-4057qib7	12751	10	(	(	-LRB-
cord-005453-4057qib7	12751	11	PBPC	PBPC	NNP
cord-005453-4057qib7	12751	12	)	)	-RRB-
cord-005453-4057qib7	12751	13	,	,	,
cord-005453-4057qib7	12751	14	and	and	CC
cord-005453-4057qib7	12751	15	Melphalan	Melphalan	NNP
cord-005453-4057qib7	12751	16	200	200	CD
cord-005453-4057qib7	12751	17	mg	mg	NNP
cord-005453-4057qib7	12751	18	/	/	SYM
cord-005453-4057qib7	12751	19	m2	m2	NNP
cord-005453-4057qib7	12751	20	is	be	VBZ
cord-005453-4057qib7	12751	21	considered	consider	VBN
cord-005453-4057qib7	12751	22	the	the	DT
cord-005453-4057qib7	12751	23	gold	gold	JJ
cord-005453-4057qib7	12751	24	standard	standard	JJ
cord-005453-4057qib7	12751	25	conditioning	conditioning	NN
cord-005453-4057qib7	12751	26	regimen	regimen	NN
cord-005453-4057qib7	12751	27	.	.	.
cord-005453-4057qib7	12752	1	The	the	DT
cord-005453-4057qib7	12752	2	standard	standard	JJ
cord-005453-4057qib7	12752	3	procedure	procedure	NN
cord-005453-4057qib7	12752	4	consists	consist	VBZ
cord-005453-4057qib7	12752	5	in	in	IN
cord-005453-4057qib7	12752	6	obtaining	obtain	VBG
cord-005453-4057qib7	12752	7	progenitors	progenitor	NNS
cord-005453-4057qib7	12752	8	,	,	,
cord-005453-4057qib7	12752	9	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	12752	10	with	with	IN
cord-005453-4057qib7	12752	11	Dimethyl	dimethyl	NN
cord-005453-4057qib7	12752	12	sulfoxide	sulfoxide	NN
cord-005453-4057qib7	12752	13	(	(	-LRB-
cord-005453-4057qib7	12752	14	DMSO	DMSO	NNP
cord-005453-4057qib7	12752	15	)	)	-RRB-
cord-005453-4057qib7	12752	16	and	and	CC
cord-005453-4057qib7	12752	17	stored	store	VBN
cord-005453-4057qib7	12752	18	and	and	CC
cord-005453-4057qib7	12752	19	subsequently	subsequently	RB
cord-005453-4057qib7	12752	20	thawed	thaw	VBN
cord-005453-4057qib7	12752	21	and	and	CC
cord-005453-4057qib7	12752	22	re	re	VBN
cord-005453-4057qib7	12752	23	-	-	VBN
cord-005453-4057qib7	12752	24	infused	infuse	VBN
cord-005453-4057qib7	12752	25	in	in	IN
cord-005453-4057qib7	12752	26	the	the	DT
cord-005453-4057qib7	12752	27	patient	patient	NN
cord-005453-4057qib7	12752	28	on	on	IN
cord-005453-4057qib7	12752	29	day	day	NN
cord-005453-4057qib7	12752	30	0	0	CD
cord-005453-4057qib7	12752	31	.	.	.
cord-005453-4057qib7	12753	1	The	the	DT
cord-005453-4057qib7	12753	2	procedure	procedure	NN
cord-005453-4057qib7	12753	3	of	of	IN
cord-005453-4057qib7	12753	4	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	12753	5	is	be	VBZ
cord-005453-4057qib7	12753	6	expensive	expensive	JJ
cord-005453-4057qib7	12753	7	and	and	CC
cord-005453-4057qib7	12753	8	has	have	VBZ
cord-005453-4057qib7	12753	9	some	some	DT
cord-005453-4057qib7	12753	10	inherent	inherent	JJ
cord-005453-4057qib7	12753	11	toxicities	toxicity	NNS
cord-005453-4057qib7	12753	12	(	(	-LRB-
cord-005453-4057qib7	12753	13	DMSO	DMSO	NNP
cord-005453-4057qib7	12753	14	)	)	-RRB-
cord-005453-4057qib7	12753	15	and	and	CC
cord-005453-4057qib7	12753	16	loss	loss	NN
cord-005453-4057qib7	12753	17	of	of	IN
cord-005453-4057qib7	12753	18	cells	cell	NNS
cord-005453-4057qib7	12753	19	during	during	IN
cord-005453-4057qib7	12753	20	the	the	DT
cord-005453-4057qib7	12753	21	procedure	procedure	NN
cord-005453-4057qib7	12753	22	.	.	.
cord-005453-4057qib7	12754	1	Several	several	JJ
cord-005453-4057qib7	12754	2	groups	group	NNS
cord-005453-4057qib7	12754	3	have	have	VBP
cord-005453-4057qib7	12754	4	used	use	VBN
cord-005453-4057qib7	12754	5	non	non	JJ
cord-005453-4057qib7	12754	6	-	-	JJ
cord-005453-4057qib7	12754	7	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12754	8	progenitors	progenitor	NNS
cord-005453-4057qib7	12754	9	showing	show	VBG
cord-005453-4057qib7	12754	10	some	some	DT
cord-005453-4057qib7	12754	11	benefits	benefit	NNS
cord-005453-4057qib7	12754	12	compared	compare	VBN
cord-005453-4057qib7	12754	13	with	with	IN
cord-005453-4057qib7	12754	14	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12754	15	transplants	transplant	NNS
cord-005453-4057qib7	12754	16	,	,	,
cord-005453-4057qib7	12754	17	mainly	mainly	RB
cord-005453-4057qib7	12754	18	a	a	DT
cord-005453-4057qib7	12754	19	faster	fast	JJR
cord-005453-4057qib7	12754	20	engraftment	engraftment	NN
cord-005453-4057qib7	12754	21	and	and	CC
cord-005453-4057qib7	12754	22	a	a	DT
cord-005453-4057qib7	12754	23	shorter	short	JJR
cord-005453-4057qib7	12754	24	length	length	NN
cord-005453-4057qib7	12754	25	of	of	IN
cord-005453-4057qib7	12754	26	hospitalization	hospitalization	NN
cord-005453-4057qib7	12754	27	.	.	.
cord-005453-4057qib7	12755	1	Objective	objective	NN
cord-005453-4057qib7	12755	2	:	:	:
cord-005453-4057qib7	12755	3	To	to	TO
cord-005453-4057qib7	12755	4	compare	compare	VB
cord-005453-4057qib7	12755	5	noncryopreserved	noncryopreserve	VBN
cord-005453-4057qib7	12755	6	vs	vs	IN
cord-005453-4057qib7	12755	7	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12755	8	auto	auto	NN
cord-005453-4057qib7	12755	9	-	-	HYPH
cord-005453-4057qib7	12755	10	HSCT	HSCT	NNP
cord-005453-4057qib7	12755	11	in	in	IN
cord-005453-4057qib7	12755	12	MM	MM	NNP
cord-005453-4057qib7	12755	13	Methods	method	NNS
cord-005453-4057qib7	12755	14	:	:	:
cord-005453-4057qib7	12755	15	We	-PRON-	PRP
cord-005453-4057qib7	12755	16	perform	perform	VBP
cord-005453-4057qib7	12755	17	an	an	DT
cord-005453-4057qib7	12755	18	unicentric	unicentric	JJ
cord-005453-4057qib7	12755	19	,	,	,
cord-005453-4057qib7	12755	20	retrospective	retrospective	JJ
cord-005453-4057qib7	12755	21	study	study	NN
cord-005453-4057qib7	12755	22	on	on	IN
cord-005453-4057qib7	12755	23	23	23	CD
cord-005453-4057qib7	12755	24	consecutive	consecutive	JJ
cord-005453-4057qib7	12755	25	first	first	JJ
cord-005453-4057qib7	12755	26	auto	auto	NN
cord-005453-4057qib7	12755	27	-	-	HYPH
cord-005453-4057qib7	12755	28	HSCT	HSCT	NNP
cord-005453-4057qib7	12755	29	MM	MM	NNP
cord-005453-4057qib7	12755	30	patients	patient	NNS
cord-005453-4057qib7	12755	31	transplanted	transplant	VBN
cord-005453-4057qib7	12755	32	with	with	IN
cord-005453-4057qib7	12755	33	PBPC	PBPC	NNP
cord-005453-4057qib7	12755	34	between	between	IN
cord-005453-4057qib7	12755	35	Nov-2011	Nov-2011	NNP
cord-005453-4057qib7	12755	36	and	and	CC
cord-005453-4057qib7	12755	37	Oct-2018	Oct-2018	NNP
cord-005453-4057qib7	12755	38	,	,	,
cord-005453-4057qib7	12755	39	and	and	CC
cord-005453-4057qib7	12755	40	conditioned	condition	VBN
cord-005453-4057qib7	12755	41	with	with	IN
cord-005453-4057qib7	12755	42	high	high	JJ
cord-005453-4057qib7	12755	43	dose	dose	NN
cord-005453-4057qib7	12755	44	melphalan	melphalan	NNP
cord-005453-4057qib7	12755	45	(	(	-LRB-
cord-005453-4057qib7	12755	46	200	200	CD
cord-005453-4057qib7	12755	47	mg	mg	NNP
cord-005453-4057qib7	12755	48	/	/	SYM
cord-005453-4057qib7	12755	49	m2	m2	NNP
cord-005453-4057qib7	12755	50	)	)	-RRB-
cord-005453-4057qib7	12755	51	.	.	.
cord-005453-4057qib7	12756	1	The	the	DT
cord-005453-4057qib7	12756	2	median	median	JJ
cord-005453-4057qib7	12756	3	follow	follow	NN
cord-005453-4057qib7	12756	4	-	-	HYPH
cord-005453-4057qib7	12756	5	up	up	NN
cord-005453-4057qib7	12756	6	was	be	VBD
cord-005453-4057qib7	12756	7	1620	1620	CD
cord-005453-4057qib7	12756	8	days	day	NNS
cord-005453-4057qib7	12757	1	(	(	-LRB-
cord-005453-4057qib7	12757	2	range	range	NN
cord-005453-4057qib7	12757	3	:	:	:
cord-005453-4057qib7	12757	4	44	44	CD
cord-005453-4057qib7	12757	5	-	-	HYPH
cord-005453-4057qib7	12757	6	2413	2413	CD
cord-005453-4057qib7	12757	7	)	)	-RRB-
cord-005453-4057qib7	12757	8	.	.	.
cord-005453-4057qib7	12758	1	9	9	CD
cord-005453-4057qib7	12758	2	patients	patient	NNS
cord-005453-4057qib7	12758	3	received	receive	VBD
cord-005453-4057qib7	12758	4	non	non	JJ
cord-005453-4057qib7	12758	5	-	-	JJ
cord-005453-4057qib7	12758	6	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12758	7	and	and	CC
cord-005453-4057qib7	12758	8	14	14	CD
cord-005453-4057qib7	12758	9	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	12758	10	auto	auto	NN
cord-005453-4057qib7	12758	11	-	-	HYPH
cord-005453-4057qib7	12758	12	HSCT	HSCT	NNP
cord-005453-4057qib7	12758	13	.	.	.
cord-005453-4057qib7	12759	1	Patients	patient	NNS
cord-005453-4057qib7	12759	2	characteristics	characteristic	NNS
cord-005453-4057qib7	12759	3	,	,	,
cord-005453-4057qib7	12759	4	without	without	IN
cord-005453-4057qib7	12759	5	differences	difference	NNS
cord-005453-4057qib7	12759	6	between	between	IN
cord-005453-4057qib7	12759	7	non	non	JJ
cord-005453-4057qib7	12759	8	-	-	JJ
cord-005453-4057qib7	12759	9	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12759	10	vs	vs	IN
cord-005453-4057qib7	12759	11	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	12759	12	:	:	:
cord-005453-4057qib7	12759	13	women	woman	NNS
cord-005453-4057qib7	12759	14	/	/	SYM
cord-005453-4057qib7	12759	15	men	man	NNS
cord-005453-4057qib7	12759	16	(	(	-LRB-
cord-005453-4057qib7	12759	17	15/8	15/8	NNP
cord-005453-4057qib7	12759	18	)	)	-RRB-
cord-005453-4057qib7	12759	19	;	;	:
cord-005453-4057qib7	12759	20	median	median	JJ
cord-005453-4057qib7	12759	21	age	age	NN
cord-005453-4057qib7	12759	22	was	be	VBD
cord-005453-4057qib7	12759	23	65	65	CD
cord-005453-4057qib7	12759	24	years	year	NNS
cord-005453-4057qib7	12760	1	(	(	-LRB-
cord-005453-4057qib7	12760	2	range	range	NN
cord-005453-4057qib7	12760	3	49	49	CD
cord-005453-4057qib7	12760	4	-	-	SYM
cord-005453-4057qib7	12760	5	72	72	CD
cord-005453-4057qib7	12760	6	)	)	-RRB-
cord-005453-4057qib7	12760	7	;	;	:
cord-005453-4057qib7	12760	8	in	in	IN
cord-005453-4057qib7	12760	9	the	the	DT
cord-005453-4057qib7	12760	10	majority	majority	NN
cord-005453-4057qib7	12760	11	auto	auto	NN
cord-005453-4057qib7	12760	12	-	-	HYPH
cord-005453-4057qib7	12760	13	HSCT	HSCT	NNP
cord-005453-4057qib7	12760	14	was	be	VBD
cord-005453-4057qib7	12760	15	done	do	VBN
cord-005453-4057qib7	12760	16	as	as	IN
cord-005453-4057qib7	12760	17	consolidation	consolidation	NN
cord-005453-4057qib7	12760	18	after	after	IN
cord-005453-4057qib7	12760	19	first	first	JJ
cord-005453-4057qib7	12760	20	line	line	NN
cord-005453-4057qib7	12760	21	therapy	therapy	NN
cord-005453-4057qib7	12760	22	(	(	-LRB-
cord-005453-4057qib7	12760	23	78	78	CD
cord-005453-4057qib7	12760	24	%	%	NN
cord-005453-4057qib7	12760	25	)	)	-RRB-
cord-005453-4057qib7	12760	26	;	;	:
cord-005453-4057qib7	12760	27	year	year	NN
cord-005453-4057qib7	12760	28	of	of	IN
cord-005453-4057qib7	12760	29	transplant	transplant	NN
cord-005453-4057qib7	12760	30	≤2014	≤2014	NNS
cord-005453-4057qib7	12760	31	(	(	-LRB-
cord-005453-4057qib7	12760	32	61	61	CD
cord-005453-4057qib7	12760	33	%	%	NN
cord-005453-4057qib7	12760	34	)	)	-RRB-
cord-005453-4057qib7	12760	35	,	,	,
cord-005453-4057qib7	12760	36	≥2015	≥2015	JJ
cord-005453-4057qib7	12760	37	(	(	-LRB-
cord-005453-4057qib7	12760	38	39	39	CD
cord-005453-4057qib7	12760	39	%	%	NN
cord-005453-4057qib7	12760	40	)	)	-RRB-
cord-005453-4057qib7	12760	41	.	.	.
cord-005453-4057qib7	12761	1	The	the	DT
cord-005453-4057qib7	12761	2	number	number	NN
cord-005453-4057qib7	12761	3	of	of	IN
cord-005453-4057qib7	12761	4	infused	infuse	VBN
cord-005453-4057qib7	12761	5	CD34	CD34	NNP
cord-005453-4057qib7	12761	6	cells	cell	NNS
cord-005453-4057qib7	12761	7	were	be	VBD
cord-005453-4057qib7	12761	8	not	not	RB
cord-005453-4057qib7	12761	9	different	different	JJ
cord-005453-4057qib7	12761	10	:	:	:
cord-005453-4057qib7	12761	11	median	median	NN
cord-005453-4057qib7	12761	12	3.5	3.5	CD
cord-005453-4057qib7	12761	13	x10	x10	NN
cord-005453-4057qib7	12761	14	/kg	/kg	.
cord-005453-4057qib7	12761	15	(	(	-LRB-
cord-005453-4057qib7	12761	16	range	range	VBP
cord-005453-4057qib7	12761	17	1.7	1.7	CD
cord-005453-4057qib7	12761	18	-	-	SYM
cord-005453-4057qib7	12761	19	11.5	11.5	CD
cord-005453-4057qib7	12761	20	)	)	-RRB-
cord-005453-4057qib7	12761	21	in	in	IN
cord-005453-4057qib7	12761	22	noncryopreserved	noncryopreserve	VBN
cord-005453-4057qib7	12761	23	patients	patient	NNS
cord-005453-4057qib7	12761	24	and	and	CC
cord-005453-4057qib7	12761	25	3.75	3.75	CD
cord-005453-4057qib7	12761	26	x10	x10	NN
cord-005453-4057qib7	12762	1	/kg	/kg	.
cord-005453-4057qib7	12763	1	(	(	-LRB-
cord-005453-4057qib7	12763	2	range	range	NNP
cord-005453-4057qib7	12763	3	2.1	2.1	CD
cord-005453-4057qib7	12763	4	-	-	SYM
cord-005453-4057qib7	12763	5	17	17	CD
cord-005453-4057qib7	12763	6	)	)	-RRB-
cord-005453-4057qib7	12763	7	in	in	IN
cord-005453-4057qib7	12763	8	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	12763	9	patients	patient	NNS
cord-005453-4057qib7	12763	10	.	.	.
cord-005453-4057qib7	12764	1	Results	result	NNS
cord-005453-4057qib7	12764	2	:	:	:
cord-005453-4057qib7	12765	1	We	-PRON-	PRP
cord-005453-4057qib7	12765	2	didn´t	didn´t	TO
cord-005453-4057qib7	12765	3	observe	observe	VB
cord-005453-4057qib7	12765	4	significant	significant	JJ
cord-005453-4057qib7	12765	5	differences	difference	NNS
cord-005453-4057qib7	12765	6	in	in	IN
cord-005453-4057qib7	12765	7	the	the	DT
cord-005453-4057qib7	12765	8	day	day	NN
cord-005453-4057qib7	12765	9	of	of	IN
cord-005453-4057qib7	12765	10	engraftment	engraftment	NN
cord-005453-4057qib7	12765	11	between	between	IN
cord-005453-4057qib7	12765	12	non	non	JJ
cord-005453-4057qib7	12765	13	-	-	JJ
cord-005453-4057qib7	12765	14	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12765	15	vs	vs	IN
cord-005453-4057qib7	12765	16	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	12765	17	although	although	IN
cord-005453-4057qib7	12765	18	always	always	RB
cord-005453-4057qib7	12765	19	was	be	VBD
cord-005453-4057qib7	12765	20	a	a	DT
cord-005453-4057qib7	12765	21	little	little	JJ
cord-005453-4057qib7	12765	22	bit	bit	NN
cord-005453-4057qib7	12765	23	faster	fast	RBR
cord-005453-4057qib7	12765	24	in	in	IN
cord-005453-4057qib7	12765	25	the	the	DT
cord-005453-4057qib7	12765	26	noncryopreserved	noncryopreserved	JJ
cord-005453-4057qib7	12765	27	group	group	NN
cord-005453-4057qib7	12765	28	with	with	IN
cord-005453-4057qib7	12765	29	a	a	DT
cord-005453-4057qib7	12765	30	tendency	tendency	NN
cord-005453-4057qib7	12765	31	to	to	TO
cord-005453-4057qib7	12765	32	faster	fast	JJR
cord-005453-4057qib7	12765	33	platelet	platelet	NN
cord-005453-4057qib7	12765	34	engraftment	engraftment	NN
cord-005453-4057qib7	12765	35	(	(	-LRB-
cord-005453-4057qib7	12765	36	>	>	NFP
cord-005453-4057qib7	12765	37	50000	50000	CD
cord-005453-4057qib7	12765	38	/	/	SYM
cord-005453-4057qib7	12765	39	mm3	mm3	NNS
cord-005453-4057qib7	12765	40	)	)	-RRB-
cord-005453-4057qib7	12765	41	:	:	:
cord-005453-4057qib7	12765	42	>	>	XX
cord-005453-4057qib7	12766	1	20000	20000	CD
cord-005453-4057qib7	12766	2	platelets	platelet	NNS
cord-005453-4057qib7	12766	3	/	/	SYM
cord-005453-4057qib7	12766	4	mm3	mm3	NNS
cord-005453-4057qib7	12766	5	(	(	-LRB-
cord-005453-4057qib7	12766	6	median	median	JJ
cord-005453-4057qib7	12766	7	day	day	NN
cord-005453-4057qib7	12766	8	:	:	:
cord-005453-4057qib7	12767	1	12	12	CD
cord-005453-4057qib7	12767	2	vs	vs	IN
cord-005453-4057qib7	12767	3	12.5	12.5	CD
cord-005453-4057qib7	12767	4	,	,	,
cord-005453-4057qib7	12767	5	P	p	NN
cord-005453-4057qib7	12767	6	0.2	0.2	CD
cord-005453-4057qib7	12767	7	)	)	-RRB-
cord-005453-4057qib7	12767	8	,	,	,
cord-005453-4057qib7	12767	9	>	>	XX
cord-005453-4057qib7	12768	1	50000	50000	CD
cord-005453-4057qib7	12768	2	platelets	platelet	NNS
cord-005453-4057qib7	12768	3	/	/	SYM
cord-005453-4057qib7	12768	4	mm3	mm3	NNS
cord-005453-4057qib7	12768	5	(	(	-LRB-
cord-005453-4057qib7	12768	6	median	median	NN
cord-005453-4057qib7	12768	7	:	:	:
cord-005453-4057qib7	12768	8	13	13	CD
cord-005453-4057qib7	12768	9	vs	vs	IN
cord-005453-4057qib7	12768	10	16	16	CD
cord-005453-4057qib7	12768	11	days	day	NNS
cord-005453-4057qib7	12768	12	,	,	,
cord-005453-4057qib7	12768	13	P	p	NN
cord-005453-4057qib7	12768	14	0.09	0.09	CD
cord-005453-4057qib7	12768	15	)	)	-RRB-
cord-005453-4057qib7	12768	16	;	;	:
cord-005453-4057qib7	12768	17	>	>	XX
cord-005453-4057qib7	12769	1	500	500	CD
cord-005453-4057qib7	12769	2	neutrophils	neutrophil	NNS
cord-005453-4057qib7	12769	3	/	/	SYM
cord-005453-4057qib7	12769	4	mm3	mm3	NNS
cord-005453-4057qib7	12769	5	(	(	-LRB-
cord-005453-4057qib7	12769	6	median	median	NN
cord-005453-4057qib7	12769	7	:	:	:
cord-005453-4057qib7	12769	8	13	13	CD
cord-005453-4057qib7	12769	9	vs	vs	IN
cord-005453-4057qib7	12769	10	13.5	13.5	CD
cord-005453-4057qib7	12769	11	days	day	NNS
cord-005453-4057qib7	12769	12	,	,	,
cord-005453-4057qib7	12769	13	P	p	NN
cord-005453-4057qib7	12769	14	0.3	0.3	CD
cord-005453-4057qib7	12769	15	)	)	-RRB-
cord-005453-4057qib7	12769	16	.	.	.
cord-005453-4057qib7	12770	1	The	the	DT
cord-005453-4057qib7	12770	2	media	medium	NNS
cord-005453-4057qib7	12770	3	of	of	IN
cord-005453-4057qib7	12770	4	days	day	NNS
cord-005453-4057qib7	12770	5	of	of	IN
cord-005453-4057qib7	12770	6	hospitalization	hospitalization	NN
cord-005453-4057qib7	12770	7	was	be	VBD
cord-005453-4057qib7	12770	8	shorter	short	JJR
cord-005453-4057qib7	12770	9	in	in	IN
cord-005453-4057qib7	12770	10	non	non	JJ
cord-005453-4057qib7	12770	11	-	-	JJ
cord-005453-4057qib7	12770	12	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12770	13	patients	patient	NNS
cord-005453-4057qib7	12770	14	(	(	-LRB-
cord-005453-4057qib7	12770	15	18	18	CD
cord-005453-4057qib7	12770	16	vs	vs	IN
cord-005453-4057qib7	12770	17	21	21	CD
cord-005453-4057qib7	12770	18	days	day	NNS
cord-005453-4057qib7	12770	19	)	)	-RRB-
cord-005453-4057qib7	12770	20	although	although	IN
cord-005453-4057qib7	12770	21	not	not	RB
cord-005453-4057qib7	12770	22	statistically	statistically	RB
cord-005453-4057qib7	12770	23	significant	significant	JJ
cord-005453-4057qib7	12770	24	(	(	-LRB-
cord-005453-4057qib7	12770	25	P	p	NN
cord-005453-4057qib7	12770	26	0.14	0.14	CD
cord-005453-4057qib7	12770	27	)	)	-RRB-
cord-005453-4057qib7	12770	28	.	.	.
cord-005453-4057qib7	12771	1	Transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	12771	2	mortality	mortality	NN
cord-005453-4057qib7	12771	3	at	at	IN
cord-005453-4057qib7	12771	4	day	day	NN
cord-005453-4057qib7	12772	1	+100	+100	NNP
cord-005453-4057qib7	12772	2	was	be	VBD
cord-005453-4057qib7	12772	3	0	0	CD
cord-005453-4057qib7	12772	4	%	%	NN
cord-005453-4057qib7	12772	5	in	in	IN
cord-005453-4057qib7	12772	6	both	both	DT
cord-005453-4057qib7	12772	7	groups	group	NNS
cord-005453-4057qib7	12772	8	.	.	.
cord-005453-4057qib7	12773	1	Overall	overall	JJ
cord-005453-4057qib7	12773	2	survival	survival	NN
cord-005453-4057qib7	12773	3	at	at	IN
cord-005453-4057qib7	12773	4	5	5	CD
cord-005453-4057qib7	12773	5	years	year	NNS
cord-005453-4057qib7	12773	6	was	be	VBD
cord-005453-4057qib7	12773	7	not	not	RB
cord-005453-4057qib7	12773	8	different	different	JJ
cord-005453-4057qib7	12773	9	:	:	:
cord-005453-4057qib7	12773	10	83.3	83.3	CD
cord-005453-4057qib7	12773	11	%	%	NN
cord-005453-4057qib7	12773	12	in	in	IN
cord-005453-4057qib7	12773	13	in	in	IN
cord-005453-4057qib7	12773	14	non	non	JJ
cord-005453-4057qib7	12773	15	-	-	JJ
cord-005453-4057qib7	12773	16	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12773	17	vs	vs	IN
cord-005453-4057qib7	12773	18	61.5	61.5	CD
cord-005453-4057qib7	12773	19	%	%	NN
cord-005453-4057qib7	12773	20	in	in	IN
cord-005453-4057qib7	12773	21	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12773	22	patients	patient	NNS
cord-005453-4057qib7	12773	23	(	(	-LRB-
cord-005453-4057qib7	12773	24	Kaplan	Kaplan	NNP
cord-005453-4057qib7	12773	25	-	-	HYPH
cord-005453-4057qib7	12773	26	Meier	Meier	NNP
cord-005453-4057qib7	12773	27	,	,	,
cord-005453-4057qib7	12773	28	Log	Log	NNP
cord-005453-4057qib7	12773	29	-	-	HYPH
cord-005453-4057qib7	12773	30	rank	rank	NN
cord-005453-4057qib7	12773	31	P	p	NN
cord-005453-4057qib7	12773	32	0.27	0.27	CD
cord-005453-4057qib7	12773	33	)	)	-RRB-
cord-005453-4057qib7	12773	34	.	.	.
cord-005453-4057qib7	12774	1	The	the	DT
cord-005453-4057qib7	12774	2	accumulative	accumulative	JJ
cord-005453-4057qib7	12774	3	incidence	incidence	NN
cord-005453-4057qib7	12774	4	of	of	IN
cord-005453-4057qib7	12774	5	relapse	relapse	NN
cord-005453-4057qib7	12774	6	at	at	IN
cord-005453-4057qib7	12774	7	the	the	DT
cord-005453-4057qib7	12774	8	median	median	NN
cord-005453-4057qib7	12774	9	follow	follow	VBP
cord-005453-4057qib7	12774	10	up	up	RP
cord-005453-4057qib7	12774	11	(	(	-LRB-
cord-005453-4057qib7	12774	12	1600	1600	CD
cord-005453-4057qib7	12774	13	days	day	NNS
cord-005453-4057qib7	12774	14	)	)	-RRB-
cord-005453-4057qib7	12774	15	was	be	VBD
cord-005453-4057qib7	12774	16	similar	similar	JJ
cord-005453-4057qib7	12774	17	:	:	:
cord-005453-4057qib7	12774	18	33.3	33.3	CD
cord-005453-4057qib7	12774	19	%	%	NN
cord-005453-4057qib7	12774	20	in	in	IN
cord-005453-4057qib7	12774	21	non	non	JJ
cord-005453-4057qib7	12774	22	-	-	JJ
cord-005453-4057qib7	12774	23	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12774	24	vs	vs	IN
cord-005453-4057qib7	12774	25	35.9	35.9	CD
cord-005453-4057qib7	12774	26	%	%	NN
cord-005453-4057qib7	12774	27	in	in	IN
cord-005453-4057qib7	12774	28	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12774	29	patients	patient	NNS
cord-005453-4057qib7	12774	30	.	.	.
cord-005453-4057qib7	12775	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12775	2	:	:	:
cord-005453-4057qib7	12776	1	In	in	IN
cord-005453-4057qib7	12776	2	our	-PRON-	PRP$
cord-005453-4057qib7	12776	3	short	short	JJ
cord-005453-4057qib7	12776	4	experience	experience	NN
cord-005453-4057qib7	12776	5	,	,	,
cord-005453-4057qib7	12776	6	auto	auto	NN
cord-005453-4057qib7	12776	7	-	-	HYPH
cord-005453-4057qib7	12776	8	HSCT	HSCT	NNP
cord-005453-4057qib7	12776	9	with	with	IN
cord-005453-4057qib7	12776	10	non	non	JJ
cord-005453-4057qib7	12776	11	-	-	JJ
cord-005453-4057qib7	12776	12	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12776	13	PBPC	PBPC	NNP
cord-005453-4057qib7	12776	14	in	in	IN
cord-005453-4057qib7	12776	15	myeloma	myeloma	NN
cord-005453-4057qib7	12776	16	patients	patient	NNS
cord-005453-4057qib7	12776	17	conditioned	condition	VBN
cord-005453-4057qib7	12776	18	with	with	IN
cord-005453-4057qib7	12776	19	high	high	JJ
cord-005453-4057qib7	12776	20	dose	dose	NN
cord-005453-4057qib7	12776	21	melphalan	melphalan	NNP
cord-005453-4057qib7	12776	22	obtain	obtain	VBP
cord-005453-4057qib7	12776	23	similar	similar	JJ
cord-005453-4057qib7	12776	24	results	result	NNS
cord-005453-4057qib7	12776	25	to	to	IN
cord-005453-4057qib7	12776	26	those	those	DT
cord-005453-4057qib7	12776	27	performed	perform	VBN
cord-005453-4057qib7	12776	28	with	with	IN
cord-005453-4057qib7	12776	29	classical	classical	JJ
cord-005453-4057qib7	12776	30	cryopreserved	cryopreserved	JJ
cord-005453-4057qib7	12776	31	PBPC	PBPC	NNP
cord-005453-4057qib7	12776	32	and	and	CC
cord-005453-4057qib7	12776	33	might	may	MD
cord-005453-4057qib7	12776	34	has	have	VBZ
cord-005453-4057qib7	12776	35	a	a	DT
cord-005453-4057qib7	12776	36	faster	fast	JJR
cord-005453-4057qib7	12776	37	platelet	platelet	NN
cord-005453-4057qib7	12776	38	engraftment	engraftment	NN
cord-005453-4057qib7	12776	39	and	and	CC
cord-005453-4057qib7	12776	40	shorter	short	JJR
cord-005453-4057qib7	12776	41	length	length	NN
cord-005453-4057qib7	12776	42	of	of	IN
cord-005453-4057qib7	12776	43	hospitalization	hospitalization	NN
cord-005453-4057qib7	12776	44	.	.	.
cord-005453-4057qib7	12777	1	If	if	IN
cord-005453-4057qib7	12777	2	no	no	DT
cord-005453-4057qib7	12777	3	advantages	advantage	NNS
cord-005453-4057qib7	12777	4	are	be	VBP
cord-005453-4057qib7	12777	5	associated	associate	VBN
cord-005453-4057qib7	12777	6	with	with	IN
cord-005453-4057qib7	12777	7	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	12777	8	,	,	,
cord-005453-4057qib7	12777	9	the	the	DT
cord-005453-4057qib7	12777	10	simplicity	simplicity	NN
cord-005453-4057qib7	12777	11	of	of	IN
cord-005453-4057qib7	12777	12	using	use	VBG
cord-005453-4057qib7	12777	13	fresh	fresh	JJ
cord-005453-4057qib7	12777	14	product	product	NN
cord-005453-4057qib7	12777	15	is	be	VBZ
cord-005453-4057qib7	12777	16	appealing	appeal	VBG
cord-005453-4057qib7	12777	17	.	.	.
cord-005453-4057qib7	12778	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12778	2	:	:	:
cord-005453-4057qib7	12778	3	Nothing	nothing	NN
cord-005453-4057qib7	12778	4	to	to	TO
cord-005453-4057qib7	12778	5	declare	declare	VB
cord-005453-4057qib7	12778	6	P565	P565	NNP
cord-005453-4057qib7	12778	7	Abstract	Abstract	NNP
cord-005453-4057qib7	12778	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	12778	9	.	.	.
cord-005453-4057qib7	12778	10	.	.	.
cord-005453-4057qib7	12779	1	Results	result	NNS
cord-005453-4057qib7	12779	2	:	:	:
cord-005453-4057qib7	12780	1	A	a	DT
cord-005453-4057qib7	12780	2	early	early	JJ
cord-005453-4057qib7	12780	3	death	death	NN
cord-005453-4057qib7	12780	4	is	be	VBZ
cord-005453-4057qib7	12780	5	observed	observe	VBN
cord-005453-4057qib7	12780	6	in	in	IN
cord-005453-4057qib7	12780	7	one	one	CD
cord-005453-4057qib7	12780	8	pt	pt	NN
cord-005453-4057qib7	12780	9	(	(	-LRB-
cord-005453-4057qib7	12780	10	Group	Group	NNP
cord-005453-4057qib7	12780	11	1	1	CD
cord-005453-4057qib7	12780	12	)	)	-RRB-
cord-005453-4057qib7	12780	13	and	and	CC
cord-005453-4057qib7	12780	14	5	5	CD
cord-005453-4057qib7	12780	15	pts(Group	pts(group	NN
cord-005453-4057qib7	12780	16	2	2	CD
cord-005453-4057qib7	12780	17	)	)	-RRB-
cord-005453-4057qib7	12780	18	.	.	.
cord-005453-4057qib7	12781	1	The	the	DT
cord-005453-4057qib7	12781	2	median	median	JJ
cord-005453-4057qib7	12781	3	delay	delay	NN
cord-005453-4057qib7	12781	4	of	of	IN
cord-005453-4057qib7	12781	5	aplasia	aplasia	NNP
cord-005453-4057qib7	12781	6	is	be	VBZ
cord-005453-4057qib7	12781	7	14	14	CD
cord-005453-4057qib7	12781	8	days	day	NNS
cord-005453-4057qib7	12781	9	(	(	-LRB-
cord-005453-4057qib7	12781	10	10	10	CD
cord-005453-4057qib7	12781	11	-	-	SYM
cord-005453-4057qib7	12781	12	22	22	CD
cord-005453-4057qib7	12781	13	)	)	-RRB-
cord-005453-4057qib7	12781	14	and	and	CC
cord-005453-4057qib7	12781	15	12	12	CD
cord-005453-4057qib7	12781	16	days	day	NNS
cord-005453-4057qib7	12781	17	(	(	-LRB-
cord-005453-4057qib7	12781	18	9	9	CD
cord-005453-4057qib7	12781	19	-	-	SYM
cord-005453-4057qib7	12781	20	17	17	CD
cord-005453-4057qib7	12781	21	)	)	-RRB-
cord-005453-4057qib7	12781	22	respectively	respectively	RB
cord-005453-4057qib7	12781	23	.	.	.
cord-005453-4057qib7	12782	1	In	in	IN
cord-005453-4057qib7	12782	2	group	group	NN
cord-005453-4057qib7	12782	3	1	1	CD
cord-005453-4057qib7	12782	4	,	,	,
cord-005453-4057qib7	12782	5	among	among	IN
cord-005453-4057qib7	12782	6	the	the	DT
cord-005453-4057qib7	12782	7	evaluable	evaluable	JJ
cord-005453-4057qib7	12782	8	pts	pt	NNS
cord-005453-4057qib7	12782	9	,	,	,
cord-005453-4057qib7	12782	10	30/37	30/37	CD
cord-005453-4057qib7	12782	11	(	(	-LRB-
cord-005453-4057qib7	12782	12	81	81	CD
cord-005453-4057qib7	12782	13	%	%	NN
cord-005453-4057qib7	12782	14	)	)	-RRB-
cord-005453-4057qib7	12782	15	are	be	VBP
cord-005453-4057qib7	12782	16	in	in	IN
cord-005453-4057qib7	12782	17	CR	CR	NNP
cord-005453-4057qib7	12782	18	,	,	,
cord-005453-4057qib7	12782	19	5	5	CD
cord-005453-4057qib7	12782	20	pts	pt	NNS
cord-005453-4057qib7	12782	21	in	in	IN
cord-005453-4057qib7	12782	22	PR	PR	NNP
cord-005453-4057qib7	12782	23	and	and	CC
cord-005453-4057qib7	12782	24	2	2	CD
cord-005453-4057qib7	12782	25	refractory	refractory	NN
cord-005453-4057qib7	12782	26	.	.	.
cord-005453-4057qib7	12783	1	In	in	IN
cord-005453-4057qib7	12783	2	Group	Group	NNP
cord-005453-4057qib7	12783	3	2	2	CD
cord-005453-4057qib7	12783	4	,	,	,
cord-005453-4057qib7	12783	5	CR	CR	NNP
cord-005453-4057qib7	12783	6	:	:	:
cord-005453-4057qib7	12783	7	35/43	35/43	CD
cord-005453-4057qib7	12783	8	(	(	-LRB-
cord-005453-4057qib7	12783	9	81	81	CD
cord-005453-4057qib7	12783	10	%	%	NN
cord-005453-4057qib7	12783	11	)	)	-RRB-
cord-005453-4057qib7	12783	12	,	,	,
cord-005453-4057qib7	12783	13	PR	PR	NNP
cord-005453-4057qib7	12783	14	:	:	:
cord-005453-4057qib7	12783	15	6	6	CD
cord-005453-4057qib7	12783	16	and	and	CC
cord-005453-4057qib7	12783	17	2	2	CD
cord-005453-4057qib7	12783	18	refractory	refractory	NN
cord-005453-4057qib7	12783	19	.	.	.
cord-005453-4057qib7	12784	1	A	a	DT
cord-005453-4057qib7	12784	2	relapse	relapse	NN
cord-005453-4057qib7	12784	3	is	be	VBZ
cord-005453-4057qib7	12784	4	observed	observe	VBN
cord-005453-4057qib7	12784	5	in	in	IN
cord-005453-4057qib7	12784	6	32	32	CD
cord-005453-4057qib7	12784	7	pts/37	pts/37	NN
cord-005453-4057qib7	12784	8	(	(	-LRB-
cord-005453-4057qib7	12784	9	86,5	86,5	CD
cord-005453-4057qib7	12784	10	%	%	NN
cord-005453-4057qib7	12784	11	)	)	-RRB-
cord-005453-4057qib7	12784	12	in	in	IN
cord-005453-4057qib7	12784	13	Group	Group	NNP
cord-005453-4057qib7	12784	14	1	1	CD
cord-005453-4057qib7	12784	15	and	and	CC
cord-005453-4057qib7	12784	16	35	35	CD
cord-005453-4057qib7	12784	17	pts/43	pts/43	NNP
cord-005453-4057qib7	12784	18	(	(	-LRB-
cord-005453-4057qib7	12784	19	81	81	CD
cord-005453-4057qib7	12784	20	%	%	NN
cord-005453-4057qib7	12784	21	)	)	-RRB-
cord-005453-4057qib7	12784	22	in	in	IN
cord-005453-4057qib7	12784	23	Group	Group	NNP
cord-005453-4057qib7	12784	24	2	2	CD
cord-005453-4057qib7	12784	25	with	with	IN
cord-005453-4057qib7	12784	26	a	a	DT
cord-005453-4057qib7	12784	27	frequency	frequency	NN
cord-005453-4057qib7	12784	28	of	of	IN
cord-005453-4057qib7	12784	29	54	54	CD
cord-005453-4057qib7	12784	30	%	%	NN
cord-005453-4057qib7	12784	31	and	and	CC
cord-005453-4057qib7	12784	32	41	41	CD
cord-005453-4057qib7	12784	33	%	%	NN
cord-005453-4057qib7	12784	34	respectively	respectively	RB
cord-005453-4057qib7	12784	35	in	in	IN
cord-005453-4057qib7	12784	36	the	the	DT
cord-005453-4057qib7	12784	37	first	first	JJ
cord-005453-4057qib7	12784	38	24	24	CD
cord-005453-4057qib7	12784	39	months	month	NNS
cord-005453-4057qib7	12784	40	.	.	.
cord-005453-4057qib7	12785	1	At	at	IN
cord-005453-4057qib7	12785	2	36	36	CD
cord-005453-4057qib7	12785	3	months	month	NNS
cord-005453-4057qib7	12785	4	:	:	:
cord-005453-4057qib7	12785	5	13	13	CD
cord-005453-4057qib7	12785	6	pts/38	pts/38	NNP
cord-005453-4057qib7	12785	7	(	(	-LRB-
cord-005453-4057qib7	12785	8	34	34	CD
cord-005453-4057qib7	12785	9	%	%	NN
cord-005453-4057qib7	12785	10	)	)	-RRB-
cord-005453-4057qib7	12785	11	in	in	IN
cord-005453-4057qib7	12785	12	Group	Group	NNP
cord-005453-4057qib7	12785	13	1	1	CD
cord-005453-4057qib7	12785	14	and	and	CC
cord-005453-4057qib7	12785	15	19	19	CD
cord-005453-4057qib7	12785	16	pts/49	pts/49	NNP
cord-005453-4057qib7	12785	17	(	(	-LRB-
cord-005453-4057qib7	12785	18	38	38	CD
cord-005453-4057qib7	12785	19	%	%	NN
cord-005453-4057qib7	12785	20	)	)	-RRB-
cord-005453-4057qib7	12785	21	in	in	IN
cord-005453-4057qib7	12785	22	Group	Group	NNP
cord-005453-4057qib7	12785	23	2	2	CD
cord-005453-4057qib7	12785	24	are	be	VBP
cord-005453-4057qib7	12785	25	dead	dead	JJ
cord-005453-4057qib7	12785	26	.	.	.
cord-005453-4057qib7	12786	1	At	at	IN
cord-005453-4057qib7	12786	2	60	60	CD
cord-005453-4057qib7	12786	3	months	month	NNS
cord-005453-4057qib7	12786	4	:	:	:
cord-005453-4057qib7	12786	5	20	20	CD
cord-005453-4057qib7	12786	6	pts	pt	NNS
cord-005453-4057qib7	12786	7	(	(	-LRB-
cord-005453-4057qib7	12786	8	52	52	CD
cord-005453-4057qib7	12786	9	%	%	NN
cord-005453-4057qib7	12786	10	)	)	-RRB-
cord-005453-4057qib7	12786	11	and	and	CC
cord-005453-4057qib7	12786	12	29	29	CD
cord-005453-4057qib7	12786	13	pts	pt	NNS
cord-005453-4057qib7	12786	14	(	(	-LRB-
cord-005453-4057qib7	12786	15	59	59	CD
cord-005453-4057qib7	12786	16	%	%	NN
cord-005453-4057qib7	12786	17	)	)	-RRB-
cord-005453-4057qib7	12786	18	.	.	.
cord-005453-4057qib7	12787	1	At	at	IN
cord-005453-4057qib7	12787	2	120	120	CD
cord-005453-4057qib7	12787	3	months	month	NNS
cord-005453-4057qib7	12787	4	:	:	:
cord-005453-4057qib7	12787	5	31	31	CD
cord-005453-4057qib7	12787	6	pts	pt	NNS
cord-005453-4057qib7	12787	7	(	(	-LRB-
cord-005453-4057qib7	12787	8	81,5	81,5	CD
cord-005453-4057qib7	12787	9	%	%	NN
cord-005453-4057qib7	12787	10	)	)	-RRB-
cord-005453-4057qib7	12787	11	and	and	CC
cord-005453-4057qib7	12787	12	37	37	CD
cord-005453-4057qib7	12787	13	pts	pt	NNS
cord-005453-4057qib7	12787	14	(	(	-LRB-
cord-005453-4057qib7	12787	15	75,5	75,5	CD
cord-005453-4057qib7	12787	16	%	%	NN
cord-005453-4057qib7	12787	17	)	)	-RRB-
cord-005453-4057qib7	12787	18	.	.	.
cord-005453-4057qib7	12788	1	The	the	DT
cord-005453-4057qib7	12788	2	overall	overall	JJ
cord-005453-4057qib7	12788	3	survival	survival	NN
cord-005453-4057qib7	12788	4	(	(	-LRB-
cord-005453-4057qib7	12788	5	OS	OS	NNP
cord-005453-4057qib7	12788	6	)	)	-RRB-
cord-005453-4057qib7	12788	7	of	of	IN
cord-005453-4057qib7	12788	8	the	the	DT
cord-005453-4057qib7	12788	9	Group	Group	NNP
cord-005453-4057qib7	12788	10	1	1	CD
cord-005453-4057qib7	12788	11	and	and	CC
cord-005453-4057qib7	12788	12	Group	Group	NNP
cord-005453-4057qib7	12788	13	2	2	CD
cord-005453-4057qib7	12788	14	pts	pt	NNS
cord-005453-4057qib7	12788	15	were	be	VBD
cord-005453-4057qib7	12788	16	66	66	CD
cord-005453-4057qib7	12788	17	%	%	NN
cord-005453-4057qib7	12788	18	and	and	CC
cord-005453-4057qib7	12788	19	62	62	CD
cord-005453-4057qib7	12788	20	%	%	NN
cord-005453-4057qib7	12788	21	at	at	IN
cord-005453-4057qib7	12788	22	36	36	CD
cord-005453-4057qib7	12788	23	months	month	NNS
cord-005453-4057qib7	12788	24	;	;	:
cord-005453-4057qib7	12788	25	47.5	47.5	CD
cord-005453-4057qib7	12788	26	%	%	NN
cord-005453-4057qib7	12788	27	and	and	CC
cord-005453-4057qib7	12788	28	38.5	38.5	CD
cord-005453-4057qib7	12788	29	%	%	NN
cord-005453-4057qib7	12788	30	at	at	IN
cord-005453-4057qib7	12788	31	60	60	CD
cord-005453-4057qib7	12788	32	months	month	NNS
cord-005453-4057qib7	12788	33	;	;	:
cord-005453-4057qib7	12788	34	18	18	CD
cord-005453-4057qib7	12788	35	%	%	NN
cord-005453-4057qib7	12788	36	and	and	CC
cord-005453-4057qib7	12788	37	24,5	24,5	CD
cord-005453-4057qib7	12788	38	%	%	NN
cord-005453-4057qib7	12788	39	at	at	IN
cord-005453-4057qib7	12788	40	120	120	CD
cord-005453-4057qib7	12788	41	months	month	NNS
cord-005453-4057qib7	12788	42	respectively	respectively	RB
cord-005453-4057qib7	12788	43	(	(	-LRB-
cord-005453-4057qib7	12788	44	without	without	IN
cord-005453-4057qib7	12788	45	significant	significant	JJ
cord-005453-4057qib7	12788	46	difference	difference	NN
cord-005453-4057qib7	12788	47	)	)	-RRB-
cord-005453-4057qib7	12788	48	.	.	.
cord-005453-4057qib7	12789	1	The	the	DT
cord-005453-4057qib7	12789	2	event	event	NN
cord-005453-4057qib7	12789	3	free	free	JJ
cord-005453-4057qib7	12789	4	survival	survival	NN
cord-005453-4057qib7	12789	5	(	(	-LRB-
cord-005453-4057qib7	12789	6	EFS	EFS	NNP
cord-005453-4057qib7	12789	7	)	)	-RRB-
cord-005453-4057qib7	12789	8	of	of	IN
cord-005453-4057qib7	12789	9	group	group	NN
cord-005453-4057qib7	12789	10	1	1	CD
cord-005453-4057qib7	12789	11	and	and	CC
cord-005453-4057qib7	12789	12	2	2	CD
cord-005453-4057qib7	12789	13	pts	pt	NNS
cord-005453-4057qib7	12789	14	were	be	VBD
cord-005453-4057qib7	12789	15	37	37	CD
cord-005453-4057qib7	12789	16	%	%	NN
cord-005453-4057qib7	12789	17	and	and	CC
cord-005453-4057qib7	12789	18	36,5	36,5	CD
cord-005453-4057qib7	12789	19	%	%	NN
cord-005453-4057qib7	12789	20	at	at	IN
cord-005453-4057qib7	12789	21	36	36	CD
cord-005453-4057qib7	12789	22	months	month	NNS
cord-005453-4057qib7	12789	23	,	,	,
cord-005453-4057qib7	12789	24	25	25	CD
cord-005453-4057qib7	12789	25	%	%	NN
cord-005453-4057qib7	12789	26	and	and	CC
cord-005453-4057qib7	12789	27	13	13	CD
cord-005453-4057qib7	12789	28	%	%	NN
cord-005453-4057qib7	12789	29	at	at	IN
cord-005453-4057qib7	12789	30	60	60	CD
cord-005453-4057qib7	12789	31	months	month	NNS
cord-005453-4057qib7	12789	32	and	and	CC
cord-005453-4057qib7	12789	33	8	8	CD
cord-005453-4057qib7	12789	34	%	%	NN
cord-005453-4057qib7	12789	35	and	and	CC
cord-005453-4057qib7	12789	36	15	15	CD
cord-005453-4057qib7	12789	37	%	%	NN
cord-005453-4057qib7	12789	38	at	at	IN
cord-005453-4057qib7	12789	39	120	120	CD
cord-005453-4057qib7	12789	40	months	month	NNS
cord-005453-4057qib7	12789	41	respectively	respectively	RB
cord-005453-4057qib7	12789	42	(	(	-LRB-
cord-005453-4057qib7	12789	43	without	without	IN
cord-005453-4057qib7	12789	44	significant	significant	JJ
cord-005453-4057qib7	12789	45	difference	difference	NN
cord-005453-4057qib7	12789	46	)	)	-RRB-
cord-005453-4057qib7	12789	47	.	.	.
cord-005453-4057qib7	12790	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12790	2	:	:	:
cord-005453-4057qib7	12791	1	These	these	DT
cord-005453-4057qib7	12791	2	2	2	CD
cord-005453-4057qib7	12791	3	protocols	protocol	NNS
cord-005453-4057qib7	12791	4	with	with	IN
cord-005453-4057qib7	12791	5	equivalent	equivalent	JJ
cord-005453-4057qib7	12791	6	toxicity	toxicity	NN
cord-005453-4057qib7	12791	7	allow	allow	VBP
cord-005453-4057qib7	12791	8	obtaining	obtaining	NN
cord-005453-4057qib7	12791	9	of	of	IN
cord-005453-4057qib7	12791	10	long	long	JJ
cord-005453-4057qib7	12791	11	-	-	HYPH
cord-005453-4057qib7	12791	12	term	term	NN
cord-005453-4057qib7	12791	13	equivalent	equivalent	JJ
cord-005453-4057qib7	12791	14	results	result	NNS
cord-005453-4057qib7	12791	15	on	on	IN
cord-005453-4057qib7	12791	16	the	the	DT
cord-005453-4057qib7	12791	17	response	response	NN
cord-005453-4057qib7	12791	18	rate	rate	NN
cord-005453-4057qib7	12791	19	early	early	JJ
cord-005453-4057qib7	12791	20	transplant	transplant	NN
cord-005453-4057qib7	12791	21	,	,	,
cord-005453-4057qib7	12791	22	on	on	IN
cord-005453-4057qib7	12791	23	the	the	DT
cord-005453-4057qib7	12791	24	rate	rate	NN
cord-005453-4057qib7	12791	25	of	of	IN
cord-005453-4057qib7	12791	26	relapse	relapse	NN
cord-005453-4057qib7	12791	27	and	and	CC
cord-005453-4057qib7	12791	28	on	on	IN
cord-005453-4057qib7	12791	29	the	the	DT
cord-005453-4057qib7	12791	30	overall	overall	JJ
cord-005453-4057qib7	12791	31	survival	survival	NN
cord-005453-4057qib7	12791	32	.	.	.
cord-005453-4057qib7	12792	1	These	these	DT
cord-005453-4057qib7	12792	2	results	result	NNS
cord-005453-4057qib7	12792	3	are	be	VBP
cord-005453-4057qib7	12792	4	identical	identical	JJ
cord-005453-4057qib7	12792	5	to	to	IN
cord-005453-4057qib7	12792	6	those	those	DT
cord-005453-4057qib7	12792	7	of	of	IN
cord-005453-4057qib7	12792	8	Fermand	Fermand	NNP
cord-005453-4057qib7	12792	9	(	(	-LRB-
cord-005453-4057qib7	12792	10	1999	1999	CD
cord-005453-4057qib7	12792	11	)	)	-RRB-
cord-005453-4057qib7	12792	12	.	.	.
cord-005453-4057qib7	12793	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12793	2	:	:	:
cord-005453-4057qib7	12793	3	Nothing	nothing	NN
cord-005453-4057qib7	12793	4	to	to	TO
cord-005453-4057qib7	12793	5	declare	declare	VB
cord-005453-4057qib7	12793	6	Background	background	NN
cord-005453-4057qib7	12793	7	:	:	:
cord-005453-4057qib7	12793	8	Dimethylsulfoxide	Dimethylsulfoxide	NNP
cord-005453-4057qib7	12793	9	(	(	-LRB-
cord-005453-4057qib7	12793	10	DMSO	DMSO	NNP
cord-005453-4057qib7	12793	11	)	)	-RRB-
cord-005453-4057qib7	12793	12	is	be	VBZ
cord-005453-4057qib7	12793	13	a	a	DT
cord-005453-4057qib7	12793	14	major	major	JJ
cord-005453-4057qib7	12793	15	intracellular	intracellular	JJ
cord-005453-4057qib7	12793	16	cryoprotectant	cryoprotectant	NN
cord-005453-4057qib7	12793	17	,	,	,
cord-005453-4057qib7	12793	18	used	use	VBN
cord-005453-4057qib7	12793	19	for	for	IN
cord-005453-4057qib7	12793	20	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	12793	21	of	of	IN
cord-005453-4057qib7	12793	22	stem	stem	NN
cord-005453-4057qib7	12793	23	cells	cell	NNS
cord-005453-4057qib7	12793	24	.	.	.
cord-005453-4057qib7	12794	1	It	-PRON-	PRP
cord-005453-4057qib7	12794	2	is	be	VBZ
cord-005453-4057qib7	12794	3	toxic	toxic	JJ
cord-005453-4057qib7	12794	4	to	to	IN
cord-005453-4057qib7	12794	5	both	both	DT
cord-005453-4057qib7	12794	6	cells	cell	NNS
cord-005453-4057qib7	12794	7	and	and	CC
cord-005453-4057qib7	12794	8	patients	patient	NNS
cord-005453-4057qib7	12794	9	at	at	IN
cord-005453-4057qib7	12794	10	temperatures	temperature	NNS
cord-005453-4057qib7	12794	11	above	above	IN
cord-005453-4057qib7	12794	12	0	0	CD
cord-005453-4057qib7	12794	13	o	o	NN
cord-005453-4057qib7	12794	14	C.	C.	NNP
cord-005453-4057qib7	12794	15	Reduction	reduction	NN
cord-005453-4057qib7	12794	16	of	of	IN
cord-005453-4057qib7	12794	17	this	this	DT
cord-005453-4057qib7	12794	18	effect	effect	NN
cord-005453-4057qib7	12794	19	is	be	VBZ
cord-005453-4057qib7	12794	20	achieved	achieve	VBN
cord-005453-4057qib7	12794	21	by	by	IN
cord-005453-4057qib7	12794	22	either	either	DT
cord-005453-4057qib7	12794	23	washing	washing	NN
cord-005453-4057qib7	12794	24	of	of	IN
cord-005453-4057qib7	12794	25	cells	cell	NNS
cord-005453-4057qib7	12794	26	after	after	IN
cord-005453-4057qib7	12794	27	thawing	thaw	VBG
cord-005453-4057qib7	12794	28	or	or	CC
cord-005453-4057qib7	12794	29	by	by	IN
cord-005453-4057qib7	12794	30	reduction	reduction	NN
cord-005453-4057qib7	12794	31	of	of	IN
cord-005453-4057qib7	12794	32	DMSO	DMSO	NNP
cord-005453-4057qib7	12794	33	during	during	IN
cord-005453-4057qib7	12794	34	freezing	freezing	NN
cord-005453-4057qib7	12794	35	and	and	CC
cord-005453-4057qib7	12794	36	storage	storage	NN
cord-005453-4057qib7	12794	37	.	.	.
cord-005453-4057qib7	12795	1	The	the	DT
cord-005453-4057qib7	12795	2	latter	latter	JJ
cord-005453-4057qib7	12795	3	requires	require	VBZ
cord-005453-4057qib7	12795	4	addition	addition	NN
cord-005453-4057qib7	12795	5	of	of	IN
cord-005453-4057qib7	12795	6	extracellular	extracellular	JJ
cord-005453-4057qib7	12795	7	cryoprotectants	cryoprotectant	NNS
cord-005453-4057qib7	12795	8	to	to	IN
cord-005453-4057qib7	12795	9	the	the	DT
cord-005453-4057qib7	12795	10	freezing	freeze	VBG
cord-005453-4057qib7	12795	11	media	medium	NNS
cord-005453-4057qib7	12795	12	.	.	.
cord-005453-4057qib7	12796	1	We	-PRON-	PRP
cord-005453-4057qib7	12796	2	assessed	assess	VBD
cord-005453-4057qib7	12796	3	the	the	DT
cord-005453-4057qib7	12796	4	effect	effect	NN
cord-005453-4057qib7	12796	5	of	of	IN
cord-005453-4057qib7	12796	6	low	low	JJ
cord-005453-4057qib7	12796	7	DMSO	DMSO	NNP
cord-005453-4057qib7	12796	8	concentration	concentration	NN
cord-005453-4057qib7	12796	9	and	and	CC
cord-005453-4057qib7	12796	10	different	different	JJ
cord-005453-4057qib7	12796	11	hematocrits	hematocrit	NNS
cord-005453-4057qib7	12796	12	of	of	IN
cord-005453-4057qib7	12796	13	the	the	DT
cord-005453-4057qib7	12796	14	frozen	frozen	JJ
cord-005453-4057qib7	12796	15	cells	cell	NNS
cord-005453-4057qib7	12796	16	on	on	IN
cord-005453-4057qib7	12796	17	cell	cell	NN
cord-005453-4057qib7	12796	18	viability	viability	NN
cord-005453-4057qib7	12796	19	and	and	CC
cord-005453-4057qib7	12796	20	hematologic	hematologic	JJ
cord-005453-4057qib7	12796	21	recovery	recovery	NN
cord-005453-4057qib7	12796	22	in	in	IN
cord-005453-4057qib7	12796	23	patients	patient	NNS
cord-005453-4057qib7	12796	24	,	,	,
cord-005453-4057qib7	12796	25	transplanted	transplant	VBN
cord-005453-4057qib7	12796	26	for	for	IN
cord-005453-4057qib7	12796	27	multiple	multiple	JJ
cord-005453-4057qib7	12796	28	myeloma	myeloma	NN
cord-005453-4057qib7	12796	29	.	.	.
cord-005453-4057qib7	12797	1	Methods	method	NNS
cord-005453-4057qib7	12797	2	:	:	:
cord-005453-4057qib7	12798	1	Cells	cell	NNS
cord-005453-4057qib7	12798	2	were	be	VBD
cord-005453-4057qib7	12798	3	non	non	JJ
cord-005453-4057qib7	12798	4	-	-	JJ
cord-005453-4057qib7	12798	5	programmed	program	VBN
cord-005453-4057qib7	12798	6	frozen	frozen	JJ
cord-005453-4057qib7	12798	7	and	and	CC
cord-005453-4057qib7	12798	8	stored	store	VBN
cord-005453-4057qib7	12798	9	at	at	IN
cord-005453-4057qib7	12798	10	-80	-80	NNP
cord-005453-4057qib7	12798	11	o	o	NN
cord-005453-4057qib7	12798	12	C	c	NN
cord-005453-4057qib7	12798	13	in	in	IN
cord-005453-4057qib7	12798	14	a	a	DT
cord-005453-4057qib7	12798	15	cryoprotectant	cryoprotectant	NN
cord-005453-4057qib7	12798	16	solution	solution	NN
cord-005453-4057qib7	12798	17	achieving	achieve	VBG
cord-005453-4057qib7	12798	18	final	final	JJ
cord-005453-4057qib7	12798	19	concentrations	concentration	NNS
cord-005453-4057qib7	12798	20	of	of	IN
cord-005453-4057qib7	12798	21	5	5	CD
cord-005453-4057qib7	12798	22	%	%	NN
cord-005453-4057qib7	12798	23	DMSO	DMSO	NNP
cord-005453-4057qib7	12798	24	,	,	,
cord-005453-4057qib7	12798	25	3.6	3.6	CD
cord-005453-4057qib7	12798	26	%	%	NN
cord-005453-4057qib7	12798	27	of	of	IN
cord-005453-4057qib7	12798	28	hydroxyethyl	hydroxyethyl	NN
cord-005453-4057qib7	12798	29	starch	starch	NN
cord-005453-4057qib7	12798	30	(	(	-LRB-
cord-005453-4057qib7	12798	31	HES	hes	UH
cord-005453-4057qib7	12798	32	,	,	,
cord-005453-4057qib7	12798	33	Weight	weight	NN
cord-005453-4057qib7	12798	34	average	average	JJ
cord-005453-4057qib7	12798	35	molecular	molecular	JJ
cord-005453-4057qib7	12798	36	weight	weight	NN
cord-005453-4057qib7	12798	37	450	450	CD
cord-005453-4057qib7	12798	38	000	000	CD
cord-005453-4057qib7	12798	39	Da	Da	NNP
cord-005453-4057qib7	12798	40	)	)	-RRB-
cord-005453-4057qib7	12798	41	and	and	CC
cord-005453-4057qib7	12798	42	3	3	CD
cord-005453-4057qib7	12798	43	%	%	NN
cord-005453-4057qib7	12798	44	of	of	IN
cord-005453-4057qib7	12798	45	human	human	JJ
cord-005453-4057qib7	12798	46	serum	serum	NN
cord-005453-4057qib7	12798	47	albumin	albumin	NN
cord-005453-4057qib7	12798	48	.	.	.
cord-005453-4057qib7	12799	1	The	the	DT
cord-005453-4057qib7	12799	2	cell	cell	NN
cord-005453-4057qib7	12799	3	concentration	concentration	NN
cord-005453-4057qib7	12799	4	in	in	IN
cord-005453-4057qib7	12799	5	the	the	DT
cord-005453-4057qib7	12799	6	frozen	frozen	JJ
cord-005453-4057qib7	12799	7	product	product	NN
cord-005453-4057qib7	12799	8	for	for	IN
cord-005453-4057qib7	12799	9	the	the	DT
cord-005453-4057qib7	12799	10	first	first	JJ
cord-005453-4057qib7	12799	11	77	77	CD
cord-005453-4057qib7	12799	12	patients	patient	NNS
cord-005453-4057qib7	12799	13	(	(	-LRB-
cord-005453-4057qib7	12799	14	84	84	CD
cord-005453-4057qib7	12799	15	transplantations	transplantation	NNS
cord-005453-4057qib7	12799	16	)	)	-RRB-
cord-005453-4057qib7	12799	17	varied	vary	VBN
cord-005453-4057qib7	12799	18	between	between	IN
cord-005453-4057qib7	12799	19	100x10	100x10	CD
cord-005453-4057qib7	12799	20	6	6	CD
cord-005453-4057qib7	12799	21	and	and	CC
cord-005453-4057qib7	12799	22	250x10	250x10	CD
cord-005453-4057qib7	12799	23	6	6	CD
cord-005453-4057qib7	12799	24	cells	cell	NNS
cord-005453-4057qib7	12799	25	/	/	SYM
cord-005453-4057qib7	12799	26	ml	ml	NN
cord-005453-4057qib7	12799	27	.	.	.
cord-005453-4057qib7	12800	1	In	in	IN
cord-005453-4057qib7	12800	2	an	an	DT
cord-005453-4057qib7	12800	3	attempt	attempt	NN
cord-005453-4057qib7	12800	4	to	to	TO
cord-005453-4057qib7	12800	5	reduce	reduce	VB
cord-005453-4057qib7	12800	6	the	the	DT
cord-005453-4057qib7	12800	7	amount	amount	NN
cord-005453-4057qib7	12800	8	of	of	IN
cord-005453-4057qib7	12800	9	DMSO	DMSO	NNP
cord-005453-4057qib7	12800	10	infused	infuse	VBN
cord-005453-4057qib7	12800	11	,	,	,
cord-005453-4057qib7	12800	12	for	for	IN
cord-005453-4057qib7	12800	13	the	the	DT
cord-005453-4057qib7	12800	14	rest	rest	NN
cord-005453-4057qib7	12800	15	of	of	IN
cord-005453-4057qib7	12800	16	the	the	DT
cord-005453-4057qib7	12800	17	patients	patient	NNS
cord-005453-4057qib7	12800	18	(	(	-LRB-
cord-005453-4057qib7	12800	19	n=172	n=172	UH
cord-005453-4057qib7	12800	20	;	;	:
cord-005453-4057qib7	12800	21	192	192	CD
cord-005453-4057qib7	12800	22	transplantations	transplantation	NNS
cord-005453-4057qib7	12800	23	)	)	-RRB-
cord-005453-4057qib7	12800	24	we	-PRON-	PRP
cord-005453-4057qib7	12800	25	further	further	RB
cord-005453-4057qib7	12800	26	decreased	decrease	VBD
cord-005453-4057qib7	12800	27	the	the	DT
cord-005453-4057qib7	12800	28	volume	volume	NN
cord-005453-4057qib7	12800	29	of	of	IN
cord-005453-4057qib7	12800	30	the	the	DT
cord-005453-4057qib7	12800	31	freezing	freeze	VBG
cord-005453-4057qib7	12800	32	suspension	suspension	NN
cord-005453-4057qib7	12800	33	by	by	IN
cord-005453-4057qib7	12800	34	removal	removal	NN
cord-005453-4057qib7	12800	35	of	of	IN
cord-005453-4057qib7	12800	36	the	the	DT
cord-005453-4057qib7	12800	37	entire	entire	JJ
cord-005453-4057qib7	12800	38	plasma	plasma	NN
cord-005453-4057qib7	12800	39	.	.	.
cord-005453-4057qib7	12801	1	The	the	DT
cord-005453-4057qib7	12801	2	average	average	JJ
cord-005453-4057qib7	12801	3	age	age	NN
cord-005453-4057qib7	12801	4	of	of	IN
cord-005453-4057qib7	12801	5	the	the	DT
cord-005453-4057qib7	12801	6	transplanted	transplanted	JJ
cord-005453-4057qib7	12801	7	patients	patient	NNS
cord-005453-4057qib7	12801	8	was	be	VBD
cord-005453-4057qib7	12801	9	55	55	CD
cord-005453-4057qib7	12801	10	(	(	-LRB-
cord-005453-4057qib7	12801	11	35	35	CD
cord-005453-4057qib7	12801	12	-71	-71	NN
cord-005453-4057qib7	12801	13	)	)	-RRB-
cord-005453-4057qib7	12801	14	.	.	.
cord-005453-4057qib7	12802	1	The	the	DT
cord-005453-4057qib7	12802	2	cells	cell	NNS
cord-005453-4057qib7	12802	3	were	be	VBD
cord-005453-4057qib7	12802	4	bedside	bedside	NN
cord-005453-4057qib7	12802	5	thawed	thaw	VBN
cord-005453-4057qib7	12802	6	at	at	IN
cord-005453-4057qib7	12802	7	37	37	CD
cord-005453-4057qib7	12802	8	o	o	NN
cord-005453-4057qib7	12802	9	C	c	NN
cord-005453-4057qib7	12802	10	water	water	NN
cord-005453-4057qib7	12802	11	bath	bath	NN
cord-005453-4057qib7	12802	12	.	.	.
cord-005453-4057qib7	12803	1	The	the	DT
cord-005453-4057qib7	12803	2	average	average	JJ
cord-005453-4057qib7	12803	3	cell	cell	NN
cord-005453-4057qib7	12803	4	dose	dose	NN
cord-005453-4057qib7	12803	5	was	be	VBD
cord-005453-4057qib7	12803	6	2,95x10	2,95x10	CD
cord-005453-4057qib7	12803	7	6	6	CD
cord-005453-4057qib7	12803	8	/kg	/kg	.
cord-005453-4057qib7	12804	1	(	(	-LRB-
cord-005453-4057qib7	12804	2	1,3	1,3	CD
cord-005453-4057qib7	12804	3	-9,2x10	-9,2x10	CD
cord-005453-4057qib7	12804	4	6	6	CD
cord-005453-4057qib7	12804	5	/kg	/kg	.
cord-005453-4057qib7	12804	6	)	)	-RRB-
cord-005453-4057qib7	12804	7	.	.	.
cord-005453-4057qib7	12805	1	Results	result	NNS
cord-005453-4057qib7	12805	2	:	:	:
cord-005453-4057qib7	12805	3	Viability	viability	NN
cord-005453-4057qib7	12805	4	of	of	IN
cord-005453-4057qib7	12805	5	the	the	DT
cord-005453-4057qib7	12805	6	stem	stem	NN
cord-005453-4057qib7	12805	7	cells	cell	NNS
cord-005453-4057qib7	12805	8	following	follow	VBG
cord-005453-4057qib7	12805	9	thawing	thaw	VBG
cord-005453-4057qib7	12805	10	assessed	assess	VBN
cord-005453-4057qib7	12805	11	by	by	IN
cord-005453-4057qib7	12805	12	trypan	trypan	NNP
cord-005453-4057qib7	12805	13	blue	blue	JJ
cord-005453-4057qib7	12805	14	exclusion	exclusion	NN
cord-005453-4057qib7	12805	15	was	be	VBD
cord-005453-4057qib7	12805	16	95,34	95,34	CD
cord-005453-4057qib7	12805	17	%	%	NN
cord-005453-4057qib7	12805	18	.	.	.
cord-005453-4057qib7	12806	1	The	the	DT
cord-005453-4057qib7	12806	2	hematocrit	hematocrit	NN
cord-005453-4057qib7	12806	3	of	of	IN
cord-005453-4057qib7	12806	4	the	the	DT
cord-005453-4057qib7	12806	5	frozen	frozen	JJ
cord-005453-4057qib7	12806	6	cells	cell	NNS
cord-005453-4057qib7	12806	7	had	have	VBD
cord-005453-4057qib7	12806	8	no	no	DT
cord-005453-4057qib7	12806	9	effect	effect	NN
cord-005453-4057qib7	12806	10	on	on	IN
cord-005453-4057qib7	12806	11	cell	cell	NN
cord-005453-4057qib7	12806	12	viability	viability	NN
cord-005453-4057qib7	12806	13	(	(	-LRB-
cord-005453-4057qib7	12806	14	94,80%(low	94,80%(low	NN
cord-005453-4057qib7	12806	15	)	)	-RRB-
cord-005453-4057qib7	12806	16	vs	vs	IN
cord-005453-4057qib7	12806	17	95,52%(high	95,52%(high	CD
cord-005453-4057qib7	12806	18	)	)	-RRB-
cord-005453-4057qib7	12806	19	)	)	-RRB-
cord-005453-4057qib7	12806	20	.	.	.
cord-005453-4057qib7	12807	1	The	the	DT
cord-005453-4057qib7	12807	2	major	major	JJ
cord-005453-4057qib7	12807	3	complaints	complaint	NNS
cord-005453-4057qib7	12807	4	,	,	,
cord-005453-4057qib7	12807	5	if	if	IN
cord-005453-4057qib7	12807	6	any	any	DT
cord-005453-4057qib7	12807	7	,	,	,
cord-005453-4057qib7	12807	8	during	during	IN
cord-005453-4057qib7	12807	9	stem	stem	NN
cord-005453-4057qib7	12807	10	cell	cell	NN
cord-005453-4057qib7	12807	11	infusion	infusion	NN
cord-005453-4057qib7	12807	12	were	be	VBD
cord-005453-4057qib7	12807	13	coughing	cough	VBG
cord-005453-4057qib7	12807	14	and	and	CC
cord-005453-4057qib7	12807	15	an	an	DT
cord-005453-4057qib7	12807	16	increase	increase	NN
cord-005453-4057qib7	12807	17	in	in	IN
cord-005453-4057qib7	12807	18	nausea	nausea	NN
cord-005453-4057qib7	12807	19	and	and	CC
cord-005453-4057qib7	12807	20	vomiting	vomiting	NN
cord-005453-4057qib7	12807	21	induced	induce	VBN
cord-005453-4057qib7	12807	22	by	by	IN
cord-005453-4057qib7	12807	23	the	the	DT
cord-005453-4057qib7	12807	24	prior	prior	JJ
cord-005453-4057qib7	12807	25	conditioning	conditioning	NN
cord-005453-4057qib7	12807	26	.	.	.
cord-005453-4057qib7	12808	1	The	the	DT
cord-005453-4057qib7	12808	2	average	average	JJ
cord-005453-4057qib7	12808	3	time	time	NN
cord-005453-4057qib7	12808	4	for	for	IN
cord-005453-4057qib7	12808	5	hematological	hematological	JJ
cord-005453-4057qib7	12808	6	recovery	recovery	NN
cord-005453-4057qib7	12808	7	was	be	VBD
cord-005453-4057qib7	12808	8	11,66	11,66	CD
cord-005453-4057qib7	12808	9	days	day	NNS
cord-005453-4057qib7	12808	10	(	(	-LRB-
cord-005453-4057qib7	12808	11	between	between	IN
cord-005453-4057qib7	12808	12	9	9	CD
cord-005453-4057qib7	12808	13	and	and	CC
cord-005453-4057qib7	12808	14	19	19	CD
cord-005453-4057qib7	12808	15	)	)	-RRB-
cord-005453-4057qib7	12808	16	for	for	IN
cord-005453-4057qib7	12808	17	the	the	DT
cord-005453-4057qib7	12808	18	neutrophils	neutrophil	NNS
cord-005453-4057qib7	12808	19	,	,	,
cord-005453-4057qib7	12808	20	and	and	CC
cord-005453-4057qib7	12808	21	12,17	12,17	CD
cord-005453-4057qib7	12808	22	(	(	-LRB-
cord-005453-4057qib7	12808	23	between	between	IN
cord-005453-4057qib7	12808	24	9	9	CD
cord-005453-4057qib7	12808	25	and	and	CC
cord-005453-4057qib7	12808	26	20	20	CD
cord-005453-4057qib7	12808	27	)	)	-RRB-
cord-005453-4057qib7	12808	28	days	day	NNS
cord-005453-4057qib7	12808	29	for	for	IN
cord-005453-4057qib7	12808	30	the	the	DT
cord-005453-4057qib7	12808	31	platelets	platelet	NNS
cord-005453-4057qib7	12808	32	.	.	.
cord-005453-4057qib7	12809	1	There	there	EX
cord-005453-4057qib7	12809	2	was	be	VBD
cord-005453-4057qib7	12809	3	no	no	DT
cord-005453-4057qib7	12809	4	significant	significant	JJ
cord-005453-4057qib7	12809	5	difference	difference	NN
cord-005453-4057qib7	12809	6	in	in	IN
cord-005453-4057qib7	12809	7	viability	viability	NN
cord-005453-4057qib7	12809	8	and	and	CC
cord-005453-4057qib7	12809	9	hematologic	hematologic	JJ
cord-005453-4057qib7	12809	10	recovery	recovery	NN
cord-005453-4057qib7	12809	11	(	(	-LRB-
cord-005453-4057qib7	12809	12	11,86	11,86	CD
cord-005453-4057qib7	12809	13	and	and	CC
cord-005453-4057qib7	12809	14	12,60	12,60	CD
cord-005453-4057qib7	12809	15	vs	vs	IN
cord-005453-4057qib7	12809	16	11,59	11,59	CD
cord-005453-4057qib7	12809	17	and	and	CC
cord-005453-4057qib7	12809	18	12,02	12,02	CD
cord-005453-4057qib7	12809	19	)	)	-RRB-
cord-005453-4057qib7	12809	20	between	between	IN
cord-005453-4057qib7	12809	21	patients	patient	NNS
cord-005453-4057qib7	12809	22	receiving	receive	VBG
cord-005453-4057qib7	12809	23	cells	cell	NNS
cord-005453-4057qib7	12809	24	frozen	freeze	VBN
cord-005453-4057qib7	12809	25	with	with	IN
cord-005453-4057qib7	12809	26	low	low	JJ
cord-005453-4057qib7	12809	27	or	or	CC
cord-005453-4057qib7	12809	28	high	high	JJ
cord-005453-4057qib7	12809	29	hematocrit	hematocrit	NN
cord-005453-4057qib7	12809	30	.	.	.
cord-005453-4057qib7	12810	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12810	2	:	:	:
cord-005453-4057qib7	12811	1	Dimethylsulfoxide	Dimethylsulfoxide	NNP
cord-005453-4057qib7	12811	2	,	,	,
cord-005453-4057qib7	12811	3	despite	despite	IN
cord-005453-4057qib7	12811	4	its	-PRON-	PRP$
cord-005453-4057qib7	12811	5	cryoprotective	cryoprotective	JJ
cord-005453-4057qib7	12811	6	properties	property	NNS
cord-005453-4057qib7	12811	7	,	,	,
cord-005453-4057qib7	12811	8	is	be	VBZ
cord-005453-4057qib7	12811	9	toxic	toxic	JJ
cord-005453-4057qib7	12811	10	for	for	IN
cord-005453-4057qib7	12811	11	stem	stem	NN
cord-005453-4057qib7	12811	12	cells	cell	NNS
cord-005453-4057qib7	12811	13	at	at	IN
cord-005453-4057qib7	12811	14	temperatures	temperature	NNS
cord-005453-4057qib7	12811	15	above	above	IN
cord-005453-4057qib7	12811	16	zero	zero	CD
cord-005453-4057qib7	12811	17	C	c	NN
cord-005453-4057qib7	12811	18	and	and	CC
cord-005453-4057qib7	12811	19	induces	induce	VBZ
cord-005453-4057qib7	12811	20	many	many	JJ
cord-005453-4057qib7	12811	21	side	side	NN
cord-005453-4057qib7	12811	22	effects	effect	NNS
cord-005453-4057qib7	12811	23	(	(	-LRB-
cord-005453-4057qib7	12811	24	cardiac	cardiac	JJ
cord-005453-4057qib7	12811	25	,	,	,
cord-005453-4057qib7	12811	26	neurologic	neurologic	JJ
cord-005453-4057qib7	12811	27	,	,	,
cord-005453-4057qib7	12811	28	respiratory	respiratory	JJ
cord-005453-4057qib7	12811	29	,	,	,
cord-005453-4057qib7	12811	30	etc	etc	FW
cord-005453-4057qib7	12811	31	.	.	.
cord-005453-4057qib7	12811	32	)	)	-RRB-
cord-005453-4057qib7	12812	1	in	in	IN
cord-005453-4057qib7	12812	2	the	the	DT
cord-005453-4057qib7	12812	3	patients	patient	NNS
cord-005453-4057qib7	12812	4	.	.	.
cord-005453-4057qib7	12813	1	To	to	TO
cord-005453-4057qib7	12813	2	reduce	reduce	VB
cord-005453-4057qib7	12813	3	those	those	DT
cord-005453-4057qib7	12813	4	side	side	NN
cord-005453-4057qib7	12813	5	effects	effect	NNS
cord-005453-4057qib7	12813	6	we	-PRON-	PRP
cord-005453-4057qib7	12813	7	use	use	VBP
cord-005453-4057qib7	12813	8	lower	low	JJR
cord-005453-4057qib7	12813	9	DMSO	DMSO	NNP
cord-005453-4057qib7	12813	10	concentration	concentration	NN
cord-005453-4057qib7	12813	11	,	,	,
cord-005453-4057qib7	12813	12	high	high	JJ
cord-005453-4057qib7	12813	13	hematocrit	hematocrit	NN
cord-005453-4057qib7	12813	14	resulting	result	VBG
cord-005453-4057qib7	12813	15	in	in	IN
cord-005453-4057qib7	12813	16	lower	low	JJR
cord-005453-4057qib7	12813	17	volume	volume	NN
cord-005453-4057qib7	12813	18	of	of	IN
cord-005453-4057qib7	12813	19	the	the	DT
cord-005453-4057qib7	12813	20	frozen	frozen	JJ
cord-005453-4057qib7	12813	21	cell	cell	NN
cord-005453-4057qib7	12813	22	suspension	suspension	NN
cord-005453-4057qib7	12813	23	,	,	,
cord-005453-4057qib7	12813	24	thus	thus	RB
cord-005453-4057qib7	12813	25	reducing	reduce	VBG
cord-005453-4057qib7	12813	26	the	the	DT
cord-005453-4057qib7	12813	27	final	final	JJ
cord-005453-4057qib7	12813	28	quantity	quantity	NN
cord-005453-4057qib7	12813	29	of	of	IN
cord-005453-4057qib7	12813	30	DMSO	DMSO	NNP
cord-005453-4057qib7	12813	31	to	to	TO
cord-005453-4057qib7	12813	32	be	be	VB
cord-005453-4057qib7	12813	33	infused	infuse	VBN
cord-005453-4057qib7	12813	34	to	to	IN
cord-005453-4057qib7	12813	35	the	the	DT
cord-005453-4057qib7	12813	36	patients	patient	NNS
cord-005453-4057qib7	12813	37	.	.	.
cord-005453-4057qib7	12814	1	This	this	DT
cord-005453-4057qib7	12814	2	does	do	VBZ
cord-005453-4057qib7	12814	3	not	not	RB
cord-005453-4057qib7	12814	4	affect	affect	VB
cord-005453-4057qib7	12814	5	the	the	DT
cord-005453-4057qib7	12814	6	cell	cell	NN
cord-005453-4057qib7	12814	7	viability	viability	NN
cord-005453-4057qib7	12814	8	or	or	CC
cord-005453-4057qib7	12814	9	the	the	DT
cord-005453-4057qib7	12814	10	hematologic	hematologic	JJ
cord-005453-4057qib7	12814	11	recovery	recovery	NN
cord-005453-4057qib7	12814	12	of	of	IN
cord-005453-4057qib7	12814	13	patients	patient	NNS
cord-005453-4057qib7	12814	14	after	after	IN
cord-005453-4057qib7	12814	15	transplantation	transplantation	NN
cord-005453-4057qib7	12814	16	.	.	.
cord-005453-4057qib7	12815	1	Our	-PRON-	PRP$
cord-005453-4057qib7	12815	2	easily	easily	RB
cord-005453-4057qib7	12815	3	performed	perform	VBN
cord-005453-4057qib7	12815	4	method	method	NN
cord-005453-4057qib7	12815	5	for	for	IN
cord-005453-4057qib7	12815	6	unprogrammed	unprogrammed	JJ
cord-005453-4057qib7	12815	7	freezing	freezing	NN
cord-005453-4057qib7	12815	8	of	of	IN
cord-005453-4057qib7	12815	9	stem	stem	NN
cord-005453-4057qib7	12815	10	cells	cell	NNS
cord-005453-4057qib7	12815	11	with	with	IN
cord-005453-4057qib7	12815	12	final	final	JJ
cord-005453-4057qib7	12815	13	DMSO	DMSO	NNP
cord-005453-4057qib7	12815	14	concentration	concentration	NN
cord-005453-4057qib7	12815	15	5	5	CD
cord-005453-4057qib7	12815	16	%	%	NN
cord-005453-4057qib7	12815	17	at	at	IN
cord-005453-4057qib7	12815	18	-80	-80	NNP
cord-005453-4057qib7	12815	19	o	o	NN
cord-005453-4057qib7	12815	20	C	C	NNP
cord-005453-4057qib7	12815	21	is	be	VBZ
cord-005453-4057qib7	12815	22	safe	safe	JJ
cord-005453-4057qib7	12815	23	,	,	,
cord-005453-4057qib7	12815	24	well	well	RB
cord-005453-4057qib7	12815	25	tolerated	tolerate	VBN
cord-005453-4057qib7	12815	26	,	,	,
cord-005453-4057qib7	12815	27	and	and	CC
cord-005453-4057qib7	12815	28	provides	provide	VBZ
cord-005453-4057qib7	12815	29	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	12815	30	,	,	,
cord-005453-4057qib7	12815	31	which	which	WDT
cord-005453-4057qib7	12815	32	allows	allow	VBZ
cord-005453-4057qib7	12815	33	high	high	JJ
cord-005453-4057qib7	12815	34	viability	viability	NN
cord-005453-4057qib7	12815	35	and	and	CC
cord-005453-4057qib7	12815	36	stable	stable	JJ
cord-005453-4057qib7	12815	37	cell	cell	NN
cord-005453-4057qib7	12815	38	engraftment	engraftment	NN
cord-005453-4057qib7	12815	39	,	,	,
cord-005453-4057qib7	12815	40	while	while	IN
cord-005453-4057qib7	12815	41	reducing	reduce	VBG
cord-005453-4057qib7	12815	42	the	the	DT
cord-005453-4057qib7	12815	43	undesired	undesired	JJ
cord-005453-4057qib7	12815	44	side	side	NN
cord-005453-4057qib7	12815	45	effects	effect	NNS
cord-005453-4057qib7	12815	46	of	of	IN
cord-005453-4057qib7	12815	47	DMSO	DMSO	NNP
cord-005453-4057qib7	12815	48	.	.	.
cord-005453-4057qib7	12816	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12816	2	:	:	:
cord-005453-4057qib7	12816	3	Nothing	nothing	NN
cord-005453-4057qib7	12816	4	to	to	TO
cord-005453-4057qib7	12816	5	disclose	disclose	VB
cord-005453-4057qib7	12816	6	The	the	DT
cord-005453-4057qib7	12816	7	conditioning	conditioning	NN
cord-005453-4057qib7	12816	8	regimen	regimen	NN
cord-005453-4057qib7	12816	9	consisted	consist	VBD
cord-005453-4057qib7	12816	10	of	of	IN
cord-005453-4057qib7	12816	11	Melphalan	Melphalan	NNP
cord-005453-4057qib7	12816	12	for	for	IN
cord-005453-4057qib7	12816	13	most	most	JJS
cord-005453-4057qib7	12816	14	of	of	IN
cord-005453-4057qib7	12816	15	the	the	DT
cord-005453-4057qib7	12816	16	patients	patient	NNS
cord-005453-4057qib7	12816	17	.	.	.
cord-005453-4057qib7	12817	1	The	the	DT
cord-005453-4057qib7	12817	2	average	average	JJ
cord-005453-4057qib7	12817	3	age	age	NN
cord-005453-4057qib7	12817	4	at	at	IN
cord-005453-4057qib7	12817	5	the	the	DT
cord-005453-4057qib7	12817	6	time	time	NN
cord-005453-4057qib7	12817	7	of	of	IN
cord-005453-4057qib7	12817	8	transplantation	transplantation	NN
cord-005453-4057qib7	12817	9	was	be	VBD
cord-005453-4057qib7	12817	10	55	55	CD
cord-005453-4057qib7	12817	11	years	year	NNS
cord-005453-4057qib7	12817	12	(	(	-LRB-
cord-005453-4057qib7	12817	13	35	35	CD
cord-005453-4057qib7	12817	14	-71	-71	NN
cord-005453-4057qib7	12817	15	)	)	-RRB-
cord-005453-4057qib7	12817	16	.	.	.
cord-005453-4057qib7	12818	1	Patients	patient	NNS
cord-005453-4057qib7	12818	2	were	be	VBD
cord-005453-4057qib7	12818	3	transplanted	transplant	VBN
cord-005453-4057qib7	12818	4	with	with	IN
cord-005453-4057qib7	12818	5	an	an	DT
cord-005453-4057qib7	12818	6	average	average	JJ
cord-005453-4057qib7	12818	7	cell	cell	NN
cord-005453-4057qib7	12818	8	dose	dose	NN
cord-005453-4057qib7	12818	9	of	of	IN
cord-005453-4057qib7	12818	10	2,95x10	2,95x10	CD
cord-005453-4057qib7	12818	11	6	6	CD
cord-005453-4057qib7	12818	12	/kg	/kg	.
cord-005453-4057qib7	12819	1	(	(	-LRB-
cord-005453-4057qib7	12819	2	1,30	1,30	CD
cord-005453-4057qib7	12819	3	-9,20x10	-9,20x10	NNP
cord-005453-4057qib7	12819	4	6	6	CD
cord-005453-4057qib7	12819	5	/kg	/kg	NFP
cord-005453-4057qib7	12819	6	)	)	-RRB-
cord-005453-4057qib7	12819	7	for	for	IN
cord-005453-4057qib7	12819	8	the	the	DT
cord-005453-4057qib7	12819	9	first	first	JJ
cord-005453-4057qib7	12819	10	transplantation	transplantation	NN
cord-005453-4057qib7	12819	11	and	and	CC
cord-005453-4057qib7	12819	12	2,36x10	2,36x10	CD
cord-005453-4057qib7	12819	13	6	6	CD
cord-005453-4057qib7	12819	14	/kg	/kg	.
cord-005453-4057qib7	12819	15	(	(	-LRB-
cord-005453-4057qib7	12819	16	1,64	1,64	CD
cord-005453-4057qib7	12819	17	-3,19x10	-3,19x10	NNP
cord-005453-4057qib7	12819	18	6	6	CD
cord-005453-4057qib7	12819	19	/kg	/kg	NFP
cord-005453-4057qib7	12819	20	)	)	-RRB-
cord-005453-4057qib7	12819	21	for	for	IN
cord-005453-4057qib7	12819	22	the	the	DT
cord-005453-4057qib7	12819	23	second	second	JJ
cord-005453-4057qib7	12819	24	one	one	CD
cord-005453-4057qib7	12820	1	(	(	-LRB-
cord-005453-4057qib7	12820	2	every	every	DT
cord-005453-4057qib7	12820	3	patient	patient	NN
cord-005453-4057qib7	12820	4	received	receive	VBD
cord-005453-4057qib7	12820	5	the	the	DT
cord-005453-4057qib7	12820	6	same	same	JJ
cord-005453-4057qib7	12820	7	cell	cell	NN
cord-005453-4057qib7	12820	8	dose	dose	NN
cord-005453-4057qib7	12820	9	as	as	IN
cord-005453-4057qib7	12820	10	for	for	IN
cord-005453-4057qib7	12820	11	the	the	DT
cord-005453-4057qib7	12820	12	first	first	JJ
cord-005453-4057qib7	12820	13	)	)	-RRB-
cord-005453-4057qib7	12820	14	with	with	IN
cord-005453-4057qib7	12820	15	average	average	JJ
cord-005453-4057qib7	12820	16	cell	cell	NN
cord-005453-4057qib7	12820	17	viability	viability	NN
cord-005453-4057qib7	12820	18	95,34	95,34	CD
cord-005453-4057qib7	12820	19	%	%	NN
cord-005453-4057qib7	12820	20	(	(	-LRB-
cord-005453-4057qib7	12820	21	70	70	CD
cord-005453-4057qib7	12820	22	-99	-99	NN
cord-005453-4057qib7	12820	23	%	%	NN
cord-005453-4057qib7	12820	24	)	)	-RRB-
cord-005453-4057qib7	12820	25	,	,	,
cord-005453-4057qib7	12820	26	with	with	IN
cord-005453-4057qib7	12820	27	little	little	JJ
cord-005453-4057qib7	12820	28	difference	difference	NN
cord-005453-4057qib7	12820	29	between	between	IN
cord-005453-4057qib7	12820	30	first	first	JJ
cord-005453-4057qib7	12820	31	and	and	CC
cord-005453-4057qib7	12820	32	second	second	JJ
cord-005453-4057qib7	12820	33	transplantation	transplantation	NN
cord-005453-4057qib7	12820	34	.	.	.
cord-005453-4057qib7	12821	1	Results	result	NNS
cord-005453-4057qib7	12821	2	:	:	:
cord-005453-4057qib7	12822	1	The	the	DT
cord-005453-4057qib7	12822	2	average	average	JJ
cord-005453-4057qib7	12822	3	time	time	NN
cord-005453-4057qib7	12822	4	for	for	IN
cord-005453-4057qib7	12822	5	hematological	hematological	JJ
cord-005453-4057qib7	12822	6	recovery	recovery	NN
cord-005453-4057qib7	12822	7	was	be	VBD
cord-005453-4057qib7	12822	8	11,60	11,60	CD
cord-005453-4057qib7	12822	9	(	(	-LRB-
cord-005453-4057qib7	12822	10	between	between	IN
cord-005453-4057qib7	12822	11	9	9	CD
cord-005453-4057qib7	12822	12	and	and	CC
cord-005453-4057qib7	12822	13	19	19	CD
cord-005453-4057qib7	12822	14	)	)	-RRB-
cord-005453-4057qib7	12822	15	days	day	NNS
cord-005453-4057qib7	12822	16	for	for	IN
cord-005453-4057qib7	12822	17	the	the	DT
cord-005453-4057qib7	12822	18	neutrophils	neutrophil	NNS
cord-005453-4057qib7	12822	19	,	,	,
cord-005453-4057qib7	12822	20	and	and	CC
cord-005453-4057qib7	12822	21	12.11	12.11	CD
cord-005453-4057qib7	12822	22	(	(	-LRB-
cord-005453-4057qib7	12822	23	between	between	IN
cord-005453-4057qib7	12822	24	9	9	CD
cord-005453-4057qib7	12822	25	and	and	CC
cord-005453-4057qib7	12822	26	20	20	CD
cord-005453-4057qib7	12822	27	)	)	-RRB-
cord-005453-4057qib7	12822	28	days	day	NNS
cord-005453-4057qib7	12822	29	for	for	IN
cord-005453-4057qib7	12822	30	the	the	DT
cord-005453-4057qib7	12822	31	platelets	platelet	NNS
cord-005453-4057qib7	12822	32	.	.	.
cord-005453-4057qib7	12823	1	We	-PRON-	PRP
cord-005453-4057qib7	12823	2	found	find	VBD
cord-005453-4057qib7	12823	3	no	no	DT
cord-005453-4057qib7	12823	4	correlation	correlation	NN
cord-005453-4057qib7	12823	5	between	between	IN
cord-005453-4057qib7	12823	6	the	the	DT
cord-005453-4057qib7	12823	7	cell	cell	NN
cord-005453-4057qib7	12823	8	dose	dose	NN
cord-005453-4057qib7	12823	9	and	and	CC
cord-005453-4057qib7	12823	10	the	the	DT
cord-005453-4057qib7	12823	11	hematological	hematological	JJ
cord-005453-4057qib7	12823	12	recovery	recovery	NN
cord-005453-4057qib7	12823	13	.	.	.
cord-005453-4057qib7	12824	1	There	there	EX
cord-005453-4057qib7	12824	2	was	be	VBD
cord-005453-4057qib7	12824	3	no	no	DT
cord-005453-4057qib7	12824	4	difference	difference	NN
cord-005453-4057qib7	12824	5	in	in	IN
cord-005453-4057qib7	12824	6	the	the	DT
cord-005453-4057qib7	12824	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12824	8	recovery	recovery	NN
cord-005453-4057qib7	12824	9	between	between	IN
cord-005453-4057qib7	12824	10	the	the	DT
cord-005453-4057qib7	12824	11	first	first	JJ
cord-005453-4057qib7	12824	12	and	and	CC
cord-005453-4057qib7	12824	13	the	the	DT
cord-005453-4057qib7	12824	14	second	second	JJ
cord-005453-4057qib7	12824	15	transplantation	transplantation	NN
cord-005453-4057qib7	12824	16	in	in	IN
cord-005453-4057qib7	12824	17	the	the	DT
cord-005453-4057qib7	12824	18	patients	patient	NNS
cord-005453-4057qib7	12824	19	,	,	,
cord-005453-4057qib7	12824	20	who	who	WP
cord-005453-4057qib7	12824	21	underwent	undergo	VBD
cord-005453-4057qib7	12824	22	tandem	tandem	NN
cord-005453-4057qib7	12824	23	or	or	CC
cord-005453-4057qib7	12824	24	two	two	CD
cord-005453-4057qib7	12824	25	transplantations	transplantation	NNS
cord-005453-4057qib7	12824	26	.	.	.
cord-005453-4057qib7	12825	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12825	2	:	:	:
cord-005453-4057qib7	12826	1	Recovery	recovery	NN
cord-005453-4057qib7	12826	2	time	time	NN
cord-005453-4057qib7	12826	3	is	be	VBZ
cord-005453-4057qib7	12826	4	considered	consider	VBN
cord-005453-4057qib7	12826	5	by	by	IN
cord-005453-4057qib7	12826	6	some	some	DT
cord-005453-4057qib7	12826	7	to	to	TO
cord-005453-4057qib7	12826	8	be	be	VB
cord-005453-4057qib7	12826	9	a	a	DT
cord-005453-4057qib7	12826	10	function	function	NN
cord-005453-4057qib7	12826	11	of	of	IN
cord-005453-4057qib7	12826	12	the	the	DT
cord-005453-4057qib7	12826	13	effective	effective	JJ
cord-005453-4057qib7	12826	14	stem	stem	NN
cord-005453-4057qib7	12826	15	cell	cell	NN
cord-005453-4057qib7	12826	16	number	number	NN
cord-005453-4057qib7	12826	17	.	.	.
cord-005453-4057qib7	12827	1	We	-PRON-	PRP
cord-005453-4057qib7	12827	2	did	do	VBD
cord-005453-4057qib7	12827	3	not	not	RB
cord-005453-4057qib7	12827	4	find	find	VB
cord-005453-4057qib7	12827	5	such	such	JJ
cord-005453-4057qib7	12827	6	correlation	correlation	NN
cord-005453-4057qib7	12827	7	,	,	,
cord-005453-4057qib7	12827	8	probably	probably	RB
cord-005453-4057qib7	12827	9	because	because	IN
cord-005453-4057qib7	12827	10	in	in	IN
cord-005453-4057qib7	12827	11	the	the	DT
cord-005453-4057qib7	12827	12	analyzed	analyze	VBN
cord-005453-4057qib7	12827	13	group	group	NN
cord-005453-4057qib7	12827	14	all	all	PDT
cord-005453-4057qib7	12827	15	the	the	DT
cord-005453-4057qib7	12827	16	patients	patient	NNS
cord-005453-4057qib7	12827	17	,	,	,
cord-005453-4057qib7	12827	18	except	except	IN
cord-005453-4057qib7	12827	19	four	four	CD
cord-005453-4057qib7	12827	20	of	of	IN
cord-005453-4057qib7	12827	21	them	-PRON-	PRP
cord-005453-4057qib7	12827	22	,	,	,
cord-005453-4057qib7	12827	23	received	receive	VBD
cord-005453-4057qib7	12827	24	a	a	DT
cord-005453-4057qib7	12827	25	dose	dose	NN
cord-005453-4057qib7	12827	26	greater	great	JJR
cord-005453-4057qib7	12827	27	than	than	IN
cord-005453-4057qib7	12827	28	2	2	CD
cord-005453-4057qib7	12827	29	x10	x10	CD
cord-005453-4057qib7	12827	30	6	6	CD
cord-005453-4057qib7	12827	31	/kg	/kg	CD
cord-005453-4057qib7	12827	32	cell	cell	NN
cord-005453-4057qib7	12827	33	,	,	,
cord-005453-4057qib7	12827	34	which	which	WDT
cord-005453-4057qib7	12827	35	is	be	VBZ
cord-005453-4057qib7	12827	36	accepted	accept	VBN
cord-005453-4057qib7	12827	37	as	as	IN
cord-005453-4057qib7	12827	38	a	a	DT
cord-005453-4057qib7	12827	39	safe	safe	JJ
cord-005453-4057qib7	12827	40	dose	dose	NN
cord-005453-4057qib7	12827	41	for	for	IN
cord-005453-4057qib7	12827	42	autologous	autologous	JJ
cord-005453-4057qib7	12827	43	stem	stem	NN
cord-005453-4057qib7	12827	44	cell	cell	NN
cord-005453-4057qib7	12827	45	transplantation	transplantation	NN
cord-005453-4057qib7	12827	46	.	.	.
cord-005453-4057qib7	12828	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12828	2	:	:	:
cord-005453-4057qib7	12828	3	Nothing	nothing	NN
cord-005453-4057qib7	12828	4	to	to	TO
cord-005453-4057qib7	12828	5	disclose	disclose	VB
cord-005453-4057qib7	12828	6	P569	P569	NNP
cord-005453-4057qib7	12828	7	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	12828	8	-	-	HYPH
cord-005453-4057qib7	12828	9	mobilized	mobilize	VBN
cord-005453-4057qib7	12828	10	patients	patient	NNS
cord-005453-4057qib7	12828	11	have	have	VBP
cord-005453-4057qib7	12828	12	a	a	DT
cord-005453-4057qib7	12828	13	high	high	JJ
cord-005453-4057qib7	12828	14	risk	risk	NN
cord-005453-4057qib7	12828	15	of	of	IN
cord-005453-4057qib7	12828	16	noninfectious	noninfectious	JJ
cord-005453-4057qib7	12828	17	fever	fever	NN
cord-005453-4057qib7	12828	18	during	during	IN
cord-005453-4057qib7	12828	19	engraftment	engraftment	NN
cord-005453-4057qib7	12828	20	after	after	IN
cord-005453-4057qib7	12828	21	autologous	autologous	JJ
cord-005453-4057qib7	12828	22	peripheral	peripheral	JJ
cord-005453-4057qib7	12828	23	blood	blood	NN
cord-005453-4057qib7	12828	24	stem	stem	NN
cord-005453-4057qib7	12828	25	cell	cell	NN
cord-005453-4057qib7	12828	26	transplantation	transplantation	NN
cord-005453-4057qib7	12828	27	Background	background	NN
cord-005453-4057qib7	12828	28	:	:	:
cord-005453-4057qib7	12828	29	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	12828	30	enables	enable	VBZ
cord-005453-4057qib7	12828	31	rapid	rapid	JJ
cord-005453-4057qib7	12828	32	and	and	CC
cord-005453-4057qib7	12828	33	efficient	efficient	JJ
cord-005453-4057qib7	12828	34	mobilization	mobilization	NN
cord-005453-4057qib7	12828	35	of	of	IN
cord-005453-4057qib7	12828	36	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12828	37	stem	stem	NN
cord-005453-4057qib7	12828	38	cells	cell	NNS
cord-005453-4057qib7	12828	39	.	.	.
cord-005453-4057qib7	12829	1	However	however	RB
cord-005453-4057qib7	12829	2	,	,	,
cord-005453-4057qib7	12829	3	its	-PRON-	PRP$
cord-005453-4057qib7	12829	4	impact	impact	NN
cord-005453-4057qib7	12829	5	on	on	IN
cord-005453-4057qib7	12829	6	adverse	adverse	JJ
cord-005453-4057qib7	12829	7	clinical	clinical	JJ
cord-005453-4057qib7	12829	8	events	event	NNS
cord-005453-4057qib7	12829	9	after	after	IN
cord-005453-4057qib7	12829	10	autologous	autologous	JJ
cord-005453-4057qib7	12829	11	peripheral	peripheral	JJ
cord-005453-4057qib7	12829	12	blood	blood	NN
cord-005453-4057qib7	12829	13	stem	stem	NN
cord-005453-4057qib7	12829	14	cell	cell	NN
cord-005453-4057qib7	12829	15	transplantation	transplantation	NN
cord-005453-4057qib7	12829	16	(	(	-LRB-
cord-005453-4057qib7	12829	17	PBSCT	PBSCT	NNP
cord-005453-4057qib7	12829	18	)	)	-RRB-
cord-005453-4057qib7	12829	19	is	be	VBZ
cord-005453-4057qib7	12829	20	not	not	RB
cord-005453-4057qib7	12829	21	fully	fully	RB
cord-005453-4057qib7	12829	22	understood	understand	VBN
cord-005453-4057qib7	12829	23	.	.	.
cord-005453-4057qib7	12830	1	Fever	fever	NN
cord-005453-4057qib7	12830	2	is	be	VBZ
cord-005453-4057qib7	12830	3	one	one	CD
cord-005453-4057qib7	12830	4	of	of	IN
cord-005453-4057qib7	12830	5	the	the	DT
cord-005453-4057qib7	12830	6	major	major	JJ
cord-005453-4057qib7	12830	7	complications	complication	NNS
cord-005453-4057qib7	12830	8	in	in	IN
cord-005453-4057qib7	12830	9	the	the	DT
cord-005453-4057qib7	12830	10	preengraftment	preengraftment	NN
cord-005453-4057qib7	12830	11	phase	phase	NN
cord-005453-4057qib7	12830	12	of	of	IN
cord-005453-4057qib7	12830	13	PBSCT	PBSCT	NNP
cord-005453-4057qib7	12830	14	.	.	.
cord-005453-4057qib7	12831	1	In	in	IN
cord-005453-4057qib7	12831	2	this	this	DT
cord-005453-4057qib7	12831	3	research	research	NN
cord-005453-4057qib7	12831	4	,	,	,
cord-005453-4057qib7	12831	5	we	-PRON-	PRP
cord-005453-4057qib7	12831	6	focused	focus	VBD
cord-005453-4057qib7	12831	7	on	on	IN
cord-005453-4057qib7	12831	8	non	non	JJ
cord-005453-4057qib7	12831	9	-	-	JJ
cord-005453-4057qib7	12831	10	infectious	infectious	JJ
cord-005453-4057qib7	12831	11	fever	fever	NN
cord-005453-4057qib7	12831	12	around	around	IN
cord-005453-4057qib7	12831	13	the	the	DT
cord-005453-4057qib7	12831	14	time	time	NN
cord-005453-4057qib7	12831	15	of	of	IN
cord-005453-4057qib7	12831	16	bone	bone	NN
cord-005453-4057qib7	12831	17	marrow	marrow	NN
cord-005453-4057qib7	12831	18	recovery	recovery	NN
cord-005453-4057qib7	12831	19	and	and	CC
cord-005453-4057qib7	12831	20	investigated	investigate	VBD
cord-005453-4057qib7	12831	21	whether	whether	IN
cord-005453-4057qib7	12831	22	plerixafor	plerixafor	NN
cord-005453-4057qib7	12831	23	as	as	IN
cord-005453-4057qib7	12831	24	mobilization	mobilization	NN
cord-005453-4057qib7	12831	25	therapy	therapy	NN
cord-005453-4057qib7	12831	26	plays	play	VBZ
cord-005453-4057qib7	12831	27	a	a	DT
cord-005453-4057qib7	12831	28	role	role	NN
cord-005453-4057qib7	12831	29	in	in	IN
cord-005453-4057qib7	12831	30	engraftment	engraftment	NN
cord-005453-4057qib7	12831	31	fever	fever	NN
cord-005453-4057qib7	12831	32	.	.	.
cord-005453-4057qib7	12832	1	Methods	method	NNS
cord-005453-4057qib7	12832	2	:	:	:
cord-005453-4057qib7	12832	3	We	-PRON-	PRP
cord-005453-4057qib7	12832	4	reviewed	review	VBD
cord-005453-4057qib7	12832	5	80	80	CD
cord-005453-4057qib7	12832	6	autologous	autologous	JJ
cord-005453-4057qib7	12832	7	PBSCTs	pbsct	NNS
cord-005453-4057qib7	12832	8	for	for	IN
cord-005453-4057qib7	12832	9	treatment	treatment	NN
cord-005453-4057qib7	12832	10	of	of	IN
cord-005453-4057qib7	12832	11	multiple	multiple	JJ
cord-005453-4057qib7	12832	12	myeloma	myeloma	NN
cord-005453-4057qib7	12832	13	at	at	IN
cord-005453-4057qib7	12832	14	the	the	DT
cord-005453-4057qib7	12832	15	Japanese	japanese	JJ
cord-005453-4057qib7	12832	16	Red	Red	NNP
cord-005453-4057qib7	12832	17	Cross	Cross	NNP
cord-005453-4057qib7	12832	18	Medical	Medical	NNP
cord-005453-4057qib7	12832	19	Center	Center	NNP
cord-005453-4057qib7	12832	20	between	between	IN
cord-005453-4057qib7	12832	21	2012	2012	CD
cord-005453-4057qib7	12832	22	-	-	SYM
cord-005453-4057qib7	12832	23	2018	2018	CD
cord-005453-4057qib7	12832	24	.	.	.
cord-005453-4057qib7	12833	1	Non	non	JJ
cord-005453-4057qib7	12833	2	-	-	JJ
cord-005453-4057qib7	12833	3	infectious	infectious	JJ
cord-005453-4057qib7	12833	4	fever	fever	NN
cord-005453-4057qib7	12833	5	was	be	VBD
cord-005453-4057qib7	12833	6	defined	define	VBN
cord-005453-4057qib7	12833	7	as	as	IN
cord-005453-4057qib7	12833	8	temperature	temperature	NN
cord-005453-4057qib7	12833	9	≥37	≥37	IN
cord-005453-4057qib7	12833	10	°	°	NN
cord-005453-4057qib7	12833	11	C	c	NN
cord-005453-4057qib7	12833	12	with	with	IN
cord-005453-4057qib7	12833	13	onset	onset	NN
cord-005453-4057qib7	12833	14	between	between	IN
cord-005453-4057qib7	12833	15	two	two	CD
cord-005453-4057qib7	12833	16	days	day	NNS
cord-005453-4057qib7	12833	17	prior	prior	RB
cord-005453-4057qib7	12833	18	to	to	IN
cord-005453-4057qib7	12833	19	and	and	CC
cord-005453-4057qib7	12833	20	two	two	CD
cord-005453-4057qib7	12833	21	days	day	NNS
cord-005453-4057qib7	12833	22	after	after	IN
cord-005453-4057qib7	12833	23	engraftment	engraftment	NN
cord-005453-4057qib7	12833	24	without	without	IN
cord-005453-4057qib7	12833	25	clinical	clinical	JJ
cord-005453-4057qib7	12833	26	or	or	CC
cord-005453-4057qib7	12833	27	microbiological	microbiological	JJ
cord-005453-4057qib7	12833	28	documentation	documentation	NN
cord-005453-4057qib7	12833	29	of	of	IN
cord-005453-4057qib7	12833	30	infection	infection	NN
cord-005453-4057qib7	12833	31	.	.	.
cord-005453-4057qib7	12834	1	Results	result	NNS
cord-005453-4057qib7	12834	2	:	:	:
cord-005453-4057qib7	12835	1	Patients	patient	NNS
cord-005453-4057qib7	12835	2	were	be	VBD
cord-005453-4057qib7	12835	3	mobilized	mobilize	VBN
cord-005453-4057qib7	12835	4	by	by	IN
cord-005453-4057qib7	12835	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12835	6	and	and	CC
cord-005453-4057qib7	12835	7	filgrastim	filgrastim	NN
cord-005453-4057qib7	12835	8	in	in	IN
cord-005453-4057qib7	12835	9	57.5	57.5	CD
cord-005453-4057qib7	12835	10	%	%	NN
cord-005453-4057qib7	12835	11	(	(	-LRB-
cord-005453-4057qib7	12835	12	n	n	NN
cord-005453-4057qib7	12835	13	=	=	SYM
cord-005453-4057qib7	12835	14	46	46	CD
cord-005453-4057qib7	12835	15	)	)	-RRB-
cord-005453-4057qib7	12835	16	and	and	CC
cord-005453-4057qib7	12835	17	filgrastim	filgrastim	NN
cord-005453-4057qib7	12835	18	and	and	CC
cord-005453-4057qib7	12835	19	plerixafor	plerixafor	NN
cord-005453-4057qib7	12835	20	in	in	IN
cord-005453-4057qib7	12835	21	42.5	42.5	CD
cord-005453-4057qib7	12835	22	%	%	NN
cord-005453-4057qib7	12835	23	(	(	-LRB-
cord-005453-4057qib7	12835	24	n	n	NN
cord-005453-4057qib7	12835	25	=	=	SYM
cord-005453-4057qib7	12835	26	34	34	CD
cord-005453-4057qib7	12835	27	)	)	-RRB-
cord-005453-4057qib7	12835	28	.	.	.
cord-005453-4057qib7	12836	1	The	the	DT
cord-005453-4057qib7	12836	2	median	median	JJ
cord-005453-4057qib7	12836	3	number	number	NN
cord-005453-4057qib7	12836	4	of	of	IN
cord-005453-4057qib7	12836	5	transfused	transfuse	VBN
cord-005453-4057qib7	12836	6	CD34	CD34	NNP
cord-005453-4057qib7	12836	7	+	+	CC
cord-005453-4057qib7	12836	8	cells	cell	NNS
cord-005453-4057qib7	12836	9	were	be	VBD
cord-005453-4057qib7	12836	10	2.61×10	2.61×10	CD
cord-005453-4057qib7	12836	11	6	6	CD
cord-005453-4057qib7	12837	1	/kg	/kg	.
cord-005453-4057qib7	12838	1	and	and	CC
cord-005453-4057qib7	12838	2	3.45×10	3.45×10	CD
cord-005453-4057qib7	12838	3	6	6	CD
cord-005453-4057qib7	12838	4	/	/	SYM
cord-005453-4057qib7	12838	5	kg	kg	NNS
cord-005453-4057qib7	12838	6	,	,	,
cord-005453-4057qib7	12838	7	respectively	respectively	RB
cord-005453-4057qib7	12838	8	(	(	-LRB-
cord-005453-4057qib7	12838	9	P=0.002	P=0.002	NNP
cord-005453-4057qib7	12838	10	)	)	-RRB-
cord-005453-4057qib7	12838	11	.	.	.
cord-005453-4057qib7	12839	1	Patients	patient	NNS
cord-005453-4057qib7	12839	2	transfused	transfuse	VBN
cord-005453-4057qib7	12839	3	with	with	IN
cord-005453-4057qib7	12839	4	plerixafor	plerixafor	NN
cord-005453-4057qib7	12839	5	-	-	HYPH
cord-005453-4057qib7	12839	6	mobilized	mobilize	VBN
cord-005453-4057qib7	12839	7	grafts	graft	NNS
cord-005453-4057qib7	12839	8	had	have	VBD
cord-005453-4057qib7	12839	9	a	a	DT
cord-005453-4057qib7	12839	10	higher	high	JJR
cord-005453-4057qib7	12839	11	risk	risk	NN
cord-005453-4057qib7	12839	12	of	of	IN
cord-005453-4057qib7	12839	13	noninfectious	noninfectious	JJ
cord-005453-4057qib7	12839	14	fever	fever	NN
cord-005453-4057qib7	12839	15	(	(	-LRB-
cord-005453-4057qib7	12839	16	85.3	85.3	CD
cord-005453-4057qib7	12839	17	%	%	NN
cord-005453-4057qib7	12839	18	vs	vs	IN
cord-005453-4057qib7	12839	19	63.0	63.0	CD
cord-005453-4057qib7	12839	20	%	%	NN
cord-005453-4057qib7	12839	21	,	,	,
cord-005453-4057qib7	12839	22	P	p	NN
cord-005453-4057qib7	12839	23	<	<	XX
cord-005453-4057qib7	12839	24	0.05	0.05	CD
cord-005453-4057qib7	12839	25	)	)	-RRB-
cord-005453-4057qib7	12839	26	.	.	.
cord-005453-4057qib7	12840	1	CD34	CD34	NNP
cord-005453-4057qib7	12840	2	+	+	CC
cord-005453-4057qib7	12840	3	cell	cell	NN
cord-005453-4057qib7	12840	4	number	number	NN
cord-005453-4057qib7	12840	5	or	or	CC
cord-005453-4057qib7	12840	6	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12840	7	pretreatment	pretreatment	NN
cord-005453-4057qib7	12840	8	had	have	VBD
cord-005453-4057qib7	12840	9	no	no	DT
cord-005453-4057qib7	12840	10	relationship	relationship	NN
cord-005453-4057qib7	12840	11	to	to	IN
cord-005453-4057qib7	12840	12	non	non	JJ
cord-005453-4057qib7	12840	13	-	-	JJ
cord-005453-4057qib7	12840	14	infectious	infectious	JJ
cord-005453-4057qib7	12840	15	fever	fever	NN
cord-005453-4057qib7	12840	16	.	.	.
cord-005453-4057qib7	12841	1	The	the	DT
cord-005453-4057qib7	12841	2	recovery	recovery	NN
cord-005453-4057qib7	12841	3	of	of	IN
cord-005453-4057qib7	12841	4	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12841	5	was	be	VBD
cord-005453-4057qib7	12841	6	more	more	RBR
cord-005453-4057qib7	12841	7	rapid	rapid	JJ
cord-005453-4057qib7	12841	8	in	in	IN
cord-005453-4057qib7	12841	9	plerixafor	plerixafor	NN
cord-005453-4057qib7	12841	10	-	-	HYPH
cord-005453-4057qib7	12841	11	mobilized	mobilize	VBN
cord-005453-4057qib7	12841	12	patients	patient	NNS
cord-005453-4057qib7	12841	13	(	(	-LRB-
cord-005453-4057qib7	12841	14	P=0.001	P=0.001	NNP
cord-005453-4057qib7	12841	15	)	)	-RRB-
cord-005453-4057qib7	12841	16	.	.	.
cord-005453-4057qib7	12842	1	However	however	RB
cord-005453-4057qib7	12842	2	,	,	,
cord-005453-4057qib7	12842	3	the	the	DT
cord-005453-4057qib7	12842	4	number	number	NN
cord-005453-4057qib7	12842	5	of	of	IN
cord-005453-4057qib7	12842	6	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12842	7	was	be	VBD
cord-005453-4057qib7	12842	8	not	not	RB
cord-005453-4057qib7	12842	9	associated	associate	VBN
cord-005453-4057qib7	12842	10	with	with	IN
cord-005453-4057qib7	12842	11	non	non	JJ
cord-005453-4057qib7	12842	12	-	-	JJ
cord-005453-4057qib7	12842	13	infectious	infectious	JJ
cord-005453-4057qib7	12842	14	fever	fever	NN
cord-005453-4057qib7	12842	15	.	.	.
cord-005453-4057qib7	12843	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12843	2	:	:	:
cord-005453-4057qib7	12844	1	Combination	combination	NN
cord-005453-4057qib7	12844	2	of	of	IN
cord-005453-4057qib7	12844	3	filgrastim	filgrastim	NN
cord-005453-4057qib7	12844	4	and	and	CC
cord-005453-4057qib7	12844	5	plerixafor	plerixafor	NN
cord-005453-4057qib7	12844	6	as	as	IN
cord-005453-4057qib7	12844	7	mobilization	mobilization	NN
cord-005453-4057qib7	12844	8	therapy	therapy	NN
cord-005453-4057qib7	12844	9	resulted	result	VBD
cord-005453-4057qib7	12844	10	in	in	IN
cord-005453-4057qib7	12844	11	an	an	DT
cord-005453-4057qib7	12844	12	increased	increase	VBN
cord-005453-4057qib7	12844	13	risk	risk	NN
cord-005453-4057qib7	12844	14	of	of	IN
cord-005453-4057qib7	12844	15	noninfectious	noninfectious	JJ
cord-005453-4057qib7	12844	16	fever	fever	NN
cord-005453-4057qib7	12844	17	during	during	IN
cord-005453-4057qib7	12844	18	engraftment	engraftment	NN
cord-005453-4057qib7	12844	19	comparing	compare	VBG
cord-005453-4057qib7	12844	20	to	to	IN
cord-005453-4057qib7	12844	21	mobilization	mobilization	NN
cord-005453-4057qib7	12844	22	with	with	IN
cord-005453-4057qib7	12844	23	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12844	24	and	and	CC
cord-005453-4057qib7	12844	25	filgrastim	filgrastim	NN
cord-005453-4057qib7	12844	26	.	.	.
cord-005453-4057qib7	12845	1	While	while	IN
cord-005453-4057qib7	12845	2	the	the	DT
cord-005453-4057qib7	12845	3	mechanism	mechanism	NN
cord-005453-4057qib7	12845	4	remains	remain	VBZ
cord-005453-4057qib7	12845	5	unclear	unclear	JJ
cord-005453-4057qib7	12845	6	and	and	CC
cord-005453-4057qib7	12845	7	requires	require	VBZ
cord-005453-4057qib7	12845	8	further	further	JJ
cord-005453-4057qib7	12845	9	studies	study	NNS
cord-005453-4057qib7	12845	10	,	,	,
cord-005453-4057qib7	12845	11	plerixafor	plerixafor	NN
cord-005453-4057qib7	12845	12	-	-	HYPH
cord-005453-4057qib7	12845	13	mobilized	mobilize	VBN
cord-005453-4057qib7	12845	14	grafts	graft	NNS
cord-005453-4057qib7	12845	15	may	may	MD
cord-005453-4057qib7	12845	16	result	result	VB
cord-005453-4057qib7	12845	17	in	in	IN
cord-005453-4057qib7	12845	18	an	an	DT
cord-005453-4057qib7	12845	19	unintended	unintended	JJ
cord-005453-4057qib7	12845	20	increase	increase	NN
cord-005453-4057qib7	12845	21	in	in	IN
cord-005453-4057qib7	12845	22	engraftment	engraftment	NN
cord-005453-4057qib7	12845	23	fever	fever	NN
cord-005453-4057qib7	12845	24	.	.	.
cord-005453-4057qib7	12846	1	Clinicians	clinician	NNS
cord-005453-4057qib7	12846	2	should	should	MD
cord-005453-4057qib7	12846	3	be	be	VB
cord-005453-4057qib7	12846	4	aware	aware	JJ
cord-005453-4057qib7	12846	5	of	of	IN
cord-005453-4057qib7	12846	6	this	this	DT
cord-005453-4057qib7	12846	7	possibility	possibility	NN
cord-005453-4057qib7	12846	8	if	if	IN
cord-005453-4057qib7	12846	9	patients	patient	NNS
cord-005453-4057qib7	12846	10	are	be	VBP
cord-005453-4057qib7	12846	11	transplanted	transplant	VBN
cord-005453-4057qib7	12846	12	with	with	IN
cord-005453-4057qib7	12846	13	those	those	DT
cord-005453-4057qib7	12846	14	grafts	graft	NNS
cord-005453-4057qib7	12846	15	.	.	.
cord-005453-4057qib7	12847	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12847	2	:	:	:
cord-005453-4057qib7	12847	3	KS	KS	NNP
cord-005453-4057qib7	12847	4	received	receive	VBD
cord-005453-4057qib7	12847	5	honorarium	honorarium	NN
cord-005453-4057qib7	12847	6	outside	outside	IN
cord-005453-4057qib7	12847	7	the	the	DT
cord-005453-4057qib7	12847	8	submitted	submit	VBN
cord-005453-4057qib7	12847	9	work	work	NN
cord-005453-4057qib7	12847	10	from	from	IN
cord-005453-4057qib7	12847	11	Janssen	Janssen	NNP
cord-005453-4057qib7	12847	12	,	,	,
cord-005453-4057qib7	12847	13	Novartis	Novartis	NNP
cord-005453-4057qib7	12847	14	,	,	,
cord-005453-4057qib7	12847	15	Celgene	Celgene	NNP
cord-005453-4057qib7	12847	16	,	,	,
cord-005453-4057qib7	12847	17	Ono	Ono	NNP
cord-005453-4057qib7	12847	18	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	12847	19	,	,	,
cord-005453-4057qib7	12847	20	Takeda	Takeda	NNP
cord-005453-4057qib7	12847	21	,	,	,
cord-005453-4057qib7	12847	22	Fujimoto	Fujimoto	NNP
cord-005453-4057qib7	12847	23	Pharmaceuticals	Pharmaceuticals	NNP
cord-005453-4057qib7	12847	24	and	and	CC
cord-005453-4057qib7	12847	25	SRL	SRL	NNP
cord-005453-4057qib7	12847	26	.	.	.
cord-005453-4057qib7	12848	1	TI	TI	NNP
cord-005453-4057qib7	12848	2	received	receive	VBD
cord-005453-4057qib7	12848	3	honorarium	honorarium	NN
cord-005453-4057qib7	12848	4	outside	outside	IN
cord-005453-4057qib7	12848	5	the	the	DT
cord-005453-4057qib7	12848	6	submitted	submit	VBN
cord-005453-4057qib7	12848	7	work	work	NN
cord-005453-4057qib7	12848	8	from	from	IN
cord-005453-4057qib7	12848	9	Janssen	Janssen	NNP
cord-005453-4057qib7	12848	10	,	,	,
cord-005453-4057qib7	12848	11	Celgene	Celgene	NNP
cord-005453-4057qib7	12848	12	,	,	,
cord-005453-4057qib7	12848	13	Ono	Ono	NNP
cord-005453-4057qib7	12848	14	Pharmaceuticals	Pharmaceuticals	NNPS
cord-005453-4057qib7	12848	15	and	and	CC
cord-005453-4057qib7	12848	16	Takeda	Takeda	NNP
cord-005453-4057qib7	12848	17	.	.	.
cord-005453-4057qib7	12848	18	 	 	_SP
cord-005453-4057qib7	12849	1	We	-PRON-	PRP
cord-005453-4057qib7	12849	2	assessed	assess	VBD
cord-005453-4057qib7	12849	3	the	the	DT
cord-005453-4057qib7	12849	4	efficacy	efficacy	NN
cord-005453-4057qib7	12849	5	of	of	IN
cord-005453-4057qib7	12849	6	a	a	DT
cord-005453-4057qib7	12849	7	new	new	JJ
cord-005453-4057qib7	12849	8	conditioning	conditioning	NN
cord-005453-4057qib7	12849	9	regimen	regimen	NN
cord-005453-4057qib7	12849	10	consisted	consist	VBN
cord-005453-4057qib7	12849	11	of	of	IN
cord-005453-4057qib7	12849	12	Decitabine	Decitabine	NNP
cord-005453-4057qib7	12849	13	(	(	-LRB-
cord-005453-4057qib7	12849	14	Dec	Dec	NNP
cord-005453-4057qib7	12849	15	)	)	-RRB-
cord-005453-4057qib7	12849	16	,	,	,
cord-005453-4057qib7	12849	17	Busulfan	Busulfan	NNP
cord-005453-4057qib7	12849	18	(	(	-LRB-
cord-005453-4057qib7	12849	19	Bu	Bu	NNP
cord-005453-4057qib7	12849	20	)	)	-RRB-
cord-005453-4057qib7	12849	21	,	,	,
cord-005453-4057qib7	12849	22	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	12849	23	(	(	-LRB-
cord-005453-4057qib7	12849	24	Cy	Cy	NNP
cord-005453-4057qib7	12849	25	)	)	-RRB-
cord-005453-4057qib7	12849	26	,	,	,
cord-005453-4057qib7	12849	27	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	12849	28	(	(	-LRB-
cord-005453-4057qib7	12849	29	Flud	Flud	NNP
cord-005453-4057qib7	12849	30	)	)	-RRB-
cord-005453-4057qib7	12849	31	and	and	CC
cord-005453-4057qib7	12849	32	cytarabine	cytarabine	NNP
cord-005453-4057qib7	12849	33	(	(	-LRB-
cord-005453-4057qib7	12849	34	Ara	Ara	NNP
cord-005453-4057qib7	12849	35	-	-	HYPH
cord-005453-4057qib7	12849	36	c	c	NNP
cord-005453-4057qib7	12849	37	)	)	-RRB-
cord-005453-4057qib7	12849	38	for	for	IN
cord-005453-4057qib7	12849	39	allo	allo	NN
cord-005453-4057qib7	12849	40	-	-	HYPH
cord-005453-4057qib7	12849	41	HSCT	HSCT	NNP
cord-005453-4057qib7	12849	42	in	in	IN
cord-005453-4057qib7	12849	43	patients	patient	NNS
cord-005453-4057qib7	12849	44	with	with	IN
cord-005453-4057qib7	12849	45	MDS	MDS	NNP
cord-005453-4057qib7	12849	46	and	and	CC
cord-005453-4057qib7	12849	47	MDS/	MDS/	NNP
cord-005453-4057qib7	12849	48	MPN	MPN	NNP
cord-005453-4057qib7	12849	49	.	.	.
cord-005453-4057qib7	12850	1	Fifty	fifty	CD
cord-005453-4057qib7	12850	2	patients	patient	NNS
cord-005453-4057qib7	12850	3	were	be	VBD
cord-005453-4057qib7	12850	4	enrolled	enrol	VBN
cord-005453-4057qib7	12850	5	,	,	,
cord-005453-4057qib7	12850	6	including	include	VBG
cord-005453-4057qib7	12850	7	46	46	CD
cord-005453-4057qib7	12850	8	with	with	IN
cord-005453-4057qib7	12850	9	MDS	MDS	NNP
cord-005453-4057qib7	12850	10	and	and	CC
cord-005453-4057qib7	12850	11	4	4	CD
cord-005453-4057qib7	12850	12	with	with	IN
cord-005453-4057qib7	12850	13	CMML	CMML	NNP
cord-005453-4057qib7	12850	14	.	.	.
cord-005453-4057qib7	12851	1	Patients	patient	NNS
cord-005453-4057qib7	12851	2	received	receive	VBD
cord-005453-4057qib7	12851	3	Dec	Dec	NNP
cord-005453-4057qib7	12851	4	20	20	CD
cord-005453-4057qib7	12851	5	mg	mg	NNP
cord-005453-4057qib7	12851	6	/	/	SYM
cord-005453-4057qib7	12851	7	m	m	NN
cord-005453-4057qib7	12851	8	2	2	CD
cord-005453-4057qib7	12851	9	/day	/day	CD
cord-005453-4057qib7	12851	10	on	on	IN
cord-005453-4057qib7	12851	11	days	day	NNS
cord-005453-4057qib7	12851	12	-9	-9	ADD
cord-005453-4057qib7	12851	13	to	to	IN
cord-005453-4057qib7	12851	14	-5	-5	NNP
cord-005453-4057qib7	12851	15	,	,	,
cord-005453-4057qib7	12851	16	combining	combine	VBG
cord-005453-4057qib7	12851	17	Bu	Bu	NNP
cord-005453-4057qib7	12851	18	/	/	SYM
cord-005453-4057qib7	12851	19	Cy/	cy/	JJ
cord-005453-4057qib7	12851	20	Flu/	Flu/	NNP
cord-005453-4057qib7	12851	21	Ara	Ara	NNP
cord-005453-4057qib7	12851	22	-	-	HYPH
cord-005453-4057qib7	12851	23	c	c	NNP
cord-005453-4057qib7	12851	24	modified	modify	VBD
cord-005453-4057qib7	12851	25	preparative	preparative	JJ
cord-005453-4057qib7	12851	26	regimen	regimen	NN
cord-005453-4057qib7	12851	27	.	.	.
cord-005453-4057qib7	12852	1	Results	result	NNS
cord-005453-4057qib7	12852	2	:	:	:
cord-005453-4057qib7	12853	1	At	at	IN
cord-005453-4057qib7	12853	2	a	a	DT
cord-005453-4057qib7	12853	3	median	median	JJ
cord-005453-4057qib7	12853	4	follow	follow	NN
cord-005453-4057qib7	12853	5	-	-	HYPH
cord-005453-4057qib7	12853	6	up	up	NN
cord-005453-4057qib7	12853	7	of	of	IN
cord-005453-4057qib7	12853	8	522	522	CD
cord-005453-4057qib7	12853	9	(	(	-LRB-
cord-005453-4057qib7	12853	10	15	15	CD
cord-005453-4057qib7	12853	11	-	-	SYM
cord-005453-4057qib7	12853	12	1313	1313	CD
cord-005453-4057qib7	12853	13	)	)	-RRB-
cord-005453-4057qib7	12853	14	days	day	NNS
cord-005453-4057qib7	12853	15	,	,	,
cord-005453-4057qib7	12853	16	the	the	DT
cord-005453-4057qib7	12853	17	overall	overall	JJ
cord-005453-4057qib7	12853	18	survival	survival	NN
cord-005453-4057qib7	12853	19	(	(	-LRB-
cord-005453-4057qib7	12853	20	OS	OS	NNP
cord-005453-4057qib7	12853	21	)	)	-RRB-
cord-005453-4057qib7	12853	22	was	be	VBD
cord-005453-4057qib7	12853	23	86	86	CD
cord-005453-4057qib7	12853	24	%	%	NN
cord-005453-4057qib7	12853	25	,	,	,
cord-005453-4057qib7	12853	26	disease	disease	NN
cord-005453-4057qib7	12853	27	-	-	HYPH
cord-005453-4057qib7	12853	28	free	free	JJ
cord-005453-4057qib7	12853	29	survival	survival	NN
cord-005453-4057qib7	12853	30	(	(	-LRB-
cord-005453-4057qib7	12853	31	DFS	DFS	NNP
cord-005453-4057qib7	12853	32	)	)	-RRB-
cord-005453-4057qib7	12853	33	was	be	VBD
cord-005453-4057qib7	12853	34	78	78	CD
cord-005453-4057qib7	12853	35	%	%	NN
cord-005453-4057qib7	12853	36	,	,	,
cord-005453-4057qib7	12853	37	and	and	CC
cord-005453-4057qib7	12853	38	relapse	relapse	NN
cord-005453-4057qib7	12853	39	incidence	incidence	NN
cord-005453-4057qib7	12853	40	was	be	VBD
cord-005453-4057qib7	12853	41	11	11	CD
cord-005453-4057qib7	12853	42	%	%	NN
cord-005453-4057qib7	12853	43	.	.	.
cord-005453-4057qib7	12854	1	The	the	DT
cord-005453-4057qib7	12854	2	incidence	incidence	NN
cord-005453-4057qib7	12854	3	of	of	IN
cord-005453-4057qib7	12854	4	severe	severe	JJ
cord-005453-4057qib7	12854	5	acute	acute	JJ
cord-005453-4057qib7	12854	6	(	(	-LRB-
cord-005453-4057qib7	12854	7	grade	grade	NN
cord-005453-4057qib7	12854	8	III	III	NNP
cord-005453-4057qib7	12854	9	/	/	SYM
cord-005453-4057qib7	12854	10	IV	IV	NNP
cord-005453-4057qib7	12854	11	)	)	-RRB-
cord-005453-4057qib7	12854	12	graft	graft	NN
cord-005453-4057qib7	12854	13	-	-	HYPH
cord-005453-4057qib7	12854	14	versus	versus	IN
cord-005453-4057qib7	12854	15	-	-	HYPH
cord-005453-4057qib7	12854	16	host	host	NN
cord-005453-4057qib7	12854	17	disease	disease	NN
cord-005453-4057qib7	12854	18	(	(	-LRB-
cord-005453-4057qib7	12854	19	GVHD	GVHD	NNP
cord-005453-4057qib7	12854	20	)	)	-RRB-
cord-005453-4057qib7	12854	21	was	be	VBD
cord-005453-4057qib7	12854	22	22	22	CD
cord-005453-4057qib7	12854	23	%	%	NN
cord-005453-4057qib7	12854	24	,	,	,
cord-005453-4057qib7	12854	25	and	and	CC
cord-005453-4057qib7	12854	26	that	that	DT
cord-005453-4057qib7	12854	27	of	of	IN
cord-005453-4057qib7	12854	28	(	(	-LRB-
cord-005453-4057qib7	12854	29	predominantly	predominantly	RB
cord-005453-4057qib7	12854	30	mild	mild	JJ
cord-005453-4057qib7	12854	31	)	)	-RRB-
cord-005453-4057qib7	12854	32	chronic	chronic	JJ
cord-005453-4057qib7	12854	33	GVHD	GVHD	NNP
cord-005453-4057qib7	12854	34	was	be	VBD
cord-005453-4057qib7	12854	35	40	40	CD
cord-005453-4057qib7	12854	36	%	%	NN
cord-005453-4057qib7	12854	37	.	.	.
cord-005453-4057qib7	12855	1	OS	OS	NNP
cord-005453-4057qib7	12855	2	at	at	IN
cord-005453-4057qib7	12855	3	2	2	CD
cord-005453-4057qib7	12855	4	years	year	NNS
cord-005453-4057qib7	12855	5	was	be	VBD
cord-005453-4057qib7	12855	6	74	74	CD
cord-005453-4057qib7	12855	7	%	%	NN
cord-005453-4057qib7	12855	8	for	for	IN
cord-005453-4057qib7	12855	9	MDS	MDS	NNP
cord-005453-4057qib7	12855	10	patients	patient	NNS
cord-005453-4057qib7	12855	11	with	with	IN
cord-005453-4057qib7	12855	12	high	high	JJ
cord-005453-4057qib7	12855	13	risk	risk	NN
cord-005453-4057qib7	12855	14	,	,	,
cord-005453-4057qib7	12855	15	86	86	CD
cord-005453-4057qib7	12855	16	%	%	NN
cord-005453-4057qib7	12855	17	for	for	IN
cord-005453-4057qib7	12855	18	MDS	MDS	NNP
cord-005453-4057qib7	12855	19	patients	patient	NNS
cord-005453-4057qib7	12855	20	with	with	IN
cord-005453-4057qib7	12855	21	very	very	RB
cord-005453-4057qib7	12855	22	high	high	JJ
cord-005453-4057qib7	12855	23	risk	risk	NN
cord-005453-4057qib7	12855	24	,	,	,
cord-005453-4057qib7	12855	25	respectively	respectively	RB
cord-005453-4057qib7	12855	26	.	.	.
cord-005453-4057qib7	12856	1	The	the	DT
cord-005453-4057qib7	12856	2	survival	survival	NN
cord-005453-4057qib7	12856	3	was	be	VBD
cord-005453-4057qib7	12856	4	delightful	delightful	JJ
cord-005453-4057qib7	12856	5	in	in	IN
cord-005453-4057qib7	12856	6	patients	patient	NNS
cord-005453-4057qib7	12856	7	with	with	IN
cord-005453-4057qib7	12856	8	poor	poor	JJ
cord-005453-4057qib7	12856	9	-	-	HYPH
cord-005453-4057qib7	12856	10	risk	risk	NN
cord-005453-4057qib7	12856	11	mutations	mutation	NNS
cord-005453-4057qib7	12856	12	,	,	,
cord-005453-4057qib7	12856	13	such	such	JJ
cord-005453-4057qib7	12856	14	as	as	IN
cord-005453-4057qib7	12856	15	TP53	TP53	NNP
cord-005453-4057qib7	12856	16	and	and	CC
cord-005453-4057qib7	12856	17	ASXL1	ASXL1	NNP
cord-005453-4057qib7	12856	18	,	,	,
cord-005453-4057qib7	12856	19	(	(	-LRB-
cord-005453-4057qib7	12856	20	86	86	CD
cord-005453-4057qib7	12856	21	%	%	NN
cord-005453-4057qib7	12856	22	)	)	-RRB-
cord-005453-4057qib7	12856	23	and	and	CC
cord-005453-4057qib7	12856	24	with	with	IN
cord-005453-4057qib7	12856	25	three	three	CD
cord-005453-4057qib7	12856	26	or	or	CC
cord-005453-4057qib7	12856	27	more	more	JJR
cord-005453-4057qib7	12856	28	gene	gene	NN
cord-005453-4057qib7	12856	29	mutations	mutation	NNS
cord-005453-4057qib7	12856	30	(	(	-LRB-
cord-005453-4057qib7	12856	31	77	77	CD
cord-005453-4057qib7	12856	32	%	%	NN
cord-005453-4057qib7	12856	33	)	)	-RRB-
cord-005453-4057qib7	12856	34	.	.	.
cord-005453-4057qib7	12857	1	Among	among	IN
cord-005453-4057qib7	12857	2	the	the	DT
cord-005453-4057qib7	12857	3	total	total	JJ
cord-005453-4057qib7	12857	4	12	12	CD
cord-005453-4057qib7	12857	5	patients	patient	NNS
cord-005453-4057qib7	12857	6	with	with	IN
cord-005453-4057qib7	12857	7	poor	poor	JJ
cord-005453-4057qib7	12857	8	-	-	HYPH
cord-005453-4057qib7	12857	9	risk	risk	NN
cord-005453-4057qib7	12857	10	mutations	mutation	NNS
cord-005453-4057qib7	12857	11	in	in	IN
cord-005453-4057qib7	12857	12	our	-PRON-	PRP$
cord-005453-4057qib7	12857	13	research	research	NN
cord-005453-4057qib7	12857	14	,	,	,
cord-005453-4057qib7	12857	15	only	only	RB
cord-005453-4057qib7	12857	16	one	one	CD
cord-005453-4057qib7	12857	17	patient	patient	NN
cord-005453-4057qib7	12857	18	(	(	-LRB-
cord-005453-4057qib7	12857	19	8	8	CD
cord-005453-4057qib7	12857	20	%	%	NN
cord-005453-4057qib7	12857	21	)	)	-RRB-
cord-005453-4057qib7	12857	22	with	with	IN
cord-005453-4057qib7	12857	23	TP53	TP53	NNP
cord-005453-4057qib7	12857	24	relapsed	relapse	VBN
cord-005453-4057qib7	12857	25	and	and	CC
cord-005453-4057qib7	12857	26	one	one	CD
cord-005453-4057qib7	12857	27	(	(	-LRB-
cord-005453-4057qib7	12857	28	8	8	CD
cord-005453-4057qib7	12857	29	%	%	NN
cord-005453-4057qib7	12857	30	)	)	-RRB-
cord-005453-4057qib7	12857	31	with	with	IN
cord-005453-4057qib7	12857	32	ASXL1and	ASXL1and	NNP
cord-005453-4057qib7	12857	33	TET2	TET2	NNP
cord-005453-4057qib7	12857	34	died	die	VBD
cord-005453-4057qib7	12857	35	.	.	.
cord-005453-4057qib7	12858	1	Result	result	NN
cord-005453-4057qib7	12858	2	of	of	IN
cord-005453-4057qib7	12858	3	continuous	continuous	JJ
cord-005453-4057qib7	12858	4	observation	observation	NN
cord-005453-4057qib7	12858	5	after	after	IN
cord-005453-4057qib7	12858	6	transplantation	transplantation	NN
cord-005453-4057qib7	12858	7	,	,	,
cord-005453-4057qib7	12858	8	the	the	DT
cord-005453-4057qib7	12858	9	percentage	percentage	NN
cord-005453-4057qib7	12858	10	of	of	IN
cord-005453-4057qib7	12858	11	NK	NK	NNP
cord-005453-4057qib7	12858	12	cells	cell	NNS
cord-005453-4057qib7	12858	13	in	in	IN
cord-005453-4057qib7	12858	14	the	the	DT
cord-005453-4057qib7	12858	15	peripheral	peripheral	JJ
cord-005453-4057qib7	12858	16	blood	blood	NN
cord-005453-4057qib7	12858	17	of	of	IN
cord-005453-4057qib7	12858	18	all	all	DT
cord-005453-4057qib7	12858	19	patients	patient	NNS
cord-005453-4057qib7	12858	20	who	who	WP
cord-005453-4057qib7	12858	21	had	have	VBD
cord-005453-4057qib7	12858	22	received	receive	VBN
cord-005453-4057qib7	12858	23	Dec	Dec	NNP
cord-005453-4057qib7	12858	24	/	/	SYM
cord-005453-4057qib7	12858	25	Flu	Flu	NNP
cord-005453-4057qib7	12858	26	/	/	SYM
cord-005453-4057qib7	12858	27	Bu	Bu	NNP
cord-005453-4057qib7	12858	28	/	/	SYM
cord-005453-4057qib7	12858	29	CY	CY	NNP
cord-005453-4057qib7	12858	30	/	/	SYM
cord-005453-4057qib7	12858	31	Ara	Ara	NNP
cord-005453-4057qib7	12858	32	-	-	HYPH
cord-005453-4057qib7	12858	33	c	c	NNP
cord-005453-4057qib7	12858	34	conditioning	conditioning	NN
cord-005453-4057qib7	12858	35	increased	increase	VBD
cord-005453-4057qib7	12858	36	at	at	IN
cord-005453-4057qib7	12858	37	day	day	NN
cord-005453-4057qib7	12858	38	28	28	CD
cord-005453-4057qib7	12858	39	,	,	,
cord-005453-4057qib7	12858	40	which	which	WDT
cord-005453-4057qib7	12858	41	may	may	MD
cord-005453-4057qib7	12858	42	essentially	essentially	RB
cord-005453-4057qib7	12858	43	contribute	contribute	VB
cord-005453-4057qib7	12858	44	to	to	IN
cord-005453-4057qib7	12858	45	disease	disease	NNP
cord-005453-4057qib7	12858	46	control	control	NN
cord-005453-4057qib7	12858	47	post	post	NN
cord-005453-4057qib7	12858	48	-	-	NN
cord-005453-4057qib7	12858	49	transplantation	transplantation	NN
cord-005453-4057qib7	12858	50	.	.	.
cord-005453-4057qib7	12859	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12859	2	:	:	:
cord-005453-4057qib7	12860	1	In	in	IN
cord-005453-4057qib7	12860	2	summary	summary	NN
cord-005453-4057qib7	12860	3	,	,	,
cord-005453-4057qib7	12860	4	the	the	DT
cord-005453-4057qib7	12860	5	addition	addition	NN
cord-005453-4057qib7	12860	6	of	of	IN
cord-005453-4057qib7	12860	7	a	a	DT
cord-005453-4057qib7	12860	8	5-day	5-day	JJ
cord-005453-4057qib7	12860	9	schedule	schedule	NN
cord-005453-4057qib7	12860	10	of	of	IN
cord-005453-4057qib7	12860	11	decitabine	decitabine	NNP
cord-005453-4057qib7	12860	12	to	to	IN
cord-005453-4057qib7	12860	13	a	a	DT
cord-005453-4057qib7	12860	14	Flu	Flu	NNP
cord-005453-4057qib7	12860	15	/	/	SYM
cord-005453-4057qib7	12860	16	Bu	Bu	NNP
cord-005453-4057qib7	12860	17	/	/	SYM
cord-005453-4057qib7	12860	18	CY	CY	NNP
cord-005453-4057qib7	12860	19	/	/	SYM
cord-005453-4057qib7	12860	20	Ara	Ara	NNP
cord-005453-4057qib7	12860	21	-	-	HYPH
cord-005453-4057qib7	12860	22	c	c	NNP
cord-005453-4057qib7	12860	23	conditioning	conditioning	NN
cord-005453-4057qib7	12860	24	regimen	regimen	NN
cord-005453-4057qib7	12860	25	has	have	VBZ
cord-005453-4057qib7	12860	26	proven	prove	VBN
cord-005453-4057qib7	12860	27	feasible	feasible	JJ
cord-005453-4057qib7	12860	28	,	,	,
cord-005453-4057qib7	12860	29	with	with	IN
cord-005453-4057qib7	12860	30	a	a	DT
cord-005453-4057qib7	12860	31	low	low	JJ
cord-005453-4057qib7	12860	32	level	level	NN
cord-005453-4057qib7	12860	33	of	of	IN
cord-005453-4057qib7	12860	34	toxicity	toxicity	NN
cord-005453-4057qib7	12860	35	and	and	CC
cord-005453-4057qib7	12860	36	promising	promise	VBG
cord-005453-4057qib7	12860	37	early	early	JJ
cord-005453-4057qib7	12860	38	disease	disease	NN
cord-005453-4057qib7	12860	39	control	control	NN
cord-005453-4057qib7	12860	40	especially	especially	RB
cord-005453-4057qib7	12860	41	in	in	IN
cord-005453-4057qib7	12860	42	patients	patient	NNS
cord-005453-4057qib7	12860	43	with	with	IN
cord-005453-4057qib7	12860	44	high	high	JJ
cord-005453-4057qib7	12860	45	risk	risk	NN
cord-005453-4057qib7	12860	46	MDS	MDS	NNP
cord-005453-4057qib7	12860	47	.	.	.
cord-005453-4057qib7	12861	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12861	2	:	:	:
cord-005453-4057qib7	12861	3	There	there	EX
cord-005453-4057qib7	12861	4	are	be	VBP
cord-005453-4057qib7	12861	5	no	no	DT
cord-005453-4057qib7	12861	6	conflicts	conflict	NNS
cord-005453-4057qib7	12861	7	of	of	IN
cord-005453-4057qib7	12861	8	interest	interest	NN
cord-005453-4057qib7	12861	9	.	.	.
cord-005453-4057qib7	12862	1	The	the	DT
cord-005453-4057qib7	12862	2	SFGM	SFGM	NNP
cord-005453-4057qib7	12862	3	-	-	HYPH
cord-005453-4057qib7	12862	4	TC	TC	NNP
cord-005453-4057qib7	12862	5	MDS	MDS	NNP
cord-005453-4057qib7	12862	6	score	score	NN
cord-005453-4057qib7	12862	7	at	at	IN
cord-005453-4057qib7	12862	8	day	day	NN
cord-005453-4057qib7	12862	9	180	180	CD
cord-005453-4057qib7	12862	10	is	be	VBZ
cord-005453-4057qib7	12862	11	associated	associate	VBN
cord-005453-4057qib7	12862	12	with	with	IN
cord-005453-4057qib7	12862	13	post	post	JJ
cord-005453-4057qib7	12862	14	-	-	JJ
cord-005453-4057qib7	12862	15	transplant	transplant	JJ
cord-005453-4057qib7	12862	16	outcomes	outcome	NNS
cord-005453-4057qib7	12862	17	in	in	IN
cord-005453-4057qib7	12862	18	patients	patient	NNS
cord-005453-4057qib7	12862	19	with	with	IN
cord-005453-4057qib7	12862	20	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	12862	21	syndrome	syndrome	NN
cord-005453-4057qib7	12862	22	who	who	WP
cord-005453-4057qib7	12862	23	underwent	undergo	VBD
cord-005453-4057qib7	12862	24	CD34	CD34	NNP
cord-005453-4057qib7	12862	25	+	+	SYM
cord-005453-4057qib7	12862	26	selected	select	VBN
cord-005453-4057qib7	12862	27	allogeneic	allogeneic	JJ
cord-005453-4057qib7	12862	28	stem	stem	NN
cord-005453-4057qib7	12862	29	cell	cell	NN
cord-005453-4057qib7	12862	30	transplant	transplant	NN
cord-005453-4057qib7	12862	31	Conclusions	conclusion	NNS
cord-005453-4057qib7	12862	32	:	:	:
cord-005453-4057qib7	12863	1	In	in	IN
cord-005453-4057qib7	12863	2	patients	patient	NNS
cord-005453-4057qib7	12863	3	with	with	IN
cord-005453-4057qib7	12863	4	MDS	MDS	NNP
cord-005453-4057qib7	12863	5	undergoing	undergo	VBG
cord-005453-4057qib7	12863	6	TCD	TCD	NNP
cord-005453-4057qib7	12863	7	-	-	HYPH
cord-005453-4057qib7	12863	8	HCT	HCT	NNP
cord-005453-4057qib7	12863	9	,	,	,
cord-005453-4057qib7	12863	10	the	the	DT
cord-005453-4057qib7	12863	11	SFGM	SFGM	NNP
cord-005453-4057qib7	12863	12	-	-	HYPH
cord-005453-4057qib7	12863	13	TC	TC	NNP
cord-005453-4057qib7	12863	14	score	score	NN
cord-005453-4057qib7	12863	15	at	at	IN
cord-005453-4057qib7	12863	16	day	day	NN
cord-005453-4057qib7	12863	17	180	180	CD
cord-005453-4057qib7	12863	18	is	be	VBZ
cord-005453-4057qib7	12863	19	significantly	significantly	RB
cord-005453-4057qib7	12863	20	associated	associate	VBN
cord-005453-4057qib7	12863	21	with	with	IN
cord-005453-4057qib7	12863	22	survival	survival	NN
cord-005453-4057qib7	12863	23	.	.	.
cord-005453-4057qib7	12864	1	The	the	DT
cord-005453-4057qib7	12864	2	lower	low	JJR
cord-005453-4057qib7	12864	3	incidence	incidence	NN
cord-005453-4057qib7	12864	4	of	of	IN
cord-005453-4057qib7	12864	5	acute	acute	JJ
cord-005453-4057qib7	12864	6	GVHD	GVHD	NNP
cord-005453-4057qib7	12864	7	in	in	IN
cord-005453-4057qib7	12864	8	recipients	recipient	NNS
cord-005453-4057qib7	12864	9	of	of	IN
cord-005453-4057qib7	12864	10	CD34-selected	cd34-selected	CD
cord-005453-4057qib7	12864	11	transplants	transplant	NNS
cord-005453-4057qib7	12864	12	and	and	CC
cord-005453-4057qib7	12864	13	the	the	DT
cord-005453-4057qib7	12864	14	use	use	NN
cord-005453-4057qib7	12864	15	of	of	IN
cord-005453-4057qib7	12864	16	myeloablative	myeloablative	JJ
cord-005453-4057qib7	12864	17	condition	condition	NN
cord-005453-4057qib7	12864	18	regimens	regimen	NNS
cord-005453-4057qib7	12864	19	,	,	,
cord-005453-4057qib7	12864	20	with	with	IN
cord-005453-4057qib7	12864	21	lower	low	JJR
cord-005453-4057qib7	12864	22	relapse	relapse	NN
cord-005453-4057qib7	12864	23	,	,	,
cord-005453-4057qib7	12864	24	may	may	MD
cord-005453-4057qib7	12864	25	explain	explain	VB
cord-005453-4057qib7	12864	26	the	the	DT
cord-005453-4057qib7	12864	27	difference	difference	NN
cord-005453-4057qib7	12864	28	with	with	IN
cord-005453-4057qib7	12864	29	the	the	DT
cord-005453-4057qib7	12864	30	original	original	JJ
cord-005453-4057qib7	12864	31	finding	finding	NN
cord-005453-4057qib7	12864	32	that	that	IN
cord-005453-4057qib7	12864	33	the	the	DT
cord-005453-4057qib7	12864	34	SFGM	SFGM	NNP
cord-005453-4057qib7	12864	35	-	-	HYPH
cord-005453-4057qib7	12864	36	TC	TC	NNP
cord-005453-4057qib7	12864	37	was	be	VBD
cord-005453-4057qib7	12864	38	predictive	predictive	JJ
cord-005453-4057qib7	12864	39	at	at	IN
cord-005453-4057qib7	12864	40	day	day	NN
cord-005453-4057qib7	12864	41	100	100	CD
cord-005453-4057qib7	12864	42	in	in	IN
cord-005453-4057qib7	12864	43	unmodified	unmodified	JJ
cord-005453-4057qib7	12864	44	grafts	graft	NNS
cord-005453-4057qib7	12864	45	.	.	.
cord-005453-4057qib7	12865	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12865	2	The	the	DT
cord-005453-4057qib7	12865	3	most	most	RBS
cord-005453-4057qib7	12865	4	frequent	frequent	JJ
cord-005453-4057qib7	12865	5	grade	grade	NN
cord-005453-4057qib7	12865	6	3	3	CD
cord-005453-4057qib7	12865	7	,	,	,
cord-005453-4057qib7	12865	8	4	4	CD
cord-005453-4057qib7	12865	9	toxicities	toxicity	NNS
cord-005453-4057qib7	12865	10	were	be	VBD
cord-005453-4057qib7	12865	11	thromobocytopenia	thromobocytopenia	NNS
cord-005453-4057qib7	12865	12	and	and	CC
cord-005453-4057qib7	12865	13	neutropenia	neutropenia	NN
cord-005453-4057qib7	12865	14	.	.	.
cord-005453-4057qib7	12866	1	Infections	infection	NNS
cord-005453-4057qib7	12866	2	developed	develop	VBN
cord-005453-4057qib7	12866	3	in	in	IN
cord-005453-4057qib7	12866	4	12	12	CD
cord-005453-4057qib7	12866	5	patients	patient	NNS
cord-005453-4057qib7	12866	6	(	(	-LRB-
cord-005453-4057qib7	12866	7	33.3	33.3	CD
cord-005453-4057qib7	12866	8	%	%	NN
cord-005453-4057qib7	12866	9	)	)	-RRB-
cord-005453-4057qib7	12866	10	,	,	,
cord-005453-4057qib7	12866	11	neutropenic	neutropenic	JJ
cord-005453-4057qib7	12866	12	fever	fever	NN
cord-005453-4057qib7	12866	13	in	in	IN
cord-005453-4057qib7	12866	14	8	8	CD
cord-005453-4057qib7	12866	15	(	(	-LRB-
cord-005453-4057qib7	12866	16	19.4	19.4	CD
cord-005453-4057qib7	12866	17	%	%	NN
cord-005453-4057qib7	12866	18	)	)	-RRB-
cord-005453-4057qib7	12866	19	.	.	.
cord-005453-4057qib7	12867	1	Five	five	CD
cord-005453-4057qib7	12867	2	patients	patient	NNS
cord-005453-4057qib7	12867	3	(	(	-LRB-
cord-005453-4057qib7	12867	4	13.9	13.9	CD
cord-005453-4057qib7	12867	5	%	%	NN
cord-005453-4057qib7	12867	6	)	)	-RRB-
cord-005453-4057qib7	12867	7	either	either	CC
cord-005453-4057qib7	12867	8	developed	develop	VBN
cord-005453-4057qib7	12867	9	or	or	CC
cord-005453-4057qib7	12867	10	experienced	experienced	JJ
cord-005453-4057qib7	12867	11	exacerbation	exacerbation	NN
cord-005453-4057qib7	12867	12	of	of	IN
cord-005453-4057qib7	12867	13	acute	acute	JJ
cord-005453-4057qib7	12867	14	graft	graft	NN
cord-005453-4057qib7	12867	15	versus	versus	IN
cord-005453-4057qib7	12867	16	host	host	NN
cord-005453-4057qib7	12867	17	disease	disease	NN
cord-005453-4057qib7	12867	18	(	(	-LRB-
cord-005453-4057qib7	12867	19	GVHD	GVHD	NNP
cord-005453-4057qib7	12867	20	)	)	-RRB-
cord-005453-4057qib7	12867	21	,	,	,
cord-005453-4057qib7	12867	22	nonechronic	nonechronic	NNP
cord-005453-4057qib7	12867	23	GVHD	GVHD	NNP
cord-005453-4057qib7	12867	24	.	.	.
cord-005453-4057qib7	12868	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12868	2	:	:	:
cord-005453-4057qib7	12869	1	Azacitidine	azacitidine	JJ
cord-005453-4057qib7	12869	2	use	use	NN
cord-005453-4057qib7	12869	3	is	be	VBZ
cord-005453-4057qib7	12869	4	associated	associate	VBN
cord-005453-4057qib7	12869	5	with	with	IN
cord-005453-4057qib7	12869	6	only	only	JJ
cord-005453-4057qib7	12869	7	modest	modest	JJ
cord-005453-4057qib7	12869	8	activity	activity	NN
cord-005453-4057qib7	12869	9	in	in	IN
cord-005453-4057qib7	12869	10	patients	patient	NNS
cord-005453-4057qib7	12869	11	who	who	WP
cord-005453-4057qib7	12869	12	relapse	relapse	VBP
cord-005453-4057qib7	12869	13	after	after	IN
cord-005453-4057qib7	12869	14	allo	allo	NN
cord-005453-4057qib7	12869	15	-	-	HYPH
cord-005453-4057qib7	12869	16	HSCT	HSCT	NNP
cord-005453-4057qib7	12869	17	.	.	.
cord-005453-4057qib7	12870	1	However	however	RB
cord-005453-4057qib7	12870	2	,	,	,
cord-005453-4057qib7	12870	3	in	in	IN
cord-005453-4057qib7	12870	4	patients	patient	NNS
cord-005453-4057qib7	12870	5	who	who	WP
cord-005453-4057qib7	12870	6	respond	respond	VBP
cord-005453-4057qib7	12870	7	to	to	IN
cord-005453-4057qib7	12870	8	treatment	treatment	NN
cord-005453-4057qib7	12870	9	it	-PRON-	PRP
cord-005453-4057qib7	12870	10	may	may	MD
cord-005453-4057qib7	12870	11	allow	allow	VB
cord-005453-4057qib7	12870	12	for	for	IN
cord-005453-4057qib7	12870	13	a	a	DT
cord-005453-4057qib7	12870	14	durable	durable	JJ
cord-005453-4057qib7	12870	15	disease	disease	NN
cord-005453-4057qib7	12870	16	control	control	NN
cord-005453-4057qib7	12870	17	.	.	.
cord-005453-4057qib7	12871	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12871	2	:	:	:
cord-005453-4057qib7	12872	1	The	the	DT
cord-005453-4057qib7	12872	2	authors	author	NNS
cord-005453-4057qib7	12872	3	declare	declare	VBP
cord-005453-4057qib7	12872	4	no	no	DT
cord-005453-4057qib7	12872	5	competing	compete	VBG
cord-005453-4057qib7	12872	6	conflicts	conflict	NNS
cord-005453-4057qib7	12872	7	of	of	IN
cord-005453-4057qib7	12872	8	interest	interest	NN
cord-005453-4057qib7	12872	9	Background	background	NN
cord-005453-4057qib7	12872	10	:	:	:
cord-005453-4057qib7	12872	11	Somatic	somatic	JJ
cord-005453-4057qib7	12872	12	mutations	mutation	NNS
cord-005453-4057qib7	12872	13	in	in	IN
cord-005453-4057qib7	12872	14	MDS	MDS	NNP
cord-005453-4057qib7	12872	15	patients	patient	NNS
cord-005453-4057qib7	12872	16	are	be	VBP
cord-005453-4057qib7	12872	17	closely	closely	RB
cord-005453-4057qib7	12872	18	related	relate	VBN
cord-005453-4057qib7	12872	19	with	with	IN
cord-005453-4057qib7	12872	20	clinical	clinical	JJ
cord-005453-4057qib7	12872	21	phenotypes	phenotype	NNS
cord-005453-4057qib7	12872	22	and	and	CC
cord-005453-4057qib7	12872	23	prognosis	prognosis	NN
cord-005453-4057qib7	12872	24	in	in	IN
cord-005453-4057qib7	12872	25	MDS	MDS	NNP
cord-005453-4057qib7	12872	26	patients	patient	NNS
cord-005453-4057qib7	12872	27	.	.	.
cord-005453-4057qib7	12873	1	But	but	CC
cord-005453-4057qib7	12873	2	whether	whether	IN
cord-005453-4057qib7	12873	3	mutations	mutation	NNS
cord-005453-4057qib7	12873	4	are	be	VBP
cord-005453-4057qib7	12873	5	prognostic	prognostic	JJ
cord-005453-4057qib7	12873	6	for	for	IN
cord-005453-4057qib7	12873	7	outcomes	outcome	NNS
cord-005453-4057qib7	12873	8	after	after	IN
cord-005453-4057qib7	12873	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	12873	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12873	11	stem	stem	NN
cord-005453-4057qib7	12873	12	-	-	HYPH
cord-005453-4057qib7	12873	13	cell	cell	NN
cord-005453-4057qib7	12873	14	transplantation	transplantation	NN
cord-005453-4057qib7	12873	15	(	(	-LRB-
cord-005453-4057qib7	12873	16	allo	allo	NN
cord-005453-4057qib7	12873	17	-	-	HYPH
cord-005453-4057qib7	12873	18	HSCT	HSCT	NNP
cord-005453-4057qib7	12873	19	)	)	-RRB-
cord-005453-4057qib7	12873	20	remains	remain	VBZ
cord-005453-4057qib7	12873	21	to	to	TO
cord-005453-4057qib7	12873	22	be	be	VB
cord-005453-4057qib7	12873	23	elaborated	elaborate	VBN
cord-005453-4057qib7	12873	24	.	.	.
cord-005453-4057qib7	12874	1	Methods	method	NNS
cord-005453-4057qib7	12874	2	:	:	:
cord-005453-4057qib7	12874	3	Targeted	target	VBN
cord-005453-4057qib7	12874	4	mutational	mutational	JJ
cord-005453-4057qib7	12874	5	analysis	analysis	NN
cord-005453-4057qib7	12874	6	were	be	VBD
cord-005453-4057qib7	12874	7	performed	perform	VBN
cord-005453-4057qib7	12874	8	on	on	IN
cord-005453-4057qib7	12874	9	samples	sample	NNS
cord-005453-4057qib7	12874	10	obtained	obtain	VBN
cord-005453-4057qib7	12874	11	before	before	IN
cord-005453-4057qib7	12874	12	transplantation	transplantation	NN
cord-005453-4057qib7	12874	13	from	from	IN
cord-005453-4057qib7	12874	14	134	134	CD
cord-005453-4057qib7	12874	15	patients	patient	NNS
cord-005453-4057qib7	12874	16	underwent	undergo	VBD
cord-005453-4057qib7	12874	17	HSCT	HSCT	NNP
cord-005453-4057qib7	12874	18	.	.	.
cord-005453-4057qib7	12875	1	We	-PRON-	PRP
cord-005453-4057qib7	12875	2	analyzed	analyze	VBD
cord-005453-4057qib7	12875	3	the	the	DT
cord-005453-4057qib7	12875	4	relationship	relationship	NN
cord-005453-4057qib7	12875	5	of	of	IN
cord-005453-4057qib7	12875	6	mutations	mutation	NNS
cord-005453-4057qib7	12875	7	and	and	CC
cord-005453-4057qib7	12875	8	clinical	clinical	JJ
cord-005453-4057qib7	12875	9	outcomes	outcome	NNS
cord-005453-4057qib7	12875	10	.	.	.
cord-005453-4057qib7	12876	1	Results	result	NNS
cord-005453-4057qib7	12876	2	:	:	:
cord-005453-4057qib7	12877	1	All	all	DT
cord-005453-4057qib7	12877	2	134	134	CD
cord-005453-4057qib7	12877	3	patients	patient	NNS
cord-005453-4057qib7	12877	4	carried	carry	VBD
cord-005453-4057qib7	12877	5	more	more	JJR
cord-005453-4057qib7	12877	6	than	than	IN
cord-005453-4057qib7	12877	7	one	one	CD
cord-005453-4057qib7	12877	8	somatic	somatic	JJ
cord-005453-4057qib7	12877	9	mutations	mutation	NNS
cord-005453-4057qib7	12877	10	,	,	,
cord-005453-4057qib7	12877	11	most	most	RBS
cord-005453-4057qib7	12877	12	frequently	frequently	RB
cord-005453-4057qib7	12877	13	in	in	IN
cord-005453-4057qib7	12877	14	KMT2D(67.16	KMT2D(67.16	NNP
cord-005453-4057qib7	12877	15	%	%	NN
cord-005453-4057qib7	12877	16	)	)	-RRB-
cord-005453-4057qib7	12877	17	,	,	,
cord-005453-4057qib7	12877	18	ARID1B	arid1b	NN
cord-005453-4057qib7	12877	19	(	(	-LRB-
cord-005453-4057qib7	12877	20	61.94	61.94	CD
cord-005453-4057qib7	12877	21	%	%	NN
cord-005453-4057qib7	12877	22	)	)	-RRB-
cord-005453-4057qib7	12877	23	,	,	,
cord-005453-4057qib7	12877	24	CCDC168(52.24	CCDC168(52.24	NNP
cord-005453-4057qib7	12877	25	%	%	NN
cord-005453-4057qib7	12877	26	)	)	-RRB-
cord-005453-4057qib7	12877	27	,	,	,
cord-005453-4057qib7	12877	28	PCLO(47.01	pclo(47.01	NN
cord-005453-4057qib7	12877	29	%	%	NN
cord-005453-4057qib7	12877	30	)	)	-RRB-
cord-005453-4057qib7	12877	31	,	,	,
cord-005453-4057qib7	12877	32	ASXL1/2	asxl1/2	NN
cord-005453-4057qib7	12877	33	(	(	-LRB-
cord-005453-4057qib7	12877	34	46.27	46.27	CD
cord-005453-4057qib7	12877	35	%	%	NN
cord-005453-4057qib7	12877	36	)	)	-RRB-
cord-005453-4057qib7	12877	37	,	,	,
cord-005453-4057qib7	12877	38	SRCAP(44.78	SRCAP(44.78	NNP
cord-005453-4057qib7	12877	39	%	%	NN
cord-005453-4057qib7	12877	40	)	)	-RRB-
cord-005453-4057qib7	12877	41	,	,	,
cord-005453-4057qib7	12877	42	U2AF1(42.54	u2af1(42.54	CD
cord-005453-4057qib7	12877	43	%	%	NN
cord-005453-4057qib7	12877	44	)	)	-RRB-
cord-005453-4057qib7	12877	45	,	,	,
cord-005453-4057qib7	12877	46	DNAH2	DNAH2	NNP
cord-005453-4057qib7	12877	47	(	(	-LRB-
cord-005453-4057qib7	12877	48	41.79	41.79	CD
cord-005453-4057qib7	12877	49	%	%	NN
cord-005453-4057qib7	12877	50	)	)	-RRB-
cord-005453-4057qib7	12877	51	,	,	,
cord-005453-4057qib7	12877	52	USH2A(41.04	ush2a(41.04	NN
cord-005453-4057qib7	12877	53	%	%	NN
cord-005453-4057qib7	12877	54	)	)	-RRB-
cord-005453-4057qib7	12877	55	and	and	CC
cord-005453-4057qib7	12877	56	TET2(34.33	TET2(34.33	NNS
cord-005453-4057qib7	12877	57	%	%	NN
cord-005453-4057qib7	12877	58	)	)	-RRB-
cord-005453-4057qib7	12877	59	.	.	.
cord-005453-4057qib7	12878	1	TP53	TP53	NNP
cord-005453-4057qib7	12878	2	mutations	mutation	NNS
cord-005453-4057qib7	12878	3	were	be	VBD
cord-005453-4057qib7	12878	4	associated	associate	VBN
cord-005453-4057qib7	12878	5	with	with	IN
cord-005453-4057qib7	12878	6	higher	high	JJR
cord-005453-4057qib7	12878	7	IPSS	IPSS	NNP
cord-005453-4057qib7	12878	8	-	-	HYPH
cord-005453-4057qib7	12878	9	R	r	NN
cord-005453-4057qib7	12878	10	risk	risk	NN
cord-005453-4057qib7	12878	11	,	,	,
cord-005453-4057qib7	12878	12	complex	complex	JJ
cord-005453-4057qib7	12878	13	karyotype	karyotype	NN
cord-005453-4057qib7	12878	14	and	and	CC
cord-005453-4057qib7	12878	15	monosomal	monosomal	JJ
cord-005453-4057qib7	12878	16	karyotype	karyotype	NN
cord-005453-4057qib7	12878	17	.	.	.
cord-005453-4057qib7	12879	1	DNAH2	DNAH2	NNP
cord-005453-4057qib7	12879	2	were	be	VBD
cord-005453-4057qib7	12879	3	more	more	RBR
cord-005453-4057qib7	12879	4	frequent	frequent	JJ
cord-005453-4057qib7	12879	5	in	in	IN
cord-005453-4057qib7	12879	6	pediatric	pediatric	JJ
cord-005453-4057qib7	12879	7	patients	patient	NNS
cord-005453-4057qib7	12879	8	.	.	.
cord-005453-4057qib7	12880	1	In	in	IN
cord-005453-4057qib7	12880	2	univariable	univariable	JJ
cord-005453-4057qib7	12880	3	analyses	analysis	NNS
cord-005453-4057qib7	12880	4	,	,	,
cord-005453-4057qib7	12880	5	TP53	TP53	NNP
cord-005453-4057qib7	12880	6	mutations	mutation	NNS
cord-005453-4057qib7	12880	7	were	be	VBD
cord-005453-4057qib7	12880	8	related	relate	VBN
cord-005453-4057qib7	12880	9	with	with	IN
cord-005453-4057qib7	12880	10	decreased	decreased	JJ
cord-005453-4057qib7	12880	11	disease	disease	NN
cord-005453-4057qib7	12880	12	-	-	HYPH
cord-005453-4057qib7	12880	13	free	free	JJ
cord-005453-4057qib7	12880	14	survival	survival	NN
cord-005453-4057qib7	12880	15	(	(	-LRB-
cord-005453-4057qib7	12880	16	P=0.047	P=0.047	NNS
cord-005453-4057qib7	12880	17	)	)	-RRB-
cord-005453-4057qib7	12880	18	;	;	:
cord-005453-4057qib7	12880	19	DNAH2	dnah2	NN
cord-005453-4057qib7	12880	20	mutations	mutation	NNS
cord-005453-4057qib7	12880	21	were	be	VBD
cord-005453-4057qib7	12880	22	related	relate	VBN
cord-005453-4057qib7	12880	23	with	with	IN
cord-005453-4057qib7	12880	24	increased	increase	VBN
cord-005453-4057qib7	12880	25	disease	disease	NN
cord-005453-4057qib7	12880	26	-	-	HYPH
cord-005453-4057qib7	12880	27	free	free	JJ
cord-005453-4057qib7	12880	28	survival	survival	NN
cord-005453-4057qib7	12880	29	(	(	-LRB-
cord-005453-4057qib7	12880	30	DFS	DFS	NNP
cord-005453-4057qib7	12880	31	)	)	-RRB-
cord-005453-4057qib7	12880	32	(	(	-LRB-
cord-005453-4057qib7	12880	33	P=0.038	P=0.038	NNP
cord-005453-4057qib7	12880	34	)	)	-RRB-
cord-005453-4057qib7	12880	35	.	.	.
cord-005453-4057qib7	12881	1	In	in	IN
cord-005453-4057qib7	12881	2	multivariable	multivariable	JJ
cord-005453-4057qib7	12881	3	analysis	analysis	NN
cord-005453-4057qib7	12881	4	including	include	VBG
cord-005453-4057qib7	12881	5	IPSS	IPSS	NNP
cord-005453-4057qib7	12881	6	-	-	HYPH
cord-005453-4057qib7	12881	7	R	r	NN
cord-005453-4057qib7	12881	8	stratification	stratification	NN
cord-005453-4057qib7	12881	9	,	,	,
cord-005453-4057qib7	12881	10	GVHD	GVHD	NNP
cord-005453-4057qib7	12881	11	,	,	,
cord-005453-4057qib7	12881	12	HCT	HCT	NNP
cord-005453-4057qib7	12881	13	-	-	HYPH
cord-005453-4057qib7	12881	14	CI	ci	NN
cord-005453-4057qib7	12881	15	and	and	CC
cord-005453-4057qib7	12881	16	candidate	candidate	NN
cord-005453-4057qib7	12881	17	genes	gene	NNS
cord-005453-4057qib7	12881	18	,	,	,
cord-005453-4057qib7	12881	19	DNAH2	dnah2	NN
cord-005453-4057qib7	12881	20	mutations	mutation	NNS
cord-005453-4057qib7	12881	21	were	be	VBD
cord-005453-4057qib7	12881	22	independently	independently	RB
cord-005453-4057qib7	12881	23	associated	associate	VBN
cord-005453-4057qib7	12881	24	with	with	IN
cord-005453-4057qib7	12881	25	better	well	JJR
cord-005453-4057qib7	12881	26	DFS(P=0.027	dfs(p=0.027	ADD
cord-005453-4057qib7	12881	27	)	)	-RRB-
cord-005453-4057qib7	12881	28	.	.	.
cord-005453-4057qib7	12882	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12882	2	:	:	:
cord-005453-4057qib7	12883	1	DNAH2	DNAH2	NNP
cord-005453-4057qib7	12884	1	mutations	mutation	NNS
cord-005453-4057qib7	12884	2	is	be	VBZ
cord-005453-4057qib7	12884	3	independently	independently	RB
cord-005453-4057qib7	12884	4	associated	associate	VBN
cord-005453-4057qib7	12884	5	with	with	IN
cord-005453-4057qib7	12884	6	better	well	JJR
cord-005453-4057qib7	12884	7	outcomes	outcome	NNS
cord-005453-4057qib7	12884	8	in	in	IN
cord-005453-4057qib7	12884	9	MDS	MDS	NNP
cord-005453-4057qib7	12884	10	patients	patient	NNS
cord-005453-4057qib7	12884	11	treated	treat	VBN
cord-005453-4057qib7	12884	12	with	with	IN
cord-005453-4057qib7	12884	13	allo	allo	NN
cord-005453-4057qib7	12884	14	-	-	HYPH
cord-005453-4057qib7	12884	15	HSCT	HSCT	NNP
cord-005453-4057qib7	12884	16	while	while	IN
cord-005453-4057qib7	12884	17	TP53	TP53	NNP
cord-005453-4057qib7	12884	18	may	may	MD
cord-005453-4057qib7	12884	19	predict	predict	VB
cord-005453-4057qib7	12884	20	unfavorable	unfavorable	JJ
cord-005453-4057qib7	12884	21	outcomes	outcome	NNS
cord-005453-4057qib7	12884	22	.	.	.
cord-005453-4057qib7	12885	1	Accounting	account	VBG
cord-005453-4057qib7	12885	2	for	for	IN
cord-005453-4057qib7	12885	3	these	these	DT
cord-005453-4057qib7	12885	4	somatic	somatic	JJ
cord-005453-4057qib7	12885	5	mutations	mutation	NNS
cord-005453-4057qib7	12885	6	may	may	MD
cord-005453-4057qib7	12885	7	help	help	VB
cord-005453-4057qib7	12885	8	better	well	JJR
cord-005453-4057qib7	12885	9	selection	selection	NN
cord-005453-4057qib7	12885	10	of	of	IN
cord-005453-4057qib7	12885	11	candidates	candidate	NNS
cord-005453-4057qib7	12885	12	for	for	IN
cord-005453-4057qib7	12885	13	allo	allo	NN
cord-005453-4057qib7	12885	14	-	-	HYPH
cord-005453-4057qib7	12885	15	HSCT	HSCT	NNP
cord-005453-4057qib7	12885	16	among	among	IN
cord-005453-4057qib7	12885	17	MDS	MDS	NNP
cord-005453-4057qib7	12885	18	patients	patient	NNS
cord-005453-4057qib7	12885	19	.	.	.
cord-005453-4057qib7	12886	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12886	2	Background	background	NN
cord-005453-4057qib7	12886	3	:	:	:
cord-005453-4057qib7	12886	4	There	there	EX
cord-005453-4057qib7	12886	5	is	be	VBZ
cord-005453-4057qib7	12886	6	a	a	DT
cord-005453-4057qib7	12886	7	controversy	controversy	NN
cord-005453-4057qib7	12886	8	among	among	IN
cord-005453-4057qib7	12886	9	experts	expert	NNS
cord-005453-4057qib7	12886	10	if	if	IN
cord-005453-4057qib7	12886	11	and	and	CC
cord-005453-4057qib7	12886	12	how	how	WRB
cord-005453-4057qib7	12886	13	patients	patient	NNS
cord-005453-4057qib7	12886	14	with	with	IN
cord-005453-4057qib7	12886	15	MDS	MDS	NNP
cord-005453-4057qib7	12886	16	and	and	CC
cord-005453-4057qib7	12886	17	sAML	saml	NN
cord-005453-4057qib7	12886	18	should	should	MD
cord-005453-4057qib7	12886	19	receive	receive	VB
cord-005453-4057qib7	12886	20	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	12886	21	therapy	therapy	NN
cord-005453-4057qib7	12886	22	before	before	IN
cord-005453-4057qib7	12886	23	transplant	transplant	NN
cord-005453-4057qib7	12886	24	.	.	.
cord-005453-4057qib7	12887	1	While	while	IN
cord-005453-4057qib7	12887	2	aiming	aim	VBG
cord-005453-4057qib7	12887	3	to	to	TO
cord-005453-4057qib7	12887	4	reduce	reduce	VB
cord-005453-4057qib7	12887	5	disease	disease	NN
cord-005453-4057qib7	12887	6	burden	burden	NN
cord-005453-4057qib7	12887	7	in	in	IN
cord-005453-4057qib7	12887	8	order	order	NN
cord-005453-4057qib7	12887	9	to	to	TO
cord-005453-4057qib7	12887	10	lower	lower	VB
cord-005453-4057qib7	12887	11	the	the	DT
cord-005453-4057qib7	12887	12	risk	risk	NN
cord-005453-4057qib7	12887	13	of	of	IN
cord-005453-4057qib7	12887	14	relapse	relapse	NN
cord-005453-4057qib7	12887	15	after	after	IN
cord-005453-4057qib7	12887	16	transplant	transplant	NN
cord-005453-4057qib7	12887	17	cytoreductive	cytoreductive	NN
cord-005453-4057qib7	12887	18	therapy	therapy	NN
cord-005453-4057qib7	12887	19	is	be	VBZ
cord-005453-4057qib7	12887	20	associated	associate	VBN
cord-005453-4057qib7	12887	21	with	with	IN
cord-005453-4057qib7	12887	22	several	several	JJ
cord-005453-4057qib7	12887	23	drawbacks	drawback	NNS
cord-005453-4057qib7	12887	24	.	.	.
cord-005453-4057qib7	12888	1	Besides	besides	IN
cord-005453-4057qib7	12888	2	a	a	DT
cord-005453-4057qib7	12888	3	considerable	considerable	JJ
cord-005453-4057qib7	12888	4	risk	risk	NN
cord-005453-4057qib7	12888	5	for	for	IN
cord-005453-4057qib7	12888	6	toxicity	toxicity	NN
cord-005453-4057qib7	12888	7	and	and	CC
cord-005453-4057qib7	12888	8	mortality	mortality	NN
cord-005453-4057qib7	12888	9	preventing	prevent	VBG
cord-005453-4057qib7	12888	10	patients	patient	NNS
cord-005453-4057qib7	12888	11	to	to	TO
cord-005453-4057qib7	12888	12	proceed	proceed	VB
cord-005453-4057qib7	12888	13	to	to	IN
cord-005453-4057qib7	12888	14	transplant	transplant	NN
cord-005453-4057qib7	12888	15	cytoreductive	cytoreductive	NN
cord-005453-4057qib7	12888	16	therapy	therapy	NN
cord-005453-4057qib7	12889	1	may	may	MD
cord-005453-4057qib7	12889	2	also	also	RB
cord-005453-4057qib7	12889	3	favour	favour	VB
cord-005453-4057qib7	12889	4	the	the	DT
cord-005453-4057qib7	12889	5	selection	selection	NN
cord-005453-4057qib7	12889	6	of	of	IN
cord-005453-4057qib7	12889	7	resistant	resistant	JJ
cord-005453-4057qib7	12889	8	clones	clone	NNS
cord-005453-4057qib7	12889	9	which	which	WDT
cord-005453-4057qib7	12889	10	may	may	MD
cord-005453-4057qib7	12889	11	be	be	VB
cord-005453-4057qib7	12889	12	difficult	difficult	JJ
cord-005453-4057qib7	12889	13	to	to	TO
cord-005453-4057qib7	12889	14	treat	treat	VB
cord-005453-4057qib7	12889	15	at	at	IN
cord-005453-4057qib7	12889	16	relapse	relapse	NN
cord-005453-4057qib7	12889	17	.	.	.
cord-005453-4057qib7	12890	1	Methods	method	NNS
cord-005453-4057qib7	12890	2	:	:	:
cord-005453-4057qib7	12890	3	To	to	TO
cord-005453-4057qib7	12890	4	address	address	VB
cord-005453-4057qib7	12890	5	this	this	DT
cord-005453-4057qib7	12890	6	hypothesis	hypothesis	NN
cord-005453-4057qib7	12890	7	we	-PRON-	PRP
cord-005453-4057qib7	12890	8	retrospectively	retrospectively	RB
cord-005453-4057qib7	12890	9	analysed	analyse	VBD
cord-005453-4057qib7	12890	10	the	the	DT
cord-005453-4057qib7	12890	11	response	response	NN
cord-005453-4057qib7	12890	12	and	and	CC
cord-005453-4057qib7	12890	13	survival	survival	NN
cord-005453-4057qib7	12890	14	following	follow	VBG
cord-005453-4057qib7	12890	15	salvage	salvage	NN
cord-005453-4057qib7	12890	16	therapy	therapy	NN
cord-005453-4057qib7	12890	17	in	in	IN
cord-005453-4057qib7	12890	18	73	73	CD
cord-005453-4057qib7	12890	19	patients	patient	NNS
cord-005453-4057qib7	12890	20	with	with	IN
cord-005453-4057qib7	12890	21	MDS	MDS	NNP
cord-005453-4057qib7	12890	22	and	and	CC
cord-005453-4057qib7	12890	23	sAML	saml	NN
cord-005453-4057qib7	12890	24	who	who	WP
cord-005453-4057qib7	12890	25	had	have	VBD
cord-005453-4057qib7	12890	26	relapsed	relapse	VBN
cord-005453-4057qib7	12890	27	in	in	IN
cord-005453-4057qib7	12890	28	median	median	JJ
cord-005453-4057qib7	12890	29	5.6	5.6	CD
cord-005453-4057qib7	12890	30	months	month	NNS
cord-005453-4057qib7	12890	31	(	(	-LRB-
cord-005453-4057qib7	12890	32	1	1	CD
cord-005453-4057qib7	12890	33	to	to	IN
cord-005453-4057qib7	12890	34	110	110	CD
cord-005453-4057qib7	12890	35	months	month	NNS
cord-005453-4057qib7	12890	36	)	)	-RRB-
cord-005453-4057qib7	12890	37	after	after	IN
cord-005453-4057qib7	12890	38	allo	allo	NNP
cord-005453-4057qib7	12890	39	-	-	HYPH
cord-005453-4057qib7	12890	40	SCT	SCT	NNP
cord-005453-4057qib7	12890	41	according	accord	VBG
cord-005453-4057qib7	12890	42	to	to	IN
cord-005453-4057qib7	12890	43	their	-PRON-	PRP$
cord-005453-4057qib7	12890	44	pre	pre	JJ
cord-005453-4057qib7	12890	45	-	-	JJ
cord-005453-4057qib7	12890	46	transplant	transplant	JJ
cord-005453-4057qib7	12890	47	strategy	strategy	NN
cord-005453-4057qib7	12890	48	(	(	-LRB-
cord-005453-4057qib7	12890	49	upfront	upfront	NN
cord-005453-4057qib7	12890	50	transplantation	transplantation	NN
cord-005453-4057qib7	12890	51	n=32	n=32	NNP
cord-005453-4057qib7	12890	52	44	44	CD
cord-005453-4057qib7	12890	53	%	%	NN
cord-005453-4057qib7	12890	54	;	;	:
cord-005453-4057qib7	12890	55	induction	induction	NN
cord-005453-4057qib7	12890	56	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12890	57	[	[	-LRB-
cord-005453-4057qib7	12890	58	CTX	CTX	NNP
cord-005453-4057qib7	12890	59	]	]	-RRB-
cord-005453-4057qib7	12890	60	n=26	n=26	RB
cord-005453-4057qib7	12890	61	36	36	CD
cord-005453-4057qib7	12890	62	%	%	NN
cord-005453-4057qib7	12890	63	;	;	,
cord-005453-4057qib7	12890	64	hypomethylating	hypomethylate	VBG
cord-005453-4057qib7	12890	65	agents	agent	NNS
cord-005453-4057qib7	12890	66	[	[	-LRB-
cord-005453-4057qib7	12890	67	HMA	HMA	NNP
cord-005453-4057qib7	12890	68	]	]	-RRB-
cord-005453-4057qib7	12891	1	n=15	n=15	NNP
cord-005453-4057qib7	12891	2	20	20	CD
cord-005453-4057qib7	12891	3	%	%	NN
cord-005453-4057qib7	12891	4	)	)	-RRB-
cord-005453-4057qib7	12891	5	.	.	.
cord-005453-4057qib7	12892	1	Results	result	NNS
cord-005453-4057qib7	12892	2	:	:	:
cord-005453-4057qib7	12893	1	The	the	DT
cord-005453-4057qib7	12893	2	majority	majority	NN
cord-005453-4057qib7	12893	3	of	of	IN
cord-005453-4057qib7	12893	4	these	these	DT
cord-005453-4057qib7	12893	5	73	73	CD
cord-005453-4057qib7	12893	6	patients	patient	NNS
cord-005453-4057qib7	12893	7	received	receive	VBD
cord-005453-4057qib7	12893	8	salvage	salvage	NN
cord-005453-4057qib7	12893	9	therapy	therapy	NN
cord-005453-4057qib7	12893	10	with	with	IN
cord-005453-4057qib7	12893	11	HMA	HMA	NNP
cord-005453-4057qib7	12893	12	(	(	-LRB-
cord-005453-4057qib7	12893	13	n=58	n=58	NN
cord-005453-4057qib7	12893	14	,	,	,
cord-005453-4057qib7	12893	15	79	79	CD
cord-005453-4057qib7	12893	16	%	%	NN
cord-005453-4057qib7	12893	17	;	;	.
cord-005453-4057qib7	12894	1	Aza	Aza	NNP
cord-005453-4057qib7	12894	2	n=57	n=57	NN
cord-005453-4057qib7	12894	3	,	,	,
cord-005453-4057qib7	12894	4	DAC	DAC	NNP
cord-005453-4057qib7	12894	5	n=1	n=1	NNP
cord-005453-4057qib7	12894	6	)	)	-RRB-
cord-005453-4057qib7	12894	7	mostly	mostly	RB
cord-005453-4057qib7	12894	8	in	in	IN
cord-005453-4057qib7	12894	9	combination	combination	NN
cord-005453-4057qib7	12894	10	with	with	IN
cord-005453-4057qib7	12894	11	DLI	DLI	NNP
cord-005453-4057qib7	12894	12	,	,	,
cord-005453-4057qib7	12894	13	while	while	IN
cord-005453-4057qib7	12894	14	the	the	DT
cord-005453-4057qib7	12894	15	remaining	remain	VBG
cord-005453-4057qib7	12894	16	received	receive	VBN
cord-005453-4057qib7	12894	17	other	other	JJ
cord-005453-4057qib7	12894	18	salvage	salvage	NN
cord-005453-4057qib7	12894	19	treatments	treatment	NNS
cord-005453-4057qib7	12894	20	(	(	-LRB-
cord-005453-4057qib7	12894	21	intensive	intensive	JJ
cord-005453-4057qib7	12894	22	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	12894	23	n=1	n=1	RB
cord-005453-4057qib7	12894	24	,	,	,
cord-005453-4057qib7	12894	25	DLI	DLI	NNP
cord-005453-4057qib7	12894	26	alone	alone	RB
cord-005453-4057qib7	12894	27	n=1	n=1	RB
cord-005453-4057qib7	12894	28	,	,	,
cord-005453-4057qib7	12894	29	2	2	CD
cord-005453-4057qib7	12894	30	nd	nd	NNP
cord-005453-4057qib7	12894	31	transplant	transplant	NN
cord-005453-4057qib7	12894	32	n=3	n=3	NN
cord-005453-4057qib7	12894	33	,	,	,
cord-005453-4057qib7	12894	34	BSC	BSC	NNP
cord-005453-4057qib7	12894	35	n=5	n=5	RB
cord-005453-4057qib7	12894	36	,	,	,
cord-005453-4057qib7	12894	37	miscellaneous	miscellaneous	JJ
cord-005453-4057qib7	12894	38	n=2	n=2	NNS
cord-005453-4057qib7	12894	39	,	,	,
cord-005453-4057qib7	12894	40	missing	miss	VBG
cord-005453-4057qib7	12894	41	information	information	NN
cord-005453-4057qib7	12894	42	n=3	n=3	NN
cord-005453-4057qib7	12894	43	)	)	-RRB-
cord-005453-4057qib7	12894	44	.	.	.
cord-005453-4057qib7	12895	1	When	when	WRB
cord-005453-4057qib7	12895	2	focussing	focusse	VBG
cord-005453-4057qib7	12895	3	on	on	IN
cord-005453-4057qib7	12895	4	those	those	DT
cord-005453-4057qib7	12895	5	patients	patient	NNS
cord-005453-4057qib7	12895	6	treated	treat	VBN
cord-005453-4057qib7	12895	7	with	with	IN
cord-005453-4057qib7	12895	8	HMA	HMA	NNP
cord-005453-4057qib7	12895	9	and	and	CC
cord-005453-4057qib7	12895	10	DLI	DLI	NNP
cord-005453-4057qib7	12896	1	it	-PRON-	PRP
cord-005453-4057qib7	12896	2	became	become	VBD
cord-005453-4057qib7	12896	3	apparent	apparent	JJ
cord-005453-4057qib7	12896	4	that	that	IN
cord-005453-4057qib7	12896	5	a	a	DT
cord-005453-4057qib7	12896	6	significantly	significantly	RB
cord-005453-4057qib7	12896	7	higher	high	JJR
cord-005453-4057qib7	12896	8	proportion	proportion	NN
cord-005453-4057qib7	12896	9	of	of	IN
cord-005453-4057qib7	12896	10	patients	patient	NNS
cord-005453-4057qib7	12896	11	in	in	IN
cord-005453-4057qib7	12896	12	the	the	DT
cord-005453-4057qib7	12896	13	upfront	upfront	JJ
cord-005453-4057qib7	12896	14	group	group	NN
cord-005453-4057qib7	12896	15	(	(	-LRB-
cord-005453-4057qib7	12896	16	58	58	CD
cord-005453-4057qib7	12896	17	%	%	NN
cord-005453-4057qib7	12896	18	)	)	-RRB-
cord-005453-4057qib7	12896	19	achieved	achieve	VBD
cord-005453-4057qib7	12896	20	CR	cr	NN
cord-005453-4057qib7	12896	21	after	after	IN
cord-005453-4057qib7	12896	22	salvage	salvage	NN
cord-005453-4057qib7	12896	23	therapy	therapy	NN
cord-005453-4057qib7	12896	24	in	in	IN
cord-005453-4057qib7	12896	25	comparison	comparison	NN
cord-005453-4057qib7	12896	26	to	to	TO
cord-005453-4057qib7	12896	27	pre	pre	VB
cord-005453-4057qib7	12896	28	-	-	JJ
cord-005453-4057qib7	12896	29	treated	treat	VBN
cord-005453-4057qib7	12896	30	patients	patient	NNS
cord-005453-4057qib7	12896	31	(	(	-LRB-
cord-005453-4057qib7	12896	32	10	10	CD
cord-005453-4057qib7	12896	33	%	%	NN
cord-005453-4057qib7	12896	34	CR	cr	NN
cord-005453-4057qib7	12896	35	,	,	,
cord-005453-4057qib7	12896	36	p=0.0005	p=0.0005	NNP
cord-005453-4057qib7	12896	37	;	;	:
cord-005453-4057qib7	12896	38	CTX	CTX	NNP
cord-005453-4057qib7	12896	39	group	group	NN
cord-005453-4057qib7	12896	40	5	5	CD
cord-005453-4057qib7	12896	41	%	%	NN
cord-005453-4057qib7	12896	42	CR	CR	NNP
cord-005453-4057qib7	12896	43	;	;	:
cord-005453-4057qib7	12896	44	HMA	HMA	NNP
cord-005453-4057qib7	12896	45	group	group	NN
cord-005453-4057qib7	12896	46	18	18	CD
cord-005453-4057qib7	12896	47	%	%	NN
cord-005453-4057qib7	12896	48	CR	cr	NN
cord-005453-4057qib7	12896	49	)	)	-RRB-
cord-005453-4057qib7	12896	50	.	.	.
cord-005453-4057qib7	12897	1	Accordingly	accordingly	RB
cord-005453-4057qib7	12897	2	,	,	,
cord-005453-4057qib7	12897	3	overall	overall	JJ
cord-005453-4057qib7	12897	4	survival	survival	NN
cord-005453-4057qib7	12897	5	(	(	-LRB-
cord-005453-4057qib7	12897	6	OS	OS	NNP
cord-005453-4057qib7	12897	7	)	)	-RRB-
cord-005453-4057qib7	12897	8	calculated	calculate	VBD
cord-005453-4057qib7	12897	9	from	from	IN
cord-005453-4057qib7	12897	10	the	the	DT
cord-005453-4057qib7	12897	11	time	time	NN
cord-005453-4057qib7	12897	12	of	of	IN
cord-005453-4057qib7	12897	13	relapse	relapse	NN
cord-005453-4057qib7	12897	14	was	be	VBD
cord-005453-4057qib7	12897	15	significantly	significantly	RB
cord-005453-4057qib7	12897	16	longer	long	JJR
cord-005453-4057qib7	12897	17	in	in	IN
cord-005453-4057qib7	12897	18	patients	patient	NNS
cord-005453-4057qib7	12897	19	in	in	IN
cord-005453-4057qib7	12897	20	the	the	DT
cord-005453-4057qib7	12897	21	upfront	upfront	JJ
cord-005453-4057qib7	12897	22	group	group	NN
cord-005453-4057qib7	12897	23	than	than	IN
cord-005453-4057qib7	12897	24	in	in	IN
cord-005453-4057qib7	12897	25	the	the	DT
cord-005453-4057qib7	12897	26	group	group	NN
cord-005453-4057qib7	12897	27	of	of	IN
cord-005453-4057qib7	12897	28	pre	pre	JJ
cord-005453-4057qib7	12897	29	-	-	JJ
cord-005453-4057qib7	12897	30	treated	treat	VBN
cord-005453-4057qib7	12897	31	patients	patient	NNS
cord-005453-4057qib7	12897	32	(	(	-LRB-
cord-005453-4057qib7	12897	33	2-year	2-year	CD
cord-005453-4057qib7	12897	34	OS	OS	NNP
cord-005453-4057qib7	12897	35	59	59	CD
cord-005453-4057qib7	12897	36	%	%	NN
cord-005453-4057qib7	12897	37	vs.	vs.	IN
cord-005453-4057qib7	12897	38	19	19	CD
cord-005453-4057qib7	12897	39	%	%	NN
cord-005453-4057qib7	12897	40	,	,	,
cord-005453-4057qib7	12897	41	p=0.0001	p=0.0001	NNP
cord-005453-4057qib7	12897	42	)	)	-RRB-
cord-005453-4057qib7	12897	43	.	.	.
cord-005453-4057qib7	12898	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12898	2	:	:	:
cord-005453-4057qib7	12899	1	Overall	overall	RB
cord-005453-4057qib7	12899	2	,	,	,
cord-005453-4057qib7	12899	3	these	these	DT
cord-005453-4057qib7	12899	4	findings	finding	NNS
cord-005453-4057qib7	12899	5	imply	imply	VBP
cord-005453-4057qib7	12899	6	that	that	IN
cord-005453-4057qib7	12899	7	pretransplant	pretransplant	NN
cord-005453-4057qib7	12899	8	therapy	therapy	NN
cord-005453-4057qib7	12899	9	may	may	MD
cord-005453-4057qib7	12899	10	favour	favour	VB
cord-005453-4057qib7	12899	11	the	the	DT
cord-005453-4057qib7	12899	12	iatrogenic	iatrogenic	JJ
cord-005453-4057qib7	12899	13	selection	selection	NN
cord-005453-4057qib7	12899	14	of	of	IN
cord-005453-4057qib7	12899	15	resistant	resistant	JJ
cord-005453-4057qib7	12899	16	clones	clone	NNS
cord-005453-4057qib7	12899	17	,	,	,
cord-005453-4057qib7	12899	18	which	which	WDT
cord-005453-4057qib7	12899	19	poorly	poorly	RB
cord-005453-4057qib7	12899	20	respond	respond	VBP
cord-005453-4057qib7	12899	21	to	to	TO
cord-005453-4057qib7	12899	22	salvage	salvage	VB
cord-005453-4057qib7	12899	23	therapy	therapy	NN
cord-005453-4057qib7	12899	24	with	with	IN
cord-005453-4057qib7	12899	25	HMA	HMA	NNP
cord-005453-4057qib7	12899	26	and	and	CC
cord-005453-4057qib7	12899	27	DLI	DLI	NNP
cord-005453-4057qib7	12899	28	in	in	IN
cord-005453-4057qib7	12899	29	case	case	NN
cord-005453-4057qib7	12899	30	of	of	IN
cord-005453-4057qib7	12899	31	relapse	relapse	NN
cord-005453-4057qib7	12899	32	after	after	IN
cord-005453-4057qib7	12899	33	allo	allo	NN
cord-005453-4057qib7	12899	34	-	-	HYPH
cord-005453-4057qib7	12899	35	SCT	SCT	NNP
cord-005453-4057qib7	12899	36	.	.	.
cord-005453-4057qib7	12900	1	Furthermore	furthermore	RB
cord-005453-4057qib7	12900	2	,	,	,
cord-005453-4057qib7	12900	3	the	the	DT
cord-005453-4057qib7	12900	4	results	result	NNS
cord-005453-4057qib7	12900	5	support	support	VBP
cord-005453-4057qib7	12900	6	the	the	DT
cord-005453-4057qib7	12900	7	concept	concept	NN
cord-005453-4057qib7	12900	8	that	that	IN
cord-005453-4057qib7	12900	9	an	an	DT
cord-005453-4057qib7	12900	10	upfront	upfront	JJ
cord-005453-4057qib7	12900	11	transplant	transplant	NN
cord-005453-4057qib7	12900	12	strategy	strategy	NN
cord-005453-4057qib7	12900	13	is	be	VBZ
cord-005453-4057qib7	12900	14	a	a	DT
cord-005453-4057qib7	12900	15	promising	promising	JJ
cord-005453-4057qib7	12900	16	alternative	alternative	NN
cord-005453-4057qib7	12900	17	for	for	IN
cord-005453-4057qib7	12900	18	patients	patient	NNS
cord-005453-4057qib7	12900	19	with	with	IN
cord-005453-4057qib7	12900	20	MDS	MDS	NNP
cord-005453-4057qib7	12900	21	and	and	CC
cord-005453-4057qib7	12900	22	sAML	saml	NN
cord-005453-4057qib7	12900	23	that	that	WDT
cord-005453-4057qib7	12900	24	can	can	MD
cord-005453-4057qib7	12900	25	be	be	VB
cord-005453-4057qib7	12900	26	augmented	augment	VBN
cord-005453-4057qib7	12900	27	by	by	IN
cord-005453-4057qib7	12900	28	salvage	salvage	NN
cord-005453-4057qib7	12900	29	therapy	therapy	NN
cord-005453-4057qib7	12900	30	with	with	IN
cord-005453-4057qib7	12900	31	HMA	HMA	NNP
cord-005453-4057qib7	12900	32	and	and	CC
cord-005453-4057qib7	12900	33	DLI	DLI	NNP
cord-005453-4057qib7	12900	34	.	.	.
cord-005453-4057qib7	12901	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12901	2	:	:	:
cord-005453-4057qib7	12902	1	TS	TS	NNP
cord-005453-4057qib7	12902	2	and	and	CC
cord-005453-4057qib7	12902	3	GK	GK	NNP
cord-005453-4057qib7	12902	4	received	receive	VBD
cord-005453-4057qib7	12902	5	travel	travel	NN
cord-005453-4057qib7	12902	6	support	support	NN
cord-005453-4057qib7	12902	7	,	,	,
cord-005453-4057qib7	12902	8	lecture	lecture	NN
cord-005453-4057qib7	12902	9	fees	fee	NNS
cord-005453-4057qib7	12902	10	and	and	CC
cord-005453-4057qib7	12902	11	research	research	NN
cord-005453-4057qib7	12902	12	funding	funding	NN
cord-005453-4057qib7	12902	13	from	from	IN
cord-005453-4057qib7	12902	14	Celgene	Celgene	NNP
cord-005453-4057qib7	12902	15	GmbH	GmbH	NNP
cord-005453-4057qib7	12902	16	Conclusions	conclusion	NNS
cord-005453-4057qib7	12902	17	:	:	:
cord-005453-4057qib7	12903	1	In	in	IN
cord-005453-4057qib7	12903	2	our	-PRON-	PRP$
cord-005453-4057qib7	12903	3	country	country	NN
cord-005453-4057qib7	12903	4	,	,	,
cord-005453-4057qib7	12903	5	this	this	DT
cord-005453-4057qib7	12903	6	procedure	procedure	NN
cord-005453-4057qib7	12903	7	has	have	VBZ
cord-005453-4057qib7	12903	8	shown	show	VBN
cord-005453-4057qib7	12903	9	to	to	TO
cord-005453-4057qib7	12903	10	be	be	VB
cord-005453-4057qib7	12903	11	feasible	feasible	JJ
cord-005453-4057qib7	12903	12	and	and	CC
cord-005453-4057qib7	12903	13	we	-PRON-	PRP
cord-005453-4057qib7	12903	14	hope	hope	VBP
cord-005453-4057qib7	12903	15	to	to	TO
cord-005453-4057qib7	12903	16	improve	improve	VB
cord-005453-4057qib7	12903	17	it	-PRON-	PRP
cord-005453-4057qib7	12903	18	,	,	,
cord-005453-4057qib7	12903	19	with	with	IN
cord-005453-4057qib7	12903	20	better	well	JJR
cord-005453-4057qib7	12903	21	infection	infection	NN
cord-005453-4057qib7	12903	22	control	control	NN
cord-005453-4057qib7	12903	23	and	and	CC
cord-005453-4057qib7	12903	24	by	by	IN
cord-005453-4057qib7	12903	25	acquiring	acquire	VBG
cord-005453-4057qib7	12903	26	more	more	JJR
cord-005453-4057qib7	12903	27	experience	experience	NN
cord-005453-4057qib7	12903	28	related	relate	VBN
cord-005453-4057qib7	12903	29	to	to	IN
cord-005453-4057qib7	12903	30	the	the	DT
cord-005453-4057qib7	12903	31	management	management	NN
cord-005453-4057qib7	12903	32	of	of	IN
cord-005453-4057qib7	12903	33	these	these	DT
cord-005453-4057qib7	12903	34	patients	patient	NNS
cord-005453-4057qib7	12903	35	.	.	.
cord-005453-4057qib7	12904	1	Background	background	NN
cord-005453-4057qib7	12904	2	:	:	:
cord-005453-4057qib7	12905	1	Extramedullar	Extramedullar	NNP
cord-005453-4057qib7	12905	2	relapse	relapse	NN
cord-005453-4057qib7	12905	3	of	of	IN
cord-005453-4057qib7	12905	4	MDS	MDS	NNP
cord-005453-4057qib7	12905	5	is	be	VBZ
cord-005453-4057qib7	12905	6	a	a	DT
cord-005453-4057qib7	12905	7	rare	rare	JJ
cord-005453-4057qib7	12905	8	complication	complication	NN
cord-005453-4057qib7	12905	9	after	after	IN
cord-005453-4057qib7	12905	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	12905	11	stem	stem	NN
cord-005453-4057qib7	12905	12	cell	cell	NN
cord-005453-4057qib7	12905	13	transplantation	transplantation	NN
cord-005453-4057qib7	12905	14	.	.	.
cord-005453-4057qib7	12906	1	We	-PRON-	PRP
cord-005453-4057qib7	12906	2	present	present	VBP
cord-005453-4057qib7	12906	3	the	the	DT
cord-005453-4057qib7	12906	4	case	case	NN
cord-005453-4057qib7	12906	5	of	of	IN
cord-005453-4057qib7	12906	6	a	a	DT
cord-005453-4057qib7	12906	7	69-year	69-year	JJ
cord-005453-4057qib7	12906	8	-	-	HYPH
cord-005453-4057qib7	12906	9	old	old	JJ
cord-005453-4057qib7	12906	10	woman	woman	NN
cord-005453-4057qib7	12906	11	who	who	WP
cord-005453-4057qib7	12906	12	was	be	VBD
cord-005453-4057qib7	12906	13	admitted	admit	VBN
cord-005453-4057qib7	12906	14	into	into	IN
cord-005453-4057qib7	12906	15	hospital	hospital	NN
cord-005453-4057qib7	12906	16	because	because	IN
cord-005453-4057qib7	12906	17	of	of	IN
cord-005453-4057qib7	12906	18	insecure	insecure	JJ
cord-005453-4057qib7	12906	19	walking	walking	NN
cord-005453-4057qib7	12906	20	.	.	.
cord-005453-4057qib7	12907	1	Paresis	Paresis	NNP
cord-005453-4057qib7	12907	2	of	of	IN
cord-005453-4057qib7	12907	3	both	both	DT
cord-005453-4057qib7	12907	4	legs	leg	NNS
cord-005453-4057qib7	12907	5	,	,	,
cord-005453-4057qib7	12907	6	hypaesthesia	hypaesthesia	NNP
cord-005453-4057qib7	12907	7	of	of	IN
cord-005453-4057qib7	12907	8	the	the	DT
cord-005453-4057qib7	12907	9	inner	inner	JJ
cord-005453-4057qib7	12907	10	thighs	thigh	NNS
cord-005453-4057qib7	12907	11	,	,	,
cord-005453-4057qib7	12907	12	increased	increase	VBN
cord-005453-4057qib7	12907	13	effort	effort	NN
cord-005453-4057qib7	12907	14	at	at	IN
cord-005453-4057qib7	12907	15	urinating	urinate	VBG
cord-005453-4057qib7	12907	16	,	,	,
cord-005453-4057qib7	12907	17	reduced	reduce	VBN
cord-005453-4057qib7	12907	18	sphincter	sphincter	NN
cord-005453-4057qib7	12907	19	tonus	tonus	NN
cord-005453-4057qib7	12907	20	,	,	,
cord-005453-4057qib7	12907	21	central	central	JJ
cord-005453-4057qib7	12907	22	paresis	paresis	NN
cord-005453-4057qib7	12907	23	of	of	IN
cord-005453-4057qib7	12907	24	the	the	DT
cord-005453-4057qib7	12907	25	right	right	JJ
cord-005453-4057qib7	12907	26	arm	arm	NN
cord-005453-4057qib7	12907	27	and	and	CC
cord-005453-4057qib7	12907	28	discreet	discreet	JJ
cord-005453-4057qib7	12907	29	paresis	paresis	NN
cord-005453-4057qib7	12907	30	of	of	IN
cord-005453-4057qib7	12907	31	the	the	DT
cord-005453-4057qib7	12907	32	right	right	JJ
cord-005453-4057qib7	12907	33	facial	facial	JJ
cord-005453-4057qib7	12907	34	nerve	nerve	NN
cord-005453-4057qib7	12907	35	were	be	VBD
cord-005453-4057qib7	12907	36	documented	document	VBN
cord-005453-4057qib7	12907	37	at	at	IN
cord-005453-4057qib7	12907	38	neurological	neurological	JJ
cord-005453-4057qib7	12907	39	exam	exam	NN
cord-005453-4057qib7	12907	40	.	.	.
cord-005453-4057qib7	12908	1	MRI	MRI	NNP
cord-005453-4057qib7	12908	2	showed	show	VBD
cord-005453-4057qib7	12908	3	a	a	DT
cord-005453-4057qib7	12908	4	large	large	JJ
cord-005453-4057qib7	12908	5	tumour	tumour	NN
cord-005453-4057qib7	12908	6	of	of	IN
cord-005453-4057qib7	12908	7	the	the	DT
cord-005453-4057qib7	12908	8	dorsal	dorsal	JJ
cord-005453-4057qib7	12908	9	thorax	thorax	NN
cord-005453-4057qib7	12908	10	that	that	WDT
cord-005453-4057qib7	12908	11	immured	immure	VBD
cord-005453-4057qib7	12908	12	the	the	DT
cord-005453-4057qib7	12908	13	adjacent	adjacent	JJ
cord-005453-4057qib7	12908	14	ribs	rib	NNS
cord-005453-4057qib7	12908	15	and	and	CC
cord-005453-4057qib7	12908	16	spine	spine	NN
cord-005453-4057qib7	12908	17	,	,	,
cord-005453-4057qib7	12908	18	affected	affect	VBD
cord-005453-4057qib7	12908	19	the	the	DT
cord-005453-4057qib7	12908	20	processus	processus	NNP
cord-005453-4057qib7	12908	21	transversus	transversus	NN
cord-005453-4057qib7	12908	22	of	of	IN
cord-005453-4057qib7	12908	23	T9	T9	NNP
cord-005453-4057qib7	12908	24	-	-	SYM
cord-005453-4057qib7	12908	25	10	10	CD
cord-005453-4057qib7	12908	26	and	and	CC
cord-005453-4057qib7	12908	27	invaded	invade	VBD
cord-005453-4057qib7	12908	28	the	the	DT
cord-005453-4057qib7	12908	29	spinal	spinal	JJ
cord-005453-4057qib7	12908	30	canal	canal	NN
cord-005453-4057qib7	12908	31	.	.	.
cord-005453-4057qib7	12909	1	The	the	DT
cord-005453-4057qib7	12909	2	patient	patient	NN
cord-005453-4057qib7	12909	3	had	have	VBD
cord-005453-4057qib7	12909	4	undergone	undergo	VBN
cord-005453-4057qib7	12909	5	RIC	RIC	NNP
cord-005453-4057qib7	12909	6	allogeneic	allogeneic	IN
cord-005453-4057qib7	12909	7	stem	stem	NN
cord-005453-4057qib7	12909	8	cell	cell	NN
cord-005453-4057qib7	12909	9	transplantation	transplantation	NN
cord-005453-4057qib7	12909	10	five	five	CD
cord-005453-4057qib7	12909	11	years	year	NNS
cord-005453-4057qib7	12909	12	ago	ago	RB
cord-005453-4057qib7	12909	13	for	for	IN
cord-005453-4057qib7	12909	14	MDS	MDS	NNP
cord-005453-4057qib7	12909	15	-	-	HYPH
cord-005453-4057qib7	12909	16	EB	EB	NNP
cord-005453-4057qib7	12909	17	2	2	CD
cord-005453-4057qib7	12909	18	with	with	IN
cord-005453-4057qib7	12909	19	complex	complex	JJ
cord-005453-4057qib7	12909	20	aberrant	aberrant	JJ
cord-005453-4057qib7	12909	21	karyotype	karyotype	NN
cord-005453-4057qib7	12909	22	.	.	.
cord-005453-4057qib7	12910	1	Following	follow	VBG
cord-005453-4057qib7	12910	2	an	an	DT
cord-005453-4057qib7	12910	3	uneventful	uneventful	JJ
cord-005453-4057qib7	12910	4	course	course	NN
cord-005453-4057qib7	12910	5	and	and	CC
cord-005453-4057qib7	12910	6	no	no	DT
cord-005453-4057qib7	12910	7	signs	sign	NNS
cord-005453-4057qib7	12910	8	of	of	IN
cord-005453-4057qib7	12910	9	GvHD	GvHD	NNP
cord-005453-4057qib7	12910	10	,	,	,
cord-005453-4057qib7	12910	11	she	-PRON-	PRP
cord-005453-4057qib7	12910	12	had	have	VBD
cord-005453-4057qib7	12910	13	been	be	VBN
cord-005453-4057qib7	12910	14	off	off	IN
cord-005453-4057qib7	12910	15	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	12910	16	since	since	IN
cord-005453-4057qib7	12910	17	4,5	4,5	CD
cord-005453-4057qib7	12910	18	years	year	NNS
cord-005453-4057qib7	12910	19	.	.	.
cord-005453-4057qib7	12911	1	At	at	IN
cord-005453-4057qib7	12911	2	the	the	DT
cord-005453-4057qib7	12911	3	time	time	NN
cord-005453-4057qib7	12911	4	of	of	IN
cord-005453-4057qib7	12911	5	the	the	DT
cord-005453-4057qib7	12911	6	admission	admission	NN
cord-005453-4057qib7	12911	7	the	the	DT
cord-005453-4057qib7	12911	8	patient	patient	NN
cord-005453-4057qib7	12911	9	had	have	VBD
cord-005453-4057qib7	12911	10	slightly	slightly	RB
cord-005453-4057qib7	12911	11	lowered	lower	VBN
cord-005453-4057qib7	12911	12	WBC	WBC	NNP
cord-005453-4057qib7	12911	13	(	(	-LRB-
cord-005453-4057qib7	12911	14	2,9	2,9	CD
cord-005453-4057qib7	12911	15	Gpt	Gpt	NNP
cord-005453-4057qib7	12911	16	/	/	SYM
cord-005453-4057qib7	12911	17	l	l	NN
cord-005453-4057qib7	12911	18	)	)	-RRB-
cord-005453-4057qib7	12911	19	and	and	CC
cord-005453-4057qib7	12911	20	PLT	PLT	NNP
cord-005453-4057qib7	12911	21	(	(	-LRB-
cord-005453-4057qib7	12911	22	111	111	CD
cord-005453-4057qib7	12911	23	Gpt	Gpt	NNP
cord-005453-4057qib7	12911	24	/	/	SYM
cord-005453-4057qib7	12911	25	l	l	NN
cord-005453-4057qib7	12911	26	)	)	-RRB-
cord-005453-4057qib7	12911	27	and	and	CC
cord-005453-4057qib7	12911	28	clearly	clearly	RB
cord-005453-4057qib7	12911	29	increased	increase	VBD
cord-005453-4057qib7	12911	30	LDH	LDH	NNP
cord-005453-4057qib7	12911	31	(	(	-LRB-
cord-005453-4057qib7	12911	32	793	793	CD
cord-005453-4057qib7	12911	33	U	u	NN
cord-005453-4057qib7	12911	34	/	/	SYM
cord-005453-4057qib7	12911	35	l	l	NN
cord-005453-4057qib7	12911	36	)	)	-RRB-
cord-005453-4057qib7	12911	37	.	.	.
cord-005453-4057qib7	12912	1	Methods	method	NNS
cord-005453-4057qib7	12912	2	:	:	:
cord-005453-4057qib7	12913	1	Histology	histology	NN
cord-005453-4057qib7	12913	2	of	of	IN
cord-005453-4057qib7	12913	3	a	a	DT
cord-005453-4057qib7	12913	4	CT	CT	NNP
cord-005453-4057qib7	12913	5	-	-	HYPH
cord-005453-4057qib7	12913	6	based	base	VBN
cord-005453-4057qib7	12913	7	biopsy	biopsy	NN
cord-005453-4057qib7	12913	8	of	of	IN
cord-005453-4057qib7	12913	9	the	the	DT
cord-005453-4057qib7	12913	10	paravertebral	paravertebral	JJ
cord-005453-4057qib7	12913	11	tumour	tumour	NN
cord-005453-4057qib7	12913	12	showed	show	VBD
cord-005453-4057qib7	12913	13	an	an	DT
cord-005453-4057qib7	12913	14	infiltration	infiltration	NN
cord-005453-4057qib7	12913	15	of	of	IN
cord-005453-4057qib7	12913	16	the	the	DT
cord-005453-4057qib7	12913	17	muscles	muscle	NNS
cord-005453-4057qib7	12913	18	by	by	IN
cord-005453-4057qib7	12913	19	blastous	blastous	JJ
cord-005453-4057qib7	12913	20	cells	cell	NNS
cord-005453-4057qib7	12913	21	that	that	WDT
cord-005453-4057qib7	12913	22	were	be	VBD
cord-005453-4057qib7	12913	23	CD45-	CD45-	VBG
cord-005453-4057qib7	12913	24	,	,	,
cord-005453-4057qib7	12913	25	CD34-	cd34-	NN
cord-005453-4057qib7	12913	26	,	,	,
cord-005453-4057qib7	12913	27	PAX5-positive	pax5-positive	JJ
cord-005453-4057qib7	12913	28	,	,	,
cord-005453-4057qib7	12913	29	TdT	tdt	NN
cord-005453-4057qib7	12913	30	and	and	CC
cord-005453-4057qib7	12913	31	CD79a	CD79a	NNP
cord-005453-4057qib7	12913	32	were	be	VBD
cord-005453-4057qib7	12913	33	questionably	questionably	RB
cord-005453-4057qib7	12913	34	positive	positive	JJ
cord-005453-4057qib7	12913	35	.	.	.
cord-005453-4057qib7	12914	1	Provisonal	provisonal	JJ
cord-005453-4057qib7	12914	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	12914	3	therefore	therefore	RB
cord-005453-4057qib7	12914	4	was	be	VBD
cord-005453-4057qib7	12914	5	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	12914	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	12914	7	,	,	,
cord-005453-4057qib7	12914	8	POX	POX	NNP
cord-005453-4057qib7	12914	9	tested	test	VBD
cord-005453-4057qib7	12914	10	negative	negative	JJ
cord-005453-4057qib7	12914	11	.	.	.
cord-005453-4057qib7	12915	1	The	the	DT
cord-005453-4057qib7	12915	2	bone	bone	NN
cord-005453-4057qib7	12915	3	marrow	marrow	NN
cord-005453-4057qib7	12915	4	was	be	VBD
cord-005453-4057qib7	12915	5	hypocellular	hypocellular	NN
cord-005453-4057qib7	12915	6	with	with	IN
cord-005453-4057qib7	12915	7	increased	increase	VBN
cord-005453-4057qib7	12915	8	numbers	number	NNS
cord-005453-4057qib7	12915	9	of	of	IN
cord-005453-4057qib7	12915	10	mature	mature	JJ
cord-005453-4057qib7	12915	11	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12915	12	,	,	,
cord-005453-4057qib7	12915	13	but	but	CC
cord-005453-4057qib7	12915	14	no	no	DT
cord-005453-4057qib7	12915	15	definite	definite	JJ
cord-005453-4057qib7	12915	16	signs	sign	NNS
cord-005453-4057qib7	12915	17	of	of	IN
cord-005453-4057qib7	12915	18	malignancy	malignancy	NN
cord-005453-4057qib7	12915	19	.	.	.
cord-005453-4057qib7	12916	1	Cerebrospinal	cerebrospinal	NN
cord-005453-4057qib7	12916	2	fluid	fluid	NN
cord-005453-4057qib7	12916	3	revealed	reveal	VBD
cord-005453-4057qib7	12916	4	1574	1574	CD
cord-005453-4057qib7	12916	5	cells	cell	NNS
cord-005453-4057qib7	12916	6	/	/	SYM
cord-005453-4057qib7	12916	7	μl	μl	VBP
cord-005453-4057qib7	12916	8	with	with	IN
cord-005453-4057qib7	12916	9	90	90	CD
cord-005453-4057qib7	12916	10	%	%	NN
cord-005453-4057qib7	12916	11	blasts	blast	NNS
cord-005453-4057qib7	12916	12	.	.	.
cord-005453-4057qib7	12917	1	Immunotype	Immunotype	NNP
cord-005453-4057qib7	12917	2	was	be	VBD
cord-005453-4057qib7	12917	3	CD34	CD34	NNP
cord-005453-4057qib7	12917	4	,	,	,
cord-005453-4057qib7	12918	1	CD117	cd117	UH
cord-005453-4057qib7	12918	2	,	,	,
cord-005453-4057qib7	12918	3	CD13	CD13	NNP
cord-005453-4057qib7	12918	4	,	,	,
cord-005453-4057qib7	12918	5	CD33	CD33	NNP
cord-005453-4057qib7	12918	6	,	,	,
cord-005453-4057qib7	12918	7	HLA	HLA	NNP
cord-005453-4057qib7	12918	8	-	-	HYPH
cord-005453-4057qib7	12918	9	DR	DR	NNP
cord-005453-4057qib7	12918	10	positive	positive	JJ
cord-005453-4057qib7	12918	11	,	,	,
cord-005453-4057qib7	12918	12	POX	pox	NN
cord-005453-4057qib7	12918	13	and	and	CC
cord-005453-4057qib7	12918	14	lymphatic	lymphatic	JJ
cord-005453-4057qib7	12918	15	markers	marker	NNS
cord-005453-4057qib7	12918	16	were	be	VBD
cord-005453-4057qib7	12918	17	negative	negative	JJ
cord-005453-4057qib7	12918	18	.	.	.
cord-005453-4057qib7	12919	1	Because	because	IN
cord-005453-4057qib7	12919	2	of	of	IN
cord-005453-4057qib7	12919	3	this	this	DT
cord-005453-4057qib7	12919	4	we	-PRON-	PRP
cord-005453-4057qib7	12919	5	finally	finally	RB
cord-005453-4057qib7	12919	6	suspected	suspect	VBD
cord-005453-4057qib7	12919	7	meningeosis	meningeosis	NNP
cord-005453-4057qib7	12919	8	leucaemica	leucaemica	NNP
cord-005453-4057qib7	12919	9	.	.	.
cord-005453-4057qib7	12920	1	We	-PRON-	PRP
cord-005453-4057qib7	12920	2	completed	complete	VBD
cord-005453-4057qib7	12920	3	the	the	DT
cord-005453-4057qib7	12920	4	diagnostic	diagnostic	JJ
cord-005453-4057qib7	12920	5	workup	workup	NN
cord-005453-4057qib7	12920	6	with	with	IN
cord-005453-4057qib7	12920	7	genetical	genetical	JJ
cord-005453-4057qib7	12920	8	and	and	CC
cord-005453-4057qib7	12920	9	chimaerism	chimaerism	NN
cord-005453-4057qib7	12920	10	tests	test	NNS
cord-005453-4057qib7	12920	11	and	and	CC
cord-005453-4057qib7	12920	12	compared	compare	VBD
cord-005453-4057qib7	12920	13	the	the	DT
cord-005453-4057qib7	12920	14	result	result	NN
cord-005453-4057qib7	12920	15	to	to	IN
cord-005453-4057qib7	12920	16	the	the	DT
cord-005453-4057qib7	12920	17	patients	patient	NNS
cord-005453-4057qib7	12920	18	'	'	POS
cord-005453-4057qib7	12920	19	MDS	mds	NN
cord-005453-4057qib7	12920	20	before	before	IN
cord-005453-4057qib7	12920	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	12920	22	stem	stem	NN
cord-005453-4057qib7	12920	23	cell	cell	NN
cord-005453-4057qib7	12920	24	transplantation	transplantation	NN
cord-005453-4057qib7	12920	25	.	.	.
cord-005453-4057qib7	12921	1	[	[	-LRB-
cord-005453-4057qib7	12921	2	[	[	-LRB-
cord-005453-4057qib7	12921	3	P580	P580	NNP
cord-005453-4057qib7	12921	4	Image	image	NN
cord-005453-4057qib7	12921	5	]	]	-RRB-
cord-005453-4057qib7	12921	6	1	1	CD
cord-005453-4057qib7	12921	7	.	.	.
cord-005453-4057qib7	12922	1	MRI	MRI	NNP
cord-005453-4057qib7	12922	2	scan	scan	NN
cord-005453-4057qib7	12922	3	of	of	IN
cord-005453-4057qib7	12922	4	the	the	DT
cord-005453-4057qib7	12922	5	large	large	JJ
cord-005453-4057qib7	12922	6	thoracic	thoracic	JJ
cord-005453-4057qib7	12922	7	tumour	tumour	NN
cord-005453-4057qib7	12922	8	]	]	-RRB-
cord-005453-4057qib7	12923	1	Results	result	NNS
cord-005453-4057qib7	12923	2	:	:	:
cord-005453-4057qib7	12924	1	Cerebrospinal	cerebrospinal	NN
cord-005453-4057qib7	12924	2	fluid	fluid	NN
cord-005453-4057qib7	12924	3	(	(	-LRB-
cord-005453-4057qib7	12924	4	CSF	CSF	NNP
cord-005453-4057qib7	12924	5	)	)	-RRB-
cord-005453-4057qib7	12924	6	cells	cell	NNS
cord-005453-4057qib7	12924	7	consisted	consist	VBD
cord-005453-4057qib7	12924	8	of	of	IN
cord-005453-4057qib7	12924	9	92	92	CD
cord-005453-4057qib7	12924	10	%	%	NN
cord-005453-4057qib7	12924	11	recipient	recipient	NN
cord-005453-4057qib7	12924	12	cells	cell	NNS
cord-005453-4057qib7	12924	13	,	,	,
cord-005453-4057qib7	12924	14	whereas	whereas	IN
cord-005453-4057qib7	12924	15	peripheral	peripheral	JJ
cord-005453-4057qib7	12924	16	blood	blood	NN
cord-005453-4057qib7	12924	17	cells	cell	NNS
cord-005453-4057qib7	12924	18	were	be	VBD
cord-005453-4057qib7	12924	19	100	100	CD
cord-005453-4057qib7	12924	20	%	%	NN
cord-005453-4057qib7	12924	21	donor	donor	NN
cord-005453-4057qib7	12924	22	.	.	.
cord-005453-4057qib7	12925	1	High	high	JJ
cord-005453-4057qib7	12925	2	risk	risk	NN
cord-005453-4057qib7	12925	3	MDS	mds	NN
cord-005453-4057qib7	12925	4	at	at	IN
cord-005453-4057qib7	12925	5	transplant	transplant	NN
cord-005453-4057qib7	12925	6	displayed	display	VBD
cord-005453-4057qib7	12925	7	a	a	DT
cord-005453-4057qib7	12925	8	complex	complex	JJ
cord-005453-4057qib7	12925	9	caryotype	caryotype	NN
cord-005453-4057qib7	12925	10	including	include	VBG
cord-005453-4057qib7	12925	11	trisomy	trisomy	NN
cord-005453-4057qib7	12925	12	8	8	CD
cord-005453-4057qib7	12925	13	and	and	CC
cord-005453-4057qib7	12925	14	tetrasomy	tetrasomy	NNP
cord-005453-4057qib7	12925	15	8	8	CD
cord-005453-4057qib7	12925	16	,	,	,
cord-005453-4057qib7	12925	17	now	now	RB
cord-005453-4057qib7	12925	18	10	10	CD
cord-005453-4057qib7	12925	19	%	%	NN
cord-005453-4057qib7	12925	20	of	of	IN
cord-005453-4057qib7	12925	21	the	the	DT
cord-005453-4057qib7	12925	22	cells	cell	NNS
cord-005453-4057qib7	12925	23	in	in	IN
cord-005453-4057qib7	12925	24	CSF	CSF	NNP
cord-005453-4057qib7	12925	25	showed	show	VBD
cord-005453-4057qib7	12925	26	trisomy	trisomy	NN
cord-005453-4057qib7	12925	27	8	8	CD
cord-005453-4057qib7	12925	28	and	and	CC
cord-005453-4057qib7	12925	29	70	70	CD
cord-005453-4057qib7	12925	30	%	%	NN
cord-005453-4057qib7	12925	31	tetrasomy	tetrasomy	NN
cord-005453-4057qib7	12925	32	8	8	CD
cord-005453-4057qib7	12925	33	.	.	.
cord-005453-4057qib7	12926	1	Chimerism	chimerism	NN
cord-005453-4057qib7	12926	2	and	and	CC
cord-005453-4057qib7	12926	3	FISH	fish	NN
cord-005453-4057qib7	12926	4	of	of	IN
cord-005453-4057qib7	12926	5	the	the	DT
cord-005453-4057qib7	12926	6	solid	solid	JJ
cord-005453-4057qib7	12926	7	tumour	tumour	NN
cord-005453-4057qib7	12926	8	could	could	MD
cord-005453-4057qib7	12926	9	not	not	RB
cord-005453-4057qib7	12926	10	be	be	VB
cord-005453-4057qib7	12926	11	performed	perform	VBN
cord-005453-4057qib7	12926	12	,	,	,
cord-005453-4057qib7	12926	13	coexpression	coexpression	NN
cord-005453-4057qib7	12926	14	of	of	IN
cord-005453-4057qib7	12926	15	myeloid	myeloid	JJ
cord-005453-4057qib7	12926	16	markers	marker	NNS
cord-005453-4057qib7	12926	17	within	within	IN
cord-005453-4057qib7	12926	18	the	the	DT
cord-005453-4057qib7	12926	19	tumour	tumour	NN
cord-005453-4057qib7	12926	20	is	be	VBZ
cord-005453-4057qib7	12926	21	pending	pende	VBG
cord-005453-4057qib7	12926	22	.	.	.
cord-005453-4057qib7	12927	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12927	2	:	:	:
cord-005453-4057qib7	12928	1	In	in	IN
cord-005453-4057qib7	12928	2	conclusion	conclusion	NN
cord-005453-4057qib7	12928	3	the	the	DT
cord-005453-4057qib7	12928	4	patient	patient	NN
cord-005453-4057qib7	12928	5	has	have	VBZ
cord-005453-4057qib7	12928	6	meningeosis	meningeosis	NN
cord-005453-4057qib7	12928	7	as	as	IN
cord-005453-4057qib7	12928	8	a	a	DT
cord-005453-4057qib7	12928	9	result	result	NN
cord-005453-4057qib7	12928	10	of	of	IN
cord-005453-4057qib7	12928	11	exclusively	exclusively	RB
cord-005453-4057qib7	12928	12	extramedullary	extramedullary	JJ
cord-005453-4057qib7	12928	13	relapse	relapse	NN
cord-005453-4057qib7	12928	14	of	of	IN
cord-005453-4057qib7	12928	15	myeloid	myeloid	NN
cord-005453-4057qib7	12928	16	blasts	blast	NNS
cord-005453-4057qib7	12928	17	originating	originate	VBG
cord-005453-4057qib7	12928	18	from	from	IN
cord-005453-4057qib7	12928	19	the	the	DT
cord-005453-4057qib7	12928	20	initial	initial	JJ
cord-005453-4057qib7	12928	21	high	high	JJ
cord-005453-4057qib7	12928	22	risk	risk	NN
cord-005453-4057qib7	12928	23	MDS	MDS	NNP
cord-005453-4057qib7	12928	24	with	with	IN
cord-005453-4057qib7	12928	25	blast	blast	NN
cord-005453-4057qib7	12928	26	excess	excess	NN
cord-005453-4057qib7	12928	27	and	and	CC
cord-005453-4057qib7	12928	28	complex	complex	JJ
cord-005453-4057qib7	12928	29	aberrant	aberrant	JJ
cord-005453-4057qib7	12928	30	caryotype	caryotype	NN
cord-005453-4057qib7	12928	31	.	.	.
cord-005453-4057qib7	12929	1	The	the	DT
cord-005453-4057qib7	12929	2	evolution	evolution	NN
cord-005453-4057qib7	12929	3	of	of	IN
cord-005453-4057qib7	12929	4	a	a	DT
cord-005453-4057qib7	12929	5	trisomy	trisomy	NN
cord-005453-4057qib7	12929	6	8	8	CD
cord-005453-4057qib7	12929	7	clone	clone	NN
cord-005453-4057qib7	12929	8	to	to	IN
cord-005453-4057qib7	12929	9	tetrasomy	tetrasomy	NN
cord-005453-4057qib7	12929	10	8	8	CD
cord-005453-4057qib7	12929	11	clone	clone	NN
cord-005453-4057qib7	12929	12	in	in	IN
cord-005453-4057qib7	12929	13	relapse	relapse	NN
cord-005453-4057qib7	12929	14	is	be	VBZ
cord-005453-4057qib7	12929	15	linked	link	VBN
cord-005453-4057qib7	12929	16	to	to	IN
cord-005453-4057qib7	12929	17	extramedullar	extramedullar	JJ
cord-005453-4057qib7	12929	18	manifestations	manifestation	NNS
cord-005453-4057qib7	12929	19	.	.	.
cord-005453-4057qib7	12930	1	Whether	whether	IN
cord-005453-4057qib7	12930	2	the	the	DT
cord-005453-4057qib7	12930	3	solid	solid	JJ
cord-005453-4057qib7	12930	4	tumour	tumour	NN
cord-005453-4057qib7	12930	5	represents	represent	VBZ
cord-005453-4057qib7	12930	6	myeloid	myeloid	JJ
cord-005453-4057qib7	12930	7	sarcoma	sarcoma	NN
cord-005453-4057qib7	12930	8	with	with	IN
cord-005453-4057qib7	12930	9	coexpression	coexpression	NN
cord-005453-4057qib7	12930	10	of	of	IN
cord-005453-4057qib7	12930	11	lymphoid	lymphoid	JJ
cord-005453-4057qib7	12930	12	markers	marker	NNS
cord-005453-4057qib7	12930	13	,	,	,
cord-005453-4057qib7	12931	1	extramedullary	extramedullary	JJ
cord-005453-4057qib7	12931	2	relapse	relapse	NN
cord-005453-4057qib7	12931	3	of	of	IN
cord-005453-4057qib7	12931	4	MDS	MDS	NNP
cord-005453-4057qib7	12931	5	with	with	IN
cord-005453-4057qib7	12931	6	lymphoid	lymphoid	JJ
cord-005453-4057qib7	12931	7	differentiation	differentiation	NN
cord-005453-4057qib7	12931	8	or	or	CC
cord-005453-4057qib7	12931	9	,	,	,
cord-005453-4057qib7	12931	10	less	less	RBR
cord-005453-4057qib7	12931	11	likely	likely	JJ
cord-005453-4057qib7	12931	12	,	,	,
cord-005453-4057qib7	12931	13	a	a	DT
cord-005453-4057qib7	12931	14	separate	separate	JJ
cord-005453-4057qib7	12931	15	lymphobastic	lymphobastic	JJ
cord-005453-4057qib7	12931	16	lymphoma	lymphoma	NN
cord-005453-4057qib7	12931	17	,	,	,
cord-005453-4057qib7	12931	18	is	be	VBZ
cord-005453-4057qib7	12931	19	not	not	RB
cord-005453-4057qib7	12931	20	yet	yet	RB
cord-005453-4057qib7	12931	21	clear	clear	JJ
cord-005453-4057qib7	12931	22	.	.	.
cord-005453-4057qib7	12932	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12932	2	Background	background	NN
cord-005453-4057qib7	12932	3	:	:	:
cord-005453-4057qib7	12933	1	Adoptive	adoptive	JJ
cord-005453-4057qib7	12933	2	T	T	NNP
cord-005453-4057qib7	12933	3	cell	cell	NN
cord-005453-4057qib7	12933	4	therapy	therapy	NN
cord-005453-4057qib7	12933	5	with	with	IN
cord-005453-4057qib7	12933	6	genetically	genetically	RB
cord-005453-4057qib7	12933	7	engineered	engineer	VBN
cord-005453-4057qib7	12933	8	T	t	NN
cord-005453-4057qib7	12933	9	cells	cell	NNS
cord-005453-4057qib7	12933	10	is	be	VBZ
cord-005453-4057qib7	12933	11	a	a	DT
cord-005453-4057qib7	12933	12	potent	potent	JJ
cord-005453-4057qib7	12933	13	innovative	innovative	JJ
cord-005453-4057qib7	12933	14	immunotherapeutic	immunotherapeutic	JJ
cord-005453-4057qib7	12933	15	approach	approach	NN
cord-005453-4057qib7	12933	16	for	for	IN
cord-005453-4057qib7	12933	17	cancer	cancer	NN
cord-005453-4057qib7	12933	18	treatment	treatment	NN
cord-005453-4057qib7	12933	19	.	.	.
cord-005453-4057qib7	12934	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	12934	2	,	,	,
cord-005453-4057qib7	12934	3	the	the	DT
cord-005453-4057qib7	12934	4	use	use	NN
cord-005453-4057qib7	12934	5	of	of	IN
cord-005453-4057qib7	12934	6	T	T	NNP
cord-005453-4057qib7	12934	7	cells	cell	NNS
cord-005453-4057qib7	12934	8	redirected	redirect	VBN
cord-005453-4057qib7	12934	9	against	against	IN
cord-005453-4057qib7	12934	10	tumor	tumor	NN
cord-005453-4057qib7	12934	11	antigens	antigen	NNS
cord-005453-4057qib7	12934	12	,	,	,
cord-005453-4057qib7	12934	13	is	be	VBZ
cord-005453-4057qib7	12934	14	severely	severely	RB
cord-005453-4057qib7	12934	15	limited	limit	VBN
cord-005453-4057qib7	12934	16	by	by	IN
cord-005453-4057qib7	12934	17	1	1	CD
cord-005453-4057qib7	12934	18	)	)	-RRB-
cord-005453-4057qib7	12934	19	the	the	DT
cord-005453-4057qib7	12934	20	difficulty	difficulty	NN
cord-005453-4057qib7	12934	21	in	in	IN
cord-005453-4057qib7	12934	22	identifying	identify	VBG
cord-005453-4057qib7	12934	23	appropriate	appropriate	JJ
cord-005453-4057qib7	12934	24	cell	cell	NN
cord-005453-4057qib7	12934	25	surface	surface	NN
cord-005453-4057qib7	12934	26	antigens	antigen	NNS
cord-005453-4057qib7	12934	27	,	,	,
cord-005453-4057qib7	12934	28	that	that	WDT
cord-005453-4057qib7	12934	29	could	could	MD
cord-005453-4057qib7	12934	30	be	be	VB
cord-005453-4057qib7	12934	31	targeted	target	VBN
cord-005453-4057qib7	12934	32	by	by	IN
cord-005453-4057qib7	12934	33	CAR	car	NN
cord-005453-4057qib7	12934	34	T	T	NNP
cord-005453-4057qib7	12934	35	cells	cell	NNS
cord-005453-4057qib7	12934	36	and	and	CC
cord-005453-4057qib7	12934	37	2	2	CD
cord-005453-4057qib7	12934	38	)	)	-RRB-
cord-005453-4057qib7	12935	1	the	the	DT
cord-005453-4057qib7	12935	2	paucity	paucity	NN
cord-005453-4057qib7	12935	3	of	of	IN
cord-005453-4057qib7	12935	4	tumor	tumor	NN
cord-005453-4057qib7	12935	5	-	-	HYPH
cord-005453-4057qib7	12935	6	specific	specific	JJ
cord-005453-4057qib7	12935	7	T	T	NNP
cord-005453-4057qib7	12935	8	cell	cell	NN
cord-005453-4057qib7	12935	9	receptors	receptor	NNS
cord-005453-4057qib7	12935	10	(	(	-LRB-
cord-005453-4057qib7	12935	11	TCRs	TCRs	NNP
cord-005453-4057qib7	12935	12	)	)	-RRB-
cord-005453-4057qib7	12935	13	against	against	IN
cord-005453-4057qib7	12935	14	shared	share	VBN
cord-005453-4057qib7	12935	15	,	,	,
cord-005453-4057qib7	12935	16	oncogenic	oncogenic	JJ
cord-005453-4057qib7	12935	17	antigens	antigen	NNS
cord-005453-4057qib7	12935	18	.	.	.
cord-005453-4057qib7	12936	1	Methods	method	NNS
cord-005453-4057qib7	12936	2	:	:	:
cord-005453-4057qib7	12936	3	Focusing	focus	VBG
cord-005453-4057qib7	12936	4	on	on	IN
cord-005453-4057qib7	12936	5	Wilms´Tumor	Wilms´Tumor	NNP
cord-005453-4057qib7	12936	6	1	1	CD
cord-005453-4057qib7	12936	7	(	(	-LRB-
cord-005453-4057qib7	12936	8	WT1	WT1	NNP
cord-005453-4057qib7	12936	9	)	)	-RRB-
cord-005453-4057qib7	12936	10	,	,	,
cord-005453-4057qib7	12936	11	a	a	DT
cord-005453-4057qib7	12936	12	tumorassociated	tumorassociated	JJ
cord-005453-4057qib7	12936	13	antigen	antigen	NN
cord-005453-4057qib7	12936	14	overexpressed	overexpresse	VBN
cord-005453-4057qib7	12936	15	by	by	IN
cord-005453-4057qib7	12936	16	acute	acute	JJ
cord-005453-4057qib7	12936	17	myeloid	myeloid	NN
cord-005453-4057qib7	12936	18	leukemia	leukemia	NN
cord-005453-4057qib7	12936	19	and	and	CC
cord-005453-4057qib7	12936	20	several	several	JJ
cord-005453-4057qib7	12936	21	solid	solid	JJ
cord-005453-4057qib7	12936	22	tumors	tumor	NNS
cord-005453-4057qib7	12936	23	,	,	,
cord-005453-4057qib7	12936	24	we	-PRON-	PRP
cord-005453-4057qib7	12936	25	designed	design	VBD
cord-005453-4057qib7	12936	26	and	and	CC
cord-005453-4057qib7	12936	27	implemented	implement	VBD
cord-005453-4057qib7	12936	28	an	an	DT
cord-005453-4057qib7	12936	29	innovative	innovative	JJ
cord-005453-4057qib7	12936	30	protocol	protocol	NN
cord-005453-4057qib7	12936	31	for	for	IN
cord-005453-4057qib7	12936	32	the	the	DT
cord-005453-4057qib7	12936	33	rapid	rapid	JJ
cord-005453-4057qib7	12936	34	isolation	isolation	NN
cord-005453-4057qib7	12936	35	of	of	IN
cord-005453-4057qib7	12936	36	WT1-specific	WT1-specific	NNP
cord-005453-4057qib7	12936	37	T	T	NNP
cord-005453-4057qib7	12936	38	cells	cell	NNS
cord-005453-4057qib7	12936	39	and	and	CC
cord-005453-4057qib7	12936	40	for	for	IN
cord-005453-4057qib7	12936	41	the	the	DT
cord-005453-4057qib7	12936	42	generation	generation	NN
cord-005453-4057qib7	12936	43	and	and	CC
cord-005453-4057qib7	12936	44	characterization	characterization	NN
cord-005453-4057qib7	12936	45	of	of	IN
cord-005453-4057qib7	12936	46	a	a	DT
cord-005453-4057qib7	12936	47	library	library	NN
cord-005453-4057qib7	12936	48	of	of	IN
cord-005453-4057qib7	12936	49	WT1-specific	WT1-specific	NNP
cord-005453-4057qib7	12936	50	TCRs	TCRs	NNPS
cord-005453-4057qib7	12936	51	displaying	display	VBG
cord-005453-4057qib7	12936	52	different	different	JJ
cord-005453-4057qib7	12936	53	human	human	JJ
cord-005453-4057qib7	12936	54	leukocyte	leukocyte	NN
cord-005453-4057qib7	12936	55	antigen	antigen	NN
cord-005453-4057qib7	12936	56	(	(	-LRB-
cord-005453-4057qib7	12936	57	HLA	HLA	NNP
cord-005453-4057qib7	12936	58	)	)	-RRB-
cord-005453-4057qib7	12936	59	restrictions	restriction	NNS
cord-005453-4057qib7	12936	60	,	,	,
cord-005453-4057qib7	12936	61	to	to	TO
cord-005453-4057qib7	12936	62	be	be	VB
cord-005453-4057qib7	12936	63	exploited	exploit	VBN
cord-005453-4057qib7	12936	64	by	by	IN
cord-005453-4057qib7	12936	65	TCR	TCR	NNP
cord-005453-4057qib7	12936	66	gene	gene	NN
cord-005453-4057qib7	12936	67	transfer	transfer	NN
cord-005453-4057qib7	12936	68	and	and	CC
cord-005453-4057qib7	12936	69	TCR	TCR	NNP
cord-005453-4057qib7	12936	70	gene	gene	NN
cord-005453-4057qib7	12936	71	editing	editing	NN
cord-005453-4057qib7	12936	72	.	.	.
cord-005453-4057qib7	12937	1	To	to	IN
cord-005453-4057qib7	12937	2	this	this	DT
cord-005453-4057qib7	12937	3	aim	aim	NN
cord-005453-4057qib7	12937	4	,	,	,
cord-005453-4057qib7	12937	5	we	-PRON-	PRP
cord-005453-4057qib7	12937	6	repetitively	repetitively	RB
cord-005453-4057qib7	12937	7	stimulated	stimulate	VBD
cord-005453-4057qib7	12937	8	T	t	NN
cord-005453-4057qib7	12937	9	cells	cell	NNS
cord-005453-4057qib7	12937	10	with	with	IN
cord-005453-4057qib7	12937	11	autologous	autologous	JJ
cord-005453-4057qib7	12937	12	antigen	antigen	NN
cord-005453-4057qib7	12937	13	-	-	HYPH
cord-005453-4057qib7	12937	14	presenting	present	VBG
cord-005453-4057qib7	12937	15	cells	cell	NNS
cord-005453-4057qib7	12937	16	,	,	,
cord-005453-4057qib7	12937	17	including	include	VBG
cord-005453-4057qib7	12937	18	immortalized	immortalize	VBN
cord-005453-4057qib7	12937	19	B	b	NN
cord-005453-4057qib7	12937	20	cells	cell	NNS
cord-005453-4057qib7	12937	21	,	,	,
cord-005453-4057qib7	12937	22	pulsed	pulse	VBN
cord-005453-4057qib7	12937	23	with	with	IN
cord-005453-4057qib7	12937	24	overlapping	overlap	VBG
cord-005453-4057qib7	12937	25	peptides	peptide	NNS
cord-005453-4057qib7	12937	26	spanning	span	VBG
cord-005453-4057qib7	12937	27	the	the	DT
cord-005453-4057qib7	12937	28	entire	entire	JJ
cord-005453-4057qib7	12937	29	WT1	WT1	NNP
cord-005453-4057qib7	12937	30	protein	protein	NN
cord-005453-4057qib7	12937	31	.	.	.
cord-005453-4057qib7	12938	1	T	T	NNP
cord-005453-4057qib7	12938	2	cell	cell	NN
cord-005453-4057qib7	12938	3	recognition	recognition	NN
cord-005453-4057qib7	12938	4	was	be	VBD
cord-005453-4057qib7	12938	5	assessed	assess	VBN
cord-005453-4057qib7	12938	6	by	by	IN
cord-005453-4057qib7	12938	7	flow	flow	NN
cord-005453-4057qib7	12938	8	cytometry	cytometry	NN
cord-005453-4057qib7	12938	9	in	in	IN
cord-005453-4057qib7	12938	10	terms	term	NNS
cord-005453-4057qib7	12938	11	of	of	IN
cord-005453-4057qib7	12938	12	CD107a	CD107a	NNP
cord-005453-4057qib7	12938	13	expression	expression	NN
cord-005453-4057qib7	12938	14	and	and	CC
cord-005453-4057qib7	12938	15	IFNγ	IFNγ	NNS
cord-005453-4057qib7	12938	16	production	production	NN
cord-005453-4057qib7	12938	17	.	.	.
cord-005453-4057qib7	12939	1	Recognized	recognize	VBN
cord-005453-4057qib7	12939	2	peptides	peptide	NNS
cord-005453-4057qib7	12939	3	were	be	VBD
cord-005453-4057qib7	12939	4	mapped	map	VBN
cord-005453-4057qib7	12939	5	by	by	IN
cord-005453-4057qib7	12939	6	a	a	DT
cord-005453-4057qib7	12939	7	deconvoluting	deconvolute	VBG
cord-005453-4057qib7	12939	8	grid	grid	NN
cord-005453-4057qib7	12939	9	and	and	CC
cord-005453-4057qib7	12939	10	T	T	NNP
cord-005453-4057qib7	12939	11	cell	cell	NN
cord-005453-4057qib7	12939	12	clonotypes	clonotype	NNS
cord-005453-4057qib7	12939	13	were	be	VBD
cord-005453-4057qib7	12939	14	longitudinally	longitudinally	RB
cord-005453-4057qib7	12939	15	tracked	track	VBN
cord-005453-4057qib7	12939	16	by	by	IN
cord-005453-4057qib7	12939	17	TCRαβ	tcrαβ	CD
cord-005453-4057qib7	12939	18	sequencing	sequencing	NN
cord-005453-4057qib7	12939	19	.	.	.
cord-005453-4057qib7	12940	1	Results	result	NNS
cord-005453-4057qib7	12940	2	:	:	:
cord-005453-4057qib7	12941	1	We	-PRON-	PRP
cord-005453-4057qib7	12941	2	successfully	successfully	RB
cord-005453-4057qib7	12941	3	expanded	expand	VBD
cord-005453-4057qib7	12941	4	tumor	tumor	NN
cord-005453-4057qib7	12941	5	-	-	HYPH
cord-005453-4057qib7	12941	6	specific	specific	JJ
cord-005453-4057qib7	12941	7	T	t	NN
cord-005453-4057qib7	12941	8	cells	cell	NNS
cord-005453-4057qib7	12941	9	from	from	IN
cord-005453-4057qib7	12941	10	14	14	CD
cord-005453-4057qib7	12941	11	consecutive	consecutive	JJ
cord-005453-4057qib7	12941	12	healthy	healthy	JJ
cord-005453-4057qib7	12941	13	donors	donor	NNS
cord-005453-4057qib7	12941	14	,	,	,
cord-005453-4057qib7	12941	15	in	in	IN
cord-005453-4057qib7	12941	16	an	an	DT
cord-005453-4057qib7	12941	17	average	average	NN
cord-005453-4057qib7	12941	18	of	of	IN
cord-005453-4057qib7	12941	19	4	4	CD
cord-005453-4057qib7	12941	20	rounds	round	NNS
cord-005453-4057qib7	12941	21	of	of	IN
cord-005453-4057qib7	12941	22	in	in	FW
cord-005453-4057qib7	12941	23	vitro	vitro	FW
cord-005453-4057qib7	12941	24	stimulations	stimulation	NNS
cord-005453-4057qib7	12941	25	.	.	.
cord-005453-4057qib7	12942	1	The	the	DT
cord-005453-4057qib7	12942	2	ability	ability	NN
cord-005453-4057qib7	12942	3	of	of	IN
cord-005453-4057qib7	12942	4	WT1specific	WT1specific	NNP
cord-005453-4057qib7	12942	5	T	t	NN
cord-005453-4057qib7	12942	6	cells	cell	NNS
cord-005453-4057qib7	12942	7	to	to	TO
cord-005453-4057qib7	12942	8	recognize	recognize	VB
cord-005453-4057qib7	12942	9	naturally	naturally	RB
cord-005453-4057qib7	12942	10	processed	process	VBN
cord-005453-4057qib7	12942	11	epitopes	epitope	NNS
cord-005453-4057qib7	12942	12	and	and	CC
cord-005453-4057qib7	12942	13	their	-PRON-	PRP$
cord-005453-4057qib7	12942	14	on	on	IN
cord-005453-4057qib7	12942	15	-	-	HYPH
cord-005453-4057qib7	12942	16	target	target	NN
cord-005453-4057qib7	12942	17	specificity	specificity	NN
cord-005453-4057qib7	12942	18	was	be	VBD
cord-005453-4057qib7	12942	19	demonstrated	demonstrate	VBN
cord-005453-4057qib7	12942	20	upon	upon	IN
cord-005453-4057qib7	12942	21	coculture	coculture	NN
cord-005453-4057qib7	12942	22	with	with	IN
cord-005453-4057qib7	12942	23	antigen	antigen	NN
cord-005453-4057qib7	12942	24	-	-	HYPH
cord-005453-4057qib7	12942	25	expressing	express	VBG
cord-005453-4057qib7	12942	26	targets	target	NNS
cord-005453-4057qib7	12942	27	including	include	VBG
cord-005453-4057qib7	12942	28	primary	primary	JJ
cord-005453-4057qib7	12942	29	leukemic	leukemic	JJ
cord-005453-4057qib7	12942	30	blasts	blast	NNS
cord-005453-4057qib7	12942	31	.	.	.
cord-005453-4057qib7	12943	1	Tracking	tracking	NN
cord-005453-4057qib7	12943	2	of	of	IN
cord-005453-4057qib7	12943	3	the	the	DT
cord-005453-4057qib7	12943	4	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	12943	5	repertoire	repertoire	NN
cord-005453-4057qib7	12943	6	during	during	IN
cord-005453-4057qib7	12943	7	culture	culture	NN
cord-005453-4057qib7	12943	8	led	lead	VBD
cord-005453-4057qib7	12943	9	to	to	IN
cord-005453-4057qib7	12943	10	the	the	DT
cord-005453-4057qib7	12943	11	identification	identification	NN
cord-005453-4057qib7	12943	12	of	of	IN
cord-005453-4057qib7	12943	13	20	20	CD
cord-005453-4057qib7	12943	14	clonotypes	clonotype	NNS
cord-005453-4057qib7	12943	15	that	that	WDT
cord-005453-4057qib7	12943	16	recognize	recognize	VBP
cord-005453-4057qib7	12943	17	several	several	JJ
cord-005453-4057qib7	12943	18	tumor	tumor	NN
cord-005453-4057qib7	12943	19	-	-	HYPH
cord-005453-4057qib7	12943	20	associated	associate	VBN
cord-005453-4057qib7	12943	21	peptides	peptide	NNS
cord-005453-4057qib7	12943	22	and	and	CC
cord-005453-4057qib7	12943	23	are	be	VBP
cord-005453-4057qib7	12943	24	restricted	restrict	VBN
cord-005453-4057qib7	12943	25	by	by	IN
cord-005453-4057qib7	12943	26	more	more	JJR
cord-005453-4057qib7	12943	27	than	than	IN
cord-005453-4057qib7	12943	28	5	5	CD
cord-005453-4057qib7	12943	29	HLA	HLA	NNP
cord-005453-4057qib7	12943	30	alleles	allele	NNS
cord-005453-4057qib7	12943	31	,	,	,
cord-005453-4057qib7	12943	32	including	include	VBG
cord-005453-4057qib7	12943	33	HLA	HLA	NNP
cord-005453-4057qib7	12943	34	-	-	HYPH
cord-005453-4057qib7	12943	35	A*02:01	A*02:01	NNP
cord-005453-4057qib7	12943	36	.	.	.
cord-005453-4057qib7	12944	1	TCRs	tcr	NNS
cord-005453-4057qib7	12944	2	were	be	VBD
cord-005453-4057qib7	12944	3	then	then	RB
cord-005453-4057qib7	12944	4	expressed	express	VBN
cord-005453-4057qib7	12944	5	via	via	IN
cord-005453-4057qib7	12944	6	genome	genome	NN
cord-005453-4057qib7	12944	7	editing	editing	NN
cord-005453-4057qib7	12944	8	.	.	.
cord-005453-4057qib7	12945	1	Briefly	briefly	RB
cord-005453-4057qib7	12945	2	,	,	,
cord-005453-4057qib7	12945	3	simultaneous	simultaneous	JJ
cord-005453-4057qib7	12945	4	editing	editing	NN
cord-005453-4057qib7	12945	5	of	of	IN
cord-005453-4057qib7	12945	6	endogenous	endogenous	JJ
cord-005453-4057qib7	12945	7	TCR	TCR	NNP
cord-005453-4057qib7	12945	8	α	α	NNP
cord-005453-4057qib7	12945	9	and	and	CC
cord-005453-4057qib7	12945	10	β	β	NN
cord-005453-4057qib7	12945	11	chain	chain	NN
cord-005453-4057qib7	12945	12	genes	gene	NNS
cord-005453-4057qib7	12945	13	was	be	VBD
cord-005453-4057qib7	12945	14	achieved	achieve	VBN
cord-005453-4057qib7	12945	15	using	use	VBG
cord-005453-4057qib7	12945	16	CRISPR	CRISPR	NNP
cord-005453-4057qib7	12945	17	/	/	SYM
cord-005453-4057qib7	12945	18	Cas9	Cas9	NNP
cord-005453-4057qib7	12945	19	technology	technology	NN
cord-005453-4057qib7	12945	20	(	(	-LRB-
cord-005453-4057qib7	12945	21	efficiency	efficiency	NN
cord-005453-4057qib7	12945	22	>	>	XX
cord-005453-4057qib7	12945	23	90	90	CD
cord-005453-4057qib7	12945	24	%	%	NN
cord-005453-4057qib7	12945	25	)	)	-RRB-
cord-005453-4057qib7	12945	26	,	,	,
cord-005453-4057qib7	12945	27	followed	follow	VBN
cord-005453-4057qib7	12945	28	by	by	IN
cord-005453-4057qib7	12945	29	transduction	transduction	NN
cord-005453-4057qib7	12945	30	of	of	IN
cord-005453-4057qib7	12945	31	T	T	NNP
cord-005453-4057qib7	12945	32	cells	cell	NNS
cord-005453-4057qib7	12945	33	with	with	IN
cord-005453-4057qib7	12945	34	lentiviral	lentiviral	JJ
cord-005453-4057qib7	12945	35	vectors	vector	NNS
cord-005453-4057qib7	12945	36	encoding	encode	VBG
cord-005453-4057qib7	12945	37	WT1-specific	WT1-specific	NNP
cord-005453-4057qib7	12945	38	TCRs	tcr	NNS
cord-005453-4057qib7	12945	39	(	(	-LRB-
cord-005453-4057qib7	12945	40	efficiency	efficiency	NN
cord-005453-4057qib7	12945	41	>	>	XX
cord-005453-4057qib7	12945	42	95	95	CD
cord-005453-4057qib7	12945	43	%	%	NN
cord-005453-4057qib7	12945	44	of	of	IN
cord-005453-4057qib7	12945	45	CD8	CD8	NNP
cord-005453-4057qib7	12945	46	+	+	CC
cord-005453-4057qib7	12945	47	T	T	NNP
cord-005453-4057qib7	12945	48	cells	cell	NNS
cord-005453-4057qib7	12945	49	)	)	-RRB-
cord-005453-4057qib7	12945	50	.	.	.
cord-005453-4057qib7	12946	1	Phenotypic	phenotypic	JJ
cord-005453-4057qib7	12946	2	characterization	characterization	NN
cord-005453-4057qib7	12946	3	of	of	IN
cord-005453-4057qib7	12946	4	edited	edit	VBN
cord-005453-4057qib7	12946	5	T	t	NN
cord-005453-4057qib7	12946	6	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12946	7	showed	show	VBD
cord-005453-4057qib7	12946	8	a	a	DT
cord-005453-4057qib7	12946	9	major	major	JJ
cord-005453-4057qib7	12946	10	enrichment	enrichment	NN
cord-005453-4057qib7	12946	11	of	of	IN
cord-005453-4057qib7	12946	12	cells	cell	NNS
cord-005453-4057qib7	12946	13	harboring	harbor	VBG
cord-005453-4057qib7	12946	14	T	T	NNP
cord-005453-4057qib7	12946	15	stem	stem	NN
cord-005453-4057qib7	12946	16	cell	cell	NN
cord-005453-4057qib7	12946	17	memory	memory	NN
cord-005453-4057qib7	12946	18	properties	property	NNS
cord-005453-4057qib7	12946	19	.	.	.
cord-005453-4057qib7	12947	1	Functional	functional	JJ
cord-005453-4057qib7	12947	2	validation	validation	NN
cord-005453-4057qib7	12947	3	of	of	IN
cord-005453-4057qib7	12947	4	the	the	DT
cord-005453-4057qib7	12947	5	edited	edit	VBN
cord-005453-4057qib7	12947	6	T	t	NN
cord-005453-4057qib7	12947	7	cells	cell	NNS
cord-005453-4057qib7	12947	8	is	be	VBZ
cord-005453-4057qib7	12947	9	currently	currently	RB
cord-005453-4057qib7	12947	10	ongoing	ongoing	JJ
cord-005453-4057qib7	12947	11	.	.	.
cord-005453-4057qib7	12948	1	Preliminary	preliminary	JJ
cord-005453-4057qib7	12948	2	results	result	NNS
cord-005453-4057qib7	12948	3	of	of	IN
cord-005453-4057qib7	12948	4	a	a	DT
cord-005453-4057qib7	12948	5	6	6	CD
cord-005453-4057qib7	12948	6	hours	hour	NNS
cord-005453-4057qib7	12948	7	coculture	coculture	NN
cord-005453-4057qib7	12948	8	experiment	experiment	NN
cord-005453-4057qib7	12948	9	show	show	VBP
cord-005453-4057qib7	12948	10	that	that	IN
cord-005453-4057qib7	12948	11	TCR	TCR	NNP
cord-005453-4057qib7	12948	12	edited	edit	VBD
cord-005453-4057qib7	12948	13	T	t	NN
cord-005453-4057qib7	12948	14	cells	cell	NNS
cord-005453-4057qib7	12948	15	kill	kill	VBP
cord-005453-4057qib7	12948	16	fresh	fresh	JJ
cord-005453-4057qib7	12948	17	WT1	WT1	NNP
cord-005453-4057qib7	12948	18	+	+	CC
cord-005453-4057qib7	12948	19	leukemic	leukemic	JJ
cord-005453-4057qib7	12948	20	blasts	blast	NNS
cord-005453-4057qib7	12948	21	,	,	,
cord-005453-4057qib7	12948	22	harvested	harvest	VBN
cord-005453-4057qib7	12948	23	from	from	IN
cord-005453-4057qib7	12948	24	HLA	HLA	NNP
cord-005453-4057qib7	12948	25	-	-	HYPH
cord-005453-4057qib7	12948	26	matched	match	VBN
cord-005453-4057qib7	12948	27	patients	patient	NNS
cord-005453-4057qib7	12948	28	,	,	,
cord-005453-4057qib7	12948	29	with	with	IN
cord-005453-4057qib7	12948	30	an	an	DT
cord-005453-4057qib7	12948	31	efficiency	efficiency	NN
cord-005453-4057qib7	12948	32	up	up	IN
cord-005453-4057qib7	12948	33	to	to	TO
cord-005453-4057qib7	12948	34	70	70	CD
cord-005453-4057qib7	12948	35	%	%	NN
cord-005453-4057qib7	12948	36	at	at	IN
cord-005453-4057qib7	12948	37	an	an	DT
cord-005453-4057qib7	12948	38	effector	effector	NN
cord-005453-4057qib7	12948	39	to	to	TO
cord-005453-4057qib7	12948	40	target	target	VB
cord-005453-4057qib7	12948	41	ratio	ratio	NN
cord-005453-4057qib7	12948	42	of	of	IN
cord-005453-4057qib7	12948	43	5	5	CD
cord-005453-4057qib7	12948	44	to	to	IN
cord-005453-4057qib7	12948	45	1	1	CD
cord-005453-4057qib7	12948	46	,	,	,
cord-005453-4057qib7	12948	47	while	while	IN
cord-005453-4057qib7	12948	48	no	no	DT
cord-005453-4057qib7	12948	49	killing	killing	NN
cord-005453-4057qib7	12948	50	of	of	IN
cord-005453-4057qib7	12948	51	controls	control	NNS
cord-005453-4057qib7	12948	52	is	be	VBZ
cord-005453-4057qib7	12948	53	observed	observe	VBN
cord-005453-4057qib7	12948	54	.	.	.
cord-005453-4057qib7	12949	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12949	2	:	:	:
cord-005453-4057qib7	12950	1	We	-PRON-	PRP
cord-005453-4057qib7	12950	2	set	set	VBD
cord-005453-4057qib7	12950	3	up	up	RP
cord-005453-4057qib7	12950	4	a	a	DT
cord-005453-4057qib7	12950	5	protocol	protocol	NN
cord-005453-4057qib7	12950	6	enabling	enable	VBG
cord-005453-4057qib7	12950	7	consistent	consistent	JJ
cord-005453-4057qib7	12950	8	and	and	CC
cord-005453-4057qib7	12950	9	efficient	efficient	JJ
cord-005453-4057qib7	12950	10	hunting	hunting	NN
cord-005453-4057qib7	12950	11	for	for	IN
cord-005453-4057qib7	12950	12	tumor	tumor	NN
cord-005453-4057qib7	12950	13	-	-	HYPH
cord-005453-4057qib7	12950	14	specific	specific	JJ
cord-005453-4057qib7	12950	15	TCRs	tcr	NNS
cord-005453-4057qib7	12950	16	with	with	IN
cord-005453-4057qib7	12950	17	no	no	DT
cord-005453-4057qib7	12950	18	need	need	NN
cord-005453-4057qib7	12950	19	for	for	IN
cord-005453-4057qib7	12950	20	labor	labor	NN
cord-005453-4057qib7	12950	21	intensive	intensive	JJ
cord-005453-4057qib7	12950	22	T	t	NN
cord-005453-4057qib7	12950	23	cell	cell	NN
cord-005453-4057qib7	12950	24	cloning	cloning	NN
cord-005453-4057qib7	12950	25	.	.	.
cord-005453-4057qib7	12951	1	TCR	TCR	NNP
cord-005453-4057qib7	12951	2	genes	gene	NNS
cord-005453-4057qib7	12951	3	can	can	MD
cord-005453-4057qib7	12951	4	be	be	VB
cord-005453-4057qib7	12951	5	easily	easily	RB
cord-005453-4057qib7	12951	6	and	and	CC
cord-005453-4057qib7	12951	7	rapidly	rapidly	RB
cord-005453-4057qib7	12951	8	used	use	VBN
cord-005453-4057qib7	12951	9	to	to	TO
cord-005453-4057qib7	12951	10	redirect	redirect	VB
cord-005453-4057qib7	12951	11	T	T	NNP
cord-005453-4057qib7	12951	12	cell	cell	NN
cord-005453-4057qib7	12951	13	specificity	specificity	NN
cord-005453-4057qib7	12951	14	against	against	IN
cord-005453-4057qib7	12951	15	cancer	cancer	NN
cord-005453-4057qib7	12951	16	cells	cell	NNS
cord-005453-4057qib7	12951	17	by	by	IN
cord-005453-4057qib7	12951	18	TCR	TCR	NNP
cord-005453-4057qib7	12951	19	gene	gene	NN
cord-005453-4057qib7	12951	20	editing	editing	NN
cord-005453-4057qib7	12951	21	.	.	.
cord-005453-4057qib7	12952	1	Disclosure	disclosure	NN
cord-005453-4057qib7	12952	2	:	:	:
cord-005453-4057qib7	12952	3	Chiara	Chiara	NNP
cord-005453-4057qib7	12953	1	Bonini	Bonini	NNP
cord-005453-4057qib7	12953	2	:	:	:
cord-005453-4057qib7	12953	3	Research	research	NN
cord-005453-4057qib7	12953	4	funding	funding	NN
cord-005453-4057qib7	12953	5	from	from	IN
cord-005453-4057qib7	12953	6	Intellia	Intellia	NNP
cord-005453-4057qib7	12953	7	Therapeutics	Therapeutics	NNP
cord-005453-4057qib7	12953	8	P583	P583	NNP
cord-005453-4057qib7	12953	9	CAR	car	NN
cord-005453-4057qib7	12953	10	T	t	NN
cord-005453-4057qib7	12953	11	cell	cell	NN
cord-005453-4057qib7	12953	12	therapy	therapy	NN
cord-005453-4057qib7	12953	13	targeting	target	VBG
cord-005453-4057qib7	12953	14	relapsed	relapse	VBN
cord-005453-4057qib7	12953	15	or	or	CC
cord-005453-4057qib7	12953	16	refractory	refractory	JJ
cord-005453-4057qib7	12954	1	CD19	CD19	NNP
cord-005453-4057qib7	12954	2	+	+	CC
cord-005453-4057qib7	12954	3	lymphoid	lymphoid	JJ
cord-005453-4057qib7	12954	4	disease	disease	NN
cord-005453-4057qib7	12954	5	with	with	IN
cord-005453-4057qib7	12954	6	third	third	JJ
cord-005453-4057qib7	12954	7	-	-	HYPH
cord-005453-4057qib7	12954	8	generation	generation	NN
cord-005453-4057qib7	12954	9	vector	vector	NN
cord-005453-4057qib7	12954	10	RV	RV	NNP
cord-005453-4057qib7	12955	1	-SFG.CD19.CD28.4	-SFG.CD19.CD28.4	NNS
cord-005453-4057qib7	12955	2	-	-	:
cord-005453-4057qib7	12955	3	1BBZETA	1bbzeta	CD
cord-005453-4057qib7	12955	4	Maria	Maria	NNP
cord-005453-4057qib7	12955	5	-	-	HYPH
cord-005453-4057qib7	12955	6	Luisa	Luisa	NNP
cord-005453-4057qib7	12955	7	Schubert	Schubert	NNP
cord-005453-4057qib7	12955	8	1	1	CD
cord-005453-4057qib7	12955	9	,	,	,
cord-005453-4057qib7	12955	10	Anita	Anita	NNP
cord-005453-4057qib7	12955	11	Schmitt	Schmitt	NNP
cord-005453-4057qib7	12955	12	1	1	CD
cord-005453-4057qib7	12955	13	,	,	,
cord-005453-4057qib7	12955	14	Leopold	Leopold	NNP
cord-005453-4057qib7	12955	15	Sellner	Sellner	NNP
cord-005453-4057qib7	12955	16	1,2	1,2	CD
cord-005453-4057qib7	12955	17	,	,	,
cord-005453-4057qib7	12955	18	Brigitte	Brigitte	NNP
cord-005453-4057qib7	12955	19	Neuber	Neuber	NNP
cord-005453-4057qib7	12955	20	1	1	CD
cord-005453-4057qib7	12955	21	,	,	,
cord-005453-4057qib7	12955	22	Angela	Angela	NNP
cord-005453-4057qib7	12955	23	Hückelhoven	Hückelhoven	NNP
cord-005453-4057qib7	12955	24	-	-	HYPH
cord-005453-4057qib7	12955	25	Krauss	Krauss	NNP
cord-005453-4057qib7	12955	26	1	1	CD
cord-005453-4057qib7	12955	27	,	,	,
cord-005453-4057qib7	12955	28	Kunz	Kunz	NNP
cord-005453-4057qib7	12955	29	Alexander	Alexander	NNP
cord-005453-4057qib7	12955	30	1	1	CD
cord-005453-4057qib7	12955	31	,	,	,
cord-005453-4057qib7	12955	32	Lei	Lei	NNP
cord-005453-4057qib7	12955	33	Wang	Wang	NNP
cord-005453-4057qib7	12955	34	1	1	CD
cord-005453-4057qib7	12955	35	,	,	,
cord-005453-4057qib7	12955	36	Gern	Gern	NNP
cord-005453-4057qib7	12955	37	Ulrike	Ulrike	NNP
cord-005453-4057qib7	12955	38	1	1	CD
cord-005453-4057qib7	12955	39	,	,	,
cord-005453-4057qib7	12955	40	Birgit	Birgit	NNP
cord-005453-4057qib7	12955	41	Michels	Michels	NNP
cord-005453-4057qib7	12955	42	1	1	CD
cord-005453-4057qib7	12955	43	,	,	,
cord-005453-4057qib7	12955	44	Susanne	Susanne	NNP
cord-005453-4057qib7	12955	45	Hofmann	Hofmann	NNP
cord-005453-4057qib7	12955	46	1	1	CD
cord-005453-4057qib7	12955	47	,	,	,
cord-005453-4057qib7	12955	48	Carsten	Carsten	NNP
cord-005453-4057qib7	12955	49	Mueller	Mueller	NNP
cord-005453-4057qib7	12955	50	-	-	HYPH
cord-005453-4057qib7	12955	51	Tidow	Tidow	NNP
cord-005453-4057qib7	12955	52	1,2	1,2	CD
cord-005453-4057qib7	12955	53	,	,	,
cord-005453-4057qib7	12955	54	Dreger	Dreger	NNP
cord-005453-4057qib7	12955	55	Peter	Peter	NNP
cord-005453-4057qib7	12955	56	1,2	1,2	CD
cord-005453-4057qib7	12955	57	,	,	,
cord-005453-4057qib7	12955	58	Michael	Michael	NNP
cord-005453-4057qib7	12955	59	Schmitt	Schmitt	NNP
cord-005453-4057qib7	12955	60	1	1	CD
cord-005453-4057qib7	12955	61	,	,	,
cord-005453-4057qib7	12956	1	2	2	LS
cord-005453-4057qib7	12956	2	Background	background	NN
cord-005453-4057qib7	12956	3	:	:	:
cord-005453-4057qib7	12956	4	T	t	NN
cord-005453-4057qib7	12956	5	cells	cell	NNS
cord-005453-4057qib7	12956	6	genetically	genetically	RB
cord-005453-4057qib7	12956	7	engineered	engineer	VBN
cord-005453-4057qib7	12956	8	to	to	TO
cord-005453-4057qib7	12956	9	express	express	VB
cord-005453-4057qib7	12956	10	chimeric	chimeric	JJ
cord-005453-4057qib7	12956	11	antigen	antigen	NN
cord-005453-4057qib7	12956	12	receptors	receptor	NNS
cord-005453-4057qib7	12956	13	(	(	-LRB-
cord-005453-4057qib7	12956	14	CARTs	cart	NNS
cord-005453-4057qib7	12956	15	)	)	-RRB-
cord-005453-4057qib7	12956	16	directed	direct	VBD
cord-005453-4057qib7	12956	17	against	against	IN
cord-005453-4057qib7	12956	18	CD19	CD19	NNP
cord-005453-4057qib7	12956	19	have	have	VBP
cord-005453-4057qib7	12956	20	demonstrated	demonstrate	VBN
cord-005453-4057qib7	12956	21	significant	significant	JJ
cord-005453-4057qib7	12956	22	efficacy	efficacy	NN
cord-005453-4057qib7	12956	23	in	in	IN
cord-005453-4057qib7	12956	24	patients	patient	NNS
cord-005453-4057qib7	12956	25	with	with	IN
cord-005453-4057qib7	12956	26	Iymphoid	Iymphoid	NNP
cord-005453-4057qib7	12956	27	malignancies	malignancy	NNS
cord-005453-4057qib7	12956	28	including	include	VBG
cord-005453-4057qib7	12956	29	relapsed	relapse	VBN
cord-005453-4057qib7	12956	30	or	or	CC
cord-005453-4057qib7	12956	31	refractory	refractory	JJ
cord-005453-4057qib7	12956	32	(	(	-LRB-
cord-005453-4057qib7	12956	33	r	r	NN
cord-005453-4057qib7	12956	34	/	/	SYM
cord-005453-4057qib7	12956	35	r	r	NN
cord-005453-4057qib7	12956	36	)	)	-RRB-
cord-005453-4057qib7	12956	37	B	b	NN
cord-005453-4057qib7	12956	38	-	-	HYPH
cord-005453-4057qib7	12956	39	lineage	lineage	NN
cord-005453-4057qib7	12956	40	acute	acute	JJ
cord-005453-4057qib7	12956	41	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	12956	42	leukemia	leukemia	NN
cord-005453-4057qib7	12956	43	(	(	-LRB-
cord-005453-4057qib7	12956	44	ALL	all	DT
cord-005453-4057qib7	12956	45	)	)	-RRB-
cord-005453-4057qib7	12956	46	or	or	CC
cord-005453-4057qib7	12956	47	r	r	NN
cord-005453-4057qib7	12956	48	/	/	SYM
cord-005453-4057qib7	12956	49	r	r	NN
cord-005453-4057qib7	12956	50	B	b	NN
cord-005453-4057qib7	12956	51	-	-	HYPH
cord-005453-4057qib7	12956	52	cell	cell	NN
cord-005453-4057qib7	12956	53	non	non	JJ
cord-005453-4057qib7	12956	54	-	-	JJ
cord-005453-4057qib7	12956	55	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	12956	56	's	's	POS
cord-005453-4057qib7	12956	57	lymphoma	lymphoma	NN
cord-005453-4057qib7	12956	58	(	(	-LRB-
cord-005453-4057qib7	12956	59	NHL	NHL	NNP
cord-005453-4057qib7	12956	60	)	)	-RRB-
cord-005453-4057qib7	12956	61	.	.	.
cord-005453-4057qib7	12957	1	Access	access	NN
cord-005453-4057qib7	12957	2	to	to	IN
cord-005453-4057qib7	12957	3	CART	cart	NN
cord-005453-4057qib7	12957	4	treatment	treatment	NN
cord-005453-4057qib7	12957	5	for	for	IN
cord-005453-4057qib7	12957	6	patients	patient	NNS
cord-005453-4057qib7	12957	7	in	in	IN
cord-005453-4057qib7	12957	8	Europe	Europe	NNP
cord-005453-4057qib7	12957	9	has	have	VBZ
cord-005453-4057qib7	12957	10	been	be	VBN
cord-005453-4057qib7	12957	11	limited	limit	VBN
cord-005453-4057qib7	12957	12	so	so	RB
cord-005453-4057qib7	12957	13	far	far	RB
cord-005453-4057qib7	12957	14	given	give	VBN
cord-005453-4057qib7	12957	15	that	that	IN
cord-005453-4057qib7	12957	16	the	the	DT
cord-005453-4057qib7	12957	17	vast	vast	JJ
cord-005453-4057qib7	12957	18	majority	majority	NN
cord-005453-4057qib7	12957	19	of	of	IN
cord-005453-4057qib7	12957	20	CART	cart	NN
cord-005453-4057qib7	12957	21	trials	trial	NNS
cord-005453-4057qib7	12957	22	have	have	VBP
cord-005453-4057qib7	12957	23	been	be	VBN
cord-005453-4057qib7	12957	24	performed	perform	VBN
cord-005453-4057qib7	12957	25	in	in	IN
cord-005453-4057qib7	12957	26	the	the	DT
cord-005453-4057qib7	12957	27	United	United	NNP
cord-005453-4057qib7	12957	28	States	States	NNP
cord-005453-4057qib7	12957	29	and	and	CC
cord-005453-4057qib7	12957	30	the	the	DT
cord-005453-4057qib7	12957	31	P.	P.	NNP
cord-005453-4057qib7	12957	32	R.	R.	NNP
cord-005453-4057qib7	12957	33	of	of	IN
cord-005453-4057qib7	12957	34	China	China	NNP
cord-005453-4057qib7	12957	35	.	.	.
cord-005453-4057qib7	12958	1	Here	here	RB
cord-005453-4057qib7	12958	2	we	-PRON-	PRP
cord-005453-4057qib7	12958	3	present	present	VBP
cord-005453-4057qib7	12958	4	the	the	DT
cord-005453-4057qib7	12958	5	preliminary	preliminary	JJ
cord-005453-4057qib7	12958	6	results	result	NNS
cord-005453-4057qib7	12958	7	of	of	IN
cord-005453-4057qib7	12958	8	the	the	DT
cord-005453-4057qib7	12958	9	first	first	JJ
cord-005453-4057qib7	12958	10	investigator	investigator	NN
cord-005453-4057qib7	12958	11	-	-	HYPH
cord-005453-4057qib7	12958	12	initiated	initiate	VBN
cord-005453-4057qib7	12958	13	trial	trial	NN
cord-005453-4057qib7	12958	14	(	(	-LRB-
cord-005453-4057qib7	12958	15	IIT	IIT	NNP
cord-005453-4057qib7	12958	16	)	)	-RRB-
cord-005453-4057qib7	12958	17	CART	cart	NN
cord-005453-4057qib7	12958	18	trial	trial	NN
cord-005453-4057qib7	12958	19	in	in	IN
cord-005453-4057qib7	12958	20	Germany	Germany	NNP
cord-005453-4057qib7	12958	21	.	.	.
cord-005453-4057qib7	12959	1	HD	HD	NNP
cord-005453-4057qib7	12959	2	-	-	HYPH
cord-005453-4057qib7	12959	3	CAR-1	CAR-1	NNP
cord-005453-4057qib7	12960	1	(	(	-LRB-
cord-005453-4057qib7	12960	2	EudraCT	EudraCT	NNP
cord-005453-4057qib7	12960	3	No	no	UH
cord-005453-4057qib7	12960	4	.	.	.
cord-005453-4057qib7	12961	1	2016	2016	CD
cord-005453-4057qib7	12961	2	-	-	SYM
cord-005453-4057qib7	12961	3	00	00	CD
cord-005453-4057qib7	12961	4	4808	4808	CD
cord-005453-4057qib7	12961	5	-	-	SYM
cord-005453-4057qib7	12961	6	60	60	CD
cord-005453-4057qib7	12961	7	;	;	:
cord-005453-4057qib7	12961	8	NCT03676504	NCT03676504	NNP
cord-005453-4057qib7	12961	9	)	)	-RRB-
cord-005453-4057qib7	12961	10	is	be	VBZ
cord-005453-4057qib7	12961	11	a	a	DT
cord-005453-4057qib7	12961	12	phase	phase	NN
cord-005453-4057qib7	12961	13	I	-PRON-	PRP
cord-005453-4057qib7	12961	14	/	/	SYM
cord-005453-4057qib7	12961	15	II	II	NNP
cord-005453-4057qib7	12961	16	trial	trial	NN
cord-005453-4057qib7	12961	17	with	with	IN
cord-005453-4057qib7	12961	18	in	in	IN
cord-005453-4057qib7	12961	19	-	-	HYPH
cord-005453-4057qib7	12961	20	house	house	NN
cord-005453-4057qib7	12961	21	CART	cart	NN
cord-005453-4057qib7	12961	22	manufacturing	manufacturing	NN
cord-005453-4057qib7	12961	23	which	which	WDT
cord-005453-4057qib7	12961	24	was	be	VBD
cord-005453-4057qib7	12961	25	initiated	initiate	VBN
cord-005453-4057qib7	12961	26	in	in	IN
cord-005453-4057qib7	12961	27	September	September	NNP
cord-005453-4057qib7	12961	28	2018	2018	CD
cord-005453-4057qib7	12961	29	at	at	IN
cord-005453-4057qib7	12961	30	the	the	DT
cord-005453-4057qib7	12961	31	University	University	NNP
cord-005453-4057qib7	12961	32	Hospital	Hospital	NNP
cord-005453-4057qib7	12961	33	Heidelberg	Heidelberg	NNP
cord-005453-4057qib7	12961	34	.	.	.
cord-005453-4057qib7	12962	1	Methods	method	NNS
cord-005453-4057qib7	12962	2	:	:	:
cord-005453-4057qib7	12962	3	Adult	adult	NN
cord-005453-4057qib7	12962	4	as	as	RB
cord-005453-4057qib7	12962	5	well	well	RB
cord-005453-4057qib7	12962	6	as	as	IN
cord-005453-4057qib7	12963	1	pediatric	pediatric	JJ
cord-005453-4057qib7	12963	2	patients	patient	NNS
cord-005453-4057qib7	12963	3	with	with	IN
cord-005453-4057qib7	12963	4	r	r	NN
cord-005453-4057qib7	12963	5	/	/	SYM
cord-005453-4057qib7	12963	6	r	r	NN
cord-005453-4057qib7	12963	7	ALL	all	DT
cord-005453-4057qib7	12963	8	and	and	CC
cord-005453-4057qib7	12963	9	patients	patient	NNS
cord-005453-4057qib7	12963	10	with	with	IN
cord-005453-4057qib7	12963	11	chronic	chronic	JJ
cord-005453-4057qib7	12963	12	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	12963	13	leukemia	leukemia	NN
cord-005453-4057qib7	12963	14	(	(	-LRB-
cord-005453-4057qib7	12963	15	CLL	CLL	NNP
cord-005453-4057qib7	12963	16	)	)	-RRB-
cord-005453-4057qib7	12963	17	or	or	CC
cord-005453-4057qib7	12963	18	NHL	NHL	NNP
cord-005453-4057qib7	12963	19	including	include	VBG
cord-005453-4057qib7	12963	20	diffuse	diffuse	VBP
cord-005453-4057qib7	12963	21	large	large	JJ
cord-005453-4057qib7	12963	22	B	b	NN
cord-005453-4057qib7	12963	23	-	-	HYPH
cord-005453-4057qib7	12963	24	cell	cell	NN
cord-005453-4057qib7	12963	25	lymphoma	lymphoma	NN
cord-005453-4057qib7	12963	26	(	(	-LRB-
cord-005453-4057qib7	12963	27	DLBCL	DLBCL	NNP
cord-005453-4057qib7	12963	28	)	)	-RRB-
cord-005453-4057qib7	12963	29	,	,	,
cord-005453-4057qib7	12963	30	follicular	follicular	JJ
cord-005453-4057qib7	12963	31	lymphoma	lymphoma	NN
cord-005453-4057qib7	12963	32	(	(	-LRB-
cord-005453-4057qib7	12963	33	FL	FL	NNP
cord-005453-4057qib7	12963	34	)	)	-RRB-
cord-005453-4057qib7	12963	35	or	or	CC
cord-005453-4057qib7	12963	36	mantle	mantle	NN
cord-005453-4057qib7	12963	37	cell	cell	NN
cord-005453-4057qib7	12963	38	lymphoma	lymphoma	NN
cord-005453-4057qib7	12963	39	(	(	-LRB-
cord-005453-4057qib7	12963	40	MCL	MCL	NNP
cord-005453-4057qib7	12963	41	)	)	-RRB-
cord-005453-4057qib7	12963	42	are	be	VBP
cord-005453-4057qib7	12963	43	treated	treat	VBN
cord-005453-4057qib7	12963	44	with	with	IN
cord-005453-4057qib7	12963	45	autologous	autologous	JJ
cord-005453-4057qib7	12963	46	T	t	NN
cord-005453-4057qib7	12963	47	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	12963	48	transduced	transduce	VBN
cord-005453-4057qib7	12963	49	with	with	IN
cord-005453-4057qib7	12963	50	a	a	DT
cord-005453-4057qib7	12963	51	third	third	JJ
cord-005453-4057qib7	12963	52	-	-	HYPH
cord-005453-4057qib7	12963	53	generation	generation	NN
cord-005453-4057qib7	12963	54	CAR	car	NN
cord-005453-4057qib7	12963	55	retroviral	retroviral	NN
cord-005453-4057qib7	12963	56	vector	vector	NN
cord-005453-4057qib7	12963	57	(	(	-LRB-
cord-005453-4057qib7	12963	58	RV	rv	NN
cord-005453-4057qib7	12963	59	-	-	HYPH
cord-005453-4057qib7	12963	60	SFG.CD19.CD28.4	SFG.CD19.CD28.4	NNP
cord-005453-4057qib7	12963	61	-	-	HYPH
cord-005453-4057qib7	12963	62	1BBzeta	1bbzeta	CD
cord-005453-4057qib7	12963	63	)	)	-RRB-
cord-005453-4057qib7	12963	64	targeting	target	VBG
cord-005453-4057qib7	12963	65	CD19	CD19	NNP
cord-005453-4057qib7	12963	66	.	.	.
cord-005453-4057qib7	12964	1	The	the	DT
cord-005453-4057qib7	12964	2	main	main	JJ
cord-005453-4057qib7	12964	3	purpose	purpose	NN
cord-005453-4057qib7	12964	4	of	of	IN
cord-005453-4057qib7	12964	5	HD	HD	NNP
cord-005453-4057qib7	12964	6	-	-	HYPH
cord-005453-4057qib7	12964	7	CAR-1	CAR-1	NNP
cord-005453-4057qib7	12964	8	is	be	VBZ
cord-005453-4057qib7	12964	9	to	to	TO
cord-005453-4057qib7	12964	10	evaluate	evaluate	VB
cord-005453-4057qib7	12964	11	safety	safety	NN
cord-005453-4057qib7	12964	12	and	and	CC
cord-005453-4057qib7	12964	13	feasibility	feasibility	NN
cord-005453-4057qib7	12964	14	of	of	IN
cord-005453-4057qib7	12964	15	escalating	escalate	VBG
cord-005453-4057qib7	12964	16	third	third	JJ
cord-005453-4057qib7	12964	17	-	-	HYPH
cord-005453-4057qib7	12964	18	generation	generation	NN
cord-005453-4057qib7	12964	19	CAR	car	NN
cord-005453-4057qib7	12964	20	T	t	NN
cord-005453-4057qib7	12964	21	cell	cell	NN
cord-005453-4057qib7	12964	22	doses	dose	NNS
cord-005453-4057qib7	12964	23	(	(	-LRB-
cord-005453-4057qib7	12964	24	1	1	CD
cord-005453-4057qib7	12964	25	-	-	SYM
cord-005453-4057qib7	12964	26	20×10	20×10	CD
cord-005453-4057qib7	12964	27	6	6	CD
cord-005453-4057qib7	12964	28	transduced	transduce	VBN
cord-005453-4057qib7	12964	29	cells	cell	NNS
cord-005453-4057qib7	12964	30	/	/	SYM
cord-005453-4057qib7	12964	31	m	m	CD
cord-005453-4057qib7	12964	32	2	2	CD
cord-005453-4057qib7	12964	33	)	)	-RRB-
cord-005453-4057qib7	12964	34	after	after	IN
cord-005453-4057qib7	12964	35	lymphodepletion	lymphodepletion	NN
cord-005453-4057qib7	12964	36	with	with	IN
cord-005453-4057qib7	12964	37	fludarabine	fludarabine	NN
cord-005453-4057qib7	12964	38	and	and	CC
cord-005453-4057qib7	12964	39	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	12964	40	.	.	.
cord-005453-4057qib7	12965	1	Patients	patient	NNS
cord-005453-4057qib7	12965	2	are	be	VBP
cord-005453-4057qib7	12965	3	monitored	monitor	VBN
cord-005453-4057qib7	12965	4	for	for	IN
cord-005453-4057qib7	12965	5	cytokine	cytokine	NN
cord-005453-4057qib7	12965	6	release	release	NN
cord-005453-4057qib7	12965	7	syndrome	syndrome	NN
cord-005453-4057qib7	12965	8	(	(	-LRB-
cord-005453-4057qib7	12965	9	CRS	CRS	NNP
cord-005453-4057qib7	12965	10	)	)	-RRB-
cord-005453-4057qib7	12965	11	,	,	,
cord-005453-4057qib7	12965	12	CAR	car	NN
cord-005453-4057qib7	12965	13	-	-	HYPH
cord-005453-4057qib7	12965	14	T	t	NN
cord-005453-4057qib7	12965	15	-	-	HYPH
cord-005453-4057qib7	12965	16	cell	cell	NN
cord-005453-4057qib7	12965	17	related	relate	VBN
cord-005453-4057qib7	12965	18	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	12965	19	syndrome	syndrome	NN
cord-005453-4057qib7	12965	20	(	(	-LRB-
cord-005453-4057qib7	12965	21	CRES	CRES	NNP
cord-005453-4057qib7	12965	22	)	)	-RRB-
cord-005453-4057qib7	12966	1	and/or	and/or	CC
cord-005453-4057qib7	12966	2	other	other	JJ
cord-005453-4057qib7	12966	3	toxicities	toxicity	NNS
cord-005453-4057qib7	12966	4	.	.	.
cord-005453-4057qib7	12967	1	In	in	IN
cord-005453-4057qib7	12967	2	vivo	vivo	NN
cord-005453-4057qib7	12967	3	function	function	NN
cord-005453-4057qib7	12967	4	,	,	,
cord-005453-4057qib7	12967	5	survival	survival	NN
cord-005453-4057qib7	12967	6	and	and	CC
cord-005453-4057qib7	12967	7	anti	anti	JJ
cord-005453-4057qib7	12967	8	-	-	JJ
cord-005453-4057qib7	12967	9	tumor	tumor	JJ
cord-005453-4057qib7	12967	10	efficacy	efficacy	NN
cord-005453-4057qib7	12967	11	of	of	IN
cord-005453-4057qib7	12967	12	CARTs	cart	NNS
cord-005453-4057qib7	12967	13	are	be	VBP
cord-005453-4057qib7	12967	14	assessed	assess	VBN
cord-005453-4057qib7	12967	15	.	.	.
cord-005453-4057qib7	12968	1	Results	result	NNS
cord-005453-4057qib7	12968	2	:	:	:
cord-005453-4057qib7	12969	1	To	to	IN
cord-005453-4057qib7	12969	2	date	date	NN
cord-005453-4057qib7	12969	3	,	,	,
cord-005453-4057qib7	12969	4	three	three	CD
cord-005453-4057qib7	12969	5	patients	patient	NNS
cord-005453-4057qib7	12969	6	(	(	-LRB-
cord-005453-4057qib7	12969	7	CLL	CLL	NNP
cord-005453-4057qib7	12969	8	,	,	,
cord-005453-4057qib7	12969	9	DLBCL	DLBCL	NNP
cord-005453-4057qib7	12969	10	and	and	CC
cord-005453-4057qib7	12969	11	MCL	MCL	NNP
cord-005453-4057qib7	12969	12	,	,	,
cord-005453-4057qib7	12969	13	respectively	respectively	RB
cord-005453-4057qib7	12969	14	)	)	-RRB-
cord-005453-4057qib7	12969	15	have	have	VBP
cord-005453-4057qib7	12969	16	been	be	VBN
cord-005453-4057qib7	12969	17	enrolled	enrol	VBN
cord-005453-4057qib7	12969	18	and	and	CC
cord-005453-4057qib7	12969	19	subjected	subject	VBN
cord-005453-4057qib7	12969	20	to	to	IN
cord-005453-4057qib7	12969	21	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	12969	22	.	.	.
cord-005453-4057qib7	12970	1	High	high	JJ
cord-005453-4057qib7	12970	2	numbers	number	NNS
cord-005453-4057qib7	12970	3	of	of	IN
cord-005453-4057qib7	12970	4	transduced	transduce	VBN
cord-005453-4057qib7	12970	5	CARTs	cart	NNS
cord-005453-4057qib7	12970	6	were	be	VBD
cord-005453-4057qib7	12970	7	harvested	harvest	VBN
cord-005453-4057qib7	12970	8	on	on	IN
cord-005453-4057qib7	12970	9	day	day	NN
cord-005453-4057qib7	12970	10	10	10	CD
cord-005453-4057qib7	12970	11	of	of	IN
cord-005453-4057qib7	12970	12	culture	culture	NN
cord-005453-4057qib7	12970	13	(	(	-LRB-
cord-005453-4057qib7	12970	14	82	82	CD
cord-005453-4057qib7	12970	15	-	-	HYPH
cord-005453-4057qib7	12970	16	123x10	123x10	CD
cord-005453-4057qib7	12970	17	6	6	CD
cord-005453-4057qib7	12970	18	CARTs	cart	NNS
cord-005453-4057qib7	12970	19	)	)	-RRB-
cord-005453-4057qib7	12970	20	.	.	.
cord-005453-4057qib7	12971	1	Transduction	transduction	NN
cord-005453-4057qib7	12971	2	efficiency	efficiency	NN
cord-005453-4057qib7	12971	3	ranged	range	VBD
cord-005453-4057qib7	12971	4	between	between	IN
cord-005453-4057qib7	12971	5	33	33	CD
cord-005453-4057qib7	12971	6	and	and	CC
cord-005453-4057qib7	12971	7	42	42	CD
cord-005453-4057qib7	12971	8	%	%	NN
cord-005453-4057qib7	12971	9	.	.	.
cord-005453-4057qib7	12972	1	CART	cart	NN
cord-005453-4057qib7	12972	2	products	product	NNS
cord-005453-4057qib7	12972	3	were	be	VBD
cord-005453-4057qib7	12972	4	sterile	sterile	JJ
cord-005453-4057qib7	12972	5	and	and	CC
cord-005453-4057qib7	12972	6	free	free	JJ
cord-005453-4057qib7	12972	7	from	from	IN
cord-005453-4057qib7	12972	8	mycoplasms	mycoplasm	NNS
cord-005453-4057qib7	12972	9	and	and	CC
cord-005453-4057qib7	12972	10	endotoxins	endotoxin	NNS
cord-005453-4057qib7	12972	11	.	.	.
cord-005453-4057qib7	12973	1	No	no	DT
cord-005453-4057qib7	12973	2	production	production	NN
cord-005453-4057qib7	12973	3	failure	failure	NN
cord-005453-4057qib7	12973	4	occurred	occur	VBD
cord-005453-4057qib7	12973	5	and	and	CC
cord-005453-4057qib7	12973	6	all	all	DT
cord-005453-4057qib7	12973	7	patients	patient	NNS
cord-005453-4057qib7	12973	8	received	receive	VBD
cord-005453-4057qib7	12973	9	the	the	DT
cord-005453-4057qib7	12973	10	CART	cart	NN
cord-005453-4057qib7	12973	11	product	product	NN
cord-005453-4057qib7	12973	12	.	.	.
cord-005453-4057qib7	12974	1	No	no	DT
cord-005453-4057qib7	12974	2	signs	sign	NNS
cord-005453-4057qib7	12974	3	of	of	IN
cord-005453-4057qib7	12974	4	CRS	CRS	NNP
cord-005453-4057qib7	12974	5	or	or	CC
cord-005453-4057qib7	12974	6	CRES	CRES	NNP
cord-005453-4057qib7	12974	7	>	>	XX
cord-005453-4057qib7	12975	1	grade	grade	NN
cord-005453-4057qib7	12975	2	2	2	CD
cord-005453-4057qib7	12975	3	have	have	VBP
cord-005453-4057qib7	12975	4	been	be	VBN
cord-005453-4057qib7	12975	5	observed	observe	VBN
cord-005453-4057qib7	12975	6	.	.	.
cord-005453-4057qib7	12976	1	Assessments	assessment	NNS
cord-005453-4057qib7	12976	2	of	of	IN
cord-005453-4057qib7	12976	3	clinical	clinical	JJ
cord-005453-4057qib7	12976	4	responses	response	NNS
cord-005453-4057qib7	12976	5	are	be	VBP
cord-005453-4057qib7	12976	6	pending	pende	VBG
cord-005453-4057qib7	12976	7	and	and	CC
cord-005453-4057qib7	12976	8	will	will	MD
cord-005453-4057qib7	12976	9	be	be	VB
cord-005453-4057qib7	12976	10	presented	present	VBN
cord-005453-4057qib7	12976	11	at	at	IN
cord-005453-4057qib7	12976	12	the	the	DT
cord-005453-4057qib7	12976	13	conference	conference	NN
cord-005453-4057qib7	12976	14	along	along	IN
cord-005453-4057qib7	12976	15	with	with	IN
cord-005453-4057qib7	12976	16	updated	update	VBN
cord-005453-4057qib7	12976	17	technical	technical	JJ
cord-005453-4057qib7	12976	18	results	result	NNS
cord-005453-4057qib7	12976	19	.	.	.
cord-005453-4057qib7	12977	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	12977	2	:	:	:
cord-005453-4057qib7	12978	1	For	for	IN
cord-005453-4057qib7	12978	2	HD	HD	NNP
cord-005453-4057qib7	12978	3	-	-	HYPH
cord-005453-4057qib7	12978	4	CAR-1	CAR-1	NNP
cord-005453-4057qib7	12978	5	,	,	,
cord-005453-4057qib7	12978	6	GMP	GMP	NNP
cord-005453-4057qib7	12978	7	-	-	HYPH
cord-005453-4057qib7	12978	8	conform	conform	VBP
cord-005453-4057qib7	12978	9	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	12978	10	as	as	RB
cord-005453-4057qib7	12978	11	well	well	RB
cord-005453-4057qib7	12978	12	as	as	IN
cord-005453-4057qib7	12978	13	CART	cart	NN
cord-005453-4057qib7	12978	14	manufacturing	manufacturing	NN
cord-005453-4057qib7	12978	15	was	be	VBD
cord-005453-4057qib7	12978	16	effective	effective	JJ
cord-005453-4057qib7	12978	17	.	.	.
cord-005453-4057qib7	12979	1	Administration	administration	NN
cord-005453-4057qib7	12979	2	,	,	,
cord-005453-4057qib7	12979	3	patient	patient	JJ
cord-005453-4057qib7	12979	4	monitoring	monitoring	NN
cord-005453-4057qib7	12979	5	and	and	CC
cord-005453-4057qib7	12979	6	follow	follow	NN
cord-005453-4057qib7	12979	7	-	-	HYPH
cord-005453-4057qib7	12979	8	up	up	NN
cord-005453-4057qib7	12979	9	were	be	VBD
cord-005453-4057qib7	12979	10	performed	perform	VBN
cord-005453-4057qib7	12979	11	in	in	IN
cord-005453-4057qib7	12979	12	-	-	HYPH
cord-005453-4057qib7	12979	13	house	house	NN
cord-005453-4057qib7	12979	14	providing	provide	VBG
cord-005453-4057qib7	12979	15	independency	independency	NN
cord-005453-4057qib7	12979	16	from	from	IN
cord-005453-4057qib7	12979	17	transport	transport	NN
cord-005453-4057qib7	12979	18	or	or	CC
cord-005453-4057qib7	12979	19	production	production	NN
cord-005453-4057qib7	12979	20	sites	site	NNS
cord-005453-4057qib7	12979	21	outside	outside	IN
cord-005453-4057qib7	12979	22	the	the	DT
cord-005453-4057qib7	12979	23	University	University	NNP
cord-005453-4057qib7	12979	24	Hospital	Hospital	NNP
cord-005453-4057qib7	12979	25	Heidelberg	Heidelberg	NNP
cord-005453-4057qib7	12979	26	,	,	,
cord-005453-4057qib7	12979	27	altogether	altogether	RB
cord-005453-4057qib7	12979	28	suggesting	suggest	VBG
cord-005453-4057qib7	12979	29	that	that	IN
cord-005453-4057qib7	12979	30	academic	academic	JJ
cord-005453-4057qib7	12979	31	CART	CART	NNP
cord-005453-4057qib7	12979	32	IITs	IITs	NNPS
cord-005453-4057qib7	12979	33	are	be	VBP
cord-005453-4057qib7	12979	34	feasible	feasible	JJ
cord-005453-4057qib7	12979	35	in	in	IN
cord-005453-4057qib7	12979	36	Germany	Germany	NNP
cord-005453-4057qib7	12979	37	.	.	.
cord-005453-4057qib7	12980	1	Clinical	clinical	JJ
cord-005453-4057qib7	12980	2	Background	background	NN
cord-005453-4057qib7	12980	3	:	:	:
cord-005453-4057qib7	12981	1	The	the	DT
cord-005453-4057qib7	12981	2	prognosis	prognosis	NN
cord-005453-4057qib7	12981	3	of	of	IN
cord-005453-4057qib7	12981	4	adult	adult	NN
cord-005453-4057qib7	12981	5	patients	patient	NNS
cord-005453-4057qib7	12981	6	(	(	-LRB-
cord-005453-4057qib7	12981	7	pts	pt	NNS
cord-005453-4057qib7	12981	8	)	)	-RRB-
cord-005453-4057qib7	12981	9	with	with	IN
cord-005453-4057qib7	12981	10	relapsed	relapse	VBN
cord-005453-4057qib7	12981	11	/	/	SYM
cord-005453-4057qib7	12981	12	refractory	refractory	NN
cord-005453-4057qib7	12981	13	(	(	-LRB-
cord-005453-4057qib7	12981	14	R	r	NN
cord-005453-4057qib7	12981	15	/	/	SYM
cord-005453-4057qib7	12981	16	R	r	NN
cord-005453-4057qib7	12981	17	)	)	-RRB-
cord-005453-4057qib7	12981	18	precursor	precursor	NN
cord-005453-4057qib7	12981	19	B	b	NN
cord-005453-4057qib7	12981	20	-	-	HYPH
cord-005453-4057qib7	12981	21	acute	acute	JJ
cord-005453-4057qib7	12981	22	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	12981	23	leukemia	leukemia	NN
cord-005453-4057qib7	12981	24	(	(	-LRB-
cord-005453-4057qib7	12981	25	ALL	all	DT
cord-005453-4057qib7	12981	26	)	)	-RRB-
cord-005453-4057qib7	12981	27	is	be	VBZ
cord-005453-4057qib7	12981	28	dismal	dismal	JJ
cord-005453-4057qib7	12981	29	,	,	,
cord-005453-4057qib7	12981	30	including	include	VBG
cord-005453-4057qib7	12981	31	with	with	IN
cord-005453-4057qib7	12981	32	allogeneic	allogeneic	JJ
cord-005453-4057qib7	12981	33	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	12981	34	stem	stem	NN
cord-005453-4057qib7	12981	35	cell	cell	NN
cord-005453-4057qib7	12981	36	transplantation	transplantation	NN
cord-005453-4057qib7	12981	37	(	(	-LRB-
cord-005453-4057qib7	12981	38	allo	allo	NN
cord-005453-4057qib7	12981	39	-	-	HYPH
cord-005453-4057qib7	12981	40	HSCT	HSCT	NNP
cord-005453-4057qib7	12981	41	)	)	-RRB-
cord-005453-4057qib7	12981	42	.	.	.
cord-005453-4057qib7	12982	1	Blinatumomab	Blinatumomab	NNP
cord-005453-4057qib7	12982	2	,	,	,
cord-005453-4057qib7	12982	3	a	a	DT
cord-005453-4057qib7	12982	4	bispecific	bispecific	NN
cord-005453-4057qib7	12982	5	CD19-directed	cd19-directe	VBN
cord-005453-4057qib7	12982	6	CD3	CD3	NNP
cord-005453-4057qib7	12982	7	T	T	NNP
cord-005453-4057qib7	12982	8	-	-	HYPH
cord-005453-4057qib7	12982	9	cell	cell	NN
cord-005453-4057qib7	12982	10	engager	engager	NN
cord-005453-4057qib7	12982	11	and	and	CC
cord-005453-4057qib7	12982	12	inotuzumab	inotuzumab	NNP
cord-005453-4057qib7	12982	13	ozogamycin	ozogamycin	NNP
cord-005453-4057qib7	12982	14	(	(	-LRB-
cord-005453-4057qib7	12982	15	IO	IO	NNP
cord-005453-4057qib7	12982	16	)	)	-RRB-
cord-005453-4057qib7	12982	17	,	,	,
cord-005453-4057qib7	12982	18	a	a	DT
cord-005453-4057qib7	12982	19	CD22-directed	cd22-directe	VBN
cord-005453-4057qib7	12982	20	antibody	antibody	NN
cord-005453-4057qib7	12982	21	-	-	HYPH
cord-005453-4057qib7	12982	22	drug	drug	NN
cord-005453-4057qib7	12982	23	conjugate	conjugate	NN
cord-005453-4057qib7	12982	24	revolutionized	revolutionize	VBD
cord-005453-4057qib7	12982	25	the	the	DT
cord-005453-4057qib7	12982	26	field	field	NN
cord-005453-4057qib7	12982	27	,	,	,
cord-005453-4057qib7	12982	28	improving	improve	VBG
cord-005453-4057qib7	12982	29	their	-PRON-	PRP$
cord-005453-4057qib7	12982	30	outcomes	outcome	NNS
cord-005453-4057qib7	12982	31	.	.	.
cord-005453-4057qib7	12983	1	Anti	Anti	NNP
cord-005453-4057qib7	12983	2	-	-	JJ
cord-005453-4057qib7	12983	3	CD19	cd19	JJ
cord-005453-4057qib7	12983	4	chimeric	chimeric	JJ
cord-005453-4057qib7	12983	5	antigen	antigen	NN
cord-005453-4057qib7	12983	6	receptor	receptor	NN
cord-005453-4057qib7	12983	7	T	T	NNP
cord-005453-4057qib7	12983	8	(	(	-LRB-
cord-005453-4057qib7	12983	9	CART	cart	NN
cord-005453-4057qib7	12983	10	)	)	-RRB-
cord-005453-4057qib7	12983	11	cell	cell	NN
cord-005453-4057qib7	12983	12	therapy	therapy	NN
cord-005453-4057qib7	12983	13	has	have	VBZ
cord-005453-4057qib7	12983	14	led	lead	VBN
cord-005453-4057qib7	12983	15	to	to	IN
cord-005453-4057qib7	12983	16	further	further	JJ
cord-005453-4057qib7	12983	17	progress	progress	NN
cord-005453-4057qib7	12983	18	and	and	CC
cord-005453-4057qib7	12983	19	improved	improved	JJ
cord-005453-4057qib7	12983	20	outcome	outcome	NN
cord-005453-4057qib7	12983	21	(	(	-LRB-
cord-005453-4057qib7	12983	22	Jacoby	Jacoby	NNP
cord-005453-4057qib7	12983	23	E	E	NNP
cord-005453-4057qib7	12983	24	;	;	:
cord-005453-4057qib7	12983	25	Am	be	VBP
cord-005453-4057qib7	12983	26	J	J	NNP
cord-005453-4057qib7	12983	27	Hematol	Hematol	NNP
cord-005453-4057qib7	12983	28	,	,	,
cord-005453-4057qib7	12983	29	2018	2018	CD
cord-005453-4057qib7	12983	30	)	)	-RRB-
cord-005453-4057qib7	12983	31	.	.	.
cord-005453-4057qib7	12984	1	Nowadays	nowadays	RB
cord-005453-4057qib7	12984	2	,	,	,
cord-005453-4057qib7	12984	3	patients	patient	NNS
cord-005453-4057qib7	12984	4	with	with	IN
cord-005453-4057qib7	12984	5	R	r	NN
cord-005453-4057qib7	12984	6	/	/	SYM
cord-005453-4057qib7	12984	7	R	r	NN
cord-005453-4057qib7	12984	8	B	b	NN
cord-005453-4057qib7	12984	9	-	-	:
cord-005453-4057qib7	12984	10	ALL	all	DT
cord-005453-4057qib7	12984	11	can	can	MD
cord-005453-4057qib7	12984	12	be	be	VB
cord-005453-4057qib7	12984	13	offered	offer	VBN
cord-005453-4057qib7	12984	14	both	both	DT
cord-005453-4057qib7	12984	15	therapies	therapy	NNS
cord-005453-4057qib7	12984	16	,	,	,
cord-005453-4057qib7	12984	17	but	but	CC
cord-005453-4057qib7	12984	18	there	there	EX
cord-005453-4057qib7	12984	19	are	be	VBP
cord-005453-4057qib7	12984	20	limited	limited	JJ
cord-005453-4057qib7	12984	21	data	datum	NNS
cord-005453-4057qib7	12984	22	on	on	IN
cord-005453-4057qib7	12984	23	the	the	DT
cord-005453-4057qib7	12984	24	safety	safety	NN
cord-005453-4057qib7	12984	25	and	and	CC
cord-005453-4057qib7	12984	26	efficacy	efficacy	NN
cord-005453-4057qib7	12984	27	of	of	IN
cord-005453-4057qib7	12984	28	CART	CART	NNP
cord-005453-4057qib7	12984	29	-cell	-cell	CD
cord-005453-4057qib7	12984	30	therapy	therapy	NN
cord-005453-4057qib7	12984	31	post	post	NN
cord-005453-4057qib7	12984	32	antibody	antibody	NN
cord-005453-4057qib7	12984	33	treatment	treatment	NN
cord-005453-4057qib7	12984	34	.	.	.
cord-005453-4057qib7	12985	1	We	-PRON-	PRP
cord-005453-4057qib7	12985	2	detailed	detail	VBD
cord-005453-4057qib7	12985	3	our	-PRON-	PRP$
cord-005453-4057qib7	12985	4	single	single	JJ
cord-005453-4057qib7	12985	5	center	center	NN
cord-005453-4057qib7	12985	6	experience	experience	NN
cord-005453-4057qib7	12985	7	in	in	IN
cord-005453-4057qib7	12985	8	this	this	DT
cord-005453-4057qib7	12985	9	regard	regard	NN
cord-005453-4057qib7	12985	10	.	.	.
cord-005453-4057qib7	12986	1	Methods	method	NNS
cord-005453-4057qib7	12986	2	:	:	:
cord-005453-4057qib7	12986	3	This	this	DT
cord-005453-4057qib7	12986	4	report	report	NN
cord-005453-4057qib7	12986	5	is	be	VBZ
cord-005453-4057qib7	12986	6	a	a	DT
cord-005453-4057qib7	12986	7	part	part	NN
cord-005453-4057qib7	12986	8	of	of	IN
cord-005453-4057qib7	12986	9	a	a	DT
cord-005453-4057qib7	12986	10	single	single	JJ
cord-005453-4057qib7	12986	11	center	center	NN
cord-005453-4057qib7	12986	12	,	,	,
cord-005453-4057qib7	12986	13	phase	phase	NN
cord-005453-4057qib7	12986	14	1b/2	1b/2	CD
cord-005453-4057qib7	12986	15	study	study	NN
cord-005453-4057qib7	12986	16	on	on	IN
cord-005453-4057qib7	12986	17	therapy	therapy	NN
cord-005453-4057qib7	12986	18	of	of	IN
cord-005453-4057qib7	12986	19	B	b	NN
cord-005453-4057qib7	12986	20	-	-	HYPH
cord-005453-4057qib7	12986	21	cell	cell	NN
cord-005453-4057qib7	12986	22	malignancies	malignancy	NNS
cord-005453-4057qib7	12986	23	with	with	IN
cord-005453-4057qib7	12986	24	locally	locally	RB
cord-005453-4057qib7	12986	25	produced	produce	VBN
cord-005453-4057qib7	12986	26	CART	cart	NN
cord-005453-4057qib7	12986	27	-	-	HYPH
cord-005453-4057qib7	12986	28	cells	cell	NNS
cord-005453-4057qib7	12986	29	(	(	-LRB-
cord-005453-4057qib7	12986	30	NCT02772198	NCT02772198	NNP
cord-005453-4057qib7	12986	31	)	)	-RRB-
cord-005453-4057qib7	12986	32	.	.	.
cord-005453-4057qib7	12987	1	The	the	DT
cord-005453-4057qib7	12987	2	approach	approach	NN
cord-005453-4057qib7	12987	3	uses	use	VBZ
cord-005453-4057qib7	12987	4	autologous	autologous	JJ
cord-005453-4057qib7	12987	5	T	t	NN
cord-005453-4057qib7	12987	6	cells	cell	NNS
cord-005453-4057qib7	12987	7	with	with	IN
cord-005453-4057qib7	12987	8	CAR	car	NN
cord-005453-4057qib7	12987	9	construct	construct	NN
cord-005453-4057qib7	12987	10	that	that	WDT
cord-005453-4057qib7	12987	11	is	be	VBZ
cord-005453-4057qib7	12987	12	composed	compose	VBN
cord-005453-4057qib7	12987	13	of	of	IN
cord-005453-4057qib7	12987	14	an	an	DT
cord-005453-4057qib7	12987	15	anti	anti	JJ
cord-005453-4057qib7	12987	16	-	-	JJ
cord-005453-4057qib7	12987	17	CD19	cd19	JJ
cord-005453-4057qib7	12987	18	single	single	JJ
cord-005453-4057qib7	12987	19	-	-	HYPH
cord-005453-4057qib7	12987	20	chain	chain	NN
cord-005453-4057qib7	12987	21	Fv	Fv	NNP
cord-005453-4057qib7	12987	22	,	,	,
cord-005453-4057qib7	12987	23	CD28	CD28	NNP
cord-005453-4057qib7	12987	24	co	co	NN
cord-005453-4057qib7	12987	25	-	-	JJ
cord-005453-4057qib7	12987	26	stimulatory	stimulatory	JJ
cord-005453-4057qib7	12987	27	and	and	CC
cord-005453-4057qib7	12987	28	CD3-zeta	cd3-zeta	JJ
cord-005453-4057qib7	12987	29	intracellular	intracellular	JJ
cord-005453-4057qib7	12987	30	domains	domain	NNS
cord-005453-4057qib7	12987	31	.	.	.
cord-005453-4057qib7	12988	1	CD19	cd19	JJ
cord-005453-4057qib7	12988	2	expression	expression	NN
cord-005453-4057qib7	12988	3	on	on	IN
cord-005453-4057qib7	12988	4	the	the	DT
cord-005453-4057qib7	12988	5	blasts	blast	NNS
cord-005453-4057qib7	12988	6	was	be	VBD
cord-005453-4057qib7	12988	7	documented	document	VBN
cord-005453-4057qib7	12988	8	prior	prior	JJ
cord-005453-4057qib7	12988	9	treatment	treatment	NN
cord-005453-4057qib7	12988	10	in	in	IN
cord-005453-4057qib7	12988	11	all	all	DT
cord-005453-4057qib7	12988	12	pts	pt	NNS
cord-005453-4057qib7	12988	13	by	by	IN
cord-005453-4057qib7	12988	14	flow	flow	NN
cord-005453-4057qib7	12988	15	cytometry	cytometry	NN
cord-005453-4057qib7	12988	16	.	.	.
cord-005453-4057qib7	12989	1	All	all	DT
cord-005453-4057qib7	12989	2	pts	pt	NNS
cord-005453-4057qib7	12989	3	received	receive	VBD
cord-005453-4057qib7	12989	4	1	1	CD
cord-005453-4057qib7	12989	5	x	x	SYM
cord-005453-4057qib7	12989	6	10	10	CD
cord-005453-4057qib7	12989	7	6	6	CD
cord-005453-4057qib7	12989	8	/kg	/kg	CD
cord-005453-4057qib7	12989	9	CART	cart	NN
cord-005453-4057qib7	12989	10	-	-	HYPH
cord-005453-4057qib7	12989	11	cells	cell	NNS
cord-005453-4057qib7	12989	12	after	after	IN
cord-005453-4057qib7	12989	13	lymphodepletion	lymphodepletion	NN
cord-005453-4057qib7	12989	14	with	with	IN
cord-005453-4057qib7	12989	15	fludarabin	fludarabin	NNP
cord-005453-4057qib7	12989	16	and	and	CC
cord-005453-4057qib7	12989	17	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	12989	18	.	.	.
cord-005453-4057qib7	12990	1	Results	result	NNS
cord-005453-4057qib7	12990	2	:	:	:
cord-005453-4057qib7	12991	1	Six	six	CD
cord-005453-4057qib7	12991	2	pts	pt	NNS
cord-005453-4057qib7	12991	3	(	(	-LRB-
cord-005453-4057qib7	12991	4	2	2	CD
cord-005453-4057qib7	12991	5	Males	Males	NNPS
cord-005453-4057qib7	12991	6	and	and	CC
cord-005453-4057qib7	12991	7	4	4	CD
cord-005453-4057qib7	12991	8	Females	female	NNS
cord-005453-4057qib7	12991	9	)	)	-RRB-
cord-005453-4057qib7	12991	10	with	with	IN
cord-005453-4057qib7	12991	11	R	r	NN
cord-005453-4057qib7	12991	12	/	/	SYM
cord-005453-4057qib7	12991	13	R	r	NN
cord-005453-4057qib7	12991	14	B	b	NN
cord-005453-4057qib7	12991	15	-	-	:
cord-005453-4057qib7	12991	16	ALL	all	DT
cord-005453-4057qib7	12991	17	were	be	VBD
cord-005453-4057qib7	12991	18	enrolled	enrol	VBN
cord-005453-4057qib7	12991	19	,	,	,
cord-005453-4057qib7	12991	20	including	include	VBG
cord-005453-4057qib7	12991	21	one	one	CD
cord-005453-4057qib7	12991	22	with	with	IN
cord-005453-4057qib7	12991	23	Ph	Ph	NNP
cord-005453-4057qib7	12991	24	-	-	JJ
cord-005453-4057qib7	12991	25	positive	positive	JJ
cord-005453-4057qib7	12991	26	B	b	NN
cord-005453-4057qib7	12991	27	-	-	:
cord-005453-4057qib7	12991	28	ALL	all	DT
cord-005453-4057qib7	12991	29	.	.	.
cord-005453-4057qib7	12992	1	The	the	DT
cord-005453-4057qib7	12992	2	median	median	JJ
cord-005453-4057qib7	12992	3	age	age	NN
cord-005453-4057qib7	12992	4	was	be	VBD
cord-005453-4057qib7	12992	5	42	42	CD
cord-005453-4057qib7	12992	6	years	year	NNS
cord-005453-4057qib7	12992	7	(	(	-LRB-
cord-005453-4057qib7	12992	8	25	25	CD
cord-005453-4057qib7	12992	9	-	-	SYM
cord-005453-4057qib7	12992	10	59	59	CD
cord-005453-4057qib7	12992	11	)	)	-RRB-
cord-005453-4057qib7	12992	12	.	.	.
cord-005453-4057qib7	12993	1	Median	median	JJ
cord-005453-4057qib7	12993	2	number	number	NN
cord-005453-4057qib7	12993	3	of	of	IN
cord-005453-4057qib7	12993	4	prior	prior	JJ
cord-005453-4057qib7	12993	5	therapy	therapy	NN
cord-005453-4057qib7	12993	6	was	be	VBD
cord-005453-4057qib7	12993	7	4	4	CD
cord-005453-4057qib7	12993	8	(	(	-LRB-
cord-005453-4057qib7	12993	9	3	3	CD
cord-005453-4057qib7	12993	10	)	)	-RRB-
cord-005453-4057qib7	12993	11	(	(	-LRB-
cord-005453-4057qib7	12993	12	4	4	LS
cord-005453-4057qib7	12993	13	)	)	-RRB-
cord-005453-4057qib7	12993	14	(	(	-LRB-
cord-005453-4057qib7	12993	15	5	5	CD
cord-005453-4057qib7	12993	16	)	)	-RRB-
cord-005453-4057qib7	12993	17	.	.	.
cord-005453-4057qib7	12994	1	Five	five	CD
cord-005453-4057qib7	12994	2	pts	pt	NNS
cord-005453-4057qib7	12994	3	had	have	VBD
cord-005453-4057qib7	12994	4	prior	prior	JJ
cord-005453-4057qib7	12994	5	allo	allo	NN
cord-005453-4057qib7	12994	6	-	-	HYPH
cord-005453-4057qib7	12994	7	HSCT	HSCT	NNP
cord-005453-4057qib7	12994	8	.	.	.
cord-005453-4057qib7	12995	1	Four	four	CD
cord-005453-4057qib7	12995	2	pts	pt	NNS
cord-005453-4057qib7	12995	3	were	be	VBD
cord-005453-4057qib7	12995	4	given	give	VBN
cord-005453-4057qib7	12995	5	antibodies	antibody	NNS
cord-005453-4057qib7	12995	6	as	as	IN
cord-005453-4057qib7	12995	7	the	the	DT
cord-005453-4057qib7	12995	8	last	last	JJ
cord-005453-4057qib7	12995	9	therapy	therapy	NN
cord-005453-4057qib7	12995	10	prior	prior	RB
cord-005453-4057qib7	12995	11	to	to	IN
cord-005453-4057qib7	12995	12	CART	cart	NN
cord-005453-4057qib7	12995	13	cells	cell	NNS
cord-005453-4057qib7	12995	14	.	.	.
cord-005453-4057qib7	12996	1	Two	two	CD
cord-005453-4057qib7	12996	2	pts	pt	NNS
cord-005453-4057qib7	12996	3	received	receive	VBN
cord-005453-4057qib7	12996	4	blinatumomab	blinatumomab	NN
cord-005453-4057qib7	12996	5	resulting	result	VBG
cord-005453-4057qib7	12996	6	in	in	IN
cord-005453-4057qib7	12996	7	PR	PR	NNP
cord-005453-4057qib7	12996	8	in	in	IN
cord-005453-4057qib7	12996	9	one	one	CD
cord-005453-4057qib7	12996	10	of	of	IN
cord-005453-4057qib7	12996	11	them	-PRON-	PRP
cord-005453-4057qib7	12996	12	.	.	.
cord-005453-4057qib7	12997	1	Two	two	CD
cord-005453-4057qib7	12997	2	additional	additional	JJ
cord-005453-4057qib7	12997	3	pts	pt	NNS
cord-005453-4057qib7	12997	4	received	receive	VBD
cord-005453-4057qib7	12997	5	IO	IO	NNP
cord-005453-4057qib7	12997	6	(	(	-LRB-
cord-005453-4057qib7	12997	7	1	1	CD
cord-005453-4057qib7	12997	8	after	after	IN
cord-005453-4057qib7	12997	9	failing	fail	VBG
cord-005453-4057qib7	12997	10	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	12997	11	)	)	-RRB-
cord-005453-4057qib7	12997	12	achieving	achieve	VBG
cord-005453-4057qib7	12997	13	MRDpositive	mrdpositive	JJ
cord-005453-4057qib7	12997	14	CR	CR	NNP
cord-005453-4057qib7	12997	15	.	.	.
cord-005453-4057qib7	12998	1	Cytokine	cytokine	NN
cord-005453-4057qib7	12998	2	release	release	NN
cord-005453-4057qib7	12998	3	syndrome	syndrome	NN
cord-005453-4057qib7	12998	4	occurred	occur	VBD
cord-005453-4057qib7	12998	5	in	in	IN
cord-005453-4057qib7	12998	6	all	all	DT
cord-005453-4057qib7	12998	7	pts	pt	NNS
cord-005453-4057qib7	12998	8	and	and	CC
cord-005453-4057qib7	12998	9	was	be	VBD
cord-005453-4057qib7	12998	10	severe	severe	JJ
cord-005453-4057qib7	12998	11	in	in	IN
cord-005453-4057qib7	12998	12	only	only	RB
cord-005453-4057qib7	12998	13	one	one	CD
cord-005453-4057qib7	12998	14	patient	patient	NN
cord-005453-4057qib7	12998	15	who	who	WP
cord-005453-4057qib7	12998	16	required	require	VBD
cord-005453-4057qib7	12998	17	tocilizumab	tocilizumab	JJ
cord-005453-4057qib7	12998	18	treatment	treatment	NN
cord-005453-4057qib7	12998	19	.	.	.
cord-005453-4057qib7	12999	1	This	this	DT
cord-005453-4057qib7	12999	2	patient	patient	NN
cord-005453-4057qib7	12999	3	was	be	VBD
cord-005453-4057qib7	12999	4	also	also	RB
cord-005453-4057qib7	12999	5	the	the	DT
cord-005453-4057qib7	12999	6	only	only	JJ
cord-005453-4057qib7	12999	7	patient	patient	NN
cord-005453-4057qib7	12999	8	who	who	WP
cord-005453-4057qib7	12999	9	experienced	experience	VBD
cord-005453-4057qib7	12999	10	neurotoxicity	neurotoxicity	NN
cord-005453-4057qib7	12999	11	(	(	-LRB-
cord-005453-4057qib7	12999	12	grade	grade	NN
cord-005453-4057qib7	12999	13	3	3	CD
cord-005453-4057qib7	12999	14	)	)	-RRB-
cord-005453-4057qib7	12999	15	,	,	,
cord-005453-4057qib7	12999	16	and	and	CC
cord-005453-4057qib7	12999	17	was	be	VBD
cord-005453-4057qib7	12999	18	treated	treat	VBN
cord-005453-4057qib7	12999	19	with	with	IN
cord-005453-4057qib7	12999	20	dexamethasone	dexamethasone	NN
cord-005453-4057qib7	12999	21	.	.	.
cord-005453-4057qib7	13000	1	This	this	DT
cord-005453-4057qib7	13000	2	patient	patient	NN
cord-005453-4057qib7	13000	3	eventually	eventually	RB
cord-005453-4057qib7	13000	4	died	die	VBD
cord-005453-4057qib7	13000	5	18	18	CD
cord-005453-4057qib7	13000	6	days	day	NNS
cord-005453-4057qib7	13000	7	post	post	NN
cord-005453-4057qib7	13000	8	infusion	infusion	NN
cord-005453-4057qib7	13000	9	of	of	IN
cord-005453-4057qib7	13000	10	CART	cart	NN
cord-005453-4057qib7	13000	11	cells	cell	NNS
cord-005453-4057qib7	13000	12	due	due	JJ
cord-005453-4057qib7	13000	13	to	to	IN
cord-005453-4057qib7	13000	14	severe	severe	JJ
cord-005453-4057qib7	13000	15	pseudomembranous	pseudomembranous	JJ
cord-005453-4057qib7	13000	16	colitis	colitis	NN
cord-005453-4057qib7	13000	17	,	,	,
cord-005453-4057qib7	13000	18	toxic	toxic	JJ
cord-005453-4057qib7	13000	19	megacolon	megacolon	NN
cord-005453-4057qib7	13000	20	and	and	CC
cord-005453-4057qib7	13000	21	sepsis	sepsis	NN
cord-005453-4057qib7	13000	22	.	.	.
cord-005453-4057qib7	13001	1	All	all	DT
cord-005453-4057qib7	13001	2	pts	pt	NNS
cord-005453-4057qib7	13001	3	had	have	VBD
cord-005453-4057qib7	13001	4	prolonged	prolong	VBN
cord-005453-4057qib7	13001	5	neutropenia	neutropenia	NN
cord-005453-4057qib7	13001	6	for	for	IN
cord-005453-4057qib7	13001	7	a	a	DT
cord-005453-4057qib7	13001	8	median	median	NN
cord-005453-4057qib7	13001	9	of	of	IN
cord-005453-4057qib7	13001	10	14	14	CD
cord-005453-4057qib7	13001	11	days	day	NNS
cord-005453-4057qib7	13001	12	(	(	-LRB-
cord-005453-4057qib7	13001	13	12	12	CD
cord-005453-4057qib7	13001	14	-	-	SYM
cord-005453-4057qib7	13001	15	18	18	CD
cord-005453-4057qib7	13001	16	)	)	-RRB-
cord-005453-4057qib7	13001	17	after	after	IN
cord-005453-4057qib7	13001	18	the	the	DT
cord-005453-4057qib7	13001	19	infusion	infusion	NN
cord-005453-4057qib7	13001	20	of	of	IN
cord-005453-4057qib7	13001	21	CART	cart	NN
cord-005453-4057qib7	13001	22	cells	cell	NNS
cord-005453-4057qib7	13001	23	.	.	.
cord-005453-4057qib7	13002	1	At	at	IN
cord-005453-4057qib7	13002	2	day	day	NN
cord-005453-4057qib7	13002	3	28	28	CD
cord-005453-4057qib7	13002	4	after	after	IN
cord-005453-4057qib7	13002	5	infusion	infusion	NN
cord-005453-4057qib7	13002	6	of	of	IN
cord-005453-4057qib7	13002	7	CART	cart	NN
cord-005453-4057qib7	13002	8	-	-	HYPH
cord-005453-4057qib7	13002	9	cells	cell	NNS
cord-005453-4057qib7	13002	10	the	the	DT
cord-005453-4057qib7	13002	11	CR	cr	NN
cord-005453-4057qib7	13002	12	for	for	IN
cord-005453-4057qib7	13002	13	the	the	DT
cord-005453-4057qib7	13002	14	entire	entire	JJ
cord-005453-4057qib7	13002	15	cohort	cohort	NN
cord-005453-4057qib7	13002	16	was	be	VBD
cord-005453-4057qib7	13002	17	67	67	CD
cord-005453-4057qib7	13002	18	%	%	NN
cord-005453-4057qib7	13002	19	:	:	:
cord-005453-4057qib7	13002	20	three	three	CD
cord-005453-4057qib7	13002	21	pts	pt	NNS
cord-005453-4057qib7	13002	22	with	with	IN
cord-005453-4057qib7	13002	23	MRD	MRD	NNP
cord-005453-4057qib7	13002	24	-	-	HYPH
cord-005453-4057qib7	13002	25	negative	negative	JJ
cord-005453-4057qib7	13002	26	and	and	CC
cord-005453-4057qib7	13002	27	one	one	CD
cord-005453-4057qib7	13002	28	with	with	IN
cord-005453-4057qib7	13002	29	MRD	MRD	NNP
cord-005453-4057qib7	13002	30	-	-	HYPH
cord-005453-4057qib7	13002	31	positive	positive	JJ
cord-005453-4057qib7	13002	32	response	response	NN
cord-005453-4057qib7	13002	33	.	.	.
cord-005453-4057qib7	13003	1	Among	among	IN
cord-005453-4057qib7	13003	2	the	the	DT
cord-005453-4057qib7	13003	3	four	four	CD
cord-005453-4057qib7	13003	4	pts	pt	NNS
cord-005453-4057qib7	13003	5	who	who	WP
cord-005453-4057qib7	13003	6	received	receive	VBD
cord-005453-4057qib7	13003	7	antibodies	antibody	NNS
cord-005453-4057qib7	13003	8	prior	prior	IN
cord-005453-4057qib7	13003	9	the	the	DT
cord-005453-4057qib7	13003	10	CART	cart	NN
cord-005453-4057qib7	13003	11	-	-	HYPH
cord-005453-4057qib7	13003	12	cells	cell	NNS
cord-005453-4057qib7	13003	13	,	,	,
cord-005453-4057qib7	13003	14	one	one	CD
cord-005453-4057qib7	13003	15	patient	patient	NN
cord-005453-4057qib7	13003	16	had	have	VBD
cord-005453-4057qib7	13003	17	MRD	MRD	NNP
cord-005453-4057qib7	13003	18	-	-	HYPH
cord-005453-4057qib7	13003	19	positive	positive	JJ
cord-005453-4057qib7	13003	20	and	and	CC
cord-005453-4057qib7	13003	21	two	two	CD
cord-005453-4057qib7	13003	22	pts	pt	NNS
cord-005453-4057qib7	13003	23	had	have	VBD
cord-005453-4057qib7	13003	24	MRD	MRD	NNP
cord-005453-4057qib7	13003	25	-	-	HYPH
cord-005453-4057qib7	13003	26	negative	negative	JJ
cord-005453-4057qib7	13003	27	response	response	NN
cord-005453-4057qib7	13003	28	.	.	.
cord-005453-4057qib7	13004	1	The	the	DT
cord-005453-4057qib7	13004	2	patient	patient	NN
cord-005453-4057qib7	13004	3	with	with	IN
cord-005453-4057qib7	13004	4	Ph	Ph	NNP
cord-005453-4057qib7	13004	5	positive	positive	JJ
cord-005453-4057qib7	13004	6	B	b	NN
cord-005453-4057qib7	13004	7	-	-	:
cord-005453-4057qib7	13004	8	ALL	all	DT
cord-005453-4057qib7	13004	9	had	have	VBD
cord-005453-4057qib7	13004	10	progressive	progressive	JJ
cord-005453-4057qib7	13004	11	disease	disease	NN
cord-005453-4057qib7	13004	12	during	during	IN
cord-005453-4057qib7	13004	13	the	the	DT
cord-005453-4057qib7	13004	14	treatment	treatment	NN
cord-005453-4057qib7	13004	15	.	.	.
cord-005453-4057qib7	13005	1	Two	two	CD
cord-005453-4057qib7	13005	2	pts	pt	NNS
cord-005453-4057qib7	13005	3	were	be	VBD
cord-005453-4057qib7	13005	4	referred	refer	VBN
cord-005453-4057qib7	13005	5	to	to	IN
cord-005453-4057qib7	13005	6	second	second	JJ
cord-005453-4057qib7	13005	7	allo	allo	NN
cord-005453-4057qib7	13005	8	-	-	HYPH
cord-005453-4057qib7	13005	9	HSCT	HSCT	NNP
cord-005453-4057qib7	13005	10	from	from	IN
cord-005453-4057qib7	13005	11	other	other	JJ
cord-005453-4057qib7	13005	12	donors	donor	NNS
cord-005453-4057qib7	13005	13	.	.	.
cord-005453-4057qib7	13006	1	One	one	CD
cord-005453-4057qib7	13006	2	patient	patient	NN
cord-005453-4057qib7	13006	3	with	with	IN
cord-005453-4057qib7	13006	4	MRD	MRD	NNP
cord-005453-4057qib7	13006	5	-	-	HYPH
cord-005453-4057qib7	13006	6	negative	negative	JJ
cord-005453-4057qib7	13006	7	response	response	NN
cord-005453-4057qib7	13006	8	relapsed	relapse	VBN
cord-005453-4057qib7	13006	9	after	after	IN
cord-005453-4057qib7	13006	10	the	the	DT
cord-005453-4057qib7	13006	11	second	second	JJ
cord-005453-4057qib7	13006	12	transplant	transplant	NN
cord-005453-4057qib7	13006	13	and	and	CC
cord-005453-4057qib7	13006	14	was	be	VBD
cord-005453-4057qib7	13006	15	treated	treat	VBN
cord-005453-4057qib7	13006	16	by	by	IN
cord-005453-4057qib7	13006	17	salvage	salvage	NN
cord-005453-4057qib7	13006	18	therapy	therapy	NN
cord-005453-4057qib7	13006	19	.	.	.
cord-005453-4057qib7	13007	1	The	the	DT
cord-005453-4057qib7	13007	2	second	second	JJ
cord-005453-4057qib7	13007	3	patient	patient	NN
cord-005453-4057qib7	13007	4	with	with	IN
cord-005453-4057qib7	13007	5	MRDnegative	MRDnegative	NNP
cord-005453-4057qib7	13007	6	response	response	NN
cord-005453-4057qib7	13007	7	demonstrated	demonstrate	VBD
cord-005453-4057qib7	13007	8	prolonged	prolonged	JJ
cord-005453-4057qib7	13007	9	remission	remission	NN
cord-005453-4057qib7	13007	10	(	(	-LRB-
cord-005453-4057qib7	13007	11	20	20	CD
cord-005453-4057qib7	13007	12	months	month	NNS
cord-005453-4057qib7	13007	13	)	)	-RRB-
cord-005453-4057qib7	13007	14	even	even	RB
cord-005453-4057qib7	13007	15	without	without	IN
cord-005453-4057qib7	13007	16	second	second	JJ
cord-005453-4057qib7	13007	17	transplantation	transplantation	NN
cord-005453-4057qib7	13007	18	.	.	.
cord-005453-4057qib7	13008	1	With	with	IN
cord-005453-4057qib7	13008	2	a	a	DT
cord-005453-4057qib7	13008	3	median	median	JJ
cord-005453-4057qib7	13008	4	follow	follow	NN
cord-005453-4057qib7	13008	5	-	-	HYPH
cord-005453-4057qib7	13008	6	up	up	NN
cord-005453-4057qib7	13008	7	of	of	IN
cord-005453-4057qib7	13008	8	11	11	CD
cord-005453-4057qib7	13008	9	months	month	NNS
cord-005453-4057qib7	13008	10	(	(	-LRB-
cord-005453-4057qib7	13008	11	3	3	CD
cord-005453-4057qib7	13008	12	)	)	-RRB-
cord-005453-4057qib7	13008	13	(	(	-LRB-
cord-005453-4057qib7	13008	14	4	4	LS
cord-005453-4057qib7	13008	15	)	)	-RRB-
cord-005453-4057qib7	13008	16	(	(	-LRB-
cord-005453-4057qib7	13008	17	5	5	LS
cord-005453-4057qib7	13008	18	)	)	-RRB-
cord-005453-4057qib7	13008	19	(	(	-LRB-
cord-005453-4057qib7	13008	20	6	6	LS
cord-005453-4057qib7	13008	21	)	)	-RRB-
cord-005453-4057qib7	13008	22	(	(	-LRB-
cord-005453-4057qib7	13008	23	7	7	LS
cord-005453-4057qib7	13008	24	)	)	-RRB-
cord-005453-4057qib7	13008	25	(	(	-LRB-
cord-005453-4057qib7	13008	26	8)	8)	NNP
cord-005453-4057qib7	13008	27	(	(	-LRB-
cord-005453-4057qib7	13008	28	9	9	CD
cord-005453-4057qib7	13008	29	)	)	-RRB-
cord-005453-4057qib7	13008	30	(	(	-LRB-
cord-005453-4057qib7	13008	31	10	10	CD
cord-005453-4057qib7	13008	32	)	)	-RRB-
cord-005453-4057qib7	13008	33	(	(	-LRB-
cord-005453-4057qib7	13008	34	11	11	CD
cord-005453-4057qib7	13008	35	)	)	-RRB-
cord-005453-4057qib7	13008	36	(	(	-LRB-
cord-005453-4057qib7	13008	37	12	12	CD
cord-005453-4057qib7	13008	38	)	)	-RRB-
cord-005453-4057qib7	13008	39	(	(	-LRB-
cord-005453-4057qib7	13008	40	13	13	CD
cord-005453-4057qib7	13008	41	)	)	-RRB-
cord-005453-4057qib7	13008	42	(	(	-LRB-
cord-005453-4057qib7	13008	43	14	14	CD
cord-005453-4057qib7	13008	44	)	)	-RRB-
cord-005453-4057qib7	13008	45	(	(	-LRB-
cord-005453-4057qib7	13008	46	15	15	CD
cord-005453-4057qib7	13008	47	)	)	-RRB-
cord-005453-4057qib7	13008	48	(	(	-LRB-
cord-005453-4057qib7	13008	49	16	16	CD
cord-005453-4057qib7	13008	50	)	)	-RRB-
cord-005453-4057qib7	13008	51	(	(	-LRB-
cord-005453-4057qib7	13008	52	17	17	CD
cord-005453-4057qib7	13008	53	)	)	-RRB-
cord-005453-4057qib7	13008	54	(	(	-LRB-
cord-005453-4057qib7	13008	55	18	18	CD
cord-005453-4057qib7	13008	56	)	)	-RRB-
cord-005453-4057qib7	13008	57	(	(	-LRB-
cord-005453-4057qib7	13008	58	19	19	CD
cord-005453-4057qib7	13008	59	)	)	-RRB-
cord-005453-4057qib7	13008	60	(	(	-LRB-
cord-005453-4057qib7	13008	61	20	20	CD
cord-005453-4057qib7	13008	62	)	)	-RRB-
cord-005453-4057qib7	13008	63	the	the	DT
cord-005453-4057qib7	13008	64	median	median	JJ
cord-005453-4057qib7	13008	65	progression	progression	NN
cord-005453-4057qib7	13008	66	-	-	HYPH
cord-005453-4057qib7	13008	67	free	free	JJ
cord-005453-4057qib7	13008	68	and	and	CC
cord-005453-4057qib7	13008	69	overall	overall	JJ
cord-005453-4057qib7	13008	70	survival	survival	NN
cord-005453-4057qib7	13008	71	for	for	IN
cord-005453-4057qib7	13008	72	the	the	DT
cord-005453-4057qib7	13008	73	entire	entire	JJ
cord-005453-4057qib7	13008	74	cohort	cohort	NN
cord-005453-4057qib7	13008	75	were	be	VBD
cord-005453-4057qib7	13008	76	7.5	7.5	CD
cord-005453-4057qib7	13008	77	and	and	CC
cord-005453-4057qib7	13008	78	9	9	CD
cord-005453-4057qib7	13008	79	months	month	NNS
cord-005453-4057qib7	13008	80	,	,	,
cord-005453-4057qib7	13008	81	respectively	respectively	RB
cord-005453-4057qib7	13008	82	.	.	.
cord-005453-4057qib7	13009	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13009	2	:	:	:
cord-005453-4057qib7	13010	1	Autologous	autologous	JJ
cord-005453-4057qib7	13010	2	anti	anti	JJ
cord-005453-4057qib7	13010	3	-	-	JJ
cord-005453-4057qib7	13010	4	CD19	cd19	JJ
cord-005453-4057qib7	13010	5	CAR	car	NN
cord-005453-4057qib7	13010	6	T	t	NN
cord-005453-4057qib7	13010	7	-	-	HYPH
cord-005453-4057qib7	13010	8	cell	cell	NN
cord-005453-4057qib7	13010	9	therapy	therapy	NN
cord-005453-4057qib7	13010	10	after	after	IN
cord-005453-4057qib7	13010	11	debulking	debulke	VBG
cord-005453-4057qib7	13010	12	treatment	treatment	NN
cord-005453-4057qib7	13010	13	with	with	IN
cord-005453-4057qib7	13010	14	antibodies	antibody	NNS
cord-005453-4057qib7	13010	15	,	,	,
cord-005453-4057qib7	13010	16	including	include	VBG
cord-005453-4057qib7	13010	17	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	13010	18	and/or	and/or	CC
cord-005453-4057qib7	13010	19	IO	IO	NNP
cord-005453-4057qib7	13010	20	,	,	,
cord-005453-4057qib7	13010	21	is	be	VBZ
cord-005453-4057qib7	13010	22	feasible	feasible	JJ
cord-005453-4057qib7	13010	23	and	and	CC
cord-005453-4057qib7	13010	24	results	result	NNS
cord-005453-4057qib7	13010	25	in	in	IN
cord-005453-4057qib7	13010	26	high	high	JJ
cord-005453-4057qib7	13010	27	response	response	NN
cord-005453-4057qib7	13010	28	rates	rate	NNS
cord-005453-4057qib7	13010	29	in	in	IN
cord-005453-4057qib7	13010	30	pts	pts	NN
cord-005453-4057qib7	13010	31	with	with	IN
cord-005453-4057qib7	13010	32	R	r	NN
cord-005453-4057qib7	13010	33	/	/	SYM
cord-005453-4057qib7	13010	34	R	r	NN
cord-005453-4057qib7	13010	35	B	b	NN
cord-005453-4057qib7	13010	36	-	-	:
cord-005453-4057qib7	13010	37	ALL	ALL	NNP
cord-005453-4057qib7	13010	38	.	.	.
cord-005453-4057qib7	13011	1	Patients	patient	NNS
cord-005453-4057qib7	13011	2	may	may	MD
cord-005453-4057qib7	13011	3	respond	respond	VB
cord-005453-4057qib7	13011	4	to	to	IN
cord-005453-4057qib7	13011	5	anti	anti	JJ
cord-005453-4057qib7	13011	6	-	-	JJ
cord-005453-4057qib7	13011	7	CD19	cd19	JJ
cord-005453-4057qib7	13011	8	CAR	car	NN
cord-005453-4057qib7	13011	9	T	t	NN
cord-005453-4057qib7	13011	10	-	-	HYPH
cord-005453-4057qib7	13011	11	cell	cell	NN
cord-005453-4057qib7	13011	12	therapy	therapy	NN
cord-005453-4057qib7	13011	13	even	even	RB
cord-005453-4057qib7	13011	14	after	after	IN
cord-005453-4057qib7	13011	15	failure	failure	NN
cord-005453-4057qib7	13011	16	to	to	IN
cord-005453-4057qib7	13011	17	their	-PRON-	PRP$
cord-005453-4057qib7	13011	18	last	last	JJ
cord-005453-4057qib7	13011	19	salvage	salvage	NN
cord-005453-4057qib7	13011	20	therapy	therapy	NN
cord-005453-4057qib7	13011	21	with	with	IN
cord-005453-4057qib7	13011	22	blinatumomab	blinatumomab	NNP
cord-005453-4057qib7	13011	23	,	,	,
cord-005453-4057qib7	13011	24	which	which	WDT
cord-005453-4057qib7	13011	25	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	13011	26	similar	similar	JJ
cord-005453-4057qib7	13011	27	mechanism	mechanism	NN
cord-005453-4057qib7	13011	28	of	of	IN
cord-005453-4057qib7	13011	29	action	action	NN
cord-005453-4057qib7	13011	30	.	.	.
cord-005453-4057qib7	13012	1	Clinical	clinical	JJ
cord-005453-4057qib7	13012	2	Background	background	NN
cord-005453-4057qib7	13012	3	:	:	:
cord-005453-4057qib7	13013	1	Genetically	genetically	RB
cord-005453-4057qib7	13013	2	engineered	engineer	VBN
cord-005453-4057qib7	13013	3	T	t	NN
cord-005453-4057qib7	13013	4	cells	cell	NNS
cord-005453-4057qib7	13013	5	expressing	express	VBG
cord-005453-4057qib7	13013	6	a	a	DT
cord-005453-4057qib7	13013	7	chimeric	chimeric	JJ
cord-005453-4057qib7	13013	8	antigen	antigen	NN
cord-005453-4057qib7	13013	9	receptor	receptor	NN
cord-005453-4057qib7	13013	10	(	(	-LRB-
cord-005453-4057qib7	13013	11	CAR	CAR	NNP
cord-005453-4057qib7	13013	12	-	-	HYPH
cord-005453-4057qib7	13013	13	T	T	NNP
cord-005453-4057qib7	13013	14	)	)	-RRB-
cord-005453-4057qib7	13013	15	targeting	target	VBG
cord-005453-4057qib7	13013	16	specific	specific	JJ
cord-005453-4057qib7	13013	17	antigens	antigen	NNS
cord-005453-4057qib7	13013	18	present	present	JJ
cord-005453-4057qib7	13013	19	on	on	IN
cord-005453-4057qib7	13013	20	acute	acute	JJ
cord-005453-4057qib7	13013	21	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13013	22	leukemia	leukemia	NN
cord-005453-4057qib7	13013	23	(	(	-LRB-
cord-005453-4057qib7	13013	24	ALL	all	DT
cord-005453-4057qib7	13013	25	)	)	-RRB-
cord-005453-4057qib7	13013	26	blasts	blast	NNS
cord-005453-4057qib7	13013	27	have	have	VBP
cord-005453-4057qib7	13013	28	generated	generate	VBN
cord-005453-4057qib7	13013	29	promising	promising	JJ
cord-005453-4057qib7	13013	30	results	result	NNS
cord-005453-4057qib7	13013	31	in	in	IN
cord-005453-4057qib7	13013	32	children	child	NNS
cord-005453-4057qib7	13013	33	and	and	CC
cord-005453-4057qib7	13013	34	adults	adult	NNS
cord-005453-4057qib7	13013	35	with	with	IN
cord-005453-4057qib7	13013	36	relapsed	relapsed	JJ
cord-005453-4057qib7	13013	37	and	and	CC
cord-005453-4057qib7	13013	38	refractory	refractory	JJ
cord-005453-4057qib7	13013	39	disease	disease	NN
cord-005453-4057qib7	13013	40	.	.	.
cord-005453-4057qib7	13014	1	The	the	DT
cord-005453-4057qib7	13014	2	below	below	JJ
cord-005453-4057qib7	13014	3	report	report	NN
cord-005453-4057qib7	13014	4	provides	provide	VBZ
cord-005453-4057qib7	13014	5	an	an	DT
cord-005453-4057qib7	13014	6	insight	insight	NN
cord-005453-4057qib7	13014	7	of	of	IN
cord-005453-4057qib7	13014	8	lineage	lineage	NN
cord-005453-4057qib7	13014	9	switch	switch	NN
cord-005453-4057qib7	13014	10	occuring	occur	VBG
cord-005453-4057qib7	13014	11	as	as	IN
cord-005453-4057qib7	13014	12	a	a	DT
cord-005453-4057qib7	13014	13	result	result	NN
cord-005453-4057qib7	13014	14	of	of	IN
cord-005453-4057qib7	13014	15	intense	intense	JJ
cord-005453-4057qib7	13014	16	immunological	immunological	JJ
cord-005453-4057qib7	13014	17	selection	selection	NN
cord-005453-4057qib7	13014	18	after	after	IN
cord-005453-4057qib7	13014	19	CAR	car	NN
cord-005453-4057qib7	13014	20	-	-	HYPH
cord-005453-4057qib7	13014	21	T	t	NN
cord-005453-4057qib7	13014	22	cell	cell	NN
cord-005453-4057qib7	13014	23	therapy	therapy	NN
cord-005453-4057qib7	13014	24	,	,	,
cord-005453-4057qib7	13014	25	even	even	RB
cord-005453-4057qib7	13014	26	with	with	IN
cord-005453-4057qib7	13014	27	a	a	DT
cord-005453-4057qib7	13014	28	tumor	tumor	NN
cord-005453-4057qib7	13014	29	clone	clone	NN
cord-005453-4057qib7	13014	30	that	that	WDT
cord-005453-4057qib7	13014	31	has	have	VBZ
cord-005453-4057qib7	13014	32	no	no	DT
cord-005453-4057qib7	13014	33	potential	potential	NN
cord-005453-4057qib7	13014	34	for	for	IN
cord-005453-4057qib7	13014	35	this	this	DT
cord-005453-4057qib7	13014	36	switch	switch	NN
cord-005453-4057qib7	13014	37	.	.	.
cord-005453-4057qib7	13015	1	Methods	method	NNS
cord-005453-4057qib7	13015	2	:	:	:
cord-005453-4057qib7	13016	1	An	an	DT
cord-005453-4057qib7	13016	2	eight	eight	CD
cord-005453-4057qib7	13016	3	year	year	NN
cord-005453-4057qib7	13016	4	old	old	JJ
cord-005453-4057qib7	13016	5	Caucasian	caucasian	JJ
cord-005453-4057qib7	13016	6	male	male	NN
cord-005453-4057qib7	13016	7	with	with	IN
cord-005453-4057qib7	13016	8	precursor	precursor	NN
cord-005453-4057qib7	13016	9	B	b	NN
cord-005453-4057qib7	13016	10	(	(	-LRB-
cord-005453-4057qib7	13016	11	pB	pb	NN
cord-005453-4057qib7	13016	12	)	)	-RRB-
cord-005453-4057qib7	13016	13	cell	cell	NN
cord-005453-4057qib7	13016	14	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	13016	15	leukemia	leukemia	NN
cord-005453-4057qib7	13016	16	was	be	VBD
cord-005453-4057qib7	13016	17	treated	treat	VBN
cord-005453-4057qib7	13016	18	with	with	IN
cord-005453-4057qib7	13016	19	CD	CD	NNP
cord-005453-4057qib7	13016	20	19	19	CD
cord-005453-4057qib7	13016	21	directed	direct	VBN
cord-005453-4057qib7	13016	22	CAR	CAR	NNP
cord-005453-4057qib7	13016	23	-	-	HYPH
cord-005453-4057qib7	13016	24	T	t	NN
cord-005453-4057qib7	13016	25	cell	cell	NN
cord-005453-4057qib7	13016	26	therapy	therapy	NN
cord-005453-4057qib7	13016	27	in	in	IN
cord-005453-4057qib7	13016	28	third	third	JJ
cord-005453-4057qib7	13016	29	remission	remission	NN
cord-005453-4057qib7	13016	30	,	,	,
cord-005453-4057qib7	13016	31	and	and	CC
cord-005453-4057qib7	13016	32	after	after	IN
cord-005453-4057qib7	13016	33	relapse	relapse	NN
cord-005453-4057qib7	13016	34	after	after	IN
cord-005453-4057qib7	13016	35	previous	previous	JJ
cord-005453-4057qib7	13016	36	bone	bone	NN
cord-005453-4057qib7	13016	37	marrow	marrow	NN
cord-005453-4057qib7	13016	38	transplantation	transplantation	NN
cord-005453-4057qib7	13016	39	(	(	-LRB-
cord-005453-4057qib7	13016	40	BMT	BMT	NNP
cord-005453-4057qib7	13016	41	)	)	-RRB-
cord-005453-4057qib7	13016	42	.	.	.
cord-005453-4057qib7	13017	1	He	-PRON-	PRP
cord-005453-4057qib7	13017	2	was	be	VBD
cord-005453-4057qib7	13017	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	13017	4	with	with	IN
cord-005453-4057qib7	13017	5	t(12;21	t(12;21	ADD
cord-005453-4057qib7	13017	6	)	)	-RRB-
cord-005453-4057qib7	13018	1	pB	pb	NN
cord-005453-4057qib7	13018	2	cell	cell	NN
cord-005453-4057qib7	13018	3	ALL	all	DT
cord-005453-4057qib7	13018	4	at	at	IN
cord-005453-4057qib7	13018	5	2	2	CD
cord-005453-4057qib7	13018	6	years	year	NNS
cord-005453-4057qib7	13018	7	of	of	IN
cord-005453-4057qib7	13018	8	age	age	NN
cord-005453-4057qib7	13018	9	and	and	CC
cord-005453-4057qib7	13018	10	treated	treat	VBN
cord-005453-4057qib7	13018	11	with	with	IN
cord-005453-4057qib7	13018	12	BFM	BFM	NNP
cord-005453-4057qib7	13018	13	protocol	protocol	NN
cord-005453-4057qib7	13018	14	.	.	.
cord-005453-4057qib7	13019	1	He	-PRON-	PRP
cord-005453-4057qib7	13019	2	relapsed	relapse	VBD
cord-005453-4057qib7	13019	3	8	8	CD
cord-005453-4057qib7	13019	4	months	month	NNS
cord-005453-4057qib7	13019	5	after	after	IN
cord-005453-4057qib7	13019	6	completion	completion	NN
cord-005453-4057qib7	13019	7	of	of	IN
cord-005453-4057qib7	13019	8	maintenance	maintenance	NN
cord-005453-4057qib7	13019	9	therapy	therapy	NN
cord-005453-4057qib7	13019	10	,	,	,
cord-005453-4057qib7	13019	11	and	and	CC
cord-005453-4057qib7	13019	12	had	have	VBD
cord-005453-4057qib7	13019	13	a	a	DT
cord-005453-4057qib7	13019	14	9/10	9/10	CD
cord-005453-4057qib7	13019	15	MMUD	MMUD	NNP
cord-005453-4057qib7	13019	16	bone	bone	NN
cord-005453-4057qib7	13019	17	marrow	marrow	NN
cord-005453-4057qib7	13019	18	transplant	transplant	NN
cord-005453-4057qib7	13019	19	after	after	IN
cord-005453-4057qib7	13019	20	etoposide	etoposide	NN
cord-005453-4057qib7	13019	21	,	,	,
cord-005453-4057qib7	13019	22	TBI	TBI	NNP
cord-005453-4057qib7	13019	23	and	and	CC
cord-005453-4057qib7	13019	24	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	13019	25	conditioning	conditioning	NN
cord-005453-4057qib7	13019	26	therapy	therapy	NN
cord-005453-4057qib7	13019	27	.	.	.
cord-005453-4057qib7	13020	1	He	-PRON-	PRP
cord-005453-4057qib7	13020	2	had	have	VBD
cord-005453-4057qib7	13020	3	cutaneous	cutaneous	JJ
cord-005453-4057qib7	13020	4	acute	acute	JJ
cord-005453-4057qib7	13020	5	and	and	CC
cord-005453-4057qib7	13020	6	chronic	chronic	JJ
cord-005453-4057qib7	13020	7	GVHD	GVHD	NNP
cord-005453-4057qib7	13020	8	but	but	CC
cord-005453-4057qib7	13021	1	8	8	CD
cord-005453-4057qib7	13021	2	months	month	NNS
cord-005453-4057qib7	13021	3	post	post	NN
cord-005453-4057qib7	13021	4	-	-	NN
cord-005453-4057qib7	13021	5	transplant	transplant	NN
cord-005453-4057qib7	13021	6	,	,	,
cord-005453-4057qib7	13021	7	he	-PRON-	PRP
cord-005453-4057qib7	13021	8	relapsed	relapse	VBD
cord-005453-4057qib7	13021	9	again	again	RB
cord-005453-4057qib7	13021	10	with	with	IN
cord-005453-4057qib7	13021	11	pB	pb	NN
cord-005453-4057qib7	13021	12	cell	cell	NN
cord-005453-4057qib7	13021	13	ALL	all	DT
cord-005453-4057qib7	13021	14	,	,	,
cord-005453-4057qib7	13021	15	with	with	IN
cord-005453-4057qib7	13021	16	the	the	DT
cord-005453-4057qib7	13021	17	same	same	JJ
cord-005453-4057qib7	13021	18	cytogenetic	cytogenetic	NN
cord-005453-4057qib7	13021	19	and	and	CC
cord-005453-4057qib7	13021	20	immunophenotypic	immunophenotypic	JJ
cord-005453-4057qib7	13021	21	disease	disease	NN
cord-005453-4057qib7	13021	22	characteristics	characteristic	NNS
cord-005453-4057qib7	13021	23	..	..	.
cord-005453-4057qib7	13022	1	He	-PRON-	PRP
cord-005453-4057qib7	13022	2	was	be	VBD
cord-005453-4057qib7	13022	3	treated	treat	VBN
cord-005453-4057qib7	13022	4	with	with	IN
cord-005453-4057qib7	13022	5	lymphodepleting	lymphodeplete	VBG
cord-005453-4057qib7	13022	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13022	7	with	with	IN
cord-005453-4057qib7	13022	8	fludarabine	fludarabine	NN
cord-005453-4057qib7	13022	9	,	,	,
cord-005453-4057qib7	13022	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	13022	11	and	and	CC
cord-005453-4057qib7	13022	12	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	13022	13	followed	follow	VBN
cord-005453-4057qib7	13022	14	by	by	IN
cord-005453-4057qib7	13022	15	infusion	infusion	NN
cord-005453-4057qib7	13022	16	of	of	IN
cord-005453-4057qib7	13022	17	CD19	CD19	NNP
cord-005453-4057qib7	13022	18	directed	direct	VBD
cord-005453-4057qib7	13022	19	CAR	CAR	NNP
cord-005453-4057qib7	13022	20	T	T	NNP
cord-005453-4057qib7	13022	21	cells	cell	NNS
cord-005453-4057qib7	13022	22	.	.	.
cord-005453-4057qib7	13023	1	He	-PRON-	PRP
cord-005453-4057qib7	13023	2	developed	develop	VBD
cord-005453-4057qib7	13023	3	cytokine	cytokine	NN
cord-005453-4057qib7	13023	4	release	release	NN
cord-005453-4057qib7	13023	5	syndrome	syndrome	NN
cord-005453-4057qib7	13023	6	of	of	IN
cord-005453-4057qib7	13023	7	grade	grade	NN
cord-005453-4057qib7	13023	8	1	1	CD
cord-005453-4057qib7	13023	9	severity	severity	NN
cord-005453-4057qib7	13023	10	manifested	manifest	VBD
cord-005453-4057qib7	13023	11	as	as	IN
cord-005453-4057qib7	13023	12	persistent	persistent	JJ
cord-005453-4057qib7	13023	13	fever	fever	NN
cord-005453-4057qib7	13023	14	,	,	,
cord-005453-4057qib7	13023	15	associated	associate	VBN
cord-005453-4057qib7	13023	16	with	with	IN
cord-005453-4057qib7	13023	17	CAR	car	NN
cord-005453-4057qib7	13023	18	T	T	NNP
cord-005453-4057qib7	13023	19	cell	cell	NN
cord-005453-4057qib7	13023	20	expansion	expansion	NN
cord-005453-4057qib7	13023	21	in	in	IN
cord-005453-4057qib7	13023	22	the	the	DT
cord-005453-4057qib7	13023	23	blood	blood	NN
cord-005453-4057qib7	13023	24	.	.	.
cord-005453-4057qib7	13024	1	After	after	IN
cord-005453-4057qib7	13024	2	CAR	car	NN
cord-005453-4057qib7	13024	3	-	-	HYPH
cord-005453-4057qib7	13024	4	T	t	NN
cord-005453-4057qib7	13024	5	infusion	infusion	NN
cord-005453-4057qib7	13024	6	,	,	,
cord-005453-4057qib7	13024	7	there	there	EX
cord-005453-4057qib7	13024	8	was	be	VBD
cord-005453-4057qib7	13024	9	no	no	DT
cord-005453-4057qib7	13024	10	detectable	detectable	JJ
cord-005453-4057qib7	13024	11	B	b	NN
cord-005453-4057qib7	13024	12	cell	cell	NN
cord-005453-4057qib7	13025	1	ALL	all	DT
cord-005453-4057qib7	13025	2	clone	clone	NN
cord-005453-4057qib7	13025	3	in	in	IN
cord-005453-4057qib7	13025	4	the	the	DT
cord-005453-4057qib7	13025	5	marrow	marrow	NN
cord-005453-4057qib7	13025	6	by	by	IN
cord-005453-4057qib7	13025	7	PCR	PCR	NNP
cord-005453-4057qib7	13025	8	and	and	CC
cord-005453-4057qib7	13025	9	the	the	DT
cord-005453-4057qib7	13025	10	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	13025	11	were	be	VBD
cord-005453-4057qib7	13025	12	negative	negative	JJ
cord-005453-4057qib7	13025	13	for	for	IN
cord-005453-4057qib7	13025	14	t(12:21	t(12:21	ADD
cord-005453-4057qib7	13025	15	)	)	-RRB-
cord-005453-4057qib7	13025	16	translocation	translocation	NN
cord-005453-4057qib7	13025	17	.	.	.
cord-005453-4057qib7	13026	1	8	8	CD
cord-005453-4057qib7	13026	2	months	month	NNS
cord-005453-4057qib7	13026	3	after	after	IN
cord-005453-4057qib7	13026	4	the	the	DT
cord-005453-4057qib7	13026	5	CAR	car	NN
cord-005453-4057qib7	13026	6	T	t	NN
cord-005453-4057qib7	13026	7	cell	cell	NN
cord-005453-4057qib7	13026	8	therapy	therapy	NN
cord-005453-4057qib7	13026	9	,	,	,
cord-005453-4057qib7	13026	10	he	-PRON-	PRP
cord-005453-4057qib7	13026	11	was	be	VBD
cord-005453-4057qib7	13026	12	found	find	VBN
cord-005453-4057qib7	13026	13	to	to	TO
cord-005453-4057qib7	13026	14	have	have	VB
cord-005453-4057qib7	13026	15	a	a	DT
cord-005453-4057qib7	13026	16	MRD	MRD	NNP
cord-005453-4057qib7	13026	17	positive	positive	JJ
cord-005453-4057qib7	13026	18	disease	disease	NN
cord-005453-4057qib7	13026	19	which	which	WDT
cord-005453-4057qib7	13026	20	was	be	VBD
cord-005453-4057qib7	13026	21	monitored	monitor	VBN
cord-005453-4057qib7	13026	22	closely	closely	RB
cord-005453-4057qib7	13026	23	.	.	.
cord-005453-4057qib7	13027	1	Results	result	NNS
cord-005453-4057qib7	13027	2	:	:	:
cord-005453-4057qib7	13028	1	We	-PRON-	PRP
cord-005453-4057qib7	13028	2	document	document	VBP
cord-005453-4057qib7	13028	3	clonal	clonal	JJ
cord-005453-4057qib7	13028	4	evolution	evolution	NN
cord-005453-4057qib7	13028	5	from	from	IN
cord-005453-4057qib7	13028	6	CD19	CD19	NNP
cord-005453-4057qib7	13028	7	negative	negative	JJ
cord-005453-4057qib7	13028	8	,	,	,
cord-005453-4057qib7	13028	9	MRD	MRD	NNP
cord-005453-4057qib7	13028	10	positive	positive	JJ
cord-005453-4057qib7	13028	11	disease	disease	NN
cord-005453-4057qib7	13028	12	to	to	IN
cord-005453-4057qib7	13028	13	AML	AML	NNP
cord-005453-4057qib7	13028	14	,	,	,
cord-005453-4057qib7	13028	15	with	with	IN
cord-005453-4057qib7	13028	16	the	the	DT
cord-005453-4057qib7	13028	17	same	same	JJ
cord-005453-4057qib7	13028	18	Ig	Ig	NNP
cord-005453-4057qib7	13028	19	rearrangement	rearrangement	NN
cord-005453-4057qib7	13028	20	(	(	-LRB-
cord-005453-4057qib7	13028	21	the	the	DT
cord-005453-4057qib7	13028	22	same	same	JJ
cord-005453-4057qib7	13028	23	clonal	clonal	JJ
cord-005453-4057qib7	13028	24	disease	disease	NN
cord-005453-4057qib7	13028	25	)	)	-RRB-
cord-005453-4057qib7	13028	26	but	but	CC
cord-005453-4057qib7	13028	27	with	with	IN
cord-005453-4057qib7	13028	28	complete	complete	JJ
cord-005453-4057qib7	13028	29	myeloid	myeloid	JJ
cord-005453-4057qib7	13028	30	phenotype	phenotype	NN
cord-005453-4057qib7	13028	31	MPO	MPO	NNP
cord-005453-4057qib7	13028	32	,	,	,
cord-005453-4057qib7	13028	33	CD33	CD33	NNP
cord-005453-4057qib7	13028	34	,	,	,
cord-005453-4057qib7	13028	35	CD13	CD13	NNP
cord-005453-4057qib7	13028	36	positive	positive	JJ
cord-005453-4057qib7	13028	37	disease	disease	NN
cord-005453-4057qib7	13028	38	.	.	.
cord-005453-4057qib7	13029	1	There	there	EX
cord-005453-4057qib7	13029	2	was	be	VBD
cord-005453-4057qib7	13029	3	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	13029	4	evolution	evolution	NN
cord-005453-4057qib7	13029	5	of	of	IN
cord-005453-4057qib7	13029	6	the	the	DT
cord-005453-4057qib7	13029	7	underlying	underlie	VBG
cord-005453-4057qib7	13029	8	clone	clone	NN
cord-005453-4057qib7	13029	9	but	but	CC
cord-005453-4057qib7	13029	10	the	the	DT
cord-005453-4057qib7	13029	11	original	original	JJ
cord-005453-4057qib7	13029	12	t(12;21	t(12;21	CD
cord-005453-4057qib7	13029	13	)	)	-RRB-
cord-005453-4057qib7	13029	14	was	be	VBD
cord-005453-4057qib7	13029	15	retained	retain	VBN
cord-005453-4057qib7	13029	16	within	within	IN
cord-005453-4057qib7	13029	17	the	the	DT
cord-005453-4057qib7	13029	18	evolved	evolved	JJ
cord-005453-4057qib7	13029	19	karyotype	karyotype	NN
cord-005453-4057qib7	13029	20	.	.	.
cord-005453-4057qib7	13030	1	Sadly	sadly	RB
cord-005453-4057qib7	13030	2	,	,	,
cord-005453-4057qib7	13030	3	our	-PRON-	PRP$
cord-005453-4057qib7	13030	4	patient	patient	NN
cord-005453-4057qib7	13030	5	developed	develop	VBD
cord-005453-4057qib7	13030	6	fludarabineneurotoxcity	fludarabineneurotoxcity	NN
cord-005453-4057qib7	13030	7	during	during	IN
cord-005453-4057qib7	13030	8	an	an	DT
cord-005453-4057qib7	13030	9	attempt	attempt	NN
cord-005453-4057qib7	13030	10	to	to	TO
cord-005453-4057qib7	13030	11	induce	induce	VB
cord-005453-4057qib7	13030	12	AML	AML	NNP
cord-005453-4057qib7	13030	13	remission	remission	NN
cord-005453-4057qib7	13030	14	,	,	,
cord-005453-4057qib7	13030	15	and	and	CC
cord-005453-4057qib7	13030	16	further	further	JJ
cord-005453-4057qib7	13030	17	curative	curative	JJ
cord-005453-4057qib7	13030	18	-	-	HYPH
cord-005453-4057qib7	13030	19	intent	intent	NN
cord-005453-4057qib7	13030	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13030	21	was	be	VBD
cord-005453-4057qib7	13030	22	not	not	RB
cord-005453-4057qib7	13030	23	possible	possible	JJ
cord-005453-4057qib7	13030	24	.	.	.
cord-005453-4057qib7	13031	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13031	2	:	:	:
cord-005453-4057qib7	13032	1	There	there	EX
cord-005453-4057qib7	13032	2	are	be	VBP
cord-005453-4057qib7	13032	3	two	two	CD
cord-005453-4057qib7	13032	4	case	case	NN
cord-005453-4057qib7	13032	5	reports	report	NNS
cord-005453-4057qib7	13032	6	of	of	IN
cord-005453-4057qib7	13032	7	MLL	MLL	NNP
cord-005453-4057qib7	13032	8	rearranged	rearrange	VBD
cord-005453-4057qib7	13032	9	B	B	NNP
cord-005453-4057qib7	13032	10	-	-	:
cord-005453-4057qib7	13032	11	ALL	all	DT
cord-005453-4057qib7	13032	12	acquiring	acquire	VBG
cord-005453-4057qib7	13032	13	a	a	DT
cord-005453-4057qib7	13032	14	clonally	clonally	RB
cord-005453-4057qib7	13032	15	related	relate	VBN
cord-005453-4057qib7	13032	16	myeloid	myeloid	NN
cord-005453-4057qib7	13032	17	phenotype	phenotype	NN
cord-005453-4057qib7	13032	18	associated	associate	VBN
cord-005453-4057qib7	13032	19	with	with	IN
cord-005453-4057qib7	13032	20	CD19-negative	cd19-negative	CD
cord-005453-4057qib7	13032	21	escape	escape	NN
cord-005453-4057qib7	13032	22	after	after	IN
cord-005453-4057qib7	13032	23	CD19	CD19	NNP
cord-005453-4057qib7	13032	24	directed	direct	VBD
cord-005453-4057qib7	13032	25	CAR	CAR	NNP
cord-005453-4057qib7	13032	26	T	t	NN
cord-005453-4057qib7	13032	27	cell	cell	NN
cord-005453-4057qib7	13032	28	therapy	therapy	NN
cord-005453-4057qib7	13032	29	,	,	,
cord-005453-4057qib7	13032	30	so	so	RB
cord-005453-4057qib7	13032	31	far	far	RB
cord-005453-4057qib7	13032	32	.	.	.
cord-005453-4057qib7	13033	1	But	but	CC
cord-005453-4057qib7	13033	2	,	,	,
cord-005453-4057qib7	13033	3	this	this	DT
cord-005453-4057qib7	13033	4	is	be	VBZ
cord-005453-4057qib7	13033	5	the	the	DT
cord-005453-4057qib7	13033	6	first	first	JJ
cord-005453-4057qib7	13033	7	Post	Post	NNP
cord-005453-4057qib7	13033	8	CAR	CAR	NNP
cord-005453-4057qib7	13033	9	-	-	HYPH
cord-005453-4057qib7	13033	10	T	t	NN
cord-005453-4057qib7	13033	11	cell	cell	NN
cord-005453-4057qib7	13033	12	therapy	therapy	NN
cord-005453-4057qib7	13033	13	transformation	transformation	NN
cord-005453-4057qib7	13033	14	of	of	IN
cord-005453-4057qib7	13033	15	ALL	all	DT
cord-005453-4057qib7	13033	16	to	to	IN
cord-005453-4057qib7	13033	17	AML	AML	NNP
cord-005453-4057qib7	13033	18	with	with	IN
cord-005453-4057qib7	13033	19	ETV6-RUNX1	ETV6-RUNX1	NNP
cord-005453-4057qib7	13033	20	mutation	mutation	NN
cord-005453-4057qib7	13033	21	,	,	,
cord-005453-4057qib7	13033	22	which	which	WDT
cord-005453-4057qib7	13033	23	is	be	VBZ
cord-005453-4057qib7	13033	24	not	not	RB
cord-005453-4057qib7	13033	25	recognised	recognise	VBN
cord-005453-4057qib7	13033	26	to	to	TO
cord-005453-4057qib7	13033	27	have	have	VB
cord-005453-4057qib7	13033	28	such	such	JJ
cord-005453-4057qib7	13033	29	lineage	lineage	NN
cord-005453-4057qib7	13033	30	-	-	HYPH
cord-005453-4057qib7	13033	31	switch	switch	NN
cord-005453-4057qib7	13033	32	potential	potential	NN
cord-005453-4057qib7	13033	33	.	.	.
cord-005453-4057qib7	13034	1	Unlike	unlike	IN
cord-005453-4057qib7	13034	2	MLL	MLL	NNP
cord-005453-4057qib7	13034	3	,	,	,
cord-005453-4057qib7	13034	4	ETV6-RUNX1	etv6-runx1	NN
cord-005453-4057qib7	13034	5	translocation	translocation	NN
cord-005453-4057qib7	13034	6	in	in	IN
cord-005453-4057qib7	13034	7	the	the	DT
cord-005453-4057qib7	13034	8	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	13034	9	of	of	IN
cord-005453-4057qib7	13034	10	acute	acute	JJ
cord-005453-4057qib7	13034	11	myeloid	myeloid	JJ
cord-005453-4057qib7	13034	12	leukemia	leukemia	NN
cord-005453-4057qib7	13034	13	is	be	VBZ
cord-005453-4057qib7	13034	14	not	not	RB
cord-005453-4057qib7	13034	15	been	be	VBN
cord-005453-4057qib7	13034	16	reported	report	VBN
cord-005453-4057qib7	13034	17	in	in	IN
cord-005453-4057qib7	13034	18	the	the	DT
cord-005453-4057qib7	13034	19	literature	literature	NN
cord-005453-4057qib7	13034	20	.	.	.
cord-005453-4057qib7	13035	1	The	the	DT
cord-005453-4057qib7	13035	2	theory	theory	NN
cord-005453-4057qib7	13035	3	behind	behind	IN
cord-005453-4057qib7	13035	4	such	such	JJ
cord-005453-4057qib7	13035	5	transformation	transformation	NN
cord-005453-4057qib7	13035	6	is	be	VBZ
cord-005453-4057qib7	13035	7	an	an	DT
cord-005453-4057qib7	13035	8	intense	intense	JJ
cord-005453-4057qib7	13035	9	immunological	immunological	JJ
cord-005453-4057qib7	13035	10	selection	selection	NN
cord-005453-4057qib7	13035	11	of	of	IN
cord-005453-4057qib7	13035	12	the	the	DT
cord-005453-4057qib7	13035	13	tumor	tumor	NN
cord-005453-4057qib7	13035	14	,	,	,
cord-005453-4057qib7	13035	15	driving	drive	VBG
cord-005453-4057qib7	13035	16	it	-PRON-	PRP
cord-005453-4057qib7	13035	17	to	to	IN
cord-005453-4057qib7	13035	18	myeloid	myeloid	JJ
cord-005453-4057qib7	13035	19	differentiation	differentiation	NN
cord-005453-4057qib7	13035	20	with	with	IN
cord-005453-4057qib7	13035	21	additional	additional	JJ
cord-005453-4057qib7	13035	22	clonal	clonal	JJ
cord-005453-4057qib7	13035	23	cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	13035	24	events	event	NNS
cord-005453-4057qib7	13035	25	.	.	.
cord-005453-4057qib7	13036	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13036	2	:	:	:
cord-005453-4057qib7	13036	3	Nothing	nothing	NN
cord-005453-4057qib7	13036	4	to	to	TO
cord-005453-4057qib7	13036	5	declare	declare	VB
cord-005453-4057qib7	13036	6	P586	P586	NNP
cord-005453-4057qib7	13036	7	IVAC	IVAC	NNP
cord-005453-4057qib7	13036	8	-	-	HYPH
cord-005453-4057qib7	13036	9	all-1	all-1	NNP
cord-005453-4057qib7	13036	10	:	:	:
cord-005453-4057qib7	13036	11	interim	interim	JJ
cord-005453-4057qib7	13036	12	analysis	analysis	NN
cord-005453-4057qib7	13036	13	of	of	IN
cord-005453-4057qib7	13036	14	a	a	DT
cord-005453-4057qib7	13036	15	phase	phase	NN
cord-005453-4057qib7	13036	16	I	-PRON-	PRP
cord-005453-4057qib7	13036	17	/	/	SYM
cord-005453-4057qib7	13036	18	II	II	NNP
cord-005453-4057qib7	13036	19	clinical	clinical	JJ
cord-005453-4057qib7	13036	20	study	study	NN
cord-005453-4057qib7	13036	21	on	on	IN
cord-005453-4057qib7	13036	22	personalized	personalized	JJ
cord-005453-4057qib7	13036	23	peptide	peptide	NN
cord-005453-4057qib7	13036	24	vaccination	vaccination	NN
cord-005453-4057qib7	13036	25	based	base	VBN
cord-005453-4057qib7	13036	26	on	on	IN
cord-005453-4057qib7	13036	27	patient	patient	JJ
cord-005453-4057qib7	13036	28	-	-	HYPH
cord-005453-4057qib7	13036	29	individual	individual	JJ
cord-005453-4057qib7	13036	30	tumor	tumor	NN
cord-005453-4057qib7	13036	31	-	-	HYPH
cord-005453-4057qib7	13036	32	specific	specific	JJ
cord-005453-4057qib7	13036	33	variants	variant	NNS
cord-005453-4057qib7	13036	34	in	in	IN
cord-005453-4057qib7	13036	35	relapsed	relapse	VBN
cord-005453-4057qib7	13036	36	pediatric	pediatric	JJ
cord-005453-4057qib7	13036	37	acute	acute	JJ
cord-005453-4057qib7	13036	38	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13036	39	leukemia	leukemia	NN
cord-005453-4057qib7	13036	40	Armin	Armin	NNP
cord-005453-4057qib7	13036	41	Rabsteyn	Rabsteyn	NNP
cord-005453-4057qib7	13036	42	1,2	1,2	CD
cord-005453-4057qib7	13036	43	,	,	,
cord-005453-4057qib7	13036	44	Christopher	Christopher	NNP
cord-005453-4057qib7	13036	45	Mohr	Mohr	NNP
cord-005453-4057qib7	13036	46	3	3	CD
cord-005453-4057qib7	13036	47	,	,	,
cord-005453-4057qib7	13036	48	Olaf	Olaf	NNP
cord-005453-4057qib7	13036	49	Witt	Witt	NNP
cord-005453-4057qib7	13036	50	2,4	2,4	CD
cord-005453-4057qib7	13036	51	,	,	,
cord-005453-4057qib7	13036	52	Roland	Roland	NNP
cord-005453-4057qib7	13036	53	Meisel	Meisel	NNP
cord-005453-4057qib7	13036	54	2,5	2,5	NNP
cord-005453-4057qib7	13036	55	,	,	,
cord-005453-4057qib7	13036	56	Cristiane	Cristiane	NNP
cord-005453-4057qib7	13036	57	Chen	Chen	NNP
cord-005453-4057qib7	13036	58	-	-	HYPH
cord-005453-4057qib7	13036	59	Santel	Santel	NNP
cord-005453-4057qib7	13036	60	6	6	CD
cord-005453-4057qib7	13036	61	,	,	,
cord-005453-4057qib7	13036	62	Tobias	Tobias	NNP
cord-005453-4057qib7	13036	63	Feuchtinger	Feuchtinger	NNP
cord-005453-4057qib7	13036	64	2,7	2,7	CD
cord-005453-4057qib7	13036	65	,	,	,
cord-005453-4057qib7	13036	66	Christopher	Christopher	NNP
cord-005453-4057qib7	13036	67	Schroeder	Schroeder	NNP
cord-005453-4057qib7	13036	68	8	8	CD
cord-005453-4057qib7	13036	69	,	,	,
cord-005453-4057qib7	13036	70	Jakob	Jakob	NNP
cord-005453-4057qib7	13036	71	Matthes	Matthes	NNP
cord-005453-4057qib7	13036	72	8	8	CD
cord-005453-4057qib7	13036	73	,	,	,
cord-005453-4057qib7	13036	74	Background	background	NN
cord-005453-4057qib7	13036	75	:	:	:
cord-005453-4057qib7	13037	1	Acute	acute	JJ
cord-005453-4057qib7	13037	2	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13037	3	leukemia	leukemia	NN
cord-005453-4057qib7	13037	4	(	(	-LRB-
cord-005453-4057qib7	13037	5	ALL	all	DT
cord-005453-4057qib7	13037	6	)	)	-RRB-
cord-005453-4057qib7	13037	7	is	be	VBZ
cord-005453-4057qib7	13037	8	the	the	DT
cord-005453-4057qib7	13037	9	most	most	RBS
cord-005453-4057qib7	13037	10	common	common	JJ
cord-005453-4057qib7	13037	11	pediatric	pediatric	JJ
cord-005453-4057qib7	13037	12	malignancy	malignancy	NN
cord-005453-4057qib7	13037	13	.	.	.
cord-005453-4057qib7	13038	1	Standard	standard	JJ
cord-005453-4057qib7	13038	2	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13038	3	is	be	VBZ
cord-005453-4057qib7	13038	4	a	a	DT
cord-005453-4057qib7	13038	5	successful	successful	JJ
cord-005453-4057qib7	13038	6	treatment	treatment	NN
cord-005453-4057qib7	13038	7	in	in	IN
cord-005453-4057qib7	13038	8	80	80	CD
cord-005453-4057qib7	13038	9	%	%	NN
cord-005453-4057qib7	13038	10	of	of	IN
cord-005453-4057qib7	13038	11	patients	patient	NNS
cord-005453-4057qib7	13038	12	,	,	,
cord-005453-4057qib7	13038	13	only	only	RB
cord-005453-4057qib7	13038	14	about	about	IN
cord-005453-4057qib7	13038	15	20	20	CD
cord-005453-4057qib7	13038	16	%	%	NN
cord-005453-4057qib7	13038	17	develop	develop	VBP
cord-005453-4057qib7	13038	18	a	a	DT
cord-005453-4057qib7	13038	19	relapse	relapse	NN
cord-005453-4057qib7	13038	20	,	,	,
cord-005453-4057qib7	13038	21	however	however	RB
cord-005453-4057qib7	13038	22	these	these	DT
cord-005453-4057qib7	13038	23	patients	patient	NNS
cord-005453-4057qib7	13038	24	have	have	VBP
cord-005453-4057qib7	13038	25	a	a	DT
cord-005453-4057qib7	13038	26	dismal	dismal	JJ
cord-005453-4057qib7	13038	27	prognosis	prognosis	NN
cord-005453-4057qib7	13038	28	.	.	.
cord-005453-4057qib7	13039	1	Prevention	prevention	NN
cord-005453-4057qib7	13039	2	of	of	IN
cord-005453-4057qib7	13039	3	relapse	relapse	NN
cord-005453-4057qib7	13039	4	after	after	IN
cord-005453-4057qib7	13039	5	firstline	firstline	JJ
cord-005453-4057qib7	13039	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13039	7	or	or	CC
cord-005453-4057qib7	13039	8	stem	stem	NN
cord-005453-4057qib7	13039	9	cell	cell	NN
cord-005453-4057qib7	13039	10	transplantation	transplantation	NN
cord-005453-4057qib7	13039	11	(	(	-LRB-
cord-005453-4057qib7	13039	12	SCT	SCT	NNP
cord-005453-4057qib7	13039	13	)	)	-RRB-
cord-005453-4057qib7	13039	14	is	be	VBZ
cord-005453-4057qib7	13039	15	therefore	therefore	RB
cord-005453-4057qib7	13039	16	an	an	DT
cord-005453-4057qib7	13039	17	urgent	urgent	JJ
cord-005453-4057qib7	13039	18	clinical	clinical	JJ
cord-005453-4057qib7	13039	19	need	need	NN
cord-005453-4057qib7	13039	20	.	.	.
cord-005453-4057qib7	13040	1	We	-PRON-	PRP
cord-005453-4057qib7	13040	2	established	establish	VBD
cord-005453-4057qib7	13040	3	a	a	DT
cord-005453-4057qib7	13040	4	platform	platform	NN
cord-005453-4057qib7	13040	5	for	for	IN
cord-005453-4057qib7	13040	6	the	the	DT
cord-005453-4057qib7	13040	7	design	design	NN
cord-005453-4057qib7	13040	8	of	of	IN
cord-005453-4057qib7	13040	9	patient	patient	JJ
cord-005453-4057qib7	13040	10	-	-	HYPH
cord-005453-4057qib7	13040	11	individual	individual	JJ
cord-005453-4057qib7	13040	12	peptide	peptide	NN
cord-005453-4057qib7	13040	13	vaccination	vaccination	NN
cord-005453-4057qib7	13040	14	cocktails	cocktail	NNS
cord-005453-4057qib7	13040	15	by	by	IN
cord-005453-4057qib7	13040	16	combination	combination	NN
cord-005453-4057qib7	13040	17	of	of	IN
cord-005453-4057qib7	13040	18	whole	whole	JJ
cord-005453-4057qib7	13040	19	exome	exome	NN
cord-005453-4057qib7	13040	20	sequencing	sequencing	NN
cord-005453-4057qib7	13040	21	of	of	IN
cord-005453-4057qib7	13040	22	tumor	tumor	NN
cord-005453-4057qib7	13040	23	and	and	CC
cord-005453-4057qib7	13040	24	normal	normal	JJ
cord-005453-4057qib7	13040	25	tissue	tissue	NN
cord-005453-4057qib7	13040	26	with	with	IN
cord-005453-4057qib7	13040	27	in	in	IN
cord-005453-4057qib7	13040	28	silico	silico	NN
cord-005453-4057qib7	13040	29	epitope	epitope	NN
cord-005453-4057qib7	13040	30	prediction	prediction	NN
cord-005453-4057qib7	13040	31	algorithms	algorithm	NNS
cord-005453-4057qib7	13040	32	for	for	IN
cord-005453-4057qib7	13040	33	individual	individual	JJ
cord-005453-4057qib7	13040	34	patient	patient	NN
cord-005453-4057qib7	13040	35	HLA	HLA	NNP
cord-005453-4057qib7	13040	36	types	type	NNS
cord-005453-4057qib7	13040	37	.	.	.
cord-005453-4057qib7	13041	1	We	-PRON-	PRP
cord-005453-4057qib7	13041	2	started	start	VBD
cord-005453-4057qib7	13041	3	clinical	clinical	JJ
cord-005453-4057qib7	13041	4	translation	translation	NN
cord-005453-4057qib7	13041	5	of	of	IN
cord-005453-4057qib7	13041	6	this	this	DT
cord-005453-4057qib7	13041	7	approach	approach	NN
cord-005453-4057qib7	13041	8	by	by	IN
cord-005453-4057qib7	13041	9	starting	start	VBG
cord-005453-4057qib7	13041	10	a	a	DT
cord-005453-4057qib7	13041	11	phase	phase	NN
cord-005453-4057qib7	13041	12	I	-PRON-	PRP
cord-005453-4057qib7	13041	13	/	/	SYM
cord-005453-4057qib7	13041	14	II	II	NNP
cord-005453-4057qib7	13041	15	clinical	clinical	JJ
cord-005453-4057qib7	13041	16	trial	trial	NN
cord-005453-4057qib7	13041	17	in	in	IN
cord-005453-4057qib7	13041	18	2016	2016	CD
cord-005453-4057qib7	13041	19	(	(	-LRB-
cord-005453-4057qib7	13041	20	NCT03559413	NCT03559413	NNP
cord-005453-4057qib7	13041	21	)	)	-RRB-
cord-005453-4057qib7	13041	22	.	.	.
cord-005453-4057qib7	13042	1	Besides	besides	IN
cord-005453-4057qib7	13042	2	feasibility	feasibility	NN
cord-005453-4057qib7	13042	3	and	and	CC
cord-005453-4057qib7	13042	4	toxicity	toxicity	NN
cord-005453-4057qib7	13042	5	assessments	assessment	NNS
cord-005453-4057qib7	13042	6	,	,	,
cord-005453-4057qib7	13042	7	we	-PRON-	PRP
cord-005453-4057qib7	13042	8	aim	aim	VBP
cord-005453-4057qib7	13042	9	to	to	TO
cord-005453-4057qib7	13042	10	assess	assess	VB
cord-005453-4057qib7	13042	11	the	the	DT
cord-005453-4057qib7	13042	12	capability	capability	NN
cord-005453-4057qib7	13042	13	of	of	IN
cord-005453-4057qib7	13042	14	the	the	DT
cord-005453-4057qib7	13042	15	peptide	peptide	NN
cord-005453-4057qib7	13042	16	vaccination	vaccination	NN
cord-005453-4057qib7	13042	17	to	to	TO
cord-005453-4057qib7	13042	18	induce	induce	VB
cord-005453-4057qib7	13042	19	neoantigen	neoantigen	NN
cord-005453-4057qib7	13042	20	-	-	HYPH
cord-005453-4057qib7	13042	21	specific	specific	JJ
cord-005453-4057qib7	13042	22	T	T	NNP
cord-005453-4057qib7	13042	23	cell	cell	NN
cord-005453-4057qib7	13042	24	responses	response	NNS
cord-005453-4057qib7	13042	25	in	in	IN
cord-005453-4057qib7	13042	26	high	high	JJ
cord-005453-4057qib7	13042	27	-	-	HYPH
cord-005453-4057qib7	13042	28	risk	risk	NN
cord-005453-4057qib7	13042	29	ALL	all	DT
cord-005453-4057qib7	13042	30	patients	patient	NNS
cord-005453-4057qib7	13042	31	to	to	TO
cord-005453-4057qib7	13042	32	target	target	VB
cord-005453-4057qib7	13042	33	residual	residual	JJ
cord-005453-4057qib7	13042	34	tumor	tumor	NN
cord-005453-4057qib7	13042	35	cells	cell	NNS
cord-005453-4057qib7	13042	36	and	and	CC
cord-005453-4057qib7	13042	37	prevent	prevent	VB
cord-005453-4057qib7	13042	38	leukemic	leukemic	JJ
cord-005453-4057qib7	13042	39	relapses	relapse	NNS
cord-005453-4057qib7	13042	40	.	.	.
cord-005453-4057qib7	13043	1	Methods	method	NNS
cord-005453-4057qib7	13043	2	:	:	:
cord-005453-4057qib7	13043	3	Key	key	JJ
cord-005453-4057qib7	13043	4	inclusion	inclusion	NN
cord-005453-4057qib7	13043	5	criteria	criterion	NNS
cord-005453-4057qib7	13043	6	are	be	VBP
cord-005453-4057qib7	13043	7	:	:	:
cord-005453-4057qib7	13043	8	pediatric	pediatric	JJ
cord-005453-4057qib7	13043	9	patients	patient	NNS
cord-005453-4057qib7	13043	10	with	with	IN
cord-005453-4057qib7	13043	11	ALL	all	DT
cord-005453-4057qib7	13043	12	who	who	WP
cord-005453-4057qib7	13043	13	suffered	suffer	VBD
cord-005453-4057qib7	13043	14	from	from	IN
cord-005453-4057qib7	13043	15	second	second	JJ
cord-005453-4057qib7	13043	16	relapse	relapse	NN
cord-005453-4057qib7	13043	17	after	after	IN
cord-005453-4057qib7	13043	18	standard	standard	JJ
cord-005453-4057qib7	13043	19	therapy	therapy	NN
cord-005453-4057qib7	13043	20	or	or	CC
cord-005453-4057qib7	13043	21	first	first	JJ
cord-005453-4057qib7	13043	22	relapse	relapse	NN
cord-005453-4057qib7	13043	23	after	after	IN
cord-005453-4057qib7	13043	24	SCT	SCT	NNP
cord-005453-4057qib7	13043	25	.	.	.
cord-005453-4057qib7	13044	1	Hematological	Hematological	NNP
cord-005453-4057qib7	13044	2	remission	remission	NN
cord-005453-4057qib7	13044	3	has	have	VBZ
cord-005453-4057qib7	13044	4	to	to	TO
cord-005453-4057qib7	13044	5	be	be	VB
cord-005453-4057qib7	13044	6	reached	reach	VBN
cord-005453-4057qib7	13044	7	prior	prior	RB
cord-005453-4057qib7	13044	8	to	to	IN
cord-005453-4057qib7	13044	9	vaccination	vaccination	NN
cord-005453-4057qib7	13044	10	.	.	.
cord-005453-4057qib7	13045	1	Nonsynonymous	nonsynonymous	JJ
cord-005453-4057qib7	13045	2	mutations	mutation	NNS
cord-005453-4057qib7	13045	3	are	be	VBP
cord-005453-4057qib7	13045	4	identified	identify	VBN
cord-005453-4057qib7	13045	5	by	by	IN
cord-005453-4057qib7	13045	6	whole	whole	JJ
cord-005453-4057qib7	13045	7	exome	exome	NN
cord-005453-4057qib7	13045	8	and	and	CC
cord-005453-4057qib7	13045	9	transcriptome	transcriptome	NN
cord-005453-4057qib7	13045	10	sequencing	sequencing	NN
cord-005453-4057qib7	13045	11	of	of	IN
cord-005453-4057qib7	13045	12	patient	patient	JJ
cord-005453-4057qib7	13045	13	leukemic	leukemic	JJ
cord-005453-4057qib7	13045	14	blasts	blast	NNS
cord-005453-4057qib7	13045	15	and	and	CC
cord-005453-4057qib7	13045	16	healthy	healthy	JJ
cord-005453-4057qib7	13045	17	reference	reference	NN
cord-005453-4057qib7	13045	18	tissue	tissue	NN
cord-005453-4057qib7	13045	19	.	.	.
cord-005453-4057qib7	13046	1	HLA	HLA	NNP
cord-005453-4057qib7	13046	2	binding	bind	VBG
cord-005453-4057qib7	13046	3	peptides	peptide	NNS
cord-005453-4057qib7	13046	4	harboring	harbor	VBG
cord-005453-4057qib7	13046	5	the	the	DT
cord-005453-4057qib7	13046	6	altered	alter	VBN
cord-005453-4057qib7	13046	7	amino	amino	JJ
cord-005453-4057qib7	13046	8	acids	acid	NNS
cord-005453-4057qib7	13046	9	are	be	VBP
cord-005453-4057qib7	13046	10	subsequently	subsequently	RB
cord-005453-4057qib7	13046	11	predicted	predict	VBN
cord-005453-4057qib7	13046	12	in	in	IN
cord-005453-4057qib7	13046	13	silico	silico	NNS
cord-005453-4057qib7	13046	14	by	by	IN
cord-005453-4057qib7	13046	15	algorithms	algorithm	NNS
cord-005453-4057qib7	13046	16	SYFPEITHI	SYFPEITHI	NNP
cord-005453-4057qib7	13046	17	,	,	,
cord-005453-4057qib7	13047	1	NetMHC	NetMHC	NNP
cord-005453-4057qib7	13047	2	and	and	CC
cord-005453-4057qib7	13047	3	NetMHCpan	NetMHCpan	NNP
cord-005453-4057qib7	13047	4	for	for	IN
cord-005453-4057qib7	13047	5	the	the	DT
cord-005453-4057qib7	13047	6	patients	patient	NNS
cord-005453-4057qib7	13047	7	'	'	POS
cord-005453-4057qib7	13047	8	individual	individual	JJ
cord-005453-4057qib7	13047	9	HLA	HLA	NNP
cord-005453-4057qib7	13047	10	type	type	NN
cord-005453-4057qib7	13047	11	.	.	.
cord-005453-4057qib7	13048	1	Vaccine	vaccine	NN
cord-005453-4057qib7	13048	2	cocktails	cocktail	NNS
cord-005453-4057qib7	13048	3	consisting	consist	VBG
cord-005453-4057qib7	13048	4	of	of	IN
cord-005453-4057qib7	13048	5	3	3	CD
cord-005453-4057qib7	13048	6	-	-	SYM
cord-005453-4057qib7	13048	7	5	5	CD
cord-005453-4057qib7	13048	8	individual	individual	JJ
cord-005453-4057qib7	13048	9	peptides	peptide	NNS
cord-005453-4057qib7	13048	10	are	be	VBP
cord-005453-4057qib7	13048	11	produced	produce	VBN
cord-005453-4057qib7	13048	12	and	and	CC
cord-005453-4057qib7	13048	13	formulated	formulate	VBN
cord-005453-4057qib7	13048	14	under	under	IN
cord-005453-4057qib7	13048	15	GMP	GMP	NNP
cord-005453-4057qib7	13048	16	conditions	condition	NNS
cord-005453-4057qib7	13048	17	.	.	.
cord-005453-4057qib7	13049	1	The	the	DT
cord-005453-4057qib7	13049	2	vaccination	vaccination	NN
cord-005453-4057qib7	13049	3	schedule	schedule	NN
cord-005453-4057qib7	13049	4	is	be	VBZ
cord-005453-4057qib7	13049	5	16	16	CD
cord-005453-4057qib7	13049	6	vaccinations	vaccination	NNS
cord-005453-4057qib7	13049	7	over	over	IN
cord-005453-4057qib7	13049	8	33	33	CD
cord-005453-4057qib7	13049	9	weeks	week	NNS
cord-005453-4057qib7	13049	10	using	use	VBG
cord-005453-4057qib7	13049	11	GM	GM	NNP
cord-005453-4057qib7	13049	12	-	-	HYPH
cord-005453-4057qib7	13049	13	CSF	CSF	NNP
cord-005453-4057qib7	13049	14	and	and	CC
cord-005453-4057qib7	13049	15	Imiquimod	Imiquimod	NNP
cord-005453-4057qib7	13049	16	as	as	IN
cord-005453-4057qib7	13049	17	adjuvants	adjuvant	NNS
cord-005453-4057qib7	13049	18	.	.	.
cord-005453-4057qib7	13050	1	Response	response	NN
cord-005453-4057qib7	13050	2	to	to	IN
cord-005453-4057qib7	13050	3	the	the	DT
cord-005453-4057qib7	13050	4	vaccination	vaccination	NN
cord-005453-4057qib7	13050	5	is	be	VBZ
cord-005453-4057qib7	13050	6	monitored	monitor	VBN
cord-005453-4057qib7	13050	7	by	by	IN
cord-005453-4057qib7	13050	8	detection	detection	NN
cord-005453-4057qib7	13050	9	of	of	IN
cord-005453-4057qib7	13050	10	T	t	NN
cord-005453-4057qib7	13050	11	cells	cell	NNS
cord-005453-4057qib7	13050	12	recognizing	recognize	VBG
cord-005453-4057qib7	13050	13	the	the	DT
cord-005453-4057qib7	13050	14	vaccinated	vaccinate	VBN
cord-005453-4057qib7	13050	15	peptides	peptide	NNS
cord-005453-4057qib7	13050	16	occurring	occur	VBG
cord-005453-4057qib7	13050	17	over	over	IN
cord-005453-4057qib7	13050	18	time	time	NN
cord-005453-4057qib7	13050	19	in	in	IN
cord-005453-4057qib7	13050	20	peripheral	peripheral	JJ
cord-005453-4057qib7	13050	21	blood	blood	NN
cord-005453-4057qib7	13050	22	of	of	IN
cord-005453-4057qib7	13050	23	patients	patient	NNS
cord-005453-4057qib7	13050	24	by	by	IN
cord-005453-4057qib7	13050	25	prestimulation	prestimulation	NN
cord-005453-4057qib7	13050	26	and	and	CC
cord-005453-4057qib7	13050	27	intracellular	intracellular	JJ
cord-005453-4057qib7	13050	28	cytokine	cytokine	NN
cord-005453-4057qib7	13050	29	staining	staining	NN
cord-005453-4057qib7	13050	30	.	.	.
cord-005453-4057qib7	13051	1	Results	result	NNS
cord-005453-4057qib7	13051	2	:	:	:
cord-005453-4057qib7	13051	3	Until	until	IN
cord-005453-4057qib7	13051	4	now	now	RB
cord-005453-4057qib7	13051	5	,	,	,
cord-005453-4057qib7	13051	6	23	23	CD
cord-005453-4057qib7	13051	7	patients	patient	NNS
cord-005453-4057qib7	13051	8	were	be	VBD
cord-005453-4057qib7	13051	9	recruited	recruit	VBN
cord-005453-4057qib7	13051	10	,	,	,
cord-005453-4057qib7	13051	11	for	for	IN
cord-005453-4057qib7	13051	12	17	17	CD
cord-005453-4057qib7	13051	13	of	of	IN
cord-005453-4057qib7	13051	14	those	those	DT
cord-005453-4057qib7	13051	15	,	,	,
cord-005453-4057qib7	13051	16	whole	whole	JJ
cord-005453-4057qib7	13051	17	exome	exome	NN
cord-005453-4057qib7	13051	18	sequencing	sequencing	NN
cord-005453-4057qib7	13051	19	was	be	VBD
cord-005453-4057qib7	13051	20	performed	perform	VBN
cord-005453-4057qib7	13051	21	to	to	TO
cord-005453-4057qib7	13051	22	identify	identify	VB
cord-005453-4057qib7	13051	23	ALL	all	DT
cord-005453-4057qib7	13051	24	-	-	HYPH
cord-005453-4057qib7	13051	25	specific	specific	JJ
cord-005453-4057qib7	13051	26	SNVs	snv	NNS
cord-005453-4057qib7	13051	27	using	use	VBG
cord-005453-4057qib7	13051	28	a	a	DT
cord-005453-4057qib7	13051	29	comparative	comparative	JJ
cord-005453-4057qib7	13051	30	bioinformatics	bioinformatics	NN
cord-005453-4057qib7	13051	31	pipeline	pipeline	NN
cord-005453-4057qib7	13051	32	.	.	.
cord-005453-4057qib7	13052	1	We	-PRON-	PRP
cord-005453-4057qib7	13052	2	found	find	VBD
cord-005453-4057qib7	13052	3	an	an	DT
cord-005453-4057qib7	13052	4	average	average	NN
cord-005453-4057qib7	13052	5	of	of	IN
cord-005453-4057qib7	13052	6	118.8	118.8	CD
cord-005453-4057qib7	13052	7	mutations	mutation	NNS
cord-005453-4057qib7	13052	8	per	per	IN
cord-005453-4057qib7	13052	9	patient	patient	NN
cord-005453-4057qib7	13052	10	on	on	IN
cord-005453-4057qib7	13052	11	DNA	dna	NN
cord-005453-4057qib7	13052	12	level	level	NN
cord-005453-4057qib7	13052	13	.	.	.
cord-005453-4057qib7	13053	1	Based	base	VBN
cord-005453-4057qib7	13053	2	on	on	IN
cord-005453-4057qib7	13053	3	these	these	DT
cord-005453-4057qib7	13053	4	data	datum	NNS
cord-005453-4057qib7	13053	5	,	,	,
cord-005453-4057qib7	13053	6	an	an	DT
cord-005453-4057qib7	13053	7	average	average	NN
cord-005453-4057qib7	13053	8	of	of	IN
cord-005453-4057qib7	13053	9	178	178	CD
cord-005453-4057qib7	13053	10	HLA	HLA	NNP
cord-005453-4057qib7	13053	11	binders	binder	NNS
cord-005453-4057qib7	13053	12	derived	derive	VBN
cord-005453-4057qib7	13053	13	from	from	IN
cord-005453-4057qib7	13053	14	neoantigens	neoantigen	NNS
cord-005453-4057qib7	13053	15	could	could	MD
cord-005453-4057qib7	13053	16	be	be	VB
cord-005453-4057qib7	13053	17	predicted	predict	VBN
cord-005453-4057qib7	13053	18	per	per	IN
cord-005453-4057qib7	13053	19	patient	patient	NN
cord-005453-4057qib7	13053	20	.	.	.
cord-005453-4057qib7	13054	1	An	an	DT
cord-005453-4057qib7	13054	2	average	average	JJ
cord-005453-4057qib7	13054	3	expression	expression	NN
cord-005453-4057qib7	13054	4	of	of	IN
cord-005453-4057qib7	13054	5	34.4	34.4	CD
cord-005453-4057qib7	13054	6	%	%	NN
cord-005453-4057qib7	13054	7	of	of	IN
cord-005453-4057qib7	13054	8	mutations	mutation	NNS
cord-005453-4057qib7	13054	9	was	be	VBD
cord-005453-4057qib7	13054	10	assessed	assess	VBN
cord-005453-4057qib7	13054	11	by	by	IN
cord-005453-4057qib7	13054	12	RNA	RNA	NNP
cord-005453-4057qib7	13054	13	sequencing	sequencing	NN
cord-005453-4057qib7	13054	14	.	.	.
cord-005453-4057qib7	13055	1	In	in	IN
cord-005453-4057qib7	13055	2	all	all	DT
cord-005453-4057qib7	13055	3	cases	case	NNS
cord-005453-4057qib7	13055	4	validated	validate	VBN
cord-005453-4057qib7	13055	5	mutations	mutation	NNS
cord-005453-4057qib7	13055	6	could	could	MD
cord-005453-4057qib7	13055	7	be	be	VB
cord-005453-4057qib7	13055	8	identified	identify	VBN
cord-005453-4057qib7	13055	9	and	and	CC
cord-005453-4057qib7	13055	10	cocktail	cocktail	NN
cord-005453-4057qib7	13055	11	design	design	NN
cord-005453-4057qib7	13055	12	was	be	VBD
cord-005453-4057qib7	13055	13	feasible	feasible	JJ
cord-005453-4057qib7	13055	14	.	.	.
cord-005453-4057qib7	13056	1	Until	until	IN
cord-005453-4057qib7	13056	2	now	now	RB
cord-005453-4057qib7	13056	3	,	,	,
cord-005453-4057qib7	13056	4	4	4	CD
cord-005453-4057qib7	13056	5	patients	patient	NNS
cord-005453-4057qib7	13056	6	received	receive	VBD
cord-005453-4057qib7	13056	7	vaccinations	vaccination	NNS
cord-005453-4057qib7	13056	8	.	.	.
cord-005453-4057qib7	13057	1	The	the	DT
cord-005453-4057qib7	13057	2	vaccine	vaccine	NN
cord-005453-4057qib7	13057	3	was	be	VBD
cord-005453-4057qib7	13057	4	generally	generally	RB
cord-005453-4057qib7	13057	5	well	well	RB
cord-005453-4057qib7	13057	6	tolerated	tolerate	VBN
cord-005453-4057qib7	13057	7	and	and	CC
cord-005453-4057qib7	13057	8	no	no	UH
cord-005453-4057qib7	13057	9	or	or	CC
cord-005453-4057qib7	13057	10	only	only	RB
cord-005453-4057qib7	13057	11	mild	mild	JJ
cord-005453-4057qib7	13057	12	side	side	NN
cord-005453-4057qib7	13057	13	effects	effect	NNS
cord-005453-4057qib7	13057	14	were	be	VBD
cord-005453-4057qib7	13057	15	observed	observe	VBN
cord-005453-4057qib7	13057	16	.	.	.
cord-005453-4057qib7	13058	1	Immune	immune	JJ
cord-005453-4057qib7	13058	2	monitoring	monitoring	NN
cord-005453-4057qib7	13058	3	was	be	VBD
cord-005453-4057qib7	13058	4	performed	perform	VBN
cord-005453-4057qib7	13058	5	for	for	IN
cord-005453-4057qib7	13058	6	2	2	CD
cord-005453-4057qib7	13058	7	patients	patient	NNS
cord-005453-4057qib7	13058	8	until	until	IN
cord-005453-4057qib7	13058	9	now	now	RB
cord-005453-4057qib7	13058	10	.	.	.
cord-005453-4057qib7	13059	1	In	in	IN
cord-005453-4057qib7	13059	2	the	the	DT
cord-005453-4057qib7	13059	3	first	first	JJ
cord-005453-4057qib7	13059	4	patient	patient	NN
cord-005453-4057qib7	13059	5	,	,	,
cord-005453-4057qib7	13059	6	we	-PRON-	PRP
cord-005453-4057qib7	13059	7	observed	observe	VBD
cord-005453-4057qib7	13059	8	a	a	DT
cord-005453-4057qib7	13059	9	transient	transient	JJ
cord-005453-4057qib7	13059	10	CD4	CD4	NNP
cord-005453-4057qib7	13059	11	+	+	CC
cord-005453-4057qib7	13059	12	response	response	NN
cord-005453-4057qib7	13059	13	against	against	IN
cord-005453-4057qib7	13059	14	one	one	CD
cord-005453-4057qib7	13059	15	vaccinated	vaccinate	VBN
cord-005453-4057qib7	13059	16	MHC	MHC	NNP
cord-005453-4057qib7	13059	17	Class	Class	NNP
cord-005453-4057qib7	13059	18	II	II	NNP
cord-005453-4057qib7	13059	19	ligand	ligand	NN
cord-005453-4057qib7	13059	20	and	and	CC
cord-005453-4057qib7	13059	21	a	a	DT
cord-005453-4057qib7	13059	22	sustained	sustained	JJ
cord-005453-4057qib7	13059	23	CD4	CD4	NNP
cord-005453-4057qib7	13059	24	+	+	CC
cord-005453-4057qib7	13059	25	response	response	NN
cord-005453-4057qib7	13059	26	against	against	IN
cord-005453-4057qib7	13059	27	the	the	DT
cord-005453-4057qib7	13059	28	included	include	VBN
cord-005453-4057qib7	13059	29	wildtype	wildtype	NN
cord-005453-4057qib7	13059	30	control	control	NN
cord-005453-4057qib7	13059	31	peptide	peptide	NN
cord-005453-4057qib7	13059	32	derived	derive	VBN
cord-005453-4057qib7	13059	33	from	from	IN
cord-005453-4057qib7	13059	34	the	the	DT
cord-005453-4057qib7	13059	35	antigen	antigen	NN
cord-005453-4057qib7	13059	36	Survivin	Survivin	NNP
cord-005453-4057qib7	13059	37	.	.	.
cord-005453-4057qib7	13060	1	In	in	IN
cord-005453-4057qib7	13060	2	the	the	DT
cord-005453-4057qib7	13060	3	second	second	JJ
cord-005453-4057qib7	13060	4	patient	patient	NN
cord-005453-4057qib7	13060	5	,	,	,
cord-005453-4057qib7	13060	6	immune	immune	JJ
cord-005453-4057qib7	13060	7	monitoring	monitoring	NN
cord-005453-4057qib7	13060	8	was	be	VBD
cord-005453-4057qib7	13060	9	performed	perform	VBN
cord-005453-4057qib7	13060	10	for	for	IN
cord-005453-4057qib7	13060	11	the	the	DT
cord-005453-4057qib7	13060	12	first	first	JJ
cord-005453-4057qib7	13060	13	8	8	CD
cord-005453-4057qib7	13060	14	vaccination	vaccination	NN
cord-005453-4057qib7	13060	15	timepoints	timepoint	NNS
cord-005453-4057qib7	13060	16	,	,	,
cord-005453-4057qib7	13060	17	a	a	DT
cord-005453-4057qib7	13060	18	T	T	NNP
cord-005453-4057qib7	13060	19	cell	cell	NN
cord-005453-4057qib7	13060	20	response	response	NN
cord-005453-4057qib7	13060	21	was	be	VBD
cord-005453-4057qib7	13060	22	not	not	RB
cord-005453-4057qib7	13060	23	measurable	measurable	JJ
cord-005453-4057qib7	13060	24	at	at	IN
cord-005453-4057qib7	13060	25	this	this	DT
cord-005453-4057qib7	13060	26	timepoint	timepoint	NN
cord-005453-4057qib7	13060	27	of	of	IN
cord-005453-4057qib7	13060	28	vaccination	vaccination	NN
cord-005453-4057qib7	13060	29	.	.	.
cord-005453-4057qib7	13061	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13061	2	:	:	:
cord-005453-4057qib7	13062	1	Whole	whole	JJ
cord-005453-4057qib7	13062	2	exome	exome	NN
cord-005453-4057qib7	13062	3	sequencing	sequencing	NN
cord-005453-4057qib7	13062	4	of	of	IN
cord-005453-4057qib7	13062	5	pediatric	pediatric	JJ
cord-005453-4057qib7	13062	6	ALL	all	DT
cord-005453-4057qib7	13062	7	patients	patient	NNS
cord-005453-4057qib7	13062	8	is	be	VBZ
cord-005453-4057qib7	13062	9	feasible	feasible	JJ
cord-005453-4057qib7	13062	10	and	and	CC
cord-005453-4057qib7	13062	11	yields	yield	VBZ
cord-005453-4057qib7	13062	12	small	small	JJ
cord-005453-4057qib7	13062	13	amounts	amount	NNS
cord-005453-4057qib7	13062	14	of	of	IN
cord-005453-4057qib7	13062	15	expressed	express	VBN
cord-005453-4057qib7	13062	16	,	,	,
cord-005453-4057qib7	13062	17	tumor	tumor	NN
cord-005453-4057qib7	13062	18	-	-	HYPH
cord-005453-4057qib7	13062	19	specific	specific	JJ
cord-005453-4057qib7	13062	20	mutations	mutation	NNS
cord-005453-4057qib7	13062	21	.	.	.
cord-005453-4057qib7	13063	1	These	these	DT
cord-005453-4057qib7	13063	2	few	few	JJ
cord-005453-4057qib7	13063	3	mutations	mutation	NNS
cord-005453-4057qib7	13063	4	are	be	VBP
cord-005453-4057qib7	13063	5	sufficient	sufficient	JJ
cord-005453-4057qib7	13063	6	to	to	TO
cord-005453-4057qib7	13063	7	predict	predict	VB
cord-005453-4057qib7	13063	8	HLA	HLA	NNP
cord-005453-4057qib7	13063	9	-	-	HYPH
cord-005453-4057qib7	13063	10	binding	bind	VBG
cord-005453-4057qib7	13063	11	peptides	peptide	NNS
cord-005453-4057qib7	13063	12	that	that	WDT
cord-005453-4057qib7	13063	13	can	can	MD
cord-005453-4057qib7	13063	14	be	be	VB
cord-005453-4057qib7	13063	15	used	use	VBN
cord-005453-4057qib7	13063	16	to	to	TO
cord-005453-4057qib7	13063	17	formulate	formulate	VB
cord-005453-4057qib7	13063	18	individualized	individualized	JJ
cord-005453-4057qib7	13063	19	peptide	peptide	JJ
cord-005453-4057qib7	13063	20	vaccine	vaccine	NN
cord-005453-4057qib7	13063	21	cocktails	cocktail	NNS
cord-005453-4057qib7	13063	22	.	.	.
cord-005453-4057qib7	13064	1	We	-PRON-	PRP
cord-005453-4057qib7	13064	2	currently	currently	RB
cord-005453-4057qib7	13064	3	conduct	conduct	VBP
cord-005453-4057qib7	13064	4	a	a	DT
cord-005453-4057qib7	13064	5	clinical	clinical	JJ
cord-005453-4057qib7	13064	6	phase	phase	NN
cord-005453-4057qib7	13064	7	I	I	NNP
cord-005453-4057qib7	13064	8	/	/	SYM
cord-005453-4057qib7	13064	9	II	II	NNP
cord-005453-4057qib7	13064	10	trial	trial	NN
cord-005453-4057qib7	13064	11	in	in	IN
cord-005453-4057qib7	13064	12	a	a	DT
cord-005453-4057qib7	13064	13	small	small	JJ
cord-005453-4057qib7	13064	14	cohort	cohort	NN
cord-005453-4057qib7	13064	15	of	of	IN
cord-005453-4057qib7	13064	16	high	high	JJ
cord-005453-4057qib7	13064	17	-	-	HYPH
cord-005453-4057qib7	13064	18	risk	risk	NN
cord-005453-4057qib7	13064	19	ALL	all	DT
cord-005453-4057qib7	13064	20	patients	patient	NNS
cord-005453-4057qib7	13064	21	to	to	TO
cord-005453-4057qib7	13064	22	assess	assess	VB
cord-005453-4057qib7	13064	23	safety	safety	NN
cord-005453-4057qib7	13064	24	,	,	,
cord-005453-4057qib7	13064	25	toxicity	toxicity	NN
cord-005453-4057qib7	13064	26	and	and	CC
cord-005453-4057qib7	13064	27	immunogenicity	immunogenicity	NN
cord-005453-4057qib7	13064	28	.	.	.
cord-005453-4057qib7	13065	1	Clinical	clinical	JJ
cord-005453-4057qib7	13065	2	Background	background	NN
cord-005453-4057qib7	13065	3	:	:	:
cord-005453-4057qib7	13066	1	Chimeric	chimeric	JJ
cord-005453-4057qib7	13066	2	antigen	antigen	NN
cord-005453-4057qib7	13066	3	receptor	receptor	NN
cord-005453-4057qib7	13066	4	T	t	NN
cord-005453-4057qib7	13066	5	cells	cell	NNS
cord-005453-4057qib7	13066	6	(	(	-LRB-
cord-005453-4057qib7	13066	7	CART	cart	NN
cord-005453-4057qib7	13066	8	)	)	-RRB-
cord-005453-4057qib7	13066	9	are	be	VBP
cord-005453-4057qib7	13066	10	considered	consider	VBN
cord-005453-4057qib7	13066	11	as	as	IN
cord-005453-4057qib7	13066	12	gene	gene	NN
cord-005453-4057qib7	13066	13	therapy	therapy	NN
cord-005453-4057qib7	13066	14	medicinal	medicinal	JJ
cord-005453-4057qib7	13066	15	products	product	NNS
cord-005453-4057qib7	13066	16	(	(	-LRB-
cord-005453-4057qib7	13066	17	GTMP	GTMP	NNP
cord-005453-4057qib7	13066	18	)	)	-RRB-
cord-005453-4057qib7	13066	19	and	and	CC
cord-005453-4057qib7	13066	20	genetically	genetically	RB
cord-005453-4057qib7	13066	21	modified	modify	VBN
cord-005453-4057qib7	13066	22	organisms	organism	NNS
cord-005453-4057qib7	13066	23	(	(	-LRB-
cord-005453-4057qib7	13066	24	GMO	GMO	NNP
cord-005453-4057qib7	13066	25	)	)	-RRB-
cord-005453-4057qib7	13066	26	.	.	.
cord-005453-4057qib7	13067	1	Hence	hence	RB
cord-005453-4057qib7	13067	2	,	,	,
cord-005453-4057qib7	13067	3	CARTs	cart	NNS
cord-005453-4057qib7	13067	4	manufacturing	manufacture	VBG
cord-005453-4057qib7	13067	5	for	for	IN
cord-005453-4057qib7	13067	6	clinical	clinical	JJ
cord-005453-4057qib7	13067	7	application	application	NN
cord-005453-4057qib7	13067	8	is	be	VBZ
cord-005453-4057qib7	13067	9	strictly	strictly	RB
cord-005453-4057qib7	13067	10	regulated	regulate	VBN
cord-005453-4057qib7	13067	11	.	.	.
cord-005453-4057qib7	13068	1	Appropriate	appropriate	JJ
cord-005453-4057qib7	13068	2	methods	method	NNS
cord-005453-4057qib7	13068	3	assessing	assess	VBG
cord-005453-4057qib7	13068	4	CAR	car	NN
cord-005453-4057qib7	13068	5	transgene	transgene	NN
cord-005453-4057qib7	13068	6	copy	copy	NN
cord-005453-4057qib7	13068	7	number	number	NN
cord-005453-4057qib7	13068	8	(	(	-LRB-
cord-005453-4057qib7	13068	9	CN	CN	NNP
cord-005453-4057qib7	13068	10	)	)	-RRB-
cord-005453-4057qib7	13068	11	in	in	IN
cord-005453-4057qib7	13068	12	a	a	DT
cord-005453-4057qib7	13068	13	CART	cart	NN
cord-005453-4057qib7	13068	14	product	product	NN
cord-005453-4057qib7	13068	15	and	and	CC
cord-005453-4057qib7	13068	16	definition	definition	NN
cord-005453-4057qib7	13068	17	of	of	IN
cord-005453-4057qib7	13068	18	the	the	DT
cord-005453-4057qib7	13068	19	frequency	frequency	NN
cord-005453-4057qib7	13068	20	of	of	IN
cord-005453-4057qib7	13068	21	CARTs	cart	NNS
cord-005453-4057qib7	13068	22	in	in	IN
cord-005453-4057qib7	13068	23	treated	treat	VBN
cord-005453-4057qib7	13068	24	CART	cart	NN
cord-005453-4057qib7	13068	25	patient	patient	NN
cord-005453-4057qib7	13068	26	are	be	VBP
cord-005453-4057qib7	13068	27	mandatory	mandatory	JJ
cord-005453-4057qib7	13068	28	.	.	.
cord-005453-4057qib7	13069	1	Although	although	IN
cord-005453-4057qib7	13069	2	quantitative	quantitative	JJ
cord-005453-4057qib7	13069	3	real	real	JJ
cord-005453-4057qib7	13069	4	-	-	HYPH
cord-005453-4057qib7	13069	5	time	time	NN
cord-005453-4057qib7	13069	6	PCR	pcr	NN
cord-005453-4057qib7	13069	7	-	-	HYPH
cord-005453-4057qib7	13069	8	based	base	VBN
cord-005453-4057qib7	13069	9	(	(	-LRB-
cord-005453-4057qib7	13069	10	qPCR	qPCR	NNP
cord-005453-4057qib7	13069	11	)	)	-RRB-
cord-005453-4057qib7	13069	12	analysis	analysis	NN
cord-005453-4057qib7	13069	13	has	have	VBZ
cord-005453-4057qib7	13069	14	been	be	VBN
cord-005453-4057qib7	13069	15	used	use	VBN
cord-005453-4057qib7	13069	16	for	for	IN
cord-005453-4057qib7	13069	17	this	this	DT
cord-005453-4057qib7	13069	18	purpose	purpose	NN
cord-005453-4057qib7	13069	19	,	,	,
cord-005453-4057qib7	13069	20	no	no	DT
cord-005453-4057qib7	13069	21	standardized	standardized	JJ
cord-005453-4057qib7	13069	22	procedure	procedure	NN
cord-005453-4057qib7	13069	23	to	to	TO
cord-005453-4057qib7	13069	24	minimize	minimize	VB
cord-005453-4057qib7	13069	25	systematic	systematic	JJ
cord-005453-4057qib7	13069	26	errors	error	NNS
cord-005453-4057qib7	13069	27	and	and	CC
cord-005453-4057qib7	13069	28	enable	enable	VB
cord-005453-4057qib7	13069	29	comparability	comparability	NN
cord-005453-4057qib7	13069	30	has	have	VBZ
cord-005453-4057qib7	13069	31	been	be	VBN
cord-005453-4057qib7	13069	32	established	establish	VBN
cord-005453-4057qib7	13069	33	yet	yet	RB
cord-005453-4057qib7	13069	34	.	.	.
cord-005453-4057qib7	13070	1	Here	here	RB
cord-005453-4057qib7	13070	2	,	,	,
cord-005453-4057qib7	13070	3	we	-PRON-	PRP
cord-005453-4057qib7	13070	4	report	report	VBP
cord-005453-4057qib7	13070	5	on	on	IN
cord-005453-4057qib7	13070	6	a	a	DT
cord-005453-4057qib7	13070	7	single	single	JJ
cord-005453-4057qib7	13070	8	copy	copy	NN
cord-005453-4057qib7	13070	9	genebased	genebased	NN
cord-005453-4057qib7	13070	10	(	(	-LRB-
cord-005453-4057qib7	13070	11	SCG	SCG	NNP
cord-005453-4057qib7	13070	12	)	)	-RRB-
cord-005453-4057qib7	13070	13	duplex	duplex	NNP
cord-005453-4057qib7	13070	14	(	(	-LRB-
cord-005453-4057qib7	13070	15	DP	DP	NNP
cord-005453-4057qib7	13070	16	)	)	-RRB-
cord-005453-4057qib7	13070	17	PCR	PCR	NNP
cord-005453-4057qib7	13070	18	(	(	-LRB-
cord-005453-4057qib7	13070	19	SCG	SCG	NNP
cord-005453-4057qib7	13070	20	-	-	HYPH
cord-005453-4057qib7	13070	21	DP	DP	NNP
cord-005453-4057qib7	13070	22	-	-	HYPH
cord-005453-4057qib7	13070	23	PCR	PCR	NNP
cord-005453-4057qib7	13070	24	)	)	-RRB-
cord-005453-4057qib7	13070	25	for	for	IN
cord-005453-4057qib7	13070	26	the	the	DT
cord-005453-4057qib7	13070	27	determination	determination	NN
cord-005453-4057qib7	13070	28	of	of	IN
cord-005453-4057qib7	13070	29	the	the	DT
cord-005453-4057qib7	13070	30	vector	vector	NN
cord-005453-4057qib7	13070	31	copy	copy	NN
cord-005453-4057qib7	13070	32	number	number	NN
cord-005453-4057qib7	13070	33	(	(	-LRB-
cord-005453-4057qib7	13070	34	VCN	VCN	NNP
cord-005453-4057qib7	13070	35	)	)	-RRB-
cord-005453-4057qib7	13070	36	in	in	IN
cord-005453-4057qib7	13070	37	CART	cart	NN
cord-005453-4057qib7	13070	38	products	product	NNS
cord-005453-4057qib7	13070	39	as	as	RB
cord-005453-4057qib7	13070	40	well	well	RB
cord-005453-4057qib7	13070	41	as	as	IN
cord-005453-4057qib7	13070	42	patient	patient	NN
cord-005453-4057qib7	13070	43	samples	sample	NNS
cord-005453-4057qib7	13070	44	following	follow	VBG
cord-005453-4057qib7	13070	45	CART	CART	NNP
cord-005453-4057qib7	13070	46	administration	administration	NN
cord-005453-4057qib7	13070	47	.	.	.
cord-005453-4057qib7	13071	1	SCG	SCG	NNP
cord-005453-4057qib7	13071	2	-	-	HYPH
cord-005453-4057qib7	13071	3	DP	DP	NNP
cord-005453-4057qib7	13071	4	-	-	HYPH
cord-005453-4057qib7	13071	5	PCR	PCR	NNP
cord-005453-4057qib7	13071	6	was	be	VBD
cord-005453-4057qib7	13071	7	validated	validate	VBN
cord-005453-4057qib7	13071	8	and	and	CC
cord-005453-4057qib7	13071	9	compared	compare	VBN
cord-005453-4057qib7	13071	10	to	to	IN
cord-005453-4057qib7	13071	11	the	the	DT
cord-005453-4057qib7	13071	12	broadly	broadly	RB
cord-005453-4057qib7	13071	13	used	use	VBN
cord-005453-4057qib7	13071	14	absolute	absolute	JJ
cord-005453-4057qib7	13071	15	copy	copy	NN
cord-005453-4057qib7	13071	16	number	number	NN
cord-005453-4057qib7	13071	17	qPCR	qpcr	NN
cord-005453-4057qib7	13071	18	(	(	-LRB-
cord-005453-4057qib7	13071	19	ACN	ACN	NNP
cord-005453-4057qib7	13071	20	)	)	-RRB-
cord-005453-4057qib7	13071	21	approach	approach	NN
cord-005453-4057qib7	13071	22	within	within	IN
cord-005453-4057qib7	13071	23	the	the	DT
cord-005453-4057qib7	13071	24	framework	framework	NN
cord-005453-4057qib7	13071	25	of	of	IN
cord-005453-4057qib7	13071	26	a	a	DT
cord-005453-4057qib7	13071	27	clinical	clinical	JJ
cord-005453-4057qib7	13071	28	trial	trial	NN
cord-005453-4057qib7	13071	29	treating	treat	VBG
cord-005453-4057qib7	13071	30	patients	patient	NNS
cord-005453-4057qib7	13071	31	with	with	IN
cord-005453-4057qib7	13071	32	good	good	JJ
cord-005453-4057qib7	13071	33	manufacturing	manufacturing	NN
cord-005453-4057qib7	13071	34	practice	practice	NN
cord-005453-4057qib7	13071	35	(	(	-LRB-
cord-005453-4057qib7	13071	36	GMP)-grade	GMP)-grade	NNP
cord-005453-4057qib7	13071	37	CARTs	cart	NNS
cord-005453-4057qib7	13071	38	(	(	-LRB-
cord-005453-4057qib7	13071	39	HD	HD	NNP
cord-005453-4057qib7	13071	40	-	-	HYPH
cord-005453-4057qib7	13071	41	CAR-1	CAR-1	NNP
cord-005453-4057qib7	13071	42	)	)	-RRB-
cord-005453-4057qib7	13071	43	.	.	.
cord-005453-4057qib7	13072	1	Methods	method	NNS
cord-005453-4057qib7	13072	2	:	:	:
cord-005453-4057qib7	13072	3	For	for	IN
cord-005453-4057qib7	13072	4	conventional	conventional	JJ
cord-005453-4057qib7	13072	5	ACN	ACN	NNP
cord-005453-4057qib7	13072	6	,	,	,
cord-005453-4057qib7	13072	7	primers	primer	NNS
cord-005453-4057qib7	13072	8	and	and	CC
cord-005453-4057qib7	13072	9	probe	probe	NN
cord-005453-4057qib7	13072	10	targeting	target	VBG
cord-005453-4057qib7	13072	11	the	the	DT
cord-005453-4057qib7	13072	12	CAR	car	NN
cord-005453-4057qib7	13072	13	vector	vector	NN
cord-005453-4057qib7	13072	14	RV	rv	NN
cord-005453-4057qib7	13072	15	-	-	HYPH
cord-005453-4057qib7	13072	16	SFG.CD19.CD28.4	SFG.CD19.CD28.4	NNP
cord-005453-4057qib7	13072	17	-	-	HYPH
cord-005453-4057qib7	13072	18	1BBzeta	1BBzeta	NNP
cord-005453-4057qib7	13072	19	were	be	VBD
cord-005453-4057qib7	13072	20	designed	design	VBN
cord-005453-4057qib7	13072	21	.	.	.
cord-005453-4057qib7	13073	1	Standard	standard	JJ
cord-005453-4057qib7	13073	2	curves	curve	NNS
cord-005453-4057qib7	13073	3	were	be	VBD
cord-005453-4057qib7	13073	4	established	establish	VBN
cord-005453-4057qib7	13073	5	via	via	IN
cord-005453-4057qib7	13073	6	serial	serial	JJ
cord-005453-4057qib7	13073	7	dilutions	dilution	NNS
cord-005453-4057qib7	13073	8	of	of	IN
cord-005453-4057qib7	13073	9	the	the	DT
cord-005453-4057qib7	13073	10	SFG.CAR	SFG.CAR	NNP
cord-005453-4057qib7	13073	11	plasmid	plasmid	NN
cord-005453-4057qib7	13073	12	.	.	.
cord-005453-4057qib7	13074	1	Amplification	amplification	NN
cord-005453-4057qib7	13074	2	of	of	IN
cord-005453-4057qib7	13074	3	the	the	DT
cord-005453-4057qib7	13074	4	standard	standard	JJ
cord-005453-4057qib7	13074	5	curve	curve	NN
cord-005453-4057qib7	13074	6	as	as	RB
cord-005453-4057qib7	13074	7	well	well	RB
cord-005453-4057qib7	13074	8	as	as	IN
cord-005453-4057qib7	13074	9	target	target	NN
cord-005453-4057qib7	13074	10	genomic	genomic	JJ
cord-005453-4057qib7	13074	11	DNA	dna	NN
cord-005453-4057qib7	13074	12	for	for	IN
cord-005453-4057qib7	13074	13	VCNdetermination	vcndetermination	NN
cord-005453-4057qib7	13074	14	was	be	VBD
cord-005453-4057qib7	13074	15	performed	perform	VBN
cord-005453-4057qib7	13074	16	as	as	IN
cord-005453-4057qib7	13074	17	singleplex	singleplex	NN
cord-005453-4057qib7	13074	18	(	(	-LRB-
cord-005453-4057qib7	13074	19	SP	SP	NNP
cord-005453-4057qib7	13074	20	)	)	-RRB-
cord-005453-4057qib7	13074	21	PCR	PCR	NNP
cord-005453-4057qib7	13074	22	(	(	-LRB-
cord-005453-4057qib7	13074	23	SP	SP	NNP
cord-005453-4057qib7	13074	24	-	-	HYPH
cord-005453-4057qib7	13074	25	CAR	CAR	NNP
cord-005453-4057qib7	13074	26	)	)	-RRB-
cord-005453-4057qib7	13074	27	(	(	-LRB-
cord-005453-4057qib7	13074	28	method	method	NN
cord-005453-4057qib7	13074	29	A	A	NNP
cord-005453-4057qib7	13074	30	)	)	-RRB-
cord-005453-4057qib7	13074	31	.	.	.
cord-005453-4057qib7	13075	1	On	on	IN
cord-005453-4057qib7	13075	2	the	the	DT
cord-005453-4057qib7	13075	3	same	same	JJ
cord-005453-4057qib7	13075	4	qPCR	qpcr	NN
cord-005453-4057qib7	13075	5	plate	plate	NN
cord-005453-4057qib7	13075	6	,	,	,
cord-005453-4057qib7	13075	7	duplex	duplex	NNP
cord-005453-4057qib7	13075	8	(	(	-LRB-
cord-005453-4057qib7	13075	9	DP	DP	NNP
cord-005453-4057qib7	13075	10	)	)	-RRB-
cord-005453-4057qib7	13075	11	qPCR	qpcr	NN
cord-005453-4057qib7	13075	12	reactions	reaction	NNS
cord-005453-4057qib7	13075	13	were	be	VBD
cord-005453-4057qib7	13075	14	carried	carry	VBN
cord-005453-4057qib7	13075	15	out	out	RP
cord-005453-4057qib7	13075	16	.	.	.
cord-005453-4057qib7	13076	1	Additionally	additionally	RB
cord-005453-4057qib7	13076	2	to	to	IN
cord-005453-4057qib7	13076	3	the	the	DT
cord-005453-4057qib7	13076	4	components	component	NNS
cord-005453-4057qib7	13076	5	comprised	comprise	VBN
cord-005453-4057qib7	13076	6	within	within	IN
cord-005453-4057qib7	13076	7	method	method	NN
cord-005453-4057qib7	13076	8	A	A	NNP
cord-005453-4057qib7	13076	9	,	,	,
cord-005453-4057qib7	13076	10	the	the	DT
cord-005453-4057qib7	13076	11	experimental	experimental	JJ
cord-005453-4057qib7	13076	12	setup	setup	NN
cord-005453-4057qib7	13076	13	contained	contain	VBD
cord-005453-4057qib7	13076	14	haploid	haploid	JJ
cord-005453-4057qib7	13076	15	human	human	JJ
cord-005453-4057qib7	13076	16	genomes	genome	NNS
cord-005453-4057qib7	13076	17	as	as	RB
cord-005453-4057qib7	13076	18	well	well	RB
cord-005453-4057qib7	13076	19	as	as	IN
cord-005453-4057qib7	13076	20	primers	primer	NNS
cord-005453-4057qib7	13076	21	and	and	CC
cord-005453-4057qib7	13076	22	probe	probe	NN
cord-005453-4057qib7	13076	23	targeting	target	VBG
cord-005453-4057qib7	13076	24	ribonuclease	ribonuclease	NN
cord-005453-4057qib7	13076	25	(	(	-LRB-
cord-005453-4057qib7	13076	26	RNAse	RNAse	NNP
cord-005453-4057qib7	13076	27	)	)	-RRB-
cord-005453-4057qib7	13076	28	P	p	NN
cord-005453-4057qib7	13076	29	as	as	IN
cord-005453-4057qib7	13076	30	human	human	JJ
cord-005453-4057qib7	13076	31	SCG	SCG	NNP
cord-005453-4057qib7	13076	32	.	.	.
cord-005453-4057qib7	13077	1	The	the	DT
cord-005453-4057qib7	13077	2	amplifications	amplification	NNS
cord-005453-4057qib7	13077	3	for	for	IN
cord-005453-4057qib7	13077	4	the	the	DT
cord-005453-4057qib7	13077	5	SFG.CAR	SFG.CAR	NNP
cord-005453-4057qib7	13077	6	plasmid	plasmid	NN
cord-005453-4057qib7	13077	7	(	(	-LRB-
cord-005453-4057qib7	13077	8	DP	dp	NN
cord-005453-4057qib7	13077	9	-	-	HYPH
cord-005453-4057qib7	13077	10	CAR	CAR	NNP
cord-005453-4057qib7	13077	11	)	)	-RRB-
cord-005453-4057qib7	13077	12	and	and	CC
cord-005453-4057qib7	13077	13	the	the	DT
cord-005453-4057qib7	13077	14	RNAseP	RNAseP	NNP
cord-005453-4057qib7	13077	15	gene	gene	NN
cord-005453-4057qib7	13077	16	(	(	-LRB-
cord-005453-4057qib7	13077	17	DP	DP	NNP
cord-005453-4057qib7	13077	18	-	-	HYPH
cord-005453-4057qib7	13077	19	RNAseP	RNAseP	NNP
cord-005453-4057qib7	13077	20	)	)	-RRB-
cord-005453-4057qib7	13077	21	were	be	VBD
cord-005453-4057qib7	13077	22	performed	perform	VBN
cord-005453-4057qib7	13077	23	simultaneously	simultaneously	RB
cord-005453-4057qib7	13077	24	(	(	-LRB-
cord-005453-4057qib7	13077	25	SCG	SCG	NNP
cord-005453-4057qib7	13077	26	-	-	HYPH
cord-005453-4057qib7	13077	27	DP	DP	NNP
cord-005453-4057qib7	13077	28	-	-	HYPH
cord-005453-4057qib7	13077	29	PCR	pcr	NN
cord-005453-4057qib7	13077	30	;	;	:
cord-005453-4057qib7	13077	31	method	method	NN
cord-005453-4057qib7	13077	32	B	b	NN
cord-005453-4057qib7	13077	33	)	)	-RRB-
cord-005453-4057qib7	13077	34	.	.	.
cord-005453-4057qib7	13078	1	SCG	SCG	NNP
cord-005453-4057qib7	13078	2	-	-	HYPH
cord-005453-4057qib7	13078	3	DP	DP	NNP
cord-005453-4057qib7	13078	4	-	-	HYPH
cord-005453-4057qib7	13078	5	PCR	PCR	NNP
cord-005453-4057qib7	13078	6	was	be	VBD
cord-005453-4057qib7	13078	7	performed	perform	VBN
cord-005453-4057qib7	13078	8	for	for	IN
cord-005453-4057qib7	13078	9	standard	standard	JJ
cord-005453-4057qib7	13078	10	curves	curve	NNS
cord-005453-4057qib7	13078	11	and	and	CC
cord-005453-4057qib7	13078	12	target	target	NN
cord-005453-4057qib7	13078	13	samples	sample	NNS
cord-005453-4057qib7	13078	14	.	.	.
cord-005453-4057qib7	13079	1	Target	target	NN
cord-005453-4057qib7	13079	2	-	-	HYPH
cord-005453-4057qib7	13079	3	sample	sample	NN
cord-005453-4057qib7	13079	4	DNA	dna	NN
cord-005453-4057qib7	13079	5	was	be	VBD
cord-005453-4057qib7	13079	6	extracted	extract	VBN
cord-005453-4057qib7	13079	7	from	from	IN
cord-005453-4057qib7	13079	8	CARTs	cart	NNS
cord-005453-4057qib7	13079	9	prepared	prepare	VBN
cord-005453-4057qib7	13079	10	from	from	IN
cord-005453-4057qib7	13079	11	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	13079	12	products	product	NNS
cord-005453-4057qib7	13079	13	of	of	IN
cord-005453-4057qib7	13079	14	three	three	CD
cord-005453-4057qib7	13079	15	healthy	healthy	JJ
cord-005453-4057qib7	13079	16	donors	donor	NNS
cord-005453-4057qib7	13079	17	(	(	-LRB-
cord-005453-4057qib7	13079	18	HD	HD	NNP
cord-005453-4057qib7	13079	19	)	)	-RRB-
cord-005453-4057qib7	13079	20	.	.	.
cord-005453-4057qib7	13080	1	Results	result	NNS
cord-005453-4057qib7	13080	2	:	:	:
cord-005453-4057qib7	13081	1	For	for	IN
cord-005453-4057qib7	13081	2	method	method	NN
cord-005453-4057qib7	13081	3	validation	validation	NN
cord-005453-4057qib7	13081	4	,	,	,
cord-005453-4057qib7	13081	5	efficiency	efficiency	NN
cord-005453-4057qib7	13081	6	and	and	CC
cord-005453-4057qib7	13081	7	linearity	linearity	NN
cord-005453-4057qib7	13081	8	(	(	-LRB-
cord-005453-4057qib7	13081	9	correlation	correlation	NN
cord-005453-4057qib7	13081	10	coefficient	coefficient	NN
cord-005453-4057qib7	13081	11	)	)	-RRB-
cord-005453-4057qib7	13081	12	of	of	IN
cord-005453-4057qib7	13081	13	the	the	DT
cord-005453-4057qib7	13081	14	qPCR	qpcr	JJ
cord-005453-4057qib7	13081	15	reactions	reaction	NNS
cord-005453-4057qib7	13081	16	of	of	IN
cord-005453-4057qib7	13081	17	method	method	NN
cord-005453-4057qib7	13081	18	A	a	NN
cord-005453-4057qib7	13081	19	(	(	-LRB-
cord-005453-4057qib7	13081	20	SP	SP	NNP
cord-005453-4057qib7	13081	21	-	-	HYPH
cord-005453-4057qib7	13081	22	CAR	CAR	NNP
cord-005453-4057qib7	13081	23	)	)	-RRB-
cord-005453-4057qib7	13081	24	and	and	CC
cord-005453-4057qib7	13081	25	method	method	NN
cord-005453-4057qib7	13081	26	B	b	NN
cord-005453-4057qib7	13081	27	(	(	-LRB-
cord-005453-4057qib7	13081	28	DP	dp	NN
cord-005453-4057qib7	13081	29	-	-	HYPH
cord-005453-4057qib7	13081	30	CAR	car	NN
cord-005453-4057qib7	13081	31	,	,	,
cord-005453-4057qib7	13081	32	DP	DP	NNP
cord-005453-4057qib7	13081	33	-	-	HYPH
cord-005453-4057qib7	13081	34	RNAseP	RNAseP	NNP
cord-005453-4057qib7	13081	35	)	)	-RRB-
cord-005453-4057qib7	13081	36	were	be	VBD
cord-005453-4057qib7	13081	37	assessed	assess	VBN
cord-005453-4057qib7	13081	38	by	by	IN
cord-005453-4057qib7	13081	39	linear	linear	JJ
cord-005453-4057qib7	13081	40	regression	regression	NN
cord-005453-4057qib7	13081	41	of	of	IN
cord-005453-4057qib7	13081	42	the	the	DT
cord-005453-4057qib7	13081	43	PCR	PCR	NNP
cord-005453-4057qib7	13081	44	signal	signal	NN
cord-005453-4057qib7	13081	45	to	to	IN
cord-005453-4057qib7	13081	46	the	the	DT
cord-005453-4057qib7	13081	47	reference	reference	NN
cord-005453-4057qib7	13081	48	standard	standard	JJ
cord-005453-4057qib7	13081	49	curve	curve	NN
cord-005453-4057qib7	13081	50	.	.	.
cord-005453-4057qib7	13082	1	Overall	overall	RB
cord-005453-4057qib7	13082	2	,	,	,
cord-005453-4057qib7	13082	3	standard	standard	JJ
cord-005453-4057qib7	13082	4	curves	curve	NNS
cord-005453-4057qib7	13082	5	were	be	VBD
cord-005453-4057qib7	13082	6	only	only	RB
cord-005453-4057qib7	13082	7	considered	consider	VBN
cord-005453-4057qib7	13082	8	valid	valid	JJ
cord-005453-4057qib7	13082	9	if	if	IN
cord-005453-4057qib7	13082	10	a	a	DT
cord-005453-4057qib7	13082	11	correlation	correlation	NN
cord-005453-4057qib7	13082	12	coefficient	coefficient	NN
cord-005453-4057qib7	13082	13	(	(	-LRB-
cord-005453-4057qib7	13082	14	R	r	NN
cord-005453-4057qib7	13082	15	2	2	CD
cord-005453-4057qib7	13082	16	)	)	-RRB-
cord-005453-4057qib7	13082	17	of	of	IN
cord-005453-4057qib7	13082	18	above	above	IN
cord-005453-4057qib7	13082	19	0.98	0.98	CD
cord-005453-4057qib7	13082	20	and	and	CC
cord-005453-4057qib7	13082	21	efficiencies	efficiency	NNS
cord-005453-4057qib7	13082	22	of	of	IN
cord-005453-4057qib7	13082	23	100	100	CD
cord-005453-4057qib7	13082	24	%	%	NN
cord-005453-4057qib7	13082	25	±	±	NNP
cord-005453-4057qib7	13082	26	10	10	CD
cord-005453-4057qib7	13082	27	%	%	NN
cord-005453-4057qib7	13082	28	were	be	VBD
cord-005453-4057qib7	13082	29	achieved	achieve	VBN
cord-005453-4057qib7	13082	30	.	.	.
cord-005453-4057qib7	13083	1	VCNs	VCNs	NNP
cord-005453-4057qib7	13083	2	applying	apply	VBG
cord-005453-4057qib7	13083	3	method	method	NN
cord-005453-4057qib7	13083	4	A	a	NN
cord-005453-4057qib7	13083	5	and	and	CC
cord-005453-4057qib7	13083	6	B	b	NN
cord-005453-4057qib7	13083	7	to	to	IN
cord-005453-4057qib7	13083	8	the	the	DT
cord-005453-4057qib7	13083	9	same	same	JJ
cord-005453-4057qib7	13083	10	target	target	NN
cord-005453-4057qib7	13083	11	sample	sample	NN
cord-005453-4057qib7	13083	12	were	be	VBD
cord-005453-4057qib7	13083	13	compared	compare	VBN
cord-005453-4057qib7	13083	14	.	.	.
cord-005453-4057qib7	13084	1	SP	SP	NNP
cord-005453-4057qib7	13084	2	-	-	HYPH
cord-005453-4057qib7	13084	3	CAR	car	NN
cord-005453-4057qib7	13084	4	PCR	PCR	NNP
cord-005453-4057qib7	13084	5	reaction	reaction	NN
cord-005453-4057qib7	13084	6	displayed	display	VBD
cord-005453-4057qib7	13084	7	efficiency	efficiency	NN
cord-005453-4057qib7	13084	8	of	of	IN
cord-005453-4057qib7	13084	9	103.5	103.5	CD
cord-005453-4057qib7	13084	10	±	±	CD
cord-005453-4057qib7	13084	11	7.1	7.1	CD
cord-005453-4057qib7	13084	12	%	%	NN
cord-005453-4057qib7	13084	13	;	;	:
cord-005453-4057qib7	13084	14	104.2	104.2	CD
cord-005453-4057qib7	13084	15	%	%	NN
cord-005453-4057qib7	13084	16	±	±	NNP
cord-005453-4057qib7	13084	17	2.1	2.1	CD
cord-005453-4057qib7	13084	18	%	%	NN
cord-005453-4057qib7	13084	19	and	and	CC
cord-005453-4057qib7	13084	20	99.3	99.3	CD
cord-005453-4057qib7	13084	21	±	±	XX
cord-005453-4057qib7	13085	1	1.6	1.6	CD
cord-005453-4057qib7	13085	2	%	%	NN
cord-005453-4057qib7	13085	3	efficiencies	efficiency	NNS
cord-005453-4057qib7	13085	4	were	be	VBD
cord-005453-4057qib7	13085	5	achieved	achieve	VBN
cord-005453-4057qib7	13085	6	for	for	IN
cord-005453-4057qib7	13085	7	DP	dp	NN
cord-005453-4057qib7	13085	8	-	-	HYPH
cord-005453-4057qib7	13085	9	CAR	car	NN
cord-005453-4057qib7	13085	10	and	and	CC
cord-005453-4057qib7	13085	11	DP	dp	NN
cord-005453-4057qib7	13085	12	-	-	HYPH
cord-005453-4057qib7	13085	13	RNAse	rnase	RP
cord-005453-4057qib7	13085	14	PCR	PCR	NNP
cord-005453-4057qib7	13085	15	reaction	reaction	NN
cord-005453-4057qib7	13085	16	,	,	,
cord-005453-4057qib7	13085	17	respectively	respectively	RB
cord-005453-4057qib7	13085	18	(	(	-LRB-
cord-005453-4057qib7	13085	19	Table	table	NN
cord-005453-4057qib7	13085	20	1	1	CD
cord-005453-4057qib7	13085	21	)	)	-RRB-
cord-005453-4057qib7	13085	22	.	.	.
cord-005453-4057qib7	13086	1	Applying	apply	VBG
cord-005453-4057qib7	13086	2	SCG	SCG	NNP
cord-005453-4057qib7	13086	3	-	-	HYPH
cord-005453-4057qib7	13086	4	DP	DP	NNP
cord-005453-4057qib7	13086	5	-	-	HYPH
cord-005453-4057qib7	13086	6	PCR	pcr	NN
cord-005453-4057qib7	13086	7	using	use	VBG
cord-005453-4057qib7	13086	8	formula	formula	NN
cord-005453-4057qib7	13086	9	for	for	IN
cord-005453-4057qib7	13086	10	relative	relative	JJ
cord-005453-4057qib7	13086	11	CN	CN	NNP
cord-005453-4057qib7	13086	12	assessment	assessment	NN
cord-005453-4057qib7	13086	13	(	(	-LRB-
cord-005453-4057qib7	13086	14	2	2	CD
cord-005453-4057qib7	13086	15	-ΔCt	-δct	NN
cord-005453-4057qib7	13086	16	(	(	-LRB-
cord-005453-4057qib7	13086	17	DP	dp	NN
cord-005453-4057qib7	13086	18	-	-	HYPH
cord-005453-4057qib7	13086	19	CAR	car	NN
cord-005453-4057qib7	13086	20	-DP	-DP	NNS
cord-005453-4057qib7	13086	21	-	-	:
cord-005453-4057qib7	13086	22	RNAseP	RNAseP	NNP
cord-005453-4057qib7	13086	23	)	)	-RRB-
cord-005453-4057qib7	13086	24	)	)	-RRB-
cord-005453-4057qib7	13086	25	on	on	IN
cord-005453-4057qib7	13086	26	HD	hd	NN
cord-005453-4057qib7	13086	27	samples	sample	NNS
cord-005453-4057qib7	13086	28	resulted	result	VBD
cord-005453-4057qib7	13086	29	in	in	IN
cord-005453-4057qib7	13086	30	an	an	DT
cord-005453-4057qib7	13086	31	average	average	NN
cord-005453-4057qib7	13086	32	of	of	IN
cord-005453-4057qib7	13086	33	0.8	0.8	CD
cord-005453-4057qib7	13086	34	±	±	CD
cord-005453-4057qib7	13086	35	0.2	0.2	CD
cord-005453-4057qib7	13086	36	increased	increase	VBD
cord-005453-4057qib7	13086	37	CN	cn	NN
cord-005453-4057qib7	13086	38	when	when	WRB
cord-005453-4057qib7	13086	39	compared	compare	VBN
cord-005453-4057qib7	13086	40	to	to	TO
cord-005453-4057qib7	13086	41	method	method	VB
cord-005453-4057qib7	13086	42	A	a	DT
cord-005453-4057qib7	13086	43	(	(	-LRB-
cord-005453-4057qib7	13086	44	Table	table	NN
cord-005453-4057qib7	13086	45	2	2	CD
cord-005453-4057qib7	13086	46	)	)	-RRB-
cord-005453-4057qib7	13086	47	.	.	.
cord-005453-4057qib7	13087	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13087	2	:	:	:
cord-005453-4057qib7	13088	1	In	in	IN
cord-005453-4057qib7	13088	2	terms	term	NNS
cord-005453-4057qib7	13088	3	of	of	IN
cord-005453-4057qib7	13088	4	efficiency	efficiency	NN
cord-005453-4057qib7	13088	5	and	and	CC
cord-005453-4057qib7	13088	6	linearity	linearity	NN
cord-005453-4057qib7	13088	7	by	by	IN
cord-005453-4057qib7	13088	8	linear	linear	JJ
cord-005453-4057qib7	13088	9	regression	regression	NN
cord-005453-4057qib7	13088	10	qPCR	qpcr	NN
cord-005453-4057qib7	13088	11	reactions	reaction	NNS
cord-005453-4057qib7	13088	12	were	be	VBD
cord-005453-4057qib7	13088	13	comparable	comparable	JJ
cord-005453-4057qib7	13088	14	.	.	.
cord-005453-4057qib7	13089	1	Validation	validation	NN
cord-005453-4057qib7	13089	2	of	of	IN
cord-005453-4057qib7	13089	3	SCG	SCG	NNP
cord-005453-4057qib7	13089	4	-	-	HYPH
cord-005453-4057qib7	13089	5	DP	DP	NNP
cord-005453-4057qib7	13089	6	-	-	HYPH
cord-005453-4057qib7	13089	7	PCR	PCR	NNP
cord-005453-4057qib7	13089	8	was	be	VBD
cord-005453-4057qib7	13089	9	achieved	achieve	VBN
cord-005453-4057qib7	13089	10	and	and	CC
cord-005453-4057qib7	13089	11	represents	represent	VBZ
cord-005453-4057qib7	13089	12	an	an	DT
cord-005453-4057qib7	13089	13	exact	exact	JJ
cord-005453-4057qib7	13089	14	and	and	CC
cord-005453-4057qib7	13089	15	less	less	RBR
cord-005453-4057qib7	13089	16	error	error	NN
cord-005453-4057qib7	13089	17	-	-	HYPH
cord-005453-4057qib7	13089	18	prone	prone	JJ
cord-005453-4057qib7	13089	19	method	method	NN
cord-005453-4057qib7	13089	20	to	to	TO
cord-005453-4057qib7	13089	21	fulfil	fulfil	VB
cord-005453-4057qib7	13089	22	regulatory	regulatory	JJ
cord-005453-4057qib7	13089	23	safety	safety	NN
cord-005453-4057qib7	13089	24	release	release	NN
cord-005453-4057qib7	13089	25	criteria	criterion	NNS
cord-005453-4057qib7	13089	26	of	of	IN
cord-005453-4057qib7	13089	27	CART	cart	NN
cord-005453-4057qib7	13089	28	products	product	NNS
cord-005453-4057qib7	13089	29	.	.	.
cord-005453-4057qib7	13090	1	Besides	besides	RB
cord-005453-4057qib7	13090	2	of	of	IN
cord-005453-4057qib7	13090	3	accurately	accurately	RB
cord-005453-4057qib7	13090	4	assessing	assess	VBG
cord-005453-4057qib7	13090	5	VCN	VCN	NNP
cord-005453-4057qib7	13090	6	of	of	IN
cord-005453-4057qib7	13090	7	transduced	transduce	VBN
cord-005453-4057qib7	13090	8	cells	cell	NNS
cord-005453-4057qib7	13090	9	,	,	,
cord-005453-4057qib7	13090	10	SCG	SCG	NNP
cord-005453-4057qib7	13090	11	-	-	HYPH
cord-005453-4057qib7	13090	12	DP	DP	NNP
cord-005453-4057qib7	13090	13	-	-	HYPH
cord-005453-4057qib7	13090	14	PCR	PCR	NNP
cord-005453-4057qib7	13090	15	is	be	VBZ
cord-005453-4057qib7	13090	16	also	also	RB
cord-005453-4057qib7	13090	17	a	a	DT
cord-005453-4057qib7	13090	18	highly	highly	RB
cord-005453-4057qib7	13090	19	robust	robust	JJ
cord-005453-4057qib7	13090	20	method	method	NN
cord-005453-4057qib7	13090	21	to	to	TO
cord-005453-4057qib7	13090	22	follow	follow	VB
cord-005453-4057qib7	13090	23	-	-	HYPH
cord-005453-4057qib7	13090	24	up	up	RP
cord-005453-4057qib7	13090	25	CARTs	cart	NNS
cord-005453-4057qib7	13090	26	in	in	IN
cord-005453-4057qib7	13090	27	treated	treat	VBN
cord-005453-4057qib7	13090	28	patients	patient	NNS
cord-005453-4057qib7	13090	29	.	.	.
cord-005453-4057qib7	13091	1	Applying	apply	VBG
cord-005453-4057qib7	13091	2	this	this	DT
cord-005453-4057qib7	13091	3	approach	approach	NN
cord-005453-4057qib7	13091	4	,	,	,
cord-005453-4057qib7	13091	5	no	no	DT
cord-005453-4057qib7	13091	6	standard	standard	JJ
cord-005453-4057qib7	13091	7	curve	curve	NN
cord-005453-4057qib7	13091	8	is	be	VBZ
cord-005453-4057qib7	13091	9	needed	need	VBN
cord-005453-4057qib7	13091	10	,	,	,
cord-005453-4057qib7	13091	11	hence	hence	RB
cord-005453-4057qib7	13091	12	significantly	significantly	RB
cord-005453-4057qib7	13091	13	economizing	economize	VBG
cord-005453-4057qib7	13091	14	required	require	VBN
cord-005453-4057qib7	13091	15	material	material	NN
cord-005453-4057qib7	13091	16	as	as	RB
cord-005453-4057qib7	13091	17	well	well	RB
cord-005453-4057qib7	13091	18	as	as	IN
cord-005453-4057qib7	13091	19	time	time	NN
cord-005453-4057qib7	13091	20	.	.	.
cord-005453-4057qib7	13092	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13092	2	:	:	:
cord-005453-4057qib7	13092	3	Nothing	nothing	NN
cord-005453-4057qib7	13092	4	to	to	TO
cord-005453-4057qib7	13092	5	declare	declare	VB
cord-005453-4057qib7	13092	6	Background	background	NN
cord-005453-4057qib7	13092	7	:	:	:
cord-005453-4057qib7	13092	8	T	T	NNP
cord-005453-4057qib7	13092	9	-	-	HYPH
cord-005453-4057qib7	13092	10	cells	cell	NNS
cord-005453-4057qib7	13092	11	'	'	POS
cord-005453-4057qib7	13092	12	antileukemic	antileukemic	JJ
cord-005453-4057qib7	13092	13	responses	response	NNS
cord-005453-4057qib7	13092	14	in	in	IN
cord-005453-4057qib7	13092	15	AML	AML	NNP
cord-005453-4057qib7	13092	16	-	-	HYPH
cord-005453-4057qib7	13092	17	pts	pts	NN
cord-005453-4057qib7	13092	18	need	need	NN
cord-005453-4057qib7	13092	19	to	to	TO
cord-005453-4057qib7	13092	20	be	be	VB
cord-005453-4057qib7	13092	21	improved	improve	VBN
cord-005453-4057qib7	13092	22	.	.	.
cord-005453-4057qib7	13093	1	DC	DC	NNP
cord-005453-4057qib7	13093	2	leu	leu	NNP
cord-005453-4057qib7	13093	3	effectively	effectively	RB
cord-005453-4057qib7	13093	4	activate	activate	VBP
cord-005453-4057qib7	13093	5	T	T	NNP
cord-005453-4057qib7	13093	6	-	-	HYPH
cord-005453-4057qib7	13093	7	cells	cell	NNS
cord-005453-4057qib7	13093	8	against	against	IN
cord-005453-4057qib7	13093	9	leukemic	leukemic	JJ
cord-005453-4057qib7	13093	10	blasts	blast	NNS
cord-005453-4057qib7	13093	11	,	,	,
cord-005453-4057qib7	13093	12	resulting	result	VBG
cord-005453-4057qib7	13093	13	in	in	IN
cord-005453-4057qib7	13093	14	blast	blast	NN
cord-005453-4057qib7	13093	15	-	-	HYPH
cord-005453-4057qib7	13093	16	lysis	lysis	NN
cord-005453-4057qib7	13093	17	ex	ex	NN
cord-005453-4057qib7	13093	18	-	-	NN
cord-005453-4057qib7	13093	19	vivo	vivo	NN
cord-005453-4057qib7	13093	20	.	.	.
cord-005453-4057qib7	13094	1	Factors	factor	NNS
cord-005453-4057qib7	13094	2	influencing	influence	VBG
cord-005453-4057qib7	13094	3	these	these	DT
cord-005453-4057qib7	13094	4	activities	activity	NNS
cord-005453-4057qib7	13094	5	are	be	VBP
cord-005453-4057qib7	13094	6	not	not	RB
cord-005453-4057qib7	13094	7	known	know	VBN
cord-005453-4057qib7	13094	8	.	.	.
cord-005453-4057qib7	13095	1	Methods	method	NNS
cord-005453-4057qib7	13095	2	:	:	:
cord-005453-4057qib7	13095	3	We	-PRON-	PRP
cord-005453-4057qib7	13095	4	generated	generate	VBD
cord-005453-4057qib7	13095	5	DC	DC	NNP
cord-005453-4057qib7	13095	6	/	/	SYM
cord-005453-4057qib7	13095	7	DC	DC	NNP
cord-005453-4057qib7	13095	8	leu	leu	NNP
cord-005453-4057qib7	13095	9	from	from	IN
cord-005453-4057qib7	13095	10	AML	AML	NNP
cord-005453-4057qib7	13095	11	-	-	HYPH
cord-005453-4057qib7	13095	12	blastcontaining	blastcontaine	VBG
cord-005453-4057qib7	13095	13	mononuclear	mononuclear	NN
cord-005453-4057qib7	13095	14	cells	cell	NNS
cord-005453-4057qib7	13095	15	(	(	-LRB-
cord-005453-4057qib7	13095	16	n=74	n=74	NNP
cord-005453-4057qib7	13095	17	)	)	-RRB-
cord-005453-4057qib7	13095	18	using	use	VBG
cord-005453-4057qib7	13095	19	standard	standard	JJ
cord-005453-4057qib7	13095	20	methods	method	NNS
cord-005453-4057qib7	13095	21	(	(	-LRB-
cord-005453-4057qib7	13095	22	MCM	MCM	NNP
cord-005453-4057qib7	13095	23	-	-	HYPH
cord-005453-4057qib7	13095	24	Mimic	Mimic	NNP
cord-005453-4057qib7	13095	25	/	/	SYM
cord-005453-4057qib7	13095	26	Ca	Ca	NNP
cord-005453-4057qib7	13095	27	-	-	HYPH
cord-005453-4057qib7	13095	28	Ionophore	Ionophore	NNP
cord-005453-4057qib7	13095	29	/	/	SYM
cord-005453-4057qib7	13095	30	Picibanil	Picibanil	NNP
cord-005453-4057qib7	13095	31	/	/	SYM
cord-005453-4057qib7	13095	32	IFN	IFN	NNP
cord-005453-4057qib7	13095	33	-	-	HYPH
cord-005453-4057qib7	13095	34	α	α	NNP
cord-005453-4057qib7	13095	35	,	,	,
cord-005453-4057qib7	13095	36	"	"	``
cord-005453-4057qib7	13095	37	MNC	mnc	NN
cord-005453-4057qib7	13095	38	-	-	HYPH
cord-005453-4057qib7	13095	39	methods	method	NNS
cord-005453-4057qib7	13095	40	"	"	''
cord-005453-4057qib7	13095	41	)	)	-RRB-
cord-005453-4057qib7	13095	42	and	and	CC
cord-005453-4057qib7	13095	43	from	from	IN
cord-005453-4057qib7	13095	44	blast	blast	NN
cord-005453-4057qib7	13095	45	-	-	HYPH
cord-005453-4057qib7	13095	46	containing	contain	VBG
cord-005453-4057qib7	13095	47	heparinized	heparinize	VBN
cord-005453-4057qib7	13095	48	whole	whole	JJ
cord-005453-4057qib7	13095	49	blood	blood	NN
cord-005453-4057qib7	13095	50	(	(	-LRB-
cord-005453-4057qib7	13095	51	n=35	n=35	NN
cord-005453-4057qib7	13095	52	)	)	-RRB-
cord-005453-4057qib7	13095	53	using	use	VBG
cord-005453-4057qib7	13095	54	modulatory	modulatory	JJ
cord-005453-4057qib7	13095	55	kits	kit	NNS
cord-005453-4057qib7	13095	56	(	(	-LRB-
cord-005453-4057qib7	13095	57	various	various	JJ
cord-005453-4057qib7	13095	58	combinations	combination	NNS
cord-005453-4057qib7	13095	59	of	of	IN
cord-005453-4057qib7	13095	60	2	2	CD
cord-005453-4057qib7	13095	61	-	-	SYM
cord-005453-4057qib7	13095	62	3	3	CD
cord-005453-4057qib7	13095	63	clinically	clinically	RB
cord-005453-4057qib7	13095	64	approved	approve	VBN
cord-005453-4057qib7	13095	65	response	response	NN
cord-005453-4057qib7	13095	66	-	-	HYPH
cord-005453-4057qib7	13095	67	modifiers	modifier	NNS
cord-005453-4057qib7	13095	68	,	,	,
cord-005453-4057qib7	13095	69	"	"	''
cord-005453-4057qib7	13095	70	WB	WB	NNP
cord-005453-4057qib7	13095	71	-	-	HYPH
cord-005453-4057qib7	13095	72	kits	kit	NNS
cord-005453-4057qib7	13095	73	"	"	''
cord-005453-4057qib7	13095	74	,	,	,
cord-005453-4057qib7	13095	75	patent	patent	NN
cord-005453-4057qib7	13095	76	102014014993	102014014993	CD
cord-005453-4057qib7	13095	77	)	)	-RRB-
cord-005453-4057qib7	13095	78	and	and	CC
cord-005453-4057qib7	13095	79	correlated	correlate	VBN
cord-005453-4057qib7	13095	80	statistically	statistically	RB
cord-005453-4057qib7	13095	81	(	(	-LRB-
cord-005453-4057qib7	13095	82	T-/U	t-/u	JJ
cord-005453-4057qib7	13095	83	-	-	HYPH
cord-005453-4057qib7	13095	84	test	test	NN
cord-005453-4057qib7	13095	85	,	,	,
cord-005453-4057qib7	13095	86	Pearsons	Pearsons	NNP
cord-005453-4057qib7	13095	87	correlation	correlation	NN
cord-005453-4057qib7	13095	88	,	,	,
cord-005453-4057qib7	13095	89	#	#	NN
cord-005453-4057qib7	13095	90	means	mean	VBZ
cord-005453-4057qib7	13095	91	significant	significant	JJ
cord-005453-4057qib7	13095	92	)	)	-RRB-
cord-005453-4057qib7	13095	93	proportions	proportion	NNS
cord-005453-4057qib7	13095	94	of	of	IN
cord-005453-4057qib7	13095	95	DC-/T	dc-/t	JJ
cord-005453-4057qib7	13095	96	-	-	HYPH
cord-005453-4057qib7	13095	97	cell	cell	NN
cord-005453-4057qib7	13095	98	-	-	HYPH
cord-005453-4057qib7	13095	99	subtypes	subtype	NNS
cord-005453-4057qib7	13095	100	/	/	SYM
cord-005453-4057qib7	13095	101	cytokine	cytokine	NN
cord-005453-4057qib7	13095	102	-	-	HYPH
cord-005453-4057qib7	13095	103	profiles	profile	NNS
cord-005453-4057qib7	13095	104	with	with	IN
cord-005453-4057qib7	13095	105	T	T	NNP
cord-005453-4057qib7	13095	106	-	-	HYPH
cord-005453-4057qib7	13095	107	cells	cell	NNS
cord-005453-4057qib7	13095	108	'	'	POS
cord-005453-4057qib7	13095	109	antileukemic	antileukemic	NN
cord-005453-4057qib7	13095	110	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13095	111	(	(	-LRB-
cord-005453-4057qib7	13095	112	CTX	CTX	NNP
cord-005453-4057qib7	13095	113	)	)	-RRB-
cord-005453-4057qib7	13095	114	,	,	,
cord-005453-4057qib7	13095	115	achieved	achieve	VBN
cord-005453-4057qib7	13095	116	after	after	IN
cord-005453-4057qib7	13095	117	mixed	mixed	JJ
cord-005453-4057qib7	13095	118	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	13095	119	culture	culture	NN
cord-005453-4057qib7	13095	120	(	(	-LRB-
cord-005453-4057qib7	13095	121	MLC	MLC	NNP
cord-005453-4057qib7	13095	122	)	)	-RRB-
cord-005453-4057qib7	13095	123	with	with	IN
cord-005453-4057qib7	13095	124	/	/	SYM
cord-005453-4057qib7	13095	125	without	without	IN
cord-005453-4057qib7	13095	126	MNCmethod-("T*DC	MNCmethod-("T*DC	NNP
cord-005453-4057qib7	13095	127	MNC	MNC	NNP
cord-005453-4057qib7	13095	128	"	"	''
cord-005453-4057qib7	13095	129	/"T*Bla	/"T*Bla	.
cord-005453-4057qib7	13096	1	MNC	MNC	NNP
cord-005453-4057qib7	13096	2	")	")	''
cord-005453-4057qib7	13096	3	or	or	CC
cord-005453-4057qib7	13096	4	WB	WB	NNP
cord-005453-4057qib7	13096	5	-	-	HYPH
cord-005453-4057qib7	13096	6	kit	kit	NN
cord-005453-4057qib7	13096	7	-	-	HYPH
cord-005453-4057qib7	13096	8	treated	treat	VBN
cord-005453-4057qib7	13096	9	cultures	culture	NNS
cord-005453-4057qib7	13096	10	(	(	-LRB-
cord-005453-4057qib7	13096	11	"	"	``
cord-005453-4057qib7	13096	12	T*DC	T*DC	NNP
cord-005453-4057qib7	13096	13	WB	WB	NNP
cord-005453-4057qib7	13096	14	"	"	''
cord-005453-4057qib7	13096	15	/T*Bla	/T*Bla	.
cord-005453-4057qib7	13097	1	WB	WB	NNP
cord-005453-4057qib7	13097	2	")	")	''
cord-005453-4057qib7	13097	3	.	.	.
cord-005453-4057qib7	13098	1	CTX	CTX	NNP
cord-005453-4057qib7	13098	2	was	be	VBD
cord-005453-4057qib7	13098	3	given	give	VBN
cord-005453-4057qib7	13098	4	as	as	IN
cord-005453-4057qib7	13098	5	proportions	proportion	NNS
cord-005453-4057qib7	13098	6	of	of	IN
cord-005453-4057qib7	13098	7	cases	case	NNS
cord-005453-4057qib7	13098	8	with	with	IN
cord-005453-4057qib7	13098	9	achieved	achieve	VBN
cord-005453-4057qib7	13098	10	or	or	CC
cord-005453-4057qib7	13098	11	"	"	``
cord-005453-4057qib7	13098	12	improved	improve	VBN
cord-005453-4057qib7	13098	13	"	"	''
cord-005453-4057qib7	13098	14	blast	blast	NN
cord-005453-4057qib7	13098	15	-	-	HYPH
cord-005453-4057qib7	13098	16	lysis	lysis	NN
cord-005453-4057qib7	13098	17	compared	compare	VBN
cord-005453-4057qib7	13098	18	to	to	TO
cord-005453-4057qib7	13098	19	control	control	NN
cord-005453-4057qib7	13098	20	and	and	CC
cord-005453-4057qib7	13098	21	as	as	IN
cord-005453-4057qib7	13098	22	frequencies	frequency	NNS
cord-005453-4057qib7	13098	23	of	of	IN
cord-005453-4057qib7	13098	24	viable	viable	JJ
cord-005453-4057qib7	13098	25	blasts	blast	NNS
cord-005453-4057qib7	13098	26	(	(	-LRB-
cord-005453-4057qib7	13098	27	bla	bla	NNP
cord-005453-4057qib7	13098	28	via	via	IN
cord-005453-4057qib7	13098	29	)	)	-RRB-
cord-005453-4057qib7	13099	1	after	after	IN
cord-005453-4057qib7	13099	2	effector	effector	NN
cord-005453-4057qib7	13099	3	-	-	HYPH
cord-005453-4057qib7	13099	4	cell	cell	NN
cord-005453-4057qib7	13099	5	-	-	HYPH
cord-005453-4057qib7	13099	6	influence	influence	NN
cord-005453-4057qib7	13099	7	.	.	.
cord-005453-4057qib7	13100	1	Pooled	pool	VBN
cord-005453-4057qib7	13100	2	data	datum	NNS
cord-005453-4057qib7	13100	3	and	and	CC
cord-005453-4057qib7	13100	4	data	datum	NNS
cord-005453-4057qib7	13100	5	obtained	obtain	VBN
cord-005453-4057qib7	13100	6	with	with	IN
cord-005453-4057qib7	13100	7	single	single	JJ
cord-005453-4057qib7	13100	8	methods	method	NNS
cord-005453-4057qib7	13100	9	in	in	IN
cord-005453-4057qib7	13100	10	different	different	JJ
cord-005453-4057qib7	13100	11	cohorts	cohort	NNS
cord-005453-4057qib7	13100	12	are	be	VBP
cord-005453-4057qib7	13100	13	given	give	VBN
cord-005453-4057qib7	13100	14	.	.	.
cord-005453-4057qib7	13101	1	Results	result	NNS
cord-005453-4057qib7	13101	2	:	:	:
cord-005453-4057qib7	13101	3	1	1	CD
cord-005453-4057qib7	13101	4	.	.	.
cord-005453-4057qib7	13102	1	Generation	generation	NN
cord-005453-4057qib7	13102	2	of	of	IN
cord-005453-4057qib7	13102	3	DC	DC	NNP
cord-005453-4057qib7	13102	4	/	/	SYM
cord-005453-4057qib7	13102	5	DC	DC	NNP
cord-005453-4057qib7	13102	6	leu	leu	NNP
cord-005453-4057qib7	13102	7	:	:	:
cord-005453-4057qib7	13102	8	with	with	IN
cord-005453-4057qib7	13102	9	a	a	DT
cord-005453-4057qib7	13102	10	)	)	-RRB-
cord-005453-4057qib7	13102	11	MNCmethods	MNCmethods	NNP
cord-005453-4057qib7	13102	12	:	:	:
cord-005453-4057qib7	13103	1	Ø18±15	ø18±15	RB
cord-005453-4057qib7	13103	2	%	%	NN
cord-005453-4057qib7	13103	3	DC	DC	NNP
cord-005453-4057qib7	13103	4	and	and	CC
cord-005453-4057qib7	13103	5	Ø11±10	ø11±10	NN
cord-005453-4057qib7	13103	6	%	%	NN
cord-005453-4057qib7	13103	7	DC	DC	NNP
cord-005453-4057qib7	13103	8	leu	leu	NNP
cord-005453-4057qib7	13103	9	and	and	CC
cord-005453-4057qib7	13103	10	b	b	LS
cord-005453-4057qib7	13103	11	)	)	-RRB-
cord-005453-4057qib7	13103	12	WB	WB	NNP
cord-005453-4057qib7	13103	13	-	-	HYPH
cord-005453-4057qib7	13103	14	kits	kit	NNS
cord-005453-4057qib7	13103	15	:	:	:
cord-005453-4057qib7	13103	16	Ø13±8	ø13±8	JJ
cord-005453-4057qib7	13103	17	%	%	NN
cord-005453-4057qib7	13103	18	DC	DC	NNP
cord-005453-4057qib7	13103	19	and	and	CC
cord-005453-4057qib7	13103	20	Ø11±13	ø11±13	NN
cord-005453-4057qib7	13103	21	%	%	NN
cord-005453-4057qib7	13103	22	DC	DC	NNP
cord-005453-4057qib7	13103	23	leu	leu	NNP
cord-005453-4057qib7	13103	24	without	without	IN
cord-005453-4057qib7	13103	25	induction	induction	NN
cord-005453-4057qib7	13103	26	of	of	IN
cord-005453-4057qib7	13103	27	blasts	blast	NNS
cord-005453-4057qib7	13103	28	'	'	POS
cord-005453-4057qib7	13103	29	proliferation	proliferation	NN
cord-005453-4057qib7	13103	30	.	.	.
cord-005453-4057qib7	13104	1	T	t	NN
cord-005453-4057qib7	13104	2	-	-	HYPH
cord-005453-4057qib7	13104	3	cell	cell	NN
cord-005453-4057qib7	13104	4	-	-	HYPH
cord-005453-4057qib7	13104	5	proliferation	proliferation	NN
cord-005453-4057qib7	13104	6	increased	increase	VBN
cord-005453-4057qib7	13104	7	(	(	-LRB-
cord-005453-4057qib7	13104	8	vs	vs	IN
cord-005453-4057qib7	13104	9	uncultured	uncultured	JJ
cord-005453-4057qib7	13104	10	T	T	NNP
cord-005453-4057qib7	13104	11	-	-	HYPH
cord-005453-4057qib7	13104	12	cells	cell	NNS
cord-005453-4057qib7	13104	13	)	)	-RRB-
cord-005453-4057qib7	13104	14	after	after	IN
cord-005453-4057qib7	13104	15	MLC	MLC	NNP
cord-005453-4057qib7	13104	16	with	with	IN
cord-005453-4057qib7	13104	17	a	a	DT
cord-005453-4057qib7	13104	18	)	)	-RRB-
cord-005453-4057qib7	13104	19	MNC	MNC	NNP
cord-005453-4057qib7	13104	20	-	-	HYPH
cord-005453-4057qib7	13104	21	methods	method	NNS
cord-005453-4057qib7	13104	22	:	:	:
cord-005453-4057qib7	13104	23	Ø34±38	ø34±38	JJ
cord-005453-4057qib7	13104	24	%	%	NN
cord-005453-4057qib7	13104	25	vs	vs	IN
cord-005453-4057qib7	13104	26	Ø7±9	Ø7±9	NNP
cord-005453-4057qib7	13104	27	%	%	NN
cord-005453-4057qib7	13104	28	and	and	CC
cord-005453-4057qib7	13104	29	b	b	LS
cord-005453-4057qib7	13104	30	)	)	-RRB-
cord-005453-4057qib7	13104	31	WB	WB	NNP
cord-005453-4057qib7	13104	32	-	-	HYPH
cord-005453-4057qib7	13104	33	kits	kit	NNS
cord-005453-4057qib7	13104	34	:	:	:
cord-005453-4057qib7	13105	1	Ø63±25	Ø63±25	NNP
cord-005453-4057qib7	13105	2	%	%	NN
cord-005453-4057qib7	13105	3	vs	vs	IN
cord-005453-4057qib7	13105	4	Ø23±20	ø23±20	JJ
cord-005453-4057qib7	13105	5	%	%	NN
cord-005453-4057qib7	13105	6	.	.	.
cord-005453-4057qib7	13106	1	2	2	LS
cord-005453-4057qib7	13106	2	.	.	.
cord-005453-4057qib7	13107	1	Antileukemic	Antileukemic	NNP
cord-005453-4057qib7	13107	2	reactivity	reactivity	NN
cord-005453-4057qib7	13107	3	(	(	-LRB-
cord-005453-4057qib7	13107	4	T	t	NN
cord-005453-4057qib7	13107	5	-	-	HYPH
cord-005453-4057qib7	13107	6	effector	effector	NN
cord-005453-4057qib7	13107	7	-	-	HYPH
cord-005453-4057qib7	13107	8	cell	cell	NN
cord-005453-4057qib7	13107	9	-	-	HYPH
cord-005453-4057qib7	13107	10	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13107	11	after	after	IN
cord-005453-4057qib7	13107	12	MLC	MLC	NNP
cord-005453-4057qib7	13107	13	)	)	-RRB-
cord-005453-4057qib7	13107	14	:	:	:
cord-005453-4057qib7	13108	1	Pooling	pool	VBG
cord-005453-4057qib7	13108	2	all	all	DT
cord-005453-4057qib7	13108	3	data	datum	NNS
cord-005453-4057qib7	13108	4	:	:	:
cord-005453-4057qib7	13108	5	a	a	LS
cord-005453-4057qib7	13108	6	)	)	-RRB-
cord-005453-4057qib7	13108	7	MNC	MNC	NNP
cord-005453-4057qib7	13108	8	-	-	HYPH
cord-005453-4057qib7	13108	9	methods	method	NNS
cord-005453-4057qib7	13108	10	(	(	-LRB-
cord-005453-4057qib7	13108	11	"	"	``
cord-005453-4057qib7	13108	12	T*DC	T*DC	NNP
cord-005453-4057qib7	13108	13	MNC	MNC	NNP
cord-005453-4057qib7	13108	14	"	"	''
cord-005453-4057qib7	13108	15	vs	vs	IN
cord-005453-4057qib7	13108	16	"	"	``
cord-005453-4057qib7	13108	17	T*Bla	t*bla	JJ
cord-005453-4057qib7	13108	18	MNC	MNC	NNP
cord-005453-4057qib7	13108	19	"	"	''
cord-005453-4057qib7	13109	1	):	):	NNP
cord-005453-4057qib7	13110	1	we	-PRON-	PRP
cord-005453-4057qib7	13110	2	found	find	VBD
cord-005453-4057qib7	13110	3	a1	a1	NNP
cord-005453-4057qib7	13110	4	)	)	-RRB-
cord-005453-4057qib7	13111	1	blast	blast	NN
cord-005453-4057qib7	13111	2	-	-	HYPH
cord-005453-4057qib7	13111	3	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13111	4	in	in	IN
cord-005453-4057qib7	13111	5	Ø70%(vs50	ø70%(vs50	CD
cord-005453-4057qib7	13111	6	%	%	NN
cord-005453-4057qib7	13111	7	)	)	-RRB-
cord-005453-4057qib7	13111	8	of	of	IN
cord-005453-4057qib7	13111	9	cases	case	NNS
cord-005453-4057qib7	13111	10	with	with	IN
cord-005453-4057qib7	13111	11	Ø59%(vs117	Ø59%(vs117	NNP
cord-005453-4057qib7	13111	12	%	%	NN
cord-005453-4057qib7	13111	13	)	)	-RRB-
cord-005453-4057qib7	13112	1	bla	bla	NNP
cord-005453-4057qib7	13113	1	via	via	IN
cord-005453-4057qib7	13113	2	,	,	,
cord-005453-4057qib7	13113	3	a2	a2	NNP
cord-005453-4057qib7	13113	4	)	)	-RRB-
cord-005453-4057qib7	13114	1	blast	blast	NN
cord-005453-4057qib7	13114	2	-	-	HYPH
cord-005453-4057qib7	13114	3	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13114	4	was	be	VBD
cord-005453-4057qib7	13114	5	improved	improve	VBN
cord-005453-4057qib7	13114	6	(	(	-LRB-
cord-005453-4057qib7	13114	7	vs	vs	IN
cord-005453-4057qib7	13114	8	control	control	NN
cord-005453-4057qib7	13114	9	)	)	-RRB-
cord-005453-4057qib7	13114	10	in	in	IN
cord-005453-4057qib7	13114	11	86	86	CD
cord-005453-4057qib7	13114	12	%	%	NN
cord-005453-4057qib7	13114	13	with	with	IN
cord-005453-4057qib7	13114	14	Ø	Ø	NNP
cord-005453-4057qib7	13114	15	decrease	decrease	NN
cord-005453-4057qib7	13114	16	of	of	IN
cord-005453-4057qib7	13114	17	bla	bla	NN
cord-005453-4057qib7	13114	18	via	via	IN
cord-005453-4057qib7	13114	19	of	of	IN
cord-005453-4057qib7	13114	20	78	78	CD
cord-005453-4057qib7	13114	21	%	%	NN
cord-005453-4057qib7	13114	22	;	;	:
cord-005453-4057qib7	13114	23	b	b	LS
cord-005453-4057qib7	13114	24	)	)	-RRB-
cord-005453-4057qib7	13114	25	WB	WB	NNP
cord-005453-4057qib7	13114	26	-	-	HYPH
cord-005453-4057qib7	13114	27	kits	kit	NNS
cord-005453-4057qib7	13114	28	(	(	-LRB-
cord-005453-4057qib7	13114	29	"	"	``
cord-005453-4057qib7	13114	30	T*DC	T*DC	NNP
cord-005453-4057qib7	13114	31	WB	WB	NNP
cord-005453-4057qib7	13114	32	"	"	''
cord-005453-4057qib7	13114	33	vs	vs	IN
cord-005453-4057qib7	13114	34	"	"	``
cord-005453-4057qib7	13114	35	T*Bla	t*bla	JJ
cord-005453-4057qib7	13114	36	WB	WB	NNP
cord-005453-4057qib7	13114	37	"	"	''
cord-005453-4057qib7	13115	1	):	):	NNP
cord-005453-4057qib7	13116	1	we	-PRON-	PRP
cord-005453-4057qib7	13116	2	found	find	VBD
cord-005453-4057qib7	13116	3	b1	b1	NN
cord-005453-4057qib7	13116	4	)	)	-RRB-
cord-005453-4057qib7	13116	5	blastcytotoxicity	blastcytotoxicity	NN
cord-005453-4057qib7	13116	6	in	in	IN
cord-005453-4057qib7	13116	7	Ø80%(vs71	ø80%(vs71	CD
cord-005453-4057qib7	13116	8	%	%	NN
cord-005453-4057qib7	13116	9	)	)	-RRB-
cord-005453-4057qib7	13116	10	of	of	IN
cord-005453-4057qib7	13116	11	cases	case	NNS
cord-005453-4057qib7	13116	12	with	with	IN
cord-005453-4057qib7	13116	13	Ø68%(vs56	ø68%(vs56	CD
cord-005453-4057qib7	13116	14	%	%	NN
cord-005453-4057qib7	13116	15	)	)	-RRB-
cord-005453-4057qib7	13117	1	bla	bla	NNP
cord-005453-4057qib7	13118	1	via	via	IN
cord-005453-4057qib7	13118	2	,	,	,
cord-005453-4057qib7	13118	3	b2	b2	NN
cord-005453-4057qib7	13118	4	)	)	-RRB-
cord-005453-4057qib7	13119	1	blast	blast	NN
cord-005453-4057qib7	13119	2	-	-	HYPH
cord-005453-4057qib7	13119	3	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13119	4	was	be	VBD
cord-005453-4057qib7	13119	5	improved	improve	VBN
cord-005453-4057qib7	13119	6	(	(	-LRB-
cord-005453-4057qib7	13119	7	vs	vs	IN
cord-005453-4057qib7	13119	8	control	control	NN
cord-005453-4057qib7	13119	9	)	)	-RRB-
cord-005453-4057qib7	13119	10	in	in	IN
cord-005453-4057qib7	13119	11	67	67	CD
cord-005453-4057qib7	13119	12	%	%	NN
cord-005453-4057qib7	13119	13	of	of	IN
cord-005453-4057qib7	13119	14	cases	case	NNS
cord-005453-4057qib7	13119	15	with	with	IN
cord-005453-4057qib7	13119	16	Ø	Ø	NNP
cord-005453-4057qib7	13119	17	decrease	decrease	NN
cord-005453-4057qib7	13119	18	of	of	IN
cord-005453-4057qib7	13119	19	bla	bla	NN
cord-005453-4057qib7	13119	20	via	via	IN
cord-005453-4057qib7	13119	21	of	of	IN
cord-005453-4057qib7	13119	22	43	43	CD
cord-005453-4057qib7	13119	23	%	%	NN
cord-005453-4057qib7	13119	24	.	.	.
cord-005453-4057qib7	13120	1	In	in	IN
cord-005453-4057qib7	13120	2	general	general	JJ
cord-005453-4057qib7	13120	3	,	,	,
cord-005453-4057qib7	13120	4	these	these	DT
cord-005453-4057qib7	13120	5	results	result	NNS
cord-005453-4057qib7	13120	6	could	could	MD
cord-005453-4057qib7	13120	7	be	be	VB
cord-005453-4057qib7	13120	8	confirmed	confirm	VBN
cord-005453-4057qib7	13120	9	with	with	IN
cord-005453-4057qib7	13120	10	single	single	JJ
cord-005453-4057qib7	13120	11	methods	method	NNS
cord-005453-4057qib7	13120	12	:	:	:
cord-005453-4057qib7	13120	13	best	good	JJS
cord-005453-4057qib7	13120	14	MNC	MNC	NNP
cord-005453-4057qib7	13120	15	-	-	HYPH
cord-005453-4057qib7	13120	16	methods	method	NNS
cord-005453-4057qib7	13120	17	were	be	VBD
cord-005453-4057qib7	13120	18	Picibanil	Picibanil	NNP
cord-005453-4057qib7	13120	19	and	and	CC
cord-005453-4057qib7	13120	20	MCM	MCM	NNP
cord-005453-4057qib7	13120	21	-	-	HYPH
cord-005453-4057qib7	13120	22	Mimic	mimic	JJ
cord-005453-4057qib7	13120	23	,	,	,
cord-005453-4057qib7	13120	24	best	good	JJS
cord-005453-4057qib7	13120	25	WBkits	wbkit	NNS
cord-005453-4057qib7	13120	26	were	be	VBD
cord-005453-4057qib7	13120	27	kits	kit	NNS
cord-005453-4057qib7	13120	28	containing	contain	VBG
cord-005453-4057qib7	13120	29	GM	GM	NNP
cord-005453-4057qib7	13120	30	-	-	,
cord-005453-4057qib7	13120	31	CSF+Picibanil	csf+picibanil	NN
cord-005453-4057qib7	13120	32	or	or	CC
cord-005453-4057qib7	13120	33	Prostaglandins	prostaglandin	NNS
cord-005453-4057qib7	13120	34	.	.	.
cord-005453-4057qib7	13121	1	3	3	LS
cord-005453-4057qib7	13121	2	.	.	.
cord-005453-4057qib7	13122	1	Correlations	correlation	NNS
cord-005453-4057qib7	13122	2	:	:	:
cord-005453-4057qib7	13123	1	Pooling	pool	VBG
cord-005453-4057qib7	13123	2	all	all	DT
cord-005453-4057qib7	13123	3	data	datum	NNS
cord-005453-4057qib7	13123	4	:	:	:
cord-005453-4057qib7	13123	5	cases	case	NNS
cord-005453-4057qib7	13123	6	with	with	IN
cord-005453-4057qib7	13123	7	"	"	``
cord-005453-4057qib7	13123	8	improved	improve	VBN
cord-005453-4057qib7	13123	9	"	"	''
cord-005453-4057qib7	13123	10	lysis	lysis	NN
cord-005453-4057qib7	13123	11	(	(	-LRB-
cord-005453-4057qib7	13123	12	vs	vs	IN
cord-005453-4057qib7	13123	13	"	"	``
cord-005453-4057qib7	13123	14	not	not	RB
cord-005453-4057qib7	13123	15	improved	improve	VBN
cord-005453-4057qib7	13123	16	"	"	''
cord-005453-4057qib7	13123	17	lysis	lysis	NN
cord-005453-4057qib7	13123	18	)	)	-RRB-
cord-005453-4057qib7	13123	19	were	be	VBD
cord-005453-4057qib7	13123	20	characterized	characterize	VBN
cord-005453-4057qib7	13123	21	by	by	IN
cord-005453-4057qib7	13123	22	a	a	DT
cord-005453-4057qib7	13123	23	)	)	-RRB-
cord-005453-4057qib7	13123	24	MNC	MNC	NNP
cord-005453-4057qib7	13123	25	-	-	HYPH
cord-005453-4057qib7	13123	26	methods	method	NNS
cord-005453-4057qib7	13123	27	:	:	:
cord-005453-4057qib7	13123	28	increased	increase	VBN
cord-005453-4057qib7	13123	29	proportions	proportion	NNS
cord-005453-4057qib7	13123	30	of	of	IN
cord-005453-4057qib7	13123	31	mature	mature	JJ
cord-005453-4057qib7	13123	32	DC	DC	NNP
cord-005453-4057qib7	13123	33	/	/	SYM
cord-005453-4057qib7	13123	34	cells	cell	NNS
cord-005453-4057qib7	13123	35	(	(	-LRB-
cord-005453-4057qib7	13123	36	Ø46±29	Ø46±29	NNP
cord-005453-4057qib7	13123	37	%	%	NN
cord-005453-4057qib7	13123	38	vs	vs	IN
cord-005453-4057qib7	13123	39	Ø35±20	ø35±20	NN
cord-005453-4057qib7	13123	40	%	%	NN
cord-005453-4057qib7	13123	41	)	)	-RRB-
cord-005453-4057qib7	13123	42	,	,	,
cord-005453-4057qib7	13123	43	DC	DC	NNP
cord-005453-4057qib7	13123	44	leu	leu	NNP
cord-005453-4057qib7	13123	45	/cells	/cells	.
cord-005453-4057qib7	13123	46	(	(	-LRB-
cord-005453-4057qib7	13123	47	Ø10±10	ø10±10	NN
cord-005453-4057qib7	13123	48	%	%	NN
cord-005453-4057qib7	13123	49	vs	vs	IN
cord-005453-4057qib7	13123	50	Ø5±4	ø5±4	CD
cord-005453-4057qib7	13123	51	%	%	NN
cord-005453-4057qib7	13123	52	)	)	-RRB-
cord-005453-4057qib7	13123	53	and	and	CC
cord-005453-4057qib7	13123	54	proliferating	proliferate	VBG
cord-005453-4057qib7	13123	55	T	t	NN
cord-005453-4057qib7	13123	56	-	-	HYPH
cord-005453-4057qib7	13123	57	cells	cell	NNS
cord-005453-4057qib7	13123	58	(	(	-LRB-
cord-005453-4057qib7	13123	59	Ø35±40	ø35±40	NN
cord-005453-4057qib7	13123	60	%	%	NN
cord-005453-4057qib7	13123	61	vs	vs	IN
cord-005453-4057qib7	13123	62	Ø19	Ø19	NNP
cord-005453-4057qib7	13123	63	±14	±14	NNP
cord-005453-4057qib7	13123	64	%	%	NN
cord-005453-4057qib7	13123	65	)	)	-RRB-
cord-005453-4057qib7	13123	66	,	,	,
cord-005453-4057qib7	13123	67	b	b	LS
cord-005453-4057qib7	13123	68	)	)	-RRB-
cord-005453-4057qib7	13123	69	WB	WB	NNP
cord-005453-4057qib7	13123	70	-	-	HYPH
cord-005453-4057qib7	13123	71	methods	method	NNS
cord-005453-4057qib7	13123	72	:	:	:
cord-005453-4057qib7	13123	73	DC	DC	NNP
cord-005453-4057qib7	13123	74	/	/	SYM
cord-005453-4057qib7	13123	75	cells	cell	NNS
cord-005453-4057qib7	13123	76	(	(	-LRB-
cord-005453-4057qib7	13123	77	r=0.781	r=0.781	NNP
cord-005453-4057qib7	13123	78	#	#	NN
cord-005453-4057qib7	13123	79	)	)	-RRB-
cord-005453-4057qib7	13123	80	,	,	,
cord-005453-4057qib7	13123	81	DC	DC	NNP
cord-005453-4057qib7	13123	82	leu	leu	NNP
cord-005453-4057qib7	13123	83	/cells	/cells	.
cord-005453-4057qib7	13123	84	(	(	-LRB-
cord-005453-4057qib7	13123	85	r=0.815	r=0.815	NNP
cord-005453-4057qib7	13123	86	#	#	$
cord-005453-4057qib7	13123	87	)	)	-RRB-
cord-005453-4057qib7	13123	88	,	,	,
cord-005453-4057qib7	13123	89	DC	DC	NNP
cord-005453-4057qib7	13123	90	leu	leu	NNP
cord-005453-4057qib7	13123	91	/bla	/bla	.
cord-005453-4057qib7	13124	1	(	(	-LRB-
cord-005453-4057qib7	13124	2	Ø40±23	Ø40±23	NNP
cord-005453-4057qib7	13124	3	%	%	NN
cord-005453-4057qib7	13124	4	vs	vs	IN
cord-005453-4057qib7	13124	5	Ø29±16	Ø29±16	NNP
cord-005453-4057qib7	13124	6	%	%	NN
cord-005453-4057qib7	13124	7	)	)	-RRB-
cord-005453-4057qib7	13124	8	,	,	,
cord-005453-4057qib7	13124	9	DC	DC	NNP
cord-005453-4057qib7	13124	10	leu	leu	NNP
cord-005453-4057qib7	13124	11	/DC	/DC	.
cord-005453-4057qib7	13125	1	(	(	-LRB-
cord-005453-4057qib7	13125	2	Ø59±22	Ø59±22	NNP
cord-005453-4057qib7	13125	3	%	%	NN
cord-005453-4057qib7	13125	4	vs	vs	IN
cord-005453-4057qib7	13125	5	Ø51±25	ø51±25	NN
cord-005453-4057qib7	13125	6	%	%	NN
cord-005453-4057qib7	13125	7	)	)	-RRB-
cord-005453-4057qib7	13125	8	,	,	,
cord-005453-4057qib7	13125	9	CD8	CD8	NNP
cord-005453-4057qib7	13125	10	+	+	CC
cord-005453-4057qib7	13125	11	T	T	NNP
cord-005453-4057qib7	13125	12	-	-	HYPH
cord-005453-4057qib7	13125	13	cells	cell	NNS
cord-005453-4057qib7	13125	14	(	(	-LRB-
cord-005453-4057qib7	13126	1	Ø58±20	Ø58±20	NNS
cord-005453-4057qib7	13126	2	%	%	NN
cord-005453-4057qib7	13126	3	vs	vs	IN
cord-005453-4057qib7	13126	4	Ø50	Ø50	NNP
cord-005453-4057qib7	13126	5	±24	±24	NNP
cord-005453-4057qib7	13126	6	%	%	NN
cord-005453-4057qib7	13126	7	)	)	-RRB-
cord-005453-4057qib7	13126	8	,	,	,
cord-005453-4057qib7	13126	9	IFN	IFN	NNP
cord-005453-4057qib7	13126	10	-	-	HYPH
cord-005453-4057qib7	13126	11	γ	γ	NNP
cord-005453-4057qib7	13126	12	(	(	-LRB-
cord-005453-4057qib7	13126	13	r=0.868	r=0.868	NNP
cord-005453-4057qib7	13126	14	#	#	NN
cord-005453-4057qib7	13126	15	)	)	-RRB-
cord-005453-4057qib7	13126	16	,	,	.
cord-005453-4057qib7	13127	1	MCP-1	MCP-1	NNP
cord-005453-4057qib7	13128	1	(	(	-LRB-
cord-005453-4057qib7	13128	2	593±242	593±242	CD
cord-005453-4057qib7	13128	3	vs	vs	IN
cord-005453-4057qib7	13128	4	547±223	547±223	CD
cord-005453-4057qib7	13128	5	pg	pg	NN
cord-005453-4057qib7	13128	6	/	/	SYM
cord-005453-4057qib7	13128	7	ml	ml	NN
cord-005453-4057qib7	13128	8	)	)	-RRB-
cord-005453-4057qib7	13128	9	.	.	.
cord-005453-4057qib7	13129	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13129	2	:	:	:
cord-005453-4057qib7	13130	1	Blasts	blast	NNS
cord-005453-4057qib7	13130	2	are	be	VBP
cord-005453-4057qib7	13130	3	regularly	regularly	RB
cord-005453-4057qib7	13130	4	converted	convert	VBN
cord-005453-4057qib7	13130	5	to	to	IN
cord-005453-4057qib7	13130	6	DC	DC	NNP
cord-005453-4057qib7	13130	7	leu	leu	NNP
cord-005453-4057qib7	13130	8	in	in	IN
cord-005453-4057qib7	13130	9	the	the	DT
cord-005453-4057qib7	13130	10	presence	presence	NN
cord-005453-4057qib7	13130	11	of	of	IN
cord-005453-4057qib7	13130	12	MNC	MNC	NNP
cord-005453-4057qib7	13130	13	-	-	HYPH
cord-005453-4057qib7	13130	14	methods	method	NNS
cord-005453-4057qib7	13130	15	and	and	CC
cord-005453-4057qib7	13130	16	WB	WB	NNP
cord-005453-4057qib7	13130	17	-	-	HYPH
cord-005453-4057qib7	13130	18	kits	kit	NNS
cord-005453-4057qib7	13130	19	(	(	-LRB-
cord-005453-4057qib7	13130	20	simulating	simulate	VBG
cord-005453-4057qib7	13130	21	the	the	DT
cord-005453-4057qib7	13130	22	in	in	IN
cord-005453-4057qib7	13130	23	vivo	vivo	NN
cord-005453-4057qib7	13130	24	microenvironment	microenvironment	NN
cord-005453-4057qib7	13130	25	)	)	-RRB-
cord-005453-4057qib7	13130	26	.	.	.
cord-005453-4057qib7	13131	1	T	T	NNP
cord-005453-4057qib7	13131	2	-	-	HYPH
cord-005453-4057qib7	13131	3	cells	cell	NNS
cord-005453-4057qib7	13131	4	'	'	POS
cord-005453-4057qib7	13131	5	coculture	coculture	NN
cord-005453-4057qib7	13131	6	with	with	IN
cord-005453-4057qib7	13131	7	DC/	DC/	-RRB-
cord-005453-4057qib7	13131	8	DC	DC	NNP
cord-005453-4057qib7	13131	9	leu	leu	NNP
cord-005453-4057qib7	13131	10	after	after	IN
cord-005453-4057qib7	13131	11	MLC	MLC	NNP
cord-005453-4057qib7	13131	12	induces	induce	VBZ
cord-005453-4057qib7	13131	13	and	and	CC
cord-005453-4057qib7	13131	14	improves	improve	VBZ
cord-005453-4057qib7	13131	15	antileukemic	antileukemic	NNP
cord-005453-4057qib7	13131	16	T	T	NNP
cord-005453-4057qib7	13131	17	-	-	HYPH
cord-005453-4057qib7	13131	18	cell	cell	NN
cord-005453-4057qib7	13131	19	activation	activation	NN
cord-005453-4057qib7	13131	20	compared	compare	VBN
cord-005453-4057qib7	13131	21	to	to	IN
cord-005453-4057qib7	13131	22	controls	control	NNS
cord-005453-4057qib7	13131	23	.	.	.
cord-005453-4057qib7	13132	1	Blast	blast	NN
cord-005453-4057qib7	13132	2	-	-	HYPH
cord-005453-4057qib7	13132	3	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13132	4	correlates	correlate	VBZ
cord-005453-4057qib7	13132	5	with	with	IN
cord-005453-4057qib7	13132	6	proportions	proportion	NNS
cord-005453-4057qib7	13132	7	of	of	IN
cord-005453-4057qib7	13132	8	DC	DC	NNP
cord-005453-4057qib7	13132	9	/	/	SYM
cord-005453-4057qib7	13132	10	DC	DC	NNP
cord-005453-4057qib7	13132	11	leu	leu	NNP
cord-005453-4057qib7	13132	12	-and	-and	HYPH
cord-005453-4057qib7	13132	13	T	t	NN
cord-005453-4057qib7	13132	14	-	-	HYPH
cord-005453-4057qib7	13132	15	cell	cell	NN
cord-005453-4057qib7	13132	16	subtypes	subtype	NNS
cord-005453-4057qib7	13132	17	and	and	CC
cord-005453-4057qib7	13132	18	released	release	VBN
cord-005453-4057qib7	13132	19	cytokines	cytokine	NNS
cord-005453-4057qib7	13132	20	.	.	.
cord-005453-4057qib7	13133	1	These	these	DT
cord-005453-4057qib7	13133	2	data	datum	NNS
cord-005453-4057qib7	13133	3	support	support	VBP
cord-005453-4057qib7	13133	4	a	a	DT
cord-005453-4057qib7	13133	5	role	role	NN
cord-005453-4057qib7	13133	6	of	of	IN
cord-005453-4057qib7	13133	7	antigen	antigen	NN
cord-005453-4057qib7	13133	8	presentation	presentation	NN
cord-005453-4057qib7	13133	9	by	by	IN
cord-005453-4057qib7	13133	10	leukemic	leukemic	JJ
cord-005453-4057qib7	13133	11	cells	cell	NNS
cord-005453-4057qib7	13133	12	(	(	-LRB-
cord-005453-4057qib7	13133	13	DC	DC	NNP
cord-005453-4057qib7	13133	14	leu	leu	NNP
cord-005453-4057qib7	13133	15	)	)	-RRB-
cord-005453-4057qib7	13133	16	for	for	IN
cord-005453-4057qib7	13133	17	the	the	DT
cord-005453-4057qib7	13133	18	stimulation	stimulation	NN
cord-005453-4057qib7	13133	19	of	of	IN
cord-005453-4057qib7	13133	20	an	an	DT
cord-005453-4057qib7	13133	21	immune	immune	JJ
cord-005453-4057qib7	13133	22	response	response	NN
cord-005453-4057qib7	13133	23	in	in	IN
cord-005453-4057qib7	13133	24	AML	AML	NNP
cord-005453-4057qib7	13133	25	in	in	IN
cord-005453-4057qib7	13133	26	vitro	vitro	FW
cord-005453-4057qib7	13133	27	and	and	CC
cord-005453-4057qib7	13133	28	possibly	possibly	RB
cord-005453-4057qib7	13133	29	in	in	IN
cord-005453-4057qib7	13133	30	vivo	vivo	NNP
cord-005453-4057qib7	13133	31	.	.	.
cord-005453-4057qib7	13134	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13134	2	:	:	:
cord-005453-4057qib7	13134	3	Nothing	nothing	NN
cord-005453-4057qib7	13134	4	to	to	TO
cord-005453-4057qib7	13134	5	declare	declare	VB
cord-005453-4057qib7	13134	6	Evaluation	Evaluation	NNP
cord-005453-4057qib7	13134	7	1	1	CD
cord-005453-4057qib7	13134	8	year	year	NN
cord-005453-4057qib7	13134	9	after	after	IN
cord-005453-4057qib7	13134	10	the	the	DT
cord-005453-4057qib7	13134	11	launch	launch	NN
cord-005453-4057qib7	13134	12	of	of	IN
cord-005453-4057qib7	13134	13	the	the	DT
cord-005453-4057qib7	13134	14	motion	motion	NN
cord-005453-4057qib7	13134	15	comic	comic	JJ
cord-005453-4057qib7	13134	16	immuno	immuno	NNP
cord-005453-4057qib7	13134	17	-	-	HYPH
cord-005453-4057qib7	13134	18	T	t	JJ
cord-005453-4057qib7	13134	19	,	,	,
cord-005453-4057qib7	13134	20	explaining	explain	VBG
cord-005453-4057qib7	13134	21	patients	patient	NNS
cord-005453-4057qib7	13134	22	and	and	CC
cord-005453-4057qib7	13134	23	their	-PRON-	PRP$
cord-005453-4057qib7	13134	24	caregivers	caregiver	NNS
cord-005453-4057qib7	13134	25	how	how	WRB
cord-005453-4057qib7	13134	26	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	13134	27	strategies	strategy	NNS
cord-005453-4057qib7	13134	28	work	work	VBP
cord-005453-4057qib7	13134	29	Background	background	NN
cord-005453-4057qib7	13134	30	:	:	:
cord-005453-4057qib7	13135	1	One	one	CD
cord-005453-4057qib7	13135	2	year	year	NN
cord-005453-4057qib7	13135	3	ago	ago	RB
cord-005453-4057qib7	13135	4	,	,	,
cord-005453-4057qib7	13135	5	the	the	DT
cord-005453-4057qib7	13135	6	first	first	JJ
cord-005453-4057qib7	13135	7	version	version	NN
cord-005453-4057qib7	13135	8	of	of	IN
cord-005453-4057qib7	13135	9	Immuno	Immuno	NNP
cord-005453-4057qib7	13135	10	-	-	HYPH
cord-005453-4057qib7	13135	11	T	T	NNP
cord-005453-4057qib7	13135	12	,	,	,
cord-005453-4057qib7	13135	13	a	a	DT
cord-005453-4057qib7	13135	14	motion	motion	NN
cord-005453-4057qib7	13135	15	comic	comic	JJ
cord-005453-4057qib7	13135	16	explaining	explaining	NN
cord-005453-4057qib7	13135	17	to	to	IN
cord-005453-4057qib7	13135	18	patients	patient	NNS
cord-005453-4057qib7	13135	19	and	and	CC
cord-005453-4057qib7	13135	20	caregivers	caregiver	NNS
cord-005453-4057qib7	13135	21	how	how	WRB
cord-005453-4057qib7	13135	22	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	13135	23	strategies	strategy	NNS
cord-005453-4057qib7	13135	24	work	work	VBP
cord-005453-4057qib7	13135	25	,	,	,
cord-005453-4057qib7	13135	26	was	be	VBD
cord-005453-4057qib7	13135	27	released	release	VBN
cord-005453-4057qib7	13135	28	.	.	.
cord-005453-4057qib7	13136	1	People	People	NNS
cord-005453-4057qib7	13136	2	were	be	VBD
cord-005453-4057qib7	13136	3	informed	inform	VBN
cord-005453-4057qib7	13136	4	on	on	IN
cord-005453-4057qib7	13136	5	and	and	CC
cord-005453-4057qib7	13136	6	inspired	inspire	VBN
cord-005453-4057qib7	13136	7	to	to	TO
cord-005453-4057qib7	13136	8	use	use	VB
cord-005453-4057qib7	13136	9	the	the	DT
cord-005453-4057qib7	13136	10	application	application	NN
cord-005453-4057qib7	13136	11	during	during	IN
cord-005453-4057qib7	13136	12	(	(	-LRB-
cord-005453-4057qib7	13136	13	inter)national	inter)national	NNP
cord-005453-4057qib7	13136	14	meetings	meeting	NNS
cord-005453-4057qib7	13136	15	and	and	CC
cord-005453-4057qib7	13136	16	events	event	NNS
cord-005453-4057qib7	13136	17	for	for	IN
cord-005453-4057qib7	13136	18	the	the	DT
cord-005453-4057qib7	13136	19	general	general	JJ
cord-005453-4057qib7	13136	20	public	public	NN
cord-005453-4057qib7	13136	21	.	.	.
cord-005453-4057qib7	13137	1	Meanwhile	meanwhile	RB
cord-005453-4057qib7	13137	2	,	,	,
cord-005453-4057qib7	13137	3	the	the	DT
cord-005453-4057qib7	13137	4	motion	motion	NN
cord-005453-4057qib7	13137	5	comic	comic	NN
cord-005453-4057qib7	13137	6	was	be	VBD
cord-005453-4057qib7	13137	7	further	further	RB
cord-005453-4057qib7	13137	8	refined	refine	VBN
cord-005453-4057qib7	13137	9	and	and	CC
cord-005453-4057qib7	13137	10	adapted	adapt	VBN
cord-005453-4057qib7	13137	11	into	into	IN
cord-005453-4057qib7	13137	12	a	a	DT
cord-005453-4057qib7	13137	13	second	second	JJ
cord-005453-4057qib7	13137	14	version	version	NN
cord-005453-4057qib7	13137	15	,	,	,
cord-005453-4057qib7	13137	16	based	base	VBN
cord-005453-4057qib7	13137	17	on	on	IN
cord-005453-4057qib7	13137	18	the	the	DT
cord-005453-4057qib7	13137	19	evaluations	evaluation	NNS
cord-005453-4057qib7	13137	20	we	-PRON-	PRP
cord-005453-4057qib7	13137	21	've	have	VB
cord-005453-4057qib7	13137	22	collected	collect	VBN
cord-005453-4057qib7	13137	23	on	on	IN
cord-005453-4057qib7	13137	24	the	the	DT
cord-005453-4057qib7	13137	25	first	first	JJ
cord-005453-4057qib7	13137	26	version	version	NN
cord-005453-4057qib7	13137	27	.	.	.
cord-005453-4057qib7	13138	1	Adaptations	adaptation	NNS
cord-005453-4057qib7	13138	2	included	include	VBD
cord-005453-4057qib7	13138	3	a	a	DT
cord-005453-4057qib7	13138	4	multi	multi	JJ
cord-005453-4057qib7	13138	5	-	-	JJ
cord-005453-4057qib7	13138	6	language	language	JJ
cord-005453-4057qib7	13138	7	tool	tool	NN
cord-005453-4057qib7	13138	8	(	(	-LRB-
cord-005453-4057qib7	13138	9	currently	currently	RB
cord-005453-4057qib7	13138	10	6	6	CD
cord-005453-4057qib7	13138	11	languages	language	NNS
cord-005453-4057qib7	13138	12	)	)	-RRB-
cord-005453-4057qib7	13138	13	,	,	,
cord-005453-4057qib7	13138	14	increased	increase	VBN
cord-005453-4057qib7	13138	15	user	user	NN
cord-005453-4057qib7	13138	16	friendliness	friendliness	NN
cord-005453-4057qib7	13138	17	,	,	,
cord-005453-4057qib7	13138	18	and	and	CC
cord-005453-4057qib7	13138	19	a	a	DT
cord-005453-4057qib7	13138	20	new	new	JJ
cord-005453-4057qib7	13138	21	supporting	support	VBG
cord-005453-4057qib7	13138	22	musical	musical	JJ
cord-005453-4057qib7	13138	23	score	score	NN
cord-005453-4057qib7	13138	24	.	.	.
cord-005453-4057qib7	13139	1	Also	also	RB
cord-005453-4057qib7	13139	2	,	,	,
cord-005453-4057qib7	13139	3	a	a	DT
cord-005453-4057qib7	13139	4	website	website	NN
cord-005453-4057qib7	13139	5	was	be	VBD
cord-005453-4057qib7	13139	6	launched	launch	VBN
cord-005453-4057qib7	13139	7	from	from	IN
cord-005453-4057qib7	13139	8	which	which	WDT
cord-005453-4057qib7	13139	9	the	the	DT
cord-005453-4057qib7	13139	10	second	second	JJ
cord-005453-4057qib7	13139	11	version	version	NN
cord-005453-4057qib7	13139	12	could	could	MD
cord-005453-4057qib7	13139	13	be	be	VB
cord-005453-4057qib7	13139	14	downloaded	download	VBN
cord-005453-4057qib7	13139	15	on	on	IN
cord-005453-4057qib7	13139	16	tablet	tablet	NN
cord-005453-4057qib7	13139	17	or	or	CC
cord-005453-4057qib7	13139	18	smartphone	smartphone	NN
cord-005453-4057qib7	13139	19	(	(	-LRB-
cord-005453-4057qib7	13139	20	both	both	DT
cord-005453-4057qib7	13139	21	android	android	NNP
cord-005453-4057qib7	13139	22	and	and	CC
cord-005453-4057qib7	13139	23	apple	apple	NNP
cord-005453-4057qib7	13139	24	)	)	-RRB-
cord-005453-4057qib7	13139	25	and	and	CC
cord-005453-4057qib7	13139	26	a	a	DT
cord-005453-4057qib7	13139	27	new	new	JJ
cord-005453-4057qib7	13139	28	online	online	JJ
cord-005453-4057qib7	13139	29	evaluation	evaluation	NN
cord-005453-4057qib7	13139	30	form	form	NN
cord-005453-4057qib7	13139	31	could	could	MD
cord-005453-4057qib7	13139	32	be	be	VB
cord-005453-4057qib7	13139	33	filled	fill	VBN
cord-005453-4057qib7	13139	34	in	in	IN
cord-005453-4057qib7	13139	35	.	.	.
cord-005453-4057qib7	13140	1	In	in	IN
cord-005453-4057qib7	13140	2	10	10	CD
cord-005453-4057qib7	13140	3	months	month	NNS
cord-005453-4057qib7	13140	4	,	,	,
cord-005453-4057qib7	13140	5	40	40	CD
cord-005453-4057qib7	13140	6	people	people	NNS
cord-005453-4057qib7	13140	7	have	have	VBP
cord-005453-4057qib7	13140	8	evaluated	evaluate	VBN
cord-005453-4057qib7	13140	9	the	the	DT
cord-005453-4057qib7	13140	10	motion	motion	NN
cord-005453-4057qib7	13140	11	comic	comic	JJ
cord-005453-4057qib7	13140	12	online	online	RB
cord-005453-4057qib7	13140	13	,	,	,
cord-005453-4057qib7	13140	14	and	and	CC
cord-005453-4057qib7	13140	15	these	these	DT
cord-005453-4057qib7	13140	16	results	result	NNS
cord-005453-4057qib7	13140	17	are	be	VBP
cord-005453-4057qib7	13140	18	presented	present	VBN
cord-005453-4057qib7	13140	19	here	here	RB
cord-005453-4057qib7	13140	20	,	,	,
cord-005453-4057qib7	13140	21	as	as	RB
cord-005453-4057qib7	13140	22	well	well	RB
cord-005453-4057qib7	13140	23	as	as	IN
cord-005453-4057qib7	13140	24	our	-PRON-	PRP$
cord-005453-4057qib7	13140	25	future	future	JJ
cord-005453-4057qib7	13140	26	plans	plan	NNS
cord-005453-4057qib7	13140	27	within	within	IN
cord-005453-4057qib7	13140	28	the	the	DT
cord-005453-4057qib7	13140	29	Immuno	Immuno	NNP
cord-005453-4057qib7	13140	30	-	-	HYPH
cord-005453-4057qib7	13140	31	T	T	NNP
cord-005453-4057qib7	13140	32	program	program	NN
cord-005453-4057qib7	13140	33	.	.	.
cord-005453-4057qib7	13141	1	Methods	method	NNS
cord-005453-4057qib7	13141	2	:	:	:
cord-005453-4057qib7	13141	3	Through	through	IN
cord-005453-4057qib7	13141	4	an	an	DT
cord-005453-4057qib7	13141	5	online	online	JJ
cord-005453-4057qib7	13141	6	questionnaire	questionnaire	NN
cord-005453-4057qib7	13141	7	,	,	,
cord-005453-4057qib7	13141	8	41	41	CD
cord-005453-4057qib7	13141	9	participants	participant	NNS
cord-005453-4057qib7	13141	10	from	from	IN
cord-005453-4057qib7	13141	11	Belgium	Belgium	NNP
cord-005453-4057qib7	13141	12	(	(	-LRB-
cord-005453-4057qib7	13141	13	n=38	n=38	NNP
cord-005453-4057qib7	13141	14	)	)	-RRB-
cord-005453-4057qib7	13141	15	and	and	CC
cord-005453-4057qib7	13141	16	the	the	DT
cord-005453-4057qib7	13141	17	Netherlands	Netherlands	NNP
cord-005453-4057qib7	13141	18	(	(	-LRB-
cord-005453-4057qib7	13141	19	n=3	n=3	NN
cord-005453-4057qib7	13141	20	)	)	-RRB-
cord-005453-4057qib7	13141	21	have	have	VBP
cord-005453-4057qib7	13141	22	evaluated	evaluate	VBN
cord-005453-4057qib7	13141	23	the	the	DT
cord-005453-4057qib7	13141	24	Dutch	dutch	JJ
cord-005453-4057qib7	13141	25	version	version	NN
cord-005453-4057qib7	13141	26	,	,	,
cord-005453-4057qib7	13141	27	and	and	CC
cord-005453-4057qib7	13141	28	4	4	CD
cord-005453-4057qib7	13141	29	Belgian	belgian	JJ
cord-005453-4057qib7	13141	30	participants	participant	NNS
cord-005453-4057qib7	13141	31	evaluated	evaluate	VBD
cord-005453-4057qib7	13141	32	the	the	DT
cord-005453-4057qib7	13141	33	French	french	JJ
cord-005453-4057qib7	13141	34	version	version	NN
cord-005453-4057qib7	13141	35	of	of	IN
cord-005453-4057qib7	13141	36	the	the	DT
cord-005453-4057qib7	13141	37	motion	motion	NN
cord-005453-4057qib7	13141	38	comic	comic	NN
cord-005453-4057qib7	13141	39	.	.	.
cord-005453-4057qib7	13142	1	Results	result	NNS
cord-005453-4057qib7	13142	2	:	:	:
cord-005453-4057qib7	13143	1	The	the	DT
cord-005453-4057qib7	13143	2	total	total	JJ
cord-005453-4057qib7	13143	3	group	group	NN
cord-005453-4057qib7	13143	4	(	(	-LRB-
cord-005453-4057qib7	13143	5	n=45	n=45	NNS
cord-005453-4057qib7	13143	6	)	)	-RRB-
cord-005453-4057qib7	13143	7	consisted	consist	VBD
cord-005453-4057qib7	13143	8	of	of	IN
cord-005453-4057qib7	13143	9	patients	patient	NNS
cord-005453-4057qib7	13143	10	(	(	-LRB-
cord-005453-4057qib7	13143	11	n=15	n=15	NNP
cord-005453-4057qib7	13143	12	)	)	-RRB-
cord-005453-4057qib7	13143	13	and	and	CC
cord-005453-4057qib7	13143	14	their	-PRON-	PRP$
cord-005453-4057qib7	13143	15	families	family	NNS
cord-005453-4057qib7	13143	16	(	(	-LRB-
cord-005453-4057qib7	13143	17	n=2	n=2	NNS
cord-005453-4057qib7	13143	18	)	)	-RRB-
cord-005453-4057qib7	13143	19	,	,	,
cord-005453-4057qib7	13143	20	general	general	JJ
cord-005453-4057qib7	13143	21	public	public	NN
cord-005453-4057qib7	13143	22	(	(	-LRB-
cord-005453-4057qib7	13143	23	n=10	n=10	NNP
cord-005453-4057qib7	13143	24	)	)	-RRB-
cord-005453-4057qib7	13143	25	,	,	,
cord-005453-4057qib7	13143	26	students	student	NNS
cord-005453-4057qib7	13143	27	(	(	-LRB-
cord-005453-4057qib7	13143	28	n=7	n=7	NNS
cord-005453-4057qib7	13143	29	)	)	-RRB-
cord-005453-4057qib7	13143	30	,	,	,
cord-005453-4057qib7	13143	31	health	health	NN
cord-005453-4057qib7	13143	32	care	care	NN
cord-005453-4057qib7	13143	33	professionals	professional	NNS
cord-005453-4057qib7	13143	34	(	(	-LRB-
cord-005453-4057qib7	13143	35	n=4	n=4	NNP
cord-005453-4057qib7	13143	36	)	)	-RRB-
cord-005453-4057qib7	13143	37	,	,	,
cord-005453-4057qib7	13143	38	researchers	researcher	NNS
cord-005453-4057qib7	13143	39	(	(	-LRB-
cord-005453-4057qib7	13143	40	n=5	n=5	NNP
cord-005453-4057qib7	13143	41	)	)	-RRB-
cord-005453-4057qib7	13143	42	and	and	CC
cord-005453-4057qib7	13143	43	kindergarten	kindergarten	NN
cord-005453-4057qib7	13143	44	teachers	teacher	NNS
cord-005453-4057qib7	13143	45	(	(	-LRB-
cord-005453-4057qib7	13143	46	n=2	n=2	NNS
cord-005453-4057qib7	13143	47	)	)	-RRB-
cord-005453-4057qib7	13143	48	.	.	.
cord-005453-4057qib7	13144	1	Participants	participant	NNS
cord-005453-4057qib7	13144	2	'	'	POS
cord-005453-4057qib7	13144	3	age	age	NN
cord-005453-4057qib7	13144	4	ranged	range	VBD
cord-005453-4057qib7	13144	5	from	from	IN
cord-005453-4057qib7	13144	6	19	19	CD
cord-005453-4057qib7	13144	7	to	to	TO
cord-005453-4057qib7	13144	8	80	80	CD
cord-005453-4057qib7	13144	9	years	year	NNS
cord-005453-4057qib7	13144	10	,	,	,
cord-005453-4057qib7	13144	11	with	with	IN
cord-005453-4057qib7	13144	12	an	an	DT
cord-005453-4057qib7	13144	13	even	even	JJ
cord-005453-4057qib7	13144	14	distribution	distribution	NN
cord-005453-4057qib7	13144	15	amongst	amongst	IN
cord-005453-4057qib7	13144	16	the	the	DT
cord-005453-4057qib7	13144	17	different	different	JJ
cord-005453-4057qib7	13144	18	generations	generation	NNS
cord-005453-4057qib7	13144	19	.	.	.
cord-005453-4057qib7	13145	1	The	the	DT
cord-005453-4057qib7	13145	2	majority	majority	NN
cord-005453-4057qib7	13145	3	of	of	IN
cord-005453-4057qib7	13145	4	the	the	DT
cord-005453-4057qib7	13145	5	evaluators	evaluator	NNS
cord-005453-4057qib7	13145	6	(	(	-LRB-
cord-005453-4057qib7	13145	7	97,8	97,8	CD
cord-005453-4057qib7	13145	8	%	%	NN
cord-005453-4057qib7	13145	9	,	,	,
cord-005453-4057qib7	13145	10	n=44	n=44	NNP
cord-005453-4057qib7	13145	11	)	)	-RRB-
cord-005453-4057qib7	13145	12	thought	think	VBD
cord-005453-4057qib7	13145	13	the	the	DT
cord-005453-4057qib7	13145	14	motion	motion	NN
cord-005453-4057qib7	13145	15	comic	comic	NN
cord-005453-4057qib7	13145	16	is	be	VBZ
cord-005453-4057qib7	13145	17	a	a	DT
cord-005453-4057qib7	13145	18	good	good	JJ
cord-005453-4057qib7	13145	19	way	way	NN
cord-005453-4057qib7	13145	20	to	to	TO
cord-005453-4057qib7	13145	21	explain	explain	VB
cord-005453-4057qib7	13145	22	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	13145	23	to	to	IN
cord-005453-4057qib7	13145	24	patients	patient	NNS
cord-005453-4057qib7	13145	25	.	.	.
cord-005453-4057qib7	13146	1	23	23	CD
cord-005453-4057qib7	13146	2	individuals	individual	NNS
cord-005453-4057qib7	13146	3	(	(	-LRB-
cord-005453-4057qib7	13146	4	51,1	51,1	CD
cord-005453-4057qib7	13146	5	%	%	NN
cord-005453-4057qib7	13146	6	)	)	-RRB-
cord-005453-4057qib7	13146	7	felt	feel	VBD
cord-005453-4057qib7	13146	8	mainly	mainly	RB
cord-005453-4057qib7	13146	9	interested	interested	JJ
cord-005453-4057qib7	13146	10	after	after	IN
cord-005453-4057qib7	13146	11	watching	watch	VBG
cord-005453-4057qib7	13146	12	immuno	immuno	NNP
cord-005453-4057qib7	13146	13	-	-	HYPH
cord-005453-4057qib7	13146	14	T	T	NNP
cord-005453-4057qib7	13146	15	,	,	,
cord-005453-4057qib7	13146	16	and	and	CC
cord-005453-4057qib7	13146	17	a	a	DT
cord-005453-4057qib7	13146	18	total	total	NN
cord-005453-4057qib7	13146	19	of	of	IN
cord-005453-4057qib7	13146	20	32	32	CD
cord-005453-4057qib7	13146	21	participants	participant	NNS
cord-005453-4057qib7	13146	22	(	(	-LRB-
cord-005453-4057qib7	13146	23	71,1	71,1	CD
cord-005453-4057qib7	13146	24	%	%	NN
cord-005453-4057qib7	13146	25	)	)	-RRB-
cord-005453-4057qib7	13146	26	felt	feel	VBD
cord-005453-4057qib7	13146	27	hopeful	hopeful	JJ
cord-005453-4057qib7	13146	28	or	or	CC
cord-005453-4057qib7	13146	29	motivated	motivated	JJ
cord-005453-4057qib7	13146	30	.	.	.
cord-005453-4057qib7	13147	1	Focussing	focusse	VBG
cord-005453-4057qib7	13147	2	on	on	IN
cord-005453-4057qib7	13147	3	the	the	DT
cord-005453-4057qib7	13147	4	patient	patient	NN
cord-005453-4057qib7	13147	5	group	group	NN
cord-005453-4057qib7	13147	6	(	(	-LRB-
cord-005453-4057qib7	13147	7	n=15	n=15	NNP
cord-005453-4057qib7	13147	8	)	)	-RRB-
cord-005453-4057qib7	13147	9	,	,	,
cord-005453-4057qib7	13147	10	all	all	DT
cord-005453-4057qib7	13147	11	of	of	IN
cord-005453-4057qib7	13147	12	the	the	DT
cord-005453-4057qib7	13147	13	responders	responder	NNS
cord-005453-4057qib7	13147	14	think	think	VBP
cord-005453-4057qib7	13147	15	the	the	DT
cord-005453-4057qib7	13147	16	Immuno	Immuno	NNP
cord-005453-4057qib7	13147	17	-	-	HYPH
cord-005453-4057qib7	13147	18	T	T	NNP
cord-005453-4057qib7	13147	19	motion	motion	NN
cord-005453-4057qib7	13147	20	comic	comic	NN
cord-005453-4057qib7	13147	21	is	be	VBZ
cord-005453-4057qib7	13147	22	a	a	DT
cord-005453-4057qib7	13147	23	good	good	JJ
cord-005453-4057qib7	13147	24	tool	tool	NN
cord-005453-4057qib7	13147	25	to	to	TO
cord-005453-4057qib7	13147	26	use	use	VB
cord-005453-4057qib7	13147	27	in	in	IN
cord-005453-4057qib7	13147	28	a	a	DT
cord-005453-4057qib7	13147	29	patient	patient	JJ
cord-005453-4057qib7	13147	30	-	-	HYPH
cord-005453-4057qib7	13147	31	doctor	doctor	NN
cord-005453-4057qib7	13147	32	consultation	consultation	NN
cord-005453-4057qib7	13147	33	.	.	.
cord-005453-4057qib7	13148	1	11	11	CD
cord-005453-4057qib7	13148	2	patients	patient	NNS
cord-005453-4057qib7	13148	3	(	(	-LRB-
cord-005453-4057qib7	13148	4	73,3	73,3	CD
cord-005453-4057qib7	13148	5	%	%	NN
cord-005453-4057qib7	13148	6	)	)	-RRB-
cord-005453-4057qib7	13148	7	felt	feel	VBD
cord-005453-4057qib7	13148	8	hopeful	hopeful	JJ
cord-005453-4057qib7	13148	9	and/or	and/or	CC
cord-005453-4057qib7	13148	10	motivated	motivated	JJ
cord-005453-4057qib7	13148	11	after	after	IN
cord-005453-4057qib7	13148	12	watching	watch	VBG
cord-005453-4057qib7	13148	13	the	the	DT
cord-005453-4057qib7	13148	14	whole	whole	JJ
cord-005453-4057qib7	13148	15	motion	motion	NN
cord-005453-4057qib7	13148	16	comic	comic	NN
cord-005453-4057qib7	13148	17	,	,	,
cord-005453-4057qib7	13148	18	while	while	IN
cord-005453-4057qib7	13148	19	3	3	CD
cord-005453-4057qib7	13148	20	of	of	IN
cord-005453-4057qib7	13148	21	them	-PRON-	PRP
cord-005453-4057qib7	13148	22	(	(	-LRB-
cord-005453-4057qib7	13148	23	20	20	CD
cord-005453-4057qib7	13148	24	%	%	NN
cord-005453-4057qib7	13148	25	)	)	-RRB-
cord-005453-4057qib7	13148	26	felt	feel	VBD
cord-005453-4057qib7	13148	27	combative	combative	JJ
cord-005453-4057qib7	13148	28	and	and	CC
cord-005453-4057qib7	13148	29	5	5	CD
cord-005453-4057qib7	13148	30	(	(	-LRB-
cord-005453-4057qib7	13148	31	33,3	33,3	CD
cord-005453-4057qib7	13148	32	%	%	NN
cord-005453-4057qib7	13148	33	)	)	-RRB-
cord-005453-4057qib7	13148	34	felt	feel	VBD
cord-005453-4057qib7	13148	35	gripped	grip	VBN
cord-005453-4057qib7	13148	36	and	and	CC
cord-005453-4057qib7	13148	37	intrigued	intrigued	JJ
cord-005453-4057qib7	13148	38	.	.	.
cord-005453-4057qib7	13149	1	As	as	IN
cord-005453-4057qib7	13149	2	for	for	IN
cord-005453-4057qib7	13149	3	the	the	DT
cord-005453-4057qib7	13149	4	new	new	JJ
cord-005453-4057qib7	13149	5	musical	musical	JJ
cord-005453-4057qib7	13149	6	score	score	NN
cord-005453-4057qib7	13149	7	,	,	,
cord-005453-4057qib7	13149	8	35	35	CD
cord-005453-4057qib7	13149	9	participants	participant	NNS
cord-005453-4057qib7	13149	10	(	(	-LRB-
cord-005453-4057qib7	13149	11	77,7	77,7	CD
cord-005453-4057qib7	13149	12	%	%	NN
cord-005453-4057qib7	13149	13	)	)	-RRB-
cord-005453-4057qib7	13149	14	think	think	VBP
cord-005453-4057qib7	13149	15	the	the	DT
cord-005453-4057qib7	13149	16	music	music	NN
cord-005453-4057qib7	13149	17	is	be	VBZ
cord-005453-4057qib7	13149	18	suitable	suitable	JJ
cord-005453-4057qib7	13149	19	for	for	IN
cord-005453-4057qib7	13149	20	the	the	DT
cord-005453-4057qib7	13149	21	app	app	NN
cord-005453-4057qib7	13149	22	,	,	,
cord-005453-4057qib7	13149	23	while	while	IN
cord-005453-4057qib7	13149	24	6	6	CD
cord-005453-4057qib7	13149	25	evaluators	evaluator	NNS
cord-005453-4057qib7	13149	26	(	(	-LRB-
cord-005453-4057qib7	13149	27	13,3	13,3	CD
cord-005453-4057qib7	13149	28	%	%	NN
cord-005453-4057qib7	13149	29	)	)	-RRB-
cord-005453-4057qib7	13149	30	think	think	VBP
cord-005453-4057qib7	13149	31	the	the	DT
cord-005453-4057qib7	13149	32	new	new	JJ
cord-005453-4057qib7	13149	33	music	music	NN
cord-005453-4057qib7	13149	34	is	be	VBZ
cord-005453-4057qib7	13149	35	not	not	RB
cord-005453-4057qib7	13149	36	or	or	CC
cord-005453-4057qib7	13149	37	not	not	RB
cord-005453-4057qib7	13149	38	at	at	RB
cord-005453-4057qib7	13149	39	all	all	RB
cord-005453-4057qib7	13149	40	fitted	fit	VBN
cord-005453-4057qib7	13149	41	to	to	TO
cord-005453-4057qib7	13149	42	support	support	VB
cord-005453-4057qib7	13149	43	the	the	DT
cord-005453-4057qib7	13149	44	motion	motion	NN
cord-005453-4057qib7	13149	45	comic	comic	NN
cord-005453-4057qib7	13149	46	.	.	.
cord-005453-4057qib7	13150	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13150	2	:	:	:
cord-005453-4057qib7	13151	1	The	the	DT
cord-005453-4057qib7	13151	2	detailed	detailed	JJ
cord-005453-4057qib7	13151	3	evaluations	evaluation	NNS
cord-005453-4057qib7	13151	4	allow	allow	VBP
cord-005453-4057qib7	13151	5	us	-PRON-	PRP
cord-005453-4057qib7	13151	6	to	to	TO
cord-005453-4057qib7	13151	7	further	further	RB
cord-005453-4057qib7	13151	8	improve	improve	VB
cord-005453-4057qib7	13151	9	Immuno	Immuno	NNP
cord-005453-4057qib7	13151	10	-	-	HYPH
cord-005453-4057qib7	13151	11	T	T	NNP
cord-005453-4057qib7	13151	12	,	,	,
cord-005453-4057qib7	13151	13	and	and	CC
cord-005453-4057qib7	13151	14	aid	aid	VB
cord-005453-4057qib7	13151	15	us	-PRON-	PRP
cord-005453-4057qib7	13151	16	in	in	IN
cord-005453-4057qib7	13151	17	the	the	DT
cord-005453-4057qib7	13151	18	development	development	NN
cord-005453-4057qib7	13151	19	of	of	IN
cord-005453-4057qib7	13151	20	other	other	JJ
cord-005453-4057qib7	13151	21	motion	motion	NN
cord-005453-4057qib7	13151	22	comics	comic_strip	NNS
cord-005453-4057qib7	13151	23	we	-PRON-	PRP
cord-005453-4057qib7	13151	24	plan	plan	VBP
cord-005453-4057qib7	13151	25	to	to	TO
cord-005453-4057qib7	13151	26	release	release	VB
cord-005453-4057qib7	13151	27	under	under	IN
cord-005453-4057qib7	13151	28	the	the	DT
cord-005453-4057qib7	13151	29	Cancer	Cancer	NNP
cord-005453-4057qib7	13151	30	-	-	HYPH
cord-005453-4057qib7	13151	31	T	T	NNP
cord-005453-4057qib7	13151	32	in	in	IN
cord-005453-4057qib7	13151	33	motion	motion	NN
cord-005453-4057qib7	13151	34	umbrella	umbrella	NN
cord-005453-4057qib7	13151	35	.	.	.
cord-005453-4057qib7	13152	1	With	with	IN
cord-005453-4057qib7	13152	2	the	the	DT
cord-005453-4057qib7	13152	3	current	current	JJ
cord-005453-4057qib7	13152	4	version	version	NN
cord-005453-4057qib7	13152	5	of	of	IN
cord-005453-4057qib7	13152	6	Immuno	Immuno	NNP
cord-005453-4057qib7	13152	7	-	-	HYPH
cord-005453-4057qib7	13152	8	T	T	NNP
cord-005453-4057qib7	13152	9	,	,	,
cord-005453-4057qib7	13152	10	a	a	DT
cord-005453-4057qib7	13152	11	single	single	JJ
cord-005453-4057qib7	13152	12	-	-	HYPH
cord-005453-4057qib7	13152	13	center	center	NN
cord-005453-4057qib7	13152	14	pilot	pilot	NN
cord-005453-4057qib7	13152	15	study	study	NN
cord-005453-4057qib7	13152	16	is	be	VBZ
cord-005453-4057qib7	13152	17	being	be	VBG
cord-005453-4057qib7	13152	18	set	set	VBN
cord-005453-4057qib7	13152	19	up	up	RP
cord-005453-4057qib7	13152	20	,	,	,
cord-005453-4057qib7	13152	21	to	to	TO
cord-005453-4057qib7	13152	22	test	test	VB
cord-005453-4057qib7	13152	23	the	the	DT
cord-005453-4057qib7	13152	24	efficacy	efficacy	NN
cord-005453-4057qib7	13152	25	and	and	CC
cord-005453-4057qib7	13152	26	usability	usability	NN
cord-005453-4057qib7	13152	27	of	of	IN
cord-005453-4057qib7	13152	28	Immuno	Immuno	NNP
cord-005453-4057qib7	13152	29	-	-	HYPH
cord-005453-4057qib7	13152	30	T	T	NNP
cord-005453-4057qib7	13152	31	,	,	,
cord-005453-4057qib7	13152	32	based	base	VBN
cord-005453-4057qib7	13152	33	on	on	IN
cord-005453-4057qib7	13152	34	qualitative	qualitative	JJ
cord-005453-4057qib7	13152	35	research	research	NN
cord-005453-4057qib7	13152	36	during	during	IN
cord-005453-4057qib7	13152	37	the	the	DT
cord-005453-4057qib7	13152	38	experience	experience	NN
cord-005453-4057qib7	13152	39	of	of	IN
cord-005453-4057qib7	13152	40	the	the	DT
cord-005453-4057qib7	13152	41	tool	tool	NN
cord-005453-4057qib7	13152	42	,	,	,
cord-005453-4057qib7	13152	43	and	and	CC
cord-005453-4057qib7	13152	44	using	use	VBG
cord-005453-4057qib7	13152	45	validated	validate	VBN
cord-005453-4057qib7	13152	46	questionnaires	questionnaire	NNS
cord-005453-4057qib7	13152	47	.	.	.
cord-005453-4057qib7	13153	1	With	with	IN
cord-005453-4057qib7	13153	2	this	this	DT
cord-005453-4057qib7	13153	3	study	study	NN
cord-005453-4057qib7	13153	4	we	-PRON-	PRP
cord-005453-4057qib7	13153	5	want	want	VBP
cord-005453-4057qib7	13153	6	to	to	TO
cord-005453-4057qib7	13153	7	evaluate	evaluate	VB
cord-005453-4057qib7	13153	8	the	the	DT
cord-005453-4057qib7	13153	9	impact	impact	NN
cord-005453-4057qib7	13153	10	of	of	IN
cord-005453-4057qib7	13153	11	Immuno	Immuno	NNP
cord-005453-4057qib7	13153	12	-	-	HYPH
cord-005453-4057qib7	13153	13	T	T	NNP
cord-005453-4057qib7	13153	14	on	on	IN
cord-005453-4057qib7	13153	15	patient	patient	JJ
cord-005453-4057qib7	13153	16	empowerment	empowerment	NN
cord-005453-4057qib7	13153	17	,	,	,
cord-005453-4057qib7	13153	18	and	and	CC
cord-005453-4057qib7	13153	19	the	the	DT
cord-005453-4057qib7	13153	20	decision	decision	NN
cord-005453-4057qib7	13153	21	making	make	VBG
cord-005453-4057qib7	13153	22	process	process	NN
cord-005453-4057qib7	13153	23	.	.	.
cord-005453-4057qib7	13154	1	The	the	DT
cord-005453-4057qib7	13154	2	study	study	NN
cord-005453-4057qib7	13154	3	protocol	protocol	NN
cord-005453-4057qib7	13154	4	will	will	MD
cord-005453-4057qib7	13154	5	be	be	VB
cord-005453-4057qib7	13154	6	presented	present	VBN
cord-005453-4057qib7	13154	7	at	at	IN
cord-005453-4057qib7	13154	8	EBMT	EBMT	NNP
cord-005453-4057qib7	13154	9	.	.	.
cord-005453-4057qib7	13155	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13155	2	:	:	:
cord-005453-4057qib7	13156	1	The	the	DT
cord-005453-4057qib7	13156	2	development	development	NN
cord-005453-4057qib7	13156	3	of	of	IN
cord-005453-4057qib7	13156	4	Immuno	Immuno	NNP
cord-005453-4057qib7	13156	5	-	-	HYPH
cord-005453-4057qib7	13156	6	T	T	NNP
cord-005453-4057qib7	13156	7	was	be	VBD
cord-005453-4057qib7	13156	8	partly	partly	RB
cord-005453-4057qib7	13156	9	financially	financially	RB
cord-005453-4057qib7	13156	10	supported	support	VBN
cord-005453-4057qib7	13156	11	by	by	IN
cord-005453-4057qib7	13156	12	Celyad	Celyad	NNP
cord-005453-4057qib7	13156	13	,	,	,
cord-005453-4057qib7	13156	14	Calgene	Calgene	NNP
cord-005453-4057qib7	13156	15	,	,	,
cord-005453-4057qib7	13156	16	Novartis	Novartis	NNP
cord-005453-4057qib7	13156	17	,	,	,
cord-005453-4057qib7	13156	18	Roche	Roche	NNP
cord-005453-4057qib7	13156	19	,	,	,
cord-005453-4057qib7	13156	20	Amgen	Amgen	NNP
cord-005453-4057qib7	13156	21	,	,	,
cord-005453-4057qib7	13156	22	BMS	BMS	NNP
cord-005453-4057qib7	13156	23	,	,	,
cord-005453-4057qib7	13156	24	but	but	CC
cord-005453-4057qib7	13156	25	these	these	DT
cord-005453-4057qib7	13156	26	companies	company	NNS
cord-005453-4057qib7	13156	27	did	do	VBD
cord-005453-4057qib7	13156	28	not	not	RB
cord-005453-4057qib7	13156	29	by	by	IN
cord-005453-4057qib7	13156	30	any	any	DT
cord-005453-4057qib7	13156	31	means	mean	NNS
cord-005453-4057qib7	13156	32	influence	influence	NN
cord-005453-4057qib7	13156	33	the	the	DT
cord-005453-4057qib7	13156	34	contents	content	NNS
cord-005453-4057qib7	13156	35	and	and	CC
cord-005453-4057qib7	13156	36	development	development	NN
cord-005453-4057qib7	13156	37	of	of	IN
cord-005453-4057qib7	13156	38	the	the	DT
cord-005453-4057qib7	13156	39	motion	motion	NN
cord-005453-4057qib7	13156	40	comic	comic	NN
cord-005453-4057qib7	13156	41	.	.	.
cord-005453-4057qib7	13157	1	A	a	DT
cord-005453-4057qib7	13157	2	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13157	3	strategy	strategy	NN
cord-005453-4057qib7	13157	4	to	to	TO
cord-005453-4057qib7	13157	5	trespass	trespass	VB
cord-005453-4057qib7	13157	6	the	the	DT
cord-005453-4057qib7	13157	7	blood	blood	NN
cord-005453-4057qib7	13157	8	brain	brain	NN
cord-005453-4057qib7	13157	9	barrier	barrier	NN
cord-005453-4057qib7	13157	10	for	for	IN
cord-005453-4057qib7	13157	11	adoptive	adoptive	JJ
cord-005453-4057qib7	13157	12	NK	NK	NNP
cord-005453-4057qib7	13157	13	cell	cell	NN
cord-005453-4057qib7	13157	14	therapy	therapy	NN
cord-005453-4057qib7	13157	15	in	in	IN
cord-005453-4057qib7	13157	16	glioblastoma	glioblastoma	NNP
cord-005453-4057qib7	13157	17	multiforme	multiforme	NN
cord-005453-4057qib7	13157	18	induced	induce	VBN
cord-005453-4057qib7	13157	19	rat	rat	NN
cord-005453-4057qib7	13157	20	:	:	:
cord-005453-4057qib7	13158	1	A	a	DT
cord-005453-4057qib7	13158	2	preclinical	preclinical	JJ
cord-005453-4057qib7	13158	3	study	study	NN
cord-005453-4057qib7	13158	4	Background	background	NN
cord-005453-4057qib7	13158	5	:	:	:
cord-005453-4057qib7	13159	1	Glioblastoma	Glioblastoma	NNP
cord-005453-4057qib7	13159	2	Multiforme	Multiforme	NNP
cord-005453-4057qib7	13159	3	(	(	-LRB-
cord-005453-4057qib7	13159	4	GBM	GBM	NNP
cord-005453-4057qib7	13159	5	)	)	-RRB-
cord-005453-4057qib7	13159	6	is	be	VBZ
cord-005453-4057qib7	13159	7	among	among	IN
cord-005453-4057qib7	13159	8	the	the	DT
cord-005453-4057qib7	13159	9	most	most	RBS
cord-005453-4057qib7	13159	10	common	common	JJ
cord-005453-4057qib7	13159	11	and	and	CC
cord-005453-4057qib7	13159	12	aggressive	aggressive	JJ
cord-005453-4057qib7	13159	13	primary	primary	JJ
cord-005453-4057qib7	13159	14	brain	brain	NN
cord-005453-4057qib7	13159	15	tumors	tumor	NNS
cord-005453-4057qib7	13159	16	with	with	IN
cord-005453-4057qib7	13159	17	very	very	RB
cord-005453-4057qib7	13159	18	poor	poor	JJ
cord-005453-4057qib7	13159	19	prognosis	prognosis	NN
cord-005453-4057qib7	13159	20	.	.	.
cord-005453-4057qib7	13160	1	According	accord	VBG
cord-005453-4057qib7	13160	2	to	to	IN
cord-005453-4057qib7	13160	3	the	the	DT
cord-005453-4057qib7	13160	4	Central	Central	NNP
cord-005453-4057qib7	13160	5	Brain	Brain	NNP
cord-005453-4057qib7	13160	6	Tumor	Tumor	NNP
cord-005453-4057qib7	13160	7	Registry	Registry	NNP
cord-005453-4057qib7	13160	8	of	of	IN
cord-005453-4057qib7	13160	9	the	the	DT
cord-005453-4057qib7	13160	10	United	United	NNP
cord-005453-4057qib7	13160	11	States	States	NNP
cord-005453-4057qib7	13160	12	,	,	,
cord-005453-4057qib7	13160	13	central	central	JJ
cord-005453-4057qib7	13160	14	nervous	nervous	JJ
cord-005453-4057qib7	13160	15	system	system	NN
cord-005453-4057qib7	13160	16	(	(	-LRB-
cord-005453-4057qib7	13160	17	CNS	CNS	NNP
cord-005453-4057qib7	13160	18	)	)	-RRB-
cord-005453-4057qib7	13160	19	tumors	tumor	NNS
cord-005453-4057qib7	13160	20	in	in	IN
cord-005453-4057qib7	13160	21	pediatric	pediatric	JJ
cord-005453-4057qib7	13160	22	patients	patient	NNS
cord-005453-4057qib7	13160	23	(	(	-LRB-
cord-005453-4057qib7	13160	24	ages	age	NNS
cord-005453-4057qib7	13160	25	between	between	IN
cord-005453-4057qib7	13160	26	0	0	CD
cord-005453-4057qib7	13160	27	-	-	SYM
cord-005453-4057qib7	13160	28	14	14	CD
cord-005453-4057qib7	13160	29	years	year	NNS
cord-005453-4057qib7	13160	30	old	old	JJ
cord-005453-4057qib7	13160	31	)	)	-RRB-
cord-005453-4057qib7	13160	32	are	be	VBP
cord-005453-4057qib7	13160	33	the	the	DT
cord-005453-4057qib7	13160	34	second	second	JJ
cord-005453-4057qib7	13160	35	most	most	RBS
cord-005453-4057qib7	13160	36	common	common	JJ
cord-005453-4057qib7	13160	37	malignancies	malignancy	NNS
cord-005453-4057qib7	13160	38	after	after	IN
cord-005453-4057qib7	13160	39	blood	blood	NN
cord-005453-4057qib7	13160	40	-	-	HYPH
cord-005453-4057qib7	13160	41	born	bear	VBN
cord-005453-4057qib7	13160	42	malignancies	malignancy	NNS
cord-005453-4057qib7	13160	43	,	,	,
cord-005453-4057qib7	13160	44	and	and	CC
cord-005453-4057qib7	13160	45	the	the	DT
cord-005453-4057qib7	13160	46	first	first	JJ
cord-005453-4057qib7	13160	47	amongst	amongst	IN
cord-005453-4057qib7	13160	48	solid	solid	JJ
cord-005453-4057qib7	13160	49	tumors	tumor	NNS
cord-005453-4057qib7	13160	50	,	,	,
cord-005453-4057qib7	13160	51	and	and	CC
cord-005453-4057qib7	13160	52	known	know	VBD
cord-005453-4057qib7	13160	53	the	the	DT
cord-005453-4057qib7	13160	54	most	most	RBS
cord-005453-4057qib7	13160	55	common	common	JJ
cord-005453-4057qib7	13160	56	cause	cause	NN
cord-005453-4057qib7	13160	57	of	of	IN
cord-005453-4057qib7	13160	58	cancer	cancer	NN
cord-005453-4057qib7	13160	59	-	-	HYPH
cord-005453-4057qib7	13160	60	related	relate	VBN
cord-005453-4057qib7	13160	61	deaths	death	NNS
cord-005453-4057qib7	13160	62	.	.	.
cord-005453-4057qib7	13161	1	Although	although	IN
cord-005453-4057qib7	13161	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13161	3	stem	stem	NN
cord-005453-4057qib7	13161	4	cell	cell	NN
cord-005453-4057qib7	13161	5	transplantation	transplantation	NN
cord-005453-4057qib7	13161	6	has	have	VBZ
cord-005453-4057qib7	13161	7	been	be	VBN
cord-005453-4057qib7	13161	8	exploited	exploit	VBN
cord-005453-4057qib7	13161	9	to	to	TO
cord-005453-4057qib7	13161	10	treat	treat	VB
cord-005453-4057qib7	13161	11	many	many	JJ
cord-005453-4057qib7	13161	12	kinds	kind	NNS
cord-005453-4057qib7	13161	13	of	of	IN
cord-005453-4057qib7	13161	14	malignancies	malignancy	NNS
cord-005453-4057qib7	13161	15	,	,	,
cord-005453-4057qib7	13161	16	currently	currently	RB
cord-005453-4057qib7	13161	17	its	-PRON-	PRP$
cord-005453-4057qib7	13161	18	success	success	NN
cord-005453-4057qib7	13161	19	rate	rate	NN
cord-005453-4057qib7	13161	20	in	in	IN
cord-005453-4057qib7	13161	21	GBM	GBM	NNP
cord-005453-4057qib7	13161	22	is	be	VBZ
cord-005453-4057qib7	13161	23	limited	limit	VBN
cord-005453-4057qib7	13161	24	.	.	.
cord-005453-4057qib7	13162	1	Therefore	therefore	RB
cord-005453-4057qib7	13162	2	,	,	,
cord-005453-4057qib7	13162	3	the	the	DT
cord-005453-4057qib7	13162	4	GBM	GBM	NNP
cord-005453-4057qib7	13162	5	treatment	treatment	NN
cord-005453-4057qib7	13162	6	paradigm	paradigm	NN
cord-005453-4057qib7	13162	7	needs	need	VBZ
cord-005453-4057qib7	13162	8	shifting	shift	VBG
cord-005453-4057qib7	13162	9	towards	towards	IN
cord-005453-4057qib7	13162	10	more	more	JJR
cord-005453-4057qib7	13162	11	effective	effective	JJ
cord-005453-4057qib7	13162	12	treatments	treatment	NNS
cord-005453-4057qib7	13162	13	such	such	JJ
cord-005453-4057qib7	13162	14	as	as	IN
cord-005453-4057qib7	13162	15	immune	immune	JJ
cord-005453-4057qib7	13162	16	cell	cell	NN
cord-005453-4057qib7	13162	17	therapy	therapy	NN
cord-005453-4057qib7	13162	18	.	.	.
cord-005453-4057qib7	13163	1	Natural	natural	JJ
cord-005453-4057qib7	13163	2	killer	killer	NN
cord-005453-4057qib7	13163	3	(	(	-LRB-
cord-005453-4057qib7	13163	4	NK	NK	NNP
cord-005453-4057qib7	13163	5	)	)	-RRB-
cord-005453-4057qib7	13163	6	cells	cell	NNS
cord-005453-4057qib7	13163	7	have	have	VBP
cord-005453-4057qib7	13163	8	been	be	VBN
cord-005453-4057qib7	13163	9	recognized	recognize	VBN
cord-005453-4057qib7	13163	10	as	as	IN
cord-005453-4057qib7	13163	11	potential	potential	JJ
cord-005453-4057qib7	13163	12	anti	anti	JJ
cord-005453-4057qib7	13163	13	-	-	JJ
cord-005453-4057qib7	13163	14	cancer	cancer	JJ
cord-005453-4057qib7	13163	15	effector	effector	NN
cord-005453-4057qib7	13163	16	cells	cell	NNS
cord-005453-4057qib7	13163	17	,	,	,
cord-005453-4057qib7	13163	18	as	as	IN
cord-005453-4057qib7	13163	19	they	-PRON-	PRP
cord-005453-4057qib7	13163	20	can	can	MD
cord-005453-4057qib7	13163	21	recognize	recognize	VB
cord-005453-4057qib7	13163	22	and	and	CC
cord-005453-4057qib7	13163	23	target	target	VB
cord-005453-4057qib7	13163	24	tumor	tumor	NN
cord-005453-4057qib7	13163	25	cells	cell	NNS
cord-005453-4057qib7	13163	26	.	.	.
cord-005453-4057qib7	13164	1	Since	since	IN
cord-005453-4057qib7	13164	2	a	a	DT
cord-005453-4057qib7	13164	3	small	small	JJ
cord-005453-4057qib7	13164	4	percentage	percentage	NN
cord-005453-4057qib7	13164	5	of	of	IN
cord-005453-4057qib7	13164	6	blood	blood	NN
cord-005453-4057qib7	13164	7	cells	cell	NNS
cord-005453-4057qib7	13164	8	are	be	VBP
cord-005453-4057qib7	13164	9	differentiated	differentiate	VBN
cord-005453-4057qib7	13164	10	as	as	IN
cord-005453-4057qib7	13164	11	NK	NK	NNP
cord-005453-4057qib7	13164	12	cells	cell	NNS
cord-005453-4057qib7	13164	13	,	,	,
cord-005453-4057qib7	13164	14	the	the	DT
cord-005453-4057qib7	13164	15	number	number	NN
cord-005453-4057qib7	13164	16	of	of	IN
cord-005453-4057qib7	13164	17	this	this	DT
cord-005453-4057qib7	13164	18	group	group	NN
cord-005453-4057qib7	13164	19	of	of	IN
cord-005453-4057qib7	13164	20	cells	cell	NNS
cord-005453-4057qib7	13164	21	is	be	VBZ
cord-005453-4057qib7	13164	22	hardly	hardly	RB
cord-005453-4057qib7	13164	23	enough	enough	JJ
cord-005453-4057qib7	13164	24	to	to	TO
cord-005453-4057qib7	13164	25	fight	fight	VB
cord-005453-4057qib7	13164	26	tumors	tumor	NNS
cord-005453-4057qib7	13164	27	,	,	,
cord-005453-4057qib7	13164	28	and	and	CC
cord-005453-4057qib7	13164	29	so	so	RB
cord-005453-4057qib7	13164	30	their	-PRON-	PRP$
cord-005453-4057qib7	13164	31	multiplication	multiplication	NN
cord-005453-4057qib7	13164	32	and	and	CC
cord-005453-4057qib7	13164	33	activation	activation	NN
cord-005453-4057qib7	13164	34	would	would	MD
cord-005453-4057qib7	13164	35	be	be	VB
cord-005453-4057qib7	13164	36	a	a	DT
cord-005453-4057qib7	13164	37	potential	potential	JJ
cord-005453-4057qib7	13164	38	effective	effective	JJ
cord-005453-4057qib7	13164	39	cancer	cancer	NN
cord-005453-4057qib7	13164	40	treatment	treatment	NN
cord-005453-4057qib7	13164	41	.	.	.
cord-005453-4057qib7	13165	1	Methods	method	NNS
cord-005453-4057qib7	13165	2	:	:	:
cord-005453-4057qib7	13166	1	This	this	DT
cord-005453-4057qib7	13166	2	preclinical	preclinical	JJ
cord-005453-4057qib7	13166	3	study	study	NN
cord-005453-4057qib7	13166	4	was	be	VBD
cord-005453-4057qib7	13166	5	focused	focus	VBN
cord-005453-4057qib7	13166	6	on	on	IN
cord-005453-4057qib7	13166	7	setting	set	VBG
cord-005453-4057qib7	13166	8	up	up	RP
cord-005453-4057qib7	13166	9	an	an	DT
cord-005453-4057qib7	13166	10	optimal	optimal	JJ
cord-005453-4057qib7	13166	11	protocol	protocol	NN
cord-005453-4057qib7	13166	12	for	for	IN
cord-005453-4057qib7	13166	13	expansion	expansion	NN
cord-005453-4057qib7	13166	14	and	and	CC
cord-005453-4057qib7	13166	15	activation	activation	NN
cord-005453-4057qib7	13166	16	of	of	IN
cord-005453-4057qib7	13166	17	naïve	naïve	JJ
cord-005453-4057qib7	13166	18	NK	NK	NNP
cord-005453-4057qib7	13166	19	cells	cell	NNS
cord-005453-4057qib7	13166	20	and	and	CC
cord-005453-4057qib7	13166	21	assessing	assess	VBG
cord-005453-4057qib7	13166	22	their	-PRON-	PRP$
cord-005453-4057qib7	13166	23	efficacy	efficacy	NN
cord-005453-4057qib7	13166	24	towards	towards	IN
cord-005453-4057qib7	13166	25	induced	induce	VBN
cord-005453-4057qib7	13166	26	GBM	GBM	NNP
cord-005453-4057qib7	13166	27	in	in	IN
cord-005453-4057qib7	13166	28	rat	rat	NN
cord-005453-4057qib7	13166	29	models	model	NNS
cord-005453-4057qib7	13166	30	.	.	.
cord-005453-4057qib7	13167	1	Ex	Ex	NNP
cord-005453-4057qib7	13167	2	-	-	NN
cord-005453-4057qib7	13167	3	vivo	vivo	NNP
cord-005453-4057qib7	13167	4	expanded	expand	VBD
cord-005453-4057qib7	13167	5	and	and	CC
cord-005453-4057qib7	13167	6	interlukin-2	interlukin-2	NNP
cord-005453-4057qib7	13168	1	(	(	-LRB-
cord-005453-4057qib7	13168	2	IL-2)and	il-2)and	CC
cord-005453-4057qib7	13168	3	heat	heat	NN
cord-005453-4057qib7	13168	4	shock	shock	NN
cord-005453-4057qib7	13168	5	protein-70	protein-70	CD
cord-005453-4057qib7	13169	1	(	(	-LRB-
cord-005453-4057qib7	13169	2	HSP-70)-treated	hsp-70)-treated	JJ
cord-005453-4057qib7	13169	3	NK	NK	NNP
cord-005453-4057qib7	13169	4	cells	cell	NNS
cord-005453-4057qib7	13169	5	have	have	VBP
cord-005453-4057qib7	13169	6	been	be	VBN
cord-005453-4057qib7	13169	7	exploited	exploit	VBN
cord-005453-4057qib7	13169	8	.	.	.
cord-005453-4057qib7	13170	1	After	after	IN
cord-005453-4057qib7	13170	2	in	in	IN
cord-005453-4057qib7	13170	3	vitro	vitro	FW
cord-005453-4057qib7	13170	4	study	study	NN
cord-005453-4057qib7	13170	5	and	and	CC
cord-005453-4057qib7	13170	6	confirming	confirm	VBG
cord-005453-4057qib7	13170	7	the	the	DT
cord-005453-4057qib7	13170	8	efficacy	efficacy	NN
cord-005453-4057qib7	13170	9	of	of	IN
cord-005453-4057qib7	13170	10	treated	treat	VBN
cord-005453-4057qib7	13170	11	cells	cell	NNS
cord-005453-4057qib7	13170	12	through	through	IN
cord-005453-4057qib7	13170	13	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13170	14	assays	assay	NNS
cord-005453-4057qib7	13170	15	,	,	,
cord-005453-4057qib7	13170	16	we	-PRON-	PRP
cord-005453-4057qib7	13170	17	induced	induce	VBD
cord-005453-4057qib7	13170	18	GBM	GBM	NNP
cord-005453-4057qib7	13170	19	in	in	IN
cord-005453-4057qib7	13170	20	6	6	CD
cord-005453-4057qib7	13170	21	male	male	JJ
cord-005453-4057qib7	13170	22	Wistar	Wistar	NNP
cord-005453-4057qib7	13170	23	rats	rat	NNS
cord-005453-4057qib7	13170	24	(	(	-LRB-
cord-005453-4057qib7	13170	25	weighted	weight	VBD
cord-005453-4057qib7	13170	26	275	275	CD
cord-005453-4057qib7	13170	27	-	-	SYM
cord-005453-4057qib7	13170	28	300	300	CD
cord-005453-4057qib7	13170	29	gr	gr	NN
cord-005453-4057qib7	13170	30	)	)	-RRB-
cord-005453-4057qib7	13170	31	using	use	VBG
cord-005453-4057qib7	13170	32	C6	C6	NNP
cord-005453-4057qib7	13170	33	tumor	tumor	NN
cord-005453-4057qib7	13170	34	cells	cell	NNS
cord-005453-4057qib7	13170	35	injection	injection	NN
cord-005453-4057qib7	13170	36	in	in	IN
cord-005453-4057qib7	13170	37	rat	rat	NN
cord-005453-4057qib7	13170	38	brain	brain	NN
cord-005453-4057qib7	13170	39	through	through	IN
cord-005453-4057qib7	13170	40	stereotactic	stereotactic	JJ
cord-005453-4057qib7	13170	41	surgery	surgery	NN
cord-005453-4057qib7	13170	42	.	.	.
cord-005453-4057qib7	13171	1	The	the	DT
cord-005453-4057qib7	13171	2	tumor	tumor	NN
cord-005453-4057qib7	13171	3	formation	formation	NN
cord-005453-4057qib7	13171	4	was	be	VBD
cord-005453-4057qib7	13171	5	proven	prove	VBN
cord-005453-4057qib7	13171	6	by	by	IN
cord-005453-4057qib7	13171	7	MRI	MRI	NNP
cord-005453-4057qib7	13171	8	imaging	imaging	NN
cord-005453-4057qib7	13171	9	.	.	.
cord-005453-4057qib7	13172	1	Following	follow	VBG
cord-005453-4057qib7	13172	2	tumor	tumor	NN
cord-005453-4057qib7	13172	3	establishment	establishment	NN
cord-005453-4057qib7	13172	4	,	,	,
cord-005453-4057qib7	13172	5	we	-PRON-	PRP
cord-005453-4057qib7	13172	6	analyzed	analyze	VBD
cord-005453-4057qib7	13172	7	the	the	DT
cord-005453-4057qib7	13172	8	effect	effect	NN
cord-005453-4057qib7	13172	9	of	of	IN
cord-005453-4057qib7	13172	10	single	single	JJ
cord-005453-4057qib7	13172	11	injection	injection	NN
cord-005453-4057qib7	13172	12	of	of	IN
cord-005453-4057qib7	13172	13	IL-2-and	IL-2-and	NNP
cord-005453-4057qib7	13172	14	HSP-70-treated	HSP-70-treated	NNP
cord-005453-4057qib7	13172	15	NK	NK	NNP
cord-005453-4057qib7	13172	16	cells	cell	NNS
cord-005453-4057qib7	13172	17	compared	compare	VBN
cord-005453-4057qib7	13172	18	with	with	IN
cord-005453-4057qib7	13172	19	single	single	JJ
cord-005453-4057qib7	13172	20	injection	injection	NN
cord-005453-4057qib7	13172	21	of	of	IN
cord-005453-4057qib7	13172	22	non	non	JJ
cord-005453-4057qib7	13172	23	-	-	JJ
cord-005453-4057qib7	13172	24	treated	treated	JJ
cord-005453-4057qib7	13172	25	NK	NK	NNP
cord-005453-4057qib7	13172	26	cells	cell	NNS
cord-005453-4057qib7	13172	27	in	in	IN
cord-005453-4057qib7	13172	28	two	two	CD
cord-005453-4057qib7	13172	29	groups	group	NNS
cord-005453-4057qib7	13172	30	of	of	IN
cord-005453-4057qib7	13172	31	rats	rat	NNS
cord-005453-4057qib7	13172	32	.	.	.
cord-005453-4057qib7	13173	1	Results	result	NNS
cord-005453-4057qib7	13173	2	:	:	:
cord-005453-4057qib7	13174	1	Systemic	systemic	JJ
cord-005453-4057qib7	13174	2	intravenous	intravenous	JJ
cord-005453-4057qib7	13174	3	delivery	delivery	NN
cord-005453-4057qib7	13174	4	of	of	IN
cord-005453-4057qib7	13174	5	IL-2-and	IL-2-and	NNP
cord-005453-4057qib7	13174	6	HSP-70-treated	HSP-70-treated	NNP
cord-005453-4057qib7	13174	7	NK	NK	NNP
cord-005453-4057qib7	13174	8	cells	cell	NNS
cord-005453-4057qib7	13174	9	through	through	IN
cord-005453-4057qib7	13174	10	tail	tail	NN
cord-005453-4057qib7	13174	11	's	's	POS
cord-005453-4057qib7	13174	12	vein	vein	NN
cord-005453-4057qib7	13174	13	resulted	result	VBD
cord-005453-4057qib7	13174	14	in	in	IN
cord-005453-4057qib7	13174	15	tumor	tumor	NN
cord-005453-4057qib7	13174	16	shrinkage	shrinkage	NN
cord-005453-4057qib7	13174	17	in	in	IN
cord-005453-4057qib7	13174	18	different	different	JJ
cord-005453-4057qib7	13174	19	time	time	NN
cord-005453-4057qib7	13174	20	intervals	interval	NNS
cord-005453-4057qib7	13174	21	and	and	CC
cord-005453-4057qib7	13174	22	complete	complete	VB
cord-005453-4057qib7	13174	23	remission	remission	NN
cord-005453-4057qib7	13174	24	in	in	IN
cord-005453-4057qib7	13174	25	the	the	DT
cord-005453-4057qib7	13174	26	first	first	JJ
cord-005453-4057qib7	13174	27	group	group	NN
cord-005453-4057qib7	13174	28	of	of	IN
cord-005453-4057qib7	13174	29	GBM	GBM	NNP
cord-005453-4057qib7	13174	30	-	-	HYPH
cord-005453-4057qib7	13174	31	induced	induce	VBN
cord-005453-4057qib7	13174	32	rat	rat	NN
cord-005453-4057qib7	13174	33	models	model	NNS
cord-005453-4057qib7	13174	34	,	,	,
cord-005453-4057qib7	13174	35	whereas	whereas	IN
cord-005453-4057qib7	13174	36	in	in	IN
cord-005453-4057qib7	13174	37	the	the	DT
cord-005453-4057qib7	13174	38	other	other	JJ
cord-005453-4057qib7	13174	39	group	group	NN
cord-005453-4057qib7	13174	40	of	of	IN
cord-005453-4057qib7	13174	41	GBM	GBM	NNP
cord-005453-4057qib7	13174	42	rats	rat	NNS
cord-005453-4057qib7	13174	43	receiving	receive	VBG
cord-005453-4057qib7	13174	44	untreated	untreated	JJ
cord-005453-4057qib7	13174	45	NK	NK	NNP
cord-005453-4057qib7	13174	46	cells	cell	NNS
cord-005453-4057qib7	13174	47	,	,	,
cord-005453-4057qib7	13174	48	the	the	DT
cord-005453-4057qib7	13174	49	tumor	tumor	NN
cord-005453-4057qib7	13174	50	progressed	progress	VBD
cord-005453-4057qib7	13174	51	.	.	.
cord-005453-4057qib7	13175	1	Therapeutic	therapeutic	JJ
cord-005453-4057qib7	13175	2	efficacy	efficacy	NN
cord-005453-4057qib7	13175	3	of	of	IN
cord-005453-4057qib7	13175	4	the	the	DT
cord-005453-4057qib7	13175	5	treated	treat	VBN
cord-005453-4057qib7	13175	6	NK	NK	NNP
cord-005453-4057qib7	13175	7	cells	cell	NNS
cord-005453-4057qib7	13175	8	was	be	VBD
cord-005453-4057qib7	13175	9	ascertained	ascertain	VBN
cord-005453-4057qib7	13175	10	compared	compare	VBN
cord-005453-4057qib7	13175	11	with	with	IN
cord-005453-4057qib7	13175	12	non	non	JJ
cord-005453-4057qib7	13175	13	-	-	JJ
cord-005453-4057qib7	13175	14	treated	treated	JJ
cord-005453-4057qib7	13175	15	NK	NK	NNP
cord-005453-4057qib7	13175	16	cells	cell	NNS
cord-005453-4057qib7	13175	17	considering	consider	VBG
cord-005453-4057qib7	13175	18	tumor	tumor	NN
cord-005453-4057qib7	13175	19	shrinkage	shrinkage	NN
cord-005453-4057qib7	13175	20	observed	observe	VBN
cord-005453-4057qib7	13175	21	in	in	IN
cord-005453-4057qib7	13175	22	MRI	MRI	NNP
cord-005453-4057qib7	13175	23	and	and	CC
cord-005453-4057qib7	13175	24	survival	survival	NN
cord-005453-4057qib7	13175	25	rates	rate	NNS
cord-005453-4057qib7	13175	26	between	between	IN
cord-005453-4057qib7	13175	27	the	the	DT
cord-005453-4057qib7	13175	28	two	two	CD
cord-005453-4057qib7	13175	29	model	model	NN
cord-005453-4057qib7	13175	30	groups	group	NNS
cord-005453-4057qib7	13175	31	.	.	.
cord-005453-4057qib7	13176	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13176	2	:	:	:
cord-005453-4057qib7	13177	1	The	the	DT
cord-005453-4057qib7	13177	2	amelioration	amelioration	NN
cord-005453-4057qib7	13177	3	of	of	IN
cord-005453-4057qib7	13177	4	tumor	tumor	NN
cord-005453-4057qib7	13177	5	which	which	WDT
cord-005453-4057qib7	13177	6	has	have	VBZ
cord-005453-4057qib7	13177	7	been	be	VBN
cord-005453-4057qib7	13177	8	confirmed	confirm	VBN
cord-005453-4057qib7	13177	9	by	by	IN
cord-005453-4057qib7	13177	10	MRI	MRI	NNP
cord-005453-4057qib7	13177	11	,	,	,
cord-005453-4057qib7	13177	12	proved	prove	VBD
cord-005453-4057qib7	13177	13	the	the	DT
cord-005453-4057qib7	13177	14	migration	migration	NN
cord-005453-4057qib7	13177	15	of	of	IN
cord-005453-4057qib7	13177	16	activated	activate	VBN
cord-005453-4057qib7	13177	17	NK	NK	NNP
cord-005453-4057qib7	13177	18	cells	cell	NNS
cord-005453-4057qib7	13177	19	through	through	IN
cord-005453-4057qib7	13177	20	blood	blood	NN
cord-005453-4057qib7	13177	21	brain	brain	NN
cord-005453-4057qib7	13177	22	barrier	barrier	NN
cord-005453-4057qib7	13177	23	and	and	CC
cord-005453-4057qib7	13177	24	homing	homing	NN
cord-005453-4057qib7	13177	25	to	to	IN
cord-005453-4057qib7	13177	26	CNS	CNS	NNP
cord-005453-4057qib7	13177	27	,	,	,
cord-005453-4057qib7	13177	28	and	and	CC
cord-005453-4057qib7	13177	29	finally	finally	RB
cord-005453-4057qib7	13177	30	targeting	target	VBG
cord-005453-4057qib7	13177	31	GBM	GBM	NNP
cord-005453-4057qib7	13177	32	tumor	tumor	NN
cord-005453-4057qib7	13177	33	cells	cell	NNS
cord-005453-4057qib7	13177	34	.	.	.
cord-005453-4057qib7	13178	1	Our	-PRON-	PRP$
cord-005453-4057qib7	13178	2	data	datum	NNS
cord-005453-4057qib7	13178	3	suggest	suggest	VBP
cord-005453-4057qib7	13178	4	that	that	IN
cord-005453-4057qib7	13178	5	NK	NK	NNP
cord-005453-4057qib7	13178	6	-	-	HYPH
cord-005453-4057qib7	13178	7	cells	cell	NNS
cord-005453-4057qib7	13178	8	treated	treat	VBN
cord-005453-4057qib7	13178	9	with	with	IN
cord-005453-4057qib7	13178	10	IL2	IL2	NNP
cord-005453-4057qib7	13178	11	/	/	SYM
cord-005453-4057qib7	13178	12	HSP70	HSP70	NNP
cord-005453-4057qib7	13178	13	may	may	MD
cord-005453-4057qib7	13178	14	be	be	VB
cord-005453-4057qib7	13178	15	a	a	DT
cord-005453-4057qib7	13178	16	promising	promising	JJ
cord-005453-4057qib7	13178	17	immune	immune	JJ
cord-005453-4057qib7	13178	18	cell	cell	NN
cord-005453-4057qib7	13178	19	-	-	HYPH
cord-005453-4057qib7	13178	20	based	base	VBN
cord-005453-4057qib7	13178	21	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13178	22	approach	approach	NN
cord-005453-4057qib7	13178	23	towards	towards	IN
cord-005453-4057qib7	13178	24	treating	treat	VBG
cord-005453-4057qib7	13178	25	the	the	DT
cord-005453-4057qib7	13178	26	fatal	fatal	JJ
cord-005453-4057qib7	13178	27	GBM	GBM	NNP
cord-005453-4057qib7	13178	28	.	.	.
cord-005453-4057qib7	13179	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13179	2	:	:	:
cord-005453-4057qib7	13179	3	Nothing	nothing	NN
cord-005453-4057qib7	13179	4	to	to	TO
cord-005453-4057qib7	13179	5	declare	declare	VB
cord-005453-4057qib7	13179	6	P592	P592	NNP
cord-005453-4057qib7	13179	7	Abstract	Abstract	NNP
cord-005453-4057qib7	13179	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	13179	9	.	.	.
cord-005453-4057qib7	13180	1	Long	long	JJ
cord-005453-4057qib7	13180	2	term	term	NN
cord-005453-4057qib7	13180	3	sorafenib	sorafenib	NN
cord-005453-4057qib7	13180	4	response	response	NN
cord-005453-4057qib7	13180	5	for	for	IN
cord-005453-4057qib7	13180	6	extramedullary	extramedullary	NNP
cord-005453-4057qib7	13181	1	FLT3	FLT3	NNP
cord-005453-4057qib7	13181	2	+	+	CC
cord-005453-4057qib7	13181	3	AML	AML	NNP
cord-005453-4057qib7	13181	4	relapse	relapse	NN
cord-005453-4057qib7	13181	5	after	after	IN
cord-005453-4057qib7	13181	6	allogeneic	allogeneic	NN
cord-005453-4057qib7	13181	7	stem	stem	NN
cord-005453-4057qib7	13181	8	cell	cell	NN
cord-005453-4057qib7	13181	9	transplantation	transplantation	NN
cord-005453-4057qib7	13181	10	Since	since	IN
cord-005453-4057qib7	13181	11	June	June	NNP
cord-005453-4057qib7	13181	12	2017	2017	CD
cord-005453-4057qib7	13181	13	,	,	,
cord-005453-4057qib7	13181	14	Sorafenib	Sorafenib	NNP
cord-005453-4057qib7	13181	15	dose	dose	NN
cord-005453-4057qib7	13181	16	has	have	VBZ
cord-005453-4057qib7	13181	17	been	be	VBN
cord-005453-4057qib7	13181	18	tapered	taper	VBN
cord-005453-4057qib7	13181	19	to	to	IN
cord-005453-4057qib7	13181	20	200	200	CD
cord-005453-4057qib7	13181	21	mg	mg	NNP
cord-005453-4057qib7	13181	22	/	/	SYM
cord-005453-4057qib7	13181	23	day	day	NN
cord-005453-4057qib7	13181	24	,	,	,
cord-005453-4057qib7	13181	25	due	due	JJ
cord-005453-4057qib7	13181	26	to	to	IN
cord-005453-4057qib7	13181	27	mild	mild	JJ
cord-005453-4057qib7	13181	28	skin	skin	NN
cord-005453-4057qib7	13181	29	and	and	CC
cord-005453-4057qib7	13181	30	GI	gi	NN
cord-005453-4057qib7	13181	31	toxicity	toxicity	NN
cord-005453-4057qib7	13181	32	.	.	.
cord-005453-4057qib7	13182	1	After	after	IN
cord-005453-4057qib7	13182	2	3	3	CD
cord-005453-4057qib7	13182	3	years	year	NNS
cord-005453-4057qib7	13182	4	of	of	IN
cord-005453-4057qib7	13182	5	treatment	treatment	NN
cord-005453-4057qib7	13182	6	,	,	,
cord-005453-4057qib7	13182	7	she	-PRON-	PRP
cord-005453-4057qib7	13182	8	maintains	maintain	VBZ
cord-005453-4057qib7	13182	9	CR	CR	NNP
cord-005453-4057qib7	13182	10	at	at	IN
cord-005453-4057qib7	13182	11	medullary	medullary	JJ
cord-005453-4057qib7	13182	12	and	and	CC
cord-005453-4057qib7	13182	13	extramedulary	extramedulary	JJ
cord-005453-4057qib7	13182	14	levels	level	NNS
cord-005453-4057qib7	13182	15	,	,	,
cord-005453-4057qib7	13182	16	with	with	IN
cord-005453-4057qib7	13182	17	no	no	DT
cord-005453-4057qib7	13182	18	evidence	evidence	NN
cord-005453-4057qib7	13182	19	of	of	IN
cord-005453-4057qib7	13182	20	a	a	DT
cord-005453-4057qib7	13182	21	disease	disease	NN
cord-005453-4057qib7	13182	22	that	that	WDT
cord-005453-4057qib7	13182	23	had	have	VBD
cord-005453-4057qib7	13182	24	escaped	escape	VBN
cord-005453-4057qib7	13182	25	the	the	DT
cord-005453-4057qib7	13182	26	mechanisms	mechanism	NNS
cord-005453-4057qib7	13182	27	of	of	IN
cord-005453-4057qib7	13182	28	action	action	NN
cord-005453-4057qib7	13182	29	of	of	IN
cord-005453-4057qib7	13182	30	chemo	chemo	NN
cord-005453-4057qib7	13182	31	,	,	,
cord-005453-4057qib7	13182	32	HSCT	HSCT	NNP
cord-005453-4057qib7	13182	33	and	and	CC
cord-005453-4057qib7	13182	34	DLI	DLI	NNP
cord-005453-4057qib7	13182	35	.	.	.
cord-005453-4057qib7	13183	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13183	2	:	:	:
cord-005453-4057qib7	13184	1	In	in	IN
cord-005453-4057qib7	13184	2	our	-PRON-	PRP$
cord-005453-4057qib7	13184	3	patient	patient	NN
cord-005453-4057qib7	13184	4	,	,	,
cord-005453-4057qib7	13184	5	treatment	treatment	NN
cord-005453-4057qib7	13184	6	with	with	IN
cord-005453-4057qib7	13184	7	Sorafenib	Sorafenib	NNP
cord-005453-4057qib7	13184	8	has	have	VBZ
cord-005453-4057qib7	13184	9	provided	provide	VBN
cord-005453-4057qib7	13184	10	long	long	JJ
cord-005453-4057qib7	13184	11	-	-	HYPH
cord-005453-4057qib7	13184	12	term	term	NN
cord-005453-4057qib7	13184	13	control	control	NN
cord-005453-4057qib7	13184	14	of	of	IN
cord-005453-4057qib7	13184	15	this	this	DT
cord-005453-4057qib7	13184	16	refractory	refractory	JJ
cord-005453-4057qib7	13184	17	extramedullary	extramedullary	JJ
cord-005453-4057qib7	13184	18	disease	disease	NN
cord-005453-4057qib7	13184	19	,	,	,
cord-005453-4057qib7	13184	20	even	even	RB
cord-005453-4057qib7	13184	21	at	at	IN
cord-005453-4057qib7	13184	22	adjusted	adjust	VBN
cord-005453-4057qib7	13184	23	doses	dose	NNS
cord-005453-4057qib7	13184	24	.	.	.
cord-005453-4057qib7	13185	1	Further	further	JJ
cord-005453-4057qib7	13185	2	studies	study	NNS
cord-005453-4057qib7	13185	3	are	be	VBP
cord-005453-4057qib7	13185	4	needed	need	VBN
cord-005453-4057qib7	13185	5	to	to	TO
cord-005453-4057qib7	13185	6	confirm	confirm	VB
cord-005453-4057qib7	13185	7	the	the	DT
cord-005453-4057qib7	13185	8	efficacy	efficacy	NN
cord-005453-4057qib7	13185	9	of	of	IN
cord-005453-4057qib7	13185	10	FLT3	FLT3	NNP
cord-005453-4057qib7	13185	11	inhibitors	inhibitor	NNS
cord-005453-4057qib7	13185	12	in	in	IN
cord-005453-4057qib7	13185	13	the	the	DT
cord-005453-4057qib7	13185	14	control	control	NN
cord-005453-4057qib7	13185	15	of	of	IN
cord-005453-4057qib7	13185	16	relapses	relapse	NNS
cord-005453-4057qib7	13185	17	after	after	IN
cord-005453-4057qib7	13185	18	allo	allo	NN
cord-005453-4057qib7	13185	19	-	-	HYPH
cord-005453-4057qib7	13185	20	HSCT	HSCT	NNP
cord-005453-4057qib7	13185	21	,	,	,
cord-005453-4057qib7	13185	22	extramedullary	extramedullary	JJ
cord-005453-4057qib7	13185	23	disease	disease	NN
cord-005453-4057qib7	13185	24	and	and	CC
cord-005453-4057qib7	13185	25	its	-PRON-	PRP$
cord-005453-4057qib7	13185	26	potential	potential	JJ
cord-005453-4057qib7	13185	27	role	role	NN
cord-005453-4057qib7	13185	28	as	as	IN
cord-005453-4057qib7	13185	29	maintenance	maintenance	NN
cord-005453-4057qib7	13185	30	agent	agent	NN
cord-005453-4057qib7	13185	31	.	.	.
cord-005453-4057qib7	13186	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13186	2	:	:	:
cord-005453-4057qib7	13186	3	Nothing	nothing	NN
cord-005453-4057qib7	13186	4	to	to	TO
cord-005453-4057qib7	13186	5	declare	declare	VB
cord-005453-4057qib7	13186	6	Background	background	NN
cord-005453-4057qib7	13186	7	:	:	:
cord-005453-4057qib7	13187	1	Although	although	IN
cord-005453-4057qib7	13187	2	chemotherapeutic(CT	chemotherapeutic(CT	NNP
cord-005453-4057qib7	13187	3	)	)	-RRB-
cord-005453-4057qib7	13187	4	agents	agent	NNS
cord-005453-4057qib7	13187	5	that	that	WDT
cord-005453-4057qib7	13187	6	used	use	VBD
cord-005453-4057qib7	13187	7	in	in	IN
cord-005453-4057qib7	13187	8	the	the	DT
cord-005453-4057qib7	13187	9	treatment	treatment	NN
cord-005453-4057qib7	13187	10	of	of	IN
cord-005453-4057qib7	13187	11	acute	acute	JJ
cord-005453-4057qib7	13187	12	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13187	13	leukemia	leukemia	NN
cord-005453-4057qib7	13187	14	(	(	-LRB-
cord-005453-4057qib7	13187	15	ALL	all	DT
cord-005453-4057qib7	13187	16	)	)	-RRB-
cord-005453-4057qib7	13187	17	increase	increase	VB
cord-005453-4057qib7	13187	18	survival	survival	NN
cord-005453-4057qib7	13187	19	,	,	,
cord-005453-4057qib7	13187	20	the	the	DT
cord-005453-4057qib7	13187	21	results	result	NNS
cord-005453-4057qib7	13187	22	are	be	VBP
cord-005453-4057qib7	13187	23	still	still	RB
cord-005453-4057qib7	13187	24	weak	weak	JJ
cord-005453-4057qib7	13187	25	.	.	.
cord-005453-4057qib7	13188	1	Longterm	longterm	JJ
cord-005453-4057qib7	13188	2	survival	survival	NN
cord-005453-4057qib7	13188	3	with	with	IN
cord-005453-4057qib7	13188	4	CT	CT	NNP
cord-005453-4057qib7	13188	5	's	's	POS
cord-005453-4057qib7	13188	6	in	in	IN
cord-005453-4057qib7	13188	7	relapse	relapse	NN
cord-005453-4057qib7	13189	1	ALL	all	DT
cord-005453-4057qib7	13189	2	cases	case	NNS
cord-005453-4057qib7	13189	3	is	be	VBZ
cord-005453-4057qib7	13189	4	difficult	difficult	JJ
cord-005453-4057qib7	13189	5	and	and	CC
cord-005453-4057qib7	13189	6	the	the	DT
cord-005453-4057qib7	13189	7	prognosis	prognosis	NN
cord-005453-4057qib7	13189	8	is	be	VBZ
cord-005453-4057qib7	13189	9	very	very	RB
cord-005453-4057qib7	13189	10	weak	weak	JJ
cord-005453-4057qib7	13189	11	.	.	.
cord-005453-4057qib7	13190	1	Inotuzumab	inotuzumab	JJ
cord-005453-4057qib7	13190	2	ozogamicin	ozogamicin	NN
cord-005453-4057qib7	13190	3	is	be	VBZ
cord-005453-4057qib7	13190	4	an	an	DT
cord-005453-4057qib7	13190	5	anti	anti	JJ
cord-005453-4057qib7	13190	6	-	-	JJ
cord-005453-4057qib7	13190	7	CD	cd	JJ
cord-005453-4057qib7	13190	8	22	22	CD
cord-005453-4057qib7	13190	9	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13190	10	antibody	antibody	NN
cord-005453-4057qib7	13190	11	and	and	CC
cord-005453-4057qib7	13190	12	it	-PRON-	PRP
cord-005453-4057qib7	13190	13	has	have	VBZ
cord-005453-4057qib7	13190	14	the	the	DT
cord-005453-4057qib7	13190	15	potential	potential	NN
cord-005453-4057qib7	13190	16	to	to	TO
cord-005453-4057qib7	13190	17	reduce	reduce	VB
cord-005453-4057qib7	13190	18	the	the	DT
cord-005453-4057qib7	13190	19	overall	overall	JJ
cord-005453-4057qib7	13190	20	toxicity	toxicity	NN
cord-005453-4057qib7	13190	21	of	of	IN
cord-005453-4057qib7	13190	22	intensive	intensive	JJ
cord-005453-4057qib7	13190	23	regimens	regimen	NNS
cord-005453-4057qib7	13190	24	for	for	IN
cord-005453-4057qib7	13190	25	ALL	all	DT
cord-005453-4057qib7	13190	26	,	,	,
cord-005453-4057qib7	13190	27	as	as	RB
cord-005453-4057qib7	13190	28	well	well	RB
cord-005453-4057qib7	13190	29	as	as	IN
cord-005453-4057qib7	13190	30	to	to	TO
cord-005453-4057qib7	13190	31	possibly	possibly	RB
cord-005453-4057qib7	13190	32	increase	increase	VB
cord-005453-4057qib7	13190	33	the	the	DT
cord-005453-4057qib7	13190	34	number	number	NN
cord-005453-4057qib7	13190	35	of	of	IN
cord-005453-4057qib7	13190	36	patients	patient	NNS
cord-005453-4057qib7	13190	37	who	who	WP
cord-005453-4057qib7	13190	38	may	may	MD
cord-005453-4057qib7	13190	39	achieve	achieve	VB
cord-005453-4057qib7	13190	40	a	a	DT
cord-005453-4057qib7	13190	41	state	state	NN
cord-005453-4057qib7	13190	42	of	of	IN
cord-005453-4057qib7	13190	43	minimal	minimal	JJ
cord-005453-4057qib7	13190	44	residual	residual	JJ
cord-005453-4057qib7	13190	45	disease	disease	NN
cord-005453-4057qib7	13190	46	.	.	.
cord-005453-4057qib7	13191	1	Methods	method	NNS
cord-005453-4057qib7	13191	2	:	:	:
cord-005453-4057qib7	13192	1	26-year	26-year	JJ
cord-005453-4057qib7	13192	2	-	-	HYPH
cord-005453-4057qib7	13192	3	old	old	JJ
cord-005453-4057qib7	13192	4	male	male	JJ
cord-005453-4057qib7	13192	5	patient	patient	NN
cord-005453-4057qib7	13192	6	was	be	VBD
cord-005453-4057qib7	13192	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	13192	8	with	with	IN
cord-005453-4057qib7	13192	9	B	b	NN
cord-005453-4057qib7	13192	10	-	-	HYPH
cord-005453-4057qib7	13192	11	cell	cell	NN
cord-005453-4057qib7	13192	12	ALL	all	DT
cord-005453-4057qib7	13192	13	in	in	IN
cord-005453-4057qib7	13192	14	December	December	NNP
cord-005453-4057qib7	13192	15	2017.After	2017.after	CD
cord-005453-4057qib7	13193	1	the	the	DT
cord-005453-4057qib7	13193	2	HOELZER	HOELZER	NNP
cord-005453-4057qib7	13193	3	KT	KT	NNP
cord-005453-4057qib7	13193	4	protocol	protocol	NN
cord-005453-4057qib7	13193	5	was	be	VBD
cord-005453-4057qib7	13193	6	started	start	VBN
cord-005453-4057qib7	13193	7	,	,	,
cord-005453-4057qib7	13193	8	maintenance	maintenance	NN
cord-005453-4057qib7	13193	9	treatment	treatment	NN
cord-005453-4057qib7	13193	10	was	be	VBD
cord-005453-4057qib7	13193	11	continued	continue	VBN
cord-005453-4057qib7	13193	12	.	.	.
cord-005453-4057qib7	13194	1	In	in	IN
cord-005453-4057qib7	13194	2	the	the	DT
cord-005453-4057qib7	13194	3	fifth	fifth	JJ
cord-005453-4057qib7	13194	4	month	month	NN
cord-005453-4057qib7	13194	5	of	of	IN
cord-005453-4057qib7	13194	6	treatment	treatment	NN
cord-005453-4057qib7	13194	7	,	,	,
cord-005453-4057qib7	13194	8	FLAG	FLAG	NNP
cord-005453-4057qib7	13194	9	CT	CT	NNP
cord-005453-4057qib7	13194	10	protocol	protocol	NN
cord-005453-4057qib7	13194	11	was	be	VBD
cord-005453-4057qib7	13194	12	started	start	VBN
cord-005453-4057qib7	13194	13	cause	cause	NN
cord-005453-4057qib7	13194	14	of	of	IN
cord-005453-4057qib7	13194	15	recurrence	recurrence	NN
cord-005453-4057qib7	13194	16	was	be	VBD
cord-005453-4057qib7	13194	17	seen	see	VBN
cord-005453-4057qib7	13194	18	on	on	IN
cord-005453-4057qib7	13194	19	5	5	CD
cord-005453-4057qib7	13194	20	%	%	NN
cord-005453-4057qib7	13194	21	blast	blast	NN
cord-005453-4057qib7	13194	22	detection	detection	NN
cord-005453-4057qib7	13194	23	in	in	IN
cord-005453-4057qib7	13194	24	peripheral	peripheral	JJ
cord-005453-4057qib7	13194	25	blood	blood	NN
cord-005453-4057qib7	13194	26	smear	smear	NN
cord-005453-4057qib7	13194	27	.	.	.
cord-005453-4057qib7	13195	1	In	in	IN
cord-005453-4057qib7	13195	2	August	August	NNP
cord-005453-4057qib7	13195	3	2018	2018	CD
cord-005453-4057qib7	13195	4	,	,	,
cord-005453-4057qib7	13195	5	inotuzumab	inotuzumab	NNS
cord-005453-4057qib7	13195	6	ozogamicin	ozogamicin	NNP
cord-005453-4057qib7	13195	7	treatment	treatment	NN
cord-005453-4057qib7	13195	8	was	be	VBD
cord-005453-4057qib7	13195	9	started	start	VBN
cord-005453-4057qib7	13195	10	and	and	CC
cord-005453-4057qib7	13195	11	six	six	CD
cord-005453-4057qib7	13195	12	cures	cure	NNS
cord-005453-4057qib7	13195	13	were	be	VBD
cord-005453-4057qib7	13195	14	completed	complete	VBN
cord-005453-4057qib7	13195	15	because	because	IN
cord-005453-4057qib7	13195	16	the	the	DT
cord-005453-4057qib7	13195	17	patient	patient	NN
cord-005453-4057qib7	13195	18	was	be	VBD
cord-005453-4057qib7	13195	19	not	not	RB
cord-005453-4057qib7	13195	20	in	in	IN
cord-005453-4057qib7	13195	21	remission	remission	NN
cord-005453-4057qib7	13195	22	.	.	.
cord-005453-4057qib7	13196	1	In	in	IN
cord-005453-4057qib7	13196	2	September	September	NNP
cord-005453-4057qib7	13196	3	2018	2018	CD
cord-005453-4057qib7	13196	4	,	,	,
cord-005453-4057qib7	13196	5	He	-PRON-	PRP
cord-005453-4057qib7	13196	6	had	have	VBD
cord-005453-4057qib7	13196	7	gone	go	VBN
cord-005453-4057qib7	13196	8	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	13196	9	bone	bone	NN
cord-005453-4057qib7	13196	10	marrow	marrow	NN
cord-005453-4057qib7	13196	11	transplantation	transplantation	NN
cord-005453-4057qib7	13196	12	from	from	IN
cord-005453-4057qib7	13196	13	his	-PRON-	PRP$
cord-005453-4057qib7	13196	14	sibling	sibling	NN
cord-005453-4057qib7	13196	15	donor(8/10)with	donor(8/10)with	XX
cord-005453-4057qib7	13197	1	Defibrotid	Defibrotid	NNP
cord-005453-4057qib7	13197	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13197	3	for	for	IN
cord-005453-4057qib7	13197	4	Veno	Veno	NNP
cord-005453-4057qib7	13197	5	-	-	HYPH
cord-005453-4057qib7	13197	6	Occlusive	Occlusive	NNP
cord-005453-4057qib7	13197	7	Disease(VOD)s	Disease(VOD)s	NNP
cord-005453-4057qib7	13197	8	.	.	.
cord-005453-4057qib7	13198	1	He	-PRON-	PRP
cord-005453-4057qib7	13198	2	engrafted	engraft	VBD
cord-005453-4057qib7	13198	3	succesfully	succesfully	RB
cord-005453-4057qib7	13198	4	and	and	CC
cord-005453-4057qib7	13198	5	chimerizm	chimerizm	NNP
cord-005453-4057qib7	13198	6	was	be	VBD
cord-005453-4057qib7	13198	7	99.85	99.85	CD
cord-005453-4057qib7	13198	8	%	%	NN
cord-005453-4057qib7	13198	9	in	in	IN
cord-005453-4057qib7	13198	10	30th	30th	JJ
cord-005453-4057qib7	13198	11	days	day	NNS
cord-005453-4057qib7	13198	12	of	of	IN
cord-005453-4057qib7	13198	13	transplantation	transplantation	NN
cord-005453-4057qib7	13198	14	.	.	.
cord-005453-4057qib7	13199	1	He	-PRON-	PRP
cord-005453-4057qib7	13199	2	is	be	VBZ
cord-005453-4057qib7	13199	3	60th	60th	JJ
cord-005453-4057qib7	13199	4	day	day	NN
cord-005453-4057qib7	13199	5	of	of	IN
cord-005453-4057qib7	13199	6	transplantation	transplantation	NN
cord-005453-4057qib7	13199	7	and	and	CC
cord-005453-4057qib7	13199	8	in	in	IN
cord-005453-4057qib7	13199	9	a	a	DT
cord-005453-4057qib7	13199	10	remission	remission	NN
cord-005453-4057qib7	13199	11	.	.	.
cord-005453-4057qib7	13200	1	Results	result	NNS
cord-005453-4057qib7	13200	2	:	:	:
cord-005453-4057qib7	13201	1	Bone	bone	NN
cord-005453-4057qib7	13201	2	marrow	marrow	NN
cord-005453-4057qib7	13201	3	transplantation	transplantation	NN
cord-005453-4057qib7	13201	4	can	can	MD
cord-005453-4057qib7	13201	5	not	not	RB
cord-005453-4057qib7	13201	6	be	be	VB
cord-005453-4057qib7	13201	7	performed	perform	VBN
cord-005453-4057qib7	13201	8	since	since	IN
cord-005453-4057qib7	13201	9	the	the	DT
cord-005453-4057qib7	13201	10	complete	complete	JJ
cord-005453-4057qib7	13201	11	response	response	NN
cord-005453-4057qib7	13201	12	can	can	MD
cord-005453-4057qib7	13201	13	not	not	RB
cord-005453-4057qib7	13201	14	be	be	VB
cord-005453-4057qib7	13201	15	achieved	achieve	VBN
cord-005453-4057qib7	13201	16	in	in	IN
cord-005453-4057qib7	13201	17	patients	patient	NNS
cord-005453-4057qib7	13201	18	with	with	IN
cord-005453-4057qib7	13201	19	relapse	relapse	NN
cord-005453-4057qib7	13201	20	and	and	CC
cord-005453-4057qib7	13201	21	resistant	resistant	JJ
cord-005453-4057qib7	13201	22	B	b	NN
cord-005453-4057qib7	13201	23	-	-	HYPH
cord-005453-4057qib7	13201	24	ALL.In	all.in	VB
cord-005453-4057qib7	13201	25	these	these	DT
cord-005453-4057qib7	13201	26	patients	patient	NNS
cord-005453-4057qib7	13201	27	,	,	,
cord-005453-4057qib7	13201	28	new	new	JJ
cord-005453-4057qib7	13201	29	therapies	therapy	NNS
cord-005453-4057qib7	13201	30	targeting	target	VBG
cord-005453-4057qib7	13201	31	malignant	malignant	JJ
cord-005453-4057qib7	13201	32	lymphoblasts	lymphoblast	NNS
cord-005453-4057qib7	13201	33	are	be	VBP
cord-005453-4057qib7	13201	34	needed	need	VBN
cord-005453-4057qib7	13201	35	.	.	.
cord-005453-4057qib7	13202	1	Inotuzumab	Inotuzumab	NNP
cord-005453-4057qib7	13202	2	ozogamicinis	ozogamicinis	VBP
cord-005453-4057qib7	13202	3	a	a	DT
cord-005453-4057qib7	13202	4	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13202	5	antibody	antibody	NN
cord-005453-4057qib7	13202	6	drug	drug	NN
cord-005453-4057qib7	13202	7	conjugate	conjugate	NN
cord-005453-4057qib7	13202	8	that	that	WDT
cord-005453-4057qib7	13202	9	targets	target	VBZ
cord-005453-4057qib7	13202	10	CD22	CD22	NNP
cord-005453-4057qib7	13202	11	antigen	antigen	NN
cord-005453-4057qib7	13202	12	on	on	IN
cord-005453-4057qib7	13202	13	malignant	malignant	JJ
cord-005453-4057qib7	13202	14	lymphoblasts	lymphoblast	NNS
cord-005453-4057qib7	13202	15	.	.	.
cord-005453-4057qib7	13203	1	In	in	IN
cord-005453-4057qib7	13203	2	many	many	JJ
cord-005453-4057qib7	13203	3	studies	study	NNS
cord-005453-4057qib7	13203	4	,	,	,
cord-005453-4057qib7	13203	5	it	-PRON-	PRP
cord-005453-4057qib7	13203	6	has	have	VBZ
cord-005453-4057qib7	13203	7	been	be	VBN
cord-005453-4057qib7	13203	8	shown	show	VBN
cord-005453-4057qib7	13203	9	that	that	IN
cord-005453-4057qib7	13203	10	Inotuzumab	Inotuzumab	NNP
cord-005453-4057qib7	13203	11	ozogamycin	ozogamycin	NN
cord-005453-4057qib7	13203	12	is	be	VBZ
cord-005453-4057qib7	13203	13	effective	effective	JJ
cord-005453-4057qib7	13203	14	and	and	CC
cord-005453-4057qib7	13203	15	reliable	reliable	JJ
cord-005453-4057qib7	13203	16	anti	anti	JJ
cord-005453-4057qib7	13203	17	-	-	JJ
cord-005453-4057qib7	13203	18	tumor	tumor	JJ
cord-005453-4057qib7	13203	19	activity	activity	NN
cord-005453-4057qib7	13203	20	in	in	IN
cord-005453-4057qib7	13203	21	adults	adult	NNS
cord-005453-4057qib7	13203	22	with	with	IN
cord-005453-4057qib7	13203	23	recurrent	recurrent	JJ
cord-005453-4057qib7	13203	24	and	and	CC
cord-005453-4057qib7	13203	25	resistant	resistant	JJ
cord-005453-4057qib7	13203	26	CD22	CD22	NNP
cord-005453-4057qib7	13203	27	positive	positive	JJ
cord-005453-4057qib7	13203	28	ALL	all	DT
cord-005453-4057qib7	13203	29	.	.	.
cord-005453-4057qib7	13204	1	However	however	RB
cord-005453-4057qib7	13204	2	,	,	,
cord-005453-4057qib7	13204	3	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13204	4	antibody	antibody	NN
cord-005453-4057qib7	13204	5	drug	drug	NN
cord-005453-4057qib7	13204	6	conjugates	conjugate	NNS
cord-005453-4057qib7	13204	7	have	have	VBP
cord-005453-4057qib7	13204	8	been	be	VBN
cord-005453-4057qib7	13204	9	shown	show	VBN
cord-005453-4057qib7	13204	10	to	to	TO
cord-005453-4057qib7	13204	11	be	be	VB
cord-005453-4057qib7	13204	12	associated	associate	VBN
cord-005453-4057qib7	13204	13	with	with	IN
cord-005453-4057qib7	13204	14	VOD	VOD	NNP
cord-005453-4057qib7	13204	15	's	's	POS
cord-005453-4057qib7	13204	16	.	.	.
cord-005453-4057qib7	13205	1	For	for	IN
cord-005453-4057qib7	13205	2	this	this	DT
cord-005453-4057qib7	13205	3	purpose	purpose	NN
cord-005453-4057qib7	13205	4	,	,	,
cord-005453-4057qib7	13205	5	we	-PRON-	PRP
cord-005453-4057qib7	13205	6	used	use	VBD
cord-005453-4057qib7	13205	7	Defibrotid	Defibrotid	NNP
cord-005453-4057qib7	13205	8	to	to	TO
cord-005453-4057qib7	13205	9	protect	protect	VB
cord-005453-4057qib7	13205	10	our	-PRON-	PRP$
cord-005453-4057qib7	13205	11	patient	patient	NN
cord-005453-4057qib7	13205	12	from	from	IN
cord-005453-4057qib7	13205	13	VOD	VOD	NNP
cord-005453-4057qib7	13205	14	.	.	.
cord-005453-4057qib7	13206	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13206	2	:	:	:
cord-005453-4057qib7	13207	1	Treatment	treatment	NN
cord-005453-4057qib7	13207	2	with	with	IN
cord-005453-4057qib7	13207	3	combination	combination	NN
cord-005453-4057qib7	13207	4	CT	CT	NNP
cord-005453-4057qib7	13207	5	regimens	regimen	NNS
cord-005453-4057qib7	13207	6	in	in	IN
cord-005453-4057qib7	13207	7	B	b	NN
cord-005453-4057qib7	13207	8	-	-	:
cord-005453-4057qib7	13207	9	ALL	all	DT
cord-005453-4057qib7	13207	10	is	be	VBZ
cord-005453-4057qib7	13207	11	suboptimal	suboptimal	JJ
cord-005453-4057qib7	13207	12	and	and	CC
cord-005453-4057qib7	13207	13	long	long	JJ
cord-005453-4057qib7	13207	14	-	-	HYPH
cord-005453-4057qib7	13207	15	term	term	NN
cord-005453-4057qib7	13207	16	survival	survival	NN
cord-005453-4057qib7	13207	17	is	be	VBZ
cord-005453-4057qib7	13207	18	achieved	achieve	VBN
cord-005453-4057qib7	13207	19	in	in	IN
cord-005453-4057qib7	13207	20	only	only	RB
cord-005453-4057qib7	13207	21	30	30	CD
cord-005453-4057qib7	13207	22	-	-	SYM
cord-005453-4057qib7	13207	23	40	40	CD
cord-005453-4057qib7	13207	24	%	%	NN
cord-005453-4057qib7	13207	25	of	of	IN
cord-005453-4057qib7	13207	26	patients	patient	NNS
cord-005453-4057qib7	13207	27	.	.	.
cord-005453-4057qib7	13208	1	Targeted	target	VBN
cord-005453-4057qib7	13208	2	molecular	molecular	JJ
cord-005453-4057qib7	13208	3	therapy	therapy	NN
cord-005453-4057qib7	13208	4	and	and	CC
cord-005453-4057qib7	13208	5	new	new	JJ
cord-005453-4057qib7	13208	6	regimens	regimen	NNS
cord-005453-4057qib7	13208	7	are	be	VBP
cord-005453-4057qib7	13208	8	needed	need	VBN
cord-005453-4057qib7	13208	9	in	in	IN
cord-005453-4057qib7	13208	10	relapse	relapse	NN
cord-005453-4057qib7	13208	11	and	and	CC
cord-005453-4057qib7	13208	12	resistant	resistant	JJ
cord-005453-4057qib7	13208	13	patients	patient	NNS
cord-005453-4057qib7	13208	14	.	.	.
cord-005453-4057qib7	13209	1	At	at	IN
cord-005453-4057qib7	13209	2	this	this	DT
cord-005453-4057qib7	13209	3	point	point	NN
cord-005453-4057qib7	13209	4	,	,	,
cord-005453-4057qib7	13209	5	Inotuzumab	Inotuzumab	NNP
cord-005453-4057qib7	13209	6	ozogamycin	ozogamycin	NN
cord-005453-4057qib7	13209	7	is	be	VBZ
cord-005453-4057qib7	13209	8	an	an	DT
cord-005453-4057qib7	13209	9	anti	anti	JJ
cord-005453-4057qib7	13209	10	-	-	JJ
cord-005453-4057qib7	13209	11	CD-22	cd-22	JJ
cord-005453-4057qib7	13209	12	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13209	13	antibody	antibody	NN
cord-005453-4057qib7	13209	14	,	,	,
cord-005453-4057qib7	13209	15	as	as	IN
cord-005453-4057qib7	13209	16	in	in	IN
cord-005453-4057qib7	13209	17	our	-PRON-	PRP$
cord-005453-4057qib7	13209	18	case	case	NN
cord-005453-4057qib7	13209	19	,	,	,
cord-005453-4057qib7	13209	20	it	-PRON-	PRP
cord-005453-4057qib7	13209	21	provides	provide	VBZ
cord-005453-4057qib7	13209	22	remission	remission	NN
cord-005453-4057qib7	13209	23	in	in	IN
cord-005453-4057qib7	13209	24	recurrent	recurrent	JJ
cord-005453-4057qib7	13209	25	and	and	CC
cord-005453-4057qib7	13209	26	resistant	resistant	JJ
cord-005453-4057qib7	13209	27	B	b	NN
cord-005453-4057qib7	13209	28	-	-	:
cord-005453-4057qib7	13209	29	ALL	all	DT
cord-005453-4057qib7	13209	30	patients	patient	NNS
cord-005453-4057qib7	13209	31	and	and	CC
cord-005453-4057qib7	13209	32	allows	allow	VBZ
cord-005453-4057qib7	13209	33	patients	patient	NNS
cord-005453-4057qib7	13209	34	to	to	TO
cord-005453-4057qib7	13209	35	complete	complete	VB
cord-005453-4057qib7	13209	36	their	-PRON-	PRP$
cord-005453-4057qib7	13209	37	treatment	treatment	NN
cord-005453-4057qib7	13209	38	with	with	IN
cord-005453-4057qib7	13209	39	an	an	DT
cord-005453-4057qib7	13209	40	allogeneic	allogeneic	NN
cord-005453-4057qib7	13209	41	transplant	transplant	NN
cord-005453-4057qib7	13209	42	from	from	IN
cord-005453-4057qib7	13209	43	a	a	DT
cord-005453-4057qib7	13209	44	fully	fully	RB
cord-005453-4057qib7	13209	45	compatible	compatible	JJ
cord-005453-4057qib7	13209	46	donor	donor	NN
cord-005453-4057qib7	13209	47	.	.	.
cord-005453-4057qib7	13210	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13210	2	:	:	:
cord-005453-4057qib7	13210	3	Nothing	nothing	NN
cord-005453-4057qib7	13210	4	to	to	TO
cord-005453-4057qib7	13210	5	declare	declare	VB
cord-005453-4057qib7	13210	6	Background	background	NN
cord-005453-4057qib7	13210	7	:	:	:
cord-005453-4057qib7	13210	8	Mesenchymal	Mesenchymal	NNS
cord-005453-4057qib7	13210	9	stem	stem	VBP
cord-005453-4057qib7	13210	10	cells	cell	NNS
cord-005453-4057qib7	13210	11	(	(	-LRB-
cord-005453-4057qib7	13210	12	MSCs	msc	NNS
cord-005453-4057qib7	13210	13	)	)	-RRB-
cord-005453-4057qib7	13210	14	are	be	VBP
cord-005453-4057qib7	13210	15	an	an	DT
cord-005453-4057qib7	13210	16	attractive	attractive	JJ
cord-005453-4057qib7	13210	17	consideration	consideration	NN
cord-005453-4057qib7	13210	18	for	for	IN
cord-005453-4057qib7	13210	19	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13210	20	cures	cure	NNS
cord-005453-4057qib7	13210	21	of	of	IN
cord-005453-4057qib7	13210	22	many	many	JJ
cord-005453-4057qib7	13210	23	difficult	difficult	JJ
cord-005453-4057qib7	13210	24	diseases	disease	NNS
cord-005453-4057qib7	13210	25	on	on	IN
cord-005453-4057qib7	13210	26	the	the	DT
cord-005453-4057qib7	13210	27	cellular	cellular	JJ
cord-005453-4057qib7	13210	28	-	-	HYPH
cord-005453-4057qib7	13210	29	level	level	NN
cord-005453-4057qib7	13210	30	.	.	.
cord-005453-4057qib7	13211	1	Due	due	IN
cord-005453-4057qib7	13211	2	to	to	IN
cord-005453-4057qib7	13211	3	the	the	DT
cord-005453-4057qib7	13211	4	trophic	trophic	JJ
cord-005453-4057qib7	13211	5	effects	effect	NNS
cord-005453-4057qib7	13211	6	of	of	IN
cord-005453-4057qib7	13211	7	the	the	DT
cord-005453-4057qib7	13211	8	cytokines	cytokine	NNS
cord-005453-4057qib7	13211	9	and	and	CC
cord-005453-4057qib7	13211	10	chemokines	chemokine	NNS
cord-005453-4057qib7	13211	11	that	that	IN
cord-005453-4057qib7	13211	12	they	-PRON-	PRP
cord-005453-4057qib7	13211	13	produce	produce	VBP
cord-005453-4057qib7	13211	14	,	,	,
cord-005453-4057qib7	13211	15	MSCs	msc	NNS
cord-005453-4057qib7	13211	16	have	have	VBP
cord-005453-4057qib7	13211	17	shown	show	VBN
cord-005453-4057qib7	13211	18	multiple	multiple	JJ
cord-005453-4057qib7	13211	19	beneficial	beneficial	JJ
cord-005453-4057qib7	13211	20	properties	property	NNS
cord-005453-4057qib7	13211	21	in	in	IN
cord-005453-4057qib7	13211	22	the	the	DT
cord-005453-4057qib7	13211	23	field	field	NN
cord-005453-4057qib7	13211	24	of	of	IN
cord-005453-4057qib7	13211	25	oncology	oncology	NN
cord-005453-4057qib7	13211	26	.	.	.
cord-005453-4057qib7	13212	1	In	in	IN
cord-005453-4057qib7	13212	2	this	this	DT
cord-005453-4057qib7	13212	3	study	study	NN
cord-005453-4057qib7	13212	4	,	,	,
cord-005453-4057qib7	13212	5	we	-PRON-	PRP
cord-005453-4057qib7	13212	6	will	will	MD
cord-005453-4057qib7	13212	7	be	be	VB
cord-005453-4057qib7	13212	8	investigating	investigate	VBG
cord-005453-4057qib7	13212	9	the	the	DT
cord-005453-4057qib7	13212	10	effect	effect	NN
cord-005453-4057qib7	13212	11	of	of	IN
cord-005453-4057qib7	13212	12	MSCs	msc	NNS
cord-005453-4057qib7	13212	13	derived	derive	VBN
cord-005453-4057qib7	13212	14	from	from	IN
cord-005453-4057qib7	13212	15	human	human	JJ
cord-005453-4057qib7	13212	16	bone	bone	NN
cord-005453-4057qib7	13212	17	marrow	marrow	NN
cord-005453-4057qib7	13212	18	(	(	-LRB-
cord-005453-4057qib7	13212	19	BM	BM	NNP
cord-005453-4057qib7	13212	20	)	)	-RRB-
cord-005453-4057qib7	13212	21	,	,	,
cord-005453-4057qib7	13212	22	adipose	adipose	JJ
cord-005453-4057qib7	13212	23	tissue	tissue	NN
cord-005453-4057qib7	13212	24	(	(	-LRB-
cord-005453-4057qib7	13212	25	AT	AT	NNP
cord-005453-4057qib7	13212	26	)	)	-RRB-
cord-005453-4057qib7	13212	27	,	,	,
cord-005453-4057qib7	13212	28	and	and	CC
cord-005453-4057qib7	13212	29	umbilical	umbilical	JJ
cord-005453-4057qib7	13212	30	cord	cord	NN
cord-005453-4057qib7	13212	31	derived	derive	VBN
cord-005453-4057qib7	13212	32	MSCs	mscs	NN
cord-005453-4057qib7	13212	33	(	(	-LRB-
cord-005453-4057qib7	13212	34	UC	UC	NNP
cord-005453-4057qib7	13212	35	-	-	HYPH
cord-005453-4057qib7	13212	36	MSCs	MSCs	NNP
cord-005453-4057qib7	13212	37	)	)	-RRB-
cord-005453-4057qib7	13212	38	on	on	IN
cord-005453-4057qib7	13212	39	ovarian	ovarian	JJ
cord-005453-4057qib7	13212	40	cancer	cancer	NN
cord-005453-4057qib7	13212	41	.	.	.
cord-005453-4057qib7	13213	1	To	to	TO
cord-005453-4057qib7	13213	2	differentiate	differentiate	VB
cord-005453-4057qib7	13213	3	the	the	DT
cord-005453-4057qib7	13213	4	MSCs	msc	NNS
cord-005453-4057qib7	13213	5	,	,	,
cord-005453-4057qib7	13213	6	we	-PRON-	PRP
cord-005453-4057qib7	13213	7	performed	perform	VBD
cord-005453-4057qib7	13213	8	a	a	DT
cord-005453-4057qib7	13213	9	comparative	comparative	JJ
cord-005453-4057qib7	13213	10	analysis	analysis	NN
cord-005453-4057qib7	13213	11	between	between	IN
cord-005453-4057qib7	13213	12	the	the	DT
cord-005453-4057qib7	13213	13	various	various	JJ
cord-005453-4057qib7	13213	14	sources	source	NNS
cord-005453-4057qib7	13213	15	for	for	IN
cord-005453-4057qib7	13213	16	proliferative	proliferative	JJ
cord-005453-4057qib7	13213	17	capacity	capacity	NN
cord-005453-4057qib7	13213	18	,	,	,
cord-005453-4057qib7	13213	19	surface	surface	NN
cord-005453-4057qib7	13213	20	antigen	antigen	NN
cord-005453-4057qib7	13213	21	expression	expression	NN
cord-005453-4057qib7	13213	22	,	,	,
cord-005453-4057qib7	13213	23	differentiation	differentiation	NN
cord-005453-4057qib7	13213	24	ability	ability	NN
cord-005453-4057qib7	13213	25	,	,	,
cord-005453-4057qib7	13213	26	tumor	tumor	NN
cord-005453-4057qib7	13213	27	marker	marker	NN
cord-005453-4057qib7	13213	28	and	and	CC
cord-005453-4057qib7	13213	29	paracrine	paracrine	JJ
cord-005453-4057qib7	13213	30	activity	activity	NN
cord-005453-4057qib7	13213	31	,	,	,
cord-005453-4057qib7	13213	32	and	and	CC
cord-005453-4057qib7	13213	33	their	-PRON-	PRP$
cord-005453-4057qib7	13213	34	influence	influence	NN
cord-005453-4057qib7	13213	35	on	on	IN
cord-005453-4057qib7	13213	36	ovarian	ovarian	JJ
cord-005453-4057qib7	13213	37	cancer	cancer	NN
cord-005453-4057qib7	13213	38	cell	cell	NN
cord-005453-4057qib7	13213	39	proliferation	proliferation	NN
cord-005453-4057qib7	13213	40	.	.	.
cord-005453-4057qib7	13214	1	Methods	method	NNS
cord-005453-4057qib7	13214	2	:	:	:
cord-005453-4057qib7	13214	3	Measurements	measurement	NNS
cord-005453-4057qib7	13214	4	of	of	IN
cord-005453-4057qib7	13214	5	ovarian	ovarian	JJ
cord-005453-4057qib7	13214	6	tumor	tumor	NN
cord-005453-4057qib7	13214	7	marker	marker	NN
cord-005453-4057qib7	13214	8	proteins	protein	NNS
cord-005453-4057qib7	13214	9	were	be	VBD
cord-005453-4057qib7	13214	10	computed	compute	VBN
cord-005453-4057qib7	13214	11	by	by	IN
cord-005453-4057qib7	13214	12	ELISA	ELISA	NNP
cord-005453-4057qib7	13214	13	.	.	.
cord-005453-4057qib7	13215	1	Proliferative	proliferative	JJ
cord-005453-4057qib7	13215	2	effects	effect	NNS
cord-005453-4057qib7	13215	3	,	,	,
cord-005453-4057qib7	13215	4	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	13215	5	effects	effect	NNS
cord-005453-4057qib7	13215	6	,	,	,
cord-005453-4057qib7	13215	7	and	and	CC
cord-005453-4057qib7	13215	8	apoptosis	apoptosis	NN
cord-005453-4057qib7	13215	9	of	of	IN
cord-005453-4057qib7	13215	10	the	the	DT
cord-005453-4057qib7	13215	11	MSCs	msc	NNS
cord-005453-4057qib7	13215	12	were	be	VBD
cord-005453-4057qib7	13215	13	measured	measure	VBN
cord-005453-4057qib7	13215	14	by	by	IN
cord-005453-4057qib7	13215	15	the	the	DT
cord-005453-4057qib7	13215	16	culture	culture	NN
cord-005453-4057qib7	13215	17	and	and	CC
cord-005453-4057qib7	13215	18	counting	counting	NN
cord-005453-4057qib7	13215	19	of	of	IN
cord-005453-4057qib7	13215	20	colony	colony	NN
cord-005453-4057qib7	13215	21	formations	formation	NNS
cord-005453-4057qib7	13215	22	.	.	.
cord-005453-4057qib7	13216	1	Flow	flow	NN
cord-005453-4057qib7	13216	2	cytometry	cytometry	NN
cord-005453-4057qib7	13216	3	(	(	-LRB-
cord-005453-4057qib7	13216	4	FCM	FCM	NNP
cord-005453-4057qib7	13216	5	)	)	-RRB-
cord-005453-4057qib7	13216	6	was	be	VBD
cord-005453-4057qib7	13216	7	used	use	VBN
cord-005453-4057qib7	13216	8	to	to	TO
cord-005453-4057qib7	13216	9	measure	measure	VB
cord-005453-4057qib7	13216	10	the	the	DT
cord-005453-4057qib7	13216	11	variation	variation	NN
cord-005453-4057qib7	13216	12	of	of	IN
cord-005453-4057qib7	13216	13	the	the	DT
cord-005453-4057qib7	13216	14	immunophenotyping	immunophenotyping	NN
cord-005453-4057qib7	13216	15	and	and	CC
cord-005453-4057qib7	13216	16	cytokine	cytokine	NN
cord-005453-4057qib7	13216	17	secretions	secretion	NNS
cord-005453-4057qib7	13216	18	in	in	IN
cord-005453-4057qib7	13216	19	co	co	NN
cord-005453-4057qib7	13216	20	-	-	NN
cord-005453-4057qib7	13216	21	culture	culture	NN
cord-005453-4057qib7	13216	22	,	,	,
cord-005453-4057qib7	13216	23	as	as	RB
cord-005453-4057qib7	13216	24	well	well	RB
cord-005453-4057qib7	13216	25	as	as	IN
cord-005453-4057qib7	13216	26	gene	gene	NN
cord-005453-4057qib7	13216	27	expression	expression	NN
cord-005453-4057qib7	13216	28	.	.	.
cord-005453-4057qib7	13217	1	Results	result	NNS
cord-005453-4057qib7	13217	2	:	:	:
cord-005453-4057qib7	13218	1	Cells	cell	NNS
cord-005453-4057qib7	13218	2	noticeably	noticeably	RB
cord-005453-4057qib7	13218	3	proliferated	proliferate	VBD
cord-005453-4057qib7	13218	4	without	without	IN
cord-005453-4057qib7	13218	5	any	any	DT
cord-005453-4057qib7	13218	6	modifications	modification	NNS
cord-005453-4057qib7	13218	7	to	to	IN
cord-005453-4057qib7	13218	8	their	-PRON-	PRP$
cord-005453-4057qib7	13218	9	immunophenotype	immunophenotype	NN
cord-005453-4057qib7	13218	10	during	during	IN
cord-005453-4057qib7	13218	11	the	the	DT
cord-005453-4057qib7	13218	12	third	third	JJ
cord-005453-4057qib7	13218	13	subculture	subculture	NN
cord-005453-4057qib7	13218	14	.	.	.
cord-005453-4057qib7	13219	1	The	the	DT
cord-005453-4057qib7	13219	2	colony	colony	NN
cord-005453-4057qib7	13219	3	-	-	HYPH
cord-005453-4057qib7	13219	4	forming	form	VBG
cord-005453-4057qib7	13219	5	unit	unit	NN
cord-005453-4057qib7	13219	6	fibroblast	fibroblast	NN
cord-005453-4057qib7	13219	7	(	(	-LRB-
cord-005453-4057qib7	13219	8	CFU	CFU	NNP
cord-005453-4057qib7	13219	9	-	-	HYPH
cord-005453-4057qib7	13219	10	F	F	NNP
cord-005453-4057qib7	13219	11	)	)	-RRB-
cord-005453-4057qib7	13219	12	test	test	NN
cord-005453-4057qib7	13219	13	showed	show	VBD
cord-005453-4057qib7	13219	14	a	a	DT
cord-005453-4057qib7	13219	15	proliferation	proliferation	NN
cord-005453-4057qib7	13219	16	of	of	IN
cord-005453-4057qib7	13219	17	the	the	DT
cord-005453-4057qib7	13219	18	MSCs	msc	NNS
cord-005453-4057qib7	13219	19	along	along	IN
cord-005453-4057qib7	13219	20	with	with	IN
cord-005453-4057qib7	13219	21	healthy	healthy	JJ
cord-005453-4057qib7	13219	22	cells	cell	NNS
cord-005453-4057qib7	13219	23	and	and	CC
cord-005453-4057qib7	13219	24	cancer	cancer	NN
cord-005453-4057qib7	13219	25	cell	cell	NN
cord-005453-4057qib7	13219	26	lines	line	NNS
cord-005453-4057qib7	13219	27	with	with	IN
cord-005453-4057qib7	13219	28	no	no	DT
cord-005453-4057qib7	13219	29	changes	change	NNS
cord-005453-4057qib7	13219	30	in	in	IN
cord-005453-4057qib7	13219	31	their	-PRON-	PRP$
cord-005453-4057qib7	13219	32	phenotype	phenotype	NN
cord-005453-4057qib7	13219	33	.	.	.
cord-005453-4057qib7	13220	1	The	the	DT
cord-005453-4057qib7	13220	2	supernatant	supernatant	NN
cord-005453-4057qib7	13220	3	of	of	IN
cord-005453-4057qib7	13220	4	MSCs	msc	NNS
cord-005453-4057qib7	13220	5	showed	show	VBD
cord-005453-4057qib7	13220	6	an	an	DT
cord-005453-4057qib7	13220	7	increase	increase	NN
cord-005453-4057qib7	13220	8	in	in	IN
cord-005453-4057qib7	13220	9	cellular	cellular	JJ
cord-005453-4057qib7	13220	10	death	death	NN
cord-005453-4057qib7	13220	11	of	of	IN
cord-005453-4057qib7	13220	12	the	the	DT
cord-005453-4057qib7	13220	13	OVCAR3	ovcar3	NN
cord-005453-4057qib7	13220	14	in	in	IN
cord-005453-4057qib7	13220	15	ovarian	ovarian	JJ
cord-005453-4057qib7	13220	16	cancer	cancer	NN
cord-005453-4057qib7	13220	17	cell	cell	NN
cord-005453-4057qib7	13220	18	lines	line	NNS
cord-005453-4057qib7	13220	19	.	.	.
cord-005453-4057qib7	13221	1	A	a	DT
cord-005453-4057qib7	13221	2	reduction	reduction	NN
cord-005453-4057qib7	13221	3	in	in	IN
cord-005453-4057qib7	13221	4	the	the	DT
cord-005453-4057qib7	13221	5	level	level	NN
cord-005453-4057qib7	13221	6	of	of	IN
cord-005453-4057qib7	13221	7	CA-125	ca-125	NN
cord-005453-4057qib7	13221	8	(	(	-LRB-
cord-005453-4057qib7	13221	9	75	75	CD
cord-005453-4057qib7	13221	10	-	-	SYM
cord-005453-4057qib7	13221	11	90	90	CD
cord-005453-4057qib7	13221	12	%	%	NN
cord-005453-4057qib7	13221	13	;	;	:
cord-005453-4057qib7	13221	14	p=0.769	p=0.769	ADD
cord-005453-4057qib7	13221	15	)	)	-RRB-
cord-005453-4057qib7	13221	16	with	with	IN
cord-005453-4057qib7	13221	17	OVCAR3	OVCAR3	NNP
cord-005453-4057qib7	13221	18	in	in	IN
cord-005453-4057qib7	13221	19	co	co	NN
cord-005453-4057qib7	13221	20	-	-	NN
cord-005453-4057qib7	13221	21	culture	culture	NN
cord-005453-4057qib7	13221	22	,	,	,
cord-005453-4057qib7	13221	23	and	and	CC
cord-005453-4057qib7	13221	24	a	a	DT
cord-005453-4057qib7	13221	25	decline	decline	NN
cord-005453-4057qib7	13221	26	of	of	IN
cord-005453-4057qib7	13221	27	LDH	LDH	NNP
cord-005453-4057qib7	13221	28	(	(	-LRB-
cord-005453-4057qib7	13221	29	10	10	CD
cord-005453-4057qib7	13221	30	-	-	SYM
cord-005453-4057qib7	13221	31	20	20	CD
cord-005453-4057qib7	13221	32	%	%	NN
cord-005453-4057qib7	13221	33	;	;	:
cord-005453-4057qib7	13221	34	p=0.03	p=0.03	NN
cord-005453-4057qib7	13221	35	)	)	-RRB-
cord-005453-4057qib7	13221	36	and	and	CC
cord-005453-4057qib7	13221	37	beta	beta	NN
cord-005453-4057qib7	13221	38	-	-	HYPH
cord-005453-4057qib7	13221	39	hCG	hcg	NN
cord-005453-4057qib7	13221	40	(	(	-LRB-
cord-005453-4057qib7	13221	41	10	10	CD
cord-005453-4057qib7	13221	42	-	-	SYM
cord-005453-4057qib7	13221	43	20	20	CD
cord-005453-4057qib7	13221	44	%	%	NN
cord-005453-4057qib7	13221	45	;	;	:
cord-005453-4057qib7	13221	46	p=0.04	p=0.04	NN
cord-005453-4057qib7	13221	47	)	)	-RRB-
cord-005453-4057qib7	13221	48	were	be	VBD
cord-005453-4057qib7	13221	49	observed	observe	VBN
cord-005453-4057qib7	13221	50	in	in	IN
cord-005453-4057qib7	13221	51	co	co	NN
cord-005453-4057qib7	13221	52	-	-	NN
cord-005453-4057qib7	13221	53	culture	culture	NN
cord-005453-4057qib7	13221	54	in	in	IN
cord-005453-4057qib7	13221	55	CAOV3	CAOV3	NNP
cord-005453-4057qib7	13221	56	,	,	,
cord-005453-4057qib7	13221	57	SKOV3	SKOV3	NNP
cord-005453-4057qib7	13221	58	and	and	CC
cord-005453-4057qib7	13221	59	IGROV3	igrov3	JJ
cord-005453-4057qib7	13221	60	cell	cell	NN
cord-005453-4057qib7	13221	61	lines	line	NNS
cord-005453-4057qib7	13221	62	.	.	.
cord-005453-4057qib7	13222	1	A	a	DT
cord-005453-4057qib7	13222	2	decrease	decrease	NN
cord-005453-4057qib7	13222	3	in	in	IN
cord-005453-4057qib7	13222	4	CD24	CD24	NNP
cord-005453-4057qib7	13222	5	of	of	IN
cord-005453-4057qib7	13222	6	the	the	DT
cord-005453-4057qib7	13222	7	cancer	cancer	NN
cord-005453-4057qib7	13222	8	cell	cell	NN
cord-005453-4057qib7	13222	9	lines	line	NNS
cord-005453-4057qib7	13222	10	in	in	IN
cord-005453-4057qib7	13222	11	co	co	NN
cord-005453-4057qib7	13222	12	-	-	NN
cord-005453-4057qib7	13222	13	culture	culture	NN
cord-005453-4057qib7	13222	14	with	with	IN
cord-005453-4057qib7	13222	15	the	the	DT
cord-005453-4057qib7	13222	16	MSC	MSC	NNP
cord-005453-4057qib7	13222	17	supernatant	supernatant	NN
cord-005453-4057qib7	13222	18	showed	show	VBD
cord-005453-4057qib7	13222	19	a	a	DT
cord-005453-4057qib7	13222	20	reduction	reduction	NN
cord-005453-4057qib7	13222	21	of	of	IN
cord-005453-4057qib7	13222	22	the	the	DT
cord-005453-4057qib7	13222	23	cancer	cancer	NN
cord-005453-4057qib7	13222	24	tumorigenicity	tumorigenicity	NN
cord-005453-4057qib7	13222	25	and	and	CC
cord-005453-4057qib7	13222	26	aggressiveness	aggressiveness	NN
cord-005453-4057qib7	13222	27	,	,	,
cord-005453-4057qib7	13222	28	while	while	IN
cord-005453-4057qib7	13222	29	the	the	DT
cord-005453-4057qib7	13222	30	rate	rate	NN
cord-005453-4057qib7	13222	31	of	of	IN
cord-005453-4057qib7	13222	32	the	the	DT
cord-005453-4057qib7	13222	33	CD24	CD24	NNP
cord-005453-4057qib7	13222	34	and	and	CC
cord-005453-4057qib7	13222	35	CD44	CD44	NNP
cord-005453-4057qib7	13222	36	asserted	assert	VBD
cord-005453-4057qib7	13222	37	their	-PRON-	PRP$
cord-005453-4057qib7	13222	38	stem	stem	NN
cord-005453-4057qib7	13222	39	state	state	NN
cord-005453-4057qib7	13222	40	.	.	.
cord-005453-4057qib7	13223	1	MSC	MSC	NNP
cord-005453-4057qib7	13223	2	supernatant	supernatant	JJ
cord-005453-4057qib7	13223	3	decreased	decrease	VBD
cord-005453-4057qib7	13223	4	cell	cell	NN
cord-005453-4057qib7	13223	5	proliferation	proliferation	NN
cord-005453-4057qib7	13223	6	and	and	CC
cord-005453-4057qib7	13223	7	MMP-2	MMP-2	NNP
cord-005453-4057qib7	13223	8	,	,	,
cord-005453-4057qib7	13223	9	MMP-9	MMP-9	NNP
cord-005453-4057qib7	13223	10	,	,	,
cord-005453-4057qib7	13223	11	and	and	CC
cord-005453-4057qib7	13223	12	CA-125	CA-125	NNP
cord-005453-4057qib7	13223	13	mRNA	mRNA	NNP
cord-005453-4057qib7	13223	14	expression	expression	NN
cord-005453-4057qib7	13223	15	,	,	,
cord-005453-4057qib7	13223	16	while	while	IN
cord-005453-4057qib7	13223	17	increasing	increase	VBG
cord-005453-4057qib7	13223	18	TIMP	TIMP	NNP
cord-005453-4057qib7	13223	19	1	1	CD
cord-005453-4057qib7	13223	20	,	,	,
cord-005453-4057qib7	13223	21	2	2	CD
cord-005453-4057qib7	13223	22	,	,	,
cord-005453-4057qib7	13223	23	and	and	CC
cord-005453-4057qib7	13223	24	3	3	CD
cord-005453-4057qib7	13223	25	.	.	.
cord-005453-4057qib7	13224	1	This	this	DT
cord-005453-4057qib7	13224	2	suggests	suggest	VBZ
cord-005453-4057qib7	13224	3	that	that	IN
cord-005453-4057qib7	13224	4	MSCs	msc	NNS
cord-005453-4057qib7	13224	5	have	have	VBP
cord-005453-4057qib7	13224	6	a	a	DT
cord-005453-4057qib7	13224	7	role	role	NN
cord-005453-4057qib7	13224	8	in	in	IN
cord-005453-4057qib7	13224	9	cell	cell	NN
cord-005453-4057qib7	13224	10	death	death	NN
cord-005453-4057qib7	13224	11	and	and	CC
cord-005453-4057qib7	13224	12	inhibition	inhibition	NN
cord-005453-4057qib7	13224	13	of	of	IN
cord-005453-4057qib7	13224	14	ovarian	ovarian	JJ
cord-005453-4057qib7	13224	15	cancer	cancer	NN
cord-005453-4057qib7	13224	16	cell	cell	NN
cord-005453-4057qib7	13224	17	proliferation	proliferation	NN
cord-005453-4057qib7	13224	18	.	.	.
cord-005453-4057qib7	13225	1	An	an	DT
cord-005453-4057qib7	13225	2	increase	increase	NN
cord-005453-4057qib7	13225	3	of	of	IN
cord-005453-4057qib7	13225	4	anti	anti	JJ
cord-005453-4057qib7	13225	5	-	-	JJ
cord-005453-4057qib7	13225	6	inflammatory	inflammatory	JJ
cord-005453-4057qib7	13225	7	IL-4	IL-4	NNP
cord-005453-4057qib7	13225	8	and	and	CC
cord-005453-4057qib7	13225	9	IL-10	IL-10	NNP
cord-005453-4057qib7	13225	10	cytokines	cytokine	NNS
cord-005453-4057qib7	13225	11	,	,	,
cord-005453-4057qib7	13225	12	and	and	CC
cord-005453-4057qib7	13225	13	a	a	DT
cord-005453-4057qib7	13225	14	decrease	decrease	NN
cord-005453-4057qib7	13225	15	in	in	IN
cord-005453-4057qib7	13225	16	growth	growth	NN
cord-005453-4057qib7	13225	17	factor	factor	NN
cord-005453-4057qib7	13225	18	GM	GM	NNP
cord-005453-4057qib7	13225	19	-	-	HYPH
cord-005453-4057qib7	13225	20	CSF	CSF	NNP
cord-005453-4057qib7	13225	21	along	along	IN
cord-005453-4057qib7	13225	22	with	with	IN
cord-005453-4057qib7	13225	23	their	-PRON-	PRP$
cord-005453-4057qib7	13225	24	proinflammatory	proinflammatory	JJ
cord-005453-4057qib7	13225	25	INF	inf	NN
cord-005453-4057qib7	13225	26	-	-	,
cord-005453-4057qib7	13225	27	a	a	NN
cord-005453-4057qib7	13225	28	,	,	,
cord-005453-4057qib7	13225	29	TNF	TNF	NNP
cord-005453-4057qib7	13225	30	-	-	HYPH
cord-005453-4057qib7	13225	31	a	a	NNP
cord-005453-4057qib7	13225	32	,	,	,
cord-005453-4057qib7	13225	33	IL-9	IL-9	NNP
cord-005453-4057qib7	13225	34	,	,	,
cord-005453-4057qib7	13225	35	and	and	CC
cord-005453-4057qib7	13225	36	IL-17a	IL-17a	NNP
cord-005453-4057qib7	13225	37	cytokines	cytokine	NNS
cord-005453-4057qib7	13225	38	were	be	VBD
cord-005453-4057qib7	13225	39	also	also	RB
cord-005453-4057qib7	13225	40	noted	note	VBN
cord-005453-4057qib7	13225	41	.	.	.
cord-005453-4057qib7	13226	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13226	2	:	:	:
cord-005453-4057qib7	13227	1	The	the	DT
cord-005453-4057qib7	13227	2	gene	gene	NN
cord-005453-4057qib7	13227	3	and	and	CC
cord-005453-4057qib7	13227	4	cytokine	cytokine	NN
cord-005453-4057qib7	13227	5	activity	activity	NN
cord-005453-4057qib7	13227	6	indicate	indicate	VBP
cord-005453-4057qib7	13227	7	a	a	DT
cord-005453-4057qib7	13227	8	potential	potential	JJ
cord-005453-4057qib7	13227	9	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13227	10	anti	anti	JJ
cord-005453-4057qib7	13227	11	-	-	JJ
cord-005453-4057qib7	13227	12	inflammatory	inflammatory	JJ
cord-005453-4057qib7	13227	13	and	and	CC
cord-005453-4057qib7	13227	14	antiproliferative	antiproliferative	JJ
cord-005453-4057qib7	13227	15	role	role	NN
cord-005453-4057qib7	13227	16	of	of	IN
cord-005453-4057qib7	13227	17	MSCs	msc	NNS
cord-005453-4057qib7	13227	18	on	on	IN
cord-005453-4057qib7	13227	19	ovarian	ovarian	JJ
cord-005453-4057qib7	13227	20	cancer	cancer	NN
cord-005453-4057qib7	13227	21	despite	despite	IN
cord-005453-4057qib7	13227	22	their	-PRON-	PRP$
cord-005453-4057qib7	13227	23	sources	source	NNS
cord-005453-4057qib7	13227	24	.	.	.
cord-005453-4057qib7	13228	1	The	the	DT
cord-005453-4057qib7	13228	2	reduction	reduction	NN
cord-005453-4057qib7	13228	3	of	of	IN
cord-005453-4057qib7	13228	4	CA-125	ca-125	NN
cord-005453-4057qib7	13228	5	,	,	,
cord-005453-4057qib7	13228	6	LDH	LDH	NNP
cord-005453-4057qib7	13228	7	,	,	,
cord-005453-4057qib7	13228	8	and	and	CC
cord-005453-4057qib7	13228	9	beta	beta	NN
cord-005453-4057qib7	13228	10	-	-	HYPH
cord-005453-4057qib7	13228	11	hCG	hcg	NN
cord-005453-4057qib7	13228	12	in	in	IN
cord-005453-4057qib7	13228	13	co	co	NN
cord-005453-4057qib7	13228	14	-	-	NN
cord-005453-4057qib7	13228	15	culture	culture	NN
cord-005453-4057qib7	13228	16	,	,	,
cord-005453-4057qib7	13228	17	along	along	IN
cord-005453-4057qib7	13228	18	with	with	IN
cord-005453-4057qib7	13228	19	the	the	DT
cord-005453-4057qib7	13228	20	decrease	decrease	NN
cord-005453-4057qib7	13228	21	in	in	IN
cord-005453-4057qib7	13228	22	CD24	CD24	NNP
cord-005453-4057qib7	13228	23	and	and	CC
cord-005453-4057qib7	13228	24	amplified	amplify	VBD
cord-005453-4057qib7	13228	25	cellular	cellular	JJ
cord-005453-4057qib7	13228	26	apoptosis	apoptosis	NN
cord-005453-4057qib7	13228	27	demonstrate	demonstrate	VBP
cord-005453-4057qib7	13228	28	the	the	DT
cord-005453-4057qib7	13228	29	beneficial	beneficial	JJ
cord-005453-4057qib7	13228	30	effects	effect	NNS
cord-005453-4057qib7	13228	31	of	of	IN
cord-005453-4057qib7	13228	32	stem	stem	NN
cord-005453-4057qib7	13228	33	cells	cell	NNS
cord-005453-4057qib7	13228	34	in	in	IN
cord-005453-4057qib7	13228	35	ovarian	ovarian	JJ
cord-005453-4057qib7	13228	36	cancer	cancer	NN
cord-005453-4057qib7	13228	37	cell	cell	NN
cord-005453-4057qib7	13228	38	lines	line	NNS
cord-005453-4057qib7	13228	39	.	.	.
cord-005453-4057qib7	13229	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13229	2	Background	background	NN
cord-005453-4057qib7	13229	3	:	:	:
cord-005453-4057qib7	13229	4	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13229	5	stem	stem	NN
cord-005453-4057qib7	13229	6	cell	cell	NN
cord-005453-4057qib7	13229	7	transplant	transplant	NN
cord-005453-4057qib7	13229	8	(	(	-LRB-
cord-005453-4057qib7	13229	9	HSCT	HSCT	NNP
cord-005453-4057qib7	13229	10	)	)	-RRB-
cord-005453-4057qib7	13229	11	is	be	VBZ
cord-005453-4057qib7	13229	12	the	the	DT
cord-005453-4057qib7	13229	13	only	only	JJ
cord-005453-4057qib7	13229	14	cure	cure	NN
cord-005453-4057qib7	13229	15	in	in	IN
cord-005453-4057qib7	13229	16	sickle	sickle	NN
cord-005453-4057qib7	13229	17	cell	cell	NN
cord-005453-4057qib7	13229	18	disease	disease	NN
cord-005453-4057qib7	13229	19	(	(	-LRB-
cord-005453-4057qib7	13229	20	SCD	SCD	NNP
cord-005453-4057qib7	13229	21	)	)	-RRB-
cord-005453-4057qib7	13229	22	so	so	RB
cord-005453-4057qib7	13229	23	far	far	RB
cord-005453-4057qib7	13229	24	.	.	.
cord-005453-4057qib7	13230	1	Because	because	IN
cord-005453-4057qib7	13230	2	of	of	IN
cord-005453-4057qib7	13230	3	the	the	DT
cord-005453-4057qib7	13230	4	risk	risk	NN
cord-005453-4057qib7	13230	5	of	of	IN
cord-005453-4057qib7	13230	6	toxicity	toxicity	NN
cord-005453-4057qib7	13230	7	,	,	,
cord-005453-4057qib7	13230	8	its	-PRON-	PRP$
cord-005453-4057qib7	13230	9	indication	indication	NN
cord-005453-4057qib7	13230	10	in	in	IN
cord-005453-4057qib7	13230	11	France	France	NNP
cord-005453-4057qib7	13230	12	is	be	VBZ
cord-005453-4057qib7	13230	13	restricted	restrict	VBN
cord-005453-4057qib7	13230	14	to	to	IN
cord-005453-4057qib7	13230	15	severe	severe	JJ
cord-005453-4057qib7	13230	16	patients	patient	NNS
cord-005453-4057qib7	13230	17	with	with	IN
cord-005453-4057qib7	13230	18	match	match	NN
cord-005453-4057qib7	13230	19	sibling	sibling	NN
cord-005453-4057qib7	13230	20	donor	donor	NN
cord-005453-4057qib7	13230	21	.	.	.
cord-005453-4057qib7	13231	1	This	this	DT
cord-005453-4057qib7	13231	2	study	study	NN
cord-005453-4057qib7	13231	3	compares	compare	VBZ
cord-005453-4057qib7	13231	4	the	the	DT
cord-005453-4057qib7	13231	5	incidence	incidence	NN
cord-005453-4057qib7	13231	6	of	of	IN
cord-005453-4057qib7	13231	7	severe	severe	JJ
cord-005453-4057qib7	13231	8	acute	acute	JJ
cord-005453-4057qib7	13231	9	toxicity	toxicity	NN
cord-005453-4057qib7	13231	10	after	after	IN
cord-005453-4057qib7	13231	11	HSCT	HSCT	NNP
cord-005453-4057qib7	13231	12	,	,	,
cord-005453-4057qib7	13231	13	between	between	IN
cord-005453-4057qib7	13231	14	children	child	NNS
cord-005453-4057qib7	13231	15	aged	age	VBN
cord-005453-4057qib7	13231	16	less	less	JJR
cord-005453-4057qib7	13231	17	than	than	IN
cord-005453-4057qib7	13231	18	13	13	CD
cord-005453-4057qib7	13231	19	years	year	NNS
cord-005453-4057qib7	13231	20	and	and	CC
cord-005453-4057qib7	13231	21	teenagers	teenager	NNS
cord-005453-4057qib7	13231	22	aged	age	VBN
cord-005453-4057qib7	13231	23	13	13	CD
cord-005453-4057qib7	13231	24	to	to	TO
cord-005453-4057qib7	13231	25	18	18	CD
cord-005453-4057qib7	13231	26	years	year	NNS
cord-005453-4057qib7	13231	27	old	old	JJ
cord-005453-4057qib7	13231	28	,	,	,
cord-005453-4057qib7	13231	29	treated	treat	VBN
cord-005453-4057qib7	13231	30	for	for	IN
cord-005453-4057qib7	13231	31	SCD	SCD	NNP
cord-005453-4057qib7	13231	32	.	.	.
cord-005453-4057qib7	13232	1	Methods	method	NNS
cord-005453-4057qib7	13232	2	:	:	:
cord-005453-4057qib7	13233	1	All	all	DT
cord-005453-4057qib7	13233	2	patients	patient	NNS
cord-005453-4057qib7	13233	3	suffering	suffer	VBG
cord-005453-4057qib7	13233	4	from	from	IN
cord-005453-4057qib7	13233	5	SCD	SCD	NNP
cord-005453-4057qib7	13233	6	,	,	,
cord-005453-4057qib7	13233	7	aged	aged	JJ
cord-005453-4057qib7	13233	8	less	less	JJR
cord-005453-4057qib7	13233	9	than	than	IN
cord-005453-4057qib7	13233	10	18	18	CD
cord-005453-4057qib7	13233	11	years	year	NNS
cord-005453-4057qib7	13233	12	at	at	IN
cord-005453-4057qib7	13233	13	transplant	transplant	NN
cord-005453-4057qib7	13233	14	,	,	,
cord-005453-4057qib7	13233	15	who	who	WP
cord-005453-4057qib7	13233	16	received	receive	VBD
cord-005453-4057qib7	13233	17	HSCT	HSCT	NNP
cord-005453-4057qib7	13233	18	in	in	IN
cord-005453-4057qib7	13233	19	CHU	CHU	NNP
cord-005453-4057qib7	13233	20	Robert	Robert	NNP
cord-005453-4057qib7	13233	21	Debré	Debré	NNP
cord-005453-4057qib7	13233	22	and	and	CC
cord-005453-4057qib7	13233	23	Necker	Necker	NNP
cord-005453-4057qib7	13233	24	,	,	,
cord-005453-4057qib7	13233	25	between	between	IN
cord-005453-4057qib7	13233	26	01/01/2005	01/01/2005	CD
cord-005453-4057qib7	13233	27	and	and	CC
cord-005453-4057qib7	13233	28	12/31/2017	12/31/2017	CD
cord-005453-4057qib7	13233	29	,	,	,
cord-005453-4057qib7	13233	30	were	be	VBD
cord-005453-4057qib7	13233	31	included	include	VBN
cord-005453-4057qib7	13233	32	.	.	.
cord-005453-4057qib7	13234	1	Severe	severe	JJ
cord-005453-4057qib7	13234	2	acute	acute	JJ
cord-005453-4057qib7	13234	3	toxicity	toxicity	NN
cord-005453-4057qib7	13234	4	,	,	,
cord-005453-4057qib7	13234	5	defined	define	VBN
cord-005453-4057qib7	13234	6	by	by	IN
cord-005453-4057qib7	13234	7	onset	onset	NN
cord-005453-4057qib7	13234	8	of	of	IN
cord-005453-4057qib7	13234	9	severe	severe	JJ
cord-005453-4057qib7	13234	10	acute	acute	JJ
cord-005453-4057qib7	13234	11	GVHd	GVHd	NNS
cord-005453-4057qib7	13234	12	,	,	,
cord-005453-4057qib7	13234	13	organ	organ	NN
cord-005453-4057qib7	13234	14	toxicity	toxicity	NN
cord-005453-4057qib7	13234	15	or	or	CC
cord-005453-4057qib7	13234	16	infection	infection	NN
cord-005453-4057qib7	13234	17	,	,	,
cord-005453-4057qib7	13234	18	was	be	VBD
cord-005453-4057qib7	13234	19	compared	compare	VBN
cord-005453-4057qib7	13234	20	between	between	IN
cord-005453-4057qib7	13234	21	the	the	DT
cord-005453-4057qib7	13234	22	two	two	CD
cord-005453-4057qib7	13234	23	groups	group	NNS
cord-005453-4057qib7	13234	24	of	of	IN
cord-005453-4057qib7	13234	25	age	age	NN
cord-005453-4057qib7	13234	26	.	.	.
cord-005453-4057qib7	13235	1	Results	result	NNS
cord-005453-4057qib7	13235	2	:	:	:
cord-005453-4057qib7	13235	3	73	73	CD
cord-005453-4057qib7	13235	4	patients	patient	NNS
cord-005453-4057qib7	13235	5	(	(	-LRB-
cord-005453-4057qib7	13235	6	59	59	CD
cord-005453-4057qib7	13235	7	children	child	NNS
cord-005453-4057qib7	13235	8	and	and	CC
cord-005453-4057qib7	13235	9	14	14	CD
cord-005453-4057qib7	13235	10	teenagers	teenager	NNS
cord-005453-4057qib7	13235	11	)	)	-RRB-
cord-005453-4057qib7	13235	12	were	be	VBD
cord-005453-4057qib7	13235	13	included	include	VBN
cord-005453-4057qib7	13235	14	.	.	.
cord-005453-4057qib7	13236	1	All	all	DT
cord-005453-4057qib7	13236	2	patients	patient	NNS
cord-005453-4057qib7	13236	3	received	receive	VBD
cord-005453-4057qib7	13236	4	a	a	DT
cord-005453-4057qib7	13236	5	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13236	6	conditioning	conditioning	NN
cord-005453-4057qib7	13236	7	regimen	regimen	NN
cord-005453-4057qib7	13236	8	.	.	.
cord-005453-4057qib7	13237	1	Bone	bone	NN
cord-005453-4057qib7	13237	2	marrow	marrow	NN
cord-005453-4057qib7	13237	3	from	from	IN
cord-005453-4057qib7	13237	4	a	a	DT
cord-005453-4057qib7	13237	5	sibling	sibling	NN
cord-005453-4057qib7	13237	6	donor	donor	NN
cord-005453-4057qib7	13237	7	was	be	VBD
cord-005453-4057qib7	13237	8	the	the	DT
cord-005453-4057qib7	13237	9	main	main	JJ
cord-005453-4057qib7	13237	10	stem	stem	NN
cord-005453-4057qib7	13237	11	cell	cell	NN
cord-005453-4057qib7	13237	12	source	source	NN
cord-005453-4057qib7	13237	13	(	(	-LRB-
cord-005453-4057qib7	13237	14	n=65	n=65	NN
cord-005453-4057qib7	13237	15	;	;	:
cord-005453-4057qib7	13237	16	89	89	CD
cord-005453-4057qib7	13237	17	%	%	NN
cord-005453-4057qib7	13237	18	)	)	-RRB-
cord-005453-4057qib7	13237	19	.	.	.
cord-005453-4057qib7	13238	1	Neither	neither	DT
cord-005453-4057qib7	13238	2	death	death	NN
cord-005453-4057qib7	13238	3	nor	nor	CC
cord-005453-4057qib7	13238	4	rejection	rejection	NN
cord-005453-4057qib7	13238	5	was	be	VBD
cord-005453-4057qib7	13238	6	observed	observe	VBN
cord-005453-4057qib7	13238	7	with	with	IN
cord-005453-4057qib7	13238	8	a	a	DT
cord-005453-4057qib7	13238	9	median	median	JJ
cord-005453-4057qib7	13238	10	follow	follow	NN
cord-005453-4057qib7	13238	11	-	-	HYPH
cord-005453-4057qib7	13238	12	up	up	NN
cord-005453-4057qib7	13238	13	of	of	IN
cord-005453-4057qib7	13238	14	29.6	29.6	CD
cord-005453-4057qib7	13238	15	months	month	NNS
cord-005453-4057qib7	13238	16	(	(	-LRB-
cord-005453-4057qib7	13238	17	range	range	NN
cord-005453-4057qib7	13238	18	,	,	,
cord-005453-4057qib7	13238	19	.	.	.
cord-005453-4057qib7	13239	1	The	the	DT
cord-005453-4057qib7	13239	2	incidence	incidence	NN
cord-005453-4057qib7	13239	3	of	of	IN
cord-005453-4057qib7	13239	4	grade	grade	NN
cord-005453-4057qib7	13239	5	III	III	NNP
cord-005453-4057qib7	13239	6	-	-	HYPH
cord-005453-4057qib7	13239	7	IV	IV	NNP
cord-005453-4057qib7	13239	8	acute	acute	JJ
cord-005453-4057qib7	13239	9	GVHd	GVHd	NNS
cord-005453-4057qib7	13239	10	was	be	VBD
cord-005453-4057qib7	13239	11	12.3	12.3	CD
cord-005453-4057qib7	13239	12	%	%	NN
cord-005453-4057qib7	13239	13	and	and	CC
cord-005453-4057qib7	13239	14	was	be	VBD
cord-005453-4057qib7	13239	15	similar	similar	JJ
cord-005453-4057qib7	13239	16	between	between	IN
cord-005453-4057qib7	13239	17	the	the	DT
cord-005453-4057qib7	13239	18	two	two	CD
cord-005453-4057qib7	13239	19	groups	group	NNS
cord-005453-4057qib7	13239	20	;	;	:
cord-005453-4057qib7	13239	21	no	no	DT
cord-005453-4057qib7	13239	22	risk	risk	NN
cord-005453-4057qib7	13239	23	factor	factor	NN
cord-005453-4057qib7	13239	24	was	be	VBD
cord-005453-4057qib7	13239	25	identified	identify	VBN
cord-005453-4057qib7	13239	26	in	in	IN
cord-005453-4057qib7	13239	27	univariate	univariate	JJ
cord-005453-4057qib7	13239	28	analysis	analysis	NN
cord-005453-4057qib7	13239	29	.	.	.
cord-005453-4057qib7	13240	1	Teenagers	teenager	NNS
cord-005453-4057qib7	13240	2	had	have	VBD
cord-005453-4057qib7	13240	3	more	more	RBR
cord-005453-4057qib7	13240	4	frequently	frequently	RB
cord-005453-4057qib7	13240	5	acute	acute	JJ
cord-005453-4057qib7	13240	6	skin	skin	NN
cord-005453-4057qib7	13240	7	toxicity	toxicity	NN
cord-005453-4057qib7	13240	8	(	(	-LRB-
cord-005453-4057qib7	13240	9	21.4	21.4	CD
cord-005453-4057qib7	13240	10	%	%	NN
cord-005453-4057qib7	13240	11	vs	vs	IN
cord-005453-4057qib7	13240	12	0	0	CD
cord-005453-4057qib7	13240	13	%	%	NN
cord-005453-4057qib7	13240	14	,	,	,
cord-005453-4057qib7	13240	15	p=0.006	p=0.006	NNP
cord-005453-4057qib7	13240	16	)	)	-RRB-
cord-005453-4057qib7	13240	17	.	.	.
cord-005453-4057qib7	13241	1	In	in	IN
cord-005453-4057qib7	13241	2	univariate	univariate	JJ
cord-005453-4057qib7	13241	3	analysis	analysis	NN
cord-005453-4057qib7	13241	4	,	,	,
cord-005453-4057qib7	13241	5	patients	patient	NNS
cord-005453-4057qib7	13241	6	presenting	present	VBG
cord-005453-4057qib7	13241	7	severe	severe	JJ
cord-005453-4057qib7	13241	8	organ	organ	NN
cord-005453-4057qib7	13241	9	toxicity	toxicity	NN
cord-005453-4057qib7	13241	10	were	be	VBD
cord-005453-4057qib7	13241	11	significantly	significantly	RB
cord-005453-4057qib7	13241	12	older	old	JJR
cord-005453-4057qib7	13241	13	than	than	IN
cord-005453-4057qib7	13241	14	others	other	NNS
cord-005453-4057qib7	13241	15	(	(	-LRB-
cord-005453-4057qib7	13241	16	9.3	9.3	CD
cord-005453-4057qib7	13241	17	vs	vs	IN
cord-005453-4057qib7	13241	18	7.5	7.5	CD
cord-005453-4057qib7	13241	19	years	year	NNS
cord-005453-4057qib7	13241	20	old	old	JJ
cord-005453-4057qib7	13241	21	,	,	,
cord-005453-4057qib7	13241	22	p=0.027	p=0.027	RB
cord-005453-4057qib7	13241	23	)	)	-RRB-
cord-005453-4057qib7	13241	24	.	.	.
cord-005453-4057qib7	13242	1	Teenagers	teenager	NNS
cord-005453-4057qib7	13242	2	were	be	VBD
cord-005453-4057qib7	13242	3	more	more	RBR
cord-005453-4057qib7	13242	4	frequently	frequently	RB
cord-005453-4057qib7	13242	5	treated	treat	VBN
cord-005453-4057qib7	13242	6	for	for	IN
cord-005453-4057qib7	13242	7	bacterial	bacterial	JJ
cord-005453-4057qib7	13242	8	(	(	-LRB-
cord-005453-4057qib7	13242	9	64.3	64.3	CD
cord-005453-4057qib7	13242	10	%	%	NN
cord-005453-4057qib7	13242	11	vs	vs	IN
cord-005453-4057qib7	13242	12	32.2	32.2	CD
cord-005453-4057qib7	13242	13	%	%	NN
cord-005453-4057qib7	13242	14	,	,	,
cord-005453-4057qib7	13242	15	p=0.035	p=0.035	NNP
cord-005453-4057qib7	13242	16	)	)	-RRB-
cord-005453-4057qib7	13242	17	or	or	CC
cord-005453-4057qib7	13242	18	BK	BK	NNP
cord-005453-4057qib7	13242	19	virus	virus	NN
cord-005453-4057qib7	13242	20	(	(	-LRB-
cord-005453-4057qib7	13242	21	42.9	42.9	CD
cord-005453-4057qib7	13242	22	%	%	NN
cord-005453-4057qib7	13242	23	vs	vs	IN
cord-005453-4057qib7	13242	24	6.8	6.8	CD
cord-005453-4057qib7	13242	25	%	%	NN
cord-005453-4057qib7	13242	26	,	,	,
cord-005453-4057qib7	13242	27	p=0.002	p=0.002	NNP
cord-005453-4057qib7	13242	28	)	)	-RRB-
cord-005453-4057qib7	13242	29	infections	infection	NNS
cord-005453-4057qib7	13242	30	.	.	.
cord-005453-4057qib7	13243	1	In	in	IN
cord-005453-4057qib7	13243	2	univariate	univariate	JJ
cord-005453-4057qib7	13243	3	analysis	analysis	NN
cord-005453-4057qib7	13243	4	,	,	,
cord-005453-4057qib7	13243	5	patients	patient	NNS
cord-005453-4057qib7	13243	6	who	who	WP
cord-005453-4057qib7	13243	7	developed	develop	VBD
cord-005453-4057qib7	13243	8	infection	infection	NN
cord-005453-4057qib7	13243	9	were	be	VBD
cord-005453-4057qib7	13243	10	also	also	RB
cord-005453-4057qib7	13243	11	significantly	significantly	RB
cord-005453-4057qib7	13243	12	older	old	JJR
cord-005453-4057qib7	13243	13	at	at	IN
cord-005453-4057qib7	13243	14	time	time	NN
cord-005453-4057qib7	13243	15	of	of	IN
cord-005453-4057qib7	13243	16	transplant	transplant	NN
cord-005453-4057qib7	13243	17	(	(	-LRB-
cord-005453-4057qib7	13243	18	respectively	respectively	RB
cord-005453-4057qib7	13243	19	9.7	9.7	CD
cord-005453-4057qib7	13243	20	vs	vs	IN
cord-005453-4057qib7	13243	21	7.5	7.5	CD
cord-005453-4057qib7	13243	22	years	year	NNS
cord-005453-4057qib7	13243	23	old	old	JJ
cord-005453-4057qib7	13243	24	,	,	,
cord-005453-4057qib7	13243	25	p=0.016	p=0.016	RB
cord-005453-4057qib7	13243	26	)	)	-RRB-
cord-005453-4057qib7	13243	27	.	.	.
cord-005453-4057qib7	13244	1	No	no	DT
cord-005453-4057qib7	13244	2	severe	severe	JJ
cord-005453-4057qib7	13244	3	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	13244	4	obstruction	obstruction	NN
cord-005453-4057qib7	13244	5	syndrome	syndrome	NN
cord-005453-4057qib7	13244	6	was	be	VBD
cord-005453-4057qib7	13244	7	observed	observe	VBN
cord-005453-4057qib7	13244	8	.	.	.
cord-005453-4057qib7	13245	1	Regarding	regard	VBG
cord-005453-4057qib7	13245	2	long	long	JJ
cord-005453-4057qib7	13245	3	-	-	HYPH
cord-005453-4057qib7	13245	4	term	term	NN
cord-005453-4057qib7	13245	5	toxicity	toxicity	NN
cord-005453-4057qib7	13245	6	,	,	,
cord-005453-4057qib7	13245	7	2	2	CD
cord-005453-4057qib7	13245	8	patients	patient	NNS
cord-005453-4057qib7	13245	9	presented	present	VBD
cord-005453-4057qib7	13245	10	an	an	DT
cord-005453-4057qib7	13245	11	extensive	extensive	JJ
cord-005453-4057qib7	13245	12	chronic	chronic	JJ
cord-005453-4057qib7	13245	13	GVHd	GVHd	NNS
cord-005453-4057qib7	13245	14	,	,	,
cord-005453-4057qib7	13245	15	they	-PRON-	PRP
cord-005453-4057qib7	13245	16	were	be	VBD
cord-005453-4057qib7	13245	17	both	both	RB
cord-005453-4057qib7	13245	18	aged	aged	JJ
cord-005453-4057qib7	13245	19	less	less	JJR
cord-005453-4057qib7	13245	20	than	than	IN
cord-005453-4057qib7	13245	21	13	13	CD
cord-005453-4057qib7	13245	22	years	year	NNS
cord-005453-4057qib7	13245	23	old	old	JJ
cord-005453-4057qib7	13245	24	.	.	.
cord-005453-4057qib7	13246	1	No	no	DT
cord-005453-4057qib7	13246	2	cut	cut	VBN
cord-005453-4057qib7	13246	3	-	-	HYPH
cord-005453-4057qib7	13246	4	off	off	NN
cord-005453-4057qib7	13246	5	of	of	IN
cord-005453-4057qib7	13246	6	age	age	NN
cord-005453-4057qib7	13246	7	could	could	MD
cord-005453-4057qib7	13246	8	have	have	VB
cord-005453-4057qib7	13246	9	been	be	VBN
cord-005453-4057qib7	13246	10	defined	define	VBN
cord-005453-4057qib7	13246	11	.	.	.
cord-005453-4057qib7	13247	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13247	2	:	:	:
cord-005453-4057qib7	13248	1	This	this	DT
cord-005453-4057qib7	13248	2	study	study	NN
cord-005453-4057qib7	13248	3	confirms	confirm	VBZ
cord-005453-4057qib7	13248	4	the	the	DT
cord-005453-4057qib7	13248	5	excellent	excellent	JJ
cord-005453-4057qib7	13248	6	results	result	NNS
cord-005453-4057qib7	13248	7	of	of	IN
cord-005453-4057qib7	13248	8	HSCT	HSCT	NNP
cord-005453-4057qib7	13248	9	in	in	IN
cord-005453-4057qib7	13248	10	SCD	SCD	NNP
cord-005453-4057qib7	13248	11	,	,	,
cord-005453-4057qib7	13248	12	with	with	IN
cord-005453-4057qib7	13248	13	a	a	DT
cord-005453-4057qib7	13248	14	5-year	5-year	CD
cord-005453-4057qib7	13248	15	event	event	NN
cord-005453-4057qib7	13248	16	-	-	HYPH
cord-005453-4057qib7	13248	17	free	free	JJ
cord-005453-4057qib7	13248	18	survival	survival	NN
cord-005453-4057qib7	13248	19	and	and	CC
cord-005453-4057qib7	13248	20	overall	overall	JJ
cord-005453-4057qib7	13248	21	survival	survival	NN
cord-005453-4057qib7	13248	22	of	of	IN
cord-005453-4057qib7	13248	23	100	100	CD
cord-005453-4057qib7	13248	24	%	%	NN
cord-005453-4057qib7	13248	25	.	.	.
cord-005453-4057qib7	13249	1	An	an	DT
cord-005453-4057qib7	13249	2	older	old	JJR
cord-005453-4057qib7	13249	3	age	age	NN
cord-005453-4057qib7	13249	4	at	at	IN
cord-005453-4057qib7	13249	5	transplant	transplant	NN
cord-005453-4057qib7	13249	6	seems	seem	VBZ
cord-005453-4057qib7	13249	7	to	to	TO
cord-005453-4057qib7	13249	8	be	be	VB
cord-005453-4057qib7	13249	9	associated	associate	VBN
cord-005453-4057qib7	13249	10	with	with	IN
cord-005453-4057qib7	13249	11	more	more	RBR
cord-005453-4057qib7	13249	12	frequent	frequent	JJ
cord-005453-4057qib7	13249	13	severe	severe	JJ
cord-005453-4057qib7	13249	14	acute	acute	JJ
cord-005453-4057qib7	13249	15	toxicity	toxicity	NN
cord-005453-4057qib7	13249	16	.	.	.
cord-005453-4057qib7	13250	1	These	these	DT
cord-005453-4057qib7	13250	2	results	result	NNS
cord-005453-4057qib7	13250	3	are	be	VBP
cord-005453-4057qib7	13250	4	consistent	consistent	JJ
cord-005453-4057qib7	13250	5	with	with	IN
cord-005453-4057qib7	13250	6	previous	previous	JJ
cord-005453-4057qib7	13250	7	studies	study	NNS
cord-005453-4057qib7	13250	8	and	and	CC
cord-005453-4057qib7	13250	9	suggest	suggest	VBP
cord-005453-4057qib7	13250	10	that	that	IN
cord-005453-4057qib7	13250	11	HSCT	HSCT	NNP
cord-005453-4057qib7	13250	12	should	should	MD
cord-005453-4057qib7	13250	13	be	be	VB
cord-005453-4057qib7	13250	14	performed	perform	VBN
cord-005453-4057qib7	13250	15	as	as	RB
cord-005453-4057qib7	13250	16	soon	soon	RB
cord-005453-4057qib7	13250	17	as	as	IN
cord-005453-4057qib7	13250	18	possible	possible	JJ
cord-005453-4057qib7	13250	19	,	,	,
cord-005453-4057qib7	13250	20	without	without	IN
cord-005453-4057qib7	13250	21	any	any	DT
cord-005453-4057qib7	13250	22	defined	define	VBN
cord-005453-4057qib7	13250	23	"	"	``
cord-005453-4057qib7	13250	24	best	good	JJS
cord-005453-4057qib7	13250	25	age	age	NN
cord-005453-4057qib7	13250	26	"	"	''
cord-005453-4057qib7	13250	27	.	.	.
cord-005453-4057qib7	13251	1	Prospective	prospective	JJ
cord-005453-4057qib7	13251	2	studies	study	NNS
cord-005453-4057qib7	13251	3	are	be	VBP
cord-005453-4057qib7	13251	4	needed	need	VBN
cord-005453-4057qib7	13251	5	,	,	,
cord-005453-4057qib7	13251	6	in	in	IN
cord-005453-4057qib7	13251	7	order	order	NN
cord-005453-4057qib7	13251	8	to	to	TO
cord-005453-4057qib7	13251	9	define	define	VB
cord-005453-4057qib7	13251	10	the	the	DT
cord-005453-4057qib7	13251	11	place	place	NN
cord-005453-4057qib7	13251	12	of	of	IN
cord-005453-4057qib7	13251	13	each	each	DT
cord-005453-4057qib7	13251	14	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13251	15	in	in	IN
cord-005453-4057qib7	13251	16	SCD	SCD	NNP
cord-005453-4057qib7	13251	17	,	,	,
cord-005453-4057qib7	13251	18	with	with	IN
cord-005453-4057qib7	13251	19	the	the	DT
cord-005453-4057qib7	13251	20	aim	aim	NN
cord-005453-4057qib7	13251	21	of	of	IN
cord-005453-4057qib7	13251	22	reducing	reduce	VBG
cord-005453-4057qib7	13251	23	treatment	treatment	NN
cord-005453-4057qib7	13251	24	-	-	HYPH
cord-005453-4057qib7	13251	25	related	relate	VBN
cord-005453-4057qib7	13251	26	toxicity	toxicity	NN
cord-005453-4057qib7	13251	27	and	and	CC
cord-005453-4057qib7	13251	28	developing	develop	VBG
cord-005453-4057qib7	13251	29	alternative	alternative	JJ
cord-005453-4057qib7	13251	30	strategies	strategy	NNS
cord-005453-4057qib7	13251	31	for	for	IN
cord-005453-4057qib7	13251	32	patients	patient	NNS
cord-005453-4057qib7	13251	33	without	without	IN
cord-005453-4057qib7	13251	34	match	match	NN
cord-005453-4057qib7	13251	35	sibling	sibling	NN
cord-005453-4057qib7	13251	36	donor	donor	NN
cord-005453-4057qib7	13251	37	.	.	.
cord-005453-4057qib7	13252	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13252	2	:	:	:
cord-005453-4057qib7	13252	3	nothing	nothing	NN
cord-005453-4057qib7	13252	4	to	to	TO
cord-005453-4057qib7	13252	5	declare	declare	VB
cord-005453-4057qib7	13252	6	P599	p599	CD
cord-005453-4057qib7	13252	7	New	new	JJ
cord-005453-4057qib7	13252	8	insights	insight	NNS
cord-005453-4057qib7	13252	9	into	into	IN
cord-005453-4057qib7	13252	10	risk	risk	NN
cord-005453-4057qib7	13252	11	factors	factor	NNS
cord-005453-4057qib7	13252	12	for	for	IN
cord-005453-4057qib7	13252	13	transplant	transplant	NN
cord-005453-4057qib7	13252	14	-	-	HYPH
cord-005453-4057qib7	13252	15	associated	associate	VBN
cord-005453-4057qib7	13252	16	thrombotic	thrombotic	JJ
cord-005453-4057qib7	13252	17	microangiopathy	microangiopathy	NNP
cord-005453-4057qib7	13252	18	(	(	-LRB-
cord-005453-4057qib7	13252	19	TA	TA	NNP
cord-005453-4057qib7	13252	20	-	-	HYPH
cord-005453-4057qib7	13252	21	TMA	TMA	NNP
cord-005453-4057qib7	13252	22	)	)	-RRB-
cord-005453-4057qib7	13252	23	in	in	IN
cord-005453-4057qib7	13252	24	paediatric	paediatric	JJ
cord-005453-4057qib7	13252	25	HSCT	HSCT	NNP
cord-005453-4057qib7	13252	26	(	(	-LRB-
cord-005453-4057qib7	13252	27	n=170	n=170	NNP
cord-005453-4057qib7	13252	28	)	)	-RRB-
cord-005453-4057qib7	13252	29	was	be	VBD
cord-005453-4057qib7	13252	30	associated	associate	VBN
cord-005453-4057qib7	13252	31	with	with	IN
cord-005453-4057qib7	13252	32	TA	TA	NNP
cord-005453-4057qib7	13252	33	-	-	HYPH
cord-005453-4057qib7	13252	34	TMA	TMA	NNP
cord-005453-4057qib7	13252	35	in	in	IN
cord-005453-4057qib7	13252	36	1	1	CD
cord-005453-4057qib7	13252	37	%	%	NN
cord-005453-4057qib7	13252	38	vs	vs	IN
cord-005453-4057qib7	13252	39	5.8	5.8	CD
cord-005453-4057qib7	13252	40	%	%	NN
cord-005453-4057qib7	13252	41	vs	vs	IN
cord-005453-4057qib7	13252	42	7.7	7.7	CD
cord-005453-4057qib7	13252	43	%	%	NN
cord-005453-4057qib7	13252	44	respectively	respectively	RB
cord-005453-4057qib7	13252	45	(	(	-LRB-
cord-005453-4057qib7	13252	46	p=0.067	p=0.067	JJ
cord-005453-4057qib7	13252	47	)	)	-RRB-
cord-005453-4057qib7	13252	48	.	.	.
cord-005453-4057qib7	13253	1	The	the	DT
cord-005453-4057qib7	13253	2	presence	presence	NN
cord-005453-4057qib7	13253	3	of	of	IN
cord-005453-4057qib7	13253	4	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	13253	5	at	at	IN
cord-005453-4057qib7	13253	6	D0	D0	NNP
cord-005453-4057qib7	13253	7	(	(	-LRB-
cord-005453-4057qib7	13253	8	n=86	n=86	NNP
cord-005453-4057qib7	13253	9	)	)	-RRB-
cord-005453-4057qib7	13253	10	was	be	VBD
cord-005453-4057qib7	13253	11	significantly	significantly	RB
cord-005453-4057qib7	13253	12	associated	associate	VBN
cord-005453-4057qib7	13253	13	with	with	IN
cord-005453-4057qib7	13253	14	an	an	DT
cord-005453-4057qib7	13253	15	increased	increase	VBN
cord-005453-4057qib7	13253	16	risk	risk	NN
cord-005453-4057qib7	13253	17	of	of	IN
cord-005453-4057qib7	13253	18	TA	TA	NNP
cord-005453-4057qib7	13253	19	-	-	HYPH
cord-005453-4057qib7	13253	20	TMA	TMA	NNP
cord-005453-4057qib7	13253	21	10.4	10.4	CD
cord-005453-4057qib7	13253	22	%	%	NN
cord-005453-4057qib7	13253	23	vs3.7	vs3.7	NN
cord-005453-4057qib7	13253	24	%	%	NN
cord-005453-4057qib7	13253	25	in	in	IN
cord-005453-4057qib7	13253	26	absence	absence	NN
cord-005453-4057qib7	13253	27	of	of	IN
cord-005453-4057qib7	13253	28	co	co	NN
cord-005453-4057qib7	13253	29	-	-	NN
cord-005453-4057qib7	13253	30	morbidity	morbidity	JJ
cord-005453-4057qib7	13253	31	(	(	-LRB-
cord-005453-4057qib7	13253	32	n=320	n=320	UH
cord-005453-4057qib7	13253	33	)	)	-RRB-
cord-005453-4057qib7	13253	34	;	;	:
cord-005453-4057qib7	13254	1	p=0.032	p=0.032	NNPS
cord-005453-4057qib7	13254	2	.	.	.
cord-005453-4057qib7	13255	1	Use	Use	NNP
cord-005453-4057qib7	13255	2	of	of	IN
cord-005453-4057qib7	13255	3	CSA	CSA	NNP
cord-005453-4057qib7	13255	4	/	/	SYM
cord-005453-4057qib7	13255	5	Tac	Tac	NNP
cord-005453-4057qib7	13255	6	-	-	HYPH
cord-005453-4057qib7	13255	7	based	base	VBN
cord-005453-4057qib7	13255	8	GvHD	GvHD	NNP
cord-005453-4057qib7	13255	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13255	10	was	be	VBD
cord-005453-4057qib7	13255	11	associated	associate	VBN
cord-005453-4057qib7	13255	12	with	with	IN
cord-005453-4057qib7	13255	13	less	less	JJR
cord-005453-4057qib7	13255	14	TA	TA	NNP
cord-005453-4057qib7	13255	15	-	-	HYPH
cord-005453-4057qib7	13255	16	TMA	TMA	NNP
cord-005453-4057qib7	13255	17	with	with	IN
cord-005453-4057qib7	13255	18	an	an	DT
cord-005453-4057qib7	13255	19	incidence	incidence	NN
cord-005453-4057qib7	13255	20	of	of	IN
cord-005453-4057qib7	13255	21	4	4	CD
cord-005453-4057qib7	13255	22	%	%	NN
cord-005453-4057qib7	13255	23	vs	vs	IN
cord-005453-4057qib7	13255	24	13	13	CD
cord-005453-4057qib7	13255	25	%	%	NN
cord-005453-4057qib7	13255	26	if	if	IN
cord-005453-4057qib7	13255	27	these	these	DT
cord-005453-4057qib7	13255	28	agents	agent	NNS
cord-005453-4057qib7	13255	29	were	be	VBD
cord-005453-4057qib7	13255	30	not	not	RB
cord-005453-4057qib7	13255	31	included	include	VBN
cord-005453-4057qib7	13255	32	(	(	-LRB-
cord-005453-4057qib7	13255	33	p=0.01	p=0.01	NNP
cord-005453-4057qib7	13255	34	)	)	-RRB-
cord-005453-4057qib7	13255	35	.	.	.
cord-005453-4057qib7	13256	1	In	in	IN
cord-005453-4057qib7	13256	2	univariate	univariate	JJ
cord-005453-4057qib7	13256	3	analysis	analysis	NN
cord-005453-4057qib7	13256	4	TA	TA	NNP
cord-005453-4057qib7	13256	5	-	-	HYPH
cord-005453-4057qib7	13256	6	TMA	TMA	NNP
cord-005453-4057qib7	13256	7	was	be	VBD
cord-005453-4057qib7	13256	8	significantly	significantly	RB
cord-005453-4057qib7	13256	9	higher	high	JJR
cord-005453-4057qib7	13256	10	among	among	IN
cord-005453-4057qib7	13256	11	patients	patient	NNS
cord-005453-4057qib7	13256	12	with	with	IN
cord-005453-4057qib7	13256	13	aGvHD	agvhd	NN
cord-005453-4057qib7	13256	14	grade	grade	NNP
cord-005453-4057qib7	13256	15	II	II	NNP
cord-005453-4057qib7	13256	16	-	-	HYPH
cord-005453-4057qib7	13256	17	IV	IV	NNP
cord-005453-4057qib7	13256	18	(	(	-LRB-
cord-005453-4057qib7	13256	19	12/138	12/138	CD
cord-005453-4057qib7	13256	20	;	;	:
cord-005453-4057qib7	13256	21	8.6	8.6	CD
cord-005453-4057qib7	13256	22	%	%	NN
cord-005453-4057qib7	13256	23	)	)	-RRB-
cord-005453-4057qib7	13256	24	vs	vs	IN
cord-005453-4057qib7	13256	25	Grade	Grade	NNP
cord-005453-4057qib7	13256	26	0-I	0-i	CD
cord-005453-4057qib7	13257	1	(	(	-LRB-
cord-005453-4057qib7	13257	2	6/227;2.6	6/227;2.6	CD
cord-005453-4057qib7	13257	3	%	%	NN
cord-005453-4057qib7	13257	4	)	)	-RRB-
cord-005453-4057qib7	13257	5	(	(	-LRB-
cord-005453-4057qib7	13257	6	p=0.01	p=0.01	NNP
cord-005453-4057qib7	13257	7	)	)	-RRB-
cord-005453-4057qib7	13257	8	.	.	.
cord-005453-4057qib7	13258	1	PRES	PRES	NNP
cord-005453-4057qib7	13258	2	was	be	VBD
cord-005453-4057qib7	13258	3	recorded	record	VBN
cord-005453-4057qib7	13258	4	among	among	IN
cord-005453-4057qib7	13258	5	10	10	CD
cord-005453-4057qib7	13258	6	cases	case	NNS
cord-005453-4057qib7	13258	7	and	and	CC
cord-005453-4057qib7	13258	8	50	50	CD
cord-005453-4057qib7	13258	9	%	%	NN
cord-005453-4057qib7	13258	10	of	of	IN
cord-005453-4057qib7	13258	11	them	-PRON-	PRP
cord-005453-4057qib7	13258	12	developed	develop	VBD
cord-005453-4057qib7	13258	13	TA	TA	NNP
cord-005453-4057qib7	13258	14	-	-	HYPH
cord-005453-4057qib7	13258	15	TMA	TMA	NNP
cord-005453-4057qib7	13258	16	.	.	.
cord-005453-4057qib7	13259	1	Two	two	CD
cord-005453-4057qib7	13259	2	out	out	IN
cord-005453-4057qib7	13259	3	of	of	IN
cord-005453-4057qib7	13259	4	the	the	DT
cord-005453-4057qib7	13259	5	21	21	CD
cord-005453-4057qib7	13259	6	patients	patient	NNS
cord-005453-4057qib7	13259	7	with	with	IN
cord-005453-4057qib7	13259	8	TA	TA	NNP
cord-005453-4057qib7	13259	9	-	-	HYPH
cord-005453-4057qib7	13259	10	TMA	TMA	NNP
cord-005453-4057qib7	13259	11	had	have	VBD
cord-005453-4057qib7	13259	12	pathological	pathological	JJ
cord-005453-4057qib7	13259	13	gene	gene	NN
cord-005453-4057qib7	13259	14	mutations	mutation	NNS
cord-005453-4057qib7	13259	15	in	in	IN
cord-005453-4057qib7	13259	16	their	-PRON-	PRP$
cord-005453-4057qib7	13259	17	complement	complement	NN
cord-005453-4057qib7	13259	18	pathway	pathway	NN
cord-005453-4057qib7	13259	19	.	.	.
cord-005453-4057qib7	13260	1	On	on	IN
cord-005453-4057qib7	13260	2	multivariate	multivariate	JJ
cord-005453-4057qib7	13260	3	analysis	analysis	NN
cord-005453-4057qib7	13260	4	the	the	DT
cord-005453-4057qib7	13260	5	presence	presence	NN
cord-005453-4057qib7	13260	6	of	of	IN
cord-005453-4057qib7	13260	7	active	active	JJ
cord-005453-4057qib7	13260	8	comorbidity	comorbidity	NN
cord-005453-4057qib7	13260	9	was	be	VBD
cord-005453-4057qib7	13260	10	a	a	DT
cord-005453-4057qib7	13260	11	risk	risk	NN
cord-005453-4057qib7	13260	12	factor	factor	NN
cord-005453-4057qib7	13260	13	for	for	IN
cord-005453-4057qib7	13260	14	TA	TA	NNP
cord-005453-4057qib7	13260	15	-	-	HYPH
cord-005453-4057qib7	13260	16	TMA	TMA	NNP
cord-005453-4057qib7	13260	17	(	(	-LRB-
cord-005453-4057qib7	13260	18	OR:6.6	OR:6.6	NNP
cord-005453-4057qib7	13260	19	;	;	:
cord-005453-4057qib7	13260	20	95	95	CD
cord-005453-4057qib7	13260	21	%	%	NN
cord-005453-4057qib7	13260	22	CI:1.1	ci:1.1	NN
cord-005453-4057qib7	13260	23	-	-	HYPH
cord-005453-4057qib7	13260	24	37.6	37.6	CD
cord-005453-4057qib7	13260	25	;	;	:
cord-005453-4057qib7	13260	26	p=0.032	p=0.032	ADD
cord-005453-4057qib7	13260	27	)	)	-RRB-
cord-005453-4057qib7	13261	1	while	while	IN
cord-005453-4057qib7	13261	2	the	the	DT
cord-005453-4057qib7	13261	3	use	use	NN
cord-005453-4057qib7	13261	4	of	of	IN
cord-005453-4057qib7	13261	5	CSA	CSA	NNP
cord-005453-4057qib7	13261	6	/	/	SYM
cord-005453-4057qib7	13261	7	Tac	Tac	NNP
cord-005453-4057qib7	13261	8	-	-	HYPH
cord-005453-4057qib7	13261	9	based	base	VBN
cord-005453-4057qib7	13261	10	GvHD	GvHD	NNP
cord-005453-4057qib7	13261	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13261	12	did	do	VBD
cord-005453-4057qib7	13261	13	not	not	RB
cord-005453-4057qib7	13261	14	increase	increase	VB
cord-005453-4057qib7	13261	15	the	the	DT
cord-005453-4057qib7	13261	16	risk	risk	NN
cord-005453-4057qib7	13261	17	for	for	IN
cord-005453-4057qib7	13261	18	TA	TA	NNP
cord-005453-4057qib7	13261	19	-	-	HYPH
cord-005453-4057qib7	13261	20	TMA	TMA	NNP
cord-005453-4057qib7	13261	21	(	(	-LRB-
cord-005453-4057qib7	13261	22	OR:0.04	OR:0.04	NNP
cord-005453-4057qib7	13261	23	;	;	:
cord-005453-4057qib7	13261	24	CI:0.004	ci:0.004	NN
cord-005453-4057qib7	13261	25	-	-	HYPH
cord-005453-4057qib7	13261	26	0.39	0.39	CD
cord-005453-4057qib7	13261	27	;	;	:
cord-005453-4057qib7	13261	28	p=0.005	p=0.005	NNP
cord-005453-4057qib7	13261	29	)	)	-RRB-
cord-005453-4057qib7	13261	30	.	.	.
cord-005453-4057qib7	13262	1	In	in	IN
cord-005453-4057qib7	13262	2	the	the	DT
cord-005453-4057qib7	13262	3	presence	presence	NN
cord-005453-4057qib7	13262	4	of	of	IN
cord-005453-4057qib7	13262	5	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	13262	6	the	the	DT
cord-005453-4057qib7	13262	7	use	use	NN
cord-005453-4057qib7	13262	8	of	of	IN
cord-005453-4057qib7	13262	9	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	13262	10	as	as	IN
cord-005453-4057qib7	13262	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13262	12	or	or	CC
cord-005453-4057qib7	13262	13	therapy	therapy	NN
cord-005453-4057qib7	13262	14	for	for	IN
cord-005453-4057qib7	13262	15	VOD	VOD	NNP
cord-005453-4057qib7	13262	16	(	(	-LRB-
cord-005453-4057qib7	13262	17	n=86	n=86	NNP
cord-005453-4057qib7	13262	18	)	)	-RRB-
cord-005453-4057qib7	13262	19	was	be	VBD
cord-005453-4057qib7	13262	20	associated	associate	VBN
cord-005453-4057qib7	13262	21	with	with	IN
cord-005453-4057qib7	13262	22	a	a	DT
cord-005453-4057qib7	13262	23	drop	drop	NN
cord-005453-4057qib7	13262	24	in	in	IN
cord-005453-4057qib7	13262	25	the	the	DT
cord-005453-4057qib7	13262	26	incidence	incidence	NN
cord-005453-4057qib7	13262	27	of	of	IN
cord-005453-4057qib7	13262	28	TA	TA	NNP
cord-005453-4057qib7	13262	29	-	-	HYPH
cord-005453-4057qib7	13262	30	TMA	TMA	NNP
cord-005453-4057qib7	13262	31	from	from	IN
cord-005453-4057qib7	13262	32	12	12	CD
cord-005453-4057qib7	13262	33	%	%	NN
cord-005453-4057qib7	13262	34	(	(	-LRB-
cord-005453-4057qib7	13262	35	9/79	9/79	CD
cord-005453-4057qib7	13262	36	)	)	-RRB-
cord-005453-4057qib7	13262	37	in	in	IN
cord-005453-4057qib7	13262	38	absence	absence	NN
cord-005453-4057qib7	13262	39	of	of	IN
cord-005453-4057qib7	13262	40	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	13262	41	to	to	IN
cord-005453-4057qib7	13262	42	0	0	CD
cord-005453-4057qib7	13262	43	%	%	NN
cord-005453-4057qib7	13262	44	(	(	-LRB-
cord-005453-4057qib7	13262	45	0/7	0/7	CD
cord-005453-4057qib7	13262	46	)	)	-RRB-
cord-005453-4057qib7	13262	47	.	.	.
cord-005453-4057qib7	13263	1	2-year	2-year	CD
cord-005453-4057qib7	13263	2	overall	overall	JJ
cord-005453-4057qib7	13263	3	survival	survival	NN
cord-005453-4057qib7	13263	4	was	be	VBD
cord-005453-4057qib7	13263	5	significantly	significantly	RB
cord-005453-4057qib7	13263	6	lower	low	JJR
cord-005453-4057qib7	13263	7	among	among	IN
cord-005453-4057qib7	13263	8	TA	TA	NNP
cord-005453-4057qib7	13263	9	-	-	HYPH
cord-005453-4057qib7	13263	10	TMA	TMA	NNP
cord-005453-4057qib7	13263	11	cases	case	NNS
cord-005453-4057qib7	13263	12	(	(	-LRB-
cord-005453-4057qib7	13263	13	58	58	CD
cord-005453-4057qib7	13263	14	%	%	NN
cord-005453-4057qib7	13263	15	)	)	-RRB-
cord-005453-4057qib7	13263	16	in	in	IN
cord-005453-4057qib7	13263	17	comparison	comparison	NN
cord-005453-4057qib7	13263	18	to	to	IN
cord-005453-4057qib7	13263	19	81.5	81.5	CD
cord-005453-4057qib7	13263	20	%	%	NN
cord-005453-4057qib7	13263	21	in	in	IN
cord-005453-4057qib7	13263	22	absence	absence	NN
cord-005453-4057qib7	13263	23	of	of	IN
cord-005453-4057qib7	13263	24	TA	TA	NNP
cord-005453-4057qib7	13263	25	-	-	HYPH
cord-005453-4057qib7	13263	26	TMA	TMA	NNP
cord-005453-4057qib7	13263	27	(	(	-LRB-
cord-005453-4057qib7	13263	28	p=0.001	p=0.001	NNP
cord-005453-4057qib7	13263	29	)	)	-RRB-
cord-005453-4057qib7	13264	1	(	(	-LRB-
cord-005453-4057qib7	13264	2	figure	figure	NN
cord-005453-4057qib7	13264	3	1	1	CD
cord-005453-4057qib7	13264	4	)	)	-RRB-
cord-005453-4057qib7	13264	5	.	.	.
cord-005453-4057qib7	13265	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13265	2	:	:	:
cord-005453-4057qib7	13266	1	Active	active	JJ
cord-005453-4057qib7	13266	2	co	co	NN
cord-005453-4057qib7	13266	3	-	-	NN
cord-005453-4057qib7	13266	4	morbidity	morbidity	NN
cord-005453-4057qib7	13266	5	is	be	VBZ
cord-005453-4057qib7	13266	6	a	a	DT
cord-005453-4057qib7	13266	7	significant	significant	JJ
cord-005453-4057qib7	13266	8	risk	risk	NN
cord-005453-4057qib7	13266	9	factor	factor	NN
cord-005453-4057qib7	13266	10	for	for	IN
cord-005453-4057qib7	13266	11	TA	TA	NNP
cord-005453-4057qib7	13266	12	-	-	HYPH
cord-005453-4057qib7	13266	13	TMA	TMA	NNP
cord-005453-4057qib7	13266	14	.	.	.
cord-005453-4057qib7	13267	1	Use	Use	NNP
cord-005453-4057qib7	13267	2	of	of	IN
cord-005453-4057qib7	13267	3	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	13267	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13267	5	in	in	IN
cord-005453-4057qib7	13267	6	patients	patient	NNS
cord-005453-4057qib7	13267	7	with	with	IN
cord-005453-4057qib7	13267	8	co	co	NNS
cord-005453-4057qib7	13267	9	-	-	NNS
cord-005453-4057qib7	13267	10	morbidities	morbidity	NNS
cord-005453-4057qib7	13267	11	at	at	IN
cord-005453-4057qib7	13267	12	the	the	DT
cord-005453-4057qib7	13267	13	time	time	NN
cord-005453-4057qib7	13267	14	of	of	IN
cord-005453-4057qib7	13267	15	HSCT	HSCT	NNP
cord-005453-4057qib7	13267	16	might	may	MD
cord-005453-4057qib7	13267	17	offer	offer	VB
cord-005453-4057qib7	13267	18	protection	protection	NN
cord-005453-4057qib7	13267	19	against	against	IN
cord-005453-4057qib7	13267	20	TA	TA	NNP
cord-005453-4057qib7	13267	21	-	-	HYPH
cord-005453-4057qib7	13267	22	TMA	TMA	NNP
cord-005453-4057qib7	13267	23	.	.	.
cord-005453-4057qib7	13268	1	Surprisingly	surprisingly	RB
cord-005453-4057qib7	13268	2	the	the	DT
cord-005453-4057qib7	13268	3	use	use	NN
cord-005453-4057qib7	13268	4	of	of	IN
cord-005453-4057qib7	13268	5	CSA	CSA	NNP
cord-005453-4057qib7	13268	6	/	/	SYM
cord-005453-4057qib7	13268	7	Tac	Tac	NNP
cord-005453-4057qib7	13268	8	based	base	VBN
cord-005453-4057qib7	13268	9	GvHD	GvHD	NNP
cord-005453-4057qib7	13268	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13268	11	is	be	VBZ
cord-005453-4057qib7	13268	12	not	not	RB
cord-005453-4057qib7	13268	13	a	a	DT
cord-005453-4057qib7	13268	14	risk	risk	NN
cord-005453-4057qib7	13268	15	factor	factor	NN
cord-005453-4057qib7	13268	16	for	for	IN
cord-005453-4057qib7	13268	17	TA	TA	NNP
cord-005453-4057qib7	13268	18	-	-	HYPH
cord-005453-4057qib7	13268	19	TMA	TMA	NNP
cord-005453-4057qib7	13268	20	probably	probably	RB
cord-005453-4057qib7	13268	21	through	through	IN
cord-005453-4057qib7	13268	22	limiting	limit	VBG
cord-005453-4057qib7	13268	23	the	the	DT
cord-005453-4057qib7	13268	24	development	development	NN
cord-005453-4057qib7	13268	25	of	of	IN
cord-005453-4057qib7	13268	26	high	high	JJ
cord-005453-4057qib7	13268	27	grades	grade	NNS
cord-005453-4057qib7	13268	28	aGvHD	agvhd	NN
cord-005453-4057qib7	13268	29	.	.	.
cord-005453-4057qib7	13269	1	The	the	DT
cord-005453-4057qib7	13269	2	association	association	NN
cord-005453-4057qib7	13269	3	between	between	IN
cord-005453-4057qib7	13269	4	PRES	PRES	NNP
cord-005453-4057qib7	13269	5	and	and	CC
cord-005453-4057qib7	13269	6	TA	TA	NNP
cord-005453-4057qib7	13269	7	-	-	HYPH
cord-005453-4057qib7	13269	8	TMA	TMA	NNP
cord-005453-4057qib7	13269	9	suggests	suggest	VBZ
cord-005453-4057qib7	13269	10	a	a	DT
cord-005453-4057qib7	13269	11	common	common	JJ
cord-005453-4057qib7	13269	12	pathway	pathway	NN
cord-005453-4057qib7	13269	13	of	of	IN
cord-005453-4057qib7	13269	14	endothelial	endothelial	JJ
cord-005453-4057qib7	13269	15	damage	damage	NN
cord-005453-4057qib7	13269	16	Background	background	NN
cord-005453-4057qib7	13269	17	:	:	:
cord-005453-4057qib7	13270	1	Gonadal	gonadal	JJ
cord-005453-4057qib7	13270	2	impairment	impairment	NN
cord-005453-4057qib7	13270	3	is	be	VBZ
cord-005453-4057qib7	13270	4	a	a	DT
cord-005453-4057qib7	13270	5	severe	severe	JJ
cord-005453-4057qib7	13270	6	late	late	JJ
cord-005453-4057qib7	13270	7	effect	effect	NN
cord-005453-4057qib7	13270	8	of	of	IN
cord-005453-4057qib7	13270	9	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13270	10	conditioning	conditioning	NN
cord-005453-4057qib7	13270	11	regimes	regime	NNS
cord-005453-4057qib7	13270	12	with	with	IN
cord-005453-4057qib7	13270	13	significant	significant	JJ
cord-005453-4057qib7	13270	14	impact	impact	NN
cord-005453-4057qib7	13270	15	on	on	IN
cord-005453-4057qib7	13270	16	quality	quality	NN
cord-005453-4057qib7	13270	17	of	of	IN
cord-005453-4057qib7	13270	18	life	life	NN
cord-005453-4057qib7	13270	19	of	of	IN
cord-005453-4057qib7	13270	20	cancer	cancer	NN
cord-005453-4057qib7	13270	21	survivors	survivor	NNS
cord-005453-4057qib7	13270	22	.	.	.
cord-005453-4057qib7	13271	1	The	the	DT
cord-005453-4057qib7	13271	2	aim	aim	NN
cord-005453-4057qib7	13271	3	of	of	IN
cord-005453-4057qib7	13271	4	this	this	DT
cord-005453-4057qib7	13271	5	study	study	NN
cord-005453-4057qib7	13271	6	was	be	VBD
cord-005453-4057qib7	13271	7	to	to	TO
cord-005453-4057qib7	13271	8	analyze	analyze	VB
cord-005453-4057qib7	13271	9	gonadal	gonadal	JJ
cord-005453-4057qib7	13271	10	function	function	NN
cord-005453-4057qib7	13271	11	after	after	IN
cord-005453-4057qib7	13271	12	Busulfan	Busulfan	NNP
cord-005453-4057qib7	13271	13	(	(	-LRB-
cord-005453-4057qib7	13271	14	Bu	Bu	NNP
cord-005453-4057qib7	13271	15	)	)	-RRB-
cord-005453-4057qib7	13271	16	or	or	CC
cord-005453-4057qib7	13271	17	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	13271	18	(	(	-LRB-
cord-005453-4057qib7	13271	19	Treo	Treo	NNP
cord-005453-4057qib7	13271	20	)	)	-RRB-
cord-005453-4057qib7	13271	21	containing	contain	VBG
cord-005453-4057qib7	13271	22	regimens	regimen	NNS
cord-005453-4057qib7	13271	23	with	with	IN
cord-005453-4057qib7	13271	24	regard	regard	NN
cord-005453-4057qib7	13271	25	to	to	IN
cord-005453-4057qib7	13271	26	pubertal	pubertal	JJ
cord-005453-4057qib7	13271	27	stage	stage	NN
cord-005453-4057qib7	13271	28	.	.	.
cord-005453-4057qib7	13272	1	Methods	method	NNS
cord-005453-4057qib7	13272	2	:	:	:
cord-005453-4057qib7	13272	3	This	this	DT
cord-005453-4057qib7	13272	4	was	be	VBD
cord-005453-4057qib7	13272	5	a	a	DT
cord-005453-4057qib7	13272	6	retrospective	retrospective	JJ
cord-005453-4057qib7	13272	7	,	,	,
cord-005453-4057qib7	13272	8	multicenter	multicenter	JJ
cord-005453-4057qib7	13272	9	study	study	NN
cord-005453-4057qib7	13272	10	involving	involve	VBG
cord-005453-4057qib7	13272	11	patients	patient	NNS
cord-005453-4057qib7	13272	12	treated	treat	VBN
cord-005453-4057qib7	13272	13	in	in	IN
cord-005453-4057qib7	13272	14	pediatric	pediatric	JJ
cord-005453-4057qib7	13272	15	EBMT	EBMT	NNP
cord-005453-4057qib7	13272	16	centers	center	NNS
cord-005453-4057qib7	13272	17	between	between	IN
cord-005453-4057qib7	13272	18	1992	1992	CD
cord-005453-4057qib7	13272	19	-	-	SYM
cord-005453-4057qib7	13272	20	2012	2012	CD
cord-005453-4057qib7	13272	21	.	.	.
cord-005453-4057qib7	13273	1	Patients	patient	NNS
cord-005453-4057qib7	13273	2	receiving	receive	VBG
cord-005453-4057qib7	13273	3	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13273	4	doses	dose	NNS
cord-005453-4057qib7	13273	5	of	of	IN
cord-005453-4057qib7	13273	6	Bu	Bu	NNP
cord-005453-4057qib7	13273	7	or	or	CC
cord-005453-4057qib7	13273	8	Treo	Treo	NNP
cord-005453-4057qib7	13273	9	as	as	IN
cord-005453-4057qib7	13273	10	part	part	NN
cord-005453-4057qib7	13273	11	of	of	IN
cord-005453-4057qib7	13273	12	HSCT	HSCT	NNP
cord-005453-4057qib7	13273	13	conditioning	conditioning	NN
cord-005453-4057qib7	13273	14	were	be	VBD
cord-005453-4057qib7	13273	15	eligible	eligible	JJ
cord-005453-4057qib7	13273	16	for	for	IN
cord-005453-4057qib7	13273	17	inclusion	inclusion	NN
cord-005453-4057qib7	13273	18	.	.	.
cord-005453-4057qib7	13274	1	Analysis	analysis	NN
cord-005453-4057qib7	13274	2	was	be	VBD
cord-005453-4057qib7	13274	3	conducted	conduct	VBN
cord-005453-4057qib7	13274	4	in	in	IN
cord-005453-4057qib7	13274	5	two	two	CD
cord-005453-4057qib7	13274	6	groups	group	NNS
cord-005453-4057qib7	13274	7	according	accord	VBG
cord-005453-4057qib7	13274	8	to	to	IN
cord-005453-4057qib7	13274	9	pubertal	pubertal	JJ
cord-005453-4057qib7	13274	10	status	status	NN
cord-005453-4057qib7	13274	11	at	at	IN
cord-005453-4057qib7	13274	12	time	time	NN
cord-005453-4057qib7	13274	13	of	of	IN
cord-005453-4057qib7	13274	14	HSCT	HSCT	NNP
cord-005453-4057qib7	13274	15	.	.	.
cord-005453-4057qib7	13275	1	Results	result	NNS
cord-005453-4057qib7	13275	2	:	:	:
cord-005453-4057qib7	13276	1	137	137	CD
cord-005453-4057qib7	13276	2	patients	patient	NNS
cord-005453-4057qib7	13276	3	(	(	-LRB-
cord-005453-4057qib7	13276	4	pts	pt	NNS
cord-005453-4057qib7	13276	5	)	)	-RRB-
cord-005453-4057qib7	13276	6	were	be	VBD
cord-005453-4057qib7	13276	7	treated	treat	VBN
cord-005453-4057qib7	13276	8	in	in	IN
cord-005453-4057qib7	13276	9	25	25	CD
cord-005453-4057qib7	13276	10	pediatric	pediatric	JJ
cord-005453-4057qib7	13276	11	EBMT	EBMT	NNP
cord-005453-4057qib7	13276	12	with	with	IN
cord-005453-4057qib7	13276	13	Bu	Bu	NNP
cord-005453-4057qib7	13276	14	or	or	CC
cord-005453-4057qib7	13276	15	Treo	Treo	NNP
cord-005453-4057qib7	13276	16	before	before	IN
cord-005453-4057qib7	13276	17	allogeneic	allogeneic	NN
cord-005453-4057qib7	13276	18	HSCT	HSCT	NNP
cord-005453-4057qib7	13276	19	.	.	.
cord-005453-4057qib7	13277	1	The	the	DT
cord-005453-4057qib7	13277	2	median	median	JJ
cord-005453-4057qib7	13277	3	age	age	NN
cord-005453-4057qib7	13277	4	at	at	IN
cord-005453-4057qib7	13277	5	transplant	transplant	NN
cord-005453-4057qib7	13277	6	was	be	VBD
cord-005453-4057qib7	13277	7	11.04	11.04	CD
cord-005453-4057qib7	13277	8	years	year	NNS
cord-005453-4057qib7	13278	1	(	(	-LRB-
cord-005453-4057qib7	13278	2	range	range	NNP
cord-005453-4057qib7	13278	3	5	5	CD
cord-005453-4057qib7	13278	4	-	-	SYM
cord-005453-4057qib7	13278	5	18	18	CD
cord-005453-4057qib7	13278	6	)	)	-RRB-
cord-005453-4057qib7	13278	7	;	;	:
cord-005453-4057qib7	13278	8	89/	89/	LS
cord-005453-4057qib7	13278	9	137	137	CD
cord-005453-4057qib7	13278	10	(	(	-LRB-
cord-005453-4057qib7	13278	11	65	65	CD
cord-005453-4057qib7	13278	12	%	%	NN
cord-005453-4057qib7	13278	13	)	)	-RRB-
cord-005453-4057qib7	13278	14	were	be	VBD
cord-005453-4057qib7	13278	15	males	male	NNS
cord-005453-4057qib7	13278	16	(	(	-LRB-
cord-005453-4057qib7	13278	17	m	m	NNP
cord-005453-4057qib7	13278	18	)	)	-RRB-
cord-005453-4057qib7	13278	19	,	,	,
cord-005453-4057qib7	13278	20	48/137	48/137	CD
cord-005453-4057qib7	13278	21	(	(	-LRB-
cord-005453-4057qib7	13278	22	35	35	CD
cord-005453-4057qib7	13278	23	%	%	NN
cord-005453-4057qib7	13278	24	)	)	-RRB-
cord-005453-4057qib7	13278	25	were	be	VBD
cord-005453-4057qib7	13278	26	females	female	NNS
cord-005453-4057qib7	13278	27	(	(	-LRB-
cord-005453-4057qib7	13278	28	f	f	NNP
cord-005453-4057qib7	13278	29	)	)	-RRB-
cord-005453-4057qib7	13278	30	.	.	.
cord-005453-4057qib7	13279	1	89/137	89/137	CD
cord-005453-4057qib7	13280	1	(	(	-LRB-
cord-005453-4057qib7	13280	2	65	65	CD
cord-005453-4057qib7	13280	3	%	%	NN
cord-005453-4057qib7	13280	4	)	)	-RRB-
cord-005453-4057qib7	13280	5	pts	pt	NNS
cord-005453-4057qib7	13280	6	were	be	VBD
cord-005453-4057qib7	13280	7	pre	pre	JJ
cord-005453-4057qib7	13280	8	-	-	JJ
cord-005453-4057qib7	13280	9	pubertal	pubertal	JJ
cord-005453-4057qib7	13280	10	at	at	IN
cord-005453-4057qib7	13280	11	HSCT	HSCT	NNP
cord-005453-4057qib7	13280	12	(	(	-LRB-
cord-005453-4057qib7	13280	13	f=	f=	NN
cord-005453-4057qib7	13280	14	27;m=62	27;m=62	CD
cord-005453-4057qib7	13280	15	)	)	-RRB-
cord-005453-4057qib7	13280	16	and	and	CC
cord-005453-4057qib7	13280	17	48/137(35	48/137(35	CD
cord-005453-4057qib7	13280	18	%	%	NN
cord-005453-4057qib7	13280	19	)	)	-RRB-
cord-005453-4057qib7	13281	1	were	be	VBD
cord-005453-4057qib7	13281	2	post	post	JJ
cord-005453-4057qib7	13281	3	pubertal	pubertal	JJ
cord-005453-4057qib7	13281	4	(	(	-LRB-
cord-005453-4057qib7	13281	5	f=21;m=27	f=21;m=27	NNP
cord-005453-4057qib7	13281	6	)	)	-RRB-
cord-005453-4057qib7	13281	7	.	.	.
cord-005453-4057qib7	13282	1	118/	118/	LS
cord-005453-4057qib7	13282	2	137	137	CD
cord-005453-4057qib7	13282	3	(	(	-LRB-
cord-005453-4057qib7	13282	4	86	86	CD
cord-005453-4057qib7	13282	5	%	%	NN
cord-005453-4057qib7	13282	6	)	)	-RRB-
cord-005453-4057qib7	13283	1	patients	patient	NNS
cord-005453-4057qib7	13283	2	received	receive	VBD
cord-005453-4057qib7	13283	3	Bu	Bu	NNP
cord-005453-4057qib7	13283	4	(	(	-LRB-
cord-005453-4057qib7	13283	5	f=38;m=80),77/118	f=38;m=80),77/118	JJ
cord-005453-4057qib7	13283	6	(	(	-LRB-
cord-005453-4057qib7	13283	7	65	65	CD
cord-005453-4057qib7	13283	8	%	%	NN
cord-005453-4057qib7	13283	9	)	)	-RRB-
cord-005453-4057qib7	13283	10	were	be	VBD
cord-005453-4057qib7	13283	11	pre	pre	JJ
cord-005453-4057qib7	13283	12	-	-	JJ
cord-005453-4057qib7	13283	13	pubertal	pubertal	JJ
cord-005453-4057qib7	13283	14	.	.	.
cord-005453-4057qib7	13284	1	19/137	19/137	CD
cord-005453-4057qib7	13285	1	(	(	-LRB-
cord-005453-4057qib7	13285	2	14%)(f=10;m=9	14%)(f=10;m=9	NNP
cord-005453-4057qib7	13285	3	)	)	-RRB-
cord-005453-4057qib7	13285	4	received	receive	VBD
cord-005453-4057qib7	13285	5	Treo,12/19	treo,12/19	NN
cord-005453-4057qib7	13286	1	(	(	-LRB-
cord-005453-4057qib7	13286	2	64	64	CD
cord-005453-4057qib7	13286	3	%	%	NN
cord-005453-4057qib7	13286	4	)	)	-RRB-
cord-005453-4057qib7	13286	5	were	be	VBD
cord-005453-4057qib7	13286	6	pre	pre	JJ
cord-005453-4057qib7	13286	7	-	-	JJ
cord-005453-4057qib7	13286	8	pubertal	pubertal	JJ
cord-005453-4057qib7	13286	9	(	(	-LRB-
cord-005453-4057qib7	13286	10	Figure	figure	NN
cord-005453-4057qib7	13286	11	1	1	CD
cord-005453-4057qib7	13286	12	)	)	-RRB-
cord-005453-4057qib7	13286	13	.	.	.
cord-005453-4057qib7	13287	1	Females	female	NNS
cord-005453-4057qib7	13287	2	who	who	WP
cord-005453-4057qib7	13287	3	received	receive	VBD
cord-005453-4057qib7	13287	4	Treo	Treo	NNP
cord-005453-4057qib7	13287	5	in	in	IN
cord-005453-4057qib7	13287	6	pre	pre	JJ
cord-005453-4057qib7	13287	7	-	-	JJ
cord-005453-4057qib7	13287	8	pubertal	pubertal	JJ
cord-005453-4057qib7	13287	9	stage	stage	NN
cord-005453-4057qib7	13287	10	(	(	-LRB-
cord-005453-4057qib7	13287	11	n=6/6	n=6/6	NNP
cord-005453-4057qib7	13287	12	)	)	-RRB-
cord-005453-4057qib7	13287	13	reached	reach	VBN
cord-005453-4057qib7	13287	14	more	more	RBR
cord-005453-4057qib7	13287	15	often	often	RB
cord-005453-4057qib7	13287	16	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13287	17	puberty	puberty	NN
cord-005453-4057qib7	13287	18	(	(	-LRB-
cord-005453-4057qib7	13287	19	100	100	CD
cord-005453-4057qib7	13287	20	%	%	NN
cord-005453-4057qib7	13287	21	vs	vs	IN
cord-005453-4057qib7	13287	22	38	38	CD
cord-005453-4057qib7	13287	23	%	%	NN
cord-005453-4057qib7	13287	24	;	;	,
cord-005453-4057qib7	13287	25	p=0.016	p=0.016	JJS
cord-005453-4057qib7	13287	26	)	)	-RRB-
cord-005453-4057qib7	13287	27	compared	compare	VBN
cord-005453-4057qib7	13287	28	to	to	IN
cord-005453-4057qib7	13287	29	pre	pre	JJ
cord-005453-4057qib7	13287	30	-	-	JJ
cord-005453-4057qib7	13287	31	pubertal	pubertal	JJ
cord-005453-4057qib7	13287	32	Bu	Bu	NNP
cord-005453-4057qib7	13287	33	group	group	NN
cord-005453-4057qib7	13287	34	(	(	-LRB-
cord-005453-4057qib7	13287	35	n=8/21	n=8/21	NNP
cord-005453-4057qib7	13287	36	)	)	-RRB-
cord-005453-4057qib7	13288	1	and	and	CC
cord-005453-4057qib7	13288	2	occurrence	occurrence	NN
cord-005453-4057qib7	13288	3	of	of	IN
cord-005453-4057qib7	13288	4	menarche	menarche	NN
cord-005453-4057qib7	13288	5	was	be	VBD
cord-005453-4057qib7	13288	6	higher	high	JJR
cord-005453-4057qib7	13288	7	in	in	IN
cord-005453-4057qib7	13288	8	Treo	Treo	NNP
cord-005453-4057qib7	13288	9	group	group	NN
cord-005453-4057qib7	13288	10	(	(	-LRB-
cord-005453-4057qib7	13288	11	p	p	NN
cord-005453-4057qib7	13288	12	<	<	XX
cord-005453-4057qib7	13288	13	.01	.01	NFP
cord-005453-4057qib7	13288	14	)	)	-RRB-
cord-005453-4057qib7	13289	1	Hormonal	hormonal	JJ
cord-005453-4057qib7	13289	2	replacement	replacement	NN
cord-005453-4057qib7	13289	3	therapy	therapy	NN
cord-005453-4057qib7	13289	4	was	be	VBD
cord-005453-4057qib7	13289	5	given	give	VBN
cord-005453-4057qib7	13289	6	in	in	IN
cord-005453-4057qib7	13289	7	13/27	13/27	CD
cord-005453-4057qib7	13289	8	(	(	-LRB-
cord-005453-4057qib7	13289	9	48	48	CD
cord-005453-4057qib7	13289	10	%	%	NN
cord-005453-4057qib7	13289	11	)	)	-RRB-
cord-005453-4057qib7	13289	12	females	female	NNS
cord-005453-4057qib7	13289	13	transplanted	transplant	VBN
cord-005453-4057qib7	13289	14	in	in	IN
cord-005453-4057qib7	13289	15	pre	pre	JJ
cord-005453-4057qib7	13289	16	-	-	JJ
cord-005453-4057qib7	13289	17	pubertal	pubertal	JJ
cord-005453-4057qib7	13289	18	stage	stage	NN
cord-005453-4057qib7	13289	19	and	and	CC
cord-005453-4057qib7	13289	20	in	in	IN
cord-005453-4057qib7	13289	21	15/21	15/21	CD
cord-005453-4057qib7	13289	22	(	(	-LRB-
cord-005453-4057qib7	13289	23	71	71	CD
cord-005453-4057qib7	13289	24	%	%	NN
cord-005453-4057qib7	13289	25	)	)	-RRB-
cord-005453-4057qib7	13289	26	of	of	IN
cord-005453-4057qib7	13289	27	those	those	DT
cord-005453-4057qib7	13289	28	transplanted	transplant	VBN
cord-005453-4057qib7	13289	29	in	in	IN
cord-005453-4057qib7	13289	30	post	post	JJ
cord-005453-4057qib7	13289	31	-	-	JJ
cord-005453-4057qib7	13289	32	pubertal	pubertal	JJ
cord-005453-4057qib7	13289	33	stage	stage	NN
cord-005453-4057qib7	13289	34	.	.	.
cord-005453-4057qib7	13290	1	77/89	77/89	CD
cord-005453-4057qib7	13290	2	(	(	-LRB-
cord-005453-4057qib7	13290	3	86	86	CD
cord-005453-4057qib7	13290	4	%	%	NN
cord-005453-4057qib7	13290	5	)	)	-RRB-
cord-005453-4057qib7	13290	6	males	male	NNS
cord-005453-4057qib7	13290	7	were	be	VBD
cord-005453-4057qib7	13290	8	pubertal	pubertal	JJ
cord-005453-4057qib7	13290	9	at	at	IN
cord-005453-4057qib7	13290	10	last	last	JJ
cord-005453-4057qib7	13290	11	follow	follow	NN
cord-005453-4057qib7	13290	12	-	-	HYPH
cord-005453-4057qib7	13290	13	up	up	NN
cord-005453-4057qib7	13290	14	and	and	CC
cord-005453-4057qib7	13290	15	8	8	CD
cord-005453-4057qib7	13290	16	of	of	IN
cord-005453-4057qib7	13290	17	them	-PRON-	PRP
cord-005453-4057qib7	13290	18	(	(	-LRB-
cord-005453-4057qib7	13290	19	10	10	CD
cord-005453-4057qib7	13290	20	%	%	NN
cord-005453-4057qib7	13290	21	)	)	-RRB-
cord-005453-4057qib7	13290	22	performed	perform	VBN
cord-005453-4057qib7	13290	23	sperm	sperm	NN
cord-005453-4057qib7	13290	24	analysis	analysis	NN
cord-005453-4057qib7	13290	25	(	(	-LRB-
cord-005453-4057qib7	13290	26	5	5	CD
cord-005453-4057qib7	13290	27	oligo	oligo	NNP
cord-005453-4057qib7	13290	28	-	-	HYPH
cord-005453-4057qib7	13290	29	azoospermic,3	azoospermic,3	NNP
cord-005453-4057qib7	13290	30	unknown	unknown	NN
cord-005453-4057qib7	13290	31	)	)	-RRB-
cord-005453-4057qib7	13290	32	.	.	.
cord-005453-4057qib7	13291	1	Three	three	CD
cord-005453-4057qib7	13291	2	pregnancies	pregnancy	NNS
cord-005453-4057qib7	13291	3	were	be	VBD
cord-005453-4057qib7	13291	4	reported	report	VBN
cord-005453-4057qib7	13291	5	in	in	IN
cord-005453-4057qib7	13291	6	the	the	DT
cord-005453-4057qib7	13291	7	population	population	NN
cord-005453-4057qib7	13291	8	group	group	NN
cord-005453-4057qib7	13291	9	,	,	,
cord-005453-4057qib7	13291	10	all	all	DT
cord-005453-4057qib7	13291	11	received	receive	VBN
cord-005453-4057qib7	13291	12	Bu	Bu	NNP
cord-005453-4057qib7	13291	13	.	.	.
cord-005453-4057qib7	13292	1	Regarding	regard	VBG
cord-005453-4057qib7	13292	2	the	the	DT
cord-005453-4057qib7	13292	3	evaluation	evaluation	NN
cord-005453-4057qib7	13292	4	of	of	IN
cord-005453-4057qib7	13292	5	hormonal	hormonal	JJ
cord-005453-4057qib7	13292	6	levels	level	NNS
cord-005453-4057qib7	13292	7	in	in	IN
cord-005453-4057qib7	13292	8	pubertal	pubertal	JJ
cord-005453-4057qib7	13292	9	patients	patient	NNS
cord-005453-4057qib7	13292	10	at	at	IN
cord-005453-4057qib7	13292	11	time	time	NN
cord-005453-4057qib7	13292	12	of	of	IN
cord-005453-4057qib7	13292	13	hormonal	hormonal	JJ
cord-005453-4057qib7	13292	14	dosage	dosage	NN
cord-005453-4057qib7	13292	15	(	(	-LRB-
cord-005453-4057qib7	13292	16	median	median	NN
cord-005453-4057qib7	13292	17	19.54	19.54	CD
cord-005453-4057qib7	13292	18	yrs	yr	NNS
cord-005453-4057qib7	13292	19	)	)	-RRB-
cord-005453-4057qib7	13292	20	(	(	-LRB-
cord-005453-4057qib7	13292	21	66	66	CD
cord-005453-4057qib7	13292	22	Bu	Bu	NNP
cord-005453-4057qib7	13292	23	and	and	CC
cord-005453-4057qib7	13292	24	15	15	CD
cord-005453-4057qib7	13292	25	Treo	Treo	NNP
cord-005453-4057qib7	13292	26	)	)	-RRB-
cord-005453-4057qib7	13292	27	,	,	,
cord-005453-4057qib7	13292	28	males	male	NNS
cord-005453-4057qib7	13292	29	treated	treat	VBN
cord-005453-4057qib7	13292	30	with	with	IN
cord-005453-4057qib7	13292	31	Treo	Treo	NNP
cord-005453-4057qib7	13292	32	had	have	VBD
cord-005453-4057qib7	13292	33	significant	significant	JJ
cord-005453-4057qib7	13292	34	lower	low	JJR
cord-005453-4057qib7	13292	35	LH	LH	NNP
cord-005453-4057qib7	13292	36	levels	level	NNS
cord-005453-4057qib7	13292	37	(	(	-LRB-
cord-005453-4057qib7	13292	38	p	p	NN
cord-005453-4057qib7	13292	39	=	=	SYM
cord-005453-4057qib7	13292	40	0.045	0.045	CD
cord-005453-4057qib7	13292	41	)	)	-RRB-
cord-005453-4057qib7	13292	42	compared	compare	VBN
cord-005453-4057qib7	13292	43	to	to	IN
cord-005453-4057qib7	13292	44	Bu	Bu	NNP
cord-005453-4057qib7	13292	45	group	group	NN
cord-005453-4057qib7	13292	46	.	.	.
cord-005453-4057qib7	13293	1	Females	female	NNS
cord-005453-4057qib7	13293	2	treated	treat	VBN
cord-005453-4057qib7	13293	3	with	with	IN
cord-005453-4057qib7	13293	4	Treo	Treo	NNP
cord-005453-4057qib7	13293	5	had	have	VBD
cord-005453-4057qib7	13293	6	significant	significant	JJ
cord-005453-4057qib7	13293	7	lower	low	JJR
cord-005453-4057qib7	13293	8	levels	level	NNS
cord-005453-4057qib7	13293	9	of	of	IN
cord-005453-4057qib7	13293	10	LH	lh	NN
cord-005453-4057qib7	13293	11	and	and	CC
cord-005453-4057qib7	13293	12	FSH	FSH	NNP
cord-005453-4057qib7	13293	13	(	(	-LRB-
cord-005453-4057qib7	13293	14	p=	p=	NNP
cord-005453-4057qib7	13293	15	0.02	0.02	CD
cord-005453-4057qib7	13293	16	and	and	CC
cord-005453-4057qib7	13293	17	p=	p=	JJ
cord-005453-4057qib7	13293	18	0.0035	0.0035	CD
cord-005453-4057qib7	13293	19	respectively	respectively	RB
cord-005453-4057qib7	13293	20	)	)	-RRB-
cord-005453-4057qib7	13293	21	.	.	.
cord-005453-4057qib7	13294	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13294	2	:	:	:
cord-005453-4057qib7	13295	1	Gonadal	gonadal	NN
cord-005453-4057qib7	13295	2	damage	damage	NN
cord-005453-4057qib7	13295	3	related	relate	VBN
cord-005453-4057qib7	13295	4	to	to	IN
cord-005453-4057qib7	13295	5	Treo	Treo	NNP
cord-005453-4057qib7	13295	6	was	be	VBD
cord-005453-4057qib7	13295	7	significantly	significantly	RB
cord-005453-4057qib7	13295	8	lower	low	JJR
cord-005453-4057qib7	13295	9	compared	compare	VBN
cord-005453-4057qib7	13295	10	to	to	IN
cord-005453-4057qib7	13295	11	Bu	Bu	NNP
cord-005453-4057qib7	13295	12	.	.	.
cord-005453-4057qib7	13296	1	We	-PRON-	PRP
cord-005453-4057qib7	13296	2	observed	observe	VBD
cord-005453-4057qib7	13296	3	that	that	DT
cord-005453-4057qib7	13296	4	:	:	:
cord-005453-4057qib7	13296	5	females	female	NNS
cord-005453-4057qib7	13296	6	transplanted	transplant	VBN
cord-005453-4057qib7	13296	7	during	during	IN
cord-005453-4057qib7	13296	8	pre	pre	JJ
cord-005453-4057qib7	13296	9	-	-	JJ
cord-005453-4057qib7	13296	10	pubertal	pubertal	JJ
cord-005453-4057qib7	13296	11	period	period	NN
cord-005453-4057qib7	13296	12	had	have	VBD
cord-005453-4057qib7	13296	13	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13296	14	puberty	puberty	NN
cord-005453-4057qib7	13296	15	more	more	RBR
cord-005453-4057qib7	13296	16	frequently	frequently	RB
cord-005453-4057qib7	13296	17	after	after	IN
cord-005453-4057qib7	13296	18	Treo	Treo	NNP
cord-005453-4057qib7	13296	19	compared	compare	VBN
cord-005453-4057qib7	13296	20	to	to	IN
cord-005453-4057qib7	13296	21	Bu	Bu	NNP
cord-005453-4057qib7	13296	22	and	and	CC
cord-005453-4057qib7	13296	23	that	that	IN
cord-005453-4057qib7	13296	24	hypogonadism	hypogonadism	NNP
cord-005453-4057qib7	13296	25	hypergonadotropic	hypergonadotropic	NNP
cord-005453-4057qib7	13296	26	was	be	VBD
cord-005453-4057qib7	13296	27	more	more	RBR
cord-005453-4057qib7	13296	28	frequent	frequent	JJ
cord-005453-4057qib7	13296	29	after	after	IN
cord-005453-4057qib7	13296	30	Bu	Bu	NNP
cord-005453-4057qib7	13296	31	than	than	IN
cord-005453-4057qib7	13296	32	Treo	Treo	NNP
cord-005453-4057qib7	13296	33	.	.	.
cord-005453-4057qib7	13297	1	These	these	DT
cord-005453-4057qib7	13297	2	results	result	NNS
cord-005453-4057qib7	13297	3	must	must	MD
cord-005453-4057qib7	13297	4	be	be	VB
cord-005453-4057qib7	13297	5	further	further	RB
cord-005453-4057qib7	13297	6	confirmed	confirm	VBN
cord-005453-4057qib7	13297	7	on	on	IN
cord-005453-4057qib7	13297	8	a	a	DT
cord-005453-4057qib7	13297	9	larger	large	JJR
cord-005453-4057qib7	13297	10	population	population	NN
cord-005453-4057qib7	13297	11	.	.	.
cord-005453-4057qib7	13298	1	Background	background	NN
cord-005453-4057qib7	13298	2	:	:	:
cord-005453-4057qib7	13299	1	Viral	viral	JJ
cord-005453-4057qib7	13299	2	infections	infection	NNS
cord-005453-4057qib7	13299	3	significantly	significantly	RB
cord-005453-4057qib7	13299	4	contribute	contribute	VBP
cord-005453-4057qib7	13299	5	to	to	IN
cord-005453-4057qib7	13299	6	both	both	CC
cord-005453-4057qib7	13299	7	morbidity	morbidity	NN
cord-005453-4057qib7	13299	8	and	and	CC
cord-005453-4057qib7	13299	9	mortality	mortality	NN
cord-005453-4057qib7	13299	10	in	in	IN
cord-005453-4057qib7	13299	11	patients	patient	NNS
cord-005453-4057qib7	13299	12	undergoing	undergo	VBG
cord-005453-4057qib7	13299	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13299	14	stem	stem	NN
cord-005453-4057qib7	13299	15	cell	cell	NN
cord-005453-4057qib7	13299	16	transplantation	transplantation	NN
cord-005453-4057qib7	13299	17	.	.	.
cord-005453-4057qib7	13300	1	Traditional	traditional	JJ
cord-005453-4057qib7	13300	2	antiviral	antiviral	JJ
cord-005453-4057qib7	13300	3	therapy	therapy	NN
cord-005453-4057qib7	13300	4	is	be	VBZ
cord-005453-4057qib7	13300	5	associated	associate	VBN
cord-005453-4057qib7	13300	6	with	with	IN
cord-005453-4057qib7	13300	7	lack	lack	NN
cord-005453-4057qib7	13300	8	of	of	IN
cord-005453-4057qib7	13300	9	efficacy	efficacy	NN
cord-005453-4057qib7	13300	10	,	,	,
cord-005453-4057qib7	13300	11	potential	potential	JJ
cord-005453-4057qib7	13300	12	toxicity	toxicity	NN
cord-005453-4057qib7	13300	13	,	,	,
cord-005453-4057qib7	13300	14	prolonged	prolong	VBN
cord-005453-4057qib7	13300	15	hospitalization	hospitalization	NN
cord-005453-4057qib7	13300	16	and	and	CC
cord-005453-4057qib7	13300	17	increased	increase	VBN
cord-005453-4057qib7	13300	18	patient	patient	NN
cord-005453-4057qib7	13300	19	costs	cost	NNS
cord-005453-4057qib7	13300	20	.	.	.
cord-005453-4057qib7	13301	1	Viral	viral	JJ
cord-005453-4057qib7	13301	2	specific	specific	JJ
cord-005453-4057qib7	13301	3	T	t	NN
cord-005453-4057qib7	13301	4	cells	cell	NNS
cord-005453-4057qib7	13301	5	can	can	MD
cord-005453-4057qib7	13301	6	be	be	VB
cord-005453-4057qib7	13301	7	manufactured	manufacture	VBN
cord-005453-4057qib7	13301	8	from	from	IN
cord-005453-4057qib7	13301	9	donor	donor	NN
cord-005453-4057qib7	13301	10	blood	blood	NN
cord-005453-4057qib7	13301	11	to	to	TO
cord-005453-4057qib7	13301	12	treat	treat	VB
cord-005453-4057qib7	13301	13	viral	viral	JJ
cord-005453-4057qib7	13301	14	infections	infection	NNS
cord-005453-4057qib7	13301	15	post	post	NN
cord-005453-4057qib7	13301	16	-	-	NN
cord-005453-4057qib7	13301	17	transplant	transplant	NN
cord-005453-4057qib7	13301	18	,	,	,
cord-005453-4057qib7	13301	19	and	and	CC
cord-005453-4057qib7	13301	20	are	be	VBP
cord-005453-4057qib7	13301	21	associated	associate	VBN
cord-005453-4057qib7	13301	22	with	with	IN
cord-005453-4057qib7	13301	23	increased	increase	VBN
cord-005453-4057qib7	13301	24	clinical	clinical	JJ
cord-005453-4057qib7	13301	25	efficacy	efficacy	NN
cord-005453-4057qib7	13301	26	and	and	CC
cord-005453-4057qib7	13301	27	low	low	JJ
cord-005453-4057qib7	13301	28	toxicity	toxicity	NN
cord-005453-4057qib7	13301	29	.	.	.
cord-005453-4057qib7	13302	1	We	-PRON-	PRP
cord-005453-4057qib7	13302	2	postulated	postulate	VBD
cord-005453-4057qib7	13302	3	that	that	IN
cord-005453-4057qib7	13302	4	direct	direct	JJ
cord-005453-4057qib7	13302	5	costs	cost	NNS
cord-005453-4057qib7	13302	6	of	of	IN
cord-005453-4057qib7	13302	7	VST	VST	NNP
cord-005453-4057qib7	13302	8	therapy	therapy	NN
cord-005453-4057qib7	13302	9	are	be	VBP
cord-005453-4057qib7	13302	10	lower	low	JJR
cord-005453-4057qib7	13302	11	compared	compare	VBN
cord-005453-4057qib7	13302	12	to	to	IN
cord-005453-4057qib7	13302	13	traditional	traditional	JJ
cord-005453-4057qib7	13302	14	anti	anti	JJ
cord-005453-4057qib7	13302	15	-	-	JJ
cord-005453-4057qib7	13302	16	viral	viral	JJ
cord-005453-4057qib7	13302	17	medications	medication	NNS
cord-005453-4057qib7	13302	18	Methods	method	NNS
cord-005453-4057qib7	13302	19	:	:	:
cord-005453-4057qib7	13302	20	VSTs	vst	NNS
cord-005453-4057qib7	13302	21	were	be	VBD
cord-005453-4057qib7	13302	22	manufactured	manufacture	VBN
cord-005453-4057qib7	13302	23	according	accord	VBG
cord-005453-4057qib7	13302	24	to	to	IN
cord-005453-4057qib7	13302	25	local	local	JJ
cord-005453-4057qib7	13302	26	protocols	protocol	NNS
cord-005453-4057qib7	13302	27	and	and	CC
cord-005453-4057qib7	13302	28	FDA	FDA	NNP
cord-005453-4057qib7	13302	29	requirements	requirement	NNS
cord-005453-4057qib7	13302	30	.	.	.
cord-005453-4057qib7	13303	1	Total	total	JJ
cord-005453-4057qib7	13303	2	drug	drug	NN
cord-005453-4057qib7	13303	3	cost	cost	NN
cord-005453-4057qib7	13303	4	(	(	-LRB-
cord-005453-4057qib7	13303	5	as	as	IN
cord-005453-4057qib7	13303	6	per	per	IN
cord-005453-4057qib7	13303	7	institutional	institutional	JJ
cord-005453-4057qib7	13303	8	charges	charge	NNS
cord-005453-4057qib7	13303	9	per	per	IN
cord-005453-4057qib7	13303	10	drug	drug	NN
cord-005453-4057qib7	13303	11	)	)	-RRB-
cord-005453-4057qib7	13303	12	was	be	VBD
cord-005453-4057qib7	13303	13	calculated	calculate	VBN
cord-005453-4057qib7	13303	14	for	for	IN
cord-005453-4057qib7	13303	15	patients	patient	NNS
cord-005453-4057qib7	13303	16	who	who	WP
cord-005453-4057qib7	13303	17	required	require	VBD
cord-005453-4057qib7	13303	18	treatment	treatment	NN
cord-005453-4057qib7	13303	19	for	for	IN
cord-005453-4057qib7	13303	20	viral	viral	JJ
cord-005453-4057qib7	13303	21	infections	infection	NNS
cord-005453-4057qib7	13303	22	post	post	VBP
cord-005453-4057qib7	13303	23	-	-	JJ
cord-005453-4057qib7	13303	24	HSCT	HSCT	NNP
cord-005453-4057qib7	13303	25	.	.	.
cord-005453-4057qib7	13304	1	Manufacturing	manufacturing	NN
cord-005453-4057qib7	13304	2	costs	cost	NNS
cord-005453-4057qib7	13304	3	of	of	IN
cord-005453-4057qib7	13304	4	VSTs	vst	NNS
cord-005453-4057qib7	13304	5	are	be	VBP
cord-005453-4057qib7	13304	6	fixed	fix	VBN
cord-005453-4057qib7	13304	7	per	per	IN
cord-005453-4057qib7	13304	8	FDA	FDA	NNP
cord-005453-4057qib7	13304	9	requirements	requirement	NNS
cord-005453-4057qib7	13304	10	.	.	.
cord-005453-4057qib7	13305	1	Patients	patient	NNS
cord-005453-4057qib7	13305	2	who	who	WP
cord-005453-4057qib7	13305	3	were	be	VBD
cord-005453-4057qib7	13305	4	treated	treat	VBN
cord-005453-4057qib7	13305	5	with	with	IN
cord-005453-4057qib7	13305	6	investigational	investigational	JJ
cord-005453-4057qib7	13305	7	antiviral	antiviral	JJ
cord-005453-4057qib7	13305	8	medications	medication	NNS
cord-005453-4057qib7	13305	9	(	(	-LRB-
cord-005453-4057qib7	13305	10	including	include	VBG
cord-005453-4057qib7	13305	11	brincidofovir	brincidofovir	NNS
cord-005453-4057qib7	13305	12	)	)	-RRB-
cord-005453-4057qib7	13305	13	were	be	VBD
cord-005453-4057qib7	13305	14	excluded	exclude	VBN
cord-005453-4057qib7	13305	15	from	from	IN
cord-005453-4057qib7	13305	16	analysis	analysis	NN
cord-005453-4057qib7	13305	17	.	.	.
cord-005453-4057qib7	13306	1	Patients	patient	NNS
cord-005453-4057qib7	13306	2	treated	treat	VBN
cord-005453-4057qib7	13306	3	with	with	IN
cord-005453-4057qib7	13306	4	VSTs	vst	NNS
cord-005453-4057qib7	13306	5	+	+	CC
cord-005453-4057qib7	13306	6	/anti	/anti	JJ
cord-005453-4057qib7	13306	7	-	-	HYPH
cord-005453-4057qib7	13306	8	viral	viral	JJ
cord-005453-4057qib7	13306	9	medications	medication	NNS
cord-005453-4057qib7	13306	10	over	over	IN
cord-005453-4057qib7	13306	11	a	a	DT
cord-005453-4057qib7	13306	12	2	2	CD
cord-005453-4057qib7	13306	13	year	year	NN
cord-005453-4057qib7	13306	14	period	period	NN
cord-005453-4057qib7	13306	15	were	be	VBD
cord-005453-4057qib7	13306	16	compared	compare	VBN
cord-005453-4057qib7	13306	17	to	to	IN
cord-005453-4057qib7	13306	18	patients	patient	NNS
cord-005453-4057qib7	13306	19	treated	treat	VBN
cord-005453-4057qib7	13306	20	only	only	RB
cord-005453-4057qib7	13306	21	using	use	VBG
cord-005453-4057qib7	13306	22	traditional	traditional	JJ
cord-005453-4057qib7	13306	23	anti	anti	JJ
cord-005453-4057qib7	13306	24	-	-	JJ
cord-005453-4057qib7	13306	25	viral	viral	JJ
cord-005453-4057qib7	13306	26	medications	medication	NNS
cord-005453-4057qib7	13306	27	,	,	,
cord-005453-4057qib7	13306	28	including	include	VBG
cord-005453-4057qib7	13306	29	cidofovir	cidofovir	NNS
cord-005453-4057qib7	13306	30	,	,	,
cord-005453-4057qib7	13306	31	ganciclovir	ganciclovir	NNP
cord-005453-4057qib7	13306	32	,	,	,
cord-005453-4057qib7	13306	33	valganciclovir	valganciclovir	NNP
cord-005453-4057qib7	13306	34	,	,	,
cord-005453-4057qib7	13306	35	foscarnet	foscarnet	NN
cord-005453-4057qib7	13306	36	and	and	CC
cord-005453-4057qib7	13306	37	rituximab	rituximab	NN
cord-005453-4057qib7	13306	38	.	.	.
cord-005453-4057qib7	13307	1	Results	result	NNS
cord-005453-4057qib7	13307	2	:	:	:
cord-005453-4057qib7	13308	1	Demographics	demographic	NNS
cord-005453-4057qib7	13308	2	are	be	VBP
cord-005453-4057qib7	13308	3	shown	show	VBN
cord-005453-4057qib7	13308	4	in	in	IN
cord-005453-4057qib7	13308	5	Table	Table	NNP
cord-005453-4057qib7	13308	6	1	1	CD
cord-005453-4057qib7	13308	7	.	.	.
cord-005453-4057qib7	13309	1	There	there	EX
cord-005453-4057qib7	13309	2	were	be	VBD
cord-005453-4057qib7	13309	3	no	no	DT
cord-005453-4057qib7	13309	4	major	major	JJ
cord-005453-4057qib7	13309	5	differences	difference	NNS
cord-005453-4057qib7	13309	6	between	between	IN
cord-005453-4057qib7	13309	7	the	the	DT
cord-005453-4057qib7	13309	8	two	two	CD
cord-005453-4057qib7	13309	9	groups	group	NNS
cord-005453-4057qib7	13309	10	treated	treat	VBN
cord-005453-4057qib7	13309	11	.	.	.
cord-005453-4057qib7	13310	1	The	the	DT
cord-005453-4057qib7	13310	2	number	number	NN
cord-005453-4057qib7	13310	3	of	of	IN
cord-005453-4057qib7	13310	4	anti	anti	JJ
cord-005453-4057qib7	13310	5	-	-	JJ
cord-005453-4057qib7	13310	6	viral	viral	JJ
cord-005453-4057qib7	13310	7	medications	medication	NNS
cord-005453-4057qib7	13310	8	used	use	VBN
cord-005453-4057qib7	13310	9	in	in	IN
cord-005453-4057qib7	13310	10	the	the	DT
cord-005453-4057qib7	13310	11	VST	VST	NNP
cord-005453-4057qib7	13310	12	group	group	NN
cord-005453-4057qib7	13310	13	was	be	VBD
cord-005453-4057qib7	13310	14	lower	low	JJR
cord-005453-4057qib7	13310	15	compared	compare	VBN
cord-005453-4057qib7	13310	16	to	to	IN
cord-005453-4057qib7	13310	17	the	the	DT
cord-005453-4057qib7	13310	18	anti	anti	JJ
cord-005453-4057qib7	13310	19	-	-	JJ
cord-005453-4057qib7	13310	20	viral	viral	JJ
cord-005453-4057qib7	13310	21	treatment	treatment	NN
cord-005453-4057qib7	13310	22	group	group	NN
cord-005453-4057qib7	13310	23	.	.	.
cord-005453-4057qib7	13311	1	Median	median	JJ
cord-005453-4057qib7	13311	2	cost	cost	NN
cord-005453-4057qib7	13311	3	of	of	IN
cord-005453-4057qib7	13311	4	VST	VST	NNP
cord-005453-4057qib7	13311	5	treatment	treatment	NN
cord-005453-4057qib7	13311	6	was	be	VBD
cord-005453-4057qib7	13311	7	significantly	significantly	RB
cord-005453-4057qib7	13311	8	lower	low	JJR
cord-005453-4057qib7	13311	9	compared	compare	VBN
cord-005453-4057qib7	13311	10	to	to	IN
cord-005453-4057qib7	13311	11	those	those	DT
cord-005453-4057qib7	13311	12	threated	threate	VBN
cord-005453-4057qib7	13311	13	with	with	IN
cord-005453-4057qib7	13311	14	traditional	traditional	JJ
cord-005453-4057qib7	13311	15	anti	anti	JJ
cord-005453-4057qib7	13311	16	-	-	JJ
cord-005453-4057qib7	13311	17	viral	viral	JJ
cord-005453-4057qib7	13311	18	therapy	therapy	NN
cord-005453-4057qib7	13311	19	(	(	-LRB-
cord-005453-4057qib7	13311	20	$	$	$
cord-005453-4057qib7	13311	21	12,757	12,757	CD
cord-005453-4057qib7	13311	22	vs	vs	IN
cord-005453-4057qib7	13311	23	$	$	$
cord-005453-4057qib7	13311	24	16,392	16,392	CD
cord-005453-4057qib7	13311	25	,	,	,
cord-005453-4057qib7	13311	26	p	p	NN
cord-005453-4057qib7	13311	27	-	-	:
cord-005453-4057qib7	13311	28	value=0.03	value=0.03	NNP
cord-005453-4057qib7	13311	29	)	)	-RRB-
cord-005453-4057qib7	13311	30	.	.	.
cord-005453-4057qib7	13312	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13312	2	:	:	:
cord-005453-4057qib7	13313	1	Treatment	treatment	NN
cord-005453-4057qib7	13313	2	with	with	IN
cord-005453-4057qib7	13313	3	VSTs	vst	NNS
cord-005453-4057qib7	13313	4	post	post	VBP
cord-005453-4057qib7	13313	5	-	-	JJ
cord-005453-4057qib7	13313	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13313	7	for	for	IN
cord-005453-4057qib7	13313	8	viral	viral	JJ
cord-005453-4057qib7	13313	9	infections	infection	NNS
cord-005453-4057qib7	13313	10	was	be	VBD
cord-005453-4057qib7	13313	11	lower	low	JJR
cord-005453-4057qib7	13313	12	in	in	IN
cord-005453-4057qib7	13313	13	cost	cost	NN
cord-005453-4057qib7	13313	14	compared	compare	VBN
cord-005453-4057qib7	13313	15	to	to	IN
cord-005453-4057qib7	13313	16	anti	anti	JJ
cord-005453-4057qib7	13313	17	-	-	JJ
cord-005453-4057qib7	13313	18	viral	viral	JJ
cord-005453-4057qib7	13313	19	medical	medical	JJ
cord-005453-4057qib7	13313	20	therapy	therapy	NN
cord-005453-4057qib7	13313	21	.	.	.
cord-005453-4057qib7	13314	1	It	-PRON-	PRP
cord-005453-4057qib7	13314	2	is	be	VBZ
cord-005453-4057qib7	13314	3	likely	likely	JJ
cord-005453-4057qib7	13314	4	that	that	IN
cord-005453-4057qib7	13314	5	overall	overall	JJ
cord-005453-4057qib7	13314	6	costs	cost	NNS
cord-005453-4057qib7	13314	7	are	be	VBP
cord-005453-4057qib7	13314	8	further	further	RB
cord-005453-4057qib7	13314	9	reduced	reduce	VBN
cord-005453-4057qib7	13314	10	with	with	IN
cord-005453-4057qib7	13314	11	VSTs	vst	NNS
cord-005453-4057qib7	13314	12	due	due	JJ
cord-005453-4057qib7	13314	13	to	to	IN
cord-005453-4057qib7	13314	14	reduced	reduce	VBN
cord-005453-4057qib7	13314	15	inpatient	inpatient	JJ
cord-005453-4057qib7	13314	16	hospital	hospital	NN
cord-005453-4057qib7	13314	17	time	time	NN
cord-005453-4057qib7	13314	18	,	,	,
cord-005453-4057qib7	13314	19	less	less	JJR
cord-005453-4057qib7	13314	20	monitoring	monitoring	NN
cord-005453-4057qib7	13314	21	of	of	IN
cord-005453-4057qib7	13314	22	labs	lab	NNS
cord-005453-4057qib7	13314	23	associated	associate	VBN
cord-005453-4057qib7	13314	24	with	with	IN
cord-005453-4057qib7	13314	25	anti	anti	JJ
cord-005453-4057qib7	13314	26	-	-	JJ
cord-005453-4057qib7	13314	27	viral	viral	JJ
cord-005453-4057qib7	13314	28	medication	medication	NN
cord-005453-4057qib7	13314	29	side	side	NN
cord-005453-4057qib7	13314	30	-	-	HYPH
cord-005453-4057qib7	13314	31	effects	effect	NNS
cord-005453-4057qib7	13314	32	and	and	CC
cord-005453-4057qib7	13314	33	reduced	reduce	VBN
cord-005453-4057qib7	13314	34	ancillary	ancillary	JJ
cord-005453-4057qib7	13314	35	costs	cost	NNS
cord-005453-4057qib7	13314	36	including	include	VBG
cord-005453-4057qib7	13314	37	nursing	nursing	NN
cord-005453-4057qib7	13314	38	and	and	CC
cord-005453-4057qib7	13314	39	pharmacy	pharmacy	NN
cord-005453-4057qib7	13314	40	.	.	.
cord-005453-4057qib7	13315	1	More	More	JJR
cord-005453-4057qib7	13315	2	studies	study	NNS
cord-005453-4057qib7	13315	3	are	be	VBP
cord-005453-4057qib7	13315	4	needed	need	VBN
cord-005453-4057qib7	13315	5	to	to	TO
cord-005453-4057qib7	13315	6	examine	examine	VB
cord-005453-4057qib7	13315	7	these	these	DT
cord-005453-4057qib7	13315	8	indirect	indirect	JJ
cord-005453-4057qib7	13315	9	costs	cost	NNS
cord-005453-4057qib7	13315	10	further	further	RB
cord-005453-4057qib7	13315	11	.	.	.
cord-005453-4057qib7	13316	1	Background	background	NN
cord-005453-4057qib7	13316	2	:	:	:
cord-005453-4057qib7	13317	1	DOCK8	DOCK8	NNP
cord-005453-4057qib7	13317	2	deficiency	deficiency	NN
cord-005453-4057qib7	13317	3	is	be	VBZ
cord-005453-4057qib7	13317	4	an	an	DT
cord-005453-4057qib7	13317	5	autosomal	autosomal	JJ
cord-005453-4057qib7	13317	6	recessive	recessive	JJ
cord-005453-4057qib7	13317	7	primary	primary	JJ
cord-005453-4057qib7	13317	8	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	13317	9	(	(	-LRB-
cord-005453-4057qib7	13317	10	PID	PID	NNP
cord-005453-4057qib7	13317	11	)	)	-RRB-
cord-005453-4057qib7	13317	12	disease	disease	NN
cord-005453-4057qib7	13317	13	caused	cause	VBN
cord-005453-4057qib7	13317	14	by	by	IN
cord-005453-4057qib7	13317	15	loss	loss	NN
cord-005453-4057qib7	13317	16	-	-	HYPH
cord-005453-4057qib7	13317	17	offunction	offunction	NN
cord-005453-4057qib7	13317	18	mutations	mutation	NNS
cord-005453-4057qib7	13317	19	in	in	IN
cord-005453-4057qib7	13317	20	the	the	DT
cord-005453-4057qib7	13317	21	DOCK8	dock8	NN
cord-005453-4057qib7	13317	22	gene	gene	NN
cord-005453-4057qib7	13317	23	(	(	-LRB-
cord-005453-4057qib7	13317	24	1	1	CD
cord-005453-4057qib7	13317	25	)	)	-RRB-
cord-005453-4057qib7	13317	26	.	.	.
cord-005453-4057qib7	13318	1	Patients	patient	NNS
cord-005453-4057qib7	13318	2	with	with	IN
cord-005453-4057qib7	13318	3	DOCK8	dock8	NN
cord-005453-4057qib7	13318	4	deficiency	deficiency	NN
cord-005453-4057qib7	13318	5	present	present	JJ
cord-005453-4057qib7	13318	6	with	with	IN
cord-005453-4057qib7	13318	7	multiple	multiple	JJ
cord-005453-4057qib7	13318	8	abnormalities	abnormality	NNS
cord-005453-4057qib7	13318	9	of	of	IN
cord-005453-4057qib7	13318	10	the	the	DT
cord-005453-4057qib7	13318	11	immune	immune	JJ
cord-005453-4057qib7	13318	12	system	system	NN
cord-005453-4057qib7	13318	13	,	,	,
cord-005453-4057qib7	13318	14	including	include	VBG
cord-005453-4057qib7	13318	15	defective	defective	JJ
cord-005453-4057qib7	13318	16	T	T	NNP
cord-005453-4057qib7	13318	17	cell	cell	NN
cord-005453-4057qib7	13318	18	function	function	NN
cord-005453-4057qib7	13318	19	and	and	CC
cord-005453-4057qib7	13318	20	impaired	impaired	JJ
cord-005453-4057qib7	13318	21	production	production	NN
cord-005453-4057qib7	13318	22	of	of	IN
cord-005453-4057qib7	13318	23	antigen	antigen	NN
cord-005453-4057qib7	13318	24	-	-	HYPH
cord-005453-4057qib7	13318	25	specific	specific	JJ
cord-005453-4057qib7	13318	26	antibodies	antibody	NNS
cord-005453-4057qib7	13318	27	.	.	.
cord-005453-4057qib7	13319	1	These	these	DT
cord-005453-4057qib7	13319	2	lead	lead	VBP
cord-005453-4057qib7	13319	3	to	to	IN
cord-005453-4057qib7	13319	4	persistent	persistent	JJ
cord-005453-4057qib7	13319	5	viral	viral	JJ
cord-005453-4057qib7	13319	6	infections	infection	NNS
cord-005453-4057qib7	13319	7	of	of	IN
cord-005453-4057qib7	13319	8	the	the	DT
cord-005453-4057qib7	13319	9	skin	skin	NN
cord-005453-4057qib7	13319	10	,	,	,
cord-005453-4057qib7	13319	11	mucocutaneous	mucocutaneous	JJ
cord-005453-4057qib7	13319	12	candidiasis	candidiasis	NN
cord-005453-4057qib7	13319	13	,	,	,
cord-005453-4057qib7	13319	14	recurrent	recurrent	JJ
cord-005453-4057qib7	13319	15	sinopulmonary	sinopulmonary	JJ
cord-005453-4057qib7	13319	16	infections	infection	NNS
cord-005453-4057qib7	13319	17	,	,	,
cord-005453-4057qib7	13319	18	atopic	atopic	JJ
cord-005453-4057qib7	13319	19	dermatitis	dermatitis	NN
cord-005453-4057qib7	13319	20	,	,	,
cord-005453-4057qib7	13319	21	and	and	CC
cord-005453-4057qib7	13319	22	other	other	JJ
cord-005453-4057qib7	13319	23	allergic	allergic	JJ
cord-005453-4057qib7	13319	24	disease	disease	NN
cord-005453-4057qib7	13319	25	,	,	,
cord-005453-4057qib7	13319	26	malignancies	malignancy	NNS
cord-005453-4057qib7	13319	27	,	,	,
cord-005453-4057qib7	13319	28	and	and	CC
cord-005453-4057qib7	13319	29	sometimes	sometimes	RB
cord-005453-4057qib7	13319	30	autoimmunity	autoimmunity	NN
cord-005453-4057qib7	13319	31	(	(	-LRB-
cord-005453-4057qib7	13319	32	2	2	CD
cord-005453-4057qib7	13319	33	)	)	-RRB-
cord-005453-4057qib7	13319	34	.	.	.
cord-005453-4057qib7	13320	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13320	2	stem	stem	NN
cord-005453-4057qib7	13320	3	cell	cell	NN
cord-005453-4057qib7	13320	4	transplantation	transplantation	NN
cord-005453-4057qib7	13320	5	(	(	-LRB-
cord-005453-4057qib7	13320	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13320	7	)	)	-RRB-
cord-005453-4057qib7	13320	8	is	be	VBZ
cord-005453-4057qib7	13320	9	currently	currently	RB
cord-005453-4057qib7	13320	10	the	the	DT
cord-005453-4057qib7	13320	11	only	only	JJ
cord-005453-4057qib7	13320	12	curative	curative	JJ
cord-005453-4057qib7	13320	13	treatment	treatment	NN
cord-005453-4057qib7	13320	14	option	option	NN
cord-005453-4057qib7	13320	15	available	available	JJ
cord-005453-4057qib7	13320	16	(	(	-LRB-
cord-005453-4057qib7	13320	17	3	3	CD
cord-005453-4057qib7	13320	18	)	)	-RRB-
cord-005453-4057qib7	13320	19	.	.	.
cord-005453-4057qib7	13321	1	Methods	method	NNS
cord-005453-4057qib7	13322	1	:	:	:
cord-005453-4057qib7	13322	2	We	-PRON-	PRP
cord-005453-4057qib7	13322	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	13322	4	evaluated	evaluate	VBD
cord-005453-4057qib7	13322	5	our	-PRON-	PRP$
cord-005453-4057qib7	13322	6	patients	patient	NNS
cord-005453-4057qib7	13322	7	who	who	WP
cord-005453-4057qib7	13322	8	underwent	undergo	VBD
cord-005453-4057qib7	13322	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	13322	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13322	11	stem	stem	NN
cord-005453-4057qib7	13322	12	cell	cell	NN
cord-005453-4057qib7	13322	13	transplantation	transplantation	NN
cord-005453-4057qib7	13322	14	due	due	IN
cord-005453-4057qib7	13322	15	to	to	IN
cord-005453-4057qib7	13322	16	DOCK8	dock8	XX
cord-005453-4057qib7	13322	17	deficiency	deficiency	NN
cord-005453-4057qib7	13322	18	in	in	IN
cord-005453-4057qib7	13322	19	Ege	Ege	NNP
cord-005453-4057qib7	13322	20	University	University	NNP
cord-005453-4057qib7	13322	21	Pediatric	Pediatric	NNP
cord-005453-4057qib7	13322	22	Stem	Stem	NNP
cord-005453-4057qib7	13322	23	Cell	Cell	NNP
cord-005453-4057qib7	13322	24	Transplantation	Transplantation	NNP
cord-005453-4057qib7	13322	25	Unit	Unit	NNP
cord-005453-4057qib7	13322	26	between	between	IN
cord-005453-4057qib7	13322	27	2013	2013	CD
cord-005453-4057qib7	13322	28	and	and	CC
cord-005453-4057qib7	13322	29	2018	2018	CD
cord-005453-4057qib7	13322	30	.	.	.
cord-005453-4057qib7	13323	1	Results	result	NNS
cord-005453-4057qib7	13323	2	:	:	:
cord-005453-4057qib7	13324	1	We	-PRON-	PRP
cord-005453-4057qib7	13324	2	identified	identify	VBD
cord-005453-4057qib7	13324	3	16	16	CD
cord-005453-4057qib7	13324	4	patients	patient	NNS
cord-005453-4057qib7	13324	5	transplanted	transplant	VBN
cord-005453-4057qib7	13324	6	at	at	IN
cord-005453-4057qib7	13324	7	a	a	DT
cord-005453-4057qib7	13324	8	median	median	JJ
cord-005453-4057qib7	13324	9	age	age	NN
cord-005453-4057qib7	13324	10	of	of	IN
cord-005453-4057qib7	13324	11	7.8	7.8	CD
cord-005453-4057qib7	13324	12	years	year	NNS
cord-005453-4057qib7	13324	13	(	(	-LRB-
cord-005453-4057qib7	13324	14	range	range	NN
cord-005453-4057qib7	13324	15	:	:	:
cord-005453-4057qib7	13324	16	2	2	CD
cord-005453-4057qib7	13324	17	-	-	SYM
cord-005453-4057qib7	13324	18	15.5	15.5	CD
cord-005453-4057qib7	13324	19	years	year	NNS
cord-005453-4057qib7	13324	20	)	)	-RRB-
cord-005453-4057qib7	13324	21	.	.	.
cord-005453-4057qib7	13325	1	Of	of	IN
cord-005453-4057qib7	13325	2	16	16	CD
cord-005453-4057qib7	13325	3	patients	patient	NNS
cord-005453-4057qib7	13325	4	;	;	:
cord-005453-4057qib7	13325	5	4	4	CD
cord-005453-4057qib7	13325	6	(	(	-LRB-
cord-005453-4057qib7	13325	7	%	%	NN
cord-005453-4057qib7	13325	8	25	25	CD
cord-005453-4057qib7	13325	9	)	)	-RRB-
cord-005453-4057qib7	13325	10	received	receive	VBD
cord-005453-4057qib7	13325	11	HSCT	HSCT	NNP
cord-005453-4057qib7	13325	12	from	from	IN
cord-005453-4057qib7	13325	13	matched	match	VBN
cord-005453-4057qib7	13325	14	sibling	sibling	NN
cord-005453-4057qib7	13325	15	,	,	,
cord-005453-4057qib7	13325	16	11	11	CD
cord-005453-4057qib7	13325	17	(	(	-LRB-
cord-005453-4057qib7	13325	18	%	%	NN
cord-005453-4057qib7	13325	19	68	68	CD
cord-005453-4057qib7	13325	20	)	)	-RRB-
cord-005453-4057qib7	13325	21	from	from	IN
cord-005453-4057qib7	13325	22	unrelated	unrelated	JJ
cord-005453-4057qib7	13325	23	donors	donor	NNS
cord-005453-4057qib7	13325	24	and	and	CC
cord-005453-4057qib7	13325	25	1	1	CD
cord-005453-4057qib7	13325	26	patient	patient	NN
cord-005453-4057qib7	13325	27	from	from	IN
cord-005453-4057qib7	13325	28	haploidentical	haploidentical	JJ
cord-005453-4057qib7	13325	29	donor	donor	NN
cord-005453-4057qib7	13325	30	.	.	.
cord-005453-4057qib7	13326	1	We	-PRON-	PRP
cord-005453-4057qib7	13326	2	used	use	VBD
cord-005453-4057qib7	13326	3	busulfan	busulfan	NN
cord-005453-4057qib7	13326	4	-	-	HYPH
cord-005453-4057qib7	13326	5	based	base	VBN
cord-005453-4057qib7	13326	6	myeloablative	myeloablative	NNP
cord-005453-4057qib7	13326	7	conditioning	conditioning	NN
cord-005453-4057qib7	13326	8	regimen	regimen	NN
cord-005453-4057qib7	13326	9	to	to	IN
cord-005453-4057qib7	13326	10	12	12	CD
cord-005453-4057qib7	13326	11	patients	patient	NNS
cord-005453-4057qib7	13326	12	(	(	-LRB-
cord-005453-4057qib7	13326	13	%	%	NN
cord-005453-4057qib7	13326	14	75	75	CD
cord-005453-4057qib7	13326	15	)	)	-RRB-
cord-005453-4057qib7	13326	16	,	,	,
cord-005453-4057qib7	13326	17	reduced	reduce	VBN
cord-005453-4057qib7	13326	18	toxicity	toxicity	NN
cord-005453-4057qib7	13326	19	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13326	20	regimen	regimen	NN
cord-005453-4057qib7	13326	21	with	with	IN
cord-005453-4057qib7	13326	22	treosulfan	treosulfan	NNP
cord-005453-4057qib7	13326	23	to	to	IN
cord-005453-4057qib7	13326	24	2	2	CD
cord-005453-4057qib7	13326	25	patients	patient	NNS
cord-005453-4057qib7	13326	26	(	(	-LRB-
cord-005453-4057qib7	13326	27	%	%	NN
cord-005453-4057qib7	13326	28	12.5	12.5	CD
cord-005453-4057qib7	13326	29	)	)	-RRB-
cord-005453-4057qib7	13326	30	and	and	CC
cord-005453-4057qib7	13326	31	nonmyeloablative	nonmyeloablative	JJ
cord-005453-4057qib7	13326	32	regimen	regimen	NN
cord-005453-4057qib7	13326	33	to	to	IN
cord-005453-4057qib7	13326	34	2	2	CD
cord-005453-4057qib7	13326	35	patients	patient	NNS
cord-005453-4057qib7	13326	36	(	(	-LRB-
cord-005453-4057qib7	13326	37	%	%	NN
cord-005453-4057qib7	13326	38	12.5	12.5	CD
cord-005453-4057qib7	13326	39	)	)	-RRB-
cord-005453-4057qib7	13326	40	.	.	.
cord-005453-4057qib7	13327	1	Eight	eight	CD
cord-005453-4057qib7	13327	2	of	of	IN
cord-005453-4057qib7	13327	3	the	the	DT
cord-005453-4057qib7	13327	4	recipients	recipient	NNS
cord-005453-4057qib7	13327	5	received	receive	VBD
cord-005453-4057qib7	13327	6	bone	bone	NN
cord-005453-4057qib7	13327	7	marrow	marrow	NN
cord-005453-4057qib7	13327	8	,	,	,
cord-005453-4057qib7	13327	9	6	6	CD
cord-005453-4057qib7	13327	10	of	of	IN
cord-005453-4057qib7	13327	11	the	the	DT
cord-005453-4057qib7	13327	12	patients	patient	NNS
cord-005453-4057qib7	13327	13	received	receive	VBD
cord-005453-4057qib7	13327	14	peripheral	peripheral	JJ
cord-005453-4057qib7	13327	15	blood	blood	NN
cord-005453-4057qib7	13327	16	stem	stem	NN
cord-005453-4057qib7	13327	17	cells	cell	NNS
cord-005453-4057qib7	13327	18	,	,	,
cord-005453-4057qib7	13327	19	2	2	CD
cord-005453-4057qib7	13327	20	of	of	IN
cord-005453-4057qib7	13327	21	the	the	DT
cord-005453-4057qib7	13327	22	recipients	recipient	NNS
cord-005453-4057qib7	13327	23	received	receive	VBD
cord-005453-4057qib7	13327	24	cord	cord	NN
cord-005453-4057qib7	13327	25	blood	blood	NN
cord-005453-4057qib7	13327	26	as	as	IN
cord-005453-4057qib7	13327	27	stem	stem	NN
cord-005453-4057qib7	13327	28	cell	cell	NN
cord-005453-4057qib7	13327	29	source	source	NN
cord-005453-4057qib7	13327	30	.	.	.
cord-005453-4057qib7	13328	1	Fifteen	fifteen	CD
cord-005453-4057qib7	13328	2	of	of	IN
cord-005453-4057qib7	13328	3	16	16	CD
cord-005453-4057qib7	13328	4	patients	patient	NNS
cord-005453-4057qib7	13328	5	(	(	-LRB-
cord-005453-4057qib7	13328	6	%	%	NN
cord-005453-4057qib7	13328	7	93	93	CD
cord-005453-4057qib7	13328	8	)	)	-RRB-
cord-005453-4057qib7	13328	9	had	have	VBD
cord-005453-4057qib7	13328	10	achieved	achieve	VBN
cord-005453-4057qib7	13329	1	engraftment	engraftment	NNP
cord-005453-4057qib7	13329	2	and	and	CC
cord-005453-4057qib7	13329	3	median	median	JJ
cord-005453-4057qib7	13329	4	follow	follow	NN
cord-005453-4057qib7	13329	5	-	-	HYPH
cord-005453-4057qib7	13329	6	up	up	NN
cord-005453-4057qib7	13329	7	of	of	IN
cord-005453-4057qib7	13329	8	patients	patient	NNS
cord-005453-4057qib7	13329	9	was	be	VBD
cord-005453-4057qib7	13329	10	29	29	CD
cord-005453-4057qib7	13329	11	months	month	NNS
cord-005453-4057qib7	13329	12	(	(	-LRB-
cord-005453-4057qib7	13329	13	1	1	CD
cord-005453-4057qib7	13329	14	-	-	SYM
cord-005453-4057qib7	13329	15	64	64	CD
cord-005453-4057qib7	13329	16	)	)	-RRB-
cord-005453-4057qib7	13329	17	.	.	.
cord-005453-4057qib7	13330	1	Grade	grade	NN
cord-005453-4057qib7	13330	2	III	III	NNP
cord-005453-4057qib7	13330	3	-	-	HYPH
cord-005453-4057qib7	13330	4	IV	IV	NNP
cord-005453-4057qib7	13330	5	acute	acute	JJ
cord-005453-4057qib7	13330	6	graft	graft	NN
cord-005453-4057qib7	13330	7	versus	versus	IN
cord-005453-4057qib7	13330	8	host	host	NN
cord-005453-4057qib7	13330	9	disease	disease	NN
cord-005453-4057qib7	13330	10	(	(	-LRB-
cord-005453-4057qib7	13330	11	GVHD	GVHD	NNP
cord-005453-4057qib7	13330	12	)	)	-RRB-
cord-005453-4057qib7	13330	13	occurred	occur	VBD
cord-005453-4057qib7	13330	14	in	in	IN
cord-005453-4057qib7	13330	15	13	13	CD
cord-005453-4057qib7	13330	16	%	%	NN
cord-005453-4057qib7	13330	17	of	of	IN
cord-005453-4057qib7	13330	18	patients	patient	NNS
cord-005453-4057qib7	13330	19	and	and	CC
cord-005453-4057qib7	13330	20	chronic	chronic	JJ
cord-005453-4057qib7	13330	21	graft	graft	NN
cord-005453-4057qib7	13330	22	versus	versus	IN
cord-005453-4057qib7	13330	23	host	host	NN
cord-005453-4057qib7	13330	24	disease	disease	NN
cord-005453-4057qib7	13330	25	was	be	VBD
cord-005453-4057qib7	13330	26	seen	see	VBN
cord-005453-4057qib7	13330	27	18	18	CD
cord-005453-4057qib7	13330	28	%	%	NN
cord-005453-4057qib7	13330	29	of	of	IN
cord-005453-4057qib7	13330	30	patients	patient	NNS
cord-005453-4057qib7	13330	31	.	.	.
cord-005453-4057qib7	13331	1	One	one	CD
cord-005453-4057qib7	13331	2	patient	patient	NN
cord-005453-4057qib7	13331	3	received	receive	VBD
cord-005453-4057qib7	13331	4	cord	cord	NN
cord-005453-4057qib7	13331	5	blood	blood	NN
cord-005453-4057qib7	13331	6	from	from	IN
cord-005453-4057qib7	13331	7	unrelated	unrelated	JJ
cord-005453-4057qib7	13331	8	donor	donor	NN
cord-005453-4057qib7	13331	9	did	do	VBD
cord-005453-4057qib7	13331	10	not	not	RB
cord-005453-4057qib7	13331	11	engraft	engraft	VB
cord-005453-4057qib7	13331	12	and	and	CC
cord-005453-4057qib7	13331	13	died	die	VBD
cord-005453-4057qib7	13331	14	from	from	IN
cord-005453-4057qib7	13331	15	septic	septic	JJ
cord-005453-4057qib7	13331	16	shock	shock	NN
cord-005453-4057qib7	13331	17	.	.	.
cord-005453-4057qib7	13332	1	Four	four	CD
cord-005453-4057qib7	13332	2	patients	patient	NNS
cord-005453-4057qib7	13332	3	died	die	VBD
cord-005453-4057qib7	13332	4	from	from	IN
cord-005453-4057qib7	13332	5	transplant	transplant	NN
cord-005453-4057qib7	13332	6	related	relate	VBN
cord-005453-4057qib7	13332	7	toxicity	toxicity	NN
cord-005453-4057qib7	13332	8	.	.	.
cord-005453-4057qib7	13333	1	Our	-PRON-	PRP$
cord-005453-4057qib7	13333	2	patient	patient	NN
cord-005453-4057qib7	13333	3	's	's	POS
cord-005453-4057qib7	13333	4	survival	survival	NN
cord-005453-4057qib7	13333	5	was	be	VBD
cord-005453-4057qib7	13333	6	%	%	NN
cord-005453-4057qib7	13333	7	68	68	CD
cord-005453-4057qib7	13333	8	;	;	:
cord-005453-4057qib7	13333	9	11/16	11/16	CD
cord-005453-4057qib7	13333	10	patients	patient	NNS
cord-005453-4057qib7	13333	11	alive	alive	JJ
cord-005453-4057qib7	13333	12	.	.	.
cord-005453-4057qib7	13334	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13334	2	:	:	:
cord-005453-4057qib7	13335	1	HSCT	HSCT	NNP
cord-005453-4057qib7	13335	2	is	be	VBZ
cord-005453-4057qib7	13335	3	the	the	DT
cord-005453-4057qib7	13335	4	only	only	JJ
cord-005453-4057qib7	13335	5	curative	curative	JJ
cord-005453-4057qib7	13335	6	treatment	treatment	NN
cord-005453-4057qib7	13335	7	option	option	NN
cord-005453-4057qib7	13335	8	for	for	IN
cord-005453-4057qib7	13335	9	DOCK8	DOCK8	NNP
cord-005453-4057qib7	13335	10	deficiency	deficiency	NN
cord-005453-4057qib7	13335	11	.	.	.
cord-005453-4057qib7	13336	1	In	in	IN
cord-005453-4057qib7	13336	2	particular	particular	JJ
cord-005453-4057qib7	13336	3	,	,	,
cord-005453-4057qib7	13336	4	patients	patient	NNS
cord-005453-4057qib7	13336	5	with	with	IN
cord-005453-4057qib7	13336	6	high	high	JJ
cord-005453-4057qib7	13336	7	comorbidity	comorbidity	NN
cord-005453-4057qib7	13336	8	scores	score	NNS
cord-005453-4057qib7	13336	9	have	have	VBP
cord-005453-4057qib7	13336	10	a	a	DT
cord-005453-4057qib7	13336	11	high	high	JJ
cord-005453-4057qib7	13336	12	risk	risk	NN
cord-005453-4057qib7	13336	13	of	of	IN
cord-005453-4057qib7	13336	14	toxicity	toxicity	NN
cord-005453-4057qib7	13336	15	and	and	CC
cord-005453-4057qib7	13336	16	toxic	toxic	JJ
cord-005453-4057qib7	13336	17	death	death	NN
cord-005453-4057qib7	13336	18	.	.	.
cord-005453-4057qib7	13337	1	Therefore	therefore	RB
cord-005453-4057qib7	13337	2	,	,	,
cord-005453-4057qib7	13337	3	reduced	reduce	VBN
cord-005453-4057qib7	13337	4	toxicity	toxicity	NN
cord-005453-4057qib7	13337	5	conditioning	conditioning	NN
cord-005453-4057qib7	13337	6	regimens	regimen	NNS
cord-005453-4057qib7	13337	7	should	should	MD
cord-005453-4057qib7	13337	8	be	be	VB
cord-005453-4057qib7	13337	9	used	use	VBN
cord-005453-4057qib7	13337	10	for	for	IN
cord-005453-4057qib7	13337	11	these	these	DT
cord-005453-4057qib7	13337	12	patients	patient	NNS
cord-005453-4057qib7	13337	13	.	.	.
cord-005453-4057qib7	13338	1	References	reference	NNS
cord-005453-4057qib7	13338	2	:	:	:
cord-005453-4057qib7	13339	1	Background	background	NN
cord-005453-4057qib7	13339	2	:	:	:
cord-005453-4057qib7	13339	3	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	13339	4	,	,	,
cord-005453-4057qib7	13339	5	a	a	DT
cord-005453-4057qib7	13339	6	low	low	JJ
cord-005453-4057qib7	13339	7	-	-	HYPH
cord-005453-4057qib7	13339	8	molecular	molecular	JJ
cord-005453-4057qib7	13339	9	-	-	HYPH
cord-005453-4057qib7	13339	10	weight	weight	NN
cord-005453-4057qib7	13339	11	synthetic	synthetic	NN
cord-005453-4057qib7	13339	12	nonpeptide	nonpeptide	NNP
cord-005453-4057qib7	13339	13	thrombopoietin	thrombopoietin	NNP
cord-005453-4057qib7	13339	14	receptor	receptor	NN
cord-005453-4057qib7	13339	15	agonist	agonist	NN
cord-005453-4057qib7	13340	1	(	(	-LRB-
cord-005453-4057qib7	13340	2	TPO	TPO	NNP
cord-005453-4057qib7	13340	3	-	-	HYPH
cord-005453-4057qib7	13340	4	R	R	NNP
cord-005453-4057qib7	13340	5	)	)	-RRB-
cord-005453-4057qib7	13340	6	,	,	,
cord-005453-4057qib7	13340	7	is	be	VBZ
cord-005453-4057qib7	13340	8	a	a	DT
cord-005453-4057qib7	13340	9	second	second	JJ
cord-005453-4057qib7	13340	10	-	-	HYPH
cord-005453-4057qib7	13340	11	generation	generation	NN
cord-005453-4057qib7	13340	12	TPO	TPO	NNP
cord-005453-4057qib7	13340	13	.	.	.
cord-005453-4057qib7	13341	1	It	-PRON-	PRP
cord-005453-4057qib7	13341	2	is	be	VBZ
cord-005453-4057qib7	13341	3	an	an	DT
cord-005453-4057qib7	13341	4	oral	oral	JJ
cord-005453-4057qib7	13341	5	thrombopoietin	thrombopoietin	XX
cord-005453-4057qib7	13341	6	mimetic	mimetic	NN
cord-005453-4057qib7	13341	7	licensed	license	VBN
cord-005453-4057qib7	13341	8	in	in	IN
cord-005453-4057qib7	13341	9	chronic	chronic	JJ
cord-005453-4057qib7	13341	10	immune	immune	JJ
cord-005453-4057qib7	13341	11	thrombocytopenic	thrombocytopenic	JJ
cord-005453-4057qib7	13341	12	purpura	purpura	NN
cord-005453-4057qib7	13341	13	that	that	WDT
cord-005453-4057qib7	13341	14	induces	induce	VBZ
cord-005453-4057qib7	13341	15	platelet	platelet	NN
cord-005453-4057qib7	13341	16	maturation	maturation	NN
cord-005453-4057qib7	13341	17	and	and	CC
cord-005453-4057qib7	13341	18	release	release	NN
cord-005453-4057qib7	13341	19	by	by	IN
cord-005453-4057qib7	13341	20	binding	bind	VBG
cord-005453-4057qib7	13341	21	to	to	IN
cord-005453-4057qib7	13341	22	c	c	NNP
cord-005453-4057qib7	13341	23	-	-	HYPH
cord-005453-4057qib7	13341	24	MPL	MPL	NNP
cord-005453-4057qib7	13341	25	receptors	receptor	NNS
cord-005453-4057qib7	13341	26	on	on	IN
cord-005453-4057qib7	13341	27	megakaryocytes	megakaryocyte	NNS
cord-005453-4057qib7	13341	28	.	.	.
cord-005453-4057qib7	13342	1	In	in	IN
cord-005453-4057qib7	13342	2	a	a	DT
cord-005453-4057qib7	13342	3	recent	recent	JJ
cord-005453-4057qib7	13342	4	study	study	NN
cord-005453-4057qib7	13342	5	;	;	:
cord-005453-4057qib7	13342	6	for	for	IN
cord-005453-4057qib7	13342	7	patients	patient	NNS
cord-005453-4057qib7	13342	8	with	with	IN
cord-005453-4057qib7	13342	9	refractory	refractory	JJ
cord-005453-4057qib7	13342	10	SAA	SAA	NNP
cord-005453-4057qib7	13342	11	,	,	,
cord-005453-4057qib7	13342	12	eltrombopag	eltrombopag	NNP
cord-005453-4057qib7	13342	13	induced	induce	VBD
cord-005453-4057qib7	13342	14	a	a	DT
cord-005453-4057qib7	13342	15	response	response	NN
cord-005453-4057qib7	13342	16	(	(	-LRB-
cord-005453-4057qib7	13342	17	at	at	IN
cord-005453-4057qib7	13342	18	12	12	CD
cord-005453-4057qib7	13342	19	weeks	week	NNS
cord-005453-4057qib7	13342	20	)	)	-RRB-
cord-005453-4057qib7	13342	21	in	in	IN
cord-005453-4057qib7	13342	22	at	at	RB
cord-005453-4057qib7	13342	23	least	least	RBS
cord-005453-4057qib7	13342	24	one	one	CD
cord-005453-4057qib7	13342	25	hematologic	hematologic	JJ
cord-005453-4057qib7	13342	26	lineage	lineage	NN
cord-005453-4057qib7	13342	27	in	in	IN
cord-005453-4057qib7	13342	28	44	44	CD
cord-005453-4057qib7	13342	29	%	%	NN
cord-005453-4057qib7	13342	30	patients	patient	NNS
cord-005453-4057qib7	13342	31	and	and	CC
cord-005453-4057qib7	13342	32	36	36	CD
cord-005453-4057qib7	13342	33	%	%	NN
cord-005453-4057qib7	13342	34	no	no	RB
cord-005453-4057qib7	13342	35	longer	longer	RB
cord-005453-4057qib7	13342	36	required	require	VBN
cord-005453-4057qib7	13342	37	platelet	platelet	NN
cord-005453-4057qib7	13342	38	transfusions	transfusion	NNS
cord-005453-4057qib7	13342	39	.	.	.
cord-005453-4057qib7	13343	1	And	and	CC
cord-005453-4057qib7	13343	2	also	also	RB
cord-005453-4057qib7	13343	3	24	24	CD
cord-005453-4057qib7	13343	4	%	%	NN
cord-005453-4057qib7	13343	5	patients	patient	NNS
cord-005453-4057qib7	13343	6	became	become	VBD
cord-005453-4057qib7	13343	7	RBC	RBC	NNP
cord-005453-4057qib7	13343	8	transfusion	transfusion	NN
cord-005453-4057qib7	13343	9	independent	independent	JJ
cord-005453-4057qib7	13343	10	and	and	CC
cord-005453-4057qib7	13343	11	36	36	CD
cord-005453-4057qib7	13343	12	%	%	NN
cord-005453-4057qib7	13343	13	had	have	VBD
cord-005453-4057qib7	13343	14	a	a	DT
cord-005453-4057qib7	13343	15	neutrophil	neutrophil	NN
cord-005453-4057qib7	13343	16	response	response	NN
cord-005453-4057qib7	13343	17	.	.	.
cord-005453-4057qib7	13344	1	Trilineage	trilineage	NN
cord-005453-4057qib7	13344	2	responses	response	NNS
cord-005453-4057qib7	13344	3	were	be	VBD
cord-005453-4057qib7	13344	4	seen	see	VBN
cord-005453-4057qib7	13344	5	in	in	IN
cord-005453-4057qib7	13344	6	24	24	CD
cord-005453-4057qib7	13344	7	%	%	NN
cord-005453-4057qib7	13344	8	of	of	IN
cord-005453-4057qib7	13344	9	patients	patient	NNS
cord-005453-4057qib7	13344	10	;	;	:
cord-005453-4057qib7	13344	11	although	although	IN
cord-005453-4057qib7	13344	12	surprising	surprising	JJ
cord-005453-4057qib7	13344	13	,	,	,
cord-005453-4057qib7	13344	14	this	this	DT
cord-005453-4057qib7	13344	15	might	may	MD
cord-005453-4057qib7	13344	16	indicate	indicate	VB
cord-005453-4057qib7	13344	17	stimulation	stimulation	NN
cord-005453-4057qib7	13344	18	of	of	IN
cord-005453-4057qib7	13344	19	c	c	NNP
cord-005453-4057qib7	13344	20	-	-	HYPH
cord-005453-4057qib7	13344	21	MPL	MPL	NNP
cord-005453-4057qib7	13344	22	receptors	receptor	NNS
cord-005453-4057qib7	13344	23	on	on	IN
cord-005453-4057qib7	13344	24	remaining	remain	VBG
cord-005453-4057qib7	13344	25	stem	stem	NN
cord-005453-4057qib7	13344	26	cells	cell	NNS
cord-005453-4057qib7	13344	27	.	.	.
cord-005453-4057qib7	13345	1	Delayed	delay	VBN
cord-005453-4057qib7	13345	2	recovery	recovery	NN
cord-005453-4057qib7	13345	3	from	from	IN
cord-005453-4057qib7	13345	4	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13345	5	is	be	VBZ
cord-005453-4057qib7	13345	6	common	common	JJ
cord-005453-4057qib7	13345	7	after	after	IN
cord-005453-4057qib7	13345	8	stem	stem	NN
cord-005453-4057qib7	13345	9	cell	cell	NN
cord-005453-4057qib7	13345	10	transplantation	transplantation	NN
cord-005453-4057qib7	13345	11	.	.	.
cord-005453-4057qib7	13346	1	In	in	IN
cord-005453-4057qib7	13346	2	a	a	DT
cord-005453-4057qib7	13346	3	study	study	NN
cord-005453-4057qib7	13346	4	including	include	VBG
cord-005453-4057qib7	13346	5	12	12	CD
cord-005453-4057qib7	13346	6	adult	adult	NN
cord-005453-4057qib7	13346	7	patients	patient	NNS
cord-005453-4057qib7	13346	8	,	,	,
cord-005453-4057qib7	13346	9	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	13346	10	was	be	VBD
cord-005453-4057qib7	13346	11	used	use	VBN
cord-005453-4057qib7	13346	12	to	to	TO
cord-005453-4057qib7	13346	13	enhance	enhance	VB
cord-005453-4057qib7	13346	14	platelet	platelet	NN
cord-005453-4057qib7	13346	15	recovery	recovery	NN
cord-005453-4057qib7	13346	16	for	for	IN
cord-005453-4057qib7	13346	17	post	post	JJ
cord-005453-4057qib7	13346	18	-	-	JJ
cord-005453-4057qib7	13346	19	HSCT	hsct	JJ
cord-005453-4057qib7	13346	20	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13346	21	.	.	.
cord-005453-4057qib7	13347	1	It	-PRON-	PRP
cord-005453-4057qib7	13347	2	is	be	VBZ
cord-005453-4057qib7	13347	3	well	well	RB
cord-005453-4057qib7	13347	4	tolerated	tolerate	VBN
cord-005453-4057qib7	13347	5	and	and	CC
cord-005453-4057qib7	13347	6	efficacious	efficacious	JJ
cord-005453-4057qib7	13347	7	offering	offer	VBG
cord-005453-4057qib7	13347	8	transfusion	transfusion	NN
cord-005453-4057qib7	13347	9	independence	independence	NN
cord-005453-4057qib7	13347	10	.	.	.
cord-005453-4057qib7	13348	1	Methods	method	NNS
cord-005453-4057qib7	13348	2	:	:	:
cord-005453-4057qib7	13348	3	In	in	IN
cord-005453-4057qib7	13348	4	our	-PRON-	PRP$
cord-005453-4057qib7	13348	5	retrospective	retrospective	JJ
cord-005453-4057qib7	13348	6	study	study	NN
cord-005453-4057qib7	13348	7	,	,	,
cord-005453-4057qib7	13348	8	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	13348	9	(	(	-LRB-
cord-005453-4057qib7	13348	10	50mg	50mg	NNP
cord-005453-4057qib7	13348	11	/	/	SYM
cord-005453-4057qib7	13348	12	day	day	NN
cord-005453-4057qib7	13348	13	)	)	-RRB-
cord-005453-4057qib7	13348	14	was	be	VBD
cord-005453-4057qib7	13348	15	started	start	VBN
cord-005453-4057qib7	13348	16	in	in	IN
cord-005453-4057qib7	13348	17	19	19	CD
cord-005453-4057qib7	13348	18	pediatric	pediatric	JJ
cord-005453-4057qib7	13348	19	patients	patient	NNS
cord-005453-4057qib7	13348	20	(	(	-LRB-
cord-005453-4057qib7	13348	21	age	age	NN
cord-005453-4057qib7	13348	22	ranging	range	VBG
cord-005453-4057qib7	13348	23	from	from	IN
cord-005453-4057qib7	13348	24	4	4	CD
cord-005453-4057qib7	13348	25	to	to	TO
cord-005453-4057qib7	13348	26	16	16	CD
cord-005453-4057qib7	13348	27	years	year	NNS
cord-005453-4057qib7	13348	28	with	with	IN
cord-005453-4057qib7	13348	29	a	a	DT
cord-005453-4057qib7	13348	30	median	median	JJ
cord-005453-4057qib7	13348	31	age	age	NN
cord-005453-4057qib7	13348	32	12.3	12.3	CD
cord-005453-4057qib7	13348	33	years	year	NNS
cord-005453-4057qib7	13348	34	)	)	-RRB-
cord-005453-4057qib7	13348	35	for	for	IN
cord-005453-4057qib7	13348	36	posthematopoietic	posthematopoietic	NNP
cord-005453-4057qib7	13348	37	stem	stem	NN
cord-005453-4057qib7	13348	38	cell	cell	NN
cord-005453-4057qib7	13348	39	transplantation	transplantation	NN
cord-005453-4057qib7	13348	40	(	(	-LRB-
cord-005453-4057qib7	13348	41	HSCT	HSCT	NNP
cord-005453-4057qib7	13348	42	)	)	-RRB-
cord-005453-4057qib7	13348	43	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13348	44	.	.	.
cord-005453-4057qib7	13349	1	All	all	DT
cord-005453-4057qib7	13349	2	patients	patient	NNS
cord-005453-4057qib7	13349	3	fulfilled	fulfil	VBD
cord-005453-4057qib7	13349	4	the	the	DT
cord-005453-4057qib7	13349	5	following	following	JJ
cord-005453-4057qib7	13349	6	3	3	CD
cord-005453-4057qib7	13349	7	criteria	criterion	NNS
cord-005453-4057qib7	13349	8	:	:	:
cord-005453-4057qib7	13349	9	(	(	-LRB-
cord-005453-4057qib7	13349	10	1	1	LS
cord-005453-4057qib7	13349	11	)	)	-RRB-
cord-005453-4057qib7	13349	12	undergone	undergo	VBN
cord-005453-4057qib7	13349	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13349	14	stem	stem	NN
cord-005453-4057qib7	13349	15	cell	cell	NN
cord-005453-4057qib7	13349	16	transplantation	transplantation	NN
cord-005453-4057qib7	13349	17	(	(	-LRB-
cord-005453-4057qib7	13349	18	HSCT	HSCT	NNP
cord-005453-4057qib7	13349	19	)	)	-RRB-
cord-005453-4057qib7	13349	20	,	,	,
cord-005453-4057qib7	13349	21	(	(	-LRB-
cord-005453-4057qib7	13349	22	2	2	LS
cord-005453-4057qib7	13349	23	)	)	-RRB-
cord-005453-4057qib7	13349	24	had	have	VBD
cord-005453-4057qib7	13349	25	improved	improve	VBN
cord-005453-4057qib7	13349	26	total	total	JJ
cord-005453-4057qib7	13349	27	leucocyte	leucocyte	NN
cord-005453-4057qib7	13349	28	counts	count	NNS
cord-005453-4057qib7	13349	29	after	after	IN
cord-005453-4057qib7	13349	30	leucocyte	leucocyte	NNP
cord-005453-4057qib7	13349	31	engraftment	engraftment	NNP
cord-005453-4057qib7	13349	32	,	,	,
cord-005453-4057qib7	13349	33	(	(	-LRB-
cord-005453-4057qib7	13349	34	3	3	LS
cord-005453-4057qib7	13349	35	)	)	-RRB-
cord-005453-4057qib7	13349	36	had	have	VBD
cord-005453-4057qib7	13349	37	prolonged	prolong	VBN
cord-005453-4057qib7	13349	38	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13349	39	(	(	-LRB-
cord-005453-4057qib7	13349	40	<	<	XX
cord-005453-4057qib7	13349	41	30.000	30.000	CD
cord-005453-4057qib7	13349	42	)	)	-RRB-
cord-005453-4057qib7	13349	43	needing	need	VBG
cord-005453-4057qib7	13349	44	platelet	platelet	NN
cord-005453-4057qib7	13349	45	transfusion	transfusion	NN
cord-005453-4057qib7	13349	46	.	.	.
cord-005453-4057qib7	13350	1	Results	result	NNS
cord-005453-4057qib7	13350	2	:	:	:
cord-005453-4057qib7	13351	1	Four	four	CD
cord-005453-4057qib7	13351	2	of	of	IN
cord-005453-4057qib7	13351	3	the	the	DT
cord-005453-4057qib7	13351	4	patients	patient	NNS
cord-005453-4057qib7	13351	5	have	have	VBP
cord-005453-4057qib7	13351	6	received	receive	VBN
cord-005453-4057qib7	13351	7	RIC	RIC	NNP
cord-005453-4057qib7	13351	8	while	while	IN
cord-005453-4057qib7	13351	9	15	15	CD
cord-005453-4057qib7	13351	10	patients	patient	NNS
cord-005453-4057qib7	13351	11	MA	MA	NNP
cord-005453-4057qib7	13351	12	conditioning	conditioning	NN
cord-005453-4057qib7	13351	13	regimens	regimen	NNS
cord-005453-4057qib7	13351	14	before	before	IN
cord-005453-4057qib7	13351	15	HSCT	HSCT	NNP
cord-005453-4057qib7	13351	16	.	.	.
cord-005453-4057qib7	13352	1	Two	two	CD
cord-005453-4057qib7	13352	2	haploidentic	haploidentic	NN
cord-005453-4057qib7	13352	3	,	,	,
cord-005453-4057qib7	13352	4	2	2	CD
cord-005453-4057qib7	13352	5	autologous	autologous	JJ
cord-005453-4057qib7	13352	6	,	,	,
cord-005453-4057qib7	13352	7	7	7	CD
cord-005453-4057qib7	13352	8	MUD	mud	NN
cord-005453-4057qib7	13352	9	,	,	,
cord-005453-4057qib7	13352	10	8	8	CD
cord-005453-4057qib7	13352	11	MSD	MSD	NNP
cord-005453-4057qib7	13352	12	transplantations	transplantation	NNS
cord-005453-4057qib7	13352	13	were	be	VBD
cord-005453-4057qib7	13352	14	performed	perform	VBN
cord-005453-4057qib7	13352	15	.	.	.
cord-005453-4057qib7	13353	1	ET	ET	NNP
cord-005453-4057qib7	13353	2	(	(	-LRB-
cord-005453-4057qib7	13353	3	50mg	50mg	NNP
cord-005453-4057qib7	13353	4	/	/	SYM
cord-005453-4057qib7	13353	5	day	day	NN
cord-005453-4057qib7	13353	6	)	)	-RRB-
cord-005453-4057qib7	13353	7	was	be	VBD
cord-005453-4057qib7	13353	8	started	start	VBN
cord-005453-4057qib7	13353	9	in	in	IN
cord-005453-4057qib7	13353	10	19	19	CD
cord-005453-4057qib7	13353	11	patients	patient	NNS
cord-005453-4057qib7	13353	12	who	who	WP
cord-005453-4057qib7	13353	13	had	have	VBD
cord-005453-4057qib7	13353	14	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13353	15	despite	despite	IN
cord-005453-4057qib7	13353	16	neutrophil	neutrophil	NN
cord-005453-4057qib7	13353	17	engraftment	engraftment	NN
cord-005453-4057qib7	13353	18	on	on	IN
cord-005453-4057qib7	13353	19	the	the	DT
cord-005453-4057qib7	13353	20	+30th	+30th	NNP
cord-005453-4057qib7	13353	21	day	day	NN
cord-005453-4057qib7	13353	22	of	of	IN
cord-005453-4057qib7	13353	23	HSCT	HSCT	NNP
cord-005453-4057qib7	13353	24	A	a	DT
cord-005453-4057qib7	13353	25	reduction	reduction	NN
cord-005453-4057qib7	13353	26	in	in	IN
cord-005453-4057qib7	13353	27	platelet	platelet	NN
cord-005453-4057qib7	13353	28	transfusions	transfusion	NNS
cord-005453-4057qib7	13353	29	and	and	CC
cord-005453-4057qib7	13353	30	a	a	DT
cord-005453-4057qib7	13353	31	platelet	platelet	NN
cord-005453-4057qib7	13353	32	count	count	NN
cord-005453-4057qib7	13353	33	of	of	IN
cord-005453-4057qib7	13353	34	more	more	JJR
cord-005453-4057qib7	13353	35	than	than	IN
cord-005453-4057qib7	13353	36	30,000	30,000	CD
cord-005453-4057qib7	13353	37	were	be	VBD
cord-005453-4057qib7	13353	38	the	the	DT
cord-005453-4057qib7	13353	39	primary	primary	JJ
cord-005453-4057qib7	13353	40	endpoints	endpoint	NNS
cord-005453-4057qib7	13353	41	.	.	.
cord-005453-4057qib7	13354	1	Before	before	IN
cord-005453-4057qib7	13354	2	ET	ET	NNP
cord-005453-4057qib7	13354	3	treatment	treatment	NN
cord-005453-4057qib7	13354	4	,	,	,
cord-005453-4057qib7	13354	5	bone	bone	NN
cord-005453-4057qib7	13354	6	marrow	marrow	NN
cord-005453-4057qib7	13354	7	biopsy	biopsy	NN
cord-005453-4057qib7	13354	8	was	be	VBD
cord-005453-4057qib7	13354	9	checked	check	VBN
cord-005453-4057qib7	13354	10	in	in	IN
cord-005453-4057qib7	13354	11	15/19	15/19	CD
cord-005453-4057qib7	13354	12	patients	patient	NNS
cord-005453-4057qib7	13354	13	,	,	,
cord-005453-4057qib7	13354	14	10/15	10/15	CD
cord-005453-4057qib7	13354	15	patients	patient	NNS
cord-005453-4057qib7	13354	16	had	have	VBD
cord-005453-4057qib7	13354	17	decreased	decrease	VBN
cord-005453-4057qib7	13354	18	number	number	NN
cord-005453-4057qib7	13354	19	of	of	IN
cord-005453-4057qib7	13354	20	megacocyocytes	megacocyocyte	NNS
cord-005453-4057qib7	13354	21	.	.	.
cord-005453-4057qib7	13355	1	None	none	NN
cord-005453-4057qib7	13355	2	of	of	IN
cord-005453-4057qib7	13355	3	the	the	DT
cord-005453-4057qib7	13355	4	patients	patient	NNS
cord-005453-4057qib7	13355	5	had	have	VBD
cord-005453-4057qib7	13355	6	active	active	JJ
cord-005453-4057qib7	13355	7	bleeding	bleeding	NN
cord-005453-4057qib7	13355	8	at	at	IN
cord-005453-4057qib7	13355	9	the	the	DT
cord-005453-4057qib7	13355	10	start	start	NN
cord-005453-4057qib7	13355	11	of	of	IN
cord-005453-4057qib7	13355	12	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	13355	13	but	but	CC
cord-005453-4057qib7	13355	14	they	-PRON-	PRP
cord-005453-4057qib7	13355	15	were	be	VBD
cord-005453-4057qib7	13355	16	all	all	RB
cord-005453-4057qib7	13355	17	at	at	IN
cord-005453-4057qib7	13355	18	high	high	JJ
cord-005453-4057qib7	13355	19	risk	risk	NN
cord-005453-4057qib7	13355	20	of	of	IN
cord-005453-4057qib7	13355	21	bleeding	bleed	VBG
cord-005453-4057qib7	13355	22	.	.	.
cord-005453-4057qib7	13356	1	According	accord	VBG
cord-005453-4057qib7	13356	2	to	to	IN
cord-005453-4057qib7	13356	3	the	the	DT
cord-005453-4057qib7	13356	4	platelet	platelet	NN
cord-005453-4057qib7	13356	5	monitoring	monitoring	NN
cord-005453-4057qib7	13356	6	,	,	,
cord-005453-4057qib7	13356	7	12	12	CD
cord-005453-4057qib7	13356	8	patients	patient	NNS
cord-005453-4057qib7	13356	9	had	have	VBD
cord-005453-4057qib7	13356	10	a	a	DT
cord-005453-4057qib7	13356	11	dose	dose	JJ
cord-005453-4057qib7	13356	12	increase	increase	NN
cord-005453-4057qib7	13356	13	starting	start	VBG
cord-005453-4057qib7	13356	14	from	from	IN
cord-005453-4057qib7	13356	15	the	the	DT
cord-005453-4057qib7	13356	16	second	second	JJ
cord-005453-4057qib7	13356	17	week	week	NN
cord-005453-4057qib7	13356	18	.	.	.
cord-005453-4057qib7	13357	1	The	the	DT
cord-005453-4057qib7	13357	2	number	number	NN
cord-005453-4057qib7	13357	3	of	of	IN
cord-005453-4057qib7	13357	4	patients	patient	NNS
cord-005453-4057qib7	13357	5	in	in	IN
cord-005453-4057qib7	13357	6	need	need	NN
cord-005453-4057qib7	13357	7	of	of	IN
cord-005453-4057qib7	13357	8	platelet	platelet	NN
cord-005453-4057qib7	13357	9	transfusions	transfusion	NNS
cord-005453-4057qib7	13357	10	was	be	VBD
cord-005453-4057qib7	13357	11	7	7	CD
cord-005453-4057qib7	13357	12	at	at	IN
cord-005453-4057qib7	13357	13	the	the	DT
cord-005453-4057qib7	13357	14	end	end	NN
cord-005453-4057qib7	13357	15	of	of	IN
cord-005453-4057qib7	13357	16	the	the	DT
cord-005453-4057qib7	13357	17	first	first	JJ
cord-005453-4057qib7	13357	18	month	month	NN
cord-005453-4057qib7	13357	19	;	;	:
cord-005453-4057qib7	13357	20	and	and	CC
cord-005453-4057qib7	13357	21	only	only	RB
cord-005453-4057qib7	13357	22	2	2	CD
cord-005453-4057qib7	13357	23	at	at	IN
cord-005453-4057qib7	13357	24	the	the	DT
cord-005453-4057qib7	13357	25	end	end	NN
cord-005453-4057qib7	13357	26	of	of	IN
cord-005453-4057qib7	13357	27	the	the	DT
cord-005453-4057qib7	13357	28	2nd	2nd	JJ
cord-005453-4057qib7	13357	29	month	month	NN
cord-005453-4057qib7	13357	30	.	.	.
cord-005453-4057qib7	13358	1	All	all	DT
cord-005453-4057qib7	13358	2	patients	patient	NNS
cord-005453-4057qib7	13358	3	had	have	VBD
cord-005453-4057qib7	13358	4	a	a	DT
cord-005453-4057qib7	13358	5	thrombocyte	thrombocyte	NN
cord-005453-4057qib7	13358	6	count	count	NN
cord-005453-4057qib7	13358	7	of	of	IN
cord-005453-4057qib7	13358	8	more	more	JJR
cord-005453-4057qib7	13358	9	than	than	IN
cord-005453-4057qib7	13358	10	30.000	30.000	CD
cord-005453-4057qib7	13358	11	in	in	IN
cord-005453-4057qib7	13358	12	the	the	DT
cord-005453-4057qib7	13358	13	third	third	JJ
cord-005453-4057qib7	13358	14	month	month	NN
cord-005453-4057qib7	13358	15	.	.	.
cord-005453-4057qib7	13359	1	In	in	IN
cord-005453-4057qib7	13359	2	11	11	CD
cord-005453-4057qib7	13359	3	patients	patient	NNS
cord-005453-4057qib7	13359	4	,	,	,
cord-005453-4057qib7	13359	5	ET	ET	NNP
cord-005453-4057qib7	13359	6	was	be	VBD
cord-005453-4057qib7	13359	7	discontinued	discontinue	VBN
cord-005453-4057qib7	13359	8	after	after	IN
cord-005453-4057qib7	13359	9	2	2	CD
cord-005453-4057qib7	13359	10	-	-	SYM
cord-005453-4057qib7	13359	11	11	11	CD
cord-005453-4057qib7	13359	12	months	month	NNS
cord-005453-4057qib7	13359	13	.	.	.
cord-005453-4057qib7	13360	1	No	no	DT
cord-005453-4057qib7	13360	2	dose	dose	NN
cord-005453-4057qib7	13360	3	limiting	limit	VBG
cord-005453-4057qib7	13360	4	toxicities	toxicity	NNS
cord-005453-4057qib7	13360	5	have	have	VBP
cord-005453-4057qib7	13360	6	been	be	VBN
cord-005453-4057qib7	13360	7	observed	observe	VBN
cord-005453-4057qib7	13360	8	.	.	.
cord-005453-4057qib7	13361	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13361	2	:	:	:
cord-005453-4057qib7	13362	1	As	as	IN
cord-005453-4057qib7	13362	2	a	a	DT
cord-005453-4057qib7	13362	3	conclusion	conclusion	NN
cord-005453-4057qib7	13362	4	,	,	,
cord-005453-4057qib7	13362	5	ET	ET	NNP
cord-005453-4057qib7	13362	6	was	be	VBD
cord-005453-4057qib7	13362	7	found	find	VBN
cord-005453-4057qib7	13362	8	highly	highly	RB
cord-005453-4057qib7	13362	9	effective	effective	JJ
cord-005453-4057qib7	13362	10	for	for	IN
cord-005453-4057qib7	13362	11	postHSCT	postHSCT	NNP
cord-005453-4057qib7	13362	12	thrombocytopenia	thrombocytopenia	NNP
cord-005453-4057qib7	13362	13	,	,	,
cord-005453-4057qib7	13362	14	with	with	IN
cord-005453-4057qib7	13362	15	no	no	DT
cord-005453-4057qib7	13362	16	drug	drug	NN
cord-005453-4057qib7	13362	17	related	relate	VBN
cord-005453-4057qib7	13362	18	adverse	adverse	JJ
cord-005453-4057qib7	13362	19	effects	effect	NNS
cord-005453-4057qib7	13362	20	.	.	.
cord-005453-4057qib7	13363	1	There	there	EX
cord-005453-4057qib7	13363	2	was	be	VBD
cord-005453-4057qib7	13363	3	a	a	DT
cord-005453-4057qib7	13363	4	gradual	gradual	JJ
cord-005453-4057qib7	13363	5	increase	increase	NN
cord-005453-4057qib7	13363	6	in	in	IN
cord-005453-4057qib7	13363	7	platelet	platelet	NN
cord-005453-4057qib7	13363	8	count	count	NN
cord-005453-4057qib7	13363	9	,	,	,
cord-005453-4057qib7	13363	10	and	and	CC
cord-005453-4057qib7	13363	11	none	none	NN
cord-005453-4057qib7	13363	12	of	of	IN
cord-005453-4057qib7	13363	13	the	the	DT
cord-005453-4057qib7	13363	14	patients	patient	NNS
cord-005453-4057qib7	13363	15	had	have	VBD
cord-005453-4057qib7	13363	16	any	any	DT
cord-005453-4057qib7	13363	17	complication	complication	NN
cord-005453-4057qib7	13363	18	due	due	IN
cord-005453-4057qib7	13363	19	to	to	IN
cord-005453-4057qib7	13363	20	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13363	21	.	.	.
cord-005453-4057qib7	13364	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13364	2	Background	background	NN
cord-005453-4057qib7	13364	3	:	:	:
cord-005453-4057qib7	13365	1	Isavuconazole	Isavuconazole	NNP
cord-005453-4057qib7	13365	2	(	(	-LRB-
cord-005453-4057qib7	13365	3	ISA	ISA	NNP
cord-005453-4057qib7	13365	4	)	)	-RRB-
cord-005453-4057qib7	13365	5	is	be	VBZ
cord-005453-4057qib7	13365	6	a	a	DT
cord-005453-4057qib7	13365	7	new	new	JJ
cord-005453-4057qib7	13365	8	triazole	triazole	NN
cord-005453-4057qib7	13365	9	approved	approve	VBN
cord-005453-4057qib7	13365	10	for	for	IN
cord-005453-4057qib7	13365	11	IFI	IFI	NNP
cord-005453-4057qib7	13365	12	treatment	treatment	NN
cord-005453-4057qib7	13365	13	in	in	IN
cord-005453-4057qib7	13365	14	the	the	DT
cord-005453-4057qib7	13365	15	adult	adult	NN
cord-005453-4057qib7	13365	16	population	population	NN
cord-005453-4057qib7	13365	17	.	.	.
cord-005453-4057qib7	13366	1	Advantages	advantage	NNS
cord-005453-4057qib7	13366	2	are	be	VBP
cord-005453-4057qib7	13366	3	activity	activity	NN
cord-005453-4057qib7	13366	4	against	against	IN
cord-005453-4057qib7	13366	5	both	both	DT
cord-005453-4057qib7	13366	6	moulds	mould	NNS
cord-005453-4057qib7	13366	7	and	and	CC
cord-005453-4057qib7	13366	8	yeasts	yeast	NNS
cord-005453-4057qib7	13366	9	spp	spp	NNS
cord-005453-4057qib7	13366	10	,	,	,
cord-005453-4057qib7	13366	11	excellent	excellent	JJ
cord-005453-4057qib7	13366	12	bioavailability	bioavailability	NN
cord-005453-4057qib7	13366	13	after	after	IN
cord-005453-4057qib7	13366	14	oral	oral	JJ
cord-005453-4057qib7	13366	15	administration	administration	NN
cord-005453-4057qib7	13366	16	without	without	IN
cord-005453-4057qib7	13366	17	relevant	relevant	JJ
cord-005453-4057qib7	13366	18	food	food	NN
cord-005453-4057qib7	13366	19	or	or	CC
cord-005453-4057qib7	13366	20	gastric	gastric	JJ
cord-005453-4057qib7	13366	21	pH	ph	NN
cord-005453-4057qib7	13366	22	effect	effect	NN
cord-005453-4057qib7	13366	23	,	,	,
cord-005453-4057qib7	13366	24	a	a	DT
cord-005453-4057qib7	13366	25	water	water	NN
cord-005453-4057qib7	13366	26	-	-	HYPH
cord-005453-4057qib7	13366	27	soluble	soluble	JJ
cord-005453-4057qib7	13366	28	prodrug	prodrug	NN
cord-005453-4057qib7	13366	29	developed	develop	VBN
cord-005453-4057qib7	13366	30	to	to	TO
cord-005453-4057qib7	13366	31	facilitate	facilitate	VB
cord-005453-4057qib7	13366	32	intravenous	intravenous	JJ
cord-005453-4057qib7	13366	33	administration	administration	NN
cord-005453-4057qib7	13366	34	without	without	IN
cord-005453-4057qib7	13366	35	nephrotoxic	nephrotoxic	NNP
cord-005453-4057qib7	13366	36	excipients	excipient	NNS
cord-005453-4057qib7	13366	37	such	such	JJ
cord-005453-4057qib7	13366	38	as	as	IN
cord-005453-4057qib7	13366	39	β	β	NN
cord-005453-4057qib7	13366	40	-	-	HYPH
cord-005453-4057qib7	13366	41	cyclodextrin	cyclodextrin	NN
cord-005453-4057qib7	13366	42	,	,	,
cord-005453-4057qib7	13366	43	potentially	potentially	RB
cord-005453-4057qib7	13366	44	poor	poor	JJ
cord-005453-4057qib7	13366	45	drug	drug	NN
cord-005453-4057qib7	13366	46	-	-	HYPH
cord-005453-4057qib7	13366	47	drug	drug	NN
cord-005453-4057qib7	13366	48	interactions	interaction	NNS
cord-005453-4057qib7	13366	49	.	.	.
cord-005453-4057qib7	13367	1	ISA	ISA	NNP
cord-005453-4057qib7	13367	2	does	do	VBZ
cord-005453-4057qib7	13367	3	not	not	RB
cord-005453-4057qib7	13367	4	currently	currently	RB
cord-005453-4057qib7	13367	5	appear	appear	VB
cord-005453-4057qib7	13367	6	to	to	TO
cord-005453-4057qib7	13367	7	require	require	VB
cord-005453-4057qib7	13367	8	TDM	TDM	NNP
cord-005453-4057qib7	13367	9	.	.	.
cord-005453-4057qib7	13368	1	ISA	ISA	NNP
cord-005453-4057qib7	13368	2	safety	safety	NN
cord-005453-4057qib7	13368	3	and	and	CC
cord-005453-4057qib7	13368	4	efficacy	efficacy	NN
cord-005453-4057qib7	13368	5	have	have	VBP
cord-005453-4057qib7	13368	6	not	not	RB
cord-005453-4057qib7	13368	7	been	be	VBN
cord-005453-4057qib7	13368	8	yet	yet	RB
cord-005453-4057qib7	13368	9	established	establish	VBN
cord-005453-4057qib7	13368	10	in	in	IN
cord-005453-4057qib7	13368	11	children	child	NNS
cord-005453-4057qib7	13368	12	and	and	CC
cord-005453-4057qib7	13368	13	,	,	,
cord-005453-4057qib7	13368	14	in	in	IN
cord-005453-4057qib7	13368	15	particular	particular	JJ
cord-005453-4057qib7	13368	16	,	,	,
cord-005453-4057qib7	13368	17	no	no	DT
cord-005453-4057qib7	13368	18	data	datum	NNS
cord-005453-4057qib7	13368	19	are	be	VBP
cord-005453-4057qib7	13368	20	available	available	JJ
cord-005453-4057qib7	13368	21	in	in	IN
cord-005453-4057qib7	13368	22	the	the	DT
cord-005453-4057qib7	13368	23	pediatric	pediatric	JJ
cord-005453-4057qib7	13368	24	HSCT	HSCT	NNP
cord-005453-4057qib7	13368	25	setting	setting	NN
cord-005453-4057qib7	13368	26	.	.	.
cord-005453-4057qib7	13369	1	Methods	method	NNS
cord-005453-4057qib7	13369	2	:	:	:
cord-005453-4057qib7	13369	3	Italian	Italian	NNP
cord-005453-4057qib7	13369	4	Association	Association	NNP
cord-005453-4057qib7	13369	5	Pediatric	Pediatric	NNP
cord-005453-4057qib7	13369	6	Hematology	Hematology	NNP
cord-005453-4057qib7	13369	7	Oncology	Oncology	NNP
cord-005453-4057qib7	13369	8	(	(	-LRB-
cord-005453-4057qib7	13369	9	AIEOP	AIEOP	NNP
cord-005453-4057qib7	13369	10	)	)	-RRB-
cord-005453-4057qib7	13369	11	multicentric	multicentric	NNP
cord-005453-4057qib7	13369	12	analysis	analysis	NN
cord-005453-4057qib7	13369	13	of	of	IN
cord-005453-4057qib7	13369	14	a	a	DT
cord-005453-4057qib7	13369	15	cohort	cohort	NN
cord-005453-4057qib7	13369	16	of	of	IN
cord-005453-4057qib7	13369	17	allogeneic	allogeneic	JJ
cord-005453-4057qib7	13369	18	HSCT	HSCT	NNP
cord-005453-4057qib7	13369	19	pediatric	pediatric	JJ
cord-005453-4057qib7	13369	20	patients	patient	NNS
cord-005453-4057qib7	13369	21	who	who	WP
cord-005453-4057qib7	13369	22	received	receive	VBD
cord-005453-4057qib7	13369	23	ISA	ISA	NNP
cord-005453-4057qib7	13369	24	as	as	IN
cord-005453-4057qib7	13369	25	IFI	IFI	NNP
cord-005453-4057qib7	13369	26	treatment	treatment	NN
cord-005453-4057qib7	13369	27	or	or	CC
cord-005453-4057qib7	13369	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13369	29	.	.	.
cord-005453-4057qib7	13370	1	Due	due	IN
cord-005453-4057qib7	13370	2	to	to	IN
cord-005453-4057qib7	13370	3	the	the	DT
cord-005453-4057qib7	13370	4	lack	lack	NN
cord-005453-4057qib7	13370	5	of	of	IN
cord-005453-4057qib7	13370	6	recommended	recommend	VBN
cord-005453-4057qib7	13370	7	dosing	dosing	NN
cord-005453-4057qib7	13370	8	in	in	IN
cord-005453-4057qib7	13370	9	pediatric	pediatric	JJ
cord-005453-4057qib7	13370	10	patients	patient	NNS
cord-005453-4057qib7	13370	11	and	and	CC
cord-005453-4057qib7	13370	12	a	a	DT
cord-005453-4057qib7	13370	13	clear	clear	JJ
cord-005453-4057qib7	13370	14	target	target	NN
cord-005453-4057qib7	13370	15	ISA	ISA	NNP
cord-005453-4057qib7	13370	16	plasma	plasma	NN
cord-005453-4057qib7	13370	17	trough	trough	NN
cord-005453-4057qib7	13370	18	-	-	HYPH
cord-005453-4057qib7	13370	19	level	level	NN
cord-005453-4057qib7	13370	20	range	range	NN
cord-005453-4057qib7	13370	21	,	,	,
cord-005453-4057qib7	13370	22	the	the	DT
cord-005453-4057qib7	13370	23	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13370	24	monitoring	monitoring	NN
cord-005453-4057qib7	13370	25	(	(	-LRB-
cord-005453-4057qib7	13370	26	TDM	TDM	NNP
cord-005453-4057qib7	13370	27	)	)	-RRB-
cord-005453-4057qib7	13370	28	of	of	IN
cord-005453-4057qib7	13370	29	ISA	ISA	NNP
cord-005453-4057qib7	13370	30	concentrations	concentration	NNS
cord-005453-4057qib7	13370	31	was	be	VBD
cord-005453-4057qib7	13370	32	applied	apply	VBN
cord-005453-4057qib7	13370	33	by	by	IN
cord-005453-4057qib7	13370	34	a	a	DT
cord-005453-4057qib7	13370	35	validated	validate	VBN
cord-005453-4057qib7	13370	36	liquid	liquid	JJ
cord-005453-4057qib7	13370	37	chromatography	chromatography	NN
cord-005453-4057qib7	13370	38	-	-	HYPH
cord-005453-4057qib7	13370	39	tandem	tandem	NN
cord-005453-4057qib7	13370	40	mass	mass	NN
cord-005453-4057qib7	13370	41	spectrometry	spectrometry	NN
cord-005453-4057qib7	13370	42	(	(	-LRB-
cord-005453-4057qib7	13370	43	HLPC	HLPC	NNP
cord-005453-4057qib7	13370	44	-	-	HYPH
cord-005453-4057qib7	13370	45	MS/	MS/	NNP
cord-005453-4057qib7	13370	46	MS	MS	NNP
cord-005453-4057qib7	13370	47	)	)	-RRB-
cord-005453-4057qib7	13370	48	assay	assay	NN
cord-005453-4057qib7	13370	49	technique	technique	NN
cord-005453-4057qib7	13370	50	.	.	.
cord-005453-4057qib7	13371	1	ISA	ISA	NNP
cord-005453-4057qib7	13371	2	trough	trough	NN
cord-005453-4057qib7	13371	3	plasma	plasma	NN
cord-005453-4057qib7	13371	4	concentrations	concentration	NNS
cord-005453-4057qib7	13371	5	(	(	-LRB-
cord-005453-4057qib7	13371	6	C0	C0	NNP
cord-005453-4057qib7	13371	7	)	)	-RRB-
cord-005453-4057qib7	13371	8	and	and	CC
cord-005453-4057qib7	13371	9	3	3	CD
cord-005453-4057qib7	13371	10	hours	hour	NNS
cord-005453-4057qib7	13371	11	after	after	IN
cord-005453-4057qib7	13371	12	drug	drug	NN
cord-005453-4057qib7	13371	13	intake	intake	NN
cord-005453-4057qib7	13371	14	(	(	-LRB-
cord-005453-4057qib7	13371	15	C3h	c3h	NN
cord-005453-4057qib7	13371	16	)	)	-RRB-
cord-005453-4057qib7	13371	17	were	be	VBD
cord-005453-4057qib7	13371	18	measured	measure	VBN
cord-005453-4057qib7	13371	19	.	.	.
cord-005453-4057qib7	13372	1	Results	result	NNS
cord-005453-4057qib7	13372	2	:	:	:
cord-005453-4057qib7	13373	1	A	a	DT
cord-005453-4057qib7	13373	2	total	total	NN
cord-005453-4057qib7	13373	3	of	of	IN
cord-005453-4057qib7	13373	4	16	16	CD
cord-005453-4057qib7	13373	5	allo	allo	NN
cord-005453-4057qib7	13373	6	-	-	HYPH
cord-005453-4057qib7	13373	7	HSCT	HSCT	NNP
cord-005453-4057qib7	13373	8	recipients	recipient	NNS
cord-005453-4057qib7	13373	9	were	be	VBD
cord-005453-4057qib7	13373	10	included	include	VBN
cord-005453-4057qib7	13373	11	,	,	,
cord-005453-4057qib7	13373	12	(	(	-LRB-
cord-005453-4057qib7	13373	13	M	M	NNP
cord-005453-4057qib7	13373	14	/	/	SYM
cord-005453-4057qib7	13373	15	F	F	NNP
cord-005453-4057qib7	13373	16	12/4	12/4	CD
cord-005453-4057qib7	13373	17	)	)	-RRB-
cord-005453-4057qib7	13373	18	;	;	:
cord-005453-4057qib7	13373	19	median	median	JJ
cord-005453-4057qib7	13373	20	age	age	NN
cord-005453-4057qib7	13373	21	:	:	:
cord-005453-4057qib7	13373	22	13,1	13,1	CD
cord-005453-4057qib7	13373	23	years	year	NNS
cord-005453-4057qib7	13373	24	,	,	,
cord-005453-4057qib7	13373	25	range	range	VBP
cord-005453-4057qib7	13373	26	5	5	CD
cord-005453-4057qib7	13373	27	-	-	SYM
cord-005453-4057qib7	13373	28	19	19	CD
cord-005453-4057qib7	13373	29	,	,	,
cord-005453-4057qib7	13373	30	median	median	JJ
cord-005453-4057qib7	13373	31	body	body	NN
cord-005453-4057qib7	13373	32	-	-	HYPH
cord-005453-4057qib7	13373	33	weight	weight	NN
cord-005453-4057qib7	13374	1	48,7	48,7	LS
cord-005453-4057qib7	13374	2	Kg	kg	CD
cord-005453-4057qib7	13374	3	(	(	-LRB-
cord-005453-4057qib7	13374	4	range	range	VBP
cord-005453-4057qib7	13374	5	17	17	CD
cord-005453-4057qib7	13374	6	-	-	SYM
cord-005453-4057qib7	13374	7	80	80	CD
cord-005453-4057qib7	13374	8	)	)	-RRB-
cord-005453-4057qib7	13374	9	.	.	.
cord-005453-4057qib7	13375	1	ISA	ISA	NNP
cord-005453-4057qib7	13375	2	was	be	VBD
cord-005453-4057qib7	13375	3	used	use	VBN
cord-005453-4057qib7	13375	4	as	as	IN
cord-005453-4057qib7	13375	5	IFI	IFI	NNP
cord-005453-4057qib7	13375	6	treatment	treatment	NN
cord-005453-4057qib7	13375	7	in	in	IN
cord-005453-4057qib7	13375	8	14	14	CD
cord-005453-4057qib7	13375	9	cases	case	NNS
cord-005453-4057qib7	13375	10	and	and	CC
cord-005453-4057qib7	13375	11	as	as	IN
cord-005453-4057qib7	13375	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13375	13	in	in	IN
cord-005453-4057qib7	13375	14	2	2	CD
cord-005453-4057qib7	13375	15	patients	patient	NNS
cord-005453-4057qib7	13375	16	.	.	.
cord-005453-4057qib7	13376	1	Donors	donor	NNS
cord-005453-4057qib7	13376	2	were	be	VBD
cord-005453-4057qib7	13376	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	13376	4	in	in	IN
cord-005453-4057qib7	13376	5	9	9	CD
cord-005453-4057qib7	13376	6	patients	patient	NNS
cord-005453-4057qib7	13376	7	,	,	,
cord-005453-4057qib7	13376	8	matched	match	VBN
cord-005453-4057qib7	13376	9	-	-	HYPH
cord-005453-4057qib7	13376	10	sibling	sibling	NN
cord-005453-4057qib7	13376	11	in	in	IN
cord-005453-4057qib7	13376	12	4	4	CD
cord-005453-4057qib7	13376	13	,	,	,
cord-005453-4057qib7	13376	14	allogenic	allogenic	JJ
cord-005453-4057qib7	13376	15	-	-	HYPH
cord-005453-4057qib7	13376	16	unrelated	unrelated	JJ
cord-005453-4057qib7	13376	17	in	in	IN
cord-005453-4057qib7	13376	18	4	4	CD
cord-005453-4057qib7	13376	19	cases	case	NNS
cord-005453-4057qib7	13376	20	.	.	.
cord-005453-4057qib7	13377	1	According	accord	VBG
cord-005453-4057qib7	13377	2	to	to	IN
cord-005453-4057qib7	13377	3	EORTC	eortc	NN
cord-005453-4057qib7	13377	4	criteria	criterion	NNS
cord-005453-4057qib7	13377	5	,	,	,
cord-005453-4057qib7	13377	6	IFI	IFI	NNP
cord-005453-4057qib7	13377	7	was	be	VBD
cord-005453-4057qib7	13377	8	proven	prove	VBN
cord-005453-4057qib7	13377	9	in	in	IN
cord-005453-4057qib7	13377	10	3	3	CD
cord-005453-4057qib7	13377	11	patients	patient	NNS
cord-005453-4057qib7	13377	12	(	(	-LRB-
cord-005453-4057qib7	13377	13	1	1	CD
cord-005453-4057qib7	13377	14	Penicilum	Penicilum	NNP
cord-005453-4057qib7	13377	15	,	,	,
cord-005453-4057qib7	13377	16	1	1	CD
cord-005453-4057qib7	13377	17	Mucor	Mucor	NNP
cord-005453-4057qib7	13377	18	,	,	,
cord-005453-4057qib7	13377	19	1	1	CD
cord-005453-4057qib7	13377	20	Aspergillus	aspergillus	NN
cord-005453-4057qib7	13377	21	fumigatus	fumigatus	NN
cord-005453-4057qib7	13377	22	)	)	-RRB-
cord-005453-4057qib7	13377	23	,	,	,
cord-005453-4057qib7	13377	24	probable	probable	JJ
cord-005453-4057qib7	13377	25	in	in	IN
cord-005453-4057qib7	13377	26	5	5	CD
cord-005453-4057qib7	13377	27	and	and	CC
cord-005453-4057qib7	13377	28	possible	possible	JJ
cord-005453-4057qib7	13377	29	in	in	IN
cord-005453-4057qib7	13377	30	7	7	CD
cord-005453-4057qib7	13377	31	patients	patient	NNS
cord-005453-4057qib7	13377	32	.	.	.
cord-005453-4057qib7	13378	1	Lungs	lung	NNS
cord-005453-4057qib7	13378	2	were	be	VBD
cord-005453-4057qib7	13378	3	the	the	DT
cord-005453-4057qib7	13378	4	main	main	JJ
cord-005453-4057qib7	13378	5	localization	localization	NN
cord-005453-4057qib7	13378	6	(	(	-LRB-
cord-005453-4057qib7	13378	7	12	12	CD
cord-005453-4057qib7	13378	8	cases	case	NNS
cord-005453-4057qib7	13378	9	)	)	-RRB-
cord-005453-4057qib7	13378	10	,	,	,
cord-005453-4057qib7	13378	11	associated	associate	VBN
cord-005453-4057qib7	13378	12	with	with	IN
cord-005453-4057qib7	13378	13	CNS	CNS	NNP
cord-005453-4057qib7	13378	14	involvement	involvement	NN
cord-005453-4057qib7	13378	15	in	in	IN
cord-005453-4057qib7	13378	16	4	4	CD
cord-005453-4057qib7	13378	17	cases	case	NNS
cord-005453-4057qib7	13378	18	and	and	CC
cord-005453-4057qib7	13378	19	paranasal	paranasal	NN
cord-005453-4057qib7	13378	20	sinuses	sinus	NNS
cord-005453-4057qib7	13378	21	in	in	IN
cord-005453-4057qib7	13378	22	3	3	CD
cord-005453-4057qib7	13378	23	;	;	SYM
cord-005453-4057qib7	13378	24	1	1	CD
cord-005453-4057qib7	13378	25	patient	patient	NN
cord-005453-4057qib7	13378	26	had	have	VBD
cord-005453-4057qib7	13378	27	possible	possible	JJ
cord-005453-4057qib7	13378	28	hepatic	hepatic	JJ
cord-005453-4057qib7	13378	29	candidiasis	candidiasis	NN
cord-005453-4057qib7	13378	30	.	.	.
cord-005453-4057qib7	13379	1	All	all	DT
cord-005453-4057qib7	13379	2	patients	patient	NNS
cord-005453-4057qib7	13379	3	,	,	,
cord-005453-4057qib7	13379	4	but	but	CC
cord-005453-4057qib7	13379	5	one	one	CD
cord-005453-4057qib7	13379	6	,	,	,
cord-005453-4057qib7	13379	7	received	receive	VBD
cord-005453-4057qib7	13379	8	ISA	ISA	NNP
cord-005453-4057qib7	13379	9	as	as	IN
cord-005453-4057qib7	13379	10	rescue	rescue	NN
cord-005453-4057qib7	13379	11	treatment	treatment	NN
cord-005453-4057qib7	13379	12	for	for	IN
cord-005453-4057qib7	13379	13	previous	previous	JJ
cord-005453-4057qib7	13379	14	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13379	15	failure	failure	NN
cord-005453-4057qib7	13379	16	(	(	-LRB-
cord-005453-4057qib7	13379	17	6	6	CD
cord-005453-4057qib7	13379	18	AmBisome	AmBisome	NNP
cord-005453-4057qib7	13379	19	,	,	,
cord-005453-4057qib7	13379	20	3	3	CD
cord-005453-4057qib7	13379	21	Voriconazole	Voriconazole	NNP
cord-005453-4057qib7	13379	22	,	,	,
cord-005453-4057qib7	13379	23	1	1	CD
cord-005453-4057qib7	13379	24	combination	combination	NN
cord-005453-4057qib7	13379	25	therapy	therapy	NN
cord-005453-4057qib7	13379	26	,	,	,
cord-005453-4057qib7	13379	27	1	1	CD
cord-005453-4057qib7	13379	28	Posaconazole	Posaconazole	NNP
cord-005453-4057qib7	13379	29	)	)	-RRB-
cord-005453-4057qib7	13379	30	.	.	.
cord-005453-4057qib7	13380	1	Seven	seven	CD
cord-005453-4057qib7	13380	2	patients	patient	NNS
cord-005453-4057qib7	13380	3	received	receive	VBD
cord-005453-4057qib7	13380	4	only	only	RB
cord-005453-4057qib7	13380	5	IV	IV	NNP
cord-005453-4057qib7	13380	6	ISA	ISA	NNP
cord-005453-4057qib7	13380	7	,	,	,
cord-005453-4057qib7	13380	8	3	3	CD
cord-005453-4057qib7	13380	9	received	receive	VBD
cord-005453-4057qib7	13380	10	only	only	RB
cord-005453-4057qib7	13380	11	oral	oral	JJ
cord-005453-4057qib7	13380	12	ISA	ISA	NNP
cord-005453-4057qib7	13380	13	whereas	whereas	IN
cord-005453-4057qib7	13380	14	6	6	CD
cord-005453-4057qib7	13380	15	patients	patient	NNS
cord-005453-4057qib7	13380	16	received	receive	VBD
cord-005453-4057qib7	13380	17	both	both	CC
cord-005453-4057qib7	13380	18	IV	IV	NNP
cord-005453-4057qib7	13380	19	and	and	CC
cord-005453-4057qib7	13380	20	oral	oral	JJ
cord-005453-4057qib7	13380	21	ISA	ISA	NNP
cord-005453-4057qib7	13380	22	.	.	.
cord-005453-4057qib7	13381	1	Patients	patient	NNS
cord-005453-4057qib7	13381	2	under	under	IN
cord-005453-4057qib7	13381	3	20	20	CD
cord-005453-4057qib7	13381	4	Kg	Kg	NNP
cord-005453-4057qib7	13381	5	body	body	NN
cord-005453-4057qib7	13381	6	weight	weight	NN
cord-005453-4057qib7	13381	7	received	receive	VBD
cord-005453-4057qib7	13381	8	half	half	DT
cord-005453-4057qib7	13381	9	ISA	ISA	NNP
cord-005453-4057qib7	13381	10	dose	dose	NN
cord-005453-4057qib7	13381	11	(	(	-LRB-
cord-005453-4057qib7	13381	12	100	100	CD
cord-005453-4057qib7	13381	13	mg	mg	NN
cord-005453-4057qib7	13381	14	TID	TID	NNP
cord-005453-4057qib7	13381	15	loading	loading	NN
cord-005453-4057qib7	13381	16	dose	dose	NN
cord-005453-4057qib7	13381	17	on	on	IN
cord-005453-4057qib7	13381	18	days	day	NNS
cord-005453-4057qib7	13381	19	1	1	CD
cord-005453-4057qib7	13381	20	and	and	CC
cord-005453-4057qib7	13381	21	2	2	CD
cord-005453-4057qib7	13381	22	,	,	,
cord-005453-4057qib7	13381	23	100	100	CD
cord-005453-4057qib7	13381	24	mg	mg	NNP
cord-005453-4057qib7	13381	25	/	/	SYM
cord-005453-4057qib7	13381	26	die	die	NNP
cord-005453-4057qib7	13381	27	manteinance	manteinance	NNP
cord-005453-4057qib7	13381	28	)	)	-RRB-
cord-005453-4057qib7	13381	29	.	.	.
cord-005453-4057qib7	13382	1	The	the	DT
cord-005453-4057qib7	13382	2	others	other	NNS
cord-005453-4057qib7	13382	3	received	receive	VBD
cord-005453-4057qib7	13382	4	adult	adult	NN
cord-005453-4057qib7	13382	5	schedule	schedule	NN
cord-005453-4057qib7	13382	6	;	;	:
cord-005453-4057qib7	13382	7	only	only	RB
cord-005453-4057qib7	13382	8	5	5	CD
cord-005453-4057qib7	13382	9	patients	patient	NNS
cord-005453-4057qib7	13382	10	received	receive	VBD
cord-005453-4057qib7	13382	11	loading	loading	NN
cord-005453-4057qib7	13382	12	dose	dose	NN
cord-005453-4057qib7	13382	13	.	.	.
cord-005453-4057qib7	13383	1	ISA	ISA	NNP
cord-005453-4057qib7	13383	2	was	be	VBD
cord-005453-4057qib7	13383	3	administered	administer	VBN
cord-005453-4057qib7	13383	4	for	for	IN
cord-005453-4057qib7	13383	5	a	a	DT
cord-005453-4057qib7	13383	6	median	median	NN
cord-005453-4057qib7	13383	7	of	of	IN
cord-005453-4057qib7	13383	8	83	83	CD
cord-005453-4057qib7	13383	9	days	day	NNS
cord-005453-4057qib7	13383	10	(	(	-LRB-
cord-005453-4057qib7	13383	11	range	range	NN
cord-005453-4057qib7	13383	12	:	:	:
cord-005453-4057qib7	13383	13	24	24	CD
cord-005453-4057qib7	13383	14	-	-	SYM
cord-005453-4057qib7	13383	15	240	240	CD
cord-005453-4057qib7	13383	16	)	)	-RRB-
cord-005453-4057qib7	13383	17	.	.	.
cord-005453-4057qib7	13384	1	In	in	IN
cord-005453-4057qib7	13384	2	3	3	CD
cord-005453-4057qib7	13384	3	patients	patient	NNS
cord-005453-4057qib7	13384	4	ISA	ISA	NNP
cord-005453-4057qib7	13384	5	was	be	VBD
cord-005453-4057qib7	13384	6	administered	administer	VBN
cord-005453-4057qib7	13384	7	in	in	IN
cord-005453-4057qib7	13384	8	combination	combination	NN
cord-005453-4057qib7	13384	9	with	with	IN
cord-005453-4057qib7	13384	10	Caspofungin	Caspofungin	NNP
cord-005453-4057qib7	13384	11	.	.	.
cord-005453-4057qib7	13385	1	TDM	TDM	NNP
cord-005453-4057qib7	13385	2	was	be	VBD
cord-005453-4057qib7	13385	3	applied	apply	VBN
cord-005453-4057qib7	13385	4	to	to	IN
cord-005453-4057qib7	13385	5	5	5	CD
cord-005453-4057qib7	13385	6	patients	patient	NNS
cord-005453-4057qib7	13385	7	including	include	VBG
cord-005453-4057qib7	13385	8	1	1	CD
cord-005453-4057qib7	13385	9	patient	patient	NN
cord-005453-4057qib7	13385	10	with	with	IN
cord-005453-4057qib7	13385	11	severe	severe	JJ
cord-005453-4057qib7	13385	12	VOD	vod	NN
cord-005453-4057qib7	13385	13	and	and	CC
cord-005453-4057qib7	13385	14	1	1	CD
cord-005453-4057qib7	13385	15	with	with	IN
cord-005453-4057qib7	13385	16	renal	renal	JJ
cord-005453-4057qib7	13385	17	failure	failure	NN
cord-005453-4057qib7	13385	18	secondary	secondary	JJ
cord-005453-4057qib7	13385	19	to	to	IN
cord-005453-4057qib7	13385	20	TA	TA	NNP
cord-005453-4057qib7	13385	21	-	-	HYPH
cord-005453-4057qib7	13385	22	TMA	TMA	NNP
cord-005453-4057qib7	13385	23	.	.	.
cord-005453-4057qib7	13386	1	The	the	DT
cord-005453-4057qib7	13386	2	median	median	JJ
cord-005453-4057qib7	13386	3	ISA	ISA	NNP
cord-005453-4057qib7	13386	4	concentrations	concentration	NNS
cord-005453-4057qib7	13386	5	were	be	VBD
cord-005453-4057qib7	13386	6	3.94	3.94	CD
cord-005453-4057qib7	13386	7	(	(	-LRB-
cord-005453-4057qib7	13386	8	1.57	1.57	CD
cord-005453-4057qib7	13386	9	-	-	SYM
cord-005453-4057qib7	13386	10	5.85	5.85	CD
cord-005453-4057qib7	13386	11	)	)	-RRB-
cord-005453-4057qib7	13387	1	mg	mg	NNP
cord-005453-4057qib7	13387	2	/	/	SYM
cord-005453-4057qib7	13387	3	L	L	NNP
cord-005453-4057qib7	13387	4	and	and	CC
cord-005453-4057qib7	13387	5	4.7	4.7	CD
cord-005453-4057qib7	13387	6	(	(	-LRB-
cord-005453-4057qib7	13387	7	1.29	1.29	CD
cord-005453-4057qib7	13387	8	-	-	SYM
cord-005453-4057qib7	13387	9	8.37	8.37	CD
cord-005453-4057qib7	13387	10	)	)	-RRB-
cord-005453-4057qib7	13388	1	mg	mg	NNP
cord-005453-4057qib7	13388	2	/	/	SYM
cord-005453-4057qib7	13388	3	L	L	NNP
cord-005453-4057qib7	13388	4	for	for	IN
cord-005453-4057qib7	13388	5	C0	c0	NN
cord-005453-4057qib7	13388	6	and	and	CC
cord-005453-4057qib7	13388	7	C3h	C3h	NNP
cord-005453-4057qib7	13388	8	,	,	,
cord-005453-4057qib7	13388	9	respectively	respectively	RB
cord-005453-4057qib7	13388	10	.	.	.
cord-005453-4057qib7	13389	1	IFI	IFI	NNP
cord-005453-4057qib7	13389	2	complete	complete	JJ
cord-005453-4057qib7	13389	3	remission	remission	NN
cord-005453-4057qib7	13389	4	was	be	VBD
cord-005453-4057qib7	13389	5	achieved	achieve	VBN
cord-005453-4057qib7	13389	6	in	in	IN
cord-005453-4057qib7	13389	7	5	5	CD
cord-005453-4057qib7	13389	8	cases	case	NNS
cord-005453-4057qib7	13389	9	,	,	,
cord-005453-4057qib7	13389	10	partial	partial	JJ
cord-005453-4057qib7	13389	11	remission	remission	NN
cord-005453-4057qib7	13389	12	in	in	IN
cord-005453-4057qib7	13389	13	3	3	CD
cord-005453-4057qib7	13389	14	;	;	:
cord-005453-4057qib7	13389	15	treatment	treatment	NN
cord-005453-4057qib7	13389	16	failure	failure	NN
cord-005453-4057qib7	13389	17	was	be	VBD
cord-005453-4057qib7	13389	18	experienced	experience	VBN
cord-005453-4057qib7	13389	19	by	by	IN
cord-005453-4057qib7	13389	20	2	2	CD
cord-005453-4057qib7	13389	21	patients	patient	NNS
cord-005453-4057qib7	13389	22	.	.	.
cord-005453-4057qib7	13390	1	In	in	IN
cord-005453-4057qib7	13390	2	3	3	CD
cord-005453-4057qib7	13390	3	cases	case	NNS
cord-005453-4057qib7	13390	4	fungal	fungal	JJ
cord-005453-4057qib7	13390	5	lesions	lesion	NNS
cord-005453-4057qib7	13390	6	remained	remain	VBD
cord-005453-4057qib7	13390	7	stable	stable	JJ
cord-005453-4057qib7	13390	8	.	.	.
cord-005453-4057qib7	13391	1	CTAE	CTAE	NNP
cord-005453-4057qib7	13391	2	grade	grade	NN
cord-005453-4057qib7	13391	3	II	II	NNP
cord-005453-4057qib7	13391	4	-	-	HYPH
cord-005453-4057qib7	13391	5	III	iii	CD
cord-005453-4057qib7	13391	6	toxicity	toxicity	NN
cord-005453-4057qib7	13391	7	was	be	VBD
cord-005453-4057qib7	13391	8	observed	observe	VBN
cord-005453-4057qib7	13391	9	during	during	IN
cord-005453-4057qib7	13391	10	treatment	treatment	NN
cord-005453-4057qib7	13391	11	in	in	IN
cord-005453-4057qib7	13391	12	3	3	CD
cord-005453-4057qib7	13391	13	patients	patient	NNS
cord-005453-4057qib7	13391	14	,	,	,
cord-005453-4057qib7	13391	15	with	with	IN
cord-005453-4057qib7	13391	16	increased	increase	VBN
cord-005453-4057qib7	13391	17	transaminase	transaminase	NN
cord-005453-4057qib7	13391	18	and/or	and/or	CC
cord-005453-4057qib7	13391	19	creatinine	creatinine	NN
cord-005453-4057qib7	13391	20	levels	level	NNS
cord-005453-4057qib7	13391	21	which	which	WDT
cord-005453-4057qib7	13391	22	resolved	resolve	VBD
cord-005453-4057qib7	13391	23	after	after	IN
cord-005453-4057qib7	13391	24	temporary	temporary	JJ
cord-005453-4057qib7	13391	25	ISA	ISA	NNP
cord-005453-4057qib7	13391	26	withdrawal	withdrawal	NN
cord-005453-4057qib7	13391	27	.	.	.
cord-005453-4057qib7	13392	1	No	no	DT
cord-005453-4057qib7	13392	2	drug	drug	NN
cord-005453-4057qib7	13392	3	-	-	HYPH
cord-005453-4057qib7	13392	4	drug	drug	NN
cord-005453-4057qib7	13392	5	interactions	interaction	NNS
cord-005453-4057qib7	13392	6	were	be	VBD
cord-005453-4057qib7	13392	7	observed	observe	VBN
cord-005453-4057qib7	13392	8	in	in	IN
cord-005453-4057qib7	13392	9	3	3	CD
cord-005453-4057qib7	13392	10	patients	patient	NNS
cord-005453-4057qib7	13392	11	receiving	receive	VBG
cord-005453-4057qib7	13392	12	CSA	CSA	NNP
cord-005453-4057qib7	13392	13	as	as	IN
cord-005453-4057qib7	13392	14	GvHD	GvHD	NNP
cord-005453-4057qib7	13392	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13392	16	and	and	CC
cord-005453-4057qib7	13392	17	no	no	DT
cord-005453-4057qib7	13392	18	modification	modification	NN
cord-005453-4057qib7	13392	19	of	of	IN
cord-005453-4057qib7	13392	20	CSA	CSA	NNP
cord-005453-4057qib7	13392	21	daily	daily	RB
cord-005453-4057qib7	13392	22	dose	dose	NN
cord-005453-4057qib7	13392	23	was	be	VBD
cord-005453-4057qib7	13392	24	needed	need	VBN
cord-005453-4057qib7	13392	25	.	.	.
cord-005453-4057qib7	13393	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13393	2	:	:	:
cord-005453-4057qib7	13394	1	Isavuconazole	Isavuconazole	NNP
cord-005453-4057qib7	13394	2	use	use	NN
cord-005453-4057qib7	13394	3	may	may	MD
cord-005453-4057qib7	13394	4	be	be	VB
cord-005453-4057qib7	13394	5	considered	consider	VBN
cord-005453-4057qib7	13394	6	in	in	IN
cord-005453-4057qib7	13394	7	the	the	DT
cord-005453-4057qib7	13394	8	pediatric	pediatric	JJ
cord-005453-4057qib7	13394	9	population	population	NN
cord-005453-4057qib7	13394	10	,	,	,
cord-005453-4057qib7	13394	11	even	even	RB
cord-005453-4057qib7	13394	12	in	in	IN
cord-005453-4057qib7	13394	13	the	the	DT
cord-005453-4057qib7	13394	14	HSCT	HSCT	NNP
cord-005453-4057qib7	13394	15	setting	setting	NN
cord-005453-4057qib7	13394	16	,	,	,
cord-005453-4057qib7	13394	17	for	for	IN
cord-005453-4057qib7	13394	18	its	-PRON-	PRP$
cord-005453-4057qib7	13394	19	safety	safety	NN
cord-005453-4057qib7	13394	20	,	,	,
cord-005453-4057qib7	13394	21	efficacy	efficacy	NN
cord-005453-4057qib7	13394	22	,	,	,
cord-005453-4057qib7	13394	23	tolerability	tolerability	NN
cord-005453-4057qib7	13394	24	,	,	,
cord-005453-4057qib7	13394	25	no	no	DT
cord-005453-4057qib7	13394	26	drug	drug	NN
cord-005453-4057qib7	13394	27	-	-	HYPH
cord-005453-4057qib7	13394	28	drug	drug	NN
cord-005453-4057qib7	13394	29	interaction	interaction	NN
cord-005453-4057qib7	13394	30	.	.	.
cord-005453-4057qib7	13395	1	Of	of	RB
cord-005453-4057qib7	13395	2	course	course	RB
cord-005453-4057qib7	13395	3	these	these	DT
cord-005453-4057qib7	13395	4	data	datum	NNS
cord-005453-4057qib7	13395	5	deserve	deserve	VBP
cord-005453-4057qib7	13395	6	further	further	JJ
cord-005453-4057qib7	13395	7	evaluation	evaluation	NN
cord-005453-4057qib7	13395	8	.	.	.
cord-005453-4057qib7	13396	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13396	2	:	:	:
cord-005453-4057qib7	13396	3	Nothing	nothing	NN
cord-005453-4057qib7	13396	4	to	to	TO
cord-005453-4057qib7	13396	5	declare	declare	VB
cord-005453-4057qib7	13396	6	P608	P608	NNP
cord-005453-4057qib7	13396	7	New	New	NNP
cord-005453-4057qib7	13396	8	treosulfan	treosulfan	NN
cord-005453-4057qib7	13396	9	-	-	HYPH
cord-005453-4057qib7	13396	10	based	base	VBN
cord-005453-4057qib7	13396	11	conditioning	conditioning	NN
cord-005453-4057qib7	13396	12	regimens	regimen	NNS
cord-005453-4057qib7	13396	13	including	include	VBG
cord-005453-4057qib7	13396	14	epigenetic	epigenetic	JJ
cord-005453-4057qib7	13396	15	agents	agent	NNS
cord-005453-4057qib7	13396	16	in	in	IN
cord-005453-4057qib7	13396	17	patients	patient	NNS
cord-005453-4057qib7	13396	18	with	with	IN
cord-005453-4057qib7	13396	19	very	very	RB
cord-005453-4057qib7	13396	20	high	high	JJ
cord-005453-4057qib7	13396	21	-	-	HYPH
cord-005453-4057qib7	13396	22	risk	risk	NN
cord-005453-4057qib7	13396	23	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	13396	24	Background	background	NN
cord-005453-4057qib7	13396	25	:	:	:
cord-005453-4057qib7	13397	1	The	the	DT
cord-005453-4057qib7	13397	2	pts	pts	NN
cord-005453-4057qib7	13397	3	aged	age	VBN
cord-005453-4057qib7	13397	4	18	18	CD
cord-005453-4057qib7	13397	5	mos	mos	NNP
cord-005453-4057qib7	13397	6	.	.	NNP
cord-005453-4057qib7	13397	7	or	or	CC
cord-005453-4057qib7	13397	8	older	old	JJR
cord-005453-4057qib7	13397	9	with	with	IN
cord-005453-4057qib7	13397	10	disseminated	disseminate	VBN
cord-005453-4057qib7	13397	11	NB	NB	NNP
cord-005453-4057qib7	13397	12	involving	involve	VBG
cord-005453-4057qib7	13397	13	bone	bone	NN
cord-005453-4057qib7	13397	14	and	and	CC
cord-005453-4057qib7	13397	15	bone	bone	NN
cord-005453-4057qib7	13397	16	marrow	marrow	NN
cord-005453-4057qib7	13397	17	constitute	constitute	VBP
cord-005453-4057qib7	13397	18	a	a	DT
cord-005453-4057qib7	13397	19	group	group	NN
cord-005453-4057qib7	13397	20	of	of	IN
cord-005453-4057qib7	13397	21	pts	pts	NN
cord-005453-4057qib7	13397	22	with	with	IN
cord-005453-4057qib7	13397	23	very	very	RB
cord-005453-4057qib7	13397	24	poor	poor	JJ
cord-005453-4057qib7	13397	25	prognosis	prognosis	NN
cord-005453-4057qib7	13397	26	.	.	.
cord-005453-4057qib7	13398	1	Although	although	IN
cord-005453-4057qib7	13398	2	the	the	DT
cord-005453-4057qib7	13398	3	majority	majority	NN
cord-005453-4057qib7	13398	4	of	of	IN
cord-005453-4057qib7	13398	5	them	-PRON-	PRP
cord-005453-4057qib7	13398	6	are	be	VBP
cord-005453-4057qib7	13398	7	responsive	responsive	JJ
cord-005453-4057qib7	13398	8	to	to	TO
cord-005453-4057qib7	13398	9	intensive	intensive	JJ
cord-005453-4057qib7	13398	10	conventional	conventional	JJ
cord-005453-4057qib7	13398	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13398	12	,	,	,
cord-005453-4057qib7	13398	13	most	most	RBS
cord-005453-4057qib7	13398	14	eventually	eventually	RB
cord-005453-4057qib7	13398	15	relapse	relapse	VBP
cord-005453-4057qib7	13398	16	with	with	IN
cord-005453-4057qib7	13398	17	EFS	EFS	NNP
cord-005453-4057qib7	13398	18	at	at	IN
cord-005453-4057qib7	13398	19	5	5	CD
cord-005453-4057qib7	13398	20	years	year	NNS
cord-005453-4057qib7	13398	21	of	of	IN
cord-005453-4057qib7	13398	22	<	<	NNP
cord-005453-4057qib7	13398	23	10	10	CD
cord-005453-4057qib7	13398	24	%	%	NN
cord-005453-4057qib7	13398	25	.	.	.
cord-005453-4057qib7	13399	1	At	at	IN
cord-005453-4057qib7	13399	2	the	the	DT
cord-005453-4057qib7	13399	3	beginning	beginning	NN
cord-005453-4057qib7	13399	4	of	of	IN
cord-005453-4057qib7	13399	5	the	the	DT
cord-005453-4057qib7	13399	6	year	year	NN
cord-005453-4057qib7	13399	7	2018	2018	CD
cord-005453-4057qib7	13399	8	we	-PRON-	PRP
cord-005453-4057qib7	13399	9	came	come	VBD
cord-005453-4057qib7	13399	10	up	up	RP
cord-005453-4057qib7	13399	11	with	with	IN
cord-005453-4057qib7	13399	12	a	a	DT
cord-005453-4057qib7	13399	13	protocol	protocol	NN
cord-005453-4057qib7	13399	14	for	for	IN
cord-005453-4057qib7	13399	15	this	this	DT
cord-005453-4057qib7	13399	16	very	very	RB
cord-005453-4057qib7	13399	17	unfavorable	unfavorable	JJ
cord-005453-4057qib7	13399	18	group	group	NN
cord-005453-4057qib7	13399	19	including	include	VBG
cord-005453-4057qib7	13399	20	epigenetic	epigenetic	JJ
cord-005453-4057qib7	13399	21	therapy	therapy	NN
cord-005453-4057qib7	13399	22	(	(	-LRB-
cord-005453-4057qib7	13399	23	5-azacitidine	5-azacitidine	CD
cord-005453-4057qib7	13399	24	)	)	-RRB-
cord-005453-4057qib7	13399	25	in	in	IN
cord-005453-4057qib7	13399	26	the	the	DT
cord-005453-4057qib7	13399	27	phases	phase	NNS
cord-005453-4057qib7	13399	28	of	of	IN
cord-005453-4057qib7	13399	29	consolidation	consolidation	NN
cord-005453-4057qib7	13399	30	.	.	.
cord-005453-4057qib7	13400	1	Methods	method	NNS
cord-005453-4057qib7	13400	2	:	:	:
cord-005453-4057qib7	13401	1	Seven	seven	CD
cord-005453-4057qib7	13401	2	pts	pt	NNS
cord-005453-4057qib7	13401	3	with	with	IN
cord-005453-4057qib7	13401	4	a	a	DT
cord-005453-4057qib7	13401	5	median	median	JJ
cord-005453-4057qib7	13401	6	age	age	NN
cord-005453-4057qib7	13401	7	of	of	IN
cord-005453-4057qib7	13401	8	4	4	CD
cord-005453-4057qib7	13401	9	(	(	-LRB-
cord-005453-4057qib7	13401	10	2,6	2,6	CD
cord-005453-4057qib7	13401	11	-	-	SYM
cord-005453-4057qib7	13401	12	8	8	CD
cord-005453-4057qib7	13401	13	)	)	-RRB-
cord-005453-4057qib7	13401	14	years	year	NNS
cord-005453-4057qib7	13401	15	completed	complete	VBD
cord-005453-4057qib7	13401	16	the	the	DT
cord-005453-4057qib7	13401	17	protocol	protocol	NN
cord-005453-4057qib7	13401	18	and	and	CC
cord-005453-4057qib7	13401	19	received	receive	VBD
cord-005453-4057qib7	13401	20	HDCT	HDCT	NNP
cord-005453-4057qib7	13401	21	with	with	IN
cord-005453-4057qib7	13401	22	autologous	autologous	JJ
cord-005453-4057qib7	13401	23	SCT	SCT	NNP
cord-005453-4057qib7	13401	24	as	as	IN
cord-005453-4057qib7	13401	25	a	a	DT
cord-005453-4057qib7	13401	26	consolidation	consolidation	NN
cord-005453-4057qib7	13401	27	.	.	.
cord-005453-4057qib7	13402	1	HDCT	HDCT	NNP
cord-005453-4057qib7	13402	2	included	include	VBD
cord-005453-4057qib7	13402	3	two	two	CD
cord-005453-4057qib7	13402	4	different	different	JJ
cord-005453-4057qib7	13402	5	epigenetic	epigenetic	JJ
cord-005453-4057qib7	13402	6	agent	agent	NN
cord-005453-4057qib7	13402	7	containing	contain	VBG
cord-005453-4057qib7	13402	8	regimes	regime	NNS
cord-005453-4057qib7	13402	9	according	accord	VBG
cord-005453-4057qib7	13402	10	to	to	IN
cord-005453-4057qib7	13402	11	tumor	tumor	NN
cord-005453-4057qib7	13402	12	response	response	NN
cord-005453-4057qib7	13402	13	to	to	IN
cord-005453-4057qib7	13402	14	the	the	DT
cord-005453-4057qib7	13402	15	induction	induction	NN
cord-005453-4057qib7	13402	16	therapy	therapy	NN
cord-005453-4057qib7	13402	17	assessed	assess	VBN
cord-005453-4057qib7	13402	18	by	by	IN
cord-005453-4057qib7	13402	19	123	123	CD
cord-005453-4057qib7	13402	20	I	I	NNP
cord-005453-4057qib7	13402	21	-	-	HYPH
cord-005453-4057qib7	13402	22	MIBG	MIBG	NNP
cord-005453-4057qib7	13402	23	and	and	CC
cord-005453-4057qib7	13402	24	MRI	MRI	NNP
cord-005453-4057qib7	13402	25	(	(	-LRB-
cord-005453-4057qib7	13402	26	CT	CT	NNP
cord-005453-4057qib7	13402	27	-	-	HYPH
cord-005453-4057qib7	13402	28	scan	scan	NNP
cord-005453-4057qib7	13402	29	)	)	-RRB-
cord-005453-4057qib7	13402	30	.	.	.
cord-005453-4057qib7	13403	1	Three	three	CD
cord-005453-4057qib7	13403	2	pts	pt	NNS
cord-005453-4057qib7	13403	3	revealing	reveal	VBG
cord-005453-4057qib7	13403	4	large	large	JJ
cord-005453-4057qib7	13403	5	active	active	JJ
cord-005453-4057qib7	13403	6	residual	residual	JJ
cord-005453-4057qib7	13403	7	tumor	tumor	NN
cord-005453-4057qib7	13403	8	assessed	assess	VBN
cord-005453-4057qib7	13403	9	by	by	IN
cord-005453-4057qib7	13403	10	123	123	CD
cord-005453-4057qib7	13403	11	I	I	NNP
cord-005453-4057qib7	13403	12	-	-	HYPH
cord-005453-4057qib7	13403	13	MIBG	MIBG	NNP
cord-005453-4057qib7	13403	14	scan	scan	NN
cord-005453-4057qib7	13403	15	or	or	CC
cord-005453-4057qib7	13403	16	multiple	multiple	JJ
cord-005453-4057qib7	13403	17	active	active	JJ
cord-005453-4057qib7	13403	18	bone	bone	NN
cord-005453-4057qib7	13403	19	metastases	metastasis	NNS
cord-005453-4057qib7	13403	20	received	receive	VBD
cord-005453-4057qib7	13403	21	a	a	DT
cord-005453-4057qib7	13403	22	conditioning	conditioning	NN
cord-005453-4057qib7	13403	23	regimen	regimen	NN
cord-005453-4057qib7	13403	24	(	(	-LRB-
cord-005453-4057qib7	13403	25	regimen	regimen	NN
cord-005453-4057qib7	13403	26	A	a	NN
cord-005453-4057qib7	13403	27	)	)	-RRB-
cord-005453-4057qib7	13403	28	including	include	VBG
cord-005453-4057qib7	13403	29	131	131	CD
cord-005453-4057qib7	13403	30	I	I	NNP
cord-005453-4057qib7	13403	31	-	-	HYPH
cord-005453-4057qib7	13403	32	MIBG	MIBG	NNP
cord-005453-4057qib7	13403	33	therapy	therapy	NN
cord-005453-4057qib7	13403	34	at	at	IN
cord-005453-4057qib7	13403	35	a	a	DT
cord-005453-4057qib7	13403	36	dose	dose	NN
cord-005453-4057qib7	13403	37	4.0	4.0	CD
cord-005453-4057qib7	13403	38	-	-	SYM
cord-005453-4057qib7	13403	39	4.4	4.4	CD
cord-005453-4057qib7	13403	40	MBe	MBe	NNS
cord-005453-4057qib7	13403	41	/	/	SYM
cord-005453-4057qib7	13403	42	kg	kg	NNS
cord-005453-4057qib7	13403	43	on	on	IN
cord-005453-4057qib7	13403	44	d-14	d-14	NNP
cord-005453-4057qib7	13403	45	,	,	,
cord-005453-4057qib7	13403	46	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	13403	47	10000	10000	CD
cord-005453-4057qib7	13403	48	mg	mg	NNP
cord-005453-4057qib7	13403	49	/	/	SYM
cord-005453-4057qib7	13403	50	m	m	NN
cord-005453-4057qib7	13403	51	2	2	CD
cord-005453-4057qib7	13403	52	/d	/d	NNP
cord-005453-4057qib7	13403	53	,	,	,
cord-005453-4057qib7	13403	54	on	on	IN
cord-005453-4057qib7	13403	55	d-6,-5	d-6,-5	NNP
cord-005453-4057qib7	13404	1	and	and	CC
cord-005453-4057qib7	13404	2	-4	-4	NNP
cord-005453-4057qib7	13404	3	(	(	-LRB-
cord-005453-4057qib7	13404	4	total	total	JJ
cord-005453-4057qib7	13404	5	30000	30000	CD
cord-005453-4057qib7	13404	6	mg	mg	NNP
cord-005453-4057qib7	13404	7	/	/	SYM
cord-005453-4057qib7	13404	8	m	m	NNP
cord-005453-4057qib7	13404	9	2	2	CD
cord-005453-4057qib7	13404	10	)	)	-RRB-
cord-005453-4057qib7	13404	11	,	,	,
cord-005453-4057qib7	13404	12	Melphalan	Melphalan	NNP
cord-005453-4057qib7	13404	13	70	70	CD
cord-005453-4057qib7	13404	14	mg	mg	NN
cord-005453-4057qib7	13405	1	/m	/m	NNP
cord-005453-4057qib7	13405	2	2	2	CD
cord-005453-4057qib7	13406	1	/d	/d	NNP
cord-005453-4057qib7	13406	2	,	,	,
cord-005453-4057qib7	13406	3	on	on	IN
cord-005453-4057qib7	13406	4	d-3,-2	d-3,-2	NNP
cord-005453-4057qib7	13406	5	(	(	-LRB-
cord-005453-4057qib7	13406	6	total	total	JJ
cord-005453-4057qib7	13406	7	140	140	CD
cord-005453-4057qib7	13406	8	mg	mg	NNP
cord-005453-4057qib7	13406	9	/	/	SYM
cord-005453-4057qib7	13406	10	m	m	NNP
cord-005453-4057qib7	13406	11	2	2	CD
cord-005453-4057qib7	13406	12	)	)	-RRB-
cord-005453-4057qib7	13406	13	,	,	,
cord-005453-4057qib7	13406	14	5-azacitidine	5-azacitidine	CD
cord-005453-4057qib7	13406	15	75	75	CD
cord-005453-4057qib7	13407	1	mg	mg	NNP
cord-005453-4057qib7	13408	1	/m	/m	NNP
cord-005453-4057qib7	13408	2	2	2	CD
cord-005453-4057qib7	13408	3	/d	/d	NNP
cord-005453-4057qib7	13408	4	on	on	IN
cord-005453-4057qib7	13408	5	d-9	d-9	NN
cord-005453-4057qib7	13408	6	to	to	IN
cord-005453-4057qib7	13409	1	d-5	d-5	NNP
cord-005453-4057qib7	13409	2	(	(	-LRB-
cord-005453-4057qib7	13409	3	total	total	JJ
cord-005453-4057qib7	13409	4	375	375	CD
cord-005453-4057qib7	13409	5	mg	mg	NNP
cord-005453-4057qib7	13409	6	/	/	SYM
cord-005453-4057qib7	13409	7	m	m	NNP
cord-005453-4057qib7	13409	8	2	2	CD
cord-005453-4057qib7	13409	9	)	)	-RRB-
cord-005453-4057qib7	13409	10	.	.	.
cord-005453-4057qib7	13410	1	Four	four	CD
cord-005453-4057qib7	13410	2	pts	pts	NN
cord-005453-4057qib7	13410	3	with	with	IN
cord-005453-4057qib7	13410	4	CR	CR	NNP
cord-005453-4057qib7	13410	5	or	or	CC
cord-005453-4057qib7	13410	6	VGPR	VGPR	NNP
cord-005453-4057qib7	13410	7	received	receive	VBD
cord-005453-4057qib7	13410	8	a	a	DT
cord-005453-4057qib7	13410	9	«	«	``
cord-005453-4057qib7	13410	10	split	split	NN
cord-005453-4057qib7	13410	11	»	»	''
cord-005453-4057qib7	13410	12	conditioning	conditioning	NN
cord-005453-4057qib7	13410	13	regimen	regimen	NN
cord-005453-4057qib7	13410	14	(	(	-LRB-
cord-005453-4057qib7	13410	15	regimen	regimen	NN
cord-005453-4057qib7	13410	16	B	B	NNP
cord-005453-4057qib7	13410	17	)	)	-RRB-
cord-005453-4057qib7	13410	18	including	include	VBG
cord-005453-4057qib7	13410	19	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	13410	20	10000	10000	CD
cord-005453-4057qib7	13410	21	mg	mg	NNP
cord-005453-4057qib7	13410	22	/	/	SYM
cord-005453-4057qib7	13410	23	m	m	NN
cord-005453-4057qib7	13411	1	2	2	LS
cord-005453-4057qib7	13411	2	/d	/d	NNP
cord-005453-4057qib7	13411	3	,	,	,
cord-005453-4057qib7	13411	4	on	on	IN
cord-005453-4057qib7	13411	5	d	d	NNP
cord-005453-4057qib7	13411	6	11	11	CD
cord-005453-4057qib7	13411	7	and	and	CC
cord-005453-4057qib7	13411	8	-10	-10	NN
cord-005453-4057qib7	13411	9	,	,	,
cord-005453-4057qib7	13411	10	and	and	CC
cord-005453-4057qib7	13411	11	on	on	IN
cord-005453-4057qib7	13411	12	d-4	d-4	NN
cord-005453-4057qib7	13411	13	and	and	CC
cord-005453-4057qib7	13411	14	d-3	d-3	NNP
cord-005453-4057qib7	13411	15	(	(	-LRB-
cord-005453-4057qib7	13411	16	total	total	JJ
cord-005453-4057qib7	13411	17	40000	40000	CD
cord-005453-4057qib7	13411	18	mg	mg	NNP
cord-005453-4057qib7	13411	19	/	/	SYM
cord-005453-4057qib7	13411	20	m	m	NNP
cord-005453-4057qib7	13411	21	2	2	CD
cord-005453-4057qib7	13411	22	)	)	-RRB-
cord-005453-4057qib7	13411	23	,	,	,
cord-005453-4057qib7	13411	24	Melphalan	Melphalan	NNP
cord-005453-4057qib7	13411	25	70	70	CD
cord-005453-4057qib7	13412	1	mg	mg	NNP
cord-005453-4057qib7	13413	1	/m	/m	NNP
cord-005453-4057qib7	13413	2	2	2	CD
cord-005453-4057qib7	13413	3	/d	/d	NNP
cord-005453-4057qib7	13413	4	,	,	,
cord-005453-4057qib7	13413	5	on	on	IN
cord-005453-4057qib7	13413	6	d-3	d-3	NN
cord-005453-4057qib7	13413	7	and	and	CC
cord-005453-4057qib7	13413	8	-2	-2	NNP
cord-005453-4057qib7	13413	9	(	(	-LRB-
cord-005453-4057qib7	13413	10	total	total	JJ
cord-005453-4057qib7	13413	11	140	140	CD
cord-005453-4057qib7	13413	12	mg	mg	NNP
cord-005453-4057qib7	13413	13	/	/	SYM
cord-005453-4057qib7	13413	14	m	m	NNP
cord-005453-4057qib7	13413	15	2	2	CD
cord-005453-4057qib7	13413	16	)	)	-RRB-
cord-005453-4057qib7	13413	17	,	,	,
cord-005453-4057qib7	13413	18	and	and	CC
cord-005453-4057qib7	13413	19	5-azacitidine	5-azacitidine	CD
cord-005453-4057qib7	13413	20	75	75	CD
cord-005453-4057qib7	13414	1	mg	mg	NNP
cord-005453-4057qib7	13414	2	/	/	SYM
cord-005453-4057qib7	13414	3	m	m	NN
cord-005453-4057qib7	13414	4	2	2	CD
cord-005453-4057qib7	13415	1	/d	/d	NNP
cord-005453-4057qib7	13415	2	,	,	,
cord-005453-4057qib7	13415	3	on	on	IN
cord-005453-4057qib7	13415	4	d	d	XX
cord-005453-4057qib7	13415	5	-14	-14	NN
cord-005453-4057qib7	13415	6	to	to	IN
cord-005453-4057qib7	13415	7	d	d	NN
cord-005453-4057qib7	13415	8	-12	-12	NNS
cord-005453-4057qib7	13415	9	and	and	CC
cord-005453-4057qib7	13415	10	on	on	IN
cord-005453-4057qib7	13415	11	d-9	d-9	NN
cord-005453-4057qib7	13415	12	to	to	IN
cord-005453-4057qib7	13416	1	-d-5	-d-5	.
cord-005453-4057qib7	13417	1	(	(	-LRB-
cord-005453-4057qib7	13417	2	total	total	NN
cord-005453-4057qib7	13417	3	600	600	CD
cord-005453-4057qib7	13417	4	mg	mg	NNP
cord-005453-4057qib7	13417	5	/	/	SYM
cord-005453-4057qib7	13417	6	m	m	NNP
cord-005453-4057qib7	13417	7	2	2	CD
cord-005453-4057qib7	13417	8	)	)	-RRB-
cord-005453-4057qib7	13417	9	.	.	.
cord-005453-4057qib7	13418	1	A	a	DT
cord-005453-4057qib7	13418	2	median	median	JJ
cord-005453-4057qib7	13418	3	number	number	NN
cord-005453-4057qib7	13418	4	of	of	IN
cord-005453-4057qib7	13418	5	5.3	5.3	CD
cord-005453-4057qib7	13418	6	(	(	-LRB-
cord-005453-4057qib7	13418	7	3.7	3.7	CD
cord-005453-4057qib7	13418	8	-	-	SYM
cord-005453-4057qib7	13418	9	7	7	CD
cord-005453-4057qib7	13418	10	)	)	-RRB-
cord-005453-4057qib7	13418	11	CD34+/kg	CD34+/kg	NNP
cord-005453-4057qib7	13418	12	was	be	VBD
cord-005453-4057qib7	13418	13	infused	infuse	VBN
cord-005453-4057qib7	13418	14	on	on	IN
cord-005453-4057qib7	13418	15	d0	d0	NNP
cord-005453-4057qib7	13418	16	.	.	.
cord-005453-4057qib7	13419	1	Results	result	NNS
cord-005453-4057qib7	13419	2	:	:	:
cord-005453-4057qib7	13420	1	The	the	DT
cord-005453-4057qib7	13420	2	median	median	JJ
cord-005453-4057qib7	13420	3	recovery	recovery	NN
cord-005453-4057qib7	13420	4	times	time	NNS
cord-005453-4057qib7	13420	5	to	to	IN
cord-005453-4057qib7	13420	6	WBC>1.0x10	wbc>1.0x10	NN
cord-005453-4057qib7	13420	7	9	9	CD
cord-005453-4057qib7	13420	8	/l	/l	NN
cord-005453-4057qib7	13420	9	and	and	CC
cord-005453-4057qib7	13420	10	to	to	IN
cord-005453-4057qib7	13420	11	an	an	DT
cord-005453-4057qib7	13420	12	unsupported	unsupported	JJ
cord-005453-4057qib7	13420	13	Plt>20x10	Plt>20x10	NNP
cord-005453-4057qib7	13420	14	11	11	CD
cord-005453-4057qib7	13420	15	/l	/l	NNP
cord-005453-4057qib7	13420	16	were	be	VBD
cord-005453-4057qib7	13420	17	10	10	CD
cord-005453-4057qib7	13420	18	(	(	-LRB-
cord-005453-4057qib7	13420	19	7	7	CD
cord-005453-4057qib7	13420	20	-	-	SYM
cord-005453-4057qib7	13420	21	12	12	CD
cord-005453-4057qib7	13420	22	)	)	-RRB-
cord-005453-4057qib7	13420	23	and	and	CC
cord-005453-4057qib7	13420	24	13	13	CD
cord-005453-4057qib7	13420	25	(	(	-LRB-
cord-005453-4057qib7	13420	26	9	9	CD
cord-005453-4057qib7	13420	27	-	-	SYM
cord-005453-4057qib7	13420	28	17	17	CD
cord-005453-4057qib7	13420	29	)	)	-RRB-
cord-005453-4057qib7	13420	30	days	day	NNS
cord-005453-4057qib7	13420	31	,	,	,
cord-005453-4057qib7	13420	32	respectively	respectively	RB
cord-005453-4057qib7	13420	33	.	.	.
cord-005453-4057qib7	13421	1	All	all	DT
cord-005453-4057qib7	13421	2	pts	pt	NNS
cord-005453-4057qib7	13421	3	experienced	experience	VBD
cord-005453-4057qib7	13421	4	grade	grade	NN
cord-005453-4057qib7	13421	5	4	4	CD
cord-005453-4057qib7	13421	6	hematological	hematological	JJ
cord-005453-4057qib7	13421	7	as	as	RB
cord-005453-4057qib7	13421	8	well	well	RB
cord-005453-4057qib7	13421	9	as	as	IN
cord-005453-4057qib7	13421	10	infectious	infectious	JJ
cord-005453-4057qib7	13421	11	toxicity	toxicity	NN
cord-005453-4057qib7	13421	12	assessed	assess	VBN
cord-005453-4057qib7	13421	13	by	by	IN
cord-005453-4057qib7	13421	14	NCI	NCI	NNP
cord-005453-4057qib7	13421	15	-	-	HYPH
cord-005453-4057qib7	13421	16	CTC	CTC	NNP
cord-005453-4057qib7	13421	17	score	score	NN
cord-005453-4057qib7	13421	18	.	.	.
cord-005453-4057qib7	13422	1	There	there	EX
cord-005453-4057qib7	13422	2	were	be	VBD
cord-005453-4057qib7	13422	3	7	7	CD
cord-005453-4057qib7	13422	4	episodes	episode	NNS
cord-005453-4057qib7	13422	5	of	of	IN
cord-005453-4057qib7	13422	6	severe	severe	JJ
cord-005453-4057qib7	13422	7	organ	organ	NN
cord-005453-4057qib7	13422	8	toxicity	toxicity	NN
cord-005453-4057qib7	13422	9	of	of	IN
cord-005453-4057qib7	13422	10	grade	grade	NN
cord-005453-4057qib7	13422	11	3	3	CD
cord-005453-4057qib7	13422	12	occurring	occur	VBG
cord-005453-4057qib7	13422	13	in	in	IN
cord-005453-4057qib7	13422	14	4	4	CD
cord-005453-4057qib7	13422	15	pts	pt	NNS
cord-005453-4057qib7	13422	16	.	.	.
cord-005453-4057qib7	13423	1	In	in	IN
cord-005453-4057qib7	13423	2	4	4	CD
cord-005453-4057qib7	13423	3	cases	case	NNS
cord-005453-4057qib7	13423	4	we	-PRON-	PRP
cord-005453-4057qib7	13423	5	observed	observe	VBD
cord-005453-4057qib7	13423	6	a	a	DT
cord-005453-4057qib7	13423	7	severe	severe	JJ
cord-005453-4057qib7	13423	8	mucositis	mucositis	NN
cord-005453-4057qib7	13423	9	,	,	,
cord-005453-4057qib7	13423	10	in	in	IN
cord-005453-4057qib7	13423	11	2	2	CD
cord-005453-4057qib7	13423	12	cases	case	NNS
cord-005453-4057qib7	13423	13	GI	gi	NN
cord-005453-4057qib7	13423	14	toxicity	toxicity	NN
cord-005453-4057qib7	13423	15	and	and	CC
cord-005453-4057qib7	13423	16	1	1	CD
cord-005453-4057qib7	13423	17	episode	episode	NN
cord-005453-4057qib7	13423	18	of	of	IN
cord-005453-4057qib7	13423	19	the	the	DT
cord-005453-4057qib7	13423	20	erythema	erythema	JJ
cord-005453-4057qib7	13423	21	multiforme	multiforme	NN
cord-005453-4057qib7	13423	22	occurred	occur	VBD
cord-005453-4057qib7	13423	23	.	.	.
cord-005453-4057qib7	13424	1	One	one	CD
cord-005453-4057qib7	13424	2	pt	pt	NN
cord-005453-4057qib7	13424	3	revealed	reveal	VBD
cord-005453-4057qib7	13424	4	a	a	DT
cord-005453-4057qib7	13424	5	lifethreatening	lifethreatening	JJ
cord-005453-4057qib7	13424	6	episode	episode	NN
cord-005453-4057qib7	13424	7	of	of	IN
cord-005453-4057qib7	13424	8	hypotension	hypotension	NN
cord-005453-4057qib7	13424	9	of	of	IN
cord-005453-4057qib7	13424	10	grade	grade	NN
cord-005453-4057qib7	13424	11	4	4	CD
cord-005453-4057qib7	13424	12	.	.	.
cord-005453-4057qib7	13425	1	No	no	DT
cord-005453-4057qib7	13425	2	transplant	transplant	NN
cord-005453-4057qib7	13425	3	-	-	HYPH
cord-005453-4057qib7	13425	4	related	relate	VBN
cord-005453-4057qib7	13425	5	death	death	NN
cord-005453-4057qib7	13425	6	occurred	occur	VBD
cord-005453-4057qib7	13425	7	.	.	.
cord-005453-4057qib7	13426	1	The	the	DT
cord-005453-4057qib7	13426	2	median	median	JJ
cord-005453-4057qib7	13426	3	number	number	NN
cord-005453-4057qib7	13426	4	of	of	IN
cord-005453-4057qib7	13426	5	transfused	transfuse	VBN
cord-005453-4057qib7	13426	6	RBC	RBC	NNP
cord-005453-4057qib7	13426	7	and	and	CC
cord-005453-4057qib7	13426	8	Plt	Plt	NNP
cord-005453-4057qib7	13426	9	doses	dose	NNS
cord-005453-4057qib7	13426	10	was	be	VBD
cord-005453-4057qib7	13426	11	3	3	CD
cord-005453-4057qib7	13426	12	(	(	-LRB-
cord-005453-4057qib7	13426	13	1	1	CD
cord-005453-4057qib7	13426	14	-	-	SYM
cord-005453-4057qib7	13426	15	4	4	CD
cord-005453-4057qib7	13426	16	)	)	-RRB-
cord-005453-4057qib7	13426	17	and	and	CC
cord-005453-4057qib7	13426	18	6	6	CD
cord-005453-4057qib7	13426	19	(	(	-LRB-
cord-005453-4057qib7	13426	20	3	3	CD
cord-005453-4057qib7	13426	21	-	-	SYM
cord-005453-4057qib7	13426	22	8	8	CD
cord-005453-4057qib7	13426	23	)	)	-RRB-
cord-005453-4057qib7	13426	24	,	,	,
cord-005453-4057qib7	13426	25	respectively	respectively	RB
cord-005453-4057qib7	13426	26	.	.	.
cord-005453-4057qib7	13427	1	All	all	DT
cord-005453-4057qib7	13427	2	pts	pt	NNS
cord-005453-4057qib7	13427	3	are	be	VBP
cord-005453-4057qib7	13427	4	alive	alive	JJ
cord-005453-4057qib7	13427	5	and	and	CC
cord-005453-4057qib7	13427	6	well	well	RB
cord-005453-4057qib7	13427	7	without	without	IN
cord-005453-4057qib7	13427	8	signs	sign	NNS
cord-005453-4057qib7	13427	9	of	of	IN
cord-005453-4057qib7	13427	10	disease	disease	NN
cord-005453-4057qib7	13427	11	progression	progression	NN
cord-005453-4057qib7	13427	12	in	in	IN
cord-005453-4057qib7	13427	13	complete	complete	JJ
cord-005453-4057qib7	13427	14	hematological	hematological	JJ
cord-005453-4057qib7	13427	15	recovery	recovery	NN
cord-005453-4057qib7	13427	16	with	with	IN
cord-005453-4057qib7	13427	17	a	a	DT
cord-005453-4057qib7	13427	18	limited	limited	JJ
cord-005453-4057qib7	13427	19	follow	follow	NN
cord-005453-4057qib7	13427	20	-	-	HYPH
cord-005453-4057qib7	13427	21	up	up	NN
cord-005453-4057qib7	13427	22	of	of	IN
cord-005453-4057qib7	13427	23	5.3	5.3	CD
cord-005453-4057qib7	13427	24	(	(	-LRB-
cord-005453-4057qib7	13427	25	4	4	CD
cord-005453-4057qib7	13427	26	-	-	SYM
cord-005453-4057qib7	13427	27	7	7	CD
cord-005453-4057qib7	13427	28	)	)	-RRB-
cord-005453-4057qib7	13427	29	mos	mos	NNP
cord-005453-4057qib7	13427	30	.	.	.
cord-005453-4057qib7	13428	1	from	from	IN
cord-005453-4057qib7	13428	2	day	day	NN
cord-005453-4057qib7	13428	3	0	0	CD
cord-005453-4057qib7	13428	4	of	of	IN
cord-005453-4057qib7	13428	5	HDCT	HDCT	NNP
cord-005453-4057qib7	13428	6	.	.	.
cord-005453-4057qib7	13429	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13429	2	:	:	:
cord-005453-4057qib7	13430	1	Although	although	IN
cord-005453-4057qib7	13430	2	it	-PRON-	PRP
cord-005453-4057qib7	13430	3	is	be	VBZ
cord-005453-4057qib7	13430	4	rather	rather	RB
cord-005453-4057qib7	13430	5	early	early	JJ
cord-005453-4057qib7	13430	6	to	to	TO
cord-005453-4057qib7	13430	7	evaluate	evaluate	VB
cord-005453-4057qib7	13430	8	the	the	DT
cord-005453-4057qib7	13430	9	efficacy	efficacy	NN
cord-005453-4057qib7	13430	10	of	of	IN
cord-005453-4057qib7	13430	11	the	the	DT
cord-005453-4057qib7	13430	12	epigenetic	epigenetic	JJ
cord-005453-4057qib7	13430	13	agent	agent	NN
cord-005453-4057qib7	13430	14	's	's	POS
cord-005453-4057qib7	13430	15	inclusion	inclusion	NN
cord-005453-4057qib7	13430	16	in	in	IN
cord-005453-4057qib7	13430	17	the	the	DT
cord-005453-4057qib7	13430	18	induction	induction	NN
cord-005453-4057qib7	13430	19	and/or	and/or	CC
cord-005453-4057qib7	13430	20	consolidation	consolidation	NN
cord-005453-4057qib7	13430	21	phases	phase	NNS
cord-005453-4057qib7	13430	22	of	of	IN
cord-005453-4057qib7	13430	23	a	a	DT
cord-005453-4057qib7	13430	24	very	very	RB
cord-005453-4057qib7	13430	25	high	high	JJ
cord-005453-4057qib7	13430	26	-	-	HYPH
cord-005453-4057qib7	13430	27	risk	risk	NN
cord-005453-4057qib7	13430	28	NB	NB	NNP
cord-005453-4057qib7	13430	29	treatment	treatment	NN
cord-005453-4057qib7	13430	30	,	,	,
cord-005453-4057qib7	13430	31	we	-PRON-	PRP
cord-005453-4057qib7	13430	32	can	can	MD
cord-005453-4057qib7	13430	33	assume	assume	VB
cord-005453-4057qib7	13430	34	that	that	IN
cord-005453-4057qib7	13430	35	,	,	,
cord-005453-4057qib7	13430	36	first	first	RB
cord-005453-4057qib7	13430	37	,	,	,
cord-005453-4057qib7	13430	38	the	the	DT
cord-005453-4057qib7	13430	39	HDCT	HDCT	NNP
cord-005453-4057qib7	13430	40	combining	combine	VBG
cord-005453-4057qib7	13430	41	MIBG	MIBG	NNP
cord-005453-4057qib7	13431	1	I	-PRON-	PRP
cord-005453-4057qib7	13431	2	131	131	CD
cord-005453-4057qib7	13431	3	and/or	and/or	CC
cord-005453-4057qib7	13431	4	high	high	JJ
cord-005453-4057qib7	13431	5	dose	dose	NN
cord-005453-4057qib7	13431	6	of	of	IN
cord-005453-4057qib7	13431	7	treosulfan	treosulfan	NNP
cord-005453-4057qib7	13431	8	with	with	IN
cord-005453-4057qib7	13431	9	epigenetic	epigenetic	JJ
cord-005453-4057qib7	13431	10	agent	agent	NN
cord-005453-4057qib7	13431	11	such	such	PDT
cord-005453-4057qib7	13431	12	a	a	DT
cord-005453-4057qib7	13431	13	5-azacitidine	5-azacitidine	CD
cord-005453-4057qib7	13431	14	was	be	VBD
cord-005453-4057qib7	13431	15	feasible	feasible	JJ
cord-005453-4057qib7	13431	16	and	and	CC
cord-005453-4057qib7	13431	17	had	have	VBD
cord-005453-4057qib7	13431	18	an	an	DT
cord-005453-4057qib7	13431	19	acceptable	acceptable	JJ
cord-005453-4057qib7	13431	20	toxicity	toxicity	NN
cord-005453-4057qib7	13431	21	.	.	.
cord-005453-4057qib7	13432	1	Second	second	RB
cord-005453-4057qib7	13432	2	,	,	,
cord-005453-4057qib7	13432	3	the	the	DT
cord-005453-4057qib7	13432	4	"	"	``
cord-005453-4057qib7	13432	5	split	split	NN
cord-005453-4057qib7	13432	6	"	"	''
cord-005453-4057qib7	13432	7	modality	modality	NN
cord-005453-4057qib7	13432	8	of	of	IN
cord-005453-4057qib7	13432	9	the	the	DT
cord-005453-4057qib7	13432	10	treosulfan	treosulfan	NNP
cord-005453-4057qib7	13432	11	use	use	NN
cord-005453-4057qib7	13432	12	in	in	IN
cord-005453-4057qib7	13432	13	conditioning	conditioning	NN
cord-005453-4057qib7	13432	14	regimen	regimen	NN
cord-005453-4057qib7	13432	15	would	would	MD
cord-005453-4057qib7	13432	16	permit	permit	VB
cord-005453-4057qib7	13432	17	to	to	TO
cord-005453-4057qib7	13432	18	increase	increase	VB
cord-005453-4057qib7	13432	19	the	the	DT
cord-005453-4057qib7	13432	20	total	total	JJ
cord-005453-4057qib7	13432	21	dose	dose	NN
cord-005453-4057qib7	13432	22	of	of	IN
cord-005453-4057qib7	13432	23	the	the	DT
cord-005453-4057qib7	13432	24	alkylating	alkylating	JJ
cord-005453-4057qib7	13432	25	agent	agent	NN
cord-005453-4057qib7	13432	26	with	with	IN
cord-005453-4057qib7	13432	27	no	no	DT
cord-005453-4057qib7	13432	28	inacceptable	inacceptable	JJ
cord-005453-4057qib7	13432	29	toxicity	toxicity	NN
cord-005453-4057qib7	13432	30	.	.	.
cord-005453-4057qib7	13433	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13433	2	:	:	:
cord-005453-4057qib7	13433	3	Nothing	nothing	NN
cord-005453-4057qib7	13433	4	to	to	TO
cord-005453-4057qib7	13433	5	declare	declare	VB
cord-005453-4057qib7	13433	6	Pre	Pre	NNP
cord-005453-4057qib7	13433	7	-	-	JJ
cord-005453-4057qib7	13433	8	and	and	CC
cord-005453-4057qib7	13433	9	-	-	HYPH
cord-005453-4057qib7	13433	10	post	post	NN
cord-005453-4057qib7	13433	11	magnetic	magnetic	JJ
cord-005453-4057qib7	13433	12	resonance	resonance	NN
cord-005453-4057qib7	13433	13	imaging	imaging	NN
cord-005453-4057qib7	13433	14	of	of	IN
cord-005453-4057qib7	13433	15	hips	hip	NNS
cord-005453-4057qib7	13433	16	and	and	CC
cord-005453-4057qib7	13433	17	knees	knee	NNS
cord-005453-4057qib7	13433	18	for	for	IN
cord-005453-4057qib7	13433	19	detecting	detect	VBG
cord-005453-4057qib7	13433	20	osteonecrosis	osteonecrosis	NN
cord-005453-4057qib7	13433	21	in	in	IN
cord-005453-4057qib7	13433	22	children	child	NNS
cord-005453-4057qib7	13433	23	undergoing	undergo	VBG
cord-005453-4057qib7	13433	24	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13433	25	cell	cell	NN
cord-005453-4057qib7	13433	26	transplantation	transplantation	NN
cord-005453-4057qib7	13433	27	:	:	:
cord-005453-4057qib7	13433	28	In	in	IN
cord-005453-4057qib7	13433	29	whom	whom	WP
cord-005453-4057qib7	13433	30	is	be	VBZ
cord-005453-4057qib7	13433	31	it	-PRON-	PRP
cord-005453-4057qib7	13433	32	necessary	necessary	JJ
cord-005453-4057qib7	13433	33	?	?	.
cord-005453-4057qib7	13434	1	Ali	Ali	NNP
cord-005453-4057qib7	13434	2	Y	Y	NNP
cord-005453-4057qib7	13434	3	Suliman	Suliman	NNP
cord-005453-4057qib7	13434	4	1	1	CD
cord-005453-4057qib7	13434	5	,	,	,
cord-005453-4057qib7	13434	6	Sue	Sue	NNP
cord-005453-4057qib7	13434	7	C	C	NNP
cord-005453-4057qib7	13434	8	Kaste	Kaste	NNP
cord-005453-4057qib7	13434	9	2	2	CD
cord-005453-4057qib7	13434	10	,	,	,
cord-005453-4057qib7	13434	11	Ying	Ying	NNP
cord-005453-4057qib7	13434	12	Li	Li	NNP
cord-005453-4057qib7	13434	13	1	1	CD
cord-005453-4057qib7	13434	14	,	,	,
cord-005453-4057qib7	13434	15	Dinesh	Dinesh	NNP
cord-005453-4057qib7	13434	16	Keerthi	Keerthi	NNP
cord-005453-4057qib7	13434	17	1	1	CD
cord-005453-4057qib7	13434	18	,	,	,
cord-005453-4057qib7	13434	19	Guolian	Guolian	NNP
cord-005453-4057qib7	13434	20	Kang	Kang	NNP
cord-005453-4057qib7	13434	21	1	1	CD
cord-005453-4057qib7	13434	22	,	,	,
cord-005453-4057qib7	13434	23	Brandon	Brandon	NNP
cord-005453-4057qib7	13434	24	M	M	NNP
cord-005453-4057qib7	13434	25	Triplett	Triplett	NNP
cord-005453-4057qib7	13434	26	1	1	CD
cord-005453-4057qib7	13434	27	,	,	,
cord-005453-4057qib7	13434	28	Ashok	Ashok	NNP
cord-005453-4057qib7	13434	29	Srinivasan	Srinivasan	NNP
cord-005453-4057qib7	13434	30	1	1	CD
cord-005453-4057qib7	13434	31	between	between	IN
cord-005453-4057qib7	13434	32	April	April	NNP
cord-005453-4057qib7	13434	33	2016	2016	CD
cord-005453-4057qib7	13434	34	and	and	CC
cord-005453-4057qib7	13434	35	August	August	NNP
cord-005453-4057qib7	13434	36	2017	2017	CD
cord-005453-4057qib7	13434	37	at	at	IN
cord-005453-4057qib7	13434	38	the	the	DT
cord-005453-4057qib7	13434	39	University	University	NNP
cord-005453-4057qib7	13434	40	Medical	Medical	NNP
cord-005453-4057qib7	13434	41	Center	Center	NNP
cord-005453-4057qib7	13434	42	Hamburg	Hamburg	NNP
cord-005453-4057qib7	13434	43	-	-	HYPH
cord-005453-4057qib7	13434	44	Eppendorf	Eppendorf	NNP
cord-005453-4057qib7	13434	45	,	,	,
cord-005453-4057qib7	13434	46	Germany	Germany	NNP
cord-005453-4057qib7	13434	47	,	,	,
cord-005453-4057qib7	13434	48	were	be	VBD
cord-005453-4057qib7	13434	49	included	include	VBN
cord-005453-4057qib7	13434	50	.	.	.
cord-005453-4057qib7	13435	1	Total	total	JJ
cord-005453-4057qib7	13435	2	and	and	CC
cord-005453-4057qib7	13435	3	active	active	JJ
cord-005453-4057qib7	13435	4	rATG	ratg	JJ
cord-005453-4057qib7	13435	5	plasma	plasma	NN
cord-005453-4057qib7	13435	6	levels	level	NNS
cord-005453-4057qib7	13435	7	were	be	VBD
cord-005453-4057qib7	13435	8	analyzed	analyze	VBN
cord-005453-4057qib7	13435	9	by	by	IN
cord-005453-4057qib7	13435	10	ELISA	ELISA	NNP
cord-005453-4057qib7	13435	11	and	and	CC
cord-005453-4057qib7	13435	12	flow	flow	NN
cord-005453-4057qib7	13435	13	cytometry	cytometry	NN
cord-005453-4057qib7	13435	14	,	,	,
cord-005453-4057qib7	13435	15	respectively	respectively	RB
cord-005453-4057qib7	13435	16	.	.	.
cord-005453-4057qib7	13436	1	Primary	primary	JJ
cord-005453-4057qib7	13436	2	endpoint	endpoint	NN
cord-005453-4057qib7	13436	3	of	of	IN
cord-005453-4057qib7	13436	4	the	the	DT
cord-005453-4057qib7	13436	5	study	study	NN
cord-005453-4057qib7	13436	6	was	be	VBD
cord-005453-4057qib7	13436	7	exposure	exposure	NN
cord-005453-4057qib7	13436	8	to	to	IN
cord-005453-4057qib7	13436	9	rATG	ratg	VB
cord-005453-4057qib7	13436	10	.	.	.
cord-005453-4057qib7	13437	1	Secondary	secondary	JJ
cord-005453-4057qib7	13437	2	endpoints	endpoint	NNS
cord-005453-4057qib7	13437	3	included	include	VBD
cord-005453-4057qib7	13437	4	transplant	transplant	NN
cord-005453-4057qib7	13437	5	-	-	HYPH
cord-005453-4057qib7	13437	6	related	relate	VBN
cord-005453-4057qib7	13437	7	mortality	mortality	NN
cord-005453-4057qib7	13437	8	,	,	,
cord-005453-4057qib7	13437	9	incidence	incidence	NN
cord-005453-4057qib7	13437	10	of	of	IN
cord-005453-4057qib7	13437	11	acute	acute	JJ
cord-005453-4057qib7	13437	12	and	and	CC
cord-005453-4057qib7	13437	13	chronic	chronic	JJ
cord-005453-4057qib7	13437	14	GvHD	GvHD	NNP
cord-005453-4057qib7	13437	15	,	,	,
cord-005453-4057qib7	13437	16	immune	immune	JJ
cord-005453-4057qib7	13437	17	reconstitution	reconstitution	NN
cord-005453-4057qib7	13437	18	,	,	,
cord-005453-4057qib7	13437	19	chimerism	chimerism	NN
cord-005453-4057qib7	13437	20	,	,	,
cord-005453-4057qib7	13437	21	rejection	rejection	NN
cord-005453-4057qib7	13437	22	and	and	CC
cord-005453-4057qib7	13437	23	viral	viral	JJ
cord-005453-4057qib7	13437	24	infections	infection	NNS
cord-005453-4057qib7	13437	25	.	.	.
cord-005453-4057qib7	13438	1	Patients	patient	NNS
cord-005453-4057qib7	13438	2	were	be	VBD
cord-005453-4057qib7	13438	3	monitored	monitor	VBN
cord-005453-4057qib7	13438	4	at	at	IN
cord-005453-4057qib7	13438	5	least	least	RBS
cord-005453-4057qib7	13438	6	100	100	CD
cord-005453-4057qib7	13438	7	days	day	NNS
cord-005453-4057qib7	13438	8	post	post	VBP
cord-005453-4057qib7	13438	9	transplantation	transplantation	NN
cord-005453-4057qib7	13438	10	.	.	.
cord-005453-4057qib7	13439	1	Statistical	statistical	JJ
cord-005453-4057qib7	13439	2	analyses	analysis	NNS
cord-005453-4057qib7	13439	3	were	be	VBD
cord-005453-4057qib7	13439	4	performed	perform	VBN
cord-005453-4057qib7	13439	5	using	use	VBG
cord-005453-4057qib7	13439	6	IBM	IBM	NNP
cord-005453-4057qib7	13439	7	SPSS	SPSS	NNP
cord-005453-4057qib7	13439	8	Statistics	Statistics	NNP
cord-005453-4057qib7	13439	9	24	24	CD
cord-005453-4057qib7	13439	10	software	software	NN
cord-005453-4057qib7	13439	11	,	,	,
cord-005453-4057qib7	13439	12	or	or	CC
cord-005453-4057qib7	13439	13	GraphPad	GraphPad	NNP
cord-005453-4057qib7	13439	14	Prism	Prism	NNP
cord-005453-4057qib7	13439	15	5	5	CD
cord-005453-4057qib7	13439	16	software	software	NN
cord-005453-4057qib7	13439	17	.	.	.
cord-005453-4057qib7	13440	1	Results	result	NNS
cord-005453-4057qib7	13440	2	:	:	:
cord-005453-4057qib7	13441	1	Median	median	JJ
cord-005453-4057qib7	13441	2	total	total	NN
cord-005453-4057qib7	13442	1	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13442	2	™	™	NN
cord-005453-4057qib7	13442	3	and	and	CC
cord-005453-4057qib7	13442	4	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13443	1	™	™	``
cord-005453-4057qib7	13443	2	peak	peak	NN
cord-005453-4057qib7	13443	3	plasma	plasma	NN
cord-005453-4057qib7	13443	4	levels	level	NNS
cord-005453-4057qib7	13443	5	were	be	VBD
cord-005453-4057qib7	13443	6	419.0	419.0	CD
cord-005453-4057qib7	13443	7	μg	μg	NNS
cord-005453-4057qib7	13443	8	/	/	SYM
cord-005453-4057qib7	13443	9	ml	ml	NNP
cord-005453-4057qib7	13443	10	and	and	CC
cord-005453-4057qib7	13443	11	60.4	60.4	CD
cord-005453-4057qib7	13443	12	μg	μg	NNP
cord-005453-4057qib7	13443	13	/	/	SYM
cord-005453-4057qib7	13443	14	ml	ml	NNS
cord-005453-4057qib7	13443	15	,	,	,
cord-005453-4057qib7	13443	16	respectively	respectively	RB
cord-005453-4057qib7	13443	17	;	;	:
cord-005453-4057qib7	13443	18	median	median	JJ
cord-005453-4057qib7	13443	19	active	active	JJ
cord-005453-4057qib7	13443	20	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13443	21	™	™	NN
cord-005453-4057qib7	13443	22	and	and	CC
cord-005453-4057qib7	13443	23	Thymoglobu	Thymoglobu	NNP
cord-005453-4057qib7	13443	24	-	-	HYPH
cord-005453-4057qib7	13443	25	line	line	NN
cord-005453-4057qib7	13443	26	™	™	HYPH
cord-005453-4057qib7	13443	27	peak	peak	NN
cord-005453-4057qib7	13443	28	plasma	plasma	NN
cord-005453-4057qib7	13443	29	levels	level	NNS
cord-005453-4057qib7	13443	30	(	(	-LRB-
cord-005453-4057qib7	13443	31	aPPL	appl	NN
cord-005453-4057qib7	13443	32	)	)	-RRB-
cord-005453-4057qib7	13443	33	were	be	VBD
cord-005453-4057qib7	13443	34	77.9	77.9	CD
cord-005453-4057qib7	13443	35	μg	μg	NNP
cord-005453-4057qib7	13443	36	/	/	SYM
cord-005453-4057qib7	13443	37	ml	ml	NN
cord-005453-4057qib7	13443	38	and	and	CC
cord-005453-4057qib7	13443	39	8.11	8.11	CD
cord-005453-4057qib7	13443	40	μg	μg	NNP
cord-005453-4057qib7	13443	41	/	/	SYM
cord-005453-4057qib7	13443	42	ml	ml	NNS
cord-005453-4057qib7	13443	43	,	,	,
cord-005453-4057qib7	13443	44	respectively	respectively	RB
cord-005453-4057qib7	13443	45	.	.	.
cord-005453-4057qib7	13444	1	Active	active	JJ
cord-005453-4057qib7	13444	2	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13444	3	™	™	HYPH
cord-005453-4057qib7	13444	4	plasma	plasma	NN
cord-005453-4057qib7	13444	5	levels	level	NNS
cord-005453-4057qib7	13444	6	showed	show	VBD
cord-005453-4057qib7	13444	7	highly	highly	RB
cord-005453-4057qib7	13444	8	variable	variable	JJ
cord-005453-4057qib7	13444	9	pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	13444	10	compared	compare	VBN
cord-005453-4057qib7	13444	11	to	to	IN
cord-005453-4057qib7	13444	12	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13444	13	™	™	NN
cord-005453-4057qib7	13444	14	.	.	.
cord-005453-4057qib7	13445	1	Neither	neither	CC
cord-005453-4057qib7	13445	2	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13445	3	™	™	NN
cord-005453-4057qib7	13445	4	nor	nor	CC
cord-005453-4057qib7	13445	5	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13445	6	™	™	NN
cord-005453-4057qib7	13445	7	exposure	exposure	NN
cord-005453-4057qib7	13445	8	correlated	correlate	VBN
cord-005453-4057qib7	13445	9	with	with	IN
cord-005453-4057qib7	13445	10	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	13445	11	count	count	NN
cord-005453-4057qib7	13445	12	prior	prior	RB
cord-005453-4057qib7	13445	13	to	to	IN
cord-005453-4057qib7	13445	14	transplantation	transplantation	NN
cord-005453-4057qib7	13445	15	,	,	,
cord-005453-4057qib7	13445	16	cell	cell	NN
cord-005453-4057qib7	13445	17	count	count	NN
cord-005453-4057qib7	13445	18	in	in	IN
cord-005453-4057qib7	13445	19	the	the	DT
cord-005453-4057qib7	13445	20	graft	graft	NN
cord-005453-4057qib7	13445	21	(	(	-LRB-
cord-005453-4057qib7	13445	22	WBC	WBC	NNP
cord-005453-4057qib7	13445	23	,	,	,
cord-005453-4057qib7	13445	24	MNC	MNC	NNP
cord-005453-4057qib7	13445	25	,	,	,
cord-005453-4057qib7	13445	26	T	T	NNP
cord-005453-4057qib7	13445	27	cells	cell	NNS
cord-005453-4057qib7	13445	28	)	)	-RRB-
cord-005453-4057qib7	13445	29	,	,	,
cord-005453-4057qib7	13445	30	age	age	NN
cord-005453-4057qib7	13445	31	,	,	,
cord-005453-4057qib7	13445	32	body	body	NN
cord-005453-4057qib7	13445	33	weight	weight	NN
cord-005453-4057qib7	13445	34	or	or	CC
cord-005453-4057qib7	13445	35	body	body	NN
cord-005453-4057qib7	13445	36	surface	surface	NN
cord-005453-4057qib7	13445	37	area	area	NN
cord-005453-4057qib7	13445	38	(	(	-LRB-
cord-005453-4057qib7	13445	39	BSA	BSA	NNP
cord-005453-4057qib7	13445	40	)	)	-RRB-
cord-005453-4057qib7	13445	41	.	.	.
cord-005453-4057qib7	13446	1	This	this	DT
cord-005453-4057qib7	13446	2	is	be	VBZ
cord-005453-4057qib7	13446	3	indicative	indicative	JJ
cord-005453-4057qib7	13446	4	for	for	IN
cord-005453-4057qib7	13446	5	a	a	DT
cord-005453-4057qib7	13446	6	saturation	saturation	NN
cord-005453-4057qib7	13446	7	effect	effect	NN
cord-005453-4057qib7	13446	8	in	in	IN
cord-005453-4057qib7	13446	9	both	both	DT
cord-005453-4057qib7	13446	10	groups	group	NNS
cord-005453-4057qib7	13446	11	.	.	.
cord-005453-4057qib7	13447	1	To	to	TO
cord-005453-4057qib7	13447	2	correlate	correlate	VB
cord-005453-4057qib7	13447	3	high	high	JJ
cord-005453-4057qib7	13447	4	or	or	CC
cord-005453-4057qib7	13447	5	low	low	JJ
cord-005453-4057qib7	13447	6	rATG	ratg	JJ
cord-005453-4057qib7	13447	7	exposure	exposure	NN
cord-005453-4057qib7	13447	8	with	with	IN
cord-005453-4057qib7	13447	9	clinical	clinical	JJ
cord-005453-4057qib7	13447	10	outcome	outcome	NN
cord-005453-4057qib7	13447	11	parameters	parameter	NNS
cord-005453-4057qib7	13447	12	,	,	,
cord-005453-4057qib7	13447	13	we	-PRON-	PRP
cord-005453-4057qib7	13447	14	built	build	VBD
cord-005453-4057qib7	13447	15	two	two	CD
cord-005453-4057qib7	13447	16	groups	group	NNS
cord-005453-4057qib7	13447	17	within	within	IN
cord-005453-4057qib7	13447	18	each	each	DT
cord-005453-4057qib7	13447	19	patient	patient	JJ
cord-005453-4057qib7	13447	20	cohort	cohort	NN
cord-005453-4057qib7	13447	21	by	by	IN
cord-005453-4057qib7	13447	22	median	median	NN
cord-005453-4057qib7	13447	23	aPPL	appl	NN
cord-005453-4057qib7	13447	24	.	.	.
cord-005453-4057qib7	13448	1	The	the	DT
cord-005453-4057qib7	13448	2	incidence	incidence	NN
cord-005453-4057qib7	13448	3	of	of	IN
cord-005453-4057qib7	13448	4	GvHD	GvHD	NNP
cord-005453-4057qib7	13448	5	was	be	VBD
cord-005453-4057qib7	13448	6	not	not	RB
cord-005453-4057qib7	13448	7	dependent	dependent	JJ
cord-005453-4057qib7	13448	8	on	on	IN
cord-005453-4057qib7	13448	9	high	high	JJ
cord-005453-4057qib7	13448	10	or	or	CC
cord-005453-4057qib7	13448	11	low	low	JJ
cord-005453-4057qib7	13448	12	rATG	ratg	JJ
cord-005453-4057qib7	13448	13	exposure	exposure	NN
cord-005453-4057qib7	13448	14	.	.	.
cord-005453-4057qib7	13449	1	Until	until	IN
cord-005453-4057qib7	13449	2	day	day	NN
cord-005453-4057qib7	13449	3	100	100	CD
cord-005453-4057qib7	13449	4	post	post	NN
cord-005453-4057qib7	13449	5	HSCT	HSCT	NNP
cord-005453-4057qib7	13449	6	,	,	,
cord-005453-4057qib7	13449	7	49	49	CD
cord-005453-4057qib7	13449	8	viral	viral	JJ
cord-005453-4057qib7	13449	9	infections	infection	NNS
cord-005453-4057qib7	13449	10	or	or	CC
cord-005453-4057qib7	13449	11	reactivations	reactivation	NNS
cord-005453-4057qib7	13449	12	(	(	-LRB-
cord-005453-4057qib7	13449	13	EBV	EBV	NNP
cord-005453-4057qib7	13449	14	,	,	,
cord-005453-4057qib7	13449	15	CMV	CMV	NNP
cord-005453-4057qib7	13449	16	,	,	,
cord-005453-4057qib7	13449	17	ADV	ADV	NNP
cord-005453-4057qib7	13449	18	,	,	,
cord-005453-4057qib7	13449	19	HHV6	HHV6	NNP
cord-005453-4057qib7	13449	20	,	,	,
cord-005453-4057qib7	13449	21	BKV	BKV	NNP
cord-005453-4057qib7	13449	22	)	)	-RRB-
cord-005453-4057qib7	13449	23	occurred	occur	VBD
cord-005453-4057qib7	13449	24	in	in	IN
cord-005453-4057qib7	13449	25	the	the	DT
cord-005453-4057qib7	13449	26	32	32	CD
cord-005453-4057qib7	13449	27	patients	patient	NNS
cord-005453-4057qib7	13449	28	.	.	.
cord-005453-4057qib7	13450	1	Interestingly	interestingly	RB
cord-005453-4057qib7	13450	2	,	,	,
cord-005453-4057qib7	13450	3	ADV	ADV	NNP
cord-005453-4057qib7	13450	4	infections	infection	NNS
cord-005453-4057qib7	13450	5	affected	affect	VBN
cord-005453-4057qib7	13450	6	only	only	JJ
cord-005453-4057qib7	13450	7	children	child	NNS
cord-005453-4057qib7	13450	8	with	with	IN
cord-005453-4057qib7	13450	9	high	high	JJ
cord-005453-4057qib7	13450	10	rATG	ratg	JJ
cord-005453-4057qib7	13450	11	exposure	exposure	NN
cord-005453-4057qib7	13450	12	.	.	.
cord-005453-4057qib7	13451	1	The	the	DT
cord-005453-4057qib7	13451	2	median	median	JJ
cord-005453-4057qib7	13451	3	time	time	NN
cord-005453-4057qib7	13451	4	to	to	IN
cord-005453-4057qib7	13451	5	leukocyte	leukocyte	NN
cord-005453-4057qib7	13451	6	engraftment	engraftment	NN
cord-005453-4057qib7	13451	7	was	be	VBD
cord-005453-4057qib7	13451	8	not	not	RB
cord-005453-4057qib7	13451	9	significantly	significantly	RB
cord-005453-4057qib7	13451	10	longer	long	RBR
cord-005453-4057qib7	13451	11	in	in	IN
cord-005453-4057qib7	13451	12	the	the	DT
cord-005453-4057qib7	13451	13	high	high	JJ
cord-005453-4057qib7	13451	14	rATG	ratg	JJ
cord-005453-4057qib7	13451	15	groups	group	NNS
cord-005453-4057qib7	13451	16	compared	compare	VBN
cord-005453-4057qib7	13451	17	to	to	IN
cord-005453-4057qib7	13451	18	the	the	DT
cord-005453-4057qib7	13451	19	low	low	JJ
cord-005453-4057qib7	13451	20	rATG	ratg	JJ
cord-005453-4057qib7	13451	21	groups	group	NNS
cord-005453-4057qib7	13451	22	(	(	-LRB-
cord-005453-4057qib7	13451	23	17	17	CD
cord-005453-4057qib7	13451	24	to	to	TO
cord-005453-4057qib7	13451	25	16	16	CD
cord-005453-4057qib7	13451	26	days	day	NNS
cord-005453-4057qib7	13451	27	for	for	IN
cord-005453-4057qib7	13451	28	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13451	29	™	™	NN
cord-005453-4057qib7	13451	30	,	,	,
cord-005453-4057qib7	13451	31	and	and	CC
cord-005453-4057qib7	13451	32	14	14	CD
cord-005453-4057qib7	13451	33	to	to	TO
cord-005453-4057qib7	13451	34	16	16	CD
cord-005453-4057qib7	13451	35	days	day	NNS
cord-005453-4057qib7	13451	36	for	for	IN
cord-005453-4057qib7	13451	37	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13451	38	™	™	NN
cord-005453-4057qib7	13451	39	)	)	-RRB-
cord-005453-4057qib7	13451	40	.	.	.
cord-005453-4057qib7	13452	1	There	there	EX
cord-005453-4057qib7	13452	2	was	be	VBD
cord-005453-4057qib7	13452	3	a	a	DT
cord-005453-4057qib7	13452	4	decreased	decrease	VBN
cord-005453-4057qib7	13452	5	and/or	and/or	CC
cord-005453-4057qib7	13452	6	delayed	delay	VBN
cord-005453-4057qib7	13452	7	recovery	recovery	NN
cord-005453-4057qib7	13452	8	of	of	IN
cord-005453-4057qib7	13452	9	CD3	CD3	NNP
cord-005453-4057qib7	13452	10	+	+	CC
cord-005453-4057qib7	13452	11	,	,	,
cord-005453-4057qib7	13452	12	CD4	CD4	NNP
cord-005453-4057qib7	13452	13	+	+	CC
cord-005453-4057qib7	13452	14	and	and	CC
cord-005453-4057qib7	13452	15	CD8	CD8	NNP
cord-005453-4057qib7	13452	16	+	+	CC
cord-005453-4057qib7	13452	17	T	T	NNP
cord-005453-4057qib7	13452	18	cell	cell	NN
cord-005453-4057qib7	13452	19	reconstitution	reconstitution	NN
cord-005453-4057qib7	13452	20	,	,	,
cord-005453-4057qib7	13452	21	but	but	CC
cord-005453-4057qib7	13452	22	not	not	RB
cord-005453-4057qib7	13452	23	of	of	IN
cord-005453-4057qib7	13452	24	B	b	NN
cord-005453-4057qib7	13452	25	cells	cell	NNS
cord-005453-4057qib7	13452	26	and	and	CC
cord-005453-4057qib7	13452	27	NK	NK	NNP
cord-005453-4057qib7	13452	28	cells	cell	NNS
cord-005453-4057qib7	13452	29	in	in	IN
cord-005453-4057qib7	13452	30	the	the	DT
cord-005453-4057qib7	13452	31	high	high	JJ
cord-005453-4057qib7	13452	32	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13452	33	™	™	HYPH
cord-005453-4057qib7	13452	34	exposure	exposure	NN
cord-005453-4057qib7	13452	35	group	group	NN
cord-005453-4057qib7	13452	36	compared	compare	VBN
cord-005453-4057qib7	13452	37	to	to	IN
cord-005453-4057qib7	13452	38	the	the	DT
cord-005453-4057qib7	13452	39	low	low	JJ
cord-005453-4057qib7	13452	40	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13452	41	™	™	HYPH
cord-005453-4057qib7	13452	42	exposure	exposure	NN
cord-005453-4057qib7	13452	43	group	group	NN
cord-005453-4057qib7	13452	44	.	.	.
cord-005453-4057qib7	13453	1	Overall	overall	JJ
cord-005453-4057qib7	13453	2	survival	survival	NN
cord-005453-4057qib7	13453	3	was	be	VBD
cord-005453-4057qib7	13453	4	not	not	RB
cord-005453-4057qib7	13453	5	statistically	statistically	RB
cord-005453-4057qib7	13453	6	significant	significant	JJ
cord-005453-4057qib7	13453	7	with	with	IN
cord-005453-4057qib7	13453	8	80	80	CD
cord-005453-4057qib7	13453	9	%	%	NN
cord-005453-4057qib7	13453	10	in	in	IN
cord-005453-4057qib7	13453	11	the	the	DT
cord-005453-4057qib7	13453	12	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13453	13	™	™	NN
cord-005453-4057qib7	13453	14	and	and	CC
cord-005453-4057qib7	13453	15	95.5	95.5	CD
cord-005453-4057qib7	13453	16	%	%	NN
cord-005453-4057qib7	13453	17	in	in	IN
cord-005453-4057qib7	13453	18	the	the	DT
cord-005453-4057qib7	13453	19	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13453	20	™	™	NN
cord-005453-4057qib7	13453	21	group	group	NN
cord-005453-4057qib7	13453	22	without	without	IN
cord-005453-4057qib7	13453	23	influence	influence	NN
cord-005453-4057qib7	13453	24	of	of	IN
cord-005453-4057qib7	13453	25	rATG	ratg	JJ
cord-005453-4057qib7	13453	26	exposure	exposure	NN
cord-005453-4057qib7	13453	27	.	.	.
cord-005453-4057qib7	13454	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13454	2	:	:	:
cord-005453-4057qib7	13455	1	High	high	JJ
cord-005453-4057qib7	13455	2	and	and	CC
cord-005453-4057qib7	13455	3	low	low	JJ
cord-005453-4057qib7	13455	4	exposure	exposure	NN
cord-005453-4057qib7	13455	5	to	to	IN
cord-005453-4057qib7	13455	6	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13455	7	™	™	NN
cord-005453-4057qib7	13455	8	or	or	CC
cord-005453-4057qib7	13455	9	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13455	10	™	™	MD
cord-005453-4057qib7	13455	11	did	do	VBD
cord-005453-4057qib7	13455	12	not	not	RB
cord-005453-4057qib7	13455	13	result	result	VB
cord-005453-4057qib7	13455	14	in	in	IN
cord-005453-4057qib7	13455	15	significant	significant	JJ
cord-005453-4057qib7	13455	16	differences	difference	NNS
cord-005453-4057qib7	13455	17	in	in	IN
cord-005453-4057qib7	13455	18	outcome	outcome	NN
cord-005453-4057qib7	13455	19	parameters	parameter	NNS
cord-005453-4057qib7	13455	20	as	as	IN
cord-005453-4057qib7	13455	21	incidence	incidence	NN
cord-005453-4057qib7	13455	22	of	of	IN
cord-005453-4057qib7	13455	23	survival	survival	NN
cord-005453-4057qib7	13455	24	,	,	,
cord-005453-4057qib7	13455	25	aGvHD	agvhd	NN
cord-005453-4057qib7	13455	26	,	,	,
cord-005453-4057qib7	13455	27	cGvHD	cGvHD	NNP
cord-005453-4057qib7	13455	28	,	,	,
cord-005453-4057qib7	13455	29	rejection	rejection	NN
cord-005453-4057qib7	13455	30	,	,	,
cord-005453-4057qib7	13455	31	or	or	CC
cord-005453-4057qib7	13455	32	mixed	mixed	JJ
cord-005453-4057qib7	13455	33	chimerism	chimerism	NN
cord-005453-4057qib7	13455	34	in	in	IN
cord-005453-4057qib7	13455	35	this	this	DT
cord-005453-4057qib7	13455	36	limited	limited	JJ
cord-005453-4057qib7	13455	37	cohort	cohort	NN
cord-005453-4057qib7	13455	38	.	.	.
cord-005453-4057qib7	13456	1	Delayed	delayed	JJ
cord-005453-4057qib7	13456	2	and	and	CC
cord-005453-4057qib7	13456	3	decreased	decrease	VBD
cord-005453-4057qib7	13456	4	immune	immune	JJ
cord-005453-4057qib7	13456	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	13456	6	in	in	IN
cord-005453-4057qib7	13456	7	the	the	DT
cord-005453-4057qib7	13456	8	high	high	JJ
cord-005453-4057qib7	13456	9	rATG	ratg	JJ
cord-005453-4057qib7	13456	10	exposure	exposure	NN
cord-005453-4057qib7	13456	11	groups	group	NNS
cord-005453-4057qib7	13456	12	did	do	VBD
cord-005453-4057qib7	13456	13	not	not	RB
cord-005453-4057qib7	13456	14	translate	translate	VB
cord-005453-4057qib7	13456	15	into	into	IN
cord-005453-4057qib7	13456	16	different	different	JJ
cord-005453-4057qib7	13456	17	clinical	clinical	JJ
cord-005453-4057qib7	13456	18	outcome	outcome	NN
cord-005453-4057qib7	13456	19	parameters	parameter	NNS
cord-005453-4057qib7	13456	20	.	.	.
cord-005453-4057qib7	13457	1	ADV	ADV	NNP
cord-005453-4057qib7	13457	2	infections	infection	NNS
cord-005453-4057qib7	13457	3	only	only	RB
cord-005453-4057qib7	13457	4	occurred	occur	VBD
cord-005453-4057qib7	13457	5	in	in	IN
cord-005453-4057qib7	13457	6	the	the	DT
cord-005453-4057qib7	13457	7	high	high	JJ
cord-005453-4057qib7	13457	8	rATG	ratg	JJ
cord-005453-4057qib7	13457	9	exposure	exposure	NN
cord-005453-4057qib7	13457	10	group	group	NN
cord-005453-4057qib7	13457	11	.	.	.
cord-005453-4057qib7	13458	1	Grafalon	Grafalon	NNP
cord-005453-4057qib7	13458	2	™	™	NN
cord-005453-4057qib7	13458	3	and	and	CC
cord-005453-4057qib7	13458	4	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	13458	5	™	™	MD
cord-005453-4057qib7	13458	6	showed	show	VBD
cord-005453-4057qib7	13458	7	distinct	distinct	JJ
cord-005453-4057qib7	13458	8	pharmacological	pharmacological	JJ
cord-005453-4057qib7	13458	9	and	and	CC
cord-005453-4057qib7	13458	10	immunological	immunological	JJ
cord-005453-4057qib7	13458	11	differences	difference	NNS
cord-005453-4057qib7	13458	12	in	in	IN
cord-005453-4057qib7	13458	13	children	child	NNS
cord-005453-4057qib7	13458	14	and	and	CC
cord-005453-4057qib7	13458	15	larger	large	JJR
cord-005453-4057qib7	13458	16	cohorts	cohort	NNS
cord-005453-4057qib7	13458	17	are	be	VBP
cord-005453-4057qib7	13458	18	needed	need	VBN
cord-005453-4057qib7	13458	19	to	to	TO
cord-005453-4057qib7	13458	20	detect	detect	VB
cord-005453-4057qib7	13458	21	clinically	clinically	RB
cord-005453-4057qib7	13458	22	significant	significant	JJ
cord-005453-4057qib7	13458	23	differences	difference	NNS
cord-005453-4057qib7	13458	24	and	and	CC
cord-005453-4057qib7	13458	25	adjust	adjust	VB
cord-005453-4057qib7	13458	26	dosing	dose	VBG
cord-005453-4057qib7	13458	27	regimens	regimen	NNS
cord-005453-4057qib7	13458	28	individually	individually	RB
cord-005453-4057qib7	13458	29	.	.	.
cord-005453-4057qib7	13459	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13459	2	:	:	:
cord-005453-4057qib7	13459	3	Nothing	nothing	NN
cord-005453-4057qib7	13459	4	to	to	TO
cord-005453-4057qib7	13459	5	declare	declare	VB
cord-005453-4057qib7	13459	6	Background	background	NN
cord-005453-4057qib7	13459	7	:	:	:
cord-005453-4057qib7	13460	1	The	the	DT
cord-005453-4057qib7	13460	2	optimal	optimal	JJ
cord-005453-4057qib7	13460	3	conditioning	conditioning	NN
cord-005453-4057qib7	13460	4	regimen	regimen	NN
cord-005453-4057qib7	13460	5	for	for	IN
cord-005453-4057qib7	13460	6	allogeneic	allogeneic	JJ
cord-005453-4057qib7	13460	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13460	8	cell	cell	NN
cord-005453-4057qib7	13460	9	transplantation	transplantation	NN
cord-005453-4057qib7	13460	10	(	(	-LRB-
cord-005453-4057qib7	13460	11	alloHCT	alloHCT	NNP
cord-005453-4057qib7	13460	12	)	)	-RRB-
cord-005453-4057qib7	13460	13	in	in	IN
cord-005453-4057qib7	13460	14	children	child	NNS
cord-005453-4057qib7	13460	15	with	with	IN
cord-005453-4057qib7	13460	16	myeloid	myeloid	JJ
cord-005453-4057qib7	13460	17	malignancies	malignancy	NNS
cord-005453-4057qib7	13460	18	remains	remain	VBZ
cord-005453-4057qib7	13460	19	undefined	undefined	JJ
cord-005453-4057qib7	13460	20	,	,	,
cord-005453-4057qib7	13460	21	particularly	particularly	RB
cord-005453-4057qib7	13460	22	when	when	WRB
cord-005453-4057qib7	13460	23	reduced	reduce	VBN
cord-005453-4057qib7	13460	24	-	-	HYPH
cord-005453-4057qib7	13460	25	intensity	intensity	NN
cord-005453-4057qib7	13460	26	conditioning	conditioning	NN
cord-005453-4057qib7	13460	27	(	(	-LRB-
cord-005453-4057qib7	13460	28	RIC	RIC	NNP
cord-005453-4057qib7	13460	29	)	)	-RRB-
cord-005453-4057qib7	13460	30	regimens	regimen	NNS
cord-005453-4057qib7	13460	31	are	be	VBP
cord-005453-4057qib7	13460	32	utilized	utilize	VBN
cord-005453-4057qib7	13460	33	.	.	.
cord-005453-4057qib7	13461	1	Methods	method	NNS
cord-005453-4057qib7	13461	2	:	:	:
cord-005453-4057qib7	13462	1	We	-PRON-	PRP
cord-005453-4057qib7	13462	2	performed	perform	VBD
cord-005453-4057qib7	13462	3	a	a	DT
cord-005453-4057qib7	13462	4	retrospective	retrospective	JJ
cord-005453-4057qib7	13462	5	review	review	NN
cord-005453-4057qib7	13462	6	of	of	IN
cord-005453-4057qib7	13462	7	children	child	NNS
cord-005453-4057qib7	13462	8	undergoing	undergo	VBG
cord-005453-4057qib7	13462	9	alloHCT	alloHCT	NNP
cord-005453-4057qib7	13462	10	for	for	IN
cord-005453-4057qib7	13462	11	acute	acute	JJ
cord-005453-4057qib7	13462	12	myeloid	myeloid	NN
cord-005453-4057qib7	13462	13	leukemia	leukemia	NN
cord-005453-4057qib7	13462	14	(	(	-LRB-
cord-005453-4057qib7	13462	15	AML	AML	NNP
cord-005453-4057qib7	13462	16	)	)	-RRB-
cord-005453-4057qib7	13462	17	and	and	CC
cord-005453-4057qib7	13462	18	myelodysplasia	myelodysplasia	NNP
cord-005453-4057qib7	13462	19	-	-	HYPH
cord-005453-4057qib7	13462	20	related	relate	VBN
cord-005453-4057qib7	13462	21	AML	AML	NNP
cord-005453-4057qib7	13462	22	(	(	-LRB-
cord-005453-4057qib7	13462	23	MDR	MDR	NNP
cord-005453-4057qib7	13462	24	-	-	HYPH
cord-005453-4057qib7	13462	25	AML	AML	NNP
cord-005453-4057qib7	13462	26	)	)	-RRB-
cord-005453-4057qib7	13462	27	over	over	IN
cord-005453-4057qib7	13462	28	a	a	DT
cord-005453-4057qib7	13462	29	10	10	CD
cord-005453-4057qib7	13462	30	year	year	NN
cord-005453-4057qib7	13462	31	period	period	NN
cord-005453-4057qib7	13462	32	(	(	-LRB-
cord-005453-4057qib7	13462	33	2008	2008	CD
cord-005453-4057qib7	13462	34	-	-	SYM
cord-005453-4057qib7	13462	35	2018	2018	CD
cord-005453-4057qib7	13462	36	)	)	-RRB-
cord-005453-4057qib7	13462	37	at	at	IN
cord-005453-4057qib7	13462	38	our	-PRON-	PRP$
cord-005453-4057qib7	13462	39	institution	institution	NN
cord-005453-4057qib7	13462	40	,	,	,
cord-005453-4057qib7	13462	41	comparing	compare	VBG
cord-005453-4057qib7	13462	42	the	the	DT
cord-005453-4057qib7	13462	43	outcomes	outcome	NNS
cord-005453-4057qib7	13462	44	of	of	IN
cord-005453-4057qib7	13462	45	those	those	DT
cord-005453-4057qib7	13462	46	who	who	WP
cord-005453-4057qib7	13462	47	received	receive	VBD
cord-005453-4057qib7	13462	48	either	either	CC
cord-005453-4057qib7	13462	49	a	a	DT
cord-005453-4057qib7	13462	50	busulfan	busulfan	NN
cord-005453-4057qib7	13462	51	(	(	-LRB-
cord-005453-4057qib7	13462	52	Bu)-or	Bu)-or	NNP
cord-005453-4057qib7	13462	53	melphalan	melphalan	NNP
cord-005453-4057qib7	13462	54	/	/	SYM
cord-005453-4057qib7	13462	55	thiotepa	thiotepa	NNP
cord-005453-4057qib7	13463	1	(	(	-LRB-
cord-005453-4057qib7	13463	2	Mel	Mel	NNP
cord-005453-4057qib7	13463	3	/	/	SYM
cord-005453-4057qib7	13463	4	Thio)-based	Thio)-based	NNP
cord-005453-4057qib7	13463	5	conditioning	conditioning	NN
cord-005453-4057qib7	13463	6	regimen	regimen	NN
cord-005453-4057qib7	13463	7	.	.	.
cord-005453-4057qib7	13464	1	Results	result	NNS
cord-005453-4057qib7	13464	2	:	:	:
cord-005453-4057qib7	13465	1	A	a	DT
cord-005453-4057qib7	13465	2	total	total	NN
cord-005453-4057qib7	13465	3	of	of	IN
cord-005453-4057qib7	13465	4	49	49	CD
cord-005453-4057qib7	13465	5	patients	patient	NNS
cord-005453-4057qib7	13465	6	were	be	VBD
cord-005453-4057qib7	13465	7	analyzed	analyze	VBN
cord-005453-4057qib7	13465	8	.	.	.
cord-005453-4057qib7	13466	1	Twentyone	Twentyone	NNP
cord-005453-4057qib7	13466	2	received	receive	VBD
cord-005453-4057qib7	13466	3	fludarabine	fludarabine	NN
cord-005453-4057qib7	13466	4	/	/	SYM
cord-005453-4057qib7	13466	5	melphalan	melphalan	NNP
cord-005453-4057qib7	13466	6	/	/	SYM
cord-005453-4057qib7	13466	7	thiotepa	thiotepa	NNP
cord-005453-4057qib7	13466	8	and	and	CC
cord-005453-4057qib7	13466	9	28	28	CD
cord-005453-4057qib7	13466	10	received	receive	VBD
cord-005453-4057qib7	13466	11	myeloablative	myeloablative	NNP
cord-005453-4057qib7	13466	12	busulfan	busulfan	NN
cord-005453-4057qib7	13466	13	-	-	HYPH
cord-005453-4057qib7	13466	14	based	base	VBN
cord-005453-4057qib7	13466	15	conditioning	conditioning	NN
cord-005453-4057qib7	13466	16	,	,	,
cord-005453-4057qib7	13466	17	either	either	CC
cord-005453-4057qib7	13466	18	in	in	IN
cord-005453-4057qib7	13466	19	combination	combination	NN
cord-005453-4057qib7	13466	20	with	with	IN
cord-005453-4057qib7	13466	21	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	13466	22	(	(	-LRB-
cord-005453-4057qib7	13466	23	N=19	N=19	NNP
cord-005453-4057qib7	13466	24	)	)	-RRB-
cord-005453-4057qib7	13466	25	or	or	CC
cord-005453-4057qib7	13466	26	fludarabine	fludarabine	NNP
cord-005453-4057qib7	13466	27	(	(	-LRB-
cord-005453-4057qib7	13466	28	N=9	N=9	NNP
cord-005453-4057qib7	13466	29	)	)	-RRB-
cord-005453-4057qib7	13466	30	.	.	.
cord-005453-4057qib7	13467	1	ATG	ATG	NNP
cord-005453-4057qib7	13467	2	was	be	VBD
cord-005453-4057qib7	13467	3	used	use	VBN
cord-005453-4057qib7	13467	4	in	in	IN
cord-005453-4057qib7	13467	5	27	27	CD
cord-005453-4057qib7	13467	6	patients	patient	NNS
cord-005453-4057qib7	13467	7	depending	depend	VBG
cord-005453-4057qib7	13467	8	on	on	IN
cord-005453-4057qib7	13467	9	donor	donor	NN
cord-005453-4057qib7	13467	10	.	.	.
cord-005453-4057qib7	13468	1	Recipients	recipient	NNS
cord-005453-4057qib7	13468	2	of	of	IN
cord-005453-4057qib7	13468	3	Mel	Mel	NNP
cord-005453-4057qib7	13468	4	/	/	SYM
cord-005453-4057qib7	13468	5	Thio	Thio	NNP
cord-005453-4057qib7	13468	6	were	be	VBD
cord-005453-4057qib7	13468	7	selected	select	VBN
cord-005453-4057qib7	13468	8	for	for	IN
cord-005453-4057qib7	13468	9	RIC	RIC	NNP
cord-005453-4057qib7	13468	10	regimens	regimen	NNS
cord-005453-4057qib7	13468	11	due	due	JJ
cord-005453-4057qib7	13468	12	to	to	IN
cord-005453-4057qib7	13468	13	pre	pre	JJ
cord-005453-4057qib7	13468	14	-	-	JJ
cord-005453-4057qib7	13468	15	transplant	transplant	JJ
cord-005453-4057qib7	13468	16	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	13468	17	(	(	-LRB-
cord-005453-4057qib7	13468	18	cardiac	cardiac	JJ
cord-005453-4057qib7	13468	19	dysfunction	dysfunction	NN
cord-005453-4057qib7	13468	20	,	,	,
cord-005453-4057qib7	13468	21	N=9	N=9	NNP
cord-005453-4057qib7	13468	22	,	,	,
cord-005453-4057qib7	13468	23	3	3	CD
cord-005453-4057qib7	13468	24	requiring	require	VBG
cord-005453-4057qib7	13468	25	peri	peri	NN
cord-005453-4057qib7	13468	26	-	-	HYPH
cord-005453-4057qib7	13468	27	transplant	transplant	NN
cord-005453-4057qib7	13468	28	milrinone	milrinone	NN
cord-005453-4057qib7	13468	29	)	)	-RRB-
cord-005453-4057qib7	13468	30	,	,	,
cord-005453-4057qib7	13468	31	transplant	transplant	NN
cord-005453-4057qib7	13468	32	during	during	IN
cord-005453-4057qib7	13468	33	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13468	34	-	-	HYPH
cord-005453-4057qib7	13468	35	induced	induce	VBN
cord-005453-4057qib7	13468	36	aplasia	aplasia	NNP
cord-005453-4057qib7	13468	37	(	(	-LRB-
cord-005453-4057qib7	13468	38	N=5	N=5	NNP
cord-005453-4057qib7	13468	39	)	)	-RRB-
cord-005453-4057qib7	13468	40	,	,	,
cord-005453-4057qib7	13468	41	underlying	underlie	VBG
cord-005453-4057qib7	13468	42	diagnosis	diagnosis	NN
cord-005453-4057qib7	13468	43	of	of	IN
cord-005453-4057qib7	13468	44	treatment	treatment	NN
cord-005453-4057qib7	13468	45	-	-	HYPH
cord-005453-4057qib7	13468	46	related	relate	VBN
cord-005453-4057qib7	13468	47	AML	AML	NNP
cord-005453-4057qib7	13468	48	(	(	-LRB-
cord-005453-4057qib7	13468	49	t	t	NNP
cord-005453-4057qib7	13468	50	-	-	HYPH
cord-005453-4057qib7	13468	51	AML	AML	NNP
cord-005453-4057qib7	13468	52	)	)	-RRB-
cord-005453-4057qib7	13468	53	and	and	CC
cord-005453-4057qib7	13468	54	significant	significant	JJ
cord-005453-4057qib7	13468	55	pre	pre	JJ
cord-005453-4057qib7	13468	56	-	-	JJ
cord-005453-4057qib7	13468	57	alloHCT	allohct	JJ
cord-005453-4057qib7	13468	58	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13468	59	exposure	exposure	NN
cord-005453-4057qib7	13468	60	(	(	-LRB-
cord-005453-4057qib7	13468	61	N=5	N=5	NNP
cord-005453-4057qib7	13468	62	)	)	-RRB-
cord-005453-4057qib7	13468	63	.	.	.
cord-005453-4057qib7	13469	1	Proportions	proportion	NNS
cord-005453-4057qib7	13469	2	of	of	IN
cord-005453-4057qib7	13469	3	patients	patient	NNS
cord-005453-4057qib7	13469	4	with	with	IN
cord-005453-4057qib7	13469	5	de	de	NNP
cord-005453-4057qib7	13469	6	novo	novo	NNP
cord-005453-4057qib7	13469	7	AML	AML	NNP
cord-005453-4057qib7	13469	8	(	(	-LRB-
cord-005453-4057qib7	13469	9	Mel/	Mel/	NNP
cord-005453-4057qib7	13469	10	Thio	Thio	NNP
cord-005453-4057qib7	13469	11	,	,	,
cord-005453-4057qib7	13469	12	57	57	CD
cord-005453-4057qib7	13469	13	%	%	NN
cord-005453-4057qib7	13469	14	;	;	:
cord-005453-4057qib7	13469	15	Bu	Bu	NNP
cord-005453-4057qib7	13469	16	,	,	,
cord-005453-4057qib7	13469	17	78	78	CD
cord-005453-4057qib7	13469	18	%	%	NN
cord-005453-4057qib7	13469	19	)	)	-RRB-
cord-005453-4057qib7	13469	20	and	and	CC
cord-005453-4057qib7	13469	21	MDR	MDR	NNP
cord-005453-4057qib7	13469	22	-	-	HYPH
cord-005453-4057qib7	13469	23	AML	AML	NNP
cord-005453-4057qib7	13469	24	(	(	-LRB-
cord-005453-4057qib7	13469	25	19	19	CD
cord-005453-4057qib7	13469	26	%	%	NN
cord-005453-4057qib7	13469	27	and	and	CC
cord-005453-4057qib7	13469	28	21	21	CD
cord-005453-4057qib7	13469	29	%	%	NN
cord-005453-4057qib7	13469	30	)	)	-RRB-
cord-005453-4057qib7	13469	31	were	be	VBD
cord-005453-4057qib7	13469	32	similar	similar	JJ
cord-005453-4057qib7	13469	33	between	between	IN
cord-005453-4057qib7	13469	34	groups	group	NNS
cord-005453-4057qib7	13469	35	;	;	:
cord-005453-4057qib7	13469	36	however	however	RB
cord-005453-4057qib7	13469	37	,	,	,
cord-005453-4057qib7	13469	38	recipients	recipient	NNS
cord-005453-4057qib7	13469	39	of	of	IN
cord-005453-4057qib7	13469	40	Mel	Mel	NNP
cord-005453-4057qib7	13469	41	/	/	SYM
cord-005453-4057qib7	13469	42	Thio	Thio	NNP
cord-005453-4057qib7	13469	43	were	be	VBD
cord-005453-4057qib7	13469	44	more	more	RBR
cord-005453-4057qib7	13469	45	likely	likely	JJ
cord-005453-4057qib7	13469	46	to	to	TO
cord-005453-4057qib7	13469	47	have	have	VB
cord-005453-4057qib7	13469	48	t	t	VBN
cord-005453-4057qib7	13469	49	-	-	HYPH
cord-005453-4057qib7	13469	50	AML	AML	NNP
cord-005453-4057qib7	13469	51	(	(	-LRB-
cord-005453-4057qib7	13469	52	24	24	CD
cord-005453-4057qib7	13469	53	%	%	NN
cord-005453-4057qib7	13469	54	vs	vs	IN
cord-005453-4057qib7	13469	55	0	0	CD
cord-005453-4057qib7	13469	56	%	%	NN
cord-005453-4057qib7	13469	57	)	)	-RRB-
cord-005453-4057qib7	13469	58	.	.	.
cord-005453-4057qib7	13470	1	Cytogenetic	cytogenetic	JJ
cord-005453-4057qib7	13470	2	and	and	CC
cord-005453-4057qib7	13470	3	molecular	molecular	JJ
cord-005453-4057qib7	13470	4	risk	risk	NN
cord-005453-4057qib7	13470	5	factors	factor	NNS
cord-005453-4057qib7	13470	6	were	be	VBD
cord-005453-4057qib7	13470	7	similar	similar	JJ
cord-005453-4057qib7	13470	8	between	between	IN
cord-005453-4057qib7	13470	9	groups	group	NNS
cord-005453-4057qib7	13470	10	.	.	.
cord-005453-4057qib7	13471	1	The	the	DT
cord-005453-4057qib7	13471	2	majority	majority	NN
cord-005453-4057qib7	13471	3	of	of	IN
cord-005453-4057qib7	13471	4	patients	patient	NNS
cord-005453-4057qib7	13471	5	were	be	VBD
cord-005453-4057qib7	13471	6	transplanted	transplant	VBN
cord-005453-4057qib7	13471	7	in	in	IN
cord-005453-4057qib7	13471	8	CR1	CR1	NNP
cord-005453-4057qib7	13472	1	(	(	-LRB-
cord-005453-4057qib7	13472	2	Mel	Mel	NNP
cord-005453-4057qib7	13472	3	/	/	SYM
cord-005453-4057qib7	13472	4	Thio	Thio	NNP
cord-005453-4057qib7	13472	5	,	,	,
cord-005453-4057qib7	13472	6	71	71	CD
cord-005453-4057qib7	13472	7	%	%	NN
cord-005453-4057qib7	13472	8	vs	vs	IN
cord-005453-4057qib7	13472	9	Bu	Bu	NNP
cord-005453-4057qib7	13472	10	,	,	,
cord-005453-4057qib7	13472	11	68	68	CD
cord-005453-4057qib7	13472	12	%	%	NN
cord-005453-4057qib7	13472	13	)	)	-RRB-
cord-005453-4057qib7	13472	14	or	or	CC
cord-005453-4057qib7	13472	15	CR2	CR2	NNP
cord-005453-4057qib7	13472	16	(	(	-LRB-
cord-005453-4057qib7	13472	17	24	24	CD
cord-005453-4057qib7	13472	18	%	%	NN
cord-005453-4057qib7	13472	19	vs	vs	IN
cord-005453-4057qib7	13472	20	38	38	CD
cord-005453-4057qib7	13472	21	%	%	NN
cord-005453-4057qib7	13472	22	)	)	-RRB-
cord-005453-4057qib7	13472	23	.	.	.
cord-005453-4057qib7	13473	1	More	More	JJR
cord-005453-4057qib7	13473	2	recipients	recipient	NNS
cord-005453-4057qib7	13473	3	of	of	IN
cord-005453-4057qib7	13473	4	Bu	Bu	NNP
cord-005453-4057qib7	13473	5	conditioning	conditioning	NN
cord-005453-4057qib7	13473	6	(	(	-LRB-
cord-005453-4057qib7	13473	7	71	71	CD
cord-005453-4057qib7	13473	8	%	%	NN
cord-005453-4057qib7	13473	9	vs	vs	IN
cord-005453-4057qib7	13473	10	43	43	CD
cord-005453-4057qib7	13473	11	%	%	NN
cord-005453-4057qib7	13473	12	)	)	-RRB-
cord-005453-4057qib7	13473	13	were	be	VBD
cord-005453-4057qib7	13473	14	MRD	MRD	NNP
cord-005453-4057qib7	13473	15	-	-	HYPH
cord-005453-4057qib7	13473	16	negative	negative	JJ
cord-005453-4057qib7	13473	17	at	at	IN
cord-005453-4057qib7	13473	18	the	the	DT
cord-005453-4057qib7	13473	19	time	time	NN
cord-005453-4057qib7	13473	20	of	of	IN
cord-005453-4057qib7	13473	21	alloHCT	alloHCT	NNP
cord-005453-4057qib7	13473	22	;	;	:
cord-005453-4057qib7	13473	23	both	both	DT
cord-005453-4057qib7	13473	24	groups	group	NNS
cord-005453-4057qib7	13473	25	had	have	VBD
cord-005453-4057qib7	13473	26	comparable	comparable	JJ
cord-005453-4057qib7	13473	27	proportions	proportion	NNS
cord-005453-4057qib7	13473	28	of	of	IN
cord-005453-4057qib7	13473	29	patients	patient	NNS
cord-005453-4057qib7	13473	30	with	with	IN
cord-005453-4057qib7	13473	31	≥M2	≥M2	NNP
cord-005453-4057qib7	13473	32	marrow	marrow	NN
cord-005453-4057qib7	13473	33	(	(	-LRB-
cord-005453-4057qib7	13473	34	~10	~10	CD
cord-005453-4057qib7	13473	35	%	%	NN
cord-005453-4057qib7	13473	36	)	)	-RRB-
cord-005453-4057qib7	13473	37	.	.	.
cord-005453-4057qib7	13474	1	Donor	donor	NN
cord-005453-4057qib7	13474	2	types	type	NNS
cord-005453-4057qib7	13474	3	and	and	CC
cord-005453-4057qib7	13474	4	stem	stem	NN
cord-005453-4057qib7	13474	5	cell	cell	NN
cord-005453-4057qib7	13474	6	sources	source	NNS
cord-005453-4057qib7	13474	7	were	be	VBD
cord-005453-4057qib7	13474	8	similar	similar	JJ
cord-005453-4057qib7	13474	9	between	between	IN
cord-005453-4057qib7	13474	10	groups	group	NNS
cord-005453-4057qib7	13474	11	,	,	,
cord-005453-4057qib7	13474	12	except	except	IN
cord-005453-4057qib7	13474	13	unrelated	unrelated	JJ
cord-005453-4057qib7	13474	14	umbilical	umbilical	JJ
cord-005453-4057qib7	13474	15	cord	cord	NN
cord-005453-4057qib7	13474	16	blood	blood	NN
cord-005453-4057qib7	13474	17	which	which	WDT
cord-005453-4057qib7	13474	18	was	be	VBD
cord-005453-4057qib7	13474	19	more	more	RBR
cord-005453-4057qib7	13474	20	common	common	JJ
cord-005453-4057qib7	13474	21	in	in	IN
cord-005453-4057qib7	13474	22	Bu	Bu	NNP
cord-005453-4057qib7	13474	23	recipients	recipient	NNS
cord-005453-4057qib7	13474	24	(	(	-LRB-
cord-005453-4057qib7	13474	25	21	21	CD
cord-005453-4057qib7	13474	26	%	%	NN
cord-005453-4057qib7	13474	27	vs	vs	IN
cord-005453-4057qib7	13474	28	10	10	CD
cord-005453-4057qib7	13474	29	%	%	NN
cord-005453-4057qib7	13474	30	)	)	-RRB-
cord-005453-4057qib7	13474	31	.	.	.
cord-005453-4057qib7	13475	1	There	there	EX
cord-005453-4057qib7	13475	2	were	be	VBD
cord-005453-4057qib7	13475	3	no	no	DT
cord-005453-4057qib7	13475	4	graft	graft	NN
cord-005453-4057qib7	13475	5	failures	failure	NNS
cord-005453-4057qib7	13475	6	in	in	IN
cord-005453-4057qib7	13475	7	Mel	Mel	NNP
cord-005453-4057qib7	13475	8	/	/	SYM
cord-005453-4057qib7	13475	9	Thio	Thio	NNP
cord-005453-4057qib7	13475	10	recipients	recipient	NNS
cord-005453-4057qib7	13475	11	,	,	,
cord-005453-4057qib7	13475	12	compared	compare	VBN
cord-005453-4057qib7	13475	13	to	to	IN
cord-005453-4057qib7	13475	14	14	14	CD
cord-005453-4057qib7	13475	15	%	%	NN
cord-005453-4057qib7	13475	16	(	(	-LRB-
cord-005453-4057qib7	13475	17	N=4	N=4	NNP
cord-005453-4057qib7	13475	18	)	)	-RRB-
cord-005453-4057qib7	13475	19	in	in	IN
cord-005453-4057qib7	13475	20	those	those	DT
cord-005453-4057qib7	13475	21	receiving	receive	VBG
cord-005453-4057qib7	13475	22	Bu	Bu	NNP
cord-005453-4057qib7	13475	23	-	-	HYPH
cord-005453-4057qib7	13475	24	based	base	VBN
cord-005453-4057qib7	13475	25	regimens	regimen	NNS
cord-005453-4057qib7	13475	26	.	.	.
cord-005453-4057qib7	13476	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	13476	2	kinetics	kinetic	NNS
cord-005453-4057qib7	13476	3	and	and	CC
cord-005453-4057qib7	13476	4	immune	immune	JJ
cord-005453-4057qib7	13476	5	reconstitution	reconstitution	NN
cord-005453-4057qib7	13476	6	were	be	VBD
cord-005453-4057qib7	13476	7	similar	similar	JJ
cord-005453-4057qib7	13476	8	.	.	.
cord-005453-4057qib7	13477	1	Overall	overall	JJ
cord-005453-4057qib7	13477	2	acute	acute	JJ
cord-005453-4057qib7	13477	3	and	and	CC
cord-005453-4057qib7	13477	4	chronic	chronic	JJ
cord-005453-4057qib7	13477	5	GVHD	GVHD	NNP
cord-005453-4057qib7	13477	6	incidence	incidence	NN
cord-005453-4057qib7	13477	7	was	be	VBD
cord-005453-4057qib7	13477	8	higher	high	JJR
cord-005453-4057qib7	13477	9	in	in	IN
cord-005453-4057qib7	13477	10	recipients	recipient	NNS
cord-005453-4057qib7	13477	11	of	of	IN
cord-005453-4057qib7	13477	12	Mel/	Mel/	NNP
cord-005453-4057qib7	13477	13	Thio	Thio	NNP
cord-005453-4057qib7	13477	14	compared	compare	VBN
cord-005453-4057qib7	13477	15	to	to	IN
cord-005453-4057qib7	13477	16	Bu	Bu	NNP
cord-005453-4057qib7	13477	17	(	(	-LRB-
cord-005453-4057qib7	13477	18	39	39	CD
cord-005453-4057qib7	13477	19	%	%	NN
cord-005453-4057qib7	13477	20	vs	vs	IN
cord-005453-4057qib7	13477	21	21	21	CD
cord-005453-4057qib7	13477	22	%	%	NN
cord-005453-4057qib7	13477	23	,	,	,
cord-005453-4057qib7	13477	24	and	and	CC
cord-005453-4057qib7	13477	25	29	29	CD
cord-005453-4057qib7	13477	26	%	%	NN
cord-005453-4057qib7	13477	27	vs	vs	IN
cord-005453-4057qib7	13477	28	18	18	CD
cord-005453-4057qib7	13477	29	%	%	NN
cord-005453-4057qib7	13477	30	,	,	,
cord-005453-4057qib7	13477	31	respectively	respectively	RB
cord-005453-4057qib7	13477	32	)	)	-RRB-
cord-005453-4057qib7	13477	33	,	,	,
cord-005453-4057qib7	13477	34	but	but	CC
cord-005453-4057qib7	13477	35	rates	rate	NNS
cord-005453-4057qib7	13477	36	of	of	IN
cord-005453-4057qib7	13477	37	grade	grade	NN
cord-005453-4057qib7	13477	38	III	III	NNP
cord-005453-4057qib7	13477	39	-	-	HYPH
cord-005453-4057qib7	13477	40	IV	IV	NNP
cord-005453-4057qib7	13477	41	acute	acute	JJ
cord-005453-4057qib7	13477	42	or	or	CC
cord-005453-4057qib7	13477	43	extensive	extensive	JJ
cord-005453-4057qib7	13477	44	chronic	chronic	JJ
cord-005453-4057qib7	13477	45	GVHD	GVHD	NNP
cord-005453-4057qib7	13477	46	were	be	VBD
cord-005453-4057qib7	13477	47	comparable	comparable	JJ
cord-005453-4057qib7	13477	48	.	.	.
cord-005453-4057qib7	13478	1	VOD	VOD	NNP
cord-005453-4057qib7	13478	2	requiring	require	VBG
cord-005453-4057qib7	13478	3	treatment	treatment	NN
cord-005453-4057qib7	13478	4	was	be	VBD
cord-005453-4057qib7	13478	5	diagnosed	diagnose	VBN
cord-005453-4057qib7	13478	6	in	in	IN
cord-005453-4057qib7	13478	7	6	6	CD
cord-005453-4057qib7	13478	8	(	(	-LRB-
cord-005453-4057qib7	13478	9	21	21	CD
cord-005453-4057qib7	13478	10	%	%	NN
cord-005453-4057qib7	13478	11	)	)	-RRB-
cord-005453-4057qib7	13478	12	recipients	recipient	NNS
cord-005453-4057qib7	13478	13	of	of	IN
cord-005453-4057qib7	13478	14	Bu	Bu	NNP
cord-005453-4057qib7	13478	15	conditioning	conditioning	NN
cord-005453-4057qib7	13478	16	and	and	CC
cord-005453-4057qib7	13478	17	no	no	DT
cord-005453-4057qib7	13478	18	Mel	Mel	NNP
cord-005453-4057qib7	13478	19	/	/	SYM
cord-005453-4057qib7	13478	20	Thio	Thio	NNP
cord-005453-4057qib7	13478	21	recipients	recipient	NNS
cord-005453-4057qib7	13478	22	.	.	.
cord-005453-4057qib7	13479	1	Median	median	JJ
cord-005453-4057qib7	13479	2	duration	duration	NN
cord-005453-4057qib7	13479	3	of	of	IN
cord-005453-4057qib7	13479	4	follow	follow	NN
cord-005453-4057qib7	13479	5	-	-	HYPH
cord-005453-4057qib7	13479	6	up	up	NN
cord-005453-4057qib7	13479	7	was	be	VBD
cord-005453-4057qib7	13479	8	30	30	CD
cord-005453-4057qib7	13479	9	months	month	NNS
cord-005453-4057qib7	13480	1	(	(	-LRB-
cord-005453-4057qib7	13480	2	range	range	NNP
cord-005453-4057qib7	13480	3	2	2	CD
cord-005453-4057qib7	13480	4	-	-	SYM
cord-005453-4057qib7	13480	5	70	70	CD
cord-005453-4057qib7	13480	6	)	)	-RRB-
cord-005453-4057qib7	13480	7	in	in	IN
cord-005453-4057qib7	13480	8	the	the	DT
cord-005453-4057qib7	13480	9	Mel	Mel	NNP
cord-005453-4057qib7	13480	10	/	/	SYM
cord-005453-4057qib7	13480	11	Thio	Thio	NNP
cord-005453-4057qib7	13480	12	group	group	NN
cord-005453-4057qib7	13480	13	,	,	,
cord-005453-4057qib7	13480	14	and	and	CC
cord-005453-4057qib7	13480	15	18	18	CD
cord-005453-4057qib7	13480	16	months	month	NNS
cord-005453-4057qib7	13480	17	(	(	-LRB-
cord-005453-4057qib7	13480	18	range	range	VBP
cord-005453-4057qib7	13480	19	1	1	CD
cord-005453-4057qib7	13480	20	-	-	SYM
cord-005453-4057qib7	13480	21	121	121	CD
cord-005453-4057qib7	13480	22	)	)	-RRB-
cord-005453-4057qib7	13480	23	in	in	IN
cord-005453-4057qib7	13480	24	the	the	DT
cord-005453-4057qib7	13480	25	Bu	Bu	NNP
cord-005453-4057qib7	13480	26	group	group	NN
cord-005453-4057qib7	13480	27	.	.	.
cord-005453-4057qib7	13481	1	Transplantrelated	transplantrelate	VBN
cord-005453-4057qib7	13481	2	mortality	mortality	NN
cord-005453-4057qib7	13481	3	(	(	-LRB-
cord-005453-4057qib7	13481	4	TRM	TRM	NNP
cord-005453-4057qib7	13481	5	)	)	-RRB-
cord-005453-4057qib7	13481	6	was	be	VBD
cord-005453-4057qib7	13481	7	similar	similar	JJ
cord-005453-4057qib7	13481	8	in	in	IN
cord-005453-4057qib7	13481	9	both	both	DT
cord-005453-4057qib7	13481	10	groups	group	NNS
cord-005453-4057qib7	13481	11	(	(	-LRB-
cord-005453-4057qib7	13481	12	1	1	CD
cord-005453-4057qib7	13481	13	patient	patient	NN
cord-005453-4057qib7	13481	14	)	)	-RRB-
cord-005453-4057qib7	13481	15	,	,	,
cord-005453-4057qib7	13481	16	occurring	occur	VBG
cord-005453-4057qib7	13481	17	before	before	IN
cord-005453-4057qib7	13481	18	day	day	NN
cord-005453-4057qib7	13481	19	100	100	CD
cord-005453-4057qib7	13481	20	.	.	.
cord-005453-4057qib7	13482	1	Relapse	relapse	NN
cord-005453-4057qib7	13482	2	incidence	incidence	NN
cord-005453-4057qib7	13482	3	was	be	VBD
cord-005453-4057qib7	13482	4	comparable	comparable	JJ
cord-005453-4057qib7	13482	5	(	(	-LRB-
cord-005453-4057qib7	13482	6	Mel	Mel	NNP
cord-005453-4057qib7	13482	7	/	/	SYM
cord-005453-4057qib7	13482	8	Thio	Thio	NNP
cord-005453-4057qib7	13482	9	,	,	,
cord-005453-4057qib7	13482	10	29	29	CD
cord-005453-4057qib7	13482	11	%	%	NN
cord-005453-4057qib7	13482	12	vs	vs	IN
cord-005453-4057qib7	13482	13	Bu	Bu	NNP
cord-005453-4057qib7	13482	14	,	,	,
cord-005453-4057qib7	13482	15	32	32	CD
cord-005453-4057qib7	13482	16	%	%	NN
cord-005453-4057qib7	13482	17	)	)	-RRB-
cord-005453-4057qib7	13482	18	;	;	:
cord-005453-4057qib7	13482	19	however	however	RB
cord-005453-4057qib7	13482	20	,	,	,
cord-005453-4057qib7	13482	21	relapse	relapse	NN
cord-005453-4057qib7	13482	22	occurred	occur	VBD
cord-005453-4057qib7	13482	23	at	at	IN
cord-005453-4057qib7	13482	24	a	a	DT
cord-005453-4057qib7	13482	25	later	later	JJ
cord-005453-4057qib7	13482	26	time	time	NN
cord-005453-4057qib7	13482	27	in	in	IN
cord-005453-4057qib7	13482	28	Mel	Mel	NNP
cord-005453-4057qib7	13482	29	/	/	SYM
cord-005453-4057qib7	13482	30	Thio	Thio	NNP
cord-005453-4057qib7	13482	31	recipients	recipient	NNS
cord-005453-4057qib7	13482	32	(	(	-LRB-
cord-005453-4057qib7	13483	1	median	median	NNP
cord-005453-4057qib7	13483	2	d	d	NNP
cord-005453-4057qib7	13483	3	+396	+396	NNP
cord-005453-4057qib7	13483	4	vs	vs	IN
cord-005453-4057qib7	13483	5	d+137	d+137	CD
cord-005453-4057qib7	13483	6	)	)	-RRB-
cord-005453-4057qib7	13483	7	.	.	.
cord-005453-4057qib7	13484	1	Overall	overall	JJ
cord-005453-4057qib7	13484	2	survival	survival	NN
cord-005453-4057qib7	13484	3	at	at	IN
cord-005453-4057qib7	13484	4	1	1	CD
cord-005453-4057qib7	13484	5	and	and	CC
cord-005453-4057qib7	13484	6	3	3	CD
cord-005453-4057qib7	13484	7	years	year	NNS
cord-005453-4057qib7	13484	8	was	be	VBD
cord-005453-4057qib7	13484	9	superior	superior	JJ
cord-005453-4057qib7	13484	10	in	in	IN
cord-005453-4057qib7	13484	11	Mel	Mel	NNP
cord-005453-4057qib7	13484	12	/	/	SYM
cord-005453-4057qib7	13484	13	Thio	Thio	NNP
cord-005453-4057qib7	13484	14	recipients	recipient	NNS
cord-005453-4057qib7	13484	15	(	(	-LRB-
cord-005453-4057qib7	13484	16	95	95	CD
cord-005453-4057qib7	13484	17	%	%	NN
cord-005453-4057qib7	13484	18	vs	vs	IN
cord-005453-4057qib7	13484	19	74	74	CD
cord-005453-4057qib7	13484	20	%	%	NN
cord-005453-4057qib7	13484	21	,	,	,
cord-005453-4057qib7	13484	22	and	and	CC
cord-005453-4057qib7	13484	23	75	75	CD
cord-005453-4057qib7	13484	24	%	%	NN
cord-005453-4057qib7	13484	25	vs	vs	IN
cord-005453-4057qib7	13484	26	50	50	CD
cord-005453-4057qib7	13484	27	%	%	NN
cord-005453-4057qib7	13484	28	,	,	,
cord-005453-4057qib7	13484	29	respectively	respectively	RB
cord-005453-4057qib7	13484	30	)	)	-RRB-
cord-005453-4057qib7	13484	31	.	.	.
cord-005453-4057qib7	13485	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13485	2	:	:	:
cord-005453-4057qib7	13486	1	In	in	IN
cord-005453-4057qib7	13486	2	our	-PRON-	PRP$
cord-005453-4057qib7	13486	3	single	single	JJ
cord-005453-4057qib7	13486	4	institution	institution	NN
cord-005453-4057qib7	13486	5	experience	experience	NN
cord-005453-4057qib7	13486	6	,	,	,
cord-005453-4057qib7	13486	7	use	use	NN
cord-005453-4057qib7	13486	8	of	of	IN
cord-005453-4057qib7	13486	9	a	a	DT
cord-005453-4057qib7	13486	10	melphalan	melphalan	NNP
cord-005453-4057qib7	13486	11	/	/	SYM
cord-005453-4057qib7	13486	12	thiotepa	thiotepa	NNP
cord-005453-4057qib7	13486	13	-	-	HYPH
cord-005453-4057qib7	13486	14	based	base	VBN
cord-005453-4057qib7	13486	15	RIC	RIC	NNP
cord-005453-4057qib7	13486	16	regimen	regimen	NN
cord-005453-4057qib7	13486	17	was	be	VBD
cord-005453-4057qib7	13486	18	associated	associate	VBN
cord-005453-4057qib7	13486	19	with	with	IN
cord-005453-4057qib7	13486	20	similar	similar	JJ
cord-005453-4057qib7	13486	21	outcomes	outcome	NNS
cord-005453-4057qib7	13486	22	compared	compare	VBN
cord-005453-4057qib7	13486	23	to	to	IN
cord-005453-4057qib7	13486	24	full	full	JJ
cord-005453-4057qib7	13486	25	-	-	HYPH
cord-005453-4057qib7	13486	26	intensity	intensity	NN
cord-005453-4057qib7	13486	27	Bu	Bu	NNP
cord-005453-4057qib7	13486	28	-	-	HYPH
cord-005453-4057qib7	13486	29	based	base	VBN
cord-005453-4057qib7	13486	30	conditioning	conditioning	NN
cord-005453-4057qib7	13486	31	,	,	,
cord-005453-4057qib7	13486	32	despite	despite	IN
cord-005453-4057qib7	13486	33	higher	high	JJR
cord-005453-4057qib7	13486	34	risk	risk	NN
cord-005453-4057qib7	13486	35	patient	patient	NN
cord-005453-4057qib7	13486	36	and	and	CC
cord-005453-4057qib7	13486	37	disease	disease	NN
cord-005453-4057qib7	13486	38	characteristics	characteristic	NNS
cord-005453-4057qib7	13486	39	.	.	.
cord-005453-4057qib7	13487	1	The	the	DT
cord-005453-4057qib7	13487	2	majority	majority	NN
cord-005453-4057qib7	13487	3	of	of	IN
cord-005453-4057qib7	13487	4	recipients	recipient	NNS
cord-005453-4057qib7	13487	5	of	of	IN
cord-005453-4057qib7	13487	6	Mel	Mel	NNP
cord-005453-4057qib7	13487	7	/	/	SYM
cord-005453-4057qib7	13487	8	Thio	Thio	NNP
cord-005453-4057qib7	13487	9	conditioning	conditioning	NN
cord-005453-4057qib7	13487	10	had	have	VBD
cord-005453-4057qib7	13487	11	significant	significant	JJ
cord-005453-4057qib7	13487	12	pre	pre	JJ
cord-005453-4057qib7	13487	13	-	-	JJ
cord-005453-4057qib7	13487	14	transplant	transplant	JJ
cord-005453-4057qib7	13487	15	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	13487	16	,	,	,
cord-005453-4057qib7	13487	17	which	which	WDT
cord-005453-4057qib7	13487	18	did	do	VBD
cord-005453-4057qib7	13487	19	not	not	RB
cord-005453-4057qib7	13487	20	translate	translate	VB
cord-005453-4057qib7	13487	21	into	into	IN
cord-005453-4057qib7	13487	22	higher	high	JJR
cord-005453-4057qib7	13487	23	TRM	TRM	NNP
cord-005453-4057qib7	13487	24	.	.	.
cord-005453-4057qib7	13488	1	While	while	IN
cord-005453-4057qib7	13488	2	Mel	Mel	NNP
cord-005453-4057qib7	13488	3	/	/	SYM
cord-005453-4057qib7	13488	4	Thio	Thio	NNP
cord-005453-4057qib7	13488	5	recipients	recipient	NNS
cord-005453-4057qib7	13488	6	had	have	VBD
cord-005453-4057qib7	13488	7	less	less	RBR
cord-005453-4057qib7	13488	8	optimal	optimal	JJ
cord-005453-4057qib7	13488	9	leukemia	leukemia	NN
cord-005453-4057qib7	13488	10	control	control	NN
cord-005453-4057qib7	13488	11	at	at	IN
cord-005453-4057qib7	13488	12	the	the	DT
cord-005453-4057qib7	13488	13	time	time	NN
cord-005453-4057qib7	13488	14	of	of	IN
cord-005453-4057qib7	13488	15	transplant	transplant	NN
cord-005453-4057qib7	13488	16	and	and	CC
cord-005453-4057qib7	13488	17	high	high	JJ
cord-005453-4057qib7	13488	18	-	-	HYPH
cord-005453-4057qib7	13488	19	risk	risk	NN
cord-005453-4057qib7	13488	20	leukemia	leukemia	NN
cord-005453-4057qib7	13488	21	features	feature	NNS
cord-005453-4057qib7	13488	22	(	(	-LRB-
cord-005453-4057qib7	13488	23	e.g.	e.g.	IN
cord-005453-4057qib7	13488	24	t	t	NNP
cord-005453-4057qib7	13488	25	-	-	HYPH
cord-005453-4057qib7	13488	26	AML	AML	NNP
cord-005453-4057qib7	13488	27	)	)	-RRB-
cord-005453-4057qib7	13488	28	,	,	,
cord-005453-4057qib7	13488	29	relapse	relapse	NN
cord-005453-4057qib7	13488	30	was	be	VBD
cord-005453-4057qib7	13488	31	similar	similar	JJ
cord-005453-4057qib7	13488	32	between	between	IN
cord-005453-4057qib7	13488	33	groups	group	NNS
cord-005453-4057qib7	13488	34	,	,	,
cord-005453-4057qib7	13488	35	occurring	occur	VBG
cord-005453-4057qib7	13488	36	later	later	RB
cord-005453-4057qib7	13488	37	in	in	IN
cord-005453-4057qib7	13488	38	Mel/	Mel/	NNP
cord-005453-4057qib7	13488	39	Thio	Thio	NNP
cord-005453-4057qib7	13488	40	recipients	recipient	NNS
cord-005453-4057qib7	13488	41	,	,	,
cord-005453-4057qib7	13488	42	which	which	WDT
cord-005453-4057qib7	13488	43	may	may	MD
cord-005453-4057qib7	13488	44	have	have	VB
cord-005453-4057qib7	13488	45	contributed	contribute	VBN
cord-005453-4057qib7	13488	46	to	to	IN
cord-005453-4057qib7	13488	47	better	well	JJR
cord-005453-4057qib7	13488	48	overall	overall	JJ
cord-005453-4057qib7	13488	49	survival	survival	NN
cord-005453-4057qib7	13488	50	.	.	.
cord-005453-4057qib7	13489	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13489	2	:	:	:
cord-005453-4057qib7	13489	3	Nothing	nothing	NN
cord-005453-4057qib7	13489	4	to	to	TO
cord-005453-4057qib7	13489	5	disclose	disclose	VB
cord-005453-4057qib7	13489	6	Methods	method	NNS
cord-005453-4057qib7	13489	7	:	:	:
cord-005453-4057qib7	13489	8	Pubertal	pubertal	JJ
cord-005453-4057qib7	13489	9	development	development	NN
cord-005453-4057qib7	13489	10	and	and	CC
cord-005453-4057qib7	13489	11	biological	biological	JJ
cord-005453-4057qib7	13489	12	gonadal	gonadal	JJ
cord-005453-4057qib7	13489	13	parameters	parameter	NNS
cord-005453-4057qib7	13489	14	were	be	VBD
cord-005453-4057qib7	13489	15	assessed	assess	VBN
cord-005453-4057qib7	13489	16	in	in	IN
cord-005453-4057qib7	13489	17	a	a	DT
cord-005453-4057qib7	13489	18	retrospective	retrospective	JJ
cord-005453-4057qib7	13489	19	monocentric	monocentric	JJ
cord-005453-4057qib7	13489	20	cohort	cohort	NN
cord-005453-4057qib7	13489	21	of	of	IN
cord-005453-4057qib7	13489	22	pre	pre	JJ
cord-005453-4057qib7	13489	23	-	-	JJ
cord-005453-4057qib7	13489	24	pubertal	pubertal	JJ
cord-005453-4057qib7	13489	25	patients	patient	NNS
cord-005453-4057qib7	13489	26	who	who	WP
cord-005453-4057qib7	13489	27	underwent	undergo	VBD
cord-005453-4057qib7	13489	28	HSCT	HSCT	NNP
cord-005453-4057qib7	13489	29	after	after	IN
cord-005453-4057qib7	13489	30	myeloablative	myeloablative	NNP
cord-005453-4057qib7	13489	31	conditioning	conditioning	NN
cord-005453-4057qib7	13489	32	with	with	IN
cord-005453-4057qib7	13489	33	Total	total	JJ
cord-005453-4057qib7	13489	34	Body	Body	NNP
cord-005453-4057qib7	13489	35	Irradiation	Irradiation	NNP
cord-005453-4057qib7	13489	36	(	(	-LRB-
cord-005453-4057qib7	13489	37	TBI	TBI	NNP
cord-005453-4057qib7	13489	38	)	)	-RRB-
cord-005453-4057qib7	13489	39	or	or	CC
cord-005453-4057qib7	13489	40	Busulfan	Busulfan	NNP
cord-005453-4057qib7	13489	41	between	between	IN
cord-005453-4057qib7	13489	42	1981	1981	CD
cord-005453-4057qib7	13489	43	and	and	CC
cord-005453-4057qib7	13489	44	2017	2017	CD
cord-005453-4057qib7	13489	45	.	.	.
cord-005453-4057qib7	13490	1	Results	result	NNS
cord-005453-4057qib7	13490	2	:	:	:
cord-005453-4057qib7	13491	1	Seventy	seventy	CD
cord-005453-4057qib7	13491	2	-	-	HYPH
cord-005453-4057qib7	13491	3	four	four	CD
cord-005453-4057qib7	13491	4	patients	patient	NNS
cord-005453-4057qib7	13491	5	(	(	-LRB-
cord-005453-4057qib7	13491	6	28	28	CD
cord-005453-4057qib7	13491	7	girls	girl	NNS
cord-005453-4057qib7	13491	8	and	and	CC
cord-005453-4057qib7	13491	9	46	46	CD
cord-005453-4057qib7	13491	10	boys	boy	NNS
cord-005453-4057qib7	13491	11	)	)	-RRB-
cord-005453-4057qib7	13491	12	were	be	VBD
cord-005453-4057qib7	13491	13	included	include	VBN
cord-005453-4057qib7	13491	14	.	.	.
cord-005453-4057qib7	13492	1	No	no	DT
cord-005453-4057qib7	13492	2	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13492	3	pubertal	pubertal	JJ
cord-005453-4057qib7	13492	4	development	development	NN
cord-005453-4057qib7	13492	5	was	be	VBD
cord-005453-4057qib7	13492	6	found	find	VBN
cord-005453-4057qib7	13492	7	in	in	IN
cord-005453-4057qib7	13492	8	50	50	CD
cord-005453-4057qib7	13492	9	%	%	NN
cord-005453-4057qib7	13492	10	of	of	IN
cord-005453-4057qib7	13492	11	girls	girl	NNS
cord-005453-4057qib7	13492	12	and	and	CC
cord-005453-4057qib7	13492	13	10	10	CD
cord-005453-4057qib7	13492	14	%	%	NN
cord-005453-4057qib7	13492	15	of	of	IN
cord-005453-4057qib7	13492	16	boys	boy	NNS
cord-005453-4057qib7	13492	17	(	(	-LRB-
cord-005453-4057qib7	13492	18	p	p	NN
cord-005453-4057qib7	13492	19	<	<	XX
cord-005453-4057qib7	13492	20	0.001	0.001	CD
cord-005453-4057qib7	13492	21	)	)	-RRB-
cord-005453-4057qib7	13492	22	and	and	CC
cord-005453-4057qib7	13492	23	delayed	delay	VBD
cord-005453-4057qib7	13492	24	puberty	puberty	NN
cord-005453-4057qib7	13492	25	or	or	CC
cord-005453-4057qib7	13492	26	no	no	DT
cord-005453-4057qib7	13492	27	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13492	28	pubertal	pubertal	JJ
cord-005453-4057qib7	13492	29	development	development	NN
cord-005453-4057qib7	13492	30	was	be	VBD
cord-005453-4057qib7	13492	31	found	find	VBN
cord-005453-4057qib7	13492	32	in	in	IN
cord-005453-4057qib7	13492	33	57	57	CD
cord-005453-4057qib7	13492	34	%	%	NN
cord-005453-4057qib7	13492	35	of	of	IN
cord-005453-4057qib7	13492	36	girls	girl	NNS
cord-005453-4057qib7	13492	37	and	and	CC
cord-005453-4057qib7	13492	38	24	24	CD
cord-005453-4057qib7	13492	39	%	%	NN
cord-005453-4057qib7	13492	40	of	of	IN
cord-005453-4057qib7	13492	41	boys	boy	NNS
cord-005453-4057qib7	13492	42	(	(	-LRB-
cord-005453-4057qib7	13492	43	p=0.009	p=0.009	NN
cord-005453-4057qib7	13492	44	)	)	-RRB-
cord-005453-4057qib7	13492	45	.	.	.
cord-005453-4057qib7	13493	1	Hormone	hormone	NN
cord-005453-4057qib7	13493	2	replacement	replacement	NN
cord-005453-4057qib7	13493	3	therapy	therapy	NN
cord-005453-4057qib7	13493	4	was	be	VBD
cord-005453-4057qib7	13493	5	used	use	VBN
cord-005453-4057qib7	13493	6	in	in	IN
cord-005453-4057qib7	13493	7	82	82	CD
cord-005453-4057qib7	13493	8	%	%	NN
cord-005453-4057qib7	13493	9	of	of	IN
cord-005453-4057qib7	13493	10	girls	girl	NNS
cord-005453-4057qib7	13493	11	and	and	CC
cord-005453-4057qib7	13493	12	24	24	CD
cord-005453-4057qib7	13493	13	%	%	NN
cord-005453-4057qib7	13493	14	of	of	IN
cord-005453-4057qib7	13493	15	boys	boy	NNS
cord-005453-4057qib7	13493	16	(	(	-LRB-
cord-005453-4057qib7	13493	17	p	p	NN
cord-005453-4057qib7	13493	18	<	<	XX
cord-005453-4057qib7	13493	19	0.001	0.001	CD
cord-005453-4057qib7	13493	20	)	)	-RRB-
cord-005453-4057qib7	13493	21	.	.	.
cord-005453-4057qib7	13494	1	In	in	IN
cord-005453-4057qib7	13494	2	univariate	univariate	JJ
cord-005453-4057qib7	13494	3	analysis	analysis	NN
cord-005453-4057qib7	13494	4	,	,	,
cord-005453-4057qib7	13494	5	TBI	TBI	NNP
cord-005453-4057qib7	13494	6	conditioning	conditioning	NN
cord-005453-4057qib7	13494	7	(	(	-LRB-
cord-005453-4057qib7	13494	8	p=0.05	p=0.05	NNP
cord-005453-4057qib7	13494	9	)	)	-RRB-
cord-005453-4057qib7	13494	10	,	,	,
cord-005453-4057qib7	13494	11	female	female	JJ
cord-005453-4057qib7	13494	12	sex	sex	NN
cord-005453-4057qib7	13494	13	(	(	-LRB-
cord-005453-4057qib7	13494	14	p	p	NN
cord-005453-4057qib7	13494	15	<	<	XX
cord-005453-4057qib7	13494	16	0.001	0.001	CD
cord-005453-4057qib7	13494	17	)	)	-RRB-
cord-005453-4057qib7	13494	18	,	,	,
cord-005453-4057qib7	13494	19	acute	acute	JJ
cord-005453-4057qib7	13494	20	GVHD	GVHD	NNP
cord-005453-4057qib7	13494	21	(	(	-LRB-
cord-005453-4057qib7	13494	22	p=0.05	p=0.05	NNP
cord-005453-4057qib7	13494	23	)	)	-RRB-
cord-005453-4057qib7	13494	24	,	,	,
cord-005453-4057qib7	13494	25	extensive	extensive	JJ
cord-005453-4057qib7	13494	26	chronic	chronic	JJ
cord-005453-4057qib7	13494	27	GVHD	GVHD	NNP
cord-005453-4057qib7	13494	28	(	(	-LRB-
cord-005453-4057qib7	13494	29	p=0.021	p=0.021	NNP
cord-005453-4057qib7	13494	30	)	)	-RRB-
cord-005453-4057qib7	13494	31	,	,	,
cord-005453-4057qib7	13494	32	steroid	steroid	NN
cord-005453-4057qib7	13494	33	treatment	treatment	NN
cord-005453-4057qib7	13494	34	>	>	XX
cord-005453-4057qib7	13494	35	6	6	CD
cord-005453-4057qib7	13494	36	months	month	NNS
cord-005453-4057qib7	13494	37	(	(	-LRB-
cord-005453-4057qib7	13494	38	p=0.016	p=0.016	RB
cord-005453-4057qib7	13494	39	)	)	-RRB-
cord-005453-4057qib7	13494	40	,	,	,
cord-005453-4057qib7	13494	41	and	and	CC
cord-005453-4057qib7	13494	42	malignant	malignant	JJ
cord-005453-4057qib7	13494	43	diseases	disease	NNS
cord-005453-4057qib7	13494	44	(	(	-LRB-
cord-005453-4057qib7	13494	45	p=0.016	p=0.016	RB
cord-005453-4057qib7	13494	46	)	)	-RRB-
cord-005453-4057qib7	13494	47	were	be	VBD
cord-005453-4057qib7	13494	48	associated	associate	VBN
cord-005453-4057qib7	13494	49	with	with	IN
cord-005453-4057qib7	13494	50	no	no	DT
cord-005453-4057qib7	13494	51	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13494	52	pubertal	pubertal	JJ
cord-005453-4057qib7	13494	53	development	development	NN
cord-005453-4057qib7	13494	54	,	,	,
cord-005453-4057qib7	13494	55	whereas	whereas	IN
cord-005453-4057qib7	13494	56	TBI	TBI	NNP
cord-005453-4057qib7	13494	57	conditioning	conditioning	NN
cord-005453-4057qib7	13494	58	(	(	-LRB-
cord-005453-4057qib7	13494	59	p=0.003	p=0.003	NNP
cord-005453-4057qib7	13494	60	)	)	-RRB-
cord-005453-4057qib7	13494	61	and	and	CC
cord-005453-4057qib7	13494	62	extensive	extensive	JJ
cord-005453-4057qib7	13494	63	chronic	chronic	JJ
cord-005453-4057qib7	13494	64	GVHD	GVHD	NNP
cord-005453-4057qib7	13494	65	(	(	-LRB-
cord-005453-4057qib7	13494	66	p=0.005	p=0.005	NNP
cord-005453-4057qib7	13494	67	)	)	-RRB-
cord-005453-4057qib7	13494	68	were	be	VBD
cord-005453-4057qib7	13494	69	associated	associate	VBN
cord-005453-4057qib7	13494	70	with	with	IN
cord-005453-4057qib7	13494	71	delayed	delay	VBN
cord-005453-4057qib7	13494	72	puberty	puberty	NN
cord-005453-4057qib7	13494	73	.	.	.
cord-005453-4057qib7	13495	1	In	in	IN
cord-005453-4057qib7	13495	2	multivariate	multivariate	JJ
cord-005453-4057qib7	13495	3	analysis	analysis	NN
cord-005453-4057qib7	13495	4	,	,	,
cord-005453-4057qib7	13495	5	factors	factor	NNS
cord-005453-4057qib7	13495	6	independently	independently	RB
cord-005453-4057qib7	13495	7	associated	associate	VBN
cord-005453-4057qib7	13495	8	with	with	IN
cord-005453-4057qib7	13495	9	no	no	DT
cord-005453-4057qib7	13495	10	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13495	11	puberty	puberty	NN
cord-005453-4057qib7	13495	12	onset	onset	NN
cord-005453-4057qib7	13495	13	were	be	VBD
cord-005453-4057qib7	13495	14	female	female	JJ
cord-005453-4057qib7	13495	15	sex	sex	NN
cord-005453-4057qib7	13495	16	(	(	-LRB-
cord-005453-4057qib7	13495	17	p=0.001	p=0.001	NNP
cord-005453-4057qib7	13495	18	)	)	-RRB-
cord-005453-4057qib7	13495	19	and	and	CC
cord-005453-4057qib7	13495	20	age	age	NN
cord-005453-4057qib7	13495	21	>	>	XX
cord-005453-4057qib7	13495	22	10	10	CD
cord-005453-4057qib7	13495	23	years	year	NNS
cord-005453-4057qib7	13495	24	(	(	-LRB-
cord-005453-4057qib7	13495	25	p=0.033	p=0.033	NNP
cord-005453-4057qib7	13495	26	)	)	-RRB-
cord-005453-4057qib7	13495	27	.	.	.
cord-005453-4057qib7	13496	1	Factors	factor	NNS
cord-005453-4057qib7	13496	2	independently	independently	RB
cord-005453-4057qib7	13496	3	associated	associate	VBD
cord-005453-4057qib7	13496	4	with	with	IN
cord-005453-4057qib7	13496	5	delayed	delay	VBN
cord-005453-4057qib7	13496	6	puberty	puberty	NN
cord-005453-4057qib7	13496	7	were	be	VBD
cord-005453-4057qib7	13496	8	extensive	extensive	JJ
cord-005453-4057qib7	13496	9	chronic	chronic	JJ
cord-005453-4057qib7	13496	10	GVHD	GVHD	NNP
cord-005453-4057qib7	13496	11	(	(	-LRB-
cord-005453-4057qib7	13496	12	p=0.041	p=0.041	NNP
cord-005453-4057qib7	13496	13	)	)	-RRB-
cord-005453-4057qib7	13496	14	and	and	CC
cord-005453-4057qib7	13496	15	age	age	NN
cord-005453-4057qib7	13496	16	>	>	XX
cord-005453-4057qib7	13496	17	10	10	CD
cord-005453-4057qib7	13496	18	years	year	NNS
cord-005453-4057qib7	13496	19	(	(	-LRB-
cord-005453-4057qib7	13496	20	p=0.031	p=0.031	NNP
cord-005453-4057qib7	13496	21	)	)	-RRB-
cord-005453-4057qib7	13496	22	.	.	.
cord-005453-4057qib7	13497	1	TBI	TBI	NNP
cord-005453-4057qib7	13497	2	was	be	VBD
cord-005453-4057qib7	13497	3	not	not	RB
cord-005453-4057qib7	13497	4	an	an	DT
cord-005453-4057qib7	13497	5	independent	independent	JJ
cord-005453-4057qib7	13497	6	risk	risk	NN
cord-005453-4057qib7	13497	7	factor	factor	NN
cord-005453-4057qib7	13497	8	for	for	IN
cord-005453-4057qib7	13497	9	pubertal	pubertal	JJ
cord-005453-4057qib7	13497	10	complications	complication	NNS
cord-005453-4057qib7	13497	11	.	.	.
cord-005453-4057qib7	13498	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13498	2	:	:	:
cord-005453-4057qib7	13499	1	This	this	DT
cord-005453-4057qib7	13499	2	study	study	NN
cord-005453-4057qib7	13499	3	confirms	confirm	VBZ
cord-005453-4057qib7	13499	4	the	the	DT
cord-005453-4057qib7	13499	5	toxicity	toxicity	NN
cord-005453-4057qib7	13499	6	of	of	IN
cord-005453-4057qib7	13499	7	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13499	8	conditioning	conditioning	NN
cord-005453-4057qib7	13499	9	on	on	IN
cord-005453-4057qib7	13499	10	pubertal	pubertal	JJ
cord-005453-4057qib7	13499	11	development	development	NN
cord-005453-4057qib7	13499	12	and	and	CC
cord-005453-4057qib7	13499	13	the	the	DT
cord-005453-4057qib7	13499	14	role	role	NN
cord-005453-4057qib7	13499	15	of	of	IN
cord-005453-4057qib7	13499	16	older	old	JJR
cord-005453-4057qib7	13499	17	age	age	NN
cord-005453-4057qib7	13499	18	and	and	CC
cord-005453-4057qib7	13499	19	female	female	JJ
cord-005453-4057qib7	13499	20	sex	sex	NN
cord-005453-4057qib7	13499	21	in	in	IN
cord-005453-4057qib7	13499	22	increased	increase	VBN
cord-005453-4057qib7	13499	23	pubertal	pubertal	JJ
cord-005453-4057qib7	13499	24	issues	issue	NNS
cord-005453-4057qib7	13499	25	,	,	,
cord-005453-4057qib7	13499	26	and	and	CC
cord-005453-4057qib7	13499	27	suggests	suggest	VBZ
cord-005453-4057qib7	13499	28	a	a	DT
cord-005453-4057qib7	13499	29	possible	possible	JJ
cord-005453-4057qib7	13499	30	role	role	NN
cord-005453-4057qib7	13499	31	of	of	IN
cord-005453-4057qib7	13499	32	GVHD	GVHD	NNP
cord-005453-4057qib7	13499	33	in	in	IN
cord-005453-4057qib7	13499	34	delayed	delay	VBN
cord-005453-4057qib7	13499	35	puberty	puberty	NN
cord-005453-4057qib7	13499	36	.	.	.
cord-005453-4057qib7	13500	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13500	2	:	:	:
cord-005453-4057qib7	13500	3	Nothing	nothing	NN
cord-005453-4057qib7	13500	4	to	to	TO
cord-005453-4057qib7	13500	5	declare	declare	VB
cord-005453-4057qib7	13500	6	P613	P613	VBN
cord-005453-4057qib7	13500	7	Abstract	Abstract	NNP
cord-005453-4057qib7	13500	8	already	already	RB
cord-005453-4057qib7	13500	9	published	publish	VBN
cord-005453-4057qib7	13500	10	.	.	.
cord-005453-4057qib7	13501	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	13501	2	elastase	elastase	NN
cord-005453-4057qib7	13501	3	activity	activity	NN
cord-005453-4057qib7	13501	4	may	may	MD
cord-005453-4057qib7	13501	5	serve	serve	VB
cord-005453-4057qib7	13501	6	as	as	IN
cord-005453-4057qib7	13501	7	a	a	DT
cord-005453-4057qib7	13501	8	marker	marker	NN
cord-005453-4057qib7	13501	9	for	for	IN
cord-005453-4057qib7	13501	10	neutrophil	neutrophil	NN
cord-005453-4057qib7	13501	11	extracellular	extracellular	JJ
cord-005453-4057qib7	13501	12	traps	trap	NNS
cord-005453-4057qib7	13501	13	formation	formation	NN
cord-005453-4057qib7	13501	14	following	follow	VBG
cord-005453-4057qib7	13501	15	stem	stem	NN
cord-005453-4057qib7	13501	16	cell	cell	NN
cord-005453-4057qib7	13501	17	transplantation	transplantation	NN
cord-005453-4057qib7	13501	18	Ronit	Ronit	NNP
cord-005453-4057qib7	13501	19	Elhasid	Elhasid	NNP
cord-005453-4057qib7	13501	20	1	1	CD
cord-005453-4057qib7	13501	21	,	,	,
cord-005453-4057qib7	13501	22	Sivan	Sivan	NNP
cord-005453-4057qib7	13501	23	Berger	Berger	NNP
cord-005453-4057qib7	13501	24	-	-	HYPH
cord-005453-4057qib7	13501	25	Achituv	Achituv	NNP
cord-005453-4057qib7	13501	26	1	1	CD
cord-005453-4057qib7	13501	27	,	,	,
cord-005453-4057qib7	13501	28	Hila	Hila	NNP
cord-005453-4057qib7	13501	29	Rosenfeld	Rosenfeld	NNP
cord-005453-4057qib7	13501	30	-	-	HYPH
cord-005453-4057qib7	13501	31	Keidar	Keidar	NNP
cord-005453-4057qib7	13501	32	1	1	CD
cord-005453-4057qib7	13501	33	,	,	,
cord-005453-4057qib7	13501	34	Szilvia	Szilvia	NNP
cord-005453-4057qib7	13501	35	Baron	Baron	NNP
cord-005453-4057qib7	13501	36	1	1	CD
cord-005453-4057qib7	13501	37	1	1	CD
cord-005453-4057qib7	13501	38	Tel	Tel	NNP
cord-005453-4057qib7	13501	39	Aviv	Aviv	NNP
cord-005453-4057qib7	13501	40	Sourasky	Sourasky	NNP
cord-005453-4057qib7	13501	41	Medical	Medical	NNP
cord-005453-4057qib7	13501	42	Center	Center	NNP
cord-005453-4057qib7	13502	1	-Tel	-Tel	VBG
cord-005453-4057qib7	13502	2	Aviv	Aviv	NNP
cord-005453-4057qib7	13502	3	University	University	NNP
cord-005453-4057qib7	13502	4	,	,	,
cord-005453-4057qib7	13502	5	Tel	Tel	NNP
cord-005453-4057qib7	13502	6	Aviv	Aviv	NNP
cord-005453-4057qib7	13503	1	,	,	,
cord-005453-4057qib7	13503	2	Israel	Israel	NNP
cord-005453-4057qib7	13503	3	Background	Background	NNP
cord-005453-4057qib7	13503	4	:	:	:
cord-005453-4057qib7	13504	1	Post	post	JJ
cord-005453-4057qib7	13504	2	-	-	JJ
cord-005453-4057qib7	13504	3	transplant	transplant	JJ
cord-005453-4057qib7	13504	4	Infections	infection	NNS
cord-005453-4057qib7	13504	5	rise	rise	VBP
cord-005453-4057qib7	13504	6	dramatically	dramatically	RB
cord-005453-4057qib7	13504	7	in	in	IN
cord-005453-4057qib7	13504	8	patients	patient	NNS
cord-005453-4057qib7	13504	9	with	with	IN
cord-005453-4057qib7	13504	10	quantitative	quantitative	JJ
cord-005453-4057qib7	13504	11	or	or	CC
cord-005453-4057qib7	13504	12	qualitative	qualitative	JJ
cord-005453-4057qib7	13504	13	neutrophil	neutrophil	NN
cord-005453-4057qib7	13504	14	defects	defect	NNS
cord-005453-4057qib7	13504	15	and	and	CC
cord-005453-4057qib7	13504	16	constitute	constitute	VBP
cord-005453-4057qib7	13504	17	a	a	DT
cord-005453-4057qib7	13504	18	major	major	JJ
cord-005453-4057qib7	13504	19	source	source	NN
cord-005453-4057qib7	13504	20	of	of	IN
cord-005453-4057qib7	13504	21	morbidity	morbidity	NN
cord-005453-4057qib7	13504	22	and	and	CC
cord-005453-4057qib7	13504	23	mortality	mortality	NN
cord-005453-4057qib7	13504	24	following	follow	VBG
cord-005453-4057qib7	13504	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13504	26	stem	stem	NN
cord-005453-4057qib7	13504	27	cell	cell	NN
cord-005453-4057qib7	13504	28	transplantation	transplantation	NN
cord-005453-4057qib7	13504	29	(	(	-LRB-
cord-005453-4057qib7	13504	30	HSCT	HSCT	NNP
cord-005453-4057qib7	13504	31	)	)	-RRB-
cord-005453-4057qib7	13504	32	.	.	.
cord-005453-4057qib7	13505	1	Neutrophils	neutrophil	NNS
cord-005453-4057qib7	13505	2	protect	protect	VBP
cord-005453-4057qib7	13505	3	the	the	DT
cord-005453-4057qib7	13505	4	host	host	NN
cord-005453-4057qib7	13505	5	from	from	IN
cord-005453-4057qib7	13505	6	microorganisms	microorganism	NNS
cord-005453-4057qib7	13505	7	via	via	IN
cord-005453-4057qib7	13505	8	multiple	multiple	JJ
cord-005453-4057qib7	13505	9	processes	process	NNS
cord-005453-4057qib7	13505	10	including	include	VBG
cord-005453-4057qib7	13505	11	phagocytosis	phagocytosis	NN
cord-005453-4057qib7	13505	12	and	and	CC
cord-005453-4057qib7	13505	13	formation	formation	NN
cord-005453-4057qib7	13505	14	of	of	IN
cord-005453-4057qib7	13505	15	neutrophil	neutrophil	NN
cord-005453-4057qib7	13505	16	extracellular	extracellular	JJ
cord-005453-4057qib7	13505	17	traps	trap	NNS
cord-005453-4057qib7	13505	18	(	(	-LRB-
cord-005453-4057qib7	13505	19	NETs	nets	NN
cord-005453-4057qib7	13505	20	)	)	-RRB-
cord-005453-4057qib7	13505	21	.	.	.
cord-005453-4057qib7	13506	1	Although	although	IN
cord-005453-4057qib7	13506	2	reactive	reactive	JJ
cord-005453-4057qib7	13506	3	oxygen	oxygen	NN
cord-005453-4057qib7	13506	4	species	specie	NNS
cord-005453-4057qib7	13506	5	(	(	-LRB-
cord-005453-4057qib7	13506	6	ROS	ROS	NNP
cord-005453-4057qib7	13506	7	)	)	-RRB-
cord-005453-4057qib7	13506	8	production	production	NN
cord-005453-4057qib7	13506	9	seems	seem	VBZ
cord-005453-4057qib7	13506	10	to	to	TO
cord-005453-4057qib7	13506	11	be	be	VB
cord-005453-4057qib7	13506	12	essential	essential	JJ
cord-005453-4057qib7	13506	13	for	for	IN
cord-005453-4057qib7	13506	14	NETs	net	NNS
cord-005453-4057qib7	13506	15	formation	formation	NN
cord-005453-4057qib7	13506	16	,	,	,
cord-005453-4057qib7	13506	17	the	the	DT
cord-005453-4057qib7	13506	18	key	key	JJ
cord-005453-4057qib7	13506	19	enzymes	enzyme	NNS
cord-005453-4057qib7	13506	20	of	of	IN
cord-005453-4057qib7	13506	21	the	the	DT
cord-005453-4057qib7	13506	22	process	process	NN
cord-005453-4057qib7	13506	23	are	be	VBP
cord-005453-4057qib7	13506	24	neutrophil	neutrophil	NN
cord-005453-4057qib7	13506	25	elastase	elastase	NN
cord-005453-4057qib7	13506	26	(	(	-LRB-
cord-005453-4057qib7	13506	27	NE	NE	NNP
cord-005453-4057qib7	13506	28	)	)	-RRB-
cord-005453-4057qib7	13506	29	and	and	CC
cord-005453-4057qib7	13506	30	myeloperoxidase	myeloperoxidase	NNP
cord-005453-4057qib7	13506	31	(	(	-LRB-
cord-005453-4057qib7	13506	32	MPO	MPO	NNP
cord-005453-4057qib7	13506	33	)	)	-RRB-
cord-005453-4057qib7	13506	34	.	.	.
cord-005453-4057qib7	13507	1	Methods	method	NNS
cord-005453-4057qib7	13507	2	:	:	:
cord-005453-4057qib7	13507	3	NE	NE	NNP
cord-005453-4057qib7	13507	4	and	and	CC
cord-005453-4057qib7	13507	5	MPO	MPO	NNP
cord-005453-4057qib7	13507	6	activity	activity	NN
cord-005453-4057qib7	13507	7	as	as	RB
cord-005453-4057qib7	13507	8	well	well	RB
cord-005453-4057qib7	13507	9	as	as	IN
cord-005453-4057qib7	13508	1	NETs	NETs	NNP
cord-005453-4057qib7	13508	2	formation	formation	NN
cord-005453-4057qib7	13508	3	were	be	VBD
cord-005453-4057qib7	13508	4	investigated	investigate	VBN
cord-005453-4057qib7	13508	5	following	follow	VBG
cord-005453-4057qib7	13508	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13508	7	in	in	IN
cord-005453-4057qib7	13508	8	11	11	CD
cord-005453-4057qib7	13508	9	patients	patient	NNS
cord-005453-4057qib7	13508	10	at	at	IN
cord-005453-4057qib7	13508	11	week	week	NN
cord-005453-4057qib7	13508	12	1	1	CD
cord-005453-4057qib7	13508	13	to	to	IN
cord-005453-4057qib7	13508	14	6	6	CD
cord-005453-4057qib7	13508	15	and	and	CC
cord-005453-4057qib7	13508	16	30	30	CD
cord-005453-4057qib7	13508	17	after	after	IN
cord-005453-4057qib7	13508	18	neutrophil	neutrophil	NN
cord-005453-4057qib7	13508	19	engraftment	engraftment	NN
cord-005453-4057qib7	13508	20	.	.	.
cord-005453-4057qib7	13509	1	Neutrophils	neutrophil	NNS
cord-005453-4057qib7	13509	2	were	be	VBD
cord-005453-4057qib7	13509	3	isolated	isolate	VBN
cord-005453-4057qib7	13509	4	using	use	VBG
cord-005453-4057qib7	13509	5	EasySep	EasySep	NNP
cord-005453-4057qib7	13509	6	Direct	Direct	NNP
cord-005453-4057qib7	13509	7	Human	Human	NNP
cord-005453-4057qib7	13509	8	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	13509	9	isolation	isolation	NN
cord-005453-4057qib7	13509	10	kit	kit	NN
cord-005453-4057qib7	13509	11	(	(	-LRB-
cord-005453-4057qib7	13509	12	StemCell	StemCell	NNP
cord-005453-4057qib7	13509	13	Technologies	Technologies	NNPS
cord-005453-4057qib7	13509	14	Inc.	Inc.	NNP
cord-005453-4057qib7	13509	15	)	)	-RRB-
cord-005453-4057qib7	13509	16	by	by	IN
cord-005453-4057qib7	13509	17	immunomagnetic	immunomagnetic	JJ
cord-005453-4057qib7	13509	18	negative	negative	JJ
cord-005453-4057qib7	13509	19	selection	selection	NN
cord-005453-4057qib7	13509	20	.	.	.
cord-005453-4057qib7	13510	1	Enzymatic	enzymatic	JJ
cord-005453-4057qib7	13510	2	activity	activity	NN
cord-005453-4057qib7	13510	3	of	of	IN
cord-005453-4057qib7	13510	4	NE	NE	NNP
cord-005453-4057qib7	13510	5	and	and	CC
cord-005453-4057qib7	13510	6	MPO	MPO	NNP
cord-005453-4057qib7	13510	7	were	be	VBD
cord-005453-4057qib7	13510	8	measured	measure	VBN
cord-005453-4057qib7	13510	9	using	use	VBG
cord-005453-4057qib7	13510	10	colorimetric	colorimetric	JJ
cord-005453-4057qib7	13510	11	assays	assay	NNS
cord-005453-4057qib7	13510	12	.	.	.
cord-005453-4057qib7	13511	1	NETs	NETs	NNP
cord-005453-4057qib7	13511	2	formation	formation	NN
cord-005453-4057qib7	13511	3	of	of	IN
cord-005453-4057qib7	13511	4	phorbol	phorbol	NNP
cord-005453-4057qib7	13511	5	12-myristate	12-myristate	CD
cord-005453-4057qib7	13511	6	13-acetate	13-acetate	CD
cord-005453-4057qib7	13511	7	(	(	-LRB-
cord-005453-4057qib7	13511	8	PMA)activated	pma)activated	JJ
cord-005453-4057qib7	13511	9	neutrophils	neutrophil	NNS
cord-005453-4057qib7	13511	10	was	be	VBD
cord-005453-4057qib7	13511	11	investigated	investigate	VBN
cord-005453-4057qib7	13511	12	by	by	IN
cord-005453-4057qib7	13511	13	confocal	confocal	JJ
cord-005453-4057qib7	13511	14	fluorescence	fluorescence	NN
cord-005453-4057qib7	13511	15	microscopy	microscopy	NN
cord-005453-4057qib7	13511	16	.	.	.
cord-005453-4057qib7	13512	1	All	all	DT
cord-005453-4057qib7	13512	2	results	result	NNS
cord-005453-4057qib7	13512	3	were	be	VBD
cord-005453-4057qib7	13512	4	compared	compare	VBN
cord-005453-4057qib7	13512	5	to	to	IN
cord-005453-4057qib7	13512	6	those	those	DT
cord-005453-4057qib7	13512	7	of	of	IN
cord-005453-4057qib7	13512	8	healthy	healthy	JJ
cord-005453-4057qib7	13512	9	volunteers	volunteer	NNS
cord-005453-4057qib7	13512	10	.	.	.
cord-005453-4057qib7	13513	1	Statistical	statistical	JJ
cord-005453-4057qib7	13513	2	significance	significance	NN
cord-005453-4057qib7	13513	3	was	be	VBD
cord-005453-4057qib7	13513	4	calculated	calculate	VBN
cord-005453-4057qib7	13513	5	using	use	VBG
cord-005453-4057qib7	13513	6	one	one	CD
cord-005453-4057qib7	13513	7	way	way	NN
cord-005453-4057qib7	13513	8	-	-	HYPH
cord-005453-4057qib7	13513	9	ANOVA	anova	NN
cord-005453-4057qib7	13513	10	with	with	IN
cord-005453-4057qib7	13513	11	Bonferroni	Bonferroni	NNP
cord-005453-4057qib7	13513	12	post	post	VB
cord-005453-4057qib7	13513	13	hoc	hoc	JJ
cord-005453-4057qib7	13513	14	test	test	NN
cord-005453-4057qib7	13513	15	.	.	.
cord-005453-4057qib7	13514	1	Results	result	NNS
cord-005453-4057qib7	13514	2	:	:	:
cord-005453-4057qib7	13514	3	11	11	CD
cord-005453-4057qib7	13514	4	patients	patient	NNS
cord-005453-4057qib7	13514	5	(	(	-LRB-
cord-005453-4057qib7	13514	6	median	median	JJ
cord-005453-4057qib7	13514	7	age	age	NN
cord-005453-4057qib7	13514	8	of	of	IN
cord-005453-4057qib7	13514	9	6.8	6.8	CD
cord-005453-4057qib7	13514	10	years	year	NNS
cord-005453-4057qib7	13514	11	[	[	-LRB-
cord-005453-4057qib7	13514	12	range	range	NN
cord-005453-4057qib7	13514	13	2	2	CD
cord-005453-4057qib7	13514	14	-	-	SYM
cord-005453-4057qib7	13514	15	22	22	CD
cord-005453-4057qib7	13514	16	years	year	NNS
cord-005453-4057qib7	13514	17	]	]	-RRB-
cord-005453-4057qib7	13514	18	)	)	-RRB-
cord-005453-4057qib7	13514	19	were	be	VBD
cord-005453-4057qib7	13514	20	investigated	investigate	VBN
cord-005453-4057qib7	13514	21	,	,	,
cord-005453-4057qib7	13514	22	6	6	CD
cord-005453-4057qib7	13514	23	following	follow	VBG
cord-005453-4057qib7	13514	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	13514	25	HSCT	HSCT	NNP
cord-005453-4057qib7	13514	26	(	(	-LRB-
cord-005453-4057qib7	13514	27	2	2	CD
cord-005453-4057qib7	13514	28	acute	acute	JJ
cord-005453-4057qib7	13514	29	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13514	30	leukemia	leukemia	NN
cord-005453-4057qib7	13514	31	,	,	,
cord-005453-4057qib7	13514	32	1	1	CD
cord-005453-4057qib7	13514	33	acute	acute	JJ
cord-005453-4057qib7	13514	34	myeloblastic	myeloblastic	JJ
cord-005453-4057qib7	13514	35	leukemia	leukemia	NN
cord-005453-4057qib7	13514	36	,	,	,
cord-005453-4057qib7	13514	37	2	2	CD
cord-005453-4057qib7	13514	38	epidermolysis	epidermolysis	NN
cord-005453-4057qib7	13514	39	bullosa	bullosa	NNP
cord-005453-4057qib7	13514	40	,	,	,
cord-005453-4057qib7	13514	41	1	1	CD
cord-005453-4057qib7	13514	42	rhabdomyosarcoma	rhabdomyosarcoma	NNP
cord-005453-4057qib7	13514	43	)	)	-RRB-
cord-005453-4057qib7	13514	44	and	and	CC
cord-005453-4057qib7	13514	45	5	5	CD
cord-005453-4057qib7	13514	46	following	follow	VBG
cord-005453-4057qib7	13514	47	autologous	autologous	JJ
cord-005453-4057qib7	13514	48	HSCT	HSCT	NNP
cord-005453-4057qib7	13514	49	(	(	-LRB-
cord-005453-4057qib7	13514	50	4	4	CD
cord-005453-4057qib7	13514	51	Ewing	Ewing	NNP
cord-005453-4057qib7	13514	52	sarcoma	sarcoma	NN
cord-005453-4057qib7	13514	53	,	,	,
cord-005453-4057qib7	13515	1	1	1	CD
cord-005453-4057qib7	13515	2	desmoplastic	desmoplastic	JJ
cord-005453-4057qib7	13515	3	small	small	JJ
cord-005453-4057qib7	13515	4	round	round	JJ
cord-005453-4057qib7	13515	5	cell	cell	NN
cord-005453-4057qib7	13515	6	tumor	tumor	NN
cord-005453-4057qib7	13515	7	)	)	-RRB-
cord-005453-4057qib7	13515	8	.	.	.
cord-005453-4057qib7	13516	1	All	all	DT
cord-005453-4057qib7	13516	2	patients	patient	NNS
cord-005453-4057qib7	13516	3	experienced	experience	VBD
cord-005453-4057qib7	13516	4	fever	fever	NN
cord-005453-4057qib7	13516	5	and	and	CC
cord-005453-4057qib7	13516	6	neutropenia	neutropenia	NN
cord-005453-4057qib7	13516	7	.	.	.
cord-005453-4057qib7	13517	1	At	at	IN
cord-005453-4057qib7	13517	2	engraftment	engraftment	NN
cord-005453-4057qib7	13517	3	,	,	,
cord-005453-4057qib7	13517	4	average	average	JJ
cord-005453-4057qib7	13517	5	NE	NE	NNP
cord-005453-4057qib7	13517	6	activity	activity	NN
cord-005453-4057qib7	13517	7	was	be	VBD
cord-005453-4057qib7	13517	8	significantly	significantly	RB
cord-005453-4057qib7	13517	9	decreased	decrease	VBN
cord-005453-4057qib7	13517	10	compared	compare	VBN
cord-005453-4057qib7	13517	11	to	to	IN
cord-005453-4057qib7	13517	12	the	the	DT
cord-005453-4057qib7	13517	13	average	average	JJ
cord-005453-4057qib7	13517	14	value	value	NN
cord-005453-4057qib7	13517	15	of	of	IN
cord-005453-4057qib7	13517	16	50	50	CD
cord-005453-4057qib7	13517	17	healthy	healthy	JJ
cord-005453-4057qib7	13517	18	individuals	individual	NNS
cord-005453-4057qib7	13517	19	.	.	.
cord-005453-4057qib7	13518	1	NE	NE	NNP
cord-005453-4057qib7	13518	2	activity	activity	NN
cord-005453-4057qib7	13518	3	improved	improve	VBD
cord-005453-4057qib7	13518	4	week	week	NN
cord-005453-4057qib7	13518	5	by	by	IN
cord-005453-4057qib7	13518	6	week	week	NN
cord-005453-4057qib7	13518	7	in	in	IN
cord-005453-4057qib7	13518	8	patients	patient	NNS
cord-005453-4057qib7	13518	9	,	,	,
cord-005453-4057qib7	13518	10	reached	reach	VBD
cord-005453-4057qib7	13518	11	the	the	DT
cord-005453-4057qib7	13518	12	lower	low	JJR
cord-005453-4057qib7	13518	13	reference	reference	NN
cord-005453-4057qib7	13518	14	range	range	NN
cord-005453-4057qib7	13518	15	at	at	IN
cord-005453-4057qib7	13518	16	4	4	CD
cord-005453-4057qib7	13518	17	weeks	week	NNS
cord-005453-4057qib7	13518	18	following	follow	VBG
cord-005453-4057qib7	13518	19	transplantation	transplantation	NN
cord-005453-4057qib7	13518	20	(	(	-LRB-
cord-005453-4057qib7	13518	21	Fig	Fig	NNP
cord-005453-4057qib7	13518	22	.	.	.
cord-005453-4057qib7	13518	23	1A	1a	NN
cord-005453-4057qib7	13518	24	)	)	-RRB-
cord-005453-4057qib7	13518	25	and	and	CC
cord-005453-4057qib7	13518	26	continued	continue	VBD
cord-005453-4057qib7	13518	27	to	to	TO
cord-005453-4057qib7	13518	28	increase	increase	VB
cord-005453-4057qib7	13518	29	.	.	.
cord-005453-4057qib7	13519	1	The	the	DT
cord-005453-4057qib7	13519	2	enzymatic	enzymatic	JJ
cord-005453-4057qib7	13519	3	activity	activity	NN
cord-005453-4057qib7	13519	4	of	of	IN
cord-005453-4057qib7	13519	5	MPO	MPO	NNP
cord-005453-4057qib7	13519	6	was	be	VBD
cord-005453-4057qib7	13519	7	comparable	comparable	JJ
cord-005453-4057qib7	13519	8	to	to	IN
cord-005453-4057qib7	13519	9	the	the	DT
cord-005453-4057qib7	13519	10	average	average	JJ
cord-005453-4057qib7	13519	11	value	value	NN
cord-005453-4057qib7	13519	12	of	of	IN
cord-005453-4057qib7	13519	13	50	50	CD
cord-005453-4057qib7	13519	14	healthy	healthy	JJ
cord-005453-4057qib7	13519	15	individuals	individual	NNS
cord-005453-4057qib7	13519	16	(	(	-LRB-
cord-005453-4057qib7	13519	17	Fig	fig	NN
cord-005453-4057qib7	13519	18	.	.	.
cord-005453-4057qib7	13519	19	1B	1b	LS
cord-005453-4057qib7	13519	20	)	)	-RRB-
cord-005453-4057qib7	13519	21	and	and	CC
cord-005453-4057qib7	13519	22	showed	show	VBD
cord-005453-4057qib7	13519	23	no	no	DT
cord-005453-4057qib7	13519	24	significant	significant	JJ
cord-005453-4057qib7	13519	25	difference	difference	NN
cord-005453-4057qib7	13519	26	between	between	IN
cord-005453-4057qib7	13519	27	the	the	DT
cord-005453-4057qib7	13519	28	distinct	distinct	JJ
cord-005453-4057qib7	13519	29	time	time	NN
cord-005453-4057qib7	13519	30	points	point	NNS
cord-005453-4057qib7	13519	31	.	.	.
cord-005453-4057qib7	13520	1	At	at	IN
cord-005453-4057qib7	13520	2	neutrophil	neutrophil	NN
cord-005453-4057qib7	13520	3	engraftment	engraftment	NN
cord-005453-4057qib7	13520	4	,	,	,
cord-005453-4057qib7	13520	5	NETs	NETs	NNP
cord-005453-4057qib7	13520	6	formation	formation	NN
cord-005453-4057qib7	13520	7	was	be	VBD
cord-005453-4057qib7	13520	8	absent	absent	JJ
cord-005453-4057qib7	13520	9	and	and	CC
cord-005453-4057qib7	13520	10	comparable	comparable	JJ
cord-005453-4057qib7	13520	11	to	to	IN
cord-005453-4057qib7	13520	12	those	those	DT
cord-005453-4057qib7	13520	13	of	of	IN
cord-005453-4057qib7	13520	14	non	non	JJ
cord-005453-4057qib7	13520	15	-	-	JJ
cord-005453-4057qib7	13520	16	activated	activate	VBN
cord-005453-4057qib7	13520	17	neutrophils	neutrophil	NNS
cord-005453-4057qib7	13520	18	(	(	-LRB-
cord-005453-4057qib7	13520	19	Fig	Fig	NNP
cord-005453-4057qib7	13520	20	.	.	.
cord-005453-4057qib7	13520	21	1C	1C	NNP
cord-005453-4057qib7	13520	22	)	)	-RRB-
cord-005453-4057qib7	13520	23	.	.	.
cord-005453-4057qib7	13521	1	Although	although	IN
cord-005453-4057qib7	13521	2	NETs	net	NNS
cord-005453-4057qib7	13521	3	formation	formation	NN
cord-005453-4057qib7	13521	4	increased	increase	VBN
cord-005453-4057qib7	13521	5	week	week	NN
cord-005453-4057qib7	13521	6	by	by	IN
cord-005453-4057qib7	13521	7	week	week	NN
cord-005453-4057qib7	13521	8	,	,	,
cord-005453-4057qib7	13521	9	it	-PRON-	PRP
cord-005453-4057qib7	13521	10	did	do	VBD
cord-005453-4057qib7	13521	11	not	not	RB
cord-005453-4057qib7	13521	12	reach	reach	VB
cord-005453-4057qib7	13521	13	the	the	DT
cord-005453-4057qib7	13521	14	average	average	NN
cord-005453-4057qib7	13521	15	of	of	IN
cord-005453-4057qib7	13521	16	7	7	CD
cord-005453-4057qib7	13521	17	normal	normal	JJ
cord-005453-4057qib7	13521	18	controls	control	NNS
cord-005453-4057qib7	13521	19	during	during	IN
cord-005453-4057qib7	13521	20	the	the	DT
cord-005453-4057qib7	13521	21	monitored	monitor	VBN
cord-005453-4057qib7	13521	22	time	time	NN
cord-005453-4057qib7	13521	23	period	period	NN
cord-005453-4057qib7	13521	24	.	.	.
cord-005453-4057qib7	13522	1	Also	also	RB
cord-005453-4057qib7	13522	2	linear	linear	JJ
cord-005453-4057qib7	13522	3	correlation	correlation	NN
cord-005453-4057qib7	13522	4	between	between	IN
cord-005453-4057qib7	13522	5	NE	NE	NNP
cord-005453-4057qib7	13522	6	activity	activity	NN
cord-005453-4057qib7	13522	7	and	and	CC
cord-005453-4057qib7	13522	8	NETs	nets	NN
cord-005453-4057qib7	13522	9	formation	formation	NN
cord-005453-4057qib7	13523	1	(	(	-LRB-
cord-005453-4057qib7	13523	2	R	r	NN
cord-005453-4057qib7	13523	3	2	2	CD
cord-005453-4057qib7	13523	4	=	=	SYM
cord-005453-4057qib7	13523	5	0.978	0.978	CD
cord-005453-4057qib7	13523	6	)	)	-RRB-
cord-005453-4057qib7	13523	7	was	be	VBD
cord-005453-4057qib7	13523	8	demonstrated	demonstrate	VBN
cord-005453-4057qib7	13523	9	.	.	.
cord-005453-4057qib7	13524	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13524	2	:	:	:
cord-005453-4057qib7	13525	1	Impaired	impaired	JJ
cord-005453-4057qib7	13525	2	NE	NE	NNP
cord-005453-4057qib7	13525	3	activity	activity	NN
cord-005453-4057qib7	13525	4	following	follow	VBG
cord-005453-4057qib7	13525	5	HSCT	HSCT	NNP
cord-005453-4057qib7	13525	6	corresponds	correspond	VBZ
cord-005453-4057qib7	13525	7	to	to	IN
cord-005453-4057qib7	13525	8	decreased	decrease	VBN
cord-005453-4057qib7	13525	9	NETs	nets	NN
cord-005453-4057qib7	13525	10	formation	formation	NN
cord-005453-4057qib7	13525	11	and	and	CC
cord-005453-4057qib7	13525	12	could	could	MD
cord-005453-4057qib7	13525	13	serve	serve	VB
cord-005453-4057qib7	13525	14	as	as	IN
cord-005453-4057qib7	13525	15	a	a	DT
cord-005453-4057qib7	13525	16	marker	marker	NN
cord-005453-4057qib7	13525	17	for	for	IN
cord-005453-4057qib7	13525	18	NETosis	NETosis	NNP
cord-005453-4057qib7	13525	19	.	.	.
cord-005453-4057qib7	13526	1	Strategies	strategy	NNS
cord-005453-4057qib7	13526	2	to	to	TO
cord-005453-4057qib7	13526	3	accelerate	accelerate	VB
cord-005453-4057qib7	13526	4	the	the	DT
cord-005453-4057qib7	13526	5	recovery	recovery	NN
cord-005453-4057qib7	13526	6	of	of	IN
cord-005453-4057qib7	13526	7	NE	NE	NNP
cord-005453-4057qib7	13526	8	function	function	NN
cord-005453-4057qib7	13526	9	post	post	NN
cord-005453-4057qib7	13526	10	transplantation	transplantation	NN
cord-005453-4057qib7	13526	11	might	may	MD
cord-005453-4057qib7	13526	12	improve	improve	VB
cord-005453-4057qib7	13526	13	NETs	net	NNS
cord-005453-4057qib7	13526	14	formation	formation	NN
cord-005453-4057qib7	13526	15	and	and	CC
cord-005453-4057qib7	13526	16	thereby	thereby	RB
cord-005453-4057qib7	13526	17	induce	induce	VB
cord-005453-4057qib7	13526	18	better	well	JJR
cord-005453-4057qib7	13526	19	infection	infection	NN
cord-005453-4057qib7	13526	20	control	control	NN
cord-005453-4057qib7	13526	21	.	.	.
cord-005453-4057qib7	13527	1	A	a	LS
cord-005453-4057qib7	13527	2	)	)	-RRB-
cord-005453-4057qib7	13528	1	The	the	DT
cord-005453-4057qib7	13528	2	average	average	NN
cord-005453-4057qib7	13528	3	of	of	IN
cord-005453-4057qib7	13528	4	NE	NE	NNP
cord-005453-4057qib7	13528	5	activity	activity	NN
cord-005453-4057qib7	13528	6	(	(	-LRB-
cord-005453-4057qib7	13528	7	N=11	N=11	NNP
cord-005453-4057qib7	13528	8	)	)	-RRB-
cord-005453-4057qib7	13528	9	during	during	IN
cord-005453-4057qib7	13528	10	30	30	CD
cord-005453-4057qib7	13528	11	weeks	week	NNS
cord-005453-4057qib7	13528	12	following	follow	VBG
cord-005453-4057qib7	13528	13	HSCT	HSCT	NNP
cord-005453-4057qib7	13528	14	.	.	.
cord-005453-4057qib7	13529	1	Reference	reference	NN
cord-005453-4057qib7	13529	2	range	range	NN
cord-005453-4057qib7	13529	3	was	be	VBD
cord-005453-4057qib7	13529	4	measured	measure	VBN
cord-005453-4057qib7	13529	5	and	and	CC
cord-005453-4057qib7	13529	6	calculated	calculate	VBN
cord-005453-4057qib7	13529	7	from	from	IN
cord-005453-4057qib7	13529	8	measurements	measurement	NNS
cord-005453-4057qib7	13529	9	of	of	IN
cord-005453-4057qib7	13529	10	50	50	CD
cord-005453-4057qib7	13529	11	healthy	healthy	JJ
cord-005453-4057qib7	13529	12	volunteers	volunteer	NNS
cord-005453-4057qib7	13529	13	using	use	VBG
cord-005453-4057qib7	13529	14	.	.	.
cord-005453-4057qib7	13530	1	B	b	NN
cord-005453-4057qib7	13530	2	)	)	-RRB-
cord-005453-4057qib7	13531	1	The	the	DT
cord-005453-4057qib7	13531	2	average	average	NN
cord-005453-4057qib7	13531	3	of	of	IN
cord-005453-4057qib7	13531	4	MPO	MPO	NNP
cord-005453-4057qib7	13531	5	activity	activity	NN
cord-005453-4057qib7	13531	6	(	(	-LRB-
cord-005453-4057qib7	13531	7	N=11	N=11	NNP
cord-005453-4057qib7	13531	8	)	)	-RRB-
cord-005453-4057qib7	13531	9	during	during	IN
cord-005453-4057qib7	13531	10	30	30	CD
cord-005453-4057qib7	13531	11	weeks	week	NNS
cord-005453-4057qib7	13531	12	following	follow	VBG
cord-005453-4057qib7	13531	13	HSCT	HSCT	NNP
cord-005453-4057qib7	13531	14	.	.	.
cord-005453-4057qib7	13532	1	Reference	reference	NN
cord-005453-4057qib7	13532	2	ranges	range	NNS
cord-005453-4057qib7	13532	3	were	be	VBD
cord-005453-4057qib7	13532	4	measured	measure	VBN
cord-005453-4057qib7	13532	5	and	and	CC
cord-005453-4057qib7	13532	6	calculated	calculate	VBN
cord-005453-4057qib7	13532	7	from	from	IN
cord-005453-4057qib7	13532	8	measurements	measurement	NNS
cord-005453-4057qib7	13532	9	of	of	IN
cord-005453-4057qib7	13532	10	50	50	CD
cord-005453-4057qib7	13532	11	healthy	healthy	JJ
cord-005453-4057qib7	13532	12	volunteers	volunteer	NNS
cord-005453-4057qib7	13532	13	using	use	VBG
cord-005453-4057qib7	13532	14	the	the	DT
cord-005453-4057qib7	13532	15	quartile	quartile	JJ
cord-005453-4057qib7	13532	16	method	method	NN
cord-005453-4057qib7	13532	17	.	.	.
cord-005453-4057qib7	13533	1	C	C	NNP
cord-005453-4057qib7	13533	2	)	)	-RRB-
cord-005453-4057qib7	13534	1	The	the	DT
cord-005453-4057qib7	13534	2	average	average	NN
cord-005453-4057qib7	13534	3	of	of	IN
cord-005453-4057qib7	13534	4	NETosis	netosis	NN
cord-005453-4057qib7	13534	5	activity	activity	NN
cord-005453-4057qib7	13534	6	after	after	IN
cord-005453-4057qib7	13534	7	100	100	CD
cord-005453-4057qib7	13534	8	nM	nm	CD
cord-005453-4057qib7	13534	9	PMA	PMA	NNP
cord-005453-4057qib7	13534	10	activation	activation	NN
cord-005453-4057qib7	13534	11	for	for	IN
cord-005453-4057qib7	13534	12	3h	3h	CD
cord-005453-4057qib7	13534	13	(	(	-LRB-
cord-005453-4057qib7	13534	14	N=11	N=11	NNP
cord-005453-4057qib7	13534	15	Background	Background	NNP
cord-005453-4057qib7	13534	16	:	:	:
cord-005453-4057qib7	13535	1	To	to	TO
cord-005453-4057qib7	13535	2	have	have	VB
cord-005453-4057qib7	13535	3	a	a	DT
cord-005453-4057qib7	13535	4	better	well	JJR
cord-005453-4057qib7	13535	5	understanding	understanding	NN
cord-005453-4057qib7	13535	6	of	of	IN
cord-005453-4057qib7	13535	7	incidence	incidence	NN
cord-005453-4057qib7	13535	8	,	,	,
cord-005453-4057qib7	13535	9	treatment	treatment	NN
cord-005453-4057qib7	13535	10	,	,	,
cord-005453-4057qib7	13535	11	outcome	outcome	NN
cord-005453-4057qib7	13535	12	and	and	CC
cord-005453-4057qib7	13535	13	risk	risk	NN
cord-005453-4057qib7	13535	14	factors	factor	NNS
cord-005453-4057qib7	13535	15	of	of	IN
cord-005453-4057qib7	13535	16	immune	immune	JJ
cord-005453-4057qib7	13535	17	cytopenia	cytopenia	NNS
cord-005453-4057qib7	13535	18	in	in	IN
cord-005453-4057qib7	13535	19	children	child	NNS
cord-005453-4057qib7	13535	20	after	after	IN
cord-005453-4057qib7	13535	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	13535	22	HSCT	HSCT	NNP
cord-005453-4057qib7	13535	23	.	.	.
cord-005453-4057qib7	13536	1	Methods	method	NNS
cord-005453-4057qib7	13536	2	:	:	:
cord-005453-4057qib7	13536	3	Between	between	IN
cord-005453-4057qib7	13536	4	January	January	NNP
cord-005453-4057qib7	13536	5	2010	2010	CD
cord-005453-4057qib7	13536	6	and	and	CC
cord-005453-4057qib7	13536	7	September	September	NNP
cord-005453-4057qib7	13536	8	2018	2018	CD
cord-005453-4057qib7	13536	9	,	,	,
cord-005453-4057qib7	13536	10	105	105	CD
cord-005453-4057qib7	13536	11	pediatric	pediatric	JJ
cord-005453-4057qib7	13536	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	13536	13	HSCT	HSCT	NNP
cord-005453-4057qib7	13536	14	have	have	VBP
cord-005453-4057qib7	13536	15	been	be	VBN
cord-005453-4057qib7	13536	16	performed	perform	VBN
cord-005453-4057qib7	13536	17	in	in	IN
cord-005453-4057qib7	13536	18	99	99	CD
cord-005453-4057qib7	13536	19	patients	patient	NNS
cord-005453-4057qib7	13536	20	at	at	IN
cord-005453-4057qib7	13536	21	the	the	DT
cord-005453-4057qib7	13536	22	Ghent	Ghent	NNP
cord-005453-4057qib7	13536	23	University	University	NNP
cord-005453-4057qib7	13536	24	Hospital	Hospital	NNP
cord-005453-4057qib7	13536	25	(	(	-LRB-
cord-005453-4057qib7	13536	26	Ghent	Ghent	NNP
cord-005453-4057qib7	13536	27	,	,	,
cord-005453-4057qib7	13536	28	Belgium	Belgium	NNP
cord-005453-4057qib7	13536	29	)	)	-RRB-
cord-005453-4057qib7	13536	30	.	.	.
cord-005453-4057qib7	13537	1	Autoimmune	autoimmune	JJ
cord-005453-4057qib7	13537	2	hemolytic	hemolytic	JJ
cord-005453-4057qib7	13537	3	anemia	anemia	NN
cord-005453-4057qib7	13537	4	was	be	VBD
cord-005453-4057qib7	13537	5	defined	define	VBN
cord-005453-4057qib7	13537	6	by	by	IN
cord-005453-4057qib7	13537	7	a	a	DT
cord-005453-4057qib7	13537	8	positive	positive	JJ
cord-005453-4057qib7	13537	9	direct	direct	JJ
cord-005453-4057qib7	13537	10	agglutinin	agglutinin	NNS
cord-005453-4057qib7	13537	11	test	test	NN
cord-005453-4057qib7	13537	12	(	(	-LRB-
cord-005453-4057qib7	13537	13	DAT	DAT	NNP
cord-005453-4057qib7	13537	14	)	)	-RRB-
cord-005453-4057qib7	13537	15	.	.	.
cord-005453-4057qib7	13538	1	DAT	DAT	NNP
cord-005453-4057qib7	13538	2	was	be	VBD
cord-005453-4057qib7	13538	3	performed	perform	VBN
cord-005453-4057qib7	13538	4	at	at	IN
cord-005453-4057qib7	13538	5	moment	moment	NN
cord-005453-4057qib7	13538	6	of	of	IN
cord-005453-4057qib7	13538	7	engraftment	engraftment	NN
cord-005453-4057qib7	13538	8	and	and	CC
cord-005453-4057qib7	13538	9	in	in	IN
cord-005453-4057qib7	13538	10	case	case	NN
cord-005453-4057qib7	13538	11	of	of	IN
cord-005453-4057qib7	13538	12	hemolysis	hemolysis	NN
cord-005453-4057qib7	13538	13	or	or	CC
cord-005453-4057qib7	13538	14	unexplained	unexplained	JJ
cord-005453-4057qib7	13538	15	anemia	anemia	NN
cord-005453-4057qib7	13538	16	.	.	.
cord-005453-4057qib7	13539	1	Platelets	platelets	NN
cord-005453-4057qib7	13539	2	antibodies	antibody	NNS
cord-005453-4057qib7	13539	3	were	be	VBD
cord-005453-4057qib7	13539	4	evaluated	evaluate	VBN
cord-005453-4057qib7	13539	5	in	in	IN
cord-005453-4057qib7	13539	6	case	case	NN
cord-005453-4057qib7	13539	7	of	of	IN
cord-005453-4057qib7	13539	8	no	no	DT
cord-005453-4057qib7	13539	9	otherwise	otherwise	RB
cord-005453-4057qib7	13539	10	explained	explain	VBN
cord-005453-4057qib7	13539	11	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13539	12	.	.	.
cord-005453-4057qib7	13540	1	Results	result	NNS
cord-005453-4057qib7	13540	2	:	:	:
cord-005453-4057qib7	13541	1	The	the	DT
cord-005453-4057qib7	13541	2	cumulative	cumulative	JJ
cord-005453-4057qib7	13541	3	incidence	incidence	NN
cord-005453-4057qib7	13541	4	of	of	IN
cord-005453-4057qib7	13541	5	post	post	FW
cord-005453-4057qib7	13541	6	allo	allo	FW
cord-005453-4057qib7	13541	7	SCT	SCT	NNP
cord-005453-4057qib7	13541	8	autoimmune	autoimmune	JJ
cord-005453-4057qib7	13541	9	cytopenia	cytopenia	NNP
cord-005453-4057qib7	13541	10	is	be	VBZ
cord-005453-4057qib7	13541	11	9.5	9.5	CD
cord-005453-4057qib7	13541	12	%	%	NN
cord-005453-4057qib7	13541	13	(	(	-LRB-
cord-005453-4057qib7	13541	14	10/105	10/105	CD
cord-005453-4057qib7	13541	15	)	)	-RRB-
cord-005453-4057qib7	13541	16	.	.	.
cord-005453-4057qib7	13542	1	In	in	IN
cord-005453-4057qib7	13542	2	9	9	CD
cord-005453-4057qib7	13542	3	cases	case	NNS
cord-005453-4057qib7	13542	4	there	there	EX
cord-005453-4057qib7	13542	5	were	be	VBD
cord-005453-4057qib7	13542	6	positive	positive	JJ
cord-005453-4057qib7	13542	7	antibodies	antibody	NNS
cord-005453-4057qib7	13542	8	against	against	IN
cord-005453-4057qib7	13542	9	red	red	JJ
cord-005453-4057qib7	13542	10	blood	blood	NN
cord-005453-4057qib7	13542	11	cells	cell	NNS
cord-005453-4057qib7	13542	12	,	,	,
cord-005453-4057qib7	13542	13	and	and	CC
cord-005453-4057qib7	13542	14	one	one	CD
cord-005453-4057qib7	13542	15	patient	patient	NN
cord-005453-4057qib7	13542	16	against	against	IN
cord-005453-4057qib7	13542	17	had	have	VBD
cord-005453-4057qib7	13542	18	antibodies	antibody	NNS
cord-005453-4057qib7	13542	19	against	against	IN
cord-005453-4057qib7	13542	20	platelets	platelet	NNS
cord-005453-4057qib7	13542	21	.	.	.
cord-005453-4057qib7	13543	1	Of	of	IN
cord-005453-4057qib7	13543	2	these	these	DT
cord-005453-4057qib7	13543	3	10	10	CD
cord-005453-4057qib7	13543	4	cases	case	NNS
cord-005453-4057qib7	13543	5	,	,	,
cord-005453-4057qib7	13543	6	only	only	RB
cord-005453-4057qib7	13543	7	4	4	CD
cord-005453-4057qib7	13543	8	(	(	-LRB-
cord-005453-4057qib7	13543	9	3.8	3.8	CD
cord-005453-4057qib7	13543	10	%	%	NN
cord-005453-4057qib7	13543	11	)	)	-RRB-
cord-005453-4057qib7	13543	12	were	be	VBD
cord-005453-4057qib7	13543	13	clinically	clinically	RB
cord-005453-4057qib7	13543	14	relevant	relevant	JJ
cord-005453-4057qib7	13543	15	and	and	CC
cord-005453-4057qib7	13543	16	needed	needed	JJ
cord-005453-4057qib7	13543	17	treatment	treatment	NN
cord-005453-4057qib7	13543	18	.	.	.
cord-005453-4057qib7	13544	1	The	the	DT
cord-005453-4057qib7	13544	2	median	median	JJ
cord-005453-4057qib7	13544	3	observation	observation	NN
cord-005453-4057qib7	13544	4	period	period	NN
cord-005453-4057qib7	13544	5	post	post	NN
cord-005453-4057qib7	13544	6	SCT	SCT	NNP
cord-005453-4057qib7	13544	7	for	for	IN
cord-005453-4057qib7	13544	8	the	the	DT
cord-005453-4057qib7	13544	9	whole	whole	JJ
cord-005453-4057qib7	13544	10	cohort	cohort	NN
cord-005453-4057qib7	13544	11	was	be	VBD
cord-005453-4057qib7	13544	12	36	36	CD
cord-005453-4057qib7	13544	13	months	month	NNS
cord-005453-4057qib7	13544	14	(	(	-LRB-
cord-005453-4057qib7	13544	15	3	3	CD
cord-005453-4057qib7	13544	16	-105	-105	NN
cord-005453-4057qib7	13544	17	)	)	-RRB-
cord-005453-4057qib7	13544	18	.	.	.
cord-005453-4057qib7	13545	1	The	the	DT
cord-005453-4057qib7	13545	2	clinically	clinically	RB
cord-005453-4057qib7	13545	3	significant	significant	JJ
cord-005453-4057qib7	13545	4	immune	immune	JJ
cord-005453-4057qib7	13545	5	cytopenia	cytopenia	NNS
cord-005453-4057qib7	13545	6	started	start	VBD
cord-005453-4057qib7	13545	7	at	at	IN
cord-005453-4057qib7	13545	8	a	a	DT
cord-005453-4057qib7	13545	9	median	median	JJ
cord-005453-4057qib7	13545	10	time	time	NN
cord-005453-4057qib7	13545	11	of	of	IN
cord-005453-4057qib7	13545	12	day+158	day+158	NNS
cord-005453-4057qib7	13545	13	and	and	CC
cord-005453-4057qib7	13545	14	day	day	NN
cord-005453-4057qib7	13545	15	+113	+113	NNP
cord-005453-4057qib7	13545	16	in	in	IN
cord-005453-4057qib7	13545	17	the	the	DT
cord-005453-4057qib7	13545	18	group	group	NN
cord-005453-4057qib7	13545	19	without	without	IN
cord-005453-4057qib7	13545	20	symptoms	symptom	NNS
cord-005453-4057qib7	13545	21	.	.	.
cord-005453-4057qib7	13546	1	The	the	DT
cord-005453-4057qib7	13546	2	patient	patient	NN
cord-005453-4057qib7	13546	3	who	who	WP
cord-005453-4057qib7	13546	4	presented	present	VBD
cord-005453-4057qib7	13546	5	the	the	DT
cord-005453-4057qib7	13546	6	autoimmune	autoimmune	JJ
cord-005453-4057qib7	13546	7	thrombopenia	thrombopenia	NNP
cord-005453-4057qib7	13546	8	developed	develop	VBD
cord-005453-4057qib7	13546	9	antibodies	antibody	NNS
cord-005453-4057qib7	13546	10	against	against	IN
cord-005453-4057qib7	13546	11	anti	anti	JJ
cord-005453-4057qib7	13546	12	-	-	JJ
cord-005453-4057qib7	13546	13	gpIIb	gpiib	JJ
cord-005453-4057qib7	13546	14	/	/	SYM
cord-005453-4057qib7	13546	15	IIIa	IIIa	NNS
cord-005453-4057qib7	13546	16	,	,	,
cord-005453-4057qib7	13546	17	this	this	DT
cord-005453-4057qib7	13546	18	was	be	VBD
cord-005453-4057qib7	13546	19	resolved	resolve	VBN
cord-005453-4057qib7	13546	20	after	after	IN
cord-005453-4057qib7	13546	21	130	130	CD
cord-005453-4057qib7	13546	22	days	day	NNS
cord-005453-4057qib7	13546	23	,	,	,
cord-005453-4057qib7	13546	24	the	the	DT
cord-005453-4057qib7	13546	25	treatment	treatment	NN
cord-005453-4057qib7	13546	26	consisted	consist	VBD
cord-005453-4057qib7	13546	27	intravenous	intravenous	JJ
cord-005453-4057qib7	13546	28	immunoglobulins	immunoglobulin	NNS
cord-005453-4057qib7	13546	29	(	(	-LRB-
cord-005453-4057qib7	13546	30	Ivig	Ivig	NNP
cord-005453-4057qib7	13546	31	)	)	-RRB-
cord-005453-4057qib7	13546	32	.	.	.
cord-005453-4057qib7	13547	1	Two	two	CD
cord-005453-4057qib7	13547	2	of	of	IN
cord-005453-4057qib7	13547	3	the	the	DT
cord-005453-4057qib7	13547	4	3	3	CD
cord-005453-4057qib7	13547	5	patients	patient	NNS
cord-005453-4057qib7	13547	6	with	with	IN
cord-005453-4057qib7	13547	7	autoimmune	autoimmune	JJ
cord-005453-4057qib7	13547	8	hemolytic	hemolytic	JJ
cord-005453-4057qib7	13547	9	anemia	anemia	NN
cord-005453-4057qib7	13547	10	had	have	VBD
cord-005453-4057qib7	13547	11	IgG	IgG	NNP
cord-005453-4057qib7	13547	12	mediated	mediate	VBN
cord-005453-4057qib7	13547	13	antibodies	antibody	NNS
cord-005453-4057qib7	13547	14	,	,	,
cord-005453-4057qib7	13547	15	and	and	CC
cord-005453-4057qib7	13547	16	1	1	CD
cord-005453-4057qib7	13547	17	had	have	VBD
cord-005453-4057qib7	13547	18	complementmediated	complementmediate	VBN
cord-005453-4057qib7	13547	19	DAT	DAT	NNP
cord-005453-4057qib7	13547	20	.	.	.
cord-005453-4057qib7	13548	1	These	these	DT
cord-005453-4057qib7	13548	2	3	3	CD
cord-005453-4057qib7	13548	3	patients	patient	NNS
cord-005453-4057qib7	13548	4	were	be	VBD
cord-005453-4057qib7	13548	5	treated	treat	VBN
cord-005453-4057qib7	13548	6	with	with	IN
cord-005453-4057qib7	13548	7	Ivig	Ivig	NNP
cord-005453-4057qib7	13548	8	,	,	,
cord-005453-4057qib7	13548	9	steroids	steroid	NNS
cord-005453-4057qib7	13548	10	,	,	,
cord-005453-4057qib7	13548	11	Rapamune	Rapamune	NNP
cord-005453-4057qib7	13548	12	and	and	CC
cord-005453-4057qib7	13548	13	rituximab	rituximab	NN
cord-005453-4057qib7	13548	14	.	.	.
cord-005453-4057qib7	13549	1	One	one	CD
cord-005453-4057qib7	13549	2	patient	patient	NN
cord-005453-4057qib7	13549	3	has	have	VBZ
cord-005453-4057qib7	13549	4	still	still	RB
cord-005453-4057qib7	13549	5	DAT	DAT	NNP
cord-005453-4057qib7	13549	6	positive	positive	JJ
cord-005453-4057qib7	13549	7	after	after	IN
cord-005453-4057qib7	13549	8	36	36	CD
cord-005453-4057qib7	13549	9	months	month	NNS
cord-005453-4057qib7	13549	10	,	,	,
cord-005453-4057qib7	13549	11	but	but	CC
cord-005453-4057qib7	13549	12	clinical	clinical	JJ
cord-005453-4057qib7	13549	13	stable	stable	NN
cord-005453-4057qib7	13549	14	.	.	.
cord-005453-4057qib7	13550	1	The	the	DT
cord-005453-4057qib7	13550	2	other	other	JJ
cord-005453-4057qib7	13550	3	two	two	CD
cord-005453-4057qib7	13550	4	are	be	VBP
cord-005453-4057qib7	13550	5	also	also	RB
cord-005453-4057qib7	13550	6	DAT	DAT	NNP
cord-005453-4057qib7	13550	7	positive	positive	JJ
cord-005453-4057qib7	13550	8	and	and	CC
cord-005453-4057qib7	13550	9	have	have	VBP
cord-005453-4057qib7	13550	10	some	some	DT
cord-005453-4057qib7	13550	11	hemolysis	hemolysis	NN
cord-005453-4057qib7	13550	12	,	,	,
cord-005453-4057qib7	13550	13	but	but	CC
cord-005453-4057qib7	13550	14	the	the	DT
cord-005453-4057qib7	13550	15	follow	follow	NN
cord-005453-4057qib7	13550	16	up	up	RP
cord-005453-4057qib7	13550	17	is	be	VBZ
cord-005453-4057qib7	13550	18	much	much	RB
cord-005453-4057qib7	13550	19	shorter	short	JJR
cord-005453-4057qib7	13550	20	(	(	-LRB-
cord-005453-4057qib7	13550	21	2	2	CD
cord-005453-4057qib7	13550	22	months	month	NNS
cord-005453-4057qib7	13550	23	)	)	-RRB-
cord-005453-4057qib7	13550	24	.	.	.
cord-005453-4057qib7	13551	1	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	13551	2	-	-	HYPH
cord-005453-4057qib7	13551	3	contained	contain	VBN
cord-005453-4057qib7	13551	4	conditioning	conditioning	NN
cord-005453-4057qib7	13551	5	regimens	regimen	NNS
cord-005453-4057qib7	13551	6	were	be	VBD
cord-005453-4057qib7	13551	7	more	more	RBR
cord-005453-4057qib7	13551	8	frequently	frequently	RB
cord-005453-4057qib7	13551	9	used	use	VBN
cord-005453-4057qib7	13551	10	in	in	IN
cord-005453-4057qib7	13551	11	patients	patient	NNS
cord-005453-4057qib7	13551	12	with	with	IN
cord-005453-4057qib7	13551	13	significant	significant	JJ
cord-005453-4057qib7	13551	14	immune	immune	JJ
cord-005453-4057qib7	13551	15	cytopenia	cytopenia	NNS
cord-005453-4057qib7	13551	16	.	.	.
cord-005453-4057qib7	13552	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13552	2	:	:	:
cord-005453-4057qib7	13553	1	Immune	immune	JJ
cord-005453-4057qib7	13553	2	cytopenia	cytopenia	NNP
cord-005453-4057qib7	13553	3	is	be	VBZ
cord-005453-4057qib7	13553	4	an	an	DT
cord-005453-4057qib7	13553	5	infrequent	infrequent	JJ
cord-005453-4057qib7	13553	6	complication	complication	NN
cord-005453-4057qib7	13553	7	after	after	IN
cord-005453-4057qib7	13553	8	allogeneic	allogeneic	NN
cord-005453-4057qib7	13553	9	HSCT	HSCT	NNP
cord-005453-4057qib7	13553	10	.	.	.
cord-005453-4057qib7	13554	1	However	however	RB
cord-005453-4057qib7	13554	2	,	,	,
cord-005453-4057qib7	13554	3	its	-PRON-	PRP$
cord-005453-4057qib7	13554	4	treatment	treatment	NN
cord-005453-4057qib7	13554	5	can	can	MD
cord-005453-4057qib7	13554	6	be	be	VB
cord-005453-4057qib7	13554	7	challenging	challenging	JJ
cord-005453-4057qib7	13554	8	,	,	,
cord-005453-4057qib7	13554	9	and	and	CC
cord-005453-4057qib7	13554	10	the	the	DT
cord-005453-4057qib7	13554	11	hemolysis	hemolysis	NN
cord-005453-4057qib7	13554	12	can	can	MD
cord-005453-4057qib7	13554	13	persist	persist	VB
cord-005453-4057qib7	13554	14	for	for	IN
cord-005453-4057qib7	13554	15	years	year	NNS
cord-005453-4057qib7	13554	16	.	.	.
cord-005453-4057qib7	13555	1	The	the	DT
cord-005453-4057qib7	13555	2	association	association	NN
cord-005453-4057qib7	13555	3	of	of	IN
cord-005453-4057qib7	13555	4	Rapamune	Rapamune	NNP
cord-005453-4057qib7	13555	5	and	and	CC
cord-005453-4057qib7	13555	6	rituximab	rituximab	NN
cord-005453-4057qib7	13555	7	was	be	VBD
cord-005453-4057qib7	13555	8	adequate	adequate	JJ
cord-005453-4057qib7	13555	9	to	to	TO
cord-005453-4057qib7	13555	10	treat	treat	VB
cord-005453-4057qib7	13555	11	this	this	DT
cord-005453-4057qib7	13555	12	problem	problem	NN
cord-005453-4057qib7	13555	13	in	in	IN
cord-005453-4057qib7	13555	14	our	-PRON-	PRP$
cord-005453-4057qib7	13555	15	patients	patient	NNS
cord-005453-4057qib7	13555	16	.	.	.
cord-005453-4057qib7	13556	1	Background	background	NN
cord-005453-4057qib7	13556	2	:	:	:
cord-005453-4057qib7	13557	1	Approaches	approach	NNS
cord-005453-4057qib7	13557	2	to	to	IN
cord-005453-4057qib7	13557	3	the	the	DT
cord-005453-4057qib7	13557	4	management	management	NN
cord-005453-4057qib7	13557	5	of	of	IN
cord-005453-4057qib7	13557	6	refractory	refractory	JJ
cord-005453-4057qib7	13557	7	and	and	CC
cord-005453-4057qib7	13557	8	relapsed	relapse	VBD
cord-005453-4057qib7	13557	9	classical	classical	JJ
cord-005453-4057qib7	13557	10	Hodgkin´s	hodgkin´	NNS
cord-005453-4057qib7	13557	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	13557	12	(	(	-LRB-
cord-005453-4057qib7	13557	13	r	r	NN
cord-005453-4057qib7	13557	14	-	-	HYPH
cord-005453-4057qib7	13557	15	r	r	NN
cord-005453-4057qib7	13557	16	cHL	chl	NN
cord-005453-4057qib7	13557	17	)	)	-RRB-
cord-005453-4057qib7	13557	18	are	be	VBP
cord-005453-4057qib7	13557	19	changing	change	VBG
cord-005453-4057qib7	13557	20	and	and	CC
cord-005453-4057qib7	13557	21	become	become	VB
cord-005453-4057qib7	13557	22	more	more	RBR
cord-005453-4057qib7	13557	23	effective	effective	JJ
cord-005453-4057qib7	13557	24	.	.	.
cord-005453-4057qib7	13558	1	The	the	DT
cord-005453-4057qib7	13558	2	role	role	NN
cord-005453-4057qib7	13558	3	of	of	IN
cord-005453-4057qib7	13558	4	anti	anti	JJ
cord-005453-4057qib7	13558	5	-	-	JJ
cord-005453-4057qib7	13558	6	CD30	CD30	NNP
cord-005453-4057qib7	13558	7	targeted	target	VBD
cord-005453-4057qib7	13558	8	immunochemotherapy	immunochemotherapy	NN
cord-005453-4057qib7	13558	9	with	with	IN
cord-005453-4057qib7	13558	10	Brentuximab	Brentuximab	NNP
cord-005453-4057qib7	13558	11	vedotin	vedotin	NNP
cord-005453-4057qib7	13558	12	(	(	-LRB-
cord-005453-4057qib7	13558	13	BV	BV	NNP
cord-005453-4057qib7	13558	14	)	)	-RRB-
cord-005453-4057qib7	13558	15	has	have	VBZ
cord-005453-4057qib7	13558	16	been	be	VBN
cord-005453-4057qib7	13558	17	extensively	extensively	RB
cord-005453-4057qib7	13558	18	investigated	investigate	VBN
cord-005453-4057qib7	13558	19	in	in	IN
cord-005453-4057qib7	13558	20	adults	adult	NNS
cord-005453-4057qib7	13558	21	with	with	IN
cord-005453-4057qib7	13558	22	r	r	NN
cord-005453-4057qib7	13558	23	-	-	HYPH
cord-005453-4057qib7	13558	24	r	r	JJ
cord-005453-4057qib7	13558	25	cHL	chl	NN
cord-005453-4057qib7	13558	26	and	and	CC
cord-005453-4057qib7	13558	27	is	be	VBZ
cord-005453-4057qib7	13558	28	only	only	RB
cord-005453-4057qib7	13558	29	to	to	TO
cord-005453-4057qib7	13558	30	be	be	VB
cord-005453-4057qib7	13558	31	elucidated	elucidate	VBN
cord-005453-4057qib7	13558	32	in	in	IN
cord-005453-4057qib7	13558	33	children	child	NNS
cord-005453-4057qib7	13558	34	.	.	.
cord-005453-4057qib7	13559	1	The	the	DT
cord-005453-4057qib7	13559	2	study	study	NN
cord-005453-4057qib7	13559	3	included	include	VBD
cord-005453-4057qib7	13559	4	14	14	CD
cord-005453-4057qib7	13559	5	children	child	NNS
cord-005453-4057qib7	13559	6	and	and	CC
cord-005453-4057qib7	13559	7	adolescents	adolescent	NNS
cord-005453-4057qib7	13559	8	with	with	IN
cord-005453-4057qib7	13559	9	r	r	NN
cord-005453-4057qib7	13559	10	-	-	HYPH
cord-005453-4057qib7	13559	11	r	r	NN
cord-005453-4057qib7	13559	12	cHL	chl	NN
cord-005453-4057qib7	13559	13	that	that	WDT
cord-005453-4057qib7	13559	14	were	be	VBD
cord-005453-4057qib7	13559	15	sucessfully	sucessfully	RB
cord-005453-4057qib7	13559	16	treated	treat	VBN
cord-005453-4057qib7	13559	17	with	with	IN
cord-005453-4057qib7	13559	18	BV	BV	NNP
cord-005453-4057qib7	13559	19	-	-	HYPH
cord-005453-4057qib7	13559	20	based	base	VBN
cord-005453-4057qib7	13559	21	therapy	therapy	NN
cord-005453-4057qib7	13559	22	prior	prior	RB
cord-005453-4057qib7	13559	23	to	to	IN
cord-005453-4057qib7	13559	24	hematopoetic	hematopoetic	JJ
cord-005453-4057qib7	13559	25	stem	stem	NN
cord-005453-4057qib7	13559	26	cell	cell	NN
cord-005453-4057qib7	13559	27	transplantation	transplantation	NN
cord-005453-4057qib7	13559	28	(	(	-LRB-
cord-005453-4057qib7	13559	29	HSCT	HSCT	NNP
cord-005453-4057qib7	13559	30	)	)	-RRB-
cord-005453-4057qib7	13559	31	.	.	.
cord-005453-4057qib7	13560	1	Median	median	JJ
cord-005453-4057qib7	13560	2	age	age	NN
cord-005453-4057qib7	13560	3	of	of	IN
cord-005453-4057qib7	13560	4	patients	patient	NNS
cord-005453-4057qib7	13560	5	was	be	VBD
cord-005453-4057qib7	13560	6	16	16	CD
cord-005453-4057qib7	13560	7	years	year	NNS
cord-005453-4057qib7	13560	8	(	(	-LRB-
cord-005453-4057qib7	13560	9	9	9	CD
cord-005453-4057qib7	13560	10	-	-	SYM
cord-005453-4057qib7	13560	11	19	19	CD
cord-005453-4057qib7	13560	12	)	)	-RRB-
cord-005453-4057qib7	13560	13	,	,	.
cord-005453-4057qib7	13561	1	main	main	JJ
cord-005453-4057qib7	13561	2	histological	histological	JJ
cord-005453-4057qib7	13561	3	variant	variant	NN
cord-005453-4057qib7	13561	4	-nodular	-nodular	CD
cord-005453-4057qib7	13561	5	sclerosis	sclerosis	NN
cord-005453-4057qib7	13561	6	(	(	-LRB-
cord-005453-4057qib7	13561	7	93	93	CD
cord-005453-4057qib7	13561	8	%	%	NN
cord-005453-4057qib7	13561	9	,	,	,
cord-005453-4057qib7	13561	10	n=13	n=13	NNP
cord-005453-4057qib7	13561	11	)	)	-RRB-
cord-005453-4057qib7	13561	12	,	,	,
cord-005453-4057qib7	13561	13	advanced	advanced	JJ
cord-005453-4057qib7	13561	14	stage	stage	NN
cord-005453-4057qib7	13561	15	at	at	IN
cord-005453-4057qib7	13561	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	13561	17	-86	-86	NNP
cord-005453-4057qib7	13561	18	%	%	NN
cord-005453-4057qib7	13561	19	(	(	-LRB-
cord-005453-4057qib7	13561	20	n=12	n=12	NNP
cord-005453-4057qib7	13561	21	)	)	-RRB-
cord-005453-4057qib7	13561	22	.	.	.
cord-005453-4057qib7	13562	1	Most	Most	JJS
cord-005453-4057qib7	13562	2	were	be	VBD
cord-005453-4057qib7	13562	3	heavily	heavily	RB
cord-005453-4057qib7	13562	4	pre	pre	VBN
cord-005453-4057qib7	13562	5	-	-	VBN
cord-005453-4057qib7	13562	6	treated	treated	JJ
cord-005453-4057qib7	13562	7	(	(	-LRB-
cord-005453-4057qib7	13562	8	median	median	JJ
cord-005453-4057qib7	13562	9	number	number	NN
cord-005453-4057qib7	13562	10	of	of	IN
cord-005453-4057qib7	13562	11	previous	previous	JJ
cord-005453-4057qib7	13562	12	therapies	therapy	NNS
cord-005453-4057qib7	13562	13	-4	-4	NFP
cord-005453-4057qib7	13562	14	)	)	-RRB-
cord-005453-4057qib7	13562	15	and	and	CC
cord-005453-4057qib7	13562	16	progression	progression	NN
cord-005453-4057qib7	13562	17	after	after	IN
cord-005453-4057qib7	13562	18	autologous	autologous	JJ
cord-005453-4057qib7	13562	19	HSCT	HSCT	NNP
cord-005453-4057qib7	13562	20	was	be	VBD
cord-005453-4057qib7	13562	21	documented	document	VBN
cord-005453-4057qib7	13562	22	in	in	IN
cord-005453-4057qib7	13562	23	4	4	CD
cord-005453-4057qib7	13562	24	(	(	-LRB-
cord-005453-4057qib7	13562	25	29	29	CD
cord-005453-4057qib7	13562	26	%	%	NN
cord-005453-4057qib7	13562	27	)	)	-RRB-
cord-005453-4057qib7	13562	28	.	.	.
cord-005453-4057qib7	13563	1	Refractory	refractory	JJ
cord-005453-4057qib7	13563	2	disease	disease	NN
cord-005453-4057qib7	13563	3	was	be	VBD
cord-005453-4057qib7	13563	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	13563	5	in	in	IN
cord-005453-4057qib7	13563	6	8	8	CD
cord-005453-4057qib7	13563	7	(	(	-LRB-
cord-005453-4057qib7	13563	8	57	57	CD
cord-005453-4057qib7	13563	9	%	%	NN
cord-005453-4057qib7	13563	10	)	)	-RRB-
cord-005453-4057qib7	13563	11	and	and	CC
cord-005453-4057qib7	13563	12	relapsed	relapse	VBD
cord-005453-4057qib7	13563	13	in	in	IN
cord-005453-4057qib7	13563	14	6	6	CD
cord-005453-4057qib7	13563	15	(	(	-LRB-
cord-005453-4057qib7	13563	16	43	43	CD
cord-005453-4057qib7	13563	17	%	%	NN
cord-005453-4057qib7	13563	18	)	)	-RRB-
cord-005453-4057qib7	13563	19	.	.	.
cord-005453-4057qib7	13564	1	Among	among	IN
cord-005453-4057qib7	13564	2	relapsed	relapse	VBN
cord-005453-4057qib7	13564	3	patients	patient	NNS
cord-005453-4057qib7	13564	4	4	4	CD
cord-005453-4057qib7	13564	5	(	(	-LRB-
cord-005453-4057qib7	13564	6	67	67	CD
cord-005453-4057qib7	13564	7	%	%	NN
cord-005453-4057qib7	13564	8	)	)	-RRB-
cord-005453-4057qib7	13564	9	were	be	VBD
cord-005453-4057qib7	13564	10	with	with	IN
cord-005453-4057qib7	13564	11	multiple	multiple	JJ
cord-005453-4057qib7	13564	12	episodes	episode	NNS
cord-005453-4057qib7	13564	13	,	,	,
cord-005453-4057qib7	13564	14	1	1	CD
cord-005453-4057qib7	13564	15	(	(	-LRB-
cord-005453-4057qib7	13564	16	16.5	16.5	CD
cord-005453-4057qib7	13564	17	%	%	NN
cord-005453-4057qib7	13564	18	)	)	-RRB-
cord-005453-4057qib7	13565	1	-early	-early	.
cord-005453-4057qib7	13566	1	and	and	CC
cord-005453-4057qib7	13566	2	1	1	CD
cord-005453-4057qib7	13566	3	(	(	-LRB-
cord-005453-4057qib7	13566	4	16.5	16.5	CD
cord-005453-4057qib7	13566	5	%	%	NN
cord-005453-4057qib7	13566	6	)	)	-RRB-
cord-005453-4057qib7	13566	7	-late	-late	NN
cord-005453-4057qib7	13566	8	relapse	relapse	NN
cord-005453-4057qib7	13566	9	.	.	.
cord-005453-4057qib7	13567	1	Treatment	treatment	NN
cord-005453-4057qib7	13567	2	regimens	regimen	NNS
cord-005453-4057qib7	13567	3	consisted	consist	VBN
cord-005453-4057qib7	13567	4	of	of	IN
cord-005453-4057qib7	13567	5	BV	BV	NNP
cord-005453-4057qib7	13567	6	in	in	IN
cord-005453-4057qib7	13567	7	monotherapy	monotherapy	NN
cord-005453-4057qib7	13567	8	1.8	1.8	CD
cord-005453-4057qib7	13567	9	mg	mg	NNP
cord-005453-4057qib7	13567	10	/	/	SYM
cord-005453-4057qib7	13567	11	kg	kg	NNP
cord-005453-4057qib7	13567	12	triweekly	triweekly	NNP
cord-005453-4057qib7	13567	13	(	(	-LRB-
cord-005453-4057qib7	13567	14	n=7	n=7	NNP
cord-005453-4057qib7	13567	15	)	)	-RRB-
cord-005453-4057qib7	13567	16	or	or	CC
cord-005453-4057qib7	13567	17	combination	combination	NN
cord-005453-4057qib7	13567	18	of	of	IN
cord-005453-4057qib7	13567	19	BV	BV	NNP
cord-005453-4057qib7	13567	20	1.8	1.8	CD
cord-005453-4057qib7	13567	21	mg	mg	NNP
cord-005453-4057qib7	13567	22	/	/	SYM
cord-005453-4057qib7	13567	23	kg	kg	NNP
cord-005453-4057qib7	13567	24	on	on	IN
cord-005453-4057qib7	13567	25	Day	day	NN
cord-005453-4057qib7	13567	26	1	1	CD
cord-005453-4057qib7	13567	27	with	with	IN
cord-005453-4057qib7	13567	28	Bendamustine	Bendamustine	NNP
cord-005453-4057qib7	13567	29	90	90	CD
cord-005453-4057qib7	13567	30	-	-	SYM
cord-005453-4057qib7	13567	31	120	120	CD
cord-005453-4057qib7	13567	32	mg/	mg/	NN
cord-005453-4057qib7	13567	33	m2	m2	NNP
cord-005453-4057qib7	13567	34	on	on	IN
cord-005453-4057qib7	13567	35	Days	day	NNS
cord-005453-4057qib7	13567	36	1	1	CD
cord-005453-4057qib7	13567	37	and	and	CC
cord-005453-4057qib7	13567	38	2	2	CD
cord-005453-4057qib7	13567	39	of	of	IN
cord-005453-4057qib7	13567	40	3-week	3-week	CD
cord-005453-4057qib7	13567	41	cycles	cycle	NNS
cord-005453-4057qib7	13567	42	(	(	-LRB-
cord-005453-4057qib7	13567	43	n=5	n=5	NNP
cord-005453-4057qib7	13567	44	)	)	-RRB-
cord-005453-4057qib7	13567	45	or	or	CC
cord-005453-4057qib7	13567	46	combination	combination	NN
cord-005453-4057qib7	13567	47	of	of	IN
cord-005453-4057qib7	13567	48	BV	BV	NNP
cord-005453-4057qib7	13567	49	1.8	1.8	CD
cord-005453-4057qib7	13567	50	mg	mg	NNP
cord-005453-4057qib7	13567	51	/	/	SYM
cord-005453-4057qib7	13567	52	kg	kg	NNP
cord-005453-4057qib7	13567	53	on	on	IN
cord-005453-4057qib7	13567	54	Day	Day	NNP
cord-005453-4057qib7	13567	55	1	1	CD
cord-005453-4057qib7	13567	56	with	with	IN
cord-005453-4057qib7	13567	57	DHAP	DHAP	NNP
cord-005453-4057qib7	13567	58	(	(	-LRB-
cord-005453-4057qib7	13567	59	n=2	n=2	NNS
cord-005453-4057qib7	13567	60	)	)	-RRB-
cord-005453-4057qib7	13567	61	.	.	.
cord-005453-4057qib7	13568	1	Median	median	JJ
cord-005453-4057qib7	13568	2	number	number	NN
cord-005453-4057qib7	13568	3	of	of	IN
cord-005453-4057qib7	13568	4	BV	BV	NNP
cord-005453-4057qib7	13568	5	infusions	infusion	NNS
cord-005453-4057qib7	13568	6	was	be	VBD
cord-005453-4057qib7	13568	7	3.5	3.5	CD
cord-005453-4057qib7	13568	8	(	(	-LRB-
cord-005453-4057qib7	13568	9	2	2	CD
cord-005453-4057qib7	13568	10	-	-	SYM
cord-005453-4057qib7	13568	11	7	7	CD
cord-005453-4057qib7	13568	12	)	)	-RRB-
cord-005453-4057qib7	13568	13	.	.	.
cord-005453-4057qib7	13569	1	All	all	DT
cord-005453-4057qib7	13569	2	selected	select	VBN
cord-005453-4057qib7	13569	3	patients	patient	NNS
cord-005453-4057qib7	13569	4	achieved	achieve	VBD
cord-005453-4057qib7	13569	5	complete	complete	JJ
cord-005453-4057qib7	13569	6	(	(	-LRB-
cord-005453-4057qib7	13569	7	n=5	n=5	JJ
cord-005453-4057qib7	13569	8	,	,	,
cord-005453-4057qib7	13569	9	36	36	CD
cord-005453-4057qib7	13569	10	%	%	NN
cord-005453-4057qib7	13569	11	)	)	-RRB-
cord-005453-4057qib7	13569	12	or	or	CC
cord-005453-4057qib7	13569	13	partial	partial	JJ
cord-005453-4057qib7	13569	14	remission	remission	NN
cord-005453-4057qib7	13569	15	(	(	-LRB-
cord-005453-4057qib7	13569	16	n=9	n=9	NN
cord-005453-4057qib7	13569	17	,	,	,
cord-005453-4057qib7	13569	18	64	64	CD
cord-005453-4057qib7	13569	19	%	%	NN
cord-005453-4057qib7	13569	20	)	)	-RRB-
cord-005453-4057qib7	13569	21	prior	prior	RB
cord-005453-4057qib7	13569	22	to	to	IN
cord-005453-4057qib7	13569	23	HSCT	HSCT	NNP
cord-005453-4057qib7	13569	24	.	.	.
cord-005453-4057qib7	13570	1	Consolidation	consolidation	NN
cord-005453-4057qib7	13570	2	with	with	IN
cord-005453-4057qib7	13570	3	autologous	autologous	JJ
cord-005453-4057qib7	13570	4	HSCT	HSCT	NNP
cord-005453-4057qib7	13570	5	was	be	VBD
cord-005453-4057qib7	13570	6	performed	perform	VBN
cord-005453-4057qib7	13570	7	in	in	IN
cord-005453-4057qib7	13570	8	9	9	CD
cord-005453-4057qib7	13570	9	(	(	-LRB-
cord-005453-4057qib7	13570	10	64	64	CD
cord-005453-4057qib7	13570	11	%	%	NN
cord-005453-4057qib7	13570	12	)	)	-RRB-
cord-005453-4057qib7	13570	13	and	and	CC
cord-005453-4057qib7	13570	14	with	with	IN
cord-005453-4057qib7	13570	15	allogeneic	allogeneic	JJ
cord-005453-4057qib7	13570	16	HSCT	HSCT	NNP
cord-005453-4057qib7	13570	17	-in	-in	.
cord-005453-4057qib7	13571	1	5	5	LS
cord-005453-4057qib7	13571	2	(	(	-LRB-
cord-005453-4057qib7	13571	3	36	36	CD
cord-005453-4057qib7	13571	4	%	%	NN
cord-005453-4057qib7	13571	5	)	)	-RRB-
cord-005453-4057qib7	13571	6	.	.	.
cord-005453-4057qib7	13572	1	Primary	primary	JJ
cord-005453-4057qib7	13572	2	end	end	NN
cord-005453-4057qib7	13572	3	points	point	NNS
cord-005453-4057qib7	13572	4	were	be	VBD
cord-005453-4057qib7	13572	5	overall	overall	JJ
cord-005453-4057qib7	13572	6	(	(	-LRB-
cord-005453-4057qib7	13572	7	OS	OS	NNP
cord-005453-4057qib7	13572	8	)	)	-RRB-
cord-005453-4057qib7	13572	9	and	and	CC
cord-005453-4057qib7	13572	10	progression	progression	NN
cord-005453-4057qib7	13572	11	free	free	JJ
cord-005453-4057qib7	13572	12	survival	survival	NN
cord-005453-4057qib7	13572	13	(	(	-LRB-
cord-005453-4057qib7	13572	14	PFS	PFS	NNP
cord-005453-4057qib7	13572	15	)	)	-RRB-
cord-005453-4057qib7	13572	16	.	.	.
cord-005453-4057qib7	13573	1	Response	response	NN
cord-005453-4057qib7	13573	2	to	to	IN
cord-005453-4057qib7	13573	3	BV	BV	NNP
cord-005453-4057qib7	13573	4	was	be	VBD
cord-005453-4057qib7	13573	5	not	not	RB
cord-005453-4057qib7	13573	6	assessed	assess	VBN
cord-005453-4057qib7	13573	7	in	in	IN
cord-005453-4057qib7	13573	8	the	the	DT
cord-005453-4057qib7	13573	9	study	study	NN
cord-005453-4057qib7	13573	10	as	as	IN
cord-005453-4057qib7	13573	11	only	only	JJ
cord-005453-4057qib7	13573	12	responders	responder	NNS
cord-005453-4057qib7	13573	13	to	to	IN
cord-005453-4057qib7	13573	14	the	the	DT
cord-005453-4057qib7	13573	15	BV	BV	NNP
cord-005453-4057qib7	13573	16	-	-	HYPH
cord-005453-4057qib7	13573	17	based	base	VBN
cord-005453-4057qib7	13573	18	treatment	treatment	NN
cord-005453-4057qib7	13573	19	were	be	VBD
cord-005453-4057qib7	13573	20	included	include	VBN
cord-005453-4057qib7	13573	21	.	.	.
cord-005453-4057qib7	13574	1	Results	result	NNS
cord-005453-4057qib7	13574	2	:	:	:
cord-005453-4057qib7	13575	1	With	with	IN
cord-005453-4057qib7	13575	2	median	median	JJ
cord-005453-4057qib7	13575	3	follow	follow	NN
cord-005453-4057qib7	13575	4	-	-	HYPH
cord-005453-4057qib7	13575	5	up	up	NN
cord-005453-4057qib7	13575	6	of	of	IN
cord-005453-4057qib7	13575	7	497	497	CD
cord-005453-4057qib7	13575	8	days	day	NNS
cord-005453-4057qib7	13575	9	(	(	-LRB-
cord-005453-4057qib7	13575	10	105	105	CD
cord-005453-4057qib7	13575	11	-	-	SYM
cord-005453-4057qib7	13575	12	1368	1368	CD
cord-005453-4057qib7	13575	13	)	)	-RRB-
cord-005453-4057qib7	13575	14	OS	OS	NNP
cord-005453-4057qib7	13575	15	and	and	CC
cord-005453-4057qib7	13575	16	PFS	PFS	NNP
cord-005453-4057qib7	13575	17	for	for	IN
cord-005453-4057qib7	13575	18	all	all	DT
cord-005453-4057qib7	13575	19	patients	patient	NNS
cord-005453-4057qib7	13575	20	are	be	VBP
cord-005453-4057qib7	13575	21	68	68	CD
cord-005453-4057qib7	13575	22	%	%	NN
cord-005453-4057qib7	13575	23	and	and	CC
cord-005453-4057qib7	13575	24	66	66	CD
cord-005453-4057qib7	13575	25	%	%	NN
cord-005453-4057qib7	13575	26	,	,	,
cord-005453-4057qib7	13575	27	respectively	respectively	RB
cord-005453-4057qib7	13575	28	.	.	.
cord-005453-4057qib7	13576	1	PFS	PFS	NNP
cord-005453-4057qib7	13576	2	after	after	IN
cord-005453-4057qib7	13576	3	autologous	autologous	JJ
cord-005453-4057qib7	13576	4	HSCT	HSCT	NNP
cord-005453-4057qib7	13576	5	and	and	CC
cord-005453-4057qib7	13576	6	allogeneic	allogeneic	IN
cord-005453-4057qib7	13576	7	HSCT	HSCT	NNP
cord-005453-4057qib7	13576	8	are	be	VBP
cord-005453-4057qib7	13576	9	70	70	CD
cord-005453-4057qib7	13576	10	%	%	NN
cord-005453-4057qib7	13576	11	and	and	CC
cord-005453-4057qib7	13576	12	60	60	CD
cord-005453-4057qib7	13576	13	%	%	NN
cord-005453-4057qib7	13576	14	,	,	,
cord-005453-4057qib7	13576	15	respectively	respectively	RB
cord-005453-4057qib7	13576	16	(	(	-LRB-
cord-005453-4057qib7	13576	17	p=0.7	p=0.7	NNP
cord-005453-4057qib7	13576	18	)	)	-RRB-
cord-005453-4057qib7	13577	1	At	at	IN
cord-005453-4057qib7	13577	2	present	present	JJ
cord-005453-4057qib7	13577	3	moment	moment	NN
cord-005453-4057qib7	13577	4	10	10	CD
cord-005453-4057qib7	13577	5	(	(	-LRB-
cord-005453-4057qib7	13577	6	71	71	CD
cord-005453-4057qib7	13577	7	%	%	NN
cord-005453-4057qib7	13577	8	)	)	-RRB-
cord-005453-4057qib7	13577	9	patients	patient	NNS
cord-005453-4057qib7	13577	10	are	be	VBP
cord-005453-4057qib7	13577	11	alive	alive	JJ
cord-005453-4057qib7	13577	12	and	and	CC
cord-005453-4057qib7	13577	13	are	be	VBP
cord-005453-4057qib7	13577	14	in	in	IN
cord-005453-4057qib7	13577	15	remission	remission	NN
cord-005453-4057qib7	13577	16	.	.	.
cord-005453-4057qib7	13578	1	Three	three	CD
cord-005453-4057qib7	13578	2	patients	patient	NNS
cord-005453-4057qib7	13578	3	died	die	VBD
cord-005453-4057qib7	13578	4	(	(	-LRB-
cord-005453-4057qib7	13578	5	21	21	CD
cord-005453-4057qib7	13578	6	%	%	NN
cord-005453-4057qib7	13578	7	)	)	-RRB-
cord-005453-4057qib7	13578	8	:	:	:
cord-005453-4057qib7	13578	9	disease	disease	NN
cord-005453-4057qib7	13578	10	progression	progression	NN
cord-005453-4057qib7	13578	11	(	(	-LRB-
cord-005453-4057qib7	13578	12	n=1	n=1	NNP
cord-005453-4057qib7	13578	13	)	)	-RRB-
cord-005453-4057qib7	13578	14	,	,	,
cord-005453-4057qib7	13578	15	postransplant	postransplant	JJ
cord-005453-4057qib7	13578	16	idiopathic	idiopathic	JJ
cord-005453-4057qib7	13578	17	pneumonia	pneumonia	NN
cord-005453-4057qib7	13578	18	syndrome	syndrome	NN
cord-005453-4057qib7	13578	19	(	(	-LRB-
cord-005453-4057qib7	13578	20	n=1	n=1	NNP
cord-005453-4057qib7	13578	21	)	)	-RRB-
cord-005453-4057qib7	13578	22	and	and	CC
cord-005453-4057qib7	13578	23	posttransplant	posttransplant	NNP
cord-005453-4057qib7	13578	24	pneumonia	pneumonia	NN
cord-005453-4057qib7	13578	25	(	(	-LRB-
cord-005453-4057qib7	13578	26	n=1	n=1	FW
cord-005453-4057qib7	13578	27	)	)	-RRB-
cord-005453-4057qib7	13578	28	.	.	.
cord-005453-4057qib7	13579	1	BV	BV	NNP
cord-005453-4057qib7	13579	2	was	be	VBD
cord-005453-4057qib7	13579	3	generally	generally	RB
cord-005453-4057qib7	13579	4	well	well	RB
cord-005453-4057qib7	13579	5	tolerated	tolerate	VBN
cord-005453-4057qib7	13579	6	with	with	IN
cord-005453-4057qib7	13579	7	only	only	JJ
cord-005453-4057qib7	13579	8	mild	mild	JJ
cord-005453-4057qib7	13579	9	polyneuropathy	polyneuropathy	NNS
cord-005453-4057qib7	13579	10	in	in	IN
cord-005453-4057qib7	13579	11	3	3	CD
cord-005453-4057qib7	13579	12	patients	patient	NNS
cord-005453-4057qib7	13579	13	(	(	-LRB-
cord-005453-4057qib7	13579	14	21	21	CD
cord-005453-4057qib7	13579	15	%	%	NN
cord-005453-4057qib7	13579	16	)	)	-RRB-
cord-005453-4057qib7	13579	17	as	as	IN
cord-005453-4057qib7	13579	18	the	the	DT
cord-005453-4057qib7	13579	19	main	main	JJ
cord-005453-4057qib7	13579	20	reversable	reversable	NN
cord-005453-4057qib7	13579	21	documented	document	VBD
cord-005453-4057qib7	13579	22	adverse	adverse	JJ
cord-005453-4057qib7	13579	23	event	event	NN
cord-005453-4057qib7	13579	24	.	.	.
cord-005453-4057qib7	13580	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13580	2	:	:	:
cord-005453-4057qib7	13581	1	In	in	IN
cord-005453-4057qib7	13581	2	prognostically	prognostically	RB
cord-005453-4057qib7	13581	3	unfavourable	unfavourable	JJ
cord-005453-4057qib7	13581	4	heavily	heavily	RB
cord-005453-4057qib7	13581	5	pretreated	pretreate	VBN
cord-005453-4057qib7	13581	6	children	child	NNS
cord-005453-4057qib7	13581	7	and	and	CC
cord-005453-4057qib7	13581	8	adolescents	adolescent	NNS
cord-005453-4057qib7	13581	9	with	with	IN
cord-005453-4057qib7	13581	10	r	r	NN
cord-005453-4057qib7	13581	11	-	-	HYPH
cord-005453-4057qib7	13581	12	r	r	JJ
cord-005453-4057qib7	13581	13	cHL	chl	NN
cord-005453-4057qib7	13581	14	achievement	achievement	NN
cord-005453-4057qib7	13581	15	of	of	IN
cord-005453-4057qib7	13581	16	response	response	NN
cord-005453-4057qib7	13581	17	to	to	IN
cord-005453-4057qib7	13581	18	BV	BV	NNP
cord-005453-4057qib7	13581	19	-	-	HYPH
cord-005453-4057qib7	13581	20	based	base	VBN
cord-005453-4057qib7	13581	21	therapy	therapy	NN
cord-005453-4057qib7	13581	22	prior	prior	RB
cord-005453-4057qib7	13581	23	to	to	IN
cord-005453-4057qib7	13581	24	HSCT	HSCT	NNP
cord-005453-4057qib7	13581	25	is	be	VBZ
cord-005453-4057qib7	13581	26	assosiated	assosiate	VBN
cord-005453-4057qib7	13581	27	with	with	IN
cord-005453-4057qib7	13581	28	promising	promising	JJ
cord-005453-4057qib7	13581	29	rates	rate	NNS
cord-005453-4057qib7	13581	30	of	of	IN
cord-005453-4057qib7	13581	31	OS	OS	NNP
cord-005453-4057qib7	13581	32	and	and	CC
cord-005453-4057qib7	13581	33	PFS	PFS	NNP
cord-005453-4057qib7	13581	34	.	.	.
cord-005453-4057qib7	13582	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13582	2	provides	provide	VBZ
cord-005453-4057qib7	13582	3	a	a	DT
cord-005453-4057qib7	13582	4	treatment	treatment	NN
cord-005453-4057qib7	13582	5	by	by	IN
cord-005453-4057qib7	13582	6	restoring	restore	VBG
cord-005453-4057qib7	13582	7	thymidine	thymidine	FW
cord-005453-4057qib7	13582	8	phosphorylase	phosphorylase	NN
cord-005453-4057qib7	13582	9	function	function	NN
cord-005453-4057qib7	13582	10	and	and	CC
cord-005453-4057qib7	13582	11	improving	improve	VBG
cord-005453-4057qib7	13582	12	disease	disease	NN
cord-005453-4057qib7	13582	13	manifestations	manifestation	NNS
cord-005453-4057qib7	13582	14	.	.	.
cord-005453-4057qib7	13583	1	Here	here	RB
cord-005453-4057qib7	13583	2	we	-PRON-	PRP
cord-005453-4057qib7	13583	3	report	report	VBP
cord-005453-4057qib7	13583	4	the	the	DT
cord-005453-4057qib7	13583	5	outcomes	outcome	NNS
cord-005453-4057qib7	13583	6	of	of	IN
cord-005453-4057qib7	13583	7	4	4	CD
cord-005453-4057qib7	13583	8	affected	affected	JJ
cord-005453-4057qib7	13583	9	siblings	sibling	NNS
cord-005453-4057qib7	13583	10	who	who	WP
cord-005453-4057qib7	13583	11	underwent	undergo	VBD
cord-005453-4057qib7	13583	12	transplantation	transplantation	NN
cord-005453-4057qib7	13583	13	using	use	VBG
cord-005453-4057qib7	13583	14	an	an	DT
cord-005453-4057qib7	13583	15	unaffected	unaffected	JJ
cord-005453-4057qib7	13583	16	sibling	sibling	NN
cord-005453-4057qib7	13583	17	donor	donor	NN
cord-005453-4057qib7	13583	18	to	to	TO
cord-005453-4057qib7	13583	19	highlight	highlight	VB
cord-005453-4057qib7	13583	20	important	important	JJ
cord-005453-4057qib7	13583	21	experiences	experience	NNS
cord-005453-4057qib7	13583	22	in	in	IN
cord-005453-4057qib7	13583	23	the	the	DT
cord-005453-4057qib7	13583	24	transplant	transplant	NN
cord-005453-4057qib7	13583	25	of	of	IN
cord-005453-4057qib7	13583	26	such	such	PDT
cord-005453-4057qib7	13583	27	a	a	DT
cord-005453-4057qib7	13583	28	rare	rare	JJ
cord-005453-4057qib7	13583	29	condition	condition	NN
cord-005453-4057qib7	13583	30	.	.	.
cord-005453-4057qib7	13584	1	Methods	method	NNS
cord-005453-4057qib7	13584	2	:	:	:
cord-005453-4057qib7	13585	1	Four	four	CD
cord-005453-4057qib7	13585	2	siblings	sibling	NNS
cord-005453-4057qib7	13585	3	of	of	IN
cord-005453-4057qib7	13585	4	consanguineous	consanguineous	JJ
cord-005453-4057qib7	13585	5	Pakistani	pakistani	JJ
cord-005453-4057qib7	13585	6	descent	descent	NN
cord-005453-4057qib7	13585	7	aged	age	VBN
cord-005453-4057qib7	13585	8	16	16	CD
cord-005453-4057qib7	13585	9	,	,	,
cord-005453-4057qib7	13585	10	15	15	CD
cord-005453-4057qib7	13585	11	,	,	,
cord-005453-4057qib7	13585	12	13	13	CD
cord-005453-4057qib7	13585	13	and	and	CC
cord-005453-4057qib7	13585	14	5	5	CD
cord-005453-4057qib7	13585	15	years	year	NNS
cord-005453-4057qib7	13585	16	underwent	undergo	VBD
cord-005453-4057qib7	13585	17	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13585	18	HSCT	HSCT	NNP
cord-005453-4057qib7	13585	19	using	use	VBG
cord-005453-4057qib7	13585	20	fully	fully	RB
cord-005453-4057qib7	13585	21	HLA	HLA	NNP
cord-005453-4057qib7	13585	22	-	-	HYPH
cord-005453-4057qib7	13585	23	matched	match	VBN
cord-005453-4057qib7	13585	24	(	(	-LRB-
cord-005453-4057qib7	13585	25	10/10	10/10	CD
cord-005453-4057qib7	13585	26	)	)	-RRB-
cord-005453-4057qib7	13585	27	peripheral	peripheral	JJ
cord-005453-4057qib7	13585	28	blood	blood	NN
cord-005453-4057qib7	13585	29	stem	stem	NN
cord-005453-4057qib7	13585	30	cells	cell	NNS
cord-005453-4057qib7	13585	31	harvested	harvest	VBN
cord-005453-4057qib7	13585	32	in	in	IN
cord-005453-4057qib7	13585	33	a	a	DT
cord-005453-4057qib7	13585	34	single	single	JJ
cord-005453-4057qib7	13585	35	apheresis	apheresis	NN
cord-005453-4057qib7	13585	36	from	from	IN
cord-005453-4057qib7	13585	37	an	an	DT
cord-005453-4057qib7	13585	38	unaffected	unaffected	JJ
cord-005453-4057qib7	13585	39	9	9	CD
cord-005453-4057qib7	13585	40	year	year	NN
cord-005453-4057qib7	13585	41	old	old	JJ
cord-005453-4057qib7	13585	42	sibling	sibling	NN
cord-005453-4057qib7	13585	43	.	.	.
cord-005453-4057qib7	13586	1	The	the	DT
cord-005453-4057qib7	13586	2	oldest	old	JJS
cord-005453-4057qib7	13586	3	sibling	sibling	NN
cord-005453-4057qib7	13586	4	,	,	,
cord-005453-4057qib7	13586	5	a	a	DT
cord-005453-4057qib7	13586	6	16	16	CD
cord-005453-4057qib7	13586	7	year	year	NN
cord-005453-4057qib7	13586	8	old	old	JJ
cord-005453-4057qib7	13586	9	male	male	NN
cord-005453-4057qib7	13586	10	,	,	,
cord-005453-4057qib7	13586	11	first	first	RB
cord-005453-4057qib7	13586	12	presented	present	VBN
cord-005453-4057qib7	13586	13	in	in	IN
cord-005453-4057qib7	13586	14	2016	2016	CD
cord-005453-4057qib7	13586	15	having	have	VBG
cord-005453-4057qib7	13586	16	emigrated	emigrate	VBN
cord-005453-4057qib7	13586	17	from	from	IN
cord-005453-4057qib7	13586	18	Pakistan	Pakistan	NNP
cord-005453-4057qib7	13586	19	with	with	IN
cord-005453-4057qib7	13586	20	a	a	DT
cord-005453-4057qib7	13586	21	history	history	NN
cord-005453-4057qib7	13586	22	of	of	IN
cord-005453-4057qib7	13586	23	growth	growth	NN
cord-005453-4057qib7	13586	24	failure	failure	NN
cord-005453-4057qib7	13586	25	and	and	CC
cord-005453-4057qib7	13586	26	abnormal	abnormal	JJ
cord-005453-4057qib7	13586	27	movements	movement	NNS
cord-005453-4057qib7	13586	28	.	.	.
cord-005453-4057qib7	13587	1	Biochemical	biochemical	JJ
cord-005453-4057qib7	13587	2	,	,	,
cord-005453-4057qib7	13587	3	nerve	nerve	NN
cord-005453-4057qib7	13587	4	conduction	conduction	NN
cord-005453-4057qib7	13587	5	and	and	CC
cord-005453-4057qib7	13587	6	imaging	imaging	NN
cord-005453-4057qib7	13587	7	studies	study	NNS
cord-005453-4057qib7	13587	8	confirmed	confirm	VBD
cord-005453-4057qib7	13587	9	a	a	DT
cord-005453-4057qib7	13587	10	diagnosis	diagnosis	NN
cord-005453-4057qib7	13587	11	of	of	IN
cord-005453-4057qib7	13587	12	MNGIE	MNGIE	NNP
cord-005453-4057qib7	13587	13	.	.	.
cord-005453-4057qib7	13588	1	Testing	test	VBG
cord-005453-4057qib7	13588	2	on	on	IN
cord-005453-4057qib7	13588	3	three	three	CD
cord-005453-4057qib7	13588	4	other	other	JJ
cord-005453-4057qib7	13588	5	siblings	sibling	NNS
cord-005453-4057qib7	13588	6	identified	identify	VBD
cord-005453-4057qib7	13588	7	similar	similar	JJ
cord-005453-4057qib7	13588	8	biochemical	biochemical	JJ
cord-005453-4057qib7	13588	9	abnormalities	abnormality	NNS
cord-005453-4057qib7	13588	10	,	,	,
cord-005453-4057qib7	13588	11	though	though	IN
cord-005453-4057qib7	13588	12	the	the	DT
cord-005453-4057qib7	13588	13	2	2	CD
cord-005453-4057qib7	13588	14	youngest	young	JJS
cord-005453-4057qib7	13588	15	children	child	NNS
cord-005453-4057qib7	13588	16	had	have	VBD
cord-005453-4057qib7	13588	17	minimal	minimal	JJ
cord-005453-4057qib7	13588	18	clinical	clinical	JJ
cord-005453-4057qib7	13588	19	manifestations	manifestation	NNS
cord-005453-4057qib7	13588	20	of	of	IN
cord-005453-4057qib7	13588	21	the	the	DT
cord-005453-4057qib7	13588	22	disease	disease	NN
cord-005453-4057qib7	13588	23	.	.	.
cord-005453-4057qib7	13589	1	Based	base	VBN
cord-005453-4057qib7	13589	2	on	on	IN
cord-005453-4057qib7	13589	3	the	the	DT
cord-005453-4057qib7	13589	4	progressive	progressive	JJ
cord-005453-4057qib7	13589	5	nature	nature	NN
cord-005453-4057qib7	13589	6	of	of	IN
cord-005453-4057qib7	13589	7	the	the	DT
cord-005453-4057qib7	13589	8	disease	disease	NN
cord-005453-4057qib7	13589	9	and	and	CC
cord-005453-4057qib7	13589	10	the	the	DT
cord-005453-4057qib7	13589	11	availability	availability	NN
cord-005453-4057qib7	13589	12	of	of	IN
cord-005453-4057qib7	13589	13	a	a	DT
cord-005453-4057qib7	13589	14	fully	fully	RB
cord-005453-4057qib7	13589	15	matched	match	VBN
cord-005453-4057qib7	13589	16	donor	donor	NN
cord-005453-4057qib7	13589	17	,	,	,
cord-005453-4057qib7	13589	18	a	a	DT
cord-005453-4057qib7	13589	19	decision	decision	NN
cord-005453-4057qib7	13589	20	was	be	VBD
cord-005453-4057qib7	13589	21	made	make	VBN
cord-005453-4057qib7	13589	22	to	to	TO
cord-005453-4057qib7	13589	23	pursue	pursue	VB
cord-005453-4057qib7	13589	24	transplant	transplant	NN
cord-005453-4057qib7	13589	25	for	for	IN
cord-005453-4057qib7	13589	26	all	all	DT
cord-005453-4057qib7	13589	27	affected	affect	VBN
cord-005453-4057qib7	13589	28	siblings	sibling	NNS
cord-005453-4057qib7	13589	29	.	.	.
cord-005453-4057qib7	13590	1	Results	result	NNS
cord-005453-4057qib7	13590	2	:	:	:
cord-005453-4057qib7	13591	1	Due	due	IN
cord-005453-4057qib7	13591	2	to	to	IN
cord-005453-4057qib7	13591	3	the	the	DT
cord-005453-4057qib7	13591	4	severity	severity	NN
cord-005453-4057qib7	13591	5	of	of	IN
cord-005453-4057qib7	13591	6	their	-PRON-	PRP$
cord-005453-4057qib7	13591	7	disease	disease	NN
cord-005453-4057qib7	13591	8	,	,	,
cord-005453-4057qib7	13591	9	the	the	DT
cord-005453-4057qib7	13591	10	2	2	CD
cord-005453-4057qib7	13591	11	oldest	old	JJS
cord-005453-4057qib7	13591	12	siblings	sibling	NNS
cord-005453-4057qib7	13591	13	were	be	VBD
cord-005453-4057qib7	13591	14	transplanted	transplant	VBN
cord-005453-4057qib7	13591	15	first	first	RB
cord-005453-4057qib7	13591	16	using	use	VBG
cord-005453-4057qib7	13591	17	a	a	DT
cord-005453-4057qib7	13591	18	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13591	19	conditioning	conditioning	NN
cord-005453-4057qib7	13591	20	regime	regime	NN
cord-005453-4057qib7	13591	21	of	of	IN
cord-005453-4057qib7	13591	22	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	13591	23	,	,	,
cord-005453-4057qib7	13591	24	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	13591	25	and	and	CC
cord-005453-4057qib7	13591	26	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	13591	27	with	with	IN
cord-005453-4057qib7	13591	28	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	13591	29	.	.	.
cord-005453-4057qib7	13592	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	13592	2	engraftment	engraftment	NN
cord-005453-4057qib7	13592	3	occurred	occur	VBD
cord-005453-4057qib7	13592	4	on	on	IN
cord-005453-4057qib7	13592	5	day	day	NN
cord-005453-4057qib7	13592	6	+	+	SYM
cord-005453-4057qib7	13592	7	11	11	CD
cord-005453-4057qib7	13592	8	for	for	IN
cord-005453-4057qib7	13592	9	both	both	DT
cord-005453-4057qib7	13592	10	,	,	,
cord-005453-4057qib7	13592	11	with	with	IN
cord-005453-4057qib7	13592	12	100	100	CD
cord-005453-4057qib7	13592	13	%	%	NN
cord-005453-4057qib7	13592	14	donor	donor	NN
cord-005453-4057qib7	13592	15	chimerism	chimerism	NN
cord-005453-4057qib7	13592	16	achieved	achieve	VBN
cord-005453-4057qib7	13592	17	.	.	.
cord-005453-4057qib7	13593	1	There	there	EX
cord-005453-4057qib7	13593	2	were	be	VBD
cord-005453-4057qib7	13593	3	no	no	DT
cord-005453-4057qib7	13593	4	significant	significant	JJ
cord-005453-4057qib7	13593	5	transplant	transplant	NN
cord-005453-4057qib7	13593	6	related	relate	VBN
cord-005453-4057qib7	13593	7	complications	complication	NNS
cord-005453-4057qib7	13593	8	.	.	.
cord-005453-4057qib7	13594	1	The	the	DT
cord-005453-4057qib7	13594	2	post	post	JJ
cord-005453-4057qib7	13594	3	-	-	JJ
cord-005453-4057qib7	13594	4	transplant	transplant	JJ
cord-005453-4057qib7	13594	5	course	course	NN
cord-005453-4057qib7	13594	6	of	of	IN
cord-005453-4057qib7	13594	7	the	the	DT
cord-005453-4057qib7	13594	8	15	15	CD
cord-005453-4057qib7	13594	9	year	year	NN
cord-005453-4057qib7	13594	10	old	old	JJ
cord-005453-4057qib7	13594	11	sibling	sibling	NN
cord-005453-4057qib7	13594	12	was	be	VBD
cord-005453-4057qib7	13594	13	complicated	complicate	VBN
cord-005453-4057qib7	13594	14	by	by	IN
cord-005453-4057qib7	13594	15	a	a	DT
cord-005453-4057qib7	13594	16	major	major	JJ
cord-005453-4057qib7	13594	17	stroke	stroke	NN
cord-005453-4057qib7	13594	18	-	-	HYPH
cord-005453-4057qib7	13594	19	like	like	JJ
cord-005453-4057qib7	13594	20	event	event	NN
cord-005453-4057qib7	13594	21	characterised	characterise	VBN
cord-005453-4057qib7	13594	22	by	by	IN
cord-005453-4057qib7	13594	23	dramatic	dramatic	JJ
cord-005453-4057qib7	13594	24	imaging	imaging	NN
cord-005453-4057qib7	13594	25	changes	change	NNS
cord-005453-4057qib7	13594	26	and	and	CC
cord-005453-4057qib7	13594	27	requiring	require	VBG
cord-005453-4057qib7	13594	28	ventilation	ventilation	NN
cord-005453-4057qib7	13594	29	,	,	,
cord-005453-4057qib7	13594	30	though	though	IN
cord-005453-4057qib7	13594	31	no	no	DT
cord-005453-4057qib7	13594	32	cause	cause	NN
cord-005453-4057qib7	13594	33	was	be	VBD
cord-005453-4057qib7	13594	34	identified	identify	VBN
cord-005453-4057qib7	13594	35	and	and	CC
cord-005453-4057qib7	13594	36	the	the	DT
cord-005453-4057qib7	13594	37	patient	patient	NN
cord-005453-4057qib7	13594	38	's	's	POS
cord-005453-4057qib7	13594	39	neurologic	neurologic	JJ
cord-005453-4057qib7	13594	40	deficits	deficit	NNS
cord-005453-4057qib7	13594	41	have	have	VBP
cord-005453-4057qib7	13594	42	since	since	IN
cord-005453-4057qib7	13594	43	resolved	resolve	VBN
cord-005453-4057qib7	13594	44	.	.	.
cord-005453-4057qib7	13595	1	Gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	13595	2	symptoms	symptom	NNS
cord-005453-4057qib7	13595	3	have	have	VBP
cord-005453-4057qib7	13595	4	persisted	persist	VBN
cord-005453-4057qib7	13595	5	and	and	CC
cord-005453-4057qib7	13595	6	both	both	DT
cord-005453-4057qib7	13595	7	remain	remain	VBP
cord-005453-4057qib7	13595	8	TPN	TPN	NNP
cord-005453-4057qib7	13595	9	dependent	dependent	JJ
cord-005453-4057qib7	13595	10	,	,	,
cord-005453-4057qib7	13595	11	though	though	IN
cord-005453-4057qib7	13595	12	symptomatically	symptomatically	RB
cord-005453-4057qib7	13595	13	have	have	VBP
cord-005453-4057qib7	13595	14	shown	show	VBN
cord-005453-4057qib7	13595	15	gradual	gradual	JJ
cord-005453-4057qib7	13595	16	improvement	improvement	NN
cord-005453-4057qib7	13595	17	.	.	.
cord-005453-4057qib7	13596	1	Following	follow	VBG
cord-005453-4057qib7	13596	2	the	the	DT
cord-005453-4057qib7	13596	3	neurologic	neurologic	JJ
cord-005453-4057qib7	13596	4	complications	complication	NNS
cord-005453-4057qib7	13596	5	in	in	IN
cord-005453-4057qib7	13596	6	their	-PRON-	PRP$
cord-005453-4057qib7	13596	7	older	old	JJR
cord-005453-4057qib7	13596	8	sibling	sibling	NN
cord-005453-4057qib7	13596	9	,	,	,
cord-005453-4057qib7	13596	10	the	the	DT
cord-005453-4057qib7	13596	11	2	2	CD
cord-005453-4057qib7	13596	12	younger	young	JJR
cord-005453-4057qib7	13596	13	siblings	sibling	NNS
cord-005453-4057qib7	13596	14	were	be	VBD
cord-005453-4057qib7	13596	15	conditioned	condition	VBN
cord-005453-4057qib7	13596	16	with	with	IN
cord-005453-4057qib7	13596	17	AUC	AUC	NNP
cord-005453-4057qib7	13596	18	-	-	HYPH
cord-005453-4057qib7	13596	19	Targeted	target	VBN
cord-005453-4057qib7	13596	20	Busulfan	Busulfan	NNP
cord-005453-4057qib7	13596	21	and	and	CC
cord-005453-4057qib7	13596	22	fludarabine	fludarabine	NN
cord-005453-4057qib7	13596	23	plus	plus	CC
cord-005453-4057qib7	13596	24	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	13596	25	.	.	.
cord-005453-4057qib7	13597	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	13597	2	engraftment	engraftment	NN
cord-005453-4057qib7	13597	3	occurred	occur	VBD
cord-005453-4057qib7	13597	4	on	on	IN
cord-005453-4057qib7	13597	5	day	day	NN
cord-005453-4057qib7	13597	6	+	+	SYM
cord-005453-4057qib7	13597	7	11	11	CD
cord-005453-4057qib7	13597	8	,	,	,
cord-005453-4057qib7	13597	9	with	with	IN
cord-005453-4057qib7	13597	10	full	full	JJ
cord-005453-4057qib7	13597	11	donor	donor	NN
cord-005453-4057qib7	13597	12	chimerism	chimerism	NN
cord-005453-4057qib7	13597	13	achieved	achieve	VBN
cord-005453-4057qib7	13597	14	.	.	.
cord-005453-4057qib7	13598	1	Progression	progression	NN
cord-005453-4057qib7	13598	2	to	to	IN
cord-005453-4057qib7	13598	3	enteral	enteral	NN
cord-005453-4057qib7	13598	4	feeding	feeding	NN
cord-005453-4057qib7	13598	5	has	have	VBZ
cord-005453-4057qib7	13598	6	been	be	VBN
cord-005453-4057qib7	13598	7	much	much	RB
cord-005453-4057qib7	13598	8	more	more	RBR
cord-005453-4057qib7	13598	9	rapid	rapid	JJ
cord-005453-4057qib7	13598	10	,	,	,
cord-005453-4057qib7	13598	11	with	with	IN
cord-005453-4057qib7	13598	12	nutrition	nutrition	NN
cord-005453-4057qib7	13598	13	now	now	RB
cord-005453-4057qib7	13598	14	fully	fully	RB
cord-005453-4057qib7	13598	15	enteral	enteral	JJ
cord-005453-4057qib7	13598	16	for	for	IN
cord-005453-4057qib7	13598	17	both	both	DT
cord-005453-4057qib7	13598	18	.	.	.
cord-005453-4057qib7	13599	1	There	there	EX
cord-005453-4057qib7	13599	2	were	be	VBD
cord-005453-4057qib7	13599	3	no	no	DT
cord-005453-4057qib7	13599	4	significant	significant	JJ
cord-005453-4057qib7	13599	5	transplant	transplant	NN
cord-005453-4057qib7	13599	6	related	relate	VBN
cord-005453-4057qib7	13599	7	complications	complication	NNS
cord-005453-4057qib7	13599	8	.	.	.
cord-005453-4057qib7	13600	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13600	2	:	:	:
cord-005453-4057qib7	13601	1	Stem	Stem	NNP
cord-005453-4057qib7	13601	2	Cell	Cell	NNP
cord-005453-4057qib7	13601	3	transplantation	transplantation	NN
cord-005453-4057qib7	13601	4	represents	represent	VBZ
cord-005453-4057qib7	13601	5	the	the	DT
cord-005453-4057qib7	13601	6	only	only	JJ
cord-005453-4057qib7	13601	7	curative	curative	JJ
cord-005453-4057qib7	13601	8	option	option	NN
cord-005453-4057qib7	13601	9	for	for	IN
cord-005453-4057qib7	13601	10	MNGIE	MNGIE	NNP
cord-005453-4057qib7	13601	11	.	.	.
cord-005453-4057qib7	13602	1	Due	due	IN
cord-005453-4057qib7	13602	2	to	to	IN
cord-005453-4057qib7	13602	3	its	-PRON-	PRP$
cord-005453-4057qib7	13602	4	rarity	rarity	NN
cord-005453-4057qib7	13602	5	and	and	CC
cord-005453-4057qib7	13602	6	relative	relative	JJ
cord-005453-4057qib7	13602	7	infancy	infancy	NN
cord-005453-4057qib7	13602	8	as	as	IN
cord-005453-4057qib7	13602	9	a	a	DT
cord-005453-4057qib7	13602	10	condition	condition	NN
cord-005453-4057qib7	13602	11	,	,	,
cord-005453-4057qib7	13602	12	little	little	JJ
cord-005453-4057qib7	13602	13	is	be	VBZ
cord-005453-4057qib7	13602	14	known	know	VBN
cord-005453-4057qib7	13602	15	of	of	IN
cord-005453-4057qib7	13602	16	the	the	DT
cord-005453-4057qib7	13602	17	expected	expect	VBN
cord-005453-4057qib7	13602	18	course	course	NN
cord-005453-4057qib7	13602	19	following	follow	VBG
cord-005453-4057qib7	13602	20	transplant	transplant	NN
cord-005453-4057qib7	13602	21	or	or	CC
cord-005453-4057qib7	13602	22	the	the	DT
cord-005453-4057qib7	13602	23	best	good	JJS
cord-005453-4057qib7	13602	24	approach	approach	NN
cord-005453-4057qib7	13602	25	to	to	IN
cord-005453-4057qib7	13602	26	transplantation	transplantation	NN
cord-005453-4057qib7	13602	27	itself	-PRON-	PRP
cord-005453-4057qib7	13602	28	.	.	.
cord-005453-4057qib7	13603	1	Despite	despite	IN
cord-005453-4057qib7	13603	2	previous	previous	JJ
cord-005453-4057qib7	13603	3	challenges	challenge	NNS
cord-005453-4057qib7	13603	4	with	with	IN
cord-005453-4057qib7	13603	5	graft	graft	NN
cord-005453-4057qib7	13603	6	failure	failure	NN
cord-005453-4057qib7	13603	7	in	in	IN
cord-005453-4057qib7	13603	8	MNGIE	MNGIE	NNP
cord-005453-4057qib7	13603	9	recipients	recipient	NNS
cord-005453-4057qib7	13603	10	,	,	,
cord-005453-4057qib7	13603	11	we	-PRON-	PRP
cord-005453-4057qib7	13603	12	were	be	VBD
cord-005453-4057qib7	13603	13	able	able	JJ
cord-005453-4057qib7	13603	14	to	to	TO
cord-005453-4057qib7	13603	15	gain	gain	VB
cord-005453-4057qib7	13603	16	rapid	rapid	JJ
cord-005453-4057qib7	13603	17	and	and	CC
cord-005453-4057qib7	13603	18	sustained	sustained	JJ
cord-005453-4057qib7	13603	19	donor	donor	NN
cord-005453-4057qib7	13603	20	engraftment	engraftment	NN
cord-005453-4057qib7	13603	21	using	use	VBG
cord-005453-4057qib7	13603	22	2	2	CD
cord-005453-4057qib7	13603	23	different	different	JJ
cord-005453-4057qib7	13603	24	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13603	25	conditioning	conditioning	NN
cord-005453-4057qib7	13603	26	regimes	regime	NNS
cord-005453-4057qib7	13603	27	with	with	IN
cord-005453-4057qib7	13603	28	minimal	minimal	JJ
cord-005453-4057qib7	13603	29	transplant	transplant	NN
cord-005453-4057qib7	13603	30	-	-	HYPH
cord-005453-4057qib7	13603	31	related	relate	VBN
cord-005453-4057qib7	13603	32	morbidity	morbidity	NN
cord-005453-4057qib7	13603	33	and	and	CC
cord-005453-4057qib7	13603	34	no	no	DT
cord-005453-4057qib7	13603	35	mortality	mortality	NN
cord-005453-4057qib7	13603	36	.	.	.
cord-005453-4057qib7	13604	1	In	in	IN
cord-005453-4057qib7	13604	2	keeping	keep	VBG
cord-005453-4057qib7	13604	3	with	with	IN
cord-005453-4057qib7	13604	4	previous	previous	JJ
cord-005453-4057qib7	13604	5	reports	report	NNS
cord-005453-4057qib7	13604	6	,	,	,
cord-005453-4057qib7	13604	7	resolution	resolution	NN
cord-005453-4057qib7	13604	8	of	of	IN
cord-005453-4057qib7	13604	9	established	establish	VBN
cord-005453-4057qib7	13604	10	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	13604	11	symptoms	symptom	NNS
cord-005453-4057qib7	13604	12	has	have	VBZ
cord-005453-4057qib7	13604	13	been	be	VBN
cord-005453-4057qib7	13604	14	slow	slow	JJ
cord-005453-4057qib7	13604	15	,	,	,
cord-005453-4057qib7	13604	16	though	though	IN
cord-005453-4057qib7	13604	17	the	the	DT
cord-005453-4057qib7	13604	18	2	2	CD
cord-005453-4057qib7	13604	19	siblings	sibling	NNS
cord-005453-4057qib7	13604	20	transplanted	transplant	VBN
cord-005453-4057qib7	13604	21	earlier	early	RBR
cord-005453-4057qib7	13604	22	in	in	IN
cord-005453-4057qib7	13604	23	their	-PRON-	PRP$
cord-005453-4057qib7	13604	24	disease	disease	NN
cord-005453-4057qib7	13604	25	course	course	NN
cord-005453-4057qib7	13604	26	have	have	VBP
cord-005453-4057qib7	13604	27	shown	show	VBN
cord-005453-4057qib7	13604	28	more	more	RBR
cord-005453-4057qib7	13604	29	rapid	rapid	JJ
cord-005453-4057qib7	13604	30	improvement	improvement	NN
cord-005453-4057qib7	13604	31	supporting	support	VBG
cord-005453-4057qib7	13604	32	the	the	DT
cord-005453-4057qib7	13604	33	role	role	NN
cord-005453-4057qib7	13604	34	of	of	IN
cord-005453-4057qib7	13604	35	early	early	JJ
cord-005453-4057qib7	13604	36	recognition	recognition	NN
cord-005453-4057qib7	13604	37	and	and	CC
cord-005453-4057qib7	13604	38	access	access	NN
cord-005453-4057qib7	13604	39	to	to	IN
cord-005453-4057qib7	13604	40	transplant	transplant	NN
cord-005453-4057qib7	13604	41	.	.	.
cord-005453-4057qib7	13605	1	It	-PRON-	PRP
cord-005453-4057qib7	13605	2	is	be	VBZ
cord-005453-4057qib7	13605	3	essential	essential	JJ
cord-005453-4057qib7	13605	4	moving	move	VBG
cord-005453-4057qib7	13605	5	forward	forward	RB
cord-005453-4057qib7	13605	6	that	that	IN
cord-005453-4057qib7	13605	7	specialised	specialised	JJ
cord-005453-4057qib7	13605	8	transplantation	transplantation	NN
cord-005453-4057qib7	13605	9	centres	centre	NNS
cord-005453-4057qib7	13605	10	collaborate	collaborate	VBP
cord-005453-4057qib7	13605	11	so	so	IN
cord-005453-4057qib7	13605	12	as	as	IN
cord-005453-4057qib7	13605	13	to	to	TO
cord-005453-4057qib7	13605	14	guide	guide	VB
cord-005453-4057qib7	13605	15	clinicians	clinician	NNS
cord-005453-4057qib7	13605	16	in	in	IN
cord-005453-4057qib7	13605	17	the	the	DT
cord-005453-4057qib7	13605	18	management	management	NN
cord-005453-4057qib7	13605	19	of	of	IN
cord-005453-4057qib7	13605	20	such	such	PDT
cord-005453-4057qib7	13605	21	a	a	DT
cord-005453-4057qib7	13605	22	challenging	challenging	JJ
cord-005453-4057qib7	13605	23	condition	condition	NN
cord-005453-4057qib7	13605	24	.	.	.
cord-005453-4057qib7	13606	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13606	2	:	:	:
cord-005453-4057qib7	13606	3	There	there	EX
cord-005453-4057qib7	13606	4	are	be	VBP
cord-005453-4057qib7	13606	5	no	no	DT
cord-005453-4057qib7	13606	6	conflicts	conflict	NNS
cord-005453-4057qib7	13606	7	of	of	IN
cord-005453-4057qib7	13606	8	interest	interest	NN
cord-005453-4057qib7	13606	9	to	to	TO
cord-005453-4057qib7	13606	10	disclose	disclose	VB
cord-005453-4057qib7	13606	11	.	.	.
cord-005453-4057qib7	13607	1	G6PC3	g6pc3	VB
cord-005453-4057qib7	13607	2	congenital	congenital	JJ
cord-005453-4057qib7	13608	1	neutropenia	neutropenia	LS
cord-005453-4057qib7	13608	2	-biology	-biology	:
cord-005453-4057qib7	13608	3	of	of	IN
cord-005453-4057qib7	13608	4	inflammatory	inflammatory	JJ
cord-005453-4057qib7	13608	5	colitis	colitis	NN
cord-005453-4057qib7	13608	6	associated	associate	VBN
cord-005453-4057qib7	13608	7	with	with	IN
cord-005453-4057qib7	13608	8	GCSF	GCSF	NNP
cord-005453-4057qib7	13608	9	use	use	VBP
cord-005453-4057qib7	13608	10	,	,	,
cord-005453-4057qib7	13608	11	and	and	CC
cord-005453-4057qib7	13608	12	disease	disease	NN
cord-005453-4057qib7	13608	13	response	response	NN
cord-005453-4057qib7	13608	14	to	to	IN
cord-005453-4057qib7	13608	15	allogeneic	allogeneic	NN
cord-005453-4057qib7	13608	16	transplant	transplant	NN
cord-005453-4057qib7	13608	17	,	,	,
cord-005453-4057qib7	13608	18	a	a	DT
cord-005453-4057qib7	13608	19	report	report	NN
cord-005453-4057qib7	13608	20	of	of	IN
cord-005453-4057qib7	13608	21	4	4	CD
cord-005453-4057qib7	13608	22	cases	case	NNS
cord-005453-4057qib7	13608	23	Background	background	NN
cord-005453-4057qib7	13608	24	:	:	:
cord-005453-4057qib7	13609	1	An	an	DT
cord-005453-4057qib7	13609	2	autosomal	autosomal	JJ
cord-005453-4057qib7	13609	3	recessive	recessive	JJ
cord-005453-4057qib7	13609	4	disease	disease	NN
cord-005453-4057qib7	13609	5	,	,	,
cord-005453-4057qib7	13609	6	Glucose-6phosphatase	Glucose-6phosphatase	NNP
cord-005453-4057qib7	13609	7	catalytic	catalytic	JJ
cord-005453-4057qib7	13609	8	subunit	subunit	NN
cord-005453-4057qib7	13609	9	3	3	CD
cord-005453-4057qib7	13610	1	(	(	-LRB-
cord-005453-4057qib7	13610	2	G6PC3	G6PC3	NNP
cord-005453-4057qib7	13610	3	)	)	-RRB-
cord-005453-4057qib7	13610	4	deficiency	deficiency	NN
cord-005453-4057qib7	13610	5	is	be	VBZ
cord-005453-4057qib7	13610	6	a	a	DT
cord-005453-4057qib7	13610	7	relatively	relatively	RB
cord-005453-4057qib7	13610	8	recently	recently	RB
cord-005453-4057qib7	13610	9	identified	identify	VBN
cord-005453-4057qib7	13610	10	cause	cause	NN
cord-005453-4057qib7	13610	11	of	of	IN
cord-005453-4057qib7	13610	12	chronic	chronic	JJ
cord-005453-4057qib7	13610	13	severe	severe	JJ
cord-005453-4057qib7	13610	14	neutropenia	neutropenia	NN
cord-005453-4057qib7	13610	15	.	.	.
cord-005453-4057qib7	13611	1	There	there	EX
cord-005453-4057qib7	13611	2	can	can	MD
cord-005453-4057qib7	13611	3	be	be	VB
cord-005453-4057qib7	13611	4	a	a	DT
cord-005453-4057qib7	13611	5	spectrum	spectrum	NN
cord-005453-4057qib7	13611	6	to	to	IN
cord-005453-4057qib7	13611	7	the	the	DT
cord-005453-4057qib7	13611	8	disease	disease	NN
cord-005453-4057qib7	13611	9	and	and	CC
cord-005453-4057qib7	13611	10	patients	patient	NNS
cord-005453-4057qib7	13611	11	may	may	MD
cord-005453-4057qib7	13611	12	also	also	RB
cord-005453-4057qib7	13611	13	present	present	VB
cord-005453-4057qib7	13611	14	with	with	IN
cord-005453-4057qib7	13611	15	non	non	JJ
cord-005453-4057qib7	13611	16	-	-	JJ
cord-005453-4057qib7	13611	17	haematological	haematological	JJ
cord-005453-4057qib7	13611	18	features	feature	NNS
cord-005453-4057qib7	13611	19	including	include	VBG
cord-005453-4057qib7	13611	20	prominent	prominent	JJ
cord-005453-4057qib7	13611	21	chest	chest	NN
cord-005453-4057qib7	13611	22	veins	vein	NNS
cord-005453-4057qib7	13611	23	,	,	,
cord-005453-4057qib7	13611	24	cardiac	cardiac	NN
cord-005453-4057qib7	13611	25	,	,	,
cord-005453-4057qib7	13611	26	endocrine	endocrine	JJ
cord-005453-4057qib7	13611	27	or	or	CC
cord-005453-4057qib7	13611	28	urogenital	urogenital	JJ
cord-005453-4057qib7	13611	29	abnormalities	abnormality	NNS
cord-005453-4057qib7	13611	30	.	.	.
cord-005453-4057qib7	13612	1	We	-PRON-	PRP
cord-005453-4057qib7	13612	2	describe	describe	VBP
cord-005453-4057qib7	13612	3	in	in	IN
cord-005453-4057qib7	13612	4	our	-PRON-	PRP$
cord-005453-4057qib7	13612	5	patient	patient	JJ
cord-005453-4057qib7	13612	6	cohort	cohort	NN
cord-005453-4057qib7	13612	7	a	a	DT
cord-005453-4057qib7	13612	8	response	response	NN
cord-005453-4057qib7	13612	9	to	to	IN
cord-005453-4057qib7	13612	10	GCSF	GCSF	NNP
cord-005453-4057qib7	13612	11	but	but	CC
cord-005453-4057qib7	13612	12	an	an	DT
cord-005453-4057qib7	13612	13	inflammatory	inflammatory	JJ
cord-005453-4057qib7	13612	14	,	,	,
cord-005453-4057qib7	13612	15	incapacitating	incapacitate	VBG
cord-005453-4057qib7	13612	16	,	,	,
cord-005453-4057qib7	13612	17	biopsyproven	biopsyproven	NN
cord-005453-4057qib7	13612	18	colitis	colitis	NN
cord-005453-4057qib7	13612	19	associated	associate	VBN
cord-005453-4057qib7	13612	20	with	with	IN
cord-005453-4057qib7	13612	21	that	that	DT
cord-005453-4057qib7	13612	22	G	G	NNP
cord-005453-4057qib7	13612	23	-	-	HYPH
cord-005453-4057qib7	13612	24	CSF	csf	NN
cord-005453-4057qib7	13612	25	response	response	NN
cord-005453-4057qib7	13612	26	.	.	.
cord-005453-4057qib7	13613	1	We	-PRON-	PRP
cord-005453-4057qib7	13613	2	have	have	VBP
cord-005453-4057qib7	13613	3	transplanted	transplant	VBN
cord-005453-4057qib7	13613	4	3	3	CD
cord-005453-4057qib7	13613	5	children	child	NNS
cord-005453-4057qib7	13613	6	with	with	IN
cord-005453-4057qib7	13613	7	such	such	JJ
cord-005453-4057qib7	13613	8	colitis	colitis	NN
cord-005453-4057qib7	13613	9	,	,	,
cord-005453-4057qib7	13613	10	and	and	CC
cord-005453-4057qib7	13613	11	describe	describe	VB
cord-005453-4057qib7	13613	12	a	a	DT
cord-005453-4057qib7	13613	13	similar	similar	JJ
cord-005453-4057qib7	13613	14	colitis	colitis	NN
cord-005453-4057qib7	13613	15	with	with	IN
cord-005453-4057qib7	13613	16	intestinal	intestinal	JJ
cord-005453-4057qib7	13613	17	failure	failure	NN
cord-005453-4057qib7	13613	18	in	in	IN
cord-005453-4057qib7	13613	19	a	a	DT
cord-005453-4057qib7	13613	20	fourth	fourth	NN
cord-005453-4057qib7	13613	21	.	.	.
cord-005453-4057qib7	13614	1	Methods	method	NNS
cord-005453-4057qib7	13614	2	:	:	:
cord-005453-4057qib7	13615	1	We	-PRON-	PRP
cord-005453-4057qib7	13615	2	investigate	investigate	VBP
cord-005453-4057qib7	13615	3	the	the	DT
cord-005453-4057qib7	13615	4	biology	biology	NN
cord-005453-4057qib7	13615	5	of	of	IN
cord-005453-4057qib7	13615	6	the	the	DT
cord-005453-4057qib7	13615	7	neutropenic	neutropenic	JJ
cord-005453-4057qib7	13615	8	colitis	colitis	NN
cord-005453-4057qib7	13615	9	,	,	,
cord-005453-4057qib7	13615	10	and	and	CC
cord-005453-4057qib7	13615	11	demonstrate	demonstrate	VB
cord-005453-4057qib7	13615	12	necrosis	necrosis	NN
cord-005453-4057qib7	13615	13	of	of	IN
cord-005453-4057qib7	13615	14	the	the	DT
cord-005453-4057qib7	13615	15	stimulated	stimulated	JJ
cord-005453-4057qib7	13615	16	neutrophils	neutrophil	NNS
cord-005453-4057qib7	13615	17	.	.	.
cord-005453-4057qib7	13616	1	In	in	IN
cord-005453-4057qib7	13616	2	vitro	vitro	FW
cord-005453-4057qib7	13616	3	studies	study	NNS
cord-005453-4057qib7	13616	4	demonstrated	demonstrate	VBD
cord-005453-4057qib7	13616	5	that	that	IN
cord-005453-4057qib7	13616	6	unstimulated	unstimulated	JJ
cord-005453-4057qib7	13616	7	neutrophils	neutrophil	NNS
cord-005453-4057qib7	13616	8	from	from	IN
cord-005453-4057qib7	13616	9	patients	patient	NNS
cord-005453-4057qib7	13616	10	with	with	IN
cord-005453-4057qib7	13616	11	G6PC3D	G6PC3D	NNP
cord-005453-4057qib7	13616	12	exhibited	exhibit	VBD
cord-005453-4057qib7	13616	13	significantly	significantly	RB
cord-005453-4057qib7	13616	14	increased	increase	VBN
cord-005453-4057qib7	13616	15	production	production	NN
cord-005453-4057qib7	13616	16	of	of	IN
cord-005453-4057qib7	13616	17	IL8	IL8	NNP
cord-005453-4057qib7	13616	18	,	,	,
cord-005453-4057qib7	13616	19	reactive	reactive	JJ
cord-005453-4057qib7	13616	20	oxygen	oxygen	NN
cord-005453-4057qib7	13616	21	species	specie	NNS
cord-005453-4057qib7	13616	22	(	(	-LRB-
cord-005453-4057qib7	13616	23	ROS	ROS	NNP
cord-005453-4057qib7	13616	24	)	)	-RRB-
cord-005453-4057qib7	13616	25	and	and	CC
cord-005453-4057qib7	13616	26	neutrophil	neutrophil	NN
cord-005453-4057qib7	13616	27	extracellular	extracellular	JJ
cord-005453-4057qib7	13616	28	traps	trap	NNS
cord-005453-4057qib7	13616	29	(	(	-LRB-
cord-005453-4057qib7	13616	30	NETs	net	NNS
cord-005453-4057qib7	13616	31	)	)	-RRB-
cord-005453-4057qib7	13616	32	alongside	alongside	IN
cord-005453-4057qib7	13616	33	significantly	significantly	RB
cord-005453-4057qib7	13616	34	higher	high	JJR
cord-005453-4057qib7	13616	35	expression	expression	NN
cord-005453-4057qib7	13616	36	of	of	IN
cord-005453-4057qib7	13616	37	CD11b	CD11b	NNS
cord-005453-4057qib7	13616	38	,	,	,
cord-005453-4057qib7	13616	39	CD66b	CD66b	NNP
cord-005453-4057qib7	13616	40	and	and	CC
cord-005453-4057qib7	13616	41	CD14	CD14	NNP
cord-005453-4057qib7	13616	42	.	.	.
cord-005453-4057qib7	13617	1	In	in	IN
cord-005453-4057qib7	13617	2	contrast	contrast	NN
cord-005453-4057qib7	13617	3	,	,	,
cord-005453-4057qib7	13617	4	neutrophils	neutrophil	NNS
cord-005453-4057qib7	13617	5	from	from	IN
cord-005453-4057qib7	13617	6	patients	patient	NNS
cord-005453-4057qib7	13617	7	with	with	IN
cord-005453-4057qib7	13617	8	G6PC3D	G6PC3D	NNP
cord-005453-4057qib7	13617	9	produced	produce	VBD
cord-005453-4057qib7	13617	10	significantly	significantly	RB
cord-005453-4057qib7	13617	11	less	less	JJR
cord-005453-4057qib7	13617	12	ROS	ROS	NNP
cord-005453-4057qib7	13617	13	,	,	,
cord-005453-4057qib7	13617	14	MMP-9	MMP-9	NNP
cord-005453-4057qib7	13617	15	,	,	,
cord-005453-4057qib7	13617	16	neutrophil	neutrophil	NN
cord-005453-4057qib7	13617	17	elastase	elastase	NN
cord-005453-4057qib7	13617	18	and	and	CC
cord-005453-4057qib7	13617	19	NETs	net	NNS
cord-005453-4057qib7	13617	20	upon	upon	IN
cord-005453-4057qib7	13617	21	stimulation	stimulation	NN
cord-005453-4057qib7	13617	22	.	.	.
cord-005453-4057qib7	13618	1	Neutrophils	neutrophils	NN
cord-005453-4057qib7	13618	2	from	from	IN
cord-005453-4057qib7	13618	3	patients	patient	NNS
cord-005453-4057qib7	13618	4	with	with	IN
cord-005453-4057qib7	13618	5	G6PC3D	G6PC3D	NNP
cord-005453-4057qib7	13618	6	also	also	RB
cord-005453-4057qib7	13618	7	exhibited	exhibit	VBD
cord-005453-4057qib7	13618	8	significantly	significantly	RB
cord-005453-4057qib7	13618	9	accelerated	accelerate	VBN
cord-005453-4057qib7	13618	10	apoptosis	apoptosis	NN
cord-005453-4057qib7	13618	11	and	and	CC
cord-005453-4057qib7	13618	12	secondary	secondary	JJ
cord-005453-4057qib7	13618	13	necrosis	necrosis	NN
cord-005453-4057qib7	13618	14	which	which	WDT
cord-005453-4057qib7	13618	15	was	be	VBD
cord-005453-4057qib7	13618	16	exaggerated	exaggerate	VBN
cord-005453-4057qib7	13618	17	upon	upon	IN
cord-005453-4057qib7	13618	18	stimulation	stimulation	NN
cord-005453-4057qib7	13618	19	with	with	IN
cord-005453-4057qib7	13618	20	live	live	JJ
cord-005453-4057qib7	13618	21	Escherichia	escherichia	NN
cord-005453-4057qib7	13618	22	coli	coli	NNS
cord-005453-4057qib7	13618	23	bacteria	bacteria	NNS
cord-005453-4057qib7	13618	24	but	but	CC
cord-005453-4057qib7	13618	25	could	could	MD
cord-005453-4057qib7	13618	26	only	only	RB
cord-005453-4057qib7	13618	27	be	be	VB
cord-005453-4057qib7	13618	28	partially	partially	RB
cord-005453-4057qib7	13618	29	rescued	rescue	VBN
cord-005453-4057qib7	13618	30	with	with	IN
cord-005453-4057qib7	13618	31	supplemental	supplemental	JJ
cord-005453-4057qib7	13618	32	exogenous	exogenous	JJ
cord-005453-4057qib7	13618	33	glucose	glucose	NN
cord-005453-4057qib7	13618	34	.	.	.
cord-005453-4057qib7	13619	1	Results	result	NNS
cord-005453-4057qib7	13619	2	:	:	:
cord-005453-4057qib7	13620	1	3	3	CD
cord-005453-4057qib7	13620	2	patients	patient	NNS
cord-005453-4057qib7	13620	3	have	have	VBP
cord-005453-4057qib7	13620	4	undergone	undergo	VBN
cord-005453-4057qib7	13620	5	HSCT	HSCT	NNP
cord-005453-4057qib7	13620	6	for	for	IN
cord-005453-4057qib7	13620	7	G6PC3	G6PC3	NNP
cord-005453-4057qib7	13620	8	neutropenic	neutropenic	JJ
cord-005453-4057qib7	13620	9	enterocolitis	enterocolitis	NN
cord-005453-4057qib7	13620	10	(	(	-LRB-
cord-005453-4057qib7	13620	11	1	1	CD
cord-005453-4057qib7	13620	12	unrelated	unrelated	JJ
cord-005453-4057qib7	13620	13	donor	donor	NN
cord-005453-4057qib7	13620	14	and	and	CC
cord-005453-4057qib7	13620	15	2	2	CD
cord-005453-4057qib7	13620	16	MSD	MSD	NNP
cord-005453-4057qib7	13620	17	)	)	-RRB-
cord-005453-4057qib7	13620	18	after	after	IN
cord-005453-4057qib7	13620	19	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	13620	20	treosulfan	treosulfan	NNP
cord-005453-4057qib7	13620	21	and	and	CC
cord-005453-4057qib7	13620	22	thiotepa	thiotepa	JJ
cord-005453-4057qib7	13620	23	conditioning	conditioning	NN
cord-005453-4057qib7	13620	24	therapy	therapy	NN
cord-005453-4057qib7	13620	25	.	.	.
cord-005453-4057qib7	13621	1	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	13621	2	was	be	VBD
cord-005453-4057qib7	13621	3	given	give	VBN
cord-005453-4057qib7	13621	4	as	as	IN
cord-005453-4057qib7	13621	5	as	as	IN
cord-005453-4057qib7	13621	6	serotherapy	serotherapy	NNP
cord-005453-4057qib7	13621	7	.	.	.
cord-005453-4057qib7	13622	1	All	all	DT
cord-005453-4057qib7	13622	2	3	3	CD
cord-005453-4057qib7	13622	3	patients	patient	NNS
cord-005453-4057qib7	13622	4	are	be	VBP
cord-005453-4057qib7	13622	5	alive	alive	JJ
cord-005453-4057qib7	13622	6	and	and	CC
cord-005453-4057qib7	13622	7	well	well	RB
cord-005453-4057qib7	13622	8	,	,	,
cord-005453-4057qib7	13622	9	immune	immune	JJ
cord-005453-4057qib7	13622	10	suppression	suppression	NN
cord-005453-4057qib7	13622	11	has	have	VBZ
cord-005453-4057qib7	13622	12	been	be	VBN
cord-005453-4057qib7	13622	13	discotniuned	discotniune	VBN
cord-005453-4057qib7	13622	14	and	and	CC
cord-005453-4057qib7	13622	15	there	there	EX
cord-005453-4057qib7	13622	16	is	be	VBZ
cord-005453-4057qib7	13622	17	no	no	DT
cord-005453-4057qib7	13622	18	GVHD	gvhd	NN
cord-005453-4057qib7	13622	19	with	with	IN
cord-005453-4057qib7	13622	20	normal	normal	JJ
cord-005453-4057qib7	13622	21	organ	organ	NN
cord-005453-4057qib7	13622	22	function	function	NN
cord-005453-4057qib7	13622	23	,	,	,
cord-005453-4057qib7	13622	24	and	and	CC
cord-005453-4057qib7	13622	25	resolution	resolution	NN
cord-005453-4057qib7	13622	26	of	of	IN
cord-005453-4057qib7	13622	27	colitis	colitis	NN
cord-005453-4057qib7	13622	28	.	.	.
cord-005453-4057qib7	13623	1	We	-PRON-	PRP
cord-005453-4057qib7	13623	2	describe	describe	VBP
cord-005453-4057qib7	13623	3	a	a	DT
cord-005453-4057qib7	13623	4	4	4	CD
cord-005453-4057qib7	13623	5	th	th	XX
cord-005453-4057qib7	13623	6	patient	patient	NN
cord-005453-4057qib7	13623	7	with	with	IN
cord-005453-4057qib7	13623	8	no	no	DT
cord-005453-4057qib7	13623	9	good	good	JJ
cord-005453-4057qib7	13623	10	donor	donor	NN
cord-005453-4057qib7	13623	11	who	who	WP
cord-005453-4057qib7	13623	12	has	have	VBZ
cord-005453-4057qib7	13623	13	continuing	continue	VBG
cord-005453-4057qib7	13623	14	intestinal	intestinal	JJ
cord-005453-4057qib7	13623	15	failure	failure	NN
cord-005453-4057qib7	13623	16	with	with	IN
cord-005453-4057qib7	13623	17	G	G	NNP
cord-005453-4057qib7	13623	18	-	-	HYPH
cord-005453-4057qib7	13623	19	CSF	CSF	NNP
cord-005453-4057qib7	13623	20	use	use	NN
cord-005453-4057qib7	13623	21	.	.	.
cord-005453-4057qib7	13624	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13624	2	:	:	:
cord-005453-4057qib7	13625	1	We	-PRON-	PRP
cord-005453-4057qib7	13625	2	describe	describe	VBP
cord-005453-4057qib7	13625	3	the	the	DT
cord-005453-4057qib7	13625	4	aetiology	aetiology	NN
cord-005453-4057qib7	13625	5	of	of	IN
cord-005453-4057qib7	13625	6	intestinal	intestinal	JJ
cord-005453-4057qib7	13625	7	inflammation	inflammation	NN
cord-005453-4057qib7	13625	8	and	and	CC
cord-005453-4057qib7	13625	9	failure	failure	NN
cord-005453-4057qib7	13625	10	with	with	IN
cord-005453-4057qib7	13625	11	an	an	DT
cord-005453-4057qib7	13625	12	extensive	extensive	JJ
cord-005453-4057qib7	13625	13	study	study	NN
cord-005453-4057qib7	13625	14	of	of	IN
cord-005453-4057qib7	13625	15	neutrophil	neutrophil	NN
cord-005453-4057qib7	13625	16	biology	biology	NN
cord-005453-4057qib7	13625	17	in	in	IN
cord-005453-4057qib7	13625	18	this	this	DT
cord-005453-4057qib7	13625	19	metabolic	metabolic	JJ
cord-005453-4057qib7	13625	20	neutropenia	neutropenia	NN
cord-005453-4057qib7	13625	21	.	.	.
cord-005453-4057qib7	13626	1	We	-PRON-	PRP
cord-005453-4057qib7	13626	2	describe	describe	VBP
cord-005453-4057qib7	13626	3	a	a	DT
cord-005453-4057qib7	13626	4	novel	novel	JJ
cord-005453-4057qib7	13626	5	indication	indication	NN
cord-005453-4057qib7	13626	6	for	for	IN
cord-005453-4057qib7	13626	7	HSCT	HSCT	NNP
cord-005453-4057qib7	13626	8	in	in	IN
cord-005453-4057qib7	13626	9	this	this	DT
cord-005453-4057qib7	13626	10	"	"	``
cord-005453-4057qib7	13626	11	G	g	NN
cord-005453-4057qib7	13626	12	-	-	HYPH
cord-005453-4057qib7	13626	13	CSFresponsive	csfresponsive	NN
cord-005453-4057qib7	13626	14	neutropenia	neutropenia	NN
cord-005453-4057qib7	13626	15	"	"	''
cord-005453-4057qib7	13626	16	.	.	.
cord-005453-4057qib7	13627	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13627	2	:	:	:
cord-005453-4057qib7	13627	3	Nothing	nothing	NN
cord-005453-4057qib7	13627	4	to	to	TO
cord-005453-4057qib7	13627	5	declare	declare	VB
cord-005453-4057qib7	13627	6	P620	P620	NNP
cord-005453-4057qib7	13627	7	Does	do	VBZ
cord-005453-4057qib7	13627	8	body	body	VB
cord-005453-4057qib7	13627	9	mass	mass	NN
cord-005453-4057qib7	13627	10	index	index	NN
cord-005453-4057qib7	13627	11	(	(	-LRB-
cord-005453-4057qib7	13627	12	BMI	BMI	NNP
cord-005453-4057qib7	13627	13	)	)	-RRB-
cord-005453-4057qib7	13627	14	pose	pose	VBP
cord-005453-4057qib7	13627	15	a	a	DT
cord-005453-4057qib7	13627	16	risk	risk	NN
cord-005453-4057qib7	13627	17	to	to	TO
cord-005453-4057qib7	13627	18	outcome	outcome	VB
cord-005453-4057qib7	13627	19	for	for	IN
cord-005453-4057qib7	13627	20	pediatric	pediatric	JJ
cord-005453-4057qib7	13627	21	non	non	JJ
cord-005453-4057qib7	13627	22	-	-	JJ
cord-005453-4057qib7	13627	23	infantile	infantile	JJ
cord-005453-4057qib7	13627	24	patients	patient	NNS
cord-005453-4057qib7	13627	25	undergoing	undergo	VBG
cord-005453-4057qib7	13627	26	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13627	27	cell	cell	NN
cord-005453-4057qib7	13627	28	transplantation	transplantation	NN
cord-005453-4057qib7	13627	29	(	(	-LRB-
cord-005453-4057qib7	13627	30	HSCT	HSCT	NNP
cord-005453-4057qib7	13627	31	)	)	-RRB-
cord-005453-4057qib7	13627	32	?	?	.
cord-005453-4057qib7	13628	1	Mona	Mona	NNP
cord-005453-4057qib7	13628	2	Al	Al	NNP
cord-005453-4057qib7	13628	3	-	-	HYPH
cord-005453-4057qib7	13628	4	Saleh	Saleh	NNP
cord-005453-4057qib7	13628	5	1	1	CD
cord-005453-4057qib7	13628	6	,	,	,
cord-005453-4057qib7	13628	7	Khawar	Khawar	NNP
cord-005453-4057qib7	13628	8	Siddiqui	Siddiqui	NNP
cord-005453-4057qib7	13628	9	1	1	CD
cord-005453-4057qib7	13628	10	,	,	,
cord-005453-4057qib7	13628	11	Amal	Amal	NNP
cord-005453-4057qib7	13628	12	Al	Al	NNP
cord-005453-4057qib7	13628	13	-	-	HYPH
cord-005453-4057qib7	13628	14	Seraihy	Seraihy	NNP
cord-005453-4057qib7	13628	15	1	1	CD
cord-005453-4057qib7	13628	16	,	,	,
cord-005453-4057qib7	13628	17	Abdullah	Abdullah	NNP
cord-005453-4057qib7	13628	18	Al	Al	NNP
cord-005453-4057qib7	13628	19	-	-	HYPH
cord-005453-4057qib7	13628	20	Jefri	Jefri	NNP
cord-005453-4057qib7	13628	21	1	1	CD
cord-005453-4057qib7	13628	22	,	,	,
cord-005453-4057qib7	13628	23	Ali	Ali	NNP
cord-005453-4057qib7	13628	24	Al	Al	NNP
cord-005453-4057qib7	13628	25	-	-	HYPH
cord-005453-4057qib7	13628	26	Ahmari	Ahmari	NNP
cord-005453-4057qib7	13628	27	1	1	CD
cord-005453-4057qib7	13628	28	,	,	,
cord-005453-4057qib7	13628	29	Hawazen	Hawazen	NNP
cord-005453-4057qib7	13628	30	Al	Al	NNP
cord-005453-4057qib7	13628	31	-	-	HYPH
cord-005453-4057qib7	13628	32	Saedi	Saedi	NNP
cord-005453-4057qib7	13628	33	1	1	CD
cord-005453-4057qib7	13628	34	,	,	,
cord-005453-4057qib7	13628	35	Awatif	Awatif	NNP
cord-005453-4057qib7	13628	36	Al	Al	NNP
cord-005453-4057qib7	13628	37	-	-	HYPH
cord-005453-4057qib7	13628	38	Anazi	Anazi	NNP
cord-005453-4057qib7	13628	39	1	1	CD
cord-005453-4057qib7	13628	40	,	,	,
cord-005453-4057qib7	13628	41	Mouhab	Mouhab	NNP
cord-005453-4057qib7	13628	42	Ayas	Ayas	NNP
cord-005453-4057qib7	13628	43	1	1	CD
cord-005453-4057qib7	13628	44	,	,	,
cord-005453-4057qib7	13628	45	Ibrahim	Ibrahim	NNP
cord-005453-4057qib7	13628	46	Al	Al	NNP
cord-005453-4057qib7	13628	47	-	-	HYPH
cord-005453-4057qib7	13628	48	Ghemlas	Ghemlas	NNP
cord-005453-4057qib7	13628	49	1	1	CD
cord-005453-4057qib7	13629	1	with	with	IN
cord-005453-4057qib7	13629	2	no	no	DT
cord-005453-4057qib7	13629	3	evidence	evidence	NN
cord-005453-4057qib7	13629	4	of	of	IN
cord-005453-4057qib7	13629	5	toxicity	toxicity	NN
cord-005453-4057qib7	13629	6	.	.	.
cord-005453-4057qib7	13630	1	As	as	IN
cord-005453-4057qib7	13630	2	benefits	benefit	NNS
cord-005453-4057qib7	13630	3	of	of	IN
cord-005453-4057qib7	13630	4	Stoss	Stoss	NNP
cord-005453-4057qib7	13630	5	therapy	therapy	NN
cord-005453-4057qib7	13630	6	in	in	IN
cord-005453-4057qib7	13630	7	HSCT	HSCT	NNP
cord-005453-4057qib7	13630	8	remain	remain	VBP
cord-005453-4057qib7	13630	9	unknown	unknown	JJ
cord-005453-4057qib7	13630	10	,	,	,
cord-005453-4057qib7	13630	11	and	and	CC
cord-005453-4057qib7	13630	12	safety	safety	NN
cord-005453-4057qib7	13630	13	has	have	VBZ
cord-005453-4057qib7	13630	14	yet	yet	RB
cord-005453-4057qib7	13630	15	to	to	TO
cord-005453-4057qib7	13630	16	have	have	VB
cord-005453-4057qib7	13630	17	been	be	VBN
cord-005453-4057qib7	13630	18	studied	study	VBN
cord-005453-4057qib7	13630	19	extensively	extensively	RB
cord-005453-4057qib7	13630	20	in	in	IN
cord-005453-4057qib7	13630	21	the	the	DT
cord-005453-4057qib7	13630	22	pediatric	pediatric	JJ
cord-005453-4057qib7	13630	23	population	population	NN
cord-005453-4057qib7	13630	24	,	,	,
cord-005453-4057qib7	13630	25	we	-PRON-	PRP
cord-005453-4057qib7	13630	26	hypothesize	hypothesize	VBP
cord-005453-4057qib7	13630	27	that	that	IN
cord-005453-4057qib7	13630	28	Stoss	Stoss	NNP
cord-005453-4057qib7	13630	29	therapy	therapy	NN
cord-005453-4057qib7	13630	30	is	be	VBZ
cord-005453-4057qib7	13630	31	an	an	DT
cord-005453-4057qib7	13630	32	effective	effective	JJ
cord-005453-4057qib7	13630	33	and	and	CC
cord-005453-4057qib7	13630	34	safe	safe	JJ
cord-005453-4057qib7	13630	35	method	method	NN
cord-005453-4057qib7	13630	36	to	to	TO
cord-005453-4057qib7	13630	37	reach	reach	VB
cord-005453-4057qib7	13630	38	and	and	CC
cord-005453-4057qib7	13630	39	attain	attain	VB
cord-005453-4057qib7	13630	40	sufficient	sufficient	JJ
cord-005453-4057qib7	13630	41	levels	level	NNS
cord-005453-4057qib7	13630	42	of	of	IN
cord-005453-4057qib7	13630	43	VD	vd	NN
cord-005453-4057qib7	13630	44	in	in	IN
cord-005453-4057qib7	13630	45	pediatric	pediatric	JJ
cord-005453-4057qib7	13630	46	patients	patient	NNS
cord-005453-4057qib7	13630	47	undergoing	undergo	VBG
cord-005453-4057qib7	13630	48	HSCT	HSCT	NNP
cord-005453-4057qib7	13630	49	.	.	.
cord-005453-4057qib7	13631	1	Methods	method	NNS
cord-005453-4057qib7	13631	2	:	:	:
cord-005453-4057qib7	13631	3	This	this	DT
cord-005453-4057qib7	13631	4	is	be	VBZ
cord-005453-4057qib7	13631	5	an	an	DT
cord-005453-4057qib7	13631	6	ongoing	ongoing	JJ
cord-005453-4057qib7	13631	7	prospective	prospective	NN
cord-005453-4057qib7	13631	8	,	,	,
cord-005453-4057qib7	13631	9	randomized	randomized	JJ
cord-005453-4057qib7	13631	10	clinical	clinical	JJ
cord-005453-4057qib7	13631	11	control	control	NN
cord-005453-4057qib7	13631	12	trial	trial	NN
cord-005453-4057qib7	13631	13	at	at	IN
cord-005453-4057qib7	13631	14	Phoenix	Phoenix	NNP
cord-005453-4057qib7	13631	15	Children	Children	NNP
cord-005453-4057qib7	13631	16	's	's	POS
cord-005453-4057qib7	13631	17	Hospital	Hospital	NNP
cord-005453-4057qib7	13631	18	that	that	WDT
cord-005453-4057qib7	13631	19	commenced	commence	VBD
cord-005453-4057qib7	13631	20	December	December	NNP
cord-005453-4057qib7	13631	21	1	1	CD
cord-005453-4057qib7	13631	22	st	st	NNP
cord-005453-4057qib7	13631	23	,	,	,
cord-005453-4057qib7	13631	24	2017	2017	CD
cord-005453-4057qib7	13631	25	.	.	.
cord-005453-4057qib7	13632	1	Following	follow	VBG
cord-005453-4057qib7	13632	2	consent	consent	NN
cord-005453-4057qib7	13632	3	,	,	,
cord-005453-4057qib7	13632	4	subjects	subject	NNS
cord-005453-4057qib7	13632	5	are	be	VBP
cord-005453-4057qib7	13632	6	randomized	randomize	VBN
cord-005453-4057qib7	13632	7	to	to	IN
cord-005453-4057qib7	13632	8	the	the	DT
cord-005453-4057qib7	13632	9	intervention	intervention	NN
cord-005453-4057qib7	13632	10	(	(	-LRB-
cord-005453-4057qib7	13632	11	Stoss	Stoss	NNP
cord-005453-4057qib7	13632	12	)	)	-RRB-
cord-005453-4057qib7	13632	13	or	or	CC
cord-005453-4057qib7	13632	14	control	control	NN
cord-005453-4057qib7	13632	15	arm	arm	NN
cord-005453-4057qib7	13632	16	prior	prior	RB
cord-005453-4057qib7	13632	17	to	to	IN
cord-005453-4057qib7	13632	18	HSCT	HSCT	NNP
cord-005453-4057qib7	13632	19	.	.	.
cord-005453-4057qib7	13633	1	Stoss	Stoss	NNP
cord-005453-4057qib7	13633	2	therapy	therapy	NN
cord-005453-4057qib7	13633	3	consists	consist	VBZ
cord-005453-4057qib7	13633	4	of	of	IN
cord-005453-4057qib7	13633	5	a	a	DT
cord-005453-4057qib7	13633	6	single	single	JJ
cord-005453-4057qib7	13633	7	oral	oral	JJ
cord-005453-4057qib7	13633	8	dose	dose	NN
cord-005453-4057qib7	13633	9	of	of	IN
cord-005453-4057qib7	13633	10	VD	VD	NNP
cord-005453-4057qib7	13633	11	(	(	-LRB-
cord-005453-4057qib7	13633	12	ranging	range	VBG
cord-005453-4057qib7	13633	13	100,000IU	100,000iu	CD
cord-005453-4057qib7	13633	14	-600,000IU	-600,000IU	NFP
cord-005453-4057qib7	13633	15	)	)	-RRB-
cord-005453-4057qib7	13633	16	,	,	,
cord-005453-4057qib7	13633	17	given	give	VBN
cord-005453-4057qib7	13633	18	based	base	VBN
cord-005453-4057qib7	13633	19	on	on	IN
cord-005453-4057qib7	13633	20	baseline	baseline	JJ
cord-005453-4057qib7	13633	21	25-hydroxyvitamin	25-hydroxyvitamin	CD
cord-005453-4057qib7	13633	22	D	d	NN
cord-005453-4057qib7	13633	23	[	[	-LRB-
cord-005453-4057qib7	13633	24	25(OH)D	25(oh)d	CD
cord-005453-4057qib7	13633	25	]	]	-RRB-
cord-005453-4057qib7	13633	26	level	level	NN
cord-005453-4057qib7	13633	27	and	and	CC
cord-005453-4057qib7	13633	28	age	age	NN
cord-005453-4057qib7	13633	29	,	,	,
cord-005453-4057qib7	13633	30	followed	follow	VBN
cord-005453-4057qib7	13633	31	by	by	IN
cord-005453-4057qib7	13633	32	standard	standard	JJ
cord-005453-4057qib7	13633	33	weekly	weekly	JJ
cord-005453-4057qib7	13633	34	supplementation	supplementation	NN
cord-005453-4057qib7	13633	35	.	.	.
cord-005453-4057qib7	13634	1	Subjects	subject	NNS
cord-005453-4057qib7	13634	2	enrolled	enrol	VBN
cord-005453-4057qib7	13634	3	on	on	IN
cord-005453-4057qib7	13634	4	the	the	DT
cord-005453-4057qib7	13634	5	control	control	NN
cord-005453-4057qib7	13634	6	arm	arm	NN
cord-005453-4057qib7	13634	7	receive	receive	VB
cord-005453-4057qib7	13634	8	standard	standard	NN
cord-005453-4057qib7	13634	9	of	of	IN
cord-005453-4057qib7	13634	10	care	care	NN
cord-005453-4057qib7	13634	11	based	base	VBN
cord-005453-4057qib7	13634	12	on	on	IN
cord-005453-4057qib7	13634	13	Endocrine	Endocrine	NNP
cord-005453-4057qib7	13634	14	Society	Society	NNP
cord-005453-4057qib7	13634	15	Guidelines	Guidelines	NNPS
cord-005453-4057qib7	13634	16	of	of	IN
cord-005453-4057qib7	13634	17	weekly	weekly	JJ
cord-005453-4057qib7	13634	18	VD	VD	NNP
cord-005453-4057qib7	13634	19	supplementation	supplementation	NN
cord-005453-4057qib7	13634	20	.	.	.
cord-005453-4057qib7	13635	1	Data	Data	NNP
cord-005453-4057qib7	13635	2	collection	collection	NN
cord-005453-4057qib7	13635	3	includes	include	VBZ
cord-005453-4057qib7	13635	4	demographics	demographic	NNS
cord-005453-4057qib7	13635	5	,	,	,
cord-005453-4057qib7	13635	6	25(OH)D	25(oh)d	CD
cord-005453-4057qib7	13635	7	levels	level	NNS
cord-005453-4057qib7	13635	8	at	at	IN
cord-005453-4057qib7	13635	9	baseline	baseline	NN
cord-005453-4057qib7	13635	10	,	,	,
cord-005453-4057qib7	13635	11	day	day	NN
cord-005453-4057qib7	13635	12	+30	+30	CD
cord-005453-4057qib7	13635	13	,	,	,
cord-005453-4057qib7	13635	14	and	and	CC
cord-005453-4057qib7	13635	15	day	day	NN
cord-005453-4057qib7	13635	16	+100	+100	NNS
cord-005453-4057qib7	13635	17	,	,	,
cord-005453-4057qib7	13635	18	VD	VD	NNP
cord-005453-4057qib7	13635	19	toxicity	toxicity	NN
cord-005453-4057qib7	13635	20	(	(	-LRB-
cord-005453-4057qib7	13635	21	hyperphosphatemia	hyperphosphatemia	NN
cord-005453-4057qib7	13635	22	,	,	,
cord-005453-4057qib7	13635	23	hyperkalemia	hyperkalemia	NN
cord-005453-4057qib7	13635	24	and	and	CC
cord-005453-4057qib7	13635	25	renal	renal	JJ
cord-005453-4057qib7	13635	26	calculi	calculus	NNS
cord-005453-4057qib7	13635	27	)	)	-RRB-
cord-005453-4057qib7	13635	28	,	,	,
cord-005453-4057qib7	13635	29	as	as	IN
cord-005453-4057qib7	13635	30	well	well	RB
cord-005453-4057qib7	13635	31	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	13635	32	were	be	VBD
cord-005453-4057qib7	13635	33	collected	collect	VBN
cord-005453-4057qib7	13635	34	.	.	.
cord-005453-4057qib7	13636	1	At	at	IN
cord-005453-4057qib7	13636	2	each	each	DT
cord-005453-4057qib7	13636	3	time	time	NN
cord-005453-4057qib7	13636	4	point	point	NN
cord-005453-4057qib7	13636	5	and	and	CC
cord-005453-4057qib7	13636	6	for	for	IN
cord-005453-4057qib7	13636	7	each	each	DT
cord-005453-4057qib7	13636	8	trial	trial	NN
cord-005453-4057qib7	13636	9	arm	arm	NN
cord-005453-4057qib7	13636	10	,	,	,
cord-005453-4057qib7	13636	11	the	the	DT
cord-005453-4057qib7	13636	12	mean	mean	JJ
cord-005453-4057qib7	13636	13	25(OH)D	25(oh)d	CD
cord-005453-4057qib7	13636	14	level	level	NN
cord-005453-4057qib7	13636	15	and	and	CC
cord-005453-4057qib7	13636	16	changes	change	NNS
cord-005453-4057qib7	13636	17	from	from	IN
cord-005453-4057qib7	13636	18	baseline	baseline	NN
cord-005453-4057qib7	13636	19	were	be	VBD
cord-005453-4057qib7	13636	20	computed	compute	VBN
cord-005453-4057qib7	13636	21	with	with	IN
cord-005453-4057qib7	13636	22	corresponding	correspond	VBG
cord-005453-4057qib7	13636	23	95	95	CD
cord-005453-4057qib7	13636	24	%	%	NN
cord-005453-4057qib7	13636	25	confidence	confidence	NN
cord-005453-4057qib7	13636	26	intervals	interval	NNS
cord-005453-4057qib7	13636	27	(	(	-LRB-
cord-005453-4057qib7	13636	28	CIs	CIs	NNP
cord-005453-4057qib7	13636	29	)	)	-RRB-
cord-005453-4057qib7	13636	30	to	to	TO
cord-005453-4057qib7	13636	31	indicate	indicate	VB
cord-005453-4057qib7	13636	32	variability	variability	NN
cord-005453-4057qib7	13636	33	.	.	.
cord-005453-4057qib7	13637	1	Results	result	NNS
cord-005453-4057qib7	13637	2	:	:	:
cord-005453-4057qib7	13637	3	Presently	presently	RB
cord-005453-4057qib7	13637	4	,	,	,
cord-005453-4057qib7	13637	5	12	12	CD
cord-005453-4057qib7	13637	6	subjects	subject	NNS
cord-005453-4057qib7	13637	7	have	have	VBP
cord-005453-4057qib7	13637	8	completed	complete	VBN
cord-005453-4057qib7	13637	9	baseline	baseline	JJ
cord-005453-4057qib7	13637	10	assessment	assessment	NN
cord-005453-4057qib7	13637	11	,	,	,
cord-005453-4057qib7	13637	12	with	with	IN
cord-005453-4057qib7	13637	13	Day	day	NN
cord-005453-4057qib7	13637	14	+30	+30	CD
cord-005453-4057qib7	13637	15	and	and	CC
cord-005453-4057qib7	13637	16	Day	day	NN
cord-005453-4057qib7	13637	17	+100	+100	NNS
cord-005453-4057qib7	13637	18	follow	follow	NN
cord-005453-4057qib7	13637	19	-	-	HYPH
cord-005453-4057qib7	13637	20	up	up	NN
cord-005453-4057qib7	13637	21	completed	complete	VBD
cord-005453-4057qib7	13637	22	for	for	IN
cord-005453-4057qib7	13637	23	11	11	CD
cord-005453-4057qib7	13637	24	and	and	CC
cord-005453-4057qib7	13637	25	9	9	CD
cord-005453-4057qib7	13637	26	of	of	IN
cord-005453-4057qib7	13637	27	these	these	DT
cord-005453-4057qib7	13637	28	,	,	,
cord-005453-4057qib7	13637	29	respectively	respectively	RB
cord-005453-4057qib7	13637	30	.	.	.
cord-005453-4057qib7	13638	1	At	at	IN
cord-005453-4057qib7	13638	2	baseline	baseline	NN
cord-005453-4057qib7	13638	3	,	,	,
cord-005453-4057qib7	13638	4	the	the	DT
cord-005453-4057qib7	13638	5	mean	mean	NN
cord-005453-4057qib7	13638	6	(	(	-LRB-
cord-005453-4057qib7	13638	7	95	95	CD
cord-005453-4057qib7	13638	8	%	%	NN
cord-005453-4057qib7	13638	9	CI	CI	NNP
cord-005453-4057qib7	13638	10	)	)	-RRB-
cord-005453-4057qib7	13638	11	25(OH)D	25(oh)d	CD
cord-005453-4057qib7	13638	12	was	be	VBD
cord-005453-4057qib7	13638	13	19.8	19.8	CD
cord-005453-4057qib7	13638	14	ng	ng	NNP
cord-005453-4057qib7	13638	15	/	/	SYM
cord-005453-4057qib7	13638	16	dl	dl	NNP
cord-005453-4057qib7	13638	17	(	(	-LRB-
cord-005453-4057qib7	13638	18	10.9	10.9	CD
cord-005453-4057qib7	13638	19	,	,	,
cord-005453-4057qib7	13638	20	28.7	28.7	CD
cord-005453-4057qib7	13638	21	)	)	-RRB-
cord-005453-4057qib7	13638	22	among	among	IN
cord-005453-4057qib7	13638	23	Stoss	Stoss	NNP
cord-005453-4057qib7	13638	24	patients	patient	NNS
cord-005453-4057qib7	13638	25	and	and	CC
cord-005453-4057qib7	13638	26	18.9	18.9	CD
cord-005453-4057qib7	13638	27	ng	ng	NNP
cord-005453-4057qib7	13638	28	/	/	SYM
cord-005453-4057qib7	13638	29	dl	dl	NNP
cord-005453-4057qib7	13638	30	(	(	-LRB-
cord-005453-4057qib7	13638	31	10	10	CD
cord-005453-4057qib7	13638	32	.	.	.
cord-005453-4057qib7	13639	1	3	3	CD
cord-005453-4057qib7	13639	2	Results	result	NNS
cord-005453-4057qib7	13639	3	:	:	:
cord-005453-4057qib7	13639	4	Total	total	JJ
cord-005453-4057qib7	13639	5	HRQoL	HRQoL	NNP
cord-005453-4057qib7	13639	6	scores	score	NNS
cord-005453-4057qib7	13639	7	of	of	IN
cord-005453-4057qib7	13639	8	transplanted	transplant	VBN
cord-005453-4057qib7	13639	9	patients	patient	NNS
cord-005453-4057qib7	13639	10	were	be	VBD
cord-005453-4057qib7	13639	11	significantly	significantly	RB
cord-005453-4057qib7	13639	12	improved	improve	VBN
cord-005453-4057qib7	13639	13	compared	compare	VBN
cord-005453-4057qib7	13639	14	to	to	IN
cord-005453-4057qib7	13639	15	those	those	DT
cord-005453-4057qib7	13639	16	on	on	IN
cord-005453-4057qib7	13639	17	supportive	supportive	JJ
cord-005453-4057qib7	13639	18	care	care	NN
cord-005453-4057qib7	13639	19	and	and	CC
cord-005453-4057qib7	13639	20	also	also	RB
cord-005453-4057qib7	13639	21	compared	compare	VBN
cord-005453-4057qib7	13639	22	to	to	IN
cord-005453-4057qib7	13639	23	healthy	healthy	JJ
cord-005453-4057qib7	13639	24	siblings	sibling	NNS
cord-005453-4057qib7	13639	25	(	(	-LRB-
cord-005453-4057qib7	13639	26	P	p	NN
cord-005453-4057qib7	13639	27	<	<	XX
cord-005453-4057qib7	13639	28	0.0001	0.0001	CD
cord-005453-4057qib7	13639	29	and	and	CC
cord-005453-4057qib7	13639	30	0.0002	0.0002	CD
cord-005453-4057qib7	13639	31	respectively	respectively	RB
cord-005453-4057qib7	13639	32	)	)	-RRB-
cord-005453-4057qib7	13639	33	,	,	,
cord-005453-4057qib7	13639	34	the	the	DT
cord-005453-4057qib7	13639	35	same	same	JJ
cord-005453-4057qib7	13639	36	was	be	VBD
cord-005453-4057qib7	13639	37	true	true	JJ
cord-005453-4057qib7	13639	38	for	for	IN
cord-005453-4057qib7	13639	39	physical	physical	JJ
cord-005453-4057qib7	13639	40	(	(	-LRB-
cord-005453-4057qib7	13639	41	P	p	NN
cord-005453-4057qib7	13639	42	<	<	XX
cord-005453-4057qib7	13639	43	0.0001	0.0001	CD
cord-005453-4057qib7	13639	44	and	and	CC
cord-005453-4057qib7	13639	45	0.0003	0.0003	CD
cord-005453-4057qib7	13639	46	respectively	respectively	RB
cord-005453-4057qib7	13639	47	)	)	-RRB-
cord-005453-4057qib7	13639	48	and	and	CC
cord-005453-4057qib7	13639	49	emotional	emotional	JJ
cord-005453-4057qib7	13639	50	functioning	functioning	NN
cord-005453-4057qib7	13639	51	(	(	-LRB-
cord-005453-4057qib7	13639	52	P	p	NN
cord-005453-4057qib7	13639	53	<	<	XX
cord-005453-4057qib7	13639	54	0.0001	0.0001	CD
cord-005453-4057qib7	13639	55	and	and	CC
cord-005453-4057qib7	13639	56	0.0073	0.0073	CD
cord-005453-4057qib7	13639	57	respectively	respectively	RB
cord-005453-4057qib7	13639	58	)	)	-RRB-
cord-005453-4057qib7	13639	59	.	.	.
cord-005453-4057qib7	13640	1	Social	social	JJ
cord-005453-4057qib7	13640	2	and	and	CC
cord-005453-4057qib7	13640	3	school	school	NN
cord-005453-4057qib7	13640	4	functioning	functioning	NN
cord-005453-4057qib7	13640	5	of	of	IN
cord-005453-4057qib7	13640	6	transplanted	transplanted	JJ
cord-005453-4057qib7	13640	7	children	child	NNS
cord-005453-4057qib7	13640	8	were	be	VBD
cord-005453-4057qib7	13640	9	not	not	RB
cord-005453-4057qib7	13640	10	different	different	JJ
cord-005453-4057qib7	13640	11	from	from	IN
cord-005453-4057qib7	13640	12	healthy	healthy	JJ
cord-005453-4057qib7	13640	13	siblings	sibling	NNS
cord-005453-4057qib7	13640	14	(	(	-LRB-
cord-005453-4057qib7	13640	15	P	p	NN
cord-005453-4057qib7	13640	16	0.5893	0.5893	CD
cord-005453-4057qib7	13640	17	and	and	CC
cord-005453-4057qib7	13640	18	0.7603	0.7603	CD
cord-005453-4057qib7	13640	19	respectively	respectively	RB
cord-005453-4057qib7	13640	20	)	)	-RRB-
cord-005453-4057qib7	13640	21	while	while	IN
cord-005453-4057qib7	13640	22	were	be	VBD
cord-005453-4057qib7	13640	23	very	very	RB
cord-005453-4057qib7	13640	24	significantly	significantly	RB
cord-005453-4057qib7	13640	25	improved	improve	VBN
cord-005453-4057qib7	13640	26	compared	compare	VBN
cord-005453-4057qib7	13640	27	to	to	IN
cord-005453-4057qib7	13640	28	children	child	NNS
cord-005453-4057qib7	13640	29	with	with	IN
cord-005453-4057qib7	13640	30	ST	ST	NNP
cord-005453-4057qib7	13640	31	on	on	IN
cord-005453-4057qib7	13640	32	supportive	supportive	JJ
cord-005453-4057qib7	13640	33	care	care	NN
cord-005453-4057qib7	13641	1	(	(	-LRB-
cord-005453-4057qib7	13641	2	P	p	NN
cord-005453-4057qib7	13641	3	<	<	XX
cord-005453-4057qib7	13641	4	0.0001	0.0001	CD
cord-005453-4057qib7	13641	5	in	in	IN
cord-005453-4057qib7	13641	6	both	both	DT
cord-005453-4057qib7	13641	7	cases	case	NNS
cord-005453-4057qib7	13641	8	)	)	-RRB-
cord-005453-4057qib7	13641	9	.	.	.
cord-005453-4057qib7	13642	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13642	2	:	:	:
cord-005453-4057qib7	13642	3	BMT	BMT	NNP
cord-005453-4057qib7	13642	4	in	in	IN
cord-005453-4057qib7	13642	5	a	a	DT
cord-005453-4057qib7	13642	6	lower	low	JJR
cord-005453-4057qib7	13642	7	-	-	HYPH
cord-005453-4057qib7	13642	8	middle	middle	JJ
cord-005453-4057qib7	13642	9	income	income	NN
cord-005453-4057qib7	13642	10	setting	setting	NN
cord-005453-4057qib7	13642	11	may	may	MD
cord-005453-4057qib7	13642	12	be	be	VB
cord-005453-4057qib7	13642	13	even	even	RB
cord-005453-4057qib7	13642	14	more	more	RBR
cord-005453-4057qib7	13642	15	impactful	impactful	JJ
cord-005453-4057qib7	13642	16	compared	compare	VBN
cord-005453-4057qib7	13642	17	to	to	IN
cord-005453-4057qib7	13642	18	high	high	JJ
cord-005453-4057qib7	13642	19	-	-	HYPH
cord-005453-4057qib7	13642	20	income	income	NN
cord-005453-4057qib7	13642	21	regions	region	NNS
cord-005453-4057qib7	13642	22	.	.	.
cord-005453-4057qib7	13643	1	Our	-PRON-	PRP$
cord-005453-4057qib7	13643	2	analysis	analysis	NN
cord-005453-4057qib7	13643	3	clearly	clearly	RB
cord-005453-4057qib7	13643	4	indicates	indicate	VBZ
cord-005453-4057qib7	13643	5	normalization	normalization	NN
cord-005453-4057qib7	13643	6	of	of	IN
cord-005453-4057qib7	13643	7	HRQoL	HRQoL	NNP
cord-005453-4057qib7	13643	8	in	in	IN
cord-005453-4057qib7	13643	9	all	all	DT
cord-005453-4057qib7	13643	10	major	major	JJ
cord-005453-4057qib7	13643	11	areas	area	NNS
cord-005453-4057qib7	13643	12	of	of	IN
cord-005453-4057qib7	13643	13	children	child	NNS
cord-005453-4057qib7	13643	14	transplanted	transplant	VBN
cord-005453-4057qib7	13643	15	for	for	IN
cord-005453-4057qib7	13643	16	ST	ST	NNP
cord-005453-4057qib7	13643	17	.	.	.
cord-005453-4057qib7	13644	1	A	a	DT
cord-005453-4057qib7	13644	2	possible	possible	JJ
cord-005453-4057qib7	13644	3	resilience	resilience	NN
cord-005453-4057qib7	13644	4	effect	effect	NN
cord-005453-4057qib7	13644	5	was	be	VBD
cord-005453-4057qib7	13644	6	noted	note	VBN
cord-005453-4057qib7	13644	7	for	for	IN
cord-005453-4057qib7	13644	8	physical	physical	JJ
cord-005453-4057qib7	13644	9	and	and	CC
cord-005453-4057qib7	13644	10	emotional	emotional	JJ
cord-005453-4057qib7	13644	11	scores	score	NNS
cord-005453-4057qib7	13644	12	which	which	WDT
cord-005453-4057qib7	13644	13	were	be	VBD
cord-005453-4057qib7	13644	14	improved	improve	VBN
cord-005453-4057qib7	13644	15	compared	compare	VBN
cord-005453-4057qib7	13644	16	to	to	IN
cord-005453-4057qib7	13644	17	healthy	healthy	JJ
cord-005453-4057qib7	13644	18	sibling	sibling	NN
cord-005453-4057qib7	13644	19	controls	control	NNS
cord-005453-4057qib7	13644	20	.	.	.
cord-005453-4057qib7	13645	1	We	-PRON-	PRP
cord-005453-4057qib7	13645	2	could	could	MD
cord-005453-4057qib7	13645	3	not	not	RB
cord-005453-4057qib7	13645	4	however	however	RB
cord-005453-4057qib7	13645	5	quantify	quantify	VB
cord-005453-4057qib7	13645	6	the	the	DT
cord-005453-4057qib7	13645	7	effect	effect	NN
cord-005453-4057qib7	13645	8	of	of	IN
cord-005453-4057qib7	13645	9	longer	long	JJR
cord-005453-4057qib7	13645	10	-	-	HYPH
cord-005453-4057qib7	13645	11	term	term	NN
cord-005453-4057qib7	13645	12	issues	issue	NNS
cord-005453-4057qib7	13645	13	like	like	IN
cord-005453-4057qib7	13645	14	fertility	fertility	NN
cord-005453-4057qib7	13645	15	impairment	impairment	NN
cord-005453-4057qib7	13645	16	after	after	IN
cord-005453-4057qib7	13645	17	BMT	BMT	NNP
cord-005453-4057qib7	13645	18	which	which	WDT
cord-005453-4057qib7	13645	19	may	may	MD
cord-005453-4057qib7	13645	20	eventually	eventually	RB
cord-005453-4057qib7	13645	21	adversely	adversely	RB
cord-005453-4057qib7	13645	22	impact	impact	VB
cord-005453-4057qib7	13645	23	HRQoL	HRQoL	NNP
cord-005453-4057qib7	13645	24	,	,	,
cord-005453-4057qib7	13645	25	particularly	particularly	RB
cord-005453-4057qib7	13645	26	in	in	IN
cord-005453-4057qib7	13645	27	the	the	DT
cord-005453-4057qib7	13645	28	Indian	indian	JJ
cord-005453-4057qib7	13645	29	culture	culture	NN
cord-005453-4057qib7	13645	30	.	.	.
cord-005453-4057qib7	13646	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13646	2	:	:	:
cord-005453-4057qib7	13647	1	None	none	NN
cord-005453-4057qib7	13647	2	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	13647	3	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13647	4	stem	stem	NN
cord-005453-4057qib7	13647	5	cell	cell	NN
cord-005453-4057qib7	13647	6	transplantation	transplantation	NN
cord-005453-4057qib7	13647	7	in	in	IN
cord-005453-4057qib7	13647	8	ataxia	ataxia	NN
cord-005453-4057qib7	13647	9	telangiectasia	telangiectasia	NN
cord-005453-4057qib7	13647	10	patients	patient	NNS
cord-005453-4057qib7	13647	11	without	without	IN
cord-005453-4057qib7	13647	12	malignancy	malignancy	NN
cord-005453-4057qib7	13647	13	Background	background	NN
cord-005453-4057qib7	13647	14	:	:	:
cord-005453-4057qib7	13648	1	Ataxia	Ataxia	NNP
cord-005453-4057qib7	13648	2	telangiectasia	telangiectasia	NNP
cord-005453-4057qib7	13648	3	(	(	-LRB-
cord-005453-4057qib7	13648	4	A	A	NNP
cord-005453-4057qib7	13648	5	-	-	HYPH
cord-005453-4057qib7	13648	6	T	T	NNP
cord-005453-4057qib7	13648	7	)	)	-RRB-
cord-005453-4057qib7	13648	8	is	be	VBZ
cord-005453-4057qib7	13648	9	a	a	DT
cord-005453-4057qib7	13648	10	primary	primary	JJ
cord-005453-4057qib7	13648	11	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	13648	12	with	with	IN
cord-005453-4057qib7	13648	13	mutations	mutation	NNS
cord-005453-4057qib7	13648	14	in	in	IN
cord-005453-4057qib7	13648	15	ATM	atm	NN
cord-005453-4057qib7	13648	16	-	-	HYPH
cord-005453-4057qib7	13648	17	gene	gene	NN
cord-005453-4057qib7	13648	18	.	.	.
cord-005453-4057qib7	13649	1	Besides	besides	IN
cord-005453-4057qib7	13649	2	a	a	DT
cord-005453-4057qib7	13649	3	slowly	slowly	RB
cord-005453-4057qib7	13649	4	progressive	progressive	JJ
cord-005453-4057qib7	13649	5	neurodegenerative	neurodegenerative	JJ
cord-005453-4057qib7	13649	6	course	course	NN
cord-005453-4057qib7	13649	7	,	,	,
cord-005453-4057qib7	13649	8	A	A	NNP
cord-005453-4057qib7	13649	9	-	-	HYPH
cord-005453-4057qib7	13649	10	T	T	NNP
cord-005453-4057qib7	13649	11	leads	lead	VBZ
cord-005453-4057qib7	13649	12	to	to	IN
cord-005453-4057qib7	13649	13	increased	increase	VBN
cord-005453-4057qib7	13649	14	susceptibility	susceptibility	NN
cord-005453-4057qib7	13649	15	to	to	IN
cord-005453-4057qib7	13649	16	malignancies	malignancy	NNS
cord-005453-4057qib7	13649	17	which	which	WDT
cord-005453-4057qib7	13649	18	affects	affect	VBZ
cord-005453-4057qib7	13649	19	25	25	CD
cord-005453-4057qib7	13649	20	%	%	NN
cord-005453-4057qib7	13649	21	of	of	IN
cord-005453-4057qib7	13649	22	patient	patient	NN
cord-005453-4057qib7	13649	23	(	(	-LRB-
cord-005453-4057qib7	13649	24	median:12.5	median:12.5	CD
cord-005453-4057qib7	13649	25	years	year	NNS
cord-005453-4057qib7	13649	26	)	)	-RRB-
cord-005453-4057qib7	13649	27	with	with	IN
cord-005453-4057qib7	13649	28	a	a	DT
cord-005453-4057qib7	13649	29	high	high	JJ
cord-005453-4057qib7	13649	30	mortality	mortality	NN
cord-005453-4057qib7	13649	31	mainly	mainly	RB
cord-005453-4057qib7	13649	32	due	due	JJ
cord-005453-4057qib7	13649	33	tocomplications	tocomplication	NNS
cord-005453-4057qib7	13649	34	of	of	IN
cord-005453-4057qib7	13649	35	conventional	conventional	JJ
cord-005453-4057qib7	13649	36	radio	radio	NN
cord-005453-4057qib7	13649	37	-	-	HYPH
cord-005453-4057qib7	13649	38	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13649	39	.	.	.
cord-005453-4057qib7	13650	1	The	the	DT
cord-005453-4057qib7	13650	2	incidence	incidence	NN
cord-005453-4057qib7	13650	3	of	of	IN
cord-005453-4057qib7	13650	4	cancer	cancer	NN
cord-005453-4057qib7	13650	5	correlates	correlate	VBZ
cord-005453-4057qib7	13650	6	with	with	IN
cord-005453-4057qib7	13650	7	the	the	DT
cord-005453-4057qib7	13650	8	extent	extent	NN
cord-005453-4057qib7	13650	9	of	of	IN
cord-005453-4057qib7	13650	10	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	13650	11	.	.	.
cord-005453-4057qib7	13651	1	Patients	patient	NNS
cord-005453-4057qib7	13651	2	often	often	RB
cord-005453-4057qib7	13651	3	develop	develop	VBP
cord-005453-4057qib7	13651	4	severe	severe	JJ
cord-005453-4057qib7	13651	5	progressive	progressive	JJ
cord-005453-4057qib7	13651	6	granulomatous	granulomatous	JJ
cord-005453-4057qib7	13651	7	skin	skin	NN
cord-005453-4057qib7	13651	8	disease	disease	NN
cord-005453-4057qib7	13651	9	with	with	IN
cord-005453-4057qib7	13651	10	evidence	evidence	NN
cord-005453-4057qib7	13651	11	of	of	IN
cord-005453-4057qib7	13651	12	vaccine	vaccine	NN
cord-005453-4057qib7	13651	13	-	-	HYPH
cord-005453-4057qib7	13651	14	strain	strain	NN
cord-005453-4057qib7	13651	15	rubella	rubella	NN
cord-005453-4057qib7	13651	16	-	-	HYPH
cord-005453-4057qib7	13651	17	virus	virus	NN
cord-005453-4057qib7	13651	18	in	in	IN
cord-005453-4057qib7	13651	19	the	the	DT
cord-005453-4057qib7	13651	20	lesions	lesion	NNS
cord-005453-4057qib7	13651	21	.	.	.
cord-005453-4057qib7	13652	1	Prolonged	prolonged	JJ
cord-005453-4057qib7	13652	2	survival	survival	NN
cord-005453-4057qib7	13652	3	,	,	,
cord-005453-4057qib7	13652	4	neurologic	neurologic	JJ
cord-005453-4057qib7	13652	5	improvement	improvement	NN
cord-005453-4057qib7	13652	6	and	and	CC
cord-005453-4057qib7	13652	7	malignancy	malignancy	NN
cord-005453-4057qib7	13652	8	prevention	prevention	NN
cord-005453-4057qib7	13652	9	was	be	VBD
cord-005453-4057qib7	13652	10	observed	observe	VBN
cord-005453-4057qib7	13652	11	in	in	IN
cord-005453-4057qib7	13652	12	Atm	atm	NN
cord-005453-4057qib7	13652	13	-	-	HYPH
cord-005453-4057qib7	13652	14	deficient	deficient	JJ
cord-005453-4057qib7	13652	15	mice	mouse	NNS
cord-005453-4057qib7	13652	16	after	after	IN
cord-005453-4057qib7	13652	17	treatment	treatment	NN
cord-005453-4057qib7	13652	18	by	by	IN
cord-005453-4057qib7	13652	19	syngeneic	syngeneic	NNS
cord-005453-4057qib7	13652	20	HSCT	HSCT	NNP
cord-005453-4057qib7	13652	21	.	.	.
cord-005453-4057qib7	13653	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	13653	2	,	,	,
cord-005453-4057qib7	13653	3	pre	pre	JJ
cord-005453-4057qib7	13653	4	-	-	JJ
cord-005453-4057qib7	13653	5	emptive	emptive	JJ
cord-005453-4057qib7	13653	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13653	7	is	be	VBZ
cord-005453-4057qib7	13653	8	not	not	RB
cord-005453-4057qib7	13653	9	routinely	routinely	RB
cord-005453-4057qib7	13653	10	performed	perform	VBN
cord-005453-4057qib7	13653	11	in	in	IN
cord-005453-4057qib7	13653	12	A	A	NNP
cord-005453-4057qib7	13653	13	-	-	HYPH
cord-005453-4057qib7	13653	14	T	t	NN
cord-005453-4057qib7	13653	15	patients	patient	NNS
cord-005453-4057qib7	13653	16	due	due	JJ
cord-005453-4057qib7	13653	17	to	to	IN
cord-005453-4057qib7	13653	18	concerns	concern	NNS
cord-005453-4057qib7	13653	19	about	about	IN
cord-005453-4057qib7	13653	20	neurodegeneration	neurodegeneration	NN
cord-005453-4057qib7	13653	21	and	and	CC
cord-005453-4057qib7	13653	22	toxicity	toxicity	NN
cord-005453-4057qib7	13653	23	.	.	.
cord-005453-4057qib7	13654	1	Methods	method	NNS
cord-005453-4057qib7	13654	2	:	:	:
cord-005453-4057qib7	13654	3	We	-PRON-	PRP
cord-005453-4057qib7	13654	4	present	present	VBP
cord-005453-4057qib7	13654	5	three	three	CD
cord-005453-4057qib7	13654	6	A	A	NNP
cord-005453-4057qib7	13654	7	-	-	HYPH
cord-005453-4057qib7	13654	8	T	t	NN
cord-005453-4057qib7	13654	9	patients	patient	NNS
cord-005453-4057qib7	13654	10	with	with	IN
cord-005453-4057qib7	13654	11	severe	severe	JJ
cord-005453-4057qib7	13654	12	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	13654	13	phenotype	phenotype	NN
cord-005453-4057qib7	13654	14	,	,	,
cord-005453-4057qib7	13654	15	undergoing	undergo	VBG
cord-005453-4057qib7	13654	16	successful	successful	JJ
cord-005453-4057qib7	13654	17	HSCT	HSCT	NNP
cord-005453-4057qib7	13654	18	as	as	IN
cord-005453-4057qib7	13654	19	an	an	DT
cord-005453-4057qib7	13654	20	individual	individual	JJ
cord-005453-4057qib7	13654	21	treatment	treatment	NN
cord-005453-4057qib7	13654	22	strategy	strategy	NN
cord-005453-4057qib7	13654	23	intending	intend	VBG
cord-005453-4057qib7	13654	24	to	to	TO
cord-005453-4057qib7	13654	25	restore	restore	VB
cord-005453-4057qib7	13654	26	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	13654	27	for	for	IN
cord-005453-4057qib7	13654	28	long	long	JJ
cord-005453-4057qib7	13654	29	-	-	HYPH
cord-005453-4057qib7	13654	30	term	term	NN
cord-005453-4057qib7	13654	31	malignancyprevention	malignancyprevention	NN
cord-005453-4057qib7	13654	32	(	(	-LRB-
cord-005453-4057qib7	13654	33	patient-1	patient-1	NNP
cord-005453-4057qib7	13654	34	)	)	-RRB-
cord-005453-4057qib7	13654	35	and	and	CC
cord-005453-4057qib7	13654	36	to	to	TO
cord-005453-4057qib7	13654	37	treat	treat	VB
cord-005453-4057qib7	13654	38	progressive	progressive	JJ
cord-005453-4057qib7	13654	39	skin	skin	NN
cord-005453-4057qib7	13654	40	/	/	SYM
cord-005453-4057qib7	13654	41	joint	joint	JJ
cord-005453-4057qib7	13654	42	granulomas	granuloma	NNS
cord-005453-4057qib7	13654	43	(	(	-LRB-
cord-005453-4057qib7	13655	1	Patients-2	Patients-2	NNP
cord-005453-4057qib7	13655	2	and	and	CC
cord-005453-4057qib7	13655	3	-3	-3	NNP
cord-005453-4057qib7	13655	4	)	)	-RRB-
cord-005453-4057qib7	13655	5	.	.	.
cord-005453-4057qib7	13656	1	Results	result	NNS
cord-005453-4057qib7	13656	2	:	:	:
cord-005453-4057qib7	13657	1	Patient-1	Patient-1	NNP
cord-005453-4057qib7	13657	2	underwent	undergo	VBD
cord-005453-4057qib7	13657	3	a	a	DT
cord-005453-4057qib7	13657	4	reduced	reduce	VBN
cord-005453-4057qib7	13657	5	intensity	intensity	NN
cord-005453-4057qib7	13657	6	conditioning	conditioning	NN
cord-005453-4057qib7	13657	7	(	(	-LRB-
cord-005453-4057qib7	13657	8	RIC	RIC	NNP
cord-005453-4057qib7	13657	9	)	)	-RRB-
cord-005453-4057qib7	13657	10	regimen	regimen	NN
cord-005453-4057qib7	13657	11	at	at	IN
cord-005453-4057qib7	13657	12	4	4	CD
cord-005453-4057qib7	13657	13	years	year	NNS
cord-005453-4057qib7	13657	14	of	of	IN
cord-005453-4057qib7	13657	15	age	age	NN
cord-005453-4057qib7	13657	16	including	include	VBG
cord-005453-4057qib7	13657	17	fludarabine	fludarabine	NN
cord-005453-4057qib7	13657	18	(	(	-LRB-
cord-005453-4057qib7	13657	19	150	150	CD
cord-005453-4057qib7	13657	20	mg	mg	NNP
cord-005453-4057qib7	13657	21	/	/	SYM
cord-005453-4057qib7	13657	22	m	m	NNP
cord-005453-4057qib7	13657	23	2	2	CD
cord-005453-4057qib7	13657	24	)	)	-RRB-
cord-005453-4057qib7	13657	25	,	,	,
cord-005453-4057qib7	13657	26	cyclophosphamide	cyclophosphamide	FW
cord-005453-4057qib7	13657	27	(	(	-LRB-
cord-005453-4057qib7	13657	28	80	80	CD
cord-005453-4057qib7	13657	29	mg	mg	NNP
cord-005453-4057qib7	13657	30	/	/	SYM
cord-005453-4057qib7	13657	31	kg	kg	NNP
cord-005453-4057qib7	13657	32	)	)	-RRB-
cord-005453-4057qib7	13657	33	,	,	,
cord-005453-4057qib7	13657	34	and	and	CC
cord-005453-4057qib7	13657	35	ATG	ATG	NNP
cord-005453-4057qib7	13657	36	-	-	HYPH
cord-005453-4057qib7	13657	37	Fresenius	Fresenius	NNP
cord-005453-4057qib7	13657	38	(	(	-LRB-
cord-005453-4057qib7	13657	39	20	20	CD
cord-005453-4057qib7	13657	40	mg	mg	NNP
cord-005453-4057qib7	13657	41	/	/	SYM
cord-005453-4057qib7	13657	42	kg	kg	NNP
cord-005453-4057qib7	13657	43	/	/	SYM
cord-005453-4057qib7	13657	44	d	d	NN
cord-005453-4057qib7	13657	45	)	)	-RRB-
cord-005453-4057qib7	13657	46	which	which	WDT
cord-005453-4057qib7	13657	47	was	be	VBD
cord-005453-4057qib7	13657	48	tolerated	tolerate	VBN
cord-005453-4057qib7	13657	49	well	well	RB
cord-005453-4057qib7	13657	50	.	.	.
cord-005453-4057qib7	13658	1	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	13658	2	engraftment	engraftment	NN
cord-005453-4057qib7	13658	3	occurred	occur	VBD
cord-005453-4057qib7	13658	4	by	by	IN
cord-005453-4057qib7	13658	5	day	day	NN
cord-005453-4057qib7	13658	6	+15	+15	NNS
cord-005453-4057qib7	13658	7	.	.	.
cord-005453-4057qib7	13659	1	There	there	EX
cord-005453-4057qib7	13659	2	was	be	VBD
cord-005453-4057qib7	13659	3	an	an	DT
cord-005453-4057qib7	13659	4	expansion	expansion	NN
cord-005453-4057qib7	13659	5	of	of	IN
cord-005453-4057qib7	13659	6	naïve	naïve	JJ
cord-005453-4057qib7	13659	7	and	and	CC
cord-005453-4057qib7	13659	8	memory	memory	NN
cord-005453-4057qib7	13659	9	CD4	CD4	NNP
cord-005453-4057qib7	13659	10	+	+	CC
cord-005453-4057qib7	13659	11	T	T	NNP
cord-005453-4057qib7	13659	12	-	-	HYPH
cord-005453-4057qib7	13659	13	cells	cell	NNS
cord-005453-4057qib7	13659	14	and	and	CC
cord-005453-4057qib7	13659	15	CD19	CD19	NNP
cord-005453-4057qib7	13659	16	+	+	CC
cord-005453-4057qib7	13659	17	cells	cell	NNS
cord-005453-4057qib7	13659	18	.	.	.
cord-005453-4057qib7	13660	1	While	while	IN
cord-005453-4057qib7	13660	2	initially	initially	RB
cord-005453-4057qib7	13660	3	a	a	DT
cord-005453-4057qib7	13660	4	mixed	mixed	JJ
cord-005453-4057qib7	13660	5	donor	donor	NN
cord-005453-4057qib7	13660	6	chimerism	chimerism	NN
cord-005453-4057qib7	13660	7	in	in	IN
cord-005453-4057qib7	13660	8	patient	patient	NN
cord-005453-4057qib7	13660	9	's	's	POS
cord-005453-4057qib7	13660	10	PBMCs	pbmc	NNS
cord-005453-4057qib7	13660	11	(	(	-LRB-
cord-005453-4057qib7	13660	12	10	10	CD
cord-005453-4057qib7	13660	13	-	-	SYM
cord-005453-4057qib7	13660	14	20	20	CD
cord-005453-4057qib7	13660	15	%	%	NN
cord-005453-4057qib7	13660	16	donor	donor	NN
cord-005453-4057qib7	13660	17	)	)	-RRB-
cord-005453-4057qib7	13660	18	was	be	VBD
cord-005453-4057qib7	13660	19	observed	observe	VBN
cord-005453-4057qib7	13660	20	,	,	,
cord-005453-4057qib7	13660	21	patient	patient	JJ
cord-005453-4057qib7	13660	22	's	's	POS
cord-005453-4057qib7	13660	23	Tcells	Tcells	NNP
cord-005453-4057qib7	13660	24	(	(	-LRB-
cord-005453-4057qib7	13660	25	CD3	CD3	NNP
cord-005453-4057qib7	13660	26	+	+	SYM
cord-005453-4057qib7	13660	27	)	)	-RRB-
cord-005453-4057qib7	13660	28	reached	reach	VBD
cord-005453-4057qib7	13660	29	over	over	IN
cord-005453-4057qib7	13660	30	90	90	CD
cord-005453-4057qib7	13660	31	%	%	NN
cord-005453-4057qib7	13660	32	of	of	IN
cord-005453-4057qib7	13660	33	donor	donor	NN
cord-005453-4057qib7	13660	34	origin	origin	NN
cord-005453-4057qib7	13660	35	over	over	IN
cord-005453-4057qib7	13660	36	time	time	NN
cord-005453-4057qib7	13660	37	.	.	.
cord-005453-4057qib7	13661	1	At	at	IN
cord-005453-4057qib7	13661	2	last	last	JJ
cord-005453-4057qib7	13661	3	follow	follow	NN
cord-005453-4057qib7	13661	4	-	-	HYPH
cord-005453-4057qib7	13661	5	up	up	NN
cord-005453-4057qib7	13661	6	(	(	-LRB-
cord-005453-4057qib7	13661	7	6	6	CD
cord-005453-4057qib7	13661	8	years	year	NNS
cord-005453-4057qib7	13661	9	)	)	-RRB-
cord-005453-4057qib7	13661	10	he	-PRON-	PRP
cord-005453-4057qib7	13661	11	is	be	VBZ
cord-005453-4057qib7	13661	12	well	well	JJ
cord-005453-4057qib7	13661	13	,	,	,
cord-005453-4057qib7	13661	14	without	without	IN
cord-005453-4057qib7	13661	15	signs	sign	NNS
cord-005453-4057qib7	13661	16	of	of	IN
cord-005453-4057qib7	13661	17	GVHD	GVHD	NNP
cord-005453-4057qib7	13661	18	and	and	CC
cord-005453-4057qib7	13661	19	organ	organ	NN
cord-005453-4057qib7	13661	20	toxicity	toxicity	NN
cord-005453-4057qib7	13661	21	,	,	,
cord-005453-4057qib7	13661	22	off	off	IN
cord-005453-4057qib7	13661	23	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	13661	24	with	with	IN
cord-005453-4057qib7	13661	25	normal	normal	JJ
cord-005453-4057qib7	13661	26	levels	level	NNS
cord-005453-4057qib7	13661	27	of	of	IN
cord-005453-4057qib7	13661	28	ATM	atm	NN
cord-005453-4057qib7	13661	29	-	-	HYPH
cord-005453-4057qib7	13661	30	protein	protein	NN
cord-005453-4057qib7	13661	31	;	;	:
cord-005453-4057qib7	13661	32	his	-PRON-	PRP$
cord-005453-4057qib7	13661	33	granulomas	granuloma	NNS
cord-005453-4057qib7	13661	34	resolved	resolve	VBN
cord-005453-4057qib7	13661	35	.	.	.
cord-005453-4057qib7	13662	1	Patient-2	Patient-2	NNP
cord-005453-4057qib7	13662	2	is	be	VBZ
cord-005453-4057qib7	13662	3	a	a	DT
cord-005453-4057qib7	13662	4	6	6	CD
cord-005453-4057qib7	13662	5	year	year	NN
cord-005453-4057qib7	13662	6	-	-	HYPH
cord-005453-4057qib7	13662	7	old	old	JJ
cord-005453-4057qib7	13662	8	male	male	NN
cord-005453-4057qib7	13662	9	who	who	WP
cord-005453-4057qib7	13662	10	was	be	VBD
cord-005453-4057qib7	13662	11	transplanted	transplant	VBN
cord-005453-4057qib7	13662	12	from	from	IN
cord-005453-4057qib7	13662	13	his	-PRON-	PRP$
cord-005453-4057qib7	13662	14	HLA	HLA	NNP
cord-005453-4057qib7	13662	15	-	-	HYPH
cord-005453-4057qib7	13662	16	identical	identical	JJ
cord-005453-4057qib7	13662	17	sibling	sibling	NN
cord-005453-4057qib7	13662	18	,	,	,
cord-005453-4057qib7	13662	19	conditioned	condition	VBN
cord-005453-4057qib7	13662	20	with	with	IN
cord-005453-4057qib7	13662	21	fludarabine	fludarabine	NN
cord-005453-4057qib7	13662	22	(	(	-LRB-
cord-005453-4057qib7	13662	23	150	150	CD
cord-005453-4057qib7	13662	24	mg	mg	NNP
cord-005453-4057qib7	13662	25	/	/	SYM
cord-005453-4057qib7	13662	26	m²	m²	NNP
cord-005453-4057qib7	13662	27	)	)	-RRB-
cord-005453-4057qib7	13662	28	,	,	,
cord-005453-4057qib7	13662	29	cyclophosphamide	cyclophosphamide	FW
cord-005453-4057qib7	13662	30	(	(	-LRB-
cord-005453-4057qib7	13662	31	120	120	CD
cord-005453-4057qib7	13662	32	mg	mg	NNP
cord-005453-4057qib7	13662	33	/	/	SYM
cord-005453-4057qib7	13662	34	kg	kg	NNP
cord-005453-4057qib7	13662	35	)	)	-RRB-
cord-005453-4057qib7	13662	36	,	,	,
cord-005453-4057qib7	13662	37	and	and	CC
cord-005453-4057qib7	13662	38	ATG	ATG	NNP
cord-005453-4057qib7	13662	39	-	-	HYPH
cord-005453-4057qib7	13662	40	Fresenius	Fresenius	NNP
cord-005453-4057qib7	13662	41	(	(	-LRB-
cord-005453-4057qib7	13662	42	20	20	CD
cord-005453-4057qib7	13662	43	mg	mg	NNP
cord-005453-4057qib7	13662	44	/	/	SYM
cord-005453-4057qib7	13662	45	kg	kg	NNP
cord-005453-4057qib7	13662	46	)	)	-RRB-
cord-005453-4057qib7	13662	47	.	.	.
cord-005453-4057qib7	13663	1	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	13663	2	engraftment	engraftment	NN
cord-005453-4057qib7	13663	3	was	be	VBD
cord-005453-4057qib7	13663	4	observed	observe	VBN
cord-005453-4057qib7	13663	5	by	by	IN
cord-005453-4057qib7	13663	6	day	day	NN
cord-005453-4057qib7	13663	7	+10	+10	CD
cord-005453-4057qib7	13663	8	.	.	.
cord-005453-4057qib7	13664	1	T	t	NN
cord-005453-4057qib7	13664	2	-	-	HYPH
cord-005453-4057qib7	13664	3	cell	cell	NN
cord-005453-4057qib7	13664	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	13664	5	started	start	VBD
cord-005453-4057qib7	13664	6	by	by	IN
cord-005453-4057qib7	13664	7	day	day	NN
cord-005453-4057qib7	13664	8	+40	+40	CD
cord-005453-4057qib7	13664	9	with	with	IN
cord-005453-4057qib7	13664	10	>	>	XX
cord-005453-4057qib7	13665	1	200μl	200μl	NNP
cord-005453-4057qib7	13665	2	CD3	CD3	NNP
cord-005453-4057qib7	13666	1	+	+	CC
cord-005453-4057qib7	13666	2	T	t	NN
cord-005453-4057qib7	13666	3	-	-	HYPH
cord-005453-4057qib7	13666	4	cells	cell	NNS
cord-005453-4057qib7	13666	5	.	.	.
cord-005453-4057qib7	13667	1	His	-PRON-	PRP$
cord-005453-4057qib7	13667	2	mixed	mixed	JJ
cord-005453-4057qib7	13667	3	chimerism	chimerism	NN
cord-005453-4057qib7	13667	4	rapidly	rapidly	RB
cord-005453-4057qib7	13667	5	turned	turn	VBD
cord-005453-4057qib7	13667	6	to	to	IN
cord-005453-4057qib7	13667	7	donor	donor	NN
cord-005453-4057qib7	13667	8	origin	origin	NN
cord-005453-4057qib7	13667	9	(	(	-LRB-
cord-005453-4057qib7	13667	10	95	95	CD
cord-005453-4057qib7	13667	11	%	%	NN
cord-005453-4057qib7	13667	12	donor	donor	NN
cord-005453-4057qib7	13667	13	CD3	cd3	NN
cord-005453-4057qib7	13667	14	+	+	CC
cord-005453-4057qib7	13667	15	)	)	-RRB-
cord-005453-4057qib7	13667	16	over	over	IN
cord-005453-4057qib7	13667	17	time	time	NN
cord-005453-4057qib7	13667	18	.	.	.
cord-005453-4057qib7	13668	1	There	there	EX
cord-005453-4057qib7	13668	2	was	be	VBD
cord-005453-4057qib7	13668	3	no	no	DT
cord-005453-4057qib7	13668	4	acute	acute	JJ
cord-005453-4057qib7	13668	5	toxicity	toxicity	NN
cord-005453-4057qib7	13668	6	,	,	,
cord-005453-4057qib7	13668	7	however	however	RB
cord-005453-4057qib7	13668	8	,	,	,
cord-005453-4057qib7	13668	9	he	-PRON-	PRP
cord-005453-4057qib7	13668	10	developed	develop	VBD
cord-005453-4057qib7	13668	11	lumbosacral	lumbosacral	JJ
cord-005453-4057qib7	13668	12	pain	pain	NN
cord-005453-4057qib7	13668	13	episodes	episode	NNS
cord-005453-4057qib7	13668	14	with	with	IN
cord-005453-4057qib7	13668	15	evidence	evidence	NN
cord-005453-4057qib7	13668	16	of	of	IN
cord-005453-4057qib7	13668	17	urine	urine	NN
cord-005453-4057qib7	13668	18	BK	BK	NNP
cord-005453-4057qib7	13668	19	-	-	HYPH
cord-005453-4057qib7	13668	20	virus	virus	NN
cord-005453-4057qib7	13668	21	with	with	IN
cord-005453-4057qib7	13668	22	spontaneous	spontaneous	JJ
cord-005453-4057qib7	13668	23	remission	remission	NN
cord-005453-4057qib7	13668	24	.	.	.
cord-005453-4057qib7	13669	1	An	an	DT
cord-005453-4057qib7	13669	2	intermittent	intermittent	JJ
cord-005453-4057qib7	13669	3	metapneumovirus	metapneumovirus	NN
cord-005453-4057qib7	13669	4	associated	associate	VBD
cord-005453-4057qib7	13669	5	pulmonary	pulmonary	JJ
cord-005453-4057qib7	13669	6	hypertension	hypertension	NN
cord-005453-4057qib7	13669	7	was	be	VBD
cord-005453-4057qib7	13669	8	observed	observe	VBN
cord-005453-4057qib7	13669	9	with	with	IN
cord-005453-4057qib7	13669	10	pericardial	pericardial	JJ
cord-005453-4057qib7	13669	11	effusion	effusion	NN
cord-005453-4057qib7	13669	12	.	.	.
cord-005453-4057qib7	13670	1	Treatment	treatment	NN
cord-005453-4057qib7	13670	2	included	include	VBD
cord-005453-4057qib7	13670	3	sildenafil	sildenafil	NN
cord-005453-4057qib7	13670	4	and	and	CC
cord-005453-4057qib7	13670	5	oxygen	oxygen	NN
cord-005453-4057qib7	13670	6	.	.	.
cord-005453-4057qib7	13671	1	At	at	IN
cord-005453-4057qib7	13671	2	last	last	JJ
cord-005453-4057qib7	13671	3	follow	follow	NN
cord-005453-4057qib7	13671	4	-	-	HYPH
cord-005453-4057qib7	13671	5	up	up	NN
cord-005453-4057qib7	13671	6	(	(	-LRB-
cord-005453-4057qib7	13671	7	9	9	CD
cord-005453-4057qib7	13671	8	months	month	NNS
cord-005453-4057qib7	13671	9	)	)	-RRB-
cord-005453-4057qib7	13671	10	patient	patient	NN
cord-005453-4057qib7	13671	11	is	be	VBZ
cord-005453-4057qib7	13671	12	well	well	RB
cord-005453-4057qib7	13671	13	without	without	IN
cord-005453-4057qib7	13671	14	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	13671	15	.	.	.
cord-005453-4057qib7	13672	1	Patient-3	Patient-3	NNP
cord-005453-4057qib7	13672	2	suffered	suffer	VBD
cord-005453-4057qib7	13672	3	from	from	IN
cord-005453-4057qib7	13672	4	recurrent	recurrent	JJ
cord-005453-4057qib7	13672	5	chest	chest	NN
cord-005453-4057qib7	13672	6	infections	infection	NNS
cord-005453-4057qib7	13672	7	,	,	,
cord-005453-4057qib7	13672	8	failure	failure	NN
cord-005453-4057qib7	13672	9	to	to	TO
cord-005453-4057qib7	13672	10	thrive	thrive	VB
cord-005453-4057qib7	13672	11	and	and	CC
cord-005453-4057qib7	13672	12	progressive	progressive	JJ
cord-005453-4057qib7	13672	13	and	and	CC
cord-005453-4057qib7	13672	14	debilitating	debilitating	JJ
cord-005453-4057qib7	13672	15	rubella	rubella	NN
cord-005453-4057qib7	13672	16	positive	positive	JJ
cord-005453-4057qib7	13672	17	progressive	progressive	JJ
cord-005453-4057qib7	13672	18	granulomas	granuloma	NNS
cord-005453-4057qib7	13672	19	of	of	IN
cord-005453-4057qib7	13672	20	the	the	DT
cord-005453-4057qib7	13672	21	skin	skin	NN
cord-005453-4057qib7	13672	22	.	.	.
cord-005453-4057qib7	13673	1	She	-PRON-	PRP
cord-005453-4057qib7	13673	2	received	receive	VBD
cord-005453-4057qib7	13673	3	alloHSCT	allohsct	NN
cord-005453-4057qib7	13673	4	from	from	IN
cord-005453-4057qib7	13673	5	an	an	DT
cord-005453-4057qib7	13673	6	HLA	HLA	NNP
cord-005453-4057qib7	13673	7	-	-	HYPH
cord-005453-4057qib7	13673	8	identical	identical	JJ
cord-005453-4057qib7	13673	9	family	family	NN
cord-005453-4057qib7	13673	10	donor	donor	NN
cord-005453-4057qib7	13673	11	at	at	IN
cord-005453-4057qib7	13673	12	6	6	CD
cord-005453-4057qib7	13673	13	years	year	NNS
cord-005453-4057qib7	13673	14	of	of	IN
cord-005453-4057qib7	13673	15	age	age	NN
cord-005453-4057qib7	13673	16	.	.	.
cord-005453-4057qib7	13674	1	Conditioning	conditioning	NN
cord-005453-4057qib7	13674	2	included	include	VBD
cord-005453-4057qib7	13674	3	busulfan	busulfan	NN
cord-005453-4057qib7	13674	4	(	(	-LRB-
cord-005453-4057qib7	13674	5	2.2	2.2	CD
cord-005453-4057qib7	13674	6	mg	mg	NNP
cord-005453-4057qib7	13674	7	/	/	SYM
cord-005453-4057qib7	13674	8	kg	kg	NNP
cord-005453-4057qib7	13674	9	)	)	-RRB-
cord-005453-4057qib7	13674	10	,	,	,
cord-005453-4057qib7	13674	11	fludarabine	fludarabine	NNP
cord-005453-4057qib7	13674	12	(	(	-LRB-
cord-005453-4057qib7	13674	13	150	150	CD
cord-005453-4057qib7	13674	14	mg	mg	NNP
cord-005453-4057qib7	13674	15	/	/	SYM
cord-005453-4057qib7	13674	16	m²	m²	NNP
cord-005453-4057qib7	13674	17	)	)	-RRB-
cord-005453-4057qib7	13674	18	,	,	,
cord-005453-4057qib7	13674	19	cyclophosphamide	cyclophosphamide	FW
cord-005453-4057qib7	13674	20	(	(	-LRB-
cord-005453-4057qib7	13674	21	40	40	CD
cord-005453-4057qib7	13674	22	mg	mg	NNP
cord-005453-4057qib7	13674	23	/	/	SYM
cord-005453-4057qib7	13674	24	kg	kg	NNP
cord-005453-4057qib7	13674	25	)	)	-RRB-
cord-005453-4057qib7	13674	26	,	,	,
cord-005453-4057qib7	13674	27	and	and	CC
cord-005453-4057qib7	13674	28	alemtuzumab	alemtuzumab	NNP
cord-005453-4057qib7	13674	29	(	(	-LRB-
cord-005453-4057qib7	13674	30	1	1	CD
cord-005453-4057qib7	13674	31	x	x	SYM
cord-005453-4057qib7	13674	32	5mg	5mg	NNP
cord-005453-4057qib7	13674	33	/	/	SYM
cord-005453-4057qib7	13674	34	m²	m²	NNP
cord-005453-4057qib7	13674	35	,	,	,
cord-005453-4057qib7	13674	36	3	3	CD
cord-005453-4057qib7	13674	37	x	x	SYM
cord-005453-4057qib7	13674	38	10mg	10mg	NN
cord-005453-4057qib7	13674	39	/	/	SYM
cord-005453-4057qib7	13674	40	m²	m²	NNP
cord-005453-4057qib7	13674	41	)	)	-RRB-
cord-005453-4057qib7	13674	42	.	.	.
cord-005453-4057qib7	13675	1	HSCT	HSCT	NNP
cord-005453-4057qib7	13675	2	was	be	VBD
cord-005453-4057qib7	13675	3	complicated	complicate	VBN
cord-005453-4057qib7	13675	4	by	by	IN
cord-005453-4057qib7	13675	5	intermittent	intermittent	JJ
cord-005453-4057qib7	13675	6	acute	acute	JJ
cord-005453-4057qib7	13675	7	renal	renal	JJ
cord-005453-4057qib7	13675	8	failure	failure	NN
cord-005453-4057qib7	13675	9	,	,	,
cord-005453-4057qib7	13675	10	CMV	CMV	NNP
cord-005453-4057qib7	13675	11	reactivation	reactivation	NN
cord-005453-4057qib7	13675	12	and	and	CC
cord-005453-4057qib7	13675	13	TMA	TMA	NNP
cord-005453-4057qib7	13675	14	.	.	.
cord-005453-4057qib7	13676	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13676	2	recovery	recovery	NN
cord-005453-4057qib7	13676	3	was	be	VBD
cord-005453-4057qib7	13676	4	observed	observe	VBN
cord-005453-4057qib7	13676	5	by	by	IN
cord-005453-4057qib7	13676	6	day	day	NN
cord-005453-4057qib7	13676	7	+22	+22	NNS
cord-005453-4057qib7	13676	8	.	.	.
cord-005453-4057qib7	13677	1	T	t	NN
cord-005453-4057qib7	13677	2	-	-	HYPH
cord-005453-4057qib7	13677	3	cell	cell	NN
cord-005453-4057qib7	13677	4	chimerism	chimerism	NN
cord-005453-4057qib7	13677	5	increased	increase	VBD
cord-005453-4057qib7	13677	6	rapidly	rapidly	RB
cord-005453-4057qib7	13677	7	over	over	IN
cord-005453-4057qib7	13677	8	time	time	NN
cord-005453-4057qib7	13677	9	(	(	-LRB-
cord-005453-4057qib7	13677	10	>	>	NFP
cord-005453-4057qib7	13677	11	90	90	CD
cord-005453-4057qib7	13677	12	%	%	NN
cord-005453-4057qib7	13677	13	donor	donor	NN
cord-005453-4057qib7	13677	14	)	)	-RRB-
cord-005453-4057qib7	13677	15	.	.	.
cord-005453-4057qib7	13678	1	At	at	IN
cord-005453-4057qib7	13678	2	last	last	JJ
cord-005453-4057qib7	13678	3	follow	follow	NN
cord-005453-4057qib7	13678	4	-	-	HYPH
cord-005453-4057qib7	13678	5	up	up	NN
cord-005453-4057qib7	13678	6	(	(	-LRB-
cord-005453-4057qib7	13678	7	7	7	CD
cord-005453-4057qib7	13678	8	months	month	NNS
cord-005453-4057qib7	13678	9	)	)	-RRB-
cord-005453-4057qib7	13678	10	patient	patient	NN
cord-005453-4057qib7	13678	11	is	be	VBZ
cord-005453-4057qib7	13678	12	well	well	JJ
cord-005453-4057qib7	13678	13	,	,	,
cord-005453-4057qib7	13678	14	off	off	IN
cord-005453-4057qib7	13678	15	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	13678	16	and	and	CC
cord-005453-4057qib7	13678	17	IVIG	IVIG	NNP
cord-005453-4057qib7	13678	18	.	.	.
cord-005453-4057qib7	13679	1	Her	-PRON-	PRP$
cord-005453-4057qib7	13679	2	skin	skin	NN
cord-005453-4057qib7	13679	3	granuloma	granuloma	NN
cord-005453-4057qib7	13679	4	resolved	resolve	VBN
cord-005453-4057qib7	13679	5	with	with	IN
cord-005453-4057qib7	13679	6	scarring	scar	VBG
cord-005453-4057qib7	13679	7	residues	residue	NNS
cord-005453-4057qib7	13679	8	.	.	.
cord-005453-4057qib7	13680	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13680	2	:	:	:
cord-005453-4057qib7	13681	1	Pre	pre	JJ
cord-005453-4057qib7	13681	2	-	-	JJ
cord-005453-4057qib7	13681	3	emptive	emptive	JJ
cord-005453-4057qib7	13681	4	alloHSCT	allohsct	NN
cord-005453-4057qib7	13681	5	is	be	VBZ
cord-005453-4057qib7	13681	6	feasible	feasible	JJ
cord-005453-4057qib7	13681	7	in	in	IN
cord-005453-4057qib7	13681	8	A	A	NNP
cord-005453-4057qib7	13681	9	-	-	HYPH
cord-005453-4057qib7	13681	10	T	t	NN
cord-005453-4057qib7	13681	11	when	when	WRB
cord-005453-4057qib7	13681	12	reduced	reduce	VBN
cord-005453-4057qib7	13681	13	intensity	intensity	NN
cord-005453-4057qib7	13681	14	conditioning	conditioning	NN
cord-005453-4057qib7	13681	15	is	be	VBZ
cord-005453-4057qib7	13681	16	used	use	VBN
cord-005453-4057qib7	13681	17	and	and	CC
cord-005453-4057qib7	13681	18	can	can	MD
cord-005453-4057qib7	13681	19	correct	correct	VB
cord-005453-4057qib7	13681	20	the	the	DT
cord-005453-4057qib7	13681	21	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	13681	22	.	.	.
cord-005453-4057qib7	13682	1	It	-PRON-	PRP
cord-005453-4057qib7	13682	2	might	may	MD
cord-005453-4057qib7	13682	3	be	be	VB
cord-005453-4057qib7	13682	4	a	a	DT
cord-005453-4057qib7	13682	5	treatment	treatment	NN
cord-005453-4057qib7	13682	6	option	option	NN
cord-005453-4057qib7	13682	7	for	for	IN
cord-005453-4057qib7	13682	8	some	some	DT
cord-005453-4057qib7	13682	9	A	A	NNP
cord-005453-4057qib7	13682	10	-	-	HYPH
cord-005453-4057qib7	13682	11	T	t	NN
cord-005453-4057qib7	13682	12	patients	patient	NNS
cord-005453-4057qib7	13682	13	at	at	IN
cord-005453-4057qib7	13682	14	high	high	JJ
cord-005453-4057qib7	13682	15	risk	risk	NN
cord-005453-4057qib7	13682	16	of	of	IN
cord-005453-4057qib7	13682	17	hematological	hematological	JJ
cord-005453-4057qib7	13682	18	malignancy	malignancy	NN
cord-005453-4057qib7	13682	19	and	and	CC
cord-005453-4057qib7	13682	20	severe	severe	JJ
cord-005453-4057qib7	13682	21	granulomatous	granulomatous	JJ
cord-005453-4057qib7	13682	22	skin	skin	NN
cord-005453-4057qib7	13682	23	disease	disease	NN
cord-005453-4057qib7	13682	24	.	.	.
cord-005453-4057qib7	13683	1	To	to	TO
cord-005453-4057qib7	13683	2	what	what	WDT
cord-005453-4057qib7	13683	3	extent	extent	NN
cord-005453-4057qib7	13683	4	the	the	DT
cord-005453-4057qib7	13683	5	restored	restore	VBN
cord-005453-4057qib7	13683	6	immune	immune	JJ
cord-005453-4057qib7	13683	7	system	system	NN
cord-005453-4057qib7	13683	8	and	and	CC
cord-005453-4057qib7	13683	9	the	the	DT
cord-005453-4057qib7	13683	10	increase	increase	NN
cord-005453-4057qib7	13683	11	of	of	IN
cord-005453-4057qib7	13683	12	ATM	atm	NN
cord-005453-4057qib7	13683	13	-	-	HYPH
cord-005453-4057qib7	13683	14	protein	protein	NN
cord-005453-4057qib7	13683	15	in	in	IN
cord-005453-4057qib7	13683	16	these	these	DT
cord-005453-4057qib7	13683	17	patients	patient	NNS
cord-005453-4057qib7	13683	18	could	could	MD
cord-005453-4057qib7	13683	19	prevent	prevent	VB
cord-005453-4057qib7	13683	20	the	the	DT
cord-005453-4057qib7	13683	21	development	development	NN
cord-005453-4057qib7	13683	22	of	of	IN
cord-005453-4057qib7	13683	23	other	other	JJ
cord-005453-4057qib7	13683	24	malignancies	malignancy	NNS
cord-005453-4057qib7	13683	25	needs	need	VBZ
cord-005453-4057qib7	13683	26	to	to	TO
cord-005453-4057qib7	13683	27	be	be	VB
cord-005453-4057qib7	13683	28	evaluated	evaluate	VBN
cord-005453-4057qib7	13683	29	further	further	RB
cord-005453-4057qib7	13683	30	.	.	.
cord-005453-4057qib7	13684	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13684	2	:	:	:
cord-005453-4057qib7	13684	3	Nothing	nothing	NN
cord-005453-4057qib7	13684	4	to	to	TO
cord-005453-4057qib7	13684	5	disclose	disclose	VB
cord-005453-4057qib7	13684	6	P625	P625	NNP
cord-005453-4057qib7	13684	7	Abstract	Abstract	NNP
cord-005453-4057qib7	13684	8	withdrawn	withdraw	VBN
cord-005453-4057qib7	13684	9	.	.	.
cord-005453-4057qib7	13685	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13685	2	stem	stem	NN
cord-005453-4057qib7	13685	3	cell	cell	NN
cord-005453-4057qib7	13685	4	transplantation	transplantation	NN
cord-005453-4057qib7	13685	5	in	in	IN
cord-005453-4057qib7	13685	6	diamond	diamond	NN
cord-005453-4057qib7	13685	7	blackfan	blackfan	NN
cord-005453-4057qib7	13685	8	anemia	anemia	NN
cord-005453-4057qib7	13685	9	:	:	:
cord-005453-4057qib7	13686	1	Brazilian	brazilian	JJ
cord-005453-4057qib7	13686	2	experience	experience	NN
cord-005453-4057qib7	13686	3	Background	background	NN
cord-005453-4057qib7	13686	4	:	:	:
cord-005453-4057qib7	13687	1	Diamond	Diamond	NNP
cord-005453-4057qib7	13687	2	-	-	HYPH
cord-005453-4057qib7	13687	3	Blackfan	Blackfan	NNP
cord-005453-4057qib7	13687	4	anemia	anemia	NN
cord-005453-4057qib7	13687	5	(	(	-LRB-
cord-005453-4057qib7	13687	6	DBA	DBA	NNP
cord-005453-4057qib7	13687	7	)	)	-RRB-
cord-005453-4057qib7	13687	8	is	be	VBZ
cord-005453-4057qib7	13687	9	a	a	DT
cord-005453-4057qib7	13687	10	rare	rare	JJ
cord-005453-4057qib7	13687	11	inherited	inherit	VBN
cord-005453-4057qib7	13687	12	red	red	JJ
cord-005453-4057qib7	13687	13	cell	cell	NN
cord-005453-4057qib7	13687	14	aplasia	aplasia	NNP
cord-005453-4057qib7	13687	15	caused	cause	VBN
cord-005453-4057qib7	13687	16	by	by	IN
cord-005453-4057qib7	13687	17	an	an	DT
cord-005453-4057qib7	13687	18	intrinsic	intrinsic	JJ
cord-005453-4057qib7	13687	19	defect	defect	NN
cord-005453-4057qib7	13687	20	of	of	IN
cord-005453-4057qib7	13687	21	erythropoietic	erythropoietic	JJ
cord-005453-4057qib7	13687	22	progenitors	progenitor	NNS
cord-005453-4057qib7	13687	23	.	.	.
cord-005453-4057qib7	13688	1	The	the	DT
cord-005453-4057qib7	13688	2	main	main	JJ
cord-005453-4057qib7	13688	3	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13688	4	approach	approach	NN
cord-005453-4057qib7	13688	5	is	be	VBZ
cord-005453-4057qib7	13688	6	based	base	VBN
cord-005453-4057qib7	13688	7	on	on	IN
cord-005453-4057qib7	13688	8	repeated	repeat	VBN
cord-005453-4057qib7	13688	9	red	red	JJ
cord-005453-4057qib7	13688	10	blood	blood	NN
cord-005453-4057qib7	13688	11	cell	cell	NN
cord-005453-4057qib7	13688	12	transfusions	transfusion	NNS
cord-005453-4057qib7	13688	13	and/or	and/or	CC
cord-005453-4057qib7	13688	14	corticosteroid	corticosteroid	NN
cord-005453-4057qib7	13688	15	therapy	therapy	NN
cord-005453-4057qib7	13688	16	.	.	.
cord-005453-4057qib7	13689	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13689	2	stem	stem	NN
cord-005453-4057qib7	13689	3	cell	cell	NN
cord-005453-4057qib7	13689	4	transplantation	transplantation	NN
cord-005453-4057qib7	13689	5	(	(	-LRB-
cord-005453-4057qib7	13689	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13689	7	)	)	-RRB-
cord-005453-4057qib7	13689	8	,	,	,
cord-005453-4057qib7	13689	9	a	a	DT
cord-005453-4057qib7	13689	10	potentially	potentially	RB
cord-005453-4057qib7	13689	11	curative	curative	JJ
cord-005453-4057qib7	13689	12	treatment	treatment	NN
cord-005453-4057qib7	13689	13	for	for	IN
cord-005453-4057qib7	13689	14	DBA	DBA	NNP
cord-005453-4057qib7	13689	15	,	,	,
cord-005453-4057qib7	13689	16	is	be	VBZ
cord-005453-4057qib7	13689	17	indicated	indicate	VBN
cord-005453-4057qib7	13689	18	for	for	IN
cord-005453-4057qib7	13689	19	patients	patient	NNS
cord-005453-4057qib7	13689	20	that	that	WDT
cord-005453-4057qib7	13689	21	do	do	VBP
cord-005453-4057qib7	13689	22	not	not	RB
cord-005453-4057qib7	13689	23	respond	respond	VB
cord-005453-4057qib7	13689	24	to	to	IN
cord-005453-4057qib7	13689	25	first	first	JJ
cord-005453-4057qib7	13689	26	-	-	HYPH
cord-005453-4057qib7	13689	27	line	line	NN
cord-005453-4057qib7	13689	28	therapy	therapy	NN
cord-005453-4057qib7	13689	29	.	.	.
cord-005453-4057qib7	13690	1	Methods	method	NNS
cord-005453-4057qib7	13690	2	:	:	:
cord-005453-4057qib7	13691	1	The	the	DT
cord-005453-4057qib7	13691	2	aim	aim	NN
cord-005453-4057qib7	13691	3	of	of	IN
cord-005453-4057qib7	13691	4	our	-PRON-	PRP$
cord-005453-4057qib7	13691	5	retrospective	retrospective	JJ
cord-005453-4057qib7	13691	6	study	study	NN
cord-005453-4057qib7	13691	7	is	be	VBZ
cord-005453-4057qib7	13691	8	to	to	TO
cord-005453-4057qib7	13691	9	report	report	VB
cord-005453-4057qib7	13691	10	the	the	DT
cord-005453-4057qib7	13691	11	outcomes	outcome	NNS
cord-005453-4057qib7	13691	12	of	of	IN
cord-005453-4057qib7	13691	13	30	30	CD
cord-005453-4057qib7	13691	14	Brazilian	brazilian	JJ
cord-005453-4057qib7	13691	15	DBA	DBA	NNP
cord-005453-4057qib7	13691	16	patients	patient	NNS
cord-005453-4057qib7	13691	17	transplanted	transplant	VBN
cord-005453-4057qib7	13691	18	between	between	IN
cord-005453-4057qib7	13691	19	1990	1990	CD
cord-005453-4057qib7	13691	20	and	and	CC
cord-005453-4057qib7	13691	21	2017	2017	CD
cord-005453-4057qib7	13691	22	in	in	IN
cord-005453-4057qib7	13691	23	9	9	CD
cord-005453-4057qib7	13691	24	BMT	BMT	NNP
cord-005453-4057qib7	13691	25	centers	center	NNS
cord-005453-4057qib7	13691	26	.	.	.
cord-005453-4057qib7	13692	1	The	the	DT
cord-005453-4057qib7	13692	2	median	median	JJ
cord-005453-4057qib7	13692	3	age	age	NN
cord-005453-4057qib7	13692	4	of	of	IN
cord-005453-4057qib7	13692	5	the	the	DT
cord-005453-4057qib7	13692	6	patients	patient	NNS
cord-005453-4057qib7	13692	7	was	be	VBD
cord-005453-4057qib7	13692	8	5	5	CD
cord-005453-4057qib7	13692	9	ys	ys	NNP
cord-005453-4057qib7	13692	10	(	(	-LRB-
cord-005453-4057qib7	13692	11	range	range	NNP
cord-005453-4057qib7	13692	12	1	1	CD
cord-005453-4057qib7	13692	13	-	-	SYM
cord-005453-4057qib7	13692	14	15	15	CD
cord-005453-4057qib7	13692	15	)	)	-RRB-
cord-005453-4057qib7	13692	16	and	and	CC
cord-005453-4057qib7	13692	17	60	60	CD
cord-005453-4057qib7	13692	18	%	%	NN
cord-005453-4057qib7	13692	19	were	be	VBD
cord-005453-4057qib7	13692	20	male	male	JJ
cord-005453-4057qib7	13692	21	.	.	.
cord-005453-4057qib7	13693	1	Seventeen	seventeen	CD
cord-005453-4057qib7	13693	2	patients	patient	NNS
cord-005453-4057qib7	13693	3	(	(	-LRB-
cord-005453-4057qib7	13693	4	57	57	CD
cord-005453-4057qib7	13693	5	%	%	NN
cord-005453-4057qib7	13693	6	)	)	-RRB-
cord-005453-4057qib7	13693	7	were	be	VBD
cord-005453-4057qib7	13693	8	transplanted	transplant	VBN
cord-005453-4057qib7	13693	9	with	with	IN
cord-005453-4057qib7	13693	10	matched	match	VBN
cord-005453-4057qib7	13693	11	related	related	JJ
cord-005453-4057qib7	13693	12	donors	donor	NNS
cord-005453-4057qib7	13693	13	(	(	-LRB-
cord-005453-4057qib7	13693	14	MRD	MRD	NNP
cord-005453-4057qib7	13693	15	)	)	-RRB-
cord-005453-4057qib7	13693	16	and	and	CC
cord-005453-4057qib7	13693	17	thirteen	thirteen	CD
cord-005453-4057qib7	13693	18	(	(	-LRB-
cord-005453-4057qib7	13693	19	43	43	CD
cord-005453-4057qib7	13693	20	%	%	NN
cord-005453-4057qib7	13693	21	)	)	-RRB-
cord-005453-4057qib7	13693	22	from	from	IN
cord-005453-4057qib7	13693	23	matched	match	VBN
cord-005453-4057qib7	13693	24	and	and	CC
cord-005453-4057qib7	13693	25	mismatched	mismatched	JJ
cord-005453-4057qib7	13693	26	unrelated	unrelated	JJ
cord-005453-4057qib7	13693	27	donors	donor	NNS
cord-005453-4057qib7	13693	28	(	(	-LRB-
cord-005453-4057qib7	13693	29	MUD	mud	NN
cord-005453-4057qib7	13693	30	/	/	SYM
cord-005453-4057qib7	13693	31	MMUD	MMUD	NNP
cord-005453-4057qib7	13693	32	)	)	-RRB-
cord-005453-4057qib7	13693	33	.	.	.
cord-005453-4057qib7	13694	1	In	in	IN
cord-005453-4057qib7	13694	2	the	the	DT
cord-005453-4057qib7	13694	3	MRD	MRD	NNP
cord-005453-4057qib7	13694	4	group	group	NN
cord-005453-4057qib7	13694	5	all	all	DT
cord-005453-4057qib7	13694	6	patients	patient	NNS
cord-005453-4057qib7	13694	7	received	receive	VBD
cord-005453-4057qib7	13694	8	bone	bone	NN
cord-005453-4057qib7	13694	9	marrow	marrow	NN
cord-005453-4057qib7	13694	10	as	as	IN
cord-005453-4057qib7	13694	11	HSC	HSC	NNP
cord-005453-4057qib7	13694	12	source	source	NN
cord-005453-4057qib7	13694	13	,	,	,
cord-005453-4057qib7	13694	14	while	while	IN
cord-005453-4057qib7	13694	15	in	in	IN
cord-005453-4057qib7	13694	16	the	the	DT
cord-005453-4057qib7	13694	17	MUD	MUD	NNP
cord-005453-4057qib7	13694	18	/	/	SYM
cord-005453-4057qib7	13694	19	MMUD	MMUD	NNP
cord-005453-4057qib7	13694	20	,	,	,
cord-005453-4057qib7	13694	21	eight	eight	CD
cord-005453-4057qib7	13694	22	patients	patient	NNS
cord-005453-4057qib7	13694	23	received	receive	VBD
cord-005453-4057qib7	13694	24	bone	bone	NN
cord-005453-4057qib7	13694	25	marrow	marrow	NN
cord-005453-4057qib7	13694	26	and	and	CC
cord-005453-4057qib7	13694	27	five	five	CD
cord-005453-4057qib7	13694	28	received	receive	VBD
cord-005453-4057qib7	13694	29	cord	cord	NN
cord-005453-4057qib7	13694	30	blood	blood	NN
cord-005453-4057qib7	13694	31	.	.	.
cord-005453-4057qib7	13695	1	All	all	DT
cord-005453-4057qib7	13695	2	patients	patient	NNS
cord-005453-4057qib7	13695	3	with	with	IN
cord-005453-4057qib7	13695	4	incompatibilities	incompatibility	NNS
cord-005453-4057qib7	13695	5	(	(	-LRB-
cord-005453-4057qib7	13695	6	mismatched	mismatched	JJ
cord-005453-4057qib7	13695	7	)	)	-RRB-
cord-005453-4057qib7	13695	8	were	be	VBD
cord-005453-4057qib7	13695	9	UCB	UCB	NNP
cord-005453-4057qib7	13695	10	(	(	-LRB-
cord-005453-4057qib7	13695	11	5/5	5/5	CD
cord-005453-4057qib7	13695	12	)	)	-RRB-
cord-005453-4057qib7	13695	13	.	.	.
cord-005453-4057qib7	13696	1	Nineteen	nineteen	CD
cord-005453-4057qib7	13696	2	recipients	recipient	NNS
cord-005453-4057qib7	13696	3	were	be	VBD
cord-005453-4057qib7	13696	4	conditioned	condition	VBN
cord-005453-4057qib7	13696	5	with	with	IN
cord-005453-4057qib7	13696	6	busulfan	busulfan	NN
cord-005453-4057qib7	13696	7	plus	plus	CC
cord-005453-4057qib7	13696	8	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	13696	9	,	,	,
cord-005453-4057qib7	13696	10	while	while	IN
cord-005453-4057qib7	13696	11	the	the	DT
cord-005453-4057qib7	13696	12	remaining	remain	VBG
cord-005453-4057qib7	13696	13	11	11	CD
cord-005453-4057qib7	13696	14	received	receive	VBN
cord-005453-4057qib7	13696	15	fludarabine	fludarabine	NN
cord-005453-4057qib7	13696	16	and	and	CC
cord-005453-4057qib7	13696	17	busulfan	busulfan	NN
cord-005453-4057qib7	13696	18	,	,	,
cord-005453-4057qib7	13696	19	which	which	WDT
cord-005453-4057qib7	13696	20	has	have	VBZ
cord-005453-4057qib7	13696	21	been	be	VBN
cord-005453-4057qib7	13696	22	the	the	DT
cord-005453-4057qib7	13696	23	preferred	preferred	JJ
cord-005453-4057qib7	13696	24	regimen	regimen	NN
cord-005453-4057qib7	13696	25	in	in	IN
cord-005453-4057qib7	13696	26	Brazil	Brazil	NNP
cord-005453-4057qib7	13696	27	in	in	IN
cord-005453-4057qib7	13696	28	the	the	DT
cord-005453-4057qib7	13696	29	recent	recent	JJ
cord-005453-4057qib7	13696	30	years	year	NNS
cord-005453-4057qib7	13696	31	.	.	.
cord-005453-4057qib7	13697	1	After	after	IN
cord-005453-4057qib7	13697	2	transplant	transplant	NN
cord-005453-4057qib7	13697	3	,	,	,
cord-005453-4057qib7	13697	4	most	most	JJS
cord-005453-4057qib7	13697	5	(	(	-LRB-
cord-005453-4057qib7	13697	6	n=24	n=24	NNP
cord-005453-4057qib7	13697	7	)	)	-RRB-
cord-005453-4057qib7	13697	8	of	of	IN
cord-005453-4057qib7	13697	9	the	the	DT
cord-005453-4057qib7	13697	10	MRD	MRD	NNP
cord-005453-4057qib7	13697	11	and	and	CC
cord-005453-4057qib7	13697	12	MUD	MUD	NNP
cord-005453-4057qib7	13697	13	recipients	recipient	NNS
cord-005453-4057qib7	13697	14	received	receive	VBD
cord-005453-4057qib7	13697	15	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	13697	16	and	and	CC
cord-005453-4057qib7	13697	17	short	short	JJ
cord-005453-4057qib7	13697	18	course	course	NN
cord-005453-4057qib7	13697	19	methotrexate	methotrexate	NNP
cord-005453-4057qib7	13697	20	as	as	IN
cord-005453-4057qib7	13697	21	graft	graft	NN
cord-005453-4057qib7	13697	22	versus	versus	IN
cord-005453-4057qib7	13697	23	host	host	NN
cord-005453-4057qib7	13697	24	disease	disease	NN
cord-005453-4057qib7	13697	25	(	(	-LRB-
cord-005453-4057qib7	13697	26	GvHD	GvHD	NNP
cord-005453-4057qib7	13697	27	)	)	-RRB-
cord-005453-4057qib7	13697	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13697	29	.	.	.
cord-005453-4057qib7	13698	1	Results	result	NNS
cord-005453-4057qib7	13698	2	:	:	:
cord-005453-4057qib7	13699	1	Twenty	twenty	CD
cord-005453-4057qib7	13699	2	-	-	HYPH
cord-005453-4057qib7	13699	3	two	two	CD
cord-005453-4057qib7	13699	4	out	out	IN
cord-005453-4057qib7	13699	5	of	of	IN
cord-005453-4057qib7	13699	6	the	the	DT
cord-005453-4057qib7	13699	7	30	30	CD
cord-005453-4057qib7	13699	8	patients	patient	NNS
cord-005453-4057qib7	13699	9	were	be	VBD
cord-005453-4057qib7	13699	10	alive	alive	JJ
cord-005453-4057qib7	13699	11	and	and	CC
cord-005453-4057qib7	13699	12	disease	disease	NN
cord-005453-4057qib7	13699	13	-	-	HYPH
cord-005453-4057qib7	13699	14	free	free	JJ
cord-005453-4057qib7	13699	15	at	at	IN
cord-005453-4057qib7	13699	16	a	a	DT
cord-005453-4057qib7	13699	17	median	median	JJ
cord-005453-4057qib7	13699	18	follow	follow	NN
cord-005453-4057qib7	13699	19	-	-	HYPH
cord-005453-4057qib7	13699	20	up	up	NN
cord-005453-4057qib7	13699	21	of	of	IN
cord-005453-4057qib7	13699	22	24	24	CD
cord-005453-4057qib7	13699	23	months	month	NNS
cord-005453-4057qib7	13699	24	(	(	-LRB-
cord-005453-4057qib7	13699	25	range	range	VBP
cord-005453-4057qib7	13699	26	1	1	CD
cord-005453-4057qib7	13699	27	to	to	IN
cord-005453-4057qib7	13699	28	213	213	CD
cord-005453-4057qib7	13699	29	months	month	NNS
cord-005453-4057qib7	13699	30	)	)	-RRB-
cord-005453-4057qib7	13699	31	.	.	.
cord-005453-4057qib7	13700	1	The	the	DT
cord-005453-4057qib7	13700	2	3-year	3-year	CD
cord-005453-4057qib7	13700	3	overall	overall	JJ
cord-005453-4057qib7	13700	4	survival	survival	NN
cord-005453-4057qib7	13700	5	(	(	-LRB-
cord-005453-4057qib7	13700	6	OS	OS	NNP
cord-005453-4057qib7	13700	7	)	)	-RRB-
cord-005453-4057qib7	13700	8	was	be	VBD
cord-005453-4057qib7	13700	9	71	71	CD
cord-005453-4057qib7	13700	10	%	%	NN
cord-005453-4057qib7	13701	1	(	(	-LRB-
cord-005453-4057qib7	13701	2	CI	CI	NNP
cord-005453-4057qib7	13701	3	51	51	CD
cord-005453-4057qib7	13701	4	-	-	SYM
cord-005453-4057qib7	13701	5	91	91	CD
cord-005453-4057qib7	13701	6	%	%	NN
cord-005453-4057qib7	13701	7	)	)	-RRB-
cord-005453-4057qib7	13702	1	(	(	-LRB-
cord-005453-4057qib7	13702	2	Fig	Fig	NNP
cord-005453-4057qib7	13702	3	1	1	CD
cord-005453-4057qib7	13702	4	)	)	-RRB-
cord-005453-4057qib7	13702	5	.	.	.
cord-005453-4057qib7	13703	1	Similar	similar	JJ
cord-005453-4057qib7	13703	2	results	result	NNS
cord-005453-4057qib7	13703	3	have	have	VBP
cord-005453-4057qib7	13703	4	been	be	VBN
cord-005453-4057qib7	13703	5	demonstrated	demonstrate	VBN
cord-005453-4057qib7	13703	6	in	in	IN
cord-005453-4057qib7	13703	7	studies	study	NNS
cord-005453-4057qib7	13703	8	from	from	IN
cord-005453-4057qib7	13703	9	Europe	Europe	NNP
cord-005453-4057qib7	13703	10	and	and	CC
cord-005453-4057qib7	13703	11	from	from	IN
cord-005453-4057qib7	13703	12	the	the	DT
cord-005453-4057qib7	13703	13	United	United	NNP
cord-005453-4057qib7	13703	14	States	States	NNP
cord-005453-4057qib7	13703	15	.	.	.
cord-005453-4057qib7	13704	1	When	when	WRB
cord-005453-4057qib7	13704	2	analyzed	analyze	VBN
cord-005453-4057qib7	13704	3	according	accord	VBG
cord-005453-4057qib7	13704	4	to	to	IN
cord-005453-4057qib7	13704	5	donor	donor	NN
cord-005453-4057qib7	13704	6	type	type	NN
cord-005453-4057qib7	13704	7	,	,	,
cord-005453-4057qib7	13704	8	OS	OS	NNP
cord-005453-4057qib7	13704	9	was	be	VBD
cord-005453-4057qib7	13704	10	73	73	CD
cord-005453-4057qib7	13704	11	%	%	NN
cord-005453-4057qib7	13705	1	(	(	-LRB-
cord-005453-4057qib7	13705	2	CI	CI	NNP
cord-005453-4057qib7	13705	3	55	55	CD
cord-005453-4057qib7	13705	4	-	-	SYM
cord-005453-4057qib7	13705	5	100	100	CD
cord-005453-4057qib7	13705	6	%	%	NN
cord-005453-4057qib7	13705	7	)	)	-RRB-
cord-005453-4057qib7	13705	8	and	and	CC
cord-005453-4057qib7	13705	9	66	66	CD
cord-005453-4057qib7	13705	10	%	%	NN
cord-005453-4057qib7	13706	1	(	(	-LRB-
cord-005453-4057qib7	13706	2	CI	CI	NNP
cord-005453-4057qib7	13706	3	43	43	CD
cord-005453-4057qib7	13706	4	-	-	SYM
cord-005453-4057qib7	13706	5	100	100	CD
cord-005453-4057qib7	13706	6	%	%	NN
cord-005453-4057qib7	13706	7	)	)	-RRB-
cord-005453-4057qib7	13706	8	in	in	IN
cord-005453-4057qib7	13706	9	MRD	MRD	NNP
cord-005453-4057qib7	13706	10	and	and	CC
cord-005453-4057qib7	13706	11	MUD	MUD	NNP
cord-005453-4057qib7	13706	12	/	/	SYM
cord-005453-4057qib7	13706	13	MMUD	MMUD	NNP
cord-005453-4057qib7	13706	14	respectively	respectively	RB
cord-005453-4057qib7	13706	15	(	(	-LRB-
cord-005453-4057qib7	13706	16	fig	fig	NN
cord-005453-4057qib7	13706	17	2	2	CD
cord-005453-4057qib7	13706	18	)	)	-RRB-
cord-005453-4057qib7	13706	19	.	.	.
cord-005453-4057qib7	13707	1	Three	three	CD
cord-005453-4057qib7	13707	2	out	out	IN
cord-005453-4057qib7	13707	3	of	of	IN
cord-005453-4057qib7	13707	4	the	the	DT
cord-005453-4057qib7	13707	5	5	5	CD
cord-005453-4057qib7	13707	6	patients	patient	NNS
cord-005453-4057qib7	13707	7	who	who	WP
cord-005453-4057qib7	13707	8	were	be	VBD
cord-005453-4057qib7	13707	9	transplanted	transplant	VBN
cord-005453-4057qib7	13707	10	with	with	IN
cord-005453-4057qib7	13707	11	UCB	UCB	NNP
cord-005453-4057qib7	13707	12	died	die	VBD
cord-005453-4057qib7	13707	13	.	.	.
cord-005453-4057qib7	13708	1	These	these	DT
cord-005453-4057qib7	13708	2	results	result	NNS
cord-005453-4057qib7	13708	3	are	be	VBP
cord-005453-4057qib7	13708	4	in	in	IN
cord-005453-4057qib7	13708	5	agreement	agreement	NN
cord-005453-4057qib7	13708	6	with	with	IN
cord-005453-4057qib7	13708	7	those	those	DT
cord-005453-4057qib7	13708	8	of	of	IN
cord-005453-4057qib7	13708	9	previously	previously	RB
cord-005453-4057qib7	13708	10	published	publish	VBN
cord-005453-4057qib7	13708	11	data	datum	NNS
cord-005453-4057qib7	13708	12	showing	show	VBG
cord-005453-4057qib7	13708	13	worse	bad	JJR
cord-005453-4057qib7	13708	14	results	result	NNS
cord-005453-4057qib7	13708	15	in	in	IN
cord-005453-4057qib7	13708	16	unrelated	unrelated	JJ
cord-005453-4057qib7	13708	17	UCB	UCB	NNP
cord-005453-4057qib7	13708	18	transplants	transplant	NNS
cord-005453-4057qib7	13708	19	.	.	.
cord-005453-4057qib7	13709	1	Twenty	twenty	CD
cord-005453-4057qib7	13709	2	-	-	HYPH
cord-005453-4057qib7	13709	3	nine	nine	CD
cord-005453-4057qib7	13709	4	out	out	IN
cord-005453-4057qib7	13709	5	of	of	IN
cord-005453-4057qib7	13709	6	the	the	DT
cord-005453-4057qib7	13709	7	30	30	CD
cord-005453-4057qib7	13709	8	patients	patient	NNS
cord-005453-4057qib7	13709	9	engrafted	engraft	VBN
cord-005453-4057qib7	13709	10	successfully	successfully	RB
cord-005453-4057qib7	13709	11	.	.	.
cord-005453-4057qib7	13710	1	In	in	IN
cord-005453-4057qib7	13710	2	25	25	CD
cord-005453-4057qib7	13710	3	of	of	IN
cord-005453-4057qib7	13710	4	the	the	DT
cord-005453-4057qib7	13710	5	evaluated	evaluate	VBN
cord-005453-4057qib7	13710	6	patients	patient	NNS
cord-005453-4057qib7	13710	7	,	,	,
cord-005453-4057qib7	13710	8	the	the	DT
cord-005453-4057qib7	13710	9	median	median	JJ
cord-005453-4057qib7	13710	10	time	time	NN
cord-005453-4057qib7	13710	11	to	to	IN
cord-005453-4057qib7	13710	12	neutrophil	neutrophil	NN
cord-005453-4057qib7	13710	13	engraftment	engraftment	NN
cord-005453-4057qib7	13710	14	was	be	VBD
cord-005453-4057qib7	13710	15	20	20	CD
cord-005453-4057qib7	13710	16	days	day	NNS
cord-005453-4057qib7	13710	17	(	(	-LRB-
cord-005453-4057qib7	13710	18	range	range	VBP
cord-005453-4057qib7	13710	19	10	10	CD
cord-005453-4057qib7	13710	20	-	-	SYM
cord-005453-4057qib7	13710	21	27	27	CD
cord-005453-4057qib7	13710	22	)	)	-RRB-
cord-005453-4057qib7	13710	23	.	.	.
cord-005453-4057qib7	13711	1	One	one	CD
cord-005453-4057qib7	13711	2	patient	patient	NN
cord-005453-4057qib7	13711	3	experienced	experience	VBD
cord-005453-4057qib7	13711	4	an	an	DT
cord-005453-4057qib7	13711	5	early	early	JJ
cord-005453-4057qib7	13711	6	death	death	NN
cord-005453-4057qib7	13711	7	from	from	IN
cord-005453-4057qib7	13711	8	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	13711	9	shock	shock	NN
cord-005453-4057qib7	13711	10	on	on	IN
cord-005453-4057qib7	13711	11	day	day	NN
cord-005453-4057qib7	13711	12	12	12	CD
cord-005453-4057qib7	13711	13	,	,	,
cord-005453-4057qib7	13711	14	before	before	IN
cord-005453-4057qib7	13711	15	neutrophil	neutrophil	NN
cord-005453-4057qib7	13711	16	recovery	recovery	NN
cord-005453-4057qib7	13711	17	,	,	,
cord-005453-4057qib7	13711	18	and	and	CC
cord-005453-4057qib7	13711	19	another	another	DT
cord-005453-4057qib7	13711	20	two	two	CD
cord-005453-4057qib7	13711	21	patients	patient	NNS
cord-005453-4057qib7	13711	22	experienced	experience	VBD
cord-005453-4057qib7	13711	23	primary	primary	JJ
cord-005453-4057qib7	13711	24	graft	graft	NN
cord-005453-4057qib7	13711	25	failure	failure	NN
cord-005453-4057qib7	13711	26	.	.	.
cord-005453-4057qib7	13712	1	Post	post	JJ
cord-005453-4057qib7	13712	2	-	-	JJ
cord-005453-4057qib7	13712	3	transplant	transplant	NN
cord-005453-4057qib7	13712	4	chimerism	chimerism	NN
cord-005453-4057qib7	13712	5	was	be	VBD
cord-005453-4057qib7	13712	6	available	available	JJ
cord-005453-4057qib7	13712	7	for	for	IN
cord-005453-4057qib7	13712	8	22	22	CD
cord-005453-4057qib7	13712	9	patients	patient	NNS
cord-005453-4057qib7	13712	10	.	.	.
cord-005453-4057qib7	13713	1	Sixteen	sixteen	CD
cord-005453-4057qib7	13713	2	had	have	VBD
cord-005453-4057qib7	13713	3	complete	complete	JJ
cord-005453-4057qib7	13713	4	chimera	chimera	NN
cord-005453-4057qib7	13713	5	(	(	-LRB-
cord-005453-4057qib7	13713	6	>	>	NFP
cord-005453-4057qib7	13713	7	90	90	CD
cord-005453-4057qib7	13713	8	%	%	NN
cord-005453-4057qib7	13713	9	chimerism	chimerism	NN
cord-005453-4057qib7	13713	10	)	)	-RRB-
cord-005453-4057qib7	13713	11	,	,	,
cord-005453-4057qib7	13713	12	while	while	IN
cord-005453-4057qib7	13713	13	6	6	CD
cord-005453-4057qib7	13713	14	patients	patient	NNS
cord-005453-4057qib7	13713	15	presented	present	VBN
cord-005453-4057qib7	13713	16	with	with	IN
cord-005453-4057qib7	13713	17	mixed	mixed	JJ
cord-005453-4057qib7	13713	18	chimerism	chimerism	NN
cord-005453-4057qib7	13713	19	.	.	.
cord-005453-4057qib7	13714	1	Acute	acute	JJ
cord-005453-4057qib7	13714	2	GvHD	GvHD	NNP
cord-005453-4057qib7	13714	3	was	be	VBD
cord-005453-4057qib7	13714	4	observed	observe	VBN
cord-005453-4057qib7	13714	5	in	in	IN
cord-005453-4057qib7	13714	6	9	9	CD
cord-005453-4057qib7	13714	7	patients	patient	NNS
cord-005453-4057qib7	13714	8	(	(	-LRB-
cord-005453-4057qib7	13714	9	32	32	CD
cord-005453-4057qib7	13714	10	%	%	NN
cord-005453-4057qib7	13714	11	)	)	-RRB-
cord-005453-4057qib7	13714	12	,	,	,
cord-005453-4057qib7	13714	13	6	6	CD
cord-005453-4057qib7	13714	14	of	of	IN
cord-005453-4057qib7	13714	15	which	which	WDT
cord-005453-4057qib7	13714	16	classified	classify	VBN
cord-005453-4057qib7	13714	17	as	as	IN
cord-005453-4057qib7	13714	18	grade	grade	NN
cord-005453-4057qib7	13714	19	IV	IV	NNP
cord-005453-4057qib7	13714	20	.	.	.
cord-005453-4057qib7	13715	1	Five	five	CD
cord-005453-4057qib7	13715	2	patients	patient	NNS
cord-005453-4057qib7	13715	3	developed	develop	VBD
cord-005453-4057qib7	13715	4	chronic	chronic	JJ
cord-005453-4057qib7	13715	5	GvHD	GvHD	NNP
cord-005453-4057qib7	13715	6	,	,	,
cord-005453-4057qib7	13715	7	considered	consider	VBN
cord-005453-4057qib7	13715	8	severe	severe	JJ
cord-005453-4057qib7	13715	9	in	in	IN
cord-005453-4057qib7	13715	10	three	three	CD
cord-005453-4057qib7	13715	11	of	of	IN
cord-005453-4057qib7	13715	12	them	-PRON-	PRP
cord-005453-4057qib7	13715	13	.	.	.
cord-005453-4057qib7	13716	1	Eight	eight	CD
cord-005453-4057qib7	13716	2	patients	patient	NNS
cord-005453-4057qib7	13716	3	died	die	VBD
cord-005453-4057qib7	13716	4	at	at	IN
cord-005453-4057qib7	13716	5	a	a	DT
cord-005453-4057qib7	13716	6	mean	mean	NN
cord-005453-4057qib7	13716	7	of	of	IN
cord-005453-4057qib7	13716	8	155	155	CD
cord-005453-4057qib7	13716	9	days	day	NNS
cord-005453-4057qib7	13716	10	(	(	-LRB-
cord-005453-4057qib7	13716	11	range	range	VBP
cord-005453-4057qib7	13716	12	12	12	CD
cord-005453-4057qib7	13716	13	-	-	SYM
cord-005453-4057qib7	13716	14	728	728	CD
cord-005453-4057qib7	13716	15	days	day	NNS
cord-005453-4057qib7	13716	16	)	)	-RRB-
cord-005453-4057qib7	13716	17	after	after	IN
cord-005453-4057qib7	13716	18	HSCT	HSCT	NNP
cord-005453-4057qib7	13716	19	and	and	CC
cord-005453-4057qib7	13716	20	the	the	DT
cord-005453-4057qib7	13716	21	main	main	JJ
cord-005453-4057qib7	13716	22	causes	cause	NNS
cord-005453-4057qib7	13716	23	of	of	IN
cord-005453-4057qib7	13716	24	death	death	NN
cord-005453-4057qib7	13716	25	were	be	VBD
cord-005453-4057qib7	13716	26	infections	infection	NNS
cord-005453-4057qib7	13716	27	and	and	CC
cord-005453-4057qib7	13716	28	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	13716	29	disorders	disorder	NNS
cord-005453-4057qib7	13716	30	.	.	.
cord-005453-4057qib7	13717	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13717	2	:	:	:
cord-005453-4057qib7	13717	3	HSCT	HSCT	NNP
cord-005453-4057qib7	13717	4	is	be	VBZ
cord-005453-4057qib7	13717	5	a	a	DT
cord-005453-4057qib7	13717	6	potentially	potentially	RB
cord-005453-4057qib7	13717	7	curative	curative	JJ
cord-005453-4057qib7	13717	8	treatment	treatment	NN
cord-005453-4057qib7	13717	9	option	option	NN
cord-005453-4057qib7	13717	10	for	for	IN
cord-005453-4057qib7	13717	11	DBA	DBA	NNP
cord-005453-4057qib7	13717	12	.	.	.
cord-005453-4057qib7	13718	1	In	in	IN
cord-005453-4057qib7	13718	2	the	the	DT
cord-005453-4057qib7	13718	3	present	present	JJ
cord-005453-4057qib7	13718	4	study	study	NN
cord-005453-4057qib7	13718	5	,	,	,
cord-005453-4057qib7	13718	6	we	-PRON-	PRP
cord-005453-4057qib7	13718	7	report	report	VBP
cord-005453-4057qib7	13718	8	the	the	DT
cord-005453-4057qib7	13718	9	outcomes	outcome	NNS
cord-005453-4057qib7	13718	10	of	of	IN
cord-005453-4057qib7	13718	11	30	30	CD
cord-005453-4057qib7	13718	12	patients	patient	NNS
cord-005453-4057qib7	13718	13	with	with	IN
cord-005453-4057qib7	13718	14	DBA	DBA	NNP
cord-005453-4057qib7	13718	15	transplanted	transplant	VBN
cord-005453-4057qib7	13718	16	in	in	IN
cord-005453-4057qib7	13718	17	Brazil	Brazil	NNP
cord-005453-4057qib7	13718	18	with	with	IN
cord-005453-4057qib7	13718	19	a	a	DT
cord-005453-4057qib7	13718	20	OS	os	NN
cord-005453-4057qib7	13718	21	of	of	IN
cord-005453-4057qib7	13718	22	71	71	CD
cord-005453-4057qib7	13718	23	%	%	NN
cord-005453-4057qib7	13718	24	,	,	,
cord-005453-4057qib7	13718	25	with	with	IN
cord-005453-4057qib7	13718	26	better	well	JJR
cord-005453-4057qib7	13718	27	results	result	NNS
cord-005453-4057qib7	13718	28	in	in	IN
cord-005453-4057qib7	13718	29	MRD	MRD	NNP
cord-005453-4057qib7	13718	30	compared	compare	VBN
cord-005453-4057qib7	13718	31	to	to	IN
cord-005453-4057qib7	13718	32	MUD	mud	NN
cord-005453-4057qib7	13718	33	,	,	,
cord-005453-4057qib7	13718	34	as	as	IN
cord-005453-4057qib7	13718	35	expected	expect	VBN
cord-005453-4057qib7	13718	36	.	.	.
cord-005453-4057qib7	13719	1	Despite	despite	IN
cord-005453-4057qib7	13719	2	the	the	DT
cord-005453-4057qib7	13719	3	small	small	JJ
cord-005453-4057qib7	13719	4	numbers	number	NNS
cord-005453-4057qib7	13719	5	,	,	,
cord-005453-4057qib7	13719	6	we	-PRON-	PRP
cord-005453-4057qib7	13719	7	observed	observe	VBD
cord-005453-4057qib7	13719	8	lower	low	JJR
cord-005453-4057qib7	13719	9	survival	survival	NN
cord-005453-4057qib7	13719	10	after	after	IN
cord-005453-4057qib7	13719	11	MUD	mud	NN
cord-005453-4057qib7	13719	12	/	/	SYM
cord-005453-4057qib7	13719	13	MMUD	MMUD	NNP
cord-005453-4057qib7	13719	14	UCB	UCB	NNP
cord-005453-4057qib7	13719	15	transplantation	transplantation	NN
cord-005453-4057qib7	13719	16	.	.	.
cord-005453-4057qib7	13720	1	Since	since	IN
cord-005453-4057qib7	13720	2	DBA	DBA	NNP
cord-005453-4057qib7	13720	3	is	be	VBZ
cord-005453-4057qib7	13720	4	a	a	DT
cord-005453-4057qib7	13720	5	rare	rare	JJ
cord-005453-4057qib7	13720	6	disease	disease	NN
cord-005453-4057qib7	13720	7	,	,	,
cord-005453-4057qib7	13720	8	international	international	JJ
cord-005453-4057qib7	13720	9	collaborative	collaborative	JJ
cord-005453-4057qib7	13720	10	studies	study	NNS
cord-005453-4057qib7	13720	11	are	be	VBP
cord-005453-4057qib7	13720	12	essential	essential	JJ
cord-005453-4057qib7	13720	13	to	to	TO
cord-005453-4057qib7	13720	14	better	better	RB
cord-005453-4057qib7	13720	15	understand	understand	VB
cord-005453-4057qib7	13720	16	the	the	DT
cord-005453-4057qib7	13720	17	benefits	benefit	NNS
cord-005453-4057qib7	13720	18	of	of	IN
cord-005453-4057qib7	13720	19	the	the	DT
cord-005453-4057qib7	13720	20	HSCT	HSCT	NNP
cord-005453-4057qib7	13720	21	in	in	IN
cord-005453-4057qib7	13720	22	the	the	DT
cord-005453-4057qib7	13720	23	treatment	treatment	NN
cord-005453-4057qib7	13720	24	of	of	IN
cord-005453-4057qib7	13720	25	these	these	DT
cord-005453-4057qib7	13720	26	patients	patient	NNS
cord-005453-4057qib7	13720	27	.	.	.
cord-005453-4057qib7	13721	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13721	2	:	:	:
cord-005453-4057qib7	13721	3	Nothing	nothing	NN
cord-005453-4057qib7	13721	4	to	to	TO
cord-005453-4057qib7	13721	5	declare	declare	VB
cord-005453-4057qib7	13721	6	P627	P627	NNP
cord-005453-4057qib7	13721	7	Treatment	Treatment	NNP
cord-005453-4057qib7	13721	8	of	of	IN
cord-005453-4057qib7	13721	9	the	the	DT
cord-005453-4057qib7	13721	10	obliterant	obliterant	JJ
cord-005453-4057qib7	13721	11	bronchiolitis	bronchiolitis	NN
cord-005453-4057qib7	13721	12	in	in	IN
cord-005453-4057qib7	13721	13	pediatric	pediatric	JJ
cord-005453-4057qib7	13721	14	allogeneic	allogeneic	NN
cord-005453-4057qib7	13721	15	recipients	recipient	NNS
cord-005453-4057qib7	13721	16	:	:	:
cord-005453-4057qib7	13722	1	Two	two	CD
cord-005453-4057qib7	13722	2	periods	period	NNS
cord-005453-4057qib7	13722	3	compared	compare	VBN
cord-005453-4057qib7	13722	4	Results	result	NNS
cord-005453-4057qib7	13722	5	:	:	:
cord-005453-4057qib7	13722	6	In	in	IN
cord-005453-4057qib7	13722	7	group	group	NN
cord-005453-4057qib7	13722	8	1	1	CD
cord-005453-4057qib7	13722	9	,	,	,
cord-005453-4057qib7	13722	10	the	the	DT
cord-005453-4057qib7	13722	11	therapies	therapy	NNS
cord-005453-4057qib7	13722	12	administered	administer	VBN
cord-005453-4057qib7	13722	13	for	for	IN
cord-005453-4057qib7	13722	14	BO	BO	NNP
cord-005453-4057qib7	13722	15	included	include	VBD
cord-005453-4057qib7	13722	16	prolonged	prolonged	JJ
cord-005453-4057qib7	13722	17	treatment	treatment	NN
cord-005453-4057qib7	13722	18	with	with	IN
cord-005453-4057qib7	13722	19	steroids	steroid	NNS
cord-005453-4057qib7	13722	20	in	in	IN
cord-005453-4057qib7	13722	21	all	all	DT
cord-005453-4057qib7	13722	22	patients	patient	NNS
cord-005453-4057qib7	13722	23	,	,	,
cord-005453-4057qib7	13722	24	anti	anti	JJ
cord-005453-4057qib7	13722	25	-	-	NNP
cord-005453-4057qib7	13722	26	TNF	TNF	NNP
cord-005453-4057qib7	13722	27	in	in	IN
cord-005453-4057qib7	13722	28	1	1	CD
cord-005453-4057qib7	13722	29	,	,	,
cord-005453-4057qib7	13722	30	azatioprine	azatioprine	NN
cord-005453-4057qib7	13722	31	in	in	IN
cord-005453-4057qib7	13722	32	4	4	CD
cord-005453-4057qib7	13722	33	;	;	:
cord-005453-4057qib7	13722	34	while	while	IN
cord-005453-4057qib7	13722	35	in	in	IN
cord-005453-4057qib7	13722	36	the	the	DT
cord-005453-4057qib7	13722	37	group	group	NN
cord-005453-4057qib7	13722	38	2	2	CD
cord-005453-4057qib7	13722	39	,	,	,
cord-005453-4057qib7	13722	40	all	all	DT
cord-005453-4057qib7	13722	41	patients	patient	NNS
cord-005453-4057qib7	13722	42	received	receive	VBD
cord-005453-4057qib7	13722	43	IMA	IMA	NNP
cord-005453-4057qib7	13722	44	,	,	,
cord-005453-4057qib7	13722	45	montelukast	montelukast	NN
cord-005453-4057qib7	13722	46	and	and	CC
cord-005453-4057qib7	13722	47	azitromicin	azitromicin	NNS
cord-005453-4057qib7	13722	48	,	,	,
cord-005453-4057qib7	13722	49	and	and	CC
cord-005453-4057qib7	13722	50	4	4	CD
cord-005453-4057qib7	13722	51	received	receive	VBD
cord-005453-4057qib7	13722	52	i.v	i.v	NNP
cord-005453-4057qib7	13722	53	.	.	.
cord-005453-4057qib7	13722	54	MPD	MPD	NNP
cord-005453-4057qib7	13722	55	.	.	.
cord-005453-4057qib7	13723	1	The	the	DT
cord-005453-4057qib7	13723	2	median	median	JJ
cord-005453-4057qib7	13723	3	duration	duration	NN
cord-005453-4057qib7	13723	4	of	of	IN
cord-005453-4057qib7	13723	5	Imatinib	Imatinib	NNP
cord-005453-4057qib7	13723	6	therapy	therapy	NN
cord-005453-4057qib7	13723	7	was	be	VBD
cord-005453-4057qib7	13723	8	4	4	CD
cord-005453-4057qib7	13723	9	years	year	NNS
cord-005453-4057qib7	13723	10	(	(	-LRB-
cord-005453-4057qib7	13723	11	0.3	0.3	CD
cord-005453-4057qib7	13723	12	-	-	SYM
cord-005453-4057qib7	13723	13	7.1	7.1	CD
cord-005453-4057qib7	13723	14	years	year	NNS
cord-005453-4057qib7	13723	15	)	)	-RRB-
cord-005453-4057qib7	13723	16	.	.	.
cord-005453-4057qib7	13724	1	After	after	IN
cord-005453-4057qib7	13724	2	a	a	DT
cord-005453-4057qib7	13724	3	median	median	JJ
cord-005453-4057qib7	13724	4	follow	follow	NN
cord-005453-4057qib7	13724	5	-	-	HYPH
cord-005453-4057qib7	13724	6	up	up	NN
cord-005453-4057qib7	13724	7	of	of	IN
cord-005453-4057qib7	13724	8	4.4	4.4	CD
cord-005453-4057qib7	13724	9	years	year	NNS
cord-005453-4057qib7	13724	10	(	(	-LRB-
cord-005453-4057qib7	13724	11	range	range	VBP
cord-005453-4057qib7	13724	12	0.5	0.5	CD
cord-005453-4057qib7	13724	13	-	-	HYPH
cord-005453-4057qib7	13724	14	12.1	12.1	CD
cord-005453-4057qib7	13724	15	yrs	yr	NNS
cord-005453-4057qib7	13724	16	)	)	-RRB-
cord-005453-4057qib7	13724	17	,	,	,
cord-005453-4057qib7	13724	18	9/11	9/11	CD
cord-005453-4057qib7	13724	19	patients	patient	NNS
cord-005453-4057qib7	13724	20	of	of	IN
cord-005453-4057qib7	13724	21	group	group	NN
cord-005453-4057qib7	13724	22	1	1	CD
cord-005453-4057qib7	13724	23	(	(	-LRB-
cord-005453-4057qib7	13724	24	82	82	CD
cord-005453-4057qib7	13724	25	%	%	NN
cord-005453-4057qib7	13724	26	)	)	-RRB-
cord-005453-4057qib7	13724	27	died	die	VBD
cord-005453-4057qib7	13724	28	with	with	IN
cord-005453-4057qib7	13724	29	BO	BO	NNP
cord-005453-4057qib7	13724	30	in	in	IN
cord-005453-4057qib7	13724	31	progress	progress	NN
cord-005453-4057qib7	13724	32	for	for	IN
cord-005453-4057qib7	13724	33	transplant	transplant	NN
cord-005453-4057qib7	13724	34	-	-	HYPH
cord-005453-4057qib7	13724	35	related	relate	VBN
cord-005453-4057qib7	13724	36	causes	cause	NNS
cord-005453-4057qib7	13724	37	.	.	.
cord-005453-4057qib7	13725	1	While	while	IN
cord-005453-4057qib7	13725	2	in	in	IN
cord-005453-4057qib7	13725	3	the	the	DT
cord-005453-4057qib7	13725	4	group	group	NN
cord-005453-4057qib7	13725	5	2	2	CD
cord-005453-4057qib7	13725	6	,	,	,
cord-005453-4057qib7	13725	7	2/14	2/14	CD
cord-005453-4057qib7	13725	8	(	(	-LRB-
cord-005453-4057qib7	13725	9	14	14	CD
cord-005453-4057qib7	13725	10	%	%	NN
cord-005453-4057qib7	13725	11	)	)	-RRB-
cord-005453-4057qib7	13725	12	died	die	VBD
cord-005453-4057qib7	13725	13	in	in	IN
cord-005453-4057qib7	13725	14	presence	presence	NN
cord-005453-4057qib7	13725	15	of	of	IN
cord-005453-4057qib7	13725	16	worsening	worsen	VBG
cord-005453-4057qib7	13725	17	BO	BO	NNP
cord-005453-4057qib7	13725	18	.	.	.
cord-005453-4057qib7	13726	1	The	the	DT
cord-005453-4057qib7	13726	2	estimated	estimate	VBN
cord-005453-4057qib7	13726	3	OS	os	NN
cord-005453-4057qib7	13726	4	at	at	IN
cord-005453-4057qib7	13726	5	1	1	CD
cord-005453-4057qib7	13726	6	year	year	NN
cord-005453-4057qib7	13726	7	after	after	IN
cord-005453-4057qib7	13726	8	HSCT	HSCT	NNP
cord-005453-4057qib7	13726	9	was	be	VBD
cord-005453-4057qib7	13726	10	75	75	CD
cord-005453-4057qib7	13726	11	%	%	NN
cord-005453-4057qib7	13726	12	(	(	-LRB-
cord-005453-4057qib7	13726	13	95	95	CD
cord-005453-4057qib7	13726	14	%	%	NN
cord-005453-4057qib7	13726	15	CI	ci	NN
cord-005453-4057qib7	13726	16	;	;	:
cord-005453-4057qib7	13726	17	50	50	CD
cord-005453-4057qib7	13726	18	-	-	SYM
cord-005453-4057qib7	13726	19	89	89	CD
cord-005453-4057qib7	13726	20	)	)	-RRB-
cord-005453-4057qib7	13726	21	in	in	IN
cord-005453-4057qib7	13726	22	group	group	NN
cord-005453-4057qib7	13726	23	1	1	CD
cord-005453-4057qib7	13726	24	and	and	CC
cord-005453-4057qib7	13726	25	83	83	CD
cord-005453-4057qib7	13726	26	%	%	NN
cord-005453-4057qib7	13726	27	(	(	-LRB-
cord-005453-4057qib7	13726	28	95	95	CD
cord-005453-4057qib7	13726	29	%	%	NN
cord-005453-4057qib7	13726	30	CI	CI	NNP
cord-005453-4057qib7	13726	31	,	,	,
cord-005453-4057qib7	13726	32	27	27	CD
cord-005453-4057qib7	13726	33	-	-	SYM
cord-005453-4057qib7	13726	34	97	97	CD
cord-005453-4057qib7	13726	35	)	)	-RRB-
cord-005453-4057qib7	13726	36	in	in	IN
cord-005453-4057qib7	13726	37	group	group	NN
cord-005453-4057qib7	13726	38	2	2	CD
cord-005453-4057qib7	13726	39	(	(	-LRB-
cord-005453-4057qib7	13726	40	p=0.103	p=0.103	NNP
cord-005453-4057qib7	13726	41	)	)	-RRB-
cord-005453-4057qib7	13727	1	(	(	-LRB-
cord-005453-4057qib7	13727	2	Figure	figure	NN
cord-005453-4057qib7	13727	3	1	1	CD
cord-005453-4057qib7	13727	4	)	)	-RRB-
cord-005453-4057qib7	13727	5	,	,	,
cord-005453-4057qib7	13727	6	while	while	IN
cord-005453-4057qib7	13727	7	the	the	DT
cord-005453-4057qib7	13727	8	OS	OS	NNP
cord-005453-4057qib7	13727	9	after	after	IN
cord-005453-4057qib7	13727	10	4	4	CD
cord-005453-4057qib7	13727	11	year	year	NN
cord-005453-4057qib7	13727	12	decreased	decrease	VBD
cord-005453-4057qib7	13727	13	at	at	IN
cord-005453-4057qib7	13727	14	42	42	CD
cord-005453-4057qib7	13727	15	%	%	NN
cord-005453-4057qib7	13727	16	(	(	-LRB-
cord-005453-4057qib7	13727	17	95	95	CD
cord-005453-4057qib7	13727	18	%	%	NN
cord-005453-4057qib7	13727	19	CI	CI	NNP
cord-005453-4057qib7	13727	20	;	;	:
cord-005453-4057qib7	13727	21	16	16	CD
cord-005453-4057qib7	13727	22	-	-	SYM
cord-005453-4057qib7	13727	23	66	66	CD
cord-005453-4057qib7	13727	24	)	)	-RRB-
cord-005453-4057qib7	13727	25	in	in	IN
cord-005453-4057qib7	13727	26	the	the	DT
cord-005453-4057qib7	13727	27	group	group	NN
cord-005453-4057qib7	13727	28	1	1	CD
cord-005453-4057qib7	13727	29	while	while	NN
cord-005453-4057qib7	13727	30	remained	remain	VBD
cord-005453-4057qib7	13727	31	stable	stable	JJ
cord-005453-4057qib7	13727	32	in	in	IN
cord-005453-4057qib7	13727	33	the	the	DT
cord-005453-4057qib7	13727	34	group	group	NN
cord-005453-4057qib7	13727	35	2	2	CD
cord-005453-4057qib7	13727	36	.	.	.
cord-005453-4057qib7	13728	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13728	2	:	:	:
cord-005453-4057qib7	13728	3	this	this	DT
cord-005453-4057qib7	13728	4	experience	experience	NN
cord-005453-4057qib7	13728	5	shows	show	VBZ
cord-005453-4057qib7	13728	6	a	a	DT
cord-005453-4057qib7	13728	7	relevant	relevant	JJ
cord-005453-4057qib7	13728	8	improving	improving	NN
cord-005453-4057qib7	13728	9	in	in	IN
cord-005453-4057qib7	13728	10	prognosis	prognosis	NN
cord-005453-4057qib7	13728	11	of	of	IN
cord-005453-4057qib7	13728	12	children	child	NNS
cord-005453-4057qib7	13728	13	with	with	IN
cord-005453-4057qib7	13728	14	BO	BO	NNP
cord-005453-4057qib7	13728	15	with	with	IN
cord-005453-4057qib7	13728	16	the	the	DT
cord-005453-4057qib7	13728	17	use	use	NN
cord-005453-4057qib7	13728	18	of	of	IN
cord-005453-4057qib7	13728	19	this	this	DT
cord-005453-4057qib7	13728	20	protocol	protocol	NN
cord-005453-4057qib7	13728	21	including	include	VBG
cord-005453-4057qib7	13728	22	IMA	IMA	NNP
cord-005453-4057qib7	13728	23	,	,	,
cord-005453-4057qib7	13728	24	since	since	IN
cord-005453-4057qib7	13728	25	the	the	DT
cord-005453-4057qib7	13728	26	significant	significant	JJ
cord-005453-4057qib7	13728	27	improving	improving	NN
cord-005453-4057qib7	13728	28	of	of	IN
cord-005453-4057qib7	13728	29	survival	survival	NN
cord-005453-4057qib7	13728	30	obtained	obtain	VBN
cord-005453-4057qib7	13728	31	,	,	,
cord-005453-4057qib7	13728	32	confirming	confirm	VBG
cord-005453-4057qib7	13728	33	as	as	IN
cord-005453-4057qib7	13728	34	reported	report	VBN
cord-005453-4057qib7	13728	35	in	in	IN
cord-005453-4057qib7	13728	36	adult	adult	NN
cord-005453-4057qib7	13728	37	populations	population	NNS
cord-005453-4057qib7	13728	38	.	.	.
cord-005453-4057qib7	13729	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13729	2	Results	result	NNS
cord-005453-4057qib7	13730	1	:	:	:
cord-005453-4057qib7	13730	2	We	-PRON-	PRP
cord-005453-4057qib7	13730	3	presented	present	VBD
cord-005453-4057qib7	13730	4	20	20	CD
cord-005453-4057qib7	13730	5	patients	patient	NNS
cord-005453-4057qib7	13730	6	with	with	IN
cord-005453-4057qib7	13730	7	PRES	PRES	NNP
cord-005453-4057qib7	13730	8	,	,	,
cord-005453-4057qib7	13730	9	age	age	NN
cord-005453-4057qib7	13730	10	ranging	range	VBG
cord-005453-4057qib7	13730	11	from	from	IN
cord-005453-4057qib7	13730	12	2	2	CD
cord-005453-4057qib7	13730	13	months	month	NNS
cord-005453-4057qib7	13730	14	to	to	IN
cord-005453-4057qib7	13730	15	19	19	CD
cord-005453-4057qib7	13730	16	years	year	NNS
cord-005453-4057qib7	13730	17	with	with	IN
cord-005453-4057qib7	13730	18	a	a	DT
cord-005453-4057qib7	13730	19	average	average	NN
cord-005453-4057qib7	13730	20	of	of	IN
cord-005453-4057qib7	13730	21	9.5	9.5	CD
cord-005453-4057qib7	13730	22	years	year	NNS
cord-005453-4057qib7	13730	23	.	.	.
cord-005453-4057qib7	13731	1	There	there	EX
cord-005453-4057qib7	13731	2	were	be	VBD
cord-005453-4057qib7	13731	3	ten	ten	CD
cord-005453-4057qib7	13731	4	patients	patient	NNS
cord-005453-4057qib7	13731	5	with	with	IN
cord-005453-4057qib7	13731	6	thalassemia	thalassemia	NN
cord-005453-4057qib7	13731	7	major	major	JJ
cord-005453-4057qib7	13731	8	,	,	,
cord-005453-4057qib7	13731	9	two	two	CD
cord-005453-4057qib7	13731	10	patient	patient	JJ
cord-005453-4057qib7	13731	11	with	with	IN
cord-005453-4057qib7	13731	12	acute	acute	JJ
cord-005453-4057qib7	13731	13	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13731	14	leukemia	leukemia	NN
cord-005453-4057qib7	13731	15	,	,	,
cord-005453-4057qib7	13731	16	three	three	CD
cord-005453-4057qib7	13731	17	patients	patient	NNS
cord-005453-4057qib7	13731	18	with	with	IN
cord-005453-4057qib7	13731	19	sickle	sickle	NN
cord-005453-4057qib7	13731	20	cell	cell	NN
cord-005453-4057qib7	13731	21	disease	disease	NN
cord-005453-4057qib7	13731	22	and	and	CC
cord-005453-4057qib7	13731	23	one	one	CD
cord-005453-4057qib7	13731	24	patient	patient	NN
cord-005453-4057qib7	13731	25	with	with	IN
cord-005453-4057qib7	13731	26	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	13731	27	syndrome	syndrome	NN
cord-005453-4057qib7	13731	28	,	,	,
cord-005453-4057qib7	13731	29	one	one	CD
cord-005453-4057qib7	13731	30	patient	patient	NN
cord-005453-4057qib7	13731	31	with	with	IN
cord-005453-4057qib7	13731	32	immune	immune	JJ
cord-005453-4057qib7	13731	33	deficiency	deficiency	NN
cord-005453-4057qib7	13731	34	,	,	,
cord-005453-4057qib7	13731	35	two	two	CD
cord-005453-4057qib7	13731	36	patients	patient	NNS
cord-005453-4057qib7	13731	37	with	with	IN
cord-005453-4057qib7	13731	38	acute	acute	JJ
cord-005453-4057qib7	13731	39	miyeloid	miyeloid	NNP
cord-005453-4057qib7	13731	40	leukemia	leukemia	NN
cord-005453-4057qib7	13731	41	,	,	,
cord-005453-4057qib7	13731	42	one	one	CD
cord-005453-4057qib7	13731	43	patient	patient	NN
cord-005453-4057qib7	13731	44	with	with	IN
cord-005453-4057qib7	13731	45	aplastic	aplastic	JJ
cord-005453-4057qib7	13731	46	anemia	anemia	NN
cord-005453-4057qib7	13731	47	.	.	.
cord-005453-4057qib7	13732	1	Ten	ten	CD
cord-005453-4057qib7	13732	2	patients	patient	NNS
cord-005453-4057qib7	13732	3	were	be	VBD
cord-005453-4057qib7	13732	4	males	male	NNS
cord-005453-4057qib7	13732	5	,	,	,
cord-005453-4057qib7	13732	6	ten	ten	CD
cord-005453-4057qib7	13732	7	were	be	VBD
cord-005453-4057qib7	13732	8	female	female	JJ
cord-005453-4057qib7	13732	9	.	.	.
cord-005453-4057qib7	13733	1	All	all	DT
cord-005453-4057qib7	13733	2	patients	patient	NNS
cord-005453-4057qib7	13733	3	were	be	VBD
cord-005453-4057qib7	13733	4	treated	treat	VBN
cord-005453-4057qib7	13733	5	with	with	IN
cord-005453-4057qib7	13733	6	CsA	csa	NN
cord-005453-4057qib7	13733	7	or	or	CC
cord-005453-4057qib7	13733	8	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	13733	9	and	and	CC
cord-005453-4057qib7	13733	10	metilprednisolone	metilprednisolone	NNP
cord-005453-4057qib7	13733	11	for	for	IN
cord-005453-4057qib7	13733	12	the	the	DT
cord-005453-4057qib7	13733	13	prophylasix	prophylasix	NN
cord-005453-4057qib7	13733	14	of	of	IN
cord-005453-4057qib7	13733	15	GVHD	GVHD	NNP
cord-005453-4057qib7	13733	16	.	.	.
cord-005453-4057qib7	13734	1	PRES	PRES	NNP
cord-005453-4057qib7	13734	2	occurred	occur	VBD
cord-005453-4057qib7	13734	3	at	at	IN
cord-005453-4057qib7	13734	4	a	a	DT
cord-005453-4057qib7	13734	5	median	median	NN
cord-005453-4057qib7	13734	6	of	of	IN
cord-005453-4057qib7	13734	7	90	90	CD
cord-005453-4057qib7	13734	8	days	day	NNS
cord-005453-4057qib7	13734	9	(	(	-LRB-
cord-005453-4057qib7	13734	10	range	range	NNP
cord-005453-4057qib7	13734	11	5	5	CD
cord-005453-4057qib7	13734	12	-	-	SYM
cord-005453-4057qib7	13734	13	625	625	CD
cord-005453-4057qib7	13734	14	)	)	-RRB-
cord-005453-4057qib7	13734	15	.	.	.
cord-005453-4057qib7	13735	1	Clinical	clinical	JJ
cord-005453-4057qib7	13735	2	findings	finding	NNS
cord-005453-4057qib7	13735	3	at	at	IN
cord-005453-4057qib7	13735	4	onset	onset	NN
cord-005453-4057qib7	13735	5	of	of	IN
cord-005453-4057qib7	13735	6	leukoencephalopathy	leukoencephalopathy	NNP
cord-005453-4057qib7	13735	7	were	be	VBD
cord-005453-4057qib7	13735	8	hypertension	hypertension	NN
cord-005453-4057qib7	13735	9	,	,	,
cord-005453-4057qib7	13735	10	headache	headache	NN
cord-005453-4057qib7	13735	11	,	,	,
cord-005453-4057qib7	13735	12	seizures	seizure	NNS
cord-005453-4057qib7	13735	13	,	,	,
cord-005453-4057qib7	13735	14	visual	visual	JJ
cord-005453-4057qib7	13735	15	disturbance	disturbance	NN
cord-005453-4057qib7	13735	16	,	,	,
cord-005453-4057qib7	13735	17	and	and	CC
cord-005453-4057qib7	13735	18	altered	alter	VBN
cord-005453-4057qib7	13735	19	mental	mental	JJ
cord-005453-4057qib7	13735	20	function	function	NN
cord-005453-4057qib7	13735	21	.	.	.
cord-005453-4057qib7	13736	1	Eighteen	eighteen	CD
cord-005453-4057qib7	13736	2	patients	patient	NNS
cord-005453-4057qib7	13736	3	alive	alive	JJ
cord-005453-4057qib7	13736	4	with	with	IN
cord-005453-4057qib7	13736	5	normal	normal	JJ
cord-005453-4057qib7	13736	6	neurological	neurological	JJ
cord-005453-4057qib7	13736	7	status	status	NN
cord-005453-4057qib7	13736	8	.	.	.
cord-005453-4057qib7	13737	1	MRI	MRI	NNP
cord-005453-4057qib7	13737	2	showed	show	VBD
cord-005453-4057qib7	13737	3	abnormalities	abnormality	NNS
cord-005453-4057qib7	13737	4	in	in	IN
cord-005453-4057qib7	13737	5	all	all	DT
cord-005453-4057qib7	13737	6	patients	patient	NNS
cord-005453-4057qib7	13737	7	including	include	VBG
cord-005453-4057qib7	13737	8	patchy	patchy	JJ
cord-005453-4057qib7	13737	9	bilateral	bilateral	JJ
cord-005453-4057qib7	13737	10	cortical	cortical	JJ
cord-005453-4057qib7	13737	11	and	and	CC
cord-005453-4057qib7	13737	12	subcortical	subcortical	JJ
cord-005453-4057qib7	13737	13	lesions	lesion	NNS
cord-005453-4057qib7	13737	14	,	,	,
cord-005453-4057qib7	13737	15	especially	especially	RB
cord-005453-4057qib7	13737	16	in	in	IN
cord-005453-4057qib7	13737	17	parieto	parieto	NN
cord-005453-4057qib7	13737	18	-	-	HYPH
cord-005453-4057qib7	13737	19	occipital	occipital	JJ
cord-005453-4057qib7	13737	20	lobes	lobe	NNS
cord-005453-4057qib7	13737	21	.	.	.
cord-005453-4057qib7	13738	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13738	2	:	:	:
cord-005453-4057qib7	13739	1	BMT	BMT	NNP
cord-005453-4057qib7	13739	2	is	be	VBZ
cord-005453-4057qib7	13739	3	associated	associate	VBN
cord-005453-4057qib7	13739	4	with	with	IN
cord-005453-4057qib7	13739	5	several	several	JJ
cord-005453-4057qib7	13739	6	neurological	neurological	JJ
cord-005453-4057qib7	13739	7	complications	complication	NNS
cord-005453-4057qib7	13739	8	that	that	WDT
cord-005453-4057qib7	13739	9	may	may	MD
cord-005453-4057qib7	13739	10	be	be	VB
cord-005453-4057qib7	13739	11	underlying	underlie	VBG
cord-005453-4057qib7	13739	12	diseases	disease	NNS
cord-005453-4057qib7	13739	13	,	,	,
cord-005453-4057qib7	13739	14	BMT	BMT	NNP
cord-005453-4057qib7	13739	15	procedure	procedure	NN
cord-005453-4057qib7	13739	16	,	,	,
cord-005453-4057qib7	13739	17	and	and	CC
cord-005453-4057qib7	13739	18	severe	severe	JJ
cord-005453-4057qib7	13739	19	immunosupression	immunosupression	NN
cord-005453-4057qib7	13739	20	.	.	.
cord-005453-4057qib7	13740	1	PRES	PRES	NNP
cord-005453-4057qib7	13740	2	is	be	VBZ
cord-005453-4057qib7	13740	3	an	an	DT
cord-005453-4057qib7	13740	4	uncommon	uncommon	JJ
cord-005453-4057qib7	13740	5	but	but	CC
cord-005453-4057qib7	13740	6	serious	serious	JJ
cord-005453-4057qib7	13740	7	complication	complication	NN
cord-005453-4057qib7	13740	8	after	after	IN
cord-005453-4057qib7	13740	9	BMT	BMT	NNP
cord-005453-4057qib7	13740	10	.	.	.
cord-005453-4057qib7	13741	1	We	-PRON-	PRP
cord-005453-4057qib7	13741	2	report	report	VBP
cord-005453-4057qib7	13741	3	20	20	CD
cord-005453-4057qib7	13741	4	cases	case	NNS
cord-005453-4057qib7	13741	5	of	of	IN
cord-005453-4057qib7	13741	6	PRES	PRES	NNP
cord-005453-4057qib7	13741	7	who	who	WP
cord-005453-4057qib7	13741	8	received	receive	VBD
cord-005453-4057qib7	13741	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	13741	10	BMT	BMT	NNP
cord-005453-4057qib7	13741	11	for	for	IN
cord-005453-4057qib7	13741	12	thalassemia	thalassemia	NN
cord-005453-4057qib7	13741	13	major	major	JJ
cord-005453-4057qib7	13741	14	to	to	TO
cord-005453-4057qib7	13741	15	emphasize	emphasize	VB
cord-005453-4057qib7	13741	16	the	the	DT
cord-005453-4057qib7	13741	17	importance	importance	NN
cord-005453-4057qib7	13741	18	of	of	IN
cord-005453-4057qib7	13741	19	early	early	JJ
cord-005453-4057qib7	13741	20	recognition	recognition	NN
cord-005453-4057qib7	13741	21	and	and	CC
cord-005453-4057qib7	13741	22	institution	institution	NN
cord-005453-4057qib7	13741	23	of	of	IN
cord-005453-4057qib7	13741	24	appropriate	appropriate	JJ
cord-005453-4057qib7	13741	25	management	management	NN
cord-005453-4057qib7	13741	26	of	of	IN
cord-005453-4057qib7	13741	27	PRES	PRES	NNP
cord-005453-4057qib7	13741	28	during	during	IN
cord-005453-4057qib7	13741	29	BMT	BMT	NNP
cord-005453-4057qib7	13741	30	.	.	.
cord-005453-4057qib7	13742	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13742	2	:	:	:
cord-005453-4057qib7	13742	3	Nothing	nothing	NN
cord-005453-4057qib7	13742	4	to	to	TO
cord-005453-4057qib7	13742	5	declare	declare	VB
cord-005453-4057qib7	13742	6	P631	p631	CD
cord-005453-4057qib7	13743	1	Continuous	continuous	JJ
cord-005453-4057qib7	13743	2	complete	complete	JJ
cord-005453-4057qib7	13743	3	molecular	molecular	JJ
cord-005453-4057qib7	13743	4	remission	remission	NN
cord-005453-4057qib7	13743	5	using	use	VBG
cord-005453-4057qib7	13743	6	three	three	CD
cord-005453-4057qib7	13743	7	different	different	JJ
cord-005453-4057qib7	13743	8	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13743	9	antibodies	antibody	NNS
cord-005453-4057qib7	13743	10	followed	follow	VBN
cord-005453-4057qib7	13743	11	by	by	IN
cord-005453-4057qib7	13743	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	13743	13	bone	bone	NN
cord-005453-4057qib7	13743	14	marrow	marrow	NN
cord-005453-4057qib7	13743	15	transplantation	transplantation	NN
cord-005453-4057qib7	13743	16	in	in	IN
cord-005453-4057qib7	13743	17	an	an	DT
cord-005453-4057qib7	13743	18	infant	infant	NN
cord-005453-4057qib7	13743	19	with	with	IN
cord-005453-4057qib7	13743	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13743	21	-	-	HYPH
cord-005453-4057qib7	13743	22	refractory	refractory	JJ
cord-005453-4057qib7	13743	23	acute	acute	JJ
cord-005453-4057qib7	13743	24	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13743	25	leukemia	leukemia	NN
cord-005453-4057qib7	13743	26	Bernd	Bernd	NNP
cord-005453-4057qib7	13743	27	Gruhn	Gruhn	NNP
cord-005453-4057qib7	13743	28	1	1	CD
cord-005453-4057qib7	13744	1	,	,	,
cord-005453-4057qib7	13744	2	Susan	Susan	NNP
cord-005453-4057qib7	13744	3	Wittig	Wittig	NNP
cord-005453-4057qib7	13744	4	1	1	CD
cord-005453-4057qib7	13744	5	,	,	,
cord-005453-4057qib7	13744	6	Thomas	Thomas	NNP
cord-005453-4057qib7	13744	7	Ernst	Ernst	NNP
cord-005453-4057qib7	13744	8	1	1	CD
cord-005453-4057qib7	13744	9	,	,	,
cord-005453-4057qib7	13744	10	Jana	Jana	NNP
cord-005453-4057qib7	13744	11	Ernst	Ernst	NNP
cord-005453-4057qib7	13744	12	1	1	CD
cord-005453-4057qib7	13744	13	1	1	CD
cord-005453-4057qib7	13744	14	University	University	NNP
cord-005453-4057qib7	13744	15	of	of	IN
cord-005453-4057qib7	13744	16	Jena	Jena	NNP
cord-005453-4057qib7	13744	17	,	,	,
cord-005453-4057qib7	13744	18	Jena	Jena	NNP
cord-005453-4057qib7	13744	19	,	,	,
cord-005453-4057qib7	13744	20	Germany	Germany	NNP
cord-005453-4057qib7	13744	21	,	,	,
cord-005453-4057qib7	13744	22	Background	background	NN
cord-005453-4057qib7	13744	23	:	:	:
cord-005453-4057qib7	13745	1	A	a	DT
cord-005453-4057qib7	13745	2	10-week	10-week	JJ
cord-005453-4057qib7	13745	3	-	-	HYPH
cord-005453-4057qib7	13745	4	old	old	JJ
cord-005453-4057qib7	13745	5	infant	infant	NN
cord-005453-4057qib7	13745	6	was	be	VBD
cord-005453-4057qib7	13745	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	13745	8	with	with	IN
cord-005453-4057qib7	13745	9	very	very	RB
cord-005453-4057qib7	13745	10	immature	immature	JJ
cord-005453-4057qib7	13745	11	acute	acute	JJ
cord-005453-4057qib7	13745	12	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13745	13	leukemia	leukemia	NN
cord-005453-4057qib7	13745	14	(	(	-LRB-
cord-005453-4057qib7	13745	15	ALL	all	DT
cord-005453-4057qib7	13745	16	)	)	-RRB-
cord-005453-4057qib7	13745	17	with	with	IN
cord-005453-4057qib7	13745	18	myeloid	myeloid	JJ
cord-005453-4057qib7	13745	19	markers	marker	NNS
cord-005453-4057qib7	13745	20	in	in	IN
cord-005453-4057qib7	13745	21	a	a	DT
cord-005453-4057qib7	13745	22	foreign	foreign	JJ
cord-005453-4057qib7	13745	23	university	university	NN
cord-005453-4057qib7	13745	24	hospital	hospital	NN
cord-005453-4057qib7	13745	25	.	.	.
cord-005453-4057qib7	13746	1	At	at	IN
cord-005453-4057qib7	13746	2	the	the	DT
cord-005453-4057qib7	13746	3	end	end	NN
cord-005453-4057qib7	13746	4	of	of	IN
cord-005453-4057qib7	13746	5	induction	induction	NN
cord-005453-4057qib7	13746	6	therapy	therapy	NN
cord-005453-4057qib7	13746	7	according	accord	VBG
cord-005453-4057qib7	13746	8	to	to	IN
cord-005453-4057qib7	13746	9	the	the	DT
cord-005453-4057qib7	13746	10	current	current	JJ
cord-005453-4057qib7	13746	11	LAL	LAL	NNP
cord-005453-4057qib7	13746	12	/	/	SYM
cord-005453-4057qib7	13746	13	SHOP	SHOP	NNP
cord-005453-4057qib7	13746	14	protocol	protocol	NN
cord-005453-4057qib7	13746	15	10	10	CD
cord-005453-4057qib7	13746	16	%	%	NN
cord-005453-4057qib7	13746	17	leukemic	leukemic	JJ
cord-005453-4057qib7	13746	18	cells	cell	NNS
cord-005453-4057qib7	13746	19	were	be	VBD
cord-005453-4057qib7	13746	20	detectable	detectable	JJ
cord-005453-4057qib7	13746	21	in	in	IN
cord-005453-4057qib7	13746	22	the	the	DT
cord-005453-4057qib7	13746	23	bone	bone	NN
cord-005453-4057qib7	13746	24	marrow	marrow	NN
cord-005453-4057qib7	13746	25	.	.	.
cord-005453-4057qib7	13747	1	Treatment	treatment	NN
cord-005453-4057qib7	13747	2	was	be	VBD
cord-005453-4057qib7	13747	3	changed	change	VBN
cord-005453-4057qib7	13747	4	to	to	IN
cord-005453-4057qib7	13747	5	fludarabine	fludarabine	VB
cord-005453-4057qib7	13747	6	,	,	,
cord-005453-4057qib7	13747	7	cytarabine	cytarabine	NN
cord-005453-4057qib7	13747	8	and	and	CC
cord-005453-4057qib7	13747	9	granulocyte	granulocyte	NN
cord-005453-4057qib7	13747	10	colony	colony	NN
cord-005453-4057qib7	13747	11	-	-	HYPH
cord-005453-4057qib7	13747	12	stimulating	stimulate	VBG
cord-005453-4057qib7	13747	13	factor	factor	NN
cord-005453-4057qib7	13747	14	(	(	-LRB-
cord-005453-4057qib7	13747	15	FLAG	flag	NN
cord-005453-4057qib7	13747	16	)	)	-RRB-
cord-005453-4057qib7	13747	17	in	in	IN
cord-005453-4057qib7	13747	18	combination	combination	NN
cord-005453-4057qib7	13747	19	with	with	IN
cord-005453-4057qib7	13747	20	liposomal	liposomal	JJ
cord-005453-4057qib7	13747	21	doxorubicin	doxorubicin	NN
cord-005453-4057qib7	13747	22	.	.	.
cord-005453-4057qib7	13748	1	After	after	IN
cord-005453-4057qib7	13748	2	this	this	DT
cord-005453-4057qib7	13748	3	re	re	NN
cord-005453-4057qib7	13748	4	-	-	NN
cord-005453-4057qib7	13748	5	induction	induction	NN
cord-005453-4057qib7	13748	6	still	still	RB
cord-005453-4057qib7	13748	7	5	5	CD
cord-005453-4057qib7	13748	8	%	%	NN
cord-005453-4057qib7	13748	9	leukemic	leukemic	JJ
cord-005453-4057qib7	13748	10	cells	cell	NNS
cord-005453-4057qib7	13748	11	were	be	VBD
cord-005453-4057qib7	13748	12	detected	detect	VBN
cord-005453-4057qib7	13748	13	in	in	IN
cord-005453-4057qib7	13748	14	bone	bone	NN
cord-005453-4057qib7	13748	15	marrow	marrow	NN
cord-005453-4057qib7	13748	16	,	,	,
cord-005453-4057qib7	13748	17	so	so	CC
cord-005453-4057qib7	13748	18	the	the	DT
cord-005453-4057qib7	13748	19	bispecific	bispecific	NN
cord-005453-4057qib7	13748	20	T	t	NN
cord-005453-4057qib7	13748	21	-	-	HYPH
cord-005453-4057qib7	13748	22	cell	cell	NN
cord-005453-4057qib7	13748	23	engager	engager	NNP
cord-005453-4057qib7	13748	24	antibody	antibody	NNP
cord-005453-4057qib7	13748	25	blinatumomab	blinatumomab	NNP
cord-005453-4057qib7	13748	26	was	be	VBD
cord-005453-4057qib7	13748	27	given	give	VBN
cord-005453-4057qib7	13748	28	.	.	.
cord-005453-4057qib7	13749	1	Due	due	IN
cord-005453-4057qib7	13749	2	to	to	IN
cord-005453-4057qib7	13749	3	an	an	DT
cord-005453-4057qib7	13749	4	increasing	increase	VBG
cord-005453-4057qib7	13749	5	portion	portion	NN
cord-005453-4057qib7	13749	6	of	of	IN
cord-005453-4057qib7	13749	7	leukemic	leukemic	JJ
cord-005453-4057qib7	13749	8	cells	cell	NNS
cord-005453-4057qib7	13749	9	during	during	IN
cord-005453-4057qib7	13749	10	the	the	DT
cord-005453-4057qib7	13749	11	continuous	continuous	JJ
cord-005453-4057qib7	13749	12	infusion	infusion	NN
cord-005453-4057qib7	13749	13	,	,	,
cord-005453-4057qib7	13749	14	antibody	antibody	NN
cord-005453-4057qib7	13749	15	therapy	therapy	NN
cord-005453-4057qib7	13749	16	was	be	VBD
cord-005453-4057qib7	13749	17	stopped	stop	VBN
cord-005453-4057qib7	13749	18	and	and	CC
cord-005453-4057qib7	13749	19	a	a	DT
cord-005453-4057qib7	13749	20	cycle	cycle	NN
cord-005453-4057qib7	13749	21	of	of	IN
cord-005453-4057qib7	13749	22	clofarabine	clofarabine	NN
cord-005453-4057qib7	13749	23	,	,	,
cord-005453-4057qib7	13749	24	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	13749	25	and	and	CC
cord-005453-4057qib7	13749	26	etoposide	etoposide	NN
cord-005453-4057qib7	13749	27	was	be	VBD
cord-005453-4057qib7	13749	28	administered	administer	VBN
cord-005453-4057qib7	13749	29	.	.	.
cord-005453-4057qib7	13750	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	13750	2	,	,	,
cord-005453-4057qib7	13750	3	still	still	RB
cord-005453-4057qib7	13750	4	31	31	CD
cord-005453-4057qib7	13750	5	%	%	NN
cord-005453-4057qib7	13750	6	leukemic	leukemic	JJ
cord-005453-4057qib7	13750	7	cells	cell	NNS
cord-005453-4057qib7	13750	8	were	be	VBD
cord-005453-4057qib7	13750	9	detectable	detectable	JJ
cord-005453-4057qib7	13750	10	afterwards	afterwards	RB
cord-005453-4057qib7	13750	11	.	.	.
cord-005453-4057qib7	13751	1	Because	because	IN
cord-005453-4057qib7	13751	2	of	of	IN
cord-005453-4057qib7	13751	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13751	4	-	-	HYPH
cord-005453-4057qib7	13751	5	refractory	refractory	JJ
cord-005453-4057qib7	13751	6	leukemia	leukemia	NN
cord-005453-4057qib7	13751	7	a	a	DT
cord-005453-4057qib7	13751	8	palliative	palliative	JJ
cord-005453-4057qib7	13751	9	oral	oral	JJ
cord-005453-4057qib7	13751	10	treatment	treatment	NN
cord-005453-4057qib7	13751	11	with	with	IN
cord-005453-4057qib7	13751	12	mercaptopurine	mercaptopurine	NNP
cord-005453-4057qib7	13751	13	was	be	VBD
cord-005453-4057qib7	13751	14	started	start	VBN
cord-005453-4057qib7	13751	15	.	.	.
cord-005453-4057qib7	13752	1	However	however	RB
cord-005453-4057qib7	13752	2	,	,	,
cord-005453-4057qib7	13752	3	the	the	DT
cord-005453-4057qib7	13752	4	parents	parent	NNS
cord-005453-4057qib7	13752	5	did	do	VBD
cord-005453-4057qib7	13752	6	not	not	RB
cord-005453-4057qib7	13752	7	accept	accept	VB
cord-005453-4057qib7	13752	8	the	the	DT
cord-005453-4057qib7	13752	9	palliative	palliative	JJ
cord-005453-4057qib7	13752	10	situation	situation	NN
cord-005453-4057qib7	13752	11	and	and	CC
cord-005453-4057qib7	13752	12	searched	search	VBD
cord-005453-4057qib7	13752	13	for	for	IN
cord-005453-4057qib7	13752	14	alternative	alternative	JJ
cord-005453-4057qib7	13752	15	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13752	16	options	option	NNS
cord-005453-4057qib7	13752	17	in	in	IN
cord-005453-4057qib7	13752	18	other	other	JJ
cord-005453-4057qib7	13752	19	university	university	NN
cord-005453-4057qib7	13752	20	hospitals	hospital	NNS
cord-005453-4057qib7	13752	21	in	in	IN
cord-005453-4057qib7	13752	22	Europe	Europe	NNP
cord-005453-4057qib7	13752	23	.	.	.
cord-005453-4057qib7	13753	1	After	after	IN
cord-005453-4057qib7	13753	2	plenty	plenty	NN
cord-005453-4057qib7	13753	3	of	of	IN
cord-005453-4057qib7	13753	4	refusals	refusal	NNS
cord-005453-4057qib7	13753	5	the	the	DT
cord-005453-4057qib7	13753	6	infant	infant	NN
cord-005453-4057qib7	13753	7	was	be	VBD
cord-005453-4057qib7	13753	8	admitted	admit	VBN
cord-005453-4057qib7	13753	9	to	to	IN
cord-005453-4057qib7	13753	10	our	-PRON-	PRP$
cord-005453-4057qib7	13753	11	hospital	hospital	NN
cord-005453-4057qib7	13753	12	five	five	CD
cord-005453-4057qib7	13753	13	months	month	NNS
cord-005453-4057qib7	13753	14	after	after	IN
cord-005453-4057qib7	13753	15	diagnosis	diagnosis	NN
cord-005453-4057qib7	13753	16	.	.	.
cord-005453-4057qib7	13754	1	Methods	method	NNS
cord-005453-4057qib7	13754	2	:	:	:
cord-005453-4057qib7	13754	3	For	for	IN
cord-005453-4057qib7	13754	4	molecular	molecular	JJ
cord-005453-4057qib7	13754	5	characterization	characterization	NN
cord-005453-4057qib7	13754	6	genomic	genomic	JJ
cord-005453-4057qib7	13754	7	DNA	dna	NN
cord-005453-4057qib7	13754	8	was	be	VBD
cord-005453-4057qib7	13754	9	isolated	isolate	VBN
cord-005453-4057qib7	13754	10	from	from	IN
cord-005453-4057qib7	13754	11	leukemic	leukemic	JJ
cord-005453-4057qib7	13754	12	cells	cell	NNS
cord-005453-4057qib7	13754	13	.	.	.
cord-005453-4057qib7	13755	1	A	a	DT
cord-005453-4057qib7	13755	2	MLL	MLL	NNP
cord-005453-4057qib7	13755	3	-	-	HYPH
cord-005453-4057qib7	13755	4	MLLT3	MLLT3	NNP
cord-005453-4057qib7	13755	5	/	/	SYM
cord-005453-4057qib7	13755	6	AF9	af9	NN
cord-005453-4057qib7	13755	7	rearrangement	rearrangement	NN
cord-005453-4057qib7	13755	8	as	as	IN
cord-005453-4057qib7	13755	9	a	a	DT
cord-005453-4057qib7	13755	10	consequence	consequence	NN
cord-005453-4057qib7	13755	11	of	of	IN
cord-005453-4057qib7	13755	12	the	the	DT
cord-005453-4057qib7	13755	13	translocation	translocation	NN
cord-005453-4057qib7	13755	14	t(9;11	t(9;11	NN
cord-005453-4057qib7	13755	15	)	)	-RRB-
cord-005453-4057qib7	13756	1	(	(	-LRB-
cord-005453-4057qib7	13756	2	p22;q23	p22;q23	NNS
cord-005453-4057qib7	13756	3	)	)	-RRB-
cord-005453-4057qib7	13756	4	was	be	VBD
cord-005453-4057qib7	13756	5	detected	detect	VBN
cord-005453-4057qib7	13756	6	and	and	CC
cord-005453-4057qib7	13756	7	used	use	VBN
cord-005453-4057qib7	13756	8	as	as	IN
cord-005453-4057qib7	13756	9	a	a	DT
cord-005453-4057qib7	13756	10	marker	marker	NN
cord-005453-4057qib7	13756	11	for	for	IN
cord-005453-4057qib7	13756	12	minimal	minimal	JJ
cord-005453-4057qib7	13756	13	residual	residual	JJ
cord-005453-4057qib7	13756	14	disease	disease	NN
cord-005453-4057qib7	13756	15	.	.	.
cord-005453-4057qib7	13757	1	For	for	IN
cord-005453-4057qib7	13757	2	further	further	JJ
cord-005453-4057qib7	13757	3	molecular	molecular	JJ
cord-005453-4057qib7	13757	4	characterization	characterization	NN
cord-005453-4057qib7	13757	5	targeted	target	VBN
cord-005453-4057qib7	13757	6	deep	deep	JJ
cord-005453-4057qib7	13757	7	next	next	JJ
cord-005453-4057qib7	13757	8	-	-	HYPH
cord-005453-4057qib7	13757	9	generation	generation	NN
cord-005453-4057qib7	13757	10	sequencing	sequencing	NN
cord-005453-4057qib7	13757	11	was	be	VBD
cord-005453-4057qib7	13757	12	performed	perform	VBN
cord-005453-4057qib7	13757	13	for	for	IN
cord-005453-4057qib7	13757	14	a	a	DT
cord-005453-4057qib7	13757	15	panel	panel	NN
cord-005453-4057qib7	13757	16	of	of	IN
cord-005453-4057qib7	13757	17	54	54	CD
cord-005453-4057qib7	13757	18	leukemia	leukemia	NN
cord-005453-4057qib7	13757	19	-	-	HYPH
cord-005453-4057qib7	13757	20	associated	associate	VBN
cord-005453-4057qib7	13757	21	genes	gene	NNS
cord-005453-4057qib7	13757	22	.	.	.
cord-005453-4057qib7	13758	1	Interestingly	interestingly	RB
cord-005453-4057qib7	13758	2	,	,	,
cord-005453-4057qib7	13758	3	no	no	DT
cord-005453-4057qib7	13758	4	mutation	mutation	NN
cord-005453-4057qib7	13758	5	was	be	VBD
cord-005453-4057qib7	13758	6	found	find	VBN
cord-005453-4057qib7	13758	7	.	.	.
cord-005453-4057qib7	13759	1	To	to	TO
cord-005453-4057qib7	13759	2	allow	allow	VB
cord-005453-4057qib7	13759	3	precise	precise	JJ
cord-005453-4057qib7	13759	4	immunophenotyping	immunophenotyping	NN
cord-005453-4057qib7	13759	5	of	of	IN
cord-005453-4057qib7	13759	6	the	the	DT
cord-005453-4057qib7	13759	7	leukemic	leukemic	JJ
cord-005453-4057qib7	13759	8	cells	cell	NNS
cord-005453-4057qib7	13759	9	treatment	treatment	NN
cord-005453-4057qib7	13759	10	with	with	IN
cord-005453-4057qib7	13759	11	mercaptopurine	mercaptopurine	NNP
cord-005453-4057qib7	13759	12	was	be	VBD
cord-005453-4057qib7	13759	13	stopped	stop	VBN
cord-005453-4057qib7	13759	14	.	.	.
cord-005453-4057qib7	13760	1	Results	result	NNS
cord-005453-4057qib7	13760	2	:	:	:
cord-005453-4057qib7	13761	1	As	as	IN
cord-005453-4057qib7	13761	2	in	in	IN
cord-005453-4057qib7	13761	3	the	the	DT
cord-005453-4057qib7	13761	4	first	first	JJ
cord-005453-4057qib7	13761	5	immunophenotyping	immunophenotype	VBG
cord-005453-4057qib7	13761	6	the	the	DT
cord-005453-4057qib7	13761	7	CD33	CD33	NNP
cord-005453-4057qib7	13761	8	antigen	antigen	NN
cord-005453-4057qib7	13761	9	was	be	VBD
cord-005453-4057qib7	13761	10	found	find	VBN
cord-005453-4057qib7	13761	11	,	,	,
cord-005453-4057qib7	13761	12	we	-PRON-	PRP
cord-005453-4057qib7	13761	13	administered	administer	VBD
cord-005453-4057qib7	13761	14	the	the	DT
cord-005453-4057qib7	13761	15	anti	anti	JJ
cord-005453-4057qib7	13761	16	-	-	JJ
cord-005453-4057qib7	13761	17	CD33	CD33	NNP
cord-005453-4057qib7	13761	18	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13761	19	antibody	antibody	NN
cord-005453-4057qib7	13761	20	gemtuzumab	gemtuzumab	VBN
cord-005453-4057qib7	13761	21	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	13761	22	twice	twice	RB
cord-005453-4057qib7	13761	23	within	within	IN
cord-005453-4057qib7	13761	24	two	two	CD
cord-005453-4057qib7	13761	25	weeks	week	NNS
cord-005453-4057qib7	13761	26	.	.	.
cord-005453-4057qib7	13762	1	Because	because	IN
cord-005453-4057qib7	13762	2	of	of	IN
cord-005453-4057qib7	13762	3	the	the	DT
cord-005453-4057qib7	13762	4	detection	detection	NN
cord-005453-4057qib7	13762	5	of	of	IN
cord-005453-4057qib7	13762	6	CD38	CD38	NNP
cord-005453-4057qib7	13762	7	+	+	CC
cord-005453-4057qib7	13762	8	leukemic	leukemic	JJ
cord-005453-4057qib7	13762	9	cells	cell	NNS
cord-005453-4057qib7	13762	10	after	after	IN
cord-005453-4057qib7	13762	11	infusion	infusion	NN
cord-005453-4057qib7	13762	12	of	of	IN
cord-005453-4057qib7	13762	13	gemtuzumab	gemtuzumab	JJ
cord-005453-4057qib7	13762	14	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	13762	15	,	,	,
cord-005453-4057qib7	13762	16	the	the	DT
cord-005453-4057qib7	13762	17	anti	anti	JJ
cord-005453-4057qib7	13762	18	-	-	JJ
cord-005453-4057qib7	13762	19	CD38	cd38	JJ
cord-005453-4057qib7	13762	20	antibody	antibody	NN
cord-005453-4057qib7	13762	21	daratumumab	daratumumab	NNP
cord-005453-4057qib7	13762	22	was	be	VBD
cord-005453-4057qib7	13762	23	given	give	VBN
cord-005453-4057qib7	13762	24	alternating	alternate	VBG
cord-005453-4057qib7	13762	25	twice	twice	RB
cord-005453-4057qib7	13762	26	within	within	IN
cord-005453-4057qib7	13762	27	two	two	CD
cord-005453-4057qib7	13762	28	weeks	week	NNS
cord-005453-4057qib7	13762	29	.	.	.
cord-005453-4057qib7	13763	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	13763	2	afterwards	afterwards	RB
cord-005453-4057qib7	13763	3	,	,	,
cord-005453-4057qib7	13763	4	leukemic	leukemic	JJ
cord-005453-4057qib7	13763	5	cells	cell	NNS
cord-005453-4057qib7	13763	6	reappeared	reappear	VBD
cord-005453-4057qib7	13763	7	being	be	VBG
cord-005453-4057qib7	13763	8	negative	negative	JJ
cord-005453-4057qib7	13763	9	for	for	IN
cord-005453-4057qib7	13763	10	CD33	CD33	NNP
cord-005453-4057qib7	13763	11	und	und	IN
cord-005453-4057qib7	13763	12	CD38	CD38	NNP
cord-005453-4057qib7	13763	13	,	,	,
cord-005453-4057qib7	13763	14	but	but	CC
cord-005453-4057qib7	13763	15	positive	positive	JJ
cord-005453-4057qib7	13763	16	for	for	IN
cord-005453-4057qib7	13763	17	CD22	CD22	NNP
cord-005453-4057qib7	13763	18	.	.	.
cord-005453-4057qib7	13764	1	Therefore	therefore	RB
cord-005453-4057qib7	13764	2	,	,	,
cord-005453-4057qib7	13764	3	we	-PRON-	PRP
cord-005453-4057qib7	13764	4	administered	administer	VBD
cord-005453-4057qib7	13764	5	the	the	DT
cord-005453-4057qib7	13764	6	third	third	JJ
cord-005453-4057qib7	13764	7	antibody	antibody	NN
cord-005453-4057qib7	13764	8	,	,	,
cord-005453-4057qib7	13764	9	the	the	DT
cord-005453-4057qib7	13764	10	anti	anti	JJ
cord-005453-4057qib7	13764	11	-	-	JJ
cord-005453-4057qib7	13764	12	CD22	CD22	NNP
cord-005453-4057qib7	13764	13	monoclonal	monoclonal	JJ
cord-005453-4057qib7	13764	14	antibody	antibody	NN
cord-005453-4057qib7	13764	15	inotuzumab	inotuzumab	NNS
cord-005453-4057qib7	13764	16	ozogamicin	ozogamicin	NNS
cord-005453-4057qib7	13764	17	,	,	,
cord-005453-4057qib7	13764	18	whereupon	whereupon	WRB
cord-005453-4057qib7	13764	19	our	-PRON-	PRP$
cord-005453-4057qib7	13764	20	patient	patient	NN
cord-005453-4057qib7	13764	21	developed	develop	VBD
cord-005453-4057qib7	13764	22	a	a	DT
cord-005453-4057qib7	13764	23	tumor	tumor	NN
cord-005453-4057qib7	13764	24	lysis	lysis	NN
cord-005453-4057qib7	13764	25	syndrome	syndrome	NN
cord-005453-4057qib7	13764	26	and	and	CC
cord-005453-4057qib7	13764	27	a	a	DT
cord-005453-4057qib7	13764	28	severe	severe	JJ
cord-005453-4057qib7	13764	29	bone	bone	NN
cord-005453-4057qib7	13764	30	marrow	marrow	NN
cord-005453-4057qib7	13764	31	aplasia	aplasia	NNP
cord-005453-4057qib7	13764	32	.	.	.
cord-005453-4057qib7	13765	1	Shortly	shortly	RB
cord-005453-4057qib7	13765	2	after	after	RB
cord-005453-4057qib7	13765	3	,	,	,
cord-005453-4057qib7	13765	4	allogeneic	allogeneic	IN
cord-005453-4057qib7	13765	5	bone	bone	NN
cord-005453-4057qib7	13765	6	marrow	marrow	NN
cord-005453-4057qib7	13765	7	transplantation	transplantation	NN
cord-005453-4057qib7	13765	8	from	from	IN
cord-005453-4057qib7	13765	9	an	an	DT
cord-005453-4057qib7	13765	10	unrelated	unrelated	JJ
cord-005453-4057qib7	13765	11	donor	donor	NN
cord-005453-4057qib7	13765	12	using	use	VBG
cord-005453-4057qib7	13765	13	a	a	DT
cord-005453-4057qib7	13765	14	special	special	JJ
cord-005453-4057qib7	13765	15	conditioning	conditioning	NN
cord-005453-4057qib7	13765	16	regimen	regimen	NN
cord-005453-4057qib7	13765	17	consisting	consist	VBG
cord-005453-4057qib7	13765	18	of	of	IN
cord-005453-4057qib7	13765	19	thymoglobulin	thymoglobulin	NNP
cord-005453-4057qib7	13765	20	,	,	,
cord-005453-4057qib7	13765	21	busulfan	busulfan	NN
cord-005453-4057qib7	13765	22	,	,	,
cord-005453-4057qib7	13765	23	fludarabine	fludarabine	NN
cord-005453-4057qib7	13765	24	and	and	CC
cord-005453-4057qib7	13765	25	clofarabine	clofarabine	NNP
cord-005453-4057qib7	13765	26	was	be	VBD
cord-005453-4057qib7	13765	27	conducted	conduct	VBN
cord-005453-4057qib7	13765	28	.	.	.
cord-005453-4057qib7	13766	1	Clofarabine	Clofarabine	NNP
cord-005453-4057qib7	13766	2	was	be	VBD
cord-005453-4057qib7	13766	3	added	add	VBN
cord-005453-4057qib7	13766	4	because	because	IN
cord-005453-4057qib7	13766	5	an	an	DT
cord-005453-4057qib7	13766	6	additional	additional	JJ
cord-005453-4057qib7	13766	7	antileukemic	antileukemic	JJ
cord-005453-4057qib7	13766	8	effect	effect	NN
cord-005453-4057qib7	13766	9	especially	especially	RB
cord-005453-4057qib7	13766	10	in	in	IN
cord-005453-4057qib7	13766	11	infant	infant	NN
cord-005453-4057qib7	13766	12	ALL	all	DT
cord-005453-4057qib7	13766	13	with	with	IN
cord-005453-4057qib7	13766	14	MLL	MLL	NNP
cord-005453-4057qib7	13766	15	rearrangement	rearrangement	NN
cord-005453-4057qib7	13766	16	was	be	VBD
cord-005453-4057qib7	13766	17	described	describe	VBN
cord-005453-4057qib7	13766	18	.	.	.
cord-005453-4057qib7	13767	1	After	after	IN
cord-005453-4057qib7	13767	2	transplantation	transplantation	NN
cord-005453-4057qib7	13767	3	the	the	DT
cord-005453-4057qib7	13767	4	patient	patient	NN
cord-005453-4057qib7	13767	5	suffered	suffer	VBD
cord-005453-4057qib7	13767	6	from	from	IN
cord-005453-4057qib7	13767	7	a	a	DT
cord-005453-4057qib7	13767	8	severe	severe	JJ
cord-005453-4057qib7	13767	9	hepatic	hepatic	JJ
cord-005453-4057qib7	13767	10	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	13767	11	obstruction	obstruction	NN
cord-005453-4057qib7	13767	12	syndrome	syndrome	NN
cord-005453-4057qib7	13767	13	with	with	IN
cord-005453-4057qib7	13767	14	massive	massive	JJ
cord-005453-4057qib7	13767	15	ascites	ascites	NN
cord-005453-4057qib7	13767	16	,	,	,
cord-005453-4057qib7	13767	17	renal	renal	JJ
cord-005453-4057qib7	13767	18	and	and	CC
cord-005453-4057qib7	13767	19	pulmonary	pulmonary	JJ
cord-005453-4057qib7	13767	20	dysfunction	dysfunction	NN
cord-005453-4057qib7	13767	21	,	,	,
cord-005453-4057qib7	13767	22	but	but	CC
cord-005453-4057qib7	13767	23	finally	finally	RB
cord-005453-4057qib7	13767	24	the	the	DT
cord-005453-4057qib7	13767	25	patient	patient	NN
cord-005453-4057qib7	13767	26	recovered	recover	VBD
cord-005453-4057qib7	13767	27	completely	completely	RB
cord-005453-4057qib7	13767	28	.	.	.
cord-005453-4057qib7	13768	1	The	the	DT
cord-005453-4057qib7	13768	2	first	first	JJ
cord-005453-4057qib7	13768	3	bone	bone	NN
cord-005453-4057qib7	13768	4	marrow	marrow	NN
cord-005453-4057qib7	13768	5	examination	examination	NN
cord-005453-4057qib7	13768	6	30	30	CD
cord-005453-4057qib7	13768	7	days	day	NNS
cord-005453-4057qib7	13768	8	after	after	IN
cord-005453-4057qib7	13768	9	transplantation	transplantation	NN
cord-005453-4057qib7	13768	10	revealed	reveal	VBD
cord-005453-4057qib7	13768	11	a	a	DT
cord-005453-4057qib7	13768	12	donor	donor	NN
cord-005453-4057qib7	13768	13	chimerism	chimerism	NN
cord-005453-4057qib7	13768	14	of	of	IN
cord-005453-4057qib7	13768	15	100	100	CD
cord-005453-4057qib7	13768	16	%	%	NN
cord-005453-4057qib7	13768	17	and	and	CC
cord-005453-4057qib7	13768	18	a	a	DT
cord-005453-4057qib7	13768	19	complete	complete	JJ
cord-005453-4057qib7	13768	20	molecular	molecular	JJ
cord-005453-4057qib7	13768	21	remission	remission	NN
cord-005453-4057qib7	13768	22	using	use	VBG
cord-005453-4057qib7	13768	23	the	the	DT
cord-005453-4057qib7	13768	24	MLL	MLL	NNP
cord-005453-4057qib7	13768	25	-	-	HYPH
cord-005453-4057qib7	13768	26	MLLT3	MLLT3	NNP
cord-005453-4057qib7	13768	27	/	/	SYM
cord-005453-4057qib7	13768	28	AF9	af9	NN
cord-005453-4057qib7	13768	29	rearrangement	rearrangement	NN
cord-005453-4057qib7	13768	30	as	as	IN
cord-005453-4057qib7	13768	31	marker	marker	NN
cord-005453-4057qib7	13768	32	for	for	IN
cord-005453-4057qib7	13768	33	minimal	minimal	JJ
cord-005453-4057qib7	13768	34	residual	residual	JJ
cord-005453-4057qib7	13768	35	disease	disease	NN
cord-005453-4057qib7	13768	36	.	.	.
cord-005453-4057qib7	13769	1	In	in	IN
cord-005453-4057qib7	13769	2	all	all	DT
cord-005453-4057qib7	13769	3	follow	follow	VB
cord-005453-4057qib7	13769	4	-	-	HYPH
cord-005453-4057qib7	13769	5	up	up	RP
cord-005453-4057qib7	13769	6	bone	bone	NN
cord-005453-4057qib7	13769	7	marrow	marrow	NN
cord-005453-4057qib7	13769	8	samples	sample	NNS
cord-005453-4057qib7	13769	9	we	-PRON-	PRP
cord-005453-4057qib7	13769	10	observed	observe	VBD
cord-005453-4057qib7	13769	11	a	a	DT
cord-005453-4057qib7	13769	12	complete	complete	JJ
cord-005453-4057qib7	13769	13	donor	donor	NN
cord-005453-4057qib7	13769	14	chimerism	chimerism	NN
cord-005453-4057qib7	13769	15	and	and	CC
cord-005453-4057qib7	13769	16	a	a	DT
cord-005453-4057qib7	13769	17	complete	complete	JJ
cord-005453-4057qib7	13769	18	molecular	molecular	JJ
cord-005453-4057qib7	13769	19	remission	remission	NN
cord-005453-4057qib7	13769	20	.	.	.
cord-005453-4057qib7	13770	1	Currently	currently	RB
cord-005453-4057qib7	13770	2	,	,	,
cord-005453-4057qib7	13770	3	eight	eight	CD
cord-005453-4057qib7	13770	4	months	month	NNS
cord-005453-4057qib7	13770	5	after	after	IN
cord-005453-4057qib7	13770	6	transplantation	transplantation	NN
cord-005453-4057qib7	13770	7	the	the	DT
cord-005453-4057qib7	13770	8	patient	patient	NN
cord-005453-4057qib7	13770	9	is	be	VBZ
cord-005453-4057qib7	13770	10	in	in	IN
cord-005453-4057qib7	13770	11	a	a	DT
cord-005453-4057qib7	13770	12	very	very	RB
cord-005453-4057qib7	13770	13	good	good	JJ
cord-005453-4057qib7	13770	14	physical	physical	JJ
cord-005453-4057qib7	13770	15	condition	condition	NN
cord-005453-4057qib7	13770	16	with	with	IN
cord-005453-4057qib7	13770	17	normal	normal	JJ
cord-005453-4057qib7	13770	18	development	development	NN
cord-005453-4057qib7	13770	19	according	accord	VBG
cord-005453-4057qib7	13770	20	to	to	IN
cord-005453-4057qib7	13770	21	the	the	DT
cord-005453-4057qib7	13770	22	age	age	NN
cord-005453-4057qib7	13770	23	.	.	.
cord-005453-4057qib7	13771	1	Background	background	NN
cord-005453-4057qib7	13771	2	:	:	:
cord-005453-4057qib7	13772	1	Paediatric	paediatric	JJ
cord-005453-4057qib7	13772	2	chronic	chronic	JJ
cord-005453-4057qib7	13772	3	graft	graft	NN
cord-005453-4057qib7	13772	4	versus	versus	IN
cord-005453-4057qib7	13772	5	host	host	NN
cord-005453-4057qib7	13772	6	disease	disease	NN
cord-005453-4057qib7	13772	7	(	(	-LRB-
cord-005453-4057qib7	13772	8	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13772	9	)	)	-RRB-
cord-005453-4057qib7	13772	10	is	be	VBZ
cord-005453-4057qib7	13772	11	a	a	DT
cord-005453-4057qib7	13772	12	debilitating	debilitating	JJ
cord-005453-4057qib7	13772	13	condition	condition	NN
cord-005453-4057qib7	13772	14	associated	associate	VBN
cord-005453-4057qib7	13772	15	with	with	IN
cord-005453-4057qib7	13772	16	substantial	substantial	JJ
cord-005453-4057qib7	13772	17	morbidity	morbidity	NN
cord-005453-4057qib7	13772	18	and	and	CC
cord-005453-4057qib7	13772	19	mortality	mortality	NN
cord-005453-4057qib7	13772	20	.	.	.
cord-005453-4057qib7	13773	1	To	to	IN
cord-005453-4057qib7	13773	2	date	date	NN
cord-005453-4057qib7	13773	3	,	,	,
cord-005453-4057qib7	13773	4	there	there	EX
cord-005453-4057qib7	13773	5	are	be	VBP
cord-005453-4057qib7	13773	6	no	no	DT
cord-005453-4057qib7	13773	7	approved	approve	VBN
cord-005453-4057qib7	13773	8	therapies	therapy	NNS
cord-005453-4057qib7	13773	9	for	for	IN
cord-005453-4057qib7	13773	10	paediatric	paediatric	JJ
cord-005453-4057qib7	13773	11	patients	patient	NNS
cord-005453-4057qib7	13773	12	with	with	IN
cord-005453-4057qib7	13773	13	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13773	14	,	,	,
cord-005453-4057qib7	13773	15	and	and	CC
cord-005453-4057qib7	13773	16	current	current	JJ
cord-005453-4057qib7	13773	17	treatments	treatment	NNS
cord-005453-4057qib7	13773	18	often	often	RB
cord-005453-4057qib7	13773	19	lack	lack	VBP
cord-005453-4057qib7	13773	20	sufficient	sufficient	JJ
cord-005453-4057qib7	13773	21	efficacy	efficacy	NN
cord-005453-4057qib7	13773	22	or	or	CC
cord-005453-4057qib7	13773	23	lead	lead	NN
cord-005453-4057qib7	13773	24	to	to	IN
cord-005453-4057qib7	13773	25	severe	severe	JJ
cord-005453-4057qib7	13773	26	/	/	SYM
cord-005453-4057qib7	13773	27	life	life	NN
cord-005453-4057qib7	13773	28	-	-	HYPH
cord-005453-4057qib7	13773	29	threatening	threaten	VBG
cord-005453-4057qib7	13773	30	toxicities	toxicity	NNS
cord-005453-4057qib7	13773	31	that	that	WDT
cord-005453-4057qib7	13773	32	limit	limit	VBP
cord-005453-4057qib7	13773	33	their	-PRON-	PRP$
cord-005453-4057qib7	13773	34	effectiveness	effectiveness	NN
cord-005453-4057qib7	13773	35	.	.	.
cord-005453-4057qib7	13774	1	Ibrutinib	Ibrutinib	NNP
cord-005453-4057qib7	13774	2	,	,	,
cord-005453-4057qib7	13774	3	a	a	DT
cord-005453-4057qib7	13774	4	first	first	JJ
cord-005453-4057qib7	13774	5	-	-	HYPH
cord-005453-4057qib7	13774	6	in	in	IN
cord-005453-4057qib7	13774	7	-	-	HYPH
cord-005453-4057qib7	13774	8	class	class	NN
cord-005453-4057qib7	13774	9	,	,	,
cord-005453-4057qib7	13774	10	once	once	RB
cord-005453-4057qib7	13774	11	-	-	HYPH
cord-005453-4057qib7	13774	12	daily	daily	JJ
cord-005453-4057qib7	13774	13	inhibitor	inhibitor	NN
cord-005453-4057qib7	13774	14	of	of	IN
cord-005453-4057qib7	13774	15	Bruton	Bruton	NNP
cord-005453-4057qib7	13774	16	's	's	POS
cord-005453-4057qib7	13774	17	tyrosine	tyrosine	NN
cord-005453-4057qib7	13774	18	kinase	kinase	NN
cord-005453-4057qib7	13774	19	(	(	-LRB-
cord-005453-4057qib7	13774	20	BTK	BTK	NNP
cord-005453-4057qib7	13774	21	)	)	-RRB-
cord-005453-4057qib7	13774	22	,	,	,
cord-005453-4057qib7	13774	23	is	be	VBZ
cord-005453-4057qib7	13774	24	approved	approve	VBN
cord-005453-4057qib7	13774	25	in	in	IN
cord-005453-4057qib7	13774	26	the	the	DT
cord-005453-4057qib7	13774	27	US	US	NNP
cord-005453-4057qib7	13774	28	for	for	IN
cord-005453-4057qib7	13774	29	the	the	DT
cord-005453-4057qib7	13774	30	treatment	treatment	NN
cord-005453-4057qib7	13774	31	of	of	IN
cord-005453-4057qib7	13774	32	adult	adult	NN
cord-005453-4057qib7	13774	33	patients	patient	NNS
cord-005453-4057qib7	13774	34	with	with	IN
cord-005453-4057qib7	13774	35	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13774	36	after	after	IN
cord-005453-4057qib7	13774	37	failure	failure	NN
cord-005453-4057qib7	13774	38	of	of	IN
cord-005453-4057qib7	13774	39	≥1	≥1	NNP
cord-005453-4057qib7	13774	40	lines	line	NNS
cord-005453-4057qib7	13774	41	of	of	IN
cord-005453-4057qib7	13774	42	systemic	systemic	JJ
cord-005453-4057qib7	13774	43	therapy	therapy	NN
cord-005453-4057qib7	13774	44	.	.	.
cord-005453-4057qib7	13775	1	This	this	DT
cord-005453-4057qib7	13775	2	phase	phase	NN
cord-005453-4057qib7	13775	3	1/2	1/2	CD
cord-005453-4057qib7	13775	4	study	study	NN
cord-005453-4057qib7	13775	5	will	will	MD
cord-005453-4057qib7	13775	6	evaluate	evaluate	VB
cord-005453-4057qib7	13775	7	the	the	DT
cord-005453-4057qib7	13775	8	use	use	NN
cord-005453-4057qib7	13775	9	of	of	IN
cord-005453-4057qib7	13775	10	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13775	11	in	in	IN
cord-005453-4057qib7	13775	12	paediatric	paediatric	JJ
cord-005453-4057qib7	13775	13	patients	patient	NNS
cord-005453-4057qib7	13775	14	with	with	IN
cord-005453-4057qib7	13775	15	moderate	moderate	JJ
cord-005453-4057qib7	13775	16	or	or	CC
cord-005453-4057qib7	13775	17	severe	severe	JJ
cord-005453-4057qib7	13775	18	cGVHD	cgvhd	NN
cord-005453-4057qib7	13775	19	.	.	.
cord-005453-4057qib7	13776	1	Methods	method	NNS
cord-005453-4057qib7	13776	2	:	:	:
cord-005453-4057qib7	13777	1	This	this	DT
cord-005453-4057qib7	13777	2	open	open	JJ
cord-005453-4057qib7	13777	3	-	-	HYPH
cord-005453-4057qib7	13777	4	label	label	NN
cord-005453-4057qib7	13777	5	,	,	,
cord-005453-4057qib7	13777	6	multicenter	multicenter	JJ
cord-005453-4057qib7	13777	7	,	,	,
cord-005453-4057qib7	13777	8	international	international	JJ
cord-005453-4057qib7	13777	9	phase	phase	NN
cord-005453-4057qib7	13777	10	1/2	1/2	CD
cord-005453-4057qib7	13777	11	study	study	NN
cord-005453-4057qib7	13777	12	(	(	-LRB-
cord-005453-4057qib7	13777	13	PCYC-1146	PCYC-1146	NNP
cord-005453-4057qib7	13777	14	)	)	-RRB-
cord-005453-4057qib7	13777	15	includes	include	VBZ
cord-005453-4057qib7	13777	16	patients	patient	NNS
cord-005453-4057qib7	13777	17	with	with	IN
cord-005453-4057qib7	13777	18	moderate	moderate	JJ
cord-005453-4057qib7	13777	19	or	or	CC
cord-005453-4057qib7	13777	20	severe	severe	JJ
cord-005453-4057qib7	13777	21	cGVHD	cgvhd	NN
cord-005453-4057qib7	13777	22	as	as	IN
cord-005453-4057qib7	13777	23	defined	define	VBN
cord-005453-4057qib7	13777	24	by	by	IN
cord-005453-4057qib7	13777	25	the	the	DT
cord-005453-4057qib7	13777	26	2014	2014	CD
cord-005453-4057qib7	13777	27	NIH	NIH	NNP
cord-005453-4057qib7	13777	28	Consensus	Consensus	NNP
cord-005453-4057qib7	13777	29	Development	Development	NNP
cord-005453-4057qib7	13777	30	Project	Project	NNP
cord-005453-4057qib7	13777	31	Criteria	Criteria	NNPS
cord-005453-4057qib7	13777	32	.	.	.
cord-005453-4057qib7	13778	1	It	-PRON-	PRP
cord-005453-4057qib7	13778	2	is	be	VBZ
cord-005453-4057qib7	13778	3	divided	divide	VBN
cord-005453-4057qib7	13778	4	into	into	IN
cord-005453-4057qib7	13778	5	two	two	CD
cord-005453-4057qib7	13778	6	parts	part	NNS
cord-005453-4057qib7	13778	7	:	:	:
cord-005453-4057qib7	13778	8	Part	Part	NNP
cord-005453-4057qib7	13778	9	A	A	NNP
cord-005453-4057qib7	13778	10	will	will	MD
cord-005453-4057qib7	13778	11	determine	determine	VB
cord-005453-4057qib7	13778	12	the	the	DT
cord-005453-4057qib7	13778	13	recommended	recommend	VBN
cord-005453-4057qib7	13778	14	paediatric	paediatric	JJ
cord-005453-4057qib7	13778	15	equivalent	equivalent	JJ
cord-005453-4057qib7	13778	16	dose	dose	NN
cord-005453-4057qib7	13778	17	(	(	-LRB-
cord-005453-4057qib7	13778	18	RPED	RPED	NNP
cord-005453-4057qib7	13778	19	)	)	-RRB-
cord-005453-4057qib7	13778	20	of	of	IN
cord-005453-4057qib7	13778	21	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13778	22	in	in	IN
cord-005453-4057qib7	13778	23	patients	patient	NNS
cord-005453-4057qib7	13778	24	aged	age	VBN
cord-005453-4057qib7	13778	25	≥1	≥1	NN
cord-005453-4057qib7	13778	26	to	to	IN
cord-005453-4057qib7	13778	27	<	<	XX
cord-005453-4057qib7	13778	28	12	12	CD
cord-005453-4057qib7	13778	29	years	year	NNS
cord-005453-4057qib7	13778	30	,	,	,
cord-005453-4057qib7	13778	31	and	and	CC
cord-005453-4057qib7	13778	32	Part	Part	NNP
cord-005453-4057qib7	13778	33	B	B	NNP
cord-005453-4057qib7	13778	34	aims	aim	VBZ
cord-005453-4057qib7	13778	35	to	to	TO
cord-005453-4057qib7	13778	36	evaluate	evaluate	VB
cord-005453-4057qib7	13778	37	the	the	DT
cord-005453-4057qib7	13778	38	safety	safety	NN
cord-005453-4057qib7	13778	39	and	and	CC
cord-005453-4057qib7	13778	40	efficacy	efficacy	NN
cord-005453-4057qib7	13778	41	of	of	IN
cord-005453-4057qib7	13778	42	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13778	43	in	in	IN
cord-005453-4057qib7	13778	44	patients	patient	NNS
cord-005453-4057qib7	13778	45	age	age	NN
cord-005453-4057qib7	13778	46	≥1	≥1	NN
cord-005453-4057qib7	13778	47	to	to	IN
cord-005453-4057qib7	13778	48	<	<	XX
cord-005453-4057qib7	13778	49	22	22	CD
cord-005453-4057qib7	13778	50	years	year	NNS
cord-005453-4057qib7	13778	51	.	.	.
cord-005453-4057qib7	13779	1	For	for	IN
cord-005453-4057qib7	13779	2	Part	Part	NNP
cord-005453-4057qib7	13779	3	A	A	NNP
cord-005453-4057qib7	13779	4	,	,	,
cord-005453-4057qib7	13779	5	patients	patient	NNS
cord-005453-4057qib7	13779	6	with	with	IN
cord-005453-4057qib7	13779	7	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13779	8	aged	age	VBN
cord-005453-4057qib7	13779	9	≥1	≥1	NNP
cord-005453-4057qib7	13779	10	to	to	IN
cord-005453-4057qib7	13779	11	<	<	XX
cord-005453-4057qib7	13779	12	12	12	CD
cord-005453-4057qib7	13779	13	years	year	NNS
cord-005453-4057qib7	13779	14	who	who	WP
cord-005453-4057qib7	13779	15	have	have	VBP
cord-005453-4057qib7	13779	16	failed	fail	VBN
cord-005453-4057qib7	13779	17	≥1	≥1	JJR
cord-005453-4057qib7	13779	18	lines	line	NNS
cord-005453-4057qib7	13779	19	of	of	IN
cord-005453-4057qib7	13779	20	systemic	systemic	JJ
cord-005453-4057qib7	13779	21	therapy	therapy	NN
cord-005453-4057qib7	13779	22	will	will	MD
cord-005453-4057qib7	13779	23	receive	receive	VB
cord-005453-4057qib7	13779	24	once	once	RB
cord-005453-4057qib7	13779	25	daily	daily	JJ
cord-005453-4057qib7	13779	26	oral	oral	JJ
cord-005453-4057qib7	13779	27	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13779	28	at	at	IN
cord-005453-4057qib7	13779	29	a	a	DT
cord-005453-4057qib7	13779	30	starting	starting	NN
cord-005453-4057qib7	13779	31	dose	dose	NN
cord-005453-4057qib7	13779	32	of	of	IN
cord-005453-4057qib7	13779	33	120	120	CD
cord-005453-4057qib7	13779	34	mg	mg	NNP
cord-005453-4057qib7	13779	35	/	/	SYM
cord-005453-4057qib7	13779	36	m	m	NN
cord-005453-4057qib7	13779	37	2	2	CD
cord-005453-4057qib7	13779	38	to	to	TO
cord-005453-4057qib7	13779	39	be	be	VB
cord-005453-4057qib7	13779	40	escalated	escalate	VBN
cord-005453-4057qib7	13780	1	up	up	IN
cord-005453-4057qib7	13780	2	to	to	TO
cord-005453-4057qib7	13780	3	240	240	CD
cord-005453-4057qib7	13780	4	mg	mg	NNP
cord-005453-4057qib7	13780	5	/	/	SYM
cord-005453-4057qib7	13780	6	m	m	NN
cord-005453-4057qib7	13780	7	2	2	CD
cord-005453-4057qib7	13780	8	after	after	IN
cord-005453-4057qib7	13780	9	14	14	CD
cord-005453-4057qib7	13780	10	days	day	NNS
cord-005453-4057qib7	13780	11	,	,	,
cord-005453-4057qib7	13780	12	if	if	IN
cord-005453-4057qib7	13780	13	no	no	DT
cord-005453-4057qib7	13780	14	grade	grade	NN
cord-005453-4057qib7	13780	15	≥3	≥3	NNP
cord-005453-4057qib7	13780	16	toxicities	toxicity	NNS
cord-005453-4057qib7	13780	17	occur	occur	VBP
cord-005453-4057qib7	13780	18	,	,	,
cord-005453-4057qib7	13780	19	until	until	IN
cord-005453-4057qib7	13780	20	the	the	DT
cord-005453-4057qib7	13780	21	RPED	RPED	NNP
cord-005453-4057qib7	13780	22	is	be	VBZ
cord-005453-4057qib7	13780	23	determined	determine	VBN
cord-005453-4057qib7	13780	24	.	.	.
cord-005453-4057qib7	13781	1	For	for	IN
cord-005453-4057qib7	13781	2	Part	Part	NNP
cord-005453-4057qib7	13781	3	B	B	NNP
cord-005453-4057qib7	13781	4	,	,	,
cord-005453-4057qib7	13781	5	patients	patient	NNS
cord-005453-4057qib7	13781	6	aged	age	VBN
cord-005453-4057qib7	13781	7	≥12	≥12	NNP
cord-005453-4057qib7	13781	8	to	to	IN
cord-005453-4057qib7	13781	9	<	<	XX
cord-005453-4057qib7	13781	10	22	22	CD
cord-005453-4057qib7	13781	11	years	year	NNS
cord-005453-4057qib7	13781	12	with	with	IN
cord-005453-4057qib7	13781	13	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13781	14	who	who	WP
cord-005453-4057qib7	13781	15	have	have	VBP
cord-005453-4057qib7	13781	16	failed	fail	VBN
cord-005453-4057qib7	13781	17	≥1	≥1	JJR
cord-005453-4057qib7	13781	18	lines	line	NNS
cord-005453-4057qib7	13781	19	of	of	IN
cord-005453-4057qib7	13781	20	systemic	systemic	JJ
cord-005453-4057qib7	13781	21	therapy	therapy	NN
cord-005453-4057qib7	13781	22	or	or	CC
cord-005453-4057qib7	13781	23	have	have	VBP
cord-005453-4057qib7	13781	24	newly	newly	RB
cord-005453-4057qib7	13781	25	diagnosed	diagnose	VBN
cord-005453-4057qib7	13781	26	cGVHD	cgvhd	NN
cord-005453-4057qib7	13781	27	will	will	MD
cord-005453-4057qib7	13781	28	receive	receive	VB
cord-005453-4057qib7	13781	29	once	once	RB
cord-005453-4057qib7	13781	30	daily	daily	JJ
cord-005453-4057qib7	13781	31	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13781	32	(	(	-LRB-
cord-005453-4057qib7	13781	33	420	420	CD
cord-005453-4057qib7	13781	34	mg	mg	NNP
cord-005453-4057qib7	13781	35	)	)	-RRB-
cord-005453-4057qib7	13781	36	until	until	IN
cord-005453-4057qib7	13781	37	one	one	CD
cord-005453-4057qib7	13781	38	of	of	IN
cord-005453-4057qib7	13781	39	the	the	DT
cord-005453-4057qib7	13781	40	following	follow	VBG
cord-005453-4057qib7	13781	41	criteria	criterion	NNS
cord-005453-4057qib7	13781	42	is	be	VBZ
cord-005453-4057qib7	13781	43	met	meet	VBN
cord-005453-4057qib7	13781	44	:	:	:
cord-005453-4057qib7	13782	1	treatment	treatment	NN
cord-005453-4057qib7	13782	2	is	be	VBZ
cord-005453-4057qib7	13782	3	no	no	DT
cord-005453-4057qib7	13782	4	longer	long	RBR
cord-005453-4057qib7	13782	5	required	require	VBN
cord-005453-4057qib7	13782	6	;	;	:
cord-005453-4057qib7	13782	7	new	new	JJ
cord-005453-4057qib7	13782	8	systemic	systemic	JJ
cord-005453-4057qib7	13782	9	treatment	treatment	NN
cord-005453-4057qib7	13782	10	for	for	IN
cord-005453-4057qib7	13782	11	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13782	12	is	be	VBZ
cord-005453-4057qib7	13782	13	initiated	initiate	VBN
cord-005453-4057qib7	13782	14	;	;	:
cord-005453-4057qib7	13782	15	progression	progression	NN
cord-005453-4057qib7	13782	16	of	of	IN
cord-005453-4057qib7	13782	17	cGVHD	cgvhd	NN
cord-005453-4057qib7	13782	18	;	;	:
cord-005453-4057qib7	13782	19	recurrence	recurrence	NN
cord-005453-4057qib7	13782	20	of	of	IN
cord-005453-4057qib7	13782	21	underlying	underlie	VBG
cord-005453-4057qib7	13782	22	disease	disease	NN
cord-005453-4057qib7	13782	23	;	;	:
cord-005453-4057qib7	13782	24	or	or	CC
cord-005453-4057qib7	13782	25	unacceptable	unacceptable	JJ
cord-005453-4057qib7	13782	26	toxicity	toxicity	NN
cord-005453-4057qib7	13782	27	.	.	.
cord-005453-4057qib7	13783	1	Patients	patient	NNS
cord-005453-4057qib7	13783	2	with	with	IN
cord-005453-4057qib7	13783	3	newly	newly	RB
cord-005453-4057qib7	13783	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	13783	5	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13783	6	will	will	MD
cord-005453-4057qib7	13783	7	receive	receive	VB
cord-005453-4057qib7	13783	8	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13783	9	in	in	IN
cord-005453-4057qib7	13783	10	addition	addition	NN
cord-005453-4057qib7	13783	11	to	to	IN
cord-005453-4057qib7	13783	12	daily	daily	JJ
cord-005453-4057qib7	13783	13	corticosteroids	corticosteroid	NNS
cord-005453-4057qib7	13783	14	(	(	-LRB-
cord-005453-4057qib7	13783	15	0.5	0.5	CD
cord-005453-4057qib7	13783	16	-	-	SYM
cord-005453-4057qib7	13783	17	1	1	CD
cord-005453-4057qib7	13783	18	mg	mg	NNP
cord-005453-4057qib7	13783	19	/	/	SYM
cord-005453-4057qib7	13783	20	kg	kg	NNP
cord-005453-4057qib7	13783	21	prednisone	prednisone	NNP
cord-005453-4057qib7	13783	22	)	)	-RRB-
cord-005453-4057qib7	13783	23	.	.	.
cord-005453-4057qib7	13784	1	Patients	patient	NNS
cord-005453-4057qib7	13784	2	<	<	XX
cord-005453-4057qib7	13785	1	12	12	CD
cord-005453-4057qib7	13785	2	years	year	NNS
cord-005453-4057qib7	13785	3	of	of	IN
cord-005453-4057qib7	13785	4	age	age	NN
cord-005453-4057qib7	13785	5	may	may	MD
cord-005453-4057qib7	13785	6	be	be	VB
cord-005453-4057qib7	13785	7	enrolled	enrol	VBN
cord-005453-4057qib7	13785	8	in	in	IN
cord-005453-4057qib7	13785	9	Part	Part	NNP
cord-005453-4057qib7	13785	10	B	B	NNP
cord-005453-4057qib7	13785	11	and	and	CC
cord-005453-4057qib7	13785	12	treated	treat	VBN
cord-005453-4057qib7	13785	13	at	at	IN
cord-005453-4057qib7	13785	14	the	the	DT
cord-005453-4057qib7	13785	15	RPED	RPED	NNP
cord-005453-4057qib7	13785	16	after	after	IN
cord-005453-4057qib7	13785	17	it	-PRON-	PRP
cord-005453-4057qib7	13785	18	is	be	VBZ
cord-005453-4057qib7	13785	19	determined	determine	VBN
cord-005453-4057qib7	13785	20	in	in	IN
cord-005453-4057qib7	13786	1	Part	part	NN
cord-005453-4057qib7	13786	2	A.	a.	NN
cord-005453-4057qib7	13786	3	Key	key	JJ
cord-005453-4057qib7	13786	4	exclusion	exclusion	NN
cord-005453-4057qib7	13786	5	criteria	criterion	NNS
cord-005453-4057qib7	13786	6	include	include	VBP
cord-005453-4057qib7	13786	7	uncontrolled	uncontrolled	JJ
cord-005453-4057qib7	13786	8	active	active	JJ
cord-005453-4057qib7	13786	9	systemic	systemic	JJ
cord-005453-4057qib7	13786	10	infection	infection	NN
cord-005453-4057qib7	13786	11	or	or	CC
cord-005453-4057qib7	13786	12	active	active	JJ
cord-005453-4057qib7	13786	13	infection	infection	NN
cord-005453-4057qib7	13786	14	requiring	require	VBG
cord-005453-4057qib7	13786	15	systemic	systemic	JJ
cord-005453-4057qib7	13786	16	treatment	treatment	NN
cord-005453-4057qib7	13786	17	;	;	:
cord-005453-4057qib7	13786	18	progressive	progressive	JJ
cord-005453-4057qib7	13786	19	underlying	underlying	JJ
cord-005453-4057qib7	13786	20	malignant	malignant	JJ
cord-005453-4057qib7	13786	21	disease	disease	NN
cord-005453-4057qib7	13786	22	or	or	CC
cord-005453-4057qib7	13786	23	any	any	DT
cord-005453-4057qib7	13786	24	post	post	JJ
cord-005453-4057qib7	13786	25	-	-	JJ
cord-005453-4057qib7	13786	26	transplant	transplant	JJ
cord-005453-4057qib7	13786	27	lymphoproliferative	lymphoproliferative	JJ
cord-005453-4057qib7	13786	28	disease	disease	NN
cord-005453-4057qib7	13786	29	;	;	:
cord-005453-4057qib7	13786	30	or	or	CC
cord-005453-4057qib7	13786	31	active	active	JJ
cord-005453-4057qib7	13786	32	hepatitis	hepatitis	NN
cord-005453-4057qib7	13786	33	C	C	NNP
cord-005453-4057qib7	13786	34	/	/	SYM
cord-005453-4057qib7	13786	35	hepatitis	hepatitis	NN
cord-005453-4057qib7	13786	36	B	B	NNP
cord-005453-4057qib7	13786	37	virus	virus	NN
cord-005453-4057qib7	13786	38	.	.	.
cord-005453-4057qib7	13787	1	Patients	patient	NNS
cord-005453-4057qib7	13787	2	must	must	MD
cord-005453-4057qib7	13787	3	have	have	VB
cord-005453-4057qib7	13787	4	adequate	adequate	JJ
cord-005453-4057qib7	13787	5	renal	renal	JJ
cord-005453-4057qib7	13787	6	,	,	,
cord-005453-4057qib7	13787	7	hepatic	hepatic	JJ
cord-005453-4057qib7	13787	8	,	,	,
cord-005453-4057qib7	13787	9	and	and	CC
cord-005453-4057qib7	13787	10	hematologic	hematologic	JJ
cord-005453-4057qib7	13787	11	function	function	NN
cord-005453-4057qib7	13787	12	to	to	TO
cord-005453-4057qib7	13787	13	be	be	VB
cord-005453-4057qib7	13787	14	enrolled	enrol	VBN
cord-005453-4057qib7	13787	15	.	.	.
cord-005453-4057qib7	13788	1	The	the	DT
cord-005453-4057qib7	13788	2	primary	primary	JJ
cord-005453-4057qib7	13788	3	endpoint	endpoint	NN
cord-005453-4057qib7	13788	4	of	of	IN
cord-005453-4057qib7	13788	5	Part	Part	NNP
cord-005453-4057qib7	13788	6	A	A	NNP
cord-005453-4057qib7	13788	7	is	be	VBZ
cord-005453-4057qib7	13788	8	the	the	DT
cord-005453-4057qib7	13788	9	RPED	RPED	NNP
cord-005453-4057qib7	13788	10	of	of	IN
cord-005453-4057qib7	13788	11	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13788	12	,	,	,
cord-005453-4057qib7	13788	13	as	as	IN
cord-005453-4057qib7	13788	14	based	base	VBN
cord-005453-4057qib7	13788	15	on	on	IN
cord-005453-4057qib7	13788	16	pharmacokinetic	pharmacokinetic	JJ
cord-005453-4057qib7	13788	17	(	(	-LRB-
cord-005453-4057qib7	13788	18	PK	PK	NNP
cord-005453-4057qib7	13788	19	)	)	-RRB-
cord-005453-4057qib7	13788	20	data	datum	NNS
cord-005453-4057qib7	13788	21	;	;	,
cord-005453-4057qib7	13788	22	secondary	secondary	JJ
cord-005453-4057qib7	13788	23	endpoints	endpoint	NNS
cord-005453-4057qib7	13788	24	include	include	VBP
cord-005453-4057qib7	13788	25	safety	safety	NN
cord-005453-4057qib7	13788	26	and	and	CC
cord-005453-4057qib7	13788	27	pharmacodynamics	pharmacodynamic	NNS
cord-005453-4057qib7	13788	28	(	(	-LRB-
cord-005453-4057qib7	13788	29	BTK	BTK	NNP
cord-005453-4057qib7	13788	30	occupancy	occupancy	NN
cord-005453-4057qib7	13788	31	)	)	-RRB-
cord-005453-4057qib7	13788	32	.	.	.
cord-005453-4057qib7	13789	1	The	the	DT
cord-005453-4057qib7	13789	2	primary	primary	JJ
cord-005453-4057qib7	13789	3	endpoints	endpoint	NNS
cord-005453-4057qib7	13789	4	of	of	IN
cord-005453-4057qib7	13789	5	Part	Part	NNP
cord-005453-4057qib7	13789	6	B	B	NNP
cord-005453-4057qib7	13789	7	are	be	VBP
cord-005453-4057qib7	13789	8	PK	PK	NNP
cord-005453-4057qib7	13789	9	and	and	CC
cord-005453-4057qib7	13789	10	safety	safety	NN
cord-005453-4057qib7	13789	11	of	of	IN
cord-005453-4057qib7	13789	12	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13789	13	in	in	IN
cord-005453-4057qib7	13789	14	paediatric	paediatric	JJ
cord-005453-4057qib7	13789	15	patients	patient	NNS
cord-005453-4057qib7	13789	16	with	with	IN
cord-005453-4057qib7	13789	17	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13789	18	.	.	.
cord-005453-4057qib7	13790	1	Secondary	secondary	JJ
cord-005453-4057qib7	13790	2	endpoints	endpoint	NNS
cord-005453-4057qib7	13790	3	for	for	IN
cord-005453-4057qib7	13790	4	Part	Part	NNP
cord-005453-4057qib7	13790	5	B	B	NNP
cord-005453-4057qib7	13790	6	include	include	VB
cord-005453-4057qib7	13790	7	response	response	NN
cord-005453-4057qib7	13790	8	rate	rate	NN
cord-005453-4057qib7	13790	9	at	at	IN
cord-005453-4057qib7	13790	10	24	24	CD
cord-005453-4057qib7	13790	11	weeks	week	NNS
cord-005453-4057qib7	13790	12	as	as	IN
cord-005453-4057qib7	13790	13	defined	define	VBN
cord-005453-4057qib7	13790	14	by	by	IN
cord-005453-4057qib7	13790	15	the	the	DT
cord-005453-4057qib7	13790	16	2014	2014	CD
cord-005453-4057qib7	13790	17	NIH	NIH	NNP
cord-005453-4057qib7	13790	18	Consensus	Consensus	NNP
cord-005453-4057qib7	13790	19	Development	Development	NNP
cord-005453-4057qib7	13790	20	Project	Project	NNP
cord-005453-4057qib7	13790	21	Criteria	criterion	NNS
cord-005453-4057qib7	13790	22	;	;	:
cord-005453-4057qib7	13790	23	duration	duration	NN
cord-005453-4057qib7	13790	24	of	of	IN
cord-005453-4057qib7	13790	25	response	response	NN
cord-005453-4057qib7	13790	26	;	;	:
cord-005453-4057qib7	13790	27	overall	overall	JJ
cord-005453-4057qib7	13790	28	survival	survival	NN
cord-005453-4057qib7	13790	29	;	;	:
cord-005453-4057qib7	13790	30	and	and	CC
cord-005453-4057qib7	13790	31	late	late	JJ
cord-005453-4057qib7	13790	32	effects	effect	NNS
cord-005453-4057qib7	13790	33	on	on	IN
cord-005453-4057qib7	13790	34	growth	growth	NN
cord-005453-4057qib7	13790	35	,	,	,
cord-005453-4057qib7	13790	36	development	development	NN
cord-005453-4057qib7	13790	37	,	,	,
cord-005453-4057qib7	13790	38	and	and	CC
cord-005453-4057qib7	13790	39	immune	immune	JJ
cord-005453-4057qib7	13790	40	reconstitution	reconstitution	NN
cord-005453-4057qib7	13790	41	.	.	.
cord-005453-4057qib7	13791	1	Results	result	NNS
cord-005453-4057qib7	13791	2	:	:	:
cord-005453-4057qib7	13792	1	This	this	DT
cord-005453-4057qib7	13792	2	global	global	JJ
cord-005453-4057qib7	13792	3	study	study	NN
cord-005453-4057qib7	13792	4	is	be	VBZ
cord-005453-4057qib7	13792	5	currently	currently	RB
cord-005453-4057qib7	13792	6	enrolling	enrol	VBG
cord-005453-4057qib7	13792	7	.	.	.
cord-005453-4057qib7	13793	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13793	2	:	:	:
cord-005453-4057qib7	13794	1	This	this	DT
cord-005453-4057qib7	13794	2	phase	phase	NN
cord-005453-4057qib7	13794	3	1/2	1/2	CD
cord-005453-4057qib7	13794	4	study	study	NN
cord-005453-4057qib7	13794	5	will	will	MD
cord-005453-4057qib7	13794	6	explore	explore	VB
cord-005453-4057qib7	13794	7	the	the	DT
cord-005453-4057qib7	13794	8	use	use	NN
cord-005453-4057qib7	13794	9	of	of	IN
cord-005453-4057qib7	13794	10	ibrutinib	ibrutinib	NN
cord-005453-4057qib7	13794	11	in	in	IN
cord-005453-4057qib7	13794	12	paediatric	paediatric	JJ
cord-005453-4057qib7	13794	13	patients	patient	NNS
cord-005453-4057qib7	13794	14	with	with	IN
cord-005453-4057qib7	13794	15	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13794	16	to	to	TO
cord-005453-4057qib7	13794	17	potentially	potentially	RB
cord-005453-4057qib7	13794	18	meet	meet	VB
cord-005453-4057qib7	13794	19	the	the	DT
cord-005453-4057qib7	13794	20	high	high	JJ
cord-005453-4057qib7	13794	21	unmet	unmet	JJ
cord-005453-4057qib7	13794	22	need	need	NN
cord-005453-4057qib7	13794	23	for	for	IN
cord-005453-4057qib7	13794	24	proven	prove	VBN
cord-005453-4057qib7	13794	25	effective	effective	JJ
cord-005453-4057qib7	13794	26	therapies	therapy	NNS
cord-005453-4057qib7	13794	27	for	for	IN
cord-005453-4057qib7	13794	28	this	this	DT
cord-005453-4057qib7	13794	29	population	population	NN
cord-005453-4057qib7	13794	30	.	.	.
cord-005453-4057qib7	13795	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13795	2	Enzyme	Enzyme	NNP
cord-005453-4057qib7	13795	3	Replacement	Replacement	NNP
cord-005453-4057qib7	13795	4	Therapy	therapy	NN
cord-005453-4057qib7	13795	5	(	(	-LRB-
cord-005453-4057qib7	13795	6	ERT	ERT	NNP
cord-005453-4057qib7	13795	7	)	)	-RRB-
cord-005453-4057qib7	13795	8	is	be	VBZ
cord-005453-4057qib7	13795	9	the	the	DT
cord-005453-4057qib7	13795	10	treatment	treatment	NN
cord-005453-4057qib7	13795	11	of	of	IN
cord-005453-4057qib7	13795	12	choice	choice	NN
cord-005453-4057qib7	13795	13	in	in	IN
cord-005453-4057qib7	13795	14	non	non	JJ
cord-005453-4057qib7	13795	15	-	-	JJ
cord-005453-4057qib7	13795	16	neuropathic	neuropathic	JJ
cord-005453-4057qib7	13795	17	Hunter	Hunter	NNP
cord-005453-4057qib7	13795	18	syndrome	syndrome	NN
cord-005453-4057qib7	13795	19	,	,	,
cord-005453-4057qib7	13795	20	but	but	CC
cord-005453-4057qib7	13795	21	as	as	IN
cord-005453-4057qib7	13795	22	the	the	DT
cord-005453-4057qib7	13795	23	recombinant	recombinant	JJ
cord-005453-4057qib7	13795	24	enzyme	enzyme	NN
cord-005453-4057qib7	13795	25	does	do	VBZ
cord-005453-4057qib7	13795	26	not	not	RB
cord-005453-4057qib7	13795	27	cross	cross	VB
cord-005453-4057qib7	13795	28	the	the	DT
cord-005453-4057qib7	13795	29	blood	blood	NN
cord-005453-4057qib7	13795	30	brain	brain	NN
cord-005453-4057qib7	13795	31	barrier	barrier	NN
cord-005453-4057qib7	13795	32	and	and	CC
cord-005453-4057qib7	13795	33	neuropathic	neuropathic	JJ
cord-005453-4057qib7	13795	34	Hunter	Hunter	NNP
cord-005453-4057qib7	13795	35	syndrome	syndrome	NN
cord-005453-4057qib7	13795	36	is	be	VBZ
cord-005453-4057qib7	13795	37	left	leave	VBN
cord-005453-4057qib7	13795	38	untreated	untreated	JJ
cord-005453-4057qib7	13795	39	.	.	.
cord-005453-4057qib7	13796	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	13796	2	stem	stem	NN
cord-005453-4057qib7	13796	3	cell	cell	NN
cord-005453-4057qib7	13796	4	transplantation	transplantation	NN
cord-005453-4057qib7	13796	5	(	(	-LRB-
cord-005453-4057qib7	13796	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13796	7	)	)	-RRB-
cord-005453-4057qib7	13796	8	is	be	VBZ
cord-005453-4057qib7	13796	9	the	the	DT
cord-005453-4057qib7	13796	10	standard	standard	NN
cord-005453-4057qib7	13796	11	of	of	IN
cord-005453-4057qib7	13796	12	care	care	NN
cord-005453-4057qib7	13796	13	in	in	IN
cord-005453-4057qib7	13796	14	patients	patient	NNS
cord-005453-4057qib7	13796	15	with	with	IN
cord-005453-4057qib7	13796	16	severe	severe	JJ
cord-005453-4057qib7	13796	17	mucopolysaccharidosis	mucopolysaccharidosis	NN
cord-005453-4057qib7	13796	18	(	(	-LRB-
cord-005453-4057qib7	13796	19	MPS	MPS	NNP
cord-005453-4057qib7	13796	20	)	)	-RRB-
cord-005453-4057qib7	13796	21	type	type	NN
cord-005453-4057qib7	13796	22	I	-PRON-	PRP
cord-005453-4057qib7	13796	23	(	(	-LRB-
cord-005453-4057qib7	13796	24	MPSIH	MPSIH	NNP
cord-005453-4057qib7	13796	25	,	,	,
cord-005453-4057qib7	13796	26	Hurler	Hurler	NNP
cord-005453-4057qib7	13796	27	syndrome	syndrome	NN
cord-005453-4057qib7	13796	28	)	)	-RRB-
cord-005453-4057qib7	13796	29	as	as	IN
cord-005453-4057qib7	13796	30	early	early	JJ
cord-005453-4057qib7	13796	31	transplantation	transplantation	NN
cord-005453-4057qib7	13796	32	halts	halt	VBZ
cord-005453-4057qib7	13796	33	cognitive	cognitive	JJ
cord-005453-4057qib7	13796	34	decline	decline	NN
cord-005453-4057qib7	13796	35	in	in	IN
cord-005453-4057qib7	13796	36	these	these	DT
cord-005453-4057qib7	13796	37	patients	patient	NNS
cord-005453-4057qib7	13796	38	and	and	CC
cord-005453-4057qib7	13796	39	significantly	significantly	RB
cord-005453-4057qib7	13796	40	improves	improve	VBZ
cord-005453-4057qib7	13796	41	survival	survival	NN
cord-005453-4057qib7	13796	42	.	.	.
cord-005453-4057qib7	13797	1	Only	only	RB
cord-005453-4057qib7	13797	2	few	few	JJ
cord-005453-4057qib7	13797	3	case	case	NN
cord-005453-4057qib7	13797	4	studies	study	NNS
cord-005453-4057qib7	13797	5	have	have	VBP
cord-005453-4057qib7	13797	6	been	be	VBN
cord-005453-4057qib7	13797	7	published	publish	VBN
cord-005453-4057qib7	13797	8	on	on	IN
cord-005453-4057qib7	13797	9	the	the	DT
cord-005453-4057qib7	13797	10	potential	potential	JJ
cord-005453-4057qib7	13797	11	benefit	benefit	NN
cord-005453-4057qib7	13797	12	of	of	IN
cord-005453-4057qib7	13797	13	HSCT	HSCT	NNP
cord-005453-4057qib7	13797	14	in	in	IN
cord-005453-4057qib7	13797	15	MPS	MPS	NNP
cord-005453-4057qib7	13797	16	II	II	NNP
cord-005453-4057qib7	13797	17	and	and	CC
cord-005453-4057qib7	13797	18	mostly	mostly	RB
cord-005453-4057qib7	13797	19	used	use	VBN
cord-005453-4057qib7	13797	20	busulfan	busulfan	NN
cord-005453-4057qib7	13797	21	-	-	HYPH
cord-005453-4057qib7	13797	22	based	base	VBN
cord-005453-4057qib7	13797	23	conditioning	conditioning	NN
cord-005453-4057qib7	13797	24	regimens	regimen	NNS
cord-005453-4057qib7	13797	25	.	.	.
cord-005453-4057qib7	13798	1	In	in	IN
cord-005453-4057qib7	13798	2	one	one	CD
cord-005453-4057qib7	13798	3	comparative	comparative	JJ
cord-005453-4057qib7	13798	4	non	non	JJ
cord-005453-4057qib7	13798	5	-	-	JJ
cord-005453-4057qib7	13798	6	randomised	randomised	JJ
cord-005453-4057qib7	13798	7	multicenter	multicenter	JJ
cord-005453-4057qib7	13798	8	study	study	NN
cord-005453-4057qib7	13798	9	,	,	,
cord-005453-4057qib7	13798	10	HSCT	HSCT	NNP
cord-005453-4057qib7	13798	11	might	may	MD
cord-005453-4057qib7	13798	12	to	to	TO
cord-005453-4057qib7	13798	13	be	be	VB
cord-005453-4057qib7	13798	14	superior	superior	JJ
cord-005453-4057qib7	13798	15	compared	compare	VBN
cord-005453-4057qib7	13798	16	to	to	IN
cord-005453-4057qib7	13798	17	ERT	ERT	NNP
cord-005453-4057qib7	13798	18	.	.	.
cord-005453-4057qib7	13799	1	Here	here	RB
cord-005453-4057qib7	13799	2	,	,	,
cord-005453-4057qib7	13799	3	we	-PRON-	PRP
cord-005453-4057qib7	13799	4	present	present	VBP
cord-005453-4057qib7	13799	5	our	-PRON-	PRP$
cord-005453-4057qib7	13799	6	experience	experience	NN
cord-005453-4057qib7	13799	7	in	in	IN
cord-005453-4057qib7	13799	8	HSCT	HSCT	NNP
cord-005453-4057qib7	13799	9	in	in	IN
cord-005453-4057qib7	13799	10	three	three	CD
cord-005453-4057qib7	13799	11	children	child	NNS
cord-005453-4057qib7	13799	12	with	with	IN
cord-005453-4057qib7	13799	13	Hunter	Hunter	NNP
cord-005453-4057qib7	13799	14	syndrome	syndrome	NN
cord-005453-4057qib7	13799	15	using	use	VBG
cord-005453-4057qib7	13799	16	a	a	DT
cord-005453-4057qib7	13799	17	treosulfan	treosulfan	NN
cord-005453-4057qib7	13799	18	-	-	HYPH
cord-005453-4057qib7	13799	19	based	base	VBN
cord-005453-4057qib7	13799	20	conditioning	conditioning	NN
cord-005453-4057qib7	13799	21	regimen	regimen	NN
cord-005453-4057qib7	13799	22	.	.	.
cord-005453-4057qib7	13800	1	Methods	method	NNS
cord-005453-4057qib7	13800	2	:	:	:
cord-005453-4057qib7	13800	3	A	a	DT
cord-005453-4057qib7	13800	4	retrospective	retrospective	JJ
cord-005453-4057qib7	13800	5	chart	chart	NN
cord-005453-4057qib7	13800	6	review	review	NN
cord-005453-4057qib7	13800	7	was	be	VBD
cord-005453-4057qib7	13800	8	carried	carry	VBN
cord-005453-4057qib7	13800	9	out	out	RP
cord-005453-4057qib7	13800	10	in	in	IN
cord-005453-4057qib7	13800	11	patients	patient	NNS
cord-005453-4057qib7	13800	12	,	,	,
cord-005453-4057qib7	13800	13	who	who	WP
cord-005453-4057qib7	13800	14	underwent	undergo	VBD
cord-005453-4057qib7	13800	15	HSCT	HSCT	NNP
cord-005453-4057qib7	13800	16	for	for	IN
cord-005453-4057qib7	13800	17	Hunter	Hunter	NNP
cord-005453-4057qib7	13800	18	syndrome	syndrome	NN
cord-005453-4057qib7	13800	19	.	.	.
cord-005453-4057qib7	13801	1	The	the	DT
cord-005453-4057qib7	13801	2	conditioning	conditioning	NN
cord-005453-4057qib7	13801	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13801	4	regimen	regimen	NN
cord-005453-4057qib7	13801	5	included	include	VBD
cord-005453-4057qib7	13801	6	fludarabine	fludarabine	NN
cord-005453-4057qib7	13801	7	,	,	,
cord-005453-4057qib7	13801	8	treosulfan	treosulfan	NNP
cord-005453-4057qib7	13801	9	,	,	,
cord-005453-4057qib7	13801	10	thiotepa	thiotepa	NNP
cord-005453-4057qib7	13801	11	and	and	CC
cord-005453-4057qib7	13801	12	ATG	ATG	NNP
cord-005453-4057qib7	13801	13	.	.	.
cord-005453-4057qib7	13802	1	All	all	DT
cord-005453-4057qib7	13802	2	patients	patient	NNS
cord-005453-4057qib7	13802	3	received	receive	VBD
cord-005453-4057qib7	13802	4	bone	bone	NN
cord-005453-4057qib7	13802	5	marrow	marrow	NN
cord-005453-4057qib7	13802	6	of	of	IN
cord-005453-4057qib7	13802	7	either	either	CC
cord-005453-4057qib7	13802	8	related	relate	VBN
cord-005453-4057qib7	13802	9	and	and	CC
cord-005453-4057qib7	13802	10	or	or	CC
cord-005453-4057qib7	13802	11	matched	match	VBN
cord-005453-4057qib7	13802	12	unrelated	unrelated	JJ
cord-005453-4057qib7	13802	13	donors	donor	NNS
cord-005453-4057qib7	13802	14	.	.	.
cord-005453-4057qib7	13803	1	GvHD	GvHD	NNP
cord-005453-4057qib7	13803	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13803	3	was	be	VBD
cord-005453-4057qib7	13803	4	performed	perform	VBN
cord-005453-4057qib7	13803	5	with	with	IN
cord-005453-4057qib7	13803	6	CsA	CsA	NNP
cord-005453-4057qib7	13803	7	and	and	CC
cord-005453-4057qib7	13803	8	methotrexat	methotrexat	NNP
cord-005453-4057qib7	13803	9	.	.	.
cord-005453-4057qib7	13804	1	Results	result	NNS
cord-005453-4057qib7	13804	2	:	:	:
cord-005453-4057qib7	13805	1	Three	three	CD
cord-005453-4057qib7	13805	2	patients	patient	NNS
cord-005453-4057qib7	13805	3	with	with	IN
cord-005453-4057qib7	13805	4	Hunter	Hunter	NNP
cord-005453-4057qib7	13805	5	syndrome	syndrome	NN
cord-005453-4057qib7	13805	6	were	be	VBD
cord-005453-4057qib7	13805	7	transplanted	transplant	VBN
cord-005453-4057qib7	13805	8	in	in	IN
cord-005453-4057qib7	13805	9	our	-PRON-	PRP$
cord-005453-4057qib7	13805	10	department	department	NN
cord-005453-4057qib7	13805	11	in	in	IN
cord-005453-4057qib7	13805	12	2010	2010	CD
cord-005453-4057qib7	13805	13	.	.	.
cord-005453-4057qib7	13806	1	The	the	DT
cord-005453-4057qib7	13806	2	age	age	NN
cord-005453-4057qib7	13806	3	was	be	VBD
cord-005453-4057qib7	13806	4	six	six	CD
cord-005453-4057qib7	13806	5	months	month	NNS
cord-005453-4057qib7	13806	6	,	,	,
cord-005453-4057qib7	13806	7	two	two	CD
cord-005453-4057qib7	13806	8	years	year	NNS
cord-005453-4057qib7	13806	9	and	and	CC
cord-005453-4057qib7	13806	10	four	four	CD
cord-005453-4057qib7	13806	11	years	year	NNS
cord-005453-4057qib7	13806	12	,	,	,
cord-005453-4057qib7	13806	13	respectively	respectively	RB
cord-005453-4057qib7	13806	14	.	.	.
cord-005453-4057qib7	13807	1	Bone	bone	NN
cord-005453-4057qib7	13807	2	marrow	marrow	NN
cord-005453-4057qib7	13807	3	donors	donor	NNS
cord-005453-4057qib7	13807	4	were	be	VBD
cord-005453-4057qib7	13807	5	related	relate	VBN
cord-005453-4057qib7	13807	6	in	in	IN
cord-005453-4057qib7	13807	7	one	one	CD
cord-005453-4057qib7	13807	8	patient	patient	NN
cord-005453-4057qib7	13807	9	and	and	CC
cord-005453-4057qib7	13807	10	matched	match	VBN
cord-005453-4057qib7	13807	11	unrelated	unrelated	JJ
cord-005453-4057qib7	13807	12	in	in	IN
cord-005453-4057qib7	13807	13	two	two	CD
cord-005453-4057qib7	13807	14	patients	patient	NNS
cord-005453-4057qib7	13807	15	.	.	.
cord-005453-4057qib7	13808	1	The	the	DT
cord-005453-4057qib7	13808	2	conditioning	conditioning	NN
cord-005453-4057qib7	13808	3	therapy	therapy	NN
cord-005453-4057qib7	13808	4	was	be	VBD
cord-005453-4057qib7	13808	5	generally	generally	RB
cord-005453-4057qib7	13808	6	well	well	RB
cord-005453-4057qib7	13808	7	tolerated	tolerate	VBN
cord-005453-4057qib7	13808	8	.	.	.
cord-005453-4057qib7	13809	1	Major	major	JJ
cord-005453-4057qib7	13809	2	complications	complication	NNS
cord-005453-4057qib7	13809	3	were	be	VBD
cord-005453-4057qib7	13809	4	fever	fever	NN
cord-005453-4057qib7	13809	5	of	of	IN
cord-005453-4057qib7	13809	6	unknown	unknown	JJ
cord-005453-4057qib7	13809	7	origin	origin	NN
cord-005453-4057qib7	13809	8	with	with	IN
cord-005453-4057qib7	13809	9	need	need	NN
cord-005453-4057qib7	13809	10	for	for	IN
cord-005453-4057qib7	13809	11	antibiotic	antibiotic	JJ
cord-005453-4057qib7	13809	12	therapy	therapy	NN
cord-005453-4057qib7	13809	13	and	and	CC
cord-005453-4057qib7	13809	14	a	a	DT
cord-005453-4057qib7	13809	15	mucositis	mucositis	NN
cord-005453-4057qib7	13809	16	.	.	.
cord-005453-4057qib7	13810	1	One	one	CD
cord-005453-4057qib7	13810	2	patient	patient	NN
cord-005453-4057qib7	13810	3	developed	develop	VBD
cord-005453-4057qib7	13810	4	a	a	DT
cord-005453-4057qib7	13810	5	CMV	CMV	NNP
cord-005453-4057qib7	13810	6	reactivation	reactivation	NN
cord-005453-4057qib7	13810	7	.	.	.
cord-005453-4057qib7	13811	1	All	all	DT
cord-005453-4057qib7	13811	2	patients	patient	NNS
cord-005453-4057qib7	13811	3	engrafted	engraft	VBN
cord-005453-4057qib7	13811	4	successfully	successfully	RB
cord-005453-4057qib7	13811	5	and	and	CC
cord-005453-4057qib7	13811	6	recovered	recover	VBD
cord-005453-4057qib7	13811	7	well	well	RB
cord-005453-4057qib7	13811	8	from	from	IN
cord-005453-4057qib7	13811	9	the	the	DT
cord-005453-4057qib7	13811	10	HSCT	HSCT	NNP
cord-005453-4057qib7	13811	11	.	.	.
cord-005453-4057qib7	13812	1	There	there	EX
cord-005453-4057qib7	13812	2	was	be	VBD
cord-005453-4057qib7	13812	3	no	no	DT
cord-005453-4057qib7	13812	4	case	case	NN
cord-005453-4057qib7	13812	5	of	of	IN
cord-005453-4057qib7	13812	6	acute	acute	JJ
cord-005453-4057qib7	13812	7	or	or	CC
cord-005453-4057qib7	13812	8	chronic	chronic	JJ
cord-005453-4057qib7	13812	9	GvHD	gvhd	NN
cord-005453-4057qib7	13812	10	.	.	.
cord-005453-4057qib7	13813	1	In	in	IN
cord-005453-4057qib7	13813	2	2018	2018	CD
cord-005453-4057qib7	13813	3	all	all	DT
cord-005453-4057qib7	13813	4	three	three	CD
cord-005453-4057qib7	13813	5	patients	patient	NNS
cord-005453-4057qib7	13813	6	are	be	VBP
cord-005453-4057qib7	13813	7	alive	alive	JJ
cord-005453-4057qib7	13813	8	.	.	.
cord-005453-4057qib7	13814	1	Donor	donor	NN
cord-005453-4057qib7	13814	2	chimerism	chimerism	NN
cord-005453-4057qib7	13814	3	is	be	VBZ
cord-005453-4057qib7	13814	4	complete	complete	JJ
cord-005453-4057qib7	13814	5	in	in	IN
cord-005453-4057qib7	13814	6	one	one	CD
cord-005453-4057qib7	13814	7	patient	patient	NN
cord-005453-4057qib7	13814	8	;	;	:
cord-005453-4057qib7	13814	9	two	two	CD
cord-005453-4057qib7	13814	10	patients	patient	NNS
cord-005453-4057qib7	13814	11	have	have	VBP
cord-005453-4057qib7	13814	12	a	a	DT
cord-005453-4057qib7	13814	13	mixed	mixed	JJ
cord-005453-4057qib7	13814	14	donor	donor	NN
cord-005453-4057qib7	13814	15	chimerism	chimerism	NN
cord-005453-4057qib7	13814	16	.	.	.
cord-005453-4057qib7	13815	1	After	after	IN
cord-005453-4057qib7	13815	2	application	application	NN
cord-005453-4057qib7	13815	3	of	of	IN
cord-005453-4057qib7	13815	4	donor	donor	NN
cord-005453-4057qib7	13815	5	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	13815	6	infusions	infusion	NNS
cord-005453-4057qib7	13815	7	in	in	IN
cord-005453-4057qib7	13815	8	one	one	CD
cord-005453-4057qib7	13815	9	patient	patient	NN
cord-005453-4057qib7	13815	10	,	,	,
cord-005453-4057qib7	13815	11	donor	donor	NN
cord-005453-4057qib7	13815	12	chimerism	chimerism	NN
cord-005453-4057qib7	13815	13	is	be	VBZ
cord-005453-4057qib7	13815	14	stable	stable	JJ
cord-005453-4057qib7	13815	15	at	at	IN
cord-005453-4057qib7	13815	16	a	a	DT
cord-005453-4057qib7	13815	17	low	low	JJ
cord-005453-4057qib7	13815	18	level	level	NN
cord-005453-4057qib7	13815	19	of	of	IN
cord-005453-4057qib7	13815	20	16	16	CD
cord-005453-4057qib7	13815	21	%	%	NN
cord-005453-4057qib7	13815	22	.	.	.
cord-005453-4057qib7	13816	1	The	the	DT
cord-005453-4057qib7	13816	2	donor	donor	NN
cord-005453-4057qib7	13816	3	chimerism	chimerism	NN
cord-005453-4057qib7	13816	4	of	of	IN
cord-005453-4057qib7	13816	5	the	the	DT
cord-005453-4057qib7	13816	6	other	other	JJ
cord-005453-4057qib7	13816	7	patient	patient	NN
cord-005453-4057qib7	13816	8	still	still	RB
cord-005453-4057qib7	13816	9	slowly	slowly	RB
cord-005453-4057qib7	13816	10	declines	decline	VBZ
cord-005453-4057qib7	13816	11	to	to	IN
cord-005453-4057qib7	13816	12	currently	currently	RB
cord-005453-4057qib7	13816	13	50	50	CD
cord-005453-4057qib7	13816	14	%	%	NN
cord-005453-4057qib7	13816	15	.	.	.
cord-005453-4057qib7	13817	1	After	after	IN
cord-005453-4057qib7	13817	2	stem	stem	NN
cord-005453-4057qib7	13817	3	cell	cell	NN
cord-005453-4057qib7	13817	4	transplantation	transplantation	NN
cord-005453-4057qib7	13817	5	,	,	,
cord-005453-4057qib7	13817	6	two	two	CD
cord-005453-4057qib7	13817	7	patients	patient	NNS
cord-005453-4057qib7	13817	8	did	do	VBD
cord-005453-4057qib7	13817	9	not	not	RB
cord-005453-4057qib7	13817	10	show	show	VB
cord-005453-4057qib7	13817	11	further	further	JJ
cord-005453-4057qib7	13817	12	progression	progression	NN
cord-005453-4057qib7	13817	13	of	of	IN
cord-005453-4057qib7	13817	14	the	the	DT
cord-005453-4057qib7	13817	15	disease	disease	NN
cord-005453-4057qib7	13817	16	and	and	CC
cord-005453-4057qib7	13817	17	even	even	RB
cord-005453-4057qib7	13817	18	achieved	achieve	VBD
cord-005453-4057qib7	13817	19	psycho	psycho	JJ
cord-005453-4057qib7	13817	20	-	-	HYPH
cord-005453-4057qib7	13817	21	motor	motor	NN
cord-005453-4057qib7	13817	22	improvements	improvement	NNS
cord-005453-4057qib7	13817	23	.	.	.
cord-005453-4057qib7	13818	1	Interestingly	interestingly	RB
cord-005453-4057qib7	13818	2	,	,	,
cord-005453-4057qib7	13818	3	one	one	CD
cord-005453-4057qib7	13818	4	of	of	IN
cord-005453-4057qib7	13818	5	these	these	DT
cord-005453-4057qib7	13818	6	patients	patient	NNS
cord-005453-4057qib7	13818	7	is	be	VBZ
cord-005453-4057qib7	13818	8	the	the	DT
cord-005453-4057qib7	13818	9	one	one	NN
cord-005453-4057qib7	13818	10	with	with	IN
cord-005453-4057qib7	13818	11	the	the	DT
cord-005453-4057qib7	13818	12	low	low	JJ
cord-005453-4057qib7	13818	13	donor	donor	NN
cord-005453-4057qib7	13818	14	chimerism	chimerism	NN
cord-005453-4057qib7	13818	15	of	of	IN
cord-005453-4057qib7	13818	16	16	16	CD
cord-005453-4057qib7	13818	17	%	%	NN
cord-005453-4057qib7	13818	18	.	.	.
cord-005453-4057qib7	13819	1	One	one	CD
cord-005453-4057qib7	13819	2	patient	patient	NN
cord-005453-4057qib7	13819	3	suffers	suffer	VBZ
cord-005453-4057qib7	13819	4	from	from	IN
cord-005453-4057qib7	13819	5	a	a	DT
cord-005453-4057qib7	13819	6	further	further	JJ
cord-005453-4057qib7	13819	7	progression	progression	NN
cord-005453-4057qib7	13819	8	of	of	IN
cord-005453-4057qib7	13819	9	the	the	DT
cord-005453-4057qib7	13819	10	underlying	underlie	VBG
cord-005453-4057qib7	13819	11	disease	disease	NN
cord-005453-4057qib7	13819	12	with	with	IN
cord-005453-4057qib7	13819	13	psycho	psycho	JJ
cord-005453-4057qib7	13819	14	-	-	HYPH
cord-005453-4057qib7	13819	15	motoric	motoric	JJ
cord-005453-4057qib7	13819	16	agitation	agitation	NN
cord-005453-4057qib7	13819	17	,	,	,
cord-005453-4057qib7	13819	18	aggressive	aggressive	JJ
cord-005453-4057qib7	13819	19	behavior	behavior	NN
cord-005453-4057qib7	13819	20	and	and	CC
cord-005453-4057qib7	13819	21	loss	loss	NN
cord-005453-4057qib7	13819	22	of	of	IN
cord-005453-4057qib7	13819	23	speech	speech	NN
cord-005453-4057qib7	13819	24	,	,	,
cord-005453-4057qib7	13819	25	that	that	WDT
cord-005453-4057qib7	13819	26	occurred	occur	VBD
cord-005453-4057qib7	13819	27	within	within	IN
cord-005453-4057qib7	13819	28	the	the	DT
cord-005453-4057qib7	13819	29	first	first	JJ
cord-005453-4057qib7	13819	30	year	year	NN
cord-005453-4057qib7	13819	31	following	follow	VBG
cord-005453-4057qib7	13819	32	HSCT	HSCT	NNP
cord-005453-4057qib7	13819	33	,	,	,
cord-005453-4057qib7	13819	34	but	but	CC
cord-005453-4057qib7	13819	35	neurocognition	neurocognition	NN
cord-005453-4057qib7	13819	36	stabilized	stabilize	VBN
cord-005453-4057qib7	13819	37	thereafter	thereafter	RB
cord-005453-4057qib7	13819	38	.	.	.
cord-005453-4057qib7	13820	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13820	2	:	:	:
cord-005453-4057qib7	13821	1	We	-PRON-	PRP
cord-005453-4057qib7	13821	2	found	find	VBD
cord-005453-4057qib7	13821	3	a	a	DT
cord-005453-4057qib7	13821	4	beneficial	beneficial	JJ
cord-005453-4057qib7	13821	5	effect	effect	NN
cord-005453-4057qib7	13821	6	of	of	IN
cord-005453-4057qib7	13821	7	HSCT	HSCT	NNP
cord-005453-4057qib7	13821	8	on	on	IN
cord-005453-4057qib7	13821	9	the	the	DT
cord-005453-4057qib7	13821	10	neuropsychological	neuropsychological	JJ
cord-005453-4057qib7	13821	11	outcome	outcome	NN
cord-005453-4057qib7	13821	12	or	or	CC
cord-005453-4057qib7	13821	13	at	at	IN
cord-005453-4057qib7	13821	14	least	least	JJS
cord-005453-4057qib7	13821	15	stabilization	stabilization	NN
cord-005453-4057qib7	13821	16	of	of	IN
cord-005453-4057qib7	13821	17	neurocognitive	neurocognitive	JJ
cord-005453-4057qib7	13821	18	function	function	NN
cord-005453-4057qib7	13821	19	in	in	IN
cord-005453-4057qib7	13821	20	our	-PRON-	PRP$
cord-005453-4057qib7	13821	21	patients	patient	NNS
cord-005453-4057qib7	13821	22	with	with	IN
cord-005453-4057qib7	13821	23	a	a	DT
cord-005453-4057qib7	13821	24	follow	follow	NN
cord-005453-4057qib7	13821	25	-	-	HYPH
cord-005453-4057qib7	13821	26	up	up	NN
cord-005453-4057qib7	13821	27	of	of	IN
cord-005453-4057qib7	13821	28	eight	eight	CD
cord-005453-4057qib7	13821	29	years	year	NNS
cord-005453-4057qib7	13821	30	.	.	.
cord-005453-4057qib7	13822	1	Despite	despite	IN
cord-005453-4057qib7	13822	2	low	low	JJ
cord-005453-4057qib7	13822	3	toxicity	toxicity	NN
cord-005453-4057qib7	13822	4	of	of	IN
cord-005453-4057qib7	13822	5	the	the	DT
cord-005453-4057qib7	13822	6	conditioning	conditioning	NN
cord-005453-4057qib7	13822	7	regimen	regimen	NN
cord-005453-4057qib7	13822	8	,	,	,
cord-005453-4057qib7	13822	9	increased	increase	VBN
cord-005453-4057qib7	13822	10	donor	donor	NN
cord-005453-4057qib7	13822	11	chimerism	chimerism	NN
cord-005453-4057qib7	13822	12	may	may	MD
cord-005453-4057qib7	13822	13	further	further	RB
cord-005453-4057qib7	13822	14	improve	improve	VB
cord-005453-4057qib7	13822	15	the	the	DT
cord-005453-4057qib7	13822	16	neurological	neurological	JJ
cord-005453-4057qib7	13822	17	outcome	outcome	NN
cord-005453-4057qib7	13822	18	.	.	.
cord-005453-4057qib7	13823	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13823	2	:	:	:
cord-005453-4057qib7	13823	3	Nothing	nothing	NN
cord-005453-4057qib7	13823	4	to	to	TO
cord-005453-4057qib7	13823	5	declare	declare	VB
cord-005453-4057qib7	13823	6	.	.	.
cord-005453-4057qib7	13824	1	Tandem	tandem	JJ
cord-005453-4057qib7	13824	2	sct	sct	NN
cord-005453-4057qib7	13824	3	in	in	IN
cord-005453-4057qib7	13824	4	pediatric	pediatric	JJ
cord-005453-4057qib7	13824	5	solid	solid	JJ
cord-005453-4057qib7	13824	6	tumors	tumor	NNS
cord-005453-4057qib7	13824	7	,	,	,
cord-005453-4057qib7	13824	8	other	other	JJ
cord-005453-4057qib7	13824	9	than	than	IN
cord-005453-4057qib7	13824	10	brain	brain	NN
cord-005453-4057qib7	13824	11	tumors	tumor	NNS
cord-005453-4057qib7	13824	12	,	,	,
cord-005453-4057qib7	13824	13	has	have	VBZ
cord-005453-4057qib7	13824	14	no	no	DT
cord-005453-4057qib7	13824	15	advantage	advantage	NN
cord-005453-4057qib7	13824	16	in	in	IN
cord-005453-4057qib7	13824	17	terms	term	NNS
cord-005453-4057qib7	13824	18	of	of	IN
cord-005453-4057qib7	13824	19	EFS	efs	NN
cord-005453-4057qib7	13824	20	over	over	IN
cord-005453-4057qib7	13824	21	single	single	JJ
cord-005453-4057qib7	13824	22	procedure	procedure	NN
cord-005453-4057qib7	13824	23	-	-	HYPH
cord-005453-4057qib7	13824	24	single	single	JJ
cord-005453-4057qib7	13824	25	center	center	NN
cord-005453-4057qib7	13824	26	experience	experience	NN
cord-005453-4057qib7	13824	27	,	,	,
cord-005453-4057qib7	13824	28	germ	germ	NN
cord-005453-4057qib7	13824	29	-	-	HYPH
cord-005453-4057qib7	13824	30	cell	cell	NN
cord-005453-4057qib7	13824	31	tumour	tumour	NN
cord-005453-4057qib7	13824	32	(	(	-LRB-
cord-005453-4057qib7	13824	33	GCT	GCT	NNP
cord-005453-4057qib7	13824	34	)	)	-RRB-
cord-005453-4057qib7	13824	35	,	,	,
cord-005453-4057qib7	13824	36	Ewing	Ewing	NNP
cord-005453-4057qib7	13824	37	sarcoma	sarcoma	NN
cord-005453-4057qib7	13824	38	(	(	-LRB-
cord-005453-4057qib7	13824	39	ES	ES	NNP
cord-005453-4057qib7	13824	40	)	)	-RRB-
cord-005453-4057qib7	13824	41	,	,	,
cord-005453-4057qib7	13824	42	nefroblastoma	nefroblastoma	NNP
cord-005453-4057qib7	13824	43	.	.	.
cord-005453-4057qib7	13825	1	Patients	patient	NNS
cord-005453-4057qib7	13825	2	were	be	VBD
cord-005453-4057qib7	13825	3	divided	divide	VBN
cord-005453-4057qib7	13825	4	into	into	IN
cord-005453-4057qib7	13825	5	2	2	CD
cord-005453-4057qib7	13825	6	groups	group	NNS
cord-005453-4057qib7	13825	7	according	accord	VBG
cord-005453-4057qib7	13825	8	to	to	IN
cord-005453-4057qib7	13825	9	the	the	DT
cord-005453-4057qib7	13825	10	number	number	NN
cord-005453-4057qib7	13825	11	of	of	IN
cord-005453-4057qib7	13825	12	procedures	procedure	NNS
cord-005453-4057qib7	13825	13	:	:	:
cord-005453-4057qib7	13825	14	1st	1st	JJ
cord-005453-4057qib7	13825	15	group	group	NN
cord-005453-4057qib7	13825	16	-	-	HYPH
cord-005453-4057qib7	13825	17	single	single	JJ
cord-005453-4057qib7	13825	18	SCT	SCT	NNP
cord-005453-4057qib7	13825	19	procedure	procedure	NN
cord-005453-4057qib7	13825	20	,	,	,
cord-005453-4057qib7	13825	21	2nd	2nd	JJ
cord-005453-4057qib7	13825	22	group	group	NN
cord-005453-4057qib7	13825	23	-	-	HYPH
cord-005453-4057qib7	13825	24	multiple	multiple	JJ
cord-005453-4057qib7	13825	25	procedures	procedure	NNS
cord-005453-4057qib7	13825	26	.	.	.
cord-005453-4057qib7	13826	1	Regimens	regimen	NNS
cord-005453-4057qib7	13826	2	used	use	VBN
cord-005453-4057qib7	13826	3	for	for	IN
cord-005453-4057qib7	13826	4	stem	stem	NN
cord-005453-4057qib7	13826	5	cell	cell	NN
cord-005453-4057qib7	13826	6	mobilisation	mobilisation	NN
cord-005453-4057qib7	13826	7	were	be	VBD
cord-005453-4057qib7	13826	8	:	:	:
cord-005453-4057qib7	13827	1	Topo	Topo	NNP
cord-005453-4057qib7	13827	2	-	-	HYPH
cord-005453-4057qib7	13827	3	Cy	Cy	NNP
cord-005453-4057qib7	13827	4	for	for	IN
cord-005453-4057qib7	13827	5	NBL	NBL	NNP
cord-005453-4057qib7	13827	6	and	and	CC
cord-005453-4057qib7	13827	7	Epi	Epi	NNP
cord-005453-4057qib7	13827	8	-	-	HYPH
cord-005453-4057qib7	13827	9	Tax	Tax	NNP
cord-005453-4057qib7	13827	10	for	for	IN
cord-005453-4057qib7	13827	11	GCT	GCT	NNP
cord-005453-4057qib7	13827	12	,	,	,
cord-005453-4057qib7	13827	13	followed	follow	VBN
cord-005453-4057qib7	13827	14	by	by	IN
cord-005453-4057qib7	13827	15	G	G	NNP
cord-005453-4057qib7	13827	16	-	-	HYPH
cord-005453-4057qib7	13827	17	CSF±Plerixafor	CSF±Plerixafor	NNP
cord-005453-4057qib7	13827	18	.	.	.
cord-005453-4057qib7	13828	1	Conditioning	conditioning	NN
cord-005453-4057qib7	13828	2	regimens	regimen	NNS
cord-005453-4057qib7	13828	3	:	:	:
cord-005453-4057qib7	13829	1	Bu	Bu	NNP
cord-005453-4057qib7	13829	2	-	-	HYPH
cord-005453-4057qib7	13829	3	Mel	Mel	NNP
cord-005453-4057qib7	13829	4	and	and	CC
cord-005453-4057qib7	13829	5	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	13829	6	-	-	HYPH
cord-005453-4057qib7	13829	7	Cy	Cy	NNP
cord-005453-4057qib7	13829	8	for	for	IN
cord-005453-4057qib7	13829	9	pts	pt	NNS
cord-005453-4057qib7	13829	10	with	with	IN
cord-005453-4057qib7	13829	11	NBL	NBL	NNP
cord-005453-4057qib7	13829	12	,	,	,
cord-005453-4057qib7	13829	13	Thio	Thio	NNP
cord-005453-4057qib7	13829	14	-	-	HYPH
cord-005453-4057qib7	13829	15	Tax	Tax	NNP
cord-005453-4057qib7	13829	16	and	and	CC
cord-005453-4057qib7	13829	17	ICE	ice	NN
cord-005453-4057qib7	13829	18	for	for	IN
cord-005453-4057qib7	13829	19	pts	pt	NNS
cord-005453-4057qib7	13829	20	with	with	IN
cord-005453-4057qib7	13829	21	GCT	GCT	NNP
cord-005453-4057qib7	13829	22	.	.	.
cord-005453-4057qib7	13830	1	Patients	patient	NNS
cord-005453-4057qib7	13830	2	received	receive	VBD
cord-005453-4057qib7	13830	3	antibiotic	antibiotic	JJ
cord-005453-4057qib7	13830	4	,	,	,
cord-005453-4057qib7	13830	5	antiviral	antiviral	JJ
cord-005453-4057qib7	13830	6	and	and	CC
cord-005453-4057qib7	13830	7	antifungal	antifungal	JJ
cord-005453-4057qib7	13830	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13830	9	,	,	,
cord-005453-4057qib7	13830	10	parenteral	parenteral	JJ
cord-005453-4057qib7	13830	11	nutrition	nutrition	NN
cord-005453-4057qib7	13830	12	and	and	CC
cord-005453-4057qib7	13830	13	supportive	supportive	JJ
cord-005453-4057qib7	13830	14	treatment	treatment	NN
cord-005453-4057qib7	13830	15	.	.	.
cord-005453-4057qib7	13831	1	Patients	patient	NNS
cord-005453-4057qib7	13831	2	received	receive	VBD
cord-005453-4057qib7	13831	3	consolidation	consolidation	NN
cord-005453-4057qib7	13831	4	treatment	treatment	NN
cord-005453-4057qib7	13831	5	,	,	,
cord-005453-4057qib7	13831	6	followed	follow	VBD
cord-005453-4057qib7	13831	7	up	up	RP
cord-005453-4057qib7	13831	8	monthly	monthly	RB
cord-005453-4057qib7	13831	9	in	in	IN
cord-005453-4057qib7	13831	10	the	the	DT
cord-005453-4057qib7	13831	11	first	first	JJ
cord-005453-4057qib7	13831	12	year	year	NN
cord-005453-4057qib7	13831	13	,	,	,
cord-005453-4057qib7	13831	14	then	then	RB
cord-005453-4057qib7	13831	15	yearly	yearly	RB
cord-005453-4057qib7	13831	16	.	.	.
cord-005453-4057qib7	13832	1	Patients	patient	NNS
cord-005453-4057qib7	13832	2	were	be	VBD
cord-005453-4057qib7	13832	3	evaluated	evaluate	VBN
cord-005453-4057qib7	13832	4	for	for	IN
cord-005453-4057qib7	13832	5	residual	residual	JJ
cord-005453-4057qib7	13832	6	disease	disease	NN
cord-005453-4057qib7	13832	7	by	by	IN
cord-005453-4057qib7	13832	8	imaging	image	VBG
cord-005453-4057qib7	13832	9	tests	test	NNS
cord-005453-4057qib7	13832	10	.	.	.
cord-005453-4057qib7	13833	1	Parents	parent	NNS
cord-005453-4057qib7	13833	2	signed	sign	VBD
cord-005453-4057qib7	13833	3	informed	informed	JJ
cord-005453-4057qib7	13833	4	consent	consent	NN
cord-005453-4057qib7	13833	5	forms	form	NNS
cord-005453-4057qib7	13833	6	.	.	.
cord-005453-4057qib7	13834	1	Results	result	NNS
cord-005453-4057qib7	13834	2	:	:	:
cord-005453-4057qib7	13835	1	We	-PRON-	PRP
cord-005453-4057qib7	13835	2	performed	perform	VBD
cord-005453-4057qib7	13835	3	67	67	CD
cord-005453-4057qib7	13835	4	SCT	SCT	NNP
cord-005453-4057qib7	13835	5	procedures	procedure	NNS
cord-005453-4057qib7	13835	6	to	to	IN
cord-005453-4057qib7	13835	7	52	52	CD
cord-005453-4057qib7	13835	8	patients	patient	NNS
cord-005453-4057qib7	13835	9	:	:	:
cord-005453-4057qib7	13835	10	65.3	65.3	CD
cord-005453-4057qib7	13835	11	%	%	NN
cord-005453-4057qib7	13835	12	NBL	NBL	NNP
cord-005453-4057qib7	13835	13	,	,	,
cord-005453-4057qib7	13835	14	17.3	17.3	CD
cord-005453-4057qib7	13835	15	%	%	NN
cord-005453-4057qib7	13835	16	ES	ES	NNP
cord-005453-4057qib7	13835	17	,	,	,
cord-005453-4057qib7	13835	18	11.6	11.6	CD
cord-005453-4057qib7	13835	19	%	%	NN
cord-005453-4057qib7	13835	20	GCT	GCT	NNP
cord-005453-4057qib7	13835	21	and	and	CC
cord-005453-4057qib7	13835	22	5.8	5.8	CD
cord-005453-4057qib7	13835	23	%	%	NN
cord-005453-4057qib7	13835	24	nefroblastoma	nefroblastoma	NN
cord-005453-4057qib7	13835	25	.	.	.
cord-005453-4057qib7	13836	1	For	for	IN
cord-005453-4057qib7	13836	2	this	this	DT
cord-005453-4057qib7	13836	3	study	study	NN
cord-005453-4057qib7	13836	4	only	only	RB
cord-005453-4057qib7	13836	5	patients	patient	NNS
cord-005453-4057qib7	13836	6	with	with	IN
cord-005453-4057qib7	13836	7	NBL	NBL	NNP
cord-005453-4057qib7	13836	8	and	and	CC
cord-005453-4057qib7	13836	9	GCT	GCT	NNP
cord-005453-4057qib7	13836	10	were	be	VBD
cord-005453-4057qib7	13836	11	considered	consider	VBN
cord-005453-4057qib7	13836	12	.	.	.
cord-005453-4057qib7	13837	1	In	in	IN
cord-005453-4057qib7	13837	2	1st	1st	JJ
cord-005453-4057qib7	13837	3	group	group	NN
cord-005453-4057qib7	13837	4	were	be	VBD
cord-005453-4057qib7	13837	5	79	79	CD
cord-005453-4057qib7	13837	6	%	%	NN
cord-005453-4057qib7	13837	7	of	of	IN
cord-005453-4057qib7	13837	8	pts	pt	NNS
cord-005453-4057qib7	13837	9	,	,	,
cord-005453-4057qib7	13837	10	21	21	CD
cord-005453-4057qib7	13837	11	%	%	NN
cord-005453-4057qib7	13837	12	in	in	IN
cord-005453-4057qib7	13837	13	2nd	2nd	JJ
cord-005453-4057qib7	13837	14	group	group	NN
cord-005453-4057qib7	13837	15	.	.	.
cord-005453-4057qib7	13838	1	Patients	patient	NNS
cord-005453-4057qib7	13838	2	were	be	VBD
cord-005453-4057qib7	13838	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	13838	4	,	,	,
cord-005453-4057qib7	13838	5	staged	stage	VBD
cord-005453-4057qib7	13838	6	and	and	CC
cord-005453-4057qib7	13838	7	treated	treat	VBN
cord-005453-4057qib7	13838	8	according	accord	VBG
cord-005453-4057qib7	13838	9	to	to	IN
cord-005453-4057qib7	13838	10	international	international	JJ
cord-005453-4057qib7	13838	11	protocols	protocol	NNS
cord-005453-4057qib7	13838	12	.	.	.
cord-005453-4057qib7	13839	1	Sex	sex	NN
cord-005453-4057qib7	13839	2	ratio	ratio	NN
cord-005453-4057qib7	13839	3	was	be	VBD
cord-005453-4057qib7	13839	4	18F/34M.	18f/34m.	CD
cord-005453-4057qib7	13839	5	Age	age	NN
cord-005453-4057qib7	13839	6	distribution	distribution	NN
cord-005453-4057qib7	13839	7	was	be	VBD
cord-005453-4057qib7	13839	8	1	1	CD
cord-005453-4057qib7	13839	9	-	-	SYM
cord-005453-4057qib7	13839	10	4	4	CD
cord-005453-4057qib7	13839	11	y	y	NN
cord-005453-4057qib7	13839	12	38	38	CD
cord-005453-4057qib7	13839	13	%	%	NN
cord-005453-4057qib7	13839	14	(	(	-LRB-
cord-005453-4057qib7	13839	15	20	20	CD
cord-005453-4057qib7	13839	16	pts	pt	NNS
cord-005453-4057qib7	13839	17	)	)	-RRB-
cord-005453-4057qib7	13839	18	,	,	,
cord-005453-4057qib7	13839	19	4	4	CD
cord-005453-4057qib7	13839	20	-	-	SYM
cord-005453-4057qib7	13839	21	10	10	CD
cord-005453-4057qib7	13839	22	y	y	NNP
cord-005453-4057qib7	13839	23	35	35	CD
cord-005453-4057qib7	13839	24	%	%	NN
cord-005453-4057qib7	13839	25	(	(	-LRB-
cord-005453-4057qib7	13839	26	18	18	CD
cord-005453-4057qib7	13839	27	pts	pt	NNS
cord-005453-4057qib7	13839	28	)	)	-RRB-
cord-005453-4057qib7	13839	29	,	,	,
cord-005453-4057qib7	13839	30	>	>	XX
cord-005453-4057qib7	13839	31	10	10	CD
cord-005453-4057qib7	13839	32	y	y	NNP
cord-005453-4057qib7	13839	33	27	27	CD
cord-005453-4057qib7	13839	34	%	%	NN
cord-005453-4057qib7	13839	35	(	(	-LRB-
cord-005453-4057qib7	13839	36	14	14	CD
cord-005453-4057qib7	13839	37	pts	pt	NNS
cord-005453-4057qib7	13839	38	)	)	-RRB-
cord-005453-4057qib7	13839	39	.	.	.
cord-005453-4057qib7	13840	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	13840	2	stem	stem	NN
cord-005453-4057qib7	13840	3	cell	cell	NN
cord-005453-4057qib7	13840	4	(	(	-LRB-
cord-005453-4057qib7	13840	5	PBSC	PBSC	NNP
cord-005453-4057qib7	13840	6	)	)	-RRB-
cord-005453-4057qib7	13840	7	mobilisation	mobilisation	NN
cord-005453-4057qib7	13840	8	was	be	VBD
cord-005453-4057qib7	13840	9	more	more	RBR
cord-005453-4057qib7	13840	10	difficult	difficult	JJ
cord-005453-4057qib7	13840	11	in	in	IN
cord-005453-4057qib7	13840	12	patients	patient	NNS
cord-005453-4057qib7	13840	13	with	with	IN
cord-005453-4057qib7	13840	14	multiple	multiple	JJ
cord-005453-4057qib7	13840	15	courses	course	NNS
cord-005453-4057qib7	13840	16	of	of	IN
cord-005453-4057qib7	13840	17	chemotherapy±radiotherapy	chemotherapy±radiotherapy	CD
cord-005453-4057qib7	13840	18	.	.	.
cord-005453-4057qib7	13841	1	We	-PRON-	PRP
cord-005453-4057qib7	13841	2	found	find	VBD
cord-005453-4057qib7	13841	3	no	no	DT
cord-005453-4057qib7	13841	4	difference	difference	NN
cord-005453-4057qib7	13841	5	in	in	IN
cord-005453-4057qib7	13841	6	the	the	DT
cord-005453-4057qib7	13841	7	period	period	NN
cord-005453-4057qib7	13841	8	of	of	IN
cord-005453-4057qib7	13841	9	engraftment	engraftment	NN
cord-005453-4057qib7	13841	10	following	follow	VBG
cord-005453-4057qib7	13841	11	a	a	DT
cord-005453-4057qib7	13841	12	2nd	2nd	JJ
cord-005453-4057qib7	13841	13	or	or	CC
cord-005453-4057qib7	13841	14	3rd	3rd	JJ
cord-005453-4057qib7	13841	15	procedure	procedure	NN
cord-005453-4057qib7	13841	16	.	.	.
cord-005453-4057qib7	13842	1	Hospitalization	hospitalization	NN
cord-005453-4057qib7	13842	2	and	and	CC
cord-005453-4057qib7	13842	3	supportive	supportive	JJ
cord-005453-4057qib7	13842	4	measures	measure	NNS
cord-005453-4057qib7	13842	5	increased	increase	VBD
cord-005453-4057qib7	13842	6	in	in	IN
cord-005453-4057qib7	13842	7	2nd	2nd	JJ
cord-005453-4057qib7	13842	8	and	and	CC
cord-005453-4057qib7	13842	9	3rd	3rd	JJ
cord-005453-4057qib7	13842	10	procedures	procedure	NNS
cord-005453-4057qib7	13842	11	(	(	-LRB-
cord-005453-4057qib7	13842	12	26	26	CD
cord-005453-4057qib7	13842	13	to	to	TO
cord-005453-4057qib7	13842	14	29	29	CD
cord-005453-4057qib7	13842	15	days	day	NNS
cord-005453-4057qib7	13842	16	)	)	-RRB-
cord-005453-4057qib7	13842	17	.	.	.
cord-005453-4057qib7	13843	1	Patients	patient	NNS
cord-005453-4057qib7	13843	2	with	with	IN
cord-005453-4057qib7	13843	3	multiple	multiple	JJ
cord-005453-4057qib7	13843	4	courses	course	NNS
cord-005453-4057qib7	13843	5	of	of	IN
cord-005453-4057qib7	13843	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13843	7	and	and	CC
cord-005453-4057qib7	13843	8	multiple	multiple	JJ
cord-005453-4057qib7	13843	9	hospitalizations	hospitalization	NNS
cord-005453-4057qib7	13843	10	had	have	VBD
cord-005453-4057qib7	13843	11	increased	increase	VBN
cord-005453-4057qib7	13843	12	infectious	infectious	JJ
cord-005453-4057qib7	13843	13	risk	risk	NN
cord-005453-4057qib7	13843	14	and	and	CC
cord-005453-4057qib7	13843	15	during	during	IN
cord-005453-4057qib7	13843	16	the	the	DT
cord-005453-4057qib7	13843	17	2nd	2nd	JJ
cord-005453-4057qib7	13843	18	or	or	CC
cord-005453-4057qib7	13843	19	3rd	3rd	JJ
cord-005453-4057qib7	13843	20	procedures	procedure	NNS
cord-005453-4057qib7	13843	21	developed	develop	VBD
cord-005453-4057qib7	13843	22	various	various	JJ
cord-005453-4057qib7	13843	23	infectious	infectious	JJ
cord-005453-4057qib7	13843	24	complications	complication	NNS
cord-005453-4057qib7	13843	25	.	.	.
cord-005453-4057qib7	13844	1	Incidence	incidence	NN
cord-005453-4057qib7	13844	2	of	of	IN
cord-005453-4057qib7	13844	3	severe	severe	JJ
cord-005453-4057qib7	13844	4	oral	oral	JJ
cord-005453-4057qib7	13844	5	mucositis	mucositis	NN
cord-005453-4057qib7	13844	6	after	after	IN
cord-005453-4057qib7	13844	7	the	the	DT
cord-005453-4057qib7	13844	8	first	first	JJ
cord-005453-4057qib7	13844	9	HSCT	HSCT	NNP
cord-005453-4057qib7	13844	10	was	be	VBD
cord-005453-4057qib7	13844	11	17	17	CD
cord-005453-4057qib7	13844	12	%	%	NN
cord-005453-4057qib7	13844	13	,	,	,
cord-005453-4057qib7	13844	14	after	after	IN
cord-005453-4057qib7	13844	15	tandem	tandem	NN
cord-005453-4057qib7	13844	16	HSCT	HSCT	NNP
cord-005453-4057qib7	13844	17	was	be	VBD
cord-005453-4057qib7	13844	18	69	69	CD
cord-005453-4057qib7	13844	19	%	%	NN
cord-005453-4057qib7	13844	20	.	.	.
cord-005453-4057qib7	13845	1	NBL	NBL	NNP
cord-005453-4057qib7	13845	2	patients	patient	NNS
cord-005453-4057qib7	13845	3	:	:	:
cord-005453-4057qib7	13846	1	1st	1st	JJ
cord-005453-4057qib7	13846	2	group-6/23	group-6/23	NNP
cord-005453-4057qib7	13846	3	patients	patient	NNS
cord-005453-4057qib7	13846	4	alive	alive	JJ
cord-005453-4057qib7	13846	5	and	and	CC
cord-005453-4057qib7	13846	6	EFS	EFS	NNP
cord-005453-4057qib7	13846	7	,	,	,
cord-005453-4057qib7	13846	8	1/23	1/23	CD
cord-005453-4057qib7	13846	9	receives	receive	VBZ
cord-005453-4057qib7	13846	10	anti	anti	JJ
cord-005453-4057qib7	13846	11	G2	G2	NNP
cord-005453-4057qib7	13846	12	treatment	treatment	NN
cord-005453-4057qib7	13846	13	;	;	:
cord-005453-4057qib7	13847	1	2nd	2nd	JJ
cord-005453-4057qib7	13847	2	group-1/7	group-1/7	JJ
cord-005453-4057qib7	13847	3	patients	patient	NNS
cord-005453-4057qib7	13847	4	-	-	:
cord-005453-4057qib7	13847	5	alive	alive	JJ
cord-005453-4057qib7	13847	6	,	,	,
cord-005453-4057qib7	13847	7	2/7	2/7	CD
cord-005453-4057qib7	13847	8	patients	patient	NNS
cord-005453-4057qib7	13847	9	-	-	:
cord-005453-4057qib7	13847	10	not	not	RB
cord-005453-4057qib7	13847	11	reached	reach	VBN
cord-005453-4057qib7	13847	12	timepoint	timepoint	NN
cord-005453-4057qib7	13847	13	for	for	IN
cord-005453-4057qib7	13847	14	mIBG	mIBG	NNP
cord-005453-4057qib7	13847	15	scan	scan	NNP
cord-005453-4057qib7	13847	16	;	;	:
cord-005453-4057qib7	13847	17	4/7	4/7	CD
cord-005453-4057qib7	13847	18	patients	patient	NNS
cord-005453-4057qib7	13847	19	-	-	HYPH
cord-005453-4057qib7	13847	20	mIBG	mIBG	NNP
cord-005453-4057qib7	13847	21	negative	negative	NN
cord-005453-4057qib7	13847	22	at	at	IN
cord-005453-4057qib7	13847	23	first	first	RB
cord-005453-4057qib7	13847	24	,	,	,
cord-005453-4057qib7	13847	25	relapsed	relapse	VBN
cord-005453-4057qib7	13847	26	after	after	IN
cord-005453-4057qib7	13847	27	6	6	CD
cord-005453-4057qib7	13847	28	mo	mo	NN
cord-005453-4057qib7	13847	29	;	;	:
cord-005453-4057qib7	13848	1	1/7	1/7	CD
cord-005453-4057qib7	13848	2	patient	patient	NN
cord-005453-4057qib7	13848	3	deceased	decease	VBN
cord-005453-4057qib7	13848	4	due	due	IN
cord-005453-4057qib7	13848	5	to	to	IN
cord-005453-4057qib7	13848	6	pulmonary	pulmonary	JJ
cord-005453-4057qib7	13848	7	toxicity	toxicity	NN
cord-005453-4057qib7	13848	8	.	.	.
cord-005453-4057qib7	13849	1	GCT	GCT	NNP
cord-005453-4057qib7	13849	2	patients	patient	NNS
cord-005453-4057qib7	13849	3	:	:	:
cord-005453-4057qib7	13850	1	1st	1st	NN
cord-005453-4057qib7	13851	1	group-1/5	group-1/5	NNP
cord-005453-4057qib7	13851	2	patients	patient	NNS
cord-005453-4057qib7	13851	3	alive	alive	JJ
cord-005453-4057qib7	13851	4	and	and	CC
cord-005453-4057qib7	13851	5	EF	EF	NNP
cord-005453-4057qib7	13851	6	,	,	,
cord-005453-4057qib7	13851	7	1/5	1/5	DT
cord-005453-4057qib7	13851	8	high	high	JJ
cord-005453-4057qib7	13851	9	values	value	NNS
cord-005453-4057qib7	13851	10	in	in	IN
cord-005453-4057qib7	13851	11	AFP	AFP	NNP
cord-005453-4057qib7	13851	12	levels	level	NNS
cord-005453-4057qib7	13851	13	and	and	CC
cord-005453-4057qib7	13851	14	receives	receive	VBZ
cord-005453-4057qib7	13851	15	metronomic	metronomic	JJ
cord-005453-4057qib7	13851	16	therapy	therapy	NN
cord-005453-4057qib7	13851	17	,	,	,
cord-005453-4057qib7	13851	18	3/5	3/5	CD
cord-005453-4057qib7	13851	19	patients	patient	NNS
cord-005453-4057qib7	13851	20	deceased	decease	VBN
cord-005453-4057qib7	13851	21	due	due	IN
cord-005453-4057qib7	13851	22	to	to	IN
cord-005453-4057qib7	13851	23	progressive	progressive	JJ
cord-005453-4057qib7	13851	24	disease	disease	NN
cord-005453-4057qib7	13851	25	,	,	,
cord-005453-4057qib7	13851	26	but	but	CC
cord-005453-4057qib7	13851	27	only	only	RB
cord-005453-4057qib7	13851	28	had	have	VBD
cord-005453-4057qib7	13851	29	2	2	CD
cord-005453-4057qib7	13851	30	SCT	SCT	NNP
cord-005453-4057qib7	13851	31	.	.	.
cord-005453-4057qib7	13852	1	Only	only	RB
cord-005453-4057qib7	13852	2	1/5	1/5	DT
cord-005453-4057qib7	13852	3	patient	patient	NN
cord-005453-4057qib7	13852	4	had	have	VBD
cord-005453-4057qib7	13852	5	one	one	CD
cord-005453-4057qib7	13852	6	procedure	procedure	NN
cord-005453-4057qib7	13852	7	and	and	CC
cord-005453-4057qib7	13852	8	died	die	VBD
cord-005453-4057qib7	13852	9	due	due	IN
cord-005453-4057qib7	13852	10	to	to	IN
cord-005453-4057qib7	13852	11	progressive	progressive	JJ
cord-005453-4057qib7	13852	12	disease	disease	NN
cord-005453-4057qib7	13852	13	.	.	.
cord-005453-4057qib7	13853	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13853	2	:	:	:
cord-005453-4057qib7	13854	1	In	in	IN
cord-005453-4057qib7	13854	2	our	-PRON-	PRP$
cord-005453-4057qib7	13854	3	study	study	NN
cord-005453-4057qib7	13854	4	,	,	,
cord-005453-4057qib7	13854	5	tandem	tandem	JJ
cord-005453-4057qib7	13854	6	HSCT	HSCT	NNP
cord-005453-4057qib7	13854	7	in	in	IN
cord-005453-4057qib7	13854	8	children	child	NNS
cord-005453-4057qib7	13854	9	with	with	IN
cord-005453-4057qib7	13854	10	solid	solid	JJ
cord-005453-4057qib7	13854	11	tumours	tumour	NNS
cord-005453-4057qib7	13854	12	lead	lead	VBP
cord-005453-4057qib7	13854	13	to	to	IN
cord-005453-4057qib7	13854	14	an	an	DT
cord-005453-4057qib7	13854	15	increase	increase	NN
cord-005453-4057qib7	13854	16	in	in	IN
cord-005453-4057qib7	13854	17	survival	survival	NN
cord-005453-4057qib7	13854	18	rates	rate	NNS
cord-005453-4057qib7	13854	19	,	,	,
cord-005453-4057qib7	13854	20	at	at	IN
cord-005453-4057qib7	13854	21	least	least	JJS
cord-005453-4057qib7	13854	22	in	in	IN
cord-005453-4057qib7	13854	23	the	the	DT
cord-005453-4057qib7	13854	24	first	first	JJ
cord-005453-4057qib7	13854	25	6	6	CD
cord-005453-4057qib7	13854	26	months	month	NNS
cord-005453-4057qib7	13854	27	after	after	IN
cord-005453-4057qib7	13854	28	SCT	SCT	NNP
cord-005453-4057qib7	13854	29	.	.	.
cord-005453-4057qib7	13855	1	Most	Most	JJS
cord-005453-4057qib7	13855	2	patients	patient	NNS
cord-005453-4057qib7	13855	3	(	(	-LRB-
cord-005453-4057qib7	13855	4	90	90	CD
cord-005453-4057qib7	13855	5	%	%	NN
cord-005453-4057qib7	13855	6	)	)	-RRB-
cord-005453-4057qib7	13855	7	had	have	VBD
cord-005453-4057qib7	13855	8	progressive	progressive	JJ
cord-005453-4057qib7	13855	9	or	or	CC
cord-005453-4057qib7	13855	10	relapsed	relapsed	JJ
cord-005453-4057qib7	13855	11	/	/	SYM
cord-005453-4057qib7	13855	12	refractory	refractory	JJ
cord-005453-4057qib7	13855	13	disease	disease	NN
cord-005453-4057qib7	13855	14	when	when	WRB
cord-005453-4057qib7	13855	15	referred	refer	VBD
cord-005453-4057qib7	13855	16	to	to	IN
cord-005453-4057qib7	13855	17	our	-PRON-	PRP$
cord-005453-4057qib7	13855	18	department	department	NN
cord-005453-4057qib7	13855	19	.	.	.
cord-005453-4057qib7	13856	1	Multiple	multiple	JJ
cord-005453-4057qib7	13856	2	procedures	procedure	NNS
cord-005453-4057qib7	13856	3	require	require	VBP
cord-005453-4057qib7	13856	4	a	a	DT
cord-005453-4057qib7	13856	5	higher	high	JJR
cord-005453-4057qib7	13856	6	number	number	NN
cord-005453-4057qib7	13856	7	of	of	IN
cord-005453-4057qib7	13856	8	CD34	CD34	NNP
cord-005453-4057qib7	13856	9	cells	cell	NNS
cord-005453-4057qib7	13856	10	,	,	,
cord-005453-4057qib7	13856	11	very	very	RB
cord-005453-4057qib7	13856	12	hard	hard	JJ
cord-005453-4057qib7	13856	13	to	to	TO
cord-005453-4057qib7	13856	14	achieve	achieve	VB
cord-005453-4057qib7	13856	15	in	in	IN
cord-005453-4057qib7	13856	16	patients	patient	NNS
cord-005453-4057qib7	13856	17	with	with	IN
cord-005453-4057qib7	13856	18	multiple	multiple	JJ
cord-005453-4057qib7	13856	19	courses	course	NNS
cord-005453-4057qib7	13856	20	of	of	IN
cord-005453-4057qib7	13856	21	chemo±	chemo±	NNP
cord-005453-4057qib7	13856	22	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	13856	23	.	.	.
cord-005453-4057qib7	13857	1	New	new	JJ
cord-005453-4057qib7	13857	2	approaches	approach	NNS
cord-005453-4057qib7	13857	3	have	have	VBP
cord-005453-4057qib7	13857	4	to	to	TO
cord-005453-4057qib7	13857	5	be	be	VB
cord-005453-4057qib7	13857	6	considered	consider	VBN
cord-005453-4057qib7	13857	7	in	in	IN
cord-005453-4057qib7	13857	8	these	these	DT
cord-005453-4057qib7	13857	9	diseases	disease	NNS
cord-005453-4057qib7	13857	10	,	,	,
cord-005453-4057qib7	13857	11	especially	especially	RB
cord-005453-4057qib7	13857	12	in	in	IN
cord-005453-4057qib7	13857	13	high	high	JJ
cord-005453-4057qib7	13857	14	risk	risk	NN
cord-005453-4057qib7	13857	15	group	group	NN
cord-005453-4057qib7	13857	16	.	.	.
cord-005453-4057qib7	13858	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13858	2	:	:	:
cord-005453-4057qib7	13858	3	Nothing	nothing	NN
cord-005453-4057qib7	13858	4	to	to	TO
cord-005453-4057qib7	13858	5	declare	declare	VB
cord-005453-4057qib7	13858	6	Background	background	NN
cord-005453-4057qib7	13858	7	:	:	:
cord-005453-4057qib7	13858	8	Antimicrobial	antimicrobial	JJ
cord-005453-4057qib7	13858	9	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13858	10	for	for	IN
cord-005453-4057qib7	13858	11	prolonged	prolonged	JJ
cord-005453-4057qib7	13858	12	neutropenia	neutropenia	NN
cord-005453-4057qib7	13858	13	occurred	occur	VBD
cord-005453-4057qib7	13858	14	during	during	IN
cord-005453-4057qib7	13858	15	the	the	DT
cord-005453-4057qib7	13858	16	pre	pre	JJ
cord-005453-4057qib7	13858	17	-	-	JJ
cord-005453-4057qib7	13858	18	engraftment	engraftment	JJ
cord-005453-4057qib7	13858	19	period	period	NN
cord-005453-4057qib7	13858	20	is	be	VBZ
cord-005453-4057qib7	13858	21	a	a	DT
cord-005453-4057qib7	13858	22	common	common	JJ
cord-005453-4057qib7	13858	23	practice	practice	NN
cord-005453-4057qib7	13858	24	in	in	IN
cord-005453-4057qib7	13858	25	allogeneic	allogeneic	JJ
cord-005453-4057qib7	13858	26	HSCT	HSCT	NNP
cord-005453-4057qib7	13858	27	recipients	recipient	NNS
cord-005453-4057qib7	13858	28	.	.	.
cord-005453-4057qib7	13859	1	Data	datum	NNS
cord-005453-4057qib7	13859	2	on	on	IN
cord-005453-4057qib7	13859	3	its	-PRON-	PRP$
cord-005453-4057qib7	13859	4	effectiveness	effectiveness	NN
cord-005453-4057qib7	13859	5	are	be	VBP
cord-005453-4057qib7	13859	6	few	few	JJ
cord-005453-4057qib7	13859	7	and	and	CC
cord-005453-4057qib7	13859	8	generally	generally	RB
cord-005453-4057qib7	13859	9	from	from	IN
cord-005453-4057qib7	13859	10	cases	case	NNS
cord-005453-4057qib7	13859	11	series	series	NN
cord-005453-4057qib7	13859	12	and	and	CC
cord-005453-4057qib7	13859	13	not	not	RB
cord-005453-4057qib7	13859	14	from	from	IN
cord-005453-4057qib7	13859	15	randomized	randomized	JJ
cord-005453-4057qib7	13859	16	clinical	clinical	JJ
cord-005453-4057qib7	13859	17	trials	trial	NNS
cord-005453-4057qib7	13859	18	,	,	,
cord-005453-4057qib7	13859	19	especially	especially	RB
cord-005453-4057qib7	13859	20	in	in	IN
cord-005453-4057qib7	13859	21	children	child	NNS
cord-005453-4057qib7	13859	22	.	.	.
cord-005453-4057qib7	13860	1	Methods	method	NNS
cord-005453-4057qib7	13860	2	:	:	:
cord-005453-4057qib7	13861	1	All	all	DT
cord-005453-4057qib7	13861	2	clinical	clinical	JJ
cord-005453-4057qib7	13861	3	records	record	NNS
cord-005453-4057qib7	13861	4	of	of	IN
cord-005453-4057qib7	13861	5	allo	allo	NN
cord-005453-4057qib7	13861	6	-	-	HYPH
cord-005453-4057qib7	13861	7	HSCT	HSCT	NNP
cord-005453-4057qib7	13861	8	performed	perform	VBD
cord-005453-4057qib7	13861	9	from	from	IN
cord-005453-4057qib7	13861	10	January	January	NNP
cord-005453-4057qib7	13861	11	1	1	CD
cord-005453-4057qib7	13861	12	st	st	NNP
cord-005453-4057qib7	13861	13	2007	2007	CD
cord-005453-4057qib7	13861	14	to	to	IN
cord-005453-4057qib7	13861	15	November	November	NNP
cord-005453-4057qib7	13861	16	30	30	CD
cord-005453-4057qib7	13861	17	th	th	CD
cord-005453-4057qib7	13861	18	2018	2018	CD
cord-005453-4057qib7	13861	19	at	at	IN
cord-005453-4057qib7	13861	20	HSCT	HSCT	NNP
cord-005453-4057qib7	13861	21	-	-	HYPH
cord-005453-4057qib7	13861	22	Unit	Unit	NNP
cord-005453-4057qib7	13861	23	of	of	IN
cord-005453-4057qib7	13861	24	Istituto	Istituto	NNP
cord-005453-4057qib7	13861	25	G.Gaslini	G.Gaslini	NNP
cord-005453-4057qib7	13861	26	,	,	,
cord-005453-4057qib7	13861	27	Genoa	Genoa	NNP
cord-005453-4057qib7	13861	28	-	-	HYPH
cord-005453-4057qib7	13861	29	Italy	Italy	NNP
cord-005453-4057qib7	13861	30	,	,	,
cord-005453-4057qib7	13861	31	were	be	VBD
cord-005453-4057qib7	13861	32	retrospectively	retrospectively	RB
cord-005453-4057qib7	13861	33	reviewed	review	VBN
cord-005453-4057qib7	13861	34	.	.	.
cord-005453-4057qib7	13862	1	Collected	collect	VBN
cord-005453-4057qib7	13862	2	data	datum	NNS
cord-005453-4057qib7	13862	3	were	be	VBD
cord-005453-4057qib7	13862	4	underlying	underlie	VBG
cord-005453-4057qib7	13862	5	diseases	disease	NNS
cord-005453-4057qib7	13862	6	,	,	,
cord-005453-4057qib7	13862	7	type	type	NN
cord-005453-4057qib7	13862	8	of	of	IN
cord-005453-4057qib7	13862	9	donor	donor	NN
cord-005453-4057qib7	13862	10	,	,	,
cord-005453-4057qib7	13862	11	antibiotic	antibiotic	JJ
cord-005453-4057qib7	13862	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13862	13	administration	administration	NN
cord-005453-4057qib7	13862	14	and	and	CC
cord-005453-4057qib7	13862	15	type	type	NN
cord-005453-4057qib7	13862	16	,	,	,
cord-005453-4057qib7	13862	17	development	development	NN
cord-005453-4057qib7	13862	18	of	of	IN
cord-005453-4057qib7	13862	19	fever	fever	NN
cord-005453-4057qib7	13862	20	and	and	CC
cord-005453-4057qib7	13862	21	pathogen	pathogen	NN
cord-005453-4057qib7	13862	22	isolated	isolate	VBN
cord-005453-4057qib7	13862	23	from	from	IN
cord-005453-4057qib7	13862	24	blood	blood	NN
cord-005453-4057qib7	13862	25	culture	culture	NN
cord-005453-4057qib7	13862	26	,	,	,
cord-005453-4057qib7	13862	27	if	if	IN
cord-005453-4057qib7	13862	28	any	any	DT
cord-005453-4057qib7	13862	29	,	,	,
cord-005453-4057qib7	13862	30	during	during	IN
cord-005453-4057qib7	13862	31	pre	pre	JJ
cord-005453-4057qib7	13862	32	-	-	JJ
cord-005453-4057qib7	13862	33	engraftment	engraftment	JJ
cord-005453-4057qib7	13862	34	neutropenia	neutropenia	NN
cord-005453-4057qib7	13862	35	.	.	.
cord-005453-4057qib7	13863	1	Antibiotic	antibiotic	JJ
cord-005453-4057qib7	13863	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13863	3	,	,	,
cord-005453-4057qib7	13863	4	usually	usually	RB
cord-005453-4057qib7	13863	5	starting	start	VBG
cord-005453-4057qib7	13863	6	together	together	RB
cord-005453-4057qib7	13863	7	with	with	IN
cord-005453-4057qib7	13863	8	the	the	DT
cord-005453-4057qib7	13863	9	conditioning	conditioning	NN
cord-005453-4057qib7	13863	10	regimen	regimen	NN
cord-005453-4057qib7	13863	11	,	,	,
cord-005453-4057qib7	13863	12	was	be	VBD
cord-005453-4057qib7	13863	13	categorized	categorize	VBN
cord-005453-4057qib7	13863	14	in	in	IN
cord-005453-4057qib7	13863	15	"	"	``
cord-005453-4057qib7	13863	16	standard	standard	JJ
cord-005453-4057qib7	13863	17	"	"	''
cord-005453-4057qib7	13863	18	(	(	-LRB-
cord-005453-4057qib7	13863	19	with	with	IN
cord-005453-4057qib7	13863	20	amoxicillin	amoxicillin	NNP
cord-005453-4057qib7	13863	21	/	/	SYM
cord-005453-4057qib7	13863	22	clavulanate	clavulanate	NNP
cord-005453-4057qib7	13863	23	or	or	CC
cord-005453-4057qib7	13863	24	ampicillin	ampicillin	NNP
cord-005453-4057qib7	13863	25	/	/	SYM
cord-005453-4057qib7	13863	26	sulbactam	sulbactam	NNP
cord-005453-4057qib7	13863	27	)	)	-RRB-
cord-005453-4057qib7	13863	28	or	or	CC
cord-005453-4057qib7	13863	29	"	"	``
cord-005453-4057qib7	13863	30	tailored	tailor	VBN
cord-005453-4057qib7	13863	31	"	"	''
cord-005453-4057qib7	13863	32	(	(	-LRB-
cord-005453-4057qib7	13863	33	when	when	WRB
cord-005453-4057qib7	13863	34	based	base	VBN
cord-005453-4057qib7	13863	35	on	on	IN
cord-005453-4057qib7	13863	36	previous	previous	JJ
cord-005453-4057qib7	13863	37	bacterial	bacterial	JJ
cord-005453-4057qib7	13863	38	isolations	isolation	NNS
cord-005453-4057qib7	13863	39	or	or	CC
cord-005453-4057qib7	13863	40	colonizations	colonization	NNS
cord-005453-4057qib7	13863	41	)	)	-RRB-
cord-005453-4057qib7	13863	42	.	.	.
cord-005453-4057qib7	13864	1	Results	result	NNS
cord-005453-4057qib7	13864	2	:	:	:
cord-005453-4057qib7	13865	1	246	246	CD
cord-005453-4057qib7	13865	2	allo	allo	NN
cord-005453-4057qib7	13865	3	-	-	HYPH
cord-005453-4057qib7	13865	4	HSCTs	hsct	NNS
cord-005453-4057qib7	13865	5	were	be	VBD
cord-005453-4057qib7	13865	6	performed	perform	VBN
cord-005453-4057qib7	13865	7	in	in	IN
cord-005453-4057qib7	13865	8	217	217	CD
cord-005453-4057qib7	13865	9	pediatric	pediatric	JJ
cord-005453-4057qib7	13865	10	patients	patient	NNS
cord-005453-4057qib7	13865	11	(	(	-LRB-
cord-005453-4057qib7	13865	12	59	59	CD
cord-005453-4057qib7	13865	13	%	%	NN
cord-005453-4057qib7	13865	14	males	male	NNS
cord-005453-4057qib7	13865	15	)	)	-RRB-
cord-005453-4057qib7	13865	16	with	with	IN
cord-005453-4057qib7	13865	17	a	a	DT
cord-005453-4057qib7	13865	18	median	median	JJ
cord-005453-4057qib7	13865	19	age	age	NN
cord-005453-4057qib7	13865	20	at	at	IN
cord-005453-4057qib7	13865	21	HSCT	HSCT	NNP
cord-005453-4057qib7	13865	22	of	of	IN
cord-005453-4057qib7	13865	23	8	8	CD
cord-005453-4057qib7	13865	24	years	year	NNS
cord-005453-4057qib7	13866	1	(	(	-LRB-
cord-005453-4057qib7	13866	2	IQR	iqr	NN
cord-005453-4057qib7	13866	3	:	:	:
cord-005453-4057qib7	13866	4	4	4	CD
cord-005453-4057qib7	13866	5	-	-	SYM
cord-005453-4057qib7	13866	6	13	13	CD
cord-005453-4057qib7	13866	7	;	;	.
cord-005453-4057qib7	13867	1	range	range	NN
cord-005453-4057qib7	13867	2	:	:	:
cord-005453-4057qib7	13867	3	0	0	CD
cord-005453-4057qib7	13867	4	-	-	SYM
cord-005453-4057qib7	13867	5	22	22	CD
cord-005453-4057qib7	13867	6	)	)	-RRB-
cord-005453-4057qib7	13867	7	.	.	.
cord-005453-4057qib7	13868	1	HSCTs	hsct	NNS
cord-005453-4057qib7	13868	2	were	be	VBD
cord-005453-4057qib7	13868	3	performed	perform	VBN
cord-005453-4057qib7	13868	4	from	from	IN
cord-005453-4057qib7	13868	5	alternative	alternative	JJ
cord-005453-4057qib7	13868	6	donor	donor	NN
cord-005453-4057qib7	13868	7	(	(	-LRB-
cord-005453-4057qib7	13868	8	AD	ad	NN
cord-005453-4057qib7	13868	9	)	)	-RRB-
cord-005453-4057qib7	13868	10	in	in	IN
cord-005453-4057qib7	13868	11	55	55	CD
cord-005453-4057qib7	13868	12	%	%	NN
cord-005453-4057qib7	13868	13	patients	patient	NNS
cord-005453-4057qib7	13868	14	,	,	,
cord-005453-4057qib7	13868	15	from	from	IN
cord-005453-4057qib7	13868	16	relative	relative	JJ
cord-005453-4057qib7	13868	17	donor	donor	NN
cord-005453-4057qib7	13868	18	(	(	-LRB-
cord-005453-4057qib7	13868	19	RD	RD	NNP
cord-005453-4057qib7	13868	20	)	)	-RRB-
cord-005453-4057qib7	13868	21	in	in	IN
cord-005453-4057qib7	13868	22	25	25	CD
cord-005453-4057qib7	13868	23	%	%	NN
cord-005453-4057qib7	13868	24	,	,	,
cord-005453-4057qib7	13868	25	and	and	CC
cord-005453-4057qib7	13868	26	from	from	IN
cord-005453-4057qib7	13868	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	13868	28	donor	donor	NN
cord-005453-4057qib7	13868	29	in	in	IN
cord-005453-4057qib7	13868	30	20	20	CD
cord-005453-4057qib7	13868	31	%	%	NN
cord-005453-4057qib7	13868	32	.	.	.
cord-005453-4057qib7	13869	1	Table	table	NN
cord-005453-4057qib7	13869	2	1	1	CD
cord-005453-4057qib7	13869	3	shows	show	VBZ
cord-005453-4057qib7	13869	4	the	the	DT
cord-005453-4057qib7	13869	5	pre	pre	JJ
cord-005453-4057qib7	13869	6	-	-	JJ
cord-005453-4057qib7	13869	7	engraftment	engraftment	JJ
cord-005453-4057qib7	13869	8	febrile	febrile	JJ
cord-005453-4057qib7	13869	9	neutropenia	neutropenia	NN
cord-005453-4057qib7	13869	10	episodes	episode	NNS
cord-005453-4057qib7	13869	11	according	accord	VBG
cord-005453-4057qib7	13869	12	to	to	IN
cord-005453-4057qib7	13869	13	type	type	NN
cord-005453-4057qib7	13869	14	of	of	IN
cord-005453-4057qib7	13869	15	antibiotic	antibiotic	JJ
cord-005453-4057qib7	13869	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13869	17	.	.	.
cord-005453-4057qib7	13870	1	224	224	CD
cord-005453-4057qib7	13870	2	(	(	-LRB-
cord-005453-4057qib7	13870	3	91	91	CD
cord-005453-4057qib7	13870	4	%	%	NN
cord-005453-4057qib7	13870	5	)	)	-RRB-
cord-005453-4057qib7	13871	1	HSCTs	hsct	NNS
cord-005453-4057qib7	13871	2	received	receive	VBD
cord-005453-4057qib7	13871	3	standard	standard	JJ
cord-005453-4057qib7	13871	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13871	5	,	,	,
cord-005453-4057qib7	13871	6	while	while	IN
cord-005453-4057qib7	13871	7	20	20	CD
cord-005453-4057qib7	13871	8	(	(	-LRB-
cord-005453-4057qib7	13871	9	8	8	CD
cord-005453-4057qib7	13871	10	%	%	NN
cord-005453-4057qib7	13871	11	)	)	-RRB-
cord-005453-4057qib7	13871	12	the	the	DT
cord-005453-4057qib7	13871	13	tailored	tailor	VBN
cord-005453-4057qib7	13871	14	one	one	NN
cord-005453-4057qib7	13871	15	;	;	:
cord-005453-4057qib7	13871	16	only	only	RB
cord-005453-4057qib7	13871	17	in	in	IN
cord-005453-4057qib7	13871	18	2	2	CD
cord-005453-4057qib7	13871	19	(	(	-LRB-
cord-005453-4057qib7	13871	20	1	1	CD
cord-005453-4057qib7	13871	21	%	%	NN
cord-005453-4057qib7	13871	22	)	)	-RRB-
cord-005453-4057qib7	13871	23	did	do	VBD
cord-005453-4057qib7	13871	24	not	not	RB
cord-005453-4057qib7	13871	25	receive	receive	VB
cord-005453-4057qib7	13871	26	any	any	DT
cord-005453-4057qib7	13871	27	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13871	28	.	.	.
cord-005453-4057qib7	13872	1	Fever	fever	NN
cord-005453-4057qib7	13872	2	occurred	occur	VBD
cord-005453-4057qib7	13872	3	in	in	IN
cord-005453-4057qib7	13872	4	194	194	CD
cord-005453-4057qib7	13872	5	(	(	-LRB-
cord-005453-4057qib7	13872	6	87	87	CD
cord-005453-4057qib7	13872	7	%	%	NN
cord-005453-4057qib7	13872	8	)	)	-RRB-
cord-005453-4057qib7	13872	9	of	of	IN
cord-005453-4057qib7	13872	10	episodes	episode	NNS
cord-005453-4057qib7	13872	11	in	in	IN
cord-005453-4057qib7	13872	12	patients	patient	NNS
cord-005453-4057qib7	13872	13	receiving	receive	VBG
cord-005453-4057qib7	13872	14	standard	standard	JJ
cord-005453-4057qib7	13872	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13872	16	,	,	,
cord-005453-4057qib7	13872	17	in	in	IN
cord-005453-4057qib7	13872	18	19	19	CD
cord-005453-4057qib7	13872	19	(	(	-LRB-
cord-005453-4057qib7	13872	20	95	95	CD
cord-005453-4057qib7	13872	21	%	%	NN
cord-005453-4057qib7	13872	22	)	)	-RRB-
cord-005453-4057qib7	13872	23	of	of	IN
cord-005453-4057qib7	13872	24	those	those	DT
cord-005453-4057qib7	13872	25	treated	treat	VBN
cord-005453-4057qib7	13872	26	with	with	IN
cord-005453-4057qib7	13872	27	tailored	tailor	VBN
cord-005453-4057qib7	13872	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13872	29	and	and	CC
cord-005453-4057qib7	13872	30	1	1	CD
cord-005453-4057qib7	13872	31	(	(	-LRB-
cord-005453-4057qib7	13872	32	50	50	CD
cord-005453-4057qib7	13872	33	%	%	NN
cord-005453-4057qib7	13872	34	)	)	-RRB-
cord-005453-4057qib7	13872	35	in	in	IN
cord-005453-4057qib7	13872	36	the	the	DT
cord-005453-4057qib7	13872	37	group	group	NN
cord-005453-4057qib7	13872	38	without	without	IN
cord-005453-4057qib7	13872	39	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13872	40	;	;	:
cord-005453-4057qib7	13872	41	only	only	RB
cord-005453-4057qib7	13872	42	13	13	CD
cord-005453-4057qib7	13872	43	%	%	NN
cord-005453-4057qib7	13872	44	of	of	IN
cord-005453-4057qib7	13872	45	patients	patient	NNS
cord-005453-4057qib7	13872	46	who	who	WP
cord-005453-4057qib7	13872	47	received	receive	VBD
cord-005453-4057qib7	13872	48	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13872	49	did	do	VBD
cord-005453-4057qib7	13872	50	not	not	RB
cord-005453-4057qib7	13872	51	develop	develop	VB
cord-005453-4057qib7	13872	52	fever	fever	NN
cord-005453-4057qib7	13872	53	.	.	.
cord-005453-4057qib7	13873	1	In	in	IN
cord-005453-4057qib7	13873	2	38	38	CD
cord-005453-4057qib7	13873	3	%	%	NN
cord-005453-4057qib7	13873	4	of	of	IN
cord-005453-4057qib7	13873	5	patients	patient	NNS
cord-005453-4057qib7	13873	6	,	,	,
cord-005453-4057qib7	13873	7	the	the	DT
cord-005453-4057qib7	13873	8	febrile	febrile	JJ
cord-005453-4057qib7	13873	9	episodes	episode	NNS
cord-005453-4057qib7	13873	10	were	be	VBD
cord-005453-4057qib7	13873	11	diagnosed	diagnose	VBN
cord-005453-4057qib7	13873	12	as	as	IN
cord-005453-4057qib7	13873	13	bloodstream	bloodstream	NN
cord-005453-4057qib7	13873	14	infections	infection	NNS
cord-005453-4057qib7	13873	15	:	:	:
cord-005453-4057qib7	13873	16	Staphylococcus	staphylococcus	NN
cord-005453-4057qib7	13873	17	aureus	aureus	NN
cord-005453-4057qib7	13873	18	in	in	IN
cord-005453-4057qib7	13873	19	2	2	CD
cord-005453-4057qib7	13873	20	%	%	NN
cord-005453-4057qib7	13873	21	;	;	:
cord-005453-4057qib7	13873	22	CoNS	CoNS	NNP
cord-005453-4057qib7	13873	23	in	in	IN
cord-005453-4057qib7	13873	24	19	19	CD
cord-005453-4057qib7	13873	25	%	%	NN
cord-005453-4057qib7	13873	26	;	;	:
cord-005453-4057qib7	13873	27	Enterococcus	Enterococcus	NNP
cord-005453-4057qib7	13873	28	spp	spp	NNS
cord-005453-4057qib7	13873	29	in	in	IN
cord-005453-4057qib7	13873	30	15	15	CD
cord-005453-4057qib7	13873	31	%	%	NN
cord-005453-4057qib7	13873	32	;	;	.
cord-005453-4057qib7	13874	1	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-005453-4057qib7	13874	2	in	in	IN
cord-005453-4057qib7	13874	3	25	25	CD
cord-005453-4057qib7	13874	4	%	%	NN
cord-005453-4057qib7	13874	5	;	;	:
cord-005453-4057qib7	13874	6	Pseudomonas	Pseudomonas	NNP
cord-005453-4057qib7	13874	7	aeruginosa	aeruginosa	NN
cord-005453-4057qib7	13874	8	in	in	IN
cord-005453-4057qib7	13874	9	11	11	CD
cord-005453-4057qib7	13874	10	%	%	NN
cord-005453-4057qib7	13874	11	;	;	,
cord-005453-4057qib7	13874	12	other	other	JJ
cord-005453-4057qib7	13874	13	non	non	JJ
cord-005453-4057qib7	13874	14	-	-	JJ
cord-005453-4057qib7	13874	15	fermenting	fermenting	JJ
cord-005453-4057qib7	13874	16	gram	gram	NN
cord-005453-4057qib7	13874	17	negatives	negative	NNS
cord-005453-4057qib7	13874	18	in	in	IN
cord-005453-4057qib7	13874	19	2	2	CD
cord-005453-4057qib7	13874	20	%	%	NN
cord-005453-4057qib7	13874	21	and	and	CC
cord-005453-4057qib7	13874	22	fungi	fungus	NNS
cord-005453-4057qib7	13874	23	in10	in10	IN
cord-005453-4057qib7	13874	24	%	%	NN
cord-005453-4057qib7	13874	25	.	.	.
cord-005453-4057qib7	13875	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13875	2	:	:	:
cord-005453-4057qib7	13876	1	The	the	DT
cord-005453-4057qib7	13876	2	occurrence	occurrence	NN
cord-005453-4057qib7	13876	3	of	of	IN
cord-005453-4057qib7	13876	4	fever	fever	NN
cord-005453-4057qib7	13876	5	in	in	IN
cord-005453-4057qib7	13876	6	patients	patient	NNS
cord-005453-4057qib7	13876	7	who	who	WP
cord-005453-4057qib7	13876	8	received	receive	VBD
cord-005453-4057qib7	13876	9	antibiotic	antibiotic	JJ
cord-005453-4057qib7	13876	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13876	11	suggested	suggest	VBD
cord-005453-4057qib7	13876	12	that	that	IN
cord-005453-4057qib7	13876	13	it	-PRON-	PRP
cord-005453-4057qib7	13876	14	could	could	MD
cord-005453-4057qib7	13876	15	not	not	RB
cord-005453-4057qib7	13876	16	be	be	VB
cord-005453-4057qib7	13876	17	effective	effective	JJ
cord-005453-4057qib7	13876	18	in	in	IN
cord-005453-4057qib7	13876	19	prevention	prevention	NN
cord-005453-4057qib7	13876	20	of	of	IN
cord-005453-4057qib7	13876	21	fever	fever	NN
cord-005453-4057qib7	13876	22	related	relate	VBN
cord-005453-4057qib7	13876	23	to	to	IN
cord-005453-4057qib7	13876	24	neutropenia	neutropenia	NN
cord-005453-4057qib7	13876	25	after	after	IN
cord-005453-4057qib7	13876	26	allo	allo	NN
cord-005453-4057qib7	13876	27	-	-	HYPH
cord-005453-4057qib7	13876	28	HSCT	HSCT	NNP
cord-005453-4057qib7	13876	29	.	.	.
cord-005453-4057qib7	13877	1	The	the	DT
cord-005453-4057qib7	13877	2	personalization	personalization	NN
cord-005453-4057qib7	13877	3	of	of	IN
cord-005453-4057qib7	13877	4	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13877	5	could	could	MD
cord-005453-4057qib7	13877	6	be	be	VB
cord-005453-4057qib7	13877	7	a	a	DT
cord-005453-4057qib7	13877	8	possible	possible	JJ
cord-005453-4057qib7	13877	9	path	path	NN
cord-005453-4057qib7	13877	10	to	to	TO
cord-005453-4057qib7	13877	11	follow	follow	VB
cord-005453-4057qib7	13877	12	these	these	DT
cord-005453-4057qib7	13877	13	patients	patient	NNS
cord-005453-4057qib7	13877	14	.	.	.
cord-005453-4057qib7	13878	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13878	2	Methods	method	NNS
cord-005453-4057qib7	13878	3	:	:	:
cord-005453-4057qib7	13879	1	A	a	DT
cord-005453-4057qib7	13879	2	total	total	NN
cord-005453-4057qib7	13879	3	of	of	IN
cord-005453-4057qib7	13879	4	15	15	CD
cord-005453-4057qib7	13879	5	patients	patient	NNS
cord-005453-4057qib7	13879	6	with	with	IN
cord-005453-4057qib7	13879	7	leukemia	leukemia	NN
cord-005453-4057qib7	13879	8	or	or	CC
cord-005453-4057qib7	13879	9	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	13879	10	were	be	VBD
cord-005453-4057qib7	13879	11	included	include	VBN
cord-005453-4057qib7	13879	12	in	in	IN
cord-005453-4057qib7	13879	13	the	the	DT
cord-005453-4057qib7	13879	14	study	study	NN
cord-005453-4057qib7	13879	15	.	.	.
cord-005453-4057qib7	13880	1	Patients	patient	NNS
cord-005453-4057qib7	13880	2	'	'	POS
cord-005453-4057qib7	13880	3	mothers	mother	NNS
cord-005453-4057qib7	13880	4	signed	sign	VBD
cord-005453-4057qib7	13880	5	an	an	DT
cord-005453-4057qib7	13880	6	informed	informed	JJ
cord-005453-4057qib7	13880	7	consent	consent	NN
cord-005453-4057qib7	13880	8	for	for	IN
cord-005453-4057qib7	13880	9	participation	participation	NN
cord-005453-4057qib7	13880	10	in	in	IN
cord-005453-4057qib7	13880	11	the	the	DT
cord-005453-4057qib7	13880	12	study	study	NN
cord-005453-4057qib7	13880	13	.	.	.
cord-005453-4057qib7	13881	1	Six	six	CD
cord-005453-4057qib7	13881	2	of	of	IN
cord-005453-4057qib7	13881	3	study	study	NN
cord-005453-4057qib7	13881	4	participants	participant	NNS
cord-005453-4057qib7	13881	5	were	be	VBD
cord-005453-4057qib7	13881	6	boys	boy	NNS
cord-005453-4057qib7	13881	7	and	and	CC
cord-005453-4057qib7	13881	8	9	9	CD
cord-005453-4057qib7	13881	9	girls	girl	NNS
cord-005453-4057qib7	13881	10	,	,	,
cord-005453-4057qib7	13881	11	all	all	DT
cord-005453-4057qib7	13881	12	aged	age	VBN
cord-005453-4057qib7	13881	13	3	3	CD
cord-005453-4057qib7	13881	14	to	to	TO
cord-005453-4057qib7	13881	15	6	6	CD
cord-005453-4057qib7	13881	16	years	year	NNS
cord-005453-4057qib7	13881	17	.	.	.
cord-005453-4057qib7	13882	1	The	the	DT
cord-005453-4057qib7	13882	2	control	control	NN
cord-005453-4057qib7	13882	3	group	group	NN
cord-005453-4057qib7	13882	4	consisted	consist	VBD
cord-005453-4057qib7	13882	5	of	of	IN
cord-005453-4057qib7	13882	6	18	18	CD
cord-005453-4057qib7	13882	7	healthy	healthy	JJ
cord-005453-4057qib7	13882	8	preschool	preschool	NN
cord-005453-4057qib7	13882	9	children	child	NNS
cord-005453-4057qib7	13882	10	(	(	-LRB-
cord-005453-4057qib7	13882	11	2	2	CD
cord-005453-4057qib7	13882	12	groups	group	NNS
cord-005453-4057qib7	13882	13	of	of	IN
cord-005453-4057qib7	13882	14	9	9	CD
cord-005453-4057qib7	13882	15	children	child	NNS
cord-005453-4057qib7	13882	16	aged	age	VBN
cord-005453-4057qib7	13882	17	5	5	CD
cord-005453-4057qib7	13882	18	to	to	TO
cord-005453-4057qib7	13882	19	6	6	CD
cord-005453-4057qib7	13882	20	years	year	NNS
cord-005453-4057qib7	13882	21	)	)	-RRB-
cord-005453-4057qib7	13882	22	,	,	,
cord-005453-4057qib7	13882	23	8	8	CD
cord-005453-4057qib7	13882	24	boys	boy	NNS
cord-005453-4057qib7	13882	25	and	and	CC
cord-005453-4057qib7	13882	26	10	10	CD
cord-005453-4057qib7	13882	27	girls	girl	NNS
cord-005453-4057qib7	13882	28	.	.	.
cord-005453-4057qib7	13883	1	Results	result	NNS
cord-005453-4057qib7	13883	2	:	:	:
cord-005453-4057qib7	13884	1	In	in	IN
cord-005453-4057qib7	13884	2	most	most	JJS
cord-005453-4057qib7	13884	3	of	of	IN
cord-005453-4057qib7	13884	4	games	game	NNS
cord-005453-4057qib7	13884	5	the	the	DT
cord-005453-4057qib7	13884	6	role	role	NN
cord-005453-4057qib7	13884	7	of	of	IN
cord-005453-4057qib7	13884	8	a	a	DT
cord-005453-4057qib7	13884	9	doctor	doctor	NN
cord-005453-4057qib7	13884	10	was	be	VBD
cord-005453-4057qib7	13884	11	played	play	VBN
cord-005453-4057qib7	13884	12	by	by	IN
cord-005453-4057qib7	13884	13	a	a	DT
cord-005453-4057qib7	13884	14	child	child	NN
cord-005453-4057qib7	13884	15	.	.	.
cord-005453-4057qib7	13885	1	Only	only	RB
cord-005453-4057qib7	13885	2	one	one	CD
cord-005453-4057qib7	13885	3	child	child	NN
cord-005453-4057qib7	13885	4	declined	decline	VBD
cord-005453-4057qib7	13885	5	to	to	TO
cord-005453-4057qib7	13885	6	impersonate	impersonate	VB
cord-005453-4057qib7	13885	7	both	both	CC
cord-005453-4057qib7	13885	8	a	a	DT
cord-005453-4057qib7	13885	9	patient	patient	NN
cord-005453-4057qib7	13885	10	and	and	CC
cord-005453-4057qib7	13885	11	a	a	DT
cord-005453-4057qib7	13885	12	doctor	doctor	NN
cord-005453-4057qib7	13885	13	.	.	.
cord-005453-4057qib7	13886	1	Younger	young	JJR
cord-005453-4057qib7	13886	2	children	child	NNS
cord-005453-4057qib7	13886	3	mostly	mostly	RB
cord-005453-4057qib7	13886	4	agreed	agree	VBD
cord-005453-4057qib7	13886	5	to	to	TO
cord-005453-4057qib7	13886	6	have	have	VB
cord-005453-4057qib7	13886	7	for	for	IN
cord-005453-4057qib7	13886	8	a	a	DT
cord-005453-4057qib7	13886	9	"	"	``
cord-005453-4057qib7	13886	10	patient	patient	JJ
cord-005453-4057qib7	13886	11	"	"	''
cord-005453-4057qib7	13886	12	a	a	DT
cord-005453-4057qib7	13886	13	toy	toy	NN
cord-005453-4057qib7	13886	14	(	(	-LRB-
cord-005453-4057qib7	13886	15	proposed	propose	VBN
cord-005453-4057qib7	13886	16	by	by	IN
cord-005453-4057qib7	13886	17	psychologist	psychologist	NN
cord-005453-4057qib7	13886	18	or	or	CC
cord-005453-4057qib7	13886	19	one	one	CD
cord-005453-4057qib7	13886	20	of	of	IN
cord-005453-4057qib7	13886	21	child	child	NN
cord-005453-4057qib7	13886	22	's	's	POS
cord-005453-4057qib7	13886	23	own	own	JJ
cord-005453-4057qib7	13886	24	)	)	-RRB-
cord-005453-4057qib7	13886	25	,	,	,
cord-005453-4057qib7	13886	26	child	child	NN
cord-005453-4057qib7	13886	27	's	's	POS
cord-005453-4057qib7	13886	28	mother	mother	NN
cord-005453-4057qib7	13886	29	or	or	CC
cord-005453-4057qib7	13886	30	a	a	DT
cord-005453-4057qib7	13886	31	medical	medical	JJ
cord-005453-4057qib7	13886	32	psychologist	psychologist	NN
cord-005453-4057qib7	13886	33	.	.	.
cord-005453-4057qib7	13887	1	The	the	DT
cord-005453-4057qib7	13887	2	game	game	NN
cord-005453-4057qib7	13887	3	lasted	last	VBD
cord-005453-4057qib7	13887	4	for	for	IN
cord-005453-4057qib7	13887	5	15	15	CD
cord-005453-4057qib7	13887	6	-20	-20	CD
cord-005453-4057qib7	13887	7	minutes	minute	NNS
cord-005453-4057qib7	13887	8	.	.	.
cord-005453-4057qib7	13888	1	Most	Most	JJS
cord-005453-4057qib7	13888	2	patients	patient	NNS
cord-005453-4057qib7	13888	3	preferred	prefer	VBD
cord-005453-4057qib7	13888	4	using	use	VBG
cord-005453-4057qib7	13888	5	real	real	JJ
cord-005453-4057qib7	13888	6	medical	medical	JJ
cord-005453-4057qib7	13888	7	consumables	consumable	NNS
cord-005453-4057qib7	13888	8	and	and	CC
cord-005453-4057qib7	13888	9	instruments	instrument	NNS
cord-005453-4057qib7	13888	10	(	(	-LRB-
cord-005453-4057qib7	13888	11	syringes	syrinx	NNS
cord-005453-4057qib7	13888	12	,	,	,
cord-005453-4057qib7	13888	13	adhesive	adhesive	JJ
cord-005453-4057qib7	13888	14	tape	tape	NN
cord-005453-4057qib7	13888	15	,	,	,
cord-005453-4057qib7	13888	16	winged	winged	JJ
cord-005453-4057qib7	13888	17	infusion	infusion	NN
cord-005453-4057qib7	13888	18	sets	set	NNS
cord-005453-4057qib7	13888	19	or	or	CC
cord-005453-4057qib7	13888	20	,	,	,
cord-005453-4057qib7	13888	21	more	more	RBR
cord-005453-4057qib7	13888	22	rarely	rarely	RB
cord-005453-4057qib7	13888	23	,	,	,
cord-005453-4057qib7	13888	24	pills	pill	NNS
cord-005453-4057qib7	13888	25	)	)	-RRB-
cord-005453-4057qib7	13888	26	.	.	.
cord-005453-4057qib7	13889	1	Most	most	RBS
cord-005453-4057qib7	13889	2	often	often	RB
cord-005453-4057qib7	13889	3	a	a	DT
cord-005453-4057qib7	13889	4	syringe	syringe	NN
cord-005453-4057qib7	13889	5	or	or	CC
cord-005453-4057qib7	13889	6	an	an	DT
cord-005453-4057qib7	13889	7	adhesive	adhesive	JJ
cord-005453-4057qib7	13889	8	tape	tape	NN
cord-005453-4057qib7	13889	9	was	be	VBD
cord-005453-4057qib7	13889	10	chosen	choose	VBN
cord-005453-4057qib7	13889	11	.	.	.
cord-005453-4057qib7	13890	1	As	as	IN
cord-005453-4057qib7	13890	2	known	know	VBN
cord-005453-4057qib7	13890	3	from	from	IN
cord-005453-4057qib7	13890	4	their	-PRON-	PRP$
cord-005453-4057qib7	13890	5	mothers	mother	NNS
cord-005453-4057qib7	13890	6	,	,	,
cord-005453-4057qib7	13890	7	among	among	IN
cord-005453-4057qib7	13890	8	medical	medical	JJ
cord-005453-4057qib7	13890	9	manipulations	manipulation	NNS
cord-005453-4057qib7	13890	10	most	most	RBS
cord-005453-4057qib7	13890	11	unpleasant	unpleasant	JJ
cord-005453-4057qib7	13890	12	for	for	IN
cord-005453-4057qib7	13890	13	children	child	NNS
cord-005453-4057qib7	13890	14	are	be	VBP
cord-005453-4057qib7	13890	15	injections	injection	NNS
cord-005453-4057qib7	13890	16	and	and	CC
cord-005453-4057qib7	13890	17	changing	change	VBG
cord-005453-4057qib7	13890	18	implanted	implant	VBN
cord-005453-4057qib7	13890	19	catheter	catheter	NN
cord-005453-4057qib7	13890	20	dressing	dressing	NN
cord-005453-4057qib7	13890	21	.	.	.
cord-005453-4057qib7	13891	1	Also	also	RB
cord-005453-4057qib7	13891	2	,	,	,
cord-005453-4057qib7	13891	3	most	most	RBS
cord-005453-4057qib7	13891	4	healthy	healthy	JJ
cord-005453-4057qib7	13891	5	preschool	preschool	NN
cord-005453-4057qib7	13891	6	children	child	NNS
cord-005453-4057qib7	13891	7	preferred	prefer	VBD
cord-005453-4057qib7	13891	8	using	use	VBG
cord-005453-4057qib7	13891	9	real	real	JJ
cord-005453-4057qib7	13891	10	medical	medical	JJ
cord-005453-4057qib7	13891	11	instruments	instrument	NNS
cord-005453-4057qib7	13891	12	over	over	IN
cord-005453-4057qib7	13891	13	toy	toy	NN
cord-005453-4057qib7	13891	14	ones	one	NNS
cord-005453-4057qib7	13891	15	.	.	.
cord-005453-4057qib7	13892	1	Group	group	NN
cord-005453-4057qib7	13892	2	1	1	CD
cord-005453-4057qib7	13892	3	more	more	RBR
cord-005453-4057qib7	13892	4	often	often	RB
cord-005453-4057qib7	13892	5	used	use	VBD
cord-005453-4057qib7	13892	6	a	a	DT
cord-005453-4057qib7	13892	7	syringe	syringe	NN
cord-005453-4057qib7	13892	8	,	,	,
cord-005453-4057qib7	13892	9	a	a	DT
cord-005453-4057qib7	13892	10	winged	winged	JJ
cord-005453-4057qib7	13892	11	infusion	infusion	NN
cord-005453-4057qib7	13892	12	set	set	NN
cord-005453-4057qib7	13892	13	,	,	,
cord-005453-4057qib7	13892	14	adhesive	adhesive	JJ
cord-005453-4057qib7	13892	15	tape	tape	NN
cord-005453-4057qib7	13892	16	,	,	,
cord-005453-4057qib7	13892	17	gauze	gauze	NN
cord-005453-4057qib7	13892	18	or	or	CC
cord-005453-4057qib7	13892	19	pills	pill	NNS
cord-005453-4057qib7	13892	20	.	.	.
cord-005453-4057qib7	13893	1	Group	group	NN
cord-005453-4057qib7	13893	2	2	2	CD
cord-005453-4057qib7	13893	3	most	most	RBS
cord-005453-4057qib7	13893	4	often	often	RB
cord-005453-4057qib7	13893	5	chose	choose	VBD
cord-005453-4057qib7	13893	6	syringe	syringe	NN
cord-005453-4057qib7	13893	7	or	or	CC
cord-005453-4057qib7	13893	8	gauze	gauze	NN
cord-005453-4057qib7	13893	9	.	.	.
cord-005453-4057qib7	13894	1	Among	among	IN
cord-005453-4057qib7	13894	2	medical	medical	JJ
cord-005453-4057qib7	13894	3	instruments	instrument	NNS
cord-005453-4057qib7	13894	4	both	both	DT
cord-005453-4057qib7	13894	5	groups	group	NNS
cord-005453-4057qib7	13894	6	more	more	RBR
cord-005453-4057qib7	13894	7	often	often	RB
cord-005453-4057qib7	13894	8	chose	choose	VBD
cord-005453-4057qib7	13894	9	a	a	DT
cord-005453-4057qib7	13894	10	phonendoscope	phonendoscope	NN
cord-005453-4057qib7	13894	11	or	or	CC
cord-005453-4057qib7	13894	12	thermometer	thermometer	NN
cord-005453-4057qib7	13894	13	.	.	.
cord-005453-4057qib7	13895	1	One	one	CD
cord-005453-4057qib7	13895	2	patient	patient	NN
cord-005453-4057qib7	13895	3	refused	refuse	VBD
cord-005453-4057qib7	13895	4	to	to	TO
cord-005453-4057qib7	13895	5	cause	cause	VB
cord-005453-4057qib7	13895	6	pain	pain	NN
cord-005453-4057qib7	13895	7	to	to	IN
cord-005453-4057qib7	13895	8	a	a	DT
cord-005453-4057qib7	13895	9	"	"	``
cord-005453-4057qib7	13895	10	toy	toy	NN
cord-005453-4057qib7	13895	11	patient	patient	NN
cord-005453-4057qib7	13895	12	"	"	''
cord-005453-4057qib7	13895	13	.	.	.
cord-005453-4057qib7	13896	1	Other	other	JJ
cord-005453-4057qib7	13896	2	children	child	NNS
cord-005453-4057qib7	13896	3	sympathized	sympathize	VBD
cord-005453-4057qib7	13896	4	with	with	IN
cord-005453-4057qib7	13896	5	a	a	DT
cord-005453-4057qib7	13896	6	"	"	``
cord-005453-4057qib7	13896	7	toy	toy	NN
cord-005453-4057qib7	13896	8	patient	patient	NN
cord-005453-4057qib7	13896	9	"	"	''
cord-005453-4057qib7	13896	10	,	,	,
cord-005453-4057qib7	13896	11	stroke	stroke	NN
cord-005453-4057qib7	13896	12	injection	injection	NN
cord-005453-4057qib7	13896	13	or	or	CC
cord-005453-4057qib7	13896	14	dressing	dress	VBG
cord-005453-4057qib7	13896	15	location	location	NN
cord-005453-4057qib7	13896	16	sites	site	NNS
cord-005453-4057qib7	13896	17	or	or	CC
cord-005453-4057qib7	13896	18	used	use	VBN
cord-005453-4057qib7	13896	19	soothing	soothing	JJ
cord-005453-4057qib7	13896	20	terms	term	NNS
cord-005453-4057qib7	13896	21	(	(	-LRB-
cord-005453-4057qib7	13896	22	"	"	``
cord-005453-4057qib7	13896	23	wait	wait	VB
cord-005453-4057qib7	13896	24	a	a	DT
cord-005453-4057qib7	13896	25	little	little	JJ
cord-005453-4057qib7	13896	26	"	"	''
cord-005453-4057qib7	13896	27	,	,	,
cord-005453-4057qib7	13896	28	"	"	``
cord-005453-4057qib7	13896	29	it	-PRON-	PRP
cord-005453-4057qib7	13896	30	's	be	VBZ
cord-005453-4057qib7	13896	31	going	go	VBG
cord-005453-4057qib7	13896	32	to	to	TO
cord-005453-4057qib7	13896	33	be	be	VB
cord-005453-4057qib7	13896	34	all	all	RB
cord-005453-4057qib7	13896	35	right	right	JJ
cord-005453-4057qib7	13896	36	"	"	''
cord-005453-4057qib7	13896	37	)	)	-RRB-
cord-005453-4057qib7	13896	38	,	,	,
cord-005453-4057qib7	13896	39	wished	wish	VBD
cord-005453-4057qib7	13896	40	prompt	prompt	JJ
cord-005453-4057qib7	13896	41	recovery	recovery	NN
cord-005453-4057qib7	13896	42	and	and	CC
cord-005453-4057qib7	13896	43	hugged	hug	VBD
cord-005453-4057qib7	13896	44	their	-PRON-	PRP$
cord-005453-4057qib7	13896	45	"	"	``
cord-005453-4057qib7	13896	46	patients	patient	NNS
cord-005453-4057qib7	13896	47	"	"	''
cord-005453-4057qib7	13896	48	.	.	.
cord-005453-4057qib7	13897	1	One	one	CD
cord-005453-4057qib7	13897	2	child	child	NN
cord-005453-4057qib7	13897	3	was	be	VBD
cord-005453-4057qib7	13897	4	angry	angry	JJ
cord-005453-4057qib7	13897	5	over	over	IN
cord-005453-4057qib7	13897	6	his	-PRON-	PRP$
cord-005453-4057qib7	13897	7	"	"	``
cord-005453-4057qib7	13897	8	patient	patient	NN
cord-005453-4057qib7	13897	9	"	"	''
cord-005453-4057qib7	13897	10	wishing	wish	VBG
cord-005453-4057qib7	13897	11	him	-PRON-	PRP
cord-005453-4057qib7	13897	12	to	to	TO
cord-005453-4057qib7	13897	13	"	"	``
cord-005453-4057qib7	13897	14	get	get	VB
cord-005453-4057qib7	13897	15	hurt	hurt	VBN
cord-005453-4057qib7	13897	16	too	too	RB
cord-005453-4057qib7	13897	17	"	"	''
cord-005453-4057qib7	13897	18	.	.	.
cord-005453-4057qib7	13898	1	First	first	JJ
cord-005453-4057qib7	13898	2	preschool	preschool	NN
cord-005453-4057qib7	13898	3	group	group	NN
cord-005453-4057qib7	13898	4	children	child	NNS
cord-005453-4057qib7	13898	5	were	be	VBD
cord-005453-4057qib7	13898	6	mostly	mostly	RB
cord-005453-4057qib7	13898	7	scolding	scold	VBG
cord-005453-4057qib7	13898	8	a	a	DT
cord-005453-4057qib7	13898	9	toy	toy	NN
cord-005453-4057qib7	13898	10	"	"	``
cord-005453-4057qib7	13898	11	patient	patient	NN
cord-005453-4057qib7	13898	12	"	"	''
cord-005453-4057qib7	13898	13	for	for	IN
cord-005453-4057qib7	13898	14	"	"	``
cord-005453-4057qib7	13898	15	being	be	VBG
cord-005453-4057qib7	13898	16	guilty	guilty	JJ
cord-005453-4057qib7	13898	17	of	of	IN
cord-005453-4057qib7	13898	18	getting	get	VBG
cord-005453-4057qib7	13898	19	sick	sick	JJ
cord-005453-4057qib7	13898	20	"	"	''
cord-005453-4057qib7	13898	21	.	.	.
cord-005453-4057qib7	13899	1	Second	second	JJ
cord-005453-4057qib7	13899	2	group	group	NN
cord-005453-4057qib7	13899	3	children	child	NNS
cord-005453-4057qib7	13899	4	were	be	VBD
cord-005453-4057qib7	13899	5	mostly	mostly	RB
cord-005453-4057qib7	13899	6	compassionate	compassionate	JJ
cord-005453-4057qib7	13899	7	,	,	,
cord-005453-4057qib7	13899	8	encouraged	encourage	VBD
cord-005453-4057qib7	13899	9	a	a	DT
cord-005453-4057qib7	13899	10	"	"	``
cord-005453-4057qib7	13899	11	toy	toy	NN
cord-005453-4057qib7	13899	12	patient	patient	NN
cord-005453-4057qib7	13899	13	"	"	''
cord-005453-4057qib7	13899	14	telling	tell	VBG
cord-005453-4057qib7	13899	15	that	that	IN
cord-005453-4057qib7	13899	16	"	"	``
cord-005453-4057qib7	13899	17	all	all	PDT
cord-005453-4057qib7	13899	18	the	the	DT
cord-005453-4057qib7	13899	19	procedures	procedure	NNS
cord-005453-4057qib7	13899	20	are	be	VBP
cord-005453-4057qib7	13899	21	needed	need	VBN
cord-005453-4057qib7	13899	22	to	to	TO
cord-005453-4057qib7	13899	23	get	get	VB
cord-005453-4057qib7	13899	24	healthy	healthy	JJ
cord-005453-4057qib7	13899	25	"	"	''
cord-005453-4057qib7	13899	26	.	.	.
cord-005453-4057qib7	13900	1	From	from	IN
cord-005453-4057qib7	13900	2	children	child	NNS
cord-005453-4057qib7	13900	3	's	's	POS
cord-005453-4057qib7	13900	4	schoolmasters	schoolmaster	NNS
cord-005453-4057qib7	13900	5	we	-PRON-	PRP
cord-005453-4057qib7	13900	6	know	know	VBP
cord-005453-4057qib7	13900	7	that	that	IN
cord-005453-4057qib7	13900	8	all	all	DT
cord-005453-4057qib7	13900	9	first	first	JJ
cord-005453-4057qib7	13900	10	group	group	NN
cord-005453-4057qib7	13900	11	children	child	NNS
cord-005453-4057qib7	13900	12	received	receive	VBD
cord-005453-4057qib7	13900	13	vaccination	vaccination	NN
cord-005453-4057qib7	13900	14	about	about	IN
cord-005453-4057qib7	13900	15	a	a	DT
cord-005453-4057qib7	13900	16	week	week	NN
cord-005453-4057qib7	13900	17	before	before	IN
cord-005453-4057qib7	13900	18	a	a	DT
cord-005453-4057qib7	13900	19	test	test	NN
cord-005453-4057qib7	13900	20	.	.	.
cord-005453-4057qib7	13901	1	Children	child	NNS
cord-005453-4057qib7	13901	2	from	from	IN
cord-005453-4057qib7	13901	3	second	second	JJ
cord-005453-4057qib7	13901	4	group	group	NN
cord-005453-4057qib7	13901	5	had	have	VBD
cord-005453-4057qib7	13901	6	no	no	DT
cord-005453-4057qib7	13901	7	injections	injection	NNS
cord-005453-4057qib7	13901	8	.	.	.
cord-005453-4057qib7	13902	1	Overall	overall	JJ
cord-005453-4057qib7	13902	2	attitude	attitude	NN
cord-005453-4057qib7	13902	3	towards	towards	IN
cord-005453-4057qib7	13902	4	toy	toy	NN
cord-005453-4057qib7	13902	5	"	"	``
cord-005453-4057qib7	13902	6	patients	patient	NNS
cord-005453-4057qib7	13902	7	"	"	''
cord-005453-4057qib7	13902	8	was	be	VBD
cord-005453-4057qib7	13902	9	more	more	RBR
cord-005453-4057qib7	13902	10	mild	mild	JJ
cord-005453-4057qib7	13902	11	in	in	IN
cord-005453-4057qib7	13902	12	the	the	DT
cord-005453-4057qib7	13902	13	second	second	JJ
cord-005453-4057qib7	13902	14	group	group	NN
cord-005453-4057qib7	13902	15	.	.	.
cord-005453-4057qib7	13903	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13903	2	:	:	:
cord-005453-4057qib7	13903	3	1	1	CD
cord-005453-4057qib7	13903	4	.	.	.
cord-005453-4057qib7	13904	1	During	during	IN
cord-005453-4057qib7	13904	2	a	a	DT
cord-005453-4057qib7	13904	3	play	play	NN
cord-005453-4057qib7	13904	4	children	child	NNS
cord-005453-4057qib7	13904	5	mostly	mostly	RB
cord-005453-4057qib7	13904	6	use	use	VBP
cord-005453-4057qib7	13904	7	the	the	DT
cord-005453-4057qib7	13904	8	medical	medical	JJ
cord-005453-4057qib7	13904	9	devices	device	NNS
cord-005453-4057qib7	13904	10	which	which	WDT
cord-005453-4057qib7	13904	11	cause	cause	VBP
cord-005453-4057qib7	13904	12	them	-PRON-	PRP
cord-005453-4057qib7	13904	13	most	most	JJS
cord-005453-4057qib7	13904	14	discomfort	discomfort	NN
cord-005453-4057qib7	13904	15	and/or	and/or	CC
cord-005453-4057qib7	13904	16	pain	pain	NN
cord-005453-4057qib7	13904	17	.	.	.
cord-005453-4057qib7	13905	1	2	2	LS
cord-005453-4057qib7	13905	2	.	.	.
cord-005453-4057qib7	13906	1	Manipulating	manipulate	VBG
cord-005453-4057qib7	13906	2	the	the	DT
cord-005453-4057qib7	13906	3	items	item	NNS
cord-005453-4057qib7	13906	4	children	child	NNS
cord-005453-4057qib7	13906	5	illustrate	illustrate	VBP
cord-005453-4057qib7	13906	6	their	-PRON-	PRP$
cord-005453-4057qib7	13906	7	own	own	JJ
cord-005453-4057qib7	13906	8	impression	impression	NN
cord-005453-4057qib7	13906	9	of	of	IN
cord-005453-4057qib7	13906	10	medical	medical	JJ
cord-005453-4057qib7	13906	11	procedures	procedure	NNS
cord-005453-4057qib7	13906	12	,	,	,
cord-005453-4057qib7	13906	13	which	which	WDT
cord-005453-4057qib7	13906	14	are	be	VBP
cord-005453-4057qib7	13906	15	most	most	RBS
cord-005453-4057qib7	13906	16	unpleasant	unpleasant	JJ
cord-005453-4057qib7	13906	17	.	.	.
cord-005453-4057qib7	13907	1	3	3	LS
cord-005453-4057qib7	13907	2	.	.	.
cord-005453-4057qib7	13908	1	Children	child	NNS
cord-005453-4057qib7	13908	2	may	may	MD
cord-005453-4057qib7	13908	3	express	express	VB
cord-005453-4057qib7	13908	4	their	-PRON-	PRP$
cord-005453-4057qib7	13908	5	negative	negative	JJ
cord-005453-4057qib7	13908	6	emotions	emotion	NNS
cord-005453-4057qib7	13908	7	directed	direct	VBN
cord-005453-4057qib7	13908	8	towards	towards	IN
cord-005453-4057qib7	13908	9	medical	medical	JJ
cord-005453-4057qib7	13908	10	manipulations	manipulation	NNS
cord-005453-4057qib7	13908	11	via	via	IN
cord-005453-4057qib7	13908	12	their	-PRON-	PRP$
cord-005453-4057qib7	13908	13	play	play	NN
cord-005453-4057qib7	13908	14	actions	action	NNS
cord-005453-4057qib7	13908	15	,	,	,
cord-005453-4057qib7	13908	16	these	these	DT
cord-005453-4057qib7	13908	17	negative	negative	JJ
cord-005453-4057qib7	13908	18	reactions	reaction	NNS
cord-005453-4057qib7	13908	19	may	may	MD
cord-005453-4057qib7	13908	20	be	be	VB
cord-005453-4057qib7	13908	21	suppressed	suppress	VBN
cord-005453-4057qib7	13908	22	in	in	IN
cord-005453-4057qib7	13908	23	different	different	JJ
cord-005453-4057qib7	13908	24	ways	way	NNS
cord-005453-4057qib7	13908	25	by	by	IN
cord-005453-4057qib7	13908	26	parents	parent	NNS
cord-005453-4057qib7	13908	27	or	or	CC
cord-005453-4057qib7	13908	28	medical	medical	JJ
cord-005453-4057qib7	13908	29	staff	staff	NN
cord-005453-4057qib7	13908	30	.	.	.
cord-005453-4057qib7	13909	1	4	4	LS
cord-005453-4057qib7	13909	2	.	.	.
cord-005453-4057qib7	13910	1	The	the	DT
cord-005453-4057qib7	13910	2	intensity	intensity	NN
cord-005453-4057qib7	13910	3	of	of	IN
cord-005453-4057qib7	13910	4	child	child	NN
cord-005453-4057qib7	13910	5	's	's	POS
cord-005453-4057qib7	13910	6	own	own	JJ
cord-005453-4057qib7	13910	7	traumatic	traumatic	JJ
cord-005453-4057qib7	13910	8	experience	experience	NN
cord-005453-4057qib7	13910	9	and	and	CC
cord-005453-4057qib7	13910	10	an	an	DT
cord-005453-4057qib7	13910	11	attitude	attitude	NN
cord-005453-4057qib7	13910	12	of	of	IN
cord-005453-4057qib7	13910	13	nearby	nearby	JJ
cord-005453-4057qib7	13910	14	adults	adult	NNS
cord-005453-4057qib7	13910	15	may	may	MD
cord-005453-4057qib7	13910	16	influence	influence	VB
cord-005453-4057qib7	13910	17	the	the	DT
cord-005453-4057qib7	13910	18	child	child	NN
cord-005453-4057qib7	13910	19	's	's	POS
cord-005453-4057qib7	13910	20	attitude	attitude	NN
cord-005453-4057qib7	13910	21	towards	towards	IN
cord-005453-4057qib7	13910	22	other	other	JJ
cord-005453-4057qib7	13910	23	patients	patient	NNS
cord-005453-4057qib7	13910	24	.	.	.
cord-005453-4057qib7	13911	1	5	5	LS
cord-005453-4057qib7	13911	2	.	.	.
cord-005453-4057qib7	13912	1	The	the	DT
cord-005453-4057qib7	13912	2	mother	mother	NN
cord-005453-4057qib7	13912	3	's	's	POS
cord-005453-4057qib7	13912	4	wish	wish	NN
cord-005453-4057qib7	13912	5	for	for	IN
cord-005453-4057qib7	13912	6	a	a	DT
cord-005453-4057qib7	13912	7	child	child	NN
cord-005453-4057qib7	13912	8	to	to	TO
cord-005453-4057qib7	13912	9	tolerate	tolerate	VB
cord-005453-4057qib7	13912	10	all	all	DT
cord-005453-4057qib7	13912	11	medical	medical	JJ
cord-005453-4057qib7	13912	12	procedures	procedure	NNS
cord-005453-4057qib7	13912	13	with	with	IN
cord-005453-4057qib7	13912	14	ease	ease	NN
cord-005453-4057qib7	13912	15	exceeds	exceed	VBZ
cord-005453-4057qib7	13912	16	real	real	JJ
cord-005453-4057qib7	13912	17	capabilities	capability	NNS
cord-005453-4057qib7	13912	18	of	of	IN
cord-005453-4057qib7	13912	19	a	a	DT
cord-005453-4057qib7	13912	20	small	small	JJ
cord-005453-4057qib7	13912	21	child	child	NN
cord-005453-4057qib7	13912	22	.	.	.
cord-005453-4057qib7	13913	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13913	2	:	:	:
cord-005453-4057qib7	13913	3	Nothing	nothing	NN
cord-005453-4057qib7	13913	4	to	to	TO
cord-005453-4057qib7	13913	5	declare	declare	VB
cord-005453-4057qib7	13913	6	.	.	.
cord-005453-4057qib7	13914	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	13914	2	stem	stem	VBP
cord-005453-4057qib7	13914	3	cell	cell	NN
cord-005453-4057qib7	13914	4	transplantation	transplantation	NN
cord-005453-4057qib7	13914	5	in	in	IN
cord-005453-4057qib7	13914	6	patients	patient	NNS
cord-005453-4057qib7	13914	7	with	with	IN
cord-005453-4057qib7	13914	8	mucopolysaccharidosis	mucopolysaccharidosis	NN
cord-005453-4057qib7	13914	9	type	type	NN
cord-005453-4057qib7	13914	10	IIIA	IIIA	NNP
cord-005453-4057qib7	13914	11	(	(	-LRB-
cord-005453-4057qib7	13914	12	Sanfilippo	Sanfilippo	NNP
cord-005453-4057qib7	13914	13	)	)	-RRB-
cord-005453-4057qib7	13915	1	:	:	:
cord-005453-4057qib7	13915	2	A	a	DT
cord-005453-4057qib7	13915	3	case	case	NN
cord-005453-4057qib7	13916	1	series	series	NNP
cord-005453-4057qib7	13916	2	Methods	Methods	NNPS
cord-005453-4057qib7	13917	1	:	:	:
cord-005453-4057qib7	13917	2	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	13917	3	SCT	SCT	NNP
cord-005453-4057qib7	13917	4	was	be	VBD
cord-005453-4057qib7	13917	5	performed	perform	VBN
cord-005453-4057qib7	13917	6	at	at	IN
cord-005453-4057qib7	13917	7	the	the	DT
cord-005453-4057qib7	13917	8	ages	age	NNS
cord-005453-4057qib7	13917	9	of	of	IN
cord-005453-4057qib7	13917	10	2	2	CD
cord-005453-4057qib7	13917	11	,	,	,
cord-005453-4057qib7	13917	12	5	5	CD
cord-005453-4057qib7	13917	13	and	and	CC
cord-005453-4057qib7	13917	14	4	4	CD
cord-005453-4057qib7	13917	15	years	year	NNS
cord-005453-4057qib7	13917	16	,	,	,
cord-005453-4057qib7	13917	17	respectively	respectively	RB
cord-005453-4057qib7	13917	18	.	.	.
cord-005453-4057qib7	13918	1	All	all	DT
cord-005453-4057qib7	13918	2	three	three	CD
cord-005453-4057qib7	13918	3	patients	patient	NNS
cord-005453-4057qib7	13918	4	received	receive	VBD
cord-005453-4057qib7	13918	5	intrathecal	intrathecal	JJ
cord-005453-4057qib7	13918	6	enzyme	enzyme	NN
cord-005453-4057qib7	13918	7	replacement	replacement	NN
cord-005453-4057qib7	13918	8	therapy	therapy	NN
cord-005453-4057qib7	13918	9	within	within	IN
cord-005453-4057qib7	13918	10	a	a	DT
cord-005453-4057qib7	13918	11	clinical	clinical	JJ
cord-005453-4057qib7	13918	12	trial	trial	NN
cord-005453-4057qib7	13918	13	setting	set	VBG
cord-005453-4057qib7	13918	14	prior	prior	RB
cord-005453-4057qib7	13918	15	to	to	IN
cord-005453-4057qib7	13918	16	HSCT	HSCT	NNP
cord-005453-4057qib7	13918	17	.	.	.
cord-005453-4057qib7	13919	1	The	the	DT
cord-005453-4057qib7	13919	2	conditioning	conditioning	NN
cord-005453-4057qib7	13919	3	regimen	regimen	NN
cord-005453-4057qib7	13919	4	consisted	consist	VBD
cord-005453-4057qib7	13919	5	of	of	IN
cord-005453-4057qib7	13919	6	treosulfan	treosulfan	NNP
cord-005453-4057qib7	13919	7	,	,	,
cord-005453-4057qib7	13919	8	fludarabine	fludarabine	NN
cord-005453-4057qib7	13919	9	,	,	,
cord-005453-4057qib7	13919	10	thiotepa	thiotepa	JJ
cord-005453-4057qib7	13919	11	and	and	CC
cord-005453-4057qib7	13919	12	thymoglobuline	thymoglobuline	NNP
cord-005453-4057qib7	13919	13	.	.	.
cord-005453-4057qib7	13920	1	GvHD	gvhd	NN
cord-005453-4057qib7	13920	2	-	-	HYPH
cord-005453-4057qib7	13920	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13920	4	was	be	VBD
cord-005453-4057qib7	13920	5	carried	carry	VBN
cord-005453-4057qib7	13920	6	out	out	RP
cord-005453-4057qib7	13920	7	with	with	IN
cord-005453-4057qib7	13920	8	CSA	CSA	NNP
cord-005453-4057qib7	13920	9	and	and	CC
cord-005453-4057qib7	13920	10	MTX	MTX	NNP
cord-005453-4057qib7	13920	11	in	in	IN
cord-005453-4057qib7	13920	12	two	two	CD
cord-005453-4057qib7	13920	13	patients	patient	NNS
cord-005453-4057qib7	13920	14	and	and	CC
cord-005453-4057qib7	13920	15	CSA	CSA	NNP
cord-005453-4057qib7	13920	16	and	and	CC
cord-005453-4057qib7	13920	17	MMF	MMF	NNP
cord-005453-4057qib7	13920	18	in	in	IN
cord-005453-4057qib7	13920	19	one	one	CD
cord-005453-4057qib7	13920	20	patient	patient	NN
cord-005453-4057qib7	13920	21	.	.	.
cord-005453-4057qib7	13921	1	Stem	stem	JJ
cord-005453-4057qib7	13921	2	cell	cell	NN
cord-005453-4057qib7	13921	3	source	source	NN
cord-005453-4057qib7	13921	4	was	be	VBD
cord-005453-4057qib7	13921	5	bone	bone	NN
cord-005453-4057qib7	13921	6	marrow	marrow	NN
cord-005453-4057qib7	13921	7	in	in	IN
cord-005453-4057qib7	13921	8	two	two	CD
cord-005453-4057qib7	13921	9	patients	patient	NNS
cord-005453-4057qib7	13921	10	and	and	CC
cord-005453-4057qib7	13921	11	peripheral	peripheral	JJ
cord-005453-4057qib7	13921	12	blood	blood	NN
cord-005453-4057qib7	13921	13	stem	stem	NN
cord-005453-4057qib7	13921	14	cells	cell	NNS
cord-005453-4057qib7	13921	15	in	in	IN
cord-005453-4057qib7	13921	16	one	one	CD
cord-005453-4057qib7	13921	17	patient	patient	NN
cord-005453-4057qib7	13921	18	.	.	.
cord-005453-4057qib7	13922	1	Results	result	NNS
cord-005453-4057qib7	13922	2	:	:	:
cord-005453-4057qib7	13923	1	The	the	DT
cord-005453-4057qib7	13923	2	conditioning	conditioning	NN
cord-005453-4057qib7	13923	3	regimen	regimen	NN
cord-005453-4057qib7	13923	4	was	be	VBD
cord-005453-4057qib7	13923	5	well	well	RB
cord-005453-4057qib7	13923	6	tolerated	tolerate	VBN
cord-005453-4057qib7	13923	7	and	and	CC
cord-005453-4057qib7	13923	8	all	all	DT
cord-005453-4057qib7	13923	9	three	three	CD
cord-005453-4057qib7	13923	10	patients	patient	NNS
cord-005453-4057qib7	13923	11	successfully	successfully	RB
cord-005453-4057qib7	13923	12	engrafted	engraft	VBD
cord-005453-4057qib7	13923	13	.	.	.
cord-005453-4057qib7	13924	1	Two	two	CD
cord-005453-4057qib7	13924	2	of	of	IN
cord-005453-4057qib7	13924	3	three	three	CD
cord-005453-4057qib7	13924	4	patients	patient	NNS
cord-005453-4057qib7	13924	5	had	have	VBD
cord-005453-4057qib7	13924	6	an	an	DT
cord-005453-4057qib7	13924	7	uncomplicated	uncomplicated	JJ
cord-005453-4057qib7	13924	8	course	course	NN
cord-005453-4057qib7	13924	9	without	without	IN
cord-005453-4057qib7	13924	10	occurrence	occurrence	NN
cord-005453-4057qib7	13924	11	of	of	IN
cord-005453-4057qib7	13924	12	acute	acute	JJ
cord-005453-4057qib7	13924	13	or	or	CC
cord-005453-4057qib7	13924	14	chronic	chronic	JJ
cord-005453-4057qib7	13924	15	graft	graft	NN
cord-005453-4057qib7	13924	16	-	-	HYPH
cord-005453-4057qib7	13924	17	versus	versus	IN
cord-005453-4057qib7	13924	18	-	-	HYPH
cord-005453-4057qib7	13924	19	host	host	NN
cord-005453-4057qib7	13924	20	-	-	HYPH
cord-005453-4057qib7	13924	21	disease	disease	NN
cord-005453-4057qib7	13924	22	(	(	-LRB-
cord-005453-4057qib7	13924	23	GVHD	GVHD	NNP
cord-005453-4057qib7	13924	24	)	)	-RRB-
cord-005453-4057qib7	13924	25	.	.	.
cord-005453-4057qib7	13925	1	At	at	IN
cord-005453-4057qib7	13925	2	last	last	JJ
cord-005453-4057qib7	13925	3	follow	follow	NN
cord-005453-4057qib7	13925	4	-	-	HYPH
cord-005453-4057qib7	13925	5	up	up	NN
cord-005453-4057qib7	13925	6	12	12	CD
cord-005453-4057qib7	13925	7	and	and	CC
cord-005453-4057qib7	13925	8	15	15	CD
cord-005453-4057qib7	13925	9	months	month	NNS
cord-005453-4057qib7	13925	10	after	after	IN
cord-005453-4057qib7	13925	11	HSCT	HSCT	NNP
cord-005453-4057qib7	13925	12	,	,	,
cord-005453-4057qib7	13925	13	both	both	DT
cord-005453-4057qib7	13925	14	patients	patient	NNS
cord-005453-4057qib7	13925	15	are	be	VBP
cord-005453-4057qib7	13925	16	in	in	IN
cord-005453-4057qib7	13925	17	good	good	JJ
cord-005453-4057qib7	13925	18	condition	condition	NN
cord-005453-4057qib7	13925	19	and	and	CC
cord-005453-4057qib7	13925	20	show	show	VB
cord-005453-4057qib7	13925	21	constant	constant	JJ
cord-005453-4057qib7	13925	22	progress	progress	NN
cord-005453-4057qib7	13925	23	of	of	IN
cord-005453-4057qib7	13925	24	psychomotor	psychomotor	NN
cord-005453-4057qib7	13925	25	development	development	NN
cord-005453-4057qib7	13925	26	.	.	.
cord-005453-4057qib7	13926	1	The	the	DT
cord-005453-4057qib7	13926	2	third	third	JJ
cord-005453-4057qib7	13926	3	patient	patient	NN
cord-005453-4057qib7	13926	4	experienced	experience	VBD
cord-005453-4057qib7	13926	5	severe	severe	JJ
cord-005453-4057qib7	13926	6	steroid	steroid	NN
cord-005453-4057qib7	13926	7	refractory	refractory	JJ
cord-005453-4057qib7	13926	8	acute	acute	JJ
cord-005453-4057qib7	13926	9	GVHD	GVHD	NNP
cord-005453-4057qib7	13926	10	of	of	IN
cord-005453-4057qib7	13926	11	intestines	intestine	NNS
cord-005453-4057qib7	13926	12	(	(	-LRB-
cord-005453-4057qib7	13926	13	stage	stage	NN
cord-005453-4057qib7	13926	14	4	4	CD
cord-005453-4057qib7	13926	15	)	)	-RRB-
cord-005453-4057qib7	13926	16	and	and	CC
cord-005453-4057qib7	13926	17	skin	skin	NN
cord-005453-4057qib7	13926	18	(	(	-LRB-
cord-005453-4057qib7	13926	19	stage	stage	NN
cord-005453-4057qib7	13926	20	3	3	CD
cord-005453-4057qib7	13926	21	)	)	-RRB-
cord-005453-4057qib7	13926	22	,	,	,
cord-005453-4057qib7	13926	23	which	which	WDT
cord-005453-4057qib7	13926	24	resolved	resolve	VBD
cord-005453-4057qib7	13926	25	under	under	IN
cord-005453-4057qib7	13926	26	intensive	intensive	JJ
cord-005453-4057qib7	13926	27	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	13926	28	with	with	IN
cord-005453-4057qib7	13926	29	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	13926	30	,	,	,
cord-005453-4057qib7	13926	31	mycophenolate	mycophenolate	JJ
cord-005453-4057qib7	13926	32	and	and	CC
cord-005453-4057qib7	13926	33	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	13926	34	.	.	.
cord-005453-4057qib7	13927	1	Around	around	IN
cord-005453-4057qib7	13927	2	day	day	NN
cord-005453-4057qib7	13927	3	110	110	CD
cord-005453-4057qib7	13927	4	after	after	IN
cord-005453-4057qib7	13927	5	HSCT	HSCT	NNP
cord-005453-4057qib7	13927	6	,	,	,
cord-005453-4057qib7	13927	7	this	this	DT
cord-005453-4057qib7	13927	8	patient	patient	NN
cord-005453-4057qib7	13927	9	showed	show	VBD
cord-005453-4057qib7	13927	10	clinical	clinical	JJ
cord-005453-4057qib7	13927	11	and	and	CC
cord-005453-4057qib7	13927	12	biochemical	biochemical	JJ
cord-005453-4057qib7	13927	13	signs	sign	NNS
cord-005453-4057qib7	13927	14	of	of	IN
cord-005453-4057qib7	13927	15	transplant	transplant	NN
cord-005453-4057qib7	13927	16	-	-	HYPH
cord-005453-4057qib7	13927	17	associated	associate	VBN
cord-005453-4057qib7	13927	18	microangiopathy	microangiopathy	NN
cord-005453-4057qib7	13927	19	(	(	-LRB-
cord-005453-4057qib7	13927	20	TMA	TMA	NNP
cord-005453-4057qib7	13927	21	)	)	-RRB-
cord-005453-4057qib7	13927	22	with	with	IN
cord-005453-4057qib7	13927	23	cerebral	cerebral	JJ
cord-005453-4057qib7	13927	24	seizures	seizure	NNS
cord-005453-4057qib7	13927	25	and	and	CC
cord-005453-4057qib7	13927	26	acute	acute	JJ
cord-005453-4057qib7	13927	27	renal	renal	JJ
cord-005453-4057qib7	13927	28	failure	failure	NN
cord-005453-4057qib7	13927	29	.	.	.
cord-005453-4057qib7	13928	1	The	the	DT
cord-005453-4057qib7	13928	2	cerebral	cerebral	JJ
cord-005453-4057qib7	13928	3	MRI	MRI	NNP
cord-005453-4057qib7	13928	4	showed	show	VBD
cord-005453-4057qib7	13928	5	progressive	progressive	JJ
cord-005453-4057qib7	13928	6	cerebral	cerebral	JJ
cord-005453-4057qib7	13928	7	atrophy	atrophy	NN
cord-005453-4057qib7	13928	8	and	and	CC
cord-005453-4057qib7	13928	9	leukoencephalopathy	leukoencephalopathy	NNP
cord-005453-4057qib7	13928	10	,	,	,
cord-005453-4057qib7	13928	11	also	also	RB
cord-005453-4057qib7	13928	12	consistent	consistent	JJ
cord-005453-4057qib7	13928	13	with	with	IN
cord-005453-4057qib7	13928	14	a	a	DT
cord-005453-4057qib7	13928	15	progress	progress	NN
cord-005453-4057qib7	13928	16	of	of	IN
cord-005453-4057qib7	13928	17	the	the	DT
cord-005453-4057qib7	13928	18	MPS	MPS	NNP
cord-005453-4057qib7	13928	19	IIIa	iiia	NN
cord-005453-4057qib7	13928	20	.	.	.
cord-005453-4057qib7	13929	1	At	at	IN
cord-005453-4057qib7	13929	2	last	last	JJ
cord-005453-4057qib7	13929	3	follow	follow	NN
cord-005453-4057qib7	13929	4	-	-	HYPH
cord-005453-4057qib7	13929	5	up	up	NN
cord-005453-4057qib7	13929	6	15	15	CD
cord-005453-4057qib7	13929	7	months	month	NNS
cord-005453-4057qib7	13929	8	after	after	IN
cord-005453-4057qib7	13929	9	HSCT	HSCT	NNP
cord-005453-4057qib7	13929	10	,	,	,
cord-005453-4057qib7	13929	11	this	this	DT
cord-005453-4057qib7	13929	12	patient	patient	NN
cord-005453-4057qib7	13929	13	had	have	VBD
cord-005453-4057qib7	13929	14	recovered	recover	VBN
cord-005453-4057qib7	13929	15	from	from	IN
cord-005453-4057qib7	13929	16	TMA	TMA	NNP
cord-005453-4057qib7	13929	17	and	and	CC
cord-005453-4057qib7	13929	18	was	be	VBD
cord-005453-4057qib7	13929	19	in	in	IN
cord-005453-4057qib7	13929	20	a	a	DT
cord-005453-4057qib7	13929	21	stable	stable	JJ
cord-005453-4057qib7	13929	22	clinical	clinical	JJ
cord-005453-4057qib7	13929	23	condition	condition	NN
cord-005453-4057qib7	13929	24	.	.	.
cord-005453-4057qib7	13930	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13930	2	:	:	:
cord-005453-4057qib7	13931	1	In	in	IN
cord-005453-4057qib7	13931	2	consideration	consideration	NN
cord-005453-4057qib7	13931	3	of	of	IN
cord-005453-4057qib7	13931	4	the	the	DT
cord-005453-4057qib7	13931	5	small	small	JJ
cord-005453-4057qib7	13931	6	case	case	NN
cord-005453-4057qib7	13931	7	number	number	NN
cord-005453-4057qib7	13931	8	and	and	CC
cord-005453-4057qib7	13931	9	the	the	DT
cord-005453-4057qib7	13931	10	short	short	JJ
cord-005453-4057qib7	13931	11	follow	follow	NN
cord-005453-4057qib7	13931	12	-	-	HYPH
cord-005453-4057qib7	13931	13	up	up	NN
cord-005453-4057qib7	13931	14	period	period	NN
cord-005453-4057qib7	13931	15	in	in	IN
cord-005453-4057qib7	13931	16	our	-PRON-	PRP$
cord-005453-4057qib7	13931	17	cohort	cohort	NN
cord-005453-4057qib7	13931	18	,	,	,
cord-005453-4057qib7	13931	19	allogeneic	allogeneic	IN
cord-005453-4057qib7	13931	20	HSCT	HSCT	NNP
cord-005453-4057qib7	13931	21	might	may	MD
cord-005453-4057qib7	13931	22	be	be	VB
cord-005453-4057qib7	13931	23	considered	consider	VBN
cord-005453-4057qib7	13931	24	as	as	IN
cord-005453-4057qib7	13931	25	a	a	DT
cord-005453-4057qib7	13931	26	salvage	salvage	NN
cord-005453-4057qib7	13931	27	therapy	therapy	NN
cord-005453-4057qib7	13931	28	for	for	IN
cord-005453-4057qib7	13931	29	patients	patient	NNS
cord-005453-4057qib7	13931	30	with	with	IN
cord-005453-4057qib7	13931	31	MPS	MPS	NNP
cord-005453-4057qib7	13931	32	IIIa	iiia	NN
cord-005453-4057qib7	13931	33	if	if	IN
cord-005453-4057qib7	13931	34	other	other	JJ
cord-005453-4057qib7	13931	35	therapeutic	therapeutic	JJ
cord-005453-4057qib7	13931	36	options	option	NNS
cord-005453-4057qib7	13931	37	are	be	VBP
cord-005453-4057qib7	13931	38	unavailable	unavailable	JJ
cord-005453-4057qib7	13931	39	for	for	IN
cord-005453-4057qib7	13931	40	children	child	NNS
cord-005453-4057qib7	13931	41	with	with	IN
cord-005453-4057qib7	13931	42	this	this	DT
cord-005453-4057qib7	13931	43	otherwise	otherwise	RB
cord-005453-4057qib7	13931	44	unfavourable	unfavourable	JJ
cord-005453-4057qib7	13931	45	prognosis	prognosis	NN
cord-005453-4057qib7	13931	46	.	.	.
cord-005453-4057qib7	13932	1	However	however	RB
cord-005453-4057qib7	13932	2	,	,	,
cord-005453-4057qib7	13932	3	the	the	DT
cord-005453-4057qib7	13932	4	early	early	JJ
cord-005453-4057qib7	13932	5	psychoneurological	psychoneurological	JJ
cord-005453-4057qib7	13932	6	course	course	NN
cord-005453-4057qib7	13932	7	after	after	IN
cord-005453-4057qib7	13932	8	transplant	transplant	NN
cord-005453-4057qib7	13932	9	seems	seem	VBZ
cord-005453-4057qib7	13932	10	promising	promise	VBG
cord-005453-4057qib7	13932	11	compared	compare	VBN
cord-005453-4057qib7	13932	12	to	to	IN
cord-005453-4057qib7	13932	13	the	the	DT
cord-005453-4057qib7	13932	14	literature	literature	NN
cord-005453-4057qib7	13932	15	and	and	CC
cord-005453-4057qib7	13932	16	HSCT	HSCT	NNP
cord-005453-4057qib7	13932	17	could	could	MD
cord-005453-4057qib7	13932	18	become	become	VB
cord-005453-4057qib7	13932	19	a	a	DT
cord-005453-4057qib7	13932	20	treatment	treatment	NN
cord-005453-4057qib7	13932	21	option	option	NN
cord-005453-4057qib7	13932	22	for	for	IN
cord-005453-4057qib7	13932	23	this	this	DT
cord-005453-4057qib7	13932	24	rare	rare	JJ
cord-005453-4057qib7	13932	25	disease	disease	NN
cord-005453-4057qib7	13932	26	.	.	.
cord-005453-4057qib7	13933	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13933	2	:	:	:
cord-005453-4057qib7	13933	3	Nothing	nothing	NN
cord-005453-4057qib7	13933	4	to	to	TO
cord-005453-4057qib7	13933	5	declare	declare	VB
cord-005453-4057qib7	13933	6	Methods	method	NNS
cord-005453-4057qib7	13933	7	:	:	:
cord-005453-4057qib7	13933	8	For	for	IN
cord-005453-4057qib7	13933	9	the	the	DT
cord-005453-4057qib7	13933	10	identification	identification	NN
cord-005453-4057qib7	13933	11	of	of	IN
cord-005453-4057qib7	13933	12	underlying	underlie	VBG
cord-005453-4057qib7	13933	13	molecular	molecular	JJ
cord-005453-4057qib7	13933	14	mechanisms	mechanism	NNS
cord-005453-4057qib7	13933	15	leading	lead	VBG
cord-005453-4057qib7	13933	16	to	to	IN
cord-005453-4057qib7	13933	17	the	the	DT
cord-005453-4057qib7	13933	18	increased	increase	VBN
cord-005453-4057qib7	13933	19	sensibility	sensibility	NN
cord-005453-4057qib7	13933	20	of	of	IN
cord-005453-4057qib7	13933	21	RMS	RMS	NNP
cord-005453-4057qib7	13933	22	cells	cell	NNS
cord-005453-4057qib7	13933	23	,	,	,
cord-005453-4057qib7	13933	24	the	the	DT
cord-005453-4057qib7	13933	25	activation	activation	NN
cord-005453-4057qib7	13933	26	status	status	NN
cord-005453-4057qib7	13933	27	of	of	IN
cord-005453-4057qib7	13933	28	different	different	JJ
cord-005453-4057qib7	13933	29	NF	nf	NN
cord-005453-4057qib7	13933	30	-	-	HYPH
cord-005453-4057qib7	13933	31	kB	kB	NNP
cord-005453-4057qib7	13933	32	signaling	signal	VBG
cord-005453-4057qib7	13933	33	pathways	pathway	NNS
cord-005453-4057qib7	13933	34	were	be	VBD
cord-005453-4057qib7	13933	35	analyzed	analyze	VBN
cord-005453-4057qib7	13933	36	using	use	VBG
cord-005453-4057qib7	13933	37	western	western	JJ
cord-005453-4057qib7	13933	38	blot	blot	NN
cord-005453-4057qib7	13933	39	analysis	analysis	NN
cord-005453-4057qib7	13933	40	and	and	CC
cord-005453-4057qib7	13933	41	quantitative	quantitative	JJ
cord-005453-4057qib7	13933	42	real	real	JJ
cord-005453-4057qib7	13933	43	time	time	NN
cord-005453-4057qib7	13933	44	PCR	PCR	NNP
cord-005453-4057qib7	13933	45	(	(	-LRB-
cord-005453-4057qib7	13933	46	qPCR	qPCR	NNP
cord-005453-4057qib7	13933	47	)	)	-RRB-
cord-005453-4057qib7	13933	48	.	.	.
cord-005453-4057qib7	13934	1	Further	further	RB
cord-005453-4057qib7	13934	2	,	,	,
cord-005453-4057qib7	13934	3	flow	flow	NN
cord-005453-4057qib7	13934	4	cytometry	cytometry	NN
cord-005453-4057qib7	13934	5	was	be	VBD
cord-005453-4057qib7	13934	6	used	use	VBN
cord-005453-4057qib7	13934	7	to	to	TO
cord-005453-4057qib7	13934	8	analyze	analyze	VB
cord-005453-4057qib7	13934	9	the	the	DT
cord-005453-4057qib7	13934	10	surface	surface	NN
cord-005453-4057qib7	13934	11	expression	expression	NN
cord-005453-4057qib7	13934	12	of	of	IN
cord-005453-4057qib7	13934	13	death	death	NN
cord-005453-4057qib7	13934	14	receptors	receptor	NNS
cord-005453-4057qib7	13934	15	on	on	IN
cord-005453-4057qib7	13934	16	either	either	CC
cord-005453-4057qib7	13934	17	SM	SM	NNP
cord-005453-4057qib7	13934	18	treated	treat	VBN
cord-005453-4057qib7	13934	19	or	or	CC
cord-005453-4057qib7	13934	20	untreated	untreated	JJ
cord-005453-4057qib7	13934	21	RMS	RMS	NNP
cord-005453-4057qib7	13934	22	cells	cell	NNS
cord-005453-4057qib7	13934	23	.	.	.
cord-005453-4057qib7	13935	1	The	the	DT
cord-005453-4057qib7	13935	2	overall	overall	JJ
cord-005453-4057qib7	13935	3	effect	effect	NN
cord-005453-4057qib7	13935	4	on	on	IN
cord-005453-4057qib7	13935	5	cell	cell	NN
cord-005453-4057qib7	13935	6	death	death	NN
cord-005453-4057qib7	13935	7	induction	induction	NN
cord-005453-4057qib7	13935	8	was	be	VBD
cord-005453-4057qib7	13935	9	measured	measure	VBN
cord-005453-4057qib7	13935	10	by	by	IN
cord-005453-4057qib7	13935	11	PI	PI	NNP
cord-005453-4057qib7	13935	12	/	/	SYM
cord-005453-4057qib7	13935	13	Hoechst	Hoechst	NNP
cord-005453-4057qib7	13935	14	staining	stain	VBG
cord-005453-4057qib7	13935	15	using	use	VBG
cord-005453-4057qib7	13935	16	a	a	DT
cord-005453-4057qib7	13935	17	fluorescent	fluorescent	JJ
cord-005453-4057qib7	13935	18	microscope	microscope	NN
cord-005453-4057qib7	13935	19	.	.	.
cord-005453-4057qib7	13936	1	Results	result	NNS
cord-005453-4057qib7	13936	2	:	:	:
cord-005453-4057qib7	13937	1	Treatment	treatment	NN
cord-005453-4057qib7	13937	2	with	with	IN
cord-005453-4057qib7	13937	3	SM	SM	NNP
cord-005453-4057qib7	13937	4	led	lead	VBD
cord-005453-4057qib7	13937	5	to	to	IN
cord-005453-4057qib7	13937	6	the	the	DT
cord-005453-4057qib7	13937	7	suspected	suspect	VBN
cord-005453-4057qib7	13937	8	degradation	degradation	NN
cord-005453-4057qib7	13937	9	of	of	IN
cord-005453-4057qib7	13937	10	IAPs	IAPs	NNP
cord-005453-4057qib7	13937	11	.	.	.
cord-005453-4057qib7	13938	1	Followed	follow	VBN
cord-005453-4057qib7	13938	2	by	by	IN
cord-005453-4057qib7	13938	3	the	the	DT
cord-005453-4057qib7	13938	4	activation	activation	NN
cord-005453-4057qib7	13938	5	of	of	IN
cord-005453-4057qib7	13938	6	both	both	CC
cord-005453-4057qib7	13938	7	the	the	DT
cord-005453-4057qib7	13938	8	canonical	canonical	JJ
cord-005453-4057qib7	13938	9	NF	nf	NN
cord-005453-4057qib7	13938	10	-	-	HYPH
cord-005453-4057qib7	13938	11	κB	κB	NNP
cord-005453-4057qib7	13938	12	signaling	signal	VBG
cord-005453-4057qib7	13938	13	pathway	pathway	NN
cord-005453-4057qib7	13938	14	,	,	,
cord-005453-4057qib7	13938	15	indicated	indicate	VBN
cord-005453-4057qib7	13938	16	by	by	IN
cord-005453-4057qib7	13938	17	the	the	DT
cord-005453-4057qib7	13938	18	phosphorylation	phosphorylation	NN
cord-005453-4057qib7	13938	19	of	of	IN
cord-005453-4057qib7	13938	20	IκBα	IκBα	NNP
cord-005453-4057qib7	13938	21	and	and	CC
cord-005453-4057qib7	13938	22	p65	p65	ADD
cord-005453-4057qib7	13938	23	,	,	,
cord-005453-4057qib7	13938	24	and	and	CC
cord-005453-4057qib7	13938	25	the	the	DT
cord-005453-4057qib7	13938	26	non	non	JJ
cord-005453-4057qib7	13938	27	-	-	JJ
cord-005453-4057qib7	13938	28	canonical	canonical	JJ
cord-005453-4057qib7	13938	29	NF	nf	NN
cord-005453-4057qib7	13938	30	-	-	HYPH
cord-005453-4057qib7	13938	31	κB	κB	NNP
cord-005453-4057qib7	13938	32	signaling	signal	VBG
cord-005453-4057qib7	13938	33	pathway	pathway	NN
cord-005453-4057qib7	13938	34	,	,	,
cord-005453-4057qib7	13938	35	as	as	IN
cord-005453-4057qib7	13938	36	indicated	indicate	VBN
cord-005453-4057qib7	13938	37	by	by	IN
cord-005453-4057qib7	13938	38	the	the	DT
cord-005453-4057qib7	13938	39	accumulation	accumulation	NN
cord-005453-4057qib7	13938	40	of	of	IN
cord-005453-4057qib7	13938	41	NIK	NIK	NNP
cord-005453-4057qib7	13938	42	and	and	CC
cord-005453-4057qib7	13938	43	the	the	DT
cord-005453-4057qib7	13938	44	degradation	degradation	NN
cord-005453-4057qib7	13938	45	of	of	IN
cord-005453-4057qib7	13938	46	p100	p100	NNP
cord-005453-4057qib7	13938	47	to	to	IN
cord-005453-4057qib7	13938	48	p52	p52	NNP
cord-005453-4057qib7	13938	49	.	.	.
cord-005453-4057qib7	13939	1	Determination	determination	NN
cord-005453-4057qib7	13939	2	of	of	IN
cord-005453-4057qib7	13939	3	selected	select	VBN
cord-005453-4057qib7	13939	4	target	target	NN
cord-005453-4057qib7	13939	5	gene	gene	NN
cord-005453-4057qib7	13939	6	transcription	transcription	NN
cord-005453-4057qib7	13939	7	revealed	reveal	VBD
cord-005453-4057qib7	13939	8	an	an	DT
cord-005453-4057qib7	13939	9	upregulation	upregulation	NN
cord-005453-4057qib7	13939	10	of	of	IN
cord-005453-4057qib7	13939	11	the	the	DT
cord-005453-4057qib7	13939	12	inhibitor	inhibitor	NN
cord-005453-4057qib7	13939	13	IκBα	IκBα	NNP
cord-005453-4057qib7	13939	14	,	,	,
cord-005453-4057qib7	13939	15	NIK	NIK	NNP
cord-005453-4057qib7	13939	16	,	,	,
cord-005453-4057qib7	13939	17	p100	p100	NNP
cord-005453-4057qib7	13939	18	,	,	,
cord-005453-4057qib7	13939	19	IL-8	IL-8	NNP
cord-005453-4057qib7	13939	20	and	and	CC
cord-005453-4057qib7	13939	21	at	at	IN
cord-005453-4057qib7	13939	22	later	later	JJ
cord-005453-4057qib7	13939	23	time	time	NN
cord-005453-4057qib7	13939	24	points	point	VBZ
cord-005453-4057qib7	13939	25	the	the	DT
cord-005453-4057qib7	13939	26	death	death	NN
cord-005453-4057qib7	13939	27	receptors	receptor	NNS
cord-005453-4057qib7	13939	28	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13939	29	-	-	HYPH
cord-005453-4057qib7	13939	30	R1	R1	NNP
cord-005453-4057qib7	13939	31	and	and	CC
cord-005453-4057qib7	13939	32	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13939	33	-	-	HYPH
cord-005453-4057qib7	13939	34	R2	R2	NNP
cord-005453-4057qib7	13939	35	.	.	.
cord-005453-4057qib7	13940	1	Analysis	analysis	NN
cord-005453-4057qib7	13940	2	of	of	IN
cord-005453-4057qib7	13940	3	gene	gene	NN
cord-005453-4057qib7	13940	4	transcription	transcription	NN
cord-005453-4057qib7	13940	5	also	also	RB
cord-005453-4057qib7	13940	6	led	lead	VBD
cord-005453-4057qib7	13940	7	to	to	IN
cord-005453-4057qib7	13940	8	the	the	DT
cord-005453-4057qib7	13940	9	finding	finding	NN
cord-005453-4057qib7	13940	10	of	of	IN
cord-005453-4057qib7	13940	11	neither	neither	DT
cord-005453-4057qib7	13940	12	up	up	RB
cord-005453-4057qib7	13940	13	-	-	HYPH
cord-005453-4057qib7	13940	14	nor	nor	CC
cord-005453-4057qib7	13940	15	downregulation	downregulation	NN
cord-005453-4057qib7	13940	16	of	of	IN
cord-005453-4057qib7	13940	17	cIAP1	ciap1	NN
cord-005453-4057qib7	13940	18	and	and	CC
cord-005453-4057qib7	13940	19	p65	p65	ADD
cord-005453-4057qib7	13940	20	.	.	.
cord-005453-4057qib7	13941	1	To	to	TO
cord-005453-4057qib7	13941	2	evaluate	evaluate	VB
cord-005453-4057qib7	13941	3	the	the	DT
cord-005453-4057qib7	13941	4	involvement	involvement	NN
cord-005453-4057qib7	13941	5	of	of	IN
cord-005453-4057qib7	13941	6	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13941	7	-	-	HYPH
cord-005453-4057qib7	13941	8	R1	R1	NNP
cord-005453-4057qib7	13941	9	and	and	CC
cord-005453-4057qib7	13941	10	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13941	11	-	-	HYPH
cord-005453-4057qib7	13941	12	R2	R2	NNP
cord-005453-4057qib7	13941	13	in	in	IN
cord-005453-4057qib7	13941	14	the	the	DT
cord-005453-4057qib7	13941	15	SM	sm	NN
cord-005453-4057qib7	13941	16	induced	induce	VBN
cord-005453-4057qib7	13941	17	sensitization	sensitization	NN
cord-005453-4057qib7	13941	18	towards	towards	IN
cord-005453-4057qib7	13941	19	NK	NK	NNP
cord-005453-4057qib7	13941	20	cell	cell	NN
cord-005453-4057qib7	13941	21	-	-	HYPH
cord-005453-4057qib7	13941	22	mediated	mediate	VBN
cord-005453-4057qib7	13941	23	killing	killing	NN
cord-005453-4057qib7	13941	24	,	,	,
cord-005453-4057qib7	13941	25	surface	surface	NN
cord-005453-4057qib7	13941	26	expression	expression	NN
cord-005453-4057qib7	13941	27	of	of	IN
cord-005453-4057qib7	13941	28	both	both	DT
cord-005453-4057qib7	13941	29	death	death	NN
cord-005453-4057qib7	13941	30	receptors	receptor	NNS
cord-005453-4057qib7	13941	31	was	be	VBD
cord-005453-4057qib7	13941	32	analyzed	analyze	VBN
cord-005453-4057qib7	13941	33	.	.	.
cord-005453-4057qib7	13942	1	Treatment	treatment	NN
cord-005453-4057qib7	13942	2	with	with	IN
cord-005453-4057qib7	13942	3	SM	sm	NN
cord-005453-4057qib7	13942	4	led	lead	VBD
cord-005453-4057qib7	13942	5	not	not	RB
cord-005453-4057qib7	13942	6	only	only	RB
cord-005453-4057qib7	13942	7	to	to	IN
cord-005453-4057qib7	13942	8	an	an	DT
cord-005453-4057qib7	13942	9	induced	induce	VBN
cord-005453-4057qib7	13942	10	transcription	transcription	NN
cord-005453-4057qib7	13942	11	of	of	IN
cord-005453-4057qib7	13942	12	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13942	13	-	-	HYPH
cord-005453-4057qib7	13942	14	R1	R1	NNP
cord-005453-4057qib7	13942	15	and	and	CC
cord-005453-4057qib7	13942	16	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13942	17	-	-	HYPH
cord-005453-4057qib7	13942	18	R2	R2	NNP
cord-005453-4057qib7	13942	19	,	,	,
cord-005453-4057qib7	13942	20	but	but	CC
cord-005453-4057qib7	13942	21	also	also	RB
cord-005453-4057qib7	13942	22	to	to	IN
cord-005453-4057qib7	13942	23	an	an	DT
cord-005453-4057qib7	13942	24	increased	increase	VBN
cord-005453-4057qib7	13942	25	surface	surface	NN
cord-005453-4057qib7	13942	26	presentation	presentation	NN
cord-005453-4057qib7	13942	27	of	of	IN
cord-005453-4057qib7	13942	28	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13942	29	-	-	HYPH
cord-005453-4057qib7	13942	30	R2	R2	NNP
cord-005453-4057qib7	13942	31	.	.	.
cord-005453-4057qib7	13943	1	Subsequent	subsequent	JJ
cord-005453-4057qib7	13943	2	ligation	ligation	NN
cord-005453-4057qib7	13943	3	of	of	IN
cord-005453-4057qib7	13943	4	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13943	5	-	-	HYPH
cord-005453-4057qib7	13943	6	R2	R2	NNP
cord-005453-4057qib7	13943	7	by	by	IN
cord-005453-4057qib7	13943	8	either	either	CC
cord-005453-4057qib7	13943	9	wt	wt	NN
cord-005453-4057qib7	13943	10	-	-	HYPH
cord-005453-4057qib7	13943	11	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13943	12	or	or	CC
cord-005453-4057qib7	13943	13	a	a	DT
cord-005453-4057qib7	13943	14	specific	specific	JJ
cord-005453-4057qib7	13943	15	agonistic	agonistic	JJ
cord-005453-4057qib7	13943	16	antibody	antibody	NN
cord-005453-4057qib7	13943	17	(	(	-LRB-
cord-005453-4057qib7	13943	18	ETR-2	ETR-2	NNP
cord-005453-4057qib7	13943	19	)	)	-RRB-
cord-005453-4057qib7	13943	20	resulted	result	VBD
cord-005453-4057qib7	13943	21	in	in	IN
cord-005453-4057qib7	13943	22	a	a	DT
cord-005453-4057qib7	13943	23	significant	significant	JJ
cord-005453-4057qib7	13943	24	increase	increase	NN
cord-005453-4057qib7	13943	25	in	in	IN
cord-005453-4057qib7	13943	26	cell	cell	NN
cord-005453-4057qib7	13943	27	death	death	NN
cord-005453-4057qib7	13943	28	induction	induction	NN
cord-005453-4057qib7	13943	29	.	.	.
cord-005453-4057qib7	13944	1	The	the	DT
cord-005453-4057qib7	13944	2	aforementioned	aforementioned	JJ
cord-005453-4057qib7	13944	3	analysis	analysis	NN
cord-005453-4057qib7	13944	4	of	of	IN
cord-005453-4057qib7	13944	5	gene	gene	NN
cord-005453-4057qib7	13944	6	transcription	transcription	NN
cord-005453-4057qib7	13944	7	hints	hint	NNS
cord-005453-4057qib7	13944	8	towards	towards	IN
cord-005453-4057qib7	13944	9	a	a	DT
cord-005453-4057qib7	13944	10	bimodal	bimodal	JJ
cord-005453-4057qib7	13944	11	feedback	feedback	NN
cord-005453-4057qib7	13944	12	mechanism	mechanism	NN
cord-005453-4057qib7	13944	13	regulating	regulate	VBG
cord-005453-4057qib7	13944	14	both	both	DT
cord-005453-4057qib7	13944	15	,	,	,
cord-005453-4057qib7	13944	16	the	the	DT
cord-005453-4057qib7	13944	17	canonical	canonical	JJ
cord-005453-4057qib7	13944	18	and	and	CC
cord-005453-4057qib7	13944	19	non	non	JJ
cord-005453-4057qib7	13944	20	-	-	JJ
cord-005453-4057qib7	13944	21	canonical	canonical	JJ
cord-005453-4057qib7	13944	22	NF	nf	NN
cord-005453-4057qib7	13944	23	-	-	HYPH
cord-005453-4057qib7	13944	24	κB	κB	NNP
cord-005453-4057qib7	13944	25	signaling	signal	VBG
cord-005453-4057qib7	13944	26	pathway	pathway	NN
cord-005453-4057qib7	13944	27	.	.	.
cord-005453-4057qib7	13945	1	On	on	IN
cord-005453-4057qib7	13945	2	the	the	DT
cord-005453-4057qib7	13945	3	one	one	CD
cord-005453-4057qib7	13945	4	side	side	NN
cord-005453-4057qib7	13945	5	,	,	,
cord-005453-4057qib7	13945	6	the	the	DT
cord-005453-4057qib7	13945	7	canonical	canonical	JJ
cord-005453-4057qib7	13945	8	pathway	pathway	NN
cord-005453-4057qib7	13945	9	is	be	VBZ
cord-005453-4057qib7	13945	10	negatively	negatively	RB
cord-005453-4057qib7	13945	11	regulated	regulate	VBN
cord-005453-4057qib7	13945	12	by	by	IN
cord-005453-4057qib7	13945	13	the	the	DT
cord-005453-4057qib7	13945	14	induced	induce	VBN
cord-005453-4057qib7	13945	15	transcription	transcription	NN
cord-005453-4057qib7	13945	16	of	of	IN
cord-005453-4057qib7	13945	17	the	the	DT
cord-005453-4057qib7	13945	18	inhibitor	inhibitor	NN
cord-005453-4057qib7	13945	19	IκBα	IκBα	NNP
cord-005453-4057qib7	13945	20	.	.	.
cord-005453-4057qib7	13946	1	On	on	IN
cord-005453-4057qib7	13946	2	the	the	DT
cord-005453-4057qib7	13946	3	other	other	JJ
cord-005453-4057qib7	13946	4	side	side	NN
cord-005453-4057qib7	13946	5	,	,	,
cord-005453-4057qib7	13946	6	the	the	DT
cord-005453-4057qib7	13946	7	induced	induce	VBN
cord-005453-4057qib7	13946	8	transcription	transcription	NN
cord-005453-4057qib7	13946	9	of	of	IN
cord-005453-4057qib7	13946	10	NIK	NIK	NNP
cord-005453-4057qib7	13946	11	,	,	,
cord-005453-4057qib7	13946	12	p100	p100	NNP
cord-005453-4057qib7	13946	13	and	and	CC
cord-005453-4057qib7	13946	14	RelB	RelB	NNP
cord-005453-4057qib7	13946	15	points	point	NNS
cord-005453-4057qib7	13946	16	towards	towards	IN
cord-005453-4057qib7	13946	17	a	a	DT
cord-005453-4057qib7	13946	18	positive	positive	JJ
cord-005453-4057qib7	13946	19	feedback	feedback	NN
cord-005453-4057qib7	13946	20	loop	loop	NN
cord-005453-4057qib7	13946	21	of	of	IN
cord-005453-4057qib7	13946	22	the	the	DT
cord-005453-4057qib7	13946	23	non	non	JJ
cord-005453-4057qib7	13946	24	-	-	JJ
cord-005453-4057qib7	13946	25	canonical	canonical	JJ
cord-005453-4057qib7	13946	26	pathway	pathway	NN
cord-005453-4057qib7	13946	27	.	.	.
cord-005453-4057qib7	13947	1	One	one	CD
cord-005453-4057qib7	13947	2	mechanism	mechanism	NN
cord-005453-4057qib7	13947	3	of	of	IN
cord-005453-4057qib7	13947	4	the	the	DT
cord-005453-4057qib7	13947	5	increased	increase	VBN
cord-005453-4057qib7	13947	6	RMS	rms	NN
cord-005453-4057qib7	13947	7	cell	cell	NN
cord-005453-4057qib7	13947	8	sensitivity	sensitivity	NN
cord-005453-4057qib7	13947	9	might	may	MD
cord-005453-4057qib7	13947	10	be	be	VB
cord-005453-4057qib7	13947	11	the	the	DT
cord-005453-4057qib7	13947	12	induced	induce	VBN
cord-005453-4057qib7	13947	13	transcription	transcription	NN
cord-005453-4057qib7	13947	14	and	and	CC
cord-005453-4057qib7	13947	15	surface	surface	NN
cord-005453-4057qib7	13947	16	presentation	presentation	NN
cord-005453-4057qib7	13947	17	of	of	IN
cord-005453-4057qib7	13947	18	the	the	DT
cord-005453-4057qib7	13947	19	death	death	NN
cord-005453-4057qib7	13947	20	receptor	receptor	NN
cord-005453-4057qib7	13947	21	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13947	22	-	-	HYPH
cord-005453-4057qib7	13947	23	R2	R2	NNP
cord-005453-4057qib7	13947	24	.	.	.
cord-005453-4057qib7	13948	1	The	the	DT
cord-005453-4057qib7	13948	2	involvement	involvement	NN
cord-005453-4057qib7	13948	3	of	of	IN
cord-005453-4057qib7	13948	4	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13948	5	receptors	receptor	NNS
cord-005453-4057qib7	13948	6	is	be	VBZ
cord-005453-4057qib7	13948	7	further	further	RB
cord-005453-4057qib7	13948	8	validated	validate	VBN
cord-005453-4057qib7	13948	9	by	by	IN
cord-005453-4057qib7	13948	10	the	the	DT
cord-005453-4057qib7	13948	11	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	13948	12	data	datum	NNS
cord-005453-4057qib7	13948	13	,	,	,
cord-005453-4057qib7	13948	14	illustrating	illustrate	VBG
cord-005453-4057qib7	13948	15	a	a	DT
cord-005453-4057qib7	13948	16	SM	sm	NN
cord-005453-4057qib7	13948	17	mediated	mediate	VBN
cord-005453-4057qib7	13948	18	sensitization	sensitization	NN
cord-005453-4057qib7	13948	19	towards	towards	IN
cord-005453-4057qib7	13948	20	a	a	DT
cord-005453-4057qib7	13948	21	TRAIL	trail	NN
cord-005453-4057qib7	13948	22	induced	induce	VBN
cord-005453-4057qib7	13948	23	cell	cell	NN
cord-005453-4057qib7	13948	24	death	death	NN
cord-005453-4057qib7	13948	25	induction	induction	NN
cord-005453-4057qib7	13948	26	.	.	.
cord-005453-4057qib7	13949	1	This	this	DT
cord-005453-4057qib7	13949	2	mode	mode	NN
cord-005453-4057qib7	13949	3	of	of	IN
cord-005453-4057qib7	13949	4	cell	cell	NN
cord-005453-4057qib7	13949	5	death	death	NN
cord-005453-4057qib7	13949	6	fits	fit	VBZ
cord-005453-4057qib7	13949	7	to	to	IN
cord-005453-4057qib7	13949	8	the	the	DT
cord-005453-4057qib7	13949	9	previous	previous	JJ
cord-005453-4057qib7	13949	10	research	research	NN
cord-005453-4057qib7	13949	11	,	,	,
cord-005453-4057qib7	13949	12	were	be	VBD
cord-005453-4057qib7	13950	1	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13950	2	transcription	transcription	NN
cord-005453-4057qib7	13950	3	could	could	MD
cord-005453-4057qib7	13950	4	be	be	VB
cord-005453-4057qib7	13950	5	induced	induce	VBN
cord-005453-4057qib7	13950	6	in	in	IN
cord-005453-4057qib7	13950	7	NK	NK	NNP
cord-005453-4057qib7	13950	8	cells	cell	NNS
cord-005453-4057qib7	13950	9	by	by	IN
cord-005453-4057qib7	13950	10	SM	sm	NN
cord-005453-4057qib7	13950	11	treatment	treatment	NN
cord-005453-4057qib7	13950	12	.	.	.
cord-005453-4057qib7	13951	1	The	the	DT
cord-005453-4057qib7	13951	2	graphical	graphical	JJ
cord-005453-4057qib7	13951	3	abstract	abstract	NN
cord-005453-4057qib7	13951	4	shows	show	VBZ
cord-005453-4057qib7	13951	5	the	the	DT
cord-005453-4057qib7	13951	6	transcriptional	transcriptional	JJ
cord-005453-4057qib7	13951	7	upregulation	upregulation	NN
cord-005453-4057qib7	13951	8	of	of	IN
cord-005453-4057qib7	13951	9	target	target	NN
cord-005453-4057qib7	13951	10	genes	gene	NNS
cord-005453-4057qib7	13951	11	leading	lead	VBG
cord-005453-4057qib7	13951	12	to	to	IN
cord-005453-4057qib7	13951	13	a	a	DT
cord-005453-4057qib7	13951	14	putative	putative	JJ
cord-005453-4057qib7	13951	15	bimodal	bimodal	JJ
cord-005453-4057qib7	13951	16	NF	nf	NN
cord-005453-4057qib7	13951	17	-	-	HYPH
cord-005453-4057qib7	13951	18	kB	kb	CD
cord-005453-4057qib7	13951	19	regulation	regulation	NN
cord-005453-4057qib7	13951	20	and	and	CC
cord-005453-4057qib7	13951	21	increased	increase	VBN
cord-005453-4057qib7	13951	22	surface	surface	NN
cord-005453-4057qib7	13951	23	presentation	presentation	NN
cord-005453-4057qib7	13951	24	of	of	IN
cord-005453-4057qib7	13951	25	TRAIL	TRAIL	NNP
cord-005453-4057qib7	13951	26	-	-	HYPH
cord-005453-4057qib7	13951	27	R2	R2	NNP
cord-005453-4057qib7	13951	28	by	by	IN
cord-005453-4057qib7	13951	29	treatment	treatment	NN
cord-005453-4057qib7	13951	30	with	with	IN
cord-005453-4057qib7	13951	31	Smac	Smac	NNP
cord-005453-4057qib7	13951	32	mimetics	mimetic	NNS
cord-005453-4057qib7	13951	33	.	.	.
cord-005453-4057qib7	13952	1	Aim	aim	VB
cord-005453-4057qib7	13952	2	:	:	:
cord-005453-4057qib7	13952	3	To	to	TO
cord-005453-4057qib7	13952	4	investigate	investigate	VB
cord-005453-4057qib7	13952	5	the	the	DT
cord-005453-4057qib7	13952	6	outcome	outcome	NN
cord-005453-4057qib7	13952	7	of	of	IN
cord-005453-4057qib7	13952	8	UCB	UCB	NNP
cord-005453-4057qib7	13952	9	transplantation	transplantation	NN
cord-005453-4057qib7	13952	10	in	in	IN
cord-005453-4057qib7	13952	11	pediatric	pediatric	JJ
cord-005453-4057qib7	13952	12	patients	patient	NNS
cord-005453-4057qib7	13952	13	with	with	IN
cord-005453-4057qib7	13952	14	malignant	malignant	JJ
cord-005453-4057qib7	13952	15	and	and	CC
cord-005453-4057qib7	13952	16	non	non	JJ
cord-005453-4057qib7	13952	17	malignant	malignant	JJ
cord-005453-4057qib7	13952	18	diseases	disease	NNS
cord-005453-4057qib7	13952	19	Methods	method	NNS
cord-005453-4057qib7	13952	20	:	:	:
cord-005453-4057qib7	13952	21	Data	datum	NNS
cord-005453-4057qib7	13952	22	from	from	IN
cord-005453-4057qib7	13952	23	30	30	CD
cord-005453-4057qib7	13952	24	patients	patient	NNS
cord-005453-4057qib7	13952	25	underwent	undergo	VBD
cord-005453-4057qib7	13952	26	first	first	JJ
cord-005453-4057qib7	13952	27	allogeneic	allogeneic	IN
cord-005453-4057qib7	13952	28	bone	bone	NN
cord-005453-4057qib7	13952	29	marrow	marrow	NN
cord-005453-4057qib7	13952	30	transplantation	transplantation	NN
cord-005453-4057qib7	13952	31	with	with	IN
cord-005453-4057qib7	13952	32	UCB	UCB	NNP
cord-005453-4057qib7	13952	33	from	from	IN
cord-005453-4057qib7	13952	34	2/1999	2/1999	CD
cord-005453-4057qib7	13952	35	until	until	IN
cord-005453-4057qib7	13952	36	6/2013	6/2013	CD
cord-005453-4057qib7	13952	37	were	be	VBD
cord-005453-4057qib7	13952	38	retrospectively	retrospectively	RB
cord-005453-4057qib7	13952	39	analyzed	analyze	VBN
cord-005453-4057qib7	13952	40	.	.	.
cord-005453-4057qib7	13953	1	Eighteen	eighteen	CD
cord-005453-4057qib7	13953	2	had	have	VBD
cord-005453-4057qib7	13953	3	malignant	malignant	JJ
cord-005453-4057qib7	13953	4	disease	disease	NN
cord-005453-4057qib7	13953	5	(	(	-LRB-
cord-005453-4057qib7	13953	6	MD	MD	NNP
cord-005453-4057qib7	13953	7	)	)	-RRB-
cord-005453-4057qib7	13953	8	,	,	,
cord-005453-4057qib7	13953	9	of	of	IN
cord-005453-4057qib7	13953	10	whom	whom	WP
cord-005453-4057qib7	13953	11	15	15	CD
cord-005453-4057qib7	13953	12	in	in	IN
cord-005453-4057qib7	13953	13	complete	complete	JJ
cord-005453-4057qib7	13953	14	hematologic	hematologic	JJ
cord-005453-4057qib7	13953	15	response	response	NN
cord-005453-4057qib7	13953	16	,	,	,
cord-005453-4057qib7	13953	17	and	and	CC
cord-005453-4057qib7	13953	18	12	12	CD
cord-005453-4057qib7	13953	19	non	non	JJ
cord-005453-4057qib7	13953	20	malignant	malignant	JJ
cord-005453-4057qib7	13953	21	disease	disease	NN
cord-005453-4057qib7	13953	22	(	(	-LRB-
cord-005453-4057qib7	13953	23	NMD	NMD	NNP
cord-005453-4057qib7	13953	24	)	)	-RRB-
cord-005453-4057qib7	13953	25	(	(	-LRB-
cord-005453-4057qib7	13953	26	SCID	SCID	NNP
cord-005453-4057qib7	13953	27	5	5	CD
cord-005453-4057qib7	13953	28	,	,	,
cord-005453-4057qib7	13953	29	chronic	chronic	JJ
cord-005453-4057qib7	13953	30	granulomatous	granulomatous	JJ
cord-005453-4057qib7	13953	31	disease	disease	NN
cord-005453-4057qib7	13953	32	1	1	CD
cord-005453-4057qib7	13953	33	,	,	,
cord-005453-4057qib7	13953	34	severe	severe	JJ
cord-005453-4057qib7	13953	35	aplastic	aplastic	JJ
cord-005453-4057qib7	13953	36	anemia	anemia	NN
cord-005453-4057qib7	13953	37	2	2	CD
cord-005453-4057qib7	13953	38	,	,	,
cord-005453-4057qib7	13953	39	s.	s.	NNP
cord-005453-4057qib7	13954	1	Kostmann	Kostmann	NNP
cord-005453-4057qib7	13954	2	1	1	CD
cord-005453-4057qib7	13954	3	,	,	,
cord-005453-4057qib7	13954	4	osteopetrosis	osteopetrosis	NN
cord-005453-4057qib7	13954	5	1	1	CD
cord-005453-4057qib7	13954	6	,	,	,
cord-005453-4057qib7	13954	7	Wiskott	Wiskott	NNP
cord-005453-4057qib7	13954	8	-	-	HYPH
cord-005453-4057qib7	13954	9	Aldrich1	Aldrich1	NNP
cord-005453-4057qib7	13954	10	,	,	,
cord-005453-4057qib7	13954	11	amegakaryocytic	amegakaryocytic	JJ
cord-005453-4057qib7	13954	12	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	13954	13	1	1	CD
cord-005453-4057qib7	13954	14	)	)	-RRB-
cord-005453-4057qib7	13954	15	.	.	.
cord-005453-4057qib7	13955	1	The	the	DT
cord-005453-4057qib7	13955	2	majority	majority	NN
cord-005453-4057qib7	13955	3	of	of	IN
cord-005453-4057qib7	13955	4	the	the	DT
cord-005453-4057qib7	13955	5	patients	patient	NNS
cord-005453-4057qib7	13955	6	were	be	VBD
cord-005453-4057qib7	13955	7	male	male	JJ
cord-005453-4057qib7	13955	8	,	,	,
cord-005453-4057qib7	13955	9	for	for	IN
cord-005453-4057qib7	13955	10	MD	MD	NNP
cord-005453-4057qib7	13955	11	and	and	CC
cord-005453-4057qib7	13955	12	NMD	NMD	NNP
cord-005453-4057qib7	13955	13	,	,	,
cord-005453-4057qib7	13955	14	as	as	RB
cord-005453-4057qib7	13955	15	well	well	RB
cord-005453-4057qib7	13955	16	(	(	-LRB-
cord-005453-4057qib7	13955	17	M:10	M:10	NNP
cord-005453-4057qib7	13955	18	/	/	SYM
cord-005453-4057qib7	13955	19	F:8	F:8	NNP
cord-005453-4057qib7	13955	20	,	,	,
cord-005453-4057qib7	13955	21	M:8	M:8	NNP
cord-005453-4057qib7	13955	22	/	/	SYM
cord-005453-4057qib7	13955	23	F:4	F:4	NNP
cord-005453-4057qib7	13955	24	,	,	,
cord-005453-4057qib7	13955	25	respectively	respectively	RB
cord-005453-4057qib7	13955	26	)	)	-RRB-
cord-005453-4057qib7	13955	27	,	,	,
cord-005453-4057qib7	13955	28	of	of	IN
cord-005453-4057qib7	13955	29	median	median	JJ
cord-005453-4057qib7	13955	30	age	age	NN
cord-005453-4057qib7	13955	31	6.5	6.5	CD
cord-005453-4057qib7	13955	32	years	year	NNS
cord-005453-4057qib7	13955	33	(	(	-LRB-
cord-005453-4057qib7	13955	34	range	range	VBP
cord-005453-4057qib7	13955	35	0.8	0.8	CD
cord-005453-4057qib7	13955	36	-	-	HYPH
cord-005453-4057qib7	13955	37	11.8	11.8	CD
cord-005453-4057qib7	13955	38	years	year	NNS
cord-005453-4057qib7	13955	39	)	)	-RRB-
cord-005453-4057qib7	13955	40	and	and	CC
cord-005453-4057qib7	13955	41	0.8	0.8	CD
cord-005453-4057qib7	13955	42	years	year	NNS
cord-005453-4057qib7	13955	43	(	(	-LRB-
cord-005453-4057qib7	13955	44	range	range	VBP
cord-005453-4057qib7	13955	45	0.4	0.4	CD
cord-005453-4057qib7	13955	46	-	-	SYM
cord-005453-4057qib7	13955	47	6.5	6.5	CD
cord-005453-4057qib7	13955	48	years	year	NNS
cord-005453-4057qib7	13955	49	)	)	-RRB-
cord-005453-4057qib7	13955	50	,	,	.
cord-005453-4057qib7	13956	1	respectively	respectively	RB
cord-005453-4057qib7	13956	2	Results	result	VBZ
cord-005453-4057qib7	13956	3	:	:	:
cord-005453-4057qib7	13957	1	All	all	DT
cord-005453-4057qib7	13957	2	patients	patient	NNS
cord-005453-4057qib7	13957	3	but	but	CC
cord-005453-4057qib7	13957	4	one	one	CD
cord-005453-4057qib7	13957	5	,	,	,
cord-005453-4057qib7	13957	6	received	receive	VBD
cord-005453-4057qib7	13957	7	1	1	CD
cord-005453-4057qib7	13957	8	UCB	UCB	NNP
cord-005453-4057qib7	13957	9	unit	unit	NN
cord-005453-4057qib7	13957	10	.	.	.
cord-005453-4057qib7	13958	1	HLA	HLA	NNP
cord-005453-4057qib7	13958	2	compatibility	compatibility	NN
cord-005453-4057qib7	13958	3	in	in	IN
cord-005453-4057qib7	13958	4	antigen	antigen	NN
cord-005453-4057qib7	13958	5	/	/	SYM
cord-005453-4057qib7	13958	6	allele	allele	NN
cord-005453-4057qib7	13958	7	level	level	NN
cord-005453-4057qib7	13958	8	was	be	VBD
cord-005453-4057qib7	13958	9	at	at	IN
cord-005453-4057qib7	13958	10	least	least	JJS
cord-005453-4057qib7	13958	11	5/6	5/6	CD
cord-005453-4057qib7	13958	12	and	and	CC
cord-005453-4057qib7	13958	13	only	only	RB
cord-005453-4057qib7	13958	14	in	in	IN
cord-005453-4057qib7	13958	15	3	3	CD
cord-005453-4057qib7	13958	16	patients	patient	NNS
cord-005453-4057qib7	13958	17	with	with	IN
cord-005453-4057qib7	13958	18	MD	MD	NNP
cord-005453-4057qib7	13958	19	was	be	VBD
cord-005453-4057qib7	13958	20	4/6	4/6	CD
cord-005453-4057qib7	13958	21	.	.	.
cord-005453-4057qib7	13959	1	Conditioning	conditioning	NN
cord-005453-4057qib7	13959	2	regimens	regimen	NNS
cord-005453-4057qib7	13959	3	were	be	VBD
cord-005453-4057qib7	13959	4	myeloablative	myeloablative	JJ
cord-005453-4057qib7	13959	5	and	and	CC
cord-005453-4057qib7	13959	6	TBI	TBI	NNP
cord-005453-4057qib7	13959	7	12	12	CD
cord-005453-4057qib7	13959	8	Gy	Gy	NNP
cord-005453-4057qib7	13959	9	was	be	VBD
cord-005453-4057qib7	13959	10	given	give	VBN
cord-005453-4057qib7	13959	11	in	in	IN
cord-005453-4057qib7	13959	12	4/30	4/30	CD
cord-005453-4057qib7	13959	13	.	.	.
cord-005453-4057qib7	13960	1	GVHD	GVHD	NNP
cord-005453-4057qib7	13960	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	13960	3	consisted	consist	VBD
cord-005453-4057qib7	13960	4	of	of	IN
cord-005453-4057qib7	13960	5	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	13960	6	and	and	CC
cord-005453-4057qib7	13960	7	ATG	ATG	NNP
cord-005453-4057qib7	13960	8	was	be	VBD
cord-005453-4057qib7	13960	9	given	give	VBN
cord-005453-4057qib7	13960	10	in	in	IN
cord-005453-4057qib7	13960	11	all	all	DT
cord-005453-4057qib7	13960	12	patients	patient	NNS
cord-005453-4057qib7	13960	13	pre	pre	JJ
cord-005453-4057qib7	13960	14	-	-	NN
cord-005453-4057qib7	13960	15	transplantation	transplantation	NN
cord-005453-4057qib7	13960	16	.	.	.
cord-005453-4057qib7	13961	1	Median	median	JJ
cord-005453-4057qib7	13961	2	value	value	NN
cord-005453-4057qib7	13961	3	of	of	IN
cord-005453-4057qib7	13961	4	nucleated	nucleated	JJ
cord-005453-4057qib7	13961	5	cells	cell	NNS
cord-005453-4057qib7	13961	6	for	for	IN
cord-005453-4057qib7	13961	7	MD	MD	NNP
cord-005453-4057qib7	13961	8	was	be	VBD
cord-005453-4057qib7	13961	9	3.75χ10	3.75χ10	CD
cord-005453-4057qib7	13961	10	7	7	CD
cord-005453-4057qib7	13961	11	/kg	/kg	.
cord-005453-4057qib7	13962	1	(	(	-LRB-
cord-005453-4057qib7	13962	2	range	range	NNP
cord-005453-4057qib7	13962	3	2	2	CD
cord-005453-4057qib7	13962	4	-	-	HYPH
cord-005453-4057qib7	13962	5	6.3χ10	6.3χ10	CD
cord-005453-4057qib7	13962	6	7	7	CD
cord-005453-4057qib7	13962	7	/	/	SYM
cord-005453-4057qib7	13962	8	kg	kg	NNP
cord-005453-4057qib7	13962	9	)	)	-RRB-
cord-005453-4057qib7	13962	10	and	and	CC
cord-005453-4057qib7	13962	11	for	for	IN
cord-005453-4057qib7	13962	12	NMD	NMD	NNP
cord-005453-4057qib7	13962	13	was	be	VBD
cord-005453-4057qib7	13962	14	11.05χ10	11.05χ10	CD
cord-005453-4057qib7	13962	15	7	7	CD
cord-005453-4057qib7	13963	1	/kg	/kg	.
cord-005453-4057qib7	13964	1	(	(	-LRB-
cord-005453-4057qib7	13964	2	range	range	NNP
cord-005453-4057qib7	13964	3	2	2	CD
cord-005453-4057qib7	13964	4	-	-	HYPH
cord-005453-4057qib7	13964	5	27.2χ10	27.2χ10	CD
cord-005453-4057qib7	13964	6	7	7	CD
cord-005453-4057qib7	13964	7	/kg	/kg	CD
cord-005453-4057qib7	13964	8	)	)	-RRB-
cord-005453-4057qib7	13964	9	.	.	.
cord-005453-4057qib7	13965	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	13965	2	and	and	CC
cord-005453-4057qib7	13965	3	platelet	platelet	NN
cord-005453-4057qib7	13965	4	engraftment	engraftment	NN
cord-005453-4057qib7	13965	5	was	be	VBD
cord-005453-4057qib7	13965	6	achieved	achieve	VBN
cord-005453-4057qib7	13965	7	in	in	IN
cord-005453-4057qib7	13965	8	13/18	13/18	CD
cord-005453-4057qib7	13965	9	and	and	CC
cord-005453-4057qib7	13965	10	12/18	12/18	CD
cord-005453-4057qib7	13965	11	patients	patient	NNS
cord-005453-4057qib7	13965	12	with	with	IN
cord-005453-4057qib7	13965	13	MD	MD	NNP
cord-005453-4057qib7	13965	14	respectively	respectively	RB
cord-005453-4057qib7	13965	15	,	,	,
cord-005453-4057qib7	13965	16	in	in	IN
cord-005453-4057qib7	13965	17	a	a	DT
cord-005453-4057qib7	13965	18	median	median	JJ
cord-005453-4057qib7	13965	19	time	time	NN
cord-005453-4057qib7	13965	20	of	of	IN
cord-005453-4057qib7	13965	21	31	31	CD
cord-005453-4057qib7	13965	22	days	day	NNS
cord-005453-4057qib7	13965	23	(	(	-LRB-
cord-005453-4057qib7	13965	24	range	range	VBP
cord-005453-4057qib7	13965	25	17	17	CD
cord-005453-4057qib7	13965	26	-	-	SYM
cord-005453-4057qib7	13965	27	44	44	CD
cord-005453-4057qib7	13965	28	)	)	-RRB-
cord-005453-4057qib7	13965	29	και	και	VBP
cord-005453-4057qib7	13965	30	43	43	CD
cord-005453-4057qib7	13965	31	days	day	NNS
cord-005453-4057qib7	13965	32	(	(	-LRB-
cord-005453-4057qib7	13965	33	range	range	VBP
cord-005453-4057qib7	13965	34	20	20	CD
cord-005453-4057qib7	13965	35	-	-	SYM
cord-005453-4057qib7	13965	36	60	60	CD
cord-005453-4057qib7	13965	37	)	)	-RRB-
cord-005453-4057qib7	13965	38	.	.	.
cord-005453-4057qib7	13966	1	In	in	IN
cord-005453-4057qib7	13966	2	patients	patient	NNS
cord-005453-4057qib7	13966	3	with	with	IN
cord-005453-4057qib7	13966	4	NMD	NMD	NNP
cord-005453-4057qib7	13966	5	,	,	,
cord-005453-4057qib7	13966	6	neutrophil	neutrophil	NN
cord-005453-4057qib7	13966	7	and	and	CC
cord-005453-4057qib7	13966	8	platelet	platelet	NN
cord-005453-4057qib7	13966	9	engraftment	engraftment	NN
cord-005453-4057qib7	13966	10	was	be	VBD
cord-005453-4057qib7	13966	11	achieved	achieve	VBN
cord-005453-4057qib7	13966	12	in	in	IN
cord-005453-4057qib7	13966	13	7/12	7/12	CD
cord-005453-4057qib7	13966	14	and	and	CC
cord-005453-4057qib7	13966	15	6/12	6/12	CD
cord-005453-4057qib7	13966	16	with	with	IN
cord-005453-4057qib7	13966	17	median	median	JJ
cord-005453-4057qib7	13966	18	day	day	NN
cord-005453-4057qib7	13966	19	of	of	IN
cord-005453-4057qib7	13966	20	engraftment	engraftment	NN
cord-005453-4057qib7	13966	21	21	21	CD
cord-005453-4057qib7	13966	22	days	day	NNS
cord-005453-4057qib7	13966	23	(	(	-LRB-
cord-005453-4057qib7	13966	24	range	range	VBP
cord-005453-4057qib7	13966	25	18	18	CD
cord-005453-4057qib7	13966	26	-	-	SYM
cord-005453-4057qib7	13966	27	28	28	CD
cord-005453-4057qib7	13966	28	)	)	-RRB-
cord-005453-4057qib7	13966	29	και	και	VBP
cord-005453-4057qib7	13966	30	29	29	CD
cord-005453-4057qib7	13966	31	days	day	NNS
cord-005453-4057qib7	13966	32	(	(	-LRB-
cord-005453-4057qib7	13966	33	range	range	NN
cord-005453-4057qib7	13966	34	respectively	respectively	RB
cord-005453-4057qib7	13966	35	.	.	.
cord-005453-4057qib7	13967	1	Acute	acute	JJ
cord-005453-4057qib7	13967	2	GVHD	GVHD	NNP
cord-005453-4057qib7	13967	3	grade	grade	NN
cord-005453-4057qib7	13967	4	ΙΙ	ΙΙ	NNP
cord-005453-4057qib7	13967	5	-	-	HYPH
cord-005453-4057qib7	13967	6	ΙV	ΙV	NNP
cord-005453-4057qib7	13967	7	presented	present	VBN
cord-005453-4057qib7	13967	8	in	in	IN
cord-005453-4057qib7	13967	9	9/18	9/18	CD
cord-005453-4057qib7	13967	10	patients	patient	NNS
cord-005453-4057qib7	13967	11	with	with	IN
cord-005453-4057qib7	13967	12	MD	MD	NNP
cord-005453-4057qib7	13967	13	and	and	CC
cord-005453-4057qib7	13967	14	4/12	4/12	CD
cord-005453-4057qib7	13967	15	with	with	IN
cord-005453-4057qib7	13967	16	NMD	NMD	NNP
cord-005453-4057qib7	13967	17	,	,	,
cord-005453-4057qib7	13967	18	although	although	IN
cord-005453-4057qib7	13967	19	none	none	NN
cord-005453-4057qib7	13967	20	had	have	VBD
cord-005453-4057qib7	13967	21	cGVHD	cGVHD	NNP
cord-005453-4057qib7	13967	22	.	.	.
cord-005453-4057qib7	13968	1	The	the	DT
cord-005453-4057qib7	13968	2	incidence	incidence	NN
cord-005453-4057qib7	13968	3	of	of	IN
cord-005453-4057qib7	13968	4	viral	viral	JJ
cord-005453-4057qib7	13968	5	infections	infection	NNS
cord-005453-4057qib7	13968	6	was	be	VBD
cord-005453-4057qib7	13968	7	22	22	CD
cord-005453-4057qib7	13968	8	cases	case	NNS
cord-005453-4057qib7	13968	9	in	in	IN
cord-005453-4057qib7	13968	10	11	11	CD
cord-005453-4057qib7	13968	11	patients	patient	NNS
cord-005453-4057qib7	13968	12	with	with	IN
cord-005453-4057qib7	13968	13	MD	MD	NNP
cord-005453-4057qib7	13968	14	and	and	CC
cord-005453-4057qib7	13968	15	9	9	CD
cord-005453-4057qib7	13968	16	cases	case	NNS
cord-005453-4057qib7	13968	17	in	in	IN
cord-005453-4057qib7	13968	18	6	6	CD
cord-005453-4057qib7	13968	19	patients	patient	NNS
cord-005453-4057qib7	13968	20	with	with	IN
cord-005453-4057qib7	13968	21	NMD	NMD	NNP
cord-005453-4057qib7	13968	22	.	.	.
cord-005453-4057qib7	13969	1	Disease	Disease	NNP
cord-005453-4057qib7	13969	2	relapse	relapse	NN
cord-005453-4057qib7	13969	3	occured	occur	VBD
cord-005453-4057qib7	13969	4	in	in	IN
cord-005453-4057qib7	13969	5	9/18	9/18	CD
cord-005453-4057qib7	13969	6	patients	patient	NNS
cord-005453-4057qib7	13969	7	with	with	IN
cord-005453-4057qib7	13969	8	MD	MD	NNP
cord-005453-4057qib7	13969	9	.	.	.
cord-005453-4057qib7	13970	1	After	after	IN
cord-005453-4057qib7	13970	2	a	a	DT
cord-005453-4057qib7	13970	3	median	median	JJ
cord-005453-4057qib7	13970	4	time	time	NN
cord-005453-4057qib7	13970	5	of	of	IN
cord-005453-4057qib7	13970	6	10	10	CD
cord-005453-4057qib7	13970	7	years	year	NNS
cord-005453-4057qib7	13970	8	follow	follow	VBP
cord-005453-4057qib7	13970	9	up	up	RP
cord-005453-4057qib7	13970	10	,	,	,
cord-005453-4057qib7	13970	11	overall	overall	JJ
cord-005453-4057qib7	13970	12	survival	survival	NN
cord-005453-4057qib7	13970	13	(	(	-LRB-
cord-005453-4057qib7	13970	14	OS	OS	NNP
cord-005453-4057qib7	13970	15	)	)	-RRB-
cord-005453-4057qib7	13970	16	and	and	CC
cord-005453-4057qib7	13970	17	event	event	VB
cord-005453-4057qib7	13970	18	free	free	JJ
cord-005453-4057qib7	13970	19	survival	survival	NN
cord-005453-4057qib7	13970	20	(	(	-LRB-
cord-005453-4057qib7	13970	21	EFS	EFS	NNP
cord-005453-4057qib7	13970	22	)	)	-RRB-
cord-005453-4057qib7	13970	23	for	for	IN
cord-005453-4057qib7	13970	24	children	child	NNS
cord-005453-4057qib7	13970	25	with	with	IN
cord-005453-4057qib7	13970	26	MD	MD	NNP
cord-005453-4057qib7	13970	27	were	be	VBD
cord-005453-4057qib7	13970	28	22	22	CD
cord-005453-4057qib7	13970	29	%	%	NN
cord-005453-4057qib7	13970	30	and	and	CC
cord-005453-4057qib7	13970	31	18.5	18.5	CD
cord-005453-4057qib7	13970	32	%	%	NN
cord-005453-4057qib7	13970	33	respectively	respectively	RB
cord-005453-4057qib7	13970	34	,	,	,
cord-005453-4057qib7	13970	35	while	while	IN
cord-005453-4057qib7	13970	36	for	for	IN
cord-005453-4057qib7	13970	37	NMD	NMD	NNP
cord-005453-4057qib7	13970	38	,	,	,
cord-005453-4057qib7	13970	39	OS	OS	NNP
cord-005453-4057qib7	13970	40	and	and	CC
cord-005453-4057qib7	13970	41	EFS	EFS	NNP
cord-005453-4057qib7	13970	42	were	be	VBD
cord-005453-4057qib7	13970	43	33%.Treatment	33%.Treatment	NNP
cord-005453-4057qib7	13970	44	related	relate	VBN
cord-005453-4057qib7	13970	45	mortality	mortality	NN
cord-005453-4057qib7	13970	46	at	at	IN
cord-005453-4057qib7	13970	47	d+100	d+100	NNS
cord-005453-4057qib7	13970	48	was	be	VBD
cord-005453-4057qib7	13970	49	8	8	CD
cord-005453-4057qib7	13970	50	%	%	NN
cord-005453-4057qib7	13970	51	for	for	IN
cord-005453-4057qib7	13970	52	MD	MD	NNP
cord-005453-4057qib7	13970	53	and	and	CC
cord-005453-4057qib7	13970	54	50	50	CD
cord-005453-4057qib7	13970	55	%	%	NN
cord-005453-4057qib7	13970	56	for	for	IN
cord-005453-4057qib7	13970	57	NMD	NMD	NNP
cord-005453-4057qib7	13970	58	.	.	.
cord-005453-4057qib7	13971	1	Among	among	IN
cord-005453-4057qib7	13971	2	18	18	CD
cord-005453-4057qib7	13971	3	patients	patient	NNS
cord-005453-4057qib7	13971	4	with	with	IN
cord-005453-4057qib7	13971	5	MD	MD	NNP
cord-005453-4057qib7	13971	6	,	,	,
cord-005453-4057qib7	13971	7	4	4	CD
cord-005453-4057qib7	13971	8	are	be	VBP
cord-005453-4057qib7	13971	9	still	still	RB
cord-005453-4057qib7	13971	10	alive	alive	JJ
cord-005453-4057qib7	13971	11	,	,	,
cord-005453-4057qib7	13971	12	while	while	IN
cord-005453-4057qib7	13971	13	the	the	DT
cord-005453-4057qib7	13971	14	rest	rest	NN
cord-005453-4057qib7	13971	15	died	die	VBD
cord-005453-4057qib7	13971	16	from	from	IN
cord-005453-4057qib7	13971	17	relapse	relapse	NN
cord-005453-4057qib7	13971	18	(	(	-LRB-
cord-005453-4057qib7	13971	19	n	n	NN
cord-005453-4057qib7	13971	20	:	:	:
cord-005453-4057qib7	13971	21	8)	8)	NNP
cord-005453-4057qib7	13971	22	,	,	,
cord-005453-4057qib7	13971	23	viral	viral	JJ
cord-005453-4057qib7	13971	24	infections	infection	NNS
cord-005453-4057qib7	13972	1	(	(	-LRB-
cord-005453-4057qib7	13972	2	n	n	NN
cord-005453-4057qib7	13972	3	:	:	:
cord-005453-4057qib7	13972	4	4	4	LS
cord-005453-4057qib7	13972	5	)	)	-RRB-
cord-005453-4057qib7	13972	6	,	,	,
cord-005453-4057qib7	13972	7	septicemia	septicemia	NN
cord-005453-4057qib7	13972	8	(	(	-LRB-
cord-005453-4057qib7	13972	9	n	n	NN
cord-005453-4057qib7	13972	10	:	:	:
cord-005453-4057qib7	13972	11	1	1	CD
cord-005453-4057qib7	13972	12	)	)	-RRB-
cord-005453-4057qib7	13972	13	and	and	CC
cord-005453-4057qib7	13972	14	aGVHD(n	aGVHD(n	NNP
cord-005453-4057qib7	13972	15	:	:	:
cord-005453-4057qib7	13972	16	1	1	CD
cord-005453-4057qib7	13972	17	)	)	-RRB-
cord-005453-4057qib7	13972	18	.	.	.
cord-005453-4057qib7	13973	1	Among	among	IN
cord-005453-4057qib7	13973	2	12	12	CD
cord-005453-4057qib7	13973	3	patients	patient	NNS
cord-005453-4057qib7	13973	4	with	with	IN
cord-005453-4057qib7	13973	5	NMD	NMD	NNP
cord-005453-4057qib7	13973	6	,	,	,
cord-005453-4057qib7	13973	7	4	4	CD
cord-005453-4057qib7	13973	8	are	be	VBP
cord-005453-4057qib7	13973	9	alive	alive	JJ
cord-005453-4057qib7	13973	10	,	,	,
cord-005453-4057qib7	13973	11	while	while	IN
cord-005453-4057qib7	13973	12	the	the	DT
cord-005453-4057qib7	13973	13	rest	rest	NN
cord-005453-4057qib7	13973	14	died	die	VBD
cord-005453-4057qib7	13973	15	from	from	IN
cord-005453-4057qib7	13973	16	viral	viral	JJ
cord-005453-4057qib7	13973	17	infections	infection	NNS
cord-005453-4057qib7	13973	18	(	(	-LRB-
cord-005453-4057qib7	13973	19	n	n	NN
cord-005453-4057qib7	13973	20	:	:	SYM
cord-005453-4057qib7	13973	21	2	2	LS
cord-005453-4057qib7	13973	22	)	)	-RRB-
cord-005453-4057qib7	13973	23	,	,	,
cord-005453-4057qib7	13973	24	septicemia	septicemia	NN
cord-005453-4057qib7	13973	25	(	(	-LRB-
cord-005453-4057qib7	13973	26	n:4	n:4	NNP
cord-005453-4057qib7	13973	27	)	)	-RRB-
cord-005453-4057qib7	13973	28	and	and	CC
cord-005453-4057qib7	13973	29	multiple	multiple	JJ
cord-005453-4057qib7	13973	30	organ	organ	NN
cord-005453-4057qib7	13973	31	failure	failure	NN
cord-005453-4057qib7	13973	32	(	(	-LRB-
cord-005453-4057qib7	13973	33	n=2	n=2	NNS
cord-005453-4057qib7	13973	34	)	)	-RRB-
cord-005453-4057qib7	13973	35	.	.	.
cord-005453-4057qib7	13974	1	The	the	DT
cord-005453-4057qib7	13974	2	median	median	JJ
cord-005453-4057qib7	13974	3	time	time	NN
cord-005453-4057qib7	13974	4	of	of	IN
cord-005453-4057qib7	13974	5	hospitalization	hospitalization	NN
cord-005453-4057qib7	13974	6	for	for	IN
cord-005453-4057qib7	13974	7	patients	patient	NNS
cord-005453-4057qib7	13974	8	with	with	IN
cord-005453-4057qib7	13974	9	MD	MD	NNP
cord-005453-4057qib7	13974	10	was	be	VBD
cord-005453-4057qib7	13974	11	76	76	CD
cord-005453-4057qib7	13974	12	days	day	NNS
cord-005453-4057qib7	13975	1	(	(	-LRB-
cord-005453-4057qib7	13975	2	range	range	NNP
cord-005453-4057qib7	13975	3	32	32	CD
cord-005453-4057qib7	13975	4	-	-	SYM
cord-005453-4057qib7	13975	5	168	168	CD
cord-005453-4057qib7	13975	6	)	)	-RRB-
cord-005453-4057qib7	13975	7	,	,	,
cord-005453-4057qib7	13975	8	whilst	whilst	IN
cord-005453-4057qib7	13975	9	for	for	IN
cord-005453-4057qib7	13975	10	NMD	NMD	NNP
cord-005453-4057qib7	13975	11	was	be	VBD
cord-005453-4057qib7	13975	12	63	63	CD
cord-005453-4057qib7	13975	13	days	day	NNS
cord-005453-4057qib7	13975	14	(	(	-LRB-
cord-005453-4057qib7	13975	15	range	range	NNP
cord-005453-4057qib7	13975	16	28	28	CD
cord-005453-4057qib7	13975	17	-	-	SYM
cord-005453-4057qib7	13975	18	114	114	CD
cord-005453-4057qib7	13975	19	)	)	-RRB-
cord-005453-4057qib7	13975	20	.	.	.
cord-005453-4057qib7	13976	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	13976	2	:	:	:
cord-005453-4057qib7	13977	1	Transplantation	transplantation	NN
cord-005453-4057qib7	13977	2	of	of	IN
cord-005453-4057qib7	13977	3	unrelated	unrelated	JJ
cord-005453-4057qib7	13977	4	UCB	UCB	NNP
cord-005453-4057qib7	13977	5	in	in	IN
cord-005453-4057qib7	13977	6	our	-PRON-	PRP$
cord-005453-4057qib7	13977	7	unit	unit	NN
cord-005453-4057qib7	13977	8	was	be	VBD
cord-005453-4057qib7	13977	9	combined	combine	VBN
cord-005453-4057qib7	13977	10	with	with	IN
cord-005453-4057qib7	13977	11	high	high	JJ
cord-005453-4057qib7	13977	12	TRM	TRM	NNP
cord-005453-4057qib7	13977	13	in	in	IN
cord-005453-4057qib7	13977	14	children	child	NNS
cord-005453-4057qib7	13977	15	with	with	IN
cord-005453-4057qib7	13977	16	NMD	NMD	NNP
cord-005453-4057qib7	13977	17	and	and	CC
cord-005453-4057qib7	13977	18	higher	high	JJR
cord-005453-4057qib7	13977	19	probability	probability	NN
cord-005453-4057qib7	13977	20	of	of	IN
cord-005453-4057qib7	13977	21	relapse	relapse	NN
cord-005453-4057qib7	13977	22	for	for	IN
cord-005453-4057qib7	13977	23	MD	MD	NNP
cord-005453-4057qib7	13977	24	.	.	.
cord-005453-4057qib7	13978	1	Disclosure	disclosure	NN
cord-005453-4057qib7	13978	2	:	:	:
cord-005453-4057qib7	13978	3	Nothing	nothing	NN
cord-005453-4057qib7	13978	4	to	to	TO
cord-005453-4057qib7	13978	5	declare	declare	VB
cord-005453-4057qib7	13978	6	P643	P643	NNP
cord-005453-4057qib7	13978	7	Serum	serum	NN
cord-005453-4057qib7	13978	8	levels	level	NNS
cord-005453-4057qib7	13978	9	of	of	IN
cord-005453-4057qib7	13978	10	5-S	5-S	NNP
cord-005453-4057qib7	13978	11	cysteinyldopa	cysteinyldopa	NN
cord-005453-4057qib7	13978	12	is	be	VBZ
cord-005453-4057qib7	13978	13	associated	associate	VBN
cord-005453-4057qib7	13978	14	with	with	IN
cord-005453-4057qib7	13978	15	stem	stem	NN
cord-005453-4057qib7	13978	16	cell	cell	NN
cord-005453-4057qib7	13978	17	transplantation	transplantation	NN
cord-005453-4057qib7	13978	18	related	relate	VBN
cord-005453-4057qib7	13978	19	complications	complication	NNS
cord-005453-4057qib7	13978	20	Yukayo	Yukayo	NNP
cord-005453-4057qib7	13978	21	Terashita	Terashita	NNP
cord-005453-4057qib7	13978	22	1	1	CD
cord-005453-4057qib7	13978	23	,	,	,
cord-005453-4057qib7	13978	24	Mamoru	Mamoru	NNP
cord-005453-4057qib7	13978	25	Honda	Honda	NNP
cord-005453-4057qib7	13978	26	1	1	CD
cord-005453-4057qib7	13978	27	,	,	,
cord-005453-4057qib7	13978	28	Minako	Minako	NNP
cord-005453-4057qib7	13978	29	Sugiyama	Sugiyama	NNP
cord-005453-4057qib7	13978	30	1	1	CD
cord-005453-4057qib7	13978	31	,	,	,
cord-005453-4057qib7	13978	32	Yuko	Yuko	NNP
cord-005453-4057qib7	13978	33	Cho	Cho	NNP
cord-005453-4057qib7	13978	34	1	1	CD
cord-005453-4057qib7	13978	35	,	,	,
cord-005453-4057qib7	13978	36	Akihiro	Akihiro	NNP
cord-005453-4057qib7	13978	37	Iguchi	Iguchi	NNP
cord-005453-4057qib7	13979	1	1	1	CD
cord-005453-4057qib7	13979	2	1	1	CD
cord-005453-4057qib7	13979	3	Hokkaido	Hokkaido	NNP
cord-005453-4057qib7	13979	4	University	University	NNP
cord-005453-4057qib7	13979	5	Hospital	Hospital	NNP
cord-005453-4057qib7	13979	6	,	,	,
cord-005453-4057qib7	13979	7	Pediatrics	Pediatrics	NNP
cord-005453-4057qib7	13979	8	,	,	,
cord-005453-4057qib7	13979	9	Sapporo	Sapporo	NNP
cord-005453-4057qib7	13979	10	,	,	,
cord-005453-4057qib7	13979	11	Japan	Japan	NNP
cord-005453-4057qib7	13979	12	Background	Background	NNP
cord-005453-4057qib7	13979	13	:	:	:
cord-005453-4057qib7	13980	1	Diffuse	diffuse	JJ
cord-005453-4057qib7	13980	2	hyperpigmentation	hyperpigmentation	NN
cord-005453-4057qib7	13980	3	is	be	VBZ
cord-005453-4057qib7	13980	4	common	common	JJ
cord-005453-4057qib7	13980	5	in	in	IN
cord-005453-4057qib7	13980	6	patients	patient	NNS
cord-005453-4057qib7	13980	7	who	who	WP
cord-005453-4057qib7	13980	8	received	receive	VBD
cord-005453-4057qib7	13980	9	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	13980	10	or	or	CC
cord-005453-4057qib7	13980	11	stem	stem	NN
cord-005453-4057qib7	13980	12	cell	cell	NN
cord-005453-4057qib7	13980	13	transplantation	transplantation	NN
cord-005453-4057qib7	13980	14	(	(	-LRB-
cord-005453-4057qib7	13980	15	SCT	SCT	NNP
cord-005453-4057qib7	13980	16	)	)	-RRB-
cord-005453-4057qib7	13980	17	.	.	.
cord-005453-4057qib7	13981	1	However	however	RB
cord-005453-4057qib7	13981	2	,	,	,
cord-005453-4057qib7	13981	3	there	there	EX
cord-005453-4057qib7	13981	4	are	be	VBP
cord-005453-4057qib7	13981	5	few	few	JJ
cord-005453-4057qib7	13981	6	reports	report	NNS
cord-005453-4057qib7	13981	7	of	of	IN
cord-005453-4057qib7	13981	8	the	the	DT
cord-005453-4057qib7	13981	9	relationship	relationship	NN
cord-005453-4057qib7	13981	10	between	between	IN
cord-005453-4057qib7	13981	11	skin	skin	NN
cord-005453-4057qib7	13981	12	reaction	reaction	NN
cord-005453-4057qib7	13981	13	such	such	JJ
cord-005453-4057qib7	13981	14	as	as	IN
cord-005453-4057qib7	13981	15	pigmentation	pigmentation	NN
cord-005453-4057qib7	13981	16	and	and	CC
cord-005453-4057qib7	13981	17	the	the	DT
cord-005453-4057qib7	13981	18	other	other	JJ
cord-005453-4057qib7	13981	19	complications	complication	NNS
cord-005453-4057qib7	13981	20	.	.	.
cord-005453-4057qib7	13982	1	Pigmentation	pigmentation	NN
cord-005453-4057qib7	13982	2	of	of	IN
cord-005453-4057qib7	13982	3	the	the	DT
cord-005453-4057qib7	13982	4	skin	skin	NN
cord-005453-4057qib7	13982	5	is	be	VBZ
cord-005453-4057qib7	13982	6	thought	think	VBN
cord-005453-4057qib7	13982	7	to	to	TO
cord-005453-4057qib7	13982	8	be	be	VB
cord-005453-4057qib7	13982	9	the	the	DT
cord-005453-4057qib7	13982	10	result	result	NN
cord-005453-4057qib7	13982	11	of	of	IN
cord-005453-4057qib7	13982	12	melanin	melanin	NN
cord-005453-4057qib7	13982	13	stagnating	stagnate	VBG
cord-005453-4057qib7	13982	14	in	in	IN
cord-005453-4057qib7	13982	15	the	the	DT
cord-005453-4057qib7	13982	16	dermic	dermic	NN
cord-005453-4057qib7	13982	17	layer	layer	NN
cord-005453-4057qib7	13982	18	due	due	JJ
cord-005453-4057qib7	13982	19	to	to	IN
cord-005453-4057qib7	13982	20	increased	increase	VBN
cord-005453-4057qib7	13982	21	synthesis	synthesis	NN
cord-005453-4057qib7	13982	22	of	of	IN
cord-005453-4057qib7	13982	23	melanin	melanin	NN
cord-005453-4057qib7	13982	24	and	and	CC
cord-005453-4057qib7	13982	25	destruction	destruction	NN
cord-005453-4057qib7	13982	26	of	of	IN
cord-005453-4057qib7	13982	27	the	the	DT
cord-005453-4057qib7	13982	28	basement	basement	NN
cord-005453-4057qib7	13982	29	membrane	membrane	NN
cord-005453-4057qib7	13982	30	due	due	IN
cord-005453-4057qib7	13982	31	to	to	IN
cord-005453-4057qib7	13982	32	inflammation	inflammation	NN
cord-005453-4057qib7	13982	33	induced	induce	VBN
cord-005453-4057qib7	13982	34	chemoradiotherapy	chemoradiotherapy	NN
cord-005453-4057qib7	13982	35	.	.	.
cord-005453-4057qib7	13983	1	Melanin	melanin	NN
cord-005453-4057qib7	13983	2	pigments	pigment	NNS
cord-005453-4057qib7	13983	3	are	be	VBP
cord-005453-4057qib7	13983	4	classified	classify	VBN
cord-005453-4057qib7	13983	5	into	into	IN
cord-005453-4057qib7	13983	6	two	two	CD
cord-005453-4057qib7	13983	7	types	type	NNS
cord-005453-4057qib7	13983	8	:	:	:
cord-005453-4057qib7	13983	9	brown	brown	JJ
cord-005453-4057qib7	13983	10	to	to	IN
cord-005453-4057qib7	13983	11	black	black	JJ
cord-005453-4057qib7	13983	12	eumelanin	eumelanin	NNS
cord-005453-4057qib7	13983	13	and	and	CC
cord-005453-4057qib7	13983	14	yellow	yellow	JJ
cord-005453-4057qib7	13983	15	to	to	IN
cord-005453-4057qib7	13983	16	reddishbrown	reddishbrown	JJ
cord-005453-4057qib7	13983	17	pheomelanin	pheomelanin	NNS
cord-005453-4057qib7	13983	18	.	.	.
cord-005453-4057qib7	13984	1	5-S	5-S	NNP
cord-005453-4057qib7	13984	2	Cysteinyldopa	Cysteinyldopa	NNP
cord-005453-4057qib7	13984	3	(	(	-LRB-
cord-005453-4057qib7	13984	4	5SCD	5scd	NN
cord-005453-4057qib7	13984	5	)	)	-RRB-
cord-005453-4057qib7	13984	6	is	be	VBZ
cord-005453-4057qib7	13984	7	precursors	precursor	NNS
cord-005453-4057qib7	13984	8	of	of	IN
cord-005453-4057qib7	13984	9	pheomelanin	pheomelanin	NNS
cord-005453-4057qib7	13984	10	,	,	,
cord-005453-4057qib7	13984	11	and	and	CC
cord-005453-4057qib7	13984	12	its	-PRON-	PRP$
cord-005453-4057qib7	13984	13	serum	serum	NN
cord-005453-4057qib7	13984	14	level	level	NN
cord-005453-4057qib7	13984	15	has	have	VBZ
cord-005453-4057qib7	13984	16	been	be	VBN
cord-005453-4057qib7	13984	17	used	use	VBN
cord-005453-4057qib7	13984	18	specific	specific	JJ
cord-005453-4057qib7	13984	19	biochemical	biochemical	JJ
cord-005453-4057qib7	13984	20	marker	marker	NN
cord-005453-4057qib7	13984	21	for	for	IN
cord-005453-4057qib7	13984	22	malignant	malignant	JJ
cord-005453-4057qib7	13984	23	melanoma	melanoma	NN
cord-005453-4057qib7	13984	24	.	.	.
cord-005453-4057qib7	13985	1	Here	here	RB
cord-005453-4057qib7	13985	2	,	,	,
cord-005453-4057qib7	13985	3	we	-PRON-	PRP
cord-005453-4057qib7	13985	4	examined	examine	VBD
cord-005453-4057qib7	13985	5	serially	serially	RB
cord-005453-4057qib7	13985	6	5SCD	5scd	JJ
cord-005453-4057qib7	13985	7	during	during	IN
cord-005453-4057qib7	13985	8	the	the	DT
cord-005453-4057qib7	13985	9	course	course	NN
cord-005453-4057qib7	13985	10	of	of	IN
cord-005453-4057qib7	13985	11	SCT	SCT	NNP
cord-005453-4057qib7	13985	12	to	to	TO
cord-005453-4057qib7	13985	13	determine	determine	VB
cord-005453-4057qib7	13985	14	association	association	NN
cord-005453-4057qib7	13985	15	with	with	IN
cord-005453-4057qib7	13985	16	SCT	SCT	NNP
cord-005453-4057qib7	13985	17	related	relate	VBN
cord-005453-4057qib7	13985	18	complications	complication	NNS
cord-005453-4057qib7	13985	19	,	,	,
cord-005453-4057qib7	13985	20	because	because	IN
cord-005453-4057qib7	13985	21	visual	visual	JJ
cord-005453-4057qib7	13985	22	evaluation	evaluation	NN
cord-005453-4057qib7	13985	23	of	of	IN
cord-005453-4057qib7	13985	24	skin	skin	NN
cord-005453-4057qib7	13985	25	color	color	NN
cord-005453-4057qib7	13985	26	is	be	VBZ
cord-005453-4057qib7	13985	27	difficult	difficult	JJ
cord-005453-4057qib7	13985	28	,	,	,
cord-005453-4057qib7	13985	29	and	and	CC
cord-005453-4057qib7	13985	30	there	there	EX
cord-005453-4057qib7	13985	31	have	have	VBP
cord-005453-4057qib7	13985	32	been	be	VBN
cord-005453-4057qib7	13985	33	no	no	DT
cord-005453-4057qib7	13985	34	reports	report	NNS
cord-005453-4057qib7	13985	35	about	about	IN
cord-005453-4057qib7	13985	36	5SCD	5scd	CD
cord-005453-4057qib7	13985	37	as	as	IN
cord-005453-4057qib7	13985	38	SCT	SCT	NNP
cord-005453-4057qib7	13985	39	related	relate	VBN
cord-005453-4057qib7	13985	40	biomarker	biomarker	NN
cord-005453-4057qib7	13985	41	.	.	.
cord-005453-4057qib7	13986	1	Methods	method	NNS
cord-005453-4057qib7	13986	2	:	:	:
cord-005453-4057qib7	13986	3	We	-PRON-	PRP
cord-005453-4057qib7	13986	4	prospectively	prospectively	RB
cord-005453-4057qib7	13986	5	analyzed	analyze	VBD
cord-005453-4057qib7	13986	6	41(27	41(27	CD
cord-005453-4057qib7	13986	7	males	male	NNS
cord-005453-4057qib7	13986	8	,	,	,
cord-005453-4057qib7	13986	9	14	14	CD
cord-005453-4057qib7	13986	10	females	female	NNS
cord-005453-4057qib7	13986	11	)	)	-RRB-
cord-005453-4057qib7	13986	12	patients	patient	NNS
cord-005453-4057qib7	13986	13	who	who	WP
cord-005453-4057qib7	13986	14	received	receive	VBD
cord-005453-4057qib7	13986	15	SCT	SCT	NNP
cord-005453-4057qib7	13986	16	between	between	IN
cord-005453-4057qib7	13986	17	May	May	NNP
cord-005453-4057qib7	13986	18	2011	2011	CD
cord-005453-4057qib7	13986	19	and	and	CC
cord-005453-4057qib7	13986	20	March	March	NNP
cord-005453-4057qib7	13986	21	2015	2015	CD
cord-005453-4057qib7	13986	22	in	in	IN
cord-005453-4057qib7	13986	23	Hokkaido	Hokkaido	NNP
cord-005453-4057qib7	13986	24	University	University	NNP
cord-005453-4057qib7	13986	25	Hospital	Hospital	NNP
cord-005453-4057qib7	13986	26	.	.	.
cord-005453-4057qib7	13987	1	The	the	DT
cord-005453-4057qib7	13987	2	median	median	JJ
cord-005453-4057qib7	13987	3	age	age	NN
cord-005453-4057qib7	13987	4	at	at	IN
cord-005453-4057qib7	13987	5	transplantation	transplantation	NN
cord-005453-4057qib7	13987	6	of	of	IN
cord-005453-4057qib7	13987	7	the	the	DT
cord-005453-4057qib7	13987	8	patients	patient	NNS
cord-005453-4057qib7	13987	9	was	be	VBD
cord-005453-4057qib7	13987	10	7.9	7.9	CD
cord-005453-4057qib7	13987	11	years	year	NNS
cord-005453-4057qib7	13987	12	(	(	-LRB-
cord-005453-4057qib7	13987	13	range	range	NN
cord-005453-4057qib7	13987	14	,	,	,
cord-005453-4057qib7	13987	15	0	0	CD
cord-005453-4057qib7	13987	16	-	-	SYM
cord-005453-4057qib7	13987	17	22	22	CD
cord-005453-4057qib7	13987	18	)	)	-RRB-
cord-005453-4057qib7	13987	19	.	.	.
cord-005453-4057qib7	13988	1	Indication	indication	NN
cord-005453-4057qib7	13988	2	for	for	IN
cord-005453-4057qib7	13988	3	SCT	SCT	NNP
cord-005453-4057qib7	13988	4	were	be	VBD
cord-005453-4057qib7	13988	5	acute	acute	JJ
cord-005453-4057qib7	13988	6	myelogenous	myelogenous	NN
cord-005453-4057qib7	13988	7	leukemia	leukemia	NN
cord-005453-4057qib7	13988	8	in	in	IN
cord-005453-4057qib7	13988	9	10	10	CD
cord-005453-4057qib7	13988	10	patients	patient	NNS
cord-005453-4057qib7	13988	11	,	,	,
cord-005453-4057qib7	13988	12	acute	acute	JJ
cord-005453-4057qib7	13988	13	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	13988	14	leukemia	leukemia	NN
cord-005453-4057qib7	13988	15	in	in	IN
cord-005453-4057qib7	13988	16	9	9	CD
cord-005453-4057qib7	13988	17	patients	patient	NNS
cord-005453-4057qib7	13988	18	,	,	,
cord-005453-4057qib7	13988	19	and	and	CC
cord-005453-4057qib7	13988	20	other	other	JJ
cord-005453-4057qib7	13988	21	disease	disease	NN
cord-005453-4057qib7	13988	22	in	in	IN
cord-005453-4057qib7	13988	23	22	22	CD
cord-005453-4057qib7	13988	24	patients	patient	NNS
cord-005453-4057qib7	13988	25	;	;	:
cord-005453-4057qib7	13988	26	juvenile	juvenile	JJ
cord-005453-4057qib7	13988	27	myelomonocytic	myelomonocytic	NN
cord-005453-4057qib7	13988	28	leukemia(2	leukemia(2	NNP
cord-005453-4057qib7	13988	29	)	)	-RRB-
cord-005453-4057qib7	13988	30	,	,	,
cord-005453-4057qib7	13988	31	malignant	malignant	JJ
cord-005453-4057qib7	13988	32	solid	solid	JJ
cord-005453-4057qib7	13988	33	tumor(11	tumor(11	NNP
cord-005453-4057qib7	13988	34	)	)	-RRB-
cord-005453-4057qib7	13988	35	,	,	,
cord-005453-4057qib7	13988	36	immunodeficiency(6	immunodeficiency(6	NN
cord-005453-4057qib7	13988	37	)	)	-RRB-
cord-005453-4057qib7	13988	38	,	,	,
cord-005453-4057qib7	13988	39	anaplastic	anaplastic	JJ
cord-005453-4057qib7	13988	40	anemia(2	anemia(2	IN
cord-005453-4057qib7	13988	41	)	)	-RRB-
cord-005453-4057qib7	13988	42	,	,	,
cord-005453-4057qib7	13988	43	and	and	CC
cord-005453-4057qib7	13988	44	Diamond	Diamond	NNP
cord-005453-4057qib7	13988	45	Blackfan	Blackfan	NNP
cord-005453-4057qib7	13988	46	anemia	anemia	NN
cord-005453-4057qib7	13988	47	(	(	-LRB-
cord-005453-4057qib7	13988	48	1	1	CD
cord-005453-4057qib7	13988	49	)	)	-RRB-
cord-005453-4057qib7	13988	50	.	.	.
cord-005453-4057qib7	13989	1	34	34	CD
cord-005453-4057qib7	13989	2	patients	patient	NNS
cord-005453-4057qib7	13989	3	received	receive	VBD
cord-005453-4057qib7	13989	4	allogeneic	allogeneic	IN
cord-005453-4057qib7	13989	5	SCT	SCT	NNP
cord-005453-4057qib7	13989	6	and	and	CC
cord-005453-4057qib7	13989	7	7	7	CD
cord-005453-4057qib7	13989	8	received	receive	VBD
cord-005453-4057qib7	13989	9	autologous	autologous	JJ
cord-005453-4057qib7	13989	10	SCT	SCT	NNP
cord-005453-4057qib7	13989	11	.	.	.
cord-005453-4057qib7	13990	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	13990	2	conditioning	conditioning	NN
cord-005453-4057qib7	13990	3	(	(	-LRB-
cord-005453-4057qib7	13990	4	MAC	MAC	NNP
cord-005453-4057qib7	13990	5	)	)	-RRB-
cord-005453-4057qib7	13990	6	was	be	VBD
cord-005453-4057qib7	13990	7	used	use	VBN
cord-005453-4057qib7	13990	8	for	for	IN
cord-005453-4057qib7	13990	9	30	30	CD
cord-005453-4057qib7	13990	10	patients	patient	NNS
cord-005453-4057qib7	13990	11	and	and	CC
cord-005453-4057qib7	13990	12	reduced	reduced	JJ
cord-005453-4057qib7	13990	13	intensity	intensity	NN
cord-005453-4057qib7	13990	14	conditioning	conditioning	NN
cord-005453-4057qib7	13990	15	(	(	-LRB-
cord-005453-4057qib7	13990	16	RIC	RIC	NNP
cord-005453-4057qib7	13990	17	)	)	-RRB-
cord-005453-4057qib7	13990	18	was	be	VBD
cord-005453-4057qib7	13990	19	used	use	VBN
cord-005453-4057qib7	13990	20	for	for	IN
cord-005453-4057qib7	13990	21	11	11	CD
cord-005453-4057qib7	13990	22	patients	patient	NNS
cord-005453-4057qib7	13990	23	.	.	.
cord-005453-4057qib7	13991	1	Sera	Sera	NNP
cord-005453-4057qib7	13991	2	were	be	VBD
cord-005453-4057qib7	13991	3	obtained	obtain	VBN
cord-005453-4057qib7	13991	4	from	from	IN
cord-005453-4057qib7	13991	5	patients	patient	NNS
cord-005453-4057qib7	13991	6	before	before	IN
cord-005453-4057qib7	13991	7	conditioning	conditioning	NN
cord-005453-4057qib7	13991	8	therapy	therapy	NN
cord-005453-4057qib7	13991	9	,	,	,
cord-005453-4057qib7	13991	10	on	on	IN
cord-005453-4057qib7	13991	11	day	day	NN
cord-005453-4057qib7	13991	12	0	0	CD
cord-005453-4057qib7	13991	13	,	,	,
cord-005453-4057qib7	13991	14	+5	+5	NN
cord-005453-4057qib7	13991	15	,	,	,
cord-005453-4057qib7	13991	16	+10	+10	CD
cord-005453-4057qib7	13991	17	,	,	,
cord-005453-4057qib7	13991	18	+15	+15	NNS
cord-005453-4057qib7	13991	19	,	,	,
cord-005453-4057qib7	13991	20	+25	+25	NNP
cord-005453-4057qib7	13991	21	and	and	CC
cord-005453-4057qib7	13991	22	+40	+40	NN
cord-005453-4057qib7	13991	23	.	.	.
cord-005453-4057qib7	13992	1	All	all	DT
cord-005453-4057qib7	13992	2	blood	blood	NN
cord-005453-4057qib7	13992	3	samples	sample	NNS
cord-005453-4057qib7	13992	4	were	be	VBD
cord-005453-4057qib7	13992	5	centrifuged	centrifuge	VBN
cord-005453-4057qib7	13992	6	at	at	IN
cord-005453-4057qib7	13992	7	3,000	3,000	CD
cord-005453-4057qib7	13992	8	rpm	rpm	NN
cord-005453-4057qib7	13992	9	for	for	IN
cord-005453-4057qib7	13992	10	15	15	CD
cord-005453-4057qib7	13992	11	min	min	NN
cord-005453-4057qib7	13992	12	,	,	,
cord-005453-4057qib7	13992	13	and	and	CC
cord-005453-4057qib7	13992	14	stored	store	VBN
cord-005453-4057qib7	13992	15	at	at	IN
cord-005453-4057qib7	13992	16	-80˚C	-80˚c	NN
cord-005453-4057qib7	13992	17	until	until	IN
cord-005453-4057qib7	13992	18	used	use	VBN
cord-005453-4057qib7	13992	19	.	.	.
cord-005453-4057qib7	13993	1	We	-PRON-	PRP
cord-005453-4057qib7	13993	2	also	also	RB
cord-005453-4057qib7	13993	3	examined	examine	VBD
cord-005453-4057qib7	13993	4	SCT	SCT	NNP
cord-005453-4057qib7	13993	5	related	relate	VBN
cord-005453-4057qib7	13993	6	complications	complication	NNS
cord-005453-4057qib7	13993	7	such	such	JJ
cord-005453-4057qib7	13993	8	as	as	IN
cord-005453-4057qib7	13993	9	graft	graft	NN
cord-005453-4057qib7	13993	10	-	-	HYPH
cord-005453-4057qib7	13993	11	Versus	versus	IN
cord-005453-4057qib7	13993	12	-	-	HYPH
cord-005453-4057qib7	13993	13	host	host	NN
cord-005453-4057qib7	13993	14	disease	disease	NN
cord-005453-4057qib7	13993	15	(	(	-LRB-
cord-005453-4057qib7	13993	16	GVHD	GVHD	NNP
cord-005453-4057qib7	13993	17	)	)	-RRB-
cord-005453-4057qib7	13993	18	,	,	,
cord-005453-4057qib7	13993	19	viral	viral	JJ
cord-005453-4057qib7	13993	20	infection	infection	NN
cord-005453-4057qib7	13993	21	,	,	,
cord-005453-4057qib7	13993	22	and	and	CC
cord-005453-4057qib7	13993	23	pre	pre	JJ
cord-005453-4057qib7	13993	24	-	-	JJ
cord-005453-4057qib7	13993	25	engraft	engraft	JJ
cord-005453-4057qib7	13993	26	syndrome	syndrome	NN
cord-005453-4057qib7	13993	27	(	(	-LRB-
cord-005453-4057qib7	13993	28	PES	PES	NNP
cord-005453-4057qib7	13993	29	)	)	-RRB-
cord-005453-4057qib7	13993	30	.	.	.
cord-005453-4057qib7	13994	1	Statistical	statistical	JJ
cord-005453-4057qib7	13994	2	analyses	analysis	NNS
cord-005453-4057qib7	13994	3	were	be	VBD
cord-005453-4057qib7	13994	4	completed	complete	VBN
cord-005453-4057qib7	13994	5	using	use	VBG
cord-005453-4057qib7	13994	6	the	the	DT
cord-005453-4057qib7	13994	7	Mann	Mann	NNP
cord-005453-4057qib7	13994	8	-	-	HYPH
cord-005453-4057qib7	13994	9	Whitney	Whitney	NNP
cord-005453-4057qib7	13994	10	U	U	NNP
cord-005453-4057qib7	13994	11	test	test	VBP
cord-005453-4057qib7	13994	12	for	for	IN
cord-005453-4057qib7	13994	13	unpaired	unpaired	JJ
cord-005453-4057qib7	13994	14	samples	sample	NNS
cord-005453-4057qib7	13994	15	,	,	,
cord-005453-4057qib7	13994	16	and	and	CC
cord-005453-4057qib7	13994	17	Kruskal	Kruskal	NNP
cord-005453-4057qib7	13994	18	-	-	HYPH
cord-005453-4057qib7	13994	19	Wallis	Wallis	NNP
cord-005453-4057qib7	13994	20	test	test	NN
cord-005453-4057qib7	13994	21	for	for	IN
cord-005453-4057qib7	13994	22	three	three	CD
cord-005453-4057qib7	13994	23	samples	sample	NNS
cord-005453-4057qib7	13994	24	.	.	.
cord-005453-4057qib7	13995	1	Each	each	DT
cord-005453-4057qib7	13995	2	test	test	NN
cord-005453-4057qib7	13995	3	was	be	VBD
cord-005453-4057qib7	13995	4	performed	perform	VBN
cord-005453-4057qib7	13995	5	with	with	IN
cord-005453-4057qib7	13995	6	a	a	DT
cord-005453-4057qib7	13995	7	5	5	CD
cord-005453-4057qib7	13995	8	%	%	NN
cord-005453-4057qib7	13995	9	level	level	NN
cord-005453-4057qib7	13995	10	of	of	IN
cord-005453-4057qib7	13995	11	significance	significance	NN
cord-005453-4057qib7	13995	12	.	.	.
cord-005453-4057qib7	13996	1	Results	result	NNS
cord-005453-4057qib7	13996	2	:	:	:
cord-005453-4057qib7	13997	1	The	the	DT
cord-005453-4057qib7	13997	2	average	average	JJ
cord-005453-4057qib7	13997	3	value	value	NN
cord-005453-4057qib7	13997	4	of	of	IN
cord-005453-4057qib7	13997	5	5SCD	5scd	RB
cord-005453-4057qib7	13997	6	reached	reach	VBD
cord-005453-4057qib7	13997	7	two	two	CD
cord-005453-4057qib7	13997	8	peaks	peak	NNS
cord-005453-4057qib7	13997	9	,	,	,
cord-005453-4057qib7	13997	10	day0	day0	NN
cord-005453-4057qib7	13997	11	(	(	-LRB-
cord-005453-4057qib7	13997	12	21.6	21.6	CD
cord-005453-4057qib7	13997	13	nmol	nmol	NNP
cord-005453-4057qib7	13997	14	/	/	SYM
cord-005453-4057qib7	13997	15	L	L	NNP
cord-005453-4057qib7	13997	16	)	)	-RRB-
cord-005453-4057qib7	13997	17	and	and	CC
cord-005453-4057qib7	13997	18	day5	day5	NN
cord-005453-4057qib7	13997	19	(	(	-LRB-
cord-005453-4057qib7	13997	20	21.7	21.7	CD
cord-005453-4057qib7	13997	21	nmol	nmol	NNP
cord-005453-4057qib7	13997	22	/	/	SYM
cord-005453-4057qib7	13997	23	L	L	NNP
cord-005453-4057qib7	13997	24	)	)	-RRB-
cord-005453-4057qib7	13997	25	,	,	,
cord-005453-4057qib7	13997	26	regardless	regardless	RB
cord-005453-4057qib7	13997	27	of	of	IN
cord-005453-4057qib7	13997	28	stem	stem	NN
cord-005453-4057qib7	13997	29	cell	cell	NN
cord-005453-4057qib7	13997	30	source	source	NN
cord-005453-4057qib7	13997	31	and	and	CC
cord-005453-4057qib7	13997	32	intensity	intensity	NN
cord-005453-4057qib7	13997	33	of	of	IN
cord-005453-4057qib7	13997	34	conditioning	conditioning	NN
cord-005453-4057qib7	13997	35	.	.	.
cord-005453-4057qib7	13998	1	In	in	IN
cord-005453-4057qib7	13998	2	all	all	DT
cord-005453-4057qib7	13998	3	patients	patient	NNS
cord-005453-4057qib7	13998	4	,	,	,
cord-005453-4057qib7	13998	5	we	-PRON-	PRP
cord-005453-4057qib7	13998	6	found	find	VBD
cord-005453-4057qib7	13998	7	that	that	IN
cord-005453-4057qib7	13998	8	the	the	DT
cord-005453-4057qib7	13998	9	level	level	NN
cord-005453-4057qib7	13998	10	of	of	IN
cord-005453-4057qib7	13998	11	5SCD	5scd	NN
cord-005453-4057qib7	13998	12	on	on	IN
cord-005453-4057qib7	13998	13	day0	day0	NNS
cord-005453-4057qib7	13998	14	was	be	VBD
cord-005453-4057qib7	13998	15	associated	associate	VBN
cord-005453-4057qib7	13998	16	with	with	IN
cord-005453-4057qib7	13998	17	viral	viral	JJ
cord-005453-4057qib7	13998	18	reactivation	reactivation	NN
cord-005453-4057qib7	13998	19	(	(	-LRB-
cord-005453-4057qib7	13998	20	p=0.049	p=0.049	NNP
cord-005453-4057qib7	13998	21	)	)	-RRB-
cord-005453-4057qib7	13998	22	,	,	.
cord-005453-4057qib7	13999	1	5SCD	5scd	JJ
cord-005453-4057qib7	13999	2	on	on	IN
cord-005453-4057qib7	13999	3	day5	day5	NNP
cord-005453-4057qib7	13999	4	was	be	VBD
cord-005453-4057qib7	13999	5	associated	associate	VBN
cord-005453-4057qib7	13999	6	with	with	IN
cord-005453-4057qib7	13999	7	PES	PES	NNP
cord-005453-4057qib7	13999	8	(	(	-LRB-
cord-005453-4057qib7	13999	9	p=0.034	p=0.034	NNP
cord-005453-4057qib7	13999	10	)	)	-RRB-
cord-005453-4057qib7	13999	11	,	,	,
cord-005453-4057qib7	13999	12	and	and	CC
cord-005453-4057qib7	13999	13	5SCD	5scd	JJ
cord-005453-4057qib7	13999	14	on	on	IN
cord-005453-4057qib7	13999	15	day40	day40	NNP
cord-005453-4057qib7	13999	16	was	be	VBD
cord-005453-4057qib7	13999	17	associated	associate	VBN
cord-005453-4057qib7	13999	18	with	with	IN
cord-005453-4057qib7	13999	19	malignant	malignant	JJ
cord-005453-4057qib7	13999	20	disease	disease	NN
cord-005453-4057qib7	13999	21	(	(	-LRB-
cord-005453-4057qib7	13999	22	p=0.04	p=0.04	NN
cord-005453-4057qib7	13999	23	)	)	-RRB-
cord-005453-4057qib7	13999	24	.	.	.
cord-005453-4057qib7	14000	1	Similarly	similarly	RB
cord-005453-4057qib7	14000	2	,	,	,
cord-005453-4057qib7	14000	3	in	in	IN
cord-005453-4057qib7	14000	4	patient	patient	NN
cord-005453-4057qib7	14000	5	who	who	WP
cord-005453-4057qib7	14000	6	received	receive	VBD
cord-005453-4057qib7	14000	7	allogeneic	allogeneic	IN
cord-005453-4057qib7	14000	8	SCT	SCT	NNP
cord-005453-4057qib7	14000	9	(	(	-LRB-
cord-005453-4057qib7	14000	10	N=34	N=34	NNP
cord-005453-4057qib7	14000	11	)	)	-RRB-
cord-005453-4057qib7	14000	12	,	,	,
cord-005453-4057qib7	14000	13	the	the	DT
cord-005453-4057qib7	14000	14	level	level	NN
cord-005453-4057qib7	14000	15	of	of	IN
cord-005453-4057qib7	14000	16	5SCD	5scd	NN
cord-005453-4057qib7	14000	17	on	on	IN
cord-005453-4057qib7	14000	18	day0	day0	NNS
cord-005453-4057qib7	14000	19	was	be	VBD
cord-005453-4057qib7	14000	20	associated	associate	VBN
cord-005453-4057qib7	14000	21	with	with	IN
cord-005453-4057qib7	14000	22	viral	viral	JJ
cord-005453-4057qib7	14000	23	reactivation	reactivation	NN
cord-005453-4057qib7	14000	24	(	(	-LRB-
cord-005453-4057qib7	14000	25	p=0.048	p=0.048	NNP
cord-005453-4057qib7	14000	26	)	)	-RRB-
cord-005453-4057qib7	14000	27	,	,	,
cord-005453-4057qib7	14000	28	5SCD	5scd	JJ
cord-005453-4057qib7	14000	29	on	on	IN
cord-005453-4057qib7	14000	30	day5	day5	NN
cord-005453-4057qib7	14000	31	was	be	VBD
cord-005453-4057qib7	14000	32	was	be	VBD
cord-005453-4057qib7	14000	33	associated	associate	VBN
cord-005453-4057qib7	14000	34	with	with	IN
cord-005453-4057qib7	14000	35	PES	PES	NNP
cord-005453-4057qib7	14000	36	(	(	-LRB-
cord-005453-4057qib7	14000	37	p=0.034	p=0.034	NNP
cord-005453-4057qib7	14000	38	)	)	-RRB-
cord-005453-4057qib7	14000	39	,	,	,
cord-005453-4057qib7	14000	40	5SCD	5scd	RB
cord-005453-4057qib7	14000	41	on	on	IN
cord-005453-4057qib7	14000	42	day	day	NN
cord-005453-4057qib7	14000	43	40	40	CD
cord-005453-4057qib7	14000	44	was	be	VBD
cord-005453-4057qib7	14000	45	associated	associate	VBN
cord-005453-4057qib7	14000	46	with	with	IN
cord-005453-4057qib7	14000	47	malignant	malignant	JJ
cord-005453-4057qib7	14000	48	disease	disease	NN
cord-005453-4057qib7	14000	49	(	(	-LRB-
cord-005453-4057qib7	14000	50	p=0.04	p=0.04	NN
cord-005453-4057qib7	14000	51	)	)	-RRB-
cord-005453-4057qib7	14000	52	.	.	.
cord-005453-4057qib7	14001	1	In	in	IN
cord-005453-4057qib7	14001	2	addition	addition	NN
cord-005453-4057qib7	14001	3	,	,	,
cord-005453-4057qib7	14001	4	the	the	DT
cord-005453-4057qib7	14001	5	level	level	NN
cord-005453-4057qib7	14001	6	of	of	IN
cord-005453-4057qib7	14001	7	5SCD	5scd	NN
cord-005453-4057qib7	14001	8	on	on	IN
cord-005453-4057qib7	14001	9	day5	day5	NN
cord-005453-4057qib7	14001	10	was	be	VBD
cord-005453-4057qib7	14001	11	associated	associate	VBN
cord-005453-4057qib7	14001	12	with	with	IN
cord-005453-4057qib7	14001	13	GVHD	GVHD	NNP
cord-005453-4057qib7	14001	14	of	of	IN
cord-005453-4057qib7	14001	15	skin	skin	NN
cord-005453-4057qib7	14001	16	(	(	-LRB-
cord-005453-4057qib7	14001	17	p=0.027	p=0.027	NNP
cord-005453-4057qib7	14001	18	)	)	-RRB-
cord-005453-4057qib7	14001	19	,	,	,
cord-005453-4057qib7	14001	20	the	the	DT
cord-005453-4057qib7	14001	21	peak	peak	NN
cord-005453-4057qib7	14001	22	level	level	NN
cord-005453-4057qib7	14001	23	of	of	IN
cord-005453-4057qib7	14001	24	5SCD	5scd	CD
cord-005453-4057qib7	14001	25	was	be	VBD
cord-005453-4057qib7	14001	26	associated	associate	VBN
cord-005453-4057qib7	14001	27	with	with	IN
cord-005453-4057qib7	14001	28	acute	acute	JJ
cord-005453-4057qib7	14001	29	GVHD	GVHD	NNP
cord-005453-4057qib7	14001	30	(	(	-LRB-
cord-005453-4057qib7	14001	31	p=0.04	p=0.04	NNP
cord-005453-4057qib7	14001	32	)	)	-RRB-
cord-005453-4057qib7	14001	33	.	.	.
cord-005453-4057qib7	14002	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14002	2	:	:	:
cord-005453-4057qib7	14003	1	We	-PRON-	PRP
cord-005453-4057qib7	14003	2	found	find	VBD
cord-005453-4057qib7	14003	3	that	that	IN
cord-005453-4057qib7	14003	4	5SCD	5scd	NN
cord-005453-4057qib7	14003	5	can	can	MD
cord-005453-4057qib7	14003	6	be	be	VB
cord-005453-4057qib7	14003	7	a	a	DT
cord-005453-4057qib7	14003	8	biomarker	biomarker	NN
cord-005453-4057qib7	14003	9	for	for	IN
cord-005453-4057qib7	14003	10	SCT	SCT	NNP
cord-005453-4057qib7	14003	11	-	-	HYPH
cord-005453-4057qib7	14003	12	related	relate	VBN
cord-005453-4057qib7	14003	13	complications	complication	NNS
cord-005453-4057qib7	14003	14	such	such	JJ
cord-005453-4057qib7	14003	15	as	as	IN
cord-005453-4057qib7	14003	16	aute	aute	NNP
cord-005453-4057qib7	14003	17	GVHD	GVHD	NNP
cord-005453-4057qib7	14003	18	.	.	.
cord-005453-4057qib7	14004	1	It	-PRON-	PRP
cord-005453-4057qib7	14004	2	is	be	VBZ
cord-005453-4057qib7	14004	3	presumed	presume	VBN
cord-005453-4057qib7	14004	4	that	that	IN
cord-005453-4057qib7	14004	5	the	the	DT
cord-005453-4057qib7	14004	6	production	production	NN
cord-005453-4057qib7	14004	7	of	of	IN
cord-005453-4057qib7	14004	8	pheomelanin	pheomelanin	NNS
cord-005453-4057qib7	14004	9	could	could	MD
cord-005453-4057qib7	14004	10	be	be	VB
cord-005453-4057qib7	14004	11	induced	induce	VBN
cord-005453-4057qib7	14004	12	by	by	IN
cord-005453-4057qib7	14004	13	inflammatory	inflammatory	JJ
cord-005453-4057qib7	14004	14	procedure	procedure	NN
cord-005453-4057qib7	14004	15	in	in	IN
cord-005453-4057qib7	14004	16	SCT	SCT	NNP
cord-005453-4057qib7	14004	17	.	.	.
cord-005453-4057qib7	14005	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14005	2	:	:	:
cord-005453-4057qib7	14005	3	Nothing	nothing	NN
cord-005453-4057qib7	14005	4	to	to	TO
cord-005453-4057qib7	14005	5	declare	declare	VB
cord-005453-4057qib7	14005	6	P644	p644	CD
cord-005453-4057qib7	14005	7	HSCT	HSCT	NNP
cord-005453-4057qib7	14005	8	in	in	IN
cord-005453-4057qib7	14005	9	children	child	NNS
cord-005453-4057qib7	14005	10	with	with	IN
cord-005453-4057qib7	14005	11	bone	bone	NN
cord-005453-4057qib7	14005	12	marrow	marrow	NN
cord-005453-4057qib7	14005	13	failure	failure	NN
cord-005453-4057qib7	14005	14	:	:	:
cord-005453-4057qib7	14005	15	Outcomes	outcome	NNS
cord-005453-4057qib7	14005	16	from	from	IN
cord-005453-4057qib7	14005	17	a	a	DT
cord-005453-4057qib7	14005	18	single	single	JJ
cord-005453-4057qib7	14005	19	Singapore	Singapore	NNP
cord-005453-4057qib7	14005	20	centre	centre	NN
cord-005453-4057qib7	14005	21	Prasad	Prasad	NNP
cord-005453-4057qib7	14005	22	Iyer	Iyer	NNP
cord-005453-4057qib7	14005	23	1	1	CD
cord-005453-4057qib7	14005	24	,	,	,
cord-005453-4057qib7	14005	25	Michaela	Michaela	NNP
cord-005453-4057qib7	14005	26	Seng	Seng	NNP
cord-005453-4057qib7	14005	27	1	1	CD
cord-005453-4057qib7	14005	28	,	,	,
cord-005453-4057qib7	14005	29	Vijayakumari	Vijayakumari	NNP
cord-005453-4057qib7	14005	30	K	K	NNP
cord-005453-4057qib7	14005	31	1	1	CD
cord-005453-4057qib7	14005	32	,	,	,
cord-005453-4057qib7	14005	33	Ah	Ah	NNP
cord-005453-4057qib7	14005	34	Moy	Moy	NNP
cord-005453-4057qib7	14005	35	Tan	Tan	NNP
cord-005453-4057qib7	14005	36	1	1	CD
cord-005453-4057qib7	14005	37	,	,	,
cord-005453-4057qib7	14005	38	Mei	Mei	NNP
cord-005453-4057qib7	14005	39	Yoke	Yoke	NNP
cord-005453-4057qib7	14005	40	Chan	Chan	NNP
cord-005453-4057qib7	14005	41	1	1	CD
cord-005453-4057qib7	14005	42	,	,	,
cord-005453-4057qib7	14005	43	Rajat	Rajat	NNP
cord-005453-4057qib7	14005	44	Bhattacharyya	Bhattacharyya	NNP
cord-005453-4057qib7	14006	1	1	1	CD
cord-005453-4057qib7	14006	2	1	1	CD
cord-005453-4057qib7	14006	3	KK	KK	NNP
cord-005453-4057qib7	14006	4	Women	Women	NNP
cord-005453-4057qib7	14006	5	's	's	POS
cord-005453-4057qib7	14006	6	and	and	CC
cord-005453-4057qib7	14007	1	Children	child	NNS
cord-005453-4057qib7	14007	2	's	's	POS
cord-005453-4057qib7	14007	3	Hospital	Hospital	NNP
cord-005453-4057qib7	14007	4	,	,	,
cord-005453-4057qib7	14007	5	Paediatric	Paediatric	NNP
cord-005453-4057qib7	14007	6	Haematology	Haematology	NNP
cord-005453-4057qib7	14007	7	-	-	HYPH
cord-005453-4057qib7	14007	8	Oncology	Oncology	NNP
cord-005453-4057qib7	14007	9	,	,	,
cord-005453-4057qib7	14007	10	Singapore	Singapore	NNP
cord-005453-4057qib7	14007	11	,	,	,
cord-005453-4057qib7	14007	12	Singapore	Singapore	NNP
cord-005453-4057qib7	14007	13	Background	Background	NNP
cord-005453-4057qib7	14007	14	:	:	:
cord-005453-4057qib7	14008	1	Children	child	NNS
cord-005453-4057qib7	14008	2	presenting	present	VBG
cord-005453-4057qib7	14008	3	with	with	IN
cord-005453-4057qib7	14008	4	pancytopenia	pancytopenia	NNP
cord-005453-4057qib7	14008	5	often	often	RB
cord-005453-4057qib7	14008	6	present	present	VBP
cord-005453-4057qib7	14008	7	a	a	DT
cord-005453-4057qib7	14008	8	challenge	challenge	NN
cord-005453-4057qib7	14008	9	to	to	IN
cord-005453-4057qib7	14008	10	the	the	DT
cord-005453-4057qib7	14008	11	paediatric	paediatric	JJ
cord-005453-4057qib7	14008	12	haematologist	haematologist	NN
cord-005453-4057qib7	14008	13	.	.	.
cord-005453-4057qib7	14009	1	The	the	DT
cord-005453-4057qib7	14009	2	underlying	underlie	VBG
cord-005453-4057qib7	14009	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	14009	4	can	can	MD
cord-005453-4057qib7	14009	5	be	be	VB
cord-005453-4057qib7	14009	6	hard	hard	JJ
cord-005453-4057qib7	14009	7	to	to	TO
cord-005453-4057qib7	14009	8	establish	establish	VB
cord-005453-4057qib7	14009	9	as	as	RB
cord-005453-4057qib7	14009	10	many	many	JJ
cord-005453-4057qib7	14009	11	of	of	IN
cord-005453-4057qib7	14009	12	the	the	DT
cord-005453-4057qib7	14009	13	inherited	inherit	VBN
cord-005453-4057qib7	14009	14	bone	bone	NN
cord-005453-4057qib7	14009	15	marrow	marrow	NN
cord-005453-4057qib7	14009	16	failure	failure	NN
cord-005453-4057qib7	14009	17	syndromes	syndrome	NNS
cord-005453-4057qib7	14009	18	(	(	-LRB-
cord-005453-4057qib7	14009	19	IBMFS	IBMFS	NNP
cord-005453-4057qib7	14009	20	)	)	-RRB-
cord-005453-4057qib7	14009	21	can	can	MD
cord-005453-4057qib7	14009	22	present	present	VB
cord-005453-4057qib7	14009	23	with	with	IN
cord-005453-4057qib7	14009	24	protean	protean	JJ
cord-005453-4057qib7	14009	25	manifestations	manifestation	NNS
cord-005453-4057qib7	14009	26	.	.	.
cord-005453-4057qib7	14010	1	The	the	DT
cord-005453-4057qib7	14010	2	large	large	JJ
cord-005453-4057qib7	14010	3	majority	majority	NN
cord-005453-4057qib7	14010	4	of	of	IN
cord-005453-4057qib7	14010	5	patients	patient	NNS
cord-005453-4057qib7	14010	6	with	with	IN
cord-005453-4057qib7	14010	7	bone	bone	NN
cord-005453-4057qib7	14010	8	marrow	marrow	NN
cord-005453-4057qib7	14010	9	failure	failure	NN
cord-005453-4057qib7	14010	10	are	be	VBP
cord-005453-4057qib7	14010	11	often	often	RB
cord-005453-4057qib7	14010	12	diagnosed	diagnose	VBN
cord-005453-4057qib7	14010	13	with	with	IN
cord-005453-4057qib7	14010	14	idiopathic	idiopathic	JJ
cord-005453-4057qib7	14010	15	severe	severe	JJ
cord-005453-4057qib7	14010	16	aplastic	aplastic	JJ
cord-005453-4057qib7	14010	17	anaemia	anaemia	NN
cord-005453-4057qib7	14010	18	(	(	-LRB-
cord-005453-4057qib7	14010	19	SAA	SAA	NNP
cord-005453-4057qib7	14010	20	)	)	-RRB-
cord-005453-4057qib7	14010	21	despite	despite	IN
cord-005453-4057qib7	14010	22	extensive	extensive	JJ
cord-005453-4057qib7	14010	23	testing	testing	NN
cord-005453-4057qib7	14010	24	.	.	.
cord-005453-4057qib7	14011	1	We	-PRON-	PRP
cord-005453-4057qib7	14011	2	report	report	VBP
cord-005453-4057qib7	14011	3	our	-PRON-	PRP$
cord-005453-4057qib7	14011	4	experience	experience	NN
cord-005453-4057qib7	14011	5	of	of	IN
cord-005453-4057qib7	14011	6	HSCT	HSCT	NNP
cord-005453-4057qib7	14011	7	in	in	IN
cord-005453-4057qib7	14011	8	patients	patient	NNS
cord-005453-4057qib7	14011	9	treated	treat	VBN
cord-005453-4057qib7	14011	10	with	with	IN
cord-005453-4057qib7	14011	11	primary	primary	JJ
cord-005453-4057qib7	14011	12	and	and	CC
cord-005453-4057qib7	14011	13	acquired	acquire	VBN
cord-005453-4057qib7	14011	14	bone	bone	NN
cord-005453-4057qib7	14011	15	marrow	marrow	NN
cord-005453-4057qib7	14011	16	failure	failure	NN
cord-005453-4057qib7	14011	17	.	.	.
cord-005453-4057qib7	14012	1	Methods	method	NNS
cord-005453-4057qib7	14012	2	:	:	:
cord-005453-4057qib7	14012	3	We	-PRON-	PRP
cord-005453-4057qib7	14012	4	reviewed	review	VBD
cord-005453-4057qib7	14012	5	case	case	NN
cord-005453-4057qib7	14012	6	notes	note	NNS
cord-005453-4057qib7	14012	7	of	of	IN
cord-005453-4057qib7	14012	8	all	all	PDT
cord-005453-4057qib7	14012	9	the	the	DT
cord-005453-4057qib7	14012	10	children	child	NNS
cord-005453-4057qib7	14012	11	who	who	WP
cord-005453-4057qib7	14012	12	underwent	undergo	VBD
cord-005453-4057qib7	14012	13	HSCT	HSCT	NNP
cord-005453-4057qib7	14012	14	for	for	IN
cord-005453-4057qib7	14012	15	bone	bone	NN
cord-005453-4057qib7	14012	16	marrow	marrow	NN
cord-005453-4057qib7	14012	17	failure	failure	NN
cord-005453-4057qib7	14012	18	in	in	IN
cord-005453-4057qib7	14012	19	our	-PRON-	PRP$
cord-005453-4057qib7	14012	20	centre	centre	NN
cord-005453-4057qib7	14012	21	.	.	.
cord-005453-4057qib7	14013	1	Results	result	NNS
cord-005453-4057qib7	14013	2	:	:	:
cord-005453-4057qib7	14014	1	A	a	DT
cord-005453-4057qib7	14014	2	total	total	NN
cord-005453-4057qib7	14014	3	of	of	IN
cord-005453-4057qib7	14014	4	fifteen	fifteen	CD
cord-005453-4057qib7	14014	5	patients	patient	NNS
cord-005453-4057qib7	14014	6	underwent	undergo	VBD
cord-005453-4057qib7	14014	7	eighteen	eighteen	CD
cord-005453-4057qib7	14014	8	stem	stem	NN
cord-005453-4057qib7	14014	9	cell	cell	NN
cord-005453-4057qib7	14014	10	transplants	transplant	NNS
cord-005453-4057qib7	14014	11	in	in	IN
cord-005453-4057qib7	14014	12	our	-PRON-	PRP$
cord-005453-4057qib7	14014	13	centre	centre	NN
cord-005453-4057qib7	14014	14	between	between	IN
cord-005453-4057qib7	14014	15	2003	2003	CD
cord-005453-4057qib7	14014	16	and	and	CC
cord-005453-4057qib7	14014	17	2016	2016	CD
cord-005453-4057qib7	14014	18	.	.	.
cord-005453-4057qib7	14015	1	Three	three	CD
cord-005453-4057qib7	14015	2	patients	patient	NNS
cord-005453-4057qib7	14015	3	were	be	VBD
cord-005453-4057qib7	14015	4	diagnosed	diagnose	VBN
cord-005453-4057qib7	14015	5	with	with	IN
cord-005453-4057qib7	14015	6	Fanconi	Fanconi	NNP
cord-005453-4057qib7	14015	7	Anaemia	Anaemia	NNP
cord-005453-4057qib7	14015	8	,	,	,
cord-005453-4057qib7	14015	9	one	one	CD
cord-005453-4057qib7	14015	10	with	with	IN
cord-005453-4057qib7	14015	11	Hoyeraal	Hoyeraal	NNP
cord-005453-4057qib7	14015	12	-	-	HYPH
cord-005453-4057qib7	14015	13	Hreidarsson	Hreidarsson	NNP
cord-005453-4057qib7	14015	14	syndrome	syndrome	NN
cord-005453-4057qib7	14015	15	,	,	,
cord-005453-4057qib7	14015	16	one	one	CD
cord-005453-4057qib7	14015	17	with	with	IN
cord-005453-4057qib7	14015	18	paroxysmal	paroxysmal	JJ
cord-005453-4057qib7	14015	19	nocturnal	nocturnal	JJ
cord-005453-4057qib7	14015	20	haemoglobinuria	haemoglobinuria	NNS
cord-005453-4057qib7	14015	21	and	and	CC
cord-005453-4057qib7	14015	22	the	the	DT
cord-005453-4057qib7	14015	23	remaining	remain	VBG
cord-005453-4057qib7	14015	24	ten	ten	CD
cord-005453-4057qib7	14015	25	children	child	NNS
cord-005453-4057qib7	14015	26	had	have	VBD
cord-005453-4057qib7	14015	27	idiopathic	idiopathic	JJ
cord-005453-4057qib7	14015	28	SAA	SAA	NNP
cord-005453-4057qib7	14015	29	.	.	.
cord-005453-4057qib7	14016	1	Eight	eight	CD
cord-005453-4057qib7	14016	2	children	child	NNS
cord-005453-4057qib7	14016	3	had	have	VBD
cord-005453-4057qib7	14016	4	matched	match	VBN
cord-005453-4057qib7	14016	5	sibling	sibling	NN
cord-005453-4057qib7	14016	6	donor	donor	NN
cord-005453-4057qib7	14016	7	transplant	transplant	NN
cord-005453-4057qib7	14016	8	,	,	,
cord-005453-4057qib7	14016	9	1	1	CD
cord-005453-4057qib7	14016	10	had	have	VBD
cord-005453-4057qib7	14016	11	a	a	DT
cord-005453-4057qib7	14016	12	matched	match	VBN
cord-005453-4057qib7	14016	13	related	related	JJ
cord-005453-4057qib7	14016	14	donor	donor	NN
cord-005453-4057qib7	14016	15	,	,	,
cord-005453-4057qib7	14016	16	1	1	CD
cord-005453-4057qib7	14016	17	had	have	VBD
cord-005453-4057qib7	14016	18	a	a	DT
cord-005453-4057qib7	14016	19	matched	match	VBN
cord-005453-4057qib7	14016	20	unrelated	unrelated	JJ
cord-005453-4057qib7	14016	21	donor	donor	NN
cord-005453-4057qib7	14016	22	,	,	,
cord-005453-4057qib7	14016	23	3	3	CD
cord-005453-4057qib7	14016	24	had	have	VBD
cord-005453-4057qib7	14016	25	umbilical	umbilical	JJ
cord-005453-4057qib7	14016	26	cord	cord	NN
cord-005453-4057qib7	14016	27	blood	blood	NN
cord-005453-4057qib7	14016	28	transplants	transplant	NNS
cord-005453-4057qib7	14016	29	and	and	CC
cord-005453-4057qib7	14016	30	the	the	DT
cord-005453-4057qib7	14016	31	remainder	remainder	NN
cord-005453-4057qib7	14016	32	5	5	CD
cord-005453-4057qib7	14016	33	were	be	VBD
cord-005453-4057qib7	14016	34	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14016	35	transplants	transplant	NNS
cord-005453-4057qib7	14016	36	.	.	.
cord-005453-4057qib7	14017	1	Four	four	CD
cord-005453-4057qib7	14017	2	of	of	IN
cord-005453-4057qib7	14017	3	the	the	DT
cord-005453-4057qib7	14017	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14017	5	transplants	transplant	NNS
cord-005453-4057qib7	14017	6	were	be	VBD
cord-005453-4057qib7	14017	7	T	t	NN
cord-005453-4057qib7	14017	8	-	-	HYPH
cord-005453-4057qib7	14017	9	cell	cell	NN
cord-005453-4057qib7	14017	10	depleted	deplete	VBN
cord-005453-4057qib7	14017	11	and	and	CC
cord-005453-4057qib7	14017	12	one	one	CD
cord-005453-4057qib7	14017	13	was	be	VBD
cord-005453-4057qib7	14017	14	T	t	NN
cord-005453-4057qib7	14017	15	-	-	HYPH
cord-005453-4057qib7	14017	16	cell	cell	NN
cord-005453-4057qib7	14017	17	replete	replete	NN
cord-005453-4057qib7	14017	18	.	.	.
cord-005453-4057qib7	14018	1	One	one	CD
cord-005453-4057qib7	14018	2	child	child	NN
cord-005453-4057qib7	14018	3	with	with	IN
cord-005453-4057qib7	14018	4	Fanconi	Fanconi	NNP
cord-005453-4057qib7	14018	5	anaemia	anaemia	NN
cord-005453-4057qib7	14018	6	had	have	VBD
cord-005453-4057qib7	14018	7	primary	primary	JJ
cord-005453-4057qib7	14018	8	graft	graft	NN
cord-005453-4057qib7	14018	9	rejection	rejection	NN
cord-005453-4057qib7	14018	10	with	with	IN
cord-005453-4057qib7	14018	11	cord	cord	NN
cord-005453-4057qib7	14018	12	blood	blood	NN
cord-005453-4057qib7	14018	13	transplant	transplant	NN
cord-005453-4057qib7	14018	14	and	and	CC
cord-005453-4057qib7	14018	15	was	be	VBD
cord-005453-4057qib7	14018	16	successfully	successfully	RB
cord-005453-4057qib7	14018	17	rescued	rescue	VBN
cord-005453-4057qib7	14018	18	with	with	IN
cord-005453-4057qib7	14018	19	a	a	DT
cord-005453-4057qib7	14018	20	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14018	21	transplant	transplant	NN
cord-005453-4057qib7	14018	22	.	.	.
cord-005453-4057qib7	14019	1	One	one	CD
cord-005453-4057qib7	14019	2	child	child	NN
cord-005453-4057qib7	14019	3	with	with	IN
cord-005453-4057qib7	14019	4	SAA	SAA	NNP
cord-005453-4057qib7	14019	5	had	have	VBD
cord-005453-4057qib7	14019	6	primary	primary	JJ
cord-005453-4057qib7	14019	7	graft	graft	NN
cord-005453-4057qib7	14019	8	rejection	rejection	NN
cord-005453-4057qib7	14019	9	twice	twice	RB
cord-005453-4057qib7	14019	10	(	(	-LRB-
cord-005453-4057qib7	14019	11	T	t	NN
cord-005453-4057qib7	14019	12	-	-	HYPH
cord-005453-4057qib7	14019	13	cell	cell	NN
cord-005453-4057qib7	14019	14	depleted	deplete	VBN
cord-005453-4057qib7	14019	15	graft	graft	NN
cord-005453-4057qib7	14019	16	)	)	-RRB-
cord-005453-4057qib7	14019	17	and	and	CC
cord-005453-4057qib7	14019	18	then	then	RB
cord-005453-4057qib7	14019	19	was	be	VBD
cord-005453-4057qib7	14019	20	rescued	rescue	VBN
cord-005453-4057qib7	14019	21	with	with	IN
cord-005453-4057qib7	14019	22	an	an	DT
cord-005453-4057qib7	14019	23	alternate	alternate	JJ
cord-005453-4057qib7	14019	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14019	25	donor	donor	NN
cord-005453-4057qib7	14019	26	with	with	IN
cord-005453-4057qib7	14019	27	a	a	DT
cord-005453-4057qib7	14019	28	T	t	NN
cord-005453-4057qib7	14019	29	-	-	HYPH
cord-005453-4057qib7	14019	30	cell	cell	NN
cord-005453-4057qib7	14019	31	replete	replete	JJ
cord-005453-4057qib7	14019	32	graft	graft	NN
cord-005453-4057qib7	14019	33	.	.	.
cord-005453-4057qib7	14020	1	Of	of	IN
cord-005453-4057qib7	14020	2	the	the	DT
cord-005453-4057qib7	14020	3	two	two	CD
cord-005453-4057qib7	14020	4	patients	patient	NNS
cord-005453-4057qib7	14020	5	who	who	WP
cord-005453-4057qib7	14020	6	died	die	VBD
cord-005453-4057qib7	14020	7	,	,	,
cord-005453-4057qib7	14020	8	one	one	PRP
cord-005453-4057qib7	14020	9	had	have	VBD
cord-005453-4057qib7	14020	10	a	a	DT
cord-005453-4057qib7	14020	11	fatal	fatal	JJ
cord-005453-4057qib7	14020	12	fungal	fungal	NN
cord-005453-4057qib7	14020	13	infection	infection	NN
cord-005453-4057qib7	14020	14	ten	ten	CD
cord-005453-4057qib7	14020	15	months	month	NNS
cord-005453-4057qib7	14020	16	after	after	IN
cord-005453-4057qib7	14020	17	transplant	transplant	NN
cord-005453-4057qib7	14020	18	,	,	,
cord-005453-4057qib7	14020	19	and	and	CC
cord-005453-4057qib7	14020	20	the	the	DT
cord-005453-4057qib7	14020	21	other	other	JJ
cord-005453-4057qib7	14020	22	died	die	VBD
cord-005453-4057qib7	14020	23	due	due	IN
cord-005453-4057qib7	14020	24	to	to	IN
cord-005453-4057qib7	14020	25	a	a	DT
cord-005453-4057qib7	14020	26	severe	severe	JJ
cord-005453-4057qib7	14020	27	influenza	influenza	NN
cord-005453-4057qib7	14020	28	pneumonitis	pneumonitis	NN
cord-005453-4057qib7	14020	29	three	three	CD
cord-005453-4057qib7	14020	30	and	and	CC
cord-005453-4057qib7	14020	31	a	a	DT
cord-005453-4057qib7	14020	32	half	half	NN
cord-005453-4057qib7	14020	33	years	year	NNS
cord-005453-4057qib7	14020	34	after	after	IN
cord-005453-4057qib7	14020	35	BMT	BMT	NNP
cord-005453-4057qib7	14020	36	.	.	.
cord-005453-4057qib7	14021	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14021	2	:	:	:
cord-005453-4057qib7	14022	1	Haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	14022	2	stem	stem	NN
cord-005453-4057qib7	14022	3	cell	cell	NN
cord-005453-4057qib7	14022	4	transplant	transplant	NN
cord-005453-4057qib7	14022	5	outcomes	outcome	NNS
cord-005453-4057qib7	14022	6	from	from	IN
cord-005453-4057qib7	14022	7	our	-PRON-	PRP$
cord-005453-4057qib7	14022	8	centre	centre	NN
cord-005453-4057qib7	14022	9	are	be	VBP
cord-005453-4057qib7	14022	10	comparable	comparable	JJ
cord-005453-4057qib7	14022	11	to	to	IN
cord-005453-4057qib7	14022	12	leading	lead	VBG
cord-005453-4057qib7	14022	13	centres	centre	NNS
cord-005453-4057qib7	14022	14	in	in	IN
cord-005453-4057qib7	14022	15	the	the	DT
cord-005453-4057qib7	14022	16	world	world	NN
cord-005453-4057qib7	14022	17	.	.	.
cord-005453-4057qib7	14023	1	The	the	DT
cord-005453-4057qib7	14023	2	understanding	understanding	NN
cord-005453-4057qib7	14023	3	of	of	IN
cord-005453-4057qib7	14023	4	underlying	underlying	JJ
cord-005453-4057qib7	14023	5	conditions	condition	NNS
cord-005453-4057qib7	14023	6	that	that	WDT
cord-005453-4057qib7	14023	7	present	present	VBP
cord-005453-4057qib7	14023	8	with	with	IN
cord-005453-4057qib7	14023	9	bone	bone	NN
cord-005453-4057qib7	14023	10	marrow	marrow	NN
cord-005453-4057qib7	14023	11	failure	failure	NN
cord-005453-4057qib7	14023	12	has	have	VBZ
cord-005453-4057qib7	14023	13	improved	improve	VBN
cord-005453-4057qib7	14023	14	our	-PRON-	PRP$
cord-005453-4057qib7	14023	15	approach	approach	NN
cord-005453-4057qib7	14023	16	and	and	CC
cord-005453-4057qib7	14023	17	the	the	DT
cord-005453-4057qib7	14023	18	way	way	NN
cord-005453-4057qib7	14023	19	we	-PRON-	PRP
cord-005453-4057qib7	14023	20	treat	treat	VBP
cord-005453-4057qib7	14023	21	bone	bone	NN
cord-005453-4057qib7	14023	22	marrow	marrow	NN
cord-005453-4057qib7	14023	23	failure	failure	NN
cord-005453-4057qib7	14023	24	syndromes	syndrome	NNS
cord-005453-4057qib7	14023	25	.	.	.
cord-005453-4057qib7	14024	1	Clinical	clinical	JJ
cord-005453-4057qib7	14024	2	Trial	Trial	NNP
cord-005453-4057qib7	14024	3	Registry	Registry	NNP
cord-005453-4057qib7	14024	4	:	:	:
cord-005453-4057qib7	14025	1	Not	not	RB
cord-005453-4057qib7	14025	2	applicable	applicable	JJ
cord-005453-4057qib7	14025	3	.	.	.
cord-005453-4057qib7	14026	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14026	2	:	:	:
cord-005453-4057qib7	14026	3	Nothing	nothing	NN
cord-005453-4057qib7	14026	4	to	to	TO
cord-005453-4057qib7	14026	5	declare	declare	VB
cord-005453-4057qib7	14026	6	.	.	.
cord-005453-4057qib7	14027	1	Methods	method	NNS
cord-005453-4057qib7	14027	2	:	:	:
cord-005453-4057qib7	14028	1	A	a	DT
cord-005453-4057qib7	14028	2	retrospective	retrospective	JJ
cord-005453-4057qib7	14028	3	study	study	NN
cord-005453-4057qib7	14028	4	was	be	VBD
cord-005453-4057qib7	14028	5	performed	perform	VBN
cord-005453-4057qib7	14028	6	in	in	IN
cord-005453-4057qib7	14028	7	children	child	NNS
cord-005453-4057qib7	14028	8	treated	treat	VBN
cord-005453-4057qib7	14028	9	with	with	IN
cord-005453-4057qib7	14028	10	HSCT	HSCT	NNP
cord-005453-4057qib7	14028	11	who	who	WP
cord-005453-4057qib7	14028	12	received	receive	VBD
cord-005453-4057qib7	14028	13	POS	POS	NNP
cord-005453-4057qib7	14028	14	or	or	CC
cord-005453-4057qib7	14028	15	FLU	FLU	NNP
cord-005453-4057qib7	14028	16	during	during	IN
cord-005453-4057qib7	14028	17	early	early	JJ
cord-005453-4057qib7	14028	18	neutropenic	neutropenic	JJ
cord-005453-4057qib7	14028	19	period	period	NN
cord-005453-4057qib7	14028	20	until	until	IN
cord-005453-4057qib7	14028	21	engraftment	engraftment	NN
cord-005453-4057qib7	14028	22	from	from	IN
cord-005453-4057qib7	14028	23	January	January	NNP
cord-005453-4057qib7	14028	24	2000	2000	CD
cord-005453-4057qib7	14028	25	to	to	IN
cord-005453-4057qib7	14028	26	December	December	NNP
cord-005453-4057qib7	14028	27	2017	2017	CD
cord-005453-4057qib7	14028	28	at	at	IN
cord-005453-4057qib7	14028	29	Siriraj	Siriraj	NNP
cord-005453-4057qib7	14028	30	hospital	hospital	NN
cord-005453-4057qib7	14028	31	in	in	IN
cord-005453-4057qib7	14028	32	Thailand	Thailand	NNP
cord-005453-4057qib7	14028	33	.	.	.
cord-005453-4057qib7	14029	1	The	the	DT
cord-005453-4057qib7	14029	2	efficacy	efficacy	NN
cord-005453-4057qib7	14029	3	,	,	,
cord-005453-4057qib7	14029	4	safety	safety	NN
cord-005453-4057qib7	14029	5	and	and	CC
cord-005453-4057qib7	14029	6	tolerability	tolerability	NN
cord-005453-4057qib7	14029	7	of	of	IN
cord-005453-4057qib7	14029	8	POS	POS	NNP
cord-005453-4057qib7	14029	9	were	be	VBD
cord-005453-4057qib7	14029	10	compared	compare	VBN
cord-005453-4057qib7	14029	11	to	to	IN
cord-005453-4057qib7	14029	12	FLU	flu	NN
cord-005453-4057qib7	14029	13	.	.	.
cord-005453-4057qib7	14030	1	Results	result	NNS
cord-005453-4057qib7	14030	2	:	:	:
cord-005453-4057qib7	14031	1	There	there	EX
cord-005453-4057qib7	14031	2	were	be	VBD
cord-005453-4057qib7	14031	3	66	66	CD
cord-005453-4057qib7	14031	4	HSCT	HSCT	NNP
cord-005453-4057qib7	14031	5	recipients	recipient	NNS
cord-005453-4057qib7	14031	6	(	(	-LRB-
cord-005453-4057qib7	14031	7	allo	allo	NN
cord-005453-4057qib7	14031	8	-	-	HYPH
cord-005453-4057qib7	14031	9	HSCT	HSCT	NNP
cord-005453-4057qib7	14031	10	62.1	62.1	CD
cord-005453-4057qib7	14031	11	%	%	NN
cord-005453-4057qib7	14031	12	,	,	,
cord-005453-4057qib7	14031	13	auto	auto	NN
cord-005453-4057qib7	14031	14	-	-	HYPH
cord-005453-4057qib7	14031	15	HSCT	HSCT	NNP
cord-005453-4057qib7	14031	16	37.9	37.9	CD
cord-005453-4057qib7	14031	17	%	%	NN
cord-005453-4057qib7	14031	18	)	)	-RRB-
cord-005453-4057qib7	14031	19	with	with	IN
cord-005453-4057qib7	14031	20	mean	mean	JJ
cord-005453-4057qib7	14031	21	age	age	NN
cord-005453-4057qib7	14031	22	of	of	IN
cord-005453-4057qib7	14031	23	7.6	7.6	CD
cord-005453-4057qib7	14031	24	+	+	SYM
cord-005453-4057qib7	14031	25	4.3	4.3	CD
cord-005453-4057qib7	14031	26	years	year	NNS
cord-005453-4057qib7	14031	27	.	.	.
cord-005453-4057qib7	14032	1	Most	Most	JJS
cord-005453-4057qib7	14032	2	of	of	IN
cord-005453-4057qib7	14032	3	the	the	DT
cord-005453-4057qib7	14032	4	patients	patient	NNS
cord-005453-4057qib7	14032	5	were	be	VBD
cord-005453-4057qib7	14032	6	thalassemia	thalassemia	NN
cord-005453-4057qib7	14032	7	(	(	-LRB-
cord-005453-4057qib7	14032	8	34.4	34.4	CD
cord-005453-4057qib7	14032	9	%	%	NN
cord-005453-4057qib7	14032	10	)	)	-RRB-
cord-005453-4057qib7	14032	11	followed	follow	VBN
cord-005453-4057qib7	14032	12	by	by	IN
cord-005453-4057qib7	14032	13	hematologic	hematologic	JJ
cord-005453-4057qib7	14032	14	malignancy	malignancy	NN
cord-005453-4057qib7	14032	15	(	(	-LRB-
cord-005453-4057qib7	14032	16	32.2	32.2	CD
cord-005453-4057qib7	14032	17	%	%	NN
cord-005453-4057qib7	14032	18	)	)	-RRB-
cord-005453-4057qib7	14032	19	and	and	CC
cord-005453-4057qib7	14032	20	solid	solid	JJ
cord-005453-4057qib7	14032	21	tumor	tumor	NN
cord-005453-4057qib7	14032	22	(	(	-LRB-
cord-005453-4057qib7	14032	23	16.7	16.7	CD
cord-005453-4057qib7	14032	24	%	%	NN
cord-005453-4057qib7	14032	25	)	)	-RRB-
cord-005453-4057qib7	14032	26	.	.	.
cord-005453-4057qib7	14033	1	Seventeen	seventeen	CD
cord-005453-4057qib7	14033	2	and	and	CC
cord-005453-4057qib7	14033	3	49	49	CD
cord-005453-4057qib7	14033	4	cases	case	NNS
cord-005453-4057qib7	14033	5	received	receive	VBD
cord-005453-4057qib7	14033	6	POS	POS	NNP
cord-005453-4057qib7	14033	7	and	and	CC
cord-005453-4057qib7	14033	8	FLU	FLU	NNP
cord-005453-4057qib7	14033	9	,	,	,
cord-005453-4057qib7	14033	10	respectively	respectively	RB
cord-005453-4057qib7	14033	11	.	.	.
cord-005453-4057qib7	14034	1	All	all	DT
cord-005453-4057qib7	14034	2	of	of	IN
cord-005453-4057qib7	14034	3	patients	patient	NNS
cord-005453-4057qib7	14034	4	in	in	IN
cord-005453-4057qib7	14034	5	POS	POS	NNP
cord-005453-4057qib7	14034	6	group	group	NN
cord-005453-4057qib7	14034	7	were	be	VBD
cord-005453-4057qib7	14034	8	allo	allo	NN
cord-005453-4057qib7	14034	9	-	-	HYPH
cord-005453-4057qib7	14034	10	HSCT	HSCT	NNP
cord-005453-4057qib7	14034	11	whereas	whereas	IN
cord-005453-4057qib7	14034	12	48.9	48.9	CD
cord-005453-4057qib7	14034	13	%	%	NN
cord-005453-4057qib7	14034	14	in	in	IN
cord-005453-4057qib7	14034	15	FLU	FLU	NNP
cord-005453-4057qib7	14034	16	group	group	NN
cord-005453-4057qib7	14034	17	were	be	VBD
cord-005453-4057qib7	14034	18	allo	allo	NN
cord-005453-4057qib7	14034	19	-	-	HYPH
cord-005453-4057qib7	14034	20	HSCT	HSCT	NNP
cord-005453-4057qib7	14034	21	.	.	.
cord-005453-4057qib7	14035	1	In	in	IN
cord-005453-4057qib7	14035	2	POS	POS	NNP
cord-005453-4057qib7	14035	3	group	group	NN
cord-005453-4057qib7	14035	4	,	,	,
cord-005453-4057qib7	14035	5	2	2	CD
cord-005453-4057qib7	14035	6	cases	case	NNS
cord-005453-4057qib7	14035	7	were	be	VBD
cord-005453-4057qib7	14035	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	14035	9	with	with	IN
cord-005453-4057qib7	14035	10	suspected	suspect	VBN
cord-005453-4057qib7	14035	11	IFI	IFI	NNP
cord-005453-4057qib7	14035	12	and	and	CC
cord-005453-4057qib7	14035	13	2	2	CD
cord-005453-4057qib7	14035	14	cases	case	NNS
cord-005453-4057qib7	14035	15	were	be	VBD
cord-005453-4057qib7	14035	16	probable	probable	JJ
cord-005453-4057qib7	14035	17	IFI	IFI	NNP
cord-005453-4057qib7	14035	18	with	with	IN
cord-005453-4057qib7	14035	19	total	total	JJ
cord-005453-4057qib7	14035	20	4	4	CD
cord-005453-4057qib7	14035	21	cases	case	NNS
cord-005453-4057qib7	14035	22	(	(	-LRB-
cord-005453-4057qib7	14035	23	23.5	23.5	CD
cord-005453-4057qib7	14035	24	%	%	NN
cord-005453-4057qib7	14035	25	)	)	-RRB-
cord-005453-4057qib7	14035	26	.	.	.
cord-005453-4057qib7	14036	1	In	in	IN
cord-005453-4057qib7	14036	2	FLU	FLU	NNP
cord-005453-4057qib7	14036	3	group	group	NN
cord-005453-4057qib7	14036	4	,	,	,
cord-005453-4057qib7	14036	5	10	10	CD
cord-005453-4057qib7	14036	6	cases	case	NNS
cord-005453-4057qib7	14036	7	were	be	VBD
cord-005453-4057qib7	14036	8	diagnosed	diagnose	VBN
cord-005453-4057qib7	14036	9	with	with	IN
cord-005453-4057qib7	14036	10	suspected	suspect	VBN
cord-005453-4057qib7	14036	11	IFI	IFI	NNP
cord-005453-4057qib7	14036	12	and	and	CC
cord-005453-4057qib7	14036	13	2	2	CD
cord-005453-4057qib7	14036	14	cases	case	NNS
cord-005453-4057qib7	14036	15	were	be	VBD
cord-005453-4057qib7	14036	16	probable	probable	JJ
cord-005453-4057qib7	14036	17	IFI	IFI	NNP
cord-005453-4057qib7	14036	18	with	with	IN
cord-005453-4057qib7	14036	19	total	total	JJ
cord-005453-4057qib7	14036	20	12	12	CD
cord-005453-4057qib7	14036	21	cases	case	NNS
cord-005453-4057qib7	14036	22	(	(	-LRB-
cord-005453-4057qib7	14036	23	24.5	24.5	CD
cord-005453-4057qib7	14036	24	%	%	NN
cord-005453-4057qib7	14036	25	)	)	-RRB-
cord-005453-4057qib7	14036	26	which	which	WDT
cord-005453-4057qib7	14036	27	compared	compare	VBD
cord-005453-4057qib7	14036	28	2	2	CD
cord-005453-4057qib7	14036	29	groups	group	NNS
cord-005453-4057qib7	14036	30	were	be	VBD
cord-005453-4057qib7	14036	31	not	not	RB
cord-005453-4057qib7	14036	32	statistically	statistically	RB
cord-005453-4057qib7	14036	33	significant	significant	JJ
cord-005453-4057qib7	14036	34	(	(	-LRB-
cord-005453-4057qib7	14036	35	p=0.937	p=0.937	NN
cord-005453-4057qib7	14036	36	)	)	-RRB-
cord-005453-4057qib7	14036	37	.	.	.
cord-005453-4057qib7	14037	1	No	no	DT
cord-005453-4057qib7	14037	2	possible	possible	JJ
cord-005453-4057qib7	14037	3	and	and	CC
cord-005453-4057qib7	14037	4	proven	prove	VBN
cord-005453-4057qib7	14037	5	IFI	IFI	NNP
cord-005453-4057qib7	14037	6	in	in	IN
cord-005453-4057qib7	14037	7	both	both	DT
cord-005453-4057qib7	14037	8	groups	group	NNS
cord-005453-4057qib7	14037	9	.	.	.
cord-005453-4057qib7	14038	1	In	in	IN
cord-005453-4057qib7	14038	2	FLU	flu	NN
cord-005453-4057qib7	14038	3	group	group	NN
cord-005453-4057qib7	14038	4	patients	patient	NNS
cord-005453-4057qib7	14038	5	received	receive	VBD
cord-005453-4057qib7	14038	6	empirical	empirical	JJ
cord-005453-4057qib7	14038	7	antifungal	antifungal	JJ
cord-005453-4057qib7	14038	8	treatment	treatment	NN
cord-005453-4057qib7	14038	9	more	more	JJR
cord-005453-4057qib7	14038	10	than	than	IN
cord-005453-4057qib7	14038	11	POS	POS	NNP
cord-005453-4057qib7	14038	12	group	group	NN
cord-005453-4057qib7	14038	13	but	but	CC
cord-005453-4057qib7	14038	14	no	no	DT
cord-005453-4057qib7	14038	15	statistical	statistical	JJ
cord-005453-4057qib7	14038	16	significance	significance	NN
cord-005453-4057qib7	14038	17	(	(	-LRB-
cord-005453-4057qib7	14038	18	20.4	20.4	CD
cord-005453-4057qib7	14038	19	%	%	NN
cord-005453-4057qib7	14038	20	VS.11.76	VS.11.76	NNP
cord-005453-4057qib7	14038	21	%	%	NN
cord-005453-4057qib7	14038	22	,	,	,
cord-005453-4057qib7	14038	23	p=0.498	p=0.498	NNP
cord-005453-4057qib7	14038	24	)	)	-RRB-
cord-005453-4057qib7	14038	25	.	.	.
cord-005453-4057qib7	14039	1	Both	both	DT
cord-005453-4057qib7	14039	2	groups	group	NNS
cord-005453-4057qib7	14039	3	had	have	VBD
cord-005453-4057qib7	14039	4	similar	similar	JJ
cord-005453-4057qib7	14039	5	rate	rate	NN
cord-005453-4057qib7	14039	6	of	of	IN
cord-005453-4057qib7	14039	7	elevated	elevated	JJ
cord-005453-4057qib7	14039	8	liver	liver	NN
cord-005453-4057qib7	14039	9	function	function	NN
cord-005453-4057qib7	14039	10	test	test	NN
cord-005453-4057qib7	14039	11	(	(	-LRB-
cord-005453-4057qib7	14039	12	p=0.567	p=0.567	NNP
cord-005453-4057qib7	14039	13	)	)	-RRB-
cord-005453-4057qib7	14039	14	.	.	.
cord-005453-4057qib7	14040	1	No	no	DT
cord-005453-4057qib7	14040	2	early	early	JJ
cord-005453-4057qib7	14040	3	discontinuation	discontinuation	NN
cord-005453-4057qib7	14040	4	of	of	IN
cord-005453-4057qib7	14040	5	antifungal	antifungal	JJ
cord-005453-4057qib7	14040	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14040	7	for	for	IN
cord-005453-4057qib7	14040	8	intolerance	intolerance	NN
cord-005453-4057qib7	14040	9	was	be	VBD
cord-005453-4057qib7	14040	10	found	find	VBN
cord-005453-4057qib7	14040	11	in	in	IN
cord-005453-4057qib7	14040	12	both	both	DT
cord-005453-4057qib7	14040	13	groups	group	NNS
cord-005453-4057qib7	14040	14	.	.	.
cord-005453-4057qib7	14041	1	Only	only	RB
cord-005453-4057qib7	14041	2	26.7	26.7	CD
cord-005453-4057qib7	14041	3	%	%	NN
cord-005453-4057qib7	14041	4	of	of	IN
cord-005453-4057qib7	14041	5	patients	patient	NNS
cord-005453-4057qib7	14041	6	achieved	achieve	VBN
cord-005453-4057qib7	14041	7	POS	POS	NNP
cord-005453-4057qib7	14041	8	target	target	NN
cord-005453-4057qib7	14041	9	trough	trough	IN
cord-005453-4057qib7	14041	10	level	level	NN
cord-005453-4057qib7	14041	11	of	of	IN
cord-005453-4057qib7	14041	12	0.7	0.7	CD
cord-005453-4057qib7	14041	13	mg	mg	NNP
cord-005453-4057qib7	14041	14	/	/	SYM
cord-005453-4057qib7	14041	15	L	L	NNP
cord-005453-4057qib7	14041	16	after	after	IN
cord-005453-4057qib7	14041	17	7	7	CD
cord-005453-4057qib7	14041	18	days	day	NNS
cord-005453-4057qib7	14041	19	of	of	IN
cord-005453-4057qib7	14041	20	treatment	treatment	NN
cord-005453-4057qib7	14041	21	with	with	IN
cord-005453-4057qib7	14041	22	started	start	VBN
cord-005453-4057qib7	14041	23	dose	dose	NN
cord-005453-4057qib7	14041	24	4	4	CD
cord-005453-4057qib7	14041	25	mg	mg	NNP
cord-005453-4057qib7	14041	26	/	/	SYM
cord-005453-4057qib7	14041	27	kg	kg	NNP
cord-005453-4057qib7	14041	28	three	three	CD
cord-005453-4057qib7	14041	29	times	time	NNS
cord-005453-4057qib7	14041	30	a	a	DT
cord-005453-4057qib7	14041	31	day	day	NN
cord-005453-4057qib7	14041	32	.	.	.
cord-005453-4057qib7	14042	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14042	2	:	:	:
cord-005453-4057qib7	14043	1	POS	POS	NNP
cord-005453-4057qib7	14043	2	and	and	CC
cord-005453-4057qib7	14043	3	FLU	FLU	NNP
cord-005453-4057qib7	14043	4	are	be	VBP
cord-005453-4057qib7	14043	5	comparably	comparably	RB
cord-005453-4057qib7	14043	6	effective	effective	JJ
cord-005453-4057qib7	14043	7	,	,	,
cord-005453-4057qib7	14043	8	safety	safety	NN
cord-005453-4057qib7	14043	9	and	and	CC
cord-005453-4057qib7	14043	10	tolerability	tolerability	NN
cord-005453-4057qib7	14043	11	in	in	IN
cord-005453-4057qib7	14043	12	IFI	IFI	NNP
cord-005453-4057qib7	14043	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14043	14	in	in	IN
cord-005453-4057qib7	14043	15	neutropenic	neutropenic	JJ
cord-005453-4057qib7	14043	16	children	child	NNS
cord-005453-4057qib7	14043	17	treated	treat	VBN
cord-005453-4057qib7	14043	18	with	with	IN
cord-005453-4057qib7	14043	19	HSCT	HSCT	NNP
cord-005453-4057qib7	14043	20	.	.	.
cord-005453-4057qib7	14044	1	Defining	define	VBG
cord-005453-4057qib7	14044	2	dose	dose	NN
cord-005453-4057qib7	14044	3	recommendation	recommendation	NN
cord-005453-4057qib7	14044	4	of	of	IN
cord-005453-4057qib7	14044	5	POS	POS	NNP
cord-005453-4057qib7	14044	6	in	in	IN
cord-005453-4057qib7	14044	7	this	this	DT
cord-005453-4057qib7	14044	8	setting	setting	NN
cord-005453-4057qib7	14044	9	requires	require	VBZ
cord-005453-4057qib7	14044	10	larger	large	JJR
cord-005453-4057qib7	14044	11	studies	study	NNS
cord-005453-4057qib7	14044	12	.	.	.
cord-005453-4057qib7	14045	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14045	2	Background	background	NN
cord-005453-4057qib7	14045	3	:	:	:
cord-005453-4057qib7	14046	1	Severe	severe	JJ
cord-005453-4057qib7	14046	2	congenital	congenital	JJ
cord-005453-4057qib7	14046	3	neutropenia	neutropenia	NN
cord-005453-4057qib7	14046	4	(	(	-LRB-
cord-005453-4057qib7	14046	5	SCN	SCN	NNP
cord-005453-4057qib7	14046	6	)	)	-RRB-
cord-005453-4057qib7	14046	7	is	be	VBZ
cord-005453-4057qib7	14046	8	typically	typically	RB
cord-005453-4057qib7	14046	9	characterized	characterize	VBN
cord-005453-4057qib7	14046	10	by	by	IN
cord-005453-4057qib7	14046	11	ANC	ANC	NNP
cord-005453-4057qib7	14046	12	of	of	IN
cord-005453-4057qib7	14046	13	<	<	XX
cord-005453-4057qib7	14046	14	500	500	CD
cord-005453-4057qib7	14047	1	/μl	/μl	NFP
cord-005453-4057qib7	14047	2	,	,	,
cord-005453-4057qib7	14047	3	maturation	maturation	NN
cord-005453-4057qib7	14047	4	arrest	arrest	NN
cord-005453-4057qib7	14047	5	of	of	IN
cord-005453-4057qib7	14047	6	bone	bone	NN
cord-005453-4057qib7	14047	7	marrow	marrow	NN
cord-005453-4057qib7	14047	8	myeloid	myeloid	NN
cord-005453-4057qib7	14047	9	precursors	precursor	NNS
cord-005453-4057qib7	14047	10	at	at	IN
cord-005453-4057qib7	14047	11	the	the	DT
cord-005453-4057qib7	14047	12	promyelocyte	promyelocyte	NNP
cord-005453-4057qib7	14047	13	-	-	HYPH
cord-005453-4057qib7	14047	14	myelocyte	myelocyte	NNP
cord-005453-4057qib7	14047	15	stage	stage	NN
cord-005453-4057qib7	14047	16	,	,	,
cord-005453-4057qib7	14047	17	and	and	CC
cord-005453-4057qib7	14047	18	susceptibility	susceptibility	NN
cord-005453-4057qib7	14047	19	to	to	IN
cord-005453-4057qib7	14047	20	lethal	lethal	JJ
cord-005453-4057qib7	14047	21	pyogenic	pyogenic	JJ
cord-005453-4057qib7	14047	22	bacterial	bacterial	JJ
cord-005453-4057qib7	14047	23	and	and	CC
cord-005453-4057qib7	14047	24	fungal	fungal	JJ
cord-005453-4057qib7	14047	25	infections	infection	NNS
cord-005453-4057qib7	14047	26	.	.	.
cord-005453-4057qib7	14048	1	SCN	SCN	NNP
cord-005453-4057qib7	14048	2	is	be	VBZ
cord-005453-4057qib7	14048	3	a	a	DT
cord-005453-4057qib7	14048	4	rare	rare	JJ
cord-005453-4057qib7	14048	5	group	group	NN
cord-005453-4057qib7	14048	6	of	of	IN
cord-005453-4057qib7	14048	7	disorders	disorder	NNS
cord-005453-4057qib7	14048	8	resulting	result	VBG
cord-005453-4057qib7	14048	9	from	from	IN
cord-005453-4057qib7	14048	10	intrinsic	intrinsic	JJ
cord-005453-4057qib7	14048	11	defects	defect	NNS
cord-005453-4057qib7	14048	12	in	in	IN
cord-005453-4057qib7	14048	13	myeloid	myeloid	JJ
cord-005453-4057qib7	14048	14	cell	cell	NN
cord-005453-4057qib7	14048	15	proliferation	proliferation	NN
cord-005453-4057qib7	14048	16	and	and	CC
cord-005453-4057qib7	14048	17	maturation	maturation	NN
cord-005453-4057qib7	14048	18	caused	cause	VBN
cord-005453-4057qib7	14048	19	by	by	IN
cord-005453-4057qib7	14048	20	mutations	mutation	NNS
cord-005453-4057qib7	14048	21	in	in	IN
cord-005453-4057qib7	14048	22	several	several	JJ
cord-005453-4057qib7	14048	23	genes	gene	NNS
cord-005453-4057qib7	14048	24	;	;	:
cord-005453-4057qib7	14048	25	ELANE	ELANE	NNP
cord-005453-4057qib7	14048	26	,	,	,
cord-005453-4057qib7	14048	27	HAX1	HAX1	NNP
cord-005453-4057qib7	14048	28	,	,	,
cord-005453-4057qib7	14048	29	GFI1	GFI1	NNP
cord-005453-4057qib7	14048	30	,	,	,
cord-005453-4057qib7	14048	31	WAS	be	VBD
cord-005453-4057qib7	14048	32	,	,	,
cord-005453-4057qib7	14048	33	and	and	CC
cord-005453-4057qib7	14048	34	G6PC3	G6PC3	NNP
cord-005453-4057qib7	14048	35	are	be	VBP
cord-005453-4057qib7	14048	36	among	among	IN
cord-005453-4057qib7	14048	37	the	the	DT
cord-005453-4057qib7	14048	38	most	most	RBS
cord-005453-4057qib7	14048	39	common	common	JJ
cord-005453-4057qib7	14048	40	ones	one	NNS
cord-005453-4057qib7	14048	41	.	.	.
cord-005453-4057qib7	14049	1	Almost	almost	RB
cord-005453-4057qib7	14049	2	10	10	CD
cord-005453-4057qib7	14049	3	%	%	NN
cord-005453-4057qib7	14049	4	of	of	IN
cord-005453-4057qib7	14049	5	patients	patient	NNS
cord-005453-4057qib7	14049	6	are	be	VBP
cord-005453-4057qib7	14049	7	refractory	refractory	JJ
cord-005453-4057qib7	14049	8	to	to	IN
cord-005453-4057qib7	14049	9	G	G	NNP
cord-005453-4057qib7	14049	10	-	-	HYPH
cord-005453-4057qib7	14049	11	CSF	CSF	NNP
cord-005453-4057qib7	14049	12	,	,	,
cord-005453-4057qib7	14049	13	and	and	CC
cord-005453-4057qib7	14049	14	the	the	DT
cord-005453-4057qib7	14049	15	only	only	JJ
cord-005453-4057qib7	14049	16	definitive	definitive	JJ
cord-005453-4057qib7	14049	17	curative	curative	JJ
cord-005453-4057qib7	14049	18	approach	approach	NN
cord-005453-4057qib7	14049	19	for	for	IN
cord-005453-4057qib7	14049	20	such	such	JJ
cord-005453-4057qib7	14049	21	patients	patient	NNS
cord-005453-4057qib7	14049	22	is	be	VBZ
cord-005453-4057qib7	14049	23	allogeneic	allogeneic	IN
cord-005453-4057qib7	14049	24	HSCT	HSCT	NNP
cord-005453-4057qib7	14049	25	.	.	.
cord-005453-4057qib7	14050	1	The	the	DT
cord-005453-4057qib7	14050	2	current	current	JJ
cord-005453-4057qib7	14050	3	absolute	absolute	JJ
cord-005453-4057qib7	14050	4	indications	indication	NNS
cord-005453-4057qib7	14050	5	for	for	IN
cord-005453-4057qib7	14050	6	HSCT	HSCT	NNP
cord-005453-4057qib7	14050	7	is	be	VBZ
cord-005453-4057qib7	14050	8	failure	failure	NN
cord-005453-4057qib7	14050	9	to	to	TO
cord-005453-4057qib7	14050	10	respond	respond	VB
cord-005453-4057qib7	14050	11	to	to	IN
cord-005453-4057qib7	14050	12	G	G	NNP
cord-005453-4057qib7	14050	13	-	-	HYPH
cord-005453-4057qib7	14050	14	CSF	csf	NN
cord-005453-4057qib7	14050	15	treatment	treatment	NN
cord-005453-4057qib7	14050	16	,	,	,
cord-005453-4057qib7	14050	17	or	or	CC
cord-005453-4057qib7	14050	18	the	the	DT
cord-005453-4057qib7	14050	19	development	development	NN
cord-005453-4057qib7	14050	20	of	of	IN
cord-005453-4057qib7	14050	21	MDS	MDS	NNP
cord-005453-4057qib7	14050	22	/	/	SYM
cord-005453-4057qib7	14050	23	leukemia	leukemia	NN
cord-005453-4057qib7	14050	24	in	in	IN
cord-005453-4057qib7	14050	25	patients	patient	NNS
cord-005453-4057qib7	14050	26	with	with	IN
cord-005453-4057qib7	14050	27	SCN	SCN	NNP
cord-005453-4057qib7	14050	28	.	.	.
cord-005453-4057qib7	14051	1	Here	here	RB
cord-005453-4057qib7	14051	2	,	,	,
cord-005453-4057qib7	14051	3	we	-PRON-	PRP
cord-005453-4057qib7	14051	4	present	present	VBP
cord-005453-4057qib7	14051	5	the	the	DT
cord-005453-4057qib7	14051	6	result	result	NN
cord-005453-4057qib7	14051	7	of	of	IN
cord-005453-4057qib7	14051	8	10	10	CD
cord-005453-4057qib7	14051	9	children	child	NNS
cord-005453-4057qib7	14051	10	with	with	IN
cord-005453-4057qib7	14051	11	SCN	SCN	NNP
cord-005453-4057qib7	14051	12	who	who	WP
cord-005453-4057qib7	14051	13	received	receive	VBD
cord-005453-4057qib7	14051	14	allogeneic	allogeneic	IN
cord-005453-4057qib7	14051	15	HSCT	HSCT	NNP
cord-005453-4057qib7	14051	16	.	.	.
cord-005453-4057qib7	14052	1	Methods	method	NNS
cord-005453-4057qib7	14052	2	:	:	:
cord-005453-4057qib7	14052	3	We	-PRON-	PRP
cord-005453-4057qib7	14052	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	14052	5	assessed	assess	VBD
cord-005453-4057qib7	14052	6	10	10	CD
cord-005453-4057qib7	14052	7	allogeneic	allogeneic	IN
cord-005453-4057qib7	14052	8	HSCT	HSCT	NNP
cord-005453-4057qib7	14052	9	in	in	IN
cord-005453-4057qib7	14052	10	children	child	NNS
cord-005453-4057qib7	14052	11	with	with	IN
cord-005453-4057qib7	14052	12	severe	severe	JJ
cord-005453-4057qib7	14052	13	congenital	congenital	JJ
cord-005453-4057qib7	14052	14	neutropenia	neutropenia	NN
cord-005453-4057qib7	14052	15	.	.	.
cord-005453-4057qib7	14053	1	All	all	DT
cord-005453-4057qib7	14053	2	patients	patient	NNS
cord-005453-4057qib7	14053	3	received	receive	VBD
cord-005453-4057qib7	14053	4	busulphan	busulphan	NNP
cord-005453-4057qib7	14053	5	(	(	-LRB-
cord-005453-4057qib7	14053	6	BU	BU	NNP
cord-005453-4057qib7	14053	7	)	)	-RRB-
cord-005453-4057qib7	14053	8	based	base	VBD
cord-005453-4057qib7	14053	9	myeloablative	myeloablative	NNP
cord-005453-4057qib7	14053	10	conditioning	conditioning	NNP
cord-005453-4057qib7	14053	11	regimen	regimen	NN
cord-005453-4057qib7	14053	12	.	.	.
cord-005453-4057qib7	14054	1	Busulphan	Busulphan	NNP
cord-005453-4057qib7	14054	2	was	be	VBD
cord-005453-4057qib7	14054	3	used	use	VBN
cord-005453-4057qib7	14054	4	according	accord	VBG
cord-005453-4057qib7	14054	5	to	to	IN
cord-005453-4057qib7	14054	6	weight	weight	NN
cord-005453-4057qib7	14054	7	adjusted	adjust	VBN
cord-005453-4057qib7	14054	8	dose	dose	NN
cord-005453-4057qib7	14054	9	.	.	.
cord-005453-4057qib7	14055	1	In	in	IN
cord-005453-4057qib7	14055	2	addition	addition	NN
cord-005453-4057qib7	14055	3	,	,	,
cord-005453-4057qib7	14055	4	all	all	DT
cord-005453-4057qib7	14055	5	patients	patient	NNS
cord-005453-4057qib7	14055	6	received	receive	VBD
cord-005453-4057qib7	14055	7	fludarabine	fludarabine	NN
cord-005453-4057qib7	14055	8	150	150	CD
cord-005453-4057qib7	14055	9	mg	mg	NNP
cord-005453-4057qib7	14055	10	/	/	SYM
cord-005453-4057qib7	14055	11	m2	m2	NNP
cord-005453-4057qib7	14055	12	in	in	IN
cord-005453-4057qib7	14055	13	five	five	CD
cord-005453-4057qib7	14055	14	days	day	NNS
cord-005453-4057qib7	14055	15	or	or	CC
cord-005453-4057qib7	14055	16	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14055	17	200	200	CD
cord-005453-4057qib7	14055	18	mg	mg	NNP
cord-005453-4057qib7	14055	19	/	/	SYM
cord-005453-4057qib7	14055	20	kg	kg	NNS
cord-005453-4057qib7	14055	21	in	in	IN
cord-005453-4057qib7	14055	22	4	4	CD
cord-005453-4057qib7	14055	23	days	day	NNS
cord-005453-4057qib7	14055	24	and	and	CC
cord-005453-4057qib7	14055	25	ATG	ATG	NNP
cord-005453-4057qib7	14055	26	30	30	CD
cord-005453-4057qib7	14055	27	mg	mg	NNP
cord-005453-4057qib7	14055	28	/	/	SYM
cord-005453-4057qib7	14055	29	kg	kg	NN
cord-005453-4057qib7	14055	30	in	in	IN
cord-005453-4057qib7	14055	31	3	3	CD
cord-005453-4057qib7	14055	32	days	day	NNS
cord-005453-4057qib7	14055	33	.	.	.
cord-005453-4057qib7	14056	1	Cyclosporin	Cyclosporin	NNP
cord-005453-4057qib7	14056	2	-	-	HYPH
cord-005453-4057qib7	14056	3	A	A	NNP
cord-005453-4057qib7	14056	4	and	and	CC
cord-005453-4057qib7	14056	5	MTX	MTX	NNP
cord-005453-4057qib7	14056	6	were	be	VBD
cord-005453-4057qib7	14056	7	used	use	VBN
cord-005453-4057qib7	14056	8	for	for	IN
cord-005453-4057qib7	14056	9	graft	graft	NN
cord-005453-4057qib7	14056	10	versus	versus	IN
cord-005453-4057qib7	14056	11	host	host	NN
cord-005453-4057qib7	14056	12	disease	disease	NN
cord-005453-4057qib7	14056	13	(	(	-LRB-
cord-005453-4057qib7	14056	14	GVHD	GVHD	NNP
cord-005453-4057qib7	14056	15	)	)	-RRB-
cord-005453-4057qib7	14056	16	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14056	17	.	.	.
cord-005453-4057qib7	14057	1	Donor	donor	NN
cord-005453-4057qib7	14057	2	chimerism	chimerism	NN
cord-005453-4057qib7	14057	3	was	be	VBD
cord-005453-4057qib7	14057	4	evaluated	evaluate	VBN
cord-005453-4057qib7	14057	5	in	in	IN
cord-005453-4057qib7	14057	6	either	either	DT
cord-005453-4057qib7	14057	7	bone	bone	NN
cord-005453-4057qib7	14057	8	marrow	marrow	NN
cord-005453-4057qib7	14057	9	or	or	CC
cord-005453-4057qib7	14057	10	peripheral	peripheral	JJ
cord-005453-4057qib7	14057	11	blood	blood	NN
cord-005453-4057qib7	14057	12	on	on	IN
cord-005453-4057qib7	14057	13	days	day	NNS
cord-005453-4057qib7	14057	14	+30	+30	CD
cord-005453-4057qib7	14057	15	,	,	,
cord-005453-4057qib7	14057	16	+100	+100	NNP
cord-005453-4057qib7	14057	17	and	and	CC
cord-005453-4057qib7	14058	1	+180	+180	NNP
cord-005453-4057qib7	14058	2	.	.	.
cord-005453-4057qib7	14058	3	Results	result	NNS
cord-005453-4057qib7	14058	4	:	:	:
cord-005453-4057qib7	14059	1	The	the	DT
cord-005453-4057qib7	14059	2	median	median	JJ
cord-005453-4057qib7	14059	3	transplantation	transplantation	NN
cord-005453-4057qib7	14059	4	age	age	NN
cord-005453-4057qib7	14059	5	of	of	IN
cord-005453-4057qib7	14059	6	the	the	DT
cord-005453-4057qib7	14059	7	patients	patient	NNS
cord-005453-4057qib7	14059	8	was	be	VBD
cord-005453-4057qib7	14059	9	49	49	CD
cord-005453-4057qib7	14059	10	months	month	NNS
cord-005453-4057qib7	14060	1	(	(	-LRB-
cord-005453-4057qib7	14060	2	range	range	NNP
cord-005453-4057qib7	14060	3	11	11	CD
cord-005453-4057qib7	14060	4	-	-	SYM
cord-005453-4057qib7	14060	5	167	167	CD
cord-005453-4057qib7	14060	6	months	month	NNS
cord-005453-4057qib7	14060	7	)	)	-RRB-
cord-005453-4057qib7	14060	8	.	.	.
cord-005453-4057qib7	14061	1	Six	six	CD
cord-005453-4057qib7	14061	2	of	of	IN
cord-005453-4057qib7	14061	3	them	-PRON-	PRP
cord-005453-4057qib7	14061	4	are	be	VBP
cord-005453-4057qib7	14061	5	male	male	JJ
cord-005453-4057qib7	14061	6	.	.	.
cord-005453-4057qib7	14062	1	Two	two	CD
cord-005453-4057qib7	14062	2	of	of	IN
cord-005453-4057qib7	14062	3	the	the	DT
cord-005453-4057qib7	14062	4	donors	donor	NNS
cord-005453-4057qib7	14062	5	were	be	VBD
cord-005453-4057qib7	14062	6	matched	match	VBN
cord-005453-4057qib7	14062	7	siblings	sibling	NNS
cord-005453-4057qib7	14062	8	and	and	CC
cord-005453-4057qib7	14062	9	8	8	CD
cord-005453-4057qib7	14062	10	were	be	VBD
cord-005453-4057qib7	14062	11	unrelated	unrelated	JJ
cord-005453-4057qib7	14063	1	two	two	CD
cord-005453-4057qib7	14063	2	of	of	IN
cord-005453-4057qib7	14063	3	which	which	WDT
cord-005453-4057qib7	14063	4	were	be	VBD
cord-005453-4057qib7	14063	5	1	1	CD
cord-005453-4057qib7	14063	6	ag	ag	NNP
cord-005453-4057qib7	14063	7	1	1	CD
cord-005453-4057qib7	14063	8	ag	ag	NNP
cord-005453-4057qib7	14063	9	mismatched	mismatch	VBN
cord-005453-4057qib7	14063	10	.	.	.
cord-005453-4057qib7	14064	1	Stem	stem	JJ
cord-005453-4057qib7	14064	2	cell	cell	NN
cord-005453-4057qib7	14064	3	source	source	NN
cord-005453-4057qib7	14064	4	was	be	VBD
cord-005453-4057qib7	14064	5	bone	bone	NN
cord-005453-4057qib7	14064	6	marrow	marrow	NN
cord-005453-4057qib7	14064	7	in	in	IN
cord-005453-4057qib7	14064	8	6	6	CD
cord-005453-4057qib7	14064	9	patients	patient	NNS
cord-005453-4057qib7	14064	10	,	,	,
cord-005453-4057qib7	14064	11	peripheral	peripheral	JJ
cord-005453-4057qib7	14064	12	blood	blood	NN
cord-005453-4057qib7	14064	13	in	in	IN
cord-005453-4057qib7	14064	14	2	2	CD
cord-005453-4057qib7	14064	15	and	and	CC
cord-005453-4057qib7	14064	16	cord	cord	NN
cord-005453-4057qib7	14064	17	blood	blood	NN
cord-005453-4057qib7	14064	18	in	in	IN
cord-005453-4057qib7	14064	19	2	2	CD
cord-005453-4057qib7	14064	20	patients	patient	NNS
cord-005453-4057qib7	14064	21	.	.	.
cord-005453-4057qib7	14065	1	All	all	DT
cord-005453-4057qib7	14065	2	patients	patient	NNS
cord-005453-4057qib7	14065	3	engrafted	engraft	VBD
cord-005453-4057qib7	14065	4	.	.	.
cord-005453-4057qib7	14066	1	The	the	DT
cord-005453-4057qib7	14066	2	median	median	JJ
cord-005453-4057qib7	14066	3	time	time	NN
cord-005453-4057qib7	14066	4	of	of	IN
cord-005453-4057qib7	14066	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	14066	6	and	and	CC
cord-005453-4057qib7	14066	7	platelet	platelet	NN
cord-005453-4057qib7	14066	8	engratment	engratment	NN
cord-005453-4057qib7	14066	9	to	to	IN
cord-005453-4057qib7	14066	10	was	be	VBD
cord-005453-4057qib7	14066	11	15	15	CD
cord-005453-4057qib7	14066	12	(	(	-LRB-
cord-005453-4057qib7	14066	13	13	13	CD
cord-005453-4057qib7	14066	14	-	-	SYM
cord-005453-4057qib7	14066	15	34	34	CD
cord-005453-4057qib7	14066	16	)	)	-RRB-
cord-005453-4057qib7	14066	17	days	day	NNS
cord-005453-4057qib7	14066	18	and	and	CC
cord-005453-4057qib7	14066	19	16(9	16(9	CD
cord-005453-4057qib7	14066	20	-	-	SYM
cord-005453-4057qib7	14066	21	90	90	CD
cord-005453-4057qib7	14066	22	)	)	-RRB-
cord-005453-4057qib7	14066	23	days	day	NNS
cord-005453-4057qib7	14066	24	,	,	,
cord-005453-4057qib7	14066	25	respectively	respectively	RB
cord-005453-4057qib7	14066	26	.	.	.
cord-005453-4057qib7	14067	1	Graft	graft	NN
cord-005453-4057qib7	14067	2	rejection	rejection	NN
cord-005453-4057qib7	14067	3	was	be	VBD
cord-005453-4057qib7	14067	4	experienced	experience	VBN
cord-005453-4057qib7	14067	5	in	in	IN
cord-005453-4057qib7	14067	6	2	2	CD
cord-005453-4057qib7	14067	7	patients	patient	NNS
cord-005453-4057qib7	14067	8	,	,	,
cord-005453-4057qib7	14067	9	one	one	CD
cord-005453-4057qib7	14067	10	of	of	IN
cord-005453-4057qib7	14067	11	them	-PRON-	PRP
cord-005453-4057qib7	14067	12	had	have	VBD
cord-005453-4057qib7	14067	13	received	receive	VBN
cord-005453-4057qib7	14067	14	unrelated	unrelated	JJ
cord-005453-4057qib7	14067	15	cord	cord	NN
cord-005453-4057qib7	14067	16	blood	blood	NN
cord-005453-4057qib7	14067	17	.	.	.
cord-005453-4057qib7	14068	1	All	all	DT
cord-005453-4057qib7	14068	2	patients	patient	NNS
cord-005453-4057qib7	14068	3	are	be	VBP
cord-005453-4057qib7	14068	4	alive	alive	JJ
cord-005453-4057qib7	14068	5	,	,	,
cord-005453-4057qib7	14068	6	eight	eight	CD
cord-005453-4057qib7	14068	7	of	of	IN
cord-005453-4057qib7	14068	8	which	which	WDT
cord-005453-4057qib7	14068	9	are	be	VBP
cord-005453-4057qib7	14068	10	with	with	IN
cord-005453-4057qib7	14068	11	full	full	JJ
cord-005453-4057qib7	14068	12	donor	donor	NN
cord-005453-4057qib7	14068	13	chimerism	chimerism	NN
cord-005453-4057qib7	14068	14	(	(	-LRB-
cord-005453-4057qib7	14068	15	between	between	IN
cord-005453-4057qib7	14068	16	95	95	CD
cord-005453-4057qib7	14068	17	-	-	SYM
cord-005453-4057qib7	14068	18	100	100	CD
cord-005453-4057qib7	14068	19	%	%	NN
cord-005453-4057qib7	14068	20	)	)	-RRB-
cord-005453-4057qib7	14068	21	without	without	IN
cord-005453-4057qib7	14068	22	any	any	DT
cord-005453-4057qib7	14068	23	complication	complication	NN
cord-005453-4057qib7	14068	24	(	(	-LRB-
cord-005453-4057qib7	14068	25	no	no	DT
cord-005453-4057qib7	14068	26	infection	infection	NN
cord-005453-4057qib7	14068	27	,	,	,
cord-005453-4057qib7	14068	28	no	no	DT
cord-005453-4057qib7	14068	29	GVHD	GVHD	NNP
cord-005453-4057qib7	14068	30	)	)	-RRB-
cord-005453-4057qib7	14068	31	with	with	IN
cord-005453-4057qib7	14068	32	a	a	DT
cord-005453-4057qib7	14068	33	median	median	JJ
cord-005453-4057qib7	14068	34	40	40	CD
cord-005453-4057qib7	14068	35	months	month	NNS
cord-005453-4057qib7	14069	1	(	(	-LRB-
cord-005453-4057qib7	14069	2	range	range	VBP
cord-005453-4057qib7	14069	3	24	24	CD
cord-005453-4057qib7	14069	4	-	-	SYM
cord-005453-4057qib7	14069	5	83	83	CD
cord-005453-4057qib7	14069	6	months	month	NNS
cord-005453-4057qib7	14069	7	)	)	-RRB-
cord-005453-4057qib7	14069	8	follow	follow	VBP
cord-005453-4057qib7	14069	9	up	up	RP
cord-005453-4057qib7	14069	10	.	.	.
cord-005453-4057qib7	14070	1	Probability	probability	NN
cord-005453-4057qib7	14070	2	of	of	IN
cord-005453-4057qib7	14070	3	disease	disease	NN
cord-005453-4057qib7	14070	4	free	free	JJ
cord-005453-4057qib7	14070	5	and	and	CC
cord-005453-4057qib7	14070	6	overall	overall	JJ
cord-005453-4057qib7	14070	7	survival	survival	NN
cord-005453-4057qib7	14070	8	were	be	VBD
cord-005453-4057qib7	14070	9	found	find	VBN
cord-005453-4057qib7	14070	10	80	80	CD
cord-005453-4057qib7	14070	11	%	%	NN
cord-005453-4057qib7	14070	12	and	and	CC
cord-005453-4057qib7	14070	13	100	100	CD
cord-005453-4057qib7	14070	14	%	%	NN
cord-005453-4057qib7	14070	15	,	,	,
cord-005453-4057qib7	14070	16	respectively	respectively	RB
cord-005453-4057qib7	14070	17	.	.	.
cord-005453-4057qib7	14071	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14071	2	:	:	:
cord-005453-4057qib7	14072	1	We	-PRON-	PRP
cord-005453-4057qib7	14072	2	concluded	conclude	VBD
cord-005453-4057qib7	14072	3	that	that	IN
cord-005453-4057qib7	14072	4	HSCT	HSCT	NNP
cord-005453-4057qib7	14072	5	is	be	VBZ
cord-005453-4057qib7	14072	6	a	a	DT
cord-005453-4057qib7	14072	7	useful	useful	JJ
cord-005453-4057qib7	14072	8	treatment	treatment	NN
cord-005453-4057qib7	14072	9	for	for	IN
cord-005453-4057qib7	14072	10	SCN	SCN	NNP
cord-005453-4057qib7	14072	11	patients	patient	NNS
cord-005453-4057qib7	14072	12	,	,	,
cord-005453-4057qib7	14072	13	especially	especially	RB
cord-005453-4057qib7	14072	14	those	those	DT
cord-005453-4057qib7	14072	15	who	who	WP
cord-005453-4057qib7	14072	16	are	be	VBP
cord-005453-4057qib7	14072	17	unresponsive	unresponsive	JJ
cord-005453-4057qib7	14072	18	to	to	IN
cord-005453-4057qib7	14072	19	GCSF	GCSF	NNP
cord-005453-4057qib7	14072	20	treatment	treatment	NN
cord-005453-4057qib7	14072	21	and	and	CC
cord-005453-4057qib7	14072	22	at	at	IN
cord-005453-4057qib7	14072	23	high	high	JJ
cord-005453-4057qib7	14072	24	risk	risk	NN
cord-005453-4057qib7	14072	25	for	for	IN
cord-005453-4057qib7	14072	26	leukemic	leukemic	JJ
cord-005453-4057qib7	14072	27	transformation	transformation	NN
cord-005453-4057qib7	14072	28	.	.	.
cord-005453-4057qib7	14073	1	However	however	RB
cord-005453-4057qib7	14073	2	,	,	,
cord-005453-4057qib7	14073	3	a	a	DT
cord-005453-4057qib7	14073	4	larger	large	JJR
cord-005453-4057qib7	14073	5	number	number	NN
cord-005453-4057qib7	14073	6	of	of	IN
cord-005453-4057qib7	14073	7	SCN	SCN	NNP
cord-005453-4057qib7	14073	8	patients	patient	NNS
cord-005453-4057qib7	14073	9	and	and	CC
cord-005453-4057qib7	14073	10	longer	long	RBR
cord-005453-4057qib7	14073	11	follow	follow	VB
cord-005453-4057qib7	14073	12	-	-	HYPH
cord-005453-4057qib7	14073	13	up	up	NN
cord-005453-4057qib7	14073	14	are	be	VBP
cord-005453-4057qib7	14073	15	necessary	necessary	JJ
cord-005453-4057qib7	14073	16	to	to	TO
cord-005453-4057qib7	14073	17	identify	identify	VB
cord-005453-4057qib7	14073	18	appropriate	appropriate	JJ
cord-005453-4057qib7	14073	19	conditioning	conditioning	NN
cord-005453-4057qib7	14073	20	regimens	regimen	NNS
cord-005453-4057qib7	14073	21	and	and	CC
cord-005453-4057qib7	14073	22	long	long	JJ
cord-005453-4057qib7	14073	23	-	-	HYPH
cord-005453-4057qib7	14073	24	term	term	NN
cord-005453-4057qib7	14073	25	prognosis	prognosis	NN
cord-005453-4057qib7	14073	26	.	.	.
cord-005453-4057qib7	14074	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14074	2	:	:	:
cord-005453-4057qib7	14074	3	Nothing	nothing	NN
cord-005453-4057qib7	14074	4	to	to	TO
cord-005453-4057qib7	14074	5	declare	declare	VB
cord-005453-4057qib7	14074	6	Background	background	NN
cord-005453-4057qib7	14074	7	:	:	:
cord-005453-4057qib7	14075	1	Prolonged	prolonged	JJ
cord-005453-4057qib7	14075	2	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	14075	3	(	(	-LRB-
cord-005453-4057qib7	14075	4	PT	pt	NN
cord-005453-4057qib7	14075	5	)	)	-RRB-
cord-005453-4057qib7	14075	6	or	or	CC
cord-005453-4057qib7	14075	7	secondary	secondary	JJ
cord-005453-4057qib7	14075	8	failure	failure	NN
cord-005453-4057qib7	14075	9	of	of	IN
cord-005453-4057qib7	14075	10	platelet	platelet	NN
cord-005453-4057qib7	14075	11	recovery	recovery	NN
cord-005453-4057qib7	14075	12	(	(	-LRB-
cord-005453-4057qib7	14075	13	SFPR	SFPR	NNP
cord-005453-4057qib7	14075	14	)	)	-RRB-
cord-005453-4057qib7	14075	15	are	be	VBP
cord-005453-4057qib7	14075	16	a	a	DT
cord-005453-4057qib7	14075	17	lifethreatening	lifethreatening	JJ
cord-005453-4057qib7	14075	18	complications	complication	NNS
cord-005453-4057qib7	14075	19	that	that	WDT
cord-005453-4057qib7	14075	20	occurs	occur	VBZ
cord-005453-4057qib7	14075	21	in	in	IN
cord-005453-4057qib7	14075	22	20	20	CD
cord-005453-4057qib7	14075	23	-	-	SYM
cord-005453-4057qib7	14075	24	40	40	CD
cord-005453-4057qib7	14075	25	%	%	NN
cord-005453-4057qib7	14075	26	and	and	CC
cord-005453-4057qib7	14075	27	12	12	CD
cord-005453-4057qib7	14075	28	-	-	SYM
cord-005453-4057qib7	14075	29	20	20	CD
cord-005453-4057qib7	14075	30	%	%	NN
cord-005453-4057qib7	14075	31	respectively	respectively	RB
cord-005453-4057qib7	14075	32	of	of	IN
cord-005453-4057qib7	14075	33	the	the	DT
cord-005453-4057qib7	14075	34	patients	patient	NNS
cord-005453-4057qib7	14075	35	following	follow	VBG
cord-005453-4057qib7	14075	36	allogeneic	allogeneic	IN
cord-005453-4057qib7	14075	37	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14075	38	stem	stem	NN
cord-005453-4057qib7	14075	39	cell	cell	NN
cord-005453-4057qib7	14075	40	transplantation	transplantation	NN
cord-005453-4057qib7	14075	41	(	(	-LRB-
cord-005453-4057qib7	14075	42	allo	allo	NN
cord-005453-4057qib7	14075	43	-	-	HYPH
cord-005453-4057qib7	14075	44	HSCT	HSCT	NNP
cord-005453-4057qib7	14075	45	)	)	-RRB-
cord-005453-4057qib7	14075	46	.	.	.
cord-005453-4057qib7	14076	1	Management	management	NN
cord-005453-4057qib7	14076	2	strategies	strategy	NNS
cord-005453-4057qib7	14076	3	,	,	,
cord-005453-4057qib7	14076	4	including	include	VBG
cord-005453-4057qib7	14076	5	the	the	DT
cord-005453-4057qib7	14076	6	use	use	NN
cord-005453-4057qib7	14076	7	of	of	IN
cord-005453-4057qib7	14076	8	growth	growth	NN
cord-005453-4057qib7	14076	9	factors	factor	NNS
cord-005453-4057qib7	14076	10	,	,	,
cord-005453-4057qib7	14076	11	CD34	CD34	NNP
cord-005453-4057qib7	14076	12	+	+	CC
cord-005453-4057qib7	14076	13	-selected	-selected	JJ
cord-005453-4057qib7	14076	14	stem	stem	NN
cord-005453-4057qib7	14076	15	cell	cell	NN
cord-005453-4057qib7	14076	16	boost	boost	NN
cord-005453-4057qib7	14076	17	,	,	,
cord-005453-4057qib7	14076	18	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	14076	19	stem	stem	NN
cord-005453-4057qib7	14076	20	cell	cell	NN
cord-005453-4057qib7	14076	21	(	(	-LRB-
cord-005453-4057qib7	14076	22	MSC	MSC	NNP
cord-005453-4057qib7	14076	23	)	)	-RRB-
cord-005453-4057qib7	14076	24	transfusion	transfusion	NN
cord-005453-4057qib7	14076	25	,	,	,
cord-005453-4057qib7	14076	26	and	and	CC
cord-005453-4057qib7	14076	27	second	second	JJ
cord-005453-4057qib7	14076	28	allo	allo	NN
cord-005453-4057qib7	14076	29	-	-	HYPH
cord-005453-4057qib7	14076	30	HSCT	HSCT	NNP
cord-005453-4057qib7	14076	31	,	,	,
cord-005453-4057qib7	14076	32	are	be	VBP
cord-005453-4057qib7	14076	33	not	not	RB
cord-005453-4057qib7	14076	34	effective	effective	JJ
cord-005453-4057qib7	14076	35	or	or	CC
cord-005453-4057qib7	14076	36	possible	possible	JJ
cord-005453-4057qib7	14076	37	for	for	IN
cord-005453-4057qib7	14076	38	all	all	DT
cord-005453-4057qib7	14076	39	patients	patient	NNS
cord-005453-4057qib7	14076	40	.	.	.
cord-005453-4057qib7	14077	1	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14077	2	,	,	,
cord-005453-4057qib7	14077	3	is	be	VBZ
cord-005453-4057qib7	14077	4	an	an	DT
cord-005453-4057qib7	14077	5	oral	oral	JJ
cord-005453-4057qib7	14077	6	non	non	JJ
cord-005453-4057qib7	14077	7	-	-	JJ
cord-005453-4057qib7	14077	8	peptide	peptide	JJ
cord-005453-4057qib7	14077	9	thrombopoietin	thrombopoietin	NNP
cord-005453-4057qib7	14077	10	receptor	receptor	NN
cord-005453-4057qib7	14077	11	agonist	agonist	NN
cord-005453-4057qib7	14077	12	,	,	,
cord-005453-4057qib7	14077	13	that	that	WDT
cord-005453-4057qib7	14077	14	leads	lead	VBZ
cord-005453-4057qib7	14077	15	to	to	TO
cord-005453-4057qib7	14077	16	signal	signal	VB
cord-005453-4057qib7	14077	17	transduction	transduction	NN
cord-005453-4057qib7	14077	18	and	and	CC
cord-005453-4057qib7	14077	19	results	result	NNS
cord-005453-4057qib7	14077	20	in	in	IN
cord-005453-4057qib7	14077	21	promoting	promote	VBG
cord-005453-4057qib7	14077	22	the	the	DT
cord-005453-4057qib7	14077	23	proliferation	proliferation	NN
cord-005453-4057qib7	14077	24	and	and	CC
cord-005453-4057qib7	14077	25	differentiation	differentiation	NN
cord-005453-4057qib7	14077	26	of	of	IN
cord-005453-4057qib7	14077	27	megakaryocytes	megakaryocyte	NNS
cord-005453-4057qib7	14077	28	.	.	.
cord-005453-4057qib7	14078	1	Some	some	DT
cord-005453-4057qib7	14078	2	recently	recently	RB
cord-005453-4057qib7	14078	3	studies	study	NNS
cord-005453-4057qib7	14078	4	show	show	VBP
cord-005453-4057qib7	14078	5	that	that	IN
cord-005453-4057qib7	14078	6	also	also	RB
cord-005453-4057qib7	14078	7	can	can	MD
cord-005453-4057qib7	14078	8	promote	promote	VB
cord-005453-4057qib7	14078	9	haematopoiesis	haematopoiesis	NN
cord-005453-4057qib7	14078	10	along	along	IN
cord-005453-4057qib7	14078	11	all	all	DT
cord-005453-4057qib7	14078	12	three	three	CD
cord-005453-4057qib7	14078	13	lineages	lineage	NNS
cord-005453-4057qib7	14078	14	.	.	.
cord-005453-4057qib7	14079	1	Methods	method	NNS
cord-005453-4057qib7	14080	1	:	:	:
cord-005453-4057qib7	14080	2	We	-PRON-	PRP
cord-005453-4057qib7	14080	3	described	describe	VBD
cord-005453-4057qib7	14080	4	our	-PRON-	PRP$
cord-005453-4057qib7	14080	5	experience	experience	NN
cord-005453-4057qib7	14080	6	in	in	IN
cord-005453-4057qib7	14080	7	4	4	CD
cord-005453-4057qib7	14080	8	paediatric	paediatric	JJ
cord-005453-4057qib7	14080	9	patients	patient	NNS
cord-005453-4057qib7	14080	10	with	with	IN
cord-005453-4057qib7	14080	11	poor	poor	JJ
cord-005453-4057qib7	14080	12	graft	graft	NN
cord-005453-4057qib7	14080	13	function	function	NN
cord-005453-4057qib7	14080	14	or	or	CC
cord-005453-4057qib7	14080	15	secondary	secondary	JJ
cord-005453-4057qib7	14080	16	failure	failure	NN
cord-005453-4057qib7	14080	17	of	of	IN
cord-005453-4057qib7	14080	18	platelet	platelet	NN
cord-005453-4057qib7	14080	19	recovery	recovery	NN
cord-005453-4057qib7	14080	20	after	after	IN
cord-005453-4057qib7	14080	21	allogeneic	allogeneic	NN
cord-005453-4057qib7	14080	22	stem	stem	NN
cord-005453-4057qib7	14080	23	cell	cell	NN
cord-005453-4057qib7	14080	24	transplantation	transplantation	NN
cord-005453-4057qib7	14080	25	treated	treat	VBN
cord-005453-4057qib7	14080	26	with	with	IN
cord-005453-4057qib7	14080	27	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14080	28	.	.	.
cord-005453-4057qib7	14081	1	Results	result	NNS
cord-005453-4057qib7	14081	2	:	:	:
cord-005453-4057qib7	14082	1	Patients	patient	NNS
cord-005453-4057qib7	14082	2	characteristics	characteristic	NNS
cord-005453-4057qib7	14082	3	are	be	VBP
cord-005453-4057qib7	14082	4	detailed	detail	VBN
cord-005453-4057qib7	14082	5	in	in	IN
cord-005453-4057qib7	14082	6	Table	Table	NNP
cord-005453-4057qib7	14082	7	1	1	CD
cord-005453-4057qib7	14082	8	.	.	.
cord-005453-4057qib7	14083	1	All	all	PDT
cord-005453-4057qib7	14083	2	the	the	DT
cord-005453-4057qib7	14083	3	patients	patient	NNS
cord-005453-4057qib7	14083	4	received	receive	VBN
cord-005453-4057qib7	14083	5	and	and	CC
cord-005453-4057qib7	14083	6	allo	allo	NN
cord-005453-4057qib7	14083	7	-	-	HYPH
cord-005453-4057qib7	14083	8	HST	HST	NNP
cord-005453-4057qib7	14083	9	.	.	.
cord-005453-4057qib7	14084	1	The	the	DT
cord-005453-4057qib7	14084	2	median	median	JJ
cord-005453-4057qib7	14084	3	dose	dose	NN
cord-005453-4057qib7	14084	4	of	of	IN
cord-005453-4057qib7	14084	5	CD34	CD34	NNP
cord-005453-4057qib7	14084	6	+	+	CC
cord-005453-4057qib7	14085	1	cells	cell	NNS
cord-005453-4057qib7	14085	2	infusion	infusion	NN
cord-005453-4057qib7	14085	3	was	be	VBD
cord-005453-4057qib7	14085	4	6.43x10e6	6.43x10e6	NNP
cord-005453-4057qib7	14085	5	/	/	SYM
cord-005453-4057qib7	14085	6	kg	kg	NN
cord-005453-4057qib7	14085	7	(	(	-LRB-
cord-005453-4057qib7	14085	8	3.95	3.95	CD
cord-005453-4057qib7	14085	9	-	-	SYM
cord-005453-4057qib7	14085	10	8.29	8.29	CD
cord-005453-4057qib7	14085	11	)	)	-RRB-
cord-005453-4057qib7	14085	12	.	.	.
cord-005453-4057qib7	14086	1	Neutrophils	neutrophils	NN
cord-005453-4057qib7	14086	2	engraftment	engraftment	NN
cord-005453-4057qib7	14086	3	occurred	occur	VBD
cord-005453-4057qib7	14086	4	in	in	IN
cord-005453-4057qib7	14086	5	+15	+15	CD
cord-005453-4057qib7	14086	6	day	day	NN
cord-005453-4057qib7	14086	7	(	(	-LRB-
cord-005453-4057qib7	14086	8	10	10	CD
cord-005453-4057qib7	14086	9	-	-	HYPH
cord-005453-4057qib7	14086	10	21d	21d	CD
cord-005453-4057qib7	14086	11	)	)	-RRB-
cord-005453-4057qib7	14086	12	and	and	CC
cord-005453-4057qib7	14086	13	platelets	platelet	NNS
cord-005453-4057qib7	14086	14	in	in	IN
cord-005453-4057qib7	14086	15	+26	+26	NNP
cord-005453-4057qib7	14086	16	day	day	NN
cord-005453-4057qib7	14086	17	(	(	-LRB-
cord-005453-4057qib7	14086	18	16	16	CD
cord-005453-4057qib7	14086	19	-	-	HYPH
cord-005453-4057qib7	14086	20	42d	42d	CD
cord-005453-4057qib7	14086	21	)	)	-RRB-
cord-005453-4057qib7	14086	22	.	.	.
cord-005453-4057qib7	14087	1	All	all	PDT
cord-005453-4057qib7	14087	2	the	the	DT
cord-005453-4057qib7	14087	3	patients	patient	NNS
cord-005453-4057qib7	14087	4	had	have	VBD
cord-005453-4057qib7	14087	5	an	an	DT
cord-005453-4057qib7	14087	6	hypoplastic	hypoplastic	JJ
cord-005453-4057qib7	14087	7	bone	bone	NN
cord-005453-4057qib7	14087	8	marrow	marrow	NN
cord-005453-4057qib7	14087	9	with	with	IN
cord-005453-4057qib7	14087	10	complete	complete	JJ
cord-005453-4057qib7	14087	11	chimerism	chimerism	NN
cord-005453-4057qib7	14087	12	.	.	.
cord-005453-4057qib7	14088	1	The	the	DT
cord-005453-4057qib7	14088	2	median	median	JJ
cord-005453-4057qib7	14088	3	duration	duration	NN
cord-005453-4057qib7	14088	4	from	from	IN
cord-005453-4057qib7	14088	5	transplantation	transplantation	NN
cord-005453-4057qib7	14088	6	to	to	IN
cord-005453-4057qib7	14088	7	SPCF	SPCF	NNP
cord-005453-4057qib7	14088	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	14088	9	was	be	VBD
cord-005453-4057qib7	14088	10	10	10	CD
cord-005453-4057qib7	14088	11	months	month	NNS
cord-005453-4057qib7	14088	12	(	(	-LRB-
cord-005453-4057qib7	14088	13	1.5	1.5	CD
cord-005453-4057qib7	14088	14	-	-	SYM
cord-005453-4057qib7	14088	15	24	24	CD
cord-005453-4057qib7	14088	16	m	m	CD
cord-005453-4057qib7	14088	17	)	)	-RRB-
cord-005453-4057qib7	14088	18	.	.	.
cord-005453-4057qib7	14089	1	One	one	CD
cord-005453-4057qib7	14089	2	of	of	IN
cord-005453-4057qib7	14089	3	the	the	DT
cord-005453-4057qib7	14089	4	patients	patient	NNS
cord-005453-4057qib7	14089	5	received	receive	VBD
cord-005453-4057qib7	14089	6	a	a	DT
cord-005453-4057qib7	14089	7	stem	stem	NN
cord-005453-4057qib7	14089	8	cell	cell	NN
cord-005453-4057qib7	14089	9	boost	boost	NN
cord-005453-4057qib7	14089	10	prior	prior	RB
cord-005453-4057qib7	14089	11	to	to	IN
cord-005453-4057qib7	14089	12	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14089	13	,	,	,
cord-005453-4057qib7	14089	14	without	without	IN
cord-005453-4057qib7	14089	15	response	response	NN
cord-005453-4057qib7	14089	16	.	.	.
cord-005453-4057qib7	14090	1	The	the	DT
cord-005453-4057qib7	14090	2	time	time	NN
cord-005453-4057qib7	14090	3	onset	onset	NN
cord-005453-4057qib7	14090	4	from	from	IN
cord-005453-4057qib7	14090	5	sPGF	sPGF	NNP
cord-005453-4057qib7	14090	6	/	/	SYM
cord-005453-4057qib7	14090	7	sFPR	sfpr	NN
cord-005453-4057qib7	14090	8	diagnosis	diagnosis	NN
cord-005453-4057qib7	14090	9	to	to	IN
cord-005453-4057qib7	14090	10	initiating	initiate	VBG
cord-005453-4057qib7	14090	11	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14090	12	was	be	VBD
cord-005453-4057qib7	14090	13	16	16	CD
cord-005453-4057qib7	14090	14	days	day	NNS
cord-005453-4057qib7	14090	15	(	(	-LRB-
cord-005453-4057qib7	14090	16	8	8	CD
cord-005453-4057qib7	14090	17	-	-	SYM
cord-005453-4057qib7	14090	18	32d	32d	CD
cord-005453-4057qib7	14090	19	)	)	-RRB-
cord-005453-4057qib7	14090	20	.	.	.
cord-005453-4057qib7	14091	1	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14091	2	was	be	VBD
cord-005453-4057qib7	14091	3	started	start	VBN
cord-005453-4057qib7	14091	4	at	at	IN
cord-005453-4057qib7	14091	5	a	a	DT
cord-005453-4057qib7	14091	6	dose	dose	NN
cord-005453-4057qib7	14091	7	of	of	IN
cord-005453-4057qib7	14091	8	1mg	1mg	NNP
cord-005453-4057qib7	14091	9	/	/	SYM
cord-005453-4057qib7	14091	10	kg	kg	NNP
cord-005453-4057qib7	14091	11	/	/	SYM
cord-005453-4057qib7	14091	12	d	d	NNP
cord-005453-4057qib7	14091	13	,	,	,
cord-005453-4057qib7	14091	14	requiring	require	VBG
cord-005453-4057qib7	14091	15	an	an	DT
cord-005453-4057qib7	14091	16	increase	increase	NN
cord-005453-4057qib7	14091	17	dose	dose	NN
cord-005453-4057qib7	14091	18	in	in	IN
cord-005453-4057qib7	14091	19	all	all	DT
cord-005453-4057qib7	14091	20	cases	case	NNS
cord-005453-4057qib7	14091	21	.	.	.
cord-005453-4057qib7	14092	1	The	the	DT
cord-005453-4057qib7	14092	2	median	median	JJ
cord-005453-4057qib7	14092	3	dose	dose	NN
cord-005453-4057qib7	14092	4	was	be	VBD
cord-005453-4057qib7	14092	5	50	50	CD
cord-005453-4057qib7	14092	6	mg	mg	NN
cord-005453-4057qib7	14092	7	/	/	SYM
cord-005453-4057qib7	14092	8	d	d	NN
cord-005453-4057qib7	14092	9	(	(	-LRB-
cord-005453-4057qib7	14092	10	25	25	CD
cord-005453-4057qib7	14092	11	-	-	SYM
cord-005453-4057qib7	14092	12	100	100	CD
cord-005453-4057qib7	14092	13	mg	mg	NNP
cord-005453-4057qib7	14092	14	)	)	-RRB-
cord-005453-4057qib7	14092	15	.	.	.
cord-005453-4057qib7	14093	1	The	the	DT
cord-005453-4057qib7	14093	2	overall	overall	JJ
cord-005453-4057qib7	14093	3	response	response	NN
cord-005453-4057qib7	14093	4	rate	rate	NN
cord-005453-4057qib7	14093	5	was	be	VBD
cord-005453-4057qib7	14093	6	50	50	CD
cord-005453-4057qib7	14093	7	%	%	NN
cord-005453-4057qib7	14093	8	(	(	-LRB-
cord-005453-4057qib7	14093	9	2/4	2/4	CD
cord-005453-4057qib7	14093	10	)	)	-RRB-
cord-005453-4057qib7	14093	11	.	.	.
cord-005453-4057qib7	14094	1	Two	two	CD
cord-005453-4057qib7	14094	2	patients	patient	NNS
cord-005453-4057qib7	14094	3	achieved	achieve	VBD
cord-005453-4057qib7	14094	4	complete	complete	JJ
cord-005453-4057qib7	14094	5	response	response	NN
cord-005453-4057qib7	14094	6	(	(	-LRB-
cord-005453-4057qib7	14094	7	CR	CR	NNP
cord-005453-4057qib7	14094	8	)	)	-RRB-
cord-005453-4057qib7	14094	9	,	,	,
cord-005453-4057qib7	14094	10	as	as	IN
cord-005453-4057qib7	14094	11	defined	define	VBN
cord-005453-4057qib7	14094	12	by	by	IN
cord-005453-4057qib7	14094	13	platelet	platelet	NN
cord-005453-4057qib7	14095	1	≥	≥	CD
cord-005453-4057qib7	14095	2	50	50	CD
cord-005453-4057qib7	14095	3	×	×	NN
cord-005453-4057qib7	14095	4	109	109	CD
cord-005453-4057qib7	14096	1	/L.	/L.	.
cord-005453-4057qib7	14097	1	Both	both	DT
cord-005453-4057qib7	14097	2	patients	patient	NNS
cord-005453-4057qib7	14097	3	already	already	RB
cord-005453-4057qib7	14097	4	got	get	VBD
cord-005453-4057qib7	14097	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	14097	6	≥	≥	NNP
cord-005453-4057qib7	14097	7	1.0	1.0	CD
cord-005453-4057qib7	14097	8	×	×	NN
cord-005453-4057qib7	14097	9	109	109	CD
cord-005453-4057qib7	14097	10	/	/	SYM
cord-005453-4057qib7	14097	11	L	l	NN
cord-005453-4057qib7	14097	12	without	without	IN
cord-005453-4057qib7	14097	13	G	G	NNP
cord-005453-4057qib7	14097	14	-	-	HYPH
cord-005453-4057qib7	14097	15	CSF	CSF	NNP
cord-005453-4057qib7	14097	16	.	.	.
cord-005453-4057qib7	14098	1	The	the	DT
cord-005453-4057qib7	14098	2	time	time	NN
cord-005453-4057qib7	14098	3	from	from	IN
cord-005453-4057qib7	14098	4	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14098	5	initiation	initiation	NN
cord-005453-4057qib7	14098	6	to	to	IN
cord-005453-4057qib7	14098	7	achieving	achieve	VBG
cord-005453-4057qib7	14098	8	CR	CR	NNP
cord-005453-4057qib7	14098	9	was	be	VBD
cord-005453-4057qib7	14098	10	21	21	CD
cord-005453-4057qib7	14098	11	(	(	-LRB-
cord-005453-4057qib7	14098	12	10	10	CD
cord-005453-4057qib7	14098	13	-	-	SYM
cord-005453-4057qib7	14098	14	49d	49d	CD
cord-005453-4057qib7	14098	15	)	)	-RRB-
cord-005453-4057qib7	14098	16	days	day	NNS
cord-005453-4057qib7	14098	17	.	.	.
cord-005453-4057qib7	14099	1	The	the	DT
cord-005453-4057qib7	14099	2	treatment	treatment	NN
cord-005453-4057qib7	14099	3	was	be	VBD
cord-005453-4057qib7	14099	4	given	give	VBN
cord-005453-4057qib7	14099	5	for	for	IN
cord-005453-4057qib7	14099	6	a	a	DT
cord-005453-4057qib7	14099	7	median	median	NN
cord-005453-4057qib7	14099	8	of	of	IN
cord-005453-4057qib7	14099	9	81	81	CD
cord-005453-4057qib7	14099	10	days	day	NNS
cord-005453-4057qib7	14099	11	(	(	-LRB-
cord-005453-4057qib7	14099	12	8	8	CD
cord-005453-4057qib7	14099	13	-	-	SYM
cord-005453-4057qib7	14099	14	203	203	CD
cord-005453-4057qib7	14099	15	)	)	-RRB-
cord-005453-4057qib7	14099	16	.	.	.
cord-005453-4057qib7	14100	1	It	-PRON-	PRP
cord-005453-4057qib7	14100	2	was	be	VBD
cord-005453-4057qib7	14100	3	discontinued	discontinue	VBN
cord-005453-4057qib7	14100	4	after	after	IN
cord-005453-4057qib7	14100	5	96	96	CD
cord-005453-4057qib7	14100	6	and	and	CC
cord-005453-4057qib7	14100	7	203	203	CD
cord-005453-4057qib7	14100	8	days	day	NNS
cord-005453-4057qib7	14100	9	respectively	respectively	RB
cord-005453-4057qib7	14100	10	in	in	IN
cord-005453-4057qib7	14100	11	the	the	DT
cord-005453-4057qib7	14100	12	two	two	CD
cord-005453-4057qib7	14100	13	responder	responder	NN
cord-005453-4057qib7	14100	14	patients	patient	NNS
cord-005453-4057qib7	14100	15	.	.	.
cord-005453-4057qib7	14101	1	Both	both	DT
cord-005453-4057qib7	14101	2	patients	patient	NNS
cord-005453-4057qib7	14101	3	maintain	maintain	VBP
cord-005453-4057qib7	14101	4	stable	stable	JJ
cord-005453-4057qib7	14101	5	blood	blood	NN
cord-005453-4057qib7	14101	6	counts	count	NNS
cord-005453-4057qib7	14101	7	after	after	IN
cord-005453-4057qib7	14101	8	discontinuing	discontinue	VBG
cord-005453-4057qib7	14101	9	the	the	DT
cord-005453-4057qib7	14101	10	treatment	treatment	NN
cord-005453-4057qib7	14101	11	.	.	.
cord-005453-4057qib7	14102	1	The	the	DT
cord-005453-4057qib7	14102	2	non	non	JJ
cord-005453-4057qib7	14102	3	-	-	NNS
cord-005453-4057qib7	14102	4	responders	responder	NNS
cord-005453-4057qib7	14102	5	patients	patient	NNS
cord-005453-4057qib7	14102	6	had	have	VBD
cord-005453-4057qib7	14102	7	to	to	TO
cord-005453-4057qib7	14102	8	stop	stop	VB
cord-005453-4057qib7	14102	9	the	the	DT
cord-005453-4057qib7	14102	10	treatment	treatment	NN
cord-005453-4057qib7	14102	11	because	because	IN
cord-005453-4057qib7	14102	12	of	of	IN
cord-005453-4057qib7	14102	13	other	other	JJ
cord-005453-4057qib7	14102	14	reasons	reason	NNS
cord-005453-4057qib7	14102	15	not	not	RB
cord-005453-4057qib7	14102	16	related	relate	VBN
cord-005453-4057qib7	14102	17	to	to	IN
cord-005453-4057qib7	14102	18	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14102	19	.	.	.
cord-005453-4057qib7	14103	1	Patient	patient	NN
cord-005453-4057qib7	14103	2	4	4	CD
cord-005453-4057qib7	14103	3	had	have	VBD
cord-005453-4057qib7	14103	4	to	to	TO
cord-005453-4057qib7	14103	5	be	be	VB
cord-005453-4057qib7	14103	6	rescued	rescue	VBN
cord-005453-4057qib7	14103	7	with	with	IN
cord-005453-4057qib7	14103	8	a	a	DT
cord-005453-4057qib7	14103	9	CD34	CD34	NNP
cord-005453-4057qib7	14104	1	+	+	CC
cord-005453-4057qib7	14104	2	cells	cell	NNS
cord-005453-4057qib7	14104	3	boost	boost	VBP
cord-005453-4057qib7	14104	4	with	with	IN
cord-005453-4057qib7	14104	5	a	a	DT
cord-005453-4057qib7	14104	6	good	good	JJ
cord-005453-4057qib7	14104	7	response	response	NN
cord-005453-4057qib7	14104	8	.	.	.
cord-005453-4057qib7	14105	1	Two	two	CD
cord-005453-4057qib7	14105	2	patients	patient	NNS
cord-005453-4057qib7	14105	3	that	that	WDT
cord-005453-4057qib7	14105	4	were	be	VBD
cord-005453-4057qib7	14105	5	in	in	IN
cord-005453-4057qib7	14105	6	treatment	treatment	NN
cord-005453-4057qib7	14105	7	with	with	IN
cord-005453-4057qib7	14105	8	voriconazole	voriconazole	NN
cord-005453-4057qib7	14105	9	for	for	IN
cord-005453-4057qib7	14105	10	a	a	DT
cord-005453-4057qib7	14105	11	fungal	fungal	JJ
cord-005453-4057qib7	14105	12	infection	infection	NN
cord-005453-4057qib7	14105	13	developed	develop	VBD
cord-005453-4057qib7	14105	14	hyperbilirubinemia	hyperbilirubinemia	NN
cord-005453-4057qib7	14105	15	.	.	.
cord-005453-4057qib7	14106	1	There	there	EX
cord-005453-4057qib7	14106	2	were	be	VBD
cord-005453-4057qib7	14106	3	no	no	DT
cord-005453-4057qib7	14106	4	grade	grade	NN
cord-005453-4057qib7	14106	5	3	3	CD
cord-005453-4057qib7	14106	6	-	-	SYM
cord-005453-4057qib7	14106	7	4	4	CD
cord-005453-4057qib7	14106	8	toxicities	toxicity	NNS
cord-005453-4057qib7	14106	9	related	relate	VBN
cord-005453-4057qib7	14106	10	to	to	IN
cord-005453-4057qib7	14106	11	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14106	12	.	.	.
cord-005453-4057qib7	14107	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14107	2	:	:	:
cord-005453-4057qib7	14108	1	In	in	IN
cord-005453-4057qib7	14108	2	our	-PRON-	PRP$
cord-005453-4057qib7	14108	3	experience	experience	NN
cord-005453-4057qib7	14108	4	,	,	,
cord-005453-4057qib7	14108	5	according	accord	VBG
cord-005453-4057qib7	14108	6	to	to	IN
cord-005453-4057qib7	14108	7	recently	recently	RB
cord-005453-4057qib7	14108	8	published	publish	VBN
cord-005453-4057qib7	14108	9	studies	study	NNS
cord-005453-4057qib7	14108	10	,	,	,
cord-005453-4057qib7	14108	11	Eltrombopag	Eltrombopag	NNP
cord-005453-4057qib7	14108	12	is	be	VBZ
cord-005453-4057qib7	14108	13	a	a	DT
cord-005453-4057qib7	14108	14	safe	safe	JJ
cord-005453-4057qib7	14108	15	and	and	CC
cord-005453-4057qib7	14108	16	efficacy	efficacy	NN
cord-005453-4057qib7	14108	17	drug	drug	NN
cord-005453-4057qib7	14108	18	in	in	IN
cord-005453-4057qib7	14108	19	the	the	DT
cord-005453-4057qib7	14108	20	treatment	treatment	NN
cord-005453-4057qib7	14108	21	of	of	IN
cord-005453-4057qib7	14108	22	secondary	secondary	JJ
cord-005453-4057qib7	14108	23	failure	failure	NN
cord-005453-4057qib7	14108	24	of	of	IN
cord-005453-4057qib7	14108	25	platelet	platelet	NN
cord-005453-4057qib7	14108	26	recovery	recovery	NN
cord-005453-4057qib7	14108	27	post	post	NN
cord-005453-4057qib7	14108	28	-	-	JJ
cord-005453-4057qib7	14108	29	HSCT	HSCT	NNP
cord-005453-4057qib7	14108	30	.	.	.
cord-005453-4057qib7	14109	1	It	-PRON-	PRP
cord-005453-4057qib7	14109	2	may	may	MD
cord-005453-4057qib7	14109	3	be	be	VB
cord-005453-4057qib7	14109	4	used	use	VBN
cord-005453-4057qib7	14109	5	successfully	successfully	RB
cord-005453-4057qib7	14109	6	in	in	IN
cord-005453-4057qib7	14109	7	children	child	NNS
cord-005453-4057qib7	14109	8	.	.	.
cord-005453-4057qib7	14110	1	Sometimes	sometimes	RB
cord-005453-4057qib7	14110	2	higher	high	JJR
cord-005453-4057qib7	14110	3	doses	dose	NNS
cord-005453-4057qib7	14110	4	may	may	MD
cord-005453-4057qib7	14110	5	be	be	VB
cord-005453-4057qib7	14110	6	considered	consider	VBN
cord-005453-4057qib7	14110	7	if	if	IN
cord-005453-4057qib7	14110	8	no	no	DT
cord-005453-4057qib7	14110	9	response	response	NN
cord-005453-4057qib7	14110	10	is	be	VBZ
cord-005453-4057qib7	14110	11	achieved	achieve	VBN
cord-005453-4057qib7	14110	12	.	.	.
cord-005453-4057qib7	14111	1	Further	further	JJ
cord-005453-4057qib7	14111	2	prospective	prospective	JJ
cord-005453-4057qib7	14111	3	trials	trial	NNS
cord-005453-4057qib7	14111	4	are	be	VBP
cord-005453-4057qib7	14111	5	needed	need	VBN
cord-005453-4057qib7	14111	6	to	to	TO
cord-005453-4057qib7	14111	7	increase	increase	VB
cord-005453-4057qib7	14111	8	the	the	DT
cord-005453-4057qib7	14111	9	level	level	NN
cord-005453-4057qib7	14111	10	of	of	IN
cord-005453-4057qib7	14111	11	evidence	evidence	NN
cord-005453-4057qib7	14111	12	and	and	CC
cord-005453-4057qib7	14111	13	to	to	TO
cord-005453-4057qib7	14111	14	identify	identify	VB
cord-005453-4057qib7	14111	15	predictors	predictor	NNS
cord-005453-4057qib7	14111	16	of	of	IN
cord-005453-4057qib7	14111	17	response	response	NN
cord-005453-4057qib7	14111	18	.	.	.
cord-005453-4057qib7	14112	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14112	2	:	:	:
cord-005453-4057qib7	14112	3	Nothing	nothing	NN
cord-005453-4057qib7	14112	4	to	to	TO
cord-005453-4057qib7	14112	5	declare	declare	VB
cord-005453-4057qib7	14112	6	Very	very	RB
cord-005453-4057qib7	14112	7	slow	slow	JJ
cord-005453-4057qib7	14112	8	clearance	clearance	NN
cord-005453-4057qib7	14112	9	of	of	IN
cord-005453-4057qib7	14112	10	busulfan	busulfan	NN
cord-005453-4057qib7	14112	11	in	in	IN
cord-005453-4057qib7	14112	12	a	a	DT
cord-005453-4057qib7	14112	13	child	child	NN
cord-005453-4057qib7	14112	14	with	with	IN
cord-005453-4057qib7	14112	15	infant	infant	NN
cord-005453-4057qib7	14112	16	leukemia	leukemia	NN
cord-005453-4057qib7	14112	17	Background	background	NN
cord-005453-4057qib7	14112	18	:	:	:
cord-005453-4057qib7	14112	19	Busulfan	Busulfan	NNP
cord-005453-4057qib7	14112	20	is	be	VBZ
cord-005453-4057qib7	14112	21	a	a	DT
cord-005453-4057qib7	14112	22	drug	drug	NN
cord-005453-4057qib7	14112	23	with	with	IN
cord-005453-4057qib7	14112	24	a	a	DT
cord-005453-4057qib7	14112	25	high	high	JJ
cord-005453-4057qib7	14112	26	interindividual	interindividual	JJ
cord-005453-4057qib7	14112	27	variability	variability	NN
cord-005453-4057qib7	14112	28	between	between	IN
cord-005453-4057qib7	14112	29	dose	dose	NN
cord-005453-4057qib7	14112	30	and	and	CC
cord-005453-4057qib7	14112	31	exposition	exposition	NN
cord-005453-4057qib7	14112	32	.	.	.
cord-005453-4057qib7	14113	1	Therefore	therefore	RB
cord-005453-4057qib7	14113	2	,	,	,
cord-005453-4057qib7	14113	3	it	-PRON-	PRP
cord-005453-4057qib7	14113	4	is	be	VBZ
cord-005453-4057qib7	14113	5	recommended	recommend	VBN
cord-005453-4057qib7	14113	6	to	to	TO
cord-005453-4057qib7	14113	7	perform	perform	VB
cord-005453-4057qib7	14113	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	14113	9	drug	drug	NN
cord-005453-4057qib7	14113	10	monitoring	monitoring	NN
cord-005453-4057qib7	14113	11	(	(	-LRB-
cord-005453-4057qib7	14113	12	TDM	TDM	NNP
cord-005453-4057qib7	14113	13	)	)	-RRB-
cord-005453-4057qib7	14113	14	in	in	IN
cord-005453-4057qib7	14113	15	the	the	DT
cord-005453-4057qib7	14113	16	context	context	NN
cord-005453-4057qib7	14113	17	of	of	IN
cord-005453-4057qib7	14113	18	myeloablative	myeloablative	JJ
cord-005453-4057qib7	14113	19	conditioning	conditioning	NN
cord-005453-4057qib7	14113	20	,	,	,
cord-005453-4057qib7	14113	21	especially	especially	RB
cord-005453-4057qib7	14113	22	in	in	IN
cord-005453-4057qib7	14113	23	children	child	NNS
cord-005453-4057qib7	14113	24	.	.	.
cord-005453-4057qib7	14114	1	Methods	method	NNS
cord-005453-4057qib7	14115	1	:	:	:
cord-005453-4057qib7	14115	2	We	-PRON-	PRP
cord-005453-4057qib7	14115	3	report	report	VBP
cord-005453-4057qib7	14115	4	on	on	IN
cord-005453-4057qib7	14115	5	a	a	DT
cord-005453-4057qib7	14115	6	7-month	7-month	NNP
cord-005453-4057qib7	14115	7	old	old	JJ
cord-005453-4057qib7	14115	8	boy	boy	NN
cord-005453-4057qib7	14115	9	(	(	-LRB-
cord-005453-4057qib7	14115	10	7.2	7.2	CD
cord-005453-4057qib7	14115	11	kg	kg	NNS
cord-005453-4057qib7	14115	12	,	,	,
cord-005453-4057qib7	14115	13	66	66	CD
cord-005453-4057qib7	14115	14	cm	cm	NNS
cord-005453-4057qib7	14115	15	)	)	-RRB-
cord-005453-4057qib7	14115	16	of	of	IN
cord-005453-4057qib7	14115	17	caucasian	caucasian	JJ
cord-005453-4057qib7	14115	18	decent	decent	JJ
cord-005453-4057qib7	14115	19	born	bear	VBN
cord-005453-4057qib7	14115	20	to	to	IN
cord-005453-4057qib7	14115	21	non	non	JJ
cord-005453-4057qib7	14115	22	-	-	JJ
cord-005453-4057qib7	14115	23	consanguine	consanguine	JJ
cord-005453-4057qib7	14115	24	parents	parent	NNS
cord-005453-4057qib7	14115	25	with	with	IN
cord-005453-4057qib7	14115	26	MLL	MLL	NNP
cord-005453-4057qib7	14115	27	-	-	HYPH
cord-005453-4057qib7	14115	28	rearranged	rearrange	VBN
cord-005453-4057qib7	14115	29	proB	prob	JJ
cord-005453-4057qib7	14115	30	-	-	HYPH
cord-005453-4057qib7	14115	31	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	14115	32	leukemia	leukemia	NN
cord-005453-4057qib7	14115	33	.	.	.
cord-005453-4057qib7	14116	1	Diagnosis	diagnosis	NN
cord-005453-4057qib7	14116	2	was	be	VBD
cord-005453-4057qib7	14116	3	established	establish	VBN
cord-005453-4057qib7	14116	4	one	one	CD
cord-005453-4057qib7	14116	5	month	month	NN
cord-005453-4057qib7	14116	6	after	after	IN
cord-005453-4057qib7	14116	7	birth	birth	NN
cord-005453-4057qib7	14116	8	from	from	IN
cord-005453-4057qib7	14116	9	peripheral	peripheral	JJ
cord-005453-4057qib7	14116	10	blood	blood	NN
cord-005453-4057qib7	14116	11	and	and	CC
cord-005453-4057qib7	14116	12	CSF	CSF	NNP
cord-005453-4057qib7	14116	13	tap	tap	NN
cord-005453-4057qib7	14116	14	showed	show	VBD
cord-005453-4057qib7	14116	15	CNS	CNS	NNP
cord-005453-4057qib7	14116	16	involvement	involvement	NN
cord-005453-4057qib7	14116	17	.	.	.
cord-005453-4057qib7	14117	1	Primary	primary	JJ
cord-005453-4057qib7	14117	2	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14117	3	was	be	VBD
cord-005453-4057qib7	14117	4	commenced	commence	VBN
cord-005453-4057qib7	14117	5	according	accord	VBG
cord-005453-4057qib7	14117	6	to	to	IN
cord-005453-4057qib7	14117	7	the	the	DT
cord-005453-4057qib7	14117	8	Interfant-06	Interfant-06	NNP
cord-005453-4057qib7	14117	9	protocol	protocol	NN
cord-005453-4057qib7	14117	10	.	.	.
cord-005453-4057qib7	14118	1	However	however	RB
cord-005453-4057qib7	14118	2	,	,	,
cord-005453-4057qib7	14118	3	MRD	MRD	NNP
cord-005453-4057qib7	14118	4	remained	remain	VBD
cord-005453-4057qib7	14118	5	positive	positive	JJ
cord-005453-4057qib7	14118	6	two	two	CD
cord-005453-4057qib7	14118	7	months	month	NNS
cord-005453-4057qib7	14118	8	under	under	IN
cord-005453-4057qib7	14118	9	treatment	treatment	NN
cord-005453-4057qib7	14118	10	,	,	,
cord-005453-4057qib7	14118	11	leading	lead	VBG
cord-005453-4057qib7	14118	12	to	to	IN
cord-005453-4057qib7	14118	13	an	an	DT
cord-005453-4057qib7	14118	14	indication	indication	NN
cord-005453-4057qib7	14118	15	for	for	IN
cord-005453-4057qib7	14118	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	14118	17	stem	stem	NN
cord-005453-4057qib7	14118	18	cell	cell	NN
cord-005453-4057qib7	14118	19	transplantation	transplantation	NN
cord-005453-4057qib7	14118	20	.	.	.
cord-005453-4057qib7	14119	1	In	in	IN
cord-005453-4057qib7	14119	2	the	the	DT
cord-005453-4057qib7	14119	3	Interfant-06	interfant-06	NN
cord-005453-4057qib7	14119	4	protocol	protocol	NN
cord-005453-4057qib7	14119	5	,	,	,
cord-005453-4057qib7	14119	6	we	-PRON-	PRP
cord-005453-4057qib7	14119	7	opted	opt	VBD
cord-005453-4057qib7	14119	8	for	for	IN
cord-005453-4057qib7	14119	9	a	a	DT
cord-005453-4057qib7	14119	10	conditioning	conditioning	NN
cord-005453-4057qib7	14119	11	regimen	regimen	NN
cord-005453-4057qib7	14119	12	comprised	comprise	VBN
cord-005453-4057qib7	14119	13	of	of	IN
cord-005453-4057qib7	14119	14	fludarabine	fludarabine	NN
cord-005453-4057qib7	14119	15	(	(	-LRB-
cord-005453-4057qib7	14119	16	1.2	1.2	CD
cord-005453-4057qib7	14119	17	mg	mg	NNP
cord-005453-4057qib7	14119	18	/	/	SYM
cord-005453-4057qib7	14119	19	kg	kg	NN
cord-005453-4057qib7	14119	20	for	for	IN
cord-005453-4057qib7	14119	21	5	5	CD
cord-005453-4057qib7	14119	22	days	day	NNS
cord-005453-4057qib7	14119	23	)	)	-RRB-
cord-005453-4057qib7	14119	24	,	,	,
cord-005453-4057qib7	14119	25	busulfan	busulfan	NN
cord-005453-4057qib7	14119	26	and	and	CC
cord-005453-4057qib7	14119	27	thiotepa	thiotepa	NNP
cord-005453-4057qib7	14119	28	(	(	-LRB-
cord-005453-4057qib7	14119	29	2x5	2x5	CD
cord-005453-4057qib7	14119	30	mg	mg	NNP
cord-005453-4057qib7	14119	31	/	/	SYM
cord-005453-4057qib7	14119	32	kg	kg	NNP
cord-005453-4057qib7	14119	33	)	)	-RRB-
cord-005453-4057qib7	14119	34	.	.	.
cord-005453-4057qib7	14120	1	In	in	IN
cord-005453-4057qib7	14120	2	our	-PRON-	PRP$
cord-005453-4057qib7	14120	3	institution	institution	NN
cord-005453-4057qib7	14120	4	,	,	,
cord-005453-4057qib7	14120	5	busulfan	busulfan	NNP
cord-005453-4057qib7	14120	6	is	be	VBZ
cord-005453-4057qib7	14120	7	applied	apply	VBN
cord-005453-4057qib7	14120	8	once	once	RB
cord-005453-4057qib7	14120	9	daily	daily	RB
cord-005453-4057qib7	14120	10	with	with	IN
cord-005453-4057qib7	14120	11	a	a	DT
cord-005453-4057qib7	14120	12	target	target	NN
cord-005453-4057qib7	14120	13	AUC	AUC	NNP
cord-005453-4057qib7	14120	14	of	of	IN
cord-005453-4057qib7	14120	15	85	85	CD
cord-005453-4057qib7	14120	16	-	-	SYM
cord-005453-4057qib7	14120	17	95	95	CD
cord-005453-4057qib7	14120	18	h*mg	h*mg	NN
cord-005453-4057qib7	14120	19	/	/	SYM
cord-005453-4057qib7	14120	20	l	l	NN
cord-005453-4057qib7	14120	21	in	in	IN
cord-005453-4057qib7	14120	22	this	this	DT
cord-005453-4057qib7	14120	23	very	very	RB
cord-005453-4057qib7	14120	24	high	high	JJ
cord-005453-4057qib7	14120	25	risk	risk	NN
cord-005453-4057qib7	14120	26	situation	situation	NN
cord-005453-4057qib7	14120	27	.	.	.
cord-005453-4057qib7	14121	1	According	accord	VBG
cord-005453-4057qib7	14121	2	to	to	IN
cord-005453-4057qib7	14121	3	body	body	NN
cord-005453-4057qib7	14121	4	weight	weight	NN
cord-005453-4057qib7	14121	5	,	,	,
cord-005453-4057qib7	14121	6	busulfan	busulfan	NN
cord-005453-4057qib7	14121	7	was	be	VBD
cord-005453-4057qib7	14121	8	given	give	VBN
cord-005453-4057qib7	14121	9	with	with	IN
cord-005453-4057qib7	14121	10	5.1	5.1	CD
cord-005453-4057qib7	14121	11	mg/	mg/	NN
cord-005453-4057qib7	14121	12	kg	kg	NNP
cord-005453-4057qib7	14121	13	as	as	IN
cord-005453-4057qib7	14121	14	a	a	DT
cord-005453-4057qib7	14121	15	three	three	CD
cord-005453-4057qib7	14121	16	-	-	HYPH
cord-005453-4057qib7	14121	17	hour	hour	NN
cord-005453-4057qib7	14121	18	infusion	infusion	NN
cord-005453-4057qib7	14121	19	on	on	IN
cord-005453-4057qib7	14121	20	the	the	DT
cord-005453-4057qib7	14121	21	first	first	JJ
cord-005453-4057qib7	14121	22	day	day	NN
cord-005453-4057qib7	14121	23	.	.	.
cord-005453-4057qib7	14122	1	Busulfan	Busulfan	NNP
cord-005453-4057qib7	14122	2	concentrations	concentration	NNS
cord-005453-4057qib7	14122	3	in	in	IN
cord-005453-4057qib7	14122	4	plasma	plasma	NN
cord-005453-4057qib7	14122	5	were	be	VBD
cord-005453-4057qib7	14122	6	measured	measure	VBN
cord-005453-4057qib7	14122	7	with	with	IN
cord-005453-4057qib7	14122	8	gas	gas	NN
cord-005453-4057qib7	14122	9	chromatography	chromatography	NN
cord-005453-4057qib7	14122	10	-	-	HYPH
cord-005453-4057qib7	14122	11	mass	mass	NN
cord-005453-4057qib7	14122	12	spectrometry	spectrometry	NN
cord-005453-4057qib7	14122	13	(	(	-LRB-
cord-005453-4057qib7	14122	14	GC	GC	NNP
cord-005453-4057qib7	14122	15	-	-	HYPH
cord-005453-4057qib7	14122	16	MS	MS	NNP
cord-005453-4057qib7	14122	17	)	)	-RRB-
cord-005453-4057qib7	14122	18	and	and	CC
cord-005453-4057qib7	14122	19	AUC	AUC	NNP
cord-005453-4057qib7	14122	20	was	be	VBD
cord-005453-4057qib7	14122	21	calculated	calculate	VBN
cord-005453-4057qib7	14122	22	using	use	VBG
cord-005453-4057qib7	14122	23	Bayesian	Bayesian	NNP
cord-005453-4057qib7	14122	24	curve	curve	NN
cord-005453-4057qib7	14122	25	fitting	fitting	NN
cord-005453-4057qib7	14122	26	.	.	.
cord-005453-4057qib7	14123	1	Results	result	NNS
cord-005453-4057qib7	14123	2	:	:	:
cord-005453-4057qib7	14124	1	Exact	exact	JJ
cord-005453-4057qib7	14124	2	busulfan	busulfan	NN
cord-005453-4057qib7	14124	3	quantification	quantification	NN
cord-005453-4057qib7	14124	4	was	be	VBD
cord-005453-4057qib7	14124	5	not	not	RB
cord-005453-4057qib7	14124	6	possible	possible	JJ
cord-005453-4057qib7	14124	7	after	after	IN
cord-005453-4057qib7	14124	8	the	the	DT
cord-005453-4057qib7	14124	9	first	first	JJ
cord-005453-4057qib7	14124	10	dose	dose	NN
cord-005453-4057qib7	14124	11	due	due	IN
cord-005453-4057qib7	14124	12	to	to	IN
cord-005453-4057qib7	14124	13	technical	technical	JJ
cord-005453-4057qib7	14124	14	reasons	reason	NNS
cord-005453-4057qib7	14124	15	.	.	.
cord-005453-4057qib7	14125	1	As	as	IN
cord-005453-4057qib7	14125	2	the	the	DT
cord-005453-4057qib7	14125	3	levels	level	NNS
cord-005453-4057qib7	14125	4	were	be	VBD
cord-005453-4057qib7	14125	5	estimated	estimate	VBN
cord-005453-4057qib7	14125	6	to	to	TO
cord-005453-4057qib7	14125	7	be	be	VB
cord-005453-4057qib7	14125	8	very	very	RB
cord-005453-4057qib7	14125	9	high	high	JJ
cord-005453-4057qib7	14125	10	,	,	,
cord-005453-4057qib7	14125	11	we	-PRON-	PRP
cord-005453-4057qib7	14125	12	decided	decide	VBD
cord-005453-4057qib7	14125	13	to	to	TO
cord-005453-4057qib7	14125	14	reduce	reduce	VB
cord-005453-4057qib7	14125	15	the	the	DT
cord-005453-4057qib7	14125	16	second	second	JJ
cord-005453-4057qib7	14125	17	dose	dose	NN
cord-005453-4057qib7	14125	18	of	of	IN
cord-005453-4057qib7	14125	19	busulfan	busulfan	NN
cord-005453-4057qib7	14125	20	by	by	IN
cord-005453-4057qib7	14125	21	25	25	CD
cord-005453-4057qib7	14125	22	%	%	NN
cord-005453-4057qib7	14125	23	.	.	.
cord-005453-4057qib7	14126	1	This	this	DT
cord-005453-4057qib7	14126	2	resulted	result	VBD
cord-005453-4057qib7	14126	3	in	in	IN
cord-005453-4057qib7	14126	4	a	a	DT
cord-005453-4057qib7	14126	5	very	very	RB
cord-005453-4057qib7	14126	6	high	high	JJ
cord-005453-4057qib7	14126	7	AUC	auc	NN
cord-005453-4057qib7	14126	8	of	of	IN
cord-005453-4057qib7	14126	9	44	44	CD
cord-005453-4057qib7	14126	10	h*mg	h*mg	NNP
cord-005453-4057qib7	14126	11	/	/	SYM
cord-005453-4057qib7	14126	12	l	l	NN
cord-005453-4057qib7	14126	13	for	for	IN
cord-005453-4057qib7	14126	14	the	the	DT
cord-005453-4057qib7	14126	15	second	second	JJ
cord-005453-4057qib7	14126	16	dose	dose	NN
cord-005453-4057qib7	14126	17	,	,	,
cord-005453-4057qib7	14126	18	so	so	IN
cord-005453-4057qib7	14126	19	that	that	DT
cord-005453-4057qib7	14126	20	busulfan	busulfan	NN
cord-005453-4057qib7	14126	21	was	be	VBD
cord-005453-4057qib7	14126	22	discontinued	discontinue	VBN
cord-005453-4057qib7	14126	23	after	after	IN
cord-005453-4057qib7	14126	24	two	two	CD
cord-005453-4057qib7	14126	25	days	day	NNS
cord-005453-4057qib7	14126	26	,	,	,
cord-005453-4057qib7	14126	27	because	because	IN
cord-005453-4057qib7	14126	28	it	-PRON-	PRP
cord-005453-4057qib7	14126	29	was	be	VBD
cord-005453-4057qib7	14126	30	calculated	calculate	VBN
cord-005453-4057qib7	14126	31	that	that	IN
cord-005453-4057qib7	14126	32	the	the	DT
cord-005453-4057qib7	14126	33	patient	patient	NN
cord-005453-4057qib7	14126	34	already	already	RB
cord-005453-4057qib7	14126	35	received	receive	VBD
cord-005453-4057qib7	14126	36	busulfan	busulfan	NN
cord-005453-4057qib7	14126	37	with	with	IN
cord-005453-4057qib7	14126	38	a	a	DT
cord-005453-4057qib7	14126	39	cumulative	cumulative	JJ
cord-005453-4057qib7	14126	40	AUC	auc	NN
cord-005453-4057qib7	14126	41	of	of	IN
cord-005453-4057qib7	14126	42	90	90	CD
cord-005453-4057qib7	14126	43	h*mg	h*mg	NN
cord-005453-4057qib7	14126	44	/	/	SYM
cord-005453-4057qib7	14126	45	ml	ml	NN
cord-005453-4057qib7	14126	46	.	.	.
cord-005453-4057qib7	14127	1	Trough	trough	NN
cord-005453-4057qib7	14127	2	levels	level	NNS
cord-005453-4057qib7	14127	3	after	after	IN
cord-005453-4057qib7	14127	4	the	the	DT
cord-005453-4057qib7	14127	5	first	first	JJ
cord-005453-4057qib7	14127	6	and	and	CC
cord-005453-4057qib7	14127	7	second	second	JJ
cord-005453-4057qib7	14127	8	dose	dose	NN
cord-005453-4057qib7	14127	9	were	be	VBD
cord-005453-4057qib7	14127	10	547	547	CD
cord-005453-4057qib7	14127	11	and	and	CC
cord-005453-4057qib7	14127	12	572	572	CD
cord-005453-4057qib7	14127	13	μg	μg	NNP
cord-005453-4057qib7	14127	14	/	/	SYM
cord-005453-4057qib7	14127	15	l	l	NN
cord-005453-4057qib7	14127	16	,	,	,
cord-005453-4057qib7	14127	17	respectively	respectively	RB
cord-005453-4057qib7	14127	18	.	.	.
cord-005453-4057qib7	14128	1	The	the	DT
cord-005453-4057qib7	14128	2	patient	patient	NN
cord-005453-4057qib7	14128	3	showed	show	VBD
cord-005453-4057qib7	14128	4	a	a	DT
cord-005453-4057qib7	14128	5	very	very	RB
cord-005453-4057qib7	14128	6	slow	slow	JJ
cord-005453-4057qib7	14128	7	clearance	clearance	NN
cord-005453-4057qib7	14128	8	of	of	IN
cord-005453-4057qib7	14128	9	2.1	2.1	CD
cord-005453-4057qib7	14128	10	l	l	NN
cord-005453-4057qib7	14128	11	/	/	SYM
cord-005453-4057qib7	14128	12	h	h	NN
cord-005453-4057qib7	14128	13	/	/	SYM
cord-005453-4057qib7	14128	14	sqm	sqm	NN
cord-005453-4057qib7	14128	15	,	,	,
cord-005453-4057qib7	14128	16	while	while	IN
cord-005453-4057qib7	14128	17	the	the	DT
cord-005453-4057qib7	14128	18	volume	volume	NN
cord-005453-4057qib7	14128	19	of	of	IN
cord-005453-4057qib7	14128	20	distribution	distribution	NN
cord-005453-4057qib7	14128	21	was	be	VBD
cord-005453-4057qib7	14128	22	in	in	IN
cord-005453-4057qib7	14128	23	the	the	DT
cord-005453-4057qib7	14128	24	usual	usual	JJ
cord-005453-4057qib7	14128	25	range	range	NN
cord-005453-4057qib7	14128	26	(	(	-LRB-
cord-005453-4057qib7	14128	27	0.86	0.86	CD
cord-005453-4057qib7	14128	28	l	l	NN
cord-005453-4057qib7	14128	29	/	/	SYM
cord-005453-4057qib7	14128	30	kg	kg	NNP
cord-005453-4057qib7	14128	31	)	)	-RRB-
cord-005453-4057qib7	14128	32	.	.	.
cord-005453-4057qib7	14129	1	Bilirubin	bilirubin	NN
cord-005453-4057qib7	14129	2	and	and	CC
cord-005453-4057qib7	14129	3	liver	liver	NN
cord-005453-4057qib7	14129	4	transaminases	transaminase	NNS
cord-005453-4057qib7	14129	5	were	be	VBD
cord-005453-4057qib7	14129	6	in	in	IN
cord-005453-4057qib7	14129	7	the	the	DT
cord-005453-4057qib7	14129	8	normal	normal	JJ
cord-005453-4057qib7	14129	9	range	range	NN
cord-005453-4057qib7	14129	10	at	at	IN
cord-005453-4057qib7	14129	11	the	the	DT
cord-005453-4057qib7	14129	12	time	time	NN
cord-005453-4057qib7	14129	13	of	of	IN
cord-005453-4057qib7	14129	14	conditioning	conditioning	NN
cord-005453-4057qib7	14129	15	,	,	,
cord-005453-4057qib7	14129	16	while	while	IN
cord-005453-4057qib7	14129	17	albumin	albumin	NN
cord-005453-4057qib7	14129	18	and	and	CC
cord-005453-4057qib7	14129	19	Quick	quick	JJ
cord-005453-4057qib7	14129	20	were	be	VBD
cord-005453-4057qib7	14129	21	decreased	decrease	VBN
cord-005453-4057qib7	14129	22	On	on	IN
cord-005453-4057qib7	14129	23	day	day	NN
cord-005453-4057qib7	14129	24	+18	+18	CD
cord-005453-4057qib7	14129	25	after	after	IN
cord-005453-4057qib7	14129	26	transplantation	transplantation	NN
cord-005453-4057qib7	14129	27	the	the	DT
cord-005453-4057qib7	14129	28	patient	patient	NN
cord-005453-4057qib7	14129	29	developed	develop	VBD
cord-005453-4057qib7	14129	30	clinical	clinical	JJ
cord-005453-4057qib7	14129	31	und	und	IN
cord-005453-4057qib7	14129	32	biochemical	biochemical	JJ
cord-005453-4057qib7	14129	33	signs	sign	NNS
cord-005453-4057qib7	14129	34	of	of	IN
cord-005453-4057qib7	14129	35	venoocclusive	venoocclusive	JJ
cord-005453-4057qib7	14129	36	disease	disease	NN
cord-005453-4057qib7	14129	37	(	(	-LRB-
cord-005453-4057qib7	14129	38	VOD	VOD	NNP
cord-005453-4057qib7	14129	39	)	)	-RRB-
cord-005453-4057qib7	14129	40	.	.	.
cord-005453-4057qib7	14130	1	VOD	VOD	NNP
cord-005453-4057qib7	14130	2	symptoms	symptom	NNS
cord-005453-4057qib7	14130	3	completely	completely	RB
cord-005453-4057qib7	14130	4	resolved	resolve	VBN
cord-005453-4057qib7	14130	5	under	under	IN
cord-005453-4057qib7	14130	6	therapy	therapy	NN
cord-005453-4057qib7	14130	7	with	with	IN
cord-005453-4057qib7	14130	8	defibrotide	defibrotide	NNP
cord-005453-4057qib7	14130	9	.	.	.
cord-005453-4057qib7	14131	1	Leukocyte	Leukocyte	NNP
cord-005453-4057qib7	14131	2	engraftment	engraftment	NN
cord-005453-4057qib7	14131	3	was	be	VBD
cord-005453-4057qib7	14131	4	established	establish	VBN
cord-005453-4057qib7	14131	5	on	on	IN
cord-005453-4057qib7	14131	6	day	day	NN
cord-005453-4057qib7	14131	7	+14	+14	CD
cord-005453-4057qib7	14131	8	.	.	.
cord-005453-4057qib7	14132	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	14132	2	,	,	,
cord-005453-4057qib7	14132	3	the	the	DT
cord-005453-4057qib7	14132	4	patients	patient	NNS
cord-005453-4057qib7	14132	5	suffered	suffer	VBD
cord-005453-4057qib7	14132	6	from	from	IN
cord-005453-4057qib7	14132	7	an	an	DT
cord-005453-4057qib7	14132	8	early	early	JJ
cord-005453-4057qib7	14132	9	relapse	relapse	NN
cord-005453-4057qib7	14132	10	of	of	IN
cord-005453-4057qib7	14132	11	the	the	DT
cord-005453-4057qib7	14132	12	leukemia	leukemia	NN
cord-005453-4057qib7	14132	13	from	from	IN
cord-005453-4057qib7	14132	14	day	day	NN
cord-005453-4057qib7	14132	15	+62	+62	NNP
cord-005453-4057qib7	14132	16	.	.	.
cord-005453-4057qib7	14133	1	Attempts	attempt	NNS
cord-005453-4057qib7	14133	2	to	to	TO
cord-005453-4057qib7	14133	3	induce	induce	VB
cord-005453-4057qib7	14133	4	a	a	DT
cord-005453-4057qib7	14133	5	second	second	JJ
cord-005453-4057qib7	14133	6	remission	remission	NN
cord-005453-4057qib7	14133	7	with	with	IN
cord-005453-4057qib7	14133	8	blinatumomab	blinatumomab	NNS
cord-005453-4057qib7	14133	9	failed	fail	VBD
cord-005453-4057qib7	14133	10	.	.	.
cord-005453-4057qib7	14134	1	The	the	DT
cord-005453-4057qib7	14134	2	patient	patient	NN
cord-005453-4057qib7	14134	3	is	be	VBZ
cord-005453-4057qib7	14134	4	currently	currently	RB
cord-005453-4057qib7	14134	5	under	under	IN
cord-005453-4057qib7	14134	6	palliative	palliative	JJ
cord-005453-4057qib7	14134	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14134	8	.	.	.
cord-005453-4057qib7	14135	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14135	2	:	:	:
cord-005453-4057qib7	14136	1	Busulfan	Busulfan	NNP
cord-005453-4057qib7	14136	2	TDM	TDM	NNP
cord-005453-4057qib7	14136	3	is	be	VBZ
cord-005453-4057qib7	14136	4	very	very	RB
cord-005453-4057qib7	14136	5	important	important	JJ
cord-005453-4057qib7	14136	6	especially	especially	RB
cord-005453-4057qib7	14136	7	in	in	IN
cord-005453-4057qib7	14136	8	infants	infant	NNS
cord-005453-4057qib7	14136	9	receiving	receive	VBG
cord-005453-4057qib7	14136	10	myeloablative	myeloablative	JJ
cord-005453-4057qib7	14136	11	doses	dose	NNS
cord-005453-4057qib7	14136	12	of	of	IN
cord-005453-4057qib7	14136	13	busulfan	busulfan	NN
cord-005453-4057qib7	14136	14	to	to	TO
cord-005453-4057qib7	14136	15	prevent	prevent	VB
cord-005453-4057qib7	14136	16	under	under	NN
cord-005453-4057qib7	14136	17	-	-	HYPH
cord-005453-4057qib7	14136	18	or	or	CC
cord-005453-4057qib7	14136	19	over	over	IN
cord-005453-4057qib7	14136	20	-	-	HYPH
cord-005453-4057qib7	14136	21	exposure	exposure	NN
cord-005453-4057qib7	14136	22	.	.	.
cord-005453-4057qib7	14137	1	There	there	EX
cord-005453-4057qib7	14137	2	is	be	VBZ
cord-005453-4057qib7	14137	3	evidence	evidence	NN
cord-005453-4057qib7	14137	4	that	that	IN
cord-005453-4057qib7	14137	5	high	high	JJ
cord-005453-4057qib7	14137	6	busulfan	busulfan	NN
cord-005453-4057qib7	14137	7	trough	trough	NN
cord-005453-4057qib7	14137	8	levels	level	NNS
cord-005453-4057qib7	14137	9	contribute	contribute	VBP
cord-005453-4057qib7	14137	10	to	to	IN
cord-005453-4057qib7	14137	11	the	the	DT
cord-005453-4057qib7	14137	12	development	development	NN
cord-005453-4057qib7	14137	13	of	of	IN
cord-005453-4057qib7	14137	14	VOD	VOD	NNP
cord-005453-4057qib7	14137	15	,	,	,
cord-005453-4057qib7	14137	16	but	but	CC
cord-005453-4057qib7	14137	17	anti	anti	JJ
cord-005453-4057qib7	14137	18	-	-	JJ
cord-005453-4057qib7	14137	19	leukemic	leukemic	JJ
cord-005453-4057qib7	14137	20	activity	activity	NN
cord-005453-4057qib7	14137	21	of	of	IN
cord-005453-4057qib7	14137	22	busulfan	busulfan	NN
cord-005453-4057qib7	14137	23	and	and	CC
cord-005453-4057qib7	14137	24	CNS	CNS	NNP
cord-005453-4057qib7	14137	25	permeability	permeability	NN
cord-005453-4057qib7	14137	26	make	make	VBP
cord-005453-4057qib7	14137	27	it	-PRON-	PRP
cord-005453-4057qib7	14137	28	a	a	DT
cord-005453-4057qib7	14137	29	valuable	valuable	JJ
cord-005453-4057qib7	14137	30	drug	drug	NN
cord-005453-4057qib7	14137	31	for	for	IN
cord-005453-4057qib7	14137	32	very	very	RB
cord-005453-4057qib7	14137	33	high	high	JJ
cord-005453-4057qib7	14137	34	risk	risk	NN
cord-005453-4057qib7	14137	35	patients	patient	NNS
cord-005453-4057qib7	14137	36	in	in	IN
cord-005453-4057qib7	14137	37	childhood	childhood	NN
cord-005453-4057qib7	14137	38	leukemia	leukemia	NN
cord-005453-4057qib7	14137	39	.	.	.
cord-005453-4057qib7	14138	1	Larger	large	JJR
cord-005453-4057qib7	14138	2	patient	patient	JJ
cord-005453-4057qib7	14138	3	cohorts	cohort	NNS
cord-005453-4057qib7	14138	4	are	be	VBP
cord-005453-4057qib7	14138	5	needed	need	VBN
cord-005453-4057qib7	14138	6	to	to	TO
cord-005453-4057qib7	14138	7	assess	assess	VB
cord-005453-4057qib7	14138	8	the	the	DT
cord-005453-4057qib7	14138	9	exposure	exposure	NN
cord-005453-4057qib7	14138	10	dependent	dependent	JJ
cord-005453-4057qib7	14138	11	risks	risk	NNS
cord-005453-4057qib7	14138	12	of	of	IN
cord-005453-4057qib7	14138	13	toxicity	toxicity	NN
cord-005453-4057qib7	14138	14	versus	versus	IN
cord-005453-4057qib7	14138	15	relapse	relapse	NN
cord-005453-4057qib7	14138	16	in	in	IN
cord-005453-4057qib7	14138	17	infants	infant	NNS
cord-005453-4057qib7	14138	18	and	and	CC
cord-005453-4057qib7	14138	19	toddlers	toddler	NNS
cord-005453-4057qib7	14138	20	.	.	.
cord-005453-4057qib7	14139	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14139	2	:	:	:
cord-005453-4057qib7	14139	3	Nothing	nothing	NN
cord-005453-4057qib7	14139	4	to	to	TO
cord-005453-4057qib7	14139	5	declare	declare	VB
cord-005453-4057qib7	14139	6	blood	blood	NN
cord-005453-4057qib7	14139	7	(	(	-LRB-
cord-005453-4057qib7	14139	8	UCB	UCB	NNP
cord-005453-4057qib7	14139	9	)	)	-RRB-
cord-005453-4057qib7	14139	10	obtained	obtain	VBD
cord-005453-4057qib7	14139	11	at	at	IN
cord-005453-4057qib7	14139	12	delivery	delivery	NN
cord-005453-4057qib7	14139	13	from	from	IN
cord-005453-4057qib7	14139	14	three	three	CD
cord-005453-4057qib7	14139	15	children	child	NNS
cord-005453-4057qib7	14139	16	who	who	WP
cord-005453-4057qib7	14139	17	received	receive	VBD
cord-005453-4057qib7	14139	18	a	a	DT
cord-005453-4057qib7	14139	19	diagnosis	diagnosis	NN
cord-005453-4057qib7	14139	20	of	of	IN
cord-005453-4057qib7	14139	21	cerebral	cerebral	JJ
cord-005453-4057qib7	14139	22	palsy	palsy	NN
cord-005453-4057qib7	14139	23	.	.	.
cord-005453-4057qib7	14140	1	Methods	method	NNS
cord-005453-4057qib7	14140	2	:	:	:
cord-005453-4057qib7	14140	3	Immunophenotyping	Immunophenotyping	NNP
cord-005453-4057qib7	14140	4	of	of	IN
cord-005453-4057qib7	14140	5	the	the	DT
cord-005453-4057qib7	14140	6	UCB	UCB	NNP
cord-005453-4057qib7	14140	7	leukocyte	leukocyte	NN
cord-005453-4057qib7	14140	8	fraction	fraction	NN
cord-005453-4057qib7	14140	9	was	be	VBD
cord-005453-4057qib7	14140	10	performed	perform	VBN
cord-005453-4057qib7	14140	11	using	use	VBG
cord-005453-4057qib7	14140	12	multicolor	multicolor	JJ
cord-005453-4057qib7	14140	13	flow	flow	NN
cord-005453-4057qib7	14140	14	cytometry	cytometry	NN
cord-005453-4057qib7	14140	15	.	.	.
cord-005453-4057qib7	14141	1	The	the	DT
cord-005453-4057qib7	14141	2	procedure	procedure	NN
cord-005453-4057qib7	14141	3	was	be	VBD
cord-005453-4057qib7	14141	4	performed	perform	VBN
cord-005453-4057qib7	14141	5	according	accord	VBG
cord-005453-4057qib7	14141	6	to	to	IN
cord-005453-4057qib7	14141	7	the	the	DT
cord-005453-4057qib7	14141	8	protocol	protocol	NN
cord-005453-4057qib7	14141	9	by	by	IN
cord-005453-4057qib7	14141	10	Shatorje	Shatorje	NNP
cord-005453-4057qib7	14141	11	and	and	CC
cord-005453-4057qib7	14141	12	colleagues	colleague	NNS
cord-005453-4057qib7	14141	13	(	(	-LRB-
cord-005453-4057qib7	14141	14	1	1	CD
cord-005453-4057qib7	14141	15	)	)	-RRB-
cord-005453-4057qib7	14141	16	.	.	.
cord-005453-4057qib7	14142	1	Briefly	briefly	RB
cord-005453-4057qib7	14142	2	,	,	,
cord-005453-4057qib7	14142	3	the	the	DT
cord-005453-4057qib7	14142	4	UCB	UCB	NNP
cord-005453-4057qib7	14142	5	samples	sample	NNS
cord-005453-4057qib7	14142	6	were	be	VBD
cord-005453-4057qib7	14142	7	labeled	label	VBN
cord-005453-4057qib7	14142	8	with	with	IN
cord-005453-4057qib7	14142	9	specific	specific	JJ
cord-005453-4057qib7	14142	10	antibodies	antibody	NNS
cord-005453-4057qib7	14142	11	and	and	CC
cord-005453-4057qib7	14142	12	incubated	incubate	VBN
cord-005453-4057qib7	14142	13	in	in	IN
cord-005453-4057qib7	14142	14	the	the	DT
cord-005453-4057qib7	14142	15	dark	dark	NN
cord-005453-4057qib7	14142	16	for	for	IN
cord-005453-4057qib7	14142	17	30	30	CD
cord-005453-4057qib7	14142	18	minutes	minute	NNS
cord-005453-4057qib7	14142	19	.	.	.
cord-005453-4057qib7	14143	1	Afterwards	afterwards	RB
cord-005453-4057qib7	14143	2	,	,	,
cord-005453-4057qib7	14143	3	the	the	DT
cord-005453-4057qib7	14143	4	samples	sample	NNS
cord-005453-4057qib7	14143	5	were	be	VBD
cord-005453-4057qib7	14143	6	treated	treat	VBN
cord-005453-4057qib7	14143	7	with	with	IN
cord-005453-4057qib7	14143	8	5ml	5ml	CD
cord-005453-4057qib7	14143	9	of	of	IN
cord-005453-4057qib7	14143	10	BD	BD	NNP
cord-005453-4057qib7	14143	11	FACS	FACS	NNP
cord-005453-4057qib7	14143	12	Lysing	Lysing	NNP
cord-005453-4057qib7	14143	13	Solution	Solution	NNP
cord-005453-4057qib7	14143	14	for	for	IN
cord-005453-4057qib7	14143	15	10	10	CD
cord-005453-4057qib7	14143	16	minutes	minute	NNS
cord-005453-4057qib7	14143	17	to	to	TO
cord-005453-4057qib7	14143	18	preserve	preserve	VB
cord-005453-4057qib7	14143	19	the	the	DT
cord-005453-4057qib7	14143	20	leukocyte	leukocyte	NN
cord-005453-4057qib7	14143	21	fraction	fraction	NN
cord-005453-4057qib7	14143	22	only	only	RB
cord-005453-4057qib7	14143	23	.	.	.
cord-005453-4057qib7	14144	1	The	the	DT
cord-005453-4057qib7	14144	2	cells	cell	NNS
cord-005453-4057qib7	14144	3	were	be	VBD
cord-005453-4057qib7	14144	4	washed	wash	VBN
cord-005453-4057qib7	14144	5	using	use	VBG
cord-005453-4057qib7	14144	6	PBS	PBS	NNP
cord-005453-4057qib7	14144	7	(	(	-LRB-
cord-005453-4057qib7	14144	8	Roche	Roche	NNP
cord-005453-4057qib7	14144	9	)	)	-RRB-
cord-005453-4057qib7	14144	10	and	and	CC
cord-005453-4057qib7	14144	11	then	then	RB
cord-005453-4057qib7	14144	12	centrifuged	centrifuge	VBN
cord-005453-4057qib7	14144	13	twice	twice	RB
cord-005453-4057qib7	14144	14	(	(	-LRB-
cord-005453-4057qib7	14144	15	1500	1500	CD
cord-005453-4057qib7	14144	16	RPM	rpm	NN
cord-005453-4057qib7	14144	17	,	,	,
cord-005453-4057qib7	14144	18	4	4	CD
cord-005453-4057qib7	14144	19	°	°	NN
cord-005453-4057qib7	14144	20	C	c	NN
cord-005453-4057qib7	14144	21	,	,	,
cord-005453-4057qib7	14144	22	4	4	CD
cord-005453-4057qib7	14144	23	minutes	minute	NNS
cord-005453-4057qib7	14144	24	)	)	-RRB-
cord-005453-4057qib7	14144	25	.	.	.
cord-005453-4057qib7	14145	1	The	the	DT
cord-005453-4057qib7	14145	2	results	result	NNS
cord-005453-4057qib7	14145	3	were	be	VBD
cord-005453-4057qib7	14145	4	analyzed	analyze	VBN
cord-005453-4057qib7	14145	5	using	use	VBG
cord-005453-4057qib7	14145	6	the	the	DT
cord-005453-4057qib7	14145	7	FACSDiva	facsdiva	NN
cord-005453-4057qib7	14145	8	software	software	NN
cord-005453-4057qib7	14145	9	(	(	-LRB-
cord-005453-4057qib7	14145	10	Becton	Becton	NNP
cord-005453-4057qib7	14145	11	Dickinson	Dickinson	NNP
cord-005453-4057qib7	14145	12	)	)	-RRB-
cord-005453-4057qib7	14145	13	.	.	.
cord-005453-4057qib7	14146	1	Results	result	NNS
cord-005453-4057qib7	14146	2	:	:	:
cord-005453-4057qib7	14147	1	We	-PRON-	PRP
cord-005453-4057qib7	14147	2	found	find	VBD
cord-005453-4057qib7	14147	3	an	an	DT
cord-005453-4057qib7	14147	4	increased	increase	VBN
cord-005453-4057qib7	14147	5	white	white	JJ
cord-005453-4057qib7	14147	6	blood	blood	NN
cord-005453-4057qib7	14147	7	cell	cell	NN
cord-005453-4057qib7	14147	8	(	(	-LRB-
cord-005453-4057qib7	14147	9	WBC	WBC	NNP
cord-005453-4057qib7	14147	10	)	)	-RRB-
cord-005453-4057qib7	14147	11	count	count	NN
cord-005453-4057qib7	14147	12	,	,	,
cord-005453-4057qib7	14147	13	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	14147	14	count	count	NN
cord-005453-4057qib7	14147	15	,	,	,
cord-005453-4057qib7	14147	16	and	and	CC
cord-005453-4057qib7	14147	17	CD4	CD4	NNP
cord-005453-4057qib7	14147	18	:	:	:
cord-005453-4057qib7	14148	1	CD8	CD8	NNP
cord-005453-4057qib7	14148	2	ratio	ratio	NN
cord-005453-4057qib7	14148	3	in	in	IN
cord-005453-4057qib7	14148	4	all	all	DT
cord-005453-4057qib7	14148	5	UCB	UCB	NNP
cord-005453-4057qib7	14148	6	samples	sample	NNS
cord-005453-4057qib7	14148	7	.	.	.
cord-005453-4057qib7	14149	1	One	one	CD
cord-005453-4057qib7	14149	2	patient	patient	NN
cord-005453-4057qib7	14149	3	had	have	VBD
cord-005453-4057qib7	14149	4	a	a	DT
cord-005453-4057qib7	14149	5	low	low	JJ
cord-005453-4057qib7	14149	6	NK	NK	NNP
cord-005453-4057qib7	14149	7	cell	cell	NN
cord-005453-4057qib7	14149	8	count	count	NN
cord-005453-4057qib7	14149	9	and	and	CC
cord-005453-4057qib7	14149	10	percentage	percentage	NN
cord-005453-4057qib7	14149	11	,	,	,
cord-005453-4057qib7	14149	12	and	and	CC
cord-005453-4057qib7	14149	13	another	another	DT
cord-005453-4057qib7	14149	14	had	have	VBD
cord-005453-4057qib7	14149	15	a	a	DT
cord-005453-4057qib7	14149	16	low	low	JJ
cord-005453-4057qib7	14149	17	B	b	NN
cord-005453-4057qib7	14149	18	-	-	HYPH
cord-005453-4057qib7	14149	19	cell	cell	NN
cord-005453-4057qib7	14149	20	count	count	NN
cord-005453-4057qib7	14149	21	and	and	CC
cord-005453-4057qib7	14149	22	percentage	percentage	NN
cord-005453-4057qib7	14149	23	.	.	.
cord-005453-4057qib7	14150	1	One	one	CD
cord-005453-4057qib7	14150	2	sample	sample	NN
cord-005453-4057qib7	14150	3	displayed	display	VBD
cord-005453-4057qib7	14150	4	high	high	JJ
cord-005453-4057qib7	14150	5	T	T	NNP
cord-005453-4057qib7	14150	6	(	(	-LRB-
cord-005453-4057qib7	14150	7	CD3	CD3	NNP
cord-005453-4057qib7	14150	8	+	+	SYM
cord-005453-4057qib7	14150	9	)	)	-RRB-
cord-005453-4057qib7	14150	10	and	and	CC
cord-005453-4057qib7	14150	11	Th	Th	NNP
cord-005453-4057qib7	14150	12	cell	cell	NN
cord-005453-4057qib7	14150	13	(	(	-LRB-
cord-005453-4057qib7	14150	14	CD4	CD4	NNP
cord-005453-4057qib7	14150	15	+	+	CC
cord-005453-4057qib7	14150	16	)	)	-RRB-
cord-005453-4057qib7	14150	17	counts	count	VBZ
cord-005453-4057qib7	14150	18	,	,	,
cord-005453-4057qib7	14150	19	but	but	CC
cord-005453-4057qib7	14150	20	with	with	IN
cord-005453-4057qib7	14150	21	percentages	percentage	NNS
cord-005453-4057qib7	14150	22	within	within	IN
cord-005453-4057qib7	14150	23	the	the	DT
cord-005453-4057qib7	14150	24	limits	limit	NNS
cord-005453-4057qib7	14150	25	of	of	IN
cord-005453-4057qib7	14150	26	the	the	DT
cord-005453-4057qib7	14150	27	reference	reference	NN
cord-005453-4057qib7	14150	28	values	value	NNS
cord-005453-4057qib7	14150	29	.	.	.
cord-005453-4057qib7	14151	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14151	2	:	:	:
cord-005453-4057qib7	14152	1	We	-PRON-	PRP
cord-005453-4057qib7	14152	2	detected	detect	VBD
cord-005453-4057qib7	14152	3	elevated	elevate	VBN
cord-005453-4057qib7	14152	4	WBC	WBC	NNP
cord-005453-4057qib7	14152	5	and	and	CC
cord-005453-4057qib7	14152	6	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	14152	7	counts	count	NNS
cord-005453-4057qib7	14152	8	in	in	IN
cord-005453-4057qib7	14152	9	all	all	DT
cord-005453-4057qib7	14152	10	UCB	UCB	NNP
cord-005453-4057qib7	14152	11	samples	sample	NNS
cord-005453-4057qib7	14152	12	,	,	,
cord-005453-4057qib7	14152	13	despite	despite	IN
cord-005453-4057qib7	14152	14	a	a	DT
cord-005453-4057qib7	14152	15	lack	lack	NN
cord-005453-4057qib7	14152	16	of	of	IN
cord-005453-4057qib7	14152	17	intrauterine	intrauterine	JJ
cord-005453-4057qib7	14152	18	infection	infection	NN
cord-005453-4057qib7	14152	19	symptoms	symptom	NNS
cord-005453-4057qib7	14152	20	.	.	.
cord-005453-4057qib7	14153	1	Many	many	JJ
cord-005453-4057qib7	14153	2	authors	author	NNS
cord-005453-4057qib7	14153	3	have	have	VBP
cord-005453-4057qib7	14153	4	described	describe	VBN
cord-005453-4057qib7	14153	5	the	the	DT
cord-005453-4057qib7	14153	6	pathogenesis	pathogenesis	NN
cord-005453-4057qib7	14153	7	of	of	IN
cord-005453-4057qib7	14153	8	hypoxic	hypoxic	JJ
cord-005453-4057qib7	14153	9	-	-	HYPH
cord-005453-4057qib7	14153	10	ischemic	ischemic	JJ
cord-005453-4057qib7	14153	11	encephalopathy	encephalopathy	NN
cord-005453-4057qib7	14153	12	.	.	.
cord-005453-4057qib7	14154	1	Briefly	briefly	RB
cord-005453-4057qib7	14154	2	,	,	,
cord-005453-4057qib7	14154	3	after	after	IN
cord-005453-4057qib7	14154	4	an	an	DT
cord-005453-4057qib7	14154	5	acute	acute	JJ
cord-005453-4057qib7	14154	6	hypoxia	hypoxia	NN
cord-005453-4057qib7	14154	7	-	-	HYPH
cord-005453-4057qib7	14154	8	ischemia	ischemia	NN
cord-005453-4057qib7	14154	9	insult	insult	NN
cord-005453-4057qib7	14154	10	,	,	,
cord-005453-4057qib7	14154	11	activated	activate	VBN
cord-005453-4057qib7	14154	12	resting	rest	VBG
cord-005453-4057qib7	14154	13	microglia	microglia	NNP
cord-005453-4057qib7	14154	14	show	show	VBP
cord-005453-4057qib7	14154	15	macrophage	macrophage	NN
cord-005453-4057qib7	14154	16	-	-	HYPH
cord-005453-4057qib7	14154	17	like	like	JJ
cord-005453-4057qib7	14154	18	activity	activity	NN
cord-005453-4057qib7	14154	19	.	.	.
cord-005453-4057qib7	14155	1	This	this	DT
cord-005453-4057qib7	14155	2	leads	lead	VBZ
cord-005453-4057qib7	14155	3	to	to	IN
cord-005453-4057qib7	14155	4	a	a	DT
cord-005453-4057qib7	14155	5	break	break	NN
cord-005453-4057qib7	14155	6	-	-	HYPH
cord-005453-4057qib7	14155	7	down	down	NN
cord-005453-4057qib7	14155	8	of	of	IN
cord-005453-4057qib7	14155	9	the	the	DT
cord-005453-4057qib7	14155	10	blood	blood	NN
cord-005453-4057qib7	14155	11	-	-	HYPH
cord-005453-4057qib7	14155	12	brain	brain	NN
cord-005453-4057qib7	14155	13	barrier	barrier	NN
cord-005453-4057qib7	14155	14	,	,	,
cord-005453-4057qib7	14155	15	infiltration	infiltration	NN
cord-005453-4057qib7	14155	16	by	by	IN
cord-005453-4057qib7	14155	17	peripheral	peripheral	JJ
cord-005453-4057qib7	14155	18	leukocytes	leukocyte	NNS
cord-005453-4057qib7	14155	19	,	,	,
cord-005453-4057qib7	14155	20	and	and	CC
cord-005453-4057qib7	14155	21	brain	brain	NN
cord-005453-4057qib7	14155	22	exposure	exposure	NN
cord-005453-4057qib7	14155	23	,	,	,
cord-005453-4057qib7	14155	24	which	which	WDT
cord-005453-4057qib7	14155	25	further	further	RB
cord-005453-4057qib7	14155	26	exacerbates	exacerbate	VBZ
cord-005453-4057qib7	14155	27	inflammation	inflammation	NN
cord-005453-4057qib7	14155	28	.	.	.
cord-005453-4057qib7	14156	1	The	the	DT
cord-005453-4057qib7	14156	2	role	role	NN
cord-005453-4057qib7	14156	3	of	of	IN
cord-005453-4057qib7	14156	4	systemic	systemic	JJ
cord-005453-4057qib7	14156	5	inflammation	inflammation	NN
cord-005453-4057qib7	14156	6	is	be	VBZ
cord-005453-4057qib7	14156	7	being	be	VBG
cord-005453-4057qib7	14156	8	evaluated	evaluate	VBN
cord-005453-4057qib7	14156	9	in	in	IN
cord-005453-4057qib7	14156	10	the	the	DT
cord-005453-4057qib7	14156	11	animal	animal	NN
cord-005453-4057qib7	14156	12	model	model	NN
cord-005453-4057qib7	14156	13	.	.	.
cord-005453-4057qib7	14157	1	It	-PRON-	PRP
cord-005453-4057qib7	14157	2	is	be	VBZ
cord-005453-4057qib7	14157	3	known	know	VBN
cord-005453-4057qib7	14157	4	that	that	IN
cord-005453-4057qib7	14157	5	systemic	systemic	JJ
cord-005453-4057qib7	14157	6	inflammation	inflammation	NN
cord-005453-4057qib7	14157	7	plays	play	VBZ
cord-005453-4057qib7	14157	8	a	a	DT
cord-005453-4057qib7	14157	9	role	role	NN
cord-005453-4057qib7	14157	10	in	in	IN
cord-005453-4057qib7	14157	11	traumatic	traumatic	JJ
cord-005453-4057qib7	14157	12	brain	brain	NN
cord-005453-4057qib7	14157	13	injury	injury	NN
cord-005453-4057qib7	14157	14	(	(	-LRB-
cord-005453-4057qib7	14157	15	TBI	TBI	NNP
cord-005453-4057qib7	14157	16	)	)	-RRB-
cord-005453-4057qib7	14157	17	and	and	CC
cord-005453-4057qib7	14157	18	is	be	VBZ
cord-005453-4057qib7	14157	19	an	an	DT
cord-005453-4057qib7	14157	20	independent	independent	JJ
cord-005453-4057qib7	14157	21	risk	risk	NN
cord-005453-4057qib7	14157	22	factor	factor	NN
cord-005453-4057qib7	14157	23	for	for	IN
cord-005453-4057qib7	14157	24	poor	poor	JJ
cord-005453-4057qib7	14157	25	outcome	outcome	NN
cord-005453-4057qib7	14157	26	in	in	IN
cord-005453-4057qib7	14157	27	isolated	isolate	VBN
cord-005453-4057qib7	14157	28	TBI	TBI	NNP
cord-005453-4057qib7	14157	29	patients	patient	NNS
cord-005453-4057qib7	14157	30	.	.	.
cord-005453-4057qib7	14158	1	On	on	IN
cord-005453-4057qib7	14158	2	the	the	DT
cord-005453-4057qib7	14158	3	other	other	JJ
cord-005453-4057qib7	14158	4	hand	hand	NN
cord-005453-4057qib7	14158	5	,	,	,
cord-005453-4057qib7	14158	6	M2-phenotype	M2-phenotype	NNP
cord-005453-4057qib7	14158	7	microglia	microglia	NNS
cord-005453-4057qib7	14158	8	inhibit	inhibit	VBP
cord-005453-4057qib7	14158	9	inflammation	inflammation	NN
cord-005453-4057qib7	14158	10	and	and	CC
cord-005453-4057qib7	14158	11	protect	protect	VB
cord-005453-4057qib7	14158	12	neurons	neuron	NNS
cord-005453-4057qib7	14158	13	from	from	IN
cord-005453-4057qib7	14158	14	secondary	secondary	JJ
cord-005453-4057qib7	14158	15	damage	damage	NN
cord-005453-4057qib7	14158	16	and	and	CC
cord-005453-4057qib7	14158	17	death	death	NN
cord-005453-4057qib7	14158	18	.	.	.
cord-005453-4057qib7	14159	1	However	however	RB
cord-005453-4057qib7	14159	2	,	,	,
cord-005453-4057qib7	14159	3	anti	anti	JJ
cord-005453-4057qib7	14159	4	-	-	JJ
cord-005453-4057qib7	14159	5	inflammatory	inflammatory	JJ
cord-005453-4057qib7	14159	6	mechanisms	mechanism	NNS
cord-005453-4057qib7	14159	7	in	in	IN
cord-005453-4057qib7	14159	8	neonates	neonate	NNS
cord-005453-4057qib7	14159	9	are	be	VBP
cord-005453-4057qib7	14159	10	immature	immature	JJ
cord-005453-4057qib7	14159	11	and	and	CC
cord-005453-4057qib7	14159	12	expose	expose	VB
cord-005453-4057qib7	14159	13	them	-PRON-	PRP
cord-005453-4057qib7	14159	14	to	to	IN
cord-005453-4057qib7	14159	15	extremely	extremely	RB
cord-005453-4057qib7	14159	16	intensive	intensive	JJ
cord-005453-4057qib7	14159	17	inflammation	inflammation	NN
cord-005453-4057qib7	14159	18	.	.	.
cord-005453-4057qib7	14160	1	Therefore	therefore	RB
cord-005453-4057qib7	14160	2	,	,	,
cord-005453-4057qib7	14160	3	anti	anti	JJ
cord-005453-4057qib7	14160	4	-	-	JJ
cord-005453-4057qib7	14160	5	inflammatory	inflammatory	JJ
cord-005453-4057qib7	14160	6	agents	agent	NNS
cord-005453-4057qib7	14160	7	,	,	,
cord-005453-4057qib7	14160	8	including	include	VBG
cord-005453-4057qib7	14160	9	stem	stem	NN
cord-005453-4057qib7	14160	10	cells	cell	NNS
cord-005453-4057qib7	14160	11	,	,	,
cord-005453-4057qib7	14160	12	may	may	MD
cord-005453-4057qib7	14160	13	be	be	VB
cord-005453-4057qib7	14160	14	beneficial	beneficial	JJ
cord-005453-4057qib7	14160	15	in	in	IN
cord-005453-4057qib7	14160	16	these	these	DT
cord-005453-4057qib7	14160	17	patients	patient	NNS
cord-005453-4057qib7	14160	18	.	.	.
cord-005453-4057qib7	14161	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14161	2	:	:	:
cord-005453-4057qib7	14162	1	Three	three	CD
cord-005453-4057qib7	14162	2	of	of	IN
cord-005453-4057qib7	14162	3	four	four	CD
cord-005453-4057qib7	14162	4	authors	author	NNS
cord-005453-4057qib7	14162	5	are	be	VBP
cord-005453-4057qib7	14162	6	employees	employee	NNS
cord-005453-4057qib7	14162	7	of	of	IN
cord-005453-4057qib7	14162	8	the	the	DT
cord-005453-4057qib7	14162	9	Polish	Polish	NNP
cord-005453-4057qib7	14162	10	Stem	Stem	NNP
cord-005453-4057qib7	14162	11	Cell	Cell	NNP
cord-005453-4057qib7	14162	12	Bank	Bank	NNP
cord-005453-4057qib7	14162	13	,	,	,
cord-005453-4057qib7	14162	14	Warsaw	Warsaw	NNP
cord-005453-4057qib7	14162	15	,	,	,
cord-005453-4057qib7	14162	16	Poland	Poland	NNP
cord-005453-4057qib7	14162	17	Reference	Reference	NNP
cord-005453-4057qib7	14162	18	:	:	:
cord-005453-4057qib7	14163	1	Background	background	NN
cord-005453-4057qib7	14163	2	:	:	:
cord-005453-4057qib7	14164	1	Under	under	IN
cord-005453-4057qib7	14164	2	the	the	DT
cord-005453-4057qib7	14164	3	hypothesis	hypothesis	NN
cord-005453-4057qib7	14164	4	that	that	IN
cord-005453-4057qib7	14164	5	early	early	JJ
cord-005453-4057qib7	14164	6	natural	natural	JJ
cord-005453-4057qib7	14164	7	killer	killer	NN
cord-005453-4057qib7	14164	8	cell	cell	NN
cord-005453-4057qib7	14164	9	infusion	infusion	NN
cord-005453-4057qib7	14164	10	(	(	-LRB-
cord-005453-4057qib7	14164	11	NKI	NKI	NNP
cord-005453-4057qib7	14164	12	)	)	-RRB-
cord-005453-4057qib7	14164	13	following	follow	VBG
cord-005453-4057qib7	14164	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14164	15	stem	stem	NN
cord-005453-4057qib7	14164	16	cell	cell	NN
cord-005453-4057qib7	14164	17	transplantation	transplantation	NN
cord-005453-4057qib7	14164	18	(	(	-LRB-
cord-005453-4057qib7	14164	19	haplo	haplo	NNP
cord-005453-4057qib7	14164	20	-	-	HYPH
cord-005453-4057qib7	14164	21	SCT	SCT	NNP
cord-005453-4057qib7	14164	22	)	)	-RRB-
cord-005453-4057qib7	14164	23	will	will	MD
cord-005453-4057qib7	14164	24	reduce	reduce	VB
cord-005453-4057qib7	14164	25	relapse	relapse	NN
cord-005453-4057qib7	14164	26	in	in	IN
cord-005453-4057qib7	14164	27	the	the	DT
cord-005453-4057qib7	14164	28	early	early	JJ
cord-005453-4057qib7	14164	29	post	post	JJ
cord-005453-4057qib7	14164	30	-	-	JJ
cord-005453-4057qib7	14164	31	transplant	transplant	JJ
cord-005453-4057qib7	14164	32	period	period	NN
cord-005453-4057qib7	14164	33	,	,	,
cord-005453-4057qib7	14164	34	we	-PRON-	PRP
cord-005453-4057qib7	14164	35	conducted	conduct	VBD
cord-005453-4057qib7	14164	36	a	a	DT
cord-005453-4057qib7	14164	37	pilot	pilot	NN
cord-005453-4057qib7	14164	38	study	study	NN
cord-005453-4057qib7	14164	39	to	to	TO
cord-005453-4057qib7	14164	40	evaluate	evaluate	VB
cord-005453-4057qib7	14164	41	the	the	DT
cord-005453-4057qib7	14164	42	safety	safety	NN
cord-005453-4057qib7	14164	43	and	and	CC
cord-005453-4057qib7	14164	44	feasibility	feasibility	NN
cord-005453-4057qib7	14164	45	of	of	IN
cord-005453-4057qib7	14164	46	NKI	NKI	NNP
cord-005453-4057qib7	14164	47	following	follow	VBG
cord-005453-4057qib7	14164	48	haplo	haplo	NNP
cord-005453-4057qib7	14164	49	-	-	HYPH
cord-005453-4057qib7	14164	50	SCT	SCT	NNP
cord-005453-4057qib7	14164	51	in	in	IN
cord-005453-4057qib7	14164	52	children	child	NNS
cord-005453-4057qib7	14164	53	with	with	IN
cord-005453-4057qib7	14164	54	recurrent	recurrent	JJ
cord-005453-4057qib7	14164	55	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14164	56	who	who	WP
cord-005453-4057qib7	14164	57	failed	fail	VBD
cord-005453-4057qib7	14164	58	previous	previous	JJ
cord-005453-4057qib7	14164	59	tandem	tandem	JJ
cord-005453-4057qib7	14164	60	high	high	JJ
cord-005453-4057qib7	14164	61	-	-	HYPH
cord-005453-4057qib7	14164	62	dose	dose	NN
cord-005453-4057qib7	14164	63	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14164	64	and	and	CC
cord-005453-4057qib7	14164	65	autologous	autologous	JJ
cord-005453-4057qib7	14164	66	SCT	SCT	NNP
cord-005453-4057qib7	14164	67	.	.	.
cord-005453-4057qib7	14165	1	Methods	method	NNS
cord-005453-4057qib7	14165	2	:	:	:
cord-005453-4057qib7	14166	1	We	-PRON-	PRP
cord-005453-4057qib7	14166	2	used	use	VBD
cord-005453-4057qib7	14166	3	the	the	DT
cord-005453-4057qib7	14166	4	high	high	JJ
cord-005453-4057qib7	14166	5	-	-	HYPH
cord-005453-4057qib7	14166	6	dose	dose	NN
cord-005453-4057qib7	14166	7	131	131	CD
cord-005453-4057qib7	14166	8	I	I	NNP
cord-005453-4057qib7	14166	9	-	-	HYPH
cord-005453-4057qib7	14166	10	metaiodo	metaiodo	JJ
cord-005453-4057qib7	14166	11	benzylguanidine	benzylguanidine	NN
cord-005453-4057qib7	14166	12	and	and	CC
cord-005453-4057qib7	14166	13	cyclophosphamide	cyclophosphamide	NNP
cord-005453-4057qib7	14166	14	/	/	SYM
cord-005453-4057qib7	14166	15	fludarabine	fludarabine	NNP
cord-005453-4057qib7	14166	16	/	/	SYM
cord-005453-4057qib7	14166	17	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	14166	18	globulin	globulin	NN
cord-005453-4057qib7	14166	19	regimen	regimen	NN
cord-005453-4057qib7	14166	20	for	for	IN
cord-005453-4057qib7	14166	21	conditioning	conditioning	NN
cord-005453-4057qib7	14166	22	and	and	CC
cord-005453-4057qib7	14166	23	infused	infuse	VBD
cord-005453-4057qib7	14166	24	3×10	3×10	CD
cord-005453-4057qib7	14166	25	7	7	CD
cord-005453-4057qib7	14166	26	/kg	/kg	NN
cord-005453-4057qib7	14166	27	of	of	IN
cord-005453-4057qib7	14166	28	ex	ex	NN
cord-005453-4057qib7	14166	29	-	-	NN
cord-005453-4057qib7	14166	30	vivo	vivo	JJ
cord-005453-4057qib7	14166	31	expanded	expand	VBN
cord-005453-4057qib7	14166	32	NK	NK	NNP
cord-005453-4057qib7	14166	33	cells	cell	NNS
cord-005453-4057qib7	14166	34	derived	derive	VBN
cord-005453-4057qib7	14166	35	from	from	IN
cord-005453-4057qib7	14166	36	a	a	DT
cord-005453-4057qib7	14166	37	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14166	38	parent	parent	NN
cord-005453-4057qib7	14166	39	donor	donor	NN
cord-005453-4057qib7	14166	40	on	on	IN
cord-005453-4057qib7	14166	41	days	day	NNS
cord-005453-4057qib7	14166	42	2	2	CD
cord-005453-4057qib7	14166	43	,	,	,
cord-005453-4057qib7	14166	44	9	9	CD
cord-005453-4057qib7	14166	45	,	,	,
cord-005453-4057qib7	14166	46	and	and	CC
cord-005453-4057qib7	14166	47	16	16	CD
cord-005453-4057qib7	14166	48	posttransplant	posttransplant	NN
cord-005453-4057qib7	14166	49	.	.	.
cord-005453-4057qib7	14167	1	Results	result	NNS
cord-005453-4057qib7	14167	2	:	:	:
cord-005453-4057qib7	14168	1	Seven	seven	CD
cord-005453-4057qib7	14168	2	children	child	NNS
cord-005453-4057qib7	14168	3	received	receive	VBD
cord-005453-4057qib7	14168	4	a	a	DT
cord-005453-4057qib7	14168	5	total	total	NN
cord-005453-4057qib7	14168	6	of	of	IN
cord-005453-4057qib7	14168	7	19	19	CD
cord-005453-4057qib7	14168	8	NKIs	nki	NNS
cord-005453-4057qib7	14168	9	,	,	,
cord-005453-4057qib7	14168	10	and	and	CC
cord-005453-4057qib7	14168	11	NKI	NKI	NNP
cord-005453-4057qib7	14168	12	-	-	HYPH
cord-005453-4057qib7	14168	13	related	relate	VBN
cord-005453-4057qib7	14168	14	acute	acute	JJ
cord-005453-4057qib7	14168	15	toxicities	toxicity	NNS
cord-005453-4057qib7	14168	16	were	be	VBD
cord-005453-4057qib7	14168	17	fever	fever	NN
cord-005453-4057qib7	14168	18	(	(	-LRB-
cord-005453-4057qib7	14168	19	n	n	NN
cord-005453-4057qib7	14168	20	=	=	SYM
cord-005453-4057qib7	14168	21	4	4	CD
cord-005453-4057qib7	14168	22	)	)	-RRB-
cord-005453-4057qib7	14168	23	followed	follow	VBN
cord-005453-4057qib7	14168	24	by	by	IN
cord-005453-4057qib7	14168	25	chills	chill	NNS
cord-005453-4057qib7	14168	26	(	(	-LRB-
cord-005453-4057qib7	14168	27	n	n	NN
cord-005453-4057qib7	14168	28	=	=	SYM
cord-005453-4057qib7	14168	29	3	3	CD
cord-005453-4057qib7	14168	30	)	)	-RRB-
cord-005453-4057qib7	14168	31	and	and	CC
cord-005453-4057qib7	14168	32	hypertension	hypertension	NN
cord-005453-4057qib7	14168	33	(	(	-LRB-
cord-005453-4057qib7	14168	34	n	n	NN
cord-005453-4057qib7	14168	35	=	=	SYM
cord-005453-4057qib7	14168	36	3	3	CD
cord-005453-4057qib7	14168	37	)	)	-RRB-
cord-005453-4057qib7	14168	38	;	;	:
cord-005453-4057qib7	14168	39	all	all	DT
cord-005453-4057qib7	14168	40	toxicities	toxicity	NNS
cord-005453-4057qib7	14168	41	were	be	VBD
cord-005453-4057qib7	14168	42	tolerable	tolerable	JJ
cord-005453-4057qib7	14168	43	.	.	.
cord-005453-4057qib7	14169	1	Grade	grade	NN
cord-005453-4057qib7	14169	2	≥II	≥II	NNP
cord-005453-4057qib7	14169	3	acute	acute	JJ
cord-005453-4057qib7	14169	4	GVHD	GVHD	NNP
cord-005453-4057qib7	14169	5	and	and	CC
cord-005453-4057qib7	14169	6	chronic	chronic	JJ
cord-005453-4057qib7	14169	7	GVHD	GVHD	NNP
cord-005453-4057qib7	14169	8	developed	develop	VBN
cord-005453-4057qib7	14169	9	in	in	IN
cord-005453-4057qib7	14169	10	two	two	CD
cord-005453-4057qib7	14169	11	and	and	CC
cord-005453-4057qib7	14169	12	five	five	CD
cord-005453-4057qib7	14169	13	patients	patient	NNS
cord-005453-4057qib7	14169	14	,	,	,
cord-005453-4057qib7	14169	15	respectively	respectively	RB
cord-005453-4057qib7	14169	16	.	.	.
cord-005453-4057qib7	14170	1	Higher	high	JJR
cord-005453-4057qib7	14170	2	amount	amount	NN
cord-005453-4057qib7	14170	3	of	of	IN
cord-005453-4057qib7	14170	4	NK	NK	NNP
cord-005453-4057qib7	14170	5	cell	cell	NN
cord-005453-4057qib7	14170	6	population	population	NN
cord-005453-4057qib7	14170	7	were	be	VBD
cord-005453-4057qib7	14170	8	detected	detect	VBN
cord-005453-4057qib7	14170	9	in	in	IN
cord-005453-4057qib7	14170	10	peripheral	peripheral	JJ
cord-005453-4057qib7	14170	11	blood	blood	NN
cord-005453-4057qib7	14170	12	until	until	IN
cord-005453-4057qib7	14170	13	60	60	CD
cord-005453-4057qib7	14170	14	days	day	NNS
cord-005453-4057qib7	14170	15	post	post	JJ
cord-005453-4057qib7	14170	16	-	-	JJ
cord-005453-4057qib7	14170	17	transplant	transplant	NN
cord-005453-4057qib7	14170	18	compared	compare	VBN
cord-005453-4057qib7	14170	19	with	with	IN
cord-005453-4057qib7	14170	20	reference	reference	NN
cord-005453-4057qib7	14170	21	cohort	cohort	NN
cord-005453-4057qib7	14170	22	.	.	.
cord-005453-4057qib7	14171	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	14171	2	and	and	CC
cord-005453-4057qib7	14171	3	BK	BK	NNP
cord-005453-4057qib7	14171	4	virus	virus	NN
cord-005453-4057qib7	14171	5	reactivation	reactivation	NN
cord-005453-4057qib7	14171	6	occurred	occur	VBD
cord-005453-4057qib7	14171	7	in	in	IN
cord-005453-4057qib7	14171	8	all	all	DT
cord-005453-4057qib7	14171	9	patients	patient	NNS
cord-005453-4057qib7	14171	10	and	and	CC
cord-005453-4057qib7	14171	11	Epstein	Epstein	NNP
cord-005453-4057qib7	14171	12	-	-	HYPH
cord-005453-4057qib7	14171	13	Barr	Barr	NNP
cord-005453-4057qib7	14171	14	virus	virus	NN
cord-005453-4057qib7	14171	15	in	in	IN
cord-005453-4057qib7	14171	16	six	six	CD
cord-005453-4057qib7	14171	17	patients	patient	NNS
cord-005453-4057qib7	14171	18	.	.	.
cord-005453-4057qib7	14172	1	Six	six	CD
cord-005453-4057qib7	14172	2	patients	patient	NNS
cord-005453-4057qib7	14172	3	died	die	VBD
cord-005453-4057qib7	14172	4	of	of	IN
cord-005453-4057qib7	14172	5	relapse	relapse	NN
cord-005453-4057qib7	14172	6	/	/	SYM
cord-005453-4057qib7	14172	7	progression	progression	NN
cord-005453-4057qib7	14172	8	(	(	-LRB-
cord-005453-4057qib7	14172	9	n	n	NN
cord-005453-4057qib7	14172	10	=	=	SYM
cord-005453-4057qib7	14172	11	5	5	CD
cord-005453-4057qib7	14172	12	)	)	-RRB-
cord-005453-4057qib7	14172	13	or	or	CC
cord-005453-4057qib7	14172	14	treatment	treatment	NN
cord-005453-4057qib7	14172	15	-	-	HYPH
cord-005453-4057qib7	14172	16	related	relate	VBN
cord-005453-4057qib7	14172	17	mortality	mortality	NN
cord-005453-4057qib7	14172	18	(	(	-LRB-
cord-005453-4057qib7	14172	19	n	n	NN
cord-005453-4057qib7	14172	20	=	=	SYM
cord-005453-4057qib7	14172	21	1	1	CD
cord-005453-4057qib7	14172	22	)	)	-RRB-
cord-005453-4057qib7	14172	23	,	,	,
cord-005453-4057qib7	14172	24	and	and	CC
cord-005453-4057qib7	14172	25	one	one	CD
cord-005453-4057qib7	14172	26	patient	patient	NN
cord-005453-4057qib7	14172	27	remained	remain	VBD
cord-005453-4057qib7	14172	28	alive	alive	JJ
cord-005453-4057qib7	14172	29	.	.	.
cord-005453-4057qib7	14173	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14173	2	:	:	:
cord-005453-4057qib7	14174	1	NKI	NKI	NNP
cord-005453-4057qib7	14174	2	following	follow	VBG
cord-005453-4057qib7	14174	3	haplo	haplo	NNP
cord-005453-4057qib7	14174	4	-	-	HYPH
cord-005453-4057qib7	14174	5	SCT	SCT	NNP
cord-005453-4057qib7	14174	6	was	be	VBD
cord-005453-4057qib7	14174	7	relatively	relatively	RB
cord-005453-4057qib7	14174	8	safe	safe	JJ
cord-005453-4057qib7	14174	9	and	and	CC
cord-005453-4057qib7	14174	10	feasible	feasible	JJ
cord-005453-4057qib7	14174	11	in	in	IN
cord-005453-4057qib7	14174	12	patients	patient	NNS
cord-005453-4057qib7	14174	13	with	with	IN
cord-005453-4057qib7	14174	14	recurrent	recurrent	JJ
cord-005453-4057qib7	14174	15	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14174	16	.	.	.
cord-005453-4057qib7	14175	1	Further	further	JJ
cord-005453-4057qib7	14175	2	studies	study	NNS
cord-005453-4057qib7	14175	3	to	to	TO
cord-005453-4057qib7	14175	4	enhance	enhance	VB
cord-005453-4057qib7	14175	5	the	the	DT
cord-005453-4057qib7	14175	6	graft	graft	NN
cord-005453-4057qib7	14175	7	-	-	HYPH
cord-005453-4057qib7	14175	8	versus	versus	IN
cord-005453-4057qib7	14175	9	-	-	HYPH
cord-005453-4057qib7	14175	10	tumor	tumor	NN
cord-005453-4057qib7	14175	11	effect	effect	NN
cord-005453-4057qib7	14175	12	without	without	IN
cord-005453-4057qib7	14175	13	increasing	increase	VBG
cord-005453-4057qib7	14175	14	GVHD	GVHD	NNP
cord-005453-4057qib7	14175	15	are	be	VBP
cord-005453-4057qib7	14175	16	needed	need	VBN
cord-005453-4057qib7	14175	17	.	.	.
cord-005453-4057qib7	14176	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14176	2	:	:	:
cord-005453-4057qib7	14176	3	Nothing	nothing	NN
cord-005453-4057qib7	14176	4	to	to	TO
cord-005453-4057qib7	14176	5	declare	declare	VB
cord-005453-4057qib7	14176	6	Regenerative	regenerative	JJ
cord-005453-4057qib7	14176	7	medicine	medicine	NN
cord-005453-4057qib7	14176	8	P652	p652	XX
cord-005453-4057qib7	14176	9	Repeated	repeat	VBD
cord-005453-4057qib7	14176	10	administration	administration	NN
cord-005453-4057qib7	14176	11	of	of	IN
cord-005453-4057qib7	14176	12	G	G	NNP
cord-005453-4057qib7	14176	13	-	-	HYPH
cord-005453-4057qib7	14176	14	CSF	CSF	NNP
cord-005453-4057qib7	14176	15	using	use	VBG
cord-005453-4057qib7	14176	16	stem	stem	NN
cord-005453-4057qib7	14176	17	cell	cell	NN
cord-005453-4057qib7	14176	18	mobilization	mobilization	NN
cord-005453-4057qib7	14176	19	protocol	protocol	NN
cord-005453-4057qib7	14176	20	could	could	MD
cord-005453-4057qib7	14176	21	induce	induce	VB
cord-005453-4057qib7	14176	22	improvement	improvement	NN
cord-005453-4057qib7	14176	23	of	of	IN
cord-005453-4057qib7	14176	24	cognitive	cognitive	JJ
cord-005453-4057qib7	14176	25	functions	function	NNS
cord-005453-4057qib7	14176	26	of	of	IN
cord-005453-4057qib7	14176	27	children	child	NNS
cord-005453-4057qib7	14176	28	with	with	IN
cord-005453-4057qib7	14176	29	cerebral	cerebral	JJ
cord-005453-4057qib7	14176	30	palsy	palsy	NN
cord-005453-4057qib7	14176	31	:	:	:
cord-005453-4057qib7	14176	32	Phase	phase	NN
cord-005453-4057qib7	14176	33	II	ii	CD
cord-005453-4057qib7	14177	1	randomized	randomized	JJ
cord-005453-4057qib7	14177	2	placebo	placebo	NN
cord-005453-4057qib7	14177	3	-	-	HYPH
cord-005453-4057qib7	14177	4	controlled	control	VBN
cord-005453-4057qib7	14177	5	study	study	NN
cord-005453-4057qib7	14177	6	Background	background	NN
cord-005453-4057qib7	14178	1	:	:	:
cord-005453-4057qib7	14178	2	We	-PRON-	PRP
cord-005453-4057qib7	14178	3	performed	perform	VBD
cord-005453-4057qib7	14178	4	phase	phase	NN
cord-005453-4057qib7	14178	5	II	ii	CD
cord-005453-4057qib7	14178	6	randomized	randomized	JJ
cord-005453-4057qib7	14178	7	placebocontrolled	placebocontrolled	JJ
cord-005453-4057qib7	14178	8	clinical	clinical	JJ
cord-005453-4057qib7	14178	9	study	study	NN
cord-005453-4057qib7	14178	10	to	to	TO
cord-005453-4057qib7	14178	11	reveal	reveal	VB
cord-005453-4057qib7	14178	12	the	the	DT
cord-005453-4057qib7	14178	13	safety	safety	NN
cord-005453-4057qib7	14178	14	and	and	CC
cord-005453-4057qib7	14178	15	feasibility	feasibility	NN
cord-005453-4057qib7	14178	16	of	of	IN
cord-005453-4057qib7	14178	17	repeated	repeat	VBN
cord-005453-4057qib7	14178	18	granulocyte	granulocyte	NN
cord-005453-4057qib7	14178	19	colony	colony	NN
cord-005453-4057qib7	14178	20	-	-	HYPH
cord-005453-4057qib7	14178	21	stimulating	stimulate	VBG
cord-005453-4057qib7	14178	22	factor	factor	NN
cord-005453-4057qib7	14178	23	(	(	-LRB-
cord-005453-4057qib7	14178	24	G	G	NNP
cord-005453-4057qib7	14178	25	-	-	HYPH
cord-005453-4057qib7	14178	26	CSF	CSF	NNP
cord-005453-4057qib7	14178	27	)	)	-RRB-
cord-005453-4057qib7	14178	28	administration	administration	NN
cord-005453-4057qib7	14178	29	for	for	IN
cord-005453-4057qib7	14178	30	improvement	improvement	NN
cord-005453-4057qib7	14178	31	of	of	IN
cord-005453-4057qib7	14178	32	cognitive	cognitive	JJ
cord-005453-4057qib7	14178	33	functions	function	NNS
cord-005453-4057qib7	14178	34	of	of	IN
cord-005453-4057qib7	14178	35	children	child	NNS
cord-005453-4057qib7	14178	36	with	with	IN
cord-005453-4057qib7	14178	37	cerebral	cerebral	JJ
cord-005453-4057qib7	14178	38	palsy	palsy	NN
cord-005453-4057qib7	14178	39	.	.	.
cord-005453-4057qib7	14179	1	Methods	method	NNS
cord-005453-4057qib7	14179	2	:	:	:
cord-005453-4057qib7	14179	3	Forty	forty	CD
cord-005453-4057qib7	14179	4	-	-	HYPH
cord-005453-4057qib7	14179	5	four	four	CD
cord-005453-4057qib7	14179	6	children	child	NNS
cord-005453-4057qib7	14179	7	with	with	IN
cord-005453-4057qib7	14179	8	non	non	JJ
cord-005453-4057qib7	14179	9	-	-	JJ
cord-005453-4057qib7	14179	10	severe	severe	JJ
cord-005453-4057qib7	14179	11	type	type	NN
cord-005453-4057qib7	14179	12	of	of	IN
cord-005453-4057qib7	14179	13	cerebral	cerebral	JJ
cord-005453-4057qib7	14179	14	palsy	palsy	NN
cord-005453-4057qib7	14179	15	were	be	VBD
cord-005453-4057qib7	14179	16	enrolled	enrol	VBN
cord-005453-4057qib7	14179	17	,	,	,
cord-005453-4057qib7	14179	18	and	and	CC
cord-005453-4057qib7	14179	19	their	-PRON-	PRP$
cord-005453-4057qib7	14179	20	age	age	NN
cord-005453-4057qib7	14179	21	were	be	VBD
cord-005453-4057qib7	14179	22	2	2	CD
cord-005453-4057qib7	14179	23	-	-	SYM
cord-005453-4057qib7	14179	24	10	10	CD
cord-005453-4057qib7	14179	25	years	year	NNS
cord-005453-4057qib7	14179	26	old	old	JJ
cord-005453-4057qib7	14179	27	.	.	.
cord-005453-4057qib7	14180	1	G	G	NNP
cord-005453-4057qib7	14180	2	-	-	HYPH
cord-005453-4057qib7	14180	3	CSF	CSF	NNP
cord-005453-4057qib7	14180	4	(	(	-LRB-
cord-005453-4057qib7	14180	5	5μg	5μg	NNP
cord-005453-4057qib7	14180	6	/	/	SYM
cord-005453-4057qib7	14180	7	kg	kg	NN
cord-005453-4057qib7	14180	8	)	)	-RRB-
cord-005453-4057qib7	14180	9	was	be	VBD
cord-005453-4057qib7	14180	10	administered	administer	VBN
cord-005453-4057qib7	14180	11	for	for	IN
cord-005453-4057qib7	14180	12	5	5	CD
cord-005453-4057qib7	14180	13	days	day	NNS
cord-005453-4057qib7	14180	14	subcutaneously	subcutaneously	RB
cord-005453-4057qib7	14180	15	every	every	DT
cord-005453-4057qib7	14180	16	3months	3months	NN
cord-005453-4057qib7	14180	17	during	during	IN
cord-005453-4057qib7	14180	18	18	18	CD
cord-005453-4057qib7	14180	19	months	month	NNS
cord-005453-4057qib7	14180	20	.	.	.
cord-005453-4057qib7	14181	1	We	-PRON-	PRP
cord-005453-4057qib7	14181	2	compared	compare	VBD
cord-005453-4057qib7	14181	3	their	-PRON-	PRP$
cord-005453-4057qib7	14181	4	cognitive	cognitive	JJ
cord-005453-4057qib7	14181	5	functions	function	NNS
cord-005453-4057qib7	14181	6	with	with	IN
cord-005453-4057qib7	14181	7	the	the	DT
cord-005453-4057qib7	14181	8	magnetic	magnetic	JJ
cord-005453-4057qib7	14181	9	resonance	resonance	NN
cord-005453-4057qib7	14181	10	imaging	imaging	NN
cord-005453-4057qib7	14181	11	(	(	-LRB-
cord-005453-4057qib7	14181	12	MRI	MRI	NNP
cord-005453-4057qib7	14181	13	)	)	-RRB-
cord-005453-4057qib7	14181	14	findings	finding	NNS
cord-005453-4057qib7	14181	15	and	and	CC
cord-005453-4057qib7	14181	16	the	the	DT
cord-005453-4057qib7	14181	17	following	follow	VBG
cord-005453-4057qib7	14181	18	tools	tool	NNS
cord-005453-4057qib7	14181	19	between	between	IN
cord-005453-4057qib7	14181	20	before	before	RB
cord-005453-4057qib7	14181	21	and	and	CC
cord-005453-4057qib7	14181	22	18	18	CD
cord-005453-4057qib7	14181	23	months	month	NNS
cord-005453-4057qib7	14181	24	after	after	IN
cord-005453-4057qib7	14181	25	treatment	treatment	NN
cord-005453-4057qib7	14181	26	;	;	:
cord-005453-4057qib7	14181	27	zoo	zoo	NN
cord-005453-4057qib7	14181	28	location	location	NN
cord-005453-4057qib7	14181	29	and	and	CC
cord-005453-4057qib7	14181	30	picture	picture	NN
cord-005453-4057qib7	14181	31	memory	memory	NN
cord-005453-4057qib7	14181	32	as	as	IN
cord-005453-4057qib7	14181	33	working	work	VBG
cord-005453-4057qib7	14181	34	memory	memory	NN
cord-005453-4057qib7	14181	35	index	index	NN
cord-005453-4057qib7	14181	36	(	(	-LRB-
cord-005453-4057qib7	14181	37	WMI	WMI	NNP
cord-005453-4057qib7	14181	38	)	)	-RRB-
cord-005453-4057qib7	14181	39	in	in	IN
cord-005453-4057qib7	14181	40	Wechsler	Wechsler	NNP
cord-005453-4057qib7	14181	41	Preschool	Preschool	NNP
cord-005453-4057qib7	14181	42	and	and	CC
cord-005453-4057qib7	14181	43	Primary	Primary	NNP
cord-005453-4057qib7	14181	44	Scale	Scale	NNP
cord-005453-4057qib7	14181	45	of	of	IN
cord-005453-4057qib7	14181	46	Intelligence	Intelligence	NNP
cord-005453-4057qib7	14181	47	(	(	-LRB-
cord-005453-4057qib7	14181	48	WPSSI	WPSSI	NNP
cord-005453-4057qib7	14181	49	)	)	-RRB-
cord-005453-4057qib7	14181	50	,	,	,
cord-005453-4057qib7	14181	51	receptive	receptive	JJ
cord-005453-4057qib7	14181	52	and	and	CC
cord-005453-4057qib7	14181	53	expressive	expressive	JJ
cord-005453-4057qib7	14181	54	vocabulary	vocabulary	NN
cord-005453-4057qib7	14181	55	test	test	NN
cord-005453-4057qib7	14181	56	(	(	-LRB-
cord-005453-4057qib7	14181	57	REVT	REVT	NNP
cord-005453-4057qib7	14181	58	)	)	-RRB-
cord-005453-4057qib7	14181	59	,	,	,
cord-005453-4057qib7	14181	60	and	and	CC
cord-005453-4057qib7	14181	61	visual	visual	JJ
cord-005453-4057qib7	14181	62	motor	motor	NN
cord-005453-4057qib7	14181	63	integration	integration	NN
cord-005453-4057qib7	14181	64	(	(	-LRB-
cord-005453-4057qib7	14181	65	VMI)/visual	vmi)/visual	JJ
cord-005453-4057qib7	14181	66	perception	perception	NN
cord-005453-4057qib7	14181	67	(	(	-LRB-
cord-005453-4057qib7	14181	68	VP	VP	NNP
cord-005453-4057qib7	14181	69	)	)	-RRB-
cord-005453-4057qib7	14181	70	test	test	NN
cord-005453-4057qib7	14181	71	.	.	.
cord-005453-4057qib7	14182	1	Mobilized	mobilize	VBN
cord-005453-4057qib7	14182	2	stem	stem	NN
cord-005453-4057qib7	14182	3	cell	cell	NN
cord-005453-4057qib7	14182	4	count	count	NN
cord-005453-4057qib7	14182	5	and	and	CC
cord-005453-4057qib7	14182	6	cytokine	cytokine	NN
cord-005453-4057qib7	14182	7	levels	level	NNS
cord-005453-4057qib7	14182	8	were	be	VBD
cord-005453-4057qib7	14182	9	measured	measure	VBN
cord-005453-4057qib7	14182	10	before	before	RB
cord-005453-4057qib7	14182	11	(	(	-LRB-
cord-005453-4057qib7	14182	12	D+0	D+0	NNP
cord-005453-4057qib7	14182	13	)	)	-RRB-
cord-005453-4057qib7	14182	14	and	and	CC
cord-005453-4057qib7	14182	15	after	after	IN
cord-005453-4057qib7	14182	16	(	(	-LRB-
cord-005453-4057qib7	14182	17	D+5	d+5	NN
cord-005453-4057qib7	14182	18	)	)	-RRB-
cord-005453-4057qib7	14182	19	G	G	NNP
cord-005453-4057qib7	14182	20	-	-	HYPH
cord-005453-4057qib7	14182	21	CSF	CSF	NNP
cord-005453-4057qib7	14182	22	administration	administration	NN
cord-005453-4057qib7	14182	23	for	for	IN
cord-005453-4057qib7	14182	24	5	5	CD
cord-005453-4057qib7	14182	25	days	day	NNS
cord-005453-4057qib7	14182	26	every	every	DT
cord-005453-4057qib7	14182	27	3	3	CD
cord-005453-4057qib7	14182	28	months	month	NNS
cord-005453-4057qib7	14182	29	.	.	.
cord-005453-4057qib7	14183	1	Results	result	NNS
cord-005453-4057qib7	14183	2	:	:	:
cord-005453-4057qib7	14184	1	No	no	DT
cord-005453-4057qib7	14184	2	significant	significant	JJ
cord-005453-4057qib7	14184	3	findings	finding	NNS
cord-005453-4057qib7	14184	4	in	in	IN
cord-005453-4057qib7	14184	5	demography	demography	NN
cord-005453-4057qib7	14184	6	was	be	VBD
cord-005453-4057qib7	14184	7	noticed	notice	VBN
cord-005453-4057qib7	14184	8	between	between	IN
cord-005453-4057qib7	14184	9	G	G	NNP
cord-005453-4057qib7	14184	10	-	-	HYPH
cord-005453-4057qib7	14184	11	CSF	CSF	NNP
cord-005453-4057qib7	14184	12	(	(	-LRB-
cord-005453-4057qib7	14184	13	G-	G-	NNP
cord-005453-4057qib7	14184	14	)	)	-RRB-
cord-005453-4057qib7	14184	15	and	and	CC
cord-005453-4057qib7	14184	16	placebo	placebo	NN
cord-005453-4057qib7	14184	17	(	(	-LRB-
cord-005453-4057qib7	14184	18	P-	P-	NNP
cord-005453-4057qib7	14184	19	)	)	-RRB-
cord-005453-4057qib7	14184	20	groups	group	NNS
cord-005453-4057qib7	14184	21	.	.	.
cord-005453-4057qib7	14185	1	No	no	DT
cord-005453-4057qib7	14185	2	serious	serious	JJ
cord-005453-4057qib7	14185	3	adverse	adverse	JJ
cord-005453-4057qib7	14185	4	events	event	NNS
cord-005453-4057qib7	14185	5	were	be	VBD
cord-005453-4057qib7	14185	6	observed	observe	VBN
cord-005453-4057qib7	14185	7	during	during	IN
cord-005453-4057qib7	14185	8	the	the	DT
cord-005453-4057qib7	14185	9	whole	whole	JJ
cord-005453-4057qib7	14185	10	study	study	NN
cord-005453-4057qib7	14185	11	period	period	NN
cord-005453-4057qib7	14185	12	.	.	.
cord-005453-4057qib7	14186	1	The	the	DT
cord-005453-4057qib7	14186	2	non	non	JJ
cord-005453-4057qib7	14186	3	-	-	JJ
cord-005453-4057qib7	14186	4	severe	severe	JJ
cord-005453-4057qib7	14186	5	adverse	adverse	JJ
cord-005453-4057qib7	14186	6	events	event	NNS
cord-005453-4057qib7	14186	7	such	such	JJ
cord-005453-4057qib7	14186	8	as	as	IN
cord-005453-4057qib7	14186	9	urticaria	urticaria	NN
cord-005453-4057qib7	14186	10	(	(	-LRB-
cord-005453-4057qib7	14186	11	n=1	n=1	CD
cord-005453-4057qib7	14186	12	)	)	-RRB-
cord-005453-4057qib7	14186	13	,	,	,
cord-005453-4057qib7	14186	14	itching	itch	VBG
cord-005453-4057qib7	14186	15	sense	sense	NN
cord-005453-4057qib7	14186	16	(	(	-LRB-
cord-005453-4057qib7	14186	17	n=3	n=3	NN
cord-005453-4057qib7	14186	18	)	)	-RRB-
cord-005453-4057qib7	14186	19	,	,	,
cord-005453-4057qib7	14186	20	bone	bone	NN
cord-005453-4057qib7	14186	21	pain	pain	NN
cord-005453-4057qib7	14186	22	(	(	-LRB-
cord-005453-4057qib7	14186	23	n=1	n=1	FW
cord-005453-4057qib7	14186	24	)	)	-RRB-
cord-005453-4057qib7	14186	25	,	,	,
cord-005453-4057qib7	14186	26	headache	headache	NN
cord-005453-4057qib7	14186	27	(	(	-LRB-
cord-005453-4057qib7	14186	28	n=1	n=1	CD
cord-005453-4057qib7	14186	29	)	)	-RRB-
cord-005453-4057qib7	14186	30	,	,	,
cord-005453-4057qib7	14186	31	fever	fever	NN
cord-005453-4057qib7	14186	32	(	(	-LRB-
cord-005453-4057qib7	14186	33	n=2	n=2	NNS
cord-005453-4057qib7	14186	34	)	)	-RRB-
cord-005453-4057qib7	14186	35	,	,	,
cord-005453-4057qib7	14186	36	and	and	CC
cord-005453-4057qib7	14186	37	stomatitis	stomatitis	NN
cord-005453-4057qib7	14186	38	(	(	-LRB-
cord-005453-4057qib7	14186	39	n=1	n=1	FW
cord-005453-4057qib7	14186	40	)	)	-RRB-
cord-005453-4057qib7	14186	41	were	be	VBD
cord-005453-4057qib7	14186	42	tolerable	tolerable	JJ
cord-005453-4057qib7	14186	43	.	.	.
cord-005453-4057qib7	14187	1	The	the	DT
cord-005453-4057qib7	14187	2	parents	parent	NNS
cord-005453-4057qib7	14187	3	felt	feel	VBD
cord-005453-4057qib7	14187	4	the	the	DT
cord-005453-4057qib7	14187	5	clinical	clinical	JJ
cord-005453-4057qib7	14187	6	improvements	improvement	NNS
cord-005453-4057qib7	14187	7	of	of	IN
cord-005453-4057qib7	14187	8	cognition	cognition	NN
cord-005453-4057qib7	14187	9	in	in	IN
cord-005453-4057qib7	14187	10	10	10	CD
cord-005453-4057qib7	14187	11	cases	case	NNS
cord-005453-4057qib7	14187	12	of	of	IN
cord-005453-4057qib7	14187	13	G	g	NN
cord-005453-4057qib7	14187	14	-	-	HYPH
cord-005453-4057qib7	14187	15	group	group	NN
cord-005453-4057qib7	14187	16	and	and	CC
cord-005453-4057qib7	14187	17	4	4	CD
cord-005453-4057qib7	14187	18	cases	case	NNS
cord-005453-4057qib7	14187	19	of	of	IN
cord-005453-4057qib7	14187	20	P	p	NN
cord-005453-4057qib7	14187	21	-	-	HYPH
cord-005453-4057qib7	14187	22	group	group	NN
cord-005453-4057qib7	14187	23	(	(	-LRB-
cord-005453-4057qib7	14187	24	p=0.0367	p=0.0367	NNP
cord-005453-4057qib7	14187	25	)	)	-RRB-
cord-005453-4057qib7	14187	26	,	,	,
cord-005453-4057qib7	14187	27	of	of	IN
cord-005453-4057qib7	14187	28	language	language	NN
cord-005453-4057qib7	14187	29	in	in	IN
cord-005453-4057qib7	14187	30	8	8	CD
cord-005453-4057qib7	14187	31	cases	case	NNS
cord-005453-4057qib7	14187	32	of	of	IN
cord-005453-4057qib7	14187	33	G	g	NN
cord-005453-4057qib7	14187	34	-	-	HYPH
cord-005453-4057qib7	14187	35	group	group	NN
cord-005453-4057qib7	14187	36	and	and	CC
cord-005453-4057qib7	14187	37	3	3	CD
cord-005453-4057qib7	14187	38	cases	case	NNS
cord-005453-4057qib7	14187	39	of	of	IN
cord-005453-4057qib7	14187	40	P	p	NN
cord-005453-4057qib7	14187	41	-	-	HYPH
cord-005453-4057qib7	14187	42	group	group	NN
cord-005453-4057qib7	14187	43	(	(	-LRB-
cord-005453-4057qib7	14187	44	p=0.0632	p=0.0632	NNS
cord-005453-4057qib7	14187	45	)	)	-RRB-
cord-005453-4057qib7	14187	46	.	.	.
cord-005453-4057qib7	14188	1	In	in	IN
cord-005453-4057qib7	14188	2	zoo	zoo	NN
cord-005453-4057qib7	14188	3	location	location	NN
cord-005453-4057qib7	14188	4	test	test	NN
cord-005453-4057qib7	14188	5	,	,	,
cord-005453-4057qib7	14188	6	we	-PRON-	PRP
cord-005453-4057qib7	14188	7	can	can	MD
cord-005453-4057qib7	14188	8	not	not	RB
cord-005453-4057qib7	14188	9	find	find	VB
cord-005453-4057qib7	14188	10	out	out	RP
cord-005453-4057qib7	14188	11	the	the	DT
cord-005453-4057qib7	14188	12	significant	significant	JJ
cord-005453-4057qib7	14188	13	score	score	NN
cord-005453-4057qib7	14188	14	(	(	-LRB-
cord-005453-4057qib7	14188	15	expressed	express	VBN
cord-005453-4057qib7	14188	16	as	as	IN
cord-005453-4057qib7	14188	17	age	age	NN
cord-005453-4057qib7	14188	18	equivalent	equivalent	JJ
cord-005453-4057qib7	14188	19	)	)	-RRB-
cord-005453-4057qib7	14188	20	differences	difference	NNS
cord-005453-4057qib7	14188	21	between	between	IN
cord-005453-4057qib7	14188	22	G	g	NN
cord-005453-4057qib7	14188	23	-	-	:
cord-005453-4057qib7	14188	24	and	and	CC
cord-005453-4057qib7	14188	25	P	p	NN
cord-005453-4057qib7	14188	26	-	-	HYPH
cord-005453-4057qib7	14188	27	groups	group	NNS
cord-005453-4057qib7	14188	28	.	.	.
cord-005453-4057qib7	14189	1	However	however	RB
cord-005453-4057qib7	14189	2	,	,	,
cord-005453-4057qib7	14189	3	in	in	IN
cord-005453-4057qib7	14189	4	picture	picture	NN
cord-005453-4057qib7	14189	5	memory	memory	NN
cord-005453-4057qib7	14189	6	test	test	NN
cord-005453-4057qib7	14189	7	,	,	,
cord-005453-4057qib7	14189	8	there	there	EX
cord-005453-4057qib7	14189	9	were	be	VBD
cord-005453-4057qib7	14189	10	significant	significant	JJ
cord-005453-4057qib7	14189	11	improvement	improvement	NN
cord-005453-4057qib7	14189	12	of	of	IN
cord-005453-4057qib7	14189	13	age	age	NN
cord-005453-4057qib7	14189	14	equivalent	equivalent	JJ
cord-005453-4057qib7	14189	15	of	of	IN
cord-005453-4057qib7	14189	16	10	10	CD
cord-005453-4057qib7	14189	17	months	month	NNS
cord-005453-4057qib7	14190	1	(	(	-LRB-
cord-005453-4057qib7	14190	2	45.60±19.66→55.60±23.27	45.60±19.66→55.60±23.27	LS
cord-005453-4057qib7	14190	3	)	)	-RRB-
cord-005453-4057qib7	14190	4	during	during	IN
cord-005453-4057qib7	14190	5	18	18	CD
cord-005453-4057qib7	14190	6	months	month	NNS
cord-005453-4057qib7	14190	7	of	of	IN
cord-005453-4057qib7	14190	8	study	study	NN
cord-005453-4057qib7	14190	9	period	period	NN
cord-005453-4057qib7	14190	10	in	in	IN
cord-005453-4057qib7	14190	11	G	g	NN
cord-005453-4057qib7	14190	12	-	-	HYPH
cord-005453-4057qib7	14190	13	group	group	NN
cord-005453-4057qib7	14190	14	compared	compare	VBN
cord-005453-4057qib7	14190	15	to	to	IN
cord-005453-4057qib7	14190	16	3	3	CD
cord-005453-4057qib7	14190	17	months	month	NNS
cord-005453-4057qib7	14190	18	in	in	IN
cord-005453-4057qib7	14190	19	P	p	NN
cord-005453-4057qib7	14190	20	-	-	HYPH
cord-005453-4057qib7	14190	21	group	group	NN
cord-005453-4057qib7	14190	22	(	(	-LRB-
cord-005453-4057qib7	14190	23	p=0.0242	p=0.0242	NN
cord-005453-4057qib7	14190	24	)	)	-RRB-
cord-005453-4057qib7	14190	25	.	.	.
cord-005453-4057qib7	14191	1	In	in	IN
cord-005453-4057qib7	14191	2	REVT	REVT	NNP
cord-005453-4057qib7	14191	3	,	,	,
cord-005453-4057qib7	14191	4	there	there	EX
cord-005453-4057qib7	14191	5	were	be	VBD
cord-005453-4057qib7	14191	6	significant	significant	JJ
cord-005453-4057qib7	14191	7	improvement	improvement	NN
cord-005453-4057qib7	14191	8	of	of	IN
cord-005453-4057qib7	14191	9	18	18	CD
cord-005453-4057qib7	14191	10	months	month	NNS
cord-005453-4057qib7	14191	11	of	of	IN
cord-005453-4057qib7	14191	12	age	age	NN
cord-005453-4057qib7	14191	13	equivalent	equivalent	JJ
cord-005453-4057qib7	14191	14	in	in	IN
cord-005453-4057qib7	14191	15	expressive	expressive	JJ
cord-005453-4057qib7	14191	16	tests	test	NNS
cord-005453-4057qib7	14191	17	of	of	IN
cord-005453-4057qib7	14191	18	G	g	NN
cord-005453-4057qib7	14191	19	-	-	HYPH
cord-005453-4057qib7	14191	20	group	group	NN
cord-005453-4057qib7	14191	21	(	(	-LRB-
cord-005453-4057qib7	14191	22	57.87±33.66→76.00±43.38	57.87±33.66→76.00±43.38	XX
cord-005453-4057qib7	14191	23	,	,	,
cord-005453-4057qib7	14191	24	p=0.0198	p=0.0198	NNP
cord-005453-4057qib7	14191	25	)	)	-RRB-
cord-005453-4057qib7	14191	26	compared	compare	VBD
cord-005453-4057qib7	14191	27	to	to	IN
cord-005453-4057qib7	14191	28	8	8	CD
cord-005453-4057qib7	14191	29	months	month	NNS
cord-005453-4057qib7	14191	30	in	in	IN
cord-005453-4057qib7	14191	31	P	p	NN
cord-005453-4057qib7	14191	32	-	-	HYPH
cord-005453-4057qib7	14191	33	group	group	NN
cord-005453-4057qib7	14191	34	.	.	.
cord-005453-4057qib7	14192	1	No	no	DT
cord-005453-4057qib7	14192	2	significant	significant	JJ
cord-005453-4057qib7	14192	3	findings	finding	NNS
cord-005453-4057qib7	14192	4	were	be	VBD
cord-005453-4057qib7	14192	5	noted	note	VBN
cord-005453-4057qib7	14192	6	in	in	IN
cord-005453-4057qib7	14192	7	receptive	receptive	JJ
cord-005453-4057qib7	14192	8	test	test	NN
cord-005453-4057qib7	14192	9	.	.	.
cord-005453-4057qib7	14193	1	VMI	VMI	NNP
cord-005453-4057qib7	14193	2	test	test	NN
cord-005453-4057qib7	14193	3	showed	show	VBD
cord-005453-4057qib7	14193	4	the	the	DT
cord-005453-4057qib7	14193	5	increasing	increase	VBG
cord-005453-4057qib7	14193	6	tendency	tendency	NN
cord-005453-4057qib7	14193	7	of	of	IN
cord-005453-4057qib7	14193	8	14	14	CD
cord-005453-4057qib7	14193	9	months	month	NNS
cord-005453-4057qib7	14193	10	of	of	IN
cord-005453-4057qib7	14193	11	age	age	NN
cord-005453-4057qib7	14193	12	equivalent	equivalent	JJ
cord-005453-4057qib7	14193	13	in	in	IN
cord-005453-4057qib7	14193	14	G	g	NN
cord-005453-4057qib7	14193	15	-	-	HYPH
cord-005453-4057qib7	14193	16	group	group	NN
cord-005453-4057qib7	14193	17	(	(	-LRB-
cord-005453-4057qib7	14193	18	47.75±13.22→61.13±17.78	47.75±13.22→61.13±17.78	CD
cord-005453-4057qib7	14193	19	,	,	,
cord-005453-4057qib7	14193	20	p=0.0746	p=0.0746	NNP
cord-005453-4057qib7	14193	21	)	)	-RRB-
cord-005453-4057qib7	14193	22	compared	compare	VBN
cord-005453-4057qib7	14193	23	to	to	IN
cord-005453-4057qib7	14193	24	P	p	NN
cord-005453-4057qib7	14193	25	-	-	HYPH
cord-005453-4057qib7	14193	26	group	group	NN
cord-005453-4057qib7	14193	27	.	.	.
cord-005453-4057qib7	14194	1	The	the	DT
cord-005453-4057qib7	14194	2	increment	increment	NN
cord-005453-4057qib7	14194	3	of	of	IN
cord-005453-4057qib7	14194	4	CD34	CD34	NNP
cord-005453-4057qib7	14194	5	+	+	CC
cord-005453-4057qib7	14194	6	cell	cell	NN
cord-005453-4057qib7	14194	7	counts	count	NNS
cord-005453-4057qib7	14194	8	in	in	IN
cord-005453-4057qib7	14194	9	peripheral	peripheral	JJ
cord-005453-4057qib7	14194	10	blood	blood	NN
cord-005453-4057qib7	14194	11	were	be	VBD
cord-005453-4057qib7	14194	12	significant	significant	JJ
cord-005453-4057qib7	14194	13	in	in	IN
cord-005453-4057qib7	14194	14	Ggroup	Ggroup	NNP
cord-005453-4057qib7	14194	15	compared	compare	VBN
cord-005453-4057qib7	14194	16	to	to	IN
cord-005453-4057qib7	14194	17	P	p	NN
cord-005453-4057qib7	14194	18	-	-	HYPH
cord-005453-4057qib7	14194	19	group	group	NN
cord-005453-4057qib7	14194	20	.	.	.
cord-005453-4057qib7	14195	1	The	the	DT
cord-005453-4057qib7	14195	2	changed	change	VBN
cord-005453-4057qib7	14195	3	levels	level	NNS
cord-005453-4057qib7	14195	4	of	of	IN
cord-005453-4057qib7	14195	5	interleukin	interleukin	NN
cord-005453-4057qib7	14195	6	(	(	-LRB-
cord-005453-4057qib7	14195	7	IL)-6	IL)-6	NNP
cord-005453-4057qib7	14195	8	,	,	,
cord-005453-4057qib7	14195	9	IL-10	IL-10	NNP
cord-005453-4057qib7	14195	10	,	,	,
cord-005453-4057qib7	14195	11	vascular	vascular	JJ
cord-005453-4057qib7	14195	12	endothelial	endothelial	JJ
cord-005453-4057qib7	14195	13	growth	growth	NN
cord-005453-4057qib7	14195	14	factor	factor	NN
cord-005453-4057qib7	14195	15	(	(	-LRB-
cord-005453-4057qib7	14195	16	VEGF	VEGF	NNP
cord-005453-4057qib7	14195	17	)	)	-RRB-
cord-005453-4057qib7	14195	18	as	as	RB
cord-005453-4057qib7	14195	19	well	well	RB
cord-005453-4057qib7	14195	20	as	as	IN
cord-005453-4057qib7	14195	21	G	G	NNP
cord-005453-4057qib7	14195	22	-	-	HYPH
cord-005453-4057qib7	14195	23	CSF	CSF	NNP
cord-005453-4057qib7	14195	24	were	be	VBD
cord-005453-4057qib7	14195	25	noted	note	VBN
cord-005453-4057qib7	14195	26	in	in	IN
cord-005453-4057qib7	14195	27	G	g	NN
cord-005453-4057qib7	14195	28	-	-	HYPH
cord-005453-4057qib7	14195	29	group	group	NN
cord-005453-4057qib7	14195	30	.	.	.
cord-005453-4057qib7	14196	1	We	-PRON-	PRP
cord-005453-4057qib7	14196	2	also	also	RB
cord-005453-4057qib7	14196	3	observed	observe	VBD
cord-005453-4057qib7	14196	4	the	the	DT
cord-005453-4057qib7	14196	5	correlation	correlation	NN
cord-005453-4057qib7	14196	6	of	of	IN
cord-005453-4057qib7	14196	7	cognitive	cognitive	JJ
cord-005453-4057qib7	14196	8	function	function	NN
cord-005453-4057qib7	14196	9	tests	test	NNS
cord-005453-4057qib7	14196	10	and	and	CC
cord-005453-4057qib7	14196	11	white	white	JJ
cord-005453-4057qib7	14196	12	matter	matter	NN
cord-005453-4057qib7	14196	13	connectoms	connectom	NNS
cord-005453-4057qib7	14196	14	of	of	IN
cord-005453-4057qib7	14196	15	several	several	JJ
cord-005453-4057qib7	14196	16	networks	network	NNS
cord-005453-4057qib7	14196	17	using	use	VBG
cord-005453-4057qib7	14196	18	functionally	functionally	RB
cord-005453-4057qib7	14196	19	-	-	HYPH
cord-005453-4057qib7	14196	20	defined	define	VBN
cord-005453-4057qib7	14196	21	white	white	JJ
cord-005453-4057qib7	14196	22	matter	matter	NN
cord-005453-4057qib7	14196	23	atlases	atlas	NNS
cord-005453-4057qib7	14196	24	.	.	.
cord-005453-4057qib7	14197	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14197	2	:	:	:
cord-005453-4057qib7	14198	1	The	the	DT
cord-005453-4057qib7	14198	2	repeated	repeated	JJ
cord-005453-4057qib7	14198	3	administration	administration	NN
cord-005453-4057qib7	14198	4	of	of	IN
cord-005453-4057qib7	14198	5	G	G	NNP
cord-005453-4057qib7	14198	6	-	-	HYPH
cord-005453-4057qib7	14198	7	CSF	CSF	NNP
cord-005453-4057qib7	14198	8	using	use	VBG
cord-005453-4057qib7	14198	9	stem	stem	NN
cord-005453-4057qib7	14198	10	cell	cell	NN
cord-005453-4057qib7	14198	11	mobilization	mobilization	NN
cord-005453-4057qib7	14198	12	protocol	protocol	NN
cord-005453-4057qib7	14198	13	is	be	VBZ
cord-005453-4057qib7	14198	14	safe	safe	JJ
cord-005453-4057qib7	14198	15	and	and	CC
cord-005453-4057qib7	14198	16	feasible	feasible	JJ
cord-005453-4057qib7	14198	17	to	to	TO
cord-005453-4057qib7	14198	18	improve	improve	VB
cord-005453-4057qib7	14198	19	the	the	DT
cord-005453-4057qib7	14198	20	language	language	NN
cord-005453-4057qib7	14198	21	and	and	CC
cord-005453-4057qib7	14198	22	cognitive	cognitive	JJ
cord-005453-4057qib7	14198	23	functions	function	NNS
cord-005453-4057qib7	14198	24	in	in	IN
cord-005453-4057qib7	14198	25	children	child	NNS
cord-005453-4057qib7	14198	26	with	with	IN
cord-005453-4057qib7	14198	27	cerebral	cerebral	JJ
cord-005453-4057qib7	14198	28	palsy	palsy	NN
cord-005453-4057qib7	14198	29	.	.	.
cord-005453-4057qib7	14199	1	Further	further	JJ
cord-005453-4057qib7	14199	2	studies	study	NNS
cord-005453-4057qib7	14199	3	for	for	IN
cord-005453-4057qib7	14199	4	cellular	cellular	JJ
cord-005453-4057qib7	14199	5	and	and	CC
cord-005453-4057qib7	14199	6	paracrine	paracrine	JJ
cord-005453-4057qib7	14199	7	effect	effect	NN
cord-005453-4057qib7	14199	8	of	of	IN
cord-005453-4057qib7	14199	9	G	G	NNP
cord-005453-4057qib7	14199	10	-	-	HYPH
cord-005453-4057qib7	14199	11	CSF	CSF	NNP
cord-005453-4057qib7	14199	12	and/or	and/or	CC
cord-005453-4057qib7	14199	13	mobilized	mobilize	VBD
cord-005453-4057qib7	14199	14	peripheral	peripheral	JJ
cord-005453-4057qib7	14199	15	blood	blood	NN
cord-005453-4057qib7	14199	16	stem	stem	NN
cord-005453-4057qib7	14199	17	cells	cell	NNS
cord-005453-4057qib7	14199	18	would	would	MD
cord-005453-4057qib7	14199	19	be	be	VB
cord-005453-4057qib7	14199	20	needed	need	VBN
cord-005453-4057qib7	14199	21	.	.	.
cord-005453-4057qib7	14200	1	Background	background	NN
cord-005453-4057qib7	14200	2	:	:	:
cord-005453-4057qib7	14201	1	While	while	IN
cord-005453-4057qib7	14201	2	high	high	JJ
cord-005453-4057qib7	14201	3	-	-	HYPH
cord-005453-4057qib7	14201	4	dose	dose	NN
cord-005453-4057qib7	14201	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14201	6	(	(	-LRB-
cord-005453-4057qib7	14201	7	HDCT	HDCT	NNP
cord-005453-4057qib7	14201	8	)	)	-RRB-
cord-005453-4057qib7	14201	9	with	with	IN
cord-005453-4057qib7	14201	10	autologous	autologous	JJ
cord-005453-4057qib7	14201	11	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14201	12	stem	stem	NN
cord-005453-4057qib7	14201	13	cell	cell	NN
cord-005453-4057qib7	14201	14	transplantation	transplantation	NN
cord-005453-4057qib7	14201	15	(	(	-LRB-
cord-005453-4057qib7	14201	16	auto	auto	NN
cord-005453-4057qib7	14201	17	-	-	HYPH
cord-005453-4057qib7	14201	18	HSCT	HSCT	NNP
cord-005453-4057qib7	14201	19	)	)	-RRB-
cord-005453-4057qib7	14201	20	is	be	VBZ
cord-005453-4057qib7	14201	21	an	an	DT
cord-005453-4057qib7	14201	22	integral	integral	JJ
cord-005453-4057qib7	14201	23	part	part	NN
cord-005453-4057qib7	14201	24	of	of	IN
cord-005453-4057qib7	14201	25	multimodal	multimodal	NN
cord-005453-4057qib7	14201	26	therapy	therapy	NN
cord-005453-4057qib7	14201	27	for	for	IN
cord-005453-4057qib7	14201	28	highrisk	highrisk	NNP
cord-005453-4057qib7	14201	29	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14201	30	(	(	-LRB-
cord-005453-4057qib7	14201	31	HR	HR	NNP
cord-005453-4057qib7	14201	32	NB	NB	NNP
cord-005453-4057qib7	14201	33	)	)	-RRB-
cord-005453-4057qib7	14201	34	,	,	,
cord-005453-4057qib7	14201	35	there	there	EX
cord-005453-4057qib7	14201	36	are	be	VBP
cord-005453-4057qib7	14201	37	still	still	RB
cord-005453-4057qib7	14201	38	subgroups	subgroup	NNS
cord-005453-4057qib7	14201	39	,	,	,
cord-005453-4057qib7	14201	40	in	in	IN
cord-005453-4057qib7	14201	41	which	which	WDT
cord-005453-4057qib7	14201	42	the	the	DT
cord-005453-4057qib7	14201	43	results	result	NNS
cord-005453-4057qib7	14201	44	are	be	VBP
cord-005453-4057qib7	14201	45	extremely	extremely	RB
cord-005453-4057qib7	14201	46	poor	poor	JJ
cord-005453-4057qib7	14201	47	.	.	.
cord-005453-4057qib7	14202	1	For	for	IN
cord-005453-4057qib7	14202	2	these	these	DT
cord-005453-4057qib7	14202	3	patients	patient	NNS
cord-005453-4057qib7	14202	4	allografting	allografte	VBG
cord-005453-4057qib7	14202	5	(	(	-LRB-
cord-005453-4057qib7	14202	6	allo	allo	NN
cord-005453-4057qib7	14202	7	-	-	HYPH
cord-005453-4057qib7	14202	8	HSCT	HSCT	NNP
cord-005453-4057qib7	14202	9	)	)	-RRB-
cord-005453-4057qib7	14202	10	may	may	MD
cord-005453-4057qib7	14202	11	offer	offer	VB
cord-005453-4057qib7	14202	12	some	some	DT
cord-005453-4057qib7	14202	13	hope	hope	NN
cord-005453-4057qib7	14202	14	.	.	.
cord-005453-4057qib7	14203	1	Methods	method	NNS
cord-005453-4057qib7	14203	2	:	:	:
cord-005453-4057qib7	14203	3	We	-PRON-	PRP
cord-005453-4057qib7	14203	4	summarize	summarize	VBP
cord-005453-4057qib7	14203	5	the	the	DT
cord-005453-4057qib7	14203	6	experience	experience	NN
cord-005453-4057qib7	14203	7	of	of	IN
cord-005453-4057qib7	14203	8	83	83	CD
cord-005453-4057qib7	14203	9	consecutive	consecutive	JJ
cord-005453-4057qib7	14203	10	HR	hr	NN
cord-005453-4057qib7	14203	11	NB	NB	NNP
cord-005453-4057qib7	14203	12	patients	patient	NNS
cord-005453-4057qib7	14203	13	receiving	receive	VBG
cord-005453-4057qib7	14203	14	therapy	therapy	NN
cord-005453-4057qib7	14203	15	in	in	IN
cord-005453-4057qib7	14203	16	our	-PRON-	PRP$
cord-005453-4057qib7	14203	17	pediatric	pediatric	JJ
cord-005453-4057qib7	14203	18	transplant	transplant	NN
cord-005453-4057qib7	14203	19	department	department	NN
cord-005453-4057qib7	14203	20	in	in	IN
cord-005453-4057qib7	14203	21	2008	2008	CD
cord-005453-4057qib7	14203	22	-	-	SYM
cord-005453-4057qib7	14203	23	2017	2017	CD
cord-005453-4057qib7	14203	24	.	.	.
cord-005453-4057qib7	14204	1	The	the	DT
cord-005453-4057qib7	14204	2	median	median	JJ
cord-005453-4057qib7	14204	3	age	age	NN
cord-005453-4057qib7	14204	4	was	be	VBD
cord-005453-4057qib7	14204	5	4	4	CD
cord-005453-4057qib7	14204	6	years	year	NNS
cord-005453-4057qib7	14204	7	(	(	-LRB-
cord-005453-4057qib7	14204	8	8	8	CD
cord-005453-4057qib7	14204	9	months	month	NNS
cord-005453-4057qib7	14204	10	to	to	IN
cord-005453-4057qib7	14204	11	22	22	CD
cord-005453-4057qib7	14204	12	years	year	NNS
cord-005453-4057qib7	14204	13	)	)	-RRB-
cord-005453-4057qib7	14204	14	.	.	.
cord-005453-4057qib7	14205	1	A	a	DT
cord-005453-4057qib7	14205	2	total	total	NN
cord-005453-4057qib7	14205	3	of	of	IN
cord-005453-4057qib7	14205	4	78	78	CD
cord-005453-4057qib7	14205	5	auto	auto	NN
cord-005453-4057qib7	14205	6	-	-	HYPH
cord-005453-4057qib7	14205	7	HSCTs	hsct	NNS
cord-005453-4057qib7	14205	8	and	and	CC
cord-005453-4057qib7	14205	9	20	20	CD
cord-005453-4057qib7	14205	10	allo	allo	NN
cord-005453-4057qib7	14205	11	-	-	HYPH
cord-005453-4057qib7	14205	12	HSCTs	hsct	NNS
cord-005453-4057qib7	14205	13	were	be	VBD
cord-005453-4057qib7	14205	14	performed	perform	VBN
cord-005453-4057qib7	14205	15	.	.	.
cord-005453-4057qib7	14206	1	All	all	DT
cord-005453-4057qib7	14206	2	auto	auto	NN
cord-005453-4057qib7	14206	3	-	-	HYPH
cord-005453-4057qib7	14206	4	HSCT	HSCT	NNP
cord-005453-4057qib7	14206	5	recipients	recipient	NNS
cord-005453-4057qib7	14206	6	were	be	VBD
cord-005453-4057qib7	14206	7	characterized	characterize	VBN
cord-005453-4057qib7	14206	8	by	by	IN
cord-005453-4057qib7	14206	9	one	one	CD
cord-005453-4057qib7	14206	10	or	or	CC
cord-005453-4057qib7	14206	11	several	several	JJ
cord-005453-4057qib7	14206	12	high	high	JJ
cord-005453-4057qib7	14206	13	-	-	HYPH
cord-005453-4057qib7	14206	14	risk	risk	NN
cord-005453-4057qib7	14206	15	features	feature	NNS
cord-005453-4057qib7	14206	16	:	:	:
cord-005453-4057qib7	14206	17	age	age	NN
cord-005453-4057qib7	14206	18	of	of	IN
cord-005453-4057qib7	14206	19	more	more	JJR
cord-005453-4057qib7	14206	20	than	than	IN
cord-005453-4057qib7	14206	21	18	18	CD
cord-005453-4057qib7	14206	22	months	month	NNS
cord-005453-4057qib7	14206	23	at	at	IN
cord-005453-4057qib7	14206	24	disease	disease	NN
cord-005453-4057qib7	14206	25	(	(	-LRB-
cord-005453-4057qib7	14206	26	onset	onset	NNP
cord-005453-4057qib7	14206	27	n=56	n=56	NNP
cord-005453-4057qib7	14206	28	)	)	-RRB-
cord-005453-4057qib7	14206	29	,	,	,
cord-005453-4057qib7	14206	30	primary	primary	JJ
cord-005453-4057qib7	14206	31	disseminated	disseminate	VBN
cord-005453-4057qib7	14206	32	disease	disease	NN
cord-005453-4057qib7	14206	33	(	(	-LRB-
cord-005453-4057qib7	14206	34	n=59	n=59	NNP
cord-005453-4057qib7	14206	35	)	)	-RRB-
cord-005453-4057qib7	14206	36	,	,	,
cord-005453-4057qib7	14206	37	unfavorable	unfavorable	JJ
cord-005453-4057qib7	14206	38	biologic	biologic	JJ
cord-005453-4057qib7	14206	39	variant	variant	NN
cord-005453-4057qib7	14206	40	(	(	-LRB-
cord-005453-4057qib7	14206	41	n=29	n=29	NNP
cord-005453-4057qib7	14206	42	)	)	-RRB-
cord-005453-4057qib7	14206	43	,	,	,
cord-005453-4057qib7	14206	44	poor	poor	JJ
cord-005453-4057qib7	14206	45	1	1	CD
cord-005453-4057qib7	14206	46	st	st	NNP
cord-005453-4057qib7	14206	47	-line	-line	HYPH
cord-005453-4057qib7	14206	48	therapy	therapy	NN
cord-005453-4057qib7	14206	49	response	response	NN
cord-005453-4057qib7	14206	50	(	(	-LRB-
cord-005453-4057qib7	14206	51	n=16	n=16	NNP
cord-005453-4057qib7	14206	52	)	)	-RRB-
cord-005453-4057qib7	14206	53	or	or	CC
cord-005453-4057qib7	14206	54	systemic	systemic	JJ
cord-005453-4057qib7	14206	55	relapse	relapse	NN
cord-005453-4057qib7	14206	56	(	(	-LRB-
cord-005453-4057qib7	14206	57	n=9	n=9	NN
cord-005453-4057qib7	14206	58	)	)	-RRB-
cord-005453-4057qib7	14206	59	.	.	.
cord-005453-4057qib7	14207	1	Most	Most	JJS
cord-005453-4057qib7	14207	2	patients	patient	NNS
cord-005453-4057qib7	14207	3	(	(	-LRB-
cord-005453-4057qib7	14207	4	n=75	n=75	NN
cord-005453-4057qib7	14207	5	)	)	-RRB-
cord-005453-4057qib7	14207	6	received	receive	VBN
cord-005453-4057qib7	14207	7	Bu	Bu	NNP
cord-005453-4057qib7	14207	8	-	-	HYPH
cord-005453-4057qib7	14207	9	Mel	Mel	NNP
cord-005453-4057qib7	14207	10	HDCT	HDCT	NNP
cord-005453-4057qib7	14207	11	(	(	-LRB-
cord-005453-4057qib7	14207	12	in	in	IN
cord-005453-4057qib7	14207	13	younger	young	JJR
cord-005453-4057qib7	14207	14	patients	patient	NNS
cord-005453-4057qib7	14207	15	oral	oral	JJ
cord-005453-4057qib7	14207	16	busulfan	busulfan	NN
cord-005453-4057qib7	14207	17	was	be	VBD
cord-005453-4057qib7	14207	18	replaced	replace	VBN
cord-005453-4057qib7	14207	19	by	by	IN
cord-005453-4057qib7	14207	20	Busilvex	Busilvex	NNP
cord-005453-4057qib7	14207	21	)	)	-RRB-
cord-005453-4057qib7	14207	22	,	,	,
cord-005453-4057qib7	14207	23	in	in	IN
cord-005453-4057qib7	14207	24	3	3	CD
cord-005453-4057qib7	14207	25	primary	primary	JJ
cord-005453-4057qib7	14207	26	resistant	resistant	JJ
cord-005453-4057qib7	14207	27	cases	case	NNS
cord-005453-4057qib7	14207	28	a	a	DT
cord-005453-4057qib7	14207	29	5D/5D	5d/5d	CD
cord-005453-4057qib7	14207	30	regimen	regimen	NN
cord-005453-4057qib7	14207	31	was	be	VBD
cord-005453-4057qib7	14207	32	used	use	VBN
cord-005453-4057qib7	14207	33	.	.	.
cord-005453-4057qib7	14208	1	A	a	DT
cord-005453-4057qib7	14208	2	total	total	NN
cord-005453-4057qib7	14208	3	of	of	IN
cord-005453-4057qib7	14208	4	20	20	CD
cord-005453-4057qib7	14208	5	patients	patient	NNS
cord-005453-4057qib7	14208	6	with	with	IN
cord-005453-4057qib7	14208	7	1st	1st	NN
cord-005453-4057qib7	14208	8	(	(	-LRB-
cord-005453-4057qib7	14208	9	n=11	n=11	NNP
cord-005453-4057qib7	14208	10	)	)	-RRB-
cord-005453-4057qib7	14208	11	or	or	CC
cord-005453-4057qib7	14208	12	2nd	2nd	JJ
cord-005453-4057qib7	14208	13	(	(	-LRB-
cord-005453-4057qib7	14208	14	n=2	n=2	NNS
cord-005453-4057qib7	14208	15	)	)	-RRB-
cord-005453-4057qib7	14209	1	chemosensitive	chemosensitive	JJ
cord-005453-4057qib7	14209	2	relapse	relapse	NN
cord-005453-4057qib7	14209	3	,	,	,
cord-005453-4057qib7	14209	4	resistant	resistant	JJ
cord-005453-4057qib7	14209	5	relapse	relapse	NN
cord-005453-4057qib7	14209	6	(	(	-LRB-
cord-005453-4057qib7	14209	7	n=4	n=4	NNS
cord-005453-4057qib7	14209	8	)	)	-RRB-
cord-005453-4057qib7	14209	9	or	or	CC
cord-005453-4057qib7	14209	10	poor	poor	JJ
cord-005453-4057qib7	14209	11	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14209	12	with	with	IN
cord-005453-4057qib7	14209	13	locally	locally	RB
cord-005453-4057qib7	14209	14	advanced	advanced	JJ
cord-005453-4057qib7	14209	15	resistant	resistant	JJ
cord-005453-4057qib7	14209	16	tumor	tumor	NN
cord-005453-4057qib7	14209	17	(	(	-LRB-
cord-005453-4057qib7	14209	18	n=3	n=3	NN
cord-005453-4057qib7	14209	19	)	)	-RRB-
cord-005453-4057qib7	14210	1	received	receive	VBD
cord-005453-4057qib7	14210	2	allo	allo	NN
cord-005453-4057qib7	14210	3	-	-	HYPH
cord-005453-4057qib7	14210	4	HSCT	HSCT	NNP
cord-005453-4057qib7	14210	5	from	from	IN
cord-005453-4057qib7	14210	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14210	7	donor	donor	NN
cord-005453-4057qib7	14210	8	with	with	IN
cord-005453-4057qib7	14210	9	fludarabine	fludarabine	NN
cord-005453-4057qib7	14210	10	-	-	HYPH
cord-005453-4057qib7	14210	11	based	base	VBN
cord-005453-4057qib7	14210	12	RIC	RIC	NNP
cord-005453-4057qib7	14210	13	.	.	.
cord-005453-4057qib7	14211	1	In	in	IN
cord-005453-4057qib7	14211	2	12	12	CD
cord-005453-4057qib7	14211	3	cases	case	NNS
cord-005453-4057qib7	14211	4	the	the	DT
cord-005453-4057qib7	14211	5	transplant	transplant	NN
cord-005453-4057qib7	14211	6	was	be	VBD
cord-005453-4057qib7	14211	7	modified	modify	VBN
cord-005453-4057qib7	14211	8	via	via	IN
cord-005453-4057qib7	14211	9	immunomagnetic	immunomagnetic	JJ
cord-005453-4057qib7	14211	10	positive	positive	JJ
cord-005453-4057qib7	14211	11	or	or	CC
cord-005453-4057qib7	14211	12	negative	negative	JJ
cord-005453-4057qib7	14211	13	selection	selection	NN
cord-005453-4057qib7	14211	14	,	,	,
cord-005453-4057qib7	14211	15	8	8	CD
cord-005453-4057qib7	14211	16	patients	patient	NNS
cord-005453-4057qib7	14211	17	received	receive	VBD
cord-005453-4057qib7	14211	18	post	post	JJ
cord-005453-4057qib7	14211	19	-	-	JJ
cord-005453-4057qib7	14211	20	transplant	transplant	NN
cord-005453-4057qib7	14211	21	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14211	22	(	(	-LRB-
cord-005453-4057qib7	14211	23	post	post	JJ
cord-005453-4057qib7	14211	24	-	-	JJ
cord-005453-4057qib7	14211	25	CY)-based	cy)-based	JJ
cord-005453-4057qib7	14211	26	GVHD	GVHD	NNP
cord-005453-4057qib7	14211	27	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14211	28	.	.	.
cord-005453-4057qib7	14212	1	GVHD	GVHD	NNP
cord-005453-4057qib7	14212	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14212	3	also	also	RB
cord-005453-4057qib7	14212	4	consisted	consist	VBD
cord-005453-4057qib7	14212	5	of	of	IN
cord-005453-4057qib7	14212	6	calceneurin	calceneurin	NNP
cord-005453-4057qib7	14212	7	inhibitors	inhibitor	NNS
cord-005453-4057qib7	14212	8	and	and	CC
cord-005453-4057qib7	14212	9	sirolimus	sirolimus	NN
cord-005453-4057qib7	14212	10	.	.	.
cord-005453-4057qib7	14213	1	Thirteen	thirteen	CD
cord-005453-4057qib7	14213	2	of	of	IN
cord-005453-4057qib7	14213	3	20	20	CD
cord-005453-4057qib7	14213	4	allo	allo	NN
cord-005453-4057qib7	14213	5	-	-	HYPH
cord-005453-4057qib7	14213	6	HSCT	HSCT	NNP
cord-005453-4057qib7	14213	7	recipients	recipient	NNS
cord-005453-4057qib7	14213	8	received	receive	VBD
cord-005453-4057qib7	14213	9	posttransplant	posttransplant	NNP
cord-005453-4057qib7	14213	10	immunoadoptive	immunoadoptive	NNP
cord-005453-4057qib7	14213	11	(	(	-LRB-
cord-005453-4057qib7	14213	12	n=6	n=6	NNP
cord-005453-4057qib7	14213	13	)	)	-RRB-
cord-005453-4057qib7	14213	14	or	or	CC
cord-005453-4057qib7	14213	15	targeted	target	VBN
cord-005453-4057qib7	14213	16	(	(	-LRB-
cord-005453-4057qib7	14213	17	n=7	n=7	JJ
cord-005453-4057qib7	14213	18	)	)	-RRB-
cord-005453-4057qib7	14213	19	therapy	therapy	NN
cord-005453-4057qib7	14213	20	.	.	.
cord-005453-4057qib7	14214	1	Results	result	NNS
cord-005453-4057qib7	14214	2	:	:	:
cord-005453-4057qib7	14215	1	The	the	DT
cord-005453-4057qib7	14215	2	5-year	5-year	CD
cord-005453-4057qib7	14215	3	OS	OS	NNP
cord-005453-4057qib7	14215	4	and	and	CC
cord-005453-4057qib7	14215	5	EFS	efs	NN
cord-005453-4057qib7	14215	6	in	in	IN
cord-005453-4057qib7	14215	7	auto	auto	NN
cord-005453-4057qib7	14215	8	-	-	HYPH
cord-005453-4057qib7	14215	9	HSCT	HSCT	NNP
cord-005453-4057qib7	14215	10	recipients	recipient	NNS
cord-005453-4057qib7	14215	11	was	be	VBD
cord-005453-4057qib7	14215	12	48	48	CD
cord-005453-4057qib7	14215	13	%	%	NN
cord-005453-4057qib7	14215	14	and	and	CC
cord-005453-4057qib7	14215	15	36	36	CD
cord-005453-4057qib7	14215	16	%	%	NN
cord-005453-4057qib7	14215	17	,	,	,
cord-005453-4057qib7	14215	18	accordingly	accordingly	RB
cord-005453-4057qib7	14215	19	.	.	.
cord-005453-4057qib7	14216	1	All	all	DT
cord-005453-4057qib7	14216	2	but	but	IN
cord-005453-4057qib7	14216	3	one	one	CD
cord-005453-4057qib7	14216	4	patient	patient	NN
cord-005453-4057qib7	14216	5	engrafted	engraft	VBD
cord-005453-4057qib7	14216	6	with	with	IN
cord-005453-4057qib7	14216	7	a	a	DT
cord-005453-4057qib7	14216	8	median	median	JJ
cord-005453-4057qib7	14216	9	time	time	NN
cord-005453-4057qib7	14216	10	of	of	IN
cord-005453-4057qib7	14216	11	17	17	CD
cord-005453-4057qib7	14216	12	(	(	-LRB-
cord-005453-4057qib7	14216	13	11	11	CD
cord-005453-4057qib7	14216	14	-	-	SYM
cord-005453-4057qib7	14216	15	51	51	CD
cord-005453-4057qib7	14216	16	)	)	-RRB-
cord-005453-4057qib7	14216	17	days	day	NNS
cord-005453-4057qib7	14216	18	.	.	.
cord-005453-4057qib7	14217	1	Bu	Bu	NNP
cord-005453-4057qib7	14217	2	-	-	HYPH
cord-005453-4057qib7	14217	3	Mel	Mel	NNP
cord-005453-4057qib7	14217	4	regimen	regimen	NN
cord-005453-4057qib7	14217	5	was	be	VBD
cord-005453-4057qib7	14217	6	characterized	characterize	VBN
cord-005453-4057qib7	14217	7	by	by	IN
cord-005453-4057qib7	14217	8	acceptable	acceptable	JJ
cord-005453-4057qib7	14217	9	toxicity	toxicity	NN
cord-005453-4057qib7	14217	10	with	with	IN
cord-005453-4057qib7	14217	11	most	most	JJS
cord-005453-4057qib7	14217	12	common	common	JJ
cord-005453-4057qib7	14217	13	toxicities	toxicity	NNS
cord-005453-4057qib7	14217	14	being	be	VBG
cord-005453-4057qib7	14217	15	oral	oral	JJ
cord-005453-4057qib7	14217	16	mucositis	mucositis	NN
cord-005453-4057qib7	14217	17	and	and	CC
cord-005453-4057qib7	14217	18	infectious	infectious	JJ
cord-005453-4057qib7	14217	19	complications	complication	NNS
cord-005453-4057qib7	14217	20	.	.	.
cord-005453-4057qib7	14218	1	The	the	DT
cord-005453-4057qib7	14218	2	VOD	VOD	NNP
cord-005453-4057qib7	14218	3	/	/	SYM
cord-005453-4057qib7	14218	4	SOS	SOS	NNP
cord-005453-4057qib7	14218	5	incidence	incidence	NN
cord-005453-4057qib7	14218	6	was	be	VBD
cord-005453-4057qib7	14218	7	only	only	RB
cord-005453-4057qib7	14218	8	3	3	CD
cord-005453-4057qib7	14218	9	%	%	NN
cord-005453-4057qib7	14218	10	.	.	.
cord-005453-4057qib7	14219	1	Four	four	CD
cord-005453-4057qib7	14219	2	patients	patient	NNS
cord-005453-4057qib7	14219	3	dies	die	VBZ
cord-005453-4057qib7	14219	4	due	due	IN
cord-005453-4057qib7	14219	5	to	to	IN
cord-005453-4057qib7	14219	6	infection	infection	NN
cord-005453-4057qib7	14219	7	(	(	-LRB-
cord-005453-4057qib7	14219	8	n=2	n=2	NNS
cord-005453-4057qib7	14219	9	)	)	-RRB-
cord-005453-4057qib7	14219	10	,	,	,
cord-005453-4057qib7	14219	11	CNS	CNS	NNP
cord-005453-4057qib7	14219	12	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	14219	13	(	(	-LRB-
cord-005453-4057qib7	14219	14	n=1	n=1	CD
cord-005453-4057qib7	14219	15	)	)	-RRB-
cord-005453-4057qib7	14219	16	,	,	,
cord-005453-4057qib7	14219	17	and	and	CC
cord-005453-4057qib7	14219	18	secondary	secondary	JJ
cord-005453-4057qib7	14219	19	leukemia	leukemia	NN
cord-005453-4057qib7	14219	20	(	(	-LRB-
cord-005453-4057qib7	14219	21	n=1	n=1	NN
cord-005453-4057qib7	14219	22	)	)	-RRB-
cord-005453-4057qib7	14219	23	.	.	.
cord-005453-4057qib7	14220	1	According	accord	VBG
cord-005453-4057qib7	14220	2	to	to	IN
cord-005453-4057qib7	14220	3	multivariate	multivariate	JJ
cord-005453-4057qib7	14220	4	analysis	analysis	NN
cord-005453-4057qib7	14220	5	the	the	DT
cord-005453-4057qib7	14220	6	most	most	RBS
cord-005453-4057qib7	14220	7	important	important	JJ
cord-005453-4057qib7	14220	8	prognostic	prognostic	JJ
cord-005453-4057qib7	14220	9	factors	factor	NNS
cord-005453-4057qib7	14220	10	were	be	VBD
cord-005453-4057qib7	14220	11	response	response	NN
cord-005453-4057qib7	14220	12	to	to	IN
cord-005453-4057qib7	14220	13	1	1	CD
cord-005453-4057qib7	14220	14	st	st	NNP
cord-005453-4057qib7	14220	15	line	line	NN
cord-005453-4057qib7	14220	16	therapy	therapy	NN
cord-005453-4057qib7	14220	17	and	and	CC
cord-005453-4057qib7	14220	18	post	post	VB
cord-005453-4057qib7	14220	19	auto	auto	NN
cord-005453-4057qib7	14220	20	-	-	HYPH
cord-005453-4057qib7	14220	21	HSCT	HSCT	NNP
cord-005453-4057qib7	14220	22	MIBG	MIBG	NNP
cord-005453-4057qib7	14220	23	scan	scan	JJ
cord-005453-4057qib7	14220	24	results	result	NNS
cord-005453-4057qib7	14220	25	.	.	.
cord-005453-4057qib7	14221	1	The	the	DT
cord-005453-4057qib7	14221	2	prognosis	prognosis	NN
cord-005453-4057qib7	14221	3	in	in	IN
cord-005453-4057qib7	14221	4	initially	initially	RB
cord-005453-4057qib7	14221	5	resistant	resistant	JJ
cord-005453-4057qib7	14221	6	patients	patient	NNS
cord-005453-4057qib7	14221	7	with	with	IN
cord-005453-4057qib7	14221	8	good	good	JJ
cord-005453-4057qib7	14221	9	response	response	NN
cord-005453-4057qib7	14221	10	to	to	IN
cord-005453-4057qib7	14221	11	2	2	CD
cord-005453-4057qib7	14221	12	nd	nd	NNP
cord-005453-4057qib7	14221	13	or	or	CC
cord-005453-4057qib7	14221	14	3	3	CD
cord-005453-4057qib7	14221	15	rd	rd	NN
cord-005453-4057qib7	14221	16	-line	-line	NN
cord-005453-4057qib7	14221	17	therapy	therapy	NN
cord-005453-4057qib7	14221	18	was	be	VBD
cord-005453-4057qib7	14221	19	still	still	RB
cord-005453-4057qib7	14221	20	very	very	RB
cord-005453-4057qib7	14221	21	poor	poor	JJ
cord-005453-4057qib7	14222	1	(	(	-LRB-
cord-005453-4057qib7	14222	2	all	all	DT
cord-005453-4057qib7	14222	3	patients	patient	NNS
cord-005453-4057qib7	14222	4	relapsed	relapse	VBD
cord-005453-4057qib7	14222	5	with	with	IN
cord-005453-4057qib7	14222	6	the	the	DT
cord-005453-4057qib7	14222	7	median	median	JJ
cord-005453-4057qib7	14222	8	EFS	efs	NN
cord-005453-4057qib7	14222	9	of	of	IN
cord-005453-4057qib7	14222	10	12	12	CD
cord-005453-4057qib7	14222	11	months	month	NNS
cord-005453-4057qib7	14222	12	)	)	-RRB-
cord-005453-4057qib7	14222	13	.	.	.
cord-005453-4057qib7	14223	1	All	all	DT
cord-005453-4057qib7	14223	2	patients	patient	NNS
cord-005453-4057qib7	14223	3	receiving	receive	VBG
cord-005453-4057qib7	14223	4	a	a	DT
cord-005453-4057qib7	14223	5	second	second	JJ
cord-005453-4057qib7	14223	6	auto	auto	NN
cord-005453-4057qib7	14223	7	-	-	HYPH
cord-005453-4057qib7	14223	8	HSCT	HSCT	NNP
cord-005453-4057qib7	14223	9	after	after	IN
cord-005453-4057qib7	14223	10	relapse	relapse	NN
cord-005453-4057qib7	14223	11	died	die	VBD
cord-005453-4057qib7	14223	12	due	due	IN
cord-005453-4057qib7	14223	13	to	to	IN
cord-005453-4057qib7	14223	14	disease	disease	NN
cord-005453-4057qib7	14223	15	progression	progression	NN
cord-005453-4057qib7	14223	16	.	.	.
cord-005453-4057qib7	14224	1	With	with	IN
cord-005453-4057qib7	14224	2	a	a	DT
cord-005453-4057qib7	14224	3	median	median	NN
cord-005453-4057qib7	14224	4	follow	follow	NN
cord-005453-4057qib7	14224	5	up	up	IN
cord-005453-4057qib7	14224	6	of	of	IN
cord-005453-4057qib7	14224	7	6	6	CD
cord-005453-4057qib7	14224	8	(	(	-LRB-
cord-005453-4057qib7	14224	9	1	1	CD
cord-005453-4057qib7	14224	10	-	-	SYM
cord-005453-4057qib7	14224	11	80	80	CD
cord-005453-4057qib7	14224	12	)	)	-RRB-
cord-005453-4057qib7	14224	13	months	month	NNS
cord-005453-4057qib7	14224	14	9	9	CD
cord-005453-4057qib7	14224	15	allo	allo	NN
cord-005453-4057qib7	14224	16	-	-	HYPH
cord-005453-4057qib7	14224	17	HSCT	HSCT	NNP
cord-005453-4057qib7	14224	18	recipients	recipient	NNS
cord-005453-4057qib7	14224	19	are	be	VBP
cord-005453-4057qib7	14224	20	alive	alive	JJ
cord-005453-4057qib7	14224	21	,	,	,
cord-005453-4057qib7	14224	22	6	6	CD
cord-005453-4057qib7	14224	23	of	of	IN
cord-005453-4057qib7	14224	24	them	-PRON-	PRP
cord-005453-4057qib7	14224	25	with	with	IN
cord-005453-4057qib7	14224	26	no	no	DT
cord-005453-4057qib7	14224	27	signs	sign	NNS
cord-005453-4057qib7	14224	28	of	of	IN
cord-005453-4057qib7	14224	29	disease	disease	NN
cord-005453-4057qib7	14224	30	progression	progression	NN
cord-005453-4057qib7	14224	31	.	.	.
cord-005453-4057qib7	14225	1	All	all	DT
cord-005453-4057qib7	14225	2	long	long	JJ
cord-005453-4057qib7	14225	3	-	-	HYPH
cord-005453-4057qib7	14225	4	term	term	NN
cord-005453-4057qib7	14225	5	responders	responder	NNS
cord-005453-4057qib7	14225	6	received	receive	VBD
cord-005453-4057qib7	14225	7	post	post	JJ
cord-005453-4057qib7	14225	8	-	-	JJ
cord-005453-4057qib7	14225	9	transplant	transplant	JJ
cord-005453-4057qib7	14225	10	therapy	therapy	NN
cord-005453-4057qib7	14225	11	.	.	.
cord-005453-4057qib7	14226	1	One	one	CD
cord-005453-4057qib7	14226	2	patient	patient	NN
cord-005453-4057qib7	14226	3	died	die	VBD
cord-005453-4057qib7	14226	4	due	due	IN
cord-005453-4057qib7	14226	5	to	to	IN
cord-005453-4057qib7	14226	6	transplant	transplant	NN
cord-005453-4057qib7	14226	7	complications	complication	NNS
cord-005453-4057qib7	14226	8	,	,	,
cord-005453-4057qib7	14226	9	other	other	JJ
cord-005453-4057qib7	14226	10	deaths	death	NNS
cord-005453-4057qib7	14226	11	were	be	VBD
cord-005453-4057qib7	14226	12	caused	cause	VBN
cord-005453-4057qib7	14226	13	by	by	IN
cord-005453-4057qib7	14226	14	disease	disease	NN
cord-005453-4057qib7	14226	15	progression	progression	NN
cord-005453-4057qib7	14226	16	.	.	.
cord-005453-4057qib7	14227	1	There	there	EX
cord-005453-4057qib7	14227	2	was	be	VBD
cord-005453-4057qib7	14227	3	no	no	DT
cord-005453-4057qib7	14227	4	obvious	obvious	JJ
cord-005453-4057qib7	14227	5	difference	difference	NN
cord-005453-4057qib7	14227	6	between	between	IN
cord-005453-4057qib7	14227	7	outcomes	outcome	NNS
cord-005453-4057qib7	14227	8	in	in	IN
cord-005453-4057qib7	14227	9	post	post	JJ
cord-005453-4057qib7	14227	10	-	-	JJ
cord-005453-4057qib7	14227	11	CY	CY	NNP
cord-005453-4057qib7	14227	12	based	base	VBN
cord-005453-4057qib7	14227	13	and	and	CC
cord-005453-4057qib7	14227	14	transplant	transplant	NN
cord-005453-4057qib7	14227	15	modification	modification	NN
cord-005453-4057qib7	14227	16	-	-	HYPH
cord-005453-4057qib7	14227	17	based	base	VBN
cord-005453-4057qib7	14227	18	transplantations	transplantation	NNS
cord-005453-4057qib7	14227	19	.	.	.
cord-005453-4057qib7	14228	1	aGVHD	aGVHD	NNP
cord-005453-4057qib7	14228	2	more	more	RBR
cord-005453-4057qib7	14228	3	often	often	RB
cord-005453-4057qib7	14228	4	developed	develop	VBN
cord-005453-4057qib7	14228	5	in	in	IN
cord-005453-4057qib7	14228	6	modified	modify	VBN
cord-005453-4057qib7	14228	7	transplant	transplant	NN
cord-005453-4057qib7	14228	8	recipients	recipient	NNS
cord-005453-4057qib7	14228	9	(	(	-LRB-
cord-005453-4057qib7	14228	10	8	8	CD
cord-005453-4057qib7	14228	11	patients	patient	NNS
cord-005453-4057qib7	14228	12	vs	vs	IN
cord-005453-4057qib7	14228	13	2	2	CD
cord-005453-4057qib7	14228	14	in	in	IN
cord-005453-4057qib7	14228	15	post	post	JJ
cord-005453-4057qib7	14228	16	-	-	JJ
cord-005453-4057qib7	14228	17	CY	CY	NNP
cord-005453-4057qib7	14228	18	group	group	NN
cord-005453-4057qib7	14228	19	,	,	,
cord-005453-4057qib7	14228	20	4	4	CD
cord-005453-4057qib7	14228	21	of	of	IN
cord-005453-4057qib7	14228	22	these	these	DT
cord-005453-4057qib7	14228	23	cases	case	NNS
cord-005453-4057qib7	14228	24	Gr	Gr	NNP
cord-005453-4057qib7	14228	25	III	III	NNP
cord-005453-4057qib7	14228	26	-	-	HYPH
cord-005453-4057qib7	14228	27	IV	IV	NNP
cord-005453-4057qib7	14228	28	)	)	-RRB-
cord-005453-4057qib7	14228	29	,	,	,
cord-005453-4057qib7	14228	30	3	3	CD
cord-005453-4057qib7	14228	31	patients	patient	NNS
cord-005453-4057qib7	14228	32	in	in	IN
cord-005453-4057qib7	14228	33	post	post	JJ
cord-005453-4057qib7	14228	34	-	-	JJ
cord-005453-4057qib7	14228	35	CY	CY	NNP
cord-005453-4057qib7	14228	36	group	group	NN
cord-005453-4057qib7	14228	37	had	have	VBD
cord-005453-4057qib7	14228	38	Grade	Grade	NNP
cord-005453-4057qib7	14228	39	III	III	NNP
cord-005453-4057qib7	14228	40	-	-	HYPH
cord-005453-4057qib7	14228	41	IV	IV	NNP
cord-005453-4057qib7	14228	42	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	14228	43	cystitis	cystitis	NN
cord-005453-4057qib7	14228	44	.	.	.
cord-005453-4057qib7	14229	1	The	the	DT
cord-005453-4057qib7	14229	2	median	median	JJ
cord-005453-4057qib7	14229	3	time	time	NN
cord-005453-4057qib7	14229	4	to	to	IN
cord-005453-4057qib7	14229	5	engraftment	engraftment	NN
cord-005453-4057qib7	14229	6	was	be	VBD
cord-005453-4057qib7	14229	7	longer	long	JJR
cord-005453-4057qib7	14229	8	for	for	IN
cord-005453-4057qib7	14229	9	PTCM	PTCM	NNP
cord-005453-4057qib7	14229	10	group	group	NN
cord-005453-4057qib7	14229	11	compared	compare	VBN
cord-005453-4057qib7	14229	12	to	to	IN
cord-005453-4057qib7	14229	13	transplant	transplant	NN
cord-005453-4057qib7	14229	14	modification	modification	NN
cord-005453-4057qib7	14229	15	group	group	NN
cord-005453-4057qib7	14229	16	(	(	-LRB-
cord-005453-4057qib7	14229	17	D	d	NN
cord-005453-4057qib7	14229	18	+23	+23	NNS
cord-005453-4057qib7	14229	19	vs.	vs.	FW
cord-005453-4057qib7	14229	20	D+17	d+17	NN
cord-005453-4057qib7	14229	21	,	,	,
cord-005453-4057qib7	14229	22	accordingly	accordingly	RB
cord-005453-4057qib7	14229	23	)	)	-RRB-
cord-005453-4057qib7	14229	24	.	.	.
cord-005453-4057qib7	14230	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14230	2	:	:	:
cord-005453-4057qib7	14231	1	While	while	IN
cord-005453-4057qib7	14231	2	single	single	JJ
cord-005453-4057qib7	14231	3	HSCT	HSCT	NNP
cord-005453-4057qib7	14231	4	with	with	IN
cord-005453-4057qib7	14231	5	auto	auto	NN
cord-005453-4057qib7	14231	6	-	-	HYPH
cord-005453-4057qib7	14231	7	HSCT	HSCT	NNP
cord-005453-4057qib7	14231	8	is	be	VBZ
cord-005453-4057qib7	14231	9	a	a	DT
cord-005453-4057qib7	14231	10	golden	golden	JJ
cord-005453-4057qib7	14231	11	standard	standard	NN
cord-005453-4057qib7	14231	12	in	in	IN
cord-005453-4057qib7	14231	13	HR	HR	NNP
cord-005453-4057qib7	14231	14	NB	NB	NNP
cord-005453-4057qib7	14231	15	patients	patient	NNS
cord-005453-4057qib7	14231	16	,	,	,
cord-005453-4057qib7	14231	17	the	the	DT
cord-005453-4057qib7	14231	18	relapse	relapse	NN
cord-005453-4057qib7	14231	19	rate	rate	NN
cord-005453-4057qib7	14231	20	is	be	VBZ
cord-005453-4057qib7	14231	21	still	still	RB
cord-005453-4057qib7	14231	22	high	high	JJ
cord-005453-4057qib7	14231	23	and	and	CC
cord-005453-4057qib7	14231	24	the	the	DT
cord-005453-4057qib7	14231	25	prognosis	prognosis	NN
cord-005453-4057qib7	14231	26	in	in	IN
cord-005453-4057qib7	14231	27	relapsed	relapse	VBN
cord-005453-4057qib7	14231	28	/	/	SYM
cord-005453-4057qib7	14231	29	refractory	refractory	JJ
cord-005453-4057qib7	14231	30	patients	patient	NNS
cord-005453-4057qib7	14231	31	is	be	VBZ
cord-005453-4057qib7	14231	32	dismal	dismal	JJ
cord-005453-4057qib7	14231	33	.	.	.
cord-005453-4057qib7	14232	1	The	the	DT
cord-005453-4057qib7	14232	2	allografting	allografting	NN
cord-005453-4057qib7	14232	3	has	have	VBZ
cord-005453-4057qib7	14232	4	some	some	DT
cord-005453-4057qib7	14232	5	limited	limited	JJ
cord-005453-4057qib7	14232	6	effectiveness	effectiveness	NN
cord-005453-4057qib7	14232	7	in	in	IN
cord-005453-4057qib7	14232	8	these	these	DT
cord-005453-4057qib7	14232	9	cases	case	NNS
cord-005453-4057qib7	14232	10	and	and	CC
cord-005453-4057qib7	14232	11	post	post	JJ
cord-005453-4057qib7	14232	12	-	-	JJ
cord-005453-4057qib7	14232	13	transplant	transplant	NN
cord-005453-4057qib7	14232	14	therapy	therapy	NN
cord-005453-4057qib7	14232	15	has	have	VBZ
cord-005453-4057qib7	14232	16	a	a	DT
cord-005453-4057qib7	14232	17	potential	potential	NN
cord-005453-4057qib7	14232	18	for	for	IN
cord-005453-4057qib7	14232	19	further	further	JJ
cord-005453-4057qib7	14232	20	improvement	improvement	NN
cord-005453-4057qib7	14232	21	.	.	.
cord-005453-4057qib7	14233	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14233	2	:	:	:
cord-005453-4057qib7	14233	3	Nothing	nothing	NN
cord-005453-4057qib7	14233	4	to	to	TO
cord-005453-4057qib7	14233	5	declare	declare	VB
cord-005453-4057qib7	14233	6	P654	P654	NNP
cord-005453-4057qib7	14233	7	Abstract	Abstract	NNP
cord-005453-4057qib7	14233	8	already	already	RB
cord-005453-4057qib7	14233	9	published	publish	VBN
cord-005453-4057qib7	14233	10	.	.	.
cord-005453-4057qib7	14234	1	Veno	Veno	NNP
cord-005453-4057qib7	14234	2	-	-	HYPH
cord-005453-4057qib7	14234	3	occlusive	occlusive	JJ
cord-005453-4057qib7	14234	4	liver	liver	NN
cord-005453-4057qib7	14234	5	disease	disease	NN
cord-005453-4057qib7	14234	6	(	(	-LRB-
cord-005453-4057qib7	14234	7	VOD	VOD	NNP
cord-005453-4057qib7	14234	8	)	)	-RRB-
cord-005453-4057qib7	14234	9	is	be	VBZ
cord-005453-4057qib7	14234	10	frequent	frequent	JJ
cord-005453-4057qib7	14234	11	but	but	CC
cord-005453-4057qib7	14234	12	well	well	RB
cord-005453-4057qib7	14234	13	treatable	treatable	JJ
cord-005453-4057qib7	14234	14	with	with	IN
cord-005453-4057qib7	14234	15	early	early	JJ
cord-005453-4057qib7	14234	16	defibrotide	defibrotide	NNP
cord-005453-4057qib7	14234	17	administration	administration	NN
cord-005453-4057qib7	14234	18	in	in	IN
cord-005453-4057qib7	14234	19	children	child	NNS
cord-005453-4057qib7	14234	20	with	with	IN
cord-005453-4057qib7	14234	21	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14234	22	receiving	receive	VBG
cord-005453-4057qib7	14234	23	high	high	JJ
cord-005453-4057qib7	14234	24	-	-	HYPH
cord-005453-4057qib7	14234	25	dose	dose	NN
cord-005453-4057qib7	14234	26	busulfan	busulfan	NN
cord-005453-4057qib7	14234	27	and	and	CC
cord-005453-4057qib7	14234	28	melphalan	melphalan	NNP
cord-005453-4057qib7	14234	29	Background	Background	NNP
cord-005453-4057qib7	14234	30	:	:	:
cord-005453-4057qib7	14234	31	Using	use	VBG
cord-005453-4057qib7	14234	32	high	high	JJ
cord-005453-4057qib7	14234	33	-	-	HYPH
cord-005453-4057qib7	14234	34	dose	dose	NN
cord-005453-4057qib7	14234	35	intravenous	intravenous	JJ
cord-005453-4057qib7	14234	36	busulfan	busulfan	NN
cord-005453-4057qib7	14234	37	and	and	CC
cord-005453-4057qib7	14234	38	melphalan	melphalan	NNP
cord-005453-4057qib7	14235	1	(	(	-LRB-
cord-005453-4057qib7	14235	2	BuMel	BuMel	NNP
cord-005453-4057qib7	14235	3	)	)	-RRB-
cord-005453-4057qib7	14235	4	prior	prior	RB
cord-005453-4057qib7	14235	5	to	to	IN
cord-005453-4057qib7	14235	6	autologous	autologous	JJ
cord-005453-4057qib7	14235	7	stem	stem	NN
cord-005453-4057qib7	14235	8	cell	cell	NN
cord-005453-4057qib7	14235	9	transplantation	transplantation	NN
cord-005453-4057qib7	14235	10	(	(	-LRB-
cord-005453-4057qib7	14235	11	SCT	SCT	NNP
cord-005453-4057qib7	14235	12	)	)	-RRB-
cord-005453-4057qib7	14235	13	in	in	IN
cord-005453-4057qib7	14235	14	children	child	NNS
cord-005453-4057qib7	14235	15	with	with	IN
cord-005453-4057qib7	14235	16	high	high	JJ
cord-005453-4057qib7	14235	17	-	-	HYPH
cord-005453-4057qib7	14235	18	risk	risk	NN
cord-005453-4057qib7	14235	19	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14235	20	,	,	,
cord-005453-4057qib7	14235	21	seems	seem	VBZ
cord-005453-4057qib7	14235	22	to	to	TO
cord-005453-4057qib7	14235	23	decrease	decrease	VB
cord-005453-4057qib7	14235	24	toxicity	toxicity	NN
cord-005453-4057qib7	14235	25	of	of	IN
cord-005453-4057qib7	14235	26	the	the	DT
cord-005453-4057qib7	14235	27	myeloablative	myeloablative	JJ
cord-005453-4057qib7	14235	28	regimen	regimen	NN
cord-005453-4057qib7	14235	29	,	,	,
cord-005453-4057qib7	14235	30	except	except	IN
cord-005453-4057qib7	14235	31	for	for	IN
cord-005453-4057qib7	14235	32	VOD	VOD	NNP
cord-005453-4057qib7	14235	33	.	.	.
cord-005453-4057qib7	14236	1	In	in	IN
cord-005453-4057qib7	14236	2	this	this	DT
cord-005453-4057qib7	14236	3	multicenter	multicenter	JJ
cord-005453-4057qib7	14236	4	retrospective	retrospective	JJ
cord-005453-4057qib7	14236	5	study	study	NN
cord-005453-4057qib7	14236	6	we	-PRON-	PRP
cord-005453-4057qib7	14236	7	aimed	aim	VBD
cord-005453-4057qib7	14236	8	to	to	TO
cord-005453-4057qib7	14236	9	assess	assess	VB
cord-005453-4057qib7	14236	10	the	the	DT
cord-005453-4057qib7	14236	11	outcome	outcome	NN
cord-005453-4057qib7	14236	12	of	of	IN
cord-005453-4057qib7	14236	13	BuMel	BuMel	NNP
cord-005453-4057qib7	14236	14	-	-	HYPH
cord-005453-4057qib7	14236	15	associated	associate	VBN
cord-005453-4057qib7	14236	16	VOD	VOD	NNP
cord-005453-4057qib7	14236	17	with	with	IN
cord-005453-4057qib7	14236	18	early	early	JJ
cord-005453-4057qib7	14236	19	defibrotide	defibrotide	NN
cord-005453-4057qib7	14236	20	treatment	treatment	NN
cord-005453-4057qib7	14236	21	intervention	intervention	NN
cord-005453-4057qib7	14236	22	.	.	.
cord-005453-4057qib7	14237	1	Methods	method	NNS
cord-005453-4057qib7	14237	2	:	:	:
cord-005453-4057qib7	14237	3	We	-PRON-	PRP
cord-005453-4057qib7	14237	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	14237	5	analyzed	analyze	VBD
cord-005453-4057qib7	14237	6	64	64	CD
cord-005453-4057qib7	14237	7	children	child	NNS
cord-005453-4057qib7	14237	8	with	with	IN
cord-005453-4057qib7	14237	9	high	high	JJ
cord-005453-4057qib7	14237	10	-	-	HYPH
cord-005453-4057qib7	14237	11	risk	risk	NN
cord-005453-4057qib7	14237	12	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14237	13	who	who	WP
cord-005453-4057qib7	14237	14	underwent	undergo	VBD
cord-005453-4057qib7	14237	15	autologous	autologous	JJ
cord-005453-4057qib7	14237	16	SCT	SCT	NNP
cord-005453-4057qib7	14237	17	with	with	IN
cord-005453-4057qib7	14237	18	i.v	i.v	NNP
cord-005453-4057qib7	14237	19	.	.	.
cord-005453-4057qib7	14238	1	BuMel	BuMel	NNP
cord-005453-4057qib7	14238	2	regimen	regimen	NN
cord-005453-4057qib7	14238	3	in	in	IN
cord-005453-4057qib7	14238	4	Slovakia	Slovakia	NNP
cord-005453-4057qib7	14238	5	and	and	CC
cord-005453-4057qib7	14238	6	Prague	Prague	NNP
cord-005453-4057qib7	14238	7	,	,	,
cord-005453-4057qib7	14238	8	Czech	Czech	NNP
cord-005453-4057qib7	14238	9	Republic	Republic	NNP
cord-005453-4057qib7	14238	10	in	in	IN
cord-005453-4057qib7	14238	11	the	the	DT
cord-005453-4057qib7	14238	12	period	period	NN
cord-005453-4057qib7	14239	1	1/2008	1/2008	LS
cord-005453-4057qib7	14240	1	-10/2018	-10/2018	:
cord-005453-4057qib7	14240	2	.	.	.
cord-005453-4057qib7	14241	1	Busulfan	Busulfan	NNP
cord-005453-4057qib7	14241	2	was	be	VBD
cord-005453-4057qib7	14241	3	administered	administer	VBN
cord-005453-4057qib7	14241	4	in	in	IN
cord-005453-4057qib7	14241	5	q6	q6	NNP
cord-005453-4057qib7	14241	6	hour	hour	NN
cord-005453-4057qib7	14241	7	schedule	schedule	NN
cord-005453-4057qib7	14241	8	,	,	,
cord-005453-4057qib7	14241	9	with	with	IN
cord-005453-4057qib7	14241	10	therapeutic	therapeutic	JJ
cord-005453-4057qib7	14241	11	drug	drug	NN
cord-005453-4057qib7	14241	12	level	level	NN
cord-005453-4057qib7	14241	13	monitoring	monitoring	NN
cord-005453-4057qib7	14241	14	in	in	IN
cord-005453-4057qib7	14241	15	84	84	CD
cord-005453-4057qib7	14241	16	%	%	NN
cord-005453-4057qib7	14241	17	of	of	IN
cord-005453-4057qib7	14241	18	patients	patient	NNS
cord-005453-4057qib7	14241	19	.	.	.
cord-005453-4057qib7	14242	1	All	all	DT
cord-005453-4057qib7	14242	2	VOD	VOD	NNP
cord-005453-4057qib7	14242	3	patients	patient	NNS
cord-005453-4057qib7	14242	4	except	except	IN
cord-005453-4057qib7	14242	5	one	one	CD
cord-005453-4057qib7	14242	6	were	be	VBD
cord-005453-4057qib7	14242	7	treated	treat	VBN
cord-005453-4057qib7	14242	8	with	with	IN
cord-005453-4057qib7	14242	9	defibrotide	defibrotide	NN
cord-005453-4057qib7	14242	10	starting	start	VBG
cord-005453-4057qib7	14242	11	at	at	IN
cord-005453-4057qib7	14242	12	a	a	DT
cord-005453-4057qib7	14242	13	standard	standard	JJ
cord-005453-4057qib7	14242	14	dose	dose	NN
cord-005453-4057qib7	14242	15	of	of	IN
cord-005453-4057qib7	14242	16	25	25	CD
cord-005453-4057qib7	14242	17	mg	mg	NNP
cord-005453-4057qib7	14242	18	/	/	SYM
cord-005453-4057qib7	14242	19	kg	kg	NNP
cord-005453-4057qib7	14242	20	/	/	SYM
cord-005453-4057qib7	14242	21	day	day	NN
cord-005453-4057qib7	14242	22	,	,	,
cord-005453-4057qib7	14242	23	given	give	VBN
cord-005453-4057qib7	14242	24	in	in	IN
cord-005453-4057qib7	14242	25	4	4	CD
cord-005453-4057qib7	14242	26	doses	dose	NNS
cord-005453-4057qib7	14242	27	per	per	IN
cord-005453-4057qib7	14242	28	day	day	NN
cord-005453-4057qib7	14242	29	.	.	.
cord-005453-4057qib7	14243	1	1	1	CD
cord-005453-4057qib7	14243	2	patient	patient	NN
cord-005453-4057qib7	14243	3	was	be	VBD
cord-005453-4057qib7	14243	4	treated	treat	VBN
cord-005453-4057qib7	14243	5	with	with	IN
cord-005453-4057qib7	14243	6	supportive	supportive	JJ
cord-005453-4057qib7	14243	7	therapy	therapy	NN
cord-005453-4057qib7	14243	8	only	only	RB
cord-005453-4057qib7	14243	9	.	.	.
cord-005453-4057qib7	14244	1	Ursodeoxycholic	ursodeoxycholic	JJ
cord-005453-4057qib7	14244	2	acid	acid	NN
cord-005453-4057qib7	14244	3	was	be	VBD
cord-005453-4057qib7	14244	4	used	use	VBN
cord-005453-4057qib7	14244	5	as	as	IN
cord-005453-4057qib7	14244	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14244	7	in	in	IN
cord-005453-4057qib7	14244	8	all	all	DT
cord-005453-4057qib7	14244	9	patients	patient	NNS
cord-005453-4057qib7	14244	10	.	.	.
cord-005453-4057qib7	14245	1	VOD	VOD	NNP
cord-005453-4057qib7	14245	2	was	be	VBD
cord-005453-4057qib7	14245	3	established	establish	VBN
cord-005453-4057qib7	14245	4	using	use	VBG
cord-005453-4057qib7	14245	5	the	the	DT
cord-005453-4057qib7	14245	6	modified	modify	VBN
cord-005453-4057qib7	14245	7	Seattle	Seattle	NNP
cord-005453-4057qib7	14245	8	clinical	clinical	JJ
cord-005453-4057qib7	14245	9	criteria	criterion	NNS
cord-005453-4057qib7	14245	10	(	(	-LRB-
cord-005453-4057qib7	14245	11	Corbacioglu	Corbacioglu	NNP
cord-005453-4057qib7	14245	12	,	,	,
cord-005453-4057qib7	14245	13	Lancet	Lancet	NNP
cord-005453-4057qib7	14245	14	2012	2012	CD
cord-005453-4057qib7	14245	15	)	)	-RRB-
cord-005453-4057qib7	14245	16	.	.	.
cord-005453-4057qib7	14246	1	Results	result	NNS
cord-005453-4057qib7	14246	2	:	:	:
cord-005453-4057qib7	14247	1	The	the	DT
cord-005453-4057qib7	14247	2	incidence	incidence	NN
cord-005453-4057qib7	14247	3	of	of	IN
cord-005453-4057qib7	14247	4	VOD	VOD	NNP
cord-005453-4057qib7	14247	5	was	be	VBD
cord-005453-4057qib7	14247	6	23	23	CD
cord-005453-4057qib7	14247	7	%	%	NN
cord-005453-4057qib7	14247	8	(	(	-LRB-
cord-005453-4057qib7	14247	9	15/64	15/64	CD
cord-005453-4057qib7	14247	10	)	)	-RRB-
cord-005453-4057qib7	14247	11	in	in	IN
cord-005453-4057qib7	14247	12	patients	patient	NNS
cord-005453-4057qib7	14247	13	treated	treat	VBN
cord-005453-4057qib7	14247	14	with	with	IN
cord-005453-4057qib7	14247	15	intravenous	intravenous	JJ
cord-005453-4057qib7	14247	16	busulfan	busulfan	NN
cord-005453-4057qib7	14247	17	and	and	CC
cord-005453-4057qib7	14247	18	melphalan	melphalan	NNP
cord-005453-4057qib7	14247	19	.	.	.
cord-005453-4057qib7	14248	1	There	there	EX
cord-005453-4057qib7	14248	2	was	be	VBD
cord-005453-4057qib7	14248	3	no	no	DT
cord-005453-4057qib7	14248	4	significant	significant	JJ
cord-005453-4057qib7	14248	5	difference	difference	NN
cord-005453-4057qib7	14248	6	in	in	IN
cord-005453-4057qib7	14248	7	busulfan	busulfan	NN
cord-005453-4057qib7	14248	8	total	total	JJ
cord-005453-4057qib7	14248	9	dose	dose	NN
cord-005453-4057qib7	14248	10	/	/	SYM
cord-005453-4057qib7	14248	11	kg	kg	NNS
cord-005453-4057qib7	14248	12	between	between	IN
cord-005453-4057qib7	14248	13	patients	patient	NNS
cord-005453-4057qib7	14248	14	with	with	IN
cord-005453-4057qib7	14248	15	(	(	-LRB-
cord-005453-4057qib7	14248	16	19.2	19.2	CD
cord-005453-4057qib7	14248	17	mg	mg	NNP
cord-005453-4057qib7	14248	18	/	/	SYM
cord-005453-4057qib7	14248	19	kg	kg	NNP
cord-005453-4057qib7	14248	20	(	(	-LRB-
cord-005453-4057qib7	14248	21	SD=1,8	SD=1,8	NNP
cord-005453-4057qib7	14248	22	)	)	-RRB-
cord-005453-4057qib7	14248	23	)	)	-RRB-
cord-005453-4057qib7	14248	24	and	and	CC
cord-005453-4057qib7	14248	25	without	without	IN
cord-005453-4057qib7	14248	26	(	(	-LRB-
cord-005453-4057qib7	14248	27	18.0	18.0	CD
cord-005453-4057qib7	14248	28	mg	mg	NNP
cord-005453-4057qib7	14248	29	/	/	SYM
cord-005453-4057qib7	14248	30	kg	kg	NNP
cord-005453-4057qib7	14248	31	(	(	-LRB-
cord-005453-4057qib7	14248	32	SD=2,4	sd=2,4	NN
cord-005453-4057qib7	14248	33	)	)	-RRB-
cord-005453-4057qib7	14248	34	)	)	-RRB-
cord-005453-4057qib7	14249	1	VOD	VOD	NNP
cord-005453-4057qib7	14249	2	manifestation	manifestation	NN
cord-005453-4057qib7	14249	3	.	.	.
cord-005453-4057qib7	14250	1	VOD	VOD	NNP
cord-005453-4057qib7	14250	2	developed	develop	VBD
cord-005453-4057qib7	14250	3	at	at	IN
cord-005453-4057qib7	14250	4	a	a	DT
cord-005453-4057qib7	14250	5	median	median	NN
cord-005453-4057qib7	14250	6	of	of	IN
cord-005453-4057qib7	14250	7	17	17	CD
cord-005453-4057qib7	14250	8	days	day	NNS
cord-005453-4057qib7	14250	9	after	after	IN
cord-005453-4057qib7	14250	10	SCT	SCT	NNP
cord-005453-4057qib7	14250	11	(	(	-LRB-
cord-005453-4057qib7	14250	12	range	range	VBP
cord-005453-4057qib7	14250	13	11	11	CD
cord-005453-4057qib7	14250	14	-22	-22	CD
cord-005453-4057qib7	14250	15	days	day	NNS
cord-005453-4057qib7	14250	16	)	)	-RRB-
cord-005453-4057qib7	14250	17	.	.	.
cord-005453-4057qib7	14251	1	Anicteric	Anicteric	NNP
cord-005453-4057qib7	14251	2	forms	form	NNS
cord-005453-4057qib7	14251	3	of	of	IN
cord-005453-4057qib7	14251	4	VOD	VOD	NNP
cord-005453-4057qib7	14251	5	were	be	VBD
cord-005453-4057qib7	14251	6	documented	document	VBN
cord-005453-4057qib7	14251	7	,	,	,
cord-005453-4057qib7	14251	8	although	although	IN
cord-005453-4057qib7	14251	9	73	73	CD
cord-005453-4057qib7	14251	10	%	%	NN
cord-005453-4057qib7	14251	11	patients	patient	NNS
cord-005453-4057qib7	14251	12	with	with	IN
cord-005453-4057qib7	14251	13	VOD	VOD	NNP
cord-005453-4057qib7	14251	14	(	(	-LRB-
cord-005453-4057qib7	14251	15	11/15	11/15	CD
cord-005453-4057qib7	14251	16	)	)	-RRB-
cord-005453-4057qib7	14251	17	presented	present	VBN
cord-005453-4057qib7	14251	18	with	with	IN
cord-005453-4057qib7	14251	19	increased	increase	VBN
cord-005453-4057qib7	14251	20	bilirubin	bilirubin	NN
cord-005453-4057qib7	14251	21	.	.	.
cord-005453-4057qib7	14252	1	73	73	CD
cord-005453-4057qib7	14252	2	%	%	NN
cord-005453-4057qib7	14252	3	patients	patient	NNS
cord-005453-4057qib7	14252	4	with	with	IN
cord-005453-4057qib7	14252	5	VOD	VOD	NNP
cord-005453-4057qib7	14252	6	(	(	-LRB-
cord-005453-4057qib7	14252	7	11/15	11/15	CD
cord-005453-4057qib7	14252	8	)	)	-RRB-
cord-005453-4057qib7	14252	9	developed	develop	VBN
cord-005453-4057qib7	14252	10	ascites	ascites	NN
cord-005453-4057qib7	14252	11	but	but	CC
cord-005453-4057qib7	14252	12	only	only	RB
cord-005453-4057qib7	14252	13	4	4	CD
cord-005453-4057qib7	14252	14	patients	patient	NNS
cord-005453-4057qib7	14252	15	(	(	-LRB-
cord-005453-4057qib7	14252	16	27	27	CD
cord-005453-4057qib7	14252	17	%	%	NN
cord-005453-4057qib7	14252	18	)	)	-RRB-
cord-005453-4057qib7	14253	1	required	required	NNP
cord-005453-4057qib7	14253	2	ascites	ascites	NN
cord-005453-4057qib7	14253	3	drainage	drainage	NN
cord-005453-4057qib7	14253	4	.	.	.
cord-005453-4057qib7	14254	1	No	no	DT
cord-005453-4057qib7	14254	2	VOD	VOD	NNP
cord-005453-4057qib7	14254	3	patient	patient	NN
cord-005453-4057qib7	14254	4	received	receive	VBD
cord-005453-4057qib7	14254	5	renal	renal	JJ
cord-005453-4057qib7	14254	6	replacement	replacement	NN
cord-005453-4057qib7	14254	7	therapy	therapy	NN
cord-005453-4057qib7	14254	8	and	and	CC
cord-005453-4057qib7	14254	9	only	only	RB
cord-005453-4057qib7	14254	10	one	one	CD
cord-005453-4057qib7	14254	11	needed	need	VBN
cord-005453-4057qib7	14254	12	mechanical	mechanical	JJ
cord-005453-4057qib7	14254	13	ventilation	ventilation	NN
cord-005453-4057qib7	14254	14	.	.	.
cord-005453-4057qib7	14255	1	Importantly	importantly	RB
cord-005453-4057qib7	14255	2	,	,	,
cord-005453-4057qib7	14255	3	we	-PRON-	PRP
cord-005453-4057qib7	14255	4	successfully	successfully	RB
cord-005453-4057qib7	14255	5	treated	treat	VBD
cord-005453-4057qib7	14255	6	VOD	VOD	NNP
cord-005453-4057qib7	14255	7	in	in	IN
cord-005453-4057qib7	14255	8	all	all	DT
cord-005453-4057qib7	14255	9	patients	patient	NNS
cord-005453-4057qib7	14255	10	.	.	.
cord-005453-4057qib7	14256	1	Relapse	relapse	NN
cord-005453-4057qib7	14256	2	or	or	CC
cord-005453-4057qib7	14256	3	progression	progression	NN
cord-005453-4057qib7	14256	4	of	of	IN
cord-005453-4057qib7	14256	5	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14256	6	was	be	VBD
cord-005453-4057qib7	14256	7	the	the	DT
cord-005453-4057qib7	14256	8	cause	cause	NN
cord-005453-4057qib7	14256	9	of	of	IN
cord-005453-4057qib7	14256	10	death	death	NN
cord-005453-4057qib7	14256	11	in	in	IN
cord-005453-4057qib7	14256	12	4	4	CD
cord-005453-4057qib7	14256	13	VOD	VOD	NNP
cord-005453-4057qib7	14256	14	patients	patient	NNS
cord-005453-4057qib7	14256	15	(	(	-LRB-
cord-005453-4057qib7	14256	16	27	27	CD
cord-005453-4057qib7	14256	17	%	%	NN
cord-005453-4057qib7	14256	18	)	)	-RRB-
cord-005453-4057qib7	14256	19	who	who	WP
cord-005453-4057qib7	14256	20	died	die	VBD
cord-005453-4057qib7	14256	21	.	.	.
cord-005453-4057qib7	14257	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14257	2	:	:	:
cord-005453-4057qib7	14258	1	Despite	despite	IN
cord-005453-4057qib7	14258	2	targeting	target	VBG
cord-005453-4057qib7	14258	3	busulfan	busulfan	NN
cord-005453-4057qib7	14258	4	levels	level	NNS
cord-005453-4057qib7	14258	5	to	to	TO
cord-005453-4057qib7	14258	6	decrease	decrease	VB
cord-005453-4057qib7	14258	7	toxicity	toxicity	NN
cord-005453-4057qib7	14258	8	of	of	IN
cord-005453-4057qib7	14258	9	the	the	DT
cord-005453-4057qib7	14258	10	regimen	regimen	NN
cord-005453-4057qib7	14258	11	,	,	,
cord-005453-4057qib7	14258	12	VOD	VOD	NNP
cord-005453-4057qib7	14258	13	is	be	VBZ
cord-005453-4057qib7	14258	14	common	common	JJ
cord-005453-4057qib7	14259	1	(	(	-LRB-
cord-005453-4057qib7	14259	2	we	-PRON-	PRP
cord-005453-4057qib7	14259	3	observed	observe	VBD
cord-005453-4057qib7	14259	4	VOD	VOD	NNP
cord-005453-4057qib7	14259	5	incidence	incidence	NN
cord-005453-4057qib7	14259	6	exactly	exactly	RB
cord-005453-4057qib7	14259	7	in	in	IN
cord-005453-4057qib7	14259	8	the	the	DT
cord-005453-4057qib7	14259	9	range	range	NN
cord-005453-4057qib7	14259	10	of	of	IN
cord-005453-4057qib7	14259	11	the	the	DT
cord-005453-4057qib7	14259	12	SIOPEN	SIOPEN	NNP
cord-005453-4057qib7	14259	13	HR	HR	NNP
cord-005453-4057qib7	14259	14	NBL-1	NBL-1	NNP
cord-005453-4057qib7	14259	15	multicenter	multicenter	JJ
cord-005453-4057qib7	14259	16	study	study	NN
cord-005453-4057qib7	14259	17	(	(	-LRB-
cord-005453-4057qib7	14259	18	Ladenstein	Ladenstein	NNP
cord-005453-4057qib7	14259	19	,	,	,
cord-005453-4057qib7	14259	20	2017	2017	CD
cord-005453-4057qib7	14259	21	)	)	-RRB-
cord-005453-4057qib7	14259	22	)	)	-RRB-
cord-005453-4057qib7	14259	23	.	.	.
cord-005453-4057qib7	14260	1	Early	early	JJ
cord-005453-4057qib7	14260	2	recognition	recognition	NN
cord-005453-4057qib7	14260	3	and	and	CC
cord-005453-4057qib7	14260	4	early	early	JJ
cord-005453-4057qib7	14260	5	treatment	treatment	NN
cord-005453-4057qib7	14260	6	with	with	IN
cord-005453-4057qib7	14260	7	defibrotide	defibrotide	NNP
cord-005453-4057qib7	14260	8	seems	seem	VBZ
cord-005453-4057qib7	14260	9	to	to	TO
cord-005453-4057qib7	14260	10	be	be	VB
cord-005453-4057qib7	14260	11	effective	effective	JJ
cord-005453-4057qib7	14260	12	in	in	IN
cord-005453-4057qib7	14260	13	VOD	VOD	NNP
cord-005453-4057qib7	14260	14	associated	associate	VBN
cord-005453-4057qib7	14260	15	with	with	IN
cord-005453-4057qib7	14260	16	BuMel	BuMel	NNP
cord-005453-4057qib7	14260	17	regimen	regimen	NN
cord-005453-4057qib7	14260	18	-none	-none	CD
cord-005453-4057qib7	14260	19	of	of	IN
cord-005453-4057qib7	14260	20	our	-PRON-	PRP$
cord-005453-4057qib7	14260	21	15	15	CD
cord-005453-4057qib7	14260	22	patients	patient	NNS
cord-005453-4057qib7	14260	23	died	die	VBD
cord-005453-4057qib7	14260	24	due	due	IN
cord-005453-4057qib7	14260	25	to	to	IN
cord-005453-4057qib7	14260	26	VOD	VOD	NNP
cord-005453-4057qib7	14260	27	.	.	.
cord-005453-4057qib7	14261	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14261	2	:	:	:
cord-005453-4057qib7	14261	3	Nothing	nothing	NN
cord-005453-4057qib7	14261	4	to	to	TO
cord-005453-4057qib7	14261	5	declare	declare	VB
cord-005453-4057qib7	14261	6	Results	result	NNS
cord-005453-4057qib7	14261	7	of	of	IN
cord-005453-4057qib7	14261	8	high	high	JJ
cord-005453-4057qib7	14261	9	-	-	HYPH
cord-005453-4057qib7	14261	10	dose	dose	NN
cord-005453-4057qib7	14261	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14261	12	(	(	-LRB-
cord-005453-4057qib7	14261	13	HDCT	HDCT	NNP
cord-005453-4057qib7	14261	14	)	)	-RRB-
cord-005453-4057qib7	14261	15	with	with	IN
cord-005453-4057qib7	14261	16	autologous	autologous	JJ
cord-005453-4057qib7	14261	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14261	18	stem	stem	NN
cord-005453-4057qib7	14261	19	cell	cell	NN
cord-005453-4057qib7	14261	20	transplantation	transplantation	NN
cord-005453-4057qib7	14261	21	(	(	-LRB-
cord-005453-4057qib7	14261	22	auto	auto	NN
cord-005453-4057qib7	14261	23	-	-	HYPH
cord-005453-4057qib7	14261	24	HSCT	HSCT	NNP
cord-005453-4057qib7	14261	25	)	)	-RRB-
cord-005453-4057qib7	14261	26	in	in	IN
cord-005453-4057qib7	14261	27	the	the	DT
cord-005453-4057qib7	14261	28	treatment	treatment	NN
cord-005453-4057qib7	14261	29	of	of	IN
cord-005453-4057qib7	14261	30	ewing	ewing	NNP
cord-005453-4057qib7	14261	31	sarcoma	sarcoma	NNP
cord-005453-4057qib7	14261	32	family	family	NN
cord-005453-4057qib7	14261	33	tumors	tumor	NNS
cord-005453-4057qib7	14261	34	(	(	-LRB-
cord-005453-4057qib7	14261	35	ESFT	ESFT	NNP
cord-005453-4057qib7	14261	36	)	)	-RRB-
cord-005453-4057qib7	14262	1	Background	background	NN
cord-005453-4057qib7	14262	2	:	:	:
cord-005453-4057qib7	14262	3	While	while	IN
cord-005453-4057qib7	14262	4	current	current	JJ
cord-005453-4057qib7	14262	5	dose	dose	NN
cord-005453-4057qib7	14262	6	-	-	HYPH
cord-005453-4057qib7	14262	7	intense	intense	JJ
cord-005453-4057qib7	14262	8	treatment	treatment	NN
cord-005453-4057qib7	14262	9	protocols	protocol	NNS
cord-005453-4057qib7	14262	10	allow	allow	VBP
cord-005453-4057qib7	14262	11	achieving	achieve	VBG
cord-005453-4057qib7	14262	12	70	70	CD
cord-005453-4057qib7	14262	13	-	-	SYM
cord-005453-4057qib7	14262	14	80	80	CD
cord-005453-4057qib7	14262	15	%	%	NN
cord-005453-4057qib7	14262	16	survival	survival	NN
cord-005453-4057qib7	14262	17	in	in	IN
cord-005453-4057qib7	14262	18	localized	localized	JJ
cord-005453-4057qib7	14262	19	ESFT	ESFT	NNP
cord-005453-4057qib7	14262	20	patients	patient	NNS
cord-005453-4057qib7	14262	21	,	,	,
cord-005453-4057qib7	14262	22	the	the	DT
cord-005453-4057qib7	14262	23	long	long	JJ
cord-005453-4057qib7	14262	24	-	-	HYPH
cord-005453-4057qib7	14262	25	term	term	NN
cord-005453-4057qib7	14262	26	survival	survival	NN
cord-005453-4057qib7	14262	27	in	in	IN
cord-005453-4057qib7	14262	28	high	high	JJ
cord-005453-4057qib7	14262	29	-	-	HYPH
cord-005453-4057qib7	14262	30	risk	risk	NN
cord-005453-4057qib7	14262	31	cases	case	NNS
cord-005453-4057qib7	14262	32	is	be	VBZ
cord-005453-4057qib7	14262	33	still	still	RB
cord-005453-4057qib7	14262	34	unsatisfactory	unsatisfactory	JJ
cord-005453-4057qib7	14262	35	.	.	.
cord-005453-4057qib7	14263	1	Although	although	IN
cord-005453-4057qib7	14263	2	there	there	EX
cord-005453-4057qib7	14263	3	is	be	VBZ
cord-005453-4057qib7	14263	4	a	a	DT
cord-005453-4057qib7	14263	5	considerable	considerable	JJ
cord-005453-4057qib7	14263	6	body	body	NN
cord-005453-4057qib7	14263	7	of	of	IN
cord-005453-4057qib7	14263	8	data	datum	NNS
cord-005453-4057qib7	14263	9	on	on	IN
cord-005453-4057qib7	14263	10	high	high	JJ
cord-005453-4057qib7	14263	11	-	-	HYPH
cord-005453-4057qib7	14263	12	dose	dose	NN
cord-005453-4057qib7	14263	13	consolidation	consolidation	NN
cord-005453-4057qib7	14263	14	the	the	DT
cord-005453-4057qib7	14263	15	real	real	JJ
cord-005453-4057qib7	14263	16	effectiveness	effectiveness	NN
cord-005453-4057qib7	14263	17	and	and	CC
cord-005453-4057qib7	14263	18	optimal	optimal	JJ
cord-005453-4057qib7	14263	19	indications	indication	NNS
cord-005453-4057qib7	14263	20	for	for	IN
cord-005453-4057qib7	14263	21	this	this	DT
cord-005453-4057qib7	14263	22	option	option	NN
cord-005453-4057qib7	14263	23	are	be	VBP
cord-005453-4057qib7	14263	24	still	still	RB
cord-005453-4057qib7	14263	25	not	not	RB
cord-005453-4057qib7	14263	26	completely	completely	RB
cord-005453-4057qib7	14263	27	clarified	clarify	VBN
cord-005453-4057qib7	14263	28	.	.	.
cord-005453-4057qib7	14264	1	Therefore	therefore	RB
cord-005453-4057qib7	14264	2	,	,	,
cord-005453-4057qib7	14264	3	a	a	DT
cord-005453-4057qib7	14264	4	large	large	JJ
cord-005453-4057qib7	14264	5	prospective	prospective	JJ
cord-005453-4057qib7	14264	6	cohort	cohort	NN
cord-005453-4057qib7	14264	7	analysis	analysis	NN
cord-005453-4057qib7	14264	8	may	may	MD
cord-005453-4057qib7	14264	9	still	still	RB
cord-005453-4057qib7	14264	10	yield	yield	VB
cord-005453-4057qib7	14264	11	useful	useful	JJ
cord-005453-4057qib7	14264	12	data	datum	NNS
cord-005453-4057qib7	14264	13	.	.	.
cord-005453-4057qib7	14265	1	Methods	method	NNS
cord-005453-4057qib7	14265	2	:	:	:
cord-005453-4057qib7	14266	1	The	the	DT
cord-005453-4057qib7	14266	2	whole	whole	JJ
cord-005453-4057qib7	14266	3	cohort	cohort	NN
cord-005453-4057qib7	14266	4	includes	include	VBZ
cord-005453-4057qib7	14266	5	73	73	CD
cord-005453-4057qib7	14266	6	consecutive	consecutive	JJ
cord-005453-4057qib7	14266	7	highrisk	highrisk	JJ
cord-005453-4057qib7	14266	8	ESFT	ESFT	NNP
cord-005453-4057qib7	14266	9	patients	patient	NNS
cord-005453-4057qib7	14266	10	with	with	IN
cord-005453-4057qib7	14266	11	median	median	JJ
cord-005453-4057qib7	14266	12	age	age	NN
cord-005453-4057qib7	14266	13	of	of	IN
cord-005453-4057qib7	14266	14	12	12	CD
cord-005453-4057qib7	14267	1	(	(	-LRB-
cord-005453-4057qib7	14267	2	range	range	NNP
cord-005453-4057qib7	14267	3	1	1	CD
cord-005453-4057qib7	14267	4	-	-	SYM
cord-005453-4057qib7	14267	5	23	23	CD
cord-005453-4057qib7	14267	6	)	)	-RRB-
cord-005453-4057qib7	14267	7	years	year	NNS
cord-005453-4057qib7	14267	8	receiving	receive	VBG
cord-005453-4057qib7	14267	9	HDCT	HDCT	NNP
cord-005453-4057qib7	14267	10	with	with	IN
cord-005453-4057qib7	14267	11	auto	auto	NN
cord-005453-4057qib7	14267	12	-	-	HYPH
cord-005453-4057qib7	14267	13	HSCT	HSCT	NNP
cord-005453-4057qib7	14267	14	in	in	IN
cord-005453-4057qib7	14267	15	2007	2007	CD
cord-005453-4057qib7	14267	16	to	to	IN
cord-005453-4057qib7	14267	17	2018	2018	CD
cord-005453-4057qib7	14267	18	after	after	IN
cord-005453-4057qib7	14267	19	obtaining	obtain	VBG
cord-005453-4057qib7	14267	20	1	1	CD
cord-005453-4057qib7	14267	21	st	st	NNP
cord-005453-4057qib7	14267	22	(	(	-LRB-
cord-005453-4057qib7	14267	23	n=25	n=25	NNP
cord-005453-4057qib7	14267	24	)	)	-RRB-
cord-005453-4057qib7	14267	25	or	or	CC
cord-005453-4057qib7	14267	26	2	2	CD
cord-005453-4057qib7	14267	27	nd	nd	NNP
cord-005453-4057qib7	14267	28	(	(	-LRB-
cord-005453-4057qib7	14267	29	n=3	n=3	NN
cord-005453-4057qib7	14267	30	)	)	-RRB-
cord-005453-4057qib7	14267	31	CR	CR	NNP
cord-005453-4057qib7	14267	32	,	,	,
cord-005453-4057qib7	14267	33	PR	PR	NNP
cord-005453-4057qib7	14267	34	(	(	-LRB-
cord-005453-4057qib7	14267	35	n=35	n=35	NNP
cord-005453-4057qib7	14267	36	)	)	-RRB-
cord-005453-4057qib7	14267	37	,	,	,
cord-005453-4057qib7	14267	38	or	or	CC
cord-005453-4057qib7	14267	39	stable	stable	JJ
cord-005453-4057qib7	14267	40	disease	disease	NN
cord-005453-4057qib7	14267	41	(	(	-LRB-
cord-005453-4057qib7	14267	42	n=10	n=10	NNP
cord-005453-4057qib7	14267	43	)	)	-RRB-
cord-005453-4057qib7	14267	44	.	.	.
cord-005453-4057qib7	14268	1	The	the	DT
cord-005453-4057qib7	14268	2	high	high	JJ
cord-005453-4057qib7	14268	3	-	-	HYPH
cord-005453-4057qib7	14268	4	risk	risk	NN
cord-005453-4057qib7	14268	5	features	feature	NNS
cord-005453-4057qib7	14268	6	included	include	VBN
cord-005453-4057qib7	14268	7	lung	lung	NN
cord-005453-4057qib7	14268	8	(	(	-LRB-
cord-005453-4057qib7	14268	9	n=52	n=52	NN
cord-005453-4057qib7	14268	10	)	)	-RRB-
cord-005453-4057qib7	14268	11	,	,	,
cord-005453-4057qib7	14268	12	bone	bone	NN
cord-005453-4057qib7	14268	13	(	(	-LRB-
cord-005453-4057qib7	14268	14	n=25	n=25	NNP
cord-005453-4057qib7	14268	15	)	)	-RRB-
cord-005453-4057qib7	14268	16	or	or	CC
cord-005453-4057qib7	14268	17	bone	bone	NN
cord-005453-4057qib7	14268	18	marrow	marrow	NN
cord-005453-4057qib7	14268	19	(	(	-LRB-
cord-005453-4057qib7	14268	20	n=11	n=11	NNP
cord-005453-4057qib7	14268	21	)	)	-RRB-
cord-005453-4057qib7	14268	22	involvement	involvement	NN
cord-005453-4057qib7	14268	23	,	,	,
cord-005453-4057qib7	14268	24	inadequate	inadequate	JJ
cord-005453-4057qib7	14268	25	local	local	JJ
cord-005453-4057qib7	14268	26	control	control	NN
cord-005453-4057qib7	14268	27	in	in	IN
cord-005453-4057qib7	14268	28	primary	primary	JJ
cord-005453-4057qib7	14268	29	axial	axial	JJ
cord-005453-4057qib7	14268	30	tumors	tumor	NNS
cord-005453-4057qib7	14268	31	(	(	-LRB-
cord-005453-4057qib7	14268	32	n=52	n=52	NN
cord-005453-4057qib7	14268	33	)	)	-RRB-
cord-005453-4057qib7	14268	34	,	,	,
cord-005453-4057qib7	14268	35	large	large	JJ
cord-005453-4057qib7	14268	36	lesions	lesion	NNS
cord-005453-4057qib7	14268	37	volume	volume	NN
cord-005453-4057qib7	14268	38	or	or	CC
cord-005453-4057qib7	14268	39	poor	poor	JJ
cord-005453-4057qib7	14268	40	treatment	treatment	NN
cord-005453-4057qib7	14268	41	response	response	NN
cord-005453-4057qib7	14268	42	(	(	-LRB-
cord-005453-4057qib7	14268	43	n=52	n=52	NN
cord-005453-4057qib7	14268	44	)	)	-RRB-
cord-005453-4057qib7	14268	45	,	,	,
cord-005453-4057qib7	14268	46	and	and	CC
cord-005453-4057qib7	14268	47	chemosensitive	chemosensitive	JJ
cord-005453-4057qib7	14268	48	relapse	relapse	NN
cord-005453-4057qib7	14268	49	(	(	-LRB-
cord-005453-4057qib7	14268	50	n=9	n=9	NN
cord-005453-4057qib7	14268	51	)	)	-RRB-
cord-005453-4057qib7	14268	52	.	.	.
cord-005453-4057qib7	14269	1	Most	Most	JJS
cord-005453-4057qib7	14269	2	patients	patient	NNS
cord-005453-4057qib7	14269	3	had	have	VBD
cord-005453-4057qib7	14269	4	several	several	JJ
cord-005453-4057qib7	14269	5	risk	risk	NN
cord-005453-4057qib7	14269	6	factors	factor	NNS
cord-005453-4057qib7	14269	7	.	.	.
cord-005453-4057qib7	14270	1	Disseminated	disseminate	VBN
cord-005453-4057qib7	14270	2	disease	disease	NN
cord-005453-4057qib7	14270	3	patients	patient	NNS
cord-005453-4057qib7	14270	4	were	be	VBD
cord-005453-4057qib7	14270	5	also	also	RB
cord-005453-4057qib7	14270	6	evaluated	evaluate	VBN
cord-005453-4057qib7	14270	7	according	accord	VBG
cord-005453-4057qib7	14270	8	to	to	IN
cord-005453-4057qib7	14270	9	prognostic	prognostic	JJ
cord-005453-4057qib7	14270	10	score	score	NN
cord-005453-4057qib7	14270	11	by	by	IN
cord-005453-4057qib7	14270	12	R.Ladenstein	R.Ladenstein	NNP
cord-005453-4057qib7	14270	13	et	et	FW
cord-005453-4057qib7	14270	14	al	al	NNP
cord-005453-4057qib7	14270	15	.	.	.
cord-005453-4057qib7	14271	1	Highdose	Highdose	NNP
cord-005453-4057qib7	14271	2	busulfan	busulfan	NN
cord-005453-4057qib7	14271	3	-	-	HYPH
cord-005453-4057qib7	14271	4	melphalan	melphalan	NNP
cord-005453-4057qib7	14271	5	followed	follow	VBN
cord-005453-4057qib7	14271	6	by	by	IN
cord-005453-4057qib7	14271	7	autologous	autologous	JJ
cord-005453-4057qib7	14271	8	stem	stem	NN
cord-005453-4057qib7	14271	9	-	-	HYPH
cord-005453-4057qib7	14271	10	cell	cell	NN
cord-005453-4057qib7	14271	11	transplantation	transplantation	NN
cord-005453-4057qib7	14271	12	(	(	-LRB-
cord-005453-4057qib7	14271	13	HDT	HDT	NNP
cord-005453-4057qib7	14271	14	/	/	SYM
cord-005453-4057qib7	14271	15	SCT	SCT	NNP
cord-005453-4057qib7	14271	16	)	)	-RRB-
cord-005453-4057qib7	14271	17	was	be	VBD
cord-005453-4057qib7	14271	18	used	use	VBN
cord-005453-4057qib7	14271	19	.	.	.
cord-005453-4057qib7	14272	1	Results	result	NNS
cord-005453-4057qib7	14272	2	:	:	:
cord-005453-4057qib7	14273	1	The	the	DT
cord-005453-4057qib7	14273	2	median	median	JJ
cord-005453-4057qib7	14273	3	observation	observation	NN
cord-005453-4057qib7	14273	4	time	time	NN
cord-005453-4057qib7	14273	5	was	be	VBD
cord-005453-4057qib7	14273	6	60	60	CD
cord-005453-4057qib7	14274	1	(	(	-LRB-
cord-005453-4057qib7	14274	2	range	range	NNP
cord-005453-4057qib7	14274	3	3	3	CD
cord-005453-4057qib7	14274	4	-	-	SYM
cord-005453-4057qib7	14274	5	130	130	CD
cord-005453-4057qib7	14274	6	)	)	-RRB-
cord-005453-4057qib7	14274	7	months	month	NNS
cord-005453-4057qib7	14274	8	.	.	.
cord-005453-4057qib7	14275	1	The	the	DT
cord-005453-4057qib7	14275	2	5-year	5-year	CD
cord-005453-4057qib7	14275	3	overall	overall	NN
cord-005453-4057qib7	14275	4	(	(	-LRB-
cord-005453-4057qib7	14275	5	OS	OS	NNP
cord-005453-4057qib7	14275	6	)	)	-RRB-
cord-005453-4057qib7	14275	7	and	and	CC
cord-005453-4057qib7	14275	8	event	event	NN
cord-005453-4057qib7	14275	9	-	-	HYPH
cord-005453-4057qib7	14275	10	free	free	JJ
cord-005453-4057qib7	14275	11	(	(	-LRB-
cord-005453-4057qib7	14275	12	EFS	efs	NN
cord-005453-4057qib7	14275	13	)	)	-RRB-
cord-005453-4057qib7	14275	14	survival	survival	NN
cord-005453-4057qib7	14275	15	were	be	VBD
cord-005453-4057qib7	14275	16	40	40	CD
cord-005453-4057qib7	14275	17	%	%	NN
cord-005453-4057qib7	14275	18	and	and	CC
cord-005453-4057qib7	14275	19	37	37	CD
cord-005453-4057qib7	14275	20	%	%	NN
cord-005453-4057qib7	14275	21	,	,	,
cord-005453-4057qib7	14275	22	accordingly	accordingly	RB
cord-005453-4057qib7	14275	23	.	.	.
cord-005453-4057qib7	14276	1	Most	most	RBS
cord-005453-4057qib7	14276	2	important	important	JJ
cord-005453-4057qib7	14276	3	outcome	outcome	NN
cord-005453-4057qib7	14276	4	predictors	predictor	NNS
cord-005453-4057qib7	14276	5	were	be	VBD
cord-005453-4057qib7	14276	6	inadequate	inadequate	JJ
cord-005453-4057qib7	14276	7	local	local	JJ
cord-005453-4057qib7	14276	8	control	control	NN
cord-005453-4057qib7	14276	9	in	in	IN
cord-005453-4057qib7	14276	10	chemoresistant	chemoresistant	JJ
cord-005453-4057qib7	14276	11	cases	case	NNS
cord-005453-4057qib7	14276	12	,	,	,
cord-005453-4057qib7	14276	13	a	a	DT
cord-005453-4057qib7	14276	14	primary	primary	JJ
cord-005453-4057qib7	14276	15	tumor	tumor	NN
cord-005453-4057qib7	14276	16	volume	volume	NN
cord-005453-4057qib7	14277	1	more	more	JJR
cord-005453-4057qib7	14277	2	than	than	IN
cord-005453-4057qib7	14277	3	200	200	CD
cord-005453-4057qib7	14277	4	mL	ml	NN
cord-005453-4057qib7	14277	5	,	,	,
cord-005453-4057qib7	14277	6	more	more	JJR
cord-005453-4057qib7	14277	7	than	than	IN
cord-005453-4057qib7	14277	8	one	one	CD
cord-005453-4057qib7	14277	9	bone	bone	NN
cord-005453-4057qib7	14277	10	metastatic	metastatic	JJ
cord-005453-4057qib7	14277	11	site	site	NN
cord-005453-4057qib7	14277	12	,	,	,
cord-005453-4057qib7	14277	13	bone	bone	NN
cord-005453-4057qib7	14277	14	marrow	marrow	NN
cord-005453-4057qib7	14277	15	involvement	involvement	NN
cord-005453-4057qib7	14277	16	and	and	CC
cord-005453-4057qib7	14277	17	additional	additional	JJ
cord-005453-4057qib7	14277	18	lung	lung	NN
cord-005453-4057qib7	14277	19	metastases	metastasis	NNS
cord-005453-4057qib7	14277	20	.	.	.
cord-005453-4057qib7	14278	1	According	accord	VBG
cord-005453-4057qib7	14278	2	to	to	IN
cord-005453-4057qib7	14278	3	prognostic	prognostic	JJ
cord-005453-4057qib7	14278	4	risk	risk	NN
cord-005453-4057qib7	14278	5	score	score	NN
cord-005453-4057qib7	14278	6	in	in	IN
cord-005453-4057qib7	14278	7	disseminated	disseminate	VBN
cord-005453-4057qib7	14278	8	disease	disease	NN
cord-005453-4057qib7	14278	9	ESFT	ESFT	NNP
cord-005453-4057qib7	14278	10	patients	patient	NNS
cord-005453-4057qib7	14278	11	identified	identify	VBD
cord-005453-4057qib7	14278	12	three	three	CD
cord-005453-4057qib7	14278	13	groups	group	NNS
cord-005453-4057qib7	14278	14	with	with	IN
cord-005453-4057qib7	14278	15	5-year	5-year	CD
cord-005453-4057qib7	14278	16	OS	OS	NNP
cord-005453-4057qib7	14278	17	rates	rate	NNS
cord-005453-4057qib7	14278	18	of	of	IN
cord-005453-4057qib7	14278	19	49	49	CD
cord-005453-4057qib7	14278	20	%	%	NN
cord-005453-4057qib7	14278	21	for	for	IN
cord-005453-4057qib7	14278	22	score	score	NN
cord-005453-4057qib7	14278	23	≤3	≤3	NNPS
cord-005453-4057qib7	14278	24	(	(	-LRB-
cord-005453-4057qib7	14278	25	19	19	CD
cord-005453-4057qib7	14278	26	patients	patient	NNS
cord-005453-4057qib7	14278	27	)	)	-RRB-
cord-005453-4057qib7	14278	28	,	,	,
cord-005453-4057qib7	14278	29	36	36	CD
cord-005453-4057qib7	14278	30	%	%	NN
cord-005453-4057qib7	14278	31	for	for	IN
cord-005453-4057qib7	14278	32	score	score	NN
cord-005453-4057qib7	14278	33	3	3	CD
cord-005453-4057qib7	14278	34	to	to	IN
cord-005453-4057qib7	14278	35	5	5	CD
cord-005453-4057qib7	14278	36	(	(	-LRB-
cord-005453-4057qib7	14278	37	27	27	CD
cord-005453-4057qib7	14278	38	patients	patient	NNS
cord-005453-4057qib7	14278	39	)	)	-RRB-
cord-005453-4057qib7	14278	40	,	,	,
cord-005453-4057qib7	14278	41	and	and	CC
cord-005453-4057qib7	14278	42	8	8	CD
cord-005453-4057qib7	14278	43	%	%	NN
cord-005453-4057qib7	14278	44	for	for	IN
cord-005453-4057qib7	14278	45	score	score	NN
cord-005453-4057qib7	14278	46	≥5	≥5	NNPS
cord-005453-4057qib7	14278	47	(	(	-LRB-
cord-005453-4057qib7	14278	48	12	12	CD
cord-005453-4057qib7	14278	49	patients	patient	NNS
cord-005453-4057qib7	14278	50	)	)	-RRB-
cord-005453-4057qib7	14278	51	,	,	,
cord-005453-4057qib7	14278	52	(	(	-LRB-
cord-005453-4057qib7	14278	53	P	p	NN
cord-005453-4057qib7	14278	54	<	<	XX
cord-005453-4057qib7	14278	55	0.01	0.01	CD
cord-005453-4057qib7	14278	56	)	)	-RRB-
cord-005453-4057qib7	14278	57	.	.	.
cord-005453-4057qib7	14279	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14279	2	:	:	:
cord-005453-4057qib7	14280	1	While	while	IN
cord-005453-4057qib7	14280	2	Bu	Bu	NNP
cord-005453-4057qib7	14280	3	-	-	HYPH
cord-005453-4057qib7	14280	4	Mel	Mel	NNP
cord-005453-4057qib7	14280	5	HDCT	HDCT	NNP
cord-005453-4057qib7	14280	6	with	with	IN
cord-005453-4057qib7	14280	7	auto	auto	NN
cord-005453-4057qib7	14280	8	-	-	HYPH
cord-005453-4057qib7	14280	9	HSCT	HSCT	NNP
cord-005453-4057qib7	14280	10	may	may	MD
cord-005453-4057qib7	14280	11	still	still	RB
cord-005453-4057qib7	14280	12	be	be	VB
cord-005453-4057qib7	14280	13	a	a	DT
cord-005453-4057qib7	14280	14	feasible	feasible	JJ
cord-005453-4057qib7	14280	15	option	option	NN
cord-005453-4057qib7	14280	16	with	with	IN
cord-005453-4057qib7	14280	17	acceptable	acceptable	JJ
cord-005453-4057qib7	14280	18	toxicity	toxicity	NN
cord-005453-4057qib7	14280	19	for	for	IN
cord-005453-4057qib7	14280	20	chemosensitive	chemosensitive	JJ
cord-005453-4057qib7	14280	21	patients	patient	NNS
cord-005453-4057qib7	14280	22	with	with	IN
cord-005453-4057qib7	14280	23	inadequate	inadequate	JJ
cord-005453-4057qib7	14280	24	local	local	JJ
cord-005453-4057qib7	14280	25	control	control	NN
cord-005453-4057qib7	14280	26	and	and	CC
cord-005453-4057qib7	14280	27	some	some	DT
cord-005453-4057qib7	14280	28	primarily	primarily	RB
cord-005453-4057qib7	14280	29	disseminated	disseminate	VBN
cord-005453-4057qib7	14280	30	cases	case	NNS
cord-005453-4057qib7	14280	31	it	-PRON-	PRP
cord-005453-4057qib7	14280	32	is	be	VBZ
cord-005453-4057qib7	14280	33	ineffective	ineffective	JJ
cord-005453-4057qib7	14280	34	in	in	IN
cord-005453-4057qib7	14280	35	primary	primary	JJ
cord-005453-4057qib7	14280	36	resistant	resistant	JJ
cord-005453-4057qib7	14280	37	or	or	CC
cord-005453-4057qib7	14280	38	very	very	RB
cord-005453-4057qib7	14280	39	high	high	JJ
cord-005453-4057qib7	14280	40	-	-	HYPH
cord-005453-4057qib7	14280	41	risk	risk	NN
cord-005453-4057qib7	14280	42	metastatic	metastatic	JJ
cord-005453-4057qib7	14280	43	patients	patient	NNS
cord-005453-4057qib7	14280	44	.	.	.
cord-005453-4057qib7	14281	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14281	2	:	:	:
cord-005453-4057qib7	14281	3	Nothing	nothing	NN
cord-005453-4057qib7	14281	4	to	to	TO
cord-005453-4057qib7	14281	5	declare	declare	VB
cord-005453-4057qib7	14281	6	Efficacy	Efficacy	NNP
cord-005453-4057qib7	14281	7	of	of	IN
cord-005453-4057qib7	14281	8	tandem	tandem	JJ
cord-005453-4057qib7	14281	9	high	high	JJ
cord-005453-4057qib7	14281	10	-	-	HYPH
cord-005453-4057qib7	14281	11	dose	dose	NN
cord-005453-4057qib7	14281	12	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14281	13	with	with	IN
cord-005453-4057qib7	14281	14	autologous	autologous	JJ
cord-005453-4057qib7	14281	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14281	16	stem	stem	NN
cord-005453-4057qib7	14281	17	cell	cell	NN
cord-005453-4057qib7	14281	18	transplantation	transplantation	NN
cord-005453-4057qib7	14281	19	in	in	IN
cord-005453-4057qib7	14281	20	the	the	DT
cord-005453-4057qib7	14281	21	treatment	treatment	NN
cord-005453-4057qib7	14281	22	of	of	IN
cord-005453-4057qib7	14281	23	infant	infant	NN
cord-005453-4057qib7	14281	24	embryonal	embryonal	JJ
cord-005453-4057qib7	14281	25	brain	brain	NN
cord-005453-4057qib7	14281	26	tumors	tumor	NNS
cord-005453-4057qib7	14281	27	day	day	NN
cord-005453-4057qib7	14281	28	+15	+15	CD
cord-005453-4057qib7	14281	29	(	(	-LRB-
cord-005453-4057qib7	14281	30	range	range	NN
cord-005453-4057qib7	14281	31	,	,	,
cord-005453-4057qib7	14281	32	8	8	CD
cord-005453-4057qib7	14281	33	-	-	SYM
cord-005453-4057qib7	14281	34	83	83	CD
cord-005453-4057qib7	14281	35	)	)	-RRB-
cord-005453-4057qib7	14281	36	,	,	,
cord-005453-4057qib7	14281	37	after	after	IN
cord-005453-4057qib7	14281	38	the	the	DT
cord-005453-4057qib7	14281	39	second	second	JJ
cord-005453-4057qib7	14281	40	auto	auto	NN
cord-005453-4057qib7	14281	41	-	-	HYPH
cord-005453-4057qib7	14281	42	HSCT	HSCT	NNP
cord-005453-4057qib7	14281	43	was	be	VBD
cord-005453-4057qib7	14281	44	day	day	NN
cord-005453-4057qib7	14281	45	+17	+17	CD
cord-005453-4057qib7	14282	1	(	(	-LRB-
cord-005453-4057qib7	14282	2	range	range	NN
cord-005453-4057qib7	14282	3	,	,	,
cord-005453-4057qib7	14282	4	9	9	CD
cord-005453-4057qib7	14282	5	-	-	SYM
cord-005453-4057qib7	14282	6	86	86	CD
cord-005453-4057qib7	14282	7	)	)	-RRB-
cord-005453-4057qib7	14282	8	.	.	.
cord-005453-4057qib7	14283	1	Two	two	CD
cord-005453-4057qib7	14283	2	-	-	HYPH
cord-005453-4057qib7	14283	3	year	year	NN
cord-005453-4057qib7	14283	4	overall	overall	JJ
cord-005453-4057qib7	14283	5	survival	survival	NN
cord-005453-4057qib7	14283	6	(	(	-LRB-
cord-005453-4057qib7	14283	7	OS	OS	NNP
cord-005453-4057qib7	14283	8	)	)	-RRB-
cord-005453-4057qib7	14283	9	was	be	VBD
cord-005453-4057qib7	14283	10	76	76	CD
cord-005453-4057qib7	14283	11	%	%	NN
cord-005453-4057qib7	14283	12	and	and	CC
cord-005453-4057qib7	14283	13	disease	disease	NN
cord-005453-4057qib7	14283	14	free	free	JJ
cord-005453-4057qib7	14283	15	survival	survival	NN
cord-005453-4057qib7	14283	16	(	(	-LRB-
cord-005453-4057qib7	14283	17	DFS	DFS	NNP
cord-005453-4057qib7	14283	18	)	)	-RRB-
cord-005453-4057qib7	14283	19	was	be	VBD
cord-005453-4057qib7	14283	20	68	68	CD
cord-005453-4057qib7	14283	21	%	%	NN
cord-005453-4057qib7	14283	22	.	.	.
cord-005453-4057qib7	14284	1	DFS	DFS	NNP
cord-005453-4057qib7	14284	2	was	be	VBD
cord-005453-4057qib7	14284	3	significantly	significantly	RB
cord-005453-4057qib7	14284	4	better	well	JJR
cord-005453-4057qib7	14284	5	among	among	IN
cord-005453-4057qib7	14284	6	patients	patient	NNS
cord-005453-4057qib7	14284	7	with	with	IN
cord-005453-4057qib7	14284	8	MB	MB	NNP
cord-005453-4057qib7	14284	9	(	(	-LRB-
cord-005453-4057qib7	14284	10	95	95	CD
cord-005453-4057qib7	14284	11	%	%	NN
cord-005453-4057qib7	14284	12	)	)	-RRB-
cord-005453-4057qib7	14284	13	and	and	CC
cord-005453-4057qib7	14284	14	PNET	PNET	NNP
cord-005453-4057qib7	14284	15	(	(	-LRB-
cord-005453-4057qib7	14284	16	75	75	CD
cord-005453-4057qib7	14284	17	%	%	NN
cord-005453-4057qib7	14284	18	)	)	-RRB-
cord-005453-4057qib7	14284	19	in	in	IN
cord-005453-4057qib7	14284	20	compared	compare	VBN
cord-005453-4057qib7	14284	21	to	to	IN
cord-005453-4057qib7	14284	22	children	child	NNS
cord-005453-4057qib7	14284	23	with	with	IN
cord-005453-4057qib7	14284	24	ETMR	ETMR	NNP
cord-005453-4057qib7	14284	25	(	(	-LRB-
cord-005453-4057qib7	14284	26	55	55	CD
cord-005453-4057qib7	14284	27	%	%	NN
cord-005453-4057qib7	14284	28	)	)	-RRB-
cord-005453-4057qib7	14284	29	,	,	,
cord-005453-4057qib7	14284	30	PB	PB	NNP
cord-005453-4057qib7	14284	31	(	(	-LRB-
cord-005453-4057qib7	14284	32	33	33	CD
cord-005453-4057qib7	14284	33	%	%	NN
cord-005453-4057qib7	14284	34	)	)	-RRB-
cord-005453-4057qib7	14284	35	and	and	CC
cord-005453-4057qib7	14284	36	ATRT	ATRT	NNP
cord-005453-4057qib7	14284	37	(	(	-LRB-
cord-005453-4057qib7	14284	38	0	0	CD
cord-005453-4057qib7	14284	39	%	%	NN
cord-005453-4057qib7	14284	40	)	)	-RRB-
cord-005453-4057qib7	14284	41	,	,	,
cord-005453-4057qib7	14284	42	(	(	-LRB-
cord-005453-4057qib7	14284	43	p=0,01	p=0,01	NN
cord-005453-4057qib7	14284	44	)	)	-RRB-
cord-005453-4057qib7	14284	45	.	.	.
cord-005453-4057qib7	14285	1	DFS	DFS	NNP
cord-005453-4057qib7	14285	2	in	in	IN
cord-005453-4057qib7	14285	3	patients	patient	NNS
cord-005453-4057qib7	14285	4	who	who	WP
cord-005453-4057qib7	14285	5	received	receive	VBD
cord-005453-4057qib7	14285	6	tandem	tandem	JJ
cord-005453-4057qib7	14285	7	auto	auto	NN
cord-005453-4057qib7	14285	8	-	-	HYPH
cord-005453-4057qib7	14285	9	HSCT	HSCT	NNP
cord-005453-4057qib7	14285	10	was	be	VBD
cord-005453-4057qib7	14285	11	75	75	CD
cord-005453-4057qib7	14285	12	%	%	NN
cord-005453-4057qib7	14285	13	in	in	IN
cord-005453-4057qib7	14285	14	compare	compare	NN
cord-005453-4057qib7	14285	15	to	to	IN
cord-005453-4057qib7	14285	16	infants	infant	NNS
cord-005453-4057qib7	14285	17	who	who	WP
cord-005453-4057qib7	14285	18	received	receive	VBD
cord-005453-4057qib7	14285	19	only	only	RB
cord-005453-4057qib7	14285	20	one	one	CD
cord-005453-4057qib7	14285	21	auto	auto	NN
cord-005453-4057qib7	14285	22	-	-	HYPH
cord-005453-4057qib7	14285	23	HSCT	HSCT	NNP
cord-005453-4057qib7	14285	24	(	(	-LRB-
cord-005453-4057qib7	14285	25	44	44	CD
cord-005453-4057qib7	14285	26	%	%	NN
cord-005453-4057qib7	14285	27	)	)	-RRB-
cord-005453-4057qib7	14285	28	,	,	,
cord-005453-4057qib7	14285	29	(	(	-LRB-
cord-005453-4057qib7	14285	30	p=0,000	p=0,000	NNP
cord-005453-4057qib7	14285	31	)	)	-RRB-
cord-005453-4057qib7	14285	32	.	.	.
cord-005453-4057qib7	14286	1	Complications	complication	NNS
cord-005453-4057qib7	14286	2	grade	grade	NN
cord-005453-4057qib7	14286	3	4	4	CD
cord-005453-4057qib7	14286	4	(	(	-LRB-
cord-005453-4057qib7	14286	5	according	accord	VBG
cord-005453-4057qib7	14286	6	to	to	IN
cord-005453-4057qib7	14286	7	COMMON	common	JJ
cord-005453-4057qib7	14286	8	TOXICITY	toxicity	NN
cord-005453-4057qib7	14286	9	CRITERIA	criterion	NNS
cord-005453-4057qib7	14286	10	2014	2014	CD
cord-005453-4057qib7	14286	11	)	)	-RRB-
cord-005453-4057qib7	14286	12	were	be	VBD
cord-005453-4057qib7	14286	13	observed	observe	VBN
cord-005453-4057qib7	14286	14	in	in	IN
cord-005453-4057qib7	14286	15	14	14	CD
cord-005453-4057qib7	14286	16	%	%	NN
cord-005453-4057qib7	14286	17	of	of	IN
cord-005453-4057qib7	14286	18	cases	case	NNS
cord-005453-4057qib7	14286	19	.	.	.
cord-005453-4057qib7	14287	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14287	2	:	:	:
cord-005453-4057qib7	14288	1	Employment	employment	NN
cord-005453-4057qib7	14288	2	of	of	IN
cord-005453-4057qib7	14288	3	tandem	tandem	JJ
cord-005453-4057qib7	14288	4	HDCT	HDCT	NNP
cord-005453-4057qib7	14288	5	with	with	IN
cord-005453-4057qib7	14288	6	auto	auto	NN
cord-005453-4057qib7	14288	7	-	-	HYPH
cord-005453-4057qib7	14288	8	HSCT	HSCT	NNP
cord-005453-4057qib7	14288	9	in	in	IN
cord-005453-4057qib7	14288	10	primary	primary	JJ
cord-005453-4057qib7	14288	11	infant	infant	NN
cord-005453-4057qib7	14288	12	embryonal	embryonal	JJ
cord-005453-4057qib7	14288	13	brain	brain	NN
cord-005453-4057qib7	14288	14	tumors	tumor	NNS
cord-005453-4057qib7	14288	15	may	may	MD
cord-005453-4057qib7	14288	16	be	be	VB
cord-005453-4057qib7	14288	17	a	a	DT
cord-005453-4057qib7	14288	18	feasible	feasible	JJ
cord-005453-4057qib7	14288	19	option	option	NN
cord-005453-4057qib7	14288	20	for	for	IN
cord-005453-4057qib7	14288	21	patients	patient	NNS
cord-005453-4057qib7	14288	22	after	after	IN
cord-005453-4057qib7	14288	23	induction	induction	NN
cord-005453-4057qib7	14288	24	treatment	treatment	NN
cord-005453-4057qib7	14288	25	.	.	.
cord-005453-4057qib7	14289	1	Both	both	DT
cord-005453-4057qib7	14289	2	conditioning	conditioning	NN
cord-005453-4057qib7	14289	3	regimens	regimen	NNS
cord-005453-4057qib7	14289	4	had	have	VBD
cord-005453-4057qib7	14289	5	acceptable	acceptable	JJ
cord-005453-4057qib7	14289	6	toxicity	toxicity	NN
cord-005453-4057qib7	14289	7	.	.	.
cord-005453-4057qib7	14290	1	All	all	DT
cord-005453-4057qib7	14290	2	patients	patient	NNS
cord-005453-4057qib7	14290	3	who	who	WP
cord-005453-4057qib7	14290	4	had	have	VBD
cord-005453-4057qib7	14290	5	tandem	tandem	JJ
cord-005453-4057qib7	14290	6	HDCT	HDCT	NNP
cord-005453-4057qib7	14290	7	with	with	IN
cord-005453-4057qib7	14290	8	auto	auto	NN
cord-005453-4057qib7	14290	9	-	-	HYPH
cord-005453-4057qib7	14290	10	HSCT	HSCT	NNP
cord-005453-4057qib7	14290	11	had	have	VBD
cord-005453-4057qib7	14290	12	better	well	JJR
cord-005453-4057qib7	14290	13	OS	OS	NNP
cord-005453-4057qib7	14290	14	(	(	-LRB-
cord-005453-4057qib7	14290	15	75	75	CD
cord-005453-4057qib7	14290	16	%	%	NN
cord-005453-4057qib7	14290	17	)	)	-RRB-
cord-005453-4057qib7	14290	18	in	in	IN
cord-005453-4057qib7	14290	19	compare	compare	NN
cord-005453-4057qib7	14290	20	with	with	IN
cord-005453-4057qib7	14290	21	single	single	JJ
cord-005453-4057qib7	14290	22	HDCT	HDCT	NNP
cord-005453-4057qib7	14290	23	(	(	-LRB-
cord-005453-4057qib7	14290	24	44	44	CD
cord-005453-4057qib7	14290	25	%	%	NN
cord-005453-4057qib7	14290	26	)	)	-RRB-
cord-005453-4057qib7	14290	27	.	.	.
cord-005453-4057qib7	14291	1	Patients	patient	NNS
cord-005453-4057qib7	14291	2	with	with	IN
cord-005453-4057qib7	14291	3	MB	mb	NN
cord-005453-4057qib7	14291	4	and	and	CC
cord-005453-4057qib7	14291	5	PNET	PNET	NNP
cord-005453-4057qib7	14291	6	had	have	VBD
cord-005453-4057qib7	14291	7	better	well	JJR
cord-005453-4057qib7	14291	8	prognosis	prognosis	NN
cord-005453-4057qib7	14291	9	with	with	IN
cord-005453-4057qib7	14291	10	OS	OS	NNP
cord-005453-4057qib7	14291	11	95	95	CD
cord-005453-4057qib7	14291	12	%	%	NN
cord-005453-4057qib7	14291	13	and	and	CC
cord-005453-4057qib7	14291	14	75	75	CD
cord-005453-4057qib7	14291	15	%	%	NN
cord-005453-4057qib7	14291	16	,	,	,
cord-005453-4057qib7	14291	17	respectively	respectively	RB
cord-005453-4057qib7	14291	18	,	,	,
cord-005453-4057qib7	14291	19	in	in	IN
cord-005453-4057qib7	14291	20	compare	compare	NN
cord-005453-4057qib7	14291	21	with	with	IN
cord-005453-4057qib7	14291	22	other	other	JJ
cord-005453-4057qib7	14291	23	embryonal	embryonal	JJ
cord-005453-4057qib7	14291	24	tumors	tumor	NNS
cord-005453-4057qib7	14291	25	.	.	.
cord-005453-4057qib7	14292	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14292	2	:	:	:
cord-005453-4057qib7	14292	3	Nothing	nothing	NN
cord-005453-4057qib7	14292	4	to	to	TO
cord-005453-4057qib7	14292	5	declare	declare	VB
cord-005453-4057qib7	14292	6	Background	background	NN
cord-005453-4057qib7	14292	7	:	:	:
cord-005453-4057qib7	14293	1	Metastatic	metastatic	JJ
cord-005453-4057qib7	14293	2	extra	extra	JJ
cord-005453-4057qib7	14293	3	ocular	ocular	JJ
cord-005453-4057qib7	14293	4	retinoblastoma	retinoblastoma	NN
cord-005453-4057qib7	14293	5	is	be	VBZ
cord-005453-4057qib7	14293	6	carrying	carry	VBG
cord-005453-4057qib7	14293	7	a	a	DT
cord-005453-4057qib7	14293	8	poor	poor	JJ
cord-005453-4057qib7	14293	9	prognosis	prognosis	NN
cord-005453-4057qib7	14293	10	.	.	.
cord-005453-4057qib7	14294	1	Therapeutic	therapeutic	JJ
cord-005453-4057qib7	14294	2	intensification	intensification	NN
cord-005453-4057qib7	14294	3	with	with	IN
cord-005453-4057qib7	14294	4	high	high	JJ
cord-005453-4057qib7	14294	5	-	-	HYPH
cord-005453-4057qib7	14294	6	dose	dose	NN
cord-005453-4057qib7	14294	7	,	,	,
cord-005453-4057qib7	14294	8	marrow	marrow	NN
cord-005453-4057qib7	14294	9	-	-	HYPH
cord-005453-4057qib7	14294	10	ablative	ablative	NN
cord-005453-4057qib7	14294	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14294	12	and	and	CC
cord-005453-4057qib7	14294	13	autologous	autologous	JJ
cord-005453-4057qib7	14294	14	HSCT	HSCT	NNP
cord-005453-4057qib7	14294	15	has	have	VBZ
cord-005453-4057qib7	14294	16	been	be	VBN
cord-005453-4057qib7	14294	17	explored	explore	VBN
cord-005453-4057qib7	14294	18	,	,	,
cord-005453-4057qib7	14294	19	but	but	CC
cord-005453-4057qib7	14294	20	its	-PRON-	PRP$
cord-005453-4057qib7	14294	21	role	role	NN
cord-005453-4057qib7	14294	22	is	be	VBZ
cord-005453-4057qib7	14294	23	not	not	RB
cord-005453-4057qib7	14294	24	yet	yet	RB
cord-005453-4057qib7	14294	25	clear	clear	JJ
cord-005453-4057qib7	14294	26	.	.	.
cord-005453-4057qib7	14295	1	This	this	DT
cord-005453-4057qib7	14295	2	study	study	NN
cord-005453-4057qib7	14295	3	aimed	aim	VBD
cord-005453-4057qib7	14295	4	to	to	TO
cord-005453-4057qib7	14295	5	evaluate	evaluate	VB
cord-005453-4057qib7	14295	6	the	the	DT
cord-005453-4057qib7	14295	7	survival	survival	NN
cord-005453-4057qib7	14295	8	outcome	outcome	NN
cord-005453-4057qib7	14295	9	of	of	IN
cord-005453-4057qib7	14295	10	patients	patient	NNS
cord-005453-4057qib7	14295	11	with	with	IN
cord-005453-4057qib7	14295	12	extraocular	extraocular	JJ
cord-005453-4057qib7	14295	13	retinoblastoma	retinoblastoma	NN
cord-005453-4057qib7	14295	14	post	post	NN
cord-005453-4057qib7	14295	15	autologous	autologous	JJ
cord-005453-4057qib7	14295	16	stem	stem	NN
cord-005453-4057qib7	14295	17	cell	cell	NN
cord-005453-4057qib7	14295	18	transplant	transplant	NN
cord-005453-4057qib7	14295	19	,	,	,
cord-005453-4057qib7	14295	20	treated	treat	VBN
cord-005453-4057qib7	14295	21	at	at	IN
cord-005453-4057qib7	14295	22	single	single	JJ
cord-005453-4057qib7	14295	23	center	center	NN
cord-005453-4057qib7	14295	24	Methods	method	NNS
cord-005453-4057qib7	14295	25	:	:	:
cord-005453-4057qib7	14295	26	This	this	DT
cord-005453-4057qib7	14295	27	is	be	VBZ
cord-005453-4057qib7	14295	28	a	a	DT
cord-005453-4057qib7	14295	29	retrospective	retrospective	JJ
cord-005453-4057qib7	14295	30	study	study	NN
cord-005453-4057qib7	14295	31	included	include	VBD
cord-005453-4057qib7	14295	32	all	all	DT
cord-005453-4057qib7	14295	33	patients	patient	NNS
cord-005453-4057qib7	14295	34	with	with	IN
cord-005453-4057qib7	14295	35	metastatic	metastatic	JJ
cord-005453-4057qib7	14295	36	extraocular	extraocular	JJ
cord-005453-4057qib7	14295	37	retinoblastoma	retinoblastoma	NN
cord-005453-4057qib7	14295	38	(	(	-LRB-
cord-005453-4057qib7	14295	39	stages	stage	NNS
cord-005453-4057qib7	14295	40	4a	4a	CD
cord-005453-4057qib7	14295	41	and	and	CC
cord-005453-4057qib7	14295	42	4b	4b	LS
cord-005453-4057qib7	14295	43	)	)	-RRB-
cord-005453-4057qib7	14295	44	that	that	WDT
cord-005453-4057qib7	14295	45	underwent	undergo	VBD
cord-005453-4057qib7	14295	46	autologous	autologous	JJ
cord-005453-4057qib7	14295	47	HSCT	HSCT	NNP
cord-005453-4057qib7	14295	48	at	at	IN
cord-005453-4057qib7	14295	49	the	the	DT
cord-005453-4057qib7	14295	50	Children	Children	NNP
cord-005453-4057qib7	14295	51	Cancer	Cancer	NNP
cord-005453-4057qib7	14295	52	Hospital	Hospital	NNP
cord-005453-4057qib7	14295	53	Egypt	Egypt	NNP
cord-005453-4057qib7	14295	54	(	(	-LRB-
cord-005453-4057qib7	14295	55	CCHE	CCHE	NNP
cord-005453-4057qib7	14295	56	)	)	-RRB-
cord-005453-4057qib7	14296	1	57357	57357	CD
cord-005453-4057qib7	14297	1	from	from	IN
cord-005453-4057qib7	14297	2	November	November	NNP
cord-005453-4057qib7	14297	3	2010	2010	CD
cord-005453-4057qib7	14297	4	to	to	IN
cord-005453-4057qib7	14297	5	July	July	NNP
cord-005453-4057qib7	14297	6	2017	2017	CD
cord-005453-4057qib7	14297	7	,	,	,
cord-005453-4057qib7	14297	8	the	the	DT
cord-005453-4057qib7	14297	9	treatment	treatment	NN
cord-005453-4057qib7	14297	10	protocol	protocol	NN
cord-005453-4057qib7	14297	11	was	be	VBD
cord-005453-4057qib7	14297	12	adopted	adopt	VBN
cord-005453-4057qib7	14297	13	from	from	IN
cord-005453-4057qib7	14297	14	COG	cog	NN
cord-005453-4057qib7	14297	15	protocol	protocol	NN
cord-005453-4057qib7	14297	16	(	(	-LRB-
cord-005453-4057qib7	14297	17	ARET0321	aret0321	NN
cord-005453-4057qib7	14297	18	)	)	-RRB-
cord-005453-4057qib7	14297	19	as	as	IN
cord-005453-4057qib7	14297	20	all	all	DT
cord-005453-4057qib7	14297	21	patients	patient	NNS
cord-005453-4057qib7	14297	22	received	receive	VBD
cord-005453-4057qib7	14297	23	4	4	CD
cord-005453-4057qib7	14297	24	cycles	cycle	NNS
cord-005453-4057qib7	14297	25	induction	induction	NN
cord-005453-4057qib7	14297	26	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14297	27	followed	follow	VBN
cord-005453-4057qib7	14297	28	by	by	IN
cord-005453-4057qib7	14297	29	consolidation	consolidation	NN
cord-005453-4057qib7	14297	30	myloablative	myloablative	NNP
cord-005453-4057qib7	14297	31	conditioning	conditioning	NN
cord-005453-4057qib7	14297	32	,	,	,
cord-005453-4057qib7	14297	33	CEM	CEM	NNP
cord-005453-4057qib7	14297	34	(	(	-LRB-
cord-005453-4057qib7	14297	35	VP16	VP16	NNP
cord-005453-4057qib7	14297	36	416.6	416.6	CD
cord-005453-4057qib7	14297	37	mg	mg	NNP
cord-005453-4057qib7	14297	38	/	/	SYM
cord-005453-4057qib7	14297	39	m2	m2	NNP
cord-005453-4057qib7	14297	40	x3	x3	NNP
cord-005453-4057qib7	14297	41	,	,	,
cord-005453-4057qib7	14297	42	Melphalan	Melphalan	NNP
cord-005453-4057qib7	14297	43	:	:	:
cord-005453-4057qib7	14297	44	40	40	CD
cord-005453-4057qib7	14297	45	mg	mg	NNP
cord-005453-4057qib7	14297	46	/	/	SYM
cord-005453-4057qib7	14297	47	m2	m2	NNP
cord-005453-4057qib7	14297	48	x4	x4	NNP
cord-005453-4057qib7	14297	49	,	,	,
cord-005453-4057qib7	14297	50	Carboplatin	Carboplatin	NNP
cord-005453-4057qib7	14297	51	:	:	:
cord-005453-4057qib7	14297	52	500	500	CD
cord-005453-4057qib7	14297	53	mg	mg	NNP
cord-005453-4057qib7	14297	54	/	/	SYM
cord-005453-4057qib7	14297	55	m2	m2	NNP
cord-005453-4057qib7	14297	56	x3	x3	NNP
cord-005453-4057qib7	14297	57	)	)	-RRB-
cord-005453-4057qib7	14297	58	and	and	CC
cord-005453-4057qib7	14297	59	stem	stem	VB
cord-005453-4057qib7	14297	60	cell	cell	NN
cord-005453-4057qib7	14297	61	rescue	rescue	NN
cord-005453-4057qib7	14297	62	.	.	.
cord-005453-4057qib7	14298	1	Patients	patient	NNS
cord-005453-4057qib7	14298	2	data	datum	NNS
cord-005453-4057qib7	14298	3	including	include	VBG
cord-005453-4057qib7	14298	4	initial	initial	JJ
cord-005453-4057qib7	14298	5	disease	disease	NN
cord-005453-4057qib7	14298	6	characteristics	characteristic	NNS
cord-005453-4057qib7	14298	7	,	,	,
cord-005453-4057qib7	14298	8	transplant	transplant	NN
cord-005453-4057qib7	14298	9	data	datum	NNS
cord-005453-4057qib7	14298	10	,	,	,
cord-005453-4057qib7	14298	11	and	and	CC
cord-005453-4057qib7	14298	12	survival	survival	NN
cord-005453-4057qib7	14298	13	outcomes	outcome	NNS
cord-005453-4057qib7	14298	14	were	be	VBD
cord-005453-4057qib7	14298	15	collected	collect	VBN
cord-005453-4057qib7	14298	16	and	and	CC
cord-005453-4057qib7	14298	17	analyzed	analyze	VBN
cord-005453-4057qib7	14298	18	Results	result	NNS
cord-005453-4057qib7	14298	19	:	:	:
cord-005453-4057qib7	14298	20	A	a	DT
cord-005453-4057qib7	14298	21	total	total	NN
cord-005453-4057qib7	14298	22	of	of	IN
cord-005453-4057qib7	14298	23	11	11	CD
cord-005453-4057qib7	14298	24	cases	case	NNS
cord-005453-4057qib7	14298	25	were	be	VBD
cord-005453-4057qib7	14298	26	included	include	VBN
cord-005453-4057qib7	14298	27	with	with	IN
cord-005453-4057qib7	14298	28	median	median	JJ
cord-005453-4057qib7	14298	29	age	age	NN
cord-005453-4057qib7	14298	30	of	of	IN
cord-005453-4057qib7	14298	31	1.7	1.7	CD
cord-005453-4057qib7	14298	32	years	year	NNS
cord-005453-4057qib7	14298	33	,	,	,
cord-005453-4057qib7	14298	34	and	and	CC
cord-005453-4057qib7	14298	35	male	male	JJ
cord-005453-4057qib7	14298	36	to	to	IN
cord-005453-4057qib7	14298	37	female	female	JJ
cord-005453-4057qib7	14298	38	ratio	ratio	NN
cord-005453-4057qib7	14298	39	2.66	2.66	CD
cord-005453-4057qib7	14298	40	.	.	.
cord-005453-4057qib7	14299	1	Nine	nine	CD
cord-005453-4057qib7	14299	2	patients	patient	NNS
cord-005453-4057qib7	14299	3	(	(	-LRB-
cord-005453-4057qib7	14299	4	81	81	CD
cord-005453-4057qib7	14299	5	%	%	NN
cord-005453-4057qib7	14299	6	)	)	-RRB-
cord-005453-4057qib7	14299	7	were	be	VBD
cord-005453-4057qib7	14299	8	initially	initially	RB
cord-005453-4057qib7	14299	9	presented	present	VBN
cord-005453-4057qib7	14299	10	by	by	IN
cord-005453-4057qib7	14299	11	extra	extra	JJ
cord-005453-4057qib7	14299	12	ocular	ocular	JJ
cord-005453-4057qib7	14299	13	disease	disease	NN
cord-005453-4057qib7	14299	14	,	,	,
cord-005453-4057qib7	14299	15	while	while	IN
cord-005453-4057qib7	14299	16	2	2	CD
cord-005453-4057qib7	14299	17	patients	patient	NNS
cord-005453-4057qib7	14299	18	were	be	VBD
cord-005453-4057qib7	14299	19	presented	present	VBN
cord-005453-4057qib7	14299	20	by	by	IN
cord-005453-4057qib7	14299	21	intra	intra	JJ
cord-005453-4057qib7	14299	22	ocular	ocular	JJ
cord-005453-4057qib7	14299	23	disease	disease	NN
cord-005453-4057qib7	14299	24	and	and	CC
cord-005453-4057qib7	14299	25	progressed	progress	VBD
cord-005453-4057qib7	14299	26	to	to	IN
cord-005453-4057qib7	14299	27	metastatic	metastatic	JJ
cord-005453-4057qib7	14299	28	disease	disease	NN
cord-005453-4057qib7	14299	29	.	.	.
cord-005453-4057qib7	14300	1	According	accord	VBG
cord-005453-4057qib7	14300	2	to	to	IN
cord-005453-4057qib7	14300	3	COG	cog	NN
cord-005453-4057qib7	14300	4	staging	staging	NN
cord-005453-4057qib7	14300	5	of	of	IN
cord-005453-4057qib7	14300	6	extra	extra	JJ
cord-005453-4057qib7	14300	7	ocular	ocular	JJ
cord-005453-4057qib7	14300	8	disease	disease	NN
cord-005453-4057qib7	14300	9	,	,	,
cord-005453-4057qib7	14300	10	4	4	CD
cord-005453-4057qib7	14300	11	patients	patient	NNS
cord-005453-4057qib7	14300	12	had	have	VBD
cord-005453-4057qib7	14300	13	stage	stage	NN
cord-005453-4057qib7	14300	14	4a	4a	CD
cord-005453-4057qib7	14300	15	,	,	,
cord-005453-4057qib7	14300	16	and	and	CC
cord-005453-4057qib7	14300	17	7	7	CD
cord-005453-4057qib7	14300	18	were	be	VBD
cord-005453-4057qib7	14300	19	stage	stage	NN
cord-005453-4057qib7	14300	20	4b	4b	CD
cord-005453-4057qib7	14300	21	(	(	-LRB-
cord-005453-4057qib7	14300	22	5	5	CD
cord-005453-4057qib7	14300	23	of	of	IN
cord-005453-4057qib7	14300	24	them	-PRON-	PRP
cord-005453-4057qib7	14300	25	had	have	VBD
cord-005453-4057qib7	14300	26	trilateral	trilateral	JJ
cord-005453-4057qib7	14300	27	disease	disease	NN
cord-005453-4057qib7	14300	28	)	)	-RRB-
cord-005453-4057qib7	14300	29	.	.	.
cord-005453-4057qib7	14301	1	After	after	IN
cord-005453-4057qib7	14301	2	induction	induction	NN
cord-005453-4057qib7	14301	3	therapy	therapy	NN
cord-005453-4057qib7	14301	4	,	,	,
cord-005453-4057qib7	14301	5	7(63	7(63	CD
cord-005453-4057qib7	14301	6	%	%	NN
cord-005453-4057qib7	14301	7	)	)	-RRB-
cord-005453-4057qib7	14301	8	showed	show	VBD
cord-005453-4057qib7	14301	9	complete	complete	JJ
cord-005453-4057qib7	14301	10	response	response	NN
cord-005453-4057qib7	14301	11	and	and	CC
cord-005453-4057qib7	14301	12	4	4	CD
cord-005453-4057qib7	14301	13	(	(	-LRB-
cord-005453-4057qib7	14301	14	36	36	CD
cord-005453-4057qib7	14301	15	%	%	NN
cord-005453-4057qib7	14301	16	)	)	-RRB-
cord-005453-4057qib7	14301	17	had	have	VBD
cord-005453-4057qib7	14301	18	≥	≥	CD
cord-005453-4057qib7	14301	19	partial	partial	JJ
cord-005453-4057qib7	14301	20	response	response	NN
cord-005453-4057qib7	14301	21	.	.	.
cord-005453-4057qib7	14302	1	With	with	IN
cord-005453-4057qib7	14302	2	average	average	JJ
cord-005453-4057qib7	14302	3	CD34	CD34	NNP
cord-005453-4057qib7	14302	4	count	count	NN
cord-005453-4057qib7	14302	5	of	of	IN
cord-005453-4057qib7	14302	6	4x10	4x10	CD
cord-005453-4057qib7	14302	7	6	6	CD
cord-005453-4057qib7	14302	8	/	/	SYM
cord-005453-4057qib7	14302	9	kg	kg	NNS
cord-005453-4057qib7	14302	10	,	,	,
cord-005453-4057qib7	14302	11	the	the	DT
cord-005453-4057qib7	14302	12	median	median	JJ
cord-005453-4057qib7	14302	13	time	time	NN
cord-005453-4057qib7	14302	14	to	to	IN
cord-005453-4057qib7	14302	15	ANC	ANC	NNP
cord-005453-4057qib7	14302	16	and	and	CC
cord-005453-4057qib7	14302	17	platelet	platelet	NN
cord-005453-4057qib7	14302	18	engraftment	engraftment	NN
cord-005453-4057qib7	14302	19	were	be	VBD
cord-005453-4057qib7	14302	20	10	10	CD
cord-005453-4057qib7	14302	21	days	day	NNS
cord-005453-4057qib7	14302	22	and	and	CC
cord-005453-4057qib7	14302	23	19	19	CD
cord-005453-4057qib7	14302	24	days	day	NNS
cord-005453-4057qib7	14302	25	respectively	respectively	RB
cord-005453-4057qib7	14302	26	,	,	,
cord-005453-4057qib7	14302	27	and	and	CC
cord-005453-4057qib7	14302	28	there	there	EX
cord-005453-4057qib7	14302	29	was	be	VBD
cord-005453-4057qib7	14302	30	no	no	DT
cord-005453-4057qib7	14302	31	transplant	transplant	NN
cord-005453-4057qib7	14302	32	related	relate	VBN
cord-005453-4057qib7	14302	33	mortality	mortality	NN
cord-005453-4057qib7	14302	34	.	.	.
cord-005453-4057qib7	14303	1	Post	post	JJ
cord-005453-4057qib7	14303	2	-	-	JJ
cord-005453-4057qib7	14303	3	transplant	transplant	NN
cord-005453-4057qib7	14303	4	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	14303	5	was	be	VBD
cord-005453-4057qib7	14303	6	given	give	VBN
cord-005453-4057qib7	14303	7	only	only	RB
cord-005453-4057qib7	14303	8	to	to	IN
cord-005453-4057qib7	14303	9	2	2	CD
cord-005453-4057qib7	14303	10	patients	patient	NNS
cord-005453-4057qib7	14303	11	.	.	.
cord-005453-4057qib7	14304	1	With	with	IN
cord-005453-4057qib7	14304	2	median	median	JJ
cord-005453-4057qib7	14304	3	duration	duration	NN
cord-005453-4057qib7	14304	4	of	of	IN
cord-005453-4057qib7	14304	5	follow	follow	NN
cord-005453-4057qib7	14304	6	up	up	IN
cord-005453-4057qib7	14304	7	of	of	IN
cord-005453-4057qib7	14304	8	32	32	CD
cord-005453-4057qib7	14304	9	months	month	NNS
cord-005453-4057qib7	14304	10	,	,	,
cord-005453-4057qib7	14304	11	the	the	DT
cord-005453-4057qib7	14304	12	overall	overall	JJ
cord-005453-4057qib7	14304	13	and	and	CC
cord-005453-4057qib7	14304	14	event	event	NN
cord-005453-4057qib7	14304	15	free	free	JJ
cord-005453-4057qib7	14304	16	survival	survival	NN
cord-005453-4057qib7	14304	17	rates	rate	NNS
cord-005453-4057qib7	14304	18	of	of	IN
cord-005453-4057qib7	14304	19	whole	whole	JJ
cord-005453-4057qib7	14304	20	patients	patient	NNS
cord-005453-4057qib7	14304	21	were	be	VBD
cord-005453-4057qib7	14304	22	88.9	88.9	CD
cord-005453-4057qib7	14304	23	%	%	NN
cord-005453-4057qib7	14304	24	and	and	CC
cord-005453-4057qib7	14304	25	87.5	87.5	CD
cord-005453-4057qib7	14304	26	%	%	NN
cord-005453-4057qib7	14304	27	respectively	respectively	RB
cord-005453-4057qib7	14304	28	Conclusions	conclusion	NNS
cord-005453-4057qib7	14304	29	:	:	:
cord-005453-4057qib7	14304	30	High	high	JJ
cord-005453-4057qib7	14304	31	dose	dose	NN
cord-005453-4057qib7	14304	32	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14304	33	and	and	CC
cord-005453-4057qib7	14304	34	stem	stem	NN
cord-005453-4057qib7	14304	35	cell	cell	NN
cord-005453-4057qib7	14304	36	transplantation	transplantation	NN
cord-005453-4057qib7	14304	37	is	be	VBZ
cord-005453-4057qib7	14304	38	a	a	DT
cord-005453-4057qib7	14304	39	promising	promising	JJ
cord-005453-4057qib7	14304	40	potential	potential	JJ
cord-005453-4057qib7	14304	41	curative	curative	JJ
cord-005453-4057qib7	14304	42	option	option	NN
cord-005453-4057qib7	14304	43	for	for	IN
cord-005453-4057qib7	14304	44	patients	patient	NNS
cord-005453-4057qib7	14304	45	with	with	IN
cord-005453-4057qib7	14304	46	metastatic	metastatic	JJ
cord-005453-4057qib7	14304	47	extra	extra	JJ
cord-005453-4057qib7	14304	48	ocular	ocular	JJ
cord-005453-4057qib7	14304	49	Only	only	RB
cord-005453-4057qib7	14304	50	two	two	CD
cord-005453-4057qib7	14304	51	primary	primary	JJ
cord-005453-4057qib7	14304	52	GF	gf	NN
cord-005453-4057qib7	14304	53	(	(	-LRB-
cord-005453-4057qib7	14304	54	1.4	1.4	CD
cord-005453-4057qib7	14304	55	%	%	NN
cord-005453-4057qib7	14304	56	)	)	-RRB-
cord-005453-4057qib7	14304	57	occurred	occur	VBD
cord-005453-4057qib7	14304	58	,	,	,
cord-005453-4057qib7	14304	59	both	both	CC
cord-005453-4057qib7	14304	60	without	without	IN
cord-005453-4057qib7	14304	61	DSA	DSA	NNP
cord-005453-4057qib7	14304	62	.	.	.
cord-005453-4057qib7	14305	1	20	20	CD
cord-005453-4057qib7	14305	2	patients	patient	NNS
cord-005453-4057qib7	14305	3	developed	develop	VBD
cord-005453-4057qib7	14305	4	a	a	DT
cord-005453-4057qib7	14305	5	primary	primary	JJ
cord-005453-4057qib7	14305	6	PGF	PGF	NNP
cord-005453-4057qib7	14305	7	(	(	-LRB-
cord-005453-4057qib7	14305	8	15	15	CD
cord-005453-4057qib7	14305	9	%	%	NN
cord-005453-4057qib7	14305	10	)	)	-RRB-
cord-005453-4057qib7	14305	11	.	.	.
cord-005453-4057qib7	14306	1	3-years	3-years	JJ
cord-005453-4057qib7	14306	2	OS	OS	NNP
cord-005453-4057qib7	14306	3	,	,	,
cord-005453-4057qib7	14306	4	3years	3years	JJ
cord-005453-4057qib7	14306	5	PFS	PFS	NNP
cord-005453-4057qib7	14306	6	and	and	CC
cord-005453-4057qib7	14306	7	1-year	1-year	CD
cord-005453-4057qib7	14306	8	NRM	NRM	NNP
cord-005453-4057qib7	14306	9	were	be	VBD
cord-005453-4057qib7	14306	10	analyzed	analyze	VBN
cord-005453-4057qib7	14306	11	according	accord	VBG
cord-005453-4057qib7	14306	12	to	to	IN
cord-005453-4057qib7	14306	13	the	the	DT
cord-005453-4057qib7	14306	14	presence	presence	NN
cord-005453-4057qib7	14306	15	of	of	IN
cord-005453-4057qib7	14306	16	DSA	DSA	NNP
cord-005453-4057qib7	14306	17	in	in	IN
cord-005453-4057qib7	14306	18	comparison	comparison	NN
cord-005453-4057qib7	14306	19	with	with	IN
cord-005453-4057qib7	14306	20	negative	negative	JJ
cord-005453-4057qib7	14306	21	population	population	NN
cord-005453-4057qib7	14306	22	.	.	.
cord-005453-4057qib7	14307	1	No	no	DT
cord-005453-4057qib7	14307	2	statistically	statistically	RB
cord-005453-4057qib7	14307	3	difference	difference	NN
cord-005453-4057qib7	14307	4	was	be	VBD
cord-005453-4057qib7	14307	5	found	find	VBN
cord-005453-4057qib7	14307	6	.	.	.
cord-005453-4057qib7	14308	1	No	no	DT
cord-005453-4057qib7	14308	2	impact	impact	NN
cord-005453-4057qib7	14308	3	of	of	IN
cord-005453-4057qib7	14308	4	the	the	DT
cord-005453-4057qib7	14308	5	presence	presence	NN
cord-005453-4057qib7	14308	6	of	of	IN
cord-005453-4057qib7	14308	7	DSA	DSA	NNP
cord-005453-4057qib7	14308	8	on	on	IN
cord-005453-4057qib7	14308	9	the	the	DT
cord-005453-4057qib7	14308	10	risk	risk	NN
cord-005453-4057qib7	14308	11	of	of	IN
cord-005453-4057qib7	14308	12	developing	develop	VBG
cord-005453-4057qib7	14308	13	GF	GF	NNP
cord-005453-4057qib7	14308	14	and	and	CC
cord-005453-4057qib7	14308	15	PGF	PGF	NNP
cord-005453-4057qib7	14308	16	was	be	VBD
cord-005453-4057qib7	14308	17	revealed	reveal	VBN
cord-005453-4057qib7	14308	18	.	.	.
cord-005453-4057qib7	14309	1	Major	major	JJ
cord-005453-4057qib7	14309	2	outcomes	outcome	NNS
cord-005453-4057qib7	14309	3	of	of	IN
cord-005453-4057qib7	14309	4	transplant	transplant	NN
cord-005453-4057qib7	14309	5	was	be	VBD
cord-005453-4057qib7	14309	6	analyzed	analyze	VBN
cord-005453-4057qib7	14309	7	separately	separately	RB
cord-005453-4057qib7	14309	8	in	in	IN
cord-005453-4057qib7	14309	9	patients	patient	NNS
cord-005453-4057qib7	14309	10	with	with	IN
cord-005453-4057qib7	14309	11	PGF	PGF	NNP
cord-005453-4057qib7	14309	12	and	and	CC
cord-005453-4057qib7	14309	13	good	good	JJ
cord-005453-4057qib7	14309	14	graft	graft	NN
cord-005453-4057qib7	14309	15	function	function	NN
cord-005453-4057qib7	14309	16	(	(	-LRB-
cord-005453-4057qib7	14309	17	GGF	GGF	NNP
cord-005453-4057qib7	14309	18	)	)	-RRB-
cord-005453-4057qib7	14309	19	.	.	.
cord-005453-4057qib7	14310	1	3-years	3-years	JJ
cord-005453-4057qib7	14310	2	OS	OS	NNP
cord-005453-4057qib7	14310	3	,	,	,
cord-005453-4057qib7	14310	4	3-years	3-years	CD
cord-005453-4057qib7	14310	5	PFS	PFS	NNP
cord-005453-4057qib7	14310	6	and	and	CC
cord-005453-4057qib7	14310	7	1year	1year	CD
cord-005453-4057qib7	14310	8	-	-	HYPH
cord-005453-4057qib7	14310	9	NRM	NRM	NNP
cord-005453-4057qib7	14310	10	in	in	IN
cord-005453-4057qib7	14310	11	GGF	GGF	NNP
cord-005453-4057qib7	14310	12	and	and	CC
cord-005453-4057qib7	14310	13	primary	primary	JJ
cord-005453-4057qib7	14310	14	PGF	PGF	NNP
cord-005453-4057qib7	14310	15	populations	population	NNS
cord-005453-4057qib7	14310	16	were	be	VBD
cord-005453-4057qib7	14310	17	62	62	CD
cord-005453-4057qib7	14310	18	%	%	NN
cord-005453-4057qib7	14310	19	vs	vs	IN
cord-005453-4057qib7	14310	20	20	20	CD
cord-005453-4057qib7	14310	21	%	%	NN
cord-005453-4057qib7	14310	22	(	(	-LRB-
cord-005453-4057qib7	14310	23	p	p	NN
cord-005453-4057qib7	14310	24	<	<	XX
cord-005453-4057qib7	14310	25	0.0001	0.0001	CD
cord-005453-4057qib7	14310	26	)	)	-RRB-
cord-005453-4057qib7	14310	27	;	;	:
cord-005453-4057qib7	14310	28	53	53	CD
cord-005453-4057qib7	14310	29	%	%	NN
cord-005453-4057qib7	14310	30	vs	vs	IN
cord-005453-4057qib7	14310	31	20	20	CD
cord-005453-4057qib7	14310	32	%	%	NN
cord-005453-4057qib7	14310	33	(	(	-LRB-
cord-005453-4057qib7	14310	34	p	p	NN
cord-005453-4057qib7	14310	35	<	<	XX
cord-005453-4057qib7	14310	36	0.001	0.001	CD
cord-005453-4057qib7	14310	37	)	)	-RRB-
cord-005453-4057qib7	14310	38	,	,	,
cord-005453-4057qib7	14310	39	12	12	CD
cord-005453-4057qib7	14310	40	%	%	NN
cord-005453-4057qib7	14310	41	vs	vs	IN
cord-005453-4057qib7	14310	42	40	40	CD
cord-005453-4057qib7	14310	43	%	%	NN
cord-005453-4057qib7	14310	44	(	(	-LRB-
cord-005453-4057qib7	14310	45	p=0.009	p=0.009	NN
cord-005453-4057qib7	14310	46	)	)	-RRB-
cord-005453-4057qib7	14310	47	,	,	,
cord-005453-4057qib7	14310	48	respectively	respectively	RB
cord-005453-4057qib7	14310	49	.	.	.
cord-005453-4057qib7	14311	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14311	2	:	:	:
cord-005453-4057qib7	14312	1	The	the	DT
cord-005453-4057qib7	14312	2	presence	presence	NN
cord-005453-4057qib7	14312	3	of	of	IN
cord-005453-4057qib7	14312	4	low	low	JJ
cord-005453-4057qib7	14312	5	level	level	NN
cord-005453-4057qib7	14312	6	of	of	IN
cord-005453-4057qib7	14312	7	DSA	DSA	NNP
cord-005453-4057qib7	14312	8	in	in	IN
cord-005453-4057qib7	14312	9	the	the	DT
cord-005453-4057qib7	14312	10	absence	absence	NN
cord-005453-4057qib7	14312	11	of	of	IN
cord-005453-4057qib7	14312	12	desensitization	desensitization	NN
cord-005453-4057qib7	14312	13	does	do	VBZ
cord-005453-4057qib7	14312	14	n't	not	RB
cord-005453-4057qib7	14312	15	correlate	correlate	VB
cord-005453-4057qib7	14312	16	with	with	IN
cord-005453-4057qib7	14312	17	the	the	DT
cord-005453-4057qib7	14312	18	risk	risk	NN
cord-005453-4057qib7	14312	19	of	of	IN
cord-005453-4057qib7	14312	20	developing	develop	VBG
cord-005453-4057qib7	14312	21	GF	GF	NNP
cord-005453-4057qib7	14312	22	and	and	CC
cord-005453-4057qib7	14312	23	PGF	PGF	NNP
cord-005453-4057qib7	14312	24	.	.	.
cord-005453-4057qib7	14313	1	Patients	patient	NNS
cord-005453-4057qib7	14313	2	who	who	WP
cord-005453-4057qib7	14313	3	experienced	experience	VBD
cord-005453-4057qib7	14313	4	a	a	DT
cord-005453-4057qib7	14313	5	PGF	PGF	NNP
cord-005453-4057qib7	14313	6	had	have	VBD
cord-005453-4057qib7	14313	7	worse	bad	JJR
cord-005453-4057qib7	14313	8	outcomes	outcome	NNS
cord-005453-4057qib7	14313	9	in	in	IN
cord-005453-4057qib7	14313	10	comparison	comparison	NN
cord-005453-4057qib7	14313	11	with	with	IN
cord-005453-4057qib7	14313	12	patients	patient	NNS
cord-005453-4057qib7	14313	13	with	with	IN
cord-005453-4057qib7	14313	14	GGF	GGF	NNP
cord-005453-4057qib7	14313	15	.	.	.
cord-005453-4057qib7	14314	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14314	2	:	:	:
cord-005453-4057qib7	14314	3	Nothing	nothing	NN
cord-005453-4057qib7	14314	4	to	to	TO
cord-005453-4057qib7	14314	5	declare	declare	VB
cord-005453-4057qib7	14314	6	.	.	.
cord-005453-4057qib7	14315	1	The	the	DT
cord-005453-4057qib7	14315	2	impact	impact	NN
cord-005453-4057qib7	14315	3	of	of	IN
cord-005453-4057qib7	14315	4	HLA	HLA	NNP
cord-005453-4057qib7	14315	5	-	-	HYPH
cord-005453-4057qib7	14315	6	DPB1	DPB1	NNP
cord-005453-4057qib7	14315	7	mismatch	mismatch	NN
cord-005453-4057qib7	14315	8	in	in	IN
cord-005453-4057qib7	14316	1	T	t	NN
cord-005453-4057qib7	14316	2	-	-	HYPH
cord-005453-4057qib7	14316	3	cell	cell	NN
cord-005453-4057qib7	14316	4	replete	replete	JJ
cord-005453-4057qib7	14316	5	unrelated	unrelated	JJ
cord-005453-4057qib7	14316	6	donor	donor	NN
cord-005453-4057qib7	14316	7	allogeneic	allogeneic	NN
cord-005453-4057qib7	14316	8	stem	stem	NN
cord-005453-4057qib7	14316	9	cell	cell	NN
cord-005453-4057qib7	14316	10	transplantation	transplantation	NN
cord-005453-4057qib7	14316	11	Background	background	NN
cord-005453-4057qib7	14316	12	:	:	:
cord-005453-4057qib7	14317	1	High	high	JJ
cord-005453-4057qib7	14317	2	resolution	resolution	NN
cord-005453-4057qib7	14317	3	matching	matching	NN
cord-005453-4057qib7	14317	4	of	of	IN
cord-005453-4057qib7	14317	5	donor	donor	NN
cord-005453-4057qib7	14317	6	-	-	HYPH
cord-005453-4057qib7	14317	7	recipient	recipient	NN
cord-005453-4057qib7	14317	8	HLA	HLA	NNP
cord-005453-4057qib7	14317	9	improves	improve	VBZ
cord-005453-4057qib7	14317	10	outcome	outcome	NN
cord-005453-4057qib7	14317	11	in	in	IN
cord-005453-4057qib7	14317	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	14317	13	stem	stem	NN
cord-005453-4057qib7	14317	14	cell	cell	NN
cord-005453-4057qib7	14317	15	transplants	transplant	NNS
cord-005453-4057qib7	14317	16	.	.	.
cord-005453-4057qib7	14318	1	Matching	match	VBG
cord-005453-4057qib7	14318	2	for	for	IN
cord-005453-4057qib7	14318	3	HLA	HLA	NNP
cord-005453-4057qib7	14318	4	-	-	HYPH
cord-005453-4057qib7	14318	5	A	A	NNP
cord-005453-4057qib7	14318	6	,	,	,
cord-005453-4057qib7	14318	7	-B	-b	ADD
cord-005453-4057qib7	14318	8	,	,	,
cord-005453-4057qib7	14318	9	-C	-C	NNS
cord-005453-4057qib7	14318	10	,	,	,
cord-005453-4057qib7	14318	11	-DRB1	-DRB1	NNP
cord-005453-4057qib7	14319	1	and	and	CC
cord-005453-4057qib7	14319	2	-DQ	-dq	NN
cord-005453-4057qib7	14319	3	is	be	VBZ
cord-005453-4057qib7	14319	4	mandatory	mandatory	JJ
cord-005453-4057qib7	14319	5	in	in	IN
cord-005453-4057qib7	14319	6	our	-PRON-	PRP$
cord-005453-4057qib7	14319	7	transplant	transplant	NN
cord-005453-4057qib7	14319	8	centre	centre	NN
cord-005453-4057qib7	14319	9	,	,	,
cord-005453-4057qib7	14319	10	to	to	TO
cord-005453-4057qib7	14319	11	identify	identify	VB
cord-005453-4057qib7	14319	12	10/10	10/10	CD
cord-005453-4057qib7	14319	13	or	or	CC
cord-005453-4057qib7	14319	14	9/10	9/10	CD
cord-005453-4057qib7	14319	15	matched	match	VBN
cord-005453-4057qib7	14319	16	unrelated	unrelated	JJ
cord-005453-4057qib7	14319	17	donors	donor	NNS
cord-005453-4057qib7	14319	18	.	.	.
cord-005453-4057qib7	14320	1	High	high	JJ
cord-005453-4057qib7	14320	2	resolution	resolution	NN
cord-005453-4057qib7	14320	3	matching	matching	NN
cord-005453-4057qib7	14320	4	for	for	IN
cord-005453-4057qib7	14320	5	DPB1	DPB1	NNP
cord-005453-4057qib7	14320	6	has	have	VBZ
cord-005453-4057qib7	14320	7	been	be	VBN
cord-005453-4057qib7	14320	8	added	add	VBN
cord-005453-4057qib7	14320	9	over	over	IN
cord-005453-4057qib7	14320	10	the	the	DT
cord-005453-4057qib7	14320	11	last	last	JJ
cord-005453-4057qib7	14320	12	10	10	CD
cord-005453-4057qib7	14320	13	-	-	SYM
cord-005453-4057qib7	14320	14	15	15	CD
cord-005453-4057qib7	14320	15	years	year	NNS
cord-005453-4057qib7	14320	16	.	.	.
cord-005453-4057qib7	14321	1	However	however	RB
cord-005453-4057qib7	14321	2	,	,	,
cord-005453-4057qib7	14321	3	the	the	DT
cord-005453-4057qib7	14321	4	role	role	NN
cord-005453-4057qib7	14321	5	of	of	IN
cord-005453-4057qib7	14321	6	DPB1	dpb1	JJ
cord-005453-4057qib7	14321	7	matching	matching	NN
cord-005453-4057qib7	14321	8	is	be	VBZ
cord-005453-4057qib7	14321	9	not	not	RB
cord-005453-4057qib7	14321	10	yet	yet	RB
cord-005453-4057qib7	14321	11	clearly	clearly	RB
cord-005453-4057qib7	14321	12	defined	define	VBN
cord-005453-4057qib7	14321	13	.	.	.
cord-005453-4057qib7	14322	1	Methods	method	NNS
cord-005453-4057qib7	14322	2	:	:	:
cord-005453-4057qib7	14322	3	In	in	IN
cord-005453-4057qib7	14322	4	this	this	DT
cord-005453-4057qib7	14322	5	study	study	NN
cord-005453-4057qib7	14322	6	,	,	,
cord-005453-4057qib7	14322	7	we	-PRON-	PRP
cord-005453-4057qib7	14322	8	retrospectively	retrospectively	RB
cord-005453-4057qib7	14322	9	analyzed	analyze	VBD
cord-005453-4057qib7	14322	10	the	the	DT
cord-005453-4057qib7	14322	11	impact	impact	NN
cord-005453-4057qib7	14322	12	of	of	IN
cord-005453-4057qib7	14322	13	HLA	HLA	NNP
cord-005453-4057qib7	14322	14	-	-	HYPH
cord-005453-4057qib7	14322	15	DPB1	DPB1	NNP
cord-005453-4057qib7	14322	16	matching	matching	NN
cord-005453-4057qib7	14322	17	on	on	IN
cord-005453-4057qib7	14322	18	the	the	DT
cord-005453-4057qib7	14322	19	outcome	outcome	NN
cord-005453-4057qib7	14322	20	of	of	IN
cord-005453-4057qib7	14322	21	T	t	NN
cord-005453-4057qib7	14322	22	-	-	HYPH
cord-005453-4057qib7	14322	23	cell	cell	NN
cord-005453-4057qib7	14322	24	replete	replete	NN
cord-005453-4057qib7	14322	25	allogeneic	allogeneic	NN
cord-005453-4057qib7	14322	26	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14322	27	stem	stem	NN
cord-005453-4057qib7	14322	28	cell	cell	NN
cord-005453-4057qib7	14322	29	transplants	transplant	NNS
cord-005453-4057qib7	14322	30	with	with	IN
cord-005453-4057qib7	14322	31	CyA	cya	NN
cord-005453-4057qib7	14322	32	/	/	SYM
cord-005453-4057qib7	14322	33	Mtx	Mtx	NNP
cord-005453-4057qib7	14322	34	-	-	:
cord-005453-4057qib7	14322	35	and	and	CC
cord-005453-4057qib7	14322	36	without	without	IN
cord-005453-4057qib7	14322	37	ATG	ATG	NNP
cord-005453-4057qib7	14322	38	as	as	IN
cord-005453-4057qib7	14322	39	GVHD	GVHD	NNP
cord-005453-4057qib7	14322	40	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14322	41	in	in	IN
cord-005453-4057qib7	14322	42	patients	patient	NNS
cord-005453-4057qib7	14322	43	with	with	IN
cord-005453-4057qib7	14322	44	hematological	hematological	JJ
cord-005453-4057qib7	14322	45	malignancies	malignancy	NNS
cord-005453-4057qib7	14322	46	at	at	IN
cord-005453-4057qib7	14322	47	Oslo	Oslo	NNP
cord-005453-4057qib7	14322	48	University	University	NNP
cord-005453-4057qib7	14322	49	Hospital	Hospital	NNP
cord-005453-4057qib7	14322	50	between	between	IN
cord-005453-4057qib7	14322	51	2005	2005	CD
cord-005453-4057qib7	14322	52	and	and	CC
cord-005453-4057qib7	14322	53	2017	2017	CD
cord-005453-4057qib7	14322	54	.	.	.
cord-005453-4057qib7	14323	1	301	301	CD
cord-005453-4057qib7	14323	2	patients	patient	NNS
cord-005453-4057qib7	14323	3	with	with	IN
cord-005453-4057qib7	14323	4	an	an	DT
cord-005453-4057qib7	14323	5	unrelated	unrelated	JJ
cord-005453-4057qib7	14323	6	donor	donor	NN
cord-005453-4057qib7	14323	7	fully	fully	RB
cord-005453-4057qib7	14323	8	matched	match	VBN
cord-005453-4057qib7	14323	9	(	(	-LRB-
cord-005453-4057qib7	14323	10	10/10	10/10	CD
cord-005453-4057qib7	14323	11	)	)	-RRB-
cord-005453-4057qib7	14323	12	at	at	IN
cord-005453-4057qib7	14323	13	HLA	HLA	NNP
cord-005453-4057qib7	14323	14	-	-	HYPH
cord-005453-4057qib7	14323	15	A	A	NNP
cord-005453-4057qib7	14323	16	,	,	,
cord-005453-4057qib7	14323	17	-B	-b	ADD
cord-005453-4057qib7	14323	18	,	,	,
cord-005453-4057qib7	14323	19	-C	-C	NNS
cord-005453-4057qib7	14323	20	,	,	,
cord-005453-4057qib7	14323	21	-DRB1	-drb1	NN
cord-005453-4057qib7	14323	22	and	and	CC
cord-005453-4057qib7	14323	23	-DQB1	-dqb1	NN
cord-005453-4057qib7	14323	24	loci	locus	NNS
cord-005453-4057qib7	14323	25	were	be	VBD
cord-005453-4057qib7	14323	26	included	include	VBN
cord-005453-4057qib7	14323	27	.	.	.
cord-005453-4057qib7	14324	1	Further	further	RB
cord-005453-4057qib7	14324	2	,	,	,
cord-005453-4057qib7	14324	3	87	87	CD
cord-005453-4057qib7	14324	4	patientrecipient	patientrecipient	NN
cord-005453-4057qib7	14324	5	pairs	pair	NNS
cord-005453-4057qib7	14324	6	were	be	VBD
cord-005453-4057qib7	14324	7	also	also	RB
cord-005453-4057qib7	14324	8	fully	fully	RB
cord-005453-4057qib7	14324	9	matched	match	VBN
cord-005453-4057qib7	14324	10	on	on	IN
cord-005453-4057qib7	14324	11	DPB1	DPB1	NNP
cord-005453-4057qib7	14324	12	(	(	-LRB-
cord-005453-4057qib7	14324	13	12/12	12/12	CD
cord-005453-4057qib7	14324	14	)	)	-RRB-
cord-005453-4057qib7	14324	15	;	;	:
cord-005453-4057qib7	14324	16	118	118	CD
cord-005453-4057qib7	14324	17	had	have	VBD
cord-005453-4057qib7	14324	18	permissive	permissive	JJ
cord-005453-4057qib7	14324	19	and	and	CC
cord-005453-4057qib7	14324	20	96	96	CD
cord-005453-4057qib7	14324	21	had	have	VBD
cord-005453-4057qib7	14324	22	non	non	JJ
cord-005453-4057qib7	14324	23	-	-	JJ
cord-005453-4057qib7	14324	24	permissive	permissive	JJ
cord-005453-4057qib7	14324	25	mimatches	mimatche	NNS
cord-005453-4057qib7	14324	26	of	of	IN
cord-005453-4057qib7	14324	27	one	one	CD
cord-005453-4057qib7	14324	28	or	or	CC
cord-005453-4057qib7	14324	29	two	two	CD
cord-005453-4057qib7	14324	30	DPB1	dpb1	JJ
cord-005453-4057qib7	14324	31	alleles	allele	NNS
cord-005453-4057qib7	14324	32	.	.	.
cord-005453-4057qib7	14325	1	The	the	DT
cord-005453-4057qib7	14325	2	Three	three	CD
cord-005453-4057qib7	14325	3	Groups	Groups	NNPS
cord-005453-4057qib7	14325	4	were	be	VBD
cord-005453-4057qib7	14325	5	comparable	comparable	JJ
cord-005453-4057qib7	14325	6	with	with	IN
cord-005453-4057qib7	14325	7	respect	respect	NN
cord-005453-4057qib7	14325	8	to	to	IN
cord-005453-4057qib7	14325	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	14325	10	,	,	,
cord-005453-4057qib7	14325	11	gender	gender	NN
cord-005453-4057qib7	14325	12	,	,	,
cord-005453-4057qib7	14325	13	age	age	NN
cord-005453-4057qib7	14325	14	,	,	,
cord-005453-4057qib7	14325	15	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	14325	16	serostatus	serostatus	NN
cord-005453-4057qib7	14325	17	and	and	CC
cord-005453-4057qib7	14325	18	conditioning	conditioning	NN
cord-005453-4057qib7	14325	19	regimen	regimen	NN
cord-005453-4057qib7	14325	20	.	.	.
cord-005453-4057qib7	14326	1	Results	result	NNS
cord-005453-4057qib7	14326	2	:	:	:
cord-005453-4057qib7	14327	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	14327	2	incidence	incidence	NN
cord-005453-4057qib7	14327	3	of	of	IN
cord-005453-4057qib7	14327	4	relapse	relapse	NN
cord-005453-4057qib7	14327	5	at	at	IN
cord-005453-4057qib7	14327	6	5	5	CD
cord-005453-4057qib7	14327	7	years	year	NNS
cord-005453-4057qib7	14327	8	were	be	VBD
cord-005453-4057qib7	14327	9	significantly	significantly	RB
cord-005453-4057qib7	14327	10	higher	high	JJR
cord-005453-4057qib7	14327	11	in	in	IN
cord-005453-4057qib7	14327	12	the	the	DT
cord-005453-4057qib7	14327	13	DPB1	DPB1	NNP
cord-005453-4057qib7	14327	14	matched	match	VBN
cord-005453-4057qib7	14327	15	pairs	pair	NNS
cord-005453-4057qib7	14327	16	compared	compare	VBN
cord-005453-4057qib7	14327	17	with	with	IN
cord-005453-4057qib7	14327	18	the	the	DT
cord-005453-4057qib7	14327	19	permissive	permissive	JJ
cord-005453-4057qib7	14327	20	and	and	CC
cord-005453-4057qib7	14327	21	non	non	JJ
cord-005453-4057qib7	14327	22	-	-	JJ
cord-005453-4057qib7	14327	23	permissive	permissive	JJ
cord-005453-4057qib7	14327	24	mimatched	mimatche	VBN
cord-005453-4057qib7	14327	25	ones	one	NNS
cord-005453-4057qib7	14327	26	,	,	,
cord-005453-4057qib7	14327	27	at	at	IN
cord-005453-4057qib7	14327	28	40	40	CD
cord-005453-4057qib7	14327	29	%	%	NN
cord-005453-4057qib7	14327	30	vs	vs	IN
cord-005453-4057qib7	14327	31	22	22	CD
cord-005453-4057qib7	14327	32	%	%	NN
cord-005453-4057qib7	14327	33	and	and	CC
cord-005453-4057qib7	14327	34	13	13	CD
cord-005453-4057qib7	14327	35	%	%	NN
cord-005453-4057qib7	14327	36	(	(	-LRB-
cord-005453-4057qib7	14327	37	p	p	NN
cord-005453-4057qib7	14327	38	<	<	XX
cord-005453-4057qib7	14327	39	0.001	0.001	CD
cord-005453-4057qib7	14327	40	)	)	-RRB-
cord-005453-4057qib7	14327	41	respectively	respectively	RB
cord-005453-4057qib7	14327	42	.	.	.
cord-005453-4057qib7	14328	1	Relpase	Relpase	NNP
cord-005453-4057qib7	14328	2	free	free	JJ
cord-005453-4057qib7	14328	3	survival	survival	NN
cord-005453-4057qib7	14328	4	and	and	CC
cord-005453-4057qib7	14328	5	overall	overall	JJ
cord-005453-4057qib7	14328	6	survival	survival	NN
cord-005453-4057qib7	14328	7	were	be	VBD
cord-005453-4057qib7	14328	8	superior	superior	JJ
cord-005453-4057qib7	14328	9	in	in	IN
cord-005453-4057qib7	14328	10	the	the	DT
cord-005453-4057qib7	14328	11	nonpermissive	nonpermissive	JJ
cord-005453-4057qib7	14328	12	and	and	CC
cord-005453-4057qib7	14328	13	permissive	permissive	JJ
cord-005453-4057qib7	14328	14	DBP1	DBP1	NNP
cord-005453-4057qib7	14328	15	mismatched	mismatched	JJ
cord-005453-4057qib7	14328	16	groups	group	NNS
cord-005453-4057qib7	14328	17	vs	vs	IN
cord-005453-4057qib7	14328	18	the	the	DT
cord-005453-4057qib7	14328	19	fully	fully	RB
cord-005453-4057qib7	14328	20	matched	match	VBN
cord-005453-4057qib7	14328	21	,	,	,
cord-005453-4057qib7	14328	22	at	at	IN
cord-005453-4057qib7	14328	23	60	60	CD
cord-005453-4057qib7	14328	24	%	%	NN
cord-005453-4057qib7	14328	25	and	and	CC
cord-005453-4057qib7	14328	26	49	49	CD
cord-005453-4057qib7	14328	27	%	%	NN
cord-005453-4057qib7	14328	28	vs	vs	IN
cord-005453-4057qib7	14328	29	29	29	CD
cord-005453-4057qib7	14328	30	%	%	NN
cord-005453-4057qib7	14328	31	(	(	-LRB-
cord-005453-4057qib7	14328	32	p=0.01	p=0.01	NNP
cord-005453-4057qib7	14328	33	)	)	-RRB-
cord-005453-4057qib7	14328	34	and	and	CC
cord-005453-4057qib7	14328	35	59	59	CD
cord-005453-4057qib7	14328	36	%	%	NN
cord-005453-4057qib7	14328	37	and	and	CC
cord-005453-4057qib7	14328	38	53	53	CD
cord-005453-4057qib7	14328	39	%	%	NN
cord-005453-4057qib7	14328	40	vs	vs	IN
cord-005453-4057qib7	14328	41	40	40	CD
cord-005453-4057qib7	14328	42	%	%	NN
cord-005453-4057qib7	14328	43	(	(	-LRB-
cord-005453-4057qib7	14328	44	p=0.09	p=0.09	NN
cord-005453-4057qib7	14328	45	)	)	-RRB-
cord-005453-4057qib7	14328	46	respectively	respectively	RB
cord-005453-4057qib7	14328	47	.	.	.
cord-005453-4057qib7	14329	1	No	no	DT
cord-005453-4057qib7	14329	2	difference	difference	NN
cord-005453-4057qib7	14329	3	in	in	IN
cord-005453-4057qib7	14329	4	frequency	frequency	NN
cord-005453-4057qib7	14329	5	of	of	IN
cord-005453-4057qib7	14329	6	acute	acute	JJ
cord-005453-4057qib7	14329	7	GVHD	GVHD	NNP
cord-005453-4057qib7	14329	8	grade	grade	NN
cord-005453-4057qib7	14329	9	II	II	NNP
cord-005453-4057qib7	14329	10	-	-	HYPH
cord-005453-4057qib7	14329	11	IV	IV	NNP
cord-005453-4057qib7	14329	12	between	between	IN
cord-005453-4057qib7	14329	13	the	the	DT
cord-005453-4057qib7	14329	14	three	three	CD
cord-005453-4057qib7	14329	15	groups	group	NNS
cord-005453-4057qib7	14329	16	were	be	VBD
cord-005453-4057qib7	14329	17	found	find	VBN
cord-005453-4057qib7	14329	18	;	;	:
cord-005453-4057qib7	14329	19	DP	DP	NNP
cord-005453-4057qib7	14329	20	match	match	VBP
cord-005453-4057qib7	14329	21	43	43	CD
cord-005453-4057qib7	14329	22	%	%	NN
cord-005453-4057qib7	14329	23	,	,	,
cord-005453-4057qib7	14329	24	permissive	permissive	JJ
cord-005453-4057qib7	14329	25	mismatch	mismatch	NN
cord-005453-4057qib7	14329	26	40	40	CD
cord-005453-4057qib7	14329	27	%	%	NN
cord-005453-4057qib7	14329	28	and	and	CC
cord-005453-4057qib7	14329	29	non	non	JJ
cord-005453-4057qib7	14329	30	-	-	JJ
cord-005453-4057qib7	14329	31	permissive	permissive	JJ
cord-005453-4057qib7	14329	32	mismatched	mismatch	VBN
cord-005453-4057qib7	14329	33	48	48	CD
cord-005453-4057qib7	14329	34	%	%	NN
cord-005453-4057qib7	14330	1	(	(	-LRB-
cord-005453-4057qib7	14330	2	p=0.49	p=0.49	NNP
cord-005453-4057qib7	14330	3	)	)	-RRB-
cord-005453-4057qib7	14330	4	.	.	.
cord-005453-4057qib7	14331	1	Neither	neither	DT
cord-005453-4057qib7	14331	2	was	be	VBD
cord-005453-4057qib7	14331	3	there	there	EX
cord-005453-4057qib7	14331	4	a	a	DT
cord-005453-4057qib7	14331	5	difference	difference	NN
cord-005453-4057qib7	14331	6	seen	see	VBN
cord-005453-4057qib7	14331	7	in	in	IN
cord-005453-4057qib7	14331	8	GVHD	GVHD	NNP
cord-005453-4057qib7	14331	9	grade	grade	NN
cord-005453-4057qib7	14331	10	III	III	NNP
cord-005453-4057qib7	14331	11	-	-	HYPH
cord-005453-4057qib7	14331	12	IV	IV	NNP
cord-005453-4057qib7	14331	13	;	;	:
cord-005453-4057qib7	14331	14	12	12	CD
cord-005453-4057qib7	14331	15	%	%	NN
cord-005453-4057qib7	14331	16	vs	vs	IN
cord-005453-4057qib7	14331	17	17	17	CD
cord-005453-4057qib7	14331	18	%	%	NN
cord-005453-4057qib7	14331	19	vs	vs	IN
cord-005453-4057qib7	14331	20	11	11	CD
cord-005453-4057qib7	14331	21	%	%	NN
cord-005453-4057qib7	14331	22	,	,	,
cord-005453-4057qib7	14331	23	respectively	respectively	RB
cord-005453-4057qib7	14331	24	.	.	.
cord-005453-4057qib7	14332	1	Finally	finally	RB
cord-005453-4057qib7	14332	2	,	,	,
cord-005453-4057qib7	14332	3	there	there	EX
cord-005453-4057qib7	14332	4	were	be	VBD
cord-005453-4057qib7	14332	5	similar	similar	JJ
cord-005453-4057qib7	14332	6	outcomes	outcome	NNS
cord-005453-4057qib7	14332	7	between	between	IN
cord-005453-4057qib7	14332	8	the	the	DT
cord-005453-4057qib7	14332	9	three	three	CD
cord-005453-4057qib7	14332	10	groups	group	NNS
cord-005453-4057qib7	14332	11	regarding	regard	VBG
cord-005453-4057qib7	14332	12	chronic	chronic	JJ
cord-005453-4057qib7	14332	13	GVHD	GVHD	NNP
cord-005453-4057qib7	14332	14	and	and	CC
cord-005453-4057qib7	14332	15	TRM	TRM	NNP
cord-005453-4057qib7	14332	16	.	.	.
cord-005453-4057qib7	14333	1	In	in	IN
cord-005453-4057qib7	14333	2	corrected	correct	VBN
cord-005453-4057qib7	14333	3	multivariate	multivariate	JJ
cord-005453-4057qib7	14333	4	analysis	analysis	NN
cord-005453-4057qib7	14333	5	,	,	,
cord-005453-4057qib7	14333	6	only	only	RB
cord-005453-4057qib7	14333	7	DP	dp	NN
cord-005453-4057qib7	14333	8	matching	matching	NN
cord-005453-4057qib7	14333	9	had	have	VBD
cord-005453-4057qib7	14333	10	significant	significant	JJ
cord-005453-4057qib7	14333	11	influence	influence	NN
cord-005453-4057qib7	14333	12	on	on	IN
cord-005453-4057qib7	14333	13	mortality	mortality	NN
cord-005453-4057qib7	14333	14	and	and	CC
cord-005453-4057qib7	14333	15	survival	survival	NN
cord-005453-4057qib7	14333	16	.	.	.
cord-005453-4057qib7	14334	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14334	2	:	:	:
cord-005453-4057qib7	14335	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14335	2	results	result	NNS
cord-005453-4057qib7	14335	3	show	show	VBP
cord-005453-4057qib7	14335	4	a	a	DT
cord-005453-4057qib7	14335	5	favorable	favorable	JJ
cord-005453-4057qib7	14335	6	relapse	relapse	NN
cord-005453-4057qib7	14335	7	free	free	JJ
cord-005453-4057qib7	14335	8	and	and	CC
cord-005453-4057qib7	14335	9	overall	overall	JJ
cord-005453-4057qib7	14335	10	survival	survival	NN
cord-005453-4057qib7	14335	11	following	follow	VBG
cord-005453-4057qib7	14335	12	a	a	DT
cord-005453-4057qib7	14335	13	MUD	mud	NN
cord-005453-4057qib7	14335	14	allotransplant	allotransplant	JJ
cord-005453-4057qib7	14335	15	with	with	IN
cord-005453-4057qib7	14335	16	a	a	DT
cord-005453-4057qib7	14335	17	DPB1	dpb1	JJ
cord-005453-4057qib7	14335	18	permissive	permissive	JJ
cord-005453-4057qib7	14335	19	or	or	CC
cord-005453-4057qib7	14335	20	non	non	JJ
cord-005453-4057qib7	14335	21	-	-	JJ
cord-005453-4057qib7	14335	22	permissive	permissive	JJ
cord-005453-4057qib7	14335	23	mismatched	mismatched	JJ
cord-005453-4057qib7	14335	24	donor	donor	NN
cord-005453-4057qib7	14335	25	compared	compare	VBN
cord-005453-4057qib7	14335	26	to	to	IN
cord-005453-4057qib7	14335	27	a	a	DT
cord-005453-4057qib7	14335	28	fully	fully	RB
cord-005453-4057qib7	14335	29	DPB1	dpb1	JJ
cord-005453-4057qib7	14335	30	matched	match	VBN
cord-005453-4057qib7	14335	31	.	.	.
cord-005453-4057qib7	14336	1	This	this	DT
cord-005453-4057qib7	14336	2	is	be	VBZ
cord-005453-4057qib7	14336	3	likely	likely	JJ
cord-005453-4057qib7	14336	4	due	due	IN
cord-005453-4057qib7	14336	5	to	to	IN
cord-005453-4057qib7	14336	6	an	an	DT
cord-005453-4057qib7	14336	7	increased	increase	VBN
cord-005453-4057qib7	14336	8	GvL	gvl	NN
cord-005453-4057qib7	14336	9	-	-	HYPH
cord-005453-4057qib7	14336	10	effect	effect	NN
cord-005453-4057qib7	14336	11	in	in	IN
cord-005453-4057qib7	14336	12	DPB1	dpb1	JJ
cord-005453-4057qib7	14336	13	mismatched	mismatched	JJ
cord-005453-4057qib7	14336	14	groups	group	NNS
cord-005453-4057qib7	14336	15	without	without	IN
cord-005453-4057qib7	14336	16	the	the	DT
cord-005453-4057qib7	14336	17	counterbalance	counterbalance	NN
cord-005453-4057qib7	14336	18	of	of	IN
cord-005453-4057qib7	14336	19	increased	increase	VBN
cord-005453-4057qib7	14336	20	acute	acute	JJ
cord-005453-4057qib7	14336	21	GVHD	GVHD	NNP
cord-005453-4057qib7	14336	22	and	and	CC
cord-005453-4057qib7	14336	23	TRM	TRM	NNP
cord-005453-4057qib7	14336	24	.	.	.
cord-005453-4057qib7	14337	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14337	2	:	:	:
cord-005453-4057qib7	14337	3	Nothing	nothing	NN
cord-005453-4057qib7	14337	4	to	to	TO
cord-005453-4057qib7	14337	5	declare	declare	VB
cord-005453-4057qib7	14337	6	P662	P662	NNS
cord-005453-4057qib7	14338	1	A	a	DT
cord-005453-4057qib7	14338	2	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14338	3	may	may	MD
cord-005453-4057qib7	14338	4	be	be	VB
cord-005453-4057qib7	14338	5	a	a	DT
cord-005453-4057qib7	14338	6	better	well	JJR
cord-005453-4057qib7	14338	7	choice	choice	NN
cord-005453-4057qib7	14338	8	than	than	IN
cord-005453-4057qib7	14338	9	a	a	DT
cord-005453-4057qib7	14338	10	female	female	JJ
cord-005453-4057qib7	14338	11	genoidentical	genoidentical	JJ
cord-005453-4057qib7	14338	12	donor	donor	NN
cord-005453-4057qib7	14338	13	to	to	TO
cord-005453-4057qib7	14338	14	transplant	transplant	VB
cord-005453-4057qib7	14338	15	a	a	DT
cord-005453-4057qib7	14338	16	patient	patient	NN
cord-005453-4057qib7	14338	17	with	with	IN
cord-005453-4057qib7	14338	18	high	high	JJ
cord-005453-4057qib7	14338	19	risk	risk	NN
cord-005453-4057qib7	14338	20	acute	acute	JJ
cord-005453-4057qib7	14338	21	myelogenous	myelogenous	NN
cord-005453-4057qib7	14338	22	leukemia	leukemia	NN
cord-005453-4057qib7	14338	23	in	in	IN
cord-005453-4057qib7	14338	24	first	first	JJ
cord-005453-4057qib7	14338	25	remission	remission	NN
cord-005453-4057qib7	14338	26	Norbert	Norbert	NNP
cord-005453-4057qib7	14338	27	Gorin	Gorin	NNP
cord-005453-4057qib7	14338	28	1	1	CD
cord-005453-4057qib7	14338	29	,	,	,
cord-005453-4057qib7	14338	30	Myriam	Myriam	NNP
cord-005453-4057qib7	14338	31	Labopin	Labopin	NNP
cord-005453-4057qib7	14338	32	1	1	CD
cord-005453-4057qib7	14338	33	,	,	,
cord-005453-4057qib7	14338	34	Didier	Didier	NNP
cord-005453-4057qib7	14338	35	Blaise	Blaise	NNP
cord-005453-4057qib7	14338	36	2	2	CD
cord-005453-4057qib7	14338	37	,	,	,
cord-005453-4057qib7	14338	38	Goda	Goda	NNP
cord-005453-4057qib7	14338	39	Choi	Choi	NNP
cord-005453-4057qib7	14338	40	3	3	CD
cord-005453-4057qib7	14338	41	,	,	,
cord-005453-4057qib7	14338	42	Gerard	Gerard	NNP
cord-005453-4057qib7	14338	43	Socie	Socie	NNP
cord-005453-4057qib7	14338	44	4	4	CD
cord-005453-4057qib7	14338	45	,	,	,
cord-005453-4057qib7	14338	46	Jean	Jean	NNP
cord-005453-4057qib7	14338	47	Henri	Henri	NNP
cord-005453-4057qib7	14338	48	Bourhis	Bourhis	NNP
cord-005453-4057qib7	14338	49	5	5	CD
cord-005453-4057qib7	14338	50	,	,	,
cord-005453-4057qib7	14338	51	Fabio	Fabio	NNP
cord-005453-4057qib7	14338	52	Ciceri	Ciceri	NNP
cord-005453-4057qib7	14338	53	6	6	CD
cord-005453-4057qib7	14338	54	,	,	,
cord-005453-4057qib7	14338	55	Emmanuelle	Emmanuelle	NNP
cord-005453-4057qib7	14338	56	Polge	Polge	NNP
cord-005453-4057qib7	14338	57	7	7	CD
cord-005453-4057qib7	14338	58	,	,	,
cord-005453-4057qib7	14338	59	Arnon	Arnon	NNP
cord-005453-4057qib7	14338	60	Nagler	Nagler	NNP
cord-005453-4057qib7	14338	61	8	8	CD
cord-005453-4057qib7	14338	62	,	,	,
cord-005453-4057qib7	14338	63	Mohamad	Mohamad	NNP
cord-005453-4057qib7	14338	64	Mohty	Mohty	NNP
cord-005453-4057qib7	14338	65	1	1	CD
cord-005453-4057qib7	14338	66	China	China	NNP
cord-005453-4057qib7	14338	67	,	,	,
cord-005453-4057qib7	14338	68	3	3	CD
cord-005453-4057qib7	14338	69	The	the	DT
cord-005453-4057qib7	14338	70	First	First	NNP
cord-005453-4057qib7	14338	71	Affiliated	Affiliated	NNP
cord-005453-4057qib7	14338	72	Hospital	Hospital	NNP
cord-005453-4057qib7	14338	73	of	of	IN
cord-005453-4057qib7	14338	74	Soochow	Soochow	NNP
cord-005453-4057qib7	14338	75	University	University	NNP
cord-005453-4057qib7	14338	76	,	,	,
cord-005453-4057qib7	14338	77	Hematology	Hematology	NNP
cord-005453-4057qib7	14338	78	,	,	,
cord-005453-4057qib7	14338	79	Suzhou	Suzhou	NNP
cord-005453-4057qib7	14338	80	,	,	,
cord-005453-4057qib7	14339	1	China	China	NNP
cord-005453-4057qib7	14339	2	Background	Background	NNP
cord-005453-4057qib7	14339	3	:	:	:
cord-005453-4057qib7	14340	1	Despite	despite	IN
cord-005453-4057qib7	14340	2	the	the	DT
cord-005453-4057qib7	14340	3	incidence	incidence	NN
cord-005453-4057qib7	14340	4	of	of	IN
cord-005453-4057qib7	14340	5	leukemia	leukemia	NN
cord-005453-4057qib7	14340	6	increases	increase	NNS
cord-005453-4057qib7	14340	7	with	with	IN
cord-005453-4057qib7	14340	8	age	age	NN
cord-005453-4057qib7	14340	9	,	,	,
cord-005453-4057qib7	14340	10	currently	currently	RB
cord-005453-4057qib7	14340	11	the	the	DT
cord-005453-4057qib7	14340	12	geriatric	geriatric	JJ
cord-005453-4057qib7	14340	13	population	population	NN
cord-005453-4057qib7	14340	14	is	be	VBZ
cord-005453-4057qib7	14340	15	poorly	poorly	RB
cord-005453-4057qib7	14340	16	represented	represent	VBN
cord-005453-4057qib7	14340	17	in	in	IN
cord-005453-4057qib7	14340	18	the	the	DT
cord-005453-4057qib7	14340	19	standards	standard	NNS
cord-005453-4057qib7	14340	20	of	of	IN
cord-005453-4057qib7	14340	21	care	care	NN
cord-005453-4057qib7	14340	22	concerning	concern	VBG
cord-005453-4057qib7	14340	23	that	that	IN
cord-005453-4057qib7	14340	24	older	old	JJR
cord-005453-4057qib7	14340	25	adults	adult	NNS
cord-005453-4057qib7	14340	26	undergoing	undergo	VBG
cord-005453-4057qib7	14340	27	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14340	28	cell	cell	NN
cord-005453-4057qib7	14340	29	transplant	transplant	NN
cord-005453-4057qib7	14340	30	(	(	-LRB-
cord-005453-4057qib7	14340	31	HCT	HCT	NNP
cord-005453-4057qib7	14340	32	)	)	-RRB-
cord-005453-4057qib7	14340	33	may	may	MD
cord-005453-4057qib7	14340	34	experience	experience	VB
cord-005453-4057qib7	14340	35	higher	high	JJR
cord-005453-4057qib7	14340	36	transplant	transplant	NN
cord-005453-4057qib7	14340	37	-	-	HYPH
cord-005453-4057qib7	14340	38	related	relate	VBN
cord-005453-4057qib7	14340	39	mortality	mortality	NN
cord-005453-4057qib7	14340	40	(	(	-LRB-
cord-005453-4057qib7	14340	41	TRM	TRM	NNP
cord-005453-4057qib7	14340	42	)	)	-RRB-
cord-005453-4057qib7	14340	43	.	.	.
cord-005453-4057qib7	14341	1	Previous	previous	JJ
cord-005453-4057qib7	14341	2	studies	study	NNS
cord-005453-4057qib7	14341	3	have	have	VBP
cord-005453-4057qib7	14341	4	demonstrated	demonstrate	VBN
cord-005453-4057qib7	14341	5	that	that	IN
cord-005453-4057qib7	14341	6	donor	donor	NN
cord-005453-4057qib7	14341	7	age	age	NN
cord-005453-4057qib7	14341	8	is	be	VBZ
cord-005453-4057qib7	14341	9	vital	vital	JJ
cord-005453-4057qib7	14341	10	for	for	IN
cord-005453-4057qib7	14341	11	older	old	JJR
cord-005453-4057qib7	14341	12	patients	patient	NNS
cord-005453-4057qib7	14341	13	by	by	IN
cord-005453-4057qib7	14341	14	affecting	affect	VBG
cord-005453-4057qib7	14341	15	TRM	TRM	NNP
cord-005453-4057qib7	14341	16	and	and	CC
cord-005453-4057qib7	14341	17	survival	survival	NN
cord-005453-4057qib7	14341	18	.	.	.
cord-005453-4057qib7	14342	1	Accordingly	accordingly	RB
cord-005453-4057qib7	14342	2	a	a	DT
cord-005453-4057qib7	14342	3	relevant	relevant	JJ
cord-005453-4057qib7	14342	4	question	question	NN
cord-005453-4057qib7	14342	5	is	be	VBZ
cord-005453-4057qib7	14342	6	whether	whether	IN
cord-005453-4057qib7	14342	7	outcomes	outcome	NNS
cord-005453-4057qib7	14342	8	can	can	MD
cord-005453-4057qib7	14342	9	be	be	VB
cord-005453-4057qib7	14342	10	improved	improve	VBN
cord-005453-4057qib7	14342	11	with	with	IN
cord-005453-4057qib7	14342	12	a	a	DT
cord-005453-4057qib7	14342	13	younger	young	JJR
cord-005453-4057qib7	14342	14	HLA	HLA	NNP
cord-005453-4057qib7	14342	15	-	-	HYPH
cord-005453-4057qib7	14342	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14342	17	offspring	offspring	NN
cord-005453-4057qib7	14342	18	donor	donor	NN
cord-005453-4057qib7	14342	19	rather	rather	RB
cord-005453-4057qib7	14342	20	than	than	IN
cord-005453-4057qib7	14342	21	an	an	DT
cord-005453-4057qib7	14342	22	older	old	JJR
cord-005453-4057qib7	14342	23	HLA	HLA	NNP
cord-005453-4057qib7	14342	24	-	-	HYPH
cord-005453-4057qib7	14342	25	matched	match	VBN
cord-005453-4057qib7	14342	26	sibling	sibling	NN
cord-005453-4057qib7	14342	27	(	(	-LRB-
cord-005453-4057qib7	14342	28	MSD	MSD	NNP
cord-005453-4057qib7	14342	29	)	)	-RRB-
cord-005453-4057qib7	14342	30	.	.	.
cord-005453-4057qib7	14343	1	In	in	IN
cord-005453-4057qib7	14343	2	our	-PRON-	PRP$
cord-005453-4057qib7	14343	3	previous	previous	JJ
cord-005453-4057qib7	14343	4	multi	multi	JJ
cord-005453-4057qib7	14343	5	-	-	JJ
cord-005453-4057qib7	14343	6	center	center	JJ
cord-005453-4057qib7	14343	7	report	report	NN
cord-005453-4057qib7	14343	8	under	under	IN
cord-005453-4057qib7	14343	9	ATG+G	ATG+G	NNP
cord-005453-4057qib7	14343	10	-	-	HYPH
cord-005453-4057qib7	14343	11	CSF	CSF	NNP
cord-005453-4057qib7	14343	12	based	base	VBN
cord-005453-4057qib7	14343	13	protocol	protocol	NN
cord-005453-4057qib7	14343	14	for	for	IN
cord-005453-4057qib7	14343	15	haplo	haplo	NN
cord-005453-4057qib7	14343	16	HCT	HCT	NNP
cord-005453-4057qib7	14343	17	,	,	,
cord-005453-4057qib7	14343	18	offspring	offspring	NN
cord-005453-4057qib7	14343	19	donor	donor	NN
cord-005453-4057qib7	14343	20	is	be	VBZ
cord-005453-4057qib7	14343	21	correlated	correlate	VBN
cord-005453-4057qib7	14343	22	with	with	IN
cord-005453-4057qib7	14343	23	lower	low	JJR
cord-005453-4057qib7	14343	24	TRM	TRM	NNP
cord-005453-4057qib7	14343	25	and	and	CC
cord-005453-4057qib7	14343	26	higher	high	JJR
cord-005453-4057qib7	14343	27	leukemia	leukemia	NN
cord-005453-4057qib7	14343	28	free	free	JJ
cord-005453-4057qib7	14343	29	survival	survival	NN
cord-005453-4057qib7	14343	30	(	(	-LRB-
cord-005453-4057qib7	14343	31	LFS	LFS	NNP
cord-005453-4057qib7	14343	32	)	)	-RRB-
cord-005453-4057qib7	14343	33	as	as	IN
cord-005453-4057qib7	14343	34	compared	compare	VBN
cord-005453-4057qib7	14343	35	with	with	IN
cord-005453-4057qib7	14343	36	older	old	JJR
cord-005453-4057qib7	14343	37	MSD	MSD	NNP
cord-005453-4057qib7	14343	38	in	in	IN
cord-005453-4057qib7	14343	39	subgroup	subgroup	NN
cord-005453-4057qib7	14343	40	analysis	analysis	NN
cord-005453-4057qib7	14343	41	for	for	IN
cord-005453-4057qib7	14343	42	recipients	recipient	NNS
cord-005453-4057qib7	14343	43	>	>	NFP
cord-005453-4057qib7	14343	44	50years	50year	NNS
cord-005453-4057qib7	14343	45	although	although	IN
cord-005453-4057qib7	14343	46	it	-PRON-	PRP
cord-005453-4057qib7	14343	47	did	do	VBD
cord-005453-4057qib7	14343	48	not	not	RB
cord-005453-4057qib7	14343	49	reach	reach	VB
cord-005453-4057qib7	14343	50	statistical	statistical	JJ
cord-005453-4057qib7	14343	51	significance	significance	NN
cord-005453-4057qib7	14343	52	.	.	.
cord-005453-4057qib7	14344	1	On	on	IN
cord-005453-4057qib7	14344	2	the	the	DT
cord-005453-4057qib7	14344	3	contrary	contrary	NN
cord-005453-4057qib7	14344	4	,	,	,
cord-005453-4057qib7	14344	5	in	in	IN
cord-005453-4057qib7	14344	6	a	a	DT
cord-005453-4057qib7	14344	7	recent	recent	JJ
cord-005453-4057qib7	14344	8	report	report	NN
cord-005453-4057qib7	14344	9	from	from	IN
cord-005453-4057qib7	14344	10	EBMT	EBMT	NNP
cord-005453-4057qib7	14344	11	and	and	CC
cord-005453-4057qib7	14344	12	CIBMTR	CIBMTR	NNP
cord-005453-4057qib7	14344	13	under	under	IN
cord-005453-4057qib7	14344	14	PTCY	PTCY	NNP
cord-005453-4057qib7	14344	15	modality	modality	NN
cord-005453-4057qib7	14344	16	for	for	IN
cord-005453-4057qib7	14344	17	haplo	haplo	NN
cord-005453-4057qib7	14344	18	HCT	HCT	NNP
cord-005453-4057qib7	14344	19	,	,	,
cord-005453-4057qib7	14344	20	among	among	IN
cord-005453-4057qib7	14344	21	patients	patient	NNS
cord-005453-4057qib7	14344	22	aged	age	VBN
cord-005453-4057qib7	14344	23	55	55	CD
cord-005453-4057qib7	14344	24	to	to	TO
cord-005453-4057qib7	14344	25	76	76	CD
cord-005453-4057qib7	14344	26	years	year	NNS
cord-005453-4057qib7	14344	27	,	,	,
cord-005453-4057qib7	14344	28	despite	despite	IN
cord-005453-4057qib7	14344	29	lower	low	JJR
cord-005453-4057qib7	14344	30	chronic	chronic	JJ
cord-005453-4057qib7	14344	31	graft	graft	NN
cord-005453-4057qib7	14344	32	-	-	HYPH
cord-005453-4057qib7	14344	33	versus	versus	IN
cord-005453-4057qib7	14344	34	-	-	HYPH
cord-005453-4057qib7	14344	35	host	host	NN
cord-005453-4057qib7	14344	36	-	-	HYPH
cord-005453-4057qib7	14344	37	disease	disease	NN
cord-005453-4057qib7	14344	38	(	(	-LRB-
cord-005453-4057qib7	14344	39	GVHD	GVHD	NNP
cord-005453-4057qib7	14344	40	)	)	-RRB-
cord-005453-4057qib7	14344	41	,	,	,
cord-005453-4057qib7	14344	42	graft	graft	NN
cord-005453-4057qib7	14344	43	failure	failure	NN
cord-005453-4057qib7	14344	44	,	,	,
cord-005453-4057qib7	14344	45	TRM	TRM	NNP
cord-005453-4057qib7	14344	46	,	,	,
cord-005453-4057qib7	14344	47	and	and	CC
cord-005453-4057qib7	14344	48	overall	overall	JJ
cord-005453-4057qib7	14344	49	mortality	mortality	NN
cord-005453-4057qib7	14344	50	were	be	VBD
cord-005453-4057qib7	14344	51	higher	high	JJR
cord-005453-4057qib7	14344	52	after	after	IN
cord-005453-4057qib7	14344	53	transplant	transplant	NN
cord-005453-4057qib7	14344	54	from	from	IN
cord-005453-4057qib7	14344	55	offspring	offspring	NN
cord-005453-4057qib7	14344	56	compared	compare	VBN
cord-005453-4057qib7	14344	57	with	with	IN
cord-005453-4057qib7	14344	58	an	an	DT
cord-005453-4057qib7	14344	59	MSD	msd	NN
cord-005453-4057qib7	14344	60	although	although	IN
cord-005453-4057qib7	14344	61	there	there	EX
cord-005453-4057qib7	14344	62	were	be	VBD
cord-005453-4057qib7	14344	63	differences	difference	NNS
cord-005453-4057qib7	14344	64	in	in	IN
cord-005453-4057qib7	14344	65	transplant	transplant	NN
cord-005453-4057qib7	14344	66	platforms	platform	NNS
cord-005453-4057qib7	14344	67	between	between	IN
cord-005453-4057qib7	14344	68	the	the	DT
cord-005453-4057qib7	14344	69	2	2	CD
cord-005453-4057qib7	14344	70	groups	group	NNS
cord-005453-4057qib7	14344	71	.	.	.
cord-005453-4057qib7	14345	1	Methods	method	NNS
cord-005453-4057qib7	14345	2	:	:	:
cord-005453-4057qib7	14345	3	We	-PRON-	PRP
cord-005453-4057qib7	14345	4	extended	extend	VBD
cord-005453-4057qib7	14345	5	our	-PRON-	PRP$
cord-005453-4057qib7	14345	6	multi	multi	JJ
cord-005453-4057qib7	14345	7	-	-	JJ
cord-005453-4057qib7	14345	8	center	center	JJ
cord-005453-4057qib7	14345	9	dataset	dataset	NN
cord-005453-4057qib7	14345	10	and	and	CC
cord-005453-4057qib7	14345	11	a	a	DT
cord-005453-4057qib7	14345	12	matched	match	VBN
cord-005453-4057qib7	14345	13	pair	pair	NN
cord-005453-4057qib7	14345	14	analysis	analysis	NN
cord-005453-4057qib7	14345	15	was	be	VBD
cord-005453-4057qib7	14345	16	performed	perform	VBN
cord-005453-4057qib7	14345	17	.	.	.
cord-005453-4057qib7	14346	1	Outcomes	outcome	NNS
cord-005453-4057qib7	14346	2	of	of	IN
cord-005453-4057qib7	14346	3	142	142	CD
cord-005453-4057qib7	14346	4	acute	acute	JJ
cord-005453-4057qib7	14346	5	leukemia	leukemia	NN
cord-005453-4057qib7	14346	6	patients	patient	NNS
cord-005453-4057qib7	14346	7	(	(	-LRB-
cord-005453-4057qib7	14346	8	>	>	XX
cord-005453-4057qib7	14346	9	=	=	SYM
cord-005453-4057qib7	14346	10	50	50	CD
cord-005453-4057qib7	14346	11	years	year	NNS
cord-005453-4057qib7	14346	12	)	)	-RRB-
cord-005453-4057qib7	14346	13	transplanted	transplant	VBN
cord-005453-4057qib7	14346	14	in	in	IN
cord-005453-4057qib7	14346	15	CR1/	CR1/	NNP
cord-005453-4057qib7	14346	16	CR2	CR2	NNP
cord-005453-4057qib7	14346	17	who	who	WP
cord-005453-4057qib7	14346	18	received	receive	VBD
cord-005453-4057qib7	14346	19	HCT	hct	NN
cord-005453-4057qib7	14346	20	from	from	IN
cord-005453-4057qib7	14346	21	offspring	offspring	NN
cord-005453-4057qib7	14346	22	(	(	-LRB-
cord-005453-4057qib7	14346	23	n=57	n=57	NNP
cord-005453-4057qib7	14346	24	)	)	-RRB-
cord-005453-4057qib7	14346	25	or	or	CC
cord-005453-4057qib7	14346	26	MSD	MSD	NNP
cord-005453-4057qib7	14346	27	(	(	-LRB-
cord-005453-4057qib7	14346	28	n=85	n=85	NN
cord-005453-4057qib7	14346	29	)	)	-RRB-
cord-005453-4057qib7	14346	30	between	between	IN
cord-005453-4057qib7	14346	31	Jan	Jan	NNP
cord-005453-4057qib7	14346	32	,	,	,
cord-005453-4057qib7	14346	33	2013	2013	CD
cord-005453-4057qib7	14346	34	and	and	CC
cord-005453-4057qib7	14346	35	June	June	NNP
cord-005453-4057qib7	14346	36	,	,	,
cord-005453-4057qib7	14346	37	2017	2017	CD
cord-005453-4057qib7	14346	38	present	present	JJ
cord-005453-4057qib7	14346	39	in	in	IN
cord-005453-4057qib7	14346	40	the	the	DT
cord-005453-4057qib7	14346	41	multi	multi	JJ
cord-005453-4057qib7	14346	42	-	-	JJ
cord-005453-4057qib7	14346	43	center	center	JJ
cord-005453-4057qib7	14346	44	database	database	NN
cord-005453-4057qib7	14346	45	were	be	VBD
cord-005453-4057qib7	14346	46	analyzed	analyze	VBN
cord-005453-4057qib7	14346	47	.	.	.
cord-005453-4057qib7	14347	1	Because	because	IN
cord-005453-4057qib7	14347	2	the	the	DT
cord-005453-4057qib7	14347	3	patient	patient	JJ
cord-005453-4057qib7	14347	4	population	population	NN
cord-005453-4057qib7	14347	5	was	be	VBD
cord-005453-4057qib7	14347	6	small	small	JJ
cord-005453-4057qib7	14347	7	,	,	,
cord-005453-4057qib7	14347	8	a	a	DT
cord-005453-4057qib7	14347	9	1:1	1:1	CD
cord-005453-4057qib7	14347	10	ratio	ratio	NN
cord-005453-4057qib7	14347	11	matched	match	VBN
cord-005453-4057qib7	14347	12	pair	pair	NN
cord-005453-4057qib7	14347	13	analysis	analysis	NN
cord-005453-4057qib7	14347	14	was	be	VBD
cord-005453-4057qib7	14347	15	implemented	implement	VBN
cord-005453-4057qib7	14347	16	with	with	IN
cord-005453-4057qib7	14347	17	the	the	DT
cord-005453-4057qib7	14347	18	following	following	JJ
cord-005453-4057qib7	14347	19	matching	matching	NN
cord-005453-4057qib7	14347	20	factors	factor	NNS
cord-005453-4057qib7	14347	21	:	:	:
cord-005453-4057qib7	14347	22	underlying	underlie	VBG
cord-005453-4057qib7	14347	23	disease	disease	NN
cord-005453-4057qib7	14347	24	(	(	-LRB-
cord-005453-4057qib7	14347	25	acute	acute	JJ
cord-005453-4057qib7	14347	26	myeloid	myeloid	NN
cord-005453-4057qib7	14347	27	leukemia	leukemia	NN
cord-005453-4057qib7	14347	28	,	,	,
cord-005453-4057qib7	14347	29	acute	acute	JJ
cord-005453-4057qib7	14347	30	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	14347	31	leukemia	leukemia	NN
cord-005453-4057qib7	14347	32	)	)	-RRB-
cord-005453-4057qib7	14347	33	,	,	,
cord-005453-4057qib7	14347	34	disease	disease	NN
cord-005453-4057qib7	14347	35	status	status	NN
cord-005453-4057qib7	14347	36	(	(	-LRB-
cord-005453-4057qib7	14347	37	CR1	CR1	NNP
cord-005453-4057qib7	14347	38	/	/	SYM
cord-005453-4057qib7	14347	39	CR2	CR2	NNP
cord-005453-4057qib7	14347	40	)	)	-RRB-
cord-005453-4057qib7	14347	41	,	,	,
cord-005453-4057qib7	14347	42	age	age	NN
cord-005453-4057qib7	14347	43	and	and	CC
cord-005453-4057qib7	14347	44	sex	sex	NN
cord-005453-4057qib7	14347	45	of	of	IN
cord-005453-4057qib7	14347	46	patients	patient	NNS
cord-005453-4057qib7	14347	47	,	,	,
cord-005453-4057qib7	14347	48	year	year	NN
cord-005453-4057qib7	14347	49	of	of	IN
cord-005453-4057qib7	14347	50	transplant	transplant	NN
cord-005453-4057qib7	14347	51	,	,	,
cord-005453-4057qib7	14347	52	blood	blood	NN
cord-005453-4057qib7	14347	53	group	group	NN
cord-005453-4057qib7	14347	54	incompatibilities	incompatibility	NNS
cord-005453-4057qib7	14347	55	,	,	,
cord-005453-4057qib7	14347	56	and	and	CC
cord-005453-4057qib7	14347	57	sex	sex	NN
cord-005453-4057qib7	14347	58	of	of	IN
cord-005453-4057qib7	14347	59	donor	donor	NN
cord-005453-4057qib7	14347	60	.	.	.
cord-005453-4057qib7	14348	1	Results	result	NNS
cord-005453-4057qib7	14348	2	:	:	:
cord-005453-4057qib7	14349	1	We	-PRON-	PRP
cord-005453-4057qib7	14349	2	were	be	VBD
cord-005453-4057qib7	14349	3	able	able	JJ
cord-005453-4057qib7	14349	4	to	to	TO
cord-005453-4057qib7	14349	5	match	match	VB
cord-005453-4057qib7	14349	6	41	41	CD
cord-005453-4057qib7	14349	7	offspring	offspring	NN
cord-005453-4057qib7	14349	8	with	with	IN
cord-005453-4057qib7	14349	9	41	41	CD
cord-005453-4057qib7	14349	10	MSD	MSD	NNP
cord-005453-4057qib7	14349	11	patients	patient	NNS
cord-005453-4057qib7	14349	12	.	.	.
cord-005453-4057qib7	14350	1	The	the	DT
cord-005453-4057qib7	14350	2	two	two	CD
cord-005453-4057qib7	14350	3	matched	match	VBN
cord-005453-4057qib7	14350	4	groups	group	NNS
cord-005453-4057qib7	14350	5	were	be	VBD
cord-005453-4057qib7	14350	6	comparable	comparable	JJ
cord-005453-4057qib7	14350	7	in	in	IN
cord-005453-4057qib7	14350	8	baseline	baseline	JJ
cord-005453-4057qib7	14350	9	characteristics	characteristic	NNS
cord-005453-4057qib7	14350	10	except	except	IN
cord-005453-4057qib7	14350	11	for	for	IN
cord-005453-4057qib7	14350	12	donor	donor	NN
cord-005453-4057qib7	14350	13	age	age	NN
cord-005453-4057qib7	14350	14	due	due	JJ
cord-005453-4057qib7	14350	15	to	to	IN
cord-005453-4057qib7	14350	16	the	the	DT
cord-005453-4057qib7	14350	17	family	family	NN
cord-005453-4057qib7	14350	18	relationship	relationship	NN
cord-005453-4057qib7	14350	19	.	.	.
cord-005453-4057qib7	14351	1	All	all	DT
cord-005453-4057qib7	14351	2	patients	patient	NNS
cord-005453-4057qib7	14351	3	achieved	achieve	VBD
cord-005453-4057qib7	14351	4	myeloid	myeloid	JJ
cord-005453-4057qib7	14351	5	recovery	recovery	NN
cord-005453-4057qib7	14351	6	with	with	IN
cord-005453-4057qib7	14351	7	a	a	DT
cord-005453-4057qib7	14351	8	median	median	JJ
cord-005453-4057qib7	14351	9	time	time	NN
cord-005453-4057qib7	14351	10	of	of	IN
cord-005453-4057qib7	14351	11	14d	14d	NNS
cord-005453-4057qib7	14351	12	and	and	CC
cord-005453-4057qib7	14351	13	12d	12d	NNS
cord-005453-4057qib7	14351	14	for	for	IN
cord-005453-4057qib7	14351	15	MSD	MSD	NNP
cord-005453-4057qib7	14351	16	cohort	cohort	NN
cord-005453-4057qib7	14351	17	and	and	CC
cord-005453-4057qib7	14351	18	offspring	offspring	NN
cord-005453-4057qib7	14351	19	group	group	NN
cord-005453-4057qib7	14351	20	(	(	-LRB-
cord-005453-4057qib7	14351	21	p=0.002	p=0.002	NNP
cord-005453-4057qib7	14351	22	)	)	-RRB-
cord-005453-4057qib7	14351	23	.	.	.
cord-005453-4057qib7	14352	1	The	the	DT
cord-005453-4057qib7	14352	2	100d	100d	NNP
cord-005453-4057qib7	14352	3	platelet	platelet	NN
cord-005453-4057qib7	14352	4	recovery	recovery	NN
cord-005453-4057qib7	14352	5	rate	rate	NN
cord-005453-4057qib7	14352	6	was	be	VBD
cord-005453-4057qib7	14352	7	95	95	CD
cord-005453-4057qib7	14352	8	%	%	NN
cord-005453-4057qib7	14352	9	in	in	IN
cord-005453-4057qib7	14352	10	both	both	DT
cord-005453-4057qib7	14352	11	groups	group	NNS
cord-005453-4057qib7	14352	12	.	.	.
cord-005453-4057qib7	14353	1	The	the	DT
cord-005453-4057qib7	14353	2	cumulative	cumulative	JJ
cord-005453-4057qib7	14353	3	incidence	incidence	NN
cord-005453-4057qib7	14353	4	of	of	IN
cord-005453-4057qib7	14353	5	grade	grade	NN
cord-005453-4057qib7	14353	6	II	II	NNP
cord-005453-4057qib7	14353	7	-	-	HYPH
cord-005453-4057qib7	14353	8	IV	IV	NNP
cord-005453-4057qib7	14353	9	acute	acute	JJ
cord-005453-4057qib7	14353	10	GVHD	GVHD	NNP
cord-005453-4057qib7	14353	11	in	in	IN
cord-005453-4057qib7	14353	12	MSD	MSD	NNP
cord-005453-4057qib7	14353	13	cohort	cohort	NN
cord-005453-4057qib7	14353	14	was	be	VBD
cord-005453-4057qib7	14353	15	significantly	significantly	RB
cord-005453-4057qib7	14353	16	lower	low	JJR
cord-005453-4057qib7	14353	17	than	than	IN
cord-005453-4057qib7	14353	18	in	in	IN
cord-005453-4057qib7	14353	19	offspring	offspring	NN
cord-005453-4057qib7	14353	20	group	group	NN
cord-005453-4057qib7	14353	21	(	(	-LRB-
cord-005453-4057qib7	14353	22	12	12	CD
cord-005453-4057qib7	14353	23	%	%	NN
cord-005453-4057qib7	14353	24	vs	vs	IN
cord-005453-4057qib7	14353	25	37	37	CD
cord-005453-4057qib7	14353	26	%	%	NN
cord-005453-4057qib7	14353	27	,	,	,
cord-005453-4057qib7	14353	28	P=0.009	p=0.009	NN
cord-005453-4057qib7	14353	29	)	)	-RRB-
cord-005453-4057qib7	14353	30	while	while	IN
cord-005453-4057qib7	14353	31	the	the	DT
cord-005453-4057qib7	14353	32	incidence	incidence	NN
cord-005453-4057qib7	14353	33	of	of	IN
cord-005453-4057qib7	14353	34	chronic	chronic	JJ
cord-005453-4057qib7	14353	35	GVHD	GVHD	NNP
cord-005453-4057qib7	14353	36	in	in	IN
cord-005453-4057qib7	14353	37	MSD	MSD	NNP
cord-005453-4057qib7	14353	38	cohort	cohort	NN
cord-005453-4057qib7	14353	39	was	be	VBD
cord-005453-4057qib7	14353	40	significantly	significantly	RB
cord-005453-4057qib7	14353	41	higher	high	JJR
cord-005453-4057qib7	14353	42	than	than	IN
cord-005453-4057qib7	14353	43	in	in	IN
cord-005453-4057qib7	14353	44	offspring	offspring	NN
cord-005453-4057qib7	14353	45	group	group	NN
cord-005453-4057qib7	14353	46	(	(	-LRB-
cord-005453-4057qib7	14353	47	51	51	CD
cord-005453-4057qib7	14353	48	%	%	NN
cord-005453-4057qib7	14353	49	vs	vs	IN
cord-005453-4057qib7	14353	50	27	27	CD
cord-005453-4057qib7	14353	51	%	%	NN
cord-005453-4057qib7	14353	52	,	,	,
cord-005453-4057qib7	14353	53	P=0.013	p=0.013	NN
cord-005453-4057qib7	14353	54	)	)	-RRB-
cord-005453-4057qib7	14353	55	.	.	.
cord-005453-4057qib7	14354	1	The	the	DT
cord-005453-4057qib7	14354	2	3-year	3-year	CD
cord-005453-4057qib7	14354	3	TRM	TRM	NNP
cord-005453-4057qib7	14354	4	(	(	-LRB-
cord-005453-4057qib7	14354	5	10	10	CD
cord-005453-4057qib7	14354	6	%	%	NN
cord-005453-4057qib7	14354	7	vs	vs	IN
cord-005453-4057qib7	14354	8	31	31	CD
cord-005453-4057qib7	14354	9	%	%	NN
cord-005453-4057qib7	14354	10	,	,	,
cord-005453-4057qib7	14354	11	P=0.028	p=0.028	NN
cord-005453-4057qib7	14354	12	)	)	-RRB-
cord-005453-4057qib7	14354	13	were	be	VBD
cord-005453-4057qib7	14354	14	significantly	significantly	RB
cord-005453-4057qib7	14354	15	lower	low	JJR
cord-005453-4057qib7	14354	16	in	in	IN
cord-005453-4057qib7	14354	17	offspring	offspring	NN
cord-005453-4057qib7	14354	18	-	-	HYPH
cord-005453-4057qib7	14354	19	HCT	hct	NN
cord-005453-4057qib7	14354	20	compared	compare	VBN
cord-005453-4057qib7	14354	21	with	with	IN
cord-005453-4057qib7	14354	22	in	in	IN
cord-005453-4057qib7	14354	23	MSD	MSD	NNP
cord-005453-4057qib7	14354	24	-	-	HYPH
cord-005453-4057qib7	14354	25	HCT	hct	NN
cord-005453-4057qib7	14354	26	and	and	CC
cord-005453-4057qib7	14354	27	relapse	relapse	NN
cord-005453-4057qib7	14354	28	incidence	incidence	NN
cord-005453-4057qib7	14354	29	was	be	VBD
cord-005453-4057qib7	14354	30	comparable	comparable	JJ
cord-005453-4057qib7	14354	31	(	(	-LRB-
cord-005453-4057qib7	14354	32	8	8	CD
cord-005453-4057qib7	14354	33	%	%	NN
cord-005453-4057qib7	14354	34	vs	vs	IN
cord-005453-4057qib7	14354	35	14	14	CD
cord-005453-4057qib7	14354	36	%	%	NN
cord-005453-4057qib7	14354	37	,	,	,
cord-005453-4057qib7	14354	38	P=0.56	P=0.56	NNP
cord-005453-4057qib7	14354	39	)	)	-RRB-
cord-005453-4057qib7	14354	40	.	.	.
cord-005453-4057qib7	14355	1	As	as	IN
cord-005453-4057qib7	14355	2	a	a	DT
cord-005453-4057qib7	14355	3	result	result	NN
cord-005453-4057qib7	14355	4	,	,	,
cord-005453-4057qib7	14355	5	the	the	DT
cord-005453-4057qib7	14355	6	3-year	3-year	JJ
cord-005453-4057qib7	14355	7	overall	overall	JJ
cord-005453-4057qib7	14355	8	survival	survival	NN
cord-005453-4057qib7	14355	9	(	(	-LRB-
cord-005453-4057qib7	14355	10	57	57	CD
cord-005453-4057qib7	14355	11	%	%	NN
cord-005453-4057qib7	14355	12	vs	vs	IN
cord-005453-4057qib7	14355	13	82	82	CD
cord-005453-4057qib7	14355	14	%	%	NN
cord-005453-4057qib7	14355	15	,	,	,
cord-005453-4057qib7	14355	16	P=0.033	P=0.033	NNP
cord-005453-4057qib7	14355	17	)	)	-RRB-
cord-005453-4057qib7	14355	18	and	and	CC
cord-005453-4057qib7	14355	19	LFS	LFS	NNP
cord-005453-4057qib7	14355	20	(	(	-LRB-
cord-005453-4057qib7	14355	21	55	55	CD
cord-005453-4057qib7	14355	22	%	%	NN
cord-005453-4057qib7	14355	23	vs	vs	IN
cord-005453-4057qib7	14355	24	82	82	CD
cord-005453-4057qib7	14355	25	%	%	NN
cord-005453-4057qib7	14355	26	,	,	,
cord-005453-4057qib7	14355	27	P=0.024	p=0.024	NN
cord-005453-4057qib7	14355	28	)	)	-RRB-
cord-005453-4057qib7	14355	29	(	(	-LRB-
cord-005453-4057qib7	14355	30	Figure	figure	NN
cord-005453-4057qib7	14355	31	1	1	CD
cord-005453-4057qib7	14355	32	)	)	-RRB-
cord-005453-4057qib7	14355	33	were	be	VBD
cord-005453-4057qib7	14355	34	significantly	significantly	RB
cord-005453-4057qib7	14355	35	higher	high	JJR
cord-005453-4057qib7	14355	36	in	in	IN
cord-005453-4057qib7	14355	37	offspring	offspring	NN
cord-005453-4057qib7	14355	38	-	-	HYPH
cord-005453-4057qib7	14355	39	HCT	hct	NN
cord-005453-4057qib7	14355	40	compared	compare	VBN
cord-005453-4057qib7	14355	41	with	with	IN
cord-005453-4057qib7	14355	42	in	in	IN
cord-005453-4057qib7	14355	43	MSD	MSD	NNP
cord-005453-4057qib7	14355	44	-	-	HYPH
cord-005453-4057qib7	14355	45	HCT	HCT	NNP
cord-005453-4057qib7	14355	46	.	.	.
cord-005453-4057qib7	14356	1	In	in	IN
cord-005453-4057qib7	14356	2	a	a	DT
cord-005453-4057qib7	14356	3	multivariate	multivariate	JJ
cord-005453-4057qib7	14356	4	analysis	analysis	NN
cord-005453-4057qib7	14356	5	,	,	,
cord-005453-4057qib7	14356	6	MSD	MSD	NNP
cord-005453-4057qib7	14356	7	-	-	HYPH
cord-005453-4057qib7	14356	8	HCT	HCT	NNP
cord-005453-4057qib7	14356	9	remained	remain	VBD
cord-005453-4057qib7	14356	10	a	a	DT
cord-005453-4057qib7	14356	11	significant	significant	JJ
cord-005453-4057qib7	14356	12	factor	factor	NN
cord-005453-4057qib7	14356	13	for	for	IN
cord-005453-4057qib7	14356	14	decreased	decrease	VBN
cord-005453-4057qib7	14356	15	overall	overall	JJ
cord-005453-4057qib7	14356	16	survival	survival	NN
cord-005453-4057qib7	14356	17	(	(	-LRB-
cord-005453-4057qib7	14356	18	HR	HR	NNP
cord-005453-4057qib7	14356	19	2.791(1.141	2.791(1.141	CD
cord-005453-4057qib7	14356	20	-	-	HYPH
cord-005453-4057qib7	14356	21	6.824	6.824	CD
cord-005453-4057qib7	14356	22	)	)	-RRB-
cord-005453-4057qib7	14356	23	,	,	,
cord-005453-4057qib7	14356	24	P=0.024	p=0.024	NN
cord-005453-4057qib7	14356	25	)	)	-RRB-
cord-005453-4057qib7	14356	26	by	by	IN
cord-005453-4057qib7	14356	27	increased	increase	VBN
cord-005453-4057qib7	14356	28	TRM	TRM	NNP
cord-005453-4057qib7	14356	29	)	)	-RRB-
cord-005453-4057qib7	14356	30	,	,	,
cord-005453-4057qib7	14356	31	P=	P=	NNP
cord-005453-4057qib7	14356	32	0.032	0.032	CD
cord-005453-4057qib7	14356	33	)	)	-RRB-
cord-005453-4057qib7	14357	1	in	in	IN
cord-005453-4057qib7	14357	2	comparison	comparison	NN
cord-005453-4057qib7	14357	3	with	with	IN
cord-005453-4057qib7	14357	4	offspring	offspring	NN
cord-005453-4057qib7	14357	5	-	-	HYPH
cord-005453-4057qib7	14357	6	HCT	hct	NN
cord-005453-4057qib7	14357	7	.	.	.
cord-005453-4057qib7	14358	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14358	2	:	:	:
cord-005453-4057qib7	14359	1	These	these	DT
cord-005453-4057qib7	14359	2	data	datum	NNS
cord-005453-4057qib7	14359	3	favor	favor	VBP
cord-005453-4057qib7	14359	4	a	a	DT
cord-005453-4057qib7	14359	5	young	young	JJ
cord-005453-4057qib7	14359	6	offspring	offspring	NN
cord-005453-4057qib7	14359	7	over	over	IN
cord-005453-4057qib7	14359	8	an	an	DT
cord-005453-4057qib7	14359	9	older	old	JJR
cord-005453-4057qib7	14359	10	MSD	msd	NN
cord-005453-4057qib7	14359	11	in	in	IN
cord-005453-4057qib7	14359	12	patients	patient	NNS
cord-005453-4057qib7	14359	13	>	>	XX
cord-005453-4057qib7	14359	14	50	50	CD
cord-005453-4057qib7	14359	15	years	year	NNS
cord-005453-4057qib7	14359	16	.	.	.
cord-005453-4057qib7	14360	1	The	the	DT
cord-005453-4057qib7	14360	2	current	current	JJ
cord-005453-4057qib7	14360	3	analyses	analysis	NNS
cord-005453-4057qib7	14360	4	confirm	confirm	VBP
cord-005453-4057qib7	14360	5	non	non	JJ
cord-005453-4057qib7	14360	6	-	-	JJ
cord-005453-4057qib7	14360	7	HLA	hla	JJ
cord-005453-4057qib7	14360	8	donor	donor	NN
cord-005453-4057qib7	14360	9	characteristics	characteristic	NNS
cord-005453-4057qib7	14360	10	,	,	,
cord-005453-4057qib7	14360	11	rather	rather	RB
cord-005453-4057qib7	14360	12	than	than	IN
cord-005453-4057qib7	14360	13	HLA	HLA	NNP
cord-005453-4057qib7	14360	14	disparity	disparity	NN
cord-005453-4057qib7	14360	15	,	,	,
cord-005453-4057qib7	14360	16	predominantly	predominantly	RB
cord-005453-4057qib7	14360	17	influence	influence	VBP
cord-005453-4057qib7	14360	18	survival	survival	NN
cord-005453-4057qib7	14360	19	in	in	IN
cord-005453-4057qib7	14360	20	older	old	JJR
cord-005453-4057qib7	14360	21	acute	acute	JJ
cord-005453-4057qib7	14360	22	leukemia	leukemia	NN
cord-005453-4057qib7	14360	23	patients	patient	NNS
cord-005453-4057qib7	14360	24	.	.	.
cord-005453-4057qib7	14361	1	Validation	validation	NN
cord-005453-4057qib7	14361	2	of	of	IN
cord-005453-4057qib7	14361	3	these	these	DT
cord-005453-4057qib7	14361	4	findings	finding	NNS
cord-005453-4057qib7	14361	5	requires	require	VBZ
cord-005453-4057qib7	14361	6	a	a	DT
cord-005453-4057qib7	14361	7	prospective	prospective	JJ
cord-005453-4057qib7	14361	8	trial	trial	NN
cord-005453-4057qib7	14361	9	wherein	wherein	WRB
cord-005453-4057qib7	14361	10	the	the	DT
cord-005453-4057qib7	14361	11	transplant	transplant	NN
cord-005453-4057qib7	14361	12	platforms	platform	NNS
cord-005453-4057qib7	14361	13	can	can	MD
cord-005453-4057qib7	14361	14	be	be	VB
cord-005453-4057qib7	14361	15	closely	closely	RB
cord-005453-4057qib7	14361	16	matched	match	VBN
cord-005453-4057qib7	14361	17	.	.	.
cord-005453-4057qib7	14362	1	[	[	-LRB-
cord-005453-4057qib7	14362	2	[	[	-LRB-
cord-005453-4057qib7	14362	3	P664	P664	NNP
cord-005453-4057qib7	14362	4	Image	image	NN
cord-005453-4057qib7	14362	5	]	]	-RRB-
cord-005453-4057qib7	14362	6	1	1	CD
cord-005453-4057qib7	14362	7	.	.	.
cord-005453-4057qib7	14363	1	Figure1	Figure1	NNP
cord-005453-4057qib7	14363	2	.	.	.
cord-005453-4057qib7	14364	1	LFS	LFS	NNP
cord-005453-4057qib7	14364	2	in	in	IN
cord-005453-4057qib7	14364	3	offspring	offspring	NN
cord-005453-4057qib7	14364	4	-	-	HYPH
cord-005453-4057qib7	14364	5	HCT	hct	NN
cord-005453-4057qib7	14364	6	compared	compare	VBN
cord-005453-4057qib7	14364	7	with	with	IN
cord-005453-4057qib7	14364	8	in	in	IN
cord-005453-4057qib7	14364	9	MSD	MSD	NNP
cord-005453-4057qib7	14364	10	-	-	HYPH
cord-005453-4057qib7	14364	11	HCT	HCT	NNP
cord-005453-4057qib7	14364	12	(	(	-LRB-
cord-005453-4057qib7	14364	13	55	55	CD
cord-005453-4057qib7	14364	14	%	%	NN
cord-005453-4057qib7	14364	15	vs	vs	IN
cord-005453-4057qib7	14364	16	82	82	CD
cord-005453-4057qib7	14364	17	%	%	NN
cord-005453-4057qib7	14364	18	,	,	,
cord-005453-4057qib7	14364	19	P=0.024	p=0.024	NN
cord-005453-4057qib7	14364	20	)	)	-RRB-
cord-005453-4057qib7	14364	21	]	]	-RRB-
cord-005453-4057qib7	14365	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14365	2	:	:	:
cord-005453-4057qib7	14365	3	Nothing	nothing	NN
cord-005453-4057qib7	14365	4	to	to	TO
cord-005453-4057qib7	14365	5	declare	declare	VB
cord-005453-4057qib7	14365	6	.	.	.
cord-005453-4057qib7	14366	1	Impact	impact	NN
cord-005453-4057qib7	14366	2	of	of	IN
cord-005453-4057qib7	14366	3	sibling	sibling	NN
cord-005453-4057qib7	14366	4	donor	donor	NN
cord-005453-4057qib7	14366	5	-	-	HYPH
cord-005453-4057qib7	14366	6	recipient	recipient	NN
cord-005453-4057qib7	14366	7	sex	sex	NN
cord-005453-4057qib7	14366	8	combinations	combination	NNS
cord-005453-4057qib7	14366	9	on	on	IN
cord-005453-4057qib7	14366	10	rejection	rejection	NN
cord-005453-4057qib7	14366	11	after	after	IN
cord-005453-4057qib7	14366	12	hla	hla	NNP
cord-005453-4057qib7	14366	13	-	-	HYPH
cord-005453-4057qib7	14366	14	matched	match	VBN
cord-005453-4057qib7	14366	15	bone	bone	NN
cord-005453-4057qib7	14366	16	marrow	marrow	NN
cord-005453-4057qib7	14366	17	transplantation	transplantation	NN
cord-005453-4057qib7	14366	18	for	for	IN
cord-005453-4057qib7	14366	19	severe	severe	JJ
cord-005453-4057qib7	14366	20	thalassemia	thalassemia	NN
cord-005453-4057qib7	14366	21	1	1	CD
cord-005453-4057qib7	14366	22	Cure2Children	Cure2Children	NNP
cord-005453-4057qib7	14366	23	Foundation	Foundation	NNP
cord-005453-4057qib7	14366	24	,	,	,
cord-005453-4057qib7	14366	25	Florence	Florence	NNP
cord-005453-4057qib7	14366	26	,	,	,
cord-005453-4057qib7	14366	27	Italy	Italy	NNP
cord-005453-4057qib7	14366	28	,	,	,
cord-005453-4057qib7	14366	29	2	2	CD
cord-005453-4057qib7	14366	30	Sankalp	Sankalp	NNP
cord-005453-4057qib7	14366	31	India	India	NNP
cord-005453-4057qib7	14366	32	Foundation	Foundation	NNP
cord-005453-4057qib7	14366	33	,	,	,
cord-005453-4057qib7	14366	34	Bangalore	Bangalore	NNP
cord-005453-4057qib7	14366	35	,	,	,
cord-005453-4057qib7	14366	36	India	India	NNP
cord-005453-4057qib7	14366	37	,	,	,
cord-005453-4057qib7	14366	38	3	3	CD
cord-005453-4057qib7	14366	39	People	People	NNS
cord-005453-4057qib7	14366	40	Tree	Tree	NNP
cord-005453-4057qib7	14366	41	Hospitals	Hospitals	NNPS
cord-005453-4057qib7	14366	42	,	,	,
cord-005453-4057qib7	14366	43	Bangalore	Bangalore	NNP
cord-005453-4057qib7	14366	44	,	,	,
cord-005453-4057qib7	14366	45	India	India	NNP
cord-005453-4057qib7	14366	46	,	,	,
cord-005453-4057qib7	14366	47	4	4	CD
cord-005453-4057qib7	14366	48	South	South	NNP
cord-005453-4057qib7	14366	49	East	East	NNP
cord-005453-4057qib7	14366	50	Asia	Asia	NNP
cord-005453-4057qib7	14366	51	Institute	Institute	NNP
cord-005453-4057qib7	14366	52	for	for	IN
cord-005453-4057qib7	14366	53	Thalassemia	Thalassemia	NNP
cord-005453-4057qib7	14366	54	,	,	,
cord-005453-4057qib7	14366	55	Jaipur	Jaipur	NNP
cord-005453-4057qib7	14366	56	,	,	,
cord-005453-4057qib7	14366	57	India	India	NNP
cord-005453-4057qib7	14366	58	,	,	,
cord-005453-4057qib7	14366	59	5	5	CD
cord-005453-4057qib7	14366	60	Pakistan	Pakistan	NNP
cord-005453-4057qib7	14366	61	Institute	Institute	NNP
cord-005453-4057qib7	14366	62	of	of	IN
cord-005453-4057qib7	14366	63	Medical	Medical	NNP
cord-005453-4057qib7	14366	64	Sciences	Sciences	NNPS
cord-005453-4057qib7	14366	65	,	,	,
cord-005453-4057qib7	14366	66	Islamabad	Islamabad	NNP
cord-005453-4057qib7	14366	67	,	,	,
cord-005453-4057qib7	14366	68	Pakistan	Pakistan	NNP
cord-005453-4057qib7	14366	69	,	,	,
cord-005453-4057qib7	14366	70	6	6	CD
cord-005453-4057qib7	14366	71	Central	Central	NNP
cord-005453-4057qib7	14366	72	Asiri	Asiri	NNP
cord-005453-4057qib7	14366	73	Hospital	Hospital	NNP
cord-005453-4057qib7	14366	74	,	,	,
cord-005453-4057qib7	14366	75	Colombo	Colombo	NNP
cord-005453-4057qib7	14366	76	,	,	,
cord-005453-4057qib7	14366	77	Sri	Sri	NNP
cord-005453-4057qib7	14366	78	Lanka	Lanka	NNP
cord-005453-4057qib7	14366	79	,	,	,
cord-005453-4057qib7	14366	80	7	7	CD
cord-005453-4057qib7	14366	81	Nawaloka	Nawaloka	NNP
cord-005453-4057qib7	14366	82	Hospital	Hospital	NNP
cord-005453-4057qib7	14366	83	,	,	,
cord-005453-4057qib7	14366	84	Colombo	Colombo	NNP
cord-005453-4057qib7	14366	85	,	,	,
cord-005453-4057qib7	14366	86	Sri	Sri	NNP
cord-005453-4057qib7	14366	87	Lanka	Lanka	NNP
cord-005453-4057qib7	14366	88	,	,	,
cord-005453-4057qib7	14366	89	8	8	CD
cord-005453-4057qib7	14366	90	Kokilaben	Kokilaben	NNP
cord-005453-4057qib7	14366	91	Dhirubhani	Dhirubhani	NNP
cord-005453-4057qib7	14366	92	Ambani	Ambani	NNP
cord-005453-4057qib7	14366	93	Hospital	Hospital	NNP
cord-005453-4057qib7	14366	94	,	,	,
cord-005453-4057qib7	14366	95	Mumbai	Mumbai	NNP
cord-005453-4057qib7	14366	96	,	,	,
cord-005453-4057qib7	14367	1	India	India	NNP
cord-005453-4057qib7	14367	2	Background	Background	NNP
cord-005453-4057qib7	14367	3	:	:	:
cord-005453-4057qib7	14368	1	Severe	severe	JJ
cord-005453-4057qib7	14368	2	thalassemia	thalassemia	NN
cord-005453-4057qib7	14368	3	(	(	-LRB-
cord-005453-4057qib7	14368	4	ST	ST	NNP
cord-005453-4057qib7	14368	5	)	)	-RRB-
cord-005453-4057qib7	14368	6	,	,	,
cord-005453-4057qib7	14368	7	i.e.	i.e.	FW
cord-005453-4057qib7	14368	8	a	a	DT
cord-005453-4057qib7	14368	9	thalassemia	thalassemia	NN
cord-005453-4057qib7	14368	10	syndrome	syndrome	NN
cord-005453-4057qib7	14368	11	with	with	IN
cord-005453-4057qib7	14368	12	inability	inability	NN
cord-005453-4057qib7	14368	13	to	to	TO
cord-005453-4057qib7	14368	14	keep	keep	VB
cord-005453-4057qib7	14368	15	spontaneous	spontaneous	JJ
cord-005453-4057qib7	14368	16	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	14368	17	>	>	XX
cord-005453-4057qib7	14368	18	7	7	CD
cord-005453-4057qib7	14368	19	g	g	NN
cord-005453-4057qib7	14368	20	/	/	SYM
cord-005453-4057qib7	14368	21	dL	dl	NN
cord-005453-4057qib7	14368	22	,	,	,
cord-005453-4057qib7	14368	23	is	be	VBZ
cord-005453-4057qib7	14368	24	a	a	DT
cord-005453-4057qib7	14368	25	common	common	JJ
cord-005453-4057qib7	14368	26	indication	indication	NN
cord-005453-4057qib7	14368	27	for	for	IN
cord-005453-4057qib7	14368	28	Bone	Bone	NNP
cord-005453-4057qib7	14368	29	Marrow	Marrow	NNP
cord-005453-4057qib7	14368	30	Transplantation	Transplantation	NNP
cord-005453-4057qib7	14368	31	(	(	-LRB-
cord-005453-4057qib7	14368	32	BMT	BMT	NNP
cord-005453-4057qib7	14368	33	)	)	-RRB-
cord-005453-4057qib7	14368	34	in	in	IN
cord-005453-4057qib7	14368	35	children	child	NNS
cord-005453-4057qib7	14368	36	in	in	IN
cord-005453-4057qib7	14368	37	the	the	DT
cord-005453-4057qib7	14368	38	Middle	Middle	NNP
cord-005453-4057qib7	14368	39	East	East	NNP
cord-005453-4057qib7	14368	40	and	and	CC
cord-005453-4057qib7	14368	41	South	South	NNP
cord-005453-4057qib7	14368	42	East	East	NNP
cord-005453-4057qib7	14368	43	Asia	Asia	NNP
cord-005453-4057qib7	14368	44	.	.	.
cord-005453-4057qib7	14369	1	Sex	sex	NN
cord-005453-4057qib7	14369	2	mismatch	mismatch	NN
cord-005453-4057qib7	14369	3	has	have	VBZ
cord-005453-4057qib7	14369	4	been	be	VBN
cord-005453-4057qib7	14369	5	associated	associate	VBN
cord-005453-4057qib7	14369	6	with	with	IN
cord-005453-4057qib7	14369	7	increased	increase	VBN
cord-005453-4057qib7	14369	8	risk	risk	NN
cord-005453-4057qib7	14369	9	of	of	IN
cord-005453-4057qib7	14369	10	solid	solid	JJ
cord-005453-4057qib7	14369	11	organ	organ	NN
cord-005453-4057qib7	14369	12	rejection	rejection	NN
cord-005453-4057qib7	14369	13	but	but	CC
cord-005453-4057qib7	14369	14	is	be	VBZ
cord-005453-4057qib7	14369	15	not	not	RB
cord-005453-4057qib7	14369	16	generally	generally	RB
cord-005453-4057qib7	14369	17	considered	consider	VBN
cord-005453-4057qib7	14369	18	an	an	DT
cord-005453-4057qib7	14369	19	important	important	JJ
cord-005453-4057qib7	14369	20	transplant	transplant	NN
cord-005453-4057qib7	14369	21	-	-	HYPH
cord-005453-4057qib7	14369	22	associated	associate	VBN
cord-005453-4057qib7	14369	23	risk	risk	NN
cord-005453-4057qib7	14369	24	factor	factor	NN
cord-005453-4057qib7	14369	25	in	in	IN
cord-005453-4057qib7	14369	26	the	the	DT
cord-005453-4057qib7	14369	27	context	context	NN
cord-005453-4057qib7	14369	28	of	of	IN
cord-005453-4057qib7	14369	29	fully	fully	RB
cord-005453-4057qib7	14369	30	matched	match	VBN
cord-005453-4057qib7	14369	31	sibling	sibling	NN
cord-005453-4057qib7	14369	32	BMT	BMT	NNP
cord-005453-4057qib7	14369	33	for	for	IN
cord-005453-4057qib7	14369	34	ST	ST	NNP
cord-005453-4057qib7	14369	35	.	.	.
cord-005453-4057qib7	14370	1	Methods	method	NNS
cord-005453-4057qib7	14370	2	:	:	:
cord-005453-4057qib7	14371	1	A	a	DT
cord-005453-4057qib7	14371	2	total	total	NN
cord-005453-4057qib7	14371	3	of	of	IN
cord-005453-4057qib7	14371	4	154	154	CD
cord-005453-4057qib7	14371	5	consecutive	consecutive	JJ
cord-005453-4057qib7	14371	6	sibling	sibling	NN
cord-005453-4057qib7	14371	7	bone	bone	NN
cord-005453-4057qib7	14371	8	marrow	marrow	NN
cord-005453-4057qib7	14371	9	transplants	transplant	NNS
cord-005453-4057qib7	14371	10	carried	carry	VBN
cord-005453-4057qib7	14371	11	out	out	RP
cord-005453-4057qib7	14371	12	between	between	IN
cord-005453-4057qib7	14371	13	January	January	NNP
cord-005453-4057qib7	14371	14	2009	2009	CD
cord-005453-4057qib7	14371	15	and	and	CC
cord-005453-4057qib7	14371	16	April	April	NNP
cord-005453-4057qib7	14371	17	2017	2017	CD
cord-005453-4057qib7	14371	18	after	after	IN
cord-005453-4057qib7	14371	19	conditioning	condition	VBG
cord-005453-4057qib7	14371	20	with	with	IN
cord-005453-4057qib7	14371	21	busulfan	busulfan	NN
cord-005453-4057qib7	14371	22	(	(	-LRB-
cord-005453-4057qib7	14371	23	14	14	CD
cord-005453-4057qib7	14371	24	mg	mg	NNP
cord-005453-4057qib7	14371	25	/	/	SYM
cord-005453-4057qib7	14371	26	kg	kg	NNP
cord-005453-4057qib7	14371	27	oral	oral	JJ
cord-005453-4057qib7	14371	28	,	,	,
cord-005453-4057qib7	14371	29	not	not	RB
cord-005453-4057qib7	14371	30	adjusted	adjust	VBN
cord-005453-4057qib7	14371	31	to	to	IN
cord-005453-4057qib7	14371	32	serum	serum	NN
cord-005453-4057qib7	14371	33	levels	level	NNS
cord-005453-4057qib7	14371	34	)	)	-RRB-
cord-005453-4057qib7	14371	35	and	and	CC
cord-005453-4057qib7	14371	36	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14371	37	(	(	-LRB-
cord-005453-4057qib7	14371	38	200	200	CD
cord-005453-4057qib7	14371	39	mg	mg	NNP
cord-005453-4057qib7	14371	40	/	/	SYM
cord-005453-4057qib7	14371	41	kg	kg	NNP
cord-005453-4057qib7	14371	42	)	)	-RRB-
cord-005453-4057qib7	14371	43	(	(	-LRB-
cord-005453-4057qib7	14371	44	2	2	CD
cord-005453-4057qib7	14371	45	patients	patient	NNS
cord-005453-4057qib7	14371	46	)	)	-RRB-
cord-005453-4057qib7	14372	1	in	in	IN
cord-005453-4057qib7	14372	2	addition	addition	NN
cord-005453-4057qib7	14372	3	to	to	IN
cord-005453-4057qib7	14372	4	either	either	DT
cord-005453-4057qib7	14372	5	thiotepa	thiotepa	NNS
cord-005453-4057qib7	14372	6	(	(	-LRB-
cord-005453-4057qib7	14372	7	10	10	CD
cord-005453-4057qib7	14372	8	mg	mg	NNP
cord-005453-4057qib7	14372	9	/	/	SYM
cord-005453-4057qib7	14372	10	kg	kg	NNP
cord-005453-4057qib7	14372	11	)	)	-RRB-
cord-005453-4057qib7	14372	12	(	(	-LRB-
cord-005453-4057qib7	14372	13	49	49	CD
cord-005453-4057qib7	14372	14	patients	patient	NNS
cord-005453-4057qib7	14372	15	)	)	-RRB-
cord-005453-4057qib7	14372	16	,	,	,
cord-005453-4057qib7	14372	17	or	or	CC
cord-005453-4057qib7	14372	18	anti	anti	JJ
cord-005453-4057qib7	14372	19	-	-	JJ
cord-005453-4057qib7	14372	20	thymocyte	thymocyte	JJ
cord-005453-4057qib7	14372	21	globulin	globulin	NN
cord-005453-4057qib7	14372	22	(	(	-LRB-
cord-005453-4057qib7	14373	1	Genzyme	Genzyme	NNP
cord-005453-4057qib7	14373	2	4	4	CD
cord-005453-4057qib7	14373	3	mg/	mg/	NN
cord-005453-4057qib7	14373	4	kg	kg	NNP
cord-005453-4057qib7	14373	5	or	or	CC
cord-005453-4057qib7	14373	6	Fresenius	Fresenius	NNP
cord-005453-4057qib7	14373	7	16	16	CD
cord-005453-4057qib7	14374	1	mg	mg	NNP
cord-005453-4057qib7	14374	2	/	/	SYM
cord-005453-4057qib7	14374	3	kg	kg	NNS
cord-005453-4057qib7	14374	4	on	on	IN
cord-005453-4057qib7	14374	5	days	day	NNS
cord-005453-4057qib7	14374	6	-12	-12	CD
cord-005453-4057qib7	14374	7	to	to	IN
cord-005453-4057qib7	14374	8	-10	-10	NN
cord-005453-4057qib7	14374	9	)	)	-RRB-
cord-005453-4057qib7	14375	1	(	(	-LRB-
cord-005453-4057qib7	14375	2	92	92	CD
cord-005453-4057qib7	14375	3	patients	patient	NNS
cord-005453-4057qib7	14375	4	)	)	-RRB-
cord-005453-4057qib7	14375	5	and	and	CC
cord-005453-4057qib7	14375	6	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	14375	7	150	150	CD
cord-005453-4057qib7	14375	8	mg	mg	NNP
cord-005453-4057qib7	14375	9	/	/	SYM
cord-005453-4057qib7	14375	10	m	m	NN
cord-005453-4057qib7	14375	11	2	2	CD
cord-005453-4057qib7	14375	12	(	(	-LRB-
cord-005453-4057qib7	14375	13	11	11	CD
cord-005453-4057qib7	14375	14	patients	patient	NNS
cord-005453-4057qib7	14375	15	)	)	-RRB-
cord-005453-4057qib7	14375	16	were	be	VBD
cord-005453-4057qib7	14375	17	analysed	analyse	VBN
cord-005453-4057qib7	14375	18	.	.	.
cord-005453-4057qib7	14376	1	All	all	DT
cord-005453-4057qib7	14376	2	cases	case	NNS
cord-005453-4057qib7	14376	3	received	receive	VBD
cord-005453-4057qib7	14376	4	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	14376	5	and	and	CC
cord-005453-4057qib7	14376	6	methotrexate	methotrexate	NNP
cord-005453-4057qib7	14376	7	or	or	CC
cord-005453-4057qib7	14376	8	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	14376	9	mofetil	mofetil	NNP
cord-005453-4057qib7	14376	10	as	as	IN
cord-005453-4057qib7	14376	11	GVHD	GVHD	NNP
cord-005453-4057qib7	14376	12	/	/	SYM
cord-005453-4057qib7	14376	13	rejection	rejection	NN
cord-005453-4057qib7	14376	14	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14376	15	.	.	.
cord-005453-4057qib7	14377	1	In	in	IN
cord-005453-4057qib7	14377	2	the	the	DT
cord-005453-4057qib7	14377	3	thiotepa	thiotepa	JJ
cord-005453-4057qib7	14377	4	group	group	NN
cord-005453-4057qib7	14377	5	methylprednisolone	methylprednisolone	NN
cord-005453-4057qib7	14377	6	at	at	IN
cord-005453-4057qib7	14377	7	0.5	0.5	CD
cord-005453-4057qib7	14377	8	mg	mg	NNP
cord-005453-4057qib7	14377	9	/	/	SYM
cord-005453-4057qib7	14377	10	kg	kg	NNP
cord-005453-4057qib7	14377	11	/	/	SYM
cord-005453-4057qib7	14377	12	day	day	NN
cord-005453-4057qib7	14377	13	was	be	VBD
cord-005453-4057qib7	14377	14	also	also	RB
cord-005453-4057qib7	14377	15	used	use	VBN
cord-005453-4057qib7	14377	16	during	during	IN
cord-005453-4057qib7	14377	17	the	the	DT
cord-005453-4057qib7	14377	18	first	first	JJ
cord-005453-4057qib7	14377	19	30	30	CD
cord-005453-4057qib7	14377	20	days	day	NNS
cord-005453-4057qib7	14377	21	after	after	IN
cord-005453-4057qib7	14377	22	BMT	BMT	NNP
cord-005453-4057qib7	14377	23	(	(	-LRB-
cord-005453-4057qib7	14377	24	Lucarelli	Lucarelli	NNP
cord-005453-4057qib7	14377	25	protocol	protocol	NN
cord-005453-4057qib7	14377	26	6i	6i	CD
cord-005453-4057qib7	14377	27	)	)	-RRB-
cord-005453-4057qib7	14377	28	.	.	.
cord-005453-4057qib7	14378	1	Bone	bone	NN
cord-005453-4057qib7	14378	2	marrow	marrow	NN
cord-005453-4057qib7	14378	3	was	be	VBD
cord-005453-4057qib7	14378	4	the	the	DT
cord-005453-4057qib7	14378	5	source	source	NN
cord-005453-4057qib7	14378	6	of	of	IN
cord-005453-4057qib7	14378	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14378	8	stem	stem	NN
cord-005453-4057qib7	14378	9	cells	cell	NNS
cord-005453-4057qib7	14378	10	in	in	IN
cord-005453-4057qib7	14378	11	all	all	DT
cord-005453-4057qib7	14378	12	cases	case	NNS
cord-005453-4057qib7	14378	13	,	,	,
cord-005453-4057qib7	14378	14	in	in	IN
cord-005453-4057qib7	14378	15	the	the	DT
cord-005453-4057qib7	14378	16	ATG	ATG	NNP
cord-005453-4057qib7	14378	17	group	group	NN
cord-005453-4057qib7	14378	18	it	-PRON-	PRP
cord-005453-4057qib7	14378	19	was	be	VBD
cord-005453-4057qib7	14378	20	G	G	NNP
cord-005453-4057qib7	14378	21	-	-	HYPH
cord-005453-4057qib7	14378	22	CSFprimed	CSFprimed	NNP
cord-005453-4057qib7	14378	23	(	(	-LRB-
cord-005453-4057qib7	14378	24	5	5	CD
cord-005453-4057qib7	14378	25	μg	μg	NNP
cord-005453-4057qib7	14378	26	/	/	SYM
cord-005453-4057qib7	14378	27	kg	kg	NN
cord-005453-4057qib7	14378	28	/	/	SYM
cord-005453-4057qib7	14378	29	dose	dose	NN
cord-005453-4057qib7	14378	30	twice	twice	RB
cord-005453-4057qib7	14378	31	daily	daily	RB
cord-005453-4057qib7	14378	32	for	for	IN
cord-005453-4057qib7	14378	33	3	3	CD
cord-005453-4057qib7	14378	34	to	to	TO
cord-005453-4057qib7	14378	35	5	5	CD
cord-005453-4057qib7	14378	36	days	day	NNS
cord-005453-4057qib7	14378	37	prior	prior	RB
cord-005453-4057qib7	14378	38	to	to	IN
cord-005453-4057qib7	14378	39	harvest	harvest	NN
cord-005453-4057qib7	14378	40	)	)	-RRB-
cord-005453-4057qib7	14378	41	.	.	.
cord-005453-4057qib7	14379	1	All	all	DT
cord-005453-4057qib7	14379	2	patients	patient	NNS
cord-005453-4057qib7	14379	3	were	be	VBD
cord-005453-4057qib7	14379	4	considered	consider	VBN
cord-005453-4057qib7	14379	5	low	low	JJ
cord-005453-4057qib7	14379	6	risk	risk	NN
cord-005453-4057qib7	14379	7	based	base	VBN
cord-005453-4057qib7	14379	8	on	on	IN
cord-005453-4057qib7	14379	9	liver	liver	NN
cord-005453-4057qib7	14379	10	size	size	NN
cord-005453-4057qib7	14379	11	<	<	XX
cord-005453-4057qib7	14379	12	2	2	CD
cord-005453-4057qib7	14379	13	cm	cm	NNP
cord-005453-4057qib7	14379	14	from	from	IN
cord-005453-4057qib7	14379	15	costal	costal	JJ
cord-005453-4057qib7	14379	16	margin	margin	NN
cord-005453-4057qib7	14379	17	and	and	CC
cord-005453-4057qib7	14379	18	age	age	NN
cord-005453-4057qib7	14379	19	less	less	JJR
cord-005453-4057qib7	14379	20	than	than	IN
cord-005453-4057qib7	14379	21	15	15	CD
cord-005453-4057qib7	14379	22	years	year	NNS
cord-005453-4057qib7	14379	23	(	(	-LRB-
cord-005453-4057qib7	14379	24	median	median	NN
cord-005453-4057qib7	14379	25	4.2	4.2	CD
cord-005453-4057qib7	14379	26	years	year	NNS
cord-005453-4057qib7	14379	27	,	,	,
cord-005453-4057qib7	14379	28	range	range	VBP
cord-005453-4057qib7	14379	29	0.9	0.9	CD
cord-005453-4057qib7	14379	30	to	to	IN
cord-005453-4057qib7	14379	31	14.5	14.5	CD
cord-005453-4057qib7	14379	32	)	)	-RRB-
cord-005453-4057qib7	14379	33	,	,	,
cord-005453-4057qib7	14379	34	all	all	DT
cord-005453-4057qib7	14379	35	sibling	sibling	NN
cord-005453-4057qib7	14379	36	pairs	pair	NNS
cord-005453-4057qib7	14379	37	where	where	WRB
cord-005453-4057qib7	14379	38	HLA	HLA	NNP
cord-005453-4057qib7	14379	39	-	-	HYPH
cord-005453-4057qib7	14379	40	compatible	compatible	JJ
cord-005453-4057qib7	14379	41	.	.	.
cord-005453-4057qib7	14380	1	Results	result	NNS
cord-005453-4057qib7	14380	2	:	:	:
cord-005453-4057qib7	14381	1	[	[	-LRB-
cord-005453-4057qib7	14381	2	[	[	-LRB-
cord-005453-4057qib7	14381	3	P665	P665	NNP
cord-005453-4057qib7	14381	4	Image	image	NN
cord-005453-4057qib7	14381	5	]	]	-RRB-
cord-005453-4057qib7	14381	6	1	1	CD
cord-005453-4057qib7	14381	7	.	.	.
cord-005453-4057qib7	14382	1	Sibling	sibling	NN
cord-005453-4057qib7	14382	2	donor	donor	NN
cord-005453-4057qib7	14382	3	-	-	HYPH
cord-005453-4057qib7	14382	4	recipient	recipient	NN
cord-005453-4057qib7	14382	5	sex	sex	NN
cord-005453-4057qib7	14382	6	combinations	combination	NNS
cord-005453-4057qib7	14382	7	.	.	.
cord-005453-4057qib7	14382	8	]	]	-RRB-
cord-005453-4057qib7	14383	1	The	the	DT
cord-005453-4057qib7	14383	2	lowest	low	JJS
cord-005453-4057qib7	14383	3	rejection	rejection	NN
cord-005453-4057qib7	14383	4	rate	rate	NN
cord-005453-4057qib7	14383	5	(	(	-LRB-
cord-005453-4057qib7	14383	6	5	5	CD
cord-005453-4057qib7	14383	7	%	%	NN
cord-005453-4057qib7	14383	8	)	)	-RRB-
cord-005453-4057qib7	14383	9	was	be	VBD
cord-005453-4057qib7	14383	10	observed	observe	VBN
cord-005453-4057qib7	14383	11	in	in	IN
cord-005453-4057qib7	14383	12	the	the	DT
cord-005453-4057qib7	14383	13	Sister	Sister	NNP
cord-005453-4057qib7	14383	14	to	to	IN
cord-005453-4057qib7	14383	15	Sister	Sister	NNP
cord-005453-4057qib7	14383	16	(	(	-LRB-
cord-005453-4057qib7	14383	17	S2S	S2S	NNP
cord-005453-4057qib7	14383	18	)	)	-RRB-
cord-005453-4057qib7	14383	19	group	group	NN
cord-005453-4057qib7	14383	20	of	of	IN
cord-005453-4057qib7	14383	21	24	24	CD
cord-005453-4057qib7	14383	22	cases	case	NNS
cord-005453-4057qib7	14383	23	,	,	,
cord-005453-4057qib7	14383	24	followed	follow	VBN
cord-005453-4057qib7	14383	25	by	by	IN
cord-005453-4057qib7	14383	26	Brother	Brother	NNP
cord-005453-4057qib7	14383	27	to	to	IN
cord-005453-4057qib7	14383	28	Brother	Brother	NNP
cord-005453-4057qib7	14383	29	(	(	-LRB-
cord-005453-4057qib7	14383	30	B2B	B2B	NNP
cord-005453-4057qib7	14383	31	)	)	-RRB-
cord-005453-4057qib7	14383	32	group	group	NN
cord-005453-4057qib7	14383	33	of	of	IN
cord-005453-4057qib7	14383	34	40	40	CD
cord-005453-4057qib7	14383	35	cases	case	NNS
cord-005453-4057qib7	14383	36	with	with	IN
cord-005453-4057qib7	14383	37	11	11	CD
cord-005453-4057qib7	14383	38	%	%	NN
cord-005453-4057qib7	14383	39	.	.	.
cord-005453-4057qib7	14384	1	In	in	IN
cord-005453-4057qib7	14384	2	the	the	DT
cord-005453-4057qib7	14384	3	Sister	Sister	NNP
cord-005453-4057qib7	14384	4	to	to	IN
cord-005453-4057qib7	14384	5	Brother	Brother	NNP
cord-005453-4057qib7	14384	6	(	(	-LRB-
cord-005453-4057qib7	14384	7	S2B	s2b	NN
cord-005453-4057qib7	14384	8	)	)	-RRB-
cord-005453-4057qib7	14384	9	group	group	NN
cord-005453-4057qib7	14384	10	of	of	IN
cord-005453-4057qib7	14384	11	59	59	CD
cord-005453-4057qib7	14384	12	cases	case	NNS
cord-005453-4057qib7	14384	13	,	,	,
cord-005453-4057qib7	14384	14	rejection	rejection	NN
cord-005453-4057qib7	14384	15	rate	rate	NN
cord-005453-4057qib7	14384	16	was	be	VBD
cord-005453-4057qib7	14384	17	21	21	CD
cord-005453-4057qib7	14384	18	%	%	NN
cord-005453-4057qib7	14384	19	,	,	,
cord-005453-4057qib7	14384	20	and	and	CC
cord-005453-4057qib7	14384	21	26	26	CD
cord-005453-4057qib7	14384	22	%	%	NN
cord-005453-4057qib7	14384	23	in	in	IN
cord-005453-4057qib7	14384	24	the	the	DT
cord-005453-4057qib7	14384	25	Brother	Brother	NNP
cord-005453-4057qib7	14384	26	to	to	IN
cord-005453-4057qib7	14384	27	Sister	Sister	NNP
cord-005453-4057qib7	14384	28	(	(	-LRB-
cord-005453-4057qib7	14384	29	B2S	B2S	NNP
cord-005453-4057qib7	14384	30	)	)	-RRB-
cord-005453-4057qib7	14384	31	group	group	NNP
cord-005453-4057qib7	14384	32	of	of	IN
cord-005453-4057qib7	14384	33	31	31	CD
cord-005453-4057qib7	14384	34	cases	case	NNS
cord-005453-4057qib7	14384	35	.	.	.
cord-005453-4057qib7	14385	1	On	on	IN
cord-005453-4057qib7	14385	2	univariate	univariate	JJ
cord-005453-4057qib7	14385	3	analysis	analysis	NN
cord-005453-4057qib7	14385	4	the	the	DT
cord-005453-4057qib7	14385	5	only	only	JJ
cord-005453-4057qib7	14385	6	significant	significant	JJ
cord-005453-4057qib7	14385	7	difference	difference	NN
cord-005453-4057qib7	14385	8	at	at	IN
cord-005453-4057qib7	14385	9	the	the	DT
cord-005453-4057qib7	14385	10	P	p	NN
cord-005453-4057qib7	14385	11	0.05	0.05	CD
cord-005453-4057qib7	14385	12	level	level	NN
cord-005453-4057qib7	14385	13	by	by	IN
cord-005453-4057qib7	14385	14	log	log	NN
cord-005453-4057qib7	14385	15	rank	rank	NN
cord-005453-4057qib7	14385	16	test	test	NN
cord-005453-4057qib7	14385	17	was	be	VBD
cord-005453-4057qib7	14385	18	B2S	B2S	NNP
cord-005453-4057qib7	14385	19	vs.	vs.	FW
cord-005453-4057qib7	14385	20	S2S	S2S	NNP
cord-005453-4057qib7	14385	21	groups	group	NNS
cord-005453-4057qib7	14385	22	(	(	-LRB-
cord-005453-4057qib7	14385	23	rejection	rejection	NN
cord-005453-4057qib7	14385	24	proportions	proportion	NNS
cord-005453-4057qib7	14385	25	of	of	IN
cord-005453-4057qib7	14385	26	26	26	CD
cord-005453-4057qib7	14385	27	%	%	NN
cord-005453-4057qib7	14385	28	and	and	CC
cord-005453-4057qib7	14385	29	5	5	CD
cord-005453-4057qib7	14385	30	%	%	NN
cord-005453-4057qib7	14385	31	respectively	respectively	RB
cord-005453-4057qib7	14385	32	)	)	-RRB-
cord-005453-4057qib7	14385	33	.	.	.
cord-005453-4057qib7	14386	1	Interestingly	interestingly	RB
cord-005453-4057qib7	14386	2	,	,	,
cord-005453-4057qib7	14386	3	all	all	DT
cord-005453-4057qib7	14386	4	3	3	CD
cord-005453-4057qib7	14386	5	patients	patient	NNS
cord-005453-4057qib7	14386	6	with	with	IN
cord-005453-4057qib7	14386	7	rejection	rejection	NN
cord-005453-4057qib7	14386	8	and	and	CC
cord-005453-4057qib7	14386	9	persistent	persistent	JJ
cord-005453-4057qib7	14386	10	pancytopenia	pancytopenia	NNP
cord-005453-4057qib7	14386	11	were	be	VBD
cord-005453-4057qib7	14386	12	female	female	JJ
cord-005453-4057qib7	14386	13	recipients	recipient	NNS
cord-005453-4057qib7	14386	14	of	of	IN
cord-005453-4057qib7	14386	15	male	male	JJ
cord-005453-4057qib7	14386	16	grafts	graft	NNS
cord-005453-4057qib7	14386	17	.	.	.
cord-005453-4057qib7	14387	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14387	2	:	:	:
cord-005453-4057qib7	14388	1	Even	even	RB
cord-005453-4057qib7	14388	2	though	though	IN
cord-005453-4057qib7	14388	3	several	several	JJ
cord-005453-4057qib7	14388	4	preparative	preparative	JJ
cord-005453-4057qib7	14388	5	regimens	regimen	NNS
cord-005453-4057qib7	14388	6	were	be	VBD
cord-005453-4057qib7	14388	7	employed	employ	VBN
cord-005453-4057qib7	14388	8	over	over	IN
cord-005453-4057qib7	14388	9	an	an	DT
cord-005453-4057qib7	14388	10	8-year	8-year	JJ
cord-005453-4057qib7	14388	11	period	period	NN
cord-005453-4057qib7	14388	12	,	,	,
cord-005453-4057qib7	14388	13	our	-PRON-	PRP$
cord-005453-4057qib7	14388	14	data	datum	NNS
cord-005453-4057qib7	14388	15	suggests	suggest	VBZ
cord-005453-4057qib7	14388	16	that	that	IN
cord-005453-4057qib7	14388	17	sex	sex	NN
cord-005453-4057qib7	14388	18	mismatch	mismatch	NN
cord-005453-4057qib7	14388	19	among	among	IN
cord-005453-4057qib7	14388	20	compatible	compatible	JJ
cord-005453-4057qib7	14388	21	siblings	sibling	NNS
cord-005453-4057qib7	14388	22	should	should	MD
cord-005453-4057qib7	14388	23	be	be	VB
cord-005453-4057qib7	14388	24	considered	consider	VBN
cord-005453-4057qib7	14388	25	as	as	IN
cord-005453-4057qib7	14388	26	a	a	DT
cord-005453-4057qib7	14388	27	relevant	relevant	JJ
cord-005453-4057qib7	14388	28	variable	variable	NN
cord-005453-4057qib7	14388	29	related	relate	VBN
cord-005453-4057qib7	14388	30	to	to	IN
cord-005453-4057qib7	14388	31	BMT	BMT	NNP
cord-005453-4057qib7	14388	32	decisionmaking	decisionmaking	NN
cord-005453-4057qib7	14388	33	.	.	.
cord-005453-4057qib7	14389	1	We	-PRON-	PRP
cord-005453-4057qib7	14389	2	also	also	RB
cord-005453-4057qib7	14389	3	recommend	recommend	VBP
cord-005453-4057qib7	14389	4	to	to	TO
cord-005453-4057qib7	14389	5	consider	consider	VB
cord-005453-4057qib7	14389	6	autologous	autologous	JJ
cord-005453-4057qib7	14389	7	back	back	RB
cord-005453-4057qib7	14389	8	up	up	RP
cord-005453-4057qib7	14389	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14389	10	stem	stem	NN
cord-005453-4057qib7	14389	11	cell	cell	NN
cord-005453-4057qib7	14389	12	collection	collection	NN
cord-005453-4057qib7	14389	13	and	and	CC
cord-005453-4057qib7	14389	14	storage	storage	NN
cord-005453-4057qib7	14389	15	in	in	IN
cord-005453-4057qib7	14389	16	sibling	sibling	NN
cord-005453-4057qib7	14389	17	sex	sex	NN
cord-005453-4057qib7	14389	18	mismatched	mismatch	VBN
cord-005453-4057qib7	14389	19	transplants	transplant	NNS
cord-005453-4057qib7	14389	20	,	,	,
cord-005453-4057qib7	14389	21	particularly	particularly	RB
cord-005453-4057qib7	14389	22	in	in	IN
cord-005453-4057qib7	14389	23	brother	brother	NN
cord-005453-4057qib7	14389	24	to	to	IN
cord-005453-4057qib7	14389	25	sister	sister	NN
cord-005453-4057qib7	14389	26	BMTs	BMTs	NNP
cord-005453-4057qib7	14389	27	.	.	.
cord-005453-4057qib7	14390	1	Same	same	JJ
cord-005453-4057qib7	14390	2	-	-	HYPH
cord-005453-4057qib7	14390	3	sex	sex	NN
cord-005453-4057qib7	14390	4	fully	fully	RB
cord-005453-4057qib7	14390	5	matched	match	VBD
cord-005453-4057qib7	14390	6	related	relate	VBN
cord-005453-4057qib7	14390	7	BMT	BMT	NNP
cord-005453-4057qib7	14390	8	for	for	IN
cord-005453-4057qib7	14390	9	severe	severe	JJ
cord-005453-4057qib7	14390	10	thalassemia	thalassemia	NN
cord-005453-4057qib7	14390	11	might	may	MD
cord-005453-4057qib7	14390	12	be	be	VB
cord-005453-4057qib7	14390	13	the	the	DT
cord-005453-4057qib7	14390	14	best	good	JJS
cord-005453-4057qib7	14390	15	scenario	scenario	NN
cord-005453-4057qib7	14390	16	in	in	IN
cord-005453-4057qib7	14390	17	which	which	WDT
cord-005453-4057qib7	14390	18	reducedintensity	reducedintensity	NN
cord-005453-4057qib7	14390	19	preparation	preparation	NN
cord-005453-4057qib7	14390	20	strategies	strategy	NNS
cord-005453-4057qib7	14390	21	aiming	aim	VBG
cord-005453-4057qib7	14390	22	at	at	IN
cord-005453-4057qib7	14390	23	maximizing	maximize	VBG
cord-005453-4057qib7	14390	24	fertility	fertility	NN
cord-005453-4057qib7	14390	25	preservation	preservation	NN
cord-005453-4057qib7	14390	26	might	may	MD
cord-005453-4057qib7	14390	27	be	be	VB
cord-005453-4057qib7	14390	28	explored	explore	VBN
cord-005453-4057qib7	14390	29	.	.	.
cord-005453-4057qib7	14391	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14391	2	:	:	:
cord-005453-4057qib7	14391	3	Nothing	nothing	NN
cord-005453-4057qib7	14391	4	to	to	TO
cord-005453-4057qib7	14391	5	declare	declare	VB
cord-005453-4057qib7	14391	6	.	.	.
cord-005453-4057qib7	14392	1	Outcomes	outcome	NNS
cord-005453-4057qib7	14392	2	of	of	IN
cord-005453-4057qib7	14392	3	T	t	NN
cord-005453-4057qib7	14392	4	-	-	HYPH
cord-005453-4057qib7	14392	5	cell	cell	NN
cord-005453-4057qib7	14392	6	replete	replete	JJ
cord-005453-4057qib7	14392	7	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14392	8	cell	cell	NN
cord-005453-4057qib7	14392	9	transplantation	transplantation	NN
cord-005453-4057qib7	14392	10	from	from	IN
cord-005453-4057qib7	14392	11	mismatched	mismatched	JJ
cord-005453-4057qib7	14392	12	related	related	JJ
cord-005453-4057qib7	14392	13	or	or	CC
cord-005453-4057qib7	14392	14	unrelated	unrelated	JJ
cord-005453-4057qib7	14392	15	donors	donor	NNS
cord-005453-4057qib7	14392	16	using	use	VBG
cord-005453-4057qib7	14392	17	high	high	JJ
cord-005453-4057qib7	14392	18	dose	dose	NN
cord-005453-4057qib7	14392	19	post	post	JJ
cord-005453-4057qib7	14392	20	-	-	JJ
cord-005453-4057qib7	14392	21	transplant	transplant	NN
cord-005453-4057qib7	14392	22	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14392	23	based	base	VBN
cord-005453-4057qib7	14392	24	GVHD	GVHD	NNP
cord-005453-4057qib7	14392	25	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14392	26	Background	background	NN
cord-005453-4057qib7	14392	27	:	:	:
cord-005453-4057qib7	14393	1	High	high	JJ
cord-005453-4057qib7	14393	2	dose	dose	NN
cord-005453-4057qib7	14393	3	post	post	JJ
cord-005453-4057qib7	14393	4	-	-	JJ
cord-005453-4057qib7	14393	5	transplant	transplant	NN
cord-005453-4057qib7	14393	6	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14393	7	(	(	-LRB-
cord-005453-4057qib7	14393	8	ptCy	ptcy	RB
cord-005453-4057qib7	14393	9	)	)	-RRB-
cord-005453-4057qib7	14393	10	based	base	VBN
cord-005453-4057qib7	14393	11	GvHD	GvHD	NNP
cord-005453-4057qib7	14393	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14393	13	overcomes	overcome	VBZ
cord-005453-4057qib7	14393	14	immunological	immunological	JJ
cord-005453-4057qib7	14393	15	barriers	barrier	NNS
cord-005453-4057qib7	14393	16	in	in	IN
cord-005453-4057qib7	14393	17	HLA	HLA	NNP
cord-005453-4057qib7	14393	18	mismatched	mismatched	JJ
cord-005453-4057qib7	14393	19	donor	donor	NN
cord-005453-4057qib7	14393	20	transplantation	transplantation	NN
cord-005453-4057qib7	14393	21	.	.	.
cord-005453-4057qib7	14394	1	ptCy	ptcy	EX
cord-005453-4057qib7	14394	2	has	have	VBZ
cord-005453-4057qib7	14394	3	been	be	VBN
cord-005453-4057qib7	14394	4	adopted	adopt	VBN
cord-005453-4057qib7	14394	5	in	in	IN
cord-005453-4057qib7	14394	6	many	many	JJ
cord-005453-4057qib7	14394	7	centers	center	NNS
cord-005453-4057qib7	14394	8	as	as	IN
cord-005453-4057qib7	14394	9	de	de	FW
cord-005453-4057qib7	14394	10	facto	facto	FW
cord-005453-4057qib7	14394	11	standard	standard	NN
cord-005453-4057qib7	14394	12	for	for	IN
cord-005453-4057qib7	14394	13	HCT	HCT	NNP
cord-005453-4057qib7	14394	14	from	from	IN
cord-005453-4057qib7	14394	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14394	16	donors	donor	NNS
cord-005453-4057qib7	14394	17	(	(	-LRB-
cord-005453-4057qib7	14394	18	haplo	haplo	NNP
cord-005453-4057qib7	14394	19	HCT	HCT	NNP
cord-005453-4057qib7	14394	20	)	)	-RRB-
cord-005453-4057qib7	14394	21	.	.	.
cord-005453-4057qib7	14395	1	It	-PRON-	PRP
cord-005453-4057qib7	14395	2	's	be	VBZ
cord-005453-4057qib7	14395	3	use	use	NN
cord-005453-4057qib7	14395	4	in	in	IN
cord-005453-4057qib7	14395	5	mismatched	mismatched	JJ
cord-005453-4057qib7	14395	6	unrelated	unrelated	JJ
cord-005453-4057qib7	14395	7	donor	donor	NN
cord-005453-4057qib7	14395	8	transplant	transplant	NN
cord-005453-4057qib7	14395	9	(	(	-LRB-
cord-005453-4057qib7	14395	10	MMUD	MMUD	NNP
cord-005453-4057qib7	14395	11	HCT	HCT	NNP
cord-005453-4057qib7	14395	12	)	)	-RRB-
cord-005453-4057qib7	14395	13	is	be	VBZ
cord-005453-4057qib7	14395	14	less	less	RBR
cord-005453-4057qib7	14395	15	well	well	RB
cord-005453-4057qib7	14395	16	established	establish	VBN
cord-005453-4057qib7	14395	17	.	.	.
cord-005453-4057qib7	14396	1	Methods	method	NNS
cord-005453-4057qib7	14396	2	:	:	:
cord-005453-4057qib7	14397	1	We	-PRON-	PRP
cord-005453-4057qib7	14397	2	analyzed	analyze	VBD
cord-005453-4057qib7	14397	3	retrospectively	retrospectively	RB
cord-005453-4057qib7	14397	4	outcomes	outcome	NNS
cord-005453-4057qib7	14397	5	of	of	IN
cord-005453-4057qib7	14397	6	contemporary	contemporary	JJ
cord-005453-4057qib7	14397	7	cohorts	cohort	NNS
cord-005453-4057qib7	14397	8	of	of	IN
cord-005453-4057qib7	14397	9	patients	patient	NNS
cord-005453-4057qib7	14397	10	who	who	WP
cord-005453-4057qib7	14397	11	underwent	undergo	VBD
cord-005453-4057qib7	14397	12	haplo	haplo	NN
cord-005453-4057qib7	14397	13	HCT	HCT	NNP
cord-005453-4057qib7	14397	14	or	or	CC
cord-005453-4057qib7	14397	15	MMUD	MMUD	NNP
cord-005453-4057qib7	14397	16	HCT	HCT	NNP
cord-005453-4057qib7	14397	17	using	use	VBG
cord-005453-4057qib7	14397	18	ptCy	ptcy	RB
cord-005453-4057qib7	14397	19	+	+	CC
cord-005453-4057qib7	14397	20	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	14397	21	(	(	-LRB-
cord-005453-4057qib7	14397	22	CSA	CSA	NNP
cord-005453-4057qib7	14397	23	)	)	-RRB-
cord-005453-4057qib7	14397	24	and	and	CC
cord-005453-4057qib7	14397	25	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	14397	26	mofetil	mofetil	NNP
cord-005453-4057qib7	14397	27	(	(	-LRB-
cord-005453-4057qib7	14397	28	MMF	MMF	NNP
cord-005453-4057qib7	14397	29	)	)	-RRB-
cord-005453-4057qib7	14397	30	at	at	IN
cord-005453-4057qib7	14397	31	our	-PRON-	PRP$
cord-005453-4057qib7	14397	32	center	center	NN
cord-005453-4057qib7	14397	33	.	.	.
cord-005453-4057qib7	14398	1	We	-PRON-	PRP
cord-005453-4057qib7	14398	2	compared	compare	VBD
cord-005453-4057qib7	14398	3	these	these	DT
cord-005453-4057qib7	14398	4	outcomes	outcome	NNS
cord-005453-4057qib7	14398	5	with	with	IN
cord-005453-4057qib7	14398	6	outcomes	outcome	NNS
cord-005453-4057qib7	14398	7	of	of	IN
cord-005453-4057qib7	14398	8	cohorts	cohort	NNS
cord-005453-4057qib7	14398	9	of	of	IN
cord-005453-4057qib7	14398	10	patients	patient	NNS
cord-005453-4057qib7	14398	11	who	who	WP
cord-005453-4057qib7	14398	12	underwent	undergo	VBD
cord-005453-4057qib7	14398	13	HCT	HCT	NNP
cord-005453-4057qib7	14398	14	from	from	IN
cord-005453-4057qib7	14398	15	matched	match	VBN
cord-005453-4057qib7	14398	16	unrelated	unrelated	JJ
cord-005453-4057qib7	14398	17	donors	donor	NNS
cord-005453-4057qib7	14398	18	(	(	-LRB-
cord-005453-4057qib7	14398	19	MUD	mud	NN
cord-005453-4057qib7	14398	20	)	)	-RRB-
cord-005453-4057qib7	14398	21	using	use	VBG
cord-005453-4057qib7	14398	22	ATG	ATG	NNP
cord-005453-4057qib7	14398	23	based	base	VBN
cord-005453-4057qib7	14398	24	GvHD	GvHD	NNP
cord-005453-4057qib7	14398	25	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14398	26	or	or	CC
cord-005453-4057qib7	14398	27	matched	match	VBN
cord-005453-4057qib7	14398	28	sibling	sibling	NN
cord-005453-4057qib7	14398	29	donor	donor	NN
cord-005453-4057qib7	14398	30	(	(	-LRB-
cord-005453-4057qib7	14398	31	MSD	MSD	NNP
cord-005453-4057qib7	14398	32	)	)	-RRB-
cord-005453-4057qib7	14398	33	with	with	IN
cord-005453-4057qib7	14398	34	CSA	CSA	NNP
cord-005453-4057qib7	14398	35	and	and	CC
cord-005453-4057qib7	14398	36	MMF	MMF	NNP
cord-005453-4057qib7	14398	37	.	.	.
cord-005453-4057qib7	14399	1	Patients	patient	NNS
cord-005453-4057qib7	14399	2	and	and	CC
cord-005453-4057qib7	14399	3	donors	donor	NNS
cord-005453-4057qib7	14399	4	were	be	VBD
cord-005453-4057qib7	14399	5	considered	consider	VBN
cord-005453-4057qib7	14399	6	matched	match	VBN
cord-005453-4057qib7	14399	7	if	if	IN
cord-005453-4057qib7	14399	8	they	-PRON-	PRP
cord-005453-4057qib7	14399	9	Background	background	VBP
cord-005453-4057qib7	14400	1	:	:	:
cord-005453-4057qib7	14400	2	HLA	HLA	NNP
cord-005453-4057qib7	14400	3	-	-	HYPH
cord-005453-4057qib7	14400	4	alloantibodies	alloantibody	NNS
cord-005453-4057qib7	14400	5	are	be	VBP
cord-005453-4057qib7	14400	6	a	a	DT
cord-005453-4057qib7	14400	7	major	major	JJ
cord-005453-4057qib7	14400	8	risk	risk	NN
cord-005453-4057qib7	14400	9	factor	factor	NN
cord-005453-4057qib7	14400	10	for	for	IN
cord-005453-4057qib7	14400	11	engraftment	engraftment	NN
cord-005453-4057qib7	14400	12	failure	failure	NN
cord-005453-4057qib7	14400	13	in	in	IN
cord-005453-4057qib7	14400	14	allogeneic	allogeneic	JJ
cord-005453-4057qib7	14400	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14400	16	stem	stem	NN
cord-005453-4057qib7	14400	17	cell	cell	NN
cord-005453-4057qib7	14400	18	transplantation	transplantation	NN
cord-005453-4057qib7	14400	19	(	(	-LRB-
cord-005453-4057qib7	14400	20	HSCT	HSCT	NNP
cord-005453-4057qib7	14400	21	)	)	-RRB-
cord-005453-4057qib7	14400	22	.	.	.
cord-005453-4057qib7	14401	1	Particularly	particularly	RB
cord-005453-4057qib7	14401	2	,	,	,
cord-005453-4057qib7	14401	3	complement	complement	VBP
cord-005453-4057qib7	14401	4	fixing	fixing	NN
cord-005453-4057qib7	14401	5	,	,	,
cord-005453-4057qib7	14401	6	donor	donor	NN
cord-005453-4057qib7	14401	7	specific	specific	JJ
cord-005453-4057qib7	14401	8	antibodies	antibody	NNS
cord-005453-4057qib7	14401	9	were	be	VBD
cord-005453-4057qib7	14401	10	shown	show	VBN
cord-005453-4057qib7	14401	11	to	to	TO
cord-005453-4057qib7	14401	12	be	be	VB
cord-005453-4057qib7	14401	13	associated	associate	VBN
cord-005453-4057qib7	14401	14	with	with	IN
cord-005453-4057qib7	14401	15	early	early	JJ
cord-005453-4057qib7	14401	16	engraftment	engraftment	NN
cord-005453-4057qib7	14401	17	failure	failure	NN
cord-005453-4057qib7	14401	18	.	.	.
cord-005453-4057qib7	14402	1	Prospective	prospective	JJ
cord-005453-4057qib7	14402	2	antibody	antibody	NN
cord-005453-4057qib7	14402	3	-	-	HYPH
cord-005453-4057qib7	14402	4	screening	screening	NN
cord-005453-4057qib7	14402	5	,	,	,
cord-005453-4057qib7	14402	6	although	although	IN
cord-005453-4057qib7	14402	7	not	not	RB
cord-005453-4057qib7	14402	8	currently	currently	RB
cord-005453-4057qib7	14402	9	required	require	VBN
cord-005453-4057qib7	14402	10	for	for	IN
cord-005453-4057qib7	14402	11	donor	donor	NN
cord-005453-4057qib7	14402	12	search	search	NN
cord-005453-4057qib7	14402	13	,	,	,
cord-005453-4057qib7	14402	14	could	could	MD
cord-005453-4057qib7	14402	15	permit	permit	VB
cord-005453-4057qib7	14402	16	early	early	JJ
cord-005453-4057qib7	14402	17	identification	identification	NN
cord-005453-4057qib7	14402	18	of	of	IN
cord-005453-4057qib7	14402	19	high	high	JJ
cord-005453-4057qib7	14402	20	risk	risk	NN
cord-005453-4057qib7	14402	21	patients	patient	NNS
cord-005453-4057qib7	14402	22	for	for	IN
cord-005453-4057qib7	14402	23	positive	positive	JJ
cord-005453-4057qib7	14402	24	crossmatch	crossmatch	NN
cord-005453-4057qib7	14402	25	.	.	.
cord-005453-4057qib7	14403	1	Aim	aim	VB
cord-005453-4057qib7	14403	2	of	of	IN
cord-005453-4057qib7	14403	3	this	this	DT
cord-005453-4057qib7	14403	4	study	study	NN
cord-005453-4057qib7	14403	5	is	be	VBZ
cord-005453-4057qib7	14403	6	to	to	TO
cord-005453-4057qib7	14403	7	set	set	VB
cord-005453-4057qib7	14403	8	the	the	DT
cord-005453-4057qib7	14403	9	basis	basis	NN
cord-005453-4057qib7	14403	10	for	for	IN
cord-005453-4057qib7	14403	11	future	future	JJ
cord-005453-4057qib7	14403	12	applicability	applicability	NN
cord-005453-4057qib7	14403	13	of	of	IN
cord-005453-4057qib7	14403	14	antibody	antibody	NN
cord-005453-4057qib7	14403	15	-	-	HYPH
cord-005453-4057qib7	14403	16	screening	screening	NN
cord-005453-4057qib7	14403	17	-	-	HYPH
cord-005453-4057qib7	14403	18	based	base	VBN
cord-005453-4057qib7	14403	19	definition	definition	NN
cord-005453-4057qib7	14403	20	of	of	IN
cord-005453-4057qib7	14403	21	acceptable	acceptable	JJ
cord-005453-4057qib7	14403	22	mismatches	mismatch	NNS
cord-005453-4057qib7	14403	23	in	in	IN
cord-005453-4057qib7	14403	24	donor	donor	NN
cord-005453-4057qib7	14403	25	selection	selection	NN
cord-005453-4057qib7	14403	26	,	,	,
cord-005453-4057qib7	14403	27	by	by	IN
cord-005453-4057qib7	14403	28	creating	create	VBG
cord-005453-4057qib7	14403	29	a	a	DT
cord-005453-4057qib7	14403	30	large	large	JJ
cord-005453-4057qib7	14403	31	prospective	prospective	JJ
cord-005453-4057qib7	14403	32	antibody	antibody	NN
cord-005453-4057qib7	14403	33	-	-	HYPH
cord-005453-4057qib7	14403	34	screening	screening	NN
cord-005453-4057qib7	14403	35	database	database	NN
cord-005453-4057qib7	14403	36	of	of	IN
cord-005453-4057qib7	14403	37	patients	patient	NNS
cord-005453-4057qib7	14403	38	due	due	JJ
cord-005453-4057qib7	14403	39	to	to	TO
cord-005453-4057qib7	14403	40	receive	receive	VB
cord-005453-4057qib7	14403	41	an	an	DT
cord-005453-4057qib7	14403	42	HLA	HLA	NNP
cord-005453-4057qib7	14403	43	-	-	HYPH
cord-005453-4057qib7	14403	44	mismatched	mismatch	VBN
cord-005453-4057qib7	14403	45	allogeneic	allogeneic	IN
cord-005453-4057qib7	14403	46	HSCT	HSCT	NNP
cord-005453-4057qib7	14403	47	.	.	.
cord-005453-4057qib7	14404	1	Methods	method	NNS
cord-005453-4057qib7	14404	2	:	:	:
cord-005453-4057qib7	14404	3	Patients	patient	NNS
cord-005453-4057qib7	14404	4	(	(	-LRB-
cord-005453-4057qib7	14404	5	n=2106	n=2106	CD
cord-005453-4057qib7	14404	6	)	)	-RRB-
cord-005453-4057qib7	14404	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	14404	8	with	with	IN
cord-005453-4057qib7	14404	9	MDS	MDS	NNP
cord-005453-4057qib7	14404	10	/	/	SYM
cord-005453-4057qib7	14404	11	MPS	MPS	NNP
cord-005453-4057qib7	14404	12	,	,	,
cord-005453-4057qib7	14404	13	NHL	NHL	NNP
cord-005453-4057qib7	14404	14	,	,	,
cord-005453-4057qib7	14404	15	MM	MM	NNP
cord-005453-4057qib7	14404	16	,	,	,
cord-005453-4057qib7	14404	17	CLL	CLL	NNP
cord-005453-4057qib7	14404	18	,	,	,
cord-005453-4057qib7	14404	19	CML	CML	NNP
cord-005453-4057qib7	14404	20	,	,	,
cord-005453-4057qib7	14404	21	anaemia	anaemia	NN
cord-005453-4057qib7	14404	22	(	(	-LRB-
cord-005453-4057qib7	14404	23	aplastic	aplastic	JJ
cord-005453-4057qib7	14404	24	anemia	anemia	NN
cord-005453-4057qib7	14404	25	,	,	,
cord-005453-4057qib7	14404	26	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	14404	27	,	,	,
cord-005453-4057qib7	14404	28	PNH	PNH	NNP
cord-005453-4057qib7	14404	29	)	)	-RRB-
cord-005453-4057qib7	14404	30	and	and	CC
cord-005453-4057qib7	14404	31	HL	HL	NNP
cord-005453-4057qib7	14404	32	were	be	VBD
cord-005453-4057qib7	14404	33	prospectively	prospectively	RB
cord-005453-4057qib7	14404	34	screened	screen	VBN
cord-005453-4057qib7	14404	35	for	for	IN
cord-005453-4057qib7	14404	36	HLA	HLA	NNP
cord-005453-4057qib7	14404	37	-	-	HYPH
cord-005453-4057qib7	14404	38	antibodies	antibody	NNS
cord-005453-4057qib7	14404	39	whenever	whenever	WRB
cord-005453-4057qib7	14404	40	initial	initial	JJ
cord-005453-4057qib7	14404	41	donor	donor	NN
cord-005453-4057qib7	14404	42	search	search	NN
cord-005453-4057qib7	14404	43	indicated	indicate	VBD
cord-005453-4057qib7	14404	44	that	that	IN
cord-005453-4057qib7	14404	45	no	no	DT
cord-005453-4057qib7	14404	46	completely	completely	RB
cord-005453-4057qib7	14404	47	matched	match	VBN
cord-005453-4057qib7	14404	48	donor	donor	NN
cord-005453-4057qib7	14404	49	would	would	MD
cord-005453-4057qib7	14404	50	be	be	VB
cord-005453-4057qib7	14404	51	available	available	JJ
cord-005453-4057qib7	14404	52	.	.	.
cord-005453-4057qib7	14405	1	Screening	screening	NN
cord-005453-4057qib7	14405	2	was	be	VBD
cord-005453-4057qib7	14405	3	performed	perform	VBN
cord-005453-4057qib7	14405	4	with	with	IN
cord-005453-4057qib7	14405	5	an	an	DT
cord-005453-4057qib7	14405	6	ELISA	ELISA	NNP
cord-005453-4057qib7	14405	7	class	class	NN
cord-005453-4057qib7	14405	8	I	i	NN
cord-005453-4057qib7	14405	9	+	+	CC
cord-005453-4057qib7	14405	10	II	II	NNP
cord-005453-4057qib7	14405	11	screening	screening	NN
cord-005453-4057qib7	14405	12	assay	assay	NN
cord-005453-4057qib7	14405	13	.	.	.
cord-005453-4057qib7	14406	1	All	all	DT
cord-005453-4057qib7	14406	2	positive	positive	JJ
cord-005453-4057qib7	14406	3	screening	screening	NN
cord-005453-4057qib7	14406	4	cases	case	NNS
cord-005453-4057qib7	14406	5	were	be	VBD
cord-005453-4057qib7	14406	6	tested	test	VBN
cord-005453-4057qib7	14406	7	for	for	IN
cord-005453-4057qib7	14406	8	antigen	antigen	NN
cord-005453-4057qib7	14406	9	-	-	HYPH
cord-005453-4057qib7	14406	10	specific	specific	JJ
cord-005453-4057qib7	14406	11	antibody	antibody	NN
cord-005453-4057qib7	14406	12	identification	identification	NN
cord-005453-4057qib7	14406	13	with	with	IN
cord-005453-4057qib7	14406	14	Luminex	Luminex	NNP
cord-005453-4057qib7	14406	15	SAB	SAB	NNP
cord-005453-4057qib7	14406	16	,	,	,
cord-005453-4057qib7	14406	17	and	and	CC
cord-005453-4057qib7	14406	18	acceptable	acceptable	JJ
cord-005453-4057qib7	14406	19	mismatches	mismatch	NNS
cord-005453-4057qib7	14406	20	were	be	VBD
cord-005453-4057qib7	14406	21	defined	define	VBN
cord-005453-4057qib7	14406	22	.	.	.
cord-005453-4057qib7	14407	1	The	the	DT
cord-005453-4057qib7	14407	2	results	result	NNS
cord-005453-4057qib7	14407	3	were	be	VBD
cord-005453-4057qib7	14407	4	subsequently	subsequently	RB
cord-005453-4057qib7	14407	5	considered	consider	VBN
cord-005453-4057qib7	14407	6	in	in	IN
cord-005453-4057qib7	14407	7	donor	donor	NN
cord-005453-4057qib7	14407	8	search	search	NN
cord-005453-4057qib7	14407	9	and	and	CC
cord-005453-4057qib7	14407	10	selection	selection	NN
cord-005453-4057qib7	14407	11	.	.	.
cord-005453-4057qib7	14408	1	We	-PRON-	PRP
cord-005453-4057qib7	14408	2	now	now	RB
cord-005453-4057qib7	14408	3	report	report	VBP
cord-005453-4057qib7	14408	4	the	the	DT
cord-005453-4057qib7	14408	5	frequencies	frequency	NNS
cord-005453-4057qib7	14408	6	of	of	IN
cord-005453-4057qib7	14408	7	alloimmunization	alloimmunization	NN
cord-005453-4057qib7	14408	8	observed	observe	VBN
cord-005453-4057qib7	14408	9	in	in	IN
cord-005453-4057qib7	14408	10	these	these	DT
cord-005453-4057qib7	14408	11	patients	patient	NNS
cord-005453-4057qib7	14408	12	.	.	.
cord-005453-4057qib7	14409	1	Results	result	NNS
cord-005453-4057qib7	14409	2	:	:	:
cord-005453-4057qib7	14410	1	The	the	DT
cord-005453-4057qib7	14410	2	highest	high	JJS
cord-005453-4057qib7	14410	3	rate	rate	NN
cord-005453-4057qib7	14410	4	of	of	IN
cord-005453-4057qib7	14410	5	alloimmunization	alloimmunization	NN
cord-005453-4057qib7	14410	6	was	be	VBD
cord-005453-4057qib7	14410	7	observed	observe	VBN
cord-005453-4057qib7	14410	8	in	in	IN
cord-005453-4057qib7	14410	9	patients	patient	NNS
cord-005453-4057qib7	14410	10	from	from	IN
cord-005453-4057qib7	14410	11	the	the	DT
cord-005453-4057qib7	14410	12	anaemia	anaemia	NN
cord-005453-4057qib7	14410	13	disease	disease	NN
cord-005453-4057qib7	14410	14	group	group	NN
cord-005453-4057qib7	14410	15	(	(	-LRB-
cord-005453-4057qib7	14410	16	overall	overall	JJ
cord-005453-4057qib7	14410	17	40.5	40.5	CD
cord-005453-4057qib7	14410	18	%	%	NN
cord-005453-4057qib7	14410	19	)	)	-RRB-
cord-005453-4057qib7	14410	20	followed	follow	VBN
cord-005453-4057qib7	14410	21	by	by	IN
cord-005453-4057qib7	14410	22	those	those	DT
cord-005453-4057qib7	14410	23	from	from	IN
cord-005453-4057qib7	14410	24	the	the	DT
cord-005453-4057qib7	14410	25	MDS	MDS	NNP
cord-005453-4057qib7	14410	26	/	/	SYM
cord-005453-4057qib7	14410	27	MPN	MPN	NNP
cord-005453-4057qib7	14410	28	group	group	NN
cord-005453-4057qib7	14410	29	(	(	-LRB-
cord-005453-4057qib7	14410	30	overall	overall	JJ
cord-005453-4057qib7	14410	31	24.8	24.8	CD
cord-005453-4057qib7	14410	32	%	%	NN
cord-005453-4057qib7	14410	33	)	)	-RRB-
cord-005453-4057qib7	14410	34	.	.	.
cord-005453-4057qib7	14411	1	The	the	DT
cord-005453-4057qib7	14411	2	lowest	low	JJS
cord-005453-4057qib7	14411	3	immunization	immunization	NN
cord-005453-4057qib7	14411	4	rates	rate	NNS
cord-005453-4057qib7	14411	5	were	be	VBD
cord-005453-4057qib7	14411	6	observed	observe	VBN
cord-005453-4057qib7	14411	7	in	in	IN
cord-005453-4057qib7	14411	8	CLL	CLL	NNP
cord-005453-4057qib7	14411	9	(	(	-LRB-
cord-005453-4057qib7	14411	10	overall	overall	JJ
cord-005453-4057qib7	14411	11	6.9	6.9	CD
cord-005453-4057qib7	14411	12	%	%	NN
cord-005453-4057qib7	14411	13	)	)	-RRB-
cord-005453-4057qib7	14411	14	and	and	CC
cord-005453-4057qib7	14411	15	HL	HL	NNP
cord-005453-4057qib7	14411	16	(	(	-LRB-
cord-005453-4057qib7	14411	17	7.0	7.0	CD
cord-005453-4057qib7	14411	18	%	%	NN
cord-005453-4057qib7	14411	19	)	)	-RRB-
cord-005453-4057qib7	14411	20	patients	patient	NNS
cord-005453-4057qib7	14411	21	.	.	.
cord-005453-4057qib7	14412	1	Alloimmunization	alloimmunization	NN
cord-005453-4057qib7	14412	2	rates	rate	NNS
cord-005453-4057qib7	14412	3	for	for	IN
cord-005453-4057qib7	14412	4	HLA	HLA	NNP
cord-005453-4057qib7	14412	5	-	-	HYPH
cord-005453-4057qib7	14412	6	class	class	NN
cord-005453-4057qib7	14412	7	I	i	NN
cord-005453-4057qib7	14412	8	antigens	antigen	VBZ
cord-005453-4057qib7	14412	9	(	(	-LRB-
cord-005453-4057qib7	14412	10	p	p	NN
cord-005453-4057qib7	14412	11	<	<	XX
cord-005453-4057qib7	14412	12	0.001	0.001	CD
cord-005453-4057qib7	14412	13	)	)	-RRB-
cord-005453-4057qib7	14412	14	were	be	VBD
cord-005453-4057qib7	14412	15	significantly	significantly	RB
cord-005453-4057qib7	14412	16	higher	high	JJR
cord-005453-4057qib7	14412	17	compared	compare	VBN
cord-005453-4057qib7	14412	18	to	to	IN
cord-005453-4057qib7	14412	19	HLA	HLA	NNP
cord-005453-4057qib7	14412	20	-	-	HYPH
cord-005453-4057qib7	14412	21	class	class	NN
cord-005453-4057qib7	14412	22	II	II	NNP
cord-005453-4057qib7	14412	23	antigens	antigen	NNS
cord-005453-4057qib7	14412	24	.	.	.
cord-005453-4057qib7	14413	1	Overall	overall	JJ
cord-005453-4057qib7	14413	2	HLA	HLA	NNP
cord-005453-4057qib7	14413	3	-	-	HYPH
cord-005453-4057qib7	14413	4	class	class	NN
cord-005453-4057qib7	14413	5	I	i	NN
cord-005453-4057qib7	14413	6	immunization	immunization	NN
cord-005453-4057qib7	14413	7	rates	rate	NNS
cord-005453-4057qib7	14413	8	ranged	range	VBD
cord-005453-4057qib7	14413	9	from	from	IN
cord-005453-4057qib7	14413	10	2.3	2.3	CD
cord-005453-4057qib7	14413	11	%	%	NN
cord-005453-4057qib7	14413	12	to	to	IN
cord-005453-4057qib7	14413	13	33.3	33.3	CD
cord-005453-4057qib7	14413	14	%	%	NN
cord-005453-4057qib7	14413	15	.	.	.
cord-005453-4057qib7	14414	1	HLA	HLA	NNP
cord-005453-4057qib7	14414	2	-	-	HYPH
cord-005453-4057qib7	14414	3	class	class	NN
cord-005453-4057qib7	14414	4	II	II	NNP
cord-005453-4057qib7	14414	5	immunization	immunization	NN
cord-005453-4057qib7	14414	6	rates	rate	NNS
cord-005453-4057qib7	14414	7	ranged	range	VBD
cord-005453-4057qib7	14414	8	from	from	IN
cord-005453-4057qib7	14414	9	4.7	4.7	CD
cord-005453-4057qib7	14414	10	%	%	NN
cord-005453-4057qib7	14414	11	to	to	IN
cord-005453-4057qib7	14414	12	19.8	19.8	CD
cord-005453-4057qib7	14414	13	%	%	NN
cord-005453-4057qib7	14414	14	(	(	-LRB-
cord-005453-4057qib7	14414	15	table	table	NN
cord-005453-4057qib7	14414	16	1	1	CD
cord-005453-4057qib7	14414	17	)	)	-RRB-
cord-005453-4057qib7	14414	18	.	.	.
cord-005453-4057qib7	14415	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14415	2	:	:	:
cord-005453-4057qib7	14416	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14416	2	findings	finding	NNS
cord-005453-4057qib7	14416	3	suggest	suggest	VBP
cord-005453-4057qib7	14416	4	that	that	IN
cord-005453-4057qib7	14416	5	patients	patient	NNS
cord-005453-4057qib7	14416	6	with	with	IN
cord-005453-4057qib7	14416	7	high	high	JJ
cord-005453-4057qib7	14416	8	transfusion	transfusion	NN
cord-005453-4057qib7	14416	9	burden	burden	NN
cord-005453-4057qib7	14416	10	like	like	IN
cord-005453-4057qib7	14416	11	anaemia	anaemia	NN
cord-005453-4057qib7	14416	12	and	and	CC
cord-005453-4057qib7	14416	13	MDS	MDS	NNP
cord-005453-4057qib7	14416	14	/	/	SYM
cord-005453-4057qib7	14416	15	MPN	MPN	NNP
cord-005453-4057qib7	14416	16	patients	patient	NNS
cord-005453-4057qib7	14416	17	have	have	VBP
cord-005453-4057qib7	14416	18	the	the	DT
cord-005453-4057qib7	14416	19	highest	high	JJS
cord-005453-4057qib7	14416	20	risk	risk	NN
cord-005453-4057qib7	14416	21	of	of	IN
cord-005453-4057qib7	14416	22	HLA	HLA	NNP
cord-005453-4057qib7	14416	23	-	-	HYPH
cord-005453-4057qib7	14416	24	alloimmunization	alloimmunization	NN
cord-005453-4057qib7	14416	25	with	with	IN
cord-005453-4057qib7	14416	26	40.5	40.5	CD
cord-005453-4057qib7	14416	27	%	%	NN
cord-005453-4057qib7	14416	28	and	and	CC
cord-005453-4057qib7	14416	29	24.8	24.8	CD
cord-005453-4057qib7	14416	30	%	%	NN
cord-005453-4057qib7	14416	31	anti	anti	JJ
cord-005453-4057qib7	14416	32	-	-	JJ
cord-005453-4057qib7	14416	33	HLA	hla	JJ
cord-005453-4057qib7	14416	34	prevalence	prevalence	NN
cord-005453-4057qib7	14416	35	rates	rate	NNS
cord-005453-4057qib7	14416	36	,	,	,
cord-005453-4057qib7	14416	37	respectively	respectively	RB
cord-005453-4057qib7	14416	38	.	.	.
cord-005453-4057qib7	14417	1	Analysis	analysis	NN
cord-005453-4057qib7	14417	2	of	of	IN
cord-005453-4057qib7	14417	3	follow	follow	VB
cord-005453-4057qib7	14417	4	-	-	HYPH
cord-005453-4057qib7	14417	5	up	up	NN
cord-005453-4057qib7	14417	6	data	datum	NNS
cord-005453-4057qib7	14417	7	,	,	,
cord-005453-4057qib7	14417	8	will	will	MD
cord-005453-4057qib7	14417	9	enable	enable	VB
cord-005453-4057qib7	14417	10	us	-PRON-	PRP
cord-005453-4057qib7	14417	11	to	to	TO
cord-005453-4057qib7	14417	12	confirm	confirm	VB
cord-005453-4057qib7	14417	13	whether	whether	IN
cord-005453-4057qib7	14417	14	prospective	prospective	JJ
cord-005453-4057qib7	14417	15	definition	definition	NN
cord-005453-4057qib7	14417	16	and	and	CC
cord-005453-4057qib7	14417	17	consideration	consideration	NN
cord-005453-4057qib7	14417	18	of	of	IN
cord-005453-4057qib7	14417	19	acceptable	acceptable	JJ
cord-005453-4057qib7	14417	20	mismatches	mismatch	NNS
cord-005453-4057qib7	14417	21	in	in	IN
cord-005453-4057qib7	14417	22	donor	donor	NN
cord-005453-4057qib7	14417	23	selection	selection	NN
cord-005453-4057qib7	14417	24	may	may	MD
cord-005453-4057qib7	14417	25	lead	lead	VB
cord-005453-4057qib7	14417	26	to	to	IN
cord-005453-4057qib7	14417	27	similar	similar	JJ
cord-005453-4057qib7	14417	28	engraftment	engraftment	NN
cord-005453-4057qib7	14417	29	failure	failure	NN
cord-005453-4057qib7	14417	30	rates	rate	NNS
cord-005453-4057qib7	14417	31	between	between	IN
cord-005453-4057qib7	14417	32	immunized	immunized	JJ
cord-005453-4057qib7	14417	33	and	and	CC
cord-005453-4057qib7	14417	34	non	non	JJ
cord-005453-4057qib7	14417	35	-	-	JJ
cord-005453-4057qib7	14417	36	immunized	immunize	VBN
cord-005453-4057qib7	14417	37	patients	patient	NNS
cord-005453-4057qib7	14417	38	undergoing	undergo	VBG
cord-005453-4057qib7	14417	39	HLAmismatched	hlamismatche	VBN
cord-005453-4057qib7	14417	40	HSCT	HSCT	NNP
cord-005453-4057qib7	14417	41	.	.	.
cord-005453-4057qib7	14418	1	Background	background	NN
cord-005453-4057qib7	14418	2	:	:	:
cord-005453-4057qib7	14418	3	Mothers	mother	NNS
cord-005453-4057qib7	14418	4	displaying	display	VBG
cord-005453-4057qib7	14418	5	a	a	DT
cord-005453-4057qib7	14418	6	persistent	persistent	JJ
cord-005453-4057qib7	14418	7	fetal	fetal	JJ
cord-005453-4057qib7	14418	8	microchimerism	microchimerism	NN
cord-005453-4057qib7	14418	9	(	(	-LRB-
cord-005453-4057qib7	14418	10	FM	FM	NNP
cord-005453-4057qib7	14418	11	)	)	-RRB-
cord-005453-4057qib7	14418	12	proved	prove	VBD
cord-005453-4057qib7	14418	13	to	to	TO
cord-005453-4057qib7	14418	14	be	be	VB
cord-005453-4057qib7	14418	15	the	the	DT
cord-005453-4057qib7	14418	16	most	most	RBS
cord-005453-4057qib7	14418	17	suitable	suitable	JJ
cord-005453-4057qib7	14418	18	donor	donor	NN
cord-005453-4057qib7	14418	19	in	in	IN
cord-005453-4057qib7	14418	20	T	T	NNP
cord-005453-4057qib7	14418	21	cell	cell	NN
cord-005453-4057qib7	14418	22	-	-	HYPH
cord-005453-4057qib7	14418	23	depleted	deplete	VBN
cord-005453-4057qib7	14418	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14418	25	stem	stem	NN
cord-005453-4057qib7	14418	26	cell	cell	NN
cord-005453-4057qib7	14418	27	transplantation	transplantation	NN
cord-005453-4057qib7	14418	28	(	(	-LRB-
cord-005453-4057qib7	14418	29	hHSCT	hHSCT	NNP
cord-005453-4057qib7	14418	30	)	)	-RRB-
cord-005453-4057qib7	14418	31	in	in	IN
cord-005453-4057qib7	14418	32	children	child	NNS
cord-005453-4057qib7	14418	33	.	.	.
cord-005453-4057qib7	14419	1	We	-PRON-	PRP
cord-005453-4057qib7	14419	2	presumed	presume	VBD
cord-005453-4057qib7	14419	3	that	that	IN
cord-005453-4057qib7	14419	4	fetal	fetal	JJ
cord-005453-4057qib7	14419	5	cells	cell	NNS
cord-005453-4057qib7	14419	6	leave	leave	VBP
cord-005453-4057qib7	14419	7	an	an	DT
cord-005453-4057qib7	14419	8	imprint	imprint	NN
cord-005453-4057qib7	14419	9	in	in	IN
cord-005453-4057qib7	14419	10	the	the	DT
cord-005453-4057qib7	14419	11	mothers	mother	NNS
cord-005453-4057qib7	14419	12	'	'	POS
cord-005453-4057qib7	14419	13	immune	immune	JJ
cord-005453-4057qib7	14419	14	system	system	NN
cord-005453-4057qib7	14419	15	which	which	WDT
cord-005453-4057qib7	14419	16	positively	positively	RB
cord-005453-4057qib7	14419	17	affects	affect	VBZ
cord-005453-4057qib7	14419	18	recognition	recognition	NN
cord-005453-4057qib7	14419	19	and	and	CC
cord-005453-4057qib7	14419	20	elimination	elimination	NN
cord-005453-4057qib7	14419	21	of	of	IN
cord-005453-4057qib7	14419	22	malignant	malignant	JJ
cord-005453-4057qib7	14419	23	cells	cell	NNS
cord-005453-4057qib7	14419	24	in	in	IN
cord-005453-4057qib7	14419	25	the	the	DT
cord-005453-4057qib7	14419	26	child	child	NN
cord-005453-4057qib7	14419	27	by	by	IN
cord-005453-4057qib7	14419	28	maternal	maternal	JJ
cord-005453-4057qib7	14419	29	effector	effector	NN
cord-005453-4057qib7	14419	30	cells	cell	NNS
cord-005453-4057qib7	14419	31	.	.	.
cord-005453-4057qib7	14420	1	Distinct	distinct	JJ
cord-005453-4057qib7	14420	2	killer	killer	NN
cord-005453-4057qib7	14420	3	cell	cell	NN
cord-005453-4057qib7	14420	4	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	14420	5	-	-	HYPH
cord-005453-4057qib7	14420	6	like	like	JJ
cord-005453-4057qib7	14420	7	receptors	receptor	NNS
cord-005453-4057qib7	14421	1	(	(	-LRB-
cord-005453-4057qib7	14421	2	KIR)/HLA	KIR)/HLA	NNP
cord-005453-4057qib7	14421	3	constellations	constellation	NNS
cord-005453-4057qib7	14421	4	are	be	VBP
cord-005453-4057qib7	14421	5	not	not	RB
cord-005453-4057qib7	14421	6	only	only	RB
cord-005453-4057qib7	14421	7	associated	associate	VBN
cord-005453-4057qib7	14421	8	with	with	IN
cord-005453-4057qib7	14421	9	reduced	reduce	VBN
cord-005453-4057qib7	14421	10	relapse	relapse	NN
cord-005453-4057qib7	14421	11	rates	rate	NNS
cord-005453-4057qib7	14421	12	after	after	IN
cord-005453-4057qib7	14421	13	HSCT	HSCT	NNP
cord-005453-4057qib7	14421	14	in	in	IN
cord-005453-4057qib7	14421	15	children	child	NNS
cord-005453-4057qib7	14421	16	,	,	,
cord-005453-4057qib7	14421	17	but	but	CC
cord-005453-4057qib7	14421	18	also	also	RB
cord-005453-4057qib7	14421	19	supposedly	supposedly	RB
cord-005453-4057qib7	14421	20	influence	influence	VB
cord-005453-4057qib7	14421	21	the	the	DT
cord-005453-4057qib7	14421	22	establishment	establishment	NN
cord-005453-4057qib7	14421	23	of	of	IN
cord-005453-4057qib7	14421	24	an	an	DT
cord-005453-4057qib7	14421	25	FM	FM	NNP
cord-005453-4057qib7	14421	26	.	.	.
cord-005453-4057qib7	14422	1	Methods	method	NNS
cord-005453-4057qib7	14422	2	:	:	:
cord-005453-4057qib7	14423	1	After	after	IN
cord-005453-4057qib7	14423	2	approval	approval	NN
cord-005453-4057qib7	14423	3	by	by	IN
cord-005453-4057qib7	14423	4	the	the	DT
cord-005453-4057qib7	14423	5	local	local	JJ
cord-005453-4057qib7	14423	6	IRB	IRB	NNP
cord-005453-4057qib7	14423	7	and	and	CC
cord-005453-4057qib7	14423	8	obtaining	obtain	VBG
cord-005453-4057qib7	14423	9	informed	informed	JJ
cord-005453-4057qib7	14423	10	consent	consent	NN
cord-005453-4057qib7	14423	11	,	,	,
cord-005453-4057qib7	14423	12	we	-PRON-	PRP
cord-005453-4057qib7	14423	13	initiated	initiate	VBD
cord-005453-4057qib7	14423	14	a	a	DT
cord-005453-4057qib7	14423	15	protocol	protocol	NN
cord-005453-4057qib7	14423	16	to	to	TO
cord-005453-4057qib7	14423	17	elucidate	elucidate	VB
cord-005453-4057qib7	14423	18	the	the	DT
cord-005453-4057qib7	14423	19	factors	factor	NNS
cord-005453-4057qib7	14423	20	that	that	WDT
cord-005453-4057qib7	14423	21	influence	influence	VBP
cord-005453-4057qib7	14423	22	the	the	DT
cord-005453-4057qib7	14423	23	establishment	establishment	NN
cord-005453-4057qib7	14423	24	,	,	,
cord-005453-4057qib7	14423	25	persistence	persistence	NN
cord-005453-4057qib7	14423	26	and	and	CC
cord-005453-4057qib7	14423	27	effect	effect	NN
cord-005453-4057qib7	14423	28	of	of	IN
cord-005453-4057qib7	14423	29	FM	FM	NNP
cord-005453-4057qib7	14423	30	.	.	.
cord-005453-4057qib7	14424	1	We	-PRON-	PRP
cord-005453-4057qib7	14424	2	established	establish	VBD
cord-005453-4057qib7	14424	3	a	a	DT
cord-005453-4057qib7	14424	4	digital	digital	JJ
cord-005453-4057qib7	14424	5	droplet	droplet	NN
cord-005453-4057qib7	14424	6	PCR	PCR	NNP
cord-005453-4057qib7	14424	7	(	(	-LRB-
cord-005453-4057qib7	14424	8	ddPCR	ddPCR	NNP
cord-005453-4057qib7	14424	9	)	)	-RRB-
cord-005453-4057qib7	14424	10	protocol	protocol	NN
cord-005453-4057qib7	14424	11	to	to	TO
cord-005453-4057qib7	14424	12	determine	determine	VB
cord-005453-4057qib7	14424	13	the	the	DT
cord-005453-4057qib7	14424	14	fetal	fetal	JJ
cord-005453-4057qib7	14424	15	microchimerism	microchimerism	NN
cord-005453-4057qib7	14424	16	.	.	.
cord-005453-4057qib7	14425	1	For	for	IN
cord-005453-4057qib7	14425	2	differentiation	differentiation	NN
cord-005453-4057qib7	14425	3	between	between	IN
cord-005453-4057qib7	14425	4	maternal	maternal	JJ
cord-005453-4057qib7	14425	5	and	and	CC
cord-005453-4057qib7	14425	6	fetal	fetal	JJ
cord-005453-4057qib7	14425	7	cells	cell	NNS
cord-005453-4057qib7	14425	8	,	,	,
cord-005453-4057qib7	14425	9	biallelic	biallelic	NN
cord-005453-4057qib7	14425	10	short	short	JJ
cord-005453-4057qib7	14425	11	insertion	insertion	NN
cord-005453-4057qib7	14425	12	/	/	SYM
cord-005453-4057qib7	14425	13	deletion	deletion	NN
cord-005453-4057qib7	14425	14	polymorphisms	polymorphism	NNS
cord-005453-4057qib7	14425	15	were	be	VBD
cord-005453-4057qib7	14425	16	used	use	VBN
cord-005453-4057qib7	14425	17	.	.	.
cord-005453-4057qib7	14426	1	KIR	KIR	NNP
cord-005453-4057qib7	14426	2	and	and	CC
cord-005453-4057qib7	14426	3	HLA	HLA	NNP
cord-005453-4057qib7	14426	4	-	-	HYPH
cord-005453-4057qib7	14426	5	C	C	NNP
cord-005453-4057qib7	14426	6	genotyping	genotyping	NN
cord-005453-4057qib7	14426	7	was	be	VBD
cord-005453-4057qib7	14426	8	performed	perform	VBN
cord-005453-4057qib7	14426	9	by	by	IN
cord-005453-4057qib7	14426	10	SSP	SSP	NNP
cord-005453-4057qib7	14426	11	-	-	HYPH
cord-005453-4057qib7	14426	12	PCR	PCR	NNP
cord-005453-4057qib7	14426	13	.	.	.
cord-005453-4057qib7	14427	1	Parental	parental	JJ
cord-005453-4057qib7	14427	2	NK	NK	NNP
cord-005453-4057qib7	14427	3	cell	cell	NN
cord-005453-4057qib7	14427	4	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	14427	5	against	against	IN
cord-005453-4057qib7	14427	6	the	the	DT
cord-005453-4057qib7	14427	7	respective	respective	JJ
cord-005453-4057qib7	14427	8	leukemic	leukemic	JJ
cord-005453-4057qib7	14427	9	blasts	blast	NNS
cord-005453-4057qib7	14427	10	and	and	CC
cord-005453-4057qib7	14427	11	KIR	KIR	NNP
cord-005453-4057qib7	14427	12	phenotyping	phenotyping	NN
cord-005453-4057qib7	14427	13	were	be	VBD
cord-005453-4057qib7	14427	14	analyzed	analyze	VBN
cord-005453-4057qib7	14427	15	by	by	IN
cord-005453-4057qib7	14427	16	flow	flow	NN
cord-005453-4057qib7	14427	17	cytometry	cytometry	NN
cord-005453-4057qib7	14427	18	.	.	.
cord-005453-4057qib7	14428	1	Results	result	NNS
cord-005453-4057qib7	14428	2	:	:	:
cord-005453-4057qib7	14429	1	We	-PRON-	PRP
cord-005453-4057qib7	14429	2	analyzed	analyze	VBD
cord-005453-4057qib7	14429	3	45	45	CD
cord-005453-4057qib7	14429	4	parents	parent	NNS
cord-005453-4057qib7	14429	5	,	,	,
cord-005453-4057qib7	14429	6	whose	whose	WP$
cord-005453-4057qib7	14429	7	children	child	NNS
cord-005453-4057qib7	14429	8	were	be	VBD
cord-005453-4057qib7	14429	9	treated	treat	VBN
cord-005453-4057qib7	14429	10	for	for	IN
cord-005453-4057qib7	14429	11	hematological	hematological	JJ
cord-005453-4057qib7	14429	12	diseases	disease	NNS
cord-005453-4057qib7	14429	13	at	at	IN
cord-005453-4057qib7	14429	14	the	the	DT
cord-005453-4057qib7	14429	15	University	University	NNP
cord-005453-4057qib7	14429	16	Medical	Medical	NNP
cord-005453-4057qib7	14429	17	Center	Center	NNP
cord-005453-4057qib7	14429	18	Hamburg	Hamburg	NNP
cord-005453-4057qib7	14429	19	-	-	HYPH
cord-005453-4057qib7	14429	20	Eppendorf	Eppendorf	NNP
cord-005453-4057qib7	14429	21	.	.	.
cord-005453-4057qib7	14430	1	A	a	DT
cord-005453-4057qib7	14430	2	fetal	fetal	JJ
cord-005453-4057qib7	14430	3	microchimerism	microchimerism	NN
cord-005453-4057qib7	14430	4	was	be	VBD
cord-005453-4057qib7	14430	5	detected	detect	VBN
cord-005453-4057qib7	14430	6	in	in	IN
cord-005453-4057qib7	14430	7	25	25	CD
cord-005453-4057qib7	14430	8	%	%	NN
cord-005453-4057qib7	14430	9	of	of	IN
cord-005453-4057qib7	14430	10	the	the	DT
cord-005453-4057qib7	14430	11	mothers	mother	NNS
cord-005453-4057qib7	14430	12	.	.	.
cord-005453-4057qib7	14431	1	The	the	DT
cord-005453-4057qib7	14431	2	amount	amount	NN
cord-005453-4057qib7	14431	3	of	of	IN
cord-005453-4057qib7	14431	4	fetal	fetal	JJ
cord-005453-4057qib7	14431	5	cells	cell	NNS
cord-005453-4057qib7	14431	6	varies	vary	VBZ
cord-005453-4057qib7	14431	7	between	between	IN
cord-005453-4057qib7	14431	8	individuals	individual	NNS
cord-005453-4057qib7	14431	9	(	(	-LRB-
cord-005453-4057qib7	14431	10	8x	8x	CD
cord-005453-4057qib7	14431	11	10	10	CD
cord-005453-4057qib7	14431	12	-6	-6	CD
cord-005453-4057qib7	14431	13	-9x	-9x	CD
cord-005453-4057qib7	14431	14	10	10	CD
cord-005453-4057qib7	14431	15	-4	-4	CD
cord-005453-4057qib7	14431	16	)	)	-RRB-
cord-005453-4057qib7	14431	17	.	.	.
cord-005453-4057qib7	14432	1	We	-PRON-	PRP
cord-005453-4057qib7	14432	2	observed	observe	VBD
cord-005453-4057qib7	14432	3	a	a	DT
cord-005453-4057qib7	14432	4	positive	positive	JJ
cord-005453-4057qib7	14432	5	correlation	correlation	NN
cord-005453-4057qib7	14432	6	between	between	IN
cord-005453-4057qib7	14432	7	a	a	DT
cord-005453-4057qib7	14432	8	persisting	persist	VBG
cord-005453-4057qib7	14432	9	FM	FM	NNP
cord-005453-4057qib7	14432	10	and	and	CC
cord-005453-4057qib7	14432	11	HLA	HLA	NNP
cord-005453-4057qib7	14432	12	-	-	HYPH
cord-005453-4057qib7	14432	13	C1	C1	NNP
cord-005453-4057qib7	14432	14	homo	homo	NN
cord-005453-4057qib7	14432	15	-	-	HYPH
cord-005453-4057qib7	14432	16	and	and	CC
cord-005453-4057qib7	14432	17	heterozygous	heterozygous	JJ
cord-005453-4057qib7	14432	18	mothers	mother	NNS
cord-005453-4057qib7	14432	19	along	along	IN
cord-005453-4057qib7	14432	20	with	with	IN
cord-005453-4057qib7	14432	21	a	a	DT
cord-005453-4057qib7	14432	22	maternal	maternal	JJ
cord-005453-4057qib7	14432	23	Cen	Cen	NNP
cord-005453-4057qib7	14432	24	A	A	NNP
cord-005453-4057qib7	14432	25	/	/	SYM
cord-005453-4057qib7	14432	26	B	B	NNP
cord-005453-4057qib7	14432	27	and	and	CC
cord-005453-4057qib7	14432	28	Cen	Cen	NNP
cord-005453-4057qib7	14432	29	B	B	NNP
cord-005453-4057qib7	14432	30	/	/	SYM
cord-005453-4057qib7	14432	31	B	B	NNP
cord-005453-4057qib7	14432	32	genotype	genotype	NN
cord-005453-4057qib7	14432	33	.	.	.
cord-005453-4057qib7	14433	1	Additionally	additionally	RB
cord-005453-4057qib7	14433	2	,	,	,
cord-005453-4057qib7	14433	3	FM	FM	NNP
cord-005453-4057qib7	14433	4	positive	positive	JJ
cord-005453-4057qib7	14433	5	mothers	mother	NNS
cord-005453-4057qib7	14433	6	showed	show	VBD
cord-005453-4057qib7	14433	7	a	a	DT
cord-005453-4057qib7	14433	8	higher	high	JJR
cord-005453-4057qib7	14433	9	surface	surface	NN
cord-005453-4057qib7	14433	10	expression	expression	NN
cord-005453-4057qib7	14433	11	of	of	IN
cord-005453-4057qib7	14433	12	the	the	DT
cord-005453-4057qib7	14433	13	HLA	HLA	NNP
cord-005453-4057qib7	14433	14	-	-	HYPH
cord-005453-4057qib7	14433	15	C1	C1	NNP
cord-005453-4057qib7	14433	16	respective	respective	JJ
cord-005453-4057qib7	14433	17	receptors	receptor	NNS
cord-005453-4057qib7	14433	18	KIR2DL2	KIR2DL2	VBZ
cord-005453-4057qib7	14433	19	/	/	SYM
cord-005453-4057qib7	14433	20	S2	s2	NN
cord-005453-4057qib7	14433	21	.	.	.
cord-005453-4057qib7	14434	1	The	the	DT
cord-005453-4057qib7	14434	2	percentage	percentage	NN
cord-005453-4057qib7	14434	3	of	of	IN
cord-005453-4057qib7	14434	4	alloreactive	alloreactive	JJ
cord-005453-4057qib7	14434	5	maternal	maternal	JJ
cord-005453-4057qib7	14434	6	NK	NK	NNP
cord-005453-4057qib7	14434	7	cells	cell	NNS
cord-005453-4057qib7	14434	8	against	against	IN
cord-005453-4057qib7	14434	9	fetal	fetal	JJ
cord-005453-4057qib7	14434	10	cells	cell	NNS
cord-005453-4057qib7	14434	11	was	be	VBD
cord-005453-4057qib7	14434	12	higher	high	JJR
cord-005453-4057qib7	14434	13	compared	compare	VBN
cord-005453-4057qib7	14434	14	to	to	IN
cord-005453-4057qib7	14434	15	paternal	paternal	JJ
cord-005453-4057qib7	14434	16	NK	NK	NNP
cord-005453-4057qib7	14434	17	cells	cell	NNS
cord-005453-4057qib7	14434	18	;	;	:
cord-005453-4057qib7	14434	19	while	while	IN
cord-005453-4057qib7	14434	20	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	14434	21	of	of	IN
cord-005453-4057qib7	14434	22	FM	FM	NNP
cord-005453-4057qib7	14434	23	positive	positive	JJ
cord-005453-4057qib7	14434	24	maternal	maternal	JJ
cord-005453-4057qib7	14434	25	NK	NK	NNP
cord-005453-4057qib7	14434	26	cells	cell	NNS
cord-005453-4057qib7	14434	27	was	be	VBD
cord-005453-4057qib7	14434	28	similar	similar	JJ
cord-005453-4057qib7	14434	29	to	to	IN
cord-005453-4057qib7	14434	30	NK	NK	NNP
cord-005453-4057qib7	14434	31	cells	cell	NNS
cord-005453-4057qib7	14434	32	from	from	IN
cord-005453-4057qib7	14434	33	FM	FM	NNP
cord-005453-4057qib7	14434	34	negative	negative	JJ
cord-005453-4057qib7	14434	35	mothers	mother	NNS
cord-005453-4057qib7	14434	36	.	.	.
cord-005453-4057qib7	14435	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14435	2	:	:	:
cord-005453-4057qib7	14436	1	Persistence	persistence	NN
cord-005453-4057qib7	14436	2	of	of	IN
cord-005453-4057qib7	14436	3	FM	FM	NNP
cord-005453-4057qib7	14436	4	was	be	VBD
cord-005453-4057qib7	14436	5	more	more	RBR
cord-005453-4057qib7	14436	6	frequent	frequent	JJ
cord-005453-4057qib7	14436	7	in	in	IN
cord-005453-4057qib7	14436	8	mothers	mother	NNS
cord-005453-4057qib7	14436	9	carrying	carry	VBG
cord-005453-4057qib7	14436	10	at	at	RB
cord-005453-4057qib7	14436	11	least	least	RBS
cord-005453-4057qib7	14436	12	one	one	CD
cord-005453-4057qib7	14436	13	HLA	HLA	NNP
cord-005453-4057qib7	14436	14	-	-	HYPH
cord-005453-4057qib7	14436	15	C1	C1	NNP
cord-005453-4057qib7	14436	16	allele	allele	NN
cord-005453-4057qib7	14436	17	and	and	CC
cord-005453-4057qib7	14436	18	a	a	DT
cord-005453-4057qib7	14436	19	centromeric	centromeric	NN
cord-005453-4057qib7	14436	20	B	b	NN
cord-005453-4057qib7	14436	21	/	/	SYM
cord-005453-4057qib7	14436	22	x	x	NN
cord-005453-4057qib7	14436	23	motif	motif	NN
cord-005453-4057qib7	14436	24	.	.	.
cord-005453-4057qib7	14437	1	Phenotypically	Phenotypically	NNP
cord-005453-4057qib7	14437	2	,	,	,
cord-005453-4057qib7	14437	3	FM	FM	NNP
cord-005453-4057qib7	14437	4	positive	positive	JJ
cord-005453-4057qib7	14437	5	mothers	mother	NNS
cord-005453-4057qib7	14437	6	had	have	VBD
cord-005453-4057qib7	14437	7	higher	high	JJR
cord-005453-4057qib7	14437	8	expression	expression	NN
cord-005453-4057qib7	14437	9	of	of	IN
cord-005453-4057qib7	14437	10	KIR2DL2	KIR2DL2	NNP
cord-005453-4057qib7	14437	11	/	/	SYM
cord-005453-4057qib7	14437	12	S2	s2	NN
cord-005453-4057qib7	14437	13	indicating	indicate	VBG
cord-005453-4057qib7	14437	14	a	a	DT
cord-005453-4057qib7	14437	15	role	role	NN
cord-005453-4057qib7	14437	16	of	of	IN
cord-005453-4057qib7	14437	17	these	these	DT
cord-005453-4057qib7	14437	18	receptors	receptor	NNS
cord-005453-4057qib7	14437	19	on	on	IN
cord-005453-4057qib7	14437	20	the	the	DT
cord-005453-4057qib7	14437	21	persistence	persistence	NN
cord-005453-4057qib7	14437	22	of	of	IN
cord-005453-4057qib7	14437	23	an	an	DT
cord-005453-4057qib7	14437	24	FM	FM	NNP
cord-005453-4057qib7	14437	25	.	.	.
cord-005453-4057qib7	14438	1	In	in	IN
cord-005453-4057qib7	14438	2	vitro	vitro	FW
cord-005453-4057qib7	14438	3	,	,	,
cord-005453-4057qib7	14438	4	maternal	maternal	JJ
cord-005453-4057qib7	14438	5	NK	NK	NNP
cord-005453-4057qib7	14438	6	cells	cell	NNS
cord-005453-4057qib7	14438	7	showed	show	VBD
cord-005453-4057qib7	14438	8	a	a	DT
cord-005453-4057qib7	14438	9	higher	high	JJR
cord-005453-4057qib7	14438	10	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	14438	11	compared	compare	VBN
cord-005453-4057qib7	14438	12	to	to	IN
cord-005453-4057qib7	14438	13	paternal	paternal	JJ
cord-005453-4057qib7	14438	14	NK	NK	NNP
cord-005453-4057qib7	14438	15	cells	cell	NNS
cord-005453-4057qib7	14438	16	.	.	.
cord-005453-4057qib7	14439	1	There	there	EX
cord-005453-4057qib7	14439	2	was	be	VBD
cord-005453-4057qib7	14439	3	no	no	DT
cord-005453-4057qib7	14439	4	difference	difference	NN
cord-005453-4057qib7	14439	5	in	in	IN
cord-005453-4057qib7	14439	6	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	14439	7	whether	whether	IN
cord-005453-4057qib7	14439	8	the	the	DT
cord-005453-4057qib7	14439	9	mothers	mother	NNS
cord-005453-4057qib7	14439	10	were	be	VBD
cord-005453-4057qib7	14439	11	FM	FM	NNP
cord-005453-4057qib7	14439	12	positive	positive	JJ
cord-005453-4057qib7	14439	13	or	or	CC
cord-005453-4057qib7	14439	14	negative	negative	JJ
cord-005453-4057qib7	14439	15	,	,	,
cord-005453-4057qib7	14439	16	suggesting	suggest	VBG
cord-005453-4057qib7	14439	17	other	other	JJ
cord-005453-4057qib7	14439	18	mechanisms	mechanism	NNS
cord-005453-4057qib7	14439	19	are	be	VBP
cord-005453-4057qib7	14439	20	responsible	responsible	JJ
cord-005453-4057qib7	14439	21	for	for	IN
cord-005453-4057qib7	14439	22	the	the	DT
cord-005453-4057qib7	14439	23	superior	superior	JJ
cord-005453-4057qib7	14439	24	outcome	outcome	NN
cord-005453-4057qib7	14439	25	in	in	IN
cord-005453-4057qib7	14439	26	transplantation	transplantation	NN
cord-005453-4057qib7	14439	27	from	from	IN
cord-005453-4057qib7	14439	28	FM	FM	NNP
cord-005453-4057qib7	14439	29	positive	positive	JJ
cord-005453-4057qib7	14439	30	mothers	mother	NNS
cord-005453-4057qib7	14439	31	.	.	.
cord-005453-4057qib7	14440	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14440	2	:	:	:
cord-005453-4057qib7	14440	3	Nothing	nothing	NN
cord-005453-4057qib7	14440	4	to	to	TO
cord-005453-4057qib7	14440	5	declare	declare	VB
cord-005453-4057qib7	14440	6	Background	background	NN
cord-005453-4057qib7	14440	7	:	:	:
cord-005453-4057qib7	14441	1	Although	although	IN
cord-005453-4057qib7	14441	2	there	there	EX
cord-005453-4057qib7	14441	3	have	have	VBP
cord-005453-4057qib7	14441	4	been	be	VBN
cord-005453-4057qib7	14441	5	significant	significant	JJ
cord-005453-4057qib7	14441	6	improvements	improvement	NNS
cord-005453-4057qib7	14441	7	with	with	IN
cord-005453-4057qib7	14441	8	conventional	conventional	JJ
cord-005453-4057qib7	14441	9	therapies	therapy	NNS
cord-005453-4057qib7	14441	10	in	in	IN
cord-005453-4057qib7	14441	11	beta	beta	NN
cord-005453-4057qib7	14441	12	thalassemia	thalassemia	NN
cord-005453-4057qib7	14441	13	major	major	JJ
cord-005453-4057qib7	14441	14	,	,	,
cord-005453-4057qib7	14441	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14441	16	stem	stem	NN
cord-005453-4057qib7	14441	17	cell	cell	NN
cord-005453-4057qib7	14441	18	transplantation	transplantation	NN
cord-005453-4057qib7	14441	19	is	be	VBZ
cord-005453-4057qib7	14441	20	only	only	RB
cord-005453-4057qib7	14441	21	curative	curative	JJ
cord-005453-4057qib7	14441	22	therapy	therapy	NN
cord-005453-4057qib7	14441	23	.	.	.
cord-005453-4057qib7	14442	1	Related	related	JJ
cord-005453-4057qib7	14442	2	donors	donor	NNS
cord-005453-4057qib7	14442	3	are	be	VBP
cord-005453-4057qib7	14442	4	preferred	prefer	VBN
cord-005453-4057qib7	14442	5	to	to	TO
cord-005453-4057qib7	14442	6	diminish	diminish	VB
cord-005453-4057qib7	14442	7	transplant	transplant	NN
cord-005453-4057qib7	14442	8	risks	risk	NNS
cord-005453-4057qib7	14442	9	.	.	.
cord-005453-4057qib7	14443	1	In	in	IN
cord-005453-4057qib7	14443	2	lack	lack	NN
cord-005453-4057qib7	14443	3	of	of	IN
cord-005453-4057qib7	14443	4	identical	identical	JJ
cord-005453-4057qib7	14443	5	related	related	JJ
cord-005453-4057qib7	14443	6	donor	donor	NN
cord-005453-4057qib7	14443	7	,	,	,
cord-005453-4057qib7	14443	8	identical	identical	JJ
cord-005453-4057qib7	14443	9	unrelated	unrelated	JJ
cord-005453-4057qib7	14443	10	donors	donor	NNS
cord-005453-4057qib7	14443	11	are	be	VBP
cord-005453-4057qib7	14443	12	second	second	RB
cord-005453-4057qib7	14443	13	best	good	JJS
cord-005453-4057qib7	14443	14	choice	choice	NN
cord-005453-4057qib7	14443	15	.	.	.
cord-005453-4057qib7	14444	1	In	in	IN
cord-005453-4057qib7	14444	2	this	this	DT
cord-005453-4057qib7	14444	3	study	study	NN
cord-005453-4057qib7	14444	4	,	,	,
cord-005453-4057qib7	14444	5	thalassemia	thalassemia	NN
cord-005453-4057qib7	14444	6	major	major	JJ
cord-005453-4057qib7	14444	7	patients	patient	NNS
cord-005453-4057qib7	14444	8	transplanted	transplant	VBN
cord-005453-4057qib7	14444	9	from	from	IN
cord-005453-4057qib7	14444	10	unrelated	unrelated	JJ
cord-005453-4057qib7	14444	11	donors	donor	NNS
cord-005453-4057qib7	14444	12	(	(	-LRB-
cord-005453-4057qib7	14444	13	MUD	mud	NN
cord-005453-4057qib7	14444	14	)	)	-RRB-
cord-005453-4057qib7	14444	15	were	be	VBD
cord-005453-4057qib7	14444	16	compared	compare	VBN
cord-005453-4057qib7	14444	17	with	with	IN
cord-005453-4057qib7	14444	18	thalassemic	thalassemic	JJ
cord-005453-4057qib7	14444	19	patients	patient	NNS
cord-005453-4057qib7	14444	20	transplanted	transplant	VBN
cord-005453-4057qib7	14444	21	from	from	IN
cord-005453-4057qib7	14444	22	relative	relative	JJ
cord-005453-4057qib7	14444	23	donor	donor	NN
cord-005453-4057qib7	14444	24	(	(	-LRB-
cord-005453-4057qib7	14444	25	MRD	MRD	NNP
cord-005453-4057qib7	14444	26	)	)	-RRB-
cord-005453-4057qib7	14444	27	retrospectively	retrospectively	RB
cord-005453-4057qib7	14444	28	.	.	.
cord-005453-4057qib7	14445	1	Methods	method	NNS
cord-005453-4057qib7	14445	2	:	:	:
cord-005453-4057qib7	14445	3	45	45	CD
cord-005453-4057qib7	14445	4	patients	patient	NNS
cord-005453-4057qib7	14445	5	who	who	WP
cord-005453-4057qib7	14445	6	were	be	VBD
cord-005453-4057qib7	14445	7	transplanted	transplant	VBN
cord-005453-4057qib7	14445	8	between	between	IN
cord-005453-4057qib7	14445	9	June	June	NNP
cord-005453-4057qib7	14445	10	2016	2016	CD
cord-005453-4057qib7	14445	11	and	and	CC
cord-005453-4057qib7	14445	12	December	December	NNP
cord-005453-4057qib7	14445	13	2017	2017	CD
cord-005453-4057qib7	14445	14	in	in	IN
cord-005453-4057qib7	14445	15	Bahçelievler	Bahçelievler	NNP
cord-005453-4057qib7	14445	16	Medical	Medical	NNP
cord-005453-4057qib7	14445	17	Park	Park	NNP
cord-005453-4057qib7	14445	18	Hospital	Hospital	NNP
cord-005453-4057qib7	14445	19	Pediatric	Pediatric	NNP
cord-005453-4057qib7	14445	20	Bone	Bone	NNP
cord-005453-4057qib7	14445	21	Marrow	Marrow	NNP
cord-005453-4057qib7	14445	22	Transplantation	Transplantation	NNP
cord-005453-4057qib7	14445	23	Unit	Unit	NNP
cord-005453-4057qib7	14445	24	were	be	VBD
cord-005453-4057qib7	14445	25	evaluated	evaluate	VBN
cord-005453-4057qib7	14445	26	retrospectively	retrospectively	RB
cord-005453-4057qib7	14445	27	.	.	.
cord-005453-4057qib7	14446	1	All	all	DT
cord-005453-4057qib7	14446	2	patients	patient	NNS
cord-005453-4057qib7	14446	3	were	be	VBD
cord-005453-4057qib7	14446	4	classified	classify	VBN
cord-005453-4057qib7	14446	5	according	accord	VBG
cord-005453-4057qib7	14446	6	to	to	IN
cord-005453-4057qib7	14446	7	pesaro	pesaro	NNP
cord-005453-4057qib7	14446	8	risk	risk	NNP
cord-005453-4057qib7	14446	9	classification	classification	NN
cord-005453-4057qib7	14446	10	.	.	.
cord-005453-4057qib7	14447	1	Thirty	thirty	CD
cord-005453-4057qib7	14447	2	four	four	CD
cord-005453-4057qib7	14447	3	of	of	IN
cord-005453-4057qib7	14447	4	45	45	CD
cord-005453-4057qib7	14447	5	received	receive	VBN
cord-005453-4057qib7	14447	6	busulfan	busulfan	NN
cord-005453-4057qib7	14447	7	,	,	,
cord-005453-4057qib7	14447	8	fludarabine	fludarabine	NN
cord-005453-4057qib7	14447	9	,	,	,
cord-005453-4057qib7	14447	10	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14447	11	,	,	,
cord-005453-4057qib7	14447	12	thioteopa	thioteopa	NNP
cord-005453-4057qib7	14447	13	for	for	IN
cord-005453-4057qib7	14447	14	conditioning	conditioning	NN
cord-005453-4057qib7	14447	15	,	,	,
cord-005453-4057qib7	14447	16	11patients	11patients	CD
cord-005453-4057qib7	14447	17	received	receive	VBD
cord-005453-4057qib7	14447	18	myeloablative	myeloablative	JJ
cord-005453-4057qib7	14447	19	preparation	preparation	NN
cord-005453-4057qib7	14447	20	regimen	regimen	NN
cord-005453-4057qib7	14447	21	with	with	IN
cord-005453-4057qib7	14447	22	treosulfan	treosulfan	NNP
cord-005453-4057qib7	14447	23	,	,	,
cord-005453-4057qib7	14447	24	fludarabine	fludarabine	NN
cord-005453-4057qib7	14447	25	,	,	,
cord-005453-4057qib7	14447	26	thiotepa	thiotepa	NNS
cord-005453-4057qib7	14447	27	,	,	,
cord-005453-4057qib7	14447	28	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14447	29	.	.	.
cord-005453-4057qib7	14448	1	All	all	DT
cord-005453-4057qib7	14448	2	patients	patient	NNS
cord-005453-4057qib7	14448	3	were	be	VBD
cord-005453-4057qib7	14448	4	given	give	VBN
cord-005453-4057qib7	14448	5	ATG	ATG	NNP
cord-005453-4057qib7	14448	6	,	,	,
cord-005453-4057qib7	14448	7	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	14448	8	and	and	CC
cord-005453-4057qib7	14448	9	methoteraxate	methoteraxate	NN
cord-005453-4057qib7	14448	10	for	for	IN
cord-005453-4057qib7	14448	11	GVHD	GVHD	NNP
cord-005453-4057qib7	14448	12	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	14448	13	.	.	.
cord-005453-4057qib7	14449	1	The	the	DT
cord-005453-4057qib7	14449	2	patients	patient	NNS
cord-005453-4057qib7	14449	3	were	be	VBD
cord-005453-4057qib7	14449	4	compared	compare	VBN
cord-005453-4057qib7	14449	5	in	in	IN
cord-005453-4057qib7	14449	6	terms	term	NNS
cord-005453-4057qib7	14449	7	of	of	IN
cord-005453-4057qib7	14449	8	acute	acute	JJ
cord-005453-4057qib7	14449	9	complications	complication	NNS
cord-005453-4057qib7	14449	10	in	in	IN
cord-005453-4057qib7	14449	11	first	first	JJ
cord-005453-4057qib7	14449	12	100	100	CD
cord-005453-4057qib7	14449	13	days	day	NNS
cord-005453-4057qib7	14449	14	,	,	,
cord-005453-4057qib7	14449	15	engraftment	engraftment	NN
cord-005453-4057qib7	14449	16	,	,	,
cord-005453-4057qib7	14449	17	chimerism	chimerism	NN
cord-005453-4057qib7	14449	18	,	,	,
cord-005453-4057qib7	14449	19	acute	acute	JJ
cord-005453-4057qib7	14449	20	and	and	CC
cord-005453-4057qib7	14449	21	chronic	chronic	JJ
cord-005453-4057qib7	14449	22	GVHD	GVHD	NNP
cord-005453-4057qib7	14449	23	after	after	IN
cord-005453-4057qib7	14449	24	transplantation	transplantation	NN
cord-005453-4057qib7	14449	25	.	.	.
cord-005453-4057qib7	14450	1	Results	result	NNS
cord-005453-4057qib7	14450	2	were	be	VBD
cord-005453-4057qib7	14450	3	evaluated	evaluate	VBN
cord-005453-4057qib7	14450	4	with	with	IN
cord-005453-4057qib7	14450	5	IBM	IBM	NNP
cord-005453-4057qib7	14450	6	SPSS	SPSS	NNP
cord-005453-4057qib7	14450	7	Statistics	Statistics	NNP
cord-005453-4057qib7	14450	8	22	22	CD
cord-005453-4057qib7	14450	9	(	(	-LRB-
cord-005453-4057qib7	14450	10	IBM	IBM	NNP
cord-005453-4057qib7	14450	11	SPSS	SPSS	NNP
cord-005453-4057qib7	14450	12	)	)	-RRB-
cord-005453-4057qib7	14450	13	program	program	NN
cord-005453-4057qib7	14450	14	.	.	.
cord-005453-4057qib7	14451	1	Results	result	NNS
cord-005453-4057qib7	14451	2	:	:	:
cord-005453-4057qib7	14452	1	A	a	DT
cord-005453-4057qib7	14452	2	total	total	NN
cord-005453-4057qib7	14452	3	of	of	IN
cord-005453-4057qib7	14452	4	45	45	CD
cord-005453-4057qib7	14452	5	patients	patient	NNS
cord-005453-4057qib7	14452	6	,	,	,
cord-005453-4057qib7	14452	7	26	26	CD
cord-005453-4057qib7	14452	8	(	(	-LRB-
cord-005453-4057qib7	14452	9	57.8	57.8	CD
cord-005453-4057qib7	14452	10	%	%	NN
cord-005453-4057qib7	14452	11	)	)	-RRB-
cord-005453-4057qib7	14452	12	male	male	NN
cord-005453-4057qib7	14452	13	and	and	CC
cord-005453-4057qib7	14452	14	19	19	CD
cord-005453-4057qib7	14452	15	(	(	-LRB-
cord-005453-4057qib7	14452	16	42.2	42.2	CD
cord-005453-4057qib7	14452	17	%	%	NN
cord-005453-4057qib7	14452	18	)	)	-RRB-
cord-005453-4057qib7	14452	19	female	female	NN
cord-005453-4057qib7	14452	20	,	,	,
cord-005453-4057qib7	14452	21	aged	age	VBN
cord-005453-4057qib7	14452	22	between	between	IN
cord-005453-4057qib7	14452	23	1	1	CD
cord-005453-4057qib7	14452	24	and	and	CC
cord-005453-4057qib7	14452	25	18	18	CD
cord-005453-4057qib7	14452	26	years	year	NNS
cord-005453-4057qib7	14453	1	(	(	-LRB-
cord-005453-4057qib7	14453	2	median	median	NN
cord-005453-4057qib7	14453	3	5	5	CD
cord-005453-4057qib7	14453	4	years	year	NNS
cord-005453-4057qib7	14453	5	)	)	-RRB-
cord-005453-4057qib7	14453	6	were	be	VBD
cord-005453-4057qib7	14453	7	evaluated	evaluate	VBN
cord-005453-4057qib7	14453	8	.	.	.
cord-005453-4057qib7	14454	1	Patients	patient	NNS
cord-005453-4057qib7	14454	2	were	be	VBD
cord-005453-4057qib7	14454	3	evaluated	evaluate	VBN
cord-005453-4057qib7	14454	4	in	in	IN
cord-005453-4057qib7	14454	5	two	two	CD
cord-005453-4057qib7	14454	6	groups	group	NNS
cord-005453-4057qib7	14454	7	as	as	IN
cord-005453-4057qib7	14454	8	"	"	``
cord-005453-4057qib7	14454	9	MUD	mud	NN
cord-005453-4057qib7	14454	10	"	"	''
cord-005453-4057qib7	14454	11	(	(	-LRB-
cord-005453-4057qib7	14454	12	n	n	NN
cord-005453-4057qib7	14454	13	=	=	SYM
cord-005453-4057qib7	14454	14	15	15	CD
cord-005453-4057qib7	14454	15	)	)	-RRB-
cord-005453-4057qib7	14454	16	and	and	CC
cord-005453-4057qib7	14454	17	"	"	``
cord-005453-4057qib7	14454	18	MRD	MRD	NNP
cord-005453-4057qib7	14454	19	"	"	''
cord-005453-4057qib7	14454	20	(	(	-LRB-
cord-005453-4057qib7	14454	21	n	n	NN
cord-005453-4057qib7	14454	22	=	=	SYM
cord-005453-4057qib7	14454	23	30	30	CD
cord-005453-4057qib7	14454	24	)	)	-RRB-
cord-005453-4057qib7	14454	25	groups	group	NNS
cord-005453-4057qib7	14454	26	.	.	.
cord-005453-4057qib7	14455	1	There	there	EX
cord-005453-4057qib7	14455	2	was	be	VBD
cord-005453-4057qib7	14455	3	no	no	DT
cord-005453-4057qib7	14455	4	difference	difference	NN
cord-005453-4057qib7	14455	5	between	between	IN
cord-005453-4057qib7	14455	6	groups	group	NNS
cord-005453-4057qib7	14455	7	about	about	IN
cord-005453-4057qib7	14455	8	given	give	VBN
cord-005453-4057qib7	14455	9	stem	stem	NN
cord-005453-4057qib7	14455	10	cells	cell	NNS
cord-005453-4057qib7	14455	11	(	(	-LRB-
cord-005453-4057qib7	14455	12	MUD	mud	NN
cord-005453-4057qib7	14455	13	6,16±1,07x10	6,16±1,07x10	CD
cord-005453-4057qib7	14455	14	6	6	CD
cord-005453-4057qib7	14455	15	/kg	/kg	NFP
cord-005453-4057qib7	14455	16	and	and	CC
cord-005453-4057qib7	14455	17	MRD	MRD	NNP
cord-005453-4057qib7	14455	18	6,25±1,24x10	6,25±1,24x10	NNP
cord-005453-4057qib7	14455	19	6	6	CD
cord-005453-4057qib7	14455	20	/	/	SYM
cord-005453-4057qib7	14455	21	kg	kg	NNP
cord-005453-4057qib7	14455	22	)	)	-RRB-
cord-005453-4057qib7	14455	23	.	.	.
cord-005453-4057qib7	14456	1	Neither	neither	CC
cord-005453-4057qib7	14456	2	significant	significant	JJ
cord-005453-4057qib7	14456	3	difference	difference	NN
cord-005453-4057qib7	14456	4	between	between	IN
cord-005453-4057qib7	14456	5	different	different	JJ
cord-005453-4057qib7	14456	6	Pesaro	Pesaro	NNP
cord-005453-4057qib7	14456	7	risk	risk	NN
cord-005453-4057qib7	14456	8	groups	group	NNS
cord-005453-4057qib7	14456	9	in	in	IN
cord-005453-4057qib7	14456	10	terms	term	NNS
cord-005453-4057qib7	14456	11	of	of	IN
cord-005453-4057qib7	14456	12	developing	develop	VBG
cord-005453-4057qib7	14456	13	acute	acute	JJ
cord-005453-4057qib7	14456	14	and	and	CC
cord-005453-4057qib7	14456	15	chronic	chronic	JJ
cord-005453-4057qib7	14456	16	GVHD	GVHD	NNP
cord-005453-4057qib7	14456	17	and	and	CC
cord-005453-4057qib7	14456	18	nor	nor	CC
cord-005453-4057qib7	14456	19	decreased	decrease	VBD
cord-005453-4057qib7	14456	20	chimerism	chimerism	NN
cord-005453-4057qib7	14456	21	were	be	VBD
cord-005453-4057qib7	14456	22	detected	detect	VBN
cord-005453-4057qib7	14456	23	.	.	.
cord-005453-4057qib7	14457	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	14457	2	engraftment	engraftment	NN
cord-005453-4057qib7	14457	3	time	time	NN
cord-005453-4057qib7	14457	4	(	(	-LRB-
cord-005453-4057qib7	14457	5	16,40	16,40	CD
cord-005453-4057qib7	14457	6	days	day	NNS
cord-005453-4057qib7	14457	7	)	)	-RRB-
cord-005453-4057qib7	14457	8	in	in	IN
cord-005453-4057qib7	14457	9	MRD	MRD	NNP
cord-005453-4057qib7	14457	10	group	group	NN
cord-005453-4057qib7	14457	11	was	be	VBD
cord-005453-4057qib7	14457	12	significantly	significantly	RB
cord-005453-4057qib7	14457	13	longer	long	JJR
cord-005453-4057qib7	14457	14	than	than	IN
cord-005453-4057qib7	14457	15	MUD	MUD	NNP
cord-005453-4057qib7	14457	16	group	group	NN
cord-005453-4057qib7	14457	17	(	(	-LRB-
cord-005453-4057qib7	14457	18	13,71	13,71	CD
cord-005453-4057qib7	14457	19	days	day	NNS
cord-005453-4057qib7	14457	20	)	)	-RRB-
cord-005453-4057qib7	14458	1	(	(	-LRB-
cord-005453-4057qib7	14458	2	p	p	NN
cord-005453-4057qib7	14458	3	=	=	SYM
cord-005453-4057qib7	14458	4	0.006	0.006	CD
cord-005453-4057qib7	14458	5	)	)	-RRB-
cord-005453-4057qib7	14459	1	but	but	CC
cord-005453-4057qib7	14459	2	no	no	DT
cord-005453-4057qib7	14459	3	difference	difference	NN
cord-005453-4057qib7	14459	4	between	between	IN
cord-005453-4057qib7	14459	5	platelet	platelet	NN
cord-005453-4057qib7	14459	6	engraftments	engraftment	NNS
cord-005453-4057qib7	14459	7	were	be	VBD
cord-005453-4057qib7	14459	8	observed	observe	VBN
cord-005453-4057qib7	14459	9	.	.	.
cord-005453-4057qib7	14460	1	GVHD	GVHD	NNP
cord-005453-4057qib7	14460	2	ratio	ratio	NN
cord-005453-4057qib7	14460	3	was	be	VBD
cord-005453-4057qib7	14460	4	33.3	33.3	CD
cord-005453-4057qib7	14460	5	%	%	NN
cord-005453-4057qib7	14460	6	in	in	IN
cord-005453-4057qib7	14460	7	MUD	MUD	NNP
cord-005453-4057qib7	14460	8	donor	donor	NN
cord-005453-4057qib7	14460	9	group	group	NN
cord-005453-4057qib7	14460	10	and	and	CC
cord-005453-4057qib7	14460	11	13.3	13.3	CD
cord-005453-4057qib7	14460	12	%	%	NN
cord-005453-4057qib7	14460	13	in	in	IN
cord-005453-4057qib7	14460	14	MRD	MRD	NNP
cord-005453-4057qib7	14460	15	group	group	NN
cord-005453-4057qib7	14460	16	and	and	CC
cord-005453-4057qib7	14460	17	no	no	DT
cord-005453-4057qib7	14460	18	statistically	statistically	RB
cord-005453-4057qib7	14460	19	significant	significant	JJ
cord-005453-4057qib7	14460	20	difference	difference	NN
cord-005453-4057qib7	14460	21	was	be	VBD
cord-005453-4057qib7	14460	22	found(p	found(p	NNP
cord-005453-4057qib7	14460	23	>	>	XX
cord-005453-4057qib7	14460	24	0.005	0.005	CD
cord-005453-4057qib7	14460	25	)	)	-RRB-
cord-005453-4057qib7	14460	26	.	.	.
cord-005453-4057qib7	14461	1	The	the	DT
cord-005453-4057qib7	14461	2	incidence	incidence	NN
cord-005453-4057qib7	14461	3	of	of	IN
cord-005453-4057qib7	14461	4	engraftment	engraftment	NN
cord-005453-4057qib7	14461	5	loss	loss	NN
cord-005453-4057qib7	14461	6	in	in	IN
cord-005453-4057qib7	14461	7	MUD	MUD	NNP
cord-005453-4057qib7	14461	8	group	group	NN
cord-005453-4057qib7	14461	9	was	be	VBD
cord-005453-4057qib7	14461	10	13.3	13.3	CD
cord-005453-4057qib7	14461	11	%	%	NN
cord-005453-4057qib7	14461	12	and	and	CC
cord-005453-4057qib7	14461	13	36.7	36.7	CD
cord-005453-4057qib7	14461	14	%	%	NN
cord-005453-4057qib7	14461	15	in	in	IN
cord-005453-4057qib7	14461	16	the	the	DT
cord-005453-4057qib7	14461	17	MRD	MRD	NNP
cord-005453-4057qib7	14461	18	group	group	NN
cord-005453-4057qib7	14461	19	,	,	,
cord-005453-4057qib7	14461	20	and	and	CC
cord-005453-4057qib7	14461	21	there	there	EX
cord-005453-4057qib7	14461	22	was	be	VBD
cord-005453-4057qib7	14461	23	no	no	DT
cord-005453-4057qib7	14461	24	statistically	statistically	RB
cord-005453-4057qib7	14461	25	significant	significant	JJ
cord-005453-4057qib7	14461	26	difference	difference	NN
cord-005453-4057qib7	14461	27	(	(	-LRB-
cord-005453-4057qib7	14461	28	p>0.05	p>0.05	NNP
cord-005453-4057qib7	14461	29	)	)	-RRB-
cord-005453-4057qib7	14461	30	.	.	.
cord-005453-4057qib7	14462	1	The	the	DT
cord-005453-4057qib7	14462	2	rate	rate	NN
cord-005453-4057qib7	14462	3	of	of	IN
cord-005453-4057qib7	14462	4	decreased	decreased	JJ
cord-005453-4057qib7	14462	5	chimerism	chimerism	NN
cord-005453-4057qib7	14462	6	was	be	VBD
cord-005453-4057qib7	14462	7	found	find	VBN
cord-005453-4057qib7	14462	8	to	to	TO
cord-005453-4057qib7	14462	9	be	be	VB
cord-005453-4057qib7	14462	10	significantly	significantly	RB
cord-005453-4057qib7	14462	11	higher	high	JJR
cord-005453-4057qib7	14462	12	in	in	IN
cord-005453-4057qib7	14462	13	the	the	DT
cord-005453-4057qib7	14462	14	MRD	MRD	NNP
cord-005453-4057qib7	14462	15	group	group	NN
cord-005453-4057qib7	14462	16	(	(	-LRB-
cord-005453-4057qib7	14462	17	50	50	CD
cord-005453-4057qib7	14462	18	%	%	NN
cord-005453-4057qib7	14462	19	)	)	-RRB-
cord-005453-4057qib7	14462	20	than	than	IN
cord-005453-4057qib7	14462	21	in	in	IN
cord-005453-4057qib7	14462	22	the	the	DT
cord-005453-4057qib7	14462	23	MUD	MUD	NNP
cord-005453-4057qib7	14462	24	group	group	NN
cord-005453-4057qib7	14462	25	(	(	-LRB-
cord-005453-4057qib7	14462	26	6.7	6.7	CD
cord-005453-4057qib7	14462	27	%	%	NN
cord-005453-4057qib7	14462	28	)	)	-RRB-
cord-005453-4057qib7	14463	1	(	(	-LRB-
cord-005453-4057qib7	14463	2	p:0.010	p:0.010	NNP
cord-005453-4057qib7	14463	3	;	;	:
cord-005453-4057qib7	14463	4	p	p	NN
cord-005453-4057qib7	14463	5	<	<	XX
cord-005453-4057qib7	14463	6	0.05	0.05	CD
cord-005453-4057qib7	14463	7	)	)	-RRB-
cord-005453-4057qib7	14463	8	.	.	.
cord-005453-4057qib7	14464	1	The	the	DT
cord-005453-4057qib7	14464	2	survival	survival	NN
cord-005453-4057qib7	14464	3	rate	rate	NN
cord-005453-4057qib7	14464	4	was	be	VBD
cord-005453-4057qib7	14464	5	92.9	92.9	CD
cord-005453-4057qib7	14464	6	%	%	NN
cord-005453-4057qib7	14464	7	in	in	IN
cord-005453-4057qib7	14464	8	the	the	DT
cord-005453-4057qib7	14464	9	MUD	MUD	NNP
cord-005453-4057qib7	14464	10	group	group	NN
cord-005453-4057qib7	14464	11	and	and	CC
cord-005453-4057qib7	14464	12	96.7	96.7	CD
cord-005453-4057qib7	14464	13	%	%	NN
cord-005453-4057qib7	14464	14	in	in	IN
cord-005453-4057qib7	14464	15	the	the	DT
cord-005453-4057qib7	14464	16	MRD	MRD	NNP
cord-005453-4057qib7	14464	17	group	group	NN
cord-005453-4057qib7	14464	18	.	.	.
cord-005453-4057qib7	14465	1	The	the	DT
cord-005453-4057qib7	14465	2	disease	disease	NN
cord-005453-4057qib7	14465	3	-	-	HYPH
cord-005453-4057qib7	14465	4	free	free	JJ
cord-005453-4057qib7	14465	5	survival	survival	NN
cord-005453-4057qib7	14465	6	rate	rate	NN
cord-005453-4057qib7	14465	7	was	be	VBD
cord-005453-4057qib7	14465	8	90.9	90.9	CD
cord-005453-4057qib7	14465	9	%	%	NN
cord-005453-4057qib7	14465	10	in	in	IN
cord-005453-4057qib7	14465	11	the	the	DT
cord-005453-4057qib7	14465	12	MUD	MUD	NNP
cord-005453-4057qib7	14465	13	group	group	NN
cord-005453-4057qib7	14465	14	and	and	CC
cord-005453-4057qib7	14465	15	50	50	CD
cord-005453-4057qib7	14465	16	%	%	NN
cord-005453-4057qib7	14465	17	in	in	IN
cord-005453-4057qib7	14465	18	the	the	DT
cord-005453-4057qib7	14465	19	MRD	MRD	NNP
cord-005453-4057qib7	14465	20	group	group	NN
cord-005453-4057qib7	14465	21	.	.	.
cord-005453-4057qib7	14466	1	The	the	DT
cord-005453-4057qib7	14466	2	disease	disease	NN
cord-005453-4057qib7	14466	3	-	-	HYPH
cord-005453-4057qib7	14466	4	free	free	JJ
cord-005453-4057qib7	14466	5	survival	survival	NN
cord-005453-4057qib7	14466	6	of	of	IN
cord-005453-4057qib7	14466	7	MUD	MUD	NNP
cord-005453-4057qib7	14466	8	group	group	NN
cord-005453-4057qib7	14466	9	was	be	VBD
cord-005453-4057qib7	14466	10	significantly	significantly	RB
cord-005453-4057qib7	14466	11	higher	high	JJR
cord-005453-4057qib7	14466	12	than	than	IN
cord-005453-4057qib7	14466	13	MRD	MRD	NNP
cord-005453-4057qib7	14466	14	group	group	NN
cord-005453-4057qib7	14466	15	(	(	-LRB-
cord-005453-4057qib7	14466	16	p:0.010	p:0.010	NNP
cord-005453-4057qib7	14466	17	)	)	-RRB-
cord-005453-4057qib7	14466	18	.	.	.
cord-005453-4057qib7	14467	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14467	2	:	:	:
cord-005453-4057qib7	14468	1	In	in	IN
cord-005453-4057qib7	14468	2	our	-PRON-	PRP$
cord-005453-4057qib7	14468	3	study	study	NN
cord-005453-4057qib7	14468	4	,	,	,
cord-005453-4057qib7	14468	5	transplant	transplant	NN
cord-005453-4057qib7	14468	6	related	relate	VBN
cord-005453-4057qib7	14468	7	complications	complication	NNS
cord-005453-4057qib7	14468	8	and	and	CC
cord-005453-4057qib7	14468	9	success	success	NN
cord-005453-4057qib7	14468	10	of	of	IN
cord-005453-4057qib7	14468	11	transplantation	transplantation	NN
cord-005453-4057qib7	14468	12	with	with	IN
cord-005453-4057qib7	14468	13	both	both	CC
cord-005453-4057qib7	14468	14	MUD	MUD	NNP
cord-005453-4057qib7	14468	15	and	and	CC
cord-005453-4057qib7	14468	16	MRDs	MRDs	NNPS
cord-005453-4057qib7	14468	17	were	be	VBD
cord-005453-4057qib7	14468	18	found	find	VBN
cord-005453-4057qib7	14468	19	to	to	TO
cord-005453-4057qib7	14468	20	be	be	VB
cord-005453-4057qib7	14468	21	similar	similar	JJ
cord-005453-4057qib7	14468	22	.	.	.
cord-005453-4057qib7	14469	1	It	-PRON-	PRP
cord-005453-4057qib7	14469	2	is	be	VBZ
cord-005453-4057qib7	14469	3	promising	promise	VBG
cord-005453-4057qib7	14469	4	for	for	IN
cord-005453-4057qib7	14469	5	MUD	mud	NN
cord-005453-4057qib7	14469	6	transplantations	transplantation	NNS
cord-005453-4057qib7	14469	7	to	to	TO
cord-005453-4057qib7	14469	8	found	find	VBD
cord-005453-4057qib7	14469	9	lower	low	JJR
cord-005453-4057qib7	14469	10	decreased	decrease	VBN
cord-005453-4057qib7	14469	11	chimerism	chimerism	NN
cord-005453-4057qib7	14469	12	and	and	CC
cord-005453-4057qib7	14469	13	similar	similar	JJ
cord-005453-4057qib7	14469	14	OS	os	NN
cord-005453-4057qib7	14469	15	and	and	CC
cord-005453-4057qib7	14469	16	DFSs	dfs	NNS
cord-005453-4057qib7	14469	17	.	.	.
cord-005453-4057qib7	14470	1	Based	base	VBN
cord-005453-4057qib7	14470	2	on	on	IN
cord-005453-4057qib7	14470	3	these	these	DT
cord-005453-4057qib7	14470	4	results	result	NNS
cord-005453-4057qib7	14470	5	,	,	,
cord-005453-4057qib7	14470	6	it	-PRON-	PRP
cord-005453-4057qib7	14470	7	was	be	VBD
cord-005453-4057qib7	14470	8	concluded	conclude	VBN
cord-005453-4057qib7	14470	9	that	that	IN
cord-005453-4057qib7	14470	10	HSCT	HSCT	NNP
cord-005453-4057qib7	14470	11	from	from	IN
cord-005453-4057qib7	14470	12	non	non	JJ
cord-005453-4057qib7	14470	13	-	-	JJ
cord-005453-4057qib7	14470	14	family	family	JJ
cord-005453-4057qib7	14470	15	donors	donor	NNS
cord-005453-4057qib7	14470	16	,	,	,
cord-005453-4057qib7	14470	17	especially	especially	RB
cord-005453-4057qib7	14470	18	for	for	IN
cord-005453-4057qib7	14470	19	patients	patient	NNS
cord-005453-4057qib7	14470	20	incompatible	incompatible	JJ
cord-005453-4057qib7	14470	21	with	with	IN
cord-005453-4057qib7	14470	22	chelation	chelation	NN
cord-005453-4057qib7	14470	23	therapy	therapy	NN
cord-005453-4057qib7	14470	24	and	and	CC
cord-005453-4057qib7	14470	25	had	have	VBD
cord-005453-4057qib7	14470	26	organ	organ	NN
cord-005453-4057qib7	14470	27	damage	damage	NN
cord-005453-4057qib7	14470	28	,	,	,
cord-005453-4057qib7	14470	29	transplantation	transplantation	NN
cord-005453-4057qib7	14470	30	from	from	IN
cord-005453-4057qib7	14470	31	unrelated	unrelated	JJ
cord-005453-4057qib7	14470	32	identical	identical	JJ
cord-005453-4057qib7	14470	33	donors	donor	NNS
cord-005453-4057qib7	14470	34	can	can	MD
cord-005453-4057qib7	14470	35	be	be	VB
cord-005453-4057qib7	14470	36	a	a	DT
cord-005453-4057qib7	14470	37	good	good	JJ
cord-005453-4057qib7	14470	38	choice	choice	NN
cord-005453-4057qib7	14470	39	.	.	.
cord-005453-4057qib7	14471	1	Although	although	IN
cord-005453-4057qib7	14471	2	the	the	DT
cord-005453-4057qib7	14471	3	results	result	NNS
cord-005453-4057qib7	14471	4	of	of	IN
cord-005453-4057qib7	14471	5	our	-PRON-	PRP$
cord-005453-4057qib7	14471	6	study	study	NN
cord-005453-4057qib7	14471	7	seem	seem	VBP
cord-005453-4057qib7	14471	8	promising	promising	JJ
cord-005453-4057qib7	14471	9	,	,	,
cord-005453-4057qib7	14471	10	larger	large	JJR
cord-005453-4057qib7	14471	11	patient	patient	NN
cord-005453-4057qib7	14471	12	groups	group	NNS
cord-005453-4057qib7	14471	13	and	and	CC
cord-005453-4057qib7	14471	14	prospective	prospective	JJ
cord-005453-4057qib7	14471	15	clinical	clinical	JJ
cord-005453-4057qib7	14471	16	trials	trial	NNS
cord-005453-4057qib7	14471	17	are	be	VBP
cord-005453-4057qib7	14471	18	required	require	VBN
cord-005453-4057qib7	14471	19	.	.	.
cord-005453-4057qib7	14472	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14472	2	:	:	:
cord-005453-4057qib7	14472	3	Nothing	nothing	NN
cord-005453-4057qib7	14472	4	to	to	TO
cord-005453-4057qib7	14472	5	declare	declare	VB
cord-005453-4057qib7	14472	6	Background	background	NN
cord-005453-4057qib7	14472	7	:	:	:
cord-005453-4057qib7	14472	8	Use	Use	NNP
cord-005453-4057qib7	14472	9	of	of	IN
cord-005453-4057qib7	14472	10	G	G	NNP
cord-005453-4057qib7	14472	11	-	-	HYPH
cord-005453-4057qib7	14472	12	CSF	csf	NN
cord-005453-4057qib7	14472	13	stimulation	stimulation	NN
cord-005453-4057qib7	14472	14	of	of	IN
cord-005453-4057qib7	14472	15	bone	bone	NN
cord-005453-4057qib7	14472	16	marrow	marrow	NN
cord-005453-4057qib7	14472	17	(	(	-LRB-
cord-005453-4057qib7	14472	18	BM	BM	NNP
cord-005453-4057qib7	14472	19	)	)	-RRB-
cord-005453-4057qib7	14472	20	donors	donor	NNS
cord-005453-4057qib7	14472	21	is	be	VBZ
cord-005453-4057qib7	14472	22	beneficial	beneficial	JJ
cord-005453-4057qib7	14472	23	in	in	IN
cord-005453-4057qib7	14472	24	many	many	JJ
cord-005453-4057qib7	14472	25	aspects	aspect	NNS
cord-005453-4057qib7	14472	26	;	;	:
cord-005453-4057qib7	14472	27	it	-PRON-	PRP
cord-005453-4057qib7	14472	28	can	can	MD
cord-005453-4057qib7	14472	29	enhance	enhance	VB
cord-005453-4057qib7	14472	30	TNC	TNC	NNP
cord-005453-4057qib7	14472	31	yield	yield	NN
cord-005453-4057qib7	14472	32	,	,	,
cord-005453-4057qib7	14472	33	but	but	CC
cord-005453-4057qib7	14472	34	also	also	RB
cord-005453-4057qib7	14472	35	have	have	VB
cord-005453-4057qib7	14472	36	an	an	DT
cord-005453-4057qib7	14472	37	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	14472	38	effect	effect	NN
cord-005453-4057qib7	14472	39	on	on	IN
cord-005453-4057qib7	14472	40	donor	donor	NN
cord-005453-4057qib7	14472	41	T	t	NN
cord-005453-4057qib7	14472	42	cell	cell	NN
cord-005453-4057qib7	14472	43	function	function	NN
cord-005453-4057qib7	14472	44	,	,	,
cord-005453-4057qib7	14473	1	particularly	particularly	RB
cord-005453-4057qib7	14473	2	invariant	invariant	JJ
cord-005453-4057qib7	14473	3	natural	natural	JJ
cord-005453-4057qib7	14473	4	killer	killer	NN
cord-005453-4057qib7	14473	5	T	t	NN
cord-005453-4057qib7	14473	6	(	(	-LRB-
cord-005453-4057qib7	14473	7	iNKT	iNKT	NNP
cord-005453-4057qib7	14473	8	)	)	-RRB-
cord-005453-4057qib7	14473	9	cells	cell	NNS
cord-005453-4057qib7	14473	10	expansion	expansion	NN
cord-005453-4057qib7	14473	11	as	as	RB
cord-005453-4057qib7	14473	12	well	well	RB
cord-005453-4057qib7	14473	13	as	as	IN
cord-005453-4057qib7	14473	14	APCs	apc	NNS
cord-005453-4057qib7	14473	15	.	.	.
cord-005453-4057qib7	14474	1	We	-PRON-	PRP
cord-005453-4057qib7	14474	2	analyzed	analyze	VBD
cord-005453-4057qib7	14474	3	outcomes	outcome	NNS
cord-005453-4057qib7	14474	4	of	of	IN
cord-005453-4057qib7	14474	5	34	34	CD
cord-005453-4057qib7	14474	6	consecutive	consecutive	JJ
cord-005453-4057qib7	14474	7	patients	patient	NNS
cord-005453-4057qib7	14474	8	receiving	receive	VBG
cord-005453-4057qib7	14474	9	bone	bone	NN
cord-005453-4057qib7	14474	10	marrow	marrow	NN
cord-005453-4057qib7	14474	11	from	from	IN
cord-005453-4057qib7	14474	12	HLA	HLA	NNP
cord-005453-4057qib7	14474	13	-	-	HYPH
cord-005453-4057qib7	14474	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14474	15	donors	donor	NNS
cord-005453-4057qib7	14474	16	that	that	WDT
cord-005453-4057qib7	14474	17	were	be	VBD
cord-005453-4057qib7	14474	18	stimulated	stimulate	VBN
cord-005453-4057qib7	14474	19	with	with	IN
cord-005453-4057qib7	14474	20	G	G	NNP
cord-005453-4057qib7	14474	21	-	-	HYPH
cord-005453-4057qib7	14474	22	CSF	CSF	NNP
cord-005453-4057qib7	14474	23	prior	prior	RB
cord-005453-4057qib7	14474	24	to	to	IN
cord-005453-4057qib7	14474	25	harvest	harvest	NN
cord-005453-4057qib7	14474	26	.	.	.
cord-005453-4057qib7	14475	1	Methods	method	NNS
cord-005453-4057qib7	14475	2	:	:	:
cord-005453-4057qib7	14475	3	In	in	IN
cord-005453-4057qib7	14475	4	the	the	DT
cord-005453-4057qib7	14475	5	time	time	NN
cord-005453-4057qib7	14475	6	period	period	NN
cord-005453-4057qib7	14475	7	between	between	IN
cord-005453-4057qib7	14475	8	05/2012	05/2012	CD
cord-005453-4057qib7	14475	9	and	and	CC
cord-005453-4057qib7	14475	10	05/	05/	CD
cord-005453-4057qib7	14475	11	2018	2018	CD
cord-005453-4057qib7	14475	12	,	,	,
cord-005453-4057qib7	14475	13	34	34	CD
cord-005453-4057qib7	14475	14	patients	patient	NNS
cord-005453-4057qib7	14475	15	received	receive	VBD
cord-005453-4057qib7	14475	16	bone	bone	NN
cord-005453-4057qib7	14475	17	marrow	marrow	NN
cord-005453-4057qib7	14475	18	from	from	IN
cord-005453-4057qib7	14475	19	donors	donor	NNS
cord-005453-4057qib7	14475	20	stimulated	stimulate	VBN
cord-005453-4057qib7	14475	21	with	with	IN
cord-005453-4057qib7	14475	22	10	10	CD
cord-005453-4057qib7	14475	23	ug	ug	NNP
cord-005453-4057qib7	14475	24	/	/	SYM
cord-005453-4057qib7	14475	25	kg	kg	NNP
cord-005453-4057qib7	14475	26	BW	BW	NNP
cord-005453-4057qib7	14475	27	of	of	IN
cord-005453-4057qib7	14475	28	G	G	NNP
cord-005453-4057qib7	14475	29	-	-	HYPH
cord-005453-4057qib7	14475	30	CSF	CSF	NNP
cord-005453-4057qib7	14475	31	on	on	IN
cord-005453-4057qib7	14475	32	days	day	NNS
cord-005453-4057qib7	14475	33	-2	-2	NNP
cord-005453-4057qib7	14475	34	,	,	,
cord-005453-4057qib7	14475	35	-1	-1	NN
cord-005453-4057qib7	14475	36	and	and	CC
cord-005453-4057qib7	14475	37	day	day	NN
cord-005453-4057qib7	14475	38	of	of	IN
cord-005453-4057qib7	14475	39	BM	BM	NNP
cord-005453-4057qib7	14475	40	collection	collection	NN
cord-005453-4057qib7	14475	41	.	.	.
cord-005453-4057qib7	14476	1	Four	four	CD
cord-005453-4057qib7	14476	2	patients	patient	NNS
cord-005453-4057qib7	14476	3	(	(	-LRB-
cord-005453-4057qib7	14476	4	12	12	CD
cord-005453-4057qib7	14476	5	%	%	NN
cord-005453-4057qib7	14476	6	)	)	-RRB-
cord-005453-4057qib7	14476	7	received	receive	VBD
cord-005453-4057qib7	14476	8	myeloablative	myeloablative	NNP
cord-005453-4057qib7	14476	9	(	(	-LRB-
cord-005453-4057qib7	14476	10	BuCy	BuCy	NNP
cord-005453-4057qib7	14476	11	)	)	-RRB-
cord-005453-4057qib7	14476	12	conditioning	conditioning	NN
cord-005453-4057qib7	14476	13	,	,	,
cord-005453-4057qib7	14476	14	one	one	CD
cord-005453-4057qib7	14476	15	(	(	-LRB-
cord-005453-4057qib7	14476	16	3	3	CD
cord-005453-4057qib7	14476	17	%	%	NN
cord-005453-4057qib7	14476	18	)	)	-RRB-
cord-005453-4057qib7	14476	19	received	receive	VBD
cord-005453-4057qib7	14476	20	TEC	TEC	NNP
cord-005453-4057qib7	14476	21	RIC	RIC	NNP
cord-005453-4057qib7	14476	22	conditioning	conditioning	NN
cord-005453-4057qib7	14476	23	while	while	IN
cord-005453-4057qib7	14476	24	29	29	CD
cord-005453-4057qib7	14476	25	(	(	-LRB-
cord-005453-4057qib7	14476	26	85	85	CD
cord-005453-4057qib7	14476	27	%	%	NN
cord-005453-4057qib7	14476	28	)	)	-RRB-
cord-005453-4057qib7	14476	29	received	receive	VBD
cord-005453-4057qib7	14476	30	NMA	NMA	NNP
cord-005453-4057qib7	14476	31	(	(	-LRB-
cord-005453-4057qib7	14476	32	"	"	``
cord-005453-4057qib7	14476	33	Baltimore	Baltimore	NNP
cord-005453-4057qib7	14476	34	"	"	''
cord-005453-4057qib7	14476	35	)	)	-RRB-
cord-005453-4057qib7	14476	36	conditioning	conditioning	NN
cord-005453-4057qib7	14476	37	.	.	.
cord-005453-4057qib7	14477	1	All	all	DT
cord-005453-4057qib7	14477	2	patients	patient	NNS
cord-005453-4057qib7	14477	3	received	receive	VBD
cord-005453-4057qib7	14477	4	posttransplantation	posttransplantation	NN
cord-005453-4057qib7	14477	5	cyclophosphamide	cyclophosphamide	FW
cord-005453-4057qib7	14477	6	(	(	-LRB-
cord-005453-4057qib7	14477	7	PTCY	PTCY	NNP
cord-005453-4057qib7	14477	8	)	)	-RRB-
cord-005453-4057qib7	14477	9	on	on	IN
cord-005453-4057qib7	14477	10	days	day	NNS
cord-005453-4057qib7	14477	11	+3	+3	NNP
cord-005453-4057qib7	14477	12	and	and	CC
cord-005453-4057qib7	14477	13	+4	+4	NN
cord-005453-4057qib7	14477	14	,	,	,
cord-005453-4057qib7	14477	15	tacrolimus	tacrolimus	NN
cord-005453-4057qib7	14477	16	and	and	CC
cord-005453-4057qib7	14477	17	MMF	MMF	NNP
cord-005453-4057qib7	14477	18	were	be	VBD
cord-005453-4057qib7	14477	19	started	start	VBN
cord-005453-4057qib7	14477	20	on	on	IN
cord-005453-4057qib7	14477	21	day	day	NN
cord-005453-4057qib7	14477	22	+5	+5	NFP
cord-005453-4057qib7	14477	23	.	.	.
cord-005453-4057qib7	14478	1	For	for	IN
cord-005453-4057qib7	14478	2	2	2	CD
cord-005453-4057qib7	14478	3	patients	patient	NNS
cord-005453-4057qib7	14478	4	donors	donor	NNS
cord-005453-4057qib7	14478	5	were	be	VBD
cord-005453-4057qib7	14478	6	fathers	father	NNS
cord-005453-4057qib7	14478	7	,	,	,
cord-005453-4057qib7	14478	8	11	11	CD
cord-005453-4057qib7	14478	9	mothers	mother	NNS
cord-005453-4057qib7	14478	10	,	,	,
cord-005453-4057qib7	14478	11	9	9	CD
cord-005453-4057qib7	14478	12	siblings	sibling	NNS
cord-005453-4057qib7	14478	13	and	and	CC
cord-005453-4057qib7	14478	14	12	12	CD
cord-005453-4057qib7	14478	15	children	child	NNS
cord-005453-4057qib7	14478	16	.	.	.
cord-005453-4057qib7	14479	1	Results	result	NNS
cord-005453-4057qib7	14479	2	:	:	:
cord-005453-4057qib7	14480	1	Median	median	JJ
cord-005453-4057qib7	14480	2	age	age	NN
cord-005453-4057qib7	14480	3	was	be	VBD
cord-005453-4057qib7	14480	4	43	43	CD
cord-005453-4057qib7	14480	5	years	year	NNS
cord-005453-4057qib7	14480	6	(	(	-LRB-
cord-005453-4057qib7	14480	7	20	20	CD
cord-005453-4057qib7	14480	8	-	-	SYM
cord-005453-4057qib7	14480	9	63	63	CD
cord-005453-4057qib7	14480	10	)	)	-RRB-
cord-005453-4057qib7	14480	11	,	,	,
cord-005453-4057qib7	14480	12	there	there	EX
cord-005453-4057qib7	14480	13	were	be	VBD
cord-005453-4057qib7	14480	14	14	14	CD
cord-005453-4057qib7	14480	15	female	female	JJ
cord-005453-4057qib7	14480	16	and	and	CC
cord-005453-4057qib7	14480	17	20	20	CD
cord-005453-4057qib7	14480	18	male	male	JJ
cord-005453-4057qib7	14480	19	patients	patient	NNS
cord-005453-4057qib7	14480	20	.	.	.
cord-005453-4057qib7	14481	1	Twelve	twelve	CD
cord-005453-4057qib7	14481	2	patients	patient	NNS
cord-005453-4057qib7	14481	3	had	have	VBD
cord-005453-4057qib7	14481	4	AML	AML	NNP
cord-005453-4057qib7	14481	5	,	,	,
cord-005453-4057qib7	14481	6	10	10	CD
cord-005453-4057qib7	14481	7	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	14481	8	lymphoma	lymphoma	NN
cord-005453-4057qib7	14481	9	,	,	,
cord-005453-4057qib7	14481	10	5	5	CD
cord-005453-4057qib7	14481	11	ALL	all	DT
cord-005453-4057qib7	14481	12	,	,	,
cord-005453-4057qib7	14481	13	3	3	CD
cord-005453-4057qib7	14481	14	MDS	MDS	NNP
cord-005453-4057qib7	14481	15	,	,	,
cord-005453-4057qib7	14481	16	3	3	CD
cord-005453-4057qib7	14481	17	NHL	NHL	NNP
cord-005453-4057qib7	14481	18	and	and	CC
cord-005453-4057qib7	14481	19	1	1	CD
cord-005453-4057qib7	14481	20	CML	CML	NNP
cord-005453-4057qib7	14481	21	.	.	.
cord-005453-4057qib7	14482	1	Median	median	JJ
cord-005453-4057qib7	14482	2	number	number	NN
cord-005453-4057qib7	14482	3	of	of	IN
cord-005453-4057qib7	14482	4	infused	infuse	VBN
cord-005453-4057qib7	14482	5	TNC	TNC	NNP
cord-005453-4057qib7	14482	6	in	in	IN
cord-005453-4057qib7	14482	7	graft	graft	NN
cord-005453-4057qib7	14482	8	was	be	VBD
cord-005453-4057qib7	14482	9	4.7x10	4.7x10	CD
cord-005453-4057qib7	14482	10	8	8	CD
cord-005453-4057qib7	14483	1	/kg	/kg	NFP
cord-005453-4057qib7	14483	2	BW	BW	NNP
cord-005453-4057qib7	14483	3	(	(	-LRB-
cord-005453-4057qib7	14483	4	1.8	1.8	CD
cord-005453-4057qib7	14483	5	-	-	SYM
cord-005453-4057qib7	14483	6	8.2	8.2	CD
cord-005453-4057qib7	14483	7	)	)	-RRB-
cord-005453-4057qib7	14483	8	and	and	CC
cord-005453-4057qib7	14483	9	CD34	CD34	NNP
cord-005453-4057qib7	14484	1	+	+	CC
cord-005453-4057qib7	14484	2	cells	cell	NNS
cord-005453-4057qib7	14484	3	1.9	1.9	CD
cord-005453-4057qib7	14484	4	x10	x10	CD
cord-005453-4057qib7	14484	5	6	6	CD
cord-005453-4057qib7	14485	1	/kg	/kg	NFP
cord-005453-4057qib7	14485	2	BW	BW	NNP
cord-005453-4057qib7	14485	3	(	(	-LRB-
cord-005453-4057qib7	14485	4	1	1	CD
cord-005453-4057qib7	14485	5	-	-	SYM
cord-005453-4057qib7	14485	6	4.5	4.5	CD
cord-005453-4057qib7	14485	7	)	)	-RRB-
cord-005453-4057qib7	14485	8	.	.	.
cord-005453-4057qib7	14486	1	After	after	IN
cord-005453-4057qib7	14486	2	median	median	NN
cord-005453-4057qib7	14486	3	follow	follow	NN
cord-005453-4057qib7	14486	4	up	up	IN
cord-005453-4057qib7	14486	5	of	of	IN
cord-005453-4057qib7	14486	6	397	397	CD
cord-005453-4057qib7	14486	7	days	day	NNS
cord-005453-4057qib7	14486	8	(	(	-LRB-
cord-005453-4057qib7	14486	9	range	range	VBP
cord-005453-4057qib7	14486	10	26	26	CD
cord-005453-4057qib7	14486	11	-	-	SYM
cord-005453-4057qib7	14486	12	2139	2139	CD
cord-005453-4057qib7	14486	13	)	)	-RRB-
cord-005453-4057qib7	14486	14	,	,	,
cord-005453-4057qib7	14486	15	overall	overall	JJ
cord-005453-4057qib7	14486	16	survival	survival	NN
cord-005453-4057qib7	14486	17	was	be	VBD
cord-005453-4057qib7	14486	18	57	57	CD
cord-005453-4057qib7	14486	19	%	%	NN
cord-005453-4057qib7	14486	20	,	,	,
cord-005453-4057qib7	14486	21	with	with	IN
cord-005453-4057qib7	14486	22	median	median	JJ
cord-005453-4057qib7	14486	23	survival	survival	NN
cord-005453-4057qib7	14486	24	of	of	IN
cord-005453-4057qib7	14486	25	71	71	CD
cord-005453-4057qib7	14486	26	months	month	NNS
cord-005453-4057qib7	14486	27	.	.	.
cord-005453-4057qib7	14487	1	Engraftment	Engraftment	NNP
cord-005453-4057qib7	14487	2	was	be	VBD
cord-005453-4057qib7	14487	3	established	establish	VBN
cord-005453-4057qib7	14487	4	in	in	IN
cord-005453-4057qib7	14487	5	29	29	CD
cord-005453-4057qib7	14487	6	(	(	-LRB-
cord-005453-4057qib7	14487	7	85	85	CD
cord-005453-4057qib7	14487	8	%	%	NN
cord-005453-4057qib7	14487	9	)	)	-RRB-
cord-005453-4057qib7	14487	10	patients	patient	NNS
cord-005453-4057qib7	14487	11	,	,	,
cord-005453-4057qib7	14487	12	2	2	CD
cord-005453-4057qib7	14487	13	(	(	-LRB-
cord-005453-4057qib7	14487	14	6	6	CD
cord-005453-4057qib7	14487	15	%	%	NN
cord-005453-4057qib7	14487	16	)	)	-RRB-
cord-005453-4057qib7	14487	17	had	have	VBD
cord-005453-4057qib7	14487	18	primary	primary	JJ
cord-005453-4057qib7	14487	19	rejection	rejection	NN
cord-005453-4057qib7	14487	20	and	and	CC
cord-005453-4057qib7	14487	21	3	3	CD
cord-005453-4057qib7	14487	22	patients	patient	NNS
cord-005453-4057qib7	14487	23	(	(	-LRB-
cord-005453-4057qib7	14487	24	9	9	CD
cord-005453-4057qib7	14487	25	%	%	NN
cord-005453-4057qib7	14487	26	)	)	-RRB-
cord-005453-4057qib7	14487	27	died	die	VBD
cord-005453-4057qib7	14487	28	in	in	IN
cord-005453-4057qib7	14487	29	sepsis	sepsis	NN
cord-005453-4057qib7	14487	30	prior	prior	RB
cord-005453-4057qib7	14487	31	to	to	IN
cord-005453-4057qib7	14487	32	engraftment	engraftment	NN
cord-005453-4057qib7	14487	33	.	.	.
cord-005453-4057qib7	14488	1	Of	of	IN
cord-005453-4057qib7	14488	2	29	29	CD
cord-005453-4057qib7	14488	3	patients	patient	NNS
cord-005453-4057qib7	14488	4	that	that	WDT
cord-005453-4057qib7	14488	5	engrafted	engraft	VBD
cord-005453-4057qib7	14488	6	,	,	,
cord-005453-4057qib7	14488	7	further	further	RB
cord-005453-4057qib7	14488	8	3	3	CD
cord-005453-4057qib7	14488	9	(	(	-LRB-
cord-005453-4057qib7	14488	10	9	9	CD
cord-005453-4057qib7	14488	11	%	%	NN
cord-005453-4057qib7	14488	12	)	)	-RRB-
cord-005453-4057qib7	14488	13	patients	patient	NNS
cord-005453-4057qib7	14488	14	had	have	VBD
cord-005453-4057qib7	14488	15	secondary	secondary	JJ
cord-005453-4057qib7	14488	16	rejection	rejection	NN
cord-005453-4057qib7	14488	17	,	,	,
cord-005453-4057qib7	14488	18	two	two	CD
cord-005453-4057qib7	14488	19	of	of	IN
cord-005453-4057qib7	14488	20	them	-PRON-	PRP
cord-005453-4057qib7	14488	21	were	be	VBD
cord-005453-4057qib7	14488	22	transplanted	transplant	VBN
cord-005453-4057qib7	14488	23	again	again	RB
cord-005453-4057qib7	14488	24	from	from	IN
cord-005453-4057qib7	14488	25	a	a	DT
cord-005453-4057qib7	14488	26	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14488	27	donor	donor	NN
cord-005453-4057qib7	14488	28	,	,	,
cord-005453-4057qib7	14488	29	both	both	DT
cord-005453-4057qib7	14488	30	using	use	VBG
cord-005453-4057qib7	14488	31	PBSC	PBSC	NNP
cord-005453-4057qib7	14488	32	as	as	IN
cord-005453-4057qib7	14488	33	a	a	DT
cord-005453-4057qib7	14488	34	source	source	NN
cord-005453-4057qib7	14488	35	of	of	IN
cord-005453-4057qib7	14488	36	graft	graft	NN
cord-005453-4057qib7	14488	37	.	.	.
cord-005453-4057qib7	14489	1	Median	median	JJ
cord-005453-4057qib7	14489	2	time	time	NN
cord-005453-4057qib7	14489	3	to	to	IN
cord-005453-4057qib7	14489	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	14489	5	recovery	recovery	NN
cord-005453-4057qib7	14490	1	(	(	-LRB-
cord-005453-4057qib7	14490	2	ANC>500	ANC>500	NNP
cord-005453-4057qib7	14490	3	)	)	-RRB-
cord-005453-4057qib7	14490	4	was	be	VBD
cord-005453-4057qib7	14490	5	23	23	CD
cord-005453-4057qib7	14490	6	days	day	NNS
cord-005453-4057qib7	14490	7	(	(	-LRB-
cord-005453-4057qib7	14490	8	12	12	CD
cord-005453-4057qib7	14490	9	-	-	SYM
cord-005453-4057qib7	14490	10	36	36	CD
cord-005453-4057qib7	14490	11	)	)	-RRB-
cord-005453-4057qib7	14490	12	,	,	,
cord-005453-4057qib7	14490	13	while	while	IN
cord-005453-4057qib7	14490	14	median	median	JJ
cord-005453-4057qib7	14490	15	time	time	NN
cord-005453-4057qib7	14490	16	to	to	IN
cord-005453-4057qib7	14490	17	platelet	platelet	NN
cord-005453-4057qib7	14490	18	recovery	recovery	NN
cord-005453-4057qib7	14490	19	(	(	-LRB-
cord-005453-4057qib7	14490	20	PLT>20x10	plt>20x10	NN
cord-005453-4057qib7	14490	21	9	9	CD
cord-005453-4057qib7	14490	22	/L	/L	,
cord-005453-4057qib7	14490	23	)	)	-RRB-
cord-005453-4057qib7	14490	24	was	be	VBD
cord-005453-4057qib7	14490	25	30	30	CD
cord-005453-4057qib7	14490	26	days	day	NNS
cord-005453-4057qib7	14490	27	(	(	-LRB-
cord-005453-4057qib7	14490	28	12	12	CD
cord-005453-4057qib7	14490	29	-	-	SYM
cord-005453-4057qib7	14490	30	72	72	CD
cord-005453-4057qib7	14490	31	)	)	-RRB-
cord-005453-4057qib7	14490	32	in	in	IN
cord-005453-4057qib7	14490	33	evaluable	evaluable	JJ
cord-005453-4057qib7	14490	34	patients	patient	NNS
cord-005453-4057qib7	14490	35	.	.	.
cord-005453-4057qib7	14491	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	14491	2	incidence	incidence	NN
cord-005453-4057qib7	14491	3	of	of	IN
cord-005453-4057qib7	14491	4	aGVHD	aGVHD	NNP
cord-005453-4057qib7	14491	5	II	II	NNP
cord-005453-4057qib7	14491	6	-	-	HYPH
cord-005453-4057qib7	14491	7	IV	IV	NNP
cord-005453-4057qib7	14491	8	was	be	VBD
cord-005453-4057qib7	14491	9	27.7	27.7	CD
cord-005453-4057qib7	14491	10	%	%	NN
cord-005453-4057qib7	14491	11	(	(	-LRB-
cord-005453-4057qib7	14491	12	95	95	CD
cord-005453-4057qib7	14491	13	%	%	NN
cord-005453-4057qib7	14491	14	CI	CI	NNP
cord-005453-4057qib7	14491	15	,	,	,
cord-005453-4057qib7	14491	16	13	13	CD
cord-005453-4057qib7	14491	17	-	-	HYPH
cord-005453-4057qib7	14491	18	44);of	44);of	NNS
cord-005453-4057qib7	14491	19	note	note	NN
cord-005453-4057qib7	14491	20	is	be	VBZ
cord-005453-4057qib7	14491	21	that	that	DT
cord-005453-4057qib7	14491	22	of	of	IN
cord-005453-4057qib7	14491	23	9	9	CD
cord-005453-4057qib7	14491	24	patients	patient	NNS
cord-005453-4057qib7	14491	25	that	that	WDT
cord-005453-4057qib7	14491	26	developed	develop	VBD
cord-005453-4057qib7	14491	27	aGVHD	aGVHD	NNP
cord-005453-4057qib7	14491	28	only	only	RB
cord-005453-4057qib7	14491	29	one	one	CD
cord-005453-4057qib7	14491	30	had	have	VBD
cord-005453-4057qib7	14491	31	grade	grade	NN
cord-005453-4057qib7	14491	32	III	III	NNP
cord-005453-4057qib7	14491	33	,	,	,
cord-005453-4057qib7	14491	34	while	while	IN
cord-005453-4057qib7	14491	35	remaining	remain	VBG
cord-005453-4057qib7	14491	36	8	8	CD
cord-005453-4057qib7	14491	37	patients	patient	NNS
cord-005453-4057qib7	14491	38	had	have	VBD
cord-005453-4057qib7	14491	39	grade	grade	NN
cord-005453-4057qib7	14491	40	II	II	NNP
cord-005453-4057qib7	14491	41	.	.	.
cord-005453-4057qib7	14492	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	14492	2	incidence	incidence	NN
cord-005453-4057qib7	14492	3	of	of	IN
cord-005453-4057qib7	14492	4	cGVHD	cGVHD	NNP
cord-005453-4057qib7	14493	1	requiring	require	VBG
cord-005453-4057qib7	14493	2	treatment	treatment	NN
cord-005453-4057qib7	14493	3	was	be	VBD
cord-005453-4057qib7	14493	4	6.9	6.9	CD
cord-005453-4057qib7	14493	5	%	%	NN
cord-005453-4057qib7	14493	6	(	(	-LRB-
cord-005453-4057qib7	14493	7	95	95	CD
cord-005453-4057qib7	14493	8	%	%	NN
cord-005453-4057qib7	14493	9	CI	CI	NNP
cord-005453-4057qib7	14493	10	,	,	,
cord-005453-4057qib7	14493	11	[	[	-LRB-
cord-005453-4057qib7	14493	12	1	1	CD
cord-005453-4057qib7	14493	13	]	]	-RRB-
cord-005453-4057qib7	14493	14	[	[	-LRB-
cord-005453-4057qib7	14493	15	2	2	CD
cord-005453-4057qib7	14493	16	]	]	-RRB-
cord-005453-4057qib7	14493	17	[	[	-LRB-
cord-005453-4057qib7	14493	18	3	3	CD
cord-005453-4057qib7	14493	19	]	]	-RRB-
cord-005453-4057qib7	14493	20	[	[	-LRB-
cord-005453-4057qib7	14493	21	4	4	CD
cord-005453-4057qib7	14493	22	]	]	-RRB-
cord-005453-4057qib7	14493	23	[	[	-LRB-
cord-005453-4057qib7	14493	24	5	5	CD
cord-005453-4057qib7	14493	25	]	]	-RRB-
cord-005453-4057qib7	14493	26	[	[	-LRB-
cord-005453-4057qib7	14493	27	6	6	CD
cord-005453-4057qib7	14493	28	]	]	-RRB-
cord-005453-4057qib7	14493	29	[	[	-LRB-
cord-005453-4057qib7	14493	30	7	7	CD
cord-005453-4057qib7	14493	31	]	]	-RRB-
cord-005453-4057qib7	14493	32	[	[	-LRB-
cord-005453-4057qib7	14493	33	8	8	CD
cord-005453-4057qib7	14493	34	]	]	-RRB-
cord-005453-4057qib7	14493	35	[	[	-LRB-
cord-005453-4057qib7	14493	36	9	9	CD
cord-005453-4057qib7	14493	37	]	]	-RRB-
cord-005453-4057qib7	14493	38	[	[	-LRB-
cord-005453-4057qib7	14493	39	10	10	CD
cord-005453-4057qib7	14493	40	]	]	-RRB-
cord-005453-4057qib7	14493	41	[	[	-LRB-
cord-005453-4057qib7	14493	42	11	11	CD
cord-005453-4057qib7	14493	43	]	]	-RRB-
cord-005453-4057qib7	14493	44	[	[	-LRB-
cord-005453-4057qib7	14493	45	12	12	CD
cord-005453-4057qib7	14493	46	]	]	-RRB-
cord-005453-4057qib7	14493	47	[	[	-LRB-
cord-005453-4057qib7	14493	48	13	13	CD
cord-005453-4057qib7	14493	49	]	]	-RRB-
cord-005453-4057qib7	14493	50	[	[	-LRB-
cord-005453-4057qib7	14493	51	14	14	CD
cord-005453-4057qib7	14493	52	]	]	-RRB-
cord-005453-4057qib7	14493	53	[	[	-LRB-
cord-005453-4057qib7	14493	54	15	15	CD
cord-005453-4057qib7	14493	55	]	]	-RRB-
cord-005453-4057qib7	14493	56	[	[	-LRB-
cord-005453-4057qib7	14493	57	16	16	CD
cord-005453-4057qib7	14493	58	]	]	-RRB-
cord-005453-4057qib7	14493	59	[	[	-LRB-
cord-005453-4057qib7	14493	60	17	17	CD
cord-005453-4057qib7	14493	61	]	]	-RRB-
cord-005453-4057qib7	14493	62	[	[	-LRB-
cord-005453-4057qib7	14493	63	18	18	CD
cord-005453-4057qib7	14493	64	]	]	-RRB-
cord-005453-4057qib7	14493	65	[	[	-LRB-
cord-005453-4057qib7	14493	66	19	19	CD
cord-005453-4057qib7	14493	67	]	]	-RRB-
cord-005453-4057qib7	14493	68	[	[	-LRB-
cord-005453-4057qib7	14493	69	20	20	CD
cord-005453-4057qib7	14493	70	]	]	-RRB-
cord-005453-4057qib7	14493	71	.	.	.
cord-005453-4057qib7	14494	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	14494	2	incidence	incidence	NN
cord-005453-4057qib7	14494	3	of	of	IN
cord-005453-4057qib7	14494	4	relapse	relapse	NN
cord-005453-4057qib7	14494	5	was	be	VBD
cord-005453-4057qib7	14494	6	36.1	36.1	CD
cord-005453-4057qib7	14494	7	%	%	NN
cord-005453-4057qib7	14494	8	(	(	-LRB-
cord-005453-4057qib7	14494	9	95	95	CD
cord-005453-4057qib7	14494	10	%	%	NN
cord-005453-4057qib7	14494	11	CI	CI	NNP
cord-005453-4057qib7	14494	12	,	,	,
cord-005453-4057qib7	14494	13	20	20	CD
cord-005453-4057qib7	14494	14	-	-	SYM
cord-005453-4057qib7	14494	15	52	52	CD
cord-005453-4057qib7	14494	16	)	)	-RRB-
cord-005453-4057qib7	14494	17	and	and	CC
cord-005453-4057qib7	14494	18	TRM	TRM	NNP
cord-005453-4057qib7	14494	19	was	be	VBD
cord-005453-4057qib7	14494	20	25.2	25.2	CD
cord-005453-4057qib7	14494	21	%	%	NN
cord-005453-4057qib7	14494	22	(	(	-LRB-
cord-005453-4057qib7	14494	23	95	95	CD
cord-005453-4057qib7	14494	24	%	%	NN
cord-005453-4057qib7	14494	25	CI	CI	NNP
cord-005453-4057qib7	14494	26	,	,	,
cord-005453-4057qib7	14494	27	11	11	CD
cord-005453-4057qib7	14494	28	-	-	SYM
cord-005453-4057qib7	14494	29	41	41	CD
cord-005453-4057qib7	14494	30	)	)	-RRB-
cord-005453-4057qib7	14494	31	.	.	.
cord-005453-4057qib7	14495	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14495	2	:	:	:
cord-005453-4057qib7	14496	1	The	the	DT
cord-005453-4057qib7	14496	2	use	use	NN
cord-005453-4057qib7	14496	3	of	of	IN
cord-005453-4057qib7	14496	4	G	G	NNP
cord-005453-4057qib7	14496	5	-	-	HYPH
cord-005453-4057qib7	14496	6	CSF	csf	NN
cord-005453-4057qib7	14496	7	mobilized	mobilize	VBD
cord-005453-4057qib7	14496	8	BM	BM	NNP
cord-005453-4057qib7	14496	9	graft	graft	NN
cord-005453-4057qib7	14496	10	in	in	IN
cord-005453-4057qib7	14496	11	the	the	DT
cord-005453-4057qib7	14496	12	HLA	HLA	NNP
cord-005453-4057qib7	14496	13	-	-	HYPH
cord-005453-4057qib7	14496	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14496	15	setting	setting	NN
cord-005453-4057qib7	14496	16	with	with	IN
cord-005453-4057qib7	14496	17	PTCY	PTCY	NNP
cord-005453-4057qib7	14496	18	has	have	VBZ
cord-005453-4057qib7	14496	19	proven	prove	VBN
cord-005453-4057qib7	14496	20	to	to	TO
cord-005453-4057qib7	14496	21	be	be	VB
cord-005453-4057qib7	14496	22	useful	useful	JJ
cord-005453-4057qib7	14496	23	to	to	IN
cord-005453-4057qib7	14496	24	us	-PRON-	PRP
cord-005453-4057qib7	14496	25	,	,	,
cord-005453-4057qib7	14496	26	not	not	RB
cord-005453-4057qib7	14496	27	only	only	RB
cord-005453-4057qib7	14496	28	in	in	IN
cord-005453-4057qib7	14496	29	terms	term	NNS
cord-005453-4057qib7	14496	30	of	of	IN
cord-005453-4057qib7	14496	31	TNC	TNC	NNP
cord-005453-4057qib7	14496	32	yield	yield	NN
cord-005453-4057qib7	14496	33	which	which	WDT
cord-005453-4057qib7	14496	34	was	be	VBD
cord-005453-4057qib7	14496	35	more	more	JJR
cord-005453-4057qib7	14496	36	than	than	IN
cord-005453-4057qib7	14496	37	satisfactory	satisfactory	JJ
cord-005453-4057qib7	14496	38	and	and	CC
cord-005453-4057qib7	14496	39	contributed	contribute	VBD
cord-005453-4057qib7	14496	40	to	to	TO
cord-005453-4057qib7	14496	41	adequate	adequate	VB
cord-005453-4057qib7	14496	42	hematological	hematological	JJ
cord-005453-4057qib7	14496	43	recovery	recovery	NN
cord-005453-4057qib7	14496	44	,	,	,
cord-005453-4057qib7	14496	45	but	but	CC
cord-005453-4057qib7	14496	46	also	also	RB
cord-005453-4057qib7	14496	47	in	in	IN
cord-005453-4057qib7	14496	48	the	the	DT
cord-005453-4057qib7	14496	49	excellent	excellent	JJ
cord-005453-4057qib7	14496	50	control	control	NN
cord-005453-4057qib7	14496	51	of	of	IN
cord-005453-4057qib7	14496	52	both	both	CC
cord-005453-4057qib7	14496	53	acute	acute	JJ
cord-005453-4057qib7	14496	54	and	and	CC
cord-005453-4057qib7	14496	55	chronic	chronic	JJ
cord-005453-4057qib7	14496	56	GVHD	GVHD	NNP
cord-005453-4057qib7	14496	57	,	,	,
cord-005453-4057qib7	14496	58	with	with	IN
cord-005453-4057qib7	14496	59	most	most	JJS
cord-005453-4057qib7	14496	60	patients	patient	NNS
cord-005453-4057qib7	14496	61	developing	develop	VBG
cord-005453-4057qib7	14496	62	aGVHD	agvhd	NN
cord-005453-4057qib7	14496	63	of	of	IN
cord-005453-4057qib7	14496	64	grade	grade	NN
cord-005453-4057qib7	14496	65	II	II	NNP
cord-005453-4057qib7	14496	66	and	and	CC
cord-005453-4057qib7	14496	67	only	only	RB
cord-005453-4057qib7	14496	68	one	one	CD
cord-005453-4057qib7	14496	69	grade	grade	NN
cord-005453-4057qib7	14496	70	III	III	NNP
cord-005453-4057qib7	14496	71	(	(	-LRB-
cord-005453-4057qib7	14496	72	actually	actually	RB
cord-005453-4057qib7	14496	73	developed	develop	VBN
cord-005453-4057qib7	14496	74	only	only	RB
cord-005453-4057qib7	14496	75	after	after	IN
cord-005453-4057qib7	14496	76	DLI	DLI	NNP
cord-005453-4057qib7	14496	77	given	give	VBN
cord-005453-4057qib7	14496	78	for	for	IN
cord-005453-4057qib7	14496	79	decreasing	decrease	VBG
cord-005453-4057qib7	14496	80	chimerism	chimerism	NN
cord-005453-4057qib7	14496	81	)	)	-RRB-
cord-005453-4057qib7	14496	82	.	.	.
cord-005453-4057qib7	14497	1	Comparative	comparative	JJ
cord-005453-4057qib7	14497	2	studies	study	NNS
cord-005453-4057qib7	14497	3	are	be	VBP
cord-005453-4057qib7	14497	4	of	of	IN
cord-005453-4057qib7	14497	5	course	course	NN
cord-005453-4057qib7	14497	6	warranted	warrant	VBN
cord-005453-4057qib7	14497	7	to	to	TO
cord-005453-4057qib7	14497	8	prove	prove	VB
cord-005453-4057qib7	14497	9	benefit	benefit	NN
cord-005453-4057qib7	14497	10	,	,	,
cord-005453-4057qib7	14497	11	but	but	CC
cord-005453-4057qib7	14497	12	this	this	DT
cord-005453-4057qib7	14497	13	data	data	NN
cord-005453-4057qib7	14497	14	contributes	contribute	VBZ
cord-005453-4057qib7	14497	15	to	to	IN
cord-005453-4057qib7	14497	16	the	the	DT
cord-005453-4057qib7	14497	17	growing	grow	VBG
cord-005453-4057qib7	14497	18	body	body	NN
cord-005453-4057qib7	14497	19	of	of	IN
cord-005453-4057qib7	14497	20	evidence	evidence	NN
cord-005453-4057qib7	14497	21	that	that	WDT
cord-005453-4057qib7	14497	22	indeed	indeed	RB
cord-005453-4057qib7	14497	23	donor	donor	NN
cord-005453-4057qib7	14497	24	stem	stem	NN
cord-005453-4057qib7	14497	25	cell	cell	NN
cord-005453-4057qib7	14497	26	stimulation	stimulation	NN
cord-005453-4057qib7	14497	27	with	with	IN
cord-005453-4057qib7	14497	28	G	G	NNP
cord-005453-4057qib7	14497	29	-	-	HYPH
cord-005453-4057qib7	14497	30	CSF	CSF	NNP
cord-005453-4057qib7	14497	31	has	have	VBZ
cord-005453-4057qib7	14497	32	potentially	potentially	RB
cord-005453-4057qib7	14497	33	powerful	powerful	JJ
cord-005453-4057qib7	14497	34	immunomodulatory	immunomodulatory	JJ
cord-005453-4057qib7	14497	35	effect	effect	NN
cord-005453-4057qib7	14497	36	.	.	.
cord-005453-4057qib7	14498	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14498	2	:	:	:
cord-005453-4057qib7	14498	3	Nothing	nothing	NN
cord-005453-4057qib7	14498	4	to	to	TO
cord-005453-4057qib7	14498	5	disclose	disclose	VB
cord-005453-4057qib7	14498	6	P674	p674	CD
cord-005453-4057qib7	14498	7	other	other	JJ
cord-005453-4057qib7	14498	8	-	-	HYPH
cord-005453-4057qib7	14498	9	relative	relative	JJ
cord-005453-4057qib7	14498	10	donors	donor	NNS
cord-005453-4057qib7	14498	11	as	as	IN
cord-005453-4057qib7	14498	12	a	a	DT
cord-005453-4057qib7	14498	13	reliable	reliable	JJ
cord-005453-4057qib7	14498	14	bank	bank	NN
cord-005453-4057qib7	14498	15	for	for	IN
cord-005453-4057qib7	14498	16	allogeneic	allogeneic	NN
cord-005453-4057qib7	14498	17	hsct	hsct	NNP
cord-005453-4057qib7	14498	18	in	in	IN
cord-005453-4057qib7	14498	19	countries	country	NNS
cord-005453-4057qib7	14498	20	with	with	IN
cord-005453-4057qib7	14498	21	culturally	culturally	RB
cord-005453-4057qib7	14498	22	accepted	accept	VBN
cord-005453-4057qib7	14498	23	cousin	cousin	NN
cord-005453-4057qib7	14498	24	-	-	HYPH
cord-005453-4057qib7	14498	25	cousin	cousin	NN
cord-005453-4057qib7	14498	26	marriages	marriage	NNS
cord-005453-4057qib7	14498	27	:	:	:
cord-005453-4057qib7	14498	28	A	a	DT
cord-005453-4057qib7	14498	29	two	two	CD
cord-005453-4057qib7	14498	30	-	-	HYPH
cord-005453-4057qib7	14498	31	year	year	NN
cord-005453-4057qib7	14498	32	report	report	NN
cord-005453-4057qib7	14498	33	from	from	IN
cord-005453-4057qib7	14498	34	a	a	DT
cord-005453-4057qib7	14498	35	pediatric	pediatric	JJ
cord-005453-4057qib7	14498	36	center	center	NN
cord-005453-4057qib7	14498	37	in	in	IN
cord-005453-4057qib7	14498	38	Iran	Iran	NNP
cord-005453-4057qib7	14498	39	Background	Background	NNP
cord-005453-4057qib7	14498	40	:	:	:
cord-005453-4057qib7	14499	1	Although	although	IN
cord-005453-4057qib7	14499	2	the	the	DT
cord-005453-4057qib7	14499	3	optimal	optimal	JJ
cord-005453-4057qib7	14499	4	donors	donor	NNS
cord-005453-4057qib7	14499	5	for	for	IN
cord-005453-4057qib7	14499	6	patients	patient	NNS
cord-005453-4057qib7	14499	7	undergoing	undergo	VBG
cord-005453-4057qib7	14499	8	allogeneic	allogeneic	IN
cord-005453-4057qib7	14499	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14499	10	stem	stem	NN
cord-005453-4057qib7	14499	11	cell	cell	NN
cord-005453-4057qib7	14499	12	transplantation	transplantation	NN
cord-005453-4057qib7	14499	13	(	(	-LRB-
cord-005453-4057qib7	14499	14	allo	allo	NN
cord-005453-4057qib7	14499	15	-	-	HYPH
cord-005453-4057qib7	14499	16	HSCT	HSCT	NNP
cord-005453-4057qib7	14499	17	)	)	-RRB-
cord-005453-4057qib7	14499	18	are	be	VBP
cord-005453-4057qib7	14499	19	fully	fully	RB
cord-005453-4057qib7	14499	20	-	-	HYPH
cord-005453-4057qib7	14499	21	matched	match	VBN
cord-005453-4057qib7	14499	22	siblings	sibling	NNS
cord-005453-4057qib7	14499	23	,	,	,
cord-005453-4057qib7	14499	24	the	the	DT
cord-005453-4057qib7	14499	25	cousincousin	cousincousin	NNP
cord-005453-4057qib7	14499	26	(	(	-LRB-
cord-005453-4057qib7	14499	27	consanguineous	consanguineous	JJ
cord-005453-4057qib7	14499	28	)	)	-RRB-
cord-005453-4057qib7	14499	29	marriages	marriage	NNS
cord-005453-4057qib7	14499	30	in	in	IN
cord-005453-4057qib7	14499	31	some	some	DT
cord-005453-4057qib7	14499	32	countries	country	NNS
cord-005453-4057qib7	14499	33	have	have	VBP
cord-005453-4057qib7	14499	34	extended	extend	VBN
cord-005453-4057qib7	14499	35	the	the	DT
cord-005453-4057qib7	14499	36	chance	chance	NN
cord-005453-4057qib7	14499	37	to	to	TO
cord-005453-4057qib7	14499	38	find	find	VB
cord-005453-4057qib7	14499	39	a	a	DT
cord-005453-4057qib7	14499	40	matched	match	VBN
cord-005453-4057qib7	14499	41	donor	donor	NN
cord-005453-4057qib7	14499	42	for	for	IN
cord-005453-4057qib7	14499	43	the	the	DT
cord-005453-4057qib7	14499	44	HSCTrecipient	hsctrecipient	NN
cord-005453-4057qib7	14499	45	.	.	.
cord-005453-4057qib7	14500	1	In	in	IN
cord-005453-4057qib7	14500	2	this	this	DT
cord-005453-4057qib7	14500	3	study	study	NN
cord-005453-4057qib7	14500	4	,	,	,
cord-005453-4057qib7	14500	5	an	an	DT
cord-005453-4057qib7	14500	6	outcome	outcome	NN
cord-005453-4057qib7	14500	7	analysis	analysis	NN
cord-005453-4057qib7	14500	8	of	of	IN
cord-005453-4057qib7	14500	9	transplanted	transplanted	JJ
cord-005453-4057qib7	14500	10	patients	patient	NNS
cord-005453-4057qib7	14500	11	receiving	receive	VBG
cord-005453-4057qib7	14500	12	stem	stem	NN
cord-005453-4057qib7	14500	13	cells	cell	NNS
cord-005453-4057qib7	14500	14	from	from	IN
cord-005453-4057qib7	14500	15	their	-PRON-	PRP$
cord-005453-4057qib7	14500	16	relatives	relative	NNS
cord-005453-4057qib7	14500	17	other	other	JJ
cord-005453-4057qib7	14500	18	than	than	IN
cord-005453-4057qib7	14500	19	siblings	sibling	NNS
cord-005453-4057qib7	14500	20	(	(	-LRB-
cord-005453-4057qib7	14500	21	other	other	JJ
cord-005453-4057qib7	14500	22	-	-	HYPH
cord-005453-4057qib7	14500	23	relatives	relative	NNS
cord-005453-4057qib7	14500	24	or	or	CC
cord-005453-4057qib7	14500	25	non	non	JJ
cord-005453-4057qib7	14500	26	-	-	JJ
cord-005453-4057qib7	14500	27	sibling	sibling	JJ
cord-005453-4057qib7	14500	28	donors	donor	NNS
cord-005453-4057qib7	14500	29	)	)	-RRB-
cord-005453-4057qib7	14500	30	is	be	VBZ
cord-005453-4057qib7	14500	31	provided	provide	VBN
cord-005453-4057qib7	14500	32	.	.	.
cord-005453-4057qib7	14501	1	Methods	method	NNS
cord-005453-4057qib7	14501	2	:	:	:
cord-005453-4057qib7	14501	3	In	in	IN
cord-005453-4057qib7	14501	4	this	this	DT
cord-005453-4057qib7	14501	5	retrospective	retrospective	JJ
cord-005453-4057qib7	14501	6	cross	cross	JJ
cord-005453-4057qib7	14501	7	-	-	JJ
cord-005453-4057qib7	14501	8	sectional	sectional	JJ
cord-005453-4057qib7	14501	9	study	study	NN
cord-005453-4057qib7	14501	10	,	,	,
cord-005453-4057qib7	14501	11	a	a	DT
cord-005453-4057qib7	14501	12	two	two	CD
cord-005453-4057qib7	14501	13	-	-	HYPH
cord-005453-4057qib7	14501	14	year	year	NN
cord-005453-4057qib7	14501	15	report	report	NN
cord-005453-4057qib7	14501	16	of	of	IN
cord-005453-4057qib7	14501	17	patients	patient	NNS
cord-005453-4057qib7	14501	18	who	who	WP
cord-005453-4057qib7	14501	19	received	receive	VBD
cord-005453-4057qib7	14501	20	allo	allo	NN
cord-005453-4057qib7	14501	21	-	-	HYPH
cord-005453-4057qib7	14501	22	HSCT	HSCT	NNP
cord-005453-4057qib7	14501	23	from	from	IN
cord-005453-4057qib7	14501	24	their	-PRON-	PRP$
cord-005453-4057qib7	14501	25	other	other	JJ
cord-005453-4057qib7	14501	26	-	-	HYPH
cord-005453-4057qib7	14501	27	relative	relative	JJ
cord-005453-4057qib7	14501	28	donors	donor	NNS
cord-005453-4057qib7	14501	29	during	during	IN
cord-005453-4057qib7	14501	30	September	September	NNP
cord-005453-4057qib7	14501	31	2016	2016	CD
cord-005453-4057qib7	14501	32	to	to	IN
cord-005453-4057qib7	14501	33	September	September	NNP
cord-005453-4057qib7	14501	34	2018	2018	CD
cord-005453-4057qib7	14501	35	at	at	IN
cord-005453-4057qib7	14501	36	the	the	DT
cord-005453-4057qib7	14501	37	Department	Department	NNP
cord-005453-4057qib7	14501	38	of	of	IN
cord-005453-4057qib7	14501	39	Stem	Stem	NNP
cord-005453-4057qib7	14501	40	Cell	Cell	NNP
cord-005453-4057qib7	14501	41	transplantation	transplantation	NN
cord-005453-4057qib7	14501	42	of	of	IN
cord-005453-4057qib7	14501	43	Children	Children	NNP
cord-005453-4057qib7	14501	44	's	's	POS
cord-005453-4057qib7	14501	45	Medical	Medical	NNP
cord-005453-4057qib7	14501	46	Center	Center	NNP
cord-005453-4057qib7	14501	47	in	in	IN
cord-005453-4057qib7	14501	48	Tehran	Tehran	NNP
cord-005453-4057qib7	14501	49	,	,	,
cord-005453-4057qib7	14501	50	Iran	Iran	NNP
cord-005453-4057qib7	14501	51	is	be	VBZ
cord-005453-4057qib7	14501	52	presented	present	VBN
cord-005453-4057qib7	14501	53	.	.	.
cord-005453-4057qib7	14502	1	The	the	DT
cord-005453-4057qib7	14502	2	patients	patient	NNS
cord-005453-4057qib7	14502	3	were	be	VBD
cord-005453-4057qib7	14502	4	followed	follow	VBN
cord-005453-4057qib7	14502	5	up	up	RP
cord-005453-4057qib7	14502	6	until	until	IN
cord-005453-4057qib7	14502	7	1	1	CD
cord-005453-4057qib7	14502	8	st	st	NNP
cord-005453-4057qib7	14502	9	December	December	NNP
cord-005453-4057qib7	14502	10	2018	2018	CD
cord-005453-4057qib7	14502	11	.	.	.
cord-005453-4057qib7	14503	1	Results	result	NNS
cord-005453-4057qib7	14503	2	:	:	:
cord-005453-4057qib7	14504	1	During	during	IN
cord-005453-4057qib7	14504	2	this	this	DT
cord-005453-4057qib7	14504	3	time	time	NN
cord-005453-4057qib7	14504	4	period	period	NN
cord-005453-4057qib7	14504	5	,	,	,
cord-005453-4057qib7	14504	6	178	178	CD
cord-005453-4057qib7	14504	7	patients	patient	NNS
cord-005453-4057qib7	14504	8	underwent	undergo	VBD
cord-005453-4057qib7	14504	9	HSCT	HSCT	NNP
cord-005453-4057qib7	14504	10	(	(	-LRB-
cord-005453-4057qib7	14504	11	both	both	DT
cord-005453-4057qib7	14504	12	autologous	autologous	JJ
cord-005453-4057qib7	14504	13	and	and	CC
cord-005453-4057qib7	14504	14	allogeneic	allogeneic	JJ
cord-005453-4057qib7	14504	15	)	)	-RRB-
cord-005453-4057qib7	14504	16	at	at	IN
cord-005453-4057qib7	14504	17	this	this	DT
cord-005453-4057qib7	14504	18	center	center	NN
cord-005453-4057qib7	14504	19	,	,	,
cord-005453-4057qib7	14504	20	of	of	IN
cord-005453-4057qib7	14504	21	which	which	WDT
cord-005453-4057qib7	14504	22	159	159	CD
cord-005453-4057qib7	14504	23	cases	case	NNS
cord-005453-4057qib7	14504	24	received	receive	VBD
cord-005453-4057qib7	14504	25	allo	allo	NN
cord-005453-4057qib7	14504	26	-	-	HYPH
cord-005453-4057qib7	14504	27	HSCT	HSCT	NNP
cord-005453-4057qib7	14504	28	.	.	.
cord-005453-4057qib7	14505	1	Out	out	IN
cord-005453-4057qib7	14505	2	of	of	IN
cord-005453-4057qib7	14505	3	allo	allo	NN
cord-005453-4057qib7	14505	4	-	-	HYPH
cord-005453-4057qib7	14505	5	HSCT	HSCT	NNP
cord-005453-4057qib7	14505	6	recipients	recipient	NNS
cord-005453-4057qib7	14505	7	,	,	,
cord-005453-4057qib7	14505	8	the	the	DT
cord-005453-4057qib7	14505	9	donors	donor	NNS
cord-005453-4057qib7	14505	10	of	of	IN
cord-005453-4057qib7	14505	11	stem	stem	NN
cord-005453-4057qib7	14505	12	cells	cell	NNS
cord-005453-4057qib7	14505	13	for	for	IN
cord-005453-4057qib7	14505	14	51	51	CD
cord-005453-4057qib7	14505	15	cases	case	NNS
cord-005453-4057qib7	14505	16	(	(	-LRB-
cord-005453-4057qib7	14505	17	32.1	32.1	CD
cord-005453-4057qib7	14505	18	%	%	NN
cord-005453-4057qib7	14505	19	)	)	-RRB-
cord-005453-4057qib7	14505	20	were	be	VBD
cord-005453-4057qib7	14505	21	their	-PRON-	PRP$
cord-005453-4057qib7	14505	22	other	other	JJ
cord-005453-4057qib7	14505	23	-	-	HYPH
cord-005453-4057qib7	14505	24	relatives	relative	NNS
cord-005453-4057qib7	14505	25	.	.	.
cord-005453-4057qib7	14506	1	The	the	DT
cord-005453-4057qib7	14506	2	median	median	NN
cord-005453-4057qib7	14506	3	(	(	-LRB-
cord-005453-4057qib7	14506	4	range	range	NN
cord-005453-4057qib7	14506	5	)	)	-RRB-
cord-005453-4057qib7	14506	6	age	age	NN
cord-005453-4057qib7	14506	7	at	at	IN
cord-005453-4057qib7	14506	8	HSCT	HSCT	NNP
cord-005453-4057qib7	14506	9	was	be	VBD
cord-005453-4057qib7	14506	10	6	6	CD
cord-005453-4057qib7	14506	11	(	(	-LRB-
cord-005453-4057qib7	14506	12	1	1	CD
cord-005453-4057qib7	14506	13	-	-	SYM
cord-005453-4057qib7	14506	14	11	11	CD
cord-005453-4057qib7	14506	15	)	)	-RRB-
cord-005453-4057qib7	14506	16	years	year	NNS
cord-005453-4057qib7	14507	1	and	and	CC
cord-005453-4057qib7	14507	2	the	the	DT
cord-005453-4057qib7	14507	3	majority	majority	NN
cord-005453-4057qib7	14507	4	of	of	IN
cord-005453-4057qib7	14507	5	patients	patient	NNS
cord-005453-4057qib7	14507	6	were	be	VBD
cord-005453-4057qib7	14507	7	boys	boy	NNS
cord-005453-4057qib7	14507	8	(	(	-LRB-
cord-005453-4057qib7	14507	9	31/51	31/51	CD
cord-005453-4057qib7	14507	10	,	,	,
cord-005453-4057qib7	14507	11	60.8	60.8	CD
cord-005453-4057qib7	14507	12	%	%	NN
cord-005453-4057qib7	14507	13	)	)	-RRB-
cord-005453-4057qib7	14507	14	.	.	.
cord-005453-4057qib7	14508	1	According	accord	VBG
cord-005453-4057qib7	14508	2	to	to	IN
cord-005453-4057qib7	14508	3	disease	disease	NN
cord-005453-4057qib7	14508	4	class	class	NN
cord-005453-4057qib7	14508	5	,	,	,
cord-005453-4057qib7	14508	6	the	the	DT
cord-005453-4057qib7	14508	7	patients	patient	NNS
cord-005453-4057qib7	14508	8	were	be	VBD
cord-005453-4057qib7	14508	9	most	most	RBS
cord-005453-4057qib7	14508	10	commonly	commonly	RB
cord-005453-4057qib7	14508	11	involved	involve	VBN
cord-005453-4057qib7	14508	12	with	with	IN
cord-005453-4057qib7	14508	13	non	non	JJ
cord-005453-4057qib7	14508	14	-	-	JJ
cord-005453-4057qib7	14508	15	malignant	malignant	JJ
cord-005453-4057qib7	14508	16	hematologic	hematologic	JJ
cord-005453-4057qib7	14508	17	diseases	disease	NNS
cord-005453-4057qib7	14508	18	(	(	-LRB-
cord-005453-4057qib7	14508	19	18/51	18/51	CD
cord-005453-4057qib7	14508	20	patients	patient	NNS
cord-005453-4057qib7	14508	21	,	,	,
cord-005453-4057qib7	14508	22	35.3	35.3	CD
cord-005453-4057qib7	14508	23	%	%	NN
cord-005453-4057qib7	14508	24	)	)	-RRB-
cord-005453-4057qib7	14509	1	(	(	-LRB-
cord-005453-4057qib7	14509	2	Figure	figure	NN
cord-005453-4057qib7	14509	3	)	)	-RRB-
cord-005453-4057qib7	14509	4	.	.	.
cord-005453-4057qib7	14510	1	The	the	DT
cord-005453-4057qib7	14510	2	source	source	NN
cord-005453-4057qib7	14510	3	of	of	IN
cord-005453-4057qib7	14510	4	HSCs	hscs	NN
cord-005453-4057qib7	14510	5	for	for	IN
cord-005453-4057qib7	14510	6	most	most	JJS
cord-005453-4057qib7	14510	7	patients	patient	NNS
cord-005453-4057qib7	14510	8	(	(	-LRB-
cord-005453-4057qib7	14510	9	48	48	CD
cord-005453-4057qib7	14510	10	cases	case	NNS
cord-005453-4057qib7	14510	11	,	,	,
cord-005453-4057qib7	14510	12	94.1	94.1	CD
cord-005453-4057qib7	14510	13	%	%	NN
cord-005453-4057qib7	14510	14	)	)	-RRB-
cord-005453-4057qib7	14510	15	was	be	VBD
cord-005453-4057qib7	14510	16	peripheral	peripheral	JJ
cord-005453-4057qib7	14510	17	blood	blood	NN
cord-005453-4057qib7	14510	18	and	and	CC
cord-005453-4057qib7	14510	19	for	for	IN
cord-005453-4057qib7	14510	20	only	only	RB
cord-005453-4057qib7	14510	21	3	3	CD
cord-005453-4057qib7	14510	22	patients	patient	NNS
cord-005453-4057qib7	14510	23	the	the	DT
cord-005453-4057qib7	14510	24	source	source	NN
cord-005453-4057qib7	14510	25	was	be	VBD
cord-005453-4057qib7	14510	26	bone	bone	NN
cord-005453-4057qib7	14510	27	marrow	marrow	NN
cord-005453-4057qib7	14510	28	.	.	.
cord-005453-4057qib7	14511	1	The	the	DT
cord-005453-4057qib7	14511	2	donors	donor	NNS
cord-005453-4057qib7	14511	3	for	for	IN
cord-005453-4057qib7	14511	4	50	50	CD
cord-005453-4057qib7	14511	5	patients	patient	NNS
cord-005453-4057qib7	14511	6	were	be	VBD
cord-005453-4057qib7	14511	7	fully	fully	RB
cord-005453-4057qib7	14511	8	matched	match	VBN
cord-005453-4057qib7	14511	9	and	and	CC
cord-005453-4057qib7	14511	10	only	only	RB
cord-005453-4057qib7	14511	11	one	one	CD
cord-005453-4057qib7	14511	12	patient	patient	NN
cord-005453-4057qib7	14511	13	received	receive	VBD
cord-005453-4057qib7	14511	14	the	the	DT
cord-005453-4057qib7	14511	15	HSCs	hscs	NN
cord-005453-4057qib7	14511	16	from	from	IN
cord-005453-4057qib7	14511	17	a	a	DT
cord-005453-4057qib7	14511	18	one	one	CD
cord-005453-4057qib7	14511	19	-	-	HYPH
cord-005453-4057qib7	14511	20	locus	locus	NN
cord-005453-4057qib7	14511	21	mismatched	mismatch	VBN
cord-005453-4057qib7	14511	22	donor	donor	NN
cord-005453-4057qib7	14511	23	.	.	.
cord-005453-4057qib7	14512	1	HSCT	HSCT	NNP
cord-005453-4057qib7	14512	2	was	be	VBD
cord-005453-4057qib7	14512	3	successful	successful	JJ
cord-005453-4057qib7	14512	4	in	in	IN
cord-005453-4057qib7	14512	5	50	50	CD
cord-005453-4057qib7	14512	6	patients	patient	NNS
cord-005453-4057qib7	14512	7	with	with	IN
cord-005453-4057qib7	14512	8	most	most	JJS
cord-005453-4057qib7	14512	9	of	of	IN
cord-005453-4057qib7	14512	10	them	-PRON-	PRP
cord-005453-4057qib7	14512	11	achieving	achieve	VBG
cord-005453-4057qib7	14512	12	full	full	JJ
cord-005453-4057qib7	14512	13	chimerism	chimerism	NN
cord-005453-4057qib7	14512	14	(	(	-LRB-
cord-005453-4057qib7	14512	15	44	44	CD
cord-005453-4057qib7	14512	16	patients	patient	NNS
cord-005453-4057qib7	14512	17	,	,	,
cord-005453-4057qib7	14512	18	86.2	86.2	CD
cord-005453-4057qib7	14512	19	%	%	NN
cord-005453-4057qib7	14512	20	)	)	-RRB-
cord-005453-4057qib7	14512	21	followed	follow	VBN
cord-005453-4057qib7	14512	22	by	by	IN
cord-005453-4057qib7	14512	23	those	those	DT
cord-005453-4057qib7	14512	24	developing	develop	VBG
cord-005453-4057qib7	14512	25	mixed	mixed	JJ
cord-005453-4057qib7	14512	26	chimerism	chimerism	NN
cord-005453-4057qib7	14512	27	(	(	-LRB-
cord-005453-4057qib7	14513	1	6	6	CD
cord-005453-4057qib7	14513	2	patients	patient	NNS
cord-005453-4057qib7	14513	3	,	,	,
cord-005453-4057qib7	14513	4	11.8	11.8	CD
cord-005453-4057qib7	14513	5	%	%	NN
cord-005453-4057qib7	14513	6	)	)	-RRB-
cord-005453-4057qib7	14513	7	and	and	CC
cord-005453-4057qib7	14513	8	only	only	RB
cord-005453-4057qib7	14513	9	one	one	CD
cord-005453-4057qib7	14513	10	patient	patient	NN
cord-005453-4057qib7	14513	11	(	(	-LRB-
cord-005453-4057qib7	14513	12	2	2	CD
cord-005453-4057qib7	14513	13	%	%	NN
cord-005453-4057qib7	14513	14	)	)	-RRB-
cord-005453-4057qib7	14513	15	experienced	experienced	JJ
cord-005453-4057qib7	14513	16	graft	graft	NN
cord-005453-4057qib7	14513	17	failure	failure	NN
cord-005453-4057qib7	14513	18	.	.	.
cord-005453-4057qib7	14514	1	Post	post	JJ
cord-005453-4057qib7	14514	2	-	-	JJ
cord-005453-4057qib7	14514	3	HSCT	hsct	JJ
cord-005453-4057qib7	14514	4	complications	complication	NNS
cord-005453-4057qib7	14514	5	included	include	VBD
cord-005453-4057qib7	14514	6	CMV	CMV	NNP
cord-005453-4057qib7	14514	7	infection	infection	NN
cord-005453-4057qib7	14514	8	in	in	IN
cord-005453-4057qib7	14514	9	34	34	CD
cord-005453-4057qib7	14514	10	patients	patient	NNS
cord-005453-4057qib7	14514	11	(	(	-LRB-
cord-005453-4057qib7	14514	12	66.7	66.7	CD
cord-005453-4057qib7	14514	13	%	%	NN
cord-005453-4057qib7	14514	14	)	)	-RRB-
cord-005453-4057qib7	14514	15	,	,	,
cord-005453-4057qib7	14514	16	other	other	JJ
cord-005453-4057qib7	14514	17	infections	infection	NNS
cord-005453-4057qib7	14514	18	in	in	IN
cord-005453-4057qib7	14514	19	7	7	CD
cord-005453-4057qib7	14514	20	(	(	-LRB-
cord-005453-4057qib7	14514	21	13.7	13.7	CD
cord-005453-4057qib7	14514	22	%	%	NN
cord-005453-4057qib7	14514	23	)	)	-RRB-
cord-005453-4057qib7	14514	24	,	,	,
cord-005453-4057qib7	14514	25	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	14514	26	cystitis	cystitis	NN
cord-005453-4057qib7	14514	27	in	in	IN
cord-005453-4057qib7	14514	28	3	3	CD
cord-005453-4057qib7	14514	29	(	(	-LRB-
cord-005453-4057qib7	14514	30	5.9	5.9	CD
cord-005453-4057qib7	14514	31	%	%	NN
cord-005453-4057qib7	14514	32	)	)	-RRB-
cord-005453-4057qib7	14514	33	and	and	CC
cord-005453-4057qib7	14514	34	PRES	PRES	NNP
cord-005453-4057qib7	14514	35	in	in	IN
cord-005453-4057qib7	14514	36	2	2	CD
cord-005453-4057qib7	14514	37	(	(	-LRB-
cord-005453-4057qib7	14514	38	3.9	3.9	CD
cord-005453-4057qib7	14514	39	%	%	NN
cord-005453-4057qib7	14514	40	)	)	-RRB-
cord-005453-4057qib7	14514	41	.	.	.
cord-005453-4057qib7	14515	1	Acute	acute	JJ
cord-005453-4057qib7	14515	2	GvHD	gvhd	NN
cord-005453-4057qib7	14515	3	occurred	occur	VBD
cord-005453-4057qib7	14515	4	in	in	IN
cord-005453-4057qib7	14515	5	22	22	CD
cord-005453-4057qib7	14515	6	patients	patient	NNS
cord-005453-4057qib7	14515	7	(	(	-LRB-
cord-005453-4057qib7	14515	8	43.1	43.1	CD
cord-005453-4057qib7	14515	9	%	%	NN
cord-005453-4057qib7	14515	10	)	)	-RRB-
cord-005453-4057qib7	14515	11	and	and	CC
cord-005453-4057qib7	14515	12	chronic	chronic	JJ
cord-005453-4057qib7	14515	13	GvHD	gvhd	NN
cord-005453-4057qib7	14515	14	in	in	IN
cord-005453-4057qib7	14515	15	3	3	CD
cord-005453-4057qib7	14515	16	(	(	-LRB-
cord-005453-4057qib7	14515	17	5.9	5.9	CD
cord-005453-4057qib7	14515	18	%	%	NN
cord-005453-4057qib7	14515	19	)	)	-RRB-
cord-005453-4057qib7	14515	20	.	.	.
cord-005453-4057qib7	14516	1	Death	death	NN
cord-005453-4057qib7	14516	2	occurred	occur	VBD
cord-005453-4057qib7	14516	3	in	in	IN
cord-005453-4057qib7	14516	4	7	7	CD
cord-005453-4057qib7	14516	5	cases	case	NNS
cord-005453-4057qib7	14516	6	and	and	CC
cord-005453-4057qib7	14516	7	5	5	CD
cord-005453-4057qib7	14516	8	of	of	IN
cord-005453-4057qib7	14516	9	them	-PRON-	PRP
cord-005453-4057qib7	14516	10	were	be	VBD
cord-005453-4057qib7	14516	11	transplant	transplant	NN
cord-005453-4057qib7	14516	12	-	-	HYPH
cord-005453-4057qib7	14516	13	related	relate	VBN
cord-005453-4057qib7	14516	14	,	,	,
cord-005453-4057qib7	14516	15	while	while	IN
cord-005453-4057qib7	14516	16	1	1	CD
cord-005453-4057qib7	14516	17	was	be	VBD
cord-005453-4057qib7	14516	18	due	due	JJ
cord-005453-4057qib7	14516	19	to	to	IN
cord-005453-4057qib7	14516	20	disease	disease	NN
cord-005453-4057qib7	14516	21	relapse	relapse	NN
cord-005453-4057qib7	14516	22	and	and	CC
cord-005453-4057qib7	14516	23	1	1	CD
cord-005453-4057qib7	14516	24	due	due	JJ
cord-005453-4057qib7	14516	25	to	to	IN
cord-005453-4057qib7	14516	26	graft	graft	NN
cord-005453-4057qib7	14516	27	failure	failure	NN
cord-005453-4057qib7	14516	28	.	.	.
cord-005453-4057qib7	14517	1	The	the	DT
cord-005453-4057qib7	14517	2	median	median	NN
cord-005453-4057qib7	14517	3	of	of	IN
cord-005453-4057qib7	14517	4	overall	overall	JJ
cord-005453-4057qib7	14517	5	survival	survival	NN
cord-005453-4057qib7	14517	6	was	be	VBD
cord-005453-4057qib7	14517	7	469	469	CD
cord-005453-4057qib7	14517	8	(	(	-LRB-
cord-005453-4057qib7	14517	9	40	40	CD
cord-005453-4057qib7	14517	10	-	-	SYM
cord-005453-4057qib7	14517	11	792	792	CD
cord-005453-4057qib7	14517	12	)	)	-RRB-
cord-005453-4057qib7	14517	13	days	day	NNS
cord-005453-4057qib7	14517	14	.	.	.
cord-005453-4057qib7	14518	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14518	2	:	:	:
cord-005453-4057qib7	14519	1	The	the	DT
cord-005453-4057qib7	14519	2	likelihood	likelihood	NN
cord-005453-4057qib7	14519	3	of	of	IN
cord-005453-4057qib7	14519	4	receiving	receive	VBG
cord-005453-4057qib7	14519	5	HSCs	hscs	NN
cord-005453-4057qib7	14519	6	from	from	IN
cord-005453-4057qib7	14519	7	an	an	DT
cord-005453-4057qib7	14519	8	HLA	HLA	NNP
cord-005453-4057qib7	14519	9	-	-	HYPH
cord-005453-4057qib7	14519	10	matched	match	VBN
cord-005453-4057qib7	14519	11	other	other	JJ
cord-005453-4057qib7	14519	12	-	-	HYPH
cord-005453-4057qib7	14519	13	relative	relative	JJ
cord-005453-4057qib7	14519	14	donor	donor	NN
cord-005453-4057qib7	14519	15	in	in	IN
cord-005453-4057qib7	14519	16	one	one	CD
cord-005453-4057qib7	14519	17	-	-	HYPH
cord-005453-4057qib7	14519	18	thirds	third	NNS
cord-005453-4057qib7	14519	19	of	of	IN
cord-005453-4057qib7	14519	20	children	child	NNS
cord-005453-4057qib7	14519	21	undergoing	undergo	VBG
cord-005453-4057qib7	14519	22	allo	allo	NN
cord-005453-4057qib7	14519	23	-	-	HYPH
cord-005453-4057qib7	14519	24	HSCT	HSCT	NNP
cord-005453-4057qib7	14519	25	,	,	,
cord-005453-4057qib7	14519	26	with	with	IN
cord-005453-4057qib7	14519	27	comparable	comparable	JJ
cord-005453-4057qib7	14519	28	outcomes	outcome	NNS
cord-005453-4057qib7	14519	29	to	to	IN
cord-005453-4057qib7	14519	30	sibling	sibling	NN
cord-005453-4057qib7	14519	31	and	and	CC
cord-005453-4057qib7	14519	32	unrelated	unrelated	JJ
cord-005453-4057qib7	14519	33	donors	donor	NNS
cord-005453-4057qib7	14519	34	(	(	-LRB-
cord-005453-4057qib7	14519	35	as	as	IN
cord-005453-4057qib7	14519	36	evidenced	evidence	VBN
cord-005453-4057qib7	14519	37	in	in	IN
cord-005453-4057qib7	14519	38	this	this	DT
cord-005453-4057qib7	14519	39	study	study	NN
cord-005453-4057qib7	14519	40	compared	compare	VBN
cord-005453-4057qib7	14519	41	with	with	IN
cord-005453-4057qib7	14519	42	other	other	JJ
cord-005453-4057qib7	14519	43	studies	study	NNS
cord-005453-4057qib7	14519	44	)	)	-RRB-
cord-005453-4057qib7	14519	45	,	,	,
cord-005453-4057qib7	14519	46	introduces	introduce	VBZ
cord-005453-4057qib7	14519	47	family	family	NN
cord-005453-4057qib7	14519	48	bank	bank	NN
cord-005453-4057qib7	14519	49	as	as	IN
cord-005453-4057qib7	14519	50	a	a	DT
cord-005453-4057qib7	14519	51	reliable	reliable	JJ
cord-005453-4057qib7	14519	52	source	source	NN
cord-005453-4057qib7	14519	53	for	for	IN
cord-005453-4057qib7	14519	54	pediatric	pediatric	JJ
cord-005453-4057qib7	14519	55	allo	allo	NN
cord-005453-4057qib7	14519	56	-	-	HYPH
cord-005453-4057qib7	14519	57	HSCT	HSCT	NNP
cord-005453-4057qib7	14519	58	in	in	IN
cord-005453-4057qib7	14519	59	countries	country	NNS
cord-005453-4057qib7	14519	60	with	with	IN
cord-005453-4057qib7	14519	61	culturally	culturally	RB
cord-005453-4057qib7	14519	62	accepted	accept	VBN
cord-005453-4057qib7	14519	63	cousin	cousin	NN
cord-005453-4057qib7	14519	64	-	-	HYPH
cord-005453-4057qib7	14519	65	cousin	cousin	NN
cord-005453-4057qib7	14519	66	marriages	marriage	NNS
cord-005453-4057qib7	14519	67	.	.	.
cord-005453-4057qib7	14520	1	Hence	hence	RB
cord-005453-4057qib7	14520	2	,	,	,
cord-005453-4057qib7	14520	3	for	for	IN
cord-005453-4057qib7	14520	4	transplant	transplant	NN
cord-005453-4057qib7	14520	5	physicians	physician	NNS
cord-005453-4057qib7	14520	6	,	,	,
cord-005453-4057qib7	14520	7	parental	parental	JJ
cord-005453-4057qib7	14520	8	consanguinity	consanguinity	NN
cord-005453-4057qib7	14520	9	would	would	MD
cord-005453-4057qib7	14520	10	be	be	VB
cord-005453-4057qib7	14520	11	an	an	DT
cord-005453-4057qib7	14520	12	indication	indication	NN
cord-005453-4057qib7	14520	13	of	of	IN
cord-005453-4057qib7	14520	14	an	an	DT
cord-005453-4057qib7	14520	15	extended	extended	JJ
cord-005453-4057qib7	14520	16	search	search	NN
cord-005453-4057qib7	14520	17	for	for	IN
cord-005453-4057qib7	14520	18	a	a	DT
cord-005453-4057qib7	14520	19	potential	potential	JJ
cord-005453-4057qib7	14520	20	matched	match	VBN
cord-005453-4057qib7	14520	21	donor	donor	NN
cord-005453-4057qib7	14520	22	among	among	IN
cord-005453-4057qib7	14520	23	the	the	DT
cord-005453-4057qib7	14520	24	patient	patient	NN
cord-005453-4057qib7	14520	25	's	's	POS
cord-005453-4057qib7	14520	26	family	family	NN
cord-005453-4057qib7	14520	27	.	.	.
cord-005453-4057qib7	14521	1	[	[	-LRB-
cord-005453-4057qib7	14521	2	[	[	-LRB-
cord-005453-4057qib7	14521	3	P674	P674	NNP
cord-005453-4057qib7	14521	4	Image	image	NN
cord-005453-4057qib7	14521	5	]	]	-RRB-
cord-005453-4057qib7	14521	6	1	1	CD
cord-005453-4057qib7	14521	7	.	.	.
cord-005453-4057qib7	14522	1	Distribution	distribution	NN
cord-005453-4057qib7	14522	2	of	of	IN
cord-005453-4057qib7	14522	3	patients	patient	NNS
cord-005453-4057qib7	14522	4	according	accord	VBG
cord-005453-4057qib7	14522	5	to	to	IN
cord-005453-4057qib7	14522	6	disease	disease	NN
cord-005453-4057qib7	14522	7	and	and	CC
cord-005453-4057qib7	14522	8	disease	disease	NN
cord-005453-4057qib7	14522	9	class	class	NN
cord-005453-4057qib7	14522	10	]	]	-RRB-
cord-005453-4057qib7	14523	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14523	2	:	:	:
cord-005453-4057qib7	14523	3	Nothing	nothing	NN
cord-005453-4057qib7	14523	4	to	to	TO
cord-005453-4057qib7	14523	5	declare	declare	VB
cord-005453-4057qib7	14523	6	.	.	.
cord-005453-4057qib7	14524	1	Abstract	Abstract	NNP
cord-005453-4057qib7	14524	2	already	already	RB
cord-005453-4057qib7	14524	3	published	publish	VBN
cord-005453-4057qib7	14524	4	.	.	.
cord-005453-4057qib7	14525	1	Update	update	NN
cord-005453-4057qib7	14525	2	on	on	IN
cord-005453-4057qib7	14525	3	the	the	DT
cord-005453-4057qib7	14525	4	HLA	HLA	NNP
cord-005453-4057qib7	14525	5	frequency	frequency	NN
cord-005453-4057qib7	14525	6	distribution	distribution	NN
cord-005453-4057qib7	14525	7	of	of	IN
cord-005453-4057qib7	14525	8	the	the	DT
cord-005453-4057qib7	14525	9	portuguese	portuguese	JJ
cord-005453-4057qib7	14525	10	bone	bone	NN
cord-005453-4057qib7	14525	11	marrow	marrow	NN
cord-005453-4057qib7	14525	12	donor	donor	NN
cord-005453-4057qib7	14525	13	registry	registry	NN
cord-005453-4057qib7	14525	14	Eduardo	Eduardo	NNP
cord-005453-4057qib7	14525	15	Espada	Espada	NNP
cord-005453-4057qib7	14525	16	1	1	CD
cord-005453-4057qib7	14525	17	,	,	,
cord-005453-4057qib7	14525	18	Dário	Dário	NNP
cord-005453-4057qib7	14525	19	Ligeiro	Ligeiro	NNP
cord-005453-4057qib7	14525	20	2	2	CD
cord-005453-4057qib7	14525	21	,	,	,
cord-005453-4057qib7	14525	22	Hélder	Hélder	NNP
cord-005453-4057qib7	14525	23	Trindade	Trindade	NNP
cord-005453-4057qib7	14525	24	2	2	CD
cord-005453-4057qib7	14525	25	,	,	,
cord-005453-4057qib7	14525	26	João	João	NNP
cord-005453-4057qib7	14525	27	Forjaz	Forjaz	NNP
cord-005453-4057qib7	14525	28	de	de	NNP
cord-005453-4057qib7	14525	29	Lacerda	Lacerda	NNP
cord-005453-4057qib7	14525	30	1	1	CD
cord-005453-4057qib7	14525	31	frequency	frequency	NN
cord-005453-4057qib7	14525	32	distribution	distribution	NN
cord-005453-4057qib7	14525	33	varied	vary	VBN
cord-005453-4057qib7	14525	34	throughout	throughout	IN
cord-005453-4057qib7	14525	35	the	the	DT
cord-005453-4057qib7	14525	36	country	country	NN
cord-005453-4057qib7	14525	37	,	,	,
cord-005453-4057qib7	14525	38	allowing	allow	VBG
cord-005453-4057qib7	14525	39	for	for	IN
cord-005453-4057qib7	14525	40	analyses	analysis	NNS
cord-005453-4057qib7	14525	41	of	of	IN
cord-005453-4057qib7	14525	42	molecular	molecular	JJ
cord-005453-4057qib7	14525	43	variance	variance	NN
cord-005453-4057qib7	14525	44	and	and	CC
cord-005453-4057qib7	14525	45	generation	generation	NN
cord-005453-4057qib7	14525	46	of	of	IN
cord-005453-4057qib7	14525	47	relatively	relatively	RB
cord-005453-4057qib7	14525	48	geographically	geographically	RB
cord-005453-4057qib7	14525	49	accurate	accurate	JJ
cord-005453-4057qib7	14525	50	graphical	graphical	JJ
cord-005453-4057qib7	14525	51	representations	representation	NNS
cord-005453-4057qib7	14525	52	of	of	IN
cord-005453-4057qib7	14525	53	genetic	genetic	JJ
cord-005453-4057qib7	14525	54	distances	distance	NNS
cord-005453-4057qib7	14525	55	between	between	IN
cord-005453-4057qib7	14525	56	regions	region	NNS
cord-005453-4057qib7	14525	57	and	and	CC
cord-005453-4057qib7	14525	58	districts	district	NNS
cord-005453-4057qib7	14525	59	.	.	.
cord-005453-4057qib7	14526	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14526	2	:	:	:
cord-005453-4057qib7	14527	1	With	with	IN
cord-005453-4057qib7	14527	2	the	the	DT
cord-005453-4057qib7	14527	3	most	most	RBS
cord-005453-4057qib7	14527	4	recent	recent	JJ
cord-005453-4057qib7	14527	5	HLA	HLA	NNP
cord-005453-4057qib7	14527	6	analysis	analysis	NN
cord-005453-4057qib7	14527	7	of	of	IN
cord-005453-4057qib7	14527	8	the	the	DT
cord-005453-4057qib7	14527	9	Portuguese	portuguese	JJ
cord-005453-4057qib7	14527	10	Bone	Bone	NNP
cord-005453-4057qib7	14527	11	Marrow	Marrow	NNP
cord-005453-4057qib7	14527	12	Donor	Donor	NNP
cord-005453-4057qib7	14527	13	Registry	Registry	NNP
cord-005453-4057qib7	14527	14	we	-PRON-	PRP
cord-005453-4057qib7	14527	15	were	be	VBD
cord-005453-4057qib7	14527	16	able	able	JJ
cord-005453-4057qib7	14527	17	to	to	TO
cord-005453-4057qib7	14527	18	extrapolate	extrapolate	VB
cord-005453-4057qib7	14527	19	high	high	JJ
cord-005453-4057qib7	14527	20	-	-	HYPH
cord-005453-4057qib7	14527	21	resolution	resolution	NN
cord-005453-4057qib7	14527	22	haplotype	haplotype	NN
cord-005453-4057qib7	14527	23	frequencies	frequency	NNS
cord-005453-4057qib7	14527	24	from	from	IN
cord-005453-4057qib7	14527	25	the	the	DT
cord-005453-4057qib7	14527	26	most	most	RBS
cord-005453-4057qib7	14527	27	common	common	JJ
cord-005453-4057qib7	14527	28	low	low	JJ
cord-005453-4057qib7	14527	29	-	-	HYPH
cord-005453-4057qib7	14527	30	resolution	resolution	NN
cord-005453-4057qib7	14527	31	HLA	HLA	NNP
cord-005453-4057qib7	14528	1	-A/-B/-DRB1	-A/-B/-DRB1	NNP
cord-005453-4057qib7	14528	2	haplotypes	haplotype	NNS
cord-005453-4057qib7	14528	3	(	(	-LRB-
cord-005453-4057qib7	14528	4	corresponding	correspond	VBG
cord-005453-4057qib7	14528	5	to	to	IN
cord-005453-4057qib7	14528	6	50	50	CD
cord-005453-4057qib7	14528	7	%	%	NN
cord-005453-4057qib7	14528	8	of	of	IN
cord-005453-4057qib7	14528	9	the	the	DT
cord-005453-4057qib7	14528	10	estimated	estimate	VBN
cord-005453-4057qib7	14528	11	haplotypes	haplotype	NNS
cord-005453-4057qib7	14528	12	at	at	IN
cord-005453-4057qib7	14528	13	that	that	DT
cord-005453-4057qib7	14528	14	level	level	NN
cord-005453-4057qib7	14528	15	)	)	-RRB-
cord-005453-4057qib7	14528	16	,	,	,
cord-005453-4057qib7	14528	17	which	which	WDT
cord-005453-4057qib7	14528	18	will	will	MD
cord-005453-4057qib7	14528	19	lead	lead	VB
cord-005453-4057qib7	14528	20	to	to	IN
cord-005453-4057qib7	14528	21	an	an	DT
cord-005453-4057qib7	14528	22	optimization	optimization	NN
cord-005453-4057qib7	14528	23	of	of	IN
cord-005453-4057qib7	14528	24	its	-PRON-	PRP$
cord-005453-4057qib7	14528	25	use	use	NN
cord-005453-4057qib7	14528	26	,	,	,
cord-005453-4057qib7	14528	27	hopefully	hopefully	RB
cord-005453-4057qib7	14528	28	limiting	limit	VBG
cord-005453-4057qib7	14528	29	the	the	DT
cord-005453-4057qib7	14528	30	time	time	NN
cord-005453-4057qib7	14528	31	between	between	IN
cord-005453-4057qib7	14528	32	donor	donor	NN
cord-005453-4057qib7	14528	33	search	search	NN
cord-005453-4057qib7	14528	34	and	and	CC
cord-005453-4057qib7	14528	35	allogeneic	allogeneic	IN
cord-005453-4057qib7	14528	36	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14528	37	stem	stem	NN
cord-005453-4057qib7	14528	38	cell	cell	NN
cord-005453-4057qib7	14528	39	transplant	transplant	NN
cord-005453-4057qib7	14528	40	.	.	.
cord-005453-4057qib7	14529	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14529	2	:	:	:
cord-005453-4057qib7	14529	3	Nothing	nothing	NN
cord-005453-4057qib7	14529	4	to	to	TO
cord-005453-4057qib7	14529	5	declare	declare	VB
cord-005453-4057qib7	14529	6	.	.	.
cord-005453-4057qib7	14530	1	Abstract	Abstract	NNP
cord-005453-4057qib7	14530	2	already	already	RB
cord-005453-4057qib7	14530	3	published	publish	VBN
cord-005453-4057qib7	14530	4	.	.	.
cord-005453-4057qib7	14531	1	Abstract	Abstract	NNP
cord-005453-4057qib7	14531	2	already	already	RB
cord-005453-4057qib7	14531	3	published	publish	VBN
cord-005453-4057qib7	14531	4	.	.	.
cord-005453-4057qib7	14532	1	Unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	14532	2	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14532	3	donor	donor	NN
cord-005453-4057qib7	14532	4	transplantation	transplantation	NN
cord-005453-4057qib7	14532	5	compared	compare	VBN
cord-005453-4057qib7	14532	6	to	to	IN
cord-005453-4057qib7	14532	7	identical	identical	JJ
cord-005453-4057qib7	14532	8	sibling	sibling	NN
cord-005453-4057qib7	14532	9	donor	donor	NN
cord-005453-4057qib7	14532	10	had	have	VBD
cord-005453-4057qib7	14532	11	better	well	JJR
cord-005453-4057qib7	14532	12	antileukemia	antileukemia	NN
cord-005453-4057qib7	14532	13	effect	effect	NN
cord-005453-4057qib7	14532	14	for	for	IN
cord-005453-4057qib7	14532	15	refractory	refractory	JJ
cord-005453-4057qib7	14532	16	/	/	SYM
cord-005453-4057qib7	14532	17	relapsed	relapse	VBD
cord-005453-4057qib7	14532	18	acute	acute	JJ
cord-005453-4057qib7	14532	19	myeloid	myeloid	NN
cord-005453-4057qib7	14532	20	leukemia	leukemia	NN
cord-005453-4057qib7	14532	21	in	in	IN
cord-005453-4057qib7	14532	22	not	not	RB
cord-005453-4057qib7	14532	23	remission	remission	NN
cord-005453-4057qib7	14532	24	status	status	NN
cord-005453-4057qib7	14532	25	Background	background	NN
cord-005453-4057qib7	14532	26	:	:	:
cord-005453-4057qib7	14533	1	Patients	patient	NNS
cord-005453-4057qib7	14533	2	diagnosed	diagnose	VBN
cord-005453-4057qib7	14533	3	with	with	IN
cord-005453-4057qib7	14533	4	SAA	SAA	NNP
cord-005453-4057qib7	14533	5	with	with	IN
cord-005453-4057qib7	14533	6	no	no	DT
cord-005453-4057qib7	14533	7	sibling	sibling	NN
cord-005453-4057qib7	14533	8	donors	donor	NNS
cord-005453-4057qib7	14533	9	and	and	CC
cord-005453-4057qib7	14533	10	who	who	WP
cord-005453-4057qib7	14533	11	are	be	VBP
cord-005453-4057qib7	14533	12	refractory	refractory	JJ
cord-005453-4057qib7	14533	13	to	to	IN
cord-005453-4057qib7	14533	14	immunosupression	immunosupression	NN
cord-005453-4057qib7	14534	1	are	be	VBP
cord-005453-4057qib7	14534	2	candidates	candidate	NNS
cord-005453-4057qib7	14534	3	to	to	IN
cord-005453-4057qib7	14534	4	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	14534	5	Stem	Stem	NNP
cord-005453-4057qib7	14534	6	Cell	Cell	NNP
cord-005453-4057qib7	14534	7	Transplant	transplant	NN
cord-005453-4057qib7	14534	8	using	use	VBG
cord-005453-4057qib7	14534	9	alternative	alternative	JJ
cord-005453-4057qib7	14534	10	donors	donor	NNS
cord-005453-4057qib7	14534	11	.	.	.
cord-005453-4057qib7	14535	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	14535	2	donor	donor	NN
cord-005453-4057qib7	14535	3	transplants	transplant	NNS
cord-005453-4057qib7	14535	4	has	have	VBZ
cord-005453-4057qib7	14535	5	been	be	VBN
cord-005453-4057qib7	14535	6	reported	report	VBN
cord-005453-4057qib7	14535	7	using	use	VBG
cord-005453-4057qib7	14535	8	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	14535	9	(	(	-LRB-
cord-005453-4057qib7	14535	10	Cy	Cy	NNP
cord-005453-4057qib7	14535	11	)	)	-RRB-
cord-005453-4057qib7	14535	12	post	post	JJ
cord-005453-4057qib7	14535	13	stem	stem	NN
cord-005453-4057qib7	14535	14	cell	cell	NN
cord-005453-4057qib7	14535	15	infusion	infusion	NN
cord-005453-4057qib7	14535	16	as	as	IN
cord-005453-4057qib7	14535	17	immunephrophylaxis	immunephrophylaxis	NNP
cord-005453-4057qib7	14535	18	.	.	.
cord-005453-4057qib7	14536	1	The	the	DT
cord-005453-4057qib7	14536	2	present	present	JJ
cord-005453-4057qib7	14536	3	study	study	NN
cord-005453-4057qib7	14536	4	has	have	VBZ
cord-005453-4057qib7	14536	5	the	the	DT
cord-005453-4057qib7	14536	6	objective	objective	NN
cord-005453-4057qib7	14536	7	of	of	IN
cord-005453-4057qib7	14536	8	evaluating	evaluate	VBG
cord-005453-4057qib7	14536	9	overall	overall	JJ
cord-005453-4057qib7	14536	10	survival	survival	NN
cord-005453-4057qib7	14536	11	and	and	CC
cord-005453-4057qib7	14536	12	engraftment	engraftment	NN
cord-005453-4057qib7	14536	13	rates	rate	NNS
cord-005453-4057qib7	14536	14	after	after	IN
cord-005453-4057qib7	14536	15	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	14536	16	stem	stem	NN
cord-005453-4057qib7	14536	17	cell	cell	NN
cord-005453-4057qib7	14536	18	transplant	transplant	NN
cord-005453-4057qib7	14536	19	for	for	IN
cord-005453-4057qib7	14536	20	SAA	SAA	NNP
cord-005453-4057qib7	14536	21	in	in	IN
cord-005453-4057qib7	14536	22	a	a	DT
cord-005453-4057qib7	14536	23	reference	reference	NN
cord-005453-4057qib7	14536	24	center	center	NN
cord-005453-4057qib7	14536	25	.	.	.
cord-005453-4057qib7	14537	1	Methods	method	NNS
cord-005453-4057qib7	14537	2	:	:	:
cord-005453-4057qib7	14537	3	15	15	CD
cord-005453-4057qib7	14537	4	SAA	SAA	NNP
cord-005453-4057qib7	14537	5	adult	adult	NN
cord-005453-4057qib7	14537	6	patients	patient	NNS
cord-005453-4057qib7	14537	7	(	(	-LRB-
cord-005453-4057qib7	14537	8	≥15	≥15	NNP
cord-005453-4057qib7	14537	9	yo	yo	NNP
cord-005453-4057qib7	14537	10	)	)	-RRB-
cord-005453-4057qib7	14537	11	received	receive	VBD
cord-005453-4057qib7	14537	12	HSCT	HSCT	NNP
cord-005453-4057qib7	14537	13	from	from	IN
cord-005453-4057qib7	14537	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14537	15	donors	donor	NNS
cord-005453-4057qib7	14537	16	from	from	IN
cord-005453-4057qib7	14537	17	de	de	NNP
cord-005453-4057qib7	14537	18	January/2010	January/2010	NNP
cord-005453-4057qib7	14538	1	to	to	IN
cord-005453-4057qib7	14538	2	August/2018	August/2018	NNP
cord-005453-4057qib7	14538	3	.	.	.
cord-005453-4057qib7	14539	1	Median	median	JJ
cord-005453-4057qib7	14539	2	age	age	NN
cord-005453-4057qib7	14539	3	was	be	VBD
cord-005453-4057qib7	14539	4	19	19	CD
cord-005453-4057qib7	14539	5	y	y	NN
cord-005453-4057qib7	14539	6	(	(	-LRB-
cord-005453-4057qib7	14539	7	15	15	CD
cord-005453-4057qib7	14539	8	-	-	SYM
cord-005453-4057qib7	14539	9	28	28	CD
cord-005453-4057qib7	14539	10	)	)	-RRB-
cord-005453-4057qib7	14539	11	;	;	:
cord-005453-4057qib7	14539	12	Donor	Donor	NNP
cord-005453-4057qib7	14539	13	was	be	VBD
cord-005453-4057qib7	14539	14	the	the	DT
cord-005453-4057qib7	14539	15	father	father	NN
cord-005453-4057qib7	14539	16	in	in	IN
cord-005453-4057qib7	14539	17	six	six	CD
cord-005453-4057qib7	14539	18	,	,	,
cord-005453-4057qib7	14539	19	mother	mother	NN
cord-005453-4057qib7	14539	20	in	in	IN
cord-005453-4057qib7	14539	21	five	five	CD
cord-005453-4057qib7	14539	22	and	and	CC
cord-005453-4057qib7	14539	23	a	a	DT
cord-005453-4057qib7	14539	24	brother	brother	NN
cord-005453-4057qib7	14539	25	in	in	IN
cord-005453-4057qib7	14539	26	four	four	CD
cord-005453-4057qib7	14539	27	cases	case	NNS
cord-005453-4057qib7	14539	28	.	.	.
cord-005453-4057qib7	14540	1	Stem	stem	JJ
cord-005453-4057qib7	14540	2	cell	cell	NN
cord-005453-4057qib7	14540	3	source	source	NN
cord-005453-4057qib7	14540	4	was	be	VBD
cord-005453-4057qib7	14540	5	marrow	marrow	NN
cord-005453-4057qib7	14540	6	in	in	IN
cord-005453-4057qib7	14540	7	13	13	CD
cord-005453-4057qib7	14540	8	cases	case	NNS
cord-005453-4057qib7	14540	9	(	(	-LRB-
cord-005453-4057qib7	14540	10	87	87	CD
cord-005453-4057qib7	14540	11	%	%	NN
cord-005453-4057qib7	14540	12	)	)	-RRB-
cord-005453-4057qib7	14540	13	.	.	.
cord-005453-4057qib7	14541	1	Conditioning	conditioning	NN
cord-005453-4057qib7	14541	2	:	:	:
cord-005453-4057qib7	14541	3	10	10	CD
cord-005453-4057qib7	14541	4	patients	patient	NNS
cord-005453-4057qib7	14541	5	(	(	-LRB-
cord-005453-4057qib7	14541	6	67	67	CD
cord-005453-4057qib7	14541	7	%	%	NN
cord-005453-4057qib7	14541	8	)	)	-RRB-
cord-005453-4057qib7	14541	9	received	receive	VBD
cord-005453-4057qib7	14541	10	Cy	Cy	NNP
cord-005453-4057qib7	14541	11	29mg	29mg	NNP
cord-005453-4057qib7	14541	12	/	/	SYM
cord-005453-4057qib7	14541	13	kg	kg	NN
cord-005453-4057qib7	14541	14	,	,	,
cord-005453-4057qib7	14541	15	fludarabine	fludarabine	NNP
cord-005453-4057qib7	14541	16	30mg	30mg	NNP
cord-005453-4057qib7	14541	17	/	/	SYM
cord-005453-4057qib7	14541	18	m²	m²	NNP
cord-005453-4057qib7	14541	19	e	e	NNP
cord-005453-4057qib7	14541	20	TBI	TBI	NNP
cord-005453-4057qib7	14541	21	200cGy	200cgy	NN
cord-005453-4057qib7	14541	22	.	.	.
cord-005453-4057qib7	14542	1	The	the	DT
cord-005453-4057qib7	14542	2	remaining	remain	VBG
cord-005453-4057qib7	14542	3	received	receive	VBD
cord-005453-4057qib7	14542	4	the	the	DT
cord-005453-4057qib7	14542	5	same	same	JJ
cord-005453-4057qib7	14542	6	drugs	drug	NNS
cord-005453-4057qib7	14542	7	but	but	CC
cord-005453-4057qib7	14542	8	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	14542	9	dose	dose	NN
cord-005453-4057qib7	14542	10	varied	varied	JJ
cord-005453-4057qib7	14542	11	from	from	IN
cord-005453-4057qib7	14542	12	300	300	CD
cord-005453-4057qib7	14542	13	-	-	HYPH
cord-005453-4057qib7	14542	14	400cGy	400cgy	CD
cord-005453-4057qib7	14542	15	,	,	,
cord-005453-4057qib7	14542	16	All	all	DT
cord-005453-4057qib7	14542	17	them	-PRON-	PRP
cord-005453-4057qib7	14542	18	received	receive	VBD
cord-005453-4057qib7	14542	19	immunephrophylaxis	immunephrophylaxis	JJ
cord-005453-4057qib7	14542	20	with	with	IN
cord-005453-4057qib7	14542	21	post	post	NN
cord-005453-4057qib7	14542	22	transplant	transplant	NN
cord-005453-4057qib7	14542	23	CY	CY	NNP
cord-005453-4057qib7	14542	24	100mg	100mg	NNP
cord-005453-4057qib7	14542	25	/	/	SYM
cord-005453-4057qib7	14542	26	Kg	Kg	NNP
cord-005453-4057qib7	14542	27	,	,	,
cord-005453-4057qib7	14542	28	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	14542	29	and	and	CC
cord-005453-4057qib7	14542	30	MMF	mmf	NN
cord-005453-4057qib7	14542	31	.	.	.
cord-005453-4057qib7	14543	1	Median	median	NN
cord-005453-4057qib7	14543	2	of	of	IN
cord-005453-4057qib7	14543	3	infused	infuse	VBN
cord-005453-4057qib7	14543	4	cells	cell	NNS
cord-005453-4057qib7	14543	5	(	(	-LRB-
cord-005453-4057qib7	14543	6	TCN	TCN	NNP
cord-005453-4057qib7	14543	7	)	)	-RRB-
cord-005453-4057qib7	14543	8	was	be	VBD
cord-005453-4057qib7	14543	9	4,94x10	4,94x10	CD
cord-005453-4057qib7	14543	10	8	8	CD
cord-005453-4057qib7	14544	1	/kg	/kg	.
cord-005453-4057qib7	14545	1	(	(	-LRB-
cord-005453-4057qib7	14545	2	2,07	2,07	CD
cord-005453-4057qib7	14545	3	-	-	SYM
cord-005453-4057qib7	14545	4	12,66	12,66	CD
cord-005453-4057qib7	14545	5	)	)	-RRB-
cord-005453-4057qib7	14545	6	.	.	.
cord-005453-4057qib7	14546	1	Results	result	NNS
cord-005453-4057qib7	14546	2	:	:	:
cord-005453-4057qib7	14547	1	eight	eight	CD
cord-005453-4057qib7	14547	2	patients	patient	NNS
cord-005453-4057qib7	14547	3	engrafted	engraft	VBN
cord-005453-4057qib7	14547	4	(	(	-LRB-
cord-005453-4057qib7	14547	5	53	53	CD
cord-005453-4057qib7	14547	6	%	%	NN
cord-005453-4057qib7	14547	7	)	)	-RRB-
cord-005453-4057qib7	14547	8	.	.	.
cord-005453-4057qib7	14548	1	Among	among	IN
cord-005453-4057qib7	14548	2	seven	seven	CD
cord-005453-4057qib7	14548	3	graft	graft	NN
cord-005453-4057qib7	14548	4	failures	failure	NNS
cord-005453-4057qib7	14548	5	four	four	CD
cord-005453-4057qib7	14548	6	received	receive	VBD
cord-005453-4057qib7	14548	7	a	a	DT
cord-005453-4057qib7	14548	8	second	second	JJ
cord-005453-4057qib7	14548	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14548	10	transplant	transplant	NN
cord-005453-4057qib7	14548	11	and	and	CC
cord-005453-4057qib7	14548	12	one	one	CD
cord-005453-4057qib7	14548	13	received	receive	VBD
cord-005453-4057qib7	14548	14	an	an	DT
cord-005453-4057qib7	14548	15	unrelated	unrelated	JJ
cord-005453-4057qib7	14548	16	donor	donor	NN
cord-005453-4057qib7	14548	17	transplant	transplant	NN
cord-005453-4057qib7	14548	18	as	as	IN
cord-005453-4057qib7	14548	19	salvage	salvage	NN
cord-005453-4057qib7	14548	20	regimen	regimen	NN
cord-005453-4057qib7	14548	21	.	.	.
cord-005453-4057qib7	14549	1	Two	two	CD
cord-005453-4057qib7	14549	2	patients	patient	NNS
cord-005453-4057qib7	14549	3	were	be	VBD
cord-005453-4057qib7	14549	4	successfully	successfully	RB
cord-005453-4057qib7	14549	5	rescued	rescue	VBN
cord-005453-4057qib7	14549	6	after	after	IN
cord-005453-4057qib7	14549	7	the	the	DT
cord-005453-4057qib7	14549	8	second	second	JJ
cord-005453-4057qib7	14549	9	haplo	haplo	NN
cord-005453-4057qib7	14549	10	and	and	CC
cord-005453-4057qib7	14549	11	the	the	DT
cord-005453-4057qib7	14549	12	others	other	NNS
cord-005453-4057qib7	14549	13	died	die	VBD
cord-005453-4057qib7	14549	14	from	from	IN
cord-005453-4057qib7	14549	15	infectious	infectious	JJ
cord-005453-4057qib7	14549	16	complications	complication	NNS
cord-005453-4057qib7	14549	17	.	.	.
cord-005453-4057qib7	14550	1	Three	three	CD
cord-005453-4057qib7	14550	2	years	year	NNS
cord-005453-4057qib7	14550	3	overall	overall	JJ
cord-005453-4057qib7	14550	4	survival	survival	NN
cord-005453-4057qib7	14550	5	was	be	VBD
cord-005453-4057qib7	14550	6	55	55	CD
cord-005453-4057qib7	14550	7	%	%	NN
cord-005453-4057qib7	14550	8	.	.	.
cord-005453-4057qib7	14551	1	Death	death	NN
cord-005453-4057qib7	14551	2	causes	cause	NNS
cord-005453-4057qib7	14551	3	included	include	VBN
cord-005453-4057qib7	14551	4	:	:	:
cord-005453-4057qib7	14551	5	five	five	CD
cord-005453-4057qib7	14551	6	infections	infection	NNS
cord-005453-4057qib7	14551	7	and	and	CC
cord-005453-4057qib7	14551	8	two	two	CD
cord-005453-4057qib7	14551	9	lung	lung	NN
cord-005453-4057qib7	14551	10	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	14551	11	.	.	.
cord-005453-4057qib7	14552	1	Median	median	JJ
cord-005453-4057qib7	14552	2	survival	survival	NN
cord-005453-4057qib7	14552	3	was	be	VBD
cord-005453-4057qib7	14552	4	93	93	CD
cord-005453-4057qib7	14552	5	days	day	NNS
cord-005453-4057qib7	14552	6	(	(	-LRB-
cord-005453-4057qib7	14552	7	17	17	CD
cord-005453-4057qib7	14552	8	-	-	SYM
cord-005453-4057qib7	14552	9	1065	1065	CD
cord-005453-4057qib7	14552	10	)	)	-RRB-
cord-005453-4057qib7	14552	11	.	.	.
cord-005453-4057qib7	14553	1	No	no	DT
cord-005453-4057qib7	14553	2	patient	patient	NN
cord-005453-4057qib7	14553	3	had	have	VBD
cord-005453-4057qib7	14553	4	acute	acute	JJ
cord-005453-4057qib7	14553	5	graft	graft	NN
cord-005453-4057qib7	14553	6	-	-	HYPH
cord-005453-4057qib7	14553	7	versus	versus	IN
cord-005453-4057qib7	14553	8	-	-	HYPH
cord-005453-4057qib7	14553	9	host	host	NN
cord-005453-4057qib7	14553	10	-	-	HYPH
cord-005453-4057qib7	14553	11	disease	disease	NN
cord-005453-4057qib7	14553	12	(	(	-LRB-
cord-005453-4057qib7	14553	13	GVHD	GVHD	NNP
cord-005453-4057qib7	14553	14	)	)	-RRB-
cord-005453-4057qib7	14553	15	and	and	CC
cord-005453-4057qib7	14554	1	one	one	CD
cord-005453-4057qib7	14554	2	patient	patient	NN
cord-005453-4057qib7	14554	3	had	have	VBD
cord-005453-4057qib7	14554	4	mild	mild	JJ
cord-005453-4057qib7	14554	5	c	c	NN
cord-005453-4057qib7	14554	6	-	-	HYPH
cord-005453-4057qib7	14554	7	GVHD	GVHD	NNP
cord-005453-4057qib7	14554	8	.	.	.
cord-005453-4057qib7	14555	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14555	2	:	:	:
cord-005453-4057qib7	14556	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	14556	2	transplant	transplant	NN
cord-005453-4057qib7	14556	3	was	be	VBD
cord-005453-4057qib7	14556	4	feasible	feasible	JJ
cord-005453-4057qib7	14556	5	as	as	IN
cord-005453-4057qib7	14556	6	therapy	therapy	NN
cord-005453-4057qib7	14556	7	for	for	IN
cord-005453-4057qib7	14556	8	SAA	SAA	NNP
cord-005453-4057qib7	14556	9	refractory	refractory	JJ
cord-005453-4057qib7	14556	10	to	to	IN
cord-005453-4057qib7	14556	11	immunessupression	immunessupression	NN
cord-005453-4057qib7	14556	12	with	with	IN
cord-005453-4057qib7	14556	13	an	an	DT
cord-005453-4057qib7	14556	14	overall	overall	JJ
cord-005453-4057qib7	14556	15	survival	survival	NN
cord-005453-4057qib7	14556	16	of	of	IN
cord-005453-4057qib7	14556	17	55	55	CD
cord-005453-4057qib7	14556	18	%	%	NN
cord-005453-4057qib7	14556	19	in	in	IN
cord-005453-4057qib7	14556	20	this	this	DT
cord-005453-4057qib7	14556	21	cohort	cohort	NN
cord-005453-4057qib7	14556	22	.	.	.
cord-005453-4057qib7	14557	1	Graft	graft	NN
cord-005453-4057qib7	14557	2	failure	failure	NN
cord-005453-4057qib7	14557	3	however	however	RB
cord-005453-4057qib7	14557	4	is	be	VBZ
cord-005453-4057qib7	14557	5	still	still	RB
cord-005453-4057qib7	14557	6	a	a	DT
cord-005453-4057qib7	14557	7	problem	problem	NN
cord-005453-4057qib7	14557	8	to	to	TO
cord-005453-4057qib7	14557	9	be	be	VB
cord-005453-4057qib7	14557	10	addressed	address	VBN
cord-005453-4057qib7	14557	11	in	in	IN
cord-005453-4057qib7	14557	12	this	this	DT
cord-005453-4057qib7	14557	13	setting	setting	NN
cord-005453-4057qib7	14557	14	.	.	.
cord-005453-4057qib7	14558	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14558	2	:	:	:
cord-005453-4057qib7	14558	3	no	no	DT
cord-005453-4057qib7	14558	4	disclosure	disclosure	NN
cord-005453-4057qib7	14558	5	Stem	Stem	NNP
cord-005453-4057qib7	14558	6	cell	cell	NN
cord-005453-4057qib7	14558	7	mobilization	mobilization	NN
cord-005453-4057qib7	14558	8	,	,	,
cord-005453-4057qib7	14558	9	collection	collection	NN
cord-005453-4057qib7	14558	10	and	and	CC
cord-005453-4057qib7	14558	11	engineering	engineering	NN
cord-005453-4057qib7	14558	12	P681	P681	NNP
cord-005453-4057qib7	14558	13	Abstract	Abstract	NNP
cord-005453-4057qib7	14558	14	already	already	RB
cord-005453-4057qib7	14558	15	published	publish	VBN
cord-005453-4057qib7	14558	16	.	.	.
cord-005453-4057qib7	14559	1	Key	key	JJ
cord-005453-4057qib7	14559	2	performance	performance	NN
cord-005453-4057qib7	14559	3	and	and	CC
cord-005453-4057qib7	14559	4	quality	quality	NN
cord-005453-4057qib7	14559	5	indicators	indicator	NNS
cord-005453-4057qib7	14559	6	for	for	IN
cord-005453-4057qib7	14559	7	a	a	DT
cord-005453-4057qib7	14559	8	successful	successful	JJ
cord-005453-4057qib7	14559	9	bone	bone	NN
cord-005453-4057qib7	14559	10	marrow	marrow	NN
cord-005453-4057qib7	14559	11	collection	collection	NN
cord-005453-4057qib7	14559	12	Marco	Marco	NNP
cord-005453-4057qib7	14559	13	Sampaio	Sampaio	NNP
cord-005453-4057qib7	14559	14	1,2	1,2	CD
cord-005453-4057qib7	14559	15	,	,	,
cord-005453-4057qib7	14559	16	Ana	Ana	NNP
cord-005453-4057qib7	14559	17	Salselas	Salselas	NNP
cord-005453-4057qib7	14559	18	2	2	CD
cord-005453-4057qib7	14559	19	,	,	,
cord-005453-4057qib7	14559	20	Fátima	Fátima	NNP
cord-005453-4057qib7	14559	21	Amado	Amado	NNP
cord-005453-4057qib7	14559	22	2	2	CD
cord-005453-4057qib7	14559	23	,	,	,
cord-005453-4057qib7	14559	24	Filipa	Filipa	NNP
cord-005453-4057qib7	14559	25	Bordalo	Bordalo	NNP
cord-005453-4057qib7	14559	26	2	2	CD
cord-005453-4057qib7	14559	27	,	,	,
cord-005453-4057qib7	14559	28	Sérgio	Sérgio	NNP
cord-005453-4057qib7	14559	29	Lopes	Lopes	NNP
cord-005453-4057qib7	14559	30	2	2	CD
cord-005453-4057qib7	14559	31	,	,	,
cord-005453-4057qib7	14559	32	Catarina	Catarina	NNP
cord-005453-4057qib7	14559	33	Pinho	Pinho	NNP
cord-005453-4057qib7	14559	34	2	2	CD
cord-005453-4057qib7	14559	35	,	,	,
cord-005453-4057qib7	14559	36	Susana	Susana	NNP
cord-005453-4057qib7	14559	37	Roncon	Roncon	NNP
cord-005453-4057qib7	14559	38	2	2	CD
cord-005453-4057qib7	14559	39	and	and	CC
cord-005453-4057qib7	14559	40	one	one	CD
cord-005453-4057qib7	14559	41	from	from	IN
cord-005453-4057qib7	14559	42	ECC	ECC	NNP
cord-005453-4057qib7	14559	43	(	(	-LRB-
cord-005453-4057qib7	14560	1	Staphylococcus	staphylococcus	NN
cord-005453-4057qib7	14560	2	spp.)presented	spp.)presente	VBD
cord-005453-4057qib7	14560	3	positive	positive	JJ
cord-005453-4057qib7	14560	4	microbiological	microbiological	JJ
cord-005453-4057qib7	14560	5	results	result	NNS
cord-005453-4057qib7	14560	6	.	.	.
cord-005453-4057qib7	14561	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14561	2	:	:	:
cord-005453-4057qib7	14561	3	BM	BM	NNP
cord-005453-4057qib7	14561	4	collection	collection	NN
cord-005453-4057qib7	14561	5	is	be	VBZ
cord-005453-4057qib7	14561	6	a	a	DT
cord-005453-4057qib7	14561	7	challenging	challenging	JJ
cord-005453-4057qib7	14561	8	strategy	strategy	NN
cord-005453-4057qib7	14561	9	because	because	IN
cord-005453-4057qib7	14561	10	it	-PRON-	PRP
cord-005453-4057qib7	14561	11	is	be	VBZ
cord-005453-4057qib7	14561	12	a	a	DT
cord-005453-4057qib7	14561	13	one	one	CD
cord-005453-4057qib7	14561	14	-	-	HYPH
cord-005453-4057qib7	14561	15	time	time	NN
cord-005453-4057qib7	14561	16	procedure	procedure	NN
cord-005453-4057qib7	14561	17	and	and	CC
cord-005453-4057qib7	14561	18	manually	manually	RB
cord-005453-4057qib7	14561	19	operatordependent	operatordependent	JJ
cord-005453-4057qib7	14561	20	technique	technique	NN
cord-005453-4057qib7	14561	21	;	;	:
cord-005453-4057qib7	14561	22	simultaneously	simultaneously	RB
cord-005453-4057qib7	14561	23	it	-PRON-	PRP
cord-005453-4057qib7	14561	24	is	be	VBZ
cord-005453-4057qib7	14561	25	more	more	RBR
cord-005453-4057qib7	14561	26	difficult	difficult	JJ
cord-005453-4057qib7	14561	27	to	to	TO
cord-005453-4057qib7	14561	28	control	control	VB
cord-005453-4057qib7	14561	29	the	the	DT
cord-005453-4057qib7	14561	30	final	final	JJ
cord-005453-4057qib7	14561	31	cellular	cellular	JJ
cord-005453-4057qib7	14561	32	content	content	NN
cord-005453-4057qib7	14561	33	of	of	IN
cord-005453-4057qib7	14561	34	the	the	DT
cord-005453-4057qib7	14561	35	BM	BM	NNP
cord-005453-4057qib7	14561	36	,	,	,
cord-005453-4057qib7	14561	37	which	which	WDT
cord-005453-4057qib7	14561	38	is	be	VBZ
cord-005453-4057qib7	14561	39	a	a	DT
cord-005453-4057qib7	14561	40	risk	risk	NN
cord-005453-4057qib7	14561	41	for	for	IN
cord-005453-4057qib7	14561	42	donor	donor	NN
cord-005453-4057qib7	14561	43	volume	volume	NN
cord-005453-4057qib7	14561	44	depletion	depletion	NN
cord-005453-4057qib7	14561	45	.	.	.
cord-005453-4057qib7	14562	1	BM	BM	NNP
cord-005453-4057qib7	14562	2	collection	collection	NN
cord-005453-4057qib7	14562	3	is	be	VBZ
cord-005453-4057qib7	14562	4	feasible	feasible	JJ
cord-005453-4057qib7	14562	5	even	even	RB
cord-005453-4057qib7	14562	6	with	with	IN
cord-005453-4057qib7	14562	7	donor	donor	NN
cord-005453-4057qib7	14562	8	and	and	CC
cord-005453-4057qib7	14562	9	recipient	recipient	NN
cord-005453-4057qib7	14562	10	weight	weight	NN
cord-005453-4057qib7	14562	11	difference	difference	NN
cord-005453-4057qib7	14562	12	.	.	.
cord-005453-4057qib7	14563	1	Poorer	poor	JJR
cord-005453-4057qib7	14563	2	performance	performance	NN
cord-005453-4057qib7	14563	3	may	may	MD
cord-005453-4057qib7	14563	4	be	be	VB
cord-005453-4057qib7	14563	5	found	find	VBN
cord-005453-4057qib7	14563	6	when	when	WRB
cord-005453-4057qib7	14563	7	higher	high	JJR
cord-005453-4057qib7	14563	8	TNC	TNC	NNP
cord-005453-4057qib7	14563	9	are	be	VBP
cord-005453-4057qib7	14563	10	requested	request	VBN
cord-005453-4057qib7	14563	11	.	.	.
cord-005453-4057qib7	14564	1	We	-PRON-	PRP
cord-005453-4057qib7	14564	2	respond	respond	VBP
cord-005453-4057qib7	14564	3	efficaciously	efficaciously	RB
cord-005453-4057qib7	14564	4	when	when	WRB
cord-005453-4057qib7	14564	5	the	the	DT
cord-005453-4057qib7	14564	6	request	request	NN
cord-005453-4057qib7	14564	7	is	be	VBZ
cord-005453-4057qib7	14564	8	between	between	IN
cord-005453-4057qib7	14564	9	200	200	CD
cord-005453-4057qib7	14564	10	and	and	CC
cord-005453-4057qib7	14564	11	400	400	CD
cord-005453-4057qib7	14564	12	*	*	NFP
cord-005453-4057qib7	14564	13	10	10	CD
cord-005453-4057qib7	14564	14	8	8	CD
cord-005453-4057qib7	14564	15	TNC	TNC	NNP
cord-005453-4057qib7	14565	1	but	but	CC
cord-005453-4057qib7	14565	2	we	-PRON-	PRP
cord-005453-4057qib7	14565	3	fail	fail	VBP
cord-005453-4057qib7	14565	4	to	to	TO
cord-005453-4057qib7	14565	5	accomplish	accomplish	VB
cord-005453-4057qib7	14565	6	higher	high	JJR
cord-005453-4057qib7	14565	7	TNC	TNC	NNP
cord-005453-4057qib7	14565	8	values	value	NNS
cord-005453-4057qib7	14565	9	.	.	.
cord-005453-4057qib7	14566	1	We	-PRON-	PRP
cord-005453-4057qib7	14566	2	must	must	MD
cord-005453-4057qib7	14566	3	emphasise	emphasise	VB
cord-005453-4057qib7	14566	4	that	that	IN
cord-005453-4057qib7	14566	5	ICC	ICC	NNP
cord-005453-4057qib7	14566	6	TNC	TNC	NNP
cord-005453-4057qib7	14566	7	demanded	demand	VBD
cord-005453-4057qib7	14566	8	was	be	VBD
cord-005453-4057qib7	14566	9	generally	generally	RB
cord-005453-4057qib7	14566	10	lower	low	JJR
cord-005453-4057qib7	14566	11	than	than	IN
cord-005453-4057qib7	14566	12	ECC	ECC	NNP
cord-005453-4057qib7	14566	13	.	.	.
cord-005453-4057qib7	14567	1	Deciding	decide	VBG
cord-005453-4057qib7	14567	2	the	the	DT
cord-005453-4057qib7	14567	3	appropriate	appropriate	JJ
cord-005453-4057qib7	14567	4	TNC	TNC	NNP
cord-005453-4057qib7	14567	5	for	for	IN
cord-005453-4057qib7	14567	6	each	each	DT
cord-005453-4057qib7	14567	7	patient	patient	NN
cord-005453-4057qib7	14567	8	remains	remain	VBZ
cord-005453-4057qib7	14567	9	a	a	DT
cord-005453-4057qib7	14567	10	dare	dare	NN
cord-005453-4057qib7	14567	11	and	and	CC
cord-005453-4057qib7	14567	12	an	an	DT
cord-005453-4057qib7	14567	13	art	art	NN
cord-005453-4057qib7	14567	14	.	.	.
cord-005453-4057qib7	14568	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14568	2	:	:	:
cord-005453-4057qib7	14568	3	Nothing	nothing	NN
cord-005453-4057qib7	14568	4	to	to	TO
cord-005453-4057qib7	14568	5	declare	declare	VB
cord-005453-4057qib7	14568	6	.	.	.
cord-005453-4057qib7	14569	1	Impact	impact	NN
cord-005453-4057qib7	14569	2	of	of	IN
cord-005453-4057qib7	14569	3	adding	add	VBG
cord-005453-4057qib7	14569	4	plerixafor	plerixafor	NN
cord-005453-4057qib7	14569	5	to	to	IN
cord-005453-4057qib7	14569	6	mobilization	mobilization	NN
cord-005453-4057qib7	14569	7	protocol	protocol	NN
cord-005453-4057qib7	14569	8	in	in	IN
cord-005453-4057qib7	14569	9	the	the	DT
cord-005453-4057qib7	14569	10	immune	immune	JJ
cord-005453-4057qib7	14569	11	reconstitution	reconstitution	NN
cord-005453-4057qib7	14569	12	of	of	IN
cord-005453-4057qib7	14569	13	VδT	VδT	NNP
cord-005453-4057qib7	14569	14	cells	cell	NNS
cord-005453-4057qib7	14569	15	after	after	IN
cord-005453-4057qib7	14569	16	autologous	autologous	JJ
cord-005453-4057qib7	14569	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14569	18	stem	stem	NN
cord-005453-4057qib7	14569	19	cell	cell	NN
cord-005453-4057qib7	14569	20	transplantation	transplantation	NN
cord-005453-4057qib7	14569	21	Efrat	Efrat	NNP
cord-005453-4057qib7	14569	22	Luttwak	Luttwak	NNP
cord-005453-4057qib7	14569	23	1,2	1,2	CD
cord-005453-4057qib7	14569	24	,	,	,
cord-005453-4057qib7	14569	25	Yael	Yael	NNP
cord-005453-4057qib7	14569	26	Chava	Chava	NNP
cord-005453-4057qib7	14569	27	Cohen	Cohen	NNP
cord-005453-4057qib7	14569	28	1,2	1,2	CD
cord-005453-4057qib7	14569	29	,	,	,
cord-005453-4057qib7	14569	30	Odelia	Odelia	NNP
cord-005453-4057qib7	14569	31	Amit	Amit	NNP
cord-005453-4057qib7	14569	32	1,2	1,2	CD
cord-005453-4057qib7	14569	33	,	,	,
cord-005453-4057qib7	14569	34	Irit	Irit	NNP
cord-005453-4057qib7	14569	35	Avivi	Avivi	NNP
cord-005453-4057qib7	14569	36	1,2	1,2	CD
cord-005453-4057qib7	14569	37	,	,	,
cord-005453-4057qib7	14569	38	Svetlana	Svetlana	NNP
cord-005453-4057qib7	14569	39	Trestman	Trestman	NNP
cord-005453-4057qib7	14569	40	1,2	1,2	CD
cord-005453-4057qib7	14569	41	,	,	,
cord-005453-4057qib7	14569	42	Esti	Esti	NNP
cord-005453-4057qib7	14569	43	Rom	Rom	NNP
cord-005453-4057qib7	14569	44	1,2	1,2	NNP
cord-005453-4057qib7	14569	45	,	,	,
cord-005453-4057qib7	14569	46	Rinat	Rinat	NNP
cord-005453-4057qib7	14569	47	Eshel	Eshel	NNP
cord-005453-4057qib7	14569	48	1,2	1,2	CD
cord-005453-4057qib7	14569	49	,	,	,
cord-005453-4057qib7	14569	50	Ram	Ram	NNP
cord-005453-4057qib7	14569	51	Ron	Ron	NNP
cord-005453-4057qib7	14569	52	1,2	1,2	CD
cord-005453-4057qib7	14569	53	1	1	CD
cord-005453-4057qib7	14569	54	Tel	Tel	NNP
cord-005453-4057qib7	14569	55	Aviv	Aviv	NNP
cord-005453-4057qib7	14569	56	Medical	Medical	NNP
cord-005453-4057qib7	14569	57	Center	Center	NNP
cord-005453-4057qib7	14569	58	,	,	,
cord-005453-4057qib7	14569	59	Tel	Tel	NNP
cord-005453-4057qib7	14569	60	Aviv	Aviv	NNP
cord-005453-4057qib7	14569	61	,	,	,
cord-005453-4057qib7	14569	62	Israel	Israel	NNP
cord-005453-4057qib7	14569	63	,	,	,
cord-005453-4057qib7	14569	64	2	2	CD
cord-005453-4057qib7	14569	65	Sackler	Sackler	NNP
cord-005453-4057qib7	14569	66	Faculty	Faculty	NNP
cord-005453-4057qib7	14569	67	of	of	IN
cord-005453-4057qib7	14569	68	Medicine	Medicine	NNP
cord-005453-4057qib7	14569	69	,	,	,
cord-005453-4057qib7	14569	70	Tel	Tel	NNP
cord-005453-4057qib7	14569	71	Aviv	Aviv	NNP
cord-005453-4057qib7	14569	72	University	University	NNP
cord-005453-4057qib7	14569	73	,	,	,
cord-005453-4057qib7	14569	74	Tel	Tel	NNP
cord-005453-4057qib7	14569	75	Aviv	Aviv	NNP
cord-005453-4057qib7	14570	1	,	,	,
cord-005453-4057qib7	14570	2	Israel	Israel	NNP
cord-005453-4057qib7	14570	3	Background	Background	NNP
cord-005453-4057qib7	14570	4	:	:	:
cord-005453-4057qib7	14571	1	Multiple	multiple	JJ
cord-005453-4057qib7	14571	2	Myeloma	Myeloma	NNP
cord-005453-4057qib7	14571	3	has	have	VBZ
cord-005453-4057qib7	14571	4	remained	remain	VBN
cord-005453-4057qib7	14571	5	an	an	DT
cord-005453-4057qib7	14571	6	incurable	incurable	JJ
cord-005453-4057qib7	14571	7	disease	disease	NN
cord-005453-4057qib7	14571	8	even	even	RB
cord-005453-4057qib7	14571	9	in	in	IN
cord-005453-4057qib7	14571	10	the	the	DT
cord-005453-4057qib7	14571	11	era	era	NN
cord-005453-4057qib7	14571	12	of	of	IN
cord-005453-4057qib7	14571	13	novel	novel	JJ
cord-005453-4057qib7	14571	14	therapies	therapy	NNS
cord-005453-4057qib7	14571	15	.	.	.
cord-005453-4057qib7	14572	1	Front	front	JJ
cord-005453-4057qib7	14572	2	line	line	NN
cord-005453-4057qib7	14572	3	treatment	treatment	NN
cord-005453-4057qib7	14572	4	typically	typically	RB
cord-005453-4057qib7	14572	5	comprises	comprise	VBZ
cord-005453-4057qib7	14572	6	of	of	IN
cord-005453-4057qib7	14572	7	induction	induction	NN
cord-005453-4057qib7	14572	8	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14572	9	with	with	IN
cord-005453-4057qib7	14572	10	4	4	CD
cord-005453-4057qib7	14572	11	-	-	SYM
cord-005453-4057qib7	14572	12	6	6	CD
cord-005453-4057qib7	14572	13	cycles	cycle	NNS
cord-005453-4057qib7	14572	14	of	of	IN
cord-005453-4057qib7	14572	15	a	a	DT
cord-005453-4057qib7	14572	16	bortezomib	bortezomib	NN
cord-005453-4057qib7	14572	17	-	-	HYPH
cord-005453-4057qib7	14572	18	based	base	VBN
cord-005453-4057qib7	14572	19	regimen	regimen	NN
cord-005453-4057qib7	14572	20	,	,	,
cord-005453-4057qib7	14572	21	stem	stem	NN
cord-005453-4057qib7	14572	22	cell	cell	NN
cord-005453-4057qib7	14572	23	mobilization	mobilization	NN
cord-005453-4057qib7	14572	24	,	,	,
cord-005453-4057qib7	14572	25	and	and	CC
cord-005453-4057qib7	14572	26	harvesting	harvesting	NN
cord-005453-4057qib7	14572	27	of	of	IN
cord-005453-4057qib7	14572	28	peripheral	peripheral	JJ
cord-005453-4057qib7	14572	29	blood	blood	NN
cord-005453-4057qib7	14572	30	stem	stem	NN
cord-005453-4057qib7	14572	31	cells	cell	NNS
cord-005453-4057qib7	14572	32	(	(	-LRB-
cord-005453-4057qib7	14572	33	PBSC	PBSC	NNP
cord-005453-4057qib7	14572	34	)	)	-RRB-
cord-005453-4057qib7	14572	35	by	by	IN
cord-005453-4057qib7	14572	36	apharesis	apharesis	NNP
cord-005453-4057qib7	14572	37	,	,	,
cord-005453-4057qib7	14572	38	followed	follow	VBN
cord-005453-4057qib7	14572	39	by	by	IN
cord-005453-4057qib7	14572	40	high	high	JJ
cord-005453-4057qib7	14572	41	dose	dose	NN
cord-005453-4057qib7	14572	42	melphalan	melphalan	NN
cord-005453-4057qib7	14572	43	with	with	IN
cord-005453-4057qib7	14572	44	HCT	HCT	NNP
cord-005453-4057qib7	14572	45	.	.	.
cord-005453-4057qib7	14573	1	While	while	IN
cord-005453-4057qib7	14573	2	brotezomib	brotezomib	NN
cord-005453-4057qib7	14573	3	-	-	HYPH
cord-005453-4057qib7	14573	4	based	base	VBN
cord-005453-4057qib7	14573	5	induction	induction	NN
cord-005453-4057qib7	14573	6	regimens	regimen	NNS
cord-005453-4057qib7	14573	7	have	have	VBP
cord-005453-4057qib7	14573	8	demonstrated	demonstrate	VBN
cord-005453-4057qib7	14573	9	no	no	DT
cord-005453-4057qib7	14573	10	adverse	adverse	JJ
cord-005453-4057qib7	14573	11	impact	impact	NN
cord-005453-4057qib7	14573	12	on	on	IN
cord-005453-4057qib7	14573	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14573	14	cell	cell	NN
cord-005453-4057qib7	14573	15	harvest	harvest	NN
cord-005453-4057qib7	14573	16	number	number	NN
cord-005453-4057qib7	14573	17	and	and	CC
cord-005453-4057qib7	14573	18	quality	quality	NN
cord-005453-4057qib7	14573	19	,	,	,
cord-005453-4057qib7	14573	20	no	no	DT
cord-005453-4057qib7	14573	21	study	study	NN
cord-005453-4057qib7	14573	22	analyzed	analyze	VBD
cord-005453-4057qib7	14573	23	the	the	DT
cord-005453-4057qib7	14573	24	impact	impact	NN
cord-005453-4057qib7	14573	25	of	of	IN
cord-005453-4057qib7	14573	26	timing	timing	NN
cord-005453-4057qib7	14573	27	of	of	IN
cord-005453-4057qib7	14573	28	the	the	DT
cord-005453-4057qib7	14573	29	last	last	JJ
cord-005453-4057qib7	14573	30	brotezomib	brotezomib	NNP
cord-005453-4057qib7	14573	31	dose	dose	NN
cord-005453-4057qib7	14573	32	prior	prior	RB
cord-005453-4057qib7	14573	33	to	to	IN
cord-005453-4057qib7	14573	34	collection	collection	NN
cord-005453-4057qib7	14573	35	.	.	.
cord-005453-4057qib7	14574	1	In	in	IN
cord-005453-4057qib7	14574	2	this	this	DT
cord-005453-4057qib7	14574	3	study	study	NN
cord-005453-4057qib7	14574	4	we	-PRON-	PRP
cord-005453-4057qib7	14574	5	aimed	aim	VBD
cord-005453-4057qib7	14574	6	to	to	TO
cord-005453-4057qib7	14574	7	determine	determine	VB
cord-005453-4057qib7	14574	8	the	the	DT
cord-005453-4057qib7	14574	9	effect	effect	NN
cord-005453-4057qib7	14574	10	of	of	IN
cord-005453-4057qib7	14574	11	the	the	DT
cord-005453-4057qib7	14574	12	timing	timing	NN
cord-005453-4057qib7	14574	13	of	of	IN
cord-005453-4057qib7	14574	14	the	the	DT
cord-005453-4057qib7	14574	15	last	last	JJ
cord-005453-4057qib7	14574	16	dose	dose	NN
cord-005453-4057qib7	14574	17	of	of	IN
cord-005453-4057qib7	14574	18	brotezomib	brotezomib	NNP
cord-005453-4057qib7	14574	19	before	before	IN
cord-005453-4057qib7	14574	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14574	21	cell	cell	NN
cord-005453-4057qib7	14574	22	collection	collection	NN
cord-005453-4057qib7	14574	23	and	and	CC
cord-005453-4057qib7	14574	24	the	the	DT
cord-005453-4057qib7	14574	25	collection	collection	NN
cord-005453-4057qib7	14574	26	yield	yield	NN
cord-005453-4057qib7	14574	27	.	.	.
cord-005453-4057qib7	14575	1	Methods	method	NNS
cord-005453-4057qib7	14575	2	:	:	:
cord-005453-4057qib7	14575	3	This	this	DT
cord-005453-4057qib7	14575	4	was	be	VBD
cord-005453-4057qib7	14575	5	a	a	DT
cord-005453-4057qib7	14575	6	single	single	JJ
cord-005453-4057qib7	14575	7	center	center	NN
cord-005453-4057qib7	14575	8	historical	historical	JJ
cord-005453-4057qib7	14575	9	prospective	prospective	JJ
cord-005453-4057qib7	14575	10	study	study	NN
cord-005453-4057qib7	14575	11	,	,	,
cord-005453-4057qib7	14575	12	including	include	VBG
cord-005453-4057qib7	14575	13	all	all	DT
cord-005453-4057qib7	14575	14	sequential	sequential	JJ
cord-005453-4057qib7	14575	15	newly	newly	RB
cord-005453-4057qib7	14575	16	diagnosed	diagnose	VBN
cord-005453-4057qib7	14575	17	patients	patient	NNS
cord-005453-4057qib7	14575	18	with	with	IN
cord-005453-4057qib7	14575	19	myeloma	myeloma	NN
cord-005453-4057qib7	14575	20	between	between	IN
cord-005453-4057qib7	14575	21	2012	2012	CD
cord-005453-4057qib7	14575	22	and	and	CC
cord-005453-4057qib7	14575	23	2017	2017	CD
cord-005453-4057qib7	14575	24	that	that	WDT
cord-005453-4057qib7	14575	25	were	be	VBD
cord-005453-4057qib7	14575	26	given	give	VBN
cord-005453-4057qib7	14575	27	a	a	DT
cord-005453-4057qib7	14575	28	bortezomib	bortezomib	NN
cord-005453-4057qib7	14575	29	-	-	HYPH
cord-005453-4057qib7	14575	30	based	base	VBN
cord-005453-4057qib7	14575	31	induction	induction	NN
cord-005453-4057qib7	14575	32	therapy	therapy	NN
cord-005453-4057qib7	14575	33	(	(	-LRB-
cord-005453-4057qib7	14575	34	≤6	≤6	NNS
cord-005453-4057qib7	14575	35	cycles	cycle	NNS
cord-005453-4057qib7	14575	36	)	)	-RRB-
cord-005453-4057qib7	14575	37	followed	follow	VBN
cord-005453-4057qib7	14575	38	by	by	IN
cord-005453-4057qib7	14575	39	PBSC	PBSC	NNP
cord-005453-4057qib7	14575	40	collection	collection	NN
cord-005453-4057qib7	14575	41	.	.	.
cord-005453-4057qib7	14576	1	We	-PRON-	PRP
cord-005453-4057qib7	14576	2	excluded	exclude	VBD
cord-005453-4057qib7	14576	3	patients	patient	NNS
cord-005453-4057qib7	14576	4	who	who	WP
cord-005453-4057qib7	14576	5	either	either	CC
cord-005453-4057qib7	14576	6	received	receive	VBD
cord-005453-4057qib7	14576	7	1	1	CD
cord-005453-4057qib7	14576	8	st	st	NNP
cord-005453-4057qib7	14576	9	line	line	NN
cord-005453-4057qib7	14576	10	VTD	VTD	NNP
cord-005453-4057qib7	14576	11	-	-	HYPH
cord-005453-4057qib7	14576	12	PACE	pace	NN
cord-005453-4057qib7	14576	13	or	or	CC
cord-005453-4057qib7	14576	14	lenalidomide	lenalidomide	NN
cord-005453-4057qib7	14576	15	-	-	HYPH
cord-005453-4057qib7	14576	16	containing	contain	VBG
cord-005453-4057qib7	14576	17	regimens	regimen	NNS
cord-005453-4057qib7	14576	18	.	.	.
cord-005453-4057qib7	14577	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	14577	2	blood	blood	NN
cord-005453-4057qib7	14577	3	CD34	CD34	NNP
cord-005453-4057qib7	14578	1	+	+	CC
cord-005453-4057qib7	14578	2	cells	cell	NNS
cord-005453-4057qib7	14578	3	were	be	VBD
cord-005453-4057qib7	14578	4	measured	measure	VBN
cord-005453-4057qib7	14578	5	on	on	IN
cord-005453-4057qib7	14578	6	the	the	DT
cord-005453-4057qib7	14578	7	day	day	NN
cord-005453-4057qib7	14578	8	of	of	IN
cord-005453-4057qib7	14578	9	collection	collection	NN
cord-005453-4057qib7	14578	10	.	.	.
cord-005453-4057qib7	14579	1	Patients	patient	NNS
cord-005453-4057qib7	14579	2	with	with	IN
cord-005453-4057qib7	14579	3	CD34	CD34	NNP
cord-005453-4057qib7	14579	4	+	+	CC
cord-005453-4057qib7	14579	5	levels	level	NNS
cord-005453-4057qib7	14579	6	of	of	IN
cord-005453-4057qib7	14579	7	>	>	SYM
cord-005453-4057qib7	14579	8	10	10	CD
cord-005453-4057qib7	14579	9	cells/	cells/	CD
cord-005453-4057qib7	14579	10	microliter	microliter	NN
cord-005453-4057qib7	14579	11	started	start	VBD
cord-005453-4057qib7	14579	12	collection	collection	NN
cord-005453-4057qib7	14579	13	on	on	IN
cord-005453-4057qib7	14579	14	the	the	DT
cord-005453-4057qib7	14579	15	same	same	JJ
cord-005453-4057qib7	14579	16	day	day	NN
cord-005453-4057qib7	14579	17	,	,	,
cord-005453-4057qib7	14579	18	while	while	IN
cord-005453-4057qib7	14579	19	those	those	DT
cord-005453-4057qib7	14579	20	with	with	IN
cord-005453-4057qib7	14579	21	lower	low	JJR
cord-005453-4057qib7	14579	22	levels	level	NNS
cord-005453-4057qib7	14579	23	were	be	VBD
cord-005453-4057qib7	14579	24	given	give	VBN
cord-005453-4057qib7	14579	25	plerixafor	plerixafor	NN
cord-005453-4057qib7	14579	26	.	.	.
cord-005453-4057qib7	14580	1	We	-PRON-	PRP
cord-005453-4057qib7	14580	2	performed	perform	VBD
cord-005453-4057qib7	14580	3	regression	regression	NN
cord-005453-4057qib7	14580	4	analyses	analysis	NNS
cord-005453-4057qib7	14580	5	to	to	TO
cord-005453-4057qib7	14580	6	analyze	analyze	VB
cord-005453-4057qib7	14580	7	the	the	DT
cord-005453-4057qib7	14580	8	impact	impact	NN
cord-005453-4057qib7	14580	9	of	of	IN
cord-005453-4057qib7	14580	10	a	a	DT
cord-005453-4057qib7	14580	11	variety	variety	NN
cord-005453-4057qib7	14580	12	of	of	IN
cord-005453-4057qib7	14580	13	precollection	precollection	NN
cord-005453-4057qib7	14580	14	factors	factor	NNS
cord-005453-4057qib7	14580	15	,	,	,
cord-005453-4057qib7	14580	16	including	include	VBG
cord-005453-4057qib7	14580	17	days	day	NNS
cord-005453-4057qib7	14580	18	from	from	IN
cord-005453-4057qib7	14580	19	last	last	JJ
cord-005453-4057qib7	14580	20	bortezomib	bortezomib	NN
cord-005453-4057qib7	14580	21	therapy	therapy	NN
cord-005453-4057qib7	14580	22	on	on	IN
cord-005453-4057qib7	14580	23	the	the	DT
cord-005453-4057qib7	14580	24	collection	collection	NN
cord-005453-4057qib7	14580	25	yield	yield	NN
cord-005453-4057qib7	14580	26	.	.	.
cord-005453-4057qib7	14581	1	Results	result	NNS
cord-005453-4057qib7	14581	2	:	:	:
cord-005453-4057qib7	14582	1	We	-PRON-	PRP
cord-005453-4057qib7	14582	2	identified	identify	VBD
cord-005453-4057qib7	14582	3	75	75	CD
cord-005453-4057qib7	14582	4	patients	patient	NNS
cord-005453-4057qib7	14582	5	who	who	WP
cord-005453-4057qib7	14582	6	fulfilled	fulfil	VBD
cord-005453-4057qib7	14582	7	the	the	DT
cord-005453-4057qib7	14582	8	inclusion	inclusion	NN
cord-005453-4057qib7	14582	9	criteria	criterion	NNS
cord-005453-4057qib7	14582	10	,	,	,
cord-005453-4057qib7	14582	11	Table	table	NN
cord-005453-4057qib7	14582	12	.	.	.
cord-005453-4057qib7	14583	1	Median	median	JJ
cord-005453-4057qib7	14583	2	time	time	NN
cord-005453-4057qib7	14583	3	from	from	IN
cord-005453-4057qib7	14583	4	last	last	JJ
cord-005453-4057qib7	14583	5	dose	dose	NN
cord-005453-4057qib7	14583	6	of	of	IN
cord-005453-4057qib7	14583	7	brotezomib	brotezomib	NNP
cord-005453-4057qib7	14583	8	to	to	IN
cord-005453-4057qib7	14583	9	first	first	JJ
cord-005453-4057qib7	14583	10	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	14583	11	was	be	VBD
cord-005453-4057qib7	14583	12	11	11	CD
cord-005453-4057qib7	14584	1	(	(	-LRB-
cord-005453-4057qib7	14584	2	range	range	NN
cord-005453-4057qib7	14584	3	,	,	,
cord-005453-4057qib7	14584	4	2	2	CD
cord-005453-4057qib7	14584	5	-	-	SYM
cord-005453-4057qib7	14584	6	27	27	CD
cord-005453-4057qib7	14584	7	)	)	-RRB-
cord-005453-4057qib7	14584	8	days	day	NNS
cord-005453-4057qib7	14584	9	.	.	.
cord-005453-4057qib7	14585	1	A	a	DT
cord-005453-4057qib7	14585	2	statistically	statistically	RB
cord-005453-4057qib7	14585	3	significant	significant	JJ
cord-005453-4057qib7	14585	4	correlation	correlation	NN
cord-005453-4057qib7	14585	5	was	be	VBD
cord-005453-4057qib7	14585	6	found	find	VBN
cord-005453-4057qib7	14585	7	between	between	IN
cord-005453-4057qib7	14585	8	the	the	DT
cord-005453-4057qib7	14585	9	days	day	NNS
cord-005453-4057qib7	14585	10	from	from	IN
cord-005453-4057qib7	14585	11	last	last	JJ
cord-005453-4057qib7	14585	12	dose	dose	NN
cord-005453-4057qib7	14585	13	of	of	IN
cord-005453-4057qib7	14585	14	brotezomib	brotezomib	NN
cord-005453-4057qib7	14585	15	and	and	CC
cord-005453-4057qib7	14585	16	both	both	CC
cord-005453-4057qib7	14585	17	the	the	DT
cord-005453-4057qib7	14585	18	first	first	JJ
cord-005453-4057qib7	14585	19	collection	collection	NN
cord-005453-4057qib7	14585	20	day	day	NN
cord-005453-4057qib7	14585	21	-	-	HYPH
cord-005453-4057qib7	14585	22	CD34	CD34	NNP
cord-005453-4057qib7	14585	23	+	+	CC
cord-005453-4057qib7	14585	24	cells	cell	NNS
cord-005453-4057qib7	14585	25	/	/	SYM
cord-005453-4057qib7	14585	26	kg	kg	NN
cord-005453-4057qib7	14585	27	(	(	-LRB-
cord-005453-4057qib7	14585	28	r=0.466	r=0.466	NNP
cord-005453-4057qib7	14585	29	,	,	,
cord-005453-4057qib7	14585	30	P	p	NN
cord-005453-4057qib7	14585	31	<	<	XX
cord-005453-4057qib7	14585	32	0.001	0.001	CD
cord-005453-4057qib7	14585	33	)	)	-RRB-
cord-005453-4057qib7	14585	34	,	,	,
cord-005453-4057qib7	14585	35	and	and	CC
cord-005453-4057qib7	14585	36	the	the	DT
cord-005453-4057qib7	14585	37	total	total	NN
cord-005453-4057qib7	14585	38	collected	collect	VBN
cord-005453-4057qib7	14585	39	CD34	CD34	NNP
cord-005453-4057qib7	14586	1	+	+	CC
cord-005453-4057qib7	14586	2	cells	cell	NNS
cord-005453-4057qib7	14586	3	/	/	SYM
cord-005453-4057qib7	14586	4	kg(r=0.341	kg(r=0.341	NN
cord-005453-4057qib7	14586	5	,	,	,
cord-005453-4057qib7	14586	6	P=0.03	P=0.03	NNP
cord-005453-4057qib7	14586	7	)	)	-RRB-
cord-005453-4057qib7	14586	8	,	,	,
cord-005453-4057qib7	14586	9	Figure	figure	NN
cord-005453-4057qib7	14586	10	.	.	.
cord-005453-4057qib7	14587	1	The	the	DT
cord-005453-4057qib7	14587	2	optimal	optimal	JJ
cord-005453-4057qib7	14587	3	cutoff	cutoff	NN
cord-005453-4057qib7	14587	4	point	point	NN
cord-005453-4057qib7	14587	5	as	as	IN
cord-005453-4057qib7	14587	6	indicated	indicate	VBN
cord-005453-4057qib7	14587	7	by	by	IN
cord-005453-4057qib7	14587	8	the	the	DT
cord-005453-4057qib7	14587	9	ROC	ROC	NNP
cord-005453-4057qib7	14587	10	curve	curve	NN
cord-005453-4057qib7	14587	11	was	be	VBD
cord-005453-4057qib7	14587	12	8.5	8.5	CD
cord-005453-4057qib7	14587	13	days	day	NNS
cord-005453-4057qib7	14587	14	according	accord	VBG
cord-005453-4057qib7	14587	15	to	to	IN
cord-005453-4057qib7	14587	16	collection	collection	NN
cord-005453-4057qib7	14587	17	success	success	NN
cord-005453-4057qib7	14587	18	with	with	IN
cord-005453-4057qib7	14587	19	sensitivity	sensitivity	NN
cord-005453-4057qib7	14587	20	of	of	IN
cord-005453-4057qib7	14587	21	79	79	CD
cord-005453-4057qib7	14587	22	%	%	NN
cord-005453-4057qib7	14587	23	and	and	CC
cord-005453-4057qib7	14587	24	specificity	specificity	NN
cord-005453-4057qib7	14587	25	of	of	IN
cord-005453-4057qib7	14587	26	74	74	CD
cord-005453-4057qib7	14587	27	%	%	NN
cord-005453-4057qib7	14587	28	,	,	,
cord-005453-4057qib7	14587	29	Youden´s	Youden´s	NNPS
cord-005453-4057qib7	14587	30	index	index	NN
cord-005453-4057qib7	14587	31	0.52	0.52	CD
cord-005453-4057qib7	14587	32	.	.	.
cord-005453-4057qib7	14588	1	In	in	IN
cord-005453-4057qib7	14588	2	multivariate	multivariate	JJ
cord-005453-4057qib7	14588	3	analysis	analysis	NN
cord-005453-4057qib7	14588	4	included	include	VBD
cord-005453-4057qib7	14588	5	other	other	JJ
cord-005453-4057qib7	14588	6	factors	factor	NNS
cord-005453-4057qib7	14588	7	affecting	affect	VBG
cord-005453-4057qib7	14588	8	collection	collection	NN
cord-005453-4057qib7	14588	9	yield	yield	NN
cord-005453-4057qib7	14588	10	(	(	-LRB-
cord-005453-4057qib7	14588	11	age	age	NN
cord-005453-4057qib7	14588	12	,	,	,
cord-005453-4057qib7	14588	13	gender	gender	NN
cord-005453-4057qib7	14588	14	,	,	,
cord-005453-4057qib7	14588	15	status	status	NN
cord-005453-4057qib7	14588	16	of	of	IN
cord-005453-4057qib7	14588	17	disease	disease	NN
cord-005453-4057qib7	14588	18	at	at	IN
cord-005453-4057qib7	14588	19	collection	collection	NN
cord-005453-4057qib7	14588	20	,	,	,
cord-005453-4057qib7	14588	21	and	and	CC
cord-005453-4057qib7	14588	22	prior	prior	JJ
cord-005453-4057qib7	14588	23	radiation	radiation	NN
cord-005453-4057qib7	14588	24	)	)	-RRB-
cord-005453-4057qib7	14589	1	-timing	-timing	:
cord-005453-4057qib7	14589	2	of	of	IN
cord-005453-4057qib7	14589	3	last	last	JJ
cord-005453-4057qib7	14589	4	dose	dose	NN
cord-005453-4057qib7	14589	5	of	of	IN
cord-005453-4057qib7	14589	6	brotizomib	brotizomib	NN
cord-005453-4057qib7	14589	7	remained	remain	VBD
cord-005453-4057qib7	14589	8	significantly	significantly	RB
cord-005453-4057qib7	14589	9	associated	associate	VBN
cord-005453-4057qib7	14589	10	with	with	IN
cord-005453-4057qib7	14589	11	the	the	DT
cord-005453-4057qib7	14589	12	total	total	NN
cord-005453-4057qib7	14589	13	collected	collect	VBN
cord-005453-4057qib7	14589	14	CD34	CD34	NNP
cord-005453-4057qib7	14589	15	+	+	CC
cord-005453-4057qib7	14589	16	cells	cell	NNS
cord-005453-4057qib7	14589	17	/	/	SYM
cord-005453-4057qib7	14589	18	kg	kg	NN
cord-005453-4057qib7	14589	19	(	(	-LRB-
cord-005453-4057qib7	14589	20	p=0.01	p=0.01	NNP
cord-005453-4057qib7	14589	21	)	)	-RRB-
cord-005453-4057qib7	14589	22	.	.	.
cord-005453-4057qib7	14590	1	Increasing	increase	VBG
cord-005453-4057qib7	14590	2	age	age	NN
cord-005453-4057qib7	14590	3	,	,	,
cord-005453-4057qib7	14590	4	female	female	JJ
cord-005453-4057qib7	14590	5	gender	gender	NN
cord-005453-4057qib7	14590	6	,	,	,
cord-005453-4057qib7	14590	7	and	and	CC
cord-005453-4057qib7	14590	8	prior	prior	JJ
cord-005453-4057qib7	14590	9	radiation	radiation	NN
cord-005453-4057qib7	14590	10	were	be	VBD
cord-005453-4057qib7	14590	11	associated	associate	VBN
cord-005453-4057qib7	14590	12	with	with	IN
cord-005453-4057qib7	14590	13	lower	low	JJR
cord-005453-4057qib7	14590	14	collection	collection	NN
cord-005453-4057qib7	14590	15	yield	yield	NN
cord-005453-4057qib7	14590	16	(	(	-LRB-
cord-005453-4057qib7	14590	17	p=0.006	p=0.006	NNS
cord-005453-4057qib7	14590	18	,	,	,
cord-005453-4057qib7	14590	19	0.012	0.012	CD
cord-005453-4057qib7	14590	20	,	,	,
cord-005453-4057qib7	14590	21	0.043	0.043	CD
cord-005453-4057qib7	14590	22	,	,	,
cord-005453-4057qib7	14590	23	respectively	respectively	RB
cord-005453-4057qib7	14590	24	)	)	-RRB-
cord-005453-4057qib7	14590	25	.	.	.
cord-005453-4057qib7	14591	1	Based	base	VBN
cord-005453-4057qib7	14591	2	on	on	IN
cord-005453-4057qib7	14591	3	this	this	DT
cord-005453-4057qib7	14591	4	,	,	,
cord-005453-4057qib7	14591	5	we	-PRON-	PRP
cord-005453-4057qib7	14591	6	developed	develop	VBD
cord-005453-4057qib7	14591	7	a	a	DT
cord-005453-4057qib7	14591	8	model	model	NN
cord-005453-4057qib7	14591	9	to	to	TO
cord-005453-4057qib7	14591	10	predict	predict	VB
cord-005453-4057qib7	14591	11	the	the	DT
cord-005453-4057qib7	14591	12	total	total	NN
cord-005453-4057qib7	14591	13	collected	collect	VBN
cord-005453-4057qib7	14591	14	CD34pos	cd34pos	NN
cord-005453-4057qib7	14591	15	cells	cell	NNS
cord-005453-4057qib7	14591	16	=	=	NFP
cord-005453-4057qib7	14592	1	11.76	11.76	CD
cord-005453-4057qib7	14592	2	+	+	CD
cord-005453-4057qib7	14592	3	0.13	0.13	CD
cord-005453-4057qib7	14593	1	(	(	-LRB-
cord-005453-4057qib7	14593	2	timing	timing	NN
cord-005453-4057qib7	14593	3	in	in	IN
cord-005453-4057qib7	14593	4	days	day	NNS
cord-005453-4057qib7	14593	5	of	of	IN
cord-005453-4057qib7	14593	6	last	last	JJ
cord-005453-4057qib7	14593	7	dose	dose	NN
cord-005453-4057qib7	14593	8	of	of	IN
cord-005453-4057qib7	14593	9	brotezomib	brotezomib	JJ
cord-005453-4057qib7	14593	10	)	)	-RRB-
cord-005453-4057qib7	14593	11	-0.1	-0.1	.
cord-005453-4057qib7	14593	12	(	(	-LRB-
cord-005453-4057qib7	14593	13	age	age	NN
cord-005453-4057qib7	14593	14	)	)	-RRB-
cord-005453-4057qib7	14594	1	-1.39	-1.39	CD
cord-005453-4057qib7	14595	1	(	(	-LRB-
cord-005453-4057qib7	14595	2	if	if	IN
cord-005453-4057qib7	14595	3	female	female	JJ
cord-005453-4057qib7	14595	4	)	)	-RRB-
cord-005453-4057qib7	14595	5	-0.01	-0.01	CD
cord-005453-4057qib7	14596	1	(	(	-LRB-
cord-005453-4057qib7	14596	2	≥PR	≥pr	NN
cord-005453-4057qib7	14596	3	)	)	-RRB-
cord-005453-4057qib7	14597	1	-1.35	-1.35	:
cord-005453-4057qib7	14598	1	(	(	-LRB-
cord-005453-4057qib7	14598	2	if	if	IN
cord-005453-4057qib7	14598	3	prior	prior	JJ
cord-005453-4057qib7	14598	4	radation	radation	NN
cord-005453-4057qib7	14598	5	)	)	-RRB-
cord-005453-4057qib7	14598	6	.	.	.
cord-005453-4057qib7	14599	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14599	2	:	:	:
cord-005453-4057qib7	14600	1	Timing	timing	NN
cord-005453-4057qib7	14600	2	of	of	IN
cord-005453-4057qib7	14600	3	last	last	JJ
cord-005453-4057qib7	14600	4	dose	dose	NN
cord-005453-4057qib7	14600	5	of	of	IN
cord-005453-4057qib7	14600	6	brotezomib	brotezomib	NNP
cord-005453-4057qib7	14600	7	is	be	VBZ
cord-005453-4057qib7	14600	8	an	an	DT
cord-005453-4057qib7	14600	9	important	important	JJ
cord-005453-4057qib7	14600	10	factor	factor	NN
cord-005453-4057qib7	14600	11	for	for	IN
cord-005453-4057qib7	14600	12	predicting	predict	VBG
cord-005453-4057qib7	14600	13	a	a	DT
cord-005453-4057qib7	14600	14	successful	successful	JJ
cord-005453-4057qib7	14600	15	collection	collection	NN
cord-005453-4057qib7	14600	16	.	.	.
cord-005453-4057qib7	14601	1	A	a	DT
cord-005453-4057qib7	14601	2	washout	washout	NN
cord-005453-4057qib7	14601	3	period	period	NN
cord-005453-4057qib7	14601	4	of	of	IN
cord-005453-4057qib7	14601	5	9	9	CD
cord-005453-4057qib7	14601	6	days	day	NNS
cord-005453-4057qib7	14601	7	is	be	VBZ
cord-005453-4057qib7	14601	8	associated	associate	VBN
cord-005453-4057qib7	14601	9	with	with	IN
cord-005453-4057qib7	14601	10	a	a	DT
cord-005453-4057qib7	14601	11	better	well	JJR
cord-005453-4057qib7	14601	12	collection	collection	NN
cord-005453-4057qib7	14601	13	yield	yield	NN
cord-005453-4057qib7	14601	14	.	.	.
cord-005453-4057qib7	14602	1	These	these	DT
cord-005453-4057qib7	14602	2	results	result	NNS
cord-005453-4057qib7	14602	3	should	should	MD
cord-005453-4057qib7	14602	4	be	be	VB
cord-005453-4057qib7	14602	5	further	further	RB
cord-005453-4057qib7	14602	6	validated	validate	VBN
cord-005453-4057qib7	14602	7	in	in	IN
cord-005453-4057qib7	14602	8	a	a	DT
cord-005453-4057qib7	14602	9	prospective	prospective	JJ
cord-005453-4057qib7	14602	10	study	study	NN
cord-005453-4057qib7	14602	11	.	.	.
cord-005453-4057qib7	14603	1	Age	age	NN
cord-005453-4057qib7	14603	2	(	(	-LRB-
cord-005453-4057qib7	14603	3	median	median	NN
cord-005453-4057qib7	14603	4	,	,	,
cord-005453-4057qib7	14603	5	range	range	NN
cord-005453-4057qib7	14603	6	)	)	-RRB-
cord-005453-4057qib7	14603	7	63	63	CD
cord-005453-4057qib7	14603	8	(	(	-LRB-
cord-005453-4057qib7	14603	9	37	37	CD
cord-005453-4057qib7	14603	10	-	-	SYM
cord-005453-4057qib7	14603	11	78	78	CD
cord-005453-4057qib7	14603	12	)	)	-RRB-
cord-005453-4057qib7	14604	1	Gender	gender	NN
cord-005453-4057qib7	14604	2	-male	-male	NN
cord-005453-4057qib7	14604	3	(	(	-LRB-
cord-005453-4057qib7	14604	4	%	%	NN
cord-005453-4057qib7	14604	5	)	)	-RRB-
cord-005453-4057qib7	14604	6	44	44	CD
cord-005453-4057qib7	14604	7	(	(	-LRB-
cord-005453-4057qib7	14604	8	59	59	CD
cord-005453-4057qib7	14604	9	)	)	-RRB-
cord-005453-4057qib7	14605	1	Prior	prior	JJ
cord-005453-4057qib7	14605	2	radiation	radiation	NN
cord-005453-4057qib7	14605	3	treatment	treatment	NN
cord-005453-4057qib7	14605	4	(	(	-LRB-
cord-005453-4057qib7	14605	5	%	%	NN
cord-005453-4057qib7	14605	6	)	)	-RRB-
cord-005453-4057qib7	14605	7	18	18	CD
cord-005453-4057qib7	14605	8	(	(	-LRB-
cord-005453-4057qib7	14605	9	24	24	CD
cord-005453-4057qib7	14605	10	)	)	-RRB-
cord-005453-4057qib7	14605	11	Disease	Disease	NNP
cord-005453-4057qib7	14605	12	status	status	NN
cord-005453-4057qib7	14605	13	at	at	IN
cord-005453-4057qib7	14605	14	collection	collection	NN
cord-005453-4057qib7	14605	15	(	(	-LRB-
cord-005453-4057qib7	14605	16	%	%	NN
cord-005453-4057qib7	14605	17	)	)	-RRB-
cord-005453-4057qib7	14606	1	≥PR	≥pr	CD
cord-005453-4057qib7	14607	1	-51	-51	NNP
cord-005453-4057qib7	14608	1	(	(	-LRB-
cord-005453-4057qib7	14608	2	Disclosure	disclosure	NN
cord-005453-4057qib7	14608	3	:	:	:
cord-005453-4057qib7	14608	4	Nothing	nothing	NN
cord-005453-4057qib7	14608	5	to	to	TO
cord-005453-4057qib7	14608	6	declare	declare	VB
cord-005453-4057qib7	14608	7	P685	P685	NNP
cord-005453-4057qib7	14608	8	Mobilization	Mobilization	NNP
cord-005453-4057qib7	14608	9	with	with	IN
cord-005453-4057qib7	14608	10	plerixafor	plerixafor	NN
cord-005453-4057qib7	14608	11	in	in	IN
cord-005453-4057qib7	14608	12	"	"	``
cord-005453-4057qib7	14608	13	poor	poor	JJ
cord-005453-4057qib7	14608	14	mobilizer	mobilizer	NN
cord-005453-4057qib7	14608	15	"	"	''
cord-005453-4057qib7	14608	16	related	relate	VBN
cord-005453-4057qib7	14608	17	and	and	CC
cord-005453-4057qib7	14608	18	unrelated	unrelated	JJ
cord-005453-4057qib7	14608	19	donors	donor	NNS
cord-005453-4057qib7	14608	20	of	of	IN
cord-005453-4057qib7	14608	21	HPC	HPC	NNP
cord-005453-4057qib7	14608	22	-	-	,
cord-005453-4057qib7	14608	23	a	a	NN
cord-005453-4057qib7	14608	24	in	in	IN
cord-005453-4057qib7	14608	25	case	case	NN
cord-005453-4057qib7	14608	26	of	of	IN
cord-005453-4057qib7	14608	27	failed	fail	VBN
cord-005453-4057qib7	14608	28	mobilization	mobilization	NN
cord-005453-4057qib7	14608	29	with	with	IN
cord-005453-4057qib7	14608	30	G	G	NNP
cord-005453-4057qib7	14608	31	-	-	HYPH
cord-005453-4057qib7	14608	32	CSF	CSF	NNP
cord-005453-4057qib7	14608	33	Background	Background	NNP
cord-005453-4057qib7	14608	34	:	:	:
cord-005453-4057qib7	14608	35	In	in	IN
cord-005453-4057qib7	14608	36	the	the	DT
cord-005453-4057qib7	14608	37	allogeneic	allogeneic	JJ
cord-005453-4057qib7	14608	38	HPC	hpc	NN
cord-005453-4057qib7	14608	39	transplantation	transplantation	NN
cord-005453-4057qib7	14608	40	,	,	,
cord-005453-4057qib7	14608	41	both	both	CC
cord-005453-4057qib7	14608	42	from	from	IN
cord-005453-4057qib7	14608	43	related	related	JJ
cord-005453-4057qib7	14608	44	and	and	CC
cord-005453-4057qib7	14608	45	unrelated	unrelated	JJ
cord-005453-4057qib7	14608	46	donors	donor	NNS
cord-005453-4057qib7	14608	47	,	,	,
cord-005453-4057qib7	14608	48	the	the	DT
cord-005453-4057qib7	14608	49	most	most	RBS
cord-005453-4057qib7	14608	50	commonly	commonly	RB
cord-005453-4057qib7	14608	51	used	use	VBN
cord-005453-4057qib7	14608	52	source	source	NN
cord-005453-4057qib7	14608	53	is	be	VBZ
cord-005453-4057qib7	14608	54	peripheral	peripheral	JJ
cord-005453-4057qib7	14608	55	blood	blood	NN
cord-005453-4057qib7	14608	56	after	after	IN
cord-005453-4057qib7	14608	57	mobilization	mobilization	NN
cord-005453-4057qib7	14608	58	with	with	IN
cord-005453-4057qib7	14608	59	G	G	NNP
cord-005453-4057qib7	14608	60	-	-	HYPH
cord-005453-4057qib7	14608	61	CSF	CSF	NNP
cord-005453-4057qib7	14608	62	.	.	.
cord-005453-4057qib7	14609	1	It	-PRON-	PRP
cord-005453-4057qib7	14609	2	is	be	VBZ
cord-005453-4057qib7	14609	3	however	however	RB
cord-005453-4057qib7	14609	4	known	know	VBN
cord-005453-4057qib7	14609	5	that	that	IN
cord-005453-4057qib7	14609	6	about	about	RB
cord-005453-4057qib7	14609	7	2	2	CD
cord-005453-4057qib7	14609	8	%	%	NN
cord-005453-4057qib7	14609	9	of	of	IN
cord-005453-4057qib7	14609	10	donors	donor	NNS
cord-005453-4057qib7	14609	11	are	be	VBP
cord-005453-4057qib7	14609	12	"	"	``
cord-005453-4057qib7	14609	13	poor	poor	JJ
cord-005453-4057qib7	14609	14	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14609	15	"	"	''
cord-005453-4057qib7	14609	16	;	;	:
cord-005453-4057qib7	14609	17	the	the	DT
cord-005453-4057qib7	14609	18	rescue	rescue	NN
cord-005453-4057qib7	14609	19	strategies	strategy	NNS
cord-005453-4057qib7	14609	20	are	be	VBP
cord-005453-4057qib7	14609	21	:	:	:
cord-005453-4057qib7	14609	22	a	a	DT
cord-005453-4057qib7	14609	23	third	third	JJ
cord-005453-4057qib7	14609	24	apheretic	apheretic	JJ
cord-005453-4057qib7	14609	25	collection	collection	NN
cord-005453-4057qib7	14609	26	;	;	:
cord-005453-4057qib7	14609	27	bone	bone	NN
cord-005453-4057qib7	14609	28	marrow	marrow	NN
cord-005453-4057qib7	14609	29	donation	donation	NN
cord-005453-4057qib7	14609	30	.	.	.
cord-005453-4057qib7	14610	1	Methods	method	NNS
cord-005453-4057qib7	14610	2	:	:	:
cord-005453-4057qib7	14611	1	In	in	IN
cord-005453-4057qib7	14611	2	2016	2016	CD
cord-005453-4057qib7	14611	3	-	-	SYM
cord-005453-4057qib7	14611	4	2017	2017	CD
cord-005453-4057qib7	14611	5	in	in	IN
cord-005453-4057qib7	14611	6	Italy	Italy	NNP
cord-005453-4057qib7	14611	7	a	a	DT
cord-005453-4057qib7	14611	8	procedure	procedure	NN
cord-005453-4057qib7	14611	9	to	to	TO
cord-005453-4057qib7	14611	10	be	be	VB
cord-005453-4057qib7	14611	11	adopted	adopt	VBN
cord-005453-4057qib7	14611	12	in	in	IN
cord-005453-4057qib7	14611	13	case	case	NN
cord-005453-4057qib7	14611	14	of	of	IN
cord-005453-4057qib7	14611	15	failed	fail	VBN
cord-005453-4057qib7	14611	16	mobilization	mobilization	NN
cord-005453-4057qib7	14611	17	of	of	IN
cord-005453-4057qib7	14611	18	peripheral	peripheral	JJ
cord-005453-4057qib7	14611	19	blood	blood	NN
cord-005453-4057qib7	14611	20	stem	stem	NN
cord-005453-4057qib7	14611	21	cells	cell	NNS
cord-005453-4057qib7	14611	22	has	have	VBZ
cord-005453-4057qib7	14611	23	been	be	VBN
cord-005453-4057qib7	14611	24	defined	define	VBN
cord-005453-4057qib7	14611	25	and	and	CC
cord-005453-4057qib7	14611	26	shared	share	VBN
cord-005453-4057qib7	14611	27	between	between	IN
cord-005453-4057qib7	14611	28	IBMDR	IBMDR	NNP
cord-005453-4057qib7	14611	29	,	,	,
cord-005453-4057qib7	14611	30	CNT	CNT	NNP
cord-005453-4057qib7	14611	31	(	(	-LRB-
cord-005453-4057qib7	14611	32	Transplant	Transplant	NNP
cord-005453-4057qib7	14611	33	National	National	NNP
cord-005453-4057qib7	14611	34	Center	Center	NNP
cord-005453-4057qib7	14611	35	)	)	-RRB-
cord-005453-4057qib7	14611	36	and	and	CC
cord-005453-4057qib7	14611	37	CNS	CNS	NNP
cord-005453-4057qib7	14611	38	(	(	-LRB-
cord-005453-4057qib7	14611	39	Blood	Blood	NNP
cord-005453-4057qib7	14611	40	National	National	NNP
cord-005453-4057qib7	14611	41	Center	Center	NNP
cord-005453-4057qib7	14611	42	)	)	-RRB-
cord-005453-4057qib7	14611	43	and	and	CC
cord-005453-4057qib7	14611	44	the	the	DT
cord-005453-4057qib7	14611	45	Scientific	Scientific	NNP
cord-005453-4057qib7	14611	46	Societies	Societies	NNPS
cord-005453-4057qib7	14611	47	SIMTI	SIMTI	NNP
cord-005453-4057qib7	14611	48	,	,	,
cord-005453-4057qib7	14611	49	SIdEM	SIdEM	NNP
cord-005453-4057qib7	14611	50	and	and	CC
cord-005453-4057qib7	14611	51	GITMO	GITMO	NNP
cord-005453-4057qib7	14611	52	,	,	,
cord-005453-4057qib7	14611	53	using	use	VBG
cord-005453-4057qib7	14611	54	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14611	55	,	,	,
cord-005453-4057qib7	14611	56	a	a	DT
cord-005453-4057qib7	14611	57	selective	selective	JJ
cord-005453-4057qib7	14611	58	reversible	reversible	JJ
cord-005453-4057qib7	14611	59	antagonist	antagonist	NN
cord-005453-4057qib7	14611	60	of	of	IN
cord-005453-4057qib7	14611	61	the	the	DT
cord-005453-4057qib7	14611	62	CXCR4	CXCR4	NNP
cord-005453-4057qib7	14611	63	receptor	receptor	NN
cord-005453-4057qib7	14611	64	with	with	IN
cord-005453-4057qib7	14611	65	its	-PRON-	PRP$
cord-005453-4057qib7	14611	66	binder	binder	NN
cord-005453-4057qib7	14611	67	(	(	-LRB-
cord-005453-4057qib7	14611	68	the	the	DT
cord-005453-4057qib7	14611	69	stromal	stromal	NN
cord-005453-4057qib7	14611	70	derived	derive	VBN
cord-005453-4057qib7	14611	71	factor	factor	NN
cord-005453-4057qib7	14611	72	SDF-1	SDF-1	NNP
cord-005453-4057qib7	14611	73	)	)	-RRB-
cord-005453-4057qib7	14611	74	,	,	,
cord-005453-4057qib7	14611	75	in	in	IN
cord-005453-4057qib7	14611	76	combination	combination	NN
cord-005453-4057qib7	14611	77	with	with	IN
cord-005453-4057qib7	14611	78	standard	standard	JJ
cord-005453-4057qib7	14611	79	G	G	NNP
cord-005453-4057qib7	14611	80	-	-	HYPH
cord-005453-4057qib7	14611	81	CSF	CSF	NNP
cord-005453-4057qib7	14611	82	dose	dose	NN
cord-005453-4057qib7	14611	83	.	.	.
cord-005453-4057qib7	14612	1	Moreover	moreover	RB
cord-005453-4057qib7	14612	2	since	since	IN
cord-005453-4057qib7	14612	3	2017	2017	CD
cord-005453-4057qib7	14612	4	,	,	,
cord-005453-4057qib7	14612	5	in	in	IN
cord-005453-4057qib7	14612	6	accordance	accordance	NN
cord-005453-4057qib7	14612	7	with	with	IN
cord-005453-4057qib7	14612	8	this	this	DT
cord-005453-4057qib7	14612	9	protocol	protocol	NN
cord-005453-4057qib7	14612	10	,	,	,
cord-005453-4057qib7	14612	11	the	the	DT
cord-005453-4057qib7	14612	12	Competent	Competent	NNP
cord-005453-4057qib7	14612	13	Authority	Authority	NNP
cord-005453-4057qib7	14612	14	(	(	-LRB-
cord-005453-4057qib7	14612	15	AIFA	AIFA	NNP
cord-005453-4057qib7	14612	16	)	)	-RRB-
cord-005453-4057qib7	14612	17	has	have	VBZ
cord-005453-4057qib7	14612	18	extended	extend	VBN
cord-005453-4057qib7	14612	19	the	the	DT
cord-005453-4057qib7	14612	20	registration	registration	NN
cord-005453-4057qib7	14612	21	of	of	IN
cord-005453-4057qib7	14612	22	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14612	23	(	(	-LRB-
cord-005453-4057qib7	14612	24	Law	Law	NNP
cord-005453-4057qib7	14612	25	no.648/96	no.648/96	NNP
cord-005453-4057qib7	14612	26	)	)	-RRB-
cord-005453-4057qib7	14612	27	,	,	,
cord-005453-4057qib7	14612	28	also	also	RB
cord-005453-4057qib7	14612	29	for	for	IN
cord-005453-4057qib7	14612	30	the	the	DT
cord-005453-4057qib7	14612	31	mobilization	mobilization	NN
cord-005453-4057qib7	14612	32	in	in	IN
cord-005453-4057qib7	14612	33	"	"	``
cord-005453-4057qib7	14612	34	poor	poor	JJ
cord-005453-4057qib7	14612	35	mobilizer	mobilizer	NN
cord-005453-4057qib7	14612	36	"	"	''
cord-005453-4057qib7	14612	37	healthy	healthy	JJ
cord-005453-4057qib7	14612	38	donors	donor	NNS
cord-005453-4057qib7	14612	39	.	.	.
cord-005453-4057qib7	14613	1	Finally	finally	RB
cord-005453-4057qib7	14613	2	,	,	,
cord-005453-4057qib7	14613	3	in	in	IN
cord-005453-4057qib7	14613	4	2018	2018	CD
cord-005453-4057qib7	14613	5	the	the	DT
cord-005453-4057qib7	14613	6	protocol	protocol	NN
cord-005453-4057qib7	14613	7	was	be	VBD
cord-005453-4057qib7	14613	8	extended	extend	VBN
cord-005453-4057qib7	14613	9	to	to	IN
cord-005453-4057qib7	14613	10	"	"	``
cord-005453-4057qib7	14613	11	poor	poor	JJ
cord-005453-4057qib7	14613	12	mobilizer	mobilizer	NN
cord-005453-4057qib7	14613	13	"	"	''
cord-005453-4057qib7	14613	14	family	family	NN
cord-005453-4057qib7	14613	15	donors	donor	NNS
cord-005453-4057qib7	14613	16	,	,	,
cord-005453-4057qib7	14613	17	making	make	VBG
cord-005453-4057qib7	14613	18	management	management	NN
cord-005453-4057qib7	14613	19	equivalent	equivalent	JJ
cord-005453-4057qib7	14613	20	in	in	IN
cord-005453-4057qib7	14613	21	related	related	JJ
cord-005453-4057qib7	14613	22	and	and	CC
cord-005453-4057qib7	14613	23	unrelated	unrelated	JJ
cord-005453-4057qib7	14613	24	donors	donor	NNS
cord-005453-4057qib7	14613	25	.	.	.
cord-005453-4057qib7	14614	1	At	at	IN
cord-005453-4057qib7	14614	2	the	the	DT
cord-005453-4057qib7	14614	3	time	time	NN
cord-005453-4057qib7	14614	4	of	of	IN
cord-005453-4057qib7	14614	5	the	the	DT
cord-005453-4057qib7	14614	6	donor´s	donor´s	NNP
cord-005453-4057qib7	14614	7	informed	informed	JJ
cord-005453-4057qib7	14614	8	consent	consent	NN
cord-005453-4057qib7	14614	9	for	for	IN
cord-005453-4057qib7	14614	10	the	the	DT
cord-005453-4057qib7	14614	11	donation	donation	NN
cord-005453-4057qib7	14614	12	of	of	IN
cord-005453-4057qib7	14614	13	HPC	HPC	NNP
cord-005453-4057qib7	14614	14	,	,	,
cord-005453-4057qib7	14614	15	the	the	DT
cord-005453-4057qib7	14614	16	hypothesis	hypothesis	NN
cord-005453-4057qib7	14614	17	of	of	IN
cord-005453-4057qib7	14614	18	the	the	DT
cord-005453-4057qib7	14614	19	lack	lack	NN
cord-005453-4057qib7	14614	20	of	of	IN
cord-005453-4057qib7	14614	21	mobilization	mobilization	NN
cord-005453-4057qib7	14614	22	or	or	CC
cord-005453-4057qib7	14614	23	inadequate	inadequate	JJ
cord-005453-4057qib7	14614	24	collection	collection	NN
cord-005453-4057qib7	14614	25	was	be	VBD
cord-005453-4057qib7	14614	26	illustrated	illustrate	VBN
cord-005453-4057qib7	14614	27	and	and	CC
cord-005453-4057qib7	14614	28	the	the	DT
cord-005453-4057qib7	14614	29	possible	possible	JJ
cord-005453-4057qib7	14614	30	actions	action	NNS
cord-005453-4057qib7	14614	31	proposed	propose	VBN
cord-005453-4057qib7	14614	32	as	as	IN
cord-005453-4057qib7	14614	33	"	"	``
cord-005453-4057qib7	14614	34	back	back	RB
cord-005453-4057qib7	14614	35	-	-	HYPH
cord-005453-4057qib7	14614	36	up	up	RP
cord-005453-4057qib7	14614	37	donation	donation	NN
cord-005453-4057qib7	14614	38	"	"	''
cord-005453-4057qib7	14614	39	were	be	VBD
cord-005453-4057qib7	14614	40	anticipated	anticipate	VBN
cord-005453-4057qib7	14614	41	.	.	.
cord-005453-4057qib7	14615	1	Failed	fail	VBN
cord-005453-4057qib7	14615	2	mobilization	mobilization	NN
cord-005453-4057qib7	14615	3	of	of	IN
cord-005453-4057qib7	14615	4	CSE	CSE	NNP
cord-005453-4057qib7	14615	5	has	have	VBZ
cord-005453-4057qib7	14615	6	been	be	VBN
cord-005453-4057qib7	14615	7	defined	define	VBN
cord-005453-4057qib7	14615	8	as	as	IN
cord-005453-4057qib7	14615	9	the	the	DT
cord-005453-4057qib7	14615	10	presence	presence	NN
cord-005453-4057qib7	14615	11	of	of	IN
cord-005453-4057qib7	14615	12	one	one	CD
cord-005453-4057qib7	14615	13	of	of	IN
cord-005453-4057qib7	14615	14	the	the	DT
cord-005453-4057qib7	14615	15	two	two	CD
cord-005453-4057qib7	14615	16	criteria	criterion	NNS
cord-005453-4057qib7	14615	17	:	:	:
cord-005453-4057qib7	14615	18	a	a	DT
cord-005453-4057qib7	14615	19	number	number	NN
cord-005453-4057qib7	14615	20	of	of	IN
cord-005453-4057qib7	14615	21	CD34	CD34	NNP
cord-005453-4057qib7	14615	22	+	+	CC
cord-005453-4057qib7	14615	23	circulating	circulate	VBG
cord-005453-4057qib7	14615	24	on	on	IN
cord-005453-4057qib7	14615	25	peripheral	peripheral	JJ
cord-005453-4057qib7	14615	26	blood	blood	NN
cord-005453-4057qib7	14615	27	lower	low	JJR
cord-005453-4057qib7	14615	28	than	than	IN
cord-005453-4057qib7	14615	29	20	20	CD
cord-005453-4057qib7	14616	1	/μL	/μL	.
cord-005453-4057qib7	14617	1	on	on	IN
cord-005453-4057qib7	14617	2	the	the	DT
cord-005453-4057qib7	14617	3	5th	5th	JJ
cord-005453-4057qib7	14617	4	day	day	NN
cord-005453-4057qib7	14617	5	of	of	IN
cord-005453-4057qib7	14617	6	stimulation	stimulation	NN
cord-005453-4057qib7	14617	7	(	(	-LRB-
cord-005453-4057qib7	14617	8	5D	5D	NNP
cord-005453-4057qib7	14617	9	)	)	-RRB-
cord-005453-4057qib7	14617	10	,	,	,
cord-005453-4057qib7	14617	11	or	or	CC
cord-005453-4057qib7	14617	12	the	the	DT
cord-005453-4057qib7	14617	13	collection	collection	NN
cord-005453-4057qib7	14617	14	of	of	IN
cord-005453-4057qib7	14617	15	CD34	CD34	NNP
cord-005453-4057qib7	14617	16	+	+	SYM
cord-005453-4057qib7	14617	17	<	<	XX
cord-005453-4057qib7	14617	18	1.0x106	1.0x106	NNP
cord-005453-4057qib7	14617	19	/	/	SYM
cord-005453-4057qib7	14617	20	kg	kg	NN
cord-005453-4057qib7	14617	21	weight	weight	NN
cord-005453-4057qib7	14617	22	of	of	IN
cord-005453-4057qib7	14617	23	the	the	DT
cord-005453-4057qib7	14617	24	recipient	recipient	NN
cord-005453-4057qib7	14617	25	at	at	IN
cord-005453-4057qib7	14617	26	first	first	JJ
cord-005453-4057qib7	14617	27	apheresis	apheresis	NN
cord-005453-4057qib7	14617	28	.	.	.
cord-005453-4057qib7	14618	1	In	in	IN
cord-005453-4057qib7	14618	2	these	these	DT
cord-005453-4057qib7	14618	3	cases	case	NNS
cord-005453-4057qib7	14618	4	,	,	,
cord-005453-4057qib7	14618	5	a	a	DT
cord-005453-4057qib7	14618	6	single	single	JJ
cord-005453-4057qib7	14618	7	dose	dose	NN
cord-005453-4057qib7	14618	8	of	of	IN
cord-005453-4057qib7	14618	9	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14618	10	is	be	VBZ
cord-005453-4057qib7	14618	11	administered	administer	VBN
cord-005453-4057qib7	14618	12	subcutaneously	subcutaneously	RB
cord-005453-4057qib7	14618	13	by	by	IN
cord-005453-4057qib7	14618	14	health	health	NN
cord-005453-4057qib7	14618	15	professionals	professional	NNS
cord-005453-4057qib7	14618	16	under	under	IN
cord-005453-4057qib7	14618	17	medical	medical	JJ
cord-005453-4057qib7	14618	18	supervision	supervision	NN
cord-005453-4057qib7	14618	19	,	,	,
cord-005453-4057qib7	14618	20	0.24mg	0.24mg	CD
cord-005453-4057qib7	14618	21	/	/	SYM
cord-005453-4057qib7	14618	22	kg	kg	NNS
cord-005453-4057qib7	14618	23	of	of	IN
cord-005453-4057qib7	14618	24	body	body	NN
cord-005453-4057qib7	14618	25	weight	weight	NN
cord-005453-4057qib7	14618	26	,	,	,
cord-005453-4057qib7	14618	27	6	6	CD
cord-005453-4057qib7	14618	28	-	-	SYM
cord-005453-4057qib7	14618	29	11	11	CD
cord-005453-4057qib7	14618	30	hours	hour	NNS
cord-005453-4057qib7	14618	31	before	before	IN
cord-005453-4057qib7	14618	32	the	the	DT
cord-005453-4057qib7	14618	33	start	start	NN
cord-005453-4057qib7	14618	34	of	of	IN
cord-005453-4057qib7	14618	35	apheresis	apheresis	NN
cord-005453-4057qib7	14618	36	.	.	.
cord-005453-4057qib7	14619	1	In	in	IN
cord-005453-4057qib7	14619	2	case	case	NN
cord-005453-4057qib7	14619	3	of	of	IN
cord-005453-4057qib7	14619	4	use	use	NN
cord-005453-4057qib7	14619	5	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14619	6	due	due	JJ
cord-005453-4057qib7	14619	7	to	to	IN
cord-005453-4057qib7	14619	8	failed	fail	VBN
cord-005453-4057qib7	14619	9	mobilization	mobilization	NN
cord-005453-4057qib7	14619	10	of	of	IN
cord-005453-4057qib7	14619	11	HPC	HPC	NNP
cord-005453-4057qib7	14619	12	-	-	HYPH
cord-005453-4057qib7	14619	13	A	a	NN
cord-005453-4057qib7	14619	14	or	or	CC
cord-005453-4057qib7	14619	15	collection	collection	NN
cord-005453-4057qib7	14619	16	of	of	IN
cord-005453-4057qib7	14619	17	an	an	DT
cord-005453-4057qib7	14619	18	inappropriate	inappropriate	JJ
cord-005453-4057qib7	14619	19	number	number	NN
cord-005453-4057qib7	14619	20	of	of	IN
cord-005453-4057qib7	14619	21	CD34	CD34	NNP
cord-005453-4057qib7	14619	22	+	+	SYM
cord-005453-4057qib7	14619	23	,	,	,
cord-005453-4057qib7	14619	24	the	the	DT
cord-005453-4057qib7	14619	25	notification	notification	NN
cord-005453-4057qib7	14619	26	is	be	VBZ
cord-005453-4057qib7	14619	27	made	make	VBN
cord-005453-4057qib7	14619	28	by	by	IN
cord-005453-4057qib7	14619	29	the	the	DT
cord-005453-4057qib7	14619	30	Collection	Collection	NNP
cord-005453-4057qib7	14619	31	Center	Center	NNP
cord-005453-4057qib7	14619	32	to	to	IN
cord-005453-4057qib7	14619	33	IBMDR	IBMDR	NNP
cord-005453-4057qib7	14619	34	(	(	-LRB-
cord-005453-4057qib7	14619	35	for	for	IN
cord-005453-4057qib7	14619	36	both	both	DT
cord-005453-4057qib7	14619	37	family	family	NN
cord-005453-4057qib7	14619	38	and	and	CC
cord-005453-4057qib7	14619	39	non	non	JJ
cord-005453-4057qib7	14619	40	-	-	JJ
cord-005453-4057qib7	14619	41	family	family	JJ
cord-005453-4057qib7	14619	42	donors	donor	NNS
cord-005453-4057qib7	14619	43	)	)	-RRB-
cord-005453-4057qib7	14619	44	,	,	,
cord-005453-4057qib7	14619	45	and	and	CC
cord-005453-4057qib7	14619	46	to	to	IN
cord-005453-4057qib7	14619	47	the	the	DT
cord-005453-4057qib7	14619	48	recipient	recipient	NN
cord-005453-4057qib7	14619	49	Transplant	Transplant	NNP
cord-005453-4057qib7	14619	50	Center	Center	NNP
cord-005453-4057qib7	14619	51	:	:	:
cord-005453-4057qib7	14619	52	both	both	DT
cord-005453-4057qib7	14619	53	donor	donor	NN
cord-005453-4057qib7	14619	54	and	and	CC
cord-005453-4057qib7	14619	55	recipient	recipient	NN
cord-005453-4057qib7	14619	56	express	express	VBP
cord-005453-4057qib7	14619	57	their	-PRON-	PRP$
cord-005453-4057qib7	14619	58	consent	consent	NN
cord-005453-4057qib7	14619	59	;	;	:
cord-005453-4057qib7	14619	60	finally	finally	RB
cord-005453-4057qib7	14619	61	once	once	IN
cord-005453-4057qib7	14619	62	the	the	DT
cord-005453-4057qib7	14619	63	collection	collection	NN
cord-005453-4057qib7	14619	64	is	be	VBZ
cord-005453-4057qib7	14619	65	completed	complete	VBN
cord-005453-4057qib7	14619	66	,	,	,
cord-005453-4057qib7	14619	67	the	the	DT
cord-005453-4057qib7	14619	68	Collection	Collection	NNP
cord-005453-4057qib7	14619	69	Center	Center	NNP
cord-005453-4057qib7	14619	70	informs	inform	VBZ
cord-005453-4057qib7	14619	71	IBMDR	IBMDR	NNP
cord-005453-4057qib7	14619	72	,	,	,
cord-005453-4057qib7	14619	73	which	which	WDT
cord-005453-4057qib7	14619	74	in	in	IN
cord-005453-4057qib7	14619	75	turn	turn	NN
cord-005453-4057qib7	14619	76	notifies	notify	VBZ
cord-005453-4057qib7	14619	77	CNT	CNT	NNP
cord-005453-4057qib7	14619	78	/	/	SYM
cord-005453-4057qib7	14619	79	CNS	CNS	NNP
cord-005453-4057qib7	14619	80	/	/	SYM
cord-005453-4057qib7	14619	81	SIMTI	SIMTI	NNP
cord-005453-4057qib7	14619	82	/	/	SYM
cord-005453-4057qib7	14619	83	SIDEM	SIDEM	NNP
cord-005453-4057qib7	14619	84	/	/	SYM
cord-005453-4057qib7	14619	85	GITMO	GITMO	NNP
cord-005453-4057qib7	14619	86	.	.	.
cord-005453-4057qib7	14620	1	Any	any	DT
cord-005453-4057qib7	14620	2	adverse	adverse	JJ
cord-005453-4057qib7	14620	3	reactions	reaction	NNS
cord-005453-4057qib7	14620	4	/	/	SYM
cord-005453-4057qib7	14620	5	events	event	NNS
cord-005453-4057qib7	14620	6	are	be	VBP
cord-005453-4057qib7	14620	7	notified	notify	VBN
cord-005453-4057qib7	14620	8	in	in	IN
cord-005453-4057qib7	14620	9	real	real	JJ
cord-005453-4057qib7	14620	10	time	time	NN
cord-005453-4057qib7	14620	11	,	,	,
cord-005453-4057qib7	14620	12	based	base	VBN
cord-005453-4057qib7	14620	13	on	on	IN
cord-005453-4057qib7	14620	14	the	the	DT
cord-005453-4057qib7	14620	15	SOP	sop	NN
cord-005453-4057qib7	14620	16	specifications	specification	NNS
cord-005453-4057qib7	14620	17	and	and	CC
cord-005453-4057qib7	14620	18	current	current	JJ
cord-005453-4057qib7	14620	19	regulations	regulation	NNS
cord-005453-4057qib7	14620	20	.	.	.
cord-005453-4057qib7	14621	1	Results	result	NNS
cord-005453-4057qib7	14621	2	:	:	:
cord-005453-4057qib7	14622	1	Since	since	IN
cord-005453-4057qib7	14622	2	the	the	DT
cord-005453-4057qib7	14622	3	introduction	introduction	NN
cord-005453-4057qib7	14622	4	of	of	IN
cord-005453-4057qib7	14622	5	the	the	DT
cord-005453-4057qib7	14622	6	national	national	JJ
cord-005453-4057qib7	14622	7	protocol	protocol	NN
cord-005453-4057qib7	14622	8	,	,	,
cord-005453-4057qib7	14622	9	7	7	CD
cord-005453-4057qib7	14622	10	donors	donor	NNS
cord-005453-4057qib7	14622	11	(	(	-LRB-
cord-005453-4057qib7	14622	12	4	4	CD
cord-005453-4057qib7	14622	13	unrelated	unrelated	JJ
cord-005453-4057qib7	14622	14	donors	donor	NNS
cord-005453-4057qib7	14622	15	and	and	CC
cord-005453-4057qib7	14622	16	3	3	CD
cord-005453-4057qib7	14622	17	related	related	JJ
cord-005453-4057qib7	14622	18	donors	donor	NNS
cord-005453-4057qib7	14622	19	)	)	-RRB-
cord-005453-4057qib7	14622	20	were	be	VBD
cord-005453-4057qib7	14622	21	treated	treat	VBN
cord-005453-4057qib7	14622	22	,	,	,
cord-005453-4057qib7	14622	23	presenting	present	VBG
cord-005453-4057qib7	14622	24	at	at	RB
cord-005453-4057qib7	14622	25	least	least	RBS
cord-005453-4057qib7	14622	26	one	one	CD
cord-005453-4057qib7	14622	27	of	of	IN
cord-005453-4057qib7	14622	28	the	the	DT
cord-005453-4057qib7	14622	29	two	two	CD
cord-005453-4057qib7	14622	30	inclusion	inclusion	NN
cord-005453-4057qib7	14622	31	criteria	criterion	NNS
cord-005453-4057qib7	14622	32	(	(	-LRB-
cord-005453-4057qib7	14622	33	CD34	CD34	NNP
cord-005453-4057qib7	14622	34	<	<	XX
cord-005453-4057qib7	14622	35	20/	20/	CD
cord-005453-4057qib7	14623	1	μL	μL	.
cord-005453-4057qib7	14624	1	at	at	IN
cord-005453-4057qib7	14624	2	5D	5d	CD
cord-005453-4057qib7	14624	3	or	or	CC
cord-005453-4057qib7	14624	4	CD34	CD34	NNP
cord-005453-4057qib7	14624	5	<	<	XX
cord-005453-4057qib7	14624	6	1x10e6	1x10e6	NNP
cord-005453-4057qib7	14624	7	/	/	SYM
cord-005453-4057qib7	14624	8	Kg	Kg	NNP
cord-005453-4057qib7	14624	9	after	after	IN
cord-005453-4057qib7	14624	10	first	first	JJ
cord-005453-4057qib7	14624	11	collection)After	collection)after	NN
cord-005453-4057qib7	14624	12	use	use	NN
cord-005453-4057qib7	14624	13	of	of	IN
cord-005453-4057qib7	14624	14	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14624	15	in	in	IN
cord-005453-4057qib7	14624	16	all	all	DT
cord-005453-4057qib7	14624	17	donors	donor	NNS
cord-005453-4057qib7	14624	18	,	,	,
cord-005453-4057qib7	14624	19	the	the	DT
cord-005453-4057qib7	14624	20	required	require	VBN
cord-005453-4057qib7	14624	21	dose	dose	NN
cord-005453-4057qib7	14624	22	of	of	IN
cord-005453-4057qib7	14624	23	CD34	CD34	NNP
cord-005453-4057qib7	14624	24	was	be	VBD
cord-005453-4057qib7	14624	25	obtained	obtain	VBN
cord-005453-4057qib7	14624	26	to	to	TO
cord-005453-4057qib7	14624	27	ensure	ensure	VB
cord-005453-4057qib7	14624	28	successful	successful	JJ
cord-005453-4057qib7	14624	29	transplantation	transplantation	NN
cord-005453-4057qib7	14624	30	,	,	,
cord-005453-4057qib7	14624	31	with	with	IN
cord-005453-4057qib7	14624	32	a	a	DT
cord-005453-4057qib7	14624	33	sufficient	sufficient	JJ
cord-005453-4057qib7	14624	34	increase	increase	NN
cord-005453-4057qib7	14624	35	in	in	IN
cord-005453-4057qib7	14624	36	the	the	DT
cord-005453-4057qib7	14624	37	CD34	CD34	NNP
cord-005453-4057qib7	14624	38	+	+	CC
cord-005453-4057qib7	14624	39	cells	cell	NNS
cord-005453-4057qib7	14624	40	.	.	.
cord-005453-4057qib7	14625	1	No	no	DT
cord-005453-4057qib7	14625	2	side	side	NN
cord-005453-4057qib7	14625	3	effects	effect	NNS
cord-005453-4057qib7	14625	4	or	or	CC
cord-005453-4057qib7	14625	5	adverse	adverse	JJ
cord-005453-4057qib7	14625	6	reactions	reaction	NNS
cord-005453-4057qib7	14625	7	related	relate	VBN
cord-005453-4057qib7	14625	8	to	to	IN
cord-005453-4057qib7	14625	9	the	the	DT
cord-005453-4057qib7	14625	10	administration	administration	NN
cord-005453-4057qib7	14625	11	of	of	IN
cord-005453-4057qib7	14625	12	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14625	13	occurred	occur	VBD
cord-005453-4057qib7	14625	14	.	.	.
cord-005453-4057qib7	14626	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14626	2	:	:	:
cord-005453-4057qib7	14627	1	In	in	IN
cord-005453-4057qib7	14627	2	cases	case	NNS
cord-005453-4057qib7	14627	3	of	of	IN
cord-005453-4057qib7	14627	4	failed	fail	VBN
cord-005453-4057qib7	14627	5	mobilization	mobilization	NN
cord-005453-4057qib7	14627	6	in	in	IN
cord-005453-4057qib7	14627	7	the	the	DT
cord-005453-4057qib7	14627	8	related	related	JJ
cord-005453-4057qib7	14627	9	and	and	CC
cord-005453-4057qib7	14627	10	unrelated	unrelated	JJ
cord-005453-4057qib7	14627	11	donor	donor	NN
cord-005453-4057qib7	14627	12	,	,	,
cord-005453-4057qib7	14627	13	the	the	DT
cord-005453-4057qib7	14627	14	use	use	NN
cord-005453-4057qib7	14627	15	of	of	IN
cord-005453-4057qib7	14627	16	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14627	17	according	accord	VBG
cord-005453-4057qib7	14627	18	to	to	IN
cord-005453-4057qib7	14627	19	the	the	DT
cord-005453-4057qib7	14627	20	methods	method	NNS
cord-005453-4057qib7	14627	21	described	describe	VBN
cord-005453-4057qib7	14627	22	in	in	IN
cord-005453-4057qib7	14627	23	the	the	DT
cord-005453-4057qib7	14627	24	shared	share	VBN
cord-005453-4057qib7	14627	25	protocol	protocol	NN
cord-005453-4057qib7	14627	26	between	between	IN
cord-005453-4057qib7	14627	27	IBMDR	IBMDR	NNP
cord-005453-4057qib7	14627	28	,	,	,
cord-005453-4057qib7	14627	29	CNS	CNS	NNP
cord-005453-4057qib7	14627	30	,	,	,
cord-005453-4057qib7	14627	31	CNT	CNT	NNP
cord-005453-4057qib7	14627	32	,	,	,
cord-005453-4057qib7	14627	33	SIMTI	SIMTI	NNP
cord-005453-4057qib7	14627	34	,	,	,
cord-005453-4057qib7	14627	35	SIdEM	SIdEM	NNP
cord-005453-4057qib7	14627	36	,	,	,
cord-005453-4057qib7	14627	37	GITMO	GITMO	NNP
cord-005453-4057qib7	14627	38	,	,	,
cord-005453-4057qib7	14627	39	proved	prove	VBD
cord-005453-4057qib7	14627	40	to	to	TO
cord-005453-4057qib7	14627	41	be	be	VB
cord-005453-4057qib7	14627	42	safe	safe	JJ
cord-005453-4057qib7	14627	43	and	and	CC
cord-005453-4057qib7	14627	44	effective	effective	JJ
cord-005453-4057qib7	14627	45	.	.	.
cord-005453-4057qib7	14628	1	This	this	DT
cord-005453-4057qib7	14628	2	protocol	protocol	NN
cord-005453-4057qib7	14628	3	emphasizes	emphasize	VBZ
cord-005453-4057qib7	14628	4	the	the	DT
cord-005453-4057qib7	14628	5	great	great	JJ
cord-005453-4057qib7	14628	6	value	value	NN
cord-005453-4057qib7	14628	7	of	of	IN
cord-005453-4057qib7	14628	8	the	the	DT
cord-005453-4057qib7	14628	9	sharing	sharing	NN
cord-005453-4057qib7	14628	10	of	of	IN
cord-005453-4057qib7	14628	11	procedures	procedure	NNS
cord-005453-4057qib7	14628	12	between	between	IN
cord-005453-4057qib7	14628	13	the	the	DT
cord-005453-4057qib7	14628	14	register	register	NN
cord-005453-4057qib7	14628	15	,	,	,
cord-005453-4057qib7	14628	16	institutions	institution	NNS
cord-005453-4057qib7	14628	17	and	and	CC
cord-005453-4057qib7	14628	18	scientific	scientific	JJ
cord-005453-4057qib7	14628	19	societies	society	NNS
cord-005453-4057qib7	14628	20	,	,	,
cord-005453-4057qib7	14628	21	ensuring	ensure	VBG
cord-005453-4057qib7	14628	22	the	the	DT
cord-005453-4057qib7	14628	23	supervision	supervision	NN
cord-005453-4057qib7	14628	24	of	of	IN
cord-005453-4057qib7	14628	25	the	the	DT
cord-005453-4057qib7	14628	26	process	process	NN
cord-005453-4057qib7	14628	27	and	and	CC
cord-005453-4057qib7	14628	28	the	the	DT
cord-005453-4057qib7	14628	29	protection	protection	NN
cord-005453-4057qib7	14628	30	of	of	IN
cord-005453-4057qib7	14628	31	the	the	DT
cord-005453-4057qib7	14628	32	donor	donor	NN
cord-005453-4057qib7	14628	33	and	and	CC
cord-005453-4057qib7	14628	34	recipient	recipient	NN
cord-005453-4057qib7	14628	35	.	.	.
cord-005453-4057qib7	14629	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14629	2	:	:	:
cord-005453-4057qib7	14629	3	Nothing	nothing	NN
cord-005453-4057qib7	14629	4	to	to	TO
cord-005453-4057qib7	14629	5	declare	declare	VB
cord-005453-4057qib7	14629	6	Background	background	NN
cord-005453-4057qib7	14629	7	:	:	:
cord-005453-4057qib7	14629	8	Autologous	autologous	JJ
cord-005453-4057qib7	14629	9	stem	stem	NN
cord-005453-4057qib7	14629	10	cells	cell	NNS
cord-005453-4057qib7	14629	11	transplantation	transplantation	NN
cord-005453-4057qib7	14629	12	(	(	-LRB-
cord-005453-4057qib7	14629	13	ASCT	ASCT	NNP
cord-005453-4057qib7	14629	14	)	)	-RRB-
cord-005453-4057qib7	14629	15	is	be	VBZ
cord-005453-4057qib7	14629	16	an	an	DT
cord-005453-4057qib7	14629	17	effective	effective	JJ
cord-005453-4057qib7	14629	18	treatment	treatment	NN
cord-005453-4057qib7	14629	19	option	option	NN
cord-005453-4057qib7	14629	20	for	for	IN
cord-005453-4057qib7	14629	21	young	young	JJ
cord-005453-4057qib7	14629	22	patients	patient	NNS
cord-005453-4057qib7	14629	23	with	with	IN
cord-005453-4057qib7	14629	24	multiple	multiple	JJ
cord-005453-4057qib7	14629	25	myeloma	myeloma	NN
cord-005453-4057qib7	14629	26	(	(	-LRB-
cord-005453-4057qib7	14629	27	MM	MM	NNP
cord-005453-4057qib7	14629	28	)	)	-RRB-
cord-005453-4057qib7	14629	29	.	.	.
cord-005453-4057qib7	14630	1	A	a	DT
cord-005453-4057qib7	14630	2	minority	minority	NN
cord-005453-4057qib7	14630	3	of	of	IN
cord-005453-4057qib7	14630	4	patients	patient	NNS
cord-005453-4057qib7	14630	5	may	may	MD
cord-005453-4057qib7	14630	6	still	still	RB
cord-005453-4057qib7	14630	7	experience	experience	VB
cord-005453-4057qib7	14630	8	untoward	untoward	JJ
cord-005453-4057qib7	14630	9	toxicity	toxicity	NN
cord-005453-4057qib7	14630	10	due	due	IN
cord-005453-4057qib7	14630	11	to	to	IN
cord-005453-4057qib7	14630	12	delayed	delay	VBN
cord-005453-4057qib7	14630	13	engraftment	engraftment	NN
cord-005453-4057qib7	14630	14	.	.	.
cord-005453-4057qib7	14631	1	Thus	thus	RB
cord-005453-4057qib7	14631	2	,	,	,
cord-005453-4057qib7	14631	3	the	the	DT
cord-005453-4057qib7	14631	4	current	current	JJ
cord-005453-4057qib7	14631	5	policy	policy	NN
cord-005453-4057qib7	14631	6	in	in	IN
cord-005453-4057qib7	14631	7	many	many	JJ
cord-005453-4057qib7	14631	8	centers	center	NNS
cord-005453-4057qib7	14631	9	is	be	VBZ
cord-005453-4057qib7	14631	10	aimed	aim	VBN
cord-005453-4057qib7	14631	11	to	to	TO
cord-005453-4057qib7	14631	12	increase	increase	VB
cord-005453-4057qib7	14631	13	the	the	DT
cord-005453-4057qib7	14631	14	target	target	NN
cord-005453-4057qib7	14631	15	dose	dose	NN
cord-005453-4057qib7	14631	16	of	of	IN
cord-005453-4057qib7	14631	17	collected	collect	VBN
cord-005453-4057qib7	14631	18	CD34	CD34	NNP
cord-005453-4057qib7	14631	19	+	+	CC
cord-005453-4057qib7	14631	20	cells	cell	NNS
cord-005453-4057qib7	14631	21	up	up	IN
cord-005453-4057qib7	14631	22	to	to	IN
cord-005453-4057qib7	14631	23	an	an	DT
cord-005453-4057qib7	14631	24	"	"	``
cord-005453-4057qib7	14631	25	optimal	optimal	JJ
cord-005453-4057qib7	14631	26	"	"	''
cord-005453-4057qib7	14631	27	level	level	NN
cord-005453-4057qib7	14631	28	of	of	IN
cord-005453-4057qib7	14631	29	4x10	4x10	CD
cord-005453-4057qib7	14631	30	6	6	CD
cord-005453-4057qib7	14631	31	/Kg	/Kg	.
cord-005453-4057qib7	14632	1	per	per	IN
cord-005453-4057qib7	14632	2	procedure	procedure	NN
cord-005453-4057qib7	14632	3	.	.	.
cord-005453-4057qib7	14633	1	Therefore	therefore	RB
cord-005453-4057qib7	14633	2	,	,	,
cord-005453-4057qib7	14633	3	an	an	DT
cord-005453-4057qib7	14633	4	ideal	ideal	JJ
cord-005453-4057qib7	14633	5	mobilization	mobilization	NN
cord-005453-4057qib7	14633	6	,	,	,
cord-005453-4057qib7	14633	7	aimed	aim	VBN
cord-005453-4057qib7	14633	8	to	to	TO
cord-005453-4057qib7	14633	9	collect	collect	VB
cord-005453-4057qib7	14633	10	4	4	CD
cord-005453-4057qib7	14633	11	to	to	TO
cord-005453-4057qib7	14633	12	8	8	CD
cord-005453-4057qib7	14633	13	CD34	CD34	NNP
cord-005453-4057qib7	14633	14	+	+	CC
cord-005453-4057qib7	14633	15	cells	cell	NNS
cord-005453-4057qib7	14633	16	/	/	SYM
cord-005453-4057qib7	14633	17	kg	kg	NNS
cord-005453-4057qib7	14633	18	in	in	IN
cord-005453-4057qib7	14633	19	one	one	CD
cord-005453-4057qib7	14633	20	apheresis	apheresis	NN
cord-005453-4057qib7	14633	21	,	,	,
cord-005453-4057qib7	14633	22	should	should	MD
cord-005453-4057qib7	14633	23	achieve	achieve	VB
cord-005453-4057qib7	14633	24	a	a	DT
cord-005453-4057qib7	14633	25	number	number	NN
cord-005453-4057qib7	14633	26	of	of	IN
cord-005453-4057qib7	14633	27	circulating	circulate	VBG
cord-005453-4057qib7	14633	28	CD34	CD34	NNP
cord-005453-4057qib7	14633	29	+	+	CC
cord-005453-4057qib7	14633	30	cells	cell	NNS
cord-005453-4057qib7	14633	31	>	>	XX
cord-005453-4057qib7	14634	1	40	40	CD
cord-005453-4057qib7	14634	2	/	/	SYM
cord-005453-4057qib7	14634	3	mcL	mcl	NN
cord-005453-4057qib7	14634	4	(	(	-LRB-
cord-005453-4057qib7	14634	5	very	very	RB
cord-005453-4057qib7	14634	6	good	good	JJ
cord-005453-4057qib7	14634	7	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14634	8	)	)	-RRB-
cord-005453-4057qib7	14634	9	.	.	.
cord-005453-4057qib7	14635	1	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14635	2	may	may	MD
cord-005453-4057qib7	14635	3	help	help	VB
cord-005453-4057qib7	14635	4	to	to	TO
cord-005453-4057qib7	14635	5	maximize	maximize	VB
cord-005453-4057qib7	14635	6	the	the	DT
cord-005453-4057qib7	14635	7	CD34	CD34	NNP
cord-005453-4057qib7	14635	8	+	+	CC
cord-005453-4057qib7	14635	9	collection	collection	NN
cord-005453-4057qib7	14635	10	but	but	CC
cord-005453-4057qib7	14635	11	its	-PRON-	PRP$
cord-005453-4057qib7	14635	12	use	use	NN
cord-005453-4057qib7	14635	13	is	be	VBZ
cord-005453-4057qib7	14635	14	limited	limit	VBN
cord-005453-4057qib7	14635	15	by	by	IN
cord-005453-4057qib7	14635	16	high	high	JJ
cord-005453-4057qib7	14635	17	cost	cost	NN
cord-005453-4057qib7	14635	18	.	.	.
cord-005453-4057qib7	14636	1	We	-PRON-	PRP
cord-005453-4057qib7	14636	2	carried	carry	VBD
cord-005453-4057qib7	14636	3	out	out	RP
cord-005453-4057qib7	14636	4	a	a	DT
cord-005453-4057qib7	14636	5	retrospective	retrospective	JJ
cord-005453-4057qib7	14636	6	analysis	analysis	NN
cord-005453-4057qib7	14636	7	aimed	aim	VBN
cord-005453-4057qib7	14636	8	to	to	TO
cord-005453-4057qib7	14636	9	predict	predict	VB
cord-005453-4057qib7	14636	10	the	the	DT
cord-005453-4057qib7	14636	11	quality	quality	NN
cord-005453-4057qib7	14636	12	of	of	IN
cord-005453-4057qib7	14636	13	mobilization	mobilization	NN
cord-005453-4057qib7	14636	14	and	and	CC
cord-005453-4057qib7	14636	15	develop	develop	VB
cord-005453-4057qib7	14636	16	an	an	DT
cord-005453-4057qib7	14636	17	algorithm	algorithm	NN
cord-005453-4057qib7	14636	18	to	to	TO
cord-005453-4057qib7	14636	19	optimize	optimize	VB
cord-005453-4057qib7	14636	20	both	both	DT
cord-005453-4057qib7	14636	21	timing	timing	NN
cord-005453-4057qib7	14636	22	of	of	IN
cord-005453-4057qib7	14636	23	collection	collection	NN
cord-005453-4057qib7	14636	24	and	and	CC
cord-005453-4057qib7	14636	25	use	use	NN
cord-005453-4057qib7	14636	26	of	of	IN
cord-005453-4057qib7	14636	27	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14636	28	.	.	.
cord-005453-4057qib7	14637	1	Methods	method	NNS
cord-005453-4057qib7	14637	2	:	:	:
cord-005453-4057qib7	14637	3	We	-PRON-	PRP
cord-005453-4057qib7	14637	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	14637	5	collected	collect	VBD
cord-005453-4057qib7	14637	6	data	datum	NNS
cord-005453-4057qib7	14637	7	from	from	IN
cord-005453-4057qib7	14637	8	91	91	CD
cord-005453-4057qib7	14637	9	mobilization	mobilization	NN
cord-005453-4057qib7	14637	10	procedure	procedure	NN
cord-005453-4057qib7	14637	11	performed	perform	VBN
cord-005453-4057qib7	14637	12	in	in	IN
cord-005453-4057qib7	14637	13	our	-PRON-	PRP$
cord-005453-4057qib7	14637	14	center	center	NN
cord-005453-4057qib7	14637	15	between	between	IN
cord-005453-4057qib7	14637	16	2006	2006	CD
cord-005453-4057qib7	14637	17	and	and	CC
cord-005453-4057qib7	14637	18	2016	2016	CD
cord-005453-4057qib7	14637	19	for	for	IN
cord-005453-4057qib7	14637	20	MM	MM	NNP
cord-005453-4057qib7	14637	21	.	.	.
cord-005453-4057qib7	14638	1	All	all	DT
cord-005453-4057qib7	14638	2	received	receive	VBD
cord-005453-4057qib7	14638	3	the	the	DT
cord-005453-4057qib7	14638	4	same	same	JJ
cord-005453-4057qib7	14638	5	mobilization	mobilization	NN
cord-005453-4057qib7	14638	6	protocol	protocol	NN
cord-005453-4057qib7	14638	7	with	with	IN
cord-005453-4057qib7	14638	8	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14638	9	(	(	-LRB-
cord-005453-4057qib7	14638	10	range	range	NNP
cord-005453-4057qib7	14638	11	3	3	CD
cord-005453-4057qib7	14638	12	-	-	SYM
cord-005453-4057qib7	14638	13	4	4	CD
cord-005453-4057qib7	14638	14	gr	gr	NNP
cord-005453-4057qib7	14638	15	/	/	SYM
cord-005453-4057qib7	14638	16	sqm	sqm	NNP
cord-005453-4057qib7	14638	17	)	)	-RRB-
cord-005453-4057qib7	14638	18	and	and	CC
cord-005453-4057qib7	14638	19	G	G	NNP
cord-005453-4057qib7	14638	20	-	-	HYPH
cord-005453-4057qib7	14638	21	CSF	CSF	NNP
cord-005453-4057qib7	14638	22	10mcg	10mcg	NNP
cord-005453-4057qib7	14638	23	/	/	SYM
cord-005453-4057qib7	14638	24	kg	kg	NNS
cord-005453-4057qib7	14638	25	from	from	IN
cord-005453-4057qib7	14638	26	+5	+5	NN
cord-005453-4057qib7	14638	27	.	.	.
cord-005453-4057qib7	14639	1	CD34	CD34	NNP
cord-005453-4057qib7	14639	2	+	+	CC
cord-005453-4057qib7	14639	3	cell	cell	NN
cord-005453-4057qib7	14639	4	count	count	NN
cord-005453-4057qib7	14639	5	was	be	VBD
cord-005453-4057qib7	14639	6	started	start	VBN
cord-005453-4057qib7	14639	7	when	when	WRB
cord-005453-4057qib7	14639	8	White	White	NNP
cord-005453-4057qib7	14639	9	Blood	Blood	NNP
cord-005453-4057qib7	14639	10	Cells	Cells	NNPS
cord-005453-4057qib7	14639	11	(	(	-LRB-
cord-005453-4057qib7	14639	12	WBC	WBC	NNP
cord-005453-4057qib7	14639	13	)	)	-RRB-
cord-005453-4057qib7	14639	14	count	count	NN
cord-005453-4057qib7	14639	15	exceeded	exceed	VBD
cord-005453-4057qib7	14639	16	1x10	1x10	CD
cord-005453-4057qib7	14639	17	9	9	CD
cord-005453-4057qib7	14640	1	/L.	/L.	NFP
cord-005453-4057qib7	14640	2	Patients	patient	NNS
cord-005453-4057qib7	14640	3	were	be	VBD
cord-005453-4057qib7	14640	4	excluded	exclude	VBN
cord-005453-4057qib7	14640	5	from	from	IN
cord-005453-4057qib7	14640	6	this	this	DT
cord-005453-4057qib7	14640	7	analysis	analysis	NN
cord-005453-4057qib7	14640	8	if	if	IN
cord-005453-4057qib7	14640	9	1	1	CD
cord-005453-4057qib7	14640	10	)	)	-RRB-
cord-005453-4057qib7	14640	11	showed	show	VBD
cord-005453-4057qib7	14640	12	a	a	DT
cord-005453-4057qib7	14640	13	CD34	CD34	NNP
cord-005453-4057qib7	14640	14	+	+	CC
cord-005453-4057qib7	14640	15	count	count	NN
cord-005453-4057qib7	14640	16	>	>	XX
cord-005453-4057qib7	14641	1	40	40	CD
cord-005453-4057qib7	14641	2	/	/	SYM
cord-005453-4057qib7	14641	3	mcL	mcl	NN
cord-005453-4057qib7	14641	4	(	(	-LRB-
cord-005453-4057qib7	14641	5	target	target	NN
cord-005453-4057qib7	14641	6	achieved	achieve	VBN
cord-005453-4057qib7	14641	7	at	at	IN
cord-005453-4057qib7	14641	8	first	first	JJ
cord-005453-4057qib7	14641	9	day	day	NN
cord-005453-4057qib7	14641	10	count	count	NN
cord-005453-4057qib7	14641	11	)	)	-RRB-
cord-005453-4057qib7	14642	1	and/or	and/or	CC
cord-005453-4057qib7	14643	1	2	2	LS
cord-005453-4057qib7	14643	2	)	)	-RRB-
cord-005453-4057qib7	14643	3	CD34	CD34	NNP
cord-005453-4057qib7	14643	4	+	+	CC
cord-005453-4057qib7	14643	5	count	count	NN
cord-005453-4057qib7	14643	6	on	on	IN
cord-005453-4057qib7	14643	7	second	second	JJ
cord-005453-4057qib7	14643	8	day	day	NN
cord-005453-4057qib7	14643	9	was	be	VBD
cord-005453-4057qib7	14643	10	missing	miss	VBG
cord-005453-4057qib7	14643	11	and/or	and/or	CC
cord-005453-4057qib7	14644	1	3	3	LS
cord-005453-4057qib7	14644	2	)	)	-RRB-
cord-005453-4057qib7	14645	1	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14645	2	was	be	VBD
cord-005453-4057qib7	14645	3	administered	administer	VBN
cord-005453-4057qib7	14645	4	on	on	IN
cord-005453-4057qib7	14645	5	first	first	JJ
cord-005453-4057qib7	14645	6	day	day	NN
cord-005453-4057qib7	14645	7	according	accord	VBG
cord-005453-4057qib7	14645	8	to	to	IN
cord-005453-4057qib7	14645	9	previous	previous	JJ
cord-005453-4057qib7	14645	10	policies	policy	NNS
cord-005453-4057qib7	14645	11	.	.	.
cord-005453-4057qib7	14646	1	Sixty	sixty	CD
cord-005453-4057qib7	14646	2	-	-	HYPH
cord-005453-4057qib7	14646	3	eight	eight	CD
cord-005453-4057qib7	14646	4	patients	patient	NNS
cord-005453-4057qib7	14646	5	were	be	VBD
cord-005453-4057qib7	14646	6	evaluable	evaluable	JJ
cord-005453-4057qib7	14646	7	for	for	IN
cord-005453-4057qib7	14646	8	the	the	DT
cord-005453-4057qib7	14646	9	study	study	NN
cord-005453-4057qib7	14646	10	.	.	.
cord-005453-4057qib7	14647	1	Univariate	univariate	JJ
cord-005453-4057qib7	14647	2	and	and	CC
cord-005453-4057qib7	14647	3	multivariate	multivariate	JJ
cord-005453-4057qib7	14647	4	logistic	logistic	JJ
cord-005453-4057qib7	14647	5	regression	regression	NN
cord-005453-4057qib7	14647	6	analysis	analysis	NN
cord-005453-4057qib7	14647	7	to	to	TO
cord-005453-4057qib7	14647	8	study	study	VB
cord-005453-4057qib7	14647	9	cCD34	cCD34	NNP
cord-005453-4057qib7	14648	1	+	+	CC
cord-005453-4057qib7	14648	2	kinetics	kinetic	NNS
cord-005453-4057qib7	14648	3	and	and	CC
cord-005453-4057qib7	14648	4	assess	assess	VB
cord-005453-4057qib7	14648	5	predictors	predictors	JJ
cord-005453-4057qib7	14648	6	impact	impact	NN
cord-005453-4057qib7	14648	7	on	on	IN
cord-005453-4057qib7	14648	8	mobilization	mobilization	NN
cord-005453-4057qib7	14648	9	was	be	VBD
cord-005453-4057qib7	14648	10	carried	carry	VBN
cord-005453-4057qib7	14648	11	out	out	RP
cord-005453-4057qib7	14648	12	.	.	.
cord-005453-4057qib7	14649	1	Ratio	ratio	NN
cord-005453-4057qib7	14649	2	CD34	CD34	NNP
cord-005453-4057qib7	14650	1	+	+	CC
cord-005453-4057qib7	14651	1	/WBC	/WBC	.
cord-005453-4057qib7	14652	1	in	in	IN
cord-005453-4057qib7	14652	2	first	first	JJ
cord-005453-4057qib7	14652	3	day	day	NN
cord-005453-4057qib7	14652	4	count	count	NN
cord-005453-4057qib7	14652	5	,	,	,
cord-005453-4057qib7	14652	6	gender	gender	NN
cord-005453-4057qib7	14652	7	,	,	,
cord-005453-4057qib7	14652	8	disease	disease	NN
cord-005453-4057qib7	14652	9	category	category	NN
cord-005453-4057qib7	14652	10	and	and	CC
cord-005453-4057qib7	14652	11	time	time	NN
cord-005453-4057qib7	14652	12	from	from	IN
cord-005453-4057qib7	14652	13	mobilization	mobilization	NN
cord-005453-4057qib7	14652	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14652	15	were	be	VBD
cord-005453-4057qib7	14652	16	also	also	RB
cord-005453-4057qib7	14652	17	included	include	VBN
cord-005453-4057qib7	14652	18	Results	result	NNS
cord-005453-4057qib7	14652	19	:	:	:
cord-005453-4057qib7	14653	1	Among	among	IN
cord-005453-4057qib7	14653	2	the	the	DT
cord-005453-4057qib7	14653	3	68	68	CD
cord-005453-4057qib7	14653	4	patients	patient	NNS
cord-005453-4057qib7	14653	5	included	include	VBN
cord-005453-4057qib7	14653	6	in	in	IN
cord-005453-4057qib7	14653	7	the	the	DT
cord-005453-4057qib7	14653	8	analysis	analysis	NN
cord-005453-4057qib7	14653	9	,	,	,
cord-005453-4057qib7	14653	10	the	the	DT
cord-005453-4057qib7	14653	11	threshold	threshold	NN
cord-005453-4057qib7	14653	12	of	of	IN
cord-005453-4057qib7	14653	13	40	40	CD
cord-005453-4057qib7	14653	14	CD34+/mcL	CD34+/mcL	NNP
cord-005453-4057qib7	14653	15	cells	cell	NNS
cord-005453-4057qib7	14653	16	on	on	IN
cord-005453-4057qib7	14653	17	the	the	DT
cord-005453-4057qib7	14653	18	second	second	JJ
cord-005453-4057qib7	14653	19	day	day	NN
cord-005453-4057qib7	14653	20	was	be	VBD
cord-005453-4057qib7	14653	21	reached	reach	VBN
cord-005453-4057qib7	14653	22	by	by	IN
cord-005453-4057qib7	14653	23	35	35	CD
cord-005453-4057qib7	14653	24	(	(	-LRB-
cord-005453-4057qib7	14653	25	51,47	51,47	CD
cord-005453-4057qib7	14653	26	%	%	NN
cord-005453-4057qib7	14653	27	)	)	-RRB-
cord-005453-4057qib7	14653	28	of	of	IN
cord-005453-4057qib7	14653	29	patients	patient	NNS
cord-005453-4057qib7	14653	30	(	(	-LRB-
cord-005453-4057qib7	14653	31	GroupA	groupa	VB
cord-005453-4057qib7	14653	32	)	)	-RRB-
cord-005453-4057qib7	14653	33	whilst	whilst	IN
cord-005453-4057qib7	14653	34	the	the	DT
cord-005453-4057qib7	14653	35	remaining	remain	VBG
cord-005453-4057qib7	14653	36	33	33	CD
cord-005453-4057qib7	14653	37	(	(	-LRB-
cord-005453-4057qib7	14653	38	24,7	24,7	CD
cord-005453-4057qib7	14653	39	%	%	NN
cord-005453-4057qib7	14653	40	)	)	-RRB-
cord-005453-4057qib7	14653	41	failed	fail	VBD
cord-005453-4057qib7	14653	42	the	the	DT
cord-005453-4057qib7	14653	43	target	target	NN
cord-005453-4057qib7	14653	44	(	(	-LRB-
cord-005453-4057qib7	14653	45	GroupB	groupb	NN
cord-005453-4057qib7	14653	46	)	)	-RRB-
cord-005453-4057qib7	14653	47	.	.	.
cord-005453-4057qib7	14654	1	Median	median	JJ
cord-005453-4057qib7	14654	2	(	(	-LRB-
cord-005453-4057qib7	14654	3	range	range	NN
cord-005453-4057qib7	14654	4	)	)	-RRB-
cord-005453-4057qib7	14655	1	WBC	WBC	NNP
cord-005453-4057qib7	14655	2	x10	x10	NNP
cord-005453-4057qib7	14655	3	9	9	CD
cord-005453-4057qib7	14655	4	/L	/L	,
cord-005453-4057qib7	14655	5	and	and	CC
cord-005453-4057qib7	14655	6	CD34	CD34	NNP
cord-005453-4057qib7	14655	7	+	+	CC
cord-005453-4057qib7	14655	8	/mcL	/mcL	NNP
cord-005453-4057qib7	14655	9	counts	count	NNS
cord-005453-4057qib7	14655	10	in	in	IN
cord-005453-4057qib7	14655	11	group	group	NN
cord-005453-4057qib7	14655	12	A	a	NN
cord-005453-4057qib7	14655	13	and	and	CC
cord-005453-4057qib7	14655	14	B	B	NNP
cord-005453-4057qib7	14655	15	were	be	VBD
cord-005453-4057qib7	14655	16	2,01	2,01	CD
cord-005453-4057qib7	14655	17	(	(	-LRB-
cord-005453-4057qib7	14655	18	1	1	CD
cord-005453-4057qib7	14655	19	-	-	SYM
cord-005453-4057qib7	14655	20	5,01	5,01	CD
cord-005453-4057qib7	14655	21	)	)	-RRB-
cord-005453-4057qib7	14655	22	and	and	CC
cord-005453-4057qib7	14655	23	21,33	21,33	CD
cord-005453-4057qib7	14655	24	(	(	-LRB-
cord-005453-4057qib7	14655	25	7,56	7,56	CD
cord-005453-4057qib7	14655	26	-39,91	-39,91	ADD
cord-005453-4057qib7	14655	27	)	)	-RRB-
cord-005453-4057qib7	14655	28	,	,	,
cord-005453-4057qib7	14655	29	1,08	1,08	CD
cord-005453-4057qib7	14655	30	(	(	-LRB-
cord-005453-4057qib7	14655	31	1	1	CD
cord-005453-4057qib7	14655	32	)	)	-RRB-
cord-005453-4057qib7	14655	33	(	(	-LRB-
cord-005453-4057qib7	14655	34	2	2	LS
cord-005453-4057qib7	14655	35	)	)	-RRB-
cord-005453-4057qib7	14656	1	(	(	-LRB-
cord-005453-4057qib7	14656	2	3	3	LS
cord-005453-4057qib7	14656	3	)	)	-RRB-
cord-005453-4057qib7	14656	4	(	(	-LRB-
cord-005453-4057qib7	14656	5	4	4	LS
cord-005453-4057qib7	14656	6	)	)	-RRB-
cord-005453-4057qib7	14656	7	(	(	-LRB-
cord-005453-4057qib7	14656	8	5	5	LS
cord-005453-4057qib7	14656	9	)	)	-RRB-
cord-005453-4057qib7	14656	10	(	(	-LRB-
cord-005453-4057qib7	14656	11	6	6	CD
cord-005453-4057qib7	14656	12	)	)	-RRB-
cord-005453-4057qib7	14656	13	46	46	CD
cord-005453-4057qib7	14656	14	)	)	-RRB-
cord-005453-4057qib7	14656	15	and	and	CC
cord-005453-4057qib7	14656	16	3,31	3,31	NN
cord-005453-4057qib7	14656	17	(	(	-LRB-
cord-005453-4057qib7	14656	18	0,06	0,06	NN
cord-005453-4057qib7	14656	19	-	-	HYPH
cord-005453-4057qib7	14656	20	31,14	31,14	CD
cord-005453-4057qib7	14656	21	)	)	-RRB-
cord-005453-4057qib7	14656	22	respectively	respectively	RB
cord-005453-4057qib7	14656	23	,	,	,
cord-005453-4057qib7	14656	24	with	with	IN
cord-005453-4057qib7	14656	25	a	a	DT
cord-005453-4057qib7	14656	26	statistically	statistically	RB
cord-005453-4057qib7	14656	27	significant	significant	JJ
cord-005453-4057qib7	14656	28	differences	difference	NNS
cord-005453-4057qib7	14656	29	among	among	IN
cord-005453-4057qib7	14656	30	group	group	NN
cord-005453-4057qib7	14656	31	(	(	-LRB-
cord-005453-4057qib7	14656	32	Mann	Mann	NNP
cord-005453-4057qib7	14656	33	-	-	HYPH
cord-005453-4057qib7	14656	34	Whitney	Whitney	NNP
cord-005453-4057qib7	14656	35	p=	p=	NNP
cord-005453-4057qib7	14656	36	0,01	0,01	NN
cord-005453-4057qib7	14656	37	and	and	CC
cord-005453-4057qib7	14656	38	p=0,02	p=0,02	MD
cord-005453-4057qib7	14656	39	respectively	respectively	RB
cord-005453-4057qib7	14656	40	)	)	-RRB-
cord-005453-4057qib7	14656	41	.	.	.
cord-005453-4057qib7	14657	1	Only	only	RB
cord-005453-4057qib7	14657	2	CD34	CD34	NNP
cord-005453-4057qib7	14657	3	+	+	CC
cord-005453-4057qib7	14658	1	/WBC	/WBC	NNP
cord-005453-4057qib7	14658	2	ratio	ratio	NN
cord-005453-4057qib7	14658	3	and	and	CC
cord-005453-4057qib7	14658	4	CD34	CD34	NNP
cord-005453-4057qib7	14659	1	+	+	CC
cord-005453-4057qib7	14660	1	/mcL	/mcL	.
cord-005453-4057qib7	14661	1	on	on	IN
cord-005453-4057qib7	14661	2	first	first	JJ
cord-005453-4057qib7	14661	3	day	day	NN
cord-005453-4057qib7	14661	4	count	count	NN
cord-005453-4057qib7	14661	5	had	have	VBD
cord-005453-4057qib7	14661	6	an	an	DT
cord-005453-4057qib7	14661	7	impact	impact	NN
cord-005453-4057qib7	14661	8	on	on	IN
cord-005453-4057qib7	14661	9	kinetics	kinetic	NNS
cord-005453-4057qib7	14661	10	and	and	CC
cord-005453-4057qib7	14661	11	optimal	optimal	JJ
cord-005453-4057qib7	14661	12	mobilization	mobilization	NN
cord-005453-4057qib7	14661	13	.	.	.
cord-005453-4057qib7	14662	1	Logistic	logistic	JJ
cord-005453-4057qib7	14662	2	regression	regression	NN
cord-005453-4057qib7	14662	3	model	model	NN
cord-005453-4057qib7	14662	4	highlight	highlight	NN
cord-005453-4057qib7	14662	5	CD34+/mcL	cd34+/mcl	XX
cord-005453-4057qib7	14663	1	(	(	-LRB-
cord-005453-4057qib7	14663	2	OR=1,270	OR=1,270	NNP
cord-005453-4057qib7	14664	1	;	;	:
cord-005453-4057qib7	14664	2	95	95	CD
cord-005453-4057qib7	14664	3	%	%	NN
cord-005453-4057qib7	14664	4	CI	ci	NN
cord-005453-4057qib7	14664	5	:	:	:
cord-005453-4057qib7	14664	6	1,060	1,060	CD
cord-005453-4057qib7	14664	7	-1,522	-1,522	NN
cord-005453-4057qib7	14664	8	)	)	-RRB-
cord-005453-4057qib7	14664	9	on	on	IN
cord-005453-4057qib7	14664	10	first	first	JJ
cord-005453-4057qib7	14664	11	count	count	NN
cord-005453-4057qib7	14664	12	as	as	IN
cord-005453-4057qib7	14664	13	an	an	DT
cord-005453-4057qib7	14664	14	independent	independent	JJ
cord-005453-4057qib7	14664	15	predictor	predictor	NN
cord-005453-4057qib7	14664	16	of	of	IN
cord-005453-4057qib7	14664	17	second	second	JJ
cord-005453-4057qib7	14664	18	day	day	NN
cord-005453-4057qib7	14664	19	optimal	optimal	JJ
cord-005453-4057qib7	14664	20	mobilizer	mobilizer	NN
cord-005453-4057qib7	14664	21	,	,	,
cord-005453-4057qib7	14664	22	with	with	IN
cord-005453-4057qib7	14664	23	AUC	AUC	NNP
cord-005453-4057qib7	14664	24	of	of	IN
cord-005453-4057qib7	14664	25	0.9	0.9	CD
cord-005453-4057qib7	14664	26	%	%	NN
cord-005453-4057qib7	14664	27	(	(	-LRB-
cord-005453-4057qib7	14664	28	0	0	CD
cord-005453-4057qib7	14664	29	,	,	,
cord-005453-4057qib7	14664	30	99	99	CD
cord-005453-4057qib7	14664	31	)	)	-RRB-
cord-005453-4057qib7	14664	32	in	in	IN
cord-005453-4057qib7	14664	33	ROC	ROC	NNP
cord-005453-4057qib7	14664	34	analysis	analysis	NN
cord-005453-4057qib7	14664	35	.	.	.
cord-005453-4057qib7	14665	1	Two	two	CD
cord-005453-4057qib7	14665	2	CD34	CD34	NNP
cord-005453-4057qib7	14665	3	+	+	CC
cord-005453-4057qib7	14665	4	thresholds	threshold	NNS
cord-005453-4057qib7	14665	5	were	be	VBD
cord-005453-4057qib7	14665	6	then	then	RB
cord-005453-4057qib7	14665	7	calculated	calculate	VBN
cord-005453-4057qib7	14665	8	:	:	:
cord-005453-4057qib7	14666	1	<	<	XX
cord-005453-4057qib7	14666	2	7,56	7,56	NNP
cord-005453-4057qib7	14666	3	/	/	SYM
cord-005453-4057qib7	14666	4	mcl	mcl	NNP
cord-005453-4057qib7	14666	5	(	(	-LRB-
cord-005453-4057qib7	14666	6	PPV	PPV	NNP
cord-005453-4057qib7	14666	7	0,81	0,81	CD
cord-005453-4057qib7	14666	8	;	;	:
cord-005453-4057qib7	14666	9	NPV	NPV	NNP
cord-005453-4057qib7	14666	10	1,0	1,0	CD
cord-005453-4057qib7	14666	11	)	)	-RRB-
cord-005453-4057qib7	14666	12	that	that	WDT
cord-005453-4057qib7	14666	13	identified	identify	VBD
cord-005453-4057qib7	14666	14	poor	poor	JJ
cord-005453-4057qib7	14666	15	mobilizer	mobilizer	NN
cord-005453-4057qib7	14666	16	,	,	,
cord-005453-4057qib7	14666	17	and	and	CC
cord-005453-4057qib7	14666	18	≥	≥	CD
cord-005453-4057qib7	14666	19	24,06	24,06	CD
cord-005453-4057qib7	14666	20	/	/	SYM
cord-005453-4057qib7	14666	21	mcl	mcl	NNP
cord-005453-4057qib7	14666	22	(	(	-LRB-
cord-005453-4057qib7	14666	23	PPV	PPV	NNP
cord-005453-4057qib7	14666	24	1,0	1,0	CD
cord-005453-4057qib7	14666	25	;	;	:
cord-005453-4057qib7	14667	1	NPV0,59	NPV0,59	NNP
cord-005453-4057qib7	14667	2	)	)	-RRB-
cord-005453-4057qib7	14667	3	that	that	WDT
cord-005453-4057qib7	14667	4	exclude	exclude	VBP
cord-005453-4057qib7	14667	5	probability	probability	NN
cord-005453-4057qib7	14667	6	to	to	TO
cord-005453-4057qib7	14667	7	fail	fail	VB
cord-005453-4057qib7	14667	8	on	on	IN
cord-005453-4057qib7	14667	9	second	second	JJ
cord-005453-4057qib7	14667	10	day	day	NN
cord-005453-4057qib7	14667	11	.	.	.
cord-005453-4057qib7	14668	1	For	for	IN
cord-005453-4057qib7	14668	2	those	those	DT
cord-005453-4057qib7	14668	3	with	with	IN
cord-005453-4057qib7	14668	4	a	a	DT
cord-005453-4057qib7	14668	5	CD34	CD34	NNP
cord-005453-4057qib7	14668	6	+	+	CC
cord-005453-4057qib7	14668	7	count	count	NN
cord-005453-4057qib7	14668	8	between	between	IN
cord-005453-4057qib7	14668	9	7,56	7,56	CD
cord-005453-4057qib7	14668	10	-	-	HYPH
cord-005453-4057qib7	14668	11	24,06	24,06	CD
cord-005453-4057qib7	14668	12	the	the	DT
cord-005453-4057qib7	14668	13	CD34+/WBC	CD34+/WBC	NNP
cord-005453-4057qib7	14668	14	ratio	ratio	NN
cord-005453-4057qib7	14668	15	(	(	-LRB-
cord-005453-4057qib7	14668	16	OR=1,768	or=1,768	NN
cord-005453-4057qib7	14668	17	,	,	,
cord-005453-4057qib7	14668	18	95	95	CD
cord-005453-4057qib7	14668	19	%	%	NN
cord-005453-4057qib7	14668	20	CI	ci	NN
cord-005453-4057qib7	14668	21	:	:	:
cord-005453-4057qib7	14668	22	1,307	1,307	CD
cord-005453-4057qib7	14668	23	-	-	SYM
cord-005453-4057qib7	14668	24	2,391	2,391	CD
cord-005453-4057qib7	14668	25	)	)	-RRB-
cord-005453-4057qib7	14668	26	was	be	VBD
cord-005453-4057qib7	14668	27	a	a	DT
cord-005453-4057qib7	14668	28	predictor	predictor	NN
cord-005453-4057qib7	14668	29	of	of	IN
cord-005453-4057qib7	14668	30	optimal	optimal	JJ
cord-005453-4057qib7	14668	31	mobilization	mobilization	NN
cord-005453-4057qib7	14668	32	(	(	-LRB-
cord-005453-4057qib7	14668	33	AUC	AUC	NNP
cord-005453-4057qib7	14668	34	0,94	0,94	NNP
cord-005453-4057qib7	14668	35	;	;	:
cord-005453-4057qib7	14668	36	0,885	0,885	CD
cord-005453-4057qib7	14668	37	-	-	SYM
cord-005453-4057qib7	14668	38	0,996	0,996	CD
cord-005453-4057qib7	14668	39	)	)	-RRB-
cord-005453-4057qib7	14668	40	;	;	:
cord-005453-4057qib7	14668	41	cut	cut	VB
cord-005453-4057qib7	14668	42	-	-	HYPH
cord-005453-4057qib7	14668	43	off	off	RP
cord-005453-4057qib7	14668	44	value	value	NN
cord-005453-4057qib7	14668	45	was	be	VBD
cord-005453-4057qib7	14668	46	5,63	5,63	CD
cord-005453-4057qib7	14668	47	(	(	-LRB-
cord-005453-4057qib7	14668	48	sensibility	sensibility	NN
cord-005453-4057qib7	14668	49	94,28	94,28	CD
cord-005453-4057qib7	14668	50	;	;	:
cord-005453-4057qib7	14668	51	specificity	specificity	NN
cord-005453-4057qib7	14668	52	84,84	84,84	CD
cord-005453-4057qib7	14668	53	)	)	-RRB-
cord-005453-4057qib7	14669	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14669	2	:	:	:
cord-005453-4057qib7	14670	1	Assessment	assessment	NN
cord-005453-4057qib7	14670	2	of	of	IN
cord-005453-4057qib7	14670	3	circulating	circulate	VBG
cord-005453-4057qib7	14670	4	WBC	WBC	NNP
cord-005453-4057qib7	14670	5	,	,	,
cord-005453-4057qib7	14670	6	CD34	CD34	NNP
cord-005453-4057qib7	14670	7	+	+	CC
cord-005453-4057qib7	14670	8	and	and	CC
cord-005453-4057qib7	14670	9	their	-PRON-	PRP$
cord-005453-4057qib7	14670	10	ratio	ratio	NN
cord-005453-4057qib7	14670	11	at	at	IN
cord-005453-4057qib7	14670	12	WBC	WBC	NNP
cord-005453-4057qib7	14670	13	recovery	recovery	NN
cord-005453-4057qib7	14670	14	in	in	IN
cord-005453-4057qib7	14670	15	a	a	DT
cord-005453-4057qib7	14670	16	chemo	chemo	NN
cord-005453-4057qib7	14670	17	-	-	HYPH
cord-005453-4057qib7	14670	18	based	base	VBN
cord-005453-4057qib7	14670	19	mobilization	mobilization	NN
cord-005453-4057qib7	14670	20	is	be	VBZ
cord-005453-4057qib7	14670	21	a	a	DT
cord-005453-4057qib7	14670	22	valid	valid	JJ
cord-005453-4057qib7	14670	23	tool	tool	NN
cord-005453-4057qib7	14670	24	to	to	TO
cord-005453-4057qib7	14670	25	manage	manage	VB
cord-005453-4057qib7	14670	26	the	the	DT
cord-005453-4057qib7	14670	27	collection	collection	NN
cord-005453-4057qib7	14670	28	strategy	strategy	NN
cord-005453-4057qib7	14670	29	and	and	CC
cord-005453-4057qib7	14670	30	the	the	DT
cord-005453-4057qib7	14670	31	on	on	IN
cord-005453-4057qib7	14670	32	-	-	HYPH
cord-005453-4057qib7	14670	33	demand	demand	NN
cord-005453-4057qib7	14670	34	use	use	NN
cord-005453-4057qib7	14670	35	of	of	IN
cord-005453-4057qib7	14670	36	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14670	37	.	.	.
cord-005453-4057qib7	14671	1	We	-PRON-	PRP
cord-005453-4057qib7	14671	2	have	have	VBP
cord-005453-4057qib7	14671	3	developed	develop	VBN
cord-005453-4057qib7	14671	4	an	an	DT
cord-005453-4057qib7	14671	5	algorithm	algorithm	NN
cord-005453-4057qib7	14671	6	aimed	aim	VBN
cord-005453-4057qib7	14671	7	to	to	IN
cord-005453-4057qib7	14671	8	the	the	DT
cord-005453-4057qib7	14671	9	use	use	NN
cord-005453-4057qib7	14671	10	of	of	IN
cord-005453-4057qib7	14671	11	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14671	12	to	to	IN
cord-005453-4057qib7	14671	13	both	both	DT
cord-005453-4057qib7	14671	14	rescue	rescue	VB
cord-005453-4057qib7	14671	15	poor	poor	JJ
cord-005453-4057qib7	14671	16	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14671	17	and	and	CC
cord-005453-4057qib7	14671	18	boost	boost	VB
cord-005453-4057qib7	14671	19	CD34	CD34	NNP
cord-005453-4057qib7	14672	1	+	+	CC
cord-005453-4057qib7	14672	2	count	count	NN
cord-005453-4057qib7	14672	3	in	in	IN
cord-005453-4057qib7	14672	4	intermediate	intermediate	JJ
cord-005453-4057qib7	14672	5	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14672	6	.	.	.
cord-005453-4057qib7	14673	1	Background	background	NN
cord-005453-4057qib7	14673	2	:	:	:
cord-005453-4057qib7	14674	1	Successful	successful	JJ
cord-005453-4057qib7	14674	2	autologous	autologous	JJ
cord-005453-4057qib7	14674	3	stem	stem	NN
cord-005453-4057qib7	14674	4	cell	cell	NN
cord-005453-4057qib7	14674	5	transplantation	transplantation	NN
cord-005453-4057qib7	14674	6	(	(	-LRB-
cord-005453-4057qib7	14674	7	ASCT	ASCT	NNP
cord-005453-4057qib7	14674	8	)	)	-RRB-
cord-005453-4057qib7	14674	9	requires	require	VBZ
cord-005453-4057qib7	14674	10	the	the	DT
cord-005453-4057qib7	14674	11	infusion	infusion	NN
cord-005453-4057qib7	14674	12	of	of	IN
cord-005453-4057qib7	14674	13	a	a	DT
cord-005453-4057qib7	14674	14	sufficient	sufficient	JJ
cord-005453-4057qib7	14674	15	number	number	NN
cord-005453-4057qib7	14674	16	of	of	IN
cord-005453-4057qib7	14674	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14674	18	stem	stem	NN
cord-005453-4057qib7	14674	19	cells	cell	NNS
cord-005453-4057qib7	14674	20	(	(	-LRB-
cord-005453-4057qib7	14674	21	HSCs	HSCs	NNP
cord-005453-4057qib7	14674	22	)	)	-RRB-
cord-005453-4057qib7	14674	23	.	.	.
cord-005453-4057qib7	14675	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	14675	2	blood	blood	NN
cord-005453-4057qib7	14675	3	(	(	-LRB-
cord-005453-4057qib7	14675	4	PB	PB	NNP
cord-005453-4057qib7	14675	5	)	)	-RRB-
cord-005453-4057qib7	14675	6	is	be	VBZ
cord-005453-4057qib7	14675	7	the	the	DT
cord-005453-4057qib7	14675	8	most	most	RBS
cord-005453-4057qib7	14675	9	commonly	commonly	RB
cord-005453-4057qib7	14675	10	used	use	VBN
cord-005453-4057qib7	14675	11	source	source	NN
cord-005453-4057qib7	14675	12	of	of	IN
cord-005453-4057qib7	14675	13	HSCs	hscs	NN
cord-005453-4057qib7	14675	14	,	,	,
cord-005453-4057qib7	14675	15	therefore	therefore	RB
cord-005453-4057qib7	14675	16	,	,	,
cord-005453-4057qib7	14675	17	it	-PRON-	PRP
cord-005453-4057qib7	14675	18	is	be	VBZ
cord-005453-4057qib7	14675	19	important	important	JJ
cord-005453-4057qib7	14675	20	to	to	TO
cord-005453-4057qib7	14675	21	optimize	optimize	VB
cord-005453-4057qib7	14675	22	methods	method	NNS
cord-005453-4057qib7	14675	23	used	use	VBN
cord-005453-4057qib7	14675	24	to	to	TO
cord-005453-4057qib7	14675	25	mobilize	mobilize	VB
cord-005453-4057qib7	14675	26	the	the	DT
cord-005453-4057qib7	14675	27	HSCs	hscs	NN
cord-005453-4057qib7	14675	28	.	.	.
cord-005453-4057qib7	14676	1	The	the	DT
cord-005453-4057qib7	14676	2	most	most	RBS
cord-005453-4057qib7	14676	3	clinically	clinically	RB
cord-005453-4057qib7	14676	4	used	use	VBN
cord-005453-4057qib7	14676	5	chemotherapeutic	chemotherapeutic	JJ
cord-005453-4057qib7	14676	6	agents	agent	NNS
cord-005453-4057qib7	14676	7	for	for	IN
cord-005453-4057qib7	14676	8	effective	effective	JJ
cord-005453-4057qib7	14676	9	mobilization	mobilization	NN
cord-005453-4057qib7	14676	10	are	be	VBP
cord-005453-4057qib7	14676	11	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	14676	12	and	and	CC
cord-005453-4057qib7	14676	13	etoposide	etoposide	RB
cord-005453-4057qib7	14676	14	.	.	.
cord-005453-4057qib7	14677	1	Recent	recent	JJ
cord-005453-4057qib7	14677	2	published	publish	VBN
cord-005453-4057qib7	14677	3	studies	study	NNS
cord-005453-4057qib7	14677	4	suggest	suggest	VBP
cord-005453-4057qib7	14677	5	that	that	IN
cord-005453-4057qib7	14677	6	etoposide	etoposide	RB
cord-005453-4057qib7	14677	7	has	have	VBZ
cord-005453-4057qib7	14677	8	a	a	DT
cord-005453-4057qib7	14677	9	better	well	JJR
cord-005453-4057qib7	14677	10	mobilization	mobilization	NN
cord-005453-4057qib7	14677	11	effect	effect	NN
cord-005453-4057qib7	14677	12	than	than	IN
cord-005453-4057qib7	14677	13	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14677	14	even	even	RB
cord-005453-4057qib7	14677	15	at	at	IN
cord-005453-4057qib7	14677	16	lower	low	JJR
cord-005453-4057qib7	14677	17	doses	dose	NNS
cord-005453-4057qib7	14677	18	,	,	,
cord-005453-4057qib7	14677	19	but	but	CC
cord-005453-4057qib7	14677	20	it	-PRON-	PRP
cord-005453-4057qib7	14677	21	is	be	VBZ
cord-005453-4057qib7	14677	22	not	not	RB
cord-005453-4057qib7	14677	23	clear	clear	JJ
cord-005453-4057qib7	14677	24	why	why	WRB
cord-005453-4057qib7	14677	25	this	this	DT
cord-005453-4057qib7	14677	26	difference	difference	NN
cord-005453-4057qib7	14677	27	occurs	occur	VBZ
cord-005453-4057qib7	14677	28	.	.	.
cord-005453-4057qib7	14678	1	In	in	IN
cord-005453-4057qib7	14678	2	this	this	DT
cord-005453-4057qib7	14678	3	study	study	NN
cord-005453-4057qib7	14678	4	,	,	,
cord-005453-4057qib7	14678	5	we	-PRON-	PRP
cord-005453-4057qib7	14678	6	tried	try	VBD
cord-005453-4057qib7	14678	7	to	to	TO
cord-005453-4057qib7	14678	8	determine	determine	VB
cord-005453-4057qib7	14678	9	whether	whether	IN
cord-005453-4057qib7	14678	10	there	there	EX
cord-005453-4057qib7	14678	11	is	be	VBZ
cord-005453-4057qib7	14678	12	a	a	DT
cord-005453-4057qib7	14678	13	difference	difference	NN
cord-005453-4057qib7	14678	14	in	in	IN
cord-005453-4057qib7	14678	15	the	the	DT
cord-005453-4057qib7	14678	16	mechanism	mechanism	NN
cord-005453-4057qib7	14678	17	of	of	IN
cord-005453-4057qib7	14678	18	mobilization	mobilization	NN
cord-005453-4057qib7	14678	19	between	between	IN
cord-005453-4057qib7	14678	20	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14678	21	and	and	CC
cord-005453-4057qib7	14678	22	etoposide	etoposide	RB
cord-005453-4057qib7	14678	23	.	.	.
cord-005453-4057qib7	14679	1	Methods	method	NNS
cord-005453-4057qib7	14679	2	:	:	:
cord-005453-4057qib7	14680	1	First	first	RB
cord-005453-4057qib7	14680	2	,	,	,
cord-005453-4057qib7	14680	3	in	in	IN
cord-005453-4057qib7	14680	4	order	order	NN
cord-005453-4057qib7	14680	5	to	to	TO
cord-005453-4057qib7	14680	6	confirm	confirm	VB
cord-005453-4057qib7	14680	7	the	the	DT
cord-005453-4057qib7	14680	8	clinical	clinical	JJ
cord-005453-4057qib7	14680	9	data	datum	NNS
cord-005453-4057qib7	14680	10	for	for	IN
cord-005453-4057qib7	14680	11	efficacy	efficacy	NN
cord-005453-4057qib7	14680	12	and	and	CC
cord-005453-4057qib7	14680	13	toxicity	toxicity	NN
cord-005453-4057qib7	14680	14	of	of	IN
cord-005453-4057qib7	14680	15	mobilization	mobilization	NN
cord-005453-4057qib7	14680	16	,	,	,
cord-005453-4057qib7	14680	17	we	-PRON-	PRP
cord-005453-4057qib7	14680	18	retrospectively	retrospectively	RB
cord-005453-4057qib7	14680	19	analyzed	analyze	VBD
cord-005453-4057qib7	14680	20	the	the	DT
cord-005453-4057qib7	14680	21	data	datum	NNS
cord-005453-4057qib7	14680	22	of	of	IN
cord-005453-4057qib7	14680	23	patients	patient	NNS
cord-005453-4057qib7	14680	24	who	who	WP
cord-005453-4057qib7	14680	25	were	be	VBD
cord-005453-4057qib7	14680	26	diagnosed	diagnose	VBN
cord-005453-4057qib7	14680	27	with	with	IN
cord-005453-4057qib7	14680	28	lymphoma	lymphoma	NN
cord-005453-4057qib7	14680	29	and	and	CC
cord-005453-4057qib7	14680	30	performed	perform	VBN
cord-005453-4057qib7	14680	31	mobilization	mobilization	NN
cord-005453-4057qib7	14680	32	using	use	VBG
cord-005453-4057qib7	14680	33	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14680	34	or	or	CC
cord-005453-4057qib7	14680	35	etoposide	etoposide	RB
cord-005453-4057qib7	14680	36	from	from	IN
cord-005453-4057qib7	14680	37	January	January	NNP
cord-005453-4057qib7	14680	38	2011	2011	CD
cord-005453-4057qib7	14680	39	to	to	IN
cord-005453-4057qib7	14680	40	December	December	NNP
cord-005453-4057qib7	14680	41	2018	2018	CD
cord-005453-4057qib7	14680	42	.	.	.
cord-005453-4057qib7	14681	1	Second	second	RB
cord-005453-4057qib7	14681	2	,	,	,
cord-005453-4057qib7	14681	3	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	14681	4	stem	stem	NN
cord-005453-4057qib7	14681	5	cells	cell	NNS
cord-005453-4057qib7	14681	6	(	(	-LRB-
cord-005453-4057qib7	14681	7	MSC	MSC	NNP
cord-005453-4057qib7	14681	8	)	)	-RRB-
cord-005453-4057qib7	14681	9	were	be	VBD
cord-005453-4057qib7	14681	10	primarily	primarily	RB
cord-005453-4057qib7	14681	11	cultured	culture	VBN
cord-005453-4057qib7	14681	12	from	from	IN
cord-005453-4057qib7	14681	13	the	the	DT
cord-005453-4057qib7	14681	14	healthy	healthy	JJ
cord-005453-4057qib7	14681	15	controls	control	NNS
cord-005453-4057qib7	14681	16	,	,	,
cord-005453-4057qib7	14681	17	then	then	RB
cord-005453-4057qib7	14681	18	treated	treat	VBN
cord-005453-4057qib7	14681	19	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14681	20	or	or	CC
cord-005453-4057qib7	14681	21	etoposide	etoposide	VBD
cord-005453-4057qib7	14681	22	at	at	IN
cord-005453-4057qib7	14681	23	a	a	DT
cord-005453-4057qib7	14681	24	concentration	concentration	NN
cord-005453-4057qib7	14681	25	of	of	IN
cord-005453-4057qib7	14681	26	10	10	CD
cord-005453-4057qib7	14681	27	%	%	NN
cord-005453-4057qib7	14681	28	inhibition	inhibition	NN
cord-005453-4057qib7	14681	29	of	of	IN
cord-005453-4057qib7	14681	30	cell	cell	NN
cord-005453-4057qib7	14681	31	growth	growth	NN
cord-005453-4057qib7	14681	32	,	,	,
cord-005453-4057qib7	14681	33	and	and	CC
cord-005453-4057qib7	14681	34	cytokine	cytokine	NN
cord-005453-4057qib7	14681	35	analysis	analysis	NN
cord-005453-4057qib7	14681	36	was	be	VBD
cord-005453-4057qib7	14681	37	performed	perform	VBN
cord-005453-4057qib7	14681	38	to	to	TO
cord-005453-4057qib7	14681	39	identify	identify	VB
cord-005453-4057qib7	14681	40	cytokines	cytokine	NNS
cord-005453-4057qib7	14681	41	known	know	VBN
cord-005453-4057qib7	14681	42	to	to	TO
cord-005453-4057qib7	14681	43	be	be	VB
cord-005453-4057qib7	14681	44	associated	associate	VBN
cord-005453-4057qib7	14681	45	with	with	IN
cord-005453-4057qib7	14681	46	mobilization	mobilization	NN
cord-005453-4057qib7	14681	47	.	.	.
cord-005453-4057qib7	14682	1	Third	third	JJ
cord-005453-4057qib7	14682	2	,	,	,
cord-005453-4057qib7	14682	3	mobilization	mobilization	NN
cord-005453-4057qib7	14682	4	mouse	mouse	NN
cord-005453-4057qib7	14682	5	model	model	NN
cord-005453-4057qib7	14682	6	using	use	VBG
cord-005453-4057qib7	14682	7	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14682	8	or	or	CC
cord-005453-4057qib7	14682	9	etoposide	etoposide	NN
cord-005453-4057qib7	14682	10	was	be	VBD
cord-005453-4057qib7	14682	11	generated	generate	VBN
cord-005453-4057qib7	14682	12	,	,	,
cord-005453-4057qib7	14682	13	total	total	JJ
cord-005453-4057qib7	14682	14	blood	blood	NN
cord-005453-4057qib7	14682	15	was	be	VBD
cord-005453-4057qib7	14682	16	collected	collect	VBN
cord-005453-4057qib7	14682	17	at	at	IN
cord-005453-4057qib7	14682	18	the	the	DT
cord-005453-4057qib7	14682	19	time	time	NN
cord-005453-4057qib7	14682	20	of	of	IN
cord-005453-4057qib7	14682	21	HSCs	hscs	NN
cord-005453-4057qib7	14682	22	collection	collection	NN
cord-005453-4057qib7	14682	23	,	,	,
cord-005453-4057qib7	14682	24	and	and	CC
cord-005453-4057qib7	14682	25	cytokine	cytokine	NN
cord-005453-4057qib7	14682	26	and	and	CC
cord-005453-4057qib7	14682	27	network	network	NN
cord-005453-4057qib7	14682	28	analysis	analysis	NN
cord-005453-4057qib7	14682	29	(	(	-LRB-
cord-005453-4057qib7	14682	30	using	use	VBG
cord-005453-4057qib7	14682	31	Ingenuity	Ingenuity	NNP
cord-005453-4057qib7	14682	32	Pathway	Pathway	NNP
cord-005453-4057qib7	14682	33	Analysis	Analysis	NNP
cord-005453-4057qib7	14682	34	)	)	-RRB-
cord-005453-4057qib7	14682	35	was	be	VBD
cord-005453-4057qib7	14682	36	performed	perform	VBN
cord-005453-4057qib7	14682	37	.	.	.
cord-005453-4057qib7	14683	1	Results	result	NNS
cord-005453-4057qib7	14683	2	:	:	:
cord-005453-4057qib7	14684	1	The	the	DT
cord-005453-4057qib7	14684	2	mobilization	mobilization	NN
cord-005453-4057qib7	14684	3	yields	yield	VBZ
cord-005453-4057qib7	14684	4	for	for	IN
cord-005453-4057qib7	14684	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14684	6	or	or	CC
cord-005453-4057qib7	14684	7	etoposide	etoposide	JJ
cord-005453-4057qib7	14684	8	were	be	VBD
cord-005453-4057qib7	14684	9	analyzed	analyze	VBN
cord-005453-4057qib7	14684	10	.	.	.
cord-005453-4057qib7	14685	1	Etoposide	Etoposide	NNP
cord-005453-4057qib7	14685	2	miblized	miblize	VBD
cord-005453-4057qib7	14685	3	a	a	DT
cord-005453-4057qib7	14685	4	significantly	significantly	RB
cord-005453-4057qib7	14685	5	higher	high	JJR
cord-005453-4057qib7	14685	6	median	median	JJ
cord-005453-4057qib7	14685	7	number	number	NN
cord-005453-4057qib7	14685	8	of	of	IN
cord-005453-4057qib7	14685	9	CD34+cells	CD34+cells	NNPS
cord-005453-4057qib7	14685	10	than	than	IN
cord-005453-4057qib7	14685	11	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14685	12	.	.	.
cord-005453-4057qib7	14686	1	The	the	DT
cord-005453-4057qib7	14686	2	rate	rate	NN
cord-005453-4057qib7	14686	3	of	of	IN
cord-005453-4057qib7	14686	4	successful	successful	JJ
cord-005453-4057qib7	14686	5	or	or	CC
cord-005453-4057qib7	14686	6	adequate	adequate	JJ
cord-005453-4057qib7	14686	7	mobilization	mobilization	NN
cord-005453-4057qib7	14686	8	was	be	VBD
cord-005453-4057qib7	14686	9	also	also	RB
cord-005453-4057qib7	14686	10	significanctly	significanctly	RB
cord-005453-4057qib7	14686	11	higher	high	JJR
cord-005453-4057qib7	14686	12	for	for	IN
cord-005453-4057qib7	14686	13	etoposide	etoposide	JJ
cord-005453-4057qib7	14686	14	in	in	IN
cord-005453-4057qib7	14686	15	univariate	univariate	JJ
cord-005453-4057qib7	14686	16	and	and	CC
cord-005453-4057qib7	14686	17	multivariate	multivariate	JJ
cord-005453-4057qib7	14686	18	analysis	analysis	NN
cord-005453-4057qib7	14687	1	(	(	-LRB-
cord-005453-4057qib7	14687	2	Table	table	NN
cord-005453-4057qib7	14687	3	1	1	CD
cord-005453-4057qib7	14687	4	)	)	-RRB-
cord-005453-4057qib7	14687	5	.	.	.
cord-005453-4057qib7	14688	1	In	in	IN
cord-005453-4057qib7	14688	2	the	the	DT
cord-005453-4057qib7	14688	3	analysis	analysis	NN
cord-005453-4057qib7	14688	4	of	of	IN
cord-005453-4057qib7	14688	5	toxicity	toxicity	NN
cord-005453-4057qib7	14688	6	during	during	IN
cord-005453-4057qib7	14688	7	mobilization	mobilization	NN
cord-005453-4057qib7	14688	8	,	,	,
cord-005453-4057qib7	14688	9	the	the	DT
cord-005453-4057qib7	14688	10	incidence	incidence	NN
cord-005453-4057qib7	14688	11	of	of	IN
cord-005453-4057qib7	14688	12	neutropenic	neutropenic	JJ
cord-005453-4057qib7	14688	13	fever	fever	NN
cord-005453-4057qib7	14688	14	was	be	VBD
cord-005453-4057qib7	14688	15	higher	high	JJR
cord-005453-4057qib7	14688	16	in	in	IN
cord-005453-4057qib7	14688	17	the	the	DT
cord-005453-4057qib7	14688	18	cyclophosphamide	cyclophosphamide	JJ
cord-005453-4057qib7	14688	19	group	group	NN
cord-005453-4057qib7	14688	20	(	(	-LRB-
cord-005453-4057qib7	14688	21	P	p	NN
cord-005453-4057qib7	14688	22	=	=	SYM
cord-005453-4057qib7	14688	23	0.007	0.007	CD
cord-005453-4057qib7	14688	24	)	)	-RRB-
cord-005453-4057qib7	14688	25	.	.	.
cord-005453-4057qib7	14689	1	During	during	IN
cord-005453-4057qib7	14689	2	mobilization	mobilization	NN
cord-005453-4057qib7	14689	3	,	,	,
cord-005453-4057qib7	14689	4	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	14689	5	maintained	maintain	VBD
cord-005453-4057qib7	14689	6	lower	low	JJR
cord-005453-4057qib7	14689	7	WBC	WBC	NNP
cord-005453-4057qib7	14689	8	counts	count	NNS
cord-005453-4057qib7	14689	9	than	than	IN
cord-005453-4057qib7	14689	10	etoposide	etoposide	JJ
cord-005453-4057qib7	14689	11	and	and	CC
cord-005453-4057qib7	14689	12	showed	show	VBD
cord-005453-4057qib7	14689	13	a	a	DT
cord-005453-4057qib7	14689	14	large	large	JJ
cord-005453-4057qib7	14689	15	increase	increase	NN
cord-005453-4057qib7	14689	16	in	in	IN
cord-005453-4057qib7	14689	17	WBC	WBC	NNP
cord-005453-4057qib7	14689	18	counts	count	VBZ
cord-005453-4057qib7	14689	19	at	at	IN
cord-005453-4057qib7	14689	20	the	the	DT
cord-005453-4057qib7	14689	21	start	start	NN
cord-005453-4057qib7	14689	22	of	of	IN
cord-005453-4057qib7	14689	23	collection	collection	NN
cord-005453-4057qib7	14689	24	(	(	-LRB-
cord-005453-4057qib7	14689	25	Figure	figure	NN
cord-005453-4057qib7	14689	26	1	1	CD
cord-005453-4057qib7	14689	27	)	)	-RRB-
cord-005453-4057qib7	14689	28	.	.	.
cord-005453-4057qib7	14690	1	The	the	DT
cord-005453-4057qib7	14690	2	cumulative	cumulative	JJ
cord-005453-4057qib7	14690	3	dose	dose	NN
cord-005453-4057qib7	14690	4	of	of	IN
cord-005453-4057qib7	14690	5	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14690	6	or	or	CC
cord-005453-4057qib7	14690	7	etoposide	etoposide	VBN
cord-005453-4057qib7	14690	8	in	in	IN
cord-005453-4057qib7	14690	9	patients	patient	NNS
cord-005453-4057qib7	14690	10	who	who	WP
cord-005453-4057qib7	14690	11	underwent	undergo	VBD
cord-005453-4057qib7	14690	12	autologous	autologous	JJ
cord-005453-4057qib7	14690	13	stem	stem	NN
cord-005453-4057qib7	14690	14	cell	cell	NN
cord-005453-4057qib7	14690	15	transplantation	transplantation	NN
cord-005453-4057qib7	14690	16	did	do	VBD
cord-005453-4057qib7	14690	17	not	not	RB
cord-005453-4057qib7	14690	18	affect	affect	VB
cord-005453-4057qib7	14690	19	leukocyte	leukocyte	NN
cord-005453-4057qib7	14690	20	(	(	-LRB-
cord-005453-4057qib7	14690	21	ANC>1000	ANC>1000	NNP
cord-005453-4057qib7	14690	22	/	/	SYM
cord-005453-4057qib7	14690	23	microL	microL	NNP
cord-005453-4057qib7	14690	24	or	or	CC
cord-005453-4057qib7	14690	25	platelet	platelet	NN
cord-005453-4057qib7	14691	1	(	(	-LRB-
cord-005453-4057qib7	14691	2	PLT	PLT	NNP
cord-005453-4057qib7	14691	3	>	>	XX
cord-005453-4057qib7	14691	4	100k	100k	CD
cord-005453-4057qib7	14691	5	/	/	SYM
cord-005453-4057qib7	14691	6	microL	microL	NNP
cord-005453-4057qib7	14691	7	)	)	-RRB-
cord-005453-4057qib7	14691	8	engraftment	engraftment	NN
cord-005453-4057qib7	14691	9	.	.	.
cord-005453-4057qib7	14692	1	In	in	IN
cord-005453-4057qib7	14692	2	MSC	MSC	NNP
cord-005453-4057qib7	14692	3	treated	treat	VBN
cord-005453-4057qib7	14692	4	with	with	IN
cord-005453-4057qib7	14692	5	etoposide	etoposide	JJ
cord-005453-4057qib7	14692	6	at	at	IN
cord-005453-4057qib7	14692	7	a	a	DT
cord-005453-4057qib7	14692	8	concentration	concentration	NN
cord-005453-4057qib7	14692	9	of	of	IN
cord-005453-4057qib7	14692	10	10	10	CD
cord-005453-4057qib7	14692	11	%	%	NN
cord-005453-4057qib7	14692	12	inhibition	inhibition	NN
cord-005453-4057qib7	14692	13	of	of	IN
cord-005453-4057qib7	14692	14	cell	cell	NN
cord-005453-4057qib7	14692	15	growth	growth	NN
cord-005453-4057qib7	14692	16	,	,	,
cord-005453-4057qib7	14692	17	IL-8	IL-8	NNP
cord-005453-4057qib7	14692	18	,	,	,
cord-005453-4057qib7	14692	19	which	which	WDT
cord-005453-4057qib7	14692	20	is	be	VBZ
cord-005453-4057qib7	14692	21	a	a	DT
cord-005453-4057qib7	14692	22	cytokine	cytokine	NN
cord-005453-4057qib7	14692	23	that	that	WDT
cord-005453-4057qib7	14692	24	promotes	promote	VBZ
cord-005453-4057qib7	14692	25	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14692	26	stem	stem	NN
cord-005453-4057qib7	14692	27	cell	cell	NN
cord-005453-4057qib7	14692	28	mobilization	mobilization	NN
cord-005453-4057qib7	14692	29	,	,	,
cord-005453-4057qib7	14692	30	were	be	VBD
cord-005453-4057qib7	14692	31	shown	show	VBN
cord-005453-4057qib7	14692	32	a	a	DT
cord-005453-4057qib7	14692	33	statistically	statistically	RB
cord-005453-4057qib7	14692	34	significant	significant	JJ
cord-005453-4057qib7	14692	35	increase	increase	NN
cord-005453-4057qib7	14692	36	(	(	-LRB-
cord-005453-4057qib7	14692	37	Figure	figure	NN
cord-005453-4057qib7	14692	38	2	2	CD
cord-005453-4057qib7	14692	39	)	)	-RRB-
cord-005453-4057qib7	14692	40	.	.	.
cord-005453-4057qib7	14693	1	In	in	IN
cord-005453-4057qib7	14693	2	the	the	DT
cord-005453-4057qib7	14693	3	mouse	mouse	NN
cord-005453-4057qib7	14693	4	model	model	NN
cord-005453-4057qib7	14693	5	of	of	IN
cord-005453-4057qib7	14693	6	mobilization	mobilization	NN
cord-005453-4057qib7	14693	7	(	(	-LRB-
cord-005453-4057qib7	14693	8	Figure	figure	NN
cord-005453-4057qib7	14693	9	3	3	CD
cord-005453-4057qib7	14693	10	)	)	-RRB-
cord-005453-4057qib7	14693	11	,	,	,
cord-005453-4057qib7	14693	12	the	the	DT
cord-005453-4057qib7	14693	13	levels	level	NNS
cord-005453-4057qib7	14693	14	of	of	IN
cord-005453-4057qib7	14693	15	KC	KC	NNP
cord-005453-4057qib7	14693	16	,	,	,
cord-005453-4057qib7	14693	17	one	one	CD
cord-005453-4057qib7	14693	18	of	of	IN
cord-005453-4057qib7	14693	19	the	the	DT
cord-005453-4057qib7	14693	20	IL-8	IL-8	NNP
cord-005453-4057qib7	14693	21	homologues	homologue	NNS
cord-005453-4057qib7	14693	22	in	in	IN
cord-005453-4057qib7	14693	23	mice	mouse	NNS
cord-005453-4057qib7	14693	24	,	,	,
cord-005453-4057qib7	14693	25	had	have	VBD
cord-005453-4057qib7	14693	26	significantly	significantly	RB
cord-005453-4057qib7	14693	27	increased	increase	VBN
cord-005453-4057qib7	14693	28	in	in	IN
cord-005453-4057qib7	14693	29	the	the	DT
cord-005453-4057qib7	14693	30	etoposide	etoposide	NN
cord-005453-4057qib7	14693	31	-	-	HYPH
cord-005453-4057qib7	14693	32	treated	treat	VBN
cord-005453-4057qib7	14693	33	group	group	NN
cord-005453-4057qib7	14693	34	compared	compare	VBN
cord-005453-4057qib7	14693	35	with	with	IN
cord-005453-4057qib7	14693	36	the	the	DT
cord-005453-4057qib7	14693	37	levels	level	NNS
cord-005453-4057qib7	14693	38	in	in	IN
cord-005453-4057qib7	14693	39	the	the	DT
cord-005453-4057qib7	14693	40	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14693	41	-	-	HYPH
cord-005453-4057qib7	14693	42	treated	treat	VBN
cord-005453-4057qib7	14693	43	group	group	NN
cord-005453-4057qib7	14693	44	.	.	.
cord-005453-4057qib7	14694	1	The	the	DT
cord-005453-4057qib7	14694	2	levels	level	NNS
cord-005453-4057qib7	14694	3	of	of	IN
cord-005453-4057qib7	14694	4	other	other	JJ
cord-005453-4057qib7	14694	5	IL-8	IL-8	NNP
cord-005453-4057qib7	14694	6	homologues	homologue	NNS
cord-005453-4057qib7	14694	7	,	,	,
cord-005453-4057qib7	14694	8	MIP-2	MIP-2	NNP
cord-005453-4057qib7	14694	9	and	and	CC
cord-005453-4057qib7	14694	10	LIX	LIX	NNP
cord-005453-4057qib7	14694	11	,	,	,
cord-005453-4057qib7	14694	12	also	also	RB
cord-005453-4057qib7	14694	13	showed	show	VBD
cord-005453-4057qib7	14694	14	increases	increase	NNS
cord-005453-4057qib7	14694	15	in	in	IN
cord-005453-4057qib7	14694	16	the	the	DT
cord-005453-4057qib7	14694	17	etoposide	etoposide	NN
cord-005453-4057qib7	14694	18	-	-	HYPH
cord-005453-4057qib7	14694	19	treated	treat	VBN
cord-005453-4057qib7	14694	20	group	group	NN
cord-005453-4057qib7	14694	21	compared	compare	VBN
cord-005453-4057qib7	14694	22	with	with	IN
cord-005453-4057qib7	14694	23	those	those	DT
cord-005453-4057qib7	14694	24	in	in	IN
cord-005453-4057qib7	14694	25	the	the	DT
cord-005453-4057qib7	14694	26	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14694	27	-	-	HYPH
cord-005453-4057qib7	14694	28	treated	treat	VBN
cord-005453-4057qib7	14694	29	group	group	NN
cord-005453-4057qib7	14694	30	;	;	:
cord-005453-4057qib7	14694	31	these	these	DT
cord-005453-4057qib7	14694	32	differences	difference	NNS
cord-005453-4057qib7	14694	33	,	,	,
cord-005453-4057qib7	14694	34	however	however	RB
cord-005453-4057qib7	14694	35	,	,	,
cord-005453-4057qib7	14694	36	were	be	VBD
cord-005453-4057qib7	14694	37	not	not	RB
cord-005453-4057qib7	14694	38	statistically	statistically	RB
cord-005453-4057qib7	14694	39	significant	significant	JJ
cord-005453-4057qib7	14695	1	(	(	-LRB-
cord-005453-4057qib7	14695	2	Figure	figure	NN
cord-005453-4057qib7	14695	3	4	4	CD
cord-005453-4057qib7	14695	4	)	)	-RRB-
cord-005453-4057qib7	14695	5	.	.	.
cord-005453-4057qib7	14696	1	Network	network	NN
cord-005453-4057qib7	14696	2	analysis	analysis	NN
cord-005453-4057qib7	14696	3	based	base	VBN
cord-005453-4057qib7	14696	4	on	on	IN
cord-005453-4057qib7	14696	5	in	in	IN
cord-005453-4057qib7	14696	6	vivo	vivo	NN
cord-005453-4057qib7	14696	7	cytokine	cytokine	NN
cord-005453-4057qib7	14696	8	results	result	NNS
cord-005453-4057qib7	14696	9	identified	identify	VBN
cord-005453-4057qib7	14696	10	that	that	IN
cord-005453-4057qib7	14696	11	etoposide	etoposide	RB
cord-005453-4057qib7	14696	12	could	could	MD
cord-005453-4057qib7	14696	13	promote	promote	VB
cord-005453-4057qib7	14696	14	mobilization	mobilization	NN
cord-005453-4057qib7	14696	15	in	in	IN
cord-005453-4057qib7	14696	16	association	association	NN
cord-005453-4057qib7	14696	17	with	with	IN
cord-005453-4057qib7	14696	18	matrix	matrix	NN
cord-005453-4057qib7	14696	19	metalloproteinase	metalloproteinase	NN
cord-005453-4057qib7	14696	20	as	as	IN
cord-005453-4057qib7	14696	21	compared	compare	VBN
cord-005453-4057qib7	14696	22	to	to	IN
cord-005453-4057qib7	14696	23	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14696	24	(	(	-LRB-
cord-005453-4057qib7	14696	25	Figure	figure	NN
cord-005453-4057qib7	14696	26	5	5	CD
cord-005453-4057qib7	14696	27	)	)	-RRB-
cord-005453-4057qib7	14696	28	.	.	.
cord-005453-4057qib7	14697	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14697	2	:	:	:
cord-005453-4057qib7	14698	1	Etoposide	Etoposide	NNP
cord-005453-4057qib7	14698	2	has	have	VBZ
cord-005453-4057qib7	14698	3	a	a	DT
cord-005453-4057qib7	14698	4	higher	high	JJR
cord-005453-4057qib7	14698	5	mobilization	mobilization	NN
cord-005453-4057qib7	14698	6	efficacy	efficacy	NN
cord-005453-4057qib7	14698	7	when	when	WRB
cord-005453-4057qib7	14698	8	compared	compare	VBN
cord-005453-4057qib7	14698	9	to	to	IN
cord-005453-4057qib7	14698	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14698	11	,	,	,
cord-005453-4057qib7	14698	12	which	which	WDT
cord-005453-4057qib7	14698	13	could	could	MD
cord-005453-4057qib7	14698	14	due	due	IN
cord-005453-4057qib7	14698	15	to	to	IN
cord-005453-4057qib7	14698	16	the	the	DT
cord-005453-4057qib7	14698	17	different	different	JJ
cord-005453-4057qib7	14698	18	mechanisms	mechanism	NNS
cord-005453-4057qib7	14698	19	of	of	IN
cord-005453-4057qib7	14698	20	mobilization	mobilization	NN
cord-005453-4057qib7	14698	21	through	through	IN
cord-005453-4057qib7	14698	22	the	the	DT
cord-005453-4057qib7	14698	23	elevation	elevation	NN
cord-005453-4057qib7	14698	24	of	of	IN
cord-005453-4057qib7	14698	25	IL8	IL8	NNP
cord-005453-4057qib7	14698	26	and	and	CC
cord-005453-4057qib7	14698	27	the	the	DT
cord-005453-4057qib7	14698	28	activation	activation	NN
cord-005453-4057qib7	14698	29	of	of	IN
cord-005453-4057qib7	14698	30	matrix	matrix	NN
cord-005453-4057qib7	14698	31	metalloproteinase	metalloproteinase	NN
cord-005453-4057qib7	14698	32	associated	associate	VBN
cord-005453-4057qib7	14698	33	therewith	therewith	RB
cord-005453-4057qib7	14698	34	.	.	.
cord-005453-4057qib7	14699	1	Background	background	NN
cord-005453-4057qib7	14699	2	:	:	:
cord-005453-4057qib7	14700	1	High	high	JJ
cord-005453-4057qib7	14700	2	-	-	HYPH
cord-005453-4057qib7	14700	3	dose	dose	NN
cord-005453-4057qib7	14700	4	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14700	5	followed	follow	VBN
cord-005453-4057qib7	14700	6	by	by	IN
cord-005453-4057qib7	14700	7	autologous	autologous	JJ
cord-005453-4057qib7	14700	8	blood	blood	NN
cord-005453-4057qib7	14700	9	stem	stem	NN
cord-005453-4057qib7	14700	10	cell	cell	NN
cord-005453-4057qib7	14700	11	transplantation	transplantation	NN
cord-005453-4057qib7	14700	12	(	(	-LRB-
cord-005453-4057qib7	14700	13	ASCT	ASCT	NNP
cord-005453-4057qib7	14700	14	)	)	-RRB-
cord-005453-4057qib7	14700	15	is	be	VBZ
cord-005453-4057qib7	14700	16	a	a	DT
cord-005453-4057qib7	14700	17	standard	standard	JJ
cord-005453-4057qib7	14700	18	therapy	therapy	NN
cord-005453-4057qib7	14700	19	for	for	IN
cord-005453-4057qib7	14700	20	wide	wide	JJ
cord-005453-4057qib7	14700	21	range	range	NN
cord-005453-4057qib7	14700	22	of	of	IN
cord-005453-4057qib7	14700	23	hematologic	hematologic	JJ
cord-005453-4057qib7	14700	24	and	and	CC
cord-005453-4057qib7	14700	25	solid	solid	JJ
cord-005453-4057qib7	14700	26	malignancies	malignancy	NNS
cord-005453-4057qib7	14700	27	.	.	.
cord-005453-4057qib7	14701	1	Although	although	IN
cord-005453-4057qib7	14701	2	various	various	JJ
cord-005453-4057qib7	14701	3	methods	method	NNS
cord-005453-4057qib7	14701	4	have	have	VBP
cord-005453-4057qib7	14701	5	been	be	VBN
cord-005453-4057qib7	14701	6	introduced	introduce	VBN
cord-005453-4057qib7	14701	7	to	to	TO
cord-005453-4057qib7	14701	8	improve	improve	VB
cord-005453-4057qib7	14701	9	the	the	DT
cord-005453-4057qib7	14701	10	peripheral	peripheral	JJ
cord-005453-4057qib7	14701	11	blood	blood	NN
cord-005453-4057qib7	14701	12	stem	stem	NN
cord-005453-4057qib7	14701	13	cell	cell	NN
cord-005453-4057qib7	14701	14	(	(	-LRB-
cord-005453-4057qib7	14701	15	PBSC	PBSC	NNP
cord-005453-4057qib7	14701	16	)	)	-RRB-
cord-005453-4057qib7	14701	17	mobilization	mobilization	NN
cord-005453-4057qib7	14701	18	,	,	,
cord-005453-4057qib7	14701	19	autologous	autologous	JJ
cord-005453-4057qib7	14701	20	stem	stem	NN
cord-005453-4057qib7	14701	21	cell	cell	NN
cord-005453-4057qib7	14701	22	collection	collection	NN
cord-005453-4057qib7	14701	23	(	(	-LRB-
cord-005453-4057qib7	14701	24	ASCC	ASCC	NNP
cord-005453-4057qib7	14701	25	)	)	-RRB-
cord-005453-4057qib7	14701	26	is	be	VBZ
cord-005453-4057qib7	14701	27	not	not	RB
cord-005453-4057qib7	14701	28	successful	successful	JJ
cord-005453-4057qib7	14701	29	in	in	IN
cord-005453-4057qib7	14701	30	every	every	DT
cord-005453-4057qib7	14701	31	patient	patient	NN
cord-005453-4057qib7	14701	32	.	.	.
cord-005453-4057qib7	14702	1	Furthermore	furthermore	RB
cord-005453-4057qib7	14702	2	,	,	,
cord-005453-4057qib7	14702	3	even	even	RB
cord-005453-4057qib7	14702	4	if	if	IN
cord-005453-4057qib7	14702	5	the	the	DT
cord-005453-4057qib7	14702	6	ASCC	ASCC	NNP
cord-005453-4057qib7	14702	7	is	be	VBZ
cord-005453-4057qib7	14702	8	complete	complete	JJ
cord-005453-4057qib7	14702	9	,	,	,
cord-005453-4057qib7	14702	10	not	not	RB
cord-005453-4057qib7	14702	11	all	all	DT
cord-005453-4057qib7	14702	12	of	of	IN
cord-005453-4057qib7	14702	13	them	-PRON-	PRP
cord-005453-4057qib7	14702	14	lead	lead	VBP
cord-005453-4057qib7	14702	15	to	to	IN
cord-005453-4057qib7	14702	16	ASCT	ASCT	NNP
cord-005453-4057qib7	14702	17	.	.	.
cord-005453-4057qib7	14703	1	We	-PRON-	PRP
cord-005453-4057qib7	14703	2	evaluated	evaluate	VBD
cord-005453-4057qib7	14703	3	the	the	DT
cord-005453-4057qib7	14703	4	result	result	NN
cord-005453-4057qib7	14703	5	of	of	IN
cord-005453-4057qib7	14703	6	ASCC	ASCC	NNP
cord-005453-4057qib7	14703	7	and	and	CC
cord-005453-4057qib7	14703	8	actual	actual	JJ
cord-005453-4057qib7	14703	9	use	use	NN
cord-005453-4057qib7	14703	10	of	of	IN
cord-005453-4057qib7	14703	11	PBSC	PBSC	NNP
cord-005453-4057qib7	14703	12	grafts	graft	NNS
cord-005453-4057qib7	14703	13	in	in	IN
cord-005453-4057qib7	14703	14	current	current	JJ
cord-005453-4057qib7	14703	15	practical	practical	JJ
cord-005453-4057qib7	14703	16	setting	setting	NN
cord-005453-4057qib7	14703	17	.	.	.
cord-005453-4057qib7	14704	1	Methods	method	NNS
cord-005453-4057qib7	14704	2	:	:	:
cord-005453-4057qib7	14704	3	We	-PRON-	PRP
cord-005453-4057qib7	14704	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	14704	5	reviewed	review	VBD
cord-005453-4057qib7	14704	6	the	the	DT
cord-005453-4057qib7	14704	7	all	all	DT
cord-005453-4057qib7	14704	8	consecutive	consecutive	JJ
cord-005453-4057qib7	14704	9	ASCC	ASCC	NNP
cord-005453-4057qib7	14704	10	procedures	procedure	NNS
cord-005453-4057qib7	14704	11	performed	perform	VBN
cord-005453-4057qib7	14704	12	at	at	IN
cord-005453-4057qib7	14704	13	the	the	DT
cord-005453-4057qib7	14704	14	Department	Department	NNP
cord-005453-4057qib7	14704	15	of	of	IN
cord-005453-4057qib7	14704	16	Oncology	Oncology	NNP
cord-005453-4057qib7	14704	17	in	in	IN
cord-005453-4057qib7	14704	18	Asan	Asan	NNP
cord-005453-4057qib7	14704	19	Medical	Medical	NNP
cord-005453-4057qib7	14704	20	Center	Center	NNP
cord-005453-4057qib7	14704	21	,	,	,
cord-005453-4057qib7	14704	22	Seoul	Seoul	NNP
cord-005453-4057qib7	14704	23	,	,	,
cord-005453-4057qib7	14704	24	Korea	Korea	NNP
cord-005453-4057qib7	14704	25	,	,	,
cord-005453-4057qib7	14704	26	between	between	IN
cord-005453-4057qib7	14704	27	January	January	NNP
cord-005453-4057qib7	14704	28	2000	2000	CD
cord-005453-4057qib7	14704	29	and	and	CC
cord-005453-4057qib7	14704	30	October	October	NNP
cord-005453-4057qib7	14704	31	2018	2018	CD
cord-005453-4057qib7	14704	32	.	.	.
cord-005453-4057qib7	14705	1	The	the	DT
cord-005453-4057qib7	14705	2	targeted	target	VBN
cord-005453-4057qib7	14705	3	number	number	NN
cord-005453-4057qib7	14705	4	of	of	IN
cord-005453-4057qib7	14705	5	Background	background	NN
cord-005453-4057qib7	14705	6	:	:	:
cord-005453-4057qib7	14705	7	Fanconi	Fanconi	NNP
cord-005453-4057qib7	14705	8	Anemia	Anemia	NNP
cord-005453-4057qib7	14705	9	(	(	-LRB-
cord-005453-4057qib7	14705	10	FA	FA	NNP
cord-005453-4057qib7	14705	11	)	)	-RRB-
cord-005453-4057qib7	14705	12	is	be	VBZ
cord-005453-4057qib7	14705	13	a	a	DT
cord-005453-4057qib7	14705	14	rare	rare	JJ
cord-005453-4057qib7	14705	15	inherited	inherit	VBN
cord-005453-4057qib7	14705	16	genetic	genetic	JJ
cord-005453-4057qib7	14705	17	bone	bone	NN
cord-005453-4057qib7	14705	18	marrow	marrow	NN
cord-005453-4057qib7	14705	19	(	(	-LRB-
cord-005453-4057qib7	14705	20	BM	BM	NNP
cord-005453-4057qib7	14705	21	)	)	-RRB-
cord-005453-4057qib7	14705	22	failure	failure	NN
cord-005453-4057qib7	14705	23	syndrome	syndrome	NN
cord-005453-4057qib7	14705	24	.	.	.
cord-005453-4057qib7	14706	1	While	while	IN
cord-005453-4057qib7	14706	2	abnormal	abnormal	JJ
cord-005453-4057qib7	14706	3	BM	bm	NN
cord-005453-4057qib7	14706	4	cells	cell	NNS
cord-005453-4057qib7	14706	5	production	production	NN
cord-005453-4057qib7	14706	6	occurs	occur	VBZ
cord-005453-4057qib7	14706	7	very	very	RB
cord-005453-4057qib7	14706	8	early	early	RB
cord-005453-4057qib7	14706	9	in	in	IN
cord-005453-4057qib7	14706	10	life	life	NN
cord-005453-4057qib7	14706	11	,	,	,
cord-005453-4057qib7	14706	12	the	the	DT
cord-005453-4057qib7	14706	13	usual	usual	JJ
cord-005453-4057qib7	14706	14	age	age	NN
cord-005453-4057qib7	14706	15	of	of	IN
cord-005453-4057qib7	14706	16	diagnosis	diagnosis	NN
cord-005453-4057qib7	14706	17	is	be	VBZ
cord-005453-4057qib7	14706	18	5	5	CD
cord-005453-4057qib7	14706	19	-	-	SYM
cord-005453-4057qib7	14706	20	10	10	CD
cord-005453-4057qib7	14706	21	years	year	NNS
cord-005453-4057qib7	14706	22	old	old	JJ
cord-005453-4057qib7	14706	23	.	.	.
cord-005453-4057qib7	14707	1	Gene	gene	NN
cord-005453-4057qib7	14707	2	therapy	therapy	NN
cord-005453-4057qib7	14707	3	(	(	-LRB-
cord-005453-4057qib7	14707	4	GT	GT	NNP
cord-005453-4057qib7	14707	5	)	)	-RRB-
cord-005453-4057qib7	14707	6	might	may	MD
cord-005453-4057qib7	14707	7	be	be	VB
cord-005453-4057qib7	14707	8	an	an	DT
cord-005453-4057qib7	14707	9	alternative	alternative	NN
cord-005453-4057qib7	14707	10	to	to	IN
cord-005453-4057qib7	14707	11	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14707	12	stem	stem	NN
cord-005453-4057qib7	14707	13	cells	cell	NNS
cord-005453-4057qib7	14707	14	(	(	-LRB-
cord-005453-4057qib7	14707	15	HSC	HSC	NNP
cord-005453-4057qib7	14707	16	)	)	-RRB-
cord-005453-4057qib7	14707	17	transplantation	transplantation	NN
cord-005453-4057qib7	14707	18	,	,	,
cord-005453-4057qib7	14707	19	but	but	CC
cord-005453-4057qib7	14707	20	harvest	harvest	VBP
cord-005453-4057qib7	14707	21	a	a	DT
cord-005453-4057qib7	14707	22	large	large	JJ
cord-005453-4057qib7	14707	23	number	number	NN
cord-005453-4057qib7	14707	24	of	of	IN
cord-005453-4057qib7	14707	25	autologous	autologous	JJ
cord-005453-4057qib7	14707	26	HSC	HSC	NNP
cord-005453-4057qib7	14707	27	remains	remain	VBZ
cord-005453-4057qib7	14707	28	a	a	DT
cord-005453-4057qib7	14707	29	challenge	challenge	NN
cord-005453-4057qib7	14707	30	.	.	.
cord-005453-4057qib7	14708	1	We	-PRON-	PRP
cord-005453-4057qib7	14708	2	started	start	VBD
cord-005453-4057qib7	14708	3	a	a	DT
cord-005453-4057qib7	14708	4	mobilization	mobilization	NN
cord-005453-4057qib7	14708	5	assay	assay	NN
cord-005453-4057qib7	14708	6	,	,	,
cord-005453-4057qib7	14708	7	FancoMob	FancoMob	NNP
cord-005453-4057qib7	14708	8	,	,	,
cord-005453-4057qib7	14708	9	to	to	TO
cord-005453-4057qib7	14708	10	evaluate	evaluate	VB
cord-005453-4057qib7	14708	11	the	the	DT
cord-005453-4057qib7	14708	12	safety	safety	NN
cord-005453-4057qib7	14708	13	and	and	CC
cord-005453-4057qib7	14708	14	the	the	DT
cord-005453-4057qib7	14708	15	efficacy	efficacy	NN
cord-005453-4057qib7	14708	16	of	of	IN
cord-005453-4057qib7	14708	17	FA	FA	NNP
cord-005453-4057qib7	14708	18	patients	patient	NNS
cord-005453-4057qib7	14708	19	'	'	POS
cord-005453-4057qib7	14708	20	mobilization	mobilization	NN
cord-005453-4057qib7	14708	21	with	with	IN
cord-005453-4057qib7	14708	22	granulocyte	granulocyte	NN
cord-005453-4057qib7	14708	23	-	-	HYPH
cord-005453-4057qib7	14708	24	colony	colony	NN
cord-005453-4057qib7	14708	25	stimulating	stimulate	VBG
cord-005453-4057qib7	14708	26	factor	factor	NN
cord-005453-4057qib7	14708	27	(	(	-LRB-
cord-005453-4057qib7	14708	28	G	G	NNP
cord-005453-4057qib7	14708	29	-	-	HYPH
cord-005453-4057qib7	14708	30	CSF	CSF	NNP
cord-005453-4057qib7	14708	31	)	)	-RRB-
cord-005453-4057qib7	14708	32	and	and	CC
cord-005453-4057qib7	14708	33	plerixafor	plerixafor	NN
cord-005453-4057qib7	14708	34	.	.	.
cord-005453-4057qib7	14709	1	This	this	DT
cord-005453-4057qib7	14709	2	study	study	NN
cord-005453-4057qib7	14709	3	is	be	VBZ
cord-005453-4057qib7	14709	4	part	part	NN
cord-005453-4057qib7	14709	5	of	of	IN
cord-005453-4057qib7	14709	6	the	the	DT
cord-005453-4057qib7	14709	7	FA	FA	NNP
cord-005453-4057qib7	14709	8	's	's	POS
cord-005453-4057qib7	14709	9	European	european	JJ
cord-005453-4057qib7	14709	10	GT	GT	NNP
cord-005453-4057qib7	14709	11	project	project	NN
cord-005453-4057qib7	14709	12	"	"	``
cord-005453-4057qib7	14709	13	EuroFancolen	EuroFancolen	NNP
cord-005453-4057qib7	14709	14	"	"	''
cord-005453-4057qib7	14709	15	.	.	.
cord-005453-4057qib7	14710	1	Methods	method	NNS
cord-005453-4057qib7	14710	2	:	:	:
cord-005453-4057qib7	14710	3	Four	four	CD
cord-005453-4057qib7	14710	4	patients	patient	NNS
cord-005453-4057qib7	14710	5	with	with	IN
cord-005453-4057qib7	14710	6	FANCA	FANCA	NNP
cord-005453-4057qib7	14710	7	mutations	mutation	NNS
cord-005453-4057qib7	14710	8	following	follow	VBG
cord-005453-4057qib7	14710	9	the	the	DT
cord-005453-4057qib7	14710	10	inclusion	inclusion	NN
cord-005453-4057qib7	14710	11	criteria	criterion	NNS
cord-005453-4057qib7	14710	12	were	be	VBD
cord-005453-4057qib7	14710	13	selected	select	VBN
cord-005453-4057qib7	14710	14	before	before	IN
cord-005453-4057qib7	14710	15	pancytopenia	pancytopenia	NNP
cord-005453-4057qib7	14710	16	.	.	.
cord-005453-4057qib7	14711	1	To	to	TO
cord-005453-4057qib7	14711	2	note	note	VB
cord-005453-4057qib7	14711	3	,	,	,
cord-005453-4057qib7	14711	4	FA4	FA4	NNP
cord-005453-4057qib7	14711	5	was	be	VBD
cord-005453-4057qib7	14711	6	diagnosed	diagnose	VBN
cord-005453-4057qib7	14711	7	before	before	IN
cord-005453-4057qib7	14711	8	clinical	clinical	JJ
cord-005453-4057qib7	14711	9	manifestation	manifestation	NN
cord-005453-4057qib7	14711	10	through	through	IN
cord-005453-4057qib7	14711	11	family	family	NN
cord-005453-4057qib7	14711	12	screening	screening	NN
cord-005453-4057qib7	14711	13	.	.	.
cord-005453-4057qib7	14712	1	They	-PRON-	PRP
cord-005453-4057qib7	14712	2	received	receive	VBD
cord-005453-4057qib7	14712	3	subcutaneous	subcutaneous	JJ
cord-005453-4057qib7	14712	4	injection	injection	NN
cord-005453-4057qib7	14712	5	of	of	IN
cord-005453-4057qib7	14712	6	G	G	NNP
cord-005453-4057qib7	14712	7	-	-	HYPH
cord-005453-4057qib7	14712	8	CSF	CSF	NNP
cord-005453-4057qib7	14712	9	(	(	-LRB-
cord-005453-4057qib7	14712	10	12	12	CD
cord-005453-4057qib7	14712	11	μg	μg	NNP
cord-005453-4057qib7	14712	12	/	/	SYM
cord-005453-4057qib7	14712	13	kg	kg	NNS
cord-005453-4057qib7	14712	14	twice	twice	PDT
cord-005453-4057qib7	14712	15	a	a	DT
cord-005453-4057qib7	14712	16	day	day	NN
cord-005453-4057qib7	14712	17	)	)	-RRB-
cord-005453-4057qib7	14712	18	from	from	IN
cord-005453-4057qib7	14712	19	D-1	D-1	NNP
cord-005453-4057qib7	14712	20	and	and	CC
cord-005453-4057qib7	14712	21	plerixafor	plerixafor	NN
cord-005453-4057qib7	14712	22	(	(	-LRB-
cord-005453-4057qib7	14712	23	0.24	0.24	CD
cord-005453-4057qib7	14712	24	mg	mg	NNP
cord-005453-4057qib7	14712	25	/	/	SYM
cord-005453-4057qib7	14712	26	kg	kg	NNP
cord-005453-4057qib7	14712	27	/	/	SYM
cord-005453-4057qib7	14712	28	day	day	NN
cord-005453-4057qib7	14712	29	)	)	-RRB-
cord-005453-4057qib7	14712	30	from	from	IN
cord-005453-4057qib7	14712	31	D-4	D-4	NNP
cord-005453-4057qib7	14712	32	.	.	.
cord-005453-4057qib7	14713	1	The	the	DT
cord-005453-4057qib7	14713	2	collection	collection	NN
cord-005453-4057qib7	14713	3	protocol	protocol	NN
cord-005453-4057qib7	14713	4	targeted	target	VBN
cord-005453-4057qib7	14713	5	3x10e6	3x10e6	NNP
cord-005453-4057qib7	14713	6	/	/	SYM
cord-005453-4057qib7	14713	7	Kg	Kg	NNP
cord-005453-4057qib7	14713	8	of	of	IN
cord-005453-4057qib7	14713	9	CD34	CD34	NNP
cord-005453-4057qib7	14713	10	+	+	CC
cord-005453-4057qib7	14713	11	cells	cell	NNS
cord-005453-4057qib7	14713	12	,	,	,
cord-005453-4057qib7	14713	13	based	base	VBN
cord-005453-4057qib7	14713	14	on	on	IN
cord-005453-4057qib7	14713	15	a	a	DT
cord-005453-4057qib7	14713	16	predicted	predict	VBN
cord-005453-4057qib7	14713	17	future	future	JJ
cord-005453-4057qib7	14713	18	weight	weight	NN
cord-005453-4057qib7	14713	19	in	in	IN
cord-005453-4057qib7	14713	20	5	5	CD
cord-005453-4057qib7	14713	21	years	year	NNS
cord-005453-4057qib7	14713	22	.	.	.
cord-005453-4057qib7	14714	1	CD34	CD34	NNP
cord-005453-4057qib7	14714	2	+	+	CC
cord-005453-4057qib7	14714	3	cells	cell	NNS
cord-005453-4057qib7	14714	4	and	and	CC
cord-005453-4057qib7	14714	5	white	white	JJ
cord-005453-4057qib7	14714	6	blood	blood	NN
cord-005453-4057qib7	14714	7	cells	cell	NNS
cord-005453-4057qib7	14714	8	(	(	-LRB-
cord-005453-4057qib7	14714	9	WBC	WBC	NNP
cord-005453-4057qib7	14714	10	)	)	-RRB-
cord-005453-4057qib7	14714	11	blood	blood	NN
cord-005453-4057qib7	14714	12	count	count	NN
cord-005453-4057qib7	14714	13	were	be	VBD
cord-005453-4057qib7	14714	14	monitored	monitor	VBN
cord-005453-4057qib7	14714	15	tightly	tightly	RB
cord-005453-4057qib7	14714	16	along	along	IN
cord-005453-4057qib7	14714	17	the	the	DT
cord-005453-4057qib7	14714	18	mobilization	mobilization	NN
cord-005453-4057qib7	14714	19	.	.	.
cord-005453-4057qib7	14715	1	Patients	patient	NNS
cord-005453-4057qib7	14715	2	with	with	IN
cord-005453-4057qib7	14715	3	more	more	JJR
cord-005453-4057qib7	14715	4	than	than	IN
cord-005453-4057qib7	14715	5	10	10	CD
cord-005453-4057qib7	14715	6	CD34	CD34	NNP
cord-005453-4057qib7	14715	7	+	+	CC
cord-005453-4057qib7	14715	8	/μl	/μl	:
cord-005453-4057qib7	14715	9	or	or	CC
cord-005453-4057qib7	14715	10	between	between	IN
cord-005453-4057qib7	14715	11	5	5	CD
cord-005453-4057qib7	14715	12	and	and	CC
cord-005453-4057qib7	14715	13	10	10	CD
cord-005453-4057qib7	14715	14	CD34	CD34	NNP
cord-005453-4057qib7	14716	1	/μl	/μl	:
cord-005453-4057qib7	14716	2	with	with	IN
cord-005453-4057qib7	14716	3	a	a	DT
cord-005453-4057qib7	14716	4	clustered	clustered	JJ
cord-005453-4057qib7	14716	5	aspect	aspect	NN
cord-005453-4057qib7	14716	6	detected	detect	VBN
cord-005453-4057qib7	14716	7	by	by	IN
cord-005453-4057qib7	14716	8	flow	flow	NN
cord-005453-4057qib7	14716	9	cytometry	cytometry	NN
cord-005453-4057qib7	14716	10	after	after	IN
cord-005453-4057qib7	14716	11	plerixafor	plerixafor	NN
cord-005453-4057qib7	14716	12	injection	injection	NN
cord-005453-4057qib7	14716	13	underwent	undergo	VBD
cord-005453-4057qib7	14716	14	apheresis	apheresis	NN
cord-005453-4057qib7	14716	15	.	.	.
cord-005453-4057qib7	14717	1	CD34	CD34	NNP
cord-005453-4057qib7	14717	2	+	+	CC
cord-005453-4057qib7	14717	3	cells	cell	NNS
cord-005453-4057qib7	14717	4	were	be	VBD
cord-005453-4057qib7	14717	5	immunoselected	immunoselecte	VBN
cord-005453-4057qib7	14717	6	from	from	IN
cord-005453-4057qib7	14717	7	the	the	DT
cord-005453-4057qib7	14717	8	collection	collection	NN
cord-005453-4057qib7	14717	9	with	with	IN
cord-005453-4057qib7	14717	10	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	14717	11	purification	purification	NN
cord-005453-4057qib7	14717	12	system	system	NN
cord-005453-4057qib7	14717	13	(	(	-LRB-
cord-005453-4057qib7	14717	14	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	14717	15	)	)	-RRB-
cord-005453-4057qib7	14717	16	and	and	CC
cord-005453-4057qib7	14717	17	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	14717	18	for	for	IN
cord-005453-4057qib7	14717	19	further	further	JJ
cord-005453-4057qib7	14717	20	GT	GT	NNP
cord-005453-4057qib7	14717	21	manipulation	manipulation	NN
cord-005453-4057qib7	14717	22	.	.	.
cord-005453-4057qib7	14718	1	Results	result	NNS
cord-005453-4057qib7	14718	2	:	:	:
cord-005453-4057qib7	14719	1	The	the	DT
cord-005453-4057qib7	14719	2	mobilization	mobilization	NN
cord-005453-4057qib7	14719	3	target	target	NN
cord-005453-4057qib7	14719	4	was	be	VBD
cord-005453-4057qib7	14719	5	not	not	RB
cord-005453-4057qib7	14719	6	achieved	achieve	VBN
cord-005453-4057qib7	14719	7	for	for	IN
cord-005453-4057qib7	14719	8	the	the	DT
cord-005453-4057qib7	14719	9	first	first	JJ
cord-005453-4057qib7	14719	10	two	two	CD
cord-005453-4057qib7	14719	11	included	include	VBN
cord-005453-4057qib7	14719	12	patients	patient	NNS
cord-005453-4057qib7	14719	13	(	(	-LRB-
cord-005453-4057qib7	14719	14	FA1	FA1	NNP
cord-005453-4057qib7	14719	15	12	12	CD
cord-005453-4057qib7	14719	16	years	year	NNS
cord-005453-4057qib7	14719	17	old	old	JJ
cord-005453-4057qib7	14719	18	and	and	CC
cord-005453-4057qib7	14719	19	FA2	fa2	JJ
cord-005453-4057qib7	14719	20	8	8	CD
cord-005453-4057qib7	14719	21	years	year	NNS
cord-005453-4057qib7	14719	22	old	old	JJ
cord-005453-4057qib7	14719	23	)	)	-RRB-
cord-005453-4057qib7	14719	24	.	.	.
cord-005453-4057qib7	14720	1	The	the	DT
cord-005453-4057qib7	14720	2	minimum	minimum	JJ
cord-005453-4057qib7	14720	3	value	value	NN
cord-005453-4057qib7	14720	4	of	of	IN
cord-005453-4057qib7	14720	5	CD34+/μl	CD34+/μl	NNP
cord-005453-4057qib7	14720	6	required	require	VBN
cord-005453-4057qib7	14720	7	was	be	VBD
cord-005453-4057qib7	14720	8	n't	not	RB
cord-005453-4057qib7	14720	9	obtained	obtain	VBN
cord-005453-4057qib7	14720	10	for	for	IN
cord-005453-4057qib7	14720	11	FA1	FA1	NNP
cord-005453-4057qib7	14720	12	and	and	CC
cord-005453-4057qib7	14720	13	the	the	DT
cord-005453-4057qib7	14720	14	flow	flow	NN
cord-005453-4057qib7	14720	15	cytometry	cytometry	NN
cord-005453-4057qib7	14720	16	CD34	CD34	NNP
cord-005453-4057qib7	14720	17	+	+	CC
cord-005453-4057qib7	14720	18	aspect	aspect	NN
cord-005453-4057qib7	14720	19	was	be	VBD
cord-005453-4057qib7	14720	20	not	not	RB
cord-005453-4057qib7	14720	21	clustered	cluster	VBN
cord-005453-4057qib7	14720	22	for	for	IN
cord-005453-4057qib7	14720	23	FA2	FA2	NNP
cord-005453-4057qib7	14720	24	.	.	.
cord-005453-4057qib7	14721	1	CD34	CD34	NNP
cord-005453-4057qib7	14721	2	+	+	CC
cord-005453-4057qib7	14721	3	cells	cell	NNS
cord-005453-4057qib7	14721	4	were	be	VBD
cord-005453-4057qib7	14721	5	mobilized	mobilize	VBN
cord-005453-4057qib7	14721	6	quickly	quickly	RB
cord-005453-4057qib7	14721	7	but	but	CC
cord-005453-4057qib7	14721	8	transitionally	transitionally	RB
cord-005453-4057qib7	14721	9	after	after	IN
cord-005453-4057qib7	14721	10	plerixafor	plerixafor	NN
cord-005453-4057qib7	14721	11	injection	injection	NN
cord-005453-4057qib7	14721	12	for	for	IN
cord-005453-4057qib7	14721	13	the	the	DT
cord-005453-4057qib7	14721	14	last	last	JJ
cord-005453-4057qib7	14721	15	two	two	CD
cord-005453-4057qib7	14721	16	patients	patient	NNS
cord-005453-4057qib7	14721	17	,	,	,
cord-005453-4057qib7	14721	18	FA3	FA3	NNP
cord-005453-4057qib7	14721	19	and	and	CC
cord-005453-4057qib7	14721	20	FA4	FA4	NNP
cord-005453-4057qib7	14721	21	,	,	,
cord-005453-4057qib7	14721	22	5	5	CD
cord-005453-4057qib7	14721	23	and	and	CC
cord-005453-4057qib7	14721	24	2	2	CD
cord-005453-4057qib7	14721	25	years	year	NNS
cord-005453-4057qib7	14721	26	old	old	JJ
cord-005453-4057qib7	14721	27	respectively	respectively	RB
cord-005453-4057qib7	14721	28	.	.	.
cord-005453-4057qib7	14722	1	Both	both	DT
cord-005453-4057qib7	14722	2	patients	patient	NNS
cord-005453-4057qib7	14722	3	underwent	undergo	VBD
cord-005453-4057qib7	14722	4	apheresis	apheresis	NN
cord-005453-4057qib7	14722	5	procedures	procedure	NNS
cord-005453-4057qib7	14722	6	.	.	.
cord-005453-4057qib7	14723	1	No	no	DT
cord-005453-4057qib7	14723	2	CD34	CD34	NNP
cord-005453-4057qib7	14723	3	+	+	CC
cord-005453-4057qib7	14723	4	cell	cell	NN
cord-005453-4057qib7	14723	5	rebound	rebound	NN
cord-005453-4057qib7	14723	6	was	be	VBD
cord-005453-4057qib7	14723	7	observed	observe	VBN
cord-005453-4057qib7	14723	8	after	after	IN
cord-005453-4057qib7	14723	9	the	the	DT
cord-005453-4057qib7	14723	10	apheresis	apheresis	NN
cord-005453-4057qib7	14723	11	was	be	VBD
cord-005453-4057qib7	14723	12	stopped	stop	VBN
cord-005453-4057qib7	14723	13	.	.	.
cord-005453-4057qib7	14724	1	Collection	collection	NN
cord-005453-4057qib7	14724	2	target	target	NN
cord-005453-4057qib7	14724	3	was	be	VBD
cord-005453-4057qib7	14724	4	not	not	RB
cord-005453-4057qib7	14724	5	achieved	achieve	VBN
cord-005453-4057qib7	14724	6	after	after	IN
cord-005453-4057qib7	14724	7	four	four	CD
cord-005453-4057qib7	14724	8	days	day	NNS
cord-005453-4057qib7	14724	9	of	of	IN
cord-005453-4057qib7	14724	10	collection	collection	NN
cord-005453-4057qib7	14724	11	for	for	IN
cord-005453-4057qib7	14724	12	FA3	FA3	NNP
cord-005453-4057qib7	14724	13	.	.	.
cord-005453-4057qib7	14725	1	It	-PRON-	PRP
cord-005453-4057qib7	14725	2	was	be	VBD
cord-005453-4057qib7	14725	3	obtained	obtain	VBN
cord-005453-4057qib7	14725	4	the	the	DT
cord-005453-4057qib7	14725	5	first	first	JJ
cord-005453-4057qib7	14725	6	day	day	NN
cord-005453-4057qib7	14725	7	for	for	IN
cord-005453-4057qib7	14725	8	FA4	FA4	NNP
cord-005453-4057qib7	14725	9	(	(	-LRB-
cord-005453-4057qib7	14725	10	Figure	figure	NN
cord-005453-4057qib7	14725	11	1	1	CD
cord-005453-4057qib7	14725	12	)	)	-RRB-
cord-005453-4057qib7	14725	13	.	.	.
cord-005453-4057qib7	14726	1	Back	back	NN
cord-005453-4057qib7	14726	2	-	-	HYPH
cord-005453-4057qib7	14726	3	up	up	NN
cord-005453-4057qib7	14726	4	for	for	IN
cord-005453-4057qib7	14726	5	HSC	HSC	NNP
cord-005453-4057qib7	14726	6	transplantation	transplantation	NN
cord-005453-4057qib7	14726	7	could	could	MD
cord-005453-4057qib7	14726	8	not	not	RB
cord-005453-4057qib7	14726	9	be	be	VB
cord-005453-4057qib7	14726	10	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	14726	11	because	because	IN
cord-005453-4057qib7	14726	12	of	of	IN
cord-005453-4057qib7	14726	13	the	the	DT
cord-005453-4057qib7	14726	14	limited	limited	JJ
cord-005453-4057qib7	14726	15	number	number	NN
cord-005453-4057qib7	14726	16	of	of	IN
cord-005453-4057qib7	14726	17	CD34	CD34	NNP
cord-005453-4057qib7	14726	18	+	+	CC
cord-005453-4057qib7	14727	1	cells	cell	NNS
cord-005453-4057qib7	14727	2	collected	collect	VBN
cord-005453-4057qib7	14727	3	in	in	IN
cord-005453-4057qib7	14727	4	patients	patient	NNS
cord-005453-4057qib7	14727	5	FA3	FA3	NNP
cord-005453-4057qib7	14727	6	and	and	CC
cord-005453-4057qib7	14727	7	FA4	FA4	NNP
cord-005453-4057qib7	14727	8	.	.	.
cord-005453-4057qib7	14728	1	No	no	DT
cord-005453-4057qib7	14728	2	short	short	JJ
cord-005453-4057qib7	14728	3	-	-	HYPH
cord-005453-4057qib7	14728	4	term	term	NN
cord-005453-4057qib7	14728	5	adverse	adverse	JJ
cord-005453-4057qib7	14728	6	events	event	NNS
cord-005453-4057qib7	14728	7	were	be	VBD
cord-005453-4057qib7	14728	8	observed	observe	VBN
cord-005453-4057qib7	14728	9	.	.	.
cord-005453-4057qib7	14729	1	Following	follow	VBG
cord-005453-4057qib7	14729	2	CD34	CD34	NNP
cord-005453-4057qib7	14729	3	+	+	CC
cord-005453-4057qib7	14729	4	immunoselection	immunoselection	NN
cord-005453-4057qib7	14729	5	,	,	,
cord-005453-4057qib7	14729	6	CD34	CD34	NNP
cord-005453-4057qib7	14729	7	+	+	CC
cord-005453-4057qib7	14729	8	cell	cell	NN
cord-005453-4057qib7	14729	9	purity	purity	NN
cord-005453-4057qib7	14729	10	and	and	CC
cord-005453-4057qib7	14729	11	recovery	recovery	NN
cord-005453-4057qib7	14729	12	were	be	VBD
cord-005453-4057qib7	14729	13	poor	poor	JJ
cord-005453-4057qib7	14729	14	but	but	CC
cord-005453-4057qib7	14729	15	in	in	IN
cord-005453-4057qib7	14729	16	the	the	DT
cord-005453-4057qib7	14729	17	normal	normal	JJ
cord-005453-4057qib7	14729	18	range	range	NN
cord-005453-4057qib7	14729	19	described	describe	VBN
cord-005453-4057qib7	14729	20	in	in	IN
cord-005453-4057qib7	14729	21	the	the	DT
cord-005453-4057qib7	14729	22	literature	literature	NN
cord-005453-4057qib7	14729	23	for	for	IN
cord-005453-4057qib7	14729	24	Fanconi	Fanconi	NNP
cord-005453-4057qib7	14729	25	patients	patient	NNS
cord-005453-4057qib7	14729	26	(	(	-LRB-
cord-005453-4057qib7	14729	27	8	8	CD
cord-005453-4057qib7	14729	28	-	-	SYM
cord-005453-4057qib7	14729	29	20	20	CD
cord-005453-4057qib7	14729	30	%	%	NN
cord-005453-4057qib7	14729	31	)	)	-RRB-
cord-005453-4057qib7	14730	1	(	(	-LRB-
cord-005453-4057qib7	14730	2	Table	table	NN
cord-005453-4057qib7	14730	3	I	i	CD
cord-005453-4057qib7	14730	4	)	)	-RRB-
cord-005453-4057qib7	14730	5	.	.	.
cord-005453-4057qib7	14731	1	One	one	CD
cord-005453-4057qib7	14731	2	month	month	NN
cord-005453-4057qib7	14731	3	after	after	IN
cord-005453-4057qib7	14731	4	the	the	DT
cord-005453-4057qib7	14731	5	collection	collection	NN
cord-005453-4057qib7	14731	6	hemograms	hemogram	NNS
cord-005453-4057qib7	14731	7	were	be	VBD
cord-005453-4057qib7	14731	8	unchanged	unchanged	JJ
cord-005453-4057qib7	14731	9	.	.	.
cord-005453-4057qib7	14732	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14732	2	:	:	:
cord-005453-4057qib7	14733	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14733	2	clinical	clinical	JJ
cord-005453-4057qib7	14733	3	study	study	NN
cord-005453-4057qib7	14733	4	offer	offer	VBP
cord-005453-4057qib7	14733	5	new	new	JJ
cord-005453-4057qib7	14733	6	data	datum	NNS
cord-005453-4057qib7	14733	7	showing	show	VBG
cord-005453-4057qib7	14733	8	that	that	IN
cord-005453-4057qib7	14733	9	mobilization	mobilization	NN
cord-005453-4057qib7	14733	10	of	of	IN
cord-005453-4057qib7	14733	11	FA	FA	NNP
cord-005453-4057qib7	14733	12	patients	patient	NNS
cord-005453-4057qib7	14733	13	with	with	IN
cord-005453-4057qib7	14733	14	G	G	NNP
cord-005453-4057qib7	14733	15	-	-	HYPH
cord-005453-4057qib7	14733	16	CSF	csf	NN
cord-005453-4057qib7	14733	17	and	and	CC
cord-005453-4057qib7	14733	18	plerixafor	plerixafor	NN
cord-005453-4057qib7	14733	19	is	be	VBZ
cord-005453-4057qib7	14733	20	safe	safe	JJ
cord-005453-4057qib7	14733	21	and	and	CC
cord-005453-4057qib7	14733	22	more	more	RBR
cord-005453-4057qib7	14733	23	efficient	efficient	JJ
cord-005453-4057qib7	14733	24	for	for	IN
cord-005453-4057qib7	14733	25	younger	young	JJR
cord-005453-4057qib7	14733	26	patients	patient	NNS
cord-005453-4057qib7	14733	27	,	,	,
cord-005453-4057qib7	14733	28	especially	especially	RB
cord-005453-4057qib7	14733	29	before	before	IN
cord-005453-4057qib7	14733	30	clinical	clinical	JJ
cord-005453-4057qib7	14733	31	manifestations	manifestation	NNS
cord-005453-4057qib7	14733	32	of	of	IN
cord-005453-4057qib7	14733	33	BM	BM	NNP
cord-005453-4057qib7	14733	34	failure	failure	NN
cord-005453-4057qib7	14733	35	.	.	.
cord-005453-4057qib7	14734	1	Further	further	JJ
cord-005453-4057qib7	14734	2	efforts	effort	NNS
cord-005453-4057qib7	14734	3	are	be	VBP
cord-005453-4057qib7	14734	4	required	require	VBN
cord-005453-4057qib7	14734	5	to	to	TO
cord-005453-4057qib7	14734	6	establish	establish	VB
cord-005453-4057qib7	14734	7	an	an	DT
cord-005453-4057qib7	14734	8	effective	effective	JJ
cord-005453-4057qib7	14734	9	technic	technic	NN
cord-005453-4057qib7	14734	10	to	to	TO
cord-005453-4057qib7	14734	11	purify	purify	VB
cord-005453-4057qib7	14734	12	the	the	DT
cord-005453-4057qib7	14734	13	CD34	CD34	NNP
cord-005453-4057qib7	14734	14	+	+	CC
cord-005453-4057qib7	14734	15	cells	cell	NNS
cord-005453-4057qib7	14734	16	after	after	IN
cord-005453-4057qib7	14734	17	harvesting	harvest	VBG
cord-005453-4057qib7	14734	18	.	.	.
cord-005453-4057qib7	14734	19	 	 	_SP
cord-005453-4057qib7	14735	1	Basal	Basal	NNP
cord-005453-4057qib7	14735	2	CD34	CD34	NNP
cord-005453-4057qib7	14735	3	+	+	CC
cord-005453-4057qib7	14735	4	cell	cell	NN
cord-005453-4057qib7	14735	5	and	and	CC
cord-005453-4057qib7	14735	6	platelets	platelet	NNS
cord-005453-4057qib7	14735	7	count	count	NN
cord-005453-4057qib7	14735	8	are	be	VBP
cord-005453-4057qib7	14735	9	a	a	DT
cord-005453-4057qib7	14735	10	strong	strong	JJ
cord-005453-4057qib7	14735	11	predictor	predictor	NN
cord-005453-4057qib7	14735	12	for	for	IN
cord-005453-4057qib7	14735	13	mobilized	mobilize	VBN
cord-005453-4057qib7	14735	14	peripheral	peripheral	JJ
cord-005453-4057qib7	14735	15	blood	blood	NN
cord-005453-4057qib7	14735	16	stem	stem	NN
cord-005453-4057qib7	14735	17	cells	cell	NNS
cord-005453-4057qib7	14735	18	on	on	IN
cord-005453-4057qib7	14735	19	the	the	DT
cord-005453-4057qib7	14735	20	4th	4th	JJ
cord-005453-4057qib7	14735	21	day	day	NN
cord-005453-4057qib7	14735	22	of	of	IN
cord-005453-4057qib7	14735	23	G	G	NNP
cord-005453-4057qib7	14735	24	-	-	HYPH
cord-005453-4057qib7	14735	25	CSF	csf	NN
cord-005453-4057qib7	14735	26	treatment	treatment	NN
cord-005453-4057qib7	14735	27	in	in	IN
cord-005453-4057qib7	14735	28	donors	donor	NNS
cord-005453-4057qib7	14735	29	cryopreserved	cryopreserve	VBN
cord-005453-4057qib7	14735	30	PBSCs	pbsc	NNS
cord-005453-4057qib7	14735	31	.	.	.
cord-005453-4057qib7	14736	1	This	this	DT
cord-005453-4057qib7	14736	2	was	be	VBD
cord-005453-4057qib7	14736	3	associated	associate	VBN
cord-005453-4057qib7	14736	4	with	with	IN
cord-005453-4057qib7	14736	5	considerable	considerable	JJ
cord-005453-4057qib7	14736	6	efforts	effort	NNS
cord-005453-4057qib7	14736	7	for	for	IN
cord-005453-4057qib7	14736	8	the	the	DT
cord-005453-4057qib7	14736	9	patients	patient	NNS
cord-005453-4057qib7	14736	10	and	and	CC
cord-005453-4057qib7	14736	11	caused	cause	VBD
cord-005453-4057qib7	14736	12	additional	additional	JJ
cord-005453-4057qib7	14736	13	treatment	treatment	NN
cord-005453-4057qib7	14736	14	costs	cost	NNS
cord-005453-4057qib7	14736	15	.	.	.
cord-005453-4057qib7	14737	1	On	on	IN
cord-005453-4057qib7	14737	2	the	the	DT
cord-005453-4057qib7	14737	3	one	one	CD
cord-005453-4057qib7	14737	4	hand	hand	NN
cord-005453-4057qib7	14737	5	,	,	,
cord-005453-4057qib7	14737	6	having	have	VBG
cord-005453-4057qib7	14737	7	the	the	DT
cord-005453-4057qib7	14737	8	therapeutic	therapeutic	JJ
cord-005453-4057qib7	14737	9	option	option	NN
cord-005453-4057qib7	14737	10	of	of	IN
cord-005453-4057qib7	14737	11	an	an	DT
cord-005453-4057qib7	14737	12	autologous	autologous	JJ
cord-005453-4057qib7	14737	13	transplantation	transplantation	NN
cord-005453-4057qib7	14737	14	in	in	IN
cord-005453-4057qib7	14737	15	the	the	DT
cord-005453-4057qib7	14737	16	future	future	NN
cord-005453-4057qib7	14737	17	may	may	MD
cord-005453-4057qib7	14737	18	represent	represent	VB
cord-005453-4057qib7	14737	19	a	a	DT
cord-005453-4057qib7	14737	20	clinically	clinically	RB
cord-005453-4057qib7	14737	21	relevant	relevant	JJ
cord-005453-4057qib7	14737	22	advantage	advantage	NN
cord-005453-4057qib7	14737	23	.	.	.
cord-005453-4057qib7	14738	1	However	however	RB
cord-005453-4057qib7	14738	2	,	,	,
cord-005453-4057qib7	14738	3	a	a	DT
cord-005453-4057qib7	14738	4	huge	huge	JJ
cord-005453-4057qib7	14738	5	number	number	NN
cord-005453-4057qib7	14738	6	of	of	IN
cord-005453-4057qib7	14738	7	stem	stem	NN
cord-005453-4057qib7	14738	8	cell	cell	NN
cord-005453-4057qib7	14738	9	products	product	NNS
cord-005453-4057qib7	14738	10	are	be	VBP
cord-005453-4057qib7	14738	11	kept	keep	VBN
cord-005453-4057qib7	14738	12	in	in	IN
cord-005453-4057qib7	14738	13	storage	storage	NN
cord-005453-4057qib7	14738	14	for	for	IN
cord-005453-4057qib7	14738	15	many	many	JJ
cord-005453-4057qib7	14738	16	years	year	NNS
cord-005453-4057qib7	14738	17	without	without	IN
cord-005453-4057qib7	14738	18	ever	ever	RB
cord-005453-4057qib7	14738	19	been	be	VBN
cord-005453-4057qib7	14738	20	used	use	VBN
cord-005453-4057qib7	14738	21	for	for	IN
cord-005453-4057qib7	14738	22	transplantation	transplantation	NN
cord-005453-4057qib7	14738	23	.	.	.
cord-005453-4057qib7	14739	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14739	2	study	study	NN
cord-005453-4057qib7	14739	3	provides	provide	VBZ
cord-005453-4057qib7	14739	4	cause	cause	NN
cord-005453-4057qib7	14739	5	for	for	IN
cord-005453-4057qib7	14739	6	a	a	DT
cord-005453-4057qib7	14739	7	careful	careful	JJ
cord-005453-4057qib7	14739	8	reevaluation	reevaluation	NN
cord-005453-4057qib7	14739	9	of	of	IN
cord-005453-4057qib7	14739	10	the	the	DT
cord-005453-4057qib7	14739	11	current	current	JJ
cord-005453-4057qib7	14739	12	clinical	clinical	JJ
cord-005453-4057qib7	14739	13	practice	practice	NN
cord-005453-4057qib7	14739	14	,	,	,
cord-005453-4057qib7	14739	15	which	which	WDT
cord-005453-4057qib7	14739	16	may	may	MD
cord-005453-4057qib7	14739	17	help	help	VB
cord-005453-4057qib7	14739	18	to	to	TO
cord-005453-4057qib7	14739	19	focus	focus	VB
cord-005453-4057qib7	14739	20	more	more	RBR
cord-005453-4057qib7	14739	21	precisely	precisely	RB
cord-005453-4057qib7	14739	22	on	on	IN
cord-005453-4057qib7	14739	23	patients	patient	NNS
cord-005453-4057qib7	14739	24	who	who	WP
cord-005453-4057qib7	14739	25	actually	actually	RB
cord-005453-4057qib7	14739	26	benefit	benefit	VBP
cord-005453-4057qib7	14739	27	from	from	IN
cord-005453-4057qib7	14739	28	a	a	DT
cord-005453-4057qib7	14739	29	cryostored	cryostore	VBN
cord-005453-4057qib7	14739	30	autologous	autologous	JJ
cord-005453-4057qib7	14739	31	stem	stem	NN
cord-005453-4057qib7	14739	32	cell	cell	NN
cord-005453-4057qib7	14739	33	graft	graft	NN
cord-005453-4057qib7	14739	34	.	.	.
cord-005453-4057qib7	14740	1	[	[	-LRB-
cord-005453-4057qib7	14740	2	[	[	-LRB-
cord-005453-4057qib7	14740	3	P693	P693	JJR
cord-005453-4057qib7	14740	4	Image	image	NN
cord-005453-4057qib7	14740	5	]	]	-RRB-
cord-005453-4057qib7	14740	6	1	1	CD
cord-005453-4057qib7	14740	7	.	.	.
cord-005453-4057qib7	14741	1	Fig	Fig	NNP
cord-005453-4057qib7	14741	2	.	.	NNP
cord-005453-4057qib7	14741	3	1	1	CD
cord-005453-4057qib7	14741	4	:	:	:
cord-005453-4057qib7	14742	1	Absolute	absolute	JJ
cord-005453-4057qib7	14742	2	numbers	number	NNS
cord-005453-4057qib7	14742	3	and	and	CC
cord-005453-4057qib7	14742	4	relative	relative	JJ
cord-005453-4057qib7	14742	5	distribution	distribution	NN
cord-005453-4057qib7	14742	6	of	of	IN
cord-005453-4057qib7	14742	7	stem	stem	NN
cord-005453-4057qib7	14742	8	cell	cell	NN
cord-005453-4057qib7	14742	9	grafts	graft	NNS
cord-005453-4057qib7	14743	1	]	]	-RRB-
cord-005453-4057qib7	14744	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14744	2	:	:	:
cord-005453-4057qib7	14744	3	The	the	DT
cord-005453-4057qib7	14744	4	authors	author	NNS
cord-005453-4057qib7	14744	5	confirm	confirm	VBP
cord-005453-4057qib7	14744	6	that	that	IN
cord-005453-4057qib7	14744	7	there	there	EX
cord-005453-4057qib7	14744	8	are	be	VBP
cord-005453-4057qib7	14744	9	no	no	DT
cord-005453-4057qib7	14744	10	potential	potential	JJ
cord-005453-4057qib7	14744	11	conflicts	conflict	NNS
cord-005453-4057qib7	14744	12	of	of	IN
cord-005453-4057qib7	14744	13	interest	interest	NN
cord-005453-4057qib7	14744	14	to	to	TO
cord-005453-4057qib7	14744	15	disclose	disclose	VB
cord-005453-4057qib7	14744	16	,	,	,
cord-005453-4057qib7	14744	17	except	except	IN
cord-005453-4057qib7	14744	18	the	the	DT
cord-005453-4057qib7	14744	19	following	follow	VBG
cord-005453-4057qib7	14744	20	:	:	:
cord-005453-4057qib7	14744	21	Katharina	Katharina	NNP
cord-005453-4057qib7	14744	22	Kriegsmann	Kriegsmann	NNP
cord-005453-4057qib7	14744	23	:	:	:
cord-005453-4057qib7	14744	24	research	research	NN
cord-005453-4057qib7	14744	25	funding	funding	NN
cord-005453-4057qib7	14744	26	from	from	IN
cord-005453-4057qib7	14744	27	BMS	BMS	NNP
cord-005453-4057qib7	14744	28	,	,	,
cord-005453-4057qib7	14744	29	Celgene	Celgene	NNP
cord-005453-4057qib7	14744	30	,	,	,
cord-005453-4057qib7	14744	31	and	and	CC
cord-005453-4057qib7	14744	32	Sanofi	Sanofi	NNP
cord-005453-4057qib7	14744	33	.	.	.
cord-005453-4057qib7	14745	1	Patrick	Patrick	NNP
cord-005453-4057qib7	14745	2	Wuchter	Wuchter	NNP
cord-005453-4057qib7	14745	3	:	:	:
cord-005453-4057qib7	14745	4	Membership	Membership	NNP
cord-005453-4057qib7	14745	5	in	in	IN
cord-005453-4057qib7	14745	6	Advisory	Advisory	NNP
cord-005453-4057qib7	14745	7	Boards	Boards	NNP
cord-005453-4057qib7	14745	8	for	for	IN
cord-005453-4057qib7	14745	9	Sanofi	Sanofi	NNP
cord-005453-4057qib7	14745	10	-	-	HYPH
cord-005453-4057qib7	14745	11	Aventis	Aventis	NNP
cord-005453-4057qib7	14745	12	.	.	.
cord-005453-4057qib7	14746	1	Reduction	reduction	NN
cord-005453-4057qib7	14746	2	of	of	IN
cord-005453-4057qib7	14746	3	dimethylsulfoxide	dimethylsulfoxide	NN
cord-005453-4057qib7	14746	4	(	(	-LRB-
cord-005453-4057qib7	14746	5	DMSO	DMSO	NNP
cord-005453-4057qib7	14746	6	)	)	-RRB-
cord-005453-4057qib7	14746	7	concentration	concentration	NN
cord-005453-4057qib7	14746	8	from	from	IN
cord-005453-4057qib7	14746	9	10	10	CD
cord-005453-4057qib7	14746	10	%	%	NN
cord-005453-4057qib7	14746	11	to	to	TO
cord-005453-4057qib7	14746	12	5	5	CD
cord-005453-4057qib7	14746	13	%	%	NN
cord-005453-4057qib7	14746	14	in	in	IN
cord-005453-4057qib7	14746	15	criopreservation	criopreservation	NN
cord-005453-4057qib7	14746	16	of	of	IN
cord-005453-4057qib7	14746	17	stem	stem	NN
cord-005453-4057qib7	14746	18	cells	cell	NNS
cord-005453-4057qib7	14746	19	.	.	.
cord-005453-4057qib7	14747	1	Influence	influence	NN
cord-005453-4057qib7	14747	2	on	on	IN
cord-005453-4057qib7	14747	3	the	the	DT
cord-005453-4057qib7	14747	4	kinetics	kinetic	NNS
cord-005453-4057qib7	14747	5	of	of	IN
cord-005453-4057qib7	14747	6	engraftment	engraftment	NN
cord-005453-4057qib7	14747	7	and	and	CC
cord-005453-4057qib7	14747	8	tolerance	tolerance	NN
cord-005453-4057qib7	14747	9	to	to	TO
cord-005453-4057qib7	14747	10	infusion	infusion	NN
cord-005453-4057qib7	14747	11	Patricia	Patricia	NNP
cord-005453-4057qib7	14747	12	Lopez	Lopez	NNP
cord-005453-4057qib7	14747	13	-	-	HYPH
cord-005453-4057qib7	14747	14	Pereira	Pereira	NNP
cord-005453-4057qib7	14747	15	1	1	CD
cord-005453-4057qib7	14747	16	,	,	,
cord-005453-4057qib7	14747	17	Beatriz	Beatriz	NNP
cord-005453-4057qib7	14747	18	Aguado	Aguado	NNP
cord-005453-4057qib7	14747	19	1	1	CD
cord-005453-4057qib7	14747	20	,	,	,
cord-005453-4057qib7	14747	21	Elena	Elena	NNP
cord-005453-4057qib7	14747	22	Sola	Sola	NNP
cord-005453-4057qib7	14747	23	1	1	CD
cord-005453-4057qib7	14747	24	,	,	,
cord-005453-4057qib7	14747	25	Carmen	Carmen	NNP
cord-005453-4057qib7	14747	26	Cámara	Cámara	NNP
cord-005453-4057qib7	14747	27	1	1	CD
cord-005453-4057qib7	14747	28	,	,	,
cord-005453-4057qib7	14747	29	Isabel	Isabel	NNP
cord-005453-4057qib7	14747	30	Vicuña	Vicuña	NNP
cord-005453-4057qib7	14747	31	1	1	CD
cord-005453-4057qib7	14747	32	,	,	,
cord-005453-4057qib7	14747	33	Lorena	Lorena	NNP
cord-005453-4057qib7	14747	34	Vega	Vega	NNP
cord-005453-4057qib7	14747	35	1	1	CD
cord-005453-4057qib7	14747	36	,	,	,
cord-005453-4057qib7	14747	37	Adrian	Adrian	NNP
cord-005453-4057qib7	14747	38	Alegre	Alegre	NNP
cord-005453-4057qib7	14747	39	1	1	CD
cord-005453-4057qib7	14747	40	1	1	CD
cord-005453-4057qib7	14747	41	Hospital	Hospital	NNP
cord-005453-4057qib7	14747	42	Universitario	Universitario	NNP
cord-005453-4057qib7	14747	43	de	de	NNP
cord-005453-4057qib7	14747	44	la	la	NNP
cord-005453-4057qib7	14747	45	Princesa	Princesa	NNP
cord-005453-4057qib7	14747	46	,	,	,
cord-005453-4057qib7	14747	47	Madrid	Madrid	NNP
cord-005453-4057qib7	14747	48	,	,	,
cord-005453-4057qib7	14748	1	Spain	Spain	NNP
cord-005453-4057qib7	14748	2	Background	Background	NNP
cord-005453-4057qib7	14748	3	:	:	:
cord-005453-4057qib7	14749	1	DMSO	DMSO	NNP
cord-005453-4057qib7	14749	2	is	be	VBZ
cord-005453-4057qib7	14749	3	the	the	DT
cord-005453-4057qib7	14749	4	cryoprotectant	cryoprotectant	NN
cord-005453-4057qib7	14749	5	most	most	RBS
cord-005453-4057qib7	14749	6	used	use	VBN
cord-005453-4057qib7	14749	7	in	in	IN
cord-005453-4057qib7	14749	8	the	the	DT
cord-005453-4057qib7	14749	9	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14749	10	of	of	IN
cord-005453-4057qib7	14749	11	stem	stem	NN
cord-005453-4057qib7	14749	12	cells	cell	NNS
cord-005453-4057qib7	14749	13	.	.	.
cord-005453-4057qib7	14750	1	It	-PRON-	PRP
cord-005453-4057qib7	14750	2	is	be	VBZ
cord-005453-4057qib7	14750	3	associated	associate	VBN
cord-005453-4057qib7	14750	4	with	with	IN
cord-005453-4057qib7	14750	5	adverse	adverse	JJ
cord-005453-4057qib7	14750	6	effects	effect	NNS
cord-005453-4057qib7	14750	7	during	during	IN
cord-005453-4057qib7	14750	8	the	the	DT
cord-005453-4057qib7	14750	9	infusion	infusion	NN
cord-005453-4057qib7	14750	10	of	of	IN
cord-005453-4057qib7	14750	11	the	the	DT
cord-005453-4057qib7	14750	12	product	product	NN
cord-005453-4057qib7	14750	13	,	,	,
cord-005453-4057qib7	14750	14	its	-PRON-	PRP$
cord-005453-4057qib7	14750	15	toxicity	toxicity	NN
cord-005453-4057qib7	14750	16	being	be	VBG
cord-005453-4057qib7	14750	17	proportional	proportional	JJ
cord-005453-4057qib7	14750	18	to	to	IN
cord-005453-4057qib7	14750	19	the	the	DT
cord-005453-4057qib7	14750	20	volume	volume	NN
cord-005453-4057qib7	14750	21	infused	infuse	VBN
cord-005453-4057qib7	14750	22	.	.	.
cord-005453-4057qib7	14751	1	The	the	DT
cord-005453-4057qib7	14751	2	most	most	RBS
cord-005453-4057qib7	14751	3	common	common	JJ
cord-005453-4057qib7	14751	4	concentration	concentration	NN
cord-005453-4057qib7	14751	5	used	use	VBN
cord-005453-4057qib7	14751	6	has	have	VBZ
cord-005453-4057qib7	14751	7	been	be	VBN
cord-005453-4057qib7	14751	8	10	10	CD
cord-005453-4057qib7	14751	9	%	%	NN
cord-005453-4057qib7	14751	10	,	,	,
cord-005453-4057qib7	14751	11	although	although	IN
cord-005453-4057qib7	14751	12	recent	recent	JJ
cord-005453-4057qib7	14751	13	publications	publication	NNS
cord-005453-4057qib7	14751	14	report	report	VBP
cord-005453-4057qib7	14751	15	that	that	IN
cord-005453-4057qib7	14751	16	reducing	reduce	VBG
cord-005453-4057qib7	14751	17	it	-PRON-	PRP
cord-005453-4057qib7	14751	18	to	to	IN
cord-005453-4057qib7	14751	19	5	5	CD
cord-005453-4057qib7	14751	20	%	%	NN
cord-005453-4057qib7	14751	21	leads	lead	VBZ
cord-005453-4057qib7	14751	22	to	to	IN
cord-005453-4057qib7	14751	23	lower	low	JJR
cord-005453-4057qib7	14751	24	rate	rate	NN
cord-005453-4057qib7	14751	25	of	of	IN
cord-005453-4057qib7	14751	26	side	side	NN
cord-005453-4057qib7	14751	27	effects	effect	NNS
cord-005453-4057qib7	14751	28	without	without	IN
cord-005453-4057qib7	14751	29	impact	impact	NN
cord-005453-4057qib7	14751	30	on	on	IN
cord-005453-4057qib7	14751	31	the	the	DT
cord-005453-4057qib7	14751	32	product	product	NN
cord-005453-4057qib7	14751	33	or	or	CC
cord-005453-4057qib7	14751	34	the	the	DT
cord-005453-4057qib7	14751	35	graft	graft	NN
cord-005453-4057qib7	14751	36	.	.	.
cord-005453-4057qib7	14752	1	We	-PRON-	PRP
cord-005453-4057qib7	14752	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	14752	3	analyzed	analyze	VBD
cord-005453-4057qib7	14752	4	207	207	CD
cord-005453-4057qib7	14752	5	patients	patient	NNS
cord-005453-4057qib7	14752	6	recipients	recipient	NNS
cord-005453-4057qib7	14752	7	of	of	IN
cord-005453-4057qib7	14752	8	autologous	autologous	JJ
cord-005453-4057qib7	14752	9	peripheral	peripheral	JJ
cord-005453-4057qib7	14752	10	blood	blood	NN
cord-005453-4057qib7	14752	11	stem	stem	NN
cord-005453-4057qib7	14752	12	cell	cell	NN
cord-005453-4057qib7	14752	13	transplantation	transplantation	NN
cord-005453-4057qib7	14752	14	(	(	-LRB-
cord-005453-4057qib7	14752	15	HCT	HCT	NNP
cord-005453-4057qib7	14752	16	)	)	-RRB-
cord-005453-4057qib7	14752	17	in	in	IN
cord-005453-4057qib7	14752	18	our	-PRON-	PRP$
cord-005453-4057qib7	14752	19	hospital	hospital	NN
cord-005453-4057qib7	14752	20	from	from	IN
cord-005453-4057qib7	14752	21	January	January	NNP
cord-005453-4057qib7	14752	22	2009	2009	CD
cord-005453-4057qib7	14752	23	to	to	IN
cord-005453-4057qib7	14752	24	September	September	NNP
cord-005453-4057qib7	14752	25	2017	2017	CD
cord-005453-4057qib7	14752	26	.	.	.
cord-005453-4057qib7	14753	1	They	-PRON-	PRP
cord-005453-4057qib7	14753	2	are	be	VBP
cord-005453-4057qib7	14753	3	divided	divide	VBN
cord-005453-4057qib7	14753	4	into	into	IN
cord-005453-4057qib7	14753	5	two	two	CD
cord-005453-4057qib7	14753	6	groups	group	NNS
cord-005453-4057qib7	14753	7	according	accord	VBG
cord-005453-4057qib7	14753	8	to	to	IN
cord-005453-4057qib7	14753	9	the	the	DT
cord-005453-4057qib7	14753	10	concentration	concentration	NN
cord-005453-4057qib7	14753	11	of	of	IN
cord-005453-4057qib7	14753	12	DMSO	DMSO	NNP
cord-005453-4057qib7	14753	13	used	use	VBN
cord-005453-4057qib7	14753	14	in	in	IN
cord-005453-4057qib7	14753	15	the	the	DT
cord-005453-4057qib7	14753	16	freezing	freezing	NN
cord-005453-4057qib7	14753	17	(	(	-LRB-
cord-005453-4057qib7	14753	18	10	10	CD
cord-005453-4057qib7	14753	19	%	%	NN
cord-005453-4057qib7	14753	20	until	until	IN
cord-005453-4057qib7	14753	21	September	September	NNP
cord-005453-4057qib7	14753	22	2014	2014	CD
cord-005453-4057qib7	14753	23	or	or	CC
cord-005453-4057qib7	14753	24	5	5	CD
cord-005453-4057qib7	14753	25	%	%	NN
cord-005453-4057qib7	14753	26	since	since	IN
cord-005453-4057qib7	14753	27	October	October	NNP
cord-005453-4057qib7	14753	28	2014	2014	CD
cord-005453-4057qib7	14753	29	)	)	-RRB-
cord-005453-4057qib7	14753	30	.	.	.
cord-005453-4057qib7	14754	1	The	the	DT
cord-005453-4057qib7	14754	2	baseline	baseline	JJ
cord-005453-4057qib7	14754	3	characteristics	characteristic	NNS
cord-005453-4057qib7	14754	4	of	of	IN
cord-005453-4057qib7	14754	5	the	the	DT
cord-005453-4057qib7	14754	6	patients	patient	NNS
cord-005453-4057qib7	14754	7	,	,	,
cord-005453-4057qib7	14754	8	the	the	DT
cord-005453-4057qib7	14754	9	infused	infuse	VBN
cord-005453-4057qib7	14754	10	product	product	NN
cord-005453-4057qib7	14754	11	and	and	CC
cord-005453-4057qib7	14754	12	the	the	DT
cord-005453-4057qib7	14754	13	graft	graft	NN
cord-005453-4057qib7	14754	14	are	be	VBP
cord-005453-4057qib7	14754	15	shown	show	VBN
cord-005453-4057qib7	14754	16	in	in	IN
cord-005453-4057qib7	14754	17	Table	Table	NNP
cord-005453-4057qib7	14754	18	1	1	CD
cord-005453-4057qib7	14754	19	.	.	.
cord-005453-4057qib7	14755	1	The	the	DT
cord-005453-4057qib7	14755	2	CD34	CD34	NNP
cord-005453-4057qib7	14755	3	count	count	NN
cord-005453-4057qib7	14755	4	was	be	VBD
cord-005453-4057qib7	14755	5	performed	perform	VBN
cord-005453-4057qib7	14755	6	by	by	IN
cord-005453-4057qib7	14755	7	flow	flow	NN
cord-005453-4057qib7	14755	8	cytometry	cytometry	NN
cord-005453-4057qib7	14755	9	.	.	.
cord-005453-4057qib7	14756	1	All	all	DT
cord-005453-4057qib7	14756	2	freezings	freezing	NNS
cord-005453-4057qib7	14756	3	were	be	VBD
cord-005453-4057qib7	14756	4	performed	perform	VBN
cord-005453-4057qib7	14756	5	with	with	IN
cord-005453-4057qib7	14756	6	a	a	DT
cord-005453-4057qib7	14756	7	biological	biological	JJ
cord-005453-4057qib7	14756	8	freezer	freezer	NN
cord-005453-4057qib7	14756	9	for	for	IN
cord-005453-4057qib7	14756	10	programmed	program	VBN
cord-005453-4057qib7	14756	11	controlled	controlled	JJ
cord-005453-4057qib7	14756	12	rate	rate	NN
cord-005453-4057qib7	14756	13	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14756	14	and	and	CC
cord-005453-4057qib7	14756	15	stored	store	VBN
cord-005453-4057qib7	14756	16	in	in	IN
cord-005453-4057qib7	14756	17	ultrafreezers	ultrafreezer	NNS
cord-005453-4057qib7	14756	18	at	at	IN
cord-005453-4057qib7	14756	19	-80ºC.	-80ºC.	JJS
cord-005453-4057qib7	14756	20	Results	result	NNS
cord-005453-4057qib7	14756	21	:	:	:
cord-005453-4057qib7	14756	22	Both	both	DT
cord-005453-4057qib7	14756	23	population	population	NN
cord-005453-4057qib7	14756	24	groups	group	NNS
cord-005453-4057qib7	14756	25	are	be	VBP
cord-005453-4057qib7	14756	26	homogeneous	homogeneous	JJ
cord-005453-4057qib7	14756	27	.	.	.
cord-005453-4057qib7	14757	1	The	the	DT
cord-005453-4057qib7	14757	2	t	t	NN
cord-005453-4057qib7	14757	3	-	-	HYPH
cord-005453-4057qib7	14757	4	test	test	NN
cord-005453-4057qib7	14757	5	was	be	VBD
cord-005453-4057qib7	14757	6	used	use	VBN
cord-005453-4057qib7	14757	7	for	for	IN
cord-005453-4057qib7	14757	8	statistical	statistical	JJ
cord-005453-4057qib7	14757	9	analysis	analysis	NN
cord-005453-4057qib7	14757	10	.	.	.
cord-005453-4057qib7	14758	1	Regarding	regard	VBG
cord-005453-4057qib7	14758	2	the	the	DT
cord-005453-4057qib7	14758	3	CD34	CD34	NNP
cord-005453-4057qib7	14758	4	+	+	CC
cord-005453-4057qib7	14758	5	variable	variable	NN
cord-005453-4057qib7	14758	6	,	,	,
cord-005453-4057qib7	14758	7	no	no	DT
cord-005453-4057qib7	14758	8	statistically	statistically	RB
cord-005453-4057qib7	14758	9	significant	significant	JJ
cord-005453-4057qib7	14758	10	differences	difference	NNS
cord-005453-4057qib7	14758	11	were	be	VBD
cord-005453-4057qib7	14758	12	observed	observe	VBN
cord-005453-4057qib7	14758	13	(	(	-LRB-
cord-005453-4057qib7	14758	14	p	p	NN
cord-005453-4057qib7	14758	15	=	=	SYM
cord-005453-4057qib7	14758	16	0.636	0.636	CD
cord-005453-4057qib7	14758	17	)	)	-RRB-
cord-005453-4057qib7	14758	18	.	.	.
cord-005453-4057qib7	14759	1	Neither	neither	CC
cord-005453-4057qib7	14759	2	for	for	IN
cord-005453-4057qib7	14759	3	the	the	DT
cord-005453-4057qib7	14759	4	variables	variable	NNS
cord-005453-4057qib7	14759	5	leukocyte	leukocyte	NN
cord-005453-4057qib7	14759	6	recovery	recovery	NN
cord-005453-4057qib7	14759	7	and	and	CC
cord-005453-4057qib7	14759	8	platelet	platelet	NN
cord-005453-4057qib7	14759	9	recovery	recovery	NN
cord-005453-4057qib7	14759	10	(	(	-LRB-
cord-005453-4057qib7	14759	11	p	p	NN
cord-005453-4057qib7	14759	12	=	=	SYM
cord-005453-4057qib7	14759	13	0.178	0.178	CD
cord-005453-4057qib7	14759	14	,	,	,
cord-005453-4057qib7	14759	15	p	p	NN
cord-005453-4057qib7	14759	16	=	=	SYM
cord-005453-4057qib7	14759	17	0.991	0.991	CD
cord-005453-4057qib7	14759	18	respectively	respectively	RB
cord-005453-4057qib7	14759	19	)	)	-RRB-
cord-005453-4057qib7	14759	20	.	.	.
cord-005453-4057qib7	14760	1	The	the	DT
cord-005453-4057qib7	14760	2	difference	difference	NN
cord-005453-4057qib7	14760	3	in	in	IN
cord-005453-4057qib7	14760	4	the	the	DT
cord-005453-4057qib7	14760	5	variable	variable	JJ
cord-005453-4057qib7	14760	6	Viability	viability	NN
cord-005453-4057qib7	14760	7	is	be	VBZ
cord-005453-4057qib7	14760	8	5.61	5.61	CD
cord-005453-4057qib7	14760	9	units	unit	NNS
cord-005453-4057qib7	14760	10	(	(	-LRB-
cord-005453-4057qib7	14760	11	CI95	CI95	NNP
cord-005453-4057qib7	14760	12	%	%	NN
cord-005453-4057qib7	14760	13	:	:	:
cord-005453-4057qib7	14760	14	[	[	-LRB-
cord-005453-4057qib7	14760	15	0.61	0.61	CD
cord-005453-4057qib7	14760	16	-	-	SYM
cord-005453-4057qib7	14760	17	10.62	10.62	CD
cord-005453-4057qib7	14760	18	]	]	-RRB-
cord-005453-4057qib7	14760	19	)	)	-RRB-
cord-005453-4057qib7	14760	20	and	and	CC
cord-005453-4057qib7	14760	21	is	be	VBZ
cord-005453-4057qib7	14760	22	statistically	statistically	RB
cord-005453-4057qib7	14760	23	significant	significant	JJ
cord-005453-4057qib7	14760	24	(	(	-LRB-
cord-005453-4057qib7	14760	25	p	p	NN
cord-005453-4057qib7	14760	26	=	=	SYM
cord-005453-4057qib7	14760	27	0.028	0.028	CD
cord-005453-4057qib7	14760	28	)	)	-RRB-
cord-005453-4057qib7	14760	29	in	in	IN
cord-005453-4057qib7	14760	30	favor	favor	NN
cord-005453-4057qib7	14760	31	of	of	IN
cord-005453-4057qib7	14760	32	DMSO	DMSO	NNP
cord-005453-4057qib7	14760	33	5	5	CD
cord-005453-4057qib7	14760	34	%	%	NN
cord-005453-4057qib7	14760	35	.	.	.
cord-005453-4057qib7	14761	1	Regarding	regard	VBG
cord-005453-4057qib7	14761	2	adverse	adverse	JJ
cord-005453-4057qib7	14761	3	effects	effect	NNS
cord-005453-4057qib7	14761	4	,	,	,
cord-005453-4057qib7	14761	5	100	100	CD
cord-005453-4057qib7	14761	6	%	%	NN
cord-005453-4057qib7	14761	7	(	(	-LRB-
cord-005453-4057qib7	14761	8	n	n	NN
cord-005453-4057qib7	14761	9	=	=	SYM
cord-005453-4057qib7	14761	10	4	4	CD
cord-005453-4057qib7	14761	11	)	)	-RRB-
cord-005453-4057qib7	14761	12	of	of	IN
cord-005453-4057qib7	14761	13	the	the	DT
cord-005453-4057qib7	14761	14	serious	serious	JJ
cord-005453-4057qib7	14761	15	adverse	adverse	JJ
cord-005453-4057qib7	14761	16	reactions	reaction	NNS
cord-005453-4057qib7	14761	17	occurred	occur	VBD
cord-005453-4057qib7	14761	18	in	in	IN
cord-005453-4057qib7	14761	19	the	the	DT
cord-005453-4057qib7	14761	20	10	10	CD
cord-005453-4057qib7	14761	21	%	%	NN
cord-005453-4057qib7	14761	22	DMSO	DMSO	NNP
cord-005453-4057qib7	14761	23	group	group	NN
cord-005453-4057qib7	14761	24	(	(	-LRB-
cord-005453-4057qib7	14761	25	hypotension	hypotension	NN
cord-005453-4057qib7	14761	26	and	and	CC
cord-005453-4057qib7	14761	27	seizures	seizure	NNS
cord-005453-4057qib7	14761	28	)	)	-RRB-
cord-005453-4057qib7	14761	29	.	.	.
cord-005453-4057qib7	14762	1	The	the	DT
cord-005453-4057qib7	14762	2	mild	mild	JJ
cord-005453-4057qib7	14762	3	and	and	CC
cord-005453-4057qib7	14762	4	moderate	moderate	JJ
cord-005453-4057qib7	14762	5	ones	one	NNS
cord-005453-4057qib7	14762	6	were	be	VBD
cord-005453-4057qib7	14762	7	similar	similar	JJ
cord-005453-4057qib7	14762	8	in	in	IN
cord-005453-4057qib7	14762	9	both	both	DT
cord-005453-4057qib7	14762	10	groups	group	NNS
cord-005453-4057qib7	14762	11	,	,	,
cord-005453-4057qib7	14762	12	most	most	RBS
cord-005453-4057qib7	14762	13	were	be	VBD
cord-005453-4057qib7	14762	14	mild	mild	JJ
cord-005453-4057qib7	14762	15	nausea	nausea	NN
cord-005453-4057qib7	14762	16	,	,	,
cord-005453-4057qib7	14762	17	vomiting	vomiting	NN
cord-005453-4057qib7	14762	18	and	and	CC
cord-005453-4057qib7	14762	19	flushing	flushing	NN
cord-005453-4057qib7	14762	20	.	.	.
cord-005453-4057qib7	14763	1	Overall	overall	RB
cord-005453-4057qib7	14763	2	,	,	,
cord-005453-4057qib7	14763	3	no	no	DT
cord-005453-4057qib7	14763	4	statistically	statistically	RB
cord-005453-4057qib7	14763	5	significant	significant	JJ
cord-005453-4057qib7	14763	6	differences	difference	NNS
cord-005453-4057qib7	14763	7	were	be	VBD
cord-005453-4057qib7	14763	8	observed	observe	VBN
cord-005453-4057qib7	14763	9	due	due	IN
cord-005453-4057qib7	14763	10	to	to	IN
cord-005453-4057qib7	14763	11	the	the	DT
cord-005453-4057qib7	14763	12	low	low	JJ
cord-005453-4057qib7	14763	13	rate	rate	NN
cord-005453-4057qib7	14763	14	of	of	IN
cord-005453-4057qib7	14763	15	adverse	adverse	JJ
cord-005453-4057qib7	14763	16	effects	effect	NNS
cord-005453-4057qib7	14763	17	found	find	VBN
cord-005453-4057qib7	14763	18	.	.	.
cord-005453-4057qib7	14764	1	PATIENTS	patient	NNS
cord-005453-4057qib7	14764	2	Starting	start	VBG
cord-005453-4057qib7	14764	3	with	with	IN
cord-005453-4057qib7	14764	4	2014	2014	CD
cord-005453-4057qib7	14764	5	until	until	IN
cord-005453-4057qib7	14764	6	October	October	NNP
cord-005453-4057qib7	14764	7	2018	2018	CD
cord-005453-4057qib7	14765	1	,	,	,
cord-005453-4057qib7	14765	2	total	total	NN
cord-005453-4057qib7	14765	3	of	of	IN
cord-005453-4057qib7	14765	4	414	414	CD
cord-005453-4057qib7	14765	5	patients	patient	NNS
cord-005453-4057qib7	14765	6	attempted	attempt	VBD
cord-005453-4057qib7	14765	7	collection	collection	NN
cord-005453-4057qib7	14765	8	of	of	IN
cord-005453-4057qib7	14765	9	autologous	autologous	JJ
cord-005453-4057qib7	14765	10	PBSCs	pbsc	NNS
cord-005453-4057qib7	14765	11	,	,	,
cord-005453-4057qib7	14765	12	and	and	CC
cord-005453-4057qib7	14765	13	38	38	CD
cord-005453-4057qib7	14765	14	poor	poor	JJ
cord-005453-4057qib7	14765	15	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14765	16	recieved	recieve	VBD
cord-005453-4057qib7	14765	17	plerixafor	plerixafor	NN
cord-005453-4057qib7	14765	18	during	during	IN
cord-005453-4057qib7	14765	19	first	first	JJ
cord-005453-4057qib7	14765	20	mobilization	mobilization	NN
cord-005453-4057qib7	14765	21	cycle	cycle	NN
cord-005453-4057qib7	14765	22	.	.	.
cord-005453-4057qib7	14766	1	in	in	IN
cord-005453-4057qib7	14766	2	total	total	NN
cord-005453-4057qib7	14766	3	,	,	,
cord-005453-4057qib7	14766	4	9	9	CD
cord-005453-4057qib7	14766	5	patients	patient	NNS
cord-005453-4057qib7	14766	6	required	require	VBD
cord-005453-4057qib7	14766	7	repeated	repeated	JJ
cord-005453-4057qib7	14766	8	mobilization	mobilization	NN
cord-005453-4057qib7	14766	9	cycles	cycle	NNS
cord-005453-4057qib7	14766	10	(	(	-LRB-
cord-005453-4057qib7	14766	11	2,2	2,2	CD
cord-005453-4057qib7	14766	12	%	%	NN
cord-005453-4057qib7	14766	13	)	)	-RRB-
cord-005453-4057qib7	14766	14	of	of	IN
cord-005453-4057qib7	14766	15	which	which	WDT
cord-005453-4057qib7	14766	16	6	6	CD
cord-005453-4057qib7	14766	17	were	be	VBD
cord-005453-4057qib7	14766	18	from	from	IN
cord-005453-4057qib7	14766	19	the	the	DT
cord-005453-4057qib7	14766	20	plerixafor	plerixafor	NN
cord-005453-4057qib7	14766	21	group	group	NN
cord-005453-4057qib7	14766	22	.	.	.
cord-005453-4057qib7	14767	1	In	in	IN
cord-005453-4057qib7	14767	2	total	total	JJ
cord-005453-4057qib7	14767	3	42	42	CD
cord-005453-4057qib7	14767	4	patients	patient	NNS
cord-005453-4057qib7	14767	5	recieved	recieve	VBD
cord-005453-4057qib7	14767	6	pleriksafor	pleriksafor	NN
cord-005453-4057qib7	14767	7	;	;	:
cord-005453-4057qib7	14767	8	23	23	CD
cord-005453-4057qib7	14767	9	females	female	NNS
cord-005453-4057qib7	14767	10	and	and	CC
cord-005453-4057qib7	14767	11	19	19	CD
cord-005453-4057qib7	14767	12	males	male	NNS
cord-005453-4057qib7	14767	13	,	,	,
cord-005453-4057qib7	14767	14	median	median	JJ
cord-005453-4057qib7	14767	15	age	age	NN
cord-005453-4057qib7	14767	16	58	58	CD
cord-005453-4057qib7	14767	17	(	(	-LRB-
cord-005453-4057qib7	14767	18	8	8	CD
cord-005453-4057qib7	14767	19	-	-	SYM
cord-005453-4057qib7	14767	20	71	71	CD
cord-005453-4057qib7	14767	21	)	)	-RRB-
cord-005453-4057qib7	14767	22	with	with	IN
cord-005453-4057qib7	14767	23	following	follow	VBG
cord-005453-4057qib7	14767	24	diagnoses	diagnosis	NNS
cord-005453-4057qib7	14767	25	:	:	:
cord-005453-4057qib7	14767	26	28	28	CD
cord-005453-4057qib7	14767	27	NHL	NHL	NNP
cord-005453-4057qib7	14767	28	,	,	,
cord-005453-4057qib7	14767	29	5	5	CD
cord-005453-4057qib7	14767	30	MH	MH	NNP
cord-005453-4057qib7	14767	31	,	,	,
cord-005453-4057qib7	14767	32	5	5	CD
cord-005453-4057qib7	14767	33	multiple	multiple	JJ
cord-005453-4057qib7	14767	34	myeloma	myeloma	NN
cord-005453-4057qib7	14767	35	,	,	,
cord-005453-4057qib7	14767	36	1	1	CD
cord-005453-4057qib7	14767	37	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	14767	38	,	,	,
cord-005453-4057qib7	14767	39	1	1	CD
cord-005453-4057qib7	14767	40	nephroblastoma	nephroblastoma	NNS
cord-005453-4057qib7	14767	41	,	,	,
cord-005453-4057qib7	14767	42	1	1	CD
cord-005453-4057qib7	14767	43	sarcoma	sarcoma	NN
cord-005453-4057qib7	14767	44	Ewing	Ewing	NNP
cord-005453-4057qib7	14767	45	and	and	CC
cord-005453-4057qib7	14767	46	1	1	CD
cord-005453-4057qib7	14767	47	seminoma	seminoma	NN
cord-005453-4057qib7	14767	48	.	.	.
cord-005453-4057qib7	14768	1	Of	of	IN
cord-005453-4057qib7	14768	2	6	6	CD
cord-005453-4057qib7	14768	3	repeated	repeat	VBN
cord-005453-4057qib7	14768	4	mobilizations	mobilization	NNS
cord-005453-4057qib7	14768	5	with	with	IN
cord-005453-4057qib7	14768	6	plerixafor	plerixafor	NN
cord-005453-4057qib7	14768	7	,	,	,
cord-005453-4057qib7	14768	8	2	2	CD
cord-005453-4057qib7	14768	9	patients	patient	NNS
cord-005453-4057qib7	14768	10	(	(	-LRB-
cord-005453-4057qib7	14768	11	33,3	33,3	CD
cord-005453-4057qib7	14768	12	%	%	NN
cord-005453-4057qib7	14768	13	)	)	-RRB-
cord-005453-4057qib7	14768	14	still	still	RB
cord-005453-4057qib7	14768	15	failed	fail	VBD
cord-005453-4057qib7	14768	16	to	to	TO
cord-005453-4057qib7	14768	17	collect	collect	VB
cord-005453-4057qib7	14768	18	adequate	adequate	JJ
cord-005453-4057qib7	14768	19	transplant	transplant	NN
cord-005453-4057qib7	14768	20	.	.	.
cord-005453-4057qib7	14769	1	In	in	IN
cord-005453-4057qib7	14769	2	this	this	DT
cord-005453-4057qib7	14769	3	period	period	NN
cord-005453-4057qib7	14769	4	we	-PRON-	PRP
cord-005453-4057qib7	14769	5	had	have	VBD
cord-005453-4057qib7	14769	6	altogether	altogether	RB
cord-005453-4057qib7	14769	7	3	3	CD
cord-005453-4057qib7	14769	8	unsuccessful	unsuccessful	JJ
cord-005453-4057qib7	14769	9	mobilizations	mobilization	NNS
cord-005453-4057qib7	14769	10	(	(	-LRB-
cord-005453-4057qib7	14769	11	33,3	33,3	CD
cord-005453-4057qib7	14769	12	%	%	NN
cord-005453-4057qib7	14769	13	in	in	IN
cord-005453-4057qib7	14769	14	repeated	repeat	VBN
cord-005453-4057qib7	14769	15	cycles	cycle	NNS
cord-005453-4057qib7	14769	16	,	,	,
cord-005453-4057qib7	14769	17	0,72	0,72	CD
cord-005453-4057qib7	14769	18	%	%	NN
cord-005453-4057qib7	14769	19	in	in	IN
cord-005453-4057qib7	14769	20	total	total	NN
cord-005453-4057qib7	14769	21	)	)	-RRB-
cord-005453-4057qib7	14769	22	.	.	.
cord-005453-4057qib7	14770	1	This	this	DT
cord-005453-4057qib7	14770	2	group	group	NN
cord-005453-4057qib7	14770	3	of	of	IN
cord-005453-4057qib7	14770	4	patients	patient	NNS
cord-005453-4057qib7	14770	5	consisted	consist	VBD
cord-005453-4057qib7	14770	6	of	of	IN
cord-005453-4057qib7	14770	7	1	1	CD
cord-005453-4057qib7	14770	8	male	male	NN
cord-005453-4057qib7	14770	9	and	and	CC
cord-005453-4057qib7	14770	10	2	2	CD
cord-005453-4057qib7	14770	11	female	female	JJ
cord-005453-4057qib7	14770	12	patients	patient	NNS
cord-005453-4057qib7	14770	13	,	,	,
cord-005453-4057qib7	14770	14	median	median	JJ
cord-005453-4057qib7	14770	15	age	age	NN
cord-005453-4057qib7	14770	16	42	42	CD
cord-005453-4057qib7	14770	17	(	(	-LRB-
cord-005453-4057qib7	14770	18	33	33	CD
cord-005453-4057qib7	14770	19	-	-	SYM
cord-005453-4057qib7	14770	20	58	58	CD
cord-005453-4057qib7	14770	21	)	)	-RRB-
cord-005453-4057qib7	14770	22	,	,	,
cord-005453-4057qib7	14770	23	diagnosis	diagnosis	NN
cord-005453-4057qib7	14770	24	of	of	IN
cord-005453-4057qib7	14770	25	NHL	NHL	NNP
cord-005453-4057qib7	14770	26	and	and	CC
cord-005453-4057qib7	14770	27	failure	failure	NN
cord-005453-4057qib7	14770	28	to	to	TO
cord-005453-4057qib7	14770	29	collect	collect	VB
cord-005453-4057qib7	14770	30	after	after	IN
cord-005453-4057qib7	14770	31	4	4	CD
cord-005453-4057qib7	14770	32	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	14770	33	procedures	procedure	NNS
cord-005453-4057qib7	14770	34	each	each	DT
cord-005453-4057qib7	14770	35	.	.	.
cord-005453-4057qib7	14771	1	Median	median	JJ
cord-005453-4057qib7	14771	2	number	number	NN
cord-005453-4057qib7	14771	3	of	of	IN
cord-005453-4057qib7	14771	4	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	14771	5	needed	need	VBN
cord-005453-4057qib7	14771	6	for	for	IN
cord-005453-4057qib7	14771	7	adequate	adequate	JJ
cord-005453-4057qib7	14771	8	collection	collection	NN
cord-005453-4057qib7	14771	9	was	be	VBD
cord-005453-4057qib7	14771	10	2	2	CD
cord-005453-4057qib7	14771	11	with	with	IN
cord-005453-4057qib7	14771	12	preemtive	preemtive	JJ
cord-005453-4057qib7	14771	13	plerixafor	plerixafor	NN
cord-005453-4057qib7	14771	14	use	use	NN
cord-005453-4057qib7	14771	15	,	,	,
cord-005453-4057qib7	14771	16	and	and	CC
cord-005453-4057qib7	14771	17	4	4	CD
cord-005453-4057qib7	14771	18	in	in	IN
cord-005453-4057qib7	14771	19	repeated	repeat	VBN
cord-005453-4057qib7	14771	20	mobilizations	mobilization	NNS
cord-005453-4057qib7	14771	21	.	.	.
cord-005453-4057qib7	14772	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14772	2	:	:	:
cord-005453-4057qib7	14773	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14773	2	expirience	expirience	NN
cord-005453-4057qib7	14773	3	shows	show	VBZ
cord-005453-4057qib7	14773	4	that	that	IN
cord-005453-4057qib7	14773	5	preemtive	preemtive	JJ
cord-005453-4057qib7	14773	6	use	use	NN
cord-005453-4057qib7	14773	7	of	of	IN
cord-005453-4057qib7	14773	8	plerixafor	plerixafor	NN
cord-005453-4057qib7	14773	9	in	in	IN
cord-005453-4057qib7	14773	10	poor	poor	JJ
cord-005453-4057qib7	14773	11	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14773	12	is	be	VBZ
cord-005453-4057qib7	14773	13	efficient	efficient	JJ
cord-005453-4057qib7	14773	14	and	and	CC
cord-005453-4057qib7	14773	15	has	have	VBZ
cord-005453-4057qib7	14773	16	enhached	enhache	VBN
cord-005453-4057qib7	14773	17	success	success	NN
cord-005453-4057qib7	14773	18	of	of	IN
cord-005453-4057qib7	14773	19	the	the	DT
cord-005453-4057qib7	14773	20	PBSC	PBSC	NNP
cord-005453-4057qib7	14773	21	collections	collection	NNS
cord-005453-4057qib7	14773	22	.	.	.
cord-005453-4057qib7	14774	1	Due	due	IN
cord-005453-4057qib7	14774	2	to	to	IN
cord-005453-4057qib7	14774	3	drug	drug	NN
cord-005453-4057qib7	14774	4	high	high	JJ
cord-005453-4057qib7	14774	5	cost	cost	NN
cord-005453-4057qib7	14774	6	each	each	DT
cord-005453-4057qib7	14774	7	institution	institution	NN
cord-005453-4057qib7	14774	8	needs	need	VBZ
cord-005453-4057qib7	14774	9	to	to	TO
cord-005453-4057qib7	14774	10	develop	develop	VB
cord-005453-4057qib7	14774	11	its	-PRON-	PRP$
cord-005453-4057qib7	14774	12	own	own	JJ
cord-005453-4057qib7	14774	13	algorythm	algorythm	NN
cord-005453-4057qib7	14774	14	in	in	IN
cord-005453-4057qib7	14774	15	management	management	NN
cord-005453-4057qib7	14774	16	of	of	IN
cord-005453-4057qib7	14774	17	poor	poor	JJ
cord-005453-4057qib7	14774	18	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14774	19	.	.	.
cord-005453-4057qib7	14775	1	The	the	DT
cord-005453-4057qib7	14775	2	factors	factor	NNS
cord-005453-4057qib7	14775	3	contributing	contribute	VBG
cord-005453-4057qib7	14775	4	to	to	IN
cord-005453-4057qib7	14775	5	plerixafor	plerixafor	NN
cord-005453-4057qib7	14775	6	mobilization	mobilization	NN
cord-005453-4057qib7	14775	7	failure	failure	NN
cord-005453-4057qib7	14775	8	still	still	RB
cord-005453-4057qib7	14775	9	need	need	VBP
cord-005453-4057qib7	14775	10	to	to	TO
cord-005453-4057qib7	14775	11	be	be	VB
cord-005453-4057qib7	14775	12	elucidated	elucidate	VBN
cord-005453-4057qib7	14775	13	.	.	.
cord-005453-4057qib7	14776	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14776	2	:	:	:
cord-005453-4057qib7	14776	3	Nothing	nothing	NN
cord-005453-4057qib7	14776	4	to	to	TO
cord-005453-4057qib7	14776	5	declare	declare	VB
cord-005453-4057qib7	14776	6	.	.	.
cord-005453-4057qib7	14777	1	Platelets	platelet	NNS
cord-005453-4057qib7	14777	2	recovered	recover	VBD
cord-005453-4057qib7	14777	3	from	from	IN
cord-005453-4057qib7	14777	4	mobilized	mobilize	VBN
cord-005453-4057qib7	14777	5	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	14777	6	units	unit	NNS
cord-005453-4057qib7	14777	7	obtained	obtain	VBN
cord-005453-4057qib7	14777	8	from	from	IN
cord-005453-4057qib7	14777	9	HLA	HLA	NNP
cord-005453-4057qib7	14777	10	-	-	HYPH
cord-005453-4057qib7	14777	11	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14777	12	donors	donor	NNS
cord-005453-4057qib7	14777	13	fulfill	fulfill	VBP
cord-005453-4057qib7	14777	14	the	the	DT
cord-005453-4057qib7	14777	15	criteria	criterion	NNS
cord-005453-4057qib7	14777	16	of	of	IN
cord-005453-4057qib7	14777	17	a	a	DT
cord-005453-4057qib7	14777	18	conventional	conventional	JJ
cord-005453-4057qib7	14777	19	hemocomponent	hemocomponent	NN
cord-005453-4057qib7	14777	20	and	and	CC
cord-005453-4057qib7	14777	21	can	can	MD
cord-005453-4057qib7	14777	22	be	be	VB
cord-005453-4057qib7	14777	23	used	use	VBN
cord-005453-4057qib7	14777	24	for	for	IN
cord-005453-4057qib7	14777	25	transfusion	transfusion	NN
cord-005453-4057qib7	14777	26	Background	background	NN
cord-005453-4057qib7	14777	27	:	:	:
cord-005453-4057qib7	14777	28	Central	central	JJ
cord-005453-4057qib7	14777	29	venous	venous	JJ
cord-005453-4057qib7	14777	30	catheter	catheter	NN
cord-005453-4057qib7	14777	31	(	(	-LRB-
cord-005453-4057qib7	14777	32	CVC	CVC	NNP
cord-005453-4057qib7	14777	33	)	)	-RRB-
cord-005453-4057qib7	14777	34	related	relate	VBN
cord-005453-4057qib7	14777	35	complications	complication	NNS
cord-005453-4057qib7	14777	36	may	may	MD
cord-005453-4057qib7	14777	37	lead	lead	VB
cord-005453-4057qib7	14777	38	to	to	IN
cord-005453-4057qib7	14777	39	high	high	JJ
cord-005453-4057qib7	14777	40	morbidity	morbidity	NN
cord-005453-4057qib7	14777	41	and	and	CC
cord-005453-4057qib7	14777	42	mortality	mortality	NN
cord-005453-4057qib7	14777	43	.	.	.
cord-005453-4057qib7	14778	1	Unlike	unlike	IN
cord-005453-4057qib7	14778	2	CVC	CVC	NNP
cord-005453-4057qib7	14778	3	,	,	,
cord-005453-4057qib7	14778	4	peripheral	peripheral	JJ
cord-005453-4057qib7	14778	5	cannulation	cannulation	NN
cord-005453-4057qib7	14778	6	offers	offer	VBZ
cord-005453-4057qib7	14778	7	a	a	DT
cord-005453-4057qib7	14778	8	quick	quick	JJ
cord-005453-4057qib7	14778	9	and	and	CC
cord-005453-4057qib7	14778	10	inexpensive	inexpensive	JJ
cord-005453-4057qib7	14778	11	method	method	NN
cord-005453-4057qib7	14778	12	for	for	IN
cord-005453-4057qib7	14778	13	safe	safe	JJ
cord-005453-4057qib7	14778	14	and	and	CC
cord-005453-4057qib7	14778	15	non	non	JJ
cord-005453-4057qib7	14778	16	-	-	JJ
cord-005453-4057qib7	14778	17	traumatic	traumatic	JJ
cord-005453-4057qib7	14778	18	vascular	vascular	JJ
cord-005453-4057qib7	14778	19	access	access	NN
cord-005453-4057qib7	14778	20	(	(	-LRB-
cord-005453-4057qib7	14778	21	VA	VA	NNP
cord-005453-4057qib7	14778	22	)	)	-RRB-
cord-005453-4057qib7	14779	1	thus	thus	RB
cord-005453-4057qib7	14779	2	its	-PRON-	PRP$
cord-005453-4057qib7	14779	3	utilization	utilization	NN
cord-005453-4057qib7	14779	4	is	be	VBZ
cord-005453-4057qib7	14779	5	strongly	strongly	RB
cord-005453-4057qib7	14779	6	recommended	recommend	VBN
cord-005453-4057qib7	14779	7	whenever	whenever	WRB
cord-005453-4057qib7	14779	8	possible	possible	JJ
cord-005453-4057qib7	14779	9	.	.	.
cord-005453-4057qib7	14780	1	The	the	DT
cord-005453-4057qib7	14780	2	ultrasound	ultrasound	NN
cord-005453-4057qib7	14780	3	(	(	-LRB-
cord-005453-4057qib7	14780	4	US	US	NNP
cord-005453-4057qib7	14780	5	)	)	-RRB-
cord-005453-4057qib7	14780	6	guidance	guidance	NN
cord-005453-4057qib7	14780	7	for	for	IN
cord-005453-4057qib7	14780	8	acquiring	acquire	VBG
cord-005453-4057qib7	14780	9	peripheral	peripheral	JJ
cord-005453-4057qib7	14780	10	VA	VA	NNP
cord-005453-4057qib7	14780	11	is	be	VBZ
cord-005453-4057qib7	14780	12	a	a	DT
cord-005453-4057qib7	14780	13	useful	useful	JJ
cord-005453-4057qib7	14780	14	tool	tool	NN
cord-005453-4057qib7	14780	15	for	for	IN
cord-005453-4057qib7	14780	16	reduction	reduction	NN
cord-005453-4057qib7	14780	17	or	or	CC
cord-005453-4057qib7	14780	18	elimination	elimination	NN
cord-005453-4057qib7	14780	19	of	of	IN
cord-005453-4057qib7	14780	20	the	the	DT
cord-005453-4057qib7	14780	21	need	need	NN
cord-005453-4057qib7	14780	22	of	of	IN
cord-005453-4057qib7	14780	23	using	use	VBG
cord-005453-4057qib7	14780	24	CVC	CVC	NNP
cord-005453-4057qib7	14780	25	for	for	IN
cord-005453-4057qib7	14780	26	stem	stem	NN
cord-005453-4057qib7	14780	27	cells	cell	NNS
cord-005453-4057qib7	14780	28	collection	collection	NN
cord-005453-4057qib7	14780	29	.	.	.
cord-005453-4057qib7	14781	1	We	-PRON-	PRP
cord-005453-4057qib7	14781	2	have	have	VBP
cord-005453-4057qib7	14781	3	made	make	VBN
cord-005453-4057qib7	14781	4	an	an	DT
cord-005453-4057qib7	14781	5	attempt	attempt	NN
cord-005453-4057qib7	14781	6	to	to	TO
cord-005453-4057qib7	14781	7	introduce	introduce	VB
cord-005453-4057qib7	14781	8	US	US	NNP
cord-005453-4057qib7	14781	9	method	method	NN
cord-005453-4057qib7	14781	10	in	in	IN
cord-005453-4057qib7	14781	11	our	-PRON-	PRP$
cord-005453-4057qib7	14781	12	apheresis	apheresis	NN
cord-005453-4057qib7	14781	13	unit	unit	NN
cord-005453-4057qib7	14781	14	having	have	VBG
cord-005453-4057qib7	14781	15	no	no	DT
cord-005453-4057qib7	14781	16	previous	previous	JJ
cord-005453-4057qib7	14781	17	experience	experience	NN
cord-005453-4057qib7	14781	18	with	with	IN
cord-005453-4057qib7	14781	19	US	US	NNP
cord-005453-4057qib7	14781	20	devices	device	NNS
cord-005453-4057qib7	14781	21	.	.	.
cord-005453-4057qib7	14782	1	The	the	DT
cord-005453-4057qib7	14782	2	aim	aim	NN
cord-005453-4057qib7	14782	3	of	of	IN
cord-005453-4057qib7	14782	4	the	the	DT
cord-005453-4057qib7	14782	5	study	study	NN
cord-005453-4057qib7	14782	6	was	be	VBD
cord-005453-4057qib7	14782	7	to	to	TO
cord-005453-4057qib7	14782	8	measure	measure	VB
cord-005453-4057qib7	14782	9	the	the	DT
cord-005453-4057qib7	14782	10	decrease	decrease	NN
cord-005453-4057qib7	14782	11	of	of	IN
cord-005453-4057qib7	14782	12	CVC	CVC	NNP
cord-005453-4057qib7	14782	13	insertions	insertion	NNS
cord-005453-4057qib7	14782	14	after	after	IN
cord-005453-4057qib7	14782	15	introducing	introduce	VBG
cord-005453-4057qib7	14782	16	US	US	NNP
cord-005453-4057qib7	14782	17	and	and	CC
cord-005453-4057qib7	14782	18	evaluate	evaluate	VB
cord-005453-4057qib7	14782	19	the	the	DT
cord-005453-4057qib7	14782	20	quality	quality	NN
cord-005453-4057qib7	14782	21	of	of	IN
cord-005453-4057qib7	14782	22	VA	VA	NNP
cord-005453-4057qib7	14782	23	by	by	IN
cord-005453-4057qib7	14782	24	comparing	compare	VBG
cord-005453-4057qib7	14782	25	average	average	JJ
cord-005453-4057qib7	14782	26	flow	flow	NN
cord-005453-4057qib7	14782	27	rate	rate	NN
cord-005453-4057qib7	14782	28	and	and	CC
cord-005453-4057qib7	14782	29	confirming	confirm	VBG
cord-005453-4057qib7	14782	30	that	that	IN
cord-005453-4057qib7	14782	31	the	the	DT
cord-005453-4057qib7	14782	32	desired	desire	VBN
cord-005453-4057qib7	14782	33	blood	blood	NN
cord-005453-4057qib7	14782	34	volume	volume	NN
cord-005453-4057qib7	14782	35	could	could	MD
cord-005453-4057qib7	14782	36	be	be	VB
cord-005453-4057qib7	14782	37	processed	process	VBN
cord-005453-4057qib7	14782	38	.	.	.
cord-005453-4057qib7	14783	1	Methods	method	NNS
cord-005453-4057qib7	14783	2	:	:	:
cord-005453-4057qib7	14784	1	The	the	DT
cord-005453-4057qib7	14784	2	theoretical	theoretical	JJ
cord-005453-4057qib7	14784	3	education	education	NN
cord-005453-4057qib7	14784	4	involved	involve	VBD
cord-005453-4057qib7	14784	5	a	a	DT
cord-005453-4057qib7	14784	6	free	free	JJ
cord-005453-4057qib7	14784	7	elearning	elearning	NN
cord-005453-4057qib7	14784	8	course	course	NN
cord-005453-4057qib7	14784	9	in	in	IN
cord-005453-4057qib7	14784	10	peripheral	peripheral	JJ
cord-005453-4057qib7	14784	11	ultrasound	ultrasound	NN
cord-005453-4057qib7	14784	12	-	-	HYPH
cord-005453-4057qib7	14784	13	guided	guide	VBN
cord-005453-4057qib7	14784	14	VA	VA	NNP
cord-005453-4057qib7	14784	15	(	(	-LRB-
cord-005453-4057qib7	14784	16	PUGVA	PUGVA	NNP
cord-005453-4057qib7	14784	17	,	,	,
cord-005453-4057qib7	14784	18	USabcd	USabcd	NNP
cord-005453-4057qib7	14784	19	,	,	,
cord-005453-4057qib7	14784	20	Aarhus	Aarhus	NNP
cord-005453-4057qib7	14784	21	,	,	,
cord-005453-4057qib7	14784	22	Denmark	Denmark	NNP
cord-005453-4057qib7	14784	23	)	)	-RRB-
cord-005453-4057qib7	14784	24	.	.	.
cord-005453-4057qib7	14785	1	Subsequently	subsequently	RB
cord-005453-4057qib7	14785	2	,	,	,
cord-005453-4057qib7	14785	3	the	the	DT
cord-005453-4057qib7	14785	4	personnel	personnel	NNS
cord-005453-4057qib7	14785	5	have	have	VBP
cord-005453-4057qib7	14785	6	implemented	implement	VBN
cord-005453-4057qib7	14785	7	knowledge	knowledge	NN
cord-005453-4057qib7	14785	8	in	in	IN
cord-005453-4057qib7	14785	9	practical	practical	JJ
cord-005453-4057qib7	14785	10	training	training	NN
cord-005453-4057qib7	14785	11	on	on	IN
cord-005453-4057qib7	14785	12	gelatine	gelatine	NN
cord-005453-4057qib7	14785	13	and	and	CC
cord-005453-4057qib7	14785	14	silicone	silicone	NN
cord-005453-4057qib7	14785	15	phantoms	phantom	NNS
cord-005453-4057qib7	14785	16	and	and	CC
cord-005453-4057qib7	14785	17	healthy	healthy	JJ
cord-005453-4057qib7	14785	18	volunteers	volunteer	NNS
cord-005453-4057qib7	14785	19	.	.	.
cord-005453-4057qib7	14786	1	The	the	DT
cord-005453-4057qib7	14786	2	practical	practical	JJ
cord-005453-4057qib7	14786	3	activities	activity	NNS
cord-005453-4057qib7	14786	4	also	also	RB
cord-005453-4057qib7	14786	5	included	include	VBD
cord-005453-4057qib7	14786	6	a	a	DT
cord-005453-4057qib7	14786	7	fiveday	fiveday	NN
cord-005453-4057qib7	14786	8	course	course	NN
cord-005453-4057qib7	14786	9	in	in	IN
cord-005453-4057qib7	14786	10	an	an	DT
cord-005453-4057qib7	14786	11	apheresis	apheresis	NN
cord-005453-4057qib7	14786	12	centre	centre	NN
cord-005453-4057qib7	14786	13	with	with	IN
cord-005453-4057qib7	14786	14	US	US	NNP
cord-005453-4057qib7	14786	15	-	-	HYPH
cord-005453-4057qib7	14786	16	guided	guide	VBN
cord-005453-4057qib7	14786	17	cannulation	cannulation	NN
cord-005453-4057qib7	14786	18	experience	experience	NN
cord-005453-4057qib7	14786	19	.	.	.
cord-005453-4057qib7	14787	1	The	the	DT
cord-005453-4057qib7	14787	2	details	detail	NNS
cord-005453-4057qib7	14787	3	concerning	concern	VBG
cord-005453-4057qib7	14787	4	VA	VA	NNP
cord-005453-4057qib7	14787	5	were	be	VBD
cord-005453-4057qib7	14787	6	recorded	record	VBN
cord-005453-4057qib7	14787	7	,	,	,
cord-005453-4057qib7	14787	8	including	include	VBG
cord-005453-4057qib7	14787	9	VA	VA	NNP
cord-005453-4057qib7	14787	10	site	site	NN
cord-005453-4057qib7	14787	11	,	,	,
cord-005453-4057qib7	14787	12	cannula	cannula	NN
cord-005453-4057qib7	14787	13	size	size	NN
cord-005453-4057qib7	14787	14	,	,	,
cord-005453-4057qib7	14787	15	average	average	JJ
cord-005453-4057qib7	14787	16	inlet	inlet	NN
cord-005453-4057qib7	14787	17	flow	flow	NN
cord-005453-4057qib7	14787	18	rate	rate	NN
cord-005453-4057qib7	14787	19	,	,	,
cord-005453-4057qib7	14787	20	number	number	NN
cord-005453-4057qib7	14787	21	of	of	IN
cord-005453-4057qib7	14787	22	inlet	inlet	NN
cord-005453-4057qib7	14787	23	pressure	pressure	NN
cord-005453-4057qib7	14787	24	alarms	alarm	NNS
cord-005453-4057qib7	14787	25	reported	report	VBN
cord-005453-4057qib7	14787	26	by	by	IN
cord-005453-4057qib7	14787	27	the	the	DT
cord-005453-4057qib7	14787	28	apheresis	apheresis	NN
cord-005453-4057qib7	14787	29	device	device	NN
cord-005453-4057qib7	14787	30	.	.	.
cord-005453-4057qib7	14788	1	The	the	DT
cord-005453-4057qib7	14788	2	procedure	procedure	NN
cord-005453-4057qib7	14788	3	details	detail	NNS
cord-005453-4057qib7	14788	4	where	where	WRB
cord-005453-4057qib7	14788	5	traditional	traditional	JJ
cord-005453-4057qib7	14788	6	approach	approach	NN
cord-005453-4057qib7	14788	7	was	be	VBD
cord-005453-4057qib7	14788	8	applied	apply	VBN
cord-005453-4057qib7	14788	9	i.e.	i.e.	FW
cord-005453-4057qib7	14788	10	palpable	palpable	JJ
cord-005453-4057qib7	14788	11	cannulation	cannulation	NN
cord-005453-4057qib7	14788	12	and	and	CC
cord-005453-4057qib7	14788	13	CVCs	CVCs	NNP
cord-005453-4057qib7	14788	14	have	have	VBP
cord-005453-4057qib7	14788	15	been	be	VBN
cord-005453-4057qib7	14788	16	collected	collect	VBN
cord-005453-4057qib7	14788	17	.	.	.
cord-005453-4057qib7	14789	1	Similarly	similarly	RB
cord-005453-4057qib7	14789	2	,	,	,
cord-005453-4057qib7	14789	3	the	the	DT
cord-005453-4057qib7	14789	4	necessary	necessary	JJ
cord-005453-4057qib7	14789	5	data	datum	NNS
cord-005453-4057qib7	14789	6	for	for	IN
cord-005453-4057qib7	14789	7	procedures	procedure	NNS
cord-005453-4057qib7	14789	8	where	where	WRB
cord-005453-4057qib7	14789	9	veins	vein	NNS
cord-005453-4057qib7	14789	10	were	be	VBD
cord-005453-4057qib7	14789	11	assessed	assess	VBN
cord-005453-4057qib7	14789	12	with	with	IN
cord-005453-4057qib7	14789	13	ultrasound	ultrasound	NN
cord-005453-4057qib7	14789	14	prior	prior	RB
cord-005453-4057qib7	14789	15	to	to	IN
cord-005453-4057qib7	14789	16	apheresis	apheresis	NN
cord-005453-4057qib7	14789	17	were	be	VBD
cord-005453-4057qib7	14789	18	recorded	record	VBN
cord-005453-4057qib7	14789	19	.	.	.
cord-005453-4057qib7	14790	1	Results	result	NNS
cord-005453-4057qib7	14790	2	:	:	:
cord-005453-4057qib7	14790	3	Before	before	IN
cord-005453-4057qib7	14790	4	introducing	introduce	VBG
cord-005453-4057qib7	14790	5	ultrasonography	ultrasonography	NN
cord-005453-4057qib7	14790	6	,	,	,
cord-005453-4057qib7	14790	7	58	58	CD
cord-005453-4057qib7	14790	8	stem	stem	NN
cord-005453-4057qib7	14790	9	cell	cell	NN
cord-005453-4057qib7	14790	10	collections	collection	NNS
cord-005453-4057qib7	14790	11	have	have	VBP
cord-005453-4057qib7	14790	12	been	be	VBN
cord-005453-4057qib7	14790	13	performed	perform	VBN
cord-005453-4057qib7	14790	14	in	in	IN
cord-005453-4057qib7	14790	15	46	46	CD
cord-005453-4057qib7	14790	16	patients	patient	NNS
cord-005453-4057qib7	14790	17	.	.	.
cord-005453-4057qib7	14791	1	Of	of	IN
cord-005453-4057qib7	14791	2	all	all	PDT
cord-005453-4057qib7	14791	3	these	these	DT
cord-005453-4057qib7	14791	4	procedures	procedure	NNS
cord-005453-4057qib7	14791	5	,	,	,
cord-005453-4057qib7	14791	6	18	18	CD
cord-005453-4057qib7	14791	7	were	be	VBD
cord-005453-4057qib7	14791	8	accomplished	accomplish	VBN
cord-005453-4057qib7	14791	9	with	with	IN
cord-005453-4057qib7	14791	10	CVC	CVC	NNP
cord-005453-4057qib7	14791	11	(	(	-LRB-
cord-005453-4057qib7	14791	12	31	31	CD
cord-005453-4057qib7	14791	13	%	%	NN
cord-005453-4057qib7	14791	14	)	)	-RRB-
cord-005453-4057qib7	14791	15	and	and	CC
cord-005453-4057qib7	14791	16	40	40	CD
cord-005453-4057qib7	14791	17	with	with	IN
cord-005453-4057qib7	14791	18	peripheral	peripheral	JJ
cord-005453-4057qib7	14791	19	VA	VA	NNP
cord-005453-4057qib7	14791	20	(	(	-LRB-
cord-005453-4057qib7	14791	21	69	69	CD
cord-005453-4057qib7	14791	22	%	%	NN
cord-005453-4057qib7	14791	23	)	)	-RRB-
cord-005453-4057qib7	14791	24	.	.	.
cord-005453-4057qib7	14792	1	Median	median	JJ
cord-005453-4057qib7	14792	2	cubital	cubital	JJ
cord-005453-4057qib7	14792	3	vein	vein	NN
cord-005453-4057qib7	14792	4	was	be	VBD
cord-005453-4057qib7	14792	5	the	the	DT
cord-005453-4057qib7	14792	6	vessel	vessel	NN
cord-005453-4057qib7	14792	7	of	of	IN
cord-005453-4057qib7	14792	8	choice	choice	NN
cord-005453-4057qib7	14792	9	.	.	.
cord-005453-4057qib7	14793	1	Out	out	IN
cord-005453-4057qib7	14793	2	of	of	IN
cord-005453-4057qib7	14793	3	the	the	DT
cord-005453-4057qib7	14793	4	40	40	CD
cord-005453-4057qib7	14793	5	peripheral	peripheral	JJ
cord-005453-4057qib7	14793	6	VA	VA	NNP
cord-005453-4057qib7	14793	7	procedures	procedure	NNS
cord-005453-4057qib7	14793	8	,	,	,
cord-005453-4057qib7	14793	9	14	14	CD
cord-005453-4057qib7	14793	10	(	(	-LRB-
cord-005453-4057qib7	14793	11	35	35	CD
cord-005453-4057qib7	14793	12	%	%	NN
cord-005453-4057qib7	14793	13	)	)	-RRB-
cord-005453-4057qib7	14793	14	were	be	VBD
cord-005453-4057qib7	14793	15	problematic	problematic	JJ
cord-005453-4057qib7	14793	16	,	,	,
cord-005453-4057qib7	14793	17	with	with	IN
cord-005453-4057qib7	14793	18	10	10	CD
cord-005453-4057qib7	14793	19	or	or	CC
cord-005453-4057qib7	14793	20	more	more	JJR
cord-005453-4057qib7	14793	21	inlet	inlet	NN
cord-005453-4057qib7	14793	22	pressure	pressure	NN
cord-005453-4057qib7	14793	23	alarms	alarm	NNS
cord-005453-4057qib7	14793	24	during	during	IN
cord-005453-4057qib7	14793	25	every	every	DT
cord-005453-4057qib7	14793	26	procedure	procedure	NN
cord-005453-4057qib7	14793	27	.	.	.
cord-005453-4057qib7	14794	1	After	after	IN
cord-005453-4057qib7	14794	2	the	the	DT
cord-005453-4057qib7	14794	3	training	training	NN
cord-005453-4057qib7	14794	4	stage	stage	NN
cord-005453-4057qib7	14794	5	,	,	,
cord-005453-4057qib7	14794	6	34	34	CD
cord-005453-4057qib7	14794	7	collection	collection	NN
cord-005453-4057qib7	14794	8	procedures	procedure	NNS
cord-005453-4057qib7	14794	9	were	be	VBD
cord-005453-4057qib7	14794	10	performed	perform	VBN
cord-005453-4057qib7	14794	11	in	in	IN
cord-005453-4057qib7	14794	12	25	25	CD
cord-005453-4057qib7	14794	13	patients	patient	NNS
cord-005453-4057qib7	14794	14	.	.	.
cord-005453-4057qib7	14795	1	After	after	IN
cord-005453-4057qib7	14795	2	introducing	introduce	VBG
cord-005453-4057qib7	14795	3	US	US	NNP
cord-005453-4057qib7	14795	4	we	-PRON-	PRP
cord-005453-4057qib7	14795	5	have	have	VBP
cord-005453-4057qib7	14795	6	observed	observe	VBN
cord-005453-4057qib7	14795	7	a	a	DT
cord-005453-4057qib7	14795	8	significant	significant	JJ
cord-005453-4057qib7	14795	9	reduction	reduction	NN
cord-005453-4057qib7	14795	10	of	of	IN
cord-005453-4057qib7	14795	11	the	the	DT
cord-005453-4057qib7	14795	12	number	number	NN
cord-005453-4057qib7	14795	13	of	of	IN
cord-005453-4057qib7	14795	14	CVC	CVC	NNP
cord-005453-4057qib7	14795	15	insertion	insertion	NN
cord-005453-4057qib7	14795	16	required	require	VBN
cord-005453-4057qib7	14795	17	for	for	IN
cord-005453-4057qib7	14795	18	successful	successful	JJ
cord-005453-4057qib7	14795	19	apheresis	apheresis	NN
cord-005453-4057qib7	14795	20	from	from	IN
cord-005453-4057qib7	14795	21	31	31	CD
cord-005453-4057qib7	14795	22	%	%	NN
cord-005453-4057qib7	14795	23	to	to	IN
cord-005453-4057qib7	14795	24	9	9	CD
cord-005453-4057qib7	14795	25	%	%	NN
cord-005453-4057qib7	14795	26	(	(	-LRB-
cord-005453-4057qib7	14795	27	p=0.01	p=0.01	NNP
cord-005453-4057qib7	14795	28	;	;	:
cord-005453-4057qib7	14795	29	Chi	Chi	NNP
cord-005453-4057qib7	14795	30	-	-	HYPH
cord-005453-4057qib7	14795	31	square	square	JJ
cord-005453-4057qib7	14795	32	test	test	NN
cord-005453-4057qib7	14795	33	with	with	IN
cord-005453-4057qib7	14795	34	Fisher	Fisher	NNP
cord-005453-4057qib7	14795	35	's	's	POS
cord-005453-4057qib7	14795	36	exact	exact	NN
cord-005453-4057qib7	14795	37	)	)	-RRB-
cord-005453-4057qib7	14795	38	.	.	.
cord-005453-4057qib7	14796	1	Thirty	thirty	CD
cord-005453-4057qib7	14796	2	one	one	CD
cord-005453-4057qib7	14796	3	procedures	procedure	NNS
cord-005453-4057qib7	14796	4	were	be	VBD
cord-005453-4057qib7	14796	5	completed	complete	VBN
cord-005453-4057qib7	14796	6	with	with	IN
cord-005453-4057qib7	14796	7	peripheral	peripheral	JJ
cord-005453-4057qib7	14796	8	VA	VA	NNP
cord-005453-4057qib7	14796	9	(	(	-LRB-
cord-005453-4057qib7	14796	10	91	91	CD
cord-005453-4057qib7	14796	11	%	%	NN
cord-005453-4057qib7	14796	12	)	)	-RRB-
cord-005453-4057qib7	14796	13	.	.	.
cord-005453-4057qib7	14797	1	Ultrasound	ultrasound	NN
cord-005453-4057qib7	14797	2	device	device	NN
cord-005453-4057qib7	14797	3	enabled	enable	VBD
cord-005453-4057qib7	14797	4	cannulation	cannulation	NN
cord-005453-4057qib7	14797	5	not	not	RB
cord-005453-4057qib7	14797	6	only	only	RB
cord-005453-4057qib7	14797	7	the	the	DT
cord-005453-4057qib7	14797	8	superficial	superficial	JJ
cord-005453-4057qib7	14797	9	veins	vein	NNS
cord-005453-4057qib7	14797	10	but	but	CC
cord-005453-4057qib7	14797	11	also	also	RB
cord-005453-4057qib7	14797	12	for	for	IN
cord-005453-4057qib7	14797	13	the	the	DT
cord-005453-4057qib7	14797	14	deeper	deep	JJR
cord-005453-4057qib7	14797	15	veins	vein	NNS
cord-005453-4057qib7	14797	16	.	.	.
cord-005453-4057qib7	14798	1	Cannulation	cannulation	NN
cord-005453-4057qib7	14798	2	sites	site	NNS
cord-005453-4057qib7	14798	3	included	include	VBD
cord-005453-4057qib7	14798	4	upper	upper	JJ
cord-005453-4057qib7	14798	5	arm	arm	NN
cord-005453-4057qib7	14798	6	cephalic	cephalic	JJ
cord-005453-4057qib7	14798	7	vein	vein	NN
cord-005453-4057qib7	14798	8	(	(	-LRB-
cord-005453-4057qib7	14798	9	39	39	CD
cord-005453-4057qib7	14798	10	%	%	NN
cord-005453-4057qib7	14798	11	)	)	-RRB-
cord-005453-4057qib7	14798	12	,	,	,
cord-005453-4057qib7	14798	13	median	median	JJ
cord-005453-4057qib7	14798	14	cubital	cubital	JJ
cord-005453-4057qib7	14798	15	vein	vein	NN
cord-005453-4057qib7	14798	16	(	(	-LRB-
cord-005453-4057qib7	14798	17	35	35	CD
cord-005453-4057qib7	14798	18	%	%	NN
cord-005453-4057qib7	14798	19	)	)	-RRB-
cord-005453-4057qib7	14798	20	,	,	,
cord-005453-4057qib7	14798	21	upper	upper	JJ
cord-005453-4057qib7	14798	22	arm	arm	NN
cord-005453-4057qib7	14798	23	basilic	basilic	JJ
cord-005453-4057qib7	14798	24	vein	vein	NN
cord-005453-4057qib7	14798	25	(	(	-LRB-
cord-005453-4057qib7	14798	26	13	13	CD
cord-005453-4057qib7	14798	27	%	%	NN
cord-005453-4057qib7	14798	28	)	)	-RRB-
cord-005453-4057qib7	14798	29	,	,	,
cord-005453-4057qib7	14798	30	median	median	JJ
cord-005453-4057qib7	14798	31	antebrachial	antebrachial	JJ
cord-005453-4057qib7	14798	32	vein	vein	NN
cord-005453-4057qib7	14798	33	(	(	-LRB-
cord-005453-4057qib7	14798	34	13	13	CD
cord-005453-4057qib7	14798	35	%	%	NN
cord-005453-4057qib7	14798	36	)	)	-RRB-
cord-005453-4057qib7	14798	37	.	.	.
cord-005453-4057qib7	14799	1	Out	out	IN
cord-005453-4057qib7	14799	2	of	of	IN
cord-005453-4057qib7	14799	3	the	the	DT
cord-005453-4057qib7	14799	4	34	34	CD
cord-005453-4057qib7	14799	5	collections	collection	NNS
cord-005453-4057qib7	14799	6	,	,	,
cord-005453-4057qib7	14799	7	13	13	CD
cord-005453-4057qib7	14799	8	were	be	VBD
cord-005453-4057qib7	14799	9	considered	consider	VBN
cord-005453-4057qib7	14799	10	problematic	problematic	JJ
cord-005453-4057qib7	14799	11	(	(	-LRB-
cord-005453-4057qib7	14799	12	42	42	CD
cord-005453-4057qib7	14799	13	%	%	NN
cord-005453-4057qib7	14799	14	)	)	-RRB-
cord-005453-4057qib7	14799	15	.	.	.
cord-005453-4057qib7	14800	1	No	no	DT
cord-005453-4057qib7	14800	2	difference	difference	NN
cord-005453-4057qib7	14800	3	in	in	IN
cord-005453-4057qib7	14800	4	an	an	DT
cord-005453-4057qib7	14800	5	average	average	JJ
cord-005453-4057qib7	14800	6	flow	flow	NN
cord-005453-4057qib7	14800	7	rate	rate	NN
cord-005453-4057qib7	14800	8	was	be	VBD
cord-005453-4057qib7	14800	9	observed	observe	VBN
cord-005453-4057qib7	14800	10	between	between	IN
cord-005453-4057qib7	14800	11	procedures	procedure	NNS
cord-005453-4057qib7	14800	12	performed	perform	VBN
cord-005453-4057qib7	14800	13	peripherally	peripherally	RB
cord-005453-4057qib7	14800	14	with	with	IN
cord-005453-4057qib7	14800	15	and	and	CC
cord-005453-4057qib7	14800	16	without	without	IN
cord-005453-4057qib7	14800	17	ultrasound	ultrasound	NN
cord-005453-4057qib7	14800	18	usage	usage	NN
cord-005453-4057qib7	14800	19	(	(	-LRB-
cord-005453-4057qib7	14800	20	p=0.34	p=0.34	NN
cord-005453-4057qib7	14800	21	;	;	:
cord-005453-4057qib7	14800	22	U	U	NNP
cord-005453-4057qib7	14800	23	Mann	Mann	NNP
cord-005453-4057qib7	14800	24	-	-	HYPH
cord-005453-4057qib7	14800	25	Whitney	Whitney	NNP
cord-005453-4057qib7	14800	26	test	test	NN
cord-005453-4057qib7	14800	27	)	)	-RRB-
cord-005453-4057qib7	14800	28	.	.	.
cord-005453-4057qib7	14801	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14801	2	:	:	:
cord-005453-4057qib7	14802	1	Despite	despite	IN
cord-005453-4057qib7	14802	2	no	no	DT
cord-005453-4057qib7	14802	3	previous	previous	JJ
cord-005453-4057qib7	14802	4	experience	experience	NN
cord-005453-4057qib7	14802	5	in	in	IN
cord-005453-4057qib7	14802	6	US	US	NNP
cord-005453-4057qib7	14802	7	guidance	guidance	NN
cord-005453-4057qib7	14802	8	,	,	,
cord-005453-4057qib7	14802	9	we	-PRON-	PRP
cord-005453-4057qib7	14802	10	have	have	VBP
cord-005453-4057qib7	14802	11	successfully	successfully	RB
cord-005453-4057qib7	14802	12	managed	manage	VBN
cord-005453-4057qib7	14802	13	to	to	TO
cord-005453-4057qib7	14802	14	introduce	introduce	VB
cord-005453-4057qib7	14802	15	the	the	DT
cord-005453-4057qib7	14802	16	new	new	JJ
cord-005453-4057qib7	14802	17	method	method	NN
cord-005453-4057qib7	14802	18	in	in	IN
cord-005453-4057qib7	14802	19	our	-PRON-	PRP$
cord-005453-4057qib7	14802	20	apheresis	apheresis	NN
cord-005453-4057qib7	14802	21	unit	unit	NN
cord-005453-4057qib7	14802	22	.	.	.
cord-005453-4057qib7	14803	1	Within	within	IN
cord-005453-4057qib7	14803	2	5	5	CD
cord-005453-4057qib7	14803	3	months	month	NNS
cord-005453-4057qib7	14803	4	,	,	,
cord-005453-4057qib7	14803	5	we	-PRON-	PRP
cord-005453-4057qib7	14803	6	have	have	VBP
cord-005453-4057qib7	14803	7	reduced	reduce	VBN
cord-005453-4057qib7	14803	8	CVC	CVC	NNP
cord-005453-4057qib7	14803	9	usage	usage	NN
cord-005453-4057qib7	14803	10	threefold	threefold	NN
cord-005453-4057qib7	14803	11	and	and	CC
cord-005453-4057qib7	14803	12	as	as	IN
cord-005453-4057qib7	14803	13	the	the	DT
cord-005453-4057qib7	14803	14	personnel	personnel	NNS
cord-005453-4057qib7	14803	15	is	be	VBZ
cord-005453-4057qib7	14803	16	gaining	gain	VBG
cord-005453-4057qib7	14803	17	more	more	JJR
cord-005453-4057qib7	14803	18	experience	experience	NN
cord-005453-4057qib7	14803	19	,	,	,
cord-005453-4057qib7	14803	20	we	-PRON-	PRP
cord-005453-4057qib7	14803	21	suppose	suppose	VBP
cord-005453-4057qib7	14803	22	that	that	IN
cord-005453-4057qib7	14803	23	the	the	DT
cord-005453-4057qib7	14803	24	CVC	CVC	NNP
cord-005453-4057qib7	14803	25	usage	usage	NN
cord-005453-4057qib7	14803	26	may	may	MD
cord-005453-4057qib7	14803	27	be	be	VB
cord-005453-4057qib7	14803	28	reduced	reduce	VBN
cord-005453-4057qib7	14803	29	to	to	IN
cord-005453-4057qib7	14803	30	episodic	episodic	JJ
cord-005453-4057qib7	14803	31	cases	case	NNS
cord-005453-4057qib7	14803	32	.	.	.
cord-005453-4057qib7	14804	1	Despite	despite	IN
cord-005453-4057qib7	14804	2	slightly	slightly	RB
cord-005453-4057qib7	14804	3	higher	high	JJR
cord-005453-4057qib7	14804	4	number	number	NN
cord-005453-4057qib7	14804	5	of	of	IN
cord-005453-4057qib7	14804	6	pressure	pressure	NN
cord-005453-4057qib7	14804	7	alarms	alarm	NNS
cord-005453-4057qib7	14804	8	,	,	,
cord-005453-4057qib7	14804	9	all	all	DT
cord-005453-4057qib7	14804	10	procedures	procedure	NNS
cord-005453-4057qib7	14804	11	with	with	IN
cord-005453-4057qib7	14804	12	ultrasound	ultrasound	NN
cord-005453-4057qib7	14804	13	guidance	guidance	NN
cord-005453-4057qib7	14804	14	were	be	VBD
cord-005453-4057qib7	14804	15	completed	complete	VBN
cord-005453-4057qib7	14804	16	as	as	IN
cord-005453-4057qib7	14804	17	planned	plan	VBN
cord-005453-4057qib7	14804	18	.	.	.
cord-005453-4057qib7	14805	1	Ultrasound	ultrasound	NN
cord-005453-4057qib7	14805	2	guidance	guidance	NN
cord-005453-4057qib7	14805	3	is	be	VBZ
cord-005453-4057qib7	14805	4	the	the	DT
cord-005453-4057qib7	14805	5	most	most	RBS
cord-005453-4057qib7	14805	6	important	important	JJ
cord-005453-4057qib7	14805	7	tool	tool	NN
cord-005453-4057qib7	14805	8	for	for	IN
cord-005453-4057qib7	14805	9	significant	significant	JJ
cord-005453-4057qib7	14805	10	increase	increase	NN
cord-005453-4057qib7	14805	11	in	in	IN
cord-005453-4057qib7	14805	12	peripheral	peripheral	JJ
cord-005453-4057qib7	14805	13	VA	VA	NNP
cord-005453-4057qib7	14805	14	usage	usage	NN
cord-005453-4057qib7	14805	15	and	and	CC
cord-005453-4057qib7	14805	16	may	may	MD
cord-005453-4057qib7	14805	17	become	become	VB
cord-005453-4057qib7	14805	18	the	the	DT
cord-005453-4057qib7	14805	19	only	only	JJ
cord-005453-4057qib7	14805	20	option	option	NN
cord-005453-4057qib7	14805	21	for	for	IN
cord-005453-4057qib7	14805	22	patients	patient	NNS
cord-005453-4057qib7	14805	23	with	with	IN
cord-005453-4057qib7	14805	24	difficult	difficult	JJ
cord-005453-4057qib7	14805	25	VA	VA	NNP
cord-005453-4057qib7	14805	26	.	.	.
cord-005453-4057qib7	14806	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14806	2	:	:	:
cord-005453-4057qib7	14806	3	Nothing	nothing	NN
cord-005453-4057qib7	14806	4	to	to	TO
cord-005453-4057qib7	14806	5	declare	declare	VB
cord-005453-4057qib7	14806	6	.	.	.
cord-005453-4057qib7	14807	1	Abstract	Abstract	NNP
cord-005453-4057qib7	14807	2	already	already	RB
cord-005453-4057qib7	14807	3	published	publish	VBN
cord-005453-4057qib7	14807	4	.	.	.
cord-005453-4057qib7	14808	1	Donor	donor	NN
cord-005453-4057qib7	14808	2	blood	blood	NN
cord-005453-4057qib7	14808	3	management	management	NN
cord-005453-4057qib7	14808	4	in	in	IN
cord-005453-4057qib7	14808	5	healthy	healthy	JJ
cord-005453-4057qib7	14808	6	bone	bone	NN
cord-005453-4057qib7	14808	7	marrow	marrow	NN
cord-005453-4057qib7	14808	8	donors	donor	NNS
cord-005453-4057qib7	14808	9	:	:	:
cord-005453-4057qib7	14809	1	A	a	DT
cord-005453-4057qib7	14809	2	retrospective	retrospective	JJ
cord-005453-4057qib7	14809	3	single	single	JJ
cord-005453-4057qib7	14809	4	institution	institution	NN
cord-005453-4057qib7	14809	5	analysis	analysis	NN
cord-005453-4057qib7	14809	6	Background	Background	NNP
cord-005453-4057qib7	14809	7	:	:	:
cord-005453-4057qib7	14809	8	Over	over	IN
cord-005453-4057qib7	14809	9	the	the	DT
cord-005453-4057qib7	14809	10	last	last	JJ
cord-005453-4057qib7	14809	11	two	two	CD
cord-005453-4057qib7	14809	12	decades	decade	NNS
cord-005453-4057qib7	14809	13	mobilized	mobilize	VBD
cord-005453-4057qib7	14809	14	peripheral	peripheral	JJ
cord-005453-4057qib7	14809	15	blood	blood	NN
cord-005453-4057qib7	14809	16	stem	stem	NN
cord-005453-4057qib7	14809	17	cells	cell	NNS
cord-005453-4057qib7	14809	18	(	(	-LRB-
cord-005453-4057qib7	14809	19	PBSC	PBSC	NNP
cord-005453-4057qib7	14809	20	)	)	-RRB-
cord-005453-4057qib7	14809	21	have	have	VBP
cord-005453-4057qib7	14809	22	been	be	VBN
cord-005453-4057qib7	14809	23	established	establish	VBN
cord-005453-4057qib7	14809	24	as	as	IN
cord-005453-4057qib7	14809	25	the	the	DT
cord-005453-4057qib7	14809	26	main	main	JJ
cord-005453-4057qib7	14809	27	source	source	NN
cord-005453-4057qib7	14809	28	of	of	IN
cord-005453-4057qib7	14809	29	stem	stem	NN
cord-005453-4057qib7	14809	30	cells	cell	NNS
cord-005453-4057qib7	14809	31	because	because	IN
cord-005453-4057qib7	14809	32	of	of	IN
cord-005453-4057qib7	14809	33	improved	improve	VBN
cord-005453-4057qib7	14809	34	engraftment	engraftment	NN
cord-005453-4057qib7	14809	35	and	and	CC
cord-005453-4057qib7	14809	36	no	no	DT
cord-005453-4057qib7	14809	37	necessity	necessity	NN
cord-005453-4057qib7	14809	38	for	for	IN
cord-005453-4057qib7	14809	39	hospitalization	hospitalization	NN
cord-005453-4057qib7	14809	40	for	for	IN
cord-005453-4057qib7	14809	41	the	the	DT
cord-005453-4057qib7	14809	42	donors	donor	NNS
cord-005453-4057qib7	14809	43	.	.	.
cord-005453-4057qib7	14810	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	14810	2	,	,	,
cord-005453-4057qib7	14810	3	due	due	IN
cord-005453-4057qib7	14810	4	to	to	IN
cord-005453-4057qib7	14810	5	the	the	DT
cord-005453-4057qib7	14810	6	introduction	introduction	NN
cord-005453-4057qib7	14810	7	of	of	IN
cord-005453-4057qib7	14810	8	promising	promise	VBG
cord-005453-4057qib7	14810	9	new	new	JJ
cord-005453-4057qib7	14810	10	transplant	transplant	NN
cord-005453-4057qib7	14810	11	regimens	regimen	NNS
cord-005453-4057qib7	14810	12	,	,	,
cord-005453-4057qib7	14810	13	especially	especially	RB
cord-005453-4057qib7	14810	14	in	in	IN
cord-005453-4057qib7	14810	15	the	the	DT
cord-005453-4057qib7	14810	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14810	17	transplantation	transplantation	NN
cord-005453-4057qib7	14810	18	setting	set	VBG
cord-005453-4057qib7	14810	19	bone	bone	NN
cord-005453-4057qib7	14810	20	marrow	marrow	NN
cord-005453-4057qib7	14810	21	(	(	-LRB-
cord-005453-4057qib7	14810	22	BM	BM	NNP
cord-005453-4057qib7	14810	23	)	)	-RRB-
cord-005453-4057qib7	14810	24	donations	donation	NNS
cord-005453-4057qib7	14810	25	are	be	VBP
cord-005453-4057qib7	14810	26	regaining	regain	VBG
cord-005453-4057qib7	14810	27	importance	importance	NN
cord-005453-4057qib7	14810	28	.	.	.
cord-005453-4057qib7	14811	1	Although	although	IN
cord-005453-4057qib7	14811	2	for	for	IN
cord-005453-4057qib7	14811	3	both	both	DT
cord-005453-4057qib7	14811	4	donation	donation	NN
cord-005453-4057qib7	14811	5	methods	method	NNS
cord-005453-4057qib7	14811	6	severe	severe	JJ
cord-005453-4057qib7	14811	7	side	side	NN
cord-005453-4057qib7	14811	8	effects	effect	NNS
cord-005453-4057qib7	14811	9	are	be	VBP
cord-005453-4057qib7	14811	10	rarely	rarely	RB
cord-005453-4057qib7	14811	11	described	describe	VBN
cord-005453-4057qib7	14811	12	,	,	,
cord-005453-4057qib7	14811	13	BM	BM	NNP
cord-005453-4057qib7	14811	14	collection	collection	NN
cord-005453-4057qib7	14811	15	is	be	VBZ
cord-005453-4057qib7	14811	16	associated	associate	VBN
cord-005453-4057qib7	14811	17	with	with	IN
cord-005453-4057qib7	14811	18	considerable	considerable	JJ
cord-005453-4057qib7	14811	19	blood	blood	NN
cord-005453-4057qib7	14811	20	loss	loss	NN
cord-005453-4057qib7	14811	21	and	and	CC
cord-005453-4057qib7	14811	22	hence	hence	RB
cord-005453-4057qib7	14811	23	symptoms	symptom	NNS
cord-005453-4057qib7	14811	24	of	of	IN
cord-005453-4057qib7	14811	25	acute	acute	JJ
cord-005453-4057qib7	14811	26	blood	blood	NN
cord-005453-4057qib7	14811	27	loss	loss	NN
cord-005453-4057qib7	14811	28	are	be	VBP
cord-005453-4057qib7	14811	29	commonly	commonly	RB
cord-005453-4057qib7	14811	30	observed	observe	VBN
cord-005453-4057qib7	14811	31	.	.	.
cord-005453-4057qib7	14812	1	Therefore	therefore	RB
cord-005453-4057qib7	14812	2	autologous	autologous	JJ
cord-005453-4057qib7	14812	3	blood	blood	NN
cord-005453-4057qib7	14812	4	are	be	VBP
cord-005453-4057qib7	14812	5	collected	collect	VBN
cord-005453-4057qib7	14812	6	routinely	routinely	RB
cord-005453-4057qib7	14812	7	in	in	IN
cord-005453-4057qib7	14812	8	some	some	DT
cord-005453-4057qib7	14812	9	institutions	institution	NNS
cord-005453-4057qib7	14812	10	before	before	IN
cord-005453-4057qib7	14812	11	donation	donation	NN
cord-005453-4057qib7	14812	12	.	.	.
cord-005453-4057qib7	14813	1	Since	since	IN
cord-005453-4057qib7	14813	2	the	the	DT
cord-005453-4057qib7	14813	3	collected	collect	VBN
cord-005453-4057qib7	14813	4	bone	bone	NN
cord-005453-4057qib7	14813	5	marrow	marrow	NN
cord-005453-4057qib7	14813	6	amount	amount	NN
cord-005453-4057qib7	14813	7	depends	depend	VBZ
cord-005453-4057qib7	14813	8	on	on	IN
cord-005453-4057qib7	14813	9	the	the	DT
cord-005453-4057qib7	14813	10	target	target	NN
cord-005453-4057qib7	14813	11	dose	dose	NN
cord-005453-4057qib7	14813	12	,	,	,
cord-005453-4057qib7	14813	13	the	the	DT
cord-005453-4057qib7	14813	14	WBC	WBC	NNP
cord-005453-4057qib7	14813	15	yield	yield	NN
cord-005453-4057qib7	14813	16	in	in	IN
cord-005453-4057qib7	14813	17	the	the	DT
cord-005453-4057qib7	14813	18	product	product	NN
cord-005453-4057qib7	14813	19	influences	influence	VBZ
cord-005453-4057qib7	14813	20	the	the	DT
cord-005453-4057qib7	14813	21	required	require	VBN
cord-005453-4057qib7	14813	22	bone	bone	NN
cord-005453-4057qib7	14813	23	marrow	marrow	NN
cord-005453-4057qib7	14813	24	volume	volume	NN
cord-005453-4057qib7	14813	25	.	.	.
cord-005453-4057qib7	14814	1	Therefore	therefore	RB
cord-005453-4057qib7	14814	2	we	-PRON-	PRP
cord-005453-4057qib7	14814	3	sought	seek	VBD
cord-005453-4057qib7	14814	4	to	to	TO
cord-005453-4057qib7	14814	5	investigate	investigate	VB
cord-005453-4057qib7	14814	6	the	the	DT
cord-005453-4057qib7	14814	7	relationship	relationship	NN
cord-005453-4057qib7	14814	8	between	between	IN
cord-005453-4057qib7	14814	9	collection	collection	NN
cord-005453-4057qib7	14814	10	volume	volume	NN
cord-005453-4057qib7	14814	11	,	,	,
cord-005453-4057qib7	14814	12	RBC	RBC	NNP
cord-005453-4057qib7	14814	13	volume	volume	NN
cord-005453-4057qib7	14814	14	removal	removal	NN
cord-005453-4057qib7	14814	15	,	,	,
cord-005453-4057qib7	14814	16	drop	drop	NN
cord-005453-4057qib7	14814	17	in	in	IN
cord-005453-4057qib7	14814	18	Hb	Hb	NNP
cord-005453-4057qib7	14814	19	and	and	CC
cord-005453-4057qib7	14814	20	indications	indication	NNS
cord-005453-4057qib7	14814	21	for	for	IN
cord-005453-4057qib7	14814	22	blood	blood	NN
cord-005453-4057qib7	14814	23	transfusion	transfusion	NN
cord-005453-4057qib7	14814	24	.	.	.
cord-005453-4057qib7	14815	1	Furthermore	furthermore	RB
cord-005453-4057qib7	14815	2	,	,	,
cord-005453-4057qib7	14815	3	we	-PRON-	PRP
cord-005453-4057qib7	14815	4	assessed	assess	VBD
cord-005453-4057qib7	14815	5	WBC	WBC	NNP
cord-005453-4057qib7	14815	6	and	and	CC
cord-005453-4057qib7	14815	7	CD34+yields	CD34+yields	NNPS
cord-005453-4057qib7	14815	8	in	in	IN
cord-005453-4057qib7	14815	9	relationship	relationship	NN
cord-005453-4057qib7	14815	10	to	to	IN
cord-005453-4057qib7	14815	11	various	various	JJ
cord-005453-4057qib7	14815	12	donor	donor	NN
cord-005453-4057qib7	14815	13	parameters	parameter	NNS
cord-005453-4057qib7	14815	14	and	and	CC
cord-005453-4057qib7	14815	15	to	to	TO
cord-005453-4057qib7	14815	16	product	product	NN
cord-005453-4057qib7	14815	17	volume	volume	NN
cord-005453-4057qib7	14815	18	,	,	,
cord-005453-4057qib7	14815	19	in	in	IN
cord-005453-4057qib7	14815	20	order	order	NN
cord-005453-4057qib7	14815	21	to	to	TO
cord-005453-4057qib7	14815	22	find	find	VB
cord-005453-4057qib7	14815	23	prediction	prediction	NN
cord-005453-4057qib7	14815	24	tools	tool	NNS
cord-005453-4057qib7	14815	25	for	for	IN
cord-005453-4057qib7	14815	26	collection	collection	NN
cord-005453-4057qib7	14815	27	volumes	volume	NNS
cord-005453-4057qib7	14815	28	.	.	.
cord-005453-4057qib7	14816	1	Methods	method	NNS
cord-005453-4057qib7	14816	2	:	:	:
cord-005453-4057qib7	14816	3	489	489	CD
cord-005453-4057qib7	14816	4	allogeneic	allogeneic	NN
cord-005453-4057qib7	14816	5	bone	bone	NN
cord-005453-4057qib7	14816	6	marrow	marrow	NN
cord-005453-4057qib7	14816	7	harvests	harvest	NNS
cord-005453-4057qib7	14816	8	from	from	IN
cord-005453-4057qib7	14816	9	adult	adult	NN
cord-005453-4057qib7	14816	10	donors	donor	NNS
cord-005453-4057qib7	14816	11	were	be	VBD
cord-005453-4057qib7	14816	12	performed	perform	VBN
cord-005453-4057qib7	14816	13	at	at	IN
cord-005453-4057qib7	14816	14	our	-PRON-	PRP$
cord-005453-4057qib7	14816	15	institution	institution	NN
cord-005453-4057qib7	14816	16	and	and	CC
cord-005453-4057qib7	14816	17	retrospectively	retrospectively	RB
cord-005453-4057qib7	14816	18	analyzed	analyze	VBN
cord-005453-4057qib7	14816	19	.	.	.
cord-005453-4057qib7	14817	1	Complete	complete	JJ
cord-005453-4057qib7	14817	2	blood	blood	NN
cord-005453-4057qib7	14817	3	counts	count	NNS
cord-005453-4057qib7	14817	4	,	,	,
cord-005453-4057qib7	14817	5	serum	serum	NN
cord-005453-4057qib7	14817	6	iron	iron	NN
cord-005453-4057qib7	14817	7	and	and	CC
cord-005453-4057qib7	14817	8	ferritin	ferritin	NN
cord-005453-4057qib7	14817	9	were	be	VBD
cord-005453-4057qib7	14817	10	assessed	assess	VBN
cord-005453-4057qib7	14817	11	at	at	IN
cord-005453-4057qib7	14817	12	work	work	NN
cord-005453-4057qib7	14817	13	-	-	HYPH
cord-005453-4057qib7	14817	14	up	up	NN
cord-005453-4057qib7	14817	15	and	and	CC
cord-005453-4057qib7	14817	16	4	4	CD
cord-005453-4057qib7	14817	17	weeks	week	NNS
cord-005453-4057qib7	14817	18	after	after	IN
cord-005453-4057qib7	14817	19	donation	donation	NN
cord-005453-4057qib7	14817	20	.	.	.
cord-005453-4057qib7	14818	1	The	the	DT
cord-005453-4057qib7	14818	2	bone	bone	NN
cord-005453-4057qib7	14818	3	marrow	marrow	NN
cord-005453-4057qib7	14818	4	product	product	NN
cord-005453-4057qib7	14818	5	quality	quality	NN
cord-005453-4057qib7	14818	6	including	include	VBG
cord-005453-4057qib7	14818	7	WBC	WBC	NNP
cord-005453-4057qib7	14818	8	,	,	,
cord-005453-4057qib7	14818	9	hematocrit	hematocrit	NN
cord-005453-4057qib7	14818	10	(	(	-LRB-
cord-005453-4057qib7	14818	11	Hct	Hct	NNP
cord-005453-4057qib7	14818	12	)	)	-RRB-
cord-005453-4057qib7	14818	13	and	and	CC
cord-005453-4057qib7	14818	14	CD34	CD34	NNP
cord-005453-4057qib7	14818	15	+	+	CC
cord-005453-4057qib7	14818	16	cells	cell	NNS
cord-005453-4057qib7	14818	17	were	be	VBD
cord-005453-4057qib7	14818	18	assessed	assess	VBN
cord-005453-4057qib7	14818	19	by	by	IN
cord-005453-4057qib7	14818	20	automatic	automatic	JJ
cord-005453-4057qib7	14818	21	hemocytometry	hemocytometry	NNP
cord-005453-4057qib7	14818	22	and	and	CC
cord-005453-4057qib7	14818	23	single	single	JJ
cord-005453-4057qib7	14818	24	-	-	HYPH
cord-005453-4057qib7	14818	25	platform	platform	NN
cord-005453-4057qib7	14818	26	flow	flow	NN
cord-005453-4057qib7	14818	27	cytometry	cytometry	NN
cord-005453-4057qib7	14818	28	with	with	IN
cord-005453-4057qib7	14818	29	ISHAGE	ISHAGE	NNP
cord-005453-4057qib7	14818	30	gating	gate	VBG
cord-005453-4057qib7	14818	31	.	.	.
cord-005453-4057qib7	14819	1	Results	result	NNS
cord-005453-4057qib7	14819	2	:	:	:
cord-005453-4057qib7	14820	1	Besides	besides	IN
cord-005453-4057qib7	14820	2	local	local	JJ
cord-005453-4057qib7	14820	3	pain	pain	NN
cord-005453-4057qib7	14820	4	most	most	JJS
cord-005453-4057qib7	14820	5	of	of	IN
cord-005453-4057qib7	14820	6	the	the	DT
cord-005453-4057qib7	14820	7	side	side	NN
cord-005453-4057qib7	14820	8	effects	effect	NNS
cord-005453-4057qib7	14820	9	were	be	VBD
cord-005453-4057qib7	14820	10	related	relate	VBN
cord-005453-4057qib7	14820	11	to	to	IN
cord-005453-4057qib7	14820	12	blood	blood	NN
cord-005453-4057qib7	14820	13	loss	loss	NN
cord-005453-4057qib7	14820	14	.	.	.
cord-005453-4057qib7	14821	1	None	none	NN
cord-005453-4057qib7	14821	2	of	of	IN
cord-005453-4057qib7	14821	3	the	the	DT
cord-005453-4057qib7	14821	4	donors	donor	NNS
cord-005453-4057qib7	14821	5	received	receive	VBD
cord-005453-4057qib7	14821	6	blood	blood	NN
cord-005453-4057qib7	14821	7	transfusions	transfusion	NNS
cord-005453-4057qib7	14821	8	.	.	.
cord-005453-4057qib7	14822	1	The	the	DT
cord-005453-4057qib7	14822	2	mean	mean	JJ
cord-005453-4057qib7	14822	3	reduction	reduction	NN
cord-005453-4057qib7	14822	4	of	of	IN
cord-005453-4057qib7	14822	5	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	14822	6	levels	level	NNS
cord-005453-4057qib7	14822	7	was	be	VBD
cord-005453-4057qib7	14822	8	2.5	2.5	CD
cord-005453-4057qib7	14822	9	g	g	NN
cord-005453-4057qib7	14822	10	/	/	SYM
cord-005453-4057qib7	14822	11	dl	dl	NN
cord-005453-4057qib7	14822	12	with	with	IN
cord-005453-4057qib7	14822	13	a	a	DT
cord-005453-4057qib7	14822	14	minimum	minimum	JJ
cord-005453-4057qib7	14822	15	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	14822	16	level	level	NN
cord-005453-4057qib7	14822	17	of	of	IN
cord-005453-4057qib7	14822	18	8.9g	8.9g	CD
cord-005453-4057qib7	14822	19	/	/	SYM
cord-005453-4057qib7	14822	20	dl	dl	NN
cord-005453-4057qib7	14822	21	and	and	CC
cord-005453-4057qib7	14822	22	a	a	DT
cord-005453-4057qib7	14822	23	persistent	persistent	JJ
cord-005453-4057qib7	14822	24	anemia	anemia	NN
cord-005453-4057qib7	14822	25	according	accord	VBG
cord-005453-4057qib7	14822	26	to	to	IN
cord-005453-4057qib7	14822	27	WHO	WHO	NNP
cord-005453-4057qib7	14822	28	criteria	criterion	NNS
cord-005453-4057qib7	14822	29	after	after	IN
cord-005453-4057qib7	14822	30	4	4	CD
cord-005453-4057qib7	14822	31	weeks	week	NNS
cord-005453-4057qib7	14822	32	in	in	IN
cord-005453-4057qib7	14822	33	7.9	7.9	CD
cord-005453-4057qib7	14822	34	%	%	NN
cord-005453-4057qib7	14822	35	and	and	CC
cord-005453-4057qib7	14822	36	pathologically	pathologically	RB
cord-005453-4057qib7	14822	37	low	low	JJ
cord-005453-4057qib7	14822	38	ferritin	ferritin	NN
cord-005453-4057qib7	14822	39	levels	level	NNS
cord-005453-4057qib7	14822	40	in	in	IN
cord-005453-4057qib7	14822	41	29	29	CD
cord-005453-4057qib7	14822	42	%	%	NN
cord-005453-4057qib7	14822	43	.	.	.
cord-005453-4057qib7	14823	1	No	no	DT
cord-005453-4057qib7	14823	2	donor	donor	NN
cord-005453-4057qib7	14823	3	presented	present	VBD
cord-005453-4057qib7	14823	4	symptoms	symptom	NNS
cord-005453-4057qib7	14823	5	with	with	IN
cord-005453-4057qib7	14823	6	indication	indication	NN
cord-005453-4057qib7	14823	7	for	for	IN
cord-005453-4057qib7	14823	8	blood	blood	NN
cord-005453-4057qib7	14823	9	transfusion	transfusion	NN
cord-005453-4057qib7	14823	10	.	.	.
cord-005453-4057qib7	14824	1	The	the	DT
cord-005453-4057qib7	14824	2	median	median	JJ
cord-005453-4057qib7	14824	3	WBC	WBC	NNP
cord-005453-4057qib7	14824	4	concentration	concentration	NN
cord-005453-4057qib7	14824	5	of	of	IN
cord-005453-4057qib7	14824	6	the	the	DT
cord-005453-4057qib7	14824	7	BM	BM	NNP
cord-005453-4057qib7	14824	8	product	product	NN
cord-005453-4057qib7	14824	9	was	be	VBD
cord-005453-4057qib7	14824	10	26.5	26.5	CD
cord-005453-4057qib7	14824	11	/	/	SYM
cord-005453-4057qib7	14824	12	nl	nl	NNP
cord-005453-4057qib7	14824	13	(	(	-LRB-
cord-005453-4057qib7	14824	14	5	5	CD
cord-005453-4057qib7	14824	15	-	-	SYM
cord-005453-4057qib7	14824	16	95	95	CD
cord-005453-4057qib7	14824	17	%	%	NN
cord-005453-4057qib7	14825	1	percentile:16.77	percentile:16.77	NNP
cord-005453-4057qib7	14825	2	-	-	HYPH
cord-005453-4057qib7	14825	3	38.75/	38.75/	NNP
cord-005453-4057qib7	14825	4	nl	nl	NN
cord-005453-4057qib7	14825	5	)	)	-RRB-
cord-005453-4057qib7	14826	1	the	the	DT
cord-005453-4057qib7	14826	2	CD34+cell	CD34+cell	NNP
cord-005453-4057qib7	14826	3	concentration	concentration	NN
cord-005453-4057qib7	14827	1	186.5	186.5	CD
cord-005453-4057qib7	14827	2	/	/	SYM
cord-005453-4057qib7	14827	3	μl	μl	XX
cord-005453-4057qib7	14828	1	(	(	-LRB-
cord-005453-4057qib7	14828	2	5	5	CD
cord-005453-4057qib7	14828	3	-	-	SYM
cord-005453-4057qib7	14828	4	95	95	CD
cord-005453-4057qib7	14828	5	%	%	NN
cord-005453-4057qib7	14828	6	percentile	percentile	NN
cord-005453-4057qib7	14828	7	:	:	:
cord-005453-4057qib7	14828	8	73.92	73.92	CD
cord-005453-4057qib7	14828	9	-	-	HYPH
cord-005453-4057qib7	14828	10	346.9	346.9	CD
cord-005453-4057qib7	14828	11	/	/	SYM
cord-005453-4057qib7	14828	12	μl	μl	NN
cord-005453-4057qib7	14828	13	)	)	-RRB-
cord-005453-4057qib7	14828	14	.	.	.
cord-005453-4057qib7	14829	1	In	in	IN
cord-005453-4057qib7	14829	2	the	the	DT
cord-005453-4057qib7	14829	3	linear	linear	JJ
cord-005453-4057qib7	14829	4	regression	regression	NN
cord-005453-4057qib7	14829	5	analysis	analysis	NN
cord-005453-4057qib7	14829	6	leukocyte	leukocyte	NN
cord-005453-4057qib7	14829	7	counts	count	VBZ
cord-005453-4057qib7	14829	8	of	of	IN
cord-005453-4057qib7	14829	9	the	the	DT
cord-005453-4057qib7	14829	10	donor	donor	NN
cord-005453-4057qib7	14829	11	before	before	IN
cord-005453-4057qib7	14829	12	donation	donation	NN
cord-005453-4057qib7	14829	13	correlated	correlate	VBD
cord-005453-4057qib7	14829	14	significantly	significantly	RB
cord-005453-4057qib7	14829	15	with	with	IN
cord-005453-4057qib7	14829	16	WBC	WBC	NNP
cord-005453-4057qib7	14829	17	concentration	concentration	NN
cord-005453-4057qib7	14829	18	in	in	IN
cord-005453-4057qib7	14829	19	the	the	DT
cord-005453-4057qib7	14829	20	product	product	NN
cord-005453-4057qib7	14829	21	.	.	.
cord-005453-4057qib7	14830	1	Thus	thus	RB
cord-005453-4057qib7	14830	2	in	in	IN
cord-005453-4057qib7	14830	3	order	order	NN
cord-005453-4057qib7	14830	4	to	to	TO
cord-005453-4057qib7	14830	5	collect	collect	VB
cord-005453-4057qib7	14830	6	with	with	IN
cord-005453-4057qib7	14830	7	90	90	CD
cord-005453-4057qib7	14830	8	%	%	NN
cord-005453-4057qib7	14830	9	certainty	certainty	NN
cord-005453-4057qib7	14830	10	the	the	DT
cord-005453-4057qib7	14830	11	300	300	CD
cord-005453-4057qib7	14830	12	Mio	Mio	NNP
cord-005453-4057qib7	14830	13	WBC	WBC	NNP
cord-005453-4057qib7	14830	14	which	which	WDT
cord-005453-4057qib7	14830	15	are	be	VBP
cord-005453-4057qib7	14830	16	a	a	DT
cord-005453-4057qib7	14830	17	typical	typical	JJ
cord-005453-4057qib7	14830	18	per	per	NN
cord-005453-4057qib7	14830	19	-	-	HYPH
cord-005453-4057qib7	14830	20	kg	kg	NN
cord-005453-4057qib7	14830	21	dose	dose	NN
cord-005453-4057qib7	14830	22	for	for	IN
cord-005453-4057qib7	14830	23	an	an	DT
cord-005453-4057qib7	14830	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	14830	25	recipient	recipient	NN
cord-005453-4057qib7	14830	26	,	,	,
cord-005453-4057qib7	14830	27	16.24	16.24	CD
cord-005453-4057qib7	14830	28	ml	ml	NNS
cord-005453-4057qib7	14830	29	of	of	IN
cord-005453-4057qib7	14830	30	bone	bone	NN
cord-005453-4057qib7	14830	31	marrow	marrow	NN
cord-005453-4057qib7	14830	32	must	must	MD
cord-005453-4057qib7	14830	33	be	be	VB
cord-005453-4057qib7	14830	34	collected	collect	VBN
cord-005453-4057qib7	14830	35	.	.	.
cord-005453-4057qib7	14831	1	Collection	collection	NN
cord-005453-4057qib7	14831	2	volume	volume	NN
cord-005453-4057qib7	14831	3	did	do	VBD
cord-005453-4057qib7	14831	4	not	not	RB
cord-005453-4057qib7	14831	5	systematically	systematically	RB
cord-005453-4057qib7	14831	6	affect	affect	VB
cord-005453-4057qib7	14831	7	WBC	WBC	NNP
cord-005453-4057qib7	14831	8	or	or	CC
cord-005453-4057qib7	14831	9	CD34	CD34	NNP
cord-005453-4057qib7	14831	10	+	+	CC
cord-005453-4057qib7	14831	11	cell	cell	NN
cord-005453-4057qib7	14831	12	concentration	concentration	NN
cord-005453-4057qib7	14831	13	.	.	.
cord-005453-4057qib7	14832	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14832	2	:	:	:
cord-005453-4057qib7	14833	1	Achieving	achieve	VBG
cord-005453-4057qib7	14833	2	high	high	JJ
cord-005453-4057qib7	14833	3	WBC	WBC	NNP
cord-005453-4057qib7	14833	4	yields	yield	NNS
cord-005453-4057qib7	14833	5	in	in	IN
cord-005453-4057qib7	14833	6	the	the	DT
cord-005453-4057qib7	14833	7	bone	bone	NN
cord-005453-4057qib7	14833	8	marrow	marrow	NN
cord-005453-4057qib7	14833	9	product	product	NN
cord-005453-4057qib7	14833	10	allowed	allow	VBN
cord-005453-4057qib7	14833	11	for	for	IN
cord-005453-4057qib7	14833	12	collection	collection	NN
cord-005453-4057qib7	14833	13	of	of	IN
cord-005453-4057qib7	14833	14	relatively	relatively	RB
cord-005453-4057qib7	14833	15	modest	modest	JJ
cord-005453-4057qib7	14833	16	BM	BM	NNP
cord-005453-4057qib7	14833	17	volumes	volume	NNS
cord-005453-4057qib7	14833	18	,	,	,
cord-005453-4057qib7	14833	19	thus	thus	RB
cord-005453-4057qib7	14833	20	protecting	protect	VBG
cord-005453-4057qib7	14833	21	donors	donor	NNS
cord-005453-4057qib7	14833	22	from	from	IN
cord-005453-4057qib7	14833	23	excessive	excessive	JJ
cord-005453-4057qib7	14833	24	blood	blood	NN
cord-005453-4057qib7	14833	25	loss	loss	NN
cord-005453-4057qib7	14833	26	.	.	.
cord-005453-4057qib7	14834	1	Acute	acute	JJ
cord-005453-4057qib7	14834	2	adverse	adverse	JJ
cord-005453-4057qib7	14834	3	events	event	NNS
cord-005453-4057qib7	14834	4	were	be	VBD
cord-005453-4057qib7	14834	5	acceptable	acceptable	JJ
cord-005453-4057qib7	14834	6	.	.	.
cord-005453-4057qib7	14835	1	Optimization	optimization	NN
cord-005453-4057qib7	14835	2	of	of	IN
cord-005453-4057qib7	14835	3	perioperative	perioperative	JJ
cord-005453-4057qib7	14835	4	management	management	NN
cord-005453-4057qib7	14835	5	in	in	IN
cord-005453-4057qib7	14835	6	healthy	healthy	JJ
cord-005453-4057qib7	14835	7	bone	bone	NN
cord-005453-4057qib7	14835	8	marrow	marrow	NN
cord-005453-4057qib7	14835	9	donors	donor	NNS
cord-005453-4057qib7	14835	10	may	may	MD
cord-005453-4057qib7	14835	11	be	be	VB
cord-005453-4057qib7	14835	12	achieved	achieve	VBN
cord-005453-4057qib7	14835	13	by	by	IN
cord-005453-4057qib7	14835	14	good	good	JJ
cord-005453-4057qib7	14835	15	collection	collection	NN
cord-005453-4057qib7	14835	16	technique	technique	NN
cord-005453-4057qib7	14835	17	and	and	CC
cord-005453-4057qib7	14835	18	reevaluation	reevaluation	NN
cord-005453-4057qib7	14835	19	of	of	IN
cord-005453-4057qib7	14835	20	WBC	WBC	NNP
cord-005453-4057qib7	14835	21	yields	yield	NNS
cord-005453-4057qib7	14835	22	of	of	IN
cord-005453-4057qib7	14835	23	each	each	DT
cord-005453-4057qib7	14835	24	institution	institution	NN
cord-005453-4057qib7	14835	25	to	to	TO
cord-005453-4057qib7	14835	26	calculate	calculate	VB
cord-005453-4057qib7	14835	27	required	require	VBN
cord-005453-4057qib7	14835	28	bone	bone	NN
cord-005453-4057qib7	14835	29	marrow	marrow	NN
cord-005453-4057qib7	14835	30	amount	amount	NN
cord-005453-4057qib7	14835	31	.	.	.
cord-005453-4057qib7	14836	1	The	the	DT
cord-005453-4057qib7	14836	2	collection	collection	NN
cord-005453-4057qib7	14836	3	of	of	IN
cord-005453-4057qib7	14836	4	autologous	autologous	JJ
cord-005453-4057qib7	14836	5	blood	blood	NN
cord-005453-4057qib7	14836	6	is	be	VBZ
cord-005453-4057qib7	14836	7	not	not	RB
cord-005453-4057qib7	14836	8	indicated	indicate	VBN
cord-005453-4057qib7	14836	9	.	.	.
cord-005453-4057qib7	14837	1	Furthermore	furthermore	RB
cord-005453-4057qib7	14837	2	stringent	stringent	JJ
cord-005453-4057qib7	14837	3	pre	pre	JJ
cord-005453-4057qib7	14837	4	-	-	JJ
cord-005453-4057qib7	14837	5	and	and	CC
cord-005453-4057qib7	14837	6	postoperative	postoperative	JJ
cord-005453-4057qib7	14837	7	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	14837	8	management	management	NN
cord-005453-4057qib7	14837	9	is	be	VBZ
cord-005453-4057qib7	14837	10	predicted	predict	VBN
cord-005453-4057qib7	14837	11	to	to	TO
cord-005453-4057qib7	14837	12	limit	limit	VB
cord-005453-4057qib7	14837	13	adverse	adverse	JJ
cord-005453-4057qib7	14837	14	effects	effect	NNS
cord-005453-4057qib7	14837	15	.	.	.
cord-005453-4057qib7	14838	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14838	2	:	:	:
cord-005453-4057qib7	14838	3	Nothing	nothing	NN
cord-005453-4057qib7	14838	4	to	to	TO
cord-005453-4057qib7	14838	5	declare	declare	VB
cord-005453-4057qib7	14838	6	.	.	.
cord-005453-4057qib7	14839	1	Donor	donor	NN
cord-005453-4057qib7	14839	2	-	-	HYPH
cord-005453-4057qib7	14839	3	recipient	recipient	NN
cord-005453-4057qib7	14839	4	weight	weight	NN
cord-005453-4057qib7	14839	5	ratio	ratio	NN
cord-005453-4057qib7	14839	6	predicts	predict	VBZ
cord-005453-4057qib7	14839	7	successful	successful	JJ
cord-005453-4057qib7	14839	8	stem	stem	NN
cord-005453-4057qib7	14839	9	cell	cell	NN
cord-005453-4057qib7	14839	10	mobilization	mobilization	NN
cord-005453-4057qib7	14839	11	on	on	IN
cord-005453-4057qib7	14839	12	day	day	NN
cord-005453-4057qib7	14839	13	four	four	CD
cord-005453-4057qib7	14839	14	of	of	IN
cord-005453-4057qib7	14839	15	GCSF	GCSF	NNP
cord-005453-4057qib7	14839	16	mobilization	mobilization	NN
cord-005453-4057qib7	14839	17	Results	result	NNS
cord-005453-4057qib7	14839	18	:	:	:
cord-005453-4057qib7	14839	19	In	in	IN
cord-005453-4057qib7	14839	20	Group	Group	NNP
cord-005453-4057qib7	14839	21	1	1	CD
cord-005453-4057qib7	14839	22	median	median	NN
cord-005453-4057qib7	14839	23	age	age	NN
cord-005453-4057qib7	14839	24	of	of	IN
cord-005453-4057qib7	14839	25	donor	donor	NN
cord-005453-4057qib7	14839	26	was	be	VBD
cord-005453-4057qib7	14839	27	41	41	CD
cord-005453-4057qib7	14839	28	years	year	NNS
cord-005453-4057qib7	14840	1	(	(	-LRB-
cord-005453-4057qib7	14840	2	range	range	VB
cord-005453-4057qib7	14840	3	19	19	CD
cord-005453-4057qib7	14840	4	to	to	TO
cord-005453-4057qib7	14840	5	51	51	CD
cord-005453-4057qib7	14840	6	years	year	NNS
cord-005453-4057qib7	14840	7	)	)	-RRB-
cord-005453-4057qib7	14840	8	.	.	.
cord-005453-4057qib7	14841	1	In	in	IN
cord-005453-4057qib7	14841	2	Group	group	NN
cord-005453-4057qib7	14841	3	2	2	CD
cord-005453-4057qib7	14841	4	median	median	NN
cord-005453-4057qib7	14841	5	age	age	NN
cord-005453-4057qib7	14841	6	of	of	IN
cord-005453-4057qib7	14841	7	donor	donor	NN
cord-005453-4057qib7	14841	8	was	be	VBD
cord-005453-4057qib7	14841	9	31years	31years	CD
cord-005453-4057qib7	14841	10	(	(	-LRB-
cord-005453-4057qib7	14841	11	range21	range21	NN
cord-005453-4057qib7	14841	12	to	to	IN
cord-005453-4057qib7	14841	13	48	48	CD
cord-005453-4057qib7	14841	14	years	year	NNS
cord-005453-4057qib7	14841	15	)	)	-RRB-
cord-005453-4057qib7	14841	16	.	.	.
cord-005453-4057qib7	14842	1	Table	table	NN
cord-005453-4057qib7	14842	2	]	]	-RRB-
cord-005453-4057qib7	14842	3	1	1	CD
cord-005453-4057qib7	14842	4	.	.	.
cord-005453-4057qib7	14843	1	Table	table	NN
cord-005453-4057qib7	14843	2	1	1	CD
cord-005453-4057qib7	14843	3	]	]	-RRB-
cord-005453-4057qib7	14843	4	elaborates	elaborate	VBZ
cord-005453-4057qib7	14843	5	other	other	JJ
cord-005453-4057qib7	14843	6	parameters	parameter	NNS
cord-005453-4057qib7	14843	7	analyzed	analyze	VBN
cord-005453-4057qib7	14843	8	between	between	IN
cord-005453-4057qib7	14843	9	the	the	DT
cord-005453-4057qib7	14843	10	two	two	CD
cord-005453-4057qib7	14843	11	groups	group	NNS
cord-005453-4057qib7	14843	12	.	.	.
cord-005453-4057qib7	14844	1	One	one	CD
cord-005453-4057qib7	14844	2	patient	patient	NN
cord-005453-4057qib7	14844	3	in	in	IN
cord-005453-4057qib7	14844	4	Group	Group	NNP
cord-005453-4057qib7	14844	5	1	1	CD
cord-005453-4057qib7	14844	6	developed	develop	VBD
cord-005453-4057qib7	14844	7	grade	grade	NN
cord-005453-4057qib7	14844	8	II	II	NNP
cord-005453-4057qib7	14844	9	acute	acute	JJ
cord-005453-4057qib7	14844	10	GVHD	GVHD	NNP
cord-005453-4057qib7	14844	11	whereas	whereas	IN
cord-005453-4057qib7	14844	12	3	3	CD
cord-005453-4057qib7	14844	13	patients	patient	NNS
cord-005453-4057qib7	14844	14	in	in	IN
cord-005453-4057qib7	14844	15	Group	Group	NNP
cord-005453-4057qib7	14844	16	2	2	CD
cord-005453-4057qib7	14844	17	developed	develop	VBD
cord-005453-4057qib7	14844	18	acute	acute	JJ
cord-005453-4057qib7	14844	19	GVHD	GVHD	NNP
cord-005453-4057qib7	14844	20	grade	grade	NN
cord-005453-4057qib7	14844	21	II	II	NNP
cord-005453-4057qib7	14844	22	-	-	HYPH
cord-005453-4057qib7	14844	23	IV	IV	NNP
cord-005453-4057qib7	14844	24	.	.	.
cord-005453-4057qib7	14845	1	At	at	IN
cord-005453-4057qib7	14845	2	the	the	DT
cord-005453-4057qib7	14845	3	last	last	JJ
cord-005453-4057qib7	14845	4	follow	follow	NN
cord-005453-4057qib7	14845	5	up	up	RP
cord-005453-4057qib7	14845	6	no	no	DT
cord-005453-4057qib7	14845	7	(	(	-LRB-
cord-005453-4057qib7	14845	8	0/9	0/9	CD
cord-005453-4057qib7	14845	9	)	)	-RRB-
cord-005453-4057qib7	14845	10	patient	patient	NN
cord-005453-4057qib7	14845	11	in	in	IN
cord-005453-4057qib7	14845	12	Group	Group	NNP
cord-005453-4057qib7	14845	13	1	1	CD
cord-005453-4057qib7	14845	14	has	have	VBZ
cord-005453-4057qib7	14845	15	any	any	DT
cord-005453-4057qib7	14845	16	symptoms	symptom	NNS
cord-005453-4057qib7	14845	17	of	of	IN
cord-005453-4057qib7	14845	18	chronic	chronic	JJ
cord-005453-4057qib7	14845	19	GVHD	GVHD	NNP
cord-005453-4057qib7	14845	20	whereas	whereas	IN
cord-005453-4057qib7	14845	21	(	(	-LRB-
cord-005453-4057qib7	14845	22	2/5	2/5	CD
cord-005453-4057qib7	14845	23	)	)	-RRB-
cord-005453-4057qib7	14845	24	patients	patient	NNS
cord-005453-4057qib7	14845	25	in	in	IN
cord-005453-4057qib7	14845	26	Group	Group	NNP
cord-005453-4057qib7	14845	27	2	2	CD
cord-005453-4057qib7	14845	28	have	have	VBP
cord-005453-4057qib7	14845	29	features	feature	NNS
cord-005453-4057qib7	14845	30	of	of	IN
cord-005453-4057qib7	14845	31	chronic	chronic	JJ
cord-005453-4057qib7	14845	32	GVHD	GVHD	NNP
cord-005453-4057qib7	14845	33	(	(	-LRB-
cord-005453-4057qib7	14846	1	one	one	CD
cord-005453-4057qib7	14846	2	extensive	extensive	JJ
cord-005453-4057qib7	14846	3	,	,	,
cord-005453-4057qib7	14846	4	one	one	CD
cord-005453-4057qib7	14846	5	limited	limited	JJ
cord-005453-4057qib7	14846	6	)	)	-RRB-
cord-005453-4057qib7	14846	7	.	.	.
cord-005453-4057qib7	14847	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14847	2	:	:	:
cord-005453-4057qib7	14848	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14848	2	observation	observation	NN
cord-005453-4057qib7	14848	3	suggests	suggest	VBZ
cord-005453-4057qib7	14848	4	that	that	IN
cord-005453-4057qib7	14848	5	upfront	upfront	JJ
cord-005453-4057qib7	14848	6	use	use	NN
cord-005453-4057qib7	14848	7	of	of	IN
cord-005453-4057qib7	14848	8	plerixafor	plerixafor	NN
cord-005453-4057qib7	14848	9	in	in	IN
cord-005453-4057qib7	14848	10	combination	combination	NN
cord-005453-4057qib7	14848	11	with	with	IN
cord-005453-4057qib7	14848	12	GCSF	GCSF	NNP
cord-005453-4057qib7	14848	13	modifies	modify	VBZ
cord-005453-4057qib7	14848	14	the	the	DT
cord-005453-4057qib7	14848	15	graft	graft	NN
cord-005453-4057qib7	14848	16	favorably	favorably	RB
cord-005453-4057qib7	14848	17	decreasing	decrease	VBG
cord-005453-4057qib7	14848	18	the	the	DT
cord-005453-4057qib7	14848	19	risk	risk	NN
cord-005453-4057qib7	14848	20	of	of	IN
cord-005453-4057qib7	14848	21	graft	graft	NN
cord-005453-4057qib7	14848	22	failure	failure	NN
cord-005453-4057qib7	14848	23	and	and	CC
cord-005453-4057qib7	14848	24	graft	graft	NN
cord-005453-4057qib7	14848	25	versus	versus	IN
cord-005453-4057qib7	14848	26	host	host	NN
cord-005453-4057qib7	14848	27	disease	disease	NN
cord-005453-4057qib7	14848	28	both	both	CC
cord-005453-4057qib7	14848	29	acute	acute	JJ
cord-005453-4057qib7	14848	30	and	and	CC
cord-005453-4057qib7	14848	31	chronic	chronic	JJ
cord-005453-4057qib7	14848	32	.	.	.
cord-005453-4057qib7	14849	1	It	-PRON-	PRP
cord-005453-4057qib7	14849	2	also	also	RB
cord-005453-4057qib7	14849	3	helps	help	VBZ
cord-005453-4057qib7	14849	4	the	the	DT
cord-005453-4057qib7	14849	5	donor	donor	NN
cord-005453-4057qib7	14849	6	by	by	IN
cord-005453-4057qib7	14849	7	decreasing	decrease	VBG
cord-005453-4057qib7	14849	8	the	the	DT
cord-005453-4057qib7	14849	9	total	total	JJ
cord-005453-4057qib7	14849	10	volume	volume	NN
cord-005453-4057qib7	14849	11	processed	process	VBN
cord-005453-4057qib7	14849	12	,	,	,
cord-005453-4057qib7	14849	13	amount	amount	NN
cord-005453-4057qib7	14849	14	of	of	IN
cord-005453-4057qib7	14849	15	ACD	ACD	NNP
cord-005453-4057qib7	14849	16	exposure	exposure	NN
cord-005453-4057qib7	14849	17	and	and	CC
cord-005453-4057qib7	14849	18	the	the	DT
cord-005453-4057qib7	14849	19	duration	duration	NN
cord-005453-4057qib7	14849	20	of	of	IN
cord-005453-4057qib7	14849	21	harvest	harvest	NN
cord-005453-4057qib7	14849	22	.	.	.
cord-005453-4057qib7	14850	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14850	2	:	:	:
cord-005453-4057qib7	14850	3	None	none	NN
cord-005453-4057qib7	14850	4	.	.	.
cord-005453-4057qib7	14851	1	Impact	impact	NN
cord-005453-4057qib7	14851	2	of	of	IN
cord-005453-4057qib7	14851	3	vitamin	vitamin	NN
cord-005453-4057qib7	14851	4	D	d	NN
cord-005453-4057qib7	14851	5	levels	level	NNS
cord-005453-4057qib7	14851	6	on	on	IN
cord-005453-4057qib7	14851	7	peripheral	peripheral	JJ
cord-005453-4057qib7	14851	8	stem	stem	NN
cord-005453-4057qib7	14851	9	cell	cell	NN
cord-005453-4057qib7	14851	10	mobilization	mobilization	NN
cord-005453-4057qib7	14851	11	in	in	IN
cord-005453-4057qib7	14851	12	autologous	autologous	JJ
cord-005453-4057qib7	14851	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14851	14	stem	stem	NN
cord-005453-4057qib7	14851	15	cell	cell	NN
cord-005453-4057qib7	14851	16	transplant	transplant	NN
cord-005453-4057qib7	14851	17	recipients	recipient	NNS
cord-005453-4057qib7	14852	1	Ferda	Ferda	NNP
cord-005453-4057qib7	14852	2	Can	Can	NNP
cord-005453-4057qib7	14852	3	1	1	CD
cord-005453-4057qib7	14852	4	,	,	,
cord-005453-4057qib7	14852	5	Zeynep	Zeynep	NNP
cord-005453-4057qib7	14852	6	Arzu	Arzu	NNP
cord-005453-4057qib7	14852	7	Yegin	Yegin	NNP
cord-005453-4057qib7	14852	8	1	1	CD
cord-005453-4057qib7	14852	9	,	,	,
cord-005453-4057qib7	14852	10	Zubeyde	Zubeyde	NNP
cord-005453-4057qib7	14852	11	Nur	Nur	NNP
cord-005453-4057qib7	14852	12	Ozkurt	Ozkurt	NNP
cord-005453-4057qib7	14852	13	1	1	CD
cord-005453-4057qib7	14852	14	,	,	,
cord-005453-4057qib7	14852	15	Orhun	Orhun	NNP
cord-005453-4057qib7	14852	16	Akdogan	Akdogan	NNP
cord-005453-4057qib7	14852	17	1	1	CD
cord-005453-4057qib7	14852	18	,	,	,
cord-005453-4057qib7	14852	19	Lale	Lale	NNP
cord-005453-4057qib7	14852	20	Aydın	Aydın	NNP
cord-005453-4057qib7	14852	21	Kaynar	Kaynar	NNP
cord-005453-4057qib7	14852	22	1	1	CD
cord-005453-4057qib7	14852	23	and	and	CC
cord-005453-4057qib7	14852	24	total	total	JJ
cord-005453-4057qib7	14852	25	product	product	NN
cord-005453-4057qib7	14853	1	CD34	CD34	NNP
cord-005453-4057qib7	14853	2	+	+	CC
cord-005453-4057qib7	14853	3	cell	cell	NN
cord-005453-4057qib7	14853	4	count	count	NN
cord-005453-4057qib7	14853	5	[	[	-LRB-
cord-005453-4057qib7	14853	6	6.7(02.8	6.7(02.8	CD
cord-005453-4057qib7	14853	7	-	-	SYM
cord-005453-4057qib7	14853	8	15	15	CD
cord-005453-4057qib7	14853	9	)	)	-RRB-
cord-005453-4057qib7	14853	10	vs	vs	IN
cord-005453-4057qib7	14853	11	5.9	5.9	CD
cord-005453-4057qib7	14853	12	(	(	-LRB-
cord-005453-4057qib7	14853	13	2.9	2.9	CD
cord-005453-4057qib7	14853	14	-	-	SYM
cord-005453-4057qib7	14853	15	17.2	17.2	CD
cord-005453-4057qib7	14853	16	)	)	-RRB-
cord-005453-4057qib7	14854	1	;	;	:
cord-005453-4057qib7	14854	2	p=0.047	p=0.047	NNS
cord-005453-4057qib7	14854	3	]	]	-RRB-
cord-005453-4057qib7	14854	4	were	be	VBD
cord-005453-4057qib7	14854	5	significantly	significantly	RB
cord-005453-4057qib7	14854	6	higher	high	JJR
cord-005453-4057qib7	14854	7	in	in	IN
cord-005453-4057qib7	14854	8	patients	patient	NNS
cord-005453-4057qib7	14854	9	receiving	receive	VBG
cord-005453-4057qib7	14854	10	chemotherapy+G	chemotherapy+g	NN
cord-005453-4057qib7	14854	11	-	-	HYPH
cord-005453-4057qib7	14854	12	CSF	csf	NN
cord-005453-4057qib7	14854	13	than	than	IN
cord-005453-4057qib7	14854	14	G	G	NNP
cord-005453-4057qib7	14854	15	-	-	HYPH
cord-005453-4057qib7	14854	16	CSF	CSF	NNP
cord-005453-4057qib7	14854	17	only	only	RB
cord-005453-4057qib7	14854	18	.	.	.
cord-005453-4057qib7	14855	1	The	the	DT
cord-005453-4057qib7	14855	2	study	study	NN
cord-005453-4057qib7	14855	3	group	group	NN
cord-005453-4057qib7	14855	4	was	be	VBD
cord-005453-4057qib7	14855	5	divided	divide	VBN
cord-005453-4057qib7	14855	6	into	into	IN
cord-005453-4057qib7	14855	7	two	two	CD
cord-005453-4057qib7	14855	8	groups	group	NNS
cord-005453-4057qib7	14855	9	based	base	VBN
cord-005453-4057qib7	14855	10	on	on	IN
cord-005453-4057qib7	14855	11	peripheral	peripheral	JJ
cord-005453-4057qib7	14855	12	CD34	CD34	NNP
cord-005453-4057qib7	14855	13	(	(	-LRB-
cord-005453-4057qib7	14855	14	cut	cut	VB
cord-005453-4057qib7	14855	15	-	-	HYPH
cord-005453-4057qib7	14855	16	off	off	RP
cord-005453-4057qib7	14855	17	level	level	NN
cord-005453-4057qib7	14855	18	:	:	:
cord-005453-4057qib7	14855	19	20x10	20x10	CD
cord-005453-4057qib7	14855	20	6	6	CD
cord-005453-4057qib7	14855	21	/kg	/kg	.
cord-005453-4057qib7	14855	22	)	)	-RRB-
cord-005453-4057qib7	14855	23	as	as	RB
cord-005453-4057qib7	14855	24	well	well	RB
cord-005453-4057qib7	14855	25	as	as	IN
cord-005453-4057qib7	14855	26	product	product	NN
cord-005453-4057qib7	14855	27	CD34	CD34	NNP
cord-005453-4057qib7	14855	28	levels	level	NNS
cord-005453-4057qib7	14855	29	(	(	-LRB-
cord-005453-4057qib7	14855	30	cut	cut	VB
cord-005453-4057qib7	14855	31	-	-	HYPH
cord-005453-4057qib7	14855	32	off	off	RP
cord-005453-4057qib7	14855	33	level	level	NN
cord-005453-4057qib7	14855	34	:	:	:
cord-005453-4057qib7	14855	35	5x10	5x10	CD
cord-005453-4057qib7	14855	36	6	6	CD
cord-005453-4057qib7	14855	37	/kg	/kg	NFP
cord-005453-4057qib7	14855	38	)	)	-RRB-
cord-005453-4057qib7	14855	39	.	.	.
cord-005453-4057qib7	14856	1	Vitamin	vitamin	NN
cord-005453-4057qib7	14856	2	D	d	NN
cord-005453-4057qib7	14856	3	levels	level	NNS
cord-005453-4057qib7	14856	4	were	be	VBD
cord-005453-4057qib7	14856	5	found	find	VBN
cord-005453-4057qib7	14856	6	to	to	TO
cord-005453-4057qib7	14856	7	be	be	VB
cord-005453-4057qib7	14856	8	similar	similar	JJ
cord-005453-4057qib7	14856	9	among	among	IN
cord-005453-4057qib7	14856	10	these	these	DT
cord-005453-4057qib7	14856	11	groups	group	NNS
cord-005453-4057qib7	14856	12	(	(	-LRB-
cord-005453-4057qib7	14856	13	p>0.05	p>0.05	NNP
cord-005453-4057qib7	14856	14	)	)	-RRB-
cord-005453-4057qib7	14856	15	.	.	.
cord-005453-4057qib7	14857	1	Total	total	JJ
cord-005453-4057qib7	14857	2	product	product	NN
cord-005453-4057qib7	14858	1	CD34	CD34	NNP
cord-005453-4057qib7	14858	2	+	+	CC
cord-005453-4057qib7	14858	3	cell	cell	NN
cord-005453-4057qib7	14858	4	count	count	NN
cord-005453-4057qib7	14858	5	was	be	VBD
cord-005453-4057qib7	14858	6	found	find	VBN
cord-005453-4057qib7	14858	7	to	to	TO
cord-005453-4057qib7	14858	8	be	be	VB
cord-005453-4057qib7	14858	9	relatively	relatively	RB
cord-005453-4057qib7	14858	10	lower	low	JJR
cord-005453-4057qib7	14858	11	in	in	IN
cord-005453-4057qib7	14858	12	patients	patient	NNS
cord-005453-4057qib7	14858	13	with	with	IN
cord-005453-4057qib7	14858	14	vitamin	vitamin	NN
cord-005453-4057qib7	14858	15	D	d	NN
cord-005453-4057qib7	14858	16	levels	level	NNS
cord-005453-4057qib7	14858	17	below	below	IN
cord-005453-4057qib7	14858	18	10	10	CD
cord-005453-4057qib7	14858	19	μg	μg	NNP
cord-005453-4057qib7	14858	20	/	/	SYM
cord-005453-4057qib7	14858	21	L	L	NNP
cord-005453-4057qib7	14858	22	[	[	-LRB-
cord-005453-4057qib7	14858	23	5.6(3.3	5.6(3.3	CD
cord-005453-4057qib7	14858	24	-	-	SYM
cord-005453-4057qib7	14858	25	10	10	CD
cord-005453-4057qib7	14858	26	)	)	-RRB-
cord-005453-4057qib7	14858	27	vs	vs	IN
cord-005453-4057qib7	14858	28	6.7(2.8	6.7(2.8	CD
cord-005453-4057qib7	14858	29	-	-	HYPH
cord-005453-4057qib7	14858	30	17.2	17.2	CD
cord-005453-4057qib7	14858	31	)	)	-RRB-
cord-005453-4057qib7	14858	32	;	;	:
cord-005453-4057qib7	14858	33	p=0,09	p=0,09	NNP
cord-005453-4057qib7	14858	34	]	]	-RRB-
cord-005453-4057qib7	14858	35	.	.	.
cord-005453-4057qib7	14859	1	(	(	-LRB-
cord-005453-4057qib7	14859	2	Figure	figure	NN
cord-005453-4057qib7	14859	3	1	1	CD
cord-005453-4057qib7	14859	4	)	)	-RRB-
cord-005453-4057qib7	14860	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14860	2	:	:	:
cord-005453-4057qib7	14861	1	Based	base	VBN
cord-005453-4057qib7	14861	2	on	on	IN
cord-005453-4057qib7	14861	3	its	-PRON-	PRP$
cord-005453-4057qib7	14861	4	effect	effect	NN
cord-005453-4057qib7	14861	5	on	on	IN
cord-005453-4057qib7	14861	6	stem	stem	NN
cord-005453-4057qib7	14861	7	cells	cell	NNS
cord-005453-4057qib7	14861	8	in	in	IN
cord-005453-4057qib7	14861	9	in	in	IN
cord-005453-4057qib7	14861	10	vitro	vitro	FW
cord-005453-4057qib7	14861	11	studies	study	NNS
cord-005453-4057qib7	14861	12	,	,	,
cord-005453-4057qib7	14861	13	it	-PRON-	PRP
cord-005453-4057qib7	14861	14	may	may	MD
cord-005453-4057qib7	14861	15	be	be	VB
cord-005453-4057qib7	14861	16	considered	consider	VBN
cord-005453-4057qib7	14861	17	that	that	IN
cord-005453-4057qib7	14861	18	vitamin	vitamin	NN
cord-005453-4057qib7	14861	19	D	d	NN
cord-005453-4057qib7	14861	20	may	may	MD
cord-005453-4057qib7	14861	21	have	have	VB
cord-005453-4057qib7	14861	22	a	a	DT
cord-005453-4057qib7	14861	23	favourable	favourable	JJ
cord-005453-4057qib7	14861	24	impact	impact	NN
cord-005453-4057qib7	14861	25	on	on	IN
cord-005453-4057qib7	14861	26	stem	stem	NN
cord-005453-4057qib7	14861	27	cell	cell	NN
cord-005453-4057qib7	14861	28	mobilization	mobilization	NN
cord-005453-4057qib7	14861	29	.	.	.
cord-005453-4057qib7	14862	1	Statistically	statistically	RB
cord-005453-4057qib7	14862	2	insignificant	insignificant	JJ
cord-005453-4057qib7	14862	3	but	but	CC
cord-005453-4057qib7	14862	4	relatively	relatively	RB
cord-005453-4057qib7	14862	5	lower	low	JJR
cord-005453-4057qib7	14862	6	total	total	JJ
cord-005453-4057qib7	14862	7	product	product	NN
cord-005453-4057qib7	14863	1	CD34	CD34	NNP
cord-005453-4057qib7	14863	2	+	+	CC
cord-005453-4057qib7	14863	3	cell	cell	NN
cord-005453-4057qib7	14863	4	count	count	NN
cord-005453-4057qib7	14863	5	in	in	IN
cord-005453-4057qib7	14863	6	patients	patient	NNS
cord-005453-4057qib7	14863	7	who	who	WP
cord-005453-4057qib7	14863	8	had	have	VBD
cord-005453-4057qib7	14863	9	lower	low	JJR
cord-005453-4057qib7	14863	10	vitamin	vitamin	NN
cord-005453-4057qib7	14863	11	D	d	NN
cord-005453-4057qib7	14863	12	levels	level	NNS
cord-005453-4057qib7	14863	13	,	,	,
cord-005453-4057qib7	14863	14	which	which	WDT
cord-005453-4057qib7	14863	15	may	may	MD
cord-005453-4057qib7	14863	16	indicate	indicate	VB
cord-005453-4057qib7	14863	17	a	a	DT
cord-005453-4057qib7	14863	18	role	role	NN
cord-005453-4057qib7	14863	19	for	for	IN
cord-005453-4057qib7	14863	20	vitamin	vitamin	NN
cord-005453-4057qib7	14863	21	D	d	NN
cord-005453-4057qib7	14863	22	in	in	IN
cord-005453-4057qib7	14863	23	stem	stem	NN
cord-005453-4057qib7	14863	24	cell	cell	NN
cord-005453-4057qib7	14863	25	mobilization	mobilization	NN
cord-005453-4057qib7	14863	26	,	,	,
cord-005453-4057qib7	14863	27	needs	need	VBZ
cord-005453-4057qib7	14863	28	to	to	TO
cord-005453-4057qib7	14863	29	be	be	VB
cord-005453-4057qib7	14863	30	confirmed	confirm	VBN
cord-005453-4057qib7	14863	31	with	with	IN
cord-005453-4057qib7	14863	32	larger	large	JJR
cord-005453-4057qib7	14863	33	studies	study	NNS
cord-005453-4057qib7	14863	34	.	.	.
cord-005453-4057qib7	14864	1	Considering	consider	VBG
cord-005453-4057qib7	14864	2	the	the	DT
cord-005453-4057qib7	14864	3	high	high	JJ
cord-005453-4057qib7	14864	4	prevalence	prevalence	NN
cord-005453-4057qib7	14864	5	of	of	IN
cord-005453-4057qib7	14864	6	vitamin	vitamin	NN
cord-005453-4057qib7	14864	7	D	d	NN
cord-005453-4057qib7	14864	8	deficiency	deficiency	NN
cord-005453-4057qib7	14864	9	in	in	IN
cord-005453-4057qib7	14864	10	the	the	DT
cord-005453-4057qib7	14864	11	general	general	JJ
cord-005453-4057qib7	14864	12	population	population	NN
cord-005453-4057qib7	14864	13	,	,	,
cord-005453-4057qib7	14864	14	the	the	DT
cord-005453-4057qib7	14864	15	possible	possible	JJ
cord-005453-4057qib7	14864	16	role	role	NN
cord-005453-4057qib7	14864	17	of	of	IN
cord-005453-4057qib7	14864	18	vitamin	vitamin	NN
cord-005453-4057qib7	14864	19	D	d	NN
cord-005453-4057qib7	14864	20	in	in	IN
cord-005453-4057qib7	14864	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14864	22	stem	stem	NN
cord-005453-4057qib7	14864	23	cell	cell	NN
cord-005453-4057qib7	14864	24	mobilization	mobilization	NN
cord-005453-4057qib7	14864	25	deserves	deserve	VBZ
cord-005453-4057qib7	14864	26	further	further	JJ
cord-005453-4057qib7	14864	27	consideration	consideration	NN
cord-005453-4057qib7	14864	28	.	.	.
cord-005453-4057qib7	14865	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14865	2	:	:	:
cord-005453-4057qib7	14865	3	Nothing	nothing	NN
cord-005453-4057qib7	14865	4	to	to	TO
cord-005453-4057qib7	14865	5	declare	declare	VB
cord-005453-4057qib7	14865	6	Background	background	NN
cord-005453-4057qib7	14865	7	:	:	:
cord-005453-4057qib7	14866	1	One	one	CD
cord-005453-4057qib7	14866	2	of	of	IN
cord-005453-4057qib7	14866	3	the	the	DT
cord-005453-4057qib7	14866	4	factors	factor	NNS
cord-005453-4057qib7	14866	5	,	,	,
cord-005453-4057qib7	14866	6	affecting	affect	VBG
cord-005453-4057qib7	14866	7	efficiency	efficiency	NN
cord-005453-4057qib7	14866	8	of	of	IN
cord-005453-4057qib7	14866	9	autologous	autologous	JJ
cord-005453-4057qib7	14866	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14866	11	stem	stem	NN
cord-005453-4057qib7	14866	12	cell	cell	NN
cord-005453-4057qib7	14866	13	transplantation	transplantation	NN
cord-005453-4057qib7	14866	14	(	(	-LRB-
cord-005453-4057qib7	14866	15	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	14866	16	)	)	-RRB-
cord-005453-4057qib7	14866	17	in	in	IN
cord-005453-4057qib7	14866	18	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	14866	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	14866	20	(	(	-LRB-
cord-005453-4057qib7	14866	21	HL	HL	NNP
cord-005453-4057qib7	14866	22	)	)	-RRB-
cord-005453-4057qib7	14866	23	patients	patient	NNS
cord-005453-4057qib7	14866	24	is	be	VBZ
cord-005453-4057qib7	14866	25	early	early	JJ
cord-005453-4057qib7	14866	26	recovery	recovery	NN
cord-005453-4057qib7	14866	27	of	of	IN
cord-005453-4057qib7	14866	28	graft	graft	NN
cord-005453-4057qib7	14866	29	,	,	,
cord-005453-4057qib7	14866	30	depending	depend	VBG
cord-005453-4057qib7	14866	31	on	on	IN
cord-005453-4057qib7	14866	32	CD	CD	NNP
cord-005453-4057qib7	14866	33	34	34	CD
cord-005453-4057qib7	14866	34	+	+	CD
cord-005453-4057qib7	14866	35	cell	cell	NN
cord-005453-4057qib7	14866	36	count	count	NN
cord-005453-4057qib7	14866	37	and	and	CC
cord-005453-4057qib7	14866	38	conditions	condition	NNS
cord-005453-4057qib7	14866	39	of	of	IN
cord-005453-4057qib7	14866	40	cell	cell	NN
cord-005453-4057qib7	14866	41	product	product	NN
cord-005453-4057qib7	14866	42	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14866	43	and	and	CC
cord-005453-4057qib7	14866	44	storage	storage	NN
cord-005453-4057qib7	14866	45	.	.	.
cord-005453-4057qib7	14867	1	It	-PRON-	PRP
cord-005453-4057qib7	14867	2	is	be	VBZ
cord-005453-4057qib7	14867	3	well	well	RB
cord-005453-4057qib7	14867	4	known	known	JJ
cord-005453-4057qib7	14867	5	,	,	,
cord-005453-4057qib7	14867	6	that	that	IN
cord-005453-4057qib7	14867	7	dimethylsulfoxide	dimethylsulfoxide	NN
cord-005453-4057qib7	14867	8	(	(	-LRB-
cord-005453-4057qib7	14867	9	DMSO	DMSO	NNP
cord-005453-4057qib7	14867	10	)	)	-RRB-
cord-005453-4057qib7	14867	11	,	,	,
cord-005453-4057qib7	14867	12	used	use	VBN
cord-005453-4057qib7	14867	13	for	for	IN
cord-005453-4057qib7	14867	14	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14867	15	,	,	,
cord-005453-4057qib7	14867	16	can	can	MD
cord-005453-4057qib7	14867	17	be	be	VB
cord-005453-4057qib7	14867	18	cardiotoxic	cardiotoxic	JJ
cord-005453-4057qib7	14867	19	and	and	CC
cord-005453-4057qib7	14867	20	cause	cause	VB
cord-005453-4057qib7	14868	1	diverse	diverse	JJ
cord-005453-4057qib7	14868	2	gastrointestinal	gastrointestinal	JJ
cord-005453-4057qib7	14868	3	,	,	,
cord-005453-4057qib7	14868	4	pulmonary	pulmonary	JJ
cord-005453-4057qib7	14868	5	,	,	,
cord-005453-4057qib7	14868	6	kidney	kidney	NN
cord-005453-4057qib7	14868	7	,	,	,
cord-005453-4057qib7	14868	8	liver	liver	NN
cord-005453-4057qib7	14868	9	side	side	NN
cord-005453-4057qib7	14868	10	effects	effect	NNS
cord-005453-4057qib7	14868	11	and	and	CC
cord-005453-4057qib7	14868	12	acute	acute	JJ
cord-005453-4057qib7	14868	13	hemolysis	hemolysis	NN
cord-005453-4057qib7	14868	14	.	.	.
cord-005453-4057qib7	14869	1	Lethal	lethal	JJ
cord-005453-4057qib7	14869	2	for	for	IN
cord-005453-4057qib7	14869	3	animals	animal	NNS
cord-005453-4057qib7	14869	4	dose	dose	VBP
cord-005453-4057qib7	14870	1	30	30	CD
cord-005453-4057qib7	14870	2	-	-	SYM
cord-005453-4057qib7	14870	3	40	40	CD
cord-005453-4057qib7	14870	4	mg	mg	NNP
cord-005453-4057qib7	14870	5	/	/	SYM
cord-005453-4057qib7	14870	6	kg	kg	NNP
cord-005453-4057qib7	14870	7	leads	lead	VBZ
cord-005453-4057qib7	14870	8	to	to	IN
cord-005453-4057qib7	14870	9	life	life	NN
cord-005453-4057qib7	14870	10	threatening	threaten	VBG
cord-005453-4057qib7	14870	11	arrhythmias	arrhythmia	NNS
cord-005453-4057qib7	14870	12	and	and	CC
cord-005453-4057qib7	14870	13	respiratory	respiratory	JJ
cord-005453-4057qib7	14870	14	arrest	arrest	NN
cord-005453-4057qib7	14870	15	.	.	.
cord-005453-4057qib7	14871	1	In	in	IN
cord-005453-4057qib7	14871	2	order	order	NN
cord-005453-4057qib7	14871	3	to	to	TO
cord-005453-4057qib7	14871	4	improve	improve	VB
cord-005453-4057qib7	14871	5	DMSO	DMSO	NNP
cord-005453-4057qib7	14871	6	toxicity	toxicity	NN
cord-005453-4057qib7	14871	7	different	different	JJ
cord-005453-4057qib7	14871	8	ways	way	NNS
cord-005453-4057qib7	14871	9	of	of	IN
cord-005453-4057qib7	14871	10	alternative	alternative	JJ
cord-005453-4057qib7	14871	11	cryoconservation	cryoconservation	NN
cord-005453-4057qib7	14871	12	modes	mode	NNS
cord-005453-4057qib7	14871	13	are	be	VBP
cord-005453-4057qib7	14871	14	studied	study	VBN
cord-005453-4057qib7	14871	15	-lower	-lower	.
cord-005453-4057qib7	14872	1	DMSO	DMSO	NNP
cord-005453-4057qib7	14872	2	concentration	concentration	NN
cord-005453-4057qib7	14872	3	(	(	-LRB-
cord-005453-4057qib7	14872	4	5	5	CD
cord-005453-4057qib7	14872	5	%	%	NN
cord-005453-4057qib7	14872	6	VS	VS	NNP
cord-005453-4057qib7	14872	7	10	10	CD
cord-005453-4057qib7	14872	8	%	%	NN
cord-005453-4057qib7	14872	9	)	)	-RRB-
cord-005453-4057qib7	14872	10	,	,	,
cord-005453-4057qib7	14872	11	temperature	temperature	NN
cord-005453-4057qib7	14872	12	-80˚C	-80˚c	NN
cord-005453-4057qib7	14872	13	instead	instead	RB
cord-005453-4057qib7	14872	14	of	of	IN
cord-005453-4057qib7	14872	15	ultra	ultra	JJ
cord-005453-4057qib7	14872	16	-	-	JJ
cord-005453-4057qib7	14872	17	low	low	JJ
cord-005453-4057qib7	14872	18	and	and	CC
cord-005453-4057qib7	14872	19	washing	washing	NN
cord-005453-4057qib7	14872	20	of	of	IN
cord-005453-4057qib7	14872	21	cell	cell	NN
cord-005453-4057qib7	14872	22	product	product	NN
cord-005453-4057qib7	14872	23	.	.	.
cord-005453-4057qib7	14873	1	Aim	Aim	NNP
cord-005453-4057qib7	14873	2	of	of	IN
cord-005453-4057qib7	14873	3	the	the	DT
cord-005453-4057qib7	14873	4	study	study	NN
cord-005453-4057qib7	14873	5	is	be	VBZ
cord-005453-4057qib7	14873	6	to	to	TO
cord-005453-4057qib7	14873	7	evaluate	evaluate	VB
cord-005453-4057qib7	14873	8	the	the	DT
cord-005453-4057qib7	14873	9	influence	influence	NN
cord-005453-4057qib7	14873	10	of	of	IN
cord-005453-4057qib7	14873	11	DMSO	DMSO	NNP
cord-005453-4057qib7	14873	12	washing	wash	VBG
cord-005453-4057qib7	14873	13	on	on	IN
cord-005453-4057qib7	14873	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14873	15	recovery	recovery	NN
cord-005453-4057qib7	14873	16	after	after	IN
cord-005453-4057qib7	14873	17	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	14873	18	.	.	.
cord-005453-4057qib7	14874	1	Methods	method	NNS
cord-005453-4057qib7	14874	2	:	:	:
cord-005453-4057qib7	14875	1	Retrospective	retrospective	JJ
cord-005453-4057qib7	14875	2	analysis	analysis	NN
cord-005453-4057qib7	14875	3	of	of	IN
cord-005453-4057qib7	14875	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14875	5	recovery	recovery	NN
cord-005453-4057qib7	14875	6	of	of	IN
cord-005453-4057qib7	14875	7	37	37	CD
cord-005453-4057qib7	14875	8	relapse	relapse	NN
cord-005453-4057qib7	14875	9	/	/	SYM
cord-005453-4057qib7	14875	10	refractory	refractory	JJ
cord-005453-4057qib7	14875	11	HL	HL	NNP
cord-005453-4057qib7	14875	12	patients	patient	NNS
cord-005453-4057qib7	14875	13	after	after	IN
cord-005453-4057qib7	14875	14	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	14875	15	was	be	VBD
cord-005453-4057qib7	14875	16	performed	perform	VBN
cord-005453-4057qib7	14875	17	.	.	.
cord-005453-4057qib7	14876	1	Mobilization	mobilization	NN
cord-005453-4057qib7	14876	2	regimen	regimen	NN
cord-005453-4057qib7	14876	3	included	include	VBD
cord-005453-4057qib7	14876	4	second	second	JJ
cord-005453-4057qib7	14876	5	line	line	NN
cord-005453-4057qib7	14876	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14876	7	for	for	IN
cord-005453-4057qib7	14876	8	HL	HL	NNP
cord-005453-4057qib7	14876	9	(	(	-LRB-
cord-005453-4057qib7	14876	10	DHAP	DHAP	NNP
cord-005453-4057qib7	14876	11	,	,	,
cord-005453-4057qib7	14876	12	BeGEV	begev	UH
cord-005453-4057qib7	14876	13	,	,	,
cord-005453-4057qib7	14876	14	IGEV	IGEV	NNP
cord-005453-4057qib7	14876	15	,	,	,
cord-005453-4057qib7	14876	16	ICE	ice	NN
cord-005453-4057qib7	14876	17	)	)	-RRB-
cord-005453-4057qib7	14876	18	with	with	IN
cord-005453-4057qib7	14876	19	consecutive	consecutive	JJ
cord-005453-4057qib7	14876	20	G	G	NNP
cord-005453-4057qib7	14876	21	-	-	HYPH
cord-005453-4057qib7	14876	22	CSF	CSF	NNP
cord-005453-4057qib7	14876	23	administration	administration	NN
cord-005453-4057qib7	14876	24	.	.	.
cord-005453-4057qib7	14877	1	CD	CD	NNP
cord-005453-4057qib7	14877	2	34	34	CD
cord-005453-4057qib7	14877	3	+	+	SYM
cord-005453-4057qib7	14877	4	cells	cell	NNS
cord-005453-4057qib7	14877	5	were	be	VBD
cord-005453-4057qib7	14877	6	assessed	assess	VBN
cord-005453-4057qib7	14877	7	,	,	,
cord-005453-4057qib7	14877	8	using	use	VBG
cord-005453-4057qib7	14877	9	6-colour	6-colour	CD
cord-005453-4057qib7	14877	10	flow	flow	NN
cord-005453-4057qib7	14877	11	cytometer	cytometer	NN
cord-005453-4057qib7	14877	12	FACS	FACS	NNP
cord-005453-4057qib7	14877	13	Canto	Canto	NNP
cord-005453-4057qib7	14877	14	II	II	NNP
cord-005453-4057qib7	14877	15	while	while	IN
cord-005453-4057qib7	14877	16	cell	cell	NN
cord-005453-4057qib7	14877	17	collection	collection	NN
cord-005453-4057qib7	14877	18	,	,	,
cord-005453-4057qib7	14877	19	thawing	thawing	NN
cord-005453-4057qib7	14877	20	and	and	CC
cord-005453-4057qib7	14877	21	washing	washing	NN
cord-005453-4057qib7	14877	22	.	.	.
cord-005453-4057qib7	14878	1	Cells	cell	NNS
cord-005453-4057qib7	14878	2	with	with	IN
cord-005453-4057qib7	14878	3	10	10	CD
cord-005453-4057qib7	14878	4	%	%	NN
cord-005453-4057qib7	14878	5	DMSO	DMSO	NNP
cord-005453-4057qib7	14878	6	were	be	VBD
cord-005453-4057qib7	14878	7	stored	store	VBN
cord-005453-4057qib7	14878	8	at	at	IN
cord-005453-4057qib7	14878	9	-196˚and	-196˚and	:
cord-005453-4057qib7	14878	10	washed	wash	VBN
cord-005453-4057qib7	14878	11	in	in	IN
cord-005453-4057qib7	14878	12	14	14	CD
cord-005453-4057qib7	14878	13	cases	case	NNS
cord-005453-4057qib7	14878	14	of	of	IN
cord-005453-4057qib7	14878	15	transplantation	transplantation	NN
cord-005453-4057qib7	14878	16	with	with	IN
cord-005453-4057qib7	14878	17	human	human	JJ
cord-005453-4057qib7	14878	18	albumin	albumin	NN
cord-005453-4057qib7	14878	19	-	-	HYPH
cord-005453-4057qib7	14878	20	dextran	dextran	NN
cord-005453-4057qib7	14878	21	(	(	-LRB-
cord-005453-4057qib7	14878	22	Reopolyglukin	Reopolyglukin	NNP
cord-005453-4057qib7	14878	23	)	)	-RRB-
cord-005453-4057qib7	14878	24	and	and	CC
cord-005453-4057qib7	14878	25	centrifugation	centrifugation	NN
cord-005453-4057qib7	14878	26	.	.	.
cord-005453-4057qib7	14879	1	Statistical	statistical	JJ
cord-005453-4057qib7	14879	2	data	datum	NNS
cord-005453-4057qib7	14879	3	processing	processing	NN
cord-005453-4057qib7	14879	4	was	be	VBD
cord-005453-4057qib7	14879	5	performed	perform	VBN
cord-005453-4057qib7	14879	6	by	by	IN
cord-005453-4057qib7	14879	7	the	the	DT
cord-005453-4057qib7	14879	8	χ2	χ2	NNP
cord-005453-4057qib7	14879	9	method	method	NN
cord-005453-4057qib7	14879	10	-Pearson	-pearson	NN
cord-005453-4057qib7	14879	11	criterion	criterion	NN
cord-005453-4057qib7	14879	12	;	;	:
cord-005453-4057qib7	14879	13	p	p	NN
cord-005453-4057qib7	14879	14	-the	-the	DT
cord-005453-4057qib7	14879	15	level	level	NN
cord-005453-4057qib7	14879	16	of	of	IN
cord-005453-4057qib7	14879	17	significance	significance	NN
cord-005453-4057qib7	14879	18	of	of	IN
cord-005453-4057qib7	14879	19	differences	difference	NNS
cord-005453-4057qib7	14879	20	.	.	.
cord-005453-4057qib7	14880	1	Results	result	NNS
cord-005453-4057qib7	14880	2	:	:	:
cord-005453-4057qib7	14881	1	Patient	patient	JJ
cord-005453-4057qib7	14881	2	groups	group	NNS
cord-005453-4057qib7	14881	3	had	have	VBD
cord-005453-4057qib7	14881	4	no	no	DT
cord-005453-4057qib7	14881	5	difference	difference	NN
cord-005453-4057qib7	14881	6	in	in	IN
cord-005453-4057qib7	14881	7	age	age	NN
cord-005453-4057qib7	14881	8	,	,	,
cord-005453-4057qib7	14881	9	disease	disease	NN
cord-005453-4057qib7	14881	10	stage	stage	NN
cord-005453-4057qib7	14881	11	,	,	,
cord-005453-4057qib7	14881	12	gender	gender	NN
cord-005453-4057qib7	14881	13	,	,	,
cord-005453-4057qib7	14881	14	time	time	NN
cord-005453-4057qib7	14881	15	from	from	IN
cord-005453-4057qib7	14881	16	treatment	treatment	NN
cord-005453-4057qib7	14881	17	start	start	NN
cord-005453-4057qib7	14881	18	to	to	IN
cord-005453-4057qib7	14881	19	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	14881	20	and	and	CC
cord-005453-4057qib7	14881	21	CD34	CD34	NNP
cord-005453-4057qib7	14881	22	+	+	CC
cord-005453-4057qib7	14881	23	cell	cell	NN
cord-005453-4057qib7	14881	24	count	count	NN
cord-005453-4057qib7	14881	25	(	(	-LRB-
cord-005453-4057qib7	14881	26	p>0,05	p>0,05	NNP
cord-005453-4057qib7	14881	27	)	)	-RRB-
cord-005453-4057qib7	14881	28	.	.	.
cord-005453-4057qib7	14882	1	Time	time	NN
cord-005453-4057qib7	14882	2	to	to	IN
cord-005453-4057qib7	14882	3	WBC	WBC	NNP
cord-005453-4057qib7	14882	4	recovery	recovery	NN
cord-005453-4057qib7	14882	5	>	>	XX
cord-005453-4057qib7	14883	1	1х10	1х10	CD
cord-005453-4057qib7	14883	2	9	9	CD
cord-005453-4057qib7	14883	3	/л	/л	NNP
cord-005453-4057qib7	14883	4	was	be	VBD
cord-005453-4057qib7	14883	5	9	9	CD
cord-005453-4057qib7	14883	6	-	-	SYM
cord-005453-4057qib7	14883	7	29	29	CD
cord-005453-4057qib7	14884	1	(	(	-LRB-
cord-005453-4057qib7	14884	2	median	median	NN
cord-005453-4057qib7	14884	3	13,6	13,6	CD
cord-005453-4057qib7	14884	4	)	)	-RRB-
cord-005453-4057qib7	14884	5	days	day	NNS
cord-005453-4057qib7	14884	6	vs	vs	IN
cord-005453-4057qib7	14884	7	10	10	CD
cord-005453-4057qib7	14884	8	-	-	SYM
cord-005453-4057qib7	14884	9	34	34	CD
cord-005453-4057qib7	14884	10	(	(	-LRB-
cord-005453-4057qib7	14884	11	median	median	JJ
cord-005453-4057qib7	14884	12	13,7	13,7	CD
cord-005453-4057qib7	14884	13	)	)	-RRB-
cord-005453-4057qib7	14884	14	days	day	NNS
cord-005453-4057qib7	14884	15	,	,	,
cord-005453-4057qib7	14884	16	time	time	NN
cord-005453-4057qib7	14884	17	to	to	IN
cord-005453-4057qib7	14884	18	platelet>30х10	platelet>30х10	NN
cord-005453-4057qib7	14884	19	9	9	CD
cord-005453-4057qib7	14884	20	/л	/л	NNP
cord-005453-4057qib7	14884	21	recovery	recovery	NN
cord-005453-4057qib7	14884	22	was	be	VBD
cord-005453-4057qib7	14884	23	11	11	CD
cord-005453-4057qib7	14884	24	-	-	SYM
cord-005453-4057qib7	14884	25	34	34	CD
cord-005453-4057qib7	14884	26	(	(	-LRB-
cord-005453-4057qib7	14884	27	median	median	NN
cord-005453-4057qib7	14884	28	16,9	16,9	CD
cord-005453-4057qib7	14884	29	)	)	-RRB-
cord-005453-4057qib7	14884	30	days	day	NNS
cord-005453-4057qib7	14884	31	vs	vs	IN
cord-005453-4057qib7	14884	32	11	11	CD
cord-005453-4057qib7	14884	33	-	-	SYM
cord-005453-4057qib7	14884	34	58	58	CD
cord-005453-4057qib7	14884	35	(	(	-LRB-
cord-005453-4057qib7	14884	36	median	median	NN
cord-005453-4057qib7	14884	37	17,9	17,9	CD
cord-005453-4057qib7	14884	38	)	)	-RRB-
cord-005453-4057qib7	14884	39	days	day	NNS
cord-005453-4057qib7	14884	40	in	in	IN
cord-005453-4057qib7	14884	41	groups	group	NNS
cord-005453-4057qib7	14884	42	without	without	IN
cord-005453-4057qib7	14884	43	and	and	CC
cord-005453-4057qib7	14884	44	with	with	IN
cord-005453-4057qib7	14884	45	cell	cell	NN
cord-005453-4057qib7	14884	46	washing	washing	NN
cord-005453-4057qib7	14884	47	respectively	respectively	RB
cord-005453-4057qib7	14884	48	(	(	-LRB-
cord-005453-4057qib7	14884	49	p=0,507	p=0,507	NNP
cord-005453-4057qib7	14884	50	)	)	-RRB-
cord-005453-4057qib7	14884	51	.	.	.
cord-005453-4057qib7	14885	1	No	no	DT
cord-005453-4057qib7	14885	2	difference	difference	NN
cord-005453-4057qib7	14885	3	in	in	IN
cord-005453-4057qib7	14885	4	blood	blood	NN
cord-005453-4057qib7	14885	5	component	component	NN
cord-005453-4057qib7	14885	6	consumption	consumption	NN
cord-005453-4057qib7	14885	7	was	be	VBD
cord-005453-4057qib7	14885	8	observed	observe	VBN
cord-005453-4057qib7	14885	9	(	(	-LRB-
cord-005453-4057qib7	14885	10	p=0,546	p=0,546	NNP
cord-005453-4057qib7	14885	11	)	)	-RRB-
cord-005453-4057qib7	14885	12	.	.	.
cord-005453-4057qib7	14886	1	In	in	IN
cord-005453-4057qib7	14886	2	18	18	CD
cord-005453-4057qib7	14886	3	out	out	IN
cord-005453-4057qib7	14886	4	of	of	IN
cord-005453-4057qib7	14886	5	23	23	CD
cord-005453-4057qib7	14886	6	(	(	-LRB-
cord-005453-4057qib7	14886	7	78	78	CD
cord-005453-4057qib7	14886	8	%	%	NN
cord-005453-4057qib7	14886	9	)	)	-RRB-
cord-005453-4057qib7	14886	10	patients	patient	NNS
cord-005453-4057qib7	14886	11	during	during	IN
cord-005453-4057qib7	14886	12	cell	cell	NN
cord-005453-4057qib7	14886	13	reinfusion	reinfusion	NN
cord-005453-4057qib7	14886	14	without	without	IN
cord-005453-4057qib7	14886	15	washing	wash	VBG
cord-005453-4057qib7	14886	16	nausea	nausea	NN
cord-005453-4057qib7	14886	17	,	,	,
cord-005453-4057qib7	14886	18	vomiting	vomiting	NN
cord-005453-4057qib7	14886	19	,	,	,
cord-005453-4057qib7	14886	20	arterial	arterial	JJ
cord-005453-4057qib7	14886	21	hypertension	hypertension	NN
cord-005453-4057qib7	14886	22	was	be	VBD
cord-005453-4057qib7	14886	23	observed	observe	VBN
cord-005453-4057qib7	14886	24	,	,	,
cord-005453-4057qib7	14886	25	no	no	DT
cord-005453-4057qib7	14886	26	reactions	reaction	NNS
cord-005453-4057qib7	14886	27	were	be	VBD
cord-005453-4057qib7	14886	28	detected	detect	VBN
cord-005453-4057qib7	14886	29	after	after	IN
cord-005453-4057qib7	14886	30	cell	cell	NN
cord-005453-4057qib7	14886	31	washing	washing	NN
cord-005453-4057qib7	14886	32	(	(	-LRB-
cord-005453-4057qib7	14886	33	p	p	NN
cord-005453-4057qib7	14886	34	=	=	SYM
cord-005453-4057qib7	14886	35	0,03	0,03	CD
cord-005453-4057qib7	14886	36	)	)	-RRB-
cord-005453-4057qib7	14886	37	.	.	.
cord-005453-4057qib7	14887	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14887	2	:	:	:
cord-005453-4057qib7	14888	1	Washing	wash	VBG
cord-005453-4057qib7	14888	2	autologous	autologous	JJ
cord-005453-4057qib7	14888	3	mononuclear	mononuclear	JJ
cord-005453-4057qib7	14888	4	cells	cell	NNS
cord-005453-4057qib7	14888	5	from	from	IN
cord-005453-4057qib7	14888	6	cryopreservant	cryopreservant	JJ
cord-005453-4057qib7	14888	7	DMSO	DMSO	NNP
cord-005453-4057qib7	14888	8	does	do	VBZ
cord-005453-4057qib7	14888	9	not	not	RB
cord-005453-4057qib7	14888	10	lead	lead	VB
cord-005453-4057qib7	14888	11	to	to	IN
cord-005453-4057qib7	14888	12	low	low	JJ
cord-005453-4057qib7	14888	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14888	14	recovery	recovery	NN
cord-005453-4057qib7	14888	15	rate	rate	NN
cord-005453-4057qib7	14888	16	after	after	IN
cord-005453-4057qib7	14888	17	autoHSCT	autoHSCT	NNP
cord-005453-4057qib7	14888	18	and	and	CC
cord-005453-4057qib7	14888	19	can	can	MD
cord-005453-4057qib7	14888	20	avoid	avoid	VB
cord-005453-4057qib7	14888	21	toxicity	toxicity	NN
cord-005453-4057qib7	14888	22	,	,	,
cord-005453-4057qib7	14888	23	thus	thus	RB
cord-005453-4057qib7	14888	24	making	make	VBG
cord-005453-4057qib7	14888	25	autoHSCT	autohsct	RB
cord-005453-4057qib7	14888	26	more	more	RBR
cord-005453-4057qib7	14888	27	safe	safe	JJ
cord-005453-4057qib7	14888	28	.	.	.
cord-005453-4057qib7	14889	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14889	2	:	:	:
cord-005453-4057qib7	14890	1	authors	author	NNS
cord-005453-4057qib7	14890	2	declare	declare	VBP
cord-005453-4057qib7	14890	3	no	no	DT
cord-005453-4057qib7	14890	4	conflict	conflict	NN
cord-005453-4057qib7	14890	5	of	of	IN
cord-005453-4057qib7	14890	6	interests	interest	NNS
cord-005453-4057qib7	14890	7	.	.	.
cord-005453-4057qib7	14891	1	Quality	Quality	NNP
cord-005453-4057qib7	14891	2	assesment	assesment	NN
cord-005453-4057qib7	14891	3	of	of	IN
cord-005453-4057qib7	14891	4	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14891	5	stem	stem	NN
cord-005453-4057qib7	14891	6	cells	cell	NNS
cord-005453-4057qib7	14891	7	autografts	autografts	NNP
cord-005453-4057qib7	14891	8	after	after	IN
cord-005453-4057qib7	14891	9	cryostorage	cryostorage	NN
cord-005453-4057qib7	14891	10	,	,	,
cord-005453-4057qib7	14891	11	harvested	harvest	VBN
cord-005453-4057qib7	14891	12	using	use	VBG
cord-005453-4057qib7	14891	13	plerixafor	plerixafor	NN
cord-005453-4057qib7	14891	14	Background	Background	NNP
cord-005453-4057qib7	14891	15	:	:	:
cord-005453-4057qib7	14892	1	The	the	DT
cord-005453-4057qib7	14892	2	introduction	introduction	NN
cord-005453-4057qib7	14892	3	of	of	IN
cord-005453-4057qib7	14892	4	high	high	JJ
cord-005453-4057qib7	14892	5	-	-	HYPH
cord-005453-4057qib7	14892	6	dose	dose	NN
cord-005453-4057qib7	14892	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	14892	8	followed	follow	VBN
cord-005453-4057qib7	14892	9	by	by	IN
cord-005453-4057qib7	14892	10	transplantation	transplantation	NN
cord-005453-4057qib7	14892	11	of	of	IN
cord-005453-4057qib7	14892	12	autologous	autologous	JJ
cord-005453-4057qib7	14892	13	hemopoietic	hemopoietic	JJ
cord-005453-4057qib7	14892	14	stem	stem	NN
cord-005453-4057qib7	14892	15	cells	cell	NNS
cord-005453-4057qib7	14892	16	(	(	-LRB-
cord-005453-4057qib7	14892	17	HSCs	hscs	NN
cord-005453-4057qib7	14892	18	)	)	-RRB-
cord-005453-4057qib7	14892	19	into	into	IN
cord-005453-4057qib7	14892	20	the	the	DT
cord-005453-4057qib7	14892	21	treatment	treatment	NN
cord-005453-4057qib7	14892	22	program	program	NN
cord-005453-4057qib7	14892	23	for	for	IN
cord-005453-4057qib7	14892	24	multiple	multiple	JJ
cord-005453-4057qib7	14892	25	myeloma	myeloma	NN
cord-005453-4057qib7	14892	26	(	(	-LRB-
cord-005453-4057qib7	14892	27	MM	MM	NNP
cord-005453-4057qib7	14892	28	)	)	-RRB-
cord-005453-4057qib7	14892	29	has	have	VBZ
cord-005453-4057qib7	14892	30	significantly	significantly	RB
cord-005453-4057qib7	14892	31	increased	increase	VBN
cord-005453-4057qib7	14892	32	the	the	DT
cord-005453-4057qib7	14892	33	frequency	frequency	NN
cord-005453-4057qib7	14892	34	of	of	IN
cord-005453-4057qib7	14892	35	achieving	achieve	VBG
cord-005453-4057qib7	14892	36	complete	complete	JJ
cord-005453-4057qib7	14892	37	remissions	remission	NNS
cord-005453-4057qib7	14892	38	and	and	CC
cord-005453-4057qib7	14892	39	overall	overall	JJ
cord-005453-4057qib7	14892	40	survival	survival	NN
cord-005453-4057qib7	14892	41	in	in	IN
cord-005453-4057qib7	14892	42	patients	patient	NNS
cord-005453-4057qib7	14892	43	.	.	.
cord-005453-4057qib7	14893	1	To	to	TO
cord-005453-4057qib7	14893	2	obtain	obtain	VB
cord-005453-4057qib7	14893	3	a	a	DT
cord-005453-4057qib7	14893	4	sufficient	sufficient	JJ
cord-005453-4057qib7	14893	5	amount	amount	NN
cord-005453-4057qib7	14893	6	of	of	IN
cord-005453-4057qib7	14893	7	HSCs	hscs	NN
cord-005453-4057qib7	14893	8	,	,	,
cord-005453-4057qib7	14893	9	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	14893	10	is	be	VBZ
cord-005453-4057qib7	14893	11	stimulated	stimulate	VBN
cord-005453-4057qib7	14893	12	with	with	IN
cord-005453-4057qib7	14893	13	granulocyte	granulocyte	NN
cord-005453-4057qib7	14893	14	-	-	HYPH
cord-005453-4057qib7	14893	15	macrophage	macrophage	NN
cord-005453-4057qib7	14893	16	factors	factor	NNS
cord-005453-4057qib7	14893	17	(	(	-LRB-
cord-005453-4057qib7	14893	18	GM	GM	NNP
cord-005453-4057qib7	14893	19	-	-	HYPH
cord-005453-4057qib7	14893	20	CSF	CSF	NNP
cord-005453-4057qib7	14893	21	)	)	-RRB-
cord-005453-4057qib7	14894	1	both	both	DT
cord-005453-4057qib7	14894	2	in	in	IN
cord-005453-4057qib7	14894	3	mono	mono	NN
cord-005453-4057qib7	14894	4	mode	mode	NN
cord-005453-4057qib7	14894	5	and	and	CC
cord-005453-4057qib7	14894	6	after	after	IN
cord-005453-4057qib7	14894	7	the	the	DT
cord-005453-4057qib7	14894	8	administration	administration	NN
cord-005453-4057qib7	14894	9	of	of	IN
cord-005453-4057qib7	14894	10	cytostatics	cytostatics	NNP
cord-005453-4057qib7	14894	11	followed	follow	VBN
cord-005453-4057qib7	14894	12	by	by	IN
cord-005453-4057qib7	14894	13	cytapheresis	cytapheresis	NN
cord-005453-4057qib7	14894	14	sessions	session	NNS
cord-005453-4057qib7	14894	15	(	(	-LRB-
cord-005453-4057qib7	14894	16	alone	alone	RB
cord-005453-4057qib7	14894	17	or	or	CC
cord-005453-4057qib7	14894	18	after	after	IN
cord-005453-4057qib7	14894	19	the	the	DT
cord-005453-4057qib7	14894	20	cytostatics	cytostatic	NNS
cord-005453-4057qib7	14894	21	followed	follow	VBN
cord-005453-4057qib7	14894	22	by	by	IN
cord-005453-4057qib7	14894	23	cytapheresis	cytapheresis	NN
cord-005453-4057qib7	14894	24	sessions	session	NNS
cord-005453-4057qib7	14894	25	)	)	-RRB-
cord-005453-4057qib7	14894	26	.	.	.
cord-005453-4057qib7	14895	1	Cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14895	2	protocols	protocol	NNS
cord-005453-4057qib7	14895	3	are	be	VBP
cord-005453-4057qib7	14895	4	used	use	VBN
cord-005453-4057qib7	14895	5	to	to	TO
cord-005453-4057qib7	14895	6	preserve	preserve	VB
cord-005453-4057qib7	14895	7	cells	cell	NNS
cord-005453-4057qib7	14895	8	in	in	IN
cord-005453-4057qib7	14895	9	a	a	DT
cord-005453-4057qib7	14895	10	viable	viable	JJ
cord-005453-4057qib7	14895	11	state	state	NN
cord-005453-4057qib7	14895	12	,	,	,
cord-005453-4057qib7	14895	13	followed	follow	VBN
cord-005453-4057qib7	14895	14	by	by	IN
cord-005453-4057qib7	14895	15	long	long	JJ
cord-005453-4057qib7	14895	16	-	-	HYPH
cord-005453-4057qib7	14895	17	term	term	NN
cord-005453-4057qib7	14895	18	storage	storage	NN
cord-005453-4057qib7	14895	19	of	of	IN
cord-005453-4057qib7	14895	20	transplants	transplant	NNS
cord-005453-4057qib7	14895	21	in	in	IN
cord-005453-4057qib7	14895	22	liquid	liquid	JJ
cord-005453-4057qib7	14895	23	nitrogen	nitrogen	NN
cord-005453-4057qib7	14895	24	.	.	.
cord-005453-4057qib7	14896	1	However	however	RB
cord-005453-4057qib7	14896	2	,	,	,
cord-005453-4057qib7	14896	3	in	in	IN
cord-005453-4057qib7	14896	4	some	some	DT
cord-005453-4057qib7	14896	5	patients	patient	NNS
cord-005453-4057qib7	14896	6	it	-PRON-	PRP
cord-005453-4057qib7	14896	7	is	be	VBZ
cord-005453-4057qib7	14896	8	not	not	RB
cord-005453-4057qib7	14896	9	possible	possible	JJ
cord-005453-4057qib7	14896	10	to	to	TO
cord-005453-4057qib7	14896	11	obtain	obtain	VB
cord-005453-4057qib7	14896	12	the	the	DT
cord-005453-4057qib7	14896	13	necessary	necessary	JJ
cord-005453-4057qib7	14896	14	amount	amount	NN
cord-005453-4057qib7	14896	15	of	of	IN
cord-005453-4057qib7	14896	16	HSCs	hscs	NN
cord-005453-4057qib7	14896	17	.	.	.
cord-005453-4057qib7	14897	1	The	the	DT
cord-005453-4057qib7	14897	2	inclusion	inclusion	NN
cord-005453-4057qib7	14897	3	of	of	IN
cord-005453-4057qib7	14897	4	plerixafor	plerixafor	NN
cord-005453-4057qib7	14897	5	in	in	IN
cord-005453-4057qib7	14897	6	standard	standard	JJ
cord-005453-4057qib7	14897	7	mobilization	mobilization	NN
cord-005453-4057qib7	14897	8	schemes	scheme	NNS
cord-005453-4057qib7	14897	9	allows	allow	VBZ
cord-005453-4057qib7	14897	10	you	-PRON-	PRP
cord-005453-4057qib7	14897	11	to	to	TO
cord-005453-4057qib7	14897	12	prepare	prepare	VB
cord-005453-4057qib7	14897	13	the	the	DT
cord-005453-4057qib7	14897	14	sufficient	sufficient	JJ
cord-005453-4057qib7	14897	15	quantity	quantity	NN
cord-005453-4057qib7	14897	16	of	of	IN
cord-005453-4057qib7	14897	17	HSCs	hscs	NN
cord-005453-4057qib7	14897	18	in	in	IN
cord-005453-4057qib7	14897	19	most	most	JJS
cord-005453-4057qib7	14897	20	patients	patient	NNS
cord-005453-4057qib7	14897	21	with	with	IN
cord-005453-4057qib7	14897	22	MM	MM	NNP
cord-005453-4057qib7	14897	23	.	.	.
cord-005453-4057qib7	14898	1	Methods	method	NNS
cord-005453-4057qib7	14898	2	:	:	:
cord-005453-4057qib7	14899	1	The	the	DT
cord-005453-4057qib7	14899	2	study	study	NN
cord-005453-4057qib7	14899	3	included	include	VBD
cord-005453-4057qib7	14899	4	18	18	CD
cord-005453-4057qib7	14899	5	samples	sample	NNS
cord-005453-4057qib7	14899	6	of	of	IN
cord-005453-4057qib7	14899	7	autografts	autografts	NNP
cord-005453-4057qib7	14899	8	from	from	IN
cord-005453-4057qib7	14899	9	18	18	CD
cord-005453-4057qib7	14899	10	patients	patient	NNS
cord-005453-4057qib7	14899	11	with	with	IN
cord-005453-4057qib7	14899	12	MM	MM	NNP
cord-005453-4057qib7	14899	13	from	from	IN
cord-005453-4057qib7	14899	14	2015	2015	CD
cord-005453-4057qib7	14899	15	to	to	IN
cord-005453-4057qib7	14899	16	2017	2017	CD
cord-005453-4057qib7	14899	17	(	(	-LRB-
cord-005453-4057qib7	14899	18	Median	Median	NNP
cord-005453-4057qib7	14899	19	2.1	2.1	CD
cord-005453-4057qib7	14899	20	±	±	CD
cord-005453-4057qib7	14899	21	0.3	0.3	CD
cord-005453-4057qib7	14899	22	)	)	-RRB-
cord-005453-4057qib7	14899	23	.	.	.
cord-005453-4057qib7	14900	1	HSCs	HSCs	NNP
cord-005453-4057qib7	14900	2	mobilization	mobilization	NN
cord-005453-4057qib7	14900	3	was	be	VBD
cord-005453-4057qib7	14900	4	performed	perform	VBN
cord-005453-4057qib7	14900	5	on	on	IN
cord-005453-4057qib7	14900	6	the	the	DT
cord-005453-4057qib7	14900	7	background	background	NN
cord-005453-4057qib7	14900	8	of	of	IN
cord-005453-4057qib7	14900	9	unstable	unstable	JJ
cord-005453-4057qib7	14900	10	blood	blood	NN
cord-005453-4057qib7	14900	11	formation	formation	NN
cord-005453-4057qib7	14900	12	after	after	IN
cord-005453-4057qib7	14900	13	high	high	JJ
cord-005453-4057qib7	14900	14	doses	dose	NNS
cord-005453-4057qib7	14900	15	of	of	IN
cord-005453-4057qib7	14900	16	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	14900	17	6	6	CD
cord-005453-4057qib7	14900	18	g	g	NN
cord-005453-4057qib7	14900	19	/	/	SYM
cord-005453-4057qib7	14900	20	m	m	NN
cord-005453-4057qib7	14900	21	2	2	CD
cord-005453-4057qib7	14900	22	with	with	IN
cord-005453-4057qib7	14900	23	the	the	DT
cord-005453-4057qib7	14900	24	subsequent	subsequent	JJ
cord-005453-4057qib7	14900	25	administration	administration	NN
cord-005453-4057qib7	14900	26	of	of	IN
cord-005453-4057qib7	14900	27	G	G	NNP
cord-005453-4057qib7	14900	28	-	-	HYPH
cord-005453-4057qib7	14900	29	CSF	CSF	NNP
cord-005453-4057qib7	14900	30	at	at	IN
cord-005453-4057qib7	14900	31	a	a	DT
cord-005453-4057qib7	14900	32	dose	dose	NN
cord-005453-4057qib7	14900	33	of	of	IN
cord-005453-4057qib7	14900	34	12	12	CD
cord-005453-4057qib7	14900	35	-	-	SYM
cord-005453-4057qib7	14900	36	24	24	CD
cord-005453-4057qib7	14900	37	μg	μg	NNP
cord-005453-4057qib7	14900	38	/	/	SYM
cord-005453-4057qib7	14900	39	kg	kg	NN
cord-005453-4057qib7	14900	40	(	(	-LRB-
cord-005453-4057qib7	14900	41	9	9	CD
cord-005453-4057qib7	14900	42	samples	sample	NNS
cord-005453-4057qib7	14900	43	from	from	IN
cord-005453-4057qib7	14900	44	9	9	CD
cord-005453-4057qib7	14900	45	patients	patient	NNS
cord-005453-4057qib7	14900	46	)	)	-RRB-
cord-005453-4057qib7	14900	47	and	and	CC
cord-005453-4057qib7	14900	48	with	with	IN
cord-005453-4057qib7	14900	49	the	the	DT
cord-005453-4057qib7	14900	50	addition	addition	NN
cord-005453-4057qib7	14900	51	of	of	IN
cord-005453-4057qib7	14900	52	plerixaphor	plerixaphor	NNP
cord-005453-4057qib7	14900	53	at	at	IN
cord-005453-4057qib7	14900	54	a	a	DT
cord-005453-4057qib7	14900	55	dose	dose	NN
cord-005453-4057qib7	14900	56	of	of	IN
cord-005453-4057qib7	14900	57	0.24	0.24	CD
cord-005453-4057qib7	14900	58	μg	μg	NNP
cord-005453-4057qib7	14900	59	/	/	SYM
cord-005453-4057qib7	14900	60	kg	kg	NNP
cord-005453-4057qib7	14900	61	(	(	-LRB-
cord-005453-4057qib7	14900	62	9	9	CD
cord-005453-4057qib7	14900	63	samples	sample	NNS
cord-005453-4057qib7	14900	64	from	from	IN
cord-005453-4057qib7	14900	65	9	9	CD
cord-005453-4057qib7	14900	66	patients	patient	NNS
cord-005453-4057qib7	14900	67	)	)	-RRB-
cord-005453-4057qib7	14900	68	.	.	.
cord-005453-4057qib7	14901	1	Immunophenotype	immunophenotype	NN
cord-005453-4057qib7	14901	2	viability	viability	NN
cord-005453-4057qib7	14901	3	of	of	IN
cord-005453-4057qib7	14901	4	HSCs	hscs	NN
cord-005453-4057qib7	14901	5	in	in	IN
cord-005453-4057qib7	14901	6	autotransplants	autotransplant	NNS
cord-005453-4057qib7	14901	7	after	after	IN
cord-005453-4057qib7	14901	8	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14901	9	were	be	VBD
cord-005453-4057qib7	14901	10	determined	determine	VBN
cord-005453-4057qib7	14901	11	by	by	IN
cord-005453-4057qib7	14901	12	flow	flow	NN
cord-005453-4057qib7	14901	13	cytometry	cytometry	NN
cord-005453-4057qib7	14901	14	using	use	VBG
cord-005453-4057qib7	14901	15	the	the	DT
cord-005453-4057qib7	14901	16	ISHAGE	ISHAGE	NNP
cord-005453-4057qib7	14901	17	protocol	protocol	NN
cord-005453-4057qib7	14901	18	on	on	IN
cord-005453-4057qib7	14901	19	a	a	DT
cord-005453-4057qib7	14901	20	flow	flow	NN
cord-005453-4057qib7	14901	21	cytometer	cytometer	NN
cord-005453-4057qib7	14901	22	(	(	-LRB-
cord-005453-4057qib7	14901	23	FACS	FACS	NNP
cord-005453-4057qib7	14901	24	CantoII	CantoII	NNP
cord-005453-4057qib7	14901	25	,	,	,
cord-005453-4057qib7	14901	26	Becton	Becton	NNP
cord-005453-4057qib7	14901	27	Dickinson	Dickinson	NNP
cord-005453-4057qib7	14901	28	)	)	-RRB-
cord-005453-4057qib7	14901	29	by	by	IN
cord-005453-4057qib7	14901	30	expressing	express	VBG
cord-005453-4057qib7	14901	31	surface	surface	NN
cord-005453-4057qib7	14901	32	markers	marker	NNS
cord-005453-4057qib7	14901	33	of	of	IN
cord-005453-4057qib7	14901	34	antibodies	antibody	NNS
cord-005453-4057qib7	14901	35	against	against	IN
cord-005453-4057qib7	14901	36	CD34	CD34	NNP
cord-005453-4057qib7	14901	37	,	,	,
cord-005453-4057qib7	14901	38	CD45	CD45	NNP
cord-005453-4057qib7	14901	39	,	,	,
cord-005453-4057qib7	14901	40	CD90	CD90	NNP
cord-005453-4057qib7	14901	41	,	,	,
cord-005453-4057qib7	14901	42	CD38	CD38	NNP
cord-005453-4057qib7	14901	43	and	and	CC
cord-005453-4057qib7	14901	44	staining	stain	VBG
cord-005453-4057qib7	14901	45	with	with	IN
cord-005453-4057qib7	14901	46	7aminoactinomycin	7aminoactinomycin	CD
cord-005453-4057qib7	14901	47	(	(	-LRB-
cord-005453-4057qib7	14901	48	7-AAD	7-aad	CD
cord-005453-4057qib7	14901	49	)	)	-RRB-
cord-005453-4057qib7	14901	50	.	.	.
cord-005453-4057qib7	14902	1	The	the	DT
cord-005453-4057qib7	14902	2	colony	colony	NN
cord-005453-4057qib7	14902	3	-	-	HYPH
cord-005453-4057qib7	14902	4	forming	form	VBG
cord-005453-4057qib7	14902	5	activity	activity	NN
cord-005453-4057qib7	14902	6	of	of	IN
cord-005453-4057qib7	14902	7	HSCs	HSCs	NNP
cord-005453-4057qib7	14903	1	(	(	-LRB-
cord-005453-4057qib7	14903	2	CFU	CFU	NNP
cord-005453-4057qib7	14903	3	-	-	HYPH
cord-005453-4057qib7	14903	4	CFU	CFU	NNP
cord-005453-4057qib7	14903	5	-	-	HYPH
cord-005453-4057qib7	14903	6	mix	mix	NN
cord-005453-4057qib7	14903	7	,	,	,
cord-005453-4057qib7	14903	8	CFU	CFU	NNP
cord-005453-4057qib7	14903	9	-	-	HYPH
cord-005453-4057qib7	14903	10	GM	GM	NNP
cord-005453-4057qib7	14903	11	,	,	,
cord-005453-4057qib7	14903	12	CFU	CFU	NNP
cord-005453-4057qib7	14903	13	-	-	HYPH
cord-005453-4057qib7	14903	14	G	G	NNP
cord-005453-4057qib7	14903	15	,	,	,
cord-005453-4057qib7	14903	16	CFU	CFU	NNP
cord-005453-4057qib7	14903	17	-	-	HYPH
cord-005453-4057qib7	14903	18	M	M	NNP
cord-005453-4057qib7	14903	19	)	)	-RRB-
cord-005453-4057qib7	14903	20	was	be	VBD
cord-005453-4057qib7	14903	21	evaluated	evaluate	VBN
cord-005453-4057qib7	14903	22	in	in	IN
cord-005453-4057qib7	14903	23	methylcellulose	methylcellulose	NN
cord-005453-4057qib7	14903	24	(	(	-LRB-
cord-005453-4057qib7	14903	25	MethoCult	MethoCult	NNP
cord-005453-4057qib7	14903	26	H4435	H4435	NNP
cord-005453-4057qib7	14903	27	,	,	,
cord-005453-4057qib7	14903	28	Stemcell	Stemcell	NNP
cord-005453-4057qib7	14903	29	Technologies	Technologies	NNPS
cord-005453-4057qib7	14903	30	,	,	,
cord-005453-4057qib7	14903	31	Canada	Canada	NNP
cord-005453-4057qib7	14903	32	)	)	-RRB-
cord-005453-4057qib7	14903	33	for	for	IN
cord-005453-4057qib7	14903	34	1x10	1x10	CD
cord-005453-4057qib7	14903	35	5	5	CD
cord-005453-4057qib7	14903	36	transplanted	transplant	VBN
cord-005453-4057qib7	14903	37	cells	cell	NNS
cord-005453-4057qib7	14903	38	for	for	IN
cord-005453-4057qib7	14903	39	14	14	CD
cord-005453-4057qib7	14903	40	days	day	NNS
cord-005453-4057qib7	14903	41	.	.	.
cord-005453-4057qib7	14904	1	Results	result	NNS
cord-005453-4057qib7	14904	2	:	:	:
cord-005453-4057qib7	14905	1	The	the	DT
cord-005453-4057qib7	14905	2	viability	viability	NN
cord-005453-4057qib7	14905	3	of	of	IN
cord-005453-4057qib7	14905	4	HSCs	hscs	NN
cord-005453-4057qib7	14905	5	in	in	IN
cord-005453-4057qib7	14905	6	autografts	autografts	NNP
cord-005453-4057qib7	14906	1	(	(	-LRB-
cord-005453-4057qib7	14906	2	CD45	CD45	NNP
cord-005453-4057qib7	14907	1	+	+	CC
cord-005453-4057qib7	14907	2	/	/	SYM
cord-005453-4057qib7	14907	3	CD34	CD34	NNP
cord-005453-4057qib7	14907	4	+	+	CC
cord-005453-4057qib7	14907	5	/	/	SYM
cord-005453-4057qib7	14907	6	7ADD-	7add-	CD
cord-005453-4057qib7	14907	7	)	)	-RRB-
cord-005453-4057qib7	14908	1	after	after	IN
cord-005453-4057qib7	14908	2	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	14908	3	in	in	IN
cord-005453-4057qib7	14908	4	both	both	DT
cord-005453-4057qib7	14908	5	groups	group	NNS
cord-005453-4057qib7	14908	6	was	be	VBD
cord-005453-4057qib7	14908	7	98	98	CD
cord-005453-4057qib7	14908	8	±	±	CD
cord-005453-4057qib7	14908	9	0.7	0.7	CD
cord-005453-4057qib7	14908	10	%	%	NN
cord-005453-4057qib7	14908	11	.	.	.
cord-005453-4057qib7	14909	1	In	in	IN
cord-005453-4057qib7	14909	2	the	the	DT
cord-005453-4057qib7	14909	3	group	group	NN
cord-005453-4057qib7	14909	4	of	of	IN
cord-005453-4057qib7	14909	5	samples	sample	NNS
cord-005453-4057qib7	14909	6	using	use	VBG
cord-005453-4057qib7	14909	7	plerixaphor	plerixaphor	NNP
cord-005453-4057qib7	14909	8	,	,	,
cord-005453-4057qib7	14909	9	a	a	DT
cord-005453-4057qib7	14909	10	higher	high	JJR
cord-005453-4057qib7	14909	11	content	content	NN
cord-005453-4057qib7	14909	12	of	of	IN
cord-005453-4057qib7	14909	13	primitive	primitive	JJ
cord-005453-4057qib7	14909	14	hemopoiesis	hemopoiesis	NN
cord-005453-4057qib7	14909	15	precursors	precursor	NNS
cord-005453-4057qib7	14909	16	(	(	-LRB-
cord-005453-4057qib7	14909	17	primitive	primitive	JJ
cord-005453-4057qib7	14909	18	cells	cell	NNS
cord-005453-4057qib7	14909	19	)	)	-RRB-
cord-005453-4057qib7	14909	20	(	(	-LRB-
cord-005453-4057qib7	14909	21	CD34	CD34	NNP
cord-005453-4057qib7	14909	22	+	+	SYM
cord-005453-4057qib7	14909	23	CD90	CD90	NNP
cord-005453-4057qib7	14909	24	+	+	CC
cord-005453-4057qib7	14909	25	CD38-	cd38-	NN
cord-005453-4057qib7	14909	26	)	)	-RRB-
cord-005453-4057qib7	14909	27	was	be	VBD
cord-005453-4057qib7	14909	28	detected	detect	VBN
cord-005453-4057qib7	14909	29	compared	compare	VBN
cord-005453-4057qib7	14909	30	with	with	IN
cord-005453-4057qib7	14909	31	the	the	DT
cord-005453-4057qib7	14909	32	control	control	NN
cord-005453-4057qib7	14909	33	group	group	NN
cord-005453-4057qib7	14909	34	(	(	-LRB-
cord-005453-4057qib7	14909	35	29.2	29.2	CD
cord-005453-4057qib7	14909	36	±	±	CD
cord-005453-4057qib7	14909	37	2.7	2.7	CD
cord-005453-4057qib7	14909	38	%	%	NN
cord-005453-4057qib7	14909	39	and	and	CC
cord-005453-4057qib7	14909	40	13.2	13.2	CD
cord-005453-4057qib7	14909	41	±	±	CD
cord-005453-4057qib7	14909	42	12	12	CD
cord-005453-4057qib7	14909	43	%	%	NN
cord-005453-4057qib7	14909	44	,	,	,
cord-005453-4057qib7	14909	45	respectively	respectively	RB
cord-005453-4057qib7	14909	46	)	)	-RRB-
cord-005453-4057qib7	14909	47	.	.	.
cord-005453-4057qib7	14910	1	The	the	DT
cord-005453-4057qib7	14910	2	CFU	CFU	NNP
cord-005453-4057qib7	14910	3	count	count	NN
cord-005453-4057qib7	14910	4	(	(	-LRB-
cord-005453-4057qib7	14910	5	CFU	CFU	NNP
cord-005453-4057qib7	14910	6	-	-	HYPH
cord-005453-4057qib7	14910	7	CFU	CFU	NNP
cord-005453-4057qib7	14910	8	-	-	HYPH
cord-005453-4057qib7	14910	9	mix	mix	NN
cord-005453-4057qib7	14910	10	,	,	,
cord-005453-4057qib7	14910	11	CFU	CFU	NNP
cord-005453-4057qib7	14910	12	-	-	HYPH
cord-005453-4057qib7	14910	13	GM	GM	NNP
cord-005453-4057qib7	14910	14	,	,	,
cord-005453-4057qib7	14910	15	CFU	CFU	NNP
cord-005453-4057qib7	14910	16	-	-	HYPH
cord-005453-4057qib7	14910	17	G	G	NNP
cord-005453-4057qib7	14910	18	,	,	,
cord-005453-4057qib7	14910	19	CFU	CFU	NNP
cord-005453-4057qib7	14910	20	-	-	HYPH
cord-005453-4057qib7	14910	21	M	M	NNP
cord-005453-4057qib7	14910	22	)	)	-RRB-
cord-005453-4057qib7	14910	23	in	in	IN
cord-005453-4057qib7	14910	24	the	the	DT
cord-005453-4057qib7	14910	25	plerixafor	plerixafor	NN
cord-005453-4057qib7	14910	26	group	group	NN
cord-005453-4057qib7	14910	27	was	be	VBD
cord-005453-4057qib7	14910	28	100	100	CD
cord-005453-4057qib7	14910	29	±	±	CD
cord-005453-4057qib7	14910	30	2.5	2.5	CD
cord-005453-4057qib7	14910	31	per	per	IN
cord-005453-4057qib7	14910	32	1x105	1x105	CD
cord-005453-4057qib7	14910	33	explanted	explante	VBN
cord-005453-4057qib7	14910	34	cells	cell	NNS
cord-005453-4057qib7	14910	35	,	,	,
cord-005453-4057qib7	14910	36	in	in	IN
cord-005453-4057qib7	14910	37	the	the	DT
cord-005453-4057qib7	14910	38	control	control	NN
cord-005453-4057qib7	14910	39	group	group	NN
cord-005453-4057qib7	14910	40	-70	-70	NN
cord-005453-4057qib7	14910	41	±	±	NNP
cord-005453-4057qib7	14910	42	1.8	1.8	CD
cord-005453-4057qib7	14910	43	(	(	-LRB-
cord-005453-4057qib7	14910	44	Figure	Figure	NNP
cord-005453-4057qib7	14910	45	1A	1a	NN
cord-005453-4057qib7	14910	46	-	-	HYPH
cord-005453-4057qib7	14910	47	D	D	NNP
cord-005453-4057qib7	14910	48	)	)	-RRB-
cord-005453-4057qib7	14910	49	.	.	.
cord-005453-4057qib7	14911	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14911	2	:	:	:
cord-005453-4057qib7	14912	1	The	the	DT
cord-005453-4057qib7	14912	2	use	use	NN
cord-005453-4057qib7	14912	3	of	of	IN
cord-005453-4057qib7	14912	4	plerixafor	plerixafor	NN
cord-005453-4057qib7	14912	5	against	against	IN
cord-005453-4057qib7	14912	6	the	the	DT
cord-005453-4057qib7	14912	7	background	background	NN
cord-005453-4057qib7	14912	8	of	of	IN
cord-005453-4057qib7	14912	9	standard	standard	JJ
cord-005453-4057qib7	14912	10	protocols	protocol	NNS
cord-005453-4057qib7	14912	11	for	for	IN
cord-005453-4057qib7	14912	12	the	the	DT
cord-005453-4057qib7	14912	13	mobilization	mobilization	NN
cord-005453-4057qib7	14912	14	of	of	IN
cord-005453-4057qib7	14912	15	HSCs	HSCs	NNP
cord-005453-4057qib7	14912	16	allows	allow	VBZ
cord-005453-4057qib7	14912	17	to	to	TO
cord-005453-4057qib7	14912	18	obtain	obtain	VB
cord-005453-4057qib7	14912	19	high	high	JJ
cord-005453-4057qib7	14912	20	-	-	HYPH
cord-005453-4057qib7	14912	21	quality	quality	NN
cord-005453-4057qib7	14912	22	graft	graft	NN
cord-005453-4057qib7	14912	23	with	with	IN
cord-005453-4057qib7	14912	24	a	a	DT
cord-005453-4057qib7	14912	25	higher	high	JJR
cord-005453-4057qib7	14912	26	content	content	NN
cord-005453-4057qib7	14912	27	of	of	IN
cord-005453-4057qib7	14912	28	primitive	primitive	JJ
cord-005453-4057qib7	14912	29	cells	cell	NNS
cord-005453-4057qib7	14912	30	and	and	CC
cord-005453-4057qib7	14912	31	proliferative	proliferative	JJ
cord-005453-4057qib7	14912	32	activity	activity	NN
cord-005453-4057qib7	14912	33	.	.	.
cord-005453-4057qib7	14913	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14913	2	:	:	:
cord-005453-4057qib7	14913	3	no	no	DT
cord-005453-4057qib7	14913	4	conflict	conflict	NN
cord-005453-4057qib7	14913	5	of	of	IN
cord-005453-4057qib7	14913	6	interest	interest	NN
cord-005453-4057qib7	14913	7	.	.	.
cord-005453-4057qib7	14914	1	Nothing	nothing	NN
cord-005453-4057qib7	14914	2	to	to	TO
cord-005453-4057qib7	14914	3	declare	declare	VB
cord-005453-4057qib7	14914	4	.	.	.
cord-005453-4057qib7	14915	1	Comparison	comparison	NN
cord-005453-4057qib7	14915	2	of	of	IN
cord-005453-4057qib7	14915	3	effectiveness	effectiveness	NN
cord-005453-4057qib7	14915	4	of	of	IN
cord-005453-4057qib7	14915	5	plerixafor	plerixafor	NN
cord-005453-4057qib7	14915	6	plus	plus	CC
cord-005453-4057qib7	14915	7	G	G	NNP
cord-005453-4057qib7	14915	8	-	-	HYPH
cord-005453-4057qib7	14915	9	CSF	CSF	NNP
cord-005453-4057qib7	14915	10	in	in	IN
cord-005453-4057qib7	14915	11	poor	poor	JJ
cord-005453-4057qib7	14915	12	and	and	CC
cord-005453-4057qib7	14915	13	very	very	RB
cord-005453-4057qib7	14915	14	poor	poor	JJ
cord-005453-4057qib7	14915	15	-	-	HYPH
cord-005453-4057qib7	14915	16	movilizers	movilizer	NNS
cord-005453-4057qib7	14915	17	:	:	:
cord-005453-4057qib7	14915	18	Efficacy	efficacy	NN
cord-005453-4057qib7	14915	19	of	of	IN
cord-005453-4057qib7	14915	20	the	the	DT
cord-005453-4057qib7	14915	21	combination	combination	NN
cord-005453-4057qib7	14915	22	of	of	IN
cord-005453-4057qib7	14915	23	plerixafor	plerixafor	NN
cord-005453-4057qib7	14915	24	and	and	CC
cord-005453-4057qib7	14915	25	G	G	NNP
cord-005453-4057qib7	14915	26	-	-	HYPH
cord-005453-4057qib7	14915	27	CSF	CSF	NNP
cord-005453-4057qib7	14915	28	in	in	IN
cord-005453-4057qib7	14915	29	poor	poor	JJ
cord-005453-4057qib7	14915	30	-	-	HYPH
cord-005453-4057qib7	14915	31	movilizer	movilizer	NN
cord-005453-4057qib7	14915	32	Background	background	NN
cord-005453-4057qib7	14915	33	:	:	:
cord-005453-4057qib7	14916	1	Healthy	healthy	JJ
cord-005453-4057qib7	14916	2	donors	donor	NNS
cord-005453-4057qib7	14916	3	ocassionally	ocassionally	RB
cord-005453-4057qib7	14916	4	show	show	VBP
cord-005453-4057qib7	14916	5	a	a	DT
cord-005453-4057qib7	14916	6	poor	poor	JJ
cord-005453-4057qib7	14916	7	response	response	NN
cord-005453-4057qib7	14916	8	to	to	IN
cord-005453-4057qib7	14916	9	mobilization	mobilization	NN
cord-005453-4057qib7	14916	10	agents	agent	NNS
cord-005453-4057qib7	14916	11	.	.	.
cord-005453-4057qib7	14917	1	Plerixafor+G	Plerixafor+G	NNP
cord-005453-4057qib7	14917	2	-	-	HYPH
cord-005453-4057qib7	14917	3	CSF	CSF	NNP
cord-005453-4057qib7	14917	4	can	can	MD
cord-005453-4057qib7	14917	5	be	be	VB
cord-005453-4057qib7	14917	6	a	a	DT
cord-005453-4057qib7	14917	7	salvage	salvage	NN
cord-005453-4057qib7	14917	8	strategy	strategy	NN
cord-005453-4057qib7	14917	9	in	in	IN
cord-005453-4057qib7	14917	10	poor	poor	JJ
cord-005453-4057qib7	14917	11	mobilizers	mobilizer	NNS
cord-005453-4057qib7	14917	12	.	.	.
cord-005453-4057qib7	14918	1	Some	some	DT
cord-005453-4057qib7	14918	2	series	series	NN
cord-005453-4057qib7	14918	3	describe	describe	VBP
cord-005453-4057qib7	14918	4	the	the	DT
cord-005453-4057qib7	14918	5	use	use	NN
cord-005453-4057qib7	14918	6	of	of	IN
cord-005453-4057qib7	14918	7	plerixafor	plerixafor	NN
cord-005453-4057qib7	14918	8	to	to	TO
cord-005453-4057qib7	14918	9	collect	collect	VB
cord-005453-4057qib7	14918	10	greater	great	JJR
cord-005453-4057qib7	14918	11	doses	dose	NNS
cord-005453-4057qib7	14918	12	of	of	IN
cord-005453-4057qib7	14918	13	CD34	CD34	NNP
cord-005453-4057qib7	14918	14	+	+	CC
cord-005453-4057qib7	14918	15	cells	cell	NNS
cord-005453-4057qib7	14918	16	in	in	IN
cord-005453-4057qib7	14918	17	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	14918	18	stem	stem	NN
cord-005453-4057qib7	14918	19	cell	cell	NN
cord-005453-4057qib7	14918	20	transplantation	transplantation	NN
cord-005453-4057qib7	14918	21	(	(	-LRB-
cord-005453-4057qib7	14918	22	HSCT	HSCT	NNP
cord-005453-4057qib7	14918	23	)	)	-RRB-
cord-005453-4057qib7	14918	24	with	with	IN
cord-005453-4057qib7	14918	25	Tcell	Tcell	NNP
cord-005453-4057qib7	14918	26	depletion	depletion	NN
cord-005453-4057qib7	14918	27	.	.	.
cord-005453-4057qib7	14919	1	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14919	2	use	use	VB
cord-005453-4057qib7	14919	3	in	in	IN
cord-005453-4057qib7	14919	4	the	the	DT
cord-005453-4057qib7	14919	5	mobilization	mobilization	NN
cord-005453-4057qib7	14919	6	protocol	protocol	NN
cord-005453-4057qib7	14919	7	could	could	MD
cord-005453-4057qib7	14919	8	help	help	VB
cord-005453-4057qib7	14919	9	collecting	collect	VBG
cord-005453-4057qib7	14919	10	higher	high	JJR
cord-005453-4057qib7	14919	11	CD34	CD34	NNP
cord-005453-4057qib7	14919	12	+	+	CC
cord-005453-4057qib7	14919	13	dose	dose	NN
cord-005453-4057qib7	14919	14	in	in	IN
cord-005453-4057qib7	14919	15	indirect	indirect	JJ
cord-005453-4057qib7	14919	16	T	t	NN
cord-005453-4057qib7	14919	17	-	-	HYPH
cord-005453-4057qib7	14919	18	cell	cell	NN
cord-005453-4057qib7	14919	19	depletion	depletion	NN
cord-005453-4057qib7	14919	20	(	(	-LRB-
cord-005453-4057qib7	14919	21	CD34	CD34	NNP
cord-005453-4057qib7	14919	22	+	+	CC
cord-005453-4057qib7	14919	23	selection	selection	NN
cord-005453-4057qib7	14919	24	)	)	-RRB-
cord-005453-4057qib7	14919	25	for	for	IN
cord-005453-4057qib7	14919	26	ex	ex	NN
cord-005453-4057qib7	14919	27	-	-	NN
cord-005453-4057qib7	14919	28	vivo	vivo	JJ
cord-005453-4057qib7	14919	29	manipulated	manipulate	VBN
cord-005453-4057qib7	14919	30	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14919	31	transplantation	transplantation	NN
cord-005453-4057qib7	14919	32	,	,	,
cord-005453-4057qib7	14919	33	with	with	IN
cord-005453-4057qib7	14919	34	less	less	JJR
cord-005453-4057qib7	14919	35	number	number	NN
cord-005453-4057qib7	14919	36	of	of	IN
cord-005453-4057qib7	14919	37	apheresis	apheresis	NN
cord-005453-4057qib7	14919	38	and	and	CC
cord-005453-4057qib7	14919	39	a	a	DT
cord-005453-4057qib7	14919	40	rapid	rapid	JJ
cord-005453-4057qib7	14919	41	engraftment	engraftment	NN
cord-005453-4057qib7	14919	42	.	.	.
cord-005453-4057qib7	14920	1	Methods	method	NNS
cord-005453-4057qib7	14920	2	:	:	:
cord-005453-4057qib7	14920	3	Data	datum	NNS
cord-005453-4057qib7	14920	4	of	of	IN
cord-005453-4057qib7	14920	5	fourteen	fourteen	CD
cord-005453-4057qib7	14920	6	healthy	healthy	JJ
cord-005453-4057qib7	14920	7	peripheral	peripheral	JJ
cord-005453-4057qib7	14920	8	-	-	HYPH
cord-005453-4057qib7	14920	9	blood	blood	NN
cord-005453-4057qib7	14920	10	donors	donor	NNS
cord-005453-4057qib7	14920	11	was	be	VBD
cord-005453-4057qib7	14920	12	retrospectively	retrospectively	RB
cord-005453-4057qib7	14920	13	collected	collect	VBN
cord-005453-4057qib7	14920	14	.	.	.
cord-005453-4057qib7	14921	1	They	-PRON-	PRP
cord-005453-4057qib7	14921	2	received	receive	VBD
cord-005453-4057qib7	14921	3	4	4	CD
cord-005453-4057qib7	14921	4	days	day	NNS
cord-005453-4057qib7	14921	5	10	10	CD
cord-005453-4057qib7	14921	6	mcg	mcg	NN
cord-005453-4057qib7	14921	7	/	/	SYM
cord-005453-4057qib7	14921	8	Kg	Kg	NNP
cord-005453-4057qib7	14921	9	/	/	SYM
cord-005453-4057qib7	14921	10	day	day	NN
cord-005453-4057qib7	14921	11	G	G	NNP
cord-005453-4057qib7	14921	12	-	-	HYPH
cord-005453-4057qib7	14921	13	CSF	CSF	NNP
cord-005453-4057qib7	14921	14	and	and	CC
cord-005453-4057qib7	14921	15	0,24	0,24	CD
cord-005453-4057qib7	14921	16	mg	mg	NNP
cord-005453-4057qib7	14921	17	/	/	SYM
cord-005453-4057qib7	14921	18	Kg	Kg	NNP
cord-005453-4057qib7	14921	19	/	/	SYM
cord-005453-4057qib7	14921	20	day	day	NN
cord-005453-4057qib7	14921	21	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14921	22	on	on	IN
cord-005453-4057qib7	14921	23	4º	4º	CD
cord-005453-4057qib7	14921	24	day	day	NN
cord-005453-4057qib7	14921	25	as	as	IN
cord-005453-4057qib7	14921	26	mobilization	mobilization	NN
cord-005453-4057qib7	14921	27	treatment	treatment	NN
cord-005453-4057qib7	14921	28	.	.	.
cord-005453-4057qib7	14922	1	Fourteen	fourteen	CD
cord-005453-4057qib7	14922	2	pediatric	pediatric	JJ
cord-005453-4057qib7	14922	3	patients	patient	NNS
cord-005453-4057qib7	14922	4	(	(	-LRB-
cord-005453-4057qib7	14922	5	median	median	JJ
cord-005453-4057qib7	14922	6	age	age	NN
cord-005453-4057qib7	14922	7	13	13	CD
cord-005453-4057qib7	14922	8	years	year	NNS
cord-005453-4057qib7	14922	9	,	,	,
cord-005453-4057qib7	14922	10	range	range	VBP
cord-005453-4057qib7	14922	11	8	8	CD
cord-005453-4057qib7	14922	12	-	-	SYM
cord-005453-4057qib7	14922	13	15	15	CD
cord-005453-4057qib7	14922	14	)	)	-RRB-
cord-005453-4057qib7	14922	15	diagnosed	diagnose	VBN
cord-005453-4057qib7	14922	16	with	with	IN
cord-005453-4057qib7	14922	17	malignant	malignant	JJ
cord-005453-4057qib7	14922	18	and	and	CC
cord-005453-4057qib7	14922	19	no	no	DT
cord-005453-4057qib7	14922	20	malignant	malignant	JJ
cord-005453-4057qib7	14922	21	hematological	hematological	JJ
cord-005453-4057qib7	14922	22	diseases	disease	NNS
cord-005453-4057qib7	14922	23	received	receive	VBD
cord-005453-4057qib7	14922	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14922	25	HSCT	HSCT	NNP
cord-005453-4057qib7	14922	26	with	with	IN
cord-005453-4057qib7	14922	27	CD34	CD34	NNP
cord-005453-4057qib7	14922	28	+	+	CC
cord-005453-4057qib7	14922	29	selection	selection	NN
cord-005453-4057qib7	14922	30	and	and	CC
cord-005453-4057qib7	14922	31	CD45RA+	CD45RA+	NNP
cord-005453-4057qib7	14922	32	depletion	depletion	NN
cord-005453-4057qib7	14922	33	between	between	IN
cord-005453-4057qib7	14922	34	February	February	NNP
cord-005453-4057qib7	14922	35	2015	2015	CD
cord-005453-4057qib7	14922	36	and	and	CC
cord-005453-4057qib7	14922	37	July	July	NNP
cord-005453-4057qib7	14922	38	2017	2017	CD
cord-005453-4057qib7	14922	39	.	.	.
cord-005453-4057qib7	14923	1	Results	result	NNS
cord-005453-4057qib7	14923	2	:	:	:
cord-005453-4057qib7	14924	1	One	one	CD
cord-005453-4057qib7	14924	2	leukoapheresis	leukoapheresis	NN
cord-005453-4057qib7	14924	3	procedure	procedure	NN
cord-005453-4057qib7	14924	4	was	be	VBD
cord-005453-4057qib7	14924	5	performed	perform	VBN
cord-005453-4057qib7	14924	6	in	in	IN
cord-005453-4057qib7	14924	7	all	all	DT
cord-005453-4057qib7	14924	8	cases	case	NNS
cord-005453-4057qib7	14924	9	.	.	.
cord-005453-4057qib7	14925	1	Median	median	JJ
cord-005453-4057qib7	14925	2	processed	process	VBN
cord-005453-4057qib7	14925	3	volume	volume	NN
cord-005453-4057qib7	14925	4	was	be	VBD
cord-005453-4057qib7	14925	5	11	11	CD
cord-005453-4057qib7	14925	6	liters	liter	NNS
cord-005453-4057qib7	14925	7	(	(	-LRB-
cord-005453-4057qib7	14925	8	range	range	NNP
cord-005453-4057qib7	14925	9	6	6	CD
cord-005453-4057qib7	14925	10	-	-	SYM
cord-005453-4057qib7	14925	11	14	14	CD
cord-005453-4057qib7	14925	12	)	)	-RRB-
cord-005453-4057qib7	14925	13	.	.	.
cord-005453-4057qib7	14926	1	Median	median	NN
cord-005453-4057qib7	14926	2	of	of	IN
cord-005453-4057qib7	14926	3	CD34	CD34	NNP
cord-005453-4057qib7	14926	4	+	+	CC
cord-005453-4057qib7	14926	5	cells	cell	NNS
cord-005453-4057qib7	14926	6	obtained	obtain	VBN
cord-005453-4057qib7	14926	7	was	be	VBD
cord-005453-4057qib7	14926	8	13,73x10	13,73x10	CD
cord-005453-4057qib7	14926	9	6	6	CD
cord-005453-4057qib7	14927	1	/Kg	/Kg	.
cord-005453-4057qib7	14928	1	(	(	-LRB-
cord-005453-4057qib7	14928	2	range	range	NNP
cord-005453-4057qib7	14928	3	7,8	7,8	NNP
cord-005453-4057qib7	14928	4	-	-	HYPH
cord-005453-4057qib7	14928	5	26,47	26,47	CD
cord-005453-4057qib7	14928	6	)	)	-RRB-
cord-005453-4057qib7	14928	7	.	.	.
cord-005453-4057qib7	14929	1	After	after	IN
cord-005453-4057qib7	14929	2	positive	positive	JJ
cord-005453-4057qib7	14929	3	selection	selection	NN
cord-005453-4057qib7	14929	4	,	,	,
cord-005453-4057qib7	14929	5	>	>	XX
cord-005453-4057qib7	14930	1	4x10	4x10	CD
cord-005453-4057qib7	14930	2	6	6	CD
cord-005453-4057qib7	14931	1	/Kg	/Kg	.
cord-005453-4057qib7	14932	1	CD34	CD34	NNP
cord-005453-4057qib7	14932	2	+	+	CC
cord-005453-4057qib7	14932	3	cells	cell	NNS
cord-005453-4057qib7	14932	4	were	be	VBD
cord-005453-4057qib7	14932	5	infused	infuse	VBN
cord-005453-4057qib7	14932	6	in	in	IN
cord-005453-4057qib7	14932	7	all	all	DT
cord-005453-4057qib7	14932	8	cases	case	NNS
cord-005453-4057qib7	14932	9	(	(	-LRB-
cord-005453-4057qib7	14932	10	Figure	figure	NN
cord-005453-4057qib7	14932	11	1	1	CD
cord-005453-4057qib7	14932	12	)	)	-RRB-
cord-005453-4057qib7	14932	13	.	.	.
cord-005453-4057qib7	14933	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	14933	2	engraftment	engraftment	NN
cord-005453-4057qib7	14933	3	was	be	VBD
cord-005453-4057qib7	14933	4	achieved	achieve	VBN
cord-005453-4057qib7	14933	5	after	after	IN
cord-005453-4057qib7	14933	6	a	a	DT
cord-005453-4057qib7	14933	7	median	median	NN
cord-005453-4057qib7	14933	8	of	of	IN
cord-005453-4057qib7	14933	9	15	15	CD
cord-005453-4057qib7	14933	10	days	day	NNS
cord-005453-4057qib7	14933	11	(	(	-LRB-
cord-005453-4057qib7	14933	12	range	range	VBP
cord-005453-4057qib7	14933	13	10	10	CD
cord-005453-4057qib7	14933	14	-	-	SYM
cord-005453-4057qib7	14933	15	17	17	CD
cord-005453-4057qib7	14933	16	)	)	-RRB-
cord-005453-4057qib7	14933	17	.	.	.
cord-005453-4057qib7	14934	1	Few	few	JJ
cord-005453-4057qib7	14934	2	donors	donor	NNS
cord-005453-4057qib7	14934	3	presented	present	VBD
cord-005453-4057qib7	14934	4	only	only	RB
cord-005453-4057qib7	14934	5	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14934	6	mild	mild	JJ
cord-005453-4057qib7	14934	7	secondary	secondary	JJ
cord-005453-4057qib7	14934	8	effects	effect	NNS
cord-005453-4057qib7	14934	9	.	.	.
cord-005453-4057qib7	14935	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14935	2	:	:	:
cord-005453-4057qib7	14936	1	Our	-PRON-	PRP$
cord-005453-4057qib7	14936	2	experience	experience	NN
cord-005453-4057qib7	14936	3	showed	show	VBD
cord-005453-4057qib7	14936	4	that	that	IN
cord-005453-4057qib7	14936	5	a	a	DT
cord-005453-4057qib7	14936	6	mobilization	mobilization	NN
cord-005453-4057qib7	14936	7	protocol	protocol	NN
cord-005453-4057qib7	14936	8	using	use	VBG
cord-005453-4057qib7	14936	9	G	G	NNP
cord-005453-4057qib7	14936	10	-	-	HYPH
cord-005453-4057qib7	14936	11	CSF	CSF	NNP
cord-005453-4057qib7	14936	12	and	and	CC
cord-005453-4057qib7	14936	13	standard	standard	JJ
cord-005453-4057qib7	14936	14	dose	dose	NN
cord-005453-4057qib7	14936	15	of	of	IN
cord-005453-4057qib7	14936	16	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	14936	17	(	(	-LRB-
cord-005453-4057qib7	14936	18	compasive	compasive	NNP
cord-005453-4057qib7	14936	19	use	use	NN
cord-005453-4057qib7	14936	20	)	)	-RRB-
cord-005453-4057qib7	14936	21	is	be	VBZ
cord-005453-4057qib7	14936	22	a	a	DT
cord-005453-4057qib7	14936	23	safe	safe	JJ
cord-005453-4057qib7	14936	24	strategy	strategy	NN
cord-005453-4057qib7	14936	25	that	that	WDT
cord-005453-4057qib7	14936	26	allows	allow	VBZ
cord-005453-4057qib7	14936	27	collecting	collect	VBG
cord-005453-4057qib7	14936	28	great	great	JJ
cord-005453-4057qib7	14936	29	CD34	CD34	NNP
cord-005453-4057qib7	14936	30	+	+	CC
cord-005453-4057qib7	14936	31	dose	dose	NN
cord-005453-4057qib7	14936	32	in	in	IN
cord-005453-4057qib7	14936	33	one	one	CD
cord-005453-4057qib7	14936	34	apheresis	apheresis	NN
cord-005453-4057qib7	14936	35	procedure	procedure	NN
cord-005453-4057qib7	14936	36	.	.	.
cord-005453-4057qib7	14937	1	This	this	DT
cord-005453-4057qib7	14937	2	could	could	MD
cord-005453-4057qib7	14937	3	be	be	VB
cord-005453-4057qib7	14937	4	useful	useful	JJ
cord-005453-4057qib7	14937	5	for	for	IN
cord-005453-4057qib7	14937	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14937	7	transplantation	transplantation	NN
cord-005453-4057qib7	14937	8	with	with	IN
cord-005453-4057qib7	14937	9	ex	ex	JJ
cord-005453-4057qib7	14937	10	-	-	JJ
cord-005453-4057qib7	14937	11	vivo	vivo	JJ
cord-005453-4057qib7	14937	12	T	t	NN
cord-005453-4057qib7	14937	13	depletion	depletion	NN
cord-005453-4057qib7	14937	14	,	,	,
cord-005453-4057qib7	14937	15	especially	especially	RB
cord-005453-4057qib7	14937	16	if	if	IN
cord-005453-4057qib7	14937	17	there´s	there´s	NNP
cord-005453-4057qib7	14937	18	a	a	DT
cord-005453-4057qib7	14937	19	weight	weight	NN
cord-005453-4057qib7	14937	20	disproportion	disproportion	NN
cord-005453-4057qib7	14937	21	between	between	IN
cord-005453-4057qib7	14937	22	donor	donor	NN
cord-005453-4057qib7	14937	23	and	and	CC
cord-005453-4057qib7	14937	24	patient	patient	NN
cord-005453-4057qib7	14937	25	.	.	.
cord-005453-4057qib7	14938	1	Background	background	NN
cord-005453-4057qib7	14938	2	:	:	:
cord-005453-4057qib7	14939	1	Mesenchymal	Mesenchymal	NNS
cord-005453-4057qib7	14939	2	stem	stem	VBP
cord-005453-4057qib7	14939	3	cells	cell	NNS
cord-005453-4057qib7	14939	4	(	(	-LRB-
cord-005453-4057qib7	14939	5	MSCs	msc	NNS
cord-005453-4057qib7	14939	6	)	)	-RRB-
cord-005453-4057qib7	14939	7	are	be	VBP
cord-005453-4057qib7	14939	8	selfrenewing	selfrenewe	VBG
cord-005453-4057qib7	14939	9	multipotent	multipotent	JJ
cord-005453-4057qib7	14939	10	progenitor	progenitor	NN
cord-005453-4057qib7	14939	11	cells	cell	NNS
cord-005453-4057qib7	14939	12	with	with	IN
cord-005453-4057qib7	14939	13	wide	wide	JJ
cord-005453-4057qib7	14939	14	differentiation	differentiation	NN
cord-005453-4057qib7	14939	15	potential	potential	NN
cord-005453-4057qib7	14939	16	.	.	.
cord-005453-4057qib7	14940	1	Their	-PRON-	PRP$
cord-005453-4057qib7	14940	2	ease	ease	NN
cord-005453-4057qib7	14940	3	of	of	IN
cord-005453-4057qib7	14940	4	isolation	isolation	NN
cord-005453-4057qib7	14940	5	and	and	CC
cord-005453-4057qib7	14940	6	expansion	expansion	NN
cord-005453-4057qib7	14940	7	in	in	IN
cord-005453-4057qib7	14940	8	vitro	vitro	FW
cord-005453-4057qib7	14940	9	as	as	RB
cord-005453-4057qib7	14940	10	well	well	RB
cord-005453-4057qib7	14940	11	as	as	IN
cord-005453-4057qib7	14940	12	their	-PRON-	PRP$
cord-005453-4057qib7	14940	13	unique	unique	JJ
cord-005453-4057qib7	14940	14	regenerative	regenerative	JJ
cord-005453-4057qib7	14940	15	therapeutic	therapeutic	JJ
cord-005453-4057qib7	14940	16	properties	property	NNS
cord-005453-4057qib7	14940	17	suggest	suggest	VBP
cord-005453-4057qib7	14940	18	the	the	DT
cord-005453-4057qib7	14940	19	use	use	NN
cord-005453-4057qib7	14940	20	of	of	IN
cord-005453-4057qib7	14940	21	MSC	MSC	NNP
cord-005453-4057qib7	14940	22	as	as	IN
cord-005453-4057qib7	14940	23	an	an	DT
cord-005453-4057qib7	14940	24	approach	approach	NN
cord-005453-4057qib7	14940	25	for	for	IN
cord-005453-4057qib7	14940	26	treating	treat	VBG
cord-005453-4057qib7	14940	27	several	several	JJ
cord-005453-4057qib7	14940	28	disorders	disorder	NNS
cord-005453-4057qib7	14940	29	.	.	.
cord-005453-4057qib7	14941	1	Extra	extra	JJ
cord-005453-4057qib7	14941	2	-	-	JJ
cord-005453-4057qib7	14941	3	embryonic	embryonic	JJ
cord-005453-4057qib7	14941	4	tissues	tissue	NNS
cord-005453-4057qib7	14941	5	as	as	IN
cord-005453-4057qib7	14941	6	placenta	placenta	NN
cord-005453-4057qib7	14941	7	have	have	VBP
cord-005453-4057qib7	14941	8	been	be	VBN
cord-005453-4057qib7	14941	9	proposed	propose	VBN
cord-005453-4057qib7	14941	10	as	as	IN
cord-005453-4057qib7	14941	11	potential	potential	JJ
cord-005453-4057qib7	14941	12	sources	source	NNS
cord-005453-4057qib7	14941	13	of	of	IN
cord-005453-4057qib7	14941	14	MSCs	msc	NNS
cord-005453-4057qib7	14941	15	due	due	IN
cord-005453-4057qib7	14941	16	to	to	IN
cord-005453-4057qib7	14941	17	the	the	DT
cord-005453-4057qib7	14941	18	absence	absence	NN
cord-005453-4057qib7	14941	19	of	of	IN
cord-005453-4057qib7	14941	20	ethical	ethical	JJ
cord-005453-4057qib7	14941	21	problems	problem	NNS
cord-005453-4057qib7	14941	22	neither	neither	CC
cord-005453-4057qib7	14941	23	risks	risk	NNS
cord-005453-4057qib7	14941	24	for	for	IN
cord-005453-4057qib7	14941	25	the	the	DT
cord-005453-4057qib7	14941	26	patients	patient	NNS
cord-005453-4057qib7	14941	27	.	.	.
cord-005453-4057qib7	14942	1	Furthermore	furthermore	RB
cord-005453-4057qib7	14942	2	,	,	,
cord-005453-4057qib7	14942	3	only	only	RB
cord-005453-4057qib7	14942	4	protocols	protocol	NNS
cord-005453-4057qib7	14942	5	using	use	VBG
cord-005453-4057qib7	14942	6	fresh	fresh	JJ
cord-005453-4057qib7	14942	7	placental	placental	NN
cord-005453-4057qib7	14942	8	tissue	tissue	NN
cord-005453-4057qib7	14942	9	have	have	VBP
cord-005453-4057qib7	14942	10	been	be	VBN
cord-005453-4057qib7	14942	11	described	describe	VBN
cord-005453-4057qib7	14942	12	so	so	RB
cord-005453-4057qib7	14942	13	far	far	RB
cord-005453-4057qib7	14942	14	.	.	.
cord-005453-4057qib7	14943	1	A	a	DT
cord-005453-4057qib7	14943	2	protocol	protocol	NN
cord-005453-4057qib7	14943	3	for	for	IN
cord-005453-4057qib7	14943	4	isolating	isolate	VBG
cord-005453-4057qib7	14943	5	MSCs	msc	NNS
cord-005453-4057qib7	14943	6	from	from	IN
cord-005453-4057qib7	14943	7	delayed	delay	VBN
cord-005453-4057qib7	14943	8	-	-	HYPH
cord-005453-4057qib7	14943	9	manipulated	manipulate	VBN
cord-005453-4057qib7	14943	10	tissue	tissue	NN
cord-005453-4057qib7	14943	11	was	be	VBD
cord-005453-4057qib7	14943	12	designed	design	VBN
cord-005453-4057qib7	14943	13	and	and	CC
cord-005453-4057qib7	14943	14	tested	test	VBN
cord-005453-4057qib7	14943	15	in	in	IN
cord-005453-4057qib7	14943	16	order	order	NN
cord-005453-4057qib7	14943	17	to	to	TO
cord-005453-4057qib7	14943	18	optimize	optimize	VB
cord-005453-4057qib7	14943	19	the	the	DT
cord-005453-4057qib7	14943	20	use	use	NN
cord-005453-4057qib7	14943	21	of	of	IN
cord-005453-4057qib7	14943	22	placental	placental	NN
cord-005453-4057qib7	14943	23	MSCs	msc	NNS
cord-005453-4057qib7	14943	24	(	(	-LRB-
cord-005453-4057qib7	14943	25	MSCs	mscs	NN
cord-005453-4057qib7	14943	26	-	-	HYPH
cord-005453-4057qib7	14943	27	P	p	NN
cord-005453-4057qib7	14943	28	)	)	-RRB-
cord-005453-4057qib7	14943	29	in	in	IN
cord-005453-4057qib7	14943	30	an	an	DT
cord-005453-4057qib7	14943	31	advanced	advanced	JJ
cord-005453-4057qib7	14943	32	therapies	therapy	NNS
cord-005453-4057qib7	14943	33	context	context	NN
cord-005453-4057qib7	14943	34	.	.	.
cord-005453-4057qib7	14944	1	Methods	method	NNS
cord-005453-4057qib7	14944	2	:	:	:
cord-005453-4057qib7	14944	3	Full	full	JJ
cord-005453-4057qib7	14944	4	term	term	NN
cord-005453-4057qib7	14944	5	placentas	placenta	NNS
cord-005453-4057qib7	14944	6	(	(	-LRB-
cord-005453-4057qib7	14944	7	n=10	n=10	NNP
cord-005453-4057qib7	14944	8	)	)	-RRB-
cord-005453-4057qib7	14944	9	were	be	VBD
cord-005453-4057qib7	14944	10	obtained	obtain	VBN
cord-005453-4057qib7	14944	11	from	from	IN
cord-005453-4057qib7	14944	12	healthy	healthy	JJ
cord-005453-4057qib7	14944	13	mothers	mother	NNS
cord-005453-4057qib7	14944	14	in	in	IN
cord-005453-4057qib7	14944	15	Hospital	Hospital	NNP
cord-005453-4057qib7	14944	16	Universitario	Universitario	NNP
cord-005453-4057qib7	14944	17	Central	Central	NNP
cord-005453-4057qib7	14944	18	de	de	FW
cord-005453-4057qib7	14944	19	Asturias	Asturias	NNP
cord-005453-4057qib7	14944	20	(	(	-LRB-
cord-005453-4057qib7	14944	21	Spain	Spain	NNP
cord-005453-4057qib7	14944	22	)	)	-RRB-
cord-005453-4057qib7	14944	23	.	.	.
cord-005453-4057qib7	14945	1	Informed	informed	JJ
cord-005453-4057qib7	14945	2	consent	consent	NN
cord-005453-4057qib7	14945	3	was	be	VBD
cord-005453-4057qib7	14945	4	obtained	obtain	VBN
cord-005453-4057qib7	14945	5	from	from	IN
cord-005453-4057qib7	14945	6	each	each	DT
cord-005453-4057qib7	14945	7	mother	mother	NN
cord-005453-4057qib7	14945	8	prior	prior	RB
cord-005453-4057qib7	14945	9	to	to	IN
cord-005453-4057qib7	14945	10	delivery	delivery	NN
cord-005453-4057qib7	14945	11	.	.	.
cord-005453-4057qib7	14946	1	After	after	IN
cord-005453-4057qib7	14946	2	dissection	dissection	NN
cord-005453-4057qib7	14946	3	of	of	IN
cord-005453-4057qib7	14946	4	12	12	CD
cord-005453-4057qib7	14946	5	gr	gr	NNP
cord-005453-4057qib7	14946	6	decidual	decidual	JJ
cord-005453-4057qib7	14946	7	tissue	tissue	NN
cord-005453-4057qib7	14946	8	it	-PRON-	PRP
cord-005453-4057qib7	14946	9	was	be	VBD
cord-005453-4057qib7	14946	10	washing	wash	VBG
cord-005453-4057qib7	14946	11	with	with	IN
cord-005453-4057qib7	14946	12	saline	saline	NN
cord-005453-4057qib7	14946	13	(	(	-LRB-
cord-005453-4057qib7	14946	14	B.	B.	NNP
cord-005453-4057qib7	14946	15	Braun	Braun	NNP
cord-005453-4057qib7	14946	16	,	,	,
cord-005453-4057qib7	14946	17	Germany	Germany	NNP
cord-005453-4057qib7	14946	18	)	)	-RRB-
cord-005453-4057qib7	14946	19	and	and	CC
cord-005453-4057qib7	14946	20	cut	cut	VBD
cord-005453-4057qib7	14946	21	into	into	IN
cord-005453-4057qib7	14946	22	small	small	JJ
cord-005453-4057qib7	14946	23	pieces	piece	NNS
cord-005453-4057qib7	14946	24	.	.	.
cord-005453-4057qib7	14947	1	These	these	DT
cord-005453-4057qib7	14947	2	biopsies	biopsy	NNS
cord-005453-4057qib7	14947	3	were	be	VBD
cord-005453-4057qib7	14947	4	conserved	conserve	VBN
cord-005453-4057qib7	14947	5	24	24	CD
cord-005453-4057qib7	14947	6	hours	hour	NNS
cord-005453-4057qib7	14947	7	in	in	IN
cord-005453-4057qib7	14947	8	DMEM	DMEM	NNP
cord-005453-4057qib7	14947	9	media	medium	NNS
cord-005453-4057qib7	14947	10	with	with	IN
cord-005453-4057qib7	14947	11	1	1	CD
cord-005453-4057qib7	14947	12	%	%	NN
cord-005453-4057qib7	14947	13	antibiotic	antibiotic	JJ
cord-005453-4057qib7	14947	14	solution	solution	NN
cord-005453-4057qib7	14947	15	100X	100x	CD
cord-005453-4057qib7	14948	1	(	(	-LRB-
cord-005453-4057qib7	14948	2	Gibco	Gibco	NNP
cord-005453-4057qib7	14948	3	,	,	,
cord-005453-4057qib7	14948	4	USAUSA	USAUSA	NNP
cord-005453-4057qib7	14948	5	)	)	-RRB-
cord-005453-4057qib7	14948	6	until	until	IN
cord-005453-4057qib7	14948	7	processing	processing	NN
cord-005453-4057qib7	14948	8	.	.	.
cord-005453-4057qib7	14949	1	The	the	DT
cord-005453-4057qib7	14949	2	day	day	NN
cord-005453-4057qib7	14949	3	after	after	RB
cord-005453-4057qib7	14949	4	,	,	,
cord-005453-4057qib7	14949	5	tissue	tissue	NN
cord-005453-4057qib7	14949	6	was	be	VBD
cord-005453-4057qib7	14949	7	mechanically	mechanically	RB
cord-005453-4057qib7	14949	8	minced	mince	VBN
cord-005453-4057qib7	14949	9	and	and	CC
cord-005453-4057qib7	14949	10	then	then	RB
cord-005453-4057qib7	14949	11	enzimatically	enzimatically	RB
cord-005453-4057qib7	14949	12	digested	digest	VBD
cord-005453-4057qib7	14949	13	with	with	IN
cord-005453-4057qib7	14949	14	a	a	DT
cord-005453-4057qib7	14949	15	combination	combination	NN
cord-005453-4057qib7	14949	16	of	of	IN
cord-005453-4057qib7	14949	17	80UI	80ui	CD
cord-005453-4057qib7	14949	18	/	/	SYM
cord-005453-4057qib7	14949	19	ml	ml	NN
cord-005453-4057qib7	14950	1	DNAse	dnase	FW
cord-005453-4057qib7	14950	2	I	-PRON-	PRP
cord-005453-4057qib7	14950	3	(	(	-LRB-
cord-005453-4057qib7	14950	4	Sigma	Sigma	NNP
cord-005453-4057qib7	14950	5	Aldrich	Aldrich	NNP
cord-005453-4057qib7	14950	6	,	,	,
cord-005453-4057qib7	14950	7	USA	USA	NNP
cord-005453-4057qib7	14950	8	)	)	-RRB-
cord-005453-4057qib7	14950	9	and	and	CC
cord-005453-4057qib7	14950	10	0.25	0.25	CD
cord-005453-4057qib7	14950	11	%	%	NN
cord-005453-4057qib7	14950	12	tripsin	tripsin	NNP
cord-005453-4057qib7	14950	13	-	-	HYPH
cord-005453-4057qib7	14950	14	EDTA	EDTA	NNP
cord-005453-4057qib7	14950	15	solution	solution	NN
cord-005453-4057qib7	14950	16	(	(	-LRB-
cord-005453-4057qib7	14950	17	w	w	NN
cord-005453-4057qib7	14950	18	/	/	SYM
cord-005453-4057qib7	14950	19	v	v	NN
cord-005453-4057qib7	14950	20	)	)	-RRB-
cord-005453-4057qib7	14951	1	(	(	-LRB-
cord-005453-4057qib7	14951	2	Biochrom	Biochrom	NNP
cord-005453-4057qib7	14951	3	,	,	,
cord-005453-4057qib7	14951	4	Germany	Germany	NNP
cord-005453-4057qib7	14951	5	)	)	-RRB-
cord-005453-4057qib7	14951	6	at	at	IN
cord-005453-4057qib7	14951	7	37ºC	37ºc	CD
cord-005453-4057qib7	14951	8	for	for	IN
cord-005453-4057qib7	14951	9	1	1	CD
cord-005453-4057qib7	14951	10	hour	hour	NN
cord-005453-4057qib7	14951	11	.	.	.
cord-005453-4057qib7	14952	1	Then	then	RB
cord-005453-4057qib7	14952	2	,	,	,
cord-005453-4057qib7	14952	3	the	the	DT
cord-005453-4057qib7	14952	4	mixture	mixture	NN
cord-005453-4057qib7	14952	5	was	be	VBD
cord-005453-4057qib7	14952	6	filtered	filter	VBN
cord-005453-4057qib7	14952	7	with	with	IN
cord-005453-4057qib7	14952	8	40μm	40μm	JJ
cord-005453-4057qib7	14952	9	Cell	cell	NN
cord-005453-4057qib7	14952	10	Strainer	strainer	NN
cord-005453-4057qib7	14952	11	(	(	-LRB-
cord-005453-4057qib7	14952	12	BD	BD	NNP
cord-005453-4057qib7	14952	13	Bioscience	Bioscience	NNP
cord-005453-4057qib7	14952	14	,	,	,
cord-005453-4057qib7	14952	15	USA	USA	NNP
cord-005453-4057qib7	14952	16	)	)	-RRB-
cord-005453-4057qib7	14952	17	and	and	CC
cord-005453-4057qib7	14952	18	centrifuge	centrifuge	NN
cord-005453-4057qib7	14952	19	at	at	IN
cord-005453-4057qib7	14952	20	300xg	300xg	NN
cord-005453-4057qib7	14952	21	for	for	IN
cord-005453-4057qib7	14952	22	5	5	CD
cord-005453-4057qib7	14952	23	minutes	minute	NNS
cord-005453-4057qib7	14952	24	.	.	.
cord-005453-4057qib7	14953	1	Finally	finally	RB
cord-005453-4057qib7	14953	2	,	,	,
cord-005453-4057qib7	14953	3	cells	cell	NNS
cord-005453-4057qib7	14953	4	were	be	VBD
cord-005453-4057qib7	14953	5	resuspended	resuspend	VBN
cord-005453-4057qib7	14953	6	in	in	IN
cord-005453-4057qib7	14953	7	5ml	5ml	NN
cord-005453-4057qib7	14953	8	of	of	IN
cord-005453-4057qib7	14953	9	DMEM	DMEM	NNP
cord-005453-4057qib7	14953	10	media	medium	NNS
cord-005453-4057qib7	14953	11	suplemented	suplemente	VBN
cord-005453-4057qib7	14953	12	with	with	IN
cord-005453-4057qib7	14953	13	10	10	CD
cord-005453-4057qib7	14953	14	%	%	NN
cord-005453-4057qib7	14953	15	FBS	fbs	NN
cord-005453-4057qib7	14953	16	and	and	CC
cord-005453-4057qib7	14953	17	antibiotic	antibiotic	NN
cord-005453-4057qib7	14953	18	,	,	,
cord-005453-4057qib7	14953	19	seeded	seed	VBN
cord-005453-4057qib7	14953	20	in	in	IN
cord-005453-4057qib7	14953	21	24-cm	24-cm	CD
cord-005453-4057qib7	14953	22	flask	flask	NN
cord-005453-4057qib7	14953	23	and	and	CC
cord-005453-4057qib7	14953	24	incubated	incubate	VBN
cord-005453-4057qib7	14953	25	in	in	IN
cord-005453-4057qib7	14953	26	Forma	Forma	NNP
cord-005453-4057qib7	14953	27	SteriCult	SteriCult	NNP
cord-005453-4057qib7	14953	28	CO	CO	NNP
cord-005453-4057qib7	14953	29	2	2	CD
cord-005453-4057qib7	14953	30	incubator	incubator	NN
cord-005453-4057qib7	14953	31	(	(	-LRB-
cord-005453-4057qib7	14953	32	Thermo	Thermo	NNP
cord-005453-4057qib7	14953	33	Fisher	Fisher	NNP
cord-005453-4057qib7	14953	34	Scientific	Scientific	NNP
cord-005453-4057qib7	14953	35	,	,	,
cord-005453-4057qib7	14953	36	USA	USA	NNP
cord-005453-4057qib7	14953	37	)	)	-RRB-
cord-005453-4057qib7	14953	38	at	at	IN
cord-005453-4057qib7	14953	39	37ºC	37ºc	CD
cord-005453-4057qib7	14953	40	,	,	,
cord-005453-4057qib7	14953	41	5%CO	5%co	CD
cord-005453-4057qib7	14953	42	2	2	CD
cord-005453-4057qib7	14953	43	.	.	.
cord-005453-4057qib7	14954	1	Culture	culture	NN
cord-005453-4057qib7	14954	2	-	-	HYPH
cord-005453-4057qib7	14954	3	expanded	expand	VBN
cord-005453-4057qib7	14954	4	MSCs	mscs	NN
cord-005453-4057qib7	14954	5	cells	cell	NNS
cord-005453-4057qib7	14954	6	were	be	VBD
cord-005453-4057qib7	14954	7	phenotipically	phenotipically	RB
cord-005453-4057qib7	14954	8	characterized	characterize	VBN
cord-005453-4057qib7	14954	9	by	by	IN
cord-005453-4057qib7	14954	10	flow	flow	NN
cord-005453-4057qib7	14954	11	cytometry	cytometry	NN
cord-005453-4057qib7	14954	12	(	(	-LRB-
cord-005453-4057qib7	14954	13	FACS	FACS	NNP
cord-005453-4057qib7	14954	14	Aria	Aria	NNP
cord-005453-4057qib7	14954	15	IIu	IIu	NNP
cord-005453-4057qib7	14954	16	,	,	,
cord-005453-4057qib7	14954	17	BD	BD	NNP
cord-005453-4057qib7	14954	18	)	)	-RRB-
cord-005453-4057qib7	14954	19	with	with	IN
cord-005453-4057qib7	14954	20	antibodies	antibody	NNS
cord-005453-4057qib7	14954	21	against	against	IN
cord-005453-4057qib7	14954	22	CD29	CD29	NNP
cord-005453-4057qib7	14954	23	,	,	,
cord-005453-4057qib7	14954	24	CD44	CD44	NNP
cord-005453-4057qib7	14954	25	,	,	,
cord-005453-4057qib7	14954	26	CD73	CD73	NNP
cord-005453-4057qib7	14954	27	,	,	,
cord-005453-4057qib7	14954	28	CD90	CD90	NNP
cord-005453-4057qib7	14954	29	,	,	,
cord-005453-4057qib7	14954	30	CD105	CD105	NNP
cord-005453-4057qib7	14954	31	,	,	,
cord-005453-4057qib7	14954	32	CD166	CD166	NNP
cord-005453-4057qib7	14954	33	,	,	,
cord-005453-4057qib7	14954	34	CD34	CD34	NNP
cord-005453-4057qib7	14954	35	,	,	,
cord-005453-4057qib7	14954	36	CD45	CD45	NNP
cord-005453-4057qib7	14954	37	,	,	,
cord-005453-4057qib7	14954	38	HLA	HLA	NNP
cord-005453-4057qib7	14954	39	-	-	HYPH
cord-005453-4057qib7	14954	40	DR	DR	NNP
cord-005453-4057qib7	14954	41	CD14	CD14	NNP
cord-005453-4057qib7	14954	42	and	and	CC
cord-005453-4057qib7	14954	43	CD19	CD19	NNP
cord-005453-4057qib7	14954	44	using	use	VBG
cord-005453-4057qib7	14954	45	Mesenchymal	Mesenchymal	NNP
cord-005453-4057qib7	14954	46	Cell	Cell	NNP
cord-005453-4057qib7	14954	47	Kit	kit	NN
cord-005453-4057qib7	14954	48	(	(	-LRB-
cord-005453-4057qib7	14954	49	Immunostep	Immunostep	NNP
cord-005453-4057qib7	14954	50	,	,	,
cord-005453-4057qib7	14954	51	Spain	Spain	NNP
cord-005453-4057qib7	14954	52	)	)	-RRB-
cord-005453-4057qib7	14954	53	.	.	.
cord-005453-4057qib7	14955	1	Afterwards	afterwards	RB
cord-005453-4057qib7	14955	2	,	,	,
cord-005453-4057qib7	14955	3	these	these	DT
cord-005453-4057qib7	14955	4	cells	cell	NNS
cord-005453-4057qib7	14955	5	were	be	VBD
cord-005453-4057qib7	14955	6	differentiated	differentiate	VBN
cord-005453-4057qib7	14955	7	to	to	IN
cord-005453-4057qib7	14955	8	adipogenic	adipogenic	NNP
cord-005453-4057qib7	14955	9	,	,	,
cord-005453-4057qib7	14955	10	osteogenic	osteogenic	JJ
cord-005453-4057qib7	14955	11	and	and	CC
cord-005453-4057qib7	14955	12	chondrogenic	chondrogenic	JJ
cord-005453-4057qib7	14955	13	lineages	lineage	NNS
cord-005453-4057qib7	14955	14	using	use	VBG
cord-005453-4057qib7	14955	15	StemMACS	StemMACS	NNP
cord-005453-4057qib7	14955	16	AdipoDiff	AdipoDiff	NNP
cord-005453-4057qib7	14955	17	Media	medium	NNS
cord-005453-4057qib7	14955	18	,	,	,
cord-005453-4057qib7	14955	19	StemMACS	StemMACS	NNP
cord-005453-4057qib7	14955	20	OsteoDiff	OsteoDiff	NNP
cord-005453-4057qib7	14955	21	Media	Media	NNP
cord-005453-4057qib7	14955	22	and	and	CC
cord-005453-4057qib7	14955	23	NH	NH	NNP
cord-005453-4057qib7	14955	24	ChondroDiff	ChondroDiff	NNP
cord-005453-4057qib7	14955	25	Medium	Medium	NNP
cord-005453-4057qib7	14956	1	(	(	-LRB-
cord-005453-4057qib7	14956	2	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	14956	3	Biotec	Biotec	NNP
cord-005453-4057qib7	14956	4	,	,	,
cord-005453-4057qib7	14956	5	Germany	Germany	NNP
cord-005453-4057qib7	14956	6	)	)	-RRB-
cord-005453-4057qib7	14956	7	respectively	respectively	RB
cord-005453-4057qib7	14956	8	.	.	.
cord-005453-4057qib7	14957	1	After	after	IN
cord-005453-4057qib7	14957	2	three	three	CD
cord-005453-4057qib7	14957	3	weeks	week	NNS
cord-005453-4057qib7	14957	4	of	of	IN
cord-005453-4057qib7	14957	5	differentiation	differentiation	NN
cord-005453-4057qib7	14957	6	cells	cell	NNS
cord-005453-4057qib7	14957	7	were	be	VBD
cord-005453-4057qib7	14957	8	fixed	fix	VBN
cord-005453-4057qib7	14957	9	in	in	IN
cord-005453-4057qib7	14957	10	4	4	CD
cord-005453-4057qib7	14957	11	%	%	NN
cord-005453-4057qib7	14957	12	paraformaldehide	paraformaldehide	NN
cord-005453-4057qib7	14957	13	(	(	-LRB-
cord-005453-4057qib7	14957	14	Merck	Merck	NNP
cord-005453-4057qib7	14957	15	,	,	,
cord-005453-4057qib7	14957	16	USA	USA	NNP
cord-005453-4057qib7	14957	17	)	)	-RRB-
cord-005453-4057qib7	14957	18	and	and	CC
cord-005453-4057qib7	14957	19	analyzed	analyze	VBD
cord-005453-4057qib7	14957	20	.	.	.
cord-005453-4057qib7	14958	1	Adipogenic	Adipogenic	NNP
cord-005453-4057qib7	14958	2	,	,	,
cord-005453-4057qib7	14958	3	osteogenic	osteogenic	JJ
cord-005453-4057qib7	14958	4	and	and	CC
cord-005453-4057qib7	14958	5	chondrogenic	chondrogenic	JJ
cord-005453-4057qib7	14958	6	differentiation	differentiation	NN
cord-005453-4057qib7	14958	7	was	be	VBD
cord-005453-4057qib7	14958	8	visualized	visualize	VBN
cord-005453-4057qib7	14958	9	after	after	IN
cord-005453-4057qib7	14958	10	staining	stain	VBG
cord-005453-4057qib7	14958	11	with	with	IN
cord-005453-4057qib7	14958	12	Oil	Oil	NNP
cord-005453-4057qib7	14958	13	Red	Red	NNP
cord-005453-4057qib7	14958	14	O	o	NN
cord-005453-4057qib7	14958	15	,	,	,
cord-005453-4057qib7	14958	16	Alkaline	Alkaline	NNP
cord-005453-4057qib7	14958	17	Phosphatase	Phosphatase	NNP
cord-005453-4057qib7	14958	18	and	and	CC
cord-005453-4057qib7	14958	19	Hematoxilin	Hematoxilin	NNP
cord-005453-4057qib7	14958	20	-	-	HYPH
cord-005453-4057qib7	14958	21	Eosin	Eosin	NNP
cord-005453-4057qib7	14958	22	(	(	-LRB-
cord-005453-4057qib7	14958	23	Sigma	Sigma	NNP
cord-005453-4057qib7	14958	24	-	-	HYPH
cord-005453-4057qib7	14958	25	Aldrich	Aldrich	NNP
cord-005453-4057qib7	14958	26	,	,	,
cord-005453-4057qib7	14958	27	USA	USA	NNP
cord-005453-4057qib7	14958	28	)	)	-RRB-
cord-005453-4057qib7	14958	29	.	.	.
cord-005453-4057qib7	14959	1	Results	result	NNS
cord-005453-4057qib7	14959	2	:	:	:
cord-005453-4057qib7	14960	1	MSCs	mscs	NN
cord-005453-4057qib7	14960	2	-	-	HYPH
cord-005453-4057qib7	14960	3	P	p	NN
cord-005453-4057qib7	14960	4	isolated	isolate	VBN
cord-005453-4057qib7	14960	5	cells	cell	NNS
cord-005453-4057qib7	14960	6	were	be	VBD
cord-005453-4057qib7	14960	7	characterized	characterize	VBN
cord-005453-4057qib7	14960	8	according	accord	VBG
cord-005453-4057qib7	14960	9	to	to	IN
cord-005453-4057qib7	14960	10	the	the	DT
cord-005453-4057qib7	14960	11	ISCT	ISCT	NNP
cord-005453-4057qib7	14960	12	criteria	criterion	NNS
cord-005453-4057qib7	14960	13	for	for	IN
cord-005453-4057qib7	14960	14	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	14960	15	stem	stem	NN
cord-005453-4057qib7	14960	16	cells	cell	NNS
cord-005453-4057qib7	14960	17	.	.	.
cord-005453-4057qib7	14961	1	They	-PRON-	PRP
cord-005453-4057qib7	14961	2	were	be	VBD
cord-005453-4057qib7	14961	3	positive	positive	JJ
cord-005453-4057qib7	14961	4	for	for	IN
cord-005453-4057qib7	14961	5	CD29	CD29	NNP
cord-005453-4057qib7	14961	6	,	,	,
cord-005453-4057qib7	14961	7	CD44	CD44	NNP
cord-005453-4057qib7	14961	8	,	,	,
cord-005453-4057qib7	14961	9	CD73	CD73	NNP
cord-005453-4057qib7	14961	10	,	,	,
cord-005453-4057qib7	14961	11	CD90	CD90	NNP
cord-005453-4057qib7	14961	12	and	and	CC
cord-005453-4057qib7	14961	13	CD105	CD105	NNP
cord-005453-4057qib7	14961	14	and	and	CC
cord-005453-4057qib7	14961	15	negative	negative	JJ
cord-005453-4057qib7	14961	16	for	for	IN
cord-005453-4057qib7	14961	17	CD14	CD14	NNP
cord-005453-4057qib7	14961	18	,	,	,
cord-005453-4057qib7	14961	19	CD34	CD34	NNP
cord-005453-4057qib7	14961	20	,	,	,
cord-005453-4057qib7	14961	21	CD45	CD45	NNP
cord-005453-4057qib7	14961	22	and	and	CC
cord-005453-4057qib7	14961	23	HLA	HLA	NNP
cord-005453-4057qib7	14961	24	-	-	HYPH
cord-005453-4057qib7	14961	25	DR	DR	NNP
cord-005453-4057qib7	14961	26	,	,	,
cord-005453-4057qib7	14961	27	indicative	indicative	JJ
cord-005453-4057qib7	14961	28	of	of	IN
cord-005453-4057qib7	14961	29	a	a	DT
cord-005453-4057qib7	14961	30	typical	typical	JJ
cord-005453-4057qib7	14961	31	MSC	MSC	NNP
cord-005453-4057qib7	14961	32	phenotype	phenotype	NN
cord-005453-4057qib7	14961	33	(	(	-LRB-
cord-005453-4057qib7	14961	34	Figure	figure	NN
cord-005453-4057qib7	14961	35	1	1	CD
cord-005453-4057qib7	14961	36	)	)	-RRB-
cord-005453-4057qib7	14961	37	.	.	.
cord-005453-4057qib7	14962	1	All	all	PDT
cord-005453-4057qib7	14962	2	the	the	DT
cord-005453-4057qib7	14962	3	markers	marker	NNS
cord-005453-4057qib7	14962	4	showed	show	VBD
cord-005453-4057qib7	14962	5	a	a	DT
cord-005453-4057qib7	14962	6	high	high	JJ
cord-005453-4057qib7	14962	7	percentage	percentage	NN
cord-005453-4057qib7	14962	8	of	of	IN
cord-005453-4057qib7	14962	9	expression	expression	NN
cord-005453-4057qib7	14962	10	between	between	IN
cord-005453-4057qib7	14962	11	84.6	84.6	CD
cord-005453-4057qib7	14962	12	and	and	CC
cord-005453-4057qib7	14962	13	99.9	99.9	CD
cord-005453-4057qib7	14962	14	%	%	NN
cord-005453-4057qib7	14962	15	,	,	,
cord-005453-4057qib7	14962	16	meaning	mean	VBG
cord-005453-4057qib7	14962	17	that	that	IN
cord-005453-4057qib7	14962	18	MSC	MSC	NNP
cord-005453-4057qib7	14962	19	population	population	NN
cord-005453-4057qib7	14962	20	obtained	obtain	VBN
cord-005453-4057qib7	14962	21	with	with	IN
cord-005453-4057qib7	14962	22	the	the	DT
cord-005453-4057qib7	14962	23	designed	design	VBN
cord-005453-4057qib7	14962	24	method	method	NN
cord-005453-4057qib7	14962	25	was	be	VBD
cord-005453-4057qib7	14962	26	very	very	RB
cord-005453-4057qib7	14962	27	homogenous	homogenous	JJ
cord-005453-4057qib7	14962	28	.	.	.
cord-005453-4057qib7	14963	1	Similarly	similarly	RB
cord-005453-4057qib7	14963	2	,	,	,
cord-005453-4057qib7	14963	3	staining	stain	VBG
cord-005453-4057qib7	14963	4	for	for	IN
cord-005453-4057qib7	14963	5	the	the	DT
cord-005453-4057qib7	14963	6	three	three	CD
cord-005453-4057qib7	14963	7	studied	study	VBN
cord-005453-4057qib7	14963	8	lineages	lineage	NNS
cord-005453-4057qib7	14963	9	was	be	VBD
cord-005453-4057qib7	14963	10	positive	positive	JJ
cord-005453-4057qib7	14963	11	(	(	-LRB-
cord-005453-4057qib7	14963	12	Figure	figure	NN
cord-005453-4057qib7	14963	13	1	1	CD
cord-005453-4057qib7	14963	14	)	)	-RRB-
cord-005453-4057qib7	14963	15	.	.	.
cord-005453-4057qib7	14964	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14964	2	:	:	:
cord-005453-4057qib7	14965	1	The	the	DT
cord-005453-4057qib7	14965	2	described	describe	VBN
cord-005453-4057qib7	14965	3	protocol	protocol	NN
cord-005453-4057qib7	14965	4	allows	allow	VBZ
cord-005453-4057qib7	14965	5	us	-PRON-	PRP
cord-005453-4057qib7	14965	6	to	to	TO
cord-005453-4057qib7	14965	7	obtain	obtain	VB
cord-005453-4057qib7	14965	8	MSCs	mscs	NN
cord-005453-4057qib7	14965	9	from	from	IN
cord-005453-4057qib7	14965	10	decidual	decidual	JJ
cord-005453-4057qib7	14965	11	placental	placental	NN
cord-005453-4057qib7	14965	12	tissue	tissue	NN
cord-005453-4057qib7	14965	13	stored	store	VBN
cord-005453-4057qib7	14965	14	and	and	CC
cord-005453-4057qib7	14965	15	processed	process	VBN
cord-005453-4057qib7	14965	16	24	24	CD
cord-005453-4057qib7	14965	17	hours	hour	NNS
cord-005453-4057qib7	14965	18	after	after	IN
cord-005453-4057qib7	14965	19	the	the	DT
cord-005453-4057qib7	14965	20	biopsy	biopsy	NN
cord-005453-4057qib7	14965	21	extraction	extraction	NN
cord-005453-4057qib7	14965	22	using	use	VBG
cord-005453-4057qib7	14965	23	a	a	DT
cord-005453-4057qib7	14965	24	unique	unique	JJ
cord-005453-4057qib7	14965	25	enzymatic	enzymatic	JJ
cord-005453-4057qib7	14965	26	digestion	digestion	NN
cord-005453-4057qib7	14965	27	.	.	.
cord-005453-4057qib7	14966	1	This	this	DT
cord-005453-4057qib7	14966	2	circumstance	circumstance	NN
cord-005453-4057qib7	14966	3	permits	permit	VBZ
cord-005453-4057qib7	14966	4	to	to	TO
cord-005453-4057qib7	14966	5	take	take	VB
cord-005453-4057qib7	14966	6	advantage	advantage	NN
cord-005453-4057qib7	14966	7	of	of	IN
cord-005453-4057qib7	14966	8	placentas	placenta	NNS
cord-005453-4057qib7	14966	9	that	that	WDT
cord-005453-4057qib7	14966	10	are	be	VBP
cord-005453-4057qib7	14966	11	discarded	discard	VBN
cord-005453-4057qib7	14966	12	after	after	IN
cord-005453-4057qib7	14966	13	delivery	delivery	NN
cord-005453-4057qib7	14966	14	giving	give	VBG
cord-005453-4057qib7	14966	15	us	-PRON-	PRP
cord-005453-4057qib7	14966	16	the	the	DT
cord-005453-4057qib7	14966	17	option	option	NN
cord-005453-4057qib7	14966	18	to	to	TO
cord-005453-4057qib7	14966	19	obtain	obtain	VB
cord-005453-4057qib7	14966	20	mesenchymal	mesenchymal	JJ
cord-005453-4057qib7	14966	21	cells	cell	NNS
cord-005453-4057qib7	14966	22	that	that	WDT
cord-005453-4057qib7	14966	23	could	could	MD
cord-005453-4057qib7	14966	24	be	be	VB
cord-005453-4057qib7	14966	25	used	use	VBN
cord-005453-4057qib7	14966	26	in	in	IN
cord-005453-4057qib7	14966	27	clinical	clinical	JJ
cord-005453-4057qib7	14966	28	trials	trial	NNS
cord-005453-4057qib7	14966	29	.	.	.
cord-005453-4057qib7	14967	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14967	2	:	:	:
cord-005453-4057qib7	14967	3	Nothing	nothing	NN
cord-005453-4057qib7	14967	4	to	to	TO
cord-005453-4057qib7	14967	5	declare	declare	VB
cord-005453-4057qib7	14967	6	Outcomes	outcome	NNS
cord-005453-4057qib7	14967	7	of	of	IN
cord-005453-4057qib7	14967	8	umbilical	umbilical	JJ
cord-005453-4057qib7	14967	9	cord	cord	NN
cord-005453-4057qib7	14967	10	transplant	transplant	NN
cord-005453-4057qib7	14967	11	in	in	IN
cord-005453-4057qib7	14967	12	high	high	JJ
cord-005453-4057qib7	14967	13	risk	risk	NN
cord-005453-4057qib7	14967	14	relapsed	relapse	VBD
cord-005453-4057qib7	14967	15	or	or	CC
cord-005453-4057qib7	14967	16	refractory	refractory	JJ
cord-005453-4057qib7	14968	1	acute	acute	JJ
cord-005453-4057qib7	14968	2	myeloid	myeloid	NN
cord-005453-4057qib7	14968	3	leukaemia	leukaemia	NN
cord-005453-4057qib7	14968	4	Background	background	NN
cord-005453-4057qib7	14968	5	:	:	:
cord-005453-4057qib7	14968	6	High	high	JJ
cord-005453-4057qib7	14968	7	-	-	HYPH
cord-005453-4057qib7	14968	8	risk	risk	NN
cord-005453-4057qib7	14968	9	relapsed	relapse	VBN
cord-005453-4057qib7	14968	10	/	/	SYM
cord-005453-4057qib7	14968	11	refractory	refractory	JJ
cord-005453-4057qib7	14968	12	acute	acute	JJ
cord-005453-4057qib7	14968	13	myeloid	myeloid	NN
cord-005453-4057qib7	14968	14	leukaemia	leukaemia	NN
cord-005453-4057qib7	14968	15	(	(	-LRB-
cord-005453-4057qib7	14968	16	AML	AML	NNP
cord-005453-4057qib7	14968	17	)	)	-RRB-
cord-005453-4057qib7	14968	18	is	be	VBZ
cord-005453-4057qib7	14968	19	a	a	DT
cord-005453-4057qib7	14968	20	fatal	fatal	JJ
cord-005453-4057qib7	14968	21	disease	disease	NN
cord-005453-4057qib7	14968	22	.	.	.
cord-005453-4057qib7	14969	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	14969	2	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	14969	3	stem	stem	NN
cord-005453-4057qib7	14969	4	cell	cell	NN
cord-005453-4057qib7	14969	5	transplantation	transplantation	NN
cord-005453-4057qib7	14969	6	represents	represent	VBZ
cord-005453-4057qib7	14969	7	the	the	DT
cord-005453-4057qib7	14969	8	only	only	JJ
cord-005453-4057qib7	14969	9	chance	chance	NN
cord-005453-4057qib7	14969	10	of	of	IN
cord-005453-4057qib7	14969	11	cure	cure	NN
cord-005453-4057qib7	14969	12	.	.	.
cord-005453-4057qib7	14970	1	As	as	IN
cord-005453-4057qib7	14970	2	the	the	DT
cord-005453-4057qib7	14970	3	transplant	transplant	NN
cord-005453-4057qib7	14970	4	relies	rely	VBZ
cord-005453-4057qib7	14970	5	on	on	IN
cord-005453-4057qib7	14970	6	the	the	DT
cord-005453-4057qib7	14970	7	graft	graft	NN
cord-005453-4057qib7	14970	8	-	-	HYPH
cord-005453-4057qib7	14970	9	versusleukaemia	versusleukaemia	NN
cord-005453-4057qib7	14970	10	(	(	-LRB-
cord-005453-4057qib7	14970	11	GvL	gvl	NN
cord-005453-4057qib7	14970	12	)	)	-RRB-
cord-005453-4057qib7	14970	13	effect	effect	NN
cord-005453-4057qib7	14970	14	,	,	,
cord-005453-4057qib7	14970	15	and	and	CC
cord-005453-4057qib7	14970	16	if	if	IN
cord-005453-4057qib7	14970	17	different	different	JJ
cord-005453-4057qib7	14970	18	donors	donor	NNS
cord-005453-4057qib7	14970	19	exert	exert	VBP
cord-005453-4057qib7	14970	20	different	different	JJ
cord-005453-4057qib7	14970	21	GvL	gvl	NN
cord-005453-4057qib7	14970	22	effects	effect	NNS
cord-005453-4057qib7	14970	23	,	,	,
cord-005453-4057qib7	14970	24	then	then	RB
cord-005453-4057qib7	14970	25	choosing	choose	VBG
cord-005453-4057qib7	14970	26	the	the	DT
cord-005453-4057qib7	14970	27	right	right	JJ
cord-005453-4057qib7	14970	28	donor	donor	NN
cord-005453-4057qib7	14970	29	assumes	assume	VBZ
cord-005453-4057qib7	14970	30	great	great	JJ
cord-005453-4057qib7	14970	31	importance	importance	NN
cord-005453-4057qib7	14970	32	.	.	.
cord-005453-4057qib7	14971	1	In	in	IN
cord-005453-4057qib7	14971	2	Manchester	Manchester	NNP
cord-005453-4057qib7	14971	3	,	,	,
cord-005453-4057qib7	14971	4	a	a	DT
cord-005453-4057qib7	14971	5	large	large	JJ
cord-005453-4057qib7	14971	6	BMT	BMT	NNP
cord-005453-4057qib7	14971	7	centre	centre	NN
cord-005453-4057qib7	14971	8	in	in	IN
cord-005453-4057qib7	14971	9	the	the	DT
cord-005453-4057qib7	14971	10	north	north	NN
cord-005453-4057qib7	14971	11	of	of	IN
cord-005453-4057qib7	14971	12	England	England	NNP
cord-005453-4057qib7	14971	13	,	,	,
cord-005453-4057qib7	14971	14	our	-PRON-	PRP$
cord-005453-4057qib7	14971	15	practice	practice	NN
cord-005453-4057qib7	14971	16	in	in	IN
cord-005453-4057qib7	14971	17	such	such	JJ
cord-005453-4057qib7	14971	18	AML	AML	NNP
cord-005453-4057qib7	14971	19	has	have	VBZ
cord-005453-4057qib7	14971	20	been	be	VBN
cord-005453-4057qib7	14971	21	to	to	TO
cord-005453-4057qib7	14971	22	choose	choose	VB
cord-005453-4057qib7	14971	23	unrelated	unrelated	JJ
cord-005453-4057qib7	14971	24	cord	cord	NN
cord-005453-4057qib7	14971	25	blood	blood	NN
cord-005453-4057qib7	14971	26	(	(	-LRB-
cord-005453-4057qib7	14971	27	UCBT	UCBT	NNP
cord-005453-4057qib7	14971	28	)	)	-RRB-
cord-005453-4057qib7	14971	29	,	,	,
cord-005453-4057qib7	14971	30	without	without	IN
cord-005453-4057qib7	14971	31	serotherapy	serotherapy	NN
cord-005453-4057qib7	14971	32	in	in	IN
cord-005453-4057qib7	14971	33	the	the	DT
cord-005453-4057qib7	14971	34	conditioning	conditioning	NN
cord-005453-4057qib7	14971	35	therapy	therapy	NN
cord-005453-4057qib7	14971	36	,	,	,
cord-005453-4057qib7	14971	37	as	as	IN
cord-005453-4057qib7	14971	38	our	-PRON-	PRP$
cord-005453-4057qib7	14971	39	preferred	preferred	JJ
cord-005453-4057qib7	14971	40	donor	donor	NN
cord-005453-4057qib7	14971	41	cell	cell	NN
cord-005453-4057qib7	14971	42	source	source	NN
cord-005453-4057qib7	14971	43	.	.	.
cord-005453-4057qib7	14972	1	Methods	method	NNS
cord-005453-4057qib7	14973	1	:	:	:
cord-005453-4057qib7	14973	2	We	-PRON-	PRP
cord-005453-4057qib7	14973	3	report	report	VBP
cord-005453-4057qib7	14973	4	the	the	DT
cord-005453-4057qib7	14973	5	results	result	NNS
cord-005453-4057qib7	14973	6	of	of	IN
cord-005453-4057qib7	14973	7	16	16	CD
cord-005453-4057qib7	14973	8	unrelated	unrelated	JJ
cord-005453-4057qib7	14973	9	UCBT	UCBT	NNPS
cord-005453-4057qib7	14973	10	in	in	IN
cord-005453-4057qib7	14973	11	15	15	CD
cord-005453-4057qib7	14973	12	patients	patient	NNS
cord-005453-4057qib7	14973	13	(	(	-LRB-
cord-005453-4057qib7	14973	14	five	five	CD
cord-005453-4057qib7	14973	15	boys	boy	NNS
cord-005453-4057qib7	14973	16	and	and	CC
cord-005453-4057qib7	14973	17	ten	ten	CD
cord-005453-4057qib7	14973	18	girls	girl	NNS
cord-005453-4057qib7	14973	19	)	)	-RRB-
cord-005453-4057qib7	14973	20	with	with	IN
cord-005453-4057qib7	14973	21	high	high	JJ
cord-005453-4057qib7	14973	22	-	-	HYPH
cord-005453-4057qib7	14973	23	risk	risk	NN
cord-005453-4057qib7	14973	24	AML	AML	NNP
cord-005453-4057qib7	14973	25	,	,	,
cord-005453-4057qib7	14973	26	defined	define	VBN
cord-005453-4057qib7	14973	27	as	as	IN
cord-005453-4057qib7	14973	28	relapsed	relapsed	JJ
cord-005453-4057qib7	14973	29	or	or	CC
cord-005453-4057qib7	14973	30	refractory	refractory	JJ
cord-005453-4057qib7	14973	31	disease	disease	NN
cord-005453-4057qib7	14973	32	.	.	.
cord-005453-4057qib7	14974	1	Thirteen	thirteen	CD
cord-005453-4057qib7	14974	2	patients	patient	NNS
cord-005453-4057qib7	14974	3	(	(	-LRB-
cord-005453-4057qib7	14974	4	81	81	CD
cord-005453-4057qib7	14974	5	%	%	NN
cord-005453-4057qib7	14974	6	)	)	-RRB-
cord-005453-4057qib7	14974	7	received	receive	VBD
cord-005453-4057qib7	14974	8	this	this	DT
cord-005453-4057qib7	14974	9	as	as	IN
cord-005453-4057qib7	14974	10	a	a	DT
cord-005453-4057qib7	14974	11	1	1	CD
cord-005453-4057qib7	14974	12	st	st	NNP
cord-005453-4057qib7	14974	13	transplant	transplant	NN
cord-005453-4057qib7	14974	14	,	,	,
cord-005453-4057qib7	14974	15	two	two	CD
cord-005453-4057qib7	14974	16	Patients	patient	NNS
cord-005453-4057qib7	14974	17	(	(	-LRB-
cord-005453-4057qib7	14974	18	13	13	CD
cord-005453-4057qib7	14974	19	%	%	NN
cord-005453-4057qib7	14974	20	)	)	-RRB-
cord-005453-4057qib7	14974	21	received	receive	VBD
cord-005453-4057qib7	14974	22	this	this	DT
cord-005453-4057qib7	14974	23	as	as	IN
cord-005453-4057qib7	14974	24	a	a	DT
cord-005453-4057qib7	14974	25	2	2	CD
cord-005453-4057qib7	14974	26	nd	nd	NNP
cord-005453-4057qib7	14974	27	transplant	transplant	NN
cord-005453-4057qib7	14974	28	for	for	IN
cord-005453-4057qib7	14974	29	relapsed	relapse	VBN
cord-005453-4057qib7	14974	30	AML	AML	NNP
cord-005453-4057qib7	14974	31	post	post	NN
cord-005453-4057qib7	14974	32	matched	match	VBN
cord-005453-4057qib7	14974	33	unrelated	unrelated	JJ
cord-005453-4057qib7	14974	34	donor	donor	NN
cord-005453-4057qib7	14974	35	transplant	transplant	NN
cord-005453-4057qib7	14974	36	,	,	,
cord-005453-4057qib7	14974	37	and	and	CC
cord-005453-4057qib7	14974	38	one	one	CD
cord-005453-4057qib7	14974	39	(	(	-LRB-
cord-005453-4057qib7	14974	40	6	6	CD
cord-005453-4057qib7	14974	41	%	%	NN
cord-005453-4057qib7	14974	42	)	)	-RRB-
cord-005453-4057qib7	14974	43	received	receive	VBD
cord-005453-4057qib7	14974	44	UCBT	UCBT	NNP
cord-005453-4057qib7	14974	45	twice	twice	RB
cord-005453-4057qib7	14974	46	,	,	,
cord-005453-4057qib7	14974	47	once	once	RB
cord-005453-4057qib7	14974	48	in	in	IN
cord-005453-4057qib7	14974	49	CR1	CR1	NNP
cord-005453-4057qib7	14974	50	and	and	CC
cord-005453-4057qib7	14974	51	once	once	RB
cord-005453-4057qib7	14974	52	in	in	IN
cord-005453-4057qib7	14974	53	CR2	CR2	NNP
cord-005453-4057qib7	14974	54	.	.	.
cord-005453-4057qib7	14975	1	Nine	nine	CD
cord-005453-4057qib7	14975	2	patients	patient	NNS
cord-005453-4057qib7	14975	3	(	(	-LRB-
cord-005453-4057qib7	14975	4	56	56	CD
cord-005453-4057qib7	14975	5	%	%	NN
cord-005453-4057qib7	14975	6	)	)	-RRB-
cord-005453-4057qib7	14975	7	had	have	VBD
cord-005453-4057qib7	14975	8	mismatched	mismatch	VBN
cord-005453-4057qib7	14975	9	UCBT	UCBT	NNP
cord-005453-4057qib7	14975	10	,	,	,
cord-005453-4057qib7	14975	11	and	and	CC
cord-005453-4057qib7	14975	12	the	the	DT
cord-005453-4057qib7	14975	13	rest	rest	NN
cord-005453-4057qib7	14975	14	were	be	VBD
cord-005453-4057qib7	14975	15	fully	fully	RB
cord-005453-4057qib7	14975	16	matched	match	VBN
cord-005453-4057qib7	14975	17	at	at	IN
cord-005453-4057qib7	14975	18	class	class	NN
cord-005453-4057qib7	14975	19	-	-	:
cord-005453-4057qib7	14975	20	I	i	JJ
cord-005453-4057qib7	14975	21	(	(	-LRB-
cord-005453-4057qib7	14975	22	HLA	HLA	NNP
cord-005453-4057qib7	14975	23	-	-	HYPH
cord-005453-4057qib7	14975	24	A	A	NNP
cord-005453-4057qib7	14975	25	,	,	,
cord-005453-4057qib7	14975	26	-B	-b	ADD
cord-005453-4057qib7	14975	27	,	,	,
cord-005453-4057qib7	14975	28	and	and	CC
cord-005453-4057qib7	14975	29	-	-	HYPH
cord-005453-4057qib7	14975	30	C	c	NN
cord-005453-4057qib7	14975	31	)	)	-RRB-
cord-005453-4057qib7	14975	32	and	and	CC
cord-005453-4057qib7	14975	33	class	class	NN
cord-005453-4057qib7	14975	34	-	-	HYPH
cord-005453-4057qib7	14975	35	II	II	NNP
cord-005453-4057qib7	14975	36	(	(	-LRB-
cord-005453-4057qib7	14975	37	HLA	HLA	NNP
cord-005453-4057qib7	14975	38	-	-	HYPH
cord-005453-4057qib7	14975	39	DRB1	DRB1	NNP
cord-005453-4057qib7	14975	40	)	)	-RRB-
cord-005453-4057qib7	14975	41	.	.	.
cord-005453-4057qib7	14976	1	Conditioning	conditioning	NN
cord-005453-4057qib7	14976	2	was	be	VBD
cord-005453-4057qib7	14976	3	given	give	VBN
cord-005453-4057qib7	14976	4	as	as	IN
cord-005453-4057qib7	14976	5	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	14976	6	,	,	,
cord-005453-4057qib7	14976	7	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	14976	8	and	and	CC
cord-005453-4057qib7	14976	9	Thiotepa	Thiotepa	NNP
cord-005453-4057qib7	14976	10	in	in	IN
cord-005453-4057qib7	14976	11	half	half	NN
cord-005453-4057qib7	14976	12	of	of	IN
cord-005453-4057qib7	14976	13	the	the	DT
cord-005453-4057qib7	14976	14	patients	patient	NNS
cord-005453-4057qib7	14976	15	(	(	-LRB-
cord-005453-4057qib7	14976	16	n	n	NN
cord-005453-4057qib7	14976	17	=	=	SYM
cord-005453-4057qib7	14976	18	8)	8)	NN
cord-005453-4057qib7	14976	19	,	,	,
cord-005453-4057qib7	14977	1	other	other	JJ
cord-005453-4057qib7	14977	2	Treosulfanbased	treosulfanbased	JJ
cord-005453-4057qib7	14977	3	regimens	regimen	NNS
cord-005453-4057qib7	14977	4	were	be	VBD
cord-005453-4057qib7	14977	5	used	use	VBN
cord-005453-4057qib7	14977	6	in	in	IN
cord-005453-4057qib7	14977	7	two	two	CD
cord-005453-4057qib7	14977	8	patients	patient	NNS
cord-005453-4057qib7	14977	9	(	(	-LRB-
cord-005453-4057qib7	14977	10	12	12	CD
cord-005453-4057qib7	14977	11	%	%	NN
cord-005453-4057qib7	14977	12	)	)	-RRB-
cord-005453-4057qib7	14977	13	,	,	,
cord-005453-4057qib7	14977	14	and	and	CC
cord-005453-4057qib7	14977	15	Busulfan	Busulfan	NNP
cord-005453-4057qib7	14977	16	-	-	HYPH
cord-005453-4057qib7	14977	17	based	base	VBN
cord-005453-4057qib7	14977	18	regimens	regimen	NNS
cord-005453-4057qib7	14977	19	were	be	VBD
cord-005453-4057qib7	14977	20	used	use	VBN
cord-005453-4057qib7	14977	21	in	in	IN
cord-005453-4057qib7	14977	22	six	six	CD
cord-005453-4057qib7	14977	23	patients	patient	NNS
cord-005453-4057qib7	14977	24	(	(	-LRB-
cord-005453-4057qib7	14977	25	38	38	CD
cord-005453-4057qib7	14977	26	%	%	NN
cord-005453-4057qib7	14977	27	)	)	-RRB-
cord-005453-4057qib7	14977	28	.	.	.
cord-005453-4057qib7	14978	1	No	no	DT
cord-005453-4057qib7	14978	2	serotherapy	serotherapy	NN
cord-005453-4057qib7	14978	3	was	be	VBD
cord-005453-4057qib7	14978	4	given	give	VBN
cord-005453-4057qib7	14978	5	.	.	.
cord-005453-4057qib7	14979	1	Results	result	NNS
cord-005453-4057qib7	14979	2	:	:	:
cord-005453-4057qib7	14980	1	The	the	DT
cord-005453-4057qib7	14980	2	median	median	JJ
cord-005453-4057qib7	14980	3	age	age	NN
cord-005453-4057qib7	14980	4	at	at	IN
cord-005453-4057qib7	14980	5	transplant	transplant	NN
cord-005453-4057qib7	14980	6	was	be	VBD
cord-005453-4057qib7	14980	7	5	5	CD
cord-005453-4057qib7	14980	8	years	year	NNS
cord-005453-4057qib7	14981	1	(	(	-LRB-
cord-005453-4057qib7	14981	2	Range	range	NN
cord-005453-4057qib7	14981	3	,	,	,
cord-005453-4057qib7	14981	4	5months	5months	JJ
cord-005453-4057qib7	14981	5	-15years	-15year	NNS
cord-005453-4057qib7	14981	6	)	)	-RRB-
cord-005453-4057qib7	14981	7	.	.	.
cord-005453-4057qib7	14982	1	Neutrophil	Neutrophil	NNP
cord-005453-4057qib7	14982	2	and	and	CC
cord-005453-4057qib7	14982	3	platelet	platelet	NN
cord-005453-4057qib7	14982	4	engraftment	engraftment	NN
cord-005453-4057qib7	14982	5	were	be	VBD
cord-005453-4057qib7	14982	6	achieved	achieve	VBN
cord-005453-4057qib7	14982	7	in	in	IN
cord-005453-4057qib7	14982	8	15	15	CD
cord-005453-4057qib7	14982	9	and	and	CC
cord-005453-4057qib7	14982	10	12	12	CD
cord-005453-4057qib7	14982	11	patients	patient	NNS
cord-005453-4057qib7	14982	12	at	at	IN
cord-005453-4057qib7	14982	13	a	a	DT
cord-005453-4057qib7	14982	14	median	median	NN
cord-005453-4057qib7	14982	15	of	of	IN
cord-005453-4057qib7	14982	16	16	16	CD
cord-005453-4057qib7	14982	17	and	and	CC
cord-005453-4057qib7	14982	18	35	35	CD
cord-005453-4057qib7	14982	19	days	day	NNS
cord-005453-4057qib7	14982	20	,	,	,
cord-005453-4057qib7	14982	21	respectively	respectively	RB
cord-005453-4057qib7	14982	22	.	.	.
cord-005453-4057qib7	14983	1	13	13	CD
cord-005453-4057qib7	14983	2	patients	patient	NNS
cord-005453-4057qib7	14983	3	(	(	-LRB-
cord-005453-4057qib7	14983	4	81	81	CD
cord-005453-4057qib7	14983	5	%	%	NN
cord-005453-4057qib7	14983	6	)	)	-RRB-
cord-005453-4057qib7	14983	7	had	have	VBD
cord-005453-4057qib7	14983	8	engraftment	engraftment	NNP
cord-005453-4057qib7	14983	9	syndrome	syndrome	NN
cord-005453-4057qib7	14983	10	.	.	.
cord-005453-4057qib7	14984	1	All	all	DT
cord-005453-4057qib7	14984	2	engrafted	engraft	VBN
cord-005453-4057qib7	14984	3	patients	patient	NNS
cord-005453-4057qib7	14984	4	achieved	achieve	VBD
cord-005453-4057qib7	14984	5	100	100	CD
cord-005453-4057qib7	14984	6	%	%	NN
cord-005453-4057qib7	14984	7	donor	donor	NN
cord-005453-4057qib7	14984	8	chimerism	chimerism	NN
cord-005453-4057qib7	14984	9	,	,	,
cord-005453-4057qib7	14984	10	except	except	IN
cord-005453-4057qib7	14984	11	one	one	CD
cord-005453-4057qib7	14984	12	patient	patient	NN
cord-005453-4057qib7	14984	13	who	who	WP
cord-005453-4057qib7	14984	14	had	have	VBD
cord-005453-4057qib7	14984	15	mixed	mix	VBN
cord-005453-4057qib7	14984	16	lymphoid	lymphoid	JJ
cord-005453-4057qib7	14984	17	chimerism	chimerism	NN
cord-005453-4057qib7	14984	18	initially	initially	RB
cord-005453-4057qib7	14984	19	,	,	,
cord-005453-4057qib7	14984	20	that	that	WDT
cord-005453-4057qib7	14984	21	was	be	VBD
cord-005453-4057qib7	14984	22	corrected	correct	VBN
cord-005453-4057qib7	14984	23	spontaneously	spontaneously	RB
cord-005453-4057qib7	14984	24	to	to	IN
cord-005453-4057qib7	14984	25	100	100	CD
cord-005453-4057qib7	14984	26	%	%	NN
cord-005453-4057qib7	14984	27	at	at	IN
cord-005453-4057qib7	14984	28	three	three	CD
cord-005453-4057qib7	14984	29	months	month	NNS
cord-005453-4057qib7	14984	30	after	after	IN
cord-005453-4057qib7	14984	31	transplant	transplant	NN
cord-005453-4057qib7	14984	32	.	.	.
cord-005453-4057qib7	14985	1	Acute	acute	JJ
cord-005453-4057qib7	14985	2	GVHD	GVHD	NNP
cord-005453-4057qib7	14985	3	Grade	Grade	NNP
cord-005453-4057qib7	14985	4	I	I	NNP
cord-005453-4057qib7	14985	5	-	-	HYPH
cord-005453-4057qib7	14985	6	II	II	NNP
cord-005453-4057qib7	14985	7	developed	develop	VBD
cord-005453-4057qib7	14985	8	in	in	IN
cord-005453-4057qib7	14985	9	six	six	CD
cord-005453-4057qib7	14985	10	patients	patient	NNS
cord-005453-4057qib7	14985	11	(	(	-LRB-
cord-005453-4057qib7	14985	12	38	38	CD
cord-005453-4057qib7	14985	13	%	%	NN
cord-005453-4057qib7	14985	14	)	)	-RRB-
cord-005453-4057qib7	14985	15	,	,	,
cord-005453-4057qib7	14985	16	and	and	CC
cord-005453-4057qib7	14985	17	Grade	Grade	NNP
cord-005453-4057qib7	14985	18	III	III	NNP
cord-005453-4057qib7	14985	19	-	-	HYPH
cord-005453-4057qib7	14985	20	IV	IV	NNP
cord-005453-4057qib7	14985	21	developed	develop	VBD
cord-005453-4057qib7	14985	22	in	in	IN
cord-005453-4057qib7	14985	23	three	three	CD
cord-005453-4057qib7	14985	24	patients	patient	NNS
cord-005453-4057qib7	14985	25	(	(	-LRB-
cord-005453-4057qib7	14985	26	19	19	CD
cord-005453-4057qib7	14985	27	%	%	NN
cord-005453-4057qib7	14985	28	)	)	-RRB-
cord-005453-4057qib7	14985	29	.	.	.
cord-005453-4057qib7	14986	1	All	all	DT
cord-005453-4057qib7	14986	2	cases	case	NNS
cord-005453-4057qib7	14986	3	resolved	resolve	VBD
cord-005453-4057qib7	14986	4	,	,	,
cord-005453-4057qib7	14986	5	except	except	IN
cord-005453-4057qib7	14986	6	two	two	CD
cord-005453-4057qib7	14986	7	patients	patient	NNS
cord-005453-4057qib7	14986	8	where	where	WRB
cord-005453-4057qib7	14986	9	acute	acute	JJ
cord-005453-4057qib7	14986	10	GVHD	GVHD	NNP
cord-005453-4057qib7	14986	11	evolved	evolve	VBD
cord-005453-4057qib7	14986	12	into	into	IN
cord-005453-4057qib7	14986	13	Chronic	Chronic	NNP
cord-005453-4057qib7	14986	14	GVHD	GVHD	NNP
cord-005453-4057qib7	14986	15	(	(	-LRB-
cord-005453-4057qib7	14986	16	One	one	CD
cord-005453-4057qib7	14986	17	with	with	IN
cord-005453-4057qib7	14986	18	Grade	grade	NN
cord-005453-4057qib7	14987	1	I	-PRON-	PRP
cord-005453-4057qib7	14987	2	skin	skin	VBP
cord-005453-4057qib7	14987	3	GVHD	GVHD	NNP
cord-005453-4057qib7	14987	4	which	which	WDT
cord-005453-4057qib7	14987	5	fully	fully	RB
cord-005453-4057qib7	14987	6	resolved	resolve	VBD
cord-005453-4057qib7	14987	7	,	,	,
cord-005453-4057qib7	14987	8	and	and	CC
cord-005453-4057qib7	14987	9	one	one	CD
cord-005453-4057qib7	14987	10	with	with	IN
cord-005453-4057qib7	14987	11	Grade	Grade	NNP
cord-005453-4057qib7	14987	12	III	III	NNP
cord-005453-4057qib7	14987	13	GVHD	GVHD	NNP
cord-005453-4057qib7	14987	14	gut	gut	NN
cord-005453-4057qib7	14987	15	colitis	colitis	NN
cord-005453-4057qib7	14987	16	who	who	WP
cord-005453-4057qib7	14987	17	was	be	VBD
cord-005453-4057qib7	14987	18	parenteral	parenteral	JJ
cord-005453-4057qib7	14987	19	nutrition	nutrition	NN
cord-005453-4057qib7	14987	20	dependent	dependent	JJ
cord-005453-4057qib7	14987	21	till	till	IN
cord-005453-4057qib7	14987	22	death	death	NN
cord-005453-4057qib7	14987	23	)	)	-RRB-
cord-005453-4057qib7	14987	24	.	.	.
cord-005453-4057qib7	14988	1	Two	two	CD
cord-005453-4057qib7	14988	2	more	more	JJR
cord-005453-4057qib7	14988	3	patients	patient	NNS
cord-005453-4057qib7	14988	4	developed	develop	VBD
cord-005453-4057qib7	14988	5	Chronic	Chronic	NNP
cord-005453-4057qib7	14988	6	Grade	grade	NN
cord-005453-4057qib7	14989	1	I	-PRON-	PRP
cord-005453-4057qib7	14989	2	skin	skin	VBP
cord-005453-4057qib7	14989	3	GVHD	GVHD	NNP
cord-005453-4057qib7	14989	4	and	and	CC
cord-005453-4057qib7	14989	5	resolved	resolve	VBD
cord-005453-4057qib7	14990	1	(	(	-LRB-
cord-005453-4057qib7	14990	2	Chronic	Chronic	NNP
cord-005453-4057qib7	14990	3	GVHD	GVHD	NNP
cord-005453-4057qib7	14990	4	developed	develop	VBN
cord-005453-4057qib7	14990	5	in	in	IN
cord-005453-4057qib7	14990	6	25	25	CD
cord-005453-4057qib7	14990	7	%	%	NN
cord-005453-4057qib7	14990	8	in	in	IN
cord-005453-4057qib7	14990	9	total	total	NN
cord-005453-4057qib7	14990	10	)	)	-RRB-
cord-005453-4057qib7	14990	11	.	.	.
cord-005453-4057qib7	14991	1	Three	three	CD
cord-005453-4057qib7	14991	2	patients	patient	NNS
cord-005453-4057qib7	14991	3	(	(	-LRB-
cord-005453-4057qib7	14991	4	17	17	CD
cord-005453-4057qib7	14991	5	%	%	NN
cord-005453-4057qib7	14991	6	)	)	-RRB-
cord-005453-4057qib7	14991	7	developed	develop	VBD
cord-005453-4057qib7	14991	8	veno	veno	NNP
cord-005453-4057qib7	14991	9	-	-	HYPH
cord-005453-4057qib7	14991	10	occlusive	occlusive	JJ
cord-005453-4057qib7	14991	11	disease	disease	NN
cord-005453-4057qib7	14991	12	(	(	-LRB-
cord-005453-4057qib7	14991	13	VOD	VOD	NNP
cord-005453-4057qib7	14991	14	)	)	-RRB-
cord-005453-4057qib7	14991	15	,	,	,
cord-005453-4057qib7	14991	16	that	that	WDT
cord-005453-4057qib7	14991	17	completely	completely	RB
cord-005453-4057qib7	14991	18	resolved	resolve	VBN
cord-005453-4057qib7	14991	19	with	with	IN
cord-005453-4057qib7	14991	20	defibrotide	defibrotide	NN
cord-005453-4057qib7	14991	21	treatment	treatment	NN
cord-005453-4057qib7	14991	22	and	and	CC
cord-005453-4057qib7	14991	23	necessitated	necessitate	VBD
cord-005453-4057qib7	14991	24	ascitic	ascitic	JJ
cord-005453-4057qib7	14991	25	drainage	drainage	NN
cord-005453-4057qib7	14991	26	in	in	IN
cord-005453-4057qib7	14991	27	one	one	CD
cord-005453-4057qib7	14991	28	of	of	IN
cord-005453-4057qib7	14991	29	them	-PRON-	PRP
cord-005453-4057qib7	14991	30	.	.	.
cord-005453-4057qib7	14992	1	Viral	viral	JJ
cord-005453-4057qib7	14992	2	reactivations	reactivation	NNS
cord-005453-4057qib7	14992	3	occurred	occur	VBD
cord-005453-4057qib7	14992	4	in	in	IN
cord-005453-4057qib7	14992	5	five	five	CD
cord-005453-4057qib7	14992	6	patients	patient	NNS
cord-005453-4057qib7	14992	7	(	(	-LRB-
cord-005453-4057qib7	14992	8	30	30	CD
cord-005453-4057qib7	14992	9	%	%	NN
cord-005453-4057qib7	14992	10	)	)	-RRB-
cord-005453-4057qib7	14992	11	and	and	CC
cord-005453-4057qib7	14992	12	were	be	VBD
cord-005453-4057qib7	14992	13	successfully	successfully	RB
cord-005453-4057qib7	14992	14	treated	treat	VBN
cord-005453-4057qib7	14992	15	.	.	.
cord-005453-4057qib7	14993	1	At	at	IN
cord-005453-4057qib7	14993	2	a	a	DT
cord-005453-4057qib7	14993	3	median	median	JJ
cord-005453-4057qib7	14993	4	follow	follow	NN
cord-005453-4057qib7	14993	5	-	-	HYPH
cord-005453-4057qib7	14993	6	up	up	NN
cord-005453-4057qib7	14993	7	of	of	IN
cord-005453-4057qib7	14993	8	20	20	CD
cord-005453-4057qib7	14993	9	months	month	NNS
cord-005453-4057qib7	14993	10	(	(	-LRB-
cord-005453-4057qib7	14993	11	Range	range	NN
cord-005453-4057qib7	14993	12	,	,	,
cord-005453-4057qib7	14993	13	seven	seven	CD
cord-005453-4057qib7	14993	14	months	month	NNS
cord-005453-4057qib7	14993	15	-four	-four	JJR
cord-005453-4057qib7	14993	16	years	year	NNS
cord-005453-4057qib7	14993	17	)	)	-RRB-
cord-005453-4057qib7	14993	18	,	,	,
cord-005453-4057qib7	14993	19	eight	eight	CD
cord-005453-4057qib7	14993	20	patients	patient	NNS
cord-005453-4057qib7	14993	21	(	(	-LRB-
cord-005453-4057qib7	14993	22	50	50	CD
cord-005453-4057qib7	14993	23	%	%	NN
cord-005453-4057qib7	14993	24	)	)	-RRB-
cord-005453-4057qib7	14993	25	died	die	VBD
cord-005453-4057qib7	14993	26	at	at	IN
cord-005453-4057qib7	14993	27	a	a	DT
cord-005453-4057qib7	14993	28	median	median	NN
cord-005453-4057qib7	14993	29	of	of	IN
cord-005453-4057qib7	14993	30	79	79	CD
cord-005453-4057qib7	14993	31	(	(	-LRB-
cord-005453-4057qib7	14993	32	Range	Range	NNP
cord-005453-4057qib7	14993	33	,	,	,
cord-005453-4057qib7	14993	34	24	24	CD
cord-005453-4057qib7	14993	35	to	to	TO
cord-005453-4057qib7	14993	36	230	230	CD
cord-005453-4057qib7	14993	37	days	day	NNS
cord-005453-4057qib7	14993	38	)	)	-RRB-
cord-005453-4057qib7	14993	39	,	,	,
cord-005453-4057qib7	14993	40	with	with	IN
cord-005453-4057qib7	14993	41	a	a	DT
cord-005453-4057qib7	14993	42	transplantrelated	transplantrelated	JJ
cord-005453-4057qib7	14993	43	mortality	mortality	NN
cord-005453-4057qib7	14993	44	of	of	IN
cord-005453-4057qib7	14993	45	25	25	CD
cord-005453-4057qib7	14993	46	%	%	NN
cord-005453-4057qib7	14993	47	and	and	CC
cord-005453-4057qib7	14993	48	relapse	relapse	NN
cord-005453-4057qib7	14993	49	-	-	HYPH
cord-005453-4057qib7	14993	50	related	relate	VBN
cord-005453-4057qib7	14993	51	mortality	mortality	NN
cord-005453-4057qib7	14993	52	of	of	IN
cord-005453-4057qib7	14993	53	25	25	CD
cord-005453-4057qib7	14993	54	%	%	NN
cord-005453-4057qib7	14993	55	.	.	.
cord-005453-4057qib7	14994	1	Five	five	CD
cord-005453-4057qib7	14994	2	patients	patient	NNS
cord-005453-4057qib7	14994	3	(	(	-LRB-
cord-005453-4057qib7	14994	4	31	31	CD
cord-005453-4057qib7	14994	5	%	%	NN
cord-005453-4057qib7	14994	6	)	)	-RRB-
cord-005453-4057qib7	14994	7	relapsed	relapse	VBN
cord-005453-4057qib7	14994	8	post	post	NN
cord-005453-4057qib7	14994	9	-	-	NNS
cord-005453-4057qib7	14994	10	UCBT	UCBT	NNPS
cord-005453-4057qib7	14994	11	;	;	:
cord-005453-4057qib7	14994	12	four	four	CD
cord-005453-4057qib7	14994	13	died	die	VBD
cord-005453-4057qib7	14994	14	and	and	CC
cord-005453-4057qib7	14994	15	one	one	PRP
cord-005453-4057qib7	14994	16	had	have	VBD
cord-005453-4057qib7	14994	17	a	a	DT
cord-005453-4057qib7	14994	18	successful	successful	JJ
cord-005453-4057qib7	14994	19	second	second	JJ
cord-005453-4057qib7	14994	20	UCBT	UCBT	NNPS
cord-005453-4057qib7	14994	21	(	(	-LRB-
cord-005453-4057qib7	14994	22	event	event	NN
cord-005453-4057qib7	14994	23	-	-	HYPH
cord-005453-4057qib7	14994	24	free	free	JJ
cord-005453-4057qib7	14994	25	survival	survival	NN
cord-005453-4057qib7	14994	26	was	be	VBD
cord-005453-4057qib7	14994	27	44	44	CD
cord-005453-4057qib7	14994	28	%	%	NN
cord-005453-4057qib7	14994	29	)	)	-RRB-
cord-005453-4057qib7	14994	30	.	.	.
cord-005453-4057qib7	14995	1	Immune	immune	JJ
cord-005453-4057qib7	14995	2	reconstitution	reconstitution	NN
cord-005453-4057qib7	14995	3	in	in	IN
cord-005453-4057qib7	14995	4	alive	alive	JJ
cord-005453-4057qib7	14995	5	patients	patient	NNS
cord-005453-4057qib7	14995	6	was	be	VBD
cord-005453-4057qib7	14995	7	achieved	achieve	VBN
cord-005453-4057qib7	14995	8	at	at	IN
cord-005453-4057qib7	14995	9	a	a	DT
cord-005453-4057qib7	14995	10	median	median	NN
cord-005453-4057qib7	14995	11	of	of	IN
cord-005453-4057qib7	14995	12	eight	eight	CD
cord-005453-4057qib7	14995	13	months	month	NNS
cord-005453-4057qib7	14995	14	.	.	.
cord-005453-4057qib7	14996	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	14996	2	:	:	:
cord-005453-4057qib7	14997	1	Very	very	RB
cord-005453-4057qib7	14997	2	high	high	JJ
cord-005453-4057qib7	14997	3	-	-	HYPH
cord-005453-4057qib7	14997	4	risk	risk	NN
cord-005453-4057qib7	14997	5	patients	patient	NNS
cord-005453-4057qib7	14997	6	treated	treat	VBN
cord-005453-4057qib7	14997	7	with	with	IN
cord-005453-4057qib7	14997	8	UCBT	UCBT	NNS
cord-005453-4057qib7	14997	9	with	with	IN
cord-005453-4057qib7	14997	10	good	good	JJ
cord-005453-4057qib7	14997	11	overall	overall	JJ
cord-005453-4057qib7	14997	12	survival	survival	NN
cord-005453-4057qib7	14997	13	and	and	CC
cord-005453-4057qib7	14997	14	event	event	NN
cord-005453-4057qib7	14997	15	-	-	HYPH
cord-005453-4057qib7	14997	16	free	free	JJ
cord-005453-4057qib7	14997	17	survival	survival	NN
cord-005453-4057qib7	14997	18	,	,	,
cord-005453-4057qib7	14997	19	similar	similar	JJ
cord-005453-4057qib7	14997	20	to	to	IN
cord-005453-4057qib7	14997	21	AML	AML	NNP
cord-005453-4057qib7	14997	22	treatment	treatment	NN
cord-005453-4057qib7	14997	23	rate	rate	NN
cord-005453-4057qib7	14997	24	with	with	IN
cord-005453-4057qib7	14997	25	low	low	JJ
cord-005453-4057qib7	14997	26	-	-	HYPH
cord-005453-4057qib7	14997	27	risk	risk	NN
cord-005453-4057qib7	14997	28	disease	disease	NN
cord-005453-4057qib7	14997	29	.	.	.
cord-005453-4057qib7	14998	1	Disclosure	disclosure	NN
cord-005453-4057qib7	14998	2	:	:	:
cord-005453-4057qib7	14998	3	Nothing	nothing	NN
cord-005453-4057qib7	14998	4	to	to	TO
cord-005453-4057qib7	14998	5	declare	declare	VB
cord-005453-4057qib7	14998	6	In	in	IN
cord-005453-4057qib7	14998	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	14998	8	transplants	transplant	NNS
cord-005453-4057qib7	14998	9	is	be	VBZ
cord-005453-4057qib7	14998	10	the	the	DT
cord-005453-4057qib7	14998	11	incidence	incidence	NN
cord-005453-4057qib7	14998	12	of	of	IN
cord-005453-4057qib7	14998	13	acute	acute	JJ
cord-005453-4057qib7	14998	14	and	and	CC
cord-005453-4057qib7	14998	15	chronic	chronic	JJ
cord-005453-4057qib7	14998	16	GVHD	GVHD	NNP
cord-005453-4057qib7	14998	17	strictly	strictly	RB
cord-005453-4057qib7	14998	18	related	related	JJ
cord-005453-4057qib7	14998	19	to	to	IN
cord-005453-4057qib7	14998	20	the	the	DT
cord-005453-4057qib7	14998	21	stem	stem	NN
cord-005453-4057qib7	14998	22	cell	cell	NN
cord-005453-4057qib7	14998	23	source	source	NN
cord-005453-4057qib7	14998	24	?	?	.
cord-005453-4057qib7	14999	1	Results	result	NNS
cord-005453-4057qib7	14999	2	:	:	:
cord-005453-4057qib7	15000	1	The	the	DT
cord-005453-4057qib7	15000	2	odds	odd	NNS
cord-005453-4057qib7	15000	3	ratio	ratio	NN
cord-005453-4057qib7	15000	4	was	be	VBD
cord-005453-4057qib7	15000	5	1.78	1.78	CD
cord-005453-4057qib7	15000	6	with	with	IN
cord-005453-4057qib7	15000	7	a	a	DT
cord-005453-4057qib7	15000	8	95	95	CD
cord-005453-4057qib7	15000	9	%	%	NN
cord-005453-4057qib7	15000	10	confidence	confidence	NN
cord-005453-4057qib7	15000	11	interval	interval	NN
cord-005453-4057qib7	15000	12	of	of	IN
cord-005453-4057qib7	15000	13	0.94	0.94	CD
cord-005453-4057qib7	15000	14	-3.37	-3.37	CD
cord-005453-4057qib7	15000	15	(	(	-LRB-
cord-005453-4057qib7	15000	16	p=0.07	p=0.07	NNP
cord-005453-4057qib7	15000	17	)	)	-RRB-
cord-005453-4057qib7	15000	18	.	.	.
cord-005453-4057qib7	15001	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15001	2	:	:	:
cord-005453-4057qib7	15002	1	The	the	DT
cord-005453-4057qib7	15002	2	risk	risk	NN
cord-005453-4057qib7	15002	3	of	of	IN
cord-005453-4057qib7	15002	4	infection	infection	NN
cord-005453-4057qib7	15002	5	of	of	IN
cord-005453-4057qib7	15002	6	the	the	DT
cord-005453-4057qib7	15002	7	UC	UC	NNP
cord-005453-4057qib7	15002	8	is	be	VBZ
cord-005453-4057qib7	15002	9	not	not	RB
cord-005453-4057qib7	15002	10	related	relate	VBN
cord-005453-4057qib7	15002	11	to	to	IN
cord-005453-4057qib7	15002	12	the	the	DT
cord-005453-4057qib7	15002	13	microbiological	microbiological	JJ
cord-005453-4057qib7	15002	14	status	status	NN
cord-005453-4057qib7	15002	15	of	of	IN
cord-005453-4057qib7	15002	16	the	the	DT
cord-005453-4057qib7	15002	17	UCB	UCB	NNP
cord-005453-4057qib7	15002	18	.	.	.
cord-005453-4057qib7	15003	1	A	a	DT
cord-005453-4057qib7	15003	2	possible	possible	JJ
cord-005453-4057qib7	15003	3	explanation	explanation	NN
cord-005453-4057qib7	15003	4	for	for	IN
cord-005453-4057qib7	15003	5	this	this	DT
cord-005453-4057qib7	15003	6	is	be	VBZ
cord-005453-4057qib7	15003	7	the	the	DT
cord-005453-4057qib7	15003	8	presence	presence	NN
cord-005453-4057qib7	15003	9	of	of	IN
cord-005453-4057qib7	15003	10	antibiotics	antibiotic	NNS
cord-005453-4057qib7	15003	11	in	in	IN
cord-005453-4057qib7	15003	12	the	the	DT
cord-005453-4057qib7	15003	13	medium	medium	NN
cord-005453-4057qib7	15003	14	used	use	VBN
cord-005453-4057qib7	15003	15	for	for	IN
cord-005453-4057qib7	15003	16	UC	UC	NNP
cord-005453-4057qib7	15003	17	,	,	,
cord-005453-4057qib7	15003	18	but	but	CC
cord-005453-4057qib7	15003	19	not	not	RB
cord-005453-4057qib7	15003	20	UCB	UCB	NNP
cord-005453-4057qib7	15003	21	,	,	,
cord-005453-4057qib7	15003	22	transport	transport	NN
cord-005453-4057qib7	15003	23	.	.	.
cord-005453-4057qib7	15004	1	This	this	DT
cord-005453-4057qib7	15004	2	means	mean	VBZ
cord-005453-4057qib7	15004	3	that	that	IN
cord-005453-4057qib7	15004	4	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	15004	5	of	of	IN
cord-005453-4057qib7	15004	6	UCs	uc	NNS
cord-005453-4057qib7	15004	7	from	from	IN
cord-005453-4057qib7	15004	8	which	which	WDT
cord-005453-4057qib7	15004	9	contaminated	contaminate	VBD
cord-005453-4057qib7	15004	10	cord	cord	NN
cord-005453-4057qib7	15004	11	blood	blood	NN
cord-005453-4057qib7	15004	12	has	have	VBZ
cord-005453-4057qib7	15004	13	been	be	VBN
cord-005453-4057qib7	15004	14	obtained	obtain	VBN
cord-005453-4057qib7	15004	15	is	be	VBZ
cord-005453-4057qib7	15004	16	justified	justify	VBN
cord-005453-4057qib7	15004	17	.	.	.
cord-005453-4057qib7	15004	18	 	 	_SP
cord-005453-4057qib7	15005	1	Comparison	comparison	NN
cord-005453-4057qib7	15005	2	of	of	IN
cord-005453-4057qib7	15005	3	turkish	turkish	JJ
cord-005453-4057qib7	15005	4	stem	stem	NN
cord-005453-4057qib7	15005	5	cell	cell	NN
cord-005453-4057qib7	15005	6	coordination	coordination	NN
cord-005453-4057qib7	15005	7	center	center	NN
cord-005453-4057qib7	15005	8	(	(	-LRB-
cord-005453-4057qib7	15005	9	TURKOK	TURKOK	NNP
cord-005453-4057qib7	15005	10	)	)	-RRB-
cord-005453-4057qib7	15005	11	with	with	IN
cord-005453-4057qib7	15005	12	Istanbul	Istanbul	NNP
cord-005453-4057qib7	15005	13	university	university	NN
cord-005453-4057qib7	15005	14	bone	bone	NN
cord-005453-4057qib7	15005	15	marrow	marrow	NN
cord-005453-4057qib7	15005	16	bank	bank	NN
cord-005453-4057qib7	15005	17	(	(	-LRB-
cord-005453-4057qib7	15005	18	TRIS	TRIS	NNP
cord-005453-4057qib7	15005	19	)	)	-RRB-
cord-005453-4057qib7	15005	20	;	;	:
cord-005453-4057qib7	15005	21	A	a	DT
cord-005453-4057qib7	15005	22	single	single	JJ
cord-005453-4057qib7	15005	23	center	center	NN
cord-005453-4057qib7	15005	24	experience	experience	NN
cord-005453-4057qib7	15005	25	in	in	IN
cord-005453-4057qib7	15005	26	match	match	NN
cord-005453-4057qib7	15005	27	unrelated	unrelated	JJ
cord-005453-4057qib7	15005	28	donors	donor	NNS
cord-005453-4057qib7	15005	29	Azize	Azize	NNP
cord-005453-4057qib7	15005	30	Mergen	Mergen	NNP
cord-005453-4057qib7	15005	31	1	1	CD
cord-005453-4057qib7	15005	32	,	,	,
cord-005453-4057qib7	15005	33	Selime	Selime	NNP
cord-005453-4057qib7	15005	34	Aydoğdu	Aydoğdu	NNP
cord-005453-4057qib7	15005	35	2	2	CD
cord-005453-4057qib7	15005	36	,	,	,
cord-005453-4057qib7	15005	37	Başak	Başak	NNP
cord-005453-4057qib7	15005	38	Aksoy	Aksoy	NNP
cord-005453-4057qib7	15005	39	3	3	CD
cord-005453-4057qib7	15005	40	,	,	,
cord-005453-4057qib7	15005	41	Yunus	Yunus	NNP
cord-005453-4057qib7	15005	42	Emre	Emre	NNP
cord-005453-4057qib7	15005	43	Savcı	Savcı	NNP
cord-005453-4057qib7	15005	44	2	2	CD
cord-005453-4057qib7	15005	45	,	,	,
cord-005453-4057qib7	15005	46	Gürcan	Gürcan	NNP
cord-005453-4057qib7	15005	47	Dikme	Dikme	NNP
cord-005453-4057qib7	15005	48	2	2	CD
cord-005453-4057qib7	15005	49	,	,	,
cord-005453-4057qib7	15005	50	Funda	Funda	NNP
cord-005453-4057qib7	15005	51	Çipe	Çipe	NNP
cord-005453-4057qib7	15005	52	2	2	CD
cord-005453-4057qib7	15005	53	,	,	,
cord-005453-4057qib7	15005	54	Ceyhun	Ceyhun	NNP
cord-005453-4057qib7	15005	55	Bozkurt	Bozkurt	NNP
cord-005453-4057qib7	15005	56	3	3	CD
cord-005453-4057qib7	15005	57	,	,	,
cord-005453-4057qib7	15005	58	Tunç	Tunç	NNP
cord-005453-4057qib7	15005	59	Fışgın	Fışgın	NNP
cord-005453-4057qib7	15005	60	1	1	CD
cord-005453-4057qib7	15006	1	Older	old	JJR
cord-005453-4057qib7	15006	2	patients	patient	NNS
cord-005453-4057qib7	15006	3	are	be	VBP
cord-005453-4057qib7	15006	4	increasingly	increasingly	RB
cord-005453-4057qib7	15006	5	being	be	VBG
cord-005453-4057qib7	15006	6	transplanted	transplant	VBN
cord-005453-4057qib7	15006	7	,	,	,
cord-005453-4057qib7	15006	8	thanks	thank	NNS
cord-005453-4057qib7	15006	9	to	to	IN
cord-005453-4057qib7	15006	10	improvement	improvement	NN
cord-005453-4057qib7	15006	11	in	in	IN
cord-005453-4057qib7	15006	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15006	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15006	14	stem	stem	NN
cord-005453-4057qib7	15006	15	cell	cell	NN
cord-005453-4057qib7	15006	16	transplantation	transplantation	NN
cord-005453-4057qib7	15006	17	(	(	-LRB-
cord-005453-4057qib7	15006	18	allo	allo	NN
cord-005453-4057qib7	15006	19	-	-	HYPH
cord-005453-4057qib7	15006	20	HSCT	HSCT	NNP
cord-005453-4057qib7	15006	21	)	)	-RRB-
cord-005453-4057qib7	15006	22	techniques	technique	NNS
cord-005453-4057qib7	15006	23	.	.	.
cord-005453-4057qib7	15007	1	Increasing	increase	VBG
cord-005453-4057qib7	15007	2	donor	donor	NN
cord-005453-4057qib7	15007	3	age	age	NN
cord-005453-4057qib7	15007	4	is	be	VBZ
cord-005453-4057qib7	15007	5	associated	associate	VBN
cord-005453-4057qib7	15007	6	with	with	IN
cord-005453-4057qib7	15007	7	greater	great	JJR
cord-005453-4057qib7	15007	8	risk	risk	NN
cord-005453-4057qib7	15007	9	for	for	IN
cord-005453-4057qib7	15007	10	mortality	mortality	NN
cord-005453-4057qib7	15007	11	and	and	CC
cord-005453-4057qib7	15007	12	graftversus	graftversus	NN
cord-005453-4057qib7	15007	13	-	-	HYPH
cord-005453-4057qib7	15007	14	host	host	NN
cord-005453-4057qib7	15007	15	disease	disease	NN
cord-005453-4057qib7	15007	16	(	(	-LRB-
cord-005453-4057qib7	15007	17	GVHD	GVHD	NNP
cord-005453-4057qib7	15007	18	)	)	-RRB-
cord-005453-4057qib7	15007	19	.	.	.
cord-005453-4057qib7	15008	1	Since	since	IN
cord-005453-4057qib7	15008	2	sibling	sibling	NN
cord-005453-4057qib7	15008	3	donors	donor	NNS
cord-005453-4057qib7	15008	4	are	be	VBP
cord-005453-4057qib7	15008	5	of	of	IN
cord-005453-4057qib7	15008	6	similar	similar	JJ
cord-005453-4057qib7	15008	7	age	age	NN
cord-005453-4057qib7	15008	8	to	to	IN
cord-005453-4057qib7	15008	9	recipients	recipient	NNS
cord-005453-4057qib7	15008	10	,	,	,
cord-005453-4057qib7	15008	11	we	-PRON-	PRP
cord-005453-4057qib7	15008	12	hypothesized	hypothesize	VBD
cord-005453-4057qib7	15008	13	that	that	IN
cord-005453-4057qib7	15008	14	,	,	,
cord-005453-4057qib7	15008	15	in	in	IN
cord-005453-4057qib7	15008	16	older	old	JJR
cord-005453-4057qib7	15008	17	patients	patient	NNS
cord-005453-4057qib7	15008	18	,	,	,
cord-005453-4057qib7	15008	19	a	a	DT
cord-005453-4057qib7	15008	20	young	young	JJ
cord-005453-4057qib7	15008	21	matched	match	VBN
cord-005453-4057qib7	15008	22	unrelated	unrelated	JJ
cord-005453-4057qib7	15008	23	donor	donor	NN
cord-005453-4057qib7	15008	24	(	(	-LRB-
cord-005453-4057qib7	15008	25	MUD	mud	NN
cord-005453-4057qib7	15008	26	)	)	-RRB-
cord-005453-4057qib7	15008	27	would	would	MD
cord-005453-4057qib7	15008	28	be	be	VB
cord-005453-4057qib7	15008	29	comparable	comparable	JJ
cord-005453-4057qib7	15008	30	to	to	IN
cord-005453-4057qib7	15008	31	an	an	DT
cord-005453-4057qib7	15008	32	HLA	HLA	NNP
cord-005453-4057qib7	15008	33	-	-	HYPH
cord-005453-4057qib7	15008	34	matched	match	VBN
cord-005453-4057qib7	15008	35	sibling	sibling	NN
cord-005453-4057qib7	15008	36	donor	donor	NN
cord-005453-4057qib7	15008	37	(	(	-LRB-
cord-005453-4057qib7	15008	38	MSD	MSD	NNP
cord-005453-4057qib7	15008	39	)	)	-RRB-
cord-005453-4057qib7	15008	40	.	.	.
cord-005453-4057qib7	15009	1	Methods	method	NNS
cord-005453-4057qib7	15009	2	:	:	:
cord-005453-4057qib7	15009	3	We	-PRON-	PRP
cord-005453-4057qib7	15009	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	15009	5	compared	compare	VBD
cord-005453-4057qib7	15009	6	outcomes	outcome	NNS
cord-005453-4057qib7	15009	7	of	of	IN
cord-005453-4057qib7	15009	8	allo	allo	NN
cord-005453-4057qib7	15009	9	-	-	HYPH
cord-005453-4057qib7	15009	10	HSCT	HSCT	NNP
cord-005453-4057qib7	15009	11	from	from	IN
cord-005453-4057qib7	15009	12	MSD	MSD	NNP
cord-005453-4057qib7	15009	13	(	(	-LRB-
cord-005453-4057qib7	15009	14	n=1797	n=1797	CD
cord-005453-4057qib7	15009	15	)	)	-RRB-
cord-005453-4057qib7	15009	16	and	and	CC
cord-005453-4057qib7	15009	17	10/10	10/10	CD
cord-005453-4057qib7	15009	18	HLA	HLA	NNP
cord-005453-4057qib7	15009	19	MUD	MUD	NNP
cord-005453-4057qib7	15009	20	(	(	-LRB-
cord-005453-4057qib7	15009	21	n=2212	n=2212	CD
cord-005453-4057qib7	15009	22	)	)	-RRB-
cord-005453-4057qib7	15009	23	in	in	IN
cord-005453-4057qib7	15009	24	patients	patient	NNS
cord-005453-4057qib7	15009	25	aged	age	VBN
cord-005453-4057qib7	15009	26	≥	≥	CD
cord-005453-4057qib7	15009	27	60	60	CD
cord-005453-4057qib7	15009	28	years	year	NNS
cord-005453-4057qib7	15009	29	with	with	IN
cord-005453-4057qib7	15009	30	hematological	hematological	JJ
cord-005453-4057qib7	15009	31	malignancies	malignancy	NNS
cord-005453-4057qib7	15009	32	transplanted	transplant	VBN
cord-005453-4057qib7	15009	33	between	between	IN
cord-005453-4057qib7	15009	34	2006	2006	CD
cord-005453-4057qib7	15009	35	-	-	SYM
cord-005453-4057qib7	15009	36	2015	2015	CD
cord-005453-4057qib7	15009	37	.	.	.
cord-005453-4057qib7	15010	1	All	all	DT
cord-005453-4057qib7	15010	2	patients	patient	NNS
cord-005453-4057qib7	15010	3	received	receive	VBD
cord-005453-4057qib7	15010	4	reduced	reduce	VBN
cord-005453-4057qib7	15010	5	-	-	HYPH
cord-005453-4057qib7	15010	6	intensity	intensity	NN
cord-005453-4057qib7	15010	7	conditioning	conditioning	NN
cord-005453-4057qib7	15010	8	and	and	CC
cord-005453-4057qib7	15010	9	graft	graft	NN
cord-005453-4057qib7	15010	10	source	source	NN
cord-005453-4057qib7	15010	11	was	be	VBD
cord-005453-4057qib7	15010	12	peripheral	peripheral	JJ
cord-005453-4057qib7	15010	13	blood	blood	NN
cord-005453-4057qib7	15010	14	.	.	.
cord-005453-4057qib7	15011	1	The	the	DT
cord-005453-4057qib7	15011	2	primary	primary	JJ
cord-005453-4057qib7	15011	3	outcome	outcome	NN
cord-005453-4057qib7	15011	4	was	be	VBD
cord-005453-4057qib7	15011	5	overall	overall	JJ
cord-005453-4057qib7	15011	6	survival	survival	NN
cord-005453-4057qib7	15011	7	.	.	.
cord-005453-4057qib7	15012	1	MSDs	msd	NNS
cord-005453-4057qib7	15012	2	served	serve	VBD
cord-005453-4057qib7	15012	3	as	as	IN
cord-005453-4057qib7	15012	4	the	the	DT
cord-005453-4057qib7	15012	5	reference	reference	NN
cord-005453-4057qib7	15012	6	category	category	NN
cord-005453-4057qib7	15012	7	and	and	CC
cord-005453-4057qib7	15012	8	were	be	VBD
cord-005453-4057qib7	15012	9	compared	compare	VBN
cord-005453-4057qib7	15012	10	to	to	IN
cord-005453-4057qib7	15012	11	MUDs	mud	NNS
cord-005453-4057qib7	15012	12	split	split	VBD
cord-005453-4057qib7	15012	13	into	into	IN
cord-005453-4057qib7	15012	14	three	three	CD
cord-005453-4057qib7	15012	15	age	age	NN
cord-005453-4057qib7	15012	16	groups	group	NNS
cord-005453-4057qib7	15012	17	(	(	-LRB-
cord-005453-4057qib7	15012	18	≤25	≤25	NNP
cord-005453-4057qib7	15012	19	[	[	-LRB-
cord-005453-4057qib7	15012	20	n=524	n=524	NNP
cord-005453-4057qib7	15012	21	]	]	-RRB-
cord-005453-4057qib7	15012	22	,	,	,
cord-005453-4057qib7	15012	23	25	25	CD
cord-005453-4057qib7	15012	24	-	-	SYM
cord-005453-4057qib7	15012	25	40	40	CD
cord-005453-4057qib7	15012	26	[	[	-LRB-
cord-005453-4057qib7	15012	27	n=1072	n=1072	CD
cord-005453-4057qib7	15012	28	]	]	-RRB-
cord-005453-4057qib7	15012	29	,	,	,
cord-005453-4057qib7	15012	30	>	>	XX
cord-005453-4057qib7	15013	1	40	40	CD
cord-005453-4057qib7	15013	2	[	[	-LRB-
cord-005453-4057qib7	15013	3	n=616	n=616	NNP
cord-005453-4057qib7	15013	4	]	]	-RRB-
cord-005453-4057qib7	15013	5	years	year	NNS
cord-005453-4057qib7	15013	6	)	)	-RRB-
cord-005453-4057qib7	15013	7	using	use	VBG
cord-005453-4057qib7	15013	8	univariable	univariable	JJ
cord-005453-4057qib7	15013	9	analyses	analysis	NNS
cord-005453-4057qib7	15013	10	and	and	CC
cord-005453-4057qib7	15013	11	multivariable	multivariable	JJ
cord-005453-4057qib7	15013	12	Cox	Cox	NNP
cord-005453-4057qib7	15013	13	regression	regression	NN
cord-005453-4057qib7	15013	14	models	model	NNS
cord-005453-4057qib7	15013	15	adjusted	adjust	VBN
cord-005453-4057qib7	15013	16	for	for	IN
cord-005453-4057qib7	15013	17	patient	patient	NN
cord-005453-4057qib7	15013	18	,	,	,
cord-005453-4057qib7	15013	19	disease	disease	NN
cord-005453-4057qib7	15013	20	,	,	,
cord-005453-4057qib7	15013	21	and	and	CC
cord-005453-4057qib7	15013	22	transplantation	transplantation	NN
cord-005453-4057qib7	15013	23	features	feature	NNS
cord-005453-4057qib7	15013	24	.	.	.
cord-005453-4057qib7	15014	1	Results	result	NNS
cord-005453-4057qib7	15014	2	:	:	:
cord-005453-4057qib7	15015	1	The	the	DT
cord-005453-4057qib7	15015	2	median	median	JJ
cord-005453-4057qib7	15015	3	age	age	NN
cord-005453-4057qib7	15015	4	of	of	IN
cord-005453-4057qib7	15015	5	HSCT	HSCT	NNP
cord-005453-4057qib7	15015	6	recipients	recipient	NNS
cord-005453-4057qib7	15015	7	was	be	VBD
cord-005453-4057qib7	15015	8	64	64	CD
cord-005453-4057qib7	15015	9	years	year	NNS
cord-005453-4057qib7	15015	10	and	and	CC
cord-005453-4057qib7	15015	11	was	be	VBD
cord-005453-4057qib7	15015	12	similar	similar	JJ
cord-005453-4057qib7	15015	13	across	across	IN
cord-005453-4057qib7	15015	14	groups	group	NNS
cord-005453-4057qib7	15015	15	.	.	.
cord-005453-4057qib7	15016	1	Median	median	JJ
cord-005453-4057qib7	15016	2	donor	donor	NN
cord-005453-4057qib7	15016	3	age	age	NN
cord-005453-4057qib7	15016	4	for	for	IN
cord-005453-4057qib7	15016	5	MSD	MSD	NNP
cord-005453-4057qib7	15016	6	was	be	VBD
cord-005453-4057qib7	15016	7	60	60	CD
cord-005453-4057qib7	15016	8	years	year	NNS
cord-005453-4057qib7	15016	9	and	and	CC
cord-005453-4057qib7	15016	10	22	22	CD
cord-005453-4057qib7	15016	11	,	,	,
cord-005453-4057qib7	15016	12	33	33	CD
cord-005453-4057qib7	15016	13	,	,	,
cord-005453-4057qib7	15016	14	and	and	CC
cord-005453-4057qib7	15016	15	45	45	CD
cord-005453-4057qib7	15016	16	for	for	IN
cord-005453-4057qib7	15016	17	the	the	DT
cord-005453-4057qib7	15016	18	MUD	MUD	NNP
cord-005453-4057qib7	15016	19	age	age	NN
cord-005453-4057qib7	15016	20	groups	group	NNS
cord-005453-4057qib7	15017	1	≤25	≤25	NNP
cord-005453-4057qib7	15017	2	,	,	,
cord-005453-4057qib7	15017	3	25	25	CD
cord-005453-4057qib7	15017	4	-	-	SYM
cord-005453-4057qib7	15017	5	40	40	CD
cord-005453-4057qib7	15017	6	,	,	,
cord-005453-4057qib7	15017	7	and	and	CC
cord-005453-4057qib7	15017	8	>	>	XX
cord-005453-4057qib7	15017	9	40	40	CD
cord-005453-4057qib7	15017	10	years	year	NNS
cord-005453-4057qib7	15017	11	.	.	.
cord-005453-4057qib7	15018	1	Acute	acute	JJ
cord-005453-4057qib7	15018	2	leukemia	leukemia	NN
cord-005453-4057qib7	15018	3	was	be	VBD
cord-005453-4057qib7	15018	4	the	the	DT
cord-005453-4057qib7	15018	5	leading	lead	VBG
cord-005453-4057qib7	15018	6	transplant	transplant	NN
cord-005453-4057qib7	15018	7	indication	indication	NN
cord-005453-4057qib7	15018	8	(	(	-LRB-
cord-005453-4057qib7	15018	9	46	46	CD
cord-005453-4057qib7	15018	10	%	%	NN
cord-005453-4057qib7	15018	11	)	)	-RRB-
cord-005453-4057qib7	15018	12	followed	follow	VBN
cord-005453-4057qib7	15018	13	by	by	IN
cord-005453-4057qib7	15018	14	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	15018	15	syndrome	syndrome	NN
cord-005453-4057qib7	15018	16	,	,	,
cord-005453-4057qib7	15018	17	myeloproliferative	myeloproliferative	JJ
cord-005453-4057qib7	15018	18	neoplasms	neoplasm	NNS
cord-005453-4057qib7	15018	19	and	and	CC
cord-005453-4057qib7	15018	20	indolent	indolent	JJ
cord-005453-4057qib7	15018	21	non	non	JJ
cord-005453-4057qib7	15018	22	-	-	JJ
cord-005453-4057qib7	15018	23	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15018	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	15018	25	.	.	.
cord-005453-4057qib7	15019	1	Disease	disease	NN
cord-005453-4057qib7	15019	2	risk	risk	NN
cord-005453-4057qib7	15019	3	distribution	distribution	NN
cord-005453-4057qib7	15019	4	was	be	VBD
cord-005453-4057qib7	15019	5	similar	similar	JJ
cord-005453-4057qib7	15019	6	across	across	IN
cord-005453-4057qib7	15019	7	donor	donor	NN
cord-005453-4057qib7	15019	8	groups	group	NNS
cord-005453-4057qib7	15019	9	(	(	-LRB-
cord-005453-4057qib7	15019	10	low	low	JJ
cord-005453-4057qib7	15019	11	[	[	-LRB-
cord-005453-4057qib7	15019	12	48	48	CD
cord-005453-4057qib7	15019	13	%	%	NN
cord-005453-4057qib7	15019	14	]	]	-RRB-
cord-005453-4057qib7	15019	15	,	,	,
cord-005453-4057qib7	15019	16	intermediate	intermediate	JJ
cord-005453-4057qib7	15019	17	[	[	-LRB-
cord-005453-4057qib7	15019	18	42	42	CD
cord-005453-4057qib7	15019	19	%	%	NN
cord-005453-4057qib7	15019	20	]	]	-RRB-
cord-005453-4057qib7	15019	21	,	,	,
cord-005453-4057qib7	15019	22	and	and	CC
cord-005453-4057qib7	15019	23	high	high	JJ
cord-005453-4057qib7	15019	24	[	[	-LRB-
cord-005453-4057qib7	15019	25	10	10	CD
cord-005453-4057qib7	15019	26	%	%	NN
cord-005453-4057qib7	15019	27	]	]	-RRB-
cord-005453-4057qib7	15019	28	in	in	IN
cord-005453-4057qib7	15019	29	the	the	DT
cord-005453-4057qib7	15019	30	complete	complete	JJ
cord-005453-4057qib7	15019	31	population	population	NN
cord-005453-4057qib7	15019	32	;	;	:
cord-005453-4057qib7	15019	33	p=0.771	p=0.771	ADD
cord-005453-4057qib7	15019	34	)	)	-RRB-
cord-005453-4057qib7	15019	35	.	.	.
cord-005453-4057qib7	15020	1	Time	time	NN
cord-005453-4057qib7	15020	2	from	from	IN
cord-005453-4057qib7	15020	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	15020	4	to	to	IN
cord-005453-4057qib7	15020	5	HSCT	HSCT	NNP
cord-005453-4057qib7	15020	6	was	be	VBD
cord-005453-4057qib7	15020	7	longer	long	JJR
cord-005453-4057qib7	15020	8	with	with	IN
cord-005453-4057qib7	15020	9	MUD	mud	NN
cord-005453-4057qib7	15020	10	compared	compare	VBN
cord-005453-4057qib7	15020	11	to	to	IN
cord-005453-4057qib7	15020	12	MSD	MSD	NNP
cord-005453-4057qib7	15020	13	and	and	CC
cord-005453-4057qib7	15020	14	increased	increase	VBD
cord-005453-4057qib7	15020	15	with	with	IN
cord-005453-4057qib7	15020	16	an	an	DT
cord-005453-4057qib7	15020	17	older	old	JJR
cord-005453-4057qib7	15020	18	age	age	NN
cord-005453-4057qib7	15020	19	of	of	IN
cord-005453-4057qib7	15020	20	MUD	mud	NN
cord-005453-4057qib7	15020	21	.	.	.
cord-005453-4057qib7	15021	1	In	in	IN
cord-005453-4057qib7	15021	2	a	a	DT
cord-005453-4057qib7	15021	3	univariate	univariate	JJ
cord-005453-4057qib7	15021	4	analysis	analysis	NN
cord-005453-4057qib7	15021	5	,	,	,
cord-005453-4057qib7	15021	6	overall	overall	JJ
cord-005453-4057qib7	15021	7	survival	survival	NN
cord-005453-4057qib7	15021	8	was	be	VBD
cord-005453-4057qib7	15021	9	49	49	CD
cord-005453-4057qib7	15021	10	%	%	NN
cord-005453-4057qib7	15021	11	(	(	-LRB-
cord-005453-4057qib7	15021	12	MSD	MSD	NNP
cord-005453-4057qib7	15021	13	)	)	-RRB-
cord-005453-4057qib7	15021	14	,	,	,
cord-005453-4057qib7	15021	15	50	50	CD
cord-005453-4057qib7	15021	16	%	%	NN
cord-005453-4057qib7	15021	17	(	(	-LRB-
cord-005453-4057qib7	15021	18	MUD≤25	MUD≤25	NNP
cord-005453-4057qib7	15021	19	)	)	-RRB-
cord-005453-4057qib7	15021	20	,	,	,
cord-005453-4057qib7	15021	21	45	45	CD
cord-005453-4057qib7	15021	22	%	%	NN
cord-005453-4057qib7	15022	1	(	(	-LRB-
cord-005453-4057qib7	15022	2	MUD	mud	RB
cord-005453-4057qib7	15022	3	25	25	CD
cord-005453-4057qib7	15022	4	-	-	SYM
cord-005453-4057qib7	15022	5	40	40	CD
cord-005453-4057qib7	15022	6	)	)	-RRB-
cord-005453-4057qib7	15022	7	,	,	,
cord-005453-4057qib7	15022	8	and	and	CC
cord-005453-4057qib7	15022	9	43	43	CD
cord-005453-4057qib7	15022	10	%	%	NN
cord-005453-4057qib7	15022	11	(	(	-LRB-
cord-005453-4057qib7	15022	12	MUD≥40	MUD≥40	NNS
cord-005453-4057qib7	15022	13	,	,	,
cord-005453-4057qib7	15022	14	p=0.002	p=0.002	NNP
cord-005453-4057qib7	15022	15	)	)	-RRB-
cord-005453-4057qib7	15022	16	.	.	.
cord-005453-4057qib7	15023	1	Corresponding	correspond	VBG
cord-005453-4057qib7	15023	2	non	non	JJ
cord-005453-4057qib7	15023	3	-	-	JJ
cord-005453-4057qib7	15023	4	relapse	relapse	JJ
cord-005453-4057qib7	15023	5	mortality	mortality	NN
cord-005453-4057qib7	15023	6	(	(	-LRB-
cord-005453-4057qib7	15023	7	NRM	NRM	NNP
cord-005453-4057qib7	15023	8	)	)	-RRB-
cord-005453-4057qib7	15023	9	cumulative	cumulative	JJ
cord-005453-4057qib7	15023	10	incidence	incidence	NN
cord-005453-4057qib7	15023	11	was	be	VBD
cord-005453-4057qib7	15023	12	22	22	CD
cord-005453-4057qib7	15023	13	%	%	NN
cord-005453-4057qib7	15023	14	,	,	,
cord-005453-4057qib7	15023	15	25%.,31	25%.,31	CD
cord-005453-4057qib7	15023	16	%	%	NN
cord-005453-4057qib7	15023	17	,	,	,
cord-005453-4057qib7	15023	18	and	and	CC
cord-005453-4057qib7	15023	19	32.2	32.2	CD
cord-005453-4057qib7	15023	20	%	%	NN
cord-005453-4057qib7	15023	21	(	(	-LRB-
cord-005453-4057qib7	15023	22	p	p	NN
cord-005453-4057qib7	15023	23	<	<	XX
cord-005453-4057qib7	15023	24	0.001	0.001	CD
cord-005453-4057qib7	15023	25	)	)	-RRB-
cord-005453-4057qib7	15024	1	(	(	-LRB-
cord-005453-4057qib7	15024	2	Figure	figure	NN
cord-005453-4057qib7	15024	3	)	)	-RRB-
cord-005453-4057qib7	15024	4	.	.	.
cord-005453-4057qib7	15025	1	GVHD	gvhd	NN
cord-005453-4057qib7	15025	2	-	-	HYPH
cord-005453-4057qib7	15025	3	relapse	relapse	NN
cord-005453-4057qib7	15025	4	-	-	HYPH
cord-005453-4057qib7	15025	5	free	free	JJ
cord-005453-4057qib7	15025	6	(	(	-LRB-
cord-005453-4057qib7	15025	7	GRFS	GRFS	NNP
cord-005453-4057qib7	15025	8	)	)	-RRB-
cord-005453-4057qib7	15025	9	was	be	VBD
cord-005453-4057qib7	15025	10	29	29	CD
cord-005453-4057qib7	15025	11	%	%	NN
cord-005453-4057qib7	15025	12	,	,	,
cord-005453-4057qib7	15025	13	30	30	CD
cord-005453-4057qib7	15025	14	%	%	NN
cord-005453-4057qib7	15025	15	,	,	,
cord-005453-4057qib7	15025	16	26	26	CD
cord-005453-4057qib7	15025	17	%	%	NN
cord-005453-4057qib7	15025	18	,	,	,
cord-005453-4057qib7	15025	19	and	and	CC
cord-005453-4057qib7	15025	20	24	24	CD
cord-005453-4057qib7	15025	21	%	%	NN
cord-005453-4057qib7	15025	22	(	(	-LRB-
cord-005453-4057qib7	15025	23	p=0.012	p=0.012	NNP
cord-005453-4057qib7	15025	24	)	)	-RRB-
cord-005453-4057qib7	15025	25	.	.	.
cord-005453-4057qib7	15026	1	In	in	IN
cord-005453-4057qib7	15026	2	a	a	DT
cord-005453-4057qib7	15026	3	multivariable	multivariable	JJ
cord-005453-4057qib7	15026	4	Cox	Cox	NNP
cord-005453-4057qib7	15026	5	model	model	NN
cord-005453-4057qib7	15026	6	,	,	,
cord-005453-4057qib7	15026	7	young	young	JJ
cord-005453-4057qib7	15026	8	MUD	mud	NN
cord-005453-4057qib7	15026	9	(	(	-LRB-
cord-005453-4057qib7	15026	10	≤25	≤25	NNP
cord-005453-4057qib7	15026	11	)	)	-RRB-
cord-005453-4057qib7	15026	12	had	have	VBD
cord-005453-4057qib7	15026	13	a	a	DT
cord-005453-4057qib7	15026	14	similar	similar	JJ
cord-005453-4057qib7	15026	15	risk	risk	NN
cord-005453-4057qib7	15026	16	for	for	IN
cord-005453-4057qib7	15026	17	mortality	mortality	NN
cord-005453-4057qib7	15026	18	compared	compare	VBN
cord-005453-4057qib7	15026	19	to	to	IN
cord-005453-4057qib7	15026	20	MSD	MSD	NNP
cord-005453-4057qib7	15026	21	(	(	-LRB-
cord-005453-4057qib7	15026	22	HR	HR	NNP
cord-005453-4057qib7	15026	23	1.00	1.00	CD
cord-005453-4057qib7	15026	24	,	,	,
cord-005453-4057qib7	15026	25	p=0.97	p=0.97	NNP
cord-005453-4057qib7	15026	26	)	)	-RRB-
cord-005453-4057qib7	15026	27	,	,	,
cord-005453-4057qib7	15026	28	while	while	IN
cord-005453-4057qib7	15026	29	a	a	DT
cord-005453-4057qib7	15026	30	monotonic	monotonic	JJ
cord-005453-4057qib7	15026	31	increase	increase	NN
cord-005453-4057qib7	15026	32	in	in	IN
cord-005453-4057qib7	15026	33	risk	risk	NN
cord-005453-4057qib7	15026	34	was	be	VBD
cord-005453-4057qib7	15026	35	observed	observe	VBN
cord-005453-4057qib7	15026	36	with	with	IN
cord-005453-4057qib7	15026	37	an	an	DT
cord-005453-4057qib7	15026	38	older	old	JJR
cord-005453-4057qib7	15026	39	donor	donor	NN
cord-005453-4057qib7	15026	40	age	age	NN
cord-005453-4057qib7	15026	41	(	(	-LRB-
cord-005453-4057qib7	15026	42	MUD	MUD	NNP
cord-005453-4057qib7	15026	43	25	25	CD
cord-005453-4057qib7	15026	44	-	-	HYPH
cord-005453-4057qib7	15026	45	40y	40y	CD
cord-005453-4057qib7	15026	46	:	:	:
cord-005453-4057qib7	15026	47	HR	HR	NNP
cord-005453-4057qib7	15026	48	1.17,p=0.014	1.17,p=0.014	CD
cord-005453-4057qib7	15026	49	;	;	:
cord-005453-4057qib7	15026	50	MUD≥40y	MUD≥40y	NNP
cord-005453-4057qib7	15026	51	:	:	:
cord-005453-4057qib7	15027	1	HR	HR	NNP
cord-005453-4057qib7	15027	2	1.26	1.26	CD
cord-005453-4057qib7	15027	3	,	,	,
cord-005453-4057qib7	15027	4	p=0.001	p=0.001	NNP
cord-005453-4057qib7	15027	5	)	)	-RRB-
cord-005453-4057qib7	15028	1	(	(	-LRB-
cord-005453-4057qib7	15028	2	Table	table	NN
cord-005453-4057qib7	15028	3	)	)	-RRB-
cord-005453-4057qib7	15028	4	.	.	.
cord-005453-4057qib7	15029	1	Findings	finding	NNS
cord-005453-4057qib7	15029	2	were	be	VBD
cord-005453-4057qib7	15029	3	confirmed	confirm	VBN
cord-005453-4057qib7	15029	4	in	in	IN
cord-005453-4057qib7	15029	5	a	a	DT
cord-005453-4057qib7	15029	6	propensity	propensity	NN
cord-005453-4057qib7	15029	7	score	score	NN
cord-005453-4057qib7	15029	8	analysis	analysis	NN
cord-005453-4057qib7	15029	9	,	,	,
cord-005453-4057qib7	15029	10	matched	match	VBN
cord-005453-4057qib7	15029	11	for	for	IN
cord-005453-4057qib7	15029	12	key	key	JJ
cord-005453-4057qib7	15029	13	covariates	covariate	NNS
cord-005453-4057qib7	15029	14	.	.	.
cord-005453-4057qib7	15030	1	NRM	NRM	NNP
cord-005453-4057qib7	15030	2	and	and	CC
cord-005453-4057qib7	15030	3	Grade	Grade	NNP
cord-005453-4057qib7	15030	4	2	2	CD
cord-005453-4057qib7	15030	5	-	-	SYM
cord-005453-4057qib7	15030	6	4	4	CD
cord-005453-4057qib7	15030	7	acute	acute	JJ
cord-005453-4057qib7	15030	8	GVHD	GVHD	NNP
cord-005453-4057qib7	15030	9	were	be	VBD
cord-005453-4057qib7	15030	10	consistently	consistently	RB
cord-005453-4057qib7	15030	11	higher	high	JJR
cord-005453-4057qib7	15030	12	with	with	IN
cord-005453-4057qib7	15030	13	MUD	mud	NN
cord-005453-4057qib7	15030	14	,	,	,
cord-005453-4057qib7	15030	15	with	with	IN
cord-005453-4057qib7	15030	16	the	the	DT
cord-005453-4057qib7	15030	17	greatest	great	JJS
cord-005453-4057qib7	15030	18	risk	risk	NN
cord-005453-4057qib7	15030	19	associated	associate	VBN
cord-005453-4057qib7	15030	20	with	with	IN
cord-005453-4057qib7	15030	21	older	old	JJR
cord-005453-4057qib7	15030	22	MUDs	mud	NNS
cord-005453-4057qib7	15030	23	.	.	.
cord-005453-4057qib7	15031	1	The	the	DT
cord-005453-4057qib7	15031	2	hazard	hazard	NN
cord-005453-4057qib7	15031	3	for	for	IN
cord-005453-4057qib7	15031	4	GRFS	GRFS	NNP
cord-005453-4057qib7	15031	5	was	be	VBD
cord-005453-4057qib7	15031	6	higher	high	JJR
cord-005453-4057qib7	15031	7	with	with	IN
cord-005453-4057qib7	15031	8	MUD	mud	NN
cord-005453-4057qib7	15031	9	aged	age	VBN
cord-005453-4057qib7	15031	10	25	25	CD
cord-005453-4057qib7	15031	11	or	or	CC
cord-005453-4057qib7	15031	12	higher	high	JJR
cord-005453-4057qib7	15031	13	compared	compare	VBN
cord-005453-4057qib7	15031	14	to	to	IN
cord-005453-4057qib7	15031	15	MSD	msd	NN
cord-005453-4057qib7	15031	16	;	;	:
cord-005453-4057qib7	15031	17	risk	risk	NN
cord-005453-4057qib7	15031	18	was	be	VBD
cord-005453-4057qib7	15031	19	not	not	RB
cord-005453-4057qib7	15031	20	higher	high	JJR
cord-005453-4057qib7	15031	21	with	with	IN
cord-005453-4057qib7	15031	22	younger	young	JJR
cord-005453-4057qib7	15031	23	MUD	mud	NN
cord-005453-4057qib7	15031	24	.	.	.
cord-005453-4057qib7	15032	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15032	2	:	:	:
cord-005453-4057qib7	15033	1	In	in	IN
cord-005453-4057qib7	15033	2	older	old	JJR
cord-005453-4057qib7	15033	3	patients	patient	NNS
cord-005453-4057qib7	15033	4	receiving	receive	VBG
cord-005453-4057qib7	15033	5	reduced	reduce	VBN
cord-005453-4057qib7	15033	6	intensity	intensity	NN
cord-005453-4057qib7	15033	7	conditioning	conditioning	NN
cord-005453-4057qib7	15033	8	,	,	,
cord-005453-4057qib7	15033	9	MSD	MSD	NNP
cord-005453-4057qib7	15033	10	remain	remain	VBP
cord-005453-4057qib7	15033	11	the	the	DT
cord-005453-4057qib7	15033	12	optimal	optimal	JJ
cord-005453-4057qib7	15033	13	choice	choice	NN
cord-005453-4057qib7	15033	14	.	.	.
cord-005453-4057qib7	15034	1	However	however	RB
cord-005453-4057qib7	15034	2	,	,	,
cord-005453-4057qib7	15034	3	when	when	WRB
cord-005453-4057qib7	15034	4	not	not	RB
cord-005453-4057qib7	15034	5	available	available	JJ
cord-005453-4057qib7	15034	6	,	,	,
cord-005453-4057qib7	15034	7	young	young	JJ
cord-005453-4057qib7	15034	8	MUD	MUD	NNP
cord-005453-4057qib7	15034	9	provide	provide	VBP
cord-005453-4057qib7	15034	10	comparable	comparable	JJ
cord-005453-4057qib7	15034	11	results	result	NNS
cord-005453-4057qib7	15034	12	.	.	.
cord-005453-4057qib7	15035	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15035	2	:	:	:
cord-005453-4057qib7	15035	3	Nothing	nothing	NN
cord-005453-4057qib7	15035	4	to	to	TO
cord-005453-4057qib7	15035	5	declare	declare	VB
cord-005453-4057qib7	15035	6	Background	Background	NNP
cord-005453-4057qib7	15035	7	:	:	:
cord-005453-4057qib7	15035	8	There	there	EX
cord-005453-4057qib7	15035	9	is	be	VBZ
cord-005453-4057qib7	15035	10	growing	grow	VBG
cord-005453-4057qib7	15035	11	evidence	evidence	NN
cord-005453-4057qib7	15035	12	that	that	IN
cord-005453-4057qib7	15035	13	community	community	NN
cord-005453-4057qib7	15035	14	acquired	acquire	VBD
cord-005453-4057qib7	15035	15	respiratory	respiratory	JJ
cord-005453-4057qib7	15035	16	virus	virus	NN
cord-005453-4057qib7	15035	17	(	(	-LRB-
cord-005453-4057qib7	15035	18	CARV	CARV	NNP
cord-005453-4057qib7	15035	19	)	)	-RRB-
cord-005453-4057qib7	15035	20	increase	increase	VB
cord-005453-4057qib7	15035	21	the	the	DT
cord-005453-4057qib7	15035	22	risk	risk	NN
cord-005453-4057qib7	15035	23	of	of	IN
cord-005453-4057qib7	15035	24	pulmonary	pulmonary	JJ
cord-005453-4057qib7	15035	25	invasive	invasive	JJ
cord-005453-4057qib7	15035	26	fungal	fungal	NN
cord-005453-4057qib7	15035	27	disease	disease	NN
cord-005453-4057qib7	15035	28	(	(	-LRB-
cord-005453-4057qib7	15035	29	IFD	IFD	NNP
cord-005453-4057qib7	15035	30	)	)	-RRB-
cord-005453-4057qib7	15035	31	in	in	IN
cord-005453-4057qib7	15035	32	recipients	recipient	NNS
cord-005453-4057qib7	15035	33	of	of	IN
cord-005453-4057qib7	15035	34	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15035	35	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15035	36	stem	stem	NN
cord-005453-4057qib7	15035	37	cell	cell	NN
cord-005453-4057qib7	15035	38	transplantation	transplantation	NN
cord-005453-4057qib7	15035	39	(	(	-LRB-
cord-005453-4057qib7	15035	40	allo	allo	NN
cord-005453-4057qib7	15035	41	-	-	HYPH
cord-005453-4057qib7	15035	42	HSCT	HSCT	NNP
cord-005453-4057qib7	15035	43	)	)	-RRB-
cord-005453-4057qib7	15035	44	.	.	.
cord-005453-4057qib7	15036	1	To	to	IN
cord-005453-4057qib7	15036	2	date	date	NN
cord-005453-4057qib7	15036	3	,	,	,
cord-005453-4057qib7	15036	4	there	there	EX
cord-005453-4057qib7	15036	5	is	be	VBZ
cord-005453-4057qib7	15036	6	a	a	DT
cord-005453-4057qib7	15036	7	lack	lack	NN
cord-005453-4057qib7	15036	8	of	of	IN
cord-005453-4057qib7	15036	9	knowledge	knowledge	NN
cord-005453-4057qib7	15036	10	regarding	regard	VBG
cord-005453-4057qib7	15036	11	the	the	DT
cord-005453-4057qib7	15036	12	rate	rate	NN
cord-005453-4057qib7	15036	13	of	of	IN
cord-005453-4057qib7	15036	14	IFD	IFD	NNP
cord-005453-4057qib7	15036	15	,	,	,
cord-005453-4057qib7	15036	16	risk	risk	NN
cord-005453-4057qib7	15036	17	factors	factor	NNS
cord-005453-4057qib7	15036	18	(	(	-LRB-
cord-005453-4057qib7	15036	19	RFs	RFs	NNP
cord-005453-4057qib7	15036	20	)	)	-RRB-
cord-005453-4057qib7	15036	21	as	as	RB
cord-005453-4057qib7	15036	22	well	well	RB
cord-005453-4057qib7	15036	23	as	as	IN
cord-005453-4057qib7	15036	24	the	the	DT
cord-005453-4057qib7	15036	25	most	most	RBS
cord-005453-4057qib7	15036	26	critical	critical	JJ
cord-005453-4057qib7	15036	27	period	period	NN
cord-005453-4057qib7	15036	28	for	for	IN
cord-005453-4057qib7	15036	29	the	the	DT
cord-005453-4057qib7	15036	30	development	development	NN
cord-005453-4057qib7	15036	31	of	of	IN
cord-005453-4057qib7	15036	32	a	a	DT
cord-005453-4057qib7	15036	33	later	later	JJ
cord-005453-4057qib7	15036	34	IFD	IFD	NNP
cord-005453-4057qib7	15036	35	after	after	IN
cord-005453-4057qib7	15036	36	CARV	CARV	NNP
cord-005453-4057qib7	15036	37	infections	infection	NNS
cord-005453-4057qib7	15036	38	in	in	IN
cord-005453-4057qib7	15036	39	allo	allo	NN
cord-005453-4057qib7	15036	40	-	-	HYPH
cord-005453-4057qib7	15036	41	HSCT	HSCT	NNP
cord-005453-4057qib7	15036	42	recipients	recipient	NNS
cord-005453-4057qib7	15036	43	.	.	.
cord-005453-4057qib7	15037	1	Methods	method	NNS
cord-005453-4057qib7	15037	2	:	:	:
cord-005453-4057qib7	15037	3	In	in	IN
cord-005453-4057qib7	15037	4	this	this	DT
cord-005453-4057qib7	15037	5	prospective	prospective	JJ
cord-005453-4057qib7	15037	6	observational	observational	JJ
cord-005453-4057qib7	15037	7	study	study	NN
cord-005453-4057qib7	15037	8	,	,	,
cord-005453-4057qib7	15037	9	we	-PRON-	PRP
cord-005453-4057qib7	15037	10	retrospectively	retrospectively	RB
cord-005453-4057qib7	15037	11	analyzed	analyze	VBD
cord-005453-4057qib7	15037	12	the	the	DT
cord-005453-4057qib7	15037	13	effect	effect	NN
cord-005453-4057qib7	15037	14	of	of	IN
cord-005453-4057qib7	15037	15	CARV	CARV	NNP
cord-005453-4057qib7	15037	16	on	on	IN
cord-005453-4057qib7	15037	17	the	the	DT
cord-005453-4057qib7	15037	18	development	development	NN
cord-005453-4057qib7	15037	19	of	of	IN
cord-005453-4057qib7	15037	20	a	a	DT
cord-005453-4057qib7	15037	21	later	later	JJ
cord-005453-4057qib7	15037	22	IFD	ifd	NN
cord-005453-4057qib7	15037	23	in	in	IN
cord-005453-4057qib7	15037	24	a	a	DT
cord-005453-4057qib7	15037	25	consecutive	consecutive	JJ
cord-005453-4057qib7	15037	26	cohort	cohort	NN
cord-005453-4057qib7	15037	27	of	of	IN
cord-005453-4057qib7	15037	28	287	287	CD
cord-005453-4057qib7	15037	29	allo	allo	NN
cord-005453-4057qib7	15037	30	-	-	HYPH
cord-005453-4057qib7	15037	31	HSCT	HSCT	NNP
cord-005453-4057qib7	15037	32	adult	adult	NN
cord-005453-4057qib7	15037	33	recipients	recipient	NNS
cord-005453-4057qib7	15037	34	who	who	WP
cord-005453-4057qib7	15037	35	developed	develop	VBD
cord-005453-4057qib7	15037	36	597	597	CD
cord-005453-4057qib7	15037	37	CARV	CARV	NNP
cord-005453-4057qib7	15037	38	infectious	infectious	JJ
cord-005453-4057qib7	15037	39	episodes	episode	NNS
cord-005453-4057qib7	15037	40	from	from	IN
cord-005453-4057qib7	15037	41	December	December	NNP
cord-005453-4057qib7	15037	42	2013	2013	CD
cord-005453-4057qib7	15037	43	to	to	IN
cord-005453-4057qib7	15037	44	December	December	NNP
cord-005453-4057qib7	15037	45	2018	2018	CD
cord-005453-4057qib7	15037	46	.	.	.
cord-005453-4057qib7	15038	1	Respiratory	respiratory	JJ
cord-005453-4057qib7	15038	2	virus	virus	NN
cord-005453-4057qib7	15038	3	in	in	IN
cord-005453-4057qib7	15038	4	upper	upper	JJ
cord-005453-4057qib7	15038	5	and/or	and/or	CC
cord-005453-4057qib7	15039	1	lower	low	JJR
cord-005453-4057qib7	15039	2	respiratory	respiratory	JJ
cord-005453-4057qib7	15039	3	tract	tract	NN
cord-005453-4057qib7	15039	4	specimens	specimen	NNS
cord-005453-4057qib7	15039	5	were	be	VBD
cord-005453-4057qib7	15039	6	tested	test	VBN
cord-005453-4057qib7	15039	7	using	use	VBG
cord-005453-4057qib7	15039	8	multiplex	multiplex	JJ
cord-005453-4057qib7	15039	9	PCR	PCR	NNP
cord-005453-4057qib7	15039	10	panel	panel	NN
cord-005453-4057qib7	15039	11	assays	assay	NNS
cord-005453-4057qib7	15039	12	.	.	.
cord-005453-4057qib7	15040	1	Results	result	NNS
cord-005453-4057qib7	15040	2	:	:	:
cord-005453-4057qib7	15040	3	Overall	overall	RB
cord-005453-4057qib7	15040	4	,	,	,
cord-005453-4057qib7	15040	5	29	29	CD
cord-005453-4057qib7	15040	6	out	out	IN
cord-005453-4057qib7	15040	7	of	of	IN
cord-005453-4057qib7	15040	8	287	287	CD
cord-005453-4057qib7	15040	9	allo	allo	NN
cord-005453-4057qib7	15040	10	-	-	HYPH
cord-005453-4057qib7	15040	11	HSCT	HSCT	NNP
cord-005453-4057qib7	15040	12	recipients	recipient	NNS
cord-005453-4057qib7	15040	13	(	(	-LRB-
cord-005453-4057qib7	15040	14	10	10	CD
cord-005453-4057qib7	15040	15	%	%	NN
cord-005453-4057qib7	15040	16	)	)	-RRB-
cord-005453-4057qib7	15040	17	developed	develop	VBD
cord-005453-4057qib7	15040	18	IFD	IFD	NNP
cord-005453-4057qib7	15040	19	within	within	IN
cord-005453-4057qib7	15040	20	2	2	CD
cord-005453-4057qib7	15040	21	months	month	NNS
cord-005453-4057qib7	15040	22	after	after	IN
cord-005453-4057qib7	15040	23	a	a	DT
cord-005453-4057qib7	15040	24	CARV	CARV	NNP
cord-005453-4057qib7	15040	25	episode	episode	NN
cord-005453-4057qib7	15040	26	at	at	IN
cord-005453-4057qib7	15040	27	median	median	NN
cord-005453-4057qib7	15040	28	of	of	IN
cord-005453-4057qib7	15040	29	21	21	CD
cord-005453-4057qib7	15040	30	days	day	NNS
cord-005453-4057qib7	15041	1	(	(	-LRB-
cord-005453-4057qib7	15041	2	range	range	NN
cord-005453-4057qib7	15041	3	0	0	CD
cord-005453-4057qib7	15041	4	-	-	SYM
cord-005453-4057qib7	15041	5	158	158	CD
cord-005453-4057qib7	15041	6	days	day	NNS
cord-005453-4057qib7	15041	7	)	)	-RRB-
cord-005453-4057qib7	15041	8	from	from	IN
cord-005453-4057qib7	15041	9	the	the	DT
cord-005453-4057qib7	15041	10	day	day	NN
cord-005453-4057qib7	15041	11	of	of	IN
cord-005453-4057qib7	15041	12	CARV	CARV	NNP
cord-005453-4057qib7	15041	13	detection	detection	NN
cord-005453-4057qib7	15041	14	.	.	.
cord-005453-4057qib7	15042	1	All	all	PDT
cord-005453-4057qib7	15042	2	the	the	DT
cord-005453-4057qib7	15042	3	IFDs	ifd	NNS
cord-005453-4057qib7	15042	4	involved	involve	VBD
cord-005453-4057qib7	15042	5	the	the	DT
cord-005453-4057qib7	15042	6	lungs	lung	NNS
cord-005453-4057qib7	15042	7	and	and	CC
cord-005453-4057qib7	15042	8	in	in	IN
cord-005453-4057qib7	15042	9	28	28	CD
cord-005453-4057qib7	15042	10	cases	case	NNS
cord-005453-4057qib7	15042	11	(	(	-LRB-
cord-005453-4057qib7	15042	12	97	97	CD
cord-005453-4057qib7	15042	13	%	%	NN
cord-005453-4057qib7	15042	14	)	)	-RRB-
cord-005453-4057qib7	15043	1	the	the	DT
cord-005453-4057qib7	15043	2	diagnostic	diagnostic	NN
cord-005453-4057qib7	15043	3	was	be	VBD
cord-005453-4057qib7	15044	1	IA	IA	NNP
cord-005453-4057qib7	15044	2	accomplishing	accomplish	VBG
cord-005453-4057qib7	15044	3	criteria	criterion	NNS
cord-005453-4057qib7	15044	4	of	of	IN
cord-005453-4057qib7	15044	5	probable	probable	JJ
cord-005453-4057qib7	15044	6	(	(	-LRB-
cord-005453-4057qib7	15044	7	n=	n=	NNP
cord-005453-4057qib7	15044	8	26	26	CD
cord-005453-4057qib7	15044	9	)	)	-RRB-
cord-005453-4057qib7	15044	10	or	or	CC
cord-005453-4057qib7	15044	11	proven	prove	VBN
cord-005453-4057qib7	15044	12	(	(	-LRB-
cord-005453-4057qib7	15044	13	n=2	n=2	NNS
cord-005453-4057qib7	15044	14	)	)	-RRB-
cord-005453-4057qib7	15044	15	.	.	.
cord-005453-4057qib7	15045	1	Of	of	IN
cord-005453-4057qib7	15045	2	note	note	NN
cord-005453-4057qib7	15045	3	,	,	,
cord-005453-4057qib7	15045	4	26	26	CD
cord-005453-4057qib7	15045	5	out	out	IN
cord-005453-4057qib7	15045	6	of	of	IN
cord-005453-4057qib7	15045	7	29	29	CD
cord-005453-4057qib7	15045	8	IFD	IFD	NNP
cord-005453-4057qib7	15045	9	(	(	-LRB-
cord-005453-4057qib7	15045	10	91	91	CD
cord-005453-4057qib7	15045	11	%	%	NN
cord-005453-4057qib7	15045	12	)	)	-RRB-
cord-005453-4057qib7	15045	13	occurred	occur	VBD
cord-005453-4057qib7	15045	14	within	within	IN
cord-005453-4057qib7	15045	15	the	the	DT
cord-005453-4057qib7	15045	16	first	first	JJ
cord-005453-4057qib7	15045	17	year	year	NN
cord-005453-4057qib7	15045	18	after	after	IN
cord-005453-4057qib7	15045	19	transplantation	transplantation	NN
cord-005453-4057qib7	15045	20	.	.	.
cord-005453-4057qib7	15046	1	The	the	DT
cord-005453-4057qib7	15046	2	overall	overall	JJ
cord-005453-4057qib7	15046	3	rate	rate	NN
cord-005453-4057qib7	15046	4	of	of	IN
cord-005453-4057qib7	15046	5	IFD	IFD	NNP
cord-005453-4057qib7	15046	6	after	after	IN
cord-005453-4057qib7	15046	7	CARV	CARV	NNP
cord-005453-4057qib7	15046	8	episodes	episode	NNS
cord-005453-4057qib7	15046	9	was	be	VBD
cord-005453-4057qib7	15046	10	5	5	CD
cord-005453-4057qib7	15046	11	%	%	NN
cord-005453-4057qib7	15046	12	whereas	whereas	IN
cord-005453-4057qib7	15046	13	this	this	DT
cord-005453-4057qib7	15046	14	rate	rate	NN
cord-005453-4057qib7	15046	15	was	be	VBD
cord-005453-4057qib7	15046	16	higher	high	JJR
cord-005453-4057qib7	15046	17	in	in	IN
cord-005453-4057qib7	15046	18	recipients	recipient	NNS
cord-005453-4057qib7	15046	19	developing	develop	VBG
cord-005453-4057qib7	15046	20	CARV	CARV	NNP
cord-005453-4057qib7	15046	21	during	during	IN
cord-005453-4057qib7	15046	22	the	the	DT
cord-005453-4057qib7	15046	23	first	first	JJ
cord-005453-4057qib7	15046	24	year	year	NN
cord-005453-4057qib7	15046	25	of	of	IN
cord-005453-4057qib7	15046	26	transplant	transplant	NN
cord-005453-4057qib7	15046	27	(	(	-LRB-
cord-005453-4057qib7	15046	28	7	7	CD
cord-005453-4057qib7	15046	29	%	%	NN
cord-005453-4057qib7	15046	30	)	)	-RRB-
cord-005453-4057qib7	15046	31	.	.	.
cord-005453-4057qib7	15047	1	IFD	IFD	NNP
cord-005453-4057qib7	15047	2	was	be	VBD
cord-005453-4057qib7	15047	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	15047	4	in	in	IN
cord-005453-4057qib7	15047	5	25	25	CD
cord-005453-4057qib7	15047	6	out	out	IN
cord-005453-4057qib7	15047	7	of	of	IN
cord-005453-4057qib7	15047	8	203	203	CD
cord-005453-4057qib7	15047	9	with	with	IN
cord-005453-4057qib7	15047	10	CARV	CARV	NNP
cord-005453-4057qib7	15047	11	lower	low	JJR
cord-005453-4057qib7	15047	12	respiratory	respiratory	JJ
cord-005453-4057qib7	15047	13	tract	tract	NN
cord-005453-4057qib7	15047	14	disease	disease	NN
cord-005453-4057qib7	15047	15	(	(	-LRB-
cord-005453-4057qib7	15047	16	LRTD	LRTD	NNP
cord-005453-4057qib7	15047	17	)	)	-RRB-
cord-005453-4057qib7	15047	18	episodes	episode	NNS
cord-005453-4057qib7	15047	19	(	(	-LRB-
cord-005453-4057qib7	15047	20	12	12	CD
cord-005453-4057qib7	15047	21	%	%	NN
cord-005453-4057qib7	15047	22	)	)	-RRB-
cord-005453-4057qib7	15047	23	compared	compare	VBN
cord-005453-4057qib7	15047	24	to	to	IN
cord-005453-4057qib7	15047	25	4	4	CD
cord-005453-4057qib7	15047	26	out	out	IN
cord-005453-4057qib7	15047	27	of	of	IN
cord-005453-4057qib7	15047	28	394	394	CD
cord-005453-4057qib7	15047	29	CARV	CARV	NNP
cord-005453-4057qib7	15047	30	upper	upper	JJ
cord-005453-4057qib7	15047	31	respiratory	respiratory	JJ
cord-005453-4057qib7	15047	32	tract	tract	NN
cord-005453-4057qib7	15047	33	disease	disease	NN
cord-005453-4057qib7	15047	34	(	(	-LRB-
cord-005453-4057qib7	15047	35	URTD	URTD	NNP
cord-005453-4057qib7	15047	36	)	)	-RRB-
cord-005453-4057qib7	15047	37	(	(	-LRB-
cord-005453-4057qib7	15047	38	1	1	CD
cord-005453-4057qib7	15047	39	%	%	NN
cord-005453-4057qib7	15047	40	)	)	-RRB-
cord-005453-4057qib7	15047	41	(	(	-LRB-
cord-005453-4057qib7	15047	42	p=	p=	NNP
cord-005453-4057qib7	15047	43	0.0001	0.0001	CD
cord-005453-4057qib7	15047	44	)	)	-RRB-
cord-005453-4057qib7	15047	45	.	.	.
cord-005453-4057qib7	15048	1	Twenty	twenty	CD
cord-005453-4057qib7	15048	2	-	-	HYPH
cord-005453-4057qib7	15048	3	three	three	CD
cord-005453-4057qib7	15048	4	out	out	IN
cord-005453-4057qib7	15048	5	of	of	IN
cord-005453-4057qib7	15048	6	133	133	CD
cord-005453-4057qib7	15048	7	CARV	CARV	NNP
cord-005453-4057qib7	15048	8	episodes	episode	NNS
cord-005453-4057qib7	15048	9	involving	involve	VBG
cord-005453-4057qib7	15048	10	the	the	DT
cord-005453-4057qib7	15048	11	LRTD	LRTD	NNP
cord-005453-4057qib7	15048	12	during	during	IN
cord-005453-4057qib7	15048	13	the	the	DT
cord-005453-4057qib7	15048	14	first	first	JJ
cord-005453-4057qib7	15048	15	year	year	NN
cord-005453-4057qib7	15048	16	after	after	IN
cord-005453-4057qib7	15048	17	transplant	transplant	NN
cord-005453-4057qib7	15048	18	(	(	-LRB-
cord-005453-4057qib7	15048	19	17	17	CD
cord-005453-4057qib7	15048	20	%	%	NN
cord-005453-4057qib7	15048	21	)	)	-RRB-
cord-005453-4057qib7	15048	22	developed	develop	VBD
cord-005453-4057qib7	15048	23	IFD	IFD	NNP
cord-005453-4057qib7	15048	24	.	.	.
cord-005453-4057qib7	15049	1	We	-PRON-	PRP
cord-005453-4057qib7	15049	2	did	do	VBD
cord-005453-4057qib7	15049	3	not	not	RB
cord-005453-4057qib7	15049	4	found	find	VBD
cord-005453-4057qib7	15049	5	differences	difference	NNS
cord-005453-4057qib7	15049	6	in	in	IN
cord-005453-4057qib7	15049	7	IFD	IFD	NNP
cord-005453-4057qib7	15049	8	rates	rate	NNS
cord-005453-4057qib7	15049	9	according	accord	VBG
cord-005453-4057qib7	15049	10	to	to	IN
cord-005453-4057qib7	15049	11	the	the	DT
cord-005453-4057qib7	15049	12	type	type	NN
cord-005453-4057qib7	15049	13	of	of	IN
cord-005453-4057qib7	15049	14	CARV	CARV	NNP
cord-005453-4057qib7	15049	15	identified	identify	VBN
cord-005453-4057qib7	15049	16	.	.	.
cord-005453-4057qib7	15050	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	15050	2	analysis	analysis	NN
cord-005453-4057qib7	15050	3	identified	identify	VBD
cord-005453-4057qib7	15050	4	4	4	CD
cord-005453-4057qib7	15050	5	RFs	rf	NNS
cord-005453-4057qib7	15050	6	for	for	IN
cord-005453-4057qib7	15050	7	IFD	IFD	NNP
cord-005453-4057qib7	15050	8	:	:	:
cord-005453-4057qib7	15050	9	the	the	DT
cord-005453-4057qib7	15050	10	use	use	NN
cord-005453-4057qib7	15050	11	of	of	IN
cord-005453-4057qib7	15050	12	ATG	ATG	NNP
cord-005453-4057qib7	15050	13	as	as	IN
cord-005453-4057qib7	15050	14	a	a	DT
cord-005453-4057qib7	15050	15	part	part	NN
cord-005453-4057qib7	15050	16	of	of	IN
cord-005453-4057qib7	15050	17	conditioning	conditioning	NN
cord-005453-4057qib7	15050	18	[	[	-LRB-
cord-005453-4057qib7	15050	19	odds	odd	NNS
cord-005453-4057qib7	15050	20	ratio	ratio	NN
cord-005453-4057qib7	15050	21	(	(	-LRB-
cord-005453-4057qib7	15050	22	OR	OR	NNP
cord-005453-4057qib7	15050	23	)	)	-RRB-
cord-005453-4057qib7	15050	24	2.7	2.7	CD
cord-005453-4057qib7	15050	25	,	,	,
cord-005453-4057qib7	15050	26	95	95	CD
cord-005453-4057qib7	15050	27	%	%	NN
cord-005453-4057qib7	15050	28	confidence	confidence	NN
cord-005453-4057qib7	15050	29	interval	interval	NN
cord-005453-4057qib7	15050	30	(	(	-LRB-
cord-005453-4057qib7	15050	31	C.I.	C.I.	NNP
cord-005453-4057qib7	15050	32	)	)	-RRB-
cord-005453-4057qib7	15050	33	1.2	1.2	CD
cord-005453-4057qib7	15050	34	-	-	SYM
cord-005453-4057qib7	15050	35	3.4	3.4	CD
cord-005453-4057qib7	15050	36	,	,	,
cord-005453-4057qib7	15050	37	p=	p=	NN
cord-005453-4057qib7	15050	38	0.01	0.01	CD
cord-005453-4057qib7	15050	39	]	]	-RRB-
cord-005453-4057qib7	15050	40	,	,	,
cord-005453-4057qib7	15050	41	CARV	CARV	NNP
cord-005453-4057qib7	15050	42	LRTD	LRTD	NNP
cord-005453-4057qib7	15050	43	(	(	-LRB-
cord-005453-4057qib7	15050	44	OR	or	CC
cord-005453-4057qib7	15050	45	11.8	11.8	CD
cord-005453-4057qib7	15051	1	,	,	,
cord-005453-4057qib7	15051	2	95	95	CD
cord-005453-4057qib7	15051	3	%	%	NN
cord-005453-4057qib7	15051	4	C.I.	C.I.	NNP
cord-005453-4057qib7	15051	5	3.8	3.8	CD
cord-005453-4057qib7	15051	6	-	-	SYM
cord-005453-4057qib7	15051	7	36	36	CD
cord-005453-4057qib7	15051	8	,	,	,
cord-005453-4057qib7	15051	9	p=	p=	JJ
cord-005453-4057qib7	15051	10	0.0001	0.0001	CD
cord-005453-4057qib7	15051	11	)	)	-RRB-
cord-005453-4057qib7	15051	12	,	,	,
cord-005453-4057qib7	15051	13	CARV	CARV	NNP
cord-005453-4057qib7	15051	14	infection	infection	NN
cord-005453-4057qib7	15051	15	during	during	IN
cord-005453-4057qib7	15051	16	the	the	DT
cord-005453-4057qib7	15051	17	first	first	JJ
cord-005453-4057qib7	15051	18	year	year	NN
cord-005453-4057qib7	15051	19	of	of	IN
cord-005453-4057qib7	15051	20	transplant	transplant	NN
cord-005453-4057qib7	15051	21	(	(	-LRB-
cord-005453-4057qib7	15051	22	OR	or	CC
cord-005453-4057qib7	15051	23	5.9	5.9	CD
cord-005453-4057qib7	15051	24	,	,	,
cord-005453-4057qib7	15051	25	P731	p731	CD
cord-005453-4057qib7	15051	26	Natural	natural	JJ
cord-005453-4057qib7	15051	27	killer	killer	NN
cord-005453-4057qib7	15051	28	cell	cell	NN
cord-005453-4057qib7	15051	29	alloreactive	alloreactive	NNP
cord-005453-4057qib7	15051	30	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15051	31	stem	stem	NN
cord-005453-4057qib7	15051	32	cell	cell	NN
cord-005453-4057qib7	15051	33	transplantation	transplantation	NN
cord-005453-4057qib7	15051	34	for	for	IN
cord-005453-4057qib7	15051	35	multiple	multiple	JJ
cord-005453-4057qib7	15051	36	myeloma	myeloma	NN
cord-005453-4057qib7	15051	37	patients	patient	NNS
cord-005453-4057qib7	15051	38	Catharina	Catharina	NNP
cord-005453-4057qib7	15051	39	Elssen	Elssen	NNP
cord-005453-4057qib7	15051	40	1	1	CD
cord-005453-4057qib7	15051	41	,	,	,
cord-005453-4057qib7	15051	42	Lotte	Lotte	NNP
cord-005453-4057qib7	15051	43	Wieten	Wieten	NNP
cord-005453-4057qib7	15051	44	1	1	CD
cord-005453-4057qib7	15051	45	,	,	,
cord-005453-4057qib7	15051	46	Peter	Peter	NNP
cord-005453-4057qib7	15051	47	Von	Von	NNP
cord-005453-4057qib7	15051	48	dem	dem	VB
cord-005453-4057qib7	15051	49	Borne	Borne	NNP
cord-005453-4057qib7	15051	50	2	2	CD
cord-005453-4057qib7	15051	51	,	,	,
cord-005453-4057qib7	15051	52	Ellen	Ellen	NNP
cord-005453-4057qib7	15051	53	Meijer	Meijer	NNP
cord-005453-4057qib7	15051	54	3	3	CD
cord-005453-4057qib7	15051	55	,	,	,
cord-005453-4057qib7	15051	56	Gerard	Gerard	NNP
cord-005453-4057qib7	15051	57	Bos	Bos	NNP
cord-005453-4057qib7	15051	58	1	1	CD
cord-005453-4057qib7	15051	59	1	1	CD
cord-005453-4057qib7	15051	60	Maastricht	Maastricht	NNP
cord-005453-4057qib7	15051	61	University	University	NNP
cord-005453-4057qib7	15051	62	Medical	Medical	NNP
cord-005453-4057qib7	15051	63	Center	Center	NNP
cord-005453-4057qib7	15051	64	,	,	,
cord-005453-4057qib7	15051	65	Maastricht	Maastricht	NNP
cord-005453-4057qib7	15051	66	,	,	,
cord-005453-4057qib7	15051	67	Netherlands	Netherlands	NNP
cord-005453-4057qib7	15051	68	,	,	,
cord-005453-4057qib7	15051	69	2	2	CD
cord-005453-4057qib7	15051	70	Leiden	Leiden	NNP
cord-005453-4057qib7	15051	71	University	University	NNP
cord-005453-4057qib7	15051	72	Medical	Medical	NNP
cord-005453-4057qib7	15051	73	Center	Center	NNP
cord-005453-4057qib7	15051	74	,	,	,
cord-005453-4057qib7	15051	75	Leiden	Leiden	NNP
cord-005453-4057qib7	15051	76	,	,	,
cord-005453-4057qib7	15051	77	Netherlands	Netherlands	NNP
cord-005453-4057qib7	15051	78	,	,	,
cord-005453-4057qib7	15051	79	3	3	CD
cord-005453-4057qib7	15051	80	Amsterdam	Amsterdam	NNP
cord-005453-4057qib7	15051	81	University	University	NNP
cord-005453-4057qib7	15051	82	Medical	Medical	NNP
cord-005453-4057qib7	15051	83	Center	Center	NNP
cord-005453-4057qib7	15051	84	,	,	,
cord-005453-4057qib7	15051	85	Location	Location	NNP
cord-005453-4057qib7	15051	86	VUMC	VUMC	NNP
cord-005453-4057qib7	15051	87	,	,	,
cord-005453-4057qib7	15051	88	Cancer	Cancer	NNP
cord-005453-4057qib7	15051	89	Center	Center	NNP
cord-005453-4057qib7	15051	90	,	,	,
cord-005453-4057qib7	15051	91	Amsterdam	Amsterdam	NNP
cord-005453-4057qib7	15051	92	,	,	,
cord-005453-4057qib7	15052	1	Netherlands	Netherlands	NNP
cord-005453-4057qib7	15052	2	Background	Background	NNP
cord-005453-4057qib7	15052	3	:	:	:
cord-005453-4057qib7	15053	1	In	in	IN
cord-005453-4057qib7	15053	2	the	the	DT
cord-005453-4057qib7	15053	3	past	past	JJ
cord-005453-4057qib7	15053	4	years	year	NNS
cord-005453-4057qib7	15053	5	many	many	JJ
cord-005453-4057qib7	15053	6	new	new	JJ
cord-005453-4057qib7	15053	7	drugs	drug	NNS
cord-005453-4057qib7	15053	8	for	for	IN
cord-005453-4057qib7	15053	9	Multiple	multiple	JJ
cord-005453-4057qib7	15053	10	myeloma	myeloma	NN
cord-005453-4057qib7	15053	11	(	(	-LRB-
cord-005453-4057qib7	15053	12	MM	MM	NNP
cord-005453-4057qib7	15053	13	)	)	-RRB-
cord-005453-4057qib7	15053	14	have	have	VBP
cord-005453-4057qib7	15053	15	been	be	VBN
cord-005453-4057qib7	15053	16	developed	develop	VBN
cord-005453-4057qib7	15053	17	and	and	CC
cord-005453-4057qib7	15053	18	are	be	VBP
cord-005453-4057qib7	15053	19	responsible	responsible	JJ
cord-005453-4057qib7	15053	20	for	for	IN
cord-005453-4057qib7	15053	21	a	a	DT
cord-005453-4057qib7	15053	22	increase	increase	NN
cord-005453-4057qib7	15053	23	in	in	IN
cord-005453-4057qib7	15053	24	survival	survival	NN
cord-005453-4057qib7	15053	25	.	.	.
cord-005453-4057qib7	15054	1	Notwithstanding	notwithstanding	IN
cord-005453-4057qib7	15054	2	such	such	JJ
cord-005453-4057qib7	15054	3	progress	progress	NN
cord-005453-4057qib7	15054	4	,	,	,
cord-005453-4057qib7	15054	5	MM	MM	NNP
cord-005453-4057qib7	15054	6	remains	remain	VBZ
cord-005453-4057qib7	15054	7	incurable	incurable	JJ
cord-005453-4057qib7	15054	8	.	.	.
cord-005453-4057qib7	15055	1	Results	result	NNS
cord-005453-4057qib7	15055	2	from	from	IN
cord-005453-4057qib7	15055	3	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15055	4	stem	stem	NN
cord-005453-4057qib7	15055	5	cell	cell	NN
cord-005453-4057qib7	15055	6	transplantation	transplantation	NN
cord-005453-4057qib7	15055	7	(	(	-LRB-
cord-005453-4057qib7	15055	8	SCT	SCT	NNP
cord-005453-4057qib7	15055	9	)	)	-RRB-
cord-005453-4057qib7	15055	10	,	,	,
cord-005453-4057qib7	15055	11	including	include	VBG
cord-005453-4057qib7	15055	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15055	13	transplantation	transplantation	NN
cord-005453-4057qib7	15055	14	,	,	,
cord-005453-4057qib7	15055	15	in	in	IN
cord-005453-4057qib7	15055	16	MM	MM	NNP
cord-005453-4057qib7	15055	17	has	have	VBZ
cord-005453-4057qib7	15055	18	shown	show	VBN
cord-005453-4057qib7	15055	19	clinical	clinical	JJ
cord-005453-4057qib7	15055	20	results	result	NNS
cord-005453-4057qib7	15055	21	.	.	.
cord-005453-4057qib7	15056	1	However	however	RB
cord-005453-4057qib7	15056	2	,	,	,
cord-005453-4057qib7	15056	3	these	these	DT
cord-005453-4057qib7	15056	4	responses	response	NNS
cord-005453-4057qib7	15056	5	are	be	VBP
cord-005453-4057qib7	15056	6	only	only	RB
cord-005453-4057qib7	15056	7	observed	observe	VBN
cord-005453-4057qib7	15056	8	in	in	IN
cord-005453-4057qib7	15056	9	a	a	DT
cord-005453-4057qib7	15056	10	minority	minority	NN
cord-005453-4057qib7	15056	11	of	of	IN
cord-005453-4057qib7	15056	12	patients	patient	NNS
cord-005453-4057qib7	15056	13	.	.	.
cord-005453-4057qib7	15057	1	We	-PRON-	PRP
cord-005453-4057qib7	15057	2	hypothesize	hypothesize	VBP
cord-005453-4057qib7	15057	3	that	that	IN
cord-005453-4057qib7	15057	4	this	this	DT
cord-005453-4057qib7	15057	5	observation	observation	NN
cord-005453-4057qib7	15057	6	might	may	MD
cord-005453-4057qib7	15057	7	be	be	VB
cord-005453-4057qib7	15057	8	due	due	JJ
cord-005453-4057qib7	15057	9	to	to	IN
cord-005453-4057qib7	15057	10	differences	difference	NNS
cord-005453-4057qib7	15057	11	in	in	IN
cord-005453-4057qib7	15057	12	natural	natural	JJ
cord-005453-4057qib7	15057	13	killer	killer	NN
cord-005453-4057qib7	15057	14	(	(	-LRB-
cord-005453-4057qib7	15057	15	NK	NK	NNP
cord-005453-4057qib7	15057	16	)	)	-RRB-
cord-005453-4057qib7	15057	17	cell	cell	NN
cord-005453-4057qib7	15057	18	alloreacitvity	alloreacitvity	NN
cord-005453-4057qib7	15057	19	,	,	,
cord-005453-4057qib7	15057	20	since	since	IN
cord-005453-4057qib7	15057	21	we	-PRON-	PRP
cord-005453-4057qib7	15057	22	have	have	VBP
cord-005453-4057qib7	15057	23	shown	show	VBN
cord-005453-4057qib7	15057	24	in	in	RP
cord-005453-4057qib7	15057	25	in	in	IN
cord-005453-4057qib7	15057	26	vivo	vivo	NN
cord-005453-4057qib7	15057	27	and	and	CC
cord-005453-4057qib7	15057	28	in	in	IN
cord-005453-4057qib7	15057	29	vitro	vitro	FW
cord-005453-4057qib7	15057	30	models	model	NNS
cord-005453-4057qib7	15057	31	that	that	WDT
cord-005453-4057qib7	15057	32	mismatched	mismatch	VBD
cord-005453-4057qib7	15057	33	alloreactive	alloreactive	JJ
cord-005453-4057qib7	15057	34	NK	NK	NNP
cord-005453-4057qib7	15057	35	cells	cell	NNS
cord-005453-4057qib7	15057	36	hold	hold	VBP
cord-005453-4057qib7	15057	37	the	the	DT
cord-005453-4057qib7	15057	38	capacity	capacity	NN
cord-005453-4057qib7	15057	39	to	to	TO
cord-005453-4057qib7	15057	40	kill	kill	VB
cord-005453-4057qib7	15057	41	MM	MM	NNP
cord-005453-4057qib7	15057	42	cells	cell	NNS
cord-005453-4057qib7	15057	43	.	.	.
cord-005453-4057qib7	15058	1	The	the	DT
cord-005453-4057qib7	15058	2	aim	aim	NN
cord-005453-4057qib7	15058	3	of	of	IN
cord-005453-4057qib7	15058	4	this	this	DT
cord-005453-4057qib7	15058	5	prospective	prospective	JJ
cord-005453-4057qib7	15058	6	phase	phase	NN
cord-005453-4057qib7	15058	7	2	2	CD
cord-005453-4057qib7	15058	8	study	study	NN
cord-005453-4057qib7	15058	9	is	be	VBZ
cord-005453-4057qib7	15058	10	to	to	TO
cord-005453-4057qib7	15058	11	evaluate	evaluate	VB
cord-005453-4057qib7	15058	12	if	if	IN
cord-005453-4057qib7	15058	13	KIR	KIR	NNP
cord-005453-4057qib7	15058	14	-	-	HYPH
cord-005453-4057qib7	15058	15	ligand	ligand	NN
cord-005453-4057qib7	15058	16	mismatched	mismatch	VBD
cord-005453-4057qib7	15058	17	haploindentical	haploindentical	NN
cord-005453-4057qib7	15058	18	bone	bone	NN
cord-005453-4057qib7	15058	19	marrow	marrow	NN
cord-005453-4057qib7	15058	20	transplantation	transplantation	NN
cord-005453-4057qib7	15058	21	(	(	-LRB-
cord-005453-4057qib7	15058	22	BMT	BMT	NNP
cord-005453-4057qib7	15058	23	)	)	-RRB-
cord-005453-4057qib7	15058	24	with	with	IN
cord-005453-4057qib7	15058	25	post	post	JJ
cord-005453-4057qib7	15058	26	-	-	JJ
cord-005453-4057qib7	15058	27	transplant	transplant	NN
cord-005453-4057qib7	15058	28	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15058	29	will	will	MD
cord-005453-4057qib7	15058	30	improve	improve	VB
cord-005453-4057qib7	15058	31	progression	progression	NN
cord-005453-4057qib7	15058	32	free	free	JJ
cord-005453-4057qib7	15058	33	survival	survival	NN
cord-005453-4057qib7	15058	34	(	(	-LRB-
cord-005453-4057qib7	15058	35	PFS	PFS	NNP
cord-005453-4057qib7	15058	36	)	)	-RRB-
cord-005453-4057qib7	15058	37	in	in	IN
cord-005453-4057qib7	15058	38	poor	poor	JJ
cord-005453-4057qib7	15058	39	risk	risk	NN
cord-005453-4057qib7	15058	40	MM	MM	NNP
cord-005453-4057qib7	15058	41	patients	patient	NNS
cord-005453-4057qib7	15058	42	.	.	.
cord-005453-4057qib7	15059	1	Methods	method	NNS
cord-005453-4057qib7	15059	2	:	:	:
cord-005453-4057qib7	15059	3	Poor	poor	JJ
cord-005453-4057qib7	15059	4	risk	risk	NN
cord-005453-4057qib7	15059	5	MM	mm	CD
cord-005453-4057qib7	15059	6	patients	patient	NNS
cord-005453-4057qib7	15059	7	,	,	,
cord-005453-4057qib7	15059	8	aged	age	VBN
cord-005453-4057qib7	15059	9	<	<	XX
cord-005453-4057qib7	15059	10	66	66	CD
cord-005453-4057qib7	15059	11	years	year	NNS
cord-005453-4057qib7	15059	12	were	be	VBD
cord-005453-4057qib7	15059	13	enrolled	enrol	VBN
cord-005453-4057qib7	15059	14	if	if	IN
cord-005453-4057qib7	15059	15	they	-PRON-	PRP
cord-005453-4057qib7	15059	16	were	be	VBD
cord-005453-4057qib7	15059	17	responsive	responsive	JJ
cord-005453-4057qib7	15059	18	to	to	IN
cord-005453-4057qib7	15059	19	their	-PRON-	PRP$
cord-005453-4057qib7	15059	20	last	last	JJ
cord-005453-4057qib7	15059	21	line	line	NN
cord-005453-4057qib7	15059	22	of	of	IN
cord-005453-4057qib7	15059	23	therapy	therapy	NN
cord-005453-4057qib7	15059	24	.	.	.
cord-005453-4057qib7	15060	1	Poor	poor	JJ
cord-005453-4057qib7	15060	2	risk	risk	NN
cord-005453-4057qib7	15060	3	was	be	VBD
cord-005453-4057qib7	15060	4	defined	define	VBN
cord-005453-4057qib7	15060	5	as	as	IN
cord-005453-4057qib7	15060	6	,	,	,
cord-005453-4057qib7	15060	7	high	high	JJ
cord-005453-4057qib7	15060	8	-	-	HYPH
cord-005453-4057qib7	15060	9	risk	risk	NN
cord-005453-4057qib7	15060	10	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	15060	11	,	,	,
cord-005453-4057qib7	15060	12	or	or	CC
cord-005453-4057qib7	15060	13	relapse	relapse	VB
cord-005453-4057qib7	15060	14	within	within	IN
cord-005453-4057qib7	15060	15	a	a	DT
cord-005453-4057qib7	15060	16	year	year	NN
cord-005453-4057qib7	15060	17	after	after	IN
cord-005453-4057qib7	15060	18	autologous	autologous	JJ
cord-005453-4057qib7	15060	19	SCT	SCT	NNP
cord-005453-4057qib7	15060	20	,	,	,
cord-005453-4057qib7	15060	21	or	or	CC
cord-005453-4057qib7	15060	22	treated	treat	VBN
cord-005453-4057qib7	15060	23	with	with	IN
cord-005453-4057qib7	15060	24	three	three	CD
cord-005453-4057qib7	15060	25	or	or	CC
cord-005453-4057qib7	15060	26	more	more	JJR
cord-005453-4057qib7	15060	27	previous	previous	JJ
cord-005453-4057qib7	15060	28	lines	line	NNS
cord-005453-4057qib7	15060	29	of	of	IN
cord-005453-4057qib7	15060	30	therapy	therapy	NN
cord-005453-4057qib7	15060	31	.	.	.
cord-005453-4057qib7	15061	1	A	a	DT
cord-005453-4057qib7	15061	2	prerequisite	prerequisite	NN
cord-005453-4057qib7	15061	3	of	of	IN
cord-005453-4057qib7	15061	4	enrolment	enrolment	NN
cord-005453-4057qib7	15061	5	was	be	VBD
cord-005453-4057qib7	15061	6	the	the	DT
cord-005453-4057qib7	15061	7	possibility	possibility	NN
cord-005453-4057qib7	15061	8	of	of	IN
cord-005453-4057qib7	15061	9	an	an	DT
cord-005453-4057qib7	15061	10	NK	NK	NNP
cord-005453-4057qib7	15061	11	cell	cell	NN
cord-005453-4057qib7	15061	12	mismatch	mismatch	NN
cord-005453-4057qib7	15061	13	and	and	CC
cord-005453-4057qib7	15061	14	availability	availability	NN
cord-005453-4057qib7	15061	15	of	of	IN
cord-005453-4057qib7	15061	16	a	a	DT
cord-005453-4057qib7	15061	17	mismatched	mismatched	JJ
cord-005453-4057qib7	15061	18	family	family	NN
cord-005453-4057qib7	15061	19	donor	donor	NN
cord-005453-4057qib7	15061	20	.	.	.
cord-005453-4057qib7	15062	1	Patients	patient	NNS
cord-005453-4057qib7	15062	2	were	be	VBD
cord-005453-4057qib7	15062	3	excluded	exclude	VBN
cord-005453-4057qib7	15062	4	if	if	IN
cord-005453-4057qib7	15062	5	donor	donor	NN
cord-005453-4057qib7	15062	6	-	-	HYPH
cord-005453-4057qib7	15062	7	specific	specific	JJ
cord-005453-4057qib7	15062	8	HLA	HLA	NNP
cord-005453-4057qib7	15062	9	-	-	HYPH
cord-005453-4057qib7	15062	10	antibodies	antibody	NNS
cord-005453-4057qib7	15062	11	were	be	VBD
cord-005453-4057qib7	15062	12	present	present	JJ
cord-005453-4057qib7	15062	13	.	.	.
cord-005453-4057qib7	15063	1	Patients	patient	NNS
cord-005453-4057qib7	15063	2	received	receive	VBD
cord-005453-4057qib7	15063	3	a	a	DT
cord-005453-4057qib7	15063	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15063	5	BMT	BMT	NNP
cord-005453-4057qib7	15063	6	with	with	IN
cord-005453-4057qib7	15063	7	a	a	DT
cord-005453-4057qib7	15063	8	non	non	JJ
cord-005453-4057qib7	15063	9	-	-	JJ
cord-005453-4057qib7	15063	10	myeloablative	myeloablative	JJ
cord-005453-4057qib7	15063	11	conditioning	conditioning	NN
cord-005453-4057qib7	15063	12	regimen	regimen	NN
cord-005453-4057qib7	15063	13	and	and	CC
cord-005453-4057qib7	15063	14	post	post	JJ
cord-005453-4057qib7	15063	15	-	-	JJ
cord-005453-4057qib7	15063	16	transplant	transplant	NN
cord-005453-4057qib7	15063	17	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15063	18	.	.	.
cord-005453-4057qib7	15064	1	Primary	primary	JJ
cord-005453-4057qib7	15064	2	endpoint	endpoint	NN
cord-005453-4057qib7	15064	3	is	be	VBZ
cord-005453-4057qib7	15064	4	PFS	PFS	NNP
cord-005453-4057qib7	15064	5	at	at	IN
cord-005453-4057qib7	15064	6	1,5	1,5	CD
cord-005453-4057qib7	15064	7	years	year	NNS
cord-005453-4057qib7	15064	8	.	.	.
cord-005453-4057qib7	15065	1	Secondary	secondary	JJ
cord-005453-4057qib7	15065	2	endpoints	endpoint	NNS
cord-005453-4057qib7	15065	3	are	be	VBP
cord-005453-4057qib7	15065	4	engraftment	engraftment	NN
cord-005453-4057qib7	15065	5	,	,	,
cord-005453-4057qib7	15065	6	bone	bone	NN
cord-005453-4057qib7	15065	7	marrow	marrow	NN
cord-005453-4057qib7	15065	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	15065	9	,	,	,
cord-005453-4057qib7	15065	10	NK	NK	NNP
cord-005453-4057qib7	15065	11	cell	cell	NN
cord-005453-4057qib7	15065	12	reconstitution	reconstitution	NN
cord-005453-4057qib7	15065	13	and	and	CC
cord-005453-4057qib7	15065	14	repertoire	repertoire	NN
cord-005453-4057qib7	15065	15	,	,	,
cord-005453-4057qib7	15065	16	graft	graft	NN
cord-005453-4057qib7	15065	17	versus	versus	IN
cord-005453-4057qib7	15065	18	host	host	NN
cord-005453-4057qib7	15065	19	disease	disease	NN
cord-005453-4057qib7	15065	20	(	(	-LRB-
cord-005453-4057qib7	15065	21	GVHD	GVHD	NNP
cord-005453-4057qib7	15065	22	)	)	-RRB-
cord-005453-4057qib7	15065	23	,	,	,
cord-005453-4057qib7	15065	24	infections	infection	NNS
cord-005453-4057qib7	15065	25	and	and	CC
cord-005453-4057qib7	15065	26	non	non	JJ
cord-005453-4057qib7	15065	27	-	-	JJ
cord-005453-4057qib7	15065	28	relapse	relapse	JJ
cord-005453-4057qib7	15065	29	mortality	mortality	NN
cord-005453-4057qib7	15065	30	(	(	-LRB-
cord-005453-4057qib7	15065	31	NRM	NRM	NNP
cord-005453-4057qib7	15065	32	)	)	-RRB-
cord-005453-4057qib7	15065	33	at	at	IN
cord-005453-4057qib7	15065	34	1,5	1,5	CD
cord-005453-4057qib7	15065	35	years	year	NNS
cord-005453-4057qib7	15065	36	.	.	.
cord-005453-4057qib7	15066	1	Results	result	NNS
cord-005453-4057qib7	15066	2	:	:	:
cord-005453-4057qib7	15067	1	In	in	IN
cord-005453-4057qib7	15067	2	total	total	JJ
cord-005453-4057qib7	15067	3	12	12	CD
cord-005453-4057qib7	15067	4	poor	poor	JJ
cord-005453-4057qib7	15067	5	risk	risk	NN
cord-005453-4057qib7	15067	6	patients	patient	NNS
cord-005453-4057qib7	15067	7	were	be	VBD
cord-005453-4057qib7	15067	8	included	include	VBN
cord-005453-4057qib7	15067	9	in	in	IN
cord-005453-4057qib7	15067	10	the	the	DT
cord-005453-4057qib7	15067	11	study	study	NN
cord-005453-4057qib7	15067	12	of	of	IN
cord-005453-4057qib7	15067	13	which	which	WDT
cord-005453-4057qib7	15067	14	10	10	CD
cord-005453-4057qib7	15067	15	could	could	MD
cord-005453-4057qib7	15067	16	be	be	VB
cord-005453-4057qib7	15067	17	evaluated	evaluate	VBN
cord-005453-4057qib7	15067	18	for	for	IN
cord-005453-4057qib7	15067	19	the	the	DT
cord-005453-4057qib7	15067	20	primary	primary	JJ
cord-005453-4057qib7	15067	21	end	end	NN
cord-005453-4057qib7	15067	22	point	point	NN
cord-005453-4057qib7	15067	23	.	.	.
cord-005453-4057qib7	15068	1	Graft	graft	NN
cord-005453-4057qib7	15068	2	failure	failure	NN
cord-005453-4057qib7	15068	3	and	and	CC
cord-005453-4057qib7	15068	4	disease	disease	NN
cord-005453-4057qib7	15068	5	progression	progression	NN
cord-005453-4057qib7	15068	6	before	before	IN
cord-005453-4057qib7	15068	7	transplant	transplant	NN
cord-005453-4057qib7	15068	8	rendered	render	VBD
cord-005453-4057qib7	15068	9	the	the	DT
cord-005453-4057qib7	15068	10	remaining	remain	VBG
cord-005453-4057qib7	15068	11	two	two	CD
cord-005453-4057qib7	15068	12	patients	patient	NNS
cord-005453-4057qib7	15068	13	not	not	RB
cord-005453-4057qib7	15068	14	evaluable	evaluable	JJ
cord-005453-4057qib7	15068	15	.	.	.
cord-005453-4057qib7	15069	1	At	at	IN
cord-005453-4057qib7	15069	2	this	this	DT
cord-005453-4057qib7	15069	3	interim	interim	JJ
cord-005453-4057qib7	15069	4	analysis	analysis	NN
cord-005453-4057qib7	15069	5	7	7	CD
cord-005453-4057qib7	15069	6	patients	patient	NNS
cord-005453-4057qib7	15069	7	have	have	VBP
cord-005453-4057qib7	15069	8	already	already	RB
cord-005453-4057qib7	15069	9	reached	reach	VBN
cord-005453-4057qib7	15069	10	the	the	DT
cord-005453-4057qib7	15069	11	1,5	1,5	CD
cord-005453-4057qib7	15069	12	years	year	NNS
cord-005453-4057qib7	15069	13	of	of	IN
cord-005453-4057qib7	15069	14	follow	follow	VBP
cord-005453-4057qib7	15069	15	up	up	RB
cord-005453-4057qib7	15069	16	,	,	,
cord-005453-4057qib7	15069	17	5	5	CD
cord-005453-4057qib7	15069	18	relapsed	relapse	VBD
cord-005453-4057qib7	15069	19	within	within	IN
cord-005453-4057qib7	15069	20	1,5	1,5	CD
cord-005453-4057qib7	15069	21	years	year	NNS
cord-005453-4057qib7	15069	22	and	and	CC
cord-005453-4057qib7	15069	23	2	2	CD
cord-005453-4057qib7	15069	24	died	die	VBD
cord-005453-4057qib7	15069	25	due	due	JJ
cord-005453-4057qib7	15069	26	to	to	IN
cord-005453-4057qib7	15069	27	treatment	treatment	NN
cord-005453-4057qib7	15069	28	related	relate	VBN
cord-005453-4057qib7	15069	29	infections	infection	NNS
cord-005453-4057qib7	15069	30	,	,	,
cord-005453-4057qib7	15069	31	without	without	IN
cord-005453-4057qib7	15069	32	showing	show	VBG
cord-005453-4057qib7	15069	33	progression	progression	NN
cord-005453-4057qib7	15069	34	of	of	IN
cord-005453-4057qib7	15069	35	disease	disease	NN
cord-005453-4057qib7	15069	36	(	(	-LRB-
cord-005453-4057qib7	15069	37	20	20	CD
cord-005453-4057qib7	15069	38	%	%	NN
cord-005453-4057qib7	15069	39	NRM	NRM	NNP
cord-005453-4057qib7	15069	40	)	)	-RRB-
cord-005453-4057qib7	15069	41	.	.	.
cord-005453-4057qib7	15070	1	Average	average	JJ
cord-005453-4057qib7	15070	2	time	time	NN
cord-005453-4057qib7	15070	3	of	of	IN
cord-005453-4057qib7	15070	4	progression	progression	NN
cord-005453-4057qib7	15070	5	is	be	VBZ
cord-005453-4057qib7	15070	6	105	105	CD
cord-005453-4057qib7	15070	7	days	day	NNS
cord-005453-4057qib7	15070	8	(	(	-LRB-
cord-005453-4057qib7	15070	9	60	60	CD
cord-005453-4057qib7	15070	10	-	-	SYM
cord-005453-4057qib7	15070	11	270	270	CD
cord-005453-4057qib7	15070	12	days	day	NNS
cord-005453-4057qib7	15070	13	)	)	-RRB-
cord-005453-4057qib7	15070	14	.	.	.
cord-005453-4057qib7	15071	1	Two	two	CD
cord-005453-4057qib7	15071	2	of	of	IN
cord-005453-4057qib7	15071	3	the	the	DT
cord-005453-4057qib7	15071	4	remaining	remain	VBG
cord-005453-4057qib7	15071	5	patients	patient	NNS
cord-005453-4057qib7	15071	6	at	at	IN
cord-005453-4057qib7	15071	7	follow	follow	VB
cord-005453-4057qib7	15071	8	up	up	RP
cord-005453-4057qib7	15071	9	,	,	,
cord-005453-4057qib7	15071	10	still	still	RB
cord-005453-4057qib7	15071	11	show	show	VB
cord-005453-4057qib7	15071	12	responsive	responsive	JJ
cord-005453-4057qib7	15071	13	disease	disease	NN
cord-005453-4057qib7	15071	14	(	(	-LRB-
cord-005453-4057qib7	15071	15	days	day	NNS
cord-005453-4057qib7	15071	16	210	210	CD
cord-005453-4057qib7	15071	17	en	en	NN
cord-005453-4057qib7	15071	18	120	120	CD
cord-005453-4057qib7	15071	19	)	)	-RRB-
cord-005453-4057qib7	15071	20	.	.	.
cord-005453-4057qib7	15072	1	The	the	DT
cord-005453-4057qib7	15072	2	average	average	JJ
cord-005453-4057qib7	15072	3	time	time	NN
cord-005453-4057qib7	15072	4	to	to	IN
cord-005453-4057qib7	15072	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	15072	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	15072	7	is	be	VBZ
cord-005453-4057qib7	15072	8	19	19	CD
cord-005453-4057qib7	15072	9	days	day	NNS
cord-005453-4057qib7	15072	10	(	(	-LRB-
cord-005453-4057qib7	15072	11	14	14	CD
cord-005453-4057qib7	15072	12	-	-	SYM
cord-005453-4057qib7	15072	13	28	28	CD
cord-005453-4057qib7	15072	14	days	day	NNS
cord-005453-4057qib7	15072	15	)	)	-RRB-
cord-005453-4057qib7	15072	16	.	.	.
cord-005453-4057qib7	15073	1	All	all	DT
cord-005453-4057qib7	15073	2	evaluated	evaluate	VBN
cord-005453-4057qib7	15073	3	patients	patient	NNS
cord-005453-4057qib7	15073	4	(	(	-LRB-
cord-005453-4057qib7	15073	5	6/10	6/10	CD
cord-005453-4057qib7	15073	6	)	)	-RRB-
cord-005453-4057qib7	15073	7	show	show	VBP
cord-005453-4057qib7	15073	8	NK	NK	NNP
cord-005453-4057qib7	15073	9	cell	cell	NN
cord-005453-4057qib7	15073	10	reconstitution	reconstitution	NN
cord-005453-4057qib7	15073	11	with	with	IN
cord-005453-4057qib7	15073	12	a	a	DT
cord-005453-4057qib7	15073	13	mature	mature	JJ
cord-005453-4057qib7	15073	14	phenotype	phenotype	NN
cord-005453-4057qib7	15073	15	in	in	IN
cord-005453-4057qib7	15073	16	the	the	DT
cord-005453-4057qib7	15073	17	bone	bone	NN
cord-005453-4057qib7	15073	18	marrow	marrow	NN
cord-005453-4057qib7	15073	19	and	and	CC
cord-005453-4057qib7	15073	20	peripheral	peripheral	JJ
cord-005453-4057qib7	15073	21	blood	blood	NN
cord-005453-4057qib7	15073	22	by	by	IN
cord-005453-4057qib7	15073	23	day	day	NN
cord-005453-4057qib7	15073	24	60	60	CD
cord-005453-4057qib7	15073	25	.	.	.
cord-005453-4057qib7	15074	1	Three	three	CD
cord-005453-4057qib7	15074	2	patients	patient	NNS
cord-005453-4057qib7	15074	3	developed	develop	VBD
cord-005453-4057qib7	15074	4	acute	acute	JJ
cord-005453-4057qib7	15074	5	GVHD	GVHD	NNP
cord-005453-4057qib7	15074	6	(	(	-LRB-
cord-005453-4057qib7	15074	7	25	25	CD
cord-005453-4057qib7	15074	8	%	%	NN
cord-005453-4057qib7	15074	9	)	)	-RRB-
cord-005453-4057qib7	15074	10	of	of	IN
cord-005453-4057qib7	15074	11	which	which	WDT
cord-005453-4057qib7	15074	12	2/12	2/12	CD
cord-005453-4057qib7	15074	13	grade	grade	NN
cord-005453-4057qib7	15074	14	I	I	NNP
cord-005453-4057qib7	15074	15	-	-	HYPH
cord-005453-4057qib7	15074	16	II	II	NNP
cord-005453-4057qib7	15074	17	aGVHD	agvhd	NN
cord-005453-4057qib7	15074	18	and	and	CC
cord-005453-4057qib7	15074	19	1/12	1/12	CD
cord-005453-4057qib7	15074	20	patient	patient	NN
cord-005453-4057qib7	15074	21	showed	show	VBD
cord-005453-4057qib7	15074	22	a	a	DT
cord-005453-4057qib7	15074	23	grade	grade	NN
cord-005453-4057qib7	15074	24	IV	IV	NNP
cord-005453-4057qib7	15074	25	aGVHD	aGVHD	NNP
cord-005453-4057qib7	15074	26	.	.	.
cord-005453-4057qib7	15075	1	Treatment	treatment	NN
cord-005453-4057qib7	15075	2	related	related	JJ
cord-005453-4057qib7	15075	3	mortality	mortality	NN
cord-005453-4057qib7	15075	4	was	be	VBD
cord-005453-4057qib7	15075	5	3/12	3/12	CD
cord-005453-4057qib7	15075	6	(	(	-LRB-
cord-005453-4057qib7	15075	7	25	25	CD
cord-005453-4057qib7	15075	8	%	%	NN
cord-005453-4057qib7	15075	9	)	)	-RRB-
cord-005453-4057qib7	15075	10	,	,	,
cord-005453-4057qib7	15075	11	which	which	WDT
cord-005453-4057qib7	15075	12	was	be	VBD
cord-005453-4057qib7	15075	13	in	in	IN
cord-005453-4057qib7	15075	14	all	all	DT
cord-005453-4057qib7	15075	15	cases	case	NNS
cord-005453-4057qib7	15075	16	due	due	JJ
cord-005453-4057qib7	15075	17	to	to	IN
cord-005453-4057qib7	15075	18	infectious	infectious	JJ
cord-005453-4057qib7	15075	19	disease	disease	NN
cord-005453-4057qib7	15075	20	.	.	.
cord-005453-4057qib7	15076	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15076	2	:	:	:
cord-005453-4057qib7	15077	1	Our	-PRON-	PRP$
cord-005453-4057qib7	15077	2	interim	interim	JJ
cord-005453-4057qib7	15077	3	analysis	analysis	NN
cord-005453-4057qib7	15077	4	of	of	IN
cord-005453-4057qib7	15077	5	mismatched	mismatched	JJ
cord-005453-4057qib7	15077	6	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15077	7	BMT	BMT	NNP
cord-005453-4057qib7	15077	8	in	in	IN
cord-005453-4057qib7	15077	9	MM	MM	NNP
cord-005453-4057qib7	15077	10	showed	show	VBD
cord-005453-4057qib7	15077	11	that	that	IN
cord-005453-4057qib7	15077	12	the	the	DT
cord-005453-4057qib7	15077	13	treatment	treatment	NN
cord-005453-4057qib7	15077	14	is	be	VBZ
cord-005453-4057qib7	15077	15	feasible	feasible	JJ
cord-005453-4057qib7	15077	16	and	and	CC
cord-005453-4057qib7	15077	17	forms	form	VBZ
cord-005453-4057qib7	15077	18	a	a	DT
cord-005453-4057qib7	15077	19	possible	possible	JJ
cord-005453-4057qib7	15077	20	platform	platform	NN
cord-005453-4057qib7	15077	21	for	for	IN
cord-005453-4057qib7	15077	22	immunotherapeutic	immunotherapeutic	JJ
cord-005453-4057qib7	15077	23	strategies	strategy	NNS
cord-005453-4057qib7	15077	24	.	.	.
cord-005453-4057qib7	15078	1	The	the	DT
cord-005453-4057qib7	15078	2	majority	majority	NN
cord-005453-4057qib7	15078	3	of	of	IN
cord-005453-4057qib7	15078	4	patients	patient	NNS
cord-005453-4057qib7	15078	5	showed	show	VBD
cord-005453-4057qib7	15078	6	an	an	DT
cord-005453-4057qib7	15078	7	early	early	JJ
cord-005453-4057qib7	15078	8	disease	disease	NN
cord-005453-4057qib7	15078	9	progression	progression	NN
cord-005453-4057qib7	15078	10	.	.	.
cord-005453-4057qib7	15079	1	We	-PRON-	PRP
cord-005453-4057qib7	15079	2	predefined	predefine	VBD
cord-005453-4057qib7	15079	3	that	that	DT
cord-005453-4057qib7	15079	4	with	with	IN
cord-005453-4057qib7	15079	5	a	a	DT
cord-005453-4057qib7	15079	6	PFS	PFS	NNP
cord-005453-4057qib7	15079	7	of	of	IN
cord-005453-4057qib7	15079	8	25	25	CD
cord-005453-4057qib7	15079	9	%	%	NN
cord-005453-4057qib7	15079	10	at	at	IN
cord-005453-4057qib7	15079	11	1,5	1,5	CD
cord-005453-4057qib7	15079	12	years	year	NNS
cord-005453-4057qib7	15079	13	we	-PRON-	PRP
cord-005453-4057qib7	15079	14	would	would	MD
cord-005453-4057qib7	15079	15	qualify	qualify	VB
cord-005453-4057qib7	15079	16	this	this	DT
cord-005453-4057qib7	15079	17	treatment	treatment	NN
cord-005453-4057qib7	15079	18	option	option	NN
cord-005453-4057qib7	15079	19	successful	successful	JJ
cord-005453-4057qib7	15079	20	.	.	.
cord-005453-4057qib7	15080	1	With	with	IN
cord-005453-4057qib7	15080	2	only	only	RB
cord-005453-4057qib7	15080	3	two	two	CD
cord-005453-4057qib7	15080	4	patients	patient	NNS
cord-005453-4057qib7	15080	5	still	still	RB
cord-005453-4057qib7	15080	6	in	in	IN
cord-005453-4057qib7	15080	7	remission	remission	NN
cord-005453-4057qib7	15080	8	this	this	DT
cord-005453-4057qib7	15080	9	goal	goal	NN
cord-005453-4057qib7	15080	10	will	will	MD
cord-005453-4057qib7	15080	11	not	not	RB
cord-005453-4057qib7	15080	12	be	be	VB
cord-005453-4057qib7	15080	13	achieved	achieve	VBN
cord-005453-4057qib7	15080	14	and	and	CC
cord-005453-4057qib7	15080	15	we	-PRON-	PRP
cord-005453-4057qib7	15080	16	hypothesize	hypothesize	VBP
cord-005453-4057qib7	15080	17	that	that	IN
cord-005453-4057qib7	15080	18	the	the	DT
cord-005453-4057qib7	15080	19	late	late	JJ
cord-005453-4057qib7	15080	20	NK	NK	NNP
cord-005453-4057qib7	15080	21	cell	cell	NN
cord-005453-4057qib7	15080	22	reconstitution	reconstitution	NN
cord-005453-4057qib7	15080	23	(	(	-LRB-
cord-005453-4057qib7	15080	24	day	day	NN
cord-005453-4057qib7	15080	25	60	60	CD
cord-005453-4057qib7	15080	26	)	)	-RRB-
cord-005453-4057qib7	15080	27	is	be	VBZ
cord-005453-4057qib7	15080	28	responsible	responsible	JJ
cord-005453-4057qib7	15080	29	for	for	IN
cord-005453-4057qib7	15080	30	the	the	DT
cord-005453-4057qib7	15080	31	lack	lack	NN
cord-005453-4057qib7	15080	32	of	of	IN
cord-005453-4057qib7	15080	33	response	response	NN
cord-005453-4057qib7	15080	34	.	.	.
cord-005453-4057qib7	15081	1	Clinical	clinical	JJ
cord-005453-4057qib7	15081	2	Background	background	NN
cord-005453-4057qib7	15081	3	:	:	:
cord-005453-4057qib7	15081	4	MSCs	msc	NNS
cord-005453-4057qib7	15081	5	are	be	VBP
cord-005453-4057qib7	15081	6	known	know	VBN
cord-005453-4057qib7	15081	7	to	to	TO
cord-005453-4057qib7	15081	8	have	have	VB
cord-005453-4057qib7	15081	9	immune	immune	JJ
cord-005453-4057qib7	15081	10	modulatory	modulatory	JJ
cord-005453-4057qib7	15081	11	capacity	capacity	NN
cord-005453-4057qib7	15081	12	and	and	CC
cord-005453-4057qib7	15081	13	may	may	MD
cord-005453-4057qib7	15081	14	be	be	VB
cord-005453-4057qib7	15081	15	effective	effective	JJ
cord-005453-4057qib7	15081	16	in	in	IN
cord-005453-4057qib7	15081	17	the	the	DT
cord-005453-4057qib7	15081	18	treatment	treatment	NN
cord-005453-4057qib7	15081	19	of	of	IN
cord-005453-4057qib7	15081	20	patients	patient	NNS
cord-005453-4057qib7	15081	21	with	with	IN
cord-005453-4057qib7	15081	22	acute	acute	JJ
cord-005453-4057qib7	15081	23	GVHD	GVHD	NNP
cord-005453-4057qib7	15081	24	.	.	.
cord-005453-4057qib7	15082	1	However	however	WRB
cord-005453-4057qib7	15082	2	clinical	clinical	JJ
cord-005453-4057qib7	15082	3	studies	study	NNS
cord-005453-4057qib7	15082	4	yielded	yield	VBD
cord-005453-4057qib7	15082	5	inconclusive	inconclusive	JJ
cord-005453-4057qib7	15082	6	results	result	NNS
cord-005453-4057qib7	15082	7	which	which	WDT
cord-005453-4057qib7	15082	8	was	be	VBD
cord-005453-4057qib7	15082	9	in	in	IN
cord-005453-4057qib7	15082	10	part	part	NN
cord-005453-4057qib7	15082	11	due	due	IN
cord-005453-4057qib7	15082	12	to	to	IN
cord-005453-4057qib7	15082	13	the	the	DT
cord-005453-4057qib7	15082	14	great	great	JJ
cord-005453-4057qib7	15082	15	heterogeneity	heterogeneity	NN
cord-005453-4057qib7	15082	16	of	of	IN
cord-005453-4057qib7	15082	17	the	the	DT
cord-005453-4057qib7	15082	18	MSC	MSC	NNP
cord-005453-4057qib7	15082	19	used	use	VBD
cord-005453-4057qib7	15082	20	.	.	.
cord-005453-4057qib7	15083	1	The	the	DT
cord-005453-4057qib7	15083	2	off	off	IN
cord-005453-4057qib7	15083	3	-	-	HYPH
cord-005453-4057qib7	15083	4	the	the	DT
cord-005453-4057qib7	15083	5	-	-	HYPH
cord-005453-4057qib7	15083	6	shelf	shelf	NN
cord-005453-4057qib7	15083	7	MSC	MSC	NNP
cord-005453-4057qib7	15083	8	preparation	preparation	NN
cord-005453-4057qib7	15083	9	"	"	``
cord-005453-4057qib7	15083	10	MSC	MSC	NNP
cord-005453-4057qib7	15083	11	-	-	HYPH
cord-005453-4057qib7	15083	12	FFM	FFM	NNP
cord-005453-4057qib7	15083	13	"	"	''
cord-005453-4057qib7	15083	14	,	,	,
cord-005453-4057qib7	15083	15	generated	generate	VBN
cord-005453-4057qib7	15083	16	by	by	IN
cord-005453-4057qib7	15083	17	a	a	DT
cord-005453-4057qib7	15083	18	proprietary	proprietary	JJ
cord-005453-4057qib7	15083	19	pooling	pooling	NN
cord-005453-4057qib7	15083	20	process	process	NN
cord-005453-4057qib7	15083	21	,	,	,
cord-005453-4057qib7	15083	22	selection	selection	NN
cord-005453-4057qib7	15083	23	by	by	IN
cord-005453-4057qib7	15083	24	plastic	plastic	NN
cord-005453-4057qib7	15083	25	-	-	HYPH
cord-005453-4057qib7	15083	26	adherence	adherence	NN
cord-005453-4057qib7	15083	27	,	,	,
cord-005453-4057qib7	15083	28	expansion	expansion	NN
cord-005453-4057qib7	15083	29	for	for	IN
cord-005453-4057qib7	15083	30	an	an	DT
cord-005453-4057qib7	15083	31	aggregate	aggregate	JJ
cord-005453-4057qib7	15083	32	four	four	CD
cord-005453-4057qib7	15083	33	weeks	week	NNS
cord-005453-4057qib7	15083	34	followed	follow	VBN
cord-005453-4057qib7	15083	35	by	by	IN
cord-005453-4057qib7	15083	36	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	15083	37	until	until	IN
cord-005453-4057qib7	15083	38	use	use	NN
cord-005453-4057qib7	15083	39	,	,	,
cord-005453-4057qib7	15083	40	is	be	VBZ
cord-005453-4057qib7	15083	41	available	available	JJ
cord-005453-4057qib7	15083	42	in	in	IN
cord-005453-4057qib7	15083	43	Germany	Germany	NNP
cord-005453-4057qib7	15083	44	through	through	IN
cord-005453-4057qib7	15083	45	a	a	DT
cord-005453-4057qib7	15083	46	national	national	JJ
cord-005453-4057qib7	15083	47	marketing	marketing	NN
cord-005453-4057qib7	15083	48	authorization	authorization	NN
cord-005453-4057qib7	15083	49	.	.	.
cord-005453-4057qib7	15084	1	"	"	''
cord-005453-4057qib7	15085	1	MSC	MSC	NNP
cord-005453-4057qib7	15085	2	-	-	HYPH
cord-005453-4057qib7	15085	3	FFM	FFM	NNP
cord-005453-4057qib7	15085	4	"	"	''
cord-005453-4057qib7	15085	5	is	be	VBZ
cord-005453-4057qib7	15085	6	indicated	indicate	VBN
cord-005453-4057qib7	15085	7	in	in	IN
cord-005453-4057qib7	15085	8	steroidrefractory	steroidrefractory	NNP
cord-005453-4057qib7	15085	9	aGvHD	aGvHD	NNP
cord-005453-4057qib7	15085	10	,	,	,
cord-005453-4057qib7	15085	11	dosed	dose	VBN
cord-005453-4057qib7	15085	12	at	at	IN
cord-005453-4057qib7	15085	13	1	1	CD
cord-005453-4057qib7	15085	14	-	-	SYM
cord-005453-4057qib7	15085	15	2	2	CD
cord-005453-4057qib7	15085	16	x10	x10	CD
cord-005453-4057qib7	15085	17	6	6	CD
cord-005453-4057qib7	15085	18	/kg	/kg	NN
cord-005453-4057qib7	15085	19	BW	BW	NNP
cord-005453-4057qib7	15085	20	i.v	i.v	NNP
cord-005453-4057qib7	15085	21	.	.	.
cord-005453-4057qib7	15086	1	in	in	IN
cord-005453-4057qib7	15086	2	four	four	CD
cord-005453-4057qib7	15086	3	doses	dose	NNS
cord-005453-4057qib7	15086	4	one	one	CD
cord-005453-4057qib7	15086	5	week	week	NN
cord-005453-4057qib7	15086	6	apart	apart	RB
cord-005453-4057qib7	15086	7	.	.	.
cord-005453-4057qib7	15087	1	Methods	method	NNS
cord-005453-4057qib7	15087	2	:	:	:
cord-005453-4057qib7	15087	3	We	-PRON-	PRP
cord-005453-4057qib7	15087	4	report	report	VBP
cord-005453-4057qib7	15087	5	seven	seven	CD
cord-005453-4057qib7	15087	6	consecutive	consecutive	JJ
cord-005453-4057qib7	15087	7	pediatric	pediatric	JJ
cord-005453-4057qib7	15087	8	patients	patient	NNS
cord-005453-4057qib7	15087	9	(	(	-LRB-
cord-005453-4057qib7	15087	10	median	median	JJ
cord-005453-4057qib7	15087	11	age	age	NN
cord-005453-4057qib7	15087	12	7.49	7.49	CD
cord-005453-4057qib7	15087	13	y	y	NNP
cord-005453-4057qib7	15087	14	)	)	-RRB-
cord-005453-4057qib7	15087	15	,	,	,
cord-005453-4057qib7	15087	16	who	who	WP
cord-005453-4057qib7	15087	17	received	receive	VBD
cord-005453-4057qib7	15087	18	"	"	``
cord-005453-4057qib7	15087	19	MSC	MSC	NNP
cord-005453-4057qib7	15087	20	-	-	HYPH
cord-005453-4057qib7	15087	21	FFM	FFM	NNP
cord-005453-4057qib7	15087	22	"	"	''
cord-005453-4057qib7	15087	23	from	from	IN
cord-005453-4057qib7	15087	24	unrelated	unrelated	JJ
cord-005453-4057qib7	15087	25	HLA	HLA	NNP
cord-005453-4057qib7	15087	26	disparate	disparate	JJ
cord-005453-4057qib7	15087	27	donors	donor	NNS
cord-005453-4057qib7	15087	28	between	between	IN
cord-005453-4057qib7	15087	29	December	December	NNP
cord-005453-4057qib7	15087	30	2017	2017	CD
cord-005453-4057qib7	15087	31	and	and	CC
cord-005453-4057qib7	15087	32	November	November	NNP
cord-005453-4057qib7	15087	33	2018	2018	CD
cord-005453-4057qib7	15087	34	in	in	IN
cord-005453-4057qib7	15087	35	our	-PRON-	PRP$
cord-005453-4057qib7	15087	36	institution	institution	NN
cord-005453-4057qib7	15087	37	.	.	.
cord-005453-4057qib7	15088	1	We	-PRON-	PRP
cord-005453-4057qib7	15088	2	gave	give	VBD
cord-005453-4057qib7	15088	3	MSC	MSC	NNP
cord-005453-4057qib7	15088	4	infusions	infusion	NNS
cord-005453-4057qib7	15088	5	to	to	IN
cord-005453-4057qib7	15088	6	6	6	CD
cord-005453-4057qib7	15088	7	patients	patient	NNS
cord-005453-4057qib7	15088	8	with	with	IN
cord-005453-4057qib7	15088	9	steroid	steroid	JJ
cord-005453-4057qib7	15088	10	-	-	HYPH
cord-005453-4057qib7	15088	11	refractory	refractory	JJ
cord-005453-4057qib7	15088	12	grades	grade	NNS
cord-005453-4057qib7	15088	13	III	III	NNP
cord-005453-4057qib7	15088	14	-	-	HYPH
cord-005453-4057qib7	15088	15	IV	IV	NNP
cord-005453-4057qib7	15088	16	aGVHD	aGVHD	NNP
cord-005453-4057qib7	15088	17	and	and	CC
cord-005453-4057qib7	15088	18	one	one	CD
cord-005453-4057qib7	15088	19	patient	patient	NN
cord-005453-4057qib7	15088	20	who	who	WP
cord-005453-4057qib7	15088	21	had	have	VBD
cord-005453-4057qib7	15088	22	therapy	therapy	NN
cord-005453-4057qib7	15088	23	-	-	HYPH
cord-005453-4057qib7	15088	24	refractory	refractory	JJ
cord-005453-4057qib7	15088	25	Background	background	NN
cord-005453-4057qib7	15088	26	:	:	:
cord-005453-4057qib7	15088	27	Regulatory	regulatory	JJ
cord-005453-4057qib7	15088	28	T	t	NN
cord-005453-4057qib7	15088	29	cells	cell	NNS
cord-005453-4057qib7	15088	30	(	(	-LRB-
cord-005453-4057qib7	15088	31	Treg	Treg	NNP
cord-005453-4057qib7	15088	32	)	)	-RRB-
cord-005453-4057qib7	15088	33	are	be	VBP
cord-005453-4057qib7	15088	34	known	know	VBN
cord-005453-4057qib7	15088	35	for	for	IN
cord-005453-4057qib7	15088	36	their	-PRON-	PRP$
cord-005453-4057qib7	15088	37	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	15088	38	function	function	NN
cord-005453-4057qib7	15088	39	and	and	CC
cord-005453-4057qib7	15088	40	have	have	VBP
cord-005453-4057qib7	15088	41	proven	prove	VBN
cord-005453-4057qib7	15088	42	successful	successful	JJ
cord-005453-4057qib7	15088	43	as	as	IN
cord-005453-4057qib7	15088	44	graft	graft	NN
cord-005453-4057qib7	15088	45	-	-	HYPH
cord-005453-4057qib7	15088	46	versus	versus	IN
cord-005453-4057qib7	15088	47	-	-	HYPH
cord-005453-4057qib7	15088	48	host	host	NN
cord-005453-4057qib7	15088	49	disease	disease	NN
cord-005453-4057qib7	15088	50	(	(	-LRB-
cord-005453-4057qib7	15088	51	GVHD	GVHD	NNP
cord-005453-4057qib7	15088	52	)	)	-RRB-
cord-005453-4057qib7	15088	53	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15088	54	after	after	IN
cord-005453-4057qib7	15088	55	allogeneic	allogeneic	NN
cord-005453-4057qib7	15088	56	bone	bone	NN
cord-005453-4057qib7	15088	57	marrow	marrow	NN
cord-005453-4057qib7	15088	58	transplantation	transplantation	NN
cord-005453-4057qib7	15088	59	in	in	IN
cord-005453-4057qib7	15088	60	a	a	DT
cord-005453-4057qib7	15088	61	number	number	NN
cord-005453-4057qib7	15088	62	of	of	IN
cord-005453-4057qib7	15088	63	preclinical	preclinical	JJ
cord-005453-4057qib7	15088	64	as	as	RB
cord-005453-4057qib7	15088	65	well	well	RB
cord-005453-4057qib7	15088	66	as	as	IN
cord-005453-4057qib7	15088	67	first	first	JJ
cord-005453-4057qib7	15088	68	clinical	clinical	JJ
cord-005453-4057qib7	15088	69	studies	study	NNS
cord-005453-4057qib7	15088	70	without	without	IN
cord-005453-4057qib7	15088	71	compromising	compromise	VBG
cord-005453-4057qib7	15088	72	graft	graft	NN
cord-005453-4057qib7	15088	73	-	-	HYPH
cord-005453-4057qib7	15088	74	versus	versus	RP
cord-005453-4057qib7	15088	75	leukemia	leukemia	NN
cord-005453-4057qib7	15088	76	(	(	-LRB-
cord-005453-4057qib7	15088	77	GVL	gvl	NN
cord-005453-4057qib7	15088	78	)	)	-RRB-
cord-005453-4057qib7	15088	79	effects	effect	NNS
cord-005453-4057qib7	15088	80	.	.	.
cord-005453-4057qib7	15089	1	In	in	IN
cord-005453-4057qib7	15089	2	murine	murine	JJ
cord-005453-4057qib7	15089	3	models	model	NNS
cord-005453-4057qib7	15089	4	of	of	IN
cord-005453-4057qib7	15089	5	acute	acute	JJ
cord-005453-4057qib7	15089	6	GVHD	GVHD	NNP
cord-005453-4057qib7	15089	7	lymph	lymph	NN
cord-005453-4057qib7	15089	8	node	node	NN
cord-005453-4057qib7	15089	9	homing	home	VBG
cord-005453-4057qib7	15089	10	capacity	capacity	NN
cord-005453-4057qib7	15089	11	via	via	IN
cord-005453-4057qib7	15089	12	CD62L	cd62l	NN
cord-005453-4057qib7	15090	1	(	(	-LRB-
cord-005453-4057qib7	15090	2	L	l	NN
cord-005453-4057qib7	15090	3	-	-	HYPH
cord-005453-4057qib7	15090	4	selectin	selectin	NNP
cord-005453-4057qib7	15090	5	)	)	-RRB-
cord-005453-4057qib7	15090	6	proved	prove	VBD
cord-005453-4057qib7	15090	7	to	to	TO
cord-005453-4057qib7	15090	8	be	be	VB
cord-005453-4057qib7	15090	9	essential	essential	JJ
cord-005453-4057qib7	15090	10	for	for	IN
cord-005453-4057qib7	15090	11	disease	disease	NN
cord-005453-4057qib7	15090	12	prevention	prevention	NN
cord-005453-4057qib7	15090	13	.	.	.
cord-005453-4057qib7	15091	1	Yet	yet	RB
cord-005453-4057qib7	15091	2	,	,	,
cord-005453-4057qib7	15091	3	Treg	Treg	NNP
cord-005453-4057qib7	15091	4	recruitment	recruitment	NN
cord-005453-4057qib7	15091	5	from	from	IN
cord-005453-4057qib7	15091	6	lymph	lymph	NN
cord-005453-4057qib7	15091	7	nodes	node	NNS
cord-005453-4057qib7	15091	8	to	to	IN
cord-005453-4057qib7	15091	9	peripheral	peripheral	JJ
cord-005453-4057qib7	15091	10	sites	site	NNS
cord-005453-4057qib7	15091	11	of	of	IN
cord-005453-4057qib7	15091	12	ongoing	ongoing	JJ
cord-005453-4057qib7	15091	13	GVHD	GVHD	NNP
cord-005453-4057qib7	15091	14	also	also	RB
cord-005453-4057qib7	15091	15	seems	seem	VBZ
cord-005453-4057qib7	15091	16	necessary	necessary	JJ
cord-005453-4057qib7	15091	17	to	to	TO
cord-005453-4057qib7	15091	18	achieve	achieve	VB
cord-005453-4057qib7	15091	19	maximum	maximum	JJ
cord-005453-4057qib7	15091	20	protective	protective	NN
cord-005453-4057qib7	15091	21	as	as	RB
cord-005453-4057qib7	15091	22	well	well	RB
cord-005453-4057qib7	15091	23	as	as	IN
cord-005453-4057qib7	15091	24	therapeutic	therapeutic	JJ
cord-005453-4057qib7	15091	25	effects	effect	NNS
cord-005453-4057qib7	15091	26	.	.	.
cord-005453-4057qib7	15092	1	The	the	DT
cord-005453-4057qib7	15092	2	chemokine	chemokine	NN
cord-005453-4057qib7	15092	3	receptor	receptor	NN
cord-005453-4057qib7	15092	4	CCR4	CCR4	NNP
cord-005453-4057qib7	15092	5	directs	direct	VBZ
cord-005453-4057qib7	15092	6	activated	activate	VBN
cord-005453-4057qib7	15092	7	T	t	NN
cord-005453-4057qib7	15092	8	cells	cell	NNS
cord-005453-4057qib7	15092	9	to	to	IN
cord-005453-4057qib7	15092	10	sites	site	NNS
cord-005453-4057qib7	15092	11	of	of	IN
cord-005453-4057qib7	15092	12	inflammation	inflammation	NN
cord-005453-4057qib7	15092	13	,	,	,
cord-005453-4057qib7	15092	14	thus	thus	RB
cord-005453-4057qib7	15092	15	high	high	JJ
cord-005453-4057qib7	15092	16	CCR4	CCR4	NNP
cord-005453-4057qib7	15092	17	expression	expression	NN
cord-005453-4057qib7	15092	18	should	should	MD
cord-005453-4057qib7	15092	19	facilitate	facilitate	VB
cord-005453-4057qib7	15092	20	Treg	Treg	NNP
cord-005453-4057qib7	15092	21	homing	homing	NN
cord-005453-4057qib7	15092	22	to	to	IN
cord-005453-4057qib7	15092	23	affected	affect	VBN
cord-005453-4057qib7	15092	24	GVHD	GVHD	NNP
cord-005453-4057qib7	15092	25	target	target	NN
cord-005453-4057qib7	15092	26	organs	organ	NNS
cord-005453-4057qib7	15092	27	.	.	.
cord-005453-4057qib7	15093	1	With	with	IN
cord-005453-4057qib7	15093	2	this	this	DT
cord-005453-4057qib7	15093	3	project	project	NN
cord-005453-4057qib7	15093	4	we	-PRON-	PRP
cord-005453-4057qib7	15093	5	lay	lay	VBP
cord-005453-4057qib7	15093	6	the	the	DT
cord-005453-4057qib7	15093	7	foundation	foundation	NN
cord-005453-4057qib7	15093	8	for	for	IN
cord-005453-4057qib7	15093	9	future	future	NN
cord-005453-4057qib7	15093	10	in	in	IN
cord-005453-4057qib7	15093	11	vivo	vivo	NN
cord-005453-4057qib7	15093	12	studies	study	NNS
cord-005453-4057qib7	15093	13	of	of	IN
cord-005453-4057qib7	15093	14	Treg	Treg	NNP
cord-005453-4057qib7	15093	15	therapy	therapy	NN
cord-005453-4057qib7	15093	16	for	for	IN
cord-005453-4057qib7	15093	17	GVHD	GVHD	NNP
cord-005453-4057qib7	15093	18	by	by	IN
cord-005453-4057qib7	15093	19	upregulation	upregulation	NN
cord-005453-4057qib7	15093	20	of	of	IN
cord-005453-4057qib7	15093	21	CCR4	CCR4	NNP
cord-005453-4057qib7	15093	22	expression	expression	NN
cord-005453-4057qib7	15093	23	.	.	.
cord-005453-4057qib7	15094	1	Methods	method	NNS
cord-005453-4057qib7	15094	2	:	:	:
cord-005453-4057qib7	15094	3	We	-PRON-	PRP
cord-005453-4057qib7	15094	4	performed	perform	VBD
cord-005453-4057qib7	15094	5	systematic	systematic	JJ
cord-005453-4057qib7	15094	6	ex	ex	FW
cord-005453-4057qib7	15094	7	vivo	vivo	NN
cord-005453-4057qib7	15094	8	analysis	analysis	NN
cord-005453-4057qib7	15094	9	of	of	IN
cord-005453-4057qib7	15094	10	CCR4	CCR4	NNP
cord-005453-4057qib7	15094	11	expression	expression	NN
cord-005453-4057qib7	15094	12	on	on	IN
cord-005453-4057qib7	15094	13	murine	murine	JJ
cord-005453-4057qib7	15094	14	naive	naive	JJ
cord-005453-4057qib7	15094	15	and	and	CC
cord-005453-4057qib7	15094	16	memory	memory	NN
cord-005453-4057qib7	15094	17	conventional	conventional	JJ
cord-005453-4057qib7	15094	18	(	(	-LRB-
cord-005453-4057qib7	15094	19	Tconv	Tconv	NNP
cord-005453-4057qib7	15094	20	)	)	-RRB-
cord-005453-4057qib7	15094	21	and	and	CC
cord-005453-4057qib7	15094	22	regulatory	regulatory	JJ
cord-005453-4057qib7	15094	23	T	t	NN
cord-005453-4057qib7	15094	24	cells	cell	NNS
cord-005453-4057qib7	15094	25	isolated	isolate	VBN
cord-005453-4057qib7	15094	26	from	from	IN
cord-005453-4057qib7	15094	27	spleen	spleen	NN
cord-005453-4057qib7	15094	28	,	,	,
cord-005453-4057qib7	15094	29	blood	blood	NN
cord-005453-4057qib7	15094	30	,	,	,
cord-005453-4057qib7	15094	31	bone	bone	NN
cord-005453-4057qib7	15094	32	marrow	marrow	NN
cord-005453-4057qib7	15094	33	,	,	,
cord-005453-4057qib7	15094	34	lymph	lymph	NN
cord-005453-4057qib7	15094	35	nodes	node	NNS
cord-005453-4057qib7	15094	36	,	,	,
cord-005453-4057qib7	15094	37	liver	liver	NN
cord-005453-4057qib7	15094	38	and	and	CC
cord-005453-4057qib7	15094	39	lung	lung	NN
cord-005453-4057qib7	15094	40	.	.	.
cord-005453-4057qib7	15095	1	Cells	cell	NNS
cord-005453-4057qib7	15095	2	were	be	VBD
cord-005453-4057qib7	15095	3	stained	stain	VBN
cord-005453-4057qib7	15095	4	for	for	IN
cord-005453-4057qib7	15095	5	characteristic	characteristic	JJ
cord-005453-4057qib7	15095	6	surface	surface	NN
cord-005453-4057qib7	15095	7	and	and	CC
cord-005453-4057qib7	15095	8	intracellular	intracellular	JJ
cord-005453-4057qib7	15095	9	markers	marker	NNS
cord-005453-4057qib7	15095	10	and	and	CC
cord-005453-4057qib7	15095	11	characterized	characterize	VBN
cord-005453-4057qib7	15095	12	by	by	IN
cord-005453-4057qib7	15095	13	multiparametric	multiparametric	NNP
cord-005453-4057qib7	15095	14	flowcytometric	flowcytometric	NNP
cord-005453-4057qib7	15095	15	analysis	analysis	NN
cord-005453-4057qib7	15095	16	.	.	.
cord-005453-4057qib7	15096	1	CCR4	ccr4	JJ
cord-005453-4057qib7	15096	2	expression	expression	NN
cord-005453-4057qib7	15096	3	kinetics	kinetics	NN
cord-005453-4057qib7	15096	4	following	follow	VBG
cord-005453-4057qib7	15096	5	stimulation	stimulation	NN
cord-005453-4057qib7	15096	6	were	be	VBD
cord-005453-4057qib7	15096	7	analysed	analyse	VBN
cord-005453-4057qib7	15096	8	in	in	IN
cord-005453-4057qib7	15096	9	Tconv	Tconv	NNP
cord-005453-4057qib7	15096	10	and	and	CC
cord-005453-4057qib7	15096	11	Treg	Treg	NNP
cord-005453-4057qib7	15096	12	isolated	isolate	VBN
cord-005453-4057qib7	15096	13	from	from	IN
cord-005453-4057qib7	15096	14	murine	murine	JJ
cord-005453-4057qib7	15096	15	splenocytes	splenocyte	NNS
cord-005453-4057qib7	15096	16	by	by	IN
cord-005453-4057qib7	15096	17	FACS	FACS	NNP
cord-005453-4057qib7	15096	18	and	and	CC
cord-005453-4057qib7	15096	19	polyclonally	polyclonally	RB
cord-005453-4057qib7	15096	20	activated	activate	VBN
cord-005453-4057qib7	15096	21	by	by	IN
cord-005453-4057qib7	15096	22	anti	anti	JJ
cord-005453-4057qib7	15096	23	-	-	JJ
cord-005453-4057qib7	15096	24	CD3	cd3	JJ
cord-005453-4057qib7	15096	25	/	/	SYM
cord-005453-4057qib7	15096	26	CD28-coated	CD28-coated	NNP
cord-005453-4057qib7	15096	27	beads	bead	NNS
cord-005453-4057qib7	15096	28	in	in	IN
cord-005453-4057qib7	15096	29	the	the	DT
cord-005453-4057qib7	15096	30	presence	presence	NN
cord-005453-4057qib7	15096	31	of	of	IN
cord-005453-4057qib7	15096	32	exogenous	exogenous	JJ
cord-005453-4057qib7	15096	33	IL-2	IL-2	NNP
cord-005453-4057qib7	15096	34	.	.	.
cord-005453-4057qib7	15096	35	Expression	expression	NN
cord-005453-4057qib7	15096	36	was	be	VBD
cord-005453-4057qib7	15096	37	monitored	monitor	VBN
cord-005453-4057qib7	15096	38	by	by	IN
cord-005453-4057qib7	15096	39	daily	daily	JJ
cord-005453-4057qib7	15096	40	flow	flow	NN
cord-005453-4057qib7	15096	41	cytometric	cytometric	NNP
cord-005453-4057qib7	15096	42	analysis	analysis	NN
cord-005453-4057qib7	15096	43	.	.	.
cord-005453-4057qib7	15097	1	CCR4	ccr4	NN
cord-005453-4057qib7	15097	2	overexpression	overexpression	NN
cord-005453-4057qib7	15097	3	was	be	VBD
cord-005453-4057qib7	15097	4	induced	induce	VBN
cord-005453-4057qib7	15097	5	by	by	IN
cord-005453-4057qib7	15097	6	transduction	transduction	NN
cord-005453-4057qib7	15097	7	of	of	IN
cord-005453-4057qib7	15097	8	expanded	expand	VBN
cord-005453-4057qib7	15097	9	Treg	Treg	NNP
cord-005453-4057qib7	15097	10	with	with	IN
cord-005453-4057qib7	15097	11	CCR4	CCR4	NNP
cord-005453-4057qib7	15097	12	mRNA	mRNA	NNP
cord-005453-4057qib7	15098	1	via	via	IN
cord-005453-4057qib7	15098	2	electroporation	electroporation	NN
cord-005453-4057qib7	15098	3	.	.	.
cord-005453-4057qib7	15099	1	Expression	expression	NN
cord-005453-4057qib7	15099	2	kinetics	kinetic	NNS
cord-005453-4057qib7	15099	3	were	be	VBD
cord-005453-4057qib7	15099	4	monitored	monitor	VBN
cord-005453-4057qib7	15099	5	by	by	IN
cord-005453-4057qib7	15099	6	FACS	FACS	NNP
cord-005453-4057qib7	15099	7	,	,	,
cord-005453-4057qib7	15099	8	receptor	receptor	NN
cord-005453-4057qib7	15099	9	function	function	NN
cord-005453-4057qib7	15099	10	was	be	VBD
cord-005453-4057qib7	15099	11	tested	test	VBN
cord-005453-4057qib7	15099	12	in	in	IN
cord-005453-4057qib7	15099	13	transwell	transwell	NNP
cord-005453-4057qib7	15099	14	migration	migration	NN
cord-005453-4057qib7	15099	15	assays	assay	NNS
cord-005453-4057qib7	15099	16	using	use	VBG
cord-005453-4057qib7	15099	17	CCR4	CCR4	NNP
cord-005453-4057qib7	15099	18	ligands	ligand	NNS
cord-005453-4057qib7	15099	19	CCL-17	CCL-17	.
cord-005453-4057qib7	15099	20	and	and	CC
cord-005453-4057qib7	15099	21	CCL-22	CCL-22	NNP
cord-005453-4057qib7	15099	22	.	.	.
cord-005453-4057qib7	15100	1	Results	result	NNS
cord-005453-4057qib7	15100	2	:	:	:
cord-005453-4057qib7	15101	1	Systematic	systematic	JJ
cord-005453-4057qib7	15101	2	analyses	analysis	NNS
cord-005453-4057qib7	15101	3	showed	show	VBD
cord-005453-4057qib7	15101	4	higher	high	JJR
cord-005453-4057qib7	15101	5	CCR4	CCR4	NNP
cord-005453-4057qib7	15101	6	expression	expression	NN
cord-005453-4057qib7	15101	7	on	on	IN
cord-005453-4057qib7	15101	8	memory	memory	NN
cord-005453-4057qib7	15101	9	Treg	Treg	NNP
cord-005453-4057qib7	15101	10	than	than	IN
cord-005453-4057qib7	15101	11	on	on	IN
cord-005453-4057qib7	15101	12	their	-PRON-	PRP$
cord-005453-4057qib7	15101	13	naive	naive	JJ
cord-005453-4057qib7	15101	14	counterpart	counterpart	NN
cord-005453-4057qib7	15101	15	in	in	IN
cord-005453-4057qib7	15101	16	all	all	DT
cord-005453-4057qib7	15101	17	examined	examine	VBN
cord-005453-4057qib7	15101	18	organs	organ	NNS
cord-005453-4057qib7	15101	19	with	with	IN
cord-005453-4057qib7	15101	20	bone	bone	NN
cord-005453-4057qib7	15101	21	marrow	marrow	NN
cord-005453-4057qib7	15101	22	samples	sample	NNS
cord-005453-4057qib7	15101	23	displaying	display	VBG
cord-005453-4057qib7	15101	24	the	the	DT
cord-005453-4057qib7	15101	25	greatest	great	JJS
cord-005453-4057qib7	15101	26	disparity	disparity	NN
cord-005453-4057qib7	15101	27	.	.	.
cord-005453-4057qib7	15102	1	Memory	Memory	NNP
cord-005453-4057qib7	15102	2	Treg	Treg	NNP
cord-005453-4057qib7	15102	3	showed	show	VBD
cord-005453-4057qib7	15102	4	higher	high	JJR
cord-005453-4057qib7	15102	5	CCR4	CCR4	NNP
cord-005453-4057qib7	15102	6	expression	expression	NN
cord-005453-4057qib7	15102	7	than	than	IN
cord-005453-4057qib7	15102	8	memory	memory	NN
cord-005453-4057qib7	15102	9	Tconv	Tconv	NNP
cord-005453-4057qib7	15102	10	in	in	IN
cord-005453-4057qib7	15102	11	all	all	DT
cord-005453-4057qib7	15102	12	analysed	analyse	VBN
cord-005453-4057qib7	15102	13	organs	organ	NNS
cord-005453-4057qib7	15102	14	,	,	,
cord-005453-4057qib7	15102	15	except	except	IN
cord-005453-4057qib7	15102	16	for	for	IN
cord-005453-4057qib7	15102	17	lymph	lymph	NN
cord-005453-4057qib7	15102	18	nodes	node	NNS
cord-005453-4057qib7	15102	19	where	where	WRB
cord-005453-4057qib7	15102	20	both	both	DT
cord-005453-4057qib7	15102	21	memory	memory	NN
cord-005453-4057qib7	15102	22	populations	population	NNS
cord-005453-4057qib7	15102	23	revealed	reveal	VBD
cord-005453-4057qib7	15102	24	equal	equal	JJ
cord-005453-4057qib7	15102	25	expression	expression	NN
cord-005453-4057qib7	15102	26	levels	level	NNS
cord-005453-4057qib7	15102	27	.	.	.
cord-005453-4057qib7	15103	1	Stimulation	stimulation	NN
cord-005453-4057qib7	15103	2	of	of	IN
cord-005453-4057qib7	15103	3	in	in	FW
cord-005453-4057qib7	15103	4	vitro	vitro	FW
cord-005453-4057qib7	15103	5	expanded	expand	VBD
cord-005453-4057qib7	15103	6	Treg	Treg	NNP
cord-005453-4057qib7	15103	7	and	and	CC
cord-005453-4057qib7	15103	8	Tconv	Tconv	NNP
cord-005453-4057qib7	15103	9	lead	lead	VBP
cord-005453-4057qib7	15103	10	to	to	IN
cord-005453-4057qib7	15103	11	a	a	DT
cord-005453-4057qib7	15103	12	strong	strong	JJ
cord-005453-4057qib7	15103	13	increase	increase	NN
cord-005453-4057qib7	15103	14	in	in	IN
cord-005453-4057qib7	15103	15	CCR4	CCR4	NNP
cord-005453-4057qib7	15103	16	expression	expression	NN
cord-005453-4057qib7	15103	17	with	with	IN
cord-005453-4057qib7	15103	18	maximum	maximum	JJ
cord-005453-4057qib7	15103	19	levels	level	NNS
cord-005453-4057qib7	15103	20	on	on	IN
cord-005453-4057qib7	15103	21	d3	d3	NNP
cord-005453-4057qib7	15103	22	and	and	CC
cord-005453-4057qib7	15103	23	d2	d2	NNP
cord-005453-4057qib7	15103	24	respectively	respectively	RB
cord-005453-4057qib7	15103	25	,	,	,
cord-005453-4057qib7	15103	26	whereas	whereas	IN
cord-005453-4057qib7	15103	27	restimulation	restimulation	NN
cord-005453-4057qib7	15103	28	(	(	-LRB-
cord-005453-4057qib7	15103	29	d7	d7	NNP
cord-005453-4057qib7	15103	30	)	)	-RRB-
cord-005453-4057qib7	15103	31	resulted	result	VBD
cord-005453-4057qib7	15103	32	in	in	IN
cord-005453-4057qib7	15103	33	no	no	DT
cord-005453-4057qib7	15103	34	further	further	JJ
cord-005453-4057qib7	15103	35	relevant	relevant	JJ
cord-005453-4057qib7	15103	36	CCR4	CCR4	NNP
cord-005453-4057qib7	15103	37	expression	expression	NN
cord-005453-4057qib7	15103	38	on	on	IN
cord-005453-4057qib7	15103	39	Treg	Treg	NNP
cord-005453-4057qib7	15103	40	.	.	.
cord-005453-4057qib7	15104	1	We	-PRON-	PRP
cord-005453-4057qib7	15104	2	performed	perform	VBD
cord-005453-4057qib7	15104	3	systematic	systematic	JJ
cord-005453-4057qib7	15104	4	optimization	optimization	NN
cord-005453-4057qib7	15104	5	of	of	IN
cord-005453-4057qib7	15104	6	stimulation	stimulation	NN
cord-005453-4057qib7	15104	7	and	and	CC
cord-005453-4057qib7	15104	8	mRNA	mrna	NN
cord-005453-4057qib7	15104	9	-	-	HYPH
cord-005453-4057qib7	15104	10	electroporation	electroporation	NN
cord-005453-4057qib7	15104	11	conditions	condition	NNS
cord-005453-4057qib7	15104	12	to	to	TO
cord-005453-4057qib7	15104	13	reliably	reliably	RB
cord-005453-4057qib7	15104	14	achieve	achieve	VB
cord-005453-4057qib7	15104	15	highlevel	highlevel	JJ
cord-005453-4057qib7	15104	16	short	short	JJ
cord-005453-4057qib7	15104	17	-	-	HYPH
cord-005453-4057qib7	15104	18	term	term	NN
cord-005453-4057qib7	15104	19	CCR4	CCR4	NNP
cord-005453-4057qib7	15104	20	expression	expression	NN
cord-005453-4057qib7	15104	21	.	.	.
cord-005453-4057qib7	15105	1	Transduction	transduction	NN
cord-005453-4057qib7	15105	2	of	of	IN
cord-005453-4057qib7	15105	3	Treg	Treg	NNP
cord-005453-4057qib7	15105	4	on	on	IN
cord-005453-4057qib7	15105	5	d11	d11	NNP
cord-005453-4057qib7	15105	6	of	of	IN
cord-005453-4057qib7	15105	7	in	in	FW
cord-005453-4057qib7	15105	8	vitro	vitro	FW
cord-005453-4057qib7	15105	9	expansion	expansion	NN
cord-005453-4057qib7	15105	10	resulted	result	VBD
cord-005453-4057qib7	15105	11	in	in	IN
cord-005453-4057qib7	15105	12	a	a	DT
cord-005453-4057qib7	15105	13	strong	strong	JJ
cord-005453-4057qib7	15105	14	CCR4	CCR4	NNP
cord-005453-4057qib7	15105	15	expression	expression	NN
cord-005453-4057qib7	15105	16	,	,	,
cord-005453-4057qib7	15105	17	with	with	IN
cord-005453-4057qib7	15105	18	maximum	maximum	JJ
cord-005453-4057qib7	15105	19	levels	level	NNS
cord-005453-4057qib7	15105	20	2h	2h	CD
cord-005453-4057qib7	15105	21	after	after	IN
cord-005453-4057qib7	15105	22	electroporation	electroporation	NN
cord-005453-4057qib7	15105	23	and	and	CC
cord-005453-4057qib7	15105	24	strong	strong	JJ
cord-005453-4057qib7	15105	25	CCR4	CCR4	NNP
cord-005453-4057qib7	15105	26	expression	expression	NN
cord-005453-4057qib7	15105	27	being	be	VBG
cord-005453-4057qib7	15105	28	detectable	detectable	JJ
cord-005453-4057qib7	15105	29	for	for	IN
cord-005453-4057qib7	15105	30	at	at	IN
cord-005453-4057qib7	15105	31	least	least	RBS
cord-005453-4057qib7	15105	32	8h	8h	CD
cord-005453-4057qib7	15105	33	.	.	.
cord-005453-4057qib7	15106	1	Transwell	Transwell	NNP
cord-005453-4057qib7	15106	2	migration	migration	NN
cord-005453-4057qib7	15106	3	assays	assay	NNS
cord-005453-4057qib7	15106	4	showed	show	VBD
cord-005453-4057qib7	15106	5	enhanced	enhance	VBN
cord-005453-4057qib7	15106	6	migrational	migrational	JJ
cord-005453-4057qib7	15106	7	properties	property	NNS
cord-005453-4057qib7	15106	8	of	of	IN
cord-005453-4057qib7	15106	9	mRNA	mRNA	NNP
cord-005453-4057qib7	15106	10	-	-	HYPH
cord-005453-4057qib7	15106	11	electroporated	electroporate	VBN
cord-005453-4057qib7	15106	12	Treg	Treg	NNP
cord-005453-4057qib7	15106	13	towards	towards	IN
cord-005453-4057qib7	15106	14	CCR4	CCR4	NNP
cord-005453-4057qib7	15106	15	ligands	ligand	NNS
cord-005453-4057qib7	15106	16	.	.	.
cord-005453-4057qib7	15107	1	Analyses	analysis	NNS
cord-005453-4057qib7	15107	2	performed	perform	VBD
cord-005453-4057qib7	15107	3	2h	2h	CD
cord-005453-4057qib7	15107	4	and	and	CC
cord-005453-4057qib7	15107	5	16h	16h	CD
cord-005453-4057qib7	15107	6	after	after	IN
cord-005453-4057qib7	15107	7	electroporation	electroporation	NN
cord-005453-4057qib7	15107	8	showed	show	VBD
cord-005453-4057qib7	15107	9	persistent	persistent	JJ
cord-005453-4057qib7	15107	10	migration	migration	NN
cord-005453-4057qib7	15107	11	even	even	RB
cord-005453-4057qib7	15107	12	though	though	IN
cord-005453-4057qib7	15107	13	measured	measure	VBN
cord-005453-4057qib7	15107	14	CCR4	CCR4	NNP
cord-005453-4057qib7	15107	15	surface	surface	NN
cord-005453-4057qib7	15107	16	expression	expression	NN
cord-005453-4057qib7	15107	17	had	have	VBD
cord-005453-4057qib7	15107	18	already	already	RB
cord-005453-4057qib7	15107	19	declined	decline	VBN
cord-005453-4057qib7	15107	20	significantly	significantly	RB
cord-005453-4057qib7	15107	21	.	.	.
cord-005453-4057qib7	15108	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15108	2	:	:	:
cord-005453-4057qib7	15109	1	We	-PRON-	PRP
cord-005453-4057qib7	15109	2	showed	show	VBD
cord-005453-4057qib7	15109	3	that	that	IN
cord-005453-4057qib7	15109	4	high	high	JJ
cord-005453-4057qib7	15109	5	CCR4	CCR4	NNP
cord-005453-4057qib7	15109	6	expression	expression	NN
cord-005453-4057qib7	15109	7	can	can	MD
cord-005453-4057qib7	15109	8	be	be	VB
cord-005453-4057qib7	15109	9	detected	detect	VBN
cord-005453-4057qib7	15109	10	on	on	IN
cord-005453-4057qib7	15109	11	memory	memory	NN
cord-005453-4057qib7	15109	12	Treg	Treg	NNP
cord-005453-4057qib7	15109	13	in	in	IN
cord-005453-4057qib7	15109	14	all	all	DT
cord-005453-4057qib7	15109	15	analysed	analyse	VBN
cord-005453-4057qib7	15109	16	organs	organ	NNS
cord-005453-4057qib7	15109	17	.	.	.
cord-005453-4057qib7	15110	1	Since	since	IN
cord-005453-4057qib7	15110	2	in	in	IN
cord-005453-4057qib7	15110	3	vitro	vitro	FW
cord-005453-4057qib7	15110	4	stimulation	stimulation	NN
cord-005453-4057qib7	15110	5	of	of	IN
cord-005453-4057qib7	15110	6	murine	murine	JJ
cord-005453-4057qib7	15110	7	Treg	Treg	NNP
cord-005453-4057qib7	15110	8	did	do	VBD
cord-005453-4057qib7	15110	9	not	not	RB
cord-005453-4057qib7	15110	10	reliably	reliably	RB
cord-005453-4057qib7	15110	11	induce	induce	VB
cord-005453-4057qib7	15110	12	CCR4	CCR4	NNP
cord-005453-4057qib7	15110	13	expression	expression	NN
cord-005453-4057qib7	15110	14	,	,	,
cord-005453-4057qib7	15110	15	we	-PRON-	PRP
cord-005453-4057qib7	15110	16	established	establish	VBD
cord-005453-4057qib7	15110	17	a	a	DT
cord-005453-4057qib7	15110	18	protocol	protocol	NN
cord-005453-4057qib7	15110	19	for	for	IN
cord-005453-4057qib7	15110	20	CCR4	CCR4	NNP
cord-005453-4057qib7	15110	21	mRNA	mrna	NN
cord-005453-4057qib7	15110	22	-	-	HYPH
cord-005453-4057qib7	15110	23	electroporation	electroporation	NN
cord-005453-4057qib7	15110	24	.	.	.
cord-005453-4057qib7	15111	1	Electroporated	Electroporated	NNP
cord-005453-4057qib7	15111	2	cells	cell	NNS
cord-005453-4057qib7	15111	3	showed	show	VBD
cord-005453-4057qib7	15111	4	stable	stable	JJ
cord-005453-4057qib7	15111	5	short	short	JJ
cord-005453-4057qib7	15111	6	-	-	HYPH
cord-005453-4057qib7	15111	7	term	term	NN
cord-005453-4057qib7	15111	8	CCR4	CCR4	NNP
cord-005453-4057qib7	15111	9	expression	expression	NN
cord-005453-4057qib7	15111	10	and	and	CC
cord-005453-4057qib7	15111	11	enhanced	enhanced	JJ
cord-005453-4057qib7	15111	12	migrational	migrational	JJ
cord-005453-4057qib7	15111	13	properties	property	NNS
cord-005453-4057qib7	15111	14	towards	towards	IN
cord-005453-4057qib7	15111	15	CCR4	CCR4	NNP
cord-005453-4057qib7	15111	16	ligands	ligand	NNS
cord-005453-4057qib7	15111	17	in	in	IN
cord-005453-4057qib7	15111	18	vitro	vitro	FW
cord-005453-4057qib7	15111	19	.	.	.
cord-005453-4057qib7	15112	1	Future	future	JJ
cord-005453-4057qib7	15112	2	studies	study	NNS
cord-005453-4057qib7	15112	3	will	will	MD
cord-005453-4057qib7	15112	4	show	show	VB
cord-005453-4057qib7	15112	5	whether	whether	IN
cord-005453-4057qib7	15112	6	the	the	DT
cord-005453-4057qib7	15112	7	induction	induction	NN
cord-005453-4057qib7	15112	8	of	of	IN
cord-005453-4057qib7	15112	9	short	short	JJ
cord-005453-4057qib7	15112	10	-	-	HYPH
cord-005453-4057qib7	15112	11	term	term	NN
cord-005453-4057qib7	15112	12	CCR4	CCR4	NNP
cord-005453-4057qib7	15112	13	expression	expression	NN
cord-005453-4057qib7	15112	14	will	will	MD
cord-005453-4057qib7	15112	15	facilitate	facilitate	VB
cord-005453-4057qib7	15112	16	in	in	IN
cord-005453-4057qib7	15112	17	vivo	vivo	NN
cord-005453-4057qib7	15112	18	homing	homing	NN
cord-005453-4057qib7	15112	19	of	of	IN
cord-005453-4057qib7	15112	20	adoptively	adoptively	RB
cord-005453-4057qib7	15112	21	transferred	transfer	VBN
cord-005453-4057qib7	15112	22	Treg	Treg	NNP
cord-005453-4057qib7	15112	23	to	to	IN
cord-005453-4057qib7	15112	24	sites	site	NNS
cord-005453-4057qib7	15112	25	of	of	IN
cord-005453-4057qib7	15112	26	ongoing	ongoing	JJ
cord-005453-4057qib7	15112	27	GVHD	GVHD	NNP
cord-005453-4057qib7	15112	28	and	and	CC
cord-005453-4057qib7	15112	29	thus	thus	RB
cord-005453-4057qib7	15112	30	mediate	mediate	VB
cord-005453-4057qib7	15112	31	long	long	JJ
cord-005453-4057qib7	15112	32	-	-	HYPH
cord-005453-4057qib7	15112	33	term	term	NN
cord-005453-4057qib7	15112	34	inflammation	inflammation	NN
cord-005453-4057qib7	15112	35	suppression	suppression	NN
cord-005453-4057qib7	15112	36	.	.	.
cord-005453-4057qib7	15113	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15113	2	:	:	:
cord-005453-4057qib7	15114	1	The	the	DT
cord-005453-4057qib7	15114	2	authors	author	NNS
cord-005453-4057qib7	15114	3	have	have	VBP
cord-005453-4057qib7	15114	4	no	no	DT
cord-005453-4057qib7	15114	5	conflict	conflict	NN
cord-005453-4057qib7	15114	6	to	to	TO
cord-005453-4057qib7	15114	7	disclose	disclose	VB
cord-005453-4057qib7	15114	8	.	.	.
cord-005453-4057qib7	15115	1	Survival	survival	NN
cord-005453-4057qib7	15115	2	and	and	CC
cord-005453-4057qib7	15115	3	immune	immune	JJ
cord-005453-4057qib7	15115	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	15115	5	of	of	IN
cord-005453-4057qib7	15115	6	syngeneic	syngeneic	NNS
cord-005453-4057qib7	15115	7	,	,	,
cord-005453-4057qib7	15115	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15115	9	and	and	CC
cord-005453-4057qib7	15115	10	allogeneic	allogeneic	IN
cord-005453-4057qib7	15115	11	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15115	12	stem	stem	NN
cord-005453-4057qib7	15115	13	cell	cell	NN
cord-005453-4057qib7	15115	14	transplantation	transplantation	NN
cord-005453-4057qib7	15115	15	in	in	IN
cord-005453-4057qib7	15115	16	ATM	atm	NN
cord-005453-4057qib7	15115	17	-	-	HYPH
cord-005453-4057qib7	15115	18	deficient	deficient	JJ
cord-005453-4057qib7	15115	19	mice	mouse	NNS
cord-005453-4057qib7	15115	20	Ruth	Ruth	NNP
cord-005453-4057qib7	15115	21	Pia	Pia	NNP
cord-005453-4057qib7	15115	22	Duecker	Duecker	NNP
cord-005453-4057qib7	15115	23	1	1	CD
cord-005453-4057qib7	15115	24	,	,	,
cord-005453-4057qib7	15115	25	Patrick	Patrick	NNP
cord-005453-4057qib7	15115	26	C.	C.	NNP
cord-005453-4057qib7	15115	27	Baer	Baer	NNP
cord-005453-4057qib7	15115	28	2	2	CD
cord-005453-4057qib7	15115	29	,	,	,
cord-005453-4057qib7	15115	30	Stefan	Stefan	NNP
cord-005453-4057qib7	15115	31	Zielen	Zielen	NNP
cord-005453-4057qib7	15115	32	1	1	CD
cord-005453-4057qib7	15115	33	,	,	,
cord-005453-4057qib7	15115	34	Ralf	Ralf	NNP
cord-005453-4057qib7	15115	35	Schubert	Schubert	NNP
cord-005453-4057qib7	15115	36	1	1	CD
cord-005453-4057qib7	15115	37	from	from	IN
cord-005453-4057qib7	15115	38	allo	allo	NN
cord-005453-4057qib7	15115	39	-	-	HYPH
cord-005453-4057qib7	15115	40	HSCT	HSCT	NNP
cord-005453-4057qib7	15115	41	.	.	.
cord-005453-4057qib7	15116	1	It´s	It´s	NNP
cord-005453-4057qib7	15116	2	not	not	RB
cord-005453-4057qib7	15116	3	necessary	necessary	JJ
cord-005453-4057qib7	15116	4	to	to	TO
cord-005453-4057qib7	15116	5	do	do	VB
cord-005453-4057qib7	15116	6	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15116	7	before	before	IN
cord-005453-4057qib7	15116	8	transplantation	transplantation	NN
cord-005453-4057qib7	15116	9	for	for	IN
cord-005453-4057qib7	15116	10	patients	patient	NNS
cord-005453-4057qib7	15116	11	with	with	IN
cord-005453-4057qib7	15116	12	bone	bone	NN
cord-005453-4057qib7	15116	13	marrow	marrow	NN
cord-005453-4057qib7	15116	14	blast	blast	NN
cord-005453-4057qib7	15116	15	cells	cell	NNS
cord-005453-4057qib7	15116	16	more	more	JJR
cord-005453-4057qib7	15116	17	than	than	IN
cord-005453-4057qib7	15116	18	10	10	CD
cord-005453-4057qib7	15116	19	%	%	NN
cord-005453-4057qib7	15116	20	at	at	IN
cord-005453-4057qib7	15116	21	the	the	DT
cord-005453-4057qib7	15116	22	time	time	NN
cord-005453-4057qib7	15116	23	of	of	IN
cord-005453-4057qib7	15116	24	diagnosis	diagnosis	NN
cord-005453-4057qib7	15116	25	.	.	.
cord-005453-4057qib7	15117	1	[	[	-LRB-
cord-005453-4057qib7	15117	2	[	[	-LRB-
cord-005453-4057qib7	15117	3	P738	P738	NNP
cord-005453-4057qib7	15117	4	Image	image	NN
cord-005453-4057qib7	15117	5	]	]	-RRB-
cord-005453-4057qib7	15117	6	1	1	CD
cord-005453-4057qib7	15117	7	.	.	.
cord-005453-4057qib7	15118	1	Figure	figure	NN
cord-005453-4057qib7	15118	2	1	1	CD
cord-005453-4057qib7	15119	1	The	the	DT
cord-005453-4057qib7	15119	2	HCI	HCI	NNP
cord-005453-4057qib7	15119	3	-	-	HYPH
cord-005453-4057qib7	15119	4	CT	CT	NNP
cord-005453-4057qib7	15119	5	of	of	IN
cord-005453-4057qib7	15119	6	patients	patient	NNS
cord-005453-4057qib7	15119	7	before	before	IN
cord-005453-4057qib7	15119	8	transplantation	transplantation	NN
cord-005453-4057qib7	15119	9	and	and	CC
cord-005453-4057qib7	15119	10	occurance	occurance	NN
cord-005453-4057qib7	15119	11	of	of	IN
cord-005453-4057qib7	15119	12	grade	grade	NN
cord-005453-4057qib7	15119	13	III	III	NNP
cord-005453-4057qib7	15119	14	-	-	HYPH
cord-005453-4057qib7	15119	15	IV	IV	NNP
cord-005453-4057qib7	15119	16	aGVHD	agvhd	NN
cord-005453-4057qib7	15119	17	on	on	IN
cord-005453-4057qib7	15119	18	overall	overall	JJ
cord-005453-4057qib7	15119	19	surviv	surviv	NN
cord-005453-4057qib7	15119	20	]	]	-RRB-
cord-005453-4057qib7	15120	1	Background	background	NN
cord-005453-4057qib7	15120	2	:	:	:
cord-005453-4057qib7	15120	3	1	1	CD
cord-005453-4057qib7	15120	4	.	.	.
cord-005453-4057qib7	15121	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	15121	2	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	15121	3	stem	stem	NN
cord-005453-4057qib7	15121	4	cell	cell	NN
cord-005453-4057qib7	15121	5	transplantation	transplantation	NN
cord-005453-4057qib7	15121	6	(	(	-LRB-
cord-005453-4057qib7	15121	7	SCT	SCT	NNP
cord-005453-4057qib7	15121	8	)	)	-RRB-
cord-005453-4057qib7	15121	9	offers	offer	VBZ
cord-005453-4057qib7	15121	10	the	the	DT
cord-005453-4057qib7	15121	11	chance	chance	NN
cord-005453-4057qib7	15121	12	of	of	IN
cord-005453-4057qib7	15121	13	cure	cure	NN
cord-005453-4057qib7	15121	14	for	for	IN
cord-005453-4057qib7	15121	15	patients	patient	NNS
cord-005453-4057qib7	15121	16	with	with	IN
cord-005453-4057qib7	15121	17	transfusion	transfusion	NN
cord-005453-4057qib7	15121	18	-	-	HYPH
cord-005453-4057qib7	15121	19	dependent	dependent	JJ
cord-005453-4057qib7	15121	20	thalassemia	thalassemia	NN
cord-005453-4057qib7	15121	21	(	(	-LRB-
cord-005453-4057qib7	15121	22	TDT	TDT	NNP
cord-005453-4057qib7	15121	23	)	)	-RRB-
cord-005453-4057qib7	15121	24	.	.	.
cord-005453-4057qib7	15122	1	Based	base	VBN
cord-005453-4057qib7	15122	2	on	on	IN
cord-005453-4057qib7	15122	3	the	the	DT
cord-005453-4057qib7	15122	4	non	non	JJ
cord-005453-4057qib7	15122	5	-	-	JJ
cord-005453-4057qib7	15122	6	neoplastic	neoplastic	JJ
cord-005453-4057qib7	15122	7	nature	nature	NN
cord-005453-4057qib7	15122	8	of	of	IN
cord-005453-4057qib7	15122	9	this	this	DT
cord-005453-4057qib7	15122	10	condition	condition	NN
cord-005453-4057qib7	15122	11	SCT	SCT	NNP
cord-005453-4057qib7	15122	12	approaches	approach	NNS
cord-005453-4057qib7	15122	13	urgently	urgently	RB
cord-005453-4057qib7	15122	14	require	require	VBP
cord-005453-4057qib7	15122	15	to	to	TO
cord-005453-4057qib7	15122	16	prove	prove	VB
cord-005453-4057qib7	15122	17	both	both	DT
cord-005453-4057qib7	15122	18	efficacious	efficacious	JJ
cord-005453-4057qib7	15122	19	and	and	CC
cord-005453-4057qib7	15122	20	safe	safe	JJ
cord-005453-4057qib7	15122	21	.	.	.
cord-005453-4057qib7	15123	1	Methods	method	NNS
cord-005453-4057qib7	15123	2	:	:	:
cord-005453-4057qib7	15123	3	2	2	CD
cord-005453-4057qib7	15123	4	.	.	.
cord-005453-4057qib7	15124	1	We	-PRON-	PRP
cord-005453-4057qib7	15124	2	report	report	VBP
cord-005453-4057qib7	15124	3	on	on	IN
cord-005453-4057qib7	15124	4	13	13	CD
cord-005453-4057qib7	15124	5	children	child	NNS
cord-005453-4057qib7	15124	6	,	,	,
cord-005453-4057qib7	15124	7	adolescents	adolescent	NNS
cord-005453-4057qib7	15124	8	and	and	CC
cord-005453-4057qib7	15124	9	young	young	JJ
cord-005453-4057qib7	15124	10	adults	adult	NNS
cord-005453-4057qib7	15124	11	(	(	-LRB-
cord-005453-4057qib7	15124	12	median	median	JJ
cord-005453-4057qib7	15124	13	age	age	NN
cord-005453-4057qib7	15124	14	:	:	:
cord-005453-4057qib7	15124	15	6	6	CD
cord-005453-4057qib7	15124	16	years	year	NNS
cord-005453-4057qib7	15124	17	;	;	:
cord-005453-4057qib7	15124	18	range	range	VBP
cord-005453-4057qib7	15124	19	2	2	CD
cord-005453-4057qib7	15124	20	-	-	SYM
cord-005453-4057qib7	15124	21	28	28	CD
cord-005453-4057qib7	15124	22	years	year	NNS
cord-005453-4057qib7	15124	23	)	)	-RRB-
cord-005453-4057qib7	15124	24	with	with	IN
cord-005453-4057qib7	15124	25	TDT	TDT	NNP
cord-005453-4057qib7	15124	26	receiving	receive	VBG
cord-005453-4057qib7	15124	27	SCT	SCT	NNP
cord-005453-4057qib7	15124	28	from	from	IN
cord-005453-4057qib7	15124	29	an	an	DT
cord-005453-4057qib7	15124	30	HLA	HLA	NNP
cord-005453-4057qib7	15124	31	-	-	HYPH
cord-005453-4057qib7	15124	32	matched	match	VBN
cord-005453-4057qib7	15124	33	donor	donor	NN
cord-005453-4057qib7	15124	34	(	(	-LRB-
cord-005453-4057qib7	15124	35	MUD	mud	NN
cord-005453-4057qib7	15124	36	n=8	n=8	NN
cord-005453-4057qib7	15124	37	,	,	,
cord-005453-4057qib7	15124	38	MSD	MSD	NNP
cord-005453-4057qib7	15124	39	n=3	n=3	NN
cord-005453-4057qib7	15124	40	,	,	,
cord-005453-4057qib7	15124	41	MFD	MFD	NNP
cord-005453-4057qib7	15124	42	n=2	n=2	NNS
cord-005453-4057qib7	15124	43	)	)	-RRB-
cord-005453-4057qib7	15124	44	in	in	IN
cord-005453-4057qib7	15124	45	our	-PRON-	PRP$
cord-005453-4057qib7	15124	46	center	center	NN
cord-005453-4057qib7	15124	47	from	from	IN
cord-005453-4057qib7	15124	48	2011	2011	CD
cord-005453-4057qib7	15124	49	-	-	SYM
cord-005453-4057qib7	15124	50	2017	2017	CD
cord-005453-4057qib7	15124	51	.	.	.
cord-005453-4057qib7	15125	1	All	all	DT
cord-005453-4057qib7	15125	2	patients	patient	NNS
cord-005453-4057qib7	15125	3	received	receive	VBD
cord-005453-4057qib7	15125	4	the	the	DT
cord-005453-4057qib7	15125	5	same	same	JJ
cord-005453-4057qib7	15125	6	treosulfan	treosulfan	NN
cord-005453-4057qib7	15125	7	-	-	HYPH
cord-005453-4057qib7	15125	8	based	base	VBN
cord-005453-4057qib7	15125	9	conditioning	conditioning	NN
cord-005453-4057qib7	15125	10	regimen	regimen	NN
cord-005453-4057qib7	15125	11	(	(	-LRB-
cord-005453-4057qib7	15125	12	treosulfan	treosulfan	NNP
cord-005453-4057qib7	15125	13	3x14g	3x14g	NNP
cord-005453-4057qib7	15125	14	/	/	SYM
cord-005453-4057qib7	15125	15	m2	m2	NNP
cord-005453-4057qib7	15125	16	,	,	,
cord-005453-4057qib7	15125	17	fludarabine	fludarabine	NNP
cord-005453-4057qib7	15125	18	4x40mg	4x40mg	CD
cord-005453-4057qib7	15125	19	/	/	SYM
cord-005453-4057qib7	15125	20	m2	m2	NNP
cord-005453-4057qib7	15125	21	,	,	,
cord-005453-4057qib7	15125	22	thiotepa	thiotepa	JJ
cord-005453-4057qib7	15125	23	1x8mg	1x8mg	CD
cord-005453-4057qib7	15125	24	/	/	SYM
cord-005453-4057qib7	15125	25	kg	kg	NNP
cord-005453-4057qib7	15125	26	)	)	-RRB-
cord-005453-4057qib7	15125	27	.	.	.
cord-005453-4057qib7	15126	1	GvHD	GvHD	NNP
cord-005453-4057qib7	15126	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15126	3	was	be	VBD
cord-005453-4057qib7	15126	4	based	base	VBN
cord-005453-4057qib7	15126	5	on	on	IN
cord-005453-4057qib7	15126	6	ATG	ATG	NNP
cord-005453-4057qib7	15126	7	-	-	HYPH
cord-005453-4057qib7	15126	8	Fresenius	Fresenius	NNP
cord-005453-4057qib7	15126	9	™	™	,
cord-005453-4057qib7	15126	10	(	(	-LRB-
cord-005453-4057qib7	15126	11	3x10mg	3x10mg	NNS
cord-005453-4057qib7	15126	12	/	/	SYM
cord-005453-4057qib7	15126	13	kg	kg	NNS
cord-005453-4057qib7	15126	14	,	,	,
cord-005453-4057qib7	15126	15	if	if	IN
cord-005453-4057qib7	15126	16	MUD	mud	NN
cord-005453-4057qib7	15126	17	or	or	CC
cord-005453-4057qib7	15126	18	MFD	MFD	NNP
cord-005453-4057qib7	15126	19	as	as	IN
cord-005453-4057qib7	15126	20	donor	donor	NN
cord-005453-4057qib7	15126	21	)	)	-RRB-
cord-005453-4057qib7	15126	22	,	,	,
cord-005453-4057qib7	15126	23	CSA	CSA	NNP
cord-005453-4057qib7	15126	24	(	(	-LRB-
cord-005453-4057qib7	15126	25	with	with	IN
cord-005453-4057qib7	15126	26	taper	taper	NN
cord-005453-4057qib7	15126	27	from	from	IN
cord-005453-4057qib7	15126	28	day	day	NN
cord-005453-4057qib7	15126	29	+270	+270	NNP
cord-005453-4057qib7	15126	30	)	)	-RRB-
cord-005453-4057qib7	15126	31	as	as	RB
cord-005453-4057qib7	15126	32	well	well	RB
cord-005453-4057qib7	15126	33	as	as	IN
cord-005453-4057qib7	15126	34	MTX	MTX	NNP
cord-005453-4057qib7	15126	35	(	(	-LRB-
cord-005453-4057qib7	15126	36	day	day	NN
cord-005453-4057qib7	15126	37	1,3,6,11	1,3,6,11	CD
cord-005453-4057qib7	15126	38	)	)	-RRB-
cord-005453-4057qib7	15126	39	in	in	IN
cord-005453-4057qib7	15126	40	9/13	9/13	CD
cord-005453-4057qib7	15126	41	and	and	CC
cord-005453-4057qib7	15126	42	MMF	mmf	NN
cord-005453-4057qib7	15126	43	in	in	IN
cord-005453-4057qib7	15126	44	4/13	4/13	CD
cord-005453-4057qib7	15126	45	patients	patient	NNS
cord-005453-4057qib7	15126	46	with	with	IN
cord-005453-4057qib7	15126	47	MTX	MTX	NNP
cord-005453-4057qib7	15126	48	toxicity	toxicity	NN
cord-005453-4057qib7	15126	49	,	,	,
cord-005453-4057qib7	15126	50	respectively	respectively	RB
cord-005453-4057qib7	15126	51	.	.	.
cord-005453-4057qib7	15127	1	Stem	stem	JJ
cord-005453-4057qib7	15127	2	cell	cell	NN
cord-005453-4057qib7	15127	3	source	source	NN
cord-005453-4057qib7	15127	4	was	be	VBD
cord-005453-4057qib7	15127	5	bone	bone	NN
cord-005453-4057qib7	15127	6	marrow	marrow	NN
cord-005453-4057qib7	15127	7	in	in	IN
cord-005453-4057qib7	15127	8	8	8	CD
cord-005453-4057qib7	15127	9	,	,	,
cord-005453-4057qib7	15127	10	peripheral	peripheral	JJ
cord-005453-4057qib7	15127	11	blood	blood	NN
cord-005453-4057qib7	15127	12	stem	stem	NN
cord-005453-4057qib7	15127	13	cells	cell	NNS
cord-005453-4057qib7	15127	14	in	in	IN
cord-005453-4057qib7	15127	15	4	4	CD
cord-005453-4057qib7	15127	16	and	and	CC
cord-005453-4057qib7	15127	17	cord	cord	NN
cord-005453-4057qib7	15127	18	blood	blood	NN
cord-005453-4057qib7	15127	19	in	in	IN
cord-005453-4057qib7	15127	20	1	1	CD
cord-005453-4057qib7	15127	21	patient	patient	NN
cord-005453-4057qib7	15127	22	.	.	.
cord-005453-4057qib7	15128	1	Prior	prior	RB
cord-005453-4057qib7	15128	2	to	to	IN
cord-005453-4057qib7	15128	3	transplantation	transplantation	NN
cord-005453-4057qib7	15128	4	6	6	CD
cord-005453-4057qib7	15128	5	children	child	NNS
cord-005453-4057qib7	15128	6	received	receive	VBD
cord-005453-4057qib7	15128	7	cytoreductive	cytoreductive	JJ
cord-005453-4057qib7	15128	8	treatment	treatment	NN
cord-005453-4057qib7	15128	9	with	with	IN
cord-005453-4057qib7	15128	10	azathioprine	azathioprine	NN
cord-005453-4057qib7	15128	11	,	,	,
cord-005453-4057qib7	15128	12	hydroxycarbamide	hydroxycarbamide	NN
cord-005453-4057qib7	15128	13	and	and	CC
cord-005453-4057qib7	15128	14	intensified	intensify	VBD
cord-005453-4057qib7	15128	15	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	15128	16	transfusion	transfusion	NN
cord-005453-4057qib7	15128	17	.	.	.
cord-005453-4057qib7	15129	1	Iron	iron	NN
cord-005453-4057qib7	15129	2	elimination	elimination	NN
cord-005453-4057qib7	15129	3	therapy	therapy	NN
cord-005453-4057qib7	15129	4	was	be	VBD
cord-005453-4057qib7	15129	5	carried	carry	VBN
cord-005453-4057qib7	15129	6	out	out	RP
cord-005453-4057qib7	15129	7	in	in	IN
cord-005453-4057qib7	15129	8	12/13	12/13	CD
cord-005453-4057qib7	15129	9	children	child	NNS
cord-005453-4057qib7	15129	10	with	with	IN
cord-005453-4057qib7	15129	11	deferasirox	deferasirox	NNP
cord-005453-4057qib7	15129	12	.	.	.
cord-005453-4057qib7	15130	1	Among	among	IN
cord-005453-4057qib7	15130	2	the	the	DT
cord-005453-4057qib7	15130	3	11	11	CD
cord-005453-4057qib7	15130	4	patients	patient	NNS
cord-005453-4057qib7	15130	5	with	with	IN
cord-005453-4057qib7	15130	6	available	available	JJ
cord-005453-4057qib7	15130	7	Ferris	Ferris	NNP
cord-005453-4057qib7	15130	8	-	-	HYPH
cord-005453-4057qib7	15130	9	can	can	MD
cord-005453-4057qib7	15130	10	™	™	VB
cord-005453-4057qib7	15130	11	analysis	analysis	NN
cord-005453-4057qib7	15130	12	4	4	CD
cord-005453-4057qib7	15130	13	patients	patient	NNS
cord-005453-4057qib7	15130	14	showed	show	VBD
cord-005453-4057qib7	15130	15	substantial	substantial	JJ
cord-005453-4057qib7	15130	16	liver	liver	NN
cord-005453-4057qib7	15130	17	iron	iron	NN
cord-005453-4057qib7	15130	18	overload	overload	NN
cord-005453-4057qib7	15130	19	(	(	-LRB-
cord-005453-4057qib7	15130	20	liver	liver	NN
cord-005453-4057qib7	15130	21	iron	iron	NN
cord-005453-4057qib7	15130	22	>	>	XX
cord-005453-4057qib7	15130	23	8mg	8mg	NNP
cord-005453-4057qib7	15130	24	/	/	SYM
cord-005453-4057qib7	15130	25	g	g	NN
cord-005453-4057qib7	15130	26	)	)	-RRB-
cord-005453-4057qib7	15130	27	despite	despite	IN
cord-005453-4057qib7	15130	28	intensive	intensive	JJ
cord-005453-4057qib7	15130	29	chelation	chelation	NN
cord-005453-4057qib7	15130	30	prior	prior	RB
cord-005453-4057qib7	15130	31	to	to	IN
cord-005453-4057qib7	15130	32	SCT	SCT	NNP
cord-005453-4057qib7	15130	33	.	.	.
cord-005453-4057qib7	15131	1	Results	result	NNS
cord-005453-4057qib7	15131	2	:	:	:
cord-005453-4057qib7	15131	3	3	3	CD
cord-005453-4057qib7	15131	4	.	.	.
cord-005453-4057qib7	15132	1	All	all	DT
cord-005453-4057qib7	15132	2	patients	patient	NNS
cord-005453-4057qib7	15132	3	achieved	achieve	VBD
cord-005453-4057qib7	15132	4	leukocyte	leukocyte	NN
cord-005453-4057qib7	15132	5	engraftment	engraftment	NN
cord-005453-4057qib7	15132	6	at	at	IN
cord-005453-4057qib7	15132	7	median	median	JJ
cord-005453-4057qib7	15132	8	day	day	NN
cord-005453-4057qib7	15132	9	+23	+23	CD
cord-005453-4057qib7	15133	1	(	(	-LRB-
cord-005453-4057qib7	15133	2	range	range	NNP
cord-005453-4057qib7	15133	3	15	15	CD
cord-005453-4057qib7	15133	4	-	-	SYM
cord-005453-4057qib7	15133	5	39	39	CD
cord-005453-4057qib7	15133	6	)	)	-RRB-
cord-005453-4057qib7	15133	7	,	,	,
cord-005453-4057qib7	15133	8	however	however	RB
cord-005453-4057qib7	15133	9	two	two	CD
cord-005453-4057qib7	15133	10	patients	patient	NNS
cord-005453-4057qib7	15133	11	required	require	VBD
cord-005453-4057qib7	15133	12	a	a	DT
cord-005453-4057qib7	15133	13	CD34-selected	CD34-selected	NNP
cord-005453-4057qib7	15133	14	PBSC	PBSC	NNP
cord-005453-4057qib7	15133	15	boost	boost	NN
cord-005453-4057qib7	15133	16	on	on	IN
cord-005453-4057qib7	15133	17	day	day	NN
cord-005453-4057qib7	15133	18	+	+	SYM
cord-005453-4057qib7	15133	19	36	36	CD
cord-005453-4057qib7	15133	20	and	and	CC
cord-005453-4057qib7	15133	21	day	day	NN
cord-005453-4057qib7	15133	22	+50	+50	NN
cord-005453-4057qib7	15133	23	based	base	VBN
cord-005453-4057qib7	15133	24	on	on	IN
cord-005453-4057qib7	15133	25	delayed	delay	VBN
cord-005453-4057qib7	15133	26	platelet	platelet	NN
cord-005453-4057qib7	15133	27	and/or	and/or	CC
cord-005453-4057qib7	15133	28	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	15133	29	engraftment	engraftment	NN
cord-005453-4057qib7	15133	30	.	.	.
cord-005453-4057qib7	15134	1	Nine	nine	CD
cord-005453-4057qib7	15134	2	patients	patient	NNS
cord-005453-4057qib7	15134	3	exhibited	exhibit	VBD
cord-005453-4057qib7	15134	4	full	full	JJ
cord-005453-4057qib7	15134	5	donor	donor	NN
cord-005453-4057qib7	15134	6	chimerism	chimerism	NN
cord-005453-4057qib7	15134	7	in	in	IN
cord-005453-4057qib7	15134	8	the	the	DT
cord-005453-4057qib7	15134	9	BM	BM	NNP
cord-005453-4057qib7	15134	10	at	at	IN
cord-005453-4057qib7	15134	11	day	day	NN
cord-005453-4057qib7	15134	12	+30	+30	CD
cord-005453-4057qib7	15134	13	,	,	,
cord-005453-4057qib7	15134	14	the	the	DT
cord-005453-4057qib7	15134	15	other	other	JJ
cord-005453-4057qib7	15134	16	4	4	CD
cord-005453-4057qib7	15134	17	showed	show	VBD
cord-005453-4057qib7	15134	18	mixed	mixed	JJ
cord-005453-4057qib7	15134	19	chimerism	chimerism	NN
cord-005453-4057qib7	15134	20	with	with	IN
cord-005453-4057qib7	15134	21	<	<	XX
cord-005453-4057qib7	15134	22	5	5	CD
cord-005453-4057qib7	15134	23	%	%	NN
cord-005453-4057qib7	15134	24	autologous	autologous	JJ
cord-005453-4057qib7	15134	25	cells	cell	NNS
cord-005453-4057qib7	15134	26	.	.	.
cord-005453-4057qib7	15135	1	On	on	IN
cord-005453-4057qib7	15135	2	day	day	NN
cord-005453-4057qib7	15135	3	+360	+360	NN
cord-005453-4057qib7	15135	4	peripheral	peripheral	JJ
cord-005453-4057qib7	15135	5	blood	blood	NN
cord-005453-4057qib7	15135	6	chimerism	chimerism	NN
cord-005453-4057qib7	15135	7	was	be	VBD
cord-005453-4057qib7	15135	8	complete	complete	JJ
cord-005453-4057qib7	15135	9	in	in	IN
cord-005453-4057qib7	15135	10	12/13	12/13	CD
cord-005453-4057qib7	15135	11	patients	patient	NNS
cord-005453-4057qib7	15135	12	with	with	IN
cord-005453-4057qib7	15135	13	the	the	DT
cord-005453-4057qib7	15135	14	remaining	remain	VBG
cord-005453-4057qib7	15135	15	patient	patient	NN
cord-005453-4057qib7	15135	16	exhibiting	exhibit	VBG
cord-005453-4057qib7	15135	17	stable	stable	JJ
cord-005453-4057qib7	15135	18	split	split	NN
cord-005453-4057qib7	15135	19	chimerism	chimerism	NN
cord-005453-4057qib7	15135	20	with	with	IN
cord-005453-4057qib7	15135	21	100	100	CD
cord-005453-4057qib7	15135	22	%	%	NN
cord-005453-4057qib7	15135	23	donor	donor	NN
cord-005453-4057qib7	15135	24	-	-	HYPH
cord-005453-4057qib7	15135	25	derived	derive	VBN
cord-005453-4057qib7	15135	26	erythrocytes	erythrocyte	NNS
cord-005453-4057qib7	15135	27	and	and	CC
cord-005453-4057qib7	15135	28	60	60	CD
cord-005453-4057qib7	15135	29	-	-	SYM
cord-005453-4057qib7	15135	30	80	80	CD
cord-005453-4057qib7	15135	31	%	%	NN
cord-005453-4057qib7	15135	32	autologous	autologous	JJ
cord-005453-4057qib7	15135	33	myeloid	myeloid	NN
cord-005453-4057qib7	15135	34	cells	cell	NNS
cord-005453-4057qib7	15135	35	.	.	.
cord-005453-4057qib7	15136	1	Acute	acute	JJ
cord-005453-4057qib7	15136	2	GvHD	GvHD	NNP
cord-005453-4057qib7	15136	3	was	be	VBD
cord-005453-4057qib7	15136	4	observed	observe	VBN
cord-005453-4057qib7	15136	5	in	in	IN
cord-005453-4057qib7	15136	6	three	three	CD
cord-005453-4057qib7	15136	7	patients	patient	NNS
cord-005453-4057qib7	15136	8	(	(	-LRB-
cord-005453-4057qib7	15136	9	grade	grade	NN
cord-005453-4057qib7	15136	10	2	2	CD
cord-005453-4057qib7	15136	11	:	:	:
cord-005453-4057qib7	15136	12	n=1	n=1	UH
cord-005453-4057qib7	15136	13	,	,	,
cord-005453-4057qib7	15136	14	grade	grade	NN
cord-005453-4057qib7	15136	15	3	3	CD
cord-005453-4057qib7	15136	16	:	:	:
cord-005453-4057qib7	15136	17	n=2	n=2	NNS
cord-005453-4057qib7	15136	18	)	)	-RRB-
cord-005453-4057qib7	15136	19	.	.	.
cord-005453-4057qib7	15137	1	However	however	RB
cord-005453-4057qib7	15137	2	,	,	,
cord-005453-4057qib7	15137	3	all	all	DT
cord-005453-4057qib7	15137	4	patients	patient	NNS
cord-005453-4057qib7	15137	5	responded	respond	VBD
cord-005453-4057qib7	15137	6	to	to	IN
cord-005453-4057qib7	15137	7	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	15137	8	therapy	therapy	NN
cord-005453-4057qib7	15137	9	with	with	IN
cord-005453-4057qib7	15137	10	steroids	steroid	NNS
cord-005453-4057qib7	15137	11	±	±	NNP
cord-005453-4057qib7	15137	12	ECP	ECP	NNP
cord-005453-4057qib7	15137	13	and	and	CC
cord-005453-4057qib7	15137	14	re	re	NN
cord-005453-4057qib7	15137	15	-	-	NN
cord-005453-4057qib7	15137	16	initiation	initiation	NN
cord-005453-4057qib7	15137	17	of	of	IN
cord-005453-4057qib7	15137	18	CNI	CNI	NNP
cord-005453-4057qib7	15137	19	(	(	-LRB-
cord-005453-4057qib7	15137	20	n=1	n=1	NNP
cord-005453-4057qib7	15137	21	)	)	-RRB-
cord-005453-4057qib7	15137	22	.	.	.
cord-005453-4057qib7	15138	1	One	one	CD
cord-005453-4057qib7	15138	2	patient	patient	NN
cord-005453-4057qib7	15138	3	suffered	suffer	VBD
cord-005453-4057qib7	15138	4	Background	background	NN
cord-005453-4057qib7	15138	5	:	:	:
cord-005453-4057qib7	15138	6	Patients	patient	NNS
cord-005453-4057qib7	15138	7	with	with	IN
cord-005453-4057qib7	15138	8	relapsed	relapsed	JJ
cord-005453-4057qib7	15138	9	or	or	CC
cord-005453-4057qib7	15138	10	refractory	refractory	JJ
cord-005453-4057qib7	15138	11	acute	acute	JJ
cord-005453-4057qib7	15138	12	myeloid	myeloid	NN
cord-005453-4057qib7	15138	13	leukaemia	leukaemia	NN
cord-005453-4057qib7	15138	14	(	(	-LRB-
cord-005453-4057qib7	15138	15	AML	AML	NNP
cord-005453-4057qib7	15138	16	)	)	-RRB-
cord-005453-4057qib7	15138	17	have	have	VBP
cord-005453-4057qib7	15138	18	a	a	DT
cord-005453-4057qib7	15138	19	poor	poor	JJ
cord-005453-4057qib7	15138	20	prognosis	prognosis	NN
cord-005453-4057qib7	15138	21	.	.	.
cord-005453-4057qib7	15139	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	15139	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15139	3	stem	stem	NN
cord-005453-4057qib7	15139	4	cell	cell	NN
cord-005453-4057qib7	15139	5	transplantation	transplantation	NN
cord-005453-4057qib7	15139	6	is	be	VBZ
cord-005453-4057qib7	15139	7	the	the	DT
cord-005453-4057qib7	15139	8	only	only	JJ
cord-005453-4057qib7	15139	9	curative	curative	JJ
cord-005453-4057qib7	15139	10	option	option	NN
cord-005453-4057qib7	15139	11	.	.	.
cord-005453-4057qib7	15140	1	However	however	RB
cord-005453-4057qib7	15140	2	,	,	,
cord-005453-4057qib7	15140	3	allogeneic	allogeneic	IN
cord-005453-4057qib7	15140	4	transplantation	transplantation	NN
cord-005453-4057qib7	15140	5	with	with	IN
cord-005453-4057qib7	15140	6	active	active	JJ
cord-005453-4057qib7	15140	7	leukemia	leukemia	NN
cord-005453-4057qib7	15140	8	failed	fail	VBD
cord-005453-4057qib7	15140	9	to	to	TO
cord-005453-4057qib7	15140	10	improve	improve	VB
cord-005453-4057qib7	15140	11	significantly	significantly	RB
cord-005453-4057qib7	15140	12	the	the	DT
cord-005453-4057qib7	15140	13	longterm	longterm	JJ
cord-005453-4057qib7	15140	14	outcome	outcome	NN
cord-005453-4057qib7	15140	15	.	.	.
cord-005453-4057qib7	15141	1	To	to	TO
cord-005453-4057qib7	15141	2	improve	improve	VB
cord-005453-4057qib7	15141	3	the	the	DT
cord-005453-4057qib7	15141	4	outcome	outcome	NN
cord-005453-4057qib7	15141	5	of	of	IN
cord-005453-4057qib7	15141	6	allo	allo	NN
cord-005453-4057qib7	15141	7	-	-	HYPH
cord-005453-4057qib7	15141	8	HSCT	HSCT	NNP
cord-005453-4057qib7	15141	9	in	in	IN
cord-005453-4057qib7	15141	10	such	such	JJ
cord-005453-4057qib7	15141	11	high	high	JJ
cord-005453-4057qib7	15141	12	-	-	HYPH
cord-005453-4057qib7	15141	13	risk	risk	NN
cord-005453-4057qib7	15141	14	and	and	CC
cord-005453-4057qib7	15141	15	refractory	refractory	JJ
cord-005453-4057qib7	15141	16	patients	patient	NNS
cord-005453-4057qib7	15141	17	,	,	,
cord-005453-4057qib7	15141	18	sequential	sequential	JJ
cord-005453-4057qib7	15141	19	schedule	schedule	NN
cord-005453-4057qib7	15141	20	of	of	IN
cord-005453-4057qib7	15141	21	cytoreduction	cytoreduction	NN
cord-005453-4057qib7	15141	22	therapy	therapy	NN
cord-005453-4057qib7	15141	23	followed	follow	VBN
cord-005453-4057qib7	15141	24	by	by	IN
cord-005453-4057qib7	15141	25	nonmyeloablative	nonmyeloablative	JJ
cord-005453-4057qib7	15141	26	conditioning	conditioning	NN
cord-005453-4057qib7	15141	27	has	have	VBZ
cord-005453-4057qib7	15141	28	been	be	VBN
cord-005453-4057qib7	15141	29	developed	develop	VBN
cord-005453-4057qib7	15141	30	.	.	.
cord-005453-4057qib7	15142	1	Methods	method	NNS
cord-005453-4057qib7	15142	2	:	:	:
cord-005453-4057qib7	15142	3	To	to	TO
cord-005453-4057qib7	15142	4	evaluate	evaluate	VB
cord-005453-4057qib7	15142	5	the	the	DT
cord-005453-4057qib7	15142	6	outcome	outcome	NN
cord-005453-4057qib7	15142	7	of	of	IN
cord-005453-4057qib7	15142	8	sequential	sequential	JJ
cord-005453-4057qib7	15142	9	intensified	intensify	VBN
cord-005453-4057qib7	15142	10	conditioning	conditioning	NN
cord-005453-4057qib7	15142	11	regimen	regimen	NN
cord-005453-4057qib7	15142	12	followed	follow	VBN
cord-005453-4057qib7	15142	13	by	by	IN
cord-005453-4057qib7	15142	14	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15142	15	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15142	16	stem	stem	NN
cord-005453-4057qib7	15142	17	cell	cell	NN
cord-005453-4057qib7	15142	18	transplantation	transplantation	NN
cord-005453-4057qib7	15142	19	(	(	-LRB-
cord-005453-4057qib7	15142	20	allo	allo	NN
cord-005453-4057qib7	15142	21	-	-	HYPH
cord-005453-4057qib7	15142	22	HSCT	HSCT	NNP
cord-005453-4057qib7	15142	23	)	)	-RRB-
cord-005453-4057qib7	15142	24	for	for	IN
cord-005453-4057qib7	15142	25	refractory	refractory	JJ
cord-005453-4057qib7	15142	26	acute	acute	JJ
cord-005453-4057qib7	15142	27	myeloid	myeloid	NN
cord-005453-4057qib7	15142	28	leukemia	leukemia	NN
cord-005453-4057qib7	15142	29	(	(	-LRB-
cord-005453-4057qib7	15142	30	AML	AML	NNP
cord-005453-4057qib7	15142	31	)	)	-RRB-
cord-005453-4057qib7	15142	32	.	.	.
cord-005453-4057qib7	15143	1	Results	result	NNS
cord-005453-4057qib7	15143	2	:	:	:
cord-005453-4057qib7	15144	1	A	a	DT
cord-005453-4057qib7	15144	2	total	total	NN
cord-005453-4057qib7	15144	3	of	of	IN
cord-005453-4057qib7	15144	4	20	20	CD
cord-005453-4057qib7	15144	5	patients	patient	NNS
cord-005453-4057qib7	15144	6	with	with	IN
cord-005453-4057qib7	15144	7	primary	primary	JJ
cord-005453-4057qib7	15144	8	or	or	CC
cord-005453-4057qib7	15144	9	secondary	secondary	JJ
cord-005453-4057qib7	15144	10	refractory	refractory	JJ
cord-005453-4057qib7	15144	11	AML	AML	NNP
cord-005453-4057qib7	15144	12	transplanted	transplant	VBN
cord-005453-4057qib7	15144	13	between	between	IN
cord-005453-4057qib7	15144	14	June	June	NNP
cord-005453-4057qib7	15144	15	2011	2011	CD
cord-005453-4057qib7	15144	16	to	to	IN
cord-005453-4057qib7	15144	17	July	July	NNP
cord-005453-4057qib7	15144	18	2018	2018	CD
cord-005453-4057qib7	15144	19	were	be	VBD
cord-005453-4057qib7	15144	20	included	include	VBN
cord-005453-4057qib7	15144	21	.	.	.
cord-005453-4057qib7	15145	1	Refractoriness	Refractoriness	NNP
cord-005453-4057qib7	15145	2	was	be	VBD
cord-005453-4057qib7	15145	3	defined	define	VBN
cord-005453-4057qib7	15145	4	as	as	IN
cord-005453-4057qib7	15145	5	primary	primary	JJ
cord-005453-4057qib7	15145	6	induction	induction	NN
cord-005453-4057qib7	15145	7	failure	failure	NN
cord-005453-4057qib7	15145	8	,	,	,
cord-005453-4057qib7	15145	9	relapse	relapse	NN
cord-005453-4057qib7	15145	10	within	within	IN
cord-005453-4057qib7	15145	11	6	6	CD
cord-005453-4057qib7	15145	12	months	month	NNS
cord-005453-4057qib7	15145	13	from	from	IN
cord-005453-4057qib7	15145	14	induction/	induction/	CD
cord-005453-4057qib7	15145	15	consolidation	consolidation	NN
cord-005453-4057qib7	15145	16	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15145	17	or	or	CC
cord-005453-4057qib7	15145	18	second	second	JJ
cord-005453-4057qib7	15145	19	relapse	relapse	NN
cord-005453-4057qib7	15145	20	.	.	.
cord-005453-4057qib7	15146	1	Median	median	JJ
cord-005453-4057qib7	15146	2	age	age	NN
cord-005453-4057qib7	15146	3	is	be	VBZ
cord-005453-4057qib7	15146	4	39	39	CD
cord-005453-4057qib7	15146	5	years	year	NNS
cord-005453-4057qib7	15146	6	(	(	-LRB-
cord-005453-4057qib7	15146	7	1	1	CD
cord-005453-4057qib7	15146	8	to	to	IN
cord-005453-4057qib7	15146	9	61	61	CD
cord-005453-4057qib7	15146	10	)	)	-RRB-
cord-005453-4057qib7	15146	11	.	.	.
cord-005453-4057qib7	15147	1	The	the	DT
cord-005453-4057qib7	15147	2	salvage	salvage	NN
cord-005453-4057qib7	15147	3	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15147	4	administered	administer	VBN
cord-005453-4057qib7	15147	5	was	be	VBD
cord-005453-4057qib7	15147	6	FLAG	FLAG	NNP
cord-005453-4057qib7	15147	7	-	-	HYPH
cord-005453-4057qib7	15147	8	IDA	IDA	NNP
cord-005453-4057qib7	15147	9	.	.	.
cord-005453-4057qib7	15148	1	Two	two	CD
cord-005453-4057qib7	15148	2	patients	patient	NNS
cord-005453-4057qib7	15148	3	did	do	VBD
cord-005453-4057qib7	15148	4	not	not	RB
cord-005453-4057qib7	15148	5	receive	receive	VB
cord-005453-4057qib7	15148	6	intensive	intensive	JJ
cord-005453-4057qib7	15148	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15148	8	because	because	IN
cord-005453-4057qib7	15148	9	of	of	IN
cord-005453-4057qib7	15148	10	no	no	DT
cord-005453-4057qib7	15148	11	recovery	recovery	NN
cord-005453-4057qib7	15148	12	after	after	IN
cord-005453-4057qib7	15148	13	induction	induction	NN
cord-005453-4057qib7	15148	14	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15148	15	.	.	.
cord-005453-4057qib7	15149	1	Seven	seven	CD
cord-005453-4057qib7	15149	2	days	day	NNS
cord-005453-4057qib7	15149	3	after	after	IN
cord-005453-4057qib7	15149	4	the	the	DT
cord-005453-4057qib7	15149	5	end	end	NN
cord-005453-4057qib7	15149	6	of	of	IN
cord-005453-4057qib7	15149	7	FLAG	FLAG	NNP
cord-005453-4057qib7	15149	8	-	-	HYPH
cord-005453-4057qib7	15149	9	IDA	IDA	NNP
cord-005453-4057qib7	15149	10	,	,	,
cord-005453-4057qib7	15149	11	a	a	DT
cord-005453-4057qib7	15149	12	reduced	reduce	VBN
cord-005453-4057qib7	15149	13	intensity	intensity	NN
cord-005453-4057qib7	15149	14	conditioning	conditioning	NN
cord-005453-4057qib7	15149	15	consisting	consist	VBG
cord-005453-4057qib7	15149	16	of	of	IN
cord-005453-4057qib7	15149	17	fludarabine,60	fludarabine,60	NNP
cord-005453-4057qib7	15149	18	mg	mg	NNP
cord-005453-4057qib7	15149	19	/	/	SYM
cord-005453-4057qib7	15149	20	m2	m2	NNP
cord-005453-4057qib7	15149	21	,	,	,
cord-005453-4057qib7	15149	22	thiotepa	thiotepa	JJ
cord-005453-4057qib7	15149	23	,	,	,
cord-005453-4057qib7	15149	24	5mg	5mg	NN
cord-005453-4057qib7	15149	25	/	/	SYM
cord-005453-4057qib7	15149	26	kg	kg	NN
cord-005453-4057qib7	15149	27	and	and	CC
cord-005453-4057qib7	15149	28	busulfan	busulfan	NN
cord-005453-4057qib7	15150	1	6,4	6,4	CD
cord-005453-4057qib7	15151	1	mg	mg	NNP
cord-005453-4057qib7	15151	2	/	/	SYM
cord-005453-4057qib7	15151	3	kg	kg	NNP
cord-005453-4057qib7	15151	4	i.v	i.v	NNP
cord-005453-4057qib7	15151	5	.	.	.
cord-005453-4057qib7	15152	1	(	(	-LRB-
cord-005453-4057qib7	15152	2	n=12	n=12	NNP
cord-005453-4057qib7	15152	3	)	)	-RRB-
cord-005453-4057qib7	15152	4	for	for	IN
cord-005453-4057qib7	15152	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15152	6	donors	donor	NNS
cord-005453-4057qib7	15152	7	or	or	CC
cord-005453-4057qib7	15152	8	fludarabine	fludarabine	NN
cord-005453-4057qib7	15152	9	plus	plus	CC
cord-005453-4057qib7	15152	10	busulfan	busulfan	NN
cord-005453-4057qib7	15152	11	(	(	-LRB-
cord-005453-4057qib7	15152	12	n=8	n=8	NN
cord-005453-4057qib7	15152	13	)	)	-RRB-
cord-005453-4057qib7	15152	14	for	for	IN
cord-005453-4057qib7	15152	15	HLA	HLA	NNP
cord-005453-4057qib7	15152	16	identical	identical	JJ
cord-005453-4057qib7	15152	17	sibling	sibling	NN
cord-005453-4057qib7	15152	18	or	or	CC
cord-005453-4057qib7	15152	19	unrelated	unrelated	JJ
cord-005453-4057qib7	15152	20	donors	donor	NNS
cord-005453-4057qib7	15152	21	was	be	VBD
cord-005453-4057qib7	15152	22	administered	administer	VBN
cord-005453-4057qib7	15152	23	.	.	.
cord-005453-4057qib7	15153	1	Graft	graft	NN
cord-005453-4057qib7	15153	2	-	-	HYPH
cord-005453-4057qib7	15153	3	versus	versus	IN
cord-005453-4057qib7	15153	4	-	-	HYPH
cord-005453-4057qib7	15153	5	host	host	NN
cord-005453-4057qib7	15153	6	disease	disease	NN
cord-005453-4057qib7	15153	7	(	(	-LRB-
cord-005453-4057qib7	15153	8	GVHD	GVHD	NNP
cord-005453-4057qib7	15153	9	)	)	-RRB-
cord-005453-4057qib7	15153	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15153	11	consisted	consist	VBD
cord-005453-4057qib7	15153	12	of	of	IN
cord-005453-4057qib7	15153	13	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	15153	14	and	and	CC
cord-005453-4057qib7	15153	15	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	15153	16	mofetil	mofetil	NNP
cord-005453-4057qib7	15153	17	.	.	.
cord-005453-4057qib7	15154	1	The	the	DT
cord-005453-4057qib7	15154	2	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	15154	3	was	be	VBD
cord-005453-4057qib7	15154	4	withdrawn	withdraw	VBN
cord-005453-4057qib7	15154	5	at	at	IN
cord-005453-4057qib7	15154	6	day	day	NN
cord-005453-4057qib7	15154	7	+35	+35	CD
cord-005453-4057qib7	15154	8	post	post	NN
cord-005453-4057qib7	15154	9	-	-	NN
cord-005453-4057qib7	15154	10	transplantation	transplantation	NN
cord-005453-4057qib7	15154	11	and	and	CC
cord-005453-4057qib7	15154	12	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	15154	13	at	at	IN
cord-005453-4057qib7	15154	14	day	day	NN
cord-005453-4057qib7	15154	15	+100	+100	NNS
cord-005453-4057qib7	15154	16	.	.	.
cord-005453-4057qib7	15155	1	Donor	donor	NN
cord-005453-4057qib7	15155	2	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	15155	3	(	(	-LRB-
cord-005453-4057qib7	15155	4	DLI	DLI	NNP
cord-005453-4057qib7	15155	5	)	)	-RRB-
cord-005453-4057qib7	15155	6	were	be	VBD
cord-005453-4057qib7	15155	7	infused	infuse	VBN
cord-005453-4057qib7	15155	8	in	in	IN
cord-005453-4057qib7	15155	9	patients	patient	NNS
cord-005453-4057qib7	15155	10	without	without	IN
cord-005453-4057qib7	15155	11	aGVHD	aGVHD	NNP
cord-005453-4057qib7	15155	12	at	at	IN
cord-005453-4057qib7	15155	13	Day	day	NN
cord-005453-4057qib7	15155	14	+120	+120	NNP
cord-005453-4057qib7	15155	15	post	post	NN
cord-005453-4057qib7	15155	16	-	-	NN
cord-005453-4057qib7	15155	17	transplantation	transplantation	NN
cord-005453-4057qib7	15155	18	.	.	.
cord-005453-4057qib7	15156	1	Seventeen	seventeen	CD
cord-005453-4057qib7	15156	2	patients	patient	NNS
cord-005453-4057qib7	15156	3	achieved	achieve	VBD
cord-005453-4057qib7	15156	4	complete	complete	JJ
cord-005453-4057qib7	15156	5	donor	donor	NN
cord-005453-4057qib7	15156	6	chimerism	chimerism	NN
cord-005453-4057qib7	15156	7	,	,	,
cord-005453-4057qib7	15156	8	3	3	CD
cord-005453-4057qib7	15156	9	patients	patient	NNS
cord-005453-4057qib7	15156	10	progressed	progress	VBD
cord-005453-4057qib7	15156	11	early	early	JJ
cord-005453-4057qib7	15156	12	and	and	CC
cord-005453-4057qib7	15156	13	1	1	CD
cord-005453-4057qib7	15156	14	patient	patient	NN
cord-005453-4057qib7	15156	15	died	die	VBD
cord-005453-4057qib7	15156	16	before	before	IN
cord-005453-4057qib7	15156	17	engraftment	engraftment	NN
cord-005453-4057qib7	15156	18	.	.	.
cord-005453-4057qib7	15157	1	One	one	CD
cord-005453-4057qib7	15157	2	of	of	IN
cord-005453-4057qib7	15157	3	the	the	DT
cord-005453-4057qib7	15157	4	patients	patient	NNS
cord-005453-4057qib7	15157	5	which	which	WDT
cord-005453-4057qib7	15157	6	recovery	recovery	NN
cord-005453-4057qib7	15157	7	was	be	VBD
cord-005453-4057qib7	15157	8	with	with	IN
cord-005453-4057qib7	15157	9	persistent	persistent	JJ
cord-005453-4057qib7	15157	10	leukemia	leukemia	NN
cord-005453-4057qib7	15157	11	reached	reach	VBD
cord-005453-4057qib7	15157	12	donor	donor	NN
cord-005453-4057qib7	15157	13	chimerism	chimerism	NN
cord-005453-4057qib7	15157	14	after	after	IN
cord-005453-4057qib7	15157	15	immunosupression	immunosupression	NN
cord-005453-4057qib7	15157	16	discontinuation	discontinuation	NN
cord-005453-4057qib7	15157	17	.	.	.
cord-005453-4057qib7	15158	1	Ten	ten	CD
cord-005453-4057qib7	15158	2	patients	patient	NNS
cord-005453-4057qib7	15158	3	are	be	VBP
cord-005453-4057qib7	15158	4	alive	alive	JJ
cord-005453-4057qib7	15158	5	in	in	IN
cord-005453-4057qib7	15158	6	complete	complete	JJ
cord-005453-4057qib7	15158	7	remission	remission	NN
cord-005453-4057qib7	15158	8	.	.	.
cord-005453-4057qib7	15159	1	Median	median	JJ
cord-005453-4057qib7	15159	2	follow	follow	NN
cord-005453-4057qib7	15159	3	-	-	HYPH
cord-005453-4057qib7	15159	4	up	up	NN
cord-005453-4057qib7	15159	5	of	of	IN
cord-005453-4057qib7	15159	6	survivors	survivor	NNS
cord-005453-4057qib7	15159	7	is	be	VBZ
cord-005453-4057qib7	15159	8	28	28	CD
cord-005453-4057qib7	15159	9	months	month	NNS
cord-005453-4057qib7	15160	1	(	(	-LRB-
cord-005453-4057qib7	15160	2	range	range	NN
cord-005453-4057qib7	15160	3	:	:	:
cord-005453-4057qib7	15160	4	6	6	CD
cord-005453-4057qib7	15160	5	-	-	SYM
cord-005453-4057qib7	15160	6	43	43	CD
cord-005453-4057qib7	15160	7	)	)	-RRB-
cord-005453-4057qib7	15160	8	.	.	.
cord-005453-4057qib7	15161	1	Five	five	CD
cord-005453-4057qib7	15161	2	patients	patient	NNS
cord-005453-4057qib7	15161	3	died	die	VBD
cord-005453-4057qib7	15161	4	of	of	IN
cord-005453-4057qib7	15161	5	leukemic	leukemic	JJ
cord-005453-4057qib7	15161	6	progression	progression	NN
cord-005453-4057qib7	15161	7	,	,	,
cord-005453-4057qib7	15161	8	3	3	CD
cord-005453-4057qib7	15161	9	as	as	IN
cord-005453-4057qib7	15161	10	result	result	NN
cord-005453-4057qib7	15161	11	of	of	IN
cord-005453-4057qib7	15161	12	GVHD	GVHD	NNP
cord-005453-4057qib7	15161	13	and	and	CC
cord-005453-4057qib7	15161	14	1	1	CD
cord-005453-4057qib7	15161	15	suffered	suffer	VBD
cord-005453-4057qib7	15161	16	intracranial	intracranial	JJ
cord-005453-4057qib7	15161	17	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	15161	18	.	.	.
cord-005453-4057qib7	15162	1	Five	five	CD
cord-005453-4057qib7	15162	2	patients	patient	NNS
cord-005453-4057qib7	15162	3	received	receive	VBD
cord-005453-4057qib7	15162	4	prophylactic	prophylactic	JJ
cord-005453-4057qib7	15162	5	DLI	DLI	NNP
cord-005453-4057qib7	15162	6	.	.	.
cord-005453-4057qib7	15163	1	The	the	DT
cord-005453-4057qib7	15163	2	incidence	incidence	NN
cord-005453-4057qib7	15163	3	of	of	IN
cord-005453-4057qib7	15163	4	acute	acute	JJ
cord-005453-4057qib7	15163	5	moderate	moderate	JJ
cord-005453-4057qib7	15163	6	-	-	HYPH
cord-005453-4057qib7	15163	7	severe	severe	JJ
cord-005453-4057qib7	15163	8	GVHD	GVHD	NNP
cord-005453-4057qib7	15163	9	and	and	CC
cord-005453-4057qib7	15163	10	moderate	moderate	JJ
cord-005453-4057qib7	15163	11	-	-	HYPH
cord-005453-4057qib7	15163	12	severe	severe	JJ
cord-005453-4057qib7	15163	13	chronic	chronic	JJ
cord-005453-4057qib7	15163	14	GVHD	GVHD	NNP
cord-005453-4057qib7	15163	15	were	be	VBD
cord-005453-4057qib7	15163	16	70	70	CD
cord-005453-4057qib7	15163	17	%	%	NN
cord-005453-4057qib7	15163	18	(	(	-LRB-
cord-005453-4057qib7	15163	19	n=14	n=14	NNP
cord-005453-4057qib7	15163	20	)	)	-RRB-
cord-005453-4057qib7	15163	21	and	and	CC
cord-005453-4057qib7	15163	22	50	50	CD
cord-005453-4057qib7	15163	23	%	%	NN
cord-005453-4057qib7	15163	24	(	(	-LRB-
cord-005453-4057qib7	15163	25	n=7	n=7	NNS
cord-005453-4057qib7	15163	26	)	)	-RRB-
cord-005453-4057qib7	15163	27	,	,	,
cord-005453-4057qib7	15163	28	respectively	respectively	RB
cord-005453-4057qib7	15163	29	.	.	.
cord-005453-4057qib7	15164	1	The	the	DT
cord-005453-4057qib7	15164	2	non	non	JJ
cord-005453-4057qib7	15164	3	-	-	JJ
cord-005453-4057qib7	15164	4	relapse	relapse	JJ
cord-005453-4057qib7	15164	5	mortality	mortality	NN
cord-005453-4057qib7	15164	6	was	be	VBD
cord-005453-4057qib7	15164	7	21	21	CD
cord-005453-4057qib7	15164	8	%	%	NN
cord-005453-4057qib7	15164	9	(	(	-LRB-
cord-005453-4057qib7	15164	10	n=4	n=4	NNP
cord-005453-4057qib7	15164	11	)	)	-RRB-
cord-005453-4057qib7	15164	12	,	,	,
cord-005453-4057qib7	15164	13	mainly	mainly	RB
cord-005453-4057qib7	15164	14	due	due	JJ
cord-005453-4057qib7	15164	15	to	to	IN
cord-005453-4057qib7	15164	16	acute	acute	JJ
cord-005453-4057qib7	15164	17	GVHD	GVHD	NNP
cord-005453-4057qib7	15164	18	(	(	-LRB-
cord-005453-4057qib7	15164	19	n=3	n=3	NN
cord-005453-4057qib7	15164	20	)	)	-RRB-
cord-005453-4057qib7	15164	21	.	.	.
cord-005453-4057qib7	15165	1	The	the	DT
cord-005453-4057qib7	15165	2	2-year	2-year	CD
cord-005453-4057qib7	15165	3	cumulative	cumulative	JJ
cord-005453-4057qib7	15165	4	incidence	incidence	NN
cord-005453-4057qib7	15165	5	of	of	IN
cord-005453-4057qib7	15165	6	relapse	relapse	NN
cord-005453-4057qib7	15165	7	posttransplantation	posttransplantation	NNP
cord-005453-4057qib7	15165	8	was	be	VBD
cord-005453-4057qib7	15165	9	36.8	36.8	CD
cord-005453-4057qib7	15165	10	%	%	NN
cord-005453-4057qib7	15165	11	.	.	.
cord-005453-4057qib7	15166	1	The	the	DT
cord-005453-4057qib7	15166	2	probability	probability	NN
cord-005453-4057qib7	15166	3	of	of	IN
cord-005453-4057qib7	15166	4	relapse	relapse	NN
cord-005453-4057qib7	15166	5	was	be	VBD
cord-005453-4057qib7	15166	6	57%±13	57%±13	CD
cord-005453-4057qib7	15166	7	%	%	NN
cord-005453-4057qib7	15166	8	.	.	.
cord-005453-4057qib7	15167	1	The	the	DT
cord-005453-4057qib7	15167	2	2-year	2-year	CD
cord-005453-4057qib7	15167	3	OS	OS	NNP
cord-005453-4057qib7	15167	4	and	and	CC
cord-005453-4057qib7	15167	5	DFS	DFS	NNP
cord-005453-4057qib7	15167	6	were	be	VBD
cord-005453-4057qib7	15167	7	46	46	CD
cord-005453-4057qib7	15167	8	%	%	NN
cord-005453-4057qib7	15167	9	±	±	CD
cord-005453-4057qib7	15167	10	12	12	CD
cord-005453-4057qib7	15167	11	%	%	NN
cord-005453-4057qib7	15167	12	and	and	CC
cord-005453-4057qib7	15167	13	38	38	CD
cord-005453-4057qib7	15167	14	%	%	NN
cord-005453-4057qib7	15167	15	±	±	CD
cord-005453-4057qib7	15167	16	12	12	CD
cord-005453-4057qib7	15167	17	%	%	NN
cord-005453-4057qib7	15167	18	Conclusions	conclusion	NNS
cord-005453-4057qib7	15167	19	:	:	:
cord-005453-4057qib7	15168	1	The	the	DT
cord-005453-4057qib7	15168	2	strategy	strategy	NN
cord-005453-4057qib7	15168	3	of	of	IN
cord-005453-4057qib7	15168	4	sequential	sequential	JJ
cord-005453-4057qib7	15168	5	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15168	6	followed	follow	VBN
cord-005453-4057qib7	15168	7	by	by	IN
cord-005453-4057qib7	15168	8	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	15168	9	±	±	NNP
cord-005453-4057qib7	15168	10	prophylactic	prophylactic	JJ
cord-005453-4057qib7	15168	11	DLI	DLI	NNP
cord-005453-4057qib7	15168	12	has	have	VBZ
cord-005453-4057qib7	15168	13	an	an	DT
cord-005453-4057qib7	15168	14	acceptable	acceptable	JJ
cord-005453-4057qib7	15168	15	toxicity	toxicity	NN
cord-005453-4057qib7	15168	16	profile	profile	NN
cord-005453-4057qib7	15168	17	and	and	CC
cord-005453-4057qib7	15168	18	improves	improve	VBZ
cord-005453-4057qib7	15168	19	both	both	PDT
cord-005453-4057qib7	15168	20	the	the	DT
cord-005453-4057qib7	15168	21	relapse	relapse	NN
cord-005453-4057qib7	15168	22	rate	rate	NN
cord-005453-4057qib7	15168	23	and	and	CC
cord-005453-4057qib7	15168	24	the	the	DT
cord-005453-4057qib7	15168	25	survival	survival	NN
cord-005453-4057qib7	15168	26	for	for	IN
cord-005453-4057qib7	15168	27	refractory	refractory	JJ
cord-005453-4057qib7	15168	28	AML	AML	NNP
cord-005453-4057qib7	15168	29	patients	patient	NNS
cord-005453-4057qib7	15168	30	.	.	.
cord-005453-4057qib7	15169	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15169	2	:	:	:
cord-005453-4057qib7	15169	3	Nothing	nothing	NN
cord-005453-4057qib7	15169	4	to	to	TO
cord-005453-4057qib7	15169	5	declare	declare	VB
cord-005453-4057qib7	15169	6	Background	background	NN
cord-005453-4057qib7	15169	7	:	:	:
cord-005453-4057qib7	15170	1	The	the	DT
cord-005453-4057qib7	15170	2	concept	concept	NN
cord-005453-4057qib7	15170	3	of	of	IN
cord-005453-4057qib7	15170	4	immunological	immunological	JJ
cord-005453-4057qib7	15170	5	intervention	intervention	NN
cord-005453-4057qib7	15170	6	to	to	TO
cord-005453-4057qib7	15170	7	prevent	prevent	VB
cord-005453-4057qib7	15170	8	relapse	relapse	NN
cord-005453-4057qib7	15170	9	after	after	IN
cord-005453-4057qib7	15170	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15170	11	stem	stem	NN
cord-005453-4057qib7	15170	12	cell	cell	NN
cord-005453-4057qib7	15170	13	transplantation	transplantation	NN
cord-005453-4057qib7	15170	14	is	be	VBZ
cord-005453-4057qib7	15170	15	associated	associate	VBN
cord-005453-4057qib7	15170	16	with	with	IN
cord-005453-4057qib7	15170	17	the	the	DT
cord-005453-4057qib7	15170	18	assessment	assessment	NN
cord-005453-4057qib7	15170	19	of	of	IN
cord-005453-4057qib7	15170	20	the	the	DT
cord-005453-4057qib7	15170	21	chimerism	chimerism	NN
cord-005453-4057qib7	15170	22	status	status	NN
cord-005453-4057qib7	15170	23	.	.	.
cord-005453-4057qib7	15171	1	Distinguishing	distinguish	VBG
cord-005453-4057qib7	15172	1	patient	patient	JJ
cord-005453-4057qib7	15172	2	and	and	CC
cord-005453-4057qib7	15172	3	donor	donor	NN
cord-005453-4057qib7	15172	4	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	15172	5	is	be	VBZ
cord-005453-4057qib7	15172	6	usually	usually	RB
cord-005453-4057qib7	15172	7	performed	perform	VBN
cord-005453-4057qib7	15172	8	by	by	IN
cord-005453-4057qib7	15172	9	STR	STR	NNP
cord-005453-4057qib7	15172	10	-	-	HYPH
cord-005453-4057qib7	15172	11	PCR	PCR	NNP
cord-005453-4057qib7	15172	12	,	,	,
cord-005453-4057qib7	15172	13	a	a	DT
cord-005453-4057qib7	15172	14	powerful	powerful	JJ
cord-005453-4057qib7	15172	15	method	method	NN
cord-005453-4057qib7	15172	16	developed	develop	VBN
cord-005453-4057qib7	15172	17	for	for	IN
cord-005453-4057qib7	15172	18	forensic	forensic	JJ
cord-005453-4057qib7	15172	19	purposes	purpose	NNS
cord-005453-4057qib7	15172	20	.	.	.
cord-005453-4057qib7	15173	1	However	however	RB
cord-005453-4057qib7	15173	2	,	,	,
cord-005453-4057qib7	15173	3	this	this	DT
cord-005453-4057qib7	15173	4	method	method	NN
cord-005453-4057qib7	15173	5	shows	show	VBZ
cord-005453-4057qib7	15173	6	restrictions	restriction	NNS
cord-005453-4057qib7	15173	7	with	with	IN
cord-005453-4057qib7	15173	8	respect	respect	NN
cord-005453-4057qib7	15173	9	to	to	IN
cord-005453-4057qib7	15173	10	detection	detection	NN
cord-005453-4057qib7	15173	11	limit	limit	NN
cord-005453-4057qib7	15173	12	,	,	,
cord-005453-4057qib7	15173	13	preciseness	preciseness	NN
cord-005453-4057qib7	15173	14	,	,	,
cord-005453-4057qib7	15173	15	and	and	CC
cord-005453-4057qib7	15173	16	the	the	DT
cord-005453-4057qib7	15173	17	possibility	possibility	NN
cord-005453-4057qib7	15173	18	of	of	IN
cord-005453-4057qib7	15173	19	automated	automated	JJ
cord-005453-4057qib7	15173	20	read	read	VBN
cord-005453-4057qib7	15173	21	out	out	RP
cord-005453-4057qib7	15173	22	.	.	.
cord-005453-4057qib7	15174	1	Digital	Digital	NNP
cord-005453-4057qib7	15174	2	PCR	PCR	NNP
cord-005453-4057qib7	15174	3	could	could	MD
cord-005453-4057qib7	15174	4	circumvent	circumvent	VB
cord-005453-4057qib7	15174	5	some	some	DT
cord-005453-4057qib7	15174	6	of	of	IN
cord-005453-4057qib7	15174	7	these	these	DT
cord-005453-4057qib7	15174	8	limitations	limitation	NNS
cord-005453-4057qib7	15174	9	.	.	.
cord-005453-4057qib7	15175	1	Methods	method	NNS
cord-005453-4057qib7	15175	2	:	:	:
cord-005453-4057qib7	15175	3	Recently	recently	RB
cord-005453-4057qib7	15175	4	,	,	,
cord-005453-4057qib7	15175	5	validated	validate	VBN
cord-005453-4057qib7	15175	6	for	for	IN
cord-005453-4057qib7	15175	7	the	the	DT
cord-005453-4057qib7	15175	8	Bio	Bio	NNP
cord-005453-4057qib7	15175	9	-	-	HYPH
cord-005453-4057qib7	15175	10	Rad	Rad	NNP
cord-005453-4057qib7	15175	11	droplet	droplet	NN
cord-005453-4057qib7	15175	12	digital	digital	JJ
cord-005453-4057qib7	15175	13	platforms	platform	NNS
cord-005453-4057qib7	15175	14	,	,	,
cord-005453-4057qib7	15175	15	the	the	DT
cord-005453-4057qib7	15175	16	Biotype	Biotype	NNP
cord-005453-4057qib7	15175	17	Mentype	Mentype	NNP
cord-005453-4057qib7	15175	18	DigitalQuant	DigitalQuant	NNP
cord-005453-4057qib7	15175	19	Assay	Assay	NNP
cord-005453-4057qib7	15175	20	was	be	VBD
cord-005453-4057qib7	15175	21	released	release	VBN
cord-005453-4057qib7	15175	22	.	.	.
cord-005453-4057qib7	15176	1	The	the	DT
cord-005453-4057qib7	15176	2	assay	assay	NN
cord-005453-4057qib7	15176	3	uses	use	VBZ
cord-005453-4057qib7	15176	4	INDEL	INDEL	NNP
cord-005453-4057qib7	15176	5	polymorphisms	polymorphism	NNS
cord-005453-4057qib7	15176	6	on	on	IN
cord-005453-4057qib7	15176	7	chromosomal	chromosomal	JJ
cord-005453-4057qib7	15176	8	DNA	dna	NN
cord-005453-4057qib7	15176	9	to	to	TO
cord-005453-4057qib7	15176	10	distinguish	distinguish	VB
cord-005453-4057qib7	15176	11	patient	patient	NN
cord-005453-4057qib7	15176	12	and	and	CC
cord-005453-4057qib7	15176	13	donor	donor	NN
cord-005453-4057qib7	15176	14	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	15176	15	on	on	IN
cord-005453-4057qib7	15176	16	a	a	DT
cord-005453-4057qib7	15176	17	FRET	fret	NN
cord-005453-4057qib7	15176	18	hydrolysis	hydrolysis	NN
cord-005453-4057qib7	15176	19	assay	assay	NN
cord-005453-4057qib7	15176	20	basis	basis	NN
cord-005453-4057qib7	15176	21	(	(	-LRB-
cord-005453-4057qib7	15176	22	"	"	``
cord-005453-4057qib7	15176	23	TaqMan	TaqMan	NNP
cord-005453-4057qib7	15176	24	assays	assay	NNS
cord-005453-4057qib7	15176	25	"	"	''
cord-005453-4057qib7	15176	26	)	)	-RRB-
cord-005453-4057qib7	15176	27	.	.	.
cord-005453-4057qib7	15177	1	Thus	thus	RB
cord-005453-4057qib7	15177	2	the	the	DT
cord-005453-4057qib7	15177	3	assay	assay	NN
cord-005453-4057qib7	15177	4	in	in	IN
cord-005453-4057qib7	15177	5	principle	principle	NN
cord-005453-4057qib7	15177	6	is	be	VBZ
cord-005453-4057qib7	15177	7	applicable	applicable	JJ
cord-005453-4057qib7	15177	8	on	on	IN
cord-005453-4057qib7	15177	9	the	the	DT
cord-005453-4057qib7	15177	10	chamber	chamber	NN
cord-005453-4057qib7	15177	11	based	base	VBN
cord-005453-4057qib7	15177	12	3	3	CD
cord-005453-4057qib7	15177	13	D	D	NNP
cord-005453-4057qib7	15177	14	digital	digital	JJ
cord-005453-4057qib7	15177	15	PCR	pcr	NN
cord-005453-4057qib7	15177	16	system	system	NN
cord-005453-4057qib7	15177	17	(	(	-LRB-
cord-005453-4057qib7	15177	18	Thermo	Thermo	NNP
cord-005453-4057qib7	15177	19	Fisher	Fisher	NNP
cord-005453-4057qib7	15177	20	)	)	-RRB-
cord-005453-4057qib7	15177	21	.	.	.
cord-005453-4057qib7	15178	1	Due	due	IN
cord-005453-4057qib7	15178	2	to	to	IN
cord-005453-4057qib7	15178	3	different	different	JJ
cord-005453-4057qib7	15178	4	reaction	reaction	NN
cord-005453-4057qib7	15178	5	chemistry	chemistry	NN
cord-005453-4057qib7	15178	6	and	and	CC
cord-005453-4057qib7	15178	7	physical	physical	JJ
cord-005453-4057qib7	15178	8	properties	property	NNS
cord-005453-4057qib7	15178	9	of	of	IN
cord-005453-4057qib7	15178	10	thermal	thermal	JJ
cord-005453-4057qib7	15178	11	transfer	transfer	NN
cord-005453-4057qib7	15178	12	between	between	IN
cord-005453-4057qib7	15178	13	the	the	DT
cord-005453-4057qib7	15178	14	digital	digital	JJ
cord-005453-4057qib7	15178	15	PCR	PCR	NNP
cord-005453-4057qib7	15178	16	platforms	platform	NNS
cord-005453-4057qib7	15178	17	protocols	protocol	NNS
cord-005453-4057qib7	15178	18	are	be	VBP
cord-005453-4057qib7	15178	19	reasonably	reasonably	RB
cord-005453-4057qib7	15178	20	not	not	RB
cord-005453-4057qib7	15178	21	fully	fully	RB
cord-005453-4057qib7	15178	22	compatible	compatible	JJ
cord-005453-4057qib7	15178	23	which	which	WDT
cord-005453-4057qib7	15178	24	would	would	MD
cord-005453-4057qib7	15178	25	lead	lead	VB
cord-005453-4057qib7	15178	26	to	to	TO
cord-005453-4057qib7	15178	27	lower	lower	VB
cord-005453-4057qib7	15178	28	fluorescence	fluorescence	NN
cord-005453-4057qib7	15178	29	intensities	intensity	NNS
cord-005453-4057qib7	15178	30	and	and	CC
cord-005453-4057qib7	15178	31	poor	poor	JJ
cord-005453-4057qib7	15178	32	signal	signal	NN
cord-005453-4057qib7	15178	33	resolution	resolution	NN
cord-005453-4057qib7	15178	34	on	on	IN
cord-005453-4057qib7	15178	35	the	the	DT
cord-005453-4057qib7	15178	36	solid	solid	JJ
cord-005453-4057qib7	15178	37	chip	chip	NN
cord-005453-4057qib7	15178	38	based	base	VBN
cord-005453-4057qib7	15178	39	Thermo	Thermo	NNP
cord-005453-4057qib7	15178	40	Fisher	Fisher	NNP
cord-005453-4057qib7	15178	41	3D	3d	JJ
cord-005453-4057qib7	15178	42	platform	platform	NN
cord-005453-4057qib7	15178	43	.	.	.
cord-005453-4057qib7	15179	1	An	an	DT
cord-005453-4057qib7	15179	2	adjusted	adjust	VBN
cord-005453-4057qib7	15179	3	PCR	PCR	NNP
cord-005453-4057qib7	15179	4	protocol	protocol	NN
cord-005453-4057qib7	15179	5	was	be	VBD
cord-005453-4057qib7	15179	6	established	establish	VBN
cord-005453-4057qib7	15179	7	and	and	CC
cord-005453-4057qib7	15179	8	optimized	optimize	VBN
cord-005453-4057qib7	15179	9	using	use	VBG
cord-005453-4057qib7	15179	10	representative	representative	JJ
cord-005453-4057qib7	15179	11	markers	marker	NNS
cord-005453-4057qib7	15179	12	,	,	,
cord-005453-4057qib7	15179	13	followed	follow	VBN
cord-005453-4057qib7	15179	14	by	by	IN
cord-005453-4057qib7	15179	15	determination	determination	NN
cord-005453-4057qib7	15179	16	of	of	IN
cord-005453-4057qib7	15179	17	tolerable	tolerable	JJ
cord-005453-4057qib7	15179	18	and	and	CC
cord-005453-4057qib7	15179	19	optimal	optimal	JJ
cord-005453-4057qib7	15179	20	amount	amount	NN
cord-005453-4057qib7	15179	21	of	of	IN
cord-005453-4057qib7	15179	22	input	input	NN
cord-005453-4057qib7	15179	23	DNA	dna	NN
cord-005453-4057qib7	15179	24	.	.	.
cord-005453-4057qib7	15180	1	Specificity	specificity	NN
cord-005453-4057qib7	15180	2	,	,	,
cord-005453-4057qib7	15180	3	sensitivity	sensitivity	NN
cord-005453-4057qib7	15180	4	and	and	CC
cord-005453-4057qib7	15180	5	reproducibility	reproducibility	NN
cord-005453-4057qib7	15180	6	testing	testing	NN
cord-005453-4057qib7	15180	7	with	with	IN
cord-005453-4057qib7	15180	8	artificial	artificial	JJ
cord-005453-4057qib7	15180	9	mixed	mixed	JJ
cord-005453-4057qib7	15180	10	samples	sample	NNS
cord-005453-4057qib7	15180	11	preceded	precede	VBD
cord-005453-4057qib7	15180	12	the	the	DT
cord-005453-4057qib7	15180	13	extensive	extensive	JJ
cord-005453-4057qib7	15180	14	verification	verification	NN
cord-005453-4057qib7	15180	15	by	by	IN
cord-005453-4057qib7	15180	16	comparative	comparative	JJ
cord-005453-4057qib7	15180	17	measurement	measurement	NN
cord-005453-4057qib7	15180	18	of	of	IN
cord-005453-4057qib7	15180	19	clinical	clinical	JJ
cord-005453-4057qib7	15180	20	samples	sample	NNS
cord-005453-4057qib7	15180	21	(	(	-LRB-
cord-005453-4057qib7	15180	22	N=59	N=59	NNP
cord-005453-4057qib7	15180	23	)	)	-RRB-
cord-005453-4057qib7	15180	24	and	and	CC
cord-005453-4057qib7	15180	25	ring	ring	NN
cord-005453-4057qib7	15180	26	-	-	HYPH
cord-005453-4057qib7	15180	27	trial	trial	NN
cord-005453-4057qib7	15180	28	samples	sample	NNS
cord-005453-4057qib7	15180	29	(	(	-LRB-
cord-005453-4057qib7	15180	30	N=20	N=20	NNP
cord-005453-4057qib7	15180	31	)	)	-RRB-
cord-005453-4057qib7	15180	32	.	.	.
cord-005453-4057qib7	15181	1	source	source	NN
cord-005453-4057qib7	15181	2	to	to	IN
cord-005453-4057qib7	15181	3	allogenic	allogenic	JJ
cord-005453-4057qib7	15181	4	BM	BM	NNP
cord-005453-4057qib7	15181	5	or	or	CC
cord-005453-4057qib7	15181	6	PBSC	PBSC	NNP
cord-005453-4057qib7	15181	7	.	.	.
cord-005453-4057qib7	15182	1	UCB	UCB	NNP
cord-005453-4057qib7	15182	2	units	unit	NNS
cord-005453-4057qib7	15182	3	are	be	VBP
cord-005453-4057qib7	15182	4	immediately	immediately	RB
cord-005453-4057qib7	15182	5	available	available	JJ
cord-005453-4057qib7	15182	6	for	for	IN
cord-005453-4057qib7	15182	7	transplantation	transplantation	NN
cord-005453-4057qib7	15182	8	as	as	IN
cord-005453-4057qib7	15182	9	they	-PRON-	PRP
cord-005453-4057qib7	15182	10	are	be	VBP
cord-005453-4057qib7	15182	11	frozen	frozen	JJ
cord-005453-4057qib7	15182	12	and	and	CC
cord-005453-4057qib7	15182	13	banked	bank	VBN
cord-005453-4057qib7	15182	14	with	with	IN
cord-005453-4057qib7	15182	15	defined	define	VBN
cord-005453-4057qib7	15182	16	HLA	HLA	NNP
cord-005453-4057qib7	15182	17	typing	typing	NN
cord-005453-4057qib7	15182	18	and	and	CC
cord-005453-4057qib7	15182	19	it	-PRON-	PRP
cord-005453-4057qib7	15182	20	has	have	VBZ
cord-005453-4057qib7	15182	21	an	an	DT
cord-005453-4057qib7	15182	22	advantage	advantage	NN
cord-005453-4057qib7	15182	23	for	for	IN
cord-005453-4057qib7	15182	24	patients	patient	NNS
cord-005453-4057qib7	15182	25	who	who	WP
cord-005453-4057qib7	15182	26	need	need	VBP
cord-005453-4057qib7	15182	27	urgent	urgent	JJ
cord-005453-4057qib7	15182	28	transplantation	transplantation	NN
cord-005453-4057qib7	15182	29	.	.	.
cord-005453-4057qib7	15183	1	In	in	IN
cord-005453-4057qib7	15183	2	addition	addition	NN
cord-005453-4057qib7	15183	3	,	,	,
cord-005453-4057qib7	15183	4	a	a	DT
cord-005453-4057qib7	15183	5	higher	high	JJR
cord-005453-4057qib7	15183	6	degree	degree	NN
cord-005453-4057qib7	15183	7	of	of	IN
cord-005453-4057qib7	15183	8	HLA	HLA	NNP
cord-005453-4057qib7	15183	9	mismatch	mismatch	NN
cord-005453-4057qib7	15183	10	appears	appear	VBZ
cord-005453-4057qib7	15183	11	to	to	TO
cord-005453-4057qib7	15183	12	be	be	VB
cord-005453-4057qib7	15183	13	acceptable	acceptable	JJ
cord-005453-4057qib7	15183	14	with	with	IN
cord-005453-4057qib7	15183	15	a	a	DT
cord-005453-4057qib7	15183	16	comparatively	comparatively	RB
cord-005453-4057qib7	15183	17	lower	low	JJR
cord-005453-4057qib7	15183	18	risk	risk	NN
cord-005453-4057qib7	15183	19	of	of	IN
cord-005453-4057qib7	15183	20	acute	acute	JJ
cord-005453-4057qib7	15183	21	and	and	CC
cord-005453-4057qib7	15183	22	chronic	chronic	JJ
cord-005453-4057qib7	15183	23	GVHD	GVHD	NNP
cord-005453-4057qib7	15183	24	.	.	.
cord-005453-4057qib7	15184	1	Meanwhile	meanwhile	RB
cord-005453-4057qib7	15184	2	,	,	,
cord-005453-4057qib7	15184	3	a	a	DT
cord-005453-4057qib7	15184	4	higher	high	JJR
cord-005453-4057qib7	15184	5	incidence	incidence	NN
cord-005453-4057qib7	15184	6	of	of	IN
cord-005453-4057qib7	15184	7	engraftment	engraftment	NN
cord-005453-4057qib7	15184	8	failure	failure	NN
cord-005453-4057qib7	15184	9	,	,	,
cord-005453-4057qib7	15184	10	delayed	delay	VBN
cord-005453-4057qib7	15184	11	neutrophil	neutrophil	NN
cord-005453-4057qib7	15184	12	and	and	CC
cord-005453-4057qib7	15184	13	platelet	platelet	NN
cord-005453-4057qib7	15184	14	recovery	recovery	NN
cord-005453-4057qib7	15184	15	,	,	,
cord-005453-4057qib7	15184	16	and	and	CC
cord-005453-4057qib7	15184	17	posttransplant	posttransplant	NN
cord-005453-4057qib7	15184	18	immune	immune	JJ
cord-005453-4057qib7	15184	19	disorders	disorder	NNS
cord-005453-4057qib7	15184	20	including	include	VBG
cord-005453-4057qib7	15184	21	pre	pre	JJ
cord-005453-4057qib7	15184	22	-	-	JJ
cord-005453-4057qib7	15184	23	engraftment	engraftment	JJ
cord-005453-4057qib7	15184	24	immune	immune	JJ
cord-005453-4057qib7	15184	25	reactions	reaction	NNS
cord-005453-4057qib7	15184	26	(	(	-LRB-
cord-005453-4057qib7	15184	27	PIR	PIR	NNP
cord-005453-4057qib7	15184	28	)	)	-RRB-
cord-005453-4057qib7	15184	29	are	be	VBP
cord-005453-4057qib7	15184	30	major	major	JJ
cord-005453-4057qib7	15184	31	problems	problem	NNS
cord-005453-4057qib7	15184	32	in	in	IN
cord-005453-4057qib7	15184	33	unrelated	unrelated	JJ
cord-005453-4057qib7	15184	34	UCBT	UCBT	NNS
cord-005453-4057qib7	15184	35	.	.	.
cord-005453-4057qib7	15185	1	Methods	method	NNS
cord-005453-4057qib7	15185	2	:	:	:
cord-005453-4057qib7	15185	3	In	in	IN
cord-005453-4057qib7	15185	4	our	-PRON-	PRP$
cord-005453-4057qib7	15185	5	institute	institute	NN
cord-005453-4057qib7	15185	6	,	,	,
cord-005453-4057qib7	15185	7	GVHD	GVHD	NNP
cord-005453-4057qib7	15185	8	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15185	9	in	in	IN
cord-005453-4057qib7	15185	10	UCBT	UCBT	NNP
cord-005453-4057qib7	15185	11	was	be	VBD
cord-005453-4057qib7	15185	12	changed	change	VBN
cord-005453-4057qib7	15185	13	after	after	IN
cord-005453-4057qib7	15185	14	March	March	NNP
cord-005453-4057qib7	15185	15	2013	2013	CD
cord-005453-4057qib7	15185	16	.	.	.
cord-005453-4057qib7	15186	1	Between	between	IN
cord-005453-4057qib7	15186	2	January	January	NNP
cord-005453-4057qib7	15186	3	2007	2007	CD
cord-005453-4057qib7	15186	4	and	and	CC
cord-005453-4057qib7	15186	5	March	March	NNP
cord-005453-4057qib7	15186	6	2013	2013	CD
cord-005453-4057qib7	15186	7	,	,	,
cord-005453-4057qib7	15186	8	thirty	thirty	CD
cord-005453-4057qib7	15186	9	-	-	HYPH
cord-005453-4057qib7	15186	10	two	two	CD
cord-005453-4057qib7	15186	11	patients	patient	NNS
cord-005453-4057qib7	15186	12	received	receive	VBD
cord-005453-4057qib7	15186	13	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	15186	14	plus	plus	CC
cord-005453-4057qib7	15186	15	methylprednisolone	methylprednisolone	NNP
cord-005453-4057qib7	15186	16	(	(	-LRB-
cord-005453-4057qib7	15186	17	Tac	Tac	NNP
cord-005453-4057qib7	15186	18	/	/	SYM
cord-005453-4057qib7	15186	19	mPSL	mpsl	NN
cord-005453-4057qib7	15186	20	)	)	-RRB-
cord-005453-4057qib7	15186	21	and	and	CC
cord-005453-4057qib7	15186	22	between	between	IN
cord-005453-4057qib7	15186	23	April	April	NNP
cord-005453-4057qib7	15186	24	2013	2013	CD
cord-005453-4057qib7	15186	25	and	and	CC
cord-005453-4057qib7	15186	26	January	January	NNP
cord-005453-4057qib7	15186	27	2018	2018	CD
cord-005453-4057qib7	15186	28	,	,	,
cord-005453-4057qib7	15186	29	thirty	thirty	CD
cord-005453-4057qib7	15186	30	-	-	HYPH
cord-005453-4057qib7	15186	31	one	one	CD
cord-005453-4057qib7	15186	32	patients	patient	NNS
cord-005453-4057qib7	15186	33	received	receive	VBD
cord-005453-4057qib7	15186	34	Tac	Tac	NNP
cord-005453-4057qib7	15186	35	plus	plus	CC
cord-005453-4057qib7	15186	36	methotrexate	methotrexate	NNP
cord-005453-4057qib7	15186	37	(	(	-LRB-
cord-005453-4057qib7	15186	38	Tac	Tac	NNP
cord-005453-4057qib7	15186	39	/	/	SYM
cord-005453-4057qib7	15186	40	MTX	MTX	NNP
cord-005453-4057qib7	15186	41	)	)	-RRB-
cord-005453-4057qib7	15186	42	for	for	IN
cord-005453-4057qib7	15186	43	GVHD	GVHD	NNP
cord-005453-4057qib7	15186	44	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15186	45	.	.	.
cord-005453-4057qib7	15187	1	To	to	TO
cord-005453-4057qib7	15187	2	investigate	investigate	VB
cord-005453-4057qib7	15187	3	better	better	RB
cord-005453-4057qib7	15187	4	GVHD	gvhd	JJ
cord-005453-4057qib7	15187	5	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15187	6	after	after	IN
cord-005453-4057qib7	15187	7	UCBT	UCBT	NNP
cord-005453-4057qib7	15187	8	,	,	,
cord-005453-4057qib7	15187	9	we	-PRON-	PRP
cord-005453-4057qib7	15187	10	compared	compare	VBD
cord-005453-4057qib7	15187	11	transplant	transplant	NN
cord-005453-4057qib7	15187	12	outcomes	outcome	NNS
cord-005453-4057qib7	15187	13	after	after	IN
cord-005453-4057qib7	15187	14	UCBT	UCBT	NNP
cord-005453-4057qib7	15187	15	using	use	VBG
cord-005453-4057qib7	15187	16	GVHD	GVHD	NNP
cord-005453-4057qib7	15187	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15187	18	with	with	IN
cord-005453-4057qib7	15187	19	Tac	Tac	NNP
cord-005453-4057qib7	15187	20	/	/	SYM
cord-005453-4057qib7	15187	21	mPSL	mPSL	NNP
cord-005453-4057qib7	15187	22	(	(	-LRB-
cord-005453-4057qib7	15187	23	n=32	n=32	NNP
cord-005453-4057qib7	15187	24	)	)	-RRB-
cord-005453-4057qib7	15187	25	and	and	CC
cord-005453-4057qib7	15187	26	Tac	Tac	NNP
cord-005453-4057qib7	15187	27	/	/	SYM
cord-005453-4057qib7	15187	28	MTX	MTX	NNP
cord-005453-4057qib7	15187	29	(	(	-LRB-
cord-005453-4057qib7	15187	30	n=31	n=31	NNP
cord-005453-4057qib7	15187	31	)	)	-RRB-
cord-005453-4057qib7	15187	32	in	in	IN
cord-005453-4057qib7	15187	33	single	single	JJ
cord-005453-4057qib7	15187	34	-	-	HYPH
cord-005453-4057qib7	15187	35	pediatric	pediatric	JJ
cord-005453-4057qib7	15187	36	transplantation	transplantation	NN
cord-005453-4057qib7	15187	37	center	center	NN
cord-005453-4057qib7	15187	38	.	.	.
cord-005453-4057qib7	15188	1	Results	result	NNS
cord-005453-4057qib7	15188	2	:	:	:
cord-005453-4057qib7	15189	1	The	the	DT
cord-005453-4057qib7	15189	2	cumulative	cumulative	JJ
cord-005453-4057qib7	15189	3	incidence	incidence	NN
cord-005453-4057qib7	15189	4	of	of	IN
cord-005453-4057qib7	15189	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	15189	6	engraftment	engraftment	NN
cord-005453-4057qib7	15189	7	at	at	IN
cord-005453-4057qib7	15189	8	day	day	NN
cord-005453-4057qib7	15189	9	30	30	CD
cord-005453-4057qib7	15189	10	in	in	IN
cord-005453-4057qib7	15189	11	Tac	Tac	NNP
cord-005453-4057qib7	15189	12	/	/	SYM
cord-005453-4057qib7	15189	13	mPSL	mpsl	NN
cord-005453-4057qib7	15189	14	group	group	NN
cord-005453-4057qib7	15189	15	was	be	VBD
cord-005453-4057qib7	15189	16	70.1	70.1	CD
cord-005453-4057qib7	15189	17	%	%	NN
cord-005453-4057qib7	15189	18	and	and	CC
cord-005453-4057qib7	15189	19	90.3	90.3	CD
cord-005453-4057qib7	15189	20	%	%	NN
cord-005453-4057qib7	15189	21	in	in	IN
cord-005453-4057qib7	15189	22	Tac	Tac	NNP
cord-005453-4057qib7	15189	23	/	/	SYM
cord-005453-4057qib7	15189	24	MTX	MTX	NNP
cord-005453-4057qib7	15189	25	group	group	NN
cord-005453-4057qib7	15189	26	(	(	-LRB-
cord-005453-4057qib7	15189	27	p=0.09	p=0.09	NNP
cord-005453-4057qib7	15189	28	)	)	-RRB-
cord-005453-4057qib7	15189	29	.	.	.
cord-005453-4057qib7	15190	1	Median	median	JJ
cord-005453-4057qib7	15190	2	time	time	NN
cord-005453-4057qib7	15190	3	of	of	IN
cord-005453-4057qib7	15190	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	15190	5	engraftment	engraftment	NN
cord-005453-4057qib7	15190	6	was	be	VBD
cord-005453-4057qib7	15190	7	2	2	CD
cord-005453-4057qib7	15190	8	days	day	NNS
cord-005453-4057qib7	15190	9	earlier	early	RBR
cord-005453-4057qib7	15190	10	in	in	IN
cord-005453-4057qib7	15190	11	Tac	Tac	NNP
cord-005453-4057qib7	15190	12	/	/	SYM
cord-005453-4057qib7	15190	13	MTX	MTX	NNP
cord-005453-4057qib7	15190	14	group	group	NN
cord-005453-4057qib7	15190	15	(	(	-LRB-
cord-005453-4057qib7	15190	16	17	17	CD
cord-005453-4057qib7	15190	17	days	day	NNS
cord-005453-4057qib7	15190	18	)	)	-RRB-
cord-005453-4057qib7	15190	19	than	than	IN
cord-005453-4057qib7	15190	20	Tac	Tac	NNP
cord-005453-4057qib7	15190	21	/	/	SYM
cord-005453-4057qib7	15190	22	mPSL	mpsl	NN
cord-005453-4057qib7	15190	23	group	group	NN
cord-005453-4057qib7	15190	24	(	(	-LRB-
cord-005453-4057qib7	15190	25	19	19	CD
cord-005453-4057qib7	15190	26	days	day	NNS
cord-005453-4057qib7	15190	27	)	)	-RRB-
cord-005453-4057qib7	15190	28	.	.	.
cord-005453-4057qib7	15191	1	According	accord	VBG
cord-005453-4057qib7	15191	2	to	to	IN
cord-005453-4057qib7	15191	3	PIR	PIR	NNP
cord-005453-4057qib7	15191	4	,	,	,
cord-005453-4057qib7	15191	5	and	and	CC
cord-005453-4057qib7	15191	6	acute	acute	JJ
cord-005453-4057qib7	15191	7	GVHD	GVHD	NNP
cord-005453-4057qib7	15191	8	,	,	,
cord-005453-4057qib7	15191	9	Tac	Tac	NNP
cord-005453-4057qib7	15191	10	/	/	SYM
cord-005453-4057qib7	15191	11	MTX	MTX	NNP
cord-005453-4057qib7	15191	12	group	group	NN
cord-005453-4057qib7	15191	13	showed	show	VBD
cord-005453-4057qib7	15191	14	superior	superior	JJ
cord-005453-4057qib7	15191	15	outcomes	outcome	NNS
cord-005453-4057qib7	15191	16	;	;	:
cord-005453-4057qib7	15191	17	the	the	DT
cord-005453-4057qib7	15191	18	incidence	incidence	NN
cord-005453-4057qib7	15191	19	of	of	IN
cord-005453-4057qib7	15191	20	PIR	PIR	NNP
cord-005453-4057qib7	15191	21	(	(	-LRB-
cord-005453-4057qib7	15191	22	p=0.020	p=0.020	NNP
cord-005453-4057qib7	15191	23	)	)	-RRB-
cord-005453-4057qib7	15191	24	and	and	CC
cord-005453-4057qib7	15191	25	the	the	DT
cord-005453-4057qib7	15191	26	cumulative	cumulative	JJ
cord-005453-4057qib7	15191	27	incidences	incidence	NNS
cord-005453-4057qib7	15191	28	of	of	IN
cord-005453-4057qib7	15191	29	acute	acute	JJ
cord-005453-4057qib7	15191	30	GVHD	GVHD	NNP
cord-005453-4057qib7	15191	31	at	at	IN
cord-005453-4057qib7	15191	32	day	day	NN
cord-005453-4057qib7	15191	33	100	100	CD
cord-005453-4057qib7	15191	34	(	(	-LRB-
cord-005453-4057qib7	15191	35	38.7	38.7	CD
cord-005453-4057qib7	15191	36	vs	vs	IN
cord-005453-4057qib7	15191	37	68.8	68.8	CD
cord-005453-4057qib7	15191	38	%	%	NN
cord-005453-4057qib7	15191	39	,	,	,
cord-005453-4057qib7	15191	40	p	p	NN
cord-005453-4057qib7	15191	41	=	=	SYM
cord-005453-4057qib7	15191	42	0.045	0.045	CD
cord-005453-4057qib7	15191	43	for	for	IN
cord-005453-4057qib7	15191	44	grade	grade	NN
cord-005453-4057qib7	15191	45	II	II	NNP
cord-005453-4057qib7	15191	46	-	-	HYPH
cord-005453-4057qib7	15191	47	IV	IV	NNP
cord-005453-4057qib7	15191	48	,	,	,
cord-005453-4057qib7	15191	49	9.7	9.7	CD
cord-005453-4057qib7	15191	50	vs	vs	IN
cord-005453-4057qib7	15191	51	34.4	34.4	CD
cord-005453-4057qib7	15191	52	%	%	NN
cord-005453-4057qib7	15191	53	,	,	,
cord-005453-4057qib7	15191	54	p=0.021	p=0.021	NNP
cord-005453-4057qib7	15191	55	for	for	IN
cord-005453-4057qib7	15191	56	grade	grade	NN
cord-005453-4057qib7	15191	57	III	III	NNP
cord-005453-4057qib7	15191	58	-	-	HYPH
cord-005453-4057qib7	15191	59	IV	IV	NNP
cord-005453-4057qib7	15191	60	)	)	-RRB-
cord-005453-4057qib7	15191	61	was	be	VBD
cord-005453-4057qib7	15191	62	significantly	significantly	RB
cord-005453-4057qib7	15191	63	lower	low	JJR
cord-005453-4057qib7	15191	64	in	in	IN
cord-005453-4057qib7	15191	65	Tac	Tac	NNP
cord-005453-4057qib7	15191	66	/	/	SYM
cord-005453-4057qib7	15191	67	MTX	MTX	NNP
cord-005453-4057qib7	15191	68	group	group	NN
cord-005453-4057qib7	15191	69	than	than	IN
cord-005453-4057qib7	15191	70	in	in	IN
cord-005453-4057qib7	15191	71	Tac	Tac	NNP
cord-005453-4057qib7	15191	72	/	/	SYM
cord-005453-4057qib7	15191	73	mPSL	mpsl	NN
cord-005453-4057qib7	15191	74	.	.	.
cord-005453-4057qib7	15192	1	However	however	RB
cord-005453-4057qib7	15192	2	,	,	,
cord-005453-4057qib7	15192	3	the	the	DT
cord-005453-4057qib7	15192	4	incidences	incidence	NNS
cord-005453-4057qib7	15192	5	of	of	IN
cord-005453-4057qib7	15192	6	relapse	relapse	NN
cord-005453-4057qib7	15192	7	(	(	-LRB-
cord-005453-4057qib7	15192	8	p=0.921	p=0.921	NNP
cord-005453-4057qib7	15192	9	)	)	-RRB-
cord-005453-4057qib7	15192	10	and	and	CC
cord-005453-4057qib7	15192	11	cytomegalovirus	cytomegalovirus	NNP
cord-005453-4057qib7	15192	12	viremia	viremia	NN
cord-005453-4057qib7	15192	13	(	(	-LRB-
cord-005453-4057qib7	15192	14	p=0.908	p=0.908	NNP
cord-005453-4057qib7	15192	15	)	)	-RRB-
cord-005453-4057qib7	15192	16	,	,	,
cord-005453-4057qib7	15192	17	and	and	CC
cord-005453-4057qib7	15192	18	estimated	estimate	VBN
cord-005453-4057qib7	15192	19	overall	overall	JJ
cord-005453-4057qib7	15192	20	survival	survival	NN
cord-005453-4057qib7	15192	21	(	(	-LRB-
cord-005453-4057qib7	15192	22	p=0.87	p=0.87	NNP
cord-005453-4057qib7	15192	23	)	)	-RRB-
cord-005453-4057qib7	15192	24	and	and	CC
cord-005453-4057qib7	15192	25	event	event	NN
cord-005453-4057qib7	15192	26	-	-	HYPH
cord-005453-4057qib7	15192	27	free	free	JJ
cord-005453-4057qib7	15192	28	survival	survival	NN
cord-005453-4057qib7	15192	29	(	(	-LRB-
cord-005453-4057qib7	15192	30	p=0.88	p=0.88	NNP
cord-005453-4057qib7	15192	31	)	)	-RRB-
cord-005453-4057qib7	15192	32	were	be	VBD
cord-005453-4057qib7	15192	33	comparable	comparable	JJ
cord-005453-4057qib7	15192	34	between	between	IN
cord-005453-4057qib7	15192	35	two	two	CD
cord-005453-4057qib7	15192	36	groups	group	NNS
cord-005453-4057qib7	15192	37	.	.	.
cord-005453-4057qib7	15193	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15193	2	:	:	:
cord-005453-4057qib7	15194	1	Our	-PRON-	PRP$
cord-005453-4057qib7	15194	2	results	result	NNS
cord-005453-4057qib7	15194	3	indicated	indicate	VBD
cord-005453-4057qib7	15194	4	that	that	IN
cord-005453-4057qib7	15194	5	GVHD	GVHD	NNP
cord-005453-4057qib7	15194	6	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15194	7	with	with	IN
cord-005453-4057qib7	15194	8	Tac	Tac	NNP
cord-005453-4057qib7	15194	9	/	/	SYM
cord-005453-4057qib7	15194	10	MTX	MTX	NNP
cord-005453-4057qib7	15194	11	had	have	VBD
cord-005453-4057qib7	15194	12	favorable	favorable	JJ
cord-005453-4057qib7	15194	13	effects	effect	NNS
cord-005453-4057qib7	15194	14	;	;	,
cord-005453-4057qib7	15194	15	reduced	reduce	VBN
cord-005453-4057qib7	15194	16	incidence	incidence	NN
cord-005453-4057qib7	15194	17	of	of	IN
cord-005453-4057qib7	15194	18	RIP	rip	NN
cord-005453-4057qib7	15194	19	and	and	CC
cord-005453-4057qib7	15194	20	acute	acute	JJ
cord-005453-4057qib7	15194	21	GVHD	GVHD	NNP
cord-005453-4057qib7	15194	22	after	after	IN
cord-005453-4057qib7	15194	23	UCBT	UCBT	NNP
cord-005453-4057qib7	15194	24	without	without	IN
cord-005453-4057qib7	15194	25	any	any	DT
cord-005453-4057qib7	15194	26	negative	negative	JJ
cord-005453-4057qib7	15194	27	influences	influence	NNS
cord-005453-4057qib7	15194	28	.	.	.
cord-005453-4057qib7	15195	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15195	2	:	:	:
cord-005453-4057qib7	15195	3	Nothing	nothing	NN
cord-005453-4057qib7	15195	4	to	to	TO
cord-005453-4057qib7	15195	5	declare	declare	VB
cord-005453-4057qib7	15195	6	Transfer	transfer	NN
cord-005453-4057qib7	15195	7	of	of	IN
cord-005453-4057qib7	15195	8	donor	donor	NN
cord-005453-4057qib7	15195	9	regulatory	regulatory	JJ
cord-005453-4057qib7	15195	10	T	T	NNP
cord-005453-4057qib7	15195	11	-	-	HYPH
cord-005453-4057qib7	15195	12	cellS	cellS	NNP
cord-005453-4057qib7	15195	13	after	after	IN
cord-005453-4057qib7	15195	14	ATG	ATG	NNP
cord-005453-4057qib7	15195	15	reconditioning	reconditioning	NN
cord-005453-4057qib7	15195	16	cures	cure	NNS
cord-005453-4057qib7	15195	17	severe	severe	JJ
cord-005453-4057qib7	15195	18	refractory	refractory	JJ
cord-005453-4057qib7	15195	19	GVHD	GVHD	NNP
cord-005453-4057qib7	15195	20	and	and	CC
cord-005453-4057qib7	15195	21	leads	lead	VBZ
cord-005453-4057qib7	15195	22	to	to	IN
cord-005453-4057qib7	15195	23	long	long	JJ
cord-005453-4057qib7	15195	24	term	term	NN
cord-005453-4057qib7	15195	25	persistence	persistence	NN
cord-005453-4057qib7	15195	26	of	of	IN
cord-005453-4057qib7	15195	27	regulatory	regulatory	JJ
cord-005453-4057qib7	15195	28	T	T	NNP
cord-005453-4057qib7	15195	29	-	-	HYPH
cord-005453-4057qib7	15195	30	cellS	cellS	NNP
cord-005453-4057qib7	15195	31	in	in	IN
cord-005453-4057qib7	15195	32	the	the	DT
cord-005453-4057qib7	15195	33	recipient	recipient	NN
cord-005453-4057qib7	15195	34	cells	cell	NNS
cord-005453-4057qib7	15195	35	on	on	IN
cord-005453-4057qib7	15195	36	a	a	DT
cord-005453-4057qib7	15195	37	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	15195	38	®	®	NN
cord-005453-4057qib7	15195	39	Plus	plus	CC
cord-005453-4057qib7	15195	40	device	device	NN
cord-005453-4057qib7	15195	41	(	(	-LRB-
cord-005453-4057qib7	15195	42	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	15195	43	Biotec	Biotec	NNP
cord-005453-4057qib7	15195	44	)	)	-RRB-
cord-005453-4057qib7	15195	45	.	.	.
cord-005453-4057qib7	15196	1	The	the	DT
cord-005453-4057qib7	15196	2	cell	cell	NN
cord-005453-4057qib7	15196	3	product	product	NN
cord-005453-4057qib7	15196	4	contained	contain	VBD
cord-005453-4057qib7	15196	5	83	83	CD
cord-005453-4057qib7	15196	6	%	%	NN
cord-005453-4057qib7	15196	7	FoxP3	FoxP3	NNP
cord-005453-4057qib7	15196	8	+	+	CC
cord-005453-4057qib7	15196	9	T	t	NN
cord-005453-4057qib7	15196	10	-	-	HYPH
cord-005453-4057qib7	15196	11	cells	cell	NNS
cord-005453-4057qib7	15196	12	.	.	.
cord-005453-4057qib7	15197	1	The	the	DT
cord-005453-4057qib7	15197	2	patient	patient	NN
cord-005453-4057qib7	15197	3	received	receive	VBD
cord-005453-4057qib7	15197	4	3,4x	3,4x	CD
cord-005453-4057qib7	15197	5	10	10	CD
cord-005453-4057qib7	15197	6	5	5	CD
cord-005453-4057qib7	15197	7	/kg	/kg	.
cord-005453-4057qib7	15197	8	T	T	NNP
cord-005453-4057qib7	15197	9	reg	reg	NN
cord-005453-4057qib7	15197	10	on	on	IN
cord-005453-4057qib7	15197	11	day	day	NN
cord-005453-4057qib7	15197	12	+177	+177	NNP
cord-005453-4057qib7	15197	13	.	.	.
cord-005453-4057qib7	15198	1	Subsequently	subsequently	RB
cord-005453-4057qib7	15198	2	intestinal	intestinal	JJ
cord-005453-4057qib7	15198	3	GvHD	GvHD	NNP
cord-005453-4057qib7	15198	4	decreased	decrease	VBD
cord-005453-4057qib7	15198	5	and	and	CC
cord-005453-4057qib7	15198	6	finally	finally	RB
cord-005453-4057qib7	15198	7	resolved	resolve	VBN
cord-005453-4057qib7	15198	8	.	.	.
cord-005453-4057qib7	15199	1	Three	three	CD
cord-005453-4057qib7	15199	2	months	month	NNS
cord-005453-4057qib7	15199	3	after	after	IN
cord-005453-4057qib7	15199	4	the	the	DT
cord-005453-4057qib7	15199	5	first	first	JJ
cord-005453-4057qib7	15199	6	T	T	NNP
cord-005453-4057qib7	15199	7	reg	reg	NN
cord-005453-4057qib7	15199	8	transfer	transfer	VB
cord-005453-4057qib7	15199	9	the	the	DT
cord-005453-4057qib7	15199	10	patient	patient	NN
cord-005453-4057qib7	15199	11	got	get	VBD
cord-005453-4057qib7	15199	12	a	a	DT
cord-005453-4057qib7	15199	13	second	second	JJ
cord-005453-4057qib7	15199	14	T	T	NNP
cord-005453-4057qib7	15199	15	reg	reg	NN
cord-005453-4057qib7	15199	16	transfer	transfer	NN
cord-005453-4057qib7	15199	17	(	(	-LRB-
cord-005453-4057qib7	15199	18	3,4x	3,4x	CD
cord-005453-4057qib7	15199	19	10	10	CD
cord-005453-4057qib7	15199	20	5	5	CD
cord-005453-4057qib7	15199	21	/kg	/kg	NFP
cord-005453-4057qib7	15199	22	)	)	-RRB-
cord-005453-4057qib7	15199	23	on	on	IN
cord-005453-4057qib7	15199	24	day	day	NN
cord-005453-4057qib7	15200	1	+281	+281	NNP
cord-005453-4057qib7	15200	2	due	due	IN
cord-005453-4057qib7	15200	3	to	to	IN
cord-005453-4057qib7	15200	4	decreasing	decrease	VBG
cord-005453-4057qib7	15200	5	T	T	NNP
cord-005453-4057qib7	15200	6	reg	reg	NN
cord-005453-4057qib7	15200	7	levels	level	NNS
cord-005453-4057qib7	15200	8	.	.	.
cord-005453-4057qib7	15201	1	Thereafter	Thereafter	NNP
cord-005453-4057qib7	15201	2	T	T	NNP
cord-005453-4057qib7	15201	3	reg	reg	NNP
cord-005453-4057qib7	15201	4	persisted	persist	VBD
cord-005453-4057qib7	15201	5	and	and	CC
cord-005453-4057qib7	15201	6	there	there	EX
cord-005453-4057qib7	15201	7	was	be	VBD
cord-005453-4057qib7	15201	8	no	no	DT
cord-005453-4057qib7	15201	9	recurrence	recurrence	NN
cord-005453-4057qib7	15201	10	of	of	IN
cord-005453-4057qib7	15201	11	GvHD	GvHD	NNP
cord-005453-4057qib7	15201	12	.	.	.
cord-005453-4057qib7	15202	1	The	the	DT
cord-005453-4057qib7	15202	2	patient	patient	NN
cord-005453-4057qib7	15202	3	is	be	VBZ
cord-005453-4057qib7	15202	4	well	well	RB
cord-005453-4057qib7	15202	5	with	with	IN
cord-005453-4057qib7	15202	6	low	low	JJ
cord-005453-4057qib7	15202	7	dose	dose	NN
cord-005453-4057qib7	15202	8	sirolimus	sirolimus	NN
cord-005453-4057qib7	15202	9	and	and	CC
cord-005453-4057qib7	15202	10	prednisone	prednisone	NN
cord-005453-4057qib7	15202	11	as	as	IN
cord-005453-4057qib7	15202	12	the	the	DT
cord-005453-4057qib7	15202	13	only	only	JJ
cord-005453-4057qib7	15202	14	immunosuppressants	immunosuppressant	NNS
cord-005453-4057qib7	15202	15	and	and	CC
cord-005453-4057qib7	15202	16	is	be	VBZ
cord-005453-4057qib7	15202	17	particularly	particularly	RB
cord-005453-4057qib7	15202	18	recovering	recover	VBG
cord-005453-4057qib7	15202	19	intestinal	intestinal	JJ
cord-005453-4057qib7	15202	20	function	function	NN
cord-005453-4057qib7	15202	21	.	.	.
cord-005453-4057qib7	15203	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15203	2	:	:	:
cord-005453-4057qib7	15204	1	This	this	DT
cord-005453-4057qib7	15204	2	case	case	NN
cord-005453-4057qib7	15204	3	illustrates	illustrate	VBZ
cord-005453-4057qib7	15204	4	an	an	DT
cord-005453-4057qib7	15204	5	unusually	unusually	RB
cord-005453-4057qib7	15204	6	severe	severe	JJ
cord-005453-4057qib7	15204	7	acute	acute	JJ
cord-005453-4057qib7	15204	8	GvHD	gvhd	NN
cord-005453-4057qib7	15204	9	after	after	IN
cord-005453-4057qib7	15204	10	matched	match	VBN
cord-005453-4057qib7	15204	11	sibling	sibling	NN
cord-005453-4057qib7	15204	12	SCT	SCT	NNP
cord-005453-4057qib7	15204	13	.	.	.
cord-005453-4057qib7	15205	1	Transfer	transfer	NN
cord-005453-4057qib7	15205	2	of	of	IN
cord-005453-4057qib7	15205	3	donorderived	donorderived	NNP
cord-005453-4057qib7	15205	4	T	T	NNP
cord-005453-4057qib7	15205	5	reg	reg	NNP
cord-005453-4057qib7	15205	6	was	be	VBD
cord-005453-4057qib7	15205	7	able	able	JJ
cord-005453-4057qib7	15205	8	to	to	TO
cord-005453-4057qib7	15205	9	cure	cure	VB
cord-005453-4057qib7	15205	10	severe	severe	JJ
cord-005453-4057qib7	15205	11	and	and	CC
cord-005453-4057qib7	15205	12	refractory	refractory	JJ
cord-005453-4057qib7	15205	13	GvHD	gvhd	NN
cord-005453-4057qib7	15205	14	after	after	IN
cord-005453-4057qib7	15205	15	T	t	NN
cord-005453-4057qib7	15205	16	-	-	HYPH
cord-005453-4057qib7	15205	17	cell	cell	NN
cord-005453-4057qib7	15205	18	ablation	ablation	NN
cord-005453-4057qib7	15205	19	by	by	IN
cord-005453-4057qib7	15205	20	ATG	ATG	NNP
cord-005453-4057qib7	15205	21	.	.	.
cord-005453-4057qib7	15206	1	Transferred	transfer	VBN
cord-005453-4057qib7	15206	2	T	T	NNP
cord-005453-4057qib7	15206	3	reg	reg	NN
cord-005453-4057qib7	15206	4	persisted	persist	VBD
cord-005453-4057qib7	15206	5	in	in	IN
cord-005453-4057qib7	15206	6	the	the	DT
cord-005453-4057qib7	15206	7	recipient	recipient	NN
cord-005453-4057qib7	15206	8	for	for	IN
cord-005453-4057qib7	15206	9	a	a	DT
cord-005453-4057qib7	15206	10	long	long	JJ
cord-005453-4057qib7	15206	11	period	period	NN
cord-005453-4057qib7	15206	12	and	and	CC
cord-005453-4057qib7	15206	13	did	do	VBD
cord-005453-4057qib7	15206	14	not	not	RB
cord-005453-4057qib7	15206	15	lead	lead	VB
cord-005453-4057qib7	15206	16	to	to	IN
cord-005453-4057qib7	15206	17	any	any	DT
cord-005453-4057qib7	15206	18	adverse	adverse	JJ
cord-005453-4057qib7	15206	19	Events	event	NNS
cord-005453-4057qib7	15206	20	.	.	.
cord-005453-4057qib7	15207	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15207	2	:	:	:
cord-005453-4057qib7	15207	3	no	no	DT
cord-005453-4057qib7	15207	4	disclosures	disclosure	NNS
cord-005453-4057qib7	15207	5	to	to	TO
cord-005453-4057qib7	15207	6	declaim	declaim	VB
cord-005453-4057qib7	15207	7	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	15207	8	HSCT	HSCT	NNP
cord-005453-4057qib7	15207	9	for	for	IN
cord-005453-4057qib7	15207	10	patients	patient	NNS
cord-005453-4057qib7	15207	11	with	with	IN
cord-005453-4057qib7	15207	12	transfusion	transfusion	NN
cord-005453-4057qib7	15207	13	dependent	dependent	JJ
cord-005453-4057qib7	15207	14	anemia	anemia	NN
cord-005453-4057qib7	15207	15	from	from	IN
cord-005453-4057qib7	15207	16	matched	match	VBN
cord-005453-4057qib7	15207	17	and	and	CC
cord-005453-4057qib7	15207	18	mismatched	mismatched	JJ
cord-005453-4057qib7	15207	19	donors	donor	NNS
cord-005453-4057qib7	15207	20	Julia	Julia	NNP
cord-005453-4057qib7	15207	21	Fekadu	Fekadu	NNP
cord-005453-4057qib7	15207	22	1	1	CD
cord-005453-4057qib7	15207	23	,	,	,
cord-005453-4057qib7	15207	24	Andrea	Andrea	NNP
cord-005453-4057qib7	15207	25	Jarisch	Jarisch	NNP
cord-005453-4057qib7	15207	26	1	1	CD
cord-005453-4057qib7	15207	27	,	,	,
cord-005453-4057qib7	15207	28	Jan	Jan	NNP
cord-005453-4057qib7	15207	29	Sörensen	Sörensen	NNP
cord-005453-4057qib7	15207	30	1	1	CD
cord-005453-4057qib7	15207	31	,	,	,
cord-005453-4057qib7	15207	32	Emilia	Emilia	NNP
cord-005453-4057qib7	15207	33	Salzmann	Salzmann	NNP
cord-005453-4057qib7	15207	34	1	1	CD
cord-005453-4057qib7	15207	35	,	,	,
cord-005453-4057qib7	15207	36	Eva	Eva	NNP
cord-005453-4057qib7	15207	37	Rettinger	Rettinger	NNP
cord-005453-4057qib7	15207	38	1	1	CD
cord-005453-4057qib7	15207	39	,	,	,
cord-005453-4057qib7	15207	40	André	André	NNP
cord-005453-4057qib7	15207	41	Willasch	Willasch	NNP
cord-005453-4057qib7	15207	42	1	1	CD
cord-005453-4057qib7	15207	43	,	,	,
cord-005453-4057qib7	15207	44	Shahrzad	Shahrzad	NNP
cord-005453-4057qib7	15207	45	Bakhtiar	Bakhtiar	NNP
cord-005453-4057qib7	15207	46	1	1	CD
cord-005453-4057qib7	15207	47	,	,	,
cord-005453-4057qib7	15207	48	Thomas	Thomas	NNP
cord-005453-4057qib7	15207	49	Klingebiel	Klingebiel	NNP
cord-005453-4057qib7	15207	50	1	1	CD
cord-005453-4057qib7	15207	51	,	,	,
cord-005453-4057qib7	15207	52	Peter	Peter	NNP
cord-005453-4057qib7	15207	53	Bader	Bader	NNP
cord-005453-4057qib7	15207	54	1	1	CD
cord-005453-4057qib7	15207	55	after	after	IN
cord-005453-4057qib7	15207	56	first	first	JJ
cord-005453-4057qib7	15207	57	ASCT	ASCT	NNP
cord-005453-4057qib7	15207	58	.	.	.
cord-005453-4057qib7	15208	1	The	the	DT
cord-005453-4057qib7	15208	2	mean	mean	JJ
cord-005453-4057qib7	15208	3	harvest	harvest	NN
cord-005453-4057qib7	15208	4	for	for	IN
cord-005453-4057qib7	15208	5	patients	patient	NNS
cord-005453-4057qib7	15208	6	receiving	receive	VBG
cord-005453-4057qib7	15208	7	DHAP	DHAP	NNP
cord-005453-4057qib7	15208	8	was	be	VBD
cord-005453-4057qib7	15208	9	10,02x10	10,02x10	CD
cord-005453-4057qib7	15208	10	6	6	CD
cord-005453-4057qib7	15208	11	CD34(+	CD34(+	NNS
cord-005453-4057qib7	15208	12	)	)	-RRB-
cord-005453-4057qib7	15208	13	cells	cell	NNS
cord-005453-4057qib7	15208	14	/	/	SYM
cord-005453-4057qib7	15208	15	kg	kg	NNS
cord-005453-4057qib7	15208	16	,	,	,
cord-005453-4057qib7	15209	1	3,04	3,04	CD
cord-005453-4057qib7	15209	2	x10	x10	CD
cord-005453-4057qib7	15209	3	6	6	CD
cord-005453-4057qib7	15209	4	CD34	CD34	NNP
cord-005453-4057qib7	15209	5	(	(	-LRB-
cord-005453-4057qib7	15209	6	+	+	NNS
cord-005453-4057qib7	15209	7	)	)	-RRB-
cord-005453-4057qib7	15209	8	cells	cell	NNS
cord-005453-4057qib7	15209	9	/	/	SYM
cord-005453-4057qib7	15209	10	kg	kg	NNS
cord-005453-4057qib7	15209	11	for	for	IN
cord-005453-4057qib7	15209	12	CY	CY	NNP
cord-005453-4057qib7	15209	13	,	,	,
cord-005453-4057qib7	15209	14	8.56	8.56	CD
cord-005453-4057qib7	15209	15	x10	x10	CD
cord-005453-4057qib7	15209	16	6	6	CD
cord-005453-4057qib7	15209	17	CD34(+	cd34(+	JJ
cord-005453-4057qib7	15209	18	)	)	-RRB-
cord-005453-4057qib7	15209	19	cells	cell	NNS
cord-005453-4057qib7	15209	20	/	/	SYM
cord-005453-4057qib7	15209	21	kg	kg	NNS
cord-005453-4057qib7	15209	22	for	for	IN
cord-005453-4057qib7	15209	23	IGEV	IGEV	NNP
cord-005453-4057qib7	15209	24	,	,	,
cord-005453-4057qib7	15209	25	6,76	6,76	CD
cord-005453-4057qib7	15209	26	x10	x10	NN
cord-005453-4057qib7	15209	27	6	6	CD
cord-005453-4057qib7	15209	28	CD34(+	cd34(+	JJ
cord-005453-4057qib7	15209	29	)	)	-RRB-
cord-005453-4057qib7	15209	30	cells	cell	NNS
cord-005453-4057qib7	15209	31	/	/	SYM
cord-005453-4057qib7	15209	32	kg	kg	NN
cord-005453-4057qib7	15209	33	for	for	IN
cord-005453-4057qib7	15209	34	ICE	ice	NN
cord-005453-4057qib7	15209	35	,	,	,
cord-005453-4057qib7	15210	1	10,52	10,52	CD
cord-005453-4057qib7	15210	2	x10	x10	CD
cord-005453-4057qib7	15210	3	6	6	CD
cord-005453-4057qib7	15210	4	CD34(+	cd34(+	JJ
cord-005453-4057qib7	15210	5	)	)	-RRB-
cord-005453-4057qib7	15210	6	cells	cell	NNS
cord-005453-4057qib7	15210	7	/	/	SYM
cord-005453-4057qib7	15210	8	kg	kg	NNS
cord-005453-4057qib7	15210	9	for	for	IN
cord-005453-4057qib7	15210	10	CHOEP	CHOEP	NNP
cord-005453-4057qib7	15210	11	.	.	.
cord-005453-4057qib7	15211	1	The	the	DT
cord-005453-4057qib7	15211	2	patient	patient	NN
cord-005453-4057qib7	15211	3	mobilized	mobilize	VBD
cord-005453-4057qib7	15211	4	with	with	IN
cord-005453-4057qib7	15211	5	VTD	VTD	NNP
cord-005453-4057qib7	15211	6	-	-	HYPH
cord-005453-4057qib7	15211	7	PACE	pace	NN
cord-005453-4057qib7	15211	8	achieved	achieve	VBD
cord-005453-4057qib7	15211	9	2,2	2,2	CD
cord-005453-4057qib7	15211	10	x10	x10	CD
cord-005453-4057qib7	15211	11	6	6	CD
cord-005453-4057qib7	15211	12	CD34(+	cd34(+	JJ
cord-005453-4057qib7	15211	13	)	)	-RRB-
cord-005453-4057qib7	15211	14	cells	cell	NNS
cord-005453-4057qib7	15211	15	/	/	SYM
cord-005453-4057qib7	15211	16	kg	kg	NNS
cord-005453-4057qib7	15211	17	after	after	IN
cord-005453-4057qib7	15211	18	2	2	CD
cord-005453-4057qib7	15211	19	apheresis	apheresis	NN
cord-005453-4057qib7	15211	20	.	.	.
cord-005453-4057qib7	15212	1	19	19	CD
cord-005453-4057qib7	15212	2	of	of	IN
cord-005453-4057qib7	15212	3	the	the	DT
cord-005453-4057qib7	15212	4	patients	patient	NNS
cord-005453-4057qib7	15212	5	achieved	achieve	VBD
cord-005453-4057qib7	15212	6	the	the	DT
cord-005453-4057qib7	15212	7	target	target	NN
cord-005453-4057qib7	15212	8	number	number	NN
cord-005453-4057qib7	15212	9	of	of	IN
cord-005453-4057qib7	15212	10	>	>	XX
cord-005453-4057qib7	15213	1	2x10	2x10	CD
cord-005453-4057qib7	15213	2	6	6	CD
cord-005453-4057qib7	15214	1	/kg	/kg	.
cord-005453-4057qib7	15215	1	CD34	CD34	NNP
cord-005453-4057qib7	15215	2	+	+	CC
cord-005453-4057qib7	15215	3	cells	cell	NNS
cord-005453-4057qib7	15215	4	after	after	IN
cord-005453-4057qib7	15215	5	1	1	CD
cord-005453-4057qib7	15215	6	apheresis	apheresis	NN
cord-005453-4057qib7	15215	7	,	,	,
cord-005453-4057qib7	15215	8	15	15	CD
cord-005453-4057qib7	15215	9	after	after	IN
cord-005453-4057qib7	15215	10	two	two	CD
cord-005453-4057qib7	15215	11	,	,	,
cord-005453-4057qib7	15215	12	and	and	CC
cord-005453-4057qib7	15215	13	2	2	CD
cord-005453-4057qib7	15215	14	after	after	IN
cord-005453-4057qib7	15215	15	three	three	CD
cord-005453-4057qib7	15215	16	apheresis	apheresis	NN
cord-005453-4057qib7	15215	17	.	.	.
cord-005453-4057qib7	15216	1	The	the	DT
cord-005453-4057qib7	15216	2	median	median	JJ
cord-005453-4057qib7	15216	3	time	time	NN
cord-005453-4057qib7	15216	4	to	to	IN
cord-005453-4057qib7	15216	5	apheresis	apheresis	NN
cord-005453-4057qib7	15216	6	was	be	VBD
cord-005453-4057qib7	15216	7	13	13	CD
cord-005453-4057qib7	15216	8	days	day	NNS
cord-005453-4057qib7	15216	9	(	(	-LRB-
cord-005453-4057qib7	15216	10	8	8	CD
cord-005453-4057qib7	15216	11	-	-	SYM
cord-005453-4057qib7	15216	12	18	18	CD
cord-005453-4057qib7	15216	13	)	)	-RRB-
cord-005453-4057qib7	15216	14	without	without	IN
cord-005453-4057qib7	15216	15	significant	significant	JJ
cord-005453-4057qib7	15216	16	difference	difference	NN
cord-005453-4057qib7	15216	17	between	between	IN
cord-005453-4057qib7	15216	18	the	the	DT
cord-005453-4057qib7	15216	19	regimens	regimen	NNS
cord-005453-4057qib7	15216	20	.	.	.
cord-005453-4057qib7	15217	1	The	the	DT
cord-005453-4057qib7	15217	2	mean	mean	JJ
cord-005453-4057qib7	15217	3	WBC	WBC	NNP
cord-005453-4057qib7	15217	4	count	count	NN
cord-005453-4057qib7	15217	5	at	at	IN
cord-005453-4057qib7	15217	6	the	the	DT
cord-005453-4057qib7	15217	7	time	time	NN
cord-005453-4057qib7	15217	8	of	of	IN
cord-005453-4057qib7	15217	9	apheresis	apheresis	NN
cord-005453-4057qib7	15217	10	was	be	VBD
cord-005453-4057qib7	15217	11	42,8x10	42,8x10	CD
cord-005453-4057qib7	15217	12	9	9	CD
cord-005453-4057qib7	15217	13	/L	/L	.
cord-005453-4057qib7	15217	14	after	after	IN
cord-005453-4057qib7	15217	15	DHAP	DHAP	NNP
cord-005453-4057qib7	15217	16	,	,	,
cord-005453-4057qib7	15217	17	34,5	34,5	CD
cord-005453-4057qib7	15217	18	x10	x10	CD
cord-005453-4057qib7	15217	19	9	9	CD
cord-005453-4057qib7	15217	20	/L	/L	.
cord-005453-4057qib7	15217	21	after	after	IN
cord-005453-4057qib7	15217	22	CY	CY	NNP
cord-005453-4057qib7	15217	23	,	,	,
cord-005453-4057qib7	15217	24	21,2	21,2	CD
cord-005453-4057qib7	15217	25	x10	x10	CD
cord-005453-4057qib7	15217	26	9	9	CD
cord-005453-4057qib7	15217	27	/L	/L	.
cord-005453-4057qib7	15217	28	after	after	IN
cord-005453-4057qib7	15217	29	IGEV	IGEV	NNP
cord-005453-4057qib7	15217	30	,	,	,
cord-005453-4057qib7	15217	31	23,1	23,1	CD
cord-005453-4057qib7	15217	32	x10	x10	CD
cord-005453-4057qib7	15217	33	9	9	CD
cord-005453-4057qib7	15217	34	/L	/L	.
cord-005453-4057qib7	15217	35	after	after	IN
cord-005453-4057qib7	15217	36	ICE	ice	NN
cord-005453-4057qib7	15217	37	,	,	,
cord-005453-4057qib7	15217	38	45,8	45,8	CD
cord-005453-4057qib7	15217	39	x10	x10	NN
cord-005453-4057qib7	15217	40	9	9	CD
cord-005453-4057qib7	15217	41	/L	/L	.
cord-005453-4057qib7	15217	42	after	after	IN
cord-005453-4057qib7	15217	43	CHOEP	CHOEP	NNP
cord-005453-4057qib7	15217	44	.	.	.
cord-005453-4057qib7	15218	1	There	there	EX
cord-005453-4057qib7	15218	2	was	be	VBD
cord-005453-4057qib7	15218	3	correlation	correlation	NN
cord-005453-4057qib7	15218	4	between	between	IN
cord-005453-4057qib7	15218	5	WBC	WBC	NNP
cord-005453-4057qib7	15218	6	and	and	CC
cord-005453-4057qib7	15218	7	CD34	CD34	NNP
cord-005453-4057qib7	15218	8	harvested	harvest	VBD
cord-005453-4057qib7	15218	9	cells	cell	NNS
cord-005453-4057qib7	15218	10	(	(	-LRB-
cord-005453-4057qib7	15218	11	p=0.005	p=0.005	NNP
cord-005453-4057qib7	15218	12	)	)	-RRB-
cord-005453-4057qib7	15218	13	.	.	.
cord-005453-4057qib7	15219	1	Grate	Grate	NNP
cord-005453-4057qib7	15219	2	3	3	CD
cord-005453-4057qib7	15219	3	-	-	SYM
cord-005453-4057qib7	15219	4	4	4	CD
cord-005453-4057qib7	15219	5	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	15219	6	was	be	VBD
cord-005453-4057qib7	15219	7	found	find	VBN
cord-005453-4057qib7	15219	8	in	in	IN
cord-005453-4057qib7	15219	9	8	8	CD
cord-005453-4057qib7	15219	10	patient	patient	NN
cord-005453-4057qib7	15219	11	(	(	-LRB-
cord-005453-4057qib7	15219	12	5	5	CD
cord-005453-4057qib7	15219	13	DHAP	DHAP	NNP
cord-005453-4057qib7	15219	14	,	,	,
cord-005453-4057qib7	15219	15	1	1	CD
cord-005453-4057qib7	15219	16	ICE	ice	NN
cord-005453-4057qib7	15219	17	,	,	,
cord-005453-4057qib7	15219	18	1IGEV	1igev	CD
cord-005453-4057qib7	15219	19	,	,	,
cord-005453-4057qib7	15219	20	1	1	CD
cord-005453-4057qib7	15219	21	VTD	vtd	NN
cord-005453-4057qib7	15219	22	-	-	HYPH
cord-005453-4057qib7	15219	23	PACE	pace	NN
cord-005453-4057qib7	15219	24	)	)	-RRB-
cord-005453-4057qib7	15219	25	.	.	.
cord-005453-4057qib7	15220	1	Grate	Grate	NNP
cord-005453-4057qib7	15220	2	3	3	CD
cord-005453-4057qib7	15220	3	-	-	SYM
cord-005453-4057qib7	15220	4	4	4	CD
cord-005453-4057qib7	15220	5	anemia	anemia	NN
cord-005453-4057qib7	15220	6	was	be	VBD
cord-005453-4057qib7	15220	7	registered	register	VBN
cord-005453-4057qib7	15220	8	in	in	IN
cord-005453-4057qib7	15220	9	3	3	CD
cord-005453-4057qib7	15220	10	patients	patient	NNS
cord-005453-4057qib7	15220	11	(	(	-LRB-
cord-005453-4057qib7	15220	12	2	2	CD
cord-005453-4057qib7	15220	13	DHAP	DHAP	NNS
cord-005453-4057qib7	15220	14	and	and	CC
cord-005453-4057qib7	15220	15	1	1	CD
cord-005453-4057qib7	15220	16	VTD	vtd	NN
cord-005453-4057qib7	15220	17	-	-	HYPH
cord-005453-4057qib7	15220	18	PACE	PACE	NNP
cord-005453-4057qib7	15220	19	)	)	-RRB-
cord-005453-4057qib7	15220	20	.	.	.
cord-005453-4057qib7	15221	1	No	no	DT
cord-005453-4057qib7	15221	2	correlation	correlation	NN
cord-005453-4057qib7	15221	3	was	be	VBD
cord-005453-4057qib7	15221	4	found	find	VBN
cord-005453-4057qib7	15221	5	between	between	IN
cord-005453-4057qib7	15221	6	the	the	DT
cord-005453-4057qib7	15221	7	CD	CD	NNP
cord-005453-4057qib7	15221	8	34	34	CD
cord-005453-4057qib7	15221	9	+	+	SYM
cord-005453-4057qib7	15221	10	harvest	harvest	NN
cord-005453-4057qib7	15221	11	and	and	CC
cord-005453-4057qib7	15221	12	the	the	DT
cord-005453-4057qib7	15221	13	age	age	NN
cord-005453-4057qib7	15221	14	,	,	,
cord-005453-4057qib7	15221	15	number	number	NN
cord-005453-4057qib7	15221	16	of	of	IN
cord-005453-4057qib7	15221	17	previous	previous	JJ
cord-005453-4057qib7	15221	18	lines	line	NNS
cord-005453-4057qib7	15222	1	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15222	2	,	,	,
cord-005453-4057qib7	15222	3	the	the	DT
cord-005453-4057qib7	15222	4	response	response	NN
cord-005453-4057qib7	15222	5	before	before	IN
cord-005453-4057qib7	15222	6	mobilization	mobilization	NN
cord-005453-4057qib7	15222	7	,	,	,
cord-005453-4057qib7	15222	8	the	the	DT
cord-005453-4057qib7	15222	9	type	type	NN
cord-005453-4057qib7	15222	10	of	of	IN
cord-005453-4057qib7	15222	11	the	the	DT
cord-005453-4057qib7	15222	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	15222	13	and	and	CC
cord-005453-4057qib7	15222	14	the	the	DT
cord-005453-4057qib7	15222	15	clinical	clinical	JJ
cord-005453-4057qib7	15222	16	stage	stage	NN
cord-005453-4057qib7	15222	17	.	.	.
cord-005453-4057qib7	15223	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15223	2	:	:	:
cord-005453-4057qib7	15224	1	Our	-PRON-	PRP$
cord-005453-4057qib7	15224	2	results	result	NNS
cord-005453-4057qib7	15224	3	demonstrate	demonstrate	VBP
cord-005453-4057qib7	15224	4	that	that	IN
cord-005453-4057qib7	15224	5	the	the	DT
cord-005453-4057qib7	15224	6	chemo	chemo	NN
cord-005453-4057qib7	15224	7	-	-	HYPH
cord-005453-4057qib7	15224	8	G	G	NNP
cord-005453-4057qib7	15224	9	-	-	HYPH
cord-005453-4057qib7	15224	10	CSF	csf	NN
cord-005453-4057qib7	15224	11	protocols	protocol	NNS
cord-005453-4057qib7	15224	12	have	have	VBP
cord-005453-4057qib7	15224	13	comparable	comparable	JJ
cord-005453-4057qib7	15224	14	effectiveness	effectiveness	NN
cord-005453-4057qib7	15224	15	with	with	IN
cord-005453-4057qib7	15224	16	accep-	accep-	JJ
cord-005453-4057qib7	15224	17	Background	background	NN
cord-005453-4057qib7	15224	18	:	:	:
cord-005453-4057qib7	15224	19	Cytomegalovirus	Cytomegalovirus	NNP
cord-005453-4057qib7	15224	20	(	(	-LRB-
cord-005453-4057qib7	15224	21	CMV	CMV	NNP
cord-005453-4057qib7	15224	22	)	)	-RRB-
cord-005453-4057qib7	15224	23	may	may	MD
cord-005453-4057qib7	15224	24	cause	cause	VB
cord-005453-4057qib7	15224	25	severe	severe	JJ
cord-005453-4057qib7	15224	26	complications	complication	NNS
cord-005453-4057qib7	15224	27	in	in	IN
cord-005453-4057qib7	15224	28	recipients	recipient	NNS
cord-005453-4057qib7	15224	29	of	of	IN
cord-005453-4057qib7	15224	30	allogeneic	allogeneic	NN
cord-005453-4057qib7	15224	31	haematologic	haematologic	JJ
cord-005453-4057qib7	15224	32	stem	stem	NN
cord-005453-4057qib7	15224	33	cell	cell	NN
cord-005453-4057qib7	15224	34	transplantation	transplantation	NN
cord-005453-4057qib7	15224	35	(	(	-LRB-
cord-005453-4057qib7	15224	36	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	15224	37	)	)	-RRB-
cord-005453-4057qib7	15224	38	.	.	.
cord-005453-4057qib7	15225	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	15225	2	(	(	-LRB-
cord-005453-4057qib7	15225	3	LTV	LTV	NNP
cord-005453-4057qib7	15225	4	,	,	,
cord-005453-4057qib7	15225	5	480/	480/	CD
cord-005453-4057qib7	15225	6	240	240	CD
cord-005453-4057qib7	15225	7	mg	mg	NNP
cord-005453-4057qib7	15225	8	daily	daily	RB
cord-005453-4057qib7	15225	9	without	without	IN
cord-005453-4057qib7	15225	10	/	/	SYM
cord-005453-4057qib7	15225	11	with	with	IN
cord-005453-4057qib7	15225	12	co	co	NN
cord-005453-4057qib7	15225	13	-	-	NN
cord-005453-4057qib7	15225	14	administration	administration	NN
cord-005453-4057qib7	15225	15	of	of	IN
cord-005453-4057qib7	15225	16	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	15225	17	)	)	-RRB-
cord-005453-4057qib7	15225	18	was	be	VBD
cord-005453-4057qib7	15225	19	recently	recently	RB
cord-005453-4057qib7	15225	20	licenced	licence	VBN
cord-005453-4057qib7	15225	21	only	only	RB
cord-005453-4057qib7	15225	22	for	for	IN
cord-005453-4057qib7	15225	23	CMV	CMV	NNP
cord-005453-4057qib7	15225	24	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15225	25	in	in	IN
cord-005453-4057qib7	15225	26	adult	adult	NN
cord-005453-4057qib7	15225	27	alloHSCT	allohsct	NN
cord-005453-4057qib7	15225	28	-	-	HYPH
cord-005453-4057qib7	15225	29	recipients	recipient	NNS
cord-005453-4057qib7	15225	30	.	.	.
cord-005453-4057qib7	15226	1	Paediatric	paediatric	JJ
cord-005453-4057qib7	15226	2	data	datum	NNS
cord-005453-4057qib7	15226	3	as	as	RB
cord-005453-4057qib7	15226	4	well	well	RB
cord-005453-4057qib7	15226	5	as	as	IN
cord-005453-4057qib7	15226	6	data	datum	NNS
cord-005453-4057qib7	15226	7	on	on	IN
cord-005453-4057qib7	15226	8	CMV	CMV	NNP
cord-005453-4057qib7	15226	9	therapy	therapy	NN
cord-005453-4057qib7	15226	10	are	be	VBP
cord-005453-4057qib7	15226	11	missing	miss	VBG
cord-005453-4057qib7	15226	12	so	so	RB
cord-005453-4057qib7	15226	13	far	far	RB
cord-005453-4057qib7	15226	14	.	.	.
cord-005453-4057qib7	15227	1	Methods	method	NNS
cord-005453-4057qib7	15227	2	:	:	:
cord-005453-4057qib7	15228	1	We	-PRON-	PRP
cord-005453-4057qib7	15228	2	administered	administer	VBD
cord-005453-4057qib7	15228	3	letermovir	letermovir	NNP
cord-005453-4057qib7	15228	4	240	240	CD
cord-005453-4057qib7	15228	5	mg	mg	NNS
cord-005453-4057qib7	15228	6	orally	orally	RB
cord-005453-4057qib7	15228	7	once	once	RB
cord-005453-4057qib7	15228	8	daily	daily	RB
cord-005453-4057qib7	15228	9	(	(	-LRB-
cord-005453-4057qib7	15228	10	with	with	IN
cord-005453-4057qib7	15228	11	no	no	DT
cord-005453-4057qib7	15228	12	co	co	NN
cord-005453-4057qib7	15228	13	-	-	NN
cord-005453-4057qib7	15228	14	administration	administration	NN
cord-005453-4057qib7	15228	15	of	of	IN
cord-005453-4057qib7	15228	16	Cyclosporine	Cyclosporine	NNP
cord-005453-4057qib7	15228	17	A	A	NNP
cord-005453-4057qib7	15228	18	)	)	-RRB-
cord-005453-4057qib7	15228	19	to	to	IN
cord-005453-4057qib7	15228	20	2	2	CD
cord-005453-4057qib7	15228	21	paediatric	paediatric	JJ
cord-005453-4057qib7	15228	22	patients	patient	NNS
cord-005453-4057qib7	15228	23	after	after	IN
cord-005453-4057qib7	15228	24	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	15228	25	.	.	.
cord-005453-4057qib7	15229	1	EDTA	edta	NN
cord-005453-4057qib7	15229	2	-	-	HYPH
cord-005453-4057qib7	15229	3	plasma	plasma	NN
cord-005453-4057qib7	15229	4	were	be	VBD
cord-005453-4057qib7	15229	5	occasionally	occasionally	RB
cord-005453-4057qib7	15229	6	obtained	obtain	VBN
cord-005453-4057qib7	15229	7	at	at	IN
cord-005453-4057qib7	15229	8	different	different	JJ
cord-005453-4057qib7	15229	9	time	time	NN
cord-005453-4057qib7	15229	10	points	point	NNS
cord-005453-4057qib7	15229	11	and	and	CC
cord-005453-4057qib7	15229	12	frozen	freeze	VBN
cord-005453-4057qib7	15229	13	for	for	IN
cord-005453-4057qib7	15229	14	determination	determination	NN
cord-005453-4057qib7	15229	15	of	of	IN
cord-005453-4057qib7	15229	16	letermovir	letermovir	NNS
cord-005453-4057qib7	15229	17	levels	level	NNS
cord-005453-4057qib7	15229	18	using	use	VBG
cord-005453-4057qib7	15229	19	liquid	liquid	JJ
cord-005453-4057qib7	15229	20	chromatography	chromatography	NN
cord-005453-4057qib7	15229	21	/	/	SYM
cord-005453-4057qib7	15229	22	mass	mass	NN
cord-005453-4057qib7	15229	23	spectrometry	spectrometry	NN
cord-005453-4057qib7	15229	24	(	(	-LRB-
cord-005453-4057qib7	15229	25	LC	LC	NNP
cord-005453-4057qib7	15229	26	-	-	HYPH
cord-005453-4057qib7	15229	27	MS	MS	NNP
cord-005453-4057qib7	15229	28	/	/	SYM
cord-005453-4057qib7	15229	29	MS	MS	NNP
cord-005453-4057qib7	15229	30	)	)	-RRB-
cord-005453-4057qib7	15229	31	.	.	.
cord-005453-4057qib7	15230	1	Results	result	NNS
cord-005453-4057qib7	15230	2	:	:	:
cord-005453-4057qib7	15231	1	For	for	IN
cord-005453-4057qib7	15231	2	details	detail	NNS
cord-005453-4057qib7	15231	3	on	on	IN
cord-005453-4057qib7	15231	4	patients	patient	NNS
cord-005453-4057qib7	15231	5	,	,	,
cord-005453-4057qib7	15231	6	treatment	treatment	NN
cord-005453-4057qib7	15231	7	and	and	CC
cord-005453-4057qib7	15231	8	CMV	CMV	NNP
cord-005453-4057qib7	15231	9	load	load	NN
cord-005453-4057qib7	15231	10	see	see	VBP
cord-005453-4057qib7	15231	11	table	table	NN
cord-005453-4057qib7	15231	12	1	1	CD
cord-005453-4057qib7	15231	13	.	.	.
cord-005453-4057qib7	15232	1	In	in	IN
cord-005453-4057qib7	15232	2	short	short	JJ
cord-005453-4057qib7	15232	3	periods	period	NNS
cord-005453-4057qib7	15232	4	of	of	IN
cord-005453-4057qib7	15232	5	letermovir	letermovir	NNP
cord-005453-4057qib7	15232	6	administration	administration	NN
cord-005453-4057qib7	15232	7	,	,	,
cord-005453-4057qib7	15232	8	CMV	CMV	NNP
cord-005453-4057qib7	15232	9	blood	blood	NN
cord-005453-4057qib7	15232	10	levels	level	NNS
cord-005453-4057qib7	15232	11	became	become	VBD
cord-005453-4057qib7	15232	12	negative	negative	JJ
cord-005453-4057qib7	15232	13	in	in	IN
cord-005453-4057qib7	15232	14	both	both	DT
cord-005453-4057qib7	15232	15	patients	patient	NNS
cord-005453-4057qib7	15232	16	.	.	.
cord-005453-4057qib7	15233	1	Considering	consider	VBG
cord-005453-4057qib7	15233	2	the	the	DT
cord-005453-4057qib7	15233	3	lacking	lacking	JJ
cord-005453-4057qib7	15233	4	safety	safety	NN
cord-005453-4057qib7	15233	5	data	datum	NNS
cord-005453-4057qib7	15233	6	in	in	IN
cord-005453-4057qib7	15233	7	paediatric	paediatric	JJ
cord-005453-4057qib7	15233	8	patients	patient	NNS
cord-005453-4057qib7	15233	9	,	,	,
cord-005453-4057qib7	15233	10	we	-PRON-	PRP
cord-005453-4057qib7	15233	11	stopped	stop	VBD
cord-005453-4057qib7	15233	12	letermovir	letermovir	NNP
cord-005453-4057qib7	15233	13	treatment	treatment	NN
cord-005453-4057qib7	15233	14	in	in	IN
cord-005453-4057qib7	15233	15	both	both	DT
cord-005453-4057qib7	15233	16	patients	patient	NNS
cord-005453-4057qib7	15233	17	,	,	,
cord-005453-4057qib7	15233	18	when	when	WRB
cord-005453-4057qib7	15233	19	liver	liver	NN
cord-005453-4057qib7	15233	20	parameters	parameter	NNS
cord-005453-4057qib7	15233	21	increased	increase	VBD
cord-005453-4057qib7	15233	22	.	.	.
cord-005453-4057qib7	15234	1	In	in	IN
cord-005453-4057qib7	15234	2	patient	patient	NN
cord-005453-4057qib7	15234	3	1	1	CD
cord-005453-4057qib7	15234	4	hepatopathy	hepatopathy	NN
cord-005453-4057qib7	15234	5	turned	turn	VBD
cord-005453-4057qib7	15234	6	out	out	RP
cord-005453-4057qib7	15234	7	to	to	TO
cord-005453-4057qib7	15234	8	represent	represent	VB
cord-005453-4057qib7	15234	9	histologically	histologically	RB
cord-005453-4057qib7	15234	10	proven	prove	VBN
cord-005453-4057qib7	15234	11	Graft	graft	NN
cord-005453-4057qib7	15234	12	versus	versus	IN
cord-005453-4057qib7	15234	13	Host	Host	NNP
cord-005453-4057qib7	15234	14	Disease	Disease	NNP
cord-005453-4057qib7	15234	15	(	(	-LRB-
cord-005453-4057qib7	15234	16	GvHD	GvHD	NNP
cord-005453-4057qib7	15234	17	)	)	-RRB-
cord-005453-4057qib7	15234	18	.	.	.
cord-005453-4057qib7	15235	1	In	in	IN
cord-005453-4057qib7	15235	2	patient	patient	JJ
cord-005453-4057qib7	15235	3	2	2	CD
cord-005453-4057qib7	15235	4	liver	liver	NN
cord-005453-4057qib7	15235	5	parameters	parameter	NNS
cord-005453-4057qib7	15235	6	further	further	RB
cord-005453-4057qib7	15235	7	increased	increase	VBD
cord-005453-4057qib7	15235	8	despite	despite	IN
cord-005453-4057qib7	15235	9	withdrawal	withdrawal	NN
cord-005453-4057qib7	15235	10	for	for	IN
cord-005453-4057qib7	15235	11	another	another	DT
cord-005453-4057qib7	15235	12	4	4	CD
cord-005453-4057qib7	15235	13	weeks	week	NNS
cord-005453-4057qib7	15235	14	,	,	,
cord-005453-4057qib7	15235	15	however	however	RB
cord-005453-4057qib7	15235	16	,	,	,
cord-005453-4057qib7	15235	17	hepatopathy	hepatopathy	NNP
cord-005453-4057qib7	15235	18	was	be	VBD
cord-005453-4057qib7	15235	19	only	only	RB
cord-005453-4057qib7	15235	20	mild	mild	JJ
cord-005453-4057qib7	15235	21	and	and	CC
cord-005453-4057qib7	15235	22	self	self	NN
cord-005453-4057qib7	15235	23	-	-	HYPH
cord-005453-4057qib7	15235	24	limiting	limit	VBG
cord-005453-4057qib7	15235	25	.	.	.
cord-005453-4057qib7	15236	1	Both	both	DT
cord-005453-4057qib7	15236	2	patients	patient	NNS
cord-005453-4057qib7	15236	3	additionally	additionally	RB
cord-005453-4057qib7	15236	4	received	receive	VBD
cord-005453-4057qib7	15236	5	other	other	JJ
cord-005453-4057qib7	15236	6	possibly	possibly	RB
cord-005453-4057qib7	15236	7	hepatotoxic	hepatotoxic	JJ
cord-005453-4057qib7	15236	8	substances	substance	NNS
cord-005453-4057qib7	15236	9	(	(	-LRB-
cord-005453-4057qib7	15236	10	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	15236	11	mofetil	mofetil	NNP
cord-005453-4057qib7	15236	12	and	and	CC
cord-005453-4057qib7	15236	13	trimethoprim/	trimethoprim/	CD
cord-005453-4057qib7	15236	14	sulfamethoxazole	sulfamethoxazole	NNP
cord-005453-4057qib7	15236	15	)	)	-RRB-
cord-005453-4057qib7	15236	16	.	.	.
cord-005453-4057qib7	15237	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	15237	2	plasma	plasma	NN
cord-005453-4057qib7	15237	3	levels	level	NNS
cord-005453-4057qib7	15237	4	were	be	VBD
cord-005453-4057qib7	15237	5	11.900ng	11.900ng	CD
cord-005453-4057qib7	15237	6	/	/	SYM
cord-005453-4057qib7	15237	7	mL	ml	NN
cord-005453-4057qib7	15237	8	(	(	-LRB-
cord-005453-4057qib7	15237	9	2h	2h	NNP
cord-005453-4057qib7	15237	10	)	)	-RRB-
cord-005453-4057qib7	15237	11	,	,	,
cord-005453-4057qib7	15237	12	11.600ng	11.600ng	CD
cord-005453-4057qib7	15237	13	/	/	SYM
cord-005453-4057qib7	15237	14	mL	ml	NN
cord-005453-4057qib7	15237	15	(	(	-LRB-
cord-005453-4057qib7	15237	16	12h	12h	CD
cord-005453-4057qib7	15237	17	)	)	-RRB-
cord-005453-4057qib7	15237	18	,	,	,
cord-005453-4057qib7	15237	19	1.640	1.640	CD
cord-005453-4057qib7	15237	20	-	-	SYM
cord-005453-4057qib7	15237	21	2.190ng	2.190ng	CD
cord-005453-4057qib7	15237	22	/	/	SYM
cord-005453-4057qib7	15237	23	mL	ml	NN
cord-005453-4057qib7	15237	24	(	(	-LRB-
cord-005453-4057qib7	15237	25	median	median	NN
cord-005453-4057qib7	15237	26	1.990ng/	1.990ng/	CD
cord-005453-4057qib7	15237	27	mL	ml	NN
cord-005453-4057qib7	15237	28	,	,	,
cord-005453-4057qib7	15237	29	n=3	n=3	NN
cord-005453-4057qib7	15237	30	,	,	,
cord-005453-4057qib7	15237	31	24h	24h	CD
cord-005453-4057qib7	15237	32	)	)	-RRB-
cord-005453-4057qib7	15237	33	and	and	CC
cord-005453-4057qib7	15237	34	1.050	1.050	CD
cord-005453-4057qib7	15237	35	ng	ng	NN
cord-005453-4057qib7	15237	36	/	/	SYM
cord-005453-4057qib7	15237	37	mL	ml	NN
cord-005453-4057qib7	15237	38	(	(	-LRB-
cord-005453-4057qib7	15237	39	36h	36h	CD
cord-005453-4057qib7	15237	40	after	after	IN
cord-005453-4057qib7	15237	41	administration	administration	NN
cord-005453-4057qib7	15237	42	)	)	-RRB-
cord-005453-4057qib7	15237	43	.	.	.
cord-005453-4057qib7	15238	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15238	2	:	:	:
cord-005453-4057qib7	15239	1	During	during	IN
cord-005453-4057qib7	15239	2	short	short	JJ
cord-005453-4057qib7	15239	3	letermovir	letermovir	NNS
cord-005453-4057qib7	15239	4	treatment	treatment	NN
cord-005453-4057qib7	15239	5	,	,	,
cord-005453-4057qib7	15239	6	we	-PRON-	PRP
cord-005453-4057qib7	15239	7	observed	observe	VBD
cord-005453-4057qib7	15239	8	fast	fast	JJ
cord-005453-4057qib7	15239	9	resolution	resolution	NN
cord-005453-4057qib7	15239	10	of	of	IN
cord-005453-4057qib7	15239	11	CMV	CMV	NNP
cord-005453-4057qib7	15239	12	viraemia	viraemia	NN
cord-005453-4057qib7	15239	13	as	as	RB
cord-005453-4057qib7	15239	14	well	well	RB
cord-005453-4057qib7	15239	15	as	as	IN
cord-005453-4057qib7	15239	16	rising	rise	VBG
cord-005453-4057qib7	15239	17	liver	liver	NN
cord-005453-4057qib7	15239	18	parameters	parameter	NNS
cord-005453-4057qib7	15239	19	in	in	IN
cord-005453-4057qib7	15239	20	both	both	DT
cord-005453-4057qib7	15239	21	patients	patient	NNS
cord-005453-4057qib7	15239	22	.	.	.
cord-005453-4057qib7	15240	1	While	while	IN
cord-005453-4057qib7	15240	2	elevated	elevated	JJ
cord-005453-4057qib7	15240	3	liver	liver	NN
cord-005453-4057qib7	15240	4	parameters	parameter	NNS
cord-005453-4057qib7	15240	5	represented	represent	VBD
cord-005453-4057qib7	15240	6	GvHD	GvHD	NNP
cord-005453-4057qib7	15240	7	in	in	IN
cord-005453-4057qib7	15240	8	1	1	CD
cord-005453-4057qib7	15240	9	patient	patient	NN
cord-005453-4057qib7	15240	10	,	,	,
cord-005453-4057qib7	15240	11	a	a	DT
cord-005453-4057qib7	15240	12	causal	causal	JJ
cord-005453-4057qib7	15240	13	relationship	relationship	NN
cord-005453-4057qib7	15240	14	with	with	IN
cord-005453-4057qib7	15240	15	letermovir	letermovir	NNS
cord-005453-4057qib7	15240	16	might	may	MD
cord-005453-4057qib7	15240	17	be	be	VB
cord-005453-4057qib7	15240	18	considered	consider	VBN
cord-005453-4057qib7	15240	19	in	in	IN
cord-005453-4057qib7	15240	20	the	the	DT
cord-005453-4057qib7	15240	21	other	other	JJ
cord-005453-4057qib7	15240	22	patient	patient	NN
cord-005453-4057qib7	15240	23	.	.	.
cord-005453-4057qib7	15241	1	Letermovir	Letermovir	NNP
cord-005453-4057qib7	15241	2	peak	peak	NN
cord-005453-4057qib7	15241	3	levels	level	NNS
cord-005453-4057qib7	15241	4	after	after	IN
cord-005453-4057qib7	15241	5	administration	administration	NN
cord-005453-4057qib7	15241	6	of	of	IN
cord-005453-4057qib7	15241	7	240	240	CD
cord-005453-4057qib7	15241	8	mg	mg	NNS
cord-005453-4057qib7	15241	9	were	be	VBD
cord-005453-4057qib7	15241	10	within	within	IN
cord-005453-4057qib7	15241	11	ranges	range	NNS
cord-005453-4057qib7	15241	12	reported	report	VBN
cord-005453-4057qib7	15241	13	in	in	IN
cord-005453-4057qib7	15241	14	adults	adult	NNS
cord-005453-4057qib7	15241	15	after	after	IN
cord-005453-4057qib7	15241	16	administration	administration	NN
cord-005453-4057qib7	15241	17	of	of	IN
cord-005453-4057qib7	15241	18	480	480	CD
cord-005453-4057qib7	15241	19	mg	mg	NN
cord-005453-4057qib7	15241	20	while	while	IN
cord-005453-4057qib7	15241	21	trough	trough	NN
cord-005453-4057qib7	15241	22	levels	level	NNS
cord-005453-4057qib7	15241	23	were	be	VBD
cord-005453-4057qib7	15241	24	higher	high	JJR
cord-005453-4057qib7	15241	25	indicating	indicate	VBG
cord-005453-4057qib7	15241	26	differences	difference	NNS
cord-005453-4057qib7	15241	27	in	in	IN
cord-005453-4057qib7	15241	28	pharmacokinetics	pharmacokinetic	NNS
cord-005453-4057qib7	15241	29	in	in	IN
cord-005453-4057qib7	15241	30	terms	term	NNS
cord-005453-4057qib7	15241	31	of	of	IN
cord-005453-4057qib7	15241	32	delayed	delayed	JJ
cord-005453-4057qib7	15241	33	clearance	clearance	NN
cord-005453-4057qib7	15241	34	.	.	.
cord-005453-4057qib7	15242	1	inguinal	inguinal	JJ
cord-005453-4057qib7	15242	2	lymphadenomegaly	lymphadenomegaly	NNP
cord-005453-4057qib7	15242	3	.	.	.
cord-005453-4057qib7	15243	1	After	after	IN
cord-005453-4057qib7	15243	2	failure	failure	NN
cord-005453-4057qib7	15243	3	to	to	TO
cord-005453-4057qib7	15243	4	respond	respond	VB
cord-005453-4057qib7	15243	5	to	to	IN
cord-005453-4057qib7	15243	6	seven	seven	CD
cord-005453-4057qib7	15243	7	conventional	conventional	JJ
cord-005453-4057qib7	15243	8	treatment	treatment	NN
cord-005453-4057qib7	15243	9	lines	line	NNS
cord-005453-4057qib7	15243	10	:	:	:
cord-005453-4057qib7	15243	11	methotrexate	methotrexate	NNP
cord-005453-4057qib7	15243	12	,	,	,
cord-005453-4057qib7	15243	13	COP	cop	NN
cord-005453-4057qib7	15243	14	(	(	-LRB-
cord-005453-4057qib7	15243	15	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	15243	16	,	,	,
cord-005453-4057qib7	15243	17	vincristin	vincristin	NNS
cord-005453-4057qib7	15243	18	and	and	CC
cord-005453-4057qib7	15243	19	prednisone	prednisone	NNP
cord-005453-4057qib7	15243	20	)	)	-RRB-
cord-005453-4057qib7	15243	21	;	;	:
cord-005453-4057qib7	15243	22	gemcitabine	gemcitabine	NNP
cord-005453-4057qib7	15243	23	;	;	:
cord-005453-4057qib7	15243	24	PUVA	PUVA	NNP
cord-005453-4057qib7	15243	25	;	;	:
cord-005453-4057qib7	15243	26	interferon	interferon	NN
cord-005453-4057qib7	15243	27	;	;	:
cord-005453-4057qib7	15243	28	acitretin	acitretin	NNP
cord-005453-4057qib7	15243	29	and	and	CC
cord-005453-4057qib7	15243	30	extracorporeal	extracorporeal	JJ
cord-005453-4057qib7	15243	31	photopheresis	photopheresis	NNP
cord-005453-4057qib7	15243	32	)	)	-RRB-
cord-005453-4057qib7	15243	33	,	,	,
cord-005453-4057qib7	15243	34	allogeneic	allogeneic	IN
cord-005453-4057qib7	15243	35	HSCT	HSCT	NNP
cord-005453-4057qib7	15243	36	from	from	IN
cord-005453-4057qib7	15243	37	an	an	DT
cord-005453-4057qib7	15243	38	identical	identical	JJ
cord-005453-4057qib7	15243	39	HLA	HLA	NNP
cord-005453-4057qib7	15243	40	male	male	JJ
cord-005453-4057qib7	15243	41	donor	donor	NN
cord-005453-4057qib7	15243	42	was	be	VBD
cord-005453-4057qib7	15243	43	indicated	indicate	VBN
cord-005453-4057qib7	15243	44	.	.	.
cord-005453-4057qib7	15244	1	The	the	DT
cord-005453-4057qib7	15244	2	non	non	JJ
cord-005453-4057qib7	15244	3	-	-	JJ
cord-005453-4057qib7	15244	4	myeloablative	myeloablative	JJ
cord-005453-4057qib7	15244	5	conditioning	conditioning	NN
cord-005453-4057qib7	15244	6	consisted	consist	VBD
cord-005453-4057qib7	15244	7	of	of	IN
cord-005453-4057qib7	15244	8	fludarabine	fludarabine	NN
cord-005453-4057qib7	15244	9	(	(	-LRB-
cord-005453-4057qib7	15244	10	200	200	CD
cord-005453-4057qib7	15244	11	mg	mg	NNP
cord-005453-4057qib7	15244	12	/	/	SYM
cord-005453-4057qib7	15244	13	m2	m2	NNP
cord-005453-4057qib7	15244	14	)	)	-RRB-
cord-005453-4057qib7	15244	15	,	,	,
cord-005453-4057qib7	15244	16	cyclophosphamide	cyclophosphamide	FW
cord-005453-4057qib7	15244	17	(	(	-LRB-
cord-005453-4057qib7	15244	18	50	50	CD
cord-005453-4057qib7	15244	19	mg	mg	NNP
cord-005453-4057qib7	15244	20	/	/	SYM
cord-005453-4057qib7	15244	21	kg	kg	NNP
cord-005453-4057qib7	15244	22	)	)	-RRB-
cord-005453-4057qib7	15244	23	and	and	CC
cord-005453-4057qib7	15244	24	total	total	JJ
cord-005453-4057qib7	15244	25	body	body	NN
cord-005453-4057qib7	15244	26	irradiation(TBI	irradiation(tbi	NN
cord-005453-4057qib7	15244	27	)	)	-RRB-
cord-005453-4057qib7	15245	1	(	(	-LRB-
cord-005453-4057qib7	15245	2	400cGy	400cgy	CD
cord-005453-4057qib7	15245	3	)	)	-RRB-
cord-005453-4057qib7	15245	4	.	.	.
cord-005453-4057qib7	15246	1	Prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15246	2	of	of	IN
cord-005453-4057qib7	15246	3	graft	graft	NN
cord-005453-4057qib7	15246	4	versus	versus	IN
cord-005453-4057qib7	15246	5	host	host	NN
cord-005453-4057qib7	15246	6	disease	disease	NN
cord-005453-4057qib7	15246	7	(	(	-LRB-
cord-005453-4057qib7	15246	8	GVHD	GVHD	NNP
cord-005453-4057qib7	15246	9	)	)	-RRB-
cord-005453-4057qib7	15246	10	was	be	VBD
cord-005453-4057qib7	15246	11	performed	perform	VBN
cord-005453-4057qib7	15246	12	with	with	IN
cord-005453-4057qib7	15246	13	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	15246	14	(	(	-LRB-
cord-005453-4057qib7	15246	15	3	3	CD
cord-005453-4057qib7	15246	16	mg	mg	NN
cord-005453-4057qib7	15246	17	/	/	SYM
cord-005453-4057qib7	15246	18	kg	kg	NNP
cord-005453-4057qib7	15246	19	)	)	-RRB-
cord-005453-4057qib7	15246	20	and	and	CC
cord-005453-4057qib7	15246	21	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	15246	22	mofetil	mofetil	NNP
cord-005453-4057qib7	15246	23	(	(	-LRB-
cord-005453-4057qib7	15246	24	30mg	30mg	NNP
cord-005453-4057qib7	15246	25	/	/	SYM
cord-005453-4057qib7	15246	26	kg	kg	NNP
cord-005453-4057qib7	15246	27	)	)	-RRB-
cord-005453-4057qib7	15246	28	.	.	.
cord-005453-4057qib7	15247	1	After	after	IN
cord-005453-4057qib7	15247	2	conditioning	conditioning	NN
cord-005453-4057qib7	15247	3	,	,	,
cord-005453-4057qib7	15247	4	there	there	EX
cord-005453-4057qib7	15247	5	was	be	VBD
cord-005453-4057qib7	15247	6	improvement	improvement	NN
cord-005453-4057qib7	15247	7	of	of	IN
cord-005453-4057qib7	15247	8	pruritus	pruritus	NN
cord-005453-4057qib7	15247	9	and	and	CC
cord-005453-4057qib7	15247	10	involution	involution	NN
cord-005453-4057qib7	15247	11	of	of	IN
cord-005453-4057qib7	15247	12	the	the	DT
cord-005453-4057qib7	15247	13	skin	skin	NN
cord-005453-4057qib7	15247	14	.	.	.
cord-005453-4057qib7	15248	1	Bone	bone	NN
cord-005453-4057qib7	15248	2	marrow	marrow	NN
cord-005453-4057qib7	15248	3	infusion	infusion	NN
cord-005453-4057qib7	15248	4	occurred	occur	VBD
cord-005453-4057qib7	15248	5	on	on	IN
cord-005453-4057qib7	15248	6	2/9/2018	2/9/2018	CD
cord-005453-4057qib7	15248	7	(	(	-LRB-
cord-005453-4057qib7	15248	8	D0	D0	NNP
cord-005453-4057qib7	15248	9	)	)	-RRB-
cord-005453-4057qib7	15248	10	.	.	.
cord-005453-4057qib7	15249	1	On	on	IN
cord-005453-4057qib7	15249	2	d	d	XX
cord-005453-4057qib7	15249	3	+	+	SYM
cord-005453-4057qib7	15249	4	83	83	CD
cord-005453-4057qib7	15249	5	he	-PRON-	PRP
cord-005453-4057qib7	15249	6	presented	present	VBD
cord-005453-4057qib7	15249	7	recurrence	recurrence	NN
cord-005453-4057qib7	15249	8	of	of	IN
cord-005453-4057qib7	15249	9	skin	skin	NN
cord-005453-4057qib7	15249	10	lesions	lesion	NNS
cord-005453-4057qib7	15249	11	of	of	IN
cord-005453-4057qib7	15249	12	fMF	fmf	CD
cord-005453-4057qib7	15249	13	.	.	.
cord-005453-4057qib7	15250	1	Donor	donor	NN
cord-005453-4057qib7	15250	2	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	15250	3	infusion	infusion	NN
cord-005453-4057qib7	15250	4	(	(	-LRB-
cord-005453-4057qib7	15250	5	DLI	DLI	NNP
cord-005453-4057qib7	15250	6	)	)	-RRB-
cord-005453-4057qib7	15250	7	was	be	VBD
cord-005453-4057qib7	15250	8	performed	perform	VBN
cord-005453-4057qib7	15250	9	(	(	-LRB-
cord-005453-4057qib7	15250	10	1	1	CD
cord-005453-4057qib7	15250	11	x	x	SYM
cord-005453-4057qib7	15250	12	10	10	CD
cord-005453-4057qib7	15250	13	7	7	CD
cord-005453-4057qib7	15250	14	CD3	CD3	NNS
cord-005453-4057qib7	15250	15	+	+	CC
cord-005453-4057qib7	15250	16	cells	cell	NNS
cord-005453-4057qib7	15250	17	/	/	SYM
cord-005453-4057qib7	15250	18	kg	kg	NN
cord-005453-4057qib7	15250	19	/	/	SYM
cord-005453-4057qib7	15250	20	recipient	recipient	NN
cord-005453-4057qib7	15250	21	)	)	-RRB-
cord-005453-4057qib7	15250	22	.	.	.
cord-005453-4057qib7	15251	1	He	-PRON-	PRP
cord-005453-4057qib7	15251	2	presented	present	VBD
cord-005453-4057qib7	15251	3	oral	oral	JJ
cord-005453-4057qib7	15251	4	lichen	lichen	NN
cord-005453-4057qib7	15251	5	and	and	CC
cord-005453-4057qib7	15251	6	diarrhea	diarrhea	NN
cord-005453-4057qib7	15251	7	respectively	respectively	RB
cord-005453-4057qib7	15251	8	as	as	IN
cord-005453-4057qib7	15251	9	manifestations	manifestation	NNS
cord-005453-4057qib7	15251	10	of	of	IN
cord-005453-4057qib7	15251	11	GVHD	GVHD	NNP
cord-005453-4057qib7	15251	12	on	on	IN
cord-005453-4057qib7	15251	13	d	d	NN
cord-005453-4057qib7	15251	14	+	+	SYM
cord-005453-4057qib7	15251	15	104	104	CD
cord-005453-4057qib7	15251	16	and	and	CC
cord-005453-4057qib7	15251	17	D	d	NN
cord-005453-4057qib7	15251	18	+	+	SYM
cord-005453-4057qib7	15251	19	112	112	CD
cord-005453-4057qib7	15251	20	.	.	.
cord-005453-4057qib7	15252	1	As	as	IN
cord-005453-4057qib7	15252	2	infectious	infectious	JJ
cord-005453-4057qib7	15252	3	intercurrence	intercurrence	NN
cord-005453-4057qib7	15252	4	,	,	,
cord-005453-4057qib7	15252	5	hemorrhagic	hemorrhagic	JJ
cord-005453-4057qib7	15252	6	cystitis	cystitis	NN
cord-005453-4057qib7	15252	7	occurred	occur	VBD
cord-005453-4057qib7	15252	8	by	by	IN
cord-005453-4057qib7	15252	9	BK	BK	NNP
cord-005453-4057qib7	15252	10	virus	virus	NN
cord-005453-4057qib7	15252	11	3	3	CD
cord-005453-4057qib7	15252	12	months	month	NNS
cord-005453-4057qib7	15252	13	after	after	IN
cord-005453-4057qib7	15252	14	the	the	DT
cord-005453-4057qib7	15252	15	first	first	JJ
cord-005453-4057qib7	15252	16	DLI	DLI	NNP
cord-005453-4057qib7	15252	17	and	and	CC
cord-005453-4057qib7	15252	18	he	-PRON-	PRP
cord-005453-4057qib7	15252	19	received	receive	VBD
cord-005453-4057qib7	15252	20	conservative	conservative	JJ
cord-005453-4057qib7	15252	21	treatment	treatment	NN
cord-005453-4057qib7	15252	22	and	and	CC
cord-005453-4057qib7	15252	23	remained	remain	VBD
cord-005453-4057qib7	15252	24	without	without	IN
cord-005453-4057qib7	15252	25	systemic	systemic	JJ
cord-005453-4057qib7	15252	26	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	15252	27	.	.	.
cord-005453-4057qib7	15253	1	Nine	nine	CD
cord-005453-4057qib7	15253	2	months	month	NNS
cord-005453-4057qib7	15253	3	after	after	IN
cord-005453-4057qib7	15253	4	HSCT	HSCT	NNP
cord-005453-4057qib7	15253	5	,	,	,
cord-005453-4057qib7	15253	6	a	a	DT
cord-005453-4057qib7	15253	7	second	second	JJ
cord-005453-4057qib7	15253	8	DLI	DLI	NNP
cord-005453-4057qib7	15253	9	(	(	-LRB-
cord-005453-4057qib7	15253	10	5	5	CD
cord-005453-4057qib7	15253	11	X	x	NN
cord-005453-4057qib7	15253	12	10	10	CD
cord-005453-4057qib7	15253	13	7	7	CD
cord-005453-4057qib7	15253	14	CD3	CD3	NNS
cord-005453-4057qib7	15253	15	+	+	CC
cord-005453-4057qib7	15253	16	cells	cell	NNS
cord-005453-4057qib7	15253	17	/	/	SYM
cord-005453-4057qib7	15253	18	Kg	Kg	NNP
cord-005453-4057qib7	15253	19	/	/	SYM
cord-005453-4057qib7	15253	20	receptor	receptor	NN
cord-005453-4057qib7	15253	21	)	)	-RRB-
cord-005453-4057qib7	15253	22	was	be	VBD
cord-005453-4057qib7	15253	23	performed	perform	VBN
cord-005453-4057qib7	15253	24	and	and	CC
cord-005453-4057qib7	15253	25	at	at	IN
cord-005453-4057qib7	15253	26	this	this	DT
cord-005453-4057qib7	15253	27	time	time	NN
cord-005453-4057qib7	15253	28	the	the	DT
cord-005453-4057qib7	15253	29	patient	patient	NN
cord-005453-4057qib7	15253	30	is	be	VBZ
cord-005453-4057qib7	15253	31	without	without	IN
cord-005453-4057qib7	15253	32	clinical	clinical	JJ
cord-005453-4057qib7	15253	33	manifestations	manifestation	NNS
cord-005453-4057qib7	15253	34	of	of	IN
cord-005453-4057qib7	15253	35	fMF	fmf	CD
cord-005453-4057qib7	15253	36	or	or	CC
cord-005453-4057qib7	15253	37	GVHD	GVHD	NNP
cord-005453-4057qib7	15253	38	.	.	.
cord-005453-4057qib7	15254	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15254	2	:	:	:
cord-005453-4057qib7	15255	1	the	the	DT
cord-005453-4057qib7	15255	2	clinical	clinical	JJ
cord-005453-4057qib7	15255	3	response	response	NN
cord-005453-4057qib7	15255	4	of	of	IN
cord-005453-4057qib7	15255	5	the	the	DT
cord-005453-4057qib7	15255	6	presented	present	VBN
cord-005453-4057qib7	15255	7	case	case	NN
cord-005453-4057qib7	15255	8	confirms	confirm	VBZ
cord-005453-4057qib7	15255	9	what	what	WP
cord-005453-4057qib7	15255	10	has	have	VBZ
cord-005453-4057qib7	15255	11	been	be	VBN
cord-005453-4057qib7	15255	12	reported	report	VBN
cord-005453-4057qib7	15255	13	in	in	IN
cord-005453-4057qib7	15255	14	the	the	DT
cord-005453-4057qib7	15255	15	literature	literature	NN
cord-005453-4057qib7	15255	16	.	.	.
cord-005453-4057qib7	15256	1	CTCLs	CTCLs	NNP
cord-005453-4057qib7	15256	2	appear	appear	VBP
cord-005453-4057qib7	15256	3	to	to	TO
cord-005453-4057qib7	15256	4	be	be	VB
cord-005453-4057qib7	15256	5	particularly	particularly	RB
cord-005453-4057qib7	15256	6	susceptible	susceptible	JJ
cord-005453-4057qib7	15256	7	to	to	IN
cord-005453-4057qib7	15256	8	GVL	GVL	NNP
cord-005453-4057qib7	15256	9	effect	effect	NN
cord-005453-4057qib7	15256	10	,	,	,
cord-005453-4057qib7	15256	11	which	which	WDT
cord-005453-4057qib7	15256	12	makes	make	VBZ
cord-005453-4057qib7	15256	13	HSCT	HSCT	NNP
cord-005453-4057qib7	15256	14	a	a	DT
cord-005453-4057qib7	15256	15	potential	potential	JJ
cord-005453-4057qib7	15256	16	cure	cure	NN
cord-005453-4057qib7	15256	17	for	for	IN
cord-005453-4057qib7	15256	18	advanced	advanced	JJ
cord-005453-4057qib7	15256	19	CTCLs	ctcl	NNS
cord-005453-4057qib7	15256	20	in	in	IN
cord-005453-4057qib7	15256	21	eligible	eligible	JJ
cord-005453-4057qib7	15256	22	patients	patient	NNS
cord-005453-4057qib7	15256	23	.	.	.
cord-005453-4057qib7	15257	1	The	the	DT
cord-005453-4057qib7	15257	2	timing	timing	NN
cord-005453-4057qib7	15257	3	to	to	TO
cord-005453-4057qib7	15257	4	perform	perform	VB
cord-005453-4057qib7	15257	5	HSCT	HSCT	NNP
cord-005453-4057qib7	15257	6	in	in	IN
cord-005453-4057qib7	15257	7	the	the	DT
cord-005453-4057qib7	15257	8	clinical	clinical	JJ
cord-005453-4057qib7	15257	9	course	course	NN
cord-005453-4057qib7	15257	10	of	of	IN
cord-005453-4057qib7	15257	11	the	the	DT
cord-005453-4057qib7	15257	12	disease	disease	NN
cord-005453-4057qib7	15257	13	remains	remain	VBZ
cord-005453-4057qib7	15257	14	a	a	DT
cord-005453-4057qib7	15257	15	matter	matter	NN
cord-005453-4057qib7	15257	16	to	to	TO
cord-005453-4057qib7	15257	17	be	be	VB
cord-005453-4057qib7	15257	18	settled	settle	VBN
cord-005453-4057qib7	15257	19	Clinical	Clinical	NNP
cord-005453-4057qib7	15257	20	Trial	Trial	NNP
cord-005453-4057qib7	15257	21	Registry	Registry	NNP
cord-005453-4057qib7	15257	22	:	:	:
cord-005453-4057qib7	15257	23	not	not	RB
cord-005453-4057qib7	15257	24	applicable	applicable	JJ
cord-005453-4057qib7	15257	25	Disclosure	disclosure	NN
cord-005453-4057qib7	15257	26	:	:	:
cord-005453-4057qib7	15257	27	no	no	DT
cord-005453-4057qib7	15257	28	conflict	conflict	NN
cord-005453-4057qib7	15257	29	of	of	IN
cord-005453-4057qib7	15257	30	interest	interest	NN
cord-005453-4057qib7	15257	31	P755	P755	NNP
cord-005453-4057qib7	15257	32	Abstract	Abstract	NNP
cord-005453-4057qib7	15257	33	already	already	RB
cord-005453-4057qib7	15257	34	published	publish	VBN
cord-005453-4057qib7	15257	35	.	.	.
cord-005453-4057qib7	15258	1	Methods	method	NNS
cord-005453-4057qib7	15258	2	:	:	:
cord-005453-4057qib7	15258	3	We	-PRON-	PRP
cord-005453-4057qib7	15258	4	applied	apply	VBD
cord-005453-4057qib7	15258	5	next	next	JJ
cord-005453-4057qib7	15258	6	generation	generation	NN
cord-005453-4057qib7	15258	7	sequencing	sequencing	NN
cord-005453-4057qib7	15258	8	(	(	-LRB-
cord-005453-4057qib7	15258	9	PGM	PGM	NNP
cord-005453-4057qib7	15258	10	,	,	,
cord-005453-4057qib7	15258	11	Ion	Ion	NNP
cord-005453-4057qib7	15258	12	Torrent/	Torrent/	NNP
cord-005453-4057qib7	15258	13	Fischer	Fischer	NNP
cord-005453-4057qib7	15258	14	Lifetechnologies	Lifetechnologies	NNP
cord-005453-4057qib7	15258	15	)	)	-RRB-
cord-005453-4057qib7	15258	16	to	to	IN
cord-005453-4057qib7	15258	17	an	an	DT
cord-005453-4057qib7	15258	18	unselected	unselected	JJ
cord-005453-4057qib7	15258	19	cohort	cohort	NN
cord-005453-4057qib7	15258	20	of	of	IN
cord-005453-4057qib7	15258	21	414	414	CD
cord-005453-4057qib7	15258	22	patients	patient	NNS
cord-005453-4057qib7	15258	23	(	(	-LRB-
cord-005453-4057qib7	15258	24	176	176	CD
cord-005453-4057qib7	15258	25	female	female	NN
cord-005453-4057qib7	15258	26	,	,	,
cord-005453-4057qib7	15258	27	238	238	CD
cord-005453-4057qib7	15258	28	male	male	JJ
cord-005453-4057qib7	15258	29	,	,	,
cord-005453-4057qib7	15258	30	median	median	JJ
cord-005453-4057qib7	15258	31	age	age	NN
cord-005453-4057qib7	15258	32	59	59	CD
cord-005453-4057qib7	15258	33	(	(	-LRB-
cord-005453-4057qib7	15258	34	2	2	CD
cord-005453-4057qib7	15258	35	-	-	SYM
cord-005453-4057qib7	15258	36	80	80	CD
cord-005453-4057qib7	15258	37	)	)	-RRB-
cord-005453-4057qib7	15258	38	years	year	NNS
cord-005453-4057qib7	15258	39	)	)	-RRB-
cord-005453-4057qib7	15258	40	who	who	WP
cord-005453-4057qib7	15258	41	had	have	VBD
cord-005453-4057qib7	15258	42	been	be	VBN
cord-005453-4057qib7	15258	43	referred	refer	VBN
cord-005453-4057qib7	15258	44	for	for	IN
cord-005453-4057qib7	15258	45	allogeneic	allogeneic	NN
cord-005453-4057qib7	15258	46	stem	stem	NN
cord-005453-4057qib7	15258	47	cell	cell	NN
cord-005453-4057qib7	15258	48	transplantation	transplantation	NN
cord-005453-4057qib7	15258	49	due	due	IN
cord-005453-4057qib7	15258	50	to	to	IN
cord-005453-4057qib7	15258	51	the	the	DT
cord-005453-4057qib7	15258	52	presence	presence	NN
cord-005453-4057qib7	15258	53	of	of	IN
cord-005453-4057qib7	15258	54	a	a	DT
cord-005453-4057qib7	15258	55	high	high	JJ
cord-005453-4057qib7	15258	56	-	-	HYPH
cord-005453-4057qib7	15258	57	risk	risk	NN
cord-005453-4057qib7	15258	58	myeloid	myeloid	NN
cord-005453-4057qib7	15258	59	disorder	disorder	NN
cord-005453-4057qib7	15258	60	DNMT3A	DNMT3A	NNP
cord-005453-4057qib7	15258	61	R882H	R882H	NNP
cord-005453-4057qib7	15258	62	(	(	-LRB-
cord-005453-4057qib7	15258	63	3.1	3.1	CD
cord-005453-4057qib7	15258	64	%	%	NN
cord-005453-4057qib7	15258	65	)	)	-RRB-
cord-005453-4057qib7	15258	66	.98	.98	NFP
cord-005453-4057qib7	15258	67	)	)	-RRB-
cord-005453-4057qib7	15258	68	,	,	,
cord-005453-4057qib7	15258	69	CEBPA	CEBPA	NNP
cord-005453-4057qib7	15258	70	(	(	-LRB-
cord-005453-4057qib7	15258	71	18.1	18.1	CD
cord-005453-4057qib7	15258	72	%	%	NN
cord-005453-4057qib7	15258	73	;	;	:
cord-005453-4057qib7	15258	74	CEB	CEB	NNP
cord-005453-4057qib7	15258	75	-	-	HYPH
cord-005453-4057qib7	15258	76	PAP198S	PAP198S	NNP
cord-005453-4057qib7	15258	77	(	(	-LRB-
cord-005453-4057qib7	15258	78	16.9	16.9	CD
cord-005453-4057qib7	15258	79	%	%	NN
cord-005453-4057qib7	15258	80	)	)	-RRB-
cord-005453-4057qib7	15258	81	VUS	VUS	NNP
cord-005453-4057qib7	15258	82	)	)	-RRB-
cord-005453-4057qib7	15258	83	KRAS	KRAS	NNP
cord-005453-4057qib7	15258	84	(	(	-LRB-
cord-005453-4057qib7	15258	85	6.5	6.5	CD
cord-005453-4057qib7	15258	86	%	%	NN
cord-005453-4057qib7	15258	87	;	;	:
cord-005453-4057qib7	15258	88	KRASR161R	KRASR161R	NNP
cord-005453-4057qib7	15258	89	(	(	-LRB-
cord-005453-4057qib7	15258	90	3.1	3.1	CD
cord-005453-4057qib7	15258	91	%	%	NN
cord-005453-4057qib7	15258	92	)	)	-RRB-
cord-005453-4057qib7	15258	93	VUS	VUS	NNP
cord-005453-4057qib7	15258	94	)	)	-RRB-
cord-005453-4057qib7	15258	95	,	,	,
cord-005453-4057qib7	15258	96	and	and	CC
cord-005453-4057qib7	15258	97	KIT	kit	NN
cord-005453-4057qib7	15258	98	(	(	-LRB-
cord-005453-4057qib7	15258	99	3.9	3.9	CD
cord-005453-4057qib7	15258	100	%	%	NN
cord-005453-4057qib7	15258	101	;	;	,
cord-005453-4057qib7	15258	102	KITM541L	kitm541l	JJ
cord-005453-4057qib7	15258	103	(	(	-LRB-
cord-005453-4057qib7	15258	104	3.9	3.9	CD
cord-005453-4057qib7	15258	105	%	%	NN
cord-005453-4057qib7	15258	106	)	)	-RRB-
cord-005453-4057qib7	15258	107	.74	.74	NFP
cord-005453-4057qib7	15258	108	)	)	-RRB-
cord-005453-4057qib7	15258	109	.	.	.
cord-005453-4057qib7	15259	1	Patients	patient	NNS
cord-005453-4057qib7	15259	2	displayed	display	VBD
cord-005453-4057qib7	15259	3	a	a	DT
cord-005453-4057qib7	15259	4	median	median	NN
cord-005453-4057qib7	15259	5	of	of	IN
cord-005453-4057qib7	15259	6	3	3	CD
cord-005453-4057qib7	15259	7	sequence	sequence	NN
cord-005453-4057qib7	15259	8	variants	variant	NNS
cord-005453-4057qib7	15259	9	(	(	-LRB-
cord-005453-4057qib7	15259	10	AML	AML	NNP
cord-005453-4057qib7	15259	11	,	,	,
cord-005453-4057qib7	15259	12	MPN	MPN	NNP
cord-005453-4057qib7	15259	13	and	and	CC
cord-005453-4057qib7	15259	14	CMML	CMML	NNP
cord-005453-4057qib7	15259	15	patients	patient	NNS
cord-005453-4057qib7	15259	16	each	each	DT
cord-005453-4057qib7	15259	17	3	3	CD
cord-005453-4057qib7	15259	18	;	;	:
cord-005453-4057qib7	15259	19	MDS	MDS	NNP
cord-005453-4057qib7	15259	20	,	,	,
cord-005453-4057qib7	15259	21	SAA	SAA	NNP
cord-005453-4057qib7	15259	22	and	and	CC
cord-005453-4057qib7	15259	23	patients	patient	NNS
cord-005453-4057qib7	15259	24	with	with	IN
cord-005453-4057qib7	15259	25	other	other	JJ
cord-005453-4057qib7	15259	26	,	,	,
cord-005453-4057qib7	15259	27	non	non	JJ
cord-005453-4057qib7	15259	28	-	-	JJ
cord-005453-4057qib7	15259	29	malignant	malignant	JJ
cord-005453-4057qib7	15259	30	hematologic	hematologic	JJ
cord-005453-4057qib7	15259	31	diseases	disease	NNS
cord-005453-4057qib7	15259	32	each	each	DT
cord-005453-4057qib7	15259	33	4	4	CD
cord-005453-4057qib7	15259	34	Sequence	sequence	NN
cord-005453-4057qib7	15259	35	variants	variant	NNS
cord-005453-4057qib7	15259	36	found	find	VBD
cord-005453-4057qib7	15259	37	most	most	RBS
cord-005453-4057qib7	15259	38	frequently	frequently	RB
cord-005453-4057qib7	15259	39	in	in	IN
cord-005453-4057qib7	15259	40	AML	AML	NNP
cord-005453-4057qib7	15259	41	were	be	VBD
cord-005453-4057qib7	15259	42	CEBPAP198S	CEBPAP198S	NNP
cord-005453-4057qib7	15259	43	(	(	-LRB-
cord-005453-4057qib7	15259	44	13.2	13.2	CD
cord-005453-4057qib7	15259	45	%	%	NN
cord-005453-4057qib7	15259	46	of	of	IN
cord-005453-4057qib7	15259	47	all	all	DT
cord-005453-4057qib7	15259	48	sequence	sequence	NN
cord-005453-4057qib7	15259	49	variants	variant	NNS
cord-005453-4057qib7	15259	50	in	in	IN
cord-005453-4057qib7	15259	51	patients	patient	NNS
cord-005453-4057qib7	15259	52	with	with	IN
cord-005453-4057qib7	15259	53	AML	AML	NNP
cord-005453-4057qib7	15259	54	,	,	,
cord-005453-4057qib7	15259	55	p	p	NN
cord-005453-4057qib7	15259	56	<	<	XX
cord-005453-4057qib7	15260	1	10	10	CD
cord-005453-4057qib7	15261	1	-3	-3	NNP
cord-005453-4057qib7	15261	2	,	,	,
cord-005453-4057qib7	15261	3	chi²	chi²	JJ
cord-005453-4057qib7	15261	4	test	test	NN
cord-005453-4057qib7	15261	5	)	)	-RRB-
cord-005453-4057qib7	15262	1	In	in	IN
cord-005453-4057qib7	15262	2	patients	patient	NNS
cord-005453-4057qib7	15262	3	suffering	suffer	VBG
cord-005453-4057qib7	15262	4	CMML	CMML	NNP
cord-005453-4057qib7	15262	5	,	,	,
cord-005453-4057qib7	15262	6	DNMT3AR882H	DNMT3AR882H	NNP
cord-005453-4057qib7	15262	7	was	be	VBD
cord-005453-4057qib7	15262	8	particularly	particularly	RB
cord-005453-4057qib7	15262	9	frequent	frequent	JJ
cord-005453-4057qib7	15262	10	(	(	-LRB-
cord-005453-4057qib7	15262	11	4.8	4.8	CD
cord-005453-4057qib7	15262	12	%	%	NN
cord-005453-4057qib7	15262	13	of	of	IN
cord-005453-4057qib7	15262	14	all	all	DT
cord-005453-4057qib7	15262	15	sequence	sequence	NN
cord-005453-4057qib7	15262	16	variants	variant	NNS
cord-005453-4057qib7	15262	17	in	in	IN
cord-005453-4057qib7	15262	18	CMML	CMML	NNP
cord-005453-4057qib7	15262	19	,	,	,
cord-005453-4057qib7	15262	20	p=.064	p=.064	NN
cord-005453-4057qib7	15262	21	)	)	-RRB-
cord-005453-4057qib7	15262	22	.	.	.
cord-005453-4057qib7	15263	1	ASXL1E1102D	ASXL1E1102D	NNP
cord-005453-4057qib7	15263	2	(	(	-LRB-
cord-005453-4057qib7	15264	1	2.1	2.1	CD
cord-005453-4057qib7	15264	2	%	%	NN
cord-005453-4057qib7	15264	3	of	of	IN
cord-005453-4057qib7	15264	4	all	all	DT
cord-005453-4057qib7	15264	5	sequence	sequence	NN
cord-005453-4057qib7	15264	6	variants	variant	NNS
cord-005453-4057qib7	15264	7	in	in	IN
cord-005453-4057qib7	15264	8	other	other	JJ
cord-005453-4057qib7	15264	9	,	,	,
cord-005453-4057qib7	15264	10	non	non	JJ
cord-005453-4057qib7	15264	11	-	-	JJ
cord-005453-4057qib7	15264	12	malignant	malignant	JJ
cord-005453-4057qib7	15264	13	hematologic	hematologic	JJ
cord-005453-4057qib7	15264	14	diseases	disease	NNS
cord-005453-4057qib7	15264	15	,	,	,
cord-005453-4057qib7	15264	16	p=.699	p=.699	NN
cord-005453-4057qib7	15264	17	)	)	-RRB-
cord-005453-4057qib7	15264	18	,	,	,
cord-005453-4057qib7	15264	19	IDH2R140Q	IDH2R140Q	NNP
cord-005453-4057qib7	15264	20	(	(	-LRB-
cord-005453-4057qib7	15264	21	2.1	2.1	CD
cord-005453-4057qib7	15264	22	%	%	NN
cord-005453-4057qib7	15264	23	,	,	,
cord-005453-4057qib7	15264	24	p=.677	p=.677	NNP
cord-005453-4057qib7	15264	25	)	)	-RRB-
cord-005453-4057qib7	15264	26	and	and	CC
cord-005453-4057qib7	15264	27	KRASR161R	krasr161r	NN
cord-005453-4057qib7	15264	28	(	(	-LRB-
cord-005453-4057qib7	15264	29	4.2	4.2	CD
cord-005453-4057qib7	15264	30	%	%	NN
cord-005453-4057qib7	15264	31	,	,	,
cord-005453-4057qib7	15264	32	p=.010	p=.010	NNP
cord-005453-4057qib7	15264	33	)	)	-RRB-
cord-005453-4057qib7	15264	34	were	be	VBD
cord-005453-4057qib7	15264	35	frequent	frequent	JJ
cord-005453-4057qib7	15264	36	in	in	IN
cord-005453-4057qib7	15264	37	other	other	JJ
cord-005453-4057qib7	15264	38	,	,	,
cord-005453-4057qib7	15264	39	non	non	JJ
cord-005453-4057qib7	15264	40	-	-	JJ
cord-005453-4057qib7	15264	41	malignant	malignant	JJ
cord-005453-4057qib7	15264	42	hematologic	hematologic	JJ
cord-005453-4057qib7	15264	43	diseases	disease	NNS
cord-005453-4057qib7	15264	44	.	.	.
cord-005453-4057qib7	15265	1	In	in	IN
cord-005453-4057qib7	15265	2	SAA	SAA	NNP
cord-005453-4057qib7	15265	3	,	,	,
cord-005453-4057qib7	15265	4	NRASG12D	NRASG12D	NNPS
cord-005453-4057qib7	15265	5	(	(	-LRB-
cord-005453-4057qib7	15265	6	4	4	CD
cord-005453-4057qib7	15265	7	%	%	NN
cord-005453-4057qib7	15265	8	of	of	IN
cord-005453-4057qib7	15265	9	all	all	DT
cord-005453-4057qib7	15265	10	sequence	sequence	NN
cord-005453-4057qib7	15265	11	variants	variant	NNS
cord-005453-4057qib7	15265	12	in	in	IN
cord-005453-4057qib7	15265	13	SAA	SAA	NNP
cord-005453-4057qib7	15265	14	patients	patient	NNS
cord-005453-4057qib7	15265	15	;	;	,
cord-005453-4057qib7	15265	16	p=.005	p=.005	NNS
cord-005453-4057qib7	15265	17	)	)	-RRB-
cord-005453-4057qib7	15265	18	was	be	VBD
cord-005453-4057qib7	15265	19	frequently	frequently	RB
cord-005453-4057qib7	15265	20	found	find	VBN
cord-005453-4057qib7	15265	21	,	,	,
cord-005453-4057qib7	15265	22	as	as	IN
cord-005453-4057qib7	15265	23	were	be	VBD
cord-005453-4057qib7	15265	24	DNMT3AK456fs	DNMT3AK456fs	NNP
cord-005453-4057qib7	15265	25	*	*	NFP
cord-005453-4057qib7	15265	26	(	(	-LRB-
cord-005453-4057qib7	15265	27	8	8	CD
cord-005453-4057qib7	15265	28	%	%	NN
cord-005453-4057qib7	15265	29	,	,	,
cord-005453-4057qib7	15265	30	p=.007	p=.007	JJ
cord-005453-4057qib7	15265	31	)	)	-RRB-
cord-005453-4057qib7	15265	32	,	,	.
cord-005453-4057qib7	15266	1	TET2L1721W	tet2l1721w	LS
cord-005453-4057qib7	15266	2	(	(	-LRB-
cord-005453-4057qib7	15266	3	8	8	CD
cord-005453-4057qib7	15266	4	%	%	NN
cord-005453-4057qib7	15266	5	,	,	,
cord-005453-4057qib7	15266	6	p=.080	p=.080	NNP
cord-005453-4057qib7	15266	7	)	)	-RRB-
cord-005453-4057qib7	15266	8	and	and	CC
cord-005453-4057qib7	15266	9	TET2I1762V	tet2i1762v	LS
cord-005453-4057qib7	15266	10	(	(	-LRB-
cord-005453-4057qib7	15266	11	8	8	CD
cord-005453-4057qib7	15266	12	%	%	NN
cord-005453-4057qib7	15266	13	,	,	,
cord-005453-4057qib7	15266	14	p=.001	p=.001	NNP
cord-005453-4057qib7	15266	15	)	)	-RRB-
cord-005453-4057qib7	15266	16	.	.	.
cord-005453-4057qib7	15267	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15267	2	:	:	:
cord-005453-4057qib7	15268	1	Taken	take	VBN
cord-005453-4057qib7	15268	2	together	together	RB
cord-005453-4057qib7	15268	3	,	,	,
cord-005453-4057qib7	15268	4	these	these	DT
cord-005453-4057qib7	15268	5	data	datum	NNS
cord-005453-4057qib7	15268	6	show	show	VBP
cord-005453-4057qib7	15268	7	that	that	IN
cord-005453-4057qib7	15268	8	VUS	VUS	NNP
cord-005453-4057qib7	15268	9	occur	occur	VBP
cord-005453-4057qib7	15268	10	with	with	IN
cord-005453-4057qib7	15268	11	high	high	JJ
cord-005453-4057qib7	15268	12	abundancy	abundancy	NN
cord-005453-4057qib7	15268	13	in	in	IN
cord-005453-4057qib7	15268	14	this	this	DT
cord-005453-4057qib7	15268	15	high	high	JJ
cord-005453-4057qib7	15268	16	-	-	HYPH
cord-005453-4057qib7	15268	17	risk	risk	NN
cord-005453-4057qib7	15268	18	cohort	cohort	NN
cord-005453-4057qib7	15268	19	of	of	IN
cord-005453-4057qib7	15268	20	patients	patient	NNS
cord-005453-4057qib7	15268	21	,	,	,
cord-005453-4057qib7	15268	22	and	and	CC
cord-005453-4057qib7	15268	23	that	that	IN
cord-005453-4057qib7	15268	24	they	-PRON-	PRP
cord-005453-4057qib7	15268	25	differ	differ	VBP
cord-005453-4057qib7	15268	26	in	in	IN
cord-005453-4057qib7	15268	27	frequency	frequency	NN
cord-005453-4057qib7	15268	28	between	between	IN
cord-005453-4057qib7	15268	29	various	various	JJ
cord-005453-4057qib7	15268	30	myeloid	myeloid	JJ
cord-005453-4057qib7	15268	31	disorders	disorder	NNS
cord-005453-4057qib7	15268	32	Methods	method	NNS
cord-005453-4057qib7	15268	33	:	:	:
cord-005453-4057qib7	15268	34	Retrospective	retrospective	JJ
cord-005453-4057qib7	15268	35	analysis	analysis	NN
cord-005453-4057qib7	15268	36	of	of	IN
cord-005453-4057qib7	15268	37	patientswho	patientswho	NN
cord-005453-4057qib7	15268	38	experienced	experience	VBD
cord-005453-4057qib7	15268	39	either	either	CC
cord-005453-4057qib7	15268	40	hematological	hematological	JJ
cord-005453-4057qib7	15268	41	relapse	relapse	NN
cord-005453-4057qib7	15268	42	or	or	CC
cord-005453-4057qib7	15268	43	progressed	progress	VBD
cord-005453-4057qib7	15268	44	to	to	IN
cord-005453-4057qib7	15268	45	AML	AML	NNP
cord-005453-4057qib7	15268	46	after	after	IN
cord-005453-4057qib7	15268	47	allo	allo	NN
cord-005453-4057qib7	15268	48	-	-	HYPH
cord-005453-4057qib7	15268	49	HSCT	HSCT	NNP
cord-005453-4057qib7	15268	50	and	and	CC
cord-005453-4057qib7	15268	51	were	be	VBD
cord-005453-4057qib7	15268	52	treated	treat	VBN
cord-005453-4057qib7	15268	53	with	with	IN
cord-005453-4057qib7	15268	54	azacitidine	azacitidine	NNP
cord-005453-4057qib7	15268	55	for	for	IN
cord-005453-4057qib7	15268	56	this	this	DT
cord-005453-4057qib7	15268	57	indication	indication	NN
cord-005453-4057qib7	15268	58	at	at	IN
cord-005453-4057qib7	15268	59	7	7	CD
cord-005453-4057qib7	15268	60	hematological	hematological	JJ
cord-005453-4057qib7	15268	61	centers	center	NNS
cord-005453-4057qib7	15268	62	in	in	IN
cord-005453-4057qib7	15268	63	Poland	Poland	NNP
cord-005453-4057qib7	15268	64	.	.	.
cord-005453-4057qib7	15269	1	The	the	DT
cord-005453-4057qib7	15269	2	primary	primary	JJ
cord-005453-4057qib7	15269	3	end	end	NN
cord-005453-4057qib7	15269	4	-	-	HYPH
cord-005453-4057qib7	15269	5	point	point	NN
cord-005453-4057qib7	15269	6	was	be	VBD
cord-005453-4057qib7	15269	7	overall	overall	JJ
cord-005453-4057qib7	15269	8	survival	survival	NN
cord-005453-4057qib7	15269	9	(	(	-LRB-
cord-005453-4057qib7	15269	10	OS	OS	NNP
cord-005453-4057qib7	15269	11	)	)	-RRB-
cord-005453-4057qib7	15269	12	,	,	,
cord-005453-4057qib7	15269	13	the	the	DT
cord-005453-4057qib7	15269	14	secondary	secondary	JJ
cord-005453-4057qib7	15269	15	-response	-response	NN
cord-005453-4057qib7	15269	16	rate	rate	NN
cord-005453-4057qib7	15269	17	.	.	.
cord-005453-4057qib7	15270	1	Results	result	NNS
cord-005453-4057qib7	15270	2	:	:	:
cord-005453-4057qib7	15270	3	36	36	CD
cord-005453-4057qib7	15270	4	patients	patient	NNS
cord-005453-4057qib7	15270	5	,	,	,
cord-005453-4057qib7	15270	6	22	22	CD
cord-005453-4057qib7	15270	7	males	male	NNS
cord-005453-4057qib7	15270	8	(	(	-LRB-
cord-005453-4057qib7	15270	9	61.1	61.1	CD
cord-005453-4057qib7	15270	10	%	%	NN
cord-005453-4057qib7	15270	11	)	)	-RRB-
cord-005453-4057qib7	15270	12	,	,	,
cord-005453-4057qib7	15270	13	median	median	JJ
cord-005453-4057qib7	15270	14	age	age	NN
cord-005453-4057qib7	15270	15	52	52	CD
cord-005453-4057qib7	15271	1	(	(	-LRB-
cord-005453-4057qib7	15271	2	range	range	NN
cord-005453-4057qib7	15271	3	,	,	,
cord-005453-4057qib7	15271	4	15	15	CD
cord-005453-4057qib7	15271	5	-	-	SYM
cord-005453-4057qib7	15271	6	66	66	CD
cord-005453-4057qib7	15271	7	)	)	-RRB-
cord-005453-4057qib7	15271	8	,	,	,
cord-005453-4057qib7	15271	9	were	be	VBD
cord-005453-4057qib7	15271	10	enrolled	enrol	VBN
cord-005453-4057qib7	15271	11	.	.	.
cord-005453-4057qib7	15272	1	The	the	DT
cord-005453-4057qib7	15272	2	primary	primary	JJ
cord-005453-4057qib7	15272	3	indication	indication	NN
cord-005453-4057qib7	15272	4	for	for	IN
cord-005453-4057qib7	15272	5	allo	allo	NN
cord-005453-4057qib7	15272	6	-	-	HYPH
cord-005453-4057qib7	15272	7	HSCT	HSCT	NNP
cord-005453-4057qib7	15272	8	was	be	VBD
cord-005453-4057qib7	15272	9	AML	AML	NNP
cord-005453-4057qib7	15272	10	Median	median	JJ
cord-005453-4057qib7	15272	11	time	time	NN
cord-005453-4057qib7	15272	12	from	from	IN
cord-005453-4057qib7	15272	13	allo-(95%CI	allo-(95%ci	NN
cord-005453-4057qib7	15272	14	:	:	:
cord-005453-4057qib7	15272	15	4.9	4.9	CD
cord-005453-4057qib7	15272	16	-	-	SYM
cord-005453-4057qib7	15272	17	11	11	CD
cord-005453-4057qib7	15272	18	)	)	-RRB-
cord-005453-4057qib7	15272	19	;	;	:
cord-005453-4057qib7	15272	20	with	with	IN
cord-005453-4057qib7	15272	21	2-year	2-year	CD
cord-005453-4057qib7	15272	22	OS	os	NN
cord-005453-4057qib7	15272	23	of	of	IN
cord-005453-4057qib7	15272	24	17.2	17.2	CD
cord-005453-4057qib7	15272	25	%	%	NN
cord-005453-4057qib7	15272	26	(	(	-LRB-
cord-005453-4057qib7	15272	27	95%CI	95%ci	CD
cord-005453-4057qib7	15272	28	:	:	:
cord-005453-4057qib7	15272	29	5.1	5.1	CD
cord-005453-4057qib7	15272	30	-	-	HYPH
cord-005453-4057qib7	15272	31	35.2	35.2	CD
cord-005453-4057qib7	15272	32	)	)	-RRB-
cord-005453-4057qib7	15272	33	.	.	.
cord-005453-4057qib7	15273	1	For	for	IN
cord-005453-4057qib7	15273	2	patients	patient	NNS
cord-005453-4057qib7	15273	3	stratified	stratify	VBN
cord-005453-4057qib7	15273	4	according	accord	VBG
cord-005453-4057qib7	15273	5	to	to	IN
cord-005453-4057qib7	15273	6	EBMT	EBMT	NNP
cord-005453-4057qib7	15273	7	AZA	AZA	NNP
cord-005453-4057qib7	15273	8	relapse	relapse	NN
cord-005453-4057qib7	15274	1	prognostic	prognostic	JJ
cord-005453-4057qib7	15274	2	score	score	NN
cord-005453-4057qib7	15274	3	2-year	2-year	CD
cord-005453-4057qib7	15274	4	OS	OS	NNP
cord-005453-4057qib7	15274	5	was	be	VBD
cord-005453-4057qib7	15274	6	:	:	:
cord-005453-4057qib7	15274	7	9	9	CD
cord-005453-4057qib7	15274	8	Prophylaxis	Prophylaxis	NNP
cord-005453-4057qib7	15274	9	of	of	IN
cord-005453-4057qib7	15274	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	15274	11	:	:	:
cord-005453-4057qib7	15275	1	with	with	IN
cord-005453-4057qib7	15275	2	ATG	ATG	NNP
cord-005453-4057qib7	15275	3	-ATGAM	-ATGAM	.
cord-005453-4057qib7	15276	1	60	60	CD
cord-005453-4057qib7	15276	2	mg	mg	NN
cord-005453-4057qib7	15277	1	/b.w.-39pts(36,8	/b.w.-39pts(36,8	:
cord-005453-4057qib7	15277	2	%	%	NN
cord-005453-4057qib7	15277	3	)	)	-RRB-
cord-005453-4057qib7	15277	4	,	,	,
cord-005453-4057qib7	15277	5	posttransplant	posttransplant	NNP
cord-005453-4057qib7	15277	6	cyclophosphomide	cyclophosphomide	NNP
cord-005453-4057qib7	15277	7	(	(	-LRB-
cord-005453-4057qib7	15277	8	PTCy	PTCy	NNPS
cord-005453-4057qib7	15278	1	)	)	-RRB-
cord-005453-4057qib7	15278	2	50mg	50mg	JJ
cord-005453-4057qib7	15278	3	/	/	SYM
cord-005453-4057qib7	15278	4	b.w	b.w	NNP
cord-005453-4057qib7	15278	5	.	.	.
cord-005453-4057qib7	15279	1	on	on	IN
cord-005453-4057qib7	15279	2	D+3;D+4	d+3;d+4	NN
cord-005453-4057qib7	15279	3	-	-	HYPH
cord-005453-4057qib7	15279	4	67pts	67pts	NN
cord-005453-4057qib7	15279	5	(	(	-LRB-
cord-005453-4057qib7	15279	6	63,2	63,2	CD
cord-005453-4057qib7	15279	7	%	%	NN
cord-005453-4057qib7	15279	8	)	)	-RRB-
cord-005453-4057qib7	15280	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15280	2	:	:	:
cord-005453-4057qib7	15281	1	Unmanipulated	Unmanipulated	NNP
cord-005453-4057qib7	15281	2	Haplo	Haplo	NNP
cord-005453-4057qib7	15281	3	-	-	HYPH
cord-005453-4057qib7	15281	4	HSCT	HSCT	NNP
cord-005453-4057qib7	15281	5	in	in	IN
cord-005453-4057qib7	15281	6	1	1	CD
cord-005453-4057qib7	15281	7	st	st	NNP
cord-005453-4057qib7	15281	8	-2	-2	NNP
cord-005453-4057qib7	15281	9	nd	nd	NNP
cord-005453-4057qib7	15281	10	CR	CR	NNP
cord-005453-4057qib7	15281	11	in	in	IN
cord-005453-4057qib7	15281	12	children	child	NNS
cord-005453-4057qib7	15281	13	and	and	CC
cord-005453-4057qib7	15281	14	adolescents	adolescent	NNS
cord-005453-4057qib7	15281	15	with	with	IN
cord-005453-4057qib7	15281	16	high	high	JJ
cord-005453-4057qib7	15281	17	risk	risk	NN
cord-005453-4057qib7	15282	1	AL	AL	NNP
cord-005453-4057qib7	15282	2	allows	allow	VBZ
cord-005453-4057qib7	15282	3	achieving	achieve	VBG
cord-005453-4057qib7	15282	4	the	the	DT
cord-005453-4057qib7	15282	5	long	long	JJ
cord-005453-4057qib7	15282	6	-	-	HYPH
cord-005453-4057qib7	15282	7	term	term	NN
cord-005453-4057qib7	15282	8	survival	survival	NN
cord-005453-4057qib7	15282	9	in	in	IN
cord-005453-4057qib7	15282	10	64,7	64,7	CD
cord-005453-4057qib7	15282	11	%	%	NN
cord-005453-4057qib7	15282	12	.	.	.
cord-005453-4057qib7	15283	1	The	the	DT
cord-005453-4057qib7	15283	2	use	use	NN
cord-005453-4057qib7	15283	3	of	of	IN
cord-005453-4057qib7	15283	4	G	G	NNP
cord-005453-4057qib7	15283	5	-	-	HYPH
cord-005453-4057qib7	15283	6	CSF	CSF	NNP
cord-005453-4057qib7	15283	7	stimulated	stimulate	VBD
cord-005453-4057qib7	15284	1	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	15284	2	Haplo	Haplo	NNP
cord-005453-4057qib7	15284	3	-	-	HYPH
cord-005453-4057qib7	15284	4	BM	BM	NNP
cord-005453-4057qib7	15284	5	is	be	VBZ
cord-005453-4057qib7	15284	6	associated	associate	VBN
cord-005453-4057qib7	15284	7	with	with	IN
cord-005453-4057qib7	15284	8	a	a	DT
cord-005453-4057qib7	15284	9	satisfactory	satisfactory	JJ
cord-005453-4057qib7	15284	10	rate	rate	NN
cord-005453-4057qib7	15284	11	of	of	IN
cord-005453-4057qib7	15284	12	engraftment	engraftment	NN
cord-005453-4057qib7	15284	13	.	.	.
cord-005453-4057qib7	15285	1	The	the	DT
cord-005453-4057qib7	15285	2	main	main	JJ
cord-005453-4057qib7	15285	3	cause	cause	NN
cord-005453-4057qib7	15285	4	of	of	IN
cord-005453-4057qib7	15285	5	death	death	NN
cord-005453-4057qib7	15285	6	in	in	IN
cord-005453-4057qib7	15285	7	our	-PRON-	PRP$
cord-005453-4057qib7	15285	8	study	study	NN
cord-005453-4057qib7	15285	9	was	be	VBD
cord-005453-4057qib7	15285	10	relapse	relapse	NN
cord-005453-4057qib7	15285	11	after	after	IN
cord-005453-4057qib7	15285	12	allo	allo	NN
cord-005453-4057qib7	15285	13	-	-	HYPH
cord-005453-4057qib7	15285	14	HSCT	HSCT	NNP
cord-005453-4057qib7	15285	15	.	.	.
cord-005453-4057qib7	15286	1	The	the	DT
cord-005453-4057qib7	15286	2	frequency	frequency	NN
cord-005453-4057qib7	15286	3	of	of	IN
cord-005453-4057qib7	15286	4	acute	acute	JJ
cord-005453-4057qib7	15286	5	and	and	CC
cord-005453-4057qib7	15286	6	chronic	chronic	JJ
cord-005453-4057qib7	15286	7	GVHD	GVHD	NNP
cord-005453-4057qib7	15286	8	was	be	VBD
cord-005453-4057qib7	15286	9	acceptable	acceptable	JJ
cord-005453-4057qib7	15286	10	,	,	,
cord-005453-4057qib7	15286	11	10-years	10-years	CD
cord-005453-4057qib7	15286	12	GRFS	grfs	NN
cord-005453-4057qib7	15286	13	rate	rate	NN
cord-005453-4057qib7	15286	14	of	of	IN
cord-005453-4057qib7	15286	15	35,3	35,3	CD
cord-005453-4057qib7	15286	16	%	%	NN
cord-005453-4057qib7	15286	17	in	in	IN
cord-005453-4057qib7	15286	18	1	1	CD
cord-005453-4057qib7	15287	1	st	st	NNP
cord-005453-4057qib7	15287	2	-2	-2	NNP
cord-005453-4057qib7	15287	3	nd	nd	NNP
cord-005453-4057qib7	15287	4	CR	CR	NNP
cord-005453-4057qib7	15287	5	represents	represent	VBZ
cord-005453-4057qib7	15287	6	good	good	JJ
cord-005453-4057qib7	15287	7	quality	quality	NN
cord-005453-4057qib7	15287	8	of	of	IN
cord-005453-4057qib7	15287	9	life	life	NN
cord-005453-4057qib7	15287	10	following	follow	VBG
cord-005453-4057qib7	15287	11	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	15287	12	Haplo	Haplo	NNP
cord-005453-4057qib7	15287	13	-	-	HYPH
cord-005453-4057qib7	15287	14	HSCT	HSCT	NNP
cord-005453-4057qib7	15287	15	and	and	CC
cord-005453-4057qib7	15287	16	therefore	therefore	RB
cord-005453-4057qib7	15287	17	may	may	MD
cord-005453-4057qib7	15287	18	be	be	VB
cord-005453-4057qib7	15287	19	recommended	recommend	VBN
cord-005453-4057qib7	15287	20	as	as	IN
cord-005453-4057qib7	15287	21	option	option	NN
cord-005453-4057qib7	15287	22	for	for	IN
cord-005453-4057qib7	15287	23	use	use	NN
cord-005453-4057qib7	15287	24	in	in	IN
cord-005453-4057qib7	15287	25	children	child	NNS
cord-005453-4057qib7	15287	26	and	and	CC
cord-005453-4057qib7	15287	27	adolescents	adolescent	NNS
cord-005453-4057qib7	15287	28	with	with	IN
cord-005453-4057qib7	15287	29	high	high	JJ
cord-005453-4057qib7	15287	30	-	-	HYPH
cord-005453-4057qib7	15287	31	risk	risk	NN
cord-005453-4057qib7	15287	32	AL	AL	NNP
cord-005453-4057qib7	15287	33	.	.	.
cord-005453-4057qib7	15288	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15288	2	:	:	:
cord-005453-4057qib7	15288	3	Nothing	nothing	NN
cord-005453-4057qib7	15288	4	to	to	TO
cord-005453-4057qib7	15288	5	declare	declare	VB
cord-005453-4057qib7	15288	6	Background	background	NN
cord-005453-4057qib7	15288	7	:	:	:
cord-005453-4057qib7	15288	8	B7-H3	B7-H3	NNP
cord-005453-4057qib7	15289	1	(	(	-LRB-
cord-005453-4057qib7	15289	2	CD276	CD276	NNP
cord-005453-4057qib7	15289	3	)	)	-RRB-
cord-005453-4057qib7	15289	4	is	be	VBZ
cord-005453-4057qib7	15289	5	thought	think	VBN
cord-005453-4057qib7	15289	6	to	to	TO
cord-005453-4057qib7	15289	7	act	act	VB
cord-005453-4057qib7	15289	8	as	as	IN
cord-005453-4057qib7	15289	9	an	an	DT
cord-005453-4057qib7	15289	10	immune	immune	JJ
cord-005453-4057qib7	15289	11	checkpoint	checkpoint	NN
cord-005453-4057qib7	15289	12	and	and	CC
cord-005453-4057qib7	15289	13	regulates	regulate	VBZ
cord-005453-4057qib7	15289	14	T	T	NNP
cord-005453-4057qib7	15289	15	and	and	CC
cord-005453-4057qib7	15289	16	NK	NK	NNP
cord-005453-4057qib7	15289	17	cell	cell	NN
cord-005453-4057qib7	15289	18	responses	response	NNS
cord-005453-4057qib7	15289	19	.	.	.
cord-005453-4057qib7	15290	1	It	-PRON-	PRP
cord-005453-4057qib7	15290	2	is	be	VBZ
cord-005453-4057qib7	15290	3	highly	highly	RB
cord-005453-4057qib7	15290	4	overexpressed	overexpresse	VBN
cord-005453-4057qib7	15290	5	on	on	IN
cord-005453-4057qib7	15290	6	many	many	JJ
cord-005453-4057qib7	15290	7	solid	solid	JJ
cord-005453-4057qib7	15290	8	tumors	tumor	NNS
cord-005453-4057qib7	15290	9	while	while	IN
cord-005453-4057qib7	15290	10	on	on	IN
cord-005453-4057qib7	15290	11	healthy	healthy	JJ
cord-005453-4057qib7	15290	12	tissue	tissue	NN
cord-005453-4057qib7	15290	13	protein	protein	NN
cord-005453-4057qib7	15290	14	expression	expression	NN
cord-005453-4057qib7	15290	15	is	be	VBZ
cord-005453-4057qib7	15290	16	limited	limit	VBN
cord-005453-4057qib7	15290	17	.	.	.
cord-005453-4057qib7	15291	1	This	this	DT
cord-005453-4057qib7	15291	2	makes	make	VBZ
cord-005453-4057qib7	15291	3	B7-H3	B7-H3	NNP
cord-005453-4057qib7	15291	4	an	an	DT
cord-005453-4057qib7	15291	5	interesting	interesting	JJ
cord-005453-4057qib7	15291	6	target	target	NN
cord-005453-4057qib7	15291	7	for	for	IN
cord-005453-4057qib7	15291	8	cancer	cancer	NN
cord-005453-4057qib7	15291	9	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	15291	10	.	.	.
cord-005453-4057qib7	15292	1	In	in	IN
cord-005453-4057qib7	15292	2	highrisk	highrisk	JJ
cord-005453-4057qib7	15292	3	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	15292	4	patients	patient	NNS
cord-005453-4057qib7	15292	5	,	,	,
cord-005453-4057qib7	15292	6	targeting	target	VBG
cord-005453-4057qib7	15292	7	disialoganglioside	disialoganglioside	NNP
cord-005453-4057qib7	15292	8	GD2	GD2	NNP
cord-005453-4057qib7	15292	9	with	with	IN
cord-005453-4057qib7	15292	10	the	the	DT
cord-005453-4057qib7	15292	11	recently	recently	RB
cord-005453-4057qib7	15292	12	approved	approve	VBN
cord-005453-4057qib7	15292	13	monoclonal	monoclonal	JJ
cord-005453-4057qib7	15292	14	antibody	antibody	NN
cord-005453-4057qib7	15292	15	(	(	-LRB-
cord-005453-4057qib7	15292	16	mAb	mAb	NNS
cord-005453-4057qib7	15292	17	)	)	-RRB-
cord-005453-4057qib7	15292	18	CH14.18	CH14.18	NNS
cord-005453-4057qib7	15292	19	after	after	IN
cord-005453-4057qib7	15292	20	autologous	autologous	JJ
cord-005453-4057qib7	15292	21	or	or	CC
cord-005453-4057qib7	15292	22	allogeneic	allogeneic	IN
cord-005453-4057qib7	15292	23	SCT	SCT	NNP
cord-005453-4057qib7	15292	24	,	,	,
cord-005453-4057qib7	15292	25	significantly	significantly	RB
cord-005453-4057qib7	15292	26	improves	improve	VBZ
cord-005453-4057qib7	15292	27	survival	survival	NN
cord-005453-4057qib7	15292	28	.	.	.
cord-005453-4057qib7	15293	1	However	however	RB
cord-005453-4057qib7	15293	2	,	,	,
cord-005453-4057qib7	15293	3	GD2	GD2	NNP
cord-005453-4057qib7	15293	4	expression	expression	NN
cord-005453-4057qib7	15293	5	is	be	VBZ
cord-005453-4057qib7	15293	6	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	15293	7	and	and	CC
cord-005453-4057qib7	15293	8	CH14.18	CH14.18	NNS
cord-005453-4057qib7	15293	9	causes	cause	VBZ
cord-005453-4057qib7	15293	10	severe	severe	JJ
cord-005453-4057qib7	15293	11	adverse	adverse	JJ
cord-005453-4057qib7	15293	12	effects	effect	NNS
cord-005453-4057qib7	15293	13	.	.	.
cord-005453-4057qib7	15294	1	Thus	thus	RB
cord-005453-4057qib7	15294	2	,	,	,
cord-005453-4057qib7	15294	3	we	-PRON-	PRP
cord-005453-4057qib7	15294	4	evaluated	evaluate	VBD
cord-005453-4057qib7	15294	5	B7-H3	B7-H3	NNP
cord-005453-4057qib7	15294	6	as	as	IN
cord-005453-4057qib7	15294	7	an	an	DT
cord-005453-4057qib7	15294	8	alternative	alternative	JJ
cord-005453-4057qib7	15294	9	or	or	CC
cord-005453-4057qib7	15294	10	additional	additional	JJ
cord-005453-4057qib7	15294	11	target	target	NN
cord-005453-4057qib7	15294	12	antigen	antigen	NN
cord-005453-4057qib7	15294	13	.	.	.
cord-005453-4057qib7	15295	1	We	-PRON-	PRP
cord-005453-4057qib7	15295	2	investigated	investigate	VBD
cord-005453-4057qib7	15295	3	different	different	JJ
cord-005453-4057qib7	15295	4	anti	anti	JJ
cord-005453-4057qib7	15295	5	-	-	JJ
cord-005453-4057qib7	15295	6	B7-H3	b7-h3	JJ
cord-005453-4057qib7	15295	7	mAb	mab	NN
cord-005453-4057qib7	15295	8	constructs	construct	NNS
cord-005453-4057qib7	15295	9	and	and	CC
cord-005453-4057qib7	15295	10	mAb	mab	NN
cord-005453-4057qib7	15295	11	-	-	HYPH
cord-005453-4057qib7	15295	12	cytokine	cytokine	NN
cord-005453-4057qib7	15295	13	fusions	fusion	NNS
cord-005453-4057qib7	15295	14	(	(	-LRB-
cord-005453-4057qib7	15295	15	immunocytokines	immunocytokines	NNP
cord-005453-4057qib7	15295	16	)	)	-RRB-
cord-005453-4057qib7	15295	17	for	for	IN
cord-005453-4057qib7	15295	18	their	-PRON-	PRP$
cord-005453-4057qib7	15295	19	ability	ability	NN
cord-005453-4057qib7	15295	20	to	to	TO
cord-005453-4057qib7	15295	21	elicit	elicit	VB
cord-005453-4057qib7	15295	22	antibody	antibody	NN
cord-005453-4057qib7	15295	23	-	-	HYPH
cord-005453-4057qib7	15295	24	dependent	dependent	JJ
cord-005453-4057qib7	15295	25	cellular	cellular	JJ
cord-005453-4057qib7	15295	26	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	15295	27	(	(	-LRB-
cord-005453-4057qib7	15295	28	ADCC	ADCC	NNP
cord-005453-4057qib7	15295	29	)	)	-RRB-
cord-005453-4057qib7	15295	30	Using	use	VBG
cord-005453-4057qib7	15295	31	expanded	expand	VBN
cord-005453-4057qib7	15295	32	γ	γ	NN
cord-005453-4057qib7	15295	33	/	/	SYM
cord-005453-4057qib7	15295	34	δ	δ	NN
cord-005453-4057qib7	15295	35	T	T	NNP
cord-005453-4057qib7	15295	36	cells	cell	NNS
cord-005453-4057qib7	15295	37	of	of	IN
cord-005453-4057qib7	15296	1	healthy	healthy	JJ
cord-005453-4057qib7	15296	2	donors	donor	NNS
cord-005453-4057qib7	15296	3	,	,	,
cord-005453-4057qib7	15296	4	cHEX5LF	cHEX5LF	NNP
cord-005453-4057qib7	15296	5	-	-	HYPH
cord-005453-4057qib7	15296	6	IL2	IL2	NNP
cord-005453-4057qib7	15296	7	was	be	VBD
cord-005453-4057qib7	15296	8	confirmed	confirm	VBN
cord-005453-4057qib7	15296	9	to	to	TO
cord-005453-4057qib7	15296	10	be	be	VB
cord-005453-4057qib7	15296	11	the	the	DT
cord-005453-4057qib7	15296	12	most	most	RBS
cord-005453-4057qib7	15296	13	effective	effective	JJ
cord-005453-4057qib7	15296	14	mAb	mab	NN
cord-005453-4057qib7	15296	15	construct	construct	NN
cord-005453-4057qib7	15296	16	.	.	.
cord-005453-4057qib7	15297	1	Interestingly	interestingly	RB
cord-005453-4057qib7	15297	2	,	,	,
cord-005453-4057qib7	15297	3	cHEK5-IL2	cHEK5-IL2	NNP
cord-005453-4057qib7	15297	4	showed	show	VBD
cord-005453-4057qib7	15297	5	comparable	comparable	JJ
cord-005453-4057qib7	15297	6	target	target	NN
cord-005453-4057qib7	15297	7	cell	cell	NN
cord-005453-4057qib7	15297	8	lysis	lysis	NN
cord-005453-4057qib7	15297	9	-however	-however	NN
cord-005453-4057qib7	15297	10	,	,	,
cord-005453-4057qib7	15297	11	lysis	lysis	NN
cord-005453-4057qib7	15297	12	was	be	VBD
cord-005453-4057qib7	15297	13	only	only	RB
cord-005453-4057qib7	15297	14	transient	transient	JJ
cord-005453-4057qib7	15297	15	while	while	IN
cord-005453-4057qib7	15297	16	cHEX5LF	cHEX5LF	NNP
cord-005453-4057qib7	15297	17	-	-	HYPH
cord-005453-4057qib7	15297	18	IL2	IL2	NNP
cord-005453-4057qib7	15297	19	mediated	mediate	VBD
cord-005453-4057qib7	15297	20	permanent	permanent	JJ
cord-005453-4057qib7	15297	21	target	target	NN
cord-005453-4057qib7	15297	22	cell	cell	NN
cord-005453-4057qib7	15297	23	lysis	lysis	NN
cord-005453-4057qib7	15297	24	.	.	.
cord-005453-4057qib7	15298	1	Using	use	VBG
cord-005453-4057qib7	15298	2	patient	patient	JJ
cord-005453-4057qib7	15298	3	PBMCs	pbmc	NNS
cord-005453-4057qib7	15298	4	after	after	IN
cord-005453-4057qib7	15298	5	receiving	receive	VBG
cord-005453-4057qib7	15298	6	allogeneic	allogeneic	IN
cord-005453-4057qib7	15298	7	SCT	SCT	NNP
cord-005453-4057qib7	15298	8	,	,	,
cord-005453-4057qib7	15298	9	cHEX5LF	cHEX5LF	NNP
cord-005453-4057qib7	15298	10	-	-	HYPH
cord-005453-4057qib7	15298	11	IL2	il2	NN
cord-005453-4057qib7	15298	12	and	and	CC
cord-005453-4057qib7	15298	13	CH14.18	CH14.18	NNP
cord-005453-4057qib7	15298	14	mediated	mediate	VBD
cord-005453-4057qib7	15298	15	comparable	comparable	JJ
cord-005453-4057qib7	15298	16	lysis	lysis	NN
cord-005453-4057qib7	15298	17	.	.	.
cord-005453-4057qib7	15299	1	Calculated	calculate	VBN
cord-005453-4057qib7	15299	2	specific	specific	JJ
cord-005453-4057qib7	15299	3	lysis	lysis	NN
cord-005453-4057qib7	15299	4	of	of	IN
cord-005453-4057qib7	15299	5	LAN-1	LAN-1	NNP
cord-005453-4057qib7	15299	6	(	(	-LRB-
cord-005453-4057qib7	15299	7	after	after	IN
cord-005453-4057qib7	15299	8	96	96	CD
cord-005453-4057qib7	15299	9	hrs	hrs	NN
cord-005453-4057qib7	15299	10	.	.	.
cord-005453-4057qib7	15299	11	;	;	:
cord-005453-4057qib7	15299	12	in	in	IN
cord-005453-4057qib7	15299	13	ascending	ascend	VBG
cord-005453-4057qib7	15299	14	order	order	NN
cord-005453-4057qib7	15299	15	)	)	-RRB-
cord-005453-4057qib7	15299	16	:	:	:
cord-005453-4057qib7	15299	17	Targets	target	NNS
cord-005453-4057qib7	15299	18	+	+	SYM
cord-005453-4057qib7	15299	19	effectors	effector	NNS
cord-005453-4057qib7	15299	20	w/o	without	IN
cord-005453-4057qib7	15299	21	mAb	mAb	NNS
cord-005453-4057qib7	15299	22	(	(	-LRB-
cord-005453-4057qib7	15299	23	22	22	CD
cord-005453-4057qib7	15299	24	%	%	NN
cord-005453-4057qib7	15299	25	)	)	-RRB-
cord-005453-4057qib7	15300	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15300	2	:	:	:
cord-005453-4057qib7	15300	3	B7-H3	B7-H3	NNP
cord-005453-4057qib7	15300	4	is	be	VBZ
cord-005453-4057qib7	15300	5	a	a	DT
cord-005453-4057qib7	15300	6	suitable	suitable	JJ
cord-005453-4057qib7	15300	7	target	target	NN
cord-005453-4057qib7	15300	8	antigen	antigen	NN
cord-005453-4057qib7	15300	9	in	in	IN
cord-005453-4057qib7	15300	10	case	case	NN
cord-005453-4057qib7	15301	1	GD2	GD2	NNP
cord-005453-4057qib7	15301	2	expression	expression	NN
cord-005453-4057qib7	15301	3	is	be	VBZ
cord-005453-4057qib7	15301	4	low	low	JJ
cord-005453-4057qib7	15301	5	or	or	CC
cord-005453-4057qib7	15301	6	absent	absent	JJ
cord-005453-4057qib7	15301	7	.	.	.
cord-005453-4057qib7	15302	1	Immunocytokines	Immunocytokines	NNP
cord-005453-4057qib7	15302	2	and	and	CC
cord-005453-4057qib7	15302	3	Fcoptimized	Fcoptimized	NNP
cord-005453-4057qib7	15302	4	mAbs	mAbs	NNP
cord-005453-4057qib7	15302	5	targeting	target	VBG
cord-005453-4057qib7	15302	6	B7-H3	B7-H3	NNP
cord-005453-4057qib7	15302	7	might	may	MD
cord-005453-4057qib7	15302	8	increase	increase	VB
cord-005453-4057qib7	15302	9	the	the	DT
cord-005453-4057qib7	15302	10	efficacy	efficacy	NN
cord-005453-4057qib7	15302	11	of	of	IN
cord-005453-4057qib7	15302	12	immunotherapy	immunotherapy	NN
cord-005453-4057qib7	15302	13	in	in	IN
cord-005453-4057qib7	15302	14	GD2-negative	GD2-negative	NNP
cord-005453-4057qib7	15302	15	tumors	tumor	NNS
cord-005453-4057qib7	15302	16	and	and	CC
cord-005453-4057qib7	15302	17	in	in	IN
cord-005453-4057qib7	15302	18	combinatory	combinatory	JJ
cord-005453-4057qib7	15302	19	approaches	approach	NNS
cord-005453-4057qib7	15302	20	.	.	.
cord-005453-4057qib7	15303	1	Until	until	IN
cord-005453-4057qib7	15303	2	now	now	RB
cord-005453-4057qib7	15303	3	,	,	,
cord-005453-4057qib7	15303	4	the	the	DT
cord-005453-4057qib7	15303	5	low	low	JJ
cord-005453-4057qib7	15303	6	-	-	HYPH
cord-005453-4057qib7	15303	7	fucose	fucose	JJ
cord-005453-4057qib7	15303	8	immunocytokine	immunocytokine	JJ
cord-005453-4057qib7	15303	9	cHEX5LF	cHEX5LF	NNP
cord-005453-4057qib7	15303	10	-	-	:
cord-005453-4057qib7	15303	11	IL2	IL2	NNP
cord-005453-4057qib7	15303	12	seems	seem	VBZ
cord-005453-4057qib7	15303	13	to	to	TO
cord-005453-4057qib7	15303	14	be	be	VB
cord-005453-4057qib7	15303	15	the	the	DT
cord-005453-4057qib7	15303	16	most	most	RBS
cord-005453-4057qib7	15303	17	promising	promising	JJ
cord-005453-4057qib7	15303	18	anti	anti	JJ
cord-005453-4057qib7	15303	19	-	-	JJ
cord-005453-4057qib7	15303	20	B7	B7	NNP
cord-005453-4057qib7	15303	21	Great	Great	NNP
cord-005453-4057qib7	15303	22	Ormond	Ormond	NNP
cord-005453-4057qib7	15303	23	Street	Street	NNP
cord-005453-4057qib7	15303	24	Hospital	Hospital	NNP
cord-005453-4057qib7	15303	25	,	,	,
cord-005453-4057qib7	15303	26	NHS	NHS	NNP
cord-005453-4057qib7	15303	27	Foundation	Foundation	NNP
cord-005453-4057qib7	15303	28	Trust	Trust	NNP
cord-005453-4057qib7	15303	29	Petersburg/	Petersburg/	NNP
cord-005453-4057qib7	15303	30	Raisa	Raisa	NNP
cord-005453-4057qib7	15303	31	Gorbacheva	Gorbacheva	NNP
cord-005453-4057qib7	15303	32	Memorial	Memorial	NNP
cord-005453-4057qib7	15303	33	Institute	Institute	NNP
cord-005453-4057qib7	15303	34	of	of	IN
cord-005453-4057qib7	15303	35	Children	Children	NNP
cord-005453-4057qib7	15303	36	's	's	POS
cord-005453-4057qib7	15303	37	Oncology	Oncology	NNP
cord-005453-4057qib7	15303	38	,	,	,
cord-005453-4057qib7	15303	39	Hematology	Hematology	NNP
cord-005453-4057qib7	15303	40	and	and	CC
cord-005453-4057qib7	15303	41	Transplantation	Transplantation	NNP
cord-005453-4057qib7	15303	42	,	,	,
cord-005453-4057qib7	15303	43	Rehabilitation	Rehabilitation	NNP
cord-005453-4057qib7	15303	44	Medicine	Medicine	NNP
cord-005453-4057qib7	15303	45	,	,	,
cord-005453-4057qib7	15303	46	Saint	Saint	NNP
cord-005453-4057qib7	15303	47	Petersburg	Petersburg	NNP
cord-005453-4057qib7	15303	48	,	,	,
cord-005453-4057qib7	15303	49	Russian	Russian	NNP
cord-005453-4057qib7	15303	50	Federation	Federation	NNP
cord-005453-4057qib7	15303	51	,	,	,
cord-005453-4057qib7	15303	52	2	2	CD
cord-005453-4057qib7	15303	53	First	First	NNP
cord-005453-4057qib7	15303	54	I.	I.	NNP
cord-005453-4057qib7	15303	55	Pavlov	Pavlov	NNP
cord-005453-4057qib7	15303	56	State	State	NNP
cord-005453-4057qib7	15303	57	Medical	Medical	NNP
cord-005453-4057qib7	15303	58	University	University	NNP
cord-005453-4057qib7	15303	59	of	of	IN
cord-005453-4057qib7	15303	60	St.	St.	NNP
cord-005453-4057qib7	15303	61	Petersburg	Petersburg	NNP
cord-005453-4057qib7	15303	62	/	/	SYM
cord-005453-4057qib7	15303	63	Raisa	Raisa	NNP
cord-005453-4057qib7	15303	64	Gorbacheva	Gorbacheva	NNP
cord-005453-4057qib7	15303	65	Memorial	Memorial	NNP
cord-005453-4057qib7	15303	66	Institute	Institute	NNP
cord-005453-4057qib7	15303	67	of	of	IN
cord-005453-4057qib7	15303	68	Children	Children	NNP
cord-005453-4057qib7	15303	69	's	's	POS
cord-005453-4057qib7	15303	70	Oncology	Oncology	NNP
cord-005453-4057qib7	15303	71	,	,	,
cord-005453-4057qib7	15303	72	Hematology	Hematology	NNP
cord-005453-4057qib7	15303	73	and	and	CC
cord-005453-4057qib7	15303	74	Transplantation	Transplantation	NNP
cord-005453-4057qib7	15303	75	,	,	,
cord-005453-4057qib7	15303	76	Bone	Bone	NNP
cord-005453-4057qib7	15303	77	Marrow	Marrow	NNP
cord-005453-4057qib7	15303	78	Transplantation	transplantation	NN
cord-005453-4057qib7	15303	79	for	for	IN
cord-005453-4057qib7	15303	80	Pediatric	Pediatric	NNP
cord-005453-4057qib7	15303	81	Solid	Solid	NNP
cord-005453-4057qib7	15303	82	Tumor	Tumor	NNP
cord-005453-4057qib7	15303	83	Petersburg	Petersburg	NNP
cord-005453-4057qib7	15303	84	/	/	SYM
cord-005453-4057qib7	15303	85	Raisa	Raisa	NNP
cord-005453-4057qib7	15303	86	Gorbacheva	Gorbacheva	NNP
cord-005453-4057qib7	15303	87	Memorial	Memorial	NNP
cord-005453-4057qib7	15303	88	Institute	Institute	NNP
cord-005453-4057qib7	15303	89	of	of	IN
cord-005453-4057qib7	15303	90	Children	Children	NNP
cord-005453-4057qib7	15303	91	's	's	POS
cord-005453-4057qib7	15303	92	Oncology	Oncology	NNP
cord-005453-4057qib7	15303	93	,	,	,
cord-005453-4057qib7	15303	94	Hematology	Hematology	NNP
cord-005453-4057qib7	15303	95	and	and	CC
cord-005453-4057qib7	15303	96	Transplantation	Transplantation	NNP
cord-005453-4057qib7	15303	97	,	,	,
cord-005453-4057qib7	15303	98	Pediatric	Pediatric	NNP
cord-005453-4057qib7	15303	99	HSCT	HSCT	NNP
cord-005453-4057qib7	15303	100	Outpatients	Outpatients	NNP
cord-005453-4057qib7	15303	101	,	,	,
cord-005453-4057qib7	15303	102	Saint	Saint	NNP
cord-005453-4057qib7	15303	103	Petersburg	Petersburg	NNP
cord-005453-4057qib7	15303	104	,	,	,
cord-005453-4057qib7	15303	105	Russian	Russian	NNP
cord-005453-4057qib7	15303	106	Federation	Federation	NNP
cord-005453-4057qib7	15303	107	1	1	CD
cord-005453-4057qib7	15303	108	University	University	NNP
cord-005453-4057qib7	15303	109	Hospital	Hospital	NNP
cord-005453-4057qib7	15304	1	Carl	Carl	NNP
cord-005453-4057qib7	15304	2	Gustav	Gustav	NNP
cord-005453-4057qib7	15304	3	Carus	Carus	NNP
cord-005453-4057qib7	15304	4	James`s	james`	VBD
cord-005453-4057qib7	15304	5	Hospital	Hospital	NNP
cord-005453-4057qib7	15304	6	Diagnosis	Diagnosis	NNP
cord-005453-4057qib7	15304	7	was	be	VBD
cord-005453-4057qib7	15304	8	AML	AML	NNP
cord-005453-4057qib7	15304	9	in	in	IN
cord-005453-4057qib7	15304	10	52	52	CD
cord-005453-4057qib7	15304	11	%	%	NN
cord-005453-4057qib7	15304	12	,	,	,
cord-005453-4057qib7	15304	13	ALL	all	DT
cord-005453-4057qib7	15304	14	in	in	IN
cord-005453-4057qib7	15304	15	36	36	CD
cord-005453-4057qib7	15304	16	%	%	NN
cord-005453-4057qib7	15304	17	and	and	CC
cord-005453-4057qib7	15304	18	MDS	MDS	NNP
cord-005453-4057qib7	15304	19	in	in	IN
cord-005453-4057qib7	15304	20	12	12	CD
cord-005453-4057qib7	15304	21	%	%	NN
cord-005453-4057qib7	15304	22	of	of	IN
cord-005453-4057qib7	15304	23	patients	patient	NNS
cord-005453-4057qib7	15304	24	.	.	.
cord-005453-4057qib7	15305	1	90	90	CD
cord-005453-4057qib7	15305	2	%	%	NN
cord-005453-4057qib7	15305	3	of	of	IN
cord-005453-4057qib7	15305	4	patients	patient	NNS
cord-005453-4057qib7	15305	5	received	receive	VBD
cord-005453-4057qib7	15305	6	PBSC	PBSC	NNP
cord-005453-4057qib7	15305	7	grafts	graft	NNS
cord-005453-4057qib7	15305	8	,	,	,
cord-005453-4057qib7	15305	9	10	10	CD
cord-005453-4057qib7	15305	10	%	%	NN
cord-005453-4057qib7	15305	11	received	receive	VBD
cord-005453-4057qib7	15305	12	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	15305	13	bone	bone	NN
cord-005453-4057qib7	15305	14	marrow	marrow	NN
cord-005453-4057qib7	15305	15	grafts	graft	NNS
cord-005453-4057qib7	15305	16	.	.	.
cord-005453-4057qib7	15306	1	OS	OS	NNP
cord-005453-4057qib7	15306	2	at	at	IN
cord-005453-4057qib7	15306	3	2	2	CD
cord-005453-4057qib7	15306	4	years	year	NNS
cord-005453-4057qib7	15306	5	was	be	VBD
cord-005453-4057qib7	15306	6	70	70	CD
cord-005453-4057qib7	15306	7	%	%	NN
cord-005453-4057qib7	15306	8	in	in	IN
cord-005453-4057qib7	15306	9	MSD	MSD	NNP
cord-005453-4057qib7	15306	10	/	/	SYM
cord-005453-4057qib7	15306	11	MUD	MUD	NNP
cord-005453-4057qib7	15306	12	-	-	HYPH
cord-005453-4057qib7	15306	13	ATG	ATG	NNP
cord-005453-4057qib7	15306	14	,	,	,
cord-005453-4057qib7	15306	15	76	76	CD
cord-005453-4057qib7	15306	16	%	%	NN
cord-005453-4057qib7	15306	17	in	in	IN
cord-005453-4057qib7	15306	18	haplo-	haplo-	NNP
cord-005453-4057qib7	15307	1	ptCy	ptcy	RB
cord-005453-4057qib7	15307	2	,	,	,
cord-005453-4057qib7	15307	3	80	80	CD
cord-005453-4057qib7	15307	4	%	%	NN
cord-005453-4057qib7	15307	5	in	in	IN
cord-005453-4057qib7	15307	6	MMUD	MMUD	NNP
cord-005453-4057qib7	15307	7	-	-	:
cord-005453-4057qib7	15307	8	ptCy	ptcy	NN
cord-005453-4057qib7	15307	9	and	and	CC
cord-005453-4057qib7	15307	10	43	43	CD
cord-005453-4057qib7	15307	11	%	%	NN
cord-005453-4057qib7	15307	12	in	in	IN
cord-005453-4057qib7	15307	13	MMUD	MMUD	NNP
cord-005453-4057qib7	15307	14	-	-	HYPH
cord-005453-4057qib7	15307	15	ATG	ATG	NNP
cord-005453-4057qib7	15307	16	groups	group	NNS
cord-005453-4057qib7	15307	17	(	(	-LRB-
cord-005453-4057qib7	15307	18	p=0.0027	p=0.0027	NNP
cord-005453-4057qib7	15307	19	)	)	-RRB-
cord-005453-4057qib7	15307	20	.	.	.
cord-005453-4057qib7	15308	1	In	in	IN
cord-005453-4057qib7	15308	2	a	a	DT
cord-005453-4057qib7	15308	3	multivariate	multivariate	JJ
cord-005453-4057qib7	15308	4	Cox	Cox	NNP
cord-005453-4057qib7	15308	5	model	model	NN
cord-005453-4057qib7	15308	6	Non	non	JJ
cord-005453-4057qib7	15308	7	-	-	JJ
cord-005453-4057qib7	15308	8	relapse	relapse	JJ
cord-005453-4057qib7	15308	9	mortality	mortality	NN
cord-005453-4057qib7	15308	10	was	be	VBD
cord-005453-4057qib7	15308	11	17	17	CD
cord-005453-4057qib7	15308	12	%	%	NN
cord-005453-4057qib7	15308	13	,	,	,
cord-005453-4057qib7	15308	14	17	17	CD
cord-005453-4057qib7	15308	15	%	%	NN
cord-005453-4057qib7	15308	16	,	,	,
cord-005453-4057qib7	15308	17	4.5	4.5	CD
cord-005453-4057qib7	15308	18	%	%	NN
cord-005453-4057qib7	15308	19	and	and	CC
cord-005453-4057qib7	15308	20	42	42	CD
cord-005453-4057qib7	15308	21	%	%	NN
cord-005453-4057qib7	15308	22	in	in	IN
cord-005453-4057qib7	15308	23	MSD	MSD	NNP
cord-005453-4057qib7	15308	24	/	/	SYM
cord-005453-4057qib7	15308	25	MUD	MUD	NNP
cord-005453-4057qib7	15308	26	-	-	HYPH
cord-005453-4057qib7	15308	27	ATG	ATG	NNP
cord-005453-4057qib7	15308	28	,	,	,
cord-005453-4057qib7	15308	29	haplo	haplo	NN
cord-005453-4057qib7	15308	30	-	-	HYPH
cord-005453-4057qib7	15308	31	ptCy	ptcy	RB
cord-005453-4057qib7	15308	32	,	,	,
cord-005453-4057qib7	15309	1	MMUD	MMUD	NNP
cord-005453-4057qib7	15309	2	-	-	:
cord-005453-4057qib7	15309	3	ptCy	ptcy	NN
cord-005453-4057qib7	15309	4	and	and	CC
cord-005453-4057qib7	15309	5	MMUD	MMUD	NNP
cord-005453-4057qib7	15309	6	-	-	HYPH
cord-005453-4057qib7	15309	7	ATG	ATG	NNP
cord-005453-4057qib7	15309	8	groups	group	NNS
cord-005453-4057qib7	15309	9	,	,	,
cord-005453-4057qib7	15309	10	respectively	respectively	RB
cord-005453-4057qib7	15309	11	.	.	.
cord-005453-4057qib7	15310	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	15310	2	incidence	incidence	NN
cord-005453-4057qib7	15310	3	of	of	IN
cord-005453-4057qib7	15310	4	acute	acute	JJ
cord-005453-4057qib7	15310	5	GvHD	gvhd	NN
cord-005453-4057qib7	15310	6	grade	grade	NN
cord-005453-4057qib7	15310	7	3	3	CD
cord-005453-4057qib7	15310	8	or	or	CC
cord-005453-4057qib7	15310	9	4	4	CD
cord-005453-4057qib7	15310	10	was	be	VBD
cord-005453-4057qib7	15310	11	6	6	CD
cord-005453-4057qib7	15310	12	%	%	NN
cord-005453-4057qib7	15310	13	,	,	,
cord-005453-4057qib7	15310	14	9.5	9.5	CD
cord-005453-4057qib7	15310	15	%	%	NN
cord-005453-4057qib7	15310	16	,	,	,
cord-005453-4057qib7	15310	17	3	3	CD
cord-005453-4057qib7	15310	18	%	%	NN
cord-005453-4057qib7	15310	19	and	and	CC
cord-005453-4057qib7	15310	20	12	12	CD
cord-005453-4057qib7	15310	21	%	%	NN
cord-005453-4057qib7	15310	22	after	after	IN
cord-005453-4057qib7	15310	23	in	in	IN
cord-005453-4057qib7	15310	24	MSD	MSD	NNP
cord-005453-4057qib7	15310	25	/	/	SYM
cord-005453-4057qib7	15310	26	MUD	MUD	NNP
cord-005453-4057qib7	15310	27	-	-	HYPH
cord-005453-4057qib7	15310	28	ATG	ATG	NNP
cord-005453-4057qib7	15310	29	,	,	,
cord-005453-4057qib7	15310	30	haplo-	haplo-	NN
cord-005453-4057qib7	15311	1	ptCy	ptcy	DT
cord-005453-4057qib7	15311	2	Cumulative	cumulative	JJ
cord-005453-4057qib7	15311	3	incidence	incidence	NN
cord-005453-4057qib7	15311	4	of	of	IN
cord-005453-4057qib7	15311	5	chronic	chronic	JJ
cord-005453-4057qib7	15311	6	GvHD	gvhd	NN
cord-005453-4057qib7	15311	7	was	be	VBD
cord-005453-4057qib7	15311	8	26	26	CD
cord-005453-4057qib7	15311	9	%	%	NN
cord-005453-4057qib7	15311	10	in	in	IN
cord-005453-4057qib7	15311	11	the	the	DT
cord-005453-4057qib7	15311	12	MSD	MSD	NNP
cord-005453-4057qib7	15311	13	/	/	SYM
cord-005453-4057qib7	15311	14	MUD	MUD	NNP
cord-005453-4057qib7	15311	15	-	-	HYPH
cord-005453-4057qib7	15311	16	ATG	ATG	NNP
cord-005453-4057qib7	15311	17	group	group	NN
cord-005453-4057qib7	15311	18	Uwe	Uwe	NNP
cord-005453-4057qib7	15311	19	Platzbecker	Platzbecker	NNP
cord-005453-4057qib7	15311	20	3	3	CD
cord-005453-4057qib7	15311	21	,	,	,
cord-005453-4057qib7	15312	1	Verena	Verena	NNP
cord-005453-4057qib7	15312	2	Wais	Wais	NNP
cord-005453-4057qib7	15312	3	4	4	CD
cord-005453-4057qib7	15312	4	Republic	Republic	NNP
cord-005453-4057qib7	15312	5	of	of	IN
cord-005453-4057qib7	15312	6	China	China	NNP
cord-005453-4057qib7	15312	7	Background	Background	NNP
cord-005453-4057qib7	15312	8	:	:	:
cord-005453-4057qib7	15312	9	There	there	EX
cord-005453-4057qib7	15312	10	are	be	VBP
cord-005453-4057qib7	15312	11	two	two	CD
cord-005453-4057qib7	15312	12	most	most	RBS
cord-005453-4057qib7	15312	13	noteworthy	noteworthy	JJ
cord-005453-4057qib7	15312	14	strategies	strategy	NNS
cord-005453-4057qib7	15312	15	of	of	IN
cord-005453-4057qib7	15312	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15312	17	stem	stem	NN
cord-005453-4057qib7	15312	18	cell	cell	NN
cord-005453-4057qib7	15312	19	transplantations	transplantation	NNS
cord-005453-4057qib7	15312	20	(	(	-LRB-
cord-005453-4057qib7	15312	21	haplo	haplo	NNP
cord-005453-4057qib7	15312	22	-	-	HYPH
cord-005453-4057qib7	15312	23	HSCT	HSCT	NNP
cord-005453-4057qib7	15312	24	)	)	-RRB-
cord-005453-4057qib7	15312	25	,	,	,
cord-005453-4057qib7	15312	26	the	the	DT
cord-005453-4057qib7	15312	27	Baltimore	Baltimore	NNP
cord-005453-4057qib7	15312	28	post	post	NN
cord-005453-4057qib7	15312	29	-	-	NN
cord-005453-4057qib7	15312	30	transplantation	transplantation	JJ
cord-005453-4057qib7	15312	31	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15312	32	(	(	-LRB-
cord-005453-4057qib7	15312	33	PTCy	PTCy	NNP
cord-005453-4057qib7	15312	34	)	)	-RRB-
cord-005453-4057qib7	15312	35	with	with	IN
cord-005453-4057qib7	15312	36	or	or	CC
cord-005453-4057qib7	15312	37	without	without	IN
cord-005453-4057qib7	15312	38	anti	anti	JJ
cord-005453-4057qib7	15312	39	-	-	JJ
cord-005453-4057qib7	15312	40	thymoglobulin	thymoglobulin	JJ
cord-005453-4057qib7	15312	41	(	(	-LRB-
cord-005453-4057qib7	15312	42	ATG	ATG	NNP
cord-005453-4057qib7	15312	43	)	)	-RRB-
cord-005453-4057qib7	15312	44	,	,	,
cord-005453-4057qib7	15312	45	and	and	CC
cord-005453-4057qib7	15312	46	the	the	DT
cord-005453-4057qib7	15312	47	Beijing	Beijing	NNP
cord-005453-4057qib7	15312	48	G	G	NNP
cord-005453-4057qib7	15312	49	-	-	HYPH
cord-005453-4057qib7	15312	50	CSF	CSF	NNP
cord-005453-4057qib7	15312	51	primed	prime	VBN
cord-005453-4057qib7	15312	52	bone	bone	NN
cord-005453-4057qib7	15312	53	marrow	marrow	NN
cord-005453-4057qib7	15312	54	(	(	-LRB-
cord-005453-4057qib7	15312	55	BM	BM	NNP
cord-005453-4057qib7	15312	56	)	)	-RRB-
cord-005453-4057qib7	15312	57	plus	plus	CC
cord-005453-4057qib7	15312	58	peripheral	peripheral	JJ
cord-005453-4057qib7	15312	59	blood	blood	NN
cord-005453-4057qib7	15312	60	stem	stem	NN
cord-005453-4057qib7	15312	61	cells	cell	NNS
cord-005453-4057qib7	15312	62	(	(	-LRB-
cord-005453-4057qib7	15312	63	PBSC	PBSC	NNP
cord-005453-4057qib7	15312	64	)	)	-RRB-
cord-005453-4057qib7	15312	65	(	(	-LRB-
cord-005453-4057qib7	15312	66	GIAC	GIAC	NNP
cord-005453-4057qib7	15312	67	)	)	-RRB-
cord-005453-4057qib7	15312	68	.	.	.
cord-005453-4057qib7	15313	1	However	however	RB
cord-005453-4057qib7	15313	2	,	,	,
cord-005453-4057qib7	15313	3	the	the	DT
cord-005453-4057qib7	15313	4	comparison	comparison	NN
cord-005453-4057qib7	15313	5	of	of	IN
cord-005453-4057qib7	15313	6	these	these	DT
cord-005453-4057qib7	15313	7	two	two	CD
cord-005453-4057qib7	15313	8	modalities	modality	NNS
cord-005453-4057qib7	15313	9	is	be	VBZ
cord-005453-4057qib7	15313	10	scarce	scarce	JJ
cord-005453-4057qib7	15313	11	.	.	.
cord-005453-4057qib7	15314	1	In	in	IN
cord-005453-4057qib7	15314	2	this	this	DT
cord-005453-4057qib7	15314	3	study	study	NN
cord-005453-4057qib7	15314	4	,	,	,
cord-005453-4057qib7	15314	5	we	-PRON-	PRP
cord-005453-4057qib7	15314	6	aim	aim	VBP
cord-005453-4057qib7	15314	7	to	to	TO
cord-005453-4057qib7	15314	8	compare	compare	VB
cord-005453-4057qib7	15314	9	these	these	DT
cord-005453-4057qib7	15314	10	two	two	CD
cord-005453-4057qib7	15314	11	approaches	approach	NNS
cord-005453-4057qib7	15314	12	for	for	IN
cord-005453-4057qib7	15314	13	hematological	hematological	JJ
cord-005453-4057qib7	15314	14	malignancies	malignancy	NNS
cord-005453-4057qib7	15314	15	based	base	VBN
cord-005453-4057qib7	15314	16	on	on	IN
cord-005453-4057qib7	15314	17	the	the	DT
cord-005453-4057qib7	15314	18	Taiwan	Taiwan	NNP
cord-005453-4057qib7	15314	19	Blood	Blood	NNP
cord-005453-4057qib7	15314	20	and	and	CC
cord-005453-4057qib7	15314	21	Marrow	Marrow	NNP
cord-005453-4057qib7	15314	22	Transplantation	transplantation	NN
cord-005453-4057qib7	15314	23	Registry	registry	NN
cord-005453-4057qib7	15314	24	(	(	-LRB-
cord-005453-4057qib7	15314	25	TBMTR	TBMTR	NNP
cord-005453-4057qib7	15314	26	)	)	-RRB-
cord-005453-4057qib7	15315	1	With	with	IN
cord-005453-4057qib7	15315	2	the	the	DT
cord-005453-4057qib7	15315	3	comparable	comparable	JJ
cord-005453-4057qib7	15315	4	CD34	CD34	NNP
cord-005453-4057qib7	15315	5	infusion	infusion	NN
cord-005453-4057qib7	15315	6	amounts	amount	NNS
cord-005453-4057qib7	15315	7	,	,	,
cord-005453-4057qib7	15315	8	the	the	DT
cord-005453-4057qib7	15315	9	neutrophil	neutrophil	NN
cord-005453-4057qib7	15315	10	engraftment	engraftment	NN
cord-005453-4057qib7	15315	11	time	time	NN
cord-005453-4057qib7	15315	12	were	be	VBD
cord-005453-4057qib7	15315	13	statistically	statistically	RB
cord-005453-4057qib7	15315	14	distinct	distinct	JJ
cord-005453-4057qib7	15315	15	among	among	IN
cord-005453-4057qib7	15315	16	these	these	DT
cord-005453-4057qib7	15315	17	three	three	CD
cord-005453-4057qib7	15315	18	groups	group	NNS
cord-005453-4057qib7	15315	19	[	[	-LRB-
cord-005453-4057qib7	15315	20	D+12	D+12	NNP
cord-005453-4057qib7	15315	21	(	(	-LRB-
cord-005453-4057qib7	15315	22	group	group	NN
cord-005453-4057qib7	15315	23	1	1	CD
cord-005453-4057qib7	15315	24	)	)	-RRB-
cord-005453-4057qib7	15315	25	vs.	vs.	FW
cord-005453-4057qib7	15315	26	D+15	D+15	NNP
cord-005453-4057qib7	15315	27	(	(	-LRB-
cord-005453-4057qib7	15315	28	group	group	NN
cord-005453-4057qib7	15315	29	2	2	CD
cord-005453-4057qib7	15315	30	)	)	-RRB-
cord-005453-4057qib7	15315	31	vs.	vs.	FW
cord-005453-4057qib7	15315	32	D+17	D+17	NNP
cord-005453-4057qib7	15315	33	(	(	-LRB-
cord-005453-4057qib7	15315	34	group	group	NN
cord-005453-4057qib7	15315	35	3	3	CD
cord-005453-4057qib7	15315	36	)	)	-RRB-
cord-005453-4057qib7	15315	37	,	,	,
cord-005453-4057qib7	15315	38	respectively	respectively	RB
cord-005453-4057qib7	15316	1	As	as	IN
cord-005453-4057qib7	15316	2	to	to	IN
cord-005453-4057qib7	15316	3	the	the	DT
cord-005453-4057qib7	15316	4	graft	graft	NN
cord-005453-4057qib7	15316	5	-	-	HYPH
cord-005453-4057qib7	15316	6	versus	versus	IN
cord-005453-4057qib7	15316	7	-	-	HYPH
cord-005453-4057qib7	15316	8	host	host	NN
cord-005453-4057qib7	15316	9	disease	disease	NN
cord-005453-4057qib7	15316	10	(	(	-LRB-
cord-005453-4057qib7	15316	11	GvHD	GvHD	NNP
cord-005453-4057qib7	15316	12	)	)	-RRB-
cord-005453-4057qib7	15316	13	,	,	,
cord-005453-4057qib7	15316	14	the	the	DT
cord-005453-4057qib7	15316	15	patients	patient	NNS
cord-005453-4057qib7	15316	16	in	in	IN
cord-005453-4057qib7	15316	17	group	group	NN
cord-005453-4057qib7	15316	18	1	1	CD
cord-005453-4057qib7	15316	19	had	have	VBD
cord-005453-4057qib7	15316	20	more	more	JJR
cord-005453-4057qib7	15316	21	grade	grade	NN
cord-005453-4057qib7	15316	22	II	II	NNP
cord-005453-4057qib7	15316	23	-	-	HYPH
cord-005453-4057qib7	15316	24	IV	IV	NNP
cord-005453-4057qib7	15316	25	but	but	CC
cord-005453-4057qib7	15316	26	similar	similar	JJ
cord-005453-4057qib7	15316	27	grade	grade	NN
cord-005453-4057qib7	15316	28	III	III	NNP
cord-005453-4057qib7	15316	29	-	-	HYPH
cord-005453-4057qib7	15316	30	IV	IV	NNP
cord-005453-4057qib7	15316	31	acute	acute	JJ
cord-005453-4057qib7	15316	32	GvHD	gvhd	NN
cord-005453-4057qib7	15316	33	compared	compare	VBN
cord-005453-4057qib7	15316	34	with	with	IN
cord-005453-4057qib7	15316	35	others	other	NNS
cord-005453-4057qib7	15316	36	(	(	-LRB-
cord-005453-4057qib7	15316	37	grade	grade	NN
cord-005453-4057qib7	15316	38	II	II	NNP
cord-005453-4057qib7	15316	39	-	-	HYPH
cord-005453-4057qib7	15316	40	IV	IV	NNP
cord-005453-4057qib7	15316	41	:	:	:
cord-005453-4057qib7	15316	42	60.0	60.0	CD
cord-005453-4057qib7	15316	43	%	%	NN
cord-005453-4057qib7	15316	44	vs.	vs.	CC
cord-005453-4057qib7	15316	45	37.5	37.5	CD
cord-005453-4057qib7	15316	46	%	%	NN
cord-005453-4057qib7	15316	47	vs.	vs.	CC
cord-005453-4057qib7	15316	48	21.6	21.6	CD
cord-005453-4057qib7	15316	49	%	%	NN
cord-005453-4057qib7	15316	50	,	,	,
cord-005453-4057qib7	15316	51	respectively	respectively	RB
cord-005453-4057qib7	15316	52	Conclusions	conclusion	NNS
cord-005453-4057qib7	15316	53	:	:	:
cord-005453-4057qib7	15317	1	Haplo	Haplo	NNP
cord-005453-4057qib7	15317	2	-	-	HYPH
cord-005453-4057qib7	15317	3	HSCT	HSCT	NNP
cord-005453-4057qib7	15317	4	with	with	IN
cord-005453-4057qib7	15317	5	different	different	JJ
cord-005453-4057qib7	15317	6	strategies	strategy	NNS
cord-005453-4057qib7	15317	7	is	be	VBZ
cord-005453-4057qib7	15317	8	a	a	DT
cord-005453-4057qib7	15317	9	feasible	feasible	JJ
cord-005453-4057qib7	15317	10	treatment	treatment	NN
cord-005453-4057qib7	15317	11	modality	modality	NN
cord-005453-4057qib7	15317	12	for	for	IN
cord-005453-4057qib7	15317	13	hematologic	hematologic	JJ
cord-005453-4057qib7	15317	14	malignancies	malignancy	NNS
cord-005453-4057qib7	15317	15	in	in	IN
cord-005453-4057qib7	15317	16	Taiwan	Taiwan	NNP
cord-005453-4057qib7	15317	17	.	.	.
cord-005453-4057qib7	15318	1	Regarding	regard	VBG
cord-005453-4057qib7	15318	2	the	the	DT
cord-005453-4057qib7	15318	3	retrospective	retrospective	JJ
cord-005453-4057qib7	15318	4	nature	nature	NN
cord-005453-4057qib7	15318	5	and	and	CC
cord-005453-4057qib7	15318	6	limited	limited	JJ
cord-005453-4057qib7	15318	7	patient	patient	JJ
cord-005453-4057qib7	15318	8	numbers	number	NNS
cord-005453-4057qib7	15318	9	of	of	IN
cord-005453-4057qib7	15318	10	this	this	DT
cord-005453-4057qib7	15318	11	study	study	NN
cord-005453-4057qib7	15318	12	Republic	Republic	NNP
cord-005453-4057qib7	15318	13	of	of	IN
cord-005453-4057qib7	15318	14	China	China	NNP
cord-005453-4057qib7	15318	15	Background	Background	NNP
cord-005453-4057qib7	15318	16	:	:	:
cord-005453-4057qib7	15318	17	We	-PRON-	PRP
cord-005453-4057qib7	15318	18	previously	previously	RB
cord-005453-4057qib7	15318	19	presented	present	VBD
cord-005453-4057qib7	15318	20	a	a	DT
cord-005453-4057qib7	15318	21	low	low	JJ
cord-005453-4057qib7	15318	22	-	-	HYPH
cord-005453-4057qib7	15318	23	resolution	resolution	NN
cord-005453-4057qib7	15318	24	HLA	HLA	NNP
cord-005453-4057qib7	15318	25	analysis	analysis	NN
cord-005453-4057qib7	15318	26	of	of	IN
cord-005453-4057qib7	15318	27	CEDACE	CEDACE	NNP
cord-005453-4057qib7	15318	28	,	,	,
cord-005453-4057qib7	15318	29	the	the	DT
cord-005453-4057qib7	15318	30	voluntary	voluntary	JJ
cord-005453-4057qib7	15318	31	Portuguese	portuguese	JJ
cord-005453-4057qib7	15318	32	Bone	Bone	NNP
cord-005453-4057qib7	15318	33	Marrow	Marrow	NNP
cord-005453-4057qib7	15318	34	Donor	Donor	NNP
cord-005453-4057qib7	15318	35	Registry	Registry	NNP
cord-005453-4057qib7	15318	36	(	(	-LRB-
cord-005453-4057qib7	15318	37	EBMT	EBMT	NNP
cord-005453-4057qib7	15318	38	2011	2011	CD
cord-005453-4057qib7	15318	39	,	,	,
cord-005453-4057qib7	15318	40	Poster	poster	NN
cord-005453-4057qib7	15318	41	P1127	P1127	NNP
cord-005453-4057qib7	15318	42	)	)	-RRB-
cord-005453-4057qib7	15318	43	and	and	CC
cord-005453-4057qib7	15318	44	,	,	,
cord-005453-4057qib7	15318	45	more	more	RBR
cord-005453-4057qib7	15318	46	recently	recently	RB
cord-005453-4057qib7	15318	47	,	,	,
cord-005453-4057qib7	15318	48	its	-PRON-	PRP$
cord-005453-4057qib7	15318	49	epidemiological	epidemiological	JJ
cord-005453-4057qib7	15318	50	characterization	characterization	NN
cord-005453-4057qib7	15318	51	(	(	-LRB-
cord-005453-4057qib7	15318	52	EBMT	EBMT	NNP
cord-005453-4057qib7	15318	53	2018	2018	CD
cord-005453-4057qib7	15318	54	,	,	,
cord-005453-4057qib7	15318	55	Poster	Poster	NNP
cord-005453-4057qib7	15318	56	B348	B348	NNP
cord-005453-4057qib7	15318	57	)	)	-RRB-
cord-005453-4057qib7	15318	58	.	.	.
cord-005453-4057qib7	15319	1	Currently	currently	RB
cord-005453-4057qib7	15319	2	,	,	,
cord-005453-4057qib7	15319	3	CEDACE	CEDACE	NNP
cord-005453-4057qib7	15319	4	is	be	VBZ
cord-005453-4057qib7	15319	5	one	one	CD
cord-005453-4057qib7	15319	6	of	of	IN
cord-005453-4057qib7	15319	7	the	the	DT
cord-005453-4057qib7	15319	8	largest	large	JJS
cord-005453-4057qib7	15319	9	bone	bone	NN
cord-005453-4057qib7	15319	10	marrow	marrow	NN
cord-005453-4057qib7	15319	11	donor	donor	NN
cord-005453-4057qib7	15319	12	registries	registry	NNS
cord-005453-4057qib7	15319	13	in	in	IN
cord-005453-4057qib7	15319	14	the	the	DT
cord-005453-4057qib7	15319	15	world	world	NN
cord-005453-4057qib7	15319	16	,	,	,
cord-005453-4057qib7	15319	17	including	include	VBG
cord-005453-4057qib7	15319	18	nearly	nearly	RB
cord-005453-4057qib7	15319	19	4	4	CD
cord-005453-4057qib7	15319	20	%	%	NN
cord-005453-4057qib7	15319	21	of	of	IN
cord-005453-4057qib7	15319	22	the	the	DT
cord-005453-4057qib7	15319	23	country	country	NN
cord-005453-4057qib7	15319	24	's	's	POS
cord-005453-4057qib7	15319	25	population	population	NN
cord-005453-4057qib7	15319	26	,	,	,
cord-005453-4057qib7	15319	27	twice	twice	PDT
cord-005453-4057qib7	15319	28	the	the	DT
cord-005453-4057qib7	15319	29	number	number	NN
cord-005453-4057qib7	15319	30	of	of	IN
cord-005453-4057qib7	15319	31	donors	donor	NNS
cord-005453-4057qib7	15319	32	present	present	JJ
cord-005453-4057qib7	15319	33	in	in	IN
cord-005453-4057qib7	15319	34	2011	2011	CD
cord-005453-4057qib7	15319	35	.	.	.
cord-005453-4057qib7	15320	1	The	the	DT
cord-005453-4057qib7	15320	2	current	current	JJ
cord-005453-4057qib7	15320	3	work	work	NN
cord-005453-4057qib7	15320	4	is	be	VBZ
cord-005453-4057qib7	15320	5	an	an	DT
cord-005453-4057qib7	15320	6	update	update	NN
cord-005453-4057qib7	15320	7	on	on	IN
cord-005453-4057qib7	15320	8	the	the	DT
cord-005453-4057qib7	15320	9	most	most	RBS
cord-005453-4057qib7	15320	10	common	common	JJ
cord-005453-4057qib7	15320	11	HLA	HLA	NNP
cord-005453-4057qib7	15320	12	haplotypes	haplotype	NNS
cord-005453-4057qib7	15320	13	found	find	VBN
cord-005453-4057qib7	15320	14	in	in	IN
cord-005453-4057qib7	15320	15	CEDACE	CEDACE	NNP
cord-005453-4057qib7	15320	16	Results	Results	NNPS
cord-005453-4057qib7	15320	17	:	:	:
cord-005453-4057qib7	15320	18	Of	of	IN
cord-005453-4057qib7	15320	19	the	the	DT
cord-005453-4057qib7	15320	20	396545	396545	CD
cord-005453-4057qib7	15320	21	donors	donor	NNS
cord-005453-4057qib7	15320	22	in	in	IN
cord-005453-4057qib7	15320	23	the	the	DT
cord-005453-4057qib7	15320	24	CEDACE	CEDACE	NNP
cord-005453-4057qib7	15320	25	registry	registry	NN
cord-005453-4057qib7	15320	26	,	,	,
cord-005453-4057qib7	15320	27	99.51	99.51	CD
cord-005453-4057qib7	15320	28	%	%	NN
cord-005453-4057qib7	15320	29	were	be	VBD
cord-005453-4057qib7	15320	30	typed	type	VBN
cord-005453-4057qib7	15320	31	in	in	IN
cord-005453-4057qib7	15320	32	at	at	RB
cord-005453-4057qib7	15320	33	least	least	JJS
cord-005453-4057qib7	15320	34	3	3	CD
cord-005453-4057qib7	15320	35	loci	locus	NNS
cord-005453-4057qib7	15320	36	(	(	-LRB-
cord-005453-4057qib7	15320	37	HLA	HLA	NNP
cord-005453-4057qib7	15320	38	-	-	HYPH
cord-005453-4057qib7	15320	39	A/-B/-DRB1	A/-B/-DRB1	NNP
cord-005453-4057qib7	15320	40	)	)	-RRB-
cord-005453-4057qib7	15320	41	,	,	,
cord-005453-4057qib7	15320	42	43.91	43.91	CD
cord-005453-4057qib7	15320	43	%	%	NN
cord-005453-4057qib7	15320	44	in	in	IN
cord-005453-4057qib7	15320	45	4	4	CD
cord-005453-4057qib7	15320	46	(	(	-LRB-
cord-005453-4057qib7	15320	47	including	include	VBG
cord-005453-4057qib7	15320	48	HLA	HLA	NNP
cord-005453-4057qib7	15320	49	-	-	HYPH
cord-005453-4057qib7	15320	50	Cw	Cw	NNP
cord-005453-4057qib7	15320	51	)	)	-RRB-
cord-005453-4057qib7	15320	52	,	,	,
cord-005453-4057qib7	15320	53	and	and	CC
cord-005453-4057qib7	15320	54	1.28	1.28	CD
cord-005453-4057qib7	15320	55	%	%	NN
cord-005453-4057qib7	15320	56	in	in	IN
cord-005453-4057qib7	15320	57	5	5	CD
cord-005453-4057qib7	15320	58	(	(	-LRB-
cord-005453-4057qib7	15320	59	including	include	VBG
cord-005453-4057qib7	15320	60	HLA	HLA	NNP
cord-005453-4057qib7	15320	61	-	-	HYPH
cord-005453-4057qib7	15320	62	DQB1)the	DQB1)the	NNP
cord-005453-4057qib7	15320	63	5	5	CD
cord-005453-4057qib7	15320	64	,	,	,
cord-005453-4057qib7	15320	65	25	25	CD
cord-005453-4057qib7	15320	66	and	and	CC
cord-005453-4057qib7	15320	67	150	150	CD
cord-005453-4057qib7	15320	68	most	most	RBS
cord-005453-4057qib7	15320	69	common	common	JJ
cord-005453-4057qib7	15320	70	haplotypes	haplotype	NNS
cord-005453-4057qib7	15320	71	accounted	account	VBD
cord-005453-4057qib7	15320	72	for	for	IN
cord-005453-4057qib7	15320	73	,	,	,
cord-005453-4057qib7	15320	74	respectively	respectively	RB
cord-005453-4057qib7	15320	75	,	,	,
cord-005453-4057qib7	15320	76	8.9	8.9	CD
cord-005453-4057qib7	15320	77	%	%	NN
cord-005453-4057qib7	15320	78	,	,	,
cord-005453-4057qib7	15320	79	23.5	23.5	CD
cord-005453-4057qib7	15320	80	%	%	NN
cord-005453-4057qib7	15320	81	and	and	CC
cord-005453-4057qib7	15320	82	50	50	CD
cord-005453-4057qib7	15320	83	%	%	NN
cord-005453-4057qib7	15320	84	of	of	IN
cord-005453-4057qib7	15320	85	the	the	DT
cord-005453-4057qib7	15320	86	haplotypes	haplotype	NNS
cord-005453-4057qib7	15320	87	found	find	VBN
cord-005453-4057qib7	15320	88	in	in	IN
cord-005453-4057qib7	15320	89	the	the	DT
cord-005453-4057qib7	15320	90	entire	entire	JJ
cord-005453-4057qib7	15320	91	registry	registry	NN
cord-005453-4057qib7	15320	92	.	.	.
cord-005453-4057qib7	15321	1	The	the	DT
cord-005453-4057qib7	15321	2	five	five	CD
cord-005453-4057qib7	15321	3	most	most	RBS
cord-005453-4057qib7	15321	4	common	common	JJ
cord-005453-4057qib7	15321	5	haplotypes	haplotype	NNS
cord-005453-4057qib7	15321	6	at	at	IN
cord-005453-4057qib7	15321	7	the	the	DT
cord-005453-4057qib7	15321	8	low	low	JJ
cord-005453-4057qib7	15321	9	-	-	HYPH
cord-005453-4057qib7	15321	10	resolution	resolution	NN
cord-005453-4057qib7	15321	11	At	at	IN
cord-005453-4057qib7	15321	12	the	the	DT
cord-005453-4057qib7	15321	13	3	3	CD
cord-005453-4057qib7	15321	14	loci	locus	NNS
cord-005453-4057qib7	15321	15	,	,	,
cord-005453-4057qib7	15321	16	low	low	JJ
cord-005453-4057qib7	15321	17	-	-	HYPH
cord-005453-4057qib7	15321	18	resolution	resolution	NN
cord-005453-4057qib7	15321	19	level	level	NN
cord-005453-4057qib7	15321	20	,	,	,
cord-005453-4057qib7	15321	21	out	out	IN
cord-005453-4057qib7	15321	22	of	of	IN
cord-005453-4057qib7	15321	23	394621	394621	CD
cord-005453-4057qib7	15321	24	donors	donor	NNS
cord-005453-4057qib7	15321	25	,	,	,
cord-005453-4057qib7	15321	26	167505	167505	CD
cord-005453-4057qib7	15321	27	individual	individual	JJ
cord-005453-4057qib7	15321	28	genotypes	genotype	NNS
cord-005453-4057qib7	15321	29	were	be	VBD
cord-005453-4057qib7	15321	30	identified	identify	VBN
cord-005453-4057qib7	15321	31	,	,	,
cord-005453-4057qib7	15321	32	leading	lead	VBG
cord-005453-4057qib7	15321	33	to	to	IN
cord-005453-4057qib7	15321	34	an	an	DT
cord-005453-4057qib7	15321	35	HLA	HLA	NNP
cord-005453-4057qib7	15321	36	matching	matching	NN
cord-005453-4057qib7	15321	37	probability	probability	NN
cord-005453-4057qib7	15321	38	at	at	IN
cord-005453-4057qib7	15321	39	this	this	DT
cord-005453-4057qib7	15321	40	level	level	NN
cord-005453-4057qib7	15321	41	of	of	IN
cord-005453-4057qib7	15321	42	57.6	57.6	CD
cord-005453-4057qib7	15321	43	%	%	NN
cord-005453-4057qib7	15321	44	HID	HID	NNP
cord-005453-4057qib7	15321	45	-	-	HYPH
cord-005453-4057qib7	15321	46	HSCT	HSCT	NNP
cord-005453-4057qib7	15321	47	)	)	-RRB-
cord-005453-4057qib7	15321	48	have	have	VBP
cord-005453-4057qib7	15321	49	a	a	DT
cord-005453-4057qib7	15321	50	stronger	strong	JJR
cord-005453-4057qib7	15321	51	anti	anti	JJ
cord-005453-4057qib7	15321	52	-	-	JJ
cord-005453-4057qib7	15321	53	leukemia	leukemia	JJ
cord-005453-4057qib7	15321	54	effect	effect	NN
cord-005453-4057qib7	15321	55	compared	compare	VBN
cord-005453-4057qib7	15321	56	to	to	IN
cord-005453-4057qib7	15321	57	identical	identical	JJ
cord-005453-4057qib7	15321	58	sibling	sibling	NN
cord-005453-4057qib7	15321	59	donor	donor	NN
cord-005453-4057qib7	15321	60	HSCT(ISD	hsct(isd	NN
cord-005453-4057qib7	15321	61	-	-	HYPH
cord-005453-4057qib7	15321	62	HSCT	HSCT	NNP
cord-005453-4057qib7	15321	63	)	)	-RRB-
cord-005453-4057qib7	15321	64	in	in	IN
cord-005453-4057qib7	15321	65	high	high	JJ
cord-005453-4057qib7	15321	66	-	-	HYPH
cord-005453-4057qib7	15321	67	risk	risk	NN
cord-005453-4057qib7	15321	68	features	feature	NNS
cord-005453-4057qib7	15321	69	.but	.but	.
cord-005453-4057qib7	15322	1	in	in	IN
cord-005453-4057qib7	15322	2	refractory	refractory	JJ
cord-005453-4057qib7	15322	3	/	/	SYM
cord-005453-4057qib7	15322	4	relapsed(R	relapsed(R	NNP
cord-005453-4057qib7	15322	5	/	/	SYM
cord-005453-4057qib7	15322	6	R	r	NN
cord-005453-4057qib7	15322	7	)	)	-RRB-
cord-005453-4057qib7	15322	8	AML	AML	NNP
cord-005453-4057qib7	15322	9	patients	patient	NNS
cord-005453-4057qib7	15322	10	who	who	WP
cord-005453-4057qib7	15322	11	not	not	RB
cord-005453-4057qib7	15322	12	in	in	IN
cord-005453-4057qib7	15322	13	remission	remission	NN
cord-005453-4057qib7	15322	14	status	status	NN
cord-005453-4057qib7	15322	15	,	,	,
cord-005453-4057qib7	15322	16	it	-PRON-	PRP
cord-005453-4057qib7	15322	17	is	be	VBZ
cord-005453-4057qib7	15322	18	unclear	unclear	JJ
cord-005453-4057qib7	15322	19	whether	whether	IN
cord-005453-4057qib7	15322	20	it	-PRON-	PRP
cord-005453-4057qib7	15322	21	also	also	RB
cord-005453-4057qib7	15322	22	augments	augment	VBZ
cord-005453-4057qib7	15322	23	the	the	DT
cord-005453-4057qib7	15322	24	GVL	GVL	NNP
cord-005453-4057qib7	15322	25	effect	effect	NN
cord-005453-4057qib7	15322	26	Antithymocyte	Antithymocyte	NNP
cord-005453-4057qib7	15322	27	globulin	globulin	NN
cord-005453-4057qib7	15322	28	was	be	VBD
cord-005453-4057qib7	15322	29	used	use	VBN
cord-005453-4057qib7	15322	30	in	in	IN
cord-005453-4057qib7	15322	31	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15322	32	HSCT	HSCT	NNP
cord-005453-4057qib7	15322	33	.	.	.
cord-005453-4057qib7	15323	1	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	15323	2	bone	bone	NN
cord-005453-4057qib7	15323	3	marrow	marrow	NN
cord-005453-4057qib7	15323	4	and	and	CC
cord-005453-4057qib7	15323	5	peripheral	peripheral	JJ
cord-005453-4057qib7	15323	6	blood	blood	NN
cord-005453-4057qib7	15323	7	stem	stem	NN
cord-005453-4057qib7	15323	8	cells	cell	NNS
cord-005453-4057qib7	15323	9	for	for	IN
cord-005453-4057qib7	15323	10	all	all	DT
cord-005453-4057qib7	15323	11	patients	patient	NNS
cord-005453-4057qib7	15323	12	.	.	.
cord-005453-4057qib7	15324	1	Cyclosporine	cyclosporine	JJ
cord-005453-4057qib7	15324	2	,	,	,
cord-005453-4057qib7	15324	3	short	short	JJ
cord-005453-4057qib7	15324	4	-	-	HYPH
cord-005453-4057qib7	15324	5	term	term	NN
cord-005453-4057qib7	15324	6	Methotrexate	Methotrexate	NNP
cord-005453-4057qib7	15324	7	were	be	VBD
cord-005453-4057qib7	15324	8	employed	employ	VBN
cord-005453-4057qib7	15324	9	for	for	IN
cord-005453-4057qib7	15324	10	GVHD	GVHD	NNP
cord-005453-4057qib7	15324	11	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15324	12	.	.	.
cord-005453-4057qib7	15325	1	Mycophenolate	Mycophenolate	NNP
cord-005453-4057qib7	15325	2	mofetil	mofetil	NNP
cord-005453-4057qib7	15325	3	included	include	VBD
cord-005453-4057qib7	15325	4	in	in	IN
cord-005453-4057qib7	15325	5	HID	HID	NNP
cord-005453-4057qib7	15325	6	-	-	HYPH
cord-005453-4057qib7	15325	7	HSCT	HSCT	NNP
cord-005453-4057qib7	15325	8	.	.	.
cord-005453-4057qib7	15326	1	performed	perform	VBN
cord-005453-4057qib7	15326	2	multivariate	multivariate	JJ
cord-005453-4057qib7	15326	3	analysis	analysis	NN
cord-005453-4057qib7	15326	4	for	for	IN
cord-005453-4057qib7	15326	5	all	all	DT
cord-005453-4057qib7	15326	6	patients	patient	NNS
cord-005453-4057qib7	15326	7	of	of	IN
cord-005453-4057qib7	15326	8	pretransplantation	pretransplantation	NN
cord-005453-4057qib7	15326	9	variables	variable	NNS
cord-005453-4057qib7	15326	10	and	and	CC
cord-005453-4057qib7	15326	11	developed	develop	VBD
cord-005453-4057qib7	15326	12	a	a	DT
cord-005453-4057qib7	15326	13	predictive	predictive	JJ
cord-005453-4057qib7	15326	14	scoring	scoring	NN
cord-005453-4057qib7	15326	15	system	system	NN
cord-005453-4057qib7	15326	16	for	for	IN
cord-005453-4057qib7	15326	17	survival	survival	NN
cord-005453-4057qib7	15326	18	according	accord	VBG
cord-005453-4057qib7	15326	19	to	to	IN
cord-005453-4057qib7	15326	20	adverse	adverse	JJ
cord-005453-4057qib7	15326	21	factors	factor	NNS
cord-005453-4057qib7	15326	22	.	.	.
cord-005453-4057qib7	15327	1	Results	result	NNS
cord-005453-4057qib7	15327	2	:	:	:
cord-005453-4057qib7	15328	1	The	the	DT
cord-005453-4057qib7	15328	2	total	total	JJ
cord-005453-4057qib7	15328	3	survivor	survivor	NN
cord-005453-4057qib7	15328	4	median	median	JJ
cord-005453-4057qib7	15328	5	period	period	NN
cord-005453-4057qib7	15328	6	of	of	IN
cord-005453-4057qib7	15328	7	follow	follow	NN
cord-005453-4057qib7	15328	8	up	up	RP
cord-005453-4057qib7	15328	9	was	be	VBD
cord-005453-4057qib7	15328	10	46	46	CD
cord-005453-4057qib7	15328	11	(	(	-LRB-
cord-005453-4057qib7	15328	12	20	20	CD
cord-005453-4057qib7	15328	13	-	-	SYM
cord-005453-4057qib7	15328	14	73	73	CD
cord-005453-4057qib7	15328	15	)	)	-RRB-
cord-005453-4057qib7	15328	16	months	month	NNS
cord-005453-4057qib7	15328	17	.	.	.
cord-005453-4057qib7	15329	1	HID	HID	NNP
cord-005453-4057qib7	15329	2	-cohort	-cohort	RB
cord-005453-4057qib7	15329	3	had	have	VBD
cord-005453-4057qib7	15329	4	higher	high	JJR
cord-005453-4057qib7	15329	5	5-year	5-year	CD
cord-005453-4057qib7	15329	6	actuarial	actuarial	NN
cord-005453-4057qib7	15329	7	of	of	IN
cord-005453-4057qib7	15329	8	OS	OS	NNP
cord-005453-4057qib7	15329	9	Multivariate	Multivariate	NNP
cord-005453-4057qib7	15329	10	analysis	analysis	NN
cord-005453-4057qib7	15329	11	showed	show	VBD
cord-005453-4057qib7	15329	12	ISD	ISD	NNP
cord-005453-4057qib7	15329	13	-	-	HYPH
cord-005453-4057qib7	15329	14	HSCT	HSCT	NNP
cord-005453-4057qib7	15329	15	,	,	,
cord-005453-4057qib7	15329	16	standard	standard	JJ
cord-005453-4057qib7	15329	17	conditioning	conditioning	NN
cord-005453-4057qib7	15329	18	regimen	regimen	NN
cord-005453-4057qib7	15329	19	and	and	CC
cord-005453-4057qib7	15329	20	less	less	JJR
cord-005453-4057qib7	15329	21	than	than	IN
cord-005453-4057qib7	15329	22	50	50	CD
cord-005453-4057qib7	15329	23	%	%	NN
cord-005453-4057qib7	15329	24	proportional	proportional	JJ
cord-005453-4057qib7	15329	25	reduction	reduction	NN
cord-005453-4057qib7	15329	26	in	in	IN
cord-005453-4057qib7	15329	27	blast	blast	NN
cord-005453-4057qib7	15329	28	percentage	percentage	NN
cord-005453-4057qib7	15329	29	pre-≥2	pre-≥2	NN
cord-005453-4057qib7	15329	30	.	.	.
cord-005453-4057qib7	15330	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15330	2	:	:	:
cord-005453-4057qib7	15331	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	15331	2	donor	donor	NN
cord-005453-4057qib7	15331	3	compared	compare	VBN
cord-005453-4057qib7	15331	4	to	to	IN
cord-005453-4057qib7	15331	5	identical	identical	JJ
cord-005453-4057qib7	15331	6	sibling	sibling	NN
cord-005453-4057qib7	15331	7	donor	donor	NN
cord-005453-4057qib7	15331	8	had	have	VBD
cord-005453-4057qib7	15332	1	better	well	JJR
cord-005453-4057qib7	15332	2	anti	anti	JJ
cord-005453-4057qib7	15332	3	-	-	JJ
cord-005453-4057qib7	15332	4	leukemia	leukemia	JJ
cord-005453-4057qib7	15332	5	effect	effect	NN
cord-005453-4057qib7	15332	6	in	in	IN
cord-005453-4057qib7	15332	7	allo	allo	NN
cord-005453-4057qib7	15332	8	-	-	HYPH
cord-005453-4057qib7	15332	9	HSCT	HSCT	NNP
cord-005453-4057qib7	15332	10	for	for	IN
cord-005453-4057qib7	15332	11	R	R	NNP
cord-005453-4057qib7	15332	12	/	/	SYM
cord-005453-4057qib7	15332	13	R	R	NNP
cord-005453-4057qib7	15332	14	AML	AML	NNP
cord-005453-4057qib7	15332	15	in	in	IN
cord-005453-4057qib7	15332	16	NR	NR	NNP
cord-005453-4057qib7	15332	17	status	status	NN
cord-005453-4057qib7	15332	18	Conditioning	conditioning	NN
cord-005453-4057qib7	15332	19	protocol	protocol	NN
cord-005453-4057qib7	15332	20	was	be	VBD
cord-005453-4057qib7	15332	21	melphalan	melphalan	NNP
cord-005453-4057qib7	15332	22	200mg	200mg	NNP
cord-005453-4057qib7	15332	23	/	/	SYM
cord-005453-4057qib7	15332	24	m2	m2	NNP
cord-005453-4057qib7	15332	25	for	for	IN
cord-005453-4057qib7	15332	26	MM	MM	NNP
cord-005453-4057qib7	15332	27	and	and	CC
cord-005453-4057qib7	15332	28	BEAM	BEAM	NNP
cord-005453-4057qib7	15332	29	for	for	IN
cord-005453-4057qib7	15332	30	NHL	NHL	NNP
cord-005453-4057qib7	15332	31	.	.	.
cord-005453-4057qib7	15333	1	The	the	DT
cord-005453-4057qib7	15333	2	quantification	quantification	NN
cord-005453-4057qib7	15333	3	and	and	CC
cord-005453-4057qib7	15333	4	characterization	characterization	NN
cord-005453-4057qib7	15333	5	of	of	IN
cord-005453-4057qib7	15333	6	γδT	γδt	NN
cord-005453-4057qib7	15333	7	cells	cell	NNS
cord-005453-4057qib7	15333	8	in	in	IN
cord-005453-4057qib7	15333	9	peripheral	peripheral	JJ
cord-005453-4057qib7	15333	10	blood	blood	NN
cord-005453-4057qib7	15333	11	samples	sample	NNS
cord-005453-4057qib7	15333	12	were	be	VBD
cord-005453-4057qib7	15333	13	performed	perform	VBN
cord-005453-4057qib7	15333	14	by	by	IN
cord-005453-4057qib7	15333	15	flow	flow	NN
cord-005453-4057qib7	15333	16	cytometry	cytometry	NN
cord-005453-4057qib7	15333	17	based	base	VBN
cord-005453-4057qib7	15333	18	on	on	IN
cord-005453-4057qib7	15333	19	the	the	DT
cord-005453-4057qib7	15333	20	expression	expression	NN
cord-005453-4057qib7	15333	21	of	of	IN
cord-005453-4057qib7	15333	22	CD3	CD3	NNP
cord-005453-4057qib7	15333	23	/	/	SYM
cord-005453-4057qib7	15333	24	CD45	CD45	NNP
cord-005453-4057qib7	15333	25	/	/	SYM
cord-005453-4057qib7	15333	26	Vδ1	Vδ1	NNP
cord-005453-4057qib7	15333	27	/	/	SYM
cord-005453-4057qib7	15333	28	Vδ2	vδ2	NN
cord-005453-4057qib7	15333	29	/	/	SYM
cord-005453-4057qib7	15333	30	Vγ9/	vγ9/	XX
cord-005453-4057qib7	15334	1	CD27	CD27	NNP
cord-005453-4057qib7	15334	2	at	at	IN
cord-005453-4057qib7	15334	3	30	30	CD
cord-005453-4057qib7	15334	4	,	,	,
cord-005453-4057qib7	15334	5	60	60	CD
cord-005453-4057qib7	15334	6	and	and	CC
cord-005453-4057qib7	15334	7	100	100	CD
cord-005453-4057qib7	15334	8	days	day	NNS
cord-005453-4057qib7	15334	9	after	after	IN
cord-005453-4057qib7	15334	10	aHSCT	ahsct	NN
cord-005453-4057qib7	15334	11	.	.	.
cord-005453-4057qib7	15335	1	Percentage	percentage	NN
cord-005453-4057qib7	15335	2	(	(	-LRB-
cord-005453-4057qib7	15335	3	%	%	NN
cord-005453-4057qib7	15335	4	)	)	-RRB-
cord-005453-4057qib7	15335	5	of	of	IN
cord-005453-4057qib7	15335	6	γδT	γδt	NN
cord-005453-4057qib7	15335	7	cells	cell	NNS
cord-005453-4057qib7	15335	8	represented	represent	VBD
cord-005453-4057qib7	15335	9	the	the	DT
cord-005453-4057qib7	15335	10	proportion	proportion	NN
cord-005453-4057qib7	15335	11	of	of	IN
cord-005453-4057qib7	15335	12	these	these	DT
cord-005453-4057qib7	15335	13	cells	cell	NNS
cord-005453-4057qib7	15335	14	among	among	IN
cord-005453-4057qib7	15335	15	all	all	DT
cord-005453-4057qib7	15335	16	T	t	NN
cord-005453-4057qib7	15335	17	cells	cell	NNS
cord-005453-4057qib7	15335	18	.	.	.
cord-005453-4057qib7	15336	1	Results	result	NNS
cord-005453-4057qib7	15336	2	:	:	:
cord-005453-4057qib7	15337	1	Median	median	JJ
cord-005453-4057qib7	15337	2	age	age	NN
cord-005453-4057qib7	15337	3	at	at	IN
cord-005453-4057qib7	15337	4	aHSCT	aHSCT	NNP
cord-005453-4057qib7	15337	5	was	be	VBD
cord-005453-4057qib7	15338	1	61	61	CD
cord-005453-4057qib7	15338	2	(	(	-LRB-
cord-005453-4057qib7	15338	3	40	40	CD
cord-005453-4057qib7	15338	4	-	-	SYM
cord-005453-4057qib7	15338	5	70	70	CD
cord-005453-4057qib7	15338	6	)	)	-RRB-
cord-005453-4057qib7	15338	7	years	year	NNS
cord-005453-4057qib7	15338	8	,	,	,
cord-005453-4057qib7	15338	9	63	63	CD
cord-005453-4057qib7	15338	10	%	%	NN
cord-005453-4057qib7	15338	11	male	male	NN
cord-005453-4057qib7	15338	12	.	.	.
cord-005453-4057qib7	15339	1	Median	median	JJ
cord-005453-4057qib7	15339	2	time	time	NN
cord-005453-4057qib7	15339	3	from	from	IN
cord-005453-4057qib7	15339	4	diagnosis	diagnosis	NN
cord-005453-4057qib7	15339	5	to	to	IN
cord-005453-4057qib7	15339	6	mobilization	mobilization	NN
cord-005453-4057qib7	15339	7	was	be	VBD
cord-005453-4057qib7	15339	8	8	8	CD
cord-005453-4057qib7	15339	9	(	(	-LRB-
cord-005453-4057qib7	15339	10	4	4	CD
cord-005453-4057qib7	15339	11	-	-	SYM
cord-005453-4057qib7	15339	12	52	52	CD
cord-005453-4057qib7	15339	13	)	)	-RRB-
cord-005453-4057qib7	15339	14	months	month	NNS
cord-005453-4057qib7	15339	15	,	,	,
cord-005453-4057qib7	15339	16	after	after	IN
cord-005453-4057qib7	15339	17	a	a	DT
cord-005453-4057qib7	15339	18	median	median	JJ
cord-005453-4057qib7	15339	19	number	number	NN
cord-005453-4057qib7	15339	20	of	of	IN
cord-005453-4057qib7	15339	21	therapeutic	therapeutic	JJ
cord-005453-4057qib7	15339	22	lines	line	NNS
cord-005453-4057qib7	15339	23	of	of	IN
cord-005453-4057qib7	15339	24	1	1	CD
cord-005453-4057qib7	15339	25	(	(	-LRB-
cord-005453-4057qib7	15339	26	1	1	CD
cord-005453-4057qib7	15339	27	-	-	SYM
cord-005453-4057qib7	15339	28	3	3	CD
cord-005453-4057qib7	15339	29	)	)	-RRB-
cord-005453-4057qib7	15339	30	;	;	:
cord-005453-4057qib7	15339	31	7pts	7pts	CD
cord-005453-4057qib7	15339	32	(	(	-LRB-
cord-005453-4057qib7	15339	33	13.0	13.0	CD
cord-005453-4057qib7	15339	34	%	%	NN
cord-005453-4057qib7	15339	35	)	)	-RRB-
cord-005453-4057qib7	15339	36	received	receive	VBD
cord-005453-4057qib7	15339	37	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	15339	38	.	.	.
cord-005453-4057qib7	15340	1	Seventeen	seventeen	CD
cord-005453-4057qib7	15340	2	pts	pts	NN
cord-005453-4057qib7	15340	3	(	(	-LRB-
cord-005453-4057qib7	15340	4	31.5	31.5	CD
cord-005453-4057qib7	15340	5	%	%	NN
cord-005453-4057qib7	15340	6	)	)	-RRB-
cord-005453-4057qib7	15340	7	were	be	VBD
cord-005453-4057qib7	15340	8	re	re	VBN
cord-005453-4057qib7	15340	9	-	-	VBN
cord-005453-4057qib7	15340	10	mobilized	mobilize	VBN
cord-005453-4057qib7	15340	11	with	with	IN
cord-005453-4057qib7	15340	12	plerixafor±G	plerixafor±G	NNP
cord-005453-4057qib7	15340	13	-	-	HYPH
cord-005453-4057qib7	15340	14	CSF	CSF	NNP
cord-005453-4057qib7	15340	15	(	(	-LRB-
cord-005453-4057qib7	15340	16	25	25	CD
cord-005453-4057qib7	15340	17	%	%	NN
cord-005453-4057qib7	15340	18	MM	MM	NNP
cord-005453-4057qib7	15340	19	vs	vs	IN
cord-005453-4057qib7	15340	20	60	60	CD
cord-005453-4057qib7	15340	21	%	%	NN
cord-005453-4057qib7	15340	22	NHL	NHL	NNP
cord-005453-4057qib7	15340	23	There	there	EX
cord-005453-4057qib7	15340	24	was	be	VBD
cord-005453-4057qib7	15340	25	no	no	DT
cord-005453-4057qib7	15340	26	difference	difference	NN
cord-005453-4057qib7	15340	27	in	in	IN
cord-005453-4057qib7	15340	28	febrile	febrile	JJ
cord-005453-4057qib7	15340	29	neutropenia	neutropenia	NN
cord-005453-4057qib7	15340	30	incidence	incidence	NN
cord-005453-4057qib7	15340	31	(	(	-LRB-
cord-005453-4057qib7	15340	32	p=0.766	p=0.766	NNP
cord-005453-4057qib7	15340	33	)	)	-RRB-
cord-005453-4057qib7	15340	34	,	,	,
cord-005453-4057qib7	15340	35	timeto	timeto	NN
cord-005453-4057qib7	15340	36	-	-	HYPH
cord-005453-4057qib7	15340	37	engraftment	engraftment	NN
cord-005453-4057qib7	15340	38	(	(	-LRB-
cord-005453-4057qib7	15340	39	p=0.093	p=0.093	NNP
cord-005453-4057qib7	15340	40	)	)	-RRB-
cord-005453-4057qib7	15340	41	,	,	,
cord-005453-4057qib7	15340	42	time	time	NN
cord-005453-4057qib7	15340	43	-	-	HYPH
cord-005453-4057qib7	15340	44	to	to	IN
cord-005453-4057qib7	15340	45	-	-	HYPH
cord-005453-4057qib7	15340	46	neutrophils>500	neutrophils>500	NNP
cord-005453-4057qib7	15340	47	/	/	SYM
cord-005453-4057qib7	15340	48	μL	μL	NNP
cord-005453-4057qib7	15340	49	(	(	-LRB-
cord-005453-4057qib7	15340	50	p=0.174	p=0.174	JJ
cord-005453-4057qib7	15340	51	)	)	-RRB-
cord-005453-4057qib7	15340	52	or	or	CC
cord-005453-4057qib7	15340	53	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	15340	54	transfusions	transfusion	NNS
cord-005453-4057qib7	15340	55	(	(	-LRB-
cord-005453-4057qib7	15340	56	p=0.076	p=0.076	NNP
cord-005453-4057qib7	15340	57	)	)	-RRB-
cord-005453-4057qib7	15340	58	.	.	.
cord-005453-4057qib7	15341	1	However	however	RB
cord-005453-4057qib7	15341	2	,	,	,
cord-005453-4057qib7	15341	3	there	there	EX
cord-005453-4057qib7	15341	4	was	be	VBD
cord-005453-4057qib7	15341	5	more	more	JJR
cord-005453-4057qib7	15341	6	time	time	NN
cord-005453-4057qib7	15341	7	-	-	HYPH
cord-005453-4057qib7	15341	8	to	to	IN
cord-005453-4057qib7	15341	9	-	-	HYPH
cord-005453-4057qib7	15341	10	platelets>20,000/	platelets>20,000/	NN
cord-005453-4057qib7	15342	1	μL	μL	NNP
cord-005453-4057qib7	15342	2	(	(	-LRB-
cord-005453-4057qib7	15342	3	4	4	CD
cord-005453-4057qib7	15342	4	vs	vs	IN
cord-005453-4057qib7	15342	5	8	8	CD
cord-005453-4057qib7	15342	6	days	day	NNS
cord-005453-4057qib7	15342	7	;	;	:
cord-005453-4057qib7	15342	8	subpopulations	subpopulation	NNS
cord-005453-4057qib7	15342	9	did	do	VBD
cord-005453-4057qib7	15342	10	not	not	RB
cord-005453-4057qib7	15342	11	affected	affect	VBN
cord-005453-4057qib7	15342	12	PFS	PFS	NNP
cord-005453-4057qib7	15342	13	.	.	.
cord-005453-4057qib7	15343	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15343	2	:	:	:
cord-005453-4057qib7	15344	1	Our	-PRON-	PRP$
cord-005453-4057qib7	15344	2	results	result	NNS
cord-005453-4057qib7	15344	3	showed	show	VBD
cord-005453-4057qib7	15344	4	that	that	IN
cord-005453-4057qib7	15344	5	pts	pt	NNS
cord-005453-4057qib7	15344	6	mobilized	mobilize	VBN
cord-005453-4057qib7	15344	7	with	with	IN
cord-005453-4057qib7	15344	8	plerixafor	plerixafor	NN
cord-005453-4057qib7	15344	9	need	need	VBP
cord-005453-4057qib7	15344	10	more	more	JJR
cord-005453-4057qib7	15344	11	collection	collection	NN
cord-005453-4057qib7	15344	12	volume	volume	NN
cord-005453-4057qib7	15344	13	(	(	-LRB-
cord-005453-4057qib7	15344	14	less	less	RBR
cord-005453-4057qib7	15344	15	CD34+cells	CD34+cells	NNPS
cord-005453-4057qib7	15344	16	,	,	,
cord-005453-4057qib7	15344	17	higher	high	JJR
cord-005453-4057qib7	15344	18	DMSO	DMSO	NNP
cord-005453-4057qib7	15344	19	)	)	-RRB-
cord-005453-4057qib7	15344	20	.	.	.
cord-005453-4057qib7	15345	1	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	15345	2	negatively	negatively	RB
cord-005453-4057qib7	15345	3	affected	affect	VBD
cord-005453-4057qib7	15345	4	platelet	platelet	NN
cord-005453-4057qib7	15345	5	recovery	recovery	NN
cord-005453-4057qib7	15345	6	,	,	,
cord-005453-4057qib7	15345	7	with	with	IN
cord-005453-4057qib7	15345	8	similar	similar	JJ
cord-005453-4057qib7	15345	9	hematologic	hematologic	JJ
cord-005453-4057qib7	15345	10	and	and	CC
cord-005453-4057qib7	15345	11	immune	immune	JJ
cord-005453-4057qib7	15345	12	recovery	recovery	NN
cord-005453-4057qib7	15345	13	for	for	IN
cord-005453-4057qib7	15345	14	the	the	DT
cord-005453-4057qib7	15345	15	remaining	remain	VBG
cord-005453-4057qib7	15345	16	variables	variable	NNS
cord-005453-4057qib7	15345	17	.	.	.
cord-005453-4057qib7	15346	1	Its	-PRON-	PRP$
cord-005453-4057qib7	15346	2	use	use	NN
cord-005453-4057qib7	15346	3	was	be	VBD
cord-005453-4057qib7	15346	4	associated	associate	VBN
cord-005453-4057qib7	15346	5	with	with	IN
cord-005453-4057qib7	15346	6	higher	high	JJR
cord-005453-4057qib7	15346	7	%	%	NN
cord-005453-4057qib7	15346	8	Vδ1	vδ1	NN
cord-005453-4057qib7	15346	9	+	+	SYM
cord-005453-4057qib7	15346	10	,	,	,
cord-005453-4057qib7	15346	11	suggesting	suggest	VBG
cord-005453-4057qib7	15346	12	that	that	IN
cord-005453-4057qib7	15346	13	it	-PRON-	PRP
cord-005453-4057qib7	15346	14	induces	induce	VBZ
cord-005453-4057qib7	15346	15	an	an	DT
cord-005453-4057qib7	15346	16	antineoplastic	antineoplastic	JJ
cord-005453-4057qib7	15346	17	phenotype	phenotype	NN
cord-005453-4057qib7	15346	18	.	.	.
cord-005453-4057qib7	15347	1	More	More	JJR
cord-005453-4057qib7	15347	2	studies	study	NNS
cord-005453-4057qib7	15347	3	with	with	IN
cord-005453-4057qib7	15347	4	larger	large	JJR
cord-005453-4057qib7	15347	5	samples	sample	NNS
cord-005453-4057qib7	15347	6	and	and	CC
cord-005453-4057qib7	15347	7	follow	follow	VB
cord-005453-4057qib7	15347	8	-	-	HYPH
cord-005453-4057qib7	15347	9	up	up	NN
cord-005453-4057qib7	15347	10	period	period	NN
cord-005453-4057qib7	15347	11	are	be	VBP
cord-005453-4057qib7	15347	12	needed	need	VBN
cord-005453-4057qib7	15347	13	to	to	TO
cord-005453-4057qib7	15347	14	evaluate	evaluate	VB
cord-005453-4057qib7	15347	15	plerixafor	plerixafor	NN
cord-005453-4057qib7	15347	16	Results	result	NNS
cord-005453-4057qib7	15347	17	:	:	:
cord-005453-4057qib7	15348	1	Total	total	JJ
cord-005453-4057qib7	15348	2	1156	1156	CD
cord-005453-4057qib7	15348	3	ASCC	ASCC	NNP
cord-005453-4057qib7	15348	4	procedures	procedure	NNS
cord-005453-4057qib7	15348	5	were	be	VBD
cord-005453-4057qib7	15348	6	carried	carry	VBN
cord-005453-4057qib7	15348	7	out	out	RP
cord-005453-4057qib7	15348	8	in	in	IN
cord-005453-4057qib7	15348	9	1072	1072	CD
cord-005453-4057qib7	15348	10	patients	patient	NNS
cord-005453-4057qib7	15348	11	over	over	IN
cord-005453-4057qib7	15348	12	18	18	CD
cord-005453-4057qib7	15348	13	years	year	NNS
cord-005453-4057qib7	15348	14	,	,	,
cord-005453-4057qib7	15348	15	once	once	RB
cord-005453-4057qib7	15348	16	in	in	IN
cord-005453-4057qib7	15348	17	985	985	CD
cord-005453-4057qib7	15348	18	patients	patient	NNS
cord-005453-4057qib7	15348	19	,	,	,
cord-005453-4057qib7	15348	20	twice	twice	RB
cord-005453-4057qib7	15348	21	in	in	IN
cord-005453-4057qib7	15348	22	83	83	CD
cord-005453-4057qib7	15348	23	patients	patient	NNS
cord-005453-4057qib7	15348	24	,	,	,
cord-005453-4057qib7	15348	25	three	three	CD
cord-005453-4057qib7	15348	26	times	time	NNS
cord-005453-4057qib7	15348	27	in	in	IN
cord-005453-4057qib7	15348	28	3	3	CD
cord-005453-4057qib7	15348	29	patients	patient	NNS
cord-005453-4057qib7	15348	30	,	,	,
cord-005453-4057qib7	15348	31	and	and	CC
cord-005453-4057qib7	15348	32	four	four	CD
cord-005453-4057qib7	15348	33	times	time	NNS
cord-005453-4057qib7	15348	34	in	in	IN
cord-005453-4057qib7	15348	35	1	1	CD
cord-005453-4057qib7	15348	36	patient	patient	NN
cord-005453-4057qib7	15348	37	.	.	.
cord-005453-4057qib7	15349	1	Non	Non	NNP
cord-005453-4057qib7	15349	2	-	-	JJ
cord-005453-4057qib7	15349	3	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15349	4	lymphoma	lymphoma	NN
cord-005453-4057qib7	15349	5	(	(	-LRB-
cord-005453-4057qib7	15349	6	NHL	NHL	NNP
cord-005453-4057qib7	15349	7	)	)	-RRB-
cord-005453-4057qib7	15349	8	comprised	comprise	VBD
cord-005453-4057qib7	15349	9	56.7	56.7	CD
cord-005453-4057qib7	15349	10	%	%	NN
cord-005453-4057qib7	15349	11	of	of	IN
cord-005453-4057qib7	15349	12	all	all	DT
cord-005453-4057qib7	15349	13	cases	case	NNS
cord-005453-4057qib7	15349	14	(	(	-LRB-
cord-005453-4057qib7	15349	15	n	n	NN
cord-005453-4057qib7	15349	16	=	=	SYM
cord-005453-4057qib7	15349	17	655	655	CD
cord-005453-4057qib7	15349	18	)	)	-RRB-
cord-005453-4057qib7	15349	19	001	001	CD
cord-005453-4057qib7	15349	20	)	)	-RRB-
cord-005453-4057qib7	15349	21	,	,	,
cord-005453-4057qib7	15349	22	total	total	JJ
cord-005453-4057qib7	15349	23	number	number	NN
cord-005453-4057qib7	15349	24	of	of	IN
cord-005453-4057qib7	15349	25	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15349	26	cycles	cycle	NNS
cord-005453-4057qib7	15349	27	before	before	IN
cord-005453-4057qib7	15349	28	ASCC	ASCC	NNP
cord-005453-4057qib7	15349	29	(	(	-LRB-
cord-005453-4057qib7	15349	30	OR	or	CC
cord-005453-4057qib7	15349	31	1.06	1.06	CD
cord-005453-4057qib7	15349	32	,	,	,
cord-005453-4057qib7	15349	33	95	95	CD
cord-005453-4057qib7	15349	34	%	%	NN
cord-005453-4057qib7	15349	35	CI	CI	NNP
cord-005453-4057qib7	15349	36	1.004	1.004	CD
cord-005453-4057qib7	15349	37	-	-	HYPH
cord-005453-4057qib7	15349	38	1.13	1.13	CD
cord-005453-4057qib7	15349	39	,	,	,
cord-005453-4057qib7	15349	40	p	p	NN
cord-005453-4057qib7	15349	41	=	=	SYM
cord-005453-4057qib7	15349	42	0.035	0.035	CD
cord-005453-4057qib7	15349	43	)	)	-RRB-
cord-005453-4057qib7	15349	44	,	,	,
cord-005453-4057qib7	15349	45	failure	failure	NN
cord-005453-4057qib7	15349	46	to	to	TO
cord-005453-4057qib7	15349	47	achieve	achieve	VB
cord-005453-4057qib7	15349	48	at	at	IN
cord-005453-4057qib7	15349	49	least	least	JJS
cord-005453-4057qib7	15349	50	partial	partial	JJ
cord-005453-4057qib7	15349	51	response	response	NN
cord-005453-4057qib7	15349	52	before	before	IN
cord-005453-4057qib7	15349	53	ASCC	ASCC	NNP
cord-005453-4057qib7	15349	54	(	(	-LRB-
cord-005453-4057qib7	15349	55	OR	or	CC
cord-005453-4057qib7	15350	1	2.97	2.97	CD
cord-005453-4057qib7	15350	2	,	,	,
cord-005453-4057qib7	15350	3	95	95	CD
cord-005453-4057qib7	15350	4	%	%	NN
cord-005453-4057qib7	15350	5	CI	CI	NNP
cord-005453-4057qib7	15350	6	1.01	1.01	CD
cord-005453-4057qib7	15350	7	-	-	HYPH
cord-005453-4057qib7	15350	8	8.73	8.73	CD
cord-005453-4057qib7	15350	9	,	,	,
cord-005453-4057qib7	15350	10	p	p	NN
cord-005453-4057qib7	15350	11	=	=	SYM
cord-005453-4057qib7	15350	12	0.048	0.048	CD
cord-005453-4057qib7	15350	13	)	)	-RRB-
cord-005453-4057qib7	15350	14	,	,	,
cord-005453-4057qib7	15350	15	total	total	JJ
cord-005453-4057qib7	15350	16	number	number	NN
cord-005453-4057qib7	15350	17	of	of	IN
cord-005453-4057qib7	15350	18	days	day	NNS
cord-005453-4057qib7	15350	19	receiving	receive	VBG
cord-005453-4057qib7	15350	20	G	G	NNP
cord-005453-4057qib7	15350	21	-	-	HYPH
cord-005453-4057qib7	15350	22	CSF	CSF	NNP
cord-005453-4057qib7	15350	23	for	for	IN
cord-005453-4057qib7	15350	24	mobilization	mobilization	NN
cord-005453-4057qib7	15350	25	(	(	-LRB-
cord-005453-4057qib7	15350	26	OR	or	CC
cord-005453-4057qib7	15350	27	1.10	1.10	CD
cord-005453-4057qib7	15350	28	,	,	,
cord-005453-4057qib7	15350	29	95	95	CD
cord-005453-4057qib7	15350	30	%	%	NN
cord-005453-4057qib7	15350	31	CI	CI	NNP
cord-005453-4057qib7	15350	32	1.002	1.002	CD
cord-005453-4057qib7	15350	33	-	-	HYPH
cord-005453-4057qib7	15350	34	1.23	1.23	CD
cord-005453-4057qib7	15350	35	,	,	,
cord-005453-4057qib7	15350	36	p	p	NN
cord-005453-4057qib7	15350	37	=	=	SYM
cord-005453-4057qib7	15350	38	0.045	0.045	CD
cord-005453-4057qib7	15350	39	)	)	-RRB-
cord-005453-4057qib7	15350	40	,	,	,
cord-005453-4057qib7	15350	41	and	and	CC
cord-005453-4057qib7	15350	42	salvage	salvage	VB
cord-005453-4057qib7	15350	43	use	use	NN
cord-005453-4057qib7	15350	44	of	of	IN
cord-005453-4057qib7	15350	45	plerixafor	plerixafor	NN
cord-005453-4057qib7	15350	46	(	(	-LRB-
cord-005453-4057qib7	15350	47	OR	or	CC
cord-005453-4057qib7	15350	48	3.78	3.78	CD
cord-005453-4057qib7	15350	49	,	,	,
cord-005453-4057qib7	15350	50	95	95	CD
cord-005453-4057qib7	15350	51	%	%	NN
cord-005453-4057qib7	15350	52	CI	CI	NNP
cord-005453-4057qib7	15350	53	1.92	1.92	CD
cord-005453-4057qib7	15350	54	-	-	SYM
cord-005453-4057qib7	15350	55	7.47	7.47	CD
cord-005453-4057qib7	15350	56	,	,	,
cord-005453-4057qib7	15350	57	p	p	NN
cord-005453-4057qib7	15350	58	<	<	XX
cord-005453-4057qib7	15350	59	0.001	0.001	CD
cord-005453-4057qib7	15350	60	)	)	-RRB-
cord-005453-4057qib7	15350	61	were	be	VBD
cord-005453-4057qib7	15350	62	found	find	VBN
cord-005453-4057qib7	15350	63	to	to	TO
cord-005453-4057qib7	15350	64	be	be	VB
cord-005453-4057qib7	15350	65	independent	independent	JJ
cord-005453-4057qib7	15350	66	factors	factor	NNS
cord-005453-4057qib7	15350	67	associated	associate	VBN
cord-005453-4057qib7	15350	68	with	with	IN
cord-005453-4057qib7	15350	69	failure	failure	NN
cord-005453-4057qib7	15350	70	of	of	IN
cord-005453-4057qib7	15350	71	ASCC	ASCC	NNP
cord-005453-4057qib7	15350	72	.	.	.
cord-005453-4057qib7	15351	1	At	at	IN
cord-005453-4057qib7	15351	2	the	the	DT
cord-005453-4057qib7	15351	3	end	end	NN
cord-005453-4057qib7	15351	4	of	of	IN
cord-005453-4057qib7	15351	5	the	the	DT
cord-005453-4057qib7	15351	6	study	study	NN
cord-005453-4057qib7	15351	7	period	period	NN
cord-005453-4057qib7	15351	8	,	,	,
cord-005453-4057qib7	15351	9	90.9	90.9	CD
cord-005453-4057qib7	15351	10	%	%	NN
cord-005453-4057qib7	15351	11	of	of	IN
cord-005453-4057qib7	15351	12	successful	successful	JJ
cord-005453-4057qib7	15351	13	collections	collection	NNS
cord-005453-4057qib7	15351	14	(	(	-LRB-
cord-005453-4057qib7	15351	15	n	n	NN
cord-005453-4057qib7	15351	16	=	=	SYM
cord-005453-4057qib7	15351	17	962/1058	962/1058	CD
cord-005453-4057qib7	15351	18	)	)	-RRB-
cord-005453-4057qib7	15351	19	were	be	VBD
cord-005453-4057qib7	15351	20	used	use	VBN
cord-005453-4057qib7	15351	21	for	for	IN
cord-005453-4057qib7	15351	22	ASCT	ASCT	NNP
cord-005453-4057qib7	15351	23	,	,	,
cord-005453-4057qib7	15351	24	4.5	4.5	CD
cord-005453-4057qib7	15351	25	%	%	NN
cord-005453-4057qib7	15351	26	(	(	-LRB-
cord-005453-4057qib7	15351	27	n=48/1056	n=48/1056	NNP
cord-005453-4057qib7	15351	28	)	)	-RRB-
cord-005453-4057qib7	15351	29	were	be	VBD
cord-005453-4057qib7	15351	30	in	in	IN
cord-005453-4057qib7	15351	31	storage	storage	NN
cord-005453-4057qib7	15351	32	awaiting	awaiting	NN
cord-005453-4057qib7	15351	33	transplantation	transplantation	NN
cord-005453-4057qib7	15352	1	Hôpital	Hôpital	NNP
cord-005453-4057qib7	15352	2	Necker	Necker	NNP
cord-005453-4057qib7	15352	3	-	-	HYPH
cord-005453-4057qib7	15352	4	Enfants	Enfants	NNP
cord-005453-4057qib7	15353	1	Malades	Malades	NNP
cord-005453-4057qib7	15353	2	Melf	Melf	NNP
cord-005453-4057qib7	15353	3	140	140	CD
cord-005453-4057qib7	15353	4	Methods	method	NNS
cord-005453-4057qib7	15353	5	:	:	:
cord-005453-4057qib7	15354	1	A	a	DT
cord-005453-4057qib7	15354	2	total	total	JJ
cord-005453-4057qib7	15354	3	103	103	CD
cord-005453-4057qib7	15354	4	AHSCT	AHSCT	NNP
cord-005453-4057qib7	15354	5	candidates	candidate	NNS
cord-005453-4057qib7	15354	6	[	[	-LRB-
cord-005453-4057qib7	15354	7	median	median	NN
cord-005453-4057qib7	15354	8	age	age	NN
cord-005453-4057qib7	15354	9	:	:	:
cord-005453-4057qib7	15354	10	57(18	57(18	CD
cord-005453-4057qib7	15354	11	-	-	SYM
cord-005453-4057qib7	15354	12	75	75	CD
cord-005453-4057qib7	15354	13	)	)	-RRB-
cord-005453-4057qib7	15354	14	years	year	NNS
cord-005453-4057qib7	15354	15	;	;	:
cord-005453-4057qib7	15354	16	male	male	JJ
cord-005453-4057qib7	15354	17	/	/	SYM
cord-005453-4057qib7	15354	18	female	female	JJ
cord-005453-4057qib7	15354	19	:	:	:
cord-005453-4057qib7	15354	20	54/49	54/49	CD
cord-005453-4057qib7	15354	21	]	]	-RRB-
cord-005453-4057qib7	15354	22	were	be	VBD
cord-005453-4057qib7	15354	23	included	include	VBN
cord-005453-4057qib7	15354	24	in	in	IN
cord-005453-4057qib7	15354	25	this	this	DT
cord-005453-4057qib7	15354	26	study	study	NN
cord-005453-4057qib7	15354	27	.	.	.
cord-005453-4057qib7	15355	1	Twenty	twenty	CD
cord-005453-4057qib7	15355	2	-	-	HYPH
cord-005453-4057qib7	15355	3	seven	seven	CD
cord-005453-4057qib7	15355	4	patients	patient	NNS
cord-005453-4057qib7	15355	5	(	(	-LRB-
cord-005453-4057qib7	15355	6	26.2	26.2	CD
cord-005453-4057qib7	15355	7	%	%	NN
cord-005453-4057qib7	15355	8	)	)	-RRB-
cord-005453-4057qib7	15355	9	were	be	VBD
cord-005453-4057qib7	15355	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	15355	11	as	as	IN
cord-005453-4057qib7	15355	12	non	non	JJ
cord-005453-4057qib7	15355	13	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15355	14	's	's	POS
cord-005453-4057qib7	15355	15	lymphoma	lymphoma	NN
cord-005453-4057qib7	15355	16	,	,	,
cord-005453-4057qib7	15355	17	8	8	CD
cord-005453-4057qib7	15355	18	patients	patient	NNS
cord-005453-4057qib7	15355	19	(	(	-LRB-
cord-005453-4057qib7	15355	20	7.8	7.8	CD
cord-005453-4057qib7	15355	21	%	%	NN
cord-005453-4057qib7	15355	22	)	)	-RRB-
cord-005453-4057qib7	15355	23	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15355	24	's	's	POS
cord-005453-4057qib7	15355	25	lymphoma	lymphoma	NN
cord-005453-4057qib7	15355	26	,	,	,
cord-005453-4057qib7	15355	27	52	52	CD
cord-005453-4057qib7	15355	28	patients	patient	NNS
cord-005453-4057qib7	15355	29	(	(	-LRB-
cord-005453-4057qib7	15355	30	50.5	50.5	CD
cord-005453-4057qib7	15355	31	%	%	NN
cord-005453-4057qib7	15355	32	)	)	-RRB-
cord-005453-4057qib7	15355	33	multiple	multiple	JJ
cord-005453-4057qib7	15355	34	myeloma	myeloma	NN
cord-005453-4057qib7	15355	35	,	,	,
cord-005453-4057qib7	15355	36	12	12	CD
cord-005453-4057qib7	15355	37	patients	patient	NNS
cord-005453-4057qib7	15355	38	(	(	-LRB-
cord-005453-4057qib7	15355	39	11.6	11.6	CD
cord-005453-4057qib7	15355	40	%	%	NN
cord-005453-4057qib7	15355	41	)	)	-RRB-
cord-005453-4057qib7	15355	42	acute	acute	JJ
cord-005453-4057qib7	15355	43	myeloid	myeloid	NN
cord-005453-4057qib7	15355	44	leukemia	leukemia	NN
cord-005453-4057qib7	15355	45	,	,	,
cord-005453-4057qib7	15355	46	3	3	CD
cord-005453-4057qib7	15355	47	patients	patient	NNS
cord-005453-4057qib7	15355	48	(	(	-LRB-
cord-005453-4057qib7	15355	49	2.9	2.9	CD
cord-005453-4057qib7	15355	50	%	%	NN
cord-005453-4057qib7	15355	51	)	)	-RRB-
cord-005453-4057qib7	15355	52	plasmocytoma	plasmocytoma	NNP
cord-005453-4057qib7	15355	53	and	and	CC
cord-005453-4057qib7	15355	54	1	1	CD
cord-005453-4057qib7	15355	55	patient	patient	NN
cord-005453-4057qib7	15355	56	(	(	-LRB-
cord-005453-4057qib7	15355	57	1	1	CD
cord-005453-4057qib7	15355	58	%	%	NN
cord-005453-4057qib7	15355	59	)	)	-RRB-
cord-005453-4057qib7	15355	60	testis	testis	NN
cord-005453-4057qib7	15355	61	cancer	cancer	NN
cord-005453-4057qib7	15355	62	.	.	.
cord-005453-4057qib7	15356	1	Premobilization	Premobilization	NNP
cord-005453-4057qib7	15356	2	serum	serum	NN
cord-005453-4057qib7	15356	3	25-hydroxy	25-hydroxy	CD
cord-005453-4057qib7	15356	4	vitamin	vitamin	NN
cord-005453-4057qib7	15356	5	D	d	NN
cord-005453-4057qib7	15356	6	(	(	-LRB-
cord-005453-4057qib7	15356	7	25-OH	25-oh	CD
cord-005453-4057qib7	15356	8	D	D	NNP
cord-005453-4057qib7	15356	9	)	)	-RRB-
cord-005453-4057qib7	15356	10	levels	level	NNS
cord-005453-4057qib7	15356	11	were	be	VBD
cord-005453-4057qib7	15356	12	measured	measure	VBN
cord-005453-4057qib7	15356	13	with	with	IN
cord-005453-4057qib7	15356	14	immunoassay	immunoassay	JJ
cord-005453-4057qib7	15356	15	method	method	NN
cord-005453-4057qib7	15356	16	Peripheral	Peripheral	NNP
cord-005453-4057qib7	15356	17	CD34	CD34	NNP
cord-005453-4057qib7	15356	18	+	+	CC
cord-005453-4057qib7	15357	1	cell	cell	NN
cord-005453-4057qib7	15357	2	count	count	NN
cord-005453-4057qib7	15357	3	Background	Background	NNP
cord-005453-4057qib7	15357	4	:	:	:
cord-005453-4057qib7	15358	1	Some	some	DT
cord-005453-4057qib7	15358	2	published	publish	VBN
cord-005453-4057qib7	15358	3	data	datum	NNS
cord-005453-4057qib7	15358	4	suggest	suggest	VBP
cord-005453-4057qib7	15358	5	a	a	DT
cord-005453-4057qib7	15358	6	positive	positive	JJ
cord-005453-4057qib7	15358	7	effect	effect	NN
cord-005453-4057qib7	15358	8	of	of	IN
cord-005453-4057qib7	15358	9	iron	iron	NN
cord-005453-4057qib7	15358	10	chelators	chelator	NNS
cord-005453-4057qib7	15358	11	on	on	IN
cord-005453-4057qib7	15358	12	the	the	DT
cord-005453-4057qib7	15358	13	risk	risk	NN
cord-005453-4057qib7	15358	14	of	of	IN
cord-005453-4057qib7	15358	15	post	post	JJ
cord-005453-4057qib7	15358	16	-	-	JJ
cord-005453-4057qib7	15358	17	transplant	transplant	JJ
cord-005453-4057qib7	15358	18	relapse	relapse	NN
cord-005453-4057qib7	15358	19	,	,	,
cord-005453-4057qib7	15358	20	with	with	IN
cord-005453-4057qib7	15358	21	an	an	DT
cord-005453-4057qib7	15358	22	improvement	improvement	NN
cord-005453-4057qib7	15358	23	in	in	IN
cord-005453-4057qib7	15358	24	overall	overall	JJ
cord-005453-4057qib7	15358	25	survival	survival	NN
cord-005453-4057qib7	15358	26	after	after	IN
cord-005453-4057qib7	15358	27	allogeneic	allogeneic	NN
cord-005453-4057qib7	15358	28	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15358	29	stem	stem	NN
cord-005453-4057qib7	15358	30	cell	cell	NN
cord-005453-4057qib7	15358	31	transplantation	transplantation	NN
cord-005453-4057qib7	15358	32	(	(	-LRB-
cord-005453-4057qib7	15358	33	HSCT	HSCT	NNP
cord-005453-4057qib7	15358	34	)	)	-RRB-
cord-005453-4057qib7	15359	1	Conditioning	conditioning	NN
cord-005453-4057qib7	15359	2	regimen	regimen	NN
cord-005453-4057qib7	15359	3	consisted	consist	VBD
cord-005453-4057qib7	15359	4	to	to	IN
cord-005453-4057qib7	15359	5	intravenous	intravenous	JJ
cord-005453-4057qib7	15359	6	Bu	Bu	NNP
cord-005453-4057qib7	15359	7	130	130	CD
cord-005453-4057qib7	15360	1	mg	mg	NNP
cord-005453-4057qib7	15360	2	/	/	SYM
cord-005453-4057qib7	15360	3	m	m	NN
cord-005453-4057qib7	15360	4	2	2	CD
cord-005453-4057qib7	15361	1	and	and	CC
cord-005453-4057qib7	15361	2	,	,	,
cord-005453-4057qib7	15361	3	Flu	Flu	NNP
cord-005453-4057qib7	15361	4	40	40	CD
cord-005453-4057qib7	15361	5	mg	mg	NNP
cord-005453-4057qib7	15361	6	/	/	SYM
cord-005453-4057qib7	15361	7	m	m	NN
cord-005453-4057qib7	15361	8	2	2	CD
cord-005453-4057qib7	15361	9	D-6	D-6	NNP
cord-005453-4057qib7	15361	10	to	to	IN
cord-005453-4057qib7	15361	11	D-3	D-3	NNP
cord-005453-4057qib7	15361	12	.	.	.
cord-005453-4057qib7	15362	1	GVHD	GVHD	NNP
cord-005453-4057qib7	15362	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15362	3	included	include	VBD
cord-005453-4057qib7	15362	4	ATG	ATG	NNP
cord-005453-4057qib7	15362	5	2.5	2.5	CD
cord-005453-4057qib7	15362	6	mg	mg	NNP
cord-005453-4057qib7	15362	7	/	/	SYM
cord-005453-4057qib7	15362	8	kg	kg	NNS
cord-005453-4057qib7	15362	9	on	on	IN
cord-005453-4057qib7	15362	10	D-2	D-2	NNP
cord-005453-4057qib7	15362	11	and	and	CC
cord-005453-4057qib7	15362	12	D-1	D-1	NNP
cord-005453-4057qib7	15362	13	,	,	,
cord-005453-4057qib7	15362	14	ciclosporin	ciclosporin	NN
cord-005453-4057qib7	15362	15	and	and	CC
cord-005453-4057qib7	15362	16	methotrexate	methotrexate	NNP
cord-005453-4057qib7	15362	17	.	.	.
cord-005453-4057qib7	15363	1	All	all	DT
cord-005453-4057qib7	15363	2	patients	patient	NNS
cord-005453-4057qib7	15363	3	received	receive	VBD
cord-005453-4057qib7	15363	4	peripheral	peripheral	JJ
cord-005453-4057qib7	15363	5	blood	blood	NN
cord-005453-4057qib7	15363	6	stem	stem	NN
cord-005453-4057qib7	15363	7	cell	cell	NN
cord-005453-4057qib7	15363	8	transplant	transplant	NN
cord-005453-4057qib7	15363	9	from	from	IN
cord-005453-4057qib7	15363	10	an	an	DT
cord-005453-4057qib7	15363	11	identical	identical	JJ
cord-005453-4057qib7	15363	12	HLA	HLA	NNP
cord-005453-4057qib7	15363	13	-	-	HYPH
cord-005453-4057qib7	15363	14	related	relate	VBN
cord-005453-4057qib7	15363	15	donor	donor	NN
cord-005453-4057qib7	15363	16	.	.	.
cord-005453-4057qib7	15364	1	Iron	iron	NN
cord-005453-4057qib7	15364	2	chelation	chelation	NN
cord-005453-4057qib7	15364	3	consisted	consist	VBD
cord-005453-4057qib7	15364	4	on	on	IN
cord-005453-4057qib7	15364	5	deferasirox	deferasirox	NNP
cord-005453-4057qib7	15364	6	(	(	-LRB-
cord-005453-4057qib7	15364	7	Exjade	Exjade	NNP
cord-005453-4057qib7	15364	8	®	®	NN
cord-005453-4057qib7	15364	9	)	)	-RRB-
cord-005453-4057qib7	15365	1	10	10	CD
cord-005453-4057qib7	15365	2	-	-	SYM
cord-005453-4057qib7	15365	3	20	20	CD
cord-005453-4057qib7	15365	4	mg	mg	NNP
cord-005453-4057qib7	15365	5	/	/	SYM
cord-005453-4057qib7	15365	6	kg	kg	NNP
cord-005453-4057qib7	15365	7	/	/	SYM
cord-005453-4057qib7	15365	8	day	day	NN
cord-005453-4057qib7	15365	9	,	,	,
cord-005453-4057qib7	15365	10	started	start	VBD
cord-005453-4057qib7	15365	11	at	at	IN
cord-005453-4057qib7	15365	12	day	day	NN
cord-005453-4057qib7	15365	13	100	100	CD
cord-005453-4057qib7	15365	14	,	,	,
cord-005453-4057qib7	15365	15	if	if	IN
cord-005453-4057qib7	15365	16	serum	serum	NN
cord-005453-4057qib7	15365	17	ferritin	ferritin	NN
cord-005453-4057qib7	15365	18	level	level	NN
cord-005453-4057qib7	15365	19	≥	≥	CD
cord-005453-4057qib7	15365	20	800	800	CD
cord-005453-4057qib7	15366	1	-1000	-1000	:
cord-005453-4057qib7	15366	2	ug	ug	NNP
cord-005453-4057qib7	15366	3	/	/	SYM
cord-005453-4057qib7	15366	4	l	l	NNP
cord-005453-4057qib7	15366	5	and	and	CC
cord-005453-4057qib7	15366	6	stopped	stop	VBD
cord-005453-4057qib7	15366	7	when	when	WRB
cord-005453-4057qib7	15366	8	the	the	DT
cord-005453-4057qib7	15366	9	level	level	NN
cord-005453-4057qib7	15366	10	decreased	decrease	VBD
cord-005453-4057qib7	15366	11	below	below	IN
cord-005453-4057qib7	15366	12	600	600	CD
cord-005453-4057qib7	15366	13	ug	ug	NNP
cord-005453-4057qib7	15366	14	/	/	SYM
cord-005453-4057qib7	15366	15	l	l	NN
cord-005453-4057qib7	15366	16	or	or	CC
cord-005453-4057qib7	15366	17	normalized	normalize	VBN
cord-005453-4057qib7	15366	18	At	at	IN
cord-005453-4057qib7	15366	19	day	day	NN
cord-005453-4057qib7	15366	20	100	100	CD
cord-005453-4057qib7	15366	21	after	after	IN
cord-005453-4057qib7	15366	22	transplant	transplant	NN
cord-005453-4057qib7	15367	1	,	,	,
cord-005453-4057qib7	15367	2	35/	35/	JJ
cord-005453-4057qib7	15367	3	40	40	CD
cord-005453-4057qib7	15367	4	patients	patient	NNS
cord-005453-4057qib7	15367	5	were	be	VBD
cord-005453-4057qib7	15367	6	evaluable	evaluable	JJ
cord-005453-4057qib7	15367	7	(	(	-LRB-
cord-005453-4057qib7	15367	8	G1=	G1=	NNP
cord-005453-4057qib7	15367	9	20	20	CD
cord-005453-4057qib7	15367	10	pts	pt	NNS
cord-005453-4057qib7	15367	11	)	)	-RRB-
cord-005453-4057qib7	15367	12	,	,	,
cord-005453-4057qib7	15367	13	(	(	-LRB-
cord-005453-4057qib7	15367	14	G2	G2	NNP
cord-005453-4057qib7	15367	15	=	=	SYM
cord-005453-4057qib7	15367	16	15	15	CD
cord-005453-4057qib7	15367	17	pts	pts	NN
cord-005453-4057qib7	15367	18	)	)	-RRB-
cord-005453-4057qib7	15367	19	.	.	.
cord-005453-4057qib7	15368	1	Patients	patient	NNS
cord-005453-4057qib7	15368	2	were	be	VBD
cord-005453-4057qib7	15368	3	ABO	ABO	NNP
cord-005453-4057qib7	15368	4	compatible	compatible	JJ
cord-005453-4057qib7	15368	5	(	(	-LRB-
cord-005453-4057qib7	15368	6	66	66	CD
cord-005453-4057qib7	15368	7	%	%	NN
cord-005453-4057qib7	15368	8	)	)	-RRB-
cord-005453-4057qib7	15368	9	,	,	,
cord-005453-4057qib7	15368	10	had	have	VBD
cord-005453-4057qib7	15368	11	major	major	JJ
cord-005453-4057qib7	15368	12	incompatibility	incompatibility	NN
cord-005453-4057qib7	15368	13	(	(	-LRB-
cord-005453-4057qib7	15368	14	29	29	CD
cord-005453-4057qib7	15368	15	%	%	NN
cord-005453-4057qib7	15368	16	)	)	-RRB-
cord-005453-4057qib7	15368	17	,	,	,
cord-005453-4057qib7	15368	18	and	and	CC
cord-005453-4057qib7	15368	19	6	6	CD
cord-005453-4057qib7	15368	20	%	%	NN
cord-005453-4057qib7	15368	21	had	have	VBD
cord-005453-4057qib7	15368	22	minor	minor	JJ
cord-005453-4057qib7	15368	23	incompatibility	incompatibility	NN
cord-005453-4057qib7	15368	24	.	.	.
cord-005453-4057qib7	15369	1	Median	median	JJ
cord-005453-4057qib7	15369	2	serum	serum	NN
cord-005453-4057qib7	15369	3	ferritin	ferritin	NN
cord-005453-4057qib7	15369	4	level	level	NN
cord-005453-4057qib7	15369	5	at	at	IN
cord-005453-4057qib7	15369	6	day	day	NN
cord-005453-4057qib7	15369	7	100	100	CD
cord-005453-4057qib7	15369	8	,	,	,
cord-005453-4057qib7	15369	9	were	be	VBD
cord-005453-4057qib7	15369	10	1200	1200	CD
cord-005453-4057qib7	15369	11	ug	ug	NNP
cord-005453-4057qib7	15369	12	/	/	SYM
cord-005453-4057qib7	15369	13	l	l	NN
cord-005453-4057qib7	15369	14	(	(	-LRB-
cord-005453-4057qib7	15369	15	833	833	CD
cord-005453-4057qib7	15369	16	-	-	SYM
cord-005453-4057qib7	15369	17	4449	4449	CD
cord-005453-4057qib7	15369	18	)	)	-RRB-
cord-005453-4057qib7	15369	19	and	and	CC
cord-005453-4057qib7	15369	20	1200	1200	CD
cord-005453-4057qib7	15369	21	ug	ug	NNP
cord-005453-4057qib7	15369	22	/	/	SYM
cord-005453-4057qib7	15369	23	l	l	NN
cord-005453-4057qib7	15369	24	(	(	-LRB-
cord-005453-4057qib7	15369	25	123	123	CD
cord-005453-4057qib7	15369	26	-	-	SYM
cord-005453-4057qib7	15369	27	1853	1853	CD
cord-005453-4057qib7	15369	28	)	)	-RRB-
cord-005453-4057qib7	15369	29	in	in	IN
cord-005453-4057qib7	15369	30	G1	G1	NNP
cord-005453-4057qib7	15369	31	and	and	CC
cord-005453-4057qib7	15369	32	G2	G2	NNP
cord-005453-4057qib7	15369	33	respectively	respectively	RB
cord-005453-4057qib7	15369	34	With	with	IN
cord-005453-4057qib7	15369	35	a	a	DT
cord-005453-4057qib7	15369	36	median	median	JJ
cord-005453-4057qib7	15369	37	follow	follow	NN
cord-005453-4057qib7	15369	38	-	-	HYPH
cord-005453-4057qib7	15369	39	up	up	NN
cord-005453-4057qib7	15369	40	of	of	IN
cord-005453-4057qib7	15369	41	34	34	CD
cord-005453-4057qib7	15369	42	months	month	NNS
cord-005453-4057qib7	15369	43	,	,	,
cord-005453-4057qib7	15369	44	(	(	-LRB-
cord-005453-4057qib7	15369	45	12	12	CD
cord-005453-4057qib7	15369	46	-	-	SYM
cord-005453-4057qib7	15369	47	68	68	CD
cord-005453-4057qib7	15369	48	)	)	-RRB-
cord-005453-4057qib7	15369	49	,	,	,
cord-005453-4057qib7	15369	50	disease	disease	NN
cord-005453-4057qib7	15369	51	relapse	relapse	NN
cord-005453-4057qib7	15369	52	incidence	incidence	NN
cord-005453-4057qib7	15369	53	was	be	VBD
cord-005453-4057qib7	15369	54	higher	high	JJR
cord-005453-4057qib7	15369	55	in	in	IN
cord-005453-4057qib7	15369	56	patients	patient	NNS
cord-005453-4057qib7	15369	57	who	who	WP
cord-005453-4057qib7	15369	58	did	do	VBD
cord-005453-4057qib7	15369	59	not	not	RB
cord-005453-4057qib7	15369	60	received	receive	VBD
cord-005453-4057qib7	15369	61	iron	iron	NN
cord-005453-4057qib7	15369	62	chelation	chelation	NN
cord-005453-4057qib7	15369	63	treatment	treatment	NN
cord-005453-4057qib7	15369	64	(	(	-LRB-
cord-005453-4057qib7	15369	65	G1	g1	NN
cord-005453-4057qib7	15369	66	:	:	:
cord-005453-4057qib7	15369	67	39.8	39.8	CD
cord-005453-4057qib7	15369	68	%	%	NN
cord-005453-4057qib7	15369	69	)	)	-RRB-
cord-005453-4057qib7	15369	70	versus	versus	IN
cord-005453-4057qib7	15369	71	those	those	DT
cord-005453-4057qib7	15369	72	who	who	WP
cord-005453-4057qib7	15369	73	received	receive	VBD
cord-005453-4057qib7	15369	74	oral	oral	JJ
cord-005453-4057qib7	15369	75	deferasirox	deferasirox	NN
cord-005453-4057qib7	15369	76	(	(	-LRB-
cord-005453-4057qib7	15369	77	G2:15.6	g2:15.6	NN
cord-005453-4057qib7	15369	78	%	%	NN
cord-005453-4057qib7	15369	79	)	)	-RRB-
cord-005453-4057qib7	15370	1	(	(	-LRB-
cord-005453-4057qib7	15370	2	Figure	figure	NN
cord-005453-4057qib7	15370	3	1	1	CD
cord-005453-4057qib7	15370	4	)	)	-RRB-
cord-005453-4057qib7	15370	5	,	,	,
cord-005453-4057qib7	15370	6	but	but	CC
cord-005453-4057qib7	15370	7	the	the	DT
cord-005453-4057qib7	15370	8	difference	difference	NN
cord-005453-4057qib7	15370	9	was	be	VBD
cord-005453-4057qib7	15370	10	not	not	RB
cord-005453-4057qib7	15370	11	statistically	statistically	RB
cord-005453-4057qib7	15370	12	significant	significant	JJ
cord-005453-4057qib7	15370	13	Conclusions	conclusion	NNS
cord-005453-4057qib7	15370	14	:	:	:
cord-005453-4057qib7	15371	1	These	these	DT
cord-005453-4057qib7	15371	2	results	result	NNS
cord-005453-4057qib7	15371	3	deserve	deserve	VBP
cord-005453-4057qib7	15371	4	more	more	JJR
cord-005453-4057qib7	15371	5	investigation	investigation	NN
cord-005453-4057qib7	15371	6	CHOEP	CHOEP	NNP
cord-005453-4057qib7	15371	7	(	(	-LRB-
cord-005453-4057qib7	15371	8	n=5	n=5	NNP
cord-005453-4057qib7	15371	9	)	)	-RRB-
cord-005453-4057qib7	15371	10	,	,	,
cord-005453-4057qib7	15371	11	and	and	CC
cord-005453-4057qib7	15371	12	1patient	1patient	CD
cord-005453-4057qib7	15371	13	received	receive	VBD
cord-005453-4057qib7	15371	14	VTD	VTD	NNP
cord-005453-4057qib7	15371	15	-	-	HYPH
cord-005453-4057qib7	15371	16	PACE	pace	NN
cord-005453-4057qib7	15371	17	10	10	CD
cord-005453-4057qib7	15372	1	μg	μg	NNP
cord-005453-4057qib7	15373	1	/kg	/kg	NFP
cord-005453-4057qib7	15373	2	depending	depend	VBG
cord-005453-4057qib7	15373	3	on	on	IN
cord-005453-4057qib7	15373	4	the	the	DT
cord-005453-4057qib7	15373	5	protocol	protocol	NN
cord-005453-4057qib7	15373	6	.	.	.
cord-005453-4057qib7	15374	1	The	the	DT
cord-005453-4057qib7	15374	2	aim	aim	NN
cord-005453-4057qib7	15374	3	was	be	VBD
cord-005453-4057qib7	15374	4	to	to	TO
cord-005453-4057qib7	15374	5	collect	collect	VB
cord-005453-4057qib7	15374	6	at	at	IN
cord-005453-4057qib7	15374	7	least	least	JJS
cord-005453-4057qib7	15374	8	2x10	2x10	CD
cord-005453-4057qib7	15374	9	6	6	CD
cord-005453-4057qib7	15374	10	CD34(+	CD34(+	NNS
cord-005453-4057qib7	15374	11	)	)	-RRB-
cord-005453-4057qib7	15374	12	cells	cell	NNS
cord-005453-4057qib7	15374	13	/	/	SYM
cord-005453-4057qib7	15374	14	kg	kg	NN
cord-005453-4057qib7	15374	15	body	body	NN
cord-005453-4057qib7	15374	16	weight	weight	NN
cord-005453-4057qib7	15374	17	.	.	.
cord-005453-4057qib7	15375	1	Results	result	NNS
cord-005453-4057qib7	15375	2	:	:	:
cord-005453-4057qib7	15376	1	Forty	forty	CD
cord-005453-4057qib7	15376	2	patients	patient	NNS
cord-005453-4057qib7	15377	1	All	all	DT
cord-005453-4057qib7	15377	2	patients	patient	NNS
cord-005453-4057qib7	15377	3	were	be	VBD
cord-005453-4057qib7	15377	4	stage	stage	NN
cord-005453-4057qib7	15377	5	III	III	NNP
cord-005453-4057qib7	15377	6	and	and	CC
cord-005453-4057qib7	15377	7	IV	IV	NNP
cord-005453-4057qib7	15377	8	at	at	IN
cord-005453-4057qib7	15377	9	diagnosis	diagnosis	NN
cord-005453-4057qib7	15377	10	.	.	.
cord-005453-4057qib7	15378	1	29	29	CD
cord-005453-4057qib7	15378	2	of	of	IN
cord-005453-4057qib7	15378	3	the	the	DT
cord-005453-4057qib7	15378	4	patients	patient	NNS
cord-005453-4057qib7	15378	5	were	be	VBD
cord-005453-4057qib7	15378	6	mobilized	mobilize	VBN
cord-005453-4057qib7	15378	7	after	after	IN
cord-005453-4057qib7	15378	8	one	one	CD
cord-005453-4057qib7	15378	9	line	line	NN
cord-005453-4057qib7	15378	10	of	of	IN
cord-005453-4057qib7	15378	11	treatment	treatment	NN
cord-005453-4057qib7	15378	12	,	,	,
cord-005453-4057qib7	15378	13	six	six	CD
cord-005453-4057qib7	15378	14	after	after	IN
cord-005453-4057qib7	15378	15	two	two	CD
cord-005453-4057qib7	15378	16	lines	line	NNS
cord-005453-4057qib7	15378	17	of	of	IN
cord-005453-4057qib7	15378	18	treatment	treatment	NN
cord-005453-4057qib7	15378	19	and	and	CC
cord-005453-4057qib7	15378	20	five	five	CD
cord-005453-4057qib7	15378	21	after	after	IN
cord-005453-4057qib7	15378	22	3	3	CD
cord-005453-4057qib7	15378	23	and	and	CC
cord-005453-4057qib7	15378	24	more	more	JJR
cord-005453-4057qib7	15378	25	lines	line	NNS
cord-005453-4057qib7	15378	26	of	of	IN
cord-005453-4057qib7	15378	27	treatment	treatment	NN
cord-005453-4057qib7	15378	28	Alexandra	Alexandra	NNP
cord-005453-4057qib7	15378	29	Martínez	Martínez	NNP
cord-005453-4057qib7	15378	30	-	-	HYPH
cord-005453-4057qib7	15378	31	Roca	Roca	NNP
cord-005453-4057qib7	15378	32	1	1	CD
cord-005453-4057qib7	15378	33	,	,	,
cord-005453-4057qib7	15378	34	Gerardo	Gerardo	NNP
cord-005453-4057qib7	15378	35	Rodriguez	Rodriguez	NNP
cord-005453-4057qib7	15378	36	-	-	HYPH
cord-005453-4057qib7	15378	37	Lobato	Lobato	NNP
cord-005453-4057qib7	15378	38	1	1	CD
cord-005453-4057qib7	15378	39	,	,	,
cord-005453-4057qib7	15378	40	Gonzalo	Gonzalo	NNP
cord-005453-4057qib7	15378	41	Gutierrez	Gutierrez	NNP
cord-005453-4057qib7	15378	42	-	-	HYPH
cord-005453-4057qib7	15378	43	Garcia	Garcia	NNP
cord-005453-4057qib7	15378	44	1,2	1,2	CD
cord-005453-4057qib7	15378	45	,	,	,
cord-005453-4057qib7	15378	46	Maria	Maria	NNP
cord-005453-4057qib7	15378	47	Suárez	Suárez	NNP
cord-005453-4057qib7	15378	48	-	-	HYPH
cord-005453-4057qib7	15378	49	Lledó	Lledó	NNP
cord-005453-4057qib7	15378	50	1	1	CD
cord-005453-4057qib7	15378	51	 	 	_SP
cord-005453-4057qib7	15378	52	Background	background	NN
cord-005453-4057qib7	15378	53	:	:	:
cord-005453-4057qib7	15378	54	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15378	55	stem	stem	NN
cord-005453-4057qib7	15378	56	cell	cell	NN
cord-005453-4057qib7	15378	57	transplantation	transplantation	NN
cord-005453-4057qib7	15378	58	(	(	-LRB-
cord-005453-4057qib7	15378	59	HSCT	HSCT	NNP
cord-005453-4057qib7	15378	60	)	)	-RRB-
cord-005453-4057qib7	15378	61	is	be	VBZ
cord-005453-4057qib7	15378	62	an	an	DT
cord-005453-4057qib7	15378	63	established	establish	VBN
cord-005453-4057qib7	15378	64	procedure	procedure	NN
cord-005453-4057qib7	15378	65	in	in	IN
cord-005453-4057qib7	15378	66	lymphoma	lymphoma	NN
cord-005453-4057qib7	15378	67	Background	background	NN
cord-005453-4057qib7	15378	68	:	:	:
cord-005453-4057qib7	15379	1	The	the	DT
cord-005453-4057qib7	15379	2	role	role	NN
cord-005453-4057qib7	15379	3	of	of	IN
cord-005453-4057qib7	15379	4	inflammatory	inflammatory	JJ
cord-005453-4057qib7	15379	5	cascade	cascade	NN
cord-005453-4057qib7	15379	6	in	in	IN
cord-005453-4057qib7	15379	7	tumor	tumor	NN
cord-005453-4057qib7	15379	8	microenvironment	microenvironment	NN
cord-005453-4057qib7	15379	9	has	have	VBZ
cord-005453-4057qib7	15379	10	been	be	VBN
cord-005453-4057qib7	15379	11	demonstrated	demonstrate	VBN
cord-005453-4057qib7	15379	12	in	in	IN
cord-005453-4057qib7	15379	13	several	several	JJ
cord-005453-4057qib7	15379	14	studies	study	NNS
cord-005453-4057qib7	15379	15	.	.	.
cord-005453-4057qib7	15380	1	As	as	IN
cord-005453-4057qib7	15380	2	a	a	DT
cord-005453-4057qib7	15380	3	part	part	NN
cord-005453-4057qib7	15380	4	of	of	IN
cord-005453-4057qib7	15380	5	this	this	DT
cord-005453-4057qib7	15380	6	issue	issue	NN
cord-005453-4057qib7	15380	7	,	,	,
cord-005453-4057qib7	15380	8	elevated	elevated	JJ
cord-005453-4057qib7	15380	9	neutrophil	neutrophil	NN
cord-005453-4057qib7	15380	10	/	/	SYM
cord-005453-4057qib7	15380	11	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	15380	12	ratio	ratio	NN
cord-005453-4057qib7	15380	13	(	(	-LRB-
cord-005453-4057qib7	15380	14	NLR	NLR	NNP
cord-005453-4057qib7	15380	15	)	)	-RRB-
cord-005453-4057qib7	15380	16	was	be	VBD
cord-005453-4057qib7	15380	17	shown	show	VBN
cord-005453-4057qib7	15380	18	to	to	TO
cord-005453-4057qib7	15380	19	be	be	VB
cord-005453-4057qib7	15380	20	associated	associate	VBN
cord-005453-4057qib7	15380	21	with	with	IN
cord-005453-4057qib7	15380	22	an	an	DT
cord-005453-4057qib7	15380	23	adverse	adverse	JJ
cord-005453-4057qib7	15380	24	prognosis	prognosis	NN
cord-005453-4057qib7	15380	25	,	,	,
cord-005453-4057qib7	15380	26	particularly	particularly	RB
cord-005453-4057qib7	15380	27	in	in	IN
cord-005453-4057qib7	15380	28	solid	solid	JJ
cord-005453-4057qib7	15380	29	tumors	tumor	NNS
cord-005453-4057qib7	15380	30	.	.	.
cord-005453-4057qib7	15381	1	The	the	DT
cord-005453-4057qib7	15381	2	aim	aim	NN
cord-005453-4057qib7	15381	3	of	of	IN
cord-005453-4057qib7	15381	4	this	this	DT
cord-005453-4057qib7	15381	5	study	study	NN
cord-005453-4057qib7	15381	6	is	be	VBZ
cord-005453-4057qib7	15381	7	to	to	TO
cord-005453-4057qib7	15381	8	determine	determine	VB
cord-005453-4057qib7	15381	9	the	the	DT
cord-005453-4057qib7	15381	10	impact	impact	NN
cord-005453-4057qib7	15381	11	of	of	IN
cord-005453-4057qib7	15381	12	pre	pre	JJ
cord-005453-4057qib7	15381	13	-	-	JJ
cord-005453-4057qib7	15381	14	transplant	transplant	NN
cord-005453-4057qib7	15381	15	NLR	NLR	NNP
cord-005453-4057qib7	15381	16	on	on	IN
cord-005453-4057qib7	15381	17	early	early	JJ
cord-005453-4057qib7	15381	18	transplant	transplant	NN
cord-005453-4057qib7	15381	19	complications	complication	NNS
cord-005453-4057qib7	15381	20	,	,	,
cord-005453-4057qib7	15381	21	as	as	RB
cord-005453-4057qib7	15381	22	well	well	RB
cord-005453-4057qib7	15381	23	as	as	IN
cord-005453-4057qib7	15381	24	post	post	JJ
cord-005453-4057qib7	15381	25	-	-	JJ
cord-005453-4057qib7	15381	26	transplant	transplant	JJ
cord-005453-4057qib7	15381	27	relapse	relapse	NN
cord-005453-4057qib7	15381	28	and	and	CC
cord-005453-4057qib7	15381	29	survival	survival	NN
cord-005453-4057qib7	15381	30	.	.	.
cord-005453-4057qib7	15382	1	Methods	method	NNS
cord-005453-4057qib7	15382	2	:	:	:
cord-005453-4057qib7	15382	3	A	a	DT
cord-005453-4057qib7	15382	4	total	total	NN
cord-005453-4057qib7	15382	5	of	of	IN
cord-005453-4057qib7	15382	6	119	119	CD
cord-005453-4057qib7	15382	7	lymphoma	lymphoma	NN
cord-005453-4057qib7	15382	8	patients	patient	NNS
cord-005453-4057qib7	15382	9	[	[	-LRB-
cord-005453-4057qib7	15382	10	median	median	NN
cord-005453-4057qib7	15382	11	age	age	NN
cord-005453-4057qib7	15382	12	:	:	:
cord-005453-4057qib7	15382	13	49(18	49(18	CD
cord-005453-4057qib7	15382	14	-	-	SYM
cord-005453-4057qib7	15382	15	71	71	CD
cord-005453-4057qib7	15382	16	)	)	-RRB-
cord-005453-4057qib7	15382	17	years	year	NNS
cord-005453-4057qib7	15382	18	;	;	:
cord-005453-4057qib7	15382	19	male	male	JJ
cord-005453-4057qib7	15382	20	/	/	SYM
cord-005453-4057qib7	15382	21	female	female	NN
cord-005453-4057qib7	15382	22	:	:	:
cord-005453-4057qib7	15382	23	64/55	64/55	LS
cord-005453-4057qib7	15382	24	]	]	-RRB-
cord-005453-4057qib7	15382	25	who	who	WP
cord-005453-4057qib7	15382	26	underwent	undergo	VBD
cord-005453-4057qib7	15382	27	autologous	autologous	JJ
cord-005453-4057qib7	15382	28	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15382	29	stem	stem	NN
cord-005453-4057qib7	15382	30	cell	cell	NN
cord-005453-4057qib7	15382	31	transplantation	transplantation	NN
cord-005453-4057qib7	15382	32	(	(	-LRB-
cord-005453-4057qib7	15382	33	HSCT	HSCT	NNP
cord-005453-4057qib7	15382	34	)	)	-RRB-
cord-005453-4057qib7	15382	35	were	be	VBD
cord-005453-4057qib7	15382	36	included	include	VBN
cord-005453-4057qib7	15382	37	in	in	IN
cord-005453-4057qib7	15382	38	this	this	DT
cord-005453-4057qib7	15382	39	retrospective	retrospective	JJ
cord-005453-4057qib7	15382	40	study	study	NN
cord-005453-4057qib7	15382	41	.	.	.
cord-005453-4057qib7	15383	1	Results	result	NNS
cord-005453-4057qib7	15383	2	:	:	:
cord-005453-4057qib7	15384	1	The	the	DT
cord-005453-4057qib7	15384	2	initial	initial	JJ
cord-005453-4057qib7	15384	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	15384	4	was	be	VBD
cord-005453-4057qib7	15384	5	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15384	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	15384	7	(	(	-LRB-
cord-005453-4057qib7	15384	8	HL	HL	NNP
cord-005453-4057qib7	15384	9	)	)	-RRB-
cord-005453-4057qib7	15384	10	in	in	IN
cord-005453-4057qib7	15384	11	35	35	CD
cord-005453-4057qib7	15384	12	(	(	-LRB-
cord-005453-4057qib7	15384	13	29.4	29.4	CD
cord-005453-4057qib7	15384	14	%	%	NN
cord-005453-4057qib7	15384	15	)	)	-RRB-
cord-005453-4057qib7	15384	16	,	,	,
cord-005453-4057qib7	15384	17	B	b	NN
cord-005453-4057qib7	15384	18	-	-	HYPH
cord-005453-4057qib7	15384	19	cell	cell	NN
cord-005453-4057qib7	15384	20	non	non	JJ
cord-005453-4057qib7	15384	21	-	-	JJ
cord-005453-4057qib7	15384	22	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	15384	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	15384	24	(	(	-LRB-
cord-005453-4057qib7	15384	25	NHL	NHL	NNP
cord-005453-4057qib7	15384	26	)	)	-RRB-
cord-005453-4057qib7	15384	27	in	in	IN
cord-005453-4057qib7	15384	28	67	67	CD
cord-005453-4057qib7	15384	29	(	(	-LRB-
cord-005453-4057qib7	15384	30	56.3	56.3	CD
cord-005453-4057qib7	15384	31	%	%	NN
cord-005453-4057qib7	15384	32	)	)	-RRB-
cord-005453-4057qib7	15384	33	and	and	CC
cord-005453-4057qib7	15384	34	T	t	NN
cord-005453-4057qib7	15384	35	-	-	HYPH
cord-005453-4057qib7	15384	36	cell	cell	NN
cord-005453-4057qib7	15384	37	NHL	NHL	NNP
cord-005453-4057qib7	15384	38	in	in	IN
cord-005453-4057qib7	15384	39	17	17	CD
cord-005453-4057qib7	15384	40	(	(	-LRB-
cord-005453-4057qib7	15384	41	14.3	14.3	CD
cord-005453-4057qib7	15384	42	%	%	NN
cord-005453-4057qib7	15384	43	)	)	-RRB-
cord-005453-4057qib7	15384	44	patients	patient	NNS
cord-005453-4057qib7	15384	45	.	.	.
cord-005453-4057qib7	15385	1	Of	of	IN
cord-005453-4057qib7	15385	2	116	116	CD
cord-005453-4057qib7	15385	3	patients	patient	NNS
cord-005453-4057qib7	15385	4	who	who	WP
cord-005453-4057qib7	15385	5	were	be	VBD
cord-005453-4057qib7	15385	6	evaluated	evaluate	VBN
cord-005453-4057qib7	15385	7	for	for	IN
cord-005453-4057qib7	15385	8	pretransplant	pretransplant	JJ
cord-005453-4057qib7	15385	9	disease	disease	NN
cord-005453-4057qib7	15385	10	status	status	NN
cord-005453-4057qib7	15385	11	,	,	,
cord-005453-4057qib7	15385	12	52	52	CD
cord-005453-4057qib7	15385	13	patients	patient	NNS
cord-005453-4057qib7	15385	14	(	(	-LRB-
cord-005453-4057qib7	15385	15	44.8	44.8	CD
cord-005453-4057qib7	15385	16	%	%	NN
cord-005453-4057qib7	15385	17	)	)	-RRB-
cord-005453-4057qib7	15385	18	were	be	VBD
cord-005453-4057qib7	15385	19	in	in	IN
cord-005453-4057qib7	15385	20	complete	complete	JJ
cord-005453-4057qib7	15385	21	remission	remission	NN
cord-005453-4057qib7	15385	22	,	,	,
cord-005453-4057qib7	15385	23	45	45	CD
cord-005453-4057qib7	15385	24	patients	patient	NNS
cord-005453-4057qib7	15385	25	(	(	-LRB-
cord-005453-4057qib7	15385	26	38.8	38.8	CD
cord-005453-4057qib7	15385	27	%	%	NN
cord-005453-4057qib7	15385	28	)	)	-RRB-
cord-005453-4057qib7	15385	29	were	be	VBD
cord-005453-4057qib7	15385	30	in	in	IN
cord-005453-4057qib7	15385	31	partial	partial	JJ
cord-005453-4057qib7	15385	32	remission	remission	NN
cord-005453-4057qib7	15385	33	and	and	CC
cord-005453-4057qib7	15385	34	19	19	CD
cord-005453-4057qib7	15385	35	(	(	-LRB-
cord-005453-4057qib7	15385	36	16.4	16.4	CD
cord-005453-4057qib7	15385	37	%	%	NN
cord-005453-4057qib7	15385	38	)	)	-RRB-
cord-005453-4057qib7	15385	39	patients	patient	NNS
cord-005453-4057qib7	15385	40	had	have	VBD
cord-005453-4057qib7	15385	41	refractory	refractory	JJ
cord-005453-4057qib7	15385	42	disease	disease	NN
cord-005453-4057qib7	15385	43	.	.	.
cord-005453-4057qib7	15386	1	Median	median	JJ
cord-005453-4057qib7	15386	2	pre	pre	JJ
cord-005453-4057qib7	15386	3	-	-	JJ
cord-005453-4057qib7	15386	4	transplant	transplant	NN
cord-005453-4057qib7	15386	5	NLR	NLR	NNP
cord-005453-4057qib7	15386	6	was	be	VBD
cord-005453-4057qib7	15386	7	found	find	VBN
cord-005453-4057qib7	15386	8	to	to	TO
cord-005453-4057qib7	15386	9	be	be	VB
cord-005453-4057qib7	15386	10	3.42(0	3.42(0	CD
cord-005453-4057qib7	15386	11	-	-	SYM
cord-005453-4057qib7	15386	12	97	97	CD
cord-005453-4057qib7	15386	13	)	)	-RRB-
cord-005453-4057qib7	15386	14	.	.	.
cord-005453-4057qib7	15387	1	When	when	WRB
cord-005453-4057qib7	15387	2	the	the	DT
cord-005453-4057qib7	15387	3	study	study	NN
cord-005453-4057qib7	15387	4	population	population	NN
cord-005453-4057qib7	15387	5	was	be	VBD
cord-005453-4057qib7	15387	6	divided	divide	VBN
cord-005453-4057qib7	15387	7	into	into	IN
cord-005453-4057qib7	15387	8	two	two	CD
cord-005453-4057qib7	15387	9	subgroups	subgroup	NNS
cord-005453-4057qib7	15387	10	as	as	IN
cord-005453-4057qib7	15387	11	"	"	``
cord-005453-4057qib7	15387	12	low-	low-	NN
cord-005453-4057qib7	15387	13	"	"	''
cord-005453-4057qib7	15387	14	and	and	CC
cord-005453-4057qib7	15387	15	"	"	``
cord-005453-4057qib7	15387	16	high	high	JJ
cord-005453-4057qib7	15387	17	-	-	HYPH
cord-005453-4057qib7	15387	18	NLR	NLR	NNP
cord-005453-4057qib7	15387	19	"	"	''
cord-005453-4057qib7	15387	20	,	,	,
cord-005453-4057qib7	15387	21	based	base	VBN
cord-005453-4057qib7	15387	22	on	on	IN
cord-005453-4057qib7	15387	23	median	median	JJ
cord-005453-4057qib7	15387	24	NLR	NLR	NNP
cord-005453-4057qib7	15387	25	value	value	NN
cord-005453-4057qib7	15387	26	,	,	,
cord-005453-4057qib7	15387	27	number	number	NN
cord-005453-4057qib7	15387	28	of	of	IN
cord-005453-4057qib7	15387	29	febrile	febrile	JJ
cord-005453-4057qib7	15387	30	days	day	NNS
cord-005453-4057qib7	15387	31	were	be	VBD
cord-005453-4057qib7	15387	32	found	find	VBN
cord-005453-4057qib7	15387	33	to	to	TO
cord-005453-4057qib7	15387	34	be	be	VB
cord-005453-4057qib7	15387	35	relatively	relatively	RB
cord-005453-4057qib7	15387	36	higher	high	JJR
cord-005453-4057qib7	15387	37	in	in	IN
cord-005453-4057qib7	15387	38	the	the	DT
cord-005453-4057qib7	15387	39	low	low	JJ
cord-005453-4057qib7	15387	40	-	-	HYPH
cord-005453-4057qib7	15387	41	NLR	NLR	NNP
cord-005453-4057qib7	15387	42	group	group	NN
cord-005453-4057qib7	15387	43	(	(	-LRB-
cord-005453-4057qib7	15387	44	p=0.051	p=0.051	NNP
cord-005453-4057qib7	15387	45	)	)	-RRB-
cord-005453-4057qib7	15387	46	.	.	.
cord-005453-4057qib7	15388	1	A	a	DT
cord-005453-4057qib7	15388	2	positive	positive	JJ
cord-005453-4057qib7	15388	3	correlation	correlation	NN
cord-005453-4057qib7	15388	4	was	be	VBD
cord-005453-4057qib7	15388	5	demonstrated	demonstrate	VBN
cord-005453-4057qib7	15388	6	between	between	IN
cord-005453-4057qib7	15388	7	NLR	NLR	NNP
cord-005453-4057qib7	15388	8	and	and	CC
cord-005453-4057qib7	15388	9	lactate	lactate	NN
cord-005453-4057qib7	15388	10	dehydrogenase	dehydrogenase	NN
cord-005453-4057qib7	15388	11	levels	level	NNS
cord-005453-4057qib7	15388	12	(	(	-LRB-
cord-005453-4057qib7	15388	13	r=0.218	r=0.218	NNS
cord-005453-4057qib7	15388	14	;	;	:
cord-005453-4057qib7	15388	15	p=0.03	p=0.03	NN
cord-005453-4057qib7	15388	16	)	)	-RRB-
cord-005453-4057qib7	15388	17	;	;	:
cord-005453-4057qib7	15388	18	and	and	CC
cord-005453-4057qib7	15388	19	NLR	NLR	NNP
cord-005453-4057qib7	15388	20	and	and	CC
cord-005453-4057qib7	15388	21	ferritin	ferritin	NN
cord-005453-4057qib7	15388	22	levels	level	NNS
cord-005453-4057qib7	15388	23	(	(	-LRB-
cord-005453-4057qib7	15388	24	r=0.277	r=0.277	NNP
cord-005453-4057qib7	15388	25	;	;	:
cord-005453-4057qib7	15388	26	p=0.003	p=0.003	NNP
cord-005453-4057qib7	15388	27	)	)	-RRB-
cord-005453-4057qib7	15388	28	.	.	.
cord-005453-4057qib7	15389	1	At	at	IN
cord-005453-4057qib7	15389	2	a	a	DT
cord-005453-4057qib7	15389	3	median	median	JJ
cord-005453-4057qib7	15389	4	follow	follow	NN
cord-005453-4057qib7	15389	5	-	-	HYPH
cord-005453-4057qib7	15389	6	up	up	NN
cord-005453-4057qib7	15389	7	of	of	IN
cord-005453-4057qib7	15389	8	24	24	CD
cord-005453-4057qib7	15389	9	(	(	-LRB-
cord-005453-4057qib7	15389	10	1	1	CD
cord-005453-4057qib7	15389	11	-	-	SYM
cord-005453-4057qib7	15389	12	264	264	CD
cord-005453-4057qib7	15389	13	)	)	-RRB-
cord-005453-4057qib7	15389	14	months	month	NNS
cord-005453-4057qib7	15389	15	,	,	,
cord-005453-4057qib7	15389	16	overall	overall	JJ
cord-005453-4057qib7	15389	17	survival	survival	NN
cord-005453-4057qib7	15389	18	(	(	-LRB-
cord-005453-4057qib7	15389	19	OS	OS	NNP
cord-005453-4057qib7	15389	20	)	)	-RRB-
cord-005453-4057qib7	15389	21	was	be	VBD
cord-005453-4057qib7	15389	22	found	find	VBN
cord-005453-4057qib7	15389	23	to	to	TO
cord-005453-4057qib7	15389	24	be	be	VB
cord-005453-4057qib7	15389	25	better	well	JJR
cord-005453-4057qib7	15389	26	in	in	IN
cord-005453-4057qib7	15389	27	the	the	DT
cord-005453-4057qib7	15389	28	low	low	JJ
cord-005453-4057qib7	15389	29	-	-	HYPH
cord-005453-4057qib7	15389	30	NLR	NLR	NNP
cord-005453-4057qib7	15389	31	group	group	NN
cord-005453-4057qib7	15389	32	without	without	IN
cord-005453-4057qib7	15389	33	statistical	statistical	JJ
cord-005453-4057qib7	15389	34	significance	significance	NN
cord-005453-4057qib7	15389	35	[	[	-LRB-
cord-005453-4057qib7	15389	36	25	25	CD
cord-005453-4057qib7	15389	37	vs	vs	IN
cord-005453-4057qib7	15389	38	13(1	13(1	CD
cord-005453-4057qib7	15389	39	-	-	SYM
cord-005453-4057qib7	15389	40	91	91	CD
cord-005453-4057qib7	15389	41	)	)	-RRB-
cord-005453-4057qib7	15389	42	months	month	NNS
cord-005453-4057qib7	15389	43	;	;	:
cord-005453-4057qib7	15389	44	p=0.069	p=0.069	NNP
cord-005453-4057qib7	15389	45	]	]	-RRB-
cord-005453-4057qib7	15389	46	.	.	.
cord-005453-4057qib7	15390	1	In	in	IN
cord-005453-4057qib7	15390	2	univariate	univariate	JJ
cord-005453-4057qib7	15390	3	analysis	analysis	NN
cord-005453-4057qib7	15390	4	,	,	,
cord-005453-4057qib7	15390	5	pre	pre	JJ
cord-005453-4057qib7	15390	6	-	-	JJ
cord-005453-4057qib7	15390	7	transplant	transplant	NN
cord-005453-4057qib7	15390	8	NLR	NLR	NNP
cord-005453-4057qib7	15390	9	represented	represent	VBD
cord-005453-4057qib7	15390	10	a	a	DT
cord-005453-4057qib7	15390	11	significant	significant	JJ
cord-005453-4057qib7	15390	12	impact	impact	NN
cord-005453-4057qib7	15390	13	on	on	IN
cord-005453-4057qib7	15390	14	OS	OS	NNP
cord-005453-4057qib7	15390	15	(	(	-LRB-
cord-005453-4057qib7	15390	16	p=0.021	p=0.021	NNP
cord-005453-4057qib7	15390	17	)	)	-RRB-
cord-005453-4057qib7	15390	18	.	.	.
cord-005453-4057qib7	15391	1	Other	other	JJ
cord-005453-4057qib7	15391	2	prognostic	prognostic	JJ
cord-005453-4057qib7	15391	3	factors	factor	NNS
cord-005453-4057qib7	15391	4	were	be	VBD
cord-005453-4057qib7	15391	5	age	age	NN
cord-005453-4057qib7	15391	6	(	(	-LRB-
cord-005453-4057qib7	15391	7	p=0.041	p=0.041	NNP
cord-005453-4057qib7	15391	8	)	)	-RRB-
cord-005453-4057qib7	15391	9	,	,	,
cord-005453-4057qib7	15391	10	platelet	platelet	NN
cord-005453-4057qib7	15391	11	engraftment	engraftment	NN
cord-005453-4057qib7	15391	12	(	(	-LRB-
cord-005453-4057qib7	15391	13	p=0.018	p=0.018	NNP
cord-005453-4057qib7	15391	14	)	)	-RRB-
cord-005453-4057qib7	15391	15	,	,	,
cord-005453-4057qib7	15391	16	post	post	JJ
cord-005453-4057qib7	15391	17	-	-	JJ
cord-005453-4057qib7	15391	18	transplant	transplant	JJ
cord-005453-4057qib7	15391	19	relapse	relapse	NN
cord-005453-4057qib7	15391	20	(	(	-LRB-
cord-005453-4057qib7	15391	21	p=0.009	p=0.009	NN
cord-005453-4057qib7	15391	22	)	)	-RRB-
cord-005453-4057qib7	15391	23	and	and	CC
cord-005453-4057qib7	15391	24	pre	pre	JJ
cord-005453-4057qib7	15391	25	-	-	JJ
cord-005453-4057qib7	15391	26	transplant	transplant	JJ
cord-005453-4057qib7	15391	27	ferritin	ferritin	NN
cord-005453-4057qib7	15391	28	level	level	NN
cord-005453-4057qib7	15391	29	(	(	-LRB-
cord-005453-4057qib7	15391	30	p	p	NN
cord-005453-4057qib7	15391	31	<	<	XX
cord-005453-4057qib7	15391	32	0.001	0.001	CD
cord-005453-4057qib7	15391	33	)	)	-RRB-
cord-005453-4057qib7	15391	34	.	.	.
cord-005453-4057qib7	15392	1	The	the	DT
cord-005453-4057qib7	15392	2	permanent	permanent	JJ
cord-005453-4057qib7	15392	3	impact	impact	NN
cord-005453-4057qib7	15392	4	of	of	IN
cord-005453-4057qib7	15392	5	ferritin	ferritin	NN
cord-005453-4057qib7	15392	6	on	on	IN
cord-005453-4057qib7	15392	7	OS	OS	NNP
cord-005453-4057qib7	15392	8	was	be	VBD
cord-005453-4057qib7	15392	9	confirmed	confirm	VBN
cord-005453-4057qib7	15392	10	in	in	IN
cord-005453-4057qib7	15392	11	multivariate	multivariate	JJ
cord-005453-4057qib7	15392	12	analysis	analysis	NN
cord-005453-4057qib7	15392	13	(	(	-LRB-
cord-005453-4057qib7	15392	14	p=0.008).Conclusions	p=0.008).Conclusions	NNP
cord-005453-4057qib7	15392	15	:	:	:
cord-005453-4057qib7	15393	1	In	in	IN
cord-005453-4057qib7	15393	2	this	this	DT
cord-005453-4057qib7	15393	3	study	study	NN
cord-005453-4057qib7	15393	4	,	,	,
cord-005453-4057qib7	15393	5	an	an	DT
cord-005453-4057qib7	15393	6	adverse	adverse	JJ
cord-005453-4057qib7	15393	7	impact	impact	NN
cord-005453-4057qib7	15393	8	of	of	IN
cord-005453-4057qib7	15393	9	elevated	elevated	JJ
cord-005453-4057qib7	15393	10	pre	pre	JJ
cord-005453-4057qib7	15393	11	-	-	JJ
cord-005453-4057qib7	15393	12	transplant	transplant	NN
cord-005453-4057qib7	15393	13	NLR	NLR	NNP
cord-005453-4057qib7	15393	14	on	on	IN
cord-005453-4057qib7	15393	15	OS	OS	NNP
cord-005453-4057qib7	15393	16	was	be	VBD
cord-005453-4057qib7	15393	17	demonstrated	demonstrate	VBN
cord-005453-4057qib7	15393	18	in	in	IN
cord-005453-4057qib7	15393	19	autologous	autologous	JJ
cord-005453-4057qib7	15393	20	HSCT	HSCT	NNP
cord-005453-4057qib7	15393	21	recipients	recipient	NNS
cord-005453-4057qib7	15393	22	with	with	IN
cord-005453-4057qib7	15393	23	lymphoma	lymphoma	NN
cord-005453-4057qib7	15393	24	.	.	.
cord-005453-4057qib7	15394	1	As	as	IN
cord-005453-4057qib7	15394	2	a	a	DT
cord-005453-4057qib7	15394	3	predictor	predictor	NN
cord-005453-4057qib7	15394	4	of	of	IN
cord-005453-4057qib7	15394	5	prognosis	prognosis	NN
cord-005453-4057qib7	15394	6	,	,	,
cord-005453-4057qib7	15394	7	NLR	NLR	NNP
cord-005453-4057qib7	15394	8	may	may	MD
cord-005453-4057qib7	15394	9	be	be	VB
cord-005453-4057qib7	15394	10	considered	consider	VBN
cord-005453-4057qib7	15394	11	as	as	IN
cord-005453-4057qib7	15394	12	a	a	DT
cord-005453-4057qib7	15394	13	safe	safe	JJ
cord-005453-4057qib7	15394	14	and	and	CC
cord-005453-4057qib7	15394	15	cost	cost	NN
cord-005453-4057qib7	15394	16	-	-	HYPH
cord-005453-4057qib7	15394	17	effective	effective	JJ
cord-005453-4057qib7	15394	18	parameter	parameter	NN
cord-005453-4057qib7	15394	19	.	.	.
cord-005453-4057qib7	15395	1	Further	further	JJ
cord-005453-4057qib7	15395	2	studies	study	NNS
cord-005453-4057qib7	15395	3	are	be	VBP
cord-005453-4057qib7	15395	4	required	require	VBN
cord-005453-4057qib7	15395	5	in	in	IN
cord-005453-4057qib7	15395	6	order	order	NN
cord-005453-4057qib7	15395	7	to	to	TO
cord-005453-4057qib7	15395	8	use	use	VB
cord-005453-4057qib7	15395	9	this	this	DT
cord-005453-4057qib7	15395	10	predictor	predictor	NN
cord-005453-4057qib7	15395	11	in	in	IN
cord-005453-4057qib7	15395	12	routine	routine	JJ
cord-005453-4057qib7	15395	13	clinical	clinical	JJ
cord-005453-4057qib7	15395	14	practice	practice	NN
cord-005453-4057qib7	15395	15	.	.	.
cord-005453-4057qib7	15396	1	Background	background	NN
cord-005453-4057qib7	15396	2	:	:	:
cord-005453-4057qib7	15397	1	High	high	JJ
cord-005453-4057qib7	15397	2	cure	cure	NN
cord-005453-4057qib7	15397	3	rates	rate	NNS
cord-005453-4057qib7	15397	4	in	in	IN
cord-005453-4057qib7	15397	5	childhood	childhood	NN
cord-005453-4057qib7	15397	6	diseases	disease	NNS
cord-005453-4057qib7	15397	7	have	have	VBP
cord-005453-4057qib7	15397	8	been	be	VBN
cord-005453-4057qib7	15397	9	achieved	achieve	VBN
cord-005453-4057qib7	15397	10	by	by	IN
cord-005453-4057qib7	15397	11	stem	stem	NN
cord-005453-4057qib7	15397	12	cell	cell	NN
cord-005453-4057qib7	15397	13	transplantation	transplantation	NN
cord-005453-4057qib7	15397	14	(	(	-LRB-
cord-005453-4057qib7	15397	15	SCT	SCT	NNP
cord-005453-4057qib7	15397	16	)	)	-RRB-
cord-005453-4057qib7	15397	17	.	.	.
cord-005453-4057qib7	15398	1	However	however	RB
cord-005453-4057qib7	15398	2	,	,	,
cord-005453-4057qib7	15398	3	there	there	EX
cord-005453-4057qib7	15398	4	is	be	VBZ
cord-005453-4057qib7	15398	5	little	little	JJ
cord-005453-4057qib7	15398	6	knowledge	knowledge	NN
cord-005453-4057qib7	15398	7	concerning	concern	VBG
cord-005453-4057qib7	15398	8	recovery	recovery	NN
cord-005453-4057qib7	15398	9	of	of	IN
cord-005453-4057qib7	15398	10	the	the	DT
cord-005453-4057qib7	15398	11	immune	immune	JJ
cord-005453-4057qib7	15398	12	system	system	NN
cord-005453-4057qib7	15398	13	and	and	CC
cord-005453-4057qib7	15398	14	community	community	NN
cord-005453-4057qib7	15398	15	-	-	HYPH
cord-005453-4057qib7	15398	16	acquired	acquire	VBN
cord-005453-4057qib7	15398	17	infection	infection	NN
cord-005453-4057qib7	15398	18	after	after	IN
cord-005453-4057qib7	15398	19	SCT	SCT	NNP
cord-005453-4057qib7	15398	20	.	.	.
cord-005453-4057qib7	15399	1	Here	here	RB
cord-005453-4057qib7	15399	2	we	-PRON-	PRP
cord-005453-4057qib7	15399	3	studied	study	VBD
cord-005453-4057qib7	15399	4	the	the	DT
cord-005453-4057qib7	15399	5	long	long	JJ
cord-005453-4057qib7	15399	6	-	-	HYPH
cord-005453-4057qib7	15399	7	term	term	NN
cord-005453-4057qib7	15399	8	reconstitution	reconstitution	NN
cord-005453-4057qib7	15399	9	of	of	IN
cord-005453-4057qib7	15399	10	the	the	DT
cord-005453-4057qib7	15399	11	immune	immune	JJ
cord-005453-4057qib7	15399	12	system	system	NN
cord-005453-4057qib7	15399	13	and	and	CC
cord-005453-4057qib7	15399	14	incidences	incidence	NNS
cord-005453-4057qib7	15399	15	of	of	IN
cord-005453-4057qib7	15399	16	community	community	NN
cord-005453-4057qib7	15399	17	-	-	HYPH
cord-005453-4057qib7	15399	18	acquired	acquire	VBN
cord-005453-4057qib7	15399	19	infection	infection	NN
cord-005453-4057qib7	15399	20	after	after	IN
cord-005453-4057qib7	15399	21	SCT.Methods	sct.method	NNS
cord-005453-4057qib7	15399	22	:	:	:
cord-005453-4057qib7	15400	1	We	-PRON-	PRP
cord-005453-4057qib7	15400	2	reviewed	review	VBD
cord-005453-4057qib7	15400	3	medical	medical	JJ
cord-005453-4057qib7	15400	4	records	record	NNS
cord-005453-4057qib7	15400	5	for	for	IN
cord-005453-4057qib7	15400	6	44	44	CD
cord-005453-4057qib7	15400	7	patients	patient	NNS
cord-005453-4057qib7	15400	8	(	(	-LRB-
cord-005453-4057qib7	15400	9	M	M	NNP
cord-005453-4057qib7	15400	10	/	/	SYM
cord-005453-4057qib7	15400	11	F	F	NNP
cord-005453-4057qib7	15400	12	:	:	:
cord-005453-4057qib7	15400	13	31/13	31/13	CD
cord-005453-4057qib7	15400	14	,	,	,
cord-005453-4057qib7	15400	15	median	median	JJ
cord-005453-4057qib7	15400	16	age	age	NN
cord-005453-4057qib7	15400	17	:	:	:
cord-005453-4057qib7	15400	18	5	5	CD
cord-005453-4057qib7	15400	19	years	year	NNS
cord-005453-4057qib7	15400	20	(	(	-LRB-
cord-005453-4057qib7	15400	21	range	range	NN
cord-005453-4057qib7	15400	22	:	:	:
cord-005453-4057qib7	15400	23	1	1	CD
cord-005453-4057qib7	15400	24	-	-	HYPH
cord-005453-4057qib7	15400	25	22years	22years	NNP
cord-005453-4057qib7	15400	26	)	)	-RRB-
cord-005453-4057qib7	15400	27	who	who	WP
cord-005453-4057qib7	15400	28	were	be	VBD
cord-005453-4057qib7	15400	29	treated	treat	VBN
cord-005453-4057qib7	15400	30	in	in	IN
cord-005453-4057qib7	15400	31	the	the	DT
cord-005453-4057qib7	15400	32	Department	Department	NNP
cord-005453-4057qib7	15400	33	of	of	IN
cord-005453-4057qib7	15400	34	Pediatrics	Pediatrics	NNP
cord-005453-4057qib7	15400	35	,	,	,
cord-005453-4057qib7	15400	36	Hokkaido	Hokkaido	NNP
cord-005453-4057qib7	15400	37	University	University	NNP
cord-005453-4057qib7	15400	38	Hospital	Hospital	NNP
cord-005453-4057qib7	15400	39	.	.	.
cord-005453-4057qib7	15401	1	We	-PRON-	PRP
cord-005453-4057qib7	15401	2	analyzed	analyze	VBD
cord-005453-4057qib7	15401	3	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	15401	4	cell	cell	NN
cord-005453-4057qib7	15401	5	counts	count	NNS
cord-005453-4057qib7	15401	6	,	,	,
cord-005453-4057qib7	15401	7	serum	serum	NN
cord-005453-4057qib7	15401	8	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	15401	9	G	G	NNP
cord-005453-4057qib7	15401	10	(	(	-LRB-
cord-005453-4057qib7	15401	11	IgG	IgG	NNP
cord-005453-4057qib7	15401	12	)	)	-RRB-
cord-005453-4057qib7	15401	13	levels	level	NNS
cord-005453-4057qib7	15401	14	,	,	,
cord-005453-4057qib7	15401	15	and	and	CC
cord-005453-4057qib7	15401	16	incidences	incidence	NNS
cord-005453-4057qib7	15401	17	of	of	IN
cord-005453-4057qib7	15401	18	community	community	NN
cord-005453-4057qib7	15401	19	-	-	HYPH
cord-005453-4057qib7	15401	20	acquired	acquire	VBN
cord-005453-4057qib7	15401	21	infection	infection	NN
cord-005453-4057qib7	15401	22	until	until	IN
cord-005453-4057qib7	15401	23	2	2	CD
cord-005453-4057qib7	15401	24	years	year	NNS
cord-005453-4057qib7	15401	25	after	after	IN
cord-005453-4057qib7	15401	26	SCT	SCT	NNP
cord-005453-4057qib7	15401	27	.	.	.
cord-005453-4057qib7	15402	1	Indications	indication	NNS
cord-005453-4057qib7	15402	2	for	for	IN
cord-005453-4057qib7	15402	3	SCT	SCT	NNP
cord-005453-4057qib7	15402	4	were	be	VBD
cord-005453-4057qib7	15402	5	ALL	all	DT
cord-005453-4057qib7	15402	6	in	in	IN
cord-005453-4057qib7	15402	7	8	8	CD
cord-005453-4057qib7	15402	8	patients	patient	NNS
cord-005453-4057qib7	15402	9	,	,	,
cord-005453-4057qib7	15402	10	AML	AML	NNP
cord-005453-4057qib7	15402	11	in	in	IN
cord-005453-4057qib7	15402	12	4	4	CD
cord-005453-4057qib7	15402	13	,	,	,
cord-005453-4057qib7	15402	14	AA	AA	NNP
cord-005453-4057qib7	15402	15	in	in	IN
cord-005453-4057qib7	15402	16	6	6	CD
cord-005453-4057qib7	15403	1	,	,	,
cord-005453-4057qib7	15403	2	NB	NB	NNP
cord-005453-4057qib7	15403	3	in	in	IN
cord-005453-4057qib7	15403	4	5	5	CD
cord-005453-4057qib7	15403	5	,	,	,
cord-005453-4057qib7	15403	6	RMS	RMS	NNP
cord-005453-4057qib7	15403	7	in	in	IN
cord-005453-4057qib7	15403	8	2	2	CD
cord-005453-4057qib7	15403	9	,	,	,
cord-005453-4057qib7	15403	10	JMML	JMML	NNP
cord-005453-4057qib7	15403	11	in	in	IN
cord-005453-4057qib7	15403	12	1	1	CD
cord-005453-4057qib7	15403	13	,	,	,
cord-005453-4057qib7	15403	14	NHL	NHL	NNP
cord-005453-4057qib7	15403	15	in	in	IN
cord-005453-4057qib7	15403	16	1	1	CD
cord-005453-4057qib7	15403	17	,	,	,
cord-005453-4057qib7	15403	18	CGD	CGD	NNP
cord-005453-4057qib7	15403	19	in	in	IN
cord-005453-4057qib7	15403	20	5	5	CD
cord-005453-4057qib7	15403	21	,	,	,
cord-005453-4057qib7	15403	22	WAS	be	VBD
cord-005453-4057qib7	15403	23	in	in	IN
cord-005453-4057qib7	15403	24	3	3	CD
cord-005453-4057qib7	15403	25	,	,	,
cord-005453-4057qib7	15403	26	XSCID	XSCID	NNP
cord-005453-4057qib7	15403	27	in	in	IN
cord-005453-4057qib7	15403	28	2	2	CD
cord-005453-4057qib7	15403	29	,	,	,
cord-005453-4057qib7	15403	30	APDS	APDS	NNP
cord-005453-4057qib7	15403	31	in	in	IN
cord-005453-4057qib7	15403	32	2	2	CD
cord-005453-4057qib7	15403	33	,	,	,
cord-005453-4057qib7	15404	1	CD40LD	CD40LD	NNP
cord-005453-4057qib7	15404	2	in	in	IN
cord-005453-4057qib7	15404	3	2	2	CD
cord-005453-4057qib7	15404	4	,	,	,
cord-005453-4057qib7	15404	5	and	and	CC
cord-005453-4057qib7	15404	6	other	other	JJ
cord-005453-4057qib7	15404	7	solid	solid	JJ
cord-005453-4057qib7	15404	8	tumor	tumor	NN
cord-005453-4057qib7	15404	9	in	in	IN
cord-005453-4057qib7	15404	10	3	3	CD
cord-005453-4057qib7	15404	11	patients	patient	NNS
cord-005453-4057qib7	15404	12	.	.	.
cord-005453-4057qib7	15405	1	Stem	stem	JJ
cord-005453-4057qib7	15405	2	cell	cell	NN
cord-005453-4057qib7	15405	3	sources	source	NNS
cord-005453-4057qib7	15405	4	were	be	VBD
cord-005453-4057qib7	15405	5	autologous	autologous	JJ
cord-005453-4057qib7	15405	6	PB	PB	NNP
cord-005453-4057qib7	15405	7	/	/	SYM
cord-005453-4057qib7	15405	8	BM	BM	NNP
cord-005453-4057qib7	15405	9	in	in	IN
cord-005453-4057qib7	15405	10	6	6	CD
cord-005453-4057qib7	15405	11	,	,	,
cord-005453-4057qib7	15405	12	allogenic	allogenic	JJ
cord-005453-4057qib7	15405	13	BM	bm	NN
cord-005453-4057qib7	15405	14	in	in	IN
cord-005453-4057qib7	15405	15	23	23	CD
cord-005453-4057qib7	15405	16	(	(	-LRB-
cord-005453-4057qib7	15405	17	9	9	CD
cord-005453-4057qib7	15405	18	related	related	JJ
cord-005453-4057qib7	15405	19	and	and	CC
cord-005453-4057qib7	15405	20	14	14	CD
cord-005453-4057qib7	15405	21	unrelated	unrelated	JJ
cord-005453-4057qib7	15405	22	)	)	-RRB-
cord-005453-4057qib7	15405	23	and	and	CC
cord-005453-4057qib7	15405	24	allogenic	allogenic	JJ
cord-005453-4057qib7	15405	25	CB	CB	NNP
cord-005453-4057qib7	15405	26	in	in	IN
cord-005453-4057qib7	15405	27	15	15	CD
cord-005453-4057qib7	15405	28	patients	patient	NNS
cord-005453-4057qib7	15405	29	.	.	.
cord-005453-4057qib7	15406	1	In	in	IN
cord-005453-4057qib7	15406	2	this	this	DT
cord-005453-4057qib7	15406	3	study	study	NN
cord-005453-4057qib7	15406	4	,	,	,
cord-005453-4057qib7	15406	5	we	-PRON-	PRP
cord-005453-4057qib7	15406	6	excluded	exclude	VBD
cord-005453-4057qib7	15406	7	patients	patient	NNS
cord-005453-4057qib7	15406	8	who	who	WP
cord-005453-4057qib7	15406	9	relapsed	relapse	VBD
cord-005453-4057qib7	15406	10	after	after	IN
cord-005453-4057qib7	15406	11	SCT.Results	SCT.Results	NNP
cord-005453-4057qib7	15406	12	:	:	:
cord-005453-4057qib7	15407	1	The	the	DT
cord-005453-4057qib7	15407	2	duration	duration	NN
cord-005453-4057qib7	15407	3	of	of	IN
cord-005453-4057qib7	15407	4	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	15407	5	cell	cell	NN
cord-005453-4057qib7	15407	6	counts	count	VBZ
cord-005453-4057qib7	15407	7	<	<	XX
cord-005453-4057qib7	15407	8	500/	500/	NNP
cord-005453-4057qib7	15407	9	ml	ml	NN
cord-005453-4057qib7	15407	10	after	after	IN
cord-005453-4057qib7	15407	11	SCT	SCT	NNP
cord-005453-4057qib7	15407	12	was	be	VBD
cord-005453-4057qib7	15407	13	14.7±11.4	14.7±11.4	CD
cord-005453-4057qib7	15407	14	months	month	NNS
cord-005453-4057qib7	15407	15	in	in	IN
cord-005453-4057qib7	15407	16	all	all	DT
cord-005453-4057qib7	15407	17	patients	patient	NNS
cord-005453-4057qib7	15407	18	.	.	.
cord-005453-4057qib7	15408	1	The	the	DT
cord-005453-4057qib7	15408	2	durations	duration	NNS
cord-005453-4057qib7	15408	3	were	be	VBD
cord-005453-4057qib7	15408	4	12.6±7.1	12.6±7.1	CD
cord-005453-4057qib7	15408	5	months	month	NNS
cord-005453-4057qib7	15408	6	in	in	IN
cord-005453-4057qib7	15408	7	patients	patient	NNS
cord-005453-4057qib7	15408	8	with	with	IN
cord-005453-4057qib7	15408	9	hematologic	hematologic	JJ
cord-005453-4057qib7	15408	10	malignancies	malignancy	NNS
cord-005453-4057qib7	15408	11	,	,	,
cord-005453-4057qib7	15408	12	11.5±7.3	11.5±7.3	CD
cord-005453-4057qib7	15408	13	months	month	NNS
cord-005453-4057qib7	15408	14	in	in	IN
cord-005453-4057qib7	15408	15	patients	patient	NNS
cord-005453-4057qib7	15408	16	with	with	IN
cord-005453-4057qib7	15408	17	hematologic	hematologic	JJ
cord-005453-4057qib7	15408	18	disorders	disorder	NNS
cord-005453-4057qib7	15408	19	such	such	JJ
cord-005453-4057qib7	15408	20	as	as	IN
cord-005453-4057qib7	15408	21	aplastic	aplastic	JJ
cord-005453-4057qib7	15408	22	anemia	anemia	NN
cord-005453-4057qib7	15408	23	and	and	CC
cord-005453-4057qib7	15408	24	PID	PID	NNP
cord-005453-4057qib7	15408	25	,	,	,
cord-005453-4057qib7	15408	26	28.8±25.9	28.8±25.9	CD
cord-005453-4057qib7	15408	27	months	month	NNS
cord-005453-4057qib7	15408	28	in	in	IN
cord-005453-4057qib7	15408	29	patients	patient	NNS
cord-005453-4057qib7	15408	30	with	with	IN
cord-005453-4057qib7	15408	31	solid	solid	JJ
cord-005453-4057qib7	15408	32	tumor	tumor	NN
cord-005453-4057qib7	15408	33	,	,	,
cord-005453-4057qib7	15408	34	16.0	16.0	CD
cord-005453-4057qib7	15408	35	±10.4	±10.4	CD
cord-005453-4057qib7	15408	36	months	month	NNS
cord-005453-4057qib7	15408	37	in	in	IN
cord-005453-4057qib7	15408	38	patients	patient	NNS
cord-005453-4057qib7	15408	39	who	who	WP
cord-005453-4057qib7	15408	40	received	receive	VBD
cord-005453-4057qib7	15408	41	autologous	autologous	JJ
cord-005453-4057qib7	15408	42	SCT	SCT	NNP
cord-005453-4057qib7	15408	43	,	,	,
cord-005453-4057qib7	15408	44	25.1±22.2	25.1±22.2	CD
cord-005453-4057qib7	15408	45	months	month	NNS
cord-005453-4057qib7	15408	46	in	in	IN
cord-005453-4057qib7	15408	47	patients	patient	NNS
cord-005453-4057qib7	15408	48	who	who	WP
cord-005453-4057qib7	15408	49	received	receive	VBD
cord-005453-4057qib7	15408	50	related	related	JJ
cord-005453-4057qib7	15408	51	BMT/	BMT/	NNP
cord-005453-4057qib7	15408	52	PBSCT	PBSCT	NNP
cord-005453-4057qib7	15408	53	,	,	,
cord-005453-4057qib7	15408	54	13.8±6.7	13.8±6.7	CD
cord-005453-4057qib7	15408	55	months	month	NNS
cord-005453-4057qib7	15408	56	in	in	IN
cord-005453-4057qib7	15408	57	patients	patient	NNS
cord-005453-4057qib7	15408	58	who	who	WP
cord-005453-4057qib7	15408	59	received	receive	VBD
cord-005453-4057qib7	15408	60	unrelated	unrelated	JJ
cord-005453-4057qib7	15408	61	BMT	BMT	NNP
cord-005453-4057qib7	15408	62	,	,	,
cord-005453-4057qib7	15408	63	and	and	CC
cord-005453-4057qib7	15408	64	10.5±5.8	10.5±5.8	CD
cord-005453-4057qib7	15408	65	months	month	NNS
cord-005453-4057qib7	15408	66	in	in	IN
cord-005453-4057qib7	15408	67	patients	patient	NNS
cord-005453-4057qib7	15408	68	who	who	WP
cord-005453-4057qib7	15408	69	received	receive	VBD
cord-005453-4057qib7	15408	70	CBT	CBT	NNP
cord-005453-4057qib7	15408	71	.	.	.
cord-005453-4057qib7	15409	1	The	the	DT
cord-005453-4057qib7	15409	2	durations	duration	NNS
cord-005453-4057qib7	15409	3	of	of	IN
cord-005453-4057qib7	15409	4	IgG	IgG	NNP
cord-005453-4057qib7	15409	5	<	<	XX
cord-005453-4057qib7	15409	6	500mg	500mg	NNP
cord-005453-4057qib7	15409	7	/	/	SYM
cord-005453-4057qib7	15409	8	dl	dl	NNP
cord-005453-4057qib7	15409	9	after	after	IN
cord-005453-4057qib7	15409	10	SCT	SCT	NNP
cord-005453-4057qib7	15409	11	were	be	VBD
cord-005453-4057qib7	15409	12	14.9±11.5	14.9±11.5	CD
cord-005453-4057qib7	15409	13	months	month	NNS
cord-005453-4057qib7	15409	14	in	in	IN
cord-005453-4057qib7	15409	15	all	all	DT
cord-005453-4057qib7	15409	16	patients	patient	NNS
cord-005453-4057qib7	15409	17	,	,	,
cord-005453-4057qib7	15410	1	15.8±9.7	15.8±9.7	CD
cord-005453-4057qib7	15410	2	months	month	NNS
cord-005453-4057qib7	15410	3	in	in	IN
cord-005453-4057qib7	15410	4	patients	patient	NNS
cord-005453-4057qib7	15410	5	with	with	IN
cord-005453-4057qib7	15410	6	hematologic	hematologic	JJ
cord-005453-4057qib7	15410	7	malignancies	malignancy	NNS
cord-005453-4057qib7	15410	8	,	,	,
cord-005453-4057qib7	15410	9	11.6±5.1	11.6±5.1	CD
cord-005453-4057qib7	15410	10	months	month	NNS
cord-005453-4057qib7	15410	11	in	in	IN
cord-005453-4057qib7	15410	12	patients	patient	NNS
cord-005453-4057qib7	15410	13	with	with	IN
cord-005453-4057qib7	15410	14	hematologic	hematologic	JJ
cord-005453-4057qib7	15410	15	disorders	disorder	NNS
cord-005453-4057qib7	15410	16	,	,	.
cord-005453-4057qib7	15411	1	11.0±8.7	11.0±8.7	CD
cord-005453-4057qib7	15411	2	months	month	NNS
cord-005453-4057qib7	15411	3	in	in	IN
cord-005453-4057qib7	15411	4	patients	patient	NNS
cord-005453-4057qib7	15411	5	with	with	IN
cord-005453-4057qib7	15411	6	solid	solid	JJ
cord-005453-4057qib7	15411	7	tumor	tumor	NN
cord-005453-4057qib7	15411	8	,	,	,
cord-005453-4057qib7	15411	9	19.0±18.6	19.0±18.6	CD
cord-005453-4057qib7	15411	10	months	month	NNS
cord-005453-4057qib7	15411	11	in	in	IN
cord-005453-4057qib7	15411	12	patients	patient	NNS
cord-005453-4057qib7	15411	13	who	who	WP
cord-005453-4057qib7	15411	14	received	receive	VBD
cord-005453-4057qib7	15411	15	autologous	autologous	JJ
cord-005453-4057qib7	15411	16	SCT	SCT	NNP
cord-005453-4057qib7	15411	17	,	,	,
cord-005453-4057qib7	15411	18	12.0±8.3	12.0±8.3	CD
cord-005453-4057qib7	15411	19	months	month	NNS
cord-005453-4057qib7	15411	20	in	in	IN
cord-005453-4057qib7	15411	21	patients	patient	NNS
cord-005453-4057qib7	15411	22	who	who	WP
cord-005453-4057qib7	15411	23	received	receive	VBD
cord-005453-4057qib7	15411	24	related	related	JJ
cord-005453-4057qib7	15411	25	BMT	BMT	NNP
cord-005453-4057qib7	15411	26	/	/	SYM
cord-005453-4057qib7	15411	27	PBSCT	PBSCT	NNP
cord-005453-4057qib7	15411	28	,	,	,
cord-005453-4057qib7	15411	29	11.5±5.7	11.5±5.7	CD
cord-005453-4057qib7	15411	30	months	month	NNS
cord-005453-4057qib7	15411	31	in	in	IN
cord-005453-4057qib7	15411	32	patients	patient	NNS
cord-005453-4057qib7	15411	33	who	who	WP
cord-005453-4057qib7	15411	34	received	receive	VBD
cord-005453-4057qib7	15411	35	unrelated	unrelated	JJ
cord-005453-4057qib7	15411	36	BMT	BMT	NNP
cord-005453-4057qib7	15411	37	,	,	,
cord-005453-4057qib7	15411	38	and	and	CC
cord-005453-4057qib7	15411	39	15.9±8.7	15.9±8.7	CD
cord-005453-4057qib7	15411	40	months	month	NNS
cord-005453-4057qib7	15411	41	in	in	IN
cord-005453-4057qib7	15411	42	patients	patient	NNS
cord-005453-4057qib7	15411	43	who	who	WP
cord-005453-4057qib7	15411	44	received	receive	VBD
cord-005453-4057qib7	15411	45	CBT	CBT	NNP
cord-005453-4057qib7	15411	46	.	.	.
cord-005453-4057qib7	15412	1	There	there	EX
cord-005453-4057qib7	15412	2	was	be	VBD
cord-005453-4057qib7	15412	3	a	a	DT
cord-005453-4057qib7	15412	4	significantly	significantly	RB
cord-005453-4057qib7	15412	5	higher	high	JJR
cord-005453-4057qib7	15412	6	incidence	incidence	NN
cord-005453-4057qib7	15412	7	of	of	IN
cord-005453-4057qib7	15412	8	community	community	NN
cord-005453-4057qib7	15412	9	-	-	HYPH
cord-005453-4057qib7	15412	10	acquired	acquire	VBN
cord-005453-4057qib7	15412	11	infection	infection	NN
cord-005453-4057qib7	15412	12	from	from	IN
cord-005453-4057qib7	15412	13	6	6	CD
cord-005453-4057qib7	15412	14	months	month	NNS
cord-005453-4057qib7	15412	15	after	after	IN
cord-005453-4057qib7	15412	16	SCT	SCT	NNP
cord-005453-4057qib7	15412	17	.	.	.
cord-005453-4057qib7	15413	1	There	there	EX
cord-005453-4057qib7	15413	2	were	be	VBD
cord-005453-4057qib7	15413	3	significant	significant	JJ
cord-005453-4057qib7	15413	4	differences	difference	NNS
cord-005453-4057qib7	15413	5	in	in	IN
cord-005453-4057qib7	15413	6	the	the	DT
cord-005453-4057qib7	15413	7	incidence	incidence	NN
cord-005453-4057qib7	15413	8	of	of	IN
cord-005453-4057qib7	15413	9	community	community	NN
cord-005453-4057qib7	15413	10	-	-	HYPH
cord-005453-4057qib7	15413	11	acquired	acquire	VBN
cord-005453-4057qib7	15413	12	infections	infection	NNS
cord-005453-4057qib7	15413	13	between	between	IN
cord-005453-4057qib7	15413	14	patients	patient	NNS
cord-005453-4057qib7	15413	15	with	with	IN
cord-005453-4057qib7	15413	16	CD4-positive	cd4-positive	JJ
cord-005453-4057qib7	15413	17	cell	cell	NN
cord-005453-4057qib7	15413	18	counts	count	NNS
cord-005453-4057qib7	15413	19	of	of	IN
cord-005453-4057qib7	15413	20	<	<	NNP
cord-005453-4057qib7	15413	21	500	500	CD
cord-005453-4057qib7	15413	22	/	/	SYM
cord-005453-4057qib7	15413	23	ml	ml	NN
cord-005453-4057qib7	15413	24	and	and	CC
cord-005453-4057qib7	15413	25	Background	Background	NNP
cord-005453-4057qib7	15413	26	:	:	:
cord-005453-4057qib7	15413	27	Allogeneic	allogeneic	NN
cord-005453-4057qib7	15413	28	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15413	29	cell	cell	NN
cord-005453-4057qib7	15413	30	transplantation	transplantation	NN
cord-005453-4057qib7	15413	31	(	(	-LRB-
cord-005453-4057qib7	15413	32	allo	allo	NN
cord-005453-4057qib7	15413	33	-	-	HYPH
cord-005453-4057qib7	15413	34	HCT	HCT	NNP
cord-005453-4057qib7	15413	35	)	)	-RRB-
cord-005453-4057qib7	15413	36	has	have	VBZ
cord-005453-4057qib7	15413	37	the	the	DT
cord-005453-4057qib7	15413	38	potential	potential	NN
cord-005453-4057qib7	15413	39	to	to	TO
cord-005453-4057qib7	15413	40	cure	cure	VB
cord-005453-4057qib7	15413	41	subgroups	subgroup	NNS
cord-005453-4057qib7	15413	42	of	of	IN
cord-005453-4057qib7	15413	43	patients	patient	NNS
cord-005453-4057qib7	15413	44	with	with	IN
cord-005453-4057qib7	15413	45	multiple	multiple	JJ
cord-005453-4057qib7	15413	46	myeloma	myeloma	NN
cord-005453-4057qib7	15413	47	(	(	-LRB-
cord-005453-4057qib7	15413	48	MM	MM	NNP
cord-005453-4057qib7	15413	49	)	)	-RRB-
cord-005453-4057qib7	15413	50	but	but	CC
cord-005453-4057qib7	15413	51	its	-PRON-	PRP$
cord-005453-4057qib7	15413	52	role	role	NN
cord-005453-4057qib7	15413	53	is	be	VBZ
cord-005453-4057qib7	15413	54	controversial	controversial	JJ
cord-005453-4057qib7	15413	55	due	due	IN
cord-005453-4057qib7	15413	56	to	to	IN
cord-005453-4057qib7	15413	57	high	high	JJ
cord-005453-4057qib7	15413	58	transplant	transplant	NN
cord-005453-4057qib7	15413	59	-	-	HYPH
cord-005453-4057qib7	15413	60	related	relate	VBN
cord-005453-4057qib7	15413	61	mortality	mortality	NN
cord-005453-4057qib7	15413	62	.	.	.
cord-005453-4057qib7	15414	1	While	while	IN
cord-005453-4057qib7	15414	2	autologous	autologous	JJ
cord-005453-4057qib7	15414	3	HCT	hct	NN
cord-005453-4057qib7	15414	4	is	be	VBZ
cord-005453-4057qib7	15414	5	well	well	RB
cord-005453-4057qib7	15414	6	established	establish	VBN
cord-005453-4057qib7	15414	7	as	as	IN
cord-005453-4057qib7	15414	8	consolidation	consolidation	NN
cord-005453-4057qib7	15414	9	after	after	IN
cord-005453-4057qib7	15414	10	induction	induction	NN
cord-005453-4057qib7	15414	11	therapy	therapy	NN
cord-005453-4057qib7	15414	12	using	use	VBG
cord-005453-4057qib7	15414	13	novel	novel	JJ
cord-005453-4057qib7	15414	14	agents	agent	NNS
cord-005453-4057qib7	15414	15	,	,	,
cord-005453-4057qib7	15414	16	allo	allo	NN
cord-005453-4057qib7	15414	17	-	-	HYPH
cord-005453-4057qib7	15414	18	HCT	HCT	NNP
cord-005453-4057qib7	15414	19	is	be	VBZ
cord-005453-4057qib7	15414	20	still	still	RB
cord-005453-4057qib7	15414	21	considered	consider	VBN
cord-005453-4057qib7	15414	22	experimental	experimental	JJ
cord-005453-4057qib7	15414	23	due	due	IN
cord-005453-4057qib7	15414	24	to	to	IN
cord-005453-4057qib7	15414	25	excessive	excessive	JJ
cord-005453-4057qib7	15414	26	early	early	JJ
cord-005453-4057qib7	15414	27	toxicity	toxicity	NN
cord-005453-4057qib7	15414	28	.	.	.
cord-005453-4057qib7	15415	1	Methods	method	NNS
cord-005453-4057qib7	15415	2	:	:	:
cord-005453-4057qib7	15415	3	We	-PRON-	PRP
cord-005453-4057qib7	15415	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	15415	5	studied	study	VBD
cord-005453-4057qib7	15415	6	45	45	CD
cord-005453-4057qib7	15415	7	MM	MM	NNP
cord-005453-4057qib7	15415	8	patients	patient	NNS
cord-005453-4057qib7	15415	9	(	(	-LRB-
cord-005453-4057qib7	15415	10	pts	pts	NNP
cord-005453-4057qib7	15415	11	)	)	-RRB-
cord-005453-4057qib7	15415	12	;	;	.
cord-005453-4057qib7	15416	1	25	25	CD
cord-005453-4057qib7	15416	2	(	(	-LRB-
cord-005453-4057qib7	15416	3	55,6	55,6	CD
cord-005453-4057qib7	15416	4	%	%	NN
cord-005453-4057qib7	15416	5	)	)	-RRB-
cord-005453-4057qib7	15416	6	were	be	VBD
cord-005453-4057qib7	15416	7	males	male	NNS
cord-005453-4057qib7	15416	8	with	with	IN
cord-005453-4057qib7	15416	9	a	a	DT
cord-005453-4057qib7	15416	10	median	median	JJ
cord-005453-4057qib7	15416	11	age	age	NN
cord-005453-4057qib7	15416	12	of	of	IN
cord-005453-4057qib7	15416	13	52	52	CD
cord-005453-4057qib7	15416	14	years	year	NNS
cord-005453-4057qib7	15417	1	(	(	-LRB-
cord-005453-4057qib7	15417	2	range	range	NN
cord-005453-4057qib7	15417	3	:	:	:
cord-005453-4057qib7	15417	4	32	32	CD
cord-005453-4057qib7	15417	5	-	-	SYM
cord-005453-4057qib7	15417	6	60	60	CD
cord-005453-4057qib7	15417	7	)	)	-RRB-
cord-005453-4057qib7	15417	8	,	,	,
cord-005453-4057qib7	15417	9	who	who	WP
cord-005453-4057qib7	15417	10	underwent	undergo	VBD
cord-005453-4057qib7	15417	11	allo	allo	NN
cord-005453-4057qib7	15417	12	-	-	HYPH
cord-005453-4057qib7	15417	13	HSCT	HSCT	NNP
cord-005453-4057qib7	15417	14	in	in	IN
cord-005453-4057qib7	15417	15	our	-PRON-	PRP$
cord-005453-4057qib7	15417	16	center	center	NN
cord-005453-4057qib7	15417	17	between	between	IN
cord-005453-4057qib7	15417	18	2007	2007	CD
cord-005453-4057qib7	15417	19	and	and	CC
cord-005453-4057qib7	15417	20	2018.Median	2018.median	CD
cord-005453-4057qib7	15417	21	time	time	NN
cord-005453-4057qib7	15417	22	between	between	IN
cord-005453-4057qib7	15417	23	diagnosis	diagnosis	NN
cord-005453-4057qib7	15417	24	and	and	CC
cord-005453-4057qib7	15417	25	allo	allo	NN
cord-005453-4057qib7	15417	26	-	-	HYPH
cord-005453-4057qib7	15417	27	HCT	HCT	NNP
cord-005453-4057qib7	15417	28	was	be	VBD
cord-005453-4057qib7	15417	29	40	40	CD
cord-005453-4057qib7	15417	30	months	month	NNS
cord-005453-4057qib7	15418	1	(	(	-LRB-
cord-005453-4057qib7	15418	2	range	range	NN
cord-005453-4057qib7	15418	3	:	:	:
cord-005453-4057qib7	15418	4	20	20	CD
cord-005453-4057qib7	15418	5	-	-	SYM
cord-005453-4057qib7	15418	6	143).Results	143).results	CD
cord-005453-4057qib7	15418	7	:	:	:
cord-005453-4057qib7	15419	1	The	the	DT
cord-005453-4057qib7	15419	2	International	International	NNP
cord-005453-4057qib7	15419	3	Staging	Staging	NNP
cord-005453-4057qib7	15419	4	System	System	NNP
cord-005453-4057qib7	15419	5	(	(	-LRB-
cord-005453-4057qib7	15419	6	ISS	ISS	NNP
cord-005453-4057qib7	15419	7	)	)	-RRB-
cord-005453-4057qib7	15419	8	was	be	VBD
cord-005453-4057qib7	15419	9	ISS	ISS	NNP
cord-005453-4057qib7	15420	1	I	-PRON-	PRP
cord-005453-4057qib7	15420	2	(	(	-LRB-
cord-005453-4057qib7	15420	3	33,3	33,3	CD
cord-005453-4057qib7	15420	4	%	%	NN
cord-005453-4057qib7	15420	5	)	)	-RRB-
cord-005453-4057qib7	15420	6	,	,	,
cord-005453-4057qib7	15420	7	ISS	ISS	NNP
cord-005453-4057qib7	15420	8	II	II	NNP
cord-005453-4057qib7	15420	9	(	(	-LRB-
cord-005453-4057qib7	15420	10	28,9	28,9	CD
cord-005453-4057qib7	15420	11	%	%	NN
cord-005453-4057qib7	15420	12	)	)	-RRB-
cord-005453-4057qib7	15420	13	,	,	,
cord-005453-4057qib7	15420	14	and	and	CC
cord-005453-4057qib7	15420	15	ISS	ISS	NNP
cord-005453-4057qib7	15420	16	III	III	NNP
cord-005453-4057qib7	15420	17	(	(	-LRB-
cord-005453-4057qib7	15420	18	37,8	37,8	CD
cord-005453-4057qib7	15420	19	%	%	NN
cord-005453-4057qib7	15420	20	)	)	-RRB-
cord-005453-4057qib7	15420	21	.	.	.
cord-005453-4057qib7	15421	1	Twentyeight	twentyeight	JJ
cord-005453-4057qib7	15421	2	(	(	-LRB-
cord-005453-4057qib7	15421	3	62,2	62,2	CD
cord-005453-4057qib7	15421	4	%	%	NN
cord-005453-4057qib7	15421	5	)	)	-RRB-
cord-005453-4057qib7	15421	6	pts	pt	NNS
cord-005453-4057qib7	15421	7	received	receive	VBD
cord-005453-4057qib7	15421	8	cells	cell	NNS
cord-005453-4057qib7	15421	9	from	from	IN
cord-005453-4057qib7	15421	10	unrelated	unrelated	JJ
cord-005453-4057qib7	15421	11	donor	donor	NN
cord-005453-4057qib7	15421	12	and	and	CC
cord-005453-4057qib7	15421	13	17	17	CD
cord-005453-4057qib7	15421	14	pts	pt	NNS
cord-005453-4057qib7	15421	15	from	from	IN
cord-005453-4057qib7	15421	16	identical	identical	JJ
cord-005453-4057qib7	15421	17	siblings	sibling	NNS
cord-005453-4057qib7	15421	18	.	.	.
cord-005453-4057qib7	15422	1	Stem	stem	JJ
cord-005453-4057qib7	15422	2	cell	cell	NN
cord-005453-4057qib7	15422	3	source	source	NN
cord-005453-4057qib7	15422	4	were	be	VBD
cord-005453-4057qib7	15422	5	:	:	:
cord-005453-4057qib7	15422	6	peripheral	peripheral	JJ
cord-005453-4057qib7	15422	7	blood	blood	NN
cord-005453-4057qib7	15422	8	(	(	-LRB-
cord-005453-4057qib7	15422	9	n=25	n=25	NNP
cord-005453-4057qib7	15422	10	)	)	-RRB-
cord-005453-4057qib7	15422	11	and	and	CC
cord-005453-4057qib7	15422	12	bone	bone	NN
cord-005453-4057qib7	15422	13	marrow	marrow	NN
cord-005453-4057qib7	15422	14	(	(	-LRB-
cord-005453-4057qib7	15422	15	n=20	n=20	NNP
cord-005453-4057qib7	15422	16	)	)	-RRB-
cord-005453-4057qib7	15422	17	.	.	.
cord-005453-4057qib7	15423	1	Grouprisk	grouprisk	NN
cord-005453-4057qib7	15423	2	distribution	distribution	NN
cord-005453-4057qib7	15423	3	using	use	VBG
cord-005453-4057qib7	15423	4	HCT	HCT	NNP
cord-005453-4057qib7	15423	5	-	-	HYPH
cord-005453-4057qib7	15423	6	CI	CI	NNP
cord-005453-4057qib7	15423	7	and	and	CC
cord-005453-4057qib7	15423	8	PAM	PAM	NNP
cord-005453-4057qib7	15423	9	index	index	NN
cord-005453-4057qib7	15423	10	can	can	MD
cord-005453-4057qib7	15423	11	be	be	VB
cord-005453-4057qib7	15423	12	seen	see	VBN
cord-005453-4057qib7	15423	13	in	in	IN
cord-005453-4057qib7	15423	14	figure	figure	NN
cord-005453-4057qib7	15423	15	1	1	CD
cord-005453-4057qib7	15423	16	.	.	.
cord-005453-4057qib7	15424	1	Response	response	NN
cord-005453-4057qib7	15424	2	was	be	VBD
cord-005453-4057qib7	15424	3	evaluated	evaluate	VBN
cord-005453-4057qib7	15424	4	at	at	IN
cord-005453-4057qib7	15424	5	day	day	NN
cord-005453-4057qib7	15424	6	+100	+100	NNS
cord-005453-4057qib7	15424	7	:	:	:
cord-005453-4057qib7	15424	8	CR	CR	NNP
cord-005453-4057qib7	15424	9	(	(	-LRB-
cord-005453-4057qib7	15424	10	53,3	53,3	CD
cord-005453-4057qib7	15424	11	%	%	NN
cord-005453-4057qib7	15424	12	)	)	-RRB-
cord-005453-4057qib7	15424	13	,	,	,
cord-005453-4057qib7	15424	14	VGPR	VGPR	NNP
cord-005453-4057qib7	15424	15	(	(	-LRB-
cord-005453-4057qib7	15424	16	11,1	11,1	CD
cord-005453-4057qib7	15424	17	%	%	NN
cord-005453-4057qib7	15424	18	)	)	-RRB-
cord-005453-4057qib7	15424	19	,	,	,
cord-005453-4057qib7	15424	20	PR	PR	NNP
cord-005453-4057qib7	15424	21	(	(	-LRB-
cord-005453-4057qib7	15424	22	22,2	22,2	CD
cord-005453-4057qib7	15424	23	%	%	NN
cord-005453-4057qib7	15424	24	)	)	-RRB-
cord-005453-4057qib7	15424	25	and	and	CC
cord-005453-4057qib7	15424	26	SD	sd	NN
cord-005453-4057qib7	15424	27	(	(	-LRB-
cord-005453-4057qib7	15424	28	2,2	2,2	CD
cord-005453-4057qib7	15424	29	%	%	NN
cord-005453-4057qib7	15424	30	)	)	-RRB-
cord-005453-4057qib7	15424	31	;	;	:
cord-005453-4057qib7	15424	32	response	response	NN
cord-005453-4057qib7	15424	33	was	be	VBD
cord-005453-4057qib7	15424	34	not	not	RB
cord-005453-4057qib7	15424	35	evaluated	evaluate	VBN
cord-005453-4057qib7	15424	36	in	in	IN
cord-005453-4057qib7	15424	37	5	5	CD
cord-005453-4057qib7	15424	38	pts	pt	NNS
cord-005453-4057qib7	15424	39	.	.	.
cord-005453-4057qib7	15425	1	Regarding	regard	VBG
cord-005453-4057qib7	15425	2	hospitalization	hospitalization	NN
cord-005453-4057qib7	15425	3	,	,	,
cord-005453-4057qib7	15425	4	11	11	CD
cord-005453-4057qib7	15425	5	(	(	-LRB-
cord-005453-4057qib7	15425	6	24,4	24,4	CD
cord-005453-4057qib7	15425	7	%	%	NN
cord-005453-4057qib7	15425	8	)	)	-RRB-
cord-005453-4057qib7	15425	9	pts	pts	NN
cord-005453-4057qib7	15425	10	and	and	CC
cord-005453-4057qib7	15425	11	22	22	CD
cord-005453-4057qib7	15425	12	(	(	-LRB-
cord-005453-4057qib7	15425	13	48,9	48,9	CD
cord-005453-4057qib7	15425	14	%	%	NN
cord-005453-4057qib7	15425	15	)	)	-RRB-
cord-005453-4057qib7	15425	16	pts	pt	NNS
cord-005453-4057qib7	15425	17	needed	need	VBN
cord-005453-4057qib7	15425	18	readmission	readmission	NN
cord-005453-4057qib7	15425	19	in	in	IN
cord-005453-4057qib7	15425	20	the	the	DT
cord-005453-4057qib7	15425	21	first	first	JJ
cord-005453-4057qib7	15425	22	100	100	CD
cord-005453-4057qib7	15425	23	days	day	NNS
cord-005453-4057qib7	15425	24	and	and	CC
cord-005453-4057qib7	15425	25	365	365	CD
cord-005453-4057qib7	15425	26	days	day	NNS
cord-005453-4057qib7	15425	27	post	post	NN
cord-005453-4057qib7	15425	28	-	-	JJ
cord-005453-4057qib7	15425	29	alloHCT	allohct	JJ
cord-005453-4057qib7	15425	30	,	,	,
cord-005453-4057qib7	15425	31	respectively	respectively	RB
cord-005453-4057qib7	15425	32	,	,	,
cord-005453-4057qib7	15425	33	and	and	CC
cord-005453-4057qib7	15425	34	median	median	JJ
cord-005453-4057qib7	15425	35	days	day	NNS
cord-005453-4057qib7	15425	36	of	of	IN
cord-005453-4057qib7	15425	37	hospitalization	hospitalization	NN
cord-005453-4057qib7	15425	38	was	be	VBD
cord-005453-4057qib7	15425	39	27	27	CD
cord-005453-4057qib7	15425	40	days	day	NNS
cord-005453-4057qib7	15426	1	(	(	-LRB-
cord-005453-4057qib7	15426	2	range	range	NN
cord-005453-4057qib7	15426	3	:	:	:
cord-005453-4057qib7	15426	4	4	4	CD
cord-005453-4057qib7	15426	5	-	-	SYM
cord-005453-4057qib7	15426	6	92	92	CD
cord-005453-4057qib7	15426	7	)	)	-RRB-
cord-005453-4057qib7	15426	8	.	.	.
cord-005453-4057qib7	15427	1	Reasons	reason	NNS
cord-005453-4057qib7	15427	2	for	for	IN
cord-005453-4057qib7	15427	3	first	first	JJ
cord-005453-4057qib7	15427	4	re	re	NN
cord-005453-4057qib7	15427	5	-	-	NN
cord-005453-4057qib7	15427	6	admission	admission	NN
cord-005453-4057qib7	15427	7	were	be	VBD
cord-005453-4057qib7	15427	8	:	:	:
cord-005453-4057qib7	15427	9	infection	infection	NN
cord-005453-4057qib7	15427	10	(	(	-LRB-
cord-005453-4057qib7	15427	11	68,2	68,2	CD
cord-005453-4057qib7	15427	12	%	%	NN
cord-005453-4057qib7	15427	13	)	)	-RRB-
cord-005453-4057qib7	15427	14	,	,	,
cord-005453-4057qib7	15427	15	GvHD	GvHD	NNP
cord-005453-4057qib7	15427	16	(	(	-LRB-
cord-005453-4057qib7	15427	17	27,3	27,3	CD
cord-005453-4057qib7	15427	18	%	%	NN
cord-005453-4057qib7	15427	19	)	)	-RRB-
cord-005453-4057qib7	15427	20	and	and	CC
cord-005453-4057qib7	15427	21	renal	renal	JJ
cord-005453-4057qib7	15427	22	insufficiency	insufficiency	NN
cord-005453-4057qib7	15427	23	(	(	-LRB-
cord-005453-4057qib7	15427	24	4,5	4,5	CD
cord-005453-4057qib7	15427	25	%	%	NN
cord-005453-4057qib7	15427	26	)	)	-RRB-
cord-005453-4057qib7	15427	27	.	.	.
cord-005453-4057qib7	15428	1	Twenty	twenty	CD
cord-005453-4057qib7	15428	2	-	-	HYPH
cord-005453-4057qib7	15428	3	seven	seven	CD
cord-005453-4057qib7	15428	4	(	(	-LRB-
cord-005453-4057qib7	15428	5	60	60	CD
cord-005453-4057qib7	15428	6	%	%	NN
cord-005453-4057qib7	15428	7	)	)	-RRB-
cord-005453-4057qib7	15428	8	died	die	VBD
cord-005453-4057qib7	15428	9	and	and	CC
cord-005453-4057qib7	15428	10	death	death	NN
cord-005453-4057qib7	15428	11	causes	cause	NNS
cord-005453-4057qib7	15428	12	were	be	VBD
cord-005453-4057qib7	15428	13	:	:	:
cord-005453-4057qib7	15428	14	infection	infection	NN
cord-005453-4057qib7	15428	15	(	(	-LRB-
cord-005453-4057qib7	15428	16	35,6	35,6	CD
cord-005453-4057qib7	15428	17	%	%	NN
cord-005453-4057qib7	15428	18	)	)	-RRB-
cord-005453-4057qib7	15428	19	,	,	,
cord-005453-4057qib7	15428	20	progression	progression	NN
cord-005453-4057qib7	15428	21	(	(	-LRB-
cord-005453-4057qib7	15428	22	15,6	15,6	CD
cord-005453-4057qib7	15428	23	%	%	NN
cord-005453-4057qib7	15428	24	)	)	-RRB-
cord-005453-4057qib7	15428	25	,	,	,
cord-005453-4057qib7	15428	26	secondary	secondary	JJ
cord-005453-4057qib7	15428	27	tumor	tumor	NN
cord-005453-4057qib7	15428	28	(	(	-LRB-
cord-005453-4057qib7	15428	29	4,4	4,4	CD
cord-005453-4057qib7	15428	30	%	%	NN
cord-005453-4057qib7	15428	31	)	)	-RRB-
cord-005453-4057qib7	15428	32	and	and	CC
cord-005453-4057qib7	15428	33	the	the	DT
cord-005453-4057qib7	15428	34	remainder	remainder	NN
cord-005453-4057qib7	15428	35	,	,	,
cord-005453-4057qib7	15428	36	GvHD	gvhd	NN
cord-005453-4057qib7	15428	37	and	and	CC
cord-005453-4057qib7	15428	38	intracranial	intracranial	JJ
cord-005453-4057qib7	15428	39	hemorrhage	hemorrhage	NN
cord-005453-4057qib7	15428	40	.	.	.
cord-005453-4057qib7	15429	1	In	in	IN
cord-005453-4057qib7	15429	2	addition	addition	NN
cord-005453-4057qib7	15429	3	,	,	,
cord-005453-4057qib7	15429	4	26	26	CD
cord-005453-4057qib7	15429	5	pts	pt	NNS
cord-005453-4057qib7	15429	6	(	(	-LRB-
cord-005453-4057qib7	15429	7	57,8	57,8	CD
cord-005453-4057qib7	15429	8	%	%	NN
cord-005453-4057qib7	15429	9	)	)	-RRB-
cord-005453-4057qib7	15429	10	suffered	suffer	VBN
cord-005453-4057qib7	15429	11	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	15429	12	(	(	-LRB-
cord-005453-4057qib7	15429	13	CMV	CMV	NNP
cord-005453-4057qib7	15429	14	)	)	-RRB-
cord-005453-4057qib7	15429	15	reactivation	reactivation	NN
cord-005453-4057qib7	15429	16	.	.	.
cord-005453-4057qib7	15430	1	Median	median	JJ
cord-005453-4057qib7	15430	2	overall	overall	JJ
cord-005453-4057qib7	15430	3	survival	survival	NN
cord-005453-4057qib7	15430	4	(	(	-LRB-
cord-005453-4057qib7	15430	5	OS	OS	NNP
cord-005453-4057qib7	15430	6	)	)	-RRB-
cord-005453-4057qib7	15430	7	was	be	VBD
cord-005453-4057qib7	15430	8	44	44	CD
cord-005453-4057qib7	15430	9	months	month	NNS
cord-005453-4057qib7	15431	1	(	(	-LRB-
cord-005453-4057qib7	15431	2	range	range	NN
cord-005453-4057qib7	15431	3	:	:	:
cord-005453-4057qib7	15431	4	11	11	CD
cord-005453-4057qib7	15431	5	-	-	SYM
cord-005453-4057qib7	15431	6	76	76	CD
cord-005453-4057qib7	15431	7	)	)	-RRB-
cord-005453-4057qib7	15431	8	.	.	.
cord-005453-4057qib7	15432	1	Univariate	Univariate	NNP
cord-005453-4057qib7	15432	2	analysis	analysis	NN
cord-005453-4057qib7	15432	3	showed	show	VBD
cord-005453-4057qib7	15432	4	that	that	IN
cord-005453-4057qib7	15432	5	re	re	NN
cord-005453-4057qib7	15432	6	-	-	NN
cord-005453-4057qib7	15432	7	admission	admission	NN
cord-005453-4057qib7	15432	8	in	in	IN
cord-005453-4057qib7	15432	9	first	first	JJ
cord-005453-4057qib7	15432	10	100	100	CD
cord-005453-4057qib7	15432	11	days	day	NNS
cord-005453-4057qib7	15432	12	(	(	-LRB-
cord-005453-4057qib7	15432	13	HR	HR	NNP
cord-005453-4057qib7	15432	14	4	4	CD
cord-005453-4057qib7	15432	15	,	,	,
cord-005453-4057qib7	15432	16	19	19	CD
cord-005453-4057qib7	15432	17	;	;	:
cord-005453-4057qib7	15432	18	p=0	p=0	NNP
cord-005453-4057qib7	15432	19	,	,	,
cord-005453-4057qib7	15432	20	001	001	CD
cord-005453-4057qib7	15432	21	)	)	-RRB-
cord-005453-4057qib7	15432	22	,	,	,
cord-005453-4057qib7	15432	23	re	re	NN
cord-005453-4057qib7	15432	24	-	-	NN
cord-005453-4057qib7	15432	25	admission	admission	NN
cord-005453-4057qib7	15432	26	in	in	IN
cord-005453-4057qib7	15432	27	first	first	JJ
cord-005453-4057qib7	15432	28	365	365	CD
cord-005453-4057qib7	15432	29	days	day	NNS
cord-005453-4057qib7	15432	30	(	(	-LRB-
cord-005453-4057qib7	15432	31	HR	HR	NNP
cord-005453-4057qib7	15432	32	3	3	CD
cord-005453-4057qib7	15432	33	,	,	,
cord-005453-4057qib7	15432	34	6	6	CD
cord-005453-4057qib7	15432	35	;	;	:
cord-005453-4057qib7	15432	36	p=0	p=0	NNP
cord-005453-4057qib7	15432	37	,	,	,
cord-005453-4057qib7	15432	38	001	001	CD
cord-005453-4057qib7	15432	39	)	)	-RRB-
cord-005453-4057qib7	15432	40	,	,	,
cord-005453-4057qib7	15432	41	CMV	CMV	NNP
cord-005453-4057qib7	15432	42	reactivation	reactivation	NN
cord-005453-4057qib7	15432	43	(	(	-LRB-
cord-005453-4057qib7	15432	44	HR	HR	NNP
cord-005453-4057qib7	15432	45	2,38	2,38	CD
cord-005453-4057qib7	15432	46	;	;	:
cord-005453-4057qib7	15432	47	p=0,038	p=0,038	NNP
cord-005453-4057qib7	15432	48	)	)	-RRB-
cord-005453-4057qib7	15432	49	,	,	,
cord-005453-4057qib7	15432	50	ISS	ISS	NNP
cord-005453-4057qib7	15432	51	(	(	-LRB-
cord-005453-4057qib7	15432	52	ISS	ISS	NNP
cord-005453-4057qib7	15432	53	-	-	HYPH
cord-005453-4057qib7	15432	54	I	I	NNP
cord-005453-4057qib7	15432	55	vs	vs	IN
cord-005453-4057qib7	15432	56	ISS	ISS	NNP
cord-005453-4057qib7	15432	57	-	-	HYPH
cord-005453-4057qib7	15432	58	II	II	NNP
cord-005453-4057qib7	15432	59	and	and	CC
cord-005453-4057qib7	15432	60	III	III	NNP
cord-005453-4057qib7	15432	61	;	;	:
cord-005453-4057qib7	15432	62	HR	HR	NNP
cord-005453-4057qib7	15432	63	0,347	0,347	CD
cord-005453-4057qib7	15432	64	;	;	:
cord-005453-4057qib7	15432	65	p=0,033	p=0,033	NNP
cord-005453-4057qib7	15432	66	)	)	-RRB-
cord-005453-4057qib7	15432	67	,	,	,
cord-005453-4057qib7	15432	68	days	day	NNS
cord-005453-4057qib7	15432	69	of	of	IN
cord-005453-4057qib7	15432	70	hospitalization	hospitalization	NN
cord-005453-4057qib7	15432	71	in	in	IN
cord-005453-4057qib7	15432	72	the	the	DT
cord-005453-4057qib7	15432	73	first	first	JJ
cord-005453-4057qib7	15432	74	100	100	CD
cord-005453-4057qib7	15432	75	days	day	NNS
cord-005453-4057qib7	15432	76	and	and	CC
cord-005453-4057qib7	15432	77	response	response	NN
cord-005453-4057qib7	15432	78	at	at	IN
cord-005453-4057qib7	15432	79	+100	+100	NNP
cord-005453-4057qib7	15432	80	day	day	NN
cord-005453-4057qib7	15432	81	(	(	-LRB-
cord-005453-4057qib7	15432	82	CR	CR	NNP
cord-005453-4057qib7	15432	83	plus	plus	CC
cord-005453-4057qib7	15432	84	VGPR	VGPR	NNP
cord-005453-4057qib7	15432	85	vs	vs	IN
cord-005453-4057qib7	15432	86	the	the	DT
cord-005453-4057qib7	15432	87	remainder	remainder	NN
cord-005453-4057qib7	15432	88	;	;	:
cord-005453-4057qib7	15432	89	HR	HR	NNP
cord-005453-4057qib7	15432	90	0,143	0,143	CD
cord-005453-4057qib7	15432	91	;	;	:
cord-005453-4057qib7	15432	92	p=0,04	p=0,04	NNP
cord-005453-4057qib7	15432	93	)	)	-RRB-
cord-005453-4057qib7	15432	94	were	be	VBD
cord-005453-4057qib7	15432	95	predictor	predictor	NN
cord-005453-4057qib7	15432	96	factors	factor	NNS
cord-005453-4057qib7	15432	97	for	for	IN
cord-005453-4057qib7	15432	98	OS	OS	NNP
cord-005453-4057qib7	15432	99	.	.	.
cord-005453-4057qib7	15433	1	Other	other	JJ
cord-005453-4057qib7	15433	2	factors	factor	NNS
cord-005453-4057qib7	15433	3	like	like	IN
cord-005453-4057qib7	15433	4	karyotype	karyotype	NN
cord-005453-4057qib7	15433	5	,	,	,
cord-005453-4057qib7	15433	6	response	response	NN
cord-005453-4057qib7	15433	7	before	before	IN
cord-005453-4057qib7	15433	8	allo	allo	NN
cord-005453-4057qib7	15433	9	-	-	HYPH
cord-005453-4057qib7	15433	10	HCT	HCT	NNP
cord-005453-4057qib7	15433	11	,	,	,
cord-005453-4057qib7	15433	12	HLA	HLA	NNP
cord-005453-4057qib7	15433	13	-	-	HYPH
cord-005453-4057qib7	15433	14	mismatch	mismatch	NN
cord-005453-4057qib7	15433	15	or	or	CC
cord-005453-4057qib7	15433	16	baseline	baseline	JJ
cord-005453-4057qib7	15433	17	CMV	CMV	NNP
cord-005453-4057qib7	15433	18	serostatus	serostatus	NN
cord-005453-4057qib7	15433	19	,	,	,
cord-005453-4057qib7	15433	20	among	among	IN
cord-005453-4057qib7	15433	21	others	other	NNS
cord-005453-4057qib7	15433	22	,	,	,
cord-005453-4057qib7	15433	23	do	do	VBP
cord-005453-4057qib7	15433	24	not	not	RB
cord-005453-4057qib7	15433	25	impact	impact	VB
cord-005453-4057qib7	15433	26	on	on	IN
cord-005453-4057qib7	15433	27	OS.Median	os.median	JJ
cord-005453-4057qib7	15433	28	OS	OS	NNP
cord-005453-4057qib7	15433	29	in	in	IN
cord-005453-4057qib7	15433	30	pts	pts	NN
cord-005453-4057qib7	15433	31	with	with	IN
cord-005453-4057qib7	15433	32	low	low	JJ
cord-005453-4057qib7	15433	33	HCT	HCT	NNP
cord-005453-4057qib7	15433	34	-	-	HYPH
cord-005453-4057qib7	15433	35	CI	CI	NNP
cord-005453-4057qib7	15433	36	were	be	VBD
cord-005453-4057qib7	15433	37	56	56	CD
cord-005453-4057qib7	15433	38	months	month	NNS
cord-005453-4057qib7	15434	1	(	(	-LRB-
cord-005453-4057qib7	15434	2	range	range	NN
cord-005453-4057qib7	15434	3	:	:	:
cord-005453-4057qib7	15434	4	0	0	CD
cord-005453-4057qib7	15434	5	-	-	SYM
cord-005453-4057qib7	15434	6	156	156	CD
cord-005453-4057qib7	15434	7	)	)	-RRB-
cord-005453-4057qib7	15434	8	vs	vs	IN
cord-005453-4057qib7	15434	9	6	6	CD
cord-005453-4057qib7	15434	10	months	month	NNS
cord-005453-4057qib7	15434	11	in	in	IN
cord-005453-4057qib7	15434	12	intermediate	intermediate	JJ
cord-005453-4057qib7	15434	13	-	-	HYPH
cord-005453-4057qib7	15434	14	high	high	JJ
cord-005453-4057qib7	15434	15	HCT	HCT	NNP
cord-005453-4057qib7	15434	16	-	-	HYPH
cord-005453-4057qib7	15434	17	CI	ci	NN
cord-005453-4057qib7	15434	18	Background	background	NN
cord-005453-4057qib7	15434	19	:	:	:
cord-005453-4057qib7	15435	1	Allo	Allo	NNP
cord-005453-4057qib7	15435	2	-	-	HYPH
cord-005453-4057qib7	15435	3	SCT	SCT	NNP
cord-005453-4057qib7	15435	4	is	be	VBZ
cord-005453-4057qib7	15435	5	a	a	DT
cord-005453-4057qib7	15435	6	potentially	potentially	RB
cord-005453-4057qib7	15435	7	curative	curative	JJ
cord-005453-4057qib7	15435	8	therapy	therapy	NN
cord-005453-4057qib7	15435	9	for	for	IN
cord-005453-4057qib7	15435	10	patients	patient	NNS
cord-005453-4057qib7	15435	11	with	with	IN
cord-005453-4057qib7	15435	12	multiple	multiple	JJ
cord-005453-4057qib7	15435	13	myeloma	myeloma	NN
cord-005453-4057qib7	15435	14	as	as	IN
cord-005453-4057qib7	15435	15	it	-PRON-	PRP
cord-005453-4057qib7	15435	16	provides	provide	VBZ
cord-005453-4057qib7	15435	17	a	a	DT
cord-005453-4057qib7	15435	18	graftversus	graftversus	NN
cord-005453-4057qib7	15435	19	-	-	HYPH
cord-005453-4057qib7	15435	20	myeloma	myeloma	NN
cord-005453-4057qib7	15435	21	effect	effect	NN
cord-005453-4057qib7	15435	22	and	and	CC
cord-005453-4057qib7	15435	23	a	a	DT
cord-005453-4057qib7	15435	24	myeloma	myeloma	NN
cord-005453-4057qib7	15435	25	-	-	HYPH
cord-005453-4057qib7	15435	26	free	free	JJ
cord-005453-4057qib7	15435	27	graft	graft	NN
cord-005453-4057qib7	15435	28	.	.	.
cord-005453-4057qib7	15436	1	Due	due	IN
cord-005453-4057qib7	15436	2	to	to	IN
cord-005453-4057qib7	15436	3	increased	increase	VBN
cord-005453-4057qib7	15436	4	NRM	NRM	NNP
cord-005453-4057qib7	15436	5	and	and	CC
cord-005453-4057qib7	15436	6	unclear	unclear	JJ
cord-005453-4057qib7	15436	7	OS	OS	NNP
cord-005453-4057qib7	15436	8	benefit	benefit	VBP
cord-005453-4057qib7	15436	9	the	the	DT
cord-005453-4057qib7	15436	10	recent	recent	JJ
cord-005453-4057qib7	15436	11	guidelines	guideline	NNS
cord-005453-4057qib7	15436	12	suggested	suggest	VBD
cord-005453-4057qib7	15436	13	allo	allo	NNP
cord-005453-4057qib7	15436	14	-	-	HYPH
cord-005453-4057qib7	15436	15	SCT	SCT	NNP
cord-005453-4057qib7	15436	16	to	to	TO
cord-005453-4057qib7	15436	17	be	be	VB
cord-005453-4057qib7	15436	18	used	use	VBN
cord-005453-4057qib7	15436	19	in	in	IN
cord-005453-4057qib7	15436	20	context	context	NN
cord-005453-4057qib7	15436	21	of	of	IN
cord-005453-4057qib7	15436	22	clinical	clinical	JJ
cord-005453-4057qib7	15436	23	trials	trial	NNS
cord-005453-4057qib7	15436	24	focusing	focus	VBG
cord-005453-4057qib7	15436	25	on	on	IN
cord-005453-4057qib7	15436	26	the	the	DT
cord-005453-4057qib7	15436	27	high	high	JJ
cord-005453-4057qib7	15436	28	-	-	HYPH
cord-005453-4057qib7	15436	29	risk	risk	NN
cord-005453-4057qib7	15436	30	patients	patient	NNS
cord-005453-4057qib7	15436	31	and	and	CC
cord-005453-4057qib7	15436	32	those	those	DT
cord-005453-4057qib7	15436	33	who	who	WP
cord-005453-4057qib7	15436	34	relapsed	relapse	VBD
cord-005453-4057qib7	15436	35	early	early	RB
cord-005453-4057qib7	15436	36	after	after	IN
cord-005453-4057qib7	15436	37	autograft	autograft	NN
cord-005453-4057qib7	15436	38	.	.	.
cord-005453-4057qib7	15437	1	Reduced	reduce	VBN
cord-005453-4057qib7	15437	2	-	-	HYPH
cord-005453-4057qib7	15437	3	intensity	intensity	NN
cord-005453-4057qib7	15437	4	conditioning	conditioning	NN
cord-005453-4057qib7	15437	5	regimens	regimen	NNS
cord-005453-4057qib7	15437	6	may	may	MD
cord-005453-4057qib7	15437	7	improve	improve	VB
cord-005453-4057qib7	15437	8	rate	rate	NN
cord-005453-4057qib7	15437	9	of	of	IN
cord-005453-4057qib7	15437	10	NRM	NRM	NNP
cord-005453-4057qib7	15437	11	;	;	:
cord-005453-4057qib7	15437	12	however	however	RB
cord-005453-4057qib7	15437	13	,	,	,
cord-005453-4057qib7	15437	14	optimal	optimal	JJ
cord-005453-4057qib7	15437	15	conditioning	conditioning	NN
cord-005453-4057qib7	15437	16	regimen	regimen	NN
cord-005453-4057qib7	15437	17	is	be	VBZ
cord-005453-4057qib7	15437	18	still	still	RB
cord-005453-4057qib7	15437	19	to	to	TO
cord-005453-4057qib7	15437	20	be	be	VB
cord-005453-4057qib7	15437	21	determined	determine	VBN
cord-005453-4057qib7	15437	22	.	.	.
cord-005453-4057qib7	15438	1	Here	here	RB
cord-005453-4057qib7	15438	2	we	-PRON-	PRP
cord-005453-4057qib7	15438	3	studied	study	VBD
cord-005453-4057qib7	15438	4	conditioning	conditioning	NN
cord-005453-4057qib7	15438	5	regimen	regimen	NN
cord-005453-4057qib7	15438	6	with	with	IN
cord-005453-4057qib7	15438	7	3	3	CD
cord-005453-4057qib7	15438	8	alkylating	alkylating	JJ
cord-005453-4057qib7	15438	9	agents	agent	NNS
cord-005453-4057qib7	15438	10	consisting	consist	VBG
cord-005453-4057qib7	15438	11	of	of	IN
cord-005453-4057qib7	15438	12	thiotepa	thiotepa	NNS
cord-005453-4057qib7	15438	13	(	(	-LRB-
cord-005453-4057qib7	15438	14	TT	TT	NNP
cord-005453-4057qib7	15438	15	)	)	-RRB-
cord-005453-4057qib7	15438	16	,	,	,
cord-005453-4057qib7	15438	17	busulfan	busulfan	FW
cord-005453-4057qib7	15438	18	(	(	-LRB-
cord-005453-4057qib7	15438	19	Bu	Bu	NNP
cord-005453-4057qib7	15438	20	)	)	-RRB-
cord-005453-4057qib7	15438	21	and	and	CC
cord-005453-4057qib7	15438	22	GvHD	GvHD	NNP
cord-005453-4057qib7	15438	23	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15438	24	with	with	IN
cord-005453-4057qib7	15438	25	post	post	JJ
cord-005453-4057qib7	15438	26	-	-	JJ
cord-005453-4057qib7	15438	27	transplant	transplant	NN
cord-005453-4057qib7	15438	28	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15438	29	(	(	-LRB-
cord-005453-4057qib7	15438	30	post	post	NNP
cord-005453-4057qib7	15438	31	-	-	JJ
cord-005453-4057qib7	15438	32	Cy	Cy	NNP
cord-005453-4057qib7	15438	33	)	)	-RRB-
cord-005453-4057qib7	15438	34	in	in	IN
cord-005453-4057qib7	15438	35	high	high	JJ
cord-005453-4057qib7	15438	36	risk	risk	NN
cord-005453-4057qib7	15438	37	myeloma	myeloma	NN
cord-005453-4057qib7	15438	38	patients	patient	NNS
cord-005453-4057qib7	15438	39	relapsing	relapse	VBG
cord-005453-4057qib7	15438	40	after	after	IN
cord-005453-4057qib7	15438	41	autograft	autograft	NN
cord-005453-4057qib7	15438	42	.	.	.
cord-005453-4057qib7	15439	1	Methods	method	NNS
cord-005453-4057qib7	15439	2	:	:	:
cord-005453-4057qib7	15440	1	A	a	DT
cord-005453-4057qib7	15440	2	total	total	NN
cord-005453-4057qib7	15440	3	of	of	IN
cord-005453-4057qib7	15440	4	40	40	CD
cord-005453-4057qib7	15440	5	patients	patient	NNS
cord-005453-4057qib7	15440	6	(	(	-LRB-
cord-005453-4057qib7	15440	7	m	m	NNP
cord-005453-4057qib7	15440	8	,	,	,
cord-005453-4057qib7	15440	9	n=23	n=23	IN
cord-005453-4057qib7	15440	10	)	)	-RRB-
cord-005453-4057qib7	15440	11	with	with	IN
cord-005453-4057qib7	15440	12	median	median	JJ
cord-005453-4057qib7	15440	13	age	age	NN
cord-005453-4057qib7	15440	14	of	of	IN
cord-005453-4057qib7	15440	15	55	55	CD
cord-005453-4057qib7	15440	16	years	year	NNS
cord-005453-4057qib7	15440	17	(	(	-LRB-
cord-005453-4057qib7	15440	18	range	range	VBP
cord-005453-4057qib7	15440	19	40	40	CD
cord-005453-4057qib7	15440	20	-	-	SYM
cord-005453-4057qib7	15440	21	67	67	CD
cord-005453-4057qib7	15440	22	)	)	-RRB-
cord-005453-4057qib7	15440	23	underwent	undergo	VBD
cord-005453-4057qib7	15440	24	an	an	DT
cord-005453-4057qib7	15440	25	allo	allo	NN
cord-005453-4057qib7	15440	26	-	-	HYPH
cord-005453-4057qib7	15440	27	SCT	sct	NN
cord-005453-4057qib7	15440	28	(	(	-LRB-
cord-005453-4057qib7	15440	29	MUD	mud	NN
cord-005453-4057qib7	15440	30	,	,	,
cord-005453-4057qib7	15440	31	n=19	n=19	JJ
cord-005453-4057qib7	15440	32	;	;	:
cord-005453-4057qib7	15440	33	MRD	MRD	NNP
cord-005453-4057qib7	15440	34	,	,	,
cord-005453-4057qib7	15440	35	n=12	n=12	VBN
cord-005453-4057qib7	15440	36	;	;	:
cord-005453-4057qib7	15440	37	MMUD	MMUD	NNP
cord-005453-4057qib7	15440	38	,	,	,
cord-005453-4057qib7	15440	39	n=6	n=6	JJ
cord-005453-4057qib7	15440	40	,	,	,
cord-005453-4057qib7	15440	41	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15440	42	,	,	,
cord-005453-4057qib7	15440	43	n=3	n=3	NN
cord-005453-4057qib7	15440	44	)	)	-RRB-
cord-005453-4057qib7	15440	45	during	during	IN
cord-005453-4057qib7	15440	46	a	a	DT
cord-005453-4057qib7	15440	47	period	period	NN
cord-005453-4057qib7	15440	48	from	from	IN
cord-005453-4057qib7	15440	49	2014	2014	CD
cord-005453-4057qib7	15440	50	to	to	IN
cord-005453-4057qib7	15440	51	2018	2018	CD
cord-005453-4057qib7	15440	52	in	in	IN
cord-005453-4057qib7	15440	53	University	University	NNP
cord-005453-4057qib7	15440	54	of	of	IN
cord-005453-4057qib7	15440	55	Hamburg	Hamburg	NNP
cord-005453-4057qib7	15440	56	.	.	.
cord-005453-4057qib7	15441	1	The	the	DT
cord-005453-4057qib7	15441	2	majority	majority	NN
cord-005453-4057qib7	15441	3	of	of	IN
cord-005453-4057qib7	15441	4	patients	patient	NNS
cord-005453-4057qib7	15441	5	had	have	VBD
cord-005453-4057qib7	15441	6	advanced	advanced	JJ
cord-005453-4057qib7	15441	7	disease	disease	NN
cord-005453-4057qib7	15441	8	(	(	-LRB-
cord-005453-4057qib7	15441	9	stage	stage	NN
cord-005453-4057qib7	15441	10	IIIAB	IIIAB	NNP
cord-005453-4057qib7	15441	11	,	,	,
cord-005453-4057qib7	15441	12	73	73	CD
cord-005453-4057qib7	15441	13	%	%	NN
cord-005453-4057qib7	15441	14	)	)	-RRB-
cord-005453-4057qib7	15441	15	and	and	CC
cord-005453-4057qib7	15441	16	high	high	JJ
cord-005453-4057qib7	15441	17	-	-	HYPH
cord-005453-4057qib7	15441	18	risk	risk	NN
cord-005453-4057qib7	15441	19	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	15441	20	(	(	-LRB-
cord-005453-4057qib7	15441	21	56	56	CD
cord-005453-4057qib7	15441	22	%	%	NN
cord-005453-4057qib7	15441	23	)	)	-RRB-
cord-005453-4057qib7	15441	24	.	.	.
cord-005453-4057qib7	15442	1	The	the	DT
cord-005453-4057qib7	15442	2	median	median	JJ
cord-005453-4057qib7	15442	3	response	response	NN
cord-005453-4057qib7	15442	4	durartion	durartion	NN
cord-005453-4057qib7	15442	5	after	after	IN
cord-005453-4057qib7	15442	6	autograft	autograft	NN
cord-005453-4057qib7	15442	7	was	be	VBD
cord-005453-4057qib7	15442	8	1.8	1.8	CD
cord-005453-4057qib7	15442	9	years	year	NNS
cord-005453-4057qib7	15443	1	(	(	-LRB-
cord-005453-4057qib7	15443	2	range	range	VBP
cord-005453-4057qib7	15443	3	0.5	0.5	CD
cord-005453-4057qib7	15443	4	-	-	SYM
cord-005453-4057qib7	15443	5	8	8	CD
cord-005453-4057qib7	15443	6	.	.	.
cord-005453-4057qib7	15443	7	3	3	CD
cord-005453-4057qib7	15443	8	)	)	-RRB-
cord-005453-4057qib7	15443	9	.	.	.
cord-005453-4057qib7	15444	1	The	the	DT
cord-005453-4057qib7	15444	2	conditioning	conditioning	NN
cord-005453-4057qib7	15444	3	included	include	VBD
cord-005453-4057qib7	15444	4	TT	TT	NNP
cord-005453-4057qib7	15444	5	(	(	-LRB-
cord-005453-4057qib7	15444	6	cum	cum	NN
cord-005453-4057qib7	15444	7	.	.	.
cord-005453-4057qib7	15445	1	dosage	dosage	NNP
cord-005453-4057qib7	15445	2	10mg	10mg	NNP
cord-005453-4057qib7	15445	3	/	/	SYM
cord-005453-4057qib7	15445	4	kg	kg	NNP
cord-005453-4057qib7	15445	5	)	)	-RRB-
cord-005453-4057qib7	15445	6	,	,	,
cord-005453-4057qib7	15445	7	Bu	Bu	NNP
cord-005453-4057qib7	15445	8	(	(	-LRB-
cord-005453-4057qib7	15445	9	median	median	JJ
cord-005453-4057qib7	15445	10	cum	cum	NN
cord-005453-4057qib7	15445	11	.	.	.
cord-005453-4057qib7	15446	1	dosage	dosage	VB
cord-005453-4057qib7	15446	2	9.6	9.6	CD
cord-005453-4057qib7	15446	3	mg	mg	NN
cord-005453-4057qib7	15447	1	/kg	/kg	NFP
cord-005453-4057qib7	15447	2	i.v	i.v	NNP
cord-005453-4057qib7	15447	3	.	.	.
cord-005453-4057qib7	15448	1	or	or	CC
cord-005453-4057qib7	15448	2	6.4	6.4	CD
cord-005453-4057qib7	15448	3	mg	mg	NNP
cord-005453-4057qib7	15448	4	/	/	SYM
cord-005453-4057qib7	15448	5	kg	kg	NNS
cord-005453-4057qib7	15448	6	in	in	IN
cord-005453-4057qib7	15448	7	elderly	elderly	JJ
cord-005453-4057qib7	15448	8	patients	patient	NNS
cord-005453-4057qib7	15448	9	)	)	-RRB-
cord-005453-4057qib7	15448	10	and	and	CC
cord-005453-4057qib7	15448	11	post	post	JJ
cord-005453-4057qib7	15448	12	-	-	JJ
cord-005453-4057qib7	15448	13	Cy	cy	JJ
cord-005453-4057qib7	15448	14	(	(	-LRB-
cord-005453-4057qib7	15448	15	cum	cum	NN
cord-005453-4057qib7	15448	16	.	.	.
cord-005453-4057qib7	15449	1	dosage	dosage	NNP
cord-005453-4057qib7	15449	2	100mg	100mg	NNP
cord-005453-4057qib7	15449	3	/	/	SYM
cord-005453-4057qib7	15449	4	kg	kg	NNP
cord-005453-4057qib7	15449	5	,	,	,
cord-005453-4057qib7	15449	6	day	day	NN
cord-005453-4057qib7	15449	7	+3	+3	NN
cord-005453-4057qib7	15449	8	and	and	CC
cord-005453-4057qib7	15449	9	+4	+4	LS
cord-005453-4057qib7	15449	10	)	)	-RRB-
cord-005453-4057qib7	15449	11	.	.	.
cord-005453-4057qib7	15450	1	Eight	eight	CD
cord-005453-4057qib7	15450	2	patients	patient	NNS
cord-005453-4057qib7	15450	3	(	(	-LRB-
cord-005453-4057qib7	15450	4	all	all	DT
cord-005453-4057qib7	15450	5	of	of	IN
cord-005453-4057qib7	15450	6	them	-PRON-	PRP
cord-005453-4057qib7	15450	7	received	receive	VBD
cord-005453-4057qib7	15450	8	allografts	allograft	NNS
cord-005453-4057qib7	15450	9	from	from	IN
cord-005453-4057qib7	15450	10	MMUD	MMUD	NNP
cord-005453-4057qib7	15450	11	or	or	CC
cord-005453-4057qib7	15450	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15450	13	donors	donor	NNS
cord-005453-4057qib7	15450	14	)	)	-RRB-
cord-005453-4057qib7	15450	15	received	receive	VBD
cord-005453-4057qib7	15450	16	additionally	additionally	RB
cord-005453-4057qib7	15450	17	fludarabine	fludarabine	NN
cord-005453-4057qib7	15450	18	(	(	-LRB-
cord-005453-4057qib7	15450	19	FLU	flu	NN
cord-005453-4057qib7	15450	20	,	,	,
cord-005453-4057qib7	15450	21	cum	cum	NN
cord-005453-4057qib7	15450	22	.	.	.
cord-005453-4057qib7	15451	1	dosage	dosage	NN
cord-005453-4057qib7	15451	2	of	of	IN
cord-005453-4057qib7	15451	3	Background	Background	NNP
cord-005453-4057qib7	15451	4	:	:	:
cord-005453-4057qib7	15452	1	The	the	DT
cord-005453-4057qib7	15452	2	overall	overall	JJ
cord-005453-4057qib7	15452	3	incidence	incidence	NN
cord-005453-4057qib7	15452	4	of	of	IN
cord-005453-4057qib7	15452	5	active	active	JJ
cord-005453-4057qib7	15452	6	CMV	CMV	NNP
cord-005453-4057qib7	15452	7	infection	infection	NN
cord-005453-4057qib7	15452	8	in	in	IN
cord-005453-4057qib7	15452	9	patients	patient	NNS
cord-005453-4057qib7	15452	10	with	with	IN
cord-005453-4057qib7	15452	11	multiple	multiple	JJ
cord-005453-4057qib7	15452	12	myeloma	myeloma	NN
cord-005453-4057qib7	15452	13	(	(	-LRB-
cord-005453-4057qib7	15452	14	MM	MM	NNP
cord-005453-4057qib7	15452	15	)	)	-RRB-
cord-005453-4057qib7	15452	16	receiving	receive	VBG
cord-005453-4057qib7	15452	17	Background	background	NN
cord-005453-4057qib7	15452	18	:	:	:
cord-005453-4057qib7	15452	19	Several	several	JJ
cord-005453-4057qib7	15452	20	scoring	scoring	NN
cord-005453-4057qib7	15452	21	systems	system	NNS
cord-005453-4057qib7	15452	22	have	have	VBP
cord-005453-4057qib7	15452	23	been	be	VBN
cord-005453-4057qib7	15452	24	developed	develop	VBN
cord-005453-4057qib7	15452	25	to	to	TO
cord-005453-4057qib7	15452	26	estimate	estimate	VB
cord-005453-4057qib7	15452	27	outcomes	outcome	NNS
cord-005453-4057qib7	15452	28	in	in	IN
cord-005453-4057qib7	15452	29	MDS	MDS	NNP
cord-005453-4057qib7	15452	30	patients	patient	NNS
cord-005453-4057qib7	15452	31	who	who	WP
cord-005453-4057qib7	15452	32	undergo	undergo	VBP
cord-005453-4057qib7	15452	33	AlloHCT	AlloHCT	NNP
cord-005453-4057qib7	15452	34	.	.	.
cord-005453-4057qib7	15453	1	However	however	RB
cord-005453-4057qib7	15453	2	,	,	,
cord-005453-4057qib7	15453	3	none	none	NN
cord-005453-4057qib7	15453	4	of	of	IN
cord-005453-4057qib7	15453	5	them	-PRON-	PRP
cord-005453-4057qib7	15453	6	have	have	VBP
cord-005453-4057qib7	15453	7	been	be	VBN
cord-005453-4057qib7	15453	8	specifically	specifically	RB
cord-005453-4057qib7	15453	9	validated	validate	VBN
cord-005453-4057qib7	15453	10	in	in	IN
cord-005453-4057qib7	15453	11	T	T	NNP
cord-005453-4057qib7	15453	12	cell	cell	NN
cord-005453-4057qib7	15453	13	depleted	deplete	VBD
cord-005453-4057qib7	15453	14	grafts	graft	NNS
cord-005453-4057qib7	15453	15	.	.	.
cord-005453-4057qib7	15454	1	The	the	DT
cord-005453-4057qib7	15454	2	aim	aim	NN
cord-005453-4057qib7	15454	3	of	of	IN
cord-005453-4057qib7	15454	4	this	this	DT
cord-005453-4057qib7	15454	5	study	study	NN
cord-005453-4057qib7	15454	6	is	be	VBZ
cord-005453-4057qib7	15454	7	to	to	TO
cord-005453-4057qib7	15454	8	investigate	investigate	VB
cord-005453-4057qib7	15454	9	the	the	DT
cord-005453-4057qib7	15454	10	prognostic	prognostic	JJ
cord-005453-4057qib7	15454	11	ability	ability	NN
cord-005453-4057qib7	15454	12	of	of	IN
cord-005453-4057qib7	15454	13	a	a	DT
cord-005453-4057qib7	15454	14	recently	recently	RB
cord-005453-4057qib7	15454	15	published	publish	VBN
cord-005453-4057qib7	15454	16	scoring	scoring	NN
cord-005453-4057qib7	15454	17	system	system	NN
cord-005453-4057qib7	15454	18	(	(	-LRB-
cord-005453-4057qib7	15454	19	SFGM	SFGM	NNP
cord-005453-4057qib7	15454	20	-	-	HYPH
cord-005453-4057qib7	15454	21	TC	TC	NNP
cord-005453-4057qib7	15454	22	)	)	-RRB-
cord-005453-4057qib7	15454	23	in	in	IN
cord-005453-4057qib7	15454	24	a	a	DT
cord-005453-4057qib7	15454	25	cohort	cohort	NN
cord-005453-4057qib7	15454	26	of	of	IN
cord-005453-4057qib7	15454	27	patients	patient	NNS
cord-005453-4057qib7	15454	28	with	with	IN
cord-005453-4057qib7	15454	29	MDS	MDS	NNP
cord-005453-4057qib7	15454	30	who	who	WP
cord-005453-4057qib7	15454	31	underwent	undergo	VBD
cord-005453-4057qib7	15454	32	TCD	TCD	NNP
cord-005453-4057qib7	15454	33	transplants	transplant	NNS
cord-005453-4057qib7	15454	34	.	.	.
cord-005453-4057qib7	15455	1	Methods	method	NNS
cord-005453-4057qib7	15455	2	:	:	:
cord-005453-4057qib7	15455	3	109	109	CD
cord-005453-4057qib7	15455	4	patients	patient	NNS
cord-005453-4057qib7	15455	5	underwent	undergo	VBD
cord-005453-4057qib7	15455	6	a	a	DT
cord-005453-4057qib7	15455	7	first	first	JJ
cord-005453-4057qib7	15455	8	TCD	TCD	NNP
cord-005453-4057qib7	15455	9	AlloHCT	AlloHCT	NNP
cord-005453-4057qib7	15455	10	for	for	IN
cord-005453-4057qib7	15455	11	MDS	MDS	NNP
cord-005453-4057qib7	15455	12	from	from	IN
cord-005453-4057qib7	15455	13	2007	2007	CD
cord-005453-4057qib7	15455	14	to	to	IN
cord-005453-4057qib7	15455	15	2018	2018	CD
cord-005453-4057qib7	15455	16	.	.	.
cord-005453-4057qib7	15456	1	The	the	DT
cord-005453-4057qib7	15456	2	SFGM	SFGM	NNP
cord-005453-4057qib7	15456	3	-	-	HYPH
cord-005453-4057qib7	15456	4	TC	TC	NNP
cord-005453-4057qib7	15456	5	score	score	NN
cord-005453-4057qib7	15456	6	(	(	-LRB-
cord-005453-4057qib7	15456	7	Caulier	Caulier	NNP
cord-005453-4057qib7	15456	8	et	et	NNP
cord-005453-4057qib7	15456	9	al	al	NNP
cord-005453-4057qib7	15456	10	.	.	.
cord-005453-4057qib7	15457	1	Curr	Curr	NNP
cord-005453-4057qib7	15457	2	Res	Res	NNP
cord-005453-4057qib7	15457	3	Transl	Transl	NNP
cord-005453-4057qib7	15457	4	Med	Med	NNP
cord-005453-4057qib7	15457	5	.	.	NNP
cord-005453-4057qib7	15457	6	2018	2018	CD
cord-005453-4057qib7	15457	7	)	)	-RRB-
cord-005453-4057qib7	15457	8	is	be	VBZ
cord-005453-4057qib7	15457	9	performed	perform	VBN
cord-005453-4057qib7	15457	10	at	at	IN
cord-005453-4057qib7	15457	11	day	day	NN
cord-005453-4057qib7	15457	12	100	100	CD
cord-005453-4057qib7	15457	13	and	and	CC
cord-005453-4057qib7	15457	14	ranges	range	VBZ
cord-005453-4057qib7	15457	15	from	from	IN
cord-005453-4057qib7	15457	16	0	0	CD
cord-005453-4057qib7	15457	17	-	-	SYM
cord-005453-4057qib7	15457	18	8	8	CD
cord-005453-4057qib7	15457	19	,	,	,
cord-005453-4057qib7	15457	20	discriminating	discriminate	VBG
cord-005453-4057qib7	15457	21	low	low	JJ
cord-005453-4057qib7	15457	22	(	(	-LRB-
cord-005453-4057qib7	15457	23	0	0	NFP
cord-005453-4057qib7	15457	24	)	)	-RRB-
cord-005453-4057qib7	15457	25	,	,	,
cord-005453-4057qib7	15457	26	intermediate	intermediate	JJ
cord-005453-4057qib7	15457	27	(	(	-LRB-
cord-005453-4057qib7	15457	28	1	1	CD
cord-005453-4057qib7	15457	29	)	)	-RRB-
cord-005453-4057qib7	15457	30	(	(	-LRB-
cord-005453-4057qib7	15457	31	2	2	LS
cord-005453-4057qib7	15457	32	)	)	-RRB-
cord-005453-4057qib7	15457	33	(	(	-LRB-
cord-005453-4057qib7	15457	34	3	3	LS
cord-005453-4057qib7	15457	35	)	)	-RRB-
cord-005453-4057qib7	15457	36	,	,	,
cord-005453-4057qib7	15457	37	and	and	CC
cord-005453-4057qib7	15457	38	high	high	JJ
cord-005453-4057qib7	15457	39	risk	risk	NN
cord-005453-4057qib7	15457	40	(	(	-LRB-
cord-005453-4057qib7	15457	41	4	4	CD
cord-005453-4057qib7	15457	42	-	-	SYM
cord-005453-4057qib7	15457	43	8	8	CD
cord-005453-4057qib7	15457	44	)	)	-RRB-
cord-005453-4057qib7	15457	45	.	.	.
cord-005453-4057qib7	15458	1	Additional	additional	JJ
cord-005453-4057qib7	15458	2	analyses	analysis	NNS
cord-005453-4057qib7	15458	3	were	be	VBD
cord-005453-4057qib7	15458	4	performed	perform	VBN
cord-005453-4057qib7	15458	5	at	at	IN
cord-005453-4057qib7	15458	6	day	day	NN
cord-005453-4057qib7	15458	7	180	180	CD
cord-005453-4057qib7	15458	8	and	and	CC
cord-005453-4057qib7	15458	9	day	day	NN
cord-005453-4057qib7	15458	10	365	365	CD
cord-005453-4057qib7	15458	11	.	.	.
cord-005453-4057qib7	15459	1	A	a	DT
cord-005453-4057qib7	15459	2	landmark	landmark	NN
cord-005453-4057qib7	15459	3	analysis	analysis	NN
cord-005453-4057qib7	15459	4	was	be	VBD
cord-005453-4057qib7	15459	5	done	do	VBN
cord-005453-4057qib7	15459	6	at	at	IN
cord-005453-4057qib7	15459	7	each	each	DT
cord-005453-4057qib7	15459	8	time	time	NN
cord-005453-4057qib7	15459	9	point	point	NN
cord-005453-4057qib7	15459	10	for	for	IN
cord-005453-4057qib7	15459	11	the	the	DT
cord-005453-4057qib7	15459	12	day	day	NN
cord-005453-4057qib7	15459	13	100	100	CD
cord-005453-4057qib7	15459	14	,	,	,
cord-005453-4057qib7	15459	15	180	180	CD
cord-005453-4057qib7	15459	16	,	,	,
cord-005453-4057qib7	15459	17	and	and	CC
cord-005453-4057qib7	15459	18	365	365	CD
cord-005453-4057qib7	15459	19	analyses	analysis	NNS
cord-005453-4057qib7	15459	20	,	,	,
cord-005453-4057qib7	15459	21	respectively	respectively	RB
cord-005453-4057qib7	15459	22	.	.	.
cord-005453-4057qib7	15460	1	Background	background	NN
cord-005453-4057qib7	15460	2	:	:	:
cord-005453-4057qib7	15461	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15461	2	stem	stem	NN
cord-005453-4057qib7	15461	3	cell	cell	NN
cord-005453-4057qib7	15461	4	transplantation	transplantation	NN
cord-005453-4057qib7	15461	5	(	(	-LRB-
cord-005453-4057qib7	15461	6	HSCT	HSCT	NNP
cord-005453-4057qib7	15461	7	)	)	-RRB-
cord-005453-4057qib7	15461	8	is	be	VBZ
cord-005453-4057qib7	15461	9	the	the	DT
cord-005453-4057qib7	15461	10	only	only	JJ
cord-005453-4057qib7	15461	11	curative	curative	JJ
cord-005453-4057qib7	15461	12	procedure	procedure	NN
cord-005453-4057qib7	15461	13	for	for	IN
cord-005453-4057qib7	15461	14	the	the	DT
cord-005453-4057qib7	15461	15	treatment	treatment	NN
cord-005453-4057qib7	15461	16	of	of	IN
cord-005453-4057qib7	15461	17	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	15461	18	syndrome	syndrome	NN
cord-005453-4057qib7	15461	19	(	(	-LRB-
cord-005453-4057qib7	15461	20	MDS	MDS	NNP
cord-005453-4057qib7	15461	21	)	)	-RRB-
cord-005453-4057qib7	15461	22	,	,	,
cord-005453-4057qib7	15461	23	but	but	CC
cord-005453-4057qib7	15461	24	among	among	IN
cord-005453-4057qib7	15461	25	several	several	JJ
cord-005453-4057qib7	15461	26	limiting	limit	VBG
cord-005453-4057qib7	15461	27	factors	factor	NNS
cord-005453-4057qib7	15461	28	for	for	IN
cord-005453-4057qib7	15461	29	its	-PRON-	PRP$
cord-005453-4057qib7	15461	30	accomplishment	accomplishment	NN
cord-005453-4057qib7	15461	31	,	,	,
cord-005453-4057qib7	15461	32	such	such	JJ
cord-005453-4057qib7	15461	33	as	as	IN
cord-005453-4057qib7	15461	34	the	the	DT
cord-005453-4057qib7	15461	35	patient´s	patient´s	NNP
cord-005453-4057qib7	15461	36	performance	performance	NN
cord-005453-4057qib7	15461	37	status	status	NN
cord-005453-4057qib7	15461	38	,	,	,
cord-005453-4057qib7	15461	39	is	be	VBZ
cord-005453-4057qib7	15461	40	a	a	DT
cord-005453-4057qib7	15461	41	very	very	RB
cord-005453-4057qib7	15461	42	relevant	relevant	JJ
cord-005453-4057qib7	15461	43	issue	issue	NN
cord-005453-4057qib7	15461	44	,	,	,
cord-005453-4057qib7	15461	45	i.e.	i.e.	FW
cord-005453-4057qib7	15461	46	,	,	,
cord-005453-4057qib7	15461	47	the	the	DT
cord-005453-4057qib7	15461	48	availability	availability	NN
cord-005453-4057qib7	15461	49	of	of	IN
cord-005453-4057qib7	15461	50	a	a	DT
cord-005453-4057qib7	15461	51	compatible	compatible	JJ
cord-005453-4057qib7	15461	52	HLA	HLA	NNP
cord-005453-4057qib7	15461	53	donor	donor	NN
cord-005453-4057qib7	15461	54	and	and	CC
cord-005453-4057qib7	15461	55	,	,	,
cord-005453-4057qib7	15461	56	when	when	WRB
cord-005453-4057qib7	15461	57	available	available	JJ
cord-005453-4057qib7	15461	58	,	,	,
cord-005453-4057qib7	15461	59	very	very	RB
cord-005453-4057qib7	15461	60	often	often	RB
cord-005453-4057qib7	15461	61	the	the	DT
cord-005453-4057qib7	15461	62	donor´s	donor´s	NNP
cord-005453-4057qib7	15461	63	age	age	NN
cord-005453-4057qib7	15461	64	and	and	CC
cord-005453-4057qib7	15461	65	comorbidities	comorbiditie	NNS
cord-005453-4057qib7	15461	66	also	also	RB
cord-005453-4057qib7	15461	67	constitute	constitute	VBP
cord-005453-4057qib7	15461	68	factors	factor	NNS
cord-005453-4057qib7	15461	69	that	that	WDT
cord-005453-4057qib7	15461	70	hinder	hinder	VBP
cord-005453-4057qib7	15461	71	this	this	DT
cord-005453-4057qib7	15461	72	medical	medical	JJ
cord-005453-4057qib7	15461	73	conduct	conduct	NN
cord-005453-4057qib7	15461	74	.	.	.
cord-005453-4057qib7	15462	1	Considering	consider	VBG
cord-005453-4057qib7	15462	2	this	this	DT
cord-005453-4057qib7	15462	3	scenario	scenario	NN
cord-005453-4057qib7	15462	4	,	,	,
cord-005453-4057qib7	15462	5	the	the	DT
cord-005453-4057qib7	15462	6	possibility	possibility	NN
cord-005453-4057qib7	15462	7	of	of	IN
cord-005453-4057qib7	15462	8	a	a	DT
cord-005453-4057qib7	15462	9	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15462	10	transplantation	transplantation	NN
cord-005453-4057qib7	15462	11	(	(	-LRB-
cord-005453-4057qib7	15462	12	HT	HT	NNP
cord-005453-4057qib7	15462	13	)	)	-RRB-
cord-005453-4057qib7	15462	14	has	have	VBZ
cord-005453-4057qib7	15462	15	emerged	emerge	VBN
cord-005453-4057qib7	15462	16	as	as	IN
cord-005453-4057qib7	15462	17	an	an	DT
cord-005453-4057qib7	15462	18	option	option	NN
cord-005453-4057qib7	15462	19	.	.	.
cord-005453-4057qib7	15463	1	In	in	IN
cord-005453-4057qib7	15463	2	Latin	Latin	NNP
cord-005453-4057qib7	15463	3	America	America	NNP
cord-005453-4057qib7	15463	4	,	,	,
cord-005453-4057qib7	15463	5	HT	HT	NNP
cord-005453-4057qib7	15463	6	has	have	VBZ
cord-005453-4057qib7	15463	7	been	be	VBN
cord-005453-4057qib7	15463	8	included	include	VBN
cord-005453-4057qib7	15463	9	as	as	IN
cord-005453-4057qib7	15463	10	a	a	DT
cord-005453-4057qib7	15463	11	treatment	treatment	NN
cord-005453-4057qib7	15463	12	option	option	NN
cord-005453-4057qib7	15463	13	since	since	IN
cord-005453-4057qib7	15463	14	2014	2014	CD
cord-005453-4057qib7	15463	15	.	.	.
cord-005453-4057qib7	15464	1	Since	since	IN
cord-005453-4057qib7	15464	2	then	then	RB
cord-005453-4057qib7	15464	3	,	,	,
cord-005453-4057qib7	15464	4	these	these	DT
cord-005453-4057qib7	15464	5	patients	patient	NNS
cord-005453-4057qib7	15464	6	have	have	VBP
cord-005453-4057qib7	15464	7	been	be	VBN
cord-005453-4057qib7	15464	8	included	include	VBN
cord-005453-4057qib7	15464	9	in	in	IN
cord-005453-4057qib7	15464	10	the	the	DT
cord-005453-4057qib7	15464	11	Latin	Latin	NNP
cord-005453-4057qib7	15464	12	American	American	NNP
cord-005453-4057qib7	15464	13	Registry	Registry	NNP
cord-005453-4057qib7	15464	14	of	of	IN
cord-005453-4057qib7	15464	15	Transplantation	Transplantation	NNP
cord-005453-4057qib7	15464	16	in	in	IN
cord-005453-4057qib7	15464	17	Myelodysplastic	Myelodysplastic	NNP
cord-005453-4057qib7	15464	18	Syndrome	Syndrome	NNP
cord-005453-4057qib7	15464	19	,	,	,
cord-005453-4057qib7	15464	20	making	make	VBG
cord-005453-4057qib7	15464	21	it	-PRON-	PRP
cord-005453-4057qib7	15464	22	possible	possible	JJ
cord-005453-4057qib7	15464	23	to	to	TO
cord-005453-4057qib7	15464	24	analyze	analyze	VB
cord-005453-4057qib7	15464	25	the	the	DT
cord-005453-4057qib7	15464	26	viability	viability	NN
cord-005453-4057qib7	15464	27	and	and	CC
cord-005453-4057qib7	15464	28	results	result	NNS
cord-005453-4057qib7	15464	29	of	of	IN
cord-005453-4057qib7	15464	30	these	these	DT
cord-005453-4057qib7	15464	31	transplants	transplant	NNS
cord-005453-4057qib7	15464	32	.	.	.
cord-005453-4057qib7	15465	1	Methods	method	NNS
cord-005453-4057qib7	15465	2	:	:	:
cord-005453-4057qib7	15466	1	From	from	IN
cord-005453-4057qib7	15466	2	October	October	NNP
cord-005453-4057qib7	15466	3	2012	2012	CD
cord-005453-4057qib7	15466	4	to	to	IN
cord-005453-4057qib7	15466	5	October	October	NNP
cord-005453-4057qib7	15466	6	2018	2018	CD
cord-005453-4057qib7	15466	7	,	,	,
cord-005453-4057qib7	15466	8	seventeen	seventeen	CD
cord-005453-4057qib7	15466	9	(	(	-LRB-
cord-005453-4057qib7	15466	10	17	17	CD
cord-005453-4057qib7	15466	11	)	)	-RRB-
cord-005453-4057qib7	15466	12	patients	patient	NNS
cord-005453-4057qib7	15466	13	were	be	VBD
cord-005453-4057qib7	15466	14	transplanted	transplant	VBN
cord-005453-4057qib7	15466	15	with	with	IN
cord-005453-4057qib7	15466	16	a	a	DT
cord-005453-4057qib7	15466	17	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15466	18	donor	donor	NN
cord-005453-4057qib7	15466	19	and	and	CC
cord-005453-4057qib7	15466	20	included	include	VBN
cord-005453-4057qib7	15466	21	in	in	IN
cord-005453-4057qib7	15466	22	the	the	DT
cord-005453-4057qib7	15466	23	Latin	Latin	NNP
cord-005453-4057qib7	15466	24	American	American	NNP
cord-005453-4057qib7	15466	25	Registry	Registry	NNP
cord-005453-4057qib7	15466	26	.	.	.
cord-005453-4057qib7	15467	1	None	none	NN
cord-005453-4057qib7	15467	2	of	of	IN
cord-005453-4057qib7	15467	3	these	these	DT
cord-005453-4057qib7	15467	4	patients	patient	NNS
cord-005453-4057qib7	15467	5	had	have	VBD
cord-005453-4057qib7	15467	6	an	an	DT
cord-005453-4057qib7	15467	7	identical	identical	JJ
cord-005453-4057qib7	15467	8	HLA	HLA	NNP
cord-005453-4057qib7	15467	9	(	(	-LRB-
cord-005453-4057qib7	15467	10	8/8	8/8	CD
cord-005453-4057qib7	15467	11	match	match	NN
cord-005453-4057qib7	15467	12	)	)	-RRB-
cord-005453-4057qib7	15467	13	related	related	JJ
cord-005453-4057qib7	15467	14	or	or	CC
cord-005453-4057qib7	15467	15	unrelated	unrelated	JJ
cord-005453-4057qib7	15467	16	donor	donor	NN
cord-005453-4057qib7	15467	17	.	.	.
cord-005453-4057qib7	15468	1	Data	datum	NNS
cord-005453-4057qib7	15468	2	were	be	VBD
cord-005453-4057qib7	15468	3	obtained	obtain	VBN
cord-005453-4057qib7	15468	4	from	from	IN
cord-005453-4057qib7	15468	5	the	the	DT
cord-005453-4057qib7	15468	6	Latin	Latin	NNP
cord-005453-4057qib7	15468	7	American	American	NNP
cord-005453-4057qib7	15468	8	Registry	Registry	NNP
cord-005453-4057qib7	15468	9	of	of	IN
cord-005453-4057qib7	15468	10	HSCT	HSCT	NNP
cord-005453-4057qib7	15468	11	in	in	IN
cord-005453-4057qib7	15468	12	MDS	MDS	NNP
cord-005453-4057qib7	15468	13	.	.	.
cord-005453-4057qib7	15469	1	The	the	DT
cord-005453-4057qib7	15469	2	statistical	statistical	JJ
cord-005453-4057qib7	15469	3	analyses	analysis	NNS
cord-005453-4057qib7	15469	4	were	be	VBD
cord-005453-4057qib7	15469	5	performed	perform	VBN
cord-005453-4057qib7	15469	6	using	use	VBG
cord-005453-4057qib7	15469	7	the	the	DT
cord-005453-4057qib7	15469	8	software	software	NN
cord-005453-4057qib7	15469	9	SPSS	SPSS	NNP
cord-005453-4057qib7	15469	10	,	,	,
cord-005453-4057qib7	15469	11	version	version	NN
cord-005453-4057qib7	15469	12	23.1	23.1	CD
cord-005453-4057qib7	15469	13	and	and	CC
cord-005453-4057qib7	15469	14	Graphpad	Graphpad	NNP
cord-005453-4057qib7	15469	15	Prism	Prism	NNP
cord-005453-4057qib7	15469	16	version	version	NN
cord-005453-4057qib7	15469	17	5.0	5.0	CD
cord-005453-4057qib7	15469	18	,	,	,
cord-005453-4057qib7	15469	19	with	with	IN
cord-005453-4057qib7	15469	20	significance	significance	NN
cord-005453-4057qib7	15469	21	being	be	VBG
cord-005453-4057qib7	15469	22	set	set	VBN
cord-005453-4057qib7	15469	23	at	at	IN
cord-005453-4057qib7	15469	24	p	p	NN
cord-005453-4057qib7	15469	25	<	<	XX
cord-005453-4057qib7	15469	26	0.05.Results	0.05.Results	NNP
cord-005453-4057qib7	15469	27	:	:	:
cord-005453-4057qib7	15470	1	Table	table	NN
cord-005453-4057qib7	15470	2	1	1	CD
cord-005453-4057qib7	15470	3	shows	show	VBZ
cord-005453-4057qib7	15470	4	the	the	DT
cord-005453-4057qib7	15470	5	patients	patient	NNS
cord-005453-4057qib7	15470	6	and	and	CC
cord-005453-4057qib7	15470	7	their	-PRON-	PRP$
cord-005453-4057qib7	15470	8	characteristics	characteristic	NNS
cord-005453-4057qib7	15470	9	.	.	.
cord-005453-4057qib7	15471	1	All	all	DT
cord-005453-4057qib7	15471	2	donors	donor	NNS
cord-005453-4057qib7	15471	3	were	be	VBD
cord-005453-4057qib7	15471	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15471	5	.	.	.
cord-005453-4057qib7	15472	1	There	there	EX
cord-005453-4057qib7	15472	2	was	be	VBD
cord-005453-4057qib7	15472	3	a	a	DT
cord-005453-4057qib7	15472	4	predominance	predominance	NN
cord-005453-4057qib7	15472	5	of	of	IN
cord-005453-4057qib7	15472	6	reduced	reduce	VBN
cord-005453-4057qib7	15472	7	intensity	intensity	NN
cord-005453-4057qib7	15472	8	conditioning	conditioning	NN
cord-005453-4057qib7	15472	9	,	,	,
cord-005453-4057qib7	15472	10	which	which	WDT
cord-005453-4057qib7	15472	11	was	be	VBD
cord-005453-4057qib7	15472	12	performed	perform	VBN
cord-005453-4057qib7	15472	13	in	in	IN
cord-005453-4057qib7	15472	14	13	13	CD
cord-005453-4057qib7	15472	15	patients	patient	NNS
cord-005453-4057qib7	15472	16	(	(	-LRB-
cord-005453-4057qib7	15472	17	76.5	76.5	CD
cord-005453-4057qib7	15472	18	%	%	NN
cord-005453-4057qib7	15472	19	)	)	-RRB-
cord-005453-4057qib7	15472	20	,	,	,
cord-005453-4057qib7	15472	21	whereas	whereas	IN
cord-005453-4057qib7	15472	22	the	the	DT
cord-005453-4057qib7	15472	23	others	other	NNS
cord-005453-4057qib7	15472	24	received	receive	VBD
cord-005453-4057qib7	15472	25	the	the	DT
cord-005453-4057qib7	15472	26	myeloablative	myeloablative	JJ
cord-005453-4057qib7	15472	27	conditioning	conditioning	NN
cord-005453-4057qib7	15472	28	.	.	.
cord-005453-4057qib7	15473	1	Cell	cell	NN
cord-005453-4057qib7	15473	2	source	source	NN
cord-005453-4057qib7	15473	3	was	be	VBD
cord-005453-4057qib7	15473	4	peripheral	peripheral	JJ
cord-005453-4057qib7	15473	5	blood	blood	NN
cord-005453-4057qib7	15473	6	in	in	IN
cord-005453-4057qib7	15473	7	10	10	CD
cord-005453-4057qib7	15473	8	(	(	-LRB-
cord-005453-4057qib7	15473	9	58.8	58.8	CD
cord-005453-4057qib7	15473	10	%	%	NN
cord-005453-4057qib7	15473	11	)	)	-RRB-
cord-005453-4057qib7	15473	12	and	and	CC
cord-005453-4057qib7	15473	13	bone	bone	NN
cord-005453-4057qib7	15473	14	marrow	marrow	NN
cord-005453-4057qib7	15473	15	in	in	IN
cord-005453-4057qib7	15473	16	7	7	CD
cord-005453-4057qib7	15473	17	(	(	-LRB-
cord-005453-4057qib7	15473	18	41.2	41.2	CD
cord-005453-4057qib7	15473	19	%	%	NN
cord-005453-4057qib7	15473	20	)	)	-RRB-
cord-005453-4057qib7	15473	21	of	of	IN
cord-005453-4057qib7	15473	22	the	the	DT
cord-005453-4057qib7	15473	23	patients	patient	NNS
cord-005453-4057qib7	15473	24	.	.	.
cord-005453-4057qib7	15474	1	Graft	graft	NN
cord-005453-4057qib7	15474	2	-	-	HYPH
cord-005453-4057qib7	15474	3	versus	versus	IN
cord-005453-4057qib7	15474	4	-	-	HYPH
cord-005453-4057qib7	15474	5	host	host	NN
cord-005453-4057qib7	15474	6	disease	disease	NN
cord-005453-4057qib7	15474	7	(	(	-LRB-
cord-005453-4057qib7	15474	8	GVHD	GVHD	NNP
cord-005453-4057qib7	15474	9	)	)	-RRB-
cord-005453-4057qib7	15474	10	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15474	11	in	in	IN
cord-005453-4057qib7	15474	12	post	post	JJ
cord-005453-4057qib7	15474	13	-	-	JJ
cord-005453-4057qib7	15474	14	HSCT	HSCT	NNP
cord-005453-4057qib7	15474	15	was	be	VBD
cord-005453-4057qib7	15474	16	carried	carry	VBN
cord-005453-4057qib7	15474	17	out	out	RP
cord-005453-4057qib7	15474	18	with	with	IN
cord-005453-4057qib7	15474	19	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15474	20	50	50	CD
cord-005453-4057qib7	15474	21	mg	mg	NNP
cord-005453-4057qib7	15474	22	/	/	SYM
cord-005453-4057qib7	15474	23	kg	kg	NNS
cord-005453-4057qib7	15474	24	on	on	IN
cord-005453-4057qib7	15474	25	D+3	d+3	NN
cord-005453-4057qib7	15474	26	and	and	CC
cord-005453-4057qib7	15474	27	D+5	d+5	NN
cord-005453-4057qib7	15474	28	,	,	,
cord-005453-4057qib7	15474	29	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	15474	30	from	from	IN
cord-005453-4057qib7	15474	31	D0	d0	NN
cord-005453-4057qib7	15474	32	and	and	CC
cord-005453-4057qib7	15474	33	mycophenolate	mycophenolate	NN
cord-005453-4057qib7	15474	34	from	from	IN
cord-005453-4057qib7	15474	35	D+1	D+1	NNP
cord-005453-4057qib7	15474	36	.	.	.
cord-005453-4057qib7	15475	1	Complete	complete	JJ
cord-005453-4057qib7	15475	2	hematologic	hematologic	JJ
cord-005453-4057qib7	15475	3	recovery	recovery	NN
cord-005453-4057qib7	15475	4	was	be	VBD
cord-005453-4057qib7	15475	5	achieved	achieve	VBN
cord-005453-4057qib7	15475	6	in	in	IN
cord-005453-4057qib7	15475	7	16	16	CD
cord-005453-4057qib7	15475	8	(	(	-LRB-
cord-005453-4057qib7	15475	9	94.1	94.1	CD
cord-005453-4057qib7	15475	10	%	%	NN
cord-005453-4057qib7	15475	11	)	)	-RRB-
cord-005453-4057qib7	15475	12	patients	patient	NNS
cord-005453-4057qib7	15475	13	.	.	.
cord-005453-4057qib7	15476	1	The	the	DT
cord-005453-4057qib7	15476	2	incidence	incidence	NN
cord-005453-4057qib7	15476	3	of	of	IN
cord-005453-4057qib7	15476	4	grade	grade	NN
cord-005453-4057qib7	15476	5	II	II	NNP
cord-005453-4057qib7	15476	6	-	-	HYPH
cord-005453-4057qib7	15476	7	IV	IV	NNP
cord-005453-4057qib7	15476	8	acute	acute	JJ
cord-005453-4057qib7	15476	9	GVHD	GVHD	NNP
cord-005453-4057qib7	15476	10	was	be	VBD
cord-005453-4057qib7	15476	11	11.7	11.7	CD
cord-005453-4057qib7	15476	12	%	%	NN
cord-005453-4057qib7	15476	13	,	,	,
cord-005453-4057qib7	15476	14	whereas	whereas	IN
cord-005453-4057qib7	15476	15	chronic	chronic	JJ
cord-005453-4057qib7	15476	16	GVHD	GVHD	NNP
cord-005453-4057qib7	15476	17	was	be	VBD
cord-005453-4057qib7	15476	18	5.8	5.8	CD
cord-005453-4057qib7	15476	19	%	%	NN
cord-005453-4057qib7	15476	20	.	.	.
cord-005453-4057qib7	15477	1	One	one	CD
cord-005453-4057qib7	15477	2	death	death	NN
cord-005453-4057qib7	15477	3	occurred	occur	VBD
cord-005453-4057qib7	15477	4	due	due	JJ
cord-005453-4057qib7	15477	5	to	to	IN
cord-005453-4057qib7	15477	6	graft	graft	NN
cord-005453-4057qib7	15477	7	failure	failure	NN
cord-005453-4057qib7	15477	8	and	and	CC
cord-005453-4057qib7	15477	9	none	none	NN
cord-005453-4057qib7	15477	10	of	of	IN
cord-005453-4057qib7	15477	11	the	the	DT
cord-005453-4057qib7	15477	12	patients	patient	NNS
cord-005453-4057qib7	15477	13	showed	show	VBD
cord-005453-4057qib7	15477	14	autologous	autologous	JJ
cord-005453-4057qib7	15477	15	recovery	recovery	NN
cord-005453-4057qib7	15477	16	.	.	.
cord-005453-4057qib7	15478	1	Three	three	CD
cord-005453-4057qib7	15478	2	other	other	JJ
cord-005453-4057qib7	15478	3	patients	patient	NNS
cord-005453-4057qib7	15478	4	died	die	VBD
cord-005453-4057qib7	15478	5	.	.	.
cord-005453-4057qib7	15479	1	One	one	CD
cord-005453-4057qib7	15479	2	on	on	IN
cord-005453-4057qib7	15479	3	D+210	d+210	NN
cord-005453-4057qib7	15479	4	due	due	IN
cord-005453-4057qib7	15479	5	to	to	IN
cord-005453-4057qib7	15479	6	a	a	DT
cord-005453-4057qib7	15479	7	fungal	fungal	JJ
cord-005453-4057qib7	15479	8	infection	infection	NN
cord-005453-4057qib7	15479	9	,	,	,
cord-005453-4057qib7	15479	10	the	the	DT
cord-005453-4057qib7	15479	11	second	second	JJ
cord-005453-4057qib7	15479	12	on	on	IN
cord-005453-4057qib7	15479	13	D+90	d+90	IN
cord-005453-4057qib7	15479	14	due	due	IN
cord-005453-4057qib7	15479	15	to	to	IN
cord-005453-4057qib7	15479	16	sinusoidal	sinusoidal	JJ
cord-005453-4057qib7	15479	17	obstruction	obstruction	NN
cord-005453-4057qib7	15479	18	syndrome	syndrome	NN
cord-005453-4057qib7	15479	19	and	and	CC
cord-005453-4057qib7	15479	20	a	a	DT
cord-005453-4057qib7	15479	21	third	third	NN
cord-005453-4057qib7	15479	22	on	on	IN
cord-005453-4057qib7	15479	23	D+61	d+61	NN
cord-005453-4057qib7	15479	24	due	due	IN
cord-005453-4057qib7	15479	25	to	to	IN
cord-005453-4057qib7	15479	26	pneumonia	pneumonia	NN
cord-005453-4057qib7	15479	27	caused	cause	VBN
cord-005453-4057qib7	15479	28	by	by	IN
cord-005453-4057qib7	15479	29	Pseudomonas	Pseudomonas	NNP
cord-005453-4057qib7	15479	30	.	.	.
cord-005453-4057qib7	15480	1	Regarding	regard	VBG
cord-005453-4057qib7	15480	2	overall	overall	JJ
cord-005453-4057qib7	15480	3	complications	complication	NNS
cord-005453-4057qib7	15480	4	,	,	,
cord-005453-4057qib7	15480	5	there	there	EX
cord-005453-4057qib7	15480	6	was	be	VBD
cord-005453-4057qib7	15480	7	a	a	DT
cord-005453-4057qib7	15480	8	predominance	predominance	NN
cord-005453-4057qib7	15480	9	of	of	IN
cord-005453-4057qib7	15480	10	mucositis	mucositis	NNP
cord-005453-4057qib7	15480	11	(	(	-LRB-
cord-005453-4057qib7	15480	12	47	47	CD
cord-005453-4057qib7	15480	13	%	%	NN
cord-005453-4057qib7	15480	14	)	)	-RRB-
cord-005453-4057qib7	15480	15	,	,	,
cord-005453-4057qib7	15480	16	overall	overall	JJ
cord-005453-4057qib7	15480	17	infections	infection	NNS
cord-005453-4057qib7	15480	18	(	(	-LRB-
cord-005453-4057qib7	15480	19	35.2	35.2	CD
cord-005453-4057qib7	15480	20	%	%	NN
cord-005453-4057qib7	15480	21	)	)	-RRB-
cord-005453-4057qib7	15480	22	and	and	CC
cord-005453-4057qib7	15480	23	reactivated	reactivate	VBD
cord-005453-4057qib7	15480	24	CMV	CMV	NNP
cord-005453-4057qib7	15480	25	in	in	IN
cord-005453-4057qib7	15480	26	23.5	23.5	CD
cord-005453-4057qib7	15480	27	%	%	NN
cord-005453-4057qib7	15480	28	of	of	IN
cord-005453-4057qib7	15480	29	cases	case	NNS
cord-005453-4057qib7	15480	30	.	.	.
cord-005453-4057qib7	15481	1	Of	of	IN
cord-005453-4057qib7	15481	2	the	the	DT
cord-005453-4057qib7	15481	3	total	total	JJ
cord-005453-4057qib7	15481	4	number	number	NN
cord-005453-4057qib7	15481	5	of	of	IN
cord-005453-4057qib7	15481	6	living	live	VBG
cord-005453-4057qib7	15481	7	patients	patient	NNS
cord-005453-4057qib7	15481	8	,	,	,
cord-005453-4057qib7	15481	9	8	8	CD
cord-005453-4057qib7	15481	10	(	(	-LRB-
cord-005453-4057qib7	15481	11	47	47	CD
cord-005453-4057qib7	15481	12	%	%	NN
cord-005453-4057qib7	15481	13	)	)	-RRB-
cord-005453-4057qib7	15481	14	achieved	achieve	VBN
cord-005453-4057qib7	15481	15	complete	complete	JJ
cord-005453-4057qib7	15481	16	remission	remission	NN
cord-005453-4057qib7	15481	17	and	and	CC
cord-005453-4057qib7	15481	18	5	5	CD
cord-005453-4057qib7	15481	19	(	(	-LRB-
cord-005453-4057qib7	15481	20	29.4	29.4	CD
cord-005453-4057qib7	15481	21	%	%	NN
cord-005453-4057qib7	15481	22	)	)	-RRB-
cord-005453-4057qib7	15481	23	showed	show	VBD
cord-005453-4057qib7	15481	24	disease	disease	NN
cord-005453-4057qib7	15481	25	relapse	relapse	NN
cord-005453-4057qib7	15481	26	.	.	.
cord-005453-4057qib7	15482	1	The	the	DT
cord-005453-4057qib7	15482	2	mean	mean	JJ
cord-005453-4057qib7	15482	3	follow	follow	NN
cord-005453-4057qib7	15482	4	-	-	HYPH
cord-005453-4057qib7	15482	5	up	up	NN
cord-005453-4057qib7	15482	6	was	be	VBD
cord-005453-4057qib7	15482	7	39	39	CD
cord-005453-4057qib7	15482	8	months	month	NNS
cord-005453-4057qib7	15482	9	(	(	-LRB-
cord-005453-4057qib7	15482	10	ranging	range	VBG
cord-005453-4057qib7	15482	11	from	from	IN
cord-005453-4057qib7	15482	12	5	5	CD
cord-005453-4057qib7	15482	13	to	to	TO
cord-005453-4057qib7	15482	14	72	72	CD
cord-005453-4057qib7	15482	15	months	month	NNS
cord-005453-4057qib7	15482	16	)	)	-RRB-
cord-005453-4057qib7	15482	17	.	.	.
cord-005453-4057qib7	15483	1	The	the	DT
cord-005453-4057qib7	15483	2	lowest	low	JJS
cord-005453-4057qib7	15483	3	probability	probability	NN
cord-005453-4057qib7	15483	4	of	of	IN
cord-005453-4057qib7	15483	5	disease	disease	NN
cord-005453-4057qib7	15483	6	-	-	HYPH
cord-005453-4057qib7	15483	7	free	free	JJ
cord-005453-4057qib7	15483	8	survival	survival	NN
cord-005453-4057qib7	15483	9	at	at	IN
cord-005453-4057qib7	15483	10	3	3	CD
cord-005453-4057qib7	15483	11	years	year	NNS
cord-005453-4057qib7	15483	12	was	be	VBD
cord-005453-4057qib7	15483	13	79	79	CD
cord-005453-4057qib7	15483	14	%	%	NN
cord-005453-4057qib7	15483	15	(	(	-LRB-
cord-005453-4057qib7	15483	16	95	95	CD
cord-005453-4057qib7	15483	17	%	%	NN
cord-005453-4057qib7	15483	18	CI	ci	NN
cord-005453-4057qib7	15483	19	:	:	:
cord-005453-4057qib7	15483	20	71.48	71.48	CD
cord-005453-4057qib7	15483	21	-88.51).Background	-88.51).background	CD
cord-005453-4057qib7	15483	22	:	:	:
cord-005453-4057qib7	15483	23	Relapse	relapse	NN
cord-005453-4057qib7	15483	24	is	be	VBZ
cord-005453-4057qib7	15483	25	the	the	DT
cord-005453-4057qib7	15483	26	most	most	RBS
cord-005453-4057qib7	15483	27	important	important	JJ
cord-005453-4057qib7	15483	28	cause	cause	NN
cord-005453-4057qib7	15483	29	of	of	IN
cord-005453-4057qib7	15483	30	failure	failure	NN
cord-005453-4057qib7	15483	31	after	after	IN
cord-005453-4057qib7	15483	32	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15483	33	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15483	34	stem	stem	NN
cord-005453-4057qib7	15483	35	cell	cell	NN
cord-005453-4057qib7	15483	36	transplantation	transplantation	NN
cord-005453-4057qib7	15483	37	(	(	-LRB-
cord-005453-4057qib7	15483	38	HSCT	HSCT	NNP
cord-005453-4057qib7	15483	39	)	)	-RRB-
cord-005453-4057qib7	15483	40	for	for	IN
cord-005453-4057qib7	15483	41	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	15483	42	-	-	HYPH
cord-005453-4057qib7	15483	43	positive	positive	JJ
cord-005453-4057qib7	15483	44	acute	acute	JJ
cord-005453-4057qib7	15483	45	myeloid	myeloid	NN
cord-005453-4057qib7	15483	46	leukemia	leukemia	NN
cord-005453-4057qib7	15483	47	(	(	-LRB-
cord-005453-4057qib7	15483	48	AML	AML	NNP
cord-005453-4057qib7	15483	49	)	)	-RRB-
cord-005453-4057qib7	15483	50	.	.	.
cord-005453-4057qib7	15484	1	Treatment	treatment	NN
cord-005453-4057qib7	15484	2	with	with	IN
cord-005453-4057qib7	15484	3	FLT3	FLT3	NNP
cord-005453-4057qib7	15484	4	tyrosine	tyrosine	NN
cord-005453-4057qib7	15484	5	kinase	kinase	NN
cord-005453-4057qib7	15484	6	inhibitors	inhibitor	NNS
cord-005453-4057qib7	15484	7	(	(	-LRB-
cord-005453-4057qib7	15484	8	TKI	TKI	NNP
cord-005453-4057qib7	15484	9	)	)	-RRB-
cord-005453-4057qib7	15484	10	constitutes	constitute	VBZ
cord-005453-4057qib7	15484	11	a	a	DT
cord-005453-4057qib7	15484	12	promising	promising	JJ
cord-005453-4057qib7	15484	13	clinical	clinical	JJ
cord-005453-4057qib7	15484	14	approach	approach	NN
cord-005453-4057qib7	15484	15	to	to	TO
cord-005453-4057qib7	15484	16	induce	induce	VB
cord-005453-4057qib7	15484	17	remission	remission	NN
cord-005453-4057qib7	15484	18	without	without	IN
cord-005453-4057qib7	15484	19	conventional	conventional	JJ
cord-005453-4057qib7	15484	20	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15484	21	.	.	.
cord-005453-4057qib7	15485	1	Methods	method	NNS
cord-005453-4057qib7	15485	2	:	:	:
cord-005453-4057qib7	15486	1	A	a	DT
cord-005453-4057qib7	15486	2	50	50	CD
cord-005453-4057qib7	15486	3	year	year	NN
cord-005453-4057qib7	15486	4	-	-	HYPH
cord-005453-4057qib7	15486	5	old	old	JJ
cord-005453-4057qib7	15486	6	woman	woman	NN
cord-005453-4057qib7	15486	7	diagnosed	diagnose	VBN
cord-005453-4057qib7	15486	8	with	with	IN
cord-005453-4057qib7	15486	9	AML	AML	NNP
cord-005453-4057qib7	15486	10	secondary	secondary	JJ
cord-005453-4057qib7	15486	11	to	to	IN
cord-005453-4057qib7	15486	12	myelodisplastic	myelodisplastic	NNP
cord-005453-4057qib7	15486	13	syndrome	syndrome	NN
cord-005453-4057qib7	15486	14	(	(	-LRB-
cord-005453-4057qib7	15486	15	MDS	MDS	NNP
cord-005453-4057qib7	15486	16	)	)	-RRB-
cord-005453-4057qib7	15486	17	with	with	IN
cord-005453-4057qib7	15486	18	NPM1	NPM1	NNP
cord-005453-4057qib7	15486	19	mutation	mutation	NN
cord-005453-4057qib7	15486	20	and	and	CC
cord-005453-4057qib7	15486	21	internal	internal	JJ
cord-005453-4057qib7	15486	22	tandem	tandem	JJ
cord-005453-4057qib7	15486	23	duplications	duplication	NNS
cord-005453-4057qib7	15486	24	of	of	IN
cord-005453-4057qib7	15486	25	the	the	DT
cord-005453-4057qib7	15486	26	FLT3	FLT3	NNP
cord-005453-4057qib7	15486	27	gene	gene	NN
cord-005453-4057qib7	15486	28	(	(	-LRB-
cord-005453-4057qib7	15486	29	FLT3-ITD	FLT3-ITD	NNP
cord-005453-4057qib7	15486	30	)	)	-RRB-
cord-005453-4057qib7	15486	31	in	in	IN
cord-005453-4057qib7	15486	32	October	October	NNP
cord-005453-4057qib7	15486	33	2013	2013	CD
cord-005453-4057qib7	15486	34	.	.	.
cord-005453-4057qib7	15487	1	After	after	IN
cord-005453-4057qib7	15487	2	achieving	achieve	VBG
cord-005453-4057qib7	15487	3	complete	complete	JJ
cord-005453-4057qib7	15487	4	remission	remission	NN
cord-005453-4057qib7	15487	5	(	(	-LRB-
cord-005453-4057qib7	15487	6	CR	cr	NN
cord-005453-4057qib7	15487	7	)	)	-RRB-
cord-005453-4057qib7	15487	8	with	with	IN
cord-005453-4057qib7	15487	9	conventional	conventional	JJ
cord-005453-4057qib7	15487	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15487	11	,	,	,
cord-005453-4057qib7	15487	12	she	-PRON-	PRP
cord-005453-4057qib7	15487	13	received	receive	VBD
cord-005453-4057qib7	15487	14	a	a	DT
cord-005453-4057qib7	15487	15	HLA	HLA	NNP
cord-005453-4057qib7	15487	16	sibling	sibling	NN
cord-005453-4057qib7	15487	17	allogenic	allogenic	NN
cord-005453-4057qib7	15487	18	-	-	HYPH
cord-005453-4057qib7	15487	19	HSCT	HSCT	NNP
cord-005453-4057qib7	15487	20	in	in	IN
cord-005453-4057qib7	15487	21	February	February	NNP
cord-005453-4057qib7	15487	22	2014	2014	CD
cord-005453-4057qib7	15487	23	,	,	,
cord-005453-4057qib7	15487	24	with	with	IN
cord-005453-4057qib7	15487	25	BuCy	BuCy	NNP
cord-005453-4057qib7	15487	26	.	.	.
cord-005453-4057qib7	15488	1	Four	four	CD
cord-005453-4057qib7	15488	2	months	month	NNS
cord-005453-4057qib7	15488	3	later	later	RB
cord-005453-4057qib7	15488	4	,	,	,
cord-005453-4057qib7	15488	5	AML	AML	NNP
cord-005453-4057qib7	15488	6	relapsed	relapse	VBD
cord-005453-4057qib7	15488	7	only	only	RB
cord-005453-4057qib7	15488	8	at	at	IN
cord-005453-4057qib7	15488	9	medullary	medullary	JJ
cord-005453-4057qib7	15488	10	level	level	NN
cord-005453-4057qib7	15489	1	(	(	-LRB-
cord-005453-4057qib7	15489	2	FLT3	FLT3	NNP
cord-005453-4057qib7	15489	3	ratio	ratio	NN
cord-005453-4057qib7	15489	4	:	:	:
cord-005453-4057qib7	15489	5	0,67	0,67	CD
cord-005453-4057qib7	15489	6	%	%	NN
cord-005453-4057qib7	15489	7	)	)	-RRB-
cord-005453-4057qib7	15489	8	,	,	,
cord-005453-4057qib7	15489	9	treated	treat	VBN
cord-005453-4057qib7	15489	10	with	with	IN
cord-005453-4057qib7	15489	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15489	12	and	and	CC
cord-005453-4057qib7	15489	13	donor	donor	NN
cord-005453-4057qib7	15489	14	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	15489	15	infusions	infusion	NNS
cord-005453-4057qib7	15489	16	(	(	-LRB-
cord-005453-4057qib7	15489	17	DLI	DLI	NNP
cord-005453-4057qib7	15489	18	)	)	-RRB-
cord-005453-4057qib7	15489	19	.	.	.
cord-005453-4057qib7	15490	1	She	-PRON-	PRP
cord-005453-4057qib7	15490	2	achieved	achieve	VBD
cord-005453-4057qib7	15490	3	2	2	CD
cord-005453-4057qib7	15490	4	nd	nd	NNP
cord-005453-4057qib7	15490	5	CR	CR	NNP
cord-005453-4057qib7	15490	6	and	and	CC
cord-005453-4057qib7	15490	7	developed	develop	VBD
cord-005453-4057qib7	15490	8	limited	limited	JJ
cord-005453-4057qib7	15490	9	chronic	chronic	JJ
cord-005453-4057qib7	15490	10	graft	graft	NN
cord-005453-4057qib7	15490	11	-	-	HYPH
cord-005453-4057qib7	15490	12	versushost	versushost	NN
cord-005453-4057qib7	15490	13	disease	disease	NN
cord-005453-4057qib7	15490	14	(	(	-LRB-
cord-005453-4057qib7	15490	15	cGVHD	cGVHD	NNP
cord-005453-4057qib7	15490	16	)	)	-RRB-
cord-005453-4057qib7	15490	17	.	.	.
cord-005453-4057qib7	15491	1	Nine	nine	CD
cord-005453-4057qib7	15491	2	months	month	NNS
cord-005453-4057qib7	15491	3	later	later	RB
cord-005453-4057qib7	15491	4	(	(	-LRB-
cord-005453-4057qib7	15491	5	April	April	NNP
cord-005453-4057qib7	15491	6	2015	2015	CD
cord-005453-4057qib7	15491	7	)	)	-RRB-
cord-005453-4057qib7	15491	8	,	,	,
cord-005453-4057qib7	15491	9	she	-PRON-	PRP
cord-005453-4057qib7	15491	10	suffered	suffer	VBD
cord-005453-4057qib7	15491	11	the	the	DT
cord-005453-4057qib7	15491	12	first	first	JJ
cord-005453-4057qib7	15491	13	extramedullary	extramedullary	JJ
cord-005453-4057qib7	15491	14	relapse	relapse	NN
cord-005453-4057qib7	15491	15	only	only	RB
cord-005453-4057qib7	15491	16	,	,	,
cord-005453-4057qib7	15491	17	breast	breast	NN
cord-005453-4057qib7	15491	18	and	and	CC
cord-005453-4057qib7	15491	19	skin	skin	NN
cord-005453-4057qib7	15491	20	.	.	.
cord-005453-4057qib7	15492	1	Disappearance	disappearance	NN
cord-005453-4057qib7	15492	2	of	of	IN
cord-005453-4057qib7	15492	3	the	the	DT
cord-005453-4057qib7	15492	4	lesions	lesion	NNS
cord-005453-4057qib7	15492	5	at	at	IN
cord-005453-4057qib7	15492	6	all	all	DT
cord-005453-4057qib7	15492	7	levels	level	NNS
cord-005453-4057qib7	15492	8	was	be	VBD
cord-005453-4057qib7	15492	9	achieved	achieve	VBN
cord-005453-4057qib7	15492	10	with	with	IN
cord-005453-4057qib7	15492	11	chemo	chemo	NN
cord-005453-4057qib7	15492	12	and	and	CC
cord-005453-4057qib7	15492	13	radiotherapy	radiotherapy	NN
cord-005453-4057qib7	15492	14	.	.	.
cord-005453-4057qib7	15493	1	She	-PRON-	PRP
cord-005453-4057qib7	15493	2	always	always	RB
cord-005453-4057qib7	15493	3	had	have	VBD
cord-005453-4057qib7	15493	4	full	full	JJ
cord-005453-4057qib7	15493	5	hematologic	hematologic	JJ
cord-005453-4057qib7	15493	6	donor	donor	NN
cord-005453-4057qib7	15493	7	chimerism	chimerism	NN
cord-005453-4057qib7	15493	8	.	.	.
cord-005453-4057qib7	15494	1	In	in	IN
cord-005453-4057qib7	15494	2	December	December	NNP
cord-005453-4057qib7	15494	3	2015	2015	CD
cord-005453-4057qib7	15494	4	,	,	,
cord-005453-4057qib7	15494	5	she	-PRON-	PRP
cord-005453-4057qib7	15494	6	referred	refer	VBD
cord-005453-4057qib7	15494	7	atypical	atypical	JJ
cord-005453-4057qib7	15494	8	precordial	precordial	JJ
cord-005453-4057qib7	15494	9	pain	pain	NN
cord-005453-4057qib7	15494	10	irradiated	irradiate	VBN
cord-005453-4057qib7	15494	11	to	to	IN
cord-005453-4057qib7	15494	12	the	the	DT
cord-005453-4057qib7	15494	13	back	back	NN
cord-005453-4057qib7	15494	14	.	.	.
cord-005453-4057qib7	15495	1	Cardiac	Cardiac	NNP
cord-005453-4057qib7	15495	2	MRI	MRI	NNP
cord-005453-4057qib7	15495	3	was	be	VBD
cord-005453-4057qib7	15495	4	performed	perform	VBN
cord-005453-4057qib7	15495	5	and	and	CC
cord-005453-4057qib7	15495	6	several	several	JJ
cord-005453-4057qib7	15495	7	masses	masse	NNS
cord-005453-4057qib7	15495	8	were	be	VBD
cord-005453-4057qib7	15495	9	visualized	visualize	VBN
cord-005453-4057qib7	15495	10	in	in	IN
cord-005453-4057qib7	15495	11	the	the	DT
cord-005453-4057qib7	15495	12	pericardial	pericardial	JJ
cord-005453-4057qib7	15495	13	sac	sac	NN
cord-005453-4057qib7	15495	14	,	,	,
cord-005453-4057qib7	15495	15	up	up	IN
cord-005453-4057qib7	15495	16	to	to	TO
cord-005453-4057qib7	15495	17	5	5	CD
cord-005453-4057qib7	15495	18	cm	cm	NNS
cord-005453-4057qib7	15495	19	in	in	IN
cord-005453-4057qib7	15495	20	diameter	diameter	NN
cord-005453-4057qib7	15495	21	.	.	.
cord-005453-4057qib7	15496	1	BM	BM	NNP
cord-005453-4057qib7	15496	2	remained	remain	VBD
cord-005453-4057qib7	15496	3	in	in	IN
cord-005453-4057qib7	15496	4	CR	CR	NNP
cord-005453-4057qib7	15496	5	with	with	IN
cord-005453-4057qib7	15496	6	full	full	JJ
cord-005453-4057qib7	15496	7	donor	donor	NN
cord-005453-4057qib7	15496	8	chimerism	chimerism	NN
cord-005453-4057qib7	15496	9	.	.	.
cord-005453-4057qib7	15497	1	Pericardial	pericardial	JJ
cord-005453-4057qib7	15497	2	fluid	fluid	NN
cord-005453-4057qib7	15497	3	showed	show	VBD
cord-005453-4057qib7	15497	4	massive	massive	JJ
cord-005453-4057qib7	15497	5	infiltration	infiltration	NN
cord-005453-4057qib7	15497	6	by	by	IN
cord-005453-4057qib7	15497	7	leukemic	leukemic	JJ
cord-005453-4057qib7	15497	8	-	-	HYPH
cord-005453-4057qib7	15497	9	FLT3	FLT3	NNP
cord-005453-4057qib7	15497	10	positive	positive	JJ
cord-005453-4057qib7	15497	11	cells	cell	NNS
cord-005453-4057qib7	15497	12	(	(	-LRB-
cord-005453-4057qib7	15497	13	ratio	ratio	NN
cord-005453-4057qib7	15497	14	:	:	:
cord-005453-4057qib7	15497	15	0,7	0,7	CD
cord-005453-4057qib7	15497	16	%	%	NN
cord-005453-4057qib7	15497	17	)	)	-RRB-
cord-005453-4057qib7	15497	18	.	.	.
cord-005453-4057qib7	15498	1	She	-PRON-	PRP
cord-005453-4057qib7	15498	2	was	be	VBD
cord-005453-4057qib7	15498	3	not	not	RB
cord-005453-4057qib7	15498	4	considered	consider	VBN
cord-005453-4057qib7	15498	5	Background	background	NN
cord-005453-4057qib7	15499	1	:	:	:
cord-005453-4057qib7	15499	2	TA	TA	NNP
cord-005453-4057qib7	15499	3	-	-	HYPH
cord-005453-4057qib7	15499	4	TMA	TMA	NNP
cord-005453-4057qib7	15499	5	is	be	VBZ
cord-005453-4057qib7	15499	6	a	a	DT
cord-005453-4057qib7	15499	7	severe	severe	JJ
cord-005453-4057qib7	15499	8	complication	complication	NN
cord-005453-4057qib7	15499	9	that	that	WDT
cord-005453-4057qib7	15499	10	can	can	MD
cord-005453-4057qib7	15499	11	reduce	reduce	VB
cord-005453-4057qib7	15499	12	survival	survival	NN
cord-005453-4057qib7	15499	13	after	after	IN
cord-005453-4057qib7	15499	14	HSCT	HSCT	NNP
cord-005453-4057qib7	15499	15	.	.	.
cord-005453-4057qib7	15500	1	Risk	risk	NN
cord-005453-4057qib7	15500	2	factors	factor	NNS
cord-005453-4057qib7	15500	3	have	have	VBP
cord-005453-4057qib7	15500	4	been	be	VBN
cord-005453-4057qib7	15500	5	variably	variably	RB
cord-005453-4057qib7	15500	6	reported	report	VBN
cord-005453-4057qib7	15500	7	in	in	IN
cord-005453-4057qib7	15500	8	adults	adult	NNS
cord-005453-4057qib7	15500	9	although	although	IN
cord-005453-4057qib7	15500	10	data	datum	NNS
cord-005453-4057qib7	15500	11	on	on	IN
cord-005453-4057qib7	15500	12	children	child	NNS
cord-005453-4057qib7	15500	13	remains	remain	VBZ
cord-005453-4057qib7	15500	14	scarce	scarce	JJ
cord-005453-4057qib7	15500	15	.	.	.
cord-005453-4057qib7	15501	1	We	-PRON-	PRP
cord-005453-4057qib7	15501	2	aimed	aim	VBD
cord-005453-4057qib7	15501	3	to	to	TO
cord-005453-4057qib7	15501	4	identify	identify	VB
cord-005453-4057qib7	15501	5	a	a	DT
cord-005453-4057qib7	15501	6	risk	risk	NN
cord-005453-4057qib7	15501	7	profile	profile	NN
cord-005453-4057qib7	15501	8	for	for	IN
cord-005453-4057qib7	15501	9	development	development	NN
cord-005453-4057qib7	15501	10	of	of	IN
cord-005453-4057qib7	15501	11	TA	TA	NNP
cord-005453-4057qib7	15501	12	-	-	HYPH
cord-005453-4057qib7	15501	13	TMA	TMA	NNP
cord-005453-4057qib7	15501	14	in	in	IN
cord-005453-4057qib7	15501	15	children	child	NNS
cord-005453-4057qib7	15501	16	undergoing	undergo	VBG
cord-005453-4057qib7	15501	17	HSCT.Methods	hsct.method	VBZ
cord-005453-4057qib7	15501	18	:	:	:
cord-005453-4057qib7	15502	1	We	-PRON-	PRP
cord-005453-4057qib7	15502	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	15502	3	reviewed	review	VBD
cord-005453-4057qib7	15502	4	clinical	clinical	JJ
cord-005453-4057qib7	15502	5	charts	chart	NNS
cord-005453-4057qib7	15502	6	of	of	IN
cord-005453-4057qib7	15502	7	398	398	CD
cord-005453-4057qib7	15502	8	children	child	NNS
cord-005453-4057qib7	15502	9	who	who	WP
cord-005453-4057qib7	15502	10	underwent	undergo	VBD
cord-005453-4057qib7	15502	11	406	406	CD
cord-005453-4057qib7	15502	12	HSCTs	hsct	NNS
cord-005453-4057qib7	15502	13	between	between	IN
cord-005453-4057qib7	15502	14	2013	2013	CD
cord-005453-4057qib7	15502	15	-	-	SYM
cord-005453-4057qib7	15502	16	16	16	CD
cord-005453-4057qib7	15502	17	:	:	:
cord-005453-4057qib7	15502	18	at	at	IN
cord-005453-4057qib7	15502	19	Great	Great	NNP
cord-005453-4057qib7	15502	20	Ormond	Ormond	NNP
cord-005453-4057qib7	15502	21	Street	Street	NNP
cord-005453-4057qib7	15502	22	Hospital	Hospital	NNP
cord-005453-4057qib7	15502	23	(	(	-LRB-
cord-005453-4057qib7	15502	24	GOSH	GOSH	NNP
cord-005453-4057qib7	15502	25	)	)	-RRB-
cord-005453-4057qib7	15502	26	and	and	CC
cord-005453-4057qib7	15502	27	the	the	DT
cord-005453-4057qib7	15502	28	Great	Great	NNP
cord-005453-4057qib7	15502	29	North	North	NNP
cord-005453-4057qib7	15502	30	Children	Children	NNPS
cord-005453-4057qib7	15502	31	's	's	POS
cord-005453-4057qib7	15502	32	Hospital	Hospital	NNP
cord-005453-4057qib7	15502	33	(	(	-LRB-
cord-005453-4057qib7	15502	34	GNCH	GNCH	NNP
cord-005453-4057qib7	15502	35	)	)	-RRB-
cord-005453-4057qib7	15502	36	.	.	.
cord-005453-4057qib7	15503	1	TA	TA	NNP
cord-005453-4057qib7	15503	2	-	-	HYPH
cord-005453-4057qib7	15503	3	TMA	TMA	NNP
cord-005453-4057qib7	15503	4	was	be	VBD
cord-005453-4057qib7	15503	5	defined	define	VBN
cord-005453-4057qib7	15503	6	according	accord	VBG
cord-005453-4057qib7	15503	7	to	to	IN
cord-005453-4057qib7	15503	8	revised	revise	VBN
cord-005453-4057qib7	15503	9	criteria	criterion	NNS
cord-005453-4057qib7	15503	10	(	(	-LRB-
cord-005453-4057qib7	15503	11	Jodele	Jodele	NNP
cord-005453-4057qib7	15503	12	et	et	NNP
cord-005453-4057qib7	15503	13	al	al	NNP
cord-005453-4057qib7	15503	14	.	.	NNP
cord-005453-4057qib7	15503	15	2013	2013	CD
cord-005453-4057qib7	15503	16	)	)	-RRB-
cord-005453-4057qib7	15503	17	.	.	.
cord-005453-4057qib7	15504	1	Risk	risk	NN
cord-005453-4057qib7	15504	2	factors	factor	NNS
cord-005453-4057qib7	15504	3	were	be	VBD
cord-005453-4057qib7	15504	4	categorized	categorize	VBN
cord-005453-4057qib7	15504	5	into	into	IN
cord-005453-4057qib7	15504	6	patient	patient	NN
cord-005453-4057qib7	15504	7	derived	derive	VBN
cord-005453-4057qib7	15504	8	[	[	-LRB-
cord-005453-4057qib7	15504	9	age	age	NN
cord-005453-4057qib7	15504	10	,	,	,
cord-005453-4057qib7	15504	11	gender	gender	NN
cord-005453-4057qib7	15504	12	,	,	,
cord-005453-4057qib7	15504	13	active	active	JJ
cord-005453-4057qib7	15504	14	co	co	NN
cord-005453-4057qib7	15504	15	-	-	NN
cord-005453-4057qib7	15504	16	morbidity	morbidity	NN
cord-005453-4057qib7	15504	17	at	at	IN
cord-005453-4057qib7	15504	18	D0	d0	NN
cord-005453-4057qib7	15504	19	of	of	IN
cord-005453-4057qib7	15504	20	HSCT	HSCT	NNP
cord-005453-4057qib7	15504	21	(	(	-LRB-
cord-005453-4057qib7	15504	22	uncontrolled	uncontrolled	JJ
cord-005453-4057qib7	15504	23	viral/	viral/	CD
cord-005453-4057qib7	15504	24	bacterial	bacterial	JJ
cord-005453-4057qib7	15504	25	or	or	CC
cord-005453-4057qib7	15504	26	fungal	fungal	JJ
cord-005453-4057qib7	15504	27	infection	infection	NN
cord-005453-4057qib7	15504	28	,	,	,
cord-005453-4057qib7	15504	29	pulmonary	pulmonary	JJ
cord-005453-4057qib7	15504	30	,	,	,
cord-005453-4057qib7	15504	31	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	15504	32	instability	instability	NN
cord-005453-4057qib7	15504	33	,	,	,
cord-005453-4057qib7	15504	34	steroid	steroid	NN
cord-005453-4057qib7	15504	35	therapy	therapy	NN
cord-005453-4057qib7	15504	36	>	>	XX
cord-005453-4057qib7	15505	1	0.3mg	0.3mg	LS
cord-005453-4057qib7	15505	2	/	/	SYM
cord-005453-4057qib7	15505	3	kg	kg	NNS
cord-005453-4057qib7	15505	4	beyond	beyond	IN
cord-005453-4057qib7	15505	5	D0	d0	NN
cord-005453-4057qib7	15505	6	,	,	,
cord-005453-4057qib7	15505	7	BCGiosis	BCGiosis	NNP
cord-005453-4057qib7	15505	8	or	or	CC
cord-005453-4057qib7	15505	9	autoimmune	autoimmune	JJ
cord-005453-4057qib7	15505	10	disease	disease	NN
cord-005453-4057qib7	15505	11	)	)	-RRB-
cord-005453-4057qib7	15505	12	,	,	,
cord-005453-4057qib7	15505	13	transplant	transplant	NN
cord-005453-4057qib7	15505	14	related	relate	VBN
cord-005453-4057qib7	15505	15	factors	factor	NNS
cord-005453-4057qib7	15505	16	(	(	-LRB-
cord-005453-4057qib7	15505	17	conditioning	conditioning	NN
cord-005453-4057qib7	15505	18	intensity	intensity	NN
cord-005453-4057qib7	15505	19	,	,	,
cord-005453-4057qib7	15505	20	stem	stem	NN
cord-005453-4057qib7	15505	21	cell	cell	NN
cord-005453-4057qib7	15505	22	source	source	NN
cord-005453-4057qib7	15505	23	,	,	,
cord-005453-4057qib7	15505	24	HLA	HLA	NNP
cord-005453-4057qib7	15505	25	-	-	HYPH
cord-005453-4057qib7	15505	26	matching	matching	NN
cord-005453-4057qib7	15505	27	,	,	,
cord-005453-4057qib7	15505	28	use	use	NN
cord-005453-4057qib7	15505	29	of	of	IN
cord-005453-4057qib7	15505	30	Ciclosporin	Ciclosporin	NNP
cord-005453-4057qib7	15505	31	A	A	NNP
cord-005453-4057qib7	15505	32	(	(	-LRB-
cord-005453-4057qib7	15505	33	CSA	CSA	NNP
cord-005453-4057qib7	15505	34	)	)	-RRB-
cord-005453-4057qib7	15505	35	or	or	CC
cord-005453-4057qib7	15505	36	Tacrolimus	Tacrolimus	NNP
cord-005453-4057qib7	15505	37	(	(	-LRB-
cord-005453-4057qib7	15505	38	Tac	Tac	NNP
cord-005453-4057qib7	15505	39	)	)	-RRB-
cord-005453-4057qib7	15505	40	,	,	,
cord-005453-4057qib7	15505	41	CD34	CD34	NNP
cord-005453-4057qib7	15505	42	+	+	CC
cord-005453-4057qib7	15505	43	dose	dose	NN
cord-005453-4057qib7	15505	44	,	,	,
cord-005453-4057qib7	15505	45	ex	ex	JJ
cord-005453-4057qib7	15505	46	-	-	JJ
cord-005453-4057qib7	15505	47	vivo	vivo	JJ
cord-005453-4057qib7	15505	48	T	t	NN
cord-005453-4057qib7	15505	49	cell	cell	NN
cord-005453-4057qib7	15505	50	depletion	depletion	NN
cord-005453-4057qib7	15505	51	,	,	,
cord-005453-4057qib7	15505	52	use	use	NN
cord-005453-4057qib7	15505	53	of	of	IN
cord-005453-4057qib7	15505	54	Defibrotide	Defibrotide	NNP
cord-005453-4057qib7	15505	55	)	)	-RRB-
cord-005453-4057qib7	15505	56	and	and	CC
cord-005453-4057qib7	15505	57	post	post	JJ
cord-005453-4057qib7	15505	58	-	-	JJ
cord-005453-4057qib7	15505	59	HSCT	hsct	JJ
cord-005453-4057qib7	15505	60	factors	factor	NNS
cord-005453-4057qib7	15505	61	(	(	-LRB-
cord-005453-4057qib7	15505	62	aGvHD	agvhd	NN
cord-005453-4057qib7	15505	63	,	,	,
cord-005453-4057qib7	15505	64	post	post	JJ
cord-005453-4057qib7	15505	65	-	-	JJ
cord-005453-4057qib7	15505	66	HSCT	hsct	JJ
cord-005453-4057qib7	15505	67	viral	viral	JJ
cord-005453-4057qib7	15505	68	reactivation	reactivation	NN
cord-005453-4057qib7	15505	69	,	,	,
cord-005453-4057qib7	15505	70	venoocclusive	venoocclusive	JJ
cord-005453-4057qib7	15505	71	disease	disease	NN
cord-005453-4057qib7	15505	72	(	(	-LRB-
cord-005453-4057qib7	15505	73	VOD	VOD	NNP
cord-005453-4057qib7	15505	74	)	)	-RRB-
cord-005453-4057qib7	15505	75	and	and	CC
cord-005453-4057qib7	15505	76	occurrence	occurrence	NN
cord-005453-4057qib7	15505	77	of	of	IN
cord-005453-4057qib7	15505	78	posterior	posterior	JJ
cord-005453-4057qib7	15505	79	reversible	reversible	JJ
cord-005453-4057qib7	15505	80	leukoencephalopathy	leukoencephalopathy	NNS
cord-005453-4057qib7	15505	81	(	(	-LRB-
cord-005453-4057qib7	15505	82	PRES).Results	PRES).Results	NNP
cord-005453-4057qib7	15505	83	:	:	:
cord-005453-4057qib7	15506	1	At	at	IN
cord-005453-4057qib7	15506	2	a	a	DT
cord-005453-4057qib7	15506	3	median	median	NN
cord-005453-4057qib7	15506	4	of	of	IN
cord-005453-4057qib7	15506	5	7	7	CD
cord-005453-4057qib7	15506	6	months	month	NNS
cord-005453-4057qib7	15506	7	post	post	JJ
cord-005453-4057qib7	15506	8	-	-	JJ
cord-005453-4057qib7	15506	9	HSCT	HSCT	NNP
cord-005453-4057qib7	15506	10	,	,	,
cord-005453-4057qib7	15506	11	TA	TA	NNP
cord-005453-4057qib7	15506	12	-	-	HYPH
cord-005453-4057qib7	15506	13	TMA	TMA	NNP
cord-005453-4057qib7	15506	14	occurred	occur	VBD
cord-005453-4057qib7	15506	15	among	among	IN
cord-005453-4057qib7	15506	16	21/406	21/406	CD
cord-005453-4057qib7	15506	17	transplants	transplant	NNS
cord-005453-4057qib7	15506	18	(	(	-LRB-
cord-005453-4057qib7	15506	19	5.1	5.1	CD
cord-005453-4057qib7	15506	20	%	%	NN
cord-005453-4057qib7	15506	21	)	)	-RRB-
cord-005453-4057qib7	15506	22	.	.	.
cord-005453-4057qib7	15507	1	There	there	EX
cord-005453-4057qib7	15507	2	was	be	VBD
cord-005453-4057qib7	15507	3	no	no	DT
cord-005453-4057qib7	15507	4	reported	report	VBN
cord-005453-4057qib7	15507	5	centre	centre	NN
cord-005453-4057qib7	15507	6	variation	variation	NN
cord-005453-4057qib7	15507	7	(	(	-LRB-
cord-005453-4057qib7	15507	8	5.7	5.7	CD
cord-005453-4057qib7	15507	9	%	%	NN
cord-005453-4057qib7	15507	10	vs	vs	IN
cord-005453-4057qib7	15507	11	4.6	4.6	CD
cord-005453-4057qib7	15507	12	%	%	NN
cord-005453-4057qib7	15507	13	in	in	IN
cord-005453-4057qib7	15507	14	GOSH	GOSH	NNP
cord-005453-4057qib7	15507	15	vs	vs	IN
cord-005453-4057qib7	15507	16	GNCH	GNCH	NNP
cord-005453-4057qib7	15507	17	;	;	:
cord-005453-4057qib7	15507	18	p=0.6	p=0.6	NNP
cord-005453-4057qib7	15507	19	)	)	-RRB-
cord-005453-4057qib7	15507	20	.	.	.
cord-005453-4057qib7	15508	1	Gender	gender	NN
cord-005453-4057qib7	15508	2	,	,	,
cord-005453-4057qib7	15508	3	underlying	underlie	VBG
cord-005453-4057qib7	15508	4	disease	disease	NN
cord-005453-4057qib7	15508	5	-primary	-primary	JJ
cord-005453-4057qib7	15508	6	immune	immune	JJ
cord-005453-4057qib7	15508	7	deficiency	deficiency	NN
cord-005453-4057qib7	15508	8	(	(	-LRB-
cord-005453-4057qib7	15508	9	PID	PID	NNP
cord-005453-4057qib7	15508	10	)	)	-RRB-
cord-005453-4057qib7	15508	11	(	(	-LRB-
cord-005453-4057qib7	15508	12	n=273	n=273	NNP
cord-005453-4057qib7	15508	13	)	)	-RRB-
cord-005453-4057qib7	15508	14	vs	vs	IN
cord-005453-4057qib7	15508	15	haematological	haematological	NN
cord-005453-4057qib7	15508	16	disease	disease	NN
cord-005453-4057qib7	15508	17	(	(	-LRB-
cord-005453-4057qib7	15508	18	n=133	n=133	NNP
cord-005453-4057qib7	15508	19	)	)	-RRB-
cord-005453-4057qib7	15508	20	,	,	,
cord-005453-4057qib7	15508	21	use	use	NN
cord-005453-4057qib7	15508	22	of	of	IN
cord-005453-4057qib7	15508	23	myeloablative	myeloablative	NNP
cord-005453-4057qib7	15508	24	(	(	-LRB-
cord-005453-4057qib7	15508	25	n=153	n=153	NNP
cord-005453-4057qib7	15508	26	)	)	-RRB-
cord-005453-4057qib7	15508	27	vs	vs	IN
cord-005453-4057qib7	15508	28	reducedor	reducedor	JJ
cord-005453-4057qib7	15508	29	minimal	minimal	JJ
cord-005453-4057qib7	15508	30	intensity	intensity	NN
cord-005453-4057qib7	15508	31	conditioning	conditioning	NN
cord-005453-4057qib7	15508	32	(	(	-LRB-
cord-005453-4057qib7	15508	33	n=229	n=229	NNP
cord-005453-4057qib7	15508	34	)	)	-RRB-
cord-005453-4057qib7	15508	35	,	,	,
cord-005453-4057qib7	15508	36	use	use	NN
cord-005453-4057qib7	15508	37	of	of	IN
cord-005453-4057qib7	15508	38	serotherapy	serotherapy	NN
cord-005453-4057qib7	15508	39	or	or	CC
cord-005453-4057qib7	15508	40	mega	mega	JJ
cord-005453-4057qib7	15508	41	doses	dose	NNS
cord-005453-4057qib7	15508	42	of	of	IN
cord-005453-4057qib7	15508	43	CD34	CD34	NNP
cord-005453-4057qib7	15508	44	≥10	≥10	NNP
cord-005453-4057qib7	15508	45	X10	X10	NNP
cord-005453-4057qib7	15508	46	*	*	NFP
cord-005453-4057qib7	15508	47	6	6	CD
cord-005453-4057qib7	15508	48	/	/	SYM
cord-005453-4057qib7	15508	49	Kg	Kg	NNP
cord-005453-4057qib7	15508	50	did	do	VBD
cord-005453-4057qib7	15508	51	not	not	RB
cord-005453-4057qib7	15508	52	influence	influence	VB
cord-005453-4057qib7	15508	53	the	the	DT
cord-005453-4057qib7	15508	54	development	development	NN
cord-005453-4057qib7	15508	55	of	of	IN
cord-005453-4057qib7	15508	56	TA	TA	NNP
cord-005453-4057qib7	15508	57	-	-	HYPH
cord-005453-4057qib7	15508	58	TMA	TMA	NNP
cord-005453-4057qib7	15508	59	.	.	.
cord-005453-4057qib7	15509	1	Donor	donor	NN
cord-005453-4057qib7	15509	2	type	type	NN
cord-005453-4057qib7	15509	3	:	:	:
cord-005453-4057qib7	15509	4	MSD/	MSD/	NNP
cord-005453-4057qib7	15509	5	MFD(n=100	MFD(n=100	NNP
cord-005453-4057qib7	15509	6	)	)	-RRB-
cord-005453-4057qib7	15509	7	vs	vs	IN
cord-005453-4057qib7	15509	8	MUD	MUD	NNP
cord-005453-4057qib7	15509	9	(	(	-LRB-
cord-005453-4057qib7	15509	10	n=129	n=129	NNP
cord-005453-4057qib7	15509	11	)	)	-RRB-
cord-005453-4057qib7	15509	12	vs	vs	IN
cord-005453-4057qib7	15509	13	MMUD	MMUD	NNP
cord-005453-4057qib7	15509	14	/	/	SYM
cord-005453-4057qib7	15509	15	Haplo	Haplo	NNP
cord-005453-4057qib7	15509	16	-	-	HYPH
cord-005453-4057qib7	15509	17	HSCT	HSCT	NNP
cord-005453-4057qib7	15509	18	Background	Background	NNP
cord-005453-4057qib7	15510	1	:	:	:
cord-005453-4057qib7	15510	2	We	-PRON-	PRP
cord-005453-4057qib7	15510	3	evaluated	evaluate	VBD
cord-005453-4057qib7	15510	4	the	the	DT
cord-005453-4057qib7	15510	5	outcome	outcome	NN
cord-005453-4057qib7	15510	6	of	of	IN
cord-005453-4057qib7	15510	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15510	8	HCT	HCT	NNP
cord-005453-4057qib7	15510	9	(	(	-LRB-
cord-005453-4057qib7	15510	10	HHCT	HHCT	NNP
cord-005453-4057qib7	15510	11	)	)	-RRB-
cord-005453-4057qib7	15510	12	using	use	VBG
cord-005453-4057qib7	15510	13	ex	ex	FW
cord-005453-4057qib7	15510	14	vivo	vivo	FW
cord-005453-4057qib7	15510	15	αβ	αβ	FW
cord-005453-4057qib7	15510	16	T	t	NN
cord-005453-4057qib7	15510	17	cell	cell	NN
cord-005453-4057qib7	15510	18	-	-	HYPH
cord-005453-4057qib7	15510	19	depleted	deplete	VBN
cord-005453-4057qib7	15510	20	(	(	-LRB-
cord-005453-4057qib7	15510	21	TCD	TCD	NNP
cord-005453-4057qib7	15510	22	)	)	-RRB-
cord-005453-4057qib7	15510	23	grafts	graft	NNS
cord-005453-4057qib7	15510	24	after	after	IN
cord-005453-4057qib7	15510	25	reduced	reduce	VBN
cord-005453-4057qib7	15510	26	-	-	HYPH
cord-005453-4057qib7	15510	27	intensity	intensity	NN
cord-005453-4057qib7	15510	28	conditioning	conditioning	NN
cord-005453-4057qib7	15510	29	(	(	-LRB-
cord-005453-4057qib7	15510	30	RIC	RIC	NNP
cord-005453-4057qib7	15510	31	)	)	-RRB-
cord-005453-4057qib7	15510	32	containing	contain	VBG
cord-005453-4057qib7	15510	33	low	low	JJ
cord-005453-4057qib7	15510	34	-	-	HYPH
cord-005453-4057qib7	15510	35	dose	dose	NN
cord-005453-4057qib7	15510	36	TBI	TBI	NNP
cord-005453-4057qib7	15510	37	(	(	-LRB-
cord-005453-4057qib7	15510	38	LD	LD	NNP
cord-005453-4057qib7	15510	39	-	-	HYPH
cord-005453-4057qib7	15510	40	TBI	TBI	NNP
cord-005453-4057qib7	15510	41	)	)	-RRB-
cord-005453-4057qib7	15510	42	in	in	IN
cord-005453-4057qib7	15510	43	pediatric	pediatric	JJ
cord-005453-4057qib7	15510	44	patients	patient	NNS
cord-005453-4057qib7	15510	45	with	with	IN
cord-005453-4057qib7	15510	46	acute	acute	JJ
cord-005453-4057qib7	15510	47	leukemia	leukemia	NN
cord-005453-4057qib7	15510	48	(	(	-LRB-
cord-005453-4057qib7	15510	49	AL	AL	NNP
cord-005453-4057qib7	15510	50	)	)	-RRB-
cord-005453-4057qib7	15510	51	in	in	IN
cord-005453-4057qib7	15510	52	complete	complete	JJ
cord-005453-4057qib7	15510	53	remission	remission	NN
cord-005453-4057qib7	15510	54	(	(	-LRB-
cord-005453-4057qib7	15510	55	CR).Methods	cr).method	NNS
cord-005453-4057qib7	15510	56	:	:	:
cord-005453-4057qib7	15510	57	Between	between	IN
cord-005453-4057qib7	15510	58	May	May	NNP
cord-005453-4057qib7	15510	59	2012	2012	CD
cord-005453-4057qib7	15510	60	and	and	CC
cord-005453-4057qib7	15510	61	October	October	NNP
cord-005453-4057qib7	15510	62	2018	2018	CD
cord-005453-4057qib7	15510	63	,	,	,
cord-005453-4057qib7	15510	64	36	36	CD
cord-005453-4057qib7	15510	65	patients	patient	NNS
cord-005453-4057qib7	15510	66	with	with	IN
cord-005453-4057qib7	15510	67	acute	acute	JJ
cord-005453-4057qib7	15510	68	leukemia	leukemia	NN
cord-005453-4057qib7	15510	69	(	(	-LRB-
cord-005453-4057qib7	15510	70	17	17	CD
cord-005453-4057qib7	15510	71	ALL	all	DT
cord-005453-4057qib7	15510	72	and	and	CC
cord-005453-4057qib7	15510	73	19	19	CD
cord-005453-4057qib7	15510	74	AML	AML	NNP
cord-005453-4057qib7	15510	75	)	)	-RRB-
cord-005453-4057qib7	15510	76	in	in	IN
cord-005453-4057qib7	15510	77	CR	CR	NNP
cord-005453-4057qib7	15510	78	received	receive	VBD
cord-005453-4057qib7	15510	79	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15510	80	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15510	81	cell	cell	NN
cord-005453-4057qib7	15510	82	transplantation	transplantation	NN
cord-005453-4057qib7	15510	83	(	(	-LRB-
cord-005453-4057qib7	15510	84	HHCT	HHCT	NNP
cord-005453-4057qib7	15510	85	)	)	-RRB-
cord-005453-4057qib7	15510	86	using	use	VBG
cord-005453-4057qib7	15510	87	TCRαβ	TCRαβ	NNP
cord-005453-4057qib7	15510	88	-	-	HYPH
cord-005453-4057qib7	15510	89	depleted	deplete	VBN
cord-005453-4057qib7	15510	90	graft	graft	NN
cord-005453-4057qib7	15510	91	at	at	IN
cord-005453-4057qib7	15510	92	Asan	Asan	NNP
cord-005453-4057qib7	15510	93	Medical	Medical	NNP
cord-005453-4057qib7	15510	94	Center	Center	NNP
cord-005453-4057qib7	15510	95	Children	Children	NNPS
cord-005453-4057qib7	15510	96	's	's	POS
cord-005453-4057qib7	15510	97	Hospital	Hospital	NNP
cord-005453-4057qib7	15510	98	.	.	.
cord-005453-4057qib7	15511	1	Eighteen	eighteen	CD
cord-005453-4057qib7	15511	2	patients	patient	NNS
cord-005453-4057qib7	15511	3	received	receive	VBD
cord-005453-4057qib7	15511	4	HHCT	HHCT	NNP
cord-005453-4057qib7	15511	5	between	between	IN
cord-005453-4057qib7	15511	6	2012	2012	CD
cord-005453-4057qib7	15511	7	and	and	CC
cord-005453-4057qib7	15511	8	2015	2015	CD
cord-005453-4057qib7	15511	9	(	(	-LRB-
cord-005453-4057qib7	15511	10	earlier	early	JJR
cord-005453-4057qib7	15511	11	time	time	NN
cord-005453-4057qib7	15511	12	period	period	NN
cord-005453-4057qib7	15511	13	)	)	-RRB-
cord-005453-4057qib7	15511	14	and	and	CC
cord-005453-4057qib7	15511	15	the	the	DT
cord-005453-4057qib7	15511	16	remaining	remain	VBG
cord-005453-4057qib7	15511	17	18	18	CD
cord-005453-4057qib7	15511	18	between	between	IN
cord-005453-4057qib7	15511	19	2016	2016	CD
cord-005453-4057qib7	15511	20	and	and	CC
cord-005453-4057qib7	15511	21	2018	2018	CD
cord-005453-4057qib7	15511	22	(	(	-LRB-
cord-005453-4057qib7	15511	23	recent	recent	JJ
cord-005453-4057qib7	15511	24	study	study	NN
cord-005453-4057qib7	15511	25	period	period	NN
cord-005453-4057qib7	15511	26	)	)	-RRB-
cord-005453-4057qib7	15511	27	.	.	.
cord-005453-4057qib7	15512	1	The	the	DT
cord-005453-4057qib7	15512	2	conditioning	conditioning	NN
cord-005453-4057qib7	15512	3	regimens	regimen	NNS
cord-005453-4057qib7	15512	4	,	,	,
cord-005453-4057qib7	15512	5	the	the	DT
cord-005453-4057qib7	15512	6	dose	dose	NN
cord-005453-4057qib7	15512	7	of	of	IN
cord-005453-4057qib7	15512	8	αβ+	αβ+	NN
cord-005453-4057qib7	15512	9	T	t	NN
cord-005453-4057qib7	15512	10	cells	cell	NNS
cord-005453-4057qib7	15512	11	and	and	CC
cord-005453-4057qib7	15512	12	GVHD	GVHD	NNP
cord-005453-4057qib7	15512	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15512	14	are	be	VBP
cord-005453-4057qib7	15512	15	summarized	summarize	VBN
cord-005453-4057qib7	15512	16	in	in	IN
cord-005453-4057qib7	15512	17	Table	Table	NNP
cord-005453-4057qib7	15512	18	.	.	.
cord-005453-4057qib7	15513	1	Results	result	NNS
cord-005453-4057qib7	15513	2	:	:	:
cord-005453-4057qib7	15514	1	All	all	DT
cord-005453-4057qib7	15514	2	36	36	CD
cord-005453-4057qib7	15514	3	patients	patient	NNS
cord-005453-4057qib7	15514	4	achieved	achieve	VBD
cord-005453-4057qib7	15514	5	a	a	DT
cord-005453-4057qib7	15514	6	sustained	sustained	JJ
cord-005453-4057qib7	15514	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	15514	8	engraftment	engraftment	NN
cord-005453-4057qib7	15514	9	at	at	IN
cord-005453-4057qib7	15514	10	a	a	DT
cord-005453-4057qib7	15514	11	median	median	NN
cord-005453-4057qib7	15514	12	of	of	IN
cord-005453-4057qib7	15514	13	10	10	CD
cord-005453-4057qib7	15514	14	days	day	NNS
cord-005453-4057qib7	15514	15	(	(	-LRB-
cord-005453-4057qib7	15514	16	range	range	NN
cord-005453-4057qib7	15514	17	,	,	,
cord-005453-4057qib7	15514	18	9	9	CD
cord-005453-4057qib7	15514	19	-	-	SYM
cord-005453-4057qib7	15514	20	13	13	CD
cord-005453-4057qib7	15514	21	)	)	-RRB-
cord-005453-4057qib7	15514	22	.	.	.
cord-005453-4057qib7	15515	1	Of	of	IN
cord-005453-4057qib7	15515	2	36	36	CD
cord-005453-4057qib7	15515	3	patients	patient	NNS
cord-005453-4057qib7	15515	4	,	,	,
cord-005453-4057qib7	15515	5	11	11	CD
cord-005453-4057qib7	15515	6	patients	patient	NNS
cord-005453-4057qib7	15515	7	(	(	-LRB-
cord-005453-4057qib7	15515	8	8	8	CD
cord-005453-4057qib7	15515	9	ALL	all	DT
cord-005453-4057qib7	15515	10	&	&	CC
cord-005453-4057qib7	15515	11	4	4	CD
cord-005453-4057qib7	15515	12	AML	AML	NNP
cord-005453-4057qib7	15515	13	)	)	-RRB-
cord-005453-4057qib7	15515	14	relapsed	relapse	VBD
cord-005453-4057qib7	15515	15	at	at	IN
cord-005453-4057qib7	15515	16	a	a	DT
cord-005453-4057qib7	15515	17	median	median	NN
cord-005453-4057qib7	15515	18	of	of	IN
cord-005453-4057qib7	15515	19	6	6	CD
cord-005453-4057qib7	15515	20	months	month	NNS
cord-005453-4057qib7	15515	21	(	(	-LRB-
cord-005453-4057qib7	15515	22	range	range	NN
cord-005453-4057qib7	15515	23	,	,	,
cord-005453-4057qib7	15515	24	3	3	CD
cord-005453-4057qib7	15515	25	-	-	SYM
cord-005453-4057qib7	15515	26	16	16	CD
cord-005453-4057qib7	15515	27	)	)	-RRB-
cord-005453-4057qib7	15515	28	after	after	IN
cord-005453-4057qib7	15515	29	transplant	transplant	NN
cord-005453-4057qib7	15515	30	.	.	.
cord-005453-4057qib7	15516	1	Of	of	IN
cord-005453-4057qib7	15516	2	the	the	DT
cord-005453-4057qib7	15516	3	11	11	CD
cord-005453-4057qib7	15516	4	patients	patient	NNS
cord-005453-4057qib7	15516	5	,	,	,
cord-005453-4057qib7	15516	6	10	10	CD
cord-005453-4057qib7	15516	7	patients	patient	NNS
cord-005453-4057qib7	15516	8	died	die	VBD
cord-005453-4057qib7	15516	9	of	of	IN
cord-005453-4057qib7	15516	10	disease	disease	NN
cord-005453-4057qib7	15516	11	.	.	.
cord-005453-4057qib7	15517	1	One	one	CD
cord-005453-4057qib7	15517	2	patient	patient	NN
cord-005453-4057qib7	15517	3	died	die	VBD
cord-005453-4057qib7	15517	4	of	of	IN
cord-005453-4057qib7	15517	5	disseminated	disseminate	VBN
cord-005453-4057qib7	15517	6	tuberculosis	tuberculosis	NN
cord-005453-4057qib7	15517	7	at	at	IN
cord-005453-4057qib7	15517	8	11	11	CD
cord-005453-4057qib7	15517	9	months	month	NNS
cord-005453-4057qib7	15517	10	after	after	IN
cord-005453-4057qib7	15517	11	transplant	transplant	NN
cord-005453-4057qib7	15517	12	,	,	,
cord-005453-4057qib7	15517	13	leading	lead	VBG
cord-005453-4057qib7	15517	14	to	to	IN
cord-005453-4057qib7	15517	15	the	the	DT
cord-005453-4057qib7	15517	16	TRM	TRM	NNP
cord-005453-4057qib7	15517	17	of	of	IN
cord-005453-4057qib7	15517	18	4	4	CD
cord-005453-4057qib7	15517	19	%	%	NN
cord-005453-4057qib7	15517	20	at	at	IN
cord-005453-4057qib7	15517	21	1	1	CD
cord-005453-4057qib7	15517	22	year	year	NN
cord-005453-4057qib7	15517	23	.	.	.
cord-005453-4057qib7	15518	1	As	as	IN
cord-005453-4057qib7	15518	2	of	of	IN
cord-005453-4057qib7	15518	3	December	December	NNP
cord-005453-4057qib7	15518	4	2018	2018	CD
cord-005453-4057qib7	15518	5	,	,	,
cord-005453-4057qib7	15518	6	25	25	CD
cord-005453-4057qib7	15518	7	of	of	IN
cord-005453-4057qib7	15518	8	the	the	DT
cord-005453-4057qib7	15518	9	36	36	CD
cord-005453-4057qib7	15518	10	patients	patient	NNS
cord-005453-4057qib7	15518	11	survive	survive	VBP
cord-005453-4057qib7	15518	12	free	free	JJ
cord-005453-4057qib7	15518	13	of	of	IN
cord-005453-4057qib7	15518	14	disease	disease	NN
cord-005453-4057qib7	15518	15	at	at	IN
cord-005453-4057qib7	15518	16	a	a	DT
cord-005453-4057qib7	15518	17	median	median	JJ
cord-005453-4057qib7	15518	18	follow	follow	NN
cord-005453-4057qib7	15518	19	-	-	HYPH
cord-005453-4057qib7	15518	20	up	up	NN
cord-005453-4057qib7	15518	21	of	of	IN
cord-005453-4057qib7	15518	22	21	21	CD
cord-005453-4057qib7	15518	23	months	month	NNS
cord-005453-4057qib7	15518	24	(	(	-LRB-
cord-005453-4057qib7	15518	25	range	range	NN
cord-005453-4057qib7	15518	26	,	,	,
cord-005453-4057qib7	15518	27	.	.	.
cord-005453-4057qib7	15519	1	At	at	IN
cord-005453-4057qib7	15519	2	a	a	DT
cord-005453-4057qib7	15519	3	median	median	JJ
cord-005453-4057qib7	15519	4	followup	followup	NN
cord-005453-4057qib7	15519	5	of	of	IN
cord-005453-4057qib7	15519	6	35	35	CD
cord-005453-4057qib7	15519	7	months	month	NNS
cord-005453-4057qib7	15519	8	(	(	-LRB-
cord-005453-4057qib7	15519	9	range	range	NN
cord-005453-4057qib7	15519	10	,	,	,
cord-005453-4057qib7	15519	11	1	1	CD
cord-005453-4057qib7	15519	12	-	-	SYM
cord-005453-4057qib7	15519	13	80	80	CD
cord-005453-4057qib7	15519	14	)	)	-RRB-
cord-005453-4057qib7	15519	15	,	,	,
cord-005453-4057qib7	15519	16	EFS	EFS	NNP
cord-005453-4057qib7	15519	17	and	and	CC
cord-005453-4057qib7	15519	18	OS	os	NN
cord-005453-4057qib7	15519	19	at	at	IN
cord-005453-4057qib7	15519	20	2	2	CD
cord-005453-4057qib7	15519	21	years	year	NNS
cord-005453-4057qib7	15519	22	for	for	IN
cord-005453-4057qib7	15519	23	all	all	DT
cord-005453-4057qib7	15519	24	patients	patient	NNS
cord-005453-4057qib7	15519	25	were	be	VBD
cord-005453-4057qib7	15519	26	59	59	CD
cord-005453-4057qib7	15519	27	%	%	NN
cord-005453-4057qib7	15519	28	and	and	CC
cord-005453-4057qib7	15519	29	67	67	CD
cord-005453-4057qib7	15519	30	%	%	NN
cord-005453-4057qib7	15519	31	,	,	,
cord-005453-4057qib7	15519	32	respectively	respectively	RB
cord-005453-4057qib7	15519	33	.	.	.
cord-005453-4057qib7	15520	1	Outcome	outcome	NN
cord-005453-4057qib7	15520	2	of	of	IN
cord-005453-4057qib7	15520	3	HHCT	HHCT	NNP
cord-005453-4057qib7	15520	4	in	in	IN
cord-005453-4057qib7	15520	5	the	the	DT
cord-005453-4057qib7	15520	6	recent	recent	JJ
cord-005453-4057qib7	15520	7	study	study	NN
cord-005453-4057qib7	15520	8	cohort	cohort	NN
cord-005453-4057qib7	15520	9	was	be	VBD
cord-005453-4057qib7	15520	10	significantly	significantly	RB
cord-005453-4057qib7	15520	11	better	well	JJR
cord-005453-4057qib7	15520	12	than	than	IN
cord-005453-4057qib7	15520	13	that	that	DT
cord-005453-4057qib7	15520	14	in	in	IN
cord-005453-4057qib7	15520	15	the	the	DT
cord-005453-4057qib7	15520	16	earlier	early	JJR
cord-005453-4057qib7	15520	17	study	study	NN
cord-005453-4057qib7	15520	18	period	period	NN
cord-005453-4057qib7	15520	19	(	(	-LRB-
cord-005453-4057qib7	15520	20	EFS	efs	NN
cord-005453-4057qib7	15520	21	of	of	IN
cord-005453-4057qib7	15520	22	85	85	CD
cord-005453-4057qib7	15520	23	%	%	NN
cord-005453-4057qib7	15520	24	vs	vs	IN
cord-005453-4057qib7	15520	25	EFS	EFS	NNP
cord-005453-4057qib7	15520	26	of	of	IN
cord-005453-4057qib7	15520	27	44	44	CD
cord-005453-4057qib7	15520	28	%	%	NN
cord-005453-4057qib7	15520	29	,	,	,
cord-005453-4057qib7	15520	30	P=0.05	p=0.05	JJ
cord-005453-4057qib7	15520	31	)	)	-RRB-
cord-005453-4057qib7	15520	32	.	.	.
cord-005453-4057qib7	15521	1	Among	among	IN
cord-005453-4057qib7	15521	2	the	the	DT
cord-005453-4057qib7	15521	3	17	17	CD
cord-005453-4057qib7	15521	4	patients	patient	NNS
cord-005453-4057qib7	15521	5	with	with	IN
cord-005453-4057qib7	15521	6	ALL	all	DT
cord-005453-4057qib7	15521	7	,	,	,
cord-005453-4057qib7	15521	8	the	the	DT
cord-005453-4057qib7	15521	9	EFS	efs	NN
cord-005453-4057qib7	15521	10	of	of	IN
cord-005453-4057qib7	15521	11	8	8	CD
cord-005453-4057qib7	15521	12	patients	patient	NNS
cord-005453-4057qib7	15521	13	,	,	,
cord-005453-4057qib7	15521	14	who	who	WP
cord-005453-4057qib7	15521	15	received	receive	VBD
cord-005453-4057qib7	15521	16	HHCT	HHCT	NNP
cord-005453-4057qib7	15521	17	in	in	IN
cord-005453-4057qib7	15521	18	early	early	JJ
cord-005453-4057qib7	15521	19	time	time	NN
cord-005453-4057qib7	15521	20	period	period	NN
cord-005453-4057qib7	15521	21	after	after	IN
cord-005453-4057qib7	15521	22	conditioning	conditioning	NN
cord-005453-4057qib7	15521	23	with	with	IN
cord-005453-4057qib7	15521	24	TBI	TBI	NNP
cord-005453-4057qib7	15521	25	of	of	IN
cord-005453-4057qib7	15521	26	600	600	CD
cord-005453-4057qib7	15521	27	cGy	cGy	NNS
cord-005453-4057qib7	15521	28	,	,	,
cord-005453-4057qib7	15521	29	was	be	VBD
cord-005453-4057qib7	15521	30	significantly	significantly	RB
cord-005453-4057qib7	15521	31	worse	bad	JJR
cord-005453-4057qib7	15521	32	than	than	IN
cord-005453-4057qib7	15521	33	that	that	DT
cord-005453-4057qib7	15521	34	of	of	IN
cord-005453-4057qib7	15521	35	9	9	CD
cord-005453-4057qib7	15521	36	patients	patient	NNS
cord-005453-4057qib7	15521	37	,	,	,
cord-005453-4057qib7	15521	38	who	who	WP
cord-005453-4057qib7	15521	39	received	receive	VBD
cord-005453-4057qib7	15521	40	in	in	IN
cord-005453-4057qib7	15521	41	recent	recent	JJ
cord-005453-4057qib7	15521	42	study	study	NN
cord-005453-4057qib7	15521	43	period	period	NN
cord-005453-4057qib7	15521	44	after	after	IN
cord-005453-4057qib7	15521	45	a	a	DT
cord-005453-4057qib7	15521	46	higher	high	JJR
cord-005453-4057qib7	15521	47	dose	dose	NN
cord-005453-4057qib7	15521	48	of	of	IN
cord-005453-4057qib7	15521	49	TBI	TBI	NNP
cord-005453-4057qib7	15521	50	at	at	IN
cord-005453-4057qib7	15521	51	800cGy	800cgy	CD
cord-005453-4057qib7	15521	52	(	(	-LRB-
cord-005453-4057qib7	15521	53	13	13	CD
cord-005453-4057qib7	15521	54	%	%	NN
cord-005453-4057qib7	15521	55	vs	vs	IN
cord-005453-4057qib7	15521	56	83	83	CD
cord-005453-4057qib7	15521	57	%	%	NN
cord-005453-4057qib7	15521	58	,	,	,
cord-005453-4057qib7	15521	59	P	p	NN
cord-005453-4057qib7	15521	60	<	<	XX
cord-005453-4057qib7	15521	61	0.05	0.05	CD
cord-005453-4057qib7	15521	62	)	)	-RRB-
cord-005453-4057qib7	15521	63	.	.	.
cord-005453-4057qib7	15522	1	The	the	DT
cord-005453-4057qib7	15522	2	EFSs	efs	NNS
cord-005453-4057qib7	15522	3	of	of	IN
cord-005453-4057qib7	15522	4	AML	AML	NNP
cord-005453-4057qib7	15522	5	were	be	VBD
cord-005453-4057qib7	15522	6	similar	similar	JJ
cord-005453-4057qib7	15522	7	between	between	IN
cord-005453-4057qib7	15522	8	the	the	DT
cord-005453-4057qib7	15522	9	two	two	CD
cord-005453-4057qib7	15522	10	study	study	NN
cord-005453-4057qib7	15522	11	groups	group	NNS
cord-005453-4057qib7	15522	12	(	(	-LRB-
cord-005453-4057qib7	15522	13	70	70	CD
cord-005453-4057qib7	15522	14	%	%	NN
cord-005453-4057qib7	15522	15	for	for	IN
cord-005453-4057qib7	15522	16	earlier	early	JJR
cord-005453-4057qib7	15522	17	cohort	cohort	NN
cord-005453-4057qib7	15522	18	vs	vs	IN
cord-005453-4057qib7	15522	19	86	86	CD
cord-005453-4057qib7	15522	20	%	%	NN
cord-005453-4057qib7	15522	21	for	for	IN
cord-005453-4057qib7	15522	22	recent	recent	JJ
cord-005453-4057qib7	15522	23	study	study	NN
cord-005453-4057qib7	15522	24	,	,	,
cord-005453-4057qib7	15522	25	P>0.05).Conclusions	p>0.05).conclusion	NNS
cord-005453-4057qib7	15522	26	:	:	:
cord-005453-4057qib7	15523	1	In	in	IN
cord-005453-4057qib7	15523	2	pediatric	pediatric	JJ
cord-005453-4057qib7	15523	3	patients	patient	NNS
cord-005453-4057qib7	15523	4	with	with	IN
cord-005453-4057qib7	15523	5	acute	acute	JJ
cord-005453-4057qib7	15523	6	leukemia	leukemia	NN
cord-005453-4057qib7	15523	7	in	in	IN
cord-005453-4057qib7	15523	8	CR	CR	NNP
cord-005453-4057qib7	15523	9	,	,	,
cord-005453-4057qib7	15523	10	our	-PRON-	PRP$
cord-005453-4057qib7	15523	11	current	current	JJ
cord-005453-4057qib7	15523	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15523	13	HCT	hct	NN
cord-005453-4057qib7	15523	14	using	use	VBG
cord-005453-4057qib7	15523	15	ex	ex	FW
cord-005453-4057qib7	15523	16	vivo	vivo	FW
cord-005453-4057qib7	15523	17	αβ	αβ	FW
cord-005453-4057qib7	15523	18	TCD	TCD	NNP
cord-005453-4057qib7	15523	19	graft	graft	NN
cord-005453-4057qib7	15523	20	after	after	IN
cord-005453-4057qib7	15523	21	RIC	RIC	NNP
cord-005453-4057qib7	15523	22	containing	contain	VBG
cord-005453-4057qib7	15523	23	LD	LD	NNP
cord-005453-4057qib7	15523	24	-	-	HYPH
cord-005453-4057qib7	15523	25	TBI	TBI	NNP
cord-005453-4057qib7	15523	26	without	without	IN
cord-005453-4057qib7	15523	27	GVHD	GVHD	NNP
cord-005453-4057qib7	15523	28	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15523	29	is	be	VBZ
cord-005453-4057qib7	15523	30	feasible	feasible	JJ
cord-005453-4057qib7	15523	31	approach	approach	NN
cord-005453-4057qib7	15523	32	with	with	IN
cord-005453-4057qib7	15523	33	a	a	DT
cord-005453-4057qib7	15523	34	low	low	JJ
cord-005453-4057qib7	15523	35	TRM	TRM	NNP
cord-005453-4057qib7	15523	36	.	.	.
cord-005453-4057qib7	15524	1	The	the	DT
cord-005453-4057qib7	15524	2	Background	Background	NNP
cord-005453-4057qib7	15524	3	:	:	:
cord-005453-4057qib7	15524	4	Anti	Anti	NNP
cord-005453-4057qib7	15524	5	-	-	JJ
cord-005453-4057qib7	15524	6	HLA	HLA	NNP
cord-005453-4057qib7	15524	7	antibodies	antibody	NNS
cord-005453-4057qib7	15524	8	(	(	-LRB-
cord-005453-4057qib7	15524	9	aHAb	ahab	XX
cord-005453-4057qib7	15524	10	)	)	-RRB-
cord-005453-4057qib7	15524	11	have	have	VBP
cord-005453-4057qib7	15524	12	been	be	VBN
cord-005453-4057qib7	15524	13	recently	recently	RB
cord-005453-4057qib7	15524	14	recognized	recognize	VBN
cord-005453-4057qib7	15524	15	as	as	IN
cord-005453-4057qib7	15524	16	an	an	DT
cord-005453-4057qib7	15524	17	important	important	JJ
cord-005453-4057qib7	15524	18	risk	risk	NN
cord-005453-4057qib7	15524	19	factor	factor	NN
cord-005453-4057qib7	15524	20	for	for	IN
cord-005453-4057qib7	15524	21	graft	graft	NN
cord-005453-4057qib7	15524	22	failure	failure	NN
cord-005453-4057qib7	15524	23	(	(	-LRB-
cord-005453-4057qib7	15524	24	GF	GF	NNP
cord-005453-4057qib7	15524	25	)	)	-RRB-
cord-005453-4057qib7	15524	26	,	,	,
cord-005453-4057qib7	15524	27	especially	especially	RB
cord-005453-4057qib7	15524	28	in	in	IN
cord-005453-4057qib7	15524	29	HLA	HLA	NNP
cord-005453-4057qib7	15524	30	-	-	HYPH
cord-005453-4057qib7	15524	31	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15524	32	stem	stem	NN
cord-005453-4057qib7	15524	33	cell	cell	NN
cord-005453-4057qib7	15524	34	transplantation	transplantation	NN
cord-005453-4057qib7	15524	35	(	(	-LRB-
cord-005453-4057qib7	15524	36	haplo	haplo	NNP
cord-005453-4057qib7	15524	37	-	-	HYPH
cord-005453-4057qib7	15524	38	HSCT	HSCT	NNP
cord-005453-4057qib7	15524	39	)	)	-RRB-
cord-005453-4057qib7	15524	40	.	.	.
cord-005453-4057qib7	15525	1	Although	although	IN
cord-005453-4057qib7	15525	2	,	,	,
cord-005453-4057qib7	15525	3	recently	recently	RB
cord-005453-4057qib7	15525	4	,	,	,
cord-005453-4057qib7	15525	5	EBMT	EBMT	NNP
cord-005453-4057qib7	15525	6	consensus	consensus	NN
cord-005453-4057qib7	15525	7	guidelines	guideline	NNS
cord-005453-4057qib7	15525	8	have	have	VBP
cord-005453-4057qib7	15525	9	been	be	VBN
cord-005453-4057qib7	15525	10	published	publish	VBN
cord-005453-4057qib7	15525	11	[	[	-LRB-
cord-005453-4057qib7	15525	12	Ciurea	Ciurea	NNP
cord-005453-4057qib7	15525	13	,	,	,
cord-005453-4057qib7	15525	14	Bone	Bone	NNP
cord-005453-4057qib7	15525	15	Marrow	Marrow	NNP
cord-005453-4057qib7	15525	16	Transplant	Transplant	NNP
cord-005453-4057qib7	15525	17	2018	2018	CD
cord-005453-4057qib7	15525	18	]	]	-RRB-
cord-005453-4057qib7	15525	19	,	,	,
cord-005453-4057qib7	15525	20	experience	experience	NN
cord-005453-4057qib7	15525	21	in	in	IN
cord-005453-4057qib7	15525	22	pediatric	pediatric	JJ
cord-005453-4057qib7	15525	23	T	t	NN
cord-005453-4057qib7	15525	24	-	-	HYPH
cord-005453-4057qib7	15525	25	cell	cell	NN
cord-005453-4057qib7	15525	26	depleted	deplete	VBN
cord-005453-4057qib7	15525	27	(	(	-LRB-
cord-005453-4057qib7	15525	28	TCD	TCD	NNP
cord-005453-4057qib7	15525	29	,	,	,
cord-005453-4057qib7	15525	30	another	another	DT
cord-005453-4057qib7	15525	31	well	well	RB
cord-005453-4057qib7	15525	32	-	-	HYPH
cord-005453-4057qib7	15525	33	known	know	VBN
cord-005453-4057qib7	15525	34	risk	risk	NN
cord-005453-4057qib7	15525	35	factor	factor	NN
cord-005453-4057qib7	15525	36	for	for	IN
cord-005453-4057qib7	15525	37	GF	GF	NNP
cord-005453-4057qib7	15525	38	)	)	-RRB-
cord-005453-4057qib7	15526	1	haplo	haplo	NNP
cord-005453-4057qib7	15526	2	-	-	HYPH
cord-005453-4057qib7	15526	3	HSCT	HSCT	NNP
cord-005453-4057qib7	15526	4	is	be	VBZ
cord-005453-4057qib7	15526	5	lacking	lack	VBG
cord-005453-4057qib7	15526	6	.	.	.
cord-005453-4057qib7	15527	1	In	in	IN
cord-005453-4057qib7	15527	2	the	the	DT
cord-005453-4057qib7	15527	3	present	present	JJ
cord-005453-4057qib7	15527	4	study	study	NN
cord-005453-4057qib7	15527	5	,	,	,
cord-005453-4057qib7	15527	6	we	-PRON-	PRP
cord-005453-4057qib7	15527	7	report	report	VBP
cord-005453-4057qib7	15527	8	our	-PRON-	PRP$
cord-005453-4057qib7	15527	9	experience	experience	NN
cord-005453-4057qib7	15527	10	on	on	IN
cord-005453-4057qib7	15527	11	the	the	DT
cord-005453-4057qib7	15527	12	use	use	NN
cord-005453-4057qib7	15527	13	of	of	IN
cord-005453-4057qib7	15527	14	a	a	DT
cord-005453-4057qib7	15527	15	desensitization	desensitization	NN
cord-005453-4057qib7	15527	16	approach	approach	NN
cord-005453-4057qib7	15527	17	based	base	VBN
cord-005453-4057qib7	15527	18	on	on	IN
cord-005453-4057qib7	15527	19	EBMT	EBMT	NNP
cord-005453-4057qib7	15527	20	guidelines	guideline	NNS
cord-005453-4057qib7	15527	21	.	.	.
cord-005453-4057qib7	15528	1	Methods	method	NNS
cord-005453-4057qib7	15528	2	:	:	:
cord-005453-4057qib7	15528	3	Between	between	IN
cord-005453-4057qib7	15528	4	June	June	NNP
cord-005453-4057qib7	15528	5	2017	2017	CD
cord-005453-4057qib7	15528	6	and	and	CC
cord-005453-4057qib7	15528	7	August	August	NNP
cord-005453-4057qib7	15528	8	2018	2018	CD
cord-005453-4057qib7	15528	9	,	,	,
cord-005453-4057qib7	15528	10	all	all	DT
cord-005453-4057qib7	15528	11	patients	patient	NNS
cord-005453-4057qib7	15528	12	affected	affect	VBN
cord-005453-4057qib7	15528	13	by	by	IN
cord-005453-4057qib7	15528	14	non	non	JJ
cord-005453-4057qib7	15528	15	-	-	JJ
cord-005453-4057qib7	15528	16	malignant	malignant	JJ
cord-005453-4057qib7	15528	17	diseases	disease	NNS
cord-005453-4057qib7	15528	18	and	and	CC
cord-005453-4057qib7	15528	19	scheduled	schedule	VBN
cord-005453-4057qib7	15528	20	for	for	IN
cord-005453-4057qib7	15528	21	a	a	DT
cord-005453-4057qib7	15528	22	transplant	transplant	NN
cord-005453-4057qib7	15528	23	from	from	IN
cord-005453-4057qib7	15528	24	an	an	DT
cord-005453-4057qib7	15528	25	HLA	HLA	NNP
cord-005453-4057qib7	15528	26	-	-	HYPH
cord-005453-4057qib7	15528	27	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15528	28	donor	donor	NN
cord-005453-4057qib7	15528	29	after	after	IN
cord-005453-4057qib7	15528	30	negative	negative	JJ
cord-005453-4057qib7	15528	31	depletion	depletion	NN
cord-005453-4057qib7	15528	32	of	of	IN
cord-005453-4057qib7	15528	33	αβ	αβ	FW
cord-005453-4057qib7	15528	34	T	t	NN
cord-005453-4057qib7	15528	35	and	and	CC
cord-005453-4057qib7	15528	36	B	B	NNP
cord-005453-4057qib7	15528	37	cells	cell	NNS
cord-005453-4057qib7	15528	38	as	as	IN
cord-005453-4057qib7	15528	39	previously	previously	RB
cord-005453-4057qib7	15528	40	described	describe	VBN
cord-005453-4057qib7	15528	41	[	[	-LRB-
cord-005453-4057qib7	15528	42	Li	Li	NNP
cord-005453-4057qib7	15528	43	Pira	Pira	NNP
cord-005453-4057qib7	15528	44	,	,	,
cord-005453-4057qib7	15528	45	Biol	Biol	NNP
cord-005453-4057qib7	15528	46	Blood	Blood	NNP
cord-005453-4057qib7	15528	47	Marrow	Marrow	NNP
cord-005453-4057qib7	15528	48	Transplant	Transplant	NNP
cord-005453-4057qib7	15528	49	.	.	.
cord-005453-4057qib7	15528	50	2016	2016	CD
cord-005453-4057qib7	15528	51	]	]	-RRB-
cord-005453-4057qib7	15528	52	,	,	,
cord-005453-4057qib7	15528	53	were	be	VBD
cord-005453-4057qib7	15528	54	tested	test	VBN
cord-005453-4057qib7	15528	55	for	for	IN
cord-005453-4057qib7	15528	56	aHAb	ahab	XX
cord-005453-4057qib7	15528	57	with	with	IN
cord-005453-4057qib7	15528	58	Luminex	Luminex	NNP
cord-005453-4057qib7	15528	59	®	®	POS
cord-005453-4057qib7	15528	60	solid	solid	JJ
cord-005453-4057qib7	15528	61	-	-	HYPH
cord-005453-4057qib7	15528	62	phase	phase	NN
cord-005453-4057qib7	15528	63	immunoassay	immunoassay	NN
cord-005453-4057qib7	15528	64	(	(	-LRB-
cord-005453-4057qib7	15528	65	One	one	CD
cord-005453-4057qib7	15528	66	Lambda	Lambda	NNP
cord-005453-4057qib7	15528	67	,	,	,
cord-005453-4057qib7	15528	68	Thermo	Thermo	NNP
cord-005453-4057qib7	15528	69	Fisher	Fisher	NNP
cord-005453-4057qib7	15528	70	Scientific	Scientific	NNP
cord-005453-4057qib7	15528	71	)	)	-RRB-
cord-005453-4057qib7	15528	72	1	1	CD
cord-005453-4057qib7	15528	73	month	month	NN
cord-005453-4057qib7	15528	74	before	before	IN
cord-005453-4057qib7	15528	75	the	the	DT
cord-005453-4057qib7	15528	76	HSCT	HSCT	NNP
cord-005453-4057qib7	15528	77	.	.	.
cord-005453-4057qib7	15529	1	All	all	DT
cord-005453-4057qib7	15529	2	patients	patient	NNS
cord-005453-4057qib7	15529	3	with	with	IN
cord-005453-4057qib7	15529	4	a	a	DT
cord-005453-4057qib7	15529	5	MFI	MFI	NNP
cord-005453-4057qib7	15529	6	higher	high	JJR
cord-005453-4057qib7	15529	7	than	than	IN
cord-005453-4057qib7	15529	8	5000	5000	CD
cord-005453-4057qib7	15529	9	,	,	,
cord-005453-4057qib7	15529	10	which	which	WDT
cord-005453-4057qib7	15529	11	is	be	VBZ
cord-005453-4057qib7	15529	12	considered	consider	VBN
cord-005453-4057qib7	15529	13	a	a	DT
cord-005453-4057qib7	15529	14	cutoff	cutoff	NN
cord-005453-4057qib7	15529	15	predicting	predict	VBG
cord-005453-4057qib7	15529	16	for	for	IN
cord-005453-4057qib7	15529	17	GF	GF	NNP
cord-005453-4057qib7	15529	18	,	,	,
cord-005453-4057qib7	15529	19	were	be	VBD
cord-005453-4057qib7	15529	20	treated	treat	VBN
cord-005453-4057qib7	15529	21	with	with	IN
cord-005453-4057qib7	15529	22	a	a	DT
cord-005453-4057qib7	15529	23	desensitization	desensitization	NN
cord-005453-4057qib7	15529	24	protocol	protocol	NN
cord-005453-4057qib7	15529	25	based	base	VBN
cord-005453-4057qib7	15529	26	on	on	IN
cord-005453-4057qib7	15529	27	the	the	DT
cord-005453-4057qib7	15529	28	use	use	NN
cord-005453-4057qib7	15529	29	of	of	IN
cord-005453-4057qib7	15529	30	anti	anti	JJ
cord-005453-4057qib7	15529	31	-	-	JJ
cord-005453-4057qib7	15529	32	CD20	cd20	JJ
cord-005453-4057qib7	15529	33	rituximab	rituximab	NN
cord-005453-4057qib7	15529	34	(	(	-LRB-
cord-005453-4057qib7	15529	35	375	375	CD
cord-005453-4057qib7	15529	36	mg	mg	NNP
cord-005453-4057qib7	15529	37	/	/	SYM
cord-005453-4057qib7	15529	38	m	m	NNP
cord-005453-4057qib7	15529	39	2	2	CD
cord-005453-4057qib7	15529	40	before	before	RB
cord-005453-4057qib7	15529	41	and	and	CC
cord-005453-4057qib7	15529	42	immediately	immediately	RB
cord-005453-4057qib7	15529	43	after	after	IN
cord-005453-4057qib7	15529	44	the	the	DT
cord-005453-4057qib7	15529	45	end	end	NN
cord-005453-4057qib7	15529	46	of	of	IN
cord-005453-4057qib7	15529	47	plasma	plasma	NN
cord-005453-4057qib7	15529	48	-	-	HYPH
cord-005453-4057qib7	15529	49	exchange	exchange	NN
cord-005453-4057qib7	15529	50	cycle	cycle	NN
cord-005453-4057qib7	15529	51	)	)	-RRB-
cord-005453-4057qib7	15529	52	and	and	CC
cord-005453-4057qib7	15530	1	plasma	plasma	NN
cord-005453-4057qib7	15530	2	-	-	HYPH
cord-005453-4057qib7	15530	3	exchange	exchange	NN
cord-005453-4057qib7	15530	4	(	(	-LRB-
cord-005453-4057qib7	15530	5	PE	PE	NNP
cord-005453-4057qib7	15530	6	)	)	-RRB-
cord-005453-4057qib7	15530	7	±	±	CC
cord-005453-4057qib7	15530	8	infusion	infusion	NN
cord-005453-4057qib7	15530	9	of	of	IN
cord-005453-4057qib7	15530	10	irradiated	irradiate	VBN
cord-005453-4057qib7	15530	11	buffy	buffy	NNP
cord-005453-4057qib7	15530	12	coat	coat	NNP
cord-005453-4057qib7	15530	13	(	(	-LRB-
cord-005453-4057qib7	15530	14	BC	BC	NNP
cord-005453-4057qib7	15530	15	)	)	-RRB-
cord-005453-4057qib7	15530	16	(	(	-LRB-
cord-005453-4057qib7	15530	17	if	if	IN
cord-005453-4057qib7	15530	18	after	after	IN
cord-005453-4057qib7	15530	19	PE	PE	NNP
cord-005453-4057qib7	15530	20	aHAb	ahab	CD
cord-005453-4057qib7	15530	21	MFI	MFI	NNP
cord-005453-4057qib7	15530	22	was	be	VBD
cord-005453-4057qib7	15530	23	still	still	RB
cord-005453-4057qib7	15530	24	>	>	XX
cord-005453-4057qib7	15530	25	5000	5000	CD
cord-005453-4057qib7	15530	26	MFI	MFI	NNP
cord-005453-4057qib7	15530	27	)	)	-RRB-
cord-005453-4057qib7	15530	28	.	.	.
cord-005453-4057qib7	15531	1	This	this	DT
cord-005453-4057qib7	15531	2	latter	latter	NN
cord-005453-4057qib7	15531	3	was	be	VBD
cord-005453-4057qib7	15531	4	obtained	obtain	VBN
cord-005453-4057qib7	15531	5	by	by	IN
cord-005453-4057qib7	15531	6	the	the	DT
cord-005453-4057qib7	15531	7	non	non	JJ
cord-005453-4057qib7	15531	8	-	-	JJ
cord-005453-4057qib7	15531	9	target	target	JJ
cord-005453-4057qib7	15531	10	fraction	fraction	NN
cord-005453-4057qib7	15531	11	of	of	IN
cord-005453-4057qib7	15531	12	the	the	DT
cord-005453-4057qib7	15531	13	αβ	αβ	XX
cord-005453-4057qib7	15531	14	T	t	NN
cord-005453-4057qib7	15531	15	-	-	HYPH
cord-005453-4057qib7	15531	16	cell	cell	NN
cord-005453-4057qib7	15531	17	/	/	SYM
cord-005453-4057qib7	15531	18	B	b	NN
cord-005453-4057qib7	15531	19	-	-	HYPH
cord-005453-4057qib7	15531	20	cell	cell	NN
cord-005453-4057qib7	15531	21	-	-	HYPH
cord-005453-4057qib7	15531	22	depletion	depletion	NN
cord-005453-4057qib7	15531	23	procedure	procedure	NN
cord-005453-4057qib7	15531	24	and	and	CC
cord-005453-4057qib7	15531	25	consisted	consist	VBD
cord-005453-4057qib7	15531	26	of	of	IN
cord-005453-4057qib7	15531	27	5	5	CD
cord-005453-4057qib7	15531	28	*	*	SYM
cord-005453-4057qib7	15531	29	10	10	CD
cord-005453-4057qib7	15531	30	7	7	CD
cord-005453-4057qib7	15531	31	irradiated	irradiate	VBN
cord-005453-4057qib7	15531	32	nucleated	nucleated	JJ
cord-005453-4057qib7	15531	33	cells	cell	NNS
cord-005453-4057qib7	15531	34	/	/	SYM
cord-005453-4057qib7	15531	35	kg	kg	NNS
cord-005453-4057qib7	15531	36	of	of	IN
cord-005453-4057qib7	15531	37	the	the	DT
cord-005453-4057qib7	15531	38	recipient	recipient	NN
cord-005453-4057qib7	15531	39	;	;	:
cord-005453-4057qib7	15531	40	this	this	DT
cord-005453-4057qib7	15531	41	was	be	VBD
cord-005453-4057qib7	15531	42	infused	infuse	VBN
cord-005453-4057qib7	15531	43	2	2	CD
cord-005453-4057qib7	15531	44	-	-	SYM
cord-005453-4057qib7	15531	45	4	4	CD
cord-005453-4057qib7	15531	46	hours	hour	NNS
cord-005453-4057qib7	15531	47	before	before	IN
cord-005453-4057qib7	15531	48	the	the	DT
cord-005453-4057qib7	15531	49	infusion	infusion	NN
cord-005453-4057qib7	15531	50	of	of	IN
cord-005453-4057qib7	15531	51	the	the	DT
cord-005453-4057qib7	15531	52	TCD	TCD	NNP
cord-005453-4057qib7	15531	53	graft	graft	NN
cord-005453-4057qib7	15531	54	.	.	.
cord-005453-4057qib7	15532	1	PE	PE	NNP
cord-005453-4057qib7	15532	2	was	be	VBD
cord-005453-4057qib7	15532	3	performed	perform	VBN
cord-005453-4057qib7	15532	4	with	with	IN
cord-005453-4057qib7	15532	5	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	15532	6	Life	Life	NNP
cord-005453-4057qib7	15532	7	18	18	CD
cord-005453-4057qib7	15532	8	TM	TM	NNP
cord-005453-4057qib7	15532	9	Apheresis	Apheresis	NNP
cord-005453-4057qib7	15532	10	Unit	Unit	NNP
cord-005453-4057qib7	15532	11	(	(	-LRB-
cord-005453-4057qib7	15532	12	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	15532	13	,	,	,
cord-005453-4057qib7	15532	14	Bergish	Bergish	NNP
cord-005453-4057qib7	15532	15	-	-	HYPH
cord-005453-4057qib7	15532	16	Gladback	Gladback	NNP
cord-005453-4057qib7	15533	1	)	)	-RRB-
cord-005453-4057qib7	15533	2	.Results	.Results	NFP
cord-005453-4057qib7	15533	3	:	:	:
cord-005453-4057qib7	15534	1	In	in	IN
cord-005453-4057qib7	15534	2	the	the	DT
cord-005453-4057qib7	15534	3	study	study	NN
cord-005453-4057qib7	15534	4	period	period	NN
cord-005453-4057qib7	15534	5	,	,	,
cord-005453-4057qib7	15534	6	37	37	CD
cord-005453-4057qib7	15534	7	patients	patient	NNS
cord-005453-4057qib7	15534	8	received	receive	VBD
cord-005453-4057qib7	15534	9	αβ	αβ	FW
cord-005453-4057qib7	15534	10	Tand	Tand	NNP
cord-005453-4057qib7	15534	11	B	b	NN
cord-005453-4057qib7	15534	12	-	-	HYPH
cord-005453-4057qib7	15534	13	cell	cell	NN
cord-005453-4057qib7	15534	14	depleted	deplete	VBN
cord-005453-4057qib7	15534	15	haplo	haplo	NNP
cord-005453-4057qib7	15534	16	-	-	HYPH
cord-005453-4057qib7	15534	17	HSCT	HSCT	NNP
cord-005453-4057qib7	15534	18	.	.	.
cord-005453-4057qib7	15535	1	Eighteen	eighteen	CD
cord-005453-4057qib7	15535	2	(	(	-LRB-
cord-005453-4057qib7	15535	3	48	48	CD
cord-005453-4057qib7	15535	4	%	%	NN
cord-005453-4057qib7	15535	5	)	)	-RRB-
cord-005453-4057qib7	15535	6	resulted	result	VBD
cord-005453-4057qib7	15535	7	positive	positive	JJ
cord-005453-4057qib7	15535	8	for	for	IN
cord-005453-4057qib7	15535	9	aHAb	ahab	XX
cord-005453-4057qib7	15535	10	(	(	-LRB-
cord-005453-4057qib7	15535	11	MFI	MFI	NNP
cord-005453-4057qib7	15535	12	>	>	XX
cord-005453-4057qib7	15535	13	1000	1000	CD
cord-005453-4057qib7	15535	14	)	)	-RRB-
cord-005453-4057qib7	15535	15	;	;	:
cord-005453-4057qib7	15535	16	14	14	CD
cord-005453-4057qib7	15535	17	(	(	-LRB-
cord-005453-4057qib7	15535	18	77	77	CD
cord-005453-4057qib7	15535	19	%	%	NN
cord-005453-4057qib7	15535	20	)	)	-RRB-
cord-005453-4057qib7	15535	21	of	of	IN
cord-005453-4057qib7	15535	22	them	-PRON-	PRP
cord-005453-4057qib7	15535	23	had	have	VBD
cord-005453-4057qib7	15535	24	an	an	DT
cord-005453-4057qib7	15535	25	MFI	mfi	NN
cord-005453-4057qib7	15535	26	>	>	XX
cord-005453-4057qib7	15536	1	5000	5000	CD
cord-005453-4057qib7	15536	2	for	for	IN
cord-005453-4057qib7	15536	3	either	either	DT
cord-005453-4057qib7	15536	4	anti	anti	JJ
cord-005453-4057qib7	15536	5	-	-	JJ
cord-005453-4057qib7	15536	6	class	class	JJ
cord-005453-4057qib7	15536	7	I	i	NN
cord-005453-4057qib7	15536	8	or	or	CC
cord-005453-4057qib7	15536	9	II	II	NNP
cord-005453-4057qib7	15536	10	aHAb	ahab	XX
cord-005453-4057qib7	15536	11	.	.	.
cord-005453-4057qib7	15537	1	These	these	DT
cord-005453-4057qib7	15537	2	patients	patient	NNS
cord-005453-4057qib7	15537	3	(	(	-LRB-
cord-005453-4057qib7	15537	4	see	see	VB
cord-005453-4057qib7	15537	5	Table	table	NN
cord-005453-4057qib7	15538	1	I	-PRON-	PRP
cord-005453-4057qib7	15538	2	Background	Background	NNP
cord-005453-4057qib7	15538	3	:	:	:
cord-005453-4057qib7	15539	1	Osteonecrosis	Osteonecrosis	NNP
cord-005453-4057qib7	15539	2	(	(	-LRB-
cord-005453-4057qib7	15539	3	ON	ON	NNP
cord-005453-4057qib7	15539	4	)	)	-RRB-
cord-005453-4057qib7	15539	5	is	be	VBZ
cord-005453-4057qib7	15539	6	a	a	DT
cord-005453-4057qib7	15539	7	debilitating	debilitating	JJ
cord-005453-4057qib7	15539	8	complication	complication	NN
cord-005453-4057qib7	15539	9	in	in	IN
cord-005453-4057qib7	15539	10	survivors	survivor	NNS
cord-005453-4057qib7	15539	11	of	of	IN
cord-005453-4057qib7	15539	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15539	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15539	14	cell	cell	NN
cord-005453-4057qib7	15539	15	transplantation	transplantation	NN
cord-005453-4057qib7	15539	16	(	(	-LRB-
cord-005453-4057qib7	15539	17	HCT	HCT	NNP
cord-005453-4057qib7	15539	18	)	)	-RRB-
cord-005453-4057qib7	15539	19	.	.	.
cord-005453-4057qib7	15540	1	Limited	limited	JJ
cord-005453-4057qib7	15540	2	data	datum	NNS
cord-005453-4057qib7	15540	3	is	be	VBZ
cord-005453-4057qib7	15540	4	available	available	JJ
cord-005453-4057qib7	15540	5	on	on	IN
cord-005453-4057qib7	15540	6	its	-PRON-	PRP$
cord-005453-4057qib7	15540	7	course	course	NN
cord-005453-4057qib7	15540	8	post	post	NN
cord-005453-4057qib7	15540	9	-	-	NN
cord-005453-4057qib7	15540	10	transplantation	transplantation	NN
cord-005453-4057qib7	15540	11	in	in	IN
cord-005453-4057qib7	15540	12	children	child	NNS
cord-005453-4057qib7	15540	13	.	.	.
cord-005453-4057qib7	15541	1	The	the	DT
cord-005453-4057qib7	15541	2	purpose	purpose	NN
cord-005453-4057qib7	15541	3	of	of	IN
cord-005453-4057qib7	15541	4	our	-PRON-	PRP$
cord-005453-4057qib7	15541	5	study	study	NN
cord-005453-4057qib7	15541	6	was	be	VBD
cord-005453-4057qib7	15541	7	to	to	TO
cord-005453-4057qib7	15541	8	identify	identify	VB
cord-005453-4057qib7	15541	9	recipients	recipient	NNS
cord-005453-4057qib7	15541	10	of	of	IN
cord-005453-4057qib7	15541	11	HCT	HCT	NNP
cord-005453-4057qib7	15541	12	in	in	IN
cord-005453-4057qib7	15541	13	whom	whom	WP
cord-005453-4057qib7	15541	14	pre	pre	VB
cord-005453-4057qib7	15541	15	-	-	JJ
cord-005453-4057qib7	15541	16	and	and	CC
cord-005453-4057qib7	15541	17	post	post	JJ
cord-005453-4057qib7	15541	18	-	-	JJ
cord-005453-4057qib7	15541	19	magnetic	magnetic	JJ
cord-005453-4057qib7	15541	20	resonance	resonance	NN
cord-005453-4057qib7	15541	21	imaging	imaging	NN
cord-005453-4057qib7	15541	22	(	(	-LRB-
cord-005453-4057qib7	15541	23	MRI	MRI	NNP
cord-005453-4057qib7	15541	24	)	)	-RRB-
cord-005453-4057qib7	15541	25	is	be	VBZ
cord-005453-4057qib7	15541	26	indicated	indicate	VBN
cord-005453-4057qib7	15541	27	.	.	.
cord-005453-4057qib7	15542	1	Methods	method	NNS
cord-005453-4057qib7	15542	2	:	:	:
cord-005453-4057qib7	15543	1	The	the	DT
cord-005453-4057qib7	15543	2	retrospective	retrospective	JJ
cord-005453-4057qib7	15543	3	cohort	cohort	NN
cord-005453-4057qib7	15543	4	consisted	consist	VBD
cord-005453-4057qib7	15543	5	of	of	IN
cord-005453-4057qib7	15543	6	436	436	CD
cord-005453-4057qib7	15543	7	patients	patient	NNS
cord-005453-4057qib7	15543	8	who	who	WP
cord-005453-4057qib7	15543	9	underwent	undergo	VBD
cord-005453-4057qib7	15543	10	first	first	RB
cord-005453-4057qib7	15543	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	15543	12	HCT	hct	NN
cord-005453-4057qib7	15543	13	from	from	IN
cord-005453-4057qib7	15543	14	1998	1998	CD
cord-005453-4057qib7	15543	15	-	-	SYM
cord-005453-4057qib7	15543	16	2014	2014	CD
cord-005453-4057qib7	15543	17	,	,	,
cord-005453-4057qib7	15543	18	and	and	CC
cord-005453-4057qib7	15543	19	prospectively	prospectively	RB
cord-005453-4057qib7	15543	20	underwent	undergo	VBD
cord-005453-4057qib7	15543	21	a	a	DT
cord-005453-4057qib7	15543	22	total	total	NN
cord-005453-4057qib7	15543	23	of	of	IN
cord-005453-4057qib7	15543	24	1092	1092	CD
cord-005453-4057qib7	15543	25	pre	pre	JJ
cord-005453-4057qib7	15543	26	-	-	JJ
cord-005453-4057qib7	15543	27	and	and	CC
cord-005453-4057qib7	15543	28	post	post	JJ
cord-005453-4057qib7	15543	29	-	-	JJ
cord-005453-4057qib7	15543	30	transplant	transplant	NN
cord-005453-4057qib7	15543	31	MRI	MRI	NNP
cord-005453-4057qib7	15543	32	studies	study	NNS
cord-005453-4057qib7	15543	33	of	of	IN
cord-005453-4057qib7	15543	34	the	the	DT
cord-005453-4057qib7	15543	35	hips	hip	NNS
cord-005453-4057qib7	15543	36	and	and	CC
cord-005453-4057qib7	15543	37	knees	knee	NNS
cord-005453-4057qib7	15543	38	done	do	VBN
cord-005453-4057qib7	15543	39	annually	annually	RB
cord-005453-4057qib7	15543	40	for	for	IN
cord-005453-4057qib7	15543	41	3	3	CD
cord-005453-4057qib7	15543	42	years	year	NNS
cord-005453-4057qib7	15543	43	regardless	regardless	RB
cord-005453-4057qib7	15543	44	of	of	IN
cord-005453-4057qib7	15543	45	symptoms	symptom	NNS
cord-005453-4057qib7	15543	46	.	.	.
cord-005453-4057qib7	15544	1	Surviving	survive	VBG
cord-005453-4057qib7	15544	2	patients	patient	NNS
cord-005453-4057qib7	15544	3	were	be	VBD
cord-005453-4057qib7	15544	4	followed	follow	VBN
cord-005453-4057qib7	15544	5	for	for	IN
cord-005453-4057qib7	15544	6	a	a	DT
cord-005453-4057qib7	15544	7	median	median	JJ
cord-005453-4057qib7	15544	8	time	time	NN
cord-005453-4057qib7	15544	9	of	of	IN
cord-005453-4057qib7	15544	10	8.33	8.33	CD
cord-005453-4057qib7	15544	11	(	(	-LRB-
cord-005453-4057qib7	15544	12	range	range	NNP
cord-005453-4057qib7	15544	13	3.93	3.93	CD
cord-005453-4057qib7	15544	14	-	-	SYM
cord-005453-4057qib7	15544	15	14.10	14.10	CD
cord-005453-4057qib7	15544	16	)	)	-RRB-
cord-005453-4057qib7	15544	17	years	year	NNS
cord-005453-4057qib7	15544	18	.	.	.
cord-005453-4057qib7	15545	1	Cases	case	NNS
cord-005453-4057qib7	15545	2	of	of	IN
cord-005453-4057qib7	15545	3	ON	ON	NNP
cord-005453-4057qib7	15545	4	were	be	VBD
cord-005453-4057qib7	15545	5	compared	compare	VBN
cord-005453-4057qib7	15545	6	to	to	IN
cord-005453-4057qib7	15545	7	controls	control	NNS
cord-005453-4057qib7	15545	8	matched	match	VBN
cord-005453-4057qib7	15545	9	for	for	IN
cord-005453-4057qib7	15545	10	age	age	NN
cord-005453-4057qib7	15545	11	,	,	,
cord-005453-4057qib7	15545	12	sex	sex	NN
cord-005453-4057qib7	15545	13	,	,	,
cord-005453-4057qib7	15545	14	transplant	transplant	NN
cord-005453-4057qib7	15545	15	type	type	NN
cord-005453-4057qib7	15545	16	,	,	,
cord-005453-4057qib7	15545	17	and	and	CC
cord-005453-4057qib7	15545	18	follow	follow	VB
cord-005453-4057qib7	15545	19	up	up	RP
cord-005453-4057qib7	15545	20	in	in	IN
cord-005453-4057qib7	15545	21	a	a	DT
cord-005453-4057qib7	15545	22	1:4	1:4	CD
cord-005453-4057qib7	15545	23	ratio	ratio	NN
cord-005453-4057qib7	15545	24	for	for	IN
cord-005453-4057qib7	15545	25	the	the	DT
cord-005453-4057qib7	15545	26	following	follow	VBG
cord-005453-4057qib7	15545	27	variables	variable	NNS
cord-005453-4057qib7	15545	28	:	:	:
cord-005453-4057qib7	15545	29	ethnicity	ethnicity	NN
cord-005453-4057qib7	15545	30	,	,	,
cord-005453-4057qib7	15545	31	underlying	underlie	VBG
cord-005453-4057qib7	15545	32	disease	disease	NN
cord-005453-4057qib7	15545	33	,	,	.
cord-005453-4057qib7	15546	1	ON	on	IN
cord-005453-4057qib7	15546	2	pre	pre	JJ
cord-005453-4057qib7	15546	3	-	-	JJ
cord-005453-4057qib7	15546	4	HCT	hct	JJ
cord-005453-4057qib7	15546	5	,	,	,
cord-005453-4057qib7	15546	6	conditioning	conditioning	NN
cord-005453-4057qib7	15546	7	regimen	regimen	NN
cord-005453-4057qib7	15546	8	,	,	,
cord-005453-4057qib7	15546	9	graft	graft	NN
cord-005453-4057qib7	15546	10	source	source	NN
cord-005453-4057qib7	15546	11	,	,	,
cord-005453-4057qib7	15546	12	bone	bone	NN
cord-005453-4057qib7	15546	13	mineral	mineral	NN
cord-005453-4057qib7	15546	14	density	density	NN
cord-005453-4057qib7	15546	15	Z	Z	NNP
cord-005453-4057qib7	15546	16	-	-	HYPH
cord-005453-4057qib7	15546	17	scores	score	NNS
cord-005453-4057qib7	15546	18	,	,	,
cord-005453-4057qib7	15546	19	body	body	NN
cord-005453-4057qib7	15546	20	mass	mass	NN
cord-005453-4057qib7	15546	21	index	index	NN
cord-005453-4057qib7	15546	22	,	,	,
cord-005453-4057qib7	15546	23	presence	presence	NN
cord-005453-4057qib7	15546	24	or	or	CC
cord-005453-4057qib7	15546	25	absence	absence	NN
cord-005453-4057qib7	15546	26	of	of	IN
cord-005453-4057qib7	15546	27	graft	graft	NN
cord-005453-4057qib7	15546	28	-	-	HYPH
cord-005453-4057qib7	15546	29	versus	versus	IN
cord-005453-4057qib7	15546	30	-	-	HYPH
cord-005453-4057qib7	15546	31	host	host	NN
cord-005453-4057qib7	15546	32	disease	disease	NN
cord-005453-4057qib7	15546	33	,	,	,
cord-005453-4057qib7	15546	34	steroid	steroid	NN
cord-005453-4057qib7	15546	35	use	use	NN
cord-005453-4057qib7	15546	36	and	and	CC
cord-005453-4057qib7	15546	37	dosage	dosage	NN
cord-005453-4057qib7	15546	38	,	,	,
cord-005453-4057qib7	15546	39	and	and	CC
cord-005453-4057qib7	15546	40	survival	survival	NN
cord-005453-4057qib7	15546	41	status	status	NN
cord-005453-4057qib7	15546	42	.	.	.
cord-005453-4057qib7	15547	1	Results	result	NNS
cord-005453-4057qib7	15547	2	:	:	:
cord-005453-4057qib7	15548	1	Thirty	thirty	CD
cord-005453-4057qib7	15548	2	(	(	-LRB-
cord-005453-4057qib7	15548	3	6.9	6.9	CD
cord-005453-4057qib7	15548	4	%	%	NN
cord-005453-4057qib7	15548	5	)	)	-RRB-
cord-005453-4057qib7	15548	6	patients	patient	NNS
cord-005453-4057qib7	15548	7	had	have	VBD
cord-005453-4057qib7	15548	8	MRI	MRI	NNP
cord-005453-4057qib7	15548	9	findings	finding	NNS
cord-005453-4057qib7	15548	10	confirming	confirm	VBG
cord-005453-4057qib7	15548	11	ON	on	IN
cord-005453-4057qib7	15548	12	post	post	JJ
cord-005453-4057qib7	15548	13	-	-	JJ
cord-005453-4057qib7	15548	14	HCT	hct	NN
cord-005453-4057qib7	15548	15	.	.	.
cord-005453-4057qib7	15549	1	All	all	DT
cord-005453-4057qib7	15549	2	patients	patient	NNS
cord-005453-4057qib7	15549	3	with	with	IN
cord-005453-4057qib7	15549	4	ON	on	IN
cord-005453-4057qib7	15549	5	except	except	IN
cord-005453-4057qib7	15549	6	one	one	CD
cord-005453-4057qib7	15549	7	were	be	VBD
cord-005453-4057qib7	15549	8	more	more	JJR
cord-005453-4057qib7	15549	9	than	than	IN
cord-005453-4057qib7	15549	10	10	10	CD
cord-005453-4057qib7	15549	11	years	year	NNS
cord-005453-4057qib7	15549	12	of	of	IN
cord-005453-4057qib7	15549	13	age	age	NN
cord-005453-4057qib7	15549	14	.	.	.
cord-005453-4057qib7	15550	1	Twenty	twenty	CD
cord-005453-4057qib7	15550	2	(	(	-LRB-
cord-005453-4057qib7	15550	3	67	67	CD
cord-005453-4057qib7	15550	4	%	%	NN
cord-005453-4057qib7	15550	5	)	)	-RRB-
cord-005453-4057qib7	15550	6	patients	patient	NNS
cord-005453-4057qib7	15550	7	were	be	VBD
cord-005453-4057qib7	15550	8	male	male	JJ
cord-005453-4057qib7	15550	9	.	.	.
cord-005453-4057qib7	15551	1	ON	on	IN
cord-005453-4057qib7	15551	2	pre	pre	JJ
cord-005453-4057qib7	15551	3	-	-	JJ
cord-005453-4057qib7	15551	4	HCT	hct	JJ
cord-005453-4057qib7	15551	5	(	(	-LRB-
cord-005453-4057qib7	15551	6	P	p	NN
cord-005453-4057qib7	15551	7	<	<	XX
cord-005453-4057qib7	15551	8	0.0001	0.0001	CD
cord-005453-4057qib7	15551	9	)	)	-RRB-
cord-005453-4057qib7	15551	10	was	be	VBD
cord-005453-4057qib7	15551	11	the	the	DT
cord-005453-4057qib7	15551	12	only	only	JJ
cord-005453-4057qib7	15551	13	factor	factor	NN
cord-005453-4057qib7	15551	14	associated	associate	VBN
cord-005453-4057qib7	15551	15	with	with	IN
cord-005453-4057qib7	15551	16	presence	presence	NN
cord-005453-4057qib7	15551	17	of	of	IN
cord-005453-4057qib7	15551	18	ON	on	IN
cord-005453-4057qib7	15551	19	post	post	JJ
cord-005453-4057qib7	15551	20	-	-	JJ
cord-005453-4057qib7	15551	21	HCT	hct	NN
cord-005453-4057qib7	15551	22	.	.	.
cord-005453-4057qib7	15552	1	Epiphyseal	Epiphyseal	NNP
cord-005453-4057qib7	15552	2	ON	ON	NNP
cord-005453-4057qib7	15552	3	was	be	VBD
cord-005453-4057qib7	15552	4	seen	see	VBN
cord-005453-4057qib7	15552	5	in	in	IN
cord-005453-4057qib7	15552	6	9	9	CD
cord-005453-4057qib7	15552	7	(	(	-LRB-
cord-005453-4057qib7	15552	8	30	30	CD
cord-005453-4057qib7	15552	9	%	%	NN
cord-005453-4057qib7	15552	10	)	)	-RRB-
cord-005453-4057qib7	15552	11	patients	patient	NNS
cord-005453-4057qib7	15552	12	pre	pre	JJ
cord-005453-4057qib7	15552	13	-	-	NN
cord-005453-4057qib7	15552	14	HCT	HCT	NNP
cord-005453-4057qib7	15552	15	,	,	,
cord-005453-4057qib7	15552	16	and	and	CC
cord-005453-4057qib7	15552	17	26	26	CD
cord-005453-4057qib7	15552	18	(	(	-LRB-
cord-005453-4057qib7	15552	19	87	87	CD
cord-005453-4057qib7	15552	20	%	%	NN
cord-005453-4057qib7	15552	21	)	)	-RRB-
cord-005453-4057qib7	15552	22	post	post	JJ
cord-005453-4057qib7	15552	23	-	-	JJ
cord-005453-4057qib7	15552	24	HCT	hct	NN
cord-005453-4057qib7	15552	25	.	.	.
cord-005453-4057qib7	15553	1	Eighteen	eighteen	CD
cord-005453-4057qib7	15553	2	(	(	-LRB-
cord-005453-4057qib7	15553	3	60	60	CD
cord-005453-4057qib7	15553	4	%	%	NN
cord-005453-4057qib7	15553	5	)	)	-RRB-
cord-005453-4057qib7	15553	6	patients	patient	NNS
cord-005453-4057qib7	15553	7	had	have	VBD
cord-005453-4057qib7	15553	8	involvement	involvement	NN
cord-005453-4057qib7	15553	9	of	of	IN
cord-005453-4057qib7	15553	10	more	more	JJR
cord-005453-4057qib7	15553	11	than	than	IN
cord-005453-4057qib7	15553	12	30	30	CD
cord-005453-4057qib7	15553	13	%	%	NN
cord-005453-4057qib7	15553	14	of	of	IN
cord-005453-4057qib7	15553	15	articular	articular	JJ
cord-005453-4057qib7	15553	16	surface	surface	NN
cord-005453-4057qib7	15553	17	,	,	,
cord-005453-4057qib7	15553	18	and	and	CC
cord-005453-4057qib7	15553	19	were	be	VBD
cord-005453-4057qib7	15553	20	more	more	RBR
cord-005453-4057qib7	15553	21	likely	likely	JJ
cord-005453-4057qib7	15553	22	to	to	TO
cord-005453-4057qib7	15553	23	undergo	undergo	VB
cord-005453-4057qib7	15553	24	surgery	surgery	NN
cord-005453-4057qib7	15553	25	(	(	-LRB-
cord-005453-4057qib7	15553	26	P	p	NN
cord-005453-4057qib7	15553	27	=	=	SYM
cord-005453-4057qib7	15553	28	0.009).Conclusions	0.009).conclusions	CD
cord-005453-4057qib7	15553	29	:	:	:
cord-005453-4057qib7	15554	1	The	the	DT
cord-005453-4057qib7	15554	2	incidence	incidence	NN
cord-005453-4057qib7	15554	3	of	of	IN
cord-005453-4057qib7	15554	4	ON	on	RB
cord-005453-4057qib7	15554	5	in	in	IN
cord-005453-4057qib7	15554	6	this	this	DT
cord-005453-4057qib7	15554	7	large	large	JJ
cord-005453-4057qib7	15554	8	pediatric	pediatric	JJ
cord-005453-4057qib7	15554	9	cohort	cohort	NN
cord-005453-4057qib7	15554	10	was	be	VBD
cord-005453-4057qib7	15554	11	7	7	CD
cord-005453-4057qib7	15554	12	%	%	NN
cord-005453-4057qib7	15554	13	.	.	.
cord-005453-4057qib7	15555	1	The	the	DT
cord-005453-4057qib7	15555	2	only	only	JJ
cord-005453-4057qib7	15555	3	risk	risk	NN
cord-005453-4057qib7	15555	4	factor	factor	NN
cord-005453-4057qib7	15555	5	for	for	IN
cord-005453-4057qib7	15555	6	ON	on	IN
cord-005453-4057qib7	15555	7	post	post	JJ
cord-005453-4057qib7	15555	8	-	-	NN
cord-005453-4057qib7	15555	9	HCT	HCT	NNP
cord-005453-4057qib7	15555	10	was	be	VBD
cord-005453-4057qib7	15555	11	pre	pre	JJ
cord-005453-4057qib7	15555	12	-	-	JJ
cord-005453-4057qib7	15555	13	existing	existing	JJ
cord-005453-4057qib7	15555	14	ON	on	RP
cord-005453-4057qib7	15555	15	.	.	.
cord-005453-4057qib7	15556	1	MRI	MRI	NNP
cord-005453-4057qib7	15556	2	evaluation	evaluation	NN
cord-005453-4057qib7	15556	3	for	for	IN
cord-005453-4057qib7	15556	4	ON	on	IN
cord-005453-4057qib7	15556	5	pre	pre	JJ
cord-005453-4057qib7	15556	6	-	-	JJ
cord-005453-4057qib7	15556	7	HCT	HCT	NNP
cord-005453-4057qib7	15556	8	is	be	VBZ
cord-005453-4057qib7	15556	9	indicated	indicate	VBN
cord-005453-4057qib7	15556	10	in	in	IN
cord-005453-4057qib7	15556	11	all	all	DT
cord-005453-4057qib7	15556	12	patients	patient	NNS
cord-005453-4057qib7	15556	13	.	.	.
cord-005453-4057qib7	15557	1	MRI	MRI	NNP
cord-005453-4057qib7	15557	2	evaluation	evaluation	NN
cord-005453-4057qib7	15557	3	for	for	IN
cord-005453-4057qib7	15557	4	ON	on	IN
cord-005453-4057qib7	15557	5	post	post	JJ
cord-005453-4057qib7	15557	6	-	-	JJ
cord-005453-4057qib7	15557	7	HCT	HCT	NNP
cord-005453-4057qib7	15557	8	is	be	VBZ
cord-005453-4057qib7	15557	9	only	only	RB
cord-005453-4057qib7	15557	10	indicated	indicate	VBN
cord-005453-4057qib7	15557	11	for	for	IN
cord-005453-4057qib7	15557	12	patients	patient	NNS
cord-005453-4057qib7	15557	13	with	with	IN
cord-005453-4057qib7	15557	14	ON	on	IN
cord-005453-4057qib7	15557	15	pre	pre	JJ
cord-005453-4057qib7	15557	16	-	-	JJ
cord-005453-4057qib7	15557	17	HCT	hct	JJ
cord-005453-4057qib7	15557	18	and	and	CC
cord-005453-4057qib7	15557	19	symptomatic	symptomatic	JJ
cord-005453-4057qib7	15557	20	patients	patient	NNS
cord-005453-4057qib7	15557	21	.	.	.
cord-005453-4057qib7	15558	1	This	this	DT
cord-005453-4057qib7	15558	2	will	will	MD
cord-005453-4057qib7	15558	3	entail	entail	VB
cord-005453-4057qib7	15558	4	cost	cost	NN
cord-005453-4057qib7	15558	5	savings	saving	NNS
cord-005453-4057qib7	15558	6	of	of	IN
cord-005453-4057qib7	15558	7	USD	usd	NN
cord-005453-4057qib7	15558	8	500,000	500,000	CD
cord-005453-4057qib7	15558	9	per	per	IN
cord-005453-4057qib7	15558	10	100	100	CD
cord-005453-4057qib7	15558	11	surviving	survive	VBG
cord-005453-4057qib7	15558	12	allogeneic	allogeneic	IN
cord-005453-4057qib7	15558	13	HCT	hct	NN
cord-005453-4057qib7	15558	14	patients	patient	NNS
cord-005453-4057qib7	15558	15	per	per	IN
cord-005453-4057qib7	15558	16	year	year	NN
cord-005453-4057qib7	15558	17	.	.	.
cord-005453-4057qib7	15559	1	Patients	patient	NNS
cord-005453-4057qib7	15559	2	with	with	IN
cord-005453-4057qib7	15559	3	more	more	JJR
cord-005453-4057qib7	15559	4	than	than	IN
cord-005453-4057qib7	15559	5	30	30	CD
cord-005453-4057qib7	15559	6	%	%	NN
cord-005453-4057qib7	15559	7	involvement	involvement	NN
cord-005453-4057qib7	15559	8	of	of	IN
cord-005453-4057qib7	15559	9	the	the	DT
cord-005453-4057qib7	15559	10	articular	articular	JJ
cord-005453-4057qib7	15559	11	surface	surface	NN
cord-005453-4057qib7	15559	12	need	nee	MD
cord-005453-4057qib7	15559	13	close	close	RB
cord-005453-4057qib7	15559	14	follow	follow	NN
cord-005453-4057qib7	15559	15	up	up	RP
cord-005453-4057qib7	15559	16	.	.	.
cord-005453-4057qib7	15560	1	Clinical	clinical	JJ
cord-005453-4057qib7	15560	2	Trial	Trial	NNP
cord-005453-4057qib7	15560	3	Registry	Registry	NNP
cord-005453-4057qib7	15560	4	:	:	:
cord-005453-4057qib7	15561	1	None	none	NN
cord-005453-4057qib7	15561	2	Disclosure	disclosure	NN
cord-005453-4057qib7	15561	3	:	:	:
cord-005453-4057qib7	15561	4	None	None	NNP
cord-005453-4057qib7	15561	5	Impact	Impact	NNP
cord-005453-4057qib7	15561	6	of	of	IN
cord-005453-4057qib7	15561	7	rabbit	rabbit	NN
cord-005453-4057qib7	15561	8	anti	anti	NNP
cord-005453-4057qib7	15561	9	thymocyte	thymocyte	NNP
cord-005453-4057qib7	15561	10	globulin	globulin	NN
cord-005453-4057qib7	15561	11	exposure	exposure	NN
cord-005453-4057qib7	15561	12	on	on	IN
cord-005453-4057qib7	15561	13	immune	immune	JJ
cord-005453-4057qib7	15561	14	reconstitution	reconstitution	NN
cord-005453-4057qib7	15561	15	and	and	CC
cord-005453-4057qib7	15561	16	outcome	outcome	NN
cord-005453-4057qib7	15561	17	after	after	IN
cord-005453-4057qib7	15561	18	stem	stem	NN
cord-005453-4057qib7	15561	19	cell	cell	NN
cord-005453-4057qib7	15561	20	transplantation	transplantation	NN
cord-005453-4057qib7	15561	21	in	in	IN
cord-005453-4057qib7	15561	22	children	child	NNS
cord-005453-4057qib7	15561	23	Background	background	NN
cord-005453-4057qib7	15561	24	:	:	:
cord-005453-4057qib7	15562	1	Rabbit	Rabbit	NNP
cord-005453-4057qib7	15562	2	anti	anti	JJ
cord-005453-4057qib7	15562	3	thymocyte	thymocyte	NN
cord-005453-4057qib7	15562	4	globulin	globulin	NN
cord-005453-4057qib7	15562	5	(	(	-LRB-
cord-005453-4057qib7	15562	6	rATG	rATG	NNP
cord-005453-4057qib7	15562	7	)	)	-RRB-
cord-005453-4057qib7	15562	8	has	have	VBZ
cord-005453-4057qib7	15562	9	been	be	VBN
cord-005453-4057qib7	15562	10	frequently	frequently	RB
cord-005453-4057qib7	15562	11	used	use	VBN
cord-005453-4057qib7	15562	12	for	for	IN
cord-005453-4057qib7	15562	13	many	many	JJ
cord-005453-4057qib7	15562	14	years	year	NNS
cord-005453-4057qib7	15562	15	as	as	IN
cord-005453-4057qib7	15562	16	GvHD	GvHD	NNP
cord-005453-4057qib7	15562	17	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15562	18	in	in	IN
cord-005453-4057qib7	15562	19	pediatric	pediatric	JJ
cord-005453-4057qib7	15562	20	stem	stem	NN
cord-005453-4057qib7	15562	21	cell	cell	NN
cord-005453-4057qib7	15562	22	transplantation	transplantation	NN
cord-005453-4057qib7	15562	23	.	.	.
cord-005453-4057qib7	15563	1	Precise	precise	JJ
cord-005453-4057qib7	15563	2	dosing	dosing	NN
cord-005453-4057qib7	15563	3	regimens	regimen	NNS
cord-005453-4057qib7	15563	4	are	be	VBP
cord-005453-4057qib7	15563	5	crucial	crucial	JJ
cord-005453-4057qib7	15563	6	but	but	CC
cord-005453-4057qib7	15563	7	remain	remain	VBP
cord-005453-4057qib7	15563	8	challenging	challenging	JJ
cord-005453-4057qib7	15563	9	due	due	IN
cord-005453-4057qib7	15563	10	to	to	IN
cord-005453-4057qib7	15563	11	several	several	JJ
cord-005453-4057qib7	15563	12	pharmacological	pharmacological	JJ
cord-005453-4057qib7	15563	13	characteristics	characteristic	NNS
cord-005453-4057qib7	15563	14	in	in	IN
cord-005453-4057qib7	15563	15	children	child	NNS
cord-005453-4057qib7	15563	16	.	.	.
cord-005453-4057qib7	15564	1	Methods	method	NNS
cord-005453-4057qib7	15564	2	:	:	:
cord-005453-4057qib7	15565	1	rATG	ratg	JJ
cord-005453-4057qib7	15565	2	levels	level	NNS
cord-005453-4057qib7	15565	3	were	be	VBD
cord-005453-4057qib7	15565	4	measured	measure	VBN
cord-005453-4057qib7	15565	5	in	in	IN
cord-005453-4057qib7	15565	6	pediatric	pediatric	JJ
cord-005453-4057qib7	15565	7	patients	patient	NNS
cord-005453-4057qib7	15565	8	undergoing	undergo	VBG
cord-005453-4057qib7	15565	9	allogeneic	allogeneic	IN
cord-005453-4057qib7	15565	10	stem	stem	NN
cord-005453-4057qib7	15565	11	cell	cell	NN
cord-005453-4057qib7	15565	12	transplantation	transplantation	NN
cord-005453-4057qib7	15565	13	after	after	IN
cord-005453-4057qib7	15565	14	obtaining	obtain	VBG
cord-005453-4057qib7	15565	15	approval	approval	NN
cord-005453-4057qib7	15565	16	by	by	IN
cord-005453-4057qib7	15565	17	the	the	DT
cord-005453-4057qib7	15565	18	local	local	JJ
cord-005453-4057qib7	15565	19	IRB	IRB	NNP
cord-005453-4057qib7	15565	20	and	and	CC
cord-005453-4057qib7	15565	21	informed	informed	JJ
cord-005453-4057qib7	15565	22	consent	consent	NN
cord-005453-4057qib7	15565	23	by	by	IN
cord-005453-4057qib7	15565	24	legal	legal	JJ
cord-005453-4057qib7	15565	25	guardians	guardian	NNS
cord-005453-4057qib7	15565	26	.	.	.
cord-005453-4057qib7	15566	1	32	32	CD
cord-005453-4057qib7	15566	2	pediatric	pediatric	JJ
cord-005453-4057qib7	15566	3	patients	patient	NNS
cord-005453-4057qib7	15566	4	who	who	WP
cord-005453-4057qib7	15566	5	received	receive	VBD
cord-005453-4057qib7	15566	6	either	either	CC
cord-005453-4057qib7	15566	7	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	15566	8	™	™	,
cord-005453-4057qib7	15566	9	(	(	-LRB-
cord-005453-4057qib7	15566	10	n=22	n=22	NNP
cord-005453-4057qib7	15566	11	)	)	-RRB-
cord-005453-4057qib7	15566	12	or	or	CC
cord-005453-4057qib7	15566	13	Grafalon	Grafalon	NNP
cord-005453-4057qib7	15566	14	™	™	NN
cord-005453-4057qib7	15566	15	(	(	-LRB-
cord-005453-4057qib7	15566	16	ATG	ATG	NNP
cord-005453-4057qib7	15566	17	-	-	HYPH
cord-005453-4057qib7	15566	18	F	F	NNP
cord-005453-4057qib7	15566	19	)	)	-RRB-
cord-005453-4057qib7	15566	20	(	(	-LRB-
cord-005453-4057qib7	15566	21	n=10	n=10	NNP
cord-005453-4057qib7	15566	22	)	)	-RRB-
cord-005453-4057qib7	15566	23	as	as	IN
cord-005453-4057qib7	15566	24	part	part	NN
cord-005453-4057qib7	15566	25	of	of	IN
cord-005453-4057qib7	15566	26	their	-PRON-	PRP$
cord-005453-4057qib7	15566	27	conditioning	conditioning	NN
cord-005453-4057qib7	15566	28	regimen	regimen	NN
cord-005453-4057qib7	15567	1	Background	background	NN
cord-005453-4057qib7	15567	2	:	:	:
cord-005453-4057qib7	15567	3	Obesity	obesity	NN
cord-005453-4057qib7	15567	4	among	among	IN
cord-005453-4057qib7	15567	5	children	child	NNS
cord-005453-4057qib7	15567	6	is	be	VBZ
cord-005453-4057qib7	15567	7	a	a	DT
cord-005453-4057qib7	15567	8	growing	grow	VBG
cord-005453-4057qib7	15567	9	health	health	NN
cord-005453-4057qib7	15567	10	problem	problem	NN
cord-005453-4057qib7	15567	11	.	.	.
cord-005453-4057qib7	15568	1	malnutrition	malnutrition	NN
cord-005453-4057qib7	15568	2	or	or	CC
cord-005453-4057qib7	15568	3	being	be	VBG
cord-005453-4057qib7	15568	4	over	over	IN
cord-005453-4057qib7	15568	5	-	-	HYPH
cord-005453-4057qib7	15568	6	weight	weight	NN
cord-005453-4057qib7	15568	7	can	can	MD
cord-005453-4057qib7	15568	8	be	be	VB
cord-005453-4057qib7	15568	9	of	of	IN
cord-005453-4057qib7	15568	10	prognostic	prognostic	JJ
cord-005453-4057qib7	15568	11	impact	impact	NN
cord-005453-4057qib7	15568	12	among	among	IN
cord-005453-4057qib7	15568	13	children	child	NNS
cord-005453-4057qib7	15568	14	who	who	WP
cord-005453-4057qib7	15568	15	need	need	VBP
cord-005453-4057qib7	15568	16	HSCT.Scientific	HSCT.Scientific	NNP
cord-005453-4057qib7	15568	17	literature	literature	NN
cord-005453-4057qib7	15568	18	shows	show	VBZ
cord-005453-4057qib7	15568	19	a	a	DT
cord-005453-4057qib7	15568	20	lot	lot	NN
cord-005453-4057qib7	15568	21	of	of	IN
cord-005453-4057qib7	15568	22	controversy	controversy	NN
cord-005453-4057qib7	15568	23	in	in	IN
cord-005453-4057qib7	15568	24	terms	term	NNS
cord-005453-4057qib7	15568	25	of	of	IN
cord-005453-4057qib7	15568	26	effect	effect	NN
cord-005453-4057qib7	15568	27	of	of	IN
cord-005453-4057qib7	15568	28	BMI	BMI	NNP
cord-005453-4057qib7	15568	29	at	at	IN
cord-005453-4057qib7	15568	30	the	the	DT
cord-005453-4057qib7	15568	31	time	time	NN
cord-005453-4057qib7	15568	32	of	of	IN
cord-005453-4057qib7	15568	33	infusion	infusion	NN
cord-005453-4057qib7	15568	34	on	on	IN
cord-005453-4057qib7	15568	35	the	the	DT
cord-005453-4057qib7	15568	36	outcome	outcome	NN
cord-005453-4057qib7	15568	37	of	of	IN
cord-005453-4057qib7	15568	38	HSCT.Methods	HSCT.Methods	NNPS
cord-005453-4057qib7	15569	1	:	:	:
cord-005453-4057qib7	15569	2	We	-PRON-	PRP
cord-005453-4057qib7	15569	3	reviewed	review	VBD
cord-005453-4057qib7	15569	4	data	datum	NNS
cord-005453-4057qib7	15569	5	of	of	IN
cord-005453-4057qib7	15569	6	patients	patient	NNS
cord-005453-4057qib7	15569	7	who	who	WP
cord-005453-4057qib7	15569	8	underwent	undergo	VBD
cord-005453-4057qib7	15569	9	HSCT	HSCT	NNP
cord-005453-4057qib7	15569	10	at	at	IN
cord-005453-4057qib7	15569	11	King	King	NNP
cord-005453-4057qib7	15569	12	Faisal	Faisal	NNP
cord-005453-4057qib7	15569	13	Specialist	Specialist	NNP
cord-005453-4057qib7	15569	14	Hospital	Hospital	NNP
cord-005453-4057qib7	15569	15	&	&	CC
cord-005453-4057qib7	15569	16	Research	Research	NNP
cord-005453-4057qib7	15569	17	Centre	Centre	NNP
cord-005453-4057qib7	15569	18	between	between	IN
cord-005453-4057qib7	15569	19	2010	2010	CD
cord-005453-4057qib7	15569	20	-	-	SYM
cord-005453-4057qib7	15569	21	2016	2016	CD
cord-005453-4057qib7	15569	22	to	to	TO
cord-005453-4057qib7	15569	23	correlate	correlate	VB
cord-005453-4057qib7	15569	24	BMI	BMI	NNP
cord-005453-4057qib7	15569	25	with	with	IN
cord-005453-4057qib7	15569	26	the	the	DT
cord-005453-4057qib7	15569	27	outcome	outcome	NN
cord-005453-4057qib7	15569	28	and	and	CC
cord-005453-4057qib7	15569	29	complications	complication	NNS
cord-005453-4057qib7	15569	30	of	of	IN
cord-005453-4057qib7	15569	31	HSCT	HSCT	NNP
cord-005453-4057qib7	15569	32	.	.	.
cord-005453-4057qib7	15570	1	Transplant	transplant	NN
cord-005453-4057qib7	15570	2	naïve	naïve	JJ
cord-005453-4057qib7	15570	3	recipients	recipient	NNS
cord-005453-4057qib7	15570	4	with	with	IN
cord-005453-4057qib7	15570	5	age	age	NN
cord-005453-4057qib7	15570	6	at	at	IN
cord-005453-4057qib7	15570	7	infusion	infusion	NN
cord-005453-4057qib7	15570	8	between	between	IN
cord-005453-4057qib7	15570	9	2	2	CD
cord-005453-4057qib7	15570	10	-	-	SYM
cord-005453-4057qib7	15570	11	14	14	CD
cord-005453-4057qib7	15570	12	years	year	NNS
cord-005453-4057qib7	15570	13	who	who	WP
cord-005453-4057qib7	15570	14	received	receive	VBD
cord-005453-4057qib7	15570	15	HSCT	HSCT	NNP
cord-005453-4057qib7	15570	16	from	from	IN
cord-005453-4057qib7	15570	17	matched	matched	JJ
cord-005453-4057qib7	15570	18	related	related	JJ
cord-005453-4057qib7	15570	19	donor	donor	NN
cord-005453-4057qib7	15570	20	or	or	CC
cord-005453-4057qib7	15570	21	autologous	autologous	JJ
cord-005453-4057qib7	15570	22	HSCT	HSCT	NNP
cord-005453-4057qib7	15570	23	,	,	,
cord-005453-4057qib7	15570	24	were	be	VBD
cord-005453-4057qib7	15570	25	included	include	VBN
cord-005453-4057qib7	15570	26	in	in	IN
cord-005453-4057qib7	15570	27	the	the	DT
cord-005453-4057qib7	15570	28	dataset	dataset	NN
cord-005453-4057qib7	15570	29	for	for	IN
cord-005453-4057qib7	15570	30	analysis	analysis	NN
cord-005453-4057qib7	15570	31	.	.	.
cord-005453-4057qib7	15571	1	A	a	DT
cord-005453-4057qib7	15571	2	total	total	NN
cord-005453-4057qib7	15571	3	of	of	IN
cord-005453-4057qib7	15571	4	423	423	CD
cord-005453-4057qib7	15571	5	patients	patient	NNS
cord-005453-4057qib7	15571	6	'	'	POS
cord-005453-4057qib7	15571	7	profiles	profile	NNS
cord-005453-4057qib7	15571	8	were	be	VBD
cord-005453-4057qib7	15571	9	reviewed	review	VBN
cord-005453-4057qib7	15571	10	of	of	IN
cord-005453-4057qib7	15571	11	whom	whom	WP
cord-005453-4057qib7	15571	12	51.1	51.1	CD
cord-005453-4057qib7	15571	13	%	%	NN
cord-005453-4057qib7	15571	14	were	be	VBD
cord-005453-4057qib7	15571	15	boys	boy	NNS
cord-005453-4057qib7	15571	16	.	.	.
cord-005453-4057qib7	15572	1	Median	median	JJ
cord-005453-4057qib7	15572	2	age	age	NN
cord-005453-4057qib7	15572	3	at	at	IN
cord-005453-4057qib7	15572	4	transplant	transplant	NN
cord-005453-4057qib7	15572	5	was	be	VBD
cord-005453-4057qib7	15572	6	7.5	7.5	CD
cord-005453-4057qib7	15572	7	years	year	NNS
cord-005453-4057qib7	15572	8	.	.	.
cord-005453-4057qib7	15573	1	Primary	primary	JJ
cord-005453-4057qib7	15573	2	indication	indication	NN
cord-005453-4057qib7	15573	3	of	of	IN
cord-005453-4057qib7	15573	4	disease	disease	NN
cord-005453-4057qib7	15573	5	was	be	VBD
cord-005453-4057qib7	15573	6	malignancy	malignancy	NN
cord-005453-4057qib7	15573	7	in	in	IN
cord-005453-4057qib7	15573	8	41.6	41.6	CD
cord-005453-4057qib7	15573	9	%	%	NN
cord-005453-4057qib7	15573	10	followed	follow	VBN
cord-005453-4057qib7	15573	11	by	by	IN
cord-005453-4057qib7	15573	12	hemoglobinopathies	hemoglobinopathy	NNS
cord-005453-4057qib7	15573	13	26.7	26.7	CD
cord-005453-4057qib7	15573	14	%	%	NN
cord-005453-4057qib7	15573	15	,	,	,
cord-005453-4057qib7	15573	16	bone	bone	NN
cord-005453-4057qib7	15573	17	marrow	marrow	NN
cord-005453-4057qib7	15573	18	failures	failure	NNS
cord-005453-4057qib7	15573	19	17.3	17.3	CD
cord-005453-4057qib7	15573	20	%	%	NN
cord-005453-4057qib7	15573	21	and	and	CC
cord-005453-4057qib7	15573	22	immune	immune	JJ
cord-005453-4057qib7	15573	23	disorders	disorder	NNS
cord-005453-4057qib7	15573	24	12.5	12.5	CD
cord-005453-4057qib7	15573	25	%	%	NN
cord-005453-4057qib7	15573	26	.	.	.
cord-005453-4057qib7	15574	1	Solid	solid	JJ
cord-005453-4057qib7	15574	2	tumors	tumor	NNS
cord-005453-4057qib7	15574	3	accounted	account	VBD
cord-005453-4057qib7	15574	4	for	for	IN
cord-005453-4057qib7	15574	5	29.5	29.5	CD
cord-005453-4057qib7	15574	6	%	%	NN
cord-005453-4057qib7	15574	7	among	among	IN
cord-005453-4057qib7	15574	8	malignant	malignant	JJ
cord-005453-4057qib7	15574	9	disorders	disorder	NNS
cord-005453-4057qib7	15574	10	.	.	.
cord-005453-4057qib7	15575	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	15575	2	conditioning	conditioning	NN
cord-005453-4057qib7	15575	3	was	be	VBD
cord-005453-4057qib7	15575	4	used	use	VBN
cord-005453-4057qib7	15575	5	in	in	IN
cord-005453-4057qib7	15575	6	97.2	97.2	CD
cord-005453-4057qib7	15575	7	%	%	NN
cord-005453-4057qib7	15575	8	transplants	transplant	NNS
cord-005453-4057qib7	15575	9	with	with	IN
cord-005453-4057qib7	15575	10	11.8	11.8	CD
cord-005453-4057qib7	15575	11	%	%	NN
cord-005453-4057qib7	15575	12	regimens	regimen	NNS
cord-005453-4057qib7	15575	13	containing	contain	VBG
cord-005453-4057qib7	15575	14	total	total	JJ
cord-005453-4057qib7	15575	15	body	body	NN
cord-005453-4057qib7	15575	16	irradiation	irradiation	NN
cord-005453-4057qib7	15575	17	.	.	.
cord-005453-4057qib7	15576	1	Majority	majority	NN
cord-005453-4057qib7	15576	2	of	of	IN
cord-005453-4057qib7	15576	3	the	the	DT
cord-005453-4057qib7	15576	4	patients	patient	NNS
cord-005453-4057qib7	15576	5	81.3	81.3	CD
cord-005453-4057qib7	15576	6	%	%	NN
cord-005453-4057qib7	15576	7	underwent	undergo	VBD
cord-005453-4057qib7	15576	8	allogeneic	allogeneic	NN
cord-005453-4057qib7	15576	9	transplantation	transplantation	NN
cord-005453-4057qib7	15576	10	using	use	VBG
cord-005453-4057qib7	15576	11	BM	BM	NNP
cord-005453-4057qib7	15576	12	as	as	IN
cord-005453-4057qib7	15576	13	the	the	DT
cord-005453-4057qib7	15576	14	source	source	NN
cord-005453-4057qib7	15576	15	in	in	IN
cord-005453-4057qib7	15576	16	80.4	80.4	CD
cord-005453-4057qib7	15576	17	%	%	NN
cord-005453-4057qib7	15576	18	and	and	CC
cord-005453-4057qib7	15576	19	PBSC	PBSC	NNP
cord-005453-4057qib7	15576	20	in	in	IN
cord-005453-4057qib7	15576	21	the	the	DT
cord-005453-4057qib7	15576	22	remaining	remain	VBG
cord-005453-4057qib7	15576	23	19.6	19.6	CD
cord-005453-4057qib7	15576	24	%	%	NN
cord-005453-4057qib7	15576	25	cases	case	NNS
cord-005453-4057qib7	15576	26	.	.	.
cord-005453-4057qib7	15577	1	Donor	donor	NN
cord-005453-4057qib7	15577	2	was	be	VBD
cord-005453-4057qib7	15577	3	HLA	HLA	NNP
cord-005453-4057qib7	15577	4	-	-	HYPH
cord-005453-4057qib7	15577	5	Identical	Identical	NNP
cord-005453-4057qib7	15577	6	Sibling	Sibling	NNP
cord-005453-4057qib7	15577	7	in	in	IN
cord-005453-4057qib7	15577	8	89	89	CD
cord-005453-4057qib7	15577	9	%	%	NN
cord-005453-4057qib7	15577	10	,	,	,
cord-005453-4057qib7	15577	11	parents	parent	NNS
cord-005453-4057qib7	15577	12	in	in	IN
cord-005453-4057qib7	15577	13	10.2	10.2	CD
cord-005453-4057qib7	15577	14	%	%	NN
cord-005453-4057qib7	15577	15	and	and	CC
cord-005453-4057qib7	15577	16	others	other	NNS
cord-005453-4057qib7	15577	17	in	in	IN
cord-005453-4057qib7	15577	18	the	the	DT
cord-005453-4057qib7	15577	19	remaining	remain	VBG
cord-005453-4057qib7	15577	20	0.9	0.9	CD
cord-005453-4057qib7	15577	21	%	%	NN
cord-005453-4057qib7	15577	22	patients	patient	NNS
cord-005453-4057qib7	15577	23	.	.	.
cord-005453-4057qib7	15578	1	Median	median	JJ
cord-005453-4057qib7	15578	2	TNC	TNC	NNP
cord-005453-4057qib7	15578	3	Dose	Dose	NNP
cord-005453-4057qib7	15578	4	was	be	VBD
cord-005453-4057qib7	15578	5	2.55	2.55	CD
cord-005453-4057qib7	15578	6	X	x	SYM
cord-005453-4057qib7	15578	7	10	10	CD
cord-005453-4057qib7	15578	8	^	^	SYM
cord-005453-4057qib7	15578	9	9	9	CD
cord-005453-4057qib7	15579	1	and	and	CC
cord-005453-4057qib7	15579	2	CD34	CD34	NNP
cord-005453-4057qib7	15579	3	was	be	VBD
cord-005453-4057qib7	15579	4	5.63	5.63	CD
cord-005453-4057qib7	15579	5	X	x	SYM
cord-005453-4057qib7	15579	6	10	10	CD
cord-005453-4057qib7	15579	7	^	^	SYM
cord-005453-4057qib7	15579	8	6	6	CD
cord-005453-4057qib7	15579	9	per	per	IN
cord-005453-4057qib7	15579	10	Kg	Kg	NNP
cord-005453-4057qib7	15579	11	of	of	IN
cord-005453-4057qib7	15579	12	the	the	DT
cord-005453-4057qib7	15579	13	body	body	NN
cord-005453-4057qib7	15579	14	weight	weight	NN
cord-005453-4057qib7	15579	15	at	at	IN
cord-005453-4057qib7	15579	16	the	the	DT
cord-005453-4057qib7	15579	17	time	time	NN
cord-005453-4057qib7	15579	18	of	of	IN
cord-005453-4057qib7	15579	19	infusion	infusion	NN
cord-005453-4057qib7	15579	20	.	.	.
cord-005453-4057qib7	15580	1	Age	age	NN
cord-005453-4057qib7	15580	2	and	and	CC
cord-005453-4057qib7	15580	3	gender	gender	NN
cord-005453-4057qib7	15580	4	specific	specific	JJ
cord-005453-4057qib7	15580	5	BMI	BMI	NNP
cord-005453-4057qib7	15580	6	percentiles	percentile	NNS
cord-005453-4057qib7	15580	7	were	be	VBD
cord-005453-4057qib7	15580	8	obtained	obtain	VBN
cord-005453-4057qib7	15580	9	and	and	CC
cord-005453-4057qib7	15580	10	classified	classify	VBN
cord-005453-4057qib7	15580	11	according	accord	VBG
cord-005453-4057qib7	15580	12	to	to	IN
cord-005453-4057qib7	15580	13	the	the	DT
cord-005453-4057qib7	15580	14	definition	definition	NN
cord-005453-4057qib7	15580	15	of	of	IN
cord-005453-4057qib7	15580	16	centers	center	NNS
cord-005453-4057qib7	15580	17	for	for	IN
cord-005453-4057qib7	15580	18	disease	disease	NN
cord-005453-4057qib7	15580	19	control	control	NN
cord-005453-4057qib7	15580	20	and	and	CC
cord-005453-4057qib7	15580	21	prevention	prevention	NN
cord-005453-4057qib7	15580	22	(	(	-LRB-
cord-005453-4057qib7	15580	23	CDC	CDC	NNP
cord-005453-4057qib7	15580	24	)	)	-RRB-
cord-005453-4057qib7	15580	25	;	;	:
cord-005453-4057qib7	15580	26	24.8	24.8	CD
cord-005453-4057qib7	15580	27	%	%	NN
cord-005453-4057qib7	15580	28	(	(	-LRB-
cord-005453-4057qib7	15580	29	105	105	CD
cord-005453-4057qib7	15580	30	)	)	-RRB-
cord-005453-4057qib7	15580	31	recipients	recipient	NNS
cord-005453-4057qib7	15580	32	were	be	VBD
cord-005453-4057qib7	15580	33	categorized	categorize	VBN
cord-005453-4057qib7	15580	34	as	as	IN
cord-005453-4057qib7	15580	35	Under	under	IN
cord-005453-4057qib7	15580	36	-	-	HYPH
cord-005453-4057qib7	15580	37	Weight	weight	NN
cord-005453-4057qib7	15580	38	,	,	,
cord-005453-4057qib7	15580	39	61.2	61.2	CD
cord-005453-4057qib7	15580	40	%	%	NN
cord-005453-4057qib7	15580	41	(	(	-LRB-
cord-005453-4057qib7	15580	42	259	259	CD
cord-005453-4057qib7	15580	43	)	)	-RRB-
cord-005453-4057qib7	15580	44	Normal	normal	JJ
cord-005453-4057qib7	15580	45	,	,	,
cord-005453-4057qib7	15580	46	5.9	5.9	CD
cord-005453-4057qib7	15580	47	%	%	NN
cord-005453-4057qib7	15580	48	(	(	-LRB-
cord-005453-4057qib7	15580	49	25	25	CD
cord-005453-4057qib7	15580	50	)	)	-RRB-
cord-005453-4057qib7	15580	51	Over	over	IN
cord-005453-4057qib7	15580	52	-	-	HYPH
cord-005453-4057qib7	15580	53	Weight	weight	NN
cord-005453-4057qib7	15580	54	and	and	CC
cord-005453-4057qib7	15580	55	remaining	remain	VBG
cord-005453-4057qib7	15580	56	8	8	CD
cord-005453-4057qib7	15580	57	%	%	NN
cord-005453-4057qib7	15580	58	(	(	-LRB-
cord-005453-4057qib7	15580	59	34	34	CD
cord-005453-4057qib7	15580	60	)	)	-RRB-
cord-005453-4057qib7	15580	61	as	as	IN
cord-005453-4057qib7	15580	62	Obese	obese	JJ
cord-005453-4057qib7	15580	63	.	.	.
cord-005453-4057qib7	15581	1	Results	result	NNS
cord-005453-4057qib7	15581	2	:	:	:
cord-005453-4057qib7	15582	1	Based	base	VBN
cord-005453-4057qib7	15582	2	on	on	IN
cord-005453-4057qib7	15582	3	chimeric	chimeric	JJ
cord-005453-4057qib7	15582	4	studies	study	NNS
cord-005453-4057qib7	15582	5	at	at	IN
cord-005453-4057qib7	15582	6	Day-100	Day-100	NNPS
cord-005453-4057qib7	15582	7	,	,	,
cord-005453-4057qib7	15582	8	our	-PRON-	PRP$
cord-005453-4057qib7	15582	9	engraftment	engraftment	NN
cord-005453-4057qib7	15582	10	rate	rate	NN
cord-005453-4057qib7	15582	11	was	be	VBD
cord-005453-4057qib7	15582	12	98.3	98.3	CD
cord-005453-4057qib7	15582	13	%	%	NN
cord-005453-4057qib7	15582	14	(	(	-LRB-
cord-005453-4057qib7	15582	15	400	400	CD
cord-005453-4057qib7	15582	16	)	)	-RRB-
cord-005453-4057qib7	15582	17	out	out	IN
cord-005453-4057qib7	15582	18	of	of	IN
cord-005453-4057qib7	15582	19	407	407	CD
cord-005453-4057qib7	15582	20	evaluable	evaluable	JJ
cord-005453-4057qib7	15582	21	cases	case	NNS
cord-005453-4057qib7	15582	22	.	.	.
cord-005453-4057qib7	15583	1	Median	median	JJ
cord-005453-4057qib7	15583	2	time	time	NN
cord-005453-4057qib7	15583	3	to	to	IN
cord-005453-4057qib7	15583	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	15583	5	recovery	recovery	NN
cord-005453-4057qib7	15583	6	was	be	VBD
cord-005453-4057qib7	15583	7	14-days	14-days	CD
cord-005453-4057qib7	15583	8	from	from	IN
cord-005453-4057qib7	15583	9	infusion	infusion	NN
cord-005453-4057qib7	15583	10	and	and	CC
cord-005453-4057qib7	15583	11	26-days	26-days	CD
cord-005453-4057qib7	15583	12	for	for	IN
cord-005453-4057qib7	15583	13	platelets	platelet	NNS
cord-005453-4057qib7	15583	14	.	.	.
cord-005453-4057qib7	15584	1	No	no	DT
cord-005453-4057qib7	15584	2	statistically	statistically	RB
cord-005453-4057qib7	15584	3	significant	significant	JJ
cord-005453-4057qib7	15584	4	difference	difference	NN
cord-005453-4057qib7	15584	5	was	be	VBD
cord-005453-4057qib7	15584	6	found	find	VBN
cord-005453-4057qib7	15584	7	for	for	IN
cord-005453-4057qib7	15584	8	engraftment	engraftment	NN
cord-005453-4057qib7	15584	9	rate	rate	NN
cord-005453-4057qib7	15584	10	on	on	IN
cord-005453-4057qib7	15584	11	D-100	d-100	NN
cord-005453-4057qib7	15584	12	as	as	IN
cord-005453-4057qib7	15584	13	it	-PRON-	PRP
cord-005453-4057qib7	15584	14	was	be	VBD
cord-005453-4057qib7	15584	15	100	100	CD
cord-005453-4057qib7	15584	16	%	%	NN
cord-005453-4057qib7	15584	17	(	(	-LRB-
cord-005453-4057qib7	15584	18	25	25	CD
cord-005453-4057qib7	15584	19	)	)	-RRB-
cord-005453-4057qib7	15584	20	among	among	IN
cord-005453-4057qib7	15584	21	98.8	98.8	CD
cord-005453-4057qib7	15584	22	%	%	NN
cord-005453-4057qib7	15584	23	(	(	-LRB-
cord-005453-4057qib7	15584	24	247	247	CD
cord-005453-4057qib7	15584	25	)	)	-RRB-
cord-005453-4057qib7	15584	26	in	in	IN
cord-005453-4057qib7	15584	27	Normal	Normal	NNP
cord-005453-4057qib7	15584	28	,	,	,
cord-005453-4057qib7	15584	29	97	97	CD
cord-005453-4057qib7	15584	30	%	%	NN
cord-005453-4057qib7	15584	31	(	(	-LRB-
cord-005453-4057qib7	15584	32	97	97	CD
cord-005453-4057qib7	15584	33	)	)	-RRB-
cord-005453-4057qib7	15584	34	in	in	IN
cord-005453-4057qib7	15584	35	Under	Under	NNP
cord-005453-4057qib7	15584	36	-	-	HYPH
cord-005453-4057qib7	15584	37	Weight	weight	NN
cord-005453-4057qib7	15584	38	and	and	CC
cord-005453-4057qib7	15584	39	96.9	96.9	CD
cord-005453-4057qib7	15584	40	%	%	NN
cord-005453-4057qib7	15584	41	(	(	-LRB-
cord-005453-4057qib7	15584	42	31	31	CD
cord-005453-4057qib7	15584	43	)	)	-RRB-
cord-005453-4057qib7	15584	44	in	in	IN
cord-005453-4057qib7	15584	45	the	the	DT
cord-005453-4057qib7	15584	46	Obese	obese	JJ
cord-005453-4057qib7	15584	47	(	(	-LRB-
cord-005453-4057qib7	15584	48	P	p	NN
cord-005453-4057qib7	15584	49	-	-	HYPH
cord-005453-4057qib7	15584	50	Value	value	NN
cord-005453-4057qib7	15584	51	:	:	:
cord-005453-4057qib7	15584	52	0.467	0.467	CD
cord-005453-4057qib7	15584	53	)	)	-RRB-
cord-005453-4057qib7	15584	54	.	.	.
cord-005453-4057qib7	15585	1	Median	median	JJ
cord-005453-4057qib7	15585	2	time	time	NN
cord-005453-4057qib7	15585	3	to	to	IN
cord-005453-4057qib7	15585	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	15585	5	recovery	recovery	NN
cord-005453-4057qib7	15585	6	from	from	IN
cord-005453-4057qib7	15585	7	the	the	DT
cord-005453-4057qib7	15585	8	infusion	infusion	NN
cord-005453-4057qib7	15585	9	date	date	NN
cord-005453-4057qib7	15585	10	was	be	VBD
cord-005453-4057qib7	15585	11	15-days	15-days	CD
cord-005453-4057qib7	15585	12	in	in	IN
cord-005453-4057qib7	15585	13	Over	over	JJ
cord-005453-4057qib7	15585	14	-	-	HYPH
cord-005453-4057qib7	15585	15	weight	weight	NN
cord-005453-4057qib7	15585	16	patients	patient	NNS
cord-005453-4057qib7	15585	17	and	and	CC
cord-005453-4057qib7	15585	18	14	14	CD
cord-005453-4057qib7	15585	19	in	in	IN
cord-005453-4057qib7	15585	20	the	the	DT
cord-005453-4057qib7	15585	21	remaining	remain	VBG
cord-005453-4057qib7	15585	22	three	three	CD
cord-005453-4057qib7	15585	23	groups	group	NNS
cord-005453-4057qib7	15585	24	(	(	-LRB-
cord-005453-4057qib7	15585	25	P	P	NNP
cord-005453-4057qib7	15585	26	-	-	HYPH
cord-005453-4057qib7	15585	27	Value	value	NN
cord-005453-4057qib7	15585	28	:	:	:
cord-005453-4057qib7	15585	29	0.841	0.841	CD
cord-005453-4057qib7	15585	30	)	)	-RRB-
cord-005453-4057qib7	15585	31	.	.	.
cord-005453-4057qib7	15586	1	Acute	acute	JJ
cord-005453-4057qib7	15586	2	Graft	Graft	NNP
cord-005453-4057qib7	15586	3	vs.	vs.	IN
cord-005453-4057qib7	15586	4	Host	Host	NNP
cord-005453-4057qib7	15586	5	Disease	Disease	NNP
cord-005453-4057qib7	15586	6	(	(	-LRB-
cord-005453-4057qib7	15586	7	aGvHD	agvhd	NN
cord-005453-4057qib7	15586	8	)	)	-RRB-
cord-005453-4057qib7	15586	9	of	of	IN
cord-005453-4057qib7	15586	10	any	any	DT
cord-005453-4057qib7	15586	11	grade	grade	NN
cord-005453-4057qib7	15586	12	at	at	IN
cord-005453-4057qib7	15586	13	Day-100	Day-100	NNP
cord-005453-4057qib7	15586	14	was	be	VBD
cord-005453-4057qib7	15586	15	recorded	record	VBN
cord-005453-4057qib7	15586	16	in	in	IN
cord-005453-4057qib7	15586	17	19.9	19.9	CD
cord-005453-4057qib7	15586	18	%	%	NN
cord-005453-4057qib7	15586	19	(	(	-LRB-
cord-005453-4057qib7	15586	20	84	84	CD
cord-005453-4057qib7	15586	21	)	)	-RRB-
cord-005453-4057qib7	15586	22	.	.	.
cord-005453-4057qib7	15587	1	Any	any	DT
cord-005453-4057qib7	15587	2	-	-	HYPH
cord-005453-4057qib7	15587	3	grade	grade	NN
cord-005453-4057qib7	15587	4	aGvHD	agvhd	NN
cord-005453-4057qib7	15587	5	was	be	VBD
cord-005453-4057qib7	15587	6	more	more	RBR
cord-005453-4057qib7	15587	7	common	common	JJ
cord-005453-4057qib7	15587	8	in	in	IN
cord-005453-4057qib7	15587	9	Over	Over	NNP
cord-005453-4057qib7	15587	10	-	-	HYPH
cord-005453-4057qib7	15587	11	Weight	weight	NN
cord-005453-4057qib7	15587	12	24	24	CD
cord-005453-4057qib7	15587	13	%	%	NN
cord-005453-4057qib7	15587	14	(	(	-LRB-
cord-005453-4057qib7	15587	15	6	6	CD
cord-005453-4057qib7	15587	16	)	)	-RRB-
cord-005453-4057qib7	15587	17	,	,	,
cord-005453-4057qib7	15587	18	followed	follow	VBN
cord-005453-4057qib7	15587	19	by	by	IN
cord-005453-4057qib7	15587	20	Obese	Obese	NNP
cord-005453-4057qib7	15587	21	with	with	IN
cord-005453-4057qib7	15587	22	23.5	23.5	CD
cord-005453-4057qib7	15587	23	%	%	NN
cord-005453-4057qib7	15587	24	(	(	-LRB-
cord-005453-4057qib7	15587	25	8)	8)	NNP
cord-005453-4057qib7	15587	26	,	,	,
cord-005453-4057qib7	15587	27	21	21	CD
cord-005453-4057qib7	15587	28	%	%	NN
cord-005453-4057qib7	15587	29	(	(	-LRB-
cord-005453-4057qib7	15587	30	22	22	CD
cord-005453-4057qib7	15587	31	)	)	-RRB-
cord-005453-4057qib7	15587	32	in	in	IN
cord-005453-4057qib7	15587	33	Under	under	NN
cord-005453-4057qib7	15587	34	-	-	HYPH
cord-005453-4057qib7	15587	35	weight	weight	NN
cord-005453-4057qib7	15587	36	and	and	CC
cord-005453-4057qib7	15587	37	18.6	18.6	CD
cord-005453-4057qib7	15587	38	%	%	NN
cord-005453-4057qib7	15587	39	(	(	-LRB-
cord-005453-4057qib7	15587	40	48	48	CD
cord-005453-4057qib7	15587	41	)	)	-RRB-
cord-005453-4057qib7	15587	42	in	in	IN
cord-005453-4057qib7	15587	43	Normal	normal	JJ
cord-005453-4057qib7	15587	44	BMI	BMI	NNP
cord-005453-4057qib7	15587	45	-	-	HYPH
cord-005453-4057qib7	15587	46	category	category	NN
cord-005453-4057qib7	15587	47	(	(	-LRB-
cord-005453-4057qib7	15587	48	P	p	NN
cord-005453-4057qib7	15587	49	-	-	HYPH
cord-005453-4057qib7	15587	50	Value	value	NN
cord-005453-4057qib7	15587	51	:	:	:
cord-005453-4057qib7	15587	52	0.770	0.770	CD
cord-005453-4057qib7	15587	53	)	)	-RRB-
cord-005453-4057qib7	15587	54	.	.	.
cord-005453-4057qib7	15588	1	Chronic	chronic	JJ
cord-005453-4057qib7	15588	2	GvHD	GvHD	NNP
cord-005453-4057qib7	15588	3	was	be	VBD
cord-005453-4057qib7	15588	4	more	more	RBR
cord-005453-4057qib7	15588	5	frequent	frequent	JJ
cord-005453-4057qib7	15588	6	in	in	IN
cord-005453-4057qib7	15588	7	Over	Over	NNP
cord-005453-4057qib7	15588	8	-	-	HYPH
cord-005453-4057qib7	15588	9	Weight	weight	NN
cord-005453-4057qib7	15588	10	(	(	-LRB-
cord-005453-4057qib7	15588	11	14.3	14.3	CD
cord-005453-4057qib7	15588	12	%	%	NN
cord-005453-4057qib7	15588	13	,	,	,
cord-005453-4057qib7	15588	14	3	3	CD
cord-005453-4057qib7	15588	15	)	)	-RRB-
cord-005453-4057qib7	15588	16	,	,	,
cord-005453-4057qib7	15588	17	compared	compare	VBN
cord-005453-4057qib7	15588	18	to	to	IN
cord-005453-4057qib7	15588	19	9	9	CD
cord-005453-4057qib7	15588	20	)	)	-RRB-
cord-005453-4057qib7	15589	1	Background	background	NN
cord-005453-4057qib7	15589	2	:	:	:
cord-005453-4057qib7	15589	3	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15589	4	stem	stem	NN
cord-005453-4057qib7	15589	5	cell	cell	NN
cord-005453-4057qib7	15589	6	transplantation	transplantation	NN
cord-005453-4057qib7	15589	7	(	(	-LRB-
cord-005453-4057qib7	15589	8	HSCT	HSCT	NNP
cord-005453-4057qib7	15589	9	)	)	-RRB-
cord-005453-4057qib7	15589	10	is	be	VBZ
cord-005453-4057qib7	15589	11	the	the	DT
cord-005453-4057qib7	15589	12	standard	standard	JJ
cord-005453-4057qib7	15589	13	treatment	treatment	NN
cord-005453-4057qib7	15589	14	for	for	IN
cord-005453-4057qib7	15589	15	children	child	NNS
cord-005453-4057qib7	15589	16	with	with	IN
cord-005453-4057qib7	15589	17	severe	severe	JJ
cord-005453-4057qib7	15589	18	aplastic	aplastic	JJ
cord-005453-4057qib7	15589	19	anemia	anemia	NN
cord-005453-4057qib7	15589	20	(	(	-LRB-
cord-005453-4057qib7	15589	21	SAA	SAA	NNP
cord-005453-4057qib7	15589	22	)	)	-RRB-
cord-005453-4057qib7	15589	23	who	who	WP
cord-005453-4057qib7	15589	24	have	have	VBP
cord-005453-4057qib7	15589	25	HLA	HLA	NNP
cord-005453-4057qib7	15589	26	-	-	HYPH
cord-005453-4057qib7	15589	27	identical	identical	JJ
cord-005453-4057qib7	15589	28	related	related	JJ
cord-005453-4057qib7	15589	29	donor	donor	NN
cord-005453-4057qib7	15589	30	.	.	.
cord-005453-4057qib7	15590	1	There	there	EX
cord-005453-4057qib7	15590	2	is	be	VBZ
cord-005453-4057qib7	15590	3	no	no	DT
cord-005453-4057qib7	15590	4	standard	standard	JJ
cord-005453-4057qib7	15590	5	conditioning	conditioning	NN
cord-005453-4057qib7	15590	6	regimen	regimen	NN
cord-005453-4057qib7	15590	7	for	for	IN
cord-005453-4057qib7	15590	8	children	child	NNS
cord-005453-4057qib7	15590	9	with	with	IN
cord-005453-4057qib7	15590	10	SAA	SAA	NNP
cord-005453-4057qib7	15590	11	secondary	secondary	JJ
cord-005453-4057qib7	15590	12	to	to	IN
cord-005453-4057qib7	15590	13	non	non	JJ
cord-005453-4057qib7	15590	14	-	-	JJ
cord-005453-4057qib7	15590	15	fanconi	fanconi	JJ
cord-005453-4057qib7	15590	16	anemia	anemia	NN
cord-005453-4057qib7	15590	17	(	(	-LRB-
cord-005453-4057qib7	15590	18	FA	FA	NNP
cord-005453-4057qib7	15590	19	)	)	-RRB-
cord-005453-4057qib7	15590	20	constitutional	constitutional	JJ
cord-005453-4057qib7	15590	21	bone	bone	NN
cord-005453-4057qib7	15590	22	marrow	marrow	NN
cord-005453-4057qib7	15590	23	failure	failure	NN
cord-005453-4057qib7	15590	24	syndromes	syndrome	NNS
cord-005453-4057qib7	15590	25	such	such	JJ
cord-005453-4057qib7	15590	26	as	as	IN
cord-005453-4057qib7	15590	27	telomeropathies	telomeropathie	NNS
cord-005453-4057qib7	15590	28	.	.	.
cord-005453-4057qib7	15591	1	We	-PRON-	PRP
cord-005453-4057qib7	15591	2	report	report	VBP
cord-005453-4057qib7	15591	3	the	the	DT
cord-005453-4057qib7	15591	4	outcome	outcome	NN
cord-005453-4057qib7	15591	5	of	of	IN
cord-005453-4057qib7	15591	6	a	a	DT
cord-005453-4057qib7	15591	7	consistent	consistent	JJ
cord-005453-4057qib7	15591	8	reduced	reduce	VBN
cord-005453-4057qib7	15591	9	intensity	intensity	NN
cord-005453-4057qib7	15591	10	conditioning	conditioning	NN
cord-005453-4057qib7	15591	11	regimen	regimen	NN
cord-005453-4057qib7	15591	12	in	in	IN
cord-005453-4057qib7	15591	13	patients	patient	NNS
cord-005453-4057qib7	15591	14	with	with	IN
cord-005453-4057qib7	15591	15	idiopathic	idiopathic	JJ
cord-005453-4057qib7	15591	16	SAA	SAA	NNP
cord-005453-4057qib7	15591	17	or	or	CC
cord-005453-4057qib7	15591	18	inherited	inherit	VBN
cord-005453-4057qib7	15591	19	bone	bone	NN
cord-005453-4057qib7	15591	20	marrow	marrow	NN
cord-005453-4057qib7	15591	21	failure	failure	NN
cord-005453-4057qib7	15591	22	syndromes	syndrome	NNS
cord-005453-4057qib7	15591	23	other	other	JJ
cord-005453-4057qib7	15591	24	than	than	IN
cord-005453-4057qib7	15591	25	FA	FA	NNP
cord-005453-4057qib7	15591	26	who	who	WP
cord-005453-4057qib7	15591	27	underwent	undergo	VBD
cord-005453-4057qib7	15591	28	HLA	HLA	NNP
cord-005453-4057qib7	15592	1	matched	match	VBN
cord-005453-4057qib7	15592	2	related	relate	VBN
cord-005453-4057qib7	15592	3	HSCT	HSCT	NNP
cord-005453-4057qib7	15592	4	Methods	Methods	NNPS
cord-005453-4057qib7	15592	5	:	:	:
cord-005453-4057qib7	15592	6	children	child	NNS
cord-005453-4057qib7	15592	7	with	with	IN
cord-005453-4057qib7	15592	8	SAA	SAA	NNP
cord-005453-4057qib7	15592	9	underwent	undergo	VBD
cord-005453-4057qib7	15592	10	HSCT	HSCT	NNP
cord-005453-4057qib7	15592	11	using	use	VBG
cord-005453-4057qib7	15592	12	the	the	DT
cord-005453-4057qib7	15592	13	following	follow	VBG
cord-005453-4057qib7	15592	14	conditioning	conditioning	NN
cord-005453-4057qib7	15592	15	regimen	regimen	NN
cord-005453-4057qib7	15592	16	:	:	:
cord-005453-4057qib7	15593	1	fludarabine	fludarabine	NNP
cord-005453-4057qib7	15593	2	175mg	175mg	NNP
cord-005453-4057qib7	15593	3	/	/	SYM
cord-005453-4057qib7	15593	4	m2	m2	NNP
cord-005453-4057qib7	15593	5	,	,	,
cord-005453-4057qib7	15593	6	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	15593	7	80	80	CD
cord-005453-4057qib7	15593	8	mg	mg	NNP
cord-005453-4057qib7	15593	9	/	/	SYM
cord-005453-4057qib7	15593	10	m2	m2	NNP
cord-005453-4057qib7	15593	11	,	,	,
cord-005453-4057qib7	15593	12	and	and	CC
cord-005453-4057qib7	15593	13	ATG	ATG	NNP
cord-005453-4057qib7	15593	14	(	(	-LRB-
cord-005453-4057qib7	15593	15	thymoglobulin	thymoglobulin	NNP
cord-005453-4057qib7	15593	16	)	)	-RRB-
cord-005453-4057qib7	15593	17	(	(	-LRB-
cord-005453-4057qib7	15593	18	10	10	CD
cord-005453-4057qib7	15593	19	mg	mg	NNP
cord-005453-4057qib7	15593	20	/	/	SYM
cord-005453-4057qib7	15593	21	kg	kg	NNP
cord-005453-4057qib7	15593	22	)	)	-RRB-
cord-005453-4057qib7	15593	23	.	.	.
cord-005453-4057qib7	15594	1	GVHD	GVHD	NNP
cord-005453-4057qib7	15594	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	15594	3	included	include	VBD
cord-005453-4057qib7	15594	4	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	15594	5	and	and	CC
cord-005453-4057qib7	15594	6	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	15594	7	mofetil	mofetil	NNP
cord-005453-4057qib7	15594	8	.	.	.
cord-005453-4057qib7	15595	1	Donors	donor	NNS
cord-005453-4057qib7	15595	2	were	be	VBD
cord-005453-4057qib7	15595	3	all	all	RB
cord-005453-4057qib7	15595	4	matched	match	VBN
cord-005453-4057qib7	15595	5	related	relate	VBN
cord-005453-4057qib7	15595	6	and	and	CC
cord-005453-4057qib7	15595	7	bone	bone	NN
cord-005453-4057qib7	15595	8	marrow	marrow	NN
cord-005453-4057qib7	15595	9	was	be	VBD
cord-005453-4057qib7	15595	10	the	the	DT
cord-005453-4057qib7	15595	11	stem	stem	NN
cord-005453-4057qib7	15595	12	cell	cell	NN
cord-005453-4057qib7	15595	13	source	source	NN
cord-005453-4057qib7	15595	14	.	.	.
cord-005453-4057qib7	15596	1	All	all	DT
cord-005453-4057qib7	15596	2	patients	patient	NNS
cord-005453-4057qib7	15596	3	had	have	VBD
cord-005453-4057qib7	15596	4	normal	normal	JJ
cord-005453-4057qib7	15596	5	chromosomal	chromosomal	JJ
cord-005453-4057qib7	15596	6	fragility	fragility	NN
cord-005453-4057qib7	15596	7	testResults	testResults	NNP
cord-005453-4057qib7	15596	8	:	:	:
cord-005453-4057qib7	15596	9	a	a	DT
cord-005453-4057qib7	15596	10	total	total	NN
cord-005453-4057qib7	15596	11	of	of	IN
cord-005453-4057qib7	15596	12	18	18	CD
cord-005453-4057qib7	15596	13	children	child	NNS
cord-005453-4057qib7	15596	14	with	with	IN
cord-005453-4057qib7	15596	15	SAA	SAA	NNP
cord-005453-4057qib7	15596	16	underwent	undergo	VBD
cord-005453-4057qib7	15596	17	HSCT	HSCT	NNP
cord-005453-4057qib7	15596	18	,	,	,
cord-005453-4057qib7	15596	19	12	12	CD
cord-005453-4057qib7	15596	20	females	female	NNS
cord-005453-4057qib7	15596	21	and	and	CC
cord-005453-4057qib7	15596	22	6	6	CD
cord-005453-4057qib7	15596	23	males	male	NNS
cord-005453-4057qib7	15596	24	.	.	.
cord-005453-4057qib7	15597	1	Average	average	JJ
cord-005453-4057qib7	15597	2	age	age	NN
cord-005453-4057qib7	15597	3	was	be	VBD
cord-005453-4057qib7	15597	4	8.1	8.1	CD
cord-005453-4057qib7	15597	5	(	(	-LRB-
cord-005453-4057qib7	15597	6	range	range	VB
cord-005453-4057qib7	15597	7	0.8	0.8	CD
cord-005453-4057qib7	15597	8	-	-	HYPH
cord-005453-4057qib7	15597	9	13.8	13.8	CD
cord-005453-4057qib7	15597	10	years	year	NNS
cord-005453-4057qib7	15597	11	)	)	-RRB-
cord-005453-4057qib7	15597	12	.	.	.
cord-005453-4057qib7	15598	1	All	all	DT
cord-005453-4057qib7	15598	2	nine	nine	CD
cord-005453-4057qib7	15598	3	patients	patient	NNS
cord-005453-4057qib7	15598	4	who	who	WP
cord-005453-4057qib7	15598	5	were	be	VBD
cord-005453-4057qib7	15598	6	tested	test	VBN
cord-005453-4057qib7	15598	7	for	for	IN
cord-005453-4057qib7	15598	8	telomere	telomere	NN
cord-005453-4057qib7	15598	9	length	length	NN
cord-005453-4057qib7	15598	10	had	have	VBD
cord-005453-4057qib7	15598	11	short	short	JJ
cord-005453-4057qib7	15598	12	telomeres	telomere	NNS
cord-005453-4057qib7	15598	13	.	.	.
cord-005453-4057qib7	15599	1	Pathogenic	pathogenic	JJ
cord-005453-4057qib7	15599	2	or	or	CC
cord-005453-4057qib7	15599	3	likely	likely	JJ
cord-005453-4057qib7	15599	4	pathogenic	pathogenic	JJ
cord-005453-4057qib7	15599	5	mutations	mutation	NNS
cord-005453-4057qib7	15599	6	were	be	VBD
cord-005453-4057qib7	15599	7	reported	report	VBN
cord-005453-4057qib7	15599	8	in	in	IN
cord-005453-4057qib7	15599	9	5	5	CD
cord-005453-4057qib7	15599	10	patients	patient	NNS
cord-005453-4057qib7	15599	11	(	(	-LRB-
cord-005453-4057qib7	15599	12	2	2	CD
cord-005453-4057qib7	15599	13	ERCC6L2	ERCC6L2	NNP
cord-005453-4057qib7	15599	14	,	,	,
cord-005453-4057qib7	15599	15	1	1	CD
cord-005453-4057qib7	15599	16	ANKRD26	ANKRD26	NNS
cord-005453-4057qib7	15599	17	,	,	,
cord-005453-4057qib7	15599	18	1	1	CD
cord-005453-4057qib7	15599	19	TINF2	tinf2	NN
cord-005453-4057qib7	15599	20	,	,	,
cord-005453-4057qib7	15599	21	1	1	CD
cord-005453-4057qib7	15599	22	LZTFL1	LZTFL1	NNP
cord-005453-4057qib7	15599	23	)	)	-RRB-
cord-005453-4057qib7	15599	24	.	.	.
cord-005453-4057qib7	15600	1	All	all	DT
cord-005453-4057qib7	15600	2	donors	donor	NNS
cord-005453-4057qib7	15600	3	had	have	VBD
cord-005453-4057qib7	15600	4	normal	normal	JJ
cord-005453-4057qib7	15600	5	physical	physical	JJ
cord-005453-4057qib7	15600	6	examination	examination	NN
cord-005453-4057qib7	15600	7	,	,	,
cord-005453-4057qib7	15600	8	normal	normal	JJ
cord-005453-4057qib7	15600	9	CBC	CBC	NNP
cord-005453-4057qib7	15600	10	,	,	,
cord-005453-4057qib7	15600	11	and	and	CC
cord-005453-4057qib7	15600	12	negative	negative	JJ
cord-005453-4057qib7	15600	13	genetic	genetic	JJ
cord-005453-4057qib7	15600	14	testing	testing	NN
cord-005453-4057qib7	15600	15	if	if	IN
cord-005453-4057qib7	15600	16	patient	patient	JJ
cord-005453-4057qib7	15600	17	mutation	mutation	NN
cord-005453-4057qib7	15600	18	is	be	VBZ
cord-005453-4057qib7	15600	19	known	know	VBN
cord-005453-4057qib7	15600	20	.	.	.
cord-005453-4057qib7	15601	1	All	all	DT
cord-005453-4057qib7	15601	2	18	18	CD
cord-005453-4057qib7	15601	3	patients	patient	NNS
cord-005453-4057qib7	15601	4	engrafted	engraft	VBN
cord-005453-4057qib7	15601	5	successfully	successfully	RB
cord-005453-4057qib7	15601	6	,	,	,
cord-005453-4057qib7	15601	7	median	median	JJ
cord-005453-4057qib7	15601	8	time	time	NN
cord-005453-4057qib7	15601	9	to	to	IN
cord-005453-4057qib7	15601	10	neutrophil	neutrophil	NN
cord-005453-4057qib7	15601	11	engraftment	engraftment	NN
cord-005453-4057qib7	15601	12	was	be	VBD
cord-005453-4057qib7	15601	13	16	16	CD
cord-005453-4057qib7	15602	1	(	(	-LRB-
cord-005453-4057qib7	15602	2	range	range	NN
cord-005453-4057qib7	15602	3	,	,	,
cord-005453-4057qib7	15602	4	11	11	CD
cord-005453-4057qib7	15602	5	-	-	SYM
cord-005453-4057qib7	15602	6	29	29	CD
cord-005453-4057qib7	15602	7	days	day	NNS
cord-005453-4057qib7	15602	8	)	)	-RRB-
cord-005453-4057qib7	15602	9	and	and	CC
cord-005453-4057qib7	15602	10	platelet	platelet	NN
cord-005453-4057qib7	15602	11	engraftment	engraftment	NN
cord-005453-4057qib7	15602	12	19	19	CD
cord-005453-4057qib7	15602	13	(	(	-LRB-
cord-005453-4057qib7	15602	14	range	range	NN
cord-005453-4057qib7	15602	15	,	,	,
cord-005453-4057qib7	15602	16	13	13	CD
cord-005453-4057qib7	15602	17	-	-	SYM
cord-005453-4057qib7	15602	18	45	45	CD
cord-005453-4057qib7	15602	19	days	day	NNS
cord-005453-4057qib7	15602	20	)	)	-RRB-
cord-005453-4057qib7	15602	21	.	.	.
cord-005453-4057qib7	15603	1	Median	median	JJ
cord-005453-4057qib7	15603	2	infused	infuse	VBN
cord-005453-4057qib7	15603	3	nucleated	nucleated	JJ
cord-005453-4057qib7	15603	4	cell	cell	NN
cord-005453-4057qib7	15603	5	dose	dose	NN
cord-005453-4057qib7	15603	6	was	be	VBD
cord-005453-4057qib7	15604	1	3.3	3.3	LS
cord-005453-4057qib7	15604	2	(	(	-LRB-
cord-005453-4057qib7	15604	3	range,0.9	range,0.9	NN
cord-005453-4057qib7	15604	4	-	-	HYPH
cord-005453-4057qib7	15604	5	7.3	7.3	CD
cord-005453-4057qib7	15604	6	X10	X10	NNP
cord-005453-4057qib7	15604	7	8	8	CD
cord-005453-4057qib7	15604	8	/kg	/kg	.
cord-005453-4057qib7	15604	9	)	)	-RRB-
cord-005453-4057qib7	15605	1	and	and	CC
cord-005453-4057qib7	15605	2	CD34	CD34	NNP
cord-005453-4057qib7	15605	3	cell	cell	NN
cord-005453-4057qib7	15605	4	dose	dose	NN
cord-005453-4057qib7	15605	5	was	be	VBD
cord-005453-4057qib7	15605	6	6.7	6.7	CD
cord-005453-4057qib7	15605	7	(	(	-LRB-
cord-005453-4057qib7	15605	8	range	range	NN
cord-005453-4057qib7	15605	9	,	,	,
cord-005453-4057qib7	15605	10	1.1	1.1	CD
cord-005453-4057qib7	15605	11	-	-	SYM
cord-005453-4057qib7	15605	12	13.1	13.1	CD
cord-005453-4057qib7	15605	13	X10	X10	NNP
cord-005453-4057qib7	15605	14	6	6	CD
cord-005453-4057qib7	15605	15	/kg	/kg	.
cord-005453-4057qib7	15605	16	)	)	-RRB-
cord-005453-4057qib7	15605	17	.	.	.
cord-005453-4057qib7	15606	1	None	none	NN
cord-005453-4057qib7	15606	2	of	of	IN
cord-005453-4057qib7	15606	3	our	-PRON-	PRP$
cord-005453-4057qib7	15606	4	patients	patient	NNS
cord-005453-4057qib7	15606	5	had	have	VBD
cord-005453-4057qib7	15606	6	acute	acute	JJ
cord-005453-4057qib7	15606	7	GVHD	GVHD	NNP
cord-005453-4057qib7	15606	8	and	and	CC
cord-005453-4057qib7	15606	9	one	one	CD
cord-005453-4057qib7	15606	10	patient	patient	NN
cord-005453-4057qib7	15606	11	had	have	VBD
cord-005453-4057qib7	15606	12	mild	mild	JJ
cord-005453-4057qib7	15606	13	classic	classic	JJ
cord-005453-4057qib7	15606	14	chronic	chronic	JJ
cord-005453-4057qib7	15606	15	GVHD	gvhd	NN
cord-005453-4057qib7	15606	16	of	of	IN
cord-005453-4057qib7	15606	17	the	the	DT
cord-005453-4057qib7	15606	18	skin	skin	NN
cord-005453-4057qib7	15606	19	that	that	WDT
cord-005453-4057qib7	15606	20	was	be	VBD
cord-005453-4057qib7	15606	21	controlled	control	VBN
cord-005453-4057qib7	15606	22	with	with	IN
cord-005453-4057qib7	15606	23	topical	topical	JJ
cord-005453-4057qib7	15606	24	therapy	therapy	NN
cord-005453-4057qib7	15606	25	for	for	IN
cord-005453-4057qib7	15606	26	a	a	DT
cord-005453-4057qib7	15606	27	short	short	JJ
cord-005453-4057qib7	15606	28	period	period	NN
cord-005453-4057qib7	15606	29	.	.	.
cord-005453-4057qib7	15607	1	Three	three	CD
cord-005453-4057qib7	15607	2	patients	patient	NNS
cord-005453-4057qib7	15607	3	had	have	VBD
cord-005453-4057qib7	15607	4	secondary	secondary	JJ
cord-005453-4057qib7	15607	5	graft	graft	NN
cord-005453-4057qib7	15607	6	failure	failure	NN
cord-005453-4057qib7	15607	7	in	in	IN
cord-005453-4057qib7	15607	8	the	the	DT
cord-005453-4057qib7	15607	9	first	first	JJ
cord-005453-4057qib7	15607	10	-	-	HYPH
cord-005453-4057qib7	15607	11	year	year	NN
cord-005453-4057qib7	15607	12	post	post	NN
cord-005453-4057qib7	15607	13	transplant	transplant	NN
cord-005453-4057qib7	15607	14	.	.	.
cord-005453-4057qib7	15608	1	First	first	JJ
cord-005453-4057qib7	15608	2	patient	patient	NN
cord-005453-4057qib7	15608	3	had	have	VBD
cord-005453-4057qib7	15608	4	pancytopenia	pancytopenia	VBN
cord-005453-4057qib7	15608	5	with	with	IN
cord-005453-4057qib7	15608	6	loss	loss	NN
cord-005453-4057qib7	15608	7	of	of	IN
cord-005453-4057qib7	15608	8	donor	donor	NN
cord-005453-4057qib7	15608	9	chimerism	chimerism	NN
cord-005453-4057qib7	15608	10	and	and	CC
cord-005453-4057qib7	15608	11	underwent	undergo	VBD
cord-005453-4057qib7	15608	12	successful	successful	JJ
cord-005453-4057qib7	15608	13	second	second	JJ
cord-005453-4057qib7	15608	14	transplant	transplant	NN
cord-005453-4057qib7	15608	15	using	use	VBG
cord-005453-4057qib7	15608	16	fludarabine	fludarabine	NN
cord-005453-4057qib7	15608	17	,	,	,
cord-005453-4057qib7	15608	18	ATG	ATG	NNP
cord-005453-4057qib7	15608	19	,	,	,
cord-005453-4057qib7	15608	20	and	and	CC
cord-005453-4057qib7	15608	21	melphalan	melphalan	NNP
cord-005453-4057qib7	15608	22	.	.	.
cord-005453-4057qib7	15609	1	The	the	DT
cord-005453-4057qib7	15609	2	second	second	JJ
cord-005453-4057qib7	15609	3	patient	patient	NN
cord-005453-4057qib7	15609	4	had	have	VBD
cord-005453-4057qib7	15609	5	a	a	DT
cord-005453-4057qib7	15609	6	nonfunctioning	nonfunctioning	JJ
cord-005453-4057qib7	15609	7	graft	graft	NN
cord-005453-4057qib7	15609	8	despite	despite	IN
cord-005453-4057qib7	15609	9	full	full	JJ
cord-005453-4057qib7	15609	10	donor	donor	NN
cord-005453-4057qib7	15609	11	chimerism	chimerism	NN
cord-005453-4057qib7	15609	12	suggesting	suggest	VBG
cord-005453-4057qib7	15609	13	that	that	IN
cord-005453-4057qib7	15609	14	the	the	DT
cord-005453-4057qib7	15609	15	related	related	JJ
cord-005453-4057qib7	15609	16	donor	donor	NN
cord-005453-4057qib7	15609	17	might	may	MD
cord-005453-4057qib7	15609	18	be	be	VB
cord-005453-4057qib7	15609	19	affected	affect	VBN
cord-005453-4057qib7	15609	20	and	and	CC
cord-005453-4057qib7	15609	21	had	have	VBD
cord-005453-4057qib7	15609	22	silent	silent	JJ
cord-005453-4057qib7	15609	23	phenotype	phenotype	NN
cord-005453-4057qib7	15609	24	.	.	.
cord-005453-4057qib7	15610	1	The	the	DT
cord-005453-4057qib7	15610	2	third	third	JJ
cord-005453-4057qib7	15610	3	patient	patient	NN
cord-005453-4057qib7	15610	4	had	have	VBD
cord-005453-4057qib7	15610	5	homozygous	homozygous	JJ
cord-005453-4057qib7	15610	6	ERCC6L2	ercc6l2	CD
cord-005453-4057qib7	15610	7	mutation	mutation	NN
cord-005453-4057qib7	15610	8	and	and	CC
cord-005453-4057qib7	15610	9	developed	develop	VBD
cord-005453-4057qib7	15610	10	progressive	progressive	JJ
cord-005453-4057qib7	15610	11	cytopenia	cytopenia	NNS
cord-005453-4057qib7	15610	12	with	with	IN
cord-005453-4057qib7	15610	13	myelodysplastic	myelodysplastic	NN
cord-005453-4057qib7	15610	14	features	feature	VBZ
cord-005453-4057qib7	15610	15	few	few	JJ
cord-005453-4057qib7	15610	16	months	month	NNS
cord-005453-4057qib7	15610	17	post	post	NN
cord-005453-4057qib7	15610	18	-	-	NN
cord-005453-4057qib7	15610	19	transplant	transplant	JJ
cord-005453-4057qib7	15610	20	and	and	CC
cord-005453-4057qib7	15610	21	subsequently	subsequently	RB
cord-005453-4057qib7	15610	22	underwent	undergo	VBD
cord-005453-4057qib7	15610	23	myeloablative	myeloablative	NNP
cord-005453-4057qib7	15610	24	matched	match	VBN
cord-005453-4057qib7	15610	25	unrelated	unrelated	JJ
cord-005453-4057qib7	15610	26	transplant	transplant	NN
cord-005453-4057qib7	15610	27	using	use	VBG
cord-005453-4057qib7	15610	28	busulfan	busulfan	NN
cord-005453-4057qib7	15610	29	,	,	,
cord-005453-4057qib7	15610	30	fludarabine	fludarabine	NN
cord-005453-4057qib7	15610	31	,	,	,
cord-005453-4057qib7	15610	32	thiotepa	thiotepa	NNP
cord-005453-4057qib7	15610	33	and	and	CC
cord-005453-4057qib7	15610	34	ATG	ATG	NNP
cord-005453-4057qib7	15610	35	.	.	.
cord-005453-4057qib7	15611	1	However	however	RB
cord-005453-4057qib7	15611	2	,	,	,
cord-005453-4057qib7	15611	3	the	the	DT
cord-005453-4057qib7	15611	4	patient	patient	NN
cord-005453-4057qib7	15611	5	progressed	progress	VBD
cord-005453-4057qib7	15611	6	to	to	TO
cord-005453-4057qib7	15611	7	have	have	VB
cord-005453-4057qib7	15611	8	acute	acute	JJ
cord-005453-4057qib7	15611	9	myeloid	myeloid	NN
cord-005453-4057qib7	15611	10	leukemia	leukemia	NN
cord-005453-4057qib7	15612	1	six	six	CD
cord-005453-4057qib7	15612	2	months	month	NNS
cord-005453-4057qib7	15612	3	post	post	NN
cord-005453-4057qib7	15612	4	HSCT	HSCT	NNP
cord-005453-4057qib7	15612	5	.	.	.
cord-005453-4057qib7	15613	1	Fifteen	fifteen	CD
cord-005453-4057qib7	15613	2	patients	patient	NNS
cord-005453-4057qib7	15613	3	(	(	-LRB-
cord-005453-4057qib7	15613	4	83	83	CD
cord-005453-4057qib7	15613	5	%	%	NN
cord-005453-4057qib7	15613	6	)	)	-RRB-
cord-005453-4057qib7	15613	7	have	have	VBP
cord-005453-4057qib7	15613	8	normal	normal	JJ
cord-005453-4057qib7	15613	9	CBC	CBC	NNP
cord-005453-4057qib7	15613	10	and	and	CC
cord-005453-4057qib7	15613	11	stable	stable	JJ
cord-005453-4057qib7	15613	12	donor	donor	NN
cord-005453-4057qib7	15613	13	chimerism	chimerism	NN
cord-005453-4057qib7	15613	14	.	.	.
cord-005453-4057qib7	15614	1	Median	median	JJ
cord-005453-4057qib7	15614	2	follow	follow	NN
cord-005453-4057qib7	15614	3	-	-	HYPH
cord-005453-4057qib7	15614	4	up	up	RP
cord-005453-4057qib7	15614	5	duration	duration	NN
cord-005453-4057qib7	15614	6	of	of	IN
cord-005453-4057qib7	15614	7	1140	1140	CD
cord-005453-4057qib7	15614	8	days	day	NNS
cord-005453-4057qib7	15614	9	(	(	-LRB-
cord-005453-4057qib7	15614	10	range	range	VBP
cord-005453-4057qib7	15614	11	330	330	CD
cord-005453-4057qib7	15614	12	-2595	-2595	HYPH
cord-005453-4057qib7	15614	13	days	day	NNS
cord-005453-4057qib7	15614	14	)	)	-RRB-
cord-005453-4057qib7	15614	15	.	.	.
cord-005453-4057qib7	15615	1	One	one	CD
cord-005453-4057qib7	15615	2	patient	patient	NN
cord-005453-4057qib7	15615	3	with	with	IN
cord-005453-4057qib7	15615	4	LZTFL1	LZTFL1	NNP
cord-005453-4057qib7	15615	5	mutation	mutation	NN
cord-005453-4057qib7	15615	6	developed	develop	VBD
cord-005453-4057qib7	15615	7	chronic	chronic	JJ
cord-005453-4057qib7	15615	8	renal	renal	JJ
cord-005453-4057qib7	15615	9	impairment	impairment	NN
cord-005453-4057qib7	15616	1	five	five	CD
cord-005453-4057qib7	15616	2	years	year	NNS
cord-005453-4057qib7	15616	3	post	post	VBP
cord-005453-4057qib7	15616	4	HSCT.Conclusions	hsct.conclusion	NNS
cord-005453-4057qib7	15616	5	:	:	:
cord-005453-4057qib7	15616	6	HSCT	HSCT	NNP
cord-005453-4057qib7	15616	7	using	use	VBG
cord-005453-4057qib7	15616	8	lower	low	JJR
cord-005453-4057qib7	15616	9	dose	dose	NN
cord-005453-4057qib7	15616	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15616	11	(	(	-LRB-
cord-005453-4057qib7	15616	12	80mg	80mg	NN
cord-005453-4057qib7	15616	13	/	/	SYM
cord-005453-4057qib7	15616	14	kg	kg	NNP
cord-005453-4057qib7	15616	15	)	)	-RRB-
cord-005453-4057qib7	15616	16	as	as	IN
cord-005453-4057qib7	15616	17	part	part	NN
cord-005453-4057qib7	15616	18	of	of	IN
cord-005453-4057qib7	15616	19	fludarabine	fludarabine	NN
cord-005453-4057qib7	15616	20	based	base	VBN
cord-005453-4057qib7	15616	21	regimen	regimen	NN
cord-005453-4057qib7	15616	22	was	be	VBD
cord-005453-4057qib7	15616	23	safe	safe	JJ
cord-005453-4057qib7	15616	24	and	and	CC
cord-005453-4057qib7	15616	25	effective	effective	JJ
cord-005453-4057qib7	15616	26	in	in	IN
cord-005453-4057qib7	15616	27	SAA	SAA	NNP
cord-005453-4057qib7	15616	28	patients	patient	NNS
cord-005453-4057qib7	15616	29	with	with	IN
cord-005453-4057qib7	15616	30	shorter	short	JJR
cord-005453-4057qib7	15616	31	telomeres	telomere	NNS
cord-005453-4057qib7	15616	32	and	and	CC
cord-005453-4057qib7	15616	33	described	describe	VBD
cord-005453-4057qib7	15616	34	genetic	genetic	JJ
cord-005453-4057qib7	15616	35	abnormalities	abnormality	NNS
cord-005453-4057qib7	15616	36	.	.	.
cord-005453-4057qib7	15617	1	Optimal	optimal	JJ
cord-005453-4057qib7	15617	2	conditioning	conditioning	NN
cord-005453-4057qib7	15617	3	regimen	regimen	NN
cord-005453-4057qib7	15617	4	in	in	IN
cord-005453-4057qib7	15617	5	ERCC6L2-associated	ercc6l2-associate	VBN
cord-005453-4057qib7	15617	6	bone	bone	NN
cord-005453-4057qib7	15617	7	marrow	marrow	NN
cord-005453-4057qib7	15617	8	failure	failure	NN
cord-005453-4057qib7	15617	9	needs	need	VBZ
cord-005453-4057qib7	15617	10	to	to	TO
cord-005453-4057qib7	15617	11	be	be	VB
cord-005453-4057qib7	15617	12	defined	define	VBN
cord-005453-4057qib7	15617	13	.	.	.
cord-005453-4057qib7	15618	1	Larger	large	JJR
cord-005453-4057qib7	15618	2	study	study	NN
cord-005453-4057qib7	15618	3	is	be	VBZ
cord-005453-4057qib7	15618	4	needed	need	VBN
cord-005453-4057qib7	15618	5	to	to	TO
cord-005453-4057qib7	15618	6	confirm	confirm	VB
cord-005453-4057qib7	15618	7	our	-PRON-	PRP$
cord-005453-4057qib7	15618	8	results	result	NNS
cord-005453-4057qib7	15618	9	.	.	.
cord-005453-4057qib7	15619	1	Clinical	clinical	JJ
cord-005453-4057qib7	15619	2	Trial	Trial	NNP
cord-005453-4057qib7	15619	3	Registry	Registry	NNP
cord-005453-4057qib7	15619	4	:	:	:
cord-005453-4057qib7	15620	1	Not	not	RB
cord-005453-4057qib7	15620	2	applicable	applicable	JJ
cord-005453-4057qib7	15620	3	Disclosure	disclosure	NN
cord-005453-4057qib7	15620	4	:	:	:
cord-005453-4057qib7	15621	1	Nothing	nothing	NN
cord-005453-4057qib7	15621	2	to	to	TO
cord-005453-4057qib7	15621	3	declare	declare	VB
cord-005453-4057qib7	15621	4	Late	late	JJ
cord-005453-4057qib7	15621	5	effects	effect	NNS
cord-005453-4057qib7	15621	6	in	in	IN
cord-005453-4057qib7	15621	7	patients	patient	NNS
cord-005453-4057qib7	15621	8	with	with	IN
cord-005453-4057qib7	15621	9	hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	15621	10	lymphohistiocytosis	lymphohistiocytosis	NNP
cord-005453-4057qib7	15621	11	treated	treat	VBN
cord-005453-4057qib7	15621	12	with	with	IN
cord-005453-4057qib7	15621	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15621	14	stem	stem	NN
cord-005453-4057qib7	15621	15	cell	cell	NN
cord-005453-4057qib7	15621	16	transplantation	transplantation	NN
cord-005453-4057qib7	15621	17	:	:	:
cord-005453-4057qib7	15621	18	A	a	DT
cord-005453-4057qib7	15621	19	review	review	NN
cord-005453-4057qib7	15621	20	of	of	IN
cord-005453-4057qib7	15621	21	the	the	DT
cord-005453-4057qib7	15621	22	literature	literature	NN
cord-005453-4057qib7	15621	23	Background	background	NN
cord-005453-4057qib7	15621	24	:	:	:
cord-005453-4057qib7	15621	25	Hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	15621	26	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	15621	27	(	(	-LRB-
cord-005453-4057qib7	15621	28	HLH	HLH	NNP
cord-005453-4057qib7	15621	29	)	)	-RRB-
cord-005453-4057qib7	15621	30	is	be	VBZ
cord-005453-4057qib7	15621	31	an	an	DT
cord-005453-4057qib7	15621	32	inherited	inherit	VBN
cord-005453-4057qib7	15621	33	or	or	CC
cord-005453-4057qib7	15621	34	acquired	acquire	VBN
cord-005453-4057qib7	15621	35	disorder	disorder	NN
cord-005453-4057qib7	15621	36	of	of	IN
cord-005453-4057qib7	15621	37	immunedysregulation	immunedysregulation	NN
cord-005453-4057qib7	15621	38	.	.	.
cord-005453-4057qib7	15622	1	Early	early	JJ
cord-005453-4057qib7	15622	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	15622	3	and	and	CC
cord-005453-4057qib7	15622	4	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	15622	5	treatment	treatment	NN
cord-005453-4057qib7	15622	6	can	can	MD
cord-005453-4057qib7	15622	7	prevent	prevent	VB
cord-005453-4057qib7	15622	8	significant	significant	JJ
cord-005453-4057qib7	15622	9	organ	organ	NN
cord-005453-4057qib7	15622	10	-	-	HYPH
cord-005453-4057qib7	15622	11	failure	failure	NN
cord-005453-4057qib7	15622	12	.	.	.
cord-005453-4057qib7	15623	1	The	the	DT
cord-005453-4057qib7	15623	2	inherited	inherit	VBN
cord-005453-4057qib7	15623	3	forms	form	NNS
cord-005453-4057qib7	15623	4	,	,	,
cord-005453-4057qib7	15623	5	and	and	CC
cord-005453-4057qib7	15623	6	some	some	DT
cord-005453-4057qib7	15623	7	acquired	acquire	VBN
cord-005453-4057qib7	15623	8	cases	case	NNS
cord-005453-4057qib7	15623	9	can	can	MD
cord-005453-4057qib7	15623	10	only	only	RB
cord-005453-4057qib7	15623	11	be	be	VB
cord-005453-4057qib7	15623	12	cured	cure	VBN
cord-005453-4057qib7	15623	13	by	by	IN
cord-005453-4057qib7	15623	14	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15623	15	stem	stem	NN
cord-005453-4057qib7	15623	16	cell	cell	NN
cord-005453-4057qib7	15623	17	transplantation	transplantation	NN
cord-005453-4057qib7	15623	18	(	(	-LRB-
cord-005453-4057qib7	15623	19	HSCT	HSCT	NNP
cord-005453-4057qib7	15623	20	)	)	-RRB-
cord-005453-4057qib7	15623	21	.	.	.
cord-005453-4057qib7	15624	1	With	with	IN
cord-005453-4057qib7	15624	2	modern	modern	JJ
cord-005453-4057qib7	15624	3	transplant	transplant	NN
cord-005453-4057qib7	15624	4	practices	practice	NNS
cord-005453-4057qib7	15624	5	,	,	,
cord-005453-4057qib7	15624	6	a	a	DT
cord-005453-4057qib7	15624	7	significant	significant	JJ
cord-005453-4057qib7	15624	8	number	number	NN
cord-005453-4057qib7	15624	9	of	of	IN
cord-005453-4057qib7	15624	10	patients	patient	NNS
cord-005453-4057qib7	15624	11	survive	survive	VBP
cord-005453-4057qib7	15624	12	.	.	.
cord-005453-4057qib7	15625	1	The	the	DT
cord-005453-4057qib7	15625	2	purpose	purpose	NN
cord-005453-4057qib7	15625	3	of	of	IN
cord-005453-4057qib7	15625	4	this	this	DT
cord-005453-4057qib7	15625	5	literature	literature	NN
cord-005453-4057qib7	15625	6	review	review	NN
cord-005453-4057qib7	15625	7	was	be	VBD
cord-005453-4057qib7	15625	8	to	to	TO
cord-005453-4057qib7	15625	9	collect	collect	VB
cord-005453-4057qib7	15625	10	data	datum	NNS
cord-005453-4057qib7	15625	11	on	on	IN
cord-005453-4057qib7	15625	12	the	the	DT
cord-005453-4057qib7	15625	13	frequency	frequency	NN
cord-005453-4057qib7	15625	14	and	and	CC
cord-005453-4057qib7	15625	15	type	type	NN
cord-005453-4057qib7	15625	16	of	of	IN
cord-005453-4057qib7	15625	17	late	late	JJ
cord-005453-4057qib7	15625	18	effects	effect	NNS
cord-005453-4057qib7	15625	19	in	in	IN
cord-005453-4057qib7	15625	20	HLH	HLH	NNP
cord-005453-4057qib7	15625	21	patients	patient	NNS
cord-005453-4057qib7	15625	22	surviving	survive	VBG
cord-005453-4057qib7	15625	23	after	after	IN
cord-005453-4057qib7	15625	24	HSCT	HSCT	NNP
cord-005453-4057qib7	15625	25	and	and	CC
cord-005453-4057qib7	15625	26	to	to	TO
cord-005453-4057qib7	15625	27	examine	examine	VB
cord-005453-4057qib7	15625	28	the	the	DT
cord-005453-4057qib7	15625	29	association	association	NN
cord-005453-4057qib7	15625	30	with	with	IN
cord-005453-4057qib7	15625	31	pre	pre	JJ
cord-005453-4057qib7	15625	32	-	-	JJ
cord-005453-4057qib7	15625	33	existing	existing	JJ
cord-005453-4057qib7	15625	34	HLH	HLH	NNP
cord-005453-4057qib7	15625	35	conditions	condition	NNS
cord-005453-4057qib7	15625	36	(	(	-LRB-
cord-005453-4057qib7	15625	37	eg	eg	IN
cord-005453-4057qib7	15625	38	.	.	.
cord-005453-4057qib7	15625	39	involvement	involvement	NN
cord-005453-4057qib7	15625	40	of	of	IN
cord-005453-4057qib7	15625	41	the	the	DT
cord-005453-4057qib7	15625	42	central	central	JJ
cord-005453-4057qib7	15625	43	nervous	nervous	JJ
cord-005453-4057qib7	15625	44	system	system	NN
cord-005453-4057qib7	15625	45	(	(	-LRB-
cord-005453-4057qib7	15625	46	CNS	CNS	NNP
cord-005453-4057qib7	15625	47	)	)	-RRB-
cord-005453-4057qib7	15625	48	before	before	IN
cord-005453-4057qib7	15625	49	transplant	transplant	NN
cord-005453-4057qib7	15625	50	)	)	-RRB-
cord-005453-4057qib7	15625	51	and	and	CC
cord-005453-4057qib7	15625	52	with	with	IN
cord-005453-4057qib7	15625	53	the	the	DT
cord-005453-4057qib7	15625	54	pre	pre	JJ
cord-005453-4057qib7	15625	55	-	-	JJ
cord-005453-4057qib7	15625	56	transplant	transplant	JJ
cord-005453-4057qib7	15625	57	conditioning	conditioning	NN
cord-005453-4057qib7	15625	58	regimens	regimen	NNS
cord-005453-4057qib7	15625	59	.	.	.
cord-005453-4057qib7	15626	1	Methods	method	NNS
cord-005453-4057qib7	15626	2	:	:	:
cord-005453-4057qib7	15626	3	The	the	DT
cord-005453-4057qib7	15626	4	MEDLINE	MEDLINE	NNP
cord-005453-4057qib7	15626	5	,	,	,
cord-005453-4057qib7	15626	6	EMBASE	EMBASE	NNP
cord-005453-4057qib7	15626	7	,	,	,
cord-005453-4057qib7	15626	8	Web	web	NN
cord-005453-4057qib7	15626	9	of	of	IN
cord-005453-4057qib7	15626	10	Science	Science	NNP
cord-005453-4057qib7	15626	11	and	and	CC
cord-005453-4057qib7	15626	12	PubMed	PubMed	NNP
cord-005453-4057qib7	15626	13	databases	database	NNS
cord-005453-4057qib7	15626	14	were	be	VBD
cord-005453-4057qib7	15626	15	searched	search	VBN
cord-005453-4057qib7	15626	16	,	,	,
cord-005453-4057qib7	15626	17	by	by	IN
cord-005453-4057qib7	15626	18	two	two	CD
cord-005453-4057qib7	15626	19	librarians	librarian	NNS
cord-005453-4057qib7	15626	20	at	at	IN
cord-005453-4057qib7	15626	21	the	the	DT
cord-005453-4057qib7	15626	22	Karolinska	Karolinska	NNP
cord-005453-4057qib7	15626	23	Institutet	Institutet	NNP
cord-005453-4057qib7	15626	24	,	,	,
cord-005453-4057qib7	15626	25	between	between	IN
cord-005453-4057qib7	15626	26	May	May	NNP
cord-005453-4057qib7	15626	27	and	and	CC
cord-005453-4057qib7	15626	28	September	September	NNP
cord-005453-4057qib7	15626	29	2016	2016	CD
cord-005453-4057qib7	15626	30	according	accord	VBG
cord-005453-4057qib7	15626	31	to	to	IN
cord-005453-4057qib7	15626	32	the	the	DT
cord-005453-4057qib7	15626	33	Preferred	Preferred	NNP
cord-005453-4057qib7	15626	34	Reporting	Reporting	NNP
cord-005453-4057qib7	15626	35	Items	Items	NNP
cord-005453-4057qib7	15626	36	for	for	IN
cord-005453-4057qib7	15626	37	Systematic	Systematic	NNP
cord-005453-4057qib7	15626	38	Review	Review	NNP
cord-005453-4057qib7	15626	39	and	and	CC
cord-005453-4057qib7	15626	40	Meta	Meta	NNP
cord-005453-4057qib7	15626	41	-	-	HYPH
cord-005453-4057qib7	15626	42	analysis	analysis	NN
cord-005453-4057qib7	15626	43	(	(	-LRB-
cord-005453-4057qib7	15626	44	PRISMA	PRISMA	NNP
cord-005453-4057qib7	15626	45	)	)	-RRB-
cord-005453-4057qib7	15626	46	statement	statement	NN
cord-005453-4057qib7	15626	47	.	.	.
cord-005453-4057qib7	15627	1	The	the	DT
cord-005453-4057qib7	15627	2	search	search	NN
cord-005453-4057qib7	15627	3	terms	term	NNS
cord-005453-4057qib7	15627	4	included	include	VBD
cord-005453-4057qib7	15627	5	"	"	``
cord-005453-4057qib7	15627	6	HLH	HLH	NNP
cord-005453-4057qib7	15627	7	"	"	''
cord-005453-4057qib7	15627	8	,	,	,
cord-005453-4057qib7	15627	9	"	"	``
cord-005453-4057qib7	15627	10	FHL	FHL	NNP
cord-005453-4057qib7	15627	11	"	"	''
cord-005453-4057qib7	15627	12	,	,	,
cord-005453-4057qib7	15627	13	"	"	``
cord-005453-4057qib7	15627	14	MAS	MAS	NNP
cord-005453-4057qib7	15627	15	"	"	''
cord-005453-4057qib7	15627	16	,	,	,
cord-005453-4057qib7	15627	17	multiple	multiple	JJ
cord-005453-4057qib7	15627	18	terms	term	NNS
cord-005453-4057qib7	15627	19	for	for	IN
cord-005453-4057qib7	15627	20	"	"	``
cord-005453-4057qib7	15627	21	HSCT	HSCT	NNP
cord-005453-4057qib7	15627	22	"	"	''
cord-005453-4057qib7	15627	23	and	and	CC
cord-005453-4057qib7	15627	24	late	late	JJ
cord-005453-4057qib7	15627	25	-	-	HYPH
cord-005453-4057qib7	15627	26	effect	effect	NN
cord-005453-4057qib7	15627	27	conditions	condition	NNS
cord-005453-4057qib7	15627	28	.	.	.
cord-005453-4057qib7	15628	1	Inclusion	inclusion	NN
cord-005453-4057qib7	15628	2	criteria	criterion	NNS
cord-005453-4057qib7	15628	3	were	be	VBD
cord-005453-4057qib7	15628	4	publications	publication	NNS
cord-005453-4057qib7	15628	5	in	in	IN
cord-005453-4057qib7	15628	6	English	English	NNP
cord-005453-4057qib7	15628	7	that	that	WDT
cord-005453-4057qib7	15628	8	included	include	VBD
cord-005453-4057qib7	15628	9	children	child	NNS
cord-005453-4057qib7	15628	10	between	between	IN
cord-005453-4057qib7	15628	11	January	January	NNP
cord-005453-4057qib7	15628	12	1995	1995	CD
cord-005453-4057qib7	15628	13	and	and	CC
cord-005453-4057qib7	15628	14	May	May	NNP
cord-005453-4057qib7	15628	15	2016	2016	CD
cord-005453-4057qib7	15628	16	.	.	.
cord-005453-4057qib7	15629	1	Authors	author	NNS
cord-005453-4057qib7	15629	2	of	of	IN
cord-005453-4057qib7	15629	3	this	this	DT
cord-005453-4057qib7	15629	4	review	review	NN
cord-005453-4057qib7	15629	5	screened	screen	VBD
cord-005453-4057qib7	15629	6	all	all	PDT
cord-005453-4057qib7	15629	7	the	the	DT
cord-005453-4057qib7	15629	8	abstracts	abstract	NNS
cord-005453-4057qib7	15629	9	of	of	IN
cord-005453-4057qib7	15629	10	studies	study	NNS
cord-005453-4057qib7	15629	11	against	against	IN
cord-005453-4057qib7	15629	12	the	the	DT
cord-005453-4057qib7	15629	13	inclusion	inclusion	NN
cord-005453-4057qib7	15629	14	criteria	criterion	NNS
cord-005453-4057qib7	15629	15	.	.	.
cord-005453-4057qib7	15630	1	Results	result	NNS
cord-005453-4057qib7	15630	2	:	:	:
cord-005453-4057qib7	15630	3	Only	only	RB
cord-005453-4057qib7	15630	4	nine	nine	CD
cord-005453-4057qib7	15630	5	papers	paper	NNS
cord-005453-4057qib7	15630	6	published	publish	VBN
cord-005453-4057qib7	15630	7	between	between	IN
cord-005453-4057qib7	15630	8	2006	2006	CD
cord-005453-4057qib7	15630	9	and	and	CC
cord-005453-4057qib7	15630	10	2016	2016	CD
cord-005453-4057qib7	15630	11	,	,	,
cord-005453-4057qib7	15630	12	with	with	IN
cord-005453-4057qib7	15630	13	information	information	NN
cord-005453-4057qib7	15630	14	on	on	IN
cord-005453-4057qib7	15630	15	late	late	JJ
cord-005453-4057qib7	15630	16	effects	effect	NNS
cord-005453-4057qib7	15630	17	in	in	IN
cord-005453-4057qib7	15630	18	HLH	HLH	NNP
cord-005453-4057qib7	15630	19	patients	patient	NNS
cord-005453-4057qib7	15630	20	who	who	WP
cord-005453-4057qib7	15630	21	had	have	VBD
cord-005453-4057qib7	15630	22	undergone	undergo	VBN
cord-005453-4057qib7	15630	23	HSCT	HSCT	NNP
cord-005453-4057qib7	15630	24	,	,	,
cord-005453-4057qib7	15630	25	were	be	VBD
cord-005453-4057qib7	15630	26	identified	identify	VBN
cord-005453-4057qib7	15630	27	.	.	.
cord-005453-4057qib7	15631	1	Three	three	CD
cord-005453-4057qib7	15631	2	reports	report	NNS
cord-005453-4057qib7	15631	3	include	include	VBP
cord-005453-4057qib7	15631	4	only	only	RB
cord-005453-4057qib7	15631	5	small	small	JJ
cord-005453-4057qib7	15631	6	numbers	number	NNS
cord-005453-4057qib7	15631	7	of	of	IN
cord-005453-4057qib7	15631	8	HLH	HLH	NNP
cord-005453-4057qib7	15631	9	patients	patient	NNS
cord-005453-4057qib7	15631	10	.	.	.
cord-005453-4057qib7	15632	1	The	the	DT
cord-005453-4057qib7	15632	2	remaining	remain	VBG
cord-005453-4057qib7	15632	3	6	6	CD
cord-005453-4057qib7	15632	4	papers	paper	NNS
cord-005453-4057qib7	15632	5	contain	contain	VBP
cord-005453-4057qib7	15632	6	data	datum	NNS
cord-005453-4057qib7	15632	7	on	on	IN
cord-005453-4057qib7	15632	8	261	261	CD
cord-005453-4057qib7	15632	9	long	long	JJ
cord-005453-4057qib7	15632	10	-	-	HYPH
cord-005453-4057qib7	15632	11	term	term	NN
cord-005453-4057qib7	15632	12	survivors	survivor	NNS
cord-005453-4057qib7	15632	13	with	with	IN
cord-005453-4057qib7	15632	14	a	a	DT
cord-005453-4057qib7	15632	15	median	median	JJ
cord-005453-4057qib7	15632	16	follow	follow	NN
cord-005453-4057qib7	15632	17	-	-	HYPH
cord-005453-4057qib7	15632	18	up	up	NN
cord-005453-4057qib7	15632	19	of	of	IN
cord-005453-4057qib7	15632	20	5.4	5.4	CD
cord-005453-4057qib7	15632	21	years	year	NNS
cord-005453-4057qib7	15632	22	.	.	.
cord-005453-4057qib7	15633	1	Five	five	CD
cord-005453-4057qib7	15633	2	papers	paper	NNS
cord-005453-4057qib7	15633	3	address	address	VBP
cord-005453-4057qib7	15633	4	neurological	neurological	JJ
cord-005453-4057qib7	15633	5	sequelae	sequela	NNS
cord-005453-4057qib7	15633	6	with	with	IN
cord-005453-4057qib7	15633	7	a	a	DT
cord-005453-4057qib7	15633	8	reported	report	VBN
cord-005453-4057qib7	15633	9	incidence	incidence	NN
cord-005453-4057qib7	15633	10	from	from	IN
cord-005453-4057qib7	15633	11	7	7	CD
cord-005453-4057qib7	15633	12	-	-	SYM
cord-005453-4057qib7	15633	13	57	57	CD
cord-005453-4057qib7	15633	14	%	%	NN
cord-005453-4057qib7	15633	15	.	.	.
cord-005453-4057qib7	15634	1	The	the	DT
cord-005453-4057qib7	15634	2	highest	high	JJS
cord-005453-4057qib7	15634	3	incidence	incidence	NN
cord-005453-4057qib7	15634	4	was	be	VBD
cord-005453-4057qib7	15634	5	found	find	VBN
cord-005453-4057qib7	15634	6	after	after	IN
cord-005453-4057qib7	15634	7	a	a	DT
cord-005453-4057qib7	15634	8	thorough	thorough	JJ
cord-005453-4057qib7	15634	9	neurological	neurological	JJ
cord-005453-4057qib7	15634	10	assessment	assessment	NN
cord-005453-4057qib7	15634	11	of	of	IN
cord-005453-4057qib7	15634	12	21	21	CD
cord-005453-4057qib7	15634	13	HLH	HLH	NNP
cord-005453-4057qib7	15634	14	patients	patient	NNS
cord-005453-4057qib7	15634	15	compared	compare	VBN
cord-005453-4057qib7	15634	16	to	to	IN
cord-005453-4057qib7	15634	17	matched	match	VBN
cord-005453-4057qib7	15634	18	sibling	sibling	NN
cord-005453-4057qib7	15634	19	controls	control	NNS
cord-005453-4057qib7	15634	20	.	.	.
cord-005453-4057qib7	15635	1	However	however	RB
cord-005453-4057qib7	15635	2	,	,	,
cord-005453-4057qib7	15635	3	the	the	DT
cord-005453-4057qib7	15635	4	association	association	NN
cord-005453-4057qib7	15635	5	with	with	IN
cord-005453-4057qib7	15635	6	CNS	CNS	NNP
cord-005453-4057qib7	15635	7	disease	disease	NN
cord-005453-4057qib7	15635	8	before	before	IN
cord-005453-4057qib7	15635	9	transplant	transplant	NN
cord-005453-4057qib7	15635	10	and	and	CC
cord-005453-4057qib7	15635	11	age	age	NN
cord-005453-4057qib7	15635	12	at	at	IN
cord-005453-4057qib7	15635	13	transplant	transplant	NN
cord-005453-4057qib7	15635	14	was	be	VBD
cord-005453-4057qib7	15635	15	not	not	RB
cord-005453-4057qib7	15635	16	clear	clear	JJ
cord-005453-4057qib7	15635	17	.	.	.
cord-005453-4057qib7	15636	1	Patients	patient	NNS
cord-005453-4057qib7	15636	2	with	with	IN
cord-005453-4057qib7	15636	3	EBVassociated	ebvassociate	VBN
cord-005453-4057qib7	15636	4	HLH	HLH	NNP
cord-005453-4057qib7	15636	5	seem	seem	VBP
cord-005453-4057qib7	15636	6	to	to	TO
cord-005453-4057qib7	15636	7	have	have	VB
cord-005453-4057qib7	15636	8	fewer	few	JJR
cord-005453-4057qib7	15636	9	long	long	JJ
cord-005453-4057qib7	15636	10	-	-	HYPH
cord-005453-4057qib7	15636	11	term	term	NN
cord-005453-4057qib7	15636	12	neurological	neurological	JJ
cord-005453-4057qib7	15636	13	problems	problem	NNS
cord-005453-4057qib7	15636	14	.	.	.
cord-005453-4057qib7	15637	1	Non	non	JJ
cord-005453-4057qib7	15637	2	-	-	JJ
cord-005453-4057qib7	15637	3	neurological	neurological	JJ
cord-005453-4057qib7	15637	4	late	late	JJ
cord-005453-4057qib7	15637	5	effects	effect	NNS
cord-005453-4057qib7	15637	6	are	be	VBP
cord-005453-4057qib7	15637	7	described	describe	VBN
cord-005453-4057qib7	15637	8	in	in	IN
cord-005453-4057qib7	15637	9	4	4	CD
cord-005453-4057qib7	15637	10	papers	paper	NNS
cord-005453-4057qib7	15637	11	only	only	RB
cord-005453-4057qib7	15637	12	,	,	,
cord-005453-4057qib7	15637	13	with	with	IN
cord-005453-4057qib7	15637	14	endocrinological	endocrinological	JJ
cord-005453-4057qib7	15637	15	problems	problem	NNS
cord-005453-4057qib7	15637	16	,	,	,
cord-005453-4057qib7	15637	17	namely	namely	RB
cord-005453-4057qib7	15637	18	short	short	JJ
cord-005453-4057qib7	15637	19	stature	stature	NN
cord-005453-4057qib7	15637	20	,	,	,
cord-005453-4057qib7	15637	21	being	be	VBG
cord-005453-4057qib7	15637	22	the	the	DT
cord-005453-4057qib7	15637	23	most	most	RBS
cord-005453-4057qib7	15637	24	frequent	frequent	JJ
cord-005453-4057qib7	15637	25	.	.	.
cord-005453-4057qib7	15638	1	One	one	CD
cord-005453-4057qib7	15638	2	paper	paper	NN
cord-005453-4057qib7	15638	3	specifically	specifically	RB
cord-005453-4057qib7	15638	4	analyzed	analyze	VBD
cord-005453-4057qib7	15638	5	poor	poor	JJ
cord-005453-4057qib7	15638	6	growth	growth	NN
cord-005453-4057qib7	15638	7	,	,	,
cord-005453-4057qib7	15638	8	thyroid	thyroid	NN
cord-005453-4057qib7	15638	9	dysfunction	dysfunction	NN
cord-005453-4057qib7	15638	10	and	and	CC
cord-005453-4057qib7	15638	11	vitamin	vitamin	NN
cord-005453-4057qib7	15638	12	D	d	NN
cord-005453-4057qib7	15638	13	deficiency	deficiency	NN
cord-005453-4057qib7	15638	14	in	in	IN
cord-005453-4057qib7	15638	15	a	a	DT
cord-005453-4057qib7	15638	16	cohort	cohort	NN
cord-005453-4057qib7	15638	17	of	of	IN
cord-005453-4057qib7	15638	18	patients	patient	NNS
cord-005453-4057qib7	15638	19	with	with	IN
cord-005453-4057qib7	15638	20	non	non	JJ
cord-005453-4057qib7	15638	21	-	-	JJ
cord-005453-4057qib7	15638	22	malignant	malignant	JJ
cord-005453-4057qib7	15638	23	disorders	disorder	NNS
cord-005453-4057qib7	15638	24	including	include	VBG
cord-005453-4057qib7	15638	25	HLH	HLH	NNP
cord-005453-4057qib7	15638	26	who	who	WP
cord-005453-4057qib7	15638	27	had	have	VBD
cord-005453-4057qib7	15638	28	undergone	undergo	VBN
cord-005453-4057qib7	15638	29	HSCT	HSCT	NNP
cord-005453-4057qib7	15638	30	after	after	IN
cord-005453-4057qib7	15638	31	a	a	DT
cord-005453-4057qib7	15638	32	reduced	reduce	VBN
cord-005453-4057qib7	15638	33	intensity	intensity	NN
cord-005453-4057qib7	15638	34	conditioning	conditioning	NN
cord-005453-4057qib7	15638	35	regimen	regimen	NN
cord-005453-4057qib7	15638	36	and	and	CC
cord-005453-4057qib7	15638	37	found	find	VBD
cord-005453-4057qib7	15638	38	significant	significant	JJ
cord-005453-4057qib7	15638	39	abnormalities	abnormality	NNS
cord-005453-4057qib7	15638	40	in	in	IN
cord-005453-4057qib7	15638	41	all	all	DT
cord-005453-4057qib7	15638	42	groups	group	NNS
cord-005453-4057qib7	15638	43	.	.	.
cord-005453-4057qib7	15639	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15639	2	:	:	:
cord-005453-4057qib7	15640	1	Data	datum	NNS
cord-005453-4057qib7	15640	2	on	on	IN
cord-005453-4057qib7	15640	3	late	late	JJ
cord-005453-4057qib7	15640	4	effects	effect	NNS
cord-005453-4057qib7	15640	5	in	in	IN
cord-005453-4057qib7	15640	6	HLH	HLH	NNP
cord-005453-4057qib7	15640	7	patients	patient	NNS
cord-005453-4057qib7	15640	8	is	be	VBZ
cord-005453-4057qib7	15640	9	scarce	scarce	JJ
cord-005453-4057qib7	15640	10	and	and	CC
cord-005453-4057qib7	15640	11	is	be	VBZ
cord-005453-4057qib7	15640	12	mostly	mostly	RB
cord-005453-4057qib7	15640	13	based	base	VBN
cord-005453-4057qib7	15640	14	on	on	IN
cord-005453-4057qib7	15640	15	the	the	DT
cord-005453-4057qib7	15640	16	retrospective	retrospective	JJ
cord-005453-4057qib7	15640	17	evaluation	evaluation	NN
cord-005453-4057qib7	15640	18	of	of	IN
cord-005453-4057qib7	15640	19	small	small	JJ
cord-005453-4057qib7	15640	20	national	national	JJ
cord-005453-4057qib7	15640	21	cohorts	cohort	NNS
cord-005453-4057qib7	15640	22	.	.	.
cord-005453-4057qib7	15641	1	The	the	DT
cord-005453-4057qib7	15641	2	available	available	JJ
cord-005453-4057qib7	15641	3	information	information	NN
cord-005453-4057qib7	15641	4	indicates	indicate	VBZ
cord-005453-4057qib7	15641	5	that	that	IN
cord-005453-4057qib7	15641	6	a	a	DT
cord-005453-4057qib7	15641	7	significant	significant	JJ
cord-005453-4057qib7	15641	8	number	number	NN
cord-005453-4057qib7	15641	9	of	of	IN
cord-005453-4057qib7	15641	10	patients	patient	NNS
cord-005453-4057qib7	15641	11	suffers	suffer	VBZ
cord-005453-4057qib7	15641	12	from	from	IN
cord-005453-4057qib7	15641	13	problems	problem	NNS
cord-005453-4057qib7	15641	14	which	which	WDT
cord-005453-4057qib7	15641	15	affect	affect	VBP
cord-005453-4057qib7	15641	16	their	-PRON-	PRP$
cord-005453-4057qib7	15641	17	daily	daily	JJ
cord-005453-4057qib7	15641	18	life	life	NN
cord-005453-4057qib7	15641	19	,	,	,
cord-005453-4057qib7	15641	20	but	but	CC
cord-005453-4057qib7	15641	21	lack	lack	NN
cord-005453-4057qib7	15641	22	of	of	IN
cord-005453-4057qib7	15641	23	information	information	NN
cord-005453-4057qib7	15641	24	does	do	VBZ
cord-005453-4057qib7	15641	25	not	not	RB
cord-005453-4057qib7	15641	26	allow	allow	VB
cord-005453-4057qib7	15641	27	to	to	TO
cord-005453-4057qib7	15641	28	analyze	analyze	VB
cord-005453-4057qib7	15641	29	the	the	DT
cord-005453-4057qib7	15641	30	association	association	NN
cord-005453-4057qib7	15641	31	between	between	IN
cord-005453-4057qib7	15641	32	pre	pre	JJ
cord-005453-4057qib7	15641	33	-	-	JJ
cord-005453-4057qib7	15641	34	transplant	transplant	JJ
cord-005453-4057qib7	15641	35	conditions	condition	NNS
cord-005453-4057qib7	15641	36	and	and	CC
cord-005453-4057qib7	15641	37	long	long	JJ
cord-005453-4057qib7	15641	38	-	-	HYPH
cord-005453-4057qib7	15641	39	term	term	NN
cord-005453-4057qib7	15641	40	sequelae	sequela	NNS
cord-005453-4057qib7	15641	41	.	.	.
cord-005453-4057qib7	15642	1	Therefore	therefore	RB
cord-005453-4057qib7	15642	2	,	,	,
cord-005453-4057qib7	15642	3	a	a	DT
cord-005453-4057qib7	15642	4	retrospective	retrospective	JJ
cord-005453-4057qib7	15642	5	comprehensive	comprehensive	JJ
cord-005453-4057qib7	15642	6	analysis	analysis	NN
cord-005453-4057qib7	15642	7	of	of	IN
cord-005453-4057qib7	15642	8	patients	patient	NNS
cord-005453-4057qib7	15642	9	registered	register	VBN
cord-005453-4057qib7	15642	10	in	in	IN
cord-005453-4057qib7	15642	11	the	the	DT
cord-005453-4057qib7	15642	12	EBMT	EBMT	NNP
cord-005453-4057qib7	15642	13	and	and	CC
cord-005453-4057qib7	15642	14	CIBMTR	CIBMTR	NNP
cord-005453-4057qib7	15642	15	registries	registry	NNS
cord-005453-4057qib7	15642	16	is	be	VBZ
cord-005453-4057qib7	15642	17	currently	currently	RB
cord-005453-4057qib7	15642	18	performed	perform	VBN
cord-005453-4057qib7	15642	19	.	.	.
cord-005453-4057qib7	15643	1	It	-PRON-	PRP
cord-005453-4057qib7	15643	2	will	will	MD
cord-005453-4057qib7	15643	3	be	be	VB
cord-005453-4057qib7	15643	4	crucial	crucial	JJ
cord-005453-4057qib7	15643	5	to	to	TO
cord-005453-4057qib7	15643	6	better	better	RB
cord-005453-4057qib7	15643	7	define	define	VB
cord-005453-4057qib7	15643	8	the	the	DT
cord-005453-4057qib7	15643	9	frequency	frequency	NN
cord-005453-4057qib7	15643	10	and	and	CC
cord-005453-4057qib7	15643	11	type	type	NN
cord-005453-4057qib7	15643	12	of	of	IN
cord-005453-4057qib7	15643	13	late	late	JJ
cord-005453-4057qib7	15643	14	effects	effect	NNS
cord-005453-4057qib7	15643	15	in	in	IN
cord-005453-4057qib7	15643	16	a	a	DT
cord-005453-4057qib7	15643	17	large	large	JJ
cord-005453-4057qib7	15643	18	cohort	cohort	NN
cord-005453-4057qib7	15643	19	.	.	.
cord-005453-4057qib7	15644	1	This	this	DT
cord-005453-4057qib7	15644	2	knowledge	knowledge	NN
cord-005453-4057qib7	15644	3	will	will	MD
cord-005453-4057qib7	15644	4	aid	aid	VB
cord-005453-4057qib7	15644	5	counselling	counselling	NN
cord-005453-4057qib7	15644	6	prior	prior	RB
cord-005453-4057qib7	15644	7	to	to	IN
cord-005453-4057qib7	15644	8	HSCT	HSCT	NNP
cord-005453-4057qib7	15644	9	,	,	,
cord-005453-4057qib7	15644	10	provide	provide	VB
cord-005453-4057qib7	15644	11	guidance	guidance	NN
cord-005453-4057qib7	15644	12	for	for	IN
cord-005453-4057qib7	15644	13	long	long	JJ
cord-005453-4057qib7	15644	14	-	-	HYPH
cord-005453-4057qib7	15644	15	term	term	NN
cord-005453-4057qib7	15644	16	monitoring	monitoring	NN
cord-005453-4057qib7	15644	17	of	of	IN
cord-005453-4057qib7	15644	18	these	these	DT
cord-005453-4057qib7	15644	19	patients	patient	NNS
cord-005453-4057qib7	15644	20	,	,	,
cord-005453-4057qib7	15644	21	and	and	CC
cord-005453-4057qib7	15644	22	potentially	potentially	RB
cord-005453-4057qib7	15644	23	identify	identify	VB
cord-005453-4057qib7	15644	24	specific	specific	JJ
cord-005453-4057qib7	15644	25	risk	risk	NN
cord-005453-4057qib7	15644	26	factors	factor	NNS
cord-005453-4057qib7	15644	27	for	for	IN
cord-005453-4057qib7	15644	28	late	late	JJ
cord-005453-4057qib7	15644	29	effects	effect	NNS
cord-005453-4057qib7	15644	30	in	in	IN
cord-005453-4057qib7	15644	31	this	this	DT
cord-005453-4057qib7	15644	32	rare	rare	JJ
cord-005453-4057qib7	15644	33	patient	patient	NN
cord-005453-4057qib7	15644	34	population	population	NN
cord-005453-4057qib7	15644	35	.	.	.
cord-005453-4057qib7	15645	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15645	2	:	:	:
cord-005453-4057qib7	15645	3	Nothing	nothing	NN
cord-005453-4057qib7	15645	4	to	to	TO
cord-005453-4057qib7	15645	5	declare	declare	VB
cord-005453-4057qib7	15645	6	.	.	.
cord-005453-4057qib7	15646	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	15646	2	stem	stem	VBP
cord-005453-4057qib7	15646	3	cell	cell	NN
cord-005453-4057qib7	15646	4	transplantation	transplantation	NN
cord-005453-4057qib7	15646	5	in	in	IN
cord-005453-4057qib7	15646	6	patients	patient	NNS
cord-005453-4057qib7	15646	7	with	with	IN
cord-005453-4057qib7	15646	8	mucopolysaccharidosis	mucopolysaccharidosis	NNP
cord-005453-4057qib7	15646	9	type	type	NN
cord-005453-4057qib7	15646	10	II	II	NNP
cord-005453-4057qib7	15646	11	(	(	-LRB-
cord-005453-4057qib7	15646	12	Morbus	Morbus	NNP
cord-005453-4057qib7	15646	13	hunter)Bernd	hunter)bernd	JJ
cord-005453-4057qib7	15646	14	Hartz	Hartz	NNP
cord-005453-4057qib7	15646	15	1	1	CD
cord-005453-4057qib7	15646	16	,	,	,
cord-005453-4057qib7	15646	17	Nicole	Nicole	NNP
cord-005453-4057qib7	15646	18	Muschol	Muschol	NNP
cord-005453-4057qib7	15646	19	2	2	CD
cord-005453-4057qib7	15646	20	,	,	,
cord-005453-4057qib7	15646	21	Matthias	Matthias	NNP
cord-005453-4057qib7	15646	22	Bleeke	Bleeke	NNP
cord-005453-4057qib7	15646	23	1	1	CD
cord-005453-4057qib7	15646	24	,	,	,
cord-005453-4057qib7	15646	25	Johanna	Johanna	NNP
cord-005453-4057qib7	15646	26	Schrum	Schrum	NNP
cord-005453-4057qib7	15646	27	1	1	CD
cord-005453-4057qib7	15646	28	,	,	,
cord-005453-4057qib7	15646	29	Ingo	Ingo	NNP
cord-005453-4057qib7	15646	30	Müller	Müller	NNP
cord-005453-4057qib7	15647	1	1Background	1background	LS
cord-005453-4057qib7	15647	2	:	:	:
cord-005453-4057qib7	15647	3	The	the	DT
cord-005453-4057qib7	15647	4	transplantation	transplantation	NN
cord-005453-4057qib7	15647	5	of	of	IN
cord-005453-4057qib7	15647	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15647	7	stem	stem	NN
cord-005453-4057qib7	15647	8	cells	cell	NNS
cord-005453-4057qib7	15647	9	(	(	-LRB-
cord-005453-4057qib7	15647	10	HSCT	HSCT	NNP
cord-005453-4057qib7	15647	11	)	)	-RRB-
cord-005453-4057qib7	15647	12	is	be	VBZ
cord-005453-4057qib7	15647	13	one	one	CD
cord-005453-4057qib7	15647	14	of	of	IN
cord-005453-4057qib7	15647	15	the	the	DT
cord-005453-4057qib7	15647	16	leading	lead	VBG
cord-005453-4057qib7	15647	17	methods	method	NNS
cord-005453-4057qib7	15647	18	of	of	IN
cord-005453-4057qib7	15647	19	treatment	treatment	NN
cord-005453-4057qib7	15647	20	in	in	IN
cord-005453-4057qib7	15647	21	patients	patient	NNS
cord-005453-4057qib7	15647	22	with	with	IN
cord-005453-4057qib7	15647	23	blood	blood	NN
cord-005453-4057qib7	15647	24	system	system	NN
cord-005453-4057qib7	15647	25	diseases	disease	NNS
cord-005453-4057qib7	15647	26	,	,	,
cord-005453-4057qib7	15647	27	primary	primary	JJ
cord-005453-4057qib7	15647	28	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	15647	29	syndromes	syndrome	NNS
cord-005453-4057qib7	15647	30	and	and	CC
cord-005453-4057qib7	15647	31	genetic	genetic	JJ
cord-005453-4057qib7	15647	32	diseases	disease	NNS
cord-005453-4057qib7	15647	33	.	.	.
cord-005453-4057qib7	15648	1	At	at	IN
cord-005453-4057qib7	15648	2	the	the	DT
cord-005453-4057qib7	15648	3	same	same	JJ
cord-005453-4057qib7	15648	4	time	time	NN
cord-005453-4057qib7	15648	5	,	,	,
cord-005453-4057qib7	15648	6	the	the	DT
cord-005453-4057qib7	15648	7	quality	quality	NN
cord-005453-4057qib7	15648	8	of	of	IN
cord-005453-4057qib7	15648	9	life	life	NN
cord-005453-4057qib7	15648	10	in	in	IN
cord-005453-4057qib7	15648	11	patients	patient	NNS
cord-005453-4057qib7	15648	12	in	in	IN
cord-005453-4057qib7	15648	13	the	the	DT
cord-005453-4057qib7	15648	14	long	long	JJ
cord-005453-4057qib7	15648	15	-	-	HYPH
cord-005453-4057qib7	15648	16	term	term	NN
cord-005453-4057qib7	15648	17	after	after	IN
cord-005453-4057qib7	15648	18	HSCT	HSCT	NNP
cord-005453-4057qib7	15648	19	significantly	significantly	RB
cord-005453-4057qib7	15648	20	differs	differ	VBZ
cord-005453-4057qib7	15648	21	from	from	IN
cord-005453-4057qib7	15648	22	the	the	DT
cord-005453-4057qib7	15648	23	quality	quality	NN
cord-005453-4057qib7	15648	24	of	of	IN
cord-005453-4057qib7	15648	25	life	life	NN
cord-005453-4057qib7	15648	26	of	of	IN
cord-005453-4057qib7	15648	27	healthy	healthy	JJ
cord-005453-4057qib7	15648	28	people	people	NNS
cord-005453-4057qib7	15648	29	of	of	IN
cord-005453-4057qib7	15648	30	the	the	DT
cord-005453-4057qib7	15648	31	same	same	JJ
cord-005453-4057qib7	15648	32	age	age	NN
cord-005453-4057qib7	15648	33	.	.	.
cord-005453-4057qib7	15649	1	Deformations	deformation	NNS
cord-005453-4057qib7	15649	2	in	in	IN
cord-005453-4057qib7	15649	3	psychosexual	psychosexual	JJ
cord-005453-4057qib7	15649	4	development	development	NN
cord-005453-4057qib7	15649	5	including	include	VBG
cord-005453-4057qib7	15649	6	problems	problem	NNS
cord-005453-4057qib7	15649	7	in	in	IN
cord-005453-4057qib7	15649	8	the	the	DT
cord-005453-4057qib7	15649	9	gender	gender	NN
cord-005453-4057qib7	15649	10	identity	identity	NN
cord-005453-4057qib7	15649	11	formation	formation	NN
cord-005453-4057qib7	15649	12	cause	cause	VBP
cord-005453-4057qib7	15649	13	social	social	JJ
cord-005453-4057qib7	15649	14	isolation	isolation	NN
cord-005453-4057qib7	15649	15	of	of	IN
cord-005453-4057qib7	15649	16	adolescents	adolescent	NNS
cord-005453-4057qib7	15649	17	,	,	,
cord-005453-4057qib7	15649	18	which	which	WDT
cord-005453-4057qib7	15649	19	makes	make	VBZ
cord-005453-4057qib7	15649	20	their	-PRON-	PRP$
cord-005453-4057qib7	15649	21	sexual	sexual	JJ
cord-005453-4057qib7	15649	22	selfrealization	selfrealization	NN
cord-005453-4057qib7	15649	23	impossible	impossible	JJ
cord-005453-4057qib7	15649	24	and	and	CC
cord-005453-4057qib7	15649	25	significantly	significantly	RB
cord-005453-4057qib7	15649	26	reduces	reduce	VBZ
cord-005453-4057qib7	15649	27	the	the	DT
cord-005453-4057qib7	15649	28	quality	quality	NN
cord-005453-4057qib7	15649	29	of	of	IN
cord-005453-4057qib7	15649	30	their	-PRON-	PRP$
cord-005453-4057qib7	15649	31	life	life	NN
cord-005453-4057qib7	15649	32	.	.	.
cord-005453-4057qib7	15650	1	The	the	DT
cord-005453-4057qib7	15650	2	purpose	purpose	NN
cord-005453-4057qib7	15650	3	of	of	IN
cord-005453-4057qib7	15650	4	our	-PRON-	PRP$
cord-005453-4057qib7	15650	5	study	study	NN
cord-005453-4057qib7	15650	6	was	be	VBD
cord-005453-4057qib7	15650	7	an	an	DT
cord-005453-4057qib7	15650	8	assessment	assessment	NN
cord-005453-4057qib7	15650	9	of	of	IN
cord-005453-4057qib7	15650	10	the	the	DT
cord-005453-4057qib7	15650	11	level	level	NN
cord-005453-4057qib7	15650	12	of	of	IN
cord-005453-4057qib7	15650	13	gender	gender	NN
cord-005453-4057qib7	15650	14	identity	identity	NN
cord-005453-4057qib7	15650	15	formation	formation	NN
cord-005453-4057qib7	15650	16	of	of	IN
cord-005453-4057qib7	15650	17	adolescents	adolescent	NNS
cord-005453-4057qib7	15650	18	and	and	CC
cord-005453-4057qib7	15650	19	psychosexual	psychosexual	JJ
cord-005453-4057qib7	15650	20	development	development	NN
cord-005453-4057qib7	15650	21	correlation	correlation	NN
cord-005453-4057qib7	15650	22	to	to	IN
cord-005453-4057qib7	15650	23	the	the	DT
cord-005453-4057qib7	15650	24	normal	normal	JJ
cord-005453-4057qib7	15650	25	adolescents	adolescent	NNS
cord-005453-4057qib7	15650	26	of	of	IN
cord-005453-4057qib7	15650	27	the	the	DT
cord-005453-4057qib7	15650	28	same	same	JJ
cord-005453-4057qib7	15650	29	age	age	NN
cord-005453-4057qib7	15650	30	.	.	.
cord-005453-4057qib7	15651	1	Methods	method	NNS
cord-005453-4057qib7	15651	2	:	:	:
cord-005453-4057qib7	15651	3	In	in	IN
cord-005453-4057qib7	15651	4	a	a	DT
cord-005453-4057qib7	15651	5	prospective	prospective	JJ
cord-005453-4057qib7	15651	6	single	single	JJ
cord-005453-4057qib7	15651	7	-	-	HYPH
cord-005453-4057qib7	15651	8	center	center	NN
cord-005453-4057qib7	15651	9	study	study	NN
cord-005453-4057qib7	15651	10	in	in	IN
cord-005453-4057qib7	15651	11	2018	2018	CD
cord-005453-4057qib7	15651	12	,	,	,
cord-005453-4057qib7	15651	13	on	on	IN
cord-005453-4057qib7	15651	14	the	the	DT
cord-005453-4057qib7	15651	15	base	base	NN
cord-005453-4057qib7	15651	16	of	of	IN
cord-005453-4057qib7	15651	17	the	the	DT
cord-005453-4057qib7	15651	18	Department	Department	NNP
cord-005453-4057qib7	15651	19	of	of	IN
cord-005453-4057qib7	15651	20	Rehabilitation	Rehabilitation	NNP
cord-005453-4057qib7	15651	21	Medicine	Medicine	NNP
cord-005453-4057qib7	15651	22	Raisa	Raisa	NNP
cord-005453-4057qib7	15651	23	Gorbacheva	Gorbacheva	NNP
cord-005453-4057qib7	15651	24	Memorial	Memorial	NNP
cord-005453-4057qib7	15651	25	Institute	Institute	NNP
cord-005453-4057qib7	15651	26	of	of	IN
cord-005453-4057qib7	15651	27	Children´s	Children´s	NNP
cord-005453-4057qib7	15651	28	Oncology	Oncology	NNP
cord-005453-4057qib7	15651	29	,	,	,
cord-005453-4057qib7	15651	30	Hematology	Hematology	NNP
cord-005453-4057qib7	15651	31	and	and	CC
cord-005453-4057qib7	15651	32	Transplantation	Transplantation	NNP
cord-005453-4057qib7	15651	33	,	,	,
cord-005453-4057qib7	15651	34	we	-PRON-	PRP
cord-005453-4057qib7	15651	35	conducted	conduct	VBD
cord-005453-4057qib7	15651	36	a	a	DT
cord-005453-4057qib7	15651	37	study	study	NN
cord-005453-4057qib7	15651	38	of	of	IN
cord-005453-4057qib7	15651	39	17	17	CD
cord-005453-4057qib7	15651	40	families	family	NNS
cord-005453-4057qib7	15651	41	.	.	.
cord-005453-4057qib7	15652	1	The	the	DT
cord-005453-4057qib7	15652	2	respondents	respondent	NNS
cord-005453-4057qib7	15652	3	were	be	VBD
cord-005453-4057qib7	15652	4	:	:	:
cord-005453-4057qib7	15652	5	1	1	LS
cord-005453-4057qib7	15652	6	)	)	-RRB-
cord-005453-4057qib7	15652	7	parents	parent	NNS
cord-005453-4057qib7	15652	8	/	/	SYM
cord-005453-4057qib7	15652	9	guardians	guardian	NNS
cord-005453-4057qib7	15652	10	of	of	IN
cord-005453-4057qib7	15652	11	patients	patient	NNS
cord-005453-4057qib7	15652	12	accompanying	accompany	VBG
cord-005453-4057qib7	15652	13	them	-PRON-	PRP
cord-005453-4057qib7	15652	14	in	in	IN
cord-005453-4057qib7	15652	15	the	the	DT
cord-005453-4057qib7	15652	16	process	process	NN
cord-005453-4057qib7	15652	17	of	of	IN
cord-005453-4057qib7	15652	18	examination	examination	NN
cord-005453-4057qib7	15652	19	;	;	:
cord-005453-4057qib7	15652	20	2	2	LS
cord-005453-4057qib7	15652	21	)	)	-RRB-
cord-005453-4057qib7	15652	22	adolescents	adolescent	NNS
cord-005453-4057qib7	15652	23	who	who	WP
cord-005453-4057qib7	15652	24	underwent	undergo	VBD
cord-005453-4057qib7	15652	25	HSCT	HSCT	NNP
cord-005453-4057qib7	15652	26	treatment	treatment	NN
cord-005453-4057qib7	15652	27	and	and	CC
cord-005453-4057qib7	15652	28	undergo	undergo	VB
cord-005453-4057qib7	15652	29	planned	planned	JJ
cord-005453-4057qib7	15652	30	examinations	examination	NNS
cord-005453-4057qib7	15652	31	at	at	IN
cord-005453-4057qib7	15652	32	the	the	DT
cord-005453-4057qib7	15652	33	clinic	clinic	NN
cord-005453-4057qib7	15652	34	in	in	IN
cord-005453-4057qib7	15652	35	the	the	DT
cord-005453-4057qib7	15652	36	posttransplant	posttransplant	NN
cord-005453-4057qib7	15652	37	period	period	NN
cord-005453-4057qib7	15652	38	(	(	-LRB-
cord-005453-4057qib7	15652	39	after	after	IN
cord-005453-4057qib7	15652	40	D	D	NNP
cord-005453-4057qib7	15652	41	+	+	CC
cord-005453-4057qib7	15652	42	100	100	CD
cord-005453-4057qib7	15652	43	)	)	-RRB-
cord-005453-4057qib7	15652	44	,	,	,
cord-005453-4057qib7	15652	45	(	(	-LRB-
cord-005453-4057qib7	15652	46	n	n	NN
cord-005453-4057qib7	15652	47	=	=	SYM
cord-005453-4057qib7	15652	48	17	17	CD
cord-005453-4057qib7	15652	49	,	,	,
cord-005453-4057qib7	15652	50	of	of	IN
cord-005453-4057qib7	15652	51	which	which	WDT
cord-005453-4057qib7	15652	52	8	8	CD
cord-005453-4057qib7	15652	53	girls	girl	NNS
cord-005453-4057qib7	15652	54	and	and	CC
cord-005453-4057qib7	15652	55	9	9	CD
cord-005453-4057qib7	15652	56	boys	boy	NNS
cord-005453-4057qib7	15652	57	,	,	,
cord-005453-4057qib7	15652	58	age	age	NN
cord-005453-4057qib7	15652	59	12	12	CD
cord-005453-4057qib7	15652	60	-17	-17	CD
cord-005453-4057qib7	15652	61	years	year	NNS
cord-005453-4057qib7	15652	62	,	,	,
cord-005453-4057qib7	15652	63	from	from	IN
cord-005453-4057qib7	15652	64	the	the	DT
cord-005453-4057qib7	15652	65	date	date	NN
cord-005453-4057qib7	15652	66	of	of	IN
cord-005453-4057qib7	15652	67	HSCT	HSCT	NNP
cord-005453-4057qib7	15652	68	1	1	CD
cord-005453-4057qib7	15652	69	-5	-5	NNP
cord-005453-4057qib7	15653	1	years).The	years).The	NNP
cord-005453-4057qib7	15653	2	following	follow	VBG
cord-005453-4057qib7	15653	3	methods	method	NNS
cord-005453-4057qib7	15653	4	were	be	VBD
cord-005453-4057qib7	15653	5	used	use	VBN
cord-005453-4057qib7	15653	6	to	to	TO
cord-005453-4057qib7	15653	7	assess	assess	VB
cord-005453-4057qib7	15653	8	gender	gender	NN
cord-005453-4057qib7	15653	9	identity	identity	NN
cord-005453-4057qib7	15653	10	:	:	:
cord-005453-4057qib7	15653	11	Specially	specially	RB
cord-005453-4057qib7	15653	12	developed	develop	VBN
cord-005453-4057qib7	15653	13	questionnaires	questionnaire	NNS
cord-005453-4057qib7	15653	14	for	for	IN
cord-005453-4057qib7	15653	15	teenagers	teenager	NNS
cord-005453-4057qib7	15653	16	and	and	CC
cord-005453-4057qib7	15653	17	parents	parent	NNS
cord-005453-4057qib7	15653	18	;	;	:
cord-005453-4057qib7	15653	19	questionnaire	questionnaire	NN
cord-005453-4057qib7	15653	20	by	by	IN
cord-005453-4057qib7	15653	21	Sandra	Sandra	NNP
cord-005453-4057qib7	15653	22	L.	L.	NNP
cord-005453-4057qib7	15653	23	Bem	Bem	NNP
cord-005453-4057qib7	15653	24	(	(	-LRB-
cord-005453-4057qib7	15653	25	Sandra	Sandra	NNP
cord-005453-4057qib7	15653	26	L.	L.	NNP
cord-005453-4057qib7	15653	27	Bem	Bem	NNP
cord-005453-4057qib7	15653	28	,	,	,
cord-005453-4057qib7	15653	29	1974	1974	CD
cord-005453-4057qib7	15653	30	)	)	-RRB-
cord-005453-4057qib7	15653	31	;	;	,
cord-005453-4057qib7	15653	32	projective	projective	JJ
cord-005453-4057qib7	15653	33	techniques	technique	NNS
cord-005453-4057qib7	15653	34	"	"	''
cord-005453-4057qib7	15653	35	The	the	DT
cord-005453-4057qib7	15653	36	Human	Human	NNP
cord-005453-4057qib7	15653	37	Picture	Picture	NNP
cord-005453-4057qib7	15653	38	"	"	''
cord-005453-4057qib7	15653	39	,	,	,
cord-005453-4057qib7	15653	40	"	"	``
cord-005453-4057qib7	15653	41	The	the	DT
cord-005453-4057qib7	15653	42	non	non	JJ
cord-005453-4057qib7	15653	43	-	-	JJ
cord-005453-4057qib7	15653	44	existent	existent	JJ
cord-005453-4057qib7	15653	45	animal	animal	NN
cord-005453-4057qib7	15653	46	"	"	''
cord-005453-4057qib7	15653	47	;	;	:
cord-005453-4057qib7	15653	48	Max	Max	NNP
cord-005453-4057qib7	15653	49	Lüscher´s	lüscher´s	JJ
cord-005453-4057qib7	15653	50	color	color	NN
cord-005453-4057qib7	15653	51	choices	choice	NNS
cord-005453-4057qib7	15653	52	test	test	VBP
cord-005453-4057qib7	15653	53	.	.	.
cord-005453-4057qib7	15654	1	Results	result	NNS
cord-005453-4057qib7	15654	2	:	:	:
cord-005453-4057qib7	15655	1	The	the	DT
cord-005453-4057qib7	15655	2	traditional	traditional	JJ
cord-005453-4057qib7	15655	3	type	type	NN
cord-005453-4057qib7	15655	4	of	of	IN
cord-005453-4057qib7	15655	5	gender	gender	NN
cord-005453-4057qib7	15655	6	identity	identity	NN
cord-005453-4057qib7	15655	7	,	,	,
cord-005453-4057qib7	15655	8	which	which	WDT
cord-005453-4057qib7	15655	9	characterizes	characterize	VBZ
cord-005453-4057qib7	15655	10	high	high	JJ
cord-005453-4057qib7	15655	11	masculinity	masculinity	NN
cord-005453-4057qib7	15655	12	among	among	IN
cord-005453-4057qib7	15655	13	male	male	JJ
cord-005453-4057qib7	15655	14	respondents	respondent	NNS
cord-005453-4057qib7	15655	15	and	and	CC
cord-005453-4057qib7	15655	16	high	high	JJ
cord-005453-4057qib7	15655	17	female	female	JJ
cord-005453-4057qib7	15655	18	gender	gender	NN
cord-005453-4057qib7	15655	19	indicators	indicator	NNS
cord-005453-4057qib7	15655	20	in	in	IN
cord-005453-4057qib7	15655	21	100	100	CD
cord-005453-4057qib7	15655	22	%	%	NN
cord-005453-4057qib7	15655	23	of	of	IN
cord-005453-4057qib7	15655	24	cases	case	NNS
cord-005453-4057qib7	15655	25	,	,	,
cord-005453-4057qib7	15655	26	was	be	VBD
cord-005453-4057qib7	15655	27	not	not	RB
cord-005453-4057qib7	15655	28	revealed	reveal	VBN
cord-005453-4057qib7	15655	29	.	.	.
cord-005453-4057qib7	15656	1	Both	both	DT
cord-005453-4057qib7	15656	2	among	among	IN
cord-005453-4057qib7	15656	3	girls	girl	NNS
cord-005453-4057qib7	15656	4	and	and	CC
cord-005453-4057qib7	15656	5	among	among	IN
cord-005453-4057qib7	15656	6	boys	boy	NNS
cord-005453-4057qib7	15656	7	,	,	,
cord-005453-4057qib7	15656	8	the	the	DT
cord-005453-4057qib7	15656	9	androgynous	androgynous	JJ
cord-005453-4057qib7	15656	10	type	type	NN
cord-005453-4057qib7	15656	11	prevails	prevail	VBZ
cord-005453-4057qib7	15656	12	with	with	IN
cord-005453-4057qib7	15656	13	a	a	DT
cord-005453-4057qib7	15656	14	tendency	tendency	NN
cord-005453-4057qib7	15656	15	toward	toward	IN
cord-005453-4057qib7	15656	16	femininity	femininity	NN
cord-005453-4057qib7	15656	17	.	.	.
cord-005453-4057qib7	15657	1	On	on	IN
cord-005453-4057qib7	15657	2	average	average	JJ
cord-005453-4057qib7	15657	3	,	,	,
cord-005453-4057qib7	15657	4	adolescents	adolescent	NNS
cord-005453-4057qib7	15657	5	see	see	VBP
cord-005453-4057qib7	15657	6	themselves	-PRON-	PRP
cord-005453-4057qib7	15657	7	as	as	IN
cord-005453-4057qib7	15657	8	a	a	DT
cord-005453-4057qib7	15657	9	bit	bit	NN
cord-005453-4057qib7	15657	10	more	more	RBR
cord-005453-4057qib7	15657	11	courageous	courageous	JJ
cord-005453-4057qib7	15657	12	than	than	IN
cord-005453-4057qib7	15657	13	their	-PRON-	PRP$
cord-005453-4057qib7	15657	14	mothers	mother	NNS
cord-005453-4057qib7	15657	15	,	,	,
cord-005453-4057qib7	15657	16	with	with	IN
cord-005453-4057qib7	15657	17	rare	rare	JJ
cord-005453-4057qib7	15657	18	exceptions	exception	NNS
cord-005453-4057qib7	15657	19	,	,	,
cord-005453-4057qib7	15657	20	regardless	regardless	RB
cord-005453-4057qib7	15657	21	of	of	IN
cord-005453-4057qib7	15657	22	gender	gender	NN
cord-005453-4057qib7	15657	23	.	.	.
cord-005453-4057qib7	15658	1	This	this	DT
cord-005453-4057qib7	15658	2	confirms	confirm	VBZ
cord-005453-4057qib7	15658	3	the	the	DT
cord-005453-4057qib7	15658	4	thesis	thesis	NN
cord-005453-4057qib7	15658	5	that	that	IN
cord-005453-4057qib7	15658	6	we	-PRON-	PRP
cord-005453-4057qib7	15658	7	received	receive	VBD
cord-005453-4057qib7	15658	8	in	in	IN
cord-005453-4057qib7	15658	9	a	a	DT
cord-005453-4057qib7	15658	10	previous	previous	JJ
cord-005453-4057qib7	15658	11	study	study	NN
cord-005453-4057qib7	15658	12	that	that	IN
cord-005453-4057qib7	15658	13	parents	parent	NNS
cord-005453-4057qib7	15658	14	tend	tend	VBP
cord-005453-4057qib7	15658	15	to	to	TO
cord-005453-4057qib7	15658	16	see	see	VB
cord-005453-4057qib7	15658	17	and	and	CC
cord-005453-4057qib7	15658	18	encourage	encourage	VB
cord-005453-4057qib7	15658	19	complacency	complacency	NN
cord-005453-4057qib7	15658	20	of	of	IN
cord-005453-4057qib7	15658	21	adolescents	adolescent	NNS
cord-005453-4057qib7	15658	22	of	of	IN
cord-005453-4057qib7	15658	23	both	both	DT
cord-005453-4057qib7	15658	24	sexes	sex	NNS
cord-005453-4057qib7	15658	25	,	,	,
cord-005453-4057qib7	15658	26	passivity	passivity	NN
cord-005453-4057qib7	15658	27	instead	instead	RB
cord-005453-4057qib7	15658	28	of	of	IN
cord-005453-4057qib7	15658	29	leadership	leadership	NN
cord-005453-4057qib7	15658	30	,	,	,
cord-005453-4057qib7	15658	31	dedication	dedication	NN
cord-005453-4057qib7	15658	32	and	and	CC
cord-005453-4057qib7	15658	33	independence	independence	NN
cord-005453-4057qib7	15658	34	.	.	.
cord-005453-4057qib7	15659	1	All	all	DT
cord-005453-4057qib7	15659	2	100	100	CD
cord-005453-4057qib7	15659	3	%	%	NN
cord-005453-4057qib7	15659	4	of	of	IN
cord-005453-4057qib7	15659	5	adolescents	adolescent	NNS
cord-005453-4057qib7	15659	6	who	who	WP
cord-005453-4057qib7	15659	7	participated	participate	VBD
cord-005453-4057qib7	15659	8	in	in	IN
cord-005453-4057qib7	15659	9	the	the	DT
cord-005453-4057qib7	15659	10	test	test	NN
cord-005453-4057qib7	15659	11	demonstrate	demonstrate	VBP
cord-005453-4057qib7	15659	12	a	a	DT
cord-005453-4057qib7	15659	13	shift	shift	NN
cord-005453-4057qib7	15659	14	in	in	IN
cord-005453-4057qib7	15659	15	the	the	DT
cord-005453-4057qib7	15659	16	theme	theme	NN
cord-005453-4057qib7	15659	17	of	of	IN
cord-005453-4057qib7	15659	18	aggression	aggression	NN
cord-005453-4057qib7	15659	19	,	,	,
cord-005453-4057qib7	15659	20	77	77	CD
cord-005453-4057qib7	15659	21	%	%	NN
cord-005453-4057qib7	15659	22	have	have	VBP
cord-005453-4057qib7	15659	23	some	some	DT
cord-005453-4057qib7	15659	24	signs	sign	NNS
cord-005453-4057qib7	15659	25	of	of	IN
cord-005453-4057qib7	15659	26	preventing	prevent	VBG
cord-005453-4057qib7	15659	27	sexual	sexual	JJ
cord-005453-4057qib7	15659	28	self	self	NN
cord-005453-4057qib7	15659	29	-	-	HYPH
cord-005453-4057qib7	15659	30	determination	determination	NN
cord-005453-4057qib7	15659	31	,	,	,
cord-005453-4057qib7	15659	32	abandoning	abandon	VBG
cord-005453-4057qib7	15659	33	their	-PRON-	PRP$
cord-005453-4057qib7	15659	34	body	body	NN
cord-005453-4057qib7	15659	35	,	,	,
cord-005453-4057qib7	15659	36	gender	gender	NN
cord-005453-4057qib7	15659	37	,	,	,
cord-005453-4057qib7	15659	38	and	and	CC
cord-005453-4057qib7	15659	39	age	age	NN
cord-005453-4057qib7	15659	40	.	.	.
cord-005453-4057qib7	15660	1	88	88	CD
cord-005453-4057qib7	15660	2	%	%	NN
cord-005453-4057qib7	15660	3	of	of	IN
cord-005453-4057qib7	15660	4	patients	patient	NNS
cord-005453-4057qib7	15660	5	do	do	VBP
cord-005453-4057qib7	15660	6	not	not	RB
cord-005453-4057qib7	15660	7	communicate	communicate	VB
cord-005453-4057qib7	15660	8	with	with	IN
cord-005453-4057qib7	15660	9	their	-PRON-	PRP$
cord-005453-4057qib7	15660	10	peers	peer	NNS
cord-005453-4057qib7	15660	11	.	.	.
cord-005453-4057qib7	15661	1	In	in	IN
cord-005453-4057qib7	15661	2	47	47	CD
cord-005453-4057qib7	15661	3	%	%	NN
cord-005453-4057qib7	15661	4	of	of	IN
cord-005453-4057qib7	15661	5	them	-PRON-	PRP
cord-005453-4057qib7	15661	6	,	,	,
cord-005453-4057qib7	15661	7	negative	negative	JJ
cord-005453-4057qib7	15661	8	emotions	emotion	NNS
cord-005453-4057qib7	15661	9	prevail	prevail	VBP
cord-005453-4057qib7	15661	10	over	over	IN
cord-005453-4057qib7	15661	11	positive	positive	JJ
cord-005453-4057qib7	15661	12	ones	one	NNS
cord-005453-4057qib7	15661	13	.	.	.
cord-005453-4057qib7	15662	1	One	one	CD
cord-005453-4057qib7	15662	2	third	third	NN
cord-005453-4057qib7	15662	3	of	of	IN
cord-005453-4057qib7	15662	4	the	the	DT
cord-005453-4057qib7	15662	5	test	test	NN
cord-005453-4057qib7	15662	6	participants	participant	NNS
cord-005453-4057qib7	15662	7	demonstrate	demonstrate	VBP
cord-005453-4057qib7	15662	8	strong	strong	JJ
cord-005453-4057qib7	15662	9	support	support	NN
cord-005453-4057qib7	15662	10	for	for	IN
cord-005453-4057qib7	15662	11	rest	rest	NN
cord-005453-4057qib7	15662	12	and	and	CC
cord-005453-4057qib7	15662	13	minimizing	minimize	VBG
cord-005453-4057qib7	15662	14	their	-PRON-	PRP$
cord-005453-4057qib7	15662	15	efforts	effort	NNS
cord-005453-4057qib7	15662	16	.	.	.
cord-005453-4057qib7	15663	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15663	2	:	:	:
cord-005453-4057qib7	15664	1	The	the	DT
cord-005453-4057qib7	15664	2	characteristics	characteristic	NNS
cord-005453-4057qib7	15664	3	of	of	IN
cord-005453-4057qib7	15664	4	family	family	NN
cord-005453-4057qib7	15664	5	upbringing	upbringing	NN
cord-005453-4057qib7	15664	6	of	of	IN
cord-005453-4057qib7	15664	7	adolescents	adolescent	NNS
cord-005453-4057qib7	15664	8	who	who	WP
cord-005453-4057qib7	15664	9	have	have	VBP
cord-005453-4057qib7	15664	10	undergone	undergo	VBN
cord-005453-4057qib7	15664	11	HSCT	HSCT	NNP
cord-005453-4057qib7	15664	12	often	often	RB
cord-005453-4057qib7	15664	13	contribute	contribute	VBP
cord-005453-4057qib7	15664	14	significantly	significantly	RB
cord-005453-4057qib7	15664	15	to	to	IN
cord-005453-4057qib7	15664	16	limiting	limit	VBG
cord-005453-4057qib7	15664	17	their	-PRON-	PRP$
cord-005453-4057qib7	15664	18	social	social	JJ
cord-005453-4057qib7	15664	19	experience	experience	NN
cord-005453-4057qib7	15664	20	and	and	CC
cord-005453-4057qib7	15664	21	lead	lead	VB
cord-005453-4057qib7	15664	22	to	to	IN
cord-005453-4057qib7	15664	23	specific	specific	JJ
cord-005453-4057qib7	15664	24	deformities	deformity	NNS
cord-005453-4057qib7	15664	25	of	of	IN
cord-005453-4057qib7	15664	26	individuality	individuality	NN
cord-005453-4057qib7	15664	27	,	,	,
cord-005453-4057qib7	15664	28	including	include	VBG
cord-005453-4057qib7	15664	29	in	in	IN
cord-005453-4057qib7	15664	30	the	the	DT
cord-005453-4057qib7	15664	31	sphere	sphere	NN
cord-005453-4057qib7	15664	32	of	of	IN
cord-005453-4057qib7	15664	33	gender	gender	NN
cord-005453-4057qib7	15664	34	identity	identity	NN
cord-005453-4057qib7	15664	35	.	.	.
cord-005453-4057qib7	15665	1	We	-PRON-	PRP
cord-005453-4057qib7	15665	2	consider	consider	VBP
cord-005453-4057qib7	15665	3	advisable	advisable	JJ
cord-005453-4057qib7	15665	4	to	to	TO
cord-005453-4057qib7	15665	5	introduce	introduce	VB
cord-005453-4057qib7	15665	6	thematic	thematic	JJ
cord-005453-4057qib7	15665	7	group	group	NN
cord-005453-4057qib7	15665	8	counseling	counseling	NN
cord-005453-4057qib7	15665	9	of	of	IN
cord-005453-4057qib7	15665	10	parents	parent	NNS
cord-005453-4057qib7	15665	11	within	within	IN
cord-005453-4057qib7	15665	12	the	the	DT
cord-005453-4057qib7	15665	13	framework	framework	NN
cord-005453-4057qib7	15665	14	of	of	IN
cord-005453-4057qib7	15665	15	the	the	DT
cord-005453-4057qib7	15665	16	"	"	``
cord-005453-4057qib7	15665	17	Patient	Patient	NNP
cord-005453-4057qib7	15665	18	's	's	POS
cord-005453-4057qib7	15665	19	School	School	NNP
cord-005453-4057qib7	15665	20	"	"	''
cord-005453-4057qib7	15665	21	in	in	IN
cord-005453-4057qib7	15665	22	psychological	psychological	JJ
cord-005453-4057qib7	15665	23	treatment	treatment	NN
cord-005453-4057qib7	15665	24	support	support	NN
cord-005453-4057qib7	15665	25	in	in	IN
cord-005453-4057qib7	15665	26	the	the	DT
cord-005453-4057qib7	15665	27	clinic	clinic	NN
cord-005453-4057qib7	15665	28	.	.	.
cord-005453-4057qib7	15666	1	Early	early	JJ
cord-005453-4057qib7	15666	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	15666	3	of	of	IN
cord-005453-4057qib7	15666	4	the	the	DT
cord-005453-4057qib7	15666	5	personal	personal	JJ
cord-005453-4057qib7	15666	6	aspects	aspect	NNS
cord-005453-4057qib7	15666	7	of	of	IN
cord-005453-4057qib7	15666	8	the	the	DT
cord-005453-4057qib7	15666	9	psychosexual	psychosexual	JJ
cord-005453-4057qib7	15666	10	development	development	NN
cord-005453-4057qib7	15666	11	of	of	IN
cord-005453-4057qib7	15666	12	adolescents	adolescent	NNS
cord-005453-4057qib7	15666	13	after	after	IN
cord-005453-4057qib7	15666	14	HSCT	HSCT	NNP
cord-005453-4057qib7	15666	15	allows	allow	VBZ
cord-005453-4057qib7	15666	16	for	for	IN
cord-005453-4057qib7	15666	17	timely	timely	JJ
cord-005453-4057qib7	15666	18	identification	identification	NN
cord-005453-4057qib7	15666	19	of	of	IN
cord-005453-4057qib7	15666	20	individual	individual	JJ
cord-005453-4057qib7	15666	21	problems	problem	NNS
cord-005453-4057qib7	15666	22	in	in	IN
cord-005453-4057qib7	15666	23	this	this	DT
cord-005453-4057qib7	15666	24	area	area	NN
cord-005453-4057qib7	15666	25	and	and	CC
cord-005453-4057qib7	15666	26	identification	identification	NN
cord-005453-4057qib7	15666	27	of	of	IN
cord-005453-4057qib7	15666	28	general	general	JJ
cord-005453-4057qib7	15666	29	trends	trend	NNS
cord-005453-4057qib7	15666	30	in	in	IN
cord-005453-4057qib7	15666	31	the	the	DT
cord-005453-4057qib7	15666	32	long	long	JJ
cord-005453-4057qib7	15666	33	term	term	NN
cord-005453-4057qib7	15666	34	after	after	IN
cord-005453-4057qib7	15666	35	HSCT.Disclosure	hsct.disclosure	CD
cord-005453-4057qib7	15666	36	:	:	:
cord-005453-4057qib7	15667	1	All	all	DT
cord-005453-4057qib7	15667	2	authors	author	NNS
cord-005453-4057qib7	15667	3	-nothing	-nothe	VBG
cord-005453-4057qib7	15667	4	to	to	TO
cord-005453-4057qib7	15667	5	disclose	disclose	VB
cord-005453-4057qib7	15667	6	.	.	.
cord-005453-4057qib7	15668	1	Abnormalities	abnormality	NNS
cord-005453-4057qib7	15668	2	in	in	IN
cord-005453-4057qib7	15668	3	the	the	DT
cord-005453-4057qib7	15668	4	morphology	morphology	NN
cord-005453-4057qib7	15668	5	of	of	IN
cord-005453-4057qib7	15668	6	the	the	DT
cord-005453-4057qib7	15668	7	umbilical	umbilical	JJ
cord-005453-4057qib7	15668	8	cord	cord	NN
cord-005453-4057qib7	15668	9	blood	blood	NN
cord-005453-4057qib7	15668	10	obtained	obtain	VBN
cord-005453-4057qib7	15668	11	at	at	IN
cord-005453-4057qib7	15668	12	delivery	delivery	NN
cord-005453-4057qib7	15668	13	from	from	IN
cord-005453-4057qib7	15668	14	children	child	NNS
cord-005453-4057qib7	15668	15	who	who	WP
cord-005453-4057qib7	15668	16	received	receive	VBD
cord-005453-4057qib7	15668	17	a	a	DT
cord-005453-4057qib7	15668	18	diagnosis	diagnosis	NN
cord-005453-4057qib7	15668	19	of	of	IN
cord-005453-4057qib7	15668	20	cerebral	cerebral	JJ
cord-005453-4057qib7	15668	21	palsy	palsy	NN
cord-005453-4057qib7	15668	22	Maciej	Maciej	NNP
cord-005453-4057qib7	15668	23	Boruczkowski	Boruczkowski	NNP
cord-005453-4057qib7	15668	24	1	1	CD
cord-005453-4057qib7	15668	25	,	,	,
cord-005453-4057qib7	15668	26	Izabela	Izabela	NNP
cord-005453-4057qib7	15668	27	Zdolińska	Zdolińska	NNP
cord-005453-4057qib7	15668	28	-	-	HYPH
cord-005453-4057qib7	15668	29	Malinowska	Malinowska	NNP
cord-005453-4057qib7	15668	30	2	2	CD
cord-005453-4057qib7	15668	31	,	,	,
cord-005453-4057qib7	15668	32	Maciej	Maciej	NNP
cord-005453-4057qib7	15668	33	Rojek	Rojek	NNP
cord-005453-4057qib7	15668	34	2	2	CD
cord-005453-4057qib7	15668	35	,	,	,
cord-005453-4057qib7	15668	36	Dariusz	Dariusz	NNP
cord-005453-4057qib7	15668	37	Boruczkowski	Boruczkowski	NNP
cord-005453-4057qib7	15668	38	2Background	2background	CD
cord-005453-4057qib7	15668	39	:	:	:
cord-005453-4057qib7	15669	1	Embryonal	embryonal	JJ
cord-005453-4057qib7	15669	2	brain	brain	NN
cord-005453-4057qib7	15669	3	tumors	tumor	NNS
cord-005453-4057qib7	15669	4	are	be	VBP
cord-005453-4057qib7	15669	5	the	the	DT
cord-005453-4057qib7	15669	6	most	most	RBS
cord-005453-4057qib7	15669	7	common	common	JJ
cord-005453-4057qib7	15669	8	malignancies	malignancy	NNS
cord-005453-4057qib7	15669	9	in	in	IN
cord-005453-4057qib7	15669	10	infants	infant	NNS
cord-005453-4057qib7	15669	11	less	less	JJR
cord-005453-4057qib7	15669	12	than	than	IN
cord-005453-4057qib7	15669	13	48	48	CD
cord-005453-4057qib7	15669	14	months	month	NNS
cord-005453-4057qib7	15669	15	of	of	IN
cord-005453-4057qib7	15669	16	age	age	NN
cord-005453-4057qib7	15669	17	.	.	.
cord-005453-4057qib7	15670	1	Histologically	Histologically	NNP
cord-005453-4057qib7	15670	2	characterized	characterize	VBN
cord-005453-4057qib7	15670	3	as	as	IN
cord-005453-4057qib7	15670	4	undifferentiated	undifferentiated	JJ
cord-005453-4057qib7	15670	5	small	small	JJ
cord-005453-4057qib7	15670	6	round	round	JJ
cord-005453-4057qib7	15670	7	cell	cell	NN
cord-005453-4057qib7	15670	8	tumors	tumor	NNS
cord-005453-4057qib7	15670	9	,	,	,
cord-005453-4057qib7	15670	10	all	all	DT
cord-005453-4057qib7	15670	11	are	be	VBP
cord-005453-4057qib7	15670	12	similarly	similarly	RB
cord-005453-4057qib7	15670	13	aggressive	aggressive	JJ
cord-005453-4057qib7	15670	14	,	,	,
cord-005453-4057qib7	15670	15	have	have	VBP
cord-005453-4057qib7	15670	16	a	a	DT
cord-005453-4057qib7	15670	17	tendency	tendency	NN
cord-005453-4057qib7	15670	18	to	to	TO
cord-005453-4057qib7	15670	19	disseminate	disseminate	VB
cord-005453-4057qib7	15670	20	throughout	throughout	IN
cord-005453-4057qib7	15670	21	central	central	JJ
cord-005453-4057qib7	15670	22	nervous	nervous	JJ
cord-005453-4057qib7	15670	23	system	system	NN
cord-005453-4057qib7	15670	24	and	and	CC
cord-005453-4057qib7	15670	25	very	very	RB
cord-005453-4057qib7	15670	26	poor	poor	JJ
cord-005453-4057qib7	15670	27	prognosis	prognosis	NN
cord-005453-4057qib7	15670	28	.	.	.
cord-005453-4057qib7	15671	1	We	-PRON-	PRP
cord-005453-4057qib7	15671	2	tried	try	VBD
cord-005453-4057qib7	15671	3	to	to	TO
cord-005453-4057qib7	15671	4	assess	assess	VB
cord-005453-4057qib7	15671	5	the	the	DT
cord-005453-4057qib7	15671	6	effectiveness	effectiveness	NN
cord-005453-4057qib7	15671	7	of	of	IN
cord-005453-4057qib7	15671	8	tandem	tandem	JJ
cord-005453-4057qib7	15671	9	highdose	highdose	NN
cord-005453-4057qib7	15671	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15671	11	(	(	-LRB-
cord-005453-4057qib7	15671	12	HDCT	HDCT	NNP
cord-005453-4057qib7	15671	13	)	)	-RRB-
cord-005453-4057qib7	15671	14	with	with	IN
cord-005453-4057qib7	15671	15	autologous	autologous	JJ
cord-005453-4057qib7	15671	16	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15671	17	stem	stem	NN
cord-005453-4057qib7	15671	18	-	-	HYPH
cord-005453-4057qib7	15671	19	cell	cell	NN
cord-005453-4057qib7	15671	20	transplantation	transplantation	NN
cord-005453-4057qib7	15671	21	(	(	-LRB-
cord-005453-4057qib7	15671	22	auto	auto	NN
cord-005453-4057qib7	15671	23	-	-	HYPH
cord-005453-4057qib7	15671	24	HSCT	HSCT	NNP
cord-005453-4057qib7	15671	25	)	)	-RRB-
cord-005453-4057qib7	15671	26	in	in	IN
cord-005453-4057qib7	15671	27	this	this	DT
cord-005453-4057qib7	15671	28	patient	patient	NN
cord-005453-4057qib7	15671	29	group	group	NN
cord-005453-4057qib7	15671	30	.	.	.
cord-005453-4057qib7	15672	1	Methods	method	NNS
cord-005453-4057qib7	15672	2	:	:	:
cord-005453-4057qib7	15673	1	From	from	IN
cord-005453-4057qib7	15673	2	2010	2010	CD
cord-005453-4057qib7	15673	3	to	to	IN
cord-005453-4057qib7	15673	4	2018	2018	CD
cord-005453-4057qib7	15673	5	,	,	,
cord-005453-4057qib7	15673	6	52	52	CD
cord-005453-4057qib7	15673	7	infants	infant	NNS
cord-005453-4057qib7	15673	8	under	under	IN
cord-005453-4057qib7	15673	9	48	48	CD
cord-005453-4057qib7	15673	10	months	month	NNS
cord-005453-4057qib7	15673	11	with	with	IN
cord-005453-4057qib7	15673	12	different	different	JJ
cord-005453-4057qib7	15673	13	primary	primary	JJ
cord-005453-4057qib7	15673	14	embryonal	embryonal	JJ
cord-005453-4057qib7	15673	15	brain	brain	NN
cord-005453-4057qib7	15673	16	tumors	tumor	NNS
cord-005453-4057qib7	15673	17	such	such	JJ
cord-005453-4057qib7	15673	18	as	as	IN
cord-005453-4057qib7	15673	19	medulloblastoma	medulloblastoma	NNP
cord-005453-4057qib7	15673	20	(	(	-LRB-
cord-005453-4057qib7	15673	21	N=28	N=28	NNP
cord-005453-4057qib7	15673	22	)	)	-RRB-
cord-005453-4057qib7	15673	23	,	,	,
cord-005453-4057qib7	15673	24	different	different	JJ
cord-005453-4057qib7	15673	25	PNET	PNET	NNP
cord-005453-4057qib7	15673	26	NOS	NOS	NNP
cord-005453-4057qib7	15673	27	(	(	-LRB-
cord-005453-4057qib7	15673	28	N=10	N=10	NNP
cord-005453-4057qib7	15673	29	)	)	-RRB-
cord-005453-4057qib7	15673	30	,	,	,
cord-005453-4057qib7	15673	31	pineoblastoma	pineoblastoma	NNP
cord-005453-4057qib7	15673	32	(	(	-LRB-
cord-005453-4057qib7	15673	33	N=3	N=3	NNP
cord-005453-4057qib7	15673	34	)	)	-RRB-
cord-005453-4057qib7	15673	35	,	,	,
cord-005453-4057qib7	15673	36	atypical	atypical	JJ
cord-005453-4057qib7	15673	37	teratoid	teratoid	NN
cord-005453-4057qib7	15673	38	rhabdoid	rhabdoid	NN
cord-005453-4057qib7	15673	39	tumor	tumor	NN
cord-005453-4057qib7	15673	40	(	(	-LRB-
cord-005453-4057qib7	15673	41	N=3	N=3	NNP
cord-005453-4057qib7	15673	42	)	)	-RRB-
cord-005453-4057qib7	15673	43	,	,	,
cord-005453-4057qib7	15673	44	ETMR	ETMR	NNP
cord-005453-4057qib7	15673	45	(	(	-LRB-
cord-005453-4057qib7	15673	46	N=8	N=8	NNP
cord-005453-4057qib7	15673	47	)	)	-RRB-
cord-005453-4057qib7	15673	48	after	after	IN
cord-005453-4057qib7	15673	49	surgical	surgical	JJ
cord-005453-4057qib7	15673	50	resection	resection	NN
cord-005453-4057qib7	15673	51	and	and	CC
cord-005453-4057qib7	15673	52	induction	induction	NN
cord-005453-4057qib7	15674	1	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15674	2	were	be	VBD
cord-005453-4057qib7	15674	3	planned	plan	VBN
cord-005453-4057qib7	15674	4	to	to	TO
cord-005453-4057qib7	15674	5	receive	receive	VB
cord-005453-4057qib7	15674	6	tandem	tandem	JJ
cord-005453-4057qib7	15674	7	HDCT	HDCT	NNP
cord-005453-4057qib7	15674	8	with	with	IN
cord-005453-4057qib7	15674	9	auto	auto	NN
cord-005453-4057qib7	15674	10	-	-	HYPH
cord-005453-4057qib7	15674	11	HSCT	HSCT	NNP
cord-005453-4057qib7	15674	12	.	.	.
cord-005453-4057qib7	15675	1	Nine	nine	CD
cord-005453-4057qib7	15675	2	patients	patient	NNS
cord-005453-4057qib7	15675	3	were	be	VBD
cord-005453-4057qib7	15675	4	conducted	conduct	VBN
cord-005453-4057qib7	15675	5	only	only	RB
cord-005453-4057qib7	15675	6	single	single	JJ
cord-005453-4057qib7	15675	7	transplantation	transplantation	NN
cord-005453-4057qib7	15675	8	because	because	IN
cord-005453-4057qib7	15675	9	of	of	IN
cord-005453-4057qib7	15675	10	the	the	DT
cord-005453-4057qib7	15675	11	development	development	NN
cord-005453-4057qib7	15675	12	of	of	IN
cord-005453-4057qib7	15675	13	lifethreatening	lifethreatening	JJ
cord-005453-4057qib7	15675	14	complications	complication	NNS
cord-005453-4057qib7	15675	15	after	after	IN
cord-005453-4057qib7	15675	16	the	the	DT
cord-005453-4057qib7	15675	17	first	first	JJ
cord-005453-4057qib7	15675	18	HDCT	HDCT	NNP
cord-005453-4057qib7	15675	19	(	(	-LRB-
cord-005453-4057qib7	15675	20	N=4	N=4	NNP
cord-005453-4057qib7	15675	21	)	)	-RRB-
cord-005453-4057qib7	15675	22	or	or	CC
cord-005453-4057qib7	15675	23	the	the	DT
cord-005453-4057qib7	15675	24	emergence	emergence	NN
cord-005453-4057qib7	15675	25	of	of	IN
cord-005453-4057qib7	15675	26	early	early	JJ
cord-005453-4057qib7	15675	27	disease	disease	NN
cord-005453-4057qib7	15675	28	progression	progression	NN
cord-005453-4057qib7	15675	29	(	(	-LRB-
cord-005453-4057qib7	15675	30	N=5	N=5	NNP
cord-005453-4057qib7	15675	31	)	)	-RRB-
cord-005453-4057qib7	15675	32	.	.	.
cord-005453-4057qib7	15676	1	At	at	IN
cord-005453-4057qib7	15676	2	the	the	DT
cord-005453-4057qib7	15676	3	moment	moment	NN
cord-005453-4057qib7	15676	4	of	of	IN
cord-005453-4057qib7	15676	5	HDCT	HDCT	NNP
cord-005453-4057qib7	15676	6	31	31	CD
cord-005453-4057qib7	15676	7	patients	patient	NNS
cord-005453-4057qib7	15676	8	were	be	VBD
cord-005453-4057qib7	15676	9	in	in	IN
cord-005453-4057qib7	15676	10	complete	complete	JJ
cord-005453-4057qib7	15676	11	remission	remission	NN
cord-005453-4057qib7	15676	12	(	(	-LRB-
cord-005453-4057qib7	15676	13	CR	CR	NNP
cord-005453-4057qib7	15676	14	)	)	-RRB-
cord-005453-4057qib7	15676	15	,	,	,
cord-005453-4057qib7	15676	16	20	20	CD
cord-005453-4057qib7	15676	17	patients	patient	NNS
cord-005453-4057qib7	15676	18	were	be	VBD
cord-005453-4057qib7	15676	19	in	in	IN
cord-005453-4057qib7	15676	20	partial	partial	JJ
cord-005453-4057qib7	15676	21	remission	remission	NN
cord-005453-4057qib7	15676	22	(	(	-LRB-
cord-005453-4057qib7	15676	23	PR	PR	NNP
cord-005453-4057qib7	15676	24	)	)	-RRB-
cord-005453-4057qib7	15676	25	and	and	CC
cord-005453-4057qib7	15676	26	1	1	CD
cord-005453-4057qib7	15676	27	patient	patient	NN
cord-005453-4057qib7	15676	28	had	have	VBD
cord-005453-4057qib7	15676	29	stable	stable	JJ
cord-005453-4057qib7	15676	30	disease	disease	NN
cord-005453-4057qib7	15676	31	(	(	-LRB-
cord-005453-4057qib7	15676	32	SD	sd	NN
cord-005453-4057qib7	15676	33	)	)	-RRB-
cord-005453-4057qib7	15676	34	.	.	.
cord-005453-4057qib7	15677	1	The	the	DT
cord-005453-4057qib7	15677	2	conditioning	conditioning	NN
cord-005453-4057qib7	15677	3	regimen	regimen	NN
cord-005453-4057qib7	15677	4	for	for	IN
cord-005453-4057qib7	15677	5	tandem	tandem	JJ
cord-005453-4057qib7	15677	6	auto	auto	NN
cord-005453-4057qib7	15677	7	-	-	HYPH
cord-005453-4057qib7	15677	8	HSCT	HSCT	NNP
cord-005453-4057qib7	15677	9	were	be	VBD
cord-005453-4057qib7	15677	10	:	:	:
cord-005453-4057qib7	15677	11	the	the	DT
cord-005453-4057qib7	15677	12	first	first	JJ
cord-005453-4057qib7	15677	13	HDCT	HDCT	NNP
cord-005453-4057qib7	15677	14	was	be	VBD
cord-005453-4057qib7	15677	15	carboplatin	carboplatin	NNS
cord-005453-4057qib7	15677	16	and	and	CC
cord-005453-4057qib7	15677	17	etoposide	etoposide	VBD
cord-005453-4057qib7	15677	18	,	,	,
cord-005453-4057qib7	15677	19	the	the	DT
cord-005453-4057qib7	15677	20	second	second	JJ
cord-005453-4057qib7	15677	21	was	be	VBD
cord-005453-4057qib7	15677	22	thiotepa	thiotepa	JJ
cord-005453-4057qib7	15677	23	and	and	CC
cord-005453-4057qib7	15677	24	cyclophosphamide	cyclophosphamide	VBD
cord-005453-4057qib7	15677	25	,	,	,
cord-005453-4057qib7	15677	26	both	both	DT
cord-005453-4057qib7	15677	27	with	with	IN
cord-005453-4057qib7	15677	28	intraventricular	intraventricular	NNP
cord-005453-4057qib7	15677	29	methotrexate	methotrexate	NNP
cord-005453-4057qib7	15677	30	.	.	.
cord-005453-4057qib7	15678	1	Results	result	NNS
cord-005453-4057qib7	15678	2	:	:	:
cord-005453-4057qib7	15679	1	The	the	DT
cord-005453-4057qib7	15679	2	median	median	JJ
cord-005453-4057qib7	15679	3	follow	follow	NN
cord-005453-4057qib7	15679	4	-	-	HYPH
cord-005453-4057qib7	15679	5	up	up	NN
cord-005453-4057qib7	15679	6	is	be	VBZ
cord-005453-4057qib7	15679	7	24	24	CD
cord-005453-4057qib7	15679	8	months	month	NNS
cord-005453-4057qib7	15679	9	(	(	-LRB-
cord-005453-4057qib7	15679	10	range	range	NN
cord-005453-4057qib7	15679	11	,	,	,
cord-005453-4057qib7	15679	12	6	6	CD
cord-005453-4057qib7	15679	13	-	-	SYM
cord-005453-4057qib7	15679	14	85	85	CD
cord-005453-4057qib7	15679	15	)	)	-RRB-
cord-005453-4057qib7	15679	16	.	.	.
cord-005453-4057qib7	15680	1	The	the	DT
cord-005453-4057qib7	15680	2	median	median	JJ
cord-005453-4057qib7	15680	3	time	time	NN
cord-005453-4057qib7	15680	4	to	to	IN
cord-005453-4057qib7	15680	5	engraftment	engraftment	NN
cord-005453-4057qib7	15680	6	after	after	IN
cord-005453-4057qib7	15680	7	the	the	DT
cord-005453-4057qib7	15680	8	first	first	JJ
cord-005453-4057qib7	15680	9	auto	auto	NN
cord-005453-4057qib7	15680	10	-	-	HYPH
cord-005453-4057qib7	15680	11	HSCT	HSCT	NNP
cord-005453-4057qib7	15680	12	was	be	VBD
cord-005453-4057qib7	15680	13	Background	background	NN
cord-005453-4057qib7	15680	14	:	:	:
cord-005453-4057qib7	15681	1	A	a	DT
cord-005453-4057qib7	15681	2	series	series	NN
cord-005453-4057qib7	15681	3	of	of	IN
cord-005453-4057qib7	15681	4	findings	finding	NNS
cord-005453-4057qib7	15681	5	suggest	suggest	VBP
cord-005453-4057qib7	15681	6	that	that	IN
cord-005453-4057qib7	15681	7	optimizing	optimize	VBG
cord-005453-4057qib7	15681	8	natural	natural	JJ
cord-005453-4057qib7	15681	9	killer	killer	NN
cord-005453-4057qib7	15681	10	(	(	-LRB-
cord-005453-4057qib7	15681	11	NK	NK	NNP
cord-005453-4057qib7	15681	12	)	)	-RRB-
cord-005453-4057qib7	15681	13	cell	cell	NN
cord-005453-4057qib7	15681	14	reactivity	reactivity	NN
cord-005453-4057qib7	15681	15	could	could	MD
cord-005453-4057qib7	15681	16	further	further	RB
cord-005453-4057qib7	15681	17	improve	improve	VB
cord-005453-4057qib7	15681	18	outcome	outcome	NN
cord-005453-4057qib7	15681	19	after	after	IN
cord-005453-4057qib7	15681	20	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15681	21	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15681	22	cell	cell	NN
cord-005453-4057qib7	15681	23	transplantation	transplantation	NN
cord-005453-4057qib7	15681	24	(	(	-LRB-
cord-005453-4057qib7	15681	25	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15681	26	)	)	-RRB-
cord-005453-4057qib7	15681	27	.	.	.
cord-005453-4057qib7	15682	1	This	this	DT
cord-005453-4057qib7	15682	2	could	could	MD
cord-005453-4057qib7	15682	3	be	be	VB
cord-005453-4057qib7	15682	4	achieved	achieve	VBN
cord-005453-4057qib7	15682	5	by	by	IN
cord-005453-4057qib7	15682	6	killer	killer	NN
cord-005453-4057qib7	15682	7	cell	cell	NN
cord-005453-4057qib7	15682	8	immunoglobulin	immunoglobulin	NN
cord-005453-4057qib7	15682	9	-	-	HYPH
cord-005453-4057qib7	15682	10	like	like	JJ
cord-005453-4057qib7	15682	11	receptor	receptor	NN
cord-005453-4057qib7	15682	12	(	(	-LRB-
cord-005453-4057qib7	15682	13	KIR	KIR	NNP
cord-005453-4057qib7	15682	14	)	)	-RRB-
cord-005453-4057qib7	15682	15	genotype	genotype	NN
cord-005453-4057qib7	15682	16	informed	inform	VBN
cord-005453-4057qib7	15682	17	donor	donor	NN
cord-005453-4057qib7	15682	18	selection	selection	NN
cord-005453-4057qib7	15682	19	.	.	.
cord-005453-4057qib7	15683	1	An	an	DT
cord-005453-4057qib7	15683	2	enhanced	enhanced	JJ
cord-005453-4057qib7	15683	3	Receptor	Receptor	NNP
cord-005453-4057qib7	15683	4	-	-	HYPH
cord-005453-4057qib7	15683	5	Ligand	Ligand	NNP
cord-005453-4057qib7	15683	6	model	model	NN
cord-005453-4057qib7	15683	7	which	which	WDT
cord-005453-4057qib7	15683	8	used	use	VBD
cord-005453-4057qib7	15683	9	KIR2DS1	kir2ds1	CD
cord-005453-4057qib7	15683	10	and	and	CC
cord-005453-4057qib7	15683	11	KIR3DL1	kir3dl1	CD
cord-005453-4057qib7	15683	12	donor	donor	NN
cord-005453-4057qib7	15683	13	genotype	genotype	NN
cord-005453-4057qib7	15683	14	information	information	NN
cord-005453-4057qib7	15683	15	to	to	TO
cord-005453-4057qib7	15683	16	augment	augment	VB
cord-005453-4057qib7	15683	17	NK	NK	NNP
cord-005453-4057qib7	15683	18	cell	cell	NN
cord-005453-4057qib7	15683	19	activation	activation	NN
cord-005453-4057qib7	15683	20	and	and	CC
cord-005453-4057qib7	15683	21	minimize	minimize	VB
cord-005453-4057qib7	15683	22	inhibition	inhibition	NN
cord-005453-4057qib7	15683	23	demonstrated	demonstrate	VBD
cord-005453-4057qib7	15683	24	improved	improved	JJ
cord-005453-4057qib7	15683	25	survival	survival	NN
cord-005453-4057qib7	15683	26	in	in	IN
cord-005453-4057qib7	15683	27	one	one	CD
cord-005453-4057qib7	15683	28	large	large	JJ
cord-005453-4057qib7	15683	29	AML	AML	NNP
cord-005453-4057qib7	15683	30	study	study	NN
cord-005453-4057qib7	15683	31	(	(	-LRB-
cord-005453-4057qib7	15683	32	Boudreau	Boudreau	NNP
cord-005453-4057qib7	15683	33	et	et	NNP
cord-005453-4057qib7	15683	34	al	al	NNP
cord-005453-4057qib7	15683	35	,	,	,
cord-005453-4057qib7	15683	36	JCO	JCO	NNP
cord-005453-4057qib7	15683	37	2017	2017	CD
cord-005453-4057qib7	15683	38	)	)	-RRB-
cord-005453-4057qib7	15683	39	.	.	.
cord-005453-4057qib7	15684	1	Likewise	likewise	RB
cord-005453-4057qib7	15684	2	,	,	,
cord-005453-4057qib7	15684	3	a	a	DT
cord-005453-4057qib7	15684	4	second	second	JJ
cord-005453-4057qib7	15684	5	model	model	NN
cord-005453-4057qib7	15684	6	built	build	VBN
cord-005453-4057qib7	15684	7	on	on	IN
cord-005453-4057qib7	15684	8	the	the	DT
cord-005453-4057qib7	15684	9	classification	classification	NN
cord-005453-4057qib7	15684	10	of	of	IN
cord-005453-4057qib7	15684	11	centromeric	centromeric	NNP
cord-005453-4057qib7	15684	12	and	and	CC
cord-005453-4057qib7	15684	13	telomeric	telomeric	JJ
cord-005453-4057qib7	15684	14	KIR	KIR	NNP
cord-005453-4057qib7	15684	15	haplotype	haplotype	NN
cord-005453-4057qib7	15684	16	motifs	motif	NNS
cord-005453-4057qib7	15684	17	,	,	,
cord-005453-4057qib7	15684	18	also	also	RB
cord-005453-4057qib7	15684	19	predicted	predict	VBD
cord-005453-4057qib7	15684	20	mortality	mortality	NN
cord-005453-4057qib7	15684	21	after	after	IN
cord-005453-4057qib7	15684	22	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15684	23	for	for	IN
cord-005453-4057qib7	15684	24	AML	AML	NNP
cord-005453-4057qib7	15684	25	(	(	-LRB-
cord-005453-4057qib7	15684	26	Cooley	Cooley	NNP
cord-005453-4057qib7	15684	27	et	et	NNP
cord-005453-4057qib7	15684	28	al	al	NNP
cord-005453-4057qib7	15684	29	,	,	,
cord-005453-4057qib7	15684	30	Blood	blood	NN
cord-005453-4057qib7	15684	31	2010	2010	CD
cord-005453-4057qib7	15684	32	)	)	-RRB-
cord-005453-4057qib7	15684	33	.	.	.
cord-005453-4057qib7	15685	1	This	this	DT
cord-005453-4057qib7	15685	2	joint	joint	JJ
cord-005453-4057qib7	15685	3	EBMT	EBMT	NNP
cord-005453-4057qib7	15685	4	and	and	CC
cord-005453-4057qib7	15685	5	CIBMTR	CIBMTR	NNP
cord-005453-4057qib7	15685	6	study	study	NN
cord-005453-4057qib7	15685	7	aimed	aim	VBN
cord-005453-4057qib7	15685	8	at	at	IN
cord-005453-4057qib7	15685	9	validating	validate	VBG
cord-005453-4057qib7	15685	10	the	the	DT
cord-005453-4057qib7	15685	11	two	two	CD
cord-005453-4057qib7	15685	12	approaches	approach	NNS
cord-005453-4057qib7	15685	13	in	in	IN
cord-005453-4057qib7	15685	14	an	an	DT
cord-005453-4057qib7	15685	15	independent	independent	JJ
cord-005453-4057qib7	15685	16	cohort	cohort	NN
cord-005453-4057qib7	15685	17	of	of	IN
cord-005453-4057qib7	15685	18	patients	patient	NNS
cord-005453-4057qib7	15685	19	with	with	IN
cord-005453-4057qib7	15685	20	MDS	MDS	NNP
cord-005453-4057qib7	15685	21	or	or	CC
cord-005453-4057qib7	15685	22	secondary	secondary	JJ
cord-005453-4057qib7	15685	23	AML.Methods	aml.method	NNS
cord-005453-4057qib7	15685	24	:	:	:
cord-005453-4057qib7	15686	1	Donor	donor	NN
cord-005453-4057qib7	15686	2	samples	sample	NNS
cord-005453-4057qib7	15686	3	were	be	VBD
cord-005453-4057qib7	15686	4	retrieved	retrieve	VBN
cord-005453-4057qib7	15686	5	from	from	IN
cord-005453-4057qib7	15686	6	the	the	DT
cord-005453-4057qib7	15686	7	Collaborative	Collaborative	NNP
cord-005453-4057qib7	15686	8	Biobank	Biobank	NNP
cord-005453-4057qib7	15686	9	(	(	-LRB-
cord-005453-4057qib7	15686	10	Dresden	Dresden	NNP
cord-005453-4057qib7	15686	11	,	,	,
cord-005453-4057qib7	15686	12	Germany	Germany	NNP
cord-005453-4057qib7	15686	13	)	)	-RRB-
cord-005453-4057qib7	15686	14	and	and	CC
cord-005453-4057qib7	15686	15	mapped	map	VBN
cord-005453-4057qib7	15686	16	to	to	IN
cord-005453-4057qib7	15686	17	patient	patient	JJ
cord-005453-4057qib7	15686	18	outcome	outcome	NN
cord-005453-4057qib7	15686	19	data	datum	NNS
cord-005453-4057qib7	15686	20	extracted	extract	VBN
cord-005453-4057qib7	15686	21	from	from	IN
cord-005453-4057qib7	15686	22	the	the	DT
cord-005453-4057qib7	15686	23	EBMT	EBMT	NNP
cord-005453-4057qib7	15686	24	and	and	CC
cord-005453-4057qib7	15686	25	CIBMTR	CIBMTR	NNP
cord-005453-4057qib7	15686	26	.	.	.
cord-005453-4057qib7	15687	1	Genotyping	genotype	VBG
cord-005453-4057qib7	15687	2	of	of	IN
cord-005453-4057qib7	15687	3	all	all	DT
cord-005453-4057qib7	15687	4	KIR	KIR	NNP
cord-005453-4057qib7	15687	5	genes	gene	NNS
cord-005453-4057qib7	15687	6	by	by	IN
cord-005453-4057qib7	15687	7	sequencing	sequence	VBG
cord-005453-4057qib7	15687	8	exons	exon	NNS
cord-005453-4057qib7	15687	9	3	3	CD
cord-005453-4057qib7	15687	10	,	,	,
cord-005453-4057qib7	15687	11	4	4	CD
cord-005453-4057qib7	15687	12	,	,	,
cord-005453-4057qib7	15687	13	5	5	CD
cord-005453-4057qib7	15687	14	,	,	,
cord-005453-4057qib7	15687	15	7	7	CD
cord-005453-4057qib7	15687	16	,	,	,
cord-005453-4057qib7	15687	17	8	8	CD
cord-005453-4057qib7	15687	18	,	,	,
cord-005453-4057qib7	15687	19	and	and	CC
cord-005453-4057qib7	15687	20	9	9	CD
cord-005453-4057qib7	15687	21	was	be	VBD
cord-005453-4057qib7	15687	22	performed	perform	VBN
cord-005453-4057qib7	15687	23	by	by	IN
cord-005453-4057qib7	15687	24	high	high	JJ
cord-005453-4057qib7	15687	25	resolution	resolution	NN
cord-005453-4057qib7	15687	26	amplicon	amplicon	NN
cord-005453-4057qib7	15687	27	-	-	HYPH
cord-005453-4057qib7	15687	28	based	base	VBN
cord-005453-4057qib7	15687	29	next	next	JJ
cord-005453-4057qib7	15687	30	generation	generation	NN
cord-005453-4057qib7	15687	31	sequencing	sequencing	NN
cord-005453-4057qib7	15687	32	.	.	.
cord-005453-4057qib7	15688	1	The	the	DT
cord-005453-4057qib7	15688	2	impact	impact	NN
cord-005453-4057qib7	15688	3	of	of	IN
cord-005453-4057qib7	15688	4	the	the	DT
cord-005453-4057qib7	15688	5	classifiers	classifier	NNS
cord-005453-4057qib7	15688	6	on	on	IN
cord-005453-4057qib7	15688	7	time	time	NN
cord-005453-4057qib7	15688	8	-	-	HYPH
cord-005453-4057qib7	15688	9	to	to	IN
cord-005453-4057qib7	15688	10	-	-	HYPH
cord-005453-4057qib7	15688	11	event	event	NN
cord-005453-4057qib7	15688	12	outcomes	outcome	NNS
cord-005453-4057qib7	15688	13	was	be	VBD
cord-005453-4057qib7	15688	14	tested	test	VBN
cord-005453-4057qib7	15688	15	in	in	IN
cord-005453-4057qib7	15688	16	cause	cause	NN
cord-005453-4057qib7	15688	17	-	-	HYPH
cord-005453-4057qib7	15688	18	specific	specific	JJ
cord-005453-4057qib7	15688	19	Cox	Cox	NNP
cord-005453-4057qib7	15688	20	regression	regression	NN
cord-005453-4057qib7	15688	21	models	model	NNS
cord-005453-4057qib7	15688	22	adjusted	adjust	VBN
cord-005453-4057qib7	15688	23	for	for	IN
cord-005453-4057qib7	15688	24	patient	patient	JJ
cord-005453-4057qib7	15688	25	age	age	NN
cord-005453-4057qib7	15688	26	,	,	,
cord-005453-4057qib7	15688	27	a	a	DT
cord-005453-4057qib7	15688	28	modified	modify	VBN
cord-005453-4057qib7	15688	29	disease	disease	NN
cord-005453-4057qib7	15688	30	risk	risk	NN
cord-005453-4057qib7	15688	31	index	index	NN
cord-005453-4057qib7	15688	32	,	,	,
cord-005453-4057qib7	15688	33	performance	performance	NN
cord-005453-4057qib7	15688	34	status	status	NN
cord-005453-4057qib7	15688	35	,	,	,
cord-005453-4057qib7	15688	36	donor	donor	NN
cord-005453-4057qib7	15688	37	age	age	NN
cord-005453-4057qib7	15688	38	,	,	,
cord-005453-4057qib7	15688	39	HLA	HLA	NNP
cord-005453-4057qib7	15688	40	-	-	HYPH
cord-005453-4057qib7	15688	41	match	match	NN
cord-005453-4057qib7	15688	42	,	,	,
cord-005453-4057qib7	15688	43	sex	sex	NN
cord-005453-4057qib7	15688	44	match	match	NN
cord-005453-4057qib7	15688	45	,	,	,
cord-005453-4057qib7	15688	46	CMV	CMV	NNP
cord-005453-4057qib7	15688	47	match	match	NN
cord-005453-4057qib7	15688	48	,	,	,
cord-005453-4057qib7	15688	49	conditioning	conditioning	NN
cord-005453-4057qib7	15688	50	intensity	intensity	NN
cord-005453-4057qib7	15688	51	,	,	,
cord-005453-4057qib7	15688	52	type	type	NN
cord-005453-4057qib7	15688	53	of	of	IN
cord-005453-4057qib7	15688	54	T	t	NN
cord-005453-4057qib7	15688	55	-	-	HYPH
cord-005453-4057qib7	15688	56	cell	cell	NN
cord-005453-4057qib7	15688	57	depletion	depletion	NN
cord-005453-4057qib7	15688	58	and	and	CC
cord-005453-4057qib7	15688	59	graft	graft	NN
cord-005453-4057qib7	15688	60	type	type	NN
cord-005453-4057qib7	15688	61	.	.	.
cord-005453-4057qib7	15689	1	Results	result	NNS
cord-005453-4057qib7	15689	2	:	:	:
cord-005453-4057qib7	15690	1	Clinical	clinical	JJ
cord-005453-4057qib7	15690	2	data	datum	NNS
cord-005453-4057qib7	15690	3	from	from	IN
cord-005453-4057qib7	15690	4	1704	1704	CD
cord-005453-4057qib7	15690	5	patients	patient	NNS
cord-005453-4057qib7	15690	6	and	and	CC
cord-005453-4057qib7	15690	7	corresponding	correspond	VBG
cord-005453-4057qib7	15690	8	donor	donor	NN
cord-005453-4057qib7	15690	9	genotype	genotype	NN
cord-005453-4057qib7	15690	10	information	information	NN
cord-005453-4057qib7	15690	11	were	be	VBD
cord-005453-4057qib7	15690	12	analyzed	analyze	VBN
cord-005453-4057qib7	15690	13	.	.	.
cord-005453-4057qib7	15691	1	The	the	DT
cord-005453-4057qib7	15691	2	median	median	JJ
cord-005453-4057qib7	15691	3	age	age	NN
cord-005453-4057qib7	15691	4	at	at	IN
cord-005453-4057qib7	15691	5	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15691	6	was	be	VBD
cord-005453-4057qib7	15691	7	59.4	59.4	CD
cord-005453-4057qib7	15691	8	years	year	NNS
cord-005453-4057qib7	15691	9	(	(	-LRB-
cord-005453-4057qib7	15691	10	range	range	NN
cord-005453-4057qib7	15691	11	,	,	,
cord-005453-4057qib7	15691	12	18.1	18.1	CD
cord-005453-4057qib7	15691	13	to	to	IN
cord-005453-4057qib7	15691	14	79.6	79.6	CD
cord-005453-4057qib7	15691	15	years	year	NNS
cord-005453-4057qib7	15691	16	)	)	-RRB-
cord-005453-4057qib7	15691	17	.	.	.
cord-005453-4057qib7	15692	1	The	the	DT
cord-005453-4057qib7	15692	2	indication	indication	NN
cord-005453-4057qib7	15692	3	for	for	IN
cord-005453-4057qib7	15692	4	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15692	5	was	be	VBD
cord-005453-4057qib7	15692	6	MDS	MDS	NNP
cord-005453-4057qib7	15692	7	for	for	IN
cord-005453-4057qib7	15692	8	72	72	CD
cord-005453-4057qib7	15692	9	%	%	NN
cord-005453-4057qib7	15692	10	and	and	CC
cord-005453-4057qib7	15692	11	sAML	saml	NN
cord-005453-4057qib7	15692	12	for	for	IN
cord-005453-4057qib7	15692	13	28	28	CD
cord-005453-4057qib7	15692	14	%	%	NN
cord-005453-4057qib7	15692	15	of	of	IN
cord-005453-4057qib7	15692	16	patients	patient	NNS
cord-005453-4057qib7	15692	17	.	.	.
cord-005453-4057qib7	15693	1	Disease	Disease	NNP
cord-005453-4057qib7	15693	2	risk	risk	NN
cord-005453-4057qib7	15693	3	was	be	VBD
cord-005453-4057qib7	15693	4	low	low	JJ
cord-005453-4057qib7	15693	5	/	/	SYM
cord-005453-4057qib7	15693	6	intermediate	intermediate	JJ
cord-005453-4057qib7	15693	7	and	and	CC
cord-005453-4057qib7	15693	8	high	high	JJ
cord-005453-4057qib7	15693	9	/	/	,
cord-005453-4057qib7	15693	10	very	very	RB
cord-005453-4057qib7	15693	11	high	high	JJ
cord-005453-4057qib7	15693	12	in	in	IN
cord-005453-4057qib7	15693	13	41	41	CD
cord-005453-4057qib7	15693	14	%	%	NN
cord-005453-4057qib7	15693	15	and	and	CC
cord-005453-4057qib7	15693	16	59	59	CD
cord-005453-4057qib7	15693	17	%	%	NN
cord-005453-4057qib7	15693	18	,	,	,
cord-005453-4057qib7	15693	19	respectively	respectively	RB
cord-005453-4057qib7	15693	20	.	.	.
cord-005453-4057qib7	15694	1	Donors	donor	NNS
cord-005453-4057qib7	15694	2	were	be	VBD
cord-005453-4057qib7	15694	3	10/10	10/10	CD
cord-005453-4057qib7	15694	4	matched	match	VBN
cord-005453-4057qib7	15694	5	for	for	IN
cord-005453-4057qib7	15694	6	79	79	CD
cord-005453-4057qib7	15694	7	%	%	NN
cord-005453-4057qib7	15694	8	of	of	IN
cord-005453-4057qib7	15694	9	patients	patient	NNS
cord-005453-4057qib7	15694	10	.	.	.
cord-005453-4057qib7	15695	1	Myeloablative	Myeloablative	NNP
cord-005453-4057qib7	15695	2	,	,	,
cord-005453-4057qib7	15695	3	reducedintensity	reducedintensity	NN
cord-005453-4057qib7	15695	4	and	and	CC
cord-005453-4057qib7	15695	5	non	non	JJ
cord-005453-4057qib7	15695	6	-	-	JJ
cord-005453-4057qib7	15695	7	myeloablative	myeloablative	JJ
cord-005453-4057qib7	15695	8	conditioning	conditioning	NN
cord-005453-4057qib7	15695	9	regimens	regimen	NNS
cord-005453-4057qib7	15695	10	were	be	VBD
cord-005453-4057qib7	15695	11	used	use	VBN
cord-005453-4057qib7	15695	12	in	in	IN
cord-005453-4057qib7	15695	13	31	31	CD
cord-005453-4057qib7	15695	14	%	%	NN
cord-005453-4057qib7	15695	15	,	,	,
cord-005453-4057qib7	15695	16	57	57	CD
cord-005453-4057qib7	15695	17	%	%	NN
cord-005453-4057qib7	15695	18	,	,	,
cord-005453-4057qib7	15695	19	and	and	CC
cord-005453-4057qib7	15695	20	12	12	CD
cord-005453-4057qib7	15695	21	%	%	NN
cord-005453-4057qib7	15695	22	of	of	IN
cord-005453-4057qib7	15695	23	patients	patient	NNS
cord-005453-4057qib7	15695	24	,	,	,
cord-005453-4057qib7	15695	25	respectively	respectively	RB
cord-005453-4057qib7	15695	26	.	.	.
cord-005453-4057qib7	15696	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	15696	2	blood	blood	NN
cord-005453-4057qib7	15696	3	stem	stem	NN
cord-005453-4057qib7	15696	4	cells	cell	NNS
cord-005453-4057qib7	15696	5	were	be	VBD
cord-005453-4057qib7	15696	6	the	the	DT
cord-005453-4057qib7	15696	7	predominant	predominant	JJ
cord-005453-4057qib7	15696	8	graft	graft	NN
cord-005453-4057qib7	15696	9	source	source	NN
cord-005453-4057qib7	15696	10	(	(	-LRB-
cord-005453-4057qib7	15696	11	93	93	CD
cord-005453-4057qib7	15696	12	%	%	NN
cord-005453-4057qib7	15696	13	of	of	IN
cord-005453-4057qib7	15696	14	patients	patient	NNS
cord-005453-4057qib7	15696	15	)	)	-RRB-
cord-005453-4057qib7	15696	16	.	.	.
cord-005453-4057qib7	15697	1	ATG	ATG	NNP
cord-005453-4057qib7	15697	2	was	be	VBD
cord-005453-4057qib7	15697	3	administered	administer	VBN
cord-005453-4057qib7	15697	4	in	in	IN
cord-005453-4057qib7	15697	5	56	56	CD
cord-005453-4057qib7	15697	6	%	%	NN
cord-005453-4057qib7	15697	7	and	and	CC
cord-005453-4057qib7	15697	8	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	15697	9	in	in	IN
cord-005453-4057qib7	15697	10	9	9	CD
cord-005453-4057qib7	15697	11	%	%	NN
cord-005453-4057qib7	15697	12	of	of	IN
cord-005453-4057qib7	15697	13	patients	patient	NNS
cord-005453-4057qib7	15697	14	.	.	.
cord-005453-4057qib7	15698	1	During	during	IN
cord-005453-4057qib7	15698	2	follow	follow	NN
cord-005453-4057qib7	15698	3	-	-	HYPH
cord-005453-4057qib7	15698	4	up	up	NN
cord-005453-4057qib7	15698	5	after	after	IN
cord-005453-4057qib7	15698	6	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15698	7	776	776	CD
cord-005453-4057qib7	15698	8	patients	patient	NNS
cord-005453-4057qib7	15698	9	died	die	VBD
cord-005453-4057qib7	15698	10	.	.	.
cord-005453-4057qib7	15699	1	In	in	IN
cord-005453-4057qib7	15699	2	univariable	univariable	JJ
cord-005453-4057qib7	15699	3	and	and	CC
cord-005453-4057qib7	15699	4	multivariable	multivariable	JJ
cord-005453-4057qib7	15699	5	analyses	analysis	NNS
cord-005453-4057qib7	15699	6	of	of	IN
cord-005453-4057qib7	15699	7	the	the	DT
cord-005453-4057qib7	15699	8	whole	whole	JJ
cord-005453-4057qib7	15699	9	cohort	cohort	NN
cord-005453-4057qib7	15699	10	,	,	,
cord-005453-4057qib7	15699	11	overall	overall	JJ
cord-005453-4057qib7	15699	12	survival	survival	NN
cord-005453-4057qib7	15699	13	and	and	CC
cord-005453-4057qib7	15699	14	the	the	DT
cord-005453-4057qib7	15699	15	cumulative	cumulative	JJ
cord-005453-4057qib7	15699	16	incidence	incidence	NN
cord-005453-4057qib7	15699	17	of	of	IN
cord-005453-4057qib7	15699	18	relapse	relapse	NN
cord-005453-4057qib7	15699	19	of	of	IN
cord-005453-4057qib7	15699	20	patients	patient	NNS
cord-005453-4057qib7	15699	21	with	with	IN
cord-005453-4057qib7	15699	22	KIRadvantageous	KIRadvantageous	NNP
cord-005453-4057qib7	15699	23	versus	versus	IN
cord-005453-4057qib7	15699	24	disadvantageous	disadvantageous	JJ
cord-005453-4057qib7	15699	25	donors	donor	NNS
cord-005453-4057qib7	15699	26	were	be	VBD
cord-005453-4057qib7	15699	27	not	not	RB
cord-005453-4057qib7	15699	28	statistically	statistically	RB
cord-005453-4057qib7	15699	29	significantly	significantly	RB
cord-005453-4057qib7	15699	30	different	different	JJ
cord-005453-4057qib7	15699	31	.	.	.
cord-005453-4057qib7	15700	1	We	-PRON-	PRP
cord-005453-4057qib7	15700	2	could	could	MD
cord-005453-4057qib7	15700	3	not	not	RB
cord-005453-4057qib7	15700	4	replicate	replicate	VB
cord-005453-4057qib7	15700	5	the	the	DT
cord-005453-4057qib7	15700	6	pattern	pattern	NN
cord-005453-4057qib7	15700	7	of	of	IN
cord-005453-4057qib7	15700	8	outcomes	outcome	NNS
cord-005453-4057qib7	15700	9	predicted	predict	VBN
cord-005453-4057qib7	15700	10	by	by	IN
cord-005453-4057qib7	15700	11	the	the	DT
cord-005453-4057qib7	15700	12	KIR3DL1/	KIR3DL1/	NNP
cord-005453-4057qib7	15700	13	Conclusions	Conclusions	NNPS
cord-005453-4057qib7	15700	14	:	:	:
cord-005453-4057qib7	15701	1	Relapse	relapse	VB
cord-005453-4057qib7	15701	2	incidence	incidence	NN
cord-005453-4057qib7	15701	3	and	and	CC
cord-005453-4057qib7	15701	4	overall	overall	JJ
cord-005453-4057qib7	15701	5	survival	survival	NN
cord-005453-4057qib7	15701	6	after	after	IN
cord-005453-4057qib7	15701	7	unrelated	unrelated	JJ
cord-005453-4057qib7	15701	8	donor	donor	NN
cord-005453-4057qib7	15701	9	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15701	10	could	could	MD
cord-005453-4057qib7	15701	11	not	not	RB
cord-005453-4057qib7	15701	12	be	be	VB
cord-005453-4057qib7	15701	13	predicted	predict	VBN
cord-005453-4057qib7	15701	14	using	use	VBG
cord-005453-4057qib7	15701	15	the	the	DT
cord-005453-4057qib7	15701	16	KIR3DL1	kir3dl1	CD
cord-005453-4057qib7	15701	17	/	/	SYM
cord-005453-4057qib7	15701	18	KIR2DS1-Receptor	KIR2DS1-Receptor	NNP
cord-005453-4057qib7	15701	19	-	-	HYPH
cord-005453-4057qib7	15701	20	Ligand	Ligand	NNP
cord-005453-4057qib7	15701	21	model	model	NN
cord-005453-4057qib7	15701	22	and	and	CC
cord-005453-4057qib7	15701	23	centromeric	centromeric	NN
cord-005453-4057qib7	15701	24	/	/	SYM
cord-005453-4057qib7	15701	25	telomeric	telomeric	JJ
cord-005453-4057qib7	15701	26	KIR	KIR	NNP
cord-005453-4057qib7	15701	27	-	-	HYPH
cord-005453-4057qib7	15701	28	motif	motif	NN
cord-005453-4057qib7	15701	29	model	model	NN
cord-005453-4057qib7	15701	30	in	in	IN
cord-005453-4057qib7	15701	31	this	this	DT
cord-005453-4057qib7	15701	32	large	large	JJ
cord-005453-4057qib7	15701	33	cohort	cohort	NN
cord-005453-4057qib7	15701	34	of	of	IN
cord-005453-4057qib7	15701	35	patients	patient	NNS
cord-005453-4057qib7	15701	36	with	with	IN
cord-005453-4057qib7	15701	37	MDS	MDS	NNP
cord-005453-4057qib7	15701	38	or	or	CC
cord-005453-4057qib7	15701	39	secondary	secondary	JJ
cord-005453-4057qib7	15701	40	AML	AML	NNP
cord-005453-4057qib7	15701	41	.	.	.
cord-005453-4057qib7	15702	1	This	this	DT
cord-005453-4057qib7	15702	2	points	point	VBZ
cord-005453-4057qib7	15702	3	at	at	IN
cord-005453-4057qib7	15702	4	the	the	DT
cord-005453-4057qib7	15702	5	possibility	possibility	NN
cord-005453-4057qib7	15702	6	of	of	IN
cord-005453-4057qib7	15702	7	interactions	interaction	NNS
cord-005453-4057qib7	15702	8	between	between	IN
cord-005453-4057qib7	15702	9	NK	nk	NN
cord-005453-4057qib7	15702	10	-	-	HYPH
cord-005453-4057qib7	15702	11	cell	cell	NN
cord-005453-4057qib7	15702	12	mediated	mediate	VBD
cord-005453-4057qib7	15702	13	alloreactivity	alloreactivity	NN
cord-005453-4057qib7	15702	14	and	and	CC
cord-005453-4057qib7	15702	15	disease	disease	NN
cord-005453-4057qib7	15702	16	type	type	NN
cord-005453-4057qib7	15702	17	or	or	CC
cord-005453-4057qib7	15702	18	procedural	procedural	JJ
cord-005453-4057qib7	15702	19	variations	variation	NNS
cord-005453-4057qib7	15702	20	of	of	IN
cord-005453-4057qib7	15702	21	alloHCT	alloHCT	NNP
cord-005453-4057qib7	15702	22	.	.	.
cord-005453-4057qib7	15703	1	Available	available	JJ
cord-005453-4057qib7	15703	2	information	information	NN
cord-005453-4057qib7	15703	3	on	on	IN
cord-005453-4057qib7	15703	4	KIR	KIR	NNP
cord-005453-4057qib7	15703	5	-	-	HYPH
cord-005453-4057qib7	15703	6	genes	gene	NNS
cord-005453-4057qib7	15703	7	,	,	,
cord-005453-4057qib7	15703	8	which	which	WDT
cord-005453-4057qib7	15703	9	have	have	VBP
cord-005453-4057qib7	15703	10	been	be	VBN
cord-005453-4057qib7	15703	11	sequenced	sequence	VBN
cord-005453-4057qib7	15703	12	but	but	CC
cord-005453-4057qib7	15703	13	not	not	RB
cord-005453-4057qib7	15703	14	yet	yet	RB
cord-005453-4057qib7	15703	15	analysed	analyse	VBN
cord-005453-4057qib7	15703	16	,	,	,
cord-005453-4057qib7	15703	17	will	will	MD
cord-005453-4057qib7	15703	18	be	be	VB
cord-005453-4057qib7	15703	19	investigated	investigate	VBN
cord-005453-4057qib7	15703	20	in	in	IN
cord-005453-4057qib7	15703	21	exploratory	exploratory	JJ
cord-005453-4057qib7	15703	22	analyses	analysis	NNS
cord-005453-4057qib7	15703	23	.	.	.
cord-005453-4057qib7	15704	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15704	2	:	:	:
cord-005453-4057qib7	15705	1	The	the	DT
cord-005453-4057qib7	15705	2	authors	author	NNS
cord-005453-4057qib7	15705	3	have	have	VBP
cord-005453-4057qib7	15705	4	nothing	nothing	NN
cord-005453-4057qib7	15705	5	to	to	TO
cord-005453-4057qib7	15705	6	disclose	disclose	VB
cord-005453-4057qib7	15705	7	In	in	IN
cord-005453-4057qib7	15705	8	the	the	DT
cord-005453-4057qib7	15705	9	absence	absence	NN
cord-005453-4057qib7	15705	10	of	of	IN
cord-005453-4057qib7	15705	11	an	an	DT
cord-005453-4057qib7	15705	12	alternative	alternative	JJ
cord-005453-4057qib7	15705	13	donor	donor	NN
cord-005453-4057qib7	15705	14	,	,	,
cord-005453-4057qib7	15705	15	it	-PRON-	PRP
cord-005453-4057qib7	15705	16	is	be	VBZ
cord-005453-4057qib7	15705	17	recommended	recommend	VBN
cord-005453-4057qib7	15705	18	that	that	IN
cord-005453-4057qib7	15705	19	patients	patient	NNS
cord-005453-4057qib7	15705	20	undergo	undergo	VBP
cord-005453-4057qib7	15705	21	desensitization	desensitization	NN
cord-005453-4057qib7	15705	22	therapy	therapy	NN
cord-005453-4057qib7	15705	23	,	,	,
cord-005453-4057qib7	15705	24	especially	especially	RB
cord-005453-4057qib7	15705	25	with	with	IN
cord-005453-4057qib7	15705	26	high	high	JJ
cord-005453-4057qib7	15705	27	DSA	DSA	NNP
cord-005453-4057qib7	15705	28	levels	level	NNS
cord-005453-4057qib7	15705	29	(	(	-LRB-
cord-005453-4057qib7	15705	30	>	>	NFP
cord-005453-4057qib7	15705	31	5,000	5,000	CD
cord-005453-4057qib7	15705	32	MFI	MFI	NNP
cord-005453-4057qib7	15705	33	)	)	-RRB-
cord-005453-4057qib7	15705	34	.	.	.
cord-005453-4057qib7	15706	1	The	the	DT
cord-005453-4057qib7	15706	2	aim	aim	NN
cord-005453-4057qib7	15706	3	of	of	IN
cord-005453-4057qib7	15706	4	this	this	DT
cord-005453-4057qib7	15706	5	study	study	NN
cord-005453-4057qib7	15706	6	is	be	VBZ
cord-005453-4057qib7	15706	7	to	to	TO
cord-005453-4057qib7	15706	8	analyze	analyze	VB
cord-005453-4057qib7	15706	9	the	the	DT
cord-005453-4057qib7	15706	10	impact	impact	NN
cord-005453-4057qib7	15706	11	of	of	IN
cord-005453-4057qib7	15706	12	DSA	DSA	NNP
cord-005453-4057qib7	15706	13	on	on	IN
cord-005453-4057qib7	15706	14	risk	risk	NN
cord-005453-4057qib7	15706	15	of	of	IN
cord-005453-4057qib7	15706	16	GF	GF	NNP
cord-005453-4057qib7	15706	17	and	and	CC
cord-005453-4057qib7	15706	18	poor	poor	JJ
cord-005453-4057qib7	15706	19	graft	graft	NN
cord-005453-4057qib7	15706	20	function	function	NN
cord-005453-4057qib7	15706	21	(	(	-LRB-
cord-005453-4057qib7	15706	22	PGF	PGF	NNP
cord-005453-4057qib7	15706	23	)	)	-RRB-
cord-005453-4057qib7	15706	24	,	,	,
cord-005453-4057qib7	15706	25	and	and	CC
cord-005453-4057qib7	15706	26	on	on	IN
cord-005453-4057qib7	15706	27	major	major	JJ
cord-005453-4057qib7	15706	28	outcomes	outcome	NNS
cord-005453-4057qib7	15706	29	in	in	IN
cord-005453-4057qib7	15706	30	a	a	DT
cord-005453-4057qib7	15706	31	consecutive	consecutive	JJ
cord-005453-4057qib7	15706	32	cohort	cohort	NN
cord-005453-4057qib7	15706	33	of	of	IN
cord-005453-4057qib7	15706	34	patients	patient	NNS
cord-005453-4057qib7	15706	35	who	who	WP
cord-005453-4057qib7	15706	36	were	be	VBD
cord-005453-4057qib7	15706	37	systematically	systematically	RB
cord-005453-4057qib7	15706	38	screened	screen	VBN
cord-005453-4057qib7	15706	39	for	for	IN
cord-005453-4057qib7	15706	40	DSA	DSA	NNP
cord-005453-4057qib7	15706	41	before	before	IN
cord-005453-4057qib7	15706	42	Haplo	Haplo	NNP
cord-005453-4057qib7	15706	43	-	-	HYPH
cord-005453-4057qib7	15706	44	SCT	SCT	NNP
cord-005453-4057qib7	15706	45	.	.	.
cord-005453-4057qib7	15707	1	Methods	method	NNS
cord-005453-4057qib7	15707	2	:	:	:
cord-005453-4057qib7	15707	3	141	141	CD
cord-005453-4057qib7	15707	4	consecutive	consecutive	JJ
cord-005453-4057qib7	15707	5	patients	patient	NNS
cord-005453-4057qib7	15707	6	were	be	VBD
cord-005453-4057qib7	15707	7	candidates	candidate	NNS
cord-005453-4057qib7	15707	8	for	for	IN
cord-005453-4057qib7	15707	9	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	15707	10	Haplo	Haplo	NNP
cord-005453-4057qib7	15707	11	-	-	HYPH
cord-005453-4057qib7	15707	12	SCT	SCT	NNP
cord-005453-4057qib7	15707	13	with	with	IN
cord-005453-4057qib7	15707	14	post	post	JJ
cord-005453-4057qib7	15707	15	-	-	JJ
cord-005453-4057qib7	15707	16	transplant	transplant	NN
cord-005453-4057qib7	15707	17	Cyclophosphamide	Cyclophosphamide	NNP
cord-005453-4057qib7	15707	18	(	(	-LRB-
cord-005453-4057qib7	15707	19	PT	PT	NNP
cord-005453-4057qib7	15707	20	-	-	HYPH
cord-005453-4057qib7	15707	21	Cy	Cy	NNP
cord-005453-4057qib7	15707	22	)	)	-RRB-
cord-005453-4057qib7	15707	23	at	at	IN
cord-005453-4057qib7	15707	24	our	-PRON-	PRP$
cord-005453-4057qib7	15707	25	center	center	NN
cord-005453-4057qib7	15707	26	from	from	IN
cord-005453-4057qib7	15707	27	January	January	NNP
cord-005453-4057qib7	15707	28	2012	2012	CD
cord-005453-4057qib7	15707	29	to	to	IN
cord-005453-4057qib7	15707	30	January	January	NNP
cord-005453-4057qib7	15707	31	2018	2018	CD
cord-005453-4057qib7	15707	32	and	and	CC
cord-005453-4057qib7	15707	33	135	135	CD
cord-005453-4057qib7	15707	34	were	be	VBD
cord-005453-4057qib7	15707	35	analyzed	analyze	VBN
cord-005453-4057qib7	15707	36	for	for	IN
cord-005453-4057qib7	15707	37	the	the	DT
cord-005453-4057qib7	15707	38	presence	presence	NN
cord-005453-4057qib7	15707	39	of	of	IN
cord-005453-4057qib7	15707	40	HLA	HLA	NNP
cord-005453-4057qib7	15707	41	antibodies	antibody	NNS
cord-005453-4057qib7	15707	42	.	.	.
cord-005453-4057qib7	15708	1	Results	result	NNS
cord-005453-4057qib7	15708	2	:	:	:
cord-005453-4057qib7	15708	3	134	134	CD
cord-005453-4057qib7	15708	4	patients	patient	NNS
cord-005453-4057qib7	15708	5	underwent	undergo	VBD
cord-005453-4057qib7	15708	6	haplo	haplo	NNP
cord-005453-4057qib7	15708	7	-	-	HYPH
cord-005453-4057qib7	15708	8	SCT	SCT	NNP
cord-005453-4057qib7	15708	9	.	.	.
cord-005453-4057qib7	15709	1	HLA	HLA	NNP
cord-005453-4057qib7	15709	2	antibodies	antibody	NNS
cord-005453-4057qib7	15709	3	were	be	VBD
cord-005453-4057qib7	15709	4	detected	detect	VBN
cord-005453-4057qib7	15709	5	in	in	IN
cord-005453-4057qib7	15709	6	40	40	CD
cord-005453-4057qib7	15709	7	patients,19	patients,19	CD
cord-005453-4057qib7	15709	8	of	of	IN
cord-005453-4057qib7	15709	9	them	-PRON-	PRP
cord-005453-4057qib7	15709	10	were	be	VBD
cord-005453-4057qib7	15709	11	DSA	DSA	NNP
cord-005453-4057qib7	15709	12	,	,	,
cord-005453-4057qib7	15709	13	while	while	IN
cord-005453-4057qib7	15709	14	21	21	CD
cord-005453-4057qib7	15709	15	were	be	VBD
cord-005453-4057qib7	15709	16	non	non	JJ
cord-005453-4057qib7	15709	17	-	-	JJ
cord-005453-4057qib7	15709	18	DSA	dsa	JJ
cord-005453-4057qib7	15709	19	(	(	-LRB-
cord-005453-4057qib7	15709	20	NDSA	NDSA	NNP
cord-005453-4057qib7	15709	21	)	)	-RRB-
cord-005453-4057qib7	15709	22	.	.	.
cord-005453-4057qib7	15710	1	10	10	CD
cord-005453-4057qib7	15710	2	patients	patient	NNS
cord-005453-4057qib7	15710	3	out	out	IN
cord-005453-4057qib7	15710	4	of	of	IN
cord-005453-4057qib7	15710	5	19	19	CD
cord-005453-4057qib7	15710	6	with	with	IN
cord-005453-4057qib7	15710	7	DSA	DSA	NNP
cord-005453-4057qib7	15710	8	were	be	VBD
cord-005453-4057qib7	15710	9	transplanted	transplant	VBN
cord-005453-4057qib7	15710	10	using	use	VBG
cord-005453-4057qib7	15710	11	the	the	DT
cord-005453-4057qib7	15710	12	same	same	JJ
cord-005453-4057qib7	15710	13	donor	donor	NN
cord-005453-4057qib7	15710	14	;	;	:
cord-005453-4057qib7	15710	15	2	2	CD
cord-005453-4057qib7	15710	16	underwent	undergo	VBD
cord-005453-4057qib7	15710	17	a	a	DT
cord-005453-4057qib7	15710	18	desensitization	desensitization	NN
cord-005453-4057qib7	15710	19	program	program	NN
cord-005453-4057qib7	15710	20	before	before	IN
cord-005453-4057qib7	15710	21	transplant	transplant	NN
cord-005453-4057qib7	15710	22	.	.	.
cord-005453-4057qib7	15711	1	Background	background	NN
cord-005453-4057qib7	15711	2	:	:	:
cord-005453-4057qib7	15712	1	A	a	DT
cord-005453-4057qib7	15712	2	recent	recent	JJ
cord-005453-4057qib7	15712	3	study	study	NN
cord-005453-4057qib7	15712	4	from	from	IN
cord-005453-4057qib7	15712	5	EBMT	EBMT	NNP
cord-005453-4057qib7	15712	6	comparing	compare	VBG
cord-005453-4057qib7	15712	7	matched	match	VBN
cord-005453-4057qib7	15712	8	sibling	sibling	NN
cord-005453-4057qib7	15712	9	(	(	-LRB-
cord-005453-4057qib7	15712	10	MSD	MSD	NNP
cord-005453-4057qib7	15712	11	)	)	-RRB-
cord-005453-4057qib7	15712	12	versus	versus	IN
cord-005453-4057qib7	15712	13	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15712	14	donors	donor	NNS
cord-005453-4057qib7	15712	15	transplantations	transplantation	NNS
cord-005453-4057qib7	15712	16	,	,	,
cord-005453-4057qib7	15712	17	showed	show	VBD
cord-005453-4057qib7	15712	18	better	well	JJR
cord-005453-4057qib7	15712	19	outcome	outcome	NN
cord-005453-4057qib7	15712	20	with	with	IN
cord-005453-4057qib7	15712	21	MSD	MSD	NNP
cord-005453-4057qib7	15712	22	in	in	IN
cord-005453-4057qib7	15712	23	adult	adult	NN
cord-005453-4057qib7	15712	24	patients	patient	NNS
cord-005453-4057qib7	15712	25	with	with	IN
cord-005453-4057qib7	15712	26	intermediate	intermediate	JJ
cord-005453-4057qib7	15712	27	risk	risk	NN
cord-005453-4057qib7	15712	28	AML	AML	NNP
cord-005453-4057qib7	15712	29	in	in	IN
cord-005453-4057qib7	15712	30	first	first	JJ
cord-005453-4057qib7	15712	31	remission	remission	NN
cord-005453-4057qib7	15712	32	(	(	-LRB-
cord-005453-4057qib7	15712	33	CR1	CR1	NNP
cord-005453-4057qib7	15712	34	)	)	-RRB-
cord-005453-4057qib7	15712	35	.	.	.
cord-005453-4057qib7	15713	1	However	however	RB
cord-005453-4057qib7	15713	2	,	,	,
cord-005453-4057qib7	15713	3	a	a	DT
cord-005453-4057qib7	15713	4	female	female	JJ
cord-005453-4057qib7	15713	5	donor	donor	NN
cord-005453-4057qib7	15713	6	to	to	IN
cord-005453-4057qib7	15713	7	a	a	DT
cord-005453-4057qib7	15713	8	male	male	JJ
cord-005453-4057qib7	15713	9	recipient	recipient	NN
cord-005453-4057qib7	15713	10	transplant	transplant	NN
cord-005453-4057qib7	15713	11	combination	combination	NN
cord-005453-4057qib7	15713	12	is	be	VBZ
cord-005453-4057qib7	15713	13	a	a	DT
cord-005453-4057qib7	15713	14	poor	poor	JJ
cord-005453-4057qib7	15713	15	prognostic	prognostic	JJ
cord-005453-4057qib7	15713	16	factor	factor	NN
cord-005453-4057qib7	15713	17	and	and	CC
cord-005453-4057qib7	15713	18	this	this	DT
cord-005453-4057qib7	15713	19	study	study	NN
cord-005453-4057qib7	15713	20	did	do	VBD
cord-005453-4057qib7	15713	21	not	not	RB
cord-005453-4057qib7	15713	22	address	address	VB
cord-005453-4057qib7	15713	23	the	the	DT
cord-005453-4057qib7	15713	24	question	question	NN
cord-005453-4057qib7	15713	25	whether	whether	IN
cord-005453-4057qib7	15713	26	in	in	IN
cord-005453-4057qib7	15713	27	this	this	DT
cord-005453-4057qib7	15713	28	situation	situation	NN
cord-005453-4057qib7	15713	29	,	,	,
cord-005453-4057qib7	15713	30	a	a	DT
cord-005453-4057qib7	15713	31	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15713	32	donor	donor	NN
cord-005453-4057qib7	15713	33	transplant	transplant	NN
cord-005453-4057qib7	15713	34	might	may	MD
cord-005453-4057qib7	15713	35	do	do	VB
cord-005453-4057qib7	15713	36	better	well	RBR
cord-005453-4057qib7	15713	37	.	.	.
cord-005453-4057qib7	15714	1	The	the	DT
cord-005453-4057qib7	15714	2	present	present	JJ
cord-005453-4057qib7	15714	3	study	study	NN
cord-005453-4057qib7	15714	4	compared	compare	VBD
cord-005453-4057qib7	15714	5	the	the	DT
cord-005453-4057qib7	15714	6	outcomes	outcome	NNS
cord-005453-4057qib7	15714	7	of	of	IN
cord-005453-4057qib7	15714	8	allografted	allografte	VBN
cord-005453-4057qib7	15714	9	male	male	JJ
cord-005453-4057qib7	15714	10	patients	patient	NNS
cord-005453-4057qib7	15714	11	according	accord	VBG
cord-005453-4057qib7	15714	12	to	to	IN
cord-005453-4057qib7	15714	13	whether	whether	IN
cord-005453-4057qib7	15714	14	they	-PRON-	PRP
cord-005453-4057qib7	15714	15	received	receive	VBD
cord-005453-4057qib7	15714	16	stem	stem	NN
cord-005453-4057qib7	15714	17	cells	cell	NNS
cord-005453-4057qib7	15714	18	from	from	IN
cord-005453-4057qib7	15714	19	a	a	DT
cord-005453-4057qib7	15714	20	female	female	JJ
cord-005453-4057qib7	15714	21	MSD	msd	NN
cord-005453-4057qib7	15714	22	or	or	CC
cord-005453-4057qib7	15714	23	a	a	DT
cord-005453-4057qib7	15714	24	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15714	25	donor	donor	NN
cord-005453-4057qib7	15714	26	,	,	,
cord-005453-4057qib7	15714	27	in	in	IN
cord-005453-4057qib7	15714	28	the	the	DT
cord-005453-4057qib7	15714	29	intermediate	intermediate	JJ
cord-005453-4057qib7	15714	30	and	and	CC
cord-005453-4057qib7	15714	31	high	high	JJ
cord-005453-4057qib7	15714	32	risk	risk	NN
cord-005453-4057qib7	15714	33	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	15714	34	groups	group	NNS
cord-005453-4057qib7	15714	35	(	(	-LRB-
cord-005453-4057qib7	15714	36	MRC	MRC	NNP
cord-005453-4057qib7	15714	37	classification).Methods	classification).method	NNS
cord-005453-4057qib7	15714	38	:	:	:
cord-005453-4057qib7	15714	39	The	the	DT
cord-005453-4057qib7	15714	40	study	study	NN
cord-005453-4057qib7	15714	41	included	include	VBD
cord-005453-4057qib7	15714	42	1066	1066	CD
cord-005453-4057qib7	15714	43	male	male	JJ
cord-005453-4057qib7	15714	44	patients	patient	NNS
cord-005453-4057qib7	15714	45	with	with	IN
cord-005453-4057qib7	15714	46	cytogenetics	cytogenetic	NNS
cord-005453-4057qib7	15714	47	transplanted	transplant	VBN
cord-005453-4057qib7	15714	48	between	between	IN
cord-005453-4057qib7	15714	49	January	January	NNP
cord-005453-4057qib7	15714	50	2007	2007	CD
cord-005453-4057qib7	15714	51	and	and	CC
cord-005453-4057qib7	15714	52	June	June	NNP
cord-005453-4057qib7	15714	53	2017	2017	CD
cord-005453-4057qib7	15714	54	and	and	CC
cord-005453-4057qib7	15714	55	reported	report	VBD
cord-005453-4057qib7	15714	56	to	to	IN
cord-005453-4057qib7	15714	57	EBMT	EBMT	NNP
cord-005453-4057qib7	15714	58	.	.	.
cord-005453-4057qib7	15715	1	834	834	CD
cord-005453-4057qib7	15715	2	received	receive	VBD
cord-005453-4057qib7	15715	3	stem	stem	NN
cord-005453-4057qib7	15715	4	cells	cell	NNS
cord-005453-4057qib7	15715	5	from	from	IN
cord-005453-4057qib7	15715	6	a	a	DT
cord-005453-4057qib7	15715	7	MSD	MSD	NNP
cord-005453-4057qib7	15715	8	female	female	JJ
cord-005453-4057qib7	15715	9	donor	donor	NN
cord-005453-4057qib7	15715	10	and	and	CC
cord-005453-4057qib7	15715	11	232	232	CD
cord-005453-4057qib7	15715	12	from	from	IN
cord-005453-4057qib7	15715	13	a	a	DT
cord-005453-4057qib7	15715	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15715	15	donor	donor	NN
cord-005453-4057qib7	15715	16	(	(	-LRB-
cord-005453-4057qib7	15715	17	133	133	CD
cord-005453-4057qib7	15715	18	male	male	NN
cord-005453-4057qib7	15715	19	and	and	CC
cord-005453-4057qib7	15715	20	99	99	CD
cord-005453-4057qib7	15715	21	female	female	NN
cord-005453-4057qib7	15715	22	)	)	-RRB-
cord-005453-4057qib7	15715	23	.	.	.
cord-005453-4057qib7	15716	1	The	the	DT
cord-005453-4057qib7	15716	2	follow	follow	NN
cord-005453-4057qib7	15716	3	up	up	RP
cord-005453-4057qib7	15716	4	was	be	VBD
cord-005453-4057qib7	15716	5	25	25	CD
cord-005453-4057qib7	15716	6	months	month	NNS
cord-005453-4057qib7	15716	7	(	(	-LRB-
cord-005453-4057qib7	15716	8	12	12	CD
cord-005453-4057qib7	15716	9	-	-	SYM
cord-005453-4057qib7	15716	10	62	62	CD
cord-005453-4057qib7	15716	11	)	)	-RRB-
cord-005453-4057qib7	15716	12	.	.	.
cord-005453-4057qib7	15717	1	We	-PRON-	PRP
cord-005453-4057qib7	15717	2	studied	study	VBD
cord-005453-4057qib7	15717	3	separately	separately	RB
cord-005453-4057qib7	15717	4	intermediate	intermediate	JJ
cord-005453-4057qib7	15717	5	and	and	CC
cord-005453-4057qib7	15717	6	high	high	JJ
cord-005453-4057qib7	15717	7	risk	risk	NN
cord-005453-4057qib7	15717	8	patients	patient	NNS
cord-005453-4057qib7	15717	9	.	.	.
cord-005453-4057qib7	15718	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	15718	2	analysis	analysis	NN
cord-005453-4057qib7	15718	3	was	be	VBD
cord-005453-4057qib7	15718	4	adjusted	adjust	VBN
cord-005453-4057qib7	15718	5	on	on	IN
cord-005453-4057qib7	15718	6	factors	factor	NNS
cord-005453-4057qib7	15718	7	differing	differ	VBG
cord-005453-4057qib7	15718	8	significantly	significantly	RB
cord-005453-4057qib7	15718	9	between	between	IN
cord-005453-4057qib7	15718	10	the	the	DT
cord-005453-4057qib7	15718	11	2	2	CD
cord-005453-4057qib7	15718	12	groups	group	NNS
cord-005453-4057qib7	15718	13	.	.	.
cord-005453-4057qib7	15719	1	Results	result	NNS
cord-005453-4057qib7	15719	2	:	:	:
cord-005453-4057qib7	15720	1	1-Intermediate	1-intermediate	CD
cord-005453-4057qib7	15720	2	risk	risk	NN
cord-005453-4057qib7	15720	3	group	group	NN
cord-005453-4057qib7	15720	4	:	:	:
cord-005453-4057qib7	15720	5	638	638	CD
cord-005453-4057qib7	15720	6	male	male	JJ
cord-005453-4057qib7	15720	7	patients	patient	NNS
cord-005453-4057qib7	15720	8	received	receive	VBD
cord-005453-4057qib7	15720	9	a	a	DT
cord-005453-4057qib7	15720	10	female	female	JJ
cord-005453-4057qib7	15720	11	MSD	msd	NN
cord-005453-4057qib7	15720	12	and	and	CC
cord-005453-4057qib7	15720	13	160	160	CD
cord-005453-4057qib7	15720	14	a	a	DT
cord-005453-4057qib7	15720	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15720	16	transplant	transplant	NN
cord-005453-4057qib7	15720	17	.	.	.
cord-005453-4057qib7	15721	1	The	the	DT
cord-005453-4057qib7	15721	2	distribution	distribution	NN
cord-005453-4057qib7	15721	3	of	of	IN
cord-005453-4057qib7	15721	4	group	group	NN
cord-005453-4057qib7	15721	5	characteristics	characteristic	NNS
cord-005453-4057qib7	15721	6	was	be	VBD
cord-005453-4057qib7	15721	7	even	even	RB
cord-005453-4057qib7	15721	8	except	except	IN
cord-005453-4057qib7	15722	1	that	that	IN
cord-005453-4057qib7	15722	2	in	in	IN
cord-005453-4057qib7	15722	3	the	the	DT
cord-005453-4057qib7	15722	4	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15722	5	transplant	transplant	NN
cord-005453-4057qib7	15722	6	group	group	NN
cord-005453-4057qib7	15722	7	,	,	,
cord-005453-4057qib7	15722	8	donors	donor	NNS
cord-005453-4057qib7	15722	9	were	be	VBD
cord-005453-4057qib7	15722	10	younger	young	JJR
cord-005453-4057qib7	15723	1	(	(	-LRB-
cord-005453-4057qib7	15723	2	39	39	CD
cord-005453-4057qib7	15723	3	y	y	NN
cord-005453-4057qib7	15723	4	versus	versus	IN
cord-005453-4057qib7	15723	5	51	51	CD
cord-005453-4057qib7	15723	6	;	;	:
cord-005453-4057qib7	15723	7	p	p	NN
cord-005453-4057qib7	15723	8	<	<	XX
cord-005453-4057qib7	15723	9	0.0001	0.0001	CD
cord-005453-4057qib7	15723	10	)	)	-RRB-
cord-005453-4057qib7	15723	11	,	,	,
cord-005453-4057qib7	15723	12	marrow	marrow	NN
cord-005453-4057qib7	15723	13	was	be	VBD
cord-005453-4057qib7	15723	14	more	more	RBR
cord-005453-4057qib7	15723	15	frequently	frequently	RB
cord-005453-4057qib7	15723	16	used	use	VBN
cord-005453-4057qib7	15723	17	(	(	-LRB-
cord-005453-4057qib7	15723	18	45	45	CD
cord-005453-4057qib7	15723	19	%	%	NN
cord-005453-4057qib7	15723	20	versus	versus	IN
cord-005453-4057qib7	15723	21	17	17	CD
cord-005453-4057qib7	15723	22	%	%	NN
cord-005453-4057qib7	15723	23	,	,	,
cord-005453-4057qib7	15723	24	p	p	NN
cord-005453-4057qib7	15723	25	<	<	XX
cord-005453-4057qib7	15723	26	0.0001	0.0001	CD
cord-005453-4057qib7	15723	27	)	)	-RRB-
cord-005453-4057qib7	15723	28	and	and	CC
cord-005453-4057qib7	15723	29	the	the	DT
cord-005453-4057qib7	15723	30	interval	interval	NN
cord-005453-4057qib7	15723	31	from	from	IN
cord-005453-4057qib7	15723	32	diagnosis	diagnosis	NN
cord-005453-4057qib7	15723	33	to	to	IN
cord-005453-4057qib7	15723	34	transplant	transplant	NN
cord-005453-4057qib7	15723	35	was	be	VBD
cord-005453-4057qib7	15723	36	longer	long	JJR
cord-005453-4057qib7	15723	37	(	(	-LRB-
cord-005453-4057qib7	15723	38	5.4	5.4	CD
cord-005453-4057qib7	15723	39	versus	versus	IN
cord-005453-4057qib7	15723	40	4.5	4.5	CD
cord-005453-4057qib7	15723	41	months	month	NNS
cord-005453-4057qib7	15723	42	,	,	,
cord-005453-4057qib7	15723	43	p	p	NN
cord-005453-4057qib7	15723	44	<	<	XX
cord-005453-4057qib7	15723	45	0.0001	0.0001	CD
cord-005453-4057qib7	15723	46	)	)	-RRB-
cord-005453-4057qib7	15723	47	.	.	.
cord-005453-4057qib7	15724	1	By	by	IN
cord-005453-4057qib7	15724	2	univariate	univariate	JJ
cord-005453-4057qib7	15724	3	analysis	analysis	NN
cord-005453-4057qib7	15724	4	at	at	IN
cord-005453-4057qib7	15724	5	two	two	CD
cord-005453-4057qib7	15724	6	years	year	NNS
cord-005453-4057qib7	15724	7	post	post	NN
cord-005453-4057qib7	15724	8	transplant	transplant	NN
cord-005453-4057qib7	15724	9	,	,	,
cord-005453-4057qib7	15724	10	cumulative	cumulative	JJ
cord-005453-4057qib7	15724	11	incidence	incidence	NN
cord-005453-4057qib7	15724	12	(	(	-LRB-
cord-005453-4057qib7	15724	13	CI	CI	NNP
cord-005453-4057qib7	15724	14	)	)	-RRB-
cord-005453-4057qib7	15724	15	of	of	IN
cord-005453-4057qib7	15724	16	NRM	NRM	NNP
cord-005453-4057qib7	15724	17	post	post	NN
cord-005453-4057qib7	15724	18	haplo	haplo	NN
cord-005453-4057qib7	15724	19	was	be	VBD
cord-005453-4057qib7	15724	20	higher	high	JJR
cord-005453-4057qib7	15724	21	(	(	-LRB-
cord-005453-4057qib7	15724	22	26	26	CD
cord-005453-4057qib7	15724	23	%	%	NN
cord-005453-4057qib7	15724	24	versus	versus	IN
cord-005453-4057qib7	15724	25	15	15	CD
cord-005453-4057qib7	15724	26	%	%	NN
cord-005453-4057qib7	15724	27	,	,	,
cord-005453-4057qib7	15724	28	p=0.002	p=0.002	NNP
cord-005453-4057qib7	15724	29	)	)	-RRB-
cord-005453-4057qib7	15724	30	and	and	CC
cord-005453-4057qib7	15724	31	CI	CI	NNP
cord-005453-4057qib7	15724	32	of	of	IN
cord-005453-4057qib7	15724	33	extensive	extensive	JJ
cord-005453-4057qib7	15724	34	chronic	chronic	JJ
cord-005453-4057qib7	15724	35	GVH	GVH	NNP
cord-005453-4057qib7	15724	36	lower	lower	RBR
cord-005453-4057qib7	15724	37	(	(	-LRB-
cord-005453-4057qib7	15724	38	14	14	CD
cord-005453-4057qib7	15724	39	%	%	NN
cord-005453-4057qib7	15724	40	versus	versus	IN
cord-005453-4057qib7	15724	41	27	27	CD
cord-005453-4057qib7	15724	42	%	%	NN
cord-005453-4057qib7	15724	43	;	;	:
cord-005453-4057qib7	15724	44	p=0.002	p=0.002	NNP
cord-005453-4057qib7	15724	45	)	)	-RRB-
cord-005453-4057qib7	15724	46	.	.	.
cord-005453-4057qib7	15725	1	LFS	LFS	NNP
cord-005453-4057qib7	15725	2	post	post	NN
cord-005453-4057qib7	15725	3	MSD	MSD	NNP
cord-005453-4057qib7	15725	4	and	and	CC
cord-005453-4057qib7	15725	5	post	post	NN
cord-005453-4057qib7	15725	6	haplo	haplo	NNP
cord-005453-4057qib7	15725	7	were	be	VBD
cord-005453-4057qib7	15725	8	64	64	CD
cord-005453-4057qib7	15725	9	%	%	NN
cord-005453-4057qib7	15725	10	and	and	CC
cord-005453-4057qib7	15725	11	51	51	CD
cord-005453-4057qib7	15725	12	%	%	NN
cord-005453-4057qib7	15725	13	(	(	-LRB-
cord-005453-4057qib7	15725	14	p=0.03	p=0.03	NNP
cord-005453-4057qib7	15725	15	)	)	-RRB-
cord-005453-4057qib7	15725	16	,	,	,
cord-005453-4057qib7	15725	17	OS	OS	NNP
cord-005453-4057qib7	15725	18	69	69	CD
cord-005453-4057qib7	15725	19	%	%	NN
cord-005453-4057qib7	15725	20	and	and	CC
cord-005453-4057qib7	15725	21	60	60	CD
cord-005453-4057qib7	15725	22	%	%	NN
cord-005453-4057qib7	15725	23	(	(	-LRB-
cord-005453-4057qib7	15725	24	NS	NS	NNP
cord-005453-4057qib7	15725	25	)	)	-RRB-
cord-005453-4057qib7	15725	26	,	,	,
cord-005453-4057qib7	15725	27	GRFS	GRFS	NNP
cord-005453-4057qib7	15725	28	(	(	-LRB-
cord-005453-4057qib7	15725	29	43	43	CD
cord-005453-4057qib7	15725	30	%	%	NN
cord-005453-4057qib7	15725	31	and	and	CC
cord-005453-4057qib7	15725	32	43	43	CD
cord-005453-4057qib7	15725	33	%	%	NN
cord-005453-4057qib7	15725	34	)	)	-RRB-
cord-005453-4057qib7	15725	35	.	.	.
cord-005453-4057qib7	15726	1	By	by	IN
cord-005453-4057qib7	15726	2	multivariate	multivariate	JJ
cord-005453-4057qib7	15726	3	analyses	analysis	NNS
cord-005453-4057qib7	15726	4	the	the	DT
cord-005453-4057qib7	15726	5	only	only	JJ
cord-005453-4057qib7	15726	6	significant	significant	JJ
cord-005453-4057qib7	15726	7	poor	poor	JJ
cord-005453-4057qib7	15726	8	risk	risk	NN
cord-005453-4057qib7	15726	9	factors	factor	NNS
cord-005453-4057qib7	15726	10	were	be	VBD
cord-005453-4057qib7	15726	11	the	the	DT
cord-005453-4057qib7	15726	12	haplo	haplo	NN
cord-005453-4057qib7	15726	13	-	-	HYPH
cord-005453-4057qib7	15726	14	identical	identical	JJ
cord-005453-4057qib7	15726	15	transplant	transplant	NN
cord-005453-4057qib7	15726	16	for	for	IN
cord-005453-4057qib7	15726	17	NRM	NRM	NNP
cord-005453-4057qib7	15726	18	(	(	-LRB-
cord-005453-4057qib7	15726	19	HR	HR	NNP
cord-005453-4057qib7	15726	20	:	:	:
cord-005453-4057qib7	15726	21	1.7	1.7	CD
cord-005453-4057qib7	15726	22	(	(	-LRB-
cord-005453-4057qib7	15726	23	1.1	1.1	CD
cord-005453-4057qib7	15726	24	-	-	HYPH
cord-005453-4057qib7	15726	25	2	2	CD
cord-005453-4057qib7	15726	26	-	-	SYM
cord-005453-4057qib7	15726	27	61	61	CD
cord-005453-4057qib7	15726	28	)	)	-RRB-
cord-005453-4057qib7	15726	29	)	)	-RRB-
cord-005453-4057qib7	15726	30	and	and	CC
cord-005453-4057qib7	15726	31	the	the	DT
cord-005453-4057qib7	15726	32	patient	patient	JJ
cord-005453-4057qib7	15726	33	age	age	NN
cord-005453-4057qib7	15726	34	for	for	IN
cord-005453-4057qib7	15726	35	OS	OS	NNP
cord-005453-4057qib7	15726	36	(	(	-LRB-
cord-005453-4057qib7	15726	37	HR	hr	NN
cord-005453-4057qib7	15726	38	:	:	:
cord-005453-4057qib7	15726	39	1.15	1.15	CD
cord-005453-4057qib7	15726	40	(	(	-LRB-
cord-005453-4057qib7	15726	41	1.02	1.02	CD
cord-005453-4057qib7	15726	42	-	-	SYM
cord-005453-4057qib7	15726	43	1.28	1.28	CD
cord-005453-4057qib7	15726	44	;	;	:
cord-005453-4057qib7	15726	45	p=0.02	p=0.02	NN
cord-005453-4057qib7	15726	46	)	)	-RRB-
cord-005453-4057qib7	15726	47	.	.	.
cord-005453-4057qib7	15727	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	15727	2	transplantation	transplantation	NN
cord-005453-4057qib7	15727	3	resulted	result	VBD
cord-005453-4057qib7	15727	4	in	in	IN
cord-005453-4057qib7	15727	5	less	less	JJR
cord-005453-4057qib7	15727	6	chronic	chronic	JJ
cord-005453-4057qib7	15727	7	GVHD	GVHD	NNP
cord-005453-4057qib7	15727	8	(	(	-LRB-
cord-005453-4057qib7	15727	9	HR	hr	NN
cord-005453-4057qib7	15727	10	:	:	:
cord-005453-4057qib7	15727	11	0.43	0.43	CD
cord-005453-4057qib7	15727	12	(	(	-LRB-
cord-005453-4057qib7	15727	13	0.29	0.29	CD
cord-005453-4057qib7	15727	14	-	-	SYM
cord-005453-4057qib7	15727	15	0.64	0.64	CD
cord-005453-4057qib7	15727	16	)	)	-RRB-
cord-005453-4057qib7	15727	17	;	;	:
cord-005453-4057qib7	15727	18	p	p	NN
cord-005453-4057qib7	15727	19	<	<	XX
cord-005453-4057qib7	15727	20	10	10	CD
cord-005453-4057qib7	15727	21	-4	-4	CD
cord-005453-4057qib7	15727	22	)	)	-RRB-
cord-005453-4057qib7	15727	23	,	,	,
cord-005453-4057qib7	15727	24	but	but	CC
cord-005453-4057qib7	15727	25	a	a	DT
cord-005453-4057qib7	15727	26	lower	low	JJR
cord-005453-4057qib7	15727	27	LFS	lfs	NN
cord-005453-4057qib7	15727	28	(	(	-LRB-
cord-005453-4057qib7	15727	29	HR	hr	NN
cord-005453-4057qib7	15727	30	:	:	:
cord-005453-4057qib7	15727	31	1.7	1.7	CD
cord-005453-4057qib7	15727	32	(	(	-LRB-
cord-005453-4057qib7	15727	33	1.1	1.1	CD
cord-005453-4057qib7	15727	34	-	-	SYM
cord-005453-4057qib7	15727	35	2.61	2.61	CD
cord-005453-4057qib7	15727	36	)	)	-RRB-
cord-005453-4057qib7	15727	37	;	;	:
cord-005453-4057qib7	15727	38	p=0.04	p=0.04	NNP
cord-005453-4057qib7	15727	39	)	)	-RRB-
cord-005453-4057qib7	15727	40	.	.	.
cord-005453-4057qib7	15728	1	2-High	2-high	CD
cord-005453-4057qib7	15728	2	risk	risk	NN
cord-005453-4057qib7	15728	3	group	group	NN
cord-005453-4057qib7	15728	4	:	:	:
cord-005453-4057qib7	15728	5	196	196	CD
cord-005453-4057qib7	15728	6	male	male	JJ
cord-005453-4057qib7	15728	7	patients	patient	NNS
cord-005453-4057qib7	15728	8	received	receive	VBD
cord-005453-4057qib7	15728	9	a	a	DT
cord-005453-4057qib7	15728	10	female	female	JJ
cord-005453-4057qib7	15728	11	MSD	msd	NN
cord-005453-4057qib7	15728	12	and	and	CC
cord-005453-4057qib7	15728	13	72	72	CD
cord-005453-4057qib7	15728	14	a	a	DT
cord-005453-4057qib7	15728	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15728	16	transplant	transplant	NN
cord-005453-4057qib7	15728	17	.	.	.
cord-005453-4057qib7	15729	1	In	in	IN
cord-005453-4057qib7	15729	2	the	the	DT
cord-005453-4057qib7	15729	3	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15729	4	group	group	NN
cord-005453-4057qib7	15729	5	,	,	,
cord-005453-4057qib7	15729	6	donors	donor	NNS
cord-005453-4057qib7	15729	7	were	be	VBD
cord-005453-4057qib7	15729	8	younger	young	JJR
cord-005453-4057qib7	15729	9	(	(	-LRB-
cord-005453-4057qib7	15729	10	38	38	CD
cord-005453-4057qib7	15729	11	y	y	NN
cord-005453-4057qib7	15729	12	versus	versus	IN
cord-005453-4057qib7	15729	13	54	54	CD
cord-005453-4057qib7	15729	14	;	;	:
cord-005453-4057qib7	15729	15	p	p	NN
cord-005453-4057qib7	15729	16	<	<	XX
cord-005453-4057qib7	15729	17	0.0001	0.0001	CD
cord-005453-4057qib7	15729	18	)	)	-RRB-
cord-005453-4057qib7	15729	19	,	,	,
cord-005453-4057qib7	15729	20	marrow	marrow	NN
cord-005453-4057qib7	15729	21	was	be	VBD
cord-005453-4057qib7	15729	22	more	more	RBR
cord-005453-4057qib7	15729	23	frequently	frequently	RB
cord-005453-4057qib7	15729	24	used	use	VBN
cord-005453-4057qib7	15729	25	(	(	-LRB-
cord-005453-4057qib7	15729	26	42	42	CD
cord-005453-4057qib7	15729	27	%	%	NN
cord-005453-4057qib7	15729	28	versus	versus	IN
cord-005453-4057qib7	15729	29	11	11	CD
cord-005453-4057qib7	15729	30	%	%	NN
cord-005453-4057qib7	15729	31	,	,	,
cord-005453-4057qib7	15729	32	p	p	NN
cord-005453-4057qib7	15729	33	<	<	XX
cord-005453-4057qib7	15729	34	0.0001	0.0001	CD
cord-005453-4057qib7	15729	35	)	)	-RRB-
cord-005453-4057qib7	15729	36	and	and	CC
cord-005453-4057qib7	15729	37	the	the	DT
cord-005453-4057qib7	15729	38	interval	interval	NN
cord-005453-4057qib7	15729	39	from	from	IN
cord-005453-4057qib7	15729	40	diagnosis	diagnosis	NN
cord-005453-4057qib7	15729	41	to	to	IN
cord-005453-4057qib7	15729	42	transplant	transplant	NN
cord-005453-4057qib7	15729	43	was	be	VBD
cord-005453-4057qib7	15729	44	longer	long	JJR
cord-005453-4057qib7	15729	45	(	(	-LRB-
cord-005453-4057qib7	15729	46	5.1	5.1	CD
cord-005453-4057qib7	15729	47	versus	versus	IN
cord-005453-4057qib7	15729	48	4.3	4.3	CD
cord-005453-4057qib7	15729	49	months	month	NNS
cord-005453-4057qib7	15729	50	,	,	,
cord-005453-4057qib7	15729	51	p=	p=	NNP
cord-005453-4057qib7	15729	52	0.003	0.003	CD
cord-005453-4057qib7	15729	53	)	)	-RRB-
cord-005453-4057qib7	15729	54	.	.	.
cord-005453-4057qib7	15730	1	By	by	IN
cord-005453-4057qib7	15730	2	multivariate	multivariate	JJ
cord-005453-4057qib7	15730	3	analysis	analysis	NN
cord-005453-4057qib7	15730	4	,	,	,
cord-005453-4057qib7	15730	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15730	6	transplants	transplant	NNS
cord-005453-4057qib7	15730	7	were	be	VBD
cord-005453-4057qib7	15730	8	associated	associate	VBN
cord-005453-4057qib7	15730	9	with	with	IN
cord-005453-4057qib7	15730	10	a	a	DT
cord-005453-4057qib7	15730	11	lower	low	JJR
cord-005453-4057qib7	15730	12	relapse	relapse	NN
cord-005453-4057qib7	15730	13	incidence	incidence	NN
cord-005453-4057qib7	15730	14	(	(	-LRB-
cord-005453-4057qib7	15730	15	HR	hr	NN
cord-005453-4057qib7	15730	16	:	:	:
cord-005453-4057qib7	15730	17	0,40	0,40	CD
cord-005453-4057qib7	15730	18	(	(	-LRB-
cord-005453-4057qib7	15730	19	0.21	0.21	CD
cord-005453-4057qib7	15730	20	-	-	SYM
cord-005453-4057qib7	15730	21	0.75	0.75	CD
cord-005453-4057qib7	15730	22	;	;	:
cord-005453-4057qib7	15730	23	p	p	NN
cord-005453-4057qib7	15730	24	=	=	SYM
cord-005453-4057qib7	15730	25	0.004),a	0.004),a	CD
cord-005453-4057qib7	15730	26	better	well	JJR
cord-005453-4057qib7	15730	27	LFS	LFS	NNP
cord-005453-4057qib7	15730	28	(	(	-LRB-
cord-005453-4057qib7	15730	29	HR	hr	NN
cord-005453-4057qib7	15730	30	:	:	:
cord-005453-4057qib7	15730	31	0,46	0,46	CD
cord-005453-4057qib7	15730	32	(	(	-LRB-
cord-005453-4057qib7	15730	33	0.28	0.28	CD
cord-005453-4057qib7	15730	34	-	-	HYPH
cord-005453-4057qib7	15730	35	0.77	0.77	CD
cord-005453-4057qib7	15730	36	;	;	.
cord-005453-4057qib7	15731	1	p	p	NN
cord-005453-4057qib7	15731	2	=	=	SYM
cord-005453-4057qib7	15731	3	0.003),OS	0.003),os	CD
cord-005453-4057qib7	15732	1	(	(	-LRB-
cord-005453-4057qib7	15732	2	HR	HR	NNP
cord-005453-4057qib7	15732	3	:	:	:
cord-005453-4057qib7	15732	4	0,43	0,43	CD
cord-005453-4057qib7	15732	5	(	(	-LRB-
cord-005453-4057qib7	15732	6	0.25	0.25	CD
cord-005453-4057qib7	15732	7	-	-	SYM
cord-005453-4057qib7	15732	8	0.75	0.75	CD
cord-005453-4057qib7	15732	9	;	;	:
cord-005453-4057qib7	15732	10	p	p	NN
cord-005453-4057qib7	15732	11	=	=	SYM
cord-005453-4057qib7	15732	12	0.003	0.003	CD
cord-005453-4057qib7	15732	13	)	)	-RRB-
cord-005453-4057qib7	15732	14	,	,	,
cord-005453-4057qib7	15732	15	and	and	CC
cord-005453-4057qib7	15732	16	GRFS	GRFS	NNP
cord-005453-4057qib7	15732	17	(	(	-LRB-
cord-005453-4057qib7	15732	18	HR	hr	NN
cord-005453-4057qib7	15732	19	:	:	:
cord-005453-4057qib7	15732	20	0,53	0,53	CD
cord-005453-4057qib7	15732	21	(	(	-LRB-
cord-005453-4057qib7	15732	22	0.34	0.34	CD
cord-005453-4057qib7	15732	23	-	-	SYM
cord-005453-4057qib7	15732	24	0.84	0.84	CD
cord-005453-4057qib7	15732	25	;	;	:
cord-005453-4057qib7	15732	26	p	p	NN
cord-005453-4057qib7	15732	27	=	=	SYM
cord-005453-4057qib7	15732	28	0.006)(see	0.006)(see	CD
cord-005453-4057qib7	15732	29	figure	figure	NN
cord-005453-4057qib7	15732	30	)	)	-RRB-
cord-005453-4057qib7	15732	31	.	.	.
cord-005453-4057qib7	15733	1	The	the	DT
cord-005453-4057qib7	15733	2	only	only	JJ
cord-005453-4057qib7	15733	3	other	other	JJ
cord-005453-4057qib7	15733	4	significant	significant	JJ
cord-005453-4057qib7	15733	5	prognostic	prognostic	JJ
cord-005453-4057qib7	15733	6	factor	factor	NN
cord-005453-4057qib7	15733	7	was	be	VBD
cord-005453-4057qib7	15733	8	patient	patient	JJ
cord-005453-4057qib7	15733	9	age	age	NN
cord-005453-4057qib7	15733	10	.	.	.
cord-005453-4057qib7	15734	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15734	2	:	:	:
cord-005453-4057qib7	15735	1	This	this	DT
cord-005453-4057qib7	15735	2	study	study	NN
cord-005453-4057qib7	15735	3	shows	show	VBZ
cord-005453-4057qib7	15735	4	that	that	IN
cord-005453-4057qib7	15735	5	in	in	IN
cord-005453-4057qib7	15735	6	a	a	DT
cord-005453-4057qib7	15735	7	male	male	JJ
cord-005453-4057qib7	15735	8	patient	patient	NN
cord-005453-4057qib7	15735	9	with	with	IN
cord-005453-4057qib7	15735	10	intermediate	intermediate	JJ
cord-005453-4057qib7	15735	11	risk	risk	NN
cord-005453-4057qib7	15735	12	AML	AML	NNP
cord-005453-4057qib7	15735	13	,	,	,
cord-005453-4057qib7	15735	14	a	a	DT
cord-005453-4057qib7	15735	15	genoidentical	genoidentical	JJ
cord-005453-4057qib7	15735	16	sister	sister	NN
cord-005453-4057qib7	15735	17	donor	donor	NN
cord-005453-4057qib7	15735	18	remains	remain	VBZ
cord-005453-4057qib7	15735	19	associated	associate	VBN
cord-005453-4057qib7	15735	20	with	with	IN
cord-005453-4057qib7	15735	21	a	a	DT
cord-005453-4057qib7	15735	22	better	well	JJR
cord-005453-4057qib7	15735	23	LFS	lfs	NN
cord-005453-4057qib7	15735	24	.	.	.
cord-005453-4057qib7	15736	1	In	in	IN
cord-005453-4057qib7	15736	2	contrast	contrast	NN
cord-005453-4057qib7	15736	3	,	,	,
cord-005453-4057qib7	15736	4	in	in	IN
cord-005453-4057qib7	15736	5	a	a	DT
cord-005453-4057qib7	15736	6	male	male	JJ
cord-005453-4057qib7	15736	7	patient	patient	NN
cord-005453-4057qib7	15736	8	with	with	IN
cord-005453-4057qib7	15736	9	high	high	JJ
cord-005453-4057qib7	15736	10	risk	risk	NN
cord-005453-4057qib7	15736	11	AML	AML	NNP
cord-005453-4057qib7	15736	12	in	in	IN
cord-005453-4057qib7	15736	13	CR1	CR1	NNP
cord-005453-4057qib7	15736	14	,	,	,
cord-005453-4057qib7	15736	15	a	a	DT
cord-005453-4057qib7	15736	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15736	17	donor	donor	NN
cord-005453-4057qib7	15736	18	may	may	MD
cord-005453-4057qib7	15736	19	be	be	VB
cord-005453-4057qib7	15736	20	a	a	DT
cord-005453-4057qib7	15736	21	better	well	JJR
cord-005453-4057qib7	15736	22	choice	choice	NN
cord-005453-4057qib7	15736	23	than	than	IN
cord-005453-4057qib7	15736	24	an	an	DT
cord-005453-4057qib7	15736	25	HLA	HLA	NNP
cord-005453-4057qib7	15736	26	genoidentical	genoidentical	JJ
cord-005453-4057qib7	15736	27	sister	sister	NN
cord-005453-4057qib7	15736	28	.	.	.
cord-005453-4057qib7	15737	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15737	2	:	:	:
cord-005453-4057qib7	15737	3	Nothing	nothing	NN
cord-005453-4057qib7	15737	4	to	to	TO
cord-005453-4057qib7	15737	5	declare	declare	VB
cord-005453-4057qib7	15737	6	P663	P663	NNS
cord-005453-4057qib7	15737	7	Abstract	Abstract	NNP
cord-005453-4057qib7	15737	8	already	already	RB
cord-005453-4057qib7	15737	9	published	publish	VBN
cord-005453-4057qib7	15737	10	.	.	.
cord-005453-4057qib7	15738	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15738	2	transplant	transplant	NN
cord-005453-4057qib7	15738	3	for	for	IN
cord-005453-4057qib7	15738	4	older	old	JJR
cord-005453-4057qib7	15738	5	acute	acute	JJ
cord-005453-4057qib7	15738	6	leukemia	leukemia	NN
cord-005453-4057qib7	15738	7	patients	patient	NNS
cord-005453-4057qib7	15738	8	:	:	:
cord-005453-4057qib7	15738	9	Improved	improve	VBN
cord-005453-4057qib7	15738	10	survival	survival	NN
cord-005453-4057qib7	15738	11	with	with	IN
cord-005453-4057qib7	15738	12	offspring	offspre	VBG
cord-005453-4057qib7	15738	13	donor	donor	NN
cord-005453-4057qib7	15738	14	in	in	IN
cord-005453-4057qib7	15738	15	comparison	comparison	NN
cord-005453-4057qib7	15738	16	with	with	IN
cord-005453-4057qib7	15738	17	older	old	JJR
cord-005453-4057qib7	15738	18	-	-	HYPH
cord-005453-4057qib7	15738	19	aged	aged	JJ
cord-005453-4057qib7	15738	20	matched	match	VBN
cord-005453-4057qib7	15738	21	siblingsYu	siblingsyu	CD
cord-005453-4057qib7	15738	22	Wang	Wang	NNP
cord-005453-4057qib7	15738	23	1	1	CD
cord-005453-4057qib7	15739	1	,	,	,
cord-005453-4057qib7	15739	2	Sheng	Sheng	NNP
cord-005453-4057qib7	15739	3	-	-	HYPH
cord-005453-4057qib7	15739	4	Ye	Ye	NNP
cord-005453-4057qib7	15739	5	Lu	Lu	NNP
cord-005453-4057qib7	15739	6	1	1	CD
cord-005453-4057qib7	15739	7	,	,	,
cord-005453-4057qib7	15739	8	Qi	Qi	NNP
cord-005453-4057qib7	15739	9	-	-	HYPH
cord-005453-4057qib7	15739	10	Fa	Fa	NNP
cord-005453-4057qib7	15739	11	Liu	Liu	NNP
cord-005453-4057qib7	15739	12	2	2	CD
cord-005453-4057qib7	15739	13	,	,	,
cord-005453-4057qib7	15740	1	De	De	NNP
cord-005453-4057qib7	15740	2	-	-	HYPH
cord-005453-4057qib7	15740	3	Pei	Pei	NNP
cord-005453-4057qib7	15740	4	Wu	Wu	NNP
cord-005453-4057qib7	15740	5	3	3	CD
cord-005453-4057qib7	15741	1	,	,	,
cord-005453-4057qib7	15741	2	Xiao	Xiao	NNP
cord-005453-4057qib7	15741	3	-	-	HYPH
cord-005453-4057qib7	15741	4	Jun	Jun	NNP
cord-005453-4057qib7	15741	5	Huang	Huang	NNP
cord-005453-4057qib7	15741	6	1Background	1Background	NNP
cord-005453-4057qib7	15741	7	:	:	:
cord-005453-4057qib7	15742	1	Post	post	JJ
cord-005453-4057qib7	15742	2	-	-	JJ
cord-005453-4057qib7	15742	3	transplant	transplant	JJ
cord-005453-4057qib7	15742	4	relapse	relapse	NN
cord-005453-4057qib7	15742	5	remains	remain	VBZ
cord-005453-4057qib7	15742	6	the	the	DT
cord-005453-4057qib7	15742	7	major	major	JJ
cord-005453-4057qib7	15742	8	cause	cause	NN
cord-005453-4057qib7	15742	9	of	of	IN
cord-005453-4057qib7	15742	10	death	death	NN
cord-005453-4057qib7	15742	11	of	of	IN
cord-005453-4057qib7	15742	12	treatment	treatment	NN
cord-005453-4057qib7	15742	13	failure	failure	NN
cord-005453-4057qib7	15742	14	.	.	.
cord-005453-4057qib7	15743	1	Therapeutic	therapeutic	JJ
cord-005453-4057qib7	15743	2	options	option	NNS
cord-005453-4057qib7	15743	3	for	for	IN
cord-005453-4057qib7	15743	4	relapse	relapse	NN
cord-005453-4057qib7	15743	5	after	after	IN
cord-005453-4057qib7	15743	6	first	first	JJ
cord-005453-4057qib7	15743	7	allogeneic	allogeneic	NN
cord-005453-4057qib7	15743	8	stem	stem	NN
cord-005453-4057qib7	15743	9	cell	cell	NN
cord-005453-4057qib7	15743	10	transplant	transplant	NN
cord-005453-4057qib7	15743	11	(	(	-LRB-
cord-005453-4057qib7	15743	12	1st	1st	JJ
cord-005453-4057qib7	15743	13	HSCT	HSCT	NNP
cord-005453-4057qib7	15743	14	)	)	-RRB-
cord-005453-4057qib7	15743	15	include	include	VBP
cord-005453-4057qib7	15743	16	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15743	17	followed	follow	VBN
cord-005453-4057qib7	15743	18	by	by	IN
cord-005453-4057qib7	15743	19	donor	donor	NN
cord-005453-4057qib7	15743	20	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	15743	21	infusion	infusion	NN
cord-005453-4057qib7	15743	22	or	or	CC
cord-005453-4057qib7	15743	23	second	second	JJ
cord-005453-4057qib7	15743	24	allo	allo	NN
cord-005453-4057qib7	15743	25	-	-	HYPH
cord-005453-4057qib7	15743	26	HSCT	HSCT	NNP
cord-005453-4057qib7	15743	27	(	(	-LRB-
cord-005453-4057qib7	15743	28	2nd	2nd	JJ
cord-005453-4057qib7	15743	29	HSCT	HSCT	NNP
cord-005453-4057qib7	15743	30	)	)	-RRB-
cord-005453-4057qib7	15743	31	from	from	IN
cord-005453-4057qib7	15743	32	the	the	DT
cord-005453-4057qib7	15743	33	original	original	JJ
cord-005453-4057qib7	15743	34	donor	donor	NN
cord-005453-4057qib7	15743	35	or	or	CC
cord-005453-4057qib7	15743	36	change	change	NN
cord-005453-4057qib7	15743	37	to	to	IN
cord-005453-4057qib7	15743	38	another	another	DT
cord-005453-4057qib7	15743	39	donor	donor	NN
cord-005453-4057qib7	15743	40	.	.	.
cord-005453-4057qib7	15744	1	However	however	RB
cord-005453-4057qib7	15744	2	,	,	,
cord-005453-4057qib7	15744	3	there	there	EX
cord-005453-4057qib7	15744	4	is	be	VBZ
cord-005453-4057qib7	15744	5	unclear	unclear	JJ
cord-005453-4057qib7	15744	6	outcome	outcome	NN
cord-005453-4057qib7	15744	7	for	for	IN
cord-005453-4057qib7	15744	8	different	different	JJ
cord-005453-4057qib7	15744	9	treatment	treatment	NN
cord-005453-4057qib7	15744	10	approach	approach	NN
cord-005453-4057qib7	15744	11	.	.	.
cord-005453-4057qib7	15745	1	In	in	IN
cord-005453-4057qib7	15745	2	this	this	DT
cord-005453-4057qib7	15745	3	retrospective	retrospective	JJ
cord-005453-4057qib7	15745	4	cohort	cohort	NN
cord-005453-4057qib7	15745	5	study	study	NN
cord-005453-4057qib7	15745	6	,	,	,
cord-005453-4057qib7	15745	7	we	-PRON-	PRP
cord-005453-4057qib7	15745	8	aim	aim	VBP
cord-005453-4057qib7	15745	9	to	to	TO
cord-005453-4057qib7	15745	10	compare	compare	VB
cord-005453-4057qib7	15745	11	the	the	DT
cord-005453-4057qib7	15745	12	clinical	clinical	JJ
cord-005453-4057qib7	15745	13	outcome	outcome	NN
cord-005453-4057qib7	15745	14	after	after	IN
cord-005453-4057qib7	15745	15	different	different	JJ
cord-005453-4057qib7	15745	16	treatment	treatment	NN
cord-005453-4057qib7	15745	17	strategy	strategy	NN
cord-005453-4057qib7	15745	18	for	for	IN
cord-005453-4057qib7	15745	19	relapse	relapse	NN
cord-005453-4057qib7	15745	20	after	after	IN
cord-005453-4057qib7	15745	21	first	first	JJ
cord-005453-4057qib7	15745	22	Allo	Allo	NNP
cord-005453-4057qib7	15745	23	-	-	HYPH
cord-005453-4057qib7	15745	24	HSCT.Methods	HSCT.Methods	NNP
cord-005453-4057qib7	15745	25	:	:	:
cord-005453-4057qib7	15746	1	Between	between	IN
cord-005453-4057qib7	15746	2	1992	1992	CD
cord-005453-4057qib7	15746	3	Jan	Jan	NNP
cord-005453-4057qib7	15746	4	and	and	CC
cord-005453-4057qib7	15746	5	2018	2018	CD
cord-005453-4057qib7	15747	1	Oct	Oct	NNP
cord-005453-4057qib7	15747	2	,	,	,
cord-005453-4057qib7	15747	3	1493	1493	CD
cord-005453-4057qib7	15747	4	consecutive	consecutive	JJ
cord-005453-4057qib7	15747	5	patients	patient	NNS
cord-005453-4057qib7	15747	6	receiving	receive	VBG
cord-005453-4057qib7	15747	7	1	1	CD
cord-005453-4057qib7	15747	8	st	st	NNP
cord-005453-4057qib7	15747	9	HSCT	HSCT	NNP
cord-005453-4057qib7	15747	10	registered	register	VBD
cord-005453-4057qib7	15747	11	to	to	IN
cord-005453-4057qib7	15747	12	the	the	DT
cord-005453-4057qib7	15747	13	BMT	BMT	NNP
cord-005453-4057qib7	15747	14	database	database	NN
cord-005453-4057qib7	15747	15	in	in	IN
cord-005453-4057qib7	15747	16	National	National	NNP
cord-005453-4057qib7	15747	17	Taiwan	Taiwan	NNP
cord-005453-4057qib7	15747	18	University	University	NNP
cord-005453-4057qib7	15747	19	Hospital	Hospital	NNP
cord-005453-4057qib7	15747	20	were	be	VBD
cord-005453-4057qib7	15747	21	analyzed	analyze	VBN
cord-005453-4057qib7	15747	22	.	.	.
cord-005453-4057qib7	15748	1	Among	among	IN
cord-005453-4057qib7	15748	2	them	-PRON-	PRP
cord-005453-4057qib7	15748	3	,	,	,
cord-005453-4057qib7	15748	4	580	580	CD
cord-005453-4057qib7	15748	5	cases	case	NNS
cord-005453-4057qib7	15748	6	had	have	VBD
cord-005453-4057qib7	15748	7	relapsed	relapse	VBN
cord-005453-4057qib7	15748	8	after	after	IN
cord-005453-4057qib7	15748	9	first	first	JJ
cord-005453-4057qib7	15748	10	Allo	Allo	NNP
cord-005453-4057qib7	15748	11	-	-	HYPH
cord-005453-4057qib7	15748	12	HSCT	HSCT	NNP
cord-005453-4057qib7	15748	13	.	.	.
cord-005453-4057qib7	15749	1	One	one	CD
cord-005453-4057qib7	15749	2	hundred	hundred	CD
cord-005453-4057qib7	15749	3	and	and	CC
cord-005453-4057qib7	15749	4	three	three	CD
cord-005453-4057qib7	15749	5	patients	patient	NNS
cord-005453-4057qib7	15749	6	who	who	WP
cord-005453-4057qib7	15749	7	received	receive	VBD
cord-005453-4057qib7	15749	8	no	no	DT
cord-005453-4057qib7	15749	9	treatment	treatment	NN
cord-005453-4057qib7	15749	10	after	after	IN
cord-005453-4057qib7	15749	11	relapse	relapse	NN
cord-005453-4057qib7	15749	12	or	or	CC
cord-005453-4057qib7	15749	13	with	with	IN
cord-005453-4057qib7	15749	14	incomplete	incomplete	JJ
cord-005453-4057qib7	15749	15	data	datum	NNS
cord-005453-4057qib7	15749	16	were	be	VBD
cord-005453-4057qib7	15749	17	excluded	exclude	VBN
cord-005453-4057qib7	15749	18	.	.	.
cord-005453-4057qib7	15750	1	Their	-PRON-	PRP$
cord-005453-4057qib7	15750	2	transplant	transplant	NN
cord-005453-4057qib7	15750	3	data	datum	NNS
cord-005453-4057qib7	15750	4	was	be	VBD
cord-005453-4057qib7	15750	5	collected	collect	VBN
cord-005453-4057qib7	15750	6	following	follow	VBG
cord-005453-4057qib7	15750	7	the	the	DT
cord-005453-4057qib7	15750	8	EBMT	EBMT	NNP
cord-005453-4057qib7	15750	9	Registry	Registry	NNP
cord-005453-4057qib7	15750	10	data	data	NN
cord-005453-4057qib7	15750	11	collection	collection	NN
cord-005453-4057qib7	15750	12	forms	form	NNS
cord-005453-4057qib7	15750	13	and	and	CC
cord-005453-4057qib7	15750	14	manuals	manual	NNS
cord-005453-4057qib7	15750	15	.	.	.
cord-005453-4057qib7	15751	1	Overall	overall	JJ
cord-005453-4057qib7	15751	2	survival	survival	NN
cord-005453-4057qib7	15751	3	rate	rate	NN
cord-005453-4057qib7	15751	4	and	and	CC
cord-005453-4057qib7	15751	5	progression	progression	NN
cord-005453-4057qib7	15751	6	free	free	JJ
cord-005453-4057qib7	15751	7	survival	survival	NN
cord-005453-4057qib7	15751	8	rate	rate	NN
cord-005453-4057qib7	15751	9	were	be	VBD
cord-005453-4057qib7	15751	10	performed	perform	VBN
cord-005453-4057qib7	15751	11	by	by	IN
cord-005453-4057qib7	15751	12	the	the	DT
cord-005453-4057qib7	15751	13	Kaplan	Kaplan	NNP
cord-005453-4057qib7	15751	14	-	-	HYPH
cord-005453-4057qib7	15751	15	Meier	Meier	NNP
cord-005453-4057qib7	15751	16	method	method	NN
cord-005453-4057qib7	15751	17	.	.	.
cord-005453-4057qib7	15752	1	Univariate	univariate	JJ
cord-005453-4057qib7	15752	2	and	and	CC
cord-005453-4057qib7	15752	3	multivariate	multivariate	JJ
cord-005453-4057qib7	15752	4	analysis	analysis	NN
cord-005453-4057qib7	15752	5	were	be	VBD
cord-005453-4057qib7	15752	6	performed	perform	VBN
cord-005453-4057qib7	15752	7	using	use	VBG
cord-005453-4057qib7	15752	8	Cox	Cox	NNP
cord-005453-4057qib7	15752	9	proportional	proportional	JJ
cord-005453-4057qib7	15752	10	hazard	hazard	NN
cord-005453-4057qib7	15752	11	regression	regression	NN
cord-005453-4057qib7	15752	12	model	model	NN
cord-005453-4057qib7	15752	13	.	.	.
cord-005453-4057qib7	15753	1	Results	result	NNS
cord-005453-4057qib7	15753	2	:	:	:
cord-005453-4057qib7	15754	1	Of	of	IN
cord-005453-4057qib7	15754	2	the	the	DT
cord-005453-4057qib7	15754	3	477	477	CD
cord-005453-4057qib7	15754	4	patients	patient	NNS
cord-005453-4057qib7	15754	5	who	who	WP
cord-005453-4057qib7	15754	6	experienced	experience	VBD
cord-005453-4057qib7	15754	7	relapse	relapse	NN
cord-005453-4057qib7	15754	8	after	after	IN
cord-005453-4057qib7	15754	9	1	1	CD
cord-005453-4057qib7	15754	10	st	st	NNP
cord-005453-4057qib7	15754	11	HSCT	HSCT	NNP
cord-005453-4057qib7	15754	12	,	,	,
cord-005453-4057qib7	15754	13	total	total	JJ
cord-005453-4057qib7	15754	14	244	244	CD
cord-005453-4057qib7	15754	15	patients	patient	NNS
cord-005453-4057qib7	15754	16	(	(	-LRB-
cord-005453-4057qib7	15754	17	51	51	CD
cord-005453-4057qib7	15754	18	%	%	NN
cord-005453-4057qib7	15754	19	)	)	-RRB-
cord-005453-4057qib7	15754	20	received	receive	VBD
cord-005453-4057qib7	15754	21	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15754	22	followed	follow	VBN
cord-005453-4057qib7	15754	23	by	by	IN
cord-005453-4057qib7	15754	24	DLI	DLI	NNP
cord-005453-4057qib7	15754	25	or	or	CC
cord-005453-4057qib7	15754	26	2	2	CD
cord-005453-4057qib7	15754	27	nd	nd	NNP
cord-005453-4057qib7	15754	28	HSCT	HSCT	NNP
cord-005453-4057qib7	15754	29	from	from	IN
cord-005453-4057qib7	15754	30	the	the	DT
cord-005453-4057qib7	15754	31	same	same	JJ
cord-005453-4057qib7	15754	32	donor	donor	NN
cord-005453-4057qib7	15754	33	(	(	-LRB-
cord-005453-4057qib7	15754	34	no	no	DT
cord-005453-4057qib7	15754	35	change	change	NN
cord-005453-4057qib7	15754	36	group	group	NN
cord-005453-4057qib7	15754	37	)	)	-RRB-
cord-005453-4057qib7	15754	38	,	,	,
cord-005453-4057qib7	15754	39	36	36	CD
cord-005453-4057qib7	15754	40	patient	patient	NN
cord-005453-4057qib7	15754	41	(	(	-LRB-
cord-005453-4057qib7	15754	42	8	8	CD
cord-005453-4057qib7	15754	43	%	%	NN
cord-005453-4057qib7	15754	44	)	)	-RRB-
cord-005453-4057qib7	15754	45	received	receive	VBD
cord-005453-4057qib7	15754	46	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15754	47	followed	follow	VBN
cord-005453-4057qib7	15754	48	by	by	IN
cord-005453-4057qib7	15754	49	2	2	CD
cord-005453-4057qib7	15754	50	nd	nd	NNP
cord-005453-4057qib7	15754	51	HSCT	HSCT	NNP
cord-005453-4057qib7	15754	52	from	from	IN
cord-005453-4057qib7	15754	53	different	different	JJ
cord-005453-4057qib7	15754	54	donors	donor	NNS
cord-005453-4057qib7	15754	55	(	(	-LRB-
cord-005453-4057qib7	15754	56	change	change	NN
cord-005453-4057qib7	15754	57	group	group	NN
cord-005453-4057qib7	15754	58	)	)	-RRB-
cord-005453-4057qib7	15754	59	,	,	,
cord-005453-4057qib7	15754	60	and	and	CC
cord-005453-4057qib7	15754	61	197	197	CD
cord-005453-4057qib7	15754	62	(	(	-LRB-
cord-005453-4057qib7	15754	63	41	41	CD
cord-005453-4057qib7	15754	64	%	%	NN
cord-005453-4057qib7	15754	65	)	)	-RRB-
cord-005453-4057qib7	15754	66	had	have	VBD
cord-005453-4057qib7	15754	67	conventional	conventional	JJ
cord-005453-4057qib7	15754	68	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15754	69	alone	alone	RB
cord-005453-4057qib7	15754	70	.	.	.
cord-005453-4057qib7	15755	1	The	the	DT
cord-005453-4057qib7	15755	2	patients	patient	NNS
cord-005453-4057qib7	15755	3	in	in	IN
cord-005453-4057qib7	15755	4	"	"	``
cord-005453-4057qib7	15755	5	change	change	NN
cord-005453-4057qib7	15755	6	group	group	NN
cord-005453-4057qib7	15755	7	"	"	''
cord-005453-4057qib7	15755	8	were	be	VBD
cord-005453-4057qib7	15755	9	younger	young	JJR
cord-005453-4057qib7	15755	10	(	(	-LRB-
cord-005453-4057qib7	15755	11	median	median	NN
cord-005453-4057qib7	15755	12	age	age	NN
cord-005453-4057qib7	15755	13	29	29	CD
cord-005453-4057qib7	15755	14	vs	vs	IN
cord-005453-4057qib7	15755	15	37	37	CD
cord-005453-4057qib7	15755	16	,	,	,
cord-005453-4057qib7	15755	17	p	p	NN
cord-005453-4057qib7	15755	18	=	=	SYM
cord-005453-4057qib7	15755	19	.02	.02	NFP
cord-005453-4057qib7	15755	20	)	)	-RRB-
cord-005453-4057qib7	15755	21	,	,	,
cord-005453-4057qib7	15755	22	and	and	CC
cord-005453-4057qib7	15755	23	had	have	VBD
cord-005453-4057qib7	15755	24	more	more	JJR
cord-005453-4057qib7	15755	25	patients	patient	NNS
cord-005453-4057qib7	15755	26	achieving	achieve	VBG
cord-005453-4057qib7	15755	27	complete	complete	JJ
cord-005453-4057qib7	15755	28	remission	remission	NN
cord-005453-4057qib7	15755	29	(	(	-LRB-
cord-005453-4057qib7	15755	30	CR	CR	NNP
cord-005453-4057qib7	15755	31	)	)	-RRB-
cord-005453-4057qib7	15755	32	prior	prior	RB
cord-005453-4057qib7	15755	33	to	to	IN
cord-005453-4057qib7	15755	34	2	2	CD
cord-005453-4057qib7	15755	35	nd	nd	NNP
cord-005453-4057qib7	15755	36	HSCT	HSCT	NNP
cord-005453-4057qib7	15755	37	(	(	-LRB-
cord-005453-4057qib7	15755	38	44	44	CD
cord-005453-4057qib7	15755	39	%	%	NN
cord-005453-4057qib7	15755	40	vs	vs	IN
cord-005453-4057qib7	15755	41	10	10	CD
cord-005453-4057qib7	15755	42	%	%	NN
cord-005453-4057qib7	15755	43	,	,	,
cord-005453-4057qib7	15755	44	p	p	NN
cord-005453-4057qib7	15755	45	=	=	SYM
cord-005453-4057qib7	15755	46	<	<	XX
cord-005453-4057qib7	15755	47	.01	.01	NFP
cord-005453-4057qib7	15755	48	)	)	-RRB-
cord-005453-4057qib7	15755	49	than	than	IN
cord-005453-4057qib7	15755	50	patients	patient	NNS
cord-005453-4057qib7	15755	51	in	in	IN
cord-005453-4057qib7	15755	52	"	"	``
cord-005453-4057qib7	15755	53	no	no	DT
cord-005453-4057qib7	15755	54	change	change	NN
cord-005453-4057qib7	15755	55	group	group	NN
cord-005453-4057qib7	15755	56	"	"	''
cord-005453-4057qib7	15755	57	.	.	.
cord-005453-4057qib7	15756	1	After	after	IN
cord-005453-4057qib7	15756	2	the	the	DT
cord-005453-4057qib7	15756	3	2	2	CD
cord-005453-4057qib7	15756	4	nd	nd	NNP
cord-005453-4057qib7	15756	5	HSCT	HSCT	NNP
cord-005453-4057qib7	15756	6	,	,	,
cord-005453-4057qib7	15756	7	the	the	DT
cord-005453-4057qib7	15756	8	CR	cr	NN
cord-005453-4057qib7	15756	9	was	be	VBD
cord-005453-4057qib7	15756	10	68	68	CD
cord-005453-4057qib7	15756	11	%	%	NN
cord-005453-4057qib7	15756	12	for	for	IN
cord-005453-4057qib7	15756	13	"	"	``
cord-005453-4057qib7	15756	14	no	no	DT
cord-005453-4057qib7	15756	15	change	change	NN
cord-005453-4057qib7	15756	16	group	group	NN
cord-005453-4057qib7	15756	17	"	"	''
cord-005453-4057qib7	15756	18	and	and	CC
cord-005453-4057qib7	15756	19	91	91	CD
cord-005453-4057qib7	15756	20	%	%	NN
cord-005453-4057qib7	15756	21	for	for	IN
cord-005453-4057qib7	15756	22	"	"	``
cord-005453-4057qib7	15756	23	change	change	NN
cord-005453-4057qib7	15756	24	group	group	NN
cord-005453-4057qib7	15756	25	"	"	''
cord-005453-4057qib7	15756	26	.	.	.
cord-005453-4057qib7	15757	1	The	the	DT
cord-005453-4057qib7	15757	2	progression	progression	NN
cord-005453-4057qib7	15757	3	-	-	HYPH
cord-005453-4057qib7	15757	4	free	free	JJ
cord-005453-4057qib7	15757	5	survival	survival	NN
cord-005453-4057qib7	15757	6	at	at	IN
cord-005453-4057qib7	15757	7	3-year	3-year	CD
cord-005453-4057qib7	15757	8	and	and	CC
cord-005453-4057qib7	15757	9	5-year	5-year	CD
cord-005453-4057qib7	15757	10	were	be	VBD
cord-005453-4057qib7	15757	11	10.5	10.5	CD
cord-005453-4057qib7	15757	12	%	%	NN
cord-005453-4057qib7	15757	13	and	and	CC
cord-005453-4057qib7	15757	14	5.9	5.9	CD
cord-005453-4057qib7	15757	15	%	%	NN
cord-005453-4057qib7	15758	1	(	(	-LRB-
cord-005453-4057qib7	15758	2	Fig	Fig	NNP
cord-005453-4057qib7	15758	3	1A	1a	NN
cord-005453-4057qib7	15758	4	,	,	,
cord-005453-4057qib7	15758	5	p	p	NN
cord-005453-4057qib7	15758	6	=	=	SYM
cord-005453-4057qib7	15758	7	.0438	.0438	NFP
cord-005453-4057qib7	15758	8	%	%	NN
cord-005453-4057qib7	15758	9	)	)	-RRB-
cord-005453-4057qib7	15758	10	,	,	,
cord-005453-4057qib7	15758	11	respectively	respectively	RB
cord-005453-4057qib7	15758	12	,	,	,
cord-005453-4057qib7	15758	13	for	for	IN
cord-005453-4057qib7	15758	14	"	"	``
cord-005453-4057qib7	15758	15	no	no	DT
cord-005453-4057qib7	15758	16	change	change	NN
cord-005453-4057qib7	15758	17	group	group	NN
cord-005453-4057qib7	15758	18	"	"	''
cord-005453-4057qib7	15758	19	and	and	CC
cord-005453-4057qib7	15758	20	9.4	9.4	CD
cord-005453-4057qib7	15758	21	%	%	NN
cord-005453-4057qib7	15758	22	and	and	CC
cord-005453-4057qib7	15758	23	9.4	9.4	CD
cord-005453-4057qib7	15758	24	%	%	NN
cord-005453-4057qib7	15758	25	,	,	,
cord-005453-4057qib7	15758	26	respectively	respectively	RB
cord-005453-4057qib7	15758	27	,	,	,
cord-005453-4057qib7	15758	28	for	for	IN
cord-005453-4057qib7	15758	29	"	"	``
cord-005453-4057qib7	15758	30	change	change	NN
cord-005453-4057qib7	15758	31	group	group	NN
cord-005453-4057qib7	15758	32	"	"	''
cord-005453-4057qib7	15758	33	.	.	.
cord-005453-4057qib7	15759	1	While	while	IN
cord-005453-4057qib7	15759	2	the	the	DT
cord-005453-4057qib7	15759	3	overall	overall	JJ
cord-005453-4057qib7	15759	4	survival	survival	NN
cord-005453-4057qib7	15759	5	(	(	-LRB-
cord-005453-4057qib7	15759	6	OS	OS	NNP
cord-005453-4057qib7	15759	7	)	)	-RRB-
cord-005453-4057qib7	15759	8	at	at	IN
cord-005453-4057qib7	15759	9	3-year	3-year	CD
cord-005453-4057qib7	15759	10	and	and	CC
cord-005453-4057qib7	15759	11	5-year	5-year	CD
cord-005453-4057qib7	15759	12	were	be	VBD
cord-005453-4057qib7	15759	13	15.8	15.8	CD
cord-005453-4057qib7	15759	14	%	%	NN
cord-005453-4057qib7	15759	15	and	and	CC
cord-005453-4057qib7	15759	16	9	9	CD
cord-005453-4057qib7	15759	17	%	%	NN
cord-005453-4057qib7	15760	1	(	(	-LRB-
cord-005453-4057qib7	15760	2	Fig	Fig	NNP
cord-005453-4057qib7	15760	3	1B	1b	NN
cord-005453-4057qib7	15760	4	,	,	,
cord-005453-4057qib7	15760	5	p	p	NN
cord-005453-4057qib7	15760	6	=	=	SYM
cord-005453-4057qib7	15760	7	.3459	.3459	:
cord-005453-4057qib7	15760	8	%	%	NN
cord-005453-4057qib7	15760	9	)	)	-RRB-
cord-005453-4057qib7	15760	10	,	,	,
cord-005453-4057qib7	15760	11	respectively	respectively	RB
cord-005453-4057qib7	15760	12	,	,	,
cord-005453-4057qib7	15760	13	for	for	IN
cord-005453-4057qib7	15760	14	"	"	``
cord-005453-4057qib7	15760	15	no	no	DT
cord-005453-4057qib7	15760	16	change	change	NN
cord-005453-4057qib7	15760	17	group	group	NN
cord-005453-4057qib7	15760	18	"	"	''
cord-005453-4057qib7	15760	19	and	and	CC
cord-005453-4057qib7	15760	20	13.5	13.5	CD
cord-005453-4057qib7	15760	21	%	%	NN
cord-005453-4057qib7	15760	22	and	and	CC
cord-005453-4057qib7	15760	23	9	9	CD
cord-005453-4057qib7	15760	24	%	%	NN
cord-005453-4057qib7	15760	25	,	,	,
cord-005453-4057qib7	15760	26	respectively	respectively	RB
cord-005453-4057qib7	15760	27	,	,	,
cord-005453-4057qib7	15760	28	for	for	IN
cord-005453-4057qib7	15760	29	"	"	``
cord-005453-4057qib7	15760	30	change	change	NN
cord-005453-4057qib7	15760	31	group	group	NN
cord-005453-4057qib7	15760	32	"	"	''
cord-005453-4057qib7	15760	33	.	.	.
cord-005453-4057qib7	15761	1	Those	those	DT
cord-005453-4057qib7	15761	2	who	who	WP
cord-005453-4057qib7	15761	3	achieved	achieve	VBD
cord-005453-4057qib7	15761	4	CR	CR	NNP
cord-005453-4057qib7	15761	5	prior	prior	RB
cord-005453-4057qib7	15761	6	to	to	IN
cord-005453-4057qib7	15761	7	2	2	CD
cord-005453-4057qib7	15761	8	nd	nd	NNP
cord-005453-4057qib7	15761	9	HSCT	HSCT	NNP
cord-005453-4057qib7	15761	10	had	have	VBD
cord-005453-4057qib7	15761	11	a	a	DT
cord-005453-4057qib7	15761	12	trend	trend	NN
cord-005453-4057qib7	15761	13	of	of	IN
cord-005453-4057qib7	15761	14	better	well	JJR
cord-005453-4057qib7	15761	15	OS	os	NN
cord-005453-4057qib7	15761	16	than	than	IN
cord-005453-4057qib7	15761	17	those	those	DT
cord-005453-4057qib7	15761	18	without	without	IN
cord-005453-4057qib7	15761	19	CR	CR	NNP
cord-005453-4057qib7	15761	20	(	(	-LRB-
cord-005453-4057qib7	15761	21	17.5	17.5	CD
cord-005453-4057qib7	15761	22	%	%	NN
cord-005453-4057qib7	15761	23	vs	vs	IN
cord-005453-4057qib7	15761	24	8.7	8.7	CD
cord-005453-4057qib7	15761	25	%	%	NN
cord-005453-4057qib7	15761	26	at	at	IN
cord-005453-4057qib7	15761	27	3-year	3-year	CD
cord-005453-4057qib7	15761	28	;	;	:
cord-005453-4057qib7	15761	29	8.7	8.7	CD
cord-005453-4057qib7	15761	30	%	%	NN
cord-005453-4057qib7	15761	31	vs	vs	IN
cord-005453-4057qib7	15761	32	9.1	9.1	CD
cord-005453-4057qib7	15761	33	%	%	NN
cord-005453-4057qib7	15761	34	at	at	IN
cord-005453-4057qib7	15761	35	5year	5year	CD
cord-005453-4057qib7	15761	36	,	,	,
cord-005453-4057qib7	15761	37	p	p	NN
cord-005453-4057qib7	15761	38	=	=	SYM
cord-005453-4057qib7	15761	39	.0365	.0365	.
cord-005453-4057qib7	15761	40	)	)	-RRB-
cord-005453-4057qib7	15762	1	(	(	-LRB-
cord-005453-4057qib7	15762	2	Fig	Fig	NNP
cord-005453-4057qib7	15762	3	1C	1c	NN
cord-005453-4057qib7	15762	4	)	)	-RRB-
cord-005453-4057qib7	15762	5	.	.	.
cord-005453-4057qib7	15763	1	There	there	EX
cord-005453-4057qib7	15763	2	were	be	VBD
cord-005453-4057qib7	15763	3	1	1	CD
cord-005453-4057qib7	15763	4	cases	case	NNS
cord-005453-4057qib7	15763	5	survived	survive	VBN
cord-005453-4057qib7	15763	6	for	for	IN
cord-005453-4057qib7	15763	7	more	more	JJR
cord-005453-4057qib7	15763	8	than	than	IN
cord-005453-4057qib7	15763	9	10	10	CD
cord-005453-4057qib7	15763	10	years	year	NNS
cord-005453-4057qib7	15763	11	in	in	IN
cord-005453-4057qib7	15763	12	"	"	``
cord-005453-4057qib7	15763	13	change	change	NN
cord-005453-4057qib7	15763	14	donor	donor	NN
cord-005453-4057qib7	15763	15	group	group	NN
cord-005453-4057qib7	15763	16	"	"	''
cord-005453-4057qib7	15763	17	and	and	CC
cord-005453-4057qib7	15764	1	6	6	CD
cord-005453-4057qib7	15764	2	cases	case	NNS
cord-005453-4057qib7	15764	3	survived	survive	VBD
cord-005453-4057qib7	15764	4	more	more	JJR
cord-005453-4057qib7	15764	5	than	than	IN
cord-005453-4057qib7	15764	6	10	10	CD
cord-005453-4057qib7	15764	7	years	year	NNS
cord-005453-4057qib7	15764	8	in	in	IN
cord-005453-4057qib7	15764	9	"	"	``
cord-005453-4057qib7	15764	10	no	no	DT
cord-005453-4057qib7	15764	11	change	change	NN
cord-005453-4057qib7	15764	12	group	group	NN
cord-005453-4057qib7	15764	13	"	"	''
cord-005453-4057qib7	15764	14	.	.	.
cord-005453-4057qib7	15765	1	Only	only	RB
cord-005453-4057qib7	15765	2	one	one	CD
cord-005453-4057qib7	15765	3	had	have	VBD
cord-005453-4057qib7	15765	4	developed	develop	VBN
cord-005453-4057qib7	15765	5	relapse	relapse	NN
cord-005453-4057qib7	15765	6	after	after	IN
cord-005453-4057qib7	15765	7	2	2	CD
cord-005453-4057qib7	15765	8	nd	nd	NNP
cord-005453-4057qib7	15765	9	HSCT	HSCT	NNP
cord-005453-4057qib7	15765	10	but	but	CC
cord-005453-4057qib7	15765	11	achieved	achieve	VBD
cord-005453-4057qib7	15765	12	subsequent	subsequent	JJ
cord-005453-4057qib7	15765	13	remission	remission	NN
cord-005453-4057qib7	15765	14	again	again	RB
cord-005453-4057qib7	15765	15	.	.	.
cord-005453-4057qib7	15766	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15766	2	:	:	:
cord-005453-4057qib7	15767	1	Our	-PRON-	PRP$
cord-005453-4057qib7	15767	2	study	study	NN
cord-005453-4057qib7	15767	3	shows	show	VBZ
cord-005453-4057qib7	15767	4	that	that	IN
cord-005453-4057qib7	15767	5	change	change	VBP
cord-005453-4057qib7	15767	6	donor	donor	NN
cord-005453-4057qib7	15767	7	had	have	VBD
cord-005453-4057qib7	15767	8	similar	similar	JJ
cord-005453-4057qib7	15767	9	poor	poor	JJ
cord-005453-4057qib7	15767	10	outcome	outcome	NN
cord-005453-4057qib7	15767	11	comparing	compare	VBG
cord-005453-4057qib7	15767	12	to	to	IN
cord-005453-4057qib7	15767	13	those	those	DT
cord-005453-4057qib7	15767	14	using	use	VBG
cord-005453-4057qib7	15767	15	the	the	DT
cord-005453-4057qib7	15767	16	same	same	JJ
cord-005453-4057qib7	15767	17	donor	donor	NN
cord-005453-4057qib7	15767	18	after	after	IN
cord-005453-4057qib7	15767	19	the	the	DT
cord-005453-4057qib7	15767	20	1	1	CD
cord-005453-4057qib7	15767	21	st	st	NNP
cord-005453-4057qib7	15767	22	HSCT	HSCT	NNP
cord-005453-4057qib7	15767	23	.	.	.
cord-005453-4057qib7	15768	1	Patients	patient	NNS
cord-005453-4057qib7	15768	2	who	who	WP
cord-005453-4057qib7	15768	3	achieved	achieve	VBD
cord-005453-4057qib7	15768	4	CR	CR	NNP
cord-005453-4057qib7	15768	5	before	before	IN
cord-005453-4057qib7	15768	6	2nd	2nd	JJ
cord-005453-4057qib7	15768	7	HSCT	HSCT	NNP
cord-005453-4057qib7	15768	8	had	have	VBD
cord-005453-4057qib7	15768	9	a	a	DT
cord-005453-4057qib7	15768	10	trend	trend	NN
cord-005453-4057qib7	15768	11	of	of	IN
cord-005453-4057qib7	15768	12	better	well	JJR
cord-005453-4057qib7	15768	13	OS	os	NN
cord-005453-4057qib7	15768	14	than	than	IN
cord-005453-4057qib7	15768	15	those	those	DT
cord-005453-4057qib7	15768	16	without	without	IN
cord-005453-4057qib7	15768	17	remission	remission	NN
cord-005453-4057qib7	15768	18	and	and	CC
cord-005453-4057qib7	15769	1	the	the	DT
cord-005453-4057qib7	15769	2	long	long	JJ
cord-005453-4057qib7	15769	3	-	-	HYPH
cord-005453-4057qib7	15769	4	term	term	NN
cord-005453-4057qib7	15769	5	survivors	survivor	NNS
cord-005453-4057qib7	15769	6	were	be	VBD
cord-005453-4057qib7	15769	7	only	only	RB
cord-005453-4057qib7	15769	8	those	those	DT
cord-005453-4057qib7	15769	9	who	who	WP
cord-005453-4057qib7	15769	10	achieved	achieve	VBD
cord-005453-4057qib7	15769	11	CR	CR	NNP
cord-005453-4057qib7	15769	12	prior	prior	RB
cord-005453-4057qib7	15769	13	to	to	IN
cord-005453-4057qib7	15769	14	2	2	CD
cord-005453-4057qib7	15769	15	nd	nd	NNP
cord-005453-4057qib7	15769	16	HSCT	HSCT	NNP
cord-005453-4057qib7	15769	17	.	.	.
cord-005453-4057qib7	15770	1	Novel	novel	JJ
cord-005453-4057qib7	15770	2	therapy	therapy	NN
cord-005453-4057qib7	15770	3	for	for	IN
cord-005453-4057qib7	15770	4	CR	cr	NN
cord-005453-4057qib7	15770	5	induction	induction	NN
cord-005453-4057qib7	15770	6	would	would	MD
cord-005453-4057qib7	15770	7	be	be	VB
cord-005453-4057qib7	15770	8	warrant	warrant	NN
cord-005453-4057qib7	15770	9	for	for	IN
cord-005453-4057qib7	15770	10	this	this	DT
cord-005453-4057qib7	15770	11	poor	poor	JJ
cord-005453-4057qib7	15770	12	prognostic	prognostic	JJ
cord-005453-4057qib7	15770	13	population	population	NN
cord-005453-4057qib7	15770	14	.	.	.
cord-005453-4057qib7	15771	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15771	2	:	:	:
cord-005453-4057qib7	15771	3	Nothing	nothing	NN
cord-005453-4057qib7	15771	4	to	to	TO
cord-005453-4057qib7	15771	5	declare	declare	VB
cord-005453-4057qib7	15771	6	Functional	functional	JJ
cord-005453-4057qib7	15771	7	relevance	relevance	NN
cord-005453-4057qib7	15771	8	of	of	IN
cord-005453-4057qib7	15771	9	fetal	fetal	JJ
cord-005453-4057qib7	15771	10	microchimerism	microchimerism	NN
cord-005453-4057qib7	15771	11	in	in	IN
cord-005453-4057qib7	15771	12	NK	NK	NNP
cord-005453-4057qib7	15771	13	cell	cell	NN
cord-005453-4057qib7	15771	14	cytotoxicity	cytotoxicity	NN
cord-005453-4057qib7	15771	15	against	against	IN
cord-005453-4057qib7	15771	16	leukemic	leukemic	JJ
cord-005453-4057qib7	15771	17	blasts	blast	NNS
cord-005453-4057qib7	15771	18	in	in	IN
cord-005453-4057qib7	15771	19	children	child	NNS
cord-005453-4057qib7	15771	20	:	:	:
cord-005453-4057qib7	15772	1	A	a	DT
cord-005453-4057qib7	15772	2	role	role	NN
cord-005453-4057qib7	15772	3	for	for	IN
cord-005453-4057qib7	15772	4	HLA	HLA	NNP
cord-005453-4057qib7	15772	5	-	-	HYPH
cord-005453-4057qib7	15772	6	C1	C1	NNP
cord-005453-4057qib7	15772	7	and	and	CC
cord-005453-4057qib7	15772	8	KIR2DL2	KIR2DL2	NNS
cord-005453-4057qib7	15772	9	/	/	SYM
cord-005453-4057qib7	15772	10	S2?Background	s2?background	NN
cord-005453-4057qib7	15772	11	:	:	:
cord-005453-4057qib7	15773	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	15773	2	stem	stem	VBP
cord-005453-4057qib7	15773	3	cell	cell	NN
cord-005453-4057qib7	15773	4	transplantation	transplantation	NN
cord-005453-4057qib7	15773	5	(	(	-LRB-
cord-005453-4057qib7	15773	6	allo	allo	FW
cord-005453-4057qib7	15773	7	-	-	HYPH
cord-005453-4057qib7	15773	8	SCT	SCT	NNP
cord-005453-4057qib7	15773	9	)	)	-RRB-
cord-005453-4057qib7	15773	10	remains	remain	VBZ
cord-005453-4057qib7	15773	11	the	the	DT
cord-005453-4057qib7	15773	12	most	most	RBS
cord-005453-4057qib7	15773	13	effective	effective	JJ
cord-005453-4057qib7	15773	14	curative	curative	JJ
cord-005453-4057qib7	15773	15	intent	intent	NN
cord-005453-4057qib7	15773	16	therapy	therapy	NN
cord-005453-4057qib7	15773	17	for	for	IN
cord-005453-4057qib7	15773	18	patients	patient	NNS
cord-005453-4057qib7	15773	19	with	with	IN
cord-005453-4057qib7	15773	20	unfavorable	unfavorable	JJ
cord-005453-4057qib7	15773	21	risk	risk	NN
cord-005453-4057qib7	15773	22	acute	acute	JJ
cord-005453-4057qib7	15773	23	leukemia	leukemia	NN
cord-005453-4057qib7	15773	24	.	.	.
cord-005453-4057qib7	15774	1	Various	various	JJ
cord-005453-4057qib7	15774	2	donor	donor	NN
cord-005453-4057qib7	15774	3	options	option	NNS
cord-005453-4057qib7	15774	4	are	be	VBP
cord-005453-4057qib7	15774	5	available	available	JJ
cord-005453-4057qib7	15774	6	for	for	IN
cord-005453-4057qib7	15774	7	the	the	DT
cord-005453-4057qib7	15774	8	patient	patient	NN
cord-005453-4057qib7	15774	9	who	who	WP
cord-005453-4057qib7	15774	10	lacks	lack	VBZ
cord-005453-4057qib7	15774	11	an	an	DT
cord-005453-4057qib7	15774	12	HLA	HLA	NNP
cord-005453-4057qib7	15774	13	-	-	HYPH
cord-005453-4057qib7	15774	14	matched	match	VBN
cord-005453-4057qib7	15774	15	sibling	sibling	NN
cord-005453-4057qib7	15774	16	donor	donor	NN
cord-005453-4057qib7	15774	17	,	,	,
cord-005453-4057qib7	15774	18	such	such	JJ
cord-005453-4057qib7	15774	19	as	as	IN
cord-005453-4057qib7	15774	20	unrelated	unrelated	JJ
cord-005453-4057qib7	15774	21	donors	donor	NNS
cord-005453-4057qib7	15774	22	(	(	-LRB-
cord-005453-4057qib7	15774	23	URD	URD	NNP
cord-005453-4057qib7	15774	24	)	)	-RRB-
cord-005453-4057qib7	15774	25	and	and	CC
cord-005453-4057qib7	15774	26	HLA	HLA	NNP
cord-005453-4057qib7	15774	27	-	-	HYPH
cord-005453-4057qib7	15774	28	mismatched	mismatch	VBN
cord-005453-4057qib7	15774	29	family	family	NN
cord-005453-4057qib7	15774	30	(	(	-LRB-
cord-005453-4057qib7	15774	31	haploidentical	haploidentical	NNP
cord-005453-4057qib7	15774	32	)	)	-RRB-
cord-005453-4057qib7	15774	33	donors	donor	NNS
cord-005453-4057qib7	15774	34	.	.	.
cord-005453-4057qib7	15775	1	In	in	IN
cord-005453-4057qib7	15775	2	order	order	NN
cord-005453-4057qib7	15775	3	to	to	TO
cord-005453-4057qib7	15775	4	discover	discover	VB
cord-005453-4057qib7	15775	5	the	the	DT
cord-005453-4057qib7	15775	6	exact	exact	JJ
cord-005453-4057qib7	15775	7	role	role	NN
cord-005453-4057qib7	15775	8	of	of	IN
cord-005453-4057qib7	15775	9	transplantation	transplantation	NN
cord-005453-4057qib7	15775	10	type	type	NN
cord-005453-4057qib7	15775	11	,	,	,
cord-005453-4057qib7	15775	12	there	there	EX
cord-005453-4057qib7	15775	13	are	be	VBP
cord-005453-4057qib7	15775	14	many	many	JJ
cord-005453-4057qib7	15775	15	retrospective	retrospective	JJ
cord-005453-4057qib7	15775	16	analysis	analysis	NN
cord-005453-4057qib7	15775	17	,	,	,
cord-005453-4057qib7	15775	18	which	which	WDT
cord-005453-4057qib7	15775	19	compared	compare	VBD
cord-005453-4057qib7	15775	20	these	these	DT
cord-005453-4057qib7	15775	21	donor	donor	NN
cord-005453-4057qib7	15775	22	sources	source	NNS
cord-005453-4057qib7	15775	23	,	,	,
cord-005453-4057qib7	15775	24	have	have	VBP
cord-005453-4057qib7	15775	25	been	be	VBN
cord-005453-4057qib7	15775	26	reported	report	VBN
cord-005453-4057qib7	15775	27	.	.	.
cord-005453-4057qib7	15776	1	Recent	recent	JJ
cord-005453-4057qib7	15776	2	studies	study	NNS
cord-005453-4057qib7	15776	3	showed	show	VBD
cord-005453-4057qib7	15776	4	some	some	DT
cord-005453-4057qib7	15776	5	promising	promising	JJ
cord-005453-4057qib7	15776	6	results	result	NNS
cord-005453-4057qib7	15776	7	of	of	IN
cord-005453-4057qib7	15776	8	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15776	9	donor	donor	NN
cord-005453-4057qib7	15776	10	transplantation	transplantation	NN
cord-005453-4057qib7	15776	11	(	(	-LRB-
cord-005453-4057qib7	15776	12	HIDT	HIDT	NNP
cord-005453-4057qib7	15776	13	)	)	-RRB-
cord-005453-4057qib7	15776	14	using	use	VBG
cord-005453-4057qib7	15776	15	post	post	JJ
cord-005453-4057qib7	15776	16	-	-	JJ
cord-005453-4057qib7	15776	17	transplant	transplant	JJ
cord-005453-4057qib7	15776	18	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15776	19	in	in	IN
cord-005453-4057qib7	15776	20	comparison	comparison	NN
cord-005453-4057qib7	15776	21	with	with	IN
cord-005453-4057qib7	15776	22	unrelated	unrelated	JJ
cord-005453-4057qib7	15776	23	donor	donor	NN
cord-005453-4057qib7	15776	24	.	.	.
cord-005453-4057qib7	15777	1	The	the	DT
cord-005453-4057qib7	15777	2	goal	goal	NN
cord-005453-4057qib7	15777	3	of	of	IN
cord-005453-4057qib7	15777	4	this	this	DT
cord-005453-4057qib7	15777	5	study	study	NN
cord-005453-4057qib7	15777	6	was	be	VBD
cord-005453-4057qib7	15777	7	to	to	TO
cord-005453-4057qib7	15777	8	compare	compare	VB
cord-005453-4057qib7	15777	9	the	the	DT
cord-005453-4057qib7	15777	10	outcome	outcome	NN
cord-005453-4057qib7	15777	11	of	of	IN
cord-005453-4057qib7	15777	12	allo	allo	NNP
cord-005453-4057qib7	15777	13	-	-	HYPH
cord-005453-4057qib7	15777	14	SCT	SCT	NNP
cord-005453-4057qib7	15777	15	from	from	IN
cord-005453-4057qib7	15777	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15777	17	versus	versus	IN
cord-005453-4057qib7	15777	18	matched	match	VBN
cord-005453-4057qib7	15777	19	unrelated	unrelated	JJ
cord-005453-4057qib7	15777	20	(	(	-LRB-
cord-005453-4057qib7	15777	21	MUD	mud	NN
cord-005453-4057qib7	15777	22	10/10	10/10	CD
cord-005453-4057qib7	15777	23	)	)	-RRB-
cord-005453-4057qib7	15777	24	or	or	CC
cord-005453-4057qib7	15777	25	mismatched	mismatch	VBN
cord-005453-4057qib7	15777	26	unrelated	unrelated	JJ
cord-005453-4057qib7	15777	27	donor	donor	NN
cord-005453-4057qib7	15777	28	at	at	IN
cord-005453-4057qib7	15777	29	a	a	DT
cord-005453-4057qib7	15777	30	single	single	JJ
cord-005453-4057qib7	15777	31	HLA	HLA	NNP
cord-005453-4057qib7	15777	32	-	-	HYPH
cord-005453-4057qib7	15777	33	locus	locus	NN
cord-005453-4057qib7	15777	34	(	(	-LRB-
cord-005453-4057qib7	15777	35	MMUD	MMUD	NNP
cord-005453-4057qib7	15777	36	9/10	9/10	CD
cord-005453-4057qib7	15777	37	)	)	-RRB-
cord-005453-4057qib7	15777	38	for	for	IN
cord-005453-4057qib7	15777	39	patients	patient	NNS
cord-005453-4057qib7	15777	40	with	with	IN
cord-005453-4057qib7	15777	41	acute	acute	JJ
cord-005453-4057qib7	15777	42	leukemia	leukemia	NN
cord-005453-4057qib7	15777	43	in	in	IN
cord-005453-4057qib7	15777	44	remission	remission	NN
cord-005453-4057qib7	15777	45	.	.	.
cord-005453-4057qib7	15778	1	Methods	method	NNS
cord-005453-4057qib7	15778	2	:	:	:
cord-005453-4057qib7	15779	1	Ninety	ninety	CD
cord-005453-4057qib7	15779	2	-	-	HYPH
cord-005453-4057qib7	15779	3	six	six	CD
cord-005453-4057qib7	15779	4	adult	adult	NN
cord-005453-4057qib7	15779	5	(	(	-LRB-
cord-005453-4057qib7	15779	6	18	18	CD
cord-005453-4057qib7	15779	7	-	-	SYM
cord-005453-4057qib7	15779	8	65	65	CD
cord-005453-4057qib7	15779	9	years	year	NNS
cord-005453-4057qib7	15779	10	)	)	-RRB-
cord-005453-4057qib7	15779	11	patients	patient	NNS
cord-005453-4057qib7	15779	12	with	with	IN
cord-005453-4057qib7	15779	13	acute	acute	JJ
cord-005453-4057qib7	15779	14	leukemia	leukemia	NN
cord-005453-4057qib7	15779	15	in	in	IN
cord-005453-4057qib7	15779	16	first	first	JJ
cord-005453-4057qib7	15779	17	or	or	CC
cord-005453-4057qib7	15779	18	second	second	JJ
cord-005453-4057qib7	15779	19	remission	remission	NN
cord-005453-4057qib7	15779	20	who	who	WP
cord-005453-4057qib7	15779	21	underwent	undergo	VBD
cord-005453-4057qib7	15779	22	allogeneic	allogeneic	JJ
cord-005453-4057qib7	15779	23	transplantation	transplantation	NN
cord-005453-4057qib7	15779	24	with	with	IN
cord-005453-4057qib7	15779	25	a	a	DT
cord-005453-4057qib7	15779	26	minimum	minimum	JJ
cord-005453-4057qib7	15779	27	100	100	CD
cord-005453-4057qib7	15779	28	days	day	NNS
cord-005453-4057qib7	15779	29	follow	follow	NN
cord-005453-4057qib7	15779	30	-	-	HYPH
cord-005453-4057qib7	15779	31	up	up	NN
cord-005453-4057qib7	15779	32	at	at	IN
cord-005453-4057qib7	15779	33	Florence	Florence	NNP
cord-005453-4057qib7	15779	34	Nightingale	Nightingale	NNP
cord-005453-4057qib7	15779	35	Hospital	Hospital	NNP
cord-005453-4057qib7	15779	36	Hematopoietic	Hematopoietic	NNP
cord-005453-4057qib7	15779	37	Stem	Stem	NNP
cord-005453-4057qib7	15779	38	Cell	Cell	NNP
cord-005453-4057qib7	15779	39	Transplantation	Transplantation	NNP
cord-005453-4057qib7	15779	40	Center	Center	NNP
cord-005453-4057qib7	15779	41	between	between	IN
cord-005453-4057qib7	15779	42	2011	2011	CD
cord-005453-4057qib7	15779	43	and	and	CC
cord-005453-4057qib7	15779	44	2017	2017	CD
cord-005453-4057qib7	15779	45	were	be	VBD
cord-005453-4057qib7	15779	46	included	include	VBN
cord-005453-4057qib7	15779	47	in	in	IN
cord-005453-4057qib7	15779	48	this	this	DT
cord-005453-4057qib7	15779	49	study	study	NN
cord-005453-4057qib7	15779	50	.	.	.
cord-005453-4057qib7	15780	1	Patient	patient	JJ
cord-005453-4057qib7	15780	2	characteristics	characteristic	NNS
cord-005453-4057qib7	15780	3	and	and	CC
cord-005453-4057qib7	15780	4	medical	medical	JJ
cord-005453-4057qib7	15780	5	records	record	NNS
cord-005453-4057qib7	15780	6	of	of	IN
cord-005453-4057qib7	15780	7	all	all	DT
cord-005453-4057qib7	15780	8	patients	patient	NNS
cord-005453-4057qib7	15780	9	were	be	VBD
cord-005453-4057qib7	15780	10	reviewed	review	VBN
cord-005453-4057qib7	15780	11	retrospectively	retrospectively	RB
cord-005453-4057qib7	15780	12	.	.	.
cord-005453-4057qib7	15781	1	Thirty	thirty	CD
cord-005453-4057qib7	15781	2	-	-	HYPH
cord-005453-4057qib7	15781	3	eight	eight	CD
cord-005453-4057qib7	15781	4	patients	patient	NNS
cord-005453-4057qib7	15781	5	who	who	WP
cord-005453-4057qib7	15781	6	received	receive	VBD
cord-005453-4057qib7	15781	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15781	8	donor	donor	NN
cord-005453-4057qib7	15781	9	transplantation	transplantation	NN
cord-005453-4057qib7	15781	10	were	be	VBD
cord-005453-4057qib7	15781	11	compared	compare	VBN
cord-005453-4057qib7	15781	12	with	with	IN
cord-005453-4057qib7	15781	13	23	23	CD
cord-005453-4057qib7	15781	14	patients	patient	NNS
cord-005453-4057qib7	15781	15	receiving	receive	VBG
cord-005453-4057qib7	15781	16	a	a	DT
cord-005453-4057qib7	15781	17	MUD	mud	NN
cord-005453-4057qib7	15781	18	10/10	10/10	CD
cord-005453-4057qib7	15781	19	and	and	CC
cord-005453-4057qib7	15781	20	35	35	CD
cord-005453-4057qib7	15781	21	receiving	receive	VBG
cord-005453-4057qib7	15781	22	a	a	DT
cord-005453-4057qib7	15781	23	MMUD	MMUD	NNP
cord-005453-4057qib7	15781	24	9/10	9/10	CD
cord-005453-4057qib7	15781	25	.	.	.
cord-005453-4057qib7	15782	1	Patients	patient	NNS
cord-005453-4057qib7	15782	2	who	who	WP
cord-005453-4057qib7	15782	3	completed	complete	VBD
cord-005453-4057qib7	15782	4	minimum	minimum	JJ
cord-005453-4057qib7	15782	5	100	100	CD
cord-005453-4057qib7	15782	6	days	day	NNS
cord-005453-4057qib7	15782	7	post	post	NN
cord-005453-4057qib7	15782	8	-	-	NN
cord-005453-4057qib7	15782	9	transplantation	transplantation	JJ
cord-005453-4057qib7	15782	10	follow	follow	NN
cord-005453-4057qib7	15782	11	-	-	HYPH
cord-005453-4057qib7	15782	12	up	up	NN
cord-005453-4057qib7	15782	13	were	be	VBD
cord-005453-4057qib7	15782	14	identified	identify	VBN
cord-005453-4057qib7	15782	15	as	as	IN
cord-005453-4057qib7	15782	16	eligible	eligible	JJ
cord-005453-4057qib7	15782	17	for	for	IN
cord-005453-4057qib7	15782	18	survival	survival	NN
cord-005453-4057qib7	15782	19	analysis	analysis	NN
cord-005453-4057qib7	15782	20	.	.	.
cord-005453-4057qib7	15783	1	Results	result	NNS
cord-005453-4057qib7	15783	2	:	:	:
cord-005453-4057qib7	15784	1	The	the	DT
cord-005453-4057qib7	15784	2	characteristics	characteristic	NNS
cord-005453-4057qib7	15784	3	of	of	IN
cord-005453-4057qib7	15784	4	the	the	DT
cord-005453-4057qib7	15784	5	patients	patient	NNS
cord-005453-4057qib7	15784	6	and	and	CC
cord-005453-4057qib7	15784	7	transplant	transplant	NN
cord-005453-4057qib7	15784	8	donors	donor	NNS
cord-005453-4057qib7	15784	9	in	in	IN
cord-005453-4057qib7	15784	10	this	this	DT
cord-005453-4057qib7	15784	11	study	study	NN
cord-005453-4057qib7	15784	12	are	be	VBP
cord-005453-4057qib7	15784	13	summarized	summarize	VBN
cord-005453-4057qib7	15784	14	in	in	IN
cord-005453-4057qib7	15784	15	Table	Table	NNP
cord-005453-4057qib7	15784	16	1	1	CD
cord-005453-4057qib7	15784	17	.	.	.
cord-005453-4057qib7	15785	1	Median	median	JJ
cord-005453-4057qib7	15785	2	age	age	NN
cord-005453-4057qib7	15785	3	of	of	IN
cord-005453-4057qib7	15785	4	patients	patient	NNS
cord-005453-4057qib7	15785	5	was	be	VBD
cord-005453-4057qib7	15785	6	39.4±14	39.4±14	CD
cord-005453-4057qib7	15785	7	years	year	NNS
cord-005453-4057qib7	15785	8	.	.	.
cord-005453-4057qib7	15786	1	Proportion	proportion	NN
cord-005453-4057qib7	15786	2	of	of	IN
cord-005453-4057qib7	15786	3	male	male	JJ
cord-005453-4057qib7	15786	4	patients	patient	NNS
cord-005453-4057qib7	15786	5	was	be	VBD
cord-005453-4057qib7	15786	6	39.1	39.1	CD
cord-005453-4057qib7	15786	7	%	%	NN
cord-005453-4057qib7	15786	8	,	,	,
cord-005453-4057qib7	15786	9	74.2	74.2	CD
cord-005453-4057qib7	15786	10	%	%	NN
cord-005453-4057qib7	15786	11	and	and	CC
cord-005453-4057qib7	15786	12	57.8	57.8	CD
cord-005453-4057qib7	15786	13	%	%	NN
cord-005453-4057qib7	15786	14	for	for	IN
cord-005453-4057qib7	15786	15	MUD	mud	NN
cord-005453-4057qib7	15786	16	10/	10/	CD
cord-005453-4057qib7	15786	17	10	10	CD
cord-005453-4057qib7	15786	18	,	,	,
cord-005453-4057qib7	15786	19	MMUD	MMUD	NNP
cord-005453-4057qib7	15786	20	9/10	9/10	CD
cord-005453-4057qib7	15786	21	and	and	CC
cord-005453-4057qib7	15786	22	HIDT	hidt	JJ
cord-005453-4057qib7	15786	23	groups	group	NNS
cord-005453-4057qib7	15786	24	,	,	,
cord-005453-4057qib7	15786	25	respectively	respectively	RB
cord-005453-4057qib7	15786	26	,	,	,
cord-005453-4057qib7	15786	27	which	which	WDT
cord-005453-4057qib7	15786	28	is	be	VBZ
cord-005453-4057qib7	15786	29	significantly	significantly	RB
cord-005453-4057qib7	15786	30	different	different	JJ
cord-005453-4057qib7	15786	31	(	(	-LRB-
cord-005453-4057qib7	15786	32	p=0.02	p=0.02	NN
cord-005453-4057qib7	15786	33	)	)	-RRB-
cord-005453-4057qib7	15786	34	.	.	.
cord-005453-4057qib7	15787	1	The	the	DT
cord-005453-4057qib7	15787	2	other	other	JJ
cord-005453-4057qib7	15787	3	baseline	baseline	JJ
cord-005453-4057qib7	15787	4	factors	factor	NNS
cord-005453-4057qib7	15787	5	were	be	VBD
cord-005453-4057qib7	15787	6	similar	similar	JJ
cord-005453-4057qib7	15787	7	,	,	,
cord-005453-4057qib7	15787	8	including	include	VBG
cord-005453-4057qib7	15787	9	patient	patient	JJ
cord-005453-4057qib7	15787	10	age	age	NN
cord-005453-4057qib7	15787	11	,	,	,
cord-005453-4057qib7	15787	12	donor	donor	NN
cord-005453-4057qib7	15787	13	age	age	NN
cord-005453-4057qib7	15787	14	,	,	,
cord-005453-4057qib7	15787	15	recipient	recipient	NN
cord-005453-4057qib7	15787	16	cytomegalovirus	cytomegalovirus	NN
cord-005453-4057qib7	15787	17	(	(	-LRB-
cord-005453-4057qib7	15787	18	CMV	CMV	NNP
cord-005453-4057qib7	15787	19	)	)	-RRB-
cord-005453-4057qib7	15787	20	status	status	NN
cord-005453-4057qib7	15787	21	,	,	,
cord-005453-4057qib7	15787	22	donor	donor	NN
cord-005453-4057qib7	15787	23	CMV	cmv	NN
cord-005453-4057qib7	15787	24	status	status	NN
cord-005453-4057qib7	15787	25	,	,	,
cord-005453-4057qib7	15787	26	graft	graft	NN
cord-005453-4057qib7	15787	27	versus	versus	IN
cord-005453-4057qib7	15787	28	host	host	NN
cord-005453-4057qib7	15787	29	disease	disease	NN
cord-005453-4057qib7	15787	30	incidence	incidence	NN
cord-005453-4057qib7	15787	31	,	,	,
cord-005453-4057qib7	15787	32	median	median	JJ
cord-005453-4057qib7	15787	33	neutrophil	neutrophil	NN
cord-005453-4057qib7	15787	34	and	and	CC
cord-005453-4057qib7	15787	35	platelet	platelet	NN
cord-005453-4057qib7	15787	36	engraftment	engraftment	NN
cord-005453-4057qib7	15787	37	times	time	NNS
cord-005453-4057qib7	15787	38	and	and	CC
cord-005453-4057qib7	15787	39	disease	disease	NN
cord-005453-4057qib7	15787	40	status	status	NN
cord-005453-4057qib7	15787	41	at	at	IN
cord-005453-4057qib7	15787	42	post	post	JJ
cord-005453-4057qib7	15787	43	-	-	JJ
cord-005453-4057qib7	15787	44	transplant	transplant	NN
cord-005453-4057qib7	15787	45	100	100	CD
cord-005453-4057qib7	15787	46	th	th	XX
cord-005453-4057qib7	15787	47	day	day	NN
cord-005453-4057qib7	15787	48	.	.	.
cord-005453-4057qib7	15788	1	No	no	DT
cord-005453-4057qib7	15788	2	significant	significant	JJ
cord-005453-4057qib7	15788	3	difference	difference	NN
cord-005453-4057qib7	15788	4	was	be	VBD
cord-005453-4057qib7	15788	5	identified	identify	VBN
cord-005453-4057qib7	15788	6	in	in	IN
cord-005453-4057qib7	15788	7	survival	survival	NN
cord-005453-4057qib7	15788	8	analysis	analysis	NN
cord-005453-4057qib7	15788	9	among	among	IN
cord-005453-4057qib7	15788	10	the	the	DT
cord-005453-4057qib7	15788	11	MUD	MUD	NNP
cord-005453-4057qib7	15788	12	10/10	10/10	CD
cord-005453-4057qib7	15788	13	,	,	,
cord-005453-4057qib7	15788	14	MMUD	MMUD	NNP
cord-005453-4057qib7	15788	15	9/10	9/10	CD
cord-005453-4057qib7	15788	16	and	and	CC
cord-005453-4057qib7	15788	17	HIDT	hidt	JJ
cord-005453-4057qib7	15788	18	groups	group	NNS
cord-005453-4057qib7	15788	19	,	,	,
cord-005453-4057qib7	15788	20	even	even	RB
cord-005453-4057qib7	15788	21	if	if	IN
cord-005453-4057qib7	15788	22	they	-PRON-	PRP
cord-005453-4057qib7	15788	23	were	be	VBD
cord-005453-4057qib7	15788	24	classified	classify	VBN
cord-005453-4057qib7	15788	25	according	accord	VBG
cord-005453-4057qib7	15788	26	to	to	IN
cord-005453-4057qib7	15788	27	primary	primary	JJ
cord-005453-4057qib7	15788	28	disease	disease	NN
cord-005453-4057qib7	15788	29	(	(	-LRB-
cord-005453-4057qib7	15788	30	AML	AML	NNP
cord-005453-4057qib7	15788	31	vs	vs	IN
cord-005453-4057qib7	15788	32	ALL	all	DT
cord-005453-4057qib7	15788	33	)	)	-RRB-
cord-005453-4057qib7	15788	34	and	and	CC
cord-005453-4057qib7	15788	35	pre	pre	JJ
cord-005453-4057qib7	15788	36	-	-	JJ
cord-005453-4057qib7	15788	37	transplant	transplant	JJ
cord-005453-4057qib7	15788	38	disease	disease	NN
cord-005453-4057qib7	15788	39	status	status	NN
cord-005453-4057qib7	15788	40	(	(	-LRB-
cord-005453-4057qib7	15788	41	CR1	CR1	NNP
cord-005453-4057qib7	15788	42	vs	vs	IN
cord-005453-4057qib7	15788	43	CR2	CR2	NNP
cord-005453-4057qib7	15788	44	)	)	-RRB-
cord-005453-4057qib7	15788	45	.	.	.
cord-005453-4057qib7	15789	1	Also	also	RB
cord-005453-4057qib7	15789	2	,	,	,
cord-005453-4057qib7	15789	3	donor	donor	NN
cord-005453-4057qib7	15789	4	CMV	cmv	NN
cord-005453-4057qib7	15789	5	status	status	NN
cord-005453-4057qib7	15789	6	(	(	-LRB-
cord-005453-4057qib7	15789	7	CMV	CMV	NNP
cord-005453-4057qib7	15789	8	IgG	igg	NN
cord-005453-4057qib7	15789	9	positivity	positivity	NN
cord-005453-4057qib7	15789	10	or	or	CC
cord-005453-4057qib7	15789	11	negativity	negativity	NN
cord-005453-4057qib7	15789	12	)	)	-RRB-
cord-005453-4057qib7	15789	13	was	be	VBD
cord-005453-4057qib7	15789	14	not	not	RB
cord-005453-4057qib7	15789	15	an	an	DT
cord-005453-4057qib7	15789	16	important	important	JJ
cord-005453-4057qib7	15789	17	factor	factor	NN
cord-005453-4057qib7	15789	18	on	on	IN
cord-005453-4057qib7	15789	19	survival	survival	NN
cord-005453-4057qib7	15789	20	analysis	analysis	NN
cord-005453-4057qib7	15789	21	when	when	WRB
cord-005453-4057qib7	15789	22	compared	compare	VBN
cord-005453-4057qib7	15789	23	between	between	IN
cord-005453-4057qib7	15789	24	these	these	DT
cord-005453-4057qib7	15789	25	three	three	CD
cord-005453-4057qib7	15789	26	groups	group	NNS
cord-005453-4057qib7	15789	27	(	(	-LRB-
cord-005453-4057qib7	15789	28	p=0.406).Conclusions	p=0.406).conclusion	NNS
cord-005453-4057qib7	15789	29	:	:	:
cord-005453-4057qib7	15789	30	In	in	IN
cord-005453-4057qib7	15789	31	our	-PRON-	PRP$
cord-005453-4057qib7	15789	32	study	study	NN
cord-005453-4057qib7	15789	33	population	population	NN
cord-005453-4057qib7	15789	34	,	,	,
cord-005453-4057qib7	15789	35	clinical	clinical	JJ
cord-005453-4057qib7	15789	36	outcomes	outcome	NNS
cord-005453-4057qib7	15789	37	of	of	IN
cord-005453-4057qib7	15789	38	HIDT	hidt	JJ
cord-005453-4057qib7	15789	39	patients	patient	NNS
cord-005453-4057qib7	15789	40	were	be	VBD
cord-005453-4057qib7	15789	41	inferior	inferior	JJ
cord-005453-4057qib7	15789	42	to	to	TO
cord-005453-4057qib7	15789	43	MUD	mud	NN
cord-005453-4057qib7	15789	44	10/10	10/10	CD
cord-005453-4057qib7	15789	45	and	and	CC
cord-005453-4057qib7	15789	46	MMUD	MMUD	NNP
cord-005453-4057qib7	15789	47	9/10	9/10	CD
cord-005453-4057qib7	15789	48	groups	group	NNS
cord-005453-4057qib7	15789	49	.	.	.
cord-005453-4057qib7	15790	1	When	when	WRB
cord-005453-4057qib7	15790	2	choosing	choose	VBG
cord-005453-4057qib7	15790	3	an	an	DT
cord-005453-4057qib7	15790	4	alternative	alternative	JJ
cord-005453-4057qib7	15790	5	donor	donor	NN
cord-005453-4057qib7	15790	6	for	for	IN
cord-005453-4057qib7	15790	7	patients	patient	NNS
cord-005453-4057qib7	15790	8	without	without	IN
cord-005453-4057qib7	15790	9	an	an	DT
cord-005453-4057qib7	15790	10	available	available	JJ
cord-005453-4057qib7	15790	11	HLA	HLA	NNP
cord-005453-4057qib7	15790	12	-	-	HYPH
cord-005453-4057qib7	15790	13	matched	match	VBN
cord-005453-4057qib7	15790	14	sibling	sibling	NN
cord-005453-4057qib7	15790	15	,	,	,
cord-005453-4057qib7	15790	16	urgency	urgency	NN
cord-005453-4057qib7	15790	17	of	of	IN
cord-005453-4057qib7	15790	18	transplantation	transplantation	NN
cord-005453-4057qib7	15790	19	and	and	CC
cord-005453-4057qib7	15790	20	host	host	NN
cord-005453-4057qib7	15790	21	/	/	SYM
cord-005453-4057qib7	15790	22	donor	donor	NN
cord-005453-4057qib7	15790	23	features	feature	NNS
cord-005453-4057qib7	15790	24	should	should	MD
cord-005453-4057qib7	15790	25	be	be	VB
cord-005453-4057qib7	15790	26	considered	consider	VBN
cord-005453-4057qib7	15790	27	.	.	.
cord-005453-4057qib7	15791	1	We	-PRON-	PRP
cord-005453-4057qib7	15791	2	believe	believe	VBP
cord-005453-4057qib7	15791	3	that	that	IN
cord-005453-4057qib7	15791	4	HIDT	HIDT	NNP
cord-005453-4057qib7	15791	5	might	may	MD
cord-005453-4057qib7	15791	6	be	be	VB
cord-005453-4057qib7	15791	7	a	a	DT
cord-005453-4057qib7	15791	8	feasible	feasible	JJ
cord-005453-4057qib7	15791	9	alternative	alternative	JJ
cord-005453-4057qib7	15791	10	choice	choice	NN
cord-005453-4057qib7	15791	11	in	in	IN
cord-005453-4057qib7	15791	12	this	this	DT
cord-005453-4057qib7	15791	13	subset	subset	NN
cord-005453-4057qib7	15791	14	of	of	IN
cord-005453-4057qib7	15791	15	patients	patient	NNS
cord-005453-4057qib7	15791	16	.	.	.
cord-005453-4057qib7	15792	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15792	2	:	:	:
cord-005453-4057qib7	15792	3	Nothing	nothing	NN
cord-005453-4057qib7	15792	4	to	to	TO
cord-005453-4057qib7	15792	5	declare	declare	VB
cord-005453-4057qib7	15792	6	P673	P673	NNP
cord-005453-4057qib7	15792	7	G	G	NNP
cord-005453-4057qib7	15792	8	-	-	HYPH
cord-005453-4057qib7	15792	9	CSF	csf	NN
cord-005453-4057qib7	15792	10	primed	prime	VBN
cord-005453-4057qib7	15792	11	bone	bone	NN
cord-005453-4057qib7	15792	12	marrow	marrow	NN
cord-005453-4057qib7	15792	13	in	in	IN
cord-005453-4057qib7	15792	14	HLA	HLA	NNP
cord-005453-4057qib7	15792	15	-	-	HYPH
cord-005453-4057qib7	15792	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15792	17	transplantation	transplantation	NN
cord-005453-4057qib7	15792	18	using	use	VBG
cord-005453-4057qib7	15792	19	post	post	JJ
cord-005453-4057qib7	15792	20	-	-	NN
cord-005453-4057qib7	15792	21	transplantation	transplantation	JJ
cord-005453-4057qib7	15792	22	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	15792	23	(	(	-LRB-
cord-005453-4057qib7	15792	24	PTCY	PTCY	NNP
cord-005453-4057qib7	15792	25	)	)	-RRB-
cord-005453-4057qib7	15792	26	could	could	MD
cord-005453-4057qib7	15792	27	promote	promote	VB
cord-005453-4057qib7	15792	28	tolerance	tolerance	NN
cord-005453-4057qib7	15792	29	and	and	CC
cord-005453-4057qib7	15792	30	further	further	RB
cord-005453-4057qib7	15792	31	reduce	reduce	VB
cord-005453-4057qib7	15792	32	risk	risk	NN
cord-005453-4057qib7	15792	33	of	of	IN
cord-005453-4057qib7	15792	34	GVHD	GVHD	NNP
cord-005453-4057qib7	15792	35	Nadira	Nadira	NNP
cord-005453-4057qib7	15792	36	Durakovic	Durakovic	NNP
cord-005453-4057qib7	15792	37	1,2	1,2	CD
cord-005453-4057qib7	15792	38	,	,	,
cord-005453-4057qib7	15792	39	Zinaida	Zinaida	NNP
cord-005453-4057qib7	15792	40	Perić	Perić	NNP
cord-005453-4057qib7	15792	41	1,2	1,2	CD
cord-005453-4057qib7	15792	42	,	,	,
cord-005453-4057qib7	15792	43	Lana	Lana	NNP
cord-005453-4057qib7	15792	44	Desnica	Desnica	NNP
cord-005453-4057qib7	15792	45	2	2	CD
cord-005453-4057qib7	15792	46	,	,	,
cord-005453-4057qib7	15792	47	Ranka	Ranka	NNP
cord-005453-4057qib7	15792	48	Serventi	Serventi	NNP
cord-005453-4057qib7	15792	49	-	-	HYPH
cord-005453-4057qib7	15792	50	Seiwerth	Seiwerth	NNP
cord-005453-4057qib7	15792	51	2	2	CD
cord-005453-4057qib7	15792	52	,	,	,
cord-005453-4057qib7	15792	53	Mirta	Mirta	NNP
cord-005453-4057qib7	15792	54	Mikulić	Mikulić	NNP
cord-005453-4057qib7	15792	55	2	2	CD
cord-005453-4057qib7	15792	56	,	,	,
cord-005453-4057qib7	15792	57	Brian	Brian	NNP
cord-005453-4057qib7	15792	58	Melamed	Melamed	NNP
cord-005453-4057qib7	15792	59	3	3	CD
cord-005453-4057qib7	15792	60	,	,	,
cord-005453-4057qib7	15792	61	Alen	Alen	NNP
cord-005453-4057qib7	15792	62	Ostojić	Ostojić	NNP
cord-005453-4057qib7	15792	63	2	2	CD
cord-005453-4057qib7	15792	64	,	,	,
cord-005453-4057qib7	15792	65	Dražen	Dražen	NNP
cord-005453-4057qib7	15792	66	Pulanić	Pulanić	NNP
cord-005453-4057qib7	15792	67	1,2	1,2	CD
cord-005453-4057qib7	15792	68	,	,	,
cord-005453-4057qib7	15792	69	Pavle	Pavle	NNP
cord-005453-4057qib7	15792	70	Rončević	Rončević	NNP
cord-005453-4057qib7	15792	71	2	2	CD
cord-005453-4057qib7	15792	72	,	,	,
cord-005453-4057qib7	15792	73	Zorana	Zorana	NNP
cord-005453-4057qib7	15792	74	Grubić	Grubić	NNP
cord-005453-4057qib7	15792	75	2	2	CD
cord-005453-4057qib7	15792	76	,	,	,
cord-005453-4057qib7	15792	77	Radovan	Radovan	NNP
cord-005453-4057qib7	15792	78	Vrhovac	Vrhovac	NNP
cord-005453-4057qib7	15792	79	1,2	1,2	CD
cord-005453-4057qib7	15792	80	implementation	implementation	NN
cord-005453-4057qib7	15792	81	,	,	,
cord-005453-4057qib7	15792	82	development	development	NN
cord-005453-4057qib7	15792	83	,	,	,
cord-005453-4057qib7	15792	84	and	and	CC
cord-005453-4057qib7	15792	85	coordination	coordination	NN
cord-005453-4057qib7	15792	86	of	of	IN
cord-005453-4057qib7	15792	87	unique	unique	JJ
cord-005453-4057qib7	15792	88	quality	quality	NN
cord-005453-4057qib7	15792	89	management	management	NN
cord-005453-4057qib7	15792	90	systems	system	NNS
cord-005453-4057qib7	15792	91	with	with	IN
cord-005453-4057qib7	15792	92	evaluation	evaluation	NN
cord-005453-4057qib7	15792	93	audits	audits	NN
cord-005453-4057qib7	15792	94	,	,	,
cord-005453-4057qib7	15792	95	intrahospital	intrahospital	NNP
cord-005453-4057qib7	15792	96	and	and	CC
cord-005453-4057qib7	15792	97	international	international	JJ
cord-005453-4057qib7	15792	98	accreditation	accreditation	NN
cord-005453-4057qib7	15792	99	and	and	CC
cord-005453-4057qib7	15792	100	certification	certification	NN
cord-005453-4057qib7	15792	101	processes	process	NNS
cord-005453-4057qib7	15792	102	.	.	.
cord-005453-4057qib7	15793	1	Quality	quality	NN
cord-005453-4057qib7	15793	2	of	of	IN
cord-005453-4057qib7	15793	3	health	health	NN
cord-005453-4057qib7	15793	4	care	care	NN
cord-005453-4057qib7	15793	5	is	be	VBZ
cord-005453-4057qib7	15793	6	a	a	DT
cord-005453-4057qib7	15793	7	major	major	JJ
cord-005453-4057qib7	15793	8	focus	focus	NN
cord-005453-4057qib7	15793	9	for	for	IN
cord-005453-4057qib7	15793	10	providers	provider	NNS
cord-005453-4057qib7	15793	11	,	,	,
cord-005453-4057qib7	15793	12	patients	patient	NNS
cord-005453-4057qib7	15793	13	,	,	,
cord-005453-4057qib7	15793	14	and	and	CC
cord-005453-4057qib7	15793	15	accreditors	accreditor	NNS
cord-005453-4057qib7	15793	16	;	;	:
cord-005453-4057qib7	15793	17	so	so	CC
cord-005453-4057qib7	15793	18	,	,	,
cord-005453-4057qib7	15793	19	in	in	IN
cord-005453-4057qib7	15793	20	this	this	DT
cord-005453-4057qib7	15793	21	study	study	NN
cord-005453-4057qib7	15793	22	,	,	,
cord-005453-4057qib7	15793	23	we	-PRON-	PRP
cord-005453-4057qib7	15793	24	aim	aim	VBP
cord-005453-4057qib7	15793	25	to	to	TO
cord-005453-4057qib7	15793	26	compare	compare	VB
cord-005453-4057qib7	15793	27	the	the	DT
cord-005453-4057qib7	15793	28	quality	quality	NN
cord-005453-4057qib7	15793	29	of	of	IN
cord-005453-4057qib7	15793	30	BM	BM	NNP
cord-005453-4057qib7	15793	31	harvested	harvest	VBN
cord-005453-4057qib7	15793	32	at	at	IN
cord-005453-4057qib7	15793	33	IPO	IPO	NNP
cord-005453-4057qib7	15793	34	-	-	HYPH
cord-005453-4057qib7	15793	35	Collection	Collection	NNP
cord-005453-4057qib7	15793	36	Centre	Centre	NNP
cord-005453-4057qib7	15793	37	(	(	-LRB-
cord-005453-4057qib7	15793	38	ICC	ICC	NNP
cord-005453-4057qib7	15793	39	)	)	-RRB-
cord-005453-4057qib7	15793	40	with	with	IN
cord-005453-4057qib7	15793	41	the	the	DT
cord-005453-4057qib7	15793	42	quality	quality	NN
cord-005453-4057qib7	15793	43	of	of	IN
cord-005453-4057qib7	15793	44	BM	BM	NNP
cord-005453-4057qib7	15793	45	received	receive	VBN
cord-005453-4057qib7	15793	46	from	from	IN
cord-005453-4057qib7	15793	47	External	External	NNP
cord-005453-4057qib7	15793	48	Collection	Collection	NNP
cord-005453-4057qib7	15793	49	Centres	Centres	NNPS
cord-005453-4057qib7	15793	50	(	(	-LRB-
cord-005453-4057qib7	15793	51	ECC	ECC	NNP
cord-005453-4057qib7	15793	52	)	)	-RRB-
cord-005453-4057qib7	15793	53	during	during	IN
cord-005453-4057qib7	15793	54	these	these	DT
cord-005453-4057qib7	15793	55	6	6	CD
cord-005453-4057qib7	15793	56	last	last	JJ
cord-005453-4057qib7	15793	57	years	year	NNS
cord-005453-4057qib7	15793	58	.	.	.
cord-005453-4057qib7	15794	1	Methods	method	NNS
cord-005453-4057qib7	15794	2	:	:	:
cord-005453-4057qib7	15795	1	This	this	DT
cord-005453-4057qib7	15795	2	retrospective	retrospective	JJ
cord-005453-4057qib7	15795	3	evaluation	evaluation	NN
cord-005453-4057qib7	15795	4	included	include	VBD
cord-005453-4057qib7	15795	5	the	the	DT
cord-005453-4057qib7	15795	6	number	number	NN
cord-005453-4057qib7	15795	7	of	of	IN
cord-005453-4057qib7	15795	8	total	total	JJ
cord-005453-4057qib7	15795	9	nucleated	nucleated	JJ
cord-005453-4057qib7	15795	10	cells	cell	NNS
cord-005453-4057qib7	15795	11	(	(	-LRB-
cord-005453-4057qib7	15795	12	TNC	TNC	NNP
cord-005453-4057qib7	15795	13	)	)	-RRB-
cord-005453-4057qib7	15795	14	requested	request	VBN
cord-005453-4057qib7	15795	15	by	by	IN
cord-005453-4057qib7	15795	16	the	the	DT
cord-005453-4057qib7	15795	17	Transplant	Transplant	NNP
cord-005453-4057qib7	15795	18	Centre	Centre	NNP
cord-005453-4057qib7	15795	19	,	,	,
cord-005453-4057qib7	15795	20	the	the	DT
cord-005453-4057qib7	15795	21	TNC	TNC	NNP
cord-005453-4057qib7	15795	22	collected	collect	VBD
cord-005453-4057qib7	15795	23	,	,	,
cord-005453-4057qib7	15795	24	and	and	CC
cord-005453-4057qib7	15795	25	the	the	DT
cord-005453-4057qib7	15795	26	results	result	NNS
cord-005453-4057qib7	15795	27	of	of	IN
cord-005453-4057qib7	15795	28	BM	BM	NNP
cord-005453-4057qib7	15795	29	microbiological	microbiological	JJ
cord-005453-4057qib7	15795	30	analysis	analysis	NN
cord-005453-4057qib7	15795	31	performed	perform	VBN
cord-005453-4057qib7	15795	32	;	;	:
cord-005453-4057qib7	15795	33	donor	donor	NN
cord-005453-4057qib7	15795	34	age	age	NN
cord-005453-4057qib7	15795	35	,	,	,
cord-005453-4057qib7	15795	36	weight	weight	NN
cord-005453-4057qib7	15795	37	and	and	CC
cord-005453-4057qib7	15795	38	infectious	infectious	JJ
cord-005453-4057qib7	15795	39	disease	disease	NN
cord-005453-4057qib7	15795	40	markers	marker	NNS
cord-005453-4057qib7	15795	41	(	(	-LRB-
cord-005453-4057qib7	15795	42	IDM	IDM	NNP
cord-005453-4057qib7	15795	43	)	)	-RRB-
cord-005453-4057qib7	15795	44	;	;	,
cord-005453-4057qib7	15795	45	patient	patient	JJ
cord-005453-4057qib7	15795	46	demographics	demographic	NNS
cord-005453-4057qib7	15795	47	and	and	CC
cord-005453-4057qib7	15795	48	diagnosis	diagnosis	NN
cord-005453-4057qib7	15795	49	.	.	.
cord-005453-4057qib7	15796	1	BM	BM	NNP
cord-005453-4057qib7	15796	2	collection	collection	NN
cord-005453-4057qib7	15796	3	technique	technique	NN
cord-005453-4057qib7	15796	4	in	in	IN
cord-005453-4057qib7	15796	5	use	use	NN
cord-005453-4057qib7	15796	6	at	at	IN
cord-005453-4057qib7	15796	7	ICC	ICC	NNP
cord-005453-4057qib7	15796	8	was	be	VBD
cord-005453-4057qib7	15796	9	validated	validate	VBN
cord-005453-4057qib7	15796	10	according	accord	VBG
cord-005453-4057qib7	15796	11	to	to	IN
cord-005453-4057qib7	15796	12	JACIE	JACIE	NNP
cord-005453-4057qib7	15796	13	Standards	Standards	NNP
cord-005453-4057qib7	15796	14	.	.	.
cord-005453-4057qib7	15797	1	We	-PRON-	PRP
cord-005453-4057qib7	15797	2	consider	consider	VBP
cord-005453-4057qib7	15797	3	successful	successful	JJ
cord-005453-4057qib7	15797	4	a	a	DT
cord-005453-4057qib7	15797	5	collection	collection	NN
cord-005453-4057qib7	15797	6	(	(	-LRB-
cord-005453-4057qib7	15797	7	SC	SC	NNP
cord-005453-4057qib7	15797	8	)	)	-RRB-
cord-005453-4057qib7	15797	9	with	with	IN
cord-005453-4057qib7	15797	10	TNC	TNC	NNP
cord-005453-4057qib7	15797	11	between	between	IN
cord-005453-4057qib7	15797	12	75	75	CD
cord-005453-4057qib7	15797	13	and	and	CC
cord-005453-4057qib7	15797	14	125	125	CD
cord-005453-4057qib7	15797	15	%	%	NN
cord-005453-4057qib7	15797	16	of	of	IN
cord-005453-4057qib7	15797	17	the	the	DT
cord-005453-4057qib7	15797	18	requested	request	VBN
cord-005453-4057qib7	15797	19	value	value	NN
cord-005453-4057qib7	15797	20	,	,	,
cord-005453-4057qib7	15797	21	unsuccessful	unsuccessful	JJ
cord-005453-4057qib7	15797	22	(	(	-LRB-
cord-005453-4057qib7	15797	23	UC	UC	NNP
cord-005453-4057qib7	15797	24	)	)	-RRB-
cord-005453-4057qib7	15798	1	if	if	IN
cord-005453-4057qib7	15798	2	lower	low	JJR
cord-005453-4057qib7	15798	3	than	than	IN
cord-005453-4057qib7	15798	4	75	75	CD
cord-005453-4057qib7	15798	5	%	%	NN
cord-005453-4057qib7	15798	6	and	and	CC
cord-005453-4057qib7	15798	7	outstanding	outstanding	JJ
cord-005453-4057qib7	15798	8	(	(	-LRB-
cord-005453-4057qib7	15798	9	OC	OC	NNP
cord-005453-4057qib7	15798	10	)	)	-RRB-
cord-005453-4057qib7	15798	11	if	if	IN
cord-005453-4057qib7	15798	12	over	over	IN
cord-005453-4057qib7	15798	13	125%.Results	125%.results	CD
cord-005453-4057qib7	15798	14	:	:	:
cord-005453-4057qib7	15798	15	A	a	DT
cord-005453-4057qib7	15798	16	total	total	NN
cord-005453-4057qib7	15798	17	of	of	IN
cord-005453-4057qib7	15798	18	106	106	CD
cord-005453-4057qib7	15798	19	BM	BM	NNP
cord-005453-4057qib7	15798	20	was	be	VBD
cord-005453-4057qib7	15798	21	collected	collect	VBN
cord-005453-4057qib7	15798	22	,	,	,
cord-005453-4057qib7	15798	23	99	99	CD
cord-005453-4057qib7	15798	24	for	for	IN
cord-005453-4057qib7	15798	25	allogenic	allogenic	JJ
cord-005453-4057qib7	15798	26	(	(	-LRB-
cord-005453-4057qib7	15798	27	75	75	CD
cord-005453-4057qib7	15798	28	unrelated	unrelated	JJ
cord-005453-4057qib7	15798	29	)	)	-RRB-
cord-005453-4057qib7	15798	30	and	and	CC
cord-005453-4057qib7	15798	31	seven	seven	CD
cord-005453-4057qib7	15798	32	for	for	IN
cord-005453-4057qib7	15798	33	autologous	autologous	JJ
cord-005453-4057qib7	15798	34	transplant	transplant	NN
cord-005453-4057qib7	15798	35	;	;	:
cord-005453-4057qib7	15798	36	21	21	CD
cord-005453-4057qib7	15798	37	unrelated	unrelated	JJ
cord-005453-4057qib7	15798	38	BM	BM	NNP
cord-005453-4057qib7	15798	39	were	be	VBD
cord-005453-4057qib7	15798	40	received	receive	VBN
cord-005453-4057qib7	15798	41	from	from	IN
cord-005453-4057qib7	15798	42	ECC	ECC	NNP
cord-005453-4057qib7	15798	43	(	(	-LRB-
cord-005453-4057qib7	15798	44	nine	nine	CD
cord-005453-4057qib7	15798	45	from	from	IN
cord-005453-4057qib7	15798	46	Germany	Germany	NNP
cord-005453-4057qib7	15798	47	,	,	,
cord-005453-4057qib7	15798	48	seven	seven	CD
cord-005453-4057qib7	15798	49	from	from	IN
cord-005453-4057qib7	15798	50	USA	USA	NNP
cord-005453-4057qib7	15798	51	and	and	CC
cord-005453-4057qib7	15798	52	five	five	CD
cord-005453-4057qib7	15798	53	from	from	IN
cord-005453-4057qib7	15798	54	Portugal	Portugal	NNP
cord-005453-4057qib7	15798	55	)	)	-RRB-
cord-005453-4057qib7	15798	56	.	.	.
cord-005453-4057qib7	15799	1	Patient	patient	JJ
cord-005453-4057qib7	15799	2	main	main	JJ
cord-005453-4057qib7	15799	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	15799	4	were	be	VBD
cord-005453-4057qib7	15799	5	severe	severe	JJ
cord-005453-4057qib7	15799	6	aplastic	aplastic	JJ
cord-005453-4057qib7	15799	7	anaemia	anaemia	NN
cord-005453-4057qib7	15799	8	(	(	-LRB-
cord-005453-4057qib7	15799	9	n=28	n=28	NN
cord-005453-4057qib7	15799	10	)	)	-RRB-
cord-005453-4057qib7	15799	11	,	,	,
cord-005453-4057qib7	15799	12	acute	acute	JJ
cord-005453-4057qib7	15799	13	myeloblastic	myeloblastic	JJ
cord-005453-4057qib7	15799	14	leukaemia	leukaemia	NN
cord-005453-4057qib7	15799	15	(	(	-LRB-
cord-005453-4057qib7	15799	16	n=20	n=20	NNP
cord-005453-4057qib7	15799	17	)	)	-RRB-
cord-005453-4057qib7	15799	18	,	,	,
cord-005453-4057qib7	15799	19	and	and	CC
cord-005453-4057qib7	15799	20	acute	acute	JJ
cord-005453-4057qib7	15799	21	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	15799	22	leukaemia	leukaemia	NN
cord-005453-4057qib7	15799	23	(	(	-LRB-
cord-005453-4057qib7	15799	24	n=15	n=15	NNP
cord-005453-4057qib7	15799	25	)	)	-RRB-
cord-005453-4057qib7	15799	26	.	.	.
cord-005453-4057qib7	15800	1	Donors	donor	NNS
cord-005453-4057qib7	15800	2	IDM	IDM	NNP
cord-005453-4057qib7	15800	3	were	be	VBD
cord-005453-4057qib7	15800	4	all	all	DT
cord-005453-4057qib7	15800	5	negative	negative	JJ
cord-005453-4057qib7	15800	6	and	and	CC
cord-005453-4057qib7	15800	7	nonreactive	nonreactive	JJ
cord-005453-4057qib7	15800	8	.	.	.
cord-005453-4057qib7	15801	1	Mean	mean	JJ
cord-005453-4057qib7	15801	2	age	age	NN
cord-005453-4057qib7	15801	3	(	(	-LRB-
cord-005453-4057qib7	15801	4	±standard	±standard	IN
cord-005453-4057qib7	15801	5	deviation	deviation	NN
cord-005453-4057qib7	15801	6	,	,	,
cord-005453-4057qib7	15801	7	SD	SD	NNP
cord-005453-4057qib7	15801	8	)	)	-RRB-
cord-005453-4057qib7	15801	9	was	be	VBD
cord-005453-4057qib7	15801	10	33	33	CD
cord-005453-4057qib7	15801	11	(	(	-LRB-
cord-005453-4057qib7	15801	12	±13.2	±13.2	CD
cord-005453-4057qib7	15801	13	)	)	-RRB-
cord-005453-4057qib7	15801	14	and	and	CC
cord-005453-4057qib7	15801	15	31	31	CD
cord-005453-4057qib7	15801	16	(	(	-LRB-
cord-005453-4057qib7	15801	17	±9.3	±9.3	NNP
cord-005453-4057qib7	15801	18	)	)	-RRB-
cord-005453-4057qib7	15801	19	years	year	NNS
cord-005453-4057qib7	15801	20	for	for	IN
cord-005453-4057qib7	15801	21	ICC	ICC	NNP
cord-005453-4057qib7	15801	22	and	and	CC
cord-005453-4057qib7	15801	23	ECC	ECC	NNP
cord-005453-4057qib7	15801	24	donors	donor	NNS
cord-005453-4057qib7	15801	25	,	,	,
cord-005453-4057qib7	15801	26	respectively	respectively	RB
cord-005453-4057qib7	15801	27	.	.	.
cord-005453-4057qib7	15802	1	At	at	IN
cord-005453-4057qib7	15802	2	ICC	ICC	NNP
cord-005453-4057qib7	15802	3	,	,	,
cord-005453-4057qib7	15802	4	we	-PRON-	PRP
cord-005453-4057qib7	15802	5	were	be	VBD
cord-005453-4057qib7	15802	6	asked	ask	VBN
cord-005453-4057qib7	15802	7	to	to	TO
cord-005453-4057qib7	15802	8	collect	collect	VB
cord-005453-4057qib7	15802	9	an	an	DT
cord-005453-4057qib7	15802	10	average	average	NN
cord-005453-4057qib7	15802	11	(	(	-LRB-
cord-005453-4057qib7	15802	12	±SD	±sd	RB
cord-005453-4057qib7	15802	13	)	)	-RRB-
cord-005453-4057qib7	15802	14	of	of	IN
cord-005453-4057qib7	15802	15	221.7	221.7	CD
cord-005453-4057qib7	15802	16	*	*	NFP
cord-005453-4057qib7	15802	17	10	10	CD
cord-005453-4057qib7	15802	18	8	8	CD
cord-005453-4057qib7	15802	19	(	(	-LRB-
cord-005453-4057qib7	15802	20	±136.0	±136.0	NN
cord-005453-4057qib7	15802	21	)	)	-RRB-
cord-005453-4057qib7	15802	22	TNC	TNC	NNP
cord-005453-4057qib7	15802	23	while	while	IN
cord-005453-4057qib7	15802	24	ECC	ECC	NNP
cord-005453-4057qib7	15802	25	were	be	VBD
cord-005453-4057qib7	15802	26	asked	ask	VBN
cord-005453-4057qib7	15802	27	for	for	IN
cord-005453-4057qib7	15802	28	184.7	184.7	CD
cord-005453-4057qib7	15802	29	*	*	NFP
cord-005453-4057qib7	15802	30	10	10	CD
cord-005453-4057qib7	15802	31	8	8	CD
cord-005453-4057qib7	15802	32	(	(	-LRB-
cord-005453-4057qib7	15802	33	±105.7	±105.7	RB
cord-005453-4057qib7	15802	34	)	)	-RRB-
cord-005453-4057qib7	15802	35	.	.	.
cord-005453-4057qib7	15803	1	We	-PRON-	PRP
cord-005453-4057qib7	15803	2	collected	collect	VBD
cord-005453-4057qib7	15803	3	169.7	169.7	CD
cord-005453-4057qib7	15803	4	*	*	SYM
cord-005453-4057qib7	15803	5	10	10	CD
cord-005453-4057qib7	15803	6	8	8	CD
cord-005453-4057qib7	15803	7	(	(	-LRB-
cord-005453-4057qib7	15803	8	±82.3	±82.3	NNP
cord-005453-4057qib7	15803	9	)	)	-RRB-
cord-005453-4057qib7	15803	10	and	and	CC
cord-005453-4057qib7	15803	11	received	receive	VBD
cord-005453-4057qib7	15803	12	204.5	204.5	CD
cord-005453-4057qib7	15803	13	*	*	NFP
cord-005453-4057qib7	15803	14	10	10	CD
cord-005453-4057qib7	15803	15	8	8	CD
cord-005453-4057qib7	15803	16	(	(	-LRB-
cord-005453-4057qib7	15803	17	±109.2	±109.2	NNP
cord-005453-4057qib7	15803	18	)	)	-RRB-
cord-005453-4057qib7	15803	19	TNC	TNC	NNP
cord-005453-4057qib7	15803	20	.	.	.
cord-005453-4057qib7	15804	1	Correlation	correlation	NN
cord-005453-4057qib7	15804	2	between	between	IN
cord-005453-4057qib7	15804	3	requested	request	VBN
cord-005453-4057qib7	15804	4	and	and	CC
cord-005453-4057qib7	15804	5	collected	collect	VBD
cord-005453-4057qib7	15804	6	TNC	TNC	NNP
cord-005453-4057qib7	15804	7	was	be	VBD
cord-005453-4057qib7	15804	8	0.69	0.69	CD
cord-005453-4057qib7	15804	9	at	at	IN
cord-005453-4057qib7	15804	10	ICC	ICC	NNP
cord-005453-4057qib7	15804	11	and	and	CC
cord-005453-4057qib7	15804	12	0.56	0.56	CD
cord-005453-4057qib7	15804	13	for	for	IN
cord-005453-4057qib7	15804	14	ECC.We	ECC.We	NNP
cord-005453-4057qib7	15804	15	had	have	VBD
cord-005453-4057qib7	15804	16	41.2	41.2	CD
cord-005453-4057qib7	15804	17	%	%	NN
cord-005453-4057qib7	15804	18	SC	SC	NNP
cord-005453-4057qib7	15804	19	and	and	CC
cord-005453-4057qib7	15804	20	26.8	26.8	CD
cord-005453-4057qib7	15804	21	%	%	NN
cord-005453-4057qib7	15804	22	OC	oc	NN
cord-005453-4057qib7	15804	23	meaning	mean	VBG
cord-005453-4057qib7	15804	24	an	an	DT
cord-005453-4057qib7	15804	25	accomplishment	accomplishment	NN
cord-005453-4057qib7	15804	26	of	of	IN
cord-005453-4057qib7	15804	27	68.0	68.0	CD
cord-005453-4057qib7	15804	28	%	%	NN
cord-005453-4057qib7	15804	29	.	.	.
cord-005453-4057qib7	15805	1	We	-PRON-	PRP
cord-005453-4057qib7	15805	2	failed	fail	VBD
cord-005453-4057qib7	15805	3	to	to	TO
cord-005453-4057qib7	15805	4	collect	collect	VB
cord-005453-4057qib7	15805	5	required	require	VBN
cord-005453-4057qib7	15805	6	TNC	TNC	NNP
cord-005453-4057qib7	15805	7	in	in	IN
cord-005453-4057qib7	15805	8	32.0	32.0	CD
cord-005453-4057qib7	15805	9	%	%	NN
cord-005453-4057qib7	15805	10	.	.	.
cord-005453-4057qib7	15806	1	Although	although	IN
cord-005453-4057qib7	15806	2	85	85	CD
cord-005453-4057qib7	15806	3	%	%	NN
cord-005453-4057qib7	15806	4	of	of	IN
cord-005453-4057qib7	15806	5	received	receive	VBN
cord-005453-4057qib7	15806	6	BM	BM	NNP
cord-005453-4057qib7	15806	7	fulfil	fulfil	VB
cord-005453-4057qib7	15806	8	TNC	TNC	NNP
cord-005453-4057qib7	15806	9	requirements	requirement	NNS
cord-005453-4057qib7	15806	10	,	,	,
cord-005453-4057qib7	15806	11	BM	BM	NNP
cord-005453-4057qib7	15806	12	processing	processing	NN
cord-005453-4057qib7	15806	13	lowered	lower	VBD
cord-005453-4057qib7	15806	14	this	this	DT
cord-005453-4057qib7	15806	15	value	value	NN
cord-005453-4057qib7	15806	16	to	to	IN
cord-005453-4057qib7	15806	17	55	55	CD
cord-005453-4057qib7	15806	18	%	%	NN
cord-005453-4057qib7	15806	19	due	due	JJ
cord-005453-4057qib7	15806	20	to	to	IN
cord-005453-4057qib7	15806	21	erythrocyte	erythrocyte	NN
cord-005453-4057qib7	15806	22	removal	removal	NN
cord-005453-4057qib7	15806	23	(	(	-LRB-
cord-005453-4057qib7	15806	24	seven	seven	CD
cord-005453-4057qib7	15806	25	patients	patient	NNS
cord-005453-4057qib7	15806	26	with	with	IN
cord-005453-4057qib7	15806	27	major	major	JJ
cord-005453-4057qib7	15806	28	ABO	ABO	NNP
cord-005453-4057qib7	15806	29	incompatibility	incompatibility	NN
cord-005453-4057qib7	15806	30	)	)	-RRB-
cord-005453-4057qib7	15806	31	and	and	CC
cord-005453-4057qib7	15806	32	plasma	plasma	NN
cord-005453-4057qib7	15806	33	reduction	reduction	NN
cord-005453-4057qib7	15806	34	(	(	-LRB-
cord-005453-4057qib7	15806	35	two	two	CD
cord-005453-4057qib7	15806	36	patients	patient	NNS
cord-005453-4057qib7	15806	37	with	with	IN
cord-005453-4057qib7	15806	38	ABO	ABO	NNP
cord-005453-4057qib7	15806	39	minor	minor	JJ
cord-005453-4057qib7	15806	40	incompatibility	incompatibility	NN
cord-005453-4057qib7	15806	41	)	)	-RRB-
cord-005453-4057qib7	15806	42	.	.	.
cord-005453-4057qib7	15807	1	These	these	DT
cord-005453-4057qib7	15807	2	steps	step	NNS
cord-005453-4057qib7	15807	3	reduce	reduce	VBP
cord-005453-4057qib7	15807	4	final	final	JJ
cord-005453-4057qib7	15807	5	TNC	TNC	NNP
cord-005453-4057qib7	15807	6	available	available	JJ
cord-005453-4057qib7	15807	7	for	for	IN
cord-005453-4057qib7	15807	8	transplant	transplant	NN
cord-005453-4057qib7	15807	9	.	.	.
cord-005453-4057qib7	15808	1	Weight	weight	NN
cord-005453-4057qib7	15808	2	difference	difference	NN
cord-005453-4057qib7	15808	3	between	between	IN
cord-005453-4057qib7	15808	4	donor	donor	NN
cord-005453-4057qib7	15808	5	and	and	CC
cord-005453-4057qib7	15808	6	patient	patient	NN
cord-005453-4057qib7	15808	7	had	have	VBD
cord-005453-4057qib7	15808	8	no	no	DT
cord-005453-4057qib7	15808	9	significant	significant	JJ
cord-005453-4057qib7	15808	10	impact	impact	NN
cord-005453-4057qib7	15808	11	on	on	IN
cord-005453-4057qib7	15808	12	final	final	JJ
cord-005453-4057qib7	15808	13	TNC	TNC	NNP
cord-005453-4057qib7	15808	14	collection	collection	NN
cord-005453-4057qib7	15808	15	performance	performance	NN
cord-005453-4057qib7	15808	16	.	.	.
cord-005453-4057qib7	15809	1	Sixteen	sixteen	CD
cord-005453-4057qib7	15809	2	BM	BM	NNP
cord-005453-4057qib7	15809	3	from	from	IN
cord-005453-4057qib7	15809	4	ICC	ICC	NNP
cord-005453-4057qib7	15809	5	(	(	-LRB-
cord-005453-4057qib7	15809	6	seven	seven	CD
cord-005453-4057qib7	15809	7	Staphylococcus	Staphylococcus	NNP
cord-005453-4057qib7	15809	8	spp	spp	NNS
cord-005453-4057qib7	15809	9	.	.	.
cord-005453-4057qib7	15810	1	,	,	,
cord-005453-4057qib7	15810	2	five	five	CD
cord-005453-4057qib7	15810	3	Propionibacterium	Propionibacterium	NNP
cord-005453-4057qib7	15810	4	acnesand	acnesand	NN
cord-005453-4057qib7	15810	5	fourCorynebacterium	fourcorynebacterium	NN
cord-005453-4057qib7	15810	6	spp	spp	NN
cord-005453-4057qib7	15810	7	.	.	.
cord-005453-4057qib7	15810	8	)	)	-RRB-
cord-005453-4057qib7	15811	1	Background	background	NN
cord-005453-4057qib7	15811	2	:	:	:
cord-005453-4057qib7	15812	1	Success	success	NN
cord-005453-4057qib7	15812	2	of	of	IN
cord-005453-4057qib7	15812	3	peripheral	peripheral	JJ
cord-005453-4057qib7	15812	4	blood	blood	NN
cord-005453-4057qib7	15812	5	stem	stem	NN
cord-005453-4057qib7	15812	6	cell	cell	NN
cord-005453-4057qib7	15812	7	(	(	-LRB-
cord-005453-4057qib7	15812	8	PBSC	PBSC	NNP
cord-005453-4057qib7	15812	9	)	)	-RRB-
cord-005453-4057qib7	15812	10	collections	collection	NNS
cord-005453-4057qib7	15812	11	depends	depend	VBZ
cord-005453-4057qib7	15812	12	on	on	IN
cord-005453-4057qib7	15812	13	patient	patient	JJ
cord-005453-4057qib7	15812	14	biological	biological	JJ
cord-005453-4057qib7	15812	15	parameters	parameter	NNS
cord-005453-4057qib7	15812	16	and	and	CC
cord-005453-4057qib7	15812	17	stable	stable	JJ
cord-005453-4057qib7	15812	18	apheresis	apheresis	NN
cord-005453-4057qib7	15812	19	device	device	NN
cord-005453-4057qib7	15812	20	performance	performance	NN
cord-005453-4057qib7	15812	21	.	.	.
cord-005453-4057qib7	15813	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	15813	2	blood	blood	NN
cord-005453-4057qib7	15814	1	CD34	CD34	NNP
cord-005453-4057qib7	15814	2	+	+	CC
cord-005453-4057qib7	15814	3	cell	cell	NN
cord-005453-4057qib7	15814	4	enumeration	enumeration	NN
cord-005453-4057qib7	15814	5	is	be	VBZ
cord-005453-4057qib7	15814	6	the	the	DT
cord-005453-4057qib7	15814	7	most	most	RBS
cord-005453-4057qib7	15814	8	reliable	reliable	JJ
cord-005453-4057qib7	15814	9	predictive	predictive	JJ
cord-005453-4057qib7	15814	10	factor	factor	NN
cord-005453-4057qib7	15814	11	of	of	IN
cord-005453-4057qib7	15814	12	apheresis	apheresis	NN
cord-005453-4057qib7	15814	13	yield	yield	NN
cord-005453-4057qib7	15814	14	however	however	RB
cord-005453-4057qib7	15814	15	,	,	,
cord-005453-4057qib7	15814	16	there	there	EX
cord-005453-4057qib7	15814	17	are	be	VBP
cord-005453-4057qib7	15814	18	some	some	DT
cord-005453-4057qib7	15814	19	unexpectedly	unexpectedly	RB
cord-005453-4057qib7	15814	20	poor	poor	JJ
cord-005453-4057qib7	15814	21	CD34	CD34	NNP
cord-005453-4057qib7	15814	22	+	+	CC
cord-005453-4057qib7	15814	23	cell	cell	NN
cord-005453-4057qib7	15814	24	harvests	harvest	NNS
cord-005453-4057qib7	15814	25	despite	despite	IN
cord-005453-4057qib7	15814	26	successful	successful	JJ
cord-005453-4057qib7	15814	27	mobilization	mobilization	NN
cord-005453-4057qib7	15814	28	.	.	.
cord-005453-4057qib7	15815	1	The	the	DT
cord-005453-4057qib7	15815	2	aim	aim	NN
cord-005453-4057qib7	15815	3	of	of	IN
cord-005453-4057qib7	15815	4	the	the	DT
cord-005453-4057qib7	15815	5	study	study	NN
cord-005453-4057qib7	15815	6	was	be	VBD
cord-005453-4057qib7	15815	7	assess	assess	VB
cord-005453-4057qib7	15815	8	total	total	JJ
cord-005453-4057qib7	15815	9	collections	collection	NNS
cord-005453-4057qib7	15816	1	CD34	CD34	NNP
cord-005453-4057qib7	15816	2	+	+	CC
cord-005453-4057qib7	15816	3	yields	yield	NNS
cord-005453-4057qib7	15816	4	and	and	CC
cord-005453-4057qib7	15816	5	factors	factor	NNS
cord-005453-4057qib7	15816	6	influencing	influence	VBG
cord-005453-4057qib7	15816	7	main	main	JJ
cord-005453-4057qib7	15816	8	apheresis	apheresis	NN
cord-005453-4057qib7	15816	9	procedure	procedure	NN
cord-005453-4057qib7	15816	10	outcomes	outcome	NNS
cord-005453-4057qib7	15816	11	including	include	VBG
cord-005453-4057qib7	15816	12	collection	collection	NN
cord-005453-4057qib7	15816	13	efficiency	efficiency	NN
cord-005453-4057qib7	15816	14	(	(	-LRB-
cord-005453-4057qib7	15816	15	CE).Methods	ce).method	NNS
cord-005453-4057qib7	15816	16	:	:	:
cord-005453-4057qib7	15816	17	Of	of	IN
cord-005453-4057qib7	15816	18	2233	2233	CD
cord-005453-4057qib7	15816	19	consecutive	consecutive	JJ
cord-005453-4057qib7	15816	20	donors	donor	NNS
cord-005453-4057qib7	15816	21	covering	cover	VBG
cord-005453-4057qib7	15816	22	the	the	DT
cord-005453-4057qib7	15816	23	period	period	NN
cord-005453-4057qib7	15816	24	1	1	CD
cord-005453-4057qib7	15816	25	-	-	HYPH
cord-005453-4057qib7	15816	26	1	1	CD
cord-005453-4057qib7	15816	27	-	-	HYPH
cord-005453-4057qib7	15816	28	2016	2016	CD
cord-005453-4057qib7	15816	29	to	to	TO
cord-005453-4057qib7	15816	30	30	30	CD
cord-005453-4057qib7	15816	31	-	-	SYM
cord-005453-4057qib7	15816	32	9	9	CD
cord-005453-4057qib7	15816	33	-	-	SYM
cord-005453-4057qib7	15816	34	2018	2018	CD
cord-005453-4057qib7	15816	35	were	be	VBD
cord-005453-4057qib7	15816	36	analyzed	analyze	VBN
cord-005453-4057qib7	15816	37	for	for	IN
cord-005453-4057qib7	15816	38	the	the	DT
cord-005453-4057qib7	15816	39	following	follow	VBG
cord-005453-4057qib7	15816	40	parameters	parameter	NNS
cord-005453-4057qib7	15816	41	:	:	:
cord-005453-4057qib7	15816	42	pre	pre	VB
cord-005453-4057qib7	15816	43	CD34	CD34	NNP
cord-005453-4057qib7	15816	44	count	count	VB
cord-005453-4057qib7	15817	1	,	,	,
cord-005453-4057qib7	15817	2	CD34	CD34	NNP
cord-005453-4057qib7	15817	3	yield	yield	NN
cord-005453-4057qib7	15817	4	per	per	IN
cord-005453-4057qib7	15817	5	procedure	procedure	NN
cord-005453-4057qib7	15817	6	,	,	,
cord-005453-4057qib7	15817	7	total	total	JJ
cord-005453-4057qib7	15817	8	CD34	CD34	NNP
cord-005453-4057qib7	15817	9	dose	dose	NN
cord-005453-4057qib7	15817	10	collected	collect	VBN
cord-005453-4057qib7	15817	11	per	per	IN
cord-005453-4057qib7	15817	12	patient	patient	NN
cord-005453-4057qib7	15817	13	,	,	,
cord-005453-4057qib7	15817	14	CD34	CD34	NNP
cord-005453-4057qib7	15817	15	collection	collection	NN
cord-005453-4057qib7	15817	16	targets	target	NNS
cord-005453-4057qib7	15817	17	requested	request	VBN
cord-005453-4057qib7	15817	18	by	by	IN
cord-005453-4057qib7	15817	19	clinical	clinical	JJ
cord-005453-4057qib7	15817	20	teams	team	NNS
cord-005453-4057qib7	15817	21	.	.	.
cord-005453-4057qib7	15818	1	The	the	DT
cord-005453-4057qib7	15818	2	efficiency	efficiency	NN
cord-005453-4057qib7	15818	3	of	of	IN
cord-005453-4057qib7	15818	4	PBSC	PBSC	NNP
cord-005453-4057qib7	15818	5	procedures	procedure	NNS
cord-005453-4057qib7	15818	6	was	be	VBD
cord-005453-4057qib7	15818	7	determined	determine	VBN
cord-005453-4057qib7	15818	8	by	by	IN
cord-005453-4057qib7	15818	9	calculating	calculate	VBG
cord-005453-4057qib7	15818	10	the	the	DT
cord-005453-4057qib7	15818	11	CE	CE	NNP
cord-005453-4057qib7	15818	12	and	and	CC
cord-005453-4057qib7	15818	13	the	the	DT
cord-005453-4057qib7	15818	14	correlation	correlation	NN
cord-005453-4057qib7	15818	15	coefficient	coefficient	NN
cord-005453-4057qib7	15818	16	between	between	IN
cord-005453-4057qib7	15818	17	pre	pre	``
cord-005453-4057qib7	15818	18	CD34	CD34	NNP
cord-005453-4057qib7	15818	19	count	count	VB
cord-005453-4057qib7	15818	20	and	and	CC
cord-005453-4057qib7	15818	21	yield	yield	VB
cord-005453-4057qib7	15818	22	per	per	IN
cord-005453-4057qib7	15818	23	procedure	procedure	NN
cord-005453-4057qib7	15818	24	.	.	.
cord-005453-4057qib7	15819	1	CE	CE	NNP
cord-005453-4057qib7	15819	2	was	be	VBD
cord-005453-4057qib7	15819	3	correlated	correlate	VBN
cord-005453-4057qib7	15819	4	to	to	TO
cord-005453-4057qib7	15819	5	preprocedure	preprocedure	VB
cord-005453-4057qib7	15819	6	WBC	WBC	NNP
cord-005453-4057qib7	15819	7	,	,	,
cord-005453-4057qib7	15819	8	platelet	platelet	NN
cord-005453-4057qib7	15819	9	count	count	NN
cord-005453-4057qib7	15819	10	,	,	,
cord-005453-4057qib7	15819	11	pre	pre	VB
cord-005453-4057qib7	15819	12	CD34	CD34	NNP
cord-005453-4057qib7	15819	13	count	count	NN
cord-005453-4057qib7	15819	14	and	and	CC
cord-005453-4057qib7	15819	15	blood	blood	NN
cord-005453-4057qib7	15819	16	volume	volume	NN
cord-005453-4057qib7	15819	17	processed	process	VBN
cord-005453-4057qib7	15819	18	.	.	.
cord-005453-4057qib7	15820	1	All	all	DT
cord-005453-4057qib7	15820	2	PBSC	PBSC	NNP
cord-005453-4057qib7	15820	3	collections	collection	NNS
cord-005453-4057qib7	15820	4	were	be	VBD
cord-005453-4057qib7	15820	5	performed	perform	VBN
cord-005453-4057qib7	15820	6	by	by	IN
cord-005453-4057qib7	15820	7	Optia	Optia	NNP
cord-005453-4057qib7	15820	8	Spectra	Spectra	NNP
cord-005453-4057qib7	15820	9	across	across	IN
cord-005453-4057qib7	15820	10	7	7	CD
cord-005453-4057qib7	15820	11	units	unit	NNS
cord-005453-4057qib7	15820	12	in	in	IN
cord-005453-4057qib7	15820	13	UK.Results	uk.results	CD
cord-005453-4057qib7	15820	14	:	:	:
cord-005453-4057qib7	15821	1	Of	of	IN
cord-005453-4057qib7	15821	2	the	the	DT
cord-005453-4057qib7	15821	3	2233	2233	CD
cord-005453-4057qib7	15821	4	donors	donor	NNS
cord-005453-4057qib7	15821	5	,	,	,
cord-005453-4057qib7	15821	6	1611	1611	CD
cord-005453-4057qib7	15821	7	were	be	VBD
cord-005453-4057qib7	15821	8	autologous	autologous	JJ
cord-005453-4057qib7	15821	9	and	and	CC
cord-005453-4057qib7	15821	10	622	622	CD
cord-005453-4057qib7	15821	11	allogeneic	allogeneic	NN
cord-005453-4057qib7	15821	12	.	.	.
cord-005453-4057qib7	15822	1	The	the	DT
cord-005453-4057qib7	15822	2	autologous	autologous	JJ
cord-005453-4057qib7	15822	3	donors	donor	NNS
cord-005453-4057qib7	15822	4	underwent	undergo	VBD
cord-005453-4057qib7	15822	5	in	in	IN
cord-005453-4057qib7	15822	6	total	total	JJ
cord-005453-4057qib7	15822	7	2543	2543	CD
cord-005453-4057qib7	15822	8	procedures	procedure	NNS
cord-005453-4057qib7	15822	9	.	.	.
cord-005453-4057qib7	15823	1	The	the	DT
cord-005453-4057qib7	15823	2	median	median	JJ
cord-005453-4057qib7	15823	3	CD34	CD34	NNP
cord-005453-4057qib7	15823	4	target	target	NN
cord-005453-4057qib7	15823	5	dose	dose	NN
cord-005453-4057qib7	15823	6	for	for	IN
cord-005453-4057qib7	15823	7	these	these	DT
cord-005453-4057qib7	15823	8	donors	donor	NNS
cord-005453-4057qib7	15823	9	was	be	VBD
cord-005453-4057qib7	15823	10	4x10	4x10	CD
cord-005453-4057qib7	15823	11	6	6	CD
cord-005453-4057qib7	15823	12	/kg.799	/kg.799	.
cord-005453-4057qib7	15823	13	(	(	-LRB-
cord-005453-4057qib7	15823	14	50	50	CD
cord-005453-4057qib7	15823	15	%	%	NN
cord-005453-4057qib7	15823	16	)	)	-RRB-
cord-005453-4057qib7	15823	17	achieved	achieve	VBD
cord-005453-4057qib7	15823	18	the	the	DT
cord-005453-4057qib7	15823	19	target	target	NN
cord-005453-4057qib7	15823	20	dose	dose	NN
cord-005453-4057qib7	15823	21	with	with	IN
cord-005453-4057qib7	15823	22	1	1	CD
cord-005453-4057qib7	15823	23	procedure	procedure	NN
cord-005453-4057qib7	15823	24	and	and	CC
cord-005453-4057qib7	15823	25	566	566	CD
cord-005453-4057qib7	15823	26	(	(	-LRB-
cord-005453-4057qib7	15823	27	35	35	CD
cord-005453-4057qib7	15823	28	%	%	NN
cord-005453-4057qib7	15823	29	)	)	-RRB-
cord-005453-4057qib7	15823	30	with	with	IN
cord-005453-4057qib7	15823	31	2	2	CD
cord-005453-4057qib7	15823	32	procedures	procedure	NNS
cord-005453-4057qib7	15823	33	.	.	.
cord-005453-4057qib7	15824	1	The	the	DT
cord-005453-4057qib7	15824	2	median	median	NN
cord-005453-4057qib7	15824	3	pre	pre	JJ
cord-005453-4057qib7	15824	4	CD34	CD34	NNP
cord-005453-4057qib7	15824	5	count	count	NN
cord-005453-4057qib7	15824	6	was	be	VBD
cord-005453-4057qib7	15824	7	30	30	CD
cord-005453-4057qib7	15824	8	/	/	SYM
cord-005453-4057qib7	15824	9	μl	μl	NN
cord-005453-4057qib7	15824	10	.	.	.
cord-005453-4057qib7	15825	1	The	the	DT
cord-005453-4057qib7	15825	2	median	median	JJ
cord-005453-4057qib7	15825	3	CD34	CD34	NNP
cord-005453-4057qib7	15825	4	yield	yield	NN
cord-005453-4057qib7	15825	5	per	per	IN
cord-005453-4057qib7	15825	6	procedure	procedure	NN
cord-005453-4057qib7	15825	7	was	be	VBD
cord-005453-4057qib7	15825	8	2.54x10	2.54x10	CD
cord-005453-4057qib7	15825	9	6	6	CD
cord-005453-4057qib7	15825	10	/kg	/kg	.
cord-005453-4057qib7	15825	11	and	and	CC
cord-005453-4057qib7	15825	12	the	the	DT
cord-005453-4057qib7	15825	13	median	median	JJ
cord-005453-4057qib7	15825	14	total	total	JJ
cord-005453-4057qib7	15825	15	CD34	CD34	NNP
cord-005453-4057qib7	15825	16	dose	dose	NN
cord-005453-4057qib7	15825	17	collected	collect	VBN
cord-005453-4057qib7	15825	18	per	per	IN
cord-005453-4057qib7	15825	19	donor	donor	NN
cord-005453-4057qib7	15825	20	was	be	VBD
cord-005453-4057qib7	15825	21	5.38x10	5.38x10	CD
cord-005453-4057qib7	15825	22	6	6	CD
cord-005453-4057qib7	15826	1	/kg	/kg	NFP
cord-005453-4057qib7	15826	2	.	.	.
cord-005453-4057qib7	15826	3	92	92	CD
cord-005453-4057qib7	15826	4	(	(	-LRB-
cord-005453-4057qib7	15826	5	5.7	5.7	CD
cord-005453-4057qib7	15826	6	%	%	NN
cord-005453-4057qib7	15826	7	)	)	-RRB-
cord-005453-4057qib7	15826	8	of	of	IN
cord-005453-4057qib7	15826	9	autologous	autologous	JJ
cord-005453-4057qib7	15826	10	donors	donor	NNS
cord-005453-4057qib7	15826	11	collected	collect	VBD
cord-005453-4057qib7	15826	12	a	a	DT
cord-005453-4057qib7	15826	13	total	total	JJ
cord-005453-4057qib7	15826	14	CD34	CD34	NNP
cord-005453-4057qib7	15826	15	dose	dose	NN
cord-005453-4057qib7	15826	16	<	<	NNP
cord-005453-4057qib7	15826	17	2x10	2x10	CD
cord-005453-4057qib7	15826	18	6	6	CD
cord-005453-4057qib7	15826	19	/kg	/kg	NFP
cord-005453-4057qib7	15826	20	,	,	,
cord-005453-4057qib7	15826	21	of	of	IN
cord-005453-4057qib7	15826	22	those	those	DT
cord-005453-4057qib7	15826	23	27	27	CD
cord-005453-4057qib7	15826	24	(	(	-LRB-
cord-005453-4057qib7	15826	25	1.7	1.7	CD
cord-005453-4057qib7	15826	26	%	%	NN
cord-005453-4057qib7	15826	27	)	)	-RRB-
cord-005453-4057qib7	15826	28	had	have	VBD
cord-005453-4057qib7	15826	29	a	a	DT
cord-005453-4057qib7	15826	30	pre	pre	JJ
cord-005453-4057qib7	15826	31	CD34	CD34	NNP
cord-005453-4057qib7	15826	32	count	count	VB
cord-005453-4057qib7	15827	1	<	<	NNP
cord-005453-4057qib7	15827	2	10	10	CD
cord-005453-4057qib7	15827	3	/	/	SYM
cord-005453-4057qib7	15827	4	μl	μl	NN
cord-005453-4057qib7	15827	5	and	and	CC
cord-005453-4057qib7	15827	6	65	65	CD
cord-005453-4057qib7	15827	7	(	(	-LRB-
cord-005453-4057qib7	15827	8	4	4	CD
cord-005453-4057qib7	15827	9	%	%	NN
cord-005453-4057qib7	15827	10	)	)	-RRB-
cord-005453-4057qib7	15828	1	>	>	XX
cord-005453-4057qib7	15829	1	10	10	CD
cord-005453-4057qib7	15829	2	/	/	SYM
cord-005453-4057qib7	15829	3	μl	μl	NN
cord-005453-4057qib7	15829	4	.	.	.
cord-005453-4057qib7	15830	1	The	the	DT
cord-005453-4057qib7	15830	2	allogeneic	allogeneic	NN
cord-005453-4057qib7	15830	3	donors	donor	NNS
cord-005453-4057qib7	15830	4	underwent	undergo	VBD
cord-005453-4057qib7	15830	5	in	in	IN
cord-005453-4057qib7	15830	6	total	total	JJ
cord-005453-4057qib7	15830	7	878	878	CD
cord-005453-4057qib7	15830	8	procedures	procedure	NNS
cord-005453-4057qib7	15830	9	.	.	.
cord-005453-4057qib7	15831	1	The	the	DT
cord-005453-4057qib7	15831	2	median	median	JJ
cord-005453-4057qib7	15831	3	CD34	CD34	NNP
cord-005453-4057qib7	15831	4	target	target	NN
cord-005453-4057qib7	15831	5	dose	dose	NN
cord-005453-4057qib7	15831	6	for	for	IN
cord-005453-4057qib7	15831	7	these	these	DT
cord-005453-4057qib7	15831	8	donors	donor	NNS
cord-005453-4057qib7	15831	9	was	be	VBD
cord-005453-4057qib7	15831	10	5x10	5x10	CD
cord-005453-4057qib7	15831	11	6	6	CD
cord-005453-4057qib7	15831	12	/	/	SYM
cord-005453-4057qib7	15831	13	kg	kg	NNS
cord-005453-4057qib7	15831	14	.	.	.
cord-005453-4057qib7	15832	1	381	381	CD
cord-005453-4057qib7	15832	2	allogeneic	allogeneic	IN
cord-005453-4057qib7	15832	3	donors	donor	NNS
cord-005453-4057qib7	15832	4	(	(	-LRB-
cord-005453-4057qib7	15832	5	61	61	CD
cord-005453-4057qib7	15832	6	%	%	NN
cord-005453-4057qib7	15832	7	)	)	-RRB-
cord-005453-4057qib7	15832	8	achieved	achieve	VBD
cord-005453-4057qib7	15832	9	the	the	DT
cord-005453-4057qib7	15832	10	target	target	NN
cord-005453-4057qib7	15832	11	dose	dose	NN
cord-005453-4057qib7	15832	12	with	with	IN
cord-005453-4057qib7	15832	13	1	1	CD
cord-005453-4057qib7	15832	14	procedure	procedure	NN
cord-005453-4057qib7	15832	15	and	and	CC
cord-005453-4057qib7	15832	16	221	221	CD
cord-005453-4057qib7	15832	17	(	(	-LRB-
cord-005453-4057qib7	15832	18	36	36	CD
cord-005453-4057qib7	15832	19	%	%	NN
cord-005453-4057qib7	15832	20	)	)	-RRB-
cord-005453-4057qib7	15832	21	with	with	IN
cord-005453-4057qib7	15832	22	2	2	CD
cord-005453-4057qib7	15832	23	procedures	procedure	NNS
cord-005453-4057qib7	15832	24	.	.	.
cord-005453-4057qib7	15833	1	The	the	DT
cord-005453-4057qib7	15833	2	median	median	NN
cord-005453-4057qib7	15833	3	pre	pre	JJ
cord-005453-4057qib7	15833	4	CD34	CD34	NNP
cord-005453-4057qib7	15833	5	count	count	NN
cord-005453-4057qib7	15833	6	was	be	VBD
cord-005453-4057qib7	15833	7	51	51	CD
cord-005453-4057qib7	15833	8	/	/	SYM
cord-005453-4057qib7	15833	9	μl	μl	NN
cord-005453-4057qib7	15833	10	.	.	.
cord-005453-4057qib7	15834	1	The	the	DT
cord-005453-4057qib7	15834	2	median	median	JJ
cord-005453-4057qib7	15834	3	CD34	CD34	NNP
cord-005453-4057qib7	15834	4	yield	yield	NN
cord-005453-4057qib7	15834	5	per	per	IN
cord-005453-4057qib7	15834	6	procedure	procedure	NN
cord-005453-4057qib7	15834	7	was	be	VBD
cord-005453-4057qib7	15834	8	4.07x10	4.07x10	CD
cord-005453-4057qib7	15834	9	6	6	CD
cord-005453-4057qib7	15834	10	/kg	/kg	.
cord-005453-4057qib7	15834	11	and	and	CC
cord-005453-4057qib7	15834	12	the	the	DT
cord-005453-4057qib7	15834	13	median	median	NN
cord-005453-4057qib7	15834	14	of	of	IN
cord-005453-4057qib7	15834	15	total	total	JJ
cord-005453-4057qib7	15834	16	CD34	CD34	NNP
cord-005453-4057qib7	15834	17	dose	dose	NN
cord-005453-4057qib7	15834	18	collected	collect	VBN
cord-005453-4057qib7	15834	19	per	per	IN
cord-005453-4057qib7	15834	20	donor	donor	NN
cord-005453-4057qib7	15834	21	was	be	VBD
cord-005453-4057qib7	15834	22	6.70x10	6.70x10	CD
cord-005453-4057qib7	15834	23	6	6	CD
cord-005453-4057qib7	15835	1	/kg	/kg	NFP
cord-005453-4057qib7	15835	2	.	.	.
cord-005453-4057qib7	15836	1	17	17	CD
cord-005453-4057qib7	15836	2	(	(	-LRB-
cord-005453-4057qib7	15836	3	2.7	2.7	CD
cord-005453-4057qib7	15836	4	)	)	-RRB-
cord-005453-4057qib7	15836	5	%	%	NN
cord-005453-4057qib7	15836	6	of	of	IN
cord-005453-4057qib7	15836	7	allogeneic	allogeneic	NN
cord-005453-4057qib7	15836	8	donors	donor	NNS
cord-005453-4057qib7	15836	9	collected	collect	VBD
cord-005453-4057qib7	15836	10	a	a	DT
cord-005453-4057qib7	15836	11	total	total	JJ
cord-005453-4057qib7	15836	12	CD34	CD34	NNP
cord-005453-4057qib7	15836	13	dose	dose	NN
cord-005453-4057qib7	15836	14	<	<	NNP
cord-005453-4057qib7	15836	15	2x10	2x10	CD
cord-005453-4057qib7	15836	16	6	6	CD
cord-005453-4057qib7	15836	17	/	/	SYM
cord-005453-4057qib7	15836	18	kg	kg	NNS
cord-005453-4057qib7	15836	19	,	,	,
cord-005453-4057qib7	15836	20	of	of	IN
cord-005453-4057qib7	15836	21	those	those	DT
cord-005453-4057qib7	15836	22	3	3	CD
cord-005453-4057qib7	15836	23	(	(	-LRB-
cord-005453-4057qib7	15836	24	0.5	0.5	CD
cord-005453-4057qib7	15836	25	%	%	NN
cord-005453-4057qib7	15836	26	)	)	-RRB-
cord-005453-4057qib7	15836	27	had	have	VBD
cord-005453-4057qib7	15836	28	a	a	DT
cord-005453-4057qib7	15836	29	pre	pre	JJ
cord-005453-4057qib7	15836	30	CD34	CD34	NNP
cord-005453-4057qib7	15836	31	count	count	VB
cord-005453-4057qib7	15837	1	<	<	NNP
cord-005453-4057qib7	15837	2	10	10	CD
cord-005453-4057qib7	15837	3	/	/	SYM
cord-005453-4057qib7	15837	4	μl	μl	NN
cord-005453-4057qib7	15837	5	and	and	CC
cord-005453-4057qib7	15837	6	14	14	CD
cord-005453-4057qib7	15837	7	(	(	-LRB-
cord-005453-4057qib7	15837	8	2.2	2.2	CD
cord-005453-4057qib7	15837	9	%	%	NN
cord-005453-4057qib7	15837	10	)	)	-RRB-
cord-005453-4057qib7	15838	1	>	>	XX
cord-005453-4057qib7	15839	1	10	10	CD
cord-005453-4057qib7	15839	2	/	/	SYM
cord-005453-4057qib7	15839	3	μl	μl	NN
cord-005453-4057qib7	15839	4	.	.	.
cord-005453-4057qib7	15840	1	The	the	DT
cord-005453-4057qib7	15840	2	median	median	NN
cord-005453-4057qib7	15840	3	CE	ce	NN
cord-005453-4057qib7	15840	4	for	for	IN
cord-005453-4057qib7	15840	5	autologous	autologous	JJ
cord-005453-4057qib7	15840	6	donors	donor	NNS
cord-005453-4057qib7	15840	7	was	be	VBD
cord-005453-4057qib7	15840	8	55	55	CD
cord-005453-4057qib7	15840	9	%	%	NN
cord-005453-4057qib7	15840	10	(	(	-LRB-
cord-005453-4057qib7	15840	11	range	range	NN
cord-005453-4057qib7	15840	12	20	20	CD
cord-005453-4057qib7	15840	13	-	-	SYM
cord-005453-4057qib7	15840	14	166	166	CD
cord-005453-4057qib7	15840	15	)	)	-RRB-
cord-005453-4057qib7	15840	16	and	and	CC
cord-005453-4057qib7	15840	17	for	for	IN
cord-005453-4057qib7	15840	18	allogeneic	allogeneic	NN
cord-005453-4057qib7	15840	19	donors	donor	NNS
cord-005453-4057qib7	15840	20	was	be	VBD
cord-005453-4057qib7	15840	21	47	47	CD
cord-005453-4057qib7	15840	22	%	%	NN
cord-005453-4057qib7	15840	23	(	(	-LRB-
cord-005453-4057qib7	15840	24	range12	range12	NNP
cord-005453-4057qib7	15840	25	-	-	HYPH
cord-005453-4057qib7	15840	26	116	116	CD
cord-005453-4057qib7	15840	27	)	)	-RRB-
cord-005453-4057qib7	15840	28	.	.	.
cord-005453-4057qib7	15841	1	The	the	DT
cord-005453-4057qib7	15841	2	CE	CE	NNP
cord-005453-4057qib7	15841	3	was	be	VBD
cord-005453-4057qib7	15841	4	negatively	negatively	RB
cord-005453-4057qib7	15841	5	correlated	correlate	VBN
cord-005453-4057qib7	15841	6	to	to	IN
cord-005453-4057qib7	15841	7	WBC	WBC	NNP
cord-005453-4057qib7	15841	8	(	(	-LRB-
cord-005453-4057qib7	15841	9	r=	r=	NNP
cord-005453-4057qib7	15841	10	-0.29	-0.29	HYPH
cord-005453-4057qib7	15841	11	and	and	CC
cord-005453-4057qib7	15841	12	-0.37	-0.37	CD
cord-005453-4057qib7	15841	13	)	)	-RRB-
cord-005453-4057qib7	15841	14	and	and	CC
cord-005453-4057qib7	15841	15	platelet	platelet	NN
cord-005453-4057qib7	15841	16	count	count	NN
cord-005453-4057qib7	15841	17	(	(	-LRB-
cord-005453-4057qib7	15841	18	r=-0.14	r=-0.14	JJ
cord-005453-4057qib7	15841	19	and	and	CC
cord-005453-4057qib7	15841	20	-0.06	-0.06	CD
cord-005453-4057qib7	15841	21	)	)	-RRB-
cord-005453-4057qib7	15841	22	for	for	IN
cord-005453-4057qib7	15841	23	auto	auto	NN
cord-005453-4057qib7	15841	24	and	and	CC
cord-005453-4057qib7	15841	25	allogeneic	allogeneic	IN
cord-005453-4057qib7	15841	26	donors	donor	NNS
cord-005453-4057qib7	15841	27	respectively	respectively	RB
cord-005453-4057qib7	15841	28	,	,	,
cord-005453-4057qib7	15841	29	but	but	CC
cord-005453-4057qib7	15841	30	did	do	VBD
cord-005453-4057qib7	15841	31	not	not	RB
cord-005453-4057qib7	15841	32	correlate	correlate	VB
cord-005453-4057qib7	15841	33	to	to	IN
cord-005453-4057qib7	15841	34	the	the	DT
cord-005453-4057qib7	15841	35	pre	pre	JJ
cord-005453-4057qib7	15841	36	CD34	CD34	NNP
cord-005453-4057qib7	15841	37	and	and	CC
cord-005453-4057qib7	15841	38	blood	blood	NN
cord-005453-4057qib7	15841	39	volume	volume	NN
cord-005453-4057qib7	15841	40	processed	process	VBN
cord-005453-4057qib7	15841	41	.	.	.
cord-005453-4057qib7	15842	1	The	the	DT
cord-005453-4057qib7	15842	2	correlation	correlation	NN
cord-005453-4057qib7	15842	3	coefficient	coefficient	NN
cord-005453-4057qib7	15842	4	between	between	IN
cord-005453-4057qib7	15842	5	pre	pre	``
cord-005453-4057qib7	15842	6	CD34	CD34	NNP
cord-005453-4057qib7	15842	7	count	count	NN
cord-005453-4057qib7	15842	8	and	and	CC
cord-005453-4057qib7	15842	9	CD34	CD34	NNP
cord-005453-4057qib7	15842	10	yield	yield	NN
cord-005453-4057qib7	15842	11	per	per	IN
cord-005453-4057qib7	15842	12	procedure	procedure	NN
cord-005453-4057qib7	15842	13	was	be	VBD
cord-005453-4057qib7	15842	14	r	r	NNP
cord-005453-4057qib7	15842	15	2	2	CD
cord-005453-4057qib7	15842	16	=	=	SYM
cord-005453-4057qib7	15842	17	0.67	0.67	CD
cord-005453-4057qib7	15842	18	for	for	IN
cord-005453-4057qib7	15842	19	the	the	DT
cord-005453-4057qib7	15842	20	autologous	autologous	JJ
cord-005453-4057qib7	15842	21	and	and	CC
cord-005453-4057qib7	15842	22	r	r	NN
cord-005453-4057qib7	15842	23	2	2	CD
cord-005453-4057qib7	15842	24	=	=	SYM
cord-005453-4057qib7	15842	25	0.34	0.34	CD
cord-005453-4057qib7	15842	26	for	for	IN
cord-005453-4057qib7	15842	27	the	the	DT
cord-005453-4057qib7	15842	28	allogeneic	allogeneic	NN
cord-005453-4057qib7	15842	29	collections	collection	NNS
cord-005453-4057qib7	15842	30	.	.	.
cord-005453-4057qib7	15843	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15843	2	:	:	:
cord-005453-4057qib7	15844	1	The	the	DT
cord-005453-4057qib7	15844	2	majority	majority	NN
cord-005453-4057qib7	15844	3	of	of	IN
cord-005453-4057qib7	15844	4	autologous	autologous	JJ
cord-005453-4057qib7	15844	5	and	and	CC
cord-005453-4057qib7	15844	6	allogeneic	allogeneic	IN
cord-005453-4057qib7	15844	7	donors	donor	NNS
cord-005453-4057qib7	15844	8	achieved	achieve	VBD
cord-005453-4057qib7	15844	9	the	the	DT
cord-005453-4057qib7	15844	10	target	target	NN
cord-005453-4057qib7	15844	11	CD34	CD34	NNP
cord-005453-4057qib7	15844	12	dose	dose	NN
cord-005453-4057qib7	15844	13	with	with	IN
cord-005453-4057qib7	15844	14	one	one	CD
cord-005453-4057qib7	15844	15	procedure	procedure	NN
cord-005453-4057qib7	15844	16	.	.	.
cord-005453-4057qib7	15845	1	94.3	94.3	CD
cord-005453-4057qib7	15845	2	%	%	NN
cord-005453-4057qib7	15845	3	of	of	IN
cord-005453-4057qib7	15845	4	autologous	autologous	JJ
cord-005453-4057qib7	15845	5	and	and	CC
cord-005453-4057qib7	15845	6	97.3	97.3	CD
cord-005453-4057qib7	15845	7	%	%	NN
cord-005453-4057qib7	15845	8	allogeneic	allogeneic	IN
cord-005453-4057qib7	15845	9	donors	donor	NNS
cord-005453-4057qib7	15845	10	collected	collect	VBD
cord-005453-4057qib7	15845	11	a	a	DT
cord-005453-4057qib7	15845	12	transplantable	transplantable	JJ
cord-005453-4057qib7	15845	13	CD34	CD34	NNP
cord-005453-4057qib7	15845	14	dose	dose	NN
cord-005453-4057qib7	15845	15	of	of	IN
cord-005453-4057qib7	15845	16	>	>	$
cord-005453-4057qib7	15845	17	2x10	2x10	CD
cord-005453-4057qib7	15845	18	6	6	CD
cord-005453-4057qib7	15846	1	/kg	/kg	NFP
cord-005453-4057qib7	15846	2	.	.	.
cord-005453-4057qib7	15847	1	4	4	CD
cord-005453-4057qib7	15847	2	%	%	NN
cord-005453-4057qib7	15847	3	of	of	IN
cord-005453-4057qib7	15847	4	autologous	autologous	JJ
cord-005453-4057qib7	15847	5	and	and	CC
cord-005453-4057qib7	15847	6	2.7	2.7	CD
cord-005453-4057qib7	15847	7	%	%	NN
cord-005453-4057qib7	15847	8	of	of	IN
cord-005453-4057qib7	15847	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	15847	10	donors	donor	NNS
cord-005453-4057qib7	15847	11	did	do	VBD
cord-005453-4057qib7	15847	12	not	not	RB
cord-005453-4057qib7	15847	13	collect	collect	VB
cord-005453-4057qib7	15847	14	a	a	DT
cord-005453-4057qib7	15847	15	transplantable	transplantable	JJ
cord-005453-4057qib7	15847	16	dose	dose	NN
cord-005453-4057qib7	15847	17	despite	despite	IN
cord-005453-4057qib7	15847	18	a	a	DT
cord-005453-4057qib7	15847	19	preCD34	preCD34	NNP
cord-005453-4057qib7	15847	20	count	count	NN
cord-005453-4057qib7	15847	21	of	of	IN
cord-005453-4057qib7	15847	22	>	>	XX
cord-005453-4057qib7	15848	1	10	10	CD
cord-005453-4057qib7	15848	2	/	/	SYM
cord-005453-4057qib7	15848	3	μl	μl	IN
cord-005453-4057qib7	15848	4	indicating	indicate	VBG
cord-005453-4057qib7	15848	5	suboptimal	suboptimal	JJ
cord-005453-4057qib7	15848	6	procedure	procedure	NN
cord-005453-4057qib7	15848	7	performance	performance	NN
cord-005453-4057qib7	15848	8	.	.	.
cord-005453-4057qib7	15849	1	The	the	DT
cord-005453-4057qib7	15849	2	CE	CE	NNP
cord-005453-4057qib7	15849	3	was	be	VBD
cord-005453-4057qib7	15849	4	variable	variable	JJ
cord-005453-4057qib7	15849	5	and	and	CC
cord-005453-4057qib7	15849	6	was	be	VBD
cord-005453-4057qib7	15849	7	negatively	negatively	RB
cord-005453-4057qib7	15849	8	correlated	correlate	VBN
cord-005453-4057qib7	15849	9	to	to	IN
cord-005453-4057qib7	15849	10	the	the	DT
cord-005453-4057qib7	15849	11	preprocedure	preprocedure	NN
cord-005453-4057qib7	15849	12	WBC	WBC	NNP
cord-005453-4057qib7	15849	13	and	and	CC
cord-005453-4057qib7	15849	14	platelet	platelet	NN
cord-005453-4057qib7	15849	15	count	count	NN
cord-005453-4057qib7	15849	16	.	.	.
cord-005453-4057qib7	15850	1	The	the	DT
cord-005453-4057qib7	15850	2	CE	ce	NN
cord-005453-4057qib7	15850	3	and	and	CC
cord-005453-4057qib7	15850	4	correlation	correlation	NN
cord-005453-4057qib7	15850	5	coefficient	coefficient	NN
cord-005453-4057qib7	15850	6	are	be	VBP
cord-005453-4057qib7	15850	7	lower	low	JJR
cord-005453-4057qib7	15850	8	in	in	IN
cord-005453-4057qib7	15850	9	allogeneic	allogeneic	NN
cord-005453-4057qib7	15850	10	donors	donor	NNS
cord-005453-4057qib7	15850	11	compared	compare	VBN
cord-005453-4057qib7	15850	12	to	to	IN
cord-005453-4057qib7	15850	13	autologous	autologous	JJ
cord-005453-4057qib7	15850	14	donors	donor	NNS
cord-005453-4057qib7	15850	15	.	.	.
cord-005453-4057qib7	15851	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15851	2	:	:	:
cord-005453-4057qib7	15851	3	Nothing	nothing	NN
cord-005453-4057qib7	15851	4	to	to	TO
cord-005453-4057qib7	15851	5	declare	declare	VB
cord-005453-4057qib7	15851	6	The	the	DT
cord-005453-4057qib7	15851	7	outcome	outcome	NN
cord-005453-4057qib7	15851	8	of	of	IN
cord-005453-4057qib7	15851	9	autologous	autologous	JJ
cord-005453-4057qib7	15851	10	blood	blood	NN
cord-005453-4057qib7	15851	11	stem	stem	NN
cord-005453-4057qib7	15851	12	cell	cell	NN
cord-005453-4057qib7	15851	13	collection	collection	NN
cord-005453-4057qib7	15851	14	and	and	CC
cord-005453-4057qib7	15851	15	its	-PRON-	PRP$
cord-005453-4057qib7	15851	16	actual	actual	JJ
cord-005453-4057qib7	15851	17	use	use	NN
cord-005453-4057qib7	15851	18	in	in	IN
cord-005453-4057qib7	15851	19	real	real	JJ
cord-005453-4057qib7	15851	20	world	world	NN
cord-005453-4057qib7	15851	21	:	:	:
cord-005453-4057qib7	15851	22	the	the	DT
cord-005453-4057qib7	15851	23	21st	21st	JJ
cord-005453-4057qib7	15851	24	century	century	NN
cord-005453-4057qib7	15851	25	experienceKyoungmin	experienceKyoungmin	NNP
cord-005453-4057qib7	15851	26	Lee	Lee	NNP
cord-005453-4057qib7	15851	27	1	1	CD
cord-005453-4057qib7	15851	28	,	,	,
cord-005453-4057qib7	15851	29	Jung	Jung	NNP
cord-005453-4057qib7	15851	30	Yong	Yong	NNP
cord-005453-4057qib7	15851	31	Hong	Hong	NNP
cord-005453-4057qib7	15851	32	1	1	CD
cord-005453-4057qib7	15851	33	,	,	,
cord-005453-4057qib7	15851	34	Dok	Dok	NNP
cord-005453-4057qib7	15851	35	Hyun	Hyun	NNP
cord-005453-4057qib7	15851	36	Yoon	Yoon	NNP
cord-005453-4057qib7	15851	37	1	1	CD
cord-005453-4057qib7	15851	38	,	,	,
cord-005453-4057qib7	15851	39	Jae	Jae	NNP
cord-005453-4057qib7	15851	40	-	-	HYPH
cord-005453-4057qib7	15851	41	Lyun	Lyun	NNP
cord-005453-4057qib7	15851	42	Lee	Lee	NNP
cord-005453-4057qib7	15851	43	1	1	CD
cord-005453-4057qib7	15851	44	,	,	,
cord-005453-4057qib7	15851	45	Shin	Shin	NNP
cord-005453-4057qib7	15851	46	Kim	Kim	NNP
cord-005453-4057qib7	15851	47	1	1	CD
cord-005453-4057qib7	15851	48	,	,	,
cord-005453-4057qib7	15851	49	Kyoung	Kyoung	NNP
cord-005453-4057qib7	15851	50	Min	Min	NNP
cord-005453-4057qib7	15851	51	Lee	Lee	NNP
cord-005453-4057qib7	15851	52	1	1	CD
cord-005453-4057qib7	15851	53	,	,	,
cord-005453-4057qib7	15851	54	Jung	Jung	NNP
cord-005453-4057qib7	15851	55	Sun	Sun	NNP
cord-005453-4057qib7	15851	56	Park	Park	NNP
cord-005453-4057qib7	15851	57	1	1	CD
cord-005453-4057qib7	15851	58	,	,	,
cord-005453-4057qib7	15851	59	Cheolwon	Cheolwon	NNP
cord-005453-4057qib7	15851	60	Suh	Suh	NNP
cord-005453-4057qib7	15851	61	1Background	1background	CD
cord-005453-4057qib7	15852	1	:	:	:
cord-005453-4057qib7	15852	2	Mobilized	mobilize	VBD
cord-005453-4057qib7	15852	3	peripheral	peripheral	JJ
cord-005453-4057qib7	15852	4	blood	blood	NN
cord-005453-4057qib7	15852	5	stem	stem	NN
cord-005453-4057qib7	15852	6	cells	cell	NNS
cord-005453-4057qib7	15852	7	(	(	-LRB-
cord-005453-4057qib7	15852	8	PBSCs	pbsc	NNS
cord-005453-4057qib7	15852	9	)	)	-RRB-
cord-005453-4057qib7	15852	10	have	have	VBP
cord-005453-4057qib7	15852	11	largely	largely	RB
cord-005453-4057qib7	15852	12	replaced	replace	VBN
cord-005453-4057qib7	15852	13	bone	bone	NN
cord-005453-4057qib7	15852	14	marrow	marrow	NN
cord-005453-4057qib7	15852	15	as	as	IN
cord-005453-4057qib7	15852	16	the	the	DT
cord-005453-4057qib7	15852	17	graft	graft	NN
cord-005453-4057qib7	15852	18	source	source	NN
cord-005453-4057qib7	15852	19	for	for	IN
cord-005453-4057qib7	15852	20	allogeneic	allogeneic	NN
cord-005453-4057qib7	15852	21	stem	stem	NN
cord-005453-4057qib7	15852	22	cell	cell	NN
cord-005453-4057qib7	15852	23	transplantation	transplantation	NN
cord-005453-4057qib7	15852	24	.	.	.
cord-005453-4057qib7	15853	1	PBSCs	pbsc	NNS
cord-005453-4057qib7	15853	2	mobilization	mobilization	NN
cord-005453-4057qib7	15853	3	with	with	IN
cord-005453-4057qib7	15853	4	G	G	NNP
cord-005453-4057qib7	15853	5	-	-	HYPH
cord-005453-4057qib7	15853	6	CSF	CSF	NNP
cord-005453-4057qib7	15853	7	is	be	VBZ
cord-005453-4057qib7	15853	8	highly	highly	RB
cord-005453-4057qib7	15853	9	effective	effective	JJ
cord-005453-4057qib7	15853	10	even	even	RB
cord-005453-4057qib7	15853	11	on	on	IN
cord-005453-4057qib7	15853	12	the	the	DT
cord-005453-4057qib7	15853	13	4th	4th	JJ
cord-005453-4057qib7	15853	14	day	day	NN
cord-005453-4057qib7	15853	15	in	in	IN
cord-005453-4057qib7	15853	16	order	order	NN
cord-005453-4057qib7	15853	17	to	to	TO
cord-005453-4057qib7	15853	18	collect	collect	VB
cord-005453-4057qib7	15853	19	enough	enough	JJ
cord-005453-4057qib7	15853	20	number	number	NN
cord-005453-4057qib7	15853	21	of	of	IN
cord-005453-4057qib7	15853	22	stem	stem	NN
cord-005453-4057qib7	15853	23	cells	cell	NNS
cord-005453-4057qib7	15853	24	.	.	.
cord-005453-4057qib7	15854	1	A	a	DT
cord-005453-4057qib7	15854	2	longitudinal	longitudinal	JJ
cord-005453-4057qib7	15854	3	,	,	,
cord-005453-4057qib7	15854	4	prospective	prospective	JJ
cord-005453-4057qib7	15854	5	,	,	,
cord-005453-4057qib7	15854	6	observational	observational	JJ
cord-005453-4057qib7	15854	7	,	,	,
cord-005453-4057qib7	15854	8	single	single	JJ
cord-005453-4057qib7	15854	9	-	-	HYPH
cord-005453-4057qib7	15854	10	center	center	NN
cord-005453-4057qib7	15854	11	,	,	,
cord-005453-4057qib7	15854	12	cohort	cohort	NN
cord-005453-4057qib7	15854	13	study	study	NN
cord-005453-4057qib7	15854	14	on	on	IN
cord-005453-4057qib7	15854	15	healthy	healthy	JJ
cord-005453-4057qib7	15854	16	donors	donor	NNS
cord-005453-4057qib7	15854	17	(	(	-LRB-
cord-005453-4057qib7	15854	18	HDs	HDs	NNP
cord-005453-4057qib7	15854	19	)	)	-RRB-
cord-005453-4057qib7	15854	20	was	be	VBD
cord-005453-4057qib7	15854	21	designed	design	VBN
cord-005453-4057qib7	15854	22	to	to	TO
cord-005453-4057qib7	15854	23	identify	identify	VB
cord-005453-4057qib7	15854	24	predictors	predictor	NNS
cord-005453-4057qib7	15854	25	of	of	IN
cord-005453-4057qib7	15854	26	CD34	CD34	NNP
cord-005453-4057qib7	15854	27	+	+	CC
cord-005453-4057qib7	15854	28	cells	cell	NNS
cord-005453-4057qib7	15854	29	on	on	IN
cord-005453-4057qib7	15854	30	the	the	DT
cord-005453-4057qib7	15854	31	4th	4th	JJ
cord-005453-4057qib7	15854	32	day	day	NN
cord-005453-4057qib7	15854	33	.	.	.
cord-005453-4057qib7	15855	1	Methods	method	NNS
cord-005453-4057qib7	15855	2	:	:	:
cord-005453-4057qib7	15856	1	As	as	IN
cord-005453-4057qib7	15856	2	potential	potential	JJ
cord-005453-4057qib7	15856	3	predictors	predictor	NNS
cord-005453-4057qib7	15856	4	of	of	IN
cord-005453-4057qib7	15856	5	mobilization	mobilization	NN
cord-005453-4057qib7	15856	6	,	,	,
cord-005453-4057qib7	15856	7	age	age	NN
cord-005453-4057qib7	15856	8	,	,	,
cord-005453-4057qib7	15856	9	sex	sex	NN
cord-005453-4057qib7	15856	10	,	,	,
cord-005453-4057qib7	15856	11	body	body	NN
cord-005453-4057qib7	15856	12	weight	weight	NN
cord-005453-4057qib7	15856	13	,	,	,
cord-005453-4057qib7	15856	14	height	height	NN
cord-005453-4057qib7	15856	15	,	,	,
cord-005453-4057qib7	15856	16	blood	blood	NN
cord-005453-4057qib7	15856	17	volume	volume	NN
cord-005453-4057qib7	15856	18	as	as	RB
cord-005453-4057qib7	15856	19	well	well	RB
cord-005453-4057qib7	15856	20	as	as	IN
cord-005453-4057qib7	15856	21	white	white	JJ
cord-005453-4057qib7	15856	22	blood	blood	NN
cord-005453-4057qib7	15856	23	cell	cell	NN
cord-005453-4057qib7	15856	24	count	count	NN
cord-005453-4057qib7	15856	25	,	,	,
cord-005453-4057qib7	15856	26	peripheral	peripheral	JJ
cord-005453-4057qib7	15856	27	blood	blood	NN
cord-005453-4057qib7	15856	28	(	(	-LRB-
cord-005453-4057qib7	15856	29	PB	PB	NNP
cord-005453-4057qib7	15856	30	)	)	-RRB-
cord-005453-4057qib7	15856	31	mononuclear	mononuclear	NN
cord-005453-4057qib7	15856	32	cells	cell	NNS
cord-005453-4057qib7	15856	33	,	,	,
cord-005453-4057qib7	15856	34	platelet	platelet	NN
cord-005453-4057qib7	15856	35	count	count	NN
cord-005453-4057qib7	15856	36	,	,	,
cord-005453-4057qib7	15856	37	hematocrit	hematocrit	NN
cord-005453-4057qib7	15856	38	,	,	,
cord-005453-4057qib7	15856	39	and	and	CC
cord-005453-4057qib7	15856	40	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	15856	41	levels	level	NNS
cord-005453-4057qib7	15856	42	were	be	VBD
cord-005453-4057qib7	15856	43	considered	consider	VBN
cord-005453-4057qib7	15856	44	.	.	.
cord-005453-4057qib7	15857	1	Two	two	CD
cord-005453-4057qib7	15857	2	different	different	JJ
cord-005453-4057qib7	15857	3	evaluations	evaluation	NNS
cord-005453-4057qib7	15857	4	of	of	IN
cord-005453-4057qib7	15857	5	CD34	CD34	NNP
cord-005453-4057qib7	15857	6	+	+	CC
cord-005453-4057qib7	15857	7	cell	cell	NN
cord-005453-4057qib7	15857	8	counts	count	NNS
cord-005453-4057qib7	15857	9	were	be	VBD
cord-005453-4057qib7	15857	10	determined	determine	VBN
cord-005453-4057qib7	15857	11	for	for	IN
cord-005453-4057qib7	15857	12	each	each	DT
cord-005453-4057qib7	15857	13	donor	donor	NN
cord-005453-4057qib7	15857	14	:	:	:
cord-005453-4057qib7	15857	15	baseline	baseline	JJ
cord-005453-4057qib7	15857	16	(	(	-LRB-
cord-005453-4057qib7	15857	17	before	before	IN
cord-005453-4057qib7	15857	18	granulocyte	granulocyte	NN
cord-005453-4057qib7	15857	19	colony	colony	NN
cord-005453-4057qib7	15857	20	-	-	HYPH
cord-005453-4057qib7	15857	21	stimulating	stimulate	VBG
cord-005453-4057qib7	15857	22	factor	factor	NN
cord-005453-4057qib7	15857	23	[	[	-LRB-
cord-005453-4057qib7	15857	24	G	G	NNP
cord-005453-4057qib7	15857	25	-	-	HYPH
cord-005453-4057qib7	15857	26	CSF	CSF	NNP
cord-005453-4057qib7	15857	27	]	]	-RRB-
cord-005453-4057qib7	15857	28	administration	administration	NN
cord-005453-4057qib7	15857	29	)	)	-RRB-
cord-005453-4057qib7	15857	30	and	and	CC
cord-005453-4057qib7	15857	31	in	in	IN
cord-005453-4057qib7	15857	32	PB	PB	NNP
cord-005453-4057qib7	15857	33	after	after	IN
cord-005453-4057qib7	15857	34	G	G	NNP
cord-005453-4057qib7	15857	35	-	-	HYPH
cord-005453-4057qib7	15857	36	CSF	CSF	NNP
cord-005453-4057qib7	15857	37	administration	administration	NN
cord-005453-4057qib7	15857	38	on	on	IN
cord-005453-4057qib7	15857	39	day	day	NN
cord-005453-4057qib7	15857	40	4	4	CD
cord-005453-4057qib7	15857	41	.	.	.
cord-005453-4057qib7	15858	1	A	a	DT
cord-005453-4057qib7	15858	2	total	total	NN
cord-005453-4057qib7	15858	3	of	of	IN
cord-005453-4057qib7	15858	4	122	122	CD
cord-005453-4057qib7	15858	5	consecutive	consecutive	JJ
cord-005453-4057qib7	15858	6	HDs	hd	NNS
cord-005453-4057qib7	15858	7	with	with	IN
cord-005453-4057qib7	15858	8	a	a	DT
cord-005453-4057qib7	15858	9	median	median	JJ
cord-005453-4057qib7	15858	10	age	age	NN
cord-005453-4057qib7	15858	11	of	of	IN
cord-005453-4057qib7	15858	12	47.5	47.5	CD
cord-005453-4057qib7	15858	13	years	year	NNS
cord-005453-4057qib7	15858	14	were	be	VBD
cord-005453-4057qib7	15858	15	enrolled	enrol	VBN
cord-005453-4057qib7	15858	16	.	.	.
cord-005453-4057qib7	15859	1	Results	result	NNS
cord-005453-4057qib7	15859	2	:	:	:
cord-005453-4057qib7	15860	1	The	the	DT
cord-005453-4057qib7	15860	2	median	median	JJ
cord-005453-4057qib7	15860	3	value	value	NN
cord-005453-4057qib7	15860	4	of	of	IN
cord-005453-4057qib7	15860	5	CD34	CD34	NNP
cord-005453-4057qib7	15860	6	+	+	CC
cord-005453-4057qib7	15860	7	on	on	IN
cord-005453-4057qib7	15860	8	day	day	NN
cord-005453-4057qib7	15860	9	4	4	CD
cord-005453-4057qib7	15860	10	was	be	VBD
cord-005453-4057qib7	15860	11	43	43	CD
cord-005453-4057qib7	15860	12	cells	cell	NNS
cord-005453-4057qib7	15861	1	/	/	NFP
cord-005453-4057qib7	15862	1	μL	μL	.
cord-005453-4057qib7	15863	1	(	(	-LRB-
cord-005453-4057qib7	15863	2	IQ	IQ	NNP
cord-005453-4057qib7	15863	3	23	23	CD
cord-005453-4057qib7	15863	4	-	-	SYM
cord-005453-4057qib7	15863	5	68	68	CD
cord-005453-4057qib7	15863	6	)	)	-RRB-
cord-005453-4057qib7	15863	7	.	.	.
cord-005453-4057qib7	15864	1	Basal	Basal	NNP
cord-005453-4057qib7	15864	2	WBC	WBC	NNP
cord-005453-4057qib7	15864	3	,	,	,
cord-005453-4057qib7	15864	4	Plt	Plt	NNP
cord-005453-4057qib7	15864	5	and	and	CC
cord-005453-4057qib7	15864	6	basal	basal	NN
cord-005453-4057qib7	15864	7	CD34	CD34	NNP
cord-005453-4057qib7	15865	1	+	+	CC
cord-005453-4057qib7	15865	2	,	,	,
cord-005453-4057qib7	15865	3	are	be	VBP
cord-005453-4057qib7	15865	4	significantly	significantly	RB
cord-005453-4057qib7	15865	5	higher	high	JJR
cord-005453-4057qib7	15865	6	for	for	IN
cord-005453-4057qib7	15865	7	group	group	NN
cord-005453-4057qib7	15865	8	with	with	IN
cord-005453-4057qib7	15865	9	CD34	CD34	NNP
cord-005453-4057qib7	15865	10	+	+	CC
cord-005453-4057qib7	15866	1	on	on	IN
cord-005453-4057qib7	15866	2	the	the	DT
cord-005453-4057qib7	15866	3	4th	4th	JJ
cord-005453-4057qib7	15866	4	day	day	NN
cord-005453-4057qib7	15866	5	over	over	IN
cord-005453-4057qib7	15866	6	the	the	DT
cord-005453-4057qib7	15866	7	median	median	NN
cord-005453-4057qib7	15866	8	than	than	IN
cord-005453-4057qib7	15866	9	below	below	RB
cord-005453-4057qib7	15866	10	.	.	.
cord-005453-4057qib7	15867	1	A	a	DT
cord-005453-4057qib7	15867	2	multivariate	multivariate	JJ
cord-005453-4057qib7	15867	3	quartile	quartile	NN
cord-005453-4057qib7	15867	4	regression	regression	NN
cord-005453-4057qib7	15867	5	analysis	analysis	NN
cord-005453-4057qib7	15867	6	,	,	,
cord-005453-4057qib7	15867	7	adjusted	adjust	VBN
cord-005453-4057qib7	15867	8	by	by	IN
cord-005453-4057qib7	15867	9	gender	gender	NN
cord-005453-4057qib7	15867	10	,	,	,
cord-005453-4057qib7	15867	11	age	age	NN
cord-005453-4057qib7	15867	12	,	,	,
cord-005453-4057qib7	15867	13	basal	basal	NN
cord-005453-4057qib7	15867	14	CD34	CD34	NNP
cord-005453-4057qib7	15867	15	+	+	CC
cord-005453-4057qib7	15867	16	and	and	CC
cord-005453-4057qib7	15867	17	basal	basal	JJ
cord-005453-4057qib7	15867	18	Plt	Plt	NNP
cord-005453-4057qib7	15867	19	,	,	,
cord-005453-4057qib7	15867	20	shows	show	VBZ
cord-005453-4057qib7	15867	21	a	a	DT
cord-005453-4057qib7	15867	22	,	,	,
cord-005453-4057qib7	15867	23	progressively	progressively	RB
cord-005453-4057qib7	15867	24	steeper	steep	JJR
cord-005453-4057qib7	15867	25	,	,	,
cord-005453-4057qib7	15867	26	relationship	relationship	NN
cord-005453-4057qib7	15867	27	between	between	IN
cord-005453-4057qib7	15867	28	baseline	baseline	JJ
cord-005453-4057qib7	15867	29	CD34	CD34	NNP
cord-005453-4057qib7	15867	30	+	+	CC
cord-005453-4057qib7	15867	31	,	,	,
cord-005453-4057qib7	15867	32	basal	basal	JJ
cord-005453-4057qib7	15867	33	Plt	Plt	NNP
cord-005453-4057qib7	15867	34	and	and	CC
cord-005453-4057qib7	15867	35	CD34	CD34	NNP
cord-005453-4057qib7	15867	36	+	+	CC
cord-005453-4057qib7	15868	1	on	on	IN
cord-005453-4057qib7	15868	2	the	the	DT
cord-005453-4057qib7	15868	3	4th	4th	JJ
cord-005453-4057qib7	15868	4	day	day	NN
cord-005453-4057qib7	15868	5	.	.	.
cord-005453-4057qib7	15869	1	The	the	DT
cord-005453-4057qib7	15869	2	basal	basal	NN
cord-005453-4057qib7	15869	3	CD34	CD34	NNP
cord-005453-4057qib7	15869	4	+	+	CC
cord-005453-4057qib7	15870	1	cut	cut	VB
cord-005453-4057qib7	15870	2	-	-	HYPH
cord-005453-4057qib7	15870	3	off	off	NN
cord-005453-4057qib7	15870	4	for	for	IN
cord-005453-4057qib7	15870	5	prevision	prevision	NN
cord-005453-4057qib7	15870	6	of	of	IN
cord-005453-4057qib7	15870	7	CD34	CD34	NNP
cord-005453-4057qib7	15870	8	+	+	CC
cord-005453-4057qib7	15871	1	on	on	IN
cord-005453-4057qib7	15871	2	the	the	DT
cord-005453-4057qib7	15871	3	4th	4th	JJ
cord-005453-4057qib7	15871	4	day	day	NN
cord-005453-4057qib7	15871	5	was	be	VBD
cord-005453-4057qib7	15871	6	<	<	XX
cord-005453-4057qib7	15871	7	=	=	SYM
cord-005453-4057qib7	15871	8	2	2	CD
cord-005453-4057qib7	15871	9	cells	cell	NNS
cord-005453-4057qib7	15871	10	/	/	SYM
cord-005453-4057qib7	15871	11	μL	μl	NN
cord-005453-4057qib7	15871	12	and	and	CC
cord-005453-4057qib7	15871	13	>	>	XX
cord-005453-4057qib7	15871	14	=3	=3	NN
cord-005453-4057qib7	15871	15	cells/	cells/	.
cord-005453-4057qib7	15872	1	μL	μL	.
cord-005453-4057qib7	15873	1	whereas	whereas	IN
cord-005453-4057qib7	15873	2	basal	basal	NN
cord-005453-4057qib7	15873	3	platelets	platelet	NNS
cord-005453-4057qib7	15873	4	count	count	NN
cord-005453-4057qib7	15873	5	was	be	VBD
cord-005453-4057qib7	15874	1	<	<	XX
cord-005453-4057qib7	15874	2	=	=	SYM
cord-005453-4057qib7	15874	3	229	229	CD
cord-005453-4057qib7	15874	4	x	x	SYM
cord-005453-4057qib7	15874	5	109	109	CD
cord-005453-4057qib7	15874	6	/	/	SYM
cord-005453-4057qib7	15874	7	L	l	NN
cord-005453-4057qib7	15874	8	and	and	CC
cord-005453-4057qib7	15874	9	>	>	XX
cord-005453-4057qib7	15875	1	=	=	SYM
cord-005453-4057qib7	15875	2	230	230	CD
cord-005453-4057qib7	15875	3	x	x	SYM
cord-005453-4057qib7	15875	4	109	109	CD
cord-005453-4057qib7	15876	1	/	/	NFP
cord-005453-4057qib7	15877	1	L.Conclusions	l.conclusion	NNS
cord-005453-4057qib7	15877	2	:	:	:
cord-005453-4057qib7	15877	3	G	G	NNP
cord-005453-4057qib7	15877	4	-	-	HYPH
cord-005453-4057qib7	15877	5	CSF	CSF	NNP
cord-005453-4057qib7	15877	6	can	can	MD
cord-005453-4057qib7	15877	7	be	be	VB
cord-005453-4057qib7	15877	8	highly	highly	RB
cord-005453-4057qib7	15877	9	effective	effective	JJ
cord-005453-4057qib7	15877	10	in	in	IN
cord-005453-4057qib7	15877	11	HDs	hd	NNS
cord-005453-4057qib7	15877	12	on	on	IN
cord-005453-4057qib7	15877	13	the	the	DT
cord-005453-4057qib7	15877	14	4th	4th	JJ
cord-005453-4057qib7	15877	15	day	day	NN
cord-005453-4057qib7	15877	16	in	in	IN
cord-005453-4057qib7	15877	17	order	order	NN
cord-005453-4057qib7	15877	18	to	to	TO
cord-005453-4057qib7	15877	19	collect	collect	VB
cord-005453-4057qib7	15877	20	enough	enough	JJ
cord-005453-4057qib7	15877	21	number	number	NN
cord-005453-4057qib7	15877	22	of	of	IN
cord-005453-4057qib7	15877	23	stem	stem	NN
cord-005453-4057qib7	15877	24	cells	cell	NNS
cord-005453-4057qib7	15877	25	and	and	CC
cord-005453-4057qib7	15877	26	we	-PRON-	PRP
cord-005453-4057qib7	15877	27	have	have	VBP
cord-005453-4057qib7	15877	28	developed	develop	VBN
cord-005453-4057qib7	15877	29	a	a	DT
cord-005453-4057qib7	15877	30	model	model	NN
cord-005453-4057qib7	15877	31	for	for	IN
cord-005453-4057qib7	15877	32	predicting	predict	VBG
cord-005453-4057qib7	15877	33	the	the	DT
cord-005453-4057qib7	15877	34	probability	probability	NN
cord-005453-4057qib7	15877	35	to	to	TO
cord-005453-4057qib7	15877	36	perform	perform	VB
cord-005453-4057qib7	15877	37	PBSC	PBSC	NNP
cord-005453-4057qib7	15877	38	collection	collection	NN
cord-005453-4057qib7	15877	39	after	after	IN
cord-005453-4057qib7	15877	40	a	a	DT
cord-005453-4057qib7	15877	41	short	short	JJ
cord-005453-4057qib7	15877	42	course	course	NN
cord-005453-4057qib7	15877	43	of	of	IN
cord-005453-4057qib7	15877	44	G	g	NN
cord-005453-4057qib7	15877	45	-	-	HYPH
cord-005453-4057qib7	15877	46	CSF.Disclosure	csf.disclosure	NN
cord-005453-4057qib7	15877	47	:	:	:
cord-005453-4057qib7	15877	48	nothing	nothing	NN
cord-005453-4057qib7	15877	49	to	to	TO
cord-005453-4057qib7	15877	50	declare	declare	VB
cord-005453-4057qib7	15877	51	P692	p692	JJ
cord-005453-4057qib7	15877	52	Pre	pre	NN
cord-005453-4057qib7	15877	53	-	-	JJ
cord-005453-4057qib7	15877	54	apheresis	apheresis	JJ
cord-005453-4057qib7	15877	55	peripheral	peripheral	JJ
cord-005453-4057qib7	15877	56	blood	blood	NN
cord-005453-4057qib7	15877	57	CD34	CD34	NNP
cord-005453-4057qib7	15877	58	+	+	CC
cord-005453-4057qib7	15877	59	cell	cell	NN
cord-005453-4057qib7	15877	60	counts	count	VBZ
cord-005453-4057qib7	15877	61	highly	highly	RB
cord-005453-4057qib7	15877	62	correlates	correlate	VBZ
cord-005453-4057qib7	15877	63	to	to	IN
cord-005453-4057qib7	15877	64	actual	actual	JJ
cord-005453-4057qib7	15877	65	stem	stem	NN
cord-005453-4057qib7	15877	66	cells	cell	NNS
cord-005453-4057qib7	15877	67	collected	collect	VBD
cord-005453-4057qib7	15877	68	Background	Background	NNP
cord-005453-4057qib7	15877	69	:	:	:
cord-005453-4057qib7	15878	1	Prediction	prediction	NN
cord-005453-4057qib7	15878	2	of	of	IN
cord-005453-4057qib7	15878	3	stem	stem	NN
cord-005453-4057qib7	15878	4	cell	cell	NN
cord-005453-4057qib7	15878	5	yield	yield	NN
cord-005453-4057qib7	15878	6	on	on	IN
cord-005453-4057qib7	15878	7	the	the	DT
cord-005453-4057qib7	15878	8	basis	basis	NN
cord-005453-4057qib7	15878	9	of	of	IN
cord-005453-4057qib7	15878	10	pre	pre	JJ
cord-005453-4057qib7	15878	11	-	-	JJ
cord-005453-4057qib7	15878	12	apheresis	apheresis	NN
cord-005453-4057qib7	15878	13	CD34	CD34	NNP
cord-005453-4057qib7	15878	14	+	+	CC
cord-005453-4057qib7	15878	15	cell	cell	NN
cord-005453-4057qib7	15878	16	count	count	NN
cord-005453-4057qib7	15878	17	and	and	CC
cord-005453-4057qib7	15878	18	the	the	DT
cord-005453-4057qib7	15878	19	processed	process	VBN
cord-005453-4057qib7	15878	20	blood	blood	NN
cord-005453-4057qib7	15878	21	volume	volume	NN
cord-005453-4057qib7	15878	22	is	be	VBZ
cord-005453-4057qib7	15878	23	essential	essential	JJ
cord-005453-4057qib7	15878	24	for	for	IN
cord-005453-4057qib7	15878	25	the	the	DT
cord-005453-4057qib7	15878	26	planning	planning	NN
cord-005453-4057qib7	15878	27	and	and	CC
cord-005453-4057qib7	15878	28	executing	executing	NN
cord-005453-4057qib7	15878	29	of	of	IN
cord-005453-4057qib7	15878	30	the	the	DT
cord-005453-4057qib7	15878	31	apheresis	apheresis	NN
cord-005453-4057qib7	15878	32	process	process	NN
cord-005453-4057qib7	15878	33	.	.	.
cord-005453-4057qib7	15879	1	Methods	method	NNS
cord-005453-4057qib7	15879	2	:	:	:
cord-005453-4057qib7	15880	1	Data	datum	NNS
cord-005453-4057qib7	15880	2	analyzed	analyze	VBD
cord-005453-4057qib7	15880	3	included	include	VBN
cord-005453-4057qib7	15880	4	donor	donor	NN
cord-005453-4057qib7	15880	5	weight	weight	NN
cord-005453-4057qib7	15880	6	,	,	,
cord-005453-4057qib7	15880	7	complete	complete	JJ
cord-005453-4057qib7	15880	8	blood	blood	NN
cord-005453-4057qib7	15880	9	count	count	NN
cord-005453-4057qib7	15880	10	and	and	CC
cord-005453-4057qib7	15880	11	CD34	CD34	NNP
cord-005453-4057qib7	15880	12	+	+	CC
cord-005453-4057qib7	15880	13	count	count	NN
cord-005453-4057qib7	15880	14	on	on	IN
cord-005453-4057qib7	15880	15	day	day	NN
cord-005453-4057qib7	15880	16	of	of	IN
cord-005453-4057qib7	15880	17	collection	collection	NN
cord-005453-4057qib7	15880	18	,	,	,
cord-005453-4057qib7	15880	19	total	total	JJ
cord-005453-4057qib7	15880	20	processed	process	VBN
cord-005453-4057qib7	15880	21	blood	blood	NN
cord-005453-4057qib7	15880	22	volume	volume	NN
cord-005453-4057qib7	15880	23	,	,	,
cord-005453-4057qib7	15880	24	CD34	CD34	NNP
cord-005453-4057qib7	15880	25	+	+	CC
cord-005453-4057qib7	15880	26	cell	cell	NN
cord-005453-4057qib7	15880	27	dose	dose	NN
cord-005453-4057qib7	15880	28	collected	collect	VBN
cord-005453-4057qib7	15880	29	in	in	IN
cord-005453-4057qib7	15880	30	the	the	DT
cord-005453-4057qib7	15880	31	apheresis	apheresis	NN
cord-005453-4057qib7	15880	32	product	product	NN
cord-005453-4057qib7	15880	33	and	and	CC
cord-005453-4057qib7	15880	34	the	the	DT
cord-005453-4057qib7	15880	35	number	number	NN
cord-005453-4057qib7	15880	36	of	of	IN
cord-005453-4057qib7	15880	37	aphereses	apherese	NNS
cord-005453-4057qib7	15880	38	performed	perform	VBN
cord-005453-4057qib7	15880	39	.	.	.
cord-005453-4057qib7	15881	1	Using	use	VBG
cord-005453-4057qib7	15881	2	the	the	DT
cord-005453-4057qib7	15881	3	method	method	NN
cord-005453-4057qib7	15881	4	described	describe	VBN
cord-005453-4057qib7	15881	5	by	by	IN
cord-005453-4057qib7	15881	6	Pierelli	Pierelli	NNP
cord-005453-4057qib7	15881	7	et	et	NNP
cord-005453-4057qib7	15881	8	al	al	NNP
cord-005453-4057qib7	15881	9	,	,	,
cord-005453-4057qib7	15881	10	predicted	predict	VBD
cord-005453-4057qib7	15881	11	CD34	CD34	NNP
cord-005453-4057qib7	15881	12	+	+	CC
cord-005453-4057qib7	15881	13	yields	yield	NNS
cord-005453-4057qib7	15881	14	were	be	VBD
cord-005453-4057qib7	15881	15	calculated	calculate	VBN
cord-005453-4057qib7	15881	16	:	:	:
cord-005453-4057qib7	15881	17	Predicted	predict	VBN
cord-005453-4057qib7	15881	18	CD34	CD34	NNP
cord-005453-4057qib7	15881	19	+	+	CC
cord-005453-4057qib7	15881	20	yield	yield	NN
cord-005453-4057qib7	15881	21	x	x	SYM
cord-005453-4057qib7	15881	22	106	106	CD
cord-005453-4057qib7	15881	23	/	/	SYM
cord-005453-4057qib7	15881	24	kg	kg	NN
cord-005453-4057qib7	15881	25	=	=	NFP
cord-005453-4057qib7	15882	1	(	(	-LRB-
cord-005453-4057qib7	15882	2	Benchmark	Benchmark	NNP
cord-005453-4057qib7	15882	3	CE	CE	NNP
cord-005453-4057qib7	15882	4	x	x	NN
cord-005453-4057qib7	15882	5	Volume	volume	NN
cord-005453-4057qib7	15882	6	of	of	IN
cord-005453-4057qib7	15882	7	blood	blood	NN
cord-005453-4057qib7	15882	8	to	to	TO
cord-005453-4057qib7	15882	9	be	be	VB
cord-005453-4057qib7	15882	10	processed	process	VBN
cord-005453-4057qib7	15883	1	x	x	LS
cord-005453-4057qib7	15883	2	peripheral	peripheral	JJ
cord-005453-4057qib7	15883	3	CD34	CD34	NNP
cord-005453-4057qib7	15884	1	+	+	CC
cord-005453-4057qib7	15884	2	count	count	NN
cord-005453-4057qib7	15884	3	per	per	IN
cord-005453-4057qib7	15884	4	μl	μl	NN
cord-005453-4057qib7	15884	5	)	)	-RRB-
cord-005453-4057qib7	15884	6	/	/	.
cord-005453-4057qib7	15885	1	(	(	-LRB-
cord-005453-4057qib7	15885	2	Patient	Patient	NNP
cord-005453-4057qib7	15885	3	's	's	POS
cord-005453-4057qib7	15885	4	weight	weight	NN
cord-005453-4057qib7	15885	5	in	in	IN
cord-005453-4057qib7	15885	6	kg	kg	NN
cord-005453-4057qib7	15885	7	x	x	NN
cord-005453-4057qib7	15885	8	metric	metric	JJ
cord-005453-4057qib7	15885	9	conversion	conversion	NN
cord-005453-4057qib7	15885	10	factor).Results	factor).Results	NNP
cord-005453-4057qib7	15885	11	:	:	:
cord-005453-4057qib7	15886	1	In	in	IN
cord-005453-4057qib7	15886	2	2017	2017	CD
cord-005453-4057qib7	15886	3	we	-PRON-	PRP
cord-005453-4057qib7	15886	4	established	establish	VBD
cord-005453-4057qib7	15886	5	the	the	DT
cord-005453-4057qib7	15886	6	method	method	NN
cord-005453-4057qib7	15886	7	described	describe	VBN
cord-005453-4057qib7	15886	8	by	by	IN
cord-005453-4057qib7	15886	9	Pierelli	Pierelli	NNP
cord-005453-4057qib7	15886	10	to	to	TO
cord-005453-4057qib7	15886	11	predict	predict	VB
cord-005453-4057qib7	15886	12	the	the	DT
cord-005453-4057qib7	15886	13	CD34	CD34	NNP
cord-005453-4057qib7	15886	14	+	+	CC
cord-005453-4057qib7	15886	15	cell	cell	NN
cord-005453-4057qib7	15886	16	yield	yield	NN
cord-005453-4057qib7	15886	17	.	.	.
cord-005453-4057qib7	15887	1	323	323	CD
cord-005453-4057qib7	15887	2	allogenic	allogenic	JJ
cord-005453-4057qib7	15887	3	aphereses	apherese	NNS
cord-005453-4057qib7	15887	4	were	be	VBD
cord-005453-4057qib7	15887	5	performed	perform	VBN
cord-005453-4057qib7	15887	6	in	in	IN
cord-005453-4057qib7	15887	7	2017	2017	CD
cord-005453-4057qib7	15887	8	with	with	IN
cord-005453-4057qib7	15887	9	this	this	DT
cord-005453-4057qib7	15887	10	approach	approach	NN
cord-005453-4057qib7	15887	11	.	.	.
cord-005453-4057qib7	15888	1	Mean	mean	JJ
cord-005453-4057qib7	15888	2	processed	process	VBN
cord-005453-4057qib7	15888	3	volume	volume	NN
cord-005453-4057qib7	15888	4	was	be	VBD
cord-005453-4057qib7	15888	5	13.71	13.71	CD
cord-005453-4057qib7	15888	6	Liters	Liters	NNPS
cord-005453-4057qib7	15888	7	.	.	.
cord-005453-4057qib7	15889	1	The	the	DT
cord-005453-4057qib7	15889	2	mean	mean	JJ
cord-005453-4057qib7	15889	3	CD34	CD34	NNP
cord-005453-4057qib7	15889	4	+	+	CC
cord-005453-4057qib7	15889	5	peripheral	peripheral	JJ
cord-005453-4057qib7	15889	6	count	count	NN
cord-005453-4057qib7	15889	7	before	before	IN
cord-005453-4057qib7	15889	8	apheresis	apheresis	NN
cord-005453-4057qib7	15889	9	was	be	VBD
cord-005453-4057qib7	15889	10	68	68	CD
cord-005453-4057qib7	15889	11	/	/	SYM
cord-005453-4057qib7	15889	12	ul	ul	NN
cord-005453-4057qib7	15889	13	,	,	,
cord-005453-4057qib7	15889	14	the	the	DT
cord-005453-4057qib7	15889	15	mean	mean	NN
cord-005453-4057qib7	15889	16	collected	collect	VBD
cord-005453-4057qib7	15889	17	CD34+count	CD34+count	NNP
cord-005453-4057qib7	15889	18	per	per	IN
cord-005453-4057qib7	15890	1	kg	kg	NNP
cord-005453-4057qib7	15890	2	bodyweight	bodyweight	NNP
cord-005453-4057qib7	15890	3	recipient	recipient	NN
cord-005453-4057qib7	15890	4	was	be	VBD
cord-005453-4057qib7	15890	5	6.35	6.35	CD
cord-005453-4057qib7	15890	6	.	.	.
cord-005453-4057qib7	15891	1	Pearson´s	pearson´s	JJ
cord-005453-4057qib7	15891	2	correlation	correlation	NN
cord-005453-4057qib7	15891	3	coefficient	coefficient	NN
cord-005453-4057qib7	15891	4	(	(	-LRB-
cord-005453-4057qib7	15891	5	r	r	NN
cord-005453-4057qib7	15891	6	)	)	-RRB-
cord-005453-4057qib7	15891	7	between	between	IN
cord-005453-4057qib7	15891	8	predicted	predict	VBN
cord-005453-4057qib7	15891	9	yield	yield	NN
cord-005453-4057qib7	15891	10	using	use	VBG
cord-005453-4057qib7	15891	11	pre	pre	JJ
cord-005453-4057qib7	15891	12	-	-	JJ
cord-005453-4057qib7	15891	13	apheresis	apheresis	JJ
cord-005453-4057qib7	15891	14	CD34+count	CD34+count	NNP
cord-005453-4057qib7	15891	15	and	and	CC
cord-005453-4057qib7	15891	16	actually	actually	RB
cord-005453-4057qib7	15891	17	collected	collect	VBD
cord-005453-4057qib7	15891	18	CD34	CD34	NNP
cord-005453-4057qib7	15891	19	+	+	CC
cord-005453-4057qib7	15892	1	cells	cell	NNS
cord-005453-4057qib7	15892	2	per	per	IN
cord-005453-4057qib7	15892	3	kg	kg	NNP
cord-005453-4057qib7	15892	4	bodyweight	bodyweight	NN
cord-005453-4057qib7	15892	5	recipient	recipient	NN
cord-005453-4057qib7	15892	6	was	be	VBD
cord-005453-4057qib7	15892	7	0.967	0.967	CD
cord-005453-4057qib7	15892	8	.	.	.
cord-005453-4057qib7	15893	1	The	the	DT
cord-005453-4057qib7	15893	2	mean	mean	JJ
cord-005453-4057qib7	15893	3	difference	difference	NN
cord-005453-4057qib7	15893	4	between	between	IN
cord-005453-4057qib7	15893	5	predicted	predict	VBN
cord-005453-4057qib7	15893	6	and	and	CC
cord-005453-4057qib7	15893	7	collected	collect	VBN
cord-005453-4057qib7	15893	8	cell	cell	NN
cord-005453-4057qib7	15893	9	dose	dose	NN
cord-005453-4057qib7	15893	10	was	be	VBD
cord-005453-4057qib7	15893	11	+4.45%.With	+4.45%.with	ADD
cord-005453-4057qib7	15893	12	knowledge	knowledge	NN
cord-005453-4057qib7	15893	13	of	of	IN
cord-005453-4057qib7	15893	14	the	the	DT
cord-005453-4057qib7	15893	15	predicted	predict	VBN
cord-005453-4057qib7	15893	16	stem	stem	NN
cord-005453-4057qib7	15893	17	cell	cell	NN
cord-005453-4057qib7	15893	18	count	count	NN
cord-005453-4057qib7	15893	19	,	,	,
cord-005453-4057qib7	15893	20	we	-PRON-	PRP
cord-005453-4057qib7	15893	21	were	be	VBD
cord-005453-4057qib7	15893	22	able	able	JJ
cord-005453-4057qib7	15893	23	to	to	TO
cord-005453-4057qib7	15893	24	adjust	adjust	VB
cord-005453-4057qib7	15893	25	apheresis	apheresis	NN
cord-005453-4057qib7	15893	26	procedure	procedure	NN
cord-005453-4057qib7	15893	27	.	.	.
cord-005453-4057qib7	15894	1	In	in	IN
cord-005453-4057qib7	15894	2	case	case	NN
cord-005453-4057qib7	15894	3	of	of	IN
cord-005453-4057qib7	15894	4	marginal	marginal	JJ
cord-005453-4057qib7	15894	5	predicted	predict	VBN
cord-005453-4057qib7	15894	6	yield	yield	NN
cord-005453-4057qib7	15894	7	compared	compare	VBN
cord-005453-4057qib7	15894	8	to	to	IN
cord-005453-4057qib7	15894	9	the	the	DT
cord-005453-4057qib7	15894	10	requested	request	VBN
cord-005453-4057qib7	15894	11	cell	cell	NN
cord-005453-4057qib7	15894	12	dose	dose	NN
cord-005453-4057qib7	15894	13	,	,	,
cord-005453-4057qib7	15894	14	we	-PRON-	PRP
cord-005453-4057qib7	15894	15	increased	increase	VBD
cord-005453-4057qib7	15894	16	the	the	DT
cord-005453-4057qib7	15894	17	blood	blood	NN
cord-005453-4057qib7	15894	18	volume	volume	NN
cord-005453-4057qib7	15894	19	to	to	TO
cord-005453-4057qib7	15894	20	be	be	VB
cord-005453-4057qib7	15894	21	processed	process	VBN
cord-005453-4057qib7	15894	22	.	.	.
cord-005453-4057qib7	15895	1	This	this	DT
cord-005453-4057qib7	15895	2	proceeding	proceeding	NN
cord-005453-4057qib7	15895	3	led	lead	VBD
cord-005453-4057qib7	15895	4	to	to	IN
cord-005453-4057qib7	15895	5	a	a	DT
cord-005453-4057qib7	15895	6	significant	significant	JJ
cord-005453-4057qib7	15895	7	reduction	reduction	NN
cord-005453-4057qib7	15895	8	of	of	IN
cord-005453-4057qib7	15895	9	second	second	JJ
cord-005453-4057qib7	15895	10	day	day	NN
cord-005453-4057qib7	15895	11	donations	donation	NNS
cord-005453-4057qib7	15895	12	in	in	IN
cord-005453-4057qib7	15895	13	2017	2017	CD
cord-005453-4057qib7	15895	14	by	by	IN
cord-005453-4057qib7	15895	15	38	38	CD
cord-005453-4057qib7	15895	16	%	%	NN
cord-005453-4057qib7	15895	17	compared	compare	VBN
cord-005453-4057qib7	15895	18	to	to	IN
cord-005453-4057qib7	15895	19	2016	2016	CD
cord-005453-4057qib7	15895	20	.	.	.
cord-005453-4057qib7	15896	1	In	in	IN
cord-005453-4057qib7	15896	2	only	only	RB
cord-005453-4057qib7	15896	3	3	3	CD
cord-005453-4057qib7	15896	4	cases	case	NNS
cord-005453-4057qib7	15896	5	we	-PRON-	PRP
cord-005453-4057qib7	15896	6	saw	see	VBD
cord-005453-4057qib7	15896	7	more	more	JJR
cord-005453-4057qib7	15896	8	than	than	IN
cord-005453-4057qib7	15896	9	-40	-40	NNS
cord-005453-4057qib7	15896	10	%	%	NN
cord-005453-4057qib7	15896	11	lower	low	JJR
cord-005453-4057qib7	15896	12	CD34	CD34	NNP
cord-005453-4057qib7	15896	13	+	+	CC
cord-005453-4057qib7	15896	14	doses	dose	NNS
cord-005453-4057qib7	15896	15	collected	collect	VBN
cord-005453-4057qib7	15896	16	than	than	IN
cord-005453-4057qib7	15896	17	initially	initially	RB
cord-005453-4057qib7	15896	18	predicted	predict	VBN
cord-005453-4057qib7	15896	19	.	.	.
cord-005453-4057qib7	15897	1	All	all	DT
cord-005453-4057qib7	15897	2	3	3	CD
cord-005453-4057qib7	15897	3	donors	donor	NNS
cord-005453-4057qib7	15897	4	showed	show	VBD
cord-005453-4057qib7	15897	5	mild	mild	JJ
cord-005453-4057qib7	15897	6	iron	iron	NN
cord-005453-4057qib7	15897	7	deficiency	deficiency	NN
cord-005453-4057qib7	15897	8	with	with	IN
cord-005453-4057qib7	15897	9	RBC	RBC	NNP
cord-005453-4057qib7	15897	10	microcytosis	microcytosis	NNP
cord-005453-4057qib7	15897	11	,	,	,
cord-005453-4057qib7	15897	12	a	a	DT
cord-005453-4057qib7	15897	13	factor	factor	NN
cord-005453-4057qib7	15897	14	known	know	VBN
cord-005453-4057qib7	15897	15	to	to	TO
cord-005453-4057qib7	15897	16	affect	affect	VB
cord-005453-4057qib7	15897	17	apheresis	apheresis	NN
cord-005453-4057qib7	15897	18	procedure	procedure	NN
cord-005453-4057qib7	15897	19	.	.	.
cord-005453-4057qib7	15898	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15898	2	:	:	:
cord-005453-4057qib7	15899	1	Pierellis	Pierellis	NNP
cord-005453-4057qib7	15899	2	method	method	NN
cord-005453-4057qib7	15899	3	of	of	IN
cord-005453-4057qib7	15899	4	calculating	calculate	VBG
cord-005453-4057qib7	15899	5	the	the	DT
cord-005453-4057qib7	15899	6	stem	stem	NN
cord-005453-4057qib7	15899	7	cell	cell	NN
cord-005453-4057qib7	15899	8	yield	yield	NN
cord-005453-4057qib7	15899	9	shows	show	VBZ
cord-005453-4057qib7	15899	10	a	a	DT
cord-005453-4057qib7	15899	11	good	good	JJ
cord-005453-4057qib7	15899	12	correlation	correlation	NN
cord-005453-4057qib7	15899	13	between	between	IN
cord-005453-4057qib7	15899	14	pre	pre	JJ
cord-005453-4057qib7	15899	15	-	-	JJ
cord-005453-4057qib7	15899	16	apheresis	apheresis	NN
cord-005453-4057qib7	15899	17	CD34	CD34	NNP
cord-005453-4057qib7	15899	18	+	+	CC
cord-005453-4057qib7	15899	19	count	count	NN
cord-005453-4057qib7	15899	20	and	and	CC
cord-005453-4057qib7	15899	21	actual	actual	JJ
cord-005453-4057qib7	15899	22	collected	collect	VBN
cord-005453-4057qib7	15899	23	stem	stem	NN
cord-005453-4057qib7	15899	24	cells	cell	NNS
cord-005453-4057qib7	15899	25	,	,	,
cord-005453-4057qib7	15899	26	making	make	VBG
cord-005453-4057qib7	15899	27	planning	planning	NN
cord-005453-4057qib7	15899	28	and	and	CC
cord-005453-4057qib7	15899	29	adjusting	adjusting	NN
cord-005453-4057qib7	15899	30	of	of	IN
cord-005453-4057qib7	15899	31	the	the	DT
cord-005453-4057qib7	15899	32	apheresis	apheresis	NN
cord-005453-4057qib7	15899	33	procedure	procedure	NN
cord-005453-4057qib7	15899	34	more	more	RBR
cord-005453-4057qib7	15899	35	feasible	feasible	JJ
cord-005453-4057qib7	15899	36	and	and	CC
cord-005453-4057qib7	15899	37	reliable	reliable	JJ
cord-005453-4057qib7	15899	38	.	.	.
cord-005453-4057qib7	15900	1	This	this	DT
cord-005453-4057qib7	15900	2	proceeding	proceeding	NN
cord-005453-4057qib7	15900	3	led	lead	VBD
cord-005453-4057qib7	15900	4	to	to	IN
cord-005453-4057qib7	15900	5	significant	significant	JJ
cord-005453-4057qib7	15900	6	reduction	reduction	NN
cord-005453-4057qib7	15900	7	of	of	IN
cord-005453-4057qib7	15900	8	second	second	JJ
cord-005453-4057qib7	15900	9	day	day	NN
cord-005453-4057qib7	15900	10	donations	donation	NNS
cord-005453-4057qib7	15900	11	.	.	.
cord-005453-4057qib7	15901	1	Attention	attention	NN
cord-005453-4057qib7	15901	2	should	should	MD
cord-005453-4057qib7	15901	3	be	be	VB
cord-005453-4057qib7	15901	4	paid	pay	VBN
cord-005453-4057qib7	15901	5	to	to	TO
cord-005453-4057qib7	15901	6	iron	iron	NN
cord-005453-4057qib7	15901	7	deficiency	deficiency	NN
cord-005453-4057qib7	15901	8	anemia	anemia	NN
cord-005453-4057qib7	15901	9	,	,	,
cord-005453-4057qib7	15901	10	leading	lead	VBG
cord-005453-4057qib7	15901	11	to	to	IN
cord-005453-4057qib7	15901	12	lower	low	JJR
cord-005453-4057qib7	15901	13	than	than	IN
cord-005453-4057qib7	15901	14	estimated	estimate	VBN
cord-005453-4057qib7	15901	15	CD34	CD34	NNP
cord-005453-4057qib7	15901	16	+	+	CC
cord-005453-4057qib7	15901	17	dose	dose	NN
cord-005453-4057qib7	15901	18	.	.	.
cord-005453-4057qib7	15902	1	[	[	-LRB-
cord-005453-4057qib7	15902	2	Background	background	NN
cord-005453-4057qib7	15902	3	:	:	:
cord-005453-4057qib7	15903	1	For	for	IN
cord-005453-4057qib7	15903	2	more	more	JJR
cord-005453-4057qib7	15903	3	than	than	IN
cord-005453-4057qib7	15903	4	a	a	DT
cord-005453-4057qib7	15903	5	decade	decade	NN
cord-005453-4057qib7	15903	6	many	many	JJ
cord-005453-4057qib7	15903	7	transplant	transplant	NN
cord-005453-4057qib7	15903	8	centers	center	NNS
cord-005453-4057qib7	15903	9	routinely	routinely	RB
cord-005453-4057qib7	15903	10	collect	collect	VBP
cord-005453-4057qib7	15903	11	and	and	CC
cord-005453-4057qib7	15903	12	cryopreserve	cryopreserve	VBP
cord-005453-4057qib7	15903	13	two	two	CD
cord-005453-4057qib7	15903	14	or	or	CC
cord-005453-4057qib7	15903	15	more	more	JJR
cord-005453-4057qib7	15903	16	peripheral	peripheral	JJ
cord-005453-4057qib7	15903	17	blood	blood	NN
cord-005453-4057qib7	15903	18	stem	stem	NN
cord-005453-4057qib7	15903	19	cell	cell	NN
cord-005453-4057qib7	15903	20	(	(	-LRB-
cord-005453-4057qib7	15903	21	PBSC	PBSC	NNP
cord-005453-4057qib7	15903	22	)	)	-RRB-
cord-005453-4057qib7	15903	23	grafts	graft	NNS
cord-005453-4057qib7	15903	24	for	for	IN
cord-005453-4057qib7	15903	25	a	a	DT
cord-005453-4057qib7	15903	26	tandem	tandem	JJ
cord-005453-4057qib7	15903	27	and/	and/	CD
cord-005453-4057qib7	15903	28	or	or	CC
cord-005453-4057qib7	15903	29	salvage	salvage	VB
cord-005453-4057qib7	15903	30	autologous	autologous	JJ
cord-005453-4057qib7	15903	31	blood	blood	NN
cord-005453-4057qib7	15903	32	stem	stem	NN
cord-005453-4057qib7	15903	33	cell	cell	NN
cord-005453-4057qib7	15903	34	transplantation	transplantation	NN
cord-005453-4057qib7	15903	35	(	(	-LRB-
cord-005453-4057qib7	15903	36	ABSCT	ABSCT	NNP
cord-005453-4057qib7	15903	37	)	)	-RRB-
cord-005453-4057qib7	15903	38	in	in	IN
cord-005453-4057qib7	15903	39	patients	patient	NNS
cord-005453-4057qib7	15903	40	with	with	IN
cord-005453-4057qib7	15903	41	hemato	hemato	JJ
cord-005453-4057qib7	15903	42	-	-	HYPH
cord-005453-4057qib7	15903	43	oncological	oncological	JJ
cord-005453-4057qib7	15903	44	diseases	disease	NNS
cord-005453-4057qib7	15903	45	.	.	.
cord-005453-4057qib7	15904	1	However	however	RB
cord-005453-4057qib7	15904	2	,	,	,
cord-005453-4057qib7	15904	3	subsequent	subsequent	JJ
cord-005453-4057qib7	15904	4	high	high	JJ
cord-005453-4057qib7	15904	5	-	-	HYPH
cord-005453-4057qib7	15904	6	dose	dose	NN
cord-005453-4057qib7	15904	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15904	8	(	(	-LRB-
cord-005453-4057qib7	15904	9	HD	hd	NN
cord-005453-4057qib7	15904	10	-	-	HYPH
cord-005453-4057qib7	15904	11	CHT	CHT	NNP
cord-005453-4057qib7	15904	12	)	)	-RRB-
cord-005453-4057qib7	15904	13	and	and	CC
cord-005453-4057qib7	15904	14	ABSCT	ABSCT	NNP
cord-005453-4057qib7	15904	15	is	be	VBZ
cord-005453-4057qib7	15904	16	in	in	IN
cord-005453-4057qib7	15904	17	many	many	JJ
cord-005453-4057qib7	15904	18	cases	case	NNS
cord-005453-4057qib7	15904	19	not	not	RB
cord-005453-4057qib7	15904	20	performed	perform	VBN
cord-005453-4057qib7	15904	21	for	for	IN
cord-005453-4057qib7	15904	22	a	a	DT
cord-005453-4057qib7	15904	23	variety	variety	NN
cord-005453-4057qib7	15904	24	of	of	IN
cord-005453-4057qib7	15904	25	reasons	reason	NNS
cord-005453-4057qib7	15904	26	,	,	,
cord-005453-4057qib7	15904	27	specifically	specifically	RB
cord-005453-4057qib7	15904	28	in	in	IN
cord-005453-4057qib7	15904	29	patients	patient	NNS
cord-005453-4057qib7	15904	30	with	with	IN
cord-005453-4057qib7	15904	31	AML	AML	NNP
cord-005453-4057qib7	15904	32	,	,	,
cord-005453-4057qib7	15904	33	ALL	all	DT
cord-005453-4057qib7	15904	34	,	,	,
cord-005453-4057qib7	15904	35	MPN	MPN	NNP
cord-005453-4057qib7	15904	36	and	and	CC
cord-005453-4057qib7	15904	37	Burkitt	Burkitt	NNP
cord-005453-4057qib7	15904	38	lymphoma	lymphoma	NN
cord-005453-4057qib7	15904	39	.	.	.
cord-005453-4057qib7	15905	1	Data	datum	NNS
cord-005453-4057qib7	15905	2	about	about	IN
cord-005453-4057qib7	15905	3	the	the	DT
cord-005453-4057qib7	15905	4	actual	actual	JJ
cord-005453-4057qib7	15905	5	utilization	utilization	NN
cord-005453-4057qib7	15905	6	rate	rate	NN
cord-005453-4057qib7	15905	7	of	of	IN
cord-005453-4057qib7	15905	8	the	the	DT
cord-005453-4057qib7	15905	9	cryostored	cryostore	VBN
cord-005453-4057qib7	15905	10	stem	stem	NN
cord-005453-4057qib7	15905	11	cell	cell	NN
cord-005453-4057qib7	15905	12	products	product	NNS
cord-005453-4057qib7	15905	13	are	be	VBP
cord-005453-4057qib7	15905	14	lacking	lack	VBG
cord-005453-4057qib7	15905	15	.	.	.
cord-005453-4057qib7	15906	1	Methods	method	NNS
cord-005453-4057qib7	15906	2	:	:	:
cord-005453-4057qib7	15906	3	We	-PRON-	PRP
cord-005453-4057qib7	15906	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	15906	5	analyzed	analyze	VBD
cord-005453-4057qib7	15906	6	the	the	DT
cord-005453-4057qib7	15906	7	collection	collection	NN
cord-005453-4057qib7	15906	8	,	,	,
cord-005453-4057qib7	15906	9	storage	storage	NN
cord-005453-4057qib7	15906	10	and	and	CC
cord-005453-4057qib7	15906	11	disposal	disposal	NN
cord-005453-4057qib7	15906	12	practices	practice	NNS
cord-005453-4057qib7	15906	13	of	of	IN
cord-005453-4057qib7	15906	14	PBSC	PBSC	NNP
cord-005453-4057qib7	15906	15	products	product	NNS
cord-005453-4057qib7	15906	16	from	from	IN
cord-005453-4057qib7	15906	17	a	a	DT
cord-005453-4057qib7	15906	18	large	large	JJ
cord-005453-4057qib7	15906	19	cohort	cohort	NN
cord-005453-4057qib7	15906	20	of	of	IN
cord-005453-4057qib7	15906	21	patients	patient	NNS
cord-005453-4057qib7	15906	22	who	who	WP
cord-005453-4057qib7	15906	23	were	be	VBD
cord-005453-4057qib7	15906	24	treated	treat	VBN
cord-005453-4057qib7	15906	25	at	at	IN
cord-005453-4057qib7	15906	26	the	the	DT
cord-005453-4057qib7	15906	27	University	University	NNP
cord-005453-4057qib7	15906	28	Hospital	Hospital	NNP
cord-005453-4057qib7	15906	29	Heidelberg	Heidelberg	NNP
cord-005453-4057qib7	15906	30	or	or	CC
cord-005453-4057qib7	15906	31	at	at	IN
cord-005453-4057qib7	15906	32	the	the	DT
cord-005453-4057qib7	15906	33	University	University	NNP
cord-005453-4057qib7	15906	34	Medical	Medical	NNP
cord-005453-4057qib7	15906	35	Center	Center	NNP
cord-005453-4057qib7	15906	36	Mannheim	Mannheim	NNP
cord-005453-4057qib7	15906	37	during	during	IN
cord-005453-4057qib7	15906	38	a	a	DT
cord-005453-4057qib7	15906	39	12-year	12-year	JJ
cord-005453-4057qib7	15906	40	period	period	NN
cord-005453-4057qib7	15906	41	.	.	.
cord-005453-4057qib7	15907	1	Disease	Disease	NNP
cord-005453-4057qib7	15907	2	entities	entity	NNS
cord-005453-4057qib7	15907	3	included	include	VBD
cord-005453-4057qib7	15907	4	acute	acute	JJ
cord-005453-4057qib7	15907	5	myeloid	myeloid	NN
cord-005453-4057qib7	15907	6	leukemia	leukemia	NN
cord-005453-4057qib7	15907	7	(	(	-LRB-
cord-005453-4057qib7	15907	8	AML	AML	NNP
cord-005453-4057qib7	15907	9	,	,	,
cord-005453-4057qib7	15907	10	n=74	n=74	NNP
cord-005453-4057qib7	15907	11	)	)	-RRB-
cord-005453-4057qib7	15907	12	,	,	,
cord-005453-4057qib7	15907	13	acute	acute	JJ
cord-005453-4057qib7	15907	14	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	15907	15	leukemia	leukemia	NN
cord-005453-4057qib7	15907	16	(	(	-LRB-
cord-005453-4057qib7	15907	17	ALL	all	DT
cord-005453-4057qib7	15907	18	,	,	,
cord-005453-4057qib7	15907	19	n=22	n=22	NNP
cord-005453-4057qib7	15907	20	)	)	-RRB-
cord-005453-4057qib7	15907	21	,	,	,
cord-005453-4057qib7	15907	22	MPN	MPN	NNP
cord-005453-4057qib7	15907	23	(	(	-LRB-
cord-005453-4057qib7	15907	24	n=18	n=18	RB
cord-005453-4057qib7	15907	25	;	;	,
cord-005453-4057qib7	15907	26	primary	primary	JJ
cord-005453-4057qib7	15907	27	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	15907	28	[	[	-LRB-
cord-005453-4057qib7	15907	29	PMF	PMF	NNP
cord-005453-4057qib7	15907	30	]	]	-RRB-
cord-005453-4057qib7	15907	31	,	,	,
cord-005453-4057qib7	15907	32	n=9	n=9	JJ
cord-005453-4057qib7	15907	33	;	;	:
cord-005453-4057qib7	15907	34	chronic	chronic	JJ
cord-005453-4057qib7	15907	35	myeloid	myeloid	NN
cord-005453-4057qib7	15907	36	leukemia	leukemia	NN
cord-005453-4057qib7	15907	37	[	[	-LRB-
cord-005453-4057qib7	15907	38	CML	CML	NNP
cord-005453-4057qib7	15907	39	]	]	-RRB-
cord-005453-4057qib7	15907	40	,	,	,
cord-005453-4057qib7	15907	41	n=7	n=7	JJ
cord-005453-4057qib7	15907	42	;	;	,
cord-005453-4057qib7	15907	43	secondary	secondary	JJ
cord-005453-4057qib7	15907	44	fibrosis	fibrosis	NN
cord-005453-4057qib7	15907	45	/	/	SYM
cord-005453-4057qib7	15907	46	essential	essential	JJ
cord-005453-4057qib7	15907	47	thrombocythemia	thrombocythemia	NN
cord-005453-4057qib7	15907	48	[	[	-LRB-
cord-005453-4057qib7	15907	49	ET	ET	NNP
cord-005453-4057qib7	15907	50	]	]	-RRB-
cord-005453-4057qib7	15907	51	,	,	,
cord-005453-4057qib7	15907	52	n=1	n=1	FW
cord-005453-4057qib7	15907	53	;	;	:
cord-005453-4057qib7	15907	54	not	not	RB
cord-005453-4057qib7	15907	55	specified	specify	VBN
cord-005453-4057qib7	15907	56	,	,	,
cord-005453-4057qib7	15907	57	n=1	n=1	CD
cord-005453-4057qib7	15907	58	)	)	-RRB-
cord-005453-4057qib7	15907	59	and	and	CC
cord-005453-4057qib7	15907	60	Burkitt	Burkitt	NNP
cord-005453-4057qib7	15907	61	lymphoma	lymphoma	NN
cord-005453-4057qib7	15907	62	(	(	-LRB-
cord-005453-4057qib7	15907	63	n=18	n=18	RB
cord-005453-4057qib7	15907	64	)	)	-RRB-
cord-005453-4057qib7	15907	65	.	.	.
cord-005453-4057qib7	15908	1	Patients	patient	NNS
cord-005453-4057qib7	15908	2	between	between	IN
cord-005453-4057qib7	15908	3	2001	2001	CD
cord-005453-4057qib7	15908	4	and	and	CC
cord-005453-4057qib7	15908	5	2012	2012	CD
cord-005453-4057qib7	15908	6	were	be	VBD
cord-005453-4057qib7	15908	7	included	include	VBN
cord-005453-4057qib7	15908	8	and	and	CC
cord-005453-4057qib7	15908	9	followed	follow	VBN
cord-005453-4057qib7	15908	10	until	until	IN
cord-005453-4057qib7	15908	11	2016.Results	2016.results	CD
cord-005453-4057qib7	15908	12	:	:	:
cord-005453-4057qib7	15909	1	An	an	DT
cord-005453-4057qib7	15909	2	adequate	adequate	JJ
cord-005453-4057qib7	15909	3	stem	stem	NN
cord-005453-4057qib7	15909	4	cell	cell	NN
cord-005453-4057qib7	15909	5	graft	graft	NN
cord-005453-4057qib7	15909	6	was	be	VBD
cord-005453-4057qib7	15909	7	defined	define	VBN
cord-005453-4057qib7	15909	8	as	as	IN
cord-005453-4057qib7	15909	9	≥2.0	≥2.0	NNP
cord-005453-4057qib7	15909	10	x10Exp6	x10exp6	JJ
cord-005453-4057qib7	15909	11	CD34	CD34	NNP
cord-005453-4057qib7	15909	12	+	+	CC
cord-005453-4057qib7	15909	13	cells	cell	NNS
cord-005453-4057qib7	15909	14	/kg	/kg	NFP
cord-005453-4057qib7	15909	15	body	body	NN
cord-005453-4057qib7	15909	16	weight	weight	NN
cord-005453-4057qib7	15909	17	.	.	.
cord-005453-4057qib7	15910	1	97	97	CD
cord-005453-4057qib7	15910	2	%	%	NN
cord-005453-4057qib7	15910	3	of	of	IN
cord-005453-4057qib7	15910	4	the	the	DT
cord-005453-4057qib7	15910	5	patients	patient	NNS
cord-005453-4057qib7	15910	6	were	be	VBD
cord-005453-4057qib7	15910	7	able	able	JJ
cord-005453-4057qib7	15910	8	to	to	TO
cord-005453-4057qib7	15910	9	collect	collect	VB
cord-005453-4057qib7	15910	10	at	at	IN
cord-005453-4057qib7	15910	11	least	least	RBS
cord-005453-4057qib7	15910	12	one	one	CD
cord-005453-4057qib7	15910	13	stem	stem	NN
cord-005453-4057qib7	15910	14	cell	cell	NN
cord-005453-4057qib7	15910	15	graft	graft	NN
cord-005453-4057qib7	15910	16	and	and	CC
cord-005453-4057qib7	15910	17	the	the	DT
cord-005453-4057qib7	15910	18	median	median	JJ
cord-005453-4057qib7	15910	19	number	number	NN
cord-005453-4057qib7	15910	20	of	of	IN
cord-005453-4057qib7	15910	21	grafts	graft	NNS
cord-005453-4057qib7	15910	22	per	per	IN
cord-005453-4057qib7	15910	23	patient	patient	NN
cord-005453-4057qib7	15910	24	was	be	VBD
cord-005453-4057qib7	15910	25	1	1	CD
cord-005453-4057qib7	15910	26	(	(	-LRB-
cord-005453-4057qib7	15910	27	range	range	VB
cord-005453-4057qib7	15910	28	0	0	CD
cord-005453-4057qib7	15910	29	-	-	SYM
cord-005453-4057qib7	15910	30	5	5	CD
cord-005453-4057qib7	15910	31	)	)	-RRB-
cord-005453-4057qib7	15910	32	.	.	.
cord-005453-4057qib7	15911	1	We	-PRON-	PRP
cord-005453-4057qib7	15911	2	could	could	MD
cord-005453-4057qib7	15911	3	demonstrate	demonstrate	VB
cord-005453-4057qib7	15911	4	that	that	IN
cord-005453-4057qib7	15911	5	only	only	RB
cord-005453-4057qib7	15911	6	31	31	CD
cord-005453-4057qib7	15911	7	%	%	NN
cord-005453-4057qib7	15911	8	of	of	IN
cord-005453-4057qib7	15911	9	all	all	DT
cord-005453-4057qib7	15911	10	patients	patient	NNS
cord-005453-4057qib7	15911	11	who	who	WP
cord-005453-4057qib7	15911	12	had	have	VBD
cord-005453-4057qib7	15911	13	collected	collect	VBN
cord-005453-4057qib7	15911	14	sufficient	sufficient	JJ
cord-005453-4057qib7	15911	15	PBSCs	pbsc	NNS
cord-005453-4057qib7	15911	16	for	for	IN
cord-005453-4057qib7	15911	17	transplant	transplant	NN
cord-005453-4057qib7	15911	18	subsequently	subsequently	RB
cord-005453-4057qib7	15911	19	underwent	undergo	VBD
cord-005453-4057qib7	15911	20	an	an	DT
cord-005453-4057qib7	15911	21	ABSCT	absct	NN
cord-005453-4057qib7	15911	22	.	.	.
cord-005453-4057qib7	15912	1	Among	among	IN
cord-005453-4057qib7	15912	2	the	the	DT
cord-005453-4057qib7	15912	3	disease	disease	NN
cord-005453-4057qib7	15912	4	entities	entitie	VBZ
cord-005453-4057qib7	15912	5	the	the	DT
cord-005453-4057qib7	15912	6	actual	actual	JJ
cord-005453-4057qib7	15912	7	use	use	NN
cord-005453-4057qib7	15912	8	of	of	IN
cord-005453-4057qib7	15912	9	the	the	DT
cord-005453-4057qib7	15912	10	stored	store	VBN
cord-005453-4057qib7	15912	11	PBSC	PBSC	NNP
cord-005453-4057qib7	15912	12	grafts	graft	NNS
cord-005453-4057qib7	15912	13	varied	vary	VBN
cord-005453-4057qib7	15912	14	considerably	considerably	RB
cord-005453-4057qib7	15912	15	from	from	IN
cord-005453-4057qib7	15912	16	0	0	CD
cord-005453-4057qib7	15912	17	%	%	NN
cord-005453-4057qib7	15912	18	to	to	TO
cord-005453-4057qib7	15912	19	56	56	CD
cord-005453-4057qib7	15912	20	%	%	NN
cord-005453-4057qib7	15912	21	(	(	-LRB-
cord-005453-4057qib7	15912	22	Figure	figure	NN
cord-005453-4057qib7	15912	23	1	1	CD
cord-005453-4057qib7	15912	24	)	)	-RRB-
cord-005453-4057qib7	15912	25	.Conclusions	.Conclusions	.
cord-005453-4057qib7	15913	1	:	:	:
cord-005453-4057qib7	15913	2	We	-PRON-	PRP
cord-005453-4057qib7	15913	3	could	could	MD
cord-005453-4057qib7	15913	4	identify	identify	VB
cord-005453-4057qib7	15913	5	striking	strike	VBG
cord-005453-4057qib7	15913	6	discrepancies	discrepancy	NNS
cord-005453-4057qib7	15913	7	between	between	IN
cord-005453-4057qib7	15913	8	the	the	DT
cord-005453-4057qib7	15913	9	collection	collection	NN
cord-005453-4057qib7	15913	10	/	/	SYM
cord-005453-4057qib7	15913	11	storage	storage	NN
cord-005453-4057qib7	15913	12	and	and	CC
cord-005453-4057qib7	15913	13	actual	actual	JJ
cord-005453-4057qib7	15913	14	utilization	utilization	NN
cord-005453-4057qib7	15913	15	of	of	IN
cord-005453-4057qib7	15913	16	Background	background	NN
cord-005453-4057qib7	15913	17	:	:	:
cord-005453-4057qib7	15913	18	Biosimilars	Biosimilars	NNP
cord-005453-4057qib7	15913	19	(	(	-LRB-
cord-005453-4057qib7	15913	20	BIO	BIO	NNP
cord-005453-4057qib7	15913	21	)	)	-RRB-
cord-005453-4057qib7	15913	22	of	of	IN
cord-005453-4057qib7	15913	23	granulocyte	granulocyte	NN
cord-005453-4057qib7	15913	24	colony	colony	NN
cord-005453-4057qib7	15913	25	stimulating	stimulate	VBG
cord-005453-4057qib7	15913	26	factors	factor	NNS
cord-005453-4057qib7	15913	27	(	(	-LRB-
cord-005453-4057qib7	15913	28	GCSF	GCSF	NNP
cord-005453-4057qib7	15913	29	)	)	-RRB-
cord-005453-4057qib7	15913	30	were	be	VBD
cord-005453-4057qib7	15913	31	approved	approve	VBN
cord-005453-4057qib7	15913	32	several	several	JJ
cord-005453-4057qib7	15913	33	years	year	NNS
cord-005453-4057qib7	15913	34	ago	ago	RB
cord-005453-4057qib7	15913	35	on	on	IN
cord-005453-4057qib7	15913	36	the	the	DT
cord-005453-4057qib7	15913	37	basis	basis	NN
cord-005453-4057qib7	15913	38	of	of	IN
cord-005453-4057qib7	15913	39	some	some	DT
cord-005453-4057qib7	15913	40	studies	study	NNS
cord-005453-4057qib7	15913	41	that	that	WDT
cord-005453-4057qib7	15913	42	indicated	indicate	VBD
cord-005453-4057qib7	15913	43	similar	similar	JJ
cord-005453-4057qib7	15913	44	efficacy	efficacy	NN
cord-005453-4057qib7	15913	45	to	to	IN
cord-005453-4057qib7	15913	46	the	the	DT
cord-005453-4057qib7	15913	47	already	already	RB
cord-005453-4057qib7	15913	48	patented	patent	VBN
cord-005453-4057qib7	15913	49	GCSF	GCSF	NNP
cord-005453-4057qib7	15914	1	(	(	-LRB-
cord-005453-4057qib7	15914	2	Neupogen	Neupogen	NNP
cord-005453-4057qib7	15914	3	®	®	NNP
cord-005453-4057qib7	15914	4	,	,	,
cord-005453-4057qib7	15914	5	NEU	NEU	NNP
cord-005453-4057qib7	15914	6	)	)	-RRB-
cord-005453-4057qib7	15915	1	both	both	DT
cord-005453-4057qib7	15915	2	in	in	IN
cord-005453-4057qib7	15915	3	terms	term	NNS
cord-005453-4057qib7	15915	4	of	of	IN
cord-005453-4057qib7	15915	5	shortening	shorten	VBG
cord-005453-4057qib7	15915	6	the	the	DT
cord-005453-4057qib7	15915	7	neutropenic	neutropenic	JJ
cord-005453-4057qib7	15915	8	period	period	NN
cord-005453-4057qib7	15915	9	after	after	IN
cord-005453-4057qib7	15915	10	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15915	11	as	as	RB
cord-005453-4057qib7	15915	12	well	well	RB
cord-005453-4057qib7	15915	13	as	as	IN
cord-005453-4057qib7	15915	14	peripheral	peripheral	JJ
cord-005453-4057qib7	15915	15	blood	blood	NN
cord-005453-4057qib7	15915	16	stem	stem	NN
cord-005453-4057qib7	15915	17	cell	cell	NN
cord-005453-4057qib7	15915	18	mobilization	mobilization	NN
cord-005453-4057qib7	15915	19	in	in	IN
cord-005453-4057qib7	15915	20	patients	patient	NNS
cord-005453-4057qib7	15915	21	with	with	IN
cord-005453-4057qib7	15915	22	lymphoma	lymphoma	NN
cord-005453-4057qib7	15915	23	and	and	CC
cord-005453-4057qib7	15915	24	multiple	multiple	JJ
cord-005453-4057qib7	15915	25	myeloma	myeloma	NN
cord-005453-4057qib7	15915	26	(	(	-LRB-
cord-005453-4057qib7	15915	27	MM	MM	NNP
cord-005453-4057qib7	15915	28	)	)	-RRB-
cord-005453-4057qib7	15915	29	treated	treat	VBN
cord-005453-4057qib7	15915	30	with	with	IN
cord-005453-4057qib7	15915	31	autologous	autologous	JJ
cord-005453-4057qib7	15915	32	stem	stem	NN
cord-005453-4057qib7	15915	33	cell	cell	NN
cord-005453-4057qib7	15915	34	transplantation	transplantation	NN
cord-005453-4057qib7	15915	35	(	(	-LRB-
cord-005453-4057qib7	15915	36	auto	auto	NN
cord-005453-4057qib7	15915	37	-	-	HYPH
cord-005453-4057qib7	15915	38	HCT	HCT	NNP
cord-005453-4057qib7	15915	39	)	)	-RRB-
cord-005453-4057qib7	15915	40	.	.	.
cord-005453-4057qib7	15916	1	However	however	RB
cord-005453-4057qib7	15916	2	,	,	,
cord-005453-4057qib7	15916	3	all	all	PDT
cord-005453-4057qib7	15916	4	these	these	DT
cord-005453-4057qib7	15916	5	studies	study	NNS
cord-005453-4057qib7	15916	6	are	be	VBP
cord-005453-4057qib7	15916	7	retrospective	retrospective	JJ
cord-005453-4057qib7	15916	8	and	and	CC
cord-005453-4057qib7	15916	9	there	there	EX
cord-005453-4057qib7	15916	10	are	be	VBP
cord-005453-4057qib7	15916	11	still	still	RB
cord-005453-4057qib7	15916	12	concerns	concern	NNS
cord-005453-4057qib7	15916	13	about	about	IN
cord-005453-4057qib7	15916	14	the	the	DT
cord-005453-4057qib7	15916	15	real	real	JJ
cord-005453-4057qib7	15916	16	efficacy	efficacy	NN
cord-005453-4057qib7	15916	17	of	of	IN
cord-005453-4057qib7	15916	18	BIO	BIO	NNP
cord-005453-4057qib7	15916	19	and	and	CC
cord-005453-4057qib7	15916	20	even	even	RB
cord-005453-4057qib7	15916	21	more	more	JJR
cord-005453-4057qib7	15916	22	about	about	IN
cord-005453-4057qib7	15916	23	the	the	DT
cord-005453-4057qib7	15916	24	real	real	JJ
cord-005453-4057qib7	15916	25	benefit	benefit	NN
cord-005453-4057qib7	15916	26	on	on	IN
cord-005453-4057qib7	15916	27	final	final	JJ
cord-005453-4057qib7	15916	28	costs	cost	NNS
cord-005453-4057qib7	15916	29	.	.	.
cord-005453-4057qib7	15917	1	Methods	method	NNS
cord-005453-4057qib7	15917	2	:	:	:
cord-005453-4057qib7	15917	3	We	-PRON-	PRP
cord-005453-4057qib7	15917	4	have	have	VBP
cord-005453-4057qib7	15917	5	retrospectively	retrospectively	RB
cord-005453-4057qib7	15917	6	compared	compare	VBN
cord-005453-4057qib7	15917	7	the	the	DT
cord-005453-4057qib7	15917	8	characteristics	characteristic	NNS
cord-005453-4057qib7	15917	9	of	of	IN
cord-005453-4057qib7	15917	10	the	the	DT
cord-005453-4057qib7	15917	11	mobilization	mobilization	NN
cord-005453-4057qib7	15917	12	procedure	procedure	NN
cord-005453-4057qib7	15917	13	in	in	IN
cord-005453-4057qib7	15917	14	both	both	DT
cord-005453-4057qib7	15917	15	patients	patient	NNS
cord-005453-4057qib7	15917	16	with	with	IN
cord-005453-4057qib7	15917	17	MM	MM	NNP
cord-005453-4057qib7	15917	18	and	and	CC
cord-005453-4057qib7	15917	19	lymphomas	lymphoma	NNS
cord-005453-4057qib7	15917	20	,	,	,
cord-005453-4057qib7	15917	21	and	and	CC
cord-005453-4057qib7	15917	22	healthy	healthy	JJ
cord-005453-4057qib7	15917	23	donors	donor	NNS
cord-005453-4057qib7	15917	24	that	that	WDT
cord-005453-4057qib7	15917	25	received	receive	VBD
cord-005453-4057qib7	15917	26	either	either	CC
cord-005453-4057qib7	15917	27	NEU	NEU	NNP
cord-005453-4057qib7	15917	28	or	or	CC
cord-005453-4057qib7	15917	29	BIO	BIO	NNP
cord-005453-4057qib7	15917	30	(	(	-LRB-
cord-005453-4057qib7	15917	31	with	with	IN
cord-005453-4057qib7	15917	32	no	no	DT
cord-005453-4057qib7	15917	33	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15917	34	)	)	-RRB-
cord-005453-4057qib7	15917	35	in	in	IN
cord-005453-4057qib7	15917	36	4	4	CD
cord-005453-4057qib7	15917	37	University	University	NNP
cord-005453-4057qib7	15917	38	Hospitals	Hospitals	NNPS
cord-005453-4057qib7	15917	39	in	in	IN
cord-005453-4057qib7	15917	40	Catalunya	Catalunya	NNP
cord-005453-4057qib7	15917	41	from	from	IN
cord-005453-4057qib7	15917	42	December	December	NNP
cord-005453-4057qib7	15917	43	/	/	SYM
cord-005453-4057qib7	15917	44	2013	2013	CD
cord-005453-4057qib7	15917	45	to	to	IN
cord-005453-4057qib7	15917	46	November	November	NNP
cord-005453-4057qib7	15917	47	2017	2017	CD
cord-005453-4057qib7	15917	48	.	.	.
cord-005453-4057qib7	15918	1	BIO	BIO	NNP
cord-005453-4057qib7	15918	2	replaced	replace	VBD
cord-005453-4057qib7	15918	3	NEU	NEU	NNP
cord-005453-4057qib7	15918	4	in	in	IN
cord-005453-4057qib7	15918	5	June	June	NNP
cord-005453-4057qib7	15918	6	2016	2016	CD
cord-005453-4057qib7	15918	7	in	in	IN
cord-005453-4057qib7	15918	8	all	all	DT
cord-005453-4057qib7	15918	9	4	4	CD
cord-005453-4057qib7	15918	10	institutions	institution	NNS
cord-005453-4057qib7	15918	11	.	.	.
cord-005453-4057qib7	15919	1	Primary	primary	JJ
cord-005453-4057qib7	15919	2	objectives	objective	NNS
cord-005453-4057qib7	15919	3	were	be	VBD
cord-005453-4057qib7	15919	4	the	the	DT
cord-005453-4057qib7	15919	5	mobilization	mobilization	NN
cord-005453-4057qib7	15919	6	rate	rate	NN
cord-005453-4057qib7	15919	7	(	(	-LRB-
cord-005453-4057qib7	15919	8	defined	define	VBN
cord-005453-4057qib7	15919	9	as	as	IN
cord-005453-4057qib7	15919	10	the	the	DT
cord-005453-4057qib7	15919	11	percentage	percentage	NN
cord-005453-4057qib7	15919	12	of	of	IN
cord-005453-4057qib7	15919	13	patients	patient	NNS
cord-005453-4057qib7	15919	14	that	that	WDT
cord-005453-4057qib7	15919	15	achieved	achieve	VBD
cord-005453-4057qib7	15919	16	≥	≥	CD
cord-005453-4057qib7	15919	17	10	10	CD
cord-005453-4057qib7	15920	1	x	x	SYM
cord-005453-4057qib7	15920	2	10	10	CD
cord-005453-4057qib7	15920	3	3	3	CD
cord-005453-4057qib7	15921	1	/ml	/ml	.
cord-005453-4057qib7	15922	1	CD34	CD34	NNP
cord-005453-4057qib7	15922	2	+	+	CC
cord-005453-4057qib7	15922	3	cells	cell	NNS
cord-005453-4057qib7	15922	4	in	in	IN
cord-005453-4057qib7	15922	5	peripheral	peripheral	JJ
cord-005453-4057qib7	15922	6	blood	blood	NN
cord-005453-4057qib7	15922	7	on	on	IN
cord-005453-4057qib7	15922	8	day	day	NN
cord-005453-4057qib7	15922	9	4	4	CD
cord-005453-4057qib7	15922	10	)	)	-RRB-
cord-005453-4057qib7	15922	11	and	and	CC
cord-005453-4057qib7	15922	12	the	the	DT
cord-005453-4057qib7	15922	13	use	use	NN
cord-005453-4057qib7	15922	14	of	of	IN
cord-005453-4057qib7	15922	15	plerixafor	plerixafor	NN
cord-005453-4057qib7	15922	16	(	(	-LRB-
cord-005453-4057qib7	15922	17	PLEX	PLEX	NNP
cord-005453-4057qib7	15922	18	)	)	-RRB-
cord-005453-4057qib7	15922	19	in	in	IN
cord-005453-4057qib7	15922	20	each	each	DT
cord-005453-4057qib7	15922	21	group	group	NN
cord-005453-4057qib7	15922	22	as	as	IN
cord-005453-4057qib7	15922	23	pre	pre	JJ
cord-005453-4057qib7	15922	24	-	-	JJ
cord-005453-4057qib7	15922	25	emptive	emptive	JJ
cord-005453-4057qib7	15922	26	strategy	strategy	NN
cord-005453-4057qib7	15922	27	.	.	.
cord-005453-4057qib7	15923	1	A	a	DT
cord-005453-4057qib7	15923	2	multivariable	multivariable	JJ
cord-005453-4057qib7	15923	3	analysis	analysis	NN
cord-005453-4057qib7	15923	4	of	of	IN
cord-005453-4057qib7	15923	5	risk	risk	NN
cord-005453-4057qib7	15923	6	factors	factor	NNS
cord-005453-4057qib7	15923	7	influencing	influence	VBG
cord-005453-4057qib7	15923	8	the	the	DT
cord-005453-4057qib7	15923	9	use	use	NN
cord-005453-4057qib7	15923	10	of	of	IN
cord-005453-4057qib7	15923	11	PLEX	PLEX	NNP
cord-005453-4057qib7	15923	12	and	and	CC
cord-005453-4057qib7	15923	13	mobilization	mobilization	NN
cord-005453-4057qib7	15923	14	failure	failure	NN
cord-005453-4057qib7	15923	15	(	(	-LRB-
cord-005453-4057qib7	15923	16	defined	define	VBN
cord-005453-4057qib7	15923	17	as	as	IN
cord-005453-4057qib7	15923	18	collection	collection	NN
cord-005453-4057qib7	15923	19	of	of	IN
cord-005453-4057qib7	15923	20	<	<	NNP
cord-005453-4057qib7	15923	21	2	2	CD
cord-005453-4057qib7	15923	22	x	x	SYM
cord-005453-4057qib7	15923	23	10	10	CD
cord-005453-4057qib7	15923	24	6	6	CD
cord-005453-4057qib7	15924	1	/kg	/kg	.
cord-005453-4057qib7	15925	1	CD34	CD34	NNP
cord-005453-4057qib7	15925	2	+	+	CC
cord-005453-4057qib7	15925	3	cells	cell	NNS
cord-005453-4057qib7	15925	4	)	)	-RRB-
cord-005453-4057qib7	15925	5	was	be	VBD
cord-005453-4057qib7	15925	6	also	also	RB
cord-005453-4057qib7	15925	7	performed	perform	VBN
cord-005453-4057qib7	15925	8	.	.	.
cord-005453-4057qib7	15926	1	Results	result	NNS
cord-005453-4057qib7	15926	2	:	:	:
cord-005453-4057qib7	15927	1	We	-PRON-	PRP
cord-005453-4057qib7	15927	2	treated	treat	VBD
cord-005453-4057qib7	15927	3	216	216	CD
cord-005453-4057qib7	15927	4	patients	patient	NNS
cord-005453-4057qib7	15927	5	(	(	-LRB-
cord-005453-4057qib7	15927	6	102	102	CD
cord-005453-4057qib7	15927	7	lymphomas	lymphoma	NNS
cord-005453-4057qib7	15927	8	and	and	CC
cord-005453-4057qib7	15927	9	114	114	CD
cord-005453-4057qib7	15927	10	MM	MM	NNP
cord-005453-4057qib7	15927	11	)	)	-RRB-
cord-005453-4057qib7	15927	12	and	and	CC
cord-005453-4057qib7	15927	13	55	55	CD
cord-005453-4057qib7	15927	14	healthy	healthy	JJ
cord-005453-4057qib7	15927	15	donors	donor	NNS
cord-005453-4057qib7	15927	16	.	.	.
cord-005453-4057qib7	15928	1	Both	both	DT
cord-005453-4057qib7	15928	2	groups	group	NNS
cord-005453-4057qib7	15928	3	of	of	IN
cord-005453-4057qib7	15928	4	patients	patient	NNS
cord-005453-4057qib7	15928	5	(	(	-LRB-
cord-005453-4057qib7	15928	6	138	138	CD
cord-005453-4057qib7	15928	7	NEU	NEU	NNP
cord-005453-4057qib7	15928	8	and	and	CC
cord-005453-4057qib7	15928	9	78	78	CD
cord-005453-4057qib7	15928	10	BIO	BIO	NNP
cord-005453-4057qib7	15928	11	)	)	-RRB-
cord-005453-4057qib7	15928	12	and	and	CC
cord-005453-4057qib7	15928	13	donors	donor	NNS
cord-005453-4057qib7	15928	14	(	(	-LRB-
cord-005453-4057qib7	15928	15	33	33	CD
cord-005453-4057qib7	15928	16	NEU	NEU	NNP
cord-005453-4057qib7	15928	17	and	and	CC
cord-005453-4057qib7	15928	18	22	22	CD
cord-005453-4057qib7	15928	19	BIO	BIO	NNP
cord-005453-4057qib7	15928	20	)	)	-RRB-
cord-005453-4057qib7	15928	21	were	be	VBD
cord-005453-4057qib7	15928	22	comparable	comparable	JJ
cord-005453-4057qib7	15928	23	regarding	regard	VBG
cord-005453-4057qib7	15928	24	pre	pre	JJ
cord-005453-4057qib7	15928	25	-	-	JJ
cord-005453-4057qib7	15928	26	mobilization	mobilization	JJ
cord-005453-4057qib7	15928	27	general	general	JJ
cord-005453-4057qib7	15928	28	characteristics	characteristic	NNS
cord-005453-4057qib7	15928	29	.	.	.
cord-005453-4057qib7	15929	1	There	there	EX
cord-005453-4057qib7	15929	2	was	be	VBD
cord-005453-4057qib7	15929	3	a	a	DT
cord-005453-4057qib7	15929	4	trend	trend	NN
cord-005453-4057qib7	15929	5	for	for	IN
cord-005453-4057qib7	15929	6	a	a	DT
cord-005453-4057qib7	15929	7	lower	low	JJR
cord-005453-4057qib7	15929	8	median	median	JJ
cord-005453-4057qib7	15929	9	CD34	CD34	NNP
cord-005453-4057qib7	15929	10	+	+	CC
cord-005453-4057qib7	15929	11	peak	peak	NN
cord-005453-4057qib7	15929	12	on	on	IN
cord-005453-4057qib7	15929	13	day	day	NN
cord-005453-4057qib7	15929	14	4	4	CD
cord-005453-4057qib7	15929	15	for	for	IN
cord-005453-4057qib7	15929	16	BIO	BIO	NNP
cord-005453-4057qib7	15929	17	patients	patient	NNS
cord-005453-4057qib7	15929	18	(	(	-LRB-
cord-005453-4057qib7	15929	19	17	17	CD
cord-005453-4057qib7	15929	20	vs	vs	IN
cord-005453-4057qib7	15929	21	20	20	CD
cord-005453-4057qib7	15929	22	,	,	,
cord-005453-4057qib7	15929	23	p	p	NN
cord-005453-4057qib7	15929	24	value	value	NN
cord-005453-4057qib7	15929	25	=	=	SYM
cord-005453-4057qib7	15929	26	0.1	0.1	CD
cord-005453-4057qib7	15929	27	)	)	-RRB-
cord-005453-4057qib7	15929	28	.	.	.
cord-005453-4057qib7	15930	1	A	a	DT
cord-005453-4057qib7	15930	2	total	total	NN
cord-005453-4057qib7	15930	3	of	of	IN
cord-005453-4057qib7	15930	4	53	53	CD
cord-005453-4057qib7	15930	5	patients	patient	NNS
cord-005453-4057qib7	15930	6	received	receive	VBD
cord-005453-4057qib7	15930	7	PLEX	PLEX	NNP
cord-005453-4057qib7	15930	8	,	,	,
cord-005453-4057qib7	15930	9	although	although	IN
cord-005453-4057qib7	15930	10	7	7	CD
cord-005453-4057qib7	15930	11	of	of	IN
cord-005453-4057qib7	15930	12	them	-PRON-	PRP
cord-005453-4057qib7	15930	13	(	(	-LRB-
cord-005453-4057qib7	15930	14	13.2	13.2	CD
cord-005453-4057qib7	15930	15	%	%	NN
cord-005453-4057qib7	15930	16	)	)	-RRB-
cord-005453-4057qib7	15930	17	out	out	IN
cord-005453-4057qib7	15930	18	of	of	IN
cord-005453-4057qib7	15930	19	strict	strict	JJ
cord-005453-4057qib7	15930	20	theoretical	theoretical	JJ
cord-005453-4057qib7	15930	21	indication	indication	NN
cord-005453-4057qib7	15930	22	,	,	,
cord-005453-4057qib7	15930	23	CD34	CD34	NNP
cord-005453-4057qib7	15930	24	+	+	CC
cord-005453-4057qib7	15930	25	cells	cell	NNS
cord-005453-4057qib7	15930	26	>	>	XX
cord-005453-4057qib7	15931	1	10	10	CD
cord-005453-4057qib7	15931	2	x	x	SYM
cord-005453-4057qib7	15931	3	10	10	CD
cord-005453-4057qib7	15931	4	3	3	CD
cord-005453-4057qib7	15932	1	/ml	/ml	.
cord-005453-4057qib7	15933	1	(	(	-LRB-
cord-005453-4057qib7	15933	2	range	range	NNP
cord-005453-4057qib7	15933	3	10.5	10.5	CD
cord-005453-4057qib7	15933	4	-	-	HYPH
cord-005453-4057qib7	15933	5	13.5	13.5	CD
cord-005453-4057qib7	15933	6	)	)	-RRB-
cord-005453-4057qib7	15933	7	and	and	CC
cord-005453-4057qib7	15933	8	were	be	VBD
cord-005453-4057qib7	15933	9	removed	remove	VBN
cord-005453-4057qib7	15933	10	for	for	IN
cord-005453-4057qib7	15933	11	further	further	JJ
cord-005453-4057qib7	15933	12	analysis	analysis	NN
cord-005453-4057qib7	15933	13	(	(	-LRB-
cord-005453-4057qib7	15933	14	n	n	NN
cord-005453-4057qib7	15933	15	=	=	SYM
cord-005453-4057qib7	15933	16	46	46	CD
cord-005453-4057qib7	15933	17	,	,	,
cord-005453-4057qib7	15933	18	31	31	CD
cord-005453-4057qib7	15933	19	in	in	IN
cord-005453-4057qib7	15933	20	the	the	DT
cord-005453-4057qib7	15933	21	NEU	NEU	NNP
cord-005453-4057qib7	15933	22	group	group	NN
cord-005453-4057qib7	15933	23	and	and	CC
cord-005453-4057qib7	15933	24	15	15	CD
cord-005453-4057qib7	15933	25	in	in	IN
cord-005453-4057qib7	15933	26	the	the	DT
cord-005453-4057qib7	15933	27	BIO	BIO	NNP
cord-005453-4057qib7	15933	28	group	group	NN
cord-005453-4057qib7	15933	29	)	)	-RRB-
cord-005453-4057qib7	15933	30	.	.	.
cord-005453-4057qib7	15934	1	Median	median	JJ
cord-005453-4057qib7	15934	2	number	number	NN
cord-005453-4057qib7	15934	3	of	of	IN
cord-005453-4057qib7	15934	4	CD34	CD34	NNP
cord-005453-4057qib7	15934	5	+	+	CC
cord-005453-4057qib7	15934	6	cells	cell	NNS
cord-005453-4057qib7	15934	7	on	on	IN
cord-005453-4057qib7	15934	8	day	day	NN
cord-005453-4057qib7	15934	9	4	4	CD
cord-005453-4057qib7	15934	10	was	be	VBD
cord-005453-4057qib7	15934	11	significantly	significantly	RB
cord-005453-4057qib7	15934	12	lower	low	JJR
cord-005453-4057qib7	15934	13	in	in	IN
cord-005453-4057qib7	15934	14	the	the	DT
cord-005453-4057qib7	15934	15	group	group	NN
cord-005453-4057qib7	15934	16	BIO	BIO	NNP
cord-005453-4057qib7	15934	17	who	who	WP
cord-005453-4057qib7	15934	18	needed	need	VBD
cord-005453-4057qib7	15934	19	PLEX	PLEX	NNP
cord-005453-4057qib7	15934	20	(	(	-LRB-
cord-005453-4057qib7	15934	21	2.4	2.4	CD
cord-005453-4057qib7	15934	22	vs	vs	IN
cord-005453-4057qib7	15934	23	4.8	4.8	CD
cord-005453-4057qib7	15934	24	for	for	IN
cord-005453-4057qib7	15934	25	NEU+PLEX	neu+plex	NN
cord-005453-4057qib7	15934	26	,	,	,
cord-005453-4057qib7	15934	27	p=002	p=002	NNP
cord-005453-4057qib7	15934	28	)	)	-RRB-
cord-005453-4057qib7	15934	29	,	,	,
cord-005453-4057qib7	15934	30	as	as	RB
cord-005453-4057qib7	15934	31	well	well	RB
cord-005453-4057qib7	15934	32	as	as	IN
cord-005453-4057qib7	15934	33	CD34	CD34	NNP
cord-005453-4057qib7	15934	34	+	+	CC
cord-005453-4057qib7	15934	35	cells	cell	NNS
cord-005453-4057qib7	15934	36	finally	finally	RB
cord-005453-4057qib7	15934	37	harvested	harvest	VBN
cord-005453-4057qib7	15934	38	(	(	-LRB-
cord-005453-4057qib7	15934	39	2.5	2.5	CD
cord-005453-4057qib7	15934	40	vs	vs	IN
cord-005453-4057qib7	15934	41	3.3x	3.3x	CD
cord-005453-4057qib7	15934	42	10	10	CD
cord-005453-4057qib7	15934	43	6	6	CD
cord-005453-4057qib7	15934	44	/kg	/kg	CD
cord-005453-4057qib7	15934	45	,	,	,
cord-005453-4057qib7	15934	46	p=0.03	p=0.03	NNP
cord-005453-4057qib7	15934	47	)	)	-RRB-
cord-005453-4057qib7	15934	48	.	.	.
cord-005453-4057qib7	15935	1	Mobilization	mobilization	NN
cord-005453-4057qib7	15935	2	failure	failure	NN
cord-005453-4057qib7	15935	3	rate	rate	NN
cord-005453-4057qib7	15935	4	was	be	VBD
cord-005453-4057qib7	15935	5	higher	high	JJR
cord-005453-4057qib7	15935	6	in	in	IN
cord-005453-4057qib7	15935	7	BIO	BIO	NNP
cord-005453-4057qib7	15935	8	group	group	NN
cord-005453-4057qib7	15935	9	(	(	-LRB-
cord-005453-4057qib7	15935	10	0	0	CD
cord-005453-4057qib7	15935	11	vs	vs	IN
cord-005453-4057qib7	15935	12	20	20	CD
cord-005453-4057qib7	15935	13	%	%	NN
cord-005453-4057qib7	15935	14	,	,	,
cord-005453-4057qib7	15935	15	p=0.01	p=0.01	NNP
cord-005453-4057qib7	15935	16	)	)	-RRB-
cord-005453-4057qib7	15935	17	.	.	.
cord-005453-4057qib7	15936	1	Regarding	regard	VBG
cord-005453-4057qib7	15936	2	no	no	DT
cord-005453-4057qib7	15936	3	PLEX	PLEX	NNP
cord-005453-4057qib7	15936	4	patients	patient	NNS
cord-005453-4057qib7	15936	5	,	,	,
cord-005453-4057qib7	15936	6	median	median	JJ
cord-005453-4057qib7	15936	7	number	number	NN
cord-005453-4057qib7	15936	8	of	of	IN
cord-005453-4057qib7	15936	9	CD34	CD34	NNP
cord-005453-4057qib7	15936	10	+	+	CC
cord-005453-4057qib7	15936	11	cells	cell	NNS
cord-005453-4057qib7	15936	12	on	on	IN
cord-005453-4057qib7	15936	13	day	day	NN
cord-005453-4057qib7	15936	14	4	4	CD
cord-005453-4057qib7	15936	15	was	be	VBD
cord-005453-4057qib7	15936	16	also	also	RB
cord-005453-4057qib7	15936	17	significantly	significantly	RB
cord-005453-4057qib7	15936	18	lower	low	JJR
cord-005453-4057qib7	15936	19	for	for	IN
cord-005453-4057qib7	15936	20	BIO	BIO	NNP
cord-005453-4057qib7	15936	21	patients	patient	NNS
cord-005453-4057qib7	15936	22	(	(	-LRB-
cord-005453-4057qib7	15936	23	33.4	33.4	CD
cord-005453-4057qib7	15936	24	vs	vs	IN
cord-005453-4057qib7	15936	25	23.7	23.7	CD
cord-005453-4057qib7	15936	26	,	,	,
cord-005453-4057qib7	15936	27	p=0.03	p=0.03	NNP
cord-005453-4057qib7	15936	28	)	)	-RRB-
cord-005453-4057qib7	15936	29	.	.	.
cord-005453-4057qib7	15937	1	Risk	risk	NN
cord-005453-4057qib7	15937	2	factors	factor	NNS
cord-005453-4057qib7	15937	3	for	for	IN
cord-005453-4057qib7	15937	4	PLEX	PLEX	NNP
cord-005453-4057qib7	15937	5	use	use	NN
cord-005453-4057qib7	15937	6	were	be	VBD
cord-005453-4057qib7	15937	7	age	age	NN
cord-005453-4057qib7	15937	8	,	,	,
cord-005453-4057qib7	15937	9	basal	basal	NN
cord-005453-4057qib7	15937	10	disease	disease	NN
cord-005453-4057qib7	15937	11	(	(	-LRB-
cord-005453-4057qib7	15937	12	lymphoma	lymphoma	NN
cord-005453-4057qib7	15937	13	)	)	-RRB-
cord-005453-4057qib7	15937	14	and	and	CC
cord-005453-4057qib7	15937	15	number	number	NN
cord-005453-4057qib7	15937	16	of	of	IN
cord-005453-4057qib7	15937	17	prior	prior	JJ
cord-005453-4057qib7	15937	18	mobilization	mobilization	NN
cord-005453-4057qib7	15937	19	therapies	therapy	NNS
cord-005453-4057qib7	15937	20	.	.	.
cord-005453-4057qib7	15938	1	The	the	DT
cord-005453-4057qib7	15938	2	use	use	NN
cord-005453-4057qib7	15938	3	of	of	IN
cord-005453-4057qib7	15938	4	BIO	BIO	NNP
cord-005453-4057qib7	15938	5	was	be	VBD
cord-005453-4057qib7	15938	6	the	the	DT
cord-005453-4057qib7	15938	7	only	only	JJ
cord-005453-4057qib7	15938	8	risk	risk	NN
cord-005453-4057qib7	15938	9	factor	factor	NN
cord-005453-4057qib7	15938	10	for	for	IN
cord-005453-4057qib7	15938	11	mobilization	mobilization	NN
cord-005453-4057qib7	15938	12	failure	failure	NN
cord-005453-4057qib7	15938	13	patients	patient	NNS
cord-005453-4057qib7	15938	14	receiving	receive	VBG
cord-005453-4057qib7	15938	15	PLEX	PLEX	NNP
cord-005453-4057qib7	15938	16	[	[	-LRB-
cord-005453-4057qib7	15938	17	HR	HR	NNP
cord-005453-4057qib7	15938	18	10.3	10.3	CD
cord-005453-4057qib7	15938	19	(	(	-LRB-
cord-005453-4057qib7	15938	20	95%CI	95%ci	CD
cord-005453-4057qib7	15938	21	1.3	1.3	CD
cord-005453-4057qib7	15938	22	-	-	HYPH
cord-005453-4057qib7	15938	23	77.8	77.8	CD
cord-005453-4057qib7	15938	24	)	)	-RRB-
cord-005453-4057qib7	15938	25	,	,	,
cord-005453-4057qib7	15938	26	p=0.02	p=0.02	NNP
cord-005453-4057qib7	15938	27	]	]	-RRB-
cord-005453-4057qib7	15938	28	.	.	.
cord-005453-4057qib7	15939	1	With	with	IN
cord-005453-4057qib7	15939	2	respect	respect	NN
cord-005453-4057qib7	15939	3	to	to	IN
cord-005453-4057qib7	15939	4	healthy	healthy	JJ
cord-005453-4057qib7	15939	5	donor	donor	NN
cord-005453-4057qib7	15939	6	mobilization	mobilization	NN
cord-005453-4057qib7	15939	7	,	,	,
cord-005453-4057qib7	15939	8	none	none	NN
cord-005453-4057qib7	15939	9	of	of	IN
cord-005453-4057qib7	15939	10	them	-PRON-	PRP
cord-005453-4057qib7	15939	11	needed	need	VBD
cord-005453-4057qib7	15939	12	PLEX	PLEX	NNP
cord-005453-4057qib7	15939	13	but	but	CC
cord-005453-4057qib7	15939	14	2	2	CD
cord-005453-4057qib7	15939	15	cases	case	NNS
cord-005453-4057qib7	15939	16	from	from	IN
cord-005453-4057qib7	15939	17	the	the	DT
cord-005453-4057qib7	15939	18	BIO	BIO	NNP
cord-005453-4057qib7	15939	19	group	group	NN
cord-005453-4057qib7	15939	20	(	(	-LRB-
cord-005453-4057qib7	15939	21	9	9	CD
cord-005453-4057qib7	15939	22	%	%	NN
cord-005453-4057qib7	15939	23	)	)	-RRB-
cord-005453-4057qib7	15939	24	needed	need	VBD
cord-005453-4057qib7	15939	25	more	more	JJR
cord-005453-4057qib7	15939	26	than	than	IN
cord-005453-4057qib7	15939	27	one	one	CD
cord-005453-4057qib7	15939	28	apheresis	apheresis	NN
cord-005453-4057qib7	15939	29	procedures	procedure	NNS
cord-005453-4057qib7	15939	30	(	(	-LRB-
cord-005453-4057qib7	15939	31	2	2	CD
cord-005453-4057qib7	15939	32	and	and	CC
cord-005453-4057qib7	15939	33	3	3	CD
cord-005453-4057qib7	15939	34	,	,	,
cord-005453-4057qib7	15939	35	respectively).Conclusions	respectively).conclusion	NNS
cord-005453-4057qib7	15940	1	:	:	:
cord-005453-4057qib7	15940	2	We	-PRON-	PRP
cord-005453-4057qib7	15940	3	found	find	VBD
cord-005453-4057qib7	15940	4	a	a	DT
cord-005453-4057qib7	15940	5	lower	low	JJR
cord-005453-4057qib7	15940	6	efficacy	efficacy	NN
cord-005453-4057qib7	15940	7	of	of	IN
cord-005453-4057qib7	15940	8	BIO	BIO	NNP
cord-005453-4057qib7	15940	9	in	in	IN
cord-005453-4057qib7	15940	10	the	the	DT
cord-005453-4057qib7	15940	11	setting	setting	NN
cord-005453-4057qib7	15940	12	of	of	IN
cord-005453-4057qib7	15940	13	stem	stem	NN
cord-005453-4057qib7	15940	14	cell	cell	NN
cord-005453-4057qib7	15940	15	mobilization	mobilization	NN
cord-005453-4057qib7	15940	16	of	of	IN
cord-005453-4057qib7	15940	17	patients	patient	NNS
cord-005453-4057qib7	15940	18	with	with	IN
cord-005453-4057qib7	15940	19	only	only	JJ
cord-005453-4057qib7	15940	20	GCSF	GCSF	NNP
cord-005453-4057qib7	15940	21	both	both	CC
cord-005453-4057qib7	15940	22	in	in	IN
cord-005453-4057qib7	15940	23	terms	term	NNS
cord-005453-4057qib7	15940	24	of	of	IN
cord-005453-4057qib7	15940	25	a	a	DT
cord-005453-4057qib7	15940	26	lower	low	JJR
cord-005453-4057qib7	15940	27	CD34	CD34	NNP
cord-005453-4057qib7	15940	28	+	+	CC
cord-005453-4057qib7	15940	29	cells	cell	NNS
cord-005453-4057qib7	15940	30	peak	peak	NN
cord-005453-4057qib7	15940	31	on	on	IN
cord-005453-4057qib7	15940	32	day	day	NN
cord-005453-4057qib7	15940	33	4	4	CD
cord-005453-4057qib7	15940	34	and	and	CC
cord-005453-4057qib7	15940	35	a	a	DT
cord-005453-4057qib7	15940	36	lower	low	JJR
cord-005453-4057qib7	15940	37	number	number	NN
cord-005453-4057qib7	15940	38	of	of	IN
cord-005453-4057qib7	15940	39	CD34	CD34	NNP
cord-005453-4057qib7	15940	40	+	+	CC
cord-005453-4057qib7	15940	41	cells	cell	NNS
cord-005453-4057qib7	15940	42	in	in	IN
cord-005453-4057qib7	15940	43	final	final	JJ
cord-005453-4057qib7	15940	44	apheresis	apheresis	NN
cord-005453-4057qib7	15940	45	product	product	NN
cord-005453-4057qib7	15940	46	.	.	.
cord-005453-4057qib7	15941	1	BIO	BIO	NNP
cord-005453-4057qib7	15941	2	GCSF	GCSF	NNP
cord-005453-4057qib7	15941	3	also	also	RB
cord-005453-4057qib7	15941	4	seems	seem	VBZ
cord-005453-4057qib7	15941	5	to	to	TO
cord-005453-4057qib7	15941	6	be	be	VB
cord-005453-4057qib7	15941	7	less	less	RBR
cord-005453-4057qib7	15941	8	effective	effective	JJ
cord-005453-4057qib7	15941	9	in	in	IN
cord-005453-4057qib7	15941	10	healthy	healthy	JJ
cord-005453-4057qib7	15941	11	donors	donor	NNS
cord-005453-4057qib7	15941	12	.	.	.
cord-005453-4057qib7	15942	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15942	2	:	:	:
cord-005453-4057qib7	15942	3	No	no	DT
cord-005453-4057qib7	15942	4	conflict	conflict	NN
cord-005453-4057qib7	15942	5	of	of	IN
cord-005453-4057qib7	15942	6	interest	interest	NN
cord-005453-4057qib7	15942	7	to	to	TO
cord-005453-4057qib7	15942	8	be	be	VB
cord-005453-4057qib7	15942	9	declaredBackground	declaredBackground	VBN
cord-005453-4057qib7	15942	10	:	:	:
cord-005453-4057qib7	15943	1	Auto	Auto	NNP
cord-005453-4057qib7	15943	2	-	-	HYPH
cord-005453-4057qib7	15943	3	SCT	SCT	NNP
cord-005453-4057qib7	15943	4	is	be	VBZ
cord-005453-4057qib7	15943	5	a	a	DT
cord-005453-4057qib7	15943	6	common	common	JJ
cord-005453-4057qib7	15943	7	treatment	treatment	NN
cord-005453-4057qib7	15943	8	in	in	IN
cord-005453-4057qib7	15943	9	patients	patient	NNS
cord-005453-4057qib7	15943	10	with	with	IN
cord-005453-4057qib7	15943	11	MM	MM	NNP
cord-005453-4057qib7	15943	12	or	or	CC
cord-005453-4057qib7	15943	13	NHL	NHL	NNP
cord-005453-4057qib7	15943	14	.	.	.
cord-005453-4057qib7	15944	1	The	the	DT
cord-005453-4057qib7	15944	2	aim	aim	NN
cord-005453-4057qib7	15944	3	of	of	IN
cord-005453-4057qib7	15944	4	the	the	DT
cord-005453-4057qib7	15944	5	prospective	prospective	JJ
cord-005453-4057qib7	15944	6	multicenter	multicenter	NN
cord-005453-4057qib7	15944	7	GOA	GOA	NNP
cord-005453-4057qib7	15944	8	(	(	-LRB-
cord-005453-4057qib7	15944	9	Graft	graft	NN
cord-005453-4057qib7	15944	10	and	and	CC
cord-005453-4057qib7	15944	11	Outcome	outcome	VB
cord-005453-4057qib7	15944	12	in	in	IN
cord-005453-4057qib7	15944	13	Autologous	autologous	JJ
cord-005453-4057qib7	15944	14	transplantation	transplantation	NN
cord-005453-4057qib7	15944	15	)	)	-RRB-
cord-005453-4057qib7	15944	16	study	study	NN
cord-005453-4057qib7	15944	17	was	be	VBD
cord-005453-4057qib7	15944	18	to	to	TO
cord-005453-4057qib7	15944	19	investigate	investigate	VB
cord-005453-4057qib7	15944	20	the	the	DT
cord-005453-4057qib7	15944	21	impact	impact	NN
cord-005453-4057qib7	15944	22	of	of	IN
cord-005453-4057qib7	15944	23	mobilization	mobilization	NN
cord-005453-4057qib7	15944	24	method	method	NN
cord-005453-4057qib7	15944	25	used	use	VBN
cord-005453-4057qib7	15944	26	on	on	IN
cord-005453-4057qib7	15944	27	the	the	DT
cord-005453-4057qib7	15944	28	cellular	cellular	JJ
cord-005453-4057qib7	15944	29	composition	composition	NN
cord-005453-4057qib7	15944	30	of	of	IN
cord-005453-4057qib7	15944	31	collected	collect	VBN
cord-005453-4057qib7	15944	32	blood	blood	NN
cord-005453-4057qib7	15944	33	grafts	graft	NNS
cord-005453-4057qib7	15944	34	and	and	CC
cord-005453-4057qib7	15944	35	eventually	eventually	RB
cord-005453-4057qib7	15944	36	hematological	hematological	JJ
cord-005453-4057qib7	15944	37	and	and	CC
cord-005453-4057qib7	15944	38	immune	immune	JJ
cord-005453-4057qib7	15944	39	recovery	recovery	NN
cord-005453-4057qib7	15944	40	as	as	RB
cord-005453-4057qib7	15944	41	well	well	RB
cord-005453-4057qib7	15944	42	as	as	IN
cord-005453-4057qib7	15944	43	long	long	JJ
cord-005453-4057qib7	15944	44	-	-	HYPH
cord-005453-4057qib7	15944	45	term	term	NN
cord-005453-4057qib7	15944	46	outcome	outcome	NN
cord-005453-4057qib7	15944	47	post	post	NN
cord-005453-4057qib7	15944	48	-	-	NN
cord-005453-4057qib7	15944	49	transplant	transplant	NN
cord-005453-4057qib7	15944	50	.	.	.
cord-005453-4057qib7	15945	1	Altogether	altogether	RB
cord-005453-4057qib7	15945	2	282	282	CD
cord-005453-4057qib7	15945	3	patients	patient	NNS
cord-005453-4057qib7	15945	4	with	with	IN
cord-005453-4057qib7	15945	5	MM	MM	NNP
cord-005453-4057qib7	15945	6	or	or	CC
cord-005453-4057qib7	15945	7	NHL	NHL	NNP
cord-005453-4057qib7	15945	8	transplanted	transplant	VBN
cord-005453-4057qib7	15945	9	between	between	IN
cord-005453-4057qib7	15945	10	5/2012	5/2012	CD
cord-005453-4057qib7	15945	11	and	and	CC
cord-005453-4057qib7	15945	12	12/2016	12/2016	CD
cord-005453-4057qib7	15945	13	at	at	IN
cord-005453-4057qib7	15945	14	four	four	CD
cord-005453-4057qib7	15945	15	university	university	NN
cord-005453-4057qib7	15945	16	hospitals	hospital	NNS
cord-005453-4057qib7	15945	17	were	be	VBD
cord-005453-4057qib7	15945	18	included	include	VBN
cord-005453-4057qib7	15945	19	.	.	.
cord-005453-4057qib7	15946	1	The	the	DT
cord-005453-4057qib7	15946	2	long	long	JJ
cord-005453-4057qib7	15946	3	-	-	HYPH
cord-005453-4057qib7	15946	4	term	term	NN
cord-005453-4057qib7	15946	5	goal	goal	NN
cord-005453-4057qib7	15946	6	of	of	IN
cord-005453-4057qib7	15946	7	the	the	DT
cord-005453-4057qib7	15946	8	study	study	NN
cord-005453-4057qib7	15946	9	is	be	VBZ
cord-005453-4057qib7	15946	10	to	to	TO
cord-005453-4057qib7	15946	11	evaluate	evaluate	VB
cord-005453-4057qib7	15946	12	characteristics	characteristic	NNS
cord-005453-4057qib7	15946	13	of	of	IN
cord-005453-4057qib7	15946	14	optimal	optimal	JJ
cord-005453-4057qib7	15946	15	blood	blood	NN
cord-005453-4057qib7	15946	16	grafts	graft	NNS
cord-005453-4057qib7	15946	17	in	in	IN
cord-005453-4057qib7	15946	18	regard	regard	NN
cord-005453-4057qib7	15946	19	to	to	IN
cord-005453-4057qib7	15946	20	post	post	JJ
cord-005453-4057qib7	15946	21	-	-	JJ
cord-005453-4057qib7	15946	22	transplant	transplant	JJ
cord-005453-4057qib7	15946	23	recovery	recovery	NN
cord-005453-4057qib7	15946	24	and	and	CC
cord-005453-4057qib7	15946	25	outcome	outcome	NN
cord-005453-4057qib7	15946	26	.	.	.
cord-005453-4057qib7	15947	1	Methods	method	NNS
cord-005453-4057qib7	15947	2	:	:	:
cord-005453-4057qib7	15947	3	Altogether	altogether	RB
cord-005453-4057qib7	15947	4	147	147	CD
cord-005453-4057qib7	15947	5	patients	patient	NNS
cord-005453-4057qib7	15947	6	with	with	IN
cord-005453-4057qib7	15947	7	MM	MM	NNP
cord-005453-4057qib7	15947	8	undergoing	undergo	VBG
cord-005453-4057qib7	15947	9	first	first	JJ
cord-005453-4057qib7	15947	10	auto	auto	NN
cord-005453-4057qib7	15947	11	-	-	HYPH
cord-005453-4057qib7	15947	12	SCT	SCT	NNP
cord-005453-4057qib7	15947	13	were	be	VBD
cord-005453-4057qib7	15947	14	compared	compare	VBN
cord-005453-4057qib7	15947	15	with	with	IN
cord-005453-4057qib7	15947	16	135	135	CD
cord-005453-4057qib7	15947	17	patients	patient	NNS
cord-005453-4057qib7	15947	18	with	with	IN
cord-005453-4057qib7	15947	19	NHL	NHL	NNP
cord-005453-4057qib7	15947	20	.	.	.
cord-005453-4057qib7	15948	1	All	all	DT
cord-005453-4057qib7	15948	2	NHL	NHL	NNP
cord-005453-4057qib7	15948	3	patients	patient	NNS
cord-005453-4057qib7	15948	4	were	be	VBD
cord-005453-4057qib7	15948	5	mobilized	mobilize	VBN
cord-005453-4057qib7	15948	6	with	with	IN
cord-005453-4057qib7	15948	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15948	8	+	+	CC
cord-005453-4057qib7	15948	9	G	G	NNP
cord-005453-4057qib7	15948	10	-	-	HYPH
cord-005453-4057qib7	15948	11	CSF	CSF	NNP
cord-005453-4057qib7	15948	12	,	,	,
cord-005453-4057qib7	15948	13	whereas	whereas	IN
cord-005453-4057qib7	15948	14	39	39	CD
cord-005453-4057qib7	15948	15	%	%	NN
cord-005453-4057qib7	15948	16	of	of	IN
cord-005453-4057qib7	15948	17	MM	MM	NNP
cord-005453-4057qib7	15948	18	patients	patient	NNS
cord-005453-4057qib7	15948	19	were	be	VBD
cord-005453-4057qib7	15948	20	mobilized	mobilize	VBN
cord-005453-4057qib7	15948	21	with	with	IN
cord-005453-4057qib7	15948	22	G	G	NNP
cord-005453-4057qib7	15948	23	-	-	HYPH
cord-005453-4057qib7	15948	24	CSF	CSF	NNP
cord-005453-4057qib7	15948	25	only	only	RB
cord-005453-4057qib7	15948	26	(	(	-LRB-
cord-005453-4057qib7	15948	27	p	p	NN
cord-005453-4057qib7	15948	28	<	<	XX
cord-005453-4057qib7	15948	29	0.001	0.001	CD
cord-005453-4057qib7	15948	30	)	)	-RRB-
cord-005453-4057qib7	15948	31	.	.	.
cord-005453-4057qib7	15949	1	Mobilization	mobilization	NN
cord-005453-4057qib7	15949	2	data	datum	NNS
cord-005453-4057qib7	15949	3	,	,	,
cord-005453-4057qib7	15949	4	graft	graft	NN
cord-005453-4057qib7	15949	5	cellular	cellular	JJ
cord-005453-4057qib7	15949	6	composition	composition	NN
cord-005453-4057qib7	15949	7	including	include	VBG
cord-005453-4057qib7	15949	8	CD34	CD34	NNP
cord-005453-4057qib7	15949	9	+	+	CC
cord-005453-4057qib7	15949	10	cell	cell	NN
cord-005453-4057qib7	15949	11	subsets	subset	NNS
cord-005453-4057qib7	15949	12	and	and	CC
cord-005453-4057qib7	15949	13	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	15949	14	subsets	subset	NNS
cord-005453-4057qib7	15949	15	of	of	IN
cord-005453-4057qib7	15949	16	the	the	DT
cord-005453-4057qib7	15949	17	blood	blood	NN
cord-005453-4057qib7	15949	18	grafts	graft	NNS
cord-005453-4057qib7	15949	19	,	,	,
cord-005453-4057qib7	15949	20	post	post	JJ
cord-005453-4057qib7	15949	21	-	-	JJ
cord-005453-4057qib7	15949	22	transplant	transplant	JJ
cord-005453-4057qib7	15949	23	hematological	hematological	JJ
cord-005453-4057qib7	15949	24	recovery	recovery	NN
cord-005453-4057qib7	15949	25	and	and	CC
cord-005453-4057qib7	15949	26	outcome	outcome	NN
cord-005453-4057qib7	15949	27	were	be	VBD
cord-005453-4057qib7	15949	28	evaluated	evaluate	VBN
cord-005453-4057qib7	15949	29	.	.	.
cord-005453-4057qib7	15950	1	The	the	DT
cord-005453-4057qib7	15950	2	median	median	JJ
cord-005453-4057qib7	15950	3	followup	followup	JJ
cord-005453-4057qib7	15950	4	time	time	NN
cord-005453-4057qib7	15950	5	was	be	VBD
cord-005453-4057qib7	15950	6	46	46	CD
cord-005453-4057qib7	15950	7	months	month	NNS
cord-005453-4057qib7	15950	8	in	in	IN
cord-005453-4057qib7	15950	9	MM	MM	NNP
cord-005453-4057qib7	15950	10	patients	patient	NNS
cord-005453-4057qib7	15950	11	and	and	CC
cord-005453-4057qib7	15950	12	35	35	CD
cord-005453-4057qib7	15950	13	months	month	NNS
cord-005453-4057qib7	15950	14	in	in	IN
cord-005453-4057qib7	15950	15	NHL	NHL	NNP
cord-005453-4057qib7	15950	16	patients	patient	NNS
cord-005453-4057qib7	15950	17	.	.	.
cord-005453-4057qib7	15951	1	Results	result	NNS
cord-005453-4057qib7	15951	2	:	:	:
cord-005453-4057qib7	15952	1	MM	MM	NNP
cord-005453-4057qib7	15952	2	patients	patient	NNS
cord-005453-4057qib7	15952	3	mobilized	mobilize	VBD
cord-005453-4057qib7	15952	4	CD34	CD34	NNP
cord-005453-4057qib7	15952	5	+	+	CC
cord-005453-4057qib7	15952	6	cells	cell	NNS
cord-005453-4057qib7	15952	7	better	well	JJR
cord-005453-4057qib7	15952	8	(	(	-LRB-
cord-005453-4057qib7	15952	9	median	median	JJ
cord-005453-4057qib7	15952	10	peak	peak	NN
cord-005453-4057qib7	15952	11	blood	blood	NN
cord-005453-4057qib7	15952	12	CD34	CD34	NNP
cord-005453-4057qib7	15953	1	+	+	CC
cord-005453-4057qib7	15953	2	65	65	CD
cord-005453-4057qib7	15954	1	vs.	vs.	NN
cord-005453-4057qib7	15954	2	40	40	CD
cord-005453-4057qib7	15954	3	x	x	SYM
cord-005453-4057qib7	15954	4	10	10	CD
cord-005453-4057qib7	15954	5	6	6	CD
cord-005453-4057qib7	15954	6	/L	/l	NN
cord-005453-4057qib7	15954	7	,	,	,
cord-005453-4057qib7	15954	8	p	p	NN
cord-005453-4057qib7	15954	9	<	<	XX
cord-005453-4057qib7	15954	10	0.001	0.001	CD
cord-005453-4057qib7	15954	11	)	)	-RRB-
cord-005453-4057qib7	15954	12	.	.	.
cord-005453-4057qib7	15955	1	The	the	DT
cord-005453-4057qib7	15955	2	median	median	JJ
cord-005453-4057qib7	15955	3	number	number	NN
cord-005453-4057qib7	15955	4	of	of	IN
cord-005453-4057qib7	15955	5	aphereses	apherese	NNS
cord-005453-4057qib7	15955	6	was	be	VBD
cord-005453-4057qib7	15955	7	2	2	CD
cord-005453-4057qib7	15955	8	in	in	IN
cord-005453-4057qib7	15955	9	both	both	DT
cord-005453-4057qib7	15955	10	groups	group	NNS
cord-005453-4057qib7	15956	1	(	(	-LRB-
cord-005453-4057qib7	15956	2	p	p	NN
cord-005453-4057qib7	15956	3	=	=	SYM
cord-005453-4057qib7	15956	4	0.09	0.09	CD
cord-005453-4057qib7	15956	5	)	)	-RRB-
cord-005453-4057qib7	15956	6	.	.	.
cord-005453-4057qib7	15957	1	Altogether	altogether	RB
cord-005453-4057qib7	15957	2	26	26	CD
cord-005453-4057qib7	15957	3	%	%	NN
cord-005453-4057qib7	15957	4	of	of	IN
cord-005453-4057qib7	15957	5	the	the	DT
cord-005453-4057qib7	15957	6	NHL	NHL	NNP
cord-005453-4057qib7	15957	7	patients	patient	NNS
cord-005453-4057qib7	15957	8	received	receive	VBD
cord-005453-4057qib7	15957	9	plerixafor	plerixafor	NN
cord-005453-4057qib7	15957	10	compared	compare	VBN
cord-005453-4057qib7	15957	11	to	to	IN
cord-005453-4057qib7	15957	12	12	12	CD
cord-005453-4057qib7	15957	13	%	%	NN
cord-005453-4057qib7	15957	14	in	in	IN
cord-005453-4057qib7	15957	15	MM	MM	NNP
cord-005453-4057qib7	15957	16	patients	patient	NNS
cord-005453-4057qib7	15957	17	(	(	-LRB-
cord-005453-4057qib7	15957	18	p	p	NN
cord-005453-4057qib7	15957	19	=	=	SYM
cord-005453-4057qib7	15957	20	0.002	0.002	CD
cord-005453-4057qib7	15957	21	)	)	-RRB-
cord-005453-4057qib7	15957	22	.	.	.
cord-005453-4057qib7	15958	1	The	the	DT
cord-005453-4057qib7	15958	2	median	median	JJ
cord-005453-4057qib7	15958	3	number	number	NN
cord-005453-4057qib7	15958	4	of	of	IN
cord-005453-4057qib7	15958	5	CD34	CD34	NNP
cord-005453-4057qib7	15958	6	+	+	CC
cord-005453-4057qib7	15958	7	cells	cell	NNS
cord-005453-4057qib7	15958	8	collected	collect	VBN
cord-005453-4057qib7	15958	9	was	be	VBD
cord-005453-4057qib7	15958	10	higher	high	JJR
cord-005453-4057qib7	15958	11	in	in	IN
cord-005453-4057qib7	15958	12	MM	MM	NNP
cord-005453-4057qib7	15958	13	patients	patient	NNS
cord-005453-4057qib7	15958	14	(	(	-LRB-
cord-005453-4057qib7	15958	15	6.4	6.4	CD
cord-005453-4057qib7	15958	16	vs.	vs.	CC
cord-005453-4057qib7	15958	17	3.9	3.9	CD
cord-005453-4057qib7	15958	18	x	x	SYM
cord-005453-4057qib7	15958	19	10	10	CD
cord-005453-4057qib7	15958	20	6	6	CD
cord-005453-4057qib7	15958	21	/kg	/kg	NN
cord-005453-4057qib7	15958	22	,	,	,
cord-005453-4057qib7	15958	23	p	p	NN
cord-005453-4057qib7	15958	24	<	<	XX
cord-005453-4057qib7	15958	25	0.001).The	0.001).the	CD
cord-005453-4057qib7	15958	26	median	median	NN
cord-005453-4057qib7	15958	27	amount	amount	NN
cord-005453-4057qib7	15958	28	of	of	IN
cord-005453-4057qib7	15958	29	CD34	CD34	NNP
cord-005453-4057qib7	15958	30	+	+	CC
cord-005453-4057qib7	15958	31	cells	cell	NNS
cord-005453-4057qib7	15958	32	(	(	-LRB-
cord-005453-4057qib7	15958	33	with	with	IN
cord-005453-4057qib7	15958	34	7-aminoactinomycin	7-aminoactinomycin	CD
cord-005453-4057qib7	15958	35	)	)	-RRB-
cord-005453-4057qib7	15958	36	in	in	IN
cord-005453-4057qib7	15958	37	the	the	DT
cord-005453-4057qib7	15958	38	infused	infuse	VBN
cord-005453-4057qib7	15958	39	graft	graft	NN
cord-005453-4057qib7	15958	40	was	be	VBD
cord-005453-4057qib7	15958	41	2.35	2.35	CD
cord-005453-4057qib7	15958	42	x	x	SYM
cord-005453-4057qib7	15958	43	10	10	CD
cord-005453-4057qib7	15958	44	6	6	CD
cord-005453-4057qib7	15959	1	/kg	/kg	NFP
cord-005453-4057qib7	15959	2	in	in	IN
cord-005453-4057qib7	15959	3	MM	MM	NNP
cord-005453-4057qib7	15959	4	group	group	NN
cord-005453-4057qib7	15959	5	and	and	CC
cord-005453-4057qib7	15959	6	2.5	2.5	CD
cord-005453-4057qib7	15959	7	x	x	SYM
cord-005453-4057qib7	15959	8	10	10	CD
cord-005453-4057qib7	15959	9	6	6	CD
cord-005453-4057qib7	15960	1	/kg	/kg	NFP
cord-005453-4057qib7	15960	2	in	in	IN
cord-005453-4057qib7	15960	3	NHL	NHL	NNP
cord-005453-4057qib7	15960	4	group	group	NN
cord-005453-4057qib7	15960	5	(	(	-LRB-
cord-005453-4057qib7	15960	6	p	p	NN
cord-005453-4057qib7	15960	7	=	=	SYM
cord-005453-4057qib7	15960	8	0.02	0.02	CD
cord-005453-4057qib7	15960	9	)	)	-RRB-
cord-005453-4057qib7	15960	10	.	.	.
cord-005453-4057qib7	15961	1	The	the	DT
cord-005453-4057qib7	15961	2	grafts	graft	NNS
cord-005453-4057qib7	15961	3	contained	contain	VBD
cord-005453-4057qib7	15961	4	more	more	JJR
cord-005453-4057qib7	15961	5	NK	NK	NNP
cord-005453-4057qib7	15961	6	cells	cell	NNS
cord-005453-4057qib7	15961	7	(	(	-LRB-
cord-005453-4057qib7	15961	8	median	median	JJ
cord-005453-4057qib7	15961	9	10.1	10.1	CD
cord-005453-4057qib7	15961	10	vs.	vs.	CC
cord-005453-4057qib7	15961	11	6.1	6.1	CD
cord-005453-4057qib7	15961	12	x	x	SYM
cord-005453-4057qib7	15961	13	10	10	CD
cord-005453-4057qib7	15961	14	6	6	CD
cord-005453-4057qib7	15961	15	/kg	/kg	NN
cord-005453-4057qib7	15961	16	,	,	,
cord-005453-4057qib7	15961	17	p	p	NN
cord-005453-4057qib7	15961	18	=	=	SYM
cord-005453-4057qib7	15961	19	0.01	0.01	CD
cord-005453-4057qib7	15961	20	)	)	-RRB-
cord-005453-4057qib7	15961	21	and	and	CC
cord-005453-4057qib7	15961	22	CD19	CD19	NNP
cord-005453-4057qib7	15961	23	+	+	CC
cord-005453-4057qib7	15961	24	cells	cell	NNS
cord-005453-4057qib7	15961	25	(	(	-LRB-
cord-005453-4057qib7	15961	26	median	median	NN
cord-005453-4057qib7	15961	27	1.69	1.69	CD
cord-005453-4057qib7	15961	28	vs.	vs.	NN
cord-005453-4057qib7	15961	29	0.00	0.00	CD
cord-005453-4057qib7	15961	30	x	x	SYM
cord-005453-4057qib7	15961	31	10	10	CD
cord-005453-4057qib7	15961	32	6	6	CD
cord-005453-4057qib7	15961	33	/kg	/kg	NN
cord-005453-4057qib7	15961	34	,	,	,
cord-005453-4057qib7	15961	35	p	p	NN
cord-005453-4057qib7	15961	36	<	<	XX
cord-005453-4057qib7	15961	37	0.001	0.001	CD
cord-005453-4057qib7	15961	38	)	)	-RRB-
cord-005453-4057qib7	15961	39	in	in	IN
cord-005453-4057qib7	15961	40	MM	MM	NNP
cord-005453-4057qib7	15961	41	patients	patient	NNS
cord-005453-4057qib7	15961	42	.	.	.
cord-005453-4057qib7	15962	1	Neutropenic	neutropenic	JJ
cord-005453-4057qib7	15962	2	fever	fever	NN
cord-005453-4057qib7	15962	3	tended	tend	VBD
cord-005453-4057qib7	15962	4	to	to	TO
cord-005453-4057qib7	15962	5	be	be	VB
cord-005453-4057qib7	15962	6	more	more	RBR
cord-005453-4057qib7	15962	7	common	common	JJ
cord-005453-4057qib7	15962	8	in	in	IN
cord-005453-4057qib7	15962	9	NHL	NHL	NNP
cord-005453-4057qib7	15962	10	patients	patient	NNS
cord-005453-4057qib7	15962	11	(	(	-LRB-
cord-005453-4057qib7	15962	12	88	88	CD
cord-005453-4057qib7	15962	13	%	%	NN
cord-005453-4057qib7	15962	14	vs.	vs.	CC
cord-005453-4057qib7	15962	15	79	79	CD
cord-005453-4057qib7	15962	16	%	%	NN
cord-005453-4057qib7	15962	17	,	,	,
cord-005453-4057qib7	15962	18	p	p	NN
cord-005453-4057qib7	15962	19	=	=	SYM
cord-005453-4057qib7	15962	20	0.06	0.06	CD
cord-005453-4057qib7	15962	21	)	)	-RRB-
cord-005453-4057qib7	15962	22	but	but	CC
cord-005453-4057qib7	15962	23	MM	MM	NNP
cord-005453-4057qib7	15962	24	patients	patient	NNS
cord-005453-4057qib7	15962	25	had	have	VBD
cord-005453-4057qib7	15962	26	significantly	significantly	RB
cord-005453-4057qib7	15962	27	more	more	JJR
cord-005453-4057qib7	15962	28	bloodstream	bloodstream	NN
cord-005453-4057qib7	15962	29	infections	infection	NNS
cord-005453-4057qib7	15962	30	(	(	-LRB-
cord-005453-4057qib7	15962	31	31	31	CD
cord-005453-4057qib7	15962	32	%	%	NN
cord-005453-4057qib7	15962	33	vs.	vs.	IN
cord-005453-4057qib7	15962	34	15	15	CD
cord-005453-4057qib7	15962	35	%	%	NN
cord-005453-4057qib7	15962	36	,	,	,
cord-005453-4057qib7	15962	37	p	p	NN
cord-005453-4057qib7	15962	38	=	=	SYM
cord-005453-4057qib7	15962	39	0.003	0.003	CD
cord-005453-4057qib7	15962	40	)	)	-RRB-
cord-005453-4057qib7	15962	41	.	.	.
cord-005453-4057qib7	15963	1	The	the	DT
cord-005453-4057qib7	15963	2	median	median	JJ
cord-005453-4057qib7	15963	3	duration	duration	NN
cord-005453-4057qib7	15963	4	of	of	IN
cord-005453-4057qib7	15963	5	hospitalization	hospitalization	NN
cord-005453-4057qib7	15963	6	was	be	VBD
cord-005453-4057qib7	15963	7	longer	long	JJR
cord-005453-4057qib7	15963	8	in	in	IN
cord-005453-4057qib7	15963	9	the	the	DT
cord-005453-4057qib7	15963	10	NHL	NHL	NNP
cord-005453-4057qib7	15963	11	patients	patient	NNS
cord-005453-4057qib7	15963	12	(	(	-LRB-
cord-005453-4057qib7	15963	13	22	22	CD
cord-005453-4057qib7	15963	14	d	d	NN
cord-005453-4057qib7	15963	15	vs.	vs.	NN
cord-005453-4057qib7	15963	16	18	18	CD
cord-005453-4057qib7	15963	17	d	d	NN
cord-005453-4057qib7	15963	18	,	,	,
cord-005453-4057qib7	15963	19	p	p	NN
cord-005453-4057qib7	15963	20	<	<	XX
cord-005453-4057qib7	15963	21	0.001	0.001	CD
cord-005453-4057qib7	15963	22	)	)	-RRB-
cord-005453-4057qib7	15963	23	and	and	CC
cord-005453-4057qib7	15963	24	the	the	DT
cord-005453-4057qib7	15963	25	NHL	NHL	NNP
cord-005453-4057qib7	15963	26	patients	patient	NNS
cord-005453-4057qib7	15963	27	had	have	VBD
cord-005453-4057qib7	15963	28	significantly	significantly	RB
cord-005453-4057qib7	15963	29	more	more	RBR
cord-005453-4057qib7	15963	30	often	often	RB
cord-005453-4057qib7	15963	31	ICU	ICU	NNP
cord-005453-4057qib7	15963	32	admissions	admission	NNS
cord-005453-4057qib7	15963	33	(	(	-LRB-
cord-005453-4057qib7	15963	34	4	4	CD
cord-005453-4057qib7	15963	35	%	%	NN
cord-005453-4057qib7	15963	36	vs.	vs.	CC
cord-005453-4057qib7	15963	37	0	0	CD
cord-005453-4057qib7	15963	38	%	%	NN
cord-005453-4057qib7	15963	39	,	,	,
cord-005453-4057qib7	15963	40	p	p	NN
cord-005453-4057qib7	15963	41	=	=	SYM
cord-005453-4057qib7	15963	42	0.02).Post	0.02).post	CD
cord-005453-4057qib7	15963	43	-	-	HYPH
cord-005453-4057qib7	15963	44	transplant	transplant	NN
cord-005453-4057qib7	15963	45	neutrophil	neutrophil	NN
cord-005453-4057qib7	15963	46	engraftment	engraftment	NN
cord-005453-4057qib7	15963	47	was	be	VBD
cord-005453-4057qib7	15963	48	faster	fast	JJR
cord-005453-4057qib7	15963	49	in	in	IN
cord-005453-4057qib7	15963	50	the	the	DT
cord-005453-4057qib7	15963	51	NHL	NHL	NNP
cord-005453-4057qib7	15963	52	group	group	NN
cord-005453-4057qib7	15963	53	(	(	-LRB-
cord-005453-4057qib7	15963	54	median	median	JJ
cord-005453-4057qib7	15963	55	9	9	CD
cord-005453-4057qib7	15963	56	d	d	NN
cord-005453-4057qib7	15963	57	vs.	vs.	FW
cord-005453-4057qib7	15963	58	12	12	CD
cord-005453-4057qib7	15963	59	d	d	NN
cord-005453-4057qib7	15963	60	,	,	,
cord-005453-4057qib7	15963	61	p	p	NN
cord-005453-4057qib7	15963	62	<	<	XX
cord-005453-4057qib7	15963	63	0.001	0.001	CD
cord-005453-4057qib7	15963	64	)	)	-RRB-
cord-005453-4057qib7	15963	65	.	.	.
cord-005453-4057qib7	15964	1	The	the	DT
cord-005453-4057qib7	15964	2	median	median	JJ
cord-005453-4057qib7	15964	3	time	time	NN
cord-005453-4057qib7	15964	4	to	to	IN
cord-005453-4057qib7	15964	5	platelet	platelet	NN
cord-005453-4057qib7	15964	6	engraftment	engraftment	NN
cord-005453-4057qib7	15964	7	was	be	VBD
cord-005453-4057qib7	15964	8	11	11	CD
cord-005453-4057qib7	15964	9	days	day	NNS
cord-005453-4057qib7	15964	10	in	in	IN
cord-005453-4057qib7	15964	11	both	both	DT
cord-005453-4057qib7	15964	12	groups	group	NNS
cord-005453-4057qib7	15964	13	.	.	.
cord-005453-4057qib7	15965	1	Platelet	platelet	NN
cord-005453-4057qib7	15965	2	count	count	NN
cord-005453-4057qib7	15965	3	was	be	VBD
cord-005453-4057qib7	15965	4	higher	high	JJR
cord-005453-4057qib7	15965	5	in	in	IN
cord-005453-4057qib7	15965	6	the	the	DT
cord-005453-4057qib7	15965	7	MM	MM	NNP
cord-005453-4057qib7	15965	8	group	group	NN
cord-005453-4057qib7	15965	9	from	from	IN
cord-005453-4057qib7	15965	10	day	day	NN
cord-005453-4057qib7	15965	11	15	15	CD
cord-005453-4057qib7	15965	12	until	until	IN
cord-005453-4057qib7	15965	13	1	1	CD
cord-005453-4057qib7	15965	14	year	year	NN
cord-005453-4057qib7	15965	15	after	after	IN
cord-005453-4057qib7	15965	16	auto	auto	NN
cord-005453-4057qib7	15965	17	-	-	HYPH
cord-005453-4057qib7	15965	18	SCT	SCT	NNP
cord-005453-4057qib7	15965	19	.	.	.
cord-005453-4057qib7	15966	1	There	there	EX
cord-005453-4057qib7	15966	2	were	be	VBD
cord-005453-4057qib7	15966	3	significantly	significantly	RB
cord-005453-4057qib7	15966	4	more	more	JJR
cord-005453-4057qib7	15966	5	early	early	JJ
cord-005453-4057qib7	15966	6	deaths	death	NNS
cord-005453-4057qib7	15966	7	(	(	-LRB-
cord-005453-4057qib7	15966	8	<	<	XX
cord-005453-4057qib7	15966	9	100	100	CD
cord-005453-4057qib7	15966	10	d	d	XX
cord-005453-4057qib7	15966	11	from	from	IN
cord-005453-4057qib7	15966	12	the	the	DT
cord-005453-4057qib7	15966	13	graft	graft	NN
cord-005453-4057qib7	15966	14	infusion	infusion	NN
cord-005453-4057qib7	15966	15	)	)	-RRB-
cord-005453-4057qib7	15966	16	(	(	-LRB-
cord-005453-4057qib7	15966	17	4	4	CD
cord-005453-4057qib7	15966	18	%	%	NN
cord-005453-4057qib7	15966	19	vs.	vs.	IN
cord-005453-4057qib7	15966	20	0	0	CD
cord-005453-4057qib7	15966	21	%	%	NN
cord-005453-4057qib7	15966	22	,	,	,
cord-005453-4057qib7	15966	23	p	p	NN
cord-005453-4057qib7	15966	24	=	=	SYM
cord-005453-4057qib7	15966	25	0.02	0.02	CD
cord-005453-4057qib7	15966	26	)	)	-RRB-
cord-005453-4057qib7	15966	27	and	and	CC
cord-005453-4057qib7	15966	28	non	non	JJ
cord-005453-4057qib7	15966	29	-	-	JJ
cord-005453-4057qib7	15966	30	relapse	relapse	JJ
cord-005453-4057qib7	15966	31	deaths	death	NNS
cord-005453-4057qib7	15966	32	(	(	-LRB-
cord-005453-4057qib7	15966	33	6	6	CD
cord-005453-4057qib7	15966	34	%	%	NN
cord-005453-4057qib7	15966	35	vs.	vs.	IN
cord-005453-4057qib7	15966	36	0	0	CD
cord-005453-4057qib7	15966	37	%	%	NN
cord-005453-4057qib7	15966	38	,	,	,
cord-005453-4057qib7	15966	39	p	p	NN
cord-005453-4057qib7	15966	40	=	=	SYM
cord-005453-4057qib7	15966	41	0.003	0.003	CD
cord-005453-4057qib7	15966	42	)	)	-RRB-
cord-005453-4057qib7	15966	43	in	in	IN
cord-005453-4057qib7	15966	44	the	the	DT
cord-005453-4057qib7	15966	45	NHL	NHL	NNP
cord-005453-4057qib7	15966	46	group	group	NN
cord-005453-4057qib7	15966	47	.	.	.
cord-005453-4057qib7	15967	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	15967	2	:	:	:
cord-005453-4057qib7	15968	1	MM	MM	NNP
cord-005453-4057qib7	15968	2	and	and	CC
cord-005453-4057qib7	15968	3	NHL	NHL	NNP
cord-005453-4057qib7	15968	4	patients	patient	NNS
cord-005453-4057qib7	15968	5	differ	differ	VBP
cord-005453-4057qib7	15968	6	in	in	IN
cord-005453-4057qib7	15968	7	terms	term	NNS
cord-005453-4057qib7	15968	8	of	of	IN
cord-005453-4057qib7	15968	9	CD34	CD34	NNP
cord-005453-4057qib7	15968	10	+	+	CC
cord-005453-4057qib7	15968	11	cell	cell	NN
cord-005453-4057qib7	15968	12	mobilization	mobilization	NN
cord-005453-4057qib7	15968	13	,	,	,
cord-005453-4057qib7	15968	14	graft	graft	NN
cord-005453-4057qib7	15968	15	cellular	cellular	JJ
cord-005453-4057qib7	15968	16	composition	composition	NN
cord-005453-4057qib7	15968	17	and	and	CC
cord-005453-4057qib7	15968	18	post	post	JJ
cord-005453-4057qib7	15968	19	-	-	JJ
cord-005453-4057qib7	15968	20	transplant	transplant	JJ
cord-005453-4057qib7	15968	21	recovery	recovery	NN
cord-005453-4057qib7	15968	22	as	as	RB
cord-005453-4057qib7	15968	23	well	well	RB
cord-005453-4057qib7	15968	24	as	as	IN
cord-005453-4057qib7	15968	25	risk	risk	NN
cord-005453-4057qib7	15968	26	of	of	IN
cord-005453-4057qib7	15968	27	non	non	JJ
cord-005453-4057qib7	15968	28	-	-	JJ
cord-005453-4057qib7	15968	29	relapse	relapse	JJ
cord-005453-4057qib7	15968	30	death	death	NN
cord-005453-4057qib7	15968	31	.	.	.
cord-005453-4057qib7	15969	1	Thus	thus	RB
cord-005453-4057qib7	15969	2	,	,	,
cord-005453-4057qib7	15969	3	the	the	DT
cord-005453-4057qib7	15969	4	optimal	optimal	JJ
cord-005453-4057qib7	15969	5	graft	graft	NN
cord-005453-4057qib7	15969	6	may	may	MD
cord-005453-4057qib7	15969	7	be	be	VB
cord-005453-4057qib7	15969	8	different	different	JJ
cord-005453-4057qib7	15969	9	in	in	IN
cord-005453-4057qib7	15969	10	NHL	NHL	NNP
cord-005453-4057qib7	15969	11	and	and	CC
cord-005453-4057qib7	15969	12	MM	MM	NNP
cord-005453-4057qib7	15969	13	patients	patient	NNS
cord-005453-4057qib7	15969	14	.	.	.
cord-005453-4057qib7	15970	1	Disclosure	disclosure	NN
cord-005453-4057qib7	15970	2	:	:	:
cord-005453-4057qib7	15971	1	The	the	DT
cord-005453-4057qib7	15971	2	study	study	NN
cord-005453-4057qib7	15971	3	was	be	VBD
cord-005453-4057qib7	15971	4	supported	support	VBN
cord-005453-4057qib7	15971	5	by	by	IN
cord-005453-4057qib7	15971	6	VTR	VTR	NNP
cord-005453-4057qib7	15971	7	fund	fund	NN
cord-005453-4057qib7	15971	8	from	from	IN
cord-005453-4057qib7	15971	9	North	North	NNP
cord-005453-4057qib7	15971	10	Savo	Savo	NNP
cord-005453-4057qib7	15971	11	Hospital	Hospital	NNP
cord-005453-4057qib7	15971	12	District	District	NNP
cord-005453-4057qib7	15971	13	and	and	CC
cord-005453-4057qib7	15971	14	study	study	NN
cord-005453-4057qib7	15971	15	grant	grant	NN
cord-005453-4057qib7	15971	16	from	from	IN
cord-005453-4057qib7	15971	17	Sanofi	Sanofi	NNP
cord-005453-4057qib7	15971	18	.	.	.
cord-005453-4057qib7	15972	1	Abstract	Abstract	NNP
cord-005453-4057qib7	15972	2	already	already	RB
cord-005453-4057qib7	15972	3	published	publish	VBN
cord-005453-4057qib7	15972	4	.	.	.
cord-005453-4057qib7	15973	1	Single	single	JJ
cord-005453-4057qib7	15973	2	-	-	HYPH
cord-005453-4057qib7	15973	3	center	center	NN
cord-005453-4057qib7	15973	4	experience	experience	NN
cord-005453-4057qib7	15973	5	in	in	IN
cord-005453-4057qib7	15973	6	use	use	NN
cord-005453-4057qib7	15973	7	of	of	IN
cord-005453-4057qib7	15973	8	plerixafor	plerixafor	NN
cord-005453-4057qib7	15973	9	for	for	IN
cord-005453-4057qib7	15973	10	autologous	autologous	JJ
cord-005453-4057qib7	15973	11	stem	stem	NN
cord-005453-4057qib7	15973	12	cell	cell	NN
cord-005453-4057qib7	15973	13	mobilization	mobilization	NN
cord-005453-4057qib7	15973	14	:	:	:
cord-005453-4057qib7	15973	15	Change	change	VB
cord-005453-4057qib7	15973	16	in	in	IN
cord-005453-4057qib7	15973	17	practice	practice	NN
cord-005453-4057qib7	15973	18	over	over	IN
cord-005453-4057qib7	15973	19	10	10	CD
cord-005453-4057qib7	15973	20	years	year	NNS
cord-005453-4057qib7	15974	1	Background	background	NN
cord-005453-4057qib7	15974	2	:	:	:
cord-005453-4057qib7	15974	3	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	15974	4	has	have	VBZ
cord-005453-4057qib7	15974	5	been	be	VBN
cord-005453-4057qib7	15974	6	proven	prove	VBN
cord-005453-4057qib7	15974	7	to	to	TO
cord-005453-4057qib7	15974	8	mobilize	mobilize	VB
cord-005453-4057qib7	15974	9	human	human	JJ
cord-005453-4057qib7	15974	10	periferal	periferal	JJ
cord-005453-4057qib7	15974	11	blood	blood	NN
cord-005453-4057qib7	15974	12	stem	stem	NN
cord-005453-4057qib7	15974	13	cells	cell	NNS
cord-005453-4057qib7	15974	14	(	(	-LRB-
cord-005453-4057qib7	15974	15	PBSCs	pbsc	NNS
cord-005453-4057qib7	15974	16	)	)	-RRB-
cord-005453-4057qib7	15974	17	alone	alone	JJ
cord-005453-4057qib7	15974	18	or	or	CC
cord-005453-4057qib7	15974	19	acting	act	VBG
cord-005453-4057qib7	15974	20	synergistically	synergistically	RB
cord-005453-4057qib7	15974	21	with	with	IN
cord-005453-4057qib7	15974	22	granulocyte	granulocyte	NN
cord-005453-4057qib7	15974	23	-	-	HYPH
cord-005453-4057qib7	15974	24	colony	colony	NN
cord-005453-4057qib7	15974	25	stimulating	stimulate	VBG
cord-005453-4057qib7	15974	26	factor	factor	NN
cord-005453-4057qib7	15974	27	(	(	-LRB-
cord-005453-4057qib7	15974	28	G	G	NNP
cord-005453-4057qib7	15974	29	-	-	HYPH
cord-005453-4057qib7	15974	30	CSF	CSF	NNP
cord-005453-4057qib7	15974	31	)	)	-RRB-
cord-005453-4057qib7	15974	32	.	.	.
cord-005453-4057qib7	15975	1	It	-PRON-	PRP
cord-005453-4057qib7	15975	2	has	have	VBZ
cord-005453-4057qib7	15975	3	mainly	mainly	RB
cord-005453-4057qib7	15975	4	been	be	VBN
cord-005453-4057qib7	15975	5	used	use	VBN
cord-005453-4057qib7	15975	6	for	for	IN
cord-005453-4057qib7	15975	7	rescue	rescue	NN
cord-005453-4057qib7	15975	8	mobilization	mobilization	NN
cord-005453-4057qib7	15975	9	after	after	IN
cord-005453-4057qib7	15975	10	failed	fail	VBN
cord-005453-4057qib7	15975	11	regimen	regimen	NN
cord-005453-4057qib7	15975	12	of	of	IN
cord-005453-4057qib7	15975	13	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	15975	14	plus	plus	CC
cord-005453-4057qib7	15975	15	G	G	NNP
cord-005453-4057qib7	15975	16	-	-	HYPH
cord-005453-4057qib7	15975	17	CSF	CSF	NNP
cord-005453-4057qib7	15975	18	,	,	,
cord-005453-4057qib7	15975	19	but	but	CC
cord-005453-4057qib7	15975	20	lately	lately	RB
cord-005453-4057qib7	15975	21	preemptive	preemptive	JJ
cord-005453-4057qib7	15975	22	use	use	NN
cord-005453-4057qib7	15975	23	in	in	IN
cord-005453-4057qib7	15975	24	poor	poor	JJ
cord-005453-4057qib7	15975	25	mobilizers	mobilizer	NNS
cord-005453-4057qib7	15975	26	has	have	VBZ
cord-005453-4057qib7	15975	27	been	be	VBN
cord-005453-4057qib7	15975	28	established	establish	VBN
cord-005453-4057qib7	15975	29	as	as	IN
cord-005453-4057qib7	15975	30	cost	cost	NN
cord-005453-4057qib7	15975	31	-	-	HYPH
cord-005453-4057qib7	15975	32	effective	effective	JJ
cord-005453-4057qib7	15975	33	.	.	.
cord-005453-4057qib7	15976	1	We	-PRON-	PRP
cord-005453-4057qib7	15976	2	aim	aim	VBP
cord-005453-4057qib7	15976	3	to	to	TO
cord-005453-4057qib7	15976	4	show	show	VB
cord-005453-4057qib7	15976	5	ten	ten	CD
cord-005453-4057qib7	15976	6	years	year	NNS
cord-005453-4057qib7	15976	7	of	of	IN
cord-005453-4057qib7	15976	8	experience	experience	NN
cord-005453-4057qib7	15976	9	and	and	CC
cord-005453-4057qib7	15976	10	change	change	NN
cord-005453-4057qib7	15976	11	in	in	IN
cord-005453-4057qib7	15976	12	practice	practice	NN
cord-005453-4057qib7	15976	13	with	with	IN
cord-005453-4057qib7	15976	14	plerixafor	plerixafor	NN
cord-005453-4057qib7	15976	15	use	use	NN
cord-005453-4057qib7	15976	16	in	in	IN
cord-005453-4057qib7	15976	17	our	-PRON-	PRP$
cord-005453-4057qib7	15976	18	center	center	NN
cord-005453-4057qib7	15976	19	.	.	.
cord-005453-4057qib7	15977	1	Methods	method	NNS
cord-005453-4057qib7	15977	2	:	:	:
cord-005453-4057qib7	15977	3	We	-PRON-	PRP
cord-005453-4057qib7	15977	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	15977	5	evaluated	evaluate	VBD
cord-005453-4057qib7	15977	6	the	the	DT
cord-005453-4057qib7	15977	7	outcome	outcome	NN
cord-005453-4057qib7	15977	8	of	of	IN
cord-005453-4057qib7	15977	9	mobilization	mobilization	NN
cord-005453-4057qib7	15977	10	procedures	procedure	NNS
cord-005453-4057qib7	15977	11	and	and	CC
cord-005453-4057qib7	15977	12	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	15977	13	collections	collection	NNS
cord-005453-4057qib7	15977	14	in	in	IN
cord-005453-4057qib7	15977	15	our	-PRON-	PRP$
cord-005453-4057qib7	15977	16	center	center	NN
cord-005453-4057qib7	15977	17	in	in	IN
cord-005453-4057qib7	15977	18	the	the	DT
cord-005453-4057qib7	15977	19	period	period	NN
cord-005453-4057qib7	15977	20	from	from	IN
cord-005453-4057qib7	15977	21	January	January	NNP
cord-005453-4057qib7	15977	22	2009	2009	CD
cord-005453-4057qib7	15977	23	to	to	IN
cord-005453-4057qib7	15977	24	October	October	NNP
cord-005453-4057qib7	15977	25	2018	2018	CD
cord-005453-4057qib7	15977	26	.	.	.
cord-005453-4057qib7	15978	1	Practice	practice	NN
cord-005453-4057qib7	15978	2	from	from	IN
cord-005453-4057qib7	15978	3	the	the	DT
cord-005453-4057qib7	15978	4	first	first	JJ
cord-005453-4057qib7	15978	5	5	5	CD
cord-005453-4057qib7	15978	6	years	year	NNS
cord-005453-4057qib7	15978	7	,	,	,
cord-005453-4057qib7	15978	8	when	when	WRB
cord-005453-4057qib7	15978	9	plerixafor	plerixafor	NN
cord-005453-4057qib7	15978	10	was	be	VBD
cord-005453-4057qib7	15978	11	mainly	mainly	RB
cord-005453-4057qib7	15978	12	used	use	VBN
cord-005453-4057qib7	15978	13	as	as	IN
cord-005453-4057qib7	15978	14	rescue	rescue	NN
cord-005453-4057qib7	15978	15	agent	agent	NN
cord-005453-4057qib7	15978	16	after	after	IN
cord-005453-4057qib7	15978	17	failed	fail	VBN
cord-005453-4057qib7	15978	18	attempt	attempt	NN
cord-005453-4057qib7	15978	19	,	,	,
cord-005453-4057qib7	15978	20	was	be	VBD
cord-005453-4057qib7	15978	21	compared	compare	VBN
cord-005453-4057qib7	15978	22	to	to	IN
cord-005453-4057qib7	15978	23	period	period	NN
cord-005453-4057qib7	15978	24	from	from	IN
cord-005453-4057qib7	15978	25	2014	2014	CD
cord-005453-4057qib7	15978	26	till	till	IN
cord-005453-4057qib7	15978	27	present	present	JJ
cord-005453-4057qib7	15978	28	when	when	WRB
cord-005453-4057qib7	15978	29	preemptive	preemptive	JJ
cord-005453-4057qib7	15978	30	use	use	NN
cord-005453-4057qib7	15978	31	in	in	IN
cord-005453-4057qib7	15978	32	poor	poor	JJ
cord-005453-4057qib7	15978	33	mobilizers	mobilizer	NNS
cord-005453-4057qib7	15978	34	(	(	-LRB-
cord-005453-4057qib7	15978	35	defined	define	VBN
cord-005453-4057qib7	15978	36	as	as	IN
cord-005453-4057qib7	15978	37	CD34	CD34	NNP
cord-005453-4057qib7	15978	38	+	+	CC
cord-005453-4057qib7	15978	39	cell	cell	NN
cord-005453-4057qib7	15978	40	counts	count	VBZ
cord-005453-4057qib7	15978	41	<	<	XX
cord-005453-4057qib7	15978	42	10	10	CD
cord-005453-4057qib7	15979	1	x	x	SYM
cord-005453-4057qib7	15979	2	10	10	CD
cord-005453-4057qib7	15979	3	6	6	CD
cord-005453-4057qib7	15979	4	/L	/l	CD
cord-005453-4057qib7	15979	5	blood	blood	NN
cord-005453-4057qib7	15979	6	)	)	-RRB-
cord-005453-4057qib7	15979	7	was	be	VBD
cord-005453-4057qib7	15979	8	established	establish	VBN
cord-005453-4057qib7	15979	9	.	.	.
cord-005453-4057qib7	15980	1	Results	result	NNS
cord-005453-4057qib7	15980	2	:	:	:
cord-005453-4057qib7	15981	1	In	in	IN
cord-005453-4057qib7	15981	2	the	the	DT
cord-005453-4057qib7	15981	3	period	period	NN
cord-005453-4057qib7	15981	4	from	from	IN
cord-005453-4057qib7	15981	5	2009	2009	CD
cord-005453-4057qib7	15981	6	to	to	IN
cord-005453-4057qib7	15981	7	2013	2013	CD
cord-005453-4057qib7	15981	8	,	,	,
cord-005453-4057qib7	15981	9	total	total	NN
cord-005453-4057qib7	15981	10	of	of	IN
cord-005453-4057qib7	15981	11	434	434	CD
cord-005453-4057qib7	15981	12	patients	patient	NNS
cord-005453-4057qib7	15981	13	underwent	undergo	VBD
cord-005453-4057qib7	15981	14	collection	collection	NN
cord-005453-4057qib7	15981	15	of	of	IN
cord-005453-4057qib7	15981	16	autologous	autologous	JJ
cord-005453-4057qib7	15981	17	PBSCs	pbsc	NNS
cord-005453-4057qib7	15981	18	,	,	,
cord-005453-4057qib7	15981	19	and	and	CC
cord-005453-4057qib7	15981	20	55	55	CD
cord-005453-4057qib7	15981	21	patients	patient	NNS
cord-005453-4057qib7	15981	22	required	require	VBD
cord-005453-4057qib7	15981	23	repeated	repeated	JJ
cord-005453-4057qib7	15981	24	mobilization	mobilization	NN
cord-005453-4057qib7	15981	25	cycles	cycle	NNS
cord-005453-4057qib7	15981	26	(	(	-LRB-
cord-005453-4057qib7	15981	27	12,7	12,7	CD
cord-005453-4057qib7	15981	28	%	%	NN
cord-005453-4057qib7	15981	29	)	)	-RRB-
cord-005453-4057qib7	15981	30	.	.	.
cord-005453-4057qib7	15982	1	G	G	NNP
cord-005453-4057qib7	15982	2	-	-	HYPH
cord-005453-4057qib7	15982	3	CSF	CSF	NNP
cord-005453-4057qib7	15982	4	alone	alone	RB
cord-005453-4057qib7	15982	5	was	be	VBD
cord-005453-4057qib7	15982	6	used	use	VBN
cord-005453-4057qib7	15982	7	in	in	IN
cord-005453-4057qib7	15982	8	39	39	CD
cord-005453-4057qib7	15982	9	patients	patient	NNS
cord-005453-4057qib7	15982	10	and	and	CC
cord-005453-4057qib7	15982	11	16	16	CD
cord-005453-4057qib7	15982	12	patients	patient	NNS
cord-005453-4057qib7	15982	13	(	(	-LRB-
cord-005453-4057qib7	15982	14	29	29	CD
cord-005453-4057qib7	15982	15	%	%	NN
cord-005453-4057qib7	15982	16	)	)	-RRB-
cord-005453-4057qib7	15982	17	recieved	recieve	VBD
cord-005453-4057qib7	15982	18	combination	combination	NN
cord-005453-4057qib7	15982	19	G	G	NNP
cord-005453-4057qib7	15982	20	-	-	HYPH
cord-005453-4057qib7	15982	21	CSF	CSF	NNP
cord-005453-4057qib7	15982	22	with	with	IN
cord-005453-4057qib7	15982	23	plerixafor	plerixafor	NN
cord-005453-4057qib7	15982	24	.	.	.
cord-005453-4057qib7	15983	1	This	this	DT
cord-005453-4057qib7	15983	2	cohort	cohort	NN
cord-005453-4057qib7	15983	3	consisted	consist	VBD
cord-005453-4057qib7	15983	4	of	of	IN
cord-005453-4057qib7	15983	5	10	10	CD
cord-005453-4057qib7	15983	6	males	male	NNS
cord-005453-4057qib7	15983	7	and	and	CC
cord-005453-4057qib7	15983	8	6	6	CD
cord-005453-4057qib7	15983	9	females	female	NNS
cord-005453-4057qib7	15983	10	with	with	IN
cord-005453-4057qib7	15983	11	Non	Non	NNP
cord-005453-4057qib7	15983	12	-	-	NNP
cord-005453-4057qib7	15983	13	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15983	14	(	(	-LRB-
cord-005453-4057qib7	15983	15	NHL	NHL	NNP
cord-005453-4057qib7	15983	16	)	)	-RRB-
cord-005453-4057qib7	15983	17	and	and	CC
cord-005453-4057qib7	15983	18	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	15983	19	lymphoma	lymphoma	NN
cord-005453-4057qib7	15983	20	(	(	-LRB-
cord-005453-4057qib7	15983	21	MH	MH	NNP
cord-005453-4057qib7	15983	22	)	)	-RRB-
cord-005453-4057qib7	15983	23	;	;	:
cord-005453-4057qib7	15983	24	13	13	CD
cord-005453-4057qib7	15983	25	and	and	CC
cord-005453-4057qib7	15983	26	3	3	CD
cord-005453-4057qib7	15983	27	respectively	respectively	RB
cord-005453-4057qib7	15983	28	.	.	.
cord-005453-4057qib7	15984	1	We	-PRON-	PRP
cord-005453-4057qib7	15984	2	noted	note	VBD
cord-005453-4057qib7	15984	3	37	37	CD
cord-005453-4057qib7	15984	4	unsuccessful	unsuccessful	JJ
cord-005453-4057qib7	15984	5	mobilizations	mobilization	NNS
cord-005453-4057qib7	15984	6	(	(	-LRB-
cord-005453-4057qib7	15984	7	67,3	67,3	CD
cord-005453-4057qib7	15984	8	%	%	NN
cord-005453-4057qib7	15984	9	in	in	IN
cord-005453-4057qib7	15984	10	repeated	repeat	VBN
cord-005453-4057qib7	15984	11	mobilization	mobilization	NN
cord-005453-4057qib7	15984	12	,	,	,
cord-005453-4057qib7	15984	13	8,5	8,5	CD
cord-005453-4057qib7	15984	14	%	%	NN
cord-005453-4057qib7	15984	15	in	in	IN
cord-005453-4057qib7	15984	16	total	total	NN
cord-005453-4057qib7	15984	17	)	)	-RRB-
cord-005453-4057qib7	15984	18	of	of	IN
cord-005453-4057qib7	15984	19	which	which	WDT
cord-005453-4057qib7	15984	20	one	one	CD
cord-005453-4057qib7	15984	21	patient	patient	NN
cord-005453-4057qib7	15984	22	was	be	VBD
cord-005453-4057qib7	15984	23	from	from	IN
cord-005453-4057qib7	15984	24	plerixafor	plerixafor	NNP
cord-005453-4057qib7	15984	25	group	group	NN
cord-005453-4057qib7	15984	26	(	(	-LRB-
cord-005453-4057qib7	15984	27	6,3%).Background	6,3%).background	CD
cord-005453-4057qib7	15984	28	:	:	:
cord-005453-4057qib7	15985	1	Transplantation	transplantation	NN
cord-005453-4057qib7	15985	2	of	of	IN
cord-005453-4057qib7	15985	3	HLA	HLA	NNP
cord-005453-4057qib7	15985	4	-	-	HYPH
cord-005453-4057qib7	15985	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	15985	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	15985	7	stem	stem	NN
cord-005453-4057qib7	15985	8	cells	cell	NNS
cord-005453-4057qib7	15985	9	(	(	-LRB-
cord-005453-4057qib7	15985	10	haplo	haplo	NNP
cord-005453-4057qib7	15985	11	-	-	HYPH
cord-005453-4057qib7	15985	12	HSCT	HSCT	NNP
cord-005453-4057qib7	15985	13	)	)	-RRB-
cord-005453-4057qib7	15985	14	is	be	VBZ
cord-005453-4057qib7	15985	15	an	an	DT
cord-005453-4057qib7	15985	16	established	establish	VBN
cord-005453-4057qib7	15985	17	procedure	procedure	NN
cord-005453-4057qib7	15985	18	for	for	IN
cord-005453-4057qib7	15985	19	the	the	DT
cord-005453-4057qib7	15985	20	treatment	treatment	NN
cord-005453-4057qib7	15985	21	of	of	IN
cord-005453-4057qib7	15985	22	several	several	JJ
cord-005453-4057qib7	15985	23	different	different	JJ
cord-005453-4057qib7	15985	24	hematological	hematological	JJ
cord-005453-4057qib7	15985	25	diseases	disease	NNS
cord-005453-4057qib7	15985	26	.	.	.
cord-005453-4057qib7	15986	1	One	one	CD
cord-005453-4057qib7	15986	2	possible	possible	JJ
cord-005453-4057qib7	15986	3	strategy	strategy	NN
cord-005453-4057qib7	15986	4	to	to	TO
cord-005453-4057qib7	15986	5	reduce	reduce	VB
cord-005453-4057qib7	15986	6	the	the	DT
cord-005453-4057qib7	15986	7	risk	risk	NN
cord-005453-4057qib7	15986	8	of	of	IN
cord-005453-4057qib7	15986	9	Graft	graft	NN
cord-005453-4057qib7	15986	10	-	-	HYPH
cord-005453-4057qib7	15986	11	versus	versus	IN
cord-005453-4057qib7	15986	12	-	-	HYPH
cord-005453-4057qib7	15986	13	Host	Host	NNP
cord-005453-4057qib7	15986	14	Disease	Disease	NNP
cord-005453-4057qib7	15986	15	is	be	VBZ
cord-005453-4057qib7	15986	16	represented	represent	VBN
cord-005453-4057qib7	15986	17	by	by	IN
cord-005453-4057qib7	15986	18	the	the	DT
cord-005453-4057qib7	15986	19	selective	selective	JJ
cord-005453-4057qib7	15986	20	depletion	depletion	NN
cord-005453-4057qib7	15986	21	of	of	IN
cord-005453-4057qib7	15986	22	ab	ab	NNP
cord-005453-4057qib7	15986	23	T	t	NN
cord-005453-4057qib7	15986	24	-	-	HYPH
cord-005453-4057qib7	15986	25	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	15986	26	(	(	-LRB-
cord-005453-4057qib7	15986	27	coupled	couple	VBN
cord-005453-4057qib7	15986	28	with	with	IN
cord-005453-4057qib7	15986	29	the	the	DT
cord-005453-4057qib7	15986	30	depletion	depletion	NN
cord-005453-4057qib7	15986	31	of	of	IN
cord-005453-4057qib7	15986	32	CD19	CD19	NNP
cord-005453-4057qib7	15986	33	+	+	CC
cord-005453-4057qib7	15986	34	B	b	NN
cord-005453-4057qib7	15986	35	-	-	HYPH
cord-005453-4057qib7	15986	36	cells	cell	NNS
cord-005453-4057qib7	15986	37	in	in	IN
cord-005453-4057qib7	15986	38	order	order	NN
cord-005453-4057qib7	15986	39	to	to	TO
cord-005453-4057qib7	15986	40	reduce	reduce	VB
cord-005453-4057qib7	15986	41	the	the	DT
cord-005453-4057qib7	15986	42	risk	risk	NN
cord-005453-4057qib7	15986	43	of	of	IN
cord-005453-4057qib7	15986	44	PTLD	PTLD	NNP
cord-005453-4057qib7	15986	45	)	)	-RRB-
cord-005453-4057qib7	15986	46	using	use	VBG
cord-005453-4057qib7	15986	47	the	the	DT
cord-005453-4057qib7	15986	48	CliniMACS	CliniMACS	NNP
cord-005453-4057qib7	15986	49	device	device	NN
cord-005453-4057qib7	15986	50	(	(	-LRB-
cord-005453-4057qib7	15986	51	Miltenyi	Miltenyi	NNP
cord-005453-4057qib7	15986	52	,	,	,
cord-005453-4057qib7	15986	53	Bergish	Bergish	NNP
cord-005453-4057qib7	15986	54	-	-	HYPH
cord-005453-4057qib7	15986	55	Gladback	Gladback	NNP
cord-005453-4057qib7	15986	56	)	)	-RRB-
cord-005453-4057qib7	15986	57	.	.	.
cord-005453-4057qib7	15987	1	Before	before	IN
cord-005453-4057qib7	15987	2	depletion	depletion	NN
cord-005453-4057qib7	15987	3	,	,	,
cord-005453-4057qib7	15987	4	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	15987	5	units	unit	NNS
cord-005453-4057qib7	15987	6	are	be	VBP
cord-005453-4057qib7	15987	7	washed	wash	VBN
cord-005453-4057qib7	15987	8	by	by	IN
cord-005453-4057qib7	15987	9	lowspeed	lowspeed	NN
cord-005453-4057qib7	15987	10	centrifugation	centrifugation	NN
cord-005453-4057qib7	15987	11	,	,	,
cord-005453-4057qib7	15987	12	resulting	result	VBG
cord-005453-4057qib7	15987	13	in	in	IN
cord-005453-4057qib7	15987	14	a	a	DT
cord-005453-4057qib7	15987	15	platelet	platelet	NN
cord-005453-4057qib7	15987	16	(	(	-LRB-
cord-005453-4057qib7	15987	17	PLT	PLT	NNP
cord-005453-4057qib7	15987	18	)	)	-RRB-
cord-005453-4057qib7	15987	19	rich	rich	JJ
cord-005453-4057qib7	15987	20	supernatant	supernatant	NN
cord-005453-4057qib7	15987	21	(	(	-LRB-
cord-005453-4057qib7	15987	22	PRS	PRS	NNP
cord-005453-4057qib7	15987	23	)	)	-RRB-
cord-005453-4057qib7	15987	24	as	as	IN
cord-005453-4057qib7	15987	25	a	a	DT
cord-005453-4057qib7	15987	26	by	by	IN
cord-005453-4057qib7	15987	27	-	-	HYPH
cord-005453-4057qib7	15987	28	product	product	NN
cord-005453-4057qib7	15987	29	generally	generally	RB
cord-005453-4057qib7	15987	30	discarded	discard	VBN
cord-005453-4057qib7	15987	31	.	.	.
cord-005453-4057qib7	15988	1	We	-PRON-	PRP
cord-005453-4057qib7	15988	2	studied	study	VBD
cord-005453-4057qib7	15988	3	the	the	DT
cord-005453-4057qib7	15988	4	possibility	possibility	NN
cord-005453-4057qib7	15988	5	of	of	IN
cord-005453-4057qib7	15988	6	recovering	recover	VBG
cord-005453-4057qib7	15988	7	PLT	PLT	NNP
cord-005453-4057qib7	15988	8	from	from	IN
cord-005453-4057qib7	15988	9	PRS	PRS	NNP
cord-005453-4057qib7	15988	10	of	of	IN
cord-005453-4057qib7	15988	11	the	the	DT
cord-005453-4057qib7	15988	12	haplo	haplo	NN
cord-005453-4057qib7	15988	13	donor	donor	NN
cord-005453-4057qib7	15988	14	for	for	IN
cord-005453-4057qib7	15988	15	transfusion	transfusion	NN
cord-005453-4057qib7	15988	16	to	to	IN
cord-005453-4057qib7	15988	17	the	the	DT
cord-005453-4057qib7	15988	18	recipient	recipient	NN
cord-005453-4057qib7	15988	19	during	during	IN
cord-005453-4057qib7	15988	20	the	the	DT
cord-005453-4057qib7	15988	21	aplasia	aplasia	JJ
cord-005453-4057qib7	15988	22	period	period	NN
cord-005453-4057qib7	15988	23	occurring	occur	VBG
cord-005453-4057qib7	15988	24	after	after	IN
cord-005453-4057qib7	15988	25	HSCT.Methods	hsct.method	NNS
cord-005453-4057qib7	15988	26	:	:	:
cord-005453-4057qib7	15988	27	HSC	HSC	NNP
cord-005453-4057qib7	15988	28	donors	donor	NNS
cord-005453-4057qib7	15988	29	were	be	VBD
cord-005453-4057qib7	15988	30	mobilized	mobilize	VBN
cord-005453-4057qib7	15988	31	with	with	IN
cord-005453-4057qib7	15988	32	G	G	NNP
cord-005453-4057qib7	15988	33	-	-	HYPH
cord-005453-4057qib7	15988	34	CSF	CSF	NNP
cord-005453-4057qib7	15988	35	(	(	-LRB-
cord-005453-4057qib7	15988	36	plus	plus	CC
cord-005453-4057qib7	15988	37	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	15988	38	in	in	IN
cord-005453-4057qib7	15988	39	6	6	CD
cord-005453-4057qib7	15988	40	out	out	IN
cord-005453-4057qib7	15988	41	of	of	IN
cord-005453-4057qib7	15988	42	24	24	CD
cord-005453-4057qib7	15988	43	donors	donor	NNS
cord-005453-4057qib7	15988	44	)	)	-RRB-
cord-005453-4057qib7	15988	45	as	as	IN
cord-005453-4057qib7	15988	46	previously	previously	RB
cord-005453-4057qib7	15988	47	described	describe	VBN
cord-005453-4057qib7	15988	48	[	[	-LRB-
cord-005453-4057qib7	15988	49	Locatelli	Locatelli	NNP
cord-005453-4057qib7	15988	50	et	et	NNP
cord-005453-4057qib7	15988	51	al	al	NNP
cord-005453-4057qib7	15988	52	,	,	,
cord-005453-4057qib7	15988	53	Blood	blood	NN
cord-005453-4057qib7	15988	54	2017	2017	CD
cord-005453-4057qib7	15988	55	]	]	-RRB-
cord-005453-4057qib7	15988	56	.	.	.
cord-005453-4057qib7	15989	1	Leukapheresis	leukapheresis	NN
cord-005453-4057qib7	15989	2	units	unit	NNS
cord-005453-4057qib7	15989	3	,	,	,
cord-005453-4057qib7	15989	4	obtained	obtain	VBN
cord-005453-4057qib7	15989	5	with	with	IN
cord-005453-4057qib7	15989	6	a	a	DT
cord-005453-4057qib7	15989	7	Spectra	Spectra	NNP
cord-005453-4057qib7	15989	8	Optia	Optia	NNP
cord-005453-4057qib7	15989	9	device	device	NN
cord-005453-4057qib7	15989	10	,	,	,
cord-005453-4057qib7	15989	11	were	be	VBD
cord-005453-4057qib7	15989	12	washed	wash	VBN
cord-005453-4057qib7	15989	13	twice	twice	RB
cord-005453-4057qib7	15989	14	(	(	-LRB-
cord-005453-4057qib7	15989	15	producing	produce	VBG
cord-005453-4057qib7	15989	16	2	2	CD
cord-005453-4057qib7	15989	17	PRS	PRS	NNP
cord-005453-4057qib7	15989	18	bags	bag	NNS
cord-005453-4057qib7	15989	19	)	)	-RRB-
cord-005453-4057qib7	15989	20	at	at	IN
cord-005453-4057qib7	15989	21	low	low	JJ
cord-005453-4057qib7	15989	22	speed	speed	NN
cord-005453-4057qib7	15989	23	to	to	TO
cord-005453-4057qib7	15989	24	remove	remove	VB
cord-005453-4057qib7	15989	25	PLT	PLT	NNP
cord-005453-4057qib7	15989	26	before	before	IN
cord-005453-4057qib7	15989	27	starting	start	VBG
cord-005453-4057qib7	15989	28	the	the	DT
cord-005453-4057qib7	15989	29	ab	ab	NNP
cord-005453-4057qib7	15989	30	T	t	NN
cord-005453-4057qib7	15989	31	-	-	HYPH
cord-005453-4057qib7	15989	32	cell	cell	NN
cord-005453-4057qib7	15989	33	/	/	SYM
cord-005453-4057qib7	15989	34	B	b	NN
cord-005453-4057qib7	15989	35	-	-	HYPH
cord-005453-4057qib7	15989	36	cell	cell	NN
cord-005453-4057qib7	15989	37	depletion	depletion	NN
cord-005453-4057qib7	15989	38	.	.	.
cord-005453-4057qib7	15990	1	The	the	DT
cord-005453-4057qib7	15990	2	two	two	CD
cord-005453-4057qib7	15990	3	PRS	PRS	NNP
cord-005453-4057qib7	15990	4	were	be	VBD
cord-005453-4057qib7	15990	5	leukodepleted	leukodeplete	VBN
cord-005453-4057qib7	15990	6	by	by	IN
cord-005453-4057qib7	15990	7	filtration	filtration	NN
cord-005453-4057qib7	15990	8	,	,	,
cord-005453-4057qib7	15990	9	centrifuged	centrifuge	VBN
cord-005453-4057qib7	15990	10	,	,	,
cord-005453-4057qib7	15990	11	resuspended	resuspended	JJ
cord-005453-4057qib7	15990	12	and	and	CC
cord-005453-4057qib7	15990	13	pooled	pool	VBN
cord-005453-4057qib7	15990	14	in	in	IN
cord-005453-4057qib7	15990	15	a	a	DT
cord-005453-4057qib7	15990	16	total	total	JJ
cord-005453-4057qib7	15990	17	volume	volume	NN
cord-005453-4057qib7	15990	18	ranging	range	VBG
cord-005453-4057qib7	15990	19	from	from	IN
cord-005453-4057qib7	15990	20	95	95	CD
cord-005453-4057qib7	15990	21	to	to	TO
cord-005453-4057qib7	15990	22	360	360	CD
cord-005453-4057qib7	15990	23	ml	ml	NN
cord-005453-4057qib7	15990	24	InterSol	InterSol	NNP
cord-005453-4057qib7	15990	25	(	(	-LRB-
cord-005453-4057qib7	15990	26	IS	be	VBZ
cord-005453-4057qib7	15990	27	-	-	HYPH
cord-005453-4057qib7	15990	28	PLT	PLT	NNP
cord-005453-4057qib7	15990	29	)	)	-RRB-
cord-005453-4057qib7	15990	30	for	for	IN
cord-005453-4057qib7	15990	31	overnight	overnight	JJ
cord-005453-4057qib7	15990	32	incubation	incubation	NN
cord-005453-4057qib7	15990	33	at	at	IN
cord-005453-4057qib7	15990	34	22	22	CD
cord-005453-4057qib7	15990	35	°	°	NN
cord-005453-4057qib7	15990	36	C	c	NN
cord-005453-4057qib7	15990	37	with	with	IN
cord-005453-4057qib7	15990	38	agitation	agitation	NN
cord-005453-4057qib7	15990	39	(	(	-LRB-
cord-005453-4057qib7	15990	40	60	60	CD
cord-005453-4057qib7	15990	41	cycles	cycle	NNS
cord-005453-4057qib7	15990	42	/	/	SYM
cord-005453-4057qib7	15990	43	min	min	NN
cord-005453-4057qib7	15990	44	)	)	-RRB-
cord-005453-4057qib7	15990	45	.	.	.
cord-005453-4057qib7	15991	1	The	the	DT
cord-005453-4057qib7	15991	2	IS	IS	NNP
cord-005453-4057qib7	15991	3	-	-	HYPH
cord-005453-4057qib7	15991	4	PLT	PLT	NNP
cord-005453-4057qib7	15991	5	samples	sample	NNS
cord-005453-4057qib7	15991	6	were	be	VBD
cord-005453-4057qib7	15991	7	analyzed	analyze	VBN
cord-005453-4057qib7	15991	8	for	for	IN
cord-005453-4057qib7	15991	9	the	the	DT
cord-005453-4057qib7	15991	10	criteria	criterion	NNS
cord-005453-4057qib7	15991	11	established	establish	VBN
cord-005453-4057qib7	15991	12	by	by	IN
cord-005453-4057qib7	15991	13	the	the	DT
cord-005453-4057qib7	15991	14	Italian	italian	JJ
cord-005453-4057qib7	15991	15	transfusion	transfusion	NN
cord-005453-4057qib7	15991	16	law	law	NN
cord-005453-4057qib7	15991	17	.	.	.
cord-005453-4057qib7	15992	1	IS	be	VBZ
cord-005453-4057qib7	15992	2	-	-	HYPH
cord-005453-4057qib7	15992	3	PLT	PLT	NNP
cord-005453-4057qib7	15992	4	bags	bag	NNS
cord-005453-4057qib7	15992	5	were	be	VBD
cord-005453-4057qib7	15992	6	examined	examine	VBN
cord-005453-4057qib7	15992	7	for	for	IN
cord-005453-4057qib7	15992	8	the	the	DT
cord-005453-4057qib7	15992	9	following	follow	VBG
cord-005453-4057qib7	15992	10	parameters	parameter	NNS
cord-005453-4057qib7	15992	11	:	:	:
cord-005453-4057qib7	15992	12	volume	volume	NN
cord-005453-4057qib7	15992	13	>	>	XX
cord-005453-4057qib7	15992	14	40ml	40ml	NN
cord-005453-4057qib7	15992	15	,	,	,
cord-005453-4057qib7	15992	16	PLT	PLT	NNP
cord-005453-4057qib7	15992	17	after	after	IN
cord-005453-4057qib7	15992	18	leukodepletion	leukodepletion	NN
cord-005453-4057qib7	15993	1	>	>	XX
cord-005453-4057qib7	15994	1	2x10	2x10	CD
cord-005453-4057qib7	15994	2	11	11	CD
cord-005453-4057qib7	15994	3	,	,	,
cord-005453-4057qib7	15994	4	residual	residual	JJ
cord-005453-4057qib7	15994	5	leukocytes	leukocyte	NNS
cord-005453-4057qib7	15994	6	<	<	XX
cord-005453-4057qib7	15994	7	1x10	1x10	CD
cord-005453-4057qib7	15994	8	6	6	CD
cord-005453-4057qib7	15994	9	,	,	,
cord-005453-4057qib7	15995	1	pH	pH	NNP
cord-005453-4057qib7	15996	1	>	>	XX
cord-005453-4057qib7	15997	1	6.4	6.4	CD
cord-005453-4057qib7	15997	2	at	at	IN
cord-005453-4057qib7	15997	3	22	22	CD
cord-005453-4057qib7	15997	4	°	°	NN
cord-005453-4057qib7	15997	5	C	c	NN
cord-005453-4057qib7	15997	6	at	at	IN
cord-005453-4057qib7	15997	7	the	the	DT
cord-005453-4057qib7	15997	8	end	end	NN
cord-005453-4057qib7	15997	9	of	of	IN
cord-005453-4057qib7	15997	10	the	the	DT
cord-005453-4057qib7	15997	11	5-day	5-day	JJ
cord-005453-4057qib7	15997	12	storage	storage	NN
cord-005453-4057qib7	15997	13	period	period	NN
cord-005453-4057qib7	15997	14	.	.	.
cord-005453-4057qib7	15998	1	The	the	DT
cord-005453-4057qib7	15998	2	sterility	sterility	NN
cord-005453-4057qib7	15998	3	was	be	VBD
cord-005453-4057qib7	15998	4	tested	test	VBN
cord-005453-4057qib7	15998	5	using	use	VBG
cord-005453-4057qib7	15998	6	BD	BD	NNP
cord-005453-4057qib7	15998	7	Bactec	Bactec	NNP
cord-005453-4057qib7	15998	8	culture	culture	NN
cord-005453-4057qib7	15998	9	vials	vial	NNS
cord-005453-4057qib7	15998	10	.	.	.
cord-005453-4057qib7	15999	1	The	the	DT
cord-005453-4057qib7	15999	2	evaluation	evaluation	NN
cord-005453-4057qib7	15999	3	of	of	IN
cord-005453-4057qib7	15999	4	the	the	DT
cord-005453-4057qib7	15999	5	residual	residual	JJ
cord-005453-4057qib7	15999	6	leukocytes	leukocyte	NNS
cord-005453-4057qib7	15999	7	was	be	VBD
cord-005453-4057qib7	15999	8	performed	perform	VBN
cord-005453-4057qib7	15999	9	with	with	IN
cord-005453-4057qib7	15999	10	the	the	DT
cord-005453-4057qib7	15999	11	BD	BD	NNP
cord-005453-4057qib7	15999	12	LeucoCount	LeucoCount	NNP
cord-005453-4057qib7	15999	13	Kit	Kit	NNP
cord-005453-4057qib7	15999	14	.	.	.
cord-005453-4057qib7	16000	1	The	the	DT
cord-005453-4057qib7	16000	2	absolute	absolute	JJ
cord-005453-4057qib7	16000	3	PLT	PLT	NNP
cord-005453-4057qib7	16000	4	counts	count	NNS
cord-005453-4057qib7	16000	5	were	be	VBD
cord-005453-4057qib7	16000	6	determined	determine	VBN
cord-005453-4057qib7	16000	7	using	use	VBG
cord-005453-4057qib7	16000	8	hemocytometer	hemocytometer	NN
cord-005453-4057qib7	16000	9	Sysmex	Sysmex	NNP
cord-005453-4057qib7	16000	10	XN2000.Results	XN2000.Results	NNP
cord-005453-4057qib7	16000	11	:	:	:
cord-005453-4057qib7	16001	1	PRS	PRS	NNP
cord-005453-4057qib7	16001	2	bags	bag	NNS
cord-005453-4057qib7	16001	3	from	from	IN
cord-005453-4057qib7	16001	4	24	24	CD
cord-005453-4057qib7	16001	5	donors	donor	NNS
cord-005453-4057qib7	16001	6	were	be	VBD
cord-005453-4057qib7	16001	7	processed	process	VBN
cord-005453-4057qib7	16001	8	to	to	TO
cord-005453-4057qib7	16001	9	produce	produce	VB
cord-005453-4057qib7	16001	10	IS	be	VBZ
cord-005453-4057qib7	16001	11	-	-	HYPH
cord-005453-4057qib7	16001	12	PLT	PLT	NNP
cord-005453-4057qib7	16001	13	units	unit	NNS
cord-005453-4057qib7	16001	14	.	.	.
cord-005453-4057qib7	16002	1	Median	median	JJ
cord-005453-4057qib7	16002	2	resuspension	resuspension	NN
cord-005453-4057qib7	16002	3	volume	volume	NN
cord-005453-4057qib7	16002	4	in	in	IN
cord-005453-4057qib7	16002	5	InterSol	InterSol	NNP
cord-005453-4057qib7	16002	6	was	be	VBD
cord-005453-4057qib7	16002	7	220	220	CD
cord-005453-4057qib7	16002	8	ml	ml	NN
cord-005453-4057qib7	16002	9	(	(	-LRB-
cord-005453-4057qib7	16002	10	range	range	VB
cord-005453-4057qib7	16002	11	95	95	CD
cord-005453-4057qib7	16002	12	-	-	HYPH
cord-005453-4057qib7	16002	13	360	360	CD
cord-005453-4057qib7	16002	14	)	)	-RRB-
cord-005453-4057qib7	16002	15	.	.	.
cord-005453-4057qib7	16003	1	The	the	DT
cord-005453-4057qib7	16003	2	absolute	absolute	JJ
cord-005453-4057qib7	16003	3	mean	mean	JJ
cord-005453-4057qib7	16003	4	value	value	NN
cord-005453-4057qib7	16003	5	of	of	IN
cord-005453-4057qib7	16003	6	PLT	PLT	NNP
cord-005453-4057qib7	16003	7	counts	count	NNS
cord-005453-4057qib7	16003	8	measured	measure	VBN
cord-005453-4057qib7	16003	9	at	at	IN
cord-005453-4057qib7	16003	10	the	the	DT
cord-005453-4057qib7	16003	11	end	end	NN
cord-005453-4057qib7	16003	12	of	of	IN
cord-005453-4057qib7	16003	13	the	the	DT
cord-005453-4057qib7	16003	14	storage	storage	NN
cord-005453-4057qib7	16003	15	period	period	NN
cord-005453-4057qib7	16003	16	was	be	VBD
cord-005453-4057qib7	16003	17	2.1	2.1	CD
cord-005453-4057qib7	16003	18	x10	x10	CD
cord-005453-4057qib7	16003	19	11	11	CD
cord-005453-4057qib7	16003	20	(	(	-LRB-
cord-005453-4057qib7	16003	21	range	range	VBP
cord-005453-4057qib7	16003	22	1.0	1.0	CD
cord-005453-4057qib7	16003	23	-	-	SYM
cord-005453-4057qib7	16003	24	6.1	6.1	CD
cord-005453-4057qib7	16003	25	x10	x10	CD
cord-005453-4057qib7	16003	26	11	11	CD
cord-005453-4057qib7	16003	27	)	)	-RRB-
cord-005453-4057qib7	16003	28	.	.	.
cord-005453-4057qib7	16004	1	This	this	DT
cord-005453-4057qib7	16004	2	value	value	NN
cord-005453-4057qib7	16004	3	was	be	VBD
cord-005453-4057qib7	16004	4	found	find	VBN
cord-005453-4057qib7	16004	5	below	below	IN
cord-005453-4057qib7	16004	6	the	the	DT
cord-005453-4057qib7	16004	7	threshold	threshold	NN
cord-005453-4057qib7	16004	8	fixed	fix	VBN
cord-005453-4057qib7	16004	9	by	by	IN
cord-005453-4057qib7	16004	10	Italian	italian	JJ
cord-005453-4057qib7	16004	11	regulation	regulation	NN
cord-005453-4057qib7	16004	12	in	in	IN
cord-005453-4057qib7	16004	13	8	8	CD
cord-005453-4057qib7	16004	14	cases	case	NNS
cord-005453-4057qib7	16004	15	(	(	-LRB-
cord-005453-4057qib7	16004	16	33.3	33.3	CD
cord-005453-4057qib7	16004	17	%	%	NN
cord-005453-4057qib7	16004	18	)	)	-RRB-
cord-005453-4057qib7	16004	19	.	.	.
cord-005453-4057qib7	16005	1	Mean	mean	JJ
cord-005453-4057qib7	16005	2	value	value	NN
cord-005453-4057qib7	16005	3	of	of	IN
cord-005453-4057qib7	16005	4	residual	residual	JJ
cord-005453-4057qib7	16005	5	leukocytes	leukocyte	NNS
cord-005453-4057qib7	16005	6	was	be	VBD
cord-005453-4057qib7	16005	7	1.3x10	1.3x10	CD
cord-005453-4057qib7	16005	8	5	5	CD
cord-005453-4057qib7	16006	1	(	(	-LRB-
cord-005453-4057qib7	16006	2	range	range	NN
cord-005453-4057qib7	16006	3	0	0	CD
cord-005453-4057qib7	16006	4	-	-	HYPH
cord-005453-4057qib7	16006	5	9x10	9x10	CD
cord-005453-4057qib7	16006	6	5	5	CD
cord-005453-4057qib7	16006	7	)	)	-RRB-
cord-005453-4057qib7	16006	8	;	;	:
cord-005453-4057qib7	16006	9	the	the	DT
cord-005453-4057qib7	16006	10	pH	pH	NNP
cord-005453-4057qib7	16006	11	value	value	NN
cord-005453-4057qib7	16006	12	was	be	VBD
cord-005453-4057qib7	16006	13	always	always	RB
cord-005453-4057qib7	16006	14	>	>	XX
cord-005453-4057qib7	16006	15	6.4	6.4	CD
cord-005453-4057qib7	16006	16	.	.	.
cord-005453-4057qib7	16007	1	Sterility	sterility	NN
cord-005453-4057qib7	16007	2	was	be	VBD
cord-005453-4057qib7	16007	3	observed	observe	VBN
cord-005453-4057qib7	16007	4	in	in	IN
cord-005453-4057qib7	16007	5	all	all	DT
cord-005453-4057qib7	16007	6	cases	case	NNS
cord-005453-4057qib7	16007	7	.	.	.
cord-005453-4057qib7	16008	1	According	accord	VBG
cord-005453-4057qib7	16008	2	to	to	IN
cord-005453-4057qib7	16008	3	the	the	DT
cord-005453-4057qib7	16008	4	work	work	NN
cord-005453-4057qib7	16008	5	of	of	IN
cord-005453-4057qib7	16008	6	Slichter	Slichter	NNP
cord-005453-4057qib7	16008	7	et	et	NNP
cord-005453-4057qib7	16008	8	al	al	NNP
cord-005453-4057qib7	16008	9	.	.	.
cord-005453-4057qib7	16009	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16009	2	:	:	:
cord-005453-4057qib7	16010	1	We	-PRON-	PRP
cord-005453-4057qib7	16010	2	demonstrated	demonstrate	VBD
cord-005453-4057qib7	16010	3	that	that	IN
cord-005453-4057qib7	16010	4	PLTs	plt	NNS
cord-005453-4057qib7	16010	5	recovered	recover	VBD
cord-005453-4057qib7	16010	6	from	from	IN
cord-005453-4057qib7	16010	7	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	16010	8	bags	bag	NNS
cord-005453-4057qib7	16010	9	can	can	MD
cord-005453-4057qib7	16010	10	be	be	VB
cord-005453-4057qib7	16010	11	accepted	accept	VBN
cord-005453-4057qib7	16010	12	as	as	IN
cord-005453-4057qib7	16010	13	a	a	DT
cord-005453-4057qib7	16010	14	conventional	conventional	JJ
cord-005453-4057qib7	16010	15	hemocomponent	hemocomponent	NN
cord-005453-4057qib7	16010	16	according	accord	VBG
cord-005453-4057qib7	16010	17	to	to	IN
cord-005453-4057qib7	16010	18	the	the	DT
cord-005453-4057qib7	16010	19	parameters	parameter	NNS
cord-005453-4057qib7	16010	20	fixed	fix	VBN
cord-005453-4057qib7	16010	21	by	by	IN
cord-005453-4057qib7	16010	22	Italian	italian	JJ
cord-005453-4057qib7	16010	23	transfusion	transfusion	NN
cord-005453-4057qib7	16010	24	law	law	NN
cord-005453-4057qib7	16010	25	and	and	CC
cord-005453-4057qib7	16010	26	thus	thus	RB
cord-005453-4057qib7	16010	27	can	can	MD
cord-005453-4057qib7	16010	28	be	be	VB
cord-005453-4057qib7	16010	29	administered	administer	VBN
cord-005453-4057qib7	16010	30	to	to	IN
cord-005453-4057qib7	16010	31	the	the	DT
cord-005453-4057qib7	16010	32	haplo	haplo	NNP
cord-005453-4057qib7	16010	33	-	-	HYPH
cord-005453-4057qib7	16010	34	HSCT	HSCT	NNP
cord-005453-4057qib7	16010	35	recipients	recipient	NNS
cord-005453-4057qib7	16010	36	early	early	RB
cord-005453-4057qib7	16010	37	after	after	IN
cord-005453-4057qib7	16010	38	transplantation	transplantation	NN
cord-005453-4057qib7	16010	39	.	.	.
cord-005453-4057qib7	16011	1	This	this	DT
cord-005453-4057qib7	16011	2	strategy	strategy	NN
cord-005453-4057qib7	16011	3	carries	carry	VBZ
cord-005453-4057qib7	16011	4	several	several	JJ
cord-005453-4057qib7	16011	5	advantages	advantage	NNS
cord-005453-4057qib7	16011	6	.	.	.
cord-005453-4057qib7	16012	1	Indeed	indeed	RB
cord-005453-4057qib7	16012	2	,	,	,
cord-005453-4057qib7	16012	3	apart	apart	RB
cord-005453-4057qib7	16012	4	from	from	IN
cord-005453-4057qib7	16012	5	the	the	DT
cord-005453-4057qib7	16012	6	obvious	obvious	JJ
cord-005453-4057qib7	16012	7	advantages	advantage	NNS
cord-005453-4057qib7	16012	8	in	in	IN
cord-005453-4057qib7	16012	9	terms	term	NNS
cord-005453-4057qib7	16012	10	of	of	IN
cord-005453-4057qib7	16012	11	reduced	reduced	JJ
cord-005453-4057qib7	16012	12	costs	cost	NNS
cord-005453-4057qib7	16012	13	,	,	,
cord-005453-4057qib7	16012	14	IS	be	VBZ
cord-005453-4057qib7	16012	15	-	-	HYPH
cord-005453-4057qib7	16012	16	PLT	PLT	NNP
cord-005453-4057qib7	16012	17	can	can	MD
cord-005453-4057qib7	16012	18	be	be	VB
cord-005453-4057qib7	16012	19	used	use	VBN
cord-005453-4057qib7	16012	20	to	to	TO
cord-005453-4057qib7	16012	21	desensitize	desensitize	VB
cord-005453-4057qib7	16012	22	the	the	DT
cord-005453-4057qib7	16012	23	recipient	recipient	NN
cord-005453-4057qib7	16012	24	by	by	IN
cord-005453-4057qib7	16012	25	absorption	absorption	NN
cord-005453-4057qib7	16012	26	of	of	IN
cord-005453-4057qib7	16012	27	anti	anti	JJ
cord-005453-4057qib7	16012	28	-	-	JJ
cord-005453-4057qib7	16012	29	HLA	HLA	NNP
cord-005453-4057qib7	16012	30	class	class	NN
cord-005453-4057qib7	16013	1	I	-PRON-	PRP
cord-005453-4057qib7	16013	2	antibodies	antibody	NNS
cord-005453-4057qib7	16013	3	,	,	,
cord-005453-4057qib7	16013	4	if	if	IN
cord-005453-4057qib7	16013	5	present	present	JJ
cord-005453-4057qib7	16013	6	in	in	IN
cord-005453-4057qib7	16013	7	the	the	DT
cord-005453-4057qib7	16013	8	recipient	recipient	NN
cord-005453-4057qib7	16013	9	.	.	.
cord-005453-4057qib7	16014	1	Moreover	moreover	RB
cord-005453-4057qib7	16014	2	,	,	,
cord-005453-4057qib7	16014	3	this	this	DT
cord-005453-4057qib7	16014	4	strategy	strategy	NN
cord-005453-4057qib7	16014	5	can	can	MD
cord-005453-4057qib7	16014	6	avoid	avoid	VB
cord-005453-4057qib7	16014	7	the	the	DT
cord-005453-4057qib7	16014	8	risk	risk	NN
cord-005453-4057qib7	16014	9	of	of	IN
cord-005453-4057qib7	16014	10	sensitizing	sensitize	VBG
cord-005453-4057qib7	16014	11	the	the	DT
cord-005453-4057qib7	16014	12	transplanted	transplanted	JJ
cord-005453-4057qib7	16014	13	patients	patient	NNS
cord-005453-4057qib7	16014	14	with	with	IN
cord-005453-4057qib7	16014	15	HLA	HLA	NNP
cord-005453-4057qib7	16014	16	alleles	allele	NNS
cord-005453-4057qib7	16014	17	that	that	WDT
cord-005453-4057qib7	16014	18	differ	differ	VBP
cord-005453-4057qib7	16014	19	from	from	IN
cord-005453-4057qib7	16014	20	the	the	DT
cord-005453-4057qib7	16014	21	donor	donor	NN
cord-005453-4057qib7	16014	22	's	's	POS
cord-005453-4057qib7	16014	23	ones	one	NNS
cord-005453-4057qib7	16014	24	.	.	.
cord-005453-4057qib7	16015	1	Finally	finally	RB
cord-005453-4057qib7	16015	2	,	,	,
cord-005453-4057qib7	16015	3	the	the	DT
cord-005453-4057qib7	16015	4	IS	IS	NNP
cord-005453-4057qib7	16015	5	-	-	HYPH
cord-005453-4057qib7	16015	6	PLT	PLT	NNP
cord-005453-4057qib7	16015	7	unit	unit	NN
cord-005453-4057qib7	16015	8	is	be	VBZ
cord-005453-4057qib7	16015	9	readily	readily	RB
cord-005453-4057qib7	16015	10	available	available	JJ
cord-005453-4057qib7	16015	11	.	.	.
cord-005453-4057qib7	16016	1	A	a	DT
cord-005453-4057qib7	16016	2	clinical	clinical	JJ
cord-005453-4057qib7	16016	3	study	study	NN
cord-005453-4057qib7	16016	4	aimed	aim	VBN
cord-005453-4057qib7	16016	5	at	at	IN
cord-005453-4057qib7	16016	6	testing	test	VBG
cord-005453-4057qib7	16016	7	the	the	DT
cord-005453-4057qib7	16016	8	use	use	NN
cord-005453-4057qib7	16016	9	of	of	IN
cord-005453-4057qib7	16016	10	IS	IS	NNP
cord-005453-4057qib7	16016	11	-	-	HYPH
cord-005453-4057qib7	16016	12	PLT	PLT	NNP
cord-005453-4057qib7	16016	13	units	unit	NNS
cord-005453-4057qib7	16016	14	in	in	IN
cord-005453-4057qib7	16016	15	transplant	transplant	NN
cord-005453-4057qib7	16016	16	recipients	recipient	NNS
cord-005453-4057qib7	16016	17	will	will	MD
cord-005453-4057qib7	16016	18	be	be	VB
cord-005453-4057qib7	16016	19	performed	perform	VBN
cord-005453-4057qib7	16016	20	to	to	TO
cord-005453-4057qib7	16016	21	confirm	confirm	VB
cord-005453-4057qib7	16016	22	the	the	DT
cord-005453-4057qib7	16016	23	clinical	clinical	JJ
cord-005453-4057qib7	16016	24	efficacy	efficacy	NN
cord-005453-4057qib7	16016	25	of	of	IN
cord-005453-4057qib7	16016	26	the	the	DT
cord-005453-4057qib7	16016	27	approach	approach	NN
cord-005453-4057qib7	16016	28	.	.	.
cord-005453-4057qib7	16017	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16017	2	:	:	:
cord-005453-4057qib7	16017	3	Nothing	nothing	NN
cord-005453-4057qib7	16017	4	to	to	TO
cord-005453-4057qib7	16017	5	declare	declare	VB
cord-005453-4057qib7	16017	6	P700	P700	NNP
cord-005453-4057qib7	16017	7	Ultrasound	Ultrasound	NNP
cord-005453-4057qib7	16017	8	guidance	guidance	NN
cord-005453-4057qib7	16017	9	as	as	IN
cord-005453-4057qib7	16017	10	a	a	DT
cord-005453-4057qib7	16017	11	powerful	powerful	JJ
cord-005453-4057qib7	16017	12	tool	tool	NN
cord-005453-4057qib7	16017	13	in	in	IN
cord-005453-4057qib7	16017	14	increasing	increase	VBG
cord-005453-4057qib7	16017	15	Background	Background	NNP
cord-005453-4057qib7	16017	16	:	:	:
cord-005453-4057qib7	16017	17	Peripheral	peripheral	JJ
cord-005453-4057qib7	16017	18	blood	blood	NN
cord-005453-4057qib7	16017	19	stem	stem	NN
cord-005453-4057qib7	16017	20	cells	cell	NNS
cord-005453-4057qib7	16017	21	are	be	VBP
cord-005453-4057qib7	16017	22	generally	generally	RB
cord-005453-4057qib7	16017	23	the	the	DT
cord-005453-4057qib7	16017	24	preferred	prefer	VBN
cord-005453-4057qib7	16017	25	graft	graft	NN
cord-005453-4057qib7	16017	26	source	source	NN
cord-005453-4057qib7	16017	27	for	for	IN
cord-005453-4057qib7	16017	28	allogeneic	allogeneic	NN
cord-005453-4057qib7	16017	29	stem	stem	NN
cord-005453-4057qib7	16017	30	cell	cell	NN
cord-005453-4057qib7	16017	31	transplantation	transplantation	NN
cord-005453-4057qib7	16017	32	for	for	IN
cord-005453-4057qib7	16017	33	malignant	malignant	JJ
cord-005453-4057qib7	16017	34	disease	disease	NN
cord-005453-4057qib7	16017	35	.	.	.
cord-005453-4057qib7	16018	1	In	in	IN
cord-005453-4057qib7	16018	2	most	most	JJS
cord-005453-4057qib7	16018	3	centers	center	NNS
cord-005453-4057qib7	16018	4	first	first	JJ
cord-005453-4057qib7	16018	5	apheresis	apheresis	NN
cord-005453-4057qib7	16018	6	is	be	VBZ
cord-005453-4057qib7	16018	7	performed	perform	VBN
cord-005453-4057qib7	16018	8	on	on	IN
cord-005453-4057qib7	16018	9	day	day	NN
cord-005453-4057qib7	16018	10	5	5	CD
cord-005453-4057qib7	16018	11	after	after	IN
cord-005453-4057qib7	16018	12	8	8	CD
cord-005453-4057qib7	16018	13	to	to	TO
cord-005453-4057qib7	16018	14	9	9	CD
cord-005453-4057qib7	16018	15	doses	dose	NNS
cord-005453-4057qib7	16018	16	of	of	IN
cord-005453-4057qib7	16018	17	granulocyte	granulocyte	NN
cord-005453-4057qib7	16018	18	colony	colony	NN
cord-005453-4057qib7	16018	19	stimulating	stimulate	VBG
cord-005453-4057qib7	16018	20	factor	factor	NN
cord-005453-4057qib7	16018	21	(	(	-LRB-
cord-005453-4057qib7	16018	22	GCSF	GCSF	NNP
cord-005453-4057qib7	16018	23	)	)	-RRB-
cord-005453-4057qib7	16018	24	up	up	IN
cord-005453-4057qib7	16018	25	to	to	IN
cord-005453-4057qib7	16018	26	5ug	5ug	NNP
cord-005453-4057qib7	16018	27	/	/	SYM
cord-005453-4057qib7	16018	28	kg	kg	NN
cord-005453-4057qib7	16018	29	twice	twice	RB
cord-005453-4057qib7	16018	30	daily	daily	RB
cord-005453-4057qib7	16018	31	.	.	.
cord-005453-4057qib7	16019	1	The	the	DT
cord-005453-4057qib7	16019	2	dose	dose	NN
cord-005453-4057qib7	16019	3	of	of	IN
cord-005453-4057qib7	16019	4	GCSF	GCSF	NNP
cord-005453-4057qib7	16019	5	and	and	CC
cord-005453-4057qib7	16019	6	the	the	DT
cord-005453-4057qib7	16019	7	number	number	NN
cord-005453-4057qib7	16019	8	of	of	IN
cord-005453-4057qib7	16019	9	apheresis	apheresis	NN
cord-005453-4057qib7	16019	10	procedures	procedure	NNS
cord-005453-4057qib7	16019	11	required	require	VBN
cord-005453-4057qib7	16019	12	contribute	contribute	VBP
cord-005453-4057qib7	16019	13	to	to	IN
cord-005453-4057qib7	16019	14	symptom	symptom	NN
cord-005453-4057qib7	16019	15	,	,	,
cord-005453-4057qib7	16019	16	travel	travel	NN
cord-005453-4057qib7	16019	17	and	and	CC
cord-005453-4057qib7	16019	18	time	time	NN
cord-005453-4057qib7	16020	1	burden	burden	NN
cord-005453-4057qib7	16020	2	donors	donor	NNS
cord-005453-4057qib7	16020	3	are	be	VBP
cord-005453-4057qib7	16020	4	put	put	VBN
cord-005453-4057qib7	16020	5	through	through	RP
cord-005453-4057qib7	16020	6	during	during	IN
cord-005453-4057qib7	16020	7	the	the	DT
cord-005453-4057qib7	16020	8	process	process	NN
cord-005453-4057qib7	16020	9	.	.	.
cord-005453-4057qib7	16021	1	We	-PRON-	PRP
cord-005453-4057qib7	16021	2	hypothesized	hypothesize	VBD
cord-005453-4057qib7	16021	3	that	that	IN
cord-005453-4057qib7	16021	4	taking	take	VBG
cord-005453-4057qib7	16021	5	donor	donor	NN
cord-005453-4057qib7	16021	6	-	-	HYPH
cord-005453-4057qib7	16021	7	recipient	recipient	NN
cord-005453-4057qib7	16021	8	weight	weight	NN
cord-005453-4057qib7	16021	9	differences	difference	NNS
cord-005453-4057qib7	16021	10	into	into	IN
cord-005453-4057qib7	16021	11	consideration	consideration	NN
cord-005453-4057qib7	16021	12	may	may	MD
cord-005453-4057qib7	16021	13	help	help	VB
cord-005453-4057qib7	16021	14	reduce	reduce	VB
cord-005453-4057qib7	16021	15	this	this	DT
cord-005453-4057qib7	16021	16	burden	burden	NN
cord-005453-4057qib7	16021	17	Methods	method	NNS
cord-005453-4057qib7	16021	18	:	:	:
cord-005453-4057qib7	16021	19	A	a	DT
cord-005453-4057qib7	16021	20	total	total	NN
cord-005453-4057qib7	16021	21	of	of	IN
cord-005453-4057qib7	16021	22	261	261	CD
cord-005453-4057qib7	16021	23	healthy	healthy	JJ
cord-005453-4057qib7	16021	24	donors	donor	NNS
cord-005453-4057qib7	16021	25	who	who	WP
cord-005453-4057qib7	16021	26	donated	donate	VBD
cord-005453-4057qib7	16021	27	peripheral	peripheral	JJ
cord-005453-4057qib7	16021	28	blood	blood	NN
cord-005453-4057qib7	16021	29	stem	stem	NN
cord-005453-4057qib7	16021	30	cells	cell	NNS
cord-005453-4057qib7	16021	31	on	on	IN
cord-005453-4057qib7	16021	32	day	day	NN
cord-005453-4057qib7	16021	33	4	4	CD
cord-005453-4057qib7	16021	34	of	of	IN
cord-005453-4057qib7	16021	35	GCSF	GCSF	NNP
cord-005453-4057qib7	16021	36	mobilization	mobilization	NN
cord-005453-4057qib7	16021	37	in	in	IN
cord-005453-4057qib7	16021	38	the	the	DT
cord-005453-4057qib7	16021	39	period	period	NN
cord-005453-4057qib7	16021	40	between	between	IN
cord-005453-4057qib7	16021	41	January	January	NNP
cord-005453-4057qib7	16021	42	2015	2015	CD
cord-005453-4057qib7	16021	43	and	and	CC
cord-005453-4057qib7	16021	44	August	August	NNP
cord-005453-4057qib7	16021	45	2018	2018	CD
cord-005453-4057qib7	16021	46	at	at	IN
cord-005453-4057qib7	16021	47	the	the	DT
cord-005453-4057qib7	16021	48	University	University	NNP
cord-005453-4057qib7	16021	49	Medical	Medical	NNP
cord-005453-4057qib7	16021	50	Center	Center	NNP
cord-005453-4057qib7	16021	51	Hamburg	Hamburg	NNP
cord-005453-4057qib7	16021	52	-	-	HYPH
cord-005453-4057qib7	16021	53	Eppendorf	Eppendorf	NNP
cord-005453-4057qib7	16021	54	were	be	VBD
cord-005453-4057qib7	16021	55	included	include	VBN
cord-005453-4057qib7	16021	56	in	in	IN
cord-005453-4057qib7	16021	57	this	this	DT
cord-005453-4057qib7	16021	58	quality	quality	NN
cord-005453-4057qib7	16021	59	control	control	NN
cord-005453-4057qib7	16021	60	evaluation	evaluation	NN
cord-005453-4057qib7	16021	61	.	.	.
cord-005453-4057qib7	16022	1	The	the	DT
cord-005453-4057qib7	16022	2	donors	donor	NNS
cord-005453-4057qib7	16022	3	were	be	VBD
cord-005453-4057qib7	16022	4	divided	divide	VBN
cord-005453-4057qib7	16022	5	into	into	IN
cord-005453-4057qib7	16022	6	two	two	CD
cord-005453-4057qib7	16022	7	cohorts	cohort	NNS
cord-005453-4057qib7	16022	8	.	.	.
cord-005453-4057qib7	16023	1	The	the	DT
cord-005453-4057qib7	16023	2	impact	impact	NN
cord-005453-4057qib7	16023	3	of	of	IN
cord-005453-4057qib7	16023	4	donorrecipient	donorrecipient	JJ
cord-005453-4057qib7	16023	5	weight	weight	NN
cord-005453-4057qib7	16023	6	ratio	ratio	NN
cord-005453-4057qib7	16023	7	on	on	IN
cord-005453-4057qib7	16023	8	stem	stem	NN
cord-005453-4057qib7	16023	9	cell	cell	NN
cord-005453-4057qib7	16023	10	harvest	harvest	NN
cord-005453-4057qib7	16023	11	was	be	VBD
cord-005453-4057qib7	16023	12	tested	test	VBN
cord-005453-4057qib7	16023	13	in	in	IN
cord-005453-4057qib7	16023	14	the	the	DT
cord-005453-4057qib7	16023	15	training	training	NN
cord-005453-4057qib7	16023	16	cohort	cohort	NN
cord-005453-4057qib7	16023	17	(	(	-LRB-
cord-005453-4057qib7	16023	18	2015	2015	CD
cord-005453-4057qib7	16023	19	-	-	SYM
cord-005453-4057qib7	16023	20	2016	2016	CD
cord-005453-4057qib7	16023	21	)	)	-RRB-
cord-005453-4057qib7	16023	22	and	and	CC
cord-005453-4057qib7	16023	23	validated	validate	VBD
cord-005453-4057qib7	16023	24	in	in	IN
cord-005453-4057qib7	16023	25	the	the	DT
cord-005453-4057qib7	16023	26	second	second	JJ
cord-005453-4057qib7	16023	27	cohort	cohort	NN
cord-005453-4057qib7	16023	28	(	(	-LRB-
cord-005453-4057qib7	16023	29	2017	2017	CD
cord-005453-4057qib7	16023	30	)	)	-RRB-
cord-005453-4057qib7	16023	31	(	(	-LRB-
cord-005453-4057qib7	16023	32	2018	2018	CD
cord-005453-4057qib7	16023	33	)	)	-RRB-
cord-005453-4057qib7	16023	34	.	.	.
cord-005453-4057qib7	16024	1	For	for	IN
cord-005453-4057qib7	16024	2	the	the	DT
cord-005453-4057qib7	16024	3	training	training	NN
cord-005453-4057qib7	16024	4	cohort	cohort	NN
cord-005453-4057qib7	16024	5	,	,	,
cord-005453-4057qib7	16024	6	donors	donor	NNS
cord-005453-4057qib7	16024	7	were	be	VBD
cord-005453-4057qib7	16024	8	grouped	group	VBN
cord-005453-4057qib7	16024	9	according	accord	VBG
cord-005453-4057qib7	16024	10	to	to	IN
cord-005453-4057qib7	16024	11	donor	donor	NN
cord-005453-4057qib7	16024	12	-	-	HYPH
cord-005453-4057qib7	16024	13	recipient	recipient	NN
cord-005453-4057qib7	16024	14	weight	weight	NN
cord-005453-4057qib7	16024	15	ratio	ratio	NN
cord-005453-4057qib7	16024	16	<	<	XX
cord-005453-4057qib7	16024	17	1.0	1.0	CD
cord-005453-4057qib7	16024	18	vs.	vs.	IN
cord-005453-4057qib7	16024	19	1.0	1.0	CD
cord-005453-4057qib7	16024	20	-	-	SYM
cord-005453-4057qib7	16024	21	1.2	1.2	CD
cord-005453-4057qib7	16024	22	vs.	vs.	FW
cord-005453-4057qib7	16024	23	>	>	XX
cord-005453-4057qib7	16024	24	1.2	1.2	CD
cord-005453-4057qib7	16024	25	.	.	.
cord-005453-4057qib7	16025	1	For	for	IN
cord-005453-4057qib7	16025	2	the	the	DT
cord-005453-4057qib7	16025	3	purpose	purpose	NN
cord-005453-4057qib7	16025	4	of	of	IN
cord-005453-4057qib7	16025	5	this	this	DT
cord-005453-4057qib7	16025	6	analysis	analysis	NN
cord-005453-4057qib7	16025	7	a	a	DT
cord-005453-4057qib7	16025	8	stem	stem	NN
cord-005453-4057qib7	16025	9	cells	cell	NNS
cord-005453-4057qib7	16025	10	dose	dose	NN
cord-005453-4057qib7	16025	11	of	of	IN
cord-005453-4057qib7	16025	12	5	5	CD
cord-005453-4057qib7	16025	13	x	x	SYM
cord-005453-4057qib7	16025	14	10	10	CD
cord-005453-4057qib7	16025	15	6	6	CD
cord-005453-4057qib7	16025	16	CD34+/kg	CD34+/kg	NNP
cord-005453-4057qib7	16025	17	recipient	recipient	NN
cord-005453-4057qib7	16025	18	weight	weight	NN
cord-005453-4057qib7	16025	19	was	be	VBD
cord-005453-4057qib7	16025	20	set	set	VBN
cord-005453-4057qib7	16025	21	for	for	IN
cord-005453-4057qib7	16025	22	successful	successful	JJ
cord-005453-4057qib7	16025	23	apheresis	apheresis	NN
cord-005453-4057qib7	16025	24	.	.	.
cord-005453-4057qib7	16026	1	Results	result	NNS
cord-005453-4057qib7	16026	2	:	:	:
cord-005453-4057qib7	16027	1	In	in	IN
cord-005453-4057qib7	16027	2	the	the	DT
cord-005453-4057qib7	16027	3	training	training	NN
cord-005453-4057qib7	16027	4	cohort	cohort	NN
cord-005453-4057qib7	16027	5	including	include	VBG
cord-005453-4057qib7	16027	6	142	142	CD
cord-005453-4057qib7	16027	7	donors	donor	NNS
cord-005453-4057qib7	16027	8	,	,	,
cord-005453-4057qib7	16027	9	52	52	CD
cord-005453-4057qib7	16027	10	(	(	-LRB-
cord-005453-4057qib7	16027	11	37	37	CD
cord-005453-4057qib7	16027	12	%	%	NN
cord-005453-4057qib7	16027	13	)	)	-RRB-
cord-005453-4057qib7	16027	14	,	,	,
cord-005453-4057qib7	16027	15	36	36	CD
cord-005453-4057qib7	16027	16	(	(	-LRB-
cord-005453-4057qib7	16027	17	25	25	CD
cord-005453-4057qib7	16027	18	%	%	NN
cord-005453-4057qib7	16027	19	)	)	-RRB-
cord-005453-4057qib7	16027	20	and	and	CC
cord-005453-4057qib7	16027	21	54	54	CD
cord-005453-4057qib7	16027	22	(	(	-LRB-
cord-005453-4057qib7	16027	23	38	38	CD
cord-005453-4057qib7	16027	24	%	%	NN
cord-005453-4057qib7	16027	25	)	)	-RRB-
cord-005453-4057qib7	16027	26	had	have	VBD
cord-005453-4057qib7	16027	27	a	a	DT
cord-005453-4057qib7	16027	28	donor	donor	NN
cord-005453-4057qib7	16027	29	-	-	HYPH
cord-005453-4057qib7	16027	30	recipient	recipient	NN
cord-005453-4057qib7	16027	31	weight	weight	NN
cord-005453-4057qib7	16027	32	ratio	ratio	NN
cord-005453-4057qib7	16027	33	of	of	IN
cord-005453-4057qib7	16027	34	<	<	NNP
cord-005453-4057qib7	16027	35	1.0	1.0	CD
cord-005453-4057qib7	16027	36	,	,	,
cord-005453-4057qib7	16028	1	1.0	1.0	CD
cord-005453-4057qib7	16028	2	-1.2	-1.2	CD
cord-005453-4057qib7	16028	3	and	and	CC
cord-005453-4057qib7	16028	4	>	>	XX
cord-005453-4057qib7	16028	5	1.2	1.2	CD
cord-005453-4057qib7	16028	6	respectively	respectively	RB
cord-005453-4057qib7	16028	7	.	.	.
cord-005453-4057qib7	16029	1	The	the	DT
cord-005453-4057qib7	16029	2	target	target	NN
cord-005453-4057qib7	16029	3	stem	stem	NN
cord-005453-4057qib7	16029	4	cells	cell	NNS
cord-005453-4057qib7	16029	5	count	count	NN
cord-005453-4057qib7	16029	6	of	of	IN
cord-005453-4057qib7	16029	7	5	5	CD
cord-005453-4057qib7	16029	8	x	x	SYM
cord-005453-4057qib7	16029	9	10	10	CD
cord-005453-4057qib7	16029	10	6	6	CD
cord-005453-4057qib7	16029	11	CD34+/kg	CD34+/kg	NNP
cord-005453-4057qib7	16029	12	recipient	recipient	NN
cord-005453-4057qib7	16029	13	weight	weight	NN
cord-005453-4057qib7	16029	14	was	be	VBD
cord-005453-4057qib7	16029	15	achieved	achieve	VBN
cord-005453-4057qib7	16029	16	in	in	IN
cord-005453-4057qib7	16029	17	36	36	CD
cord-005453-4057qib7	16029	18	of	of	IN
cord-005453-4057qib7	16029	19	52	52	CD
cord-005453-4057qib7	16029	20	(	(	-LRB-
cord-005453-4057qib7	16029	21	69	69	CD
cord-005453-4057qib7	16029	22	%	%	NN
cord-005453-4057qib7	16029	23	)	)	-RRB-
cord-005453-4057qib7	16029	24	,	,	,
cord-005453-4057qib7	16029	25	26	26	CD
cord-005453-4057qib7	16029	26	of	of	IN
cord-005453-4057qib7	16029	27	36	36	CD
cord-005453-4057qib7	16029	28	(	(	-LRB-
cord-005453-4057qib7	16029	29	72	72	CD
cord-005453-4057qib7	16029	30	%	%	NN
cord-005453-4057qib7	16029	31	)	)	-RRB-
cord-005453-4057qib7	16029	32	and	and	CC
cord-005453-4057qib7	16029	33	45	45	CD
cord-005453-4057qib7	16029	34	of	of	IN
cord-005453-4057qib7	16029	35	54	54	CD
cord-005453-4057qib7	16029	36	(	(	-LRB-
cord-005453-4057qib7	16029	37	83	83	CD
cord-005453-4057qib7	16029	38	%	%	NN
cord-005453-4057qib7	16029	39	)	)	-RRB-
cord-005453-4057qib7	16029	40	donors	donor	NNS
cord-005453-4057qib7	16029	41	with	with	IN
cord-005453-4057qib7	16029	42	donor	donor	NN
cord-005453-4057qib7	16029	43	:	:	:
cord-005453-4057qib7	16029	44	recipient	recipient	NN
cord-005453-4057qib7	16029	45	weight	weight	NN
cord-005453-4057qib7	16029	46	ratio	ratio	NN
cord-005453-4057qib7	16029	47	<	<	XX
cord-005453-4057qib7	16029	48	1.0	1.0	CD
cord-005453-4057qib7	16029	49	,	,	,
cord-005453-4057qib7	16030	1	1.0	1.0	CD
cord-005453-4057qib7	16030	2	-1.2	-1.2	CD
cord-005453-4057qib7	16030	3	and	and	CC
cord-005453-4057qib7	16030	4	>	>	XX
cord-005453-4057qib7	16030	5	1.2	1.2	CD
cord-005453-4057qib7	16030	6	respectively	respectively	RB
cord-005453-4057qib7	16030	7	.	.	.
cord-005453-4057qib7	16031	1	The	the	DT
cord-005453-4057qib7	16031	2	cut	cut	NN
cord-005453-4057qib7	16031	3	-	-	HYPH
cord-005453-4057qib7	16031	4	off	off	NN
cord-005453-4057qib7	16031	5	for	for	IN
cord-005453-4057qib7	16031	6	the	the	DT
cord-005453-4057qib7	16031	7	validation	validation	NN
cord-005453-4057qib7	16031	8	cohort	cohort	NN
cord-005453-4057qib7	16031	9	was	be	VBD
cord-005453-4057qib7	16031	10	therefore	therefore	RB
cord-005453-4057qib7	16031	11	set	set	VBN
cord-005453-4057qib7	16031	12	at	at	IN
cord-005453-4057qib7	16031	13	a	a	DT
cord-005453-4057qib7	16031	14	weight	weight	NN
cord-005453-4057qib7	16031	15	ratio	ratio	NN
cord-005453-4057qib7	16031	16	of	of	IN
cord-005453-4057qib7	16031	17	1.2.In	1.2.in	CD
cord-005453-4057qib7	16031	18	der	der	NN
cord-005453-4057qib7	16031	19	validation	validation	NN
cord-005453-4057qib7	16031	20	cohort	cohort	NN
cord-005453-4057qib7	16031	21	including	include	VBG
cord-005453-4057qib7	16031	22	119	119	CD
cord-005453-4057qib7	16031	23	donors	donor	NNS
cord-005453-4057qib7	16031	24	,	,	,
cord-005453-4057qib7	16031	25	75	75	CD
cord-005453-4057qib7	16031	26	(	(	-LRB-
cord-005453-4057qib7	16031	27	48	48	CD
cord-005453-4057qib7	16031	28	%	%	NN
cord-005453-4057qib7	16031	29	)	)	-RRB-
cord-005453-4057qib7	16031	30	had	have	VBD
cord-005453-4057qib7	16031	31	a	a	DT
cord-005453-4057qib7	16031	32	weight	weight	NN
cord-005453-4057qib7	16031	33	ratio	ratio	NN
cord-005453-4057qib7	16031	34	>	>	XX
cord-005453-4057qib7	16031	35	1.2	1.2	CD
cord-005453-4057qib7	16031	36	while	while	IN
cord-005453-4057qib7	16031	37	62	62	CD
cord-005453-4057qib7	16031	38	(	(	-LRB-
cord-005453-4057qib7	16031	39	52	52	CD
cord-005453-4057qib7	16031	40	%	%	NN
cord-005453-4057qib7	16031	41	)	)	-RRB-
cord-005453-4057qib7	16031	42	had	have	VBD
cord-005453-4057qib7	16031	43	a	a	DT
cord-005453-4057qib7	16031	44	weight	weight	NN
cord-005453-4057qib7	16031	45	ratio	ratio	NN
cord-005453-4057qib7	16031	46	≤	≤	NN
cord-005453-4057qib7	16031	47	1.2	1.2	CD
cord-005453-4057qib7	16031	48	.	.	.
cord-005453-4057qib7	16032	1	Overall	overall	RB
cord-005453-4057qib7	16032	2	in	in	IN
cord-005453-4057qib7	16032	3	this	this	DT
cord-005453-4057qib7	16032	4	cohort	cohort	NN
cord-005453-4057qib7	16032	5	target	target	NN
cord-005453-4057qib7	16032	6	cell	cell	NN
cord-005453-4057qib7	16032	7	count	count	NN
cord-005453-4057qib7	16032	8	of	of	IN
cord-005453-4057qib7	16032	9	5	5	CD
cord-005453-4057qib7	16032	10	x	x	SYM
cord-005453-4057qib7	16032	11	10	10	CD
cord-005453-4057qib7	16032	12	6	6	CD
cord-005453-4057qib7	16032	13	CD34	CD34	NNP
cord-005453-4057qib7	16032	14	+	+	CC
cord-005453-4057qib7	16032	15	/kg	/kg	CD
cord-005453-4057qib7	16032	16	recipient	recipient	NN
cord-005453-4057qib7	16032	17	weight	weight	NN
cord-005453-4057qib7	16032	18	was	be	VBD
cord-005453-4057qib7	16032	19	reached	reach	VBN
cord-005453-4057qib7	16032	20	in	in	IN
cord-005453-4057qib7	16032	21	92	92	CD
cord-005453-4057qib7	16032	22	(	(	-LRB-
cord-005453-4057qib7	16032	23	77	77	CD
cord-005453-4057qib7	16032	24	%	%	NN
cord-005453-4057qib7	16032	25	)	)	-RRB-
cord-005453-4057qib7	16032	26	cases	case	NNS
cord-005453-4057qib7	16032	27	.	.	.
cord-005453-4057qib7	16033	1	This	this	DT
cord-005453-4057qib7	16033	2	target	target	NN
cord-005453-4057qib7	16033	3	was	be	VBD
cord-005453-4057qib7	16033	4	reached	reach	VBN
cord-005453-4057qib7	16033	5	in	in	IN
cord-005453-4057qib7	16033	6	43	43	CD
cord-005453-4057qib7	16033	7	of	of	IN
cord-005453-4057qib7	16033	8	62	62	CD
cord-005453-4057qib7	16033	9	(	(	-LRB-
cord-005453-4057qib7	16033	10	69	69	CD
cord-005453-4057qib7	16033	11	%	%	NN
cord-005453-4057qib7	16033	12	)	)	-RRB-
cord-005453-4057qib7	16033	13	of	of	IN
cord-005453-4057qib7	16033	14	donors	donor	NNS
cord-005453-4057qib7	16033	15	with	with	IN
cord-005453-4057qib7	16033	16	weight	weight	NN
cord-005453-4057qib7	16033	17	ratio	ratio	NN
cord-005453-4057qib7	16033	18	≤	≤	NNP
cord-005453-4057qib7	16033	19	1.2	1.2	CD
cord-005453-4057qib7	16033	20	and	and	CC
cord-005453-4057qib7	16033	21	in	in	IN
cord-005453-4057qib7	16033	22	49	49	CD
cord-005453-4057qib7	16033	23	of	of	IN
cord-005453-4057qib7	16033	24	57	57	CD
cord-005453-4057qib7	16033	25	(	(	-LRB-
cord-005453-4057qib7	16033	26	86	86	CD
cord-005453-4057qib7	16033	27	%	%	NN
cord-005453-4057qib7	16033	28	)	)	-RRB-
cord-005453-4057qib7	16033	29	donors	donor	NNS
cord-005453-4057qib7	16033	30	with	with	IN
cord-005453-4057qib7	16033	31	weight	weight	NN
cord-005453-4057qib7	16033	32	ratio	ratio	NN
cord-005453-4057qib7	16033	33	>	>	NNP
cord-005453-4057qib7	16033	34	1.2	1.2	CD
cord-005453-4057qib7	16033	35	,	,	,
cord-005453-4057qib7	16033	36	p	p	NN
cord-005453-4057qib7	16033	37	=	=	SYM
cord-005453-4057qib7	16033	38	0.03.Conclusions	0.03.conclusion	NNS
cord-005453-4057qib7	16033	39	:	:	:
cord-005453-4057qib7	16034	1	A	a	DT
cord-005453-4057qib7	16034	2	donor	donor	NN
cord-005453-4057qib7	16034	3	-	-	HYPH
cord-005453-4057qib7	16034	4	recipient	recipient	NN
cord-005453-4057qib7	16034	5	weight	weight	NN
cord-005453-4057qib7	16034	6	ratio	ratio	NN
cord-005453-4057qib7	16034	7	of	of	IN
cord-005453-4057qib7	16034	8	>	>	$
cord-005453-4057qib7	16034	9	1.2	1.2	CD
cord-005453-4057qib7	16034	10	is	be	VBZ
cord-005453-4057qib7	16034	11	seen	see	VBN
cord-005453-4057qib7	16034	12	in	in	IN
cord-005453-4057qib7	16034	13	about	about	RB
cord-005453-4057qib7	16034	14	40	40	CD
cord-005453-4057qib7	16034	15	%	%	NN
cord-005453-4057qib7	16034	16	of	of	IN
cord-005453-4057qib7	16034	17	peripheral	peripheral	JJ
cord-005453-4057qib7	16034	18	blood	blood	NN
cord-005453-4057qib7	16034	19	stem	stem	NN
cord-005453-4057qib7	16034	20	cell	cell	NN
cord-005453-4057qib7	16034	21	donations	donation	NNS
cord-005453-4057qib7	16034	22	for	for	IN
cord-005453-4057qib7	16034	23	allogeneic	allogeneic	NN
cord-005453-4057qib7	16034	24	stem	stem	NN
cord-005453-4057qib7	16034	25	cell	cell	NN
cord-005453-4057qib7	16034	26	transplantation	transplantation	NN
cord-005453-4057qib7	16034	27	.	.	.
cord-005453-4057qib7	16035	1	In	in	IN
cord-005453-4057qib7	16035	2	these	these	DT
cord-005453-4057qib7	16035	3	cases	case	NNS
cord-005453-4057qib7	16035	4	apheresis	apheresis	NN
cord-005453-4057qib7	16035	5	on	on	IN
cord-005453-4057qib7	16035	6	day	day	NN
cord-005453-4057qib7	16035	7	4	4	CD
cord-005453-4057qib7	16035	8	after	after	IN
cord-005453-4057qib7	16035	9	7	7	CD
cord-005453-4057qib7	16035	10	doses	dose	NNS
cord-005453-4057qib7	16035	11	of	of	IN
cord-005453-4057qib7	16035	12	GCSF	GCSF	NNP
cord-005453-4057qib7	16035	13	is	be	VBZ
cord-005453-4057qib7	16035	14	reasonable	reasonable	JJ
cord-005453-4057qib7	16035	15	.	.	.
cord-005453-4057qib7	16036	1	Donors	donor	NNS
cord-005453-4057qib7	16036	2	with	with	IN
cord-005453-4057qib7	16036	3	lower	low	JJR
cord-005453-4057qib7	16036	4	weight	weight	NN
cord-005453-4057qib7	16036	5	ratios	ratio	NNS
cord-005453-4057qib7	16036	6	should	should	MD
cord-005453-4057qib7	16036	7	preferentially	preferentially	RB
cord-005453-4057qib7	16036	8	donate	donate	VB
cord-005453-4057qib7	16036	9	on	on	IN
cord-005453-4057qib7	16036	10	day	day	NN
cord-005453-4057qib7	16036	11	5	5	CD
cord-005453-4057qib7	16036	12	after	after	IN
cord-005453-4057qib7	16036	13	8	8	CD
cord-005453-4057qib7	16036	14	to	to	TO
cord-005453-4057qib7	16036	15	9	9	CD
cord-005453-4057qib7	16036	16	doses	dose	NNS
cord-005453-4057qib7	16036	17	of	of	IN
cord-005453-4057qib7	16036	18	GCSF.Disclosure	GCSF.Disclosure	:
cord-005453-4057qib7	16036	19	:	:	:
cord-005453-4057qib7	16037	1	All	all	DT
cord-005453-4057qib7	16037	2	authors	author	NNS
cord-005453-4057qib7	16037	3	declare	declare	VBP
cord-005453-4057qib7	16037	4	no	no	DT
cord-005453-4057qib7	16037	5	conflicts	conflict	NNS
cord-005453-4057qib7	16037	6	of	of	IN
cord-005453-4057qib7	16037	7	interest	interest	NN
cord-005453-4057qib7	16037	8	Background	background	NN
cord-005453-4057qib7	16037	9	:	:	:
cord-005453-4057qib7	16037	10	The	the	DT
cord-005453-4057qib7	16037	11	effect	effect	NN
cord-005453-4057qib7	16037	12	of	of	IN
cord-005453-4057qib7	16037	13	a	a	DT
cord-005453-4057qib7	16037	14	second	second	JJ
cord-005453-4057qib7	16037	15	mobilization	mobilization	NN
cord-005453-4057qib7	16037	16	and	and	CC
cord-005453-4057qib7	16037	17	collection	collection	NN
cord-005453-4057qib7	16037	18	of	of	IN
cord-005453-4057qib7	16037	19	peripheral	peripheral	JJ
cord-005453-4057qib7	16037	20	blood	blood	NN
cord-005453-4057qib7	16037	21	stem	stem	NN
cord-005453-4057qib7	16037	22	cells	cell	NNS
cord-005453-4057qib7	16037	23	(	(	-LRB-
cord-005453-4057qib7	16037	24	PBSC	PBSC	NNP
cord-005453-4057qib7	16037	25	)	)	-RRB-
cord-005453-4057qib7	16037	26	on	on	IN
cord-005453-4057qib7	16037	27	the	the	DT
cord-005453-4057qib7	16037	28	cell	cell	NN
cord-005453-4057qib7	16037	29	yield	yield	NN
cord-005453-4057qib7	16037	30	is	be	VBZ
cord-005453-4057qib7	16037	31	low	low	JJ
cord-005453-4057qib7	16037	32	,	,	,
cord-005453-4057qib7	16037	33	as	as	IN
cord-005453-4057qib7	16037	34	we	-PRON-	PRP
cord-005453-4057qib7	16037	35	previously	previously	RB
cord-005453-4057qib7	16037	36	demonstrated	demonstrate	VBD
cord-005453-4057qib7	16037	37	.	.	.
cord-005453-4057qib7	16038	1	However	however	RB
cord-005453-4057qib7	16038	2	,	,	,
cord-005453-4057qib7	16038	3	donor	donor	NN
cord-005453-4057qib7	16038	4	safety	safety	NN
cord-005453-4057qib7	16038	5	has	have	VBZ
cord-005453-4057qib7	16038	6	been	be	VBN
cord-005453-4057qib7	16038	7	poorly	poorly	RB
cord-005453-4057qib7	16038	8	addressed	address	VBN
cord-005453-4057qib7	16038	9	with	with	IN
cord-005453-4057qib7	16038	10	no	no	DT
cord-005453-4057qib7	16038	11	changes	change	NNS
cord-005453-4057qib7	16038	12	in	in	IN
cord-005453-4057qib7	16038	13	the	the	DT
cord-005453-4057qib7	16038	14	clinical	clinical	JJ
cord-005453-4057qib7	16038	15	practices	practice	NNS
cord-005453-4057qib7	16038	16	.	.	.
cord-005453-4057qib7	16039	1	Methods	method	NNS
cord-005453-4057qib7	16039	2	:	:	:
cord-005453-4057qib7	16039	3	Second	second	JJ
cord-005453-4057qib7	16039	4	donations	donation	NNS
cord-005453-4057qib7	16039	5	of	of	IN
cord-005453-4057qib7	16039	6	unrelated	unrelated	JJ
cord-005453-4057qib7	16039	7	and	and	CC
cord-005453-4057qib7	16039	8	related	related	JJ
cord-005453-4057qib7	16039	9	donors	donor	NNS
cord-005453-4057qib7	16039	10	performed	perform	VBN
cord-005453-4057qib7	16039	11	between	between	IN
cord-005453-4057qib7	16039	12	2001	2001	CD
cord-005453-4057qib7	16039	13	and	and	CC
cord-005453-4057qib7	16039	14	2017	2017	CD
cord-005453-4057qib7	16039	15	were	be	VBD
cord-005453-4057qib7	16039	16	evaluated	evaluate	VBN
cord-005453-4057qib7	16039	17	(	(	-LRB-
cord-005453-4057qib7	16039	18	n=24	n=24	NNP
cord-005453-4057qib7	16039	19	)	)	-RRB-
cord-005453-4057qib7	16039	20	,	,	,
cord-005453-4057qib7	16039	21	including	include	VBG
cord-005453-4057qib7	16039	22	PBSC+PBSC	PBSC+PBSC	NNP
cord-005453-4057qib7	16039	23	(	(	-LRB-
cord-005453-4057qib7	16039	24	n=18	n=18	RB
cord-005453-4057qib7	16039	25	)	)	-RRB-
cord-005453-4057qib7	16039	26	,	,	,
cord-005453-4057qib7	16039	27	bone	bone	NN
cord-005453-4057qib7	16039	28	marrow	marrow	NN
cord-005453-4057qib7	16039	29	(	(	-LRB-
cord-005453-4057qib7	16039	30	BM)+PBSC	BM)+PBSC	NNP
cord-005453-4057qib7	16039	31	(	(	-LRB-
cord-005453-4057qib7	16039	32	n=5	n=5	NNP
cord-005453-4057qib7	16039	33	)	)	-RRB-
cord-005453-4057qib7	16039	34	and	and	CC
cord-005453-4057qib7	16039	35	PBSC+BM	PBSC+BM	NNP
cord-005453-4057qib7	16039	36	(	(	-LRB-
cord-005453-4057qib7	16039	37	n=1	n=1	NN
cord-005453-4057qib7	16039	38	)	)	-RRB-
cord-005453-4057qib7	16039	39	.	.	.
cord-005453-4057qib7	16040	1	Analytical	analytical	JJ
cord-005453-4057qib7	16040	2	parameters	parameter	NNS
cord-005453-4057qib7	16040	3	including	include	VBG
cord-005453-4057qib7	16040	4	leukocyte	leukocyte	NN
cord-005453-4057qib7	16040	5	,	,	,
cord-005453-4057qib7	16040	6	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	16040	7	,	,	,
cord-005453-4057qib7	16040	8	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	16040	9	and	and	CC
cord-005453-4057qib7	16040	10	LDH	LDH	NNP
cord-005453-4057qib7	16040	11	quantification	quantification	NN
cord-005453-4057qib7	16040	12	,	,	,
cord-005453-4057qib7	16040	13	obtained	obtain	VBN
cord-005453-4057qib7	16040	14	on	on	IN
cord-005453-4057qib7	16040	15	the	the	DT
cord-005453-4057qib7	16040	16	pre	pre	JJ
cord-005453-4057qib7	16040	17	-	-	JJ
cord-005453-4057qib7	16040	18	harvest	harvest	JJ
cord-005453-4057qib7	16040	19	evaluation	evaluation	NN
cord-005453-4057qib7	16040	20	of	of	IN
cord-005453-4057qib7	16040	21	first	first	JJ
cord-005453-4057qib7	16040	22	and	and	CC
cord-005453-4057qib7	16040	23	second	second	JJ
cord-005453-4057qib7	16040	24	donation	donation	NN
cord-005453-4057qib7	16040	25	,	,	,
cord-005453-4057qib7	16040	26	were	be	VBD
cord-005453-4057qib7	16040	27	retrospectively	retrospectively	RB
cord-005453-4057qib7	16040	28	analyzed	analyze	VBN
cord-005453-4057qib7	16040	29	and	and	CC
cord-005453-4057qib7	16040	30	compared	compare	VBN
cord-005453-4057qib7	16040	31	for	for	IN
cord-005453-4057qib7	16040	32	all	all	DT
cord-005453-4057qib7	16040	33	donors	donor	NNS
cord-005453-4057qib7	16040	34	.	.	.
cord-005453-4057qib7	16041	1	The	the	DT
cord-005453-4057qib7	16041	2	Portuguese	portuguese	JJ
cord-005453-4057qib7	16041	3	Bone	Bone	NNP
cord-005453-4057qib7	16041	4	Marrow	Marrow	NNP
cord-005453-4057qib7	16041	5	Donors	donor	NNS
cord-005453-4057qib7	16041	6	Registry	Registry	NNP
cord-005453-4057qib7	16041	7	(	(	-LRB-
cord-005453-4057qib7	16041	8	CEDACE	CEDACE	NNP
cord-005453-4057qib7	16041	9	)	)	-RRB-
cord-005453-4057qib7	16041	10	recommends	recommend	VBZ
cord-005453-4057qib7	16041	11	a	a	DT
cord-005453-4057qib7	16041	12	time	time	NN
cord-005453-4057qib7	16041	13	between	between	IN
cord-005453-4057qib7	16041	14	donations	donation	NNS
cord-005453-4057qib7	16041	15	no	no	DT
cord-005453-4057qib7	16041	16	lesser	less	JJR
cord-005453-4057qib7	16041	17	than	than	IN
cord-005453-4057qib7	16041	18	6	6	CD
cord-005453-4057qib7	16041	19	months	month	NNS
cord-005453-4057qib7	16041	20	.	.	.
cord-005453-4057qib7	16042	1	It	-PRON-	PRP
cord-005453-4057qib7	16042	2	also	also	RB
cord-005453-4057qib7	16042	3	states	state	VBZ
cord-005453-4057qib7	16042	4	that	that	IN
cord-005453-4057qib7	16042	5	in	in	IN
cord-005453-4057qib7	16042	6	very	very	RB
cord-005453-4057qib7	16042	7	urgent	urgent	JJ
cord-005453-4057qib7	16042	8	situations	situation	NNS
cord-005453-4057qib7	16042	9	like	like	IN
cord-005453-4057qib7	16042	10	graft	graft	NN
cord-005453-4057qib7	16042	11	failure	failure	NN
cord-005453-4057qib7	16042	12	,	,	,
cord-005453-4057qib7	16042	13	donor	donor	NN
cord-005453-4057qib7	16042	14	should	should	MD
cord-005453-4057qib7	16042	15	be	be	VB
cord-005453-4057qib7	16042	16	clinical	clinical	JJ
cord-005453-4057qib7	16042	17	and	and	CC
cord-005453-4057qib7	16042	18	analytical	analytical	JJ
cord-005453-4057qib7	16042	19	cleared	clear	VBN
cord-005453-4057qib7	16042	20	and	and	CC
cord-005453-4057qib7	16042	21	its	-PRON-	PRP$
cord-005453-4057qib7	16042	22	safety	safety	NN
cord-005453-4057qib7	16042	23	ensured	ensure	VBD
cord-005453-4057qib7	16042	24	.	.	.
cord-005453-4057qib7	16043	1	In	in	IN
cord-005453-4057qib7	16043	2	order	order	NN
cord-005453-4057qib7	16043	3	to	to	TO
cord-005453-4057qib7	16043	4	evaluate	evaluate	VB
cord-005453-4057qib7	16043	5	the	the	DT
cord-005453-4057qib7	16043	6	impact	impact	NN
cord-005453-4057qib7	16043	7	of	of	IN
cord-005453-4057qib7	16043	8	time	time	NN
cord-005453-4057qib7	16043	9	between	between	IN
cord-005453-4057qib7	16043	10	donations	donation	NNS
cord-005453-4057qib7	16043	11	,	,	,
cord-005453-4057qib7	16043	12	donor	donor	NN
cord-005453-4057qib7	16043	13	population	population	NN
cord-005453-4057qib7	16043	14	was	be	VBD
cord-005453-4057qib7	16043	15	divided	divide	VBN
cord-005453-4057qib7	16043	16	in	in	IN
cord-005453-4057qib7	16043	17	3	3	CD
cord-005453-4057qib7	16043	18	groups	group	NNS
cord-005453-4057qib7	16043	19	:	:	:
cord-005453-4057qib7	16043	20	<	<	XX
cord-005453-4057qib7	16043	21	2	2	CD
cord-005453-4057qib7	16043	22	months	month	NNS
cord-005453-4057qib7	16043	23	,	,	,
cord-005453-4057qib7	16043	24	2	2	CD
cord-005453-4057qib7	16043	25	-	-	SYM
cord-005453-4057qib7	16043	26	6	6	CD
cord-005453-4057qib7	16043	27	months	month	NNS
cord-005453-4057qib7	16043	28	,	,	,
cord-005453-4057qib7	16043	29	>	>	XX
cord-005453-4057qib7	16043	30	6	6	CD
cord-005453-4057qib7	16043	31	months	month	NNS
cord-005453-4057qib7	16043	32	;	;	:
cord-005453-4057qib7	16043	33	to	to	TO
cord-005453-4057qib7	16043	34	determine	determine	VB
cord-005453-4057qib7	16043	35	the	the	DT
cord-005453-4057qib7	16043	36	influence	influence	NN
cord-005453-4057qib7	16043	37	of	of	IN
cord-005453-4057qib7	16043	38	donor	donor	NN
cord-005453-4057qib7	16043	39	age	age	NN
cord-005453-4057qib7	16043	40	,	,	,
cord-005453-4057qib7	16043	41	donors	donor	NNS
cord-005453-4057qib7	16043	42	were	be	VBD
cord-005453-4057qib7	16043	43	divided	divide	VBN
cord-005453-4057qib7	16043	44	in	in	IN
cord-005453-4057qib7	16043	45	2	2	CD
cord-005453-4057qib7	16043	46	groups	group	NNS
cord-005453-4057qib7	16043	47	:	:	:
cord-005453-4057qib7	16043	48	<	<	XX
cord-005453-4057qib7	16043	49	40	40	CD
cord-005453-4057qib7	16043	50	and	and	CC
cord-005453-4057qib7	16043	51	≥40	≥40	NNP
cord-005453-4057qib7	16043	52	years	year	NNS
cord-005453-4057qib7	16043	53	.	.	.
cord-005453-4057qib7	16044	1	Results	result	NNS
cord-005453-4057qib7	16044	2	:	:	:
cord-005453-4057qib7	16045	1	Among	among	IN
cord-005453-4057qib7	16045	2	the	the	DT
cord-005453-4057qib7	16045	3	total	total	NN
cord-005453-4057qib7	16045	4	of	of	IN
cord-005453-4057qib7	16045	5	24	24	CD
cord-005453-4057qib7	16045	6	donors	donor	NNS
cord-005453-4057qib7	16045	7	,	,	,
cord-005453-4057qib7	16045	8	13	13	CD
cord-005453-4057qib7	16045	9	were	be	VBD
cord-005453-4057qib7	16045	10	volunteer	volunteer	NN
cord-005453-4057qib7	16045	11	donors	donor	NNS
cord-005453-4057qib7	16045	12	of	of	IN
cord-005453-4057qib7	16045	13	CEDACE	CEDACE	NNP
cord-005453-4057qib7	16045	14	and	and	CC
cord-005453-4057qib7	16045	15	11	11	CD
cord-005453-4057qib7	16045	16	were	be	VBD
cord-005453-4057qib7	16045	17	familiar	familiar	JJ
cord-005453-4057qib7	16045	18	.	.	.
cord-005453-4057qib7	16046	1	Fifteen	fifteen	CD
cord-005453-4057qib7	16046	2	second	second	JJ
cord-005453-4057qib7	16046	3	donations	donation	NNS
cord-005453-4057qib7	16046	4	were	be	VBD
cord-005453-4057qib7	16046	5	performed	perform	VBN
cord-005453-4057qib7	16046	6	because	because	IN
cord-005453-4057qib7	16046	7	of	of	IN
cord-005453-4057qib7	16046	8	recipient	recipient	NN
cord-005453-4057qib7	16046	9	graft	graft	NN
cord-005453-4057qib7	16046	10	failure	failure	NN
cord-005453-4057qib7	16046	11	and	and	CC
cord-005453-4057qib7	16046	12	9	9	CD
cord-005453-4057qib7	16046	13	due	due	IN
cord-005453-4057qib7	16046	14	to	to	IN
cord-005453-4057qib7	16046	15	disease	disease	NN
cord-005453-4057qib7	16046	16	progression	progression	NN
cord-005453-4057qib7	16046	17	or	or	CC
cord-005453-4057qib7	16046	18	relapse	relapse	NN
cord-005453-4057qib7	16046	19	.	.	.
cord-005453-4057qib7	16047	1	At	at	IN
cord-005453-4057qib7	16047	2	the	the	DT
cord-005453-4057qib7	16047	3	time	time	NN
cord-005453-4057qib7	16047	4	of	of	IN
cord-005453-4057qib7	16047	5	second	second	JJ
cord-005453-4057qib7	16047	6	collection	collection	NN
cord-005453-4057qib7	16047	7	,	,	,
cord-005453-4057qib7	16047	8	median	median	JJ
cord-005453-4057qib7	16047	9	donor	donor	NN
cord-005453-4057qib7	16047	10	age	age	NN
cord-005453-4057qib7	16047	11	was	be	VBD
cord-005453-4057qib7	16047	12	37	37	CD
cord-005453-4057qib7	16047	13	years	year	NNS
cord-005453-4057qib7	16048	1	(	(	-LRB-
cord-005453-4057qib7	16048	2	range	range	NNP
cord-005453-4057qib7	16048	3	23	23	CD
cord-005453-4057qib7	16048	4	-	-	SYM
cord-005453-4057qib7	16048	5	57	57	CD
cord-005453-4057qib7	16048	6	)	)	-RRB-
cord-005453-4057qib7	16048	7	.	.	.
cord-005453-4057qib7	16049	1	The	the	DT
cord-005453-4057qib7	16049	2	median	median	JJ
cord-005453-4057qib7	16049	3	delay	delay	NN
cord-005453-4057qib7	16049	4	between	between	IN
cord-005453-4057qib7	16049	5	both	both	DT
cord-005453-4057qib7	16049	6	collections	collection	NNS
cord-005453-4057qib7	16049	7	was	be	VBD
cord-005453-4057qib7	16049	8	262	262	CD
cord-005453-4057qib7	16049	9	days	day	NNS
cord-005453-4057qib7	16049	10	(	(	-LRB-
cord-005453-4057qib7	16049	11	37	37	CD
cord-005453-4057qib7	16049	12	-	-	SYM
cord-005453-4057qib7	16049	13	1519	1519	CD
cord-005453-4057qib7	16049	14	)	)	-RRB-
cord-005453-4057qib7	16049	15	.	.	.
cord-005453-4057qib7	16050	1	Time	time	NN
cord-005453-4057qib7	16050	2	between	between	IN
cord-005453-4057qib7	16050	3	donations	donation	NNS
cord-005453-4057qib7	16050	4	did	do	VBD
cord-005453-4057qib7	16050	5	not	not	RB
cord-005453-4057qib7	16050	6	seem	seem	VB
cord-005453-4057qib7	16050	7	to	to	TO
cord-005453-4057qib7	16050	8	substantially	substantially	RB
cord-005453-4057qib7	16050	9	impact	impact	VB
cord-005453-4057qib7	16050	10	the	the	DT
cord-005453-4057qib7	16050	11	analytical	analytical	JJ
cord-005453-4057qib7	16050	12	donor	donor	NN
cord-005453-4057qib7	16050	13	evaluation	evaluation	NN
cord-005453-4057qib7	16050	14	:	:	:
cord-005453-4057qib7	16050	15	leukocytes	leukocyte	NNS
cord-005453-4057qib7	16050	16	,	,	,
cord-005453-4057qib7	16050	17	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	16050	18	,	,	,
cord-005453-4057qib7	16050	19	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	16050	20	and	and	CC
cord-005453-4057qib7	16050	21	LDH	LDH	NNP
cord-005453-4057qib7	16050	22	results	result	NNS
cord-005453-4057qib7	16050	23	are	be	VBP
cord-005453-4057qib7	16050	24	kept	keep	VBN
cord-005453-4057qib7	16050	25	within	within	IN
cord-005453-4057qib7	16050	26	the	the	DT
cord-005453-4057qib7	16050	27	reference	reference	NN
cord-005453-4057qib7	16050	28	values	value	NNS
cord-005453-4057qib7	16050	29	.	.	.
cord-005453-4057qib7	16051	1	However	however	RB
cord-005453-4057qib7	16051	2	,	,	,
cord-005453-4057qib7	16051	3	donors	donor	NNS
cord-005453-4057qib7	16051	4	with	with	IN
cord-005453-4057qib7	16051	5	less	less	JJR
cord-005453-4057qib7	16051	6	than	than	IN
cord-005453-4057qib7	16051	7	2	2	CD
cord-005453-4057qib7	16051	8	months	month	NNS
cord-005453-4057qib7	16051	9	between	between	IN
cord-005453-4057qib7	16051	10	donations	donation	NNS
cord-005453-4057qib7	16051	11	showed	show	VBD
cord-005453-4057qib7	16051	12	a	a	DT
cord-005453-4057qib7	16051	13	slight	slight	JJ
cord-005453-4057qib7	16051	14	decrease	decrease	NN
cord-005453-4057qib7	16051	15	on	on	IN
cord-005453-4057qib7	16051	16	leukocyte	leukocyte	NN
cord-005453-4057qib7	16051	17	counts	count	NNS
cord-005453-4057qib7	16051	18	(	(	-LRB-
cord-005453-4057qib7	16051	19	35	35	CD
cord-005453-4057qib7	16051	20	%	%	NN
cord-005453-4057qib7	16051	21	)	)	-RRB-
cord-005453-4057qib7	16051	22	and	and	CC
cord-005453-4057qib7	16051	23	hemoglobin	hemoglobin	NN
cord-005453-4057qib7	16051	24	values	value	NNS
cord-005453-4057qib7	16051	25	(	(	-LRB-
cord-005453-4057qib7	16051	26	12	12	CD
cord-005453-4057qib7	16051	27	%	%	NN
cord-005453-4057qib7	16051	28	)	)	-RRB-
cord-005453-4057qib7	16051	29	,	,	,
cord-005453-4057qib7	16051	30	from	from	IN
cord-005453-4057qib7	16051	31	the	the	DT
cord-005453-4057qib7	16051	32	first	first	JJ
cord-005453-4057qib7	16051	33	to	to	IN
cord-005453-4057qib7	16051	34	the	the	DT
cord-005453-4057qib7	16051	35	second	second	JJ
cord-005453-4057qib7	16051	36	pre	pre	JJ
cord-005453-4057qib7	16051	37	-	-	JJ
cord-005453-4057qib7	16051	38	harvest	harvest	JJ
cord-005453-4057qib7	16051	39	evaluation	evaluation	NN
cord-005453-4057qib7	16051	40	.	.	.
cord-005453-4057qib7	16052	1	Donor	donor	NN
cord-005453-4057qib7	16052	2	age	age	NN
cord-005453-4057qib7	16052	3	showed	show	VBD
cord-005453-4057qib7	16052	4	no	no	DT
cord-005453-4057qib7	16052	5	significant	significant	JJ
cord-005453-4057qib7	16052	6	influence	influence	NN
cord-005453-4057qib7	16052	7	on	on	IN
cord-005453-4057qib7	16052	8	the	the	DT
cord-005453-4057qib7	16052	9	analytical	analytical	JJ
cord-005453-4057qib7	16052	10	evaluation	evaluation	NN
cord-005453-4057qib7	16052	11	.	.	.
cord-005453-4057qib7	16053	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	16053	2	,	,	,
cord-005453-4057qib7	16053	3	when	when	WRB
cord-005453-4057qib7	16053	4	considering	consider	VBG
cord-005453-4057qib7	16053	5	only	only	RB
cord-005453-4057qib7	16053	6	the	the	DT
cord-005453-4057qib7	16053	7	PBSC+PBSC	PBSC+PBSC	NNP
cord-005453-4057qib7	16053	8	donations	donation	NNS
cord-005453-4057qib7	16053	9	,	,	,
cord-005453-4057qib7	16053	10	donors	donor	NNS
cord-005453-4057qib7	16053	11	with	with	IN
cord-005453-4057qib7	16053	12	≥40	≥40	NNP
cord-005453-4057qib7	16053	13	years	year	NNS
cord-005453-4057qib7	16053	14	showed	show	VBD
cord-005453-4057qib7	16053	15	a	a	DT
cord-005453-4057qib7	16053	16	small	small	JJ
cord-005453-4057qib7	16053	17	decrease	decrease	NN
cord-005453-4057qib7	16053	18	on	on	IN
cord-005453-4057qib7	16053	19	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	16053	20	counts	count	NNS
cord-005453-4057qib7	16053	21	(	(	-LRB-
cord-005453-4057qib7	16053	22	19	19	CD
cord-005453-4057qib7	16053	23	%	%	NN
cord-005453-4057qib7	16053	24	)	)	-RRB-
cord-005453-4057qib7	16054	1	.Conclusions	.conclusion	NNS
cord-005453-4057qib7	16054	2	:	:	:
cord-005453-4057qib7	16055	1	This	this	DT
cord-005453-4057qib7	16055	2	study	study	NN
cord-005453-4057qib7	16055	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	16055	4	that	that	IN
cord-005453-4057qib7	16055	5	the	the	DT
cord-005453-4057qib7	16055	6	analytical	analytical	JJ
cord-005453-4057qib7	16055	7	parameters	parameter	NNS
cord-005453-4057qib7	16055	8	,	,	,
cord-005453-4057qib7	16055	9	chosen	choose	VBN
cord-005453-4057qib7	16055	10	based	base	VBN
cord-005453-4057qib7	16055	11	on	on	IN
cord-005453-4057qib7	16055	12	literature	literature	NN
cord-005453-4057qib7	16055	13	,	,	,
cord-005453-4057qib7	16055	14	had	have	VBD
cord-005453-4057qib7	16055	15	no	no	DT
cord-005453-4057qib7	16055	16	significant	significant	JJ
cord-005453-4057qib7	16055	17	changes	change	NNS
cord-005453-4057qib7	16055	18	between	between	IN
cord-005453-4057qib7	16055	19	first	first	JJ
cord-005453-4057qib7	16055	20	and	and	CC
cord-005453-4057qib7	16055	21	second	second	JJ
cord-005453-4057qib7	16055	22	donation	donation	NN
cord-005453-4057qib7	16055	23	.	.	.
cord-005453-4057qib7	16056	1	However	however	RB
cord-005453-4057qib7	16056	2	,	,	,
cord-005453-4057qib7	16056	3	particular	particular	JJ
cord-005453-4057qib7	16056	4	attention	attention	NN
cord-005453-4057qib7	16056	5	should	should	MD
cord-005453-4057qib7	16056	6	be	be	VB
cord-005453-4057qib7	16056	7	paid	pay	VBN
cord-005453-4057qib7	16056	8	when	when	WRB
cord-005453-4057qib7	16056	9	time	time	NN
cord-005453-4057qib7	16056	10	between	between	IN
cord-005453-4057qib7	16056	11	donations	donation	NNS
cord-005453-4057qib7	16056	12	is	be	VBZ
cord-005453-4057qib7	16056	13	lesser	less	JJR
cord-005453-4057qib7	16056	14	than	than	IN
cord-005453-4057qib7	16056	15	2	2	CD
cord-005453-4057qib7	16056	16	months	month	NNS
cord-005453-4057qib7	16056	17	or	or	CC
cord-005453-4057qib7	16056	18	donor	donor	NN
cord-005453-4057qib7	16056	19	age	age	NN
cord-005453-4057qib7	16056	20	is	be	VBZ
cord-005453-4057qib7	16056	21	≥40	≥40	NNP
cord-005453-4057qib7	16056	22	years	year	NNS
cord-005453-4057qib7	16056	23	.	.	.
cord-005453-4057qib7	16057	1	As	as	IN
cord-005453-4057qib7	16057	2	we	-PRON-	PRP
cord-005453-4057qib7	16057	3	concluded	conclude	VBD
cord-005453-4057qib7	16057	4	that	that	IN
cord-005453-4057qib7	16057	5	no	no	DT
cord-005453-4057qib7	16057	6	significant	significant	JJ
cord-005453-4057qib7	16057	7	changes	change	NNS
cord-005453-4057qib7	16057	8	were	be	VBD
cord-005453-4057qib7	16057	9	observed	observe	VBN
cord-005453-4057qib7	16057	10	in	in	IN
cord-005453-4057qib7	16057	11	the	the	DT
cord-005453-4057qib7	16057	12	group	group	NN
cord-005453-4057qib7	16057	13	of	of	IN
cord-005453-4057qib7	16057	14	2	2	CD
cord-005453-4057qib7	16057	15	-	-	SYM
cord-005453-4057qib7	16057	16	6	6	CD
cord-005453-4057qib7	16057	17	months	month	NNS
cord-005453-4057qib7	16057	18	,	,	,
cord-005453-4057qib7	16057	19	it	-PRON-	PRP
cord-005453-4057qib7	16057	20	is	be	VBZ
cord-005453-4057qib7	16057	21	our	-PRON-	PRP$
cord-005453-4057qib7	16057	22	opinion	opinion	NN
cord-005453-4057qib7	16057	23	that	that	IN
cord-005453-4057qib7	16057	24	the	the	DT
cord-005453-4057qib7	16057	25	minimum	minimum	NN
cord-005453-4057qib7	16057	26	of	of	IN
cord-005453-4057qib7	16057	27	6	6	CD
cord-005453-4057qib7	16057	28	-	-	SYM
cord-005453-4057qib7	16057	29	12	12	CD
cord-005453-4057qib7	16057	30	months	month	NNS
cord-005453-4057qib7	16057	31	established	establish	VBN
cord-005453-4057qib7	16057	32	by	by	IN
cord-005453-4057qib7	16057	33	the	the	DT
cord-005453-4057qib7	16057	34	registries	registry	NNS
cord-005453-4057qib7	16057	35	can	can	MD
cord-005453-4057qib7	16057	36	be	be	VB
cord-005453-4057qib7	16057	37	shortened	shorten	VBN
cord-005453-4057qib7	16057	38	to	to	IN
cord-005453-4057qib7	16057	39	2	2	CD
cord-005453-4057qib7	16057	40	months	month	NNS
cord-005453-4057qib7	16057	41	ensuring	ensure	VBG
cord-005453-4057qib7	16057	42	donor	donor	NN
cord-005453-4057qib7	16057	43	safety	safety	NN
cord-005453-4057qib7	16057	44	.	.	.
cord-005453-4057qib7	16058	1	An	an	DT
cord-005453-4057qib7	16058	2	accurate	accurate	JJ
cord-005453-4057qib7	16058	3	donor	donor	NN
cord-005453-4057qib7	16058	4	risk	risk	NN
cord-005453-4057qib7	16058	5	assessment	assessment	NN
cord-005453-4057qib7	16058	6	with	with	IN
cord-005453-4057qib7	16058	7	a	a	DT
cord-005453-4057qib7	16058	8	larger	large	JJR
cord-005453-4057qib7	16058	9	population	population	NN
cord-005453-4057qib7	16058	10	should	should	MD
cord-005453-4057qib7	16058	11	be	be	VB
cord-005453-4057qib7	16058	12	accomplished	accomplish	VBN
cord-005453-4057qib7	16058	13	in	in	IN
cord-005453-4057qib7	16058	14	order	order	NN
cord-005453-4057qib7	16058	15	to	to	TO
cord-005453-4057qib7	16058	16	strengthen	strengthen	VB
cord-005453-4057qib7	16058	17	this	this	DT
cord-005453-4057qib7	16058	18	recommendation	recommendation	NN
cord-005453-4057qib7	16058	19	.	.	.
cord-005453-4057qib7	16059	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16059	2	:	:	:
cord-005453-4057qib7	16059	3	Nothing	nothing	NN
cord-005453-4057qib7	16059	4	to	to	TO
cord-005453-4057qib7	16059	5	declare	declare	VB
cord-005453-4057qib7	16059	6	.	.	.
cord-005453-4057qib7	16060	1	Gaurav	Gaurav	NNP
cord-005453-4057qib7	16060	2	Kharya	Kharya	NNP
cord-005453-4057qib7	16060	3	1	1	CD
cord-005453-4057qib7	16060	4	,	,	,
cord-005453-4057qib7	16060	5	Atish	Atish	NNP
cord-005453-4057qib7	16060	6	Bakane	Bakane	NNP
cord-005453-4057qib7	16060	7	1	1	CD
cord-005453-4057qib7	16060	8	,	,	,
cord-005453-4057qib7	16060	9	Pratibha	Pratibha	NNP
cord-005453-4057qib7	16060	10	Dhiman	Dhiman	NNP
cord-005453-4057qib7	16060	11	1	1	CD
cord-005453-4057qib7	16060	12	,	,	,
cord-005453-4057qib7	16060	13	Anil	Anil	NNP
cord-005453-4057qib7	16060	14	Khetrapal	Khetrapal	NNP
cord-005453-4057qib7	16060	15	1	1	CD
cord-005453-4057qib7	16060	16	,	,	,
cord-005453-4057qib7	16060	17	Vikrant	Vikrant	NNP
cord-005453-4057qib7	16060	18	Bhar	Bhar	NNP
cord-005453-4057qib7	16061	1	1	1	CD
cord-005453-4057qib7	16061	2	Background	background	NN
cord-005453-4057qib7	16061	3	:	:	:
cord-005453-4057qib7	16061	4	T	t	NN
cord-005453-4057qib7	16061	5	cell	cell	NN
cord-005453-4057qib7	16061	6	replete	replete	JJ
cord-005453-4057qib7	16061	7	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16061	8	stem	stem	NN
cord-005453-4057qib7	16061	9	cell	cell	NN
cord-005453-4057qib7	16061	10	transplant	transplant	NN
cord-005453-4057qib7	16061	11	(	(	-LRB-
cord-005453-4057qib7	16061	12	HHSCT	HHSCT	NNP
cord-005453-4057qib7	16061	13	)	)	-RRB-
cord-005453-4057qib7	16061	14	is	be	VBZ
cord-005453-4057qib7	16061	15	complicated	complicate	VBN
cord-005453-4057qib7	16061	16	mainly	mainly	RB
cord-005453-4057qib7	16061	17	by	by	IN
cord-005453-4057qib7	16061	18	increased	increase	VBN
cord-005453-4057qib7	16061	19	risk	risk	NN
cord-005453-4057qib7	16061	20	of	of	IN
cord-005453-4057qib7	16061	21	graft	graft	NN
cord-005453-4057qib7	16061	22	failure	failure	NN
cord-005453-4057qib7	16061	23	(	(	-LRB-
cord-005453-4057qib7	16061	24	GF	GF	NNP
cord-005453-4057qib7	16061	25	)	)	-RRB-
cord-005453-4057qib7	16061	26	and	and	CC
cord-005453-4057qib7	16061	27	graft	graft	NN
cord-005453-4057qib7	16061	28	versus	versus	IN
cord-005453-4057qib7	16061	29	host	host	NN
cord-005453-4057qib7	16061	30	disease	disease	NN
cord-005453-4057qib7	16061	31	(	(	-LRB-
cord-005453-4057qib7	16061	32	GVHD	GVHD	NNP
cord-005453-4057qib7	16061	33	)	)	-RRB-
cord-005453-4057qib7	16061	34	.	.	.
cord-005453-4057qib7	16062	1	Conventionally	conventionally	RB
cord-005453-4057qib7	16062	2	GCSF	GCSF	NNP
cord-005453-4057qib7	16062	3	has	have	VBZ
cord-005453-4057qib7	16062	4	been	be	VBN
cord-005453-4057qib7	16062	5	used	use	VBN
cord-005453-4057qib7	16062	6	to	to	TO
cord-005453-4057qib7	16062	7	mobilize	mobilize	VB
cord-005453-4057qib7	16062	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16062	9	stem	stem	NN
cord-005453-4057qib7	16062	10	cells	cell	NNS
cord-005453-4057qib7	16062	11	(	(	-LRB-
cord-005453-4057qib7	16062	12	HSC	HSC	NNP
cord-005453-4057qib7	16062	13	)	)	-RRB-
cord-005453-4057qib7	16062	14	.	.	.
cord-005453-4057qib7	16063	1	In	in	IN
cord-005453-4057qib7	16063	2	TCR	TCR	NNP
cord-005453-4057qib7	16063	3	HHSCT	HHSCT	NNP
cord-005453-4057qib7	16063	4	GCSF	GCSF	NNP
cord-005453-4057qib7	16063	5	mobilized	mobilize	VBD
cord-005453-4057qib7	16063	6	graft	graft	NN
cord-005453-4057qib7	16063	7	with	with	IN
cord-005453-4057qib7	16063	8	megadose	megadose	NN
cord-005453-4057qib7	16063	9	of	of	IN
cord-005453-4057qib7	16063	10	CD34	CD34	NNP
cord-005453-4057qib7	16063	11	+	+	CC
cord-005453-4057qib7	16063	12	cells	cell	NNS
cord-005453-4057qib7	16063	13	expose	expose	VBP
cord-005453-4057qib7	16063	14	the	the	DT
cord-005453-4057qib7	16063	15	patient	patient	NN
cord-005453-4057qib7	16063	16	to	to	IN
cord-005453-4057qib7	16063	17	higher	high	JJR
cord-005453-4057qib7	16063	18	doses	dose	NNS
cord-005453-4057qib7	16063	19	of	of	IN
cord-005453-4057qib7	16063	20	alloreactive	alloreactive	JJ
cord-005453-4057qib7	16063	21	T	T	NNP
cord-005453-4057qib7	16063	22	cells	cell	NNS
cord-005453-4057qib7	16063	23	increasing	increase	VBG
cord-005453-4057qib7	16063	24	the	the	DT
cord-005453-4057qib7	16063	25	risk	risk	NN
cord-005453-4057qib7	16063	26	of	of	IN
cord-005453-4057qib7	16063	27	GVHD	GVHD	NNP
cord-005453-4057qib7	16063	28	.	.	.
cord-005453-4057qib7	16064	1	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	16064	2	based	base	VBN
cord-005453-4057qib7	16064	3	mobilization	mobilization	NN
cord-005453-4057qib7	16064	4	gives	give	VBZ
cord-005453-4057qib7	16064	5	an	an	DT
cord-005453-4057qib7	16064	6	advantage	advantage	NN
cord-005453-4057qib7	16064	7	of	of	IN
cord-005453-4057qib7	16064	8	giving	give	VBG
cord-005453-4057qib7	16064	9	high	high	JJ
cord-005453-4057qib7	16064	10	CD34	CD34	NNP
cord-005453-4057qib7	16064	11	cell	cell	NN
cord-005453-4057qib7	16064	12	dose	dose	NN
cord-005453-4057qib7	16064	13	limiting	limit	VBG
cord-005453-4057qib7	16064	14	exposure	exposure	NN
cord-005453-4057qib7	16064	15	to	to	IN
cord-005453-4057qib7	16064	16	high	high	JJ
cord-005453-4057qib7	16064	17	alloreactive	alloreactive	JJ
cord-005453-4057qib7	16064	18	T	T	NNP
cord-005453-4057qib7	16064	19	cell	cell	NN
cord-005453-4057qib7	16064	20	dose	dose	NN
cord-005453-4057qib7	16064	21	.	.	.
cord-005453-4057qib7	16065	1	We	-PRON-	PRP
cord-005453-4057qib7	16065	2	share	share	VBP
cord-005453-4057qib7	16065	3	our	-PRON-	PRP$
cord-005453-4057qib7	16065	4	experience	experience	NN
cord-005453-4057qib7	16065	5	of	of	IN
cord-005453-4057qib7	16065	6	GCSF	GCSF	NNP
cord-005453-4057qib7	16065	7	+	+	CC
cord-005453-4057qib7	16065	8	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	16065	9	based	base	VBN
cord-005453-4057qib7	16065	10	mobilization	mobilization	NN
cord-005453-4057qib7	16065	11	for	for	IN
cord-005453-4057qib7	16065	12	TCR	TCR	NNP
cord-005453-4057qib7	16065	13	HHSCT	HHSCT	NNP
cord-005453-4057qib7	16065	14	.	.	.
cord-005453-4057qib7	16066	1	Methods	method	NNS
cord-005453-4057qib7	16066	2	:	:	:
cord-005453-4057qib7	16066	3	9	9	CD
cord-005453-4057qib7	16066	4	consecutive	consecutive	JJ
cord-005453-4057qib7	16066	5	patients	patient	NNS
cord-005453-4057qib7	16066	6	suffering	suffer	VBG
cord-005453-4057qib7	16066	7	from	from	IN
cord-005453-4057qib7	16066	8	SCD	SCD	NNP
cord-005453-4057qib7	16066	9	who	who	WP
cord-005453-4057qib7	16066	10	underwent	undergo	VBD
cord-005453-4057qib7	16066	11	HHSCT	HHSCT	NNP
cord-005453-4057qib7	16066	12	between	between	IN
cord-005453-4057qib7	16066	13	Jan	Jan	NNP
cord-005453-4057qib7	16066	14	2018	2018	CD
cord-005453-4057qib7	16066	15	till	till	IN
cord-005453-4057qib7	16066	16	date	date	NN
cord-005453-4057qib7	16066	17	along	along	IN
cord-005453-4057qib7	16066	18	with	with	IN
cord-005453-4057qib7	16066	19	the	the	DT
cord-005453-4057qib7	16066	20	respective	respective	JJ
cord-005453-4057qib7	16066	21	donors	donor	NNS
cord-005453-4057qib7	16066	22	were	be	VBD
cord-005453-4057qib7	16066	23	enrolled	enrol	VBN
cord-005453-4057qib7	16066	24	in	in	IN
cord-005453-4057qib7	16066	25	the	the	DT
cord-005453-4057qib7	16066	26	study	study	NN
cord-005453-4057qib7	16066	27	(	(	-LRB-
cord-005453-4057qib7	16066	28	Group	Group	NNP
cord-005453-4057qib7	16066	29	1	1	CD
cord-005453-4057qib7	16066	30	)	)	-RRB-
cord-005453-4057qib7	16066	31	.	.	.
cord-005453-4057qib7	16067	1	All	all	DT
cord-005453-4057qib7	16067	2	9	9	CD
cord-005453-4057qib7	16067	3	underwent	undergo	VBD
cord-005453-4057qib7	16067	4	pre	pre	JJ
cord-005453-4057qib7	16067	5	-	-	JJ
cord-005453-4057qib7	16067	6	transplant	transplant	JJ
cord-005453-4057qib7	16067	7	immune	immune	JJ
cord-005453-4057qib7	16067	8	suppression	suppression	NN
cord-005453-4057qib7	16067	9	(	(	-LRB-
cord-005453-4057qib7	16067	10	PTIS	PTIS	NNP
cord-005453-4057qib7	16067	11	)	)	-RRB-
cord-005453-4057qib7	16067	12	2	2	CD
cord-005453-4057qib7	16067	13	cycles	cycle	NNS
cord-005453-4057qib7	16067	14	at	at	IN
cord-005453-4057qib7	16067	15	3	3	CD
cord-005453-4057qib7	16067	16	weekly	weekly	JJ
cord-005453-4057qib7	16067	17	intervals	interval	NNS
cord-005453-4057qib7	16067	18	using	use	VBG
cord-005453-4057qib7	16067	19	fludarabine+cyclophosphamide+dexamethasone	fludarabine+cyclophosphamide+dexamethasone	NNP
cord-005453-4057qib7	16067	20	.	.	.
cord-005453-4057qib7	16068	1	The	the	DT
cord-005453-4057qib7	16068	2	graft	graft	NN
cord-005453-4057qib7	16068	3	was	be	VBD
cord-005453-4057qib7	16068	4	mobilized	mobilize	VBN
cord-005453-4057qib7	16068	5	using	use	VBG
cord-005453-4057qib7	16068	6	GCSF@10mcg	GCSF@10mcg	NNP
cord-005453-4057qib7	16068	7	/	/	SYM
cord-005453-4057qib7	16068	8	kg	kg	NNP
cord-005453-4057qib7	16068	9	/	/	SYM
cord-005453-4057qib7	16068	10	day(D1-D5)+plerixafor@0.24mg	day(D1-D5)+plerixafor@0.24mg	NNS
cord-005453-4057qib7	16068	11	/	/	SYM
cord-005453-4057qib7	16068	12	kg(D5	kg(D5	NNP
cord-005453-4057qib7	16068	13	)	)	-RRB-
cord-005453-4057qib7	16069	1	6	6	CD
cord-005453-4057qib7	16069	2	-	-	SYM
cord-005453-4057qib7	16069	3	8	8	CD
cord-005453-4057qib7	16069	4	hours	hour	NNS
cord-005453-4057qib7	16069	5	before	before	IN
cord-005453-4057qib7	16069	6	the	the	DT
cord-005453-4057qib7	16069	7	PBSCH	PBSCH	NNP
cord-005453-4057qib7	16069	8	.	.	.
cord-005453-4057qib7	16070	1	GVHD	GVHD	NNP
cord-005453-4057qib7	16070	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16070	3	included	include	VBD
cord-005453-4057qib7	16070	4	PTCy	PTCy	NNS
cord-005453-4057qib7	16070	5	50	50	CD
cord-005453-4057qib7	16070	6	mg	mg	NNP
cord-005453-4057qib7	16070	7	/	/	SYM
cord-005453-4057qib7	16070	8	kg/	kg/	NNP
cord-005453-4057qib7	16070	9	day	day	NN
cord-005453-4057qib7	16070	10	on	on	IN
cord-005453-4057qib7	16070	11	D3	D3	NNP
cord-005453-4057qib7	16070	12	and	and	CC
cord-005453-4057qib7	16070	13	4	4	CD
cord-005453-4057qib7	16070	14	,	,	,
cord-005453-4057qib7	16070	15	sirolimus	sirolimus	NN
cord-005453-4057qib7	16070	16	and	and	CC
cord-005453-4057qib7	16070	17	MMF	mmf	NN
cord-005453-4057qib7	16070	18	starting	start	VBG
cord-005453-4057qib7	16070	19	from	from	IN
cord-005453-4057qib7	16070	20	D5	D5	NNP
cord-005453-4057qib7	16070	21	.	.	.
cord-005453-4057qib7	16071	1	Group	group	NN
cord-005453-4057qib7	16071	2	2	2	CD
cord-005453-4057qib7	16071	3	included	include	VBD
cord-005453-4057qib7	16071	4	5	5	CD
cord-005453-4057qib7	16071	5	historical	historical	JJ
cord-005453-4057qib7	16071	6	controls	control	NNS
cord-005453-4057qib7	16071	7	where	where	WRB
cord-005453-4057qib7	16071	8	graft	graft	NN
cord-005453-4057qib7	16071	9	was	be	VBD
cord-005453-4057qib7	16071	10	mobilized	mobilize	VBN
cord-005453-4057qib7	16071	11	using	use	VBG
cord-005453-4057qib7	16071	12	GCSF@10mcg	GCSF@10mcg	NNP
cord-005453-4057qib7	16071	13	/	/	SYM
cord-005453-4057qib7	16071	14	kg	kg	NN
cord-005453-4057qib7	16071	15	/	/	SYM
cord-005453-4057qib7	16071	16	day(D1-D5	day(d1-d5	NN
cord-005453-4057qib7	16071	17	)	)	-RRB-
cord-005453-4057qib7	16071	18	.	.	.
cord-005453-4057qib7	16072	1	Various	various	JJ
cord-005453-4057qib7	16072	2	parameters	parameter	NNS
cord-005453-4057qib7	16072	3	pertaining	pertain	VBG
cord-005453-4057qib7	16072	4	to	to	IN
cord-005453-4057qib7	16072	5	mobilization	mobilization	NN
cord-005453-4057qib7	16072	6	,	,	,
cord-005453-4057qib7	16072	7	harvest	harvest	NN
cord-005453-4057qib7	16072	8	,	,	,
cord-005453-4057qib7	16072	9	engraftment	engraftment	NN
cord-005453-4057qib7	16072	10	,	,	,
cord-005453-4057qib7	16072	11	GF	GF	NNP
cord-005453-4057qib7	16072	12	and	and	CC
cord-005453-4057qib7	16072	13	GVHD	GVHD	NNP
cord-005453-4057qib7	16072	14	were	be	VBD
cord-005453-4057qib7	16072	15	assessed	assess	VBN
cord-005453-4057qib7	16072	16	between	between	IN
cord-005453-4057qib7	16072	17	the	the	DT
cord-005453-4057qib7	16072	18	two	two	CD
cord-005453-4057qib7	16072	19	groups	group	NNS
cord-005453-4057qib7	16072	20	.	.	.
cord-005453-4057qib7	16073	1	Background	background	NN
cord-005453-4057qib7	16073	2	:	:	:
cord-005453-4057qib7	16074	1	Poor	poor	JJ
cord-005453-4057qib7	16074	2	mobilizers	mobilizer	NNS
cord-005453-4057qib7	16074	3	(	(	-LRB-
cord-005453-4057qib7	16074	4	PM	pm	NN
cord-005453-4057qib7	16074	5	)	)	-RRB-
cord-005453-4057qib7	16074	6	defined	define	VBN
cord-005453-4057qib7	16074	7	as	as	IN
cord-005453-4057qib7	16074	8	those	those	DT
cord-005453-4057qib7	16074	9	with	with	IN
cord-005453-4057qib7	16074	10	a	a	DT
cord-005453-4057qib7	16074	11	peripheral	peripheral	JJ
cord-005453-4057qib7	16074	12	blood	blood	NN
cord-005453-4057qib7	16074	13	CD34	CD34	NNP
cord-005453-4057qib7	16075	1	+	+	CC
cord-005453-4057qib7	16075	2	count	count	VB
cord-005453-4057qib7	16075	3	≤10cells/	≤10cells/	NNP
cord-005453-4057qib7	16076	1	μl	μl	RB
cord-005453-4057qib7	16076	2	on	on	IN
cord-005453-4057qib7	16076	3	day+4	day+4	NNP
cord-005453-4057qib7	16076	4	is	be	VBZ
cord-005453-4057qib7	16076	5	a	a	DT
cord-005453-4057qib7	16076	6	significant	significant	JJ
cord-005453-4057qib7	16076	7	risk	risk	NN
cord-005453-4057qib7	16076	8	factor	factor	NN
cord-005453-4057qib7	16076	9	for	for	IN
cord-005453-4057qib7	16076	10	mobilization	mobilization	NN
cord-005453-4057qib7	16076	11	failure	failure	NN
cord-005453-4057qib7	16076	12	.	.	.
cord-005453-4057qib7	16077	1	Within	within	IN
cord-005453-4057qib7	16077	2	these	these	DT
cord-005453-4057qib7	16077	3	,	,	,
cord-005453-4057qib7	16077	4	patients	patient	NNS
cord-005453-4057qib7	16077	5	with	with	IN
cord-005453-4057qib7	16077	6	<	<	XX
cord-005453-4057qib7	16077	7	5cells	5cells	CD
cord-005453-4057qib7	16078	1	/μl	/μl	:
cord-005453-4057qib7	16078	2	are	be	VBP
cord-005453-4057qib7	16078	3	considered	consider	VBN
cord-005453-4057qib7	16078	4	as	as	IN
cord-005453-4057qib7	16078	5	very	very	RB
cord-005453-4057qib7	16078	6	poor	poor	JJ
cord-005453-4057qib7	16078	7	mobilizers	mobilizer	NNS
cord-005453-4057qib7	16078	8	(	(	-LRB-
cord-005453-4057qib7	16078	9	VPM	VPM	NNP
cord-005453-4057qib7	16078	10	)	)	-RRB-
cord-005453-4057qib7	16078	11	.	.	.
cord-005453-4057qib7	16079	1	Use	use	NN
cord-005453-4057qib7	16079	2	of	of	IN
cord-005453-4057qib7	16079	3	plerixafor	plerixafor	NN
cord-005453-4057qib7	16079	4	in	in	IN
cord-005453-4057qib7	16079	5	VPM	VPM	NNP
cord-005453-4057qib7	16079	6	patient	patient	NN
cord-005453-4057qib7	16079	7	is	be	VBZ
cord-005453-4057qib7	16079	8	controversial	controversial	JJ
cord-005453-4057qib7	16079	9	.	.	.
cord-005453-4057qib7	16080	1	The	the	DT
cord-005453-4057qib7	16080	2	aim	aim	NN
cord-005453-4057qib7	16080	3	of	of	IN
cord-005453-4057qib7	16080	4	our	-PRON-	PRP$
cord-005453-4057qib7	16080	5	study	study	NN
cord-005453-4057qib7	16080	6	is	be	VBZ
cord-005453-4057qib7	16080	7	to	to	TO
cord-005453-4057qib7	16080	8	compare	compare	VB
cord-005453-4057qib7	16080	9	mobilizing	mobilizing	NN
cord-005453-4057qib7	16080	10	and	and	CC
cord-005453-4057qib7	16080	11	engraftment	engraftment	NN
cord-005453-4057qib7	16080	12	between	between	IN
cord-005453-4057qib7	16080	13	PM	PM	NNP
cord-005453-4057qib7	16080	14	and	and	CC
cord-005453-4057qib7	16080	15	VPM	VPM	NNP
cord-005453-4057qib7	16080	16	who	who	WP
cord-005453-4057qib7	16080	17	received	receive	VBD
cord-005453-4057qib7	16080	18	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	16080	19	plus	plus	CC
cord-005453-4057qib7	16080	20	G	G	NNP
cord-005453-4057qib7	16080	21	-	-	HYPH
cord-005453-4057qib7	16080	22	CSF	CSF	NNP
cord-005453-4057qib7	16080	23	(	(	-LRB-
cord-005453-4057qib7	16080	24	P+G	P+G	NNP
cord-005453-4057qib7	16080	25	-	-	HYPH
cord-005453-4057qib7	16080	26	CSF).Methods	CSF).Methods	NNP
cord-005453-4057qib7	16080	27	:	:	:
cord-005453-4057qib7	16081	1	In	in	IN
cord-005453-4057qib7	16081	2	our	-PRON-	PRP$
cord-005453-4057qib7	16081	3	center	center	NN
cord-005453-4057qib7	16081	4	,	,	,
cord-005453-4057qib7	16081	5	mobilization	mobilization	NN
cord-005453-4057qib7	16081	6	with	with	IN
cord-005453-4057qib7	16081	7	G	G	NNP
cord-005453-4057qib7	16081	8	-	-	HYPH
cord-005453-4057qib7	16081	9	CSF	CSF	NNP
cord-005453-4057qib7	16081	10	at	at	IN
cord-005453-4057qib7	16081	11	dose	dose	NN
cord-005453-4057qib7	16081	12	of	of	IN
cord-005453-4057qib7	16081	13	10μg	10μg	CD
cord-005453-4057qib7	16081	14	/	/	SYM
cord-005453-4057qib7	16081	15	Kg	Kg	NNP
cord-005453-4057qib7	16081	16	/	/	SYM
cord-005453-4057qib7	16081	17	day	day	NN
cord-005453-4057qib7	16081	18	was	be	VBD
cord-005453-4057qib7	16081	19	used	use	VBN
cord-005453-4057qib7	16081	20	in	in	IN
cord-005453-4057qib7	16081	21	all	all	DT
cord-005453-4057qib7	16081	22	pts	pt	NNS
cord-005453-4057qib7	16081	23	.	.	.
cord-005453-4057qib7	16082	1	Apheresis	Apheresis	NNP
cord-005453-4057qib7	16082	2	were	be	VBD
cord-005453-4057qib7	16082	3	scheduled	schedule	VBN
cord-005453-4057qib7	16082	4	on	on	IN
cord-005453-4057qib7	16082	5	day+5	day+5	NN
cord-005453-4057qib7	16082	6	.	.	.
cord-005453-4057qib7	16083	1	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	16083	2	(	(	-LRB-
cord-005453-4057qib7	16083	3	0.24	0.24	CD
cord-005453-4057qib7	16083	4	mg	mg	NNP
cord-005453-4057qib7	16083	5	/	/	SYM
cord-005453-4057qib7	16083	6	kg	kg	NNP
cord-005453-4057qib7	16083	7	)	)	-RRB-
cord-005453-4057qib7	16083	8	was	be	VBD
cord-005453-4057qib7	16083	9	added	add	VBN
cord-005453-4057qib7	16083	10	if	if	IN
cord-005453-4057qib7	16083	11	the	the	DT
cord-005453-4057qib7	16083	12	number	number	NN
cord-005453-4057qib7	16083	13	of	of	IN
cord-005453-4057qib7	16083	14	CD34	CD34	NNP
cord-005453-4057qib7	16083	15	+	+	CC
cord-005453-4057qib7	16083	16	cells	cell	NNS
cord-005453-4057qib7	16083	17	on	on	IN
cord-005453-4057qib7	16083	18	day	day	NN
cord-005453-4057qib7	16083	19	+4	+4	NN
cord-005453-4057qib7	16083	20	was	be	VBD
cord-005453-4057qib7	16083	21	<	<	XX
cord-005453-4057qib7	16083	22	10	10	CD
cord-005453-4057qib7	16084	1	/uL	/uL	:
cord-005453-4057qib7	16084	2	for	for	IN
cord-005453-4057qib7	16084	3	2x10	2x10	CD
cord-005453-4057qib7	16084	4	6	6	CD
cord-005453-4057qib7	16084	5	CD34	CD34	NNP
cord-005453-4057qib7	16085	1	+	+	CC
cord-005453-4057qib7	16085	2	/kg	/kg	NFP
cord-005453-4057qib7	16085	3	requested	request	VBN
cord-005453-4057qib7	16085	4	(	(	-LRB-
cord-005453-4057qib7	16085	5	or	or	CC
cord-005453-4057qib7	16085	6	<	<	XX
cord-005453-4057qib7	16085	7	20	20	CD
cord-005453-4057qib7	16085	8	/	/	SYM
cord-005453-4057qib7	16085	9	uL	ul	NN
cord-005453-4057qib7	16085	10	for	for	IN
cord-005453-4057qib7	16085	11	4x10	4x10	CD
cord-005453-4057qib7	16085	12	6	6	CD
cord-005453-4057qib7	16085	13	CD34	CD34	NNP
cord-005453-4057qib7	16086	1	+	+	CC
cord-005453-4057qib7	16087	1	/kg	/kg	LS
cord-005453-4057qib7	16087	2	)	)	-RRB-
cord-005453-4057qib7	16087	3	,	,	,
cord-005453-4057qib7	16087	4	or	or	CC
cord-005453-4057qib7	16087	5	if	if	IN
cord-005453-4057qib7	16087	6	the	the	DT
cord-005453-4057qib7	16087	7	number	number	NN
cord-005453-4057qib7	16087	8	of	of	IN
cord-005453-4057qib7	16087	9	CD34	CD34	NNP
cord-005453-4057qib7	16087	10	+	+	CC
cord-005453-4057qib7	16087	11	cells	cell	NNS
cord-005453-4057qib7	16087	12	collected	collect	VBN
cord-005453-4057qib7	16087	13	in	in	IN
cord-005453-4057qib7	16087	14	the	the	DT
cord-005453-4057qib7	16087	15	first	first	JJ
cord-005453-4057qib7	16087	16	apheresis	apheresis	NN
cord-005453-4057qib7	16087	17	was	be	VBD
cord-005453-4057qib7	16087	18	<	<	XX
cord-005453-4057qib7	16087	19	50	50	CD
cord-005453-4057qib7	16087	20	%	%	NN
cord-005453-4057qib7	16087	21	of	of	IN
cord-005453-4057qib7	16087	22	CD34	CD34	NNP
cord-005453-4057qib7	16088	1	+	+	CC
cord-005453-4057qib7	16088	2	cells	cell	NNS
cord-005453-4057qib7	16088	3	requested	request	VBD
cord-005453-4057qib7	16088	4	.	.	.
cord-005453-4057qib7	16089	1	Between	between	IN
cord-005453-4057qib7	16089	2	January	January	NNP
cord-005453-4057qib7	16089	3	2016	2016	CD
cord-005453-4057qib7	16089	4	and	and	CC
cord-005453-4057qib7	16089	5	September	September	NNP
cord-005453-4057qib7	16089	6	2018	2018	CD
cord-005453-4057qib7	16089	7	,	,	,
cord-005453-4057qib7	16089	8	37	37	CD
cord-005453-4057qib7	16089	9	out	out	IN
cord-005453-4057qib7	16089	10	of	of	IN
cord-005453-4057qib7	16089	11	157pts	157pts	CD
cord-005453-4057qib7	16089	12	(	(	-LRB-
cord-005453-4057qib7	16089	13	23,6	23,6	CD
cord-005453-4057qib7	16089	14	%	%	NN
cord-005453-4057qib7	16089	15	)	)	-RRB-
cord-005453-4057qib7	16089	16	received	receive	VBD
cord-005453-4057qib7	16089	17	Plerixafor	Plerixafor	NNP
cord-005453-4057qib7	16089	18	for	for	IN
cord-005453-4057qib7	16089	19	mobilization	mobilization	NN
cord-005453-4057qib7	16089	20	.	.	.
cord-005453-4057qib7	16090	1	We	-PRON-	PRP
cord-005453-4057qib7	16090	2	retrospectively	retrospectively	RB
cord-005453-4057qib7	16090	3	studied	study	VBD
cord-005453-4057qib7	16090	4	30	30	CD
cord-005453-4057qib7	16090	5	pts	pts	NN
cord-005453-4057qib7	16090	6	who	who	WP
cord-005453-4057qib7	16090	7	mobilized	mobilize	VBD
cord-005453-4057qib7	16090	8	with	with	IN
cord-005453-4057qib7	16090	9	P+G	P+G	NNP
cord-005453-4057qib7	16090	10	-	-	HYPH
cord-005453-4057qib7	16090	11	CSFdue	CSFdue	NNP
cord-005453-4057qib7	16090	12	to	to	IN
cord-005453-4057qib7	16090	13	the	the	DT
cord-005453-4057qib7	16090	14	number	number	NN
cord-005453-4057qib7	16090	15	of	of	IN
cord-005453-4057qib7	16090	16	CD34	CD34	NNP
cord-005453-4057qib7	16090	17	+	+	CC
cord-005453-4057qib7	16090	18	cells	cell	NNS
cord-005453-4057qib7	16090	19	on	on	IN
cord-005453-4057qib7	16090	20	day	day	NN
cord-005453-4057qib7	16090	21	+4	+4	NN
cord-005453-4057qib7	16090	22	was	be	VBD
cord-005453-4057qib7	16090	23	<	<	XX
cord-005453-4057qib7	16090	24	10	10	CD
cord-005453-4057qib7	16091	1	/uL.Results	/uL.Results	NNP
cord-005453-4057qib7	16091	2	:	:	:
cord-005453-4057qib7	16092	1	Twelve	twelve	CD
cord-005453-4057qib7	16092	2	out	out	IN
cord-005453-4057qib7	16092	3	of	of	IN
cord-005453-4057qib7	16092	4	30	30	CD
cord-005453-4057qib7	16092	5	pts	pt	NNS
cord-005453-4057qib7	16092	6	were	be	VBD
cord-005453-4057qib7	16092	7	PM	PM	NNP
cord-005453-4057qib7	16092	8	,	,	,
cord-005453-4057qib7	16092	9	7	7	CD
cord-005453-4057qib7	16092	10	were	be	VBD
cord-005453-4057qib7	16092	11	females	female	NNS
cord-005453-4057qib7	16092	12	,	,	,
cord-005453-4057qib7	16092	13	median	median	JJ
cord-005453-4057qib7	16092	14	age	age	NN
cord-005453-4057qib7	16093	1	55,5	55,5	CD
cord-005453-4057qib7	16093	2	years	year	NNS
cord-005453-4057qib7	16093	3	(	(	-LRB-
cord-005453-4057qib7	16093	4	range:32	range:32	NNP
cord-005453-4057qib7	16093	5	-	-	HYPH
cord-005453-4057qib7	16093	6	70	70	CD
cord-005453-4057qib7	16093	7	)	)	-RRB-
cord-005453-4057qib7	16093	8	.	.	.
cord-005453-4057qib7	16094	1	Patients	patient	NNS
cord-005453-4057qib7	16094	2	'	'	POS
cord-005453-4057qib7	16094	3	baseline	baseline	JJ
cord-005453-4057qib7	16094	4	diseases	disease	NNS
cord-005453-4057qib7	16094	5	were	be	VBD
cord-005453-4057qib7	16094	6	:	:	:
cord-005453-4057qib7	16094	7	10	10	CD
cord-005453-4057qib7	16094	8	non	non	JJ
cord-005453-4057qib7	16094	9	-	-	JJ
cord-005453-4057qib7	16094	10	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	16094	11	lymphoma	lymphoma	NN
cord-005453-4057qib7	16094	12	(	(	-LRB-
cord-005453-4057qib7	16094	13	NHL	NHL	NNP
cord-005453-4057qib7	16094	14	)	)	-RRB-
cord-005453-4057qib7	16094	15	(	(	-LRB-
cord-005453-4057qib7	16094	16	83,3	83,3	CD
cord-005453-4057qib7	16094	17	%	%	NN
cord-005453-4057qib7	16094	18	)	)	-RRB-
cord-005453-4057qib7	16094	19	,	,	,
cord-005453-4057qib7	16094	20	1	1	CD
cord-005453-4057qib7	16094	21	multiple	multiple	JJ
cord-005453-4057qib7	16094	22	myeloma	myeloma	NN
cord-005453-4057qib7	16094	23	(	(	-LRB-
cord-005453-4057qib7	16094	24	MM	MM	NNP
cord-005453-4057qib7	16094	25	)	)	-RRB-
cord-005453-4057qib7	16094	26	and	and	CC
cord-005453-4057qib7	16094	27	1	1	CD
cord-005453-4057qib7	16094	28	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	16094	29	lymphoma	lymphoma	NN
cord-005453-4057qib7	16094	30	.	.	.
cord-005453-4057qib7	16095	1	Median	median	JJ
cord-005453-4057qib7	16095	2	CD34	CD34	NNP
cord-005453-4057qib7	16095	3	+	+	CC
cord-005453-4057qib7	16095	4	cell	cell	NN
cord-005453-4057qib7	16095	5	count	count	NN
cord-005453-4057qib7	16095	6	on	on	IN
cord-005453-4057qib7	16095	7	day	day	NN
cord-005453-4057qib7	16095	8	+4	+4	NN
cord-005453-4057qib7	16095	9	was	be	VBD
cord-005453-4057qib7	16095	10	8/	8/	CD
cord-005453-4057qib7	16095	11	uL	ul	NN
cord-005453-4057qib7	16096	1	(	(	-LRB-
cord-005453-4057qib7	16096	2	range:6	range:6	NNP
cord-005453-4057qib7	16096	3	-	-	HYPH
cord-005453-4057qib7	16096	4	10).There	10).there	CD
cord-005453-4057qib7	16096	5	was	be	VBD
cord-005453-4057qib7	16096	6	no	no	DT
cord-005453-4057qib7	16096	7	mobilization	mobilization	NN
cord-005453-4057qib7	16096	8	failure	failure	NN
cord-005453-4057qib7	16096	9	.	.	.
cord-005453-4057qib7	16097	1	Eighteen	eighteen	CD
cord-005453-4057qib7	16097	2	out	out	IN
cord-005453-4057qib7	16097	3	of	of	IN
cord-005453-4057qib7	16097	4	30	30	CD
cord-005453-4057qib7	16097	5	pts	pts	NN
cord-005453-4057qib7	16097	6	(	(	-LRB-
cord-005453-4057qib7	16097	7	60	60	CD
cord-005453-4057qib7	16097	8	%	%	NN
cord-005453-4057qib7	16097	9	)	)	-RRB-
cord-005453-4057qib7	16097	10	were	be	VBD
cord-005453-4057qib7	16097	11	VPM	VPM	NNP
cord-005453-4057qib7	16097	12	,	,	,
cord-005453-4057qib7	16097	13	9	9	CD
cord-005453-4057qib7	16097	14	were	be	VBD
cord-005453-4057qib7	16097	15	females	female	NNS
cord-005453-4057qib7	16097	16	,	,	,
cord-005453-4057qib7	16097	17	median	median	JJ
cord-005453-4057qib7	16097	18	age	age	NN
cord-005453-4057qib7	16097	19	62,5	62,5	CD
cord-005453-4057qib7	16097	20	years	year	NNS
cord-005453-4057qib7	16097	21	(	(	-LRB-
cord-005453-4057qib7	16097	22	range:34	range:34	NN
cord-005453-4057qib7	16097	23	-	-	HYPH
cord-005453-4057qib7	16097	24	69	69	CD
cord-005453-4057qib7	16097	25	)	)	-RRB-
cord-005453-4057qib7	16097	26	.	.	.
cord-005453-4057qib7	16098	1	Patients	patient	NNS
cord-005453-4057qib7	16098	2	'	'	POS
cord-005453-4057qib7	16098	3	baseline	baseline	JJ
cord-005453-4057qib7	16098	4	diseases	disease	NNS
cord-005453-4057qib7	16098	5	were	be	VBD
cord-005453-4057qib7	16098	6	:	:	:
cord-005453-4057qib7	16098	7	10	10	CD
cord-005453-4057qib7	16098	8	NHL	NHL	NNP
cord-005453-4057qib7	16098	9	(	(	-LRB-
cord-005453-4057qib7	16098	10	55,5	55,5	CD
cord-005453-4057qib7	16098	11	%	%	NN
cord-005453-4057qib7	16098	12	)	)	-RRB-
cord-005453-4057qib7	16098	13	,	,	,
cord-005453-4057qib7	16098	14	7	7	CD
cord-005453-4057qib7	16098	15	MM	mm	NN
cord-005453-4057qib7	16098	16	and	and	CC
cord-005453-4057qib7	16098	17	1	1	CD
cord-005453-4057qib7	16098	18	solid	solid	JJ
cord-005453-4057qib7	16098	19	tumor	tumor	NN
cord-005453-4057qib7	16098	20	.	.	.
cord-005453-4057qib7	16099	1	Median	median	JJ
cord-005453-4057qib7	16099	2	CD34	CD34	NNP
cord-005453-4057qib7	16099	3	+	+	CC
cord-005453-4057qib7	16099	4	cell	cell	NN
cord-005453-4057qib7	16099	5	count	count	NN
cord-005453-4057qib7	16099	6	on	on	IN
cord-005453-4057qib7	16099	7	day+4	day+4	NNP
cord-005453-4057qib7	16099	8	was	be	VBD
cord-005453-4057qib7	16099	9	2,5/	2,5/	CD
cord-005453-4057qib7	16100	1	uL	uL	NNP
cord-005453-4057qib7	16101	1	(	(	-LRB-
cord-005453-4057qib7	16101	2	range:2	range:2	NNP
cord-005453-4057qib7	16101	3	-	-	HYPH
cord-005453-4057qib7	16101	4	5	5	CD
cord-005453-4057qib7	16101	5	)	)	-RRB-
cord-005453-4057qib7	16101	6	.	.	.
cord-005453-4057qib7	16102	1	Two	two	CD
cord-005453-4057qib7	16102	2	out	out	IN
cord-005453-4057qib7	16102	3	of	of	IN
cord-005453-4057qib7	16102	4	18	18	CD
cord-005453-4057qib7	16102	5	pts	pt	NNS
cord-005453-4057qib7	16102	6	(	(	-LRB-
cord-005453-4057qib7	16102	7	16,6	16,6	CD
cord-005453-4057qib7	16102	8	%	%	NN
cord-005453-4057qib7	16102	9	)	)	-RRB-
cord-005453-4057qib7	16102	10	were	be	VBD
cord-005453-4057qib7	16102	11	considered	consider	VBN
cord-005453-4057qib7	16102	12	mobilization	mobilization	NN
cord-005453-4057qib7	16102	13	failure	failure	NN
cord-005453-4057qib7	16102	14	,	,	,
cord-005453-4057qib7	16102	15	in	in	IN
cord-005453-4057qib7	16102	16	2	2	CD
cord-005453-4057qib7	16102	17	of	of	IN
cord-005453-4057qib7	16102	18	them	-PRON-	PRP
cord-005453-4057qib7	16102	19	did	do	VBD
cord-005453-4057qib7	16102	20	not	not	RB
cord-005453-4057qib7	16102	21	realized	realize	VBN
cord-005453-4057qib7	16102	22	apheresis	apheresis	NN
cord-005453-4057qib7	16102	23	due	due	IN
cord-005453-4057qib7	16102	24	to	to	IN
cord-005453-4057qib7	16102	25	CD34	CD34	NNP
cord-005453-4057qib7	16102	26	+	+	CC
cord-005453-4057qib7	16103	1	cell	cell	NN
cord-005453-4057qib7	16103	2	count	count	NN
cord-005453-4057qib7	16103	3	on	on	IN
cord-005453-4057qib7	16103	4	day	day	NN
cord-005453-4057qib7	16103	5	+5	+5	NFP
cord-005453-4057qib7	16103	6	was	be	VBD
cord-005453-4057qib7	16103	7	2/	2/	CD
cord-005453-4057qib7	16104	1	uL.	ul.	LS
cord-005453-4057qib7	16104	2	No	no	DT
cord-005453-4057qib7	16104	3	difference	difference	NN
cord-005453-4057qib7	16104	4	was	be	VBD
cord-005453-4057qib7	16104	5	seen	see	VBN
cord-005453-4057qib7	16104	6	between	between	IN
cord-005453-4057qib7	16104	7	both	both	DT
cord-005453-4057qib7	16104	8	groups	group	NNS
cord-005453-4057qib7	16104	9	regarding	regard	VBG
cord-005453-4057qib7	16104	10	gender	gender	NN
cord-005453-4057qib7	16104	11	,	,	,
cord-005453-4057qib7	16104	12	age	age	NN
cord-005453-4057qib7	16104	13	,	,	,
cord-005453-4057qib7	16104	14	patients	patient	NNS
cord-005453-4057qib7	16104	15	baseline	baseline	JJ
cord-005453-4057qib7	16104	16	disease	disease	NN
cord-005453-4057qib7	16104	17	or	or	CC
cord-005453-4057qib7	16104	18	median	median	JJ
cord-005453-4057qib7	16104	19	CD34	CD34	NNP
cord-005453-4057qib7	16104	20	+	+	CC
cord-005453-4057qib7	16104	21	cells	cell	NNS
cord-005453-4057qib7	16104	22	count	count	VBP
cord-005453-4057qib7	16104	23	on	on	IN
cord-005453-4057qib7	16104	24	day	day	NN
cord-005453-4057qib7	16104	25	+4.VPM	+4.VPM	.
cord-005453-4057qib7	16104	26	needed	need	VBN
cord-005453-4057qib7	16104	27	more	more	JJR
cord-005453-4057qib7	16104	28	apheresis	apheresis	NN
cord-005453-4057qib7	16104	29	sessions	session	NNS
cord-005453-4057qib7	16104	30	,	,	,
cord-005453-4057qib7	16104	31	5/16	5/16	CD
cord-005453-4057qib7	16104	32	pts	pts	NN
cord-005453-4057qib7	16104	33	required	require	VBN
cord-005453-4057qib7	16104	34	2	2	CD
cord-005453-4057qib7	16104	35	sessions	session	NNS
cord-005453-4057qib7	16104	36	against	against	IN
cord-005453-4057qib7	16104	37	1/12	1/12	CD
cord-005453-4057qib7	16104	38	pts	pt	NNS
cord-005453-4057qib7	16104	39	in	in	IN
cord-005453-4057qib7	16104	40	PM	pm	NN
cord-005453-4057qib7	16104	41	(	(	-LRB-
cord-005453-4057qib7	16104	42	p	p	NN
cord-005453-4057qib7	16104	43	=	=	SYM
cord-005453-4057qib7	16104	44	not	not	RB
cord-005453-4057qib7	16104	45	significant	significant	JJ
cord-005453-4057qib7	16104	46	(	(	-LRB-
cord-005453-4057qib7	16104	47	ns	ns	IN
cord-005453-4057qib7	16104	48	)	)	-RRB-
cord-005453-4057qib7	16104	49	.	.	.
cord-005453-4057qib7	16105	1	We	-PRON-	PRP
cord-005453-4057qib7	16105	2	obtained	obtain	VBD
cord-005453-4057qib7	16105	3	enough	enough	JJ
cord-005453-4057qib7	16105	4	cells	cell	NNS
cord-005453-4057qib7	16105	5	to	to	TO
cord-005453-4057qib7	16105	6	carry	carry	VB
cord-005453-4057qib7	16105	7	ASCT	ASCT	NNP
cord-005453-4057qib7	16105	8	in	in	IN
cord-005453-4057qib7	16105	9	90	90	CD
cord-005453-4057qib7	16105	10	%	%	NN
cord-005453-4057qib7	16105	11	pts	pt	NNS
cord-005453-4057qib7	16105	12	,	,	,
cord-005453-4057qib7	16105	13	although	although	IN
cord-005453-4057qib7	16105	14	mean	mean	JJ
cord-005453-4057qib7	16105	15	number	number	NN
cord-005453-4057qib7	16105	16	of	of	IN
cord-005453-4057qib7	16105	17	CD34	CD34	NNP
cord-005453-4057qib7	16105	18	+	+	CC
cord-005453-4057qib7	16105	19	cells	cell	NNS
cord-005453-4057qib7	16105	20	obtained	obtain	VBN
cord-005453-4057qib7	16105	21	in	in	IN
cord-005453-4057qib7	16105	22	VPM	VPM	NNP
cord-005453-4057qib7	16105	23	was	be	VBD
cord-005453-4057qib7	16105	24	lower	low	JJR
cord-005453-4057qib7	16105	25	than	than	IN
cord-005453-4057qib7	16105	26	in	in	IN
cord-005453-4057qib7	16105	27	PM	PM	NNP
cord-005453-4057qib7	16105	28	(	(	-LRB-
cord-005453-4057qib7	16105	29	4,89x10	4,89x10	CD
cord-005453-4057qib7	16105	30	6	6	CD
cord-005453-4057qib7	16105	31	/kg	/kg	.
cord-005453-4057qib7	16105	32	vs	vs	IN
cord-005453-4057qib7	16105	33	6,38x10	6,38x10	CD
cord-005453-4057qib7	16105	34	6	6	CD
cord-005453-4057qib7	16105	35	/kg	/kg	NN
cord-005453-4057qib7	16105	36	,	,	,
cord-005453-4057qib7	16105	37	respectively	respectively	RB
cord-005453-4057qib7	16105	38	)	)	-RRB-
cord-005453-4057qib7	16106	1	(	(	-LRB-
cord-005453-4057qib7	16106	2	p	p	NN
cord-005453-4057qib7	16106	3	=	=	SYM
cord-005453-4057qib7	16106	4	ns).Twenty	ns).Twenty	NNP
cord-005453-4057qib7	16106	5	-	-	HYPH
cord-005453-4057qib7	16106	6	six	six	CD
cord-005453-4057qib7	16106	7	pts	pt	NNS
cord-005453-4057qib7	16106	8	underwent	undergo	VBD
cord-005453-4057qib7	16106	9	ASCT	ASCT	NNP
cord-005453-4057qib7	16106	10	and	and	CC
cord-005453-4057qib7	16106	11	mean	mean	JJ
cord-005453-4057qib7	16106	12	number	number	NN
cord-005453-4057qib7	16106	13	of	of	IN
cord-005453-4057qib7	16106	14	CD34	CD34	NNP
cord-005453-4057qib7	16107	1	+	+	CC
cord-005453-4057qib7	16107	2	cells	cell	NNS
cord-005453-4057qib7	16107	3	infused	infuse	VBN
cord-005453-4057qib7	16107	4	were	be	VBD
cord-005453-4057qib7	16107	5	4,27x10	4,27x10	CD
cord-005453-4057qib7	16107	6	6	6	CD
cord-005453-4057qib7	16108	1	/kg	/kg	NFP
cord-005453-4057qib7	16108	2	in	in	IN
cord-005453-4057qib7	16108	3	VPM	VPM	NNP
cord-005453-4057qib7	16109	1	vs	vs	IN
cord-005453-4057qib7	16109	2	have	have	VBP
cord-005453-4057qib7	16109	3	been	be	VBN
cord-005453-4057qib7	16109	4	the	the	DT
cord-005453-4057qib7	16109	5	only	only	JJ
cord-005453-4057qib7	16109	6	route	route	NN
cord-005453-4057qib7	16109	7	used	use	VBN
cord-005453-4057qib7	16109	8	for	for	IN
cord-005453-4057qib7	16109	9	cHPC	cHPC	NNP
cord-005453-4057qib7	16109	10	administration	administration	NN
cord-005453-4057qib7	16109	11	.	.	.
cord-005453-4057qib7	16110	1	The	the	DT
cord-005453-4057qib7	16110	2	appearance	appearance	NN
cord-005453-4057qib7	16110	3	of	of	IN
cord-005453-4057qib7	16110	4	other	other	JJ
cord-005453-4057qib7	16110	5	catheters	catheter	NNS
cord-005453-4057qib7	16110	6	types	type	NNS
cord-005453-4057qib7	16110	7	made	make	VBD
cord-005453-4057qib7	16110	8	us	-PRON-	PRP
cord-005453-4057qib7	16110	9	to	to	TO
cord-005453-4057qib7	16110	10	reconsider	reconsider	VB
cord-005453-4057qib7	16110	11	the	the	DT
cord-005453-4057qib7	16110	12	exclusive	exclusive	JJ
cord-005453-4057qib7	16110	13	use	use	NN
cord-005453-4057qib7	16110	14	of	of	IN
cord-005453-4057qib7	16110	15	the	the	DT
cord-005453-4057qib7	16110	16	CVC	CVC	NNP
cord-005453-4057qib7	16110	17	for	for	IN
cord-005453-4057qib7	16110	18	the	the	DT
cord-005453-4057qib7	16110	19	infusion	infusion	NN
cord-005453-4057qib7	16110	20	of	of	IN
cord-005453-4057qib7	16110	21	cHPC	cHPC	NNP
cord-005453-4057qib7	16110	22	.	.	.
cord-005453-4057qib7	16111	1	We	-PRON-	PRP
cord-005453-4057qib7	16111	2	analyzed	analyze	VBD
cord-005453-4057qib7	16111	3	the	the	DT
cord-005453-4057qib7	16111	4	use	use	NN
cord-005453-4057qib7	16111	5	of	of	IN
cord-005453-4057qib7	16111	6	a	a	DT
cord-005453-4057qib7	16111	7	peripheral	peripheral	JJ
cord-005453-4057qib7	16111	8	IV	IV	NNP
cord-005453-4057qib7	16111	9	cannula	cannula	NN
cord-005453-4057qib7	16111	10	(	(	-LRB-
cord-005453-4057qib7	16111	11	PIVC	PIVC	NNP
cord-005453-4057qib7	16111	12	)	)	-RRB-
cord-005453-4057qib7	16111	13	as	as	IN
cord-005453-4057qib7	16111	14	an	an	DT
cord-005453-4057qib7	16111	15	alternative	alternative	NN
cord-005453-4057qib7	16111	16	to	to	IN
cord-005453-4057qib7	16111	17	CVC	CVC	NNP
cord-005453-4057qib7	16111	18	for	for	IN
cord-005453-4057qib7	16111	19	the	the	DT
cord-005453-4057qib7	16111	20	infusion	infusion	NN
cord-005453-4057qib7	16111	21	of	of	IN
cord-005453-4057qib7	16111	22	cHPC	chpc	NN
cord-005453-4057qib7	16111	23	in	in	IN
cord-005453-4057qib7	16111	24	patients	patient	NNS
cord-005453-4057qib7	16111	25	with	with	IN
cord-005453-4057qib7	16111	26	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	16111	27	diseases	disease	NNS
cord-005453-4057qib7	16111	28	.	.	.
cord-005453-4057qib7	16112	1	Methods	method	NNS
cord-005453-4057qib7	16112	2	:	:	:
cord-005453-4057qib7	16112	3	Medical	medical	JJ
cord-005453-4057qib7	16112	4	records	record	NNS
cord-005453-4057qib7	16112	5	of	of	IN
cord-005453-4057qib7	16112	6	65	65	CD
cord-005453-4057qib7	16112	7	patients	patient	NNS
cord-005453-4057qib7	16112	8	who	who	WP
cord-005453-4057qib7	16112	9	received	receive	VBD
cord-005453-4057qib7	16112	10	an	an	DT
cord-005453-4057qib7	16112	11	ASCT	asct	NN
cord-005453-4057qib7	16112	12	for	for	IN
cord-005453-4057qib7	16112	13	hematological	hematological	JJ
cord-005453-4057qib7	16112	14	malignant	malignant	JJ
cord-005453-4057qib7	16112	15	diseases	disease	NNS
cord-005453-4057qib7	16112	16	at	at	IN
cord-005453-4057qib7	16112	17	the	the	DT
cord-005453-4057qib7	16112	18	Hospital	Hospital	NNP
cord-005453-4057qib7	16112	19	Clínic	Clínic	NNP
cord-005453-4057qib7	16112	20	of	of	IN
cord-005453-4057qib7	16112	21	Barcelona	Barcelona	NNP
cord-005453-4057qib7	16112	22	from	from	IN
cord-005453-4057qib7	16112	23	January	January	NNP
cord-005453-4057qib7	16112	24	2017	2017	CD
cord-005453-4057qib7	16112	25	to	to	IN
cord-005453-4057qib7	16112	26	February	February	NNP
cord-005453-4057qib7	16112	27	2018	2018	CD
cord-005453-4057qib7	16112	28	were	be	VBD
cord-005453-4057qib7	16112	29	reviewed	review	VBN
cord-005453-4057qib7	16112	30	.	.	.
cord-005453-4057qib7	16113	1	Of	of	IN
cord-005453-4057qib7	16113	2	those	those	DT
cord-005453-4057qib7	16113	3	,	,	,
cord-005453-4057qib7	16113	4	eight	eight	CD
cord-005453-4057qib7	16113	5	were	be	VBD
cord-005453-4057qib7	16113	6	infused	infuse	VBN
cord-005453-4057qib7	16113	7	through	through	IN
cord-005453-4057qib7	16113	8	a	a	DT
cord-005453-4057qib7	16113	9	PIVC	PIVC	NNP
cord-005453-4057qib7	16113	10	due	due	JJ
cord-005453-4057qib7	16113	11	to	to	IN
cord-005453-4057qib7	16113	12	cardiac	cardiac	JJ
cord-005453-4057qib7	16113	13	impairment	impairment	NN
cord-005453-4057qib7	16113	14	related	relate	VBN
cord-005453-4057qib7	16113	15	to	to	IN
cord-005453-4057qib7	16113	16	previous	previous	JJ
cord-005453-4057qib7	16113	17	treatments	treatment	NNS
cord-005453-4057qib7	16113	18	,	,	,
cord-005453-4057qib7	16113	19	ischemic	ischemic	JJ
cord-005453-4057qib7	16113	20	cardiomyopathy	cardiomyopathy	NN
cord-005453-4057qib7	16113	21	or	or	CC
cord-005453-4057qib7	16113	22	amyloid	amyloid	NN
cord-005453-4057qib7	16113	23	deposition	deposition	NN
cord-005453-4057qib7	16113	24	.	.	.
cord-005453-4057qib7	16114	1	HPC	HPC	NNP
cord-005453-4057qib7	16114	2	were	be	VBD
cord-005453-4057qib7	16114	3	obtained	obtain	VBN
cord-005453-4057qib7	16114	4	from	from	IN
cord-005453-4057qib7	16114	5	peripheral	peripheral	JJ
cord-005453-4057qib7	16114	6	blood	blood	NN
cord-005453-4057qib7	16114	7	by	by	IN
cord-005453-4057qib7	16114	8	apheresis	apheresis	NN
cord-005453-4057qib7	16114	9	after	after	IN
cord-005453-4057qib7	16114	10	mobilization	mobilization	NN
cord-005453-4057qib7	16114	11	with	with	IN
cord-005453-4057qib7	16114	12	G	G	NNP
cord-005453-4057qib7	16114	13	-	-	HYPH
cord-005453-4057qib7	16114	14	CSF	CSF	NNP
cord-005453-4057qib7	16114	15	using	use	VBG
cord-005453-4057qib7	16114	16	ACD	ACD	NNP
cord-005453-4057qib7	16114	17	-	-	HYPH
cord-005453-4057qib7	16114	18	A	A	NNP
cord-005453-4057qib7	16114	19	as	as	IN
cord-005453-4057qib7	16114	20	an	an	DT
cord-005453-4057qib7	16114	21	anticoagulant	anticoagulant	NN
cord-005453-4057qib7	16114	22	.	.	.
cord-005453-4057qib7	16115	1	Cryopreservation	Cryopreservation	NNP
cord-005453-4057qib7	16115	2	was	be	VBD
cord-005453-4057qib7	16115	3	performed	perform	VBN
cord-005453-4057qib7	16115	4	with	with	IN
cord-005453-4057qib7	16115	5	autologous	autologous	JJ
cord-005453-4057qib7	16115	6	plasma	plasma	NN
cord-005453-4057qib7	16115	7	and	and	CC
cord-005453-4057qib7	16115	8	DMSO	DMSO	NNP
cord-005453-4057qib7	16115	9	10	10	CD
cord-005453-4057qib7	16115	10	%	%	NN
cord-005453-4057qib7	16115	11	by	by	IN
cord-005453-4057qib7	16115	12	mechanical	mechanical	JJ
cord-005453-4057qib7	16115	13	means	mean	NNS
cord-005453-4057qib7	16115	14	and	and	CC
cord-005453-4057qib7	16115	15	stored	store	VBN
cord-005453-4057qib7	16115	16	in	in	IN
cord-005453-4057qib7	16115	17	liquid	liquid	JJ
cord-005453-4057qib7	16115	18	nitrogen	nitrogen	NN
cord-005453-4057qib7	16115	19	.	.	.
cord-005453-4057qib7	16116	1	Analytical	analytical	JJ
cord-005453-4057qib7	16116	2	controls	control	NNS
cord-005453-4057qib7	16116	3	were	be	VBD
cord-005453-4057qib7	16116	4	performed	perform	VBN
cord-005453-4057qib7	16116	5	including	include	VBG
cord-005453-4057qib7	16116	6	hematocrit	hematocrit	NN
cord-005453-4057qib7	16116	7	,	,	,
cord-005453-4057qib7	16116	8	total	total	JJ
cord-005453-4057qib7	16116	9	nucleated	nucleated	JJ
cord-005453-4057qib7	16116	10	cells	cell	NNS
cord-005453-4057qib7	16116	11	,	,	,
cord-005453-4057qib7	16116	12	total	total	JJ
cord-005453-4057qib7	16116	13	polymorphonuclear	polymorphonuclear	JJ
cord-005453-4057qib7	16116	14	neutrophils	neutrophil	NNS
cord-005453-4057qib7	16116	15	and	and	CC
cord-005453-4057qib7	16116	16	platelets	platelet	NNS
cord-005453-4057qib7	16116	17	using	use	VBG
cord-005453-4057qib7	16116	18	the	the	DT
cord-005453-4057qib7	16116	19	ADVIA	ADVIA	NNP
cord-005453-4057qib7	16116	20	120	120	CD
cord-005453-4057qib7	16116	21	analyzer	analyzer	NN
cord-005453-4057qib7	16116	22	.	.	.
cord-005453-4057qib7	16117	1	The	the	DT
cord-005453-4057qib7	16117	2	CD34	CD34	NNP
cord-005453-4057qib7	16118	1	+	+	CC
cord-005453-4057qib7	16119	1	/	/	NFP
cord-005453-4057qib7	16120	1	CD45	CD45	NNP
cord-005453-4057qib7	16120	2	+	+	CC
cord-005453-4057qib7	16120	3	population	population	NN
cord-005453-4057qib7	16120	4	was	be	VBD
cord-005453-4057qib7	16120	5	analyzed	analyze	VBN
cord-005453-4057qib7	16120	6	by	by	IN
cord-005453-4057qib7	16120	7	flow	flow	NN
cord-005453-4057qib7	16120	8	cytometry	cytometry	NN
cord-005453-4057qib7	16120	9	following	follow	VBG
cord-005453-4057qib7	16120	10	the	the	DT
cord-005453-4057qib7	16120	11	ISHAGE	ISHAGE	NNP
cord-005453-4057qib7	16120	12	single	single	JJ
cord-005453-4057qib7	16120	13	-	-	HYPH
cord-005453-4057qib7	16120	14	platform	platform	NN
cord-005453-4057qib7	16120	15	protocol	protocol	NN
cord-005453-4057qib7	16120	16	.	.	.
cord-005453-4057qib7	16121	1	Viability	viability	NN
cord-005453-4057qib7	16121	2	of	of	IN
cord-005453-4057qib7	16121	3	total	total	JJ
cord-005453-4057qib7	16121	4	nucleated	nucleated	JJ
cord-005453-4057qib7	16121	5	cellularity	cellularity	NN
cord-005453-4057qib7	16121	6	was	be	VBD
cord-005453-4057qib7	16121	7	carried	carry	VBN
cord-005453-4057qib7	16121	8	out	out	RP
cord-005453-4057qib7	16121	9	by	by	IN
cord-005453-4057qib7	16121	10	vital	vital	JJ
cord-005453-4057qib7	16121	11	staining	staining	NN
cord-005453-4057qib7	16121	12	with	with	IN
cord-005453-4057qib7	16121	13	Acridine	Acridine	NNP
cord-005453-4057qib7	16121	14	Orange	Orange	NNP
cord-005453-4057qib7	16121	15	and	and	CC
cord-005453-4057qib7	16121	16	the	the	DT
cord-005453-4057qib7	16121	17	specific	specific	JJ
cord-005453-4057qib7	16121	18	viability	viability	NN
cord-005453-4057qib7	16121	19	of	of	IN
cord-005453-4057qib7	16121	20	the	the	DT
cord-005453-4057qib7	16121	21	CD34	CD34	NNP
cord-005453-4057qib7	16121	22	+	+	CC
cord-005453-4057qib7	16121	23	population	population	NN
cord-005453-4057qib7	16121	24	through	through	IN
cord-005453-4057qib7	16121	25	the	the	DT
cord-005453-4057qib7	16121	26	technique	technique	NN
cord-005453-4057qib7	16121	27	of	of	IN
cord-005453-4057qib7	16121	28	7-Aminoactinomycin	7-Aminoactinomycin	NNP
cord-005453-4057qib7	16121	29	D.	D.	NNP
cord-005453-4057qib7	16121	30	Thawing	Thawing	NNP
cord-005453-4057qib7	16121	31	was	be	VBD
cord-005453-4057qib7	16121	32	performed	perform	VBN
cord-005453-4057qib7	16121	33	bag	bag	NN
cord-005453-4057qib7	16121	34	to	to	TO
cord-005453-4057qib7	16121	35	bag	bag	NN
cord-005453-4057qib7	16121	36	by	by	IN
cord-005453-4057qib7	16121	37	immersion	immersion	NN
cord-005453-4057qib7	16121	38	in	in	IN
cord-005453-4057qib7	16121	39	a	a	DT
cord-005453-4057qib7	16121	40	water	water	NN
cord-005453-4057qib7	16121	41	bath	bath	NN
cord-005453-4057qib7	16121	42	at	at	IN
cord-005453-4057qib7	16121	43	37ºC	37ºc	CD
cord-005453-4057qib7	16121	44	and	and	CC
cord-005453-4057qib7	16121	45	transferred	transfer	VBN
cord-005453-4057qib7	16121	46	to	to	IN
cord-005453-4057qib7	16121	47	the	the	DT
cord-005453-4057qib7	16121	48	bedside	bedside	NN
cord-005453-4057qib7	16121	49	of	of	IN
cord-005453-4057qib7	16121	50	the	the	DT
cord-005453-4057qib7	16121	51	patient	patient	NN
cord-005453-4057qib7	16121	52	for	for	IN
cord-005453-4057qib7	16121	53	gravity	gravity	NN
cord-005453-4057qib7	16121	54	infusion	infusion	NN
cord-005453-4057qib7	16121	55	using	use	VBG
cord-005453-4057qib7	16121	56	an	an	DT
cord-005453-4057qib7	16121	57	infusion	infusion	NN
cord-005453-4057qib7	16121	58	set	set	VBN
cord-005453-4057qib7	16121	59	without	without	IN
cord-005453-4057qib7	16121	60	filter	filter	NN
cord-005453-4057qib7	16121	61	through	through	IN
cord-005453-4057qib7	16121	62	PIVC	PIVC	NNP
cord-005453-4057qib7	16121	63	of	of	IN
cord-005453-4057qib7	16121	64	22	22	CD
cord-005453-4057qib7	16121	65	Gauche	gauche	JJ
cord-005453-4057qib7	16121	66	.	.	.
cord-005453-4057qib7	16122	1	Vital	vital	JJ
cord-005453-4057qib7	16122	2	sings	sing	VBZ
cord-005453-4057qib7	16122	3	monitoring	monitor	VBG
cord-005453-4057qib7	16122	4	performed	perform	VBN
cord-005453-4057qib7	16122	5	before	before	RB
cord-005453-4057qib7	16122	6	,	,	,
cord-005453-4057qib7	16122	7	during	during	IN
cord-005453-4057qib7	16122	8	and	and	CC
cord-005453-4057qib7	16122	9	the	the	DT
cord-005453-4057qib7	16122	10	end	end	NN
cord-005453-4057qib7	16122	11	of	of	IN
cord-005453-4057qib7	16122	12	the	the	DT
cord-005453-4057qib7	16122	13	every	every	DT
cord-005453-4057qib7	16122	14	infusion	infusion	NN
cord-005453-4057qib7	16122	15	bag	bag	NN
cord-005453-4057qib7	16122	16	including	include	VBG
cord-005453-4057qib7	16122	17	:	:	:
cord-005453-4057qib7	16122	18	blood	blood	NN
cord-005453-4057qib7	16122	19	pressure	pressure	NN
cord-005453-4057qib7	16122	20	,	,	,
cord-005453-4057qib7	16122	21	heart	heart	NN
cord-005453-4057qib7	16122	22	rate	rate	NN
cord-005453-4057qib7	16122	23	,	,	,
cord-005453-4057qib7	16122	24	oxygen	oxygen	NN
cord-005453-4057qib7	16122	25	saturation	saturation	NN
cord-005453-4057qib7	16122	26	,	,	,
cord-005453-4057qib7	16122	27	body	body	NN
cord-005453-4057qib7	16122	28	temperature	temperature	NN
cord-005453-4057qib7	16122	29	and	and	CC
cord-005453-4057qib7	16122	30	central	central	JJ
cord-005453-4057qib7	16122	31	venous	venous	JJ
cord-005453-4057qib7	16122	32	pressure	pressure	NN
cord-005453-4057qib7	16122	33	.	.	.
cord-005453-4057qib7	16123	1	Other	other	JJ
cord-005453-4057qib7	16123	2	aspects	aspect	NNS
cord-005453-4057qib7	16123	3	assessed	assess	VBN
cord-005453-4057qib7	16123	4	during	during	IN
cord-005453-4057qib7	16123	5	the	the	DT
cord-005453-4057qib7	16123	6	infusion	infusion	NN
cord-005453-4057qib7	16123	7	were	be	VBD
cord-005453-4057qib7	16123	8	pain	pain	NN
cord-005453-4057qib7	16123	9	,	,	,
cord-005453-4057qib7	16123	10	cold	cold	JJ
cord-005453-4057qib7	16123	11	sensation	sensation	NN
cord-005453-4057qib7	16123	12	and	and	CC
cord-005453-4057qib7	16123	13	signs	sign	NNS
cord-005453-4057qib7	16123	14	of	of	IN
cord-005453-4057qib7	16123	15	extravasation	extravasation	NN
cord-005453-4057qib7	16123	16	in	in	IN
cord-005453-4057qib7	16123	17	the	the	DT
cord-005453-4057qib7	16123	18	area	area	NN
cord-005453-4057qib7	16123	19	of	of	IN
cord-005453-4057qib7	16123	20	PIVC	PIVC	NNP
cord-005453-4057qib7	16123	21	insertion	insertion	NN
cord-005453-4057qib7	16123	22	.	.	.
cord-005453-4057qib7	16124	1	After	after	IN
cord-005453-4057qib7	16124	2	the	the	DT
cord-005453-4057qib7	16124	3	infusion	infusion	NN
cord-005453-4057qib7	16124	4	,	,	,
cord-005453-4057qib7	16124	5	the	the	DT
cord-005453-4057qib7	16124	6	recovery	recovery	NN
cord-005453-4057qib7	16124	7	time	time	NN
cord-005453-4057qib7	16124	8	of	of	IN
cord-005453-4057qib7	16124	9	the	the	DT
cord-005453-4057qib7	16124	10	granulocyte	granulocyte	NNP
cord-005453-4057qib7	16124	11	series	series	NN
cord-005453-4057qib7	16124	12	and	and	CC
cord-005453-4057qib7	16124	13	platelet	platelet	NN
cord-005453-4057qib7	16124	14	were	be	VBD
cord-005453-4057qib7	16124	15	evaluated	evaluate	VBN
cord-005453-4057qib7	16124	16	.	.	.
cord-005453-4057qib7	16125	1	Results	result	NNS
cord-005453-4057qib7	16125	2	:	:	:
cord-005453-4057qib7	16126	1	Median	median	JJ
cord-005453-4057qib7	16126	2	volume	volume	NN
cord-005453-4057qib7	16126	3	and	and	CC
cord-005453-4057qib7	16126	4	bags	bag	NNS
cord-005453-4057qib7	16126	5	administered	administer	VBN
cord-005453-4057qib7	16126	6	was	be	VBD
cord-005453-4057qib7	16126	7	480	480	CD
cord-005453-4057qib7	16126	8	(	(	-LRB-
cord-005453-4057qib7	16126	9	360	360	CD
cord-005453-4057qib7	16126	10	-	-	HYPH
cord-005453-4057qib7	16126	11	600	600	CD
cord-005453-4057qib7	16126	12	)	)	-RRB-
cord-005453-4057qib7	16126	13	mL	ml	NN
cord-005453-4057qib7	16126	14	and	and	CC
cord-005453-4057qib7	16126	15	4	4	CD
cord-005453-4057qib7	16126	16	(	(	-LRB-
cord-005453-4057qib7	16126	17	3	3	CD
cord-005453-4057qib7	16126	18	)	)	-RRB-
cord-005453-4057qib7	16127	1	(	(	-LRB-
cord-005453-4057qib7	16127	2	4	4	LS
cord-005453-4057qib7	16127	3	)	)	-RRB-
cord-005453-4057qib7	16127	4	(	(	-LRB-
cord-005453-4057qib7	16127	5	5	5	CD
cord-005453-4057qib7	16127	6	)	)	-RRB-
cord-005453-4057qib7	16127	7	.	.	.
cord-005453-4057qib7	16128	1	The	the	DT
cord-005453-4057qib7	16128	2	median	median	NN
cord-005453-4057qib7	16128	3	of	of	IN
cord-005453-4057qib7	16128	4	total	total	JJ
cord-005453-4057qib7	16128	5	nucleated	nucleated	JJ
cord-005453-4057qib7	16128	6	cells	cell	NNS
cord-005453-4057qib7	16128	7	,	,	,
cord-005453-4057qib7	16128	8	total	total	JJ
cord-005453-4057qib7	16128	9	nucleated	nucleated	JJ
cord-005453-4057qib7	16128	10	cells	cell	NNS
cord-005453-4057qib7	16128	11	/	/	SYM
cord-005453-4057qib7	16128	12	mL	ml	NN
cord-005453-4057qib7	16128	13	and	and	CC
cord-005453-4057qib7	16129	1	total	total	JJ
cord-005453-4057qib7	16129	2	CD34	CD34	NNP
cord-005453-4057qib7	16130	1	+	+	CC
cord-005453-4057qib7	16131	1	cells	cell	NNS
cord-005453-4057qib7	16131	2	/	/	SYM
cord-005453-4057qib7	16131	3	Kg	Kg	NNP
cord-005453-4057qib7	16131	4	was	be	VBD
cord-005453-4057qib7	16131	5	462.6	462.6	CD
cord-005453-4057qib7	16131	6	x	x	SYM
cord-005453-4057qib7	16131	7	10	10	CD
cord-005453-4057qib7	16131	8	8	8	CD
cord-005453-4057qib7	16131	9	(	(	-LRB-
cord-005453-4057qib7	16131	10	329.5	329.5	CD
cord-005453-4057qib7	16131	11	-	-	HYPH
cord-005453-4057qib7	16131	12	657.8	657.8	CD
cord-005453-4057qib7	16131	13	)	)	-RRB-
cord-005453-4057qib7	16131	14	,	,	.
cord-005453-4057qib7	16132	1	107.3	107.3	CD
cord-005453-4057qib7	16132	2	x	x	SYM
cord-005453-4057qib7	16132	3	10	10	CD
cord-005453-4057qib7	16132	4	8	8	CD
cord-005453-4057qib7	16132	5	(	(	-LRB-
cord-005453-4057qib7	16132	6	64.66	64.66	CD
cord-005453-4057qib7	16132	7	-	-	SYM
cord-005453-4057qib7	16132	8	156.7	156.7	CD
cord-005453-4057qib7	16132	9	)	)	-RRB-
cord-005453-4057qib7	16132	10	and	and	CC
cord-005453-4057qib7	16132	11	3.24	3.24	CD
cord-005453-4057qib7	16132	12	(	(	-LRB-
cord-005453-4057qib7	16132	13	2.46	2.46	CD
cord-005453-4057qib7	16132	14	-	-	SYM
cord-005453-4057qib7	16132	15	4.6	4.6	CD
cord-005453-4057qib7	16132	16	)	)	-RRB-
cord-005453-4057qib7	16132	17	respectively	respectively	RB
cord-005453-4057qib7	16132	18	.	.	.
cord-005453-4057qib7	16133	1	Vital	vital	JJ
cord-005453-4057qib7	16133	2	signs	sign	NNS
cord-005453-4057qib7	16133	3	were	be	VBD
cord-005453-4057qib7	16133	4	within	within	IN
cord-005453-4057qib7	16133	5	the	the	DT
cord-005453-4057qib7	16133	6	normal	normal	JJ
cord-005453-4057qib7	16133	7	range	range	NN
cord-005453-4057qib7	16133	8	and	and	CC
cord-005453-4057qib7	16133	9	allowed	allow	VBD
cord-005453-4057qib7	16133	10	to	to	TO
cord-005453-4057qib7	16133	11	perform	perform	VB
cord-005453-4057qib7	16133	12	the	the	DT
cord-005453-4057qib7	16133	13	infusion	infusion	NN
cord-005453-4057qib7	16133	14	in	in	IN
cord-005453-4057qib7	16133	15	an	an	DT
cord-005453-4057qib7	16133	16	average	average	NN
cord-005453-4057qib7	16133	17	of	of	IN
cord-005453-4057qib7	16133	18	20	20	CD
cord-005453-4057qib7	16133	19	-	-	SYM
cord-005453-4057qib7	16133	20	30	30	CD
cord-005453-4057qib7	16133	21	minutes	minute	NNS
cord-005453-4057qib7	16133	22	/	/	SYM
cord-005453-4057qib7	16133	23	bag	bag	NN
cord-005453-4057qib7	16133	24	.	.	.
cord-005453-4057qib7	16134	1	No	no	DT
cord-005453-4057qib7	16134	2	patient	patient	NN
cord-005453-4057qib7	16134	3	required	require	VBD
cord-005453-4057qib7	16134	4	stopping	stop	VBG
cord-005453-4057qib7	16134	5	the	the	DT
cord-005453-4057qib7	16134	6	infusion	infusion	NN
cord-005453-4057qib7	16134	7	due	due	IN
cord-005453-4057qib7	16134	8	to	to	IN
cord-005453-4057qib7	16134	9	pain	pain	NN
cord-005453-4057qib7	16134	10	in	in	IN
cord-005453-4057qib7	16134	11	the	the	DT
cord-005453-4057qib7	16134	12	area	area	NN
cord-005453-4057qib7	16134	13	of	of	IN
cord-005453-4057qib7	16134	14	peripheral	peripheral	JJ
cord-005453-4057qib7	16134	15	catheter	catheter	NN
cord-005453-4057qib7	16134	16	insertion	insertion	NN
cord-005453-4057qib7	16134	17	and	and	CC
cord-005453-4057qib7	16134	18	no	no	DT
cord-005453-4057qib7	16134	19	extravasations	extravasation	NNS
cord-005453-4057qib7	16134	20	were	be	VBD
cord-005453-4057qib7	16134	21	detected	detect	VBN
cord-005453-4057qib7	16134	22	.	.	.
cord-005453-4057qib7	16135	1	All	all	DT
cord-005453-4057qib7	16135	2	patients	patient	NNS
cord-005453-4057qib7	16135	3	referred	refer	VBD
cord-005453-4057qib7	16135	4	some	some	DT
cord-005453-4057qib7	16135	5	cold	cold	JJ
cord-005453-4057qib7	16135	6	sensation	sensation	NN
cord-005453-4057qib7	16135	7	in	in	IN
cord-005453-4057qib7	16135	8	the	the	DT
cord-005453-4057qib7	16135	9	insertion	insertion	NN
cord-005453-4057qib7	16135	10	vein	vein	NN
cord-005453-4057qib7	16135	11	and	and	CC
cord-005453-4057qib7	16135	12	its	-PRON-	PRP$
cord-005453-4057qib7	16135	13	path	path	NN
cord-005453-4057qib7	16135	14	.	.	.
cord-005453-4057qib7	16136	1	Median	median	JJ
cord-005453-4057qib7	16136	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16136	3	recovery	recovery	NN
cord-005453-4057qib7	16136	4	was	be	VBD
cord-005453-4057qib7	16136	5	14	14	CD
cord-005453-4057qib7	16136	6	(	(	-LRB-
cord-005453-4057qib7	16136	7	11	11	CD
cord-005453-4057qib7	16136	8	-	-	SYM
cord-005453-4057qib7	16136	9	19	19	CD
cord-005453-4057qib7	16136	10	)	)	-RRB-
cord-005453-4057qib7	16136	11	days	day	NNS
cord-005453-4057qib7	16136	12	for	for	IN
cord-005453-4057qib7	16136	13	neutrophils	neutrophil	NNS
cord-005453-4057qib7	16136	14	and	and	CC
cord-005453-4057qib7	16136	15	11	11	CD
cord-005453-4057qib7	16136	16	(	(	-LRB-
cord-005453-4057qib7	16136	17	0	0	CD
cord-005453-4057qib7	16136	18	-	-	SYM
cord-005453-4057qib7	16136	19	19	19	CD
cord-005453-4057qib7	16136	20	)	)	-RRB-
cord-005453-4057qib7	16136	21	days	day	NNS
cord-005453-4057qib7	16136	22	for	for	IN
cord-005453-4057qib7	16136	23	platelets	platelet	NNS
cord-005453-4057qib7	16136	24	,	,	,
cord-005453-4057qib7	16136	25	similar	similar	JJ
cord-005453-4057qib7	16136	26	to	to	IN
cord-005453-4057qib7	16136	27	the	the	DT
cord-005453-4057qib7	16136	28	recovery	recovery	NN
cord-005453-4057qib7	16136	29	experienced	experience	VBN
cord-005453-4057qib7	16136	30	from	from	IN
cord-005453-4057qib7	16136	31	patients	patient	NNS
cord-005453-4057qib7	16136	32	who	who	WP
cord-005453-4057qib7	16136	33	received	receive	VBD
cord-005453-4057qib7	16136	34	cHPC	chpc	NN
cord-005453-4057qib7	16136	35	through	through	IN
cord-005453-4057qib7	16136	36	CVC.Conclusions	cvc.conclusion	NNS
cord-005453-4057qib7	16136	37	:	:	:
cord-005453-4057qib7	16137	1	Based	base	VBN
cord-005453-4057qib7	16137	2	on	on	IN
cord-005453-4057qib7	16137	3	our	-PRON-	PRP$
cord-005453-4057qib7	16137	4	data	datum	NNS
cord-005453-4057qib7	16137	5	,	,	,
cord-005453-4057qib7	16137	6	we	-PRON-	PRP
cord-005453-4057qib7	16137	7	conclude	conclude	VBP
cord-005453-4057qib7	16137	8	that	that	IN
cord-005453-4057qib7	16137	9	the	the	DT
cord-005453-4057qib7	16137	10	administration	administration	NN
cord-005453-4057qib7	16137	11	of	of	IN
cord-005453-4057qib7	16137	12	cHPC	cHPC	NNP
cord-005453-4057qib7	16137	13	,	,	,
cord-005453-4057qib7	16137	14	through	through	IN
cord-005453-4057qib7	16137	15	PIVC	PIVC	NNP
cord-005453-4057qib7	16137	16	and	and	CC
cord-005453-4057qib7	16137	17	by	by	IN
cord-005453-4057qib7	16137	18	gravity	gravity	NN
cord-005453-4057qib7	16137	19	is	be	VBZ
cord-005453-4057qib7	16137	20	safe	safe	JJ
cord-005453-4057qib7	16137	21	for	for	IN
cord-005453-4057qib7	16137	22	the	the	DT
cord-005453-4057qib7	16137	23	product	product	NN
cord-005453-4057qib7	16137	24	and	and	CC
cord-005453-4057qib7	16137	25	for	for	IN
cord-005453-4057qib7	16137	26	the	the	DT
cord-005453-4057qib7	16137	27	patient	patient	NN
cord-005453-4057qib7	16137	28	,	,	,
cord-005453-4057qib7	16137	29	being	be	VBG
cord-005453-4057qib7	16137	30	the	the	DT
cord-005453-4057qib7	16137	31	preferred	preferred	JJ
cord-005453-4057qib7	16137	32	choice	choice	NN
cord-005453-4057qib7	16137	33	for	for	IN
cord-005453-4057qib7	16137	34	patients	patient	NNS
cord-005453-4057qib7	16137	35	suffering	suffer	VBG
cord-005453-4057qib7	16137	36	from	from	IN
cord-005453-4057qib7	16137	37	some	some	DT
cord-005453-4057qib7	16137	38	type	type	NN
cord-005453-4057qib7	16137	39	of	of	IN
cord-005453-4057qib7	16137	40	cardiovascular	cardiovascular	JJ
cord-005453-4057qib7	16137	41	disease	disease	NN
cord-005453-4057qib7	16137	42	.	.	.
cord-005453-4057qib7	16138	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16138	2	:	:	:
cord-005453-4057qib7	16138	3	Nothing	nothing	NN
cord-005453-4057qib7	16138	4	to	to	TO
cord-005453-4057qib7	16138	5	declare	declare	VB
cord-005453-4057qib7	16138	6	Background	background	NN
cord-005453-4057qib7	16138	7	:	:	:
cord-005453-4057qib7	16139	1	By	by	IN
cord-005453-4057qib7	16139	2	selective	selective	JJ
cord-005453-4057qib7	16139	3	depletion	depletion	NN
cord-005453-4057qib7	16139	4	of	of	IN
cord-005453-4057qib7	16139	5	potentially	potentially	RB
cord-005453-4057qib7	16139	6	alloreactive	alloreactive	JJ
cord-005453-4057qib7	16139	7	CD45RA	CD45RA	NNP
cord-005453-4057qib7	16139	8	+	+	CC
cord-005453-4057qib7	16139	9	cells	cell	NNS
cord-005453-4057qib7	16139	10	,	,	,
cord-005453-4057qib7	16139	11	T	T	NNP
cord-005453-4057qib7	16139	12	memory	memory	NN
cord-005453-4057qib7	16139	13	cells	cell	NNS
cord-005453-4057qib7	16139	14	might	may	MD
cord-005453-4057qib7	16139	15	be	be	VB
cord-005453-4057qib7	16139	16	retained	retain	VBN
cord-005453-4057qib7	16139	17	in	in	IN
cord-005453-4057qib7	16139	18	the	the	DT
cord-005453-4057qib7	16139	19	graft	graft	NN
cord-005453-4057qib7	16139	20	and	and	CC
cord-005453-4057qib7	16139	21	could	could	MD
cord-005453-4057qib7	16139	22	mediate	mediate	VB
cord-005453-4057qib7	16139	23	pathogen	pathogen	NN
cord-005453-4057qib7	16139	24	specific	specific	JJ
cord-005453-4057qib7	16139	25	immunity	immunity	NN
cord-005453-4057qib7	16139	26	.	.	.
cord-005453-4057qib7	16140	1	However	however	RB
cord-005453-4057qib7	16140	2	,	,	,
cord-005453-4057qib7	16140	3	CD45RA	cd45ra	NN
cord-005453-4057qib7	16140	4	expression	expression	NN
cord-005453-4057qib7	16140	5	is	be	VBZ
cord-005453-4057qib7	16140	6	not	not	RB
cord-005453-4057qib7	16140	7	restricted	restrict	VBN
cord-005453-4057qib7	16140	8	to	to	IN
cord-005453-4057qib7	16140	9	naïve	naïve	JJ
cord-005453-4057qib7	16140	10	T	t	NN
cord-005453-4057qib7	16140	11	cells	cell	NNS
cord-005453-4057qib7	16140	12	,	,	,
cord-005453-4057qib7	16140	13	but	but	CC
cord-005453-4057qib7	16140	14	also	also	RB
cord-005453-4057qib7	16140	15	available	available	JJ
cord-005453-4057qib7	16140	16	on	on	IN
cord-005453-4057qib7	16140	17	B	b	NN
cord-005453-4057qib7	16140	18	cells	cell	NNS
cord-005453-4057qib7	16140	19	,	,	,
cord-005453-4057qib7	16140	20	NK	NK	NNP
cord-005453-4057qib7	16140	21	cells	cell	NNS
cord-005453-4057qib7	16140	22	and	and	CC
cord-005453-4057qib7	16140	23	CD34	CD34	NNP
cord-005453-4057qib7	16140	24	+	+	CC
cord-005453-4057qib7	16140	25	stem	stem	NN
cord-005453-4057qib7	16140	26	cells	cell	NNS
cord-005453-4057qib7	16140	27	to	to	IN
cord-005453-4057qib7	16140	28	some	some	DT
cord-005453-4057qib7	16140	29	extent	extent	NN
cord-005453-4057qib7	16140	30	.	.	.
cord-005453-4057qib7	16141	1	Methods	method	NNS
cord-005453-4057qib7	16141	2	:	:	:
cord-005453-4057qib7	16141	3	Within	within	IN
cord-005453-4057qib7	16141	4	this	this	DT
cord-005453-4057qib7	16141	5	project	project	NN
cord-005453-4057qib7	16141	6	we	-PRON-	PRP
cord-005453-4057qib7	16141	7	aim	aim	VBP
cord-005453-4057qib7	16141	8	to	to	TO
cord-005453-4057qib7	16141	9	analyze	analyze	VB
cord-005453-4057qib7	16141	10	CD45RA	cd45ra	NN
cord-005453-4057qib7	16141	11	expression	expression	NN
cord-005453-4057qib7	16141	12	on	on	IN
cord-005453-4057qib7	16141	13	stem	stem	NN
cord-005453-4057qib7	16141	14	-	-	HYPH
cord-005453-4057qib7	16141	15	and	and	CC
cord-005453-4057qib7	16141	16	NK	NK	NNP
cord-005453-4057qib7	16141	17	cells	cell	NNS
cord-005453-4057qib7	16141	18	by	by	IN
cord-005453-4057qib7	16141	19	flow	flow	NN
cord-005453-4057qib7	16141	20	cytometric	cytometric	NNP
cord-005453-4057qib7	16141	21	analysis	analysis	NN
cord-005453-4057qib7	16141	22	to	to	TO
cord-005453-4057qib7	16141	23	estimate	estimate	VB
cord-005453-4057qib7	16141	24	the	the	DT
cord-005453-4057qib7	16141	25	eventual	eventual	JJ
cord-005453-4057qib7	16141	26	loss	loss	NN
cord-005453-4057qib7	16141	27	of	of	IN
cord-005453-4057qib7	16141	28	these	these	DT
cord-005453-4057qib7	16141	29	cells	cell	NNS
cord-005453-4057qib7	16141	30	during	during	IN
cord-005453-4057qib7	16141	31	CD45RA	cd45ra	NN
cord-005453-4057qib7	16141	32	-	-	HYPH
cord-005453-4057qib7	16141	33	depletion	depletion	NN
cord-005453-4057qib7	16141	34	.	.	.
cord-005453-4057qib7	16142	1	Furthermore	furthermore	RB
cord-005453-4057qib7	16142	2	,	,	,
cord-005453-4057qib7	16142	3	CliniMACS	clinimacs	NN
cord-005453-4057qib7	16142	4	depletion	depletion	NN
cord-005453-4057qib7	16142	5	following	follow	VBG
cord-005453-4057qib7	16142	6	a	a	DT
cord-005453-4057qib7	16142	7	one	one	CD
cord-005453-4057qib7	16142	8	-	-	HYPH
cord-005453-4057qib7	16142	9	step	step	NN
cord-005453-4057qib7	16142	10	approach	approach	NN
cord-005453-4057qib7	16142	11	of	of	IN
cord-005453-4057qib7	16142	12	direct	direct	JJ
cord-005453-4057qib7	16142	13	CD45RAdepletion	CD45RAdepletion	NNP
cord-005453-4057qib7	16142	14	and	and	CC
cord-005453-4057qib7	16142	15	a	a	DT
cord-005453-4057qib7	16142	16	two	two	CD
cord-005453-4057qib7	16142	17	-	-	HYPH
cord-005453-4057qib7	16142	18	step	step	NN
cord-005453-4057qib7	16142	19	approach	approach	NN
cord-005453-4057qib7	16142	20	with	with	IN
cord-005453-4057qib7	16142	21	primary	primary	JJ
cord-005453-4057qib7	16142	22	CD34selection	CD34selection	NNP
cord-005453-4057qib7	16142	23	followed	follow	VBN
cord-005453-4057qib7	16142	24	by	by	IN
cord-005453-4057qib7	16142	25	CD45RA	cd45ra	NN
cord-005453-4057qib7	16142	26	-	-	HYPH
cord-005453-4057qib7	16142	27	depletion	depletion	NN
cord-005453-4057qib7	16142	28	of	of	IN
cord-005453-4057qib7	16142	29	the	the	DT
cord-005453-4057qib7	16142	30	negative	negative	JJ
cord-005453-4057qib7	16142	31	fraction	fraction	NN
cord-005453-4057qib7	16142	32	was	be	VBD
cord-005453-4057qib7	16142	33	investigated	investigate	VBN
cord-005453-4057qib7	16142	34	.	.	.
cord-005453-4057qib7	16143	1	Results	result	NNS
cord-005453-4057qib7	16143	2	:	:	:
cord-005453-4057qib7	16143	3	CD45RA	cd45ra	NN
cord-005453-4057qib7	16143	4	expression	expression	NN
cord-005453-4057qib7	16143	5	on	on	IN
cord-005453-4057qib7	16143	6	CD34	CD34	NNP
cord-005453-4057qib7	16143	7	+	+	CC
cord-005453-4057qib7	16143	8	stem	stem	NN
cord-005453-4057qib7	16143	9	cells	cell	NNS
cord-005453-4057qib7	16143	10	was	be	VBD
cord-005453-4057qib7	16143	11	in	in	IN
cord-005453-4057qib7	16143	12	median	median	JJ
cord-005453-4057qib7	16143	13	16.9	16.9	CD
cord-005453-4057qib7	16143	14	%	%	NN
cord-005453-4057qib7	16143	15	.	.	.
cord-005453-4057qib7	16144	1	With	with	IN
cord-005453-4057qib7	16144	2	a	a	DT
cord-005453-4057qib7	16144	3	Median	Median	NNP
cord-005453-4057qib7	16144	4	of	of	IN
cord-005453-4057qib7	16144	5	99.4	99.4	CD
cord-005453-4057qib7	16144	6	%	%	NN
cord-005453-4057qib7	16144	7	CD45RA	cd45ra	NN
cord-005453-4057qib7	16144	8	expression	expression	NN
cord-005453-4057qib7	16144	9	was	be	VBD
cord-005453-4057qib7	16144	10	measurable	measurable	JJ
cord-005453-4057qib7	16144	11	on	on	IN
cord-005453-4057qib7	16144	12	nearly	nearly	RB
cord-005453-4057qib7	16144	13	all	all	DT
cord-005453-4057qib7	16144	14	B	b	NN
cord-005453-4057qib7	16144	15	cells	cell	NNS
cord-005453-4057qib7	16144	16	,	,	,
cord-005453-4057qib7	16144	17	which	which	WDT
cord-005453-4057qib7	16144	18	obviates	obviate	VBZ
cord-005453-4057qib7	16144	19	depletion	depletion	NN
cord-005453-4057qib7	16144	20	via	via	IN
cord-005453-4057qib7	16144	21	CD19	CD19	NNP
cord-005453-4057qib7	16144	22	.	.	.
cord-005453-4057qib7	16145	1	A	a	DT
cord-005453-4057qib7	16145	2	comparably	comparably	RB
cord-005453-4057qib7	16145	3	high	high	JJ
cord-005453-4057qib7	16145	4	CD45RA	cd45ra	NN
cord-005453-4057qib7	16145	5	expression	expression	NN
cord-005453-4057qib7	16145	6	of	of	IN
cord-005453-4057qib7	16145	7	in	in	IN
cord-005453-4057qib7	16145	8	median	median	JJ
cord-005453-4057qib7	16145	9	96.0	96.0	CD
cord-005453-4057qib7	16145	10	%	%	NN
cord-005453-4057qib7	16145	11	was	be	VBD
cord-005453-4057qib7	16145	12	detected	detect	VBN
cord-005453-4057qib7	16145	13	on	on	IN
cord-005453-4057qib7	16145	14	NK	NK	NNP
cord-005453-4057qib7	16145	15	cells	cell	NNS
cord-005453-4057qib7	16145	16	.	.	.
cord-005453-4057qib7	16146	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	16146	2	,	,	,
cord-005453-4057qib7	16146	3	the	the	DT
cord-005453-4057qib7	16146	4	amount	amount	NN
cord-005453-4057qib7	16146	5	of	of	IN
cord-005453-4057qib7	16146	6	NK	NK	NNP
cord-005453-4057qib7	16146	7	cells	cell	NNS
cord-005453-4057qib7	16146	8	in	in	IN
cord-005453-4057qib7	16146	9	the	the	DT
cord-005453-4057qib7	16146	10	CD45RA	cd45ra	NN
cord-005453-4057qib7	16146	11	-	-	HYPH
cord-005453-4057qib7	16146	12	depleted	deplete	VBN
cord-005453-4057qib7	16146	13	product	product	NN
cord-005453-4057qib7	16146	14	was	be	VBD
cord-005453-4057qib7	16146	15	0.24	0.24	CD
cord-005453-4057qib7	16146	16	%	%	NN
cord-005453-4057qib7	16146	17	.	.	.
cord-005453-4057qib7	16147	1	CliniMACS	clinimacs	NN
cord-005453-4057qib7	16147	2	depletion	depletion	NN
cord-005453-4057qib7	16147	3	following	follow	VBG
cord-005453-4057qib7	16147	4	one	one	CD
cord-005453-4057qib7	16147	5	-	-	HYPH
cord-005453-4057qib7	16147	6	step	step	NN
cord-005453-4057qib7	16147	7	approach	approach	NN
cord-005453-4057qib7	16147	8	resulted	result	VBD
cord-005453-4057qib7	16147	9	in	in	IN
cord-005453-4057qib7	16147	10	a	a	DT
cord-005453-4057qib7	16147	11	stem	stem	NN
cord-005453-4057qib7	16147	12	cell	cell	NN
cord-005453-4057qib7	16147	13	recovery	recovery	NN
cord-005453-4057qib7	16147	14	of	of	IN
cord-005453-4057qib7	16147	15	52.0	52.0	CD
cord-005453-4057qib7	16147	16	%	%	NN
cord-005453-4057qib7	16147	17	.	.	.
cord-005453-4057qib7	16148	1	Memory	memory	NN
cord-005453-4057qib7	16148	2	T	t	CD
cord-005453-4057qib7	16148	3	cell	cell	NN
cord-005453-4057qib7	16148	4	recovery	recovery	NN
cord-005453-4057qib7	16148	5	was	be	VBD
cord-005453-4057qib7	16148	6	24.2	24.2	CD
cord-005453-4057qib7	16148	7	%	%	NN
cord-005453-4057qib7	16148	8	following	follow	VBG
cord-005453-4057qib7	16148	9	one	one	CD
cord-005453-4057qib7	16148	10	-	-	HYPH
cord-005453-4057qib7	16148	11	step	step	NN
cord-005453-4057qib7	16148	12	and	and	CC
cord-005453-4057qib7	16148	13	42.0	42.0	CD
cord-005453-4057qib7	16148	14	%	%	NN
cord-005453-4057qib7	16148	15	applying	apply	VBG
cord-005453-4057qib7	16148	16	two	two	CD
cord-005453-4057qib7	16148	17	-	-	HYPH
cord-005453-4057qib7	16148	18	step	step	NN
cord-005453-4057qib7	16148	19	approach	approach	NN
cord-005453-4057qib7	16148	20	.	.	.
cord-005453-4057qib7	16149	1	Depletion	depletion	NN
cord-005453-4057qib7	16149	2	quality	quality	NN
cord-005453-4057qib7	16149	3	measured	measure	VBN
cord-005453-4057qib7	16149	4	by	by	IN
cord-005453-4057qib7	16149	5	log	log	NN
cord-005453-4057qib7	16149	6	-	-	HYPH
cord-005453-4057qib7	16149	7	depletion	depletion	NN
cord-005453-4057qib7	16149	8	was	be	VBD
cord-005453-4057qib7	16149	9	3.9	3.9	CD
cord-005453-4057qib7	16149	10	and	and	CC
cord-005453-4057qib7	16149	11	3.8	3.8	CD
cord-005453-4057qib7	16149	12	for	for	IN
cord-005453-4057qib7	16149	13	CD45RA	cd45ra	NN
cord-005453-4057qib7	16149	14	+	+	CC
cord-005453-4057qib7	16149	15	T	t	NN
cord-005453-4057qib7	16149	16	cells	cell	NNS
cord-005453-4057qib7	16149	17	and	and	CC
cord-005453-4057qib7	16149	18	3.2	3.2	CD
cord-005453-4057qib7	16149	19	and	and	CC
cord-005453-4057qib7	16149	20	3.6	3.6	CD
cord-005453-4057qib7	16149	21	for	for	IN
cord-005453-4057qib7	16149	22	CD19	CD19	NNP
cord-005453-4057qib7	16149	23	+	+	CC
cord-005453-4057qib7	16149	24	B	b	NN
cord-005453-4057qib7	16149	25	cells	cell	NNS
cord-005453-4057qib7	16149	26	for	for	IN
cord-005453-4057qib7	16149	27	one	one	CD
cord-005453-4057qib7	16149	28	-	-	HYPH
cord-005453-4057qib7	16149	29	and	and	CC
cord-005453-4057qib7	16149	30	two	two	CD
cord-005453-4057qib7	16149	31	-	-	HYPH
cord-005453-4057qib7	16149	32	step	step	NN
cord-005453-4057qib7	16149	33	approaches	approach	NNS
cord-005453-4057qib7	16149	34	,	,	,
cord-005453-4057qib7	16149	35	respectively	respectively	RB
cord-005453-4057qib7	16149	36	.	.	.
cord-005453-4057qib7	16150	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16150	2	:	:	:
cord-005453-4057qib7	16150	3	With	with	IN
cord-005453-4057qib7	16150	4	regard	regard	NN
cord-005453-4057qib7	16150	5	to	to	IN
cord-005453-4057qib7	16150	6	stem	stem	VB
cord-005453-4057qib7	16150	7	cell	cell	NN
cord-005453-4057qib7	16150	8	recovery	recovery	NN
cord-005453-4057qib7	16150	9	,	,	,
cord-005453-4057qib7	16150	10	a	a	DT
cord-005453-4057qib7	16150	11	previous	previous	JJ
cord-005453-4057qib7	16150	12	CD34-selection	cd34-selection	NN
cord-005453-4057qib7	16150	13	before	before	IN
cord-005453-4057qib7	16150	14	CD45RA	cd45ra	NN
cord-005453-4057qib7	16150	15	-	-	HYPH
cord-005453-4057qib7	16150	16	depletion	depletion	NN
cord-005453-4057qib7	16150	17	is	be	VBZ
cord-005453-4057qib7	16150	18	recommendable	recommendable	JJ
cord-005453-4057qib7	16150	19	.	.	.
cord-005453-4057qib7	16151	1	Background	background	NN
cord-005453-4057qib7	16151	2	:	:	:
cord-005453-4057qib7	16152	1	Current	current	JJ
cord-005453-4057qib7	16152	2	clinical	clinical	JJ
cord-005453-4057qib7	16152	3	practice	practice	NN
cord-005453-4057qib7	16152	4	of	of	IN
cord-005453-4057qib7	16152	5	routine	routine	JJ
cord-005453-4057qib7	16152	6	use	use	NN
cord-005453-4057qib7	16152	7	of	of	IN
cord-005453-4057qib7	16152	8	filters	filter	NNS
cord-005453-4057qib7	16152	9	for	for	IN
cord-005453-4057qib7	16152	10	infusion	infusion	NN
cord-005453-4057qib7	16152	11	of	of	IN
cord-005453-4057qib7	16152	12	autologous	autologous	JJ
cord-005453-4057qib7	16152	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16152	14	cell	cell	NN
cord-005453-4057qib7	16152	15	transplantation	transplantation	NN
cord-005453-4057qib7	16152	16	(	(	-LRB-
cord-005453-4057qib7	16152	17	AHCT	AHCT	NNP
cord-005453-4057qib7	16152	18	)	)	-RRB-
cord-005453-4057qib7	16152	19	at	at	IN
cord-005453-4057qib7	16152	20	bone	bone	NN
cord-005453-4057qib7	16152	21	marrow	marrow	NN
cord-005453-4057qib7	16152	22	transplant	transplant	NN
cord-005453-4057qib7	16152	23	centers	center	NNS
cord-005453-4057qib7	16152	24	across	across	IN
cord-005453-4057qib7	16152	25	North	North	NNP
cord-005453-4057qib7	16152	26	America	America	NNP
cord-005453-4057qib7	16152	27	and	and	CC
cord-005453-4057qib7	16152	28	Europe	Europe	NNP
cord-005453-4057qib7	16152	29	is	be	VBZ
cord-005453-4057qib7	16152	30	not	not	RB
cord-005453-4057qib7	16152	31	known	know	VBN
cord-005453-4057qib7	16152	32	.	.	.
cord-005453-4057qib7	16153	1	The	the	DT
cord-005453-4057qib7	16153	2	use	use	NN
cord-005453-4057qib7	16153	3	of	of	IN
cord-005453-4057qib7	16153	4	"	"	``
cord-005453-4057qib7	16153	5	Y	Y	NNP
cord-005453-4057qib7	16153	6	"	"	''
cord-005453-4057qib7	16153	7	administration	administration	NN
cord-005453-4057qib7	16153	8	tubing	tubing	NN
cord-005453-4057qib7	16153	9	without	without	IN
cord-005453-4057qib7	16153	10	a	a	DT
cord-005453-4057qib7	16153	11	filter	filter	NN
cord-005453-4057qib7	16153	12	could	could	MD
cord-005453-4057qib7	16153	13	possibly	possibly	RB
cord-005453-4057qib7	16153	14	increase	increase	VB
cord-005453-4057qib7	16153	15	the	the	DT
cord-005453-4057qib7	16153	16	risk	risk	NN
cord-005453-4057qib7	16153	17	of	of	IN
cord-005453-4057qib7	16153	18	infusion	infusion	NN
cord-005453-4057qib7	16153	19	of	of	IN
cord-005453-4057qib7	16153	20	macro	macro	NN
cord-005453-4057qib7	16153	21	-	-	HYPH
cord-005453-4057qib7	16153	22	aggregates	aggregate	NNS
cord-005453-4057qib7	16153	23	and	and	CC
cord-005453-4057qib7	16153	24	cellular	cellular	JJ
cord-005453-4057qib7	16153	25	debris	debris	NN
cord-005453-4057qib7	16153	26	,	,	,
cord-005453-4057qib7	16153	27	which	which	WDT
cord-005453-4057qib7	16153	28	may	may	MD
cord-005453-4057qib7	16153	29	result	result	VB
cord-005453-4057qib7	16153	30	in	in	IN
cord-005453-4057qib7	16153	31	increased	increase	VBN
cord-005453-4057qib7	16153	32	side	side	NN
cord-005453-4057qib7	16153	33	effects	effect	NNS
cord-005453-4057qib7	16153	34	.	.	.
cord-005453-4057qib7	16154	1	Methods	method	NNS
cord-005453-4057qib7	16154	2	:	:	:
cord-005453-4057qib7	16154	3	We	-PRON-	PRP
cord-005453-4057qib7	16154	4	carried	carry	VBD
cord-005453-4057qib7	16154	5	out	out	RP
cord-005453-4057qib7	16154	6	a	a	DT
cord-005453-4057qib7	16154	7	retrospective	retrospective	JJ
cord-005453-4057qib7	16154	8	chart	chart	NN
cord-005453-4057qib7	16154	9	review	review	NN
cord-005453-4057qib7	16154	10	of	of	IN
cord-005453-4057qib7	16154	11	patients	patient	NNS
cord-005453-4057qib7	16154	12	(	(	-LRB-
cord-005453-4057qib7	16154	13	pts	pts	NN
cord-005453-4057qib7	16154	14	)	)	-RRB-
cord-005453-4057qib7	16154	15	at	at	IN
cord-005453-4057qib7	16154	16	Spectrum	Spectrum	NNP
cord-005453-4057qib7	16154	17	Health	Health	NNP
cord-005453-4057qib7	16154	18	who	who	WP
cord-005453-4057qib7	16154	19	underwent	undergo	VBD
cord-005453-4057qib7	16154	20	AHCT	AHCT	NNP
cord-005453-4057qib7	16154	21	.	.	.
cord-005453-4057qib7	16155	1	Group	Group	NNP
cord-005453-4057qib7	16155	2	A	A	NNP
cord-005453-4057qib7	16155	3	(	(	-LRB-
cord-005453-4057qib7	16155	4	Gp	Gp	NNP
cord-005453-4057qib7	16155	5	A	A	NNP
cord-005453-4057qib7	16155	6	)	)	-RRB-
cord-005453-4057qib7	16155	7	pts	pts	NN
cord-005453-4057qib7	16155	8	received	receive	VBD
cord-005453-4057qib7	16155	9	AHCT	AHCT	NNP
cord-005453-4057qib7	16155	10	using	use	VBG
cord-005453-4057qib7	16155	11	a	a	DT
cord-005453-4057qib7	16155	12	"	"	``
cord-005453-4057qib7	16155	13	Y	Y	NNP
cord-005453-4057qib7	16155	14	"	"	''
cord-005453-4057qib7	16155	15	administration	administration	NN
cord-005453-4057qib7	16155	16	tubing	tubing	NN
cord-005453-4057qib7	16155	17	with	with	IN
cord-005453-4057qib7	16155	18	170-micron	170-micron	CD
cord-005453-4057qib7	16155	19	filter	filter	NN
cord-005453-4057qib7	16155	20	from	from	IN
cord-005453-4057qib7	16155	21	3/2013	3/2013	CD
cord-005453-4057qib7	16155	22	-3/2017	-3/2017	NFP
cord-005453-4057qib7	16155	23	.	.	.
cord-005453-4057qib7	16156	1	These	these	DT
cord-005453-4057qib7	16156	2	patients	patient	NNS
cord-005453-4057qib7	16156	3	were	be	VBD
cord-005453-4057qib7	16156	4	compared	compare	VBN
cord-005453-4057qib7	16156	5	to	to	IN
cord-005453-4057qib7	16156	6	a	a	DT
cord-005453-4057qib7	16156	7	control	control	NN
cord-005453-4057qib7	16156	8	group	group	NN
cord-005453-4057qib7	16156	9	(	(	-LRB-
cord-005453-4057qib7	16156	10	Gp	Gp	NNP
cord-005453-4057qib7	16156	11	B	B	NNP
cord-005453-4057qib7	16156	12	)	)	-RRB-
cord-005453-4057qib7	16156	13	that	that	WDT
cord-005453-4057qib7	16156	14	received	receive	VBD
cord-005453-4057qib7	16156	15	AHCT	AHCT	NNP
cord-005453-4057qib7	16156	16	without	without	IN
cord-005453-4057qib7	16156	17	filter	filter	NN
cord-005453-4057qib7	16156	18	administration	administration	NN
cord-005453-4057qib7	16156	19	tubing	tubing	NN
cord-005453-4057qib7	16156	20	from	from	IN
cord-005453-4057qib7	16156	21	3/2014	3/2014	CD
cord-005453-4057qib7	16156	22	-	-	:
cord-005453-4057qib7	16156	23	4/2016.This	4/2016.this	CD
cord-005453-4057qib7	16156	24	change	change	NN
cord-005453-4057qib7	16156	25	in	in	IN
cord-005453-4057qib7	16156	26	clinical	clinical	JJ
cord-005453-4057qib7	16156	27	practice	practice	NN
cord-005453-4057qib7	16156	28	occurred	occur	VBD
cord-005453-4057qib7	16156	29	due	due	IN
cord-005453-4057qib7	16156	30	to	to	IN
cord-005453-4057qib7	16156	31	a	a	DT
cord-005453-4057qib7	16156	32	change	change	NN
cord-005453-4057qib7	16156	33	in	in	IN
cord-005453-4057qib7	16156	34	policy	policy	NN
cord-005453-4057qib7	16156	35	at	at	IN
cord-005453-4057qib7	16156	36	our	-PRON-	PRP$
cord-005453-4057qib7	16156	37	transplant	transplant	NN
cord-005453-4057qib7	16156	38	center	center	NN
cord-005453-4057qib7	16156	39	as	as	IN
cord-005453-4057qib7	16156	40	a	a	DT
cord-005453-4057qib7	16156	41	result	result	NN
cord-005453-4057qib7	16156	42	of	of	IN
cord-005453-4057qib7	16156	43	inorganic	inorganic	JJ
cord-005453-4057qib7	16156	44	particles	particle	NNS
cord-005453-4057qib7	16156	45	noticed	notice	VBN
cord-005453-4057qib7	16156	46	during	during	IN
cord-005453-4057qib7	16156	47	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	16156	48	.	.	.
cord-005453-4057qib7	16157	1	We	-PRON-	PRP
cord-005453-4057qib7	16157	2	compared	compare	VBD
cord-005453-4057qib7	16157	3	the	the	DT
cord-005453-4057qib7	16157	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	16157	5	and	and	CC
cord-005453-4057qib7	16157	6	platelet	platelet	NN
cord-005453-4057qib7	16157	7	engraftment	engraftment	NN
cord-005453-4057qib7	16157	8	duration	duration	NN
cord-005453-4057qib7	16157	9	between	between	IN
cord-005453-4057qib7	16157	10	these	these	DT
cord-005453-4057qib7	16157	11	groups	group	NNS
cord-005453-4057qib7	16157	12	.	.	.
cord-005453-4057qib7	16158	1	We	-PRON-	PRP
cord-005453-4057qib7	16158	2	also	also	RB
cord-005453-4057qib7	16158	3	studied	study	VBD
cord-005453-4057qib7	16158	4	the	the	DT
cord-005453-4057qib7	16158	5	length	length	NN
cord-005453-4057qib7	16158	6	of	of	IN
cord-005453-4057qib7	16158	7	hospital	hospital	NN
cord-005453-4057qib7	16158	8	stay	stay	NN
cord-005453-4057qib7	16158	9	and	and	CC
cord-005453-4057qib7	16158	10	the	the	DT
cord-005453-4057qib7	16158	11	effect	effect	NN
cord-005453-4057qib7	16158	12	of	of	IN
cord-005453-4057qib7	16158	13	filter	filter	NN
cord-005453-4057qib7	16158	14	use	use	NN
cord-005453-4057qib7	16158	15	on	on	IN
cord-005453-4057qib7	16158	16	any	any	DT
cord-005453-4057qib7	16158	17	immediate	immediate	JJ
cord-005453-4057qib7	16158	18	side	side	NN
cord-005453-4057qib7	16158	19	effects	effect	NNS
cord-005453-4057qib7	16158	20	after	after	IN
cord-005453-4057qib7	16158	21	infusion	infusion	NN
cord-005453-4057qib7	16158	22	.	.	.
cord-005453-4057qib7	16159	1	Due	due	IN
cord-005453-4057qib7	16159	2	to	to	IN
cord-005453-4057qib7	16159	3	the	the	DT
cord-005453-4057qib7	16159	4	retrospective	retrospective	JJ
cord-005453-4057qib7	16159	5	nature	nature	NN
cord-005453-4057qib7	16159	6	of	of	IN
cord-005453-4057qib7	16159	7	the	the	DT
cord-005453-4057qib7	16159	8	study	study	NN
cord-005453-4057qib7	16159	9	it	-PRON-	PRP
cord-005453-4057qib7	16159	10	was	be	VBD
cord-005453-4057qib7	16159	11	not	not	RB
cord-005453-4057qib7	16159	12	feasible	feasible	JJ
cord-005453-4057qib7	16159	13	to	to	TO
cord-005453-4057qib7	16159	14	evaluate	evaluate	VB
cord-005453-4057qib7	16159	15	the	the	DT
cord-005453-4057qib7	16159	16	difference	difference	NN
cord-005453-4057qib7	16159	17	in	in	IN
cord-005453-4057qib7	16159	18	duration	duration	NN
cord-005453-4057qib7	16159	19	of	of	IN
cord-005453-4057qib7	16159	20	infusion	infusion	NN
cord-005453-4057qib7	16159	21	between	between	IN
cord-005453-4057qib7	16159	22	these	these	DT
cord-005453-4057qib7	16159	23	groups	group	NNS
cord-005453-4057qib7	16159	24	Results	result	NNS
cord-005453-4057qib7	16159	25	:	:	:
cord-005453-4057qib7	16160	1	The	the	DT
cord-005453-4057qib7	16160	2	two	two	CD
cord-005453-4057qib7	16160	3	groups	group	NNS
cord-005453-4057qib7	16160	4	were	be	VBD
cord-005453-4057qib7	16160	5	similar	similar	JJ
cord-005453-4057qib7	16160	6	in	in	IN
cord-005453-4057qib7	16160	7	their	-PRON-	PRP$
cord-005453-4057qib7	16160	8	age	age	NN
cord-005453-4057qib7	16160	9	,	,	,
cord-005453-4057qib7	16160	10	gender	gender	NN
cord-005453-4057qib7	16160	11	,	,	,
cord-005453-4057qib7	16160	12	primary	primary	JJ
cord-005453-4057qib7	16160	13	disease	disease	NN
cord-005453-4057qib7	16160	14	distribution	distribution	NN
cord-005453-4057qib7	16160	15	and	and	CC
cord-005453-4057qib7	16160	16	median	median	JJ
cord-005453-4057qib7	16160	17	number	number	NN
cord-005453-4057qib7	16160	18	of	of	IN
cord-005453-4057qib7	16160	19	CD34	CD34	NNP
cord-005453-4057qib7	16160	20	stem	stem	NN
cord-005453-4057qib7	16160	21	cells	cell	NNS
cord-005453-4057qib7	16160	22	infused	infuse	VBN
cord-005453-4057qib7	16160	23	(	(	-LRB-
cord-005453-4057qib7	16160	24	Table	table	NN
cord-005453-4057qib7	16160	25	)	)	-RRB-
cord-005453-4057qib7	16160	26	.	.	.
cord-005453-4057qib7	16161	1	There	there	EX
cord-005453-4057qib7	16161	2	was	be	VBD
cord-005453-4057qib7	16161	3	no	no	DT
cord-005453-4057qib7	16161	4	difference	difference	NN
cord-005453-4057qib7	16161	5	in	in	IN
cord-005453-4057qib7	16161	6	median	median	JJ
cord-005453-4057qib7	16161	7	neutrophil	neutrophil	NN
cord-005453-4057qib7	16161	8	(	(	-LRB-
cord-005453-4057qib7	16161	9	11	11	CD
cord-005453-4057qib7	16161	10	vs	vs	IN
cord-005453-4057qib7	16161	11	11	11	CD
cord-005453-4057qib7	16161	12	days	day	NNS
cord-005453-4057qib7	16161	13	)	)	-RRB-
cord-005453-4057qib7	16161	14	or	or	CC
cord-005453-4057qib7	16161	15	platelet	platelet	NN
cord-005453-4057qib7	16161	16	engraftment	engraftment	NN
cord-005453-4057qib7	16161	17	(	(	-LRB-
cord-005453-4057qib7	16161	18	19	19	CD
cord-005453-4057qib7	16161	19	vs	vs	IN
cord-005453-4057qib7	16161	20	19	19	CD
cord-005453-4057qib7	16161	21	days	day	NNS
cord-005453-4057qib7	16161	22	)	)	-RRB-
cord-005453-4057qib7	16161	23	duration	duration	NN
cord-005453-4057qib7	16161	24	for	for	IN
cord-005453-4057qib7	16161	25	the	the	DT
cord-005453-4057qib7	16161	26	filter	filter	NN
cord-005453-4057qib7	16161	27	group	group	NN
cord-005453-4057qib7	16161	28	and	and	CC
cord-005453-4057qib7	16161	29	the	the	DT
cord-005453-4057qib7	16161	30	nonfilter	nonfilter	NNP
cord-005453-4057qib7	16161	31	group	group	NNP
cord-005453-4057qib7	16161	32	respectively	respectively	RB
cord-005453-4057qib7	16161	33	.	.	.
cord-005453-4057qib7	16162	1	The	the	DT
cord-005453-4057qib7	16162	2	median	median	JJ
cord-005453-4057qib7	16162	3	length	length	NN
cord-005453-4057qib7	16162	4	of	of	IN
cord-005453-4057qib7	16162	5	hospital	hospital	NN
cord-005453-4057qib7	16162	6	stay	stay	NN
cord-005453-4057qib7	16162	7	was	be	VBD
cord-005453-4057qib7	16162	8	also	also	RB
cord-005453-4057qib7	16162	9	comparable	comparable	JJ
cord-005453-4057qib7	16162	10	(	(	-LRB-
cord-005453-4057qib7	16162	11	17	17	CD
cord-005453-4057qib7	16162	12	days	day	NNS
cord-005453-4057qib7	16162	13	)	)	-RRB-
cord-005453-4057qib7	16162	14	.	.	.
cord-005453-4057qib7	16163	1	There	there	EX
cord-005453-4057qib7	16163	2	was	be	VBD
cord-005453-4057qib7	16163	3	no	no	DT
cord-005453-4057qib7	16163	4	statistically	statistically	RB
cord-005453-4057qib7	16163	5	significant	significant	JJ
cord-005453-4057qib7	16163	6	difference	difference	NN
cord-005453-4057qib7	16163	7	in	in	IN
cord-005453-4057qib7	16163	8	the	the	DT
cord-005453-4057qib7	16163	9	immediate	immediate	JJ
cord-005453-4057qib7	16163	10	side	side	NN
cord-005453-4057qib7	16163	11	effects	effect	NNS
cord-005453-4057qib7	16163	12	(	(	-LRB-
cord-005453-4057qib7	16163	13	fever	fever	NN
cord-005453-4057qib7	16163	14	,	,	,
cord-005453-4057qib7	16163	15	cough	cough	NN
cord-005453-4057qib7	16163	16	,	,	,
cord-005453-4057qib7	16163	17	dyspnea	dyspnea	NN
cord-005453-4057qib7	16163	18	,	,	,
cord-005453-4057qib7	16163	19	fluid	fluid	JJ
cord-005453-4057qib7	16163	20	overload	overload	NN
cord-005453-4057qib7	16163	21	,	,	,
cord-005453-4057qib7	16163	22	flushing	flushing	NN
cord-005453-4057qib7	16163	23	,	,	,
cord-005453-4057qib7	16163	24	nausea	nausea	NN
cord-005453-4057qib7	16163	25	,	,	,
cord-005453-4057qib7	16163	26	vomiting	vomiting	NN
cord-005453-4057qib7	16163	27	,	,	,
cord-005453-4057qib7	16163	28	hypertension	hypertension	NN
cord-005453-4057qib7	16163	29	,	,	,
cord-005453-4057qib7	16163	30	hypotension	hypotension	NN
cord-005453-4057qib7	16163	31	and	and	CC
cord-005453-4057qib7	16163	32	anaphylaxis	anaphylaxis	NN
cord-005453-4057qib7	16163	33	)	)	-RRB-
cord-005453-4057qib7	16163	34	or	or	CC
cord-005453-4057qib7	16163	35	confirmed	confirm	VBD
cord-005453-4057qib7	16163	36	post	post	JJ
cord-005453-4057qib7	16163	37	-	-	JJ
cord-005453-4057qib7	16163	38	transplant	transplant	JJ
cord-005453-4057qib7	16163	39	infections	infection	NNS
cord-005453-4057qib7	16163	40	(	(	-LRB-
cord-005453-4057qib7	16163	41	viral	viral	JJ
cord-005453-4057qib7	16163	42	,	,	,
cord-005453-4057qib7	16163	43	bacterial	bacterial	JJ
cord-005453-4057qib7	16163	44	,	,	,
cord-005453-4057qib7	16163	45	fungal	fungal	NN
cord-005453-4057qib7	16163	46	)	)	-RRB-
cord-005453-4057qib7	16163	47	experienced	experience	VBN
cord-005453-4057qib7	16163	48	by	by	IN
cord-005453-4057qib7	16163	49	these	these	DT
cord-005453-4057qib7	16163	50	two	two	CD
cord-005453-4057qib7	16163	51	groups	group	NNS
cord-005453-4057qib7	16163	52	.	.	.
cord-005453-4057qib7	16164	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16164	2	:	:	:
cord-005453-4057qib7	16165	1	Our	-PRON-	PRP$
cord-005453-4057qib7	16165	2	results	result	NNS
cord-005453-4057qib7	16165	3	show	show	VBP
cord-005453-4057qib7	16165	4	that	that	IN
cord-005453-4057qib7	16165	5	the	the	DT
cord-005453-4057qib7	16165	6	routine	routine	JJ
cord-005453-4057qib7	16165	7	use	use	NN
cord-005453-4057qib7	16165	8	of	of	IN
cord-005453-4057qib7	16165	9	filter	filter	NN
cord-005453-4057qib7	16165	10	does	do	VBZ
cord-005453-4057qib7	16165	11	not	not	RB
cord-005453-4057qib7	16165	12	prolong	prolong	VB
cord-005453-4057qib7	16165	13	hospital	hospital	NN
cord-005453-4057qib7	16165	14	stay	stay	NN
cord-005453-4057qib7	16165	15	,	,	,
cord-005453-4057qib7	16165	16	and	and	CC
cord-005453-4057qib7	16165	17	neutrophil/	neutrophil/	CD
cord-005453-4057qib7	16165	18	platelet	platelet	NN
cord-005453-4057qib7	16165	19	engraftment	engraftment	NN
cord-005453-4057qib7	16165	20	duration	duration	NN
cord-005453-4057qib7	16165	21	,	,	,
cord-005453-4057qib7	16165	22	thereby	thereby	RB
cord-005453-4057qib7	16165	23	,	,	,
cord-005453-4057qib7	16165	24	suggesting	suggest	VBG
cord-005453-4057qib7	16165	25	that	that	IN
cord-005453-4057qib7	16165	26	viable	viable	JJ
cord-005453-4057qib7	16165	27	stem	stem	NN
cord-005453-4057qib7	16165	28	cells	cell	NNS
cord-005453-4057qib7	16165	29	are	be	VBP
cord-005453-4057qib7	16165	30	not	not	RB
cord-005453-4057qib7	16165	31	affected	affect	VBN
cord-005453-4057qib7	16165	32	.	.	.
cord-005453-4057qib7	16166	1	On	on	IN
cord-005453-4057qib7	16166	2	the	the	DT
cord-005453-4057qib7	16166	3	other	other	JJ
cord-005453-4057qib7	16166	4	hand	hand	NN
cord-005453-4057qib7	16166	5	,	,	,
cord-005453-4057qib7	16166	6	filter	filter	NN
cord-005453-4057qib7	16166	7	use	use	NN
cord-005453-4057qib7	16166	8	failed	fail	VBD
cord-005453-4057qib7	16166	9	to	to	TO
cord-005453-4057qib7	16166	10	demonstrate	demonstrate	VB
cord-005453-4057qib7	16166	11	any	any	DT
cord-005453-4057qib7	16166	12	appreciable	appreciable	JJ
cord-005453-4057qib7	16166	13	decline	decline	NN
cord-005453-4057qib7	16166	14	in	in	IN
cord-005453-4057qib7	16166	15	the	the	DT
cord-005453-4057qib7	16166	16	immediate	immediate	JJ
cord-005453-4057qib7	16166	17	side	side	NN
cord-005453-4057qib7	16166	18	effects	effect	NNS
cord-005453-4057qib7	16166	19	experienced	experience	VBN
cord-005453-4057qib7	16166	20	after	after	IN
cord-005453-4057qib7	16166	21	AHCT	AHCT	NNP
cord-005453-4057qib7	16166	22	.	.	.
cord-005453-4057qib7	16167	1	Gp	Gp	NNP
cord-005453-4057qib7	16167	2	Background	background	NN
cord-005453-4057qib7	16167	3	:	:	:
cord-005453-4057qib7	16167	4	Allo	Allo	NNP
cord-005453-4057qib7	16167	5	-	-	HYPH
cord-005453-4057qib7	16167	6	HSCT	HSCT	NNP
cord-005453-4057qib7	16167	7	from	from	IN
cord-005453-4057qib7	16167	8	related	related	JJ
cord-005453-4057qib7	16167	9	haplo	haplo	NN
cord-005453-4057qib7	16167	10	-	-	HYPH
cord-005453-4057qib7	16167	11	identical	identical	JJ
cord-005453-4057qib7	16167	12	donors	donor	NNS
cord-005453-4057qib7	16167	13	(	(	-LRB-
cord-005453-4057qib7	16167	14	Haplo	Haplo	NNP
cord-005453-4057qib7	16167	15	-	-	HYPH
cord-005453-4057qib7	16167	16	HSCT	HSCT	NNP
cord-005453-4057qib7	16167	17	)	)	-RRB-
cord-005453-4057qib7	16167	18	with	with	IN
cord-005453-4057qib7	16167	19	post	post	JJ
cord-005453-4057qib7	16167	20	-	-	JJ
cord-005453-4057qib7	16167	21	transplant	transplant	JJ
cord-005453-4057qib7	16167	22	high	high	JJ
cord-005453-4057qib7	16167	23	-	-	HYPH
cord-005453-4057qib7	16167	24	dose	dose	NN
cord-005453-4057qib7	16167	25	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	16167	26	is	be	VBZ
cord-005453-4057qib7	16167	27	increasingly	increasingly	RB
cord-005453-4057qib7	16167	28	employed	employ	VBN
cord-005453-4057qib7	16167	29	in	in	IN
cord-005453-4057qib7	16167	30	patients	patient	NNS
cord-005453-4057qib7	16167	31	who	who	WP
cord-005453-4057qib7	16167	32	lack	lack	VBP
cord-005453-4057qib7	16167	33	a	a	DT
cord-005453-4057qib7	16167	34	matched	match	VBN
cord-005453-4057qib7	16167	35	related	related	JJ
cord-005453-4057qib7	16167	36	or	or	CC
cord-005453-4057qib7	16167	37	unrelated	unrelated	JJ
cord-005453-4057qib7	16167	38	donor	donor	NN
cord-005453-4057qib7	16167	39	.	.	.
cord-005453-4057qib7	16168	1	The	the	DT
cord-005453-4057qib7	16168	2	current	current	JJ
cord-005453-4057qib7	16168	3	standard	standard	NN
cord-005453-4057qib7	16168	4	is	be	VBZ
cord-005453-4057qib7	16168	5	to	to	TO
cord-005453-4057qib7	16168	6	use	use	VB
cord-005453-4057qib7	16168	7	bone	bone	NN
cord-005453-4057qib7	16168	8	marrow	marrow	NN
cord-005453-4057qib7	16168	9	grafts	graft	NNS
cord-005453-4057qib7	16168	10	(	(	-LRB-
cord-005453-4057qib7	16168	11	BM	BM	NNP
cord-005453-4057qib7	16168	12	)	)	-RRB-
cord-005453-4057qib7	16168	13	as	as	IN
cord-005453-4057qib7	16168	14	peripheral	peripheral	JJ
cord-005453-4057qib7	16168	15	blood	blood	NN
cord-005453-4057qib7	16168	16	stem	stem	NN
cord-005453-4057qib7	16168	17	cell	cell	NN
cord-005453-4057qib7	16168	18	grafts	graft	NNS
cord-005453-4057qib7	16168	19	(	(	-LRB-
cord-005453-4057qib7	16168	20	PBSC	PBSC	NNP
cord-005453-4057qib7	16168	21	)	)	-RRB-
cord-005453-4057qib7	16168	22	have	have	VBP
cord-005453-4057qib7	16168	23	been	be	VBN
cord-005453-4057qib7	16168	24	associated	associate	VBN
cord-005453-4057qib7	16168	25	with	with	IN
cord-005453-4057qib7	16168	26	an	an	DT
cord-005453-4057qib7	16168	27	increased	increase	VBN
cord-005453-4057qib7	16168	28	risk	risk	NN
cord-005453-4057qib7	16168	29	of	of	IN
cord-005453-4057qib7	16168	30	acute	acute	JJ
cord-005453-4057qib7	16168	31	and	and	CC
cord-005453-4057qib7	16168	32	chronic	chronic	JJ
cord-005453-4057qib7	16168	33	GvHD	GvHD	NNP
cord-005453-4057qib7	16168	34	.	.	.
cord-005453-4057qib7	16169	1	Thus	thus	RB
cord-005453-4057qib7	16169	2	,	,	,
cord-005453-4057qib7	16169	3	the	the	DT
cord-005453-4057qib7	16169	4	aim	aim	NN
cord-005453-4057qib7	16169	5	of	of	IN
cord-005453-4057qib7	16169	6	our	-PRON-	PRP$
cord-005453-4057qib7	16169	7	study	study	NN
cord-005453-4057qib7	16169	8	was	be	VBD
cord-005453-4057qib7	16169	9	to	to	TO
cord-005453-4057qib7	16169	10	compare	compare	VB
cord-005453-4057qib7	16169	11	the	the	DT
cord-005453-4057qib7	16169	12	main	main	JJ
cord-005453-4057qib7	16169	13	transplant	transplant	NN
cord-005453-4057qib7	16169	14	outcomes	outcome	NNS
cord-005453-4057qib7	16169	15	and	and	CC
cord-005453-4057qib7	16169	16	especially	especially	RB
cord-005453-4057qib7	16169	17	the	the	DT
cord-005453-4057qib7	16169	18	incidence	incidence	NN
cord-005453-4057qib7	16169	19	of	of	IN
cord-005453-4057qib7	16169	20	acute	acute	JJ
cord-005453-4057qib7	16169	21	and	and	CC
cord-005453-4057qib7	16169	22	chronic	chronic	JJ
cord-005453-4057qib7	16169	23	GVHD	GVHD	NNP
cord-005453-4057qib7	16169	24	in	in	IN
cord-005453-4057qib7	16169	25	recipients	recipient	NNS
cord-005453-4057qib7	16169	26	of	of	IN
cord-005453-4057qib7	16169	27	BM	BM	NNP
cord-005453-4057qib7	16169	28	and	and	CC
cord-005453-4057qib7	16169	29	PBSC	PBSC	NNP
cord-005453-4057qib7	16169	30	grafts	graft	NNS
cord-005453-4057qib7	16169	31	.	.	.
cord-005453-4057qib7	16170	1	Methods	method	NNS
cord-005453-4057qib7	16170	2	:	:	:
cord-005453-4057qib7	16171	1	Thirty	thirty	CD
cord-005453-4057qib7	16171	2	-	-	HYPH
cord-005453-4057qib7	16171	3	five	five	CD
cord-005453-4057qib7	16171	4	unselected	unselected	JJ
cord-005453-4057qib7	16171	5	patients	patient	NNS
cord-005453-4057qib7	16171	6	with	with	IN
cord-005453-4057qib7	16171	7	hematologic	hematologic	JJ
cord-005453-4057qib7	16171	8	malignancy	malignancy	NN
cord-005453-4057qib7	16171	9	who	who	WP
cord-005453-4057qib7	16171	10	underwent	undergo	VBD
cord-005453-4057qib7	16171	11	an	an	DT
cord-005453-4057qib7	16171	12	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16171	13	transplant	transplant	NN
cord-005453-4057qib7	16171	14	at	at	IN
cord-005453-4057qib7	16171	15	our	-PRON-	PRP$
cord-005453-4057qib7	16171	16	Unit	Unit	NNP
cord-005453-4057qib7	16171	17	between	between	IN
cord-005453-4057qib7	16171	18	2011	2011	CD
cord-005453-4057qib7	16171	19	and	and	CC
cord-005453-4057qib7	16171	20	2018	2018	CD
cord-005453-4057qib7	16171	21	and	and	CC
cord-005453-4057qib7	16171	22	received	receive	VBN
cord-005453-4057qib7	16171	23	BM	BM	NNP
cord-005453-4057qib7	16171	24	(	(	-LRB-
cord-005453-4057qib7	16171	25	n	n	NN
cord-005453-4057qib7	16171	26	=	=	SYM
cord-005453-4057qib7	16171	27	17	17	CD
cord-005453-4057qib7	16171	28	)	)	-RRB-
cord-005453-4057qib7	16171	29	or	or	CC
cord-005453-4057qib7	16171	30	PBSC	PBSC	NNP
cord-005453-4057qib7	16171	31	(	(	-LRB-
cord-005453-4057qib7	16171	32	n	n	NN
cord-005453-4057qib7	16171	33	=	=	SYM
cord-005453-4057qib7	16171	34	18	18	CD
cord-005453-4057qib7	16171	35	)	)	-RRB-
cord-005453-4057qib7	16171	36	grafts	graft	NNS
cord-005453-4057qib7	16171	37	after	after	IN
cord-005453-4057qib7	16171	38	the	the	DT
cord-005453-4057qib7	16171	39	same	same	JJ
cord-005453-4057qib7	16171	40	TBF	tbf	NN
cord-005453-4057qib7	16171	41	conditioning	conditioning	NN
cord-005453-4057qib7	16171	42	regimen	regimen	NN
cord-005453-4057qib7	16171	43	were	be	VBD
cord-005453-4057qib7	16171	44	analysed	analyse	VBN
cord-005453-4057qib7	16171	45	in	in	IN
cord-005453-4057qib7	16171	46	order	order	NN
cord-005453-4057qib7	16171	47	to	to	TO
cord-005453-4057qib7	16171	48	assess	assess	VB
cord-005453-4057qib7	16171	49	differences	difference	NNS
cord-005453-4057qib7	16171	50	in	in	IN
cord-005453-4057qib7	16171	51	transplant	transplant	NN
cord-005453-4057qib7	16171	52	outcomes	outcome	NNS
cord-005453-4057qib7	16171	53	.	.	.
cord-005453-4057qib7	16172	1	Our	-PRON-	PRP$
cord-005453-4057qib7	16172	2	GVHD	GVHD	NNP
cord-005453-4057qib7	16172	3	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16172	4	consisted	consist	VBD
cord-005453-4057qib7	16172	5	in	in	IN
cord-005453-4057qib7	16172	6	cyclosporine	cyclosporine	NN
cord-005453-4057qib7	16172	7	A	a	NN
cord-005453-4057qib7	16172	8	(	(	-LRB-
cord-005453-4057qib7	16172	9	CsA	csa	NN
cord-005453-4057qib7	16172	10	)	)	-RRB-
cord-005453-4057qib7	16172	11	from	from	IN
cord-005453-4057qib7	16172	12	day	day	NN
cord-005453-4057qib7	16172	13	-1	-1	.
cord-005453-4057qib7	16173	1	to	to	IN
cord-005453-4057qib7	16173	2	+180	+180	NNP
cord-005453-4057qib7	16173	3	,	,	,
cord-005453-4057qib7	16173	4	a	a	DT
cord-005453-4057qib7	16173	5	methotrexate	methotrexate	NNP
cord-005453-4057qib7	16173	6	"	"	``
cord-005453-4057qib7	16173	7	short	short	JJ
cord-005453-4057qib7	16173	8	course	course	NN
cord-005453-4057qib7	16173	9	"	"	''
cord-005453-4057qib7	16173	10	and	and	CC
cord-005453-4057qib7	16173	11	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	16173	12	mofetil	mofetil	NNP
cord-005453-4057qib7	16173	13	(	(	-LRB-
cord-005453-4057qib7	16173	14	MMF	MMF	NNP
cord-005453-4057qib7	16173	15	)	)	-RRB-
cord-005453-4057qib7	16173	16	from	from	IN
cord-005453-4057qib7	16173	17	day	day	NN
cord-005453-4057qib7	16173	18	+1	+1	XX
cord-005453-4057qib7	16173	19	to	to	IN
cord-005453-4057qib7	16173	20	+28.Results	+28.Results	NNP
cord-005453-4057qib7	16173	21	:	:	:
cord-005453-4057qib7	16174	1	No	no	DT
cord-005453-4057qib7	16174	2	statistically	statistically	RB
cord-005453-4057qib7	16174	3	-	-	HYPH
cord-005453-4057qib7	16174	4	significant	significant	JJ
cord-005453-4057qib7	16174	5	differences	difference	NNS
cord-005453-4057qib7	16174	6	were	be	VBD
cord-005453-4057qib7	16174	7	observed	observe	VBN
cord-005453-4057qib7	16174	8	between	between	IN
cord-005453-4057qib7	16174	9	patients	patient	NNS
cord-005453-4057qib7	16174	10	who	who	WP
cord-005453-4057qib7	16174	11	received	receive	VBD
cord-005453-4057qib7	16174	12	BM	BM	NNP
cord-005453-4057qib7	16174	13	grafts	graft	NNS
cord-005453-4057qib7	16174	14	and	and	CC
cord-005453-4057qib7	16174	15	those	those	DT
cord-005453-4057qib7	16174	16	who	who	WP
cord-005453-4057qib7	16174	17	received	receive	VBD
cord-005453-4057qib7	16174	18	PBSC	PBSC	NNP
cord-005453-4057qib7	16174	19	grafts	graft	NNS
cord-005453-4057qib7	16174	20	.	.	.
cord-005453-4057qib7	16175	1	At	at	IN
cord-005453-4057qib7	16175	2	transplant	transplant	NN
cord-005453-4057qib7	16175	3	fourteen	fourteen	CD
cord-005453-4057qib7	16175	4	patients	patient	NNS
cord-005453-4057qib7	16175	5	were	be	VBD
cord-005453-4057qib7	16175	6	in	in	IN
cord-005453-4057qib7	16175	7	first	first	JJ
cord-005453-4057qib7	16175	8	complete	complete	JJ
cord-005453-4057qib7	16175	9	remission	remission	NN
cord-005453-4057qib7	16175	10	(	(	-LRB-
cord-005453-4057qib7	16175	11	CR	CR	NNP
cord-005453-4057qib7	16175	12	)	)	-RRB-
cord-005453-4057qib7	16175	13	,	,	,
cord-005453-4057qib7	16175	14	twelve	twelve	CD
cord-005453-4057qib7	16175	15	in	in	IN
cord-005453-4057qib7	16175	16	advanced	advanced	JJ
cord-005453-4057qib7	16175	17	CR	cr	NN
cord-005453-4057qib7	16175	18	and	and	CC
cord-005453-4057qib7	16175	19	9	9	CD
cord-005453-4057qib7	16175	20	had	have	VBD
cord-005453-4057qib7	16175	21	active	active	JJ
cord-005453-4057qib7	16175	22	disease	disease	NN
cord-005453-4057qib7	16175	23	.	.	.
cord-005453-4057qib7	16176	1	According	accord	VBG
cord-005453-4057qib7	16176	2	to	to	IN
cord-005453-4057qib7	16176	3	Sorror	Sorror	NNP
cord-005453-4057qib7	16176	4	's	's	POS
cord-005453-4057qib7	16176	5	risk	risk	NN
cord-005453-4057qib7	16176	6	,	,	,
cord-005453-4057qib7	16176	7	nine	nine	CD
cord-005453-4057qib7	16176	8	patients	patient	NNS
cord-005453-4057qib7	16176	9	were	be	VBD
cord-005453-4057qib7	16176	10	low	low	JJ
cord-005453-4057qib7	16176	11	-	-	HYPH
cord-005453-4057qib7	16176	12	risk	risk	NN
cord-005453-4057qib7	16176	13	,	,	,
cord-005453-4057qib7	16176	14	nine	nine	CD
cord-005453-4057qib7	16176	15	intermediate	intermediate	JJ
cord-005453-4057qib7	16176	16	-	-	HYPH
cord-005453-4057qib7	16176	17	risk	risk	NN
cord-005453-4057qib7	16176	18	and	and	CC
cord-005453-4057qib7	16176	19	seventeen	seventeen	CD
cord-005453-4057qib7	16176	20	high	high	JJ
cord-005453-4057qib7	16176	21	-	-	HYPH
cord-005453-4057qib7	16176	22	risk	risk	NN
cord-005453-4057qib7	16176	23	.	.	.
cord-005453-4057qib7	16177	1	Twenty	twenty	CD
cord-005453-4057qib7	16177	2	-	-	HYPH
cord-005453-4057qib7	16177	3	eight	eight	CD
cord-005453-4057qib7	16177	4	CMV+	CMV+	NNP
cord-005453-4057qib7	16177	5	patients	patient	NNS
cord-005453-4057qib7	16177	6	received	receive	VBD
cord-005453-4057qib7	16177	7	the	the	DT
cord-005453-4057qib7	16177	8	graft	graft	NN
cord-005453-4057qib7	16177	9	from	from	IN
cord-005453-4057qib7	16177	10	twenty	twenty	CD
cord-005453-4057qib7	16177	11	-	-	HYPH
cord-005453-4057qib7	16177	12	three	three	CD
cord-005453-4057qib7	16177	13	CMV+	CMV+	NNP
cord-005453-4057qib7	16177	14	and	and	CC
cord-005453-4057qib7	16177	15	five	five	CD
cord-005453-4057qib7	16177	16	CMV	CMV	NNP
cord-005453-4057qib7	16177	17	-	-	HYPH
cord-005453-4057qib7	16177	18	donors	donor	NNS
cord-005453-4057qib7	16177	19	,	,	,
cord-005453-4057qib7	16177	20	seven	seven	CD
cord-005453-4057qib7	16177	21	CMV	CMV	NNP
cord-005453-4057qib7	16177	22	-	-	HYPH
cord-005453-4057qib7	16177	23	patients	patient	NNS
cord-005453-4057qib7	16177	24	received	receive	VBD
cord-005453-4057qib7	16177	25	the	the	DT
cord-005453-4057qib7	16177	26	graft	graft	NN
cord-005453-4057qib7	16177	27	from	from	IN
cord-005453-4057qib7	16177	28	five	five	CD
cord-005453-4057qib7	16177	29	CMV+	CMV+	NNP
cord-005453-4057qib7	16177	30	and	and	CC
cord-005453-4057qib7	16177	31	two	two	CD
cord-005453-4057qib7	16177	32	CMVdonors	cmvdonor	NNS
cord-005453-4057qib7	16177	33	.	.	.
cord-005453-4057qib7	16178	1	Mean	mean	JJ
cord-005453-4057qib7	16178	2	age	age	NN
cord-005453-4057qib7	16178	3	at	at	IN
cord-005453-4057qib7	16178	4	transplant	transplant	NN
cord-005453-4057qib7	16178	5	was	be	VBD
cord-005453-4057qib7	16178	6	51	51	CD
cord-005453-4057qib7	16178	7	years	year	NNS
cord-005453-4057qib7	16179	1	(	(	-LRB-
cord-005453-4057qib7	16179	2	range	range	NNP
cord-005453-4057qib7	16179	3	23	23	CD
cord-005453-4057qib7	16179	4	-	-	SYM
cord-005453-4057qib7	16179	5	72	72	CD
cord-005453-4057qib7	16179	6	)	)	-RRB-
cord-005453-4057qib7	16179	7	,	,	,
cord-005453-4057qib7	16179	8	mean	mean	JJ
cord-005453-4057qib7	16179	9	donor	donor	NNP
cord-005453-4057qib7	16179	10	's	's	POS
cord-005453-4057qib7	16179	11	age	age	NN
cord-005453-4057qib7	16179	12	38	38	CD
cord-005453-4057qib7	16179	13	years	year	NNS
cord-005453-4057qib7	16179	14	(	(	-LRB-
cord-005453-4057qib7	16179	15	range18	range18	NNP
cord-005453-4057qib7	16179	16	-	-	SYM
cord-005453-4057qib7	16179	17	39	39	CD
cord-005453-4057qib7	16179	18	)	)	-RRB-
cord-005453-4057qib7	16179	19	and	and	CC
cord-005453-4057qib7	16179	20	mean	mean	VB
cord-005453-4057qib7	16179	21	follow	follow	VB
cord-005453-4057qib7	16179	22	-	-	HYPH
cord-005453-4057qib7	16179	23	up	up	NN
cord-005453-4057qib7	16179	24	16.9	16.9	CD
cord-005453-4057qib7	16179	25	months	month	NNS
cord-005453-4057qib7	16180	1	(	(	-LRB-
cord-005453-4057qib7	16180	2	range	range	VBP
cord-005453-4057qib7	16180	3	1.9	1.9	CD
cord-005453-4057qib7	16180	4	-	-	HYPH
cord-005453-4057qib7	16180	5	56.7	56.7	CD
cord-005453-4057qib7	16180	6	)	)	-RRB-
cord-005453-4057qib7	16180	7	.	.	.
cord-005453-4057qib7	16181	1	Median	median	JJ
cord-005453-4057qib7	16181	2	CD	CD	NNP
cord-005453-4057qib7	16181	3	34	34	CD
cord-005453-4057qib7	16181	4	+	+	CD
cord-005453-4057qib7	16181	5	cell	cell	NN
cord-005453-4057qib7	16181	6	dose	dose	NN
cord-005453-4057qib7	16181	7	was	be	VBD
cord-005453-4057qib7	16181	8	5.2x10	5.2x10	CD
cord-005453-4057qib7	16181	9	6	6	CD
cord-005453-4057qib7	16181	10	/kg	/kg	.
cord-005453-4057qib7	16181	11	(	(	-LRB-
cord-005453-4057qib7	16181	12	range1.4	range1.4	NNP
cord-005453-4057qib7	16181	13	-	-	SYM
cord-005453-4057qib7	16181	14	10.4	10.4	CD
cord-005453-4057qib7	16181	15	)	)	-RRB-
cord-005453-4057qib7	16181	16	,	,	,
cord-005453-4057qib7	16181	17	3.6	3.6	CD
cord-005453-4057qib7	16181	18	x10	x10	CD
cord-005453-4057qib7	16181	19	6	6	CD
cord-005453-4057qib7	16181	20	/kg	/kg	.
cord-005453-4057qib7	16181	21	(	(	-LRB-
cord-005453-4057qib7	16181	22	range	range	VB
cord-005453-4057qib7	16181	23	1.4	1.4	CD
cord-005453-4057qib7	16181	24	-	-	SYM
cord-005453-4057qib7	16181	25	7.7	7.7	CD
cord-005453-4057qib7	16181	26	)	)	-RRB-
cord-005453-4057qib7	16181	27	in	in	IN
cord-005453-4057qib7	16181	28	BM	BM	NNP
cord-005453-4057qib7	16181	29	recipients	recipient	NNS
cord-005453-4057qib7	16181	30	and	and	CC
cord-005453-4057qib7	16181	31	14.0	14.0	CD
cord-005453-4057qib7	16181	32	x10	x10	CD
cord-005453-4057qib7	16181	33	6	6	CD
cord-005453-4057qib7	16182	1	/kg	/kg	NFP
cord-005453-4057qib7	16182	2	(	(	-LRB-
cord-005453-4057qib7	16182	3	range	range	VB
cord-005453-4057qib7	16182	4	4.2	4.2	CD
cord-005453-4057qib7	16182	5	-	-	HYPH
cord-005453-4057qib7	16182	6	10.4	10.4	CD
cord-005453-4057qib7	16182	7	)	)	-RRB-
cord-005453-4057qib7	16182	8	in	in	IN
cord-005453-4057qib7	16182	9	PBSC	PBSC	NNP
cord-005453-4057qib7	16182	10	recipients	recipient	NNS
cord-005453-4057qib7	16182	11	.	.	.
cord-005453-4057qib7	16183	1	Median	median	JJ
cord-005453-4057qib7	16183	2	time	time	NN
cord-005453-4057qib7	16183	3	to	to	IN
cord-005453-4057qib7	16183	4	neutrophil	neutrophil	NN
cord-005453-4057qib7	16183	5	recovery	recovery	NN
cord-005453-4057qib7	16183	6	(	(	-LRB-
cord-005453-4057qib7	16183	7	>	>	VBZ
cord-005453-4057qib7	16183	8	500	500	CD
cord-005453-4057qib7	16183	9	/	/	SYM
cord-005453-4057qib7	16183	10	μl	μl	NN
cord-005453-4057qib7	16183	11	)	)	-RRB-
cord-005453-4057qib7	16183	12	was	be	VBD
cord-005453-4057qib7	16183	13	22	22	CD
cord-005453-4057qib7	16183	14	days	day	NNS
cord-005453-4057qib7	16184	1	(	(	-LRB-
cord-005453-4057qib7	16184	2	range	range	NNP
cord-005453-4057qib7	16184	3	16	16	CD
cord-005453-4057qib7	16184	4	-	-	SYM
cord-005453-4057qib7	16184	5	39	39	CD
cord-005453-4057qib7	16184	6	)	)	-RRB-
cord-005453-4057qib7	16185	1	posttransplant	posttransplant	NNP
cord-005453-4057qib7	16185	2	,	,	,
cord-005453-4057qib7	16185	3	23	23	CD
cord-005453-4057qib7	16185	4	days	day	NNS
cord-005453-4057qib7	16185	5	(	(	-LRB-
cord-005453-4057qib7	16185	6	range	range	VBP
cord-005453-4057qib7	16185	7	18	18	CD
cord-005453-4057qib7	16185	8	-	-	SYM
cord-005453-4057qib7	16185	9	27	27	CD
cord-005453-4057qib7	16185	10	)	)	-RRB-
cord-005453-4057qib7	16185	11	for	for	IN
cord-005453-4057qib7	16185	12	BM	BM	NNP
cord-005453-4057qib7	16185	13	recipients	recipient	NNS
cord-005453-4057qib7	16185	14	and	and	CC
cord-005453-4057qib7	16185	15	20	20	CD
cord-005453-4057qib7	16185	16	(	(	-LRB-
cord-005453-4057qib7	16185	17	range	range	NNP
cord-005453-4057qib7	16185	18	16	16	CD
cord-005453-4057qib7	16185	19	-	-	SYM
cord-005453-4057qib7	16185	20	39	39	CD
cord-005453-4057qib7	16185	21	)	)	-RRB-
cord-005453-4057qib7	16185	22	for	for	IN
cord-005453-4057qib7	16185	23	PBSC	PBSC	NNP
cord-005453-4057qib7	16185	24	recipients	recipient	NNS
cord-005453-4057qib7	16185	25	.	.	.
cord-005453-4057qib7	16186	1	Platelet	platelet	NN
cord-005453-4057qib7	16186	2	recovery	recovery	NN
cord-005453-4057qib7	16186	3	(	(	-LRB-
cord-005453-4057qib7	16186	4	>	>	XX
cord-005453-4057qib7	16187	1	20.000	20.000	CD
cord-005453-4057qib7	16187	2	/	/	SYM
cord-005453-4057qib7	16187	3	μl	μl	NN
cord-005453-4057qib7	16187	4	)	)	-RRB-
cord-005453-4057qib7	16187	5	occurred	occur	VBD
cord-005453-4057qib7	16187	6	in	in	IN
cord-005453-4057qib7	16187	7	all	all	DT
cord-005453-4057qib7	16187	8	patients	patient	NNS
cord-005453-4057qib7	16187	9	except	except	IN
cord-005453-4057qib7	16187	10	one	one	CD
cord-005453-4057qib7	16187	11	at	at	IN
cord-005453-4057qib7	16187	12	a	a	DT
cord-005453-4057qib7	16187	13	median	median	NN
cord-005453-4057qib7	16187	14	of	of	IN
cord-005453-4057qib7	16187	15	17	17	CD
cord-005453-4057qib7	16187	16	days	day	NNS
cord-005453-4057qib7	16187	17	(	(	-LRB-
cord-005453-4057qib7	16187	18	range	range	VBP
cord-005453-4057qib7	16187	19	10	10	CD
cord-005453-4057qib7	16187	20	-	-	SYM
cord-005453-4057qib7	16187	21	151	151	CD
cord-005453-4057qib7	16187	22	)	)	-RRB-
cord-005453-4057qib7	16188	1	post	post	JJ
cord-005453-4057qib7	16188	2	-	-	JJ
cord-005453-4057qib7	16188	3	transplant	transplant	NN
cord-005453-4057qib7	16188	4	,	,	,
cord-005453-4057qib7	16188	5	at	at	IN
cord-005453-4057qib7	16188	6	a	a	DT
cord-005453-4057qib7	16188	7	median	median	NN
cord-005453-4057qib7	16188	8	of	of	IN
cord-005453-4057qib7	16188	9	20	20	CD
cord-005453-4057qib7	16188	10	days	day	NNS
cord-005453-4057qib7	16188	11	(	(	-LRB-
cord-005453-4057qib7	16188	12	11	11	CD
cord-005453-4057qib7	16188	13	-	-	SYM
cord-005453-4057qib7	16188	14	151	151	CD
cord-005453-4057qib7	16188	15	)	)	-RRB-
cord-005453-4057qib7	16188	16	post	post	JJ
cord-005453-4057qib7	16188	17	-	-	NN
cord-005453-4057qib7	16188	18	transplant	transplant	NN
cord-005453-4057qib7	16188	19	for	for	IN
cord-005453-4057qib7	16188	20	BM	BM	NNP
cord-005453-4057qib7	16188	21	recipients	recipient	NNS
cord-005453-4057qib7	16188	22	and	and	CC
cord-005453-4057qib7	16188	23	at	at	IN
cord-005453-4057qib7	16188	24	a	a	DT
cord-005453-4057qib7	16188	25	median	median	NN
cord-005453-4057qib7	16188	26	of	of	IN
cord-005453-4057qib7	16188	27	14	14	CD
cord-005453-4057qib7	16188	28	days	day	NNS
cord-005453-4057qib7	16188	29	(	(	-LRB-
cord-005453-4057qib7	16188	30	range	range	NN
cord-005453-4057qib7	16188	31	(	(	-LRB-
cord-005453-4057qib7	16188	32	10	10	CD
cord-005453-4057qib7	16188	33	-	-	SYM
cord-005453-4057qib7	16188	34	26	26	CD
cord-005453-4057qib7	16188	35	)	)	-RRB-
cord-005453-4057qib7	16188	36	for	for	IN
cord-005453-4057qib7	16188	37	PBSC	PBSC	NNP
cord-005453-4057qib7	16188	38	recipients	recipient	NNS
cord-005453-4057qib7	16188	39	.	.	.
cord-005453-4057qib7	16189	1	Seven	seven	CD
cord-005453-4057qib7	16189	2	patients	patient	NNS
cord-005453-4057qib7	16189	3	never	never	RB
cord-005453-4057qib7	16189	4	reached	reach	VBD
cord-005453-4057qib7	16189	5	platelets	platelet	NNS
cord-005453-4057qib7	16189	6	>	>	XX
cord-005453-4057qib7	16190	1	50.000	50.000	CD
cord-005453-4057qib7	16190	2	/	/	SYM
cord-005453-4057qib7	16190	3	μl	μl	NN
cord-005453-4057qib7	16190	4	.	.	.
cord-005453-4057qib7	16191	1	Three	three	CD
cord-005453-4057qib7	16191	2	patients	patient	NNS
cord-005453-4057qib7	16191	3	developed	develop	VBD
cord-005453-4057qib7	16191	4	a	a	DT
cord-005453-4057qib7	16191	5	poor	poor	JJ
cord-005453-4057qib7	16191	6	graft	graft	NN
cord-005453-4057qib7	16191	7	function	function	NN
cord-005453-4057qib7	16191	8	.	.	.
cord-005453-4057qib7	16192	1	Acute	acute	JJ
cord-005453-4057qib7	16192	2	and	and	CC
cord-005453-4057qib7	16192	3	chronic	chronic	JJ
cord-005453-4057qib7	16192	4	GVHD	GVHD	NNP
cord-005453-4057qib7	16192	5	incidence	incidence	NN
cord-005453-4057qib7	16192	6	was	be	VBD
cord-005453-4057qib7	16192	7	28.5	28.5	CD
cord-005453-4057qib7	16192	8	%	%	NN
cord-005453-4057qib7	16192	9	and	and	CC
cord-005453-4057qib7	16192	10	22.8	22.8	CD
cord-005453-4057qib7	16192	11	%	%	NN
cord-005453-4057qib7	16192	12	and	and	CC
cord-005453-4057qib7	16192	13	the	the	DT
cord-005453-4057qib7	16192	14	risks	risk	NNS
cord-005453-4057qib7	16192	15	of	of	IN
cord-005453-4057qib7	16192	16	acute	acute	JJ
cord-005453-4057qib7	16192	17	(	(	-LRB-
cord-005453-4057qib7	16192	18	hazard	hazard	NN
cord-005453-4057qib7	16192	19	ratio	ratio	NN
cord-005453-4057qib7	16192	20	[	[	-LRB-
cord-005453-4057qib7	16192	21	HR	HR	NNP
cord-005453-4057qib7	16192	22	]	]	-RRB-
cord-005453-4057qib7	16192	23	,	,	,
cord-005453-4057qib7	16192	24	1.04	1.04	CD
cord-005453-4057qib7	16192	25	;	;	:
cord-005453-4057qib7	16192	26	P	p	NN
cord-005453-4057qib7	16192	27	=	=	SYM
cord-005453-4057qib7	16192	28	.955	.955	CD
cord-005453-4057qib7	16192	29	)	)	-RRB-
cord-005453-4057qib7	16192	30	and	and	CC
cord-005453-4057qib7	16192	31	chronic	chronic	JJ
cord-005453-4057qib7	16192	32	(	(	-LRB-
cord-005453-4057qib7	16192	33	HR	HR	NNP
cord-005453-4057qib7	16192	34	,	,	,
cord-005453-4057qib7	16192	35	0.85	0.85	CD
cord-005453-4057qib7	16192	36	;	;	:
cord-005453-4057qib7	16192	37	P	p	NN
cord-005453-4057qib7	16192	38	=	=	SYM
cord-005453-4057qib7	16192	39	.816	.816	NFP
cord-005453-4057qib7	16192	40	)	)	-RRB-
cord-005453-4057qib7	16192	41	graft	graft	NN
cord-005453-4057qib7	16192	42	-	-	HYPH
cord-005453-4057qib7	16192	43	versus	versus	IN
cord-005453-4057qib7	16192	44	-	-	HYPH
cord-005453-4057qib7	16192	45	host	host	NN
cord-005453-4057qib7	16192	46	disease	disease	NN
cord-005453-4057qib7	16192	47	were	be	VBD
cord-005453-4057qib7	16192	48	similar	similar	JJ
cord-005453-4057qib7	16192	49	in	in	IN
cord-005453-4057qib7	16192	50	the	the	DT
cord-005453-4057qib7	16192	51	two	two	CD
cord-005453-4057qib7	16192	52	patient	patient	JJ
cord-005453-4057qib7	16192	53	groups	group	NNS
cord-005453-4057qib7	16192	54	.	.	.
cord-005453-4057qib7	16193	1	In	in	IN
cord-005453-4057qib7	16193	2	addition	addition	NN
cord-005453-4057qib7	16193	3	,	,	,
cord-005453-4057qib7	16193	4	there	there	EX
cord-005453-4057qib7	16193	5	were	be	VBD
cord-005453-4057qib7	16193	6	no	no	DT
cord-005453-4057qib7	16193	7	differences	difference	NNS
cord-005453-4057qib7	16193	8	in	in	IN
cord-005453-4057qib7	16193	9	relapse	relapse	NN
cord-005453-4057qib7	16193	10	risks	risk	VBZ
cord-005453-4057qib7	16193	11	post	post	JJ
cord-005453-4057qib7	16193	12	-	-	NN
cord-005453-4057qib7	16193	13	transplant	transplant	NN
cord-005453-4057qib7	16193	14	(	(	-LRB-
cord-005453-4057qib7	16193	15	HR	HR	NNP
cord-005453-4057qib7	16193	16	,	,	,
cord-005453-4057qib7	16193	17	0.90	0.90	CD
cord-005453-4057qib7	16193	18	;	;	:
cord-005453-4057qib7	16193	19	P	p	NN
cord-005453-4057qib7	16193	20	=	=	SYM
cord-005453-4057qib7	16193	21	.898	.898	CD
cord-005453-4057qib7	16193	22	)	)	-RRB-
cord-005453-4057qib7	16193	23	;	;	:
cord-005453-4057qib7	16193	24	relapse	relapse	NN
cord-005453-4057qib7	16193	25	-	-	HYPH
cord-005453-4057qib7	16193	26	free	free	JJ
cord-005453-4057qib7	16193	27	survival	survival	NN
cord-005453-4057qib7	16193	28	was	be	VBD
cord-005453-4057qib7	16193	29	better	well	JJR
cord-005453-4057qib7	16193	30	with	with	IN
cord-005453-4057qib7	16193	31	PBSC	PBSC	NNP
cord-005453-4057qib7	16193	32	grafts	graft	NNS
cord-005453-4057qib7	16193	33	but	but	CC
cord-005453-4057qib7	16193	34	this	this	DT
cord-005453-4057qib7	16193	35	difference	difference	NN
cord-005453-4057qib7	16193	36	did	do	VBD
cord-005453-4057qib7	16193	37	not	not	RB
cord-005453-4057qib7	16193	38	reach	reach	VB
cord-005453-4057qib7	16193	39	any	any	DT
cord-005453-4057qib7	16193	40	statistical	statistical	JJ
cord-005453-4057qib7	16193	41	significance	significance	NN
cord-005453-4057qib7	16193	42	.	.	.
cord-005453-4057qib7	16194	1	Finally	finally	RB
cord-005453-4057qib7	16194	2	,	,	,
cord-005453-4057qib7	16194	3	no	no	DT
cord-005453-4057qib7	16194	4	significant	significant	JJ
cord-005453-4057qib7	16194	5	differences	difference	NNS
cord-005453-4057qib7	16194	6	were	be	VBD
cord-005453-4057qib7	16194	7	noted	note	VBN
cord-005453-4057qib7	16194	8	in	in	IN
cord-005453-4057qib7	16194	9	overall	overall	JJ
cord-005453-4057qib7	16194	10	mortality	mortality	NN
cord-005453-4057qib7	16194	11	by	by	IN
cord-005453-4057qib7	16194	12	graft	graft	NN
cord-005453-4057qib7	16194	13	type	type	NN
cord-005453-4057qib7	16194	14	(	(	-LRB-
cord-005453-4057qib7	16194	15	HR	hr	NN
cord-005453-4057qib7	16194	16	,	,	,
cord-005453-4057qib7	16194	17	0.62	0.62	CD
cord-005453-4057qib7	16194	18	;	;	:
cord-005453-4057qib7	16194	19	P	p	NN
cord-005453-4057qib7	16194	20	=	=	SYM
cord-005453-4057qib7	16194	21	.441).Conclusions	.441).Conclusions	.
cord-005453-4057qib7	16195	1	:	:	:
cord-005453-4057qib7	16196	1	Despite	despite	IN
cord-005453-4057qib7	16196	2	in	in	IN
cord-005453-4057qib7	16196	3	haplo	haplo	NNP
cord-005453-4057qib7	16196	4	-	-	HYPH
cord-005453-4057qib7	16196	5	HSCT	HSCT	NNP
cord-005453-4057qib7	16196	6	the	the	DT
cord-005453-4057qib7	16196	7	incidence	incidence	NN
cord-005453-4057qib7	16196	8	of	of	IN
cord-005453-4057qib7	16196	9	acute	acute	JJ
cord-005453-4057qib7	16196	10	and	and	CC
cord-005453-4057qib7	16196	11	chronic	chronic	JJ
cord-005453-4057qib7	16196	12	GVHD	GVHD	NNP
cord-005453-4057qib7	16196	13	is	be	VBZ
cord-005453-4057qib7	16196	14	reported	report	VBN
cord-005453-4057qib7	16196	15	to	to	TO
cord-005453-4057qib7	16196	16	be	be	VB
cord-005453-4057qib7	16196	17	higher	high	JJR
cord-005453-4057qib7	16196	18	with	with	IN
cord-005453-4057qib7	16196	19	PBSC	PBSC	NNP
cord-005453-4057qib7	16196	20	than	than	IN
cord-005453-4057qib7	16196	21	with	with	IN
cord-005453-4057qib7	16196	22	BM	BM	NNP
cord-005453-4057qib7	16197	1	our	-PRON-	PRP$
cord-005453-4057qib7	16197	2	small	small	JJ
cord-005453-4057qib7	16197	3	patient	patient	NN
cord-005453-4057qib7	16197	4	series	series	NN
cord-005453-4057qib7	16197	5	does	do	VBZ
cord-005453-4057qib7	16197	6	not	not	RB
cord-005453-4057qib7	16197	7	confirm	confirm	VB
cord-005453-4057qib7	16197	8	this	this	DT
cord-005453-4057qib7	16197	9	assumption	assumption	NN
cord-005453-4057qib7	16197	10	that	that	WDT
cord-005453-4057qib7	16197	11	should	should	MD
cord-005453-4057qib7	16197	12	be	be	VB
cord-005453-4057qib7	16197	13	clarified	clarify	VBN
cord-005453-4057qib7	16197	14	by	by	IN
cord-005453-4057qib7	16197	15	additional	additional	JJ
cord-005453-4057qib7	16197	16	studies	study	NNS
cord-005453-4057qib7	16197	17	.	.	.
cord-005453-4057qib7	16198	1	Instead	instead	RB
cord-005453-4057qib7	16198	2	,	,	,
cord-005453-4057qib7	16198	3	our	-PRON-	PRP$
cord-005453-4057qib7	16198	4	data	datum	NNS
cord-005453-4057qib7	16198	5	suggest	suggest	VBP
cord-005453-4057qib7	16198	6	that	that	IN
cord-005453-4057qib7	16198	7	PBSC	PBSC	NNP
cord-005453-4057qib7	16198	8	Background	Background	NNP
cord-005453-4057qib7	16198	9	:	:	:
cord-005453-4057qib7	16199	1	Since	since	IN
cord-005453-4057qib7	16199	2	1988	1988	CD
cord-005453-4057qib7	16199	3	,	,	,
cord-005453-4057qib7	16199	4	cord	cord	NN
cord-005453-4057qib7	16199	5	blood	blood	NN
cord-005453-4057qib7	16199	6	(	(	-LRB-
cord-005453-4057qib7	16199	7	CBU	CBU	NNP
cord-005453-4057qib7	16199	8	)	)	-RRB-
cord-005453-4057qib7	16199	9	has	have	VBZ
cord-005453-4057qib7	16199	10	become	become	VBN
cord-005453-4057qib7	16199	11	an	an	DT
cord-005453-4057qib7	16199	12	alternative	alternative	JJ
cord-005453-4057qib7	16199	13	source	source	NN
cord-005453-4057qib7	16199	14	of	of	IN
cord-005453-4057qib7	16199	15	stem	stem	NN
cord-005453-4057qib7	16199	16	cells	cell	NNS
cord-005453-4057qib7	16199	17	for	for	IN
cord-005453-4057qib7	16199	18	transplantation	transplantation	NN
cord-005453-4057qib7	16199	19	,	,	,
cord-005453-4057qib7	16199	20	with	with	IN
cord-005453-4057qib7	16199	21	approximately	approximately	RB
cord-005453-4057qib7	16199	22	35,000	35,000	CD
cord-005453-4057qib7	16199	23	procedures	procedure	NNS
cord-005453-4057qib7	16199	24	currently	currently	RB
cord-005453-4057qib7	16199	25	performed	perform	VBN
cord-005453-4057qib7	16199	26	.	.	.
cord-005453-4057qib7	16200	1	With	with	IN
cord-005453-4057qib7	16200	2	a	a	DT
cord-005453-4057qib7	16200	3	2-year	2-year	CD
cord-005453-4057qib7	16200	4	GS	GS	NNP
cord-005453-4057qib7	16200	5	of	of	IN
cord-005453-4057qib7	16200	6	50%.Objective	50%.objective	CD
cord-005453-4057qib7	16200	7	:	:	:
cord-005453-4057qib7	16200	8	Analyze	analyze	VB
cord-005453-4057qib7	16200	9	the	the	DT
cord-005453-4057qib7	16200	10	outcomes	outcome	NNS
cord-005453-4057qib7	16200	11	from	from	IN
cord-005453-4057qib7	16200	12	all	all	PDT
cord-005453-4057qib7	16200	13	the	the	DT
cord-005453-4057qib7	16200	14	patients	patient	NNS
cord-005453-4057qib7	16200	15	transplanted	transplant	VBN
cord-005453-4057qib7	16200	16	with	with	IN
cord-005453-4057qib7	16200	17	CBU	CBU	NNP
cord-005453-4057qib7	16200	18	in	in	IN
cord-005453-4057qib7	16200	19	our	-PRON-	PRP$
cord-005453-4057qib7	16200	20	hospital	hospital	NN
cord-005453-4057qib7	16200	21	unit	unit	NN
cord-005453-4057qib7	16200	22	.	.	.
cord-005453-4057qib7	16201	1	Methods	method	NNS
cord-005453-4057qib7	16201	2	:	:	:
cord-005453-4057qib7	16201	3	Retrospective	retrospective	JJ
cord-005453-4057qib7	16201	4	,	,	,
cord-005453-4057qib7	16201	5	longitudinal	longitudinal	JJ
cord-005453-4057qib7	16201	6	study	study	NN
cord-005453-4057qib7	16201	7	.	.	.
cord-005453-4057qib7	16202	1	All	all	DT
cord-005453-4057qib7	16202	2	patients	patient	NNS
cord-005453-4057qib7	16202	3	transplanted	transplant	VBN
cord-005453-4057qib7	16202	4	with	with	IN
cord-005453-4057qib7	16202	5	CBU	CBU	NNP
cord-005453-4057qib7	16202	6	in	in	IN
cord-005453-4057qib7	16202	7	our	-PRON-	PRP$
cord-005453-4057qib7	16202	8	hospital	hospital	NN
cord-005453-4057qib7	16202	9	between	between	IN
cord-005453-4057qib7	16202	10	2007	2007	CD
cord-005453-4057qib7	16202	11	and	and	CC
cord-005453-4057qib7	16202	12	2017	2017	CD
cord-005453-4057qib7	16202	13	were	be	VBD
cord-005453-4057qib7	16202	14	included	include	VBN
cord-005453-4057qib7	16202	15	.	.	.
cord-005453-4057qib7	16203	1	We	-PRON-	PRP
cord-005453-4057qib7	16203	2	analyzed	analyze	VBD
cord-005453-4057qib7	16203	3	40	40	CD
cord-005453-4057qib7	16203	4	patients	patient	NNS
cord-005453-4057qib7	16203	5	with	with	IN
cord-005453-4057qib7	16203	6	ages	age	NNS
cord-005453-4057qib7	16203	7	from	from	IN
cord-005453-4057qib7	16203	8	7	7	CD
cord-005453-4057qib7	16203	9	months	month	NNS
cord-005453-4057qib7	16203	10	to	to	IN
cord-005453-4057qib7	16203	11	14	14	CD
cord-005453-4057qib7	16203	12	years	year	NNS
cord-005453-4057qib7	16203	13	.	.	.
cord-005453-4057qib7	16204	1	Results	result	NNS
cord-005453-4057qib7	16204	2	:	:	:
cord-005453-4057qib7	16205	1	Two	two	CD
cord-005453-4057qib7	16205	2	of	of	IN
cord-005453-4057qib7	16205	3	them	-PRON-	PRP
cord-005453-4057qib7	16205	4	received	receive	VBD
cord-005453-4057qib7	16205	5	doubled	double	VBN
cord-005453-4057qib7	16205	6	cord	cord	NN
cord-005453-4057qib7	16205	7	transplantation	transplantation	NN
cord-005453-4057qib7	16206	1	the	the	DT
cord-005453-4057qib7	16206	2	ratio	ratio	NN
cord-005453-4057qib7	16206	3	male	male	NN
cord-005453-4057qib7	16206	4	:	:	:
cord-005453-4057qib7	16206	5	female	female	JJ
cord-005453-4057qib7	16206	6	was	be	VBD
cord-005453-4057qib7	16206	7	1.3	1.3	CD
cord-005453-4057qib7	16206	8	:	:	SYM
cord-005453-4057qib7	16206	9	1	1	CD
cord-005453-4057qib7	16206	10	.	.	.
cord-005453-4057qib7	16207	1	The	the	DT
cord-005453-4057qib7	16207	2	transplanted	transplanted	JJ
cord-005453-4057qib7	16207	3	pathologies	pathology	NNS
cord-005453-4057qib7	16207	4	were	be	VBD
cord-005453-4057qib7	16207	5	:	:	:
cord-005453-4057qib7	16207	6	Bone	bone	NN
cord-005453-4057qib7	16207	7	marrow	marrow	NN
cord-005453-4057qib7	16207	8	failure	failure	NN
cord-005453-4057qib7	16207	9	35	35	CD
cord-005453-4057qib7	16207	10	%	%	NN
cord-005453-4057qib7	16207	11	,	,	,
cord-005453-4057qib7	16207	12	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	16207	13	25	25	CD
cord-005453-4057qib7	16207	14	%	%	NN
cord-005453-4057qib7	16207	15	,	,	,
cord-005453-4057qib7	16207	16	AML	AML	NNP
cord-005453-4057qib7	16207	17	20	20	CD
cord-005453-4057qib7	16207	18	%	%	NN
cord-005453-4057qib7	16207	19	,	,	,
cord-005453-4057qib7	16207	20	ALL	all	DT
cord-005453-4057qib7	16207	21	17.5	17.5	CD
cord-005453-4057qib7	16207	22	%	%	NN
cord-005453-4057qib7	16207	23	,	,	,
cord-005453-4057qib7	16207	24	Osteopetrosis	Osteopetrosis	NNP
cord-005453-4057qib7	16207	25	2.5	2.5	CD
cord-005453-4057qib7	16207	26	%	%	NN
cord-005453-4057qib7	16207	27	.	.	.
cord-005453-4057qib7	16208	1	RIC	RIC	NNP
cord-005453-4057qib7	16208	2	regimens	regimen	NNS
cord-005453-4057qib7	16208	3	were	be	VBD
cord-005453-4057qib7	16208	4	used	use	VBN
cord-005453-4057qib7	16208	5	in	in	IN
cord-005453-4057qib7	16208	6	patients	patient	NNS
cord-005453-4057qib7	16208	7	with	with	IN
cord-005453-4057qib7	16208	8	bone	bone	NN
cord-005453-4057qib7	16208	9	marrow	marrow	NN
cord-005453-4057qib7	16208	10	failure	failure	NN
cord-005453-4057qib7	16208	11	and	and	CC
cord-005453-4057qib7	16208	12	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	16208	13	and	and	CC
cord-005453-4057qib7	16208	14	myeloablative	myeloablative	JJ
cord-005453-4057qib7	16208	15	conditioning	conditioning	NN
cord-005453-4057qib7	16208	16	regimens	regimen	NNS
cord-005453-4057qib7	16208	17	were	be	VBD
cord-005453-4057qib7	16208	18	used	use	VBN
cord-005453-4057qib7	16208	19	in	in	IN
cord-005453-4057qib7	16208	20	patients	patient	NNS
cord-005453-4057qib7	16208	21	with	with	IN
cord-005453-4057qib7	16208	22	malignant	malignant	JJ
cord-005453-4057qib7	16208	23	hematology	hematology	NN
cord-005453-4057qib7	16208	24	diseases	disease	NNS
cord-005453-4057qib7	16208	25	.	.	.
cord-005453-4057qib7	16209	1	Antithymocyte	antithymocyte	JJ
cord-005453-4057qib7	16209	2	rabbit	rabbit	NN
cord-005453-4057qib7	16209	3	globulin	globulin	NN
cord-005453-4057qib7	16209	4	(	(	-LRB-
cord-005453-4057qib7	16209	5	ATG	ATG	NNP
cord-005453-4057qib7	16209	6	)	)	-RRB-
cord-005453-4057qib7	16210	1	based	base	VBN
cord-005453-4057qib7	16210	2	serotherapy	serotherapy	NNP
cord-005453-4057qib7	16210	3	was	be	VBD
cord-005453-4057qib7	16210	4	used	use	VBN
cord-005453-4057qib7	16210	5	.	.	.
cord-005453-4057qib7	16211	1	One	one	CD
cord-005453-4057qib7	16211	2	case	case	NN
cord-005453-4057qib7	16211	3	received	receive	VBD
cord-005453-4057qib7	16211	4	CBU	CBU	NNP
cord-005453-4057qib7	16211	5	from	from	IN
cord-005453-4057qib7	16211	6	a	a	DT
cord-005453-4057qib7	16211	7	related	related	JJ
cord-005453-4057qib7	16211	8	donor	donor	NN
cord-005453-4057qib7	16211	9	(	(	-LRB-
cord-005453-4057qib7	16211	10	sister	sister	NN
cord-005453-4057qib7	16211	11	)	)	-RRB-
cord-005453-4057qib7	16211	12	,	,	,
cord-005453-4057qib7	16211	13	the	the	DT
cord-005453-4057qib7	16211	14	rest	rest	NN
cord-005453-4057qib7	16211	15	received	receive	VBD
cord-005453-4057qib7	16211	16	unrelated	unrelated	JJ
cord-005453-4057qib7	16211	17	CBU	CBU	NNP
cord-005453-4057qib7	16211	18	obtained	obtain	VBN
cord-005453-4057qib7	16211	19	from	from	IN
cord-005453-4057qib7	16211	20	Centro	Centro	NNP
cord-005453-4057qib7	16211	21	Nacional	Nacional	NNP
cord-005453-4057qib7	16211	22	de	de	NNP
cord-005453-4057qib7	16211	23	la	la	NNP
cord-005453-4057qib7	16211	24	Trasfusión	Trasfusión	NNP
cord-005453-4057qib7	16211	25	Sanguínea	Sanguínea	NNP
cord-005453-4057qib7	16211	26	.	.	.
cord-005453-4057qib7	16212	1	The	the	DT
cord-005453-4057qib7	16212	2	infusion	infusion	NN
cord-005453-4057qib7	16212	3	of	of	IN
cord-005453-4057qib7	16212	4	CD34	CD34	NNP
cord-005453-4057qib7	16212	5	+	+	CC
cord-005453-4057qib7	16212	6	was	be	VBD
cord-005453-4057qib7	16212	7	in	in	IN
cord-005453-4057qib7	16212	8	a	a	DT
cord-005453-4057qib7	16212	9	range	range	NN
cord-005453-4057qib7	16212	10	of	of	IN
cord-005453-4057qib7	16212	11	0.11	0.11	CD
cord-005453-4057qib7	16212	12	to	to	IN
cord-005453-4057qib7	16212	13	of	of	IN
cord-005453-4057qib7	16212	14	2.7	2.7	CD
cord-005453-4057qib7	16212	15	X10	X10	NNP
cord-005453-4057qib7	16212	16	6	6	CD
cord-005453-4057qib7	16212	17	/kg	/kg	NFP
cord-005453-4057qib7	16212	18	with	with	IN
cord-005453-4057qib7	16212	19	and	and	CC
cord-005453-4057qib7	16212	20	average	average	NN
cord-005453-4057qib7	16212	21	of	of	IN
cord-005453-4057qib7	16212	22	0.43	0.43	CD
cord-005453-4057qib7	16212	23	X	x	SYM
cord-005453-4057qib7	16212	24	10	10	CD
cord-005453-4057qib7	16212	25	6	6	CD
cord-005453-4057qib7	16212	26	/	/	SYM
cord-005453-4057qib7	16212	27	kg	kg	NNS
cord-005453-4057qib7	16212	28	.	.	.
cord-005453-4057qib7	16213	1	Compatibility	compatibility	NN
cord-005453-4057qib7	16213	2	was	be	VBD
cord-005453-4057qib7	16213	3	4/6	4/6	CD
cord-005453-4057qib7	16213	4	in	in	IN
cord-005453-4057qib7	16213	5	70	70	CD
cord-005453-4057qib7	16213	6	%	%	NN
cord-005453-4057qib7	16213	7	,	,	,
cord-005453-4057qib7	16213	8	5/6	5/6	CD
cord-005453-4057qib7	16213	9	in	in	IN
cord-005453-4057qib7	16213	10	20	20	CD
cord-005453-4057qib7	16213	11	%	%	NN
cord-005453-4057qib7	16213	12	and	and	CC
cord-005453-4057qib7	16213	13	6/6	6/6	CD
cord-005453-4057qib7	16213	14	in	in	IN
cord-005453-4057qib7	16213	15	10	10	CD
cord-005453-4057qib7	16213	16	%	%	NN
cord-005453-4057qib7	16213	17	.	.	.
cord-005453-4057qib7	16214	1	Post	post	JJ
cord-005453-4057qib7	16214	2	-	-	JJ
cord-005453-4057qib7	16214	3	thawing	thaw	VBG
cord-005453-4057qib7	16214	4	cellularity	cellularity	NN
cord-005453-4057qib7	16214	5	was	be	VBD
cord-005453-4057qib7	16214	6	not	not	RB
cord-005453-4057qib7	16214	7	measured	measure	VBN
cord-005453-4057qib7	16214	8	.	.	.
cord-005453-4057qib7	16215	1	The	the	DT
cord-005453-4057qib7	16215	2	HLA	HLA	NNP
cord-005453-4057qib7	16215	3	-	-	HYPH
cord-005453-4057qib7	16215	4	C	C	NNP
cord-005453-4057qib7	16215	5	was	be	VBD
cord-005453-4057qib7	16215	6	not	not	RB
cord-005453-4057qib7	16215	7	analyzed	analyze	VBN
cord-005453-4057qib7	16215	8	.	.	.
cord-005453-4057qib7	16216	1	Forty	forty	CD
cord-005453-4057qib7	16216	2	two	two	CD
cord-005453-4057qib7	16216	3	point	point	NN
cord-005453-4057qib7	16216	4	five	five	CD
cord-005453-4057qib7	16216	5	percent	percent	NN
cord-005453-4057qib7	16216	6	of	of	IN
cord-005453-4057qib7	16216	7	the	the	DT
cord-005453-4057qib7	16216	8	patients	patient	NNS
cord-005453-4057qib7	16216	9	had	have	VBD
cord-005453-4057qib7	16216	10	a	a	DT
cord-005453-4057qib7	16216	11	successful	successful	JJ
cord-005453-4057qib7	16216	12	engraftment	engraftment	NN
cord-005453-4057qib7	16216	13	;	;	:
cord-005453-4057qib7	16216	14	the	the	DT
cord-005453-4057qib7	16216	15	average	average	JJ
cord-005453-4057qib7	16216	16	time	time	NN
cord-005453-4057qib7	16216	17	of	of	IN
cord-005453-4057qib7	16216	18	engraftment	engraftment	NN
cord-005453-4057qib7	16216	19	was	be	VBD
cord-005453-4057qib7	16216	20	30	30	CD
cord-005453-4057qib7	16216	21	days	day	NNS
cord-005453-4057qib7	16216	22	.	.	.
cord-005453-4057qib7	16217	1	Primary	primary	JJ
cord-005453-4057qib7	16217	2	graft	graft	NN
cord-005453-4057qib7	16217	3	failure	failure	NN
cord-005453-4057qib7	16217	4	was	be	VBD
cord-005453-4057qib7	16217	5	detected	detect	VBN
cord-005453-4057qib7	16217	6	in	in	IN
cord-005453-4057qib7	16217	7	57.5	57.5	CD
cord-005453-4057qib7	16217	8	%	%	NN
cord-005453-4057qib7	16217	9	and	and	CC
cord-005453-4057qib7	16217	10	secondary	secondary	JJ
cord-005453-4057qib7	16217	11	graft	graft	NN
cord-005453-4057qib7	16217	12	failure	failure	NN
cord-005453-4057qib7	16217	13	in	in	IN
cord-005453-4057qib7	16217	14	10	10	CD
cord-005453-4057qib7	16217	15	%	%	NN
cord-005453-4057qib7	16217	16	,	,	,
cord-005453-4057qib7	16217	17	for	for	IN
cord-005453-4057qib7	16217	18	a	a	DT
cord-005453-4057qib7	16217	19	total	total	JJ
cord-005453-4057qib7	16217	20	success	success	NN
cord-005453-4057qib7	16217	21	of	of	IN
cord-005453-4057qib7	16217	22	32.5	32.5	CD
cord-005453-4057qib7	16217	23	%	%	NN
cord-005453-4057qib7	16217	24	.	.	.
cord-005453-4057qib7	16218	1	GVHD	GVHD	NNP
cord-005453-4057qib7	16218	2	was	be	VBD
cord-005453-4057qib7	16218	3	detected	detect	VBN
cord-005453-4057qib7	16218	4	in	in	IN
cord-005453-4057qib7	16218	5	20	20	CD
cord-005453-4057qib7	16218	6	%	%	NN
cord-005453-4057qib7	16218	7	of	of	IN
cord-005453-4057qib7	16218	8	patients	patient	NNS
cord-005453-4057qib7	16218	9	,	,	,
cord-005453-4057qib7	16218	10	of	of	IN
cord-005453-4057qib7	16218	11	which	which	WDT
cord-005453-4057qib7	16218	12	90	90	CD
cord-005453-4057qib7	16218	13	%	%	NN
cord-005453-4057qib7	16218	14	was	be	VBD
cord-005453-4057qib7	16218	15	grade	grade	NN
cord-005453-4057qib7	16218	16	I	I	NNP
cord-005453-4057qib7	16218	17	-	-	HYPH
cord-005453-4057qib7	16218	18	II	II	NNP
cord-005453-4057qib7	16218	19	and	and	CC
cord-005453-4057qib7	16218	20	10	10	CD
cord-005453-4057qib7	16218	21	%	%	NN
cord-005453-4057qib7	16218	22	grade	grade	NN
cord-005453-4057qib7	16218	23	III	III	NNP
cord-005453-4057qib7	16218	24	-	-	HYPH
cord-005453-4057qib7	16218	25	IV	IV	NNP
cord-005453-4057qib7	16218	26	.	.	.
cord-005453-4057qib7	16219	1	The	the	DT
cord-005453-4057qib7	16219	2	overall	overall	JJ
cord-005453-4057qib7	16219	3	mortality	mortality	NN
cord-005453-4057qib7	16219	4	was	be	VBD
cord-005453-4057qib7	16219	5	52.5	52.5	CD
cord-005453-4057qib7	16219	6	%	%	NN
cord-005453-4057qib7	16219	7	.	.	.
cord-005453-4057qib7	16220	1	Causes	cause	NNS
cord-005453-4057qib7	16220	2	of	of	IN
cord-005453-4057qib7	16220	3	death	death	NN
cord-005453-4057qib7	16220	4	were	be	VBD
cord-005453-4057qib7	16220	5	:	:	:
cord-005453-4057qib7	16220	6	infection	infection	NN
cord-005453-4057qib7	16220	7	45	45	CD
cord-005453-4057qib7	16220	8	%	%	NN
cord-005453-4057qib7	16221	1	Relapse	relapse	NN
cord-005453-4057qib7	16221	2	30	30	CD
cord-005453-4057qib7	16221	3	%	%	NN
cord-005453-4057qib7	16221	4	,	,	,
cord-005453-4057qib7	16221	5	Hemorrhage	hemorrhage	NN
cord-005453-4057qib7	16221	6	20	20	CD
cord-005453-4057qib7	16221	7	%	%	NN
cord-005453-4057qib7	16221	8	and	and	CC
cord-005453-4057qib7	16221	9	GVHD	GVHD	NNP
cord-005453-4057qib7	16221	10	5	5	CD
cord-005453-4057qib7	16221	11	%	%	NN
cord-005453-4057qib7	16221	12	.	.	.
cord-005453-4057qib7	16222	1	The	the	DT
cord-005453-4057qib7	16222	2	CBSCT	CBSCT	NNP
cord-005453-4057qib7	16222	3	continues	continue	VBZ
cord-005453-4057qib7	16222	4	to	to	TO
cord-005453-4057qib7	16222	5	be	be	VB
cord-005453-4057qib7	16222	6	an	an	DT
cord-005453-4057qib7	16222	7	essential	essential	JJ
cord-005453-4057qib7	16222	8	alternative	alternative	NN
cord-005453-4057qib7	16222	9	in	in	IN
cord-005453-4057qib7	16222	10	our	-PRON-	PRP$
cord-005453-4057qib7	16222	11	patients	patient	NNS
cord-005453-4057qib7	16222	12	who	who	WP
cord-005453-4057qib7	16222	13	required	require	VBD
cord-005453-4057qib7	16222	14	transplantation	transplantation	NN
cord-005453-4057qib7	16222	15	knowing	know	VBG
cord-005453-4057qib7	16222	16	that	that	IN
cord-005453-4057qib7	16222	17	this	this	DT
cord-005453-4057qib7	16222	18	stem	stem	NN
cord-005453-4057qib7	16222	19	cell	cell	NN
cord-005453-4057qib7	16222	20	source	source	NN
cord-005453-4057qib7	16222	21	allows	allow	VBZ
cord-005453-4057qib7	16222	22	the	the	DT
cord-005453-4057qib7	16222	23	procedure	procedure	NN
cord-005453-4057qib7	16222	24	to	to	TO
cord-005453-4057qib7	16222	25	be	be	VB
cord-005453-4057qib7	16222	26	done	do	VBN
cord-005453-4057qib7	16222	27	with	with	IN
cord-005453-4057qib7	16222	28	less	less	JJR
cord-005453-4057qib7	16222	29	histocompatibility	histocompatibility	NN
cord-005453-4057qib7	16222	30	requirements	requirement	NNS
cord-005453-4057qib7	16222	31	and	and	CC
cord-005453-4057qib7	16222	32	it	-PRON-	PRP
cord-005453-4057qib7	16222	33	is	be	VBZ
cord-005453-4057qib7	16222	34	available	available	JJ
cord-005453-4057qib7	16222	35	immediately	immediately	RB
cord-005453-4057qib7	16222	36	,	,	,
cord-005453-4057qib7	16222	37	which	which	WDT
cord-005453-4057qib7	16222	38	facilitates	facilitate	VBZ
cord-005453-4057qib7	16222	39	the	the	DT
cord-005453-4057qib7	16222	40	process	process	NN
cord-005453-4057qib7	16222	41	considering	consider	VBG
cord-005453-4057qib7	16222	42	the	the	DT
cord-005453-4057qib7	16222	43	great	great	JJ
cord-005453-4057qib7	16222	44	diversity	diversity	NN
cord-005453-4057qib7	16222	45	that	that	WDT
cord-005453-4057qib7	16222	46	exists	exist	VBZ
cord-005453-4057qib7	16222	47	within	within	IN
cord-005453-4057qib7	16222	48	our	-PRON-	PRP$
cord-005453-4057qib7	16222	49	population	population	NN
cord-005453-4057qib7	16222	50	.	.	.
cord-005453-4057qib7	16223	1	However	however	RB
cord-005453-4057qib7	16223	2	,	,	,
cord-005453-4057qib7	16223	3	in	in	IN
cord-005453-4057qib7	16223	4	our	-PRON-	PRP$
cord-005453-4057qib7	16223	5	experience	experience	NN
cord-005453-4057qib7	16223	6	,	,	,
cord-005453-4057qib7	16223	7	the	the	DT
cord-005453-4057qib7	16223	8	CBSCT	CBSCT	NNP
cord-005453-4057qib7	16223	9	has	have	VBZ
cord-005453-4057qib7	16223	10	shown	show	VBN
cord-005453-4057qib7	16223	11	a	a	DT
cord-005453-4057qib7	16223	12	higher	high	JJR
cord-005453-4057qib7	16223	13	mortality	mortality	NN
cord-005453-4057qib7	16223	14	risk	risk	NN
cord-005453-4057qib7	16223	15	,	,	,
cord-005453-4057qib7	16223	16	which	which	WDT
cord-005453-4057qib7	16223	17	can	can	MD
cord-005453-4057qib7	16223	18	be	be	VB
cord-005453-4057qib7	16223	19	improved	improve	VBN
cord-005453-4057qib7	16223	20	by	by	IN
cord-005453-4057qib7	16223	21	analyzing	analyze	VBG
cord-005453-4057qib7	16223	22	the	the	DT
cord-005453-4057qib7	16223	23	HLA	HLA	NNP
cord-005453-4057qib7	16223	24	C	C	NNP
cord-005453-4057qib7	16223	25	,	,	,
cord-005453-4057qib7	16223	26	choosing	choose	VBG
cord-005453-4057qib7	16223	27	in	in	IN
cord-005453-4057qib7	16223	28	this	this	DT
cord-005453-4057qib7	16223	29	way	way	NN
cord-005453-4057qib7	16223	30	the	the	DT
cord-005453-4057qib7	16223	31	units	unit	NNS
cord-005453-4057qib7	16223	32	with	with	IN
cord-005453-4057qib7	16223	33	better	well	JJR
cord-005453-4057qib7	16223	34	compatibility	compatibility	NN
cord-005453-4057qib7	16223	35	,	,	,
cord-005453-4057qib7	16223	36	and	and	CC
cord-005453-4057qib7	16223	37	improving	improve	VBG
cord-005453-4057qib7	16223	38	cellular	cellular	JJ
cord-005453-4057qib7	16223	39	dosage	dosage	NN
cord-005453-4057qib7	16223	40	since	since	IN
cord-005453-4057qib7	16223	41	this	this	DT
cord-005453-4057qib7	16223	42	is	be	VBZ
cord-005453-4057qib7	16223	43	key	key	JJ
cord-005453-4057qib7	16223	44	in	in	IN
cord-005453-4057qib7	16223	45	success	success	NN
cord-005453-4057qib7	16223	46	.	.	.
cord-005453-4057qib7	16224	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16224	2	:	:	:
cord-005453-4057qib7	16224	3	nothing	nothing	NN
cord-005453-4057qib7	16224	4	to	to	TO
cord-005453-4057qib7	16224	5	declare	declare	VB
cord-005453-4057qib7	16224	6	The	the	DT
cord-005453-4057qib7	16224	7	risk	risk	NN
cord-005453-4057qib7	16224	8	of	of	IN
cord-005453-4057qib7	16224	9	infection	infection	NN
cord-005453-4057qib7	16224	10	of	of	IN
cord-005453-4057qib7	16224	11	the	the	DT
cord-005453-4057qib7	16224	12	umbilical	umbilical	JJ
cord-005453-4057qib7	16224	13	cord	cord	NN
cord-005453-4057qib7	16224	14	is	be	VBZ
cord-005453-4057qib7	16224	15	not	not	RB
cord-005453-4057qib7	16224	16	related	relate	VBN
cord-005453-4057qib7	16224	17	to	to	IN
cord-005453-4057qib7	16224	18	the	the	DT
cord-005453-4057qib7	16224	19	microbiological	microbiological	JJ
cord-005453-4057qib7	16224	20	status	status	NN
cord-005453-4057qib7	16224	21	of	of	IN
cord-005453-4057qib7	16224	22	the	the	DT
cord-005453-4057qib7	16224	23	umbilical	umbilical	JJ
cord-005453-4057qib7	16224	24	cord	cord	NN
cord-005453-4057qib7	16224	25	blood	blood	NN
cord-005453-4057qib7	16224	26	Methods	method	NNS
cord-005453-4057qib7	16224	27	:	:	:
cord-005453-4057qib7	16224	28	The	the	DT
cord-005453-4057qib7	16224	29	statistical	statistical	JJ
cord-005453-4057qib7	16224	30	analysis	analysis	NN
cord-005453-4057qib7	16224	31	was	be	VBD
cord-005453-4057qib7	16224	32	carried	carry	VBN
cord-005453-4057qib7	16224	33	out	out	RP
cord-005453-4057qib7	16224	34	on	on	IN
cord-005453-4057qib7	16224	35	data	datum	NNS
cord-005453-4057qib7	16224	36	obtained	obtain	VBN
cord-005453-4057qib7	16224	37	from	from	IN
cord-005453-4057qib7	16224	38	samples	sample	NNS
cord-005453-4057qib7	16224	39	taken	take	VBN
cord-005453-4057qib7	16224	40	in	in	IN
cord-005453-4057qib7	16224	41	Poland	Poland	NNP
cord-005453-4057qib7	16224	42	between	between	IN
cord-005453-4057qib7	16224	43	01-Jan-2017	01-Jan-2017	NNP
cord-005453-4057qib7	16224	44	and	and	CC
cord-005453-4057qib7	16224	45	31-Dec-2017	31-Dec-2017	NNP
cord-005453-4057qib7	16224	46	.	.	.
cord-005453-4057qib7	16225	1	The	the	DT
cord-005453-4057qib7	16225	2	samples	sample	NNS
cord-005453-4057qib7	16225	3	were	be	VBD
cord-005453-4057qib7	16225	4	collected	collect	VBN
cord-005453-4057qib7	16225	5	in	in	IN
cord-005453-4057qib7	16225	6	hospitals	hospital	NNS
cord-005453-4057qib7	16225	7	by	by	IN
cord-005453-4057qib7	16225	8	external	external	JJ
cord-005453-4057qib7	16225	9	midwifes	midwife	NNS
cord-005453-4057qib7	16225	10	and	and	CC
cord-005453-4057qib7	16225	11	sent	send	VBN
cord-005453-4057qib7	16225	12	to	to	IN
cord-005453-4057qib7	16225	13	the	the	DT
cord-005453-4057qib7	16225	14	PBKM	PBKM	NNP
cord-005453-4057qib7	16225	15	in	in	IN
cord-005453-4057qib7	16225	16	accordance	accordance	NN
cord-005453-4057qib7	16225	17	with	with	IN
cord-005453-4057qib7	16225	18	the	the	DT
cord-005453-4057qib7	16225	19	requirements	requirement	NNS
cord-005453-4057qib7	16225	20	of	of	IN
cord-005453-4057qib7	16225	21	the	the	DT
cord-005453-4057qib7	16225	22	American	American	NNP
cord-005453-4057qib7	16225	23	Association	Association	NNP
cord-005453-4057qib7	16225	24	of	of	IN
cord-005453-4057qib7	16225	25	Blood	Blood	NNP
cord-005453-4057qib7	16225	26	Banks	Banks	NNPS
cord-005453-4057qib7	16225	27	.	.	.
cord-005453-4057qib7	16226	1	After	after	IN
cord-005453-4057qib7	16226	2	arrival	arrival	NN
cord-005453-4057qib7	16226	3	in	in	IN
cord-005453-4057qib7	16226	4	the	the	DT
cord-005453-4057qib7	16226	5	laboratory	laboratory	NN
cord-005453-4057qib7	16226	6	,	,	,
cord-005453-4057qib7	16226	7	the	the	DT
cord-005453-4057qib7	16226	8	blood	blood	NN
cord-005453-4057qib7	16226	9	samples	sample	NNS
cord-005453-4057qib7	16226	10	were	be	VBD
cord-005453-4057qib7	16226	11	cultured	cultured	JJ
cord-005453-4057qib7	16226	12	and	and	CC
cord-005453-4057qib7	16226	13	the	the	DT
cord-005453-4057qib7	16226	14	UCs	uc	NNS
cord-005453-4057qib7	16226	15	were	be	VBD
cord-005453-4057qib7	16226	16	assessed	assess	VBN
cord-005453-4057qib7	16226	17	immediately	immediately	RB
cord-005453-4057qib7	16226	18	for	for	IN
cord-005453-4057qib7	16226	19	visual	visual	JJ
cord-005453-4057qib7	16226	20	signs	sign	NNS
cord-005453-4057qib7	16226	21	of	of	IN
cord-005453-4057qib7	16226	22	infection	infection	NN
cord-005453-4057qib7	16226	23	,	,	,
cord-005453-4057qib7	16226	24	such	such	JJ
cord-005453-4057qib7	16226	25	as	as	IN
cord-005453-4057qib7	16226	26	odor	odor	NN
cord-005453-4057qib7	16226	27	,	,	,
cord-005453-4057qib7	16226	28	altered	alter	VBN
cord-005453-4057qib7	16226	29	color	color	NN
cord-005453-4057qib7	16226	30	,	,	,
cord-005453-4057qib7	16226	31	or	or	CC
cord-005453-4057qib7	16226	32	visible	visible	JJ
cord-005453-4057qib7	16226	33	bloom	bloom	NN
cord-005453-4057qib7	16226	34	.	.	.
cord-005453-4057qib7	16227	1	The	the	DT
cord-005453-4057qib7	16227	2	status	status	NN
cord-005453-4057qib7	16227	3	of	of	IN
cord-005453-4057qib7	16227	4	both	both	DT
cord-005453-4057qib7	16227	5	kinds	kind	NNS
cord-005453-4057qib7	16227	6	of	of	IN
cord-005453-4057qib7	16227	7	samples	sample	NNS
cord-005453-4057qib7	16227	8	was	be	VBD
cord-005453-4057qib7	16227	9	introduced	introduce	VBN
cord-005453-4057qib7	16227	10	into	into	IN
cord-005453-4057qib7	16227	11	the	the	DT
cord-005453-4057qib7	16227	12	PBKM	PBKM	NNP
cord-005453-4057qib7	16227	13	general	general	JJ
cord-005453-4057qib7	16227	14	database	database	NN
cord-005453-4057qib7	16227	15	.	.	.
cord-005453-4057qib7	16228	1	For	for	IN
cord-005453-4057qib7	16228	2	the	the	DT
cord-005453-4057qib7	16228	3	purpose	purpose	NN
cord-005453-4057qib7	16228	4	of	of	IN
cord-005453-4057qib7	16228	5	this	this	DT
cord-005453-4057qib7	16228	6	analysis	analysis	NN
cord-005453-4057qib7	16228	7	,	,	,
cord-005453-4057qib7	16228	8	the	the	DT
cord-005453-4057qib7	16228	9	UCs	uc	NNS
cord-005453-4057qib7	16228	10	were	be	VBD
cord-005453-4057qib7	16228	11	considered	consider	VBN
cord-005453-4057qib7	16228	12	as	as	RB
cord-005453-4057qib7	16228	13	microbiologically	microbiologically	RB
cord-005453-4057qib7	16228	14	pure	pure	JJ
cord-005453-4057qib7	16228	15	if	if	IN
cord-005453-4057qib7	16228	16	stored	store	VBN
cord-005453-4057qib7	16228	17	,	,	,
cord-005453-4057qib7	16228	18	destroyed	destroy	VBN
cord-005453-4057qib7	16228	19	after	after	IN
cord-005453-4057qib7	16228	20	storage	storage	NN
cord-005453-4057qib7	16228	21	,	,	,
cord-005453-4057qib7	16228	22	or	or	CC
cord-005453-4057qib7	16228	23	handed	hand	VBN
cord-005453-4057qib7	16228	24	over	over	RP
cord-005453-4057qib7	16228	25	to	to	IN
cord-005453-4057qib7	16228	26	the	the	DT
cord-005453-4057qib7	16228	27	PBKM	PBKM	NNP
cord-005453-4057qib7	16228	28	.	.	.
cord-005453-4057qib7	16229	1	Samples	sample	NNS
cord-005453-4057qib7	16229	2	marked	mark	VBN
cord-005453-4057qib7	16229	3	as	as	IN
cord-005453-4057qib7	16229	4	infected	infect	VBN
cord-005453-4057qib7	16229	5	or	or	CC
cord-005453-4057qib7	16229	6	disqualified	disqualify	VBN
cord-005453-4057qib7	16229	7	for	for	IN
cord-005453-4057qib7	16229	8	unknown	unknown	JJ
cord-005453-4057qib7	16229	9	reasons	reason	NNS
cord-005453-4057qib7	16229	10	(	(	-LRB-
cord-005453-4057qib7	16229	11	other	other	JJ
cord-005453-4057qib7	16229	12	than	than	IN
cord-005453-4057qib7	16229	13	termination	termination	NN
cord-005453-4057qib7	16229	14	of	of	IN
cord-005453-4057qib7	16229	15	the	the	DT
cord-005453-4057qib7	16229	16	contract	contract	NN
cord-005453-4057qib7	16229	17	with	with	IN
cord-005453-4057qib7	16229	18	the	the	DT
cord-005453-4057qib7	16229	19	customer	customer	NN
cord-005453-4057qib7	16229	20	,	,	,
cord-005453-4057qib7	16229	21	viral	viral	JJ
cord-005453-4057qib7	16229	22	infection	infection	NN
cord-005453-4057qib7	16229	23	of	of	IN
cord-005453-4057qib7	16229	24	the	the	DT
cord-005453-4057qib7	16229	25	mother	mother	NN
cord-005453-4057qib7	16229	26	,	,	,
cord-005453-4057qib7	16229	27	and	and	CC
cord-005453-4057qib7	16229	28	lack	lack	NN
cord-005453-4057qib7	16229	29	of	of	IN
cord-005453-4057qib7	16229	30	cell	cell	NN
cord-005453-4057qib7	16229	31	growth	growth	NN
cord-005453-4057qib7	16229	32	)	)	-RRB-
cord-005453-4057qib7	16229	33	were	be	VBD
cord-005453-4057qib7	16229	34	considered	consider	VBN
cord-005453-4057qib7	16229	35	as	as	IN
cord-005453-4057qib7	16229	36	infected	infect	VBN
cord-005453-4057qib7	16229	37	.	.	.
cord-005453-4057qib7	16230	1	At	at	IN
cord-005453-4057qib7	16230	2	the	the	DT
cord-005453-4057qib7	16230	3	time	time	NN
cord-005453-4057qib7	16230	4	of	of	IN
cord-005453-4057qib7	16230	5	the	the	DT
cord-005453-4057qib7	16230	6	statistical	statistical	JJ
cord-005453-4057qib7	16230	7	analysis	analysis	NN
cord-005453-4057qib7	16230	8	,	,	,
cord-005453-4057qib7	16230	9	the	the	DT
cord-005453-4057qib7	16230	10	samples	sample	NNS
cord-005453-4057qib7	16230	11	of	of	IN
cord-005453-4057qib7	16230	12	unknown	unknown	JJ
cord-005453-4057qib7	16230	13	UCB	UCB	NNP
cord-005453-4057qib7	16230	14	microbiological	microbiological	JJ
cord-005453-4057qib7	16230	15	culture	culture	NN
cord-005453-4057qib7	16230	16	status	status	NN
cord-005453-4057qib7	16230	17	were	be	VBD
cord-005453-4057qib7	16230	18	removed	remove	VBN
cord-005453-4057qib7	16230	19	from	from	IN
cord-005453-4057qib7	16230	20	the	the	DT
cord-005453-4057qib7	16230	21	generated	generate	VBN
cord-005453-4057qib7	16230	22	report	report	NN
cord-005453-4057qib7	16230	23	.	.	.
cord-005453-4057qib7	16231	1	The	the	DT
cord-005453-4057qib7	16231	2	data	datum	NNS
cord-005453-4057qib7	16231	3	was	be	VBD
cord-005453-4057qib7	16231	4	summarized	summarize	VBN
cord-005453-4057qib7	16231	5	as	as	IN
cord-005453-4057qib7	16231	6	percentages	percentage	NNS
cord-005453-4057qib7	16231	7	and	and	CC
cord-005453-4057qib7	16231	8	the	the	DT
cord-005453-4057qib7	16231	9	odds	odd	NNS
cord-005453-4057qib7	16231	10	ratio	ratio	NN
cord-005453-4057qib7	16231	11	was	be	VBD
cord-005453-4057qib7	16231	12	calculated	calculate	VBN
cord-005453-4057qib7	16231	13	.	.	.
cord-005453-4057qib7	16232	1	Statistical	statistical	JJ
cord-005453-4057qib7	16232	2	significance	significance	NN
cord-005453-4057qib7	16232	3	was	be	VBD
cord-005453-4057qib7	16232	4	considered	consider	VBN
cord-005453-4057qib7	16232	5	at	at	IN
cord-005453-4057qib7	16232	6	p˂0.05.Background	p˂0.05.background	NN
cord-005453-4057qib7	16232	7	:	:	:
cord-005453-4057qib7	16233	1	Match	match	VB
cord-005453-4057qib7	16233	2	family	family	NN
cord-005453-4057qib7	16233	3	donors	donor	NNS
cord-005453-4057qib7	16233	4	are	be	VBP
cord-005453-4057qib7	16233	5	the	the	DT
cord-005453-4057qib7	16233	6	preferable	preferable	JJ
cord-005453-4057qib7	16233	7	options	option	NNS
cord-005453-4057qib7	16233	8	in	in	IN
cord-005453-4057qib7	16233	9	allogenic	allogenic	JJ
cord-005453-4057qib7	16233	10	stem	stem	NN
cord-005453-4057qib7	16233	11	cell	cell	NN
cord-005453-4057qib7	16233	12	transplant	transplant	NN
cord-005453-4057qib7	16233	13	.	.	.
cord-005453-4057qib7	16234	1	However	however	RB
cord-005453-4057qib7	16234	2	,	,	,
cord-005453-4057qib7	16234	3	in	in	IN
cord-005453-4057qib7	16234	4	the	the	DT
cord-005453-4057qib7	16234	5	absence	absence	NN
cord-005453-4057qib7	16234	6	of	of	IN
cord-005453-4057qib7	16234	7	donor	donor	NN
cord-005453-4057qib7	16234	8	relatives	relative	NNS
cord-005453-4057qib7	16234	9	match	match	VBP
cord-005453-4057qib7	16234	10	unrelated	unrelated	JJ
cord-005453-4057qib7	16234	11	donors	donor	NNS
cord-005453-4057qib7	16234	12	have	have	VBP
cord-005453-4057qib7	16234	13	been	be	VBN
cord-005453-4057qib7	16234	14	an	an	DT
cord-005453-4057qib7	16234	15	option	option	NN
cord-005453-4057qib7	16234	16	.	.	.
cord-005453-4057qib7	16235	1	In	in	IN
cord-005453-4057qib7	16235	2	this	this	DT
cord-005453-4057qib7	16235	3	study	study	NN
cord-005453-4057qib7	16235	4	,	,	,
cord-005453-4057qib7	16235	5	the	the	DT
cord-005453-4057qib7	16235	6	donor	donor	NN
cord-005453-4057qib7	16235	7	screening	screening	NN
cord-005453-4057qib7	16235	8	,	,	,
cord-005453-4057qib7	16235	9	transplant	transplant	NN
cord-005453-4057qib7	16235	10	preparation	preparation	NN
cord-005453-4057qib7	16235	11	phases	phase	NNS
cord-005453-4057qib7	16235	12	of	of	IN
cord-005453-4057qib7	16235	13	Turkish	turkish	JJ
cord-005453-4057qib7	16235	14	Stem	Stem	NNP
cord-005453-4057qib7	16235	15	Cell	Cell	NNP
cord-005453-4057qib7	16235	16	Coordination	Coordination	NNP
cord-005453-4057qib7	16235	17	Center	Center	NNP
cord-005453-4057qib7	16235	18	(	(	-LRB-
cord-005453-4057qib7	16235	19	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16235	20	)	)	-RRB-
cord-005453-4057qib7	16235	21	and	and	CC
cord-005453-4057qib7	16235	22	the	the	DT
cord-005453-4057qib7	16235	23	İstanbul	İstanbul	NNP
cord-005453-4057qib7	16235	24	University	University	NNP
cord-005453-4057qib7	16235	25	Bone	Bone	NNP
cord-005453-4057qib7	16235	26	Marrow	Marrow	NNP
cord-005453-4057qib7	16235	27	Bank	Bank	NNP
cord-005453-4057qib7	16235	28	(	(	-LRB-
cord-005453-4057qib7	16235	29	TRIS	TRIS	NNP
cord-005453-4057qib7	16235	30	)	)	-RRB-
cord-005453-4057qib7	16235	31	,	,	,
cord-005453-4057qib7	16235	32	were	be	VBD
cord-005453-4057qib7	16235	33	compared	compare	VBN
cord-005453-4057qib7	16235	34	.	.	.
cord-005453-4057qib7	16236	1	Methods	method	NNS
cord-005453-4057qib7	16236	2	:	:	:
cord-005453-4057qib7	16236	3	The	the	DT
cord-005453-4057qib7	16236	4	unrelated	unrelated	JJ
cord-005453-4057qib7	16236	5	donor	donor	NN
cord-005453-4057qib7	16236	6	scanning	scanning	NN
cord-005453-4057qib7	16236	7	data	datum	NNS
cord-005453-4057qib7	16236	8	between	between	IN
cord-005453-4057qib7	16236	9	March	March	NNP
cord-005453-4057qib7	16236	10	2015	2015	CD
cord-005453-4057qib7	16236	11	and	and	CC
cord-005453-4057qib7	16236	12	November	November	NNP
cord-005453-4057qib7	16236	13	2018	2018	CD
cord-005453-4057qib7	16236	14	in	in	IN
cord-005453-4057qib7	16236	15	Pediatric	pediatric	JJ
cord-005453-4057qib7	16236	16	stem	stem	NN
cord-005453-4057qib7	16236	17	cell	cell	NN
cord-005453-4057qib7	16236	18	transplantation	transplantation	NN
cord-005453-4057qib7	16236	19	Unit	Unit	NNP
cord-005453-4057qib7	16236	20	of	of	IN
cord-005453-4057qib7	16236	21	Altınbas	Altınbas	NNP
cord-005453-4057qib7	16236	22	University	University	NNP
cord-005453-4057qib7	16236	23	Bahcelievler	Bahcelievler	NNP
cord-005453-4057qib7	16236	24	Medical	Medical	NNP
cord-005453-4057qib7	16236	25	Park	Park	NNP
cord-005453-4057qib7	16236	26	Hospital	Hospital	NNP
cord-005453-4057qib7	16236	27	were	be	VBD
cord-005453-4057qib7	16236	28	evaluated	evaluate	VBN
cord-005453-4057qib7	16236	29	.	.	.
cord-005453-4057qib7	16237	1	93	93	CD
cord-005453-4057qib7	16237	2	unrelated	unrelated	JJ
cord-005453-4057qib7	16237	3	transplants	transplant	NNS
cord-005453-4057qib7	16237	4	were	be	VBD
cord-005453-4057qib7	16237	5	performed	perform	VBN
cord-005453-4057qib7	16237	6	in	in	IN
cord-005453-4057qib7	16237	7	total	total	NN
cord-005453-4057qib7	16237	8	.	.	.
cord-005453-4057qib7	16238	1	65	65	CD
cord-005453-4057qib7	16238	2	%	%	NN
cord-005453-4057qib7	16238	3	of	of	IN
cord-005453-4057qib7	16238	4	these	these	DT
cord-005453-4057qib7	16238	5	transplants	transplant	NNS
cord-005453-4057qib7	16238	6	(	(	-LRB-
cord-005453-4057qib7	16238	7	n=61	n=61	NNP
cord-005453-4057qib7	16238	8	)	)	-RRB-
cord-005453-4057qib7	16238	9	were	be	VBD
cord-005453-4057qib7	16238	10	included	include	VBN
cord-005453-4057qib7	16238	11	from	from	IN
cord-005453-4057qib7	16238	12	the	the	DT
cord-005453-4057qib7	16238	13	donors	donor	NNS
cord-005453-4057qib7	16238	14	of	of	IN
cord-005453-4057qib7	16238	15	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16238	16	registration	registration	NN
cord-005453-4057qib7	16238	17	system	system	NN
cord-005453-4057qib7	16238	18	and	and	CC
cord-005453-4057qib7	16238	19	34,4	34,4	CD
cord-005453-4057qib7	16238	20	%	%	NN
cord-005453-4057qib7	16238	21	of	of	IN
cord-005453-4057qib7	16238	22	these	these	DT
cord-005453-4057qib7	16238	23	transplants	transplant	NNS
cord-005453-4057qib7	16238	24	(	(	-LRB-
cord-005453-4057qib7	16238	25	n=32	n=32	NNP
cord-005453-4057qib7	16238	26	)	)	-RRB-
cord-005453-4057qib7	16238	27	were	be	VBD
cord-005453-4057qib7	16238	28	included	include	VBN
cord-005453-4057qib7	16238	29	by	by	IN
cord-005453-4057qib7	16238	30	means	mean	NNS
cord-005453-4057qib7	16238	31	of	of	IN
cord-005453-4057qib7	16238	32	TRIS	TRIS	NNP
cord-005453-4057qib7	16238	33	from	from	IN
cord-005453-4057qib7	16238	34	donors	donor	NNS
cord-005453-4057qib7	16238	35	outside	outside	IN
cord-005453-4057qib7	16238	36	of	of	IN
cord-005453-4057qib7	16238	37	Turkey	Turkey	NNP
cord-005453-4057qib7	16238	38	.	.	.
cord-005453-4057qib7	16239	1	8	8	CD
cord-005453-4057qib7	16239	2	patients	patient	NNS
cord-005453-4057qib7	16239	3	(	(	-LRB-
cord-005453-4057qib7	16239	4	5	5	CD
cord-005453-4057qib7	16239	5	TRIS	TRIS	NNP
cord-005453-4057qib7	16239	6	,	,	,
cord-005453-4057qib7	16239	7	3	3	CD
cord-005453-4057qib7	16239	8	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16239	9	)	)	-RRB-
cord-005453-4057qib7	16239	10	were	be	VBD
cord-005453-4057qib7	16239	11	excluded	exclude	VBN
cord-005453-4057qib7	16239	12	from	from	IN
cord-005453-4057qib7	16239	13	the	the	DT
cord-005453-4057qib7	16239	14	study	study	NN
cord-005453-4057qib7	16239	15	in	in	IN
cord-005453-4057qib7	16239	16	consequence	consequence	NN
cord-005453-4057qib7	16239	17	of	of	IN
cord-005453-4057qib7	16239	18	screening	screening	NN
cord-005453-4057qib7	16239	19	update	update	NN
cord-005453-4057qib7	16239	20	and	and	CC
cord-005453-4057qib7	16239	21	postpone	postpone	NN
cord-005453-4057qib7	16239	22	of	of	IN
cord-005453-4057qib7	16239	23	transplantation	transplantation	NN
cord-005453-4057qib7	16239	24	.	.	.
cord-005453-4057qib7	16240	1	The	the	DT
cord-005453-4057qib7	16240	2	statistics	statistic	NNS
cord-005453-4057qib7	16240	3	were	be	VBD
cord-005453-4057qib7	16240	4	carried	carry	VBN
cord-005453-4057qib7	16240	5	out	out	RP
cord-005453-4057qib7	16240	6	on	on	IN
cord-005453-4057qib7	16240	7	a	a	DT
cord-005453-4057qib7	16240	8	total	total	NN
cord-005453-4057qib7	16240	9	of	of	IN
cord-005453-4057qib7	16240	10	85	85	CD
cord-005453-4057qib7	16240	11	patients	patient	NNS
cord-005453-4057qib7	16240	12	,	,	,
cord-005453-4057qib7	16240	13	67,1	67,1	CD
cord-005453-4057qib7	16240	14	%	%	NN
cord-005453-4057qib7	16240	15	of	of	IN
cord-005453-4057qib7	16240	16	whom	whom	WP
cord-005453-4057qib7	16240	17	were	be	VBD
cord-005453-4057qib7	16240	18	in	in	IN
cord-005453-4057qib7	16240	19	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16240	20	(	(	-LRB-
cord-005453-4057qib7	16240	21	n=57	n=57	NNP
cord-005453-4057qib7	16240	22	)	)	-RRB-
cord-005453-4057qib7	16240	23	and	and	CC
cord-005453-4057qib7	16240	24	32,9	32,9	CD
cord-005453-4057qib7	16240	25	%	%	NN
cord-005453-4057qib7	16240	26	were	be	VBD
cord-005453-4057qib7	16240	27	transplanted	transplant	VBN
cord-005453-4057qib7	16240	28	via	via	IN
cord-005453-4057qib7	16240	29	TRIS	TRIS	NNP
cord-005453-4057qib7	16240	30	(	(	-LRB-
cord-005453-4057qib7	16240	31	n=28	n=28	NN
cord-005453-4057qib7	16240	32	)	)	-RRB-
cord-005453-4057qib7	16240	33	.	.	.
cord-005453-4057qib7	16241	1	The	the	DT
cord-005453-4057qib7	16241	2	day	day	NN
cord-005453-4057qib7	16241	3	of	of	IN
cord-005453-4057qib7	16241	4	application	application	NN
cord-005453-4057qib7	16241	5	to	to	TO
cord-005453-4057qib7	16241	6	stem	stem	VB
cord-005453-4057qib7	16241	7	cell	cell	NN
cord-005453-4057qib7	16241	8	transplantation	transplantation	NN
cord-005453-4057qib7	16241	9	unit	unit	NN
cord-005453-4057qib7	16241	10	,	,	,
cord-005453-4057qib7	16241	11	reply	reply	NN
cord-005453-4057qib7	16241	12	dates	date	NNS
cord-005453-4057qib7	16241	13	and	and	CC
cord-005453-4057qib7	16241	14	the	the	DT
cord-005453-4057qib7	16241	15	transplantation	transplantation	NN
cord-005453-4057qib7	16241	16	dates	date	NNS
cord-005453-4057qib7	16241	17	were	be	VBD
cord-005453-4057qib7	16241	18	examined	examine	VBN
cord-005453-4057qib7	16241	19	for	for	IN
cord-005453-4057qib7	16241	20	the	the	DT
cord-005453-4057qib7	16241	21	transplant	transplant	NN
cord-005453-4057qib7	16241	22	patients	patient	NNS
cord-005453-4057qib7	16241	23	.	.	.
cord-005453-4057qib7	16242	1	Results	result	NNS
cord-005453-4057qib7	16242	2	:	:	:
cord-005453-4057qib7	16243	1	In	in	IN
cord-005453-4057qib7	16243	2	the	the	DT
cord-005453-4057qib7	16243	3	current	current	JJ
cord-005453-4057qib7	16243	4	study	study	NN
cord-005453-4057qib7	16243	5	,	,	,
cord-005453-4057qib7	16243	6	the	the	DT
cord-005453-4057qib7	16243	7	average	average	JJ
cord-005453-4057qib7	16243	8	response	response	NN
cord-005453-4057qib7	16243	9	time	time	NN
cord-005453-4057qib7	16243	10	of	of	IN
cord-005453-4057qib7	16243	11	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16243	12	was	be	VBD
cord-005453-4057qib7	16243	13	found	find	VBN
cord-005453-4057qib7	16243	14	as	as	IN
cord-005453-4057qib7	16243	15	0,91±2,96	0,91±2,96	CD
cord-005453-4057qib7	16243	16	day	day	NN
cord-005453-4057qib7	16243	17	(	(	-LRB-
cord-005453-4057qib7	16243	18	median	median	NN
cord-005453-4057qib7	16243	19	:	:	SYM
cord-005453-4057qib7	16243	20	0	0	CD
cord-005453-4057qib7	16243	21	)	)	-RRB-
cord-005453-4057qib7	16243	22	,	,	,
cord-005453-4057qib7	16243	23	the	the	DT
cord-005453-4057qib7	16243	24	average	average	JJ
cord-005453-4057qib7	16243	25	transplant	transplant	NN
cord-005453-4057qib7	16243	26	time	time	NN
cord-005453-4057qib7	16243	27	after	after	IN
cord-005453-4057qib7	16243	28	receiving	receive	VBG
cord-005453-4057qib7	16243	29	a	a	DT
cord-005453-4057qib7	16243	30	reply	reply	NN
cord-005453-4057qib7	16243	31	was	be	VBD
cord-005453-4057qib7	16243	32	found	find	VBN
cord-005453-4057qib7	16243	33	as	as	IN
cord-005453-4057qib7	16243	34	98,24±63,89	98,24±63,89	CD
cord-005453-4057qib7	16243	35	(	(	-LRB-
cord-005453-4057qib7	16243	36	median	median	NN
cord-005453-4057qib7	16243	37	:	:	:
cord-005453-4057qib7	16243	38	85	85	CD
cord-005453-4057qib7	16243	39	)	)	-RRB-
cord-005453-4057qib7	16243	40	day	day	NN
cord-005453-4057qib7	16243	41	,	,	,
cord-005453-4057qib7	16243	42	the	the	DT
cord-005453-4057qib7	16243	43	average	average	JJ
cord-005453-4057qib7	16243	44	number	number	NN
cord-005453-4057qib7	16243	45	of	of	IN
cord-005453-4057qib7	16243	46	days	day	NNS
cord-005453-4057qib7	16243	47	from	from	IN
cord-005453-4057qib7	16243	48	date	date	NN
cord-005453-4057qib7	16243	49	of	of	IN
cord-005453-4057qib7	16243	50	application	application	NN
cord-005453-4057qib7	16243	51	to	to	IN
cord-005453-4057qib7	16243	52	date	date	NN
cord-005453-4057qib7	16243	53	of	of	IN
cord-005453-4057qib7	16243	54	transplantation	transplantation	NN
cord-005453-4057qib7	16243	55	of	of	IN
cord-005453-4057qib7	16243	56	patients	patient	NNS
cord-005453-4057qib7	16243	57	was	be	VBD
cord-005453-4057qib7	16243	58	found	find	VBN
cord-005453-4057qib7	16243	59	as	as	IN
cord-005453-4057qib7	16243	60	101,12±63,17	101,12±63,17	NNP
cord-005453-4057qib7	16243	61	(	(	-LRB-
cord-005453-4057qib7	16243	62	median	median	NN
cord-005453-4057qib7	16243	63	:	:	:
cord-005453-4057qib7	16243	64	89	89	CD
cord-005453-4057qib7	16243	65	)	)	-RRB-
cord-005453-4057qib7	16243	66	.	.	.
cord-005453-4057qib7	16244	1	The	the	DT
cord-005453-4057qib7	16244	2	average	average	JJ
cord-005453-4057qib7	16244	3	response	response	NN
cord-005453-4057qib7	16244	4	time	time	NN
cord-005453-4057qib7	16244	5	of	of	IN
cord-005453-4057qib7	16244	6	TRIS	TRIS	NNP
cord-005453-4057qib7	16244	7	was	be	VBD
cord-005453-4057qib7	16244	8	18,78±18,36	18,78±18,36	CD
cord-005453-4057qib7	16245	1	(	(	-LRB-
cord-005453-4057qib7	16245	2	median	median	NN
cord-005453-4057qib7	16245	3	:	:	:
cord-005453-4057qib7	16245	4	15	15	CD
cord-005453-4057qib7	16245	5	)	)	-RRB-
cord-005453-4057qib7	16245	6	day	day	NN
cord-005453-4057qib7	16245	7	,	,	,
cord-005453-4057qib7	16245	8	the	the	DT
cord-005453-4057qib7	16245	9	average	average	JJ
cord-005453-4057qib7	16245	10	transplant	transplant	NN
cord-005453-4057qib7	16245	11	time	time	NN
cord-005453-4057qib7	16245	12	after	after	IN
cord-005453-4057qib7	16245	13	receiving	receive	VBG
cord-005453-4057qib7	16245	14	a	a	DT
cord-005453-4057qib7	16245	15	reply	reply	NN
cord-005453-4057qib7	16245	16	from	from	IN
cord-005453-4057qib7	16245	17	TRIS	TRIS	NNP
cord-005453-4057qib7	16245	18	was	be	VBD
cord-005453-4057qib7	16245	19	136,82±63,84	136,82±63,84	CD
cord-005453-4057qib7	16246	1	(	(	-LRB-
cord-005453-4057qib7	16246	2	Median	median	NN
cord-005453-4057qib7	16246	3	:	:	:
cord-005453-4057qib7	16246	4	119	119	CD
cord-005453-4057qib7	16246	5	)	)	-RRB-
cord-005453-4057qib7	16246	6	day	day	NN
cord-005453-4057qib7	16246	7	,	,	,
cord-005453-4057qib7	16246	8	average	average	JJ
cord-005453-4057qib7	16246	9	number	number	NN
cord-005453-4057qib7	16246	10	of	of	IN
cord-005453-4057qib7	16246	11	days	day	NNS
cord-005453-4057qib7	16246	12	from	from	IN
cord-005453-4057qib7	16246	13	date	date	NN
cord-005453-4057qib7	16246	14	of	of	IN
cord-005453-4057qib7	16246	15	application	application	NN
cord-005453-4057qib7	16246	16	of	of	IN
cord-005453-4057qib7	16246	17	TRIS	TRIS	NNP
cord-005453-4057qib7	16246	18	to	to	IN
cord-005453-4057qib7	16246	19	date	date	NN
cord-005453-4057qib7	16246	20	of	of	IN
cord-005453-4057qib7	16246	21	transplantation	transplantation	NN
cord-005453-4057qib7	16246	22	of	of	IN
cord-005453-4057qib7	16246	23	patients	patient	NNS
cord-005453-4057qib7	16247	1	155,61±72,23	155,61±72,23	CD
cord-005453-4057qib7	16248	1	(	(	-LRB-
cord-005453-4057qib7	16248	2	Median	median	NN
cord-005453-4057qib7	16248	3	:	:	:
cord-005453-4057qib7	16248	4	140	140	CD
cord-005453-4057qib7	16248	5	)	)	-RRB-
cord-005453-4057qib7	16248	6	day	day	NN
cord-005453-4057qib7	16248	7	.	.	.
cord-005453-4057qib7	16249	1	The	the	DT
cord-005453-4057qib7	16249	2	average	average	JJ
cord-005453-4057qib7	16249	3	response	response	NN
cord-005453-4057qib7	16249	4	time	time	NN
cord-005453-4057qib7	16249	5	of	of	IN
cord-005453-4057qib7	16249	6	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16249	7	,	,	,
cord-005453-4057qib7	16249	8	the	the	DT
cord-005453-4057qib7	16249	9	average	average	JJ
cord-005453-4057qib7	16249	10	transplant	transplant	NN
cord-005453-4057qib7	16249	11	time	time	NN
cord-005453-4057qib7	16249	12	after	after	IN
cord-005453-4057qib7	16249	13	receiving	receive	VBG
cord-005453-4057qib7	16249	14	a	a	DT
cord-005453-4057qib7	16249	15	reply	reply	NN
cord-005453-4057qib7	16249	16	from	from	IN
cord-005453-4057qib7	16249	17	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16249	18	and	and	CC
cord-005453-4057qib7	16249	19	the	the	DT
cord-005453-4057qib7	16249	20	average	average	JJ
cord-005453-4057qib7	16249	21	number	number	NN
cord-005453-4057qib7	16249	22	of	of	IN
cord-005453-4057qib7	16249	23	days	day	NNS
cord-005453-4057qib7	16249	24	from	from	IN
cord-005453-4057qib7	16249	25	date	date	NN
cord-005453-4057qib7	16249	26	of	of	IN
cord-005453-4057qib7	16249	27	application	application	NN
cord-005453-4057qib7	16249	28	of	of	IN
cord-005453-4057qib7	16249	29	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16249	30	to	to	IN
cord-005453-4057qib7	16249	31	date	date	NN
cord-005453-4057qib7	16249	32	of	of	IN
cord-005453-4057qib7	16249	33	transplantation	transplantation	NN
cord-005453-4057qib7	16249	34	of	of	IN
cord-005453-4057qib7	16249	35	patients	patient	NNS
cord-005453-4057qib7	16249	36	was	be	VBD
cord-005453-4057qib7	16249	37	shorter	short	JJR
cord-005453-4057qib7	16249	38	than	than	IN
cord-005453-4057qib7	16249	39	TRIS	TRIS	NNP
cord-005453-4057qib7	16249	40	.	.	.
cord-005453-4057qib7	16250	1	The	the	DT
cord-005453-4057qib7	16250	2	difference	difference	NN
cord-005453-4057qib7	16250	3	between	between	IN
cord-005453-4057qib7	16250	4	them	-PRON-	PRP
cord-005453-4057qib7	16250	5	was	be	VBD
cord-005453-4057qib7	16250	6	found	find	VBN
cord-005453-4057qib7	16251	1	statistically	statistically	RB
cord-005453-4057qib7	16251	2	significant	significant	JJ
cord-005453-4057qib7	16251	3	(	(	-LRB-
cord-005453-4057qib7	16251	4	p	p	NN
cord-005453-4057qib7	16251	5	<	<	XX
cord-005453-4057qib7	16251	6	0.05).Conclusions	0.05).conclusion	NNS
cord-005453-4057qib7	16251	7	:	:	:
cord-005453-4057qib7	16251	8	In	in	IN
cord-005453-4057qib7	16251	9	this	this	DT
cord-005453-4057qib7	16251	10	study	study	NN
cord-005453-4057qib7	16251	11	,	,	,
cord-005453-4057qib7	16251	12	it	-PRON-	PRP
cord-005453-4057qib7	16251	13	was	be	VBD
cord-005453-4057qib7	16251	14	determined	determine	VBN
cord-005453-4057qib7	16251	15	that	that	IN
cord-005453-4057qib7	16251	16	the	the	DT
cord-005453-4057qib7	16251	17	transplantation	transplantation	NN
cord-005453-4057qib7	16251	18	processes	process	VBZ
cord-005453-4057qib7	16251	19	with	with	IN
cord-005453-4057qib7	16251	20	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16251	21	were	be	VBD
cord-005453-4057qib7	16251	22	progressing	progress	VBG
cord-005453-4057qib7	16251	23	more	more	RBR
cord-005453-4057qib7	16251	24	rapidly	rapidly	RB
cord-005453-4057qib7	16251	25	.	.	.
cord-005453-4057qib7	16252	1	The	the	DT
cord-005453-4057qib7	16252	2	rapid	rapid	JJ
cord-005453-4057qib7	16252	3	progress	progress	NN
cord-005453-4057qib7	16252	4	of	of	IN
cord-005453-4057qib7	16252	5	the	the	DT
cord-005453-4057qib7	16252	6	process	process	NN
cord-005453-4057qib7	16252	7	was	be	VBD
cord-005453-4057qib7	16252	8	attributed	attribute	VBN
cord-005453-4057qib7	16252	9	to	to	IN
cord-005453-4057qib7	16252	10	the	the	DT
cord-005453-4057qib7	16252	11	fact	fact	NN
cord-005453-4057qib7	16252	12	that	that	IN
cord-005453-4057qib7	16252	13	all	all	DT
cord-005453-4057qib7	16252	14	donor	donor	NN
cord-005453-4057qib7	16252	15	HLA	HLA	NNP
cord-005453-4057qib7	16252	16	tissue	tissue	NN
cord-005453-4057qib7	16252	17	groups	group	NNS
cord-005453-4057qib7	16252	18	in	in	IN
cord-005453-4057qib7	16252	19	the	the	DT
cord-005453-4057qib7	16252	20	TURKOK	TURKOK	NNP
cord-005453-4057qib7	16252	21	database	database	NN
cord-005453-4057qib7	16252	22	were	be	VBD
cord-005453-4057qib7	16252	23	studied	study	VBN
cord-005453-4057qib7	16252	24	in	in	IN
cord-005453-4057qib7	16252	25	high	high	JJ
cord-005453-4057qib7	16252	26	resolution	resolution	NN
cord-005453-4057qib7	16252	27	.	.	.
cord-005453-4057qib7	16253	1	In	in	IN
cord-005453-4057qib7	16253	2	international	international	JJ
cord-005453-4057qib7	16253	3	scans	scan	NNS
cord-005453-4057qib7	16253	4	carried	carry	VBN
cord-005453-4057qib7	16253	5	out	out	RP
cord-005453-4057qib7	16253	6	through	through	IN
cord-005453-4057qib7	16253	7	TRIS	TRIS	NNP
cord-005453-4057qib7	16253	8	,	,	,
cord-005453-4057qib7	16253	9	it	-PRON-	PRP
cord-005453-4057qib7	16253	10	was	be	VBD
cord-005453-4057qib7	16253	11	thought	think	VBN
cord-005453-4057qib7	16253	12	that	that	IN
cord-005453-4057qib7	16253	13	the	the	DT
cord-005453-4057qib7	16253	14	examination	examination	NN
cord-005453-4057qib7	16253	15	of	of	IN
cord-005453-4057qib7	16253	16	the	the	DT
cord-005453-4057qib7	16253	17	donor	donor	NN
cord-005453-4057qib7	16253	18	castings	casting	NNS
cord-005453-4057qib7	16253	19	coming	come	VBG
cord-005453-4057qib7	16253	20	from	from	IN
cord-005453-4057qib7	16253	21	bone	bone	NN
cord-005453-4057qib7	16253	22	marrow	marrow	NN
cord-005453-4057qib7	16253	23	banks	bank	NNS
cord-005453-4057qib7	16253	24	and	and	CC
cord-005453-4057qib7	16253	25	the	the	DT
cord-005453-4057qib7	16253	26	time	time	NN
cord-005453-4057qib7	16253	27	differences	difference	NNS
cord-005453-4057qib7	16253	28	between	between	IN
cord-005453-4057qib7	16253	29	the	the	DT
cord-005453-4057qib7	16253	30	countries	country	NNS
cord-005453-4057qib7	16253	31	prolong	prolong	VBP
cord-005453-4057qib7	16253	32	the	the	DT
cord-005453-4057qib7	16253	33	process	process	NN
cord-005453-4057qib7	16253	34	.	.	.
cord-005453-4057qib7	16254	1	It	-PRON-	PRP
cord-005453-4057qib7	16254	2	was	be	VBD
cord-005453-4057qib7	16254	3	thought	think	VBN
cord-005453-4057qib7	16254	4	that	that	IN
cord-005453-4057qib7	16254	5	HLA	HLA	NNP
cord-005453-4057qib7	16254	6	tests	test	NNS
cord-005453-4057qib7	16254	7	of	of	IN
cord-005453-4057qib7	16254	8	the	the	DT
cord-005453-4057qib7	16254	9	registered	register	VBN
cord-005453-4057qib7	16254	10	donors	donor	NNS
cord-005453-4057qib7	16254	11	in	in	IN
cord-005453-4057qib7	16254	12	the	the	DT
cord-005453-4057qib7	16254	13	TRIS	TRIS	NNP
cord-005453-4057qib7	16254	14	database	database	NN
cord-005453-4057qib7	16254	15	and	and	CC
cord-005453-4057qib7	16254	16	some	some	DT
cord-005453-4057qib7	16254	17	international	international	JJ
cord-005453-4057qib7	16254	18	bone	bone	NN
cord-005453-4057qib7	16254	19	marrow	marrow	NN
cord-005453-4057qib7	16254	20	banks	bank	NNS
cord-005453-4057qib7	16254	21	were	be	VBD
cord-005453-4057qib7	16254	22	studied	study	VBN
cord-005453-4057qib7	16254	23	in	in	IN
cord-005453-4057qib7	16254	24	low	low	JJ
cord-005453-4057qib7	16254	25	resolution	resolution	NN
cord-005453-4057qib7	16254	26	but	but	CC
cord-005453-4057qib7	16254	27	not	not	RB
cord-005453-4057qib7	16254	28	studied	study	VBD
cord-005453-4057qib7	16254	29	the	the	DT
cord-005453-4057qib7	16254	30	all	all	DT
cord-005453-4057qib7	16254	31	HLA	HLA	NNP
cord-005453-4057qib7	16254	32	loci	locus	NNS
cord-005453-4057qib7	16254	33	,	,	,
cord-005453-4057qib7	16254	34	the	the	DT
cord-005453-4057qib7	16254	35	centers	center	NNS
cord-005453-4057qib7	16254	36	wanted	want	VBD
cord-005453-4057qib7	16254	37	high	high	JJ
cord-005453-4057qib7	16254	38	-	-	HYPH
cord-005453-4057qib7	16254	39	resolution	resolution	NN
cord-005453-4057qib7	16254	40	HLA	HLA	NNP
cord-005453-4057qib7	16254	41	,	,	,
cord-005453-4057qib7	16254	42	and	and	CC
cord-005453-4057qib7	16254	43	therefore	therefore	RB
cord-005453-4057qib7	16254	44	the	the	DT
cord-005453-4057qib7	16254	45	involvement	involvement	NN
cord-005453-4057qib7	16254	46	of	of	IN
cord-005453-4057qib7	16254	47	social	social	JJ
cord-005453-4057qib7	16254	48	security	security	NN
cord-005453-4057qib7	16254	49	institutions	institution	NNS
cord-005453-4057qib7	16254	50	and	and	CC
cord-005453-4057qib7	16254	51	payment	payment	NN
cord-005453-4057qib7	16254	52	procedures	procedure	NNS
cord-005453-4057qib7	16254	53	were	be	VBD
cord-005453-4057qib7	16254	54	among	among	IN
cord-005453-4057qib7	16254	55	the	the	DT
cord-005453-4057qib7	16254	56	factors	factor	NNS
cord-005453-4057qib7	16254	57	extending	extend	VBG
cord-005453-4057qib7	16254	58	this	this	DT
cord-005453-4057qib7	16254	59	process	process	NN
cord-005453-4057qib7	16254	60	.	.	.
cord-005453-4057qib7	16255	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16255	2	:	:	:
cord-005453-4057qib7	16255	3	Nothing	nothing	NN
cord-005453-4057qib7	16255	4	to	to	TO
cord-005453-4057qib7	16255	5	declare	declare	VB
cord-005453-4057qib7	16255	6	Background	background	NN
cord-005453-4057qib7	16255	7	:	:	:
cord-005453-4057qib7	16255	8	Allogeneic	allogeneic	NN
cord-005453-4057qib7	16255	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16255	10	stem	stem	NN
cord-005453-4057qib7	16255	11	cell	cell	NN
cord-005453-4057qib7	16255	12	transplantation	transplantation	NN
cord-005453-4057qib7	16255	13	(	(	-LRB-
cord-005453-4057qib7	16255	14	AHSCT	AHSCT	NNP
cord-005453-4057qib7	16255	15	)	)	-RRB-
cord-005453-4057qib7	16255	16	is	be	VBZ
cord-005453-4057qib7	16255	17	being	be	VBG
cord-005453-4057qib7	16255	18	performed	perform	VBN
cord-005453-4057qib7	16255	19	for	for	IN
cord-005453-4057qib7	16255	20	a	a	DT
cord-005453-4057qib7	16255	21	group	group	NN
cord-005453-4057qib7	16255	22	of	of	IN
cord-005453-4057qib7	16255	23	hematologic	hematologic	JJ
cord-005453-4057qib7	16255	24	diseases	disease	NNS
cord-005453-4057qib7	16255	25	with	with	IN
cord-005453-4057qib7	16255	26	a	a	DT
cord-005453-4057qib7	16255	27	curative	curative	JJ
cord-005453-4057qib7	16255	28	intent	intent	NN
cord-005453-4057qib7	16255	29	.	.	.
cord-005453-4057qib7	16256	1	Outcomes	outcome	NNS
cord-005453-4057qib7	16256	2	after	after	IN
cord-005453-4057qib7	16256	3	AHSCT	AHSCT	NNP
cord-005453-4057qib7	16256	4	are	be	VBP
cord-005453-4057qib7	16256	5	influenced	influence	VBN
cord-005453-4057qib7	16256	6	by	by	IN
cord-005453-4057qib7	16256	7	the	the	DT
cord-005453-4057qib7	16256	8	type	type	NN
cord-005453-4057qib7	16256	9	of	of	IN
cord-005453-4057qib7	16256	10	donor	donor	NN
cord-005453-4057qib7	16256	11	used	use	VBN
cord-005453-4057qib7	16256	12	.	.	.
cord-005453-4057qib7	16257	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	16257	2	transplantation	transplantation	NN
cord-005453-4057qib7	16257	3	is	be	VBZ
cord-005453-4057qib7	16257	4	an	an	DT
cord-005453-4057qib7	16257	5	emerging	emerge	VBG
cord-005453-4057qib7	16257	6	option	option	NN
cord-005453-4057qib7	16257	7	when	when	WRB
cord-005453-4057qib7	16257	8	a	a	DT
cord-005453-4057qib7	16257	9	fullmatched	fullmatched	JJ
cord-005453-4057qib7	16257	10	donor	donor	NN
cord-005453-4057qib7	16257	11	is	be	VBZ
cord-005453-4057qib7	16257	12	unavailable	unavailable	JJ
cord-005453-4057qib7	16257	13	.	.	.
cord-005453-4057qib7	16258	1	Methods	method	NNS
cord-005453-4057qib7	16258	2	:	:	:
cord-005453-4057qib7	16258	3	We	-PRON-	PRP
cord-005453-4057qib7	16258	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	16258	5	analyzed	analyze	VBD
cord-005453-4057qib7	16258	6	our	-PRON-	PRP$
cord-005453-4057qib7	16258	7	transplants	transplant	NNS
cord-005453-4057qib7	16258	8	performed	perform	VBN
cord-005453-4057qib7	16258	9	between	between	IN
cord-005453-4057qib7	16258	10	January	January	NNP
cord-005453-4057qib7	16258	11	2015	2015	CD
cord-005453-4057qib7	16258	12	and	and	CC
cord-005453-4057qib7	16258	13	November	November	NNP
cord-005453-4057qib7	16258	14	2018	2018	CD
cord-005453-4057qib7	16258	15	,	,	,
cord-005453-4057qib7	16258	16	investigating	investigate	VBG
cord-005453-4057qib7	16258	17	outcomes	outcome	NNS
cord-005453-4057qib7	16258	18	and	and	CC
cord-005453-4057qib7	16258	19	complications	complication	NNS
cord-005453-4057qib7	16258	20	among	among	IN
cord-005453-4057qib7	16258	21	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16258	22	stem	stem	NN
cord-005453-4057qib7	16258	23	cell	cell	NN
cord-005453-4057qib7	16258	24	recipients	recipient	NNS
cord-005453-4057qib7	16258	25	.	.	.
cord-005453-4057qib7	16259	1	Results	result	NNS
cord-005453-4057qib7	16259	2	:	:	:
cord-005453-4057qib7	16260	1	One	one	CD
cord-005453-4057qib7	16260	2	hundred	hundred	CD
cord-005453-4057qib7	16260	3	and	and	CC
cord-005453-4057qib7	16260	4	nineteen	nineteen	CD
cord-005453-4057qib7	16260	5	patients	patient	NNS
cord-005453-4057qib7	16260	6	underwent	undergo	VBD
cord-005453-4057qib7	16260	7	AHSCT	AHSCT	NNP
cord-005453-4057qib7	16260	8	,	,	,
cord-005453-4057qib7	16260	9	9	9	CD
cord-005453-4057qib7	16260	10	of	of	IN
cord-005453-4057qib7	16260	11	them	-PRON-	PRP
cord-005453-4057qib7	16260	12	(	(	-LRB-
cord-005453-4057qib7	16260	13	7.5	7.5	CD
cord-005453-4057qib7	16260	14	%	%	NN
cord-005453-4057qib7	16260	15	)	)	-RRB-
cord-005453-4057qib7	16260	16	were	be	VBD
cord-005453-4057qib7	16260	17	recipient	recipient	NN
cord-005453-4057qib7	16260	18	of	of	IN
cord-005453-4057qib7	16260	19	a	a	DT
cord-005453-4057qib7	16260	20	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16260	21	stem	stem	NN
cord-005453-4057qib7	16260	22	cell	cell	NN
cord-005453-4057qib7	16260	23	and	and	CC
cord-005453-4057qib7	16260	24	included	include	VBN
cord-005453-4057qib7	16260	25	in	in	IN
cord-005453-4057qib7	16260	26	this	this	DT
cord-005453-4057qib7	16260	27	study	study	NN
cord-005453-4057qib7	16260	28	.	.	.
cord-005453-4057qib7	16261	1	One	one	CD
cord-005453-4057qib7	16261	2	patient	patient	NN
cord-005453-4057qib7	16261	3	diagnosed	diagnose	VBN
cord-005453-4057qib7	16261	4	with	with	IN
cord-005453-4057qib7	16261	5	acute	acute	JJ
cord-005453-4057qib7	16261	6	lymphoblastic	lymphoblastic	JJ
cord-005453-4057qib7	16261	7	leukemia	leukemia	NN
cord-005453-4057qib7	16261	8	(	(	-LRB-
cord-005453-4057qib7	16261	9	ALL	all	DT
cord-005453-4057qib7	16261	10	)	)	-RRB-
cord-005453-4057qib7	16261	11	were	be	VBD
cord-005453-4057qib7	16261	12	performed	perform	VBN
cord-005453-4057qib7	16261	13	a	a	DT
cord-005453-4057qib7	16261	14	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16261	15	AHSCT	AHSCT	NNP
cord-005453-4057qib7	16261	16	for	for	IN
cord-005453-4057qib7	16261	17	two	two	CD
cord-005453-4057qib7	16261	18	times	time	NNS
cord-005453-4057qib7	16261	19	due	due	JJ
cord-005453-4057qib7	16261	20	to	to	IN
cord-005453-4057qib7	16261	21	relapse	relapse	NN
cord-005453-4057qib7	16261	22	.	.	.
cord-005453-4057qib7	16262	1	Among	among	IN
cord-005453-4057qib7	16262	2	those	those	DT
cord-005453-4057qib7	16262	3	9	9	CD
cord-005453-4057qib7	16262	4	transplants	transplant	NNS
cord-005453-4057qib7	16262	5	,	,	,
cord-005453-4057qib7	16262	6	4	4	CD
cord-005453-4057qib7	16262	7	of	of	IN
cord-005453-4057qib7	16262	8	them	-PRON-	PRP
cord-005453-4057qib7	16262	9	were	be	VBD
cord-005453-4057qib7	16262	10	diagnosed	diagnose	VBN
cord-005453-4057qib7	16262	11	with	with	IN
cord-005453-4057qib7	16262	12	acute	acute	JJ
cord-005453-4057qib7	16262	13	myeloid	myeloid	NN
cord-005453-4057qib7	16262	14	leukemia	leukemia	NN
cord-005453-4057qib7	16262	15	,	,	,
cord-005453-4057qib7	16262	16	2	2	CD
cord-005453-4057qib7	16262	17	with	with	IN
cord-005453-4057qib7	16262	18	ALL	all	DT
cord-005453-4057qib7	16262	19	,	,	,
cord-005453-4057qib7	16262	20	1	1	CD
cord-005453-4057qib7	16262	21	with	with	IN
cord-005453-4057qib7	16262	22	chronic	chronic	JJ
cord-005453-4057qib7	16262	23	lymphocytic	lymphocytic	JJ
cord-005453-4057qib7	16262	24	leukemia	leukemia	NN
cord-005453-4057qib7	16262	25	,	,	,
cord-005453-4057qib7	16262	26	1	1	CD
cord-005453-4057qib7	16262	27	with	with	IN
cord-005453-4057qib7	16262	28	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	16262	29	syndrome	syndrome	NN
cord-005453-4057qib7	16262	30	and	and	CC
cord-005453-4057qib7	16262	31	1	1	CD
cord-005453-4057qib7	16262	32	with	with	IN
cord-005453-4057qib7	16262	33	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	16262	34	lymphoma	lymphoma	NN
cord-005453-4057qib7	16262	35	.	.	.
cord-005453-4057qib7	16263	1	The	the	DT
cord-005453-4057qib7	16263	2	mean	mean	JJ
cord-005453-4057qib7	16263	3	age	age	NN
cord-005453-4057qib7	16263	4	of	of	IN
cord-005453-4057qib7	16263	5	group	group	NN
cord-005453-4057qib7	16263	6	was	be	VBD
cord-005453-4057qib7	16263	7	35.7±15.2	35.7±15.2	CD
cord-005453-4057qib7	16263	8	years	year	NNS
cord-005453-4057qib7	16263	9	.	.	.
cord-005453-4057qib7	16264	1	Three	three	CD
cord-005453-4057qib7	16264	2	patients	patient	NNS
cord-005453-4057qib7	16264	3	(	(	-LRB-
cord-005453-4057qib7	16264	4	2	2	CD
cord-005453-4057qib7	16264	5	AML	AML	NNP
cord-005453-4057qib7	16264	6	,	,	,
cord-005453-4057qib7	16264	7	1	1	CD
cord-005453-4057qib7	16264	8	ALL	all	DT
cord-005453-4057qib7	16264	9	)	)	-RRB-
cord-005453-4057qib7	16264	10	were	be	VBD
cord-005453-4057qib7	16264	11	in	in	IN
cord-005453-4057qib7	16264	12	remission	remission	NN
cord-005453-4057qib7	16264	13	at	at	IN
cord-005453-4057qib7	16264	14	the	the	DT
cord-005453-4057qib7	16264	15	time	time	NN
cord-005453-4057qib7	16264	16	of	of	IN
cord-005453-4057qib7	16264	17	transplantation	transplantation	NN
cord-005453-4057qib7	16264	18	.	.	.
cord-005453-4057qib7	16265	1	Patients	patient	NNS
cord-005453-4057qib7	16265	2	were	be	VBD
cord-005453-4057qib7	16265	3	given	give	VBN
cord-005453-4057qib7	16265	4	a	a	DT
cord-005453-4057qib7	16265	5	conditioning	conditioning	NN
cord-005453-4057qib7	16265	6	regimen	regimen	NN
cord-005453-4057qib7	16265	7	based	base	VBN
cord-005453-4057qib7	16265	8	mostly	mostly	RB
cord-005453-4057qib7	16265	9	on	on	IN
cord-005453-4057qib7	16265	10	busulfan	busulfan	NN
cord-005453-4057qib7	16265	11	,	,	,
cord-005453-4057qib7	16265	12	fludarabin	fludarabin	JJ
cord-005453-4057qib7	16265	13	and	and	CC
cord-005453-4057qib7	16265	14	total	total	JJ
cord-005453-4057qib7	16265	15	body	body	NN
cord-005453-4057qib7	16265	16	irradiation	irradiation	NN
cord-005453-4057qib7	16265	17	with	with	IN
cord-005453-4057qib7	16265	18	a	a	DT
cord-005453-4057qib7	16265	19	myeloablative	myeloablative	JJ
cord-005453-4057qib7	16265	20	intent	intent	NN
cord-005453-4057qib7	16265	21	.	.	.
cord-005453-4057qib7	16266	1	Patients	patient	NNS
cord-005453-4057qib7	16266	2	were	be	VBD
cord-005453-4057qib7	16266	3	also	also	RB
cord-005453-4057qib7	16266	4	given	give	VBN
cord-005453-4057qib7	16266	5	a	a	DT
cord-005453-4057qib7	16266	6	various	various	JJ
cord-005453-4057qib7	16266	7	combinations	combination	NNS
cord-005453-4057qib7	16266	8	of	of	IN
cord-005453-4057qib7	16266	9	post	post	JJ
cord-005453-4057qib7	16266	10	-	-	JJ
cord-005453-4057qib7	16266	11	transplant	transplant	NN
cord-005453-4057qib7	16266	12	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	16266	13	,	,	,
cord-005453-4057qib7	16266	14	calcineurin	calcineurin	NNP
cord-005453-4057qib7	16266	15	inhibitors	inhibitor	NNS
cord-005453-4057qib7	16266	16	,	,	,
cord-005453-4057qib7	16266	17	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	16266	18	mofetil	mofetil	NNP
cord-005453-4057qib7	16266	19	and	and	CC
cord-005453-4057qib7	16266	20	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	16266	21	globulin	globulin	NNP
cord-005453-4057qib7	16266	22	for	for	IN
cord-005453-4057qib7	16266	23	graft	graft	NN
cord-005453-4057qib7	16266	24	versus	versus	IN
cord-005453-4057qib7	16266	25	host	host	NN
cord-005453-4057qib7	16266	26	disease	disease	NN
cord-005453-4057qib7	16266	27	(	(	-LRB-
cord-005453-4057qib7	16266	28	GVHD	GVHD	NNP
cord-005453-4057qib7	16266	29	)	)	-RRB-
cord-005453-4057qib7	16266	30	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16266	31	;	;	:
cord-005453-4057qib7	16266	32	post	post	JJ
cord-005453-4057qib7	16266	33	-	-	JJ
cord-005453-4057qib7	16266	34	transplant	transplant	NN
cord-005453-4057qib7	16266	35	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	16266	36	administered	administer	VBN
cord-005453-4057qib7	16266	37	on	on	IN
cord-005453-4057qib7	16266	38	6	6	CD
cord-005453-4057qib7	16266	39	(	(	-LRB-
cord-005453-4057qib7	16266	40	67	67	CD
cord-005453-4057qib7	16266	41	%	%	NN
cord-005453-4057qib7	16266	42	)	)	-RRB-
cord-005453-4057qib7	16266	43	of	of	IN
cord-005453-4057qib7	16266	44	those	those	DT
cord-005453-4057qib7	16266	45	transplantations	transplantation	NNS
cord-005453-4057qib7	16266	46	.	.	.
cord-005453-4057qib7	16267	1	Peripheral	peripheral	JJ
cord-005453-4057qib7	16267	2	blood	blood	NN
cord-005453-4057qib7	16267	3	was	be	VBD
cord-005453-4057qib7	16267	4	the	the	DT
cord-005453-4057qib7	16267	5	source	source	NN
cord-005453-4057qib7	16267	6	of	of	IN
cord-005453-4057qib7	16267	7	stem	stem	NN
cord-005453-4057qib7	16267	8	cells	cell	NNS
cord-005453-4057qib7	16267	9	in	in	IN
cord-005453-4057qib7	16267	10	all	all	DT
cord-005453-4057qib7	16267	11	patients	patient	NNS
cord-005453-4057qib7	16267	12	.	.	.
cord-005453-4057qib7	16268	1	Patients	patient	NNS
cord-005453-4057qib7	16268	2	were	be	VBD
cord-005453-4057qib7	16268	3	infused	infuse	VBN
cord-005453-4057qib7	16268	4	with	with	IN
cord-005453-4057qib7	16268	5	mean	mean	JJ
cord-005453-4057qib7	16268	6	6.15±0.67x10	6.15±0.67x10	CD
cord-005453-4057qib7	16268	7	6	6	CD
cord-005453-4057qib7	16268	8	/kg	/kg	CD
cord-005453-4057qib7	16268	9	of	of	IN
cord-005453-4057qib7	16268	10	CD34	CD34	NNP
cord-005453-4057qib7	16268	11	+	+	CC
cord-005453-4057qib7	16268	12	cells	cell	NNS
cord-005453-4057qib7	16268	13	.	.	.
cord-005453-4057qib7	16269	1	Hematological	Hematological	NNP
cord-005453-4057qib7	16269	2	recovery	recovery	NN
cord-005453-4057qib7	16269	3	was	be	VBD
cord-005453-4057qib7	16269	4	achieved	achieve	VBN
cord-005453-4057qib7	16269	5	with	with	IN
cord-005453-4057qib7	16269	6	neutrophil	neutrophil	NN
cord-005453-4057qib7	16269	7	engraftment	engraftment	NN
cord-005453-4057qib7	16269	8	at	at	IN
cord-005453-4057qib7	16269	9	a	a	DT
cord-005453-4057qib7	16269	10	mean	mean	NN
cord-005453-4057qib7	16269	11	of	of	IN
cord-005453-4057qib7	16269	12	19.2±2.1	19.2±2.1	CD
cord-005453-4057qib7	16269	13	days	day	NNS
cord-005453-4057qib7	16269	14	and	and	CC
cord-005453-4057qib7	16269	15	platelet	platelet	NN
cord-005453-4057qib7	16269	16	engraftment	engraftment	NN
cord-005453-4057qib7	16269	17	at	at	IN
cord-005453-4057qib7	16269	18	a	a	DT
cord-005453-4057qib7	16269	19	mean	mean	NN
cord-005453-4057qib7	16269	20	of	of	IN
cord-005453-4057qib7	16269	21	17.3±2.7	17.3±2.7	CD
cord-005453-4057qib7	16269	22	days	day	NNS
cord-005453-4057qib7	16269	23	.	.	.
cord-005453-4057qib7	16270	1	After	after	IN
cord-005453-4057qib7	16270	2	a	a	DT
cord-005453-4057qib7	16270	3	median	median	JJ
cord-005453-4057qib7	16270	4	8month	8month	JJ
cord-005453-4057qib7	16270	5	(	(	-LRB-
cord-005453-4057qib7	16270	6	0.2	0.2	CD
cord-005453-4057qib7	16270	7	-	-	SYM
cord-005453-4057qib7	16270	8	40.6	40.6	CD
cord-005453-4057qib7	16270	9	months	month	NNS
cord-005453-4057qib7	16270	10	)	)	-RRB-
cord-005453-4057qib7	16270	11	follow	follow	VBP
cord-005453-4057qib7	16270	12	up	up	RP
cord-005453-4057qib7	16270	13	,	,	,
cord-005453-4057qib7	16270	14	the	the	DT
cord-005453-4057qib7	16270	15	cumulative	cumulative	JJ
cord-005453-4057qib7	16270	16	rates	rate	NNS
cord-005453-4057qib7	16270	17	of	of	IN
cord-005453-4057qib7	16270	18	grade	grade	NN
cord-005453-4057qib7	16270	19	3	3	CD
cord-005453-4057qib7	16270	20	-	-	SYM
cord-005453-4057qib7	16270	21	4	4	CD
cord-005453-4057qib7	16270	22	GVHD	GVHD	NNP
cord-005453-4057qib7	16270	23	,	,	,
cord-005453-4057qib7	16270	24	relapse	relapse	NN
cord-005453-4057qib7	16270	25	and	and	CC
cord-005453-4057qib7	16270	26	non	non	JJ
cord-005453-4057qib7	16270	27	-	-	JJ
cord-005453-4057qib7	16270	28	relapse	relapse	JJ
cord-005453-4057qib7	16270	29	mortality	mortality	NN
cord-005453-4057qib7	16270	30	were	be	VBD
cord-005453-4057qib7	16270	31	11	11	CD
cord-005453-4057qib7	16270	32	%	%	NN
cord-005453-4057qib7	16270	33	,	,	,
cord-005453-4057qib7	16270	34	28	28	CD
cord-005453-4057qib7	16270	35	%	%	NN
cord-005453-4057qib7	16270	36	(	(	-LRB-
cord-005453-4057qib7	16270	37	n=7	n=7	NN
cord-005453-4057qib7	16270	38	)	)	-RRB-
cord-005453-4057qib7	16270	39	and	and	CC
cord-005453-4057qib7	16270	40	71	71	CD
cord-005453-4057qib7	16270	41	%	%	NN
cord-005453-4057qib7	16270	42	,	,	,
cord-005453-4057qib7	16270	43	respectively	respectively	RB
cord-005453-4057qib7	16270	44	.	.	.
cord-005453-4057qib7	16271	1	One	one	CD
cord-005453-4057qib7	16271	2	patient	patient	NN
cord-005453-4057qib7	16271	3	died	die	VBD
cord-005453-4057qib7	16271	4	due	due	IN
cord-005453-4057qib7	16271	5	to	to	IN
cord-005453-4057qib7	16271	6	relapse	relapse	NN
cord-005453-4057qib7	16271	7	,	,	,
cord-005453-4057qib7	16271	8	at	at	IN
cord-005453-4057qib7	16271	9	the	the	DT
cord-005453-4057qib7	16271	10	end	end	NN
cord-005453-4057qib7	16271	11	of	of	IN
cord-005453-4057qib7	16271	12	the	the	DT
cord-005453-4057qib7	16271	13	follow	follow	NN
cord-005453-4057qib7	16271	14	up	up	RP
cord-005453-4057qib7	16271	15	two	two	CD
cord-005453-4057qib7	16271	16	were	be	VBD
cord-005453-4057qib7	16271	17	still	still	RB
cord-005453-4057qib7	16271	18	alive	alive	JJ
cord-005453-4057qib7	16271	19	with	with	IN
cord-005453-4057qib7	16271	20	remission	remission	NN
cord-005453-4057qib7	16271	21	.	.	.
cord-005453-4057qib7	16272	1	Only	only	RB
cord-005453-4057qib7	16272	2	one	one	CD
cord-005453-4057qib7	16272	3	patient	patient	NN
cord-005453-4057qib7	16272	4	has	have	VBZ
cord-005453-4057qib7	16272	5	died	die	VBN
cord-005453-4057qib7	16272	6	due	due	IN
cord-005453-4057qib7	16272	7	to	to	IN
cord-005453-4057qib7	16272	8	chronic	chronic	JJ
cord-005453-4057qib7	16272	9	GVHD	GVHD	NNP
cord-005453-4057qib7	16272	10	affecting	affect	VBG
cord-005453-4057qib7	16272	11	serosa	serosa	NN
cord-005453-4057qib7	16272	12	and	and	CC
cord-005453-4057qib7	16272	13	resulting	result	VBG
cord-005453-4057qib7	16272	14	with	with	IN
cord-005453-4057qib7	16272	15	a	a	DT
cord-005453-4057qib7	16272	16	fatal	fatal	JJ
cord-005453-4057qib7	16272	17	tracheoesophageal	tracheoesophageal	JJ
cord-005453-4057qib7	16272	18	fistula	fistula	NN
cord-005453-4057qib7	16272	19	.	.	.
cord-005453-4057qib7	16273	1	The	the	DT
cord-005453-4057qib7	16273	2	mean	mean	JJ
cord-005453-4057qib7	16273	3	overall	overall	JJ
cord-005453-4057qib7	16273	4	survival	survival	NN
cord-005453-4057qib7	16273	5	was	be	VBD
cord-005453-4057qib7	16273	6	6.9±2.6	6.9±2.6	CD
cord-005453-4057qib7	16273	7	months	month	NNS
cord-005453-4057qib7	16273	8	in	in	IN
cord-005453-4057qib7	16273	9	our	-PRON-	PRP$
cord-005453-4057qib7	16273	10	study	study	NN
cord-005453-4057qib7	16273	11	.	.	.
cord-005453-4057qib7	16274	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16274	2	:	:	:
cord-005453-4057qib7	16275	1	Haploidentical	haploidentical	JJ
cord-005453-4057qib7	16275	2	transplant	transplant	NN
cord-005453-4057qib7	16275	3	is	be	VBZ
cord-005453-4057qib7	16275	4	a	a	DT
cord-005453-4057qib7	16275	5	feasible	feasible	JJ
cord-005453-4057qib7	16275	6	option	option	NN
cord-005453-4057qib7	16275	7	in	in	IN
cord-005453-4057qib7	16275	8	hematologic	hematologic	JJ
cord-005453-4057qib7	16275	9	malignancies	malignancy	NNS
cord-005453-4057qib7	16275	10	with	with	IN
cord-005453-4057qib7	16275	11	novel	novel	JJ
cord-005453-4057qib7	16275	12	GVHD	GVHD	NNP
cord-005453-4057qib7	16275	13	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16275	14	approaches	approach	NNS
cord-005453-4057qib7	16275	15	,	,	,
cord-005453-4057qib7	16275	16	especially	especially	RB
cord-005453-4057qib7	16275	17	post	post	JJ
cord-005453-4057qib7	16275	18	-	-	NN
cord-005453-4057qib7	16275	19	transplantation	transplantation	JJ
cord-005453-4057qib7	16275	20	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	16275	21	.	.	.
cord-005453-4057qib7	16276	1	However	however	RB
cord-005453-4057qib7	16276	2	,	,	,
cord-005453-4057qib7	16276	3	these	these	DT
cord-005453-4057qib7	16276	4	results	result	NNS
cord-005453-4057qib7	16276	5	need	need	VBP
cord-005453-4057qib7	16276	6	to	to	TO
cord-005453-4057qib7	16276	7	be	be	VB
cord-005453-4057qib7	16276	8	supported	support	VBN
cord-005453-4057qib7	16276	9	with	with	IN
cord-005453-4057qib7	16276	10	further	further	JJ
cord-005453-4057qib7	16276	11	investigations	investigation	NNS
cord-005453-4057qib7	16276	12	with	with	IN
cord-005453-4057qib7	16276	13	a	a	DT
cord-005453-4057qib7	16276	14	larger	large	JJR
cord-005453-4057qib7	16276	15	patient	patient	NN
cord-005453-4057qib7	16276	16	group	group	NN
cord-005453-4057qib7	16276	17	.	.	.
cord-005453-4057qib7	16277	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16277	2	:	:	:
cord-005453-4057qib7	16277	3	Nothing	nothing	NN
cord-005453-4057qib7	16277	4	to	to	TO
cord-005453-4057qib7	16277	5	declare	declare	VB
cord-005453-4057qib7	16277	6	Results	result	NNS
cord-005453-4057qib7	16277	7	:	:	:
cord-005453-4057qib7	16277	8	A	a	DT
cord-005453-4057qib7	16277	9	total	total	NN
cord-005453-4057qib7	16277	10	of	of	IN
cord-005453-4057qib7	16277	11	25	25	CD
cord-005453-4057qib7	16277	12	patients	patient	NNS
cord-005453-4057qib7	16277	13	between	between	IN
cord-005453-4057qib7	16277	14	19	19	CD
cord-005453-4057qib7	16277	15	and	and	CC
cord-005453-4057qib7	16277	16	58	58	CD
cord-005453-4057qib7	16277	17	years	year	NNS
cord-005453-4057qib7	16277	18	(	(	-LRB-
cord-005453-4057qib7	16277	19	median	median	JJ
cord-005453-4057qib7	16277	20	age	age	NN
cord-005453-4057qib7	16277	21	:	:	:
cord-005453-4057qib7	16277	22	33	33	CD
cord-005453-4057qib7	16277	23	years	year	NNS
cord-005453-4057qib7	16277	24	)	)	-RRB-
cord-005453-4057qib7	16277	25	.	.	.
cord-005453-4057qib7	16278	1	Transplant	transplant	NN
cord-005453-4057qib7	16278	2	was	be	VBD
cord-005453-4057qib7	16278	3	done	do	VBN
cord-005453-4057qib7	16278	4	for	for	IN
cord-005453-4057qib7	16278	5	following	follow	VBG
cord-005453-4057qib7	16278	6	disease	disease	NN
cord-005453-4057qib7	16278	7	:	:	:
cord-005453-4057qib7	16278	8	acute	acute	JJ
cord-005453-4057qib7	16278	9	leukemia	leukemia	NN
cord-005453-4057qib7	16278	10	(	(	-LRB-
cord-005453-4057qib7	16278	11	n=9	n=9	NN
cord-005453-4057qib7	16278	12	,	,	,
cord-005453-4057qib7	16278	13	36	36	CD
cord-005453-4057qib7	16278	14	%	%	NN
cord-005453-4057qib7	16278	15	)	)	-RRB-
cord-005453-4057qib7	16278	16	,	,	,
cord-005453-4057qib7	16278	17	aplastic	aplastic	JJ
cord-005453-4057qib7	16278	18	anemia	anemia	NN
cord-005453-4057qib7	16278	19	(	(	-LRB-
cord-005453-4057qib7	16278	20	n=5	n=5	RB
cord-005453-4057qib7	16278	21	,	,	,
cord-005453-4057qib7	16278	22	20	20	CD
cord-005453-4057qib7	16278	23	%	%	NN
cord-005453-4057qib7	16278	24	)	)	-RRB-
cord-005453-4057qib7	16278	25	,	,	,
cord-005453-4057qib7	16278	26	lymphoma	lymphoma	NN
cord-005453-4057qib7	16278	27	(	(	-LRB-
cord-005453-4057qib7	16278	28	n=4	n=4	NNS
cord-005453-4057qib7	16278	29	,	,	,
cord-005453-4057qib7	16278	30	16	16	CD
cord-005453-4057qib7	16278	31	%	%	NN
cord-005453-4057qib7	16278	32	)	)	-RRB-
cord-005453-4057qib7	16278	33	,	,	,
cord-005453-4057qib7	16278	34	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	16278	35	(	(	-LRB-
cord-005453-4057qib7	16278	36	n=3	n=3	NN
cord-005453-4057qib7	16278	37	,	,	,
cord-005453-4057qib7	16278	38	12	12	CD
cord-005453-4057qib7	16278	39	%	%	NN
cord-005453-4057qib7	16278	40	)	)	-RRB-
cord-005453-4057qib7	16278	41	,	,	,
cord-005453-4057qib7	16278	42	myelodisplastic	myelodisplastic	NNP
cord-005453-4057qib7	16278	43	syndrome	syndrome	NN
cord-005453-4057qib7	16278	44	(	(	-LRB-
cord-005453-4057qib7	16278	45	n=2	n=2	NNS
cord-005453-4057qib7	16278	46	,	,	,
cord-005453-4057qib7	16278	47	8	8	CD
cord-005453-4057qib7	16278	48	%	%	NN
cord-005453-4057qib7	16278	49	)	)	-RRB-
cord-005453-4057qib7	16278	50	,	,	,
cord-005453-4057qib7	16278	51	chronic	chronic	JJ
cord-005453-4057qib7	16278	52	myeloid	myeloid	NN
cord-005453-4057qib7	16278	53	leukemia	leukemia	NN
cord-005453-4057qib7	16278	54	(	(	-LRB-
cord-005453-4057qib7	16278	55	n=2	n=2	NNS
cord-005453-4057qib7	16278	56	,	,	,
cord-005453-4057qib7	16278	57	8	8	CD
cord-005453-4057qib7	16278	58	%	%	NN
cord-005453-4057qib7	16278	59	)	)	-RRB-
cord-005453-4057qib7	16278	60	.	.	.
cord-005453-4057qib7	16279	1	Ten	ten	CD
cord-005453-4057qib7	16279	2	donors	donor	NNS
cord-005453-4057qib7	16279	3	were	be	VBD
cord-005453-4057qib7	16279	4	from	from	IN
cord-005453-4057qib7	16279	5	Turkey	Turkey	NNP
cord-005453-4057qib7	16279	6	and	and	CC
cord-005453-4057qib7	16279	7	fifteen	fifteen	CD
cord-005453-4057qib7	16279	8	donors	donor	NNS
cord-005453-4057qib7	16279	9	were	be	VBD
cord-005453-4057qib7	16279	10	from	from	IN
cord-005453-4057qib7	16279	11	different	different	JJ
cord-005453-4057qib7	16279	12	countries	country	NNS
cord-005453-4057qib7	16279	13	of	of	IN
cord-005453-4057qib7	16279	14	Europe	Europe	NNP
cord-005453-4057qib7	16279	15	and	and	CC
cord-005453-4057qib7	16279	16	America	America	NNP
cord-005453-4057qib7	16279	17	.	.	.
cord-005453-4057qib7	16280	1	Two	two	CD
cord-005453-4057qib7	16280	2	of	of	IN
cord-005453-4057qib7	16280	3	25	25	CD
cord-005453-4057qib7	16280	4	donors	donor	NNS
cord-005453-4057qib7	16280	5	were	be	VBD
cord-005453-4057qib7	16280	6	9/10	9/10	CD
cord-005453-4057qib7	16280	7	and	and	CC
cord-005453-4057qib7	16280	8	the	the	DT
cord-005453-4057qib7	16280	9	other	other	JJ
cord-005453-4057qib7	16280	10	23	23	CD
cord-005453-4057qib7	16280	11	was	be	VBD
cord-005453-4057qib7	16280	12	10/10	10/10	CD
cord-005453-4057qib7	16280	13	HLA	HLA	NNP
cord-005453-4057qib7	16280	14	matched	match	VBN
cord-005453-4057qib7	16280	15	.	.	.
cord-005453-4057qib7	16281	1	The	the	DT
cord-005453-4057qib7	16281	2	conditioning	conditioning	NN
cord-005453-4057qib7	16281	3	regimen	regimen	NN
cord-005453-4057qib7	16281	4	was	be	VBD
cord-005453-4057qib7	16281	5	mostly	mostly	RB
cord-005453-4057qib7	16281	6	non	non	JJ
cord-005453-4057qib7	16281	7	myeloablative	myeloablative	NNP
cord-005453-4057qib7	16281	8	(	(	-LRB-
cord-005453-4057qib7	16281	9	n=17	n=17	NNP
cord-005453-4057qib7	16281	10	,	,	,
cord-005453-4057qib7	16281	11	68	68	CD
cord-005453-4057qib7	16281	12	%	%	NN
cord-005453-4057qib7	16281	13	)	)	-RRB-
cord-005453-4057qib7	16281	14	while	while	IN
cord-005453-4057qib7	16281	15	eight	eight	CD
cord-005453-4057qib7	16281	16	patients	patient	NNS
cord-005453-4057qib7	16281	17	were	be	VBD
cord-005453-4057qib7	16281	18	treated	treat	VBN
cord-005453-4057qib7	16281	19	with	with	IN
cord-005453-4057qib7	16281	20	myeloablative	myeloablative	JJ
cord-005453-4057qib7	16281	21	regimen	regimen	NN
cord-005453-4057qib7	16281	22	.	.	.
cord-005453-4057qib7	16282	1	Other	other	JJ
cord-005453-4057qib7	16282	2	than	than	IN
cord-005453-4057qib7	16282	3	two	two	CD
cord-005453-4057qib7	16282	4	patients	patient	NNS
cord-005453-4057qib7	16282	5	who	who	WP
cord-005453-4057qib7	16282	6	took	take	VBD
cord-005453-4057qib7	16282	7	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	16282	8	and	and	CC
cord-005453-4057qib7	16282	9	mycophenolate	mycophenolate	NNP
cord-005453-4057qib7	16282	10	mofetile	mofetile	NNP
cord-005453-4057qib7	16282	11	all	all	DT
cord-005453-4057qib7	16282	12	of	of	IN
cord-005453-4057qib7	16282	13	them	-PRON-	PRP
cord-005453-4057qib7	16282	14	got	get	VBD
cord-005453-4057qib7	16282	15	cyclophosphamide	cyclophosphamide	RB
cord-005453-4057qib7	16282	16	and	and	CC
cord-005453-4057qib7	16282	17	methotrexate	methotrexate	NN
cord-005453-4057qib7	16282	18	for	for	IN
cord-005453-4057qib7	16282	19	graft	graft	NN
cord-005453-4057qib7	16282	20	versus	versus	IN
cord-005453-4057qib7	16282	21	host	host	NN
cord-005453-4057qib7	16282	22	disease	disease	NN
cord-005453-4057qib7	16282	23	(	(	-LRB-
cord-005453-4057qib7	16282	24	GVHD	GVHD	NNP
cord-005453-4057qib7	16282	25	)	)	-RRB-
cord-005453-4057qib7	16282	26	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16282	27	.	.	.
cord-005453-4057qib7	16283	1	The	the	DT
cord-005453-4057qib7	16283	2	median	median	JJ
cord-005453-4057qib7	16283	3	time	time	NN
cord-005453-4057qib7	16283	4	of	of	IN
cord-005453-4057qib7	16283	5	neutrophil	neutrophil	NN
cord-005453-4057qib7	16283	6	and	and	CC
cord-005453-4057qib7	16283	7	platelets	platelet	NNS
cord-005453-4057qib7	16283	8	engrafman	engrafman	NNP
cord-005453-4057qib7	16283	9	were	be	VBD
cord-005453-4057qib7	16283	10	18	18	CD
cord-005453-4057qib7	16283	11	days	day	NNS
cord-005453-4057qib7	16284	1	(	(	-LRB-
cord-005453-4057qib7	16284	2	range	range	NNP
cord-005453-4057qib7	16284	3	11	11	CD
cord-005453-4057qib7	16284	4	-	-	SYM
cord-005453-4057qib7	16284	5	31	31	CD
cord-005453-4057qib7	16284	6	)	)	-RRB-
cord-005453-4057qib7	16284	7	and	and	CC
cord-005453-4057qib7	16284	8	13,5	13,5	CD
cord-005453-4057qib7	16284	9	days	day	NNS
cord-005453-4057qib7	16284	10	(	(	-LRB-
cord-005453-4057qib7	16284	11	range	range	NNP
cord-005453-4057qib7	16284	12	9	9	CD
cord-005453-4057qib7	16284	13	-	-	SYM
cord-005453-4057qib7	16284	14	36	36	CD
cord-005453-4057qib7	16284	15	)	)	-RRB-
cord-005453-4057qib7	16284	16	respectively	respectively	RB
cord-005453-4057qib7	16284	17	.	.	.
cord-005453-4057qib7	16285	1	Acute	acute	JJ
cord-005453-4057qib7	16285	2	GVHD	GVHD	NNP
cord-005453-4057qib7	16285	3	was	be	VBD
cord-005453-4057qib7	16285	4	seen	see	VBN
cord-005453-4057qib7	16285	5	nearly	nearly	RB
cord-005453-4057qib7	16285	6	half	half	NN
cord-005453-4057qib7	16285	7	of	of	IN
cord-005453-4057qib7	16285	8	the	the	DT
cord-005453-4057qib7	16285	9	patients	patient	NNS
cord-005453-4057qib7	16285	10	(	(	-LRB-
cord-005453-4057qib7	16285	11	47,8%).Overall	47,8%).overall	CD
cord-005453-4057qib7	16285	12	survival	survival	NN
cord-005453-4057qib7	16285	13	was	be	VBD
cord-005453-4057qib7	16285	14	40	40	CD
cord-005453-4057qib7	16285	15	%	%	NN
cord-005453-4057qib7	16285	16	for	for	IN
cord-005453-4057qib7	16285	17	all	all	DT
cord-005453-4057qib7	16285	18	patients	patient	NNS
cord-005453-4057qib7	16285	19	and	and	CC
cord-005453-4057qib7	16285	20	15	15	CD
cord-005453-4057qib7	16285	21	of	of	IN
cord-005453-4057qib7	16285	22	25	25	CD
cord-005453-4057qib7	16285	23	patiens	patien	NNS
cord-005453-4057qib7	16285	24	(	(	-LRB-
cord-005453-4057qib7	16285	25	60	60	CD
cord-005453-4057qib7	16285	26	%	%	NN
cord-005453-4057qib7	16285	27	)	)	-RRB-
cord-005453-4057qib7	16285	28	died	die	VBD
cord-005453-4057qib7	16285	29	within	within	IN
cord-005453-4057qib7	16285	30	first	first	JJ
cord-005453-4057qib7	16285	31	month	month	NN
cord-005453-4057qib7	16285	32	to	to	IN
cord-005453-4057qib7	16285	33	18	18	CD
cord-005453-4057qib7	16285	34	months	month	NNS
cord-005453-4057qib7	16285	35	(	(	-LRB-
cord-005453-4057qib7	16285	36	median	median	JJ
cord-005453-4057qib7	16285	37	3	3	CD
cord-005453-4057qib7	16285	38	months	month	NNS
cord-005453-4057qib7	16285	39	)	)	-RRB-
cord-005453-4057qib7	16285	40	.	.	.
cord-005453-4057qib7	16286	1	The	the	DT
cord-005453-4057qib7	16286	2	mortality	mortality	NN
cord-005453-4057qib7	16286	3	rate	rate	NN
cord-005453-4057qib7	16286	4	was	be	VBD
cord-005453-4057qib7	16286	5	more	more	RBR
cord-005453-4057qib7	16286	6	higher	high	JJR
cord-005453-4057qib7	16286	7	for	for	IN
cord-005453-4057qib7	16286	8	the	the	DT
cord-005453-4057qib7	16286	9	recipients	recipient	NNS
cord-005453-4057qib7	16286	10	who	who	WP
cord-005453-4057qib7	16286	11	had	have	VBD
cord-005453-4057qib7	16286	12	donor	donor	NN
cord-005453-4057qib7	16286	13	source	source	NN
cord-005453-4057qib7	16286	14	from	from	IN
cord-005453-4057qib7	16286	15	countries	country	NNS
cord-005453-4057qib7	16286	16	other	other	JJ
cord-005453-4057qib7	16286	17	than	than	IN
cord-005453-4057qib7	16286	18	Turkey	Turkey	NNP
cord-005453-4057qib7	16286	19	(	(	-LRB-
cord-005453-4057qib7	16286	20	30	30	CD
cord-005453-4057qib7	16286	21	%	%	NN
cord-005453-4057qib7	16286	22	vs	vs	IN
cord-005453-4057qib7	16286	23	80	80	CD
cord-005453-4057qib7	16286	24	%	%	NN
cord-005453-4057qib7	16286	25	p=0,018	p=0,018	NN
cord-005453-4057qib7	16286	26	)	)	-RRB-
cord-005453-4057qib7	16286	27	.	.	.
cord-005453-4057qib7	16287	1	Transplant	transplant	NN
cord-005453-4057qib7	16287	2	related	relate	VBN
cord-005453-4057qib7	16287	3	mortality	mortality	NN
cord-005453-4057qib7	16287	4	was	be	VBD
cord-005453-4057qib7	16287	5	the	the	DT
cord-005453-4057qib7	16287	6	most	most	RBS
cord-005453-4057qib7	16287	7	common	common	JJ
cord-005453-4057qib7	16287	8	reason	reason	NN
cord-005453-4057qib7	16287	9	of	of	IN
cord-005453-4057qib7	16287	10	mortality	mortality	NN
cord-005453-4057qib7	16287	11	(	(	-LRB-
cord-005453-4057qib7	16287	12	n=7/	n=7/	NNP
cord-005453-4057qib7	16287	13	15	15	CD
cord-005453-4057qib7	16287	14	,	,	,
cord-005453-4057qib7	16287	15	46,7	46,7	CD
cord-005453-4057qib7	16287	16	%	%	NN
cord-005453-4057qib7	16287	17	)	)	-RRB-
cord-005453-4057qib7	16287	18	and	and	CC
cord-005453-4057qib7	16287	19	other	other	JJ
cord-005453-4057qib7	16287	20	reasons	reason	NNS
cord-005453-4057qib7	16287	21	were	be	VBD
cord-005453-4057qib7	16287	22	GVHD	GVHD	NNP
cord-005453-4057qib7	16287	23	(	(	-LRB-
cord-005453-4057qib7	16287	24	33,3	33,3	CD
cord-005453-4057qib7	16287	25	%	%	NN
cord-005453-4057qib7	16287	26	)	)	-RRB-
cord-005453-4057qib7	16287	27	,	,	,
cord-005453-4057qib7	16287	28	infections	infection	NNS
cord-005453-4057qib7	16287	29	and	and	CC
cord-005453-4057qib7	16287	30	cirrhosis	cirrhosis	NN
cord-005453-4057qib7	16287	31	respectively	respectively	RB
cord-005453-4057qib7	16287	32	.	.	.
cord-005453-4057qib7	16288	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16288	2	:	:	:
cord-005453-4057qib7	16289	1	We	-PRON-	PRP
cord-005453-4057qib7	16289	2	found	find	VBD
cord-005453-4057qib7	16289	3	the	the	DT
cord-005453-4057qib7	16289	4	mortality	mortality	NN
cord-005453-4057qib7	16289	5	rate	rate	NN
cord-005453-4057qib7	16289	6	more	more	RBR
cord-005453-4057qib7	16289	7	higher	high	JJR
cord-005453-4057qib7	16289	8	in	in	IN
cord-005453-4057qib7	16289	9	the	the	DT
cord-005453-4057qib7	16289	10	patients	patient	NNS
cord-005453-4057qib7	16289	11	whose	whose	WP$
cord-005453-4057qib7	16289	12	donors	donor	NNS
cord-005453-4057qib7	16289	13	were	be	VBD
cord-005453-4057qib7	16289	14	from	from	IN
cord-005453-4057qib7	16289	15	out	out	IN
cord-005453-4057qib7	16289	16	of	of	IN
cord-005453-4057qib7	16289	17	our	-PRON-	PRP$
cord-005453-4057qib7	16289	18	country	country	NN
cord-005453-4057qib7	16289	19	.	.	.
cord-005453-4057qib7	16290	1	However	however	RB
cord-005453-4057qib7	16290	2	,	,	,
cord-005453-4057qib7	16290	3	we	-PRON-	PRP
cord-005453-4057qib7	16290	4	need	need	VBP
cord-005453-4057qib7	16290	5	to	to	TO
cord-005453-4057qib7	16290	6	further	further	JJ
cord-005453-4057qib7	16290	7	multicentric	multicentric	JJ
cord-005453-4057qib7	16290	8	and	and	CC
cord-005453-4057qib7	16290	9	prospective	prospective	JJ
cord-005453-4057qib7	16290	10	investigations	investigation	NNS
cord-005453-4057qib7	16290	11	to	to	TO
cord-005453-4057qib7	16290	12	confirm	confirm	VB
cord-005453-4057qib7	16290	13	our	-PRON-	PRP$
cord-005453-4057qib7	16290	14	hypothesis	hypothesis	NN
cord-005453-4057qib7	16290	15	,	,	,
cord-005453-4057qib7	16290	16	it	-PRON-	PRP
cord-005453-4057qib7	16290	17	would	would	MD
cord-005453-4057qib7	16290	18	be	be	VB
cord-005453-4057qib7	16290	19	related	relate	VBN
cord-005453-4057qib7	16290	20	with	with	IN
cord-005453-4057qib7	16290	21	impact	impact	NN
cord-005453-4057qib7	16290	22	of	of	IN
cord-005453-4057qib7	16290	23	ethnicity	ethnicity	NN
cord-005453-4057qib7	16290	24	.	.	.
cord-005453-4057qib7	16291	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16291	2	:	:	:
cord-005453-4057qib7	16291	3	Nothing	nothing	NN
cord-005453-4057qib7	16291	4	to	to	TO
cord-005453-4057qib7	16291	5	disclose	disclose	VB
cord-005453-4057qib7	16291	6	Late	late	RB
cord-005453-4057qib7	16291	7	-	-	HYPH
cord-005453-4057qib7	16291	8	breaking	break	VBG
cord-005453-4057qib7	16291	9	abstracts	abstract	NNS
cord-005453-4057qib7	16291	10	P725	P725	NNP
cord-005453-4057qib7	16291	11	targeted	target	VBD
cord-005453-4057qib7	16291	12	twice	twice	JJ
cord-005453-4057qib7	16291	13	daily	daily	JJ
cord-005453-4057qib7	16291	14	busulfan	busulfan	NN
cord-005453-4057qib7	16291	15	-	-	HYPH
cord-005453-4057qib7	16291	16	based	base	VBN
cord-005453-4057qib7	16291	17	ric	ric	NN
cord-005453-4057qib7	16291	18	-	-	HYPH
cord-005453-4057qib7	16291	19	conditioning	conditioning	NN
cord-005453-4057qib7	16291	20	for	for	IN
cord-005453-4057qib7	16291	21	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16291	22	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16291	23	stem	stem	NN
cord-005453-4057qib7	16291	24	cell	cell	NN
cord-005453-4057qib7	16291	25	transplantation	transplantation	NN
cord-005453-4057qib7	16291	26	in	in	IN
cord-005453-4057qib7	16291	27	pediatric	pediatric	JJ
cord-005453-4057qib7	16291	28	patients	patient	NNS
cord-005453-4057qib7	16291	29	with	with	IN
cord-005453-4057qib7	16291	30	chronic	chronic	JJ
cord-005453-4057qib7	16291	31	granulomatous	granulomatous	JJ
cord-005453-4057qib7	16291	32	disease	disease	NN
cord-005453-4057qib7	16291	33	:	:	:
cord-005453-4057qib7	16292	1	A	a	DT
cord-005453-4057qib7	16292	2	10-year	10-year	CD
cord-005453-4057qib7	16292	3	experience	experience	NN
cord-005453-4057qib7	16292	4	with	with	IN
cord-005453-4057qib7	16292	5	the	the	DT
cord-005453-4057qib7	16292	6	Zurich	Zurich	NNP
cord-005453-4057qib7	16292	7	protocol	protocol	NN
cord-005453-4057qib7	16292	8	Matthias	Matthias	NNP
cord-005453-4057qib7	16292	9	Felber	Felber	NNP
cord-005453-4057qib7	16292	10	1	1	CD
cord-005453-4057qib7	16292	11	,	,	,
cord-005453-4057qib7	16292	12	Mathias	Mathias	NNP
cord-005453-4057qib7	16292	13	Hauri	Hauri	NNP
cord-005453-4057qib7	16292	14	-	-	HYPH
cord-005453-4057qib7	16292	15	Hohl	Hohl	NNP
cord-005453-4057qib7	16292	16	1	1	CD
cord-005453-4057qib7	16292	17	,	,	,
cord-005453-4057qib7	16292	18	Ulrike	Ulrike	NNP
cord-005453-4057qib7	16292	19	Zeilhofer	Zeilhofer	NNP
cord-005453-4057qib7	16292	20	1	1	CD
cord-005453-4057qib7	16292	21	,	,	,
cord-005453-4057qib7	16292	22	Federica	Federica	NNP
cord-005453-4057qib7	16292	23	Achini	Achini	NNP
cord-005453-4057qib7	16292	24	1	1	CD
cord-005453-4057qib7	16292	25	,	,	,
cord-005453-4057qib7	16292	26	Jana	Jana	NNP
cord-005453-4057qib7	16292	27	Pachlopnik	Pachlopnik	NNP
cord-005453-4057qib7	16292	28	-	-	HYPH
cord-005453-4057qib7	16292	29	Schmid	Schmid	NNP
cord-005453-4057qib7	16292	30	2	2	CD
cord-005453-4057qib7	16292	31	,	,	,
cord-005453-4057qib7	16292	32	Janine	Janine	NNP
cord-005453-4057qib7	16292	33	Reichenbach	Reichenbach	NNP
cord-005453-4057qib7	16292	34	2	2	CD
cord-005453-4057qib7	16292	35	,	,	,
cord-005453-4057qib7	16292	36	Seraina	Seraina	NNP
cord-005453-4057qib7	16292	37	Prader	Prader	NNP
cord-005453-4057qib7	16292	38	2	2	CD
cord-005453-4057qib7	16292	39	,	,	,
cord-005453-4057qib7	16292	40	Tayfun	Tayfun	NNP
cord-005453-4057qib7	16292	41	Güngör	Güngör	NNP
cord-005453-4057qib7	16292	42	1Background	1background	CD
cord-005453-4057qib7	16292	43	:	:	:
cord-005453-4057qib7	16292	44	Chronic	chronic	JJ
cord-005453-4057qib7	16292	45	granulomatous	granulomatous	JJ
cord-005453-4057qib7	16292	46	disease	disease	NN
cord-005453-4057qib7	16292	47	(	(	-LRB-
cord-005453-4057qib7	16292	48	CGD	CGD	NNP
cord-005453-4057qib7	16292	49	)	)	-RRB-
cord-005453-4057qib7	16292	50	needs	need	VBZ
cord-005453-4057qib7	16292	51	sufficient	sufficient	JJ
cord-005453-4057qib7	16292	52	myeloablation	myeloablation	NN
cord-005453-4057qib7	16292	53	to	to	TO
cord-005453-4057qib7	16292	54	avoid	avoid	VB
cord-005453-4057qib7	16292	55	graft	graft	NN
cord-005453-4057qib7	16292	56	failure	failure	NN
cord-005453-4057qib7	16292	57	.	.	.
cord-005453-4057qib7	16293	1	For	for	IN
cord-005453-4057qib7	16293	2	this	this	DT
cord-005453-4057qib7	16293	3	purpose	purpose	NN
cord-005453-4057qib7	16293	4	the	the	DT
cord-005453-4057qib7	16293	5	EBMT	EBMT	NNP
cord-005453-4057qib7	16293	6	Inborn	inborn	JJ
cord-005453-4057qib7	16293	7	errors	error	NNS
cord-005453-4057qib7	16293	8	working	work	VBG
cord-005453-4057qib7	16293	9	Party	Party	NNP
cord-005453-4057qib7	16293	10	currently	currently	RB
cord-005453-4057qib7	16293	11	recommends	recommend	VBZ
cord-005453-4057qib7	16293	12	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	16293	13	or	or	CC
cord-005453-4057qib7	16293	14	Busulfan	Busulfan	NNP
cord-005453-4057qib7	16293	15	-	-	HYPH
cord-005453-4057qib7	16293	16	based	base	VBN
cord-005453-4057qib7	16293	17	conditioning	conditioning	NN
cord-005453-4057qib7	16293	18	regimens	regimen	NNS
cord-005453-4057qib7	16293	19	for	for	IN
cord-005453-4057qib7	16293	20	CGD	CGD	NNP
cord-005453-4057qib7	16293	21	-	-	HYPH
cord-005453-4057qib7	16293	22	SCT	SCT	NNP
cord-005453-4057qib7	16293	23	.	.	.
cord-005453-4057qib7	16294	1	We	-PRON-	PRP
cord-005453-4057qib7	16294	2	analyzed	analyze	VBD
cord-005453-4057qib7	16294	3	the	the	DT
cord-005453-4057qib7	16294	4	last	last	JJ
cord-005453-4057qib7	16294	5	10	10	CD
cord-005453-4057qib7	16294	6	years	year	NNS
cord-005453-4057qib7	16294	7	of	of	IN
cord-005453-4057qib7	16294	8	targeted	target	VBN
cord-005453-4057qib7	16294	9	Busulfan	Busulfan	NNP
cord-005453-4057qib7	16294	10	-	-	HYPH
cord-005453-4057qib7	16294	11	based	base	VBN
cord-005453-4057qib7	16294	12	RIC	RIC	NNP
cord-005453-4057qib7	16294	13	-	-	HYPH
cord-005453-4057qib7	16294	14	conditioning	conditioning	NN
cord-005453-4057qib7	16294	15	including	include	VBG
cord-005453-4057qib7	16294	16	engraftment	engraftment	NN
cord-005453-4057qib7	16294	17	,	,	,
cord-005453-4057qib7	16294	18	GvHD	GvHD	NNP
cord-005453-4057qib7	16294	19	rates	rate	NNS
cord-005453-4057qib7	16294	20	,	,	,
cord-005453-4057qib7	16294	21	chimerism	chimerism	NN
cord-005453-4057qib7	16294	22	and	and	CC
cord-005453-4057qib7	16294	23	late	late	JJ
cord-005453-4057qib7	16294	24	term	term	NN
cord-005453-4057qib7	16294	25	effects	effect	NNS
cord-005453-4057qib7	16294	26	in	in	IN
cord-005453-4057qib7	16294	27	our	-PRON-	PRP$
cord-005453-4057qib7	16294	28	pediatric	pediatric	JJ
cord-005453-4057qib7	16294	29	SCT	SCT	NNP
cord-005453-4057qib7	16294	30	center	center	NN
cord-005453-4057qib7	16294	31	in	in	IN
cord-005453-4057qib7	16294	32	Zurich	Zurich	NNP
cord-005453-4057qib7	16294	33	.	.	.
cord-005453-4057qib7	16295	1	Methods	method	NNS
cord-005453-4057qib7	16295	2	:	:	:
cord-005453-4057qib7	16296	1	Between	between	IN
cord-005453-4057qib7	16296	2	2008	2008	CD
cord-005453-4057qib7	16296	3	and	and	CC
cord-005453-4057qib7	16296	4	2018	2018	CD
cord-005453-4057qib7	16296	5	,	,	,
cord-005453-4057qib7	16296	6	n=34	n=34	NNP
cord-005453-4057qib7	16296	7	consecutive	consecutive	JJ
cord-005453-4057qib7	16296	8	pediatric	pediatric	JJ
cord-005453-4057qib7	16296	9	CGD	CGD	NNP
cord-005453-4057qib7	16296	10	patients	patient	NNS
cord-005453-4057qib7	16296	11	(	(	-LRB-
cord-005453-4057qib7	16296	12	median	median	JJ
cord-005453-4057qib7	16296	13	age	age	NN
cord-005453-4057qib7	16296	14	6	6	CD
cord-005453-4057qib7	16296	15	years	year	NNS
cord-005453-4057qib7	16296	16	,	,	,
cord-005453-4057qib7	16296	17	range	range	VBP
cord-005453-4057qib7	16296	18	1	1	CD
cord-005453-4057qib7	16296	19	-	-	SYM
cord-005453-4057qib7	16296	20	16	16	CD
cord-005453-4057qib7	16296	21	years	year	NNS
cord-005453-4057qib7	16296	22	,	,	,
cord-005453-4057qib7	16296	23	n=4	n=4	JJ
cord-005453-4057qib7	16296	24	female	female	NN
cord-005453-4057qib7	16296	25	,	,	,
cord-005453-4057qib7	16296	26	n=9	n=9	JJ
cord-005453-4057qib7	16296	27	autosomal	autosomal	JJ
cord-005453-4057qib7	16296	28	recessive	recessive	JJ
cord-005453-4057qib7	16296	29	inheritance	inheritance	NN
cord-005453-4057qib7	16296	30	)	)	-RRB-
cord-005453-4057qib7	16296	31	have	have	VBP
cord-005453-4057qib7	16296	32	been	be	VBN
cord-005453-4057qib7	16296	33	transplanted	transplant	VBN
cord-005453-4057qib7	16296	34	.	.	.
cord-005453-4057qib7	16297	1	All	all	DT
cord-005453-4057qib7	16297	2	patients	patient	NNS
cord-005453-4057qib7	16297	3	received	receive	VBD
cord-005453-4057qib7	16297	4	therapeutic	therapeutic	JJ
cord-005453-4057qib7	16297	5	drug	drug	NN
cord-005453-4057qib7	16297	6	monitoring	monitoring	NN
cord-005453-4057qib7	16297	7	of	of	IN
cord-005453-4057qib7	16297	8	twice	twice	RB
cord-005453-4057qib7	16297	9	daily	daily	RB
cord-005453-4057qib7	16297	10	administered	administer	VBN
cord-005453-4057qib7	16297	11	iv	iv	CD
cord-005453-4057qib7	16297	12	Busulfan	Busulfan	NNP
cord-005453-4057qib7	16297	13	(	(	-LRB-
cord-005453-4057qib7	16297	14	3	3	CD
cord-005453-4057qib7	16297	15	or	or	CC
cord-005453-4057qib7	16297	16	4	4	CD
cord-005453-4057qib7	16297	17	hour	hour	NN
cord-005453-4057qib7	16297	18	infusions	infusion	NNS
cord-005453-4057qib7	16297	19	;	;	:
cord-005453-4057qib7	16297	20	d-5	d-5	ADD
cord-005453-4057qib7	16297	21	to	to	IN
cord-005453-4057qib7	16297	22	-d2	-d2	NN
cord-005453-4057qib7	16297	23	)	)	-RRB-
cord-005453-4057qib7	16297	24	to	to	TO
cord-005453-4057qib7	16297	25	achieve	achieve	VB
cord-005453-4057qib7	16297	26	a	a	DT
cord-005453-4057qib7	16297	27	targeted	target	VBN
cord-005453-4057qib7	16297	28	cumulative	cumulative	JJ
cord-005453-4057qib7	16297	29	AUC	auc	NN
cord-005453-4057qib7	16297	30	of	of	IN
cord-005453-4057qib7	16297	31	45	45	CD
cord-005453-4057qib7	16297	32	-	-	SYM
cord-005453-4057qib7	16297	33	70	70	CD
cord-005453-4057qib7	16297	34	mg	mg	NNP
cord-005453-4057qib7	16297	35	/	/	SYM
cord-005453-4057qib7	16297	36	L*h	l*h	NN
cord-005453-4057qib7	16297	37	.	.	.
cord-005453-4057qib7	16298	1	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	16298	2	(	(	-LRB-
cord-005453-4057qib7	16298	3	180	180	CD
cord-005453-4057qib7	16298	4	mg/	mg/	NN
cord-005453-4057qib7	16298	5	sqm	sqm	NN
cord-005453-4057qib7	16298	6	;	;	:
cord-005453-4057qib7	16298	7	d-8	d-8	NNP
cord-005453-4057qib7	16298	8	to	to	IN
cord-005453-4057qib7	16298	9	-d3	-d3	ADD
cord-005453-4057qib7	16298	10	)	)	-RRB-
cord-005453-4057qib7	16298	11	and	and	CC
cord-005453-4057qib7	16298	12	serotherapy	serotherapy	NNP
cord-005453-4057qib7	16299	1	(	(	-LRB-
cord-005453-4057qib7	16299	2	Thymoglobuline	Thymoglobuline	NNP
cord-005453-4057qib7	16299	3	7.5	7.5	CD
cord-005453-4057qib7	16299	4	mg/	mg/	NN
cord-005453-4057qib7	16299	5	kg	kg	NNP
cord-005453-4057qib7	16299	6	total	total	NN
cord-005453-4057qib7	16299	7	,	,	,
cord-005453-4057qib7	16299	8	d-5	d-5	NN
cord-005453-4057qib7	16299	9	to	to	IN
cord-005453-4057qib7	16299	10	d-3	d-3	NNP
cord-005453-4057qib7	16299	11	)	)	-RRB-
cord-005453-4057qib7	16299	12	or	or	CC
cord-005453-4057qib7	16299	13	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	16299	14	(	(	-LRB-
cord-005453-4057qib7	16299	15	0.5	0.5	CD
cord-005453-4057qib7	16299	16	-	-	SYM
cord-005453-4057qib7	16299	17	0.6	0.6	CD
cord-005453-4057qib7	16299	18	mg	mg	NNP
cord-005453-4057qib7	16299	19	/	/	SYM
cord-005453-4057qib7	16299	20	kg	kg	NNP
cord-005453-4057qib7	16299	21	total	total	NN
cord-005453-4057qib7	16299	22	;	;	:
cord-005453-4057qib7	16299	23	d-8-to	d-8-to	NNP
cord-005453-4057qib7	16299	24	d-6	d-6	NNP
cord-005453-4057qib7	16299	25	)	)	-RRB-
cord-005453-4057qib7	16299	26	were	be	VBD
cord-005453-4057qib7	16299	27	used	use	VBN
cord-005453-4057qib7	16299	28	for	for	IN
cord-005453-4057qib7	16299	29	immunoablation	immunoablation	NN
cord-005453-4057qib7	16299	30	.	.	.
cord-005453-4057qib7	16300	1	Donors	donor	NNS
cord-005453-4057qib7	16300	2	were	be	VBD
cord-005453-4057qib7	16300	3	matched	match	VBN
cord-005453-4057qib7	16300	4	unrelated	unrelated	JJ
cord-005453-4057qib7	16300	5	(	(	-LRB-
cord-005453-4057qib7	16300	6	10/10	10/10	CD
cord-005453-4057qib7	16300	7	HLA	HLA	NNP
cord-005453-4057qib7	16300	8	;	;	:
cord-005453-4057qib7	16300	9	n=	n=	NNP
cord-005453-4057qib7	16300	10	19	19	CD
cord-005453-4057qib7	16300	11	)	)	-RRB-
cord-005453-4057qib7	16300	12	,	,	,
cord-005453-4057qib7	16300	13	mismatched	mismatch	VBN
cord-005453-4057qib7	16300	14	unrelated	unrelated	JJ
cord-005453-4057qib7	16300	15	(	(	-LRB-
cord-005453-4057qib7	16300	16	9/10	9/10	CD
cord-005453-4057qib7	16300	17	HLA	HLA	NNP
cord-005453-4057qib7	16300	18	;	;	:
cord-005453-4057qib7	16300	19	n=	n=	NNP
cord-005453-4057qib7	16300	20	7	7	CD
cord-005453-4057qib7	16300	21	)	)	-RRB-
cord-005453-4057qib7	16300	22	,	,	,
cord-005453-4057qib7	16300	23	mismatched	mismatch	VBN
cord-005453-4057qib7	16300	24	unrelated	unrelated	JJ
cord-005453-4057qib7	16300	25	(	(	-LRB-
cord-005453-4057qib7	16300	26	HLA	HLA	NNP
cord-005453-4057qib7	16300	27	8/10	8/10	CD
cord-005453-4057qib7	16300	28	;	;	:
cord-005453-4057qib7	16300	29	n=1	n=1	CD
cord-005453-4057qib7	16300	30	)	)	-RRB-
cord-005453-4057qib7	16300	31	,	,	,
cord-005453-4057qib7	16300	32	matched	match	VBN
cord-005453-4057qib7	16300	33	sibling	sibling	NN
cord-005453-4057qib7	16300	34	(	(	-LRB-
cord-005453-4057qib7	16300	35	HLA	HLA	NNP
cord-005453-4057qib7	16300	36	6/6	6/6	CD
cord-005453-4057qib7	16300	37	;	;	:
cord-005453-4057qib7	16300	38	n=	n=	NNP
cord-005453-4057qib7	16300	39	5	5	CD
cord-005453-4057qib7	16300	40	)	)	-RRB-
cord-005453-4057qib7	16300	41	and	and	CC
cord-005453-4057qib7	16300	42	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16300	43	parental	parental	NN
cord-005453-4057qib7	16300	44	(	(	-LRB-
cord-005453-4057qib7	16300	45	HLA	HLA	NNP
cord-005453-4057qib7	16300	46	5/10	5/10	CD
cord-005453-4057qib7	16300	47	;	;	:
cord-005453-4057qib7	16300	48	n=2	n=2	NNS
cord-005453-4057qib7	16300	49	)	)	-RRB-
cord-005453-4057qib7	16300	50	.	.	.
cord-005453-4057qib7	16301	1	For	for	IN
cord-005453-4057qib7	16301	2	2	2	CD
cord-005453-4057qib7	16301	3	patients	patient	NNS
cord-005453-4057qib7	16301	4	with	with	IN
cord-005453-4057qib7	16301	5	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16301	6	donor	donor	NN
cord-005453-4057qib7	16301	7	post	post	NN
cord-005453-4057qib7	16301	8	-	-	JJ
cord-005453-4057qib7	16301	9	transplant	transplant	NN
cord-005453-4057qib7	16301	10	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	16301	11	(	(	-LRB-
cord-005453-4057qib7	16301	12	d-3	d-3	NN
cord-005453-4057qib7	16301	13	and	and	CC
cord-005453-4057qib7	16301	14	d-4	d-4	NN
cord-005453-4057qib7	16301	15	with	with	IN
cord-005453-4057qib7	16301	16	50	50	CD
cord-005453-4057qib7	16301	17	mg	mg	NNP
cord-005453-4057qib7	16301	18	/	/	SYM
cord-005453-4057qib7	16301	19	kg	kg	NNP
cord-005453-4057qib7	16301	20	iv	iv	CD
cord-005453-4057qib7	16301	21	each	each	DT
cord-005453-4057qib7	16301	22	)	)	-RRB-
cord-005453-4057qib7	16301	23	and	and	CC
cord-005453-4057qib7	16301	24	upfront	upfront	JJ
cord-005453-4057qib7	16301	25	ATG	ATG	NNP
cord-005453-4057qib7	16301	26	-	-	HYPH
cord-005453-4057qib7	16301	27	Grafalon	Grafalon	NNP
cord-005453-4057qib7	16301	28	(	(	-LRB-
cord-005453-4057qib7	16301	29	40	40	CD
cord-005453-4057qib7	16301	30	mg	mg	NNP
cord-005453-4057qib7	16301	31	/	/	SYM
cord-005453-4057qib7	16301	32	kg	kg	NNP
cord-005453-4057qib7	16301	33	-12	-12	NN
cord-005453-4057qib7	16301	34	to	to	IN
cord-005453-4057qib7	16301	35	-	-	HYPH
cord-005453-4057qib7	16301	36	d-9	d-9	NN
cord-005453-4057qib7	16301	37	)	)	-RRB-
cord-005453-4057qib7	16301	38	was	be	VBD
cord-005453-4057qib7	16301	39	used	use	VBN
cord-005453-4057qib7	16301	40	.	.	.
cord-005453-4057qib7	16302	1	Stem	stem	JJ
cord-005453-4057qib7	16302	2	cell	cell	NN
cord-005453-4057qib7	16302	3	sources	source	NNS
cord-005453-4057qib7	16302	4	were	be	VBD
cord-005453-4057qib7	16302	5	BM	BM	NNP
cord-005453-4057qib7	16302	6	(	(	-LRB-
cord-005453-4057qib7	16302	7	n=29	n=29	NNP
cord-005453-4057qib7	16302	8	)	)	-RRB-
cord-005453-4057qib7	16302	9	and	and	CC
cord-005453-4057qib7	16302	10	PBSC	PBSC	NNP
cord-005453-4057qib7	16302	11	(	(	-LRB-
cord-005453-4057qib7	16302	12	n=5	n=5	RB
cord-005453-4057qib7	16302	13	)	)	-RRB-
cord-005453-4057qib7	16302	14	.	.	.
cord-005453-4057qib7	16303	1	GVHDprophylaxis	GVHDprophylaxis	NNP
cord-005453-4057qib7	16303	2	included	include	VBD
cord-005453-4057qib7	16303	3	iv	iv	NNP
cord-005453-4057qib7	16303	4	CSA	CSA	NNP
cord-005453-4057qib7	16303	5	(	(	-LRB-
cord-005453-4057qib7	16303	6	d-3	d-3	NNP
cord-005453-4057qib7	16303	7	;	;	,
cord-005453-4057qib7	16303	8	continuous	continuous	JJ
cord-005453-4057qib7	16303	9	infusion	infusion	NN
cord-005453-4057qib7	16303	10	)	)	-RRB-
cord-005453-4057qib7	16303	11	and	and	CC
cord-005453-4057qib7	16303	12	iv	iv	LS
cord-005453-4057qib7	16303	13	.	.	.
cord-005453-4057qib7	16303	14	MMF	MMF	NNP
cord-005453-4057qib7	16303	15	(	(	-LRB-
cord-005453-4057qib7	16303	16	d-0	d-0	NNP
cord-005453-4057qib7	16303	17	,	,	,
cord-005453-4057qib7	16303	18	in	in	IN
cord-005453-4057qib7	16303	19	2	2	CD
cord-005453-4057qib7	16303	20	-	-	SYM
cord-005453-4057qib7	16303	21	3	3	CD
cord-005453-4057qib7	16303	22	doses).Results	doses).result	NNS
cord-005453-4057qib7	16303	23	:	:	:
cord-005453-4057qib7	16303	24	Follow	follow	VB
cord-005453-4057qib7	16303	25	-	-	HYPH
cord-005453-4057qib7	16303	26	up	up	NN
cord-005453-4057qib7	16303	27	was	be	VBD
cord-005453-4057qib7	16303	28	6	6	CD
cord-005453-4057qib7	16303	29	to	to	TO
cord-005453-4057qib7	16303	30	118	118	CD
cord-005453-4057qib7	16303	31	months	month	NNS
cord-005453-4057qib7	16303	32	.	.	.
cord-005453-4057qib7	16304	1	Good	good	JJ
cord-005453-4057qib7	16304	2	overall	overall	JJ
cord-005453-4057qib7	16304	3	engraftment	engraftment	NN
cord-005453-4057qib7	16304	4	was	be	VBD
cord-005453-4057qib7	16304	5	noted	note	VBN
cord-005453-4057qib7	16304	6	,	,	,
cord-005453-4057qib7	16304	7	with	with	IN
cord-005453-4057qib7	16304	8	n=1	n=1	JJ
cord-005453-4057qib7	16304	9	secondary	secondary	JJ
cord-005453-4057qib7	16304	10	graft	graft	NN
cord-005453-4057qib7	16304	11	failure	failure	NN
cord-005453-4057qib7	16304	12	followed	follow	VBN
cord-005453-4057qib7	16304	13	by	by	IN
cord-005453-4057qib7	16304	14	successful	successful	JJ
cord-005453-4057qib7	16304	15	retransplantation	retransplantation	NN
cord-005453-4057qib7	16304	16	.	.	.
cord-005453-4057qib7	16305	1	In	in	IN
cord-005453-4057qib7	16305	2	one	one	CD
cord-005453-4057qib7	16305	3	patient	patient	NN
cord-005453-4057qib7	16305	4	a	a	DT
cord-005453-4057qib7	16305	5	stem	stem	NN
cord-005453-4057qib7	16305	6	cell	cell	NN
cord-005453-4057qib7	16305	7	boost	boost	NN
cord-005453-4057qib7	16305	8	/	/	SYM
cord-005453-4057qib7	16305	9	DLI	DLI	NNP
cord-005453-4057qib7	16305	10	was	be	VBD
cord-005453-4057qib7	16305	11	necessary	necessary	JJ
cord-005453-4057qib7	16305	12	due	due	IN
cord-005453-4057qib7	16305	13	to	to	IN
cord-005453-4057qib7	16305	14	decreasing	decrease	VBG
cord-005453-4057qib7	16305	15	myeloid	myeloid	JJ
cord-005453-4057qib7	16305	16	donor	donor	NN
cord-005453-4057qib7	16305	17	chimerism	chimerism	NN
cord-005453-4057qib7	16305	18	during	during	IN
cord-005453-4057qib7	16305	19	EBV	EBV	NNP
cord-005453-4057qib7	16305	20	reactivation	reactivation	NN
cord-005453-4057qib7	16305	21	,	,	,
cord-005453-4057qib7	16305	22	resulting	result	VBG
cord-005453-4057qib7	16305	23	in	in	IN
cord-005453-4057qib7	16305	24	rapid	rapid	JJ
cord-005453-4057qib7	16305	25	myeloid	myeloid	JJ
cord-005453-4057qib7	16305	26	donor	donor	NN
cord-005453-4057qib7	16305	27	reconstitution	reconstitution	NN
cord-005453-4057qib7	16305	28	after	after	IN
cord-005453-4057qib7	16305	29	intervention	intervention	NN
cord-005453-4057qib7	16305	30	.	.	.
cord-005453-4057qib7	16306	1	Low	low	JJ
cord-005453-4057qib7	16306	2	rates	rate	NNS
cord-005453-4057qib7	16306	3	of	of	IN
cord-005453-4057qib7	16306	4	GvHD	GvHD	NNP
cord-005453-4057qib7	16306	5	were	be	VBD
cord-005453-4057qib7	16306	6	documented	document	VBN
cord-005453-4057qib7	16306	7	with	with	IN
cord-005453-4057qib7	16306	8	n=2	n=2	NNS
cord-005453-4057qib7	16306	9	aGvHD	aGvHD	.
cord-005453-4057qib7	16306	10	grade	grade	NN
cord-005453-4057qib7	16306	11	IV	IV	NNP
cord-005453-4057qib7	16306	12	and	and	CC
cord-005453-4057qib7	16306	13	n=2mild	n=2mild	CD
cord-005453-4057qib7	16306	14	/	/	SYM
cord-005453-4057qib7	16306	15	limited	limited	JJ
cord-005453-4057qib7	16306	16	cGvHD	cgvhd	NN
cord-005453-4057qib7	16306	17	(	(	-LRB-
cord-005453-4057qib7	16306	18	NIH	NIH	NNP
cord-005453-4057qib7	16306	19	criteria	criterion	NNS
cord-005453-4057qib7	16306	20	)	)	-RRB-
cord-005453-4057qib7	16306	21	.	.	.
cord-005453-4057qib7	16307	1	With	with	IN
cord-005453-4057qib7	16307	2	exception	exception	NN
cord-005453-4057qib7	16307	3	of	of	IN
cord-005453-4057qib7	16307	4	one	one	CD
cord-005453-4057qib7	16307	5	patient	patient	NN
cord-005453-4057qib7	16307	6	,	,	,
cord-005453-4057qib7	16307	7	myeloid	myeloid	JJ
cord-005453-4057qib7	16307	8	donor	donor	NN
cord-005453-4057qib7	16307	9	chimerism	chimerism	NN
cord-005453-4057qib7	16307	10	at	at	IN
cord-005453-4057qib7	16307	11	last	last	JJ
cord-005453-4057qib7	16307	12	follow	follow	NN
cord-005453-4057qib7	16307	13	-	-	HYPH
cord-005453-4057qib7	16307	14	up	up	NN
cord-005453-4057qib7	16307	15	was	be	VBD
cord-005453-4057qib7	16307	16	over	over	IN
cord-005453-4057qib7	16307	17	82	82	CD
cord-005453-4057qib7	16307	18	%	%	NN
cord-005453-4057qib7	16307	19	,	,	,
cord-005453-4057qib7	16307	20	mostly	mostly	RB
cord-005453-4057qib7	16307	21	over	over	IN
cord-005453-4057qib7	16307	22	95	95	CD
cord-005453-4057qib7	16307	23	%	%	NN
cord-005453-4057qib7	16307	24	.	.	.
cord-005453-4057qib7	16308	1	Overall	overall	JJ
cord-005453-4057qib7	16308	2	survival	survival	NN
cord-005453-4057qib7	16308	3	was	be	VBD
cord-005453-4057qib7	16308	4	31/34	31/34	CD
cord-005453-4057qib7	16308	5	(	(	-LRB-
cord-005453-4057qib7	16308	6	91	91	CD
cord-005453-4057qib7	16308	7	%	%	NN
cord-005453-4057qib7	16308	8	)	)	-RRB-
cord-005453-4057qib7	16308	9	.	.	.
cord-005453-4057qib7	16309	1	Deaths	death	NNS
cord-005453-4057qib7	16309	2	were	be	VBD
cord-005453-4057qib7	16309	3	due	due	JJ
cord-005453-4057qib7	16309	4	to	to	IN
cord-005453-4057qib7	16309	5	GI	GI	NNP
cord-005453-4057qib7	16309	6	-	-	HYPH
cord-005453-4057qib7	16309	7	GvHD	GvHD	NNP
cord-005453-4057qib7	16309	8	(	(	-LRB-
cord-005453-4057qib7	16309	9	n=1	n=1	CD
cord-005453-4057qib7	16309	10	)	)	-RRB-
cord-005453-4057qib7	16309	11	,	,	,
cord-005453-4057qib7	16309	12	autoimmune	autoimmune	JJ
cord-005453-4057qib7	16309	13	hemolytic	hemolytic	JJ
cord-005453-4057qib7	16309	14	anemia	anemia	NN
cord-005453-4057qib7	16309	15	/	/	SYM
cord-005453-4057qib7	16309	16	sepsis	sepsis	NN
cord-005453-4057qib7	16309	17	(	(	-LRB-
cord-005453-4057qib7	16309	18	n=1	n=1	FW
cord-005453-4057qib7	16309	19	)	)	-RRB-
cord-005453-4057qib7	16309	20	and	and	CC
cord-005453-4057qib7	16309	21	thrombotic	thrombotic	JJ
cord-005453-4057qib7	16309	22	microangiopathy	microangiopathy	NNP
cord-005453-4057qib7	16310	1	(	(	-LRB-
cord-005453-4057qib7	16310	2	n=1).Conclusions	n=1).conclusion	NNS
cord-005453-4057qib7	16310	3	:	:	:
cord-005453-4057qib7	16310	4	Precision	precision	NN
cord-005453-4057qib7	16310	5	dosing	dosing	NN
cord-005453-4057qib7	16310	6	of	of	IN
cord-005453-4057qib7	16310	7	iv	iv	NNP
cord-005453-4057qib7	16310	8	Busulfan	Busulfan	NNP
cord-005453-4057qib7	16310	9	in	in	IN
cord-005453-4057qib7	16310	10	combination	combination	NN
cord-005453-4057qib7	16310	11	with	with	IN
cord-005453-4057qib7	16310	12	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	16310	13	and	and	CC
cord-005453-4057qib7	16310	14	serotherapy	serotherapy	NN
cord-005453-4057qib7	16310	15	results	result	NNS
cord-005453-4057qib7	16310	16	in	in	IN
cord-005453-4057qib7	16310	17	excellent	excellent	JJ
cord-005453-4057qib7	16310	18	outcome	outcome	NN
cord-005453-4057qib7	16310	19	of	of	IN
cord-005453-4057qib7	16310	20	HSCT	HSCT	NNP
cord-005453-4057qib7	16310	21	for	for	IN
cord-005453-4057qib7	16310	22	pediatric	pediatric	JJ
cord-005453-4057qib7	16310	23	CGD	CGD	NNP
cord-005453-4057qib7	16310	24	-	-	HYPH
cord-005453-4057qib7	16310	25	patients	patient	NNS
cord-005453-4057qib7	16310	26	with	with	IN
cord-005453-4057qib7	16310	27	good	good	JJ
cord-005453-4057qib7	16310	28	engraftment	engraftment	NN
cord-005453-4057qib7	16310	29	,	,	,
cord-005453-4057qib7	16310	30	low	low	JJ
cord-005453-4057qib7	16310	31	overall	overall	JJ
cord-005453-4057qib7	16310	32	cGvHD	cgvhd	NN
cord-005453-4057qib7	16310	33	rates	rate	NNS
cord-005453-4057qib7	16310	34	and	and	CC
cord-005453-4057qib7	16310	35	stable	stable	JJ
cord-005453-4057qib7	16310	36	,	,	,
cord-005453-4057qib7	16310	37	mostly	mostly	RB
cord-005453-4057qib7	16310	38	excellent	excellent	JJ
cord-005453-4057qib7	16310	39	donor	donor	NN
cord-005453-4057qib7	16310	40	chimerism	chimerism	NN
cord-005453-4057qib7	16310	41	.	.	.
cord-005453-4057qib7	16311	1	Graft	graft	NN
cord-005453-4057qib7	16311	2	failure	failure	NN
cord-005453-4057qib7	16311	3	rate	rate	NN
cord-005453-4057qib7	16311	4	was	be	VBD
cord-005453-4057qib7	16311	5	as	as	RB
cord-005453-4057qib7	16311	6	low	low	JJ
cord-005453-4057qib7	16311	7	as	as	IN
cord-005453-4057qib7	16311	8	3	3	CD
cord-005453-4057qib7	16311	9	%	%	NN
cord-005453-4057qib7	16311	10	.	.	.
cord-005453-4057qib7	16312	1	Low	low	JJ
cord-005453-4057qib7	16312	2	dose	dose	NN
cord-005453-4057qib7	16312	3	Alemtuzumab	Alemtuzumab	NNP
cord-005453-4057qib7	16312	4	prevented	prevent	VBD
cord-005453-4057qib7	16312	5	GVHD	GVHD	NNP
cord-005453-4057qib7	16312	6	in	in	IN
cord-005453-4057qib7	16312	7	the	the	DT
cord-005453-4057qib7	16312	8	majority	majority	NN
cord-005453-4057qib7	16312	9	of	of	IN
cord-005453-4057qib7	16312	10	patients	patient	NNS
cord-005453-4057qib7	16312	11	.	.	.
cord-005453-4057qib7	16313	1	This	this	DT
cord-005453-4057qib7	16313	2	analysis	analysis	NN
cord-005453-4057qib7	16313	3	demonstrates	demonstrate	VBZ
cord-005453-4057qib7	16313	4	that	that	IN
cord-005453-4057qib7	16313	5	targeted	target	VBN
cord-005453-4057qib7	16313	6	Busulfan	Busulfan	NNP
cord-005453-4057qib7	16313	7	-	-	HYPH
cord-005453-4057qib7	16313	8	based	base	VBN
cord-005453-4057qib7	16313	9	conditioning	conditioning	NN
cord-005453-4057qib7	16313	10	is	be	VBZ
cord-005453-4057qib7	16313	11	a	a	DT
cord-005453-4057qib7	16313	12	valid	valid	JJ
cord-005453-4057qib7	16313	13	option	option	NN
cord-005453-4057qib7	16313	14	for	for	IN
cord-005453-4057qib7	16313	15	pediatric	pediatric	JJ
cord-005453-4057qib7	16313	16	CGD	CGD	NNP
cord-005453-4057qib7	16313	17	-	-	HYPH
cord-005453-4057qib7	16313	18	patients	patient	NNS
cord-005453-4057qib7	16313	19	.	.	.
cord-005453-4057qib7	16314	1	Serum	serum	NN
cord-005453-4057qib7	16314	2	alemtuzumab	alemtuzumab	NNS
cord-005453-4057qib7	16314	3	or	or	CC
cord-005453-4057qib7	16314	4	ATG	ATG	NNP
cord-005453-4057qib7	16314	5	monitoring	monitoring	NN
cord-005453-4057qib7	16314	6	could	could	MD
cord-005453-4057qib7	16314	7	further	further	RB
cord-005453-4057qib7	16314	8	improve	improve	VB
cord-005453-4057qib7	16314	9	GF	GF	NNP
cord-005453-4057qib7	16314	10	and	and	CC
cord-005453-4057qib7	16314	11	GVHD	GVHD	NNP
cord-005453-4057qib7	16314	12	rates	rate	NNS
cord-005453-4057qib7	16314	13	in	in	IN
cord-005453-4057qib7	16314	14	the	the	DT
cord-005453-4057qib7	16314	15	future	future	NN
cord-005453-4057qib7	16314	16	.	.	.
cord-005453-4057qib7	16315	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16315	2	:	:	:
cord-005453-4057qib7	16316	1	The	the	DT
cord-005453-4057qib7	16316	2	authors	author	NNS
cord-005453-4057qib7	16316	3	declare	declare	VBP
cord-005453-4057qib7	16316	4	no	no	DT
cord-005453-4057qib7	16316	5	conflict	conflict	NN
cord-005453-4057qib7	16316	6	of	of	IN
cord-005453-4057qib7	16316	7	interest	interest	NN
cord-005453-4057qib7	16316	8	.	.	.
cord-005453-4057qib7	16317	1	Abstract	Abstract	NNP
cord-005453-4057qib7	16317	2	already	already	RB
cord-005453-4057qib7	16317	3	published	publish	VBN
cord-005453-4057qib7	16317	4	.	.	.
cord-005453-4057qib7	16318	1	Young	Young	NNP
cord-005453-4057qib7	16318	2	HLA	HLA	NNP
cord-005453-4057qib7	16318	3	-	-	HYPH
cord-005453-4057qib7	16318	4	matched	match	VBN
cord-005453-4057qib7	16318	5	unrelated	unrelated	JJ
cord-005453-4057qib7	16318	6	donors	donor	NNS
cord-005453-4057qib7	16318	7	are	be	VBP
cord-005453-4057qib7	16318	8	comparable	comparable	JJ
cord-005453-4057qib7	16318	9	to	to	IN
cord-005453-4057qib7	16318	10	matched	match	VBN
cord-005453-4057qib7	16318	11	sibling	sibling	NN
cord-005453-4057qib7	16318	12	donors	donor	NNS
cord-005453-4057qib7	16318	13	in	in	IN
cord-005453-4057qib7	16318	14	elderly	elderly	JJ
cord-005453-4057qib7	16318	15	patients	patient	NNS
cord-005453-4057qib7	16318	16	receiving	receive	VBG
cord-005453-4057qib7	16318	17	reduced	reduce	VBN
cord-005453-4057qib7	16318	18	-	-	HYPH
cord-005453-4057qib7	16318	19	intensity	intensity	NN
cord-005453-4057qib7	16318	20	conditioning	conditioning	NN
cord-005453-4057qib7	16318	21	:	:	:
cord-005453-4057qib7	16318	22	an	an	DT
cord-005453-4057qib7	16318	23	analysis	analysis	NN
cord-005453-4057qib7	16318	24	on	on	IN
cord-005453-4057qib7	16318	25	behalf	behalf	NN
cord-005453-4057qib7	16318	26	of	of	IN
cord-005453-4057qib7	16318	27	the	the	DT
cord-005453-4057qib7	16318	28	EBMT	EBMT	NNP
cord-005453-4057qib7	16318	29	scientific	scientific	JJ
cord-005453-4057qib7	16318	30	council	council	NN
cord-005453-4057qib7	16318	31	95	95	CD
cord-005453-4057qib7	16318	32	%	%	NN
cord-005453-4057qib7	16318	33	C.I.	C.I.	NNP
cord-005453-4057qib7	16318	34	1.7	1.7	CD
cord-005453-4057qib7	16318	35	-	-	SYM
cord-005453-4057qib7	16318	36	20.6	20.6	CD
cord-005453-4057qib7	16318	37	,	,	,
cord-005453-4057qib7	16318	38	p=	p=	NN
cord-005453-4057qib7	16318	39	0.001	0.001	CD
cord-005453-4057qib7	16318	40	)	)	-RRB-
cord-005453-4057qib7	16318	41	and	and	CC
cord-005453-4057qib7	16318	42	voriconazol	voriconazol	NN
cord-005453-4057qib7	16318	43	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16318	44	during	during	IN
cord-005453-4057qib7	16318	45	CARV	CARV	NNP
cord-005453-4057qib7	16318	46	(	(	-LRB-
cord-005453-4057qib7	16318	47	OR	or	CC
cord-005453-4057qib7	16319	1	4.2	4.2	CD
cord-005453-4057qib7	16319	2	,	,	,
cord-005453-4057qib7	16319	3	95	95	CD
cord-005453-4057qib7	16319	4	%	%	NN
cord-005453-4057qib7	16319	5	C.I.	C.I.	NNP
cord-005453-4057qib7	16319	6	1.1	1.1	CD
cord-005453-4057qib7	16319	7	-	-	HYPH
cord-005453-4057qib7	16319	8	115.6	115.6	CD
cord-005453-4057qib7	16319	9	,	,	,
cord-005453-4057qib7	16319	10	p=	p=	NN
cord-005453-4057qib7	16319	11	0.03	0.03	CD
cord-005453-4057qib7	16319	12	)	)	-RRB-
cord-005453-4057qib7	16319	13	.	.	.
cord-005453-4057qib7	16320	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16320	2	:	:	:
cord-005453-4057qib7	16321	1	We	-PRON-	PRP
cord-005453-4057qib7	16321	2	provide	provide	VBP
cord-005453-4057qib7	16321	3	evidence	evidence	NN
cord-005453-4057qib7	16321	4	that	that	IN
cord-005453-4057qib7	16321	5	IFD	IFD	NNP
cord-005453-4057qib7	16321	6	after	after	IN
cord-005453-4057qib7	16321	7	CARV	CARV	NNP
cord-005453-4057qib7	16321	8	infection	infection	NN
cord-005453-4057qib7	16321	9	.	.	.
cord-005453-4057qib7	16322	1	Allo	Allo	NNP
cord-005453-4057qib7	16322	2	-	-	HYPH
cord-005453-4057qib7	16322	3	HSCT	HSCT	NNP
cord-005453-4057qib7	16322	4	recipients	recipient	NNS
cord-005453-4057qib7	16322	5	developing	develop	VBG
cord-005453-4057qib7	16322	6	a	a	DT
cord-005453-4057qib7	16322	7	CARV	CARV	NNP
cord-005453-4057qib7	16322	8	LRTD	LRTD	NNP
cord-005453-4057qib7	16322	9	during	during	IN
cord-005453-4057qib7	16322	10	the	the	DT
cord-005453-4057qib7	16322	11	first	first	JJ
cord-005453-4057qib7	16322	12	year	year	NN
cord-005453-4057qib7	16322	13	after	after	IN
cord-005453-4057qib7	16322	14	transplant	transplant	NN
cord-005453-4057qib7	16322	15	may	may	MD
cord-005453-4057qib7	16322	16	benefit	benefit	VB
cord-005453-4057qib7	16322	17	from	from	IN
cord-005453-4057qib7	16322	18	an	an	DT
cord-005453-4057qib7	16322	19	adequate	adequate	JJ
cord-005453-4057qib7	16322	20	antifungal	antifungal	NN
cord-005453-4057qib7	16322	21	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16322	22	and	and	CC
cord-005453-4057qib7	16322	23	a	a	DT
cord-005453-4057qib7	16322	24	close	close	JJ
cord-005453-4057qib7	16322	25	monitoring	monitoring	NN
cord-005453-4057qib7	16322	26	for	for	IN
cord-005453-4057qib7	16322	27	the	the	DT
cord-005453-4057qib7	16322	28	development	development	NN
cord-005453-4057qib7	16322	29	of	of	IN
cord-005453-4057qib7	16322	30	a	a	DT
cord-005453-4057qib7	16322	31	later	later	JJ
cord-005453-4057qib7	16322	32	IFD.Disclosure	ifd.disclosure	NN
cord-005453-4057qib7	16322	33	:	:	:
cord-005453-4057qib7	16323	1	Jose	Jose	NNP
cord-005453-4057qib7	16323	2	Luis	Luis	NNP
cord-005453-4057qib7	16323	3	Piñana	Piñana	NNP
cord-005453-4057qib7	16323	4	has	have	VBZ
cord-005453-4057qib7	16323	5	received	receive	VBN
cord-005453-4057qib7	16323	6	both	both	DT
cord-005453-4057qib7	16323	7	,	,	,
cord-005453-4057qib7	16323	8	advisory	advisory	JJ
cord-005453-4057qib7	16323	9	for	for	IN
cord-005453-4057qib7	16323	10	preclinical	preclinical	JJ
cord-005453-4057qib7	16323	11	/	/	SYM
cord-005453-4057qib7	16323	12	clinical	clinical	JJ
cord-005453-4057qib7	16323	13	research	research	NN
cord-005453-4057qib7	16323	14	and	and	CC
cord-005453-4057qib7	16323	15	financial	financial	JJ
cord-005453-4057qib7	16323	16	support	support	NN
cord-005453-4057qib7	16323	17	to	to	TO
cord-005453-4057qib7	16323	18	assist	assist	VB
cord-005453-4057qib7	16323	19	to	to	IN
cord-005453-4057qib7	16323	20	the	the	DT
cord-005453-4057qib7	16323	21	Spanish	spanish	JJ
cord-005453-4057qib7	16323	22	society	society	NN
cord-005453-4057qib7	16323	23	of	of	IN
cord-005453-4057qib7	16323	24	hematology	hematology	NNP
cord-005453-4057qib7	16323	25	annual	annual	JJ
cord-005453-4057qib7	16323	26	meeting	meeting	NN
cord-005453-4057qib7	16323	27	2018	2018	CD
cord-005453-4057qib7	16323	28	from	from	IN
cord-005453-4057qib7	16323	29	MSD	MSD	NNP
cord-005453-4057qib7	16323	30	.	.	.
cord-005453-4057qib7	16324	1	Favorable	favorable	JJ
cord-005453-4057qib7	16324	2	outcome	outcome	NN
cord-005453-4057qib7	16324	3	and	and	CC
cord-005453-4057qib7	16324	4	engraftment	engraftment	NN
cord-005453-4057qib7	16324	5	following	follow	VBG
cord-005453-4057qib7	16324	6	reducedintensity	reducedintensity	NN
cord-005453-4057qib7	16324	7	conditioned	condition	VBN
cord-005453-4057qib7	16324	8	allo	allo	NN
cord-005453-4057qib7	16324	9	-	-	HYPH
cord-005453-4057qib7	16324	10	HSCT	HSCT	NNP
cord-005453-4057qib7	16324	11	in	in	IN
cord-005453-4057qib7	16324	12	children	child	NNS
cord-005453-4057qib7	16324	13	with	with	IN
cord-005453-4057qib7	16324	14	primary	primary	JJ
cord-005453-4057qib7	16324	15	haemophagocytic	haemophagocytic	JJ
cord-005453-4057qib7	16324	16	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	16324	17	(	(	-LRB-
cord-005453-4057qib7	16324	18	HLH	HLH	NNP
cord-005453-4057qib7	16324	19	)	)	-RRB-
cord-005453-4057qib7	16324	20	and	and	CC
cord-005453-4057qib7	16324	21	high	high	JJ
cord-005453-4057qib7	16324	22	-	-	HYPH
cord-005453-4057qib7	16324	23	risk	risk	NN
cord-005453-4057qib7	16324	24	langerhans	langerhans	NNP
cord-005453-4057qib7	16324	25	cell	cell	NN
cord-005453-4057qib7	16324	26	histiocytosis	histiocytosis	NN
cord-005453-4057qib7	16324	27	(	(	-LRB-
cord-005453-4057qib7	16324	28	LCH	LCH	NNP
cord-005453-4057qib7	16324	29	)	)	-RRB-
cord-005453-4057qib7	16324	30	Laura	Laura	NNP
cord-005453-4057qib7	16324	31	M.	M.	NNP
cord-005453-4057qib7	16324	32	Moser	Moser	NNP
cord-005453-4057qib7	16324	33	,	,	,
cord-005453-4057qib7	16324	34	Emilia	Emilia	NNP
cord-005453-4057qib7	16324	35	Salzmann	Salzmann	NNP
cord-005453-4057qib7	16324	36	-	-	HYPH
cord-005453-4057qib7	16324	37	Manrique	Manrique	NNP
cord-005453-4057qib7	16324	38	,	,	,
cord-005453-4057qib7	16324	39	Andrea	Andrea	NNP
cord-005453-4057qib7	16324	40	Jarisch	Jarisch	NNP
cord-005453-4057qib7	16324	41	,	,	,
cord-005453-4057qib7	16324	42	Jan	Jan	NNP
cord-005453-4057qib7	16324	43	Sörensen	Sörensen	NNP
cord-005453-4057qib7	16324	44	,	,	,
cord-005453-4057qib7	16324	45	Shahrzad	Shahrzad	NNP
cord-005453-4057qib7	16324	46	Bakhtiar	Bakhtiar	NNP
cord-005453-4057qib7	16324	47	,	,	,
cord-005453-4057qib7	16324	48	Peter	Peter	NNP
cord-005453-4057qib7	16324	49	Bader	Bader	NNP
cord-005453-4057qib7	16324	50	Background	Background	NNP
cord-005453-4057qib7	16324	51	:	:	:
cord-005453-4057qib7	16324	52	Primary	primary	JJ
cord-005453-4057qib7	16324	53	haemophagocytic	haemophagocytic	JJ
cord-005453-4057qib7	16324	54	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	16324	55	(	(	-LRB-
cord-005453-4057qib7	16324	56	HLH	HLH	NNP
cord-005453-4057qib7	16324	57	)	)	-RRB-
cord-005453-4057qib7	16324	58	and	and	CC
cord-005453-4057qib7	16324	59	high	high	JJ
cord-005453-4057qib7	16324	60	-	-	HYPH
cord-005453-4057qib7	16324	61	risk	risk	NN
cord-005453-4057qib7	16324	62	Langerhans	Langerhans	NNP
cord-005453-4057qib7	16324	63	cell	cell	NN
cord-005453-4057qib7	16324	64	histiocytosis	histiocytosis	NN
cord-005453-4057qib7	16325	1	(	(	-LRB-
cord-005453-4057qib7	16325	2	LCH	LCH	NNP
cord-005453-4057qib7	16325	3	)	)	-RRB-
cord-005453-4057qib7	16325	4	represent	represent	VBP
cord-005453-4057qib7	16325	5	two	two	CD
cord-005453-4057qib7	16325	6	major	major	JJ
cord-005453-4057qib7	16325	7	entities	entity	NNS
cord-005453-4057qib7	16325	8	of	of	IN
cord-005453-4057qib7	16325	9	childhood	childhood	NN
cord-005453-4057qib7	16325	10	histiocytoses	histiocytose	NNS
cord-005453-4057qib7	16325	11	,	,	,
cord-005453-4057qib7	16325	12	which	which	WDT
cord-005453-4057qib7	16325	13	are	be	VBP
cord-005453-4057qib7	16325	14	-although	-although	:
cord-005453-4057qib7	16325	15	only	only	RB
cord-005453-4057qib7	16325	16	of	of	IN
cord-005453-4057qib7	16325	17	rare	rare	JJ
cord-005453-4057qib7	16325	18	occurrence	occurrence	NN
cord-005453-4057qib7	16326	1	-severe	-severe	JJ
cord-005453-4057qib7	16327	1	in	in	IN
cord-005453-4057qib7	16327	2	their	-PRON-	PRP$
cord-005453-4057qib7	16327	3	clinical	clinical	JJ
cord-005453-4057qib7	16327	4	manifestations	manifestation	NNS
cord-005453-4057qib7	16327	5	.	.	.
cord-005453-4057qib7	16328	1	Patients	patient	NNS
cord-005453-4057qib7	16328	2	present	present	JJ
cord-005453-4057qib7	16328	3	with	with	IN
cord-005453-4057qib7	16328	4	multisystemic	multisystemic	JJ
cord-005453-4057qib7	16328	5	uncontrolled	uncontrolled	JJ
cord-005453-4057qib7	16328	6	inflammation	inflammation	NN
cord-005453-4057qib7	16328	7	and	and	CC
cord-005453-4057qib7	16328	8	multi	multi	JJ
cord-005453-4057qib7	16328	9	-	-	JJ
cord-005453-4057qib7	16328	10	organ	organ	JJ
cord-005453-4057qib7	16328	11	involvement	involvement	NN
cord-005453-4057qib7	16328	12	requiring	require	VBG
cord-005453-4057qib7	16328	13	diverse	diverse	JJ
cord-005453-4057qib7	16328	14	courses	course	NNS
cord-005453-4057qib7	16328	15	of	of	IN
cord-005453-4057qib7	16328	16	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	16328	17	and	and	CC
cord-005453-4057qib7	16328	18	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	16328	19	regimens	regimen	NNS
cord-005453-4057qib7	16328	20	.	.	.
cord-005453-4057qib7	16329	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	16329	2	haematopoietic	haematopoietic	JJ
cord-005453-4057qib7	16329	3	stem	stem	NN
cord-005453-4057qib7	16329	4	cell	cell	NN
cord-005453-4057qib7	16329	5	transplantation	transplantation	NN
cord-005453-4057qib7	16329	6	(	(	-LRB-
cord-005453-4057qib7	16329	7	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	16329	8	)	)	-RRB-
cord-005453-4057qib7	16329	9	is	be	VBZ
cord-005453-4057qib7	16329	10	the	the	DT
cord-005453-4057qib7	16329	11	only	only	RB
cord-005453-4057qib7	16329	12	available	available	JJ
cord-005453-4057qib7	16329	13	curative	curative	JJ
cord-005453-4057qib7	16329	14	option	option	NN
cord-005453-4057qib7	16329	15	;	;	:
cord-005453-4057qib7	16329	16	however	however	RB
cord-005453-4057qib7	16329	17	,	,	,
cord-005453-4057qib7	16329	18	the	the	DT
cord-005453-4057qib7	16329	19	cumulative	cumulative	JJ
cord-005453-4057qib7	16329	20	treatment	treatment	NN
cord-005453-4057qib7	16329	21	toxicity	toxicity	NN
cord-005453-4057qib7	16329	22	and	and	CC
cord-005453-4057qib7	16329	23	the	the	DT
cord-005453-4057qib7	16329	24	underlying	underlying	JJ
cord-005453-4057qib7	16329	25	inflammatory	inflammatory	JJ
cord-005453-4057qib7	16329	26	disease	disease	NN
cord-005453-4057qib7	16329	27	often	often	RB
cord-005453-4057qib7	16329	28	result	result	VBP
cord-005453-4057qib7	16329	29	in	in	IN
cord-005453-4057qib7	16329	30	high	high	JJ
cord-005453-4057qib7	16329	31	organ	organ	NN
cord-005453-4057qib7	16329	32	toxicity	toxicity	NN
cord-005453-4057qib7	16329	33	and	and	CC
cord-005453-4057qib7	16329	34	inflammatory	inflammatory	JJ
cord-005453-4057qib7	16329	35	complications	complication	NNS
cord-005453-4057qib7	16329	36	of	of	IN
cord-005453-4057qib7	16329	37	transplantation	transplantation	NN
cord-005453-4057qib7	16329	38	,	,	,
cord-005453-4057qib7	16329	39	such	such	JJ
cord-005453-4057qib7	16329	40	as	as	IN
cord-005453-4057qib7	16329	41	Graft	graft	NN
cord-005453-4057qib7	16329	42	versus	versus	IN
cord-005453-4057qib7	16329	43	Host	Host	NNP
cord-005453-4057qib7	16329	44	Disease	Disease	NNP
cord-005453-4057qib7	16329	45	(	(	-LRB-
cord-005453-4057qib7	16329	46	GVHD	GVHD	NNP
cord-005453-4057qib7	16329	47	)	)	-RRB-
cord-005453-4057qib7	16330	1	and/or	and/or	CC
cord-005453-4057qib7	16330	2	graft	graft	NN
cord-005453-4057qib7	16330	3	failure	failure	NN
cord-005453-4057qib7	16330	4	.	.	.
cord-005453-4057qib7	16331	1	Especially	especially	RB
cord-005453-4057qib7	16331	2	patients	patient	NNS
cord-005453-4057qib7	16331	3	with	with	IN
cord-005453-4057qib7	16331	4	unrelated	unrelated	JJ
cord-005453-4057qib7	16331	5	donors	donor	NNS
cord-005453-4057qib7	16331	6	often	often	RB
cord-005453-4057qib7	16331	7	deal	deal	VBP
cord-005453-4057qib7	16331	8	with	with	IN
cord-005453-4057qib7	16331	9	high	high	JJ
cord-005453-4057qib7	16331	10	transplant	transplant	NN
cord-005453-4057qib7	16331	11	-	-	HYPH
cord-005453-4057qib7	16331	12	related	relate	VBN
cord-005453-4057qib7	16331	13	mortality	mortality	NN
cord-005453-4057qib7	16331	14	(	(	-LRB-
cord-005453-4057qib7	16331	15	TRM	TRM	NNP
cord-005453-4057qib7	16331	16	)	)	-RRB-
cord-005453-4057qib7	16331	17	in	in	IN
cord-005453-4057qib7	16331	18	the	the	DT
cord-005453-4057qib7	16331	19	setting	setting	NN
cord-005453-4057qib7	16331	20	of	of	IN
cord-005453-4057qib7	16331	21	conventional	conventional	JJ
cord-005453-4057qib7	16331	22	intensity	intensity	NN
cord-005453-4057qib7	16331	23	conditioning	conditioning	NN
cord-005453-4057qib7	16331	24	.	.	.
cord-005453-4057qib7	16332	1	Herein	herein	RB
cord-005453-4057qib7	16332	2	,	,	,
cord-005453-4057qib7	16332	3	we	-PRON-	PRP
cord-005453-4057qib7	16332	4	present	present	VBP
cord-005453-4057qib7	16332	5	the	the	DT
cord-005453-4057qib7	16332	6	clinical	clinical	JJ
cord-005453-4057qib7	16332	7	course	course	NN
cord-005453-4057qib7	16332	8	of	of	IN
cord-005453-4057qib7	16332	9	the	the	DT
cord-005453-4057qib7	16332	10	disease	disease	NN
cord-005453-4057qib7	16332	11	and	and	CC
cord-005453-4057qib7	16332	12	transplant	transplant	NN
cord-005453-4057qib7	16332	13	outcome	outcome	NN
cord-005453-4057qib7	16332	14	of	of	IN
cord-005453-4057qib7	16332	15	14	14	CD
cord-005453-4057qib7	16332	16	children	child	NNS
cord-005453-4057qib7	16332	17	diagnosed	diagnose	VBN
cord-005453-4057qib7	16332	18	with	with	IN
cord-005453-4057qib7	16332	19	primary	primary	JJ
cord-005453-4057qib7	16332	20	HLH	HLH	NNP
cord-005453-4057qib7	16332	21	(	(	-LRB-
cord-005453-4057qib7	16332	22	n=12	n=12	NNP
cord-005453-4057qib7	16332	23	)	)	-RRB-
cord-005453-4057qib7	16332	24	and	and	CC
cord-005453-4057qib7	16332	25	high	high	JJ
cord-005453-4057qib7	16332	26	-	-	HYPH
cord-005453-4057qib7	16332	27	risk	risk	NN
cord-005453-4057qib7	16332	28	LCH	LCH	NNP
cord-005453-4057qib7	16332	29	(	(	-LRB-
cord-005453-4057qib7	16332	30	n=3	n=3	NN
cord-005453-4057qib7	16332	31	)	)	-RRB-
cord-005453-4057qib7	16332	32	who	who	WP
cord-005453-4057qib7	16332	33	underwent	undergo	VBD
cord-005453-4057qib7	16332	34	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	16332	35	at	at	IN
cord-005453-4057qib7	16332	36	our	-PRON-	PRP$
cord-005453-4057qib7	16332	37	centre	centre	NN
cord-005453-4057qib7	16332	38	from	from	IN
cord-005453-4057qib7	16332	39	02/2003	02/2003	CD
cord-005453-4057qib7	16332	40	to	to	IN
cord-005453-4057qib7	16332	41	08/2018.Methods	08/2018.methods	CD
cord-005453-4057qib7	16332	42	:	:	:
cord-005453-4057qib7	16333	1	The	the	DT
cord-005453-4057qib7	16333	2	HLH	HLH	NNP
cord-005453-4057qib7	16333	3	cohort	cohort	NN
cord-005453-4057qib7	16333	4	consisted	consist	VBD
cord-005453-4057qib7	16333	5	of	of	IN
cord-005453-4057qib7	16333	6	7	7	CD
cord-005453-4057qib7	16333	7	cases	case	NNS
cord-005453-4057qib7	16333	8	of	of	IN
cord-005453-4057qib7	16333	9	familial	familial	JJ
cord-005453-4057qib7	16333	10	HLH	HLH	NNP
cord-005453-4057qib7	16333	11	(	(	-LRB-
cord-005453-4057qib7	16333	12	fHLH	fhlh	NN
cord-005453-4057qib7	16333	13	)	)	-RRB-
cord-005453-4057qib7	16333	14	,	,	,
cord-005453-4057qib7	16333	15	4	4	CD
cord-005453-4057qib7	16333	16	cases	case	NNS
cord-005453-4057qib7	16333	17	of	of	IN
cord-005453-4057qib7	16333	18	Griscelli	Griscelli	NNP
cord-005453-4057qib7	16333	19	syndrome	syndrome	NN
cord-005453-4057qib7	16333	20	,	,	,
cord-005453-4057qib7	16333	21	one	one	CD
cord-005453-4057qib7	16333	22	XIAP	xiap	NN
cord-005453-4057qib7	16333	23	-	-	HYPH
cord-005453-4057qib7	16333	24	deficient	deficient	JJ
cord-005453-4057qib7	16333	25	patient	patient	NN
cord-005453-4057qib7	16333	26	and	and	CC
cord-005453-4057qib7	16333	27	one	one	CD
cord-005453-4057qib7	16333	28	HLH	HLH	NNP
cord-005453-4057qib7	16333	29	-	-	HYPH
cord-005453-4057qib7	16333	30	patient	patient	NN
cord-005453-4057qib7	16333	31	with	with	IN
cord-005453-4057qib7	16333	32	inconclusive	inconclusive	JJ
cord-005453-4057qib7	16333	33	genetic	genetic	JJ
cord-005453-4057qib7	16333	34	testing	testing	NN
cord-005453-4057qib7	16333	35	.	.	.
cord-005453-4057qib7	16334	1	All	all	DT
cord-005453-4057qib7	16334	2	HLH	HLH	NNP
cord-005453-4057qib7	16334	3	patients	patient	NNS
cord-005453-4057qib7	16334	4	had	have	VBD
cord-005453-4057qib7	16334	5	developed	develop	VBN
cord-005453-4057qib7	16334	6	clinical	clinical	JJ
cord-005453-4057qib7	16334	7	symptoms	symptom	NNS
cord-005453-4057qib7	16334	8	prior	prior	RB
cord-005453-4057qib7	16334	9	to	to	IN
cord-005453-4057qib7	16334	10	transplantation	transplantation	NN
cord-005453-4057qib7	16334	11	and	and	CC
cord-005453-4057qib7	16334	12	had	have	VBD
cord-005453-4057qib7	16334	13	been	be	VBN
cord-005453-4057qib7	16334	14	treated	treat	VBN
cord-005453-4057qib7	16334	15	according	accord	VBG
cord-005453-4057qib7	16334	16	to	to	IN
cord-005453-4057qib7	16334	17	HLH	HLH	NNP
cord-005453-4057qib7	16334	18	-	-	HYPH
cord-005453-4057qib7	16334	19	protocols	protocol	NNS
cord-005453-4057qib7	16334	20	94	94	CD
cord-005453-4057qib7	16334	21	,	,	,
cord-005453-4057qib7	16334	22	2004	2004	CD
cord-005453-4057qib7	16334	23	HLH	HLH	NNP
cord-005453-4057qib7	16334	24	-	-	HYPH
cord-005453-4057qib7	16334	25	protocols	protocol	NNS
cord-005453-4057qib7	16334	26	94	94	CD
cord-005453-4057qib7	16334	27	,	,	,
cord-005453-4057qib7	16334	28	or	or	CC
cord-005453-4057qib7	16334	29	2015	2015	CD
cord-005453-4057qib7	16334	30	Median	median	JJ
cord-005453-4057qib7	16334	31	age	age	NN
cord-005453-4057qib7	16334	32	at	at	IN
cord-005453-4057qib7	16334	33	transplantation	transplantation	NN
cord-005453-4057qib7	16334	34	was	be	VBD
cord-005453-4057qib7	16334	35	10	10	CD
cord-005453-4057qib7	16334	36	months	month	NNS
cord-005453-4057qib7	16334	37	(	(	-LRB-
cord-005453-4057qib7	16334	38	4	4	CD
cord-005453-4057qib7	16334	39	to	to	TO
cord-005453-4057qib7	16334	40	128	128	CD
cord-005453-4057qib7	16334	41	months	month	NNS
cord-005453-4057qib7	16334	42	)	)	-RRB-
cord-005453-4057qib7	16334	43	.	.	.
cord-005453-4057qib7	16335	1	Stem	stem	NN
cord-005453-4057qib7	16335	2	cells	cell	NNS
cord-005453-4057qib7	16335	3	were	be	VBD
cord-005453-4057qib7	16335	4	derived	derive	VBN
cord-005453-4057qib7	16335	5	from	from	IN
cord-005453-4057qib7	16335	6	HLA	HLA	NNP
cord-005453-4057qib7	16335	7	-	-	HYPH
cord-005453-4057qib7	16335	8	matched	match	VBN
cord-005453-4057qib7	16335	9	siblings	sibling	NNS
cord-005453-4057qib7	16335	10	(	(	-LRB-
cord-005453-4057qib7	16335	11	MSD	MSD	NNP
cord-005453-4057qib7	16335	12	,	,	,
cord-005453-4057qib7	16335	13	n=	n=	NNP
cord-005453-4057qib7	16335	14	4	4	CD
cord-005453-4057qib7	16335	15	)	)	-RRB-
cord-005453-4057qib7	16335	16	,	,	,
cord-005453-4057qib7	16335	17	matched	match	VBD
cord-005453-4057qib7	16335	18	unrelated	unrelated	JJ
cord-005453-4057qib7	16335	19	donors	donor	NNS
cord-005453-4057qib7	16335	20	(	(	-LRB-
cord-005453-4057qib7	16335	21	MUD	mud	NN
cord-005453-4057qib7	16335	22	,	,	,
cord-005453-4057qib7	16335	23	n	n	NN
cord-005453-4057qib7	16335	24	=	=	SYM
cord-005453-4057qib7	16335	25	9	9	CD
cord-005453-4057qib7	16335	26	)	)	-RRB-
cord-005453-4057qib7	16335	27	or	or	CC
cord-005453-4057qib7	16335	28	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16335	29	donors	donor	NNS
cord-005453-4057qib7	16335	30	(	(	-LRB-
cord-005453-4057qib7	16335	31	n=1).The	n=1).The	NNP
cord-005453-4057qib7	16335	32	majority	majority	NN
cord-005453-4057qib7	16335	33	of	of	IN
cord-005453-4057qib7	16335	34	patients	patient	NNS
cord-005453-4057qib7	16335	35	(	(	-LRB-
cord-005453-4057qib7	16335	36	9/14	9/14	CD
cord-005453-4057qib7	16335	37	)	)	-RRB-
cord-005453-4057qib7	16335	38	received	receive	VBD
cord-005453-4057qib7	16335	39	a	a	DT
cord-005453-4057qib7	16335	40	RIC	RIC	NNP
cord-005453-4057qib7	16335	41	regimen	regimen	NN
cord-005453-4057qib7	16335	42	containing	contain	VBG
cord-005453-4057qib7	16335	43	fludarabine	fludarabine	NN
cord-005453-4057qib7	16335	44	,	,	,
cord-005453-4057qib7	16335	45	melphalan	melphalan	NNP
cord-005453-4057qib7	16335	46	and	and	CC
cord-005453-4057qib7	16335	47	thiotepa	thiotepa	NNP
cord-005453-4057qib7	16335	48	(	(	-LRB-
cord-005453-4057qib7	16335	49	n=8	n=8	NN
cord-005453-4057qib7	16335	50	)	)	-RRB-
cord-005453-4057qib7	16335	51	and	and	CC
cord-005453-4057qib7	16335	52	fludarabine	fludarabine	NN
cord-005453-4057qib7	16335	53	plus	plus	CC
cord-005453-4057qib7	16335	54	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	16335	55	(	(	-LRB-
cord-005453-4057qib7	16335	56	n=1	n=1	FW
cord-005453-4057qib7	16335	57	)	)	-RRB-
cord-005453-4057qib7	16335	58	.	.	.
cord-005453-4057qib7	16336	1	Myeloablative	myeloablative	JJ
cord-005453-4057qib7	16336	2	treatment	treatment	NN
cord-005453-4057qib7	16336	3	(	(	-LRB-
cord-005453-4057qib7	16336	4	5/14	5/14	CD
cord-005453-4057qib7	16336	5	)	)	-RRB-
cord-005453-4057qib7	16336	6	included	include	VBD
cord-005453-4057qib7	16336	7	a	a	DT
cord-005453-4057qib7	16336	8	treosulfan	treosulfan	NN
cord-005453-4057qib7	16336	9	-	-	HYPH
cord-005453-4057qib7	16336	10	based	base	VBN
cord-005453-4057qib7	16336	11	regimen	regimen	NN
cord-005453-4057qib7	16336	12	(	(	-LRB-
cord-005453-4057qib7	16336	13	n=3	n=3	NN
cord-005453-4057qib7	16336	14	)	)	-RRB-
cord-005453-4057qib7	16336	15	and	and	CC
cord-005453-4057qib7	16336	16	busulfan	busulfan	NN
cord-005453-4057qib7	16336	17	-	-	HYPH
cord-005453-4057qib7	16336	18	containing	contain	VBG
cord-005453-4057qib7	16336	19	treatment	treatment	NN
cord-005453-4057qib7	16336	20	(	(	-LRB-
cord-005453-4057qib7	16336	21	n=2	n=2	NNS
cord-005453-4057qib7	16336	22	)	)	-RRB-
cord-005453-4057qib7	16336	23	.	.	.
cord-005453-4057qib7	16337	1	The	the	DT
cord-005453-4057qib7	16337	2	entire	entire	JJ
cord-005453-4057qib7	16337	3	cohort	cohort	NN
cord-005453-4057qib7	16337	4	received	receive	VBD
cord-005453-4057qib7	16337	5	serotherapy	serotherapy	NN
cord-005453-4057qib7	16337	6	using	use	VBG
cord-005453-4057qib7	16337	7	either	either	CC
cord-005453-4057qib7	16337	8	muromonab	muromonab	NN
cord-005453-4057qib7	16337	9	(	(	-LRB-
cord-005453-4057qib7	16337	10	n=3	n=3	NN
cord-005453-4057qib7	16337	11	)	)	-RRB-
cord-005453-4057qib7	16337	12	,	,	,
cord-005453-4057qib7	16337	13	ATG	ATG	NNP
cord-005453-4057qib7	16337	14	-	-	HYPH
cord-005453-4057qib7	16337	15	Fresenius	Fresenius	NNP
cord-005453-4057qib7	16337	16	®	®	.
cord-005453-4057qib7	16337	17	(	(	-LRB-
cord-005453-4057qib7	16337	18	n=9	n=9	NN
cord-005453-4057qib7	16337	19	)	)	-RRB-
cord-005453-4057qib7	16337	20	or	or	CC
cord-005453-4057qib7	16337	21	alemtuzumab	alemtuzumab	NNP
cord-005453-4057qib7	16338	1	(	(	-LRB-
cord-005453-4057qib7	16338	2	n=2).Results	n=2).result	NNS
cord-005453-4057qib7	16338	3	:	:	:
cord-005453-4057qib7	16339	1	The	the	DT
cord-005453-4057qib7	16339	2	overall	overall	JJ
cord-005453-4057qib7	16339	3	survival	survival	NN
cord-005453-4057qib7	16339	4	of	of	IN
cord-005453-4057qib7	16339	5	the	the	DT
cord-005453-4057qib7	16339	6	entire	entire	JJ
cord-005453-4057qib7	16339	7	cohort	cohort	NN
cord-005453-4057qib7	16339	8	was	be	VBD
cord-005453-4057qib7	16339	9	78.6	78.6	CD
cord-005453-4057qib7	16339	10	%	%	NN
cord-005453-4057qib7	16339	11	(	(	-LRB-
cord-005453-4057qib7	16339	12	11/14	11/14	CD
cord-005453-4057qib7	16339	13	)	)	-RRB-
cord-005453-4057qib7	16339	14	on	on	IN
cord-005453-4057qib7	16339	15	a	a	DT
cord-005453-4057qib7	16339	16	median	median	JJ
cord-005453-4057qib7	16339	17	follow	follow	NN
cord-005453-4057qib7	16339	18	-	-	HYPH
cord-005453-4057qib7	16339	19	up	up	NN
cord-005453-4057qib7	16339	20	of	of	IN
cord-005453-4057qib7	16339	21	9.9	9.9	CD
cord-005453-4057qib7	16339	22	years	year	NNS
cord-005453-4057qib7	16340	1	(	(	-LRB-
cord-005453-4057qib7	16340	2	Figure	figure	NN
cord-005453-4057qib7	16340	3	 	 	_SP
cord-005453-4057qib7	16340	4	1	1	CD
cord-005453-4057qib7	16340	5	A+B	A+B	NNP
cord-005453-4057qib7	16340	6	)	)	-RRB-
cord-005453-4057qib7	16340	7	.All	.All	.
cord-005453-4057qib7	16341	1	LCH	LCH	NNP
cord-005453-4057qib7	16341	2	patients	patient	NNS
cord-005453-4057qib7	16341	3	,	,	,
cord-005453-4057qib7	16341	4	being	be	VBG
cord-005453-4057qib7	16341	5	treated	treat	VBN
cord-005453-4057qib7	16341	6	with	with	IN
cord-005453-4057qib7	16341	7	fludarabine	fludarabine	NN
cord-005453-4057qib7	16341	8	,	,	,
cord-005453-4057qib7	16341	9	melphalan	melphalan	NNP
cord-005453-4057qib7	16341	10	and	and	CC
cord-005453-4057qib7	16341	11	thiotepa	thiotepa	NNP
cord-005453-4057qib7	16341	12	,	,	,
cord-005453-4057qib7	16341	13	survived	survive	VBD
cord-005453-4057qib7	16341	14	transplantation	transplantation	NN
cord-005453-4057qib7	16341	15	and	and	CC
cord-005453-4057qib7	16341	16	showed	show	VBD
cord-005453-4057qib7	16341	17	complete	complete	JJ
cord-005453-4057qib7	16341	18	remission	remission	NN
cord-005453-4057qib7	16341	19	(	(	-LRB-
cord-005453-4057qib7	16341	20	3/3	3/3	CD
cord-005453-4057qib7	16341	21	)	)	-RRB-
cord-005453-4057qib7	16341	22	.	.	.
cord-005453-4057qib7	16342	1	Within	within	IN
cord-005453-4057qib7	16342	2	the	the	DT
cord-005453-4057qib7	16342	3	HLH	HLH	NNP
cord-005453-4057qib7	16342	4	cohort	cohort	NN
cord-005453-4057qib7	16342	5	the	the	DT
cord-005453-4057qib7	16342	6	overall	overall	JJ
cord-005453-4057qib7	16342	7	survival	survival	NN
cord-005453-4057qib7	16342	8	was	be	VBD
cord-005453-4057qib7	16342	9	72.7	72.7	CD
cord-005453-4057qib7	16342	10	%	%	NN
cord-005453-4057qib7	16342	11	(	(	-LRB-
cord-005453-4057qib7	16342	12	8/11	8/11	CD
cord-005453-4057qib7	16342	13	)	)	-RRB-
cord-005453-4057qib7	16342	14	.	.	.
cord-005453-4057qib7	16343	1	Fatalities	fatality	NNS
cord-005453-4057qib7	16343	2	(	(	-LRB-
cord-005453-4057qib7	16343	3	n=3	n=3	NN
cord-005453-4057qib7	16343	4	)	)	-RRB-
cord-005453-4057qib7	16343	5	included	include	VBD
cord-005453-4057qib7	16343	6	two	two	CD
cord-005453-4057qib7	16343	7	patients	patient	NNS
cord-005453-4057qib7	16343	8	from	from	IN
cord-005453-4057qib7	16343	9	the	the	DT
cord-005453-4057qib7	16343	10	myeloablative	myeloablative	NNP
cord-005453-4057qib7	16343	11	group	group	NN
cord-005453-4057qib7	16343	12	and	and	CC
cord-005453-4057qib7	16343	13	one	one	CD
cord-005453-4057qib7	16343	14	RIC	ric	NN
cord-005453-4057qib7	16343	15	-	-	HYPH
cord-005453-4057qib7	16343	16	treated	treat	VBN
cord-005453-4057qib7	16343	17	patient	patient	NN
cord-005453-4057qib7	16343	18	.	.	.
cord-005453-4057qib7	16344	1	The	the	DT
cord-005453-4057qib7	16344	2	cause	cause	NN
cord-005453-4057qib7	16344	3	of	of	IN
cord-005453-4057qib7	16344	4	death	death	NN
cord-005453-4057qib7	16344	5	were	be	VBD
cord-005453-4057qib7	16344	6	progressive	progressive	JJ
cord-005453-4057qib7	16344	7	disease	disease	NN
cord-005453-4057qib7	16344	8	activity	activity	NN
cord-005453-4057qib7	16344	9	during	during	IN
cord-005453-4057qib7	16344	10	the	the	DT
cord-005453-4057qib7	16344	11	conditioning	conditioning	NN
cord-005453-4057qib7	16344	12	phase	phase	NN
cord-005453-4057qib7	16344	13	,	,	,
cord-005453-4057qib7	16344	14	leading	lead	VBG
cord-005453-4057qib7	16344	15	to	to	IN
cord-005453-4057qib7	16344	16	multi	multi	JJ
cord-005453-4057qib7	16344	17	-	-	JJ
cord-005453-4057qib7	16344	18	organ	organ	JJ
cord-005453-4057qib7	16344	19	failure	failure	NN
cord-005453-4057qib7	16344	20	on	on	IN
cord-005453-4057qib7	16344	21	day	day	NN
cord-005453-4057qib7	16344	22	+15	+15	CD
cord-005453-4057qib7	16344	23	despite	despite	IN
cord-005453-4057qib7	16344	24	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	16344	25	treatment	treatment	NN
cord-005453-4057qib7	16344	26	(	(	-LRB-
cord-005453-4057qib7	16344	27	n=1	n=1	FW
cord-005453-4057qib7	16344	28	)	)	-RRB-
cord-005453-4057qib7	16344	29	and	and	CC
cord-005453-4057qib7	16344	30	complicated	complicated	JJ
cord-005453-4057qib7	16344	31	cerebral	cerebral	JJ
cord-005453-4057qib7	16344	32	seizures	seizure	NNS
cord-005453-4057qib7	16344	33	followed	follow	VBN
cord-005453-4057qib7	16344	34	by	by	IN
cord-005453-4057qib7	16344	35	lung	lung	NN
cord-005453-4057qib7	16344	36	haemorrhage	haemorrhage	NN
cord-005453-4057qib7	16344	37	,	,	,
cord-005453-4057qib7	16344	38	possibly	possibly	RB
cord-005453-4057qib7	16344	39	due	due	IN
cord-005453-4057qib7	16344	40	to	to	IN
cord-005453-4057qib7	16344	41	aspiration	aspiration	NN
cord-005453-4057qib7	16344	42	pneumonia	pneumonia	NN
cord-005453-4057qib7	16344	43	with	with	IN
cord-005453-4057qib7	16344	44	evidence	evidence	NN
cord-005453-4057qib7	16344	45	of	of	IN
cord-005453-4057qib7	16344	46	Enterococcus	Enterococcus	NNP
cord-005453-4057qib7	16344	47	faecium	faecium	NN
cord-005453-4057qib7	16344	48	,	,	,
cord-005453-4057qib7	16344	49	resulting	result	VBG
cord-005453-4057qib7	16344	50	in	in	IN
cord-005453-4057qib7	16344	51	septic	septic	JJ
cord-005453-4057qib7	16344	52	multi	multi	JJ
cord-005453-4057qib7	16344	53	-	-	JJ
cord-005453-4057qib7	16344	54	organ	organ	JJ
cord-005453-4057qib7	16344	55	failure	failure	NN
cord-005453-4057qib7	16344	56	on	on	IN
cord-005453-4057qib7	16344	57	day	day	NN
cord-005453-4057qib7	16344	58	+4	+4	NFP
cord-005453-4057qib7	16344	59	(	(	-LRB-
cord-005453-4057qib7	16344	60	n=1	n=1	FW
cord-005453-4057qib7	16344	61	)	)	-RRB-
cord-005453-4057qib7	16344	62	.	.	.
cord-005453-4057qib7	16345	1	A	a	DT
cord-005453-4057qib7	16345	2	third	third	JJ
cord-005453-4057qib7	16345	3	HLH	HLH	NNP
cord-005453-4057qib7	16345	4	patient	patient	NN
cord-005453-4057qib7	16345	5	developed	develop	VBD
cord-005453-4057qib7	16345	6	a	a	DT
cord-005453-4057qib7	16345	7	sudden	sudden	JJ
cord-005453-4057qib7	16345	8	cerebral	cerebral	JJ
cord-005453-4057qib7	16345	9	edema	edema	NN
cord-005453-4057qib7	16345	10	and	and	CC
cord-005453-4057qib7	16345	11	ensuing	ensue	VBG
cord-005453-4057qib7	16345	12	respiratory	respiratory	JJ
cord-005453-4057qib7	16345	13	insufficiency	insufficiency	NN
cord-005453-4057qib7	16345	14	on	on	IN
cord-005453-4057qib7	16345	15	day	day	NN
cord-005453-4057qib7	16345	16	+4	+4	NN
cord-005453-4057qib7	16345	17	.	.	.
cord-005453-4057qib7	16346	1	Whether	whether	IN
cord-005453-4057qib7	16346	2	this	this	DT
cord-005453-4057qib7	16346	3	was	be	VBD
cord-005453-4057qib7	16346	4	caused	cause	VBN
cord-005453-4057qib7	16346	5	by	by	IN
cord-005453-4057qib7	16346	6	acute	acute	JJ
cord-005453-4057qib7	16346	7	neurotoxic	neurotoxic	JJ
cord-005453-4057qib7	16346	8	damage	damage	NN
cord-005453-4057qib7	16346	9	by	by	IN
cord-005453-4057qib7	16346	10	fludarabine	fludarabine	NN
cord-005453-4057qib7	16346	11	or	or	CC
cord-005453-4057qib7	16346	12	a	a	DT
cord-005453-4057qib7	16346	13	consequence	consequence	NN
cord-005453-4057qib7	16346	14	of	of	IN
cord-005453-4057qib7	16346	15	relapsed	relapse	VBN
cord-005453-4057qib7	16346	16	HLH	HLH	NNP
cord-005453-4057qib7	16346	17	could	could	MD
cord-005453-4057qib7	16346	18	not	not	RB
cord-005453-4057qib7	16346	19	be	be	VB
cord-005453-4057qib7	16346	20	conclusively	conclusively	RB
cord-005453-4057qib7	16346	21	specified	specify	VBN
cord-005453-4057qib7	16346	22	.	.	.
cord-005453-4057qib7	16347	1	None	none	NN
cord-005453-4057qib7	16347	2	of	of	IN
cord-005453-4057qib7	16347	3	our	-PRON-	PRP$
cord-005453-4057qib7	16347	4	patients	patient	NNS
cord-005453-4057qib7	16347	5	suffered	suffer	VBD
cord-005453-4057qib7	16347	6	from	from	IN
cord-005453-4057qib7	16347	7	transplant	transplant	NN
cord-005453-4057qib7	16347	8	failure	failure	NN
cord-005453-4057qib7	16347	9	or	or	CC
cord-005453-4057qib7	16347	10	nonengraftment	nonengraftment	NN
cord-005453-4057qib7	16347	11	.	.	.
cord-005453-4057qib7	16348	1	There	there	EX
cord-005453-4057qib7	16348	2	was	be	VBD
cord-005453-4057qib7	16348	3	neither	neither	CC
cord-005453-4057qib7	16348	4	severe	severe	JJ
cord-005453-4057qib7	16348	5	acute	acute	JJ
cord-005453-4057qib7	16348	6	GVHD	GVHD	NNP
cord-005453-4057qib7	16348	7	(	(	-LRB-
cord-005453-4057qib7	16348	8	III	III	NNP
cord-005453-4057qib7	16348	9	-	-	HYPH
cord-005453-4057qib7	16348	10	IV	IV	NNP
cord-005453-4057qib7	16348	11	)	)	-RRB-
cord-005453-4057qib7	16348	12	nor	nor	CC
cord-005453-4057qib7	16348	13	chronic	chronic	JJ
cord-005453-4057qib7	16348	14	GVHD	GVHD	NNP
cord-005453-4057qib7	16348	15	observed	observe	VBD
cord-005453-4057qib7	16348	16	in	in	IN
cord-005453-4057qib7	16348	17	this	this	DT
cord-005453-4057qib7	16348	18	cohort	cohort	NN
cord-005453-4057qib7	16348	19	.	.	.
cord-005453-4057qib7	16349	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16349	2	:	:	:
cord-005453-4057qib7	16349	3	Primary	primary	JJ
cord-005453-4057qib7	16349	4	HLH	HLH	NNP
cord-005453-4057qib7	16349	5	and	and	CC
cord-005453-4057qib7	16349	6	high	high	JJ
cord-005453-4057qib7	16349	7	-	-	HYPH
cord-005453-4057qib7	16349	8	risk	risk	NN
cord-005453-4057qib7	16349	9	LCH	LCH	NNP
cord-005453-4057qib7	16349	10	are	be	VBP
cord-005453-4057qib7	16349	11	lifethreatening	lifethreatene	VBG
cord-005453-4057qib7	16349	12	medical	medical	JJ
cord-005453-4057qib7	16349	13	conditions	condition	NNS
cord-005453-4057qib7	16349	14	needing	need	VBG
cord-005453-4057qib7	16349	15	rapid	rapid	JJ
cord-005453-4057qib7	16349	16	alloHSCT	alloHSCT	NNP
cord-005453-4057qib7	16349	17	.	.	.
cord-005453-4057qib7	16350	1	RIC	RIC	NNP
cord-005453-4057qib7	16350	2	regimens	regimen	NNS
cord-005453-4057qib7	16350	3	are	be	VBP
cord-005453-4057qib7	16350	4	well	well	RB
cord-005453-4057qib7	16350	5	-	-	HYPH
cord-005453-4057qib7	16350	6	tolerated	tolerate	VBN
cord-005453-4057qib7	16350	7	and	and	CC
cord-005453-4057qib7	16350	8	sufficient	sufficient	JJ
cord-005453-4057qib7	16350	9	for	for	IN
cord-005453-4057qib7	16350	10	proper	proper	JJ
cord-005453-4057qib7	16350	11	engraftment	engraftment	NN
cord-005453-4057qib7	16350	12	and	and	CC
cord-005453-4057qib7	16350	13	disease	disease	NN
cord-005453-4057qib7	16350	14	clearance	clearance	NN
cord-005453-4057qib7	16350	15	.	.	.
cord-005453-4057qib7	16351	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16351	2	:	:	:
cord-005453-4057qib7	16352	1	The	the	DT
cord-005453-4057qib7	16352	2	authors	author	NNS
cord-005453-4057qib7	16352	3	have	have	VBP
cord-005453-4057qib7	16352	4	no	no	DT
cord-005453-4057qib7	16352	5	conflicts	conflict	NNS
cord-005453-4057qib7	16352	6	of	of	IN
cord-005453-4057qib7	16352	7	interest	interest	NN
cord-005453-4057qib7	16352	8	to	to	TO
cord-005453-4057qib7	16352	9	disclose	disclose	VB
cord-005453-4057qib7	16352	10	.	.	.
cord-005453-4057qib7	16353	1	Abstract	Abstract	NNP
cord-005453-4057qib7	16353	2	withdrawn	withdraw	VBN
cord-005453-4057qib7	16353	3	.	.	.
cord-005453-4057qib7	16354	1	thrombocytopenia	thrombocytopenia	NNP
cord-005453-4057qib7	16354	2	following	follow	VBG
cord-005453-4057qib7	16355	1	allo	allo	NNP
cord-005453-4057qib7	16355	2	-	-	HYPH
cord-005453-4057qib7	16355	3	SCT	sct	NN
cord-005453-4057qib7	16355	4	concomitant	concomitant	NN
cord-005453-4057qib7	16355	5	to	to	IN
cord-005453-4057qib7	16355	6	stem	stem	NN
cord-005453-4057qib7	16355	7	cell	cell	NN
cord-005453-4057qib7	16355	8	boosts	boost	NNS
cord-005453-4057qib7	16355	9	.	.	.
cord-005453-4057qib7	16356	1	Steroid	steroid	JJ
cord-005453-4057qib7	16356	2	refractoriness	refractoriness	NN
cord-005453-4057qib7	16356	3	was	be	VBD
cord-005453-4057qib7	16356	4	defined	define	VBN
cord-005453-4057qib7	16356	5	as	as	IN
cord-005453-4057qib7	16356	6	:	:	:
cord-005453-4057qib7	16356	7	progression	progression	NN
cord-005453-4057qib7	16356	8	after	after	IN
cord-005453-4057qib7	16356	9	three	three	CD
cord-005453-4057qib7	16356	10	days	day	NNS
cord-005453-4057qib7	16356	11	or	or	CC
cord-005453-4057qib7	16356	12	no	no	DT
cord-005453-4057qib7	16356	13	response	response	NN
cord-005453-4057qib7	16356	14	after	after	IN
cord-005453-4057qib7	16356	15	5	5	CD
cord-005453-4057qib7	16356	16	days	day	NNS
cord-005453-4057qib7	16356	17	of	of	IN
cord-005453-4057qib7	16356	18	steroid	steroid	NN
cord-005453-4057qib7	16356	19	treatment	treatment	NN
cord-005453-4057qib7	16356	20	.	.	.
cord-005453-4057qib7	16357	1	The	the	DT
cord-005453-4057qib7	16357	2	median	median	JJ
cord-005453-4057qib7	16357	3	time	time	NN
cord-005453-4057qib7	16357	4	from	from	IN
cord-005453-4057qib7	16357	5	SCT	SCT	NNP
cord-005453-4057qib7	16357	6	to	to	IN
cord-005453-4057qib7	16357	7	the	the	DT
cord-005453-4057qib7	16357	8	onset	onset	NN
cord-005453-4057qib7	16357	9	of	of	IN
cord-005453-4057qib7	16357	10	aGvHD	agvhd	NN
cord-005453-4057qib7	16357	11	was	be	VBD
cord-005453-4057qib7	16357	12	22.5	22.5	CD
cord-005453-4057qib7	16357	13	d	d	NN
cord-005453-4057qib7	16357	14	(	(	-LRB-
cord-005453-4057qib7	16357	15	range	range	NNP
cord-005453-4057qib7	16357	16	9	9	CD
cord-005453-4057qib7	16357	17	-	-	SYM
cord-005453-4057qib7	16357	18	122	122	CD
cord-005453-4057qib7	16357	19	d	d	NN
cord-005453-4057qib7	16357	20	)	)	-RRB-
cord-005453-4057qib7	16357	21	,	,	,
cord-005453-4057qib7	16357	22	and	and	CC
cord-005453-4057qib7	16357	23	11	11	CD
cord-005453-4057qib7	16357	24	d	d	XX
cord-005453-4057qib7	16357	25	(	(	-LRB-
cord-005453-4057qib7	16357	26	range	range	NNP
cord-005453-4057qib7	16357	27	3	3	CD
cord-005453-4057qib7	16357	28	-	-	SYM
cord-005453-4057qib7	16357	29	40	40	CD
cord-005453-4057qib7	16357	30	d	d	NN
cord-005453-4057qib7	16357	31	)	)	-RRB-
cord-005453-4057qib7	16357	32	from	from	IN
cord-005453-4057qib7	16357	33	the	the	DT
cord-005453-4057qib7	16357	34	onset	onset	NN
cord-005453-4057qib7	16357	35	of	of	IN
cord-005453-4057qib7	16357	36	aGvHD	agvhd	NN
cord-005453-4057qib7	16357	37	to	to	IN
cord-005453-4057qib7	16357	38	the	the	DT
cord-005453-4057qib7	16357	39	first	first	JJ
cord-005453-4057qib7	16357	40	MSC	MSC	NNP
cord-005453-4057qib7	16357	41	infusion	infusion	NN
cord-005453-4057qib7	16357	42	,	,	,
cord-005453-4057qib7	16357	43	respectively	respectively	RB
cord-005453-4057qib7	16357	44	.	.	.
cord-005453-4057qib7	16358	1	The	the	DT
cord-005453-4057qib7	16358	2	majority	majority	NN
cord-005453-4057qib7	16358	3	of	of	IN
cord-005453-4057qib7	16358	4	our	-PRON-	PRP$
cord-005453-4057qib7	16358	5	patients	patient	NNS
cord-005453-4057qib7	16358	6	(	(	-LRB-
cord-005453-4057qib7	16358	7	n=5	n=5	RB
cord-005453-4057qib7	16358	8	)	)	-RRB-
cord-005453-4057qib7	16358	9	suffered	suffer	VBD
cord-005453-4057qib7	16358	10	from	from	IN
cord-005453-4057qib7	16358	11	a	a	DT
cord-005453-4057qib7	16358	12	malignant	malignant	JJ
cord-005453-4057qib7	16358	13	disease	disease	NN
cord-005453-4057qib7	16358	14	and	and	CC
cord-005453-4057qib7	16358	15	received	receive	VBD
cord-005453-4057qib7	16358	16	a	a	DT
cord-005453-4057qib7	16358	17	graft	graft	NN
cord-005453-4057qib7	16358	18	from	from	IN
cord-005453-4057qib7	16358	19	a	a	DT
cord-005453-4057qib7	16358	20	matched	match	VBN
cord-005453-4057qib7	16358	21	unrelated	unrelated	JJ
cord-005453-4057qib7	16358	22	donor	donor	NN
cord-005453-4057qib7	16358	23	(	(	-LRB-
cord-005453-4057qib7	16358	24	n=6	n=6	NNP
cord-005453-4057qib7	16358	25	)	)	-RRB-
cord-005453-4057qib7	16358	26	,	,	,
cord-005453-4057qib7	16358	27	while	while	IN
cord-005453-4057qib7	16358	28	one	one	CD
cord-005453-4057qib7	16358	29	patient	patient	NN
cord-005453-4057qib7	16358	30	had	have	VBD
cord-005453-4057qib7	16358	31	a	a	DT
cord-005453-4057qib7	16358	32	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16358	33	donor	donor	NN
cord-005453-4057qib7	16358	34	.	.	.
cord-005453-4057qib7	16359	1	GvHD	GvHD	NNP
cord-005453-4057qib7	16359	2	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16359	3	was	be	VBD
cord-005453-4057qib7	16359	4	performed	perform	VBN
cord-005453-4057qib7	16359	5	in	in	IN
cord-005453-4057qib7	16359	6	all	all	DT
cord-005453-4057qib7	16359	7	patients	patient	NNS
cord-005453-4057qib7	16359	8	except	except	IN
cord-005453-4057qib7	16359	9	the	the	DT
cord-005453-4057qib7	16359	10	patient	patient	NN
cord-005453-4057qib7	16359	11	with	with	IN
cord-005453-4057qib7	16359	12	the	the	DT
cord-005453-4057qib7	16359	13	haplo	haplo	NN
cord-005453-4057qib7	16359	14	-	-	HYPH
cord-005453-4057qib7	16359	15	identical	identical	JJ
cord-005453-4057qib7	16359	16	graft	graft	NN
cord-005453-4057qib7	16359	17	.	.	.
cord-005453-4057qib7	16360	1	All	all	DT
cord-005453-4057qib7	16360	2	patients	patient	NNS
cord-005453-4057qib7	16360	3	with	with	IN
cord-005453-4057qib7	16360	4	aGvHD	aGvHD	NNS
cord-005453-4057qib7	16360	5	were	be	VBD
cord-005453-4057qib7	16360	6	treated	treat	VBN
cord-005453-4057qib7	16360	7	with	with	IN
cord-005453-4057qib7	16360	8	steroids	steroid	NNS
cord-005453-4057qib7	16360	9	and	and	CC
cord-005453-4057qib7	16360	10	the	the	DT
cord-005453-4057qib7	16360	11	patient	patient	NN
cord-005453-4057qib7	16360	12	with	with	IN
cord-005453-4057qib7	16360	13	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	16360	14	required	require	VBN
cord-005453-4057qib7	16360	15	regularly	regularly	RB
cord-005453-4057qib7	16360	16	transfusions	transfusion	NNS
cord-005453-4057qib7	16360	17	and	and	CC
cord-005453-4057qib7	16360	18	Romiplostin	Romiplostin	NNP
cord-005453-4057qib7	16360	19	therapy	therapy	NN
cord-005453-4057qib7	16360	20	.	.	.
cord-005453-4057qib7	16361	1	The	the	DT
cord-005453-4057qib7	16361	2	median	median	JJ
cord-005453-4057qib7	16361	3	MSC	MSC	NNP
cord-005453-4057qib7	16361	4	dose	dose	NN
cord-005453-4057qib7	16361	5	was	be	VBD
cord-005453-4057qib7	16361	6	1.7x10	1.7x10	CD
cord-005453-4057qib7	16361	7	6	6	CD
cord-005453-4057qib7	16361	8	cells	cell	NNS
cord-005453-4057qib7	16361	9	/	/	SYM
cord-005453-4057qib7	16361	10	kg	kg	NN
cord-005453-4057qib7	16361	11	BW	BW	NNP
cord-005453-4057qib7	16361	12	(	(	-LRB-
cord-005453-4057qib7	16361	13	minimum	minimum	JJ
cord-005453-4057qib7	16361	14	1.1	1.1	CD
cord-005453-4057qib7	16361	15	x10	x10	CD
cord-005453-4057qib7	16361	16	6	6	CD
cord-005453-4057qib7	16361	17	;	;	:
cord-005453-4057qib7	16361	18	maximum	maximum	JJ
cord-005453-4057qib7	16361	19	3	3	CD
cord-005453-4057qib7	16361	20	x10	x10	CD
cord-005453-4057qib7	16361	21	6	6	CD
cord-005453-4057qib7	16361	22	)	)	-RRB-
cord-005453-4057qib7	16361	23	.	.	.
cord-005453-4057qib7	16362	1	Three	three	CD
cord-005453-4057qib7	16362	2	patients	patient	NNS
cord-005453-4057qib7	16362	3	received	receive	VBD
cord-005453-4057qib7	16362	4	2	2	CD
cord-005453-4057qib7	16362	5	MSC	MSC	NNP
cord-005453-4057qib7	16362	6	doses	dose	NNS
cord-005453-4057qib7	16362	7	,	,	,
cord-005453-4057qib7	16362	8	two	two	CD
cord-005453-4057qib7	16362	9	patients	patient	NNS
cord-005453-4057qib7	16362	10	4	4	CD
cord-005453-4057qib7	16362	11	,	,	,
cord-005453-4057qib7	16362	12	one	one	CD
cord-005453-4057qib7	16362	13	patient	patient	NN
cord-005453-4057qib7	16362	14	5	5	CD
cord-005453-4057qib7	16362	15	and	and	CC
cord-005453-4057qib7	16362	16	another	another	DT
cord-005453-4057qib7	16362	17	7	7	CD
cord-005453-4057qib7	16362	18	doses	dose	NNS
cord-005453-4057qib7	16362	19	.	.	.
cord-005453-4057qib7	16363	1	Results	result	NNS
cord-005453-4057qib7	16363	2	:	:	:
cord-005453-4057qib7	16364	1	At	at	IN
cord-005453-4057qib7	16364	2	the	the	DT
cord-005453-4057qib7	16364	3	time	time	NN
cord-005453-4057qib7	16364	4	point	point	NN
cord-005453-4057qib7	16364	5	of	of	IN
cord-005453-4057qib7	16364	6	aGvHD	agvhd	NN
cord-005453-4057qib7	16364	7	manifestation	manifestation	NNP
cord-005453-4057qib7	16364	8	and	and	CC
cord-005453-4057qib7	16364	9	MSC	MSC	NNP
cord-005453-4057qib7	16364	10	application	application	NN
cord-005453-4057qib7	16364	11	,	,	,
cord-005453-4057qib7	16364	12	two	two	CD
cord-005453-4057qib7	16364	13	patients	patient	NNS
cord-005453-4057qib7	16364	14	had	have	VBD
cord-005453-4057qib7	16364	15	CMV	CMV	NNP
cord-005453-4057qib7	16364	16	reactivation	reactivation	NN
cord-005453-4057qib7	16364	17	,	,	,
cord-005453-4057qib7	16364	18	one	one	CD
cord-005453-4057qib7	16364	19	patient	patient	NN
cord-005453-4057qib7	16364	20	adenovirus	adenovirus	NN
cord-005453-4057qib7	16364	21	infection	infection	NN
cord-005453-4057qib7	16364	22	and	and	CC
cord-005453-4057qib7	16364	23	one	one	CD
cord-005453-4057qib7	16364	24	patient	patient	JJ
cord-005453-4057qib7	16364	25	EBVreactivation	ebvreactivation	NN
cord-005453-4057qib7	16364	26	.	.	.
cord-005453-4057qib7	16365	1	By	by	IN
cord-005453-4057qib7	16365	2	day	day	NN
cord-005453-4057qib7	16365	3	28	28	CD
cord-005453-4057qib7	16365	4	,	,	,
cord-005453-4057qib7	16365	5	5/6	5/6	CD
cord-005453-4057qib7	16365	6	aGvHD	agvhd	NN
cord-005453-4057qib7	16365	7	patients	patient	NNS
cord-005453-4057qib7	16365	8	responded	respond	VBD
cord-005453-4057qib7	16365	9	to	to	IN
cord-005453-4057qib7	16365	10	MSC	MSC	NNP
cord-005453-4057qib7	16365	11	administration	administration	NN
cord-005453-4057qib7	16365	12	:	:	:
cord-005453-4057qib7	16365	13	3	3	CD
cord-005453-4057qib7	16365	14	with	with	IN
cord-005453-4057qib7	16365	15	complete	complete	JJ
cord-005453-4057qib7	16365	16	response	response	NN
cord-005453-4057qib7	16365	17	and	and	CC
cord-005453-4057qib7	16365	18	2	2	CD
cord-005453-4057qib7	16365	19	with	with	IN
cord-005453-4057qib7	16365	20	partial	partial	JJ
cord-005453-4057qib7	16365	21	response	response	NN
cord-005453-4057qib7	16365	22	.	.	.
cord-005453-4057qib7	16366	1	At	at	IN
cord-005453-4057qib7	16366	2	the	the	DT
cord-005453-4057qib7	16366	3	last	last	JJ
cord-005453-4057qib7	16366	4	follow	follow	NN
cord-005453-4057qib7	16366	5	-	-	HYPH
cord-005453-4057qib7	16366	6	up	up	NN
cord-005453-4057qib7	16366	7	(	(	-LRB-
cord-005453-4057qib7	16366	8	median	median	NN
cord-005453-4057qib7	16366	9	:	:	:
cord-005453-4057qib7	16366	10	4.42	4.42	CD
cord-005453-4057qib7	16366	11	months	month	NNS
cord-005453-4057qib7	16366	12	,	,	,
cord-005453-4057qib7	16366	13	range	range	VBP
cord-005453-4057qib7	16366	14	0,82	0,82	CD
cord-005453-4057qib7	16366	15	-	-	HYPH
cord-005453-4057qib7	16366	16	12.06	12.06	CD
cord-005453-4057qib7	16366	17	months	month	NNS
cord-005453-4057qib7	16366	18	)	)	-RRB-
cord-005453-4057qib7	16366	19	,	,	,
cord-005453-4057qib7	16366	20	4	4	CD
cord-005453-4057qib7	16366	21	of	of	IN
cord-005453-4057qib7	16366	22	6	6	CD
cord-005453-4057qib7	16366	23	patients	patient	NNS
cord-005453-4057qib7	16366	24	were	be	VBD
cord-005453-4057qib7	16366	25	alive	alive	JJ
cord-005453-4057qib7	16366	26	without	without	IN
cord-005453-4057qib7	16366	27	acute	acute	JJ
cord-005453-4057qib7	16366	28	or	or	CC
cord-005453-4057qib7	16366	29	chronic	chronic	JJ
cord-005453-4057qib7	16366	30	GVHD	GVHD	NNP
cord-005453-4057qib7	16366	31	.	.	.
cord-005453-4057qib7	16367	1	One	one	CD
cord-005453-4057qib7	16367	2	patient	patient	NN
cord-005453-4057qib7	16367	3	died	die	VBD
cord-005453-4057qib7	16367	4	soon	soon	RB
cord-005453-4057qib7	16367	5	after	after	IN
cord-005453-4057qib7	16367	6	MSC	MSC	NNP
cord-005453-4057qib7	16367	7	treatment	treatment	NN
cord-005453-4057qib7	16367	8	with	with	IN
cord-005453-4057qib7	16367	9	no	no	DT
cord-005453-4057qib7	16367	10	obvious	obvious	JJ
cord-005453-4057qib7	16367	11	response	response	NN
cord-005453-4057qib7	16367	12	in	in	IN
cord-005453-4057qib7	16367	13	the	the	DT
cord-005453-4057qib7	16367	14	course	course	NN
cord-005453-4057qib7	16367	15	of	of	IN
cord-005453-4057qib7	16367	16	a	a	DT
cord-005453-4057qib7	16367	17	systemic	systemic	JJ
cord-005453-4057qib7	16367	18	hyperinflammation	hyperinflammation	NN
cord-005453-4057qib7	16367	19	syndrome	syndrome	NN
cord-005453-4057qib7	16367	20	.	.	.
cord-005453-4057qib7	16368	1	The	the	DT
cord-005453-4057qib7	16368	2	other	other	JJ
cord-005453-4057qib7	16368	3	patient	patient	NN
cord-005453-4057qib7	16368	4	although	although	IN
cord-005453-4057qib7	16368	5	complete	complete	JJ
cord-005453-4057qib7	16368	6	responder	responder	NN
cord-005453-4057qib7	16368	7	to	to	IN
cord-005453-4057qib7	16368	8	MSC	MSC	NNP
cord-005453-4057qib7	16368	9	-	-	HYPH
cord-005453-4057qib7	16368	10	FFM	FFM	NNP
cord-005453-4057qib7	16368	11	developed	develop	VBD
cord-005453-4057qib7	16368	12	fatal	fatal	JJ
cord-005453-4057qib7	16368	13	adenovirus	adenovirus	NN
cord-005453-4057qib7	16368	14	sepsis	sepsis	NN
cord-005453-4057qib7	16368	15	.	.	.
cord-005453-4057qib7	16369	1	This	this	DT
cord-005453-4057qib7	16369	2	based	base	VBN
cord-005453-4057qib7	16369	3	on	on	IN
cord-005453-4057qib7	16369	4	the	the	DT
cord-005453-4057qib7	16369	5	profound	profound	JJ
cord-005453-4057qib7	16369	6	Tcell	Tcell	NNP
cord-005453-4057qib7	16369	7	depletion	depletion	NN
cord-005453-4057qib7	16369	8	induced	induce	VBN
cord-005453-4057qib7	16369	9	by	by	IN
cord-005453-4057qib7	16369	10	concomitant	concomitant	JJ
cord-005453-4057qib7	16369	11	application	application	NN
cord-005453-4057qib7	16369	12	of	of	IN
cord-005453-4057qib7	16369	13	steroids	steroid	NNS
cord-005453-4057qib7	16369	14	.	.	.
cord-005453-4057qib7	16370	1	The	the	DT
cord-005453-4057qib7	16370	2	overall	overall	JJ
cord-005453-4057qib7	16370	3	survival	survival	NN
cord-005453-4057qib7	16370	4	probability	probability	NN
cord-005453-4057qib7	16370	5	at	at	IN
cord-005453-4057qib7	16370	6	six	six	CD
cord-005453-4057qib7	16370	7	month	month	NN
cord-005453-4057qib7	16370	8	was	be	VBD
cord-005453-4057qib7	16370	9	66.7	66.7	CD
cord-005453-4057qib7	16370	10	%	%	NN
cord-005453-4057qib7	16370	11	.	.	.
cord-005453-4057qib7	16371	1	No	no	DT
cord-005453-4057qib7	16371	2	acute	acute	JJ
cord-005453-4057qib7	16371	3	side	side	NN
cord-005453-4057qib7	16371	4	effects	effect	NNS
cord-005453-4057qib7	16371	5	occurred	occur	VBD
cord-005453-4057qib7	16371	6	after	after	IN
cord-005453-4057qib7	16371	7	MSC	MSC	NNP
cord-005453-4057qib7	16371	8	infusions	infusion	NNS
cord-005453-4057qib7	16371	9	.	.	.
cord-005453-4057qib7	16372	1	The	the	DT
cord-005453-4057qib7	16372	2	previously	previously	RB
cord-005453-4057qib7	16372	3	mentioned	mention	VBN
cord-005453-4057qib7	16372	4	patient	patient	JJ
cord-005453-4057qib7	16372	5	suffering	suffer	VBG
cord-005453-4057qib7	16372	6	from	from	IN
cord-005453-4057qib7	16372	7	thrombocytopenia	thrombocytopenia	NN
cord-005453-4057qib7	16372	8	did	do	VBD
cord-005453-4057qib7	16372	9	not	not	RB
cord-005453-4057qib7	16372	10	need	need	VB
cord-005453-4057qib7	16372	11	any	any	DT
cord-005453-4057qib7	16372	12	further	further	JJ
cord-005453-4057qib7	16372	13	transfusions	transfusion	NNS
cord-005453-4057qib7	16372	14	after	after	IN
cord-005453-4057qib7	16372	15	receiving	receive	VBG
cord-005453-4057qib7	16372	16	2	2	CD
cord-005453-4057qib7	16372	17	doses	dose	NNS
cord-005453-4057qib7	16372	18	MSCs	msc	NNS
cord-005453-4057qib7	16372	19	combined	combine	VBN
cord-005453-4057qib7	16372	20	with	with	IN
cord-005453-4057qib7	16372	21	stem	stem	NN
cord-005453-4057qib7	16372	22	cell	cell	NN
cord-005453-4057qib7	16372	23	boosts	boost	NNS
cord-005453-4057qib7	16372	24	while	while	IN
cord-005453-4057qib7	16372	25	continuing	continue	VBG
cord-005453-4057qib7	16372	26	Romiplostin	Romiplostin	NNP
cord-005453-4057qib7	16372	27	application	application	NN
cord-005453-4057qib7	16372	28	.	.	.
cord-005453-4057qib7	16373	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16373	2	:	:	:
cord-005453-4057qib7	16374	1	Our	-PRON-	PRP$
cord-005453-4057qib7	16374	2	data	datum	NNS
cord-005453-4057qib7	16374	3	confirm	confirm	VBP
cord-005453-4057qib7	16374	4	excellent	excellent	JJ
cord-005453-4057qib7	16374	5	tolerability	tolerability	NN
cord-005453-4057qib7	16374	6	and	and	CC
cord-005453-4057qib7	16374	7	high	high	JJ
cord-005453-4057qib7	16374	8	efficacy	efficacy	NN
cord-005453-4057qib7	16374	9	of	of	IN
cord-005453-4057qib7	16374	10	the	the	DT
cord-005453-4057qib7	16374	11	licensed	licensed	JJ
cord-005453-4057qib7	16374	12	off	off	IN
cord-005453-4057qib7	16374	13	-	-	HYPH
cord-005453-4057qib7	16374	14	the	the	DT
cord-005453-4057qib7	16374	15	-	-	HYPH
cord-005453-4057qib7	16374	16	shelf	shelf	NN
cord-005453-4057qib7	16374	17	MSC	MSC	NNP
cord-005453-4057qib7	16374	18	preparation	preparation	NN
cord-005453-4057qib7	16374	19	"	"	``
cord-005453-4057qib7	16374	20	MSC	MSC	NNP
cord-005453-4057qib7	16374	21	-	-	HYPH
cord-005453-4057qib7	16374	22	FFM	FFM	NNP
cord-005453-4057qib7	16374	23	"	"	''
cord-005453-4057qib7	16374	24	in	in	IN
cord-005453-4057qib7	16374	25	pediatric	pediatric	JJ
cord-005453-4057qib7	16374	26	steroid	steroid	JJ
cord-005453-4057qib7	16374	27	-	-	HYPH
cord-005453-4057qib7	16374	28	refractory	refractory	JJ
cord-005453-4057qib7	16374	29	aGvHD	agvhd	NN
cord-005453-4057qib7	16374	30	.	.	.
cord-005453-4057qib7	16375	1	In	in	IN
cord-005453-4057qib7	16375	2	our	-PRON-	PRP$
cord-005453-4057qib7	16375	3	center	center	NN
cord-005453-4057qib7	16375	4	,	,	,
cord-005453-4057qib7	16375	5	current	current	JJ
cord-005453-4057qib7	16375	6	treatment	treatment	NN
cord-005453-4057qib7	16375	7	algorithms	algorithm	NNS
cord-005453-4057qib7	16375	8	have	have	VBP
cord-005453-4057qib7	16375	9	escalated	escalate	VBN
cord-005453-4057qib7	16375	10	"	"	``
cord-005453-4057qib7	16375	11	MSC	MSC	NNP
cord-005453-4057qib7	16375	12	-	-	HYPH
cord-005453-4057qib7	16375	13	FFM	FFM	NNP
cord-005453-4057qib7	16375	14	"	"	''
cord-005453-4057qib7	16375	15	to	to	IN
cord-005453-4057qib7	16375	16	the	the	DT
cord-005453-4057qib7	16375	17	second	second	JJ
cord-005453-4057qib7	16375	18	line	line	NN
cord-005453-4057qib7	16375	19	,	,	,
cord-005453-4057qib7	16375	20	i.e.	i.e.	FW
cord-005453-4057qib7	16375	21	immediately	immediately	RB
cord-005453-4057qib7	16375	22	after	after	IN
cord-005453-4057qib7	16375	23	steroid	steroid	NN
cord-005453-4057qib7	16375	24	refractoriness	refractoriness	NN
cord-005453-4057qib7	16375	25	has	have	VBZ
cord-005453-4057qib7	16375	26	been	be	VBN
cord-005453-4057qib7	16375	27	established	establish	VBN
cord-005453-4057qib7	16375	28	.	.	.
cord-005453-4057qib7	16376	1	Besides	besides	IN
cord-005453-4057qib7	16376	2	immunoregulatory	immunoregulatory	JJ
cord-005453-4057qib7	16376	3	properties	property	NNS
cord-005453-4057qib7	16376	4	,	,	,
cord-005453-4057qib7	16376	5	this	this	DT
cord-005453-4057qib7	16376	6	product	product	NN
cord-005453-4057qib7	16376	7	might	may	MD
cord-005453-4057qib7	16376	8	facilitate	facilitate	VB
cord-005453-4057qib7	16376	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16376	10	stem	stem	NN
cord-005453-4057qib7	16376	11	cell	cell	NN
cord-005453-4057qib7	16376	12	engraftment	engraftment	NN
cord-005453-4057qib7	16376	13	.	.	.
cord-005453-4057qib7	16377	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16377	2	:	:	:
cord-005453-4057qib7	16378	1	Novartis	Novartis	NNP
cord-005453-4057qib7	16378	2	(	(	-LRB-
cord-005453-4057qib7	16378	3	consultancy	consultancy	NN
cord-005453-4057qib7	16378	4	:	:	:
cord-005453-4057qib7	16378	5	included	include	VBN
cord-005453-4057qib7	16378	6	expert	expert	JJ
cord-005453-4057qib7	16378	7	testimony	testimony	NN
cord-005453-4057qib7	16378	8	,	,	,
cord-005453-4057qib7	16378	9	speaker	speaker	NNP
cord-005453-4057qib7	16378	10	bureau	bureau	NNP
cord-005453-4057qib7	16378	11	,	,	,
cord-005453-4057qib7	16378	12	Honoraria	Honoraria	NNP
cord-005453-4057qib7	16378	13	)	)	-RRB-
cord-005453-4057qib7	16378	14	,	,	,
cord-005453-4057qib7	16378	15	Medac	Medac	NNP
cord-005453-4057qib7	16378	16	(	(	-LRB-
cord-005453-4057qib7	16378	17	Research	Research	NNP
cord-005453-4057qib7	16378	18	Funding	Funding	NNP
cord-005453-4057qib7	16378	19	,	,	,
cord-005453-4057qib7	16378	20	Patents	Patents	NNPS
cord-005453-4057qib7	16378	21	and	and	CC
cord-005453-4057qib7	16378	22	Royalties	Royalties	NNPS
cord-005453-4057qib7	16378	23	)	)	-RRB-
cord-005453-4057qib7	16378	24	,	,	,
cord-005453-4057qib7	16378	25	Riemser	Riemser	NNP
cord-005453-4057qib7	16378	26	(	(	-LRB-
cord-005453-4057qib7	16378	27	Research	Research	NNP
cord-005453-4057qib7	16378	28	Funding	Funding	NNP
cord-005453-4057qib7	16378	29	)	)	-RRB-
cord-005453-4057qib7	16378	30	,	,	,
cord-005453-4057qib7	16378	31	Neovii	Neovii	NNP
cord-005453-4057qib7	16378	32	(	(	-LRB-
cord-005453-4057qib7	16378	33	Research	Research	NNP
cord-005453-4057qib7	16378	34	Funding	Funding	NNP
cord-005453-4057qib7	16378	35	)	)	-RRB-
cord-005453-4057qib7	16378	36	,	,	,
cord-005453-4057qib7	16378	37	Amgen	Amgen	NNP
cord-005453-4057qib7	16378	38	(	(	-LRB-
cord-005453-4057qib7	16378	39	Honoraria	Honoraria	NNP
cord-005453-4057qib7	16378	40	)	)	-RRB-
cord-005453-4057qib7	16378	41	Expression	expression	NN
cord-005453-4057qib7	16378	42	of	of	IN
cord-005453-4057qib7	16378	43	CCR4	CCR4	NNP
cord-005453-4057qib7	16378	44	modulates	modulate	VBZ
cord-005453-4057qib7	16378	45	migrational	migrational	JJ
cord-005453-4057qib7	16378	46	properties	property	NNS
cord-005453-4057qib7	16378	47	of	of	IN
cord-005453-4057qib7	16378	48	in	in	FW
cord-005453-4057qib7	16378	49	vitro	vitro	FW
cord-005453-4057qib7	16378	50	expanded	expand	VBN
cord-005453-4057qib7	16378	51	murine	murine	JJ
cord-005453-4057qib7	16378	52	regulatory	regulatory	JJ
cord-005453-4057qib7	16378	53	t	t	NN
cord-005453-4057qib7	16378	54	cells	cell	NNS
cord-005453-4057qib7	16378	55	Laura	Laura	NNP
cord-005453-4057qib7	16378	56	M.	M.	NNP
cord-005453-4057qib7	16378	57	Moser	Moser	NNP
cord-005453-4057qib7	16378	58	1,2	1,2	CD
cord-005453-4057qib7	16378	59	,	,	,
cord-005453-4057qib7	16378	60	Ulrike	Ulrike	NNP
cord-005453-4057qib7	16378	61	Tischler	Tischler	NNP
cord-005453-4057qib7	16378	62	1	1	CD
cord-005453-4057qib7	16378	63	,	,	,
cord-005453-4057qib7	16378	64	Christin	Christin	NNP
cord-005453-4057qib7	16378	65	Riegel	Riegel	NNP
cord-005453-4057qib7	16378	66	1	1	CD
cord-005453-4057qib7	16378	67	,	,	,
cord-005453-4057qib7	16378	68	Julia	Julia	NNP
cord-005453-4057qib7	16378	69	Minderjahn	Minderjahn	NNP
cord-005453-4057qib7	16378	70	1	1	CD
cord-005453-4057qib7	16378	71	,	,	,
cord-005453-4057qib7	16378	72	Rüdiger	Rüdiger	NNP
cord-005453-4057qib7	16378	73	Eder	Eder	NNP
cord-005453-4057qib7	16378	74	1	1	CD
cord-005453-4057qib7	16378	75	,	,	,
cord-005453-4057qib7	16378	76	Jaqueline	Jaqueline	NNP
cord-005453-4057qib7	16378	77	Dirmeier	Dirmeier	NNP
cord-005453-4057qib7	16378	78	1	1	CD
cord-005453-4057qib7	16378	79	,	,	,
cord-005453-4057qib7	16378	80	Isabel	Isabel	NNP
cord-005453-4057qib7	16378	81	Zimmermann	Zimmermann	NNP
cord-005453-4057qib7	16378	82	1	1	CD
cord-005453-4057qib7	16378	83	,	,	,
cord-005453-4057qib7	16378	84	Evelyn	Evelyn	NNP
cord-005453-4057qib7	16378	85	Röseler	Röseler	NNP
cord-005453-4057qib7	16378	86	1	1	CD
cord-005453-4057qib7	16378	87	,	,	,
cord-005453-4057qib7	16378	88	Petra	Petra	NNP
cord-005453-4057qib7	16378	89	Hoffmann	Hoffmann	NNP
cord-005453-4057qib7	16378	90	1,3	1,3	NNP
cord-005453-4057qib7	16378	91	,	,	,
cord-005453-4057qib7	16378	92	Matthias	Matthias	NNP
cord-005453-4057qib7	16378	93	Edinger	Edinger	NNP
cord-005453-4057qib7	16378	94	1	1	CD
cord-005453-4057qib7	16378	95	,	,	,
cord-005453-4057qib7	16379	1	3	3	CD
cord-005453-4057qib7	16379	2	Background	background	NN
cord-005453-4057qib7	16379	3	:	:	:
cord-005453-4057qib7	16380	1	Hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16380	2	stem	stem	NN
cord-005453-4057qib7	16380	3	cell	cell	NN
cord-005453-4057qib7	16380	4	transplantation	transplantation	NN
cord-005453-4057qib7	16380	5	(	(	-LRB-
cord-005453-4057qib7	16380	6	HSCT	HSCT	NNP
cord-005453-4057qib7	16380	7	)	)	-RRB-
cord-005453-4057qib7	16380	8	as	as	IN
cord-005453-4057qib7	16380	9	it	-PRON-	PRP
cord-005453-4057qib7	16380	10	is	be	VBZ
cord-005453-4057qib7	16380	11	carried	carry	VBN
cord-005453-4057qib7	16380	12	out	out	RP
cord-005453-4057qib7	16380	13	successfully	successfully	RB
cord-005453-4057qib7	16380	14	at	at	IN
cord-005453-4057qib7	16380	15	other	other	JJ
cord-005453-4057qib7	16380	16	genetic	genetic	JJ
cord-005453-4057qib7	16380	17	instability	instability	NN
cord-005453-4057qib7	16380	18	syndromes	syndrome	NNS
cord-005453-4057qib7	16380	19	seems	seem	VBZ
cord-005453-4057qib7	16380	20	to	to	TO
cord-005453-4057qib7	16380	21	be	be	VB
cord-005453-4057qib7	16380	22	an	an	DT
cord-005453-4057qib7	16380	23	encouraging	encouraging	JJ
cord-005453-4057qib7	16380	24	opportunity	opportunity	NN
cord-005453-4057qib7	16380	25	for	for	IN
cord-005453-4057qib7	16380	26	a	a	DT
cord-005453-4057qib7	16380	27	curative	curative	JJ
cord-005453-4057qib7	16380	28	therapy	therapy	NN
cord-005453-4057qib7	16380	29	to	to	TO
cord-005453-4057qib7	16380	30	restore	restore	VB
cord-005453-4057qib7	16380	31	immunity	immunity	NN
cord-005453-4057qib7	16380	32	and	and	CC
cord-005453-4057qib7	16380	33	prevent	prevent	VB
cord-005453-4057qib7	16380	34	the	the	DT
cord-005453-4057qib7	16380	35	development	development	NN
cord-005453-4057qib7	16380	36	of	of	IN
cord-005453-4057qib7	16380	37	hematologic	hematologic	JJ
cord-005453-4057qib7	16380	38	malignancies	malignancy	NNS
cord-005453-4057qib7	16380	39	in	in	IN
cord-005453-4057qib7	16380	40	Ataxiatelangiectasia	Ataxiatelangiectasia	NNP
cord-005453-4057qib7	16380	41	(	(	-LRB-
cord-005453-4057qib7	16380	42	A	A	NNP
cord-005453-4057qib7	16380	43	-	-	HYPH
cord-005453-4057qib7	16380	44	T	T	NNP
cord-005453-4057qib7	16380	45	)	)	-RRB-
cord-005453-4057qib7	16380	46	.	.	.
cord-005453-4057qib7	16381	1	However	however	RB
cord-005453-4057qib7	16381	2	,	,	,
cord-005453-4057qib7	16381	3	experience	experience	NN
cord-005453-4057qib7	16381	4	in	in	IN
cord-005453-4057qib7	16381	5	the	the	DT
cord-005453-4057qib7	16381	6	conditioning	conditioning	NN
cord-005453-4057qib7	16381	7	regimen	regimen	NN
cord-005453-4057qib7	16381	8	is	be	VBZ
cord-005453-4057qib7	16381	9	limited	limit	VBN
cord-005453-4057qib7	16381	10	and	and	CC
cord-005453-4057qib7	16381	11	no	no	DT
cord-005453-4057qib7	16381	12	transplantation	transplantation	NN
cord-005453-4057qib7	16381	13	strategy	strategy	NN
cord-005453-4057qib7	16381	14	for	for	IN
cord-005453-4057qib7	16381	15	A	A	NNP
cord-005453-4057qib7	16381	16	-	-	HYPH
cord-005453-4057qib7	16381	17	T	t	NN
cord-005453-4057qib7	16381	18	patients	patient	NNS
cord-005453-4057qib7	16381	19	exists	exist	VBZ
cord-005453-4057qib7	16381	20	,	,	,
cord-005453-4057qib7	16381	21	especially	especially	RB
cord-005453-4057qib7	16381	22	in	in	IN
cord-005453-4057qib7	16381	23	an	an	DT
cord-005453-4057qib7	16381	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	16381	25	setting	setting	NN
cord-005453-4057qib7	16381	26	.	.	.
cord-005453-4057qib7	16382	1	Conditioning	conditioning	NN
cord-005453-4057qib7	16382	2	regimen	regimen	NN
cord-005453-4057qib7	16382	3	and	and	CC
cord-005453-4057qib7	16382	4	donor	donor	NN
cord-005453-4057qib7	16382	5	selection	selection	NN
cord-005453-4057qib7	16382	6	are	be	VBP
cord-005453-4057qib7	16382	7	critical	critical	JJ
cord-005453-4057qib7	16382	8	factors	factor	NNS
cord-005453-4057qib7	16382	9	in	in	IN
cord-005453-4057qib7	16382	10	the	the	DT
cord-005453-4057qib7	16382	11	clinical	clinical	JJ
cord-005453-4057qib7	16382	12	setting	setting	NN
cord-005453-4057qib7	16382	13	of	of	IN
cord-005453-4057qib7	16382	14	HSCT	HSCT	NNP
cord-005453-4057qib7	16382	15	and	and	CC
cord-005453-4057qib7	16382	16	incur	incur	VB
cord-005453-4057qib7	16382	17	substantial	substantial	JJ
cord-005453-4057qib7	16382	18	risks	risk	NNS
cord-005453-4057qib7	16382	19	,	,	,
cord-005453-4057qib7	16382	20	especially	especially	RB
cord-005453-4057qib7	16382	21	in	in	IN
cord-005453-4057qib7	16382	22	A	a	NN
cord-005453-4057qib7	16382	23	-	-	HYPH
cord-005453-4057qib7	16382	24	T.	t.	NN
cord-005453-4057qib7	16383	1	The	the	DT
cord-005453-4057qib7	16383	2	aim	aim	NN
cord-005453-4057qib7	16383	3	of	of	IN
cord-005453-4057qib7	16383	4	this	this	DT
cord-005453-4057qib7	16383	5	study	study	NN
cord-005453-4057qib7	16383	6	was	be	VBD
cord-005453-4057qib7	16383	7	(	(	-LRB-
cord-005453-4057qib7	16383	8	1	1	CD
cord-005453-4057qib7	16383	9	)	)	-RRB-
cord-005453-4057qib7	16383	10	to	to	TO
cord-005453-4057qib7	16383	11	evaluate	evaluate	VB
cord-005453-4057qib7	16383	12	whether	whether	IN
cord-005453-4057qib7	16383	13	different	different	JJ
cord-005453-4057qib7	16383	14	approaches	approach	NNS
cord-005453-4057qib7	16383	15	of	of	IN
cord-005453-4057qib7	16383	16	HSCT	HSCT	NNP
cord-005453-4057qib7	16383	17	including	include	VBG
cord-005453-4057qib7	16383	18	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16383	19	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16383	20	HSCT	HSCT	NNP
cord-005453-4057qib7	16383	21	are	be	VBP
cord-005453-4057qib7	16383	22	feasible	feasible	JJ
cord-005453-4057qib7	16383	23	in	in	IN
cord-005453-4057qib7	16383	24	regard	regard	NN
cord-005453-4057qib7	16383	25	to	to	IN
cord-005453-4057qib7	16383	26	graft	graft	NN
cord-005453-4057qib7	16383	27	versus	versus	IN
cord-005453-4057qib7	16383	28	host	host	NN
cord-005453-4057qib7	16383	29	response	response	NN
cord-005453-4057qib7	16383	30	(	(	-LRB-
cord-005453-4057qib7	16383	31	GvHD	GvHD	NNP
cord-005453-4057qib7	16383	32	)	)	-RRB-
cord-005453-4057qib7	16383	33	and	and	CC
cord-005453-4057qib7	16384	1	sufficient	sufficient	JJ
cord-005453-4057qib7	16384	2	concerning	concern	VBG
cord-005453-4057qib7	16384	3	immune	immune	JJ
cord-005453-4057qib7	16384	4	reconstitution	reconstitution	NN
cord-005453-4057qib7	16384	5	(	(	-LRB-
cord-005453-4057qib7	16384	6	2	2	CD
cord-005453-4057qib7	16384	7	)	)	-RRB-
cord-005453-4057qib7	16384	8	and	and	CC
cord-005453-4057qib7	16384	9	to	to	IN
cord-005453-4057qib7	16384	10	de	de	FW
cord-005453-4057qib7	16384	11	-	-	VB
cord-005453-4057qib7	16384	12	escalate	escalate	VB
cord-005453-4057qib7	16384	13	the	the	DT
cord-005453-4057qib7	16384	14	toxic	toxic	JJ
cord-005453-4057qib7	16384	15	effects	effect	NNS
cord-005453-4057qib7	16384	16	of	of	IN
cord-005453-4057qib7	16384	17	the	the	DT
cord-005453-4057qib7	16384	18	conditioning	conditioning	NN
cord-005453-4057qib7	16384	19	regimen	regimen	NN
cord-005453-4057qib7	16384	20	by	by	IN
cord-005453-4057qib7	16384	21	reducing	reduce	VBG
cord-005453-4057qib7	16384	22	the	the	DT
cord-005453-4057qib7	16384	23	dose	dose	NN
cord-005453-4057qib7	16384	24	of	of	IN
cord-005453-4057qib7	16384	25	cyclophosphamide	cyclophosphamide	NN
cord-005453-4057qib7	16384	26	(	(	-LRB-
cord-005453-4057qib7	16384	27	CP).Methods	cp).method	NNS
cord-005453-4057qib7	16384	28	:	:	:
cord-005453-4057qib7	16384	29	T	t	NN
cord-005453-4057qib7	16384	30	cells	cell	NNS
cord-005453-4057qib7	16384	31	from	from	IN
cord-005453-4057qib7	16384	32	syngeneic	syngeneic	NNS
cord-005453-4057qib7	16384	33	,	,	,
cord-005453-4057qib7	16384	34	allogeneic	allogeneic	NN
cord-005453-4057qib7	16384	35	and	and	CC
cord-005453-4057qib7	16384	36	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16384	37	donor	donor	NN
cord-005453-4057qib7	16384	38	mice	mouse	NNS
cord-005453-4057qib7	16384	39	were	be	VBD
cord-005453-4057qib7	16384	40	used	use	VBN
cord-005453-4057qib7	16384	41	to	to	TO
cord-005453-4057qib7	16384	42	determine	determine	VB
cord-005453-4057qib7	16384	43	GvHD	GvHD	NNP
cord-005453-4057qib7	16384	44	induced	induce	VBN
cord-005453-4057qib7	16384	45	T	t	NN
cord-005453-4057qib7	16384	46	cell	cell	NN
cord-005453-4057qib7	16384	47	proliferation	proliferation	NN
cord-005453-4057qib7	16384	48	in	in	IN
cord-005453-4057qib7	16384	49	a	a	DT
cord-005453-4057qib7	16384	50	mixed	mixed	JJ
cord-005453-4057qib7	16384	51	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	16384	52	reaction	reaction	NN
cord-005453-4057qib7	16384	53	(	(	-LRB-
cord-005453-4057qib7	16384	54	MLR	MLR	NNP
cord-005453-4057qib7	16384	55	)	)	-RRB-
cord-005453-4057qib7	16384	56	.	.	.
cord-005453-4057qib7	16385	1	Atm	atm	NN
cord-005453-4057qib7	16385	2	-	-	HYPH
cord-005453-4057qib7	16385	3	deficient	deficient	JJ
cord-005453-4057qib7	16385	4	mice	mouse	NNS
cord-005453-4057qib7	16385	5	were	be	VBD
cord-005453-4057qib7	16385	6	treated	treat	VBN
cord-005453-4057qib7	16385	7	with	with	IN
cord-005453-4057qib7	16385	8	CP	CP	NNP
cord-005453-4057qib7	16385	9	or	or	CC
cord-005453-4057qib7	16385	10	reduced	reduce	VBN
cord-005453-4057qib7	16385	11	CP	cp	NN
cord-005453-4057qib7	16385	12	in	in	IN
cord-005453-4057qib7	16385	13	combination	combination	NN
cord-005453-4057qib7	16385	14	with	with	IN
cord-005453-4057qib7	16385	15	Fludarabine	Fludarabine	NNP
cord-005453-4057qib7	16385	16	(	(	-LRB-
cord-005453-4057qib7	16385	17	FLU	FLU	NNP
cord-005453-4057qib7	16385	18	)	)	-RRB-
cord-005453-4057qib7	16385	19	and	and	CC
cord-005453-4057qib7	16385	20	transplanted	transplant	VBN
cord-005453-4057qib7	16385	21	with	with	IN
cord-005453-4057qib7	16385	22	5x10	5x10	CD
cord-005453-4057qib7	16385	23	6	6	CD
cord-005453-4057qib7	16385	24	CD90.2	cd90.2	JJ
cord-005453-4057qib7	16385	25	depleted	deplete	VBN
cord-005453-4057qib7	16385	26	bone	bone	NN
cord-005453-4057qib7	16385	27	marrow	marrow	NN
cord-005453-4057qib7	16385	28	donor	donor	NN
cord-005453-4057qib7	16385	29	cells	cell	NNS
cord-005453-4057qib7	16385	30	from	from	IN
cord-005453-4057qib7	16385	31	129	129	CD
cord-005453-4057qib7	16385	32	/	/	SYM
cord-005453-4057qib7	16385	33	SvEv	SvEv	NNP
cord-005453-4057qib7	16385	34	GFP	GFP	NNP
cord-005453-4057qib7	16385	35	-	-	HYPH
cord-005453-4057qib7	16385	36	transfected	transfecte	VBN
cord-005453-4057qib7	16385	37	wildtype	wildtype	NN
cord-005453-4057qib7	16385	38	mice	mouse	NNS
cord-005453-4057qib7	16385	39	(	(	-LRB-
cord-005453-4057qib7	16385	40	syngeneic	syngeneic	NNS
cord-005453-4057qib7	16385	41	)	)	-RRB-
cord-005453-4057qib7	16385	42	or	or	CC
cord-005453-4057qib7	16385	43	from	from	IN
cord-005453-4057qib7	16385	44	mice	mouse	NNS
cord-005453-4057qib7	16385	45	of	of	IN
cord-005453-4057qib7	16385	46	the	the	DT
cord-005453-4057qib7	16385	47	F1	F1	NNP
cord-005453-4057qib7	16385	48	generation	generation	NN
cord-005453-4057qib7	16385	49	of	of	IN
cord-005453-4057qib7	16385	50	129	129	CD
cord-005453-4057qib7	16385	51	/	/	SYM
cord-005453-4057qib7	16385	52	SvEv	SvEv	NNP
cord-005453-4057qib7	16385	53	wildtype	wildtype	JJ
cord-005453-4057qib7	16385	54	mice	mouse	NNS
cord-005453-4057qib7	16385	55	and	and	CC
cord-005453-4057qib7	16385	56	C57BL/6	C57BL/6	NNP
cord-005453-4057qib7	16385	57	mice	mouse	NNS
cord-005453-4057qib7	16385	58	(	(	-LRB-
cord-005453-4057qib7	16385	59	haploidentical	haploidentical	NNP
cord-005453-4057qib7	16385	60	)	)	-RRB-
cord-005453-4057qib7	16385	61	,	,	,
cord-005453-4057qib7	16385	62	or	or	CC
cord-005453-4057qib7	16385	63	from	from	IN
cord-005453-4057qib7	16385	64	C57BL/6	C57BL/6	NNP
cord-005453-4057qib7	16385	65	mice	mouse	NNS
cord-005453-4057qib7	16385	66	(	(	-LRB-
cord-005453-4057qib7	16385	67	allogeneic	allogeneic	NN
cord-005453-4057qib7	16385	68	)	)	-RRB-
cord-005453-4057qib7	16385	69	.	.	.
cord-005453-4057qib7	16386	1	Tracking	tracking	NN
cord-005453-4057qib7	16386	2	of	of	IN
cord-005453-4057qib7	16386	3	GFP	gfp	NN
cord-005453-4057qib7	16386	4	-	-	HYPH
cord-005453-4057qib7	16386	5	positive	positive	JJ
cord-005453-4057qib7	16386	6	donor	donor	NN
cord-005453-4057qib7	16386	7	derived	derive	VBN
cord-005453-4057qib7	16386	8	cells	cell	NNS
cord-005453-4057qib7	16386	9	was	be	VBD
cord-005453-4057qib7	16386	10	performed	perform	VBN
cord-005453-4057qib7	16386	11	using	use	VBG
cord-005453-4057qib7	16386	12	flow	flow	NN
cord-005453-4057qib7	16386	13	cytometry	cytometry	NN
cord-005453-4057qib7	16386	14	and	and	CC
cord-005453-4057qib7	16386	15	Atm	Atm	NNP
cord-005453-4057qib7	16386	16	PCR	PCR	NNP
cord-005453-4057qib7	16386	17	.	.	.
cord-005453-4057qib7	16387	1	Oxidative	oxidative	JJ
cord-005453-4057qib7	16387	2	stress	stress	NN
cord-005453-4057qib7	16387	3	and	and	CC
cord-005453-4057qib7	16387	4	damage	damage	NN
cord-005453-4057qib7	16387	5	were	be	VBD
cord-005453-4057qib7	16387	6	detected	detect	VBN
cord-005453-4057qib7	16387	7	by	by	IN
cord-005453-4057qib7	16387	8	a	a	DT
cord-005453-4057qib7	16387	9	RT	RT	NNP
cord-005453-4057qib7	16387	10	Profiler	profiler	NN
cord-005453-4057qib7	16387	11	PCR	PCR	NNP
cord-005453-4057qib7	16387	12	Array	Array	NNP
cord-005453-4057qib7	16387	13	and	and	CC
cord-005453-4057qib7	16387	14	8-Hydroxy-2′deoxyguanosine	8-hydroxy-2′deoxyguanosine	CD
cord-005453-4057qib7	16387	15	.	.	.
cord-005453-4057qib7	16388	1	Results	result	NNS
cord-005453-4057qib7	16388	2	:	:	:
cord-005453-4057qib7	16389	1	MLR	MLR	NNP
cord-005453-4057qib7	16389	2	resulted	result	VBD
cord-005453-4057qib7	16389	3	in	in	IN
cord-005453-4057qib7	16389	4	an	an	DT
cord-005453-4057qib7	16389	5	increased	increase	VBN
cord-005453-4057qib7	16389	6	proliferation	proliferation	NN
cord-005453-4057qib7	16389	7	of	of	IN
cord-005453-4057qib7	16389	8	allogeneic	allogeneic	NN
cord-005453-4057qib7	16389	9	donor	donor	NN
cord-005453-4057qib7	16389	10	T	t	NN
cord-005453-4057qib7	16389	11	cells	cell	NNS
cord-005453-4057qib7	16389	12	compared	compare	VBN
cord-005453-4057qib7	16389	13	to	to	IN
cord-005453-4057qib7	16389	14	syngeneic	syngeneic	NNS
cord-005453-4057qib7	16389	15	and	and	CC
cord-005453-4057qib7	16389	16	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16389	17	donor	donor	NN
cord-005453-4057qib7	16389	18	cells	cell	NNS
cord-005453-4057qib7	16389	19	.	.	.
cord-005453-4057qib7	16390	1	Response	response	NN
cord-005453-4057qib7	16390	2	was	be	VBD
cord-005453-4057qib7	16390	3	lower	low	JJR
cord-005453-4057qib7	16390	4	on	on	IN
cord-005453-4057qib7	16390	5	dendritic	dendritic	JJ
cord-005453-4057qib7	16390	6	cells	cell	NNS
cord-005453-4057qib7	16390	7	isolated	isolate	VBN
cord-005453-4057qib7	16390	8	from	from	IN
cord-005453-4057qib7	16390	9	Atm	atm	NN
cord-005453-4057qib7	16390	10	-	-	HYPH
cord-005453-4057qib7	16390	11	deficient	deficient	JJ
cord-005453-4057qib7	16390	12	mice	mouse	NNS
cord-005453-4057qib7	16390	13	compared	compare	VBN
cord-005453-4057qib7	16390	14	to	to	IN
cord-005453-4057qib7	16390	15	wildtype	wildtype	JJ
cord-005453-4057qib7	16390	16	controls	control	NNS
cord-005453-4057qib7	16390	17	.	.	.
cord-005453-4057qib7	16391	1	In	in	IN
cord-005453-4057qib7	16391	2	vivo	vivo	NN
cord-005453-4057qib7	16391	3	results	result	NNS
cord-005453-4057qib7	16391	4	showed	show	VBD
cord-005453-4057qib7	16391	5	the	the	DT
cord-005453-4057qib7	16391	6	restoration	restoration	NN
cord-005453-4057qib7	16391	7	of	of	IN
cord-005453-4057qib7	16391	8	T	T	NNP
cord-005453-4057qib7	16391	9	cells	cell	NNS
cord-005453-4057qib7	16391	10	in	in	IN
cord-005453-4057qib7	16391	11	Atm	atm	NN
cord-005453-4057qib7	16391	12	-	-	HYPH
cord-005453-4057qib7	16391	13	deficient	deficient	JJ
cord-005453-4057qib7	16391	14	mice	mouse	NNS
cord-005453-4057qib7	16391	15	accompanied	accompany	VBN
cord-005453-4057qib7	16391	16	by	by	IN
cord-005453-4057qib7	16391	17	a	a	DT
cord-005453-4057qib7	16391	18	prolonged	prolonged	JJ
cord-005453-4057qib7	16391	19	life	life	NN
cord-005453-4057qib7	16391	20	span	span	NN
cord-005453-4057qib7	16391	21	and	and	CC
cord-005453-4057qib7	16391	22	through	through	IN
cord-005453-4057qib7	16391	23	reduction	reduction	NN
cord-005453-4057qib7	16391	24	of	of	IN
cord-005453-4057qib7	16391	25	thymic	thymic	JJ
cord-005453-4057qib7	16391	26	tumors	tumor	NNS
cord-005453-4057qib7	16391	27	.	.	.
cord-005453-4057qib7	16392	1	However	however	RB
cord-005453-4057qib7	16392	2	,	,	,
cord-005453-4057qib7	16392	3	allogeneic	allogeneic	IN
cord-005453-4057qib7	16392	4	stem	stem	NN
cord-005453-4057qib7	16392	5	cell	cell	NN
cord-005453-4057qib7	16392	6	transplantation	transplantation	NN
cord-005453-4057qib7	16392	7	was	be	VBD
cord-005453-4057qib7	16392	8	accompanied	accompany	VBN
cord-005453-4057qib7	16392	9	with	with	IN
cord-005453-4057qib7	16392	10	a	a	DT
cord-005453-4057qib7	16392	11	higher	high	JJR
cord-005453-4057qib7	16392	12	mortality	mortality	NN
cord-005453-4057qib7	16392	13	rate	rate	NN
cord-005453-4057qib7	16392	14	,	,	,
cord-005453-4057qib7	16392	15	compared	compare	VBN
cord-005453-4057qib7	16392	16	to	to	IN
cord-005453-4057qib7	16392	17	the	the	DT
cord-005453-4057qib7	16392	18	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16392	19	and	and	CC
cord-005453-4057qib7	16392	20	syngeneic	syngeneic	NNS
cord-005453-4057qib7	16392	21	setting	setting	NN
cord-005453-4057qib7	16392	22	.	.	.
cord-005453-4057qib7	16393	1	Decreased	decrease	VBN
cord-005453-4057qib7	16394	1	antioxidative	antioxidative	JJ
cord-005453-4057qib7	16394	2	capacity	capacity	NN
cord-005453-4057qib7	16394	3	and	and	CC
cord-005453-4057qib7	16394	4	a	a	DT
cord-005453-4057qib7	16394	5	higher	high	JJR
cord-005453-4057qib7	16394	6	DNA	dna	NN
cord-005453-4057qib7	16394	7	-	-	HYPH
cord-005453-4057qib7	16394	8	damage	damage	NN
cord-005453-4057qib7	16394	9	were	be	VBD
cord-005453-4057qib7	16394	10	seen	see	VBN
cord-005453-4057qib7	16394	11	in	in	IN
cord-005453-4057qib7	16394	12	CP	CP	NNP
cord-005453-4057qib7	16394	13	treated	treat	VBN
cord-005453-4057qib7	16394	14	Atmdeficient	Atmdeficient	NNP
cord-005453-4057qib7	16394	15	mice	mouse	NNS
cord-005453-4057qib7	16394	16	.	.	.
cord-005453-4057qib7	16395	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16395	2	:	:	:
cord-005453-4057qib7	16396	1	Haploidentical	Haploidentical	NNP
cord-005453-4057qib7	16396	2	HSCT	HSCT	NNP
cord-005453-4057qib7	16396	3	seems	seem	VBZ
cord-005453-4057qib7	16396	4	to	to	TO
cord-005453-4057qib7	16396	5	be	be	VB
cord-005453-4057qib7	16396	6	a	a	DT
cord-005453-4057qib7	16396	7	feasible	feasible	JJ
cord-005453-4057qib7	16396	8	strategy	strategy	NN
cord-005453-4057qib7	16396	9	for	for	IN
cord-005453-4057qib7	16396	10	A	a	NN
cord-005453-4057qib7	16396	11	-	-	HYPH
cord-005453-4057qib7	16396	12	T.	t.	NN
cord-005453-4057qib7	16397	1	Our	-PRON-	PRP$
cord-005453-4057qib7	16397	2	data	datum	NNS
cord-005453-4057qib7	16397	3	provided	provide	VBD
cord-005453-4057qib7	16397	4	further	further	JJ
cord-005453-4057qib7	16397	5	evidence	evidence	NN
cord-005453-4057qib7	16397	6	for	for	IN
cord-005453-4057qib7	16397	7	the	the	DT
cord-005453-4057qib7	16397	8	high	high	JJ
cord-005453-4057qib7	16397	9	sensitivity	sensitivity	NN
cord-005453-4057qib7	16397	10	against	against	IN
cord-005453-4057qib7	16397	11	ROS	ROS	NNP
cord-005453-4057qib7	16397	12	-	-	HYPH
cord-005453-4057qib7	16397	13	inducing	induce	VBG
cord-005453-4057qib7	16397	14	agents	agent	NNS
cord-005453-4057qib7	16397	15	in	in	IN
cord-005453-4057qib7	16397	16	A	A	NNP
cord-005453-4057qib7	16397	17	-	-	HYPH
cord-005453-4057qib7	16397	18	T	t	NN
cord-005453-4057qib7	16397	19	and	and	CC
cord-005453-4057qib7	16397	20	this	this	DT
cord-005453-4057qib7	16397	21	fact	fact	NN
cord-005453-4057qib7	16397	22	needs	need	VBZ
cord-005453-4057qib7	16397	23	to	to	TO
cord-005453-4057qib7	16397	24	be	be	VB
cord-005453-4057qib7	16397	25	taken	take	VBN
cord-005453-4057qib7	16397	26	into	into	IN
cord-005453-4057qib7	16397	27	consideration	consideration	NN
cord-005453-4057qib7	16397	28	in	in	IN
cord-005453-4057qib7	16397	29	the	the	DT
cord-005453-4057qib7	16397	30	choice	choice	NN
cord-005453-4057qib7	16397	31	of	of	IN
cord-005453-4057qib7	16397	32	the	the	DT
cord-005453-4057qib7	16397	33	host	host	NN
cord-005453-4057qib7	16397	34	-	-	HYPH
cord-005453-4057qib7	16397	35	conditioning	conditioning	NN
cord-005453-4057qib7	16397	36	strategy	strategy	NN
cord-005453-4057qib7	16397	37	.	.	.
cord-005453-4057qib7	16398	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16398	2	:	:	:
cord-005453-4057qib7	16398	3	Nothing	nothing	NN
cord-005453-4057qib7	16398	4	to	to	TO
cord-005453-4057qib7	16398	5	declare	declare	VB
cord-005453-4057qib7	16398	6	This	this	DT
cord-005453-4057qib7	16398	7	research	research	NN
cord-005453-4057qib7	16398	8	received	receive	VBD
cord-005453-4057qib7	16398	9	funding	funding	NN
cord-005453-4057qib7	16398	10	from	from	IN
cord-005453-4057qib7	16398	11	Action	Action	NNP
cord-005453-4057qib7	16398	12	for	for	IN
cord-005453-4057qib7	16398	13	A	A	NNP
cord-005453-4057qib7	16398	14	-	-	HYPH
cord-005453-4057qib7	16398	15	T	T	NNP
cord-005453-4057qib7	16398	16	Charity	Charity	NNP
cord-005453-4057qib7	16398	17	(	(	-LRB-
cord-005453-4057qib7	16398	18	14GOU01	14gou01	CD
cord-005453-4057qib7	16398	19	)	)	-RRB-
cord-005453-4057qib7	16399	1	Background	background	NN
cord-005453-4057qib7	16399	2	:	:	:
cord-005453-4057qib7	16399	3	Prognosis	prognosis	NN
cord-005453-4057qib7	16399	4	of	of	IN
cord-005453-4057qib7	16399	5	pediatric	pediatric	JJ
cord-005453-4057qib7	16399	6	patients	patient	NNS
cord-005453-4057qib7	16399	7	and	and	CC
cord-005453-4057qib7	16399	8	young	young	JJ
cord-005453-4057qib7	16399	9	adults	adult	NNS
cord-005453-4057qib7	16399	10	suffering	suffer	VBG
cord-005453-4057qib7	16399	11	from	from	IN
cord-005453-4057qib7	16399	12	refractory	refractory	JJ
cord-005453-4057qib7	16399	13	or	or	CC
cord-005453-4057qib7	16399	14	high	high	JJ
cord-005453-4057qib7	16399	15	-	-	HYPH
cord-005453-4057qib7	16399	16	risk	risk	NN
cord-005453-4057qib7	16399	17	soft	soft	JJ
cord-005453-4057qib7	16399	18	tissue	tissue	NN
cord-005453-4057qib7	16399	19	sarcomas	sarcoma	NNS
cord-005453-4057qib7	16399	20	remains	remain	VBZ
cord-005453-4057qib7	16399	21	poor	poor	JJ
cord-005453-4057qib7	16399	22	with	with	IN
cord-005453-4057qib7	16399	23	limited	limited	JJ
cord-005453-4057qib7	16399	24	improvement	improvement	NN
cord-005453-4057qib7	16399	25	over	over	IN
cord-005453-4057qib7	16399	26	the	the	DT
cord-005453-4057qib7	16399	27	last	last	JJ
cord-005453-4057qib7	16399	28	decades	decade	NNS
cord-005453-4057qib7	16399	29	despite	despite	IN
cord-005453-4057qib7	16399	30	multimodal	multimodal	JJ
cord-005453-4057qib7	16399	31	treatment	treatment	NN
cord-005453-4057qib7	16399	32	strategies	strategy	NNS
cord-005453-4057qib7	16399	33	.	.	.
cord-005453-4057qib7	16400	1	Replacing	replace	VBG
cord-005453-4057qib7	16400	2	the	the	DT
cord-005453-4057qib7	16400	3	immune	immune	JJ
cord-005453-4057qib7	16400	4	system	system	NN
cord-005453-4057qib7	16400	5	by	by	IN
cord-005453-4057qib7	16400	6	an	an	DT
cord-005453-4057qib7	16400	7	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16400	8	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16400	9	stem	stem	NN
cord-005453-4057qib7	16400	10	cell	cell	NN
cord-005453-4057qib7	16400	11	transplantation	transplantation	NN
cord-005453-4057qib7	16400	12	(	(	-LRB-
cord-005453-4057qib7	16400	13	HSCT	HSCT	NNP
cord-005453-4057qib7	16400	14	)	)	-RRB-
cord-005453-4057qib7	16400	15	in	in	IN
cord-005453-4057qib7	16400	16	refractory	refractory	JJ
cord-005453-4057qib7	16400	17	solid	solid	JJ
cord-005453-4057qib7	16400	18	malignancies	malignancy	NNS
cord-005453-4057qib7	16400	19	has	have	VBZ
cord-005453-4057qib7	16400	20	been	be	VBN
cord-005453-4057qib7	16400	21	proposed	propose	VBN
cord-005453-4057qib7	16400	22	as	as	IN
cord-005453-4057qib7	16400	23	a	a	DT
cord-005453-4057qib7	16400	24	potentially	potentially	RB
cord-005453-4057qib7	16400	25	curative	curative	JJ
cord-005453-4057qib7	16400	26	therapy	therapy	NN
cord-005453-4057qib7	16400	27	due	due	IN
cord-005453-4057qib7	16400	28	to	to	IN
cord-005453-4057qib7	16400	29	its	-PRON-	PRP$
cord-005453-4057qib7	16400	30	presumable	presumable	JJ
cord-005453-4057qib7	16400	31	graft	graft	NN
cord-005453-4057qib7	16400	32	versus	versus	IN
cord-005453-4057qib7	16400	33	tumor	tumor	NN
cord-005453-4057qib7	16400	34	effect	effect	NN
cord-005453-4057qib7	16400	35	.	.	.
cord-005453-4057qib7	16401	1	Based	base	VBN
cord-005453-4057qib7	16401	2	on	on	IN
cord-005453-4057qib7	16401	3	this	this	DT
cord-005453-4057qib7	16401	4	concept	concept	NN
cord-005453-4057qib7	16401	5	we	-PRON-	PRP
cord-005453-4057qib7	16401	6	additionally	additionally	RB
cord-005453-4057qib7	16401	7	performed	perform	VBD
cord-005453-4057qib7	16401	8	consecutive	consecutive	JJ
cord-005453-4057qib7	16401	9	donor	donor	NN
cord-005453-4057qib7	16401	10	-	-	HYPH
cord-005453-4057qib7	16401	11	derived	derive	VBN
cord-005453-4057qib7	16401	12	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	16401	13	infusions	infusion	NNS
cord-005453-4057qib7	16401	14	in	in	IN
cord-005453-4057qib7	16401	15	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16401	16	HSCT	hsct	NN
cord-005453-4057qib7	16401	17	-	-	HYPH
cord-005453-4057qib7	16401	18	patients	patient	NNS
cord-005453-4057qib7	16401	19	with	with	IN
cord-005453-4057qib7	16401	20	refractory	refractory	JJ
cord-005453-4057qib7	16401	21	or	or	CC
cord-005453-4057qib7	16401	22	relapsed	relapse	VBN
cord-005453-4057qib7	16401	23	solid	solid	JJ
cord-005453-4057qib7	16401	24	malignancy	malignancy	NN
cord-005453-4057qib7	16401	25	to	to	TO
cord-005453-4057qib7	16401	26	further	further	RB
cord-005453-4057qib7	16401	27	increase	increase	VB
cord-005453-4057qib7	16401	28	anti	anti	JJ
cord-005453-4057qib7	16401	29	-	-	JJ
cord-005453-4057qib7	16401	30	tumor	tumor	JJ
cord-005453-4057qib7	16401	31	efficacy	efficacy	NN
cord-005453-4057qib7	16401	32	post	post	NN
cord-005453-4057qib7	16401	33	-	-	NN
cord-005453-4057qib7	16401	34	transplant	transplant	NN
cord-005453-4057qib7	16401	35	.	.	.
cord-005453-4057qib7	16402	1	Methods	method	NNS
cord-005453-4057qib7	16402	2	:	:	:
cord-005453-4057qib7	16402	3	Pediatric	pediatric	JJ
cord-005453-4057qib7	16402	4	patients	patient	NNS
cord-005453-4057qib7	16402	5	with	with	IN
cord-005453-4057qib7	16402	6	relapsed	relapse	VBN
cord-005453-4057qib7	16402	7	and/or	and/or	CC
cord-005453-4057qib7	16402	8	refractory	refractory	JJ
cord-005453-4057qib7	16402	9	cancers	cancer	NNS
cord-005453-4057qib7	16402	10	or	or	CC
cord-005453-4057qib7	16402	11	with	with	IN
cord-005453-4057qib7	16402	12	delayed	delay	VBN
cord-005453-4057qib7	16402	13	responses	response	NNS
cord-005453-4057qib7	16402	14	to	to	IN
cord-005453-4057qib7	16402	15	the	the	DT
cord-005453-4057qib7	16402	16	respective	respective	JJ
cord-005453-4057qib7	16402	17	induction	induction	NN
cord-005453-4057qib7	16402	18	therapies	therapy	NNS
cord-005453-4057qib7	16402	19	were	be	VBD
cord-005453-4057qib7	16402	20	offered	offer	VBN
cord-005453-4057qib7	16402	21	donorderived	donorderived	JJ
cord-005453-4057qib7	16402	22	cellular	cellular	JJ
cord-005453-4057qib7	16402	23	therapies	therapy	NNS
cord-005453-4057qib7	16402	24	after	after	IN
cord-005453-4057qib7	16402	25	immune	immune	JJ
cord-005453-4057qib7	16402	26	system	system	NN
cord-005453-4057qib7	16402	27	replacement	replacement	NN
cord-005453-4057qib7	16402	28	by	by	IN
cord-005453-4057qib7	16402	29	an	an	DT
cord-005453-4057qib7	16402	30	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16402	31	HSCT	HSCT	NNP
cord-005453-4057qib7	16402	32	.	.	.
cord-005453-4057qib7	16403	1	Cellular	cellular	JJ
cord-005453-4057qib7	16403	2	immunotherapies	immunotherapy	NNS
cord-005453-4057qib7	16403	3	comprised	comprise	VBN
cord-005453-4057qib7	16403	4	of	of	IN
cord-005453-4057qib7	16403	5	donor	donor	NN
cord-005453-4057qib7	16403	6	lymphocyte	lymphocyte	NN
cord-005453-4057qib7	16403	7	infusions	infusion	NNS
cord-005453-4057qib7	16403	8	(	(	-LRB-
cord-005453-4057qib7	16403	9	DLI	DLI	NNP
cord-005453-4057qib7	16403	10	)	)	-RRB-
cord-005453-4057qib7	16403	11	,	,	,
cord-005453-4057qib7	16403	12	natural	natural	JJ
cord-005453-4057qib7	16403	13	killer	killer	NN
cord-005453-4057qib7	16403	14	(	(	-LRB-
cord-005453-4057qib7	16403	15	NK	NK	NNP
cord-005453-4057qib7	16403	16	)	)	-RRB-
cord-005453-4057qib7	16403	17	cell	cell	NN
cord-005453-4057qib7	16403	18	or	or	CC
cord-005453-4057qib7	16403	19	cytokine	cytokine	NN
cord-005453-4057qib7	16403	20	-	-	HYPH
cord-005453-4057qib7	16403	21	induced	induce	VBN
cord-005453-4057qib7	16403	22	killer	killer	NN
cord-005453-4057qib7	16403	23	(	(	-LRB-
cord-005453-4057qib7	16403	24	CIK	CIK	NNP
cord-005453-4057qib7	16403	25	)	)	-RRB-
cord-005453-4057qib7	16403	26	cell	cell	NN
cord-005453-4057qib7	16403	27	infusions	infusion	NNS
cord-005453-4057qib7	16403	28	generated	generate	VBN
cord-005453-4057qib7	16403	29	from	from	IN
cord-005453-4057qib7	16403	30	the	the	DT
cord-005453-4057qib7	16403	31	original	original	JJ
cord-005453-4057qib7	16403	32	stem	stem	NN
cord-005453-4057qib7	16403	33	cell	cell	NN
cord-005453-4057qib7	16403	34	donors	donor	NNS
cord-005453-4057qib7	16403	35	.	.	.
cord-005453-4057qib7	16404	1	Allogeneic	Allogeneic	NNP
cord-005453-4057qib7	16404	2	NK	NK	NNP
cord-005453-4057qib7	16404	3	cells	cell	NNS
cord-005453-4057qib7	16404	4	were	be	VBD
cord-005453-4057qib7	16404	5	generated	generate	VBN
cord-005453-4057qib7	16404	6	from	from	IN
cord-005453-4057qib7	16404	7	unstimulated	unstimulated	JJ
cord-005453-4057qib7	16404	8	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	16404	9	by	by	IN
cord-005453-4057qib7	16404	10	a	a	DT
cord-005453-4057qib7	16404	11	two	two	CD
cord-005453-4057qib7	16404	12	-	-	HYPH
cord-005453-4057qib7	16404	13	step	step	NN
cord-005453-4057qib7	16404	14	purification	purification	NN
cord-005453-4057qib7	16404	15	procedure	procedure	NN
cord-005453-4057qib7	16404	16	using	use	VBG
cord-005453-4057qib7	16404	17	immunomagnetic	immunomagnetic	JJ
cord-005453-4057qib7	16404	18	CD3	CD3	NNP
cord-005453-4057qib7	16404	19	T	T	NNP
cord-005453-4057qib7	16404	20	cell	cell	NN
cord-005453-4057qib7	16404	21	depletion	depletion	NN
cord-005453-4057qib7	16404	22	,	,	,
cord-005453-4057qib7	16404	23	followed	follow	VBN
cord-005453-4057qib7	16404	24	by	by	IN
cord-005453-4057qib7	16404	25	NK	NK	NNP
cord-005453-4057qib7	16404	26	cell	cell	NN
cord-005453-4057qib7	16404	27	enrichment	enrichment	NN
cord-005453-4057qib7	16404	28	(	(	-LRB-
cord-005453-4057qib7	16404	29	CD56	CD56	NNP
cord-005453-4057qib7	16404	30	+	+	SYM
cord-005453-4057qib7	16404	31	)	)	-RRB-
cord-005453-4057qib7	16404	32	with	with	IN
cord-005453-4057qib7	16404	33	or	or	CC
cord-005453-4057qib7	16404	34	without	without	IN
cord-005453-4057qib7	16404	35	in	in	IN
cord-005453-4057qib7	16404	36	vitro	vitro	FW
cord-005453-4057qib7	16404	37	IL-2	il-2	NN
cord-005453-4057qib7	16404	38	stimulation	stimulation	NN
cord-005453-4057qib7	16404	39	and	and	CC
cord-005453-4057qib7	16404	40	expansion	expansion	NN
cord-005453-4057qib7	16404	41	for	for	IN
cord-005453-4057qib7	16404	42	9	9	CD
cord-005453-4057qib7	16404	43	-	-	SYM
cord-005453-4057qib7	16404	44	14	14	CD
cord-005453-4057qib7	16404	45	days	day	NNS
cord-005453-4057qib7	16404	46	.	.	.
cord-005453-4057qib7	16405	1	For	for	IN
cord-005453-4057qib7	16405	2	CIK	CIK	NNP
cord-005453-4057qib7	16405	3	cell	cell	NN
cord-005453-4057qib7	16405	4	generation	generation	NN
cord-005453-4057qib7	16405	5	peripheral	peripheral	JJ
cord-005453-4057qib7	16405	6	blood	blood	NN
cord-005453-4057qib7	16405	7	mononuclear	mononuclear	NN
cord-005453-4057qib7	16405	8	cells	cell	NNS
cord-005453-4057qib7	16405	9	were	be	VBD
cord-005453-4057qib7	16405	10	isolated	isolate	VBN
cord-005453-4057qib7	16405	11	and	and	CC
cord-005453-4057qib7	16405	12	activated	activate	VBN
cord-005453-4057qib7	16405	13	by	by	IN
cord-005453-4057qib7	16405	14	in	in	FW
cord-005453-4057qib7	16405	15	vitro	vitro	FW
cord-005453-4057qib7	16405	16	cytokine	cytokine	JJ
cord-005453-4057qib7	16405	17	stimulation	stimulation	NN
cord-005453-4057qib7	16405	18	(	(	-LRB-
cord-005453-4057qib7	16405	19	INF	INF	NNP
cord-005453-4057qib7	16405	20	-	-	HYPH
cord-005453-4057qib7	16405	21	γ	γ	NNP
cord-005453-4057qib7	16405	22	,	,	,
cord-005453-4057qib7	16405	23	anti	anti	NNP
cord-005453-4057qib7	16405	24	-	-	NNP
cord-005453-4057qib7	16405	25	CD3	CD3	NNP
cord-005453-4057qib7	16405	26	,	,	,
cord-005453-4057qib7	16406	1	IL-2	IL-2	NNP
cord-005453-4057qib7	16406	2	and	and	CC
cord-005453-4057qib7	16406	3	IL-15	IL-15	NNP
cord-005453-4057qib7	16406	4	)	)	-RRB-
cord-005453-4057qib7	16406	5	an	an	DT
cord-005453-4057qib7	16406	6	expanded	expand	VBN
cord-005453-4057qib7	16406	7	over	over	IN
cord-005453-4057qib7	16406	8	10	10	CD
cord-005453-4057qib7	16406	9	-	-	SYM
cord-005453-4057qib7	16406	10	12	12	CD
cord-005453-4057qib7	16406	11	days	day	NNS
cord-005453-4057qib7	16406	12	.	.	.
cord-005453-4057qib7	16407	1	Expanded	expand	VBN
cord-005453-4057qib7	16407	2	CIK	CIK	NNP
cord-005453-4057qib7	16407	3	cells	cell	NNS
cord-005453-4057qib7	16407	4	represented	represent	VBD
cord-005453-4057qib7	16407	5	a	a	DT
cord-005453-4057qib7	16407	6	heterogeneous	heterogeneous	JJ
cord-005453-4057qib7	16407	7	population	population	NN
cord-005453-4057qib7	16407	8	of	of	IN
cord-005453-4057qib7	16407	9	polyclonal	polyclonal	JJ
cord-005453-4057qib7	16407	10	T	t	NN
cord-005453-4057qib7	16407	11	cells	cell	NNS
cord-005453-4057qib7	16407	12	with	with	IN
cord-005453-4057qib7	16407	13	in	in	IN
cord-005453-4057qib7	16407	14	part	part	NN
cord-005453-4057qib7	16407	15	shared	share	VBN
cord-005453-4057qib7	16407	16	phenotypic	phenotypic	JJ
cord-005453-4057qib7	16407	17	and	and	CC
cord-005453-4057qib7	16407	18	functional	functional	JJ
cord-005453-4057qib7	16407	19	properties	property	NNS
cord-005453-4057qib7	16407	20	of	of	IN
cord-005453-4057qib7	16407	21	NK	NK	NNP
cord-005453-4057qib7	16407	22	cells	cell	NNS
cord-005453-4057qib7	16407	23	.	.	.
cord-005453-4057qib7	16408	1	Results	result	NNS
cord-005453-4057qib7	16408	2	:	:	:
cord-005453-4057qib7	16409	1	Between	between	IN
cord-005453-4057qib7	16409	2	October	October	NNP
cord-005453-4057qib7	16409	3	1	1	CD
cord-005453-4057qib7	16409	4	st	st	NNP
cord-005453-4057qib7	16409	5	2003	2003	CD
cord-005453-4057qib7	16409	6	and	and	CC
cord-005453-4057qib7	16409	7	January	January	NNP
cord-005453-4057qib7	16409	8	1	1	CD
cord-005453-4057qib7	16409	9	st	st	NNP
cord-005453-4057qib7	16409	10	2014	2014	CD
cord-005453-4057qib7	16409	11	a	a	DT
cord-005453-4057qib7	16409	12	total	total	NN
cord-005453-4057qib7	16409	13	of	of	IN
cord-005453-4057qib7	16409	14	18	18	CD
cord-005453-4057qib7	16409	15	patients	patient	NNS
cord-005453-4057qib7	16409	16	(	(	-LRB-
cord-005453-4057qib7	16409	17	eight	eight	CD
cord-005453-4057qib7	16409	18	patients	patient	NNS
cord-005453-4057qib7	16409	19	with	with	IN
cord-005453-4057qib7	16409	20	rhabdomyosarcoma	rhabdomyosarcoma	NNP
cord-005453-4057qib7	16409	21	,	,	,
cord-005453-4057qib7	16409	22	one	one	CD
cord-005453-4057qib7	16409	23	patient	patient	NN
cord-005453-4057qib7	16409	24	with	with	IN
cord-005453-4057qib7	16409	25	synovial	synovial	JJ
cord-005453-4057qib7	16409	26	sarcoma	sarcoma	NN
cord-005453-4057qib7	16409	27	,	,	,
cord-005453-4057qib7	16409	28	two	two	CD
cord-005453-4057qib7	16409	29	patients	patient	NNS
cord-005453-4057qib7	16409	30	with	with	IN
cord-005453-4057qib7	16409	31	Ewing	Ewing	NNP
cord-005453-4057qib7	16409	32	sarcoma	sarcoma	NN
cord-005453-4057qib7	16409	33	,	,	,
cord-005453-4057qib7	16409	34	five	five	CD
cord-005453-4057qib7	16409	35	patients	patient	NNS
cord-005453-4057qib7	16409	36	with	with	IN
cord-005453-4057qib7	16409	37	neuroblastoma	neuroblastoma	NN
cord-005453-4057qib7	16409	38	,	,	,
cord-005453-4057qib7	16409	39	one	one	CD
cord-005453-4057qib7	16409	40	patient	patient	NN
cord-005453-4057qib7	16409	41	with	with	IN
cord-005453-4057qib7	16409	42	hepatoblastoma	hepatoblastoma	NNP
cord-005453-4057qib7	16409	43	,	,	,
cord-005453-4057qib7	16409	44	and	and	CC
cord-005453-4057qib7	16409	45	one	one	CD
cord-005453-4057qib7	16409	46	patient	patient	NN
cord-005453-4057qib7	16409	47	with	with	IN
cord-005453-4057qib7	16409	48	nasopharynx	nasopharynx	NN
cord-005453-4057qib7	16409	49	carcinoma	carcinoma	NN
cord-005453-4057qib7	16409	50	)	)	-RRB-
cord-005453-4057qib7	16409	51	were	be	VBD
cord-005453-4057qib7	16409	52	enrolled	enrol	VBN
cord-005453-4057qib7	16409	53	.	.	.
cord-005453-4057qib7	16410	1	Seven	seven	CD
cord-005453-4057qib7	16410	2	of	of	IN
cord-005453-4057qib7	16410	3	18	18	CD
cord-005453-4057qib7	16410	4	(	(	-LRB-
cord-005453-4057qib7	16410	5	39	39	CD
cord-005453-4057qib7	16410	6	%	%	NN
cord-005453-4057qib7	16410	7	)	)	-RRB-
cord-005453-4057qib7	16410	8	patients	patient	NNS
cord-005453-4057qib7	16410	9	in	in	IN
cord-005453-4057qib7	16410	10	this	this	DT
cord-005453-4057qib7	16410	11	study	study	NN
cord-005453-4057qib7	16410	12	had	have	VBD
cord-005453-4057qib7	16410	13	achieved	achieve	VBN
cord-005453-4057qib7	16410	14	complete	complete	JJ
cord-005453-4057qib7	16410	15	remission	remission	NN
cord-005453-4057qib7	16410	16	(	(	-LRB-
cord-005453-4057qib7	16410	17	CR	CR	NNP
cord-005453-4057qib7	16410	18	)	)	-RRB-
cord-005453-4057qib7	16410	19	before	before	IN
cord-005453-4057qib7	16410	20	HSCT	HSCT	NNP
cord-005453-4057qib7	16410	21	while	while	IN
cord-005453-4057qib7	16410	22	another	another	DT
cord-005453-4057qib7	16410	23	7	7	CD
cord-005453-4057qib7	16410	24	of	of	IN
cord-005453-4057qib7	16410	25	18	18	CD
cord-005453-4057qib7	16410	26	(	(	-LRB-
cord-005453-4057qib7	16410	27	39	39	CD
cord-005453-4057qib7	16410	28	%	%	NN
cord-005453-4057qib7	16410	29	)	)	-RRB-
cord-005453-4057qib7	16410	30	patients	patient	NNS
cord-005453-4057qib7	16410	31	had	have	VBD
cord-005453-4057qib7	16410	32	obtained	obtain	VBN
cord-005453-4057qib7	16410	33	at	at	IN
cord-005453-4057qib7	16410	34	least	least	JJS
cord-005453-4057qib7	16410	35	very	very	RB
cord-005453-4057qib7	16410	36	good	good	JJ
cord-005453-4057qib7	16410	37	partial	partial	JJ
cord-005453-4057qib7	16410	38	or	or	CC
cord-005453-4057qib7	16410	39	partial	partial	JJ
cord-005453-4057qib7	16410	40	response	response	NN
cord-005453-4057qib7	16410	41	(	(	-LRB-
cord-005453-4057qib7	16410	42	VGPR	VGPR	NNP
cord-005453-4057qib7	16410	43	or	or	CC
cord-005453-4057qib7	16410	44	PR	PR	NNP
cord-005453-4057qib7	16410	45	)	)	-RRB-
cord-005453-4057qib7	16410	46	.	.	.
cord-005453-4057qib7	16411	1	DLI	DLI	NNP
cord-005453-4057qib7	16411	2	was	be	VBD
cord-005453-4057qib7	16411	3	applied	apply	VBN
cord-005453-4057qib7	16411	4	in	in	IN
cord-005453-4057qib7	16411	5	5	5	CD
cord-005453-4057qib7	16411	6	patients	patient	NNS
cord-005453-4057qib7	16411	7	,	,	,
cord-005453-4057qib7	16411	8	NK	NK	NNP
cord-005453-4057qib7	16411	9	cell	cell	NN
cord-005453-4057qib7	16411	10	treatment	treatment	NN
cord-005453-4057qib7	16411	11	was	be	VBD
cord-005453-4057qib7	16411	12	offered	offer	VBN
cord-005453-4057qib7	16411	13	to	to	IN
cord-005453-4057qib7	16411	14	another	another	DT
cord-005453-4057qib7	16411	15	6	6	CD
cord-005453-4057qib7	16411	16	patients	patient	NNS
cord-005453-4057qib7	16411	17	,	,	,
cord-005453-4057qib7	16411	18	while	while	IN
cord-005453-4057qib7	16411	19	CIK	CIK	NNP
cord-005453-4057qib7	16411	20	cell	cell	NN
cord-005453-4057qib7	16411	21	therapy	therapy	NN
cord-005453-4057qib7	16411	22	was	be	VBD
cord-005453-4057qib7	16411	23	given	give	VBN
cord-005453-4057qib7	16411	24	to	to	IN
cord-005453-4057qib7	16411	25	7	7	CD
cord-005453-4057qib7	16411	26	patients.1.5-year	patients.1.5-year	NNP
cord-005453-4057qib7	16411	27	probabilities	probability	NNS
cord-005453-4057qib7	16411	28	of	of	IN
cord-005453-4057qib7	16411	29	overall	overall	JJ
cord-005453-4057qib7	16411	30	survival	survival	NN
cord-005453-4057qib7	16411	31	(	(	-LRB-
cord-005453-4057qib7	16411	32	OS	OS	NNP
cord-005453-4057qib7	16411	33	)	)	-RRB-
cord-005453-4057qib7	16411	34	and	and	CC
cord-005453-4057qib7	16411	35	progression	progression	NN
cord-005453-4057qib7	16411	36	-	-	HYPH
cord-005453-4057qib7	16411	37	free	free	JJ
cord-005453-4057qib7	16411	38	survival	survival	NN
cord-005453-4057qib7	16411	39	(	(	-LRB-
cord-005453-4057qib7	16411	40	PFS	PFS	NNP
cord-005453-4057qib7	16411	41	)	)	-RRB-
cord-005453-4057qib7	16411	42	were	be	VBD
cord-005453-4057qib7	16411	43	16.2	16.2	CD
cord-005453-4057qib7	16411	44	%	%	NN
cord-005453-4057qib7	16411	45	and	and	CC
cord-005453-4057qib7	16411	46	15.9	15.9	CD
cord-005453-4057qib7	16411	47	%	%	NN
cord-005453-4057qib7	16411	48	for	for	IN
cord-005453-4057qib7	16411	49	all	all	DT
cord-005453-4057qib7	16411	50	patients	patient	NNS
cord-005453-4057qib7	16411	51	with	with	IN
cord-005453-4057qib7	16411	52	a	a	DT
cord-005453-4057qib7	16411	53	median	median	NN
cord-005453-4057qib7	16411	54	follow	follow	NN
cord-005453-4057qib7	16411	55	up	up	IN
cord-005453-4057qib7	16411	56	of	of	IN
cord-005453-4057qib7	16411	57	8.5	8.5	CD
cord-005453-4057qib7	16411	58	months	month	NNS
cord-005453-4057qib7	16411	59	(	(	-LRB-
cord-005453-4057qib7	16411	60	range	range	NN
cord-005453-4057qib7	16411	61	,	,	,
cord-005453-4057qib7	16411	62	1.5	1.5	CD
cord-005453-4057qib7	16411	63	-	-	SYM
cord-005453-4057qib7	16411	64	115.1	115.1	CD
cord-005453-4057qib7	16411	65	months	month	NNS
cord-005453-4057qib7	16411	66	)	)	-RRB-
cord-005453-4057qib7	16411	67	.	.	.
cord-005453-4057qib7	16412	1	Patients	patient	NNS
cord-005453-4057qib7	16412	2	in	in	IN
cord-005453-4057qib7	16412	3	CR	CR	NNP
cord-005453-4057qib7	16412	4	at	at	IN
cord-005453-4057qib7	16412	5	the	the	DT
cord-005453-4057qib7	16412	6	time	time	NN
cord-005453-4057qib7	16412	7	of	of	IN
cord-005453-4057qib7	16412	8	immune	immune	JJ
cord-005453-4057qib7	16412	9	cell	cell	NN
cord-005453-4057qib7	16412	10	therapy	therapy	NN
cord-005453-4057qib7	16412	11	(	(	-LRB-
cord-005453-4057qib7	16412	12	IT	it	NN
cord-005453-4057qib7	16412	13	)	)	-RRB-
cord-005453-4057qib7	16412	14	showed	show	VBD
cord-005453-4057qib7	16412	15	estimated	estimate	VBN
cord-005453-4057qib7	16412	16	1.5-year	1.5-year	CD
cord-005453-4057qib7	16412	17	OS	OS	NNP
cord-005453-4057qib7	16412	18	and	and	CC
cord-005453-4057qib7	16412	19	PFS	PFS	NNP
cord-005453-4057qib7	16412	20	of	of	IN
cord-005453-4057qib7	16412	21	49.6	49.6	CD
cord-005453-4057qib7	16412	22	%	%	NN
cord-005453-4057qib7	16412	23	and	and	CC
cord-005453-4057qib7	16412	24	42.7	42.7	CD
cord-005453-4057qib7	16412	25	%	%	NN
cord-005453-4057qib7	16412	26	,	,	,
cord-005453-4057qib7	16412	27	respectively	respectively	RB
cord-005453-4057qib7	16412	28	.	.	.
cord-005453-4057qib7	16413	1	The	the	DT
cord-005453-4057qib7	16413	2	majority	majority	NN
cord-005453-4057qib7	16413	3	of	of	IN
cord-005453-4057qib7	16413	4	patients	patient	NNS
cord-005453-4057qib7	16413	5	relapsed	relapse	VBN
cord-005453-4057qib7	16413	6	and	and	CC
cord-005453-4057qib7	16413	7	ultimately	ultimately	RB
cord-005453-4057qib7	16413	8	succumbed	succumb	VBD
cord-005453-4057qib7	16413	9	to	to	IN
cord-005453-4057qib7	16413	10	their	-PRON-	PRP$
cord-005453-4057qib7	16413	11	diseases	disease	NNS
cord-005453-4057qib7	16413	12	with	with	IN
cord-005453-4057qib7	16413	13	two	two	CD
cord-005453-4057qib7	16413	14	of	of	IN
cord-005453-4057qib7	16413	15	18	18	CD
cord-005453-4057qib7	16413	16	(	(	-LRB-
cord-005453-4057qib7	16413	17	11	11	CD
cord-005453-4057qib7	16413	18	%	%	NN
cord-005453-4057qib7	16413	19	)	)	-RRB-
cord-005453-4057qib7	16413	20	patients	patient	NNS
cord-005453-4057qib7	16413	21	still	still	RB
cord-005453-4057qib7	16413	22	being	be	VBG
cord-005453-4057qib7	16413	23	alive	alive	JJ
cord-005453-4057qib7	16413	24	9.6	9.6	CD
cord-005453-4057qib7	16413	25	and	and	CC
cord-005453-4057qib7	16413	26	9.3	9.3	CD
cord-005453-4057qib7	16413	27	years	year	NNS
cord-005453-4057qib7	16413	28	after	after	IN
cord-005453-4057qib7	16413	29	IT	it	PRP
cord-005453-4057qib7	16413	30	.	.	.
cord-005453-4057qib7	16414	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	16414	2	incidence	incidence	NN
cord-005453-4057qib7	16414	3	of	of	IN
cord-005453-4057qib7	16414	4	relapse	relapse	NN
cord-005453-4057qib7	16414	5	was	be	VBD
cord-005453-4057qib7	16414	6	79.8	79.8	CD
cord-005453-4057qib7	16414	7	%	%	NN
cord-005453-4057qib7	16414	8	at	at	IN
cord-005453-4057qib7	16414	9	1.5	1.5	CD
cord-005453-4057qib7	16414	10	years	year	NNS
cord-005453-4057qib7	16414	11	.	.	.
cord-005453-4057qib7	16415	1	T	T	NNP
cord-005453-4057qib7	16415	2	cell	cell	NN
cord-005453-4057qib7	16415	3	engraftment	engraftment	NN
cord-005453-4057qib7	16415	4	and	and	CC
cord-005453-4057qib7	16415	5	immune	immune	JJ
cord-005453-4057qib7	16415	6	reconstitution	reconstitution	NN
cord-005453-4057qib7	16415	7	(	(	-LRB-
cord-005453-4057qib7	16415	8	IR	IR	NNP
cord-005453-4057qib7	16415	9	)	)	-RRB-
cord-005453-4057qib7	16415	10	was	be	VBD
cord-005453-4057qib7	16415	11	improved	improve	VBN
cord-005453-4057qib7	16415	12	by	by	IN
cord-005453-4057qib7	16415	13	IT	IT	NNP
cord-005453-4057qib7	16415	14	,	,	,
cord-005453-4057qib7	16415	15	and	and	CC
cord-005453-4057qib7	16415	16	correlated	correlate	VBN
cord-005453-4057qib7	16415	17	with	with	IN
cord-005453-4057qib7	16415	18	treatment	treatment	NN
cord-005453-4057qib7	16415	19	response	response	NN
cord-005453-4057qib7	16415	20	.	.	.
cord-005453-4057qib7	16416	1	However	however	RB
cord-005453-4057qib7	16416	2	,	,	,
cord-005453-4057qib7	16416	3	two	two	CD
cord-005453-4057qib7	16416	4	of	of	IN
cord-005453-4057qib7	16416	5	18	18	CD
cord-005453-4057qib7	16416	6	heavily	heavily	RB
cord-005453-4057qib7	16416	7	pretreated	pretreate	VBN
cord-005453-4057qib7	16416	8	patients	patient	NNS
cord-005453-4057qib7	16416	9	(	(	-LRB-
cord-005453-4057qib7	16416	10	11	11	CD
cord-005453-4057qib7	16416	11	%	%	NN
cord-005453-4057qib7	16416	12	)	)	-RRB-
cord-005453-4057qib7	16416	13	died	die	VBD
cord-005453-4057qib7	16416	14	due	due	IN
cord-005453-4057qib7	16416	15	to	to	IN
cord-005453-4057qib7	16416	16	cumulative	cumulative	JJ
cord-005453-4057qib7	16416	17	treatment	treatment	NN
cord-005453-4057qib7	16416	18	-	-	HYPH
cord-005453-4057qib7	16416	19	related	relate	VBN
cord-005453-4057qib7	16416	20	mortality	mortality	NN
cord-005453-4057qib7	16416	21	(	(	-LRB-
cord-005453-4057qib7	16416	22	TRM	TRM	NNP
cord-005453-4057qib7	16416	23	)	)	-RRB-
cord-005453-4057qib7	16416	24	.	.	.
cord-005453-4057qib7	16417	1	Furthermore	furthermore	RB
cord-005453-4057qib7	16417	2	,	,	,
cord-005453-4057qib7	16417	3	acute	acute	JJ
cord-005453-4057qib7	16417	4	graft	graft	NN
cord-005453-4057qib7	16417	5	-	-	HYPH
cord-005453-4057qib7	16417	6	versus	versus	IN
cord-005453-4057qib7	16417	7	-	-	HYPH
cord-005453-4057qib7	16417	8	host	host	NN
cord-005453-4057qib7	16417	9	-	-	HYPH
cord-005453-4057qib7	16417	10	disease	disease	NN
cord-005453-4057qib7	16417	11	(	(	-LRB-
cord-005453-4057qib7	16417	12	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16417	13	)	)	-RRB-
cord-005453-4057qib7	16417	14	occurred	occur	VBD
cord-005453-4057qib7	16417	15	in	in	IN
cord-005453-4057qib7	16417	16	9	9	CD
cord-005453-4057qib7	16417	17	of	of	IN
cord-005453-4057qib7	16417	18	18	18	CD
cord-005453-4057qib7	16417	19	patients	patient	NNS
cord-005453-4057qib7	16417	20	(	(	-LRB-
cord-005453-4057qib7	16417	21	50	50	CD
cord-005453-4057qib7	16417	22	%	%	NN
cord-005453-4057qib7	16417	23	)	)	-RRB-
cord-005453-4057qib7	16417	24	with	with	IN
cord-005453-4057qib7	16417	25	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16417	26	grade	grade	NN
cord-005453-4057qib7	16417	27	I	I	NNP
cord-005453-4057qib7	16417	28	-	-	HYPH
cord-005453-4057qib7	16417	29	II	II	NNP
cord-005453-4057qib7	16417	30	observed	observe	VBD
cord-005453-4057qib7	16417	31	in	in	IN
cord-005453-4057qib7	16417	32	6	6	CD
cord-005453-4057qib7	16417	33	(	(	-LRB-
cord-005453-4057qib7	16417	34	33	33	CD
cord-005453-4057qib7	16417	35	%	%	NN
cord-005453-4057qib7	16417	36	)	)	-RRB-
cord-005453-4057qib7	16417	37	and	and	CC
cord-005453-4057qib7	16417	38	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16417	39	grade	grade	NN
cord-005453-4057qib7	16417	40	III	III	NNP
cord-005453-4057qib7	16417	41	seen	see	VBN
cord-005453-4057qib7	16417	42	in	in	IN
cord-005453-4057qib7	16417	43	three	three	CD
cord-005453-4057qib7	16417	44	(	(	-LRB-
cord-005453-4057qib7	16417	45	17	17	CD
cord-005453-4057qib7	16417	46	%	%	NN
cord-005453-4057qib7	16417	47	)	)	-RRB-
cord-005453-4057qib7	16417	48	patients	patient	NNS
cord-005453-4057qib7	16417	49	.	.	.
cord-005453-4057qib7	16418	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16418	2	:	:	:
cord-005453-4057qib7	16419	1	Altogether	altogether	RB
cord-005453-4057qib7	16419	2	,	,	,
cord-005453-4057qib7	16419	3	the	the	DT
cord-005453-4057qib7	16419	4	results	result	NNS
cord-005453-4057qib7	16419	5	of	of	IN
cord-005453-4057qib7	16419	6	this	this	DT
cord-005453-4057qib7	16419	7	study	study	NN
cord-005453-4057qib7	16419	8	indicate	indicate	VBP
cord-005453-4057qib7	16419	9	that	that	IN
cord-005453-4057qib7	16419	10	allogeneic	allogeneic	NN
cord-005453-4057qib7	16419	11	donor	donor	NN
cord-005453-4057qib7	16419	12	-	-	HYPH
cord-005453-4057qib7	16419	13	derived	derive	VBN
cord-005453-4057qib7	16419	14	cellular	cellular	JJ
cord-005453-4057qib7	16419	15	therapy	therapy	NN
cord-005453-4057qib7	16419	16	at	at	IN
cord-005453-4057qib7	16419	17	its	-PRON-	PRP$
cord-005453-4057qib7	16419	18	current	current	JJ
cord-005453-4057qib7	16419	19	state	state	NN
cord-005453-4057qib7	16419	20	offers	offer	VBZ
cord-005453-4057qib7	16419	21	curative	curative	JJ
cord-005453-4057qib7	16419	22	benefit	benefit	NN
cord-005453-4057qib7	16419	23	in	in	IN
cord-005453-4057qib7	16419	24	selected	select	VBN
cord-005453-4057qib7	16419	25	refractory	refractory	JJ
cord-005453-4057qib7	16419	26	childhood	childhood	NN
cord-005453-4057qib7	16419	27	cancers	cancer	NNS
cord-005453-4057qib7	16419	28	but	but	CC
cord-005453-4057qib7	16419	29	warrants	warrant	NNS
cord-005453-4057qib7	16419	30	further	further	JJ
cord-005453-4057qib7	16419	31	improvement	improvement	NN
cord-005453-4057qib7	16419	32	.	.	.
cord-005453-4057qib7	16420	1	Background	background	NN
cord-005453-4057qib7	16420	2	:	:	:
cord-005453-4057qib7	16421	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	16421	2	stem	stem	VBP
cord-005453-4057qib7	16421	3	cell	cell	NN
cord-005453-4057qib7	16421	4	transplantation	transplantation	NN
cord-005453-4057qib7	16421	5	(	(	-LRB-
cord-005453-4057qib7	16421	6	allo	allo	FW
cord-005453-4057qib7	16421	7	-	-	HYPH
cord-005453-4057qib7	16421	8	SCT	SCT	NNP
cord-005453-4057qib7	16421	9	)	)	-RRB-
cord-005453-4057qib7	16421	10	is	be	VBZ
cord-005453-4057qib7	16421	11	the	the	DT
cord-005453-4057qib7	16421	12	only	only	JJ
cord-005453-4057qib7	16421	13	curative	curative	JJ
cord-005453-4057qib7	16421	14	treatment	treatment	NN
cord-005453-4057qib7	16421	15	option	option	NN
cord-005453-4057qib7	16421	16	for	for	IN
cord-005453-4057qib7	16421	17	a	a	DT
cord-005453-4057qib7	16421	18	variety	variety	NN
cord-005453-4057qib7	16421	19	of	of	IN
cord-005453-4057qib7	16421	20	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	16421	21	diseases	disease	NNS
cord-005453-4057qib7	16421	22	.	.	.
cord-005453-4057qib7	16422	1	The	the	DT
cord-005453-4057qib7	16422	2	success	success	NN
cord-005453-4057qib7	16422	3	of	of	IN
cord-005453-4057qib7	16422	4	allo	allo	NN
cord-005453-4057qib7	16422	5	-	-	HYPH
cord-005453-4057qib7	16422	6	SCT	SCT	NNP
cord-005453-4057qib7	16422	7	is	be	VBZ
cord-005453-4057qib7	16422	8	strongly	strongly	RB
cord-005453-4057qib7	16422	9	associated	associate	VBN
cord-005453-4057qib7	16422	10	with	with	IN
cord-005453-4057qib7	16422	11	rapid	rapid	JJ
cord-005453-4057qib7	16422	12	and	and	CC
cord-005453-4057qib7	16422	13	sustained	sustained	JJ
cord-005453-4057qib7	16422	14	immune	immune	JJ
cord-005453-4057qib7	16422	15	reconstitution	reconstitution	NN
cord-005453-4057qib7	16422	16	(	(	-LRB-
cord-005453-4057qib7	16422	17	IR	IR	NNP
cord-005453-4057qib7	16422	18	)	)	-RRB-
cord-005453-4057qib7	16422	19	.	.	.
cord-005453-4057qib7	16423	1	We	-PRON-	PRP
cord-005453-4057qib7	16423	2	analyzed	analyze	VBD
cord-005453-4057qib7	16423	3	the	the	DT
cord-005453-4057qib7	16423	4	IR	IR	NNP
cord-005453-4057qib7	16423	5	in	in	IN
cord-005453-4057qib7	16423	6	patients	patient	NNS
cord-005453-4057qib7	16423	7	who	who	WP
cord-005453-4057qib7	16423	8	received	receive	VBD
cord-005453-4057qib7	16423	9	an	an	DT
cord-005453-4057qib7	16423	10	allo	allo	NN
cord-005453-4057qib7	16423	11	-	-	HYPH
cord-005453-4057qib7	16423	12	SCT	SCT	NNP
cord-005453-4057qib7	16423	13	for	for	IN
cord-005453-4057qib7	16423	14	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	16423	15	diseases	disease	NNS
cord-005453-4057qib7	16423	16	.	.	.
cord-005453-4057qib7	16424	1	IR	IR	NNP
cord-005453-4057qib7	16424	2	was	be	VBD
cord-005453-4057qib7	16424	3	assessed	assess	VBN
cord-005453-4057qib7	16424	4	on	on	IN
cord-005453-4057qib7	16424	5	days	day	NNS
cord-005453-4057qib7	16424	6	+30	+30	CD
cord-005453-4057qib7	16424	7	,	,	,
cord-005453-4057qib7	16424	8	+60	+60	NNP
cord-005453-4057qib7	16424	9	,	,	,
cord-005453-4057qib7	16424	10	+90	+90	CD
cord-005453-4057qib7	16424	11	,	,	,
cord-005453-4057qib7	16424	12	+180	+180	NNP
cord-005453-4057qib7	16424	13	and	and	CC
cord-005453-4057qib7	16424	14	+365	+365	NNP
cord-005453-4057qib7	16424	15	after	after	IN
cord-005453-4057qib7	16424	16	allo	allo	NN
cord-005453-4057qib7	16424	17	-	-	HYPH
cord-005453-4057qib7	16424	18	SCT	sct	NN
cord-005453-4057qib7	16424	19	analyzing	analyzing	NN
cord-005453-4057qib7	16424	20	leukocytes	leukocyte	NNS
cord-005453-4057qib7	16424	21	,	,	,
cord-005453-4057qib7	16424	22	lymphocytes	lymphocyte	NNS
cord-005453-4057qib7	16424	23	,	,	,
cord-005453-4057qib7	16424	24	monocytes	monocyte	NNS
cord-005453-4057qib7	16424	25	,	,	,
cord-005453-4057qib7	16424	26	CD3	CD3	NNP
cord-005453-4057qib7	16424	27	+	+	CC
cord-005453-4057qib7	16424	28	T	T	NNP
cord-005453-4057qib7	16424	29	cells	cell	NNS
cord-005453-4057qib7	16424	30	,	,	,
cord-005453-4057qib7	16424	31	CD3	CD3	NNP
cord-005453-4057qib7	16424	32	+	+	CC
cord-005453-4057qib7	16424	33	CD4	CD4	NNP
cord-005453-4057qib7	16424	34	+	+	CC
cord-005453-4057qib7	16424	35	T	T	NNP
cord-005453-4057qib7	16424	36	helper	helper	NN
cord-005453-4057qib7	16424	37	cells	cell	NNS
cord-005453-4057qib7	16424	38	,	,	,
cord-005453-4057qib7	16424	39	CD3	CD3	NNP
cord-005453-4057qib7	16424	40	+	+	CC
cord-005453-4057qib7	16424	41	CD8	CD8	NNP
cord-005453-4057qib7	16424	42	+	+	CC
cord-005453-4057qib7	16424	43	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	16424	44	T	t	NN
cord-005453-4057qib7	16424	45	cells	cell	NNS
cord-005453-4057qib7	16424	46	,	,	,
cord-005453-4057qib7	16424	47	CD3	CD3	NNP
cord-005453-4057qib7	16424	48	-CD56	-cd56	DT
cord-005453-4057qib7	16424	49	+	+	JJ
cord-005453-4057qib7	16424	50	natural	natural	JJ
cord-005453-4057qib7	16424	51	killer	killer	NN
cord-005453-4057qib7	16424	52	(	(	-LRB-
cord-005453-4057qib7	16424	53	NK	NK	NNP
cord-005453-4057qib7	16424	54	)	)	-RRB-
cord-005453-4057qib7	16424	55	cells	cell	NNS
cord-005453-4057qib7	16424	56	and	and	CC
cord-005453-4057qib7	16424	57	CD19	CD19	NNP
cord-005453-4057qib7	16424	58	+	+	CC
cord-005453-4057qib7	16424	59	B	b	NN
cord-005453-4057qib7	16424	60	cells	cell	NNS
cord-005453-4057qib7	16424	61	.	.	.
cord-005453-4057qib7	16425	1	Methods	method	NNS
cord-005453-4057qib7	16425	2	:	:	:
cord-005453-4057qib7	16425	3	We	-PRON-	PRP
cord-005453-4057qib7	16425	4	analyzed	analyze	VBD
cord-005453-4057qib7	16425	5	IR	IR	NNP
cord-005453-4057qib7	16425	6	-	-	HYPH
cord-005453-4057qib7	16425	7	data	datum	NNS
cord-005453-4057qib7	16425	8	of	of	IN
cord-005453-4057qib7	16425	9	116	116	CD
cord-005453-4057qib7	16425	10	consecutive	consecutive	JJ
cord-005453-4057qib7	16425	11	patients	patient	NNS
cord-005453-4057qib7	16425	12	receiving	receive	VBG
cord-005453-4057qib7	16425	13	allo	allo	NN
cord-005453-4057qib7	16425	14	-	-	HYPH
cord-005453-4057qib7	16425	15	SCTs	sct	NNS
cord-005453-4057qib7	16425	16	between	between	IN
cord-005453-4057qib7	16425	17	September	September	NNP
cord-005453-4057qib7	16425	18	2001	2001	CD
cord-005453-4057qib7	16425	19	and	and	CC
cord-005453-4057qib7	16425	20	November	November	NNP
cord-005453-4057qib7	16425	21	2018	2018	CD
cord-005453-4057qib7	16425	22	.	.	.
cord-005453-4057qib7	16426	1	Indications	indication	NNS
cord-005453-4057qib7	16426	2	of	of	IN
cord-005453-4057qib7	16426	3	allo	allo	NNP
cord-005453-4057qib7	16426	4	-	-	HYPH
cord-005453-4057qib7	16426	5	SCT	SCT	NNP
cord-005453-4057qib7	16426	6	were	be	VBD
cord-005453-4057qib7	16426	7	hereditary	hereditary	JJ
cord-005453-4057qib7	16426	8	anemias	anemia	NNS
cord-005453-4057qib7	16426	9	(	(	-LRB-
cord-005453-4057qib7	16426	10	thalassemia	thalassemia	NN
cord-005453-4057qib7	16426	11	,	,	,
cord-005453-4057qib7	16426	12	sickle	sickle	NN
cord-005453-4057qib7	16426	13	cell	cell	NN
cord-005453-4057qib7	16426	14	disease	disease	NN
cord-005453-4057qib7	16426	15	,	,	,
cord-005453-4057qib7	16426	16	Diamond	Diamond	NNP
cord-005453-4057qib7	16426	17	Blackfan	Blackfan	NNP
cord-005453-4057qib7	16426	18	Anemia	anemia	NN
cord-005453-4057qib7	16426	19	;	;	:
cord-005453-4057qib7	16426	20	HA	HA	NNP
cord-005453-4057qib7	16426	21	,	,	,
cord-005453-4057qib7	16426	22	n=35	n=35	NN
cord-005453-4057qib7	16426	23	,	,	,
cord-005453-4057qib7	16426	24	30	30	CD
cord-005453-4057qib7	16426	25	%	%	NN
cord-005453-4057qib7	16426	26	)	)	-RRB-
cord-005453-4057qib7	16426	27	,	,	,
cord-005453-4057qib7	16426	28	inherited	inherit	VBN
cord-005453-4057qib7	16426	29	bone	bone	NN
cord-005453-4057qib7	16426	30	marrow	marrow	NN
cord-005453-4057qib7	16426	31	failure	failure	NN
cord-005453-4057qib7	16426	32	syndrome	syndrome	NN
cord-005453-4057qib7	16426	33	(	(	-LRB-
cord-005453-4057qib7	16426	34	Fanconi	Fanconi	NNP
cord-005453-4057qib7	16426	35	anemia	anemia	NN
cord-005453-4057qib7	16426	36	,	,	,
cord-005453-4057qib7	16426	37	severe	severe	JJ
cord-005453-4057qib7	16426	38	aplastic	aplastic	JJ
cord-005453-4057qib7	16426	39	anemia	anemia	NN
cord-005453-4057qib7	16426	40	,	,	,
cord-005453-4057qib7	16426	41	others	other	NNS
cord-005453-4057qib7	16426	42	;	;	:
cord-005453-4057qib7	16426	43	BMFS	BMFS	NNP
cord-005453-4057qib7	16426	44	,	,	,
cord-005453-4057qib7	16426	45	n=34	n=34	NNP
cord-005453-4057qib7	16426	46	,	,	,
cord-005453-4057qib7	16426	47	29	29	CD
cord-005453-4057qib7	16426	48	%	%	NN
cord-005453-4057qib7	16426	49	)	)	-RRB-
cord-005453-4057qib7	16426	50	,	,	,
cord-005453-4057qib7	16426	51	hemophagocytic	hemophagocytic	JJ
cord-005453-4057qib7	16426	52	lymphohistiocytosis	lymphohistiocytosis	NN
cord-005453-4057qib7	16426	53	(	(	-LRB-
cord-005453-4057qib7	16426	54	HLH	HLH	NNP
cord-005453-4057qib7	16426	55	,	,	,
cord-005453-4057qib7	16426	56	n=12	n=12	NNP
cord-005453-4057qib7	16426	57	,	,	,
cord-005453-4057qib7	16426	58	10	10	CD
cord-005453-4057qib7	16426	59	%	%	NN
cord-005453-4057qib7	16426	60	)	)	-RRB-
cord-005453-4057qib7	16426	61	,	,	,
cord-005453-4057qib7	16426	62	immunodeficiency	immunodeficiency	NN
cord-005453-4057qib7	16426	63	(	(	-LRB-
cord-005453-4057qib7	16426	64	ID	ID	NNP
cord-005453-4057qib7	16426	65	,	,	,
cord-005453-4057qib7	16426	66	n=28	n=28	NN
cord-005453-4057qib7	16426	67	,	,	,
cord-005453-4057qib7	16426	68	24	24	CD
cord-005453-4057qib7	16426	69	%	%	NN
cord-005453-4057qib7	16426	70	)	)	-RRB-
cord-005453-4057qib7	16426	71	and	and	CC
cord-005453-4057qib7	16426	72	metabolic	metabolic	JJ
cord-005453-4057qib7	16426	73	disorders	disorder	NNS
cord-005453-4057qib7	16426	74	(	(	-LRB-
cord-005453-4057qib7	16426	75	n=7	n=7	NNS
cord-005453-4057qib7	16426	76	,	,	,
cord-005453-4057qib7	16426	77	6	6	CD
cord-005453-4057qib7	16426	78	%	%	NN
cord-005453-4057qib7	16426	79	)	)	-RRB-
cord-005453-4057qib7	16426	80	.	.	.
cord-005453-4057qib7	16427	1	The	the	DT
cord-005453-4057qib7	16427	2	median	median	JJ
cord-005453-4057qib7	16427	3	age	age	NN
cord-005453-4057qib7	16427	4	at	at	IN
cord-005453-4057qib7	16427	5	allo	allo	NN
cord-005453-4057qib7	16427	6	-	-	HYPH
cord-005453-4057qib7	16427	7	SCT	SCT	NNP
cord-005453-4057qib7	16427	8	was	be	VBD
cord-005453-4057qib7	16427	9	7	7	CD
cord-005453-4057qib7	16427	10	years	year	NNS
cord-005453-4057qib7	16427	11	(	(	-LRB-
cord-005453-4057qib7	16427	12	range	range	NN
cord-005453-4057qib7	16427	13	,	,	,
cord-005453-4057qib7	16427	14	0.2	0.2	CD
cord-005453-4057qib7	16427	15	-26	-26	CD
cord-005453-4057qib7	16427	16	)	)	-RRB-
cord-005453-4057qib7	16427	17	and	and	CC
cord-005453-4057qib7	16428	1	at	at	IN
cord-005453-4057qib7	16428	2	diagnosis	diagnosis	NN
cord-005453-4057qib7	16428	3	0.8	0.8	CD
cord-005453-4057qib7	16428	4	years	year	NNS
cord-005453-4057qib7	16428	5	(	(	-LRB-
cord-005453-4057qib7	16428	6	range	range	NN
cord-005453-4057qib7	16428	7	,	,	,
cord-005453-4057qib7	16428	8	-0.5	-0.5	XX
cord-005453-4057qib7	16429	1	-17.8).Patients	-17.8).Patients	NNP
cord-005453-4057qib7	16429	2	received	receive	VBD
cord-005453-4057qib7	16429	3	1	1	CD
cord-005453-4057qib7	16429	4	st	st	NNP
cord-005453-4057qib7	16429	5	allo	allo	NNP
cord-005453-4057qib7	16429	6	-	-	HYPH
cord-005453-4057qib7	16429	7	SCT	SCT	NNP
cord-005453-4057qib7	16429	8	from	from	IN
cord-005453-4057qib7	16429	9	MSD	MSD	NNP
cord-005453-4057qib7	16429	10	/	/	SYM
cord-005453-4057qib7	16429	11	MFD	MFD	NNP
cord-005453-4057qib7	16429	12	(	(	-LRB-
cord-005453-4057qib7	16430	1	n=53	n=53	NNP
cord-005453-4057qib7	16430	2	,	,	,
cord-005453-4057qib7	16430	3	46	46	CD
cord-005453-4057qib7	16430	4	%	%	NN
cord-005453-4057qib7	16430	5	)	)	-RRB-
cord-005453-4057qib7	16430	6	,	,	,
cord-005453-4057qib7	16430	7	MUD	MUD	NNP
cord-005453-4057qib7	16430	8	(	(	-LRB-
cord-005453-4057qib7	16430	9	n=42	n=42	NN
cord-005453-4057qib7	16430	10	,	,	,
cord-005453-4057qib7	16430	11	36	36	CD
cord-005453-4057qib7	16430	12	%	%	NN
cord-005453-4057qib7	16430	13	)	)	-RRB-
cord-005453-4057qib7	16430	14	,	,	,
cord-005453-4057qib7	16430	15	haploidentical	haploidentical	JJ
cord-005453-4057qib7	16430	16	mismatch	mismatch	NN
cord-005453-4057qib7	16430	17	family	family	NN
cord-005453-4057qib7	16430	18	donors	donor	NNS
cord-005453-4057qib7	16430	19	(	(	-LRB-
cord-005453-4057qib7	16430	20	n=15	n=15	NNP
cord-005453-4057qib7	16430	21	,	,	,
cord-005453-4057qib7	16430	22	13	13	CD
cord-005453-4057qib7	16430	23	%	%	NN
cord-005453-4057qib7	16430	24	)	)	-RRB-
cord-005453-4057qib7	16430	25	and	and	CC
cord-005453-4057qib7	16430	26	MMUD	MMUD	NNP
cord-005453-4057qib7	16430	27	(	(	-LRB-
cord-005453-4057qib7	16430	28	n=6	n=6	JJ
cord-005453-4057qib7	16430	29	,	,	,
cord-005453-4057qib7	16430	30	5	5	CD
cord-005453-4057qib7	16430	31	%	%	NN
cord-005453-4057qib7	16430	32	)	)	-RRB-
cord-005453-4057qib7	16430	33	.	.	.
cord-005453-4057qib7	16431	1	Conditioning	conditioning	NN
cord-005453-4057qib7	16431	2	regimens	regimen	NNS
cord-005453-4057qib7	16431	3	were	be	VBD
cord-005453-4057qib7	16431	4	Busulphan	Busulphan	NNP
cord-005453-4057qib7	16431	5	-	-	HYPH
cord-005453-4057qib7	16431	6	based	base	VBN
cord-005453-4057qib7	16431	7	(	(	-LRB-
cord-005453-4057qib7	16431	8	n=14	n=14	NN
cord-005453-4057qib7	16431	9	,	,	,
cord-005453-4057qib7	16431	10	12	12	CD
cord-005453-4057qib7	16431	11	%	%	NN
cord-005453-4057qib7	16431	12	)	)	-RRB-
cord-005453-4057qib7	16431	13	,	,	,
cord-005453-4057qib7	16431	14	Treosulphan	Treosulphan	NNP
cord-005453-4057qib7	16431	15	-	-	HYPH
cord-005453-4057qib7	16431	16	based	base	VBN
cord-005453-4057qib7	16431	17	(	(	-LRB-
cord-005453-4057qib7	16431	18	n=45	n=45	NNS
cord-005453-4057qib7	16431	19	,	,	,
cord-005453-4057qib7	16431	20	39	39	CD
cord-005453-4057qib7	16431	21	%	%	NN
cord-005453-4057qib7	16431	22	)	)	-RRB-
cord-005453-4057qib7	16431	23	,	,	,
cord-005453-4057qib7	16431	24	Flu	Flu	NNP
cord-005453-4057qib7	16431	25	-	-	HYPH
cord-005453-4057qib7	16431	26	Mel	Mel	NNP
cord-005453-4057qib7	16431	27	-	-	HYPH
cord-005453-4057qib7	16431	28	Thio	Thio	NNP
cord-005453-4057qib7	16431	29	(	(	-LRB-
cord-005453-4057qib7	16431	30	n=35	n=35	NNP
cord-005453-4057qib7	16431	31	,	,	,
cord-005453-4057qib7	16431	32	30	30	CD
cord-005453-4057qib7	16431	33	%	%	NN
cord-005453-4057qib7	16431	34	)	)	-RRB-
cord-005453-4057qib7	16431	35	or	or	CC
cord-005453-4057qib7	16431	36	others	other	NNS
cord-005453-4057qib7	16431	37	(	(	-LRB-
cord-005453-4057qib7	16431	38	n=22	n=22	NNP
cord-005453-4057qib7	16431	39	,	,	,
cord-005453-4057qib7	16431	40	19	19	CD
cord-005453-4057qib7	16431	41	%	%	NN
cord-005453-4057qib7	16431	42	)	)	-RRB-
cord-005453-4057qib7	16431	43	.	.	.
cord-005453-4057qib7	16432	1	Graft	graft	NN
cord-005453-4057qib7	16432	2	sources	source	NNS
cord-005453-4057qib7	16432	3	were	be	VBD
cord-005453-4057qib7	16432	4	BM	BM	NNP
cord-005453-4057qib7	16432	5	(	(	-LRB-
cord-005453-4057qib7	16432	6	n=84	n=84	''
cord-005453-4057qib7	16432	7	,	,	,
cord-005453-4057qib7	16432	8	72	72	CD
cord-005453-4057qib7	16432	9	%	%	NN
cord-005453-4057qib7	16432	10	)	)	-RRB-
cord-005453-4057qib7	16432	11	and	and	CC
cord-005453-4057qib7	16432	12	PBSC	PBSC	NNP
cord-005453-4057qib7	16432	13	(	(	-LRB-
cord-005453-4057qib7	16432	14	n=32	n=32	NNP
cord-005453-4057qib7	16432	15	,	,	,
cord-005453-4057qib7	16432	16	28%).In	28%).in	CD
cord-005453-4057qib7	16432	17	order	order	NN
cord-005453-4057qib7	16432	18	to	to	TO
cord-005453-4057qib7	16432	19	consider	consider	VB
cord-005453-4057qib7	16432	20	the	the	DT
cord-005453-4057qib7	16432	21	age	age	NN
cord-005453-4057qib7	16432	22	-	-	HYPH
cord-005453-4057qib7	16432	23	dependency	dependency	NN
cord-005453-4057qib7	16432	24	of	of	IN
cord-005453-4057qib7	16432	25	IR	IR	NNP
cord-005453-4057qib7	16432	26	we	-PRON-	PRP
cord-005453-4057qib7	16432	27	normalized	normalize	VBD
cord-005453-4057qib7	16432	28	each	each	DT
cord-005453-4057qib7	16432	29	absolute	absolute	JJ
cord-005453-4057qib7	16432	30	cell	cell	NN
cord-005453-4057qib7	16432	31	count	count	NN
cord-005453-4057qib7	16432	32	with	with	IN
cord-005453-4057qib7	16432	33	its	-PRON-	PRP$
cord-005453-4057qib7	16432	34	corresponding	correspond	VBG
cord-005453-4057qib7	16432	35	age	age	NN
cord-005453-4057qib7	16432	36	-	-	HYPH
cord-005453-4057qib7	16432	37	specific	specific	JJ
cord-005453-4057qib7	16432	38	expected	expect	VBN
cord-005453-4057qib7	16432	39	mean	mean	JJ
cord-005453-4057qib7	16432	40	values	value	NNS
cord-005453-4057qib7	16432	41	.	.	.
cord-005453-4057qib7	16433	1	(	(	-LRB-
cord-005453-4057qib7	16433	2	Huenecke	Huenecke	NNP
cord-005453-4057qib7	16433	3	et	et	FW
cord-005453-4057qib7	16433	4	al	al	NNP
cord-005453-4057qib7	16433	5	.	.	.
cord-005453-4057qib7	16434	1	;	;	:
cord-005453-4057qib7	16434	2	Eur	Eur	NNP
cord-005453-4057qib7	16434	3	J	J	NNP
cord-005453-4057qib7	16434	4	Haematol	Haematol	NNP
cord-005453-4057qib7	16434	5	;	;	:
cord-005453-4057qib7	16434	6	2008	2008	CD
cord-005453-4057qib7	16434	7	)	)	-RRB-
cord-005453-4057qib7	16435	1	Results	result	NNS
cord-005453-4057qib7	16435	2	:	:	:
cord-005453-4057qib7	16436	1	The	the	DT
cord-005453-4057qib7	16436	2	IR	IR	NNP
cord-005453-4057qib7	16436	3	pattern	pattern	NN
cord-005453-4057qib7	16436	4	was	be	VBD
cord-005453-4057qib7	16436	5	similar	similar	JJ
cord-005453-4057qib7	16436	6	between	between	IN
cord-005453-4057qib7	16436	7	the	the	DT
cord-005453-4057qib7	16436	8	HA	HA	NNP
cord-005453-4057qib7	16436	9	and	and	CC
cord-005453-4057qib7	16436	10	BMFS	BMFS	NNP
cord-005453-4057qib7	16436	11	groups	group	NNS
cord-005453-4057qib7	16436	12	.	.	.
cord-005453-4057qib7	16437	1	The	the	DT
cord-005453-4057qib7	16437	2	CD4	CD4	NNP
cord-005453-4057qib7	16437	3	+	+	CC
cord-005453-4057qib7	16437	4	T	t	NN
cord-005453-4057qib7	16437	5	cells	cell	NNS
cord-005453-4057qib7	16437	6	were	be	VBD
cord-005453-4057qib7	16437	7	recovering	recover	VBG
cord-005453-4057qib7	16437	8	slightly	slightly	RB
cord-005453-4057qib7	16437	9	faster	fast	RBR
cord-005453-4057qib7	16437	10	in	in	IN
cord-005453-4057qib7	16437	11	HA	HA	NNP
cord-005453-4057qib7	16437	12	patients	patient	NNS
cord-005453-4057qib7	16437	13	compared	compare	VBN
cord-005453-4057qib7	16437	14	to	to	IN
cord-005453-4057qib7	16437	15	the	the	DT
cord-005453-4057qib7	16437	16	recovery	recovery	NN
cord-005453-4057qib7	16437	17	of	of	IN
cord-005453-4057qib7	16437	18	BMFS	BMFS	NNP
cord-005453-4057qib7	16437	19	patients	patient	NNS
cord-005453-4057qib7	16437	20	.	.	.
cord-005453-4057qib7	16438	1	Monocytes	Monocytes	NNP
cord-005453-4057qib7	16438	2	and	and	CC
cord-005453-4057qib7	16438	3	NK	NK	NNP
cord-005453-4057qib7	16438	4	cells	cell	NNS
cord-005453-4057qib7	16438	5	proliferate	proliferate	VBP
cord-005453-4057qib7	16438	6	very	very	RB
cord-005453-4057qib7	16438	7	fast	fast	RB
cord-005453-4057qib7	16438	8	.	.	.
cord-005453-4057qib7	16439	1	At	at	IN
cord-005453-4057qib7	16439	2	day	day	NN
cord-005453-4057qib7	16439	3	+60	+60	CD
cord-005453-4057qib7	16439	4	half	half	NN
cord-005453-4057qib7	16439	5	of	of	IN
cord-005453-4057qib7	16439	6	the	the	DT
cord-005453-4057qib7	16439	7	patients	patient	NNS
cord-005453-4057qib7	16439	8	already	already	RB
cord-005453-4057qib7	16439	9	reached	reach	VBD
cord-005453-4057qib7	16439	10	their	-PRON-	PRP$
cord-005453-4057qib7	16439	11	respective	respective	JJ
cord-005453-4057qib7	16439	12	monocytes	monocyte	NNS
cord-005453-4057qib7	16439	13	reference	reference	NN
cord-005453-4057qib7	16439	14	value	value	NN
cord-005453-4057qib7	16439	15	except	except	IN
cord-005453-4057qib7	16439	16	for	for	IN
cord-005453-4057qib7	16439	17	ID	ID	NNP
cord-005453-4057qib7	16439	18	patients	patient	NNS
cord-005453-4057qib7	16439	19	,	,	,
cord-005453-4057qib7	16439	20	who	who	WP
cord-005453-4057qib7	16439	21	reached	reach	VBD
cord-005453-4057qib7	16439	22	80	80	CD
cord-005453-4057qib7	16439	23	%	%	NN
cord-005453-4057qib7	16439	24	of	of	IN
cord-005453-4057qib7	16439	25	the	the	DT
cord-005453-4057qib7	16439	26	reference	reference	NN
cord-005453-4057qib7	16439	27	value	value	NN
cord-005453-4057qib7	16439	28	at	at	IN
cord-005453-4057qib7	16439	29	the	the	DT
cord-005453-4057qib7	16439	30	end	end	NN
cord-005453-4057qib7	16439	31	of	of	IN
cord-005453-4057qib7	16439	32	the	the	DT
cord-005453-4057qib7	16439	33	first	first	JJ
cord-005453-4057qib7	16439	34	year	year	NN
cord-005453-4057qib7	16439	35	.	.	.
cord-005453-4057qib7	16440	1	CD3	CD3	NNP
cord-005453-4057qib7	16440	2	+	+	CC
cord-005453-4057qib7	16440	3	CD8	CD8	NNP
cord-005453-4057qib7	16440	4	+	+	CC
cord-005453-4057qib7	16440	5	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	16440	6	T	t	NN
cord-005453-4057qib7	16440	7	cells	cell	NNS
cord-005453-4057qib7	16440	8	recovered	recover	VBN
cord-005453-4057qib7	16440	9	significantly	significantly	RB
cord-005453-4057qib7	16440	10	faster	fast	RBR
cord-005453-4057qib7	16440	11	in	in	IN
cord-005453-4057qib7	16440	12	patients	patient	NNS
cord-005453-4057qib7	16440	13	with	with	IN
cord-005453-4057qib7	16440	14	hematologic	hematologic	JJ
cord-005453-4057qib7	16440	15	diseases	disease	NNS
cord-005453-4057qib7	16440	16	compared	compare	VBN
cord-005453-4057qib7	16440	17	to	to	IN
cord-005453-4057qib7	16440	18	patients	patient	NNS
cord-005453-4057qib7	16440	19	with	with	IN
cord-005453-4057qib7	16440	20	HLH	HLH	NNP
cord-005453-4057qib7	16440	21	(	(	-LRB-
cord-005453-4057qib7	16440	22	P	p	NN
cord-005453-4057qib7	16440	23	<	<	XX
cord-005453-4057qib7	16440	24	0.001	0.001	CD
cord-005453-4057qib7	16440	25	)	)	-RRB-
cord-005453-4057qib7	16440	26	and	and	CC
cord-005453-4057qib7	16440	27	ID	ID	NNP
cord-005453-4057qib7	16440	28	(	(	-LRB-
cord-005453-4057qib7	16440	29	P=0.047	P=0.047	NNS
cord-005453-4057qib7	16440	30	)	)	-RRB-
cord-005453-4057qib7	16440	31	.	.	.
cord-005453-4057qib7	16441	1	Half	half	NN
cord-005453-4057qib7	16441	2	of	of	IN
cord-005453-4057qib7	16441	3	the	the	DT
cord-005453-4057qib7	16441	4	patients	patient	NNS
cord-005453-4057qib7	16441	5	reached	reach	VBD
cord-005453-4057qib7	16441	6	the	the	DT
cord-005453-4057qib7	16441	7	reference	reference	NN
cord-005453-4057qib7	16441	8	value	value	NN
cord-005453-4057qib7	16441	9	of	of	IN
cord-005453-4057qib7	16441	10	cytotoxic	cytotoxic	JJ
cord-005453-4057qib7	16441	11	T	t	NN
cord-005453-4057qib7	16441	12	cells	cell	NNS
cord-005453-4057qib7	16441	13	in	in	IN
cord-005453-4057qib7	16441	14	the	the	DT
cord-005453-4057qib7	16441	15	hematologic	hematologic	JJ
cord-005453-4057qib7	16441	16	diseases	disease	NNS
cord-005453-4057qib7	16441	17	group	group	NN
cord-005453-4057qib7	16441	18	at	at	IN
cord-005453-4057qib7	16441	19	day	day	NN
cord-005453-4057qib7	16441	20	+365	+365	NNP
cord-005453-4057qib7	16441	21	.	.	.
cord-005453-4057qib7	16442	1	By	by	IN
cord-005453-4057qib7	16442	2	far	far	RB
cord-005453-4057qib7	16442	3	inferior	inferior	JJ
cord-005453-4057qib7	16442	4	was	be	VBD
cord-005453-4057qib7	16442	5	the	the	DT
cord-005453-4057qib7	16442	6	IR	IR	NNP
cord-005453-4057qib7	16442	7	for	for	IN
cord-005453-4057qib7	16442	8	the	the	DT
cord-005453-4057qib7	16442	9	HLH	HLH	NNP
cord-005453-4057qib7	16442	10	patients	patient	NNS
cord-005453-4057qib7	16442	11	.	.	.
cord-005453-4057qib7	16443	1	In	in	IN
cord-005453-4057qib7	16443	2	this	this	DT
cord-005453-4057qib7	16443	3	group	group	NN
cord-005453-4057qib7	16443	4	only	only	RB
cord-005453-4057qib7	16443	5	50	50	CD
cord-005453-4057qib7	16443	6	%	%	NN
cord-005453-4057qib7	16443	7	of	of	IN
cord-005453-4057qib7	16443	8	the	the	DT
cord-005453-4057qib7	16443	9	patients	patient	NNS
cord-005453-4057qib7	16443	10	reached	reach	VBD
cord-005453-4057qib7	16443	11	the	the	DT
cord-005453-4057qib7	16443	12	45	45	CD
cord-005453-4057qib7	16443	13	th	th	XX
cord-005453-4057qib7	16443	14	percentile	percentile	NN
cord-005453-4057qib7	16443	15	of	of	IN
cord-005453-4057qib7	16443	16	the	the	DT
cord-005453-4057qib7	16443	17	healthy	healthy	JJ
cord-005453-4057qib7	16443	18	age	age	NN
cord-005453-4057qib7	16443	19	-	-	HYPH
cord-005453-4057qib7	16443	20	matched	match	VBN
cord-005453-4057qib7	16443	21	reference	reference	NN
cord-005453-4057qib7	16443	22	.	.	.
cord-005453-4057qib7	16444	1	In	in	IN
cord-005453-4057qib7	16444	2	the	the	DT
cord-005453-4057qib7	16444	3	ID	ID	NNP
cord-005453-4057qib7	16444	4	group	group	NN
cord-005453-4057qib7	16444	5	50	50	CD
cord-005453-4057qib7	16444	6	%	%	NN
cord-005453-4057qib7	16444	7	of	of	IN
cord-005453-4057qib7	16444	8	all	all	DT
cord-005453-4057qib7	16444	9	patients	patient	NNS
cord-005453-4057qib7	16444	10	reached	reach	VBD
cord-005453-4057qib7	16444	11	the	the	DT
cord-005453-4057qib7	16444	12	87	87	CD
cord-005453-4057qib7	16444	13	th	th	XX
cord-005453-4057qib7	16444	14	percentile	percentile	NN
cord-005453-4057qib7	16444	15	of	of	IN
cord-005453-4057qib7	16444	16	the	the	DT
cord-005453-4057qib7	16444	17	age	age	NN
cord-005453-4057qib7	16444	18	-	-	HYPH
cord-005453-4057qib7	16444	19	matched	match	VBN
cord-005453-4057qib7	16444	20	reference	reference	NN
cord-005453-4057qib7	16444	21	group	group	NN
cord-005453-4057qib7	16444	22	at	at	IN
cord-005453-4057qib7	16444	23	day	day	NN
cord-005453-4057qib7	16445	1	+365.B	+365.b	NN
cord-005453-4057qib7	16445	2	cells	cell	NNS
cord-005453-4057qib7	16445	3	are	be	VBP
cord-005453-4057qib7	16445	4	profoundly	profoundly	RB
cord-005453-4057qib7	16445	5	decreased	decrease	VBN
cord-005453-4057qib7	16445	6	at	at	IN
cord-005453-4057qib7	16445	7	day	day	NN
cord-005453-4057qib7	16445	8	+30	+30	CD
cord-005453-4057qib7	16445	9	in	in	IN
cord-005453-4057qib7	16445	10	all	all	DT
cord-005453-4057qib7	16445	11	groups	group	NNS
cord-005453-4057qib7	16445	12	.	.	.
cord-005453-4057qib7	16446	1	However	however	RB
cord-005453-4057qib7	16446	2	,	,	,
cord-005453-4057qib7	16446	3	the	the	DT
cord-005453-4057qib7	16446	4	longitudinal	longitudinal	JJ
cord-005453-4057qib7	16446	5	expansion	expansion	NN
cord-005453-4057qib7	16446	6	of	of	IN
cord-005453-4057qib7	16446	7	B	b	NN
cord-005453-4057qib7	16446	8	cells	cell	NNS
cord-005453-4057qib7	16446	9	was	be	VBD
cord-005453-4057qib7	16446	10	significantly	significantly	RB
cord-005453-4057qib7	16446	11	lower	low	JJR
cord-005453-4057qib7	16446	12	both	both	CC
cord-005453-4057qib7	16446	13	in	in	IN
cord-005453-4057qib7	16446	14	the	the	DT
cord-005453-4057qib7	16446	15	ID	ID	NNP
cord-005453-4057qib7	16446	16	group	group	NN
cord-005453-4057qib7	16446	17	and	and	CC
cord-005453-4057qib7	16446	18	HLH	HLH	NNP
cord-005453-4057qib7	16446	19	group	group	NN
cord-005453-4057qib7	16446	20	compared	compare	VBN
cord-005453-4057qib7	16446	21	to	to	IN
cord-005453-4057qib7	16446	22	the	the	DT
cord-005453-4057qib7	16446	23	hematologic	hematologic	JJ
cord-005453-4057qib7	16446	24	diseases	disease	NNS
cord-005453-4057qib7	16446	25	group	group	NN
cord-005453-4057qib7	16446	26	.	.	.
cord-005453-4057qib7	16447	1	At	at	IN
cord-005453-4057qib7	16447	2	day	day	NN
cord-005453-4057qib7	16447	3	+365	+365	NNP
cord-005453-4057qib7	16447	4	fifty	fifty	CD
cord-005453-4057qib7	16447	5	percent	percent	NN
cord-005453-4057qib7	16447	6	of	of	IN
cord-005453-4057qib7	16447	7	patients	patient	NNS
cord-005453-4057qib7	16447	8	with	with	IN
cord-005453-4057qib7	16447	9	ID	ID	NNP
cord-005453-4057qib7	16447	10	,	,	,
cord-005453-4057qib7	16447	11	HLH	HLH	NNP
cord-005453-4057qib7	16447	12	and	and	CC
cord-005453-4057qib7	16447	13	hematologic	hematologic	JJ
cord-005453-4057qib7	16447	14	diseases	disease	NNS
cord-005453-4057qib7	16447	15	reached	reach	VBD
cord-005453-4057qib7	16447	16	the	the	DT
cord-005453-4057qib7	16447	17	37	37	CD
cord-005453-4057qib7	16447	18	th	th	XX
cord-005453-4057qib7	16447	19	percentile	percentile	NN
cord-005453-4057qib7	16447	20	,	,	,
cord-005453-4057qib7	16447	21	52	52	CD
cord-005453-4057qib7	16447	22	th	th	XX
cord-005453-4057qib7	16447	23	percentile	percentile	NN
cord-005453-4057qib7	16447	24	and	and	CC
cord-005453-4057qib7	16447	25	the	the	DT
cord-005453-4057qib7	16447	26	100	100	CD
cord-005453-4057qib7	16447	27	th	th	XX
cord-005453-4057qib7	16447	28	percentile	percentile	NN
cord-005453-4057qib7	16447	29	,	,	,
cord-005453-4057qib7	16447	30	respectively	respectively	RB
cord-005453-4057qib7	16447	31	(	(	-LRB-
cord-005453-4057qib7	16447	32	P	p	NN
cord-005453-4057qib7	16447	33	<	<	XX
cord-005453-4057qib7	16447	34	0.001	0.001	CD
cord-005453-4057qib7	16447	35	;	;	:
cord-005453-4057qib7	16447	36	P=0.027).Conclusions	P=0.027).Conclusions	NNP
cord-005453-4057qib7	16447	37	:	:	:
cord-005453-4057qib7	16448	1	Allo	Allo	NNP
cord-005453-4057qib7	16448	2	-	-	HYPH
cord-005453-4057qib7	16448	3	SCT	SCT	NNP
cord-005453-4057qib7	16448	4	is	be	VBZ
cord-005453-4057qib7	16448	5	the	the	DT
cord-005453-4057qib7	16448	6	only	only	JJ
cord-005453-4057qib7	16448	7	curative	curative	JJ
cord-005453-4057qib7	16448	8	option	option	NN
cord-005453-4057qib7	16448	9	for	for	IN
cord-005453-4057qib7	16448	10	patients	patient	NNS
cord-005453-4057qib7	16448	11	with	with	IN
cord-005453-4057qib7	16448	12	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	16448	13	diseases	disease	NNS
cord-005453-4057qib7	16448	14	.	.	.
cord-005453-4057qib7	16449	1	IR	IR	NNP
cord-005453-4057qib7	16449	2	is	be	VBZ
cord-005453-4057qib7	16449	3	dynamic	dynamic	JJ
cord-005453-4057qib7	16449	4	and	and	CC
cord-005453-4057qib7	16449	5	revealed	reveal	VBD
cord-005453-4057qib7	16449	6	a	a	DT
cord-005453-4057qib7	16449	7	complex	complex	JJ
cord-005453-4057qib7	16449	8	diversity	diversity	NN
cord-005453-4057qib7	16449	9	pattern	pattern	NN
cord-005453-4057qib7	16449	10	with	with	IN
cord-005453-4057qib7	16449	11	regard	regard	NN
cord-005453-4057qib7	16449	12	to	to	IN
cord-005453-4057qib7	16449	13	the	the	DT
cord-005453-4057qib7	16449	14	original	original	JJ
cord-005453-4057qib7	16449	15	disease	disease	NN
cord-005453-4057qib7	16449	16	.	.	.
cord-005453-4057qib7	16450	1	To	to	TO
cord-005453-4057qib7	16450	2	investigate	investigate	VB
cord-005453-4057qib7	16450	3	factors	factor	NNS
cord-005453-4057qib7	16450	4	influencing	influence	VBG
cord-005453-4057qib7	16450	5	IR	IR	NNP
cord-005453-4057qib7	16450	6	after	after	IN
cord-005453-4057qib7	16450	7	allo	allo	NN
cord-005453-4057qib7	16450	8	-	-	HYPH
cord-005453-4057qib7	16450	9	SCT	SCT	NNP
cord-005453-4057qib7	16450	10	is	be	VBZ
cord-005453-4057qib7	16450	11	crucial	crucial	JJ
cord-005453-4057qib7	16450	12	to	to	TO
cord-005453-4057qib7	16450	13	improve	improve	VB
cord-005453-4057qib7	16450	14	outcome	outcome	NN
cord-005453-4057qib7	16450	15	of	of	IN
cord-005453-4057qib7	16450	16	these	these	DT
cord-005453-4057qib7	16450	17	patients	patient	NNS
cord-005453-4057qib7	16450	18	.	.	.
cord-005453-4057qib7	16451	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16451	2	:	:	:
cord-005453-4057qib7	16451	3	Nothing	nothing	NN
cord-005453-4057qib7	16451	4	to	to	TO
cord-005453-4057qib7	16451	5	declare	declare	VB
cord-005453-4057qib7	16451	6	.	.	.
cord-005453-4057qib7	16452	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	16452	2	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16452	3	stem	stem	NN
cord-005453-4057qib7	16452	4	cell	cell	NN
cord-005453-4057qib7	16452	5	transplantation	transplantation	NN
cord-005453-4057qib7	16452	6	in	in	IN
cord-005453-4057qib7	16452	7	patients	patient	NNS
cord-005453-4057qib7	16452	8	with	with	IN
cord-005453-4057qib7	16452	9	myelodysplastic	myelodysplastic	JJ
cord-005453-4057qib7	16452	10	syndrome	syndrome	NN
cord-005453-4057qib7	16452	11	of	of	IN
cord-005453-4057qib7	16452	12	relatively	relatively	RB
cord-005453-4057qib7	16452	13	high	high	JJ
cord-005453-4057qib7	16452	14	-	-	HYPH
cord-005453-4057qib7	16452	15	risk	risk	NN
cord-005453-4057qib7	16452	16	groups	group	NNS
cord-005453-4057qib7	16452	17	:	:	:
cord-005453-4057qib7	16452	18	curative	curative	JJ
cord-005453-4057qib7	16452	19	effect	effect	NN
cord-005453-4057qib7	16452	20	analysis	analysis	NN
cord-005453-4057qib7	16452	21	and	and	CC
cord-005453-4057qib7	16452	22	optimal	optimal	JJ
cord-005453-4057qib7	16452	23	timing	timing	NN
cord-005453-4057qib7	16452	24	selection	selection	NN
cord-005453-4057qib7	16452	25	Results	result	NNS
cord-005453-4057qib7	16452	26	:	:	:
cord-005453-4057qib7	16452	27	Among	among	IN
cord-005453-4057qib7	16452	28	the	the	DT
cord-005453-4057qib7	16452	29	135	135	CD
cord-005453-4057qib7	16452	30	patients	patient	NNS
cord-005453-4057qib7	16452	31	,	,	,
cord-005453-4057qib7	16452	32	133	133	CD
cord-005453-4057qib7	16452	33	patients	patient	NNS
cord-005453-4057qib7	16452	34	were	be	VBD
cord-005453-4057qib7	16452	35	transplanted	transplant	VBN
cord-005453-4057qib7	16452	36	successfully	successfully	RB
cord-005453-4057qib7	16452	37	.	.	.
cord-005453-4057qib7	16453	1	The	the	DT
cord-005453-4057qib7	16453	2	3-year	3-year	CD
cord-005453-4057qib7	16453	3	overall	overall	JJ
cord-005453-4057qib7	16453	4	survival	survival	NN
cord-005453-4057qib7	16453	5	(	(	-LRB-
cord-005453-4057qib7	16453	6	OS	os	NN
cord-005453-4057qib7	16453	7	)	)	-RRB-
cord-005453-4057qib7	16453	8	rate	rate	NN
cord-005453-4057qib7	16453	9	and	and	CC
cord-005453-4057qib7	16453	10	disease	disease	NN
cord-005453-4057qib7	16453	11	-	-	HYPH
cord-005453-4057qib7	16453	12	free	free	JJ
cord-005453-4057qib7	16453	13	survival	survival	NN
cord-005453-4057qib7	16453	14	(	(	-LRB-
cord-005453-4057qib7	16453	15	DFS	DFS	NNP
cord-005453-4057qib7	16453	16	)	)	-RRB-
cord-005453-4057qib7	16453	17	rate	rate	NN
cord-005453-4057qib7	16453	18	was	be	VBD
cord-005453-4057qib7	16453	19	76.8	76.8	CD
cord-005453-4057qib7	16453	20	%	%	NN
cord-005453-4057qib7	16453	21	±4.2	±4.2	JJ
cord-005453-4057qib7	16453	22	%	%	NN
cord-005453-4057qib7	16453	23	and	and	CC
cord-005453-4057qib7	16453	24	76.7%±4.3	76.7%±4.3	CD
cord-005453-4057qib7	16453	25	%	%	NN
cord-005453-4057qib7	16453	26	respectively	respectively	RB
cord-005453-4057qib7	16453	27	.	.	.
cord-005453-4057qib7	16454	1	The	the	DT
cord-005453-4057qib7	16454	2	3-year	3-year	CD
cord-005453-4057qib7	16454	3	cumulative	cumulative	JJ
cord-005453-4057qib7	16454	4	relapse	relapse	NN
cord-005453-4057qib7	16454	5	rate	rate	NN
cord-005453-4057qib7	16454	6	(	(	-LRB-
cord-005453-4057qib7	16454	7	RR	RR	NNP
cord-005453-4057qib7	16454	8	)	)	-RRB-
cord-005453-4057qib7	16454	9	and	and	CC
cord-005453-4057qib7	16454	10	the	the	DT
cord-005453-4057qib7	16454	11	non	non	JJ
cord-005453-4057qib7	16454	12	-	-	JJ
cord-005453-4057qib7	16454	13	relapse	relapse	JJ
cord-005453-4057qib7	16454	14	mortality	mortality	NN
cord-005453-4057qib7	16454	15	(	(	-LRB-
cord-005453-4057qib7	16454	16	NRM	NRM	NNP
cord-005453-4057qib7	16454	17	)	)	-RRB-
cord-005453-4057qib7	16454	18	rate	rate	NN
cord-005453-4057qib7	16454	19	was	be	VBD
cord-005453-4057qib7	16454	20	13.9%±0.1	13.9%±0.1	CD
cord-005453-4057qib7	16454	21	%	%	NN
cord-005453-4057qib7	16454	22	and	and	CC
cord-005453-4057qib7	16454	23	18.4%±0.1	18.4%±0.1	CD
cord-005453-4057qib7	16454	24	%	%	NN
cord-005453-4057qib7	16454	25	respectively	respectively	RB
cord-005453-4057qib7	16454	26	.	.	.
cord-005453-4057qib7	16455	1	The	the	DT
cord-005453-4057qib7	16455	2	incidence	incidence	NN
cord-005453-4057qib7	16455	3	of	of	IN
cord-005453-4057qib7	16455	4	grade	grade	NN
cord-005453-4057qib7	16455	5	II	II	NNP
cord-005453-4057qib7	16455	6	-	-	HYPH
cord-005453-4057qib7	16455	7	IV	IV	NNP
cord-005453-4057qib7	16455	8	acute	acute	JJ
cord-005453-4057qib7	16455	9	graft	graft	NN
cord-005453-4057qib7	16455	10	versus	versus	IN
cord-005453-4057qib7	16455	11	host	host	NN
cord-005453-4057qib7	16455	12	disease	disease	NN
cord-005453-4057qib7	16455	13	(	(	-LRB-
cord-005453-4057qib7	16455	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16455	15	)	)	-RRB-
cord-005453-4057qib7	16455	16	was	be	VBD
cord-005453-4057qib7	16455	17	25.2%±0.1	25.2%±0.1	CD
cord-005453-4057qib7	16455	18	%	%	NN
cord-005453-4057qib7	16455	19	.	.	.
cord-005453-4057qib7	16456	1	For	for	IN
cord-005453-4057qib7	16456	2	the	the	DT
cord-005453-4057qib7	16456	3	patients	patient	NNS
cord-005453-4057qib7	16456	4	who	who	WP
cord-005453-4057qib7	16456	5	survived	survive	VBD
cord-005453-4057qib7	16456	6	more	more	JJR
cord-005453-4057qib7	16456	7	than	than	IN
cord-005453-4057qib7	16456	8	100	100	CD
cord-005453-4057qib7	16456	9	days	day	NNS
cord-005453-4057qib7	16456	10	after	after	IN
cord-005453-4057qib7	16456	11	allo	allo	NN
cord-005453-4057qib7	16456	12	-	-	HYPH
cord-005453-4057qib7	16456	13	HCT	HCT	NNP
cord-005453-4057qib7	16456	14	,	,	,
cord-005453-4057qib7	16456	15	the	the	DT
cord-005453-4057qib7	16456	16	2	2	CD
cord-005453-4057qib7	16456	17	years	year	NNS
cord-005453-4057qib7	16456	18	cumulative	cumulative	JJ
cord-005453-4057qib7	16456	19	incidence	incidence	NN
cord-005453-4057qib7	16456	20	of	of	IN
cord-005453-4057qib7	16456	21	chronic	chronic	JJ
cord-005453-4057qib7	16456	22	graft	graft	NN
cord-005453-4057qib7	16456	23	versus	versus	IN
cord-005453-4057qib7	16456	24	host	host	NN
cord-005453-4057qib7	16456	25	disease	disease	NN
cord-005453-4057qib7	16456	26	(	(	-LRB-
cord-005453-4057qib7	16456	27	cGVHD	cGVHD	NNP
cord-005453-4057qib7	16456	28	)	)	-RRB-
cord-005453-4057qib7	16456	29	was	be	VBD
cord-005453-4057qib7	16456	30	33.4%±0.2	33.4%±0.2	NNP
cord-005453-4057qib7	16456	31	%	%	NN
cord-005453-4057qib7	16456	32	.	.	.
cord-005453-4057qib7	16457	1	Univariate	Univariate	NNP
cord-005453-4057qib7	16457	2	analysis	analysis	NN
cord-005453-4057qib7	16457	3	showed	show	VBD
cord-005453-4057qib7	16457	4	that	that	IN
cord-005453-4057qib7	16457	5	the	the	DT
cord-005453-4057qib7	16457	6	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16457	7	cell	cell	NN
cord-005453-4057qib7	16457	8	transplantation	transplantation	NN
cord-005453-4057qib7	16457	9	comorbidity	comorbidity	NN
cord-005453-4057qib7	16457	10	index(HCT	index(HCT	NNP
cord-005453-4057qib7	16457	11	-	-	HYPH
cord-005453-4057qib7	16457	12	CI	CI	NNP
cord-005453-4057qib7	16457	13	)	)	-RRB-
cord-005453-4057qib7	16457	14	and	and	CC
cord-005453-4057qib7	16457	15	grade	grade	NN
cord-005453-4057qib7	16457	16	III	III	NNP
cord-005453-4057qib7	16457	17	-	-	HYPH
cord-005453-4057qib7	16457	18	IV	IV	NNP
cord-005453-4057qib7	16457	19	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16457	20	are	be	VBP
cord-005453-4057qib7	16457	21	the	the	DT
cord-005453-4057qib7	16457	22	high	high	JJ
cord-005453-4057qib7	16457	23	risk	risk	NN
cord-005453-4057qib7	16457	24	factors	factor	NNS
cord-005453-4057qib7	16457	25	for	for	IN
cord-005453-4057qib7	16457	26	OS(81.2±4.5	OS(81.2±4.5	NNP
cord-005453-4057qib7	16457	27	%	%	NN
cord-005453-4057qib7	16457	28	vs	vs	IN
cord-005453-4057qib7	16457	29	62.8±10	62.8±10	CD
cord-005453-4057qib7	16457	30	%	%	NN
cord-005453-4057qib7	16457	31	,	,	,
cord-005453-4057qib7	16457	32	P=0.027	p=0.027	JJ
cord-005453-4057qib7	16457	33	and	and	CC
cord-005453-4057qib7	16457	34	81.9±4.4	81.9±4.4	CD
cord-005453-4057qib7	16457	35	%	%	NN
cord-005453-4057qib7	16457	36	vs	vs	IN
cord-005453-4057qib7	16457	37	51.1±11.8%,P	51.1±11.8%,p	CD
cord-005453-4057qib7	16457	38	<	<	XX
cord-005453-4057qib7	16457	39	0.001	0.001	CD
cord-005453-4057qib7	16457	40	)	)	-RRB-
cord-005453-4057qib7	16457	41	.	.	.
cord-005453-4057qib7	16458	1	Multivariate	multivariate	JJ
cord-005453-4057qib7	16458	2	analysis	analysis	NN
cord-005453-4057qib7	16458	3	demonstrated	demonstrate	VBD
cord-005453-4057qib7	16458	4	that	that	IN
cord-005453-4057qib7	16458	5	grade	grade	NN
cord-005453-4057qib7	16458	6	III	III	NNP
cord-005453-4057qib7	16458	7	-	-	HYPH
cord-005453-4057qib7	16458	8	IV	IV	NNP
cord-005453-4057qib7	16458	9	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16458	10	and	and	CC
cord-005453-4057qib7	16458	11	HCT	HCT	NNP
cord-005453-4057qib7	16458	12	-	-	HYPH
cord-005453-4057qib7	16458	13	CI	CI	NNP
cord-005453-4057qib7	16458	14	are	be	VBP
cord-005453-4057qib7	16458	15	independent	independent	JJ
cord-005453-4057qib7	16458	16	risk	risk	NN
cord-005453-4057qib7	16458	17	factors	factor	NNS
cord-005453-4057qib7	16458	18	for	for	IN
cord-005453-4057qib7	16458	19	OS(HR=6.206	OS(HR=6.206	NNP
cord-005453-4057qib7	16458	20	,	,	,
cord-005453-4057qib7	16458	21	P	p	NN
cord-005453-4057qib7	16458	22	<	<	XX
cord-005453-4057qib7	16458	23	0.001	0.001	CD
cord-005453-4057qib7	16458	24	,	,	,
cord-005453-4057qib7	16458	25	95	95	CD
cord-005453-4057qib7	16458	26	%	%	NN
cord-005453-4057qib7	16459	1	CI:2.529~15.288	CI:2.529~15.288	NNP
cord-005453-4057qib7	16459	2	and	and	CC
cord-005453-4057qib7	16459	3	HR=2.651,P=0.025	HR=2.651,P=0.025	NNP
cord-005453-4057qib7	16459	4	,	,	,
cord-005453-4057qib7	16459	5	95%CI:1.127~6.232	95%ci:1.127~6.232	CD
cord-005453-4057qib7	16459	6	)	)	-RRB-
cord-005453-4057qib7	16459	7	.	.	.
cord-005453-4057qib7	16460	1	Chemotherapy	chemotherapy	NN
cord-005453-4057qib7	16460	2	before	before	IN
cord-005453-4057qib7	16460	3	transplantation	transplantation	NN
cord-005453-4057qib7	16460	4	did	do	VBD
cord-005453-4057qib7	16460	5	not	not	RB
cord-005453-4057qib7	16460	6	improve	improve	VB
cord-005453-4057qib7	16460	7	OS	OS	NNP
cord-005453-4057qib7	16460	8	or	or	CC
cord-005453-4057qib7	16460	9	DFS	DFS	NNP
cord-005453-4057qib7	16460	10	for	for	IN
cord-005453-4057qib7	16460	11	patients	patient	NNS
cord-005453-4057qib7	16460	12	with	with	IN
cord-005453-4057qib7	16460	13	bone	bone	NN
cord-005453-4057qib7	16460	14	marrow	marrow	NN
cord-005453-4057qib7	16460	15	blast	blast	NN
cord-005453-4057qib7	16460	16	cells	cell	NNS
cord-005453-4057qib7	16460	17	more	more	JJR
cord-005453-4057qib7	16460	18	than	than	IN
cord-005453-4057qib7	16460	19	10	10	CD
cord-005453-4057qib7	16460	20	%	%	NN
cord-005453-4057qib7	16460	21	at	at	IN
cord-005453-4057qib7	16460	22	the	the	DT
cord-005453-4057qib7	16460	23	time	time	NN
cord-005453-4057qib7	16460	24	of	of	IN
cord-005453-4057qib7	16460	25	diagnosis	diagnosis	NN
cord-005453-4057qib7	16460	26	.	.	.
cord-005453-4057qib7	16461	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16461	2	:	:	:
cord-005453-4057qib7	16462	1	Allo	Allo	NNP
cord-005453-4057qib7	16462	2	-	-	HYPH
cord-005453-4057qib7	16462	3	HSCT	HSCT	NNP
cord-005453-4057qib7	16462	4	is	be	VBZ
cord-005453-4057qib7	16462	5	an	an	DT
cord-005453-4057qib7	16462	6	effective	effective	JJ
cord-005453-4057qib7	16462	7	treatment	treatment	NN
cord-005453-4057qib7	16462	8	for	for	IN
cord-005453-4057qib7	16462	9	MDS	MDS	NNP
cord-005453-4057qib7	16462	10	patients	patient	NNS
cord-005453-4057qib7	16462	11	of	of	IN
cord-005453-4057qib7	16462	12	relatively	relatively	RB
cord-005453-4057qib7	16462	13	high	high	JJ
cord-005453-4057qib7	16462	14	-	-	HYPH
cord-005453-4057qib7	16462	15	risk	risk	NN
cord-005453-4057qib7	16462	16	groups	group	NNS
cord-005453-4057qib7	16462	17	.	.	.
cord-005453-4057qib7	16463	1	The	the	DT
cord-005453-4057qib7	16463	2	physical	physical	JJ
cord-005453-4057qib7	16463	3	condition	condition	NN
cord-005453-4057qib7	16463	4	of	of	IN
cord-005453-4057qib7	16463	5	the	the	DT
cord-005453-4057qib7	16463	6	patients	patient	NNS
cord-005453-4057qib7	16463	7	and	and	CC
cord-005453-4057qib7	16463	8	occurrence	occurrence	NN
cord-005453-4057qib7	16463	9	of	of	IN
cord-005453-4057qib7	16463	10	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16463	11	are	be	VBP
cord-005453-4057qib7	16463	12	independent	independent	JJ
cord-005453-4057qib7	16463	13	risk	risk	NN
cord-005453-4057qib7	16463	14	factors	factor	NNS
cord-005453-4057qib7	16463	15	.	.	.
cord-005453-4057qib7	16464	1	For	for	IN
cord-005453-4057qib7	16464	2	intermediate	intermediate	JJ
cord-005453-4057qib7	16464	3	and	and	CC
cord-005453-4057qib7	16464	4	high	high	JJ
cord-005453-4057qib7	16464	5	risk	risk	NN
cord-005453-4057qib7	16464	6	IPSS	IPSS	NNP
cord-005453-4057qib7	16464	7	-	-	HYPH
cord-005453-4057qib7	16464	8	R	R	NNP
cord-005453-4057qib7	16464	9	MDS	MDS	NNP
cord-005453-4057qib7	16464	10	patients	patient	NNS
cord-005453-4057qib7	16464	11	,	,	,
cord-005453-4057qib7	16464	12	transplantation	transplantation	NN
cord-005453-4057qib7	16464	13	before	before	IN
cord-005453-4057qib7	16464	14	the	the	DT
cord-005453-4057qib7	16464	15	disease	disease	NN
cord-005453-4057qib7	16464	16	progressed	progress	VBD
cord-005453-4057qib7	16464	17	into	into	IN
cord-005453-4057qib7	16464	18	very	very	RB
cord-005453-4057qib7	16464	19	high	high	JJ
cord-005453-4057qib7	16464	20	risk	risk	NN
cord-005453-4057qib7	16464	21	can	can	MD
cord-005453-4057qib7	16464	22	achieve	achieve	VB
cord-005453-4057qib7	16464	23	better	well	JJR
cord-005453-4057qib7	16464	24	prognosis	prognosis	NN
cord-005453-4057qib7	16464	25	,	,	,
cord-005453-4057qib7	16464	26	high	high	JJ
cord-005453-4057qib7	16464	27	-	-	HYPH
cord-005453-4057qib7	16464	28	risk	risk	NN
cord-005453-4057qib7	16464	29	group	group	NN
cord-005453-4057qib7	16464	30	can	can	MD
cord-005453-4057qib7	16464	31	still	still	RB
cord-005453-4057qib7	16464	32	benefit	benefit	VB
cord-005453-4057qib7	16464	33	from	from	IN
cord-005453-4057qib7	16464	34	rebound	rebound	NN
cord-005453-4057qib7	16464	35	GvHD	gvhd	NN
cord-005453-4057qib7	16464	36	after	after	IN
cord-005453-4057qib7	16464	37	CNI	CNI	NNP
cord-005453-4057qib7	16464	38	tapering	tapering	NNP
cord-005453-4057qib7	16464	39	which	which	WDT
cord-005453-4057qib7	16464	40	was	be	VBD
cord-005453-4057qib7	16464	41	promptly	promptly	RB
cord-005453-4057qib7	16464	42	responsive	responsive	JJ
cord-005453-4057qib7	16464	43	to	to	IN
cord-005453-4057qib7	16464	44	treatment	treatment	NN
cord-005453-4057qib7	16464	45	steroids	steroid	NNS
cord-005453-4057qib7	16464	46	,	,	,
cord-005453-4057qib7	16464	47	FK506	FK506	NNP
cord-005453-4057qib7	16464	48	and	and	CC
cord-005453-4057qib7	16464	49	ECP	ECP	NNP
cord-005453-4057qib7	16464	50	.	.	.
cord-005453-4057qib7	16465	1	Aa	Aa	NNP
cord-005453-4057qib7	16466	1	one	one	CD
cord-005453-4057qib7	16466	2	year	year	NN
cord-005453-4057qib7	16466	3	after	after	IN
cord-005453-4057qib7	16466	4	SCT	SCT	NNP
cord-005453-4057qib7	16466	5	12/13	12/13	CD
cord-005453-4057qib7	16466	6	patients	patient	NNS
cord-005453-4057qib7	16466	7	were	be	VBD
cord-005453-4057qib7	16466	8	without	without	IN
cord-005453-4057qib7	16466	9	GvHD	GvHD	NNP
cord-005453-4057qib7	16466	10	and	and	CC
cord-005453-4057qib7	16466	11	off	off	IN
cord-005453-4057qib7	16466	12	all	all	DT
cord-005453-4057qib7	16466	13	immunosuppression	immunosuppression	NN
cord-005453-4057qib7	16466	14	while	while	IN
cord-005453-4057qib7	16466	15	one	one	CD
cord-005453-4057qib7	16466	16	single	single	JJ
cord-005453-4057qib7	16466	17	patient	patient	NN
cord-005453-4057qib7	16466	18	was	be	VBD
cord-005453-4057qib7	16466	19	still	still	RB
cord-005453-4057qib7	16466	20	on	on	IN
cord-005453-4057qib7	16466	21	taper	taper	NN
cord-005453-4057qib7	16466	22	of	of	IN
cord-005453-4057qib7	16466	23	immunosuppressant	immunosuppressant	NN
cord-005453-4057qib7	16466	24	after	after	IN
cord-005453-4057qib7	16466	25	rebound	rebound	NN
cord-005453-4057qib7	16466	26	acute	acute	JJ
cord-005453-4057qib7	16466	27	GvHD	gvhd	NN
cord-005453-4057qib7	16466	28	.	.	.
cord-005453-4057qib7	16467	1	No	no	DT
cord-005453-4057qib7	16467	2	chronic	chronic	JJ
cord-005453-4057qib7	16467	3	GvHD	gvhd	NN
cord-005453-4057qib7	16467	4	occurred	occur	VBD
cord-005453-4057qib7	16467	5	.	.	.
cord-005453-4057qib7	16468	1	SCTrelated	sctrelated	JJ
cord-005453-4057qib7	16468	2	toxicity	toxicity	NN
cord-005453-4057qib7	16468	3	was	be	VBD
cord-005453-4057qib7	16468	4	common	common	JJ
cord-005453-4057qib7	16468	5	with	with	IN
cord-005453-4057qib7	16468	6	mucositis	mucositis	NNP
cord-005453-4057qib7	16468	7	in	in	IN
cord-005453-4057qib7	16468	8	all	all	DT
cord-005453-4057qib7	16468	9	patients	patient	NNS
cord-005453-4057qib7	16468	10	(	(	-LRB-
cord-005453-4057qib7	16468	11	WHO	who	WP
cord-005453-4057qib7	16468	12	grade	grade	NN
cord-005453-4057qib7	16468	13	4	4	CD
cord-005453-4057qib7	16468	14	:	:	:
cord-005453-4057qib7	16468	15	n=5	n=5	NNP
cord-005453-4057qib7	16468	16	)	)	-RRB-
cord-005453-4057qib7	16468	17	,	,	,
cord-005453-4057qib7	16468	18	elevated	elevated	JJ
cord-005453-4057qib7	16468	19	liver	liver	NN
cord-005453-4057qib7	16468	20	enzymes	enzyme	NNS
cord-005453-4057qib7	16468	21	(	(	-LRB-
cord-005453-4057qib7	16468	22	≥grade	≥grade	IN
cord-005453-4057qib7	16468	23	3	3	CD
cord-005453-4057qib7	16468	24	:	:	:
cord-005453-4057qib7	16468	25	n=9	n=9	NN
cord-005453-4057qib7	16468	26	)	)	-RRB-
cord-005453-4057qib7	16468	27	and	and	CC
cord-005453-4057qib7	16468	28	impaired	impair	VBN
cord-005453-4057qib7	16468	29	renal	renal	JJ
cord-005453-4057qib7	16468	30	function	function	NN
cord-005453-4057qib7	16468	31	(	(	-LRB-
cord-005453-4057qib7	16468	32	GFR	GFR	NNP
cord-005453-4057qib7	16468	33	40	40	CD
cord-005453-4057qib7	16468	34	-	-	HYPH
cord-005453-4057qib7	16468	35	60ml	60ml	NN
cord-005453-4057qib7	16468	36	/	/	SYM
cord-005453-4057qib7	16468	37	min	min	NN
cord-005453-4057qib7	16468	38	:	:	:
cord-005453-4057qib7	16468	39	n=8	n=8	NN
cord-005453-4057qib7	16468	40	)	)	-RRB-
cord-005453-4057qib7	16468	41	.	.	.
cord-005453-4057qib7	16469	1	Five	five	CD
cord-005453-4057qib7	16469	2	patients	patient	NNS
cord-005453-4057qib7	16469	3	developed	develop	VBD
cord-005453-4057qib7	16469	4	neurologic	neurologic	JJ
cord-005453-4057qib7	16469	5	symptoms	symptom	NNS
cord-005453-4057qib7	16469	6	(	(	-LRB-
cord-005453-4057qib7	16469	7	seizures	seizure	NNS
cord-005453-4057qib7	16469	8	n=2	n=2	NNS
cord-005453-4057qib7	16469	9	,	,	,
cord-005453-4057qib7	16469	10	PRES	PRES	NNP
cord-005453-4057qib7	16469	11	n=1	n=1	NNP
cord-005453-4057qib7	16469	12	,	,	,
cord-005453-4057qib7	16469	13	pseudotumor	pseudotumor	NN
cord-005453-4057qib7	16469	14	cerebri	cerebri	NNP
cord-005453-4057qib7	16469	15	n=2	n=2	NNS
cord-005453-4057qib7	16469	16	)	)	-RRB-
cord-005453-4057qib7	16469	17	which	which	WDT
cord-005453-4057qib7	16469	18	all	all	DT
cord-005453-4057qib7	16469	19	resolved	resolve	VBD
cord-005453-4057qib7	16469	20	without	without	IN
cord-005453-4057qib7	16469	21	sequelae	sequela	NNS
cord-005453-4057qib7	16469	22	.	.	.
cord-005453-4057qib7	16470	1	Overall	overall	JJ
cord-005453-4057qib7	16470	2	survival	survival	NN
cord-005453-4057qib7	16470	3	and	and	CC
cord-005453-4057qib7	16470	4	transfusion	transfusion	NN
cord-005453-4057qib7	16470	5	-	-	HYPH
cord-005453-4057qib7	16470	6	free	free	JJ
cord-005453-4057qib7	16470	7	survival	survival	NN
cord-005453-4057qib7	16470	8	was	be	VBD
cord-005453-4057qib7	16470	9	100	100	CD
cord-005453-4057qib7	16470	10	%	%	NN
cord-005453-4057qib7	16470	11	with	with	IN
cord-005453-4057qib7	16470	12	a	a	DT
cord-005453-4057qib7	16470	13	median	median	JJ
cord-005453-4057qib7	16470	14	observation	observation	NN
cord-005453-4057qib7	16470	15	time	time	NN
cord-005453-4057qib7	16470	16	of	of	IN
cord-005453-4057qib7	16470	17	5	5	CD
cord-005453-4057qib7	16470	18	(	(	-LRB-
cord-005453-4057qib7	16470	19	2	2	CD
cord-005453-4057qib7	16470	20	-	-	SYM
cord-005453-4057qib7	16470	21	8	8	CD
cord-005453-4057qib7	16470	22	)	)	-RRB-
cord-005453-4057qib7	16470	23	years	year	NNS
cord-005453-4057qib7	16470	24	.	.	.
cord-005453-4057qib7	16471	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16471	2	:	:	:
cord-005453-4057qib7	16471	3	4	4	CD
cord-005453-4057qib7	16471	4	.	.	.
cord-005453-4057qib7	16472	1	Treosulfan	Treosulfan	NNP
cord-005453-4057qib7	16472	2	-	-	HYPH
cord-005453-4057qib7	16472	3	based	base	VBN
cord-005453-4057qib7	16472	4	conditioning	conditioning	NN
cord-005453-4057qib7	16472	5	followed	follow	VBN
cord-005453-4057qib7	16472	6	by	by	IN
cord-005453-4057qib7	16472	7	SCT	SCT	NNP
cord-005453-4057qib7	16472	8	from	from	IN
cord-005453-4057qib7	16472	9	HLA	HLA	NNP
cord-005453-4057qib7	16472	10	-	-	HYPH
cord-005453-4057qib7	16472	11	matched	match	VBN
cord-005453-4057qib7	16472	12	related	related	JJ
cord-005453-4057qib7	16472	13	or	or	CC
cord-005453-4057qib7	16472	14	unrelated	unrelated	JJ
cord-005453-4057qib7	16472	15	donors	donor	NNS
cord-005453-4057qib7	16472	16	represents	represent	VBZ
cord-005453-4057qib7	16472	17	a	a	DT
cord-005453-4057qib7	16472	18	highly	highly	RB
cord-005453-4057qib7	16472	19	efficacious	efficacious	JJ
cord-005453-4057qib7	16472	20	treatment	treatment	NN
cord-005453-4057qib7	16472	21	approach	approach	NN
cord-005453-4057qib7	16472	22	for	for	IN
cord-005453-4057qib7	16472	23	children	child	NNS
cord-005453-4057qib7	16472	24	,	,	,
cord-005453-4057qib7	16472	25	adolescents	adolescent	NNS
cord-005453-4057qib7	16472	26	and	and	CC
cord-005453-4057qib7	16472	27	young	young	JJ
cord-005453-4057qib7	16472	28	adults	adult	NNS
cord-005453-4057qib7	16472	29	with	with	IN
cord-005453-4057qib7	16472	30	TDT	TDT	NNP
cord-005453-4057qib7	16472	31	and	and	CC
cord-005453-4057qib7	16472	32	exhibits	exhibit	VBZ
cord-005453-4057qib7	16472	33	an	an	DT
cord-005453-4057qib7	16472	34	acceptable	acceptable	JJ
cord-005453-4057qib7	16472	35	but	but	CC
cord-005453-4057qib7	16472	36	not	not	RB
cord-005453-4057qib7	16472	37	negligible	negligible	JJ
cord-005453-4057qib7	16472	38	safety	safety	NN
cord-005453-4057qib7	16472	39	profile	profile	NN
cord-005453-4057qib7	16472	40	.	.	.
cord-005453-4057qib7	16473	1	An	an	DT
cord-005453-4057qib7	16473	2	individual	individual	JJ
cord-005453-4057qib7	16473	3	risk	risk	NN
cord-005453-4057qib7	16473	4	-	-	HYPH
cord-005453-4057qib7	16473	5	benefit	benefit	NN
cord-005453-4057qib7	16473	6	assessment	assessment	NN
cord-005453-4057qib7	16473	7	incorporating	incorporate	VBG
cord-005453-4057qib7	16473	8	hazards	hazard	NNS
cord-005453-4057qib7	16473	9	such	such	JJ
cord-005453-4057qib7	16473	10	as	as	IN
cord-005453-4057qib7	16473	11	secondary	secondary	JJ
cord-005453-4057qib7	16473	12	graft	graft	NN
cord-005453-4057qib7	16473	13	failure	failure	NN
cord-005453-4057qib7	16473	14	,	,	,
cord-005453-4057qib7	16473	15	GvHD	gvhd	NN
cord-005453-4057qib7	16473	16	and	and	CC
cord-005453-4057qib7	16473	17	long	long	JJ
cord-005453-4057qib7	16473	18	-	-	HYPH
cord-005453-4057qib7	16473	19	term	term	NN
cord-005453-4057qib7	16473	20	toxicity	toxicity	NN
cord-005453-4057qib7	16473	21	including	include	VBG
cord-005453-4057qib7	16473	22	infertility	infertility	NN
cord-005453-4057qib7	16473	23	and	and	CC
cord-005453-4057qib7	16473	24	2	2	CD
cord-005453-4057qib7	16473	25	nd	nd	NNP
cord-005453-4057qib7	16473	26	malignancy	malignancy	NN
cord-005453-4057qib7	16473	27	has	have	VBZ
cord-005453-4057qib7	16473	28	to	to	TO
cord-005453-4057qib7	16473	29	be	be	VB
cord-005453-4057qib7	16473	30	executed	execute	VBN
cord-005453-4057qib7	16473	31	in	in	IN
cord-005453-4057qib7	16473	32	the	the	DT
cord-005453-4057qib7	16473	33	informed	informed	JJ
cord-005453-4057qib7	16473	34	consent	consent	NN
cord-005453-4057qib7	16473	35	process	process	NN
cord-005453-4057qib7	16473	36	for	for	IN
cord-005453-4057qib7	16473	37	every	every	DT
cord-005453-4057qib7	16473	38	patient	patient	NN
cord-005453-4057qib7	16473	39	and	and	CC
cord-005453-4057qib7	16473	40	his	-PRON-	PRP$
cord-005453-4057qib7	16473	41	/	/	SYM
cord-005453-4057qib7	16473	42	her	-PRON-	PRP$
cord-005453-4057qib7	16473	43	guardians	guardian	NNS
cord-005453-4057qib7	16473	44	.	.	.
cord-005453-4057qib7	16474	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16474	2	:	:	:
cord-005453-4057qib7	16474	3	"	"	``
cord-005453-4057qib7	16474	4	Nothing	nothing	NN
cord-005453-4057qib7	16474	5	to	to	TO
cord-005453-4057qib7	16474	6	declare	declare	VB
cord-005453-4057qib7	16474	7	"	"	``
cord-005453-4057qib7	16474	8	P740	P740	NNP
cord-005453-4057qib7	16474	9	Abstract	Abstract	NNP
cord-005453-4057qib7	16474	10	already	already	RB
cord-005453-4057qib7	16474	11	published	publish	VBN
cord-005453-4057qib7	16474	12	.	.	.
cord-005453-4057qib7	16475	1	Early	early	JJ
cord-005453-4057qib7	16475	2	iron	iron	NN
cord-005453-4057qib7	16475	3	chelation	chelation	NN
cord-005453-4057qib7	16475	4	with	with	IN
cord-005453-4057qib7	16475	5	deferasirox	deferasirox	NNP
cord-005453-4057qib7	16475	6	might	may	MD
cord-005453-4057qib7	16475	7	prevent	prevent	VB
cord-005453-4057qib7	16475	8	relapse	relapse	NN
cord-005453-4057qib7	16475	9	after	after	IN
cord-005453-4057qib7	16475	10	busulfan	busulfan	NN
cord-005453-4057qib7	16475	11	plus	plus	CC
cord-005453-4057qib7	16475	12	fludarabine	fludarabine	NN
cord-005453-4057qib7	16475	13	and	and	CC
cord-005453-4057qib7	16475	14	ATG	ATG	NNP
cord-005453-4057qib7	16475	15	as	as	IN
cord-005453-4057qib7	16475	16	a	a	DT
cord-005453-4057qib7	16475	17	myeloablative	myeloablative	JJ
cord-005453-4057qib7	16475	18	conditioning	conditioning	NN
cord-005453-4057qib7	16475	19	for	for	IN
cord-005453-4057qib7	16475	20	HLA	HLA	NNP
cord-005453-4057qib7	16475	21	-	-	HYPH
cord-005453-4057qib7	16475	22	identical	identical	JJ
cord-005453-4057qib7	16475	23	sibling	sibling	NN
cord-005453-4057qib7	16475	24	allogeneic	allogeneic	NN
cord-005453-4057qib7	16475	25	HCT	hct	NN
cord-005453-4057qib7	16475	26	in	in	IN
cord-005453-4057qib7	16475	27	AML	AML	NNP
cord-005453-4057qib7	16475	28	Results	result	NNS
cord-005453-4057qib7	16475	29	:	:	:
cord-005453-4057qib7	16475	30	We	-PRON-	PRP
cord-005453-4057qib7	16475	31	show	show	VBP
cord-005453-4057qib7	16475	32	an	an	DT
cord-005453-4057qib7	16475	33	excellent	excellent	JJ
cord-005453-4057qib7	16475	34	concordance	concordance	NN
cord-005453-4057qib7	16475	35	between	between	IN
cord-005453-4057qib7	16475	36	chimerism	chimerism	NN
cord-005453-4057qib7	16475	37	assessment	assessment	NN
cord-005453-4057qib7	16475	38	on	on	IN
cord-005453-4057qib7	16475	39	Bio	Bio	NNP
cord-005453-4057qib7	16475	40	-	-	HYPH
cord-005453-4057qib7	16475	41	Rad	Rad	NNP
cord-005453-4057qib7	16475	42	and	and	CC
cord-005453-4057qib7	16475	43	3	3	CD
cord-005453-4057qib7	16475	44	D	d	NN
cord-005453-4057qib7	16475	45	platforms	platform	NNS
cord-005453-4057qib7	16475	46	over	over	IN
cord-005453-4057qib7	16475	47	the	the	DT
cord-005453-4057qib7	16475	48	complete	complete	JJ
cord-005453-4057qib7	16475	49	range	range	NN
cord-005453-4057qib7	16475	50	of	of	IN
cord-005453-4057qib7	16475	51	mixture	mixture	NN
cord-005453-4057qib7	16475	52	ratios	ratio	NNS
cord-005453-4057qib7	16476	1	(	(	-LRB-
cord-005453-4057qib7	16476	2	R	r	NN
cord-005453-4057qib7	16476	3	2	2	CD
cord-005453-4057qib7	16476	4	>	>	XX
cord-005453-4057qib7	16476	5	0,9	0,9	CD
cord-005453-4057qib7	16476	6	)	)	-RRB-
cord-005453-4057qib7	16477	1	and	and	CC
cord-005453-4057qib7	16477	2	proof	proof	NN
cord-005453-4057qib7	16477	3	the	the	DT
cord-005453-4057qib7	16477	4	lower	low	JJR
cord-005453-4057qib7	16477	5	detection	detection	NN
cord-005453-4057qib7	16477	6	limit	limit	NN
cord-005453-4057qib7	16477	7	(	(	-LRB-
cord-005453-4057qib7	16477	8	0,1	0,1	CD
cord-005453-4057qib7	16477	9	%	%	NN
cord-005453-4057qib7	16477	10	)	)	-RRB-
cord-005453-4057qib7	16477	11	compared	compare	VBN
cord-005453-4057qib7	16477	12	to	to	IN
cord-005453-4057qib7	16477	13	STR	STR	NNP
cord-005453-4057qib7	16477	14	-	-	HYPH
cord-005453-4057qib7	16477	15	PCR.Conclusions	pcr.conclusion	NNS
cord-005453-4057qib7	16477	16	:	:	:
cord-005453-4057qib7	16478	1	Our	-PRON-	PRP$
cord-005453-4057qib7	16478	2	results	result	NNS
cord-005453-4057qib7	16478	3	promote	promote	VBP
cord-005453-4057qib7	16478	4	the	the	DT
cord-005453-4057qib7	16478	5	transfer	transfer	NN
cord-005453-4057qib7	16478	6	of	of	IN
cord-005453-4057qib7	16478	7	the	the	DT
cord-005453-4057qib7	16478	8	established	establish	VBN
cord-005453-4057qib7	16478	9	Mentype	Mentype	NNP
cord-005453-4057qib7	16478	10	assay	assay	NN
cord-005453-4057qib7	16478	11	to	to	IN
cord-005453-4057qib7	16478	12	a	a	DT
cord-005453-4057qib7	16478	13	more	more	RBR
cord-005453-4057qib7	16478	14	diverse	diverse	JJ
cord-005453-4057qib7	16478	15	instrument	instrument	NN
cord-005453-4057qib7	16478	16	portfolio	portfolio	NN
cord-005453-4057qib7	16478	17	.	.	.
cord-005453-4057qib7	16479	1	That	that	DT
cord-005453-4057qib7	16479	2	will	will	MD
cord-005453-4057qib7	16479	3	allow	allow	VB
cord-005453-4057qib7	16479	4	to	to	TO
cord-005453-4057qib7	16479	5	implement	implement	VB
cord-005453-4057qib7	16479	6	the	the	DT
cord-005453-4057qib7	16479	7	analysis	analysis	NN
cord-005453-4057qib7	16479	8	of	of	IN
cord-005453-4057qib7	16479	9	patient	patient	NN
cord-005453-4057qib7	16479	10	and	and	CC
cord-005453-4057qib7	16479	11	donor	donor	NN
cord-005453-4057qib7	16479	12	hematopoiesis	hematopoiesis	NN
cord-005453-4057qib7	16479	13	by	by	IN
cord-005453-4057qib7	16479	14	digital	digital	JJ
cord-005453-4057qib7	16479	15	PCR	PCR	NNP
cord-005453-4057qib7	16479	16	methods	method	NNS
cord-005453-4057qib7	16479	17	in	in	IN
cord-005453-4057qib7	16479	18	our	-PRON-	PRP$
cord-005453-4057qib7	16479	19	lab	lab	NN
cord-005453-4057qib7	16479	20	.	.	.
cord-005453-4057qib7	16480	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16480	2	Background	background	NN
cord-005453-4057qib7	16480	3	:	:	:
cord-005453-4057qib7	16480	4	With	with	IN
cord-005453-4057qib7	16480	5	the	the	DT
cord-005453-4057qib7	16480	6	immense	immense	JJ
cord-005453-4057qib7	16480	7	progress	progress	NN
cord-005453-4057qib7	16480	8	in	in	IN
cord-005453-4057qib7	16480	9	therapeutic	therapeutic	JJ
cord-005453-4057qib7	16480	10	regimens	regimen	NNS
cord-005453-4057qib7	16480	11	in	in	IN
cord-005453-4057qib7	16480	12	pediatric	pediatric	JJ
cord-005453-4057qib7	16480	13	oncology	oncology	NN
cord-005453-4057qib7	16480	14	and	and	CC
cord-005453-4057qib7	16480	15	stem	stem	NN
cord-005453-4057qib7	16480	16	cell	cell	NN
cord-005453-4057qib7	16480	17	transplantation	transplantation	NN
cord-005453-4057qib7	16480	18	the	the	DT
cord-005453-4057qib7	16480	19	survivor	survivor	NN
cord-005453-4057qib7	16480	20	rates	rate	NNS
cord-005453-4057qib7	16480	21	increased	increase	VBD
cord-005453-4057qib7	16480	22	up	up	RB
cord-005453-4057qib7	16480	23	to	to	TO
cord-005453-4057qib7	16480	24	80	80	CD
cord-005453-4057qib7	16480	25	%	%	NN
cord-005453-4057qib7	16480	26	.	.	.
cord-005453-4057qib7	16481	1	At	at	IN
cord-005453-4057qib7	16481	2	the	the	DT
cord-005453-4057qib7	16481	3	same	same	JJ
cord-005453-4057qib7	16481	4	time	time	NN
cord-005453-4057qib7	16481	5	the	the	DT
cord-005453-4057qib7	16481	6	field	field	NN
cord-005453-4057qib7	16481	7	of	of	IN
cord-005453-4057qib7	16481	8	reproductive	reproductive	JJ
cord-005453-4057qib7	16481	9	medicine	medicine	NN
cord-005453-4057qib7	16481	10	has	have	VBZ
cord-005453-4057qib7	16481	11	achieved	achieve	VBN
cord-005453-4057qib7	16481	12	substantial	substantial	JJ
cord-005453-4057qib7	16481	13	advances	advance	NNS
cord-005453-4057qib7	16481	14	to	to	TO
cord-005453-4057qib7	16481	15	offer	offer	VB
cord-005453-4057qib7	16481	16	potential	potential	JJ
cord-005453-4057qib7	16481	17	options	option	NNS
cord-005453-4057qib7	16481	18	for	for	IN
cord-005453-4057qib7	16481	19	fertility	fertility	NN
cord-005453-4057qib7	16481	20	preservation	preservation	NN
cord-005453-4057qib7	16481	21	.	.	.
cord-005453-4057qib7	16482	1	Therefore	therefore	RB
cord-005453-4057qib7	16482	2	it	-PRON-	PRP
cord-005453-4057qib7	16482	3	is	be	VBZ
cord-005453-4057qib7	16482	4	of	of	IN
cord-005453-4057qib7	16482	5	great	great	JJ
cord-005453-4057qib7	16482	6	importance	importance	NN
cord-005453-4057qib7	16482	7	to	to	TO
cord-005453-4057qib7	16482	8	implement	implement	VB
cord-005453-4057qib7	16482	9	fertility	fertility	NN
cord-005453-4057qib7	16482	10	counseling	counseling	NN
cord-005453-4057qib7	16482	11	and	and	CC
cord-005453-4057qib7	16482	12	fertility	fertility	NN
cord-005453-4057qib7	16482	13	preserving	preserve	VBG
cord-005453-4057qib7	16482	14	(	(	-LRB-
cord-005453-4057qib7	16482	15	FP	FP	NNP
cord-005453-4057qib7	16482	16	)	)	-RRB-
cord-005453-4057qib7	16482	17	procedures	procedure	NNS
cord-005453-4057qib7	16482	18	for	for	IN
cord-005453-4057qib7	16482	19	patients	patient	NNS
cord-005453-4057qib7	16482	20	facing	face	VBG
cord-005453-4057qib7	16482	21	gonadotoxic	gonadotoxic	JJ
cord-005453-4057qib7	16482	22	therapy	therapy	NN
cord-005453-4057qib7	16482	23	.	.	.
cord-005453-4057qib7	16483	1	In	in	IN
cord-005453-4057qib7	16483	2	the	the	DT
cord-005453-4057qib7	16483	3	report	report	NN
cord-005453-4057qib7	16483	4	on	on	IN
cord-005453-4057qib7	16483	5	the	the	DT
cord-005453-4057qib7	16483	6	expert	expert	NN
cord-005453-4057qib7	16483	7	meeting	meeting	NN
cord-005453-4057qib7	16483	8	of	of	IN
cord-005453-4057qib7	16483	9	the	the	DT
cord-005453-4057qib7	16483	10	Paediatric	Paediatric	NNP
cord-005453-4057qib7	16483	11	Diseases	Diseases	NNPS
cord-005453-4057qib7	16483	12	Working	Working	NNP
cord-005453-4057qib7	16483	13	Party	Party	NNP
cord-005453-4057qib7	16483	14	(	(	-LRB-
cord-005453-4057qib7	16483	15	PDWP	PDWP	NNP
cord-005453-4057qib7	16483	16	)	)	-RRB-
cord-005453-4057qib7	16483	17	of	of	IN
cord-005453-4057qib7	16483	18	the	the	DT
cord-005453-4057qib7	16483	19	EBMT	EBMT	NNP
cord-005453-4057qib7	16483	20	in	in	IN
cord-005453-4057qib7	16483	21	2017	2017	CD
cord-005453-4057qib7	16483	22	counseling	counseling	NN
cord-005453-4057qib7	16483	23	related	relate	VBN
cord-005453-4057qib7	16483	24	to	to	IN
cord-005453-4057qib7	16483	25	FP	FP	NNP
cord-005453-4057qib7	16483	26	opportunities	opportunity	NNS
cord-005453-4057qib7	16483	27	should	should	MD
cord-005453-4057qib7	16483	28	be	be	VB
cord-005453-4057qib7	16483	29	offered	offer	VBN
cord-005453-4057qib7	16483	30	to	to	IN
cord-005453-4057qib7	16483	31	each	each	DT
cord-005453-4057qib7	16483	32	patient	patient	JJ
cord-005453-4057qib7	16483	33	receiving	receive	VBG
cord-005453-4057qib7	16483	34	stem	stem	NN
cord-005453-4057qib7	16483	35	cell	cell	NN
cord-005453-4057qib7	16483	36	transplantation	transplantation	NN
cord-005453-4057qib7	16483	37	(	(	-LRB-
cord-005453-4057qib7	16483	38	SCT	SCT	NNP
cord-005453-4057qib7	16483	39	)	)	-RRB-
cord-005453-4057qib7	16483	40	,	,	,
cord-005453-4057qib7	16483	41	as	as	IN
cord-005453-4057qib7	16483	42	part	part	NN
cord-005453-4057qib7	16483	43	of	of	IN
cord-005453-4057qib7	16483	44	the	the	DT
cord-005453-4057qib7	16483	45	pre	pre	JJ
cord-005453-4057qib7	16483	46	-	-	JJ
cord-005453-4057qib7	16483	47	SCT	sct	JJ
cord-005453-4057qib7	16483	48	workup	workup	NN
cord-005453-4057qib7	16483	49	by	by	IN
cord-005453-4057qib7	16483	50	a	a	DT
cord-005453-4057qib7	16483	51	dedicated	dedicated	JJ
cord-005453-4057qib7	16483	52	and	and	CC
cord-005453-4057qib7	16483	53	trained	trained	JJ
cord-005453-4057qib7	16483	54	team	team	NN
cord-005453-4057qib7	16483	55	.	.	.
cord-005453-4057qib7	16484	1	Yet	yet	CC
cord-005453-4057qib7	16484	2	there	there	EX
cord-005453-4057qib7	16484	3	many	many	JJ
cord-005453-4057qib7	16484	4	medical	medical	JJ
cord-005453-4057qib7	16484	5	,	,	,
cord-005453-4057qib7	16484	6	ethical	ethical	JJ
cord-005453-4057qib7	16484	7	,	,	,
cord-005453-4057qib7	16484	8	structural	structural	JJ
cord-005453-4057qib7	16484	9	and	and	CC
cord-005453-4057qib7	16484	10	financial	financial	JJ
cord-005453-4057qib7	16484	11	issues	issue	NNS
cord-005453-4057qib7	16484	12	to	to	TO
cord-005453-4057qib7	16484	13	consider	consider	VB
cord-005453-4057qib7	16484	14	and	and	CC
cord-005453-4057qib7	16484	15	overcome	overcome	VB
cord-005453-4057qib7	16484	16	.	.	.
cord-005453-4057qib7	16485	1	We	-PRON-	PRP
cord-005453-4057qib7	16485	2	describe	describe	VBP
cord-005453-4057qib7	16485	3	the	the	DT
cord-005453-4057qib7	16485	4	setting	setting	NN
cord-005453-4057qib7	16485	5	up	up	RP
cord-005453-4057qib7	16485	6	process	process	NN
cord-005453-4057qib7	16485	7	to	to	TO
cord-005453-4057qib7	16485	8	enable	enable	VB
cord-005453-4057qib7	16485	9	fertility	fertility	NN
cord-005453-4057qib7	16485	10	counseling	counsel	VBG
cord-005453-4057qib7	16485	11	for	for	IN
cord-005453-4057qib7	16485	12	all	all	DT
cord-005453-4057qib7	16485	13	children	child	NNS
cord-005453-4057qib7	16485	14	with	with	IN
cord-005453-4057qib7	16485	15	newly	newly	RB
cord-005453-4057qib7	16485	16	diagnosed	diagnose	VBN
cord-005453-4057qib7	16485	17	cancer	cancer	NN
cord-005453-4057qib7	16485	18	or	or	CC
cord-005453-4057qib7	16485	19	those	those	DT
cord-005453-4057qib7	16485	20	facing	face	VBG
cord-005453-4057qib7	16485	21	stem	stem	NN
cord-005453-4057qib7	16485	22	cell	cell	NN
cord-005453-4057qib7	16485	23	transplantation	transplantation	NN
cord-005453-4057qib7	16485	24	for	for	IN
cord-005453-4057qib7	16485	25	malignant	malignant	JJ
cord-005453-4057qib7	16485	26	and	and	CC
cord-005453-4057qib7	16485	27	nonmalignant	nonmalignant	JJ
cord-005453-4057qib7	16485	28	diseases	disease	NNS
cord-005453-4057qib7	16485	29	in	in	IN
cord-005453-4057qib7	16485	30	our	-PRON-	PRP$
cord-005453-4057qib7	16485	31	department	department	NN
cord-005453-4057qib7	16485	32	of	of	IN
cord-005453-4057qib7	16485	33	pediatric	pediatric	NNP
cord-005453-4057qib7	16485	34	oncology	oncology	NNP
cord-005453-4057qib7	16485	35	and	and	CC
cord-005453-4057qib7	16485	36	immunology	immunology	NN
cord-005453-4057qib7	16485	37	/	/	SYM
cord-005453-4057qib7	16485	38	stem	stem	NN
cord-005453-4057qib7	16485	39	cell	cell	NN
cord-005453-4057qib7	16485	40	transplantation	transplantation	NN
cord-005453-4057qib7	16485	41	.	.	.
cord-005453-4057qib7	16486	1	Methods	method	NNS
cord-005453-4057qib7	16486	2	:	:	:
cord-005453-4057qib7	16486	3	At	at	IN
cord-005453-4057qib7	16486	4	our	-PRON-	PRP$
cord-005453-4057qib7	16486	5	tertiary	tertiary	JJ
cord-005453-4057qib7	16486	6	care	care	NN
cord-005453-4057qib7	16486	7	center	center	NN
cord-005453-4057qib7	16486	8	we	-PRON-	PRP
cord-005453-4057qib7	16486	9	assembled	assemble	VBD
cord-005453-4057qib7	16486	10	a	a	DT
cord-005453-4057qib7	16486	11	multidisciplinary	multidisciplinary	JJ
cord-005453-4057qib7	16486	12	team	team	NN
cord-005453-4057qib7	16486	13	involved	involve	VBN
cord-005453-4057qib7	16486	14	in	in	IN
cord-005453-4057qib7	16486	15	fertility	fertility	NN
cord-005453-4057qib7	16486	16	preservation	preservation	NN
cord-005453-4057qib7	16486	17	(	(	-LRB-
cord-005453-4057qib7	16486	18	pediatric	pediatric	JJ
cord-005453-4057qib7	16486	19	hematology	hematology	NN
cord-005453-4057qib7	16486	20	/	/	SYM
cord-005453-4057qib7	16486	21	oncology	oncology	NN
cord-005453-4057qib7	16486	22	,	,	,
cord-005453-4057qib7	16486	23	pediatric	pediatric	JJ
cord-005453-4057qib7	16486	24	immunology/	immunology/	NN
cord-005453-4057qib7	16486	25	stem	stem	NN
cord-005453-4057qib7	16486	26	cell	cell	NN
cord-005453-4057qib7	16486	27	transplantation	transplantation	NN
cord-005453-4057qib7	16486	28	,	,	,
cord-005453-4057qib7	16486	29	reproductive	reproductive	JJ
cord-005453-4057qib7	16486	30	medicine	medicine	NN
cord-005453-4057qib7	16486	31	,	,	,
cord-005453-4057qib7	16486	32	andrology	andrology	NN
cord-005453-4057qib7	16486	33	,	,	,
cord-005453-4057qib7	16486	34	psychology	psychology	NN
cord-005453-4057qib7	16486	35	and	and	CC
cord-005453-4057qib7	16486	36	pediatric	pediatric	JJ
cord-005453-4057qib7	16486	37	surgery	surgery	NN
cord-005453-4057qib7	16486	38	)	)	-RRB-
cord-005453-4057qib7	16486	39	.	.	.
cord-005453-4057qib7	16487	1	We	-PRON-	PRP
cord-005453-4057qib7	16487	2	developed	develop	VBD
cord-005453-4057qib7	16487	3	an	an	DT
cord-005453-4057qib7	16487	4	internal	internal	JJ
cord-005453-4057qib7	16487	5	grading	grading	NN
cord-005453-4057qib7	16487	6	system	system	NN
cord-005453-4057qib7	16487	7	for	for	IN
cord-005453-4057qib7	16487	8	recommendations	recommendation	NNS
cord-005453-4057qib7	16487	9	regarding	regard	VBG
cord-005453-4057qib7	16487	10	fertility	fertility	NN
cord-005453-4057qib7	16487	11	preservation	preservation	NN
cord-005453-4057qib7	16487	12	based	base	VBN
cord-005453-4057qib7	16487	13	on	on	IN
cord-005453-4057qib7	16487	14	the	the	DT
cord-005453-4057qib7	16487	15	current	current	JJ
cord-005453-4057qib7	16487	16	recommendations	recommendation	NNS
cord-005453-4057qib7	16487	17	for	for	IN
cord-005453-4057qib7	16487	18	fertility	fertility	NN
cord-005453-4057qib7	16487	19	preservation	preservation	NN
cord-005453-4057qib7	16487	20	of	of	IN
cord-005453-4057qib7	16487	21	leading	lead	VBG
cord-005453-4057qib7	16487	22	societies	society	NNS
cord-005453-4057qib7	16487	23	in	in	IN
cord-005453-4057qib7	16487	24	this	this	DT
cord-005453-4057qib7	16487	25	field	field	NN
cord-005453-4057qib7	16487	26	like	like	IN
cord-005453-4057qib7	16487	27	EBMT	EBMT	NNP
cord-005453-4057qib7	16487	28	,	,	,
cord-005453-4057qib7	16487	29	GPOH	GPOH	NNP
cord-005453-4057qib7	16487	30	and	and	CC
cord-005453-4057qib7	16487	31	DGGG	DGGG	NNP
cord-005453-4057qib7	16487	32	.	.	.
cord-005453-4057qib7	16488	1	It	-PRON-	PRP
cord-005453-4057qib7	16488	2	is	be	VBZ
cord-005453-4057qib7	16488	3	important	important	JJ
cord-005453-4057qib7	16488	4	to	to	TO
cord-005453-4057qib7	16488	5	find	find	VB
cord-005453-4057qib7	16488	6	a	a	DT
cord-005453-4057qib7	16488	7	consensus	consensus	NN
cord-005453-4057qib7	16488	8	within	within	IN
cord-005453-4057qib7	16488	9	the	the	DT
cord-005453-4057qib7	16488	10	team	team	NN
cord-005453-4057qib7	16488	11	for	for	IN
cord-005453-4057qib7	16488	12	the	the	DT
cord-005453-4057qib7	16488	13	counseling	counseling	NN
cord-005453-4057qib7	16488	14	to	to	TO
cord-005453-4057qib7	16488	15	ensure	ensure	VB
cord-005453-4057qib7	16488	16	reliable	reliable	JJ
cord-005453-4057qib7	16488	17	counseling	counseling	NN
cord-005453-4057qib7	16488	18	.	.	.
cord-005453-4057qib7	16489	1	The	the	DT
cord-005453-4057qib7	16489	2	third	third	JJ
cord-005453-4057qib7	16489	3	step	step	NN
cord-005453-4057qib7	16489	4	is	be	VBZ
cord-005453-4057qib7	16489	5	to	to	TO
cord-005453-4057qib7	16489	6	implement	implement	VB
cord-005453-4057qib7	16489	7	structures	structure	NNS
cord-005453-4057qib7	16489	8	needed	need	VBN
cord-005453-4057qib7	16489	9	for	for	IN
cord-005453-4057qib7	16489	10	fertility	fertility	NN
cord-005453-4057qib7	16489	11	counseling	counseling	NN
cord-005453-4057qib7	16489	12	and	and	CC
cord-005453-4057qib7	16489	13	performance	performance	NN
cord-005453-4057qib7	16489	14	of	of	IN
cord-005453-4057qib7	16489	15	invasive	invasive	JJ
cord-005453-4057qib7	16489	16	procedures	procedure	NNS
cord-005453-4057qib7	16489	17	including	include	VBG
cord-005453-4057qib7	16489	18	legal	legal	JJ
cord-005453-4057qib7	16489	19	aspects	aspect	NNS
cord-005453-4057qib7	16489	20	(	(	-LRB-
cord-005453-4057qib7	16489	21	AMG	AMG	NNP
cord-005453-4057qib7	16489	22	)	)	-RRB-
cord-005453-4057qib7	16489	23	.	.	.
cord-005453-4057qib7	16490	1	A	a	DT
cord-005453-4057qib7	16490	2	detailed	detailed	JJ
cord-005453-4057qib7	16490	3	description	description	NN
cord-005453-4057qib7	16490	4	of	of	IN
cord-005453-4057qib7	16490	5	this	this	DT
cord-005453-4057qib7	16490	6	process	process	NN
cord-005453-4057qib7	16490	7	is	be	VBZ
cord-005453-4057qib7	16490	8	given	give	VBN
cord-005453-4057qib7	16490	9	.	.	.
cord-005453-4057qib7	16491	1	Results	result	NNS
cord-005453-4057qib7	16491	2	:	:	:
cord-005453-4057qib7	16492	1	After	after	IN
cord-005453-4057qib7	16492	2	setting	set	VBG
cord-005453-4057qib7	16492	3	up	up	RP
cord-005453-4057qib7	16492	4	structures	structure	NNS
cord-005453-4057qib7	16492	5	for	for	IN
cord-005453-4057qib7	16492	6	the	the	DT
cord-005453-4057qib7	16492	7	counseling	counseling	NN
cord-005453-4057qib7	16492	8	process	process	NN
cord-005453-4057qib7	16492	9	we	-PRON-	PRP
cord-005453-4057qib7	16492	10	counseled	counsel	VBD
cord-005453-4057qib7	16492	11	140	140	CD
cord-005453-4057qib7	16492	12	oncology	oncology	NN
cord-005453-4057qib7	16492	13	and	and	CC
cord-005453-4057qib7	16492	14	stem	stem	NN
cord-005453-4057qib7	16492	15	cell	cell	NN
cord-005453-4057qib7	16492	16	transplant	transplant	NN
cord-005453-4057qib7	16492	17	patients	patient	NNS
cord-005453-4057qib7	16492	18	(	(	-LRB-
cord-005453-4057qib7	16492	19	0	0	CD
cord-005453-4057qib7	16492	20	-	-	SYM
cord-005453-4057qib7	16492	21	18	18	CD
cord-005453-4057qib7	16492	22	years	year	NNS
cord-005453-4057qib7	16492	23	)	)	-RRB-
cord-005453-4057qib7	16492	24	between	between	IN
cord-005453-4057qib7	16492	25	January	January	NNP
cord-005453-4057qib7	16492	26	2017	2017	CD
cord-005453-4057qib7	16492	27	and	and	CC
cord-005453-4057qib7	16492	28	May	May	NNP
cord-005453-4057qib7	16492	29	2018	2018	CD
cord-005453-4057qib7	16492	30	.	.	.
cord-005453-4057qib7	16493	1	We	-PRON-	PRP
cord-005453-4057qib7	16493	2	analysed	analyse	VBD
cord-005453-4057qib7	16493	3	data	datum	NNS
cord-005453-4057qib7	16493	4	of	of	IN
cord-005453-4057qib7	16493	5	the	the	DT
cord-005453-4057qib7	16493	6	patients	patient	NNS
cord-005453-4057qib7	16493	7	including	include	VBG
cord-005453-4057qib7	16493	8	age	age	NN
cord-005453-4057qib7	16493	9	subgroups	subgroup	NNS
cord-005453-4057qib7	16493	10	and	and	CC
cord-005453-4057qib7	16493	11	disease	disease	NN
cord-005453-4057qib7	16493	12	entities	entity	NNS
cord-005453-4057qib7	16493	13	and	and	CC
cord-005453-4057qib7	16493	14	the	the	DT
cord-005453-4057qib7	16493	15	results	result	NNS
cord-005453-4057qib7	16493	16	of	of	IN
cord-005453-4057qib7	16493	17	the	the	DT
cord-005453-4057qib7	16493	18	counseling	counseling	NN
cord-005453-4057qib7	16493	19	process	process	NN
cord-005453-4057qib7	16493	20	.	.	.
cord-005453-4057qib7	16494	1	For	for	IN
cord-005453-4057qib7	16494	2	those	those	DT
cord-005453-4057qib7	16494	3	patients	patient	NNS
cord-005453-4057qib7	16494	4	undergoing	undergo	VBG
cord-005453-4057qib7	16494	5	stem	stem	NN
cord-005453-4057qib7	16494	6	cell	cell	NN
cord-005453-4057qib7	16494	7	transplantation	transplantation	NN
cord-005453-4057qib7	16494	8	the	the	DT
cord-005453-4057qib7	16494	9	risk	risk	NN
cord-005453-4057qib7	16494	10	of	of	IN
cord-005453-4057qib7	16494	11	gonadotoxicity	gonadotoxicity	NN
cord-005453-4057qib7	16494	12	is	be	VBZ
cord-005453-4057qib7	16494	13	very	very	RB
cord-005453-4057qib7	16494	14	high	high	JJ
cord-005453-4057qib7	16494	15	,	,	,
cord-005453-4057qib7	16494	16	therefore	therefore	RB
cord-005453-4057qib7	16494	17	even	even	RB
cord-005453-4057qib7	16494	18	the	the	DT
cord-005453-4057qib7	16494	19	very	very	RB
cord-005453-4057qib7	16494	20	young	young	JJ
cord-005453-4057qib7	16494	21	children	child	NNS
cord-005453-4057qib7	16494	22	underwent	undergo	VBD
cord-005453-4057qib7	16494	23	fertility	fertility	NN
cord-005453-4057qib7	16494	24	preserving	preserve	VBG
cord-005453-4057qib7	16494	25	procedures	procedure	NNS
cord-005453-4057qib7	16494	26	in	in	IN
cord-005453-4057qib7	16494	27	alignment	alignment	NN
cord-005453-4057qib7	16494	28	with	with	IN
cord-005453-4057qib7	16494	29	our	-PRON-	PRP$
cord-005453-4057qib7	16494	30	recommendations	recommendation	NNS
cord-005453-4057qib7	16494	31	if	if	IN
cord-005453-4057qib7	16494	32	they	-PRON-	PRP
cord-005453-4057qib7	16494	33	suffered	suffer	VBD
cord-005453-4057qib7	16494	34	from	from	IN
cord-005453-4057qib7	16494	35	a	a	DT
cord-005453-4057qib7	16494	36	nonmalignant	nonmalignant	NNP
cord-005453-4057qib7	16494	37	disease	disease	NN
cord-005453-4057qib7	16494	38	.	.	.
cord-005453-4057qib7	16495	1	Currently	currently	RB
cord-005453-4057qib7	16495	2	we	-PRON-	PRP
cord-005453-4057qib7	16495	3	discourage	discourage	VBP
cord-005453-4057qib7	16495	4	tissue	tissue	NN
cord-005453-4057qib7	16495	5	preserving	preserve	VBG
cord-005453-4057qib7	16495	6	in	in	IN
cord-005453-4057qib7	16495	7	malignant	malignant	JJ
cord-005453-4057qib7	16495	8	systemic	systemic	JJ
cord-005453-4057qib7	16495	9	disease	disease	NN
cord-005453-4057qib7	16495	10	due	due	JJ
cord-005453-4057qib7	16495	11	to	to	IN
cord-005453-4057qib7	16495	12	possible	possible	JJ
cord-005453-4057qib7	16495	13	contamination	contamination	NN
cord-005453-4057qib7	16495	14	with	with	IN
cord-005453-4057qib7	16495	15	malignant	malignant	JJ
cord-005453-4057qib7	16495	16	cells	cell	NNS
cord-005453-4057qib7	16495	17	.	.	.
cord-005453-4057qib7	16496	1	Postpubertal	postpubertal	JJ
cord-005453-4057qib7	16496	2	female	female	JJ
cord-005453-4057qib7	16496	3	patients	patient	NNS
cord-005453-4057qib7	16496	4	were	be	VBD
cord-005453-4057qib7	16496	5	more	more	RBR
cord-005453-4057qib7	16496	6	likely	likely	JJ
cord-005453-4057qib7	16496	7	to	to	TO
cord-005453-4057qib7	16496	8	undergo	undergo	VB
cord-005453-4057qib7	16496	9	invasive	invasive	JJ
cord-005453-4057qib7	16496	10	procedures	procedure	NNS
cord-005453-4057qib7	16496	11	such	such	JJ
cord-005453-4057qib7	16496	12	as	as	IN
cord-005453-4057qib7	16496	13	ovarian	ovarian	JJ
cord-005453-4057qib7	16496	14	tissue	tissue	NN
cord-005453-4057qib7	16496	15	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	16496	16	in	in	IN
cord-005453-4057qib7	16496	17	the	the	DT
cord-005453-4057qib7	16496	18	case	case	NN
cord-005453-4057qib7	16496	19	of	of	IN
cord-005453-4057qib7	16496	20	oncological	oncological	JJ
cord-005453-4057qib7	16496	21	diseases	disease	NNS
cord-005453-4057qib7	16496	22	,	,	,
cord-005453-4057qib7	16496	23	while	while	IN
cord-005453-4057qib7	16496	24	sperm	sperm	NN
cord-005453-4057qib7	16496	25	cryopreservation	cryopreservation	NN
cord-005453-4057qib7	16496	26	was	be	VBD
cord-005453-4057qib7	16496	27	recommended	recommend	VBN
cord-005453-4057qib7	16496	28	in	in	IN
cord-005453-4057qib7	16496	29	all	all	DT
cord-005453-4057qib7	16496	30	postpubertal	postpubertal	JJ
cord-005453-4057qib7	16496	31	male	male	JJ
cord-005453-4057qib7	16496	32	patients	patient	NNS
cord-005453-4057qib7	16496	33	.	.	.
cord-005453-4057qib7	16497	1	Overall	overall	RB
cord-005453-4057qib7	16497	2	a	a	DT
cord-005453-4057qib7	16497	3	high	high	JJ
cord-005453-4057qib7	16497	4	percentage	percentage	NN
cord-005453-4057qib7	16497	5	of	of	IN
cord-005453-4057qib7	16497	6	the	the	DT
cord-005453-4057qib7	16497	7	patients	patient	NNS
cord-005453-4057qib7	16497	8	and	and	CC
cord-005453-4057qib7	16497	9	their	-PRON-	PRP$
cord-005453-4057qib7	16497	10	family	family	NN
cord-005453-4057qib7	16497	11	followed	follow	VBD
cord-005453-4057qib7	16497	12	our	-PRON-	PRP$
cord-005453-4057qib7	16497	13	recommendations	recommendation	NNS
cord-005453-4057qib7	16497	14	.	.	.
cord-005453-4057qib7	16498	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16498	2	:	:	:
cord-005453-4057qib7	16499	1	Fertility	fertility	NN
cord-005453-4057qib7	16499	2	preservation	preservation	NN
cord-005453-4057qib7	16499	3	should	should	MD
cord-005453-4057qib7	16499	4	be	be	VB
cord-005453-4057qib7	16499	5	considered	consider	VBN
cord-005453-4057qib7	16499	6	as	as	IN
cord-005453-4057qib7	16499	7	a	a	DT
cord-005453-4057qib7	16499	8	very	very	RB
cord-005453-4057qib7	16499	9	important	important	JJ
cord-005453-4057qib7	16499	10	part	part	NN
cord-005453-4057qib7	16499	11	of	of	IN
cord-005453-4057qib7	16499	12	the	the	DT
cord-005453-4057qib7	16499	13	treatment	treatment	NN
cord-005453-4057qib7	16499	14	plan	plan	NN
cord-005453-4057qib7	16499	15	for	for	IN
cord-005453-4057qib7	16499	16	newly	newly	RB
cord-005453-4057qib7	16499	17	diagnosed	diagnose	VBN
cord-005453-4057qib7	16499	18	children	child	NNS
cord-005453-4057qib7	16499	19	and	and	CC
cord-005453-4057qib7	16499	20	young	young	JJ
cord-005453-4057qib7	16499	21	adults	adult	NNS
cord-005453-4057qib7	16499	22	with	with	IN
cord-005453-4057qib7	16499	23	cancer	cancer	NN
cord-005453-4057qib7	16499	24	and	and	CC
cord-005453-4057qib7	16499	25	those	those	DT
cord-005453-4057qib7	16499	26	facing	face	VBG
cord-005453-4057qib7	16499	27	stem	stem	NN
cord-005453-4057qib7	16499	28	cell	cell	NN
cord-005453-4057qib7	16499	29	transplantation	transplantation	NN
cord-005453-4057qib7	16499	30	.	.	.
cord-005453-4057qib7	16500	1	Unfortunately	unfortunately	RB
cord-005453-4057qib7	16500	2	there	there	EX
cord-005453-4057qib7	16500	3	is	be	VBZ
cord-005453-4057qib7	16500	4	still	still	RB
cord-005453-4057qib7	16500	5	a	a	DT
cord-005453-4057qib7	16500	6	great	great	JJ
cord-005453-4057qib7	16500	7	need	need	NN
cord-005453-4057qib7	16500	8	for	for	IN
cord-005453-4057qib7	16500	9	setting	set	VBG
cord-005453-4057qib7	16500	10	up	up	RP
cord-005453-4057qib7	16500	11	structures	structure	NNS
cord-005453-4057qib7	16500	12	in	in	IN
cord-005453-4057qib7	16500	13	institutions	institution	NNS
cord-005453-4057qib7	16500	14	taking	take	VBG
cord-005453-4057qib7	16500	15	care	care	NN
cord-005453-4057qib7	16500	16	of	of	IN
cord-005453-4057qib7	16500	17	these	these	DT
cord-005453-4057qib7	16500	18	patients	patient	NNS
cord-005453-4057qib7	16500	19	.	.	.
cord-005453-4057qib7	16501	1	In	in	IN
cord-005453-4057qib7	16501	2	addition	addition	NN
cord-005453-4057qib7	16501	3	fertility	fertility	NN
cord-005453-4057qib7	16501	4	preservation	preservation	NN
cord-005453-4057qib7	16501	5	sadly	sadly	RB
cord-005453-4057qib7	16501	6	lacks	lack	VBZ
cord-005453-4057qib7	16501	7	funding	funding	NN
cord-005453-4057qib7	16501	8	by	by	IN
cord-005453-4057qib7	16501	9	health	health	NN
cord-005453-4057qib7	16501	10	insurance	insurance	NN
cord-005453-4057qib7	16501	11	in	in	IN
cord-005453-4057qib7	16501	12	some	some	DT
cord-005453-4057qib7	16501	13	countries	country	NNS
cord-005453-4057qib7	16501	14	.	.	.
cord-005453-4057qib7	16502	1	With	with	IN
cord-005453-4057qib7	16502	2	the	the	DT
cord-005453-4057qib7	16502	3	presentation	presentation	NN
cord-005453-4057qib7	16502	4	of	of	IN
cord-005453-4057qib7	16502	5	our	-PRON-	PRP$
cord-005453-4057qib7	16502	6	experience	experience	NN
cord-005453-4057qib7	16502	7	and	and	CC
cord-005453-4057qib7	16502	8	data	datum	NNS
cord-005453-4057qib7	16502	9	we	-PRON-	PRP
cord-005453-4057qib7	16502	10	want	want	VBP
cord-005453-4057qib7	16502	11	to	to	TO
cord-005453-4057qib7	16502	12	facilitate	facilitate	VB
cord-005453-4057qib7	16502	13	incorporation	incorporation	NN
cord-005453-4057qib7	16502	14	of	of	IN
cord-005453-4057qib7	16502	15	fertility	fertility	NN
cord-005453-4057qib7	16502	16	counseling	counsel	VBG
cord-005453-4057qib7	16502	17	in	in	IN
cord-005453-4057qib7	16502	18	other	other	JJ
cord-005453-4057qib7	16502	19	pediatric	pediatric	JJ
cord-005453-4057qib7	16502	20	care	care	NN
cord-005453-4057qib7	16502	21	centers	center	NNS
cord-005453-4057qib7	16502	22	to	to	TO
cord-005453-4057qib7	16502	23	provide	provide	VB
cord-005453-4057qib7	16502	24	counseling	counseling	NN
cord-005453-4057qib7	16502	25	for	for	IN
cord-005453-4057qib7	16502	26	pediatric	pediatric	JJ
cord-005453-4057qib7	16502	27	patients	patient	NNS
cord-005453-4057qib7	16502	28	in	in	IN
cord-005453-4057qib7	16502	29	need	need	NN
cord-005453-4057qib7	16502	30	for	for	IN
cord-005453-4057qib7	16502	31	fertility	fertility	NN
cord-005453-4057qib7	16502	32	preservation	preservation	NN
cord-005453-4057qib7	16502	33	.	.	.
cord-005453-4057qib7	16503	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16503	2	:	:	:
cord-005453-4057qib7	16503	3	no	no	DT
cord-005453-4057qib7	16503	4	conflict	conflict	NN
cord-005453-4057qib7	16503	5	of	of	IN
cord-005453-4057qib7	16503	6	interest	interest	NN
cord-005453-4057qib7	16503	7	Regulatory	Regulatory	NNP
cord-005453-4057qib7	16503	8	T	T	NNP
cord-005453-4057qib7	16503	9	-	-	HYPH
cord-005453-4057qib7	16503	10	cells	cell	NNS
cord-005453-4057qib7	16503	11	(	(	-LRB-
cord-005453-4057qib7	16503	12	T	T	NNP
cord-005453-4057qib7	16503	13	reg	reg	NNP
cord-005453-4057qib7	16503	14	)	)	-RRB-
cord-005453-4057qib7	16503	15	have	have	VBP
cord-005453-4057qib7	16503	16	been	be	VBN
cord-005453-4057qib7	16503	17	shown	show	VBN
cord-005453-4057qib7	16503	18	to	to	TO
cord-005453-4057qib7	16503	19	play	play	VB
cord-005453-4057qib7	16503	20	a	a	DT
cord-005453-4057qib7	16503	21	role	role	NN
cord-005453-4057qib7	16503	22	not	not	RB
cord-005453-4057qib7	16503	23	only	only	RB
cord-005453-4057qib7	16503	24	in	in	IN
cord-005453-4057qib7	16503	25	autoimmune	autoimmune	JJ
cord-005453-4057qib7	16503	26	diseases	disease	NNS
cord-005453-4057qib7	16503	27	and	and	CC
cord-005453-4057qib7	16503	28	solid	solid	JJ
cord-005453-4057qib7	16503	29	organ	organ	NN
cord-005453-4057qib7	16503	30	transplantation	transplantation	NN
cord-005453-4057qib7	16503	31	but	but	CC
cord-005453-4057qib7	16503	32	also	also	RB
cord-005453-4057qib7	16503	33	in	in	IN
cord-005453-4057qib7	16503	34	GvHD	GvHD	NNP
cord-005453-4057qib7	16503	35	.	.	.
cord-005453-4057qib7	16504	1	Several	several	JJ
cord-005453-4057qib7	16504	2	mouse	mouse	NN
cord-005453-4057qib7	16504	3	models	model	NNS
cord-005453-4057qib7	16504	4	showed	show	VBD
cord-005453-4057qib7	16504	5	a	a	DT
cord-005453-4057qib7	16504	6	decrease	decrease	NN
cord-005453-4057qib7	16504	7	of	of	IN
cord-005453-4057qib7	16504	8	GvHD	gvhd	NN
cord-005453-4057qib7	16504	9	incidence	incidence	NN
cord-005453-4057qib7	16504	10	after	after	IN
cord-005453-4057qib7	16504	11	T	T	NNP
cord-005453-4057qib7	16504	12	reg	reg	NNP
cord-005453-4057qib7	16504	13	administration	administration	NN
cord-005453-4057qib7	16504	14	.	.	.
cord-005453-4057qib7	16505	1	The	the	DT
cord-005453-4057qib7	16505	2	few	few	JJ
cord-005453-4057qib7	16505	3	clinical	clinical	JJ
cord-005453-4057qib7	16505	4	trials	trial	NNS
cord-005453-4057qib7	16505	5	regarding	regard	VBG
cord-005453-4057qib7	16505	6	the	the	DT
cord-005453-4057qib7	16505	7	application	application	NN
cord-005453-4057qib7	16505	8	of	of	IN
cord-005453-4057qib7	16505	9	T	T	NNP
cord-005453-4057qib7	16505	10	reg	reg	NNP
cord-005453-4057qib7	16505	11	for	for	IN
cord-005453-4057qib7	16505	12	the	the	DT
cord-005453-4057qib7	16505	13	treatment	treatment	NN
cord-005453-4057qib7	16505	14	of	of	IN
cord-005453-4057qib7	16505	15	GvHD	GvHD	NNP
cord-005453-4057qib7	16505	16	are	be	VBP
cord-005453-4057qib7	16505	17	encouraging	encouraging	JJ
cord-005453-4057qib7	16505	18	,	,	,
cord-005453-4057qib7	16505	19	however	however	RB
cord-005453-4057qib7	16505	20	the	the	DT
cord-005453-4057qib7	16505	21	data	data	NN
cord-005453-4057qib7	16505	22	is	be	VBZ
cord-005453-4057qib7	16505	23	limited	limited	JJ
cord-005453-4057qib7	16505	24	.	.	.
cord-005453-4057qib7	16506	1	Methods	method	NNS
cord-005453-4057qib7	16506	2	:	:	:
cord-005453-4057qib7	16506	3	Patient	patient	NN
cord-005453-4057qib7	16506	4	:	:	:
cord-005453-4057qib7	16507	1	A	a	DT
cord-005453-4057qib7	16507	2	14-year	14-year	JJ
cord-005453-4057qib7	16507	3	-	-	HYPH
cord-005453-4057qib7	16507	4	old	old	JJ
cord-005453-4057qib7	16507	5	boy	boy	NN
cord-005453-4057qib7	16507	6	underwent	undergo	VBD
cord-005453-4057qib7	16507	7	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16507	8	SCT	SCT	NNP
cord-005453-4057qib7	16507	9	for	for	IN
cord-005453-4057qib7	16507	10	chronic	chronic	JJ
cord-005453-4057qib7	16507	11	myeloid	myeloid	NN
cord-005453-4057qib7	16507	12	leukemia	leukemia	NN
cord-005453-4057qib7	16507	13	refractory	refractory	JJ
cord-005453-4057qib7	16507	14	to	to	IN
cord-005453-4057qib7	16507	15	imatinib	imatinib	NN
cord-005453-4057qib7	16507	16	,	,	,
cord-005453-4057qib7	16507	17	dasatinib	dasatinib	NN
cord-005453-4057qib7	16507	18	and	and	CC
cord-005453-4057qib7	16507	19	nilotinib	nilotinib	JJ
cord-005453-4057qib7	16507	20	treatment	treatment	NN
cord-005453-4057qib7	16507	21	from	from	IN
cord-005453-4057qib7	16507	22	his	-PRON-	PRP$
cord-005453-4057qib7	16507	23	10/10	10/10	CD
cord-005453-4057qib7	16507	24	HLA	HLA	NNP
cord-005453-4057qib7	16507	25	identical	identical	JJ
cord-005453-4057qib7	16507	26	brother	brother	NN
cord-005453-4057qib7	16507	27	.	.	.
cord-005453-4057qib7	16508	1	Freshly	freshly	RB
cord-005453-4057qib7	16508	2	derived	derive	VBN
cord-005453-4057qib7	16508	3	unmanipulated	unmanipulated	JJ
cord-005453-4057qib7	16508	4	bone	bone	NN
cord-005453-4057qib7	16508	5	marrow	marrow	NN
cord-005453-4057qib7	16508	6	was	be	VBD
cord-005453-4057qib7	16508	7	transplanted	transplant	VBN
cord-005453-4057qib7	16508	8	after	after	IN
cord-005453-4057qib7	16508	9	conditioning	condition	VBG
cord-005453-4057qib7	16508	10	with	with	IN
cord-005453-4057qib7	16508	11	of	of	IN
cord-005453-4057qib7	16508	12	fludarabine	fludarabine	NN
cord-005453-4057qib7	16508	13	(	(	-LRB-
cord-005453-4057qib7	16508	14	40	40	CD
cord-005453-4057qib7	16508	15	mg	mg	NNP
cord-005453-4057qib7	16508	16	/	/	SYM
cord-005453-4057qib7	16508	17	m²/d	m²/d	NN
cord-005453-4057qib7	16508	18	,	,	,
cord-005453-4057qib7	16508	19	day	day	NN
cord-005453-4057qib7	16508	20	-7	-7	ADD
cord-005453-4057qib7	16508	21	to	to	IN
cord-005453-4057qib7	16508	22	-4	-4	ADD
cord-005453-4057qib7	16508	23	)	)	-RRB-
cord-005453-4057qib7	16508	24	,	,	,
cord-005453-4057qib7	16508	25	thiotepa	thiotepa	JJ
cord-005453-4057qib7	16508	26	(	(	-LRB-
cord-005453-4057qib7	16508	27	2x	2x	CD
cord-005453-4057qib7	16508	28	5mg/	5mg/	CD
cord-005453-4057qib7	16508	29	kg	kg	NN
cord-005453-4057qib7	16508	30	,	,	,
cord-005453-4057qib7	16508	31	day	day	NN
cord-005453-4057qib7	16508	32	-3	-3	NNP
cord-005453-4057qib7	16508	33	)	)	-RRB-
cord-005453-4057qib7	16508	34	and	and	CC
cord-005453-4057qib7	16508	35	melphalan	melphalan	NNP
cord-005453-4057qib7	16508	36	(	(	-LRB-
cord-005453-4057qib7	16508	37	160	160	CD
cord-005453-4057qib7	16508	38	mg	mg	NNP
cord-005453-4057qib7	16508	39	/	/	SYM
cord-005453-4057qib7	16508	40	m²	m²	NNP
cord-005453-4057qib7	16508	41	,	,	,
cord-005453-4057qib7	16508	42	day	day	NN
cord-005453-4057qib7	16508	43	-2	-2	CD
cord-005453-4057qib7	16508	44	)	)	-RRB-
cord-005453-4057qib7	16508	45	.	.	.
cord-005453-4057qib7	16509	1	Cyclosporin	Cyclosporin	NNP
cord-005453-4057qib7	16509	2	A	a	DT
cord-005453-4057qib7	16509	3	(	(	-LRB-
cord-005453-4057qib7	16509	4	CsA	csa	NN
cord-005453-4057qib7	16509	5	)	)	-RRB-
cord-005453-4057qib7	16509	6	and	and	CC
cord-005453-4057qib7	16509	7	mycophenolatmofetil	mycophenolatmofetil	NNP
cord-005453-4057qib7	16509	8	(	(	-LRB-
cord-005453-4057qib7	16509	9	MMF	MMF	NNP
cord-005453-4057qib7	16509	10	)	)	-RRB-
cord-005453-4057qib7	16509	11	were	be	VBD
cord-005453-4057qib7	16509	12	used	use	VBN
cord-005453-4057qib7	16509	13	for	for	IN
cord-005453-4057qib7	16509	14	GvHD	GvHD	NNP
cord-005453-4057qib7	16509	15	prophylaxis	prophylaxis	NN
cord-005453-4057qib7	16509	16	.	.	.
cord-005453-4057qib7	16510	1	Leukocyte	Leukocyte	NNP
cord-005453-4057qib7	16510	2	regeneration	regeneration	NN
cord-005453-4057qib7	16510	3	(	(	-LRB-
cord-005453-4057qib7	16510	4	>	>	NFP
cord-005453-4057qib7	16510	5	1000	1000	CD
cord-005453-4057qib7	16510	6	/	/	SYM
cord-005453-4057qib7	16510	7	μl	μl	NN
cord-005453-4057qib7	16510	8	)	)	-RRB-
cord-005453-4057qib7	16510	9	was	be	VBD
cord-005453-4057qib7	16510	10	seen	see	VBN
cord-005453-4057qib7	16510	11	on	on	IN
cord-005453-4057qib7	16510	12	day	day	NN
cord-005453-4057qib7	16510	13	+15	+15	CD
cord-005453-4057qib7	16511	1	,	,	,
cord-005453-4057qib7	16511	2	granulocyte	granulocyte	NN
cord-005453-4057qib7	16511	3	regeneration	regeneration	NN
cord-005453-4057qib7	16511	4	(	(	-LRB-
cord-005453-4057qib7	16511	5	>	>	NFP
cord-005453-4057qib7	16511	6	500	500	CD
cord-005453-4057qib7	16511	7	/	/	SYM
cord-005453-4057qib7	16511	8	μl	μl	NN
cord-005453-4057qib7	16511	9	)	)	-RRB-
cord-005453-4057qib7	16511	10	on	on	IN
cord-005453-4057qib7	16511	11	day	day	NN
cord-005453-4057qib7	16511	12	+16	+16	NNP
cord-005453-4057qib7	16511	13	and	and	CC
cord-005453-4057qib7	16511	14	thrombocyte	thrombocyte	NN
cord-005453-4057qib7	16511	15	regeneration	regeneration	NN
cord-005453-4057qib7	16511	16	(	(	-LRB-
cord-005453-4057qib7	16511	17	>	>	NFP
cord-005453-4057qib7	16511	18	50.000	50.000	CD
cord-005453-4057qib7	16511	19	/	/	SYM
cord-005453-4057qib7	16511	20	μl	μl	NN
cord-005453-4057qib7	16511	21	)	)	-RRB-
cord-005453-4057qib7	16511	22	on	on	IN
cord-005453-4057qib7	16511	23	day	day	NN
cord-005453-4057qib7	16511	24	+21	+21	CD
cord-005453-4057qib7	16511	25	.	.	.
cord-005453-4057qib7	16512	1	On	on	IN
cord-005453-4057qib7	16512	2	day	day	NN
cord-005453-4057qib7	16512	3	+30	+30	CD
cord-005453-4057qib7	16512	4	after	after	IN
cord-005453-4057qib7	16512	5	SCT	SCT	NNP
cord-005453-4057qib7	16512	6	he	-PRON-	PRP
cord-005453-4057qib7	16512	7	developed	develop	VBD
cord-005453-4057qib7	16512	8	acute	acute	JJ
cord-005453-4057qib7	16512	9	intestinal	intestinal	JJ
cord-005453-4057qib7	16512	10	GvHD	GvHD	NNP
cord-005453-4057qib7	16512	11	that	that	WDT
cord-005453-4057qib7	16512	12	exacerbated	exacerbate	VBD
cord-005453-4057qib7	16512	13	to	to	IN
cord-005453-4057qib7	16512	14	grade	grade	NN
cord-005453-4057qib7	16512	15	IV	IV	NNP
cord-005453-4057qib7	16512	16	°	°	NN
cord-005453-4057qib7	16512	17	(bloody	(bloody	NN
cord-005453-4057qib7	16512	18	diarrhea	diarrhea	NN
cord-005453-4057qib7	16512	19	,	,	,
cord-005453-4057qib7	16512	20	ileus	ileus	NNP
cord-005453-4057qib7	16512	21	)	)	-RRB-
cord-005453-4057qib7	16512	22	and	and	CC
cord-005453-4057qib7	16512	23	did	do	VBD
cord-005453-4057qib7	16512	24	neither	neither	CC
cord-005453-4057qib7	16512	25	respond	respond	VB
cord-005453-4057qib7	16512	26	to	to	IN
cord-005453-4057qib7	16512	27	steroids	steroid	NNS
cord-005453-4057qib7	16512	28	,	,	,
cord-005453-4057qib7	16512	29	nor	nor	CC
cord-005453-4057qib7	16512	30	to	to	IN
cord-005453-4057qib7	16512	31	different	different	JJ
cord-005453-4057qib7	16512	32	immunosuppressive	immunosuppressive	JJ
cord-005453-4057qib7	16512	33	drugs	drug	NNS
cord-005453-4057qib7	16512	34	such	such	JJ
cord-005453-4057qib7	16512	35	as	as	IN
cord-005453-4057qib7	16512	36	cyclosporin	cyclosporin	NN
cord-005453-4057qib7	16512	37	,	,	,
cord-005453-4057qib7	16512	38	tacrolimus	tacrolimus	NNP
cord-005453-4057qib7	16512	39	,	,	,
cord-005453-4057qib7	16512	40	sirolimus	sirolimus	NNP
cord-005453-4057qib7	16512	41	,	,	,
cord-005453-4057qib7	16512	42	mycophenolatemofetil	mycophenolatemofetil	NNP
cord-005453-4057qib7	16512	43	and	and	CC
cord-005453-4057qib7	16512	44	ruxolitinib	ruxolitinib	NNP
cord-005453-4057qib7	16512	45	.	.	.
cord-005453-4057qib7	16513	1	Extracorporal	Extracorporal	NNP
cord-005453-4057qib7	16513	2	photopheresis	photopheresis	NNP
cord-005453-4057qib7	16513	3	and	and	CC
cord-005453-4057qib7	16513	4	the	the	DT
cord-005453-4057qib7	16513	5	administration	administration	NN
cord-005453-4057qib7	16513	6	of	of	IN
cord-005453-4057qib7	16513	7	immunmodulatory	immunmodulatory	NNP
cord-005453-4057qib7	16513	8	antibodies	antibodies	NNP
cord-005453-4057qib7	16513	9	(	(	-LRB-
cord-005453-4057qib7	16513	10	adalimumab	adalimumab	NNP
cord-005453-4057qib7	16513	11	and	and	CC
cord-005453-4057qib7	16513	12	tocilizumab	tocilizumab	NNP
cord-005453-4057qib7	16513	13	)	)	-RRB-
cord-005453-4057qib7	16513	14	did	do	VBD
cord-005453-4057qib7	16513	15	not	not	RB
cord-005453-4057qib7	16513	16	succeed	succeed	VB
cord-005453-4057qib7	16513	17	either	either	RB
cord-005453-4057qib7	16513	18	.	.	.
cord-005453-4057qib7	16514	1	Results	result	NNS
cord-005453-4057qib7	16514	2	:	:	:
cord-005453-4057qib7	16515	1	By	by	IN
cord-005453-4057qib7	16515	2	administration	administration	NN
cord-005453-4057qib7	16515	3	of	of	IN
cord-005453-4057qib7	16515	4	low	low	JJ
cord-005453-4057qib7	16515	5	-	-	HYPH
cord-005453-4057qib7	16515	6	dose	dose	NN
cord-005453-4057qib7	16515	7	interleukin-2	interleukin-2	IN
cord-005453-4057qib7	16515	8	(	(	-LRB-
cord-005453-4057qib7	16515	9	IL-2	IL-2	NNP
cord-005453-4057qib7	16515	10	)	)	-RRB-
cord-005453-4057qib7	16515	11	in	in	IN
cord-005453-4057qib7	16515	12	vivo	vivo	NN
cord-005453-4057qib7	16515	13	induction	induction	NN
cord-005453-4057qib7	16515	14	of	of	IN
cord-005453-4057qib7	16515	15	T	T	NNP
cord-005453-4057qib7	16515	16	reg	reg	NNP
cord-005453-4057qib7	16515	17	was	be	VBD
cord-005453-4057qib7	16515	18	expected	expect	VBN
cord-005453-4057qib7	16515	19	but	but	CC
cord-005453-4057qib7	16515	20	did	do	VBD
cord-005453-4057qib7	16515	21	not	not	RB
cord-005453-4057qib7	16515	22	succeed	succeed	VB
cord-005453-4057qib7	16515	23	.	.	.
cord-005453-4057qib7	16516	1	Finally	finally	RB
cord-005453-4057qib7	16516	2	antithymocyte	antithymocyte	NNP
cord-005453-4057qib7	16516	3	globuline	globuline	NNP
cord-005453-4057qib7	16516	4	(	(	-LRB-
cord-005453-4057qib7	16516	5	ATG	ATG	NNP
cord-005453-4057qib7	16516	6	,	,	,
cord-005453-4057qib7	16516	7	20	20	CD
cord-005453-4057qib7	16516	8	mg	mg	NNP
cord-005453-4057qib7	16516	9	/	/	SYM
cord-005453-4057qib7	16516	10	kg/	kg/	NNP
cord-005453-4057qib7	16516	11	d	d	NNP
cord-005453-4057qib7	16516	12	)	)	-RRB-
cord-005453-4057qib7	16516	13	was	be	VBD
cord-005453-4057qib7	16516	14	administered	administer	VBN
cord-005453-4057qib7	16516	15	on	on	IN
cord-005453-4057qib7	16516	16	day	day	NN
cord-005453-4057qib7	16516	17	+150	+150	NNP
cord-005453-4057qib7	16516	18	to	to	IN
cord-005453-4057qib7	16516	19	+152	+152	NNP
cord-005453-4057qib7	16516	20	to	to	TO
cord-005453-4057qib7	16516	21	eliminate	eliminate	VB
cord-005453-4057qib7	16516	22	the	the	DT
cord-005453-4057qib7	16516	23	GvHD	gvhd	NN
cord-005453-4057qib7	16516	24	-	-	HYPH
cord-005453-4057qib7	16516	25	triggering	trigger	VBG
cord-005453-4057qib7	16516	26	cells	cell	NNS
cord-005453-4057qib7	16516	27	.	.	.
cord-005453-4057qib7	16517	1	Hence	hence	RB
cord-005453-4057qib7	16517	2	,	,	,
cord-005453-4057qib7	16517	3	the	the	DT
cord-005453-4057qib7	16517	4	GvHD	gvhd	NN
cord-005453-4057qib7	16517	5	declined	decline	VBD
cord-005453-4057qib7	16517	6	to	to	IN
cord-005453-4057qib7	16517	7	grade	grade	NN
cord-005453-4057qib7	16517	8	III	III	NNP
cord-005453-4057qib7	16517	9	.	.	.
cord-005453-4057qib7	16518	1	Finally	finally	RB
cord-005453-4057qib7	16518	2	,	,	,
cord-005453-4057qib7	16518	3	a	a	DT
cord-005453-4057qib7	16518	4	decision	decision	NN
cord-005453-4057qib7	16518	5	was	be	VBD
cord-005453-4057qib7	16518	6	made	make	VBN
cord-005453-4057qib7	16518	7	to	to	TO
cord-005453-4057qib7	16518	8	manufacture	manufacture	VB
cord-005453-4057qib7	16518	9	T	T	NNP
cord-005453-4057qib7	16518	10	reg	reg	NN
cord-005453-4057qib7	16518	11	from	from	IN
cord-005453-4057qib7	16518	12	his	-PRON-	PRP$
cord-005453-4057qib7	16518	13	stem	stem	NN
cord-005453-4057qib7	16518	14	cell	cell	NN
cord-005453-4057qib7	16518	15	donor	donor	NN
cord-005453-4057qib7	16518	16	.	.	.
cord-005453-4057qib7	16519	1	From	from	IN
cord-005453-4057qib7	16519	2	an	an	DT
cord-005453-4057qib7	16519	3	unstimulated	unstimulated	JJ
cord-005453-4057qib7	16519	4	leukapheresis	leukapheresis	NN
cord-005453-4057qib7	16519	5	T	T	NNP
cord-005453-4057qib7	16519	6	reg	reg	NNP
cord-005453-4057qib7	16519	7	were	be	VBD
cord-005453-4057qib7	16519	8	selected	select	VBN
cord-005453-4057qib7	16519	9	by	by	IN
cord-005453-4057qib7	16519	10	magnetic	magnetic	JJ
cord-005453-4057qib7	16519	11	depletion	depletion	NN
cord-005453-4057qib7	16519	12	of	of	IN
cord-005453-4057qib7	16519	13	CD8	CD8	NNP
cord-005453-4057qib7	16519	14	+	+	CC
cord-005453-4057qib7	16519	15	T	T	NNP
cord-005453-4057qib7	16519	16	-	-	HYPH
cord-005453-4057qib7	16519	17	cells	cell	NNS
cord-005453-4057qib7	16519	18	and	and	CC
cord-005453-4057qib7	16519	19	CD19	CD19	NNP
cord-005453-4057qib7	16519	20	+	+	CC
cord-005453-4057qib7	16519	21	B	b	NN
cord-005453-4057qib7	16519	22	-	-	HYPH
cord-005453-4057qib7	16519	23	cells	cell	NNS
cord-005453-4057qib7	16519	24	followed	follow	VBN
cord-005453-4057qib7	16519	25	by	by	IN
cord-005453-4057qib7	16519	26	positive	positive	JJ
cord-005453-4057qib7	16519	27	selection	selection	NN
cord-005453-4057qib7	16519	28	of	of	IN
cord-005453-4057qib7	16519	29	CD25	CD25	NNP
cord-005453-4057qib7	16519	30	+	+	CC
cord-005453-4057qib7	16519	31	Background	background	NN
cord-005453-4057qib7	16519	32	:	:	:
cord-005453-4057qib7	16520	1	Treatment	treatment	NN
cord-005453-4057qib7	16520	2	of	of	IN
cord-005453-4057qib7	16520	3	patients	patient	NNS
cord-005453-4057qib7	16520	4	with	with	IN
cord-005453-4057qib7	16520	5	transfusion	transfusion	NN
cord-005453-4057qib7	16520	6	dependent	dependent	JJ
cord-005453-4057qib7	16520	7	anemia	anemia	NN
cord-005453-4057qib7	16520	8	like	like	IN
cord-005453-4057qib7	16520	9	thalassemia	thalassemia	NN
cord-005453-4057qib7	16520	10	major	major	NN
cord-005453-4057qib7	16520	11	(	(	-LRB-
cord-005453-4057qib7	16520	12	TM	TM	NNP
cord-005453-4057qib7	16520	13	)	)	-RRB-
cord-005453-4057qib7	16520	14	,	,	,
cord-005453-4057qib7	16520	15	sickle	sickle	NN
cord-005453-4057qib7	16520	16	cell	cell	NN
cord-005453-4057qib7	16520	17	disease	disease	NN
cord-005453-4057qib7	16520	18	(	(	-LRB-
cord-005453-4057qib7	16520	19	SCD	SCD	NNP
cord-005453-4057qib7	16520	20	)	)	-RRB-
cord-005453-4057qib7	16520	21	and	and	CC
cord-005453-4057qib7	16520	22	Diamond	Diamond	NNP
cord-005453-4057qib7	16520	23	-	-	HYPH
cord-005453-4057qib7	16520	24	Blackfan	Blackfan	NNP
cord-005453-4057qib7	16520	25	anemia	anemia	NN
cord-005453-4057qib7	16520	26	(	(	-LRB-
cord-005453-4057qib7	16520	27	DBA	DBA	NNP
cord-005453-4057qib7	16520	28	)	)	-RRB-
cord-005453-4057qib7	16520	29	has	have	VBZ
cord-005453-4057qib7	16520	30	improved	improve	VBN
cord-005453-4057qib7	16520	31	over	over	IN
cord-005453-4057qib7	16520	32	the	the	DT
cord-005453-4057qib7	16520	33	last	last	JJ
cord-005453-4057qib7	16520	34	decades	decade	NNS
cord-005453-4057qib7	16520	35	.	.	.
cord-005453-4057qib7	16521	1	For	for	IN
cord-005453-4057qib7	16521	2	the	the	DT
cord-005453-4057qib7	16521	3	vast	vast	JJ
cord-005453-4057qib7	16521	4	majority	majority	NN
cord-005453-4057qib7	16521	5	of	of	IN
cord-005453-4057qib7	16521	6	patients	patient	NNS
cord-005453-4057qib7	16521	7	,	,	,
cord-005453-4057qib7	16521	8	allogeneic	allogeneic	IN
cord-005453-4057qib7	16521	9	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16521	10	stem	stem	NN
cord-005453-4057qib7	16521	11	cell	cell	NN
cord-005453-4057qib7	16521	12	transplantation	transplantation	NN
cord-005453-4057qib7	16521	13	(	(	-LRB-
cord-005453-4057qib7	16521	14	HSCT	HSCT	NNP
cord-005453-4057qib7	16521	15	)	)	-RRB-
cord-005453-4057qib7	16521	16	is	be	VBZ
cord-005453-4057qib7	16521	17	the	the	DT
cord-005453-4057qib7	16521	18	only	only	RB
cord-005453-4057qib7	16521	19	available	available	JJ
cord-005453-4057qib7	16521	20	curative	curative	JJ
cord-005453-4057qib7	16521	21	therapy	therapy	NN
cord-005453-4057qib7	16521	22	.	.	.
cord-005453-4057qib7	16522	1	For	for	IN
cord-005453-4057qib7	16522	2	a	a	DT
cord-005453-4057qib7	16522	3	long	long	JJ
cord-005453-4057qib7	16522	4	time	time	NN
cord-005453-4057qib7	16522	5	,	,	,
cord-005453-4057qib7	16522	6	HSCT	HSCT	NNP
cord-005453-4057qib7	16522	7	has	have	VBZ
cord-005453-4057qib7	16522	8	only	only	RB
cord-005453-4057qib7	16522	9	been	be	VBN
cord-005453-4057qib7	16522	10	performed	perform	VBN
cord-005453-4057qib7	16522	11	from	from	IN
cord-005453-4057qib7	16522	12	HLA	HLA	NNP
cord-005453-4057qib7	16522	13	-	-	HYPH
cord-005453-4057qib7	16522	14	identical	identical	JJ
cord-005453-4057qib7	16522	15	sibling	sibling	NN
cord-005453-4057qib7	16522	16	donors	donor	NNS
cord-005453-4057qib7	16522	17	(	(	-LRB-
cord-005453-4057qib7	16522	18	MSD	MSD	NNP
cord-005453-4057qib7	16522	19	)	)	-RRB-
cord-005453-4057qib7	16522	20	or	or	CC
cord-005453-4057qib7	16522	21	matched	match	VBN
cord-005453-4057qib7	16522	22	family	family	NN
cord-005453-4057qib7	16522	23	donors	donor	NNS
cord-005453-4057qib7	16522	24	(	(	-LRB-
cord-005453-4057qib7	16522	25	MFD	MFD	NNP
cord-005453-4057qib7	16522	26	)	)	-RRB-
cord-005453-4057qib7	16522	27	.	.	.
cord-005453-4057qib7	16523	1	However	however	RB
cord-005453-4057qib7	16523	2	,	,	,
cord-005453-4057qib7	16523	3	approximately	approximately	RB
cord-005453-4057qib7	16523	4	only	only	RB
cord-005453-4057qib7	16523	5	25	25	CD
cord-005453-4057qib7	16523	6	-	-	SYM
cord-005453-4057qib7	16523	7	30	30	CD
cord-005453-4057qib7	16523	8	%	%	NN
cord-005453-4057qib7	16523	9	of	of	IN
cord-005453-4057qib7	16523	10	affected	affected	JJ
cord-005453-4057qib7	16523	11	patients	patient	NNS
cord-005453-4057qib7	16523	12	do	do	VBP
cord-005453-4057qib7	16523	13	have	have	VB
cord-005453-4057qib7	16523	14	a	a	DT
cord-005453-4057qib7	16523	15	matched	match	VBN
cord-005453-4057qib7	16523	16	sibling	sibling	NN
cord-005453-4057qib7	16523	17	donor	donor	NN
cord-005453-4057qib7	16523	18	,	,	,
cord-005453-4057qib7	16523	19	therefore	therefore	RB
cord-005453-4057qib7	16523	20	HSCT	HSCT	NNP
cord-005453-4057qib7	16523	21	from	from	IN
cord-005453-4057qib7	16523	22	10/	10/	CD
cord-005453-4057qib7	16523	23	10	10	CD
cord-005453-4057qib7	16523	24	(	(	-LRB-
cord-005453-4057qib7	16523	25	MUD	mud	NN
cord-005453-4057qib7	16523	26	)	)	-RRB-
cord-005453-4057qib7	16523	27	and	and	CC
cord-005453-4057qib7	16523	28	even	even	RB
cord-005453-4057qib7	16523	29	9/10	9/10	CD
cord-005453-4057qib7	16523	30	(	(	-LRB-
cord-005453-4057qib7	16523	31	MMUD	MMUD	NNP
cord-005453-4057qib7	16523	32	)	)	-RRB-
cord-005453-4057qib7	16524	1	matched	match	VBN
cord-005453-4057qib7	16524	2	unrelated	unrelated	JJ
cord-005453-4057qib7	16524	3	donors	donor	NNS
cord-005453-4057qib7	16524	4	has	have	VBZ
cord-005453-4057qib7	16524	5	gained	gain	VBN
cord-005453-4057qib7	16524	6	importance	importance	NN
cord-005453-4057qib7	16524	7	in	in	IN
cord-005453-4057qib7	16524	8	recent	recent	JJ
cord-005453-4057qib7	16524	9	years	year	NNS
cord-005453-4057qib7	16524	10	.	.	.
cord-005453-4057qib7	16525	1	Methods	method	NNS
cord-005453-4057qib7	16525	2	:	:	:
cord-005453-4057qib7	16525	3	36	36	CD
cord-005453-4057qib7	16525	4	patients	patient	NNS
cord-005453-4057qib7	16525	5	(	(	-LRB-
cord-005453-4057qib7	16525	6	age	age	NN
cord-005453-4057qib7	16525	7	range	range	NN
cord-005453-4057qib7	16525	8	:	:	:
cord-005453-4057qib7	16525	9	2	2	CD
cord-005453-4057qib7	16525	10	-	-	SYM
cord-005453-4057qib7	16525	11	27	27	CD
cord-005453-4057qib7	16525	12	years	year	NNS
cord-005453-4057qib7	16525	13	)	)	-RRB-
cord-005453-4057qib7	16525	14	with	with	IN
cord-005453-4057qib7	16525	15	SCD	SCD	NNP
cord-005453-4057qib7	16525	16	(	(	-LRB-
cord-005453-4057qib7	16525	17	n=7	n=7	NNP
cord-005453-4057qib7	16525	18	)	)	-RRB-
cord-005453-4057qib7	16525	19	,	,	,
cord-005453-4057qib7	16525	20	DBA	DBA	NNP
cord-005453-4057qib7	16525	21	(	(	-LRB-
cord-005453-4057qib7	16525	22	n=6	n=6	NNP
cord-005453-4057qib7	16525	23	)	)	-RRB-
cord-005453-4057qib7	16525	24	or	or	CC
cord-005453-4057qib7	16525	25	TM	TM	NNP
cord-005453-4057qib7	16525	26	(	(	-LRB-
cord-005453-4057qib7	16525	27	n=23	n=23	NNP
cord-005453-4057qib7	16525	28	)	)	-RRB-
cord-005453-4057qib7	16525	29	,	,	,
cord-005453-4057qib7	16525	30	receiving	receive	VBG
cord-005453-4057qib7	16525	31	HSCT	HSCT	NNP
cord-005453-4057qib7	16525	32	from	from	IN
cord-005453-4057qib7	16525	33	a	a	DT
cord-005453-4057qib7	16525	34	MSD	MSD	NNP
cord-005453-4057qib7	16525	35	,	,	,
cord-005453-4057qib7	16525	36	MFD	MFD	NNP
cord-005453-4057qib7	16525	37	,	,	,
cord-005453-4057qib7	16525	38	MUD	MUD	NNP
cord-005453-4057qib7	16525	39	or	or	CC
cord-005453-4057qib7	16525	40	MMUD	MMUD	NNP
cord-005453-4057qib7	16525	41	between	between	IN
cord-005453-4057qib7	16525	42	2010	2010	CD
cord-005453-4057qib7	16525	43	and	and	CC
cord-005453-4057qib7	16525	44	2019	2019	CD
cord-005453-4057qib7	16525	45	were	be	VBD
cord-005453-4057qib7	16525	46	included	include	VBN
cord-005453-4057qib7	16525	47	in	in	IN
cord-005453-4057qib7	16525	48	our	-PRON-	PRP$
cord-005453-4057qib7	16525	49	analysis	analysis	NN
cord-005453-4057qib7	16525	50	.	.	.
cord-005453-4057qib7	16526	1	23	23	CD
cord-005453-4057qib7	16526	2	patients	patient	NNS
cord-005453-4057qib7	16526	3	received	receive	VBD
cord-005453-4057qib7	16526	4	transplants	transplant	NNS
cord-005453-4057qib7	16526	5	from	from	IN
cord-005453-4057qib7	16526	6	MSD	MSD	NNP
cord-005453-4057qib7	16526	7	/	/	SYM
cord-005453-4057qib7	16526	8	MFD	MFD	NNP
cord-005453-4057qib7	16526	9	,	,	,
cord-005453-4057qib7	16526	10	13	13	CD
cord-005453-4057qib7	16526	11	patients	patient	NNS
cord-005453-4057qib7	16526	12	from	from	IN
cord-005453-4057qib7	16526	13	MUD/	MUD/	NNP
cord-005453-4057qib7	16526	14	MMUD	MMUD	NNP
cord-005453-4057qib7	16526	15	.	.	.
cord-005453-4057qib7	16527	1	7	7	CD
cord-005453-4057qib7	16527	2	patients	patient	NNS
cord-005453-4057qib7	16527	3	were	be	VBD
cord-005453-4057qib7	16527	4	identical	identical	JJ
cord-005453-4057qib7	16527	5	for	for	IN
cord-005453-4057qib7	16527	6	HLA	HLA	NNP
cord-005453-4057qib7	16527	7	-	-	HYPH
cord-005453-4057qib7	16527	8	A	A	NNP
cord-005453-4057qib7	16527	9	,	,	,
cord-005453-4057qib7	16527	10	B	B	NNP
cord-005453-4057qib7	16527	11	,	,	,
cord-005453-4057qib7	16527	12	CW	CW	NNP
cord-005453-4057qib7	16527	13	,	,	,
cord-005453-4057qib7	16527	14	DRB1	DRB1	NNP
cord-005453-4057qib7	16527	15	and	and	CC
cord-005453-4057qib7	16527	16	DQB1	DQB1	NNP
cord-005453-4057qib7	16527	17	,	,	,
cord-005453-4057qib7	16527	18	6	6	CD
cord-005453-4057qib7	16527	19	patients	patient	NNS
cord-005453-4057qib7	16527	20	shared	share	VBD
cord-005453-4057qib7	16527	21	only	only	RB
cord-005453-4057qib7	16527	22	9/10	9/10	CD
cord-005453-4057qib7	16527	23	genes	gene	NNS
cord-005453-4057qib7	16527	24	.	.	.
cord-005453-4057qib7	16528	1	We	-PRON-	PRP
cord-005453-4057qib7	16528	2	analyzed	analyze	VBD
cord-005453-4057qib7	16528	3	extended	extended	JJ
cord-005453-4057qib7	16528	4	haplotypes	haplotype	NNS
cord-005453-4057qib7	16528	5	including	include	VBG
cord-005453-4057qib7	16528	6	DRB3	DRB3	NNP
cord-005453-4057qib7	16528	7	,	,	,
cord-005453-4057qib7	16528	8	DRB4	DRB4	NNP
cord-005453-4057qib7	16528	9	,	,	,
cord-005453-4057qib7	16528	10	DRB5	DRB5	NNP
cord-005453-4057qib7	16528	11	and	and	CC
cord-005453-4057qib7	16528	12	DPB1	DPB1	NNP
cord-005453-4057qib7	16528	13	for	for	IN
cord-005453-4057qib7	16528	14	all	all	DT
cord-005453-4057qib7	16528	15	patients	patient	NNS
cord-005453-4057qib7	16528	16	with	with	IN
cord-005453-4057qib7	16528	17	thalassemia	thalassemia	NN
cord-005453-4057qib7	16528	18	.	.	.
cord-005453-4057qib7	16529	1	7	7	CD
cord-005453-4057qib7	16529	2	pairs	pair	NNS
cord-005453-4057qib7	16529	3	showed	show	VBD
cord-005453-4057qib7	16529	4	non	non	JJ
cord-005453-4057qib7	16529	5	-	-	JJ
cord-005453-4057qib7	16529	6	permissive	permissive	JJ
cord-005453-4057qib7	16529	7	DPB1	dpb1	JJ
cord-005453-4057qib7	16529	8	mismatch	mismatch	NN
cord-005453-4057qib7	16529	9	and	and	CC
cord-005453-4057qib7	16529	10	1	1	CD
cord-005453-4057qib7	16529	11	pair	pair	NN
cord-005453-4057qib7	16529	12	mismatch	mismatch	NN
cord-005453-4057qib7	16529	13	for	for	IN
cord-005453-4057qib7	16529	14	DPB1	DPB1	NNP
cord-005453-4057qib7	16529	15	and	and	CC
cord-005453-4057qib7	16529	16	DRB4.Results	DRB4.Results	NNP
cord-005453-4057qib7	16529	17	:	:	:
cord-005453-4057qib7	16529	18	Median	median	JJ
cord-005453-4057qib7	16529	19	time	time	NN
cord-005453-4057qib7	16529	20	for	for	IN
cord-005453-4057qib7	16529	21	granulocyte	granulocyte	NN
cord-005453-4057qib7	16529	22	recovery	recovery	NN
cord-005453-4057qib7	16529	23	was	be	VBD
cord-005453-4057qib7	16529	24	20	20	CD
cord-005453-4057qib7	16529	25	days	day	NNS
cord-005453-4057qib7	16529	26	in	in	IN
cord-005453-4057qib7	16529	27	patients	patient	NNS
cord-005453-4057qib7	16529	28	transplanted	transplant	VBN
cord-005453-4057qib7	16529	29	from	from	IN
cord-005453-4057qib7	16529	30	MSD	MSD	NNP
cord-005453-4057qib7	16529	31	/	/	SYM
cord-005453-4057qib7	16529	32	MFD	MFD	NNP
cord-005453-4057qib7	16529	33	and	and	CC
cord-005453-4057qib7	16529	34	22	22	CD
cord-005453-4057qib7	16529	35	days	day	NNS
cord-005453-4057qib7	16529	36	in	in	IN
cord-005453-4057qib7	16529	37	patients	patient	NNS
cord-005453-4057qib7	16529	38	transplanted	transplant	VBN
cord-005453-4057qib7	16529	39	from	from	IN
cord-005453-4057qib7	16529	40	MUD	mud	NN
cord-005453-4057qib7	16529	41	/	/	SYM
cord-005453-4057qib7	16529	42	MMUD	MMUD	NNP
cord-005453-4057qib7	16529	43	.	.	.
cord-005453-4057qib7	16530	1	Platelet	platelet	NN
cord-005453-4057qib7	16530	2	recovery	recovery	NN
cord-005453-4057qib7	16530	3	was	be	VBD
cord-005453-4057qib7	16530	4	reached	reach	VBN
cord-005453-4057qib7	16530	5	after	after	IN
cord-005453-4057qib7	16530	6	22	22	CD
cord-005453-4057qib7	16530	7	days	day	NNS
cord-005453-4057qib7	16530	8	after	after	IN
cord-005453-4057qib7	16530	9	HSCT	HSCT	NNP
cord-005453-4057qib7	16530	10	from	from	IN
cord-005453-4057qib7	16530	11	MSD	MSD	NNP
cord-005453-4057qib7	16530	12	/	/	SYM
cord-005453-4057qib7	16530	13	MFD	MFD	NNP
cord-005453-4057qib7	16530	14	and	and	CC
cord-005453-4057qib7	16530	15	24	24	CD
cord-005453-4057qib7	16530	16	days	day	NNS
cord-005453-4057qib7	16530	17	after	after	IN
cord-005453-4057qib7	16530	18	HSCT	HSCT	NNP
cord-005453-4057qib7	16530	19	from	from	IN
cord-005453-4057qib7	16530	20	MUD/	MUD/	NNP
cord-005453-4057qib7	16530	21	MMUD	MMUD	NNP
cord-005453-4057qib7	16530	22	.	.	.
cord-005453-4057qib7	16531	1	28/36	28/36	CD
cord-005453-4057qib7	16531	2	(	(	-LRB-
cord-005453-4057qib7	16531	3	80	80	CD
cord-005453-4057qib7	16531	4	%	%	NN
cord-005453-4057qib7	16531	5	)	)	-RRB-
cord-005453-4057qib7	16531	6	patients	patient	NNS
cord-005453-4057qib7	16531	7	showed	show	VBD
cord-005453-4057qib7	16531	8	complete	complete	JJ
cord-005453-4057qib7	16531	9	donor	donor	NN
cord-005453-4057qib7	16531	10	chimerism	chimerism	NN
cord-005453-4057qib7	16531	11	in	in	IN
cord-005453-4057qib7	16531	12	all	all	DT
cord-005453-4057qib7	16531	13	controls	control	NNS
cord-005453-4057qib7	16531	14	.	.	.
cord-005453-4057qib7	16532	1	5/36	5/36	CD
cord-005453-4057qib7	16532	2	(	(	-LRB-
cord-005453-4057qib7	16532	3	13	13	CD
cord-005453-4057qib7	16532	4	%	%	NN
cord-005453-4057qib7	16532	5	)	)	-RRB-
cord-005453-4057qib7	16532	6	patients	patient	NNS
cord-005453-4057qib7	16532	7	showed	show	VBD
cord-005453-4057qib7	16532	8	low	low	JJ
cord-005453-4057qib7	16532	9	level	level	NN
cord-005453-4057qib7	16532	10	mixed	mix	VBN
cord-005453-4057qib7	16532	11	chimerism	chimerism	NN
cord-005453-4057qib7	16532	12	up	up	IN
cord-005453-4057qib7	16532	13	to	to	TO
cord-005453-4057qib7	16532	14	20	20	CD
cord-005453-4057qib7	16532	15	%	%	NN
cord-005453-4057qib7	16532	16	during	during	IN
cord-005453-4057qib7	16532	17	follow	follow	NN
cord-005453-4057qib7	16532	18	up	up	RP
cord-005453-4057qib7	16532	19	.	.	.
cord-005453-4057qib7	16533	1	1	1	CD
cord-005453-4057qib7	16533	2	patient	patient	NN
cord-005453-4057qib7	16533	3	died	die	VBD
cord-005453-4057qib7	16533	4	shortly	shortly	RB
cord-005453-4057qib7	16533	5	after	after	IN
cord-005453-4057qib7	16533	6	HSCT	HSCT	NNP
cord-005453-4057qib7	16533	7	,	,	,
cord-005453-4057qib7	16533	8	1	1	CD
cord-005453-4057qib7	16533	9	patient	patient	NN
cord-005453-4057qib7	16533	10	showed	show	VBD
cord-005453-4057qib7	16533	11	slowly	slowly	RB
cord-005453-4057qib7	16533	12	increasing	increase	VBG
cord-005453-4057qib7	16533	13	mixed	mixed	JJ
cord-005453-4057qib7	16533	14	chimerism	chimerism	NN
cord-005453-4057qib7	16533	15	and	and	CC
cord-005453-4057qib7	16533	16	finally	finally	RB
cord-005453-4057qib7	16533	17	developed	develop	VBD
cord-005453-4057qib7	16533	18	autologous	autologous	JJ
cord-005453-4057qib7	16533	19	recovery	recovery	NN
cord-005453-4057qib7	16533	20	and	and	CC
cord-005453-4057qib7	16533	21	one	one	CD
cord-005453-4057qib7	16533	22	patient	patient	NN
cord-005453-4057qib7	16533	23	rejected	reject	VBD
cord-005453-4057qib7	16533	24	the	the	DT
cord-005453-4057qib7	16533	25	graft	graft	NN
cord-005453-4057qib7	16533	26	.	.	.
cord-005453-4057qib7	16534	1	Cumulative	cumulative	JJ
cord-005453-4057qib7	16534	2	incidence	incidence	NN
cord-005453-4057qib7	16534	3	of	of	IN
cord-005453-4057qib7	16534	4	grade	grade	NN
cord-005453-4057qib7	16534	5	II	II	NNP
cord-005453-4057qib7	16534	6	-	-	HYPH
cord-005453-4057qib7	16534	7	IV	IV	NNP
cord-005453-4057qib7	16534	8	acute	acute	JJ
cord-005453-4057qib7	16534	9	graft	graft	NN
cord-005453-4057qib7	16534	10	-	-	HYPH
cord-005453-4057qib7	16534	11	versushost	versushost	NN
cord-005453-4057qib7	16534	12	disease	disease	NN
cord-005453-4057qib7	16534	13	(	(	-LRB-
cord-005453-4057qib7	16534	14	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16534	15	)	)	-RRB-
cord-005453-4057qib7	16534	16	of	of	IN
cord-005453-4057qib7	16534	17	MUD	MUD	NNP
cord-005453-4057qib7	16534	18	/	/	SYM
cord-005453-4057qib7	16534	19	MMUD	MMUD	NNP
cord-005453-4057qib7	16534	20	was	be	VBD
cord-005453-4057qib7	16534	21	15,2	15,2	CD
cord-005453-4057qib7	16534	22	%	%	NN
cord-005453-4057qib7	16534	23	,	,	,
cord-005453-4057qib7	16534	24	whereas	whereas	IN
cord-005453-4057qib7	16534	25	only	only	RB
cord-005453-4057qib7	16534	26	2	2	CD
cord-005453-4057qib7	16534	27	cases	case	NNS
cord-005453-4057qib7	16534	28	of	of	IN
cord-005453-4057qib7	16534	29	aGVHD	aGVHD	NNP
cord-005453-4057qib7	16534	30	grade	grade	NN
cord-005453-4057qib7	16534	31	I	-PRON-	PRP
cord-005453-4057qib7	16534	32	occurred	occur	VBD
cord-005453-4057qib7	16534	33	in	in	IN
cord-005453-4057qib7	16534	34	patients	patient	NNS
cord-005453-4057qib7	16534	35	transplanted	transplant	VBN
cord-005453-4057qib7	16534	36	from	from	IN
cord-005453-4057qib7	16534	37	MSD	MSD	NNP
cord-005453-4057qib7	16534	38	/	/	SYM
cord-005453-4057qib7	16534	39	MFD	MFD	NNP
cord-005453-4057qib7	16534	40	.	.	.
cord-005453-4057qib7	16535	1	As	as	IN
cord-005453-4057qib7	16535	2	1	1	CD
cord-005453-4057qib7	16535	3	patient	patient	NN
cord-005453-4057qib7	16535	4	rejected	reject	VBD
cord-005453-4057qib7	16535	5	the	the	DT
cord-005453-4057qib7	16535	6	graft	graft	NN
cord-005453-4057qib7	16535	7	from	from	IN
cord-005453-4057qib7	16535	8	a	a	DT
cord-005453-4057qib7	16535	9	HLA	HLA	NNP
cord-005453-4057qib7	16535	10	-	-	HYPH
cord-005453-4057qib7	16535	11	identical	identical	JJ
cord-005453-4057qib7	16535	12	parent	parent	NN
cord-005453-4057qib7	16535	13	,	,	,
cord-005453-4057qib7	16535	14	1	1	CD
cord-005453-4057qib7	16535	15	patient	patient	NN
cord-005453-4057qib7	16535	16	transplanted	transplant	VBN
cord-005453-4057qib7	16535	17	from	from	IN
cord-005453-4057qib7	16535	18	a	a	DT
cord-005453-4057qib7	16535	19	HLA	HLA	NNP
cord-005453-4057qib7	16535	20	-	-	HYPH
cord-005453-4057qib7	16535	21	identical	identical	JJ
cord-005453-4057qib7	16535	22	grandparent	grandparent	NN
cord-005453-4057qib7	16535	23	developed	develop	VBD
cord-005453-4057qib7	16535	24	autologous	autologous	JJ
cord-005453-4057qib7	16535	25	recovery	recovery	NN
cord-005453-4057qib7	16535	26	after	after	IN
cord-005453-4057qib7	16535	27	1	1	CD
cord-005453-4057qib7	16535	28	year	year	NN
cord-005453-4057qib7	16535	29	and	and	CC
cord-005453-4057qib7	16535	30	1	1	CD
cord-005453-4057qib7	16535	31	patient	patient	NN
cord-005453-4057qib7	16535	32	transplanted	transplant	VBN
cord-005453-4057qib7	16535	33	from	from	IN
cord-005453-4057qib7	16535	34	a	a	DT
cord-005453-4057qib7	16535	35	MUD	mud	NN
cord-005453-4057qib7	16535	36	lost	lose	VBD
cord-005453-4057qib7	16535	37	the	the	DT
cord-005453-4057qib7	16535	38	graft	graft	NN
cord-005453-4057qib7	16535	39	due	due	IN
cord-005453-4057qib7	16535	40	to	to	IN
cord-005453-4057qib7	16535	41	hemophagocytosis	hemophagocytosis	NNP
cord-005453-4057qib7	16535	42	,	,	,
cord-005453-4057qib7	16535	43	the	the	DT
cord-005453-4057qib7	16535	44	probability	probability	NN
cord-005453-4057qib7	16535	45	of	of	IN
cord-005453-4057qib7	16535	46	event	event	NN
cord-005453-4057qib7	16535	47	-	-	HYPH
cord-005453-4057qib7	16535	48	free	free	JJ
cord-005453-4057qib7	16535	49	survival	survival	NN
cord-005453-4057qib7	16535	50	was	be	VBD
cord-005453-4057qib7	16535	51	89,5	89,5	CD
cord-005453-4057qib7	16535	52	%	%	NN
cord-005453-4057qib7	16535	53	after	after	IN
cord-005453-4057qib7	16535	54	HSCT	HSCT	NNP
cord-005453-4057qib7	16535	55	from	from	IN
cord-005453-4057qib7	16535	56	MSD	MSD	NNP
cord-005453-4057qib7	16535	57	/	/	SYM
cord-005453-4057qib7	16535	58	MFD	MFD	NNP
cord-005453-4057qib7	16535	59	and	and	CC
cord-005453-4057qib7	16535	60	83,9	83,9	CD
cord-005453-4057qib7	16535	61	%	%	NN
cord-005453-4057qib7	16535	62	from	from	IN
cord-005453-4057qib7	16535	63	MUD/	MUD/	NNP
cord-005453-4057qib7	16536	1	MMUD.Altogether	mmud.altogether	DT
cord-005453-4057qib7	16536	2	34/36	34/36	CD
cord-005453-4057qib7	16536	3	patients	patient	NNS
cord-005453-4057qib7	16536	4	(	(	-LRB-
cord-005453-4057qib7	16536	5	94,4	94,4	CD
cord-005453-4057qib7	16536	6	%	%	NN
cord-005453-4057qib7	16536	7	)	)	-RRB-
cord-005453-4057qib7	16536	8	are	be	VBP
cord-005453-4057qib7	16536	9	alive	alive	JJ
cord-005453-4057qib7	16536	10	and	and	CC
cord-005453-4057qib7	16536	11	transfusion	transfusion	NN
cord-005453-4057qib7	16536	12	-	-	HYPH
cord-005453-4057qib7	16536	13	independent	independent	JJ
cord-005453-4057qib7	16536	14	with	with	IN
cord-005453-4057qib7	16536	15	complete	complete	JJ
cord-005453-4057qib7	16536	16	donor	donor	NN
cord-005453-4057qib7	16536	17	chimerism	chimerism	NN
cord-005453-4057qib7	16536	18	two	two	CD
cord-005453-4057qib7	16536	19	years	year	NNS
cord-005453-4057qib7	16536	20	after	after	IN
cord-005453-4057qib7	16536	21	HSCT	HSCT	NNP
cord-005453-4057qib7	16536	22	;	;	:
cord-005453-4057qib7	16536	23	resulting	result	VBG
cord-005453-4057qib7	16536	24	in	in	IN
cord-005453-4057qib7	16536	25	an	an	DT
cord-005453-4057qib7	16536	26	overall	overall	JJ
cord-005453-4057qib7	16536	27	survival	survival	NN
cord-005453-4057qib7	16536	28	probability	probability	NN
cord-005453-4057qib7	16536	29	of	of	IN
cord-005453-4057qib7	16536	30	93,1	93,1	CD
cord-005453-4057qib7	16536	31	%	%	NN
cord-005453-4057qib7	16536	32	.	.	.
cord-005453-4057qib7	16537	1	In	in	IN
cord-005453-4057qib7	16537	2	contrast	contrast	NN
cord-005453-4057qib7	16537	3	,	,	,
cord-005453-4057qib7	16537	4	overall	overall	JJ
cord-005453-4057qib7	16537	5	survival	survival	NN
cord-005453-4057qib7	16537	6	probability	probability	NN
cord-005453-4057qib7	16537	7	was	be	VBD
cord-005453-4057qib7	16537	8	100	100	CD
cord-005453-4057qib7	16537	9	%	%	NN
cord-005453-4057qib7	16537	10	in	in	IN
cord-005453-4057qib7	16537	11	the	the	DT
cord-005453-4057qib7	16537	12	group	group	NN
cord-005453-4057qib7	16537	13	of	of	IN
cord-005453-4057qib7	16537	14	patients	patient	NNS
cord-005453-4057qib7	16537	15	transplanted	transplant	VBN
cord-005453-4057qib7	16537	16	from	from	IN
cord-005453-4057qib7	16537	17	MSD	MSD	NNP
cord-005453-4057qib7	16537	18	/	/	SYM
cord-005453-4057qib7	16537	19	MFD	MFD	NNP
cord-005453-4057qib7	16537	20	and	and	CC
cord-005453-4057qib7	16537	21	80,1	80,1	CD
cord-005453-4057qib7	16537	22	%	%	NN
cord-005453-4057qib7	16537	23	in	in	IN
cord-005453-4057qib7	16537	24	patients	patient	NNS
cord-005453-4057qib7	16537	25	transplanted	transplant	VBN
cord-005453-4057qib7	16537	26	from	from	IN
cord-005453-4057qib7	16537	27	MUD/	MUD/	NNP
cord-005453-4057qib7	16537	28	MMUD	MMUD	NNP
cord-005453-4057qib7	16537	29	after	after	IN
cord-005453-4057qib7	16537	30	2	2	CD
cord-005453-4057qib7	16537	31	years	year	NNS
cord-005453-4057qib7	16537	32	.	.	.
cord-005453-4057qib7	16538	1	There	there	EX
cord-005453-4057qib7	16538	2	were	be	VBD
cord-005453-4057qib7	16538	3	2	2	CD
cord-005453-4057qib7	16538	4	patients	patient	NNS
cord-005453-4057qib7	16538	5	with	with	IN
cord-005453-4057qib7	16538	6	thalassemia	thalassemia	NN
cord-005453-4057qib7	16538	7	(	(	-LRB-
cord-005453-4057qib7	16538	8	6,9	6,9	CD
cord-005453-4057qib7	16538	9	%	%	NN
cord-005453-4057qib7	16538	10	)	)	-RRB-
cord-005453-4057qib7	16538	11	who	who	WP
cord-005453-4057qib7	16538	12	died	die	VBD
cord-005453-4057qib7	16538	13	from	from	IN
cord-005453-4057qib7	16538	14	transplantation	transplantation	NN
cord-005453-4057qib7	16538	15	-	-	HYPH
cord-005453-4057qib7	16538	16	related	relate	VBN
cord-005453-4057qib7	16538	17	causes	cause	NNS
cord-005453-4057qib7	16538	18	.	.	.
cord-005453-4057qib7	16539	1	The	the	DT
cord-005453-4057qib7	16539	2	first	first	JJ
cord-005453-4057qib7	16539	3	patient	patient	NN
cord-005453-4057qib7	16539	4	died	die	VBD
cord-005453-4057qib7	16539	5	13	13	CD
cord-005453-4057qib7	16539	6	days	day	NNS
cord-005453-4057qib7	16539	7	after	after	IN
cord-005453-4057qib7	16539	8	HSCT	HSCT	NNP
cord-005453-4057qib7	16539	9	from	from	IN
cord-005453-4057qib7	16539	10	a	a	DT
cord-005453-4057qib7	16539	11	MMUD	MMUD	NNP
cord-005453-4057qib7	16539	12	due	due	JJ
cord-005453-4057qib7	16539	13	to	to	IN
cord-005453-4057qib7	16539	14	candida	candida	NN
cord-005453-4057qib7	16539	15	sepsis	sepsis	NN
cord-005453-4057qib7	16539	16	with	with	IN
cord-005453-4057qib7	16539	17	pulseless	pulseless	JJ
cord-005453-4057qib7	16539	18	electrical	electrical	JJ
cord-005453-4057qib7	16539	19	activity	activity	NN
cord-005453-4057qib7	16539	20	resulting	result	VBG
cord-005453-4057qib7	16539	21	from	from	IN
cord-005453-4057qib7	16539	22	cardiac	cardiac	JJ
cord-005453-4057qib7	16539	23	iron	iron	NN
cord-005453-4057qib7	16539	24	overload	overload	NN
cord-005453-4057qib7	16539	25	.	.	.
cord-005453-4057qib7	16540	1	The	the	DT
cord-005453-4057qib7	16540	2	second	second	JJ
cord-005453-4057qib7	16540	3	patient	patient	NN
cord-005453-4057qib7	16540	4	died	die	VBD
cord-005453-4057qib7	16540	5	5	5	CD
cord-005453-4057qib7	16540	6	months	month	NNS
cord-005453-4057qib7	16540	7	after	after	IN
cord-005453-4057qib7	16540	8	HSCT	HSCT	NNP
cord-005453-4057qib7	16540	9	from	from	IN
cord-005453-4057qib7	16540	10	a	a	DT
cord-005453-4057qib7	16540	11	MUD	mud	NN
cord-005453-4057qib7	16540	12	due	due	JJ
cord-005453-4057qib7	16540	13	to	to	IN
cord-005453-4057qib7	16540	14	graft	graft	NN
cord-005453-4057qib7	16540	15	failure	failure	NN
cord-005453-4057qib7	16540	16	.	.	.
cord-005453-4057qib7	16541	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16541	2	:	:	:
cord-005453-4057qib7	16541	3	HSCT	HSCT	NNP
cord-005453-4057qib7	16541	4	from	from	IN
cord-005453-4057qib7	16541	5	MUD	MUD	NNP
cord-005453-4057qib7	16541	6	and	and	CC
cord-005453-4057qib7	16541	7	MMUD	MMUD	NNP
cord-005453-4057qib7	16541	8	is	be	VBZ
cord-005453-4057qib7	16541	9	a	a	DT
cord-005453-4057qib7	16541	10	feasible	feasible	JJ
cord-005453-4057qib7	16541	11	therapy	therapy	NN
cord-005453-4057qib7	16541	12	option	option	NN
cord-005453-4057qib7	16541	13	for	for	IN
cord-005453-4057qib7	16541	14	patients	patient	NNS
cord-005453-4057qib7	16541	15	with	with	IN
cord-005453-4057qib7	16541	16	transfusion	transfusion	NN
cord-005453-4057qib7	16541	17	dependent	dependent	JJ
cord-005453-4057qib7	16541	18	anemia	anemia	NN
cord-005453-4057qib7	16541	19	.	.	.
cord-005453-4057qib7	16542	1	Nevertheless	nevertheless	RB
cord-005453-4057qib7	16542	2	,	,	,
cord-005453-4057qib7	16542	3	it	-PRON-	PRP
cord-005453-4057qib7	16542	4	should	should	MD
cord-005453-4057qib7	16542	5	be	be	VB
cord-005453-4057qib7	16542	6	noted	note	VBN
cord-005453-4057qib7	16542	7	that	that	IN
cord-005453-4057qib7	16542	8	iron	iron	NN
cord-005453-4057qib7	16542	9	overload	overload	NN
cord-005453-4057qib7	16542	10	can	can	MD
cord-005453-4057qib7	16542	11	cause	cause	VB
cord-005453-4057qib7	16542	12	severe	severe	JJ
cord-005453-4057qib7	16542	13	complications	complication	NNS
cord-005453-4057qib7	16542	14	;	;	:
cord-005453-4057qib7	16542	15	therefore	therefore	RB
cord-005453-4057qib7	16542	16	,	,	,
cord-005453-4057qib7	16542	17	measurement	measurement	NN
cord-005453-4057qib7	16542	18	of	of	IN
cord-005453-4057qib7	16542	19	liver	liver	NN
cord-005453-4057qib7	16542	20	and	and	CC
cord-005453-4057qib7	16542	21	heart	heart	NN
cord-005453-4057qib7	16542	22	iron	iron	NN
cord-005453-4057qib7	16542	23	concentration	concentration	NN
cord-005453-4057qib7	16542	24	through	through	IN
cord-005453-4057qib7	16542	25	MRI	MRI	NNP
cord-005453-4057qib7	16542	26	prior	prior	RB
cord-005453-4057qib7	16542	27	to	to	IN
cord-005453-4057qib7	16542	28	HSCT	HSCT	NNP
cord-005453-4057qib7	16542	29	as	as	RB
cord-005453-4057qib7	16542	30	well	well	RB
cord-005453-4057qib7	16542	31	as	as	IN
cord-005453-4057qib7	16542	32	phlebotomy	phlebotomy	NN
cord-005453-4057qib7	16542	33	after	after	IN
cord-005453-4057qib7	16542	34	transplantation	transplantation	NN
cord-005453-4057qib7	16542	35	are	be	VBP
cord-005453-4057qib7	16542	36	advisable	advisable	JJ
cord-005453-4057qib7	16542	37	.	.	.
cord-005453-4057qib7	16543	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16543	2	:	:	:
cord-005453-4057qib7	16544	1	Novartis	Novartis	NNP
cord-005453-4057qib7	16544	2	(	(	-LRB-
cord-005453-4057qib7	16544	3	consultancy	consultancy	NN
cord-005453-4057qib7	16544	4	:	:	:
cord-005453-4057qib7	16544	5	included	include	VBN
cord-005453-4057qib7	16544	6	expert	expert	JJ
cord-005453-4057qib7	16544	7	testimony	testimony	NN
cord-005453-4057qib7	16544	8	,	,	,
cord-005453-4057qib7	16544	9	speaker	speaker	NNP
cord-005453-4057qib7	16544	10	bureau	bureau	NNP
cord-005453-4057qib7	16544	11	,	,	,
cord-005453-4057qib7	16544	12	Honoraria	Honoraria	NNP
cord-005453-4057qib7	16544	13	)	)	-RRB-
cord-005453-4057qib7	16544	14	,	,	,
cord-005453-4057qib7	16544	15	Medac	Medac	NNP
cord-005453-4057qib7	16544	16	(	(	-LRB-
cord-005453-4057qib7	16544	17	Research	Research	NNP
cord-005453-4057qib7	16544	18	Funding	Funding	NNP
cord-005453-4057qib7	16544	19	,	,	,
cord-005453-4057qib7	16544	20	Patents	Patents	NNPS
cord-005453-4057qib7	16544	21	and	and	CC
cord-005453-4057qib7	16544	22	Royalties	Royalties	NNPS
cord-005453-4057qib7	16544	23	)	)	-RRB-
cord-005453-4057qib7	16544	24	,	,	,
cord-005453-4057qib7	16544	25	Riemser	Riemser	NNP
cord-005453-4057qib7	16544	26	(	(	-LRB-
cord-005453-4057qib7	16544	27	Research	Research	NNP
cord-005453-4057qib7	16544	28	Funding	Funding	NNP
cord-005453-4057qib7	16544	29	)	)	-RRB-
cord-005453-4057qib7	16544	30	,	,	,
cord-005453-4057qib7	16544	31	Neovii	Neovii	NNP
cord-005453-4057qib7	16544	32	(	(	-LRB-
cord-005453-4057qib7	16544	33	Research	Research	NNP
cord-005453-4057qib7	16544	34	Funding	Funding	NNP
cord-005453-4057qib7	16544	35	)	)	-RRB-
cord-005453-4057qib7	16544	36	,	,	.
cord-005453-4057qib7	16545	1	Amgen	Amgen	NNP
cord-005453-4057qib7	16545	2	(	(	-LRB-
cord-005453-4057qib7	16545	3	Honoraria	Honoraria	NNP
cord-005453-4057qib7	16545	4	)	)	-RRB-
cord-005453-4057qib7	16545	5	Background	background	NN
cord-005453-4057qib7	16545	6	:	:	:
cord-005453-4057qib7	16546	1	The	the	DT
cord-005453-4057qib7	16546	2	therapeutic	therapeutic	JJ
cord-005453-4057qib7	16546	3	options	option	NNS
cord-005453-4057qib7	16546	4	for	for	IN
cord-005453-4057qib7	16546	5	patients	patient	NNS
cord-005453-4057qib7	16546	6	with	with	IN
cord-005453-4057qib7	16546	7	Hodgkin´s	hodgkin´	NNS
cord-005453-4057qib7	16546	8	disease	disease	NN
cord-005453-4057qib7	16546	9	who	who	WP
cord-005453-4057qib7	16546	10	relapse	relapse	VBP
cord-005453-4057qib7	16546	11	after	after	IN
cord-005453-4057qib7	16546	12	first	first	JJ
cord-005453-4057qib7	16546	13	high	high	JJ
cord-005453-4057qib7	16546	14	-	-	HYPH
cord-005453-4057qib7	16546	15	dose	dose	NN
cord-005453-4057qib7	16546	16	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	16546	17	with	with	IN
cord-005453-4057qib7	16546	18	autologous	autologous	JJ
cord-005453-4057qib7	16546	19	stem	stem	NN
cord-005453-4057qib7	16546	20	cell	cell	NN
cord-005453-4057qib7	16546	21	(	(	-LRB-
cord-005453-4057qib7	16546	22	1	1	CD
cord-005453-4057qib7	16546	23	st	st	NNP
cord-005453-4057qib7	16546	24	ASCT	ASCT	NNP
cord-005453-4057qib7	16546	25	)	)	-RRB-
cord-005453-4057qib7	16546	26	support	support	NN
cord-005453-4057qib7	16546	27	are	be	VBP
cord-005453-4057qib7	16546	28	limited	limited	JJ
cord-005453-4057qib7	16546	29	.	.	.
cord-005453-4057qib7	16547	1	Allogeneic	allogeneic	IN
cord-005453-4057qib7	16547	2	stem	stem	VBP
cord-005453-4057qib7	16547	3	cell	cell	NN
cord-005453-4057qib7	16547	4	transplantation	transplantation	NN
cord-005453-4057qib7	16547	5	in	in	IN
cord-005453-4057qib7	16547	6	this	this	DT
cord-005453-4057qib7	16547	7	setting	setting	NN
cord-005453-4057qib7	16547	8	is	be	VBZ
cord-005453-4057qib7	16547	9	associated	associate	VBN
cord-005453-4057qib7	16547	10	with	with	IN
cord-005453-4057qib7	16547	11	a	a	DT
cord-005453-4057qib7	16547	12	high	high	JJ
cord-005453-4057qib7	16547	13	level	level	NN
cord-005453-4057qib7	16547	14	of	of	IN
cord-005453-4057qib7	16547	15	transplant	transplant	NN
cord-005453-4057qib7	16547	16	-	-	HYPH
cord-005453-4057qib7	16547	17	dependent	dependent	JJ
cord-005453-4057qib7	16547	18	mortality	mortality	NN
cord-005453-4057qib7	16547	19	rates	rate	NNS
cord-005453-4057qib7	16547	20	in	in	IN
cord-005453-4057qib7	16547	21	excess	excess	NN
cord-005453-4057qib7	16547	22	of	of	IN
cord-005453-4057qib7	16547	23	50	50	CD
cord-005453-4057qib7	16547	24	-	-	SYM
cord-005453-4057qib7	16547	25	65	65	CD
cord-005453-4057qib7	16547	26	%	%	NN
cord-005453-4057qib7	16547	27	.	.	.
cord-005453-4057qib7	16548	1	New	new	JJ
cord-005453-4057qib7	16548	2	agent	agent	NN
cord-005453-4057qib7	16548	3	,	,	,
cord-005453-4057qib7	16548	4	such	such	JJ
cord-005453-4057qib7	16548	5	as	as	IN
cord-005453-4057qib7	16548	6	brentuximab	brentuximab	NNP
cord-005453-4057qib7	16548	7	vedotin	vedotin	NNP
cord-005453-4057qib7	16548	8	,	,	,
cord-005453-4057qib7	16548	9	have	have	VBP
cord-005453-4057qib7	16548	10	been	be	VBN
cord-005453-4057qib7	16548	11	approved	approve	VBN
cord-005453-4057qib7	16548	12	for	for	IN
cord-005453-4057qib7	16548	13	the	the	DT
cord-005453-4057qib7	16548	14	treatment	treatment	NN
cord-005453-4057qib7	16548	15	of	of	IN
cord-005453-4057qib7	16548	16	these	these	DT
cord-005453-4057qib7	16548	17	patients	patient	NNS
cord-005453-4057qib7	16548	18	,	,	,
cord-005453-4057qib7	16548	19	however	however	RB
cord-005453-4057qib7	16548	20	,	,	,
cord-005453-4057qib7	16548	21	their	-PRON-	PRP$
cord-005453-4057qib7	16548	22	efficacy	efficacy	NN
cord-005453-4057qib7	16548	23	to	to	TO
cord-005453-4057qib7	16548	24	provide	provide	VB
cord-005453-4057qib7	16548	25	longterm	longterm	JJ
cord-005453-4057qib7	16548	26	control	control	NN
cord-005453-4057qib7	16548	27	or	or	CC
cord-005453-4057qib7	16548	28	cure	cure	NN
cord-005453-4057qib7	16548	29	is	be	VBZ
cord-005453-4057qib7	16548	30	still	still	RB
cord-005453-4057qib7	16548	31	unknown	unknown	JJ
cord-005453-4057qib7	16548	32	.	.	.
cord-005453-4057qib7	16549	1	A	a	DT
cord-005453-4057qib7	16549	2	second	second	JJ
cord-005453-4057qib7	16549	3	autologous	autologous	JJ
cord-005453-4057qib7	16549	4	stem	stem	NN
cord-005453-4057qib7	16549	5	cell	cell	NN
cord-005453-4057qib7	16549	6	(	(	-LRB-
cord-005453-4057qib7	16549	7	2	2	CD
cord-005453-4057qib7	16549	8	nd	nd	NNP
cord-005453-4057qib7	16549	9	ASCT	ASCT	NNP
cord-005453-4057qib7	16549	10	)	)	-RRB-
cord-005453-4057qib7	16549	11	has	have	VBZ
cord-005453-4057qib7	16549	12	historically	historically	RB
cord-005453-4057qib7	16549	13	been	be	VBN
cord-005453-4057qib7	16549	14	considered	consider	VBN
cord-005453-4057qib7	16549	15	as	as	IN
cord-005453-4057qib7	16549	16	an	an	DT
cord-005453-4057qib7	16549	17	option	option	NN
cord-005453-4057qib7	16549	18	only	only	RB
cord-005453-4057qib7	16549	19	in	in	IN
cord-005453-4057qib7	16549	20	a	a	DT
cord-005453-4057qib7	16549	21	small	small	JJ
cord-005453-4057qib7	16549	22	group	group	NN
cord-005453-4057qib7	16549	23	of	of	IN
cord-005453-4057qib7	16549	24	patients	patient	NNS
cord-005453-4057qib7	16549	25	so	so	IN
cord-005453-4057qib7	16549	26	the	the	DT
cord-005453-4057qib7	16549	27	published	publish	VBN
cord-005453-4057qib7	16549	28	experience	experience	NN
cord-005453-4057qib7	16549	29	is	be	VBZ
cord-005453-4057qib7	16549	30	scarce	scarce	JJ
cord-005453-4057qib7	16549	31	.	.	.
cord-005453-4057qib7	16550	1	We	-PRON-	PRP
cord-005453-4057qib7	16550	2	report	report	VBP
cord-005453-4057qib7	16550	3	our	-PRON-	PRP$
cord-005453-4057qib7	16550	4	institution´s	institution´s	NNP
cord-005453-4057qib7	16550	5	experience	experience	NN
cord-005453-4057qib7	16550	6	with	with	IN
cord-005453-4057qib7	16550	7	second	second	JJ
cord-005453-4057qib7	16550	8	autologous	autologous	JJ
cord-005453-4057qib7	16550	9	transplants	transplant	NNS
cord-005453-4057qib7	16550	10	in	in	IN
cord-005453-4057qib7	16550	11	this	this	DT
cord-005453-4057qib7	16550	12	patient	patient	JJ
cord-005453-4057qib7	16550	13	population	population	NN
cord-005453-4057qib7	16550	14	.	.	.
cord-005453-4057qib7	16551	1	Methods	method	NNS
cord-005453-4057qib7	16551	2	:	:	:
cord-005453-4057qib7	16551	3	We	-PRON-	PRP
cord-005453-4057qib7	16551	4	evaluated	evaluate	VBD
cord-005453-4057qib7	16551	5	the	the	DT
cord-005453-4057qib7	16551	6	outcome	outcome	NN
cord-005453-4057qib7	16551	7	of	of	IN
cord-005453-4057qib7	16551	8	16	16	CD
cord-005453-4057qib7	16551	9	adult	adult	NN
cord-005453-4057qib7	16551	10	patients	patient	NNS
cord-005453-4057qib7	16551	11	(	(	-LRB-
cord-005453-4057qib7	16551	12	7	7	CD
cord-005453-4057qib7	16551	13	(	(	-LRB-
cord-005453-4057qib7	16551	14	44	44	CD
cord-005453-4057qib7	16551	15	%	%	NN
cord-005453-4057qib7	16551	16	)	)	-RRB-
cord-005453-4057qib7	16551	17	female	female	NN
cord-005453-4057qib7	16551	18	and	and	CC
cord-005453-4057qib7	16551	19	9	9	CD
cord-005453-4057qib7	16551	20	(	(	-LRB-
cord-005453-4057qib7	16551	21	56	56	CD
cord-005453-4057qib7	16551	22	%	%	NN
cord-005453-4057qib7	16551	23	)	)	-RRB-
cord-005453-4057qib7	16551	24	male	male	NN
cord-005453-4057qib7	16551	25	)	)	-RRB-
cord-005453-4057qib7	16551	26	,	,	,
cord-005453-4057qib7	16551	27	who	who	WP
cord-005453-4057qib7	16551	28	received	receive	VBD
cord-005453-4057qib7	16551	29	an	an	DT
cord-005453-4057qib7	16551	30	2	2	CD
cord-005453-4057qib7	16551	31	nd	nd	NNP
cord-005453-4057qib7	16551	32	ASCT	ASCT	NNP
cord-005453-4057qib7	16551	33	between	between	IN
cord-005453-4057qib7	16551	34	10/2013	10/2013	CD
cord-005453-4057qib7	16551	35	and	and	CC
cord-005453-4057qib7	16551	36	08/2018	08/2018	CD
cord-005453-4057qib7	16551	37	.	.	.
cord-005453-4057qib7	16552	1	Planned	plan	VBN
cord-005453-4057qib7	16552	2	tandem	tandem	NN
cord-005453-4057qib7	16552	3	ASCT	ASCT	NNP
cord-005453-4057qib7	16552	4	were	be	VBD
cord-005453-4057qib7	16552	5	excluded	exclude	VBN
cord-005453-4057qib7	16552	6	.	.	.
cord-005453-4057qib7	16553	1	The	the	DT
cord-005453-4057qib7	16553	2	median	median	JJ
cord-005453-4057qib7	16553	3	age	age	NN
cord-005453-4057qib7	16553	4	at	at	IN
cord-005453-4057qib7	16553	5	2	2	CD
cord-005453-4057qib7	16553	6	nd	nd	NNP
cord-005453-4057qib7	16553	7	ASCT	ASCT	NNP
cord-005453-4057qib7	16553	8	was	be	VBD
cord-005453-4057qib7	16553	9	32	32	CD
cord-005453-4057qib7	16553	10	years	year	NNS
cord-005453-4057qib7	16554	1	(	(	-LRB-
cord-005453-4057qib7	16554	2	range	range	NNP
cord-005453-4057qib7	16554	3	21	21	CD
cord-005453-4057qib7	16554	4	-	-	SYM
cord-005453-4057qib7	16554	5	54	54	CD
cord-005453-4057qib7	16554	6	)	)	-RRB-
cord-005453-4057qib7	16554	7	,	,	,
cord-005453-4057qib7	16554	8	15	15	CD
cord-005453-4057qib7	16554	9	(	(	-LRB-
cord-005453-4057qib7	16554	10	94	94	CD
cord-005453-4057qib7	16554	11	%	%	NN
cord-005453-4057qib7	16554	12	)	)	-RRB-
cord-005453-4057qib7	16554	13	patients	patient	NNS
cord-005453-4057qib7	16554	14	had	have	VBD
cord-005453-4057qib7	16554	15	a	a	DT
cord-005453-4057qib7	16554	16	Karnofsky	Karnofsky	NNP
cord-005453-4057qib7	16554	17	performance	performance	NN
cord-005453-4057qib7	16554	18	score	score	NN
cord-005453-4057qib7	16554	19	≥80	≥80	CD
cord-005453-4057qib7	16554	20	%	%	NN
cord-005453-4057qib7	16554	21	.	.	.
cord-005453-4057qib7	16555	1	12	12	CD
cord-005453-4057qib7	16555	2	(	(	-LRB-
cord-005453-4057qib7	16555	3	75	75	CD
cord-005453-4057qib7	16555	4	%	%	NN
cord-005453-4057qib7	16555	5	)	)	-RRB-
cord-005453-4057qib7	16555	6	patients	patient	NNS
cord-005453-4057qib7	16555	7	were	be	VBD
cord-005453-4057qib7	16555	8	in	in	IN
cord-005453-4057qib7	16555	9	complete	complete	JJ
cord-005453-4057qib7	16555	10	remission	remission	NN
cord-005453-4057qib7	16555	11	(	(	-LRB-
cord-005453-4057qib7	16555	12	CR	CR	NNP
cord-005453-4057qib7	16555	13	)	)	-RRB-
cord-005453-4057qib7	16555	14	and	and	CC
cord-005453-4057qib7	16555	15	4	4	CD
cord-005453-4057qib7	16555	16	(	(	-LRB-
cord-005453-4057qib7	16555	17	25	25	CD
cord-005453-4057qib7	16555	18	%	%	NN
cord-005453-4057qib7	16555	19	)	)	-RRB-
cord-005453-4057qib7	16555	20	patients	patient	NNS
cord-005453-4057qib7	16555	21	were	be	VBD
cord-005453-4057qib7	16555	22	in	in	IN
cord-005453-4057qib7	16555	23	partial	partial	JJ
cord-005453-4057qib7	16555	24	remission	remission	NN
cord-005453-4057qib7	16555	25	(	(	-LRB-
cord-005453-4057qib7	16555	26	PR	PR	NNP
cord-005453-4057qib7	16555	27	)	)	-RRB-
cord-005453-4057qib7	16555	28	at	at	IN
cord-005453-4057qib7	16555	29	day	day	NN
cord-005453-4057qib7	16555	30	100	100	CD
cord-005453-4057qib7	16555	31	after	after	IN
cord-005453-4057qib7	16555	32	1	1	CD
cord-005453-4057qib7	16555	33	st	st	NNP
cord-005453-4057qib7	16555	34	ASCT	ASCT	NNP
cord-005453-4057qib7	16555	35	.	.	.
cord-005453-4057qib7	16556	1	Seven	seven	CD
cord-005453-4057qib7	16556	2	(	(	-LRB-
cord-005453-4057qib7	16556	3	44	44	CD
cord-005453-4057qib7	16556	4	%	%	NN
cord-005453-4057qib7	16556	5	)	)	-RRB-
cord-005453-4057qib7	16556	6	relapses	relapse	NNS
cord-005453-4057qib7	16556	7	within	within	IN
cord-005453-4057qib7	16556	8	12	12	CD
cord-005453-4057qib7	16556	9	months	month	NNS
cord-005453-4057qib7	16556	10	after	after	IN
cord-005453-4057qib7	16556	11	1	1	CD
cord-005453-4057qib7	16556	12	st	st	NNP
cord-005453-4057qib7	16556	13	ASCT	ASCT	NNP
cord-005453-4057qib7	16556	14	.	.	.
cord-005453-4057qib7	16557	1	Patients	patient	NNS
cord-005453-4057qib7	16557	2	received	receive	VBD
cord-005453-4057qib7	16557	3	a	a	DT
cord-005453-4057qib7	16557	4	median	median	NN
cord-005453-4057qib7	16557	5	of	of	IN
cord-005453-4057qib7	16557	6	1	1	CD
cord-005453-4057qib7	16557	7	(	(	-LRB-
cord-005453-4057qib7	16557	8	0	0	CD
cord-005453-4057qib7	16557	9	-	-	SYM
cord-005453-4057qib7	16557	10	3	3	CD
cord-005453-4057qib7	16557	11	)	)	-RRB-
cord-005453-4057qib7	16557	12	treatment	treatment	NN
cord-005453-4057qib7	16557	13	lines	line	NNS
cord-005453-4057qib7	16557	14	between	between	IN
cord-005453-4057qib7	16557	15	1	1	CD
cord-005453-4057qib7	16557	16	st	st	NNP
cord-005453-4057qib7	16557	17	ASCT	ASCT	NNP
cord-005453-4057qib7	16557	18	and	and	CC
cord-005453-4057qib7	16557	19	2	2	CD
cord-005453-4057qib7	16557	20	nd	nd	NNP
cord-005453-4057qib7	16557	21	ASCT	ASCT	NNP
cord-005453-4057qib7	16557	22	.	.	.
cord-005453-4057qib7	16558	1	Only	only	RB
cord-005453-4057qib7	16558	2	4	4	CD
cord-005453-4057qib7	16558	3	(	(	-LRB-
cord-005453-4057qib7	16558	4	25	25	CD
cord-005453-4057qib7	16558	5	%	%	NN
cord-005453-4057qib7	16558	6	)	)	-RRB-
cord-005453-4057qib7	16558	7	patients	patient	NNS
cord-005453-4057qib7	16558	8	received	receive	VBD
cord-005453-4057qib7	16558	9	brentuximab	brentuximab	NNP
cord-005453-4057qib7	16558	10	vedotin	vedotin	NNP
cord-005453-4057qib7	16558	11	and	and	CC
cord-005453-4057qib7	16558	12	none	none	NN
cord-005453-4057qib7	16558	13	of	of	IN
cord-005453-4057qib7	16558	14	the	the	DT
cord-005453-4057qib7	16558	15	patients	patient	NNS
cord-005453-4057qib7	16558	16	in	in	IN
cord-005453-4057qib7	16558	17	our	-PRON-	PRP$
cord-005453-4057qib7	16558	18	series	series	NN
cord-005453-4057qib7	16558	19	received	receive	VBD
cord-005453-4057qib7	16558	20	checkpoint	checkpoint	NN
cord-005453-4057qib7	16558	21	inhibitors	inhibitor	NNS
cord-005453-4057qib7	16558	22	as	as	IN
cord-005453-4057qib7	16558	23	salvage	salvage	NN
cord-005453-4057qib7	16558	24	after	after	IN
cord-005453-4057qib7	16558	25	1	1	CD
cord-005453-4057qib7	16558	26	st	st	NNP
cord-005453-4057qib7	16558	27	ASCT	ASCT	NNP
cord-005453-4057qib7	16558	28	.	.	.
cord-005453-4057qib7	16559	1	The	the	DT
cord-005453-4057qib7	16559	2	median	median	JJ
cord-005453-4057qib7	16559	3	interval	interval	NN
cord-005453-4057qib7	16559	4	from	from	IN
cord-005453-4057qib7	16559	5	1	1	CD
cord-005453-4057qib7	16559	6	st	st	NNP
cord-005453-4057qib7	16559	7	ASCT	ASCT	NNP
cord-005453-4057qib7	16559	8	to	to	TO
cord-005453-4057qib7	16559	9	relapse	relapse	VB
cord-005453-4057qib7	16559	10	/	/	SYM
cord-005453-4057qib7	16559	11	progression	progression	NN
cord-005453-4057qib7	16559	12	was12,9	was12,9	NN
cord-005453-4057qib7	16559	13	months	month	NNS
cord-005453-4057qib7	16560	1	(	(	-LRB-
cord-005453-4057qib7	16560	2	range	range	NNP
cord-005453-4057qib7	16560	3	2,9	2,9	CD
cord-005453-4057qib7	16560	4	-	-	HYPH
cord-005453-4057qib7	16560	5	133,3	133,3	CD
cord-005453-4057qib7	16560	6	)	)	-RRB-
cord-005453-4057qib7	16560	7	.	.	.
cord-005453-4057qib7	16561	1	The	the	DT
cord-005453-4057qib7	16561	2	median	median	JJ
cord-005453-4057qib7	16561	3	interval	interval	NN
cord-005453-4057qib7	16561	4	from	from	IN
cord-005453-4057qib7	16561	5	relapse	relapse	NN
cord-005453-4057qib7	16561	6	/	/	SYM
cord-005453-4057qib7	16561	7	progression	progression	NN
cord-005453-4057qib7	16561	8	to	to	IN
cord-005453-4057qib7	16561	9	2	2	CD
cord-005453-4057qib7	16561	10	nd	nd	NNP
cord-005453-4057qib7	16561	11	ASCT	ASCT	NNP
cord-005453-4057qib7	16561	12	was	be	VBD
cord-005453-4057qib7	16561	13	9,2	9,2	CD
cord-005453-4057qib7	16561	14	months	month	NNS
cord-005453-4057qib7	16562	1	(	(	-LRB-
cord-005453-4057qib7	16562	2	range	range	NNP
cord-005453-4057qib7	16562	3	1,4	1,4	CD
cord-005453-4057qib7	16562	4	-	-	HYPH
cord-005453-4057qib7	16562	5	46,6	46,6	CD
cord-005453-4057qib7	16562	6	)	)	-RRB-
cord-005453-4057qib7	16562	7	.	.	.
cord-005453-4057qib7	16563	1	All	all	DT
cord-005453-4057qib7	16563	2	patients	patient	NNS
cord-005453-4057qib7	16563	3	received	receive	VBD
cord-005453-4057qib7	16563	4	BEAM	BEAM	NNP
cord-005453-4057qib7	16563	5	as	as	IN
cord-005453-4057qib7	16563	6	the	the	DT
cord-005453-4057qib7	16563	7	conditioning	conditioning	NN
cord-005453-4057qib7	16563	8	regimen	regimen	NN
cord-005453-4057qib7	16563	9	for	for	IN
cord-005453-4057qib7	16563	10	1	1	CD
cord-005453-4057qib7	16563	11	st	st	NNP
cord-005453-4057qib7	16563	12	ASCT	ASCT	NNP
cord-005453-4057qib7	16563	13	,	,	,
cord-005453-4057qib7	16563	14	and	and	CC
cord-005453-4057qib7	16563	15	BeEAM	beeam	RB
cord-005453-4057qib7	16563	16	as	as	IN
cord-005453-4057qib7	16563	17	the	the	DT
cord-005453-4057qib7	16563	18	conditioning	conditioning	NN
cord-005453-4057qib7	16563	19	regimen	regimen	NN
cord-005453-4057qib7	16563	20	for	for	IN
cord-005453-4057qib7	16563	21	2	2	CD
cord-005453-4057qib7	16563	22	nd	nd	NNP
cord-005453-4057qib7	16563	23	ASCT.Results	asct.results	CD
cord-005453-4057qib7	16563	24	:	:	:
cord-005453-4057qib7	16563	25	The	the	DT
cord-005453-4057qib7	16563	26	median	median	JJ
cord-005453-4057qib7	16563	27	time	time	NN
cord-005453-4057qib7	16563	28	to	to	IN
cord-005453-4057qib7	16563	29	neutrophil	neutrophil	NN
cord-005453-4057qib7	16563	30	recovery	recovery	NN
cord-005453-4057qib7	16563	31	(	(	-LRB-
cord-005453-4057qib7	16563	32	>	>	NFP
cord-005453-4057qib7	16563	33	0.5x10	0.5x10	CD
cord-005453-4057qib7	16563	34	9	9	CD
cord-005453-4057qib7	16563	35	/L	/L	.
cord-005453-4057qib7	16563	36	)	)	-RRB-
cord-005453-4057qib7	16563	37	after	after	IN
cord-005453-4057qib7	16563	38	2	2	CD
cord-005453-4057qib7	16563	39	nd	nd	NNP
cord-005453-4057qib7	16563	40	ASCT	ASCT	NNP
cord-005453-4057qib7	16563	41	were	be	VBD
cord-005453-4057qib7	16563	42	10	10	CD
cord-005453-4057qib7	16563	43	days	day	NNS
cord-005453-4057qib7	16563	44	(	(	-LRB-
cord-005453-4057qib7	16564	1	range	range	NNP
cord-005453-4057qib7	16564	2	8	8	CD
cord-005453-4057qib7	16564	3	-	-	SYM
cord-005453-4057qib7	16564	4	17	17	CD
cord-005453-4057qib7	16564	5	)	)	-RRB-
cord-005453-4057qib7	16564	6	.	.	.
cord-005453-4057qib7	16565	1	Best	good	JJS
cord-005453-4057qib7	16565	2	response	response	NN
cord-005453-4057qib7	16565	3	at	at	IN
cord-005453-4057qib7	16565	4	day	day	NN
cord-005453-4057qib7	16565	5	100	100	CD
cord-005453-4057qib7	16565	6	following	follow	VBG
cord-005453-4057qib7	16565	7	2	2	CD
cord-005453-4057qib7	16565	8	nd	nd	NNP
cord-005453-4057qib7	16565	9	ASCT	ASCT	NNP
cord-005453-4057qib7	16565	10	included	include	VBD
cord-005453-4057qib7	16565	11	CR	CR	NNP
cord-005453-4057qib7	16565	12	in	in	IN
cord-005453-4057qib7	16565	13	12	12	CD
cord-005453-4057qib7	16565	14	(	(	-LRB-
cord-005453-4057qib7	16565	15	75	75	CD
cord-005453-4057qib7	16565	16	%	%	NN
cord-005453-4057qib7	16565	17	)	)	-RRB-
cord-005453-4057qib7	16565	18	patients	patient	NNS
cord-005453-4057qib7	16565	19	and	and	CC
cord-005453-4057qib7	16565	20	PR	PR	NNP
cord-005453-4057qib7	16565	21	in	in	IN
cord-005453-4057qib7	16565	22	3	3	CD
cord-005453-4057qib7	16565	23	(	(	-LRB-
cord-005453-4057qib7	16565	24	19	19	CD
cord-005453-4057qib7	16565	25	%	%	NN
cord-005453-4057qib7	16565	26	)	)	-RRB-
cord-005453-4057qib7	16565	27	;	;	:
cord-005453-4057qib7	16565	28	1	1	CD
cord-005453-4057qib7	16565	29	(	(	-LRB-
cord-005453-4057qib7	16565	30	6	6	CD
cord-005453-4057qib7	16565	31	%	%	NN
cord-005453-4057qib7	16565	32	)	)	-RRB-
cord-005453-4057qib7	16565	33	had	have	VBD
cord-005453-4057qib7	16565	34	stable	stable	JJ
cord-005453-4057qib7	16565	35	disease	disease	NN
cord-005453-4057qib7	16565	36	.	.	.
cord-005453-4057qib7	16566	1	3	3	LS
cord-005453-4057qib7	16566	2	(	(	-LRB-
cord-005453-4057qib7	16566	3	19	19	CD
cord-005453-4057qib7	16566	4	%	%	NN
cord-005453-4057qib7	16566	5	)	)	-RRB-
cord-005453-4057qib7	16566	6	patients	patient	NNS
cord-005453-4057qib7	16566	7	received	receive	VBD
cord-005453-4057qib7	16566	8	brentuximab	brentuximab	NNP
cord-005453-4057qib7	16566	9	vedotin	vedotin	NNP
cord-005453-4057qib7	16566	10	and	and	CC
cord-005453-4057qib7	16566	11	none	none	NN
cord-005453-4057qib7	16566	12	of	of	IN
cord-005453-4057qib7	16566	13	the	the	DT
cord-005453-4057qib7	16566	14	patients	patient	NNS
cord-005453-4057qib7	16566	15	received	receive	VBD
cord-005453-4057qib7	16566	16	checkpoint	checkpoint	NN
cord-005453-4057qib7	16566	17	inhibitors	inhibitor	NNS
cord-005453-4057qib7	16566	18	after	after	IN
cord-005453-4057qib7	16566	19	2	2	CD
cord-005453-4057qib7	16566	20	nd	nd	NNP
cord-005453-4057qib7	16566	21	ASCT	ASCT	NNP
cord-005453-4057qib7	16566	22	.	.	.
cord-005453-4057qib7	16567	1	14	14	CD
cord-005453-4057qib7	16567	2	(	(	-LRB-
cord-005453-4057qib7	16567	3	87,5	87,5	CD
cord-005453-4057qib7	16567	4	%	%	NN
cord-005453-4057qib7	16567	5	)	)	-RRB-
cord-005453-4057qib7	16567	6	patients	patient	NNS
cord-005453-4057qib7	16567	7	are	be	VBP
cord-005453-4057qib7	16567	8	currently	currently	RB
cord-005453-4057qib7	16567	9	alive	alive	JJ
cord-005453-4057qib7	16567	10	,	,	,
cord-005453-4057qib7	16567	11	with	with	IN
cord-005453-4057qib7	16567	12	a	a	DT
cord-005453-4057qib7	16567	13	median	median	JJ
cord-005453-4057qib7	16567	14	follow	follow	NN
cord-005453-4057qib7	16567	15	-	-	HYPH
cord-005453-4057qib7	16567	16	up	up	NN
cord-005453-4057qib7	16567	17	49,8	49,8	CD
cord-005453-4057qib7	16567	18	months	month	NNS
cord-005453-4057qib7	16568	1	(	(	-LRB-
cord-005453-4057qib7	16568	2	range	range	NN
cord-005453-4057qib7	16568	3	4,2	4,2	CD
cord-005453-4057qib7	16568	4	-	-	HYPH
cord-005453-4057qib7	16568	5	154,2).2	154,2).2	CD
cord-005453-4057qib7	16568	6	patient	patient	NN
cord-005453-4057qib7	16568	7	died	die	VBD
cord-005453-4057qib7	16568	8	after	after	IN
cord-005453-4057qib7	16568	9	2	2	CD
cord-005453-4057qib7	16568	10	nd	nd	NNP
cord-005453-4057qib7	16568	11	ASCT	ASCT	NNP
cord-005453-4057qib7	16568	12	.	.	.
cord-005453-4057qib7	16569	1	Causes	cause	NNS
cord-005453-4057qib7	16569	2	of	of	IN
cord-005453-4057qib7	16569	3	death	death	NN
cord-005453-4057qib7	16569	4	were	be	VBD
cord-005453-4057qib7	16569	5	HL	HL	NNP
cord-005453-4057qib7	16569	6	progression	progression	NN
cord-005453-4057qib7	16569	7	.	.	.
cord-005453-4057qib7	16570	1	The	the	DT
cord-005453-4057qib7	16570	2	5-year	5-year	CD
cord-005453-4057qib7	16570	3	overall	overall	JJ
cord-005453-4057qib7	16570	4	survival	survival	NN
cord-005453-4057qib7	16570	5	was	be	VBD
cord-005453-4057qib7	16570	6	86%.Conclusions	86%.conclusions	CD
cord-005453-4057qib7	16570	7	:	:	:
cord-005453-4057qib7	16571	1	The	the	DT
cord-005453-4057qib7	16571	2	second	second	JJ
cord-005453-4057qib7	16571	3	ASCT	asct	NN
cord-005453-4057qib7	16571	4	in	in	IN
cord-005453-4057qib7	16571	5	patients	patient	NNS
cord-005453-4057qib7	16571	6	with	with	IN
cord-005453-4057qib7	16571	7	a	a	DT
cord-005453-4057qib7	16571	8	longterm	longterm	JJ
cord-005453-4057qib7	16571	9	response	response	NN
cord-005453-4057qib7	16571	10	after	after	IN
cord-005453-4057qib7	16571	11	the	the	DT
cord-005453-4057qib7	16571	12	first	first	JJ
cord-005453-4057qib7	16571	13	ASCT	ASCT	NNP
cord-005453-4057qib7	16571	14	may	may	MD
cord-005453-4057qib7	16571	15	be	be	VB
cord-005453-4057qib7	16571	16	the	the	DT
cord-005453-4057qib7	16571	17	optimal	optimal	JJ
cord-005453-4057qib7	16571	18	therapeutic	therapeutic	JJ
cord-005453-4057qib7	16571	19	option	option	NN
cord-005453-4057qib7	16571	20	,	,	,
cord-005453-4057qib7	16571	21	the	the	DT
cord-005453-4057qib7	16571	22	effectiveness	effectiveness	NN
cord-005453-4057qib7	16571	23	of	of	IN
cord-005453-4057qib7	16571	24	which	which	WDT
cord-005453-4057qib7	16571	25	can	can	MD
cord-005453-4057qib7	16571	26	be	be	VB
cord-005453-4057qib7	16571	27	enhanced	enhance	VBN
cord-005453-4057qib7	16571	28	by	by	IN
cord-005453-4057qib7	16571	29	using	use	VBG
cord-005453-4057qib7	16571	30	new	new	JJ
cord-005453-4057qib7	16571	31	drugs	drug	NNS
cord-005453-4057qib7	16571	32	,	,	,
cord-005453-4057qib7	16571	33	such	such	JJ
cord-005453-4057qib7	16571	34	as	as	IN
cord-005453-4057qib7	16571	35	brentuximab	brentuximab	NNP
cord-005453-4057qib7	16571	36	vedotin	vedotin	NNP
cord-005453-4057qib7	16571	37	,	,	,
cord-005453-4057qib7	16571	38	at	at	IN
cord-005453-4057qib7	16571	39	all	all	DT
cord-005453-4057qib7	16571	40	stages	stage	NNS
cord-005453-4057qib7	16571	41	of	of	IN
cord-005453-4057qib7	16571	42	treatment	treatment	NN
cord-005453-4057qib7	16571	43	.	.	.
cord-005453-4057qib7	16572	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16572	2	:	:	:
cord-005453-4057qib7	16572	3	Nothing	nothing	NN
cord-005453-4057qib7	16572	4	to	to	TO
cord-005453-4057qib7	16572	5	declare	declare	VB
cord-005453-4057qib7	16572	6	Effectiveness	Effectiveness	NNP
cord-005453-4057qib7	16572	7	of	of	IN
cord-005453-4057qib7	16572	8	chemo	chemo	NN
cord-005453-4057qib7	16572	9	-	-	HYPH
cord-005453-4057qib7	16572	10	G	G	NNP
cord-005453-4057qib7	16572	11	-	-	HYPH
cord-005453-4057qib7	16572	12	CSF	csf	NN
cord-005453-4057qib7	16572	13	protocols	protocol	NNS
cord-005453-4057qib7	16572	14	for	for	IN
cord-005453-4057qib7	16572	15	mobilization	mobilization	NN
cord-005453-4057qib7	16572	16	of	of	IN
cord-005453-4057qib7	16572	17	peripheral	peripheral	JJ
cord-005453-4057qib7	16572	18	stem	stem	NN
cord-005453-4057qib7	16572	19	cells	cell	NNS
cord-005453-4057qib7	16572	20	in	in	IN
cord-005453-4057qib7	16572	21	patients	patient	NNS
cord-005453-4057qib7	16572	22	with	with	IN
cord-005453-4057qib7	16572	23	non	non	JJ
cord-005453-4057qib7	16572	24	-	-	JJ
cord-005453-4057qib7	16572	25	hodgkin	hodgkin	JJ
cord-005453-4057qib7	16572	26	lymphomas	lymphoma	NNS
cord-005453-4057qib7	16572	27	and	and	CC
cord-005453-4057qib7	16572	28	hodgkin	hodgkin	NNP
cord-005453-4057qib7	16572	29	disease	disease	NNP
cord-005453-4057qib7	16572	30	-	-	HYPH
cord-005453-4057qib7	16572	31	single	single	JJ
cord-005453-4057qib7	16572	32	center	center	NN
cord-005453-4057qib7	16572	33	experienceIlina	experienceilina	JJ
cord-005453-4057qib7	16572	34	Micheva	Micheva	NNP
cord-005453-4057qib7	16572	35	1	1	CD
cord-005453-4057qib7	16572	36	,	,	,
cord-005453-4057qib7	16572	37	Stela	Stela	NNP
cord-005453-4057qib7	16572	38	Dimitrova	Dimitrova	NNP
cord-005453-4057qib7	16572	39	1	1	CD
cord-005453-4057qib7	16572	40	,	,	,
cord-005453-4057qib7	16572	41	Vladimir	Vladimir	NNP
cord-005453-4057qib7	16572	42	Gerov	Gerov	NNP
cord-005453-4057qib7	16572	43	1	1	CD
cord-005453-4057qib7	16572	44	,	,	,
cord-005453-4057qib7	16572	45	Trifon	Trifon	NNP
cord-005453-4057qib7	16572	46	Chervenkov	Chervenkov	NNP
cord-005453-4057qib7	16572	47	2	2	CD
cord-005453-4057qib7	16572	48	,	,	,
cord-005453-4057qib7	16572	49	Liana	Liana	NNP
cord-005453-4057qib7	16572	50	Gercheva	Gercheva	NNP
cord-005453-4057qib7	16572	51	1	1	CD
cord-005453-4057qib7	16572	52	,	,	,
cord-005453-4057qib7	16572	53	Igor	Igor	NNP
cord-005453-4057qib7	16572	54	Reznik	Reznik	NNP
cord-005453-4057qib7	16572	55	1Background	1background	CD
cord-005453-4057qib7	16572	56	:	:	:
cord-005453-4057qib7	16572	57	High	high	JJ
cord-005453-4057qib7	16572	58	-	-	HYPH
cord-005453-4057qib7	16572	59	dose	dose	NN
cord-005453-4057qib7	16572	60	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	16572	61	and	and	CC
cord-005453-4057qib7	16572	62	autologous	autologous	JJ
cord-005453-4057qib7	16572	63	stem	stem	NN
cord-005453-4057qib7	16572	64	cell	cell	NN
cord-005453-4057qib7	16572	65	transplantation	transplantation	NN
cord-005453-4057qib7	16572	66	(	(	-LRB-
cord-005453-4057qib7	16572	67	ASCT	ASCT	NNP
cord-005453-4057qib7	16572	68	)	)	-RRB-
cord-005453-4057qib7	16572	69	play	play	VB
cord-005453-4057qib7	16572	70	an	an	DT
cord-005453-4057qib7	16572	71	important	important	JJ
cord-005453-4057qib7	16572	72	role	role	NN
cord-005453-4057qib7	16572	73	in	in	IN
cord-005453-4057qib7	16572	74	achieving	achieve	VBG
cord-005453-4057qib7	16572	75	long	long	JJ
cord-005453-4057qib7	16572	76	-	-	HYPH
cord-005453-4057qib7	16572	77	term	term	NN
cord-005453-4057qib7	16572	78	remission	remission	NN
cord-005453-4057qib7	16572	79	in	in	IN
cord-005453-4057qib7	16572	80	patients	patient	NNS
cord-005453-4057qib7	16572	81	with	with	IN
cord-005453-4057qib7	16572	82	non	non	JJ
cord-005453-4057qib7	16572	83	-	-	JJ
cord-005453-4057qib7	16572	84	Hodgkin	hodgkin	JJ
cord-005453-4057qib7	16572	85	lymphoma	lymphoma	NN
cord-005453-4057qib7	16572	86	(	(	-LRB-
cord-005453-4057qib7	16572	87	NHL	NHL	NNP
cord-005453-4057qib7	16572	88	)	)	-RRB-
cord-005453-4057qib7	16572	89	and	and	CC
cord-005453-4057qib7	16572	90	Hodgkin	Hodgkin	NNP
cord-005453-4057qib7	16572	91	disease	disease	NN
cord-005453-4057qib7	16572	92	(	(	-LRB-
cord-005453-4057qib7	16572	93	HD	HD	NNP
cord-005453-4057qib7	16572	94	)	)	-RRB-
cord-005453-4057qib7	16572	95	.	.	.
cord-005453-4057qib7	16573	1	Granulocyte	Granulocyte	NNP
cord-005453-4057qib7	16573	2	colony	colony	NN
cord-005453-4057qib7	16573	3	stimulating	stimulate	VBG
cord-005453-4057qib7	16573	4	factor	factor	NN
cord-005453-4057qib7	16574	1	(	(	-LRB-
cord-005453-4057qib7	16574	2	G	G	NNP
cord-005453-4057qib7	16574	3	-	-	HYPH
cord-005453-4057qib7	16574	4	CSF	CSF	NNP
cord-005453-4057qib7	16574	5	)	)	-RRB-
cord-005453-4057qib7	16574	6	combined	combine	VBN
cord-005453-4057qib7	16574	7	with	with	IN
cord-005453-4057qib7	16574	8	high	high	JJ
cord-005453-4057qib7	16574	9	-	-	HYPH
cord-005453-4057qib7	16574	10	dose	dose	NN
cord-005453-4057qib7	16574	11	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	16574	12	is	be	VBZ
cord-005453-4057qib7	16574	13	a	a	DT
cord-005453-4057qib7	16574	14	frequently	frequently	RB
cord-005453-4057qib7	16574	15	used	use	VBN
cord-005453-4057qib7	16574	16	mobilization	mobilization	NN
cord-005453-4057qib7	16574	17	approach	approach	NN
cord-005453-4057qib7	16574	18	;	;	:
cord-005453-4057qib7	16574	19	however	however	RB
cord-005453-4057qib7	16574	20	,	,	,
cord-005453-4057qib7	16574	21	the	the	DT
cord-005453-4057qib7	16574	22	optimal	optimal	JJ
cord-005453-4057qib7	16574	23	mobilization	mobilization	NN
cord-005453-4057qib7	16574	24	strategy	strategy	NN
cord-005453-4057qib7	16574	25	has	have	VBZ
cord-005453-4057qib7	16574	26	not	not	RB
cord-005453-4057qib7	16574	27	been	be	VBN
cord-005453-4057qib7	16574	28	determined	determine	VBN
cord-005453-4057qib7	16574	29	.	.	.
cord-005453-4057qib7	16575	1	The	the	DT
cord-005453-4057qib7	16575	2	objective	objective	NN
cord-005453-4057qib7	16575	3	of	of	IN
cord-005453-4057qib7	16575	4	the	the	DT
cord-005453-4057qib7	16575	5	study	study	NN
cord-005453-4057qib7	16575	6	was	be	VBD
cord-005453-4057qib7	16575	7	to	to	TO
cord-005453-4057qib7	16575	8	analyze	analyze	VB
cord-005453-4057qib7	16575	9	the	the	DT
cord-005453-4057qib7	16575	10	mobilizing	mobilize	VBG
cord-005453-4057qib7	16575	11	potential	potential	NN
cord-005453-4057qib7	16575	12	of	of	IN
cord-005453-4057qib7	16575	13	different	different	JJ
cord-005453-4057qib7	16575	14	regimens	regimen	NNS
cord-005453-4057qib7	16575	15	used	use	VBN
cord-005453-4057qib7	16575	16	for	for	IN
cord-005453-4057qib7	16575	17	the	the	DT
cord-005453-4057qib7	16575	18	collection	collection	NN
cord-005453-4057qib7	16575	19	of	of	IN
cord-005453-4057qib7	16575	20	peripheral	peripheral	JJ
cord-005453-4057qib7	16575	21	stem	stem	NN
cord-005453-4057qib7	16575	22	cells	cell	NNS
cord-005453-4057qib7	16575	23	in	in	IN
cord-005453-4057qib7	16575	24	patients	patient	NNS
cord-005453-4057qib7	16575	25	with	with	IN
cord-005453-4057qib7	16575	26	relapsed	relapsed	JJ
cord-005453-4057qib7	16575	27	or	or	CC
cord-005453-4057qib7	16575	28	refractory	refractory	JJ
cord-005453-4057qib7	16575	29	(	(	-LRB-
cord-005453-4057qib7	16575	30	R	r	NN
cord-005453-4057qib7	16575	31	/	/	SYM
cord-005453-4057qib7	16575	32	R	r	NN
cord-005453-4057qib7	16575	33	)	)	-RRB-
cord-005453-4057qib7	16575	34	NHL	NHL	NNP
cord-005453-4057qib7	16575	35	and	and	CC
cord-005453-4057qib7	16575	36	HD	hd	NN
cord-005453-4057qib7	16575	37	.	.	.
cord-005453-4057qib7	16576	1	Methods	method	NNS
cord-005453-4057qib7	16576	2	:	:	:
cord-005453-4057qib7	16576	3	We	-PRON-	PRP
cord-005453-4057qib7	16576	4	retrospectively	retrospectively	RB
cord-005453-4057qib7	16576	5	analyzed	analyze	VBD
cord-005453-4057qib7	16576	6	40	40	CD
cord-005453-4057qib7	16576	7	patients	patient	NNS
cord-005453-4057qib7	16576	8	with	with	IN
cord-005453-4057qib7	16576	9	R	r	NN
cord-005453-4057qib7	16576	10	/	/	SYM
cord-005453-4057qib7	16576	11	R	R	NNP
cord-005453-4057qib7	16576	12	NHL	NHL	NNP
cord-005453-4057qib7	16576	13	and	and	CC
cord-005453-4057qib7	16576	14	HD	HD	NNP
cord-005453-4057qib7	16576	15	undergoing	undergo	VBG
cord-005453-4057qib7	16576	16	stem	stem	NN
cord-005453-4057qib7	16576	17	cell	cell	NN
cord-005453-4057qib7	16576	18	collection	collection	NN
cord-005453-4057qib7	16576	19	after	after	IN
cord-005453-4057qib7	16576	20	chemo	chemo	NN
cord-005453-4057qib7	16576	21	-	-	HYPH
cord-005453-4057qib7	16576	22	mobilization	mobilization	NN
cord-005453-4057qib7	16576	23	in	in	IN
cord-005453-4057qib7	16576	24	the	the	DT
cord-005453-4057qib7	16576	25	transplant	transplant	NN
cord-005453-4057qib7	16576	26	unit	unit	NN
cord-005453-4057qib7	16576	27	at	at	IN
cord-005453-4057qib7	16576	28	the	the	DT
cord-005453-4057qib7	16576	29	University	University	NNP
cord-005453-4057qib7	16576	30	Hospital	Hospital	NNP
cord-005453-4057qib7	16576	31	,	,	,
cord-005453-4057qib7	16576	32	Varna	Varna	NNP
cord-005453-4057qib7	16576	33	.	.	.
cord-005453-4057qib7	16577	1	Patients	patient	NNS
cord-005453-4057qib7	16577	2	were	be	VBD
cord-005453-4057qib7	16577	3	mobilized	mobilize	VBN
cord-005453-4057qib7	16577	4	after	after	IN
cord-005453-4057qib7	16577	5	DHAP	DHAP	NNP
cord-005453-4057qib7	16577	6	Letermovir	Letermovir	NNP
cord-005453-4057qib7	16577	7	is	be	VBZ
cord-005453-4057qib7	16577	8	promising	promising	JJ
cord-005453-4057qib7	16577	9	,	,	,
cord-005453-4057qib7	16577	10	even	even	RB
cord-005453-4057qib7	16577	11	as	as	IN
cord-005453-4057qib7	16577	12	a	a	DT
cord-005453-4057qib7	16577	13	therapeutic	therapeutic	JJ
cord-005453-4057qib7	16577	14	agent	agent	NN
cord-005453-4057qib7	16577	15	.	.	.
cord-005453-4057qib7	16578	1	More	More	JJR
cord-005453-4057qib7	16578	2	paediatric	paediatric	JJ
cord-005453-4057qib7	16578	3	data	datum	NNS
cord-005453-4057qib7	16578	4	are	be	VBP
cord-005453-4057qib7	16578	5	urgently	urgently	RB
cord-005453-4057qib7	16578	6	needed	need	VBN
cord-005453-4057qib7	16578	7	.	.	.
cord-005453-4057qib7	16579	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16579	2	:	:	:
cord-005453-4057qib7	16579	3	Nothing	nothing	NN
cord-005453-4057qib7	16579	4	to	to	TO
cord-005453-4057qib7	16579	5	declare	declare	VB
cord-005453-4057qib7	16579	6	P752	P752	NNP
cord-005453-4057qib7	16579	7	Development	Development	NNP
cord-005453-4057qib7	16579	8	of	of	IN
cord-005453-4057qib7	16579	9	paroxysmal	paroxysmal	JJ
cord-005453-4057qib7	16579	10	nocturnal	nocturnal	JJ
cord-005453-4057qib7	16579	11	hemoglobinuria	hemoglobinuria	NN
cord-005453-4057qib7	16579	12	in	in	IN
cord-005453-4057qib7	16579	13	a	a	DT
cord-005453-4057qib7	16579	14	patient	patient	NN
cord-005453-4057qib7	16579	15	after	after	IN
cord-005453-4057qib7	16579	16	mudallohsct	mudallohsct	NNS
cord-005453-4057qib7	16579	17	due	due	IN
cord-005453-4057qib7	16579	18	to	to	IN
cord-005453-4057qib7	16579	19	JAK2V617Fpositive	JAK2V617Fpositive	NNP
cord-005453-4057qib7	16579	20	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	16579	21	-	-	:
cord-005453-4057qib7	16579	22	a	a	DT
cord-005453-4057qib7	16579	23	case	case	NN
cord-005453-4057qib7	16579	24	of	of	IN
cord-005453-4057qib7	16579	25	successful	successful	JJ
cord-005453-4057qib7	16579	26	treatment	treatment	NN
cord-005453-4057qib7	16579	27	with	with	IN
cord-005453-4057qib7	16579	28	the	the	DT
cord-005453-4057qib7	16579	29	second	second	JJ
cord-005453-4057qib7	16579	30	transplantation	transplantation	NN
cord-005453-4057qib7	16579	31	from	from	IN
cord-005453-4057qib7	16579	32	another	another	DT
cord-005453-4057qib7	16579	33	donor	donor	NN
cord-005453-4057qib7	16579	34	Agnieszka	Agnieszka	NNP
cord-005453-4057qib7	16579	35	Tomaszewska	Tomaszewska	NNP
cord-005453-4057qib7	16579	36	1	1	CD
cord-005453-4057qib7	16579	37	,	,	,
cord-005453-4057qib7	16579	38	Barbara	Barbara	NNP
cord-005453-4057qib7	16579	39	Nasiłowska	Nasiłowska	NNP
cord-005453-4057qib7	16579	40	-	-	HYPH
cord-005453-4057qib7	16579	41	Adamska	Adamska	NNP
cord-005453-4057qib7	16579	42	2	2	CD
cord-005453-4057qib7	16579	43	,	,	,
cord-005453-4057qib7	16579	44	Iwona	Iwona	NNP
cord-005453-4057qib7	16579	45	Solarska	Solarska	NNP
cord-005453-4057qib7	16579	46	2	2	CD
cord-005453-4057qib7	16579	47	,	,	,
cord-005453-4057qib7	16579	48	Kazimierz	Kazimierz	NNP
cord-005453-4057qib7	16579	49	Hałaburda	Hałaburda	NNP
cord-005453-4057qib7	16579	50	2Background	2background	CD
cord-005453-4057qib7	16579	51	:	:	:
cord-005453-4057qib7	16580	1	Paroxysmal	Paroxysmal	NNP
cord-005453-4057qib7	16580	2	nocturnal	nocturnal	JJ
cord-005453-4057qib7	16580	3	hemoglobinuria	hemoglobinuria	NN
cord-005453-4057qib7	16580	4	(	(	-LRB-
cord-005453-4057qib7	16580	5	PNH	PNH	NNP
cord-005453-4057qib7	16580	6	)	)	-RRB-
cord-005453-4057qib7	16580	7	is	be	VBZ
cord-005453-4057qib7	16580	8	a	a	DT
cord-005453-4057qib7	16580	9	very	very	RB
cord-005453-4057qib7	16580	10	rare	rare	JJ
cord-005453-4057qib7	16580	11	disease	disease	NN
cord-005453-4057qib7	16580	12	associated	associate	VBN
cord-005453-4057qib7	16580	13	with	with	IN
cord-005453-4057qib7	16580	14	PIG	PIG	NNP
cord-005453-4057qib7	16580	15	-	-	HYPH
cord-005453-4057qib7	16580	16	A	a	NN
cord-005453-4057qib7	16580	17	gene	gene	NN
cord-005453-4057qib7	16580	18	mutations	mutation	NNS
cord-005453-4057qib7	16580	19	in	in	IN
cord-005453-4057qib7	16580	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16580	21	stem	stem	NN
cord-005453-4057qib7	16580	22	cells	cell	NNS
cord-005453-4057qib7	16580	23	.	.	.
cord-005453-4057qib7	16581	1	There	there	EX
cord-005453-4057qib7	16581	2	are	be	VBP
cord-005453-4057qib7	16581	3	only	only	RB
cord-005453-4057qib7	16581	4	single	single	JJ
cord-005453-4057qib7	16581	5	case	case	NN
cord-005453-4057qib7	16581	6	reports	report	VBZ
cord-005453-4057qib7	16581	7	on	on	IN
cord-005453-4057qib7	16581	8	evolving	evolve	VBG
cord-005453-4057qib7	16581	9	myeloproliferative	myeloproliferative	JJ
cord-005453-4057qib7	16581	10	diseases	disease	NNS
cord-005453-4057qib7	16581	11	to	to	IN
cord-005453-4057qib7	16581	12	PNH	PNH	NNP
cord-005453-4057qib7	16581	13	in	in	IN
cord-005453-4057qib7	16581	14	the	the	DT
cord-005453-4057qib7	16581	15	literature	literature	NN
cord-005453-4057qib7	16581	16	.	.	.
cord-005453-4057qib7	16582	1	There	there	EX
cord-005453-4057qib7	16582	2	is	be	VBZ
cord-005453-4057qib7	16582	3	no	no	DT
cord-005453-4057qib7	16582	4	data	data	NN
cord-005453-4057qib7	16582	5	concerning	concern	VBG
cord-005453-4057qib7	16582	6	development	development	NN
cord-005453-4057qib7	16582	7	of	of	IN
cord-005453-4057qib7	16582	8	PNH	PNH	NNP
cord-005453-4057qib7	16582	9	de	de	NNP
cord-005453-4057qib7	16582	10	novo	novo	NNP
cord-005453-4057qib7	16582	11	after	after	IN
cord-005453-4057qib7	16582	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16582	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16582	14	stem	stem	NN
cord-005453-4057qib7	16582	15	cell	cell	NN
cord-005453-4057qib7	16582	16	transplantation	transplantation	NN
cord-005453-4057qib7	16582	17	.	.	.
cord-005453-4057qib7	16583	1	In	in	IN
cord-005453-4057qib7	16583	2	our	-PRON-	PRP$
cord-005453-4057qib7	16583	3	report	report	NN
cord-005453-4057qib7	16583	4	we	-PRON-	PRP
cord-005453-4057qib7	16583	5	describe	describe	VBP
cord-005453-4057qib7	16583	6	a	a	DT
cord-005453-4057qib7	16583	7	patient	patient	NN
cord-005453-4057qib7	16583	8	with	with	IN
cord-005453-4057qib7	16583	9	recurrence	recurrence	NN
cord-005453-4057qib7	16583	10	of	of	IN
cord-005453-4057qib7	16583	11	JAK2V617-positive	jak2v617-positive	JJ
cord-005453-4057qib7	16583	12	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	16583	13	5	5	CD
cord-005453-4057qib7	16583	14	years	year	NNS
cord-005453-4057qib7	16583	15	after	after	IN
cord-005453-4057qib7	16583	16	matched	match	VBN
cord-005453-4057qib7	16583	17	unrelated	unrelated	JJ
cord-005453-4057qib7	16583	18	donor	donor	NN
cord-005453-4057qib7	16583	19	allogeneic	allogeneic	NN
cord-005453-4057qib7	16583	20	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16583	21	stem	stem	NN
cord-005453-4057qib7	16583	22	cell	cell	NN
cord-005453-4057qib7	16583	23	transplantation	transplantation	NN
cord-005453-4057qib7	16583	24	(	(	-LRB-
cord-005453-4057qib7	16583	25	MUDalloHSCT	MUDalloHSCT	NFP
cord-005453-4057qib7	16583	26	)	)	-RRB-
cord-005453-4057qib7	16583	27	with	with	IN
cord-005453-4057qib7	16583	28	simultaneous	simultaneous	JJ
cord-005453-4057qib7	16583	29	development	development	NN
cord-005453-4057qib7	16583	30	of	of	IN
cord-005453-4057qib7	16583	31	clinically	clinically	RB
cord-005453-4057qib7	16583	32	significant	significant	JJ
cord-005453-4057qib7	16583	33	PNH	PNH	NNP
cord-005453-4057qib7	16583	34	.	.	.
cord-005453-4057qib7	16584	1	A	a	DT
cord-005453-4057qib7	16584	2	51	51	CD
cord-005453-4057qib7	16584	3	year	year	NN
cord-005453-4057qib7	16584	4	-	-	HYPH
cord-005453-4057qib7	16584	5	old	old	JJ
cord-005453-4057qib7	16584	6	-	-	HYPH
cord-005453-4057qib7	16584	7	man	man	NN
cord-005453-4057qib7	16584	8	with	with	IN
cord-005453-4057qib7	16584	9	a	a	DT
cord-005453-4057qib7	16584	10	history	history	NN
cord-005453-4057qib7	16584	11	of	of	IN
cord-005453-4057qib7	16584	12	MUDal	MUDal	NNP
cord-005453-4057qib7	16584	13	-	-	HYPH
cord-005453-4057qib7	16584	14	loHSCT	loHSCT	NNP
cord-005453-4057qib7	16584	15	in	in	IN
cord-005453-4057qib7	16584	16	May	May	NNP
cord-005453-4057qib7	16584	17	2011	2011	CD
cord-005453-4057qib7	16584	18	due	due	IN
cord-005453-4057qib7	16584	19	to	to	IN
cord-005453-4057qib7	16584	20	JAK2V617-positive	JAK2V617-positive	NNP
cord-005453-4057qib7	16584	21	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	16584	22	secondary	secondary	JJ
cord-005453-4057qib7	16584	23	to	to	IN
cord-005453-4057qib7	16584	24	essential	essential	JJ
cord-005453-4057qib7	16584	25	thrombocythemia	thrombocythemia	NN
cord-005453-4057qib7	16584	26	was	be	VBD
cord-005453-4057qib7	16584	27	admitted	admit	VBN
cord-005453-4057qib7	16584	28	to	to	IN
cord-005453-4057qib7	16584	29	our	-PRON-	PRP$
cord-005453-4057qib7	16584	30	department	department	NN
cord-005453-4057qib7	16584	31	5	5	CD
cord-005453-4057qib7	16584	32	years	year	NNS
cord-005453-4057qib7	16584	33	later	later	RB
cord-005453-4057qib7	16584	34	with	with	IN
cord-005453-4057qib7	16584	35	mild	mild	JJ
cord-005453-4057qib7	16584	36	anemia	anemia	NN
cord-005453-4057qib7	16584	37	(	(	-LRB-
cord-005453-4057qib7	16584	38	Hb-11.0	hb-11.0	IN
cord-005453-4057qib7	16584	39	g	g	NN
cord-005453-4057qib7	16584	40	/	/	SYM
cord-005453-4057qib7	16584	41	dL	dl	NN
cord-005453-4057qib7	16584	42	)	)	-RRB-
cord-005453-4057qib7	16584	43	and	and	CC
cord-005453-4057qib7	16584	44	elevated	elevated	JJ
cord-005453-4057qib7	16584	45	lactate	lactate	NN
cord-005453-4057qib7	16584	46	dehydrogenase	dehydrogenase	NN
cord-005453-4057qib7	16584	47	(	(	-LRB-
cord-005453-4057qib7	16584	48	1400	1400	CD
cord-005453-4057qib7	16584	49	U	U	NNP
cord-005453-4057qib7	16584	50	/	/	SYM
cord-005453-4057qib7	16584	51	L	L	NNP
cord-005453-4057qib7	16584	52	)	)	-RRB-
cord-005453-4057qib7	16584	53	.	.	.
cord-005453-4057qib7	16585	1	During	during	IN
cord-005453-4057qib7	16585	2	last	last	JJ
cord-005453-4057qib7	16585	3	5	5	CD
cord-005453-4057qib7	16585	4	years	year	NNS
cord-005453-4057qib7	16585	5	he	-PRON-	PRP
cord-005453-4057qib7	16585	6	remained	remain	VBD
cord-005453-4057qib7	16585	7	in	in	IN
cord-005453-4057qib7	16585	8	complete	complete	JJ
cord-005453-4057qib7	16585	9	remission	remission	NN
cord-005453-4057qib7	16585	10	of	of	IN
cord-005453-4057qib7	16585	11	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	16585	12	with	with	IN
cord-005453-4057qib7	16585	13	JAK2V617	JAK2V617	NNP
cord-005453-4057qib7	16585	14	mutation	mutation	NN
cord-005453-4057qib7	16585	15	negativisation	negativisation	NN
cord-005453-4057qib7	16585	16	and	and	CC
cord-005453-4057qib7	16585	17	100	100	CD
cord-005453-4057qib7	16585	18	%	%	NN
cord-005453-4057qib7	16585	19	donor	donor	NN
cord-005453-4057qib7	16585	20	chimerism	chimerism	NN
cord-005453-4057qib7	16585	21	.	.	.
cord-005453-4057qib7	16586	1	Suspecting	suspect	VBG
cord-005453-4057qib7	16586	2	disease	disease	NN
cord-005453-4057qib7	16586	3	recurrence	recurrence	NN
cord-005453-4057qib7	16586	4	we	-PRON-	PRP
cord-005453-4057qib7	16586	5	performed	perform	VBD
cord-005453-4057qib7	16586	6	trephine	trephine	NNP
cord-005453-4057qib7	16586	7	biopsy	biopsy	NNP
cord-005453-4057qib7	16586	8	confirming	confirm	VBG
cord-005453-4057qib7	16586	9	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	16586	10	(	(	-LRB-
cord-005453-4057qib7	16586	11	MF2	MF2	NNP
cord-005453-4057qib7	16586	12	/	/	SYM
cord-005453-4057qib7	16586	13	MF3	MF3	NNP
cord-005453-4057qib7	16586	14	)	)	-RRB-
cord-005453-4057qib7	16586	15	with	with	IN
cord-005453-4057qib7	16586	16	heterozygous	heterozygous	JJ
cord-005453-4057qib7	16586	17	JAK2V617	JAK2V617	NNP
cord-005453-4057qib7	16586	18	mutation	mutation	NN
cord-005453-4057qib7	16586	19	and	and	CC
cord-005453-4057qib7	16586	20	in	in	IN
cord-005453-4057qib7	16586	21	flow	flow	NN
cord-005453-4057qib7	16586	22	cytometry	cytometry	NN
cord-005453-4057qib7	16586	23	analysis	analysis	NN
cord-005453-4057qib7	16586	24	of	of	IN
cord-005453-4057qib7	16586	25	bone	bone	NN
cord-005453-4057qib7	16586	26	marrow	marrow	NN
cord-005453-4057qib7	16586	27	we	-PRON-	PRP
cord-005453-4057qib7	16586	28	identified	identify	VBD
cord-005453-4057qib7	16586	29	cell	cell	NN
cord-005453-4057qib7	16586	30	membrane	membrane	NN
cord-005453-4057qib7	16586	31	defect	defect	NN
cord-005453-4057qib7	16586	32	in	in	IN
cord-005453-4057qib7	16586	33	myeloid	myeloid	JJ
cord-005453-4057qib7	16586	34	line	line	NN
cord-005453-4057qib7	16586	35	(	(	-LRB-
cord-005453-4057qib7	16586	36	loss	loss	NN
cord-005453-4057qib7	16586	37	of	of	IN
cord-005453-4057qib7	16586	38	CD66c	CD66c	NNP
cord-005453-4057qib7	16586	39	)	)	-RRB-
cord-005453-4057qib7	16586	40	.	.	.
cord-005453-4057qib7	16587	1	We	-PRON-	PRP
cord-005453-4057qib7	16587	2	decided	decide	VBD
cord-005453-4057qib7	16587	3	to	to	TO
cord-005453-4057qib7	16587	4	perform	perform	VB
cord-005453-4057qib7	16587	5	detailed	detailed	JJ
cord-005453-4057qib7	16587	6	diagnostic	diagnostic	JJ
cord-005453-4057qib7	16587	7	tests	test	NNS
cord-005453-4057qib7	16587	8	on	on	IN
cord-005453-4057qib7	16587	9	PNH	PNH	NNP
cord-005453-4057qib7	16587	10	-multiparametric	-multiparametric	JJ
cord-005453-4057qib7	16587	11	flow	flow	NN
cord-005453-4057qib7	16587	12	cytometry	cytometry	NN
cord-005453-4057qib7	16587	13	of	of	IN
cord-005453-4057qib7	16587	14	peripheral	peripheral	JJ
cord-005453-4057qib7	16587	15	blood	blood	NN
cord-005453-4057qib7	16587	16	revealed	reveal	VBD
cord-005453-4057qib7	16587	17	89	89	CD
cord-005453-4057qib7	16587	18	%	%	NN
cord-005453-4057qib7	16587	19	granulocytes	granulocyte	NNS
cord-005453-4057qib7	16587	20	and	and	CC
cord-005453-4057qib7	16587	21	15	15	CD
cord-005453-4057qib7	16587	22	%	%	NN
cord-005453-4057qib7	16587	23	red	red	JJ
cord-005453-4057qib7	16587	24	blood	blood	NN
cord-005453-4057qib7	16587	25	cells	cell	NNS
cord-005453-4057qib7	16587	26	with	with	IN
cord-005453-4057qib7	16587	27	loss	loss	NN
cord-005453-4057qib7	16587	28	of	of	IN
cord-005453-4057qib7	16587	29	GPI	GPI	NNP
cord-005453-4057qib7	16587	30	-	-	HYPH
cord-005453-4057qib7	16587	31	anchored	anchor	VBN
cord-005453-4057qib7	16587	32	proteins	protein	NNS
cord-005453-4057qib7	16587	33	-PNH	-pnh	DT
cord-005453-4057qib7	16587	34	clone	clone	NN
cord-005453-4057qib7	16587	35	.	.	.
cord-005453-4057qib7	16588	1	These	these	DT
cord-005453-4057qib7	16588	2	results	result	NNS
cord-005453-4057qib7	16588	3	corresponded	correspond	VBD
cord-005453-4057qib7	16588	4	with	with	IN
cord-005453-4057qib7	16588	5	donor	donor	NN
cord-005453-4057qib7	16588	6	chimerism	chimerism	NN
cord-005453-4057qib7	16588	7	-it	-it	:
cord-005453-4057qib7	16588	8	was	be	VBD
cord-005453-4057qib7	16588	9	only	only	RB
cord-005453-4057qib7	16588	10	20	20	CD
cord-005453-4057qib7	16588	11	%	%	NN
cord-005453-4057qib7	16588	12	of	of	IN
cord-005453-4057qib7	16588	13	donor	donor	NN
cord-005453-4057qib7	16588	14	DNA	dna	NN
cord-005453-4057qib7	16588	15	in	in	IN
cord-005453-4057qib7	16588	16	bone	bone	NN
cord-005453-4057qib7	16588	17	marrow	marrow	NN
cord-005453-4057qib7	16588	18	and	and	CC
cord-005453-4057qib7	16588	19	33	33	CD
cord-005453-4057qib7	16588	20	%	%	NN
cord-005453-4057qib7	16588	21	in	in	IN
cord-005453-4057qib7	16588	22	blood	blood	NN
cord-005453-4057qib7	16588	23	tests	test	NNS
cord-005453-4057qib7	16588	24	.	.	.
cord-005453-4057qib7	16589	1	Molecular	molecular	JJ
cord-005453-4057qib7	16589	2	analysis	analysis	NN
cord-005453-4057qib7	16589	3	did	do	VBD
cord-005453-4057qib7	16589	4	n't	not	RB
cord-005453-4057qib7	16589	5	revealed	reveal	VBN
cord-005453-4057qib7	16589	6	any	any	DT
cord-005453-4057qib7	16589	7	mutations	mutation	NNS
cord-005453-4057qib7	16589	8	in	in	IN
cord-005453-4057qib7	16589	9	genes	gene	NNS
cord-005453-4057qib7	16589	10	:	:	:
cord-005453-4057qib7	16589	11	CALR	CALR	NNP
cord-005453-4057qib7	16589	12	,	,	,
cord-005453-4057qib7	16589	13	ASXL1	ASXL1	NNP
cord-005453-4057qib7	16589	14	and	and	CC
cord-005453-4057qib7	16589	15	MPL	MPL	NNP
cord-005453-4057qib7	16589	16	.	.	.
cord-005453-4057qib7	16590	1	Finally	finally	RB
cord-005453-4057qib7	16590	2	the	the	DT
cord-005453-4057qib7	16590	3	diagnosis	diagnosis	NN
cord-005453-4057qib7	16590	4	of	of	IN
cord-005453-4057qib7	16590	5	myelofibrosis	myelofibrosis	NN
cord-005453-4057qib7	16590	6	recurrence	recurrence	NN
cord-005453-4057qib7	16590	7	after	after	IN
cord-005453-4057qib7	16590	8	MUDalloHSCT	mudallohsct	NN
cord-005453-4057qib7	16590	9	with	with	IN
cord-005453-4057qib7	16590	10	presence	presence	NN
cord-005453-4057qib7	16590	11	of	of	IN
cord-005453-4057qib7	16590	12	PNH	PNH	NNP
cord-005453-4057qib7	16590	13	clone	clone	NN
cord-005453-4057qib7	16590	14	was	be	VBD
cord-005453-4057qib7	16590	15	established	establish	VBN
cord-005453-4057qib7	16590	16	.	.	.
cord-005453-4057qib7	16591	1	The	the	DT
cord-005453-4057qib7	16591	2	therapy	therapy	NN
cord-005453-4057qib7	16591	3	with	with	IN
cord-005453-4057qib7	16591	4	eculizumab	eculizumab	NNS
cord-005453-4057qib7	16591	5	was	be	VBD
cord-005453-4057qib7	16591	6	unreachable	unreachable	JJ
cord-005453-4057qib7	16591	7	.	.	.
cord-005453-4057qib7	16592	1	So	so	RB
cord-005453-4057qib7	16592	2	the	the	DT
cord-005453-4057qib7	16592	3	second	second	JJ
cord-005453-4057qib7	16592	4	alloHSCT	allohsct	NN
cord-005453-4057qib7	16592	5	from	from	IN
cord-005453-4057qib7	16592	6	another	another	DT
cord-005453-4057qib7	16592	7	matched	match	VBN
cord-005453-4057qib7	16592	8	unrelated	unrelated	JJ
cord-005453-4057qib7	16592	9	donor	donor	NN
cord-005453-4057qib7	16592	10	after	after	IN
cord-005453-4057qib7	16592	11	fludarabinemelphalan	fludarabinemelphalan	JJ
cord-005453-4057qib7	16592	12	-	-	HYPH
cord-005453-4057qib7	16592	13	thymoglobuline	thymoglobuline	NNP
cord-005453-4057qib7	16592	14	-	-	HYPH
cord-005453-4057qib7	16592	15	TBI	TBI	NNP
cord-005453-4057qib7	16592	16	200	200	CD
cord-005453-4057qib7	16592	17	cGy	cGy	NNS
cord-005453-4057qib7	16592	18	conditioning	conditioning	NN
cord-005453-4057qib7	16592	19	was	be	VBD
cord-005453-4057qib7	16592	20	performed	perform	VBN
cord-005453-4057qib7	16592	21	on	on	IN
cord-005453-4057qib7	16592	22	21.10.2016	21.10.2016	NNP
cord-005453-4057qib7	16592	23	.	.	.
cord-005453-4057qib7	16593	1	We	-PRON-	PRP
cord-005453-4057qib7	16593	2	did	do	VBD
cord-005453-4057qib7	16593	3	n't	not	RB
cord-005453-4057qib7	16593	4	observe	observe	VB
cord-005453-4057qib7	16593	5	any	any	DT
cord-005453-4057qib7	16593	6	complications	complication	NNS
cord-005453-4057qib7	16593	7	of	of	IN
cord-005453-4057qib7	16593	8	this	this	DT
cord-005453-4057qib7	16593	9	procedure	procedure	NN
cord-005453-4057qib7	16593	10	,	,	,
cord-005453-4057qib7	16593	11	engraftment	engraftment	NNP
cord-005453-4057qib7	16593	12	was	be	VBD
cord-005453-4057qib7	16593	13	slightly	slightly	RB
cord-005453-4057qib7	16593	14	delayed	delay	VBN
cord-005453-4057qib7	16593	15	:	:	:
cord-005453-4057qib7	16594	1	ANC>0.5G	ANC>0.5G	NNP
cord-005453-4057qib7	16594	2	/	/	SYM
cord-005453-4057qib7	16594	3	L	L	NNP
cord-005453-4057qib7	16594	4	on	on	IN
cord-005453-4057qib7	16594	5	the	the	DT
cord-005453-4057qib7	16594	6	29	29	CD
cord-005453-4057qib7	16594	7	day	day	NN
cord-005453-4057qib7	16594	8	and	and	CC
cord-005453-4057qib7	16594	9	PLT>50G	PLT>50G	NNP
cord-005453-4057qib7	16594	10	/	/	SYM
cord-005453-4057qib7	16594	11	L	L	NNP
cord-005453-4057qib7	16594	12	on	on	IN
cord-005453-4057qib7	16594	13	the	the	DT
cord-005453-4057qib7	16594	14	50	50	CD
cord-005453-4057qib7	16594	15	day	day	NN
cord-005453-4057qib7	16594	16	.	.	.
cord-005453-4057qib7	16595	1	Results	result	NNS
cord-005453-4057qib7	16595	2	:	:	:
cord-005453-4057qib7	16596	1	At	at	IN
cord-005453-4057qib7	16596	2	present	present	JJ
cord-005453-4057qib7	16596	3	,	,	,
cord-005453-4057qib7	16596	4	more	more	JJR
cord-005453-4057qib7	16596	5	than	than	IN
cord-005453-4057qib7	16596	6	2	2	CD
cord-005453-4057qib7	16596	7	years	year	NNS
cord-005453-4057qib7	16596	8	after	after	IN
cord-005453-4057qib7	16596	9	the	the	DT
cord-005453-4057qib7	16596	10	second	second	JJ
cord-005453-4057qib7	16596	11	MUDalloPBSCT	mudallopbsct	NN
cord-005453-4057qib7	16596	12	,	,	,
cord-005453-4057qib7	16596	13	the	the	DT
cord-005453-4057qib7	16596	14	patient	patient	NN
cord-005453-4057qib7	16596	15	remains	remain	VBZ
cord-005453-4057qib7	16596	16	in	in	IN
cord-005453-4057qib7	16596	17	a	a	DT
cord-005453-4057qib7	16596	18	very	very	RB
cord-005453-4057qib7	16596	19	good	good	JJ
cord-005453-4057qib7	16596	20	condition	condition	NN
cord-005453-4057qib7	16596	21	with	with	IN
cord-005453-4057qib7	16596	22	100	100	CD
cord-005453-4057qib7	16596	23	%	%	NN
cord-005453-4057qib7	16596	24	of	of	IN
cord-005453-4057qib7	16596	25	the	the	DT
cord-005453-4057qib7	16596	26	second	second	JJ
cord-005453-4057qib7	16596	27	donor	donor	NN
cord-005453-4057qib7	16596	28	chimerism	chimerism	NN
cord-005453-4057qib7	16596	29	and	and	CC
cord-005453-4057qib7	16596	30	without	without	IN
cord-005453-4057qib7	16596	31	any	any	DT
cord-005453-4057qib7	16596	32	features	feature	NNS
cord-005453-4057qib7	16596	33	of	of	IN
cord-005453-4057qib7	16596	34	PNH	PNH	NNP
cord-005453-4057qib7	16596	35	(	(	-LRB-
cord-005453-4057qib7	16596	36	clone	clone	NN
cord-005453-4057qib7	16596	37	is	be	VBZ
cord-005453-4057qib7	16596	38	undetectable	undetectable	JJ
cord-005453-4057qib7	16596	39	)	)	-RRB-
cord-005453-4057qib7	16596	40	and	and	CC
cord-005453-4057qib7	16596	41	myelofibrosis	myelofibrosis	NNP
cord-005453-4057qib7	16596	42	.	.	.
cord-005453-4057qib7	16597	1	Conclusions	conclusion	NNS
cord-005453-4057qib7	16597	2	:	:	:
cord-005453-4057qib7	16598	1	Presented	present	VBN
cord-005453-4057qib7	16598	2	case	case	NN
cord-005453-4057qib7	16598	3	is	be	VBZ
cord-005453-4057qib7	16598	4	the	the	DT
cord-005453-4057qib7	16598	5	first	first	JJ
cord-005453-4057qib7	16598	6	in	in	IN
cord-005453-4057qib7	16598	7	the	the	DT
cord-005453-4057qib7	16598	8	literature	literature	NN
cord-005453-4057qib7	16598	9	well	well	RB
cord-005453-4057qib7	16598	10	documented	document	VBD
cord-005453-4057qib7	16598	11	myelofibrosis	myelofibrosis	JJ
cord-005453-4057qib7	16598	12	recurrence	recurrence	NN
cord-005453-4057qib7	16598	13	after	after	IN
cord-005453-4057qib7	16598	14	MUDal	MUDal	NNP
cord-005453-4057qib7	16598	15	-	-	HYPH
cord-005453-4057qib7	16598	16	loHSCT	loHSCT	NNP
cord-005453-4057qib7	16598	17	with	with	IN
cord-005453-4057qib7	16598	18	concurrently	concurrently	RB
cord-005453-4057qib7	16598	19	development	development	NN
cord-005453-4057qib7	16598	20	of	of	IN
cord-005453-4057qib7	16598	21	clinically	clinically	RB
cord-005453-4057qib7	16598	22	significant	significant	JJ
cord-005453-4057qib7	16598	23	paroxysmal	paroxysmal	JJ
cord-005453-4057qib7	16598	24	nocturnal	nocturnal	JJ
cord-005453-4057qib7	16598	25	hemoglobinuria	hemoglobinuria	NNS
cord-005453-4057qib7	16598	26	.	.	.
cord-005453-4057qib7	16599	1	The	the	DT
cord-005453-4057qib7	16599	2	second	second	JJ
cord-005453-4057qib7	16599	3	MUDalloHSCT	mudallohsct	NN
cord-005453-4057qib7	16599	4	from	from	IN
cord-005453-4057qib7	16599	5	another	another	DT
cord-005453-4057qib7	16599	6	donor	donor	NN
cord-005453-4057qib7	16599	7	was	be	VBD
cord-005453-4057qib7	16599	8	safe	safe	JJ
cord-005453-4057qib7	16599	9	and	and	CC
cord-005453-4057qib7	16599	10	successful	successful	JJ
cord-005453-4057qib7	16599	11	treatment	treatment	NN
cord-005453-4057qib7	16599	12	strategy	strategy	NN
cord-005453-4057qib7	16599	13	in	in	IN
cord-005453-4057qib7	16599	14	this	this	DT
cord-005453-4057qib7	16599	15	situation	situation	NN
cord-005453-4057qib7	16599	16	.	.	.
cord-005453-4057qib7	16600	1	Disclosure	disclosure	NN
cord-005453-4057qib7	16600	2	:	:	:
cord-005453-4057qib7	16600	3	Nothing	nothing	NN
cord-005453-4057qib7	16600	4	to	to	TO
cord-005453-4057qib7	16600	5	declare	declare	VB
cord-005453-4057qib7	16600	6	.	.	.
cord-005453-4057qib7	16601	1	Abstract	Abstract	NNP
cord-005453-4057qib7	16601	2	already	already	RB
cord-005453-4057qib7	16601	3	published	publish	VBN
cord-005453-4057qib7	16601	4	.	.	.
cord-005453-4057qib7	16602	1	Cutaneous	cutaneous	JJ
cord-005453-4057qib7	16602	2	refractory	refractory	JJ
cord-005453-4057qib7	16602	3	T	t	NN
cord-005453-4057qib7	16602	4	-	-	HYPH
cord-005453-4057qib7	16602	5	cell	cell	NN
cord-005453-4057qib7	16602	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	16602	7	treated	treat	VBN
cord-005453-4057qib7	16602	8	with	with	IN
cord-005453-4057qib7	16602	9	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16602	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16602	11	stem	stem	NN
cord-005453-4057qib7	16602	12	cell	cell	NN
cord-005453-4057qib7	16602	13	transplantationMarcia	transplantationMarcia	NNS
cord-005453-4057qib7	16603	1	Silva	Silva	NNP
cord-005453-4057qib7	16603	2	1	1	CD
cord-005453-4057qib7	16603	3	,	,	,
cord-005453-4057qib7	16603	4	Ercole	Ercole	NNP
cord-005453-4057qib7	16603	5	Orlando	Orlando	NNP
cord-005453-4057qib7	16603	6	1	1	CD
cord-005453-4057qib7	16603	7	,	,	,
cord-005453-4057qib7	16603	8	Maria	Maria	NNP
cord-005453-4057qib7	16603	9	Claudia	Claudia	NNP
cord-005453-4057qib7	16603	10	Moreira	Moreira	NNP
cord-005453-4057qib7	16603	11	1	1	CD
cord-005453-4057qib7	16603	12	,	,	,
cord-005453-4057qib7	16603	13	Simone	Simone	NNP
cord-005453-4057qib7	16603	14	Lermontov	Lermontov	NNP
cord-005453-4057qib7	16603	15	1	1	CD
cord-005453-4057qib7	16603	16	,	,	,
cord-005453-4057qib7	16603	17	Simone	Simone	NNP
cord-005453-4057qib7	16603	18	Maradei	Maradei	NNP
cord-005453-4057qib7	16603	19	1	1	CD
cord-005453-4057qib7	16603	20	,	,	,
cord-005453-4057qib7	16603	21	Yung	Yung	NNP
cord-005453-4057qib7	16603	22	Gonzaga	Gonzaga	NNP
cord-005453-4057qib7	16603	23	1	1	CD
cord-005453-4057qib7	16603	24	,	,	,
cord-005453-4057qib7	16603	25	Leonardo	Leonardo	NNP
cord-005453-4057qib7	16603	26	Arcuri	Arcuri	NNP
cord-005453-4057qib7	16603	27	1	1	CD
cord-005453-4057qib7	16603	28	,	,	,
cord-005453-4057qib7	16603	29	Renato	Renato	NNP
cord-005453-4057qib7	16603	30	Araujo	Araujo	NNP
cord-005453-4057qib7	16603	31	1	1	CD
cord-005453-4057qib7	16603	32	,	,	,
cord-005453-4057qib7	16603	33	Decio	Decio	NNP
cord-005453-4057qib7	16603	34	Lerner	Lerner	NNP
cord-005453-4057qib7	16603	35	1	1	CD
cord-005453-4057qib7	16603	36	1	1	CD
cord-005453-4057qib7	16603	37	Instituto	Instituto	NNP
cord-005453-4057qib7	16603	38	Nacional	Nacional	NNP
cord-005453-4057qib7	16603	39	de	de	NNP
cord-005453-4057qib7	16603	40	Cancer	Cancer	NNP
cord-005453-4057qib7	16603	41	,	,	,
cord-005453-4057qib7	16603	42	CEMO	CEMO	NNP
cord-005453-4057qib7	16603	43	,	,	,
cord-005453-4057qib7	16603	44	Rio	Rio	NNP
cord-005453-4057qib7	16603	45	de	de	NNP
cord-005453-4057qib7	16603	46	Janeiro	Janeiro	NNP
cord-005453-4057qib7	16603	47	,	,	,
cord-005453-4057qib7	16603	48	BrazilBackground	BrazilBackground	NNP
cord-005453-4057qib7	16603	49	:	:	:
cord-005453-4057qib7	16604	1	Folliculotropic	Folliculotropic	NNP
cord-005453-4057qib7	16604	2	mycosis	mycosis	NNP
cord-005453-4057qib7	16604	3	fungoides	fungoides	NNP
cord-005453-4057qib7	16604	4	(	(	-LRB-
cord-005453-4057qib7	16604	5	fMF	fMF	NNP
cord-005453-4057qib7	16604	6	)	)	-RRB-
cord-005453-4057qib7	16604	7	is	be	VBZ
cord-005453-4057qib7	16604	8	an	an	DT
cord-005453-4057qib7	16604	9	aggressive	aggressive	JJ
cord-005453-4057qib7	16604	10	clinical	clinical	JJ
cord-005453-4057qib7	16604	11	course	course	NN
cord-005453-4057qib7	16604	12	variant	variant	NN
cord-005453-4057qib7	16604	13	of	of	IN
cord-005453-4057qib7	16604	14	cutaneous	cutaneous	JJ
cord-005453-4057qib7	16604	15	T	t	NN
cord-005453-4057qib7	16604	16	-	-	HYPH
cord-005453-4057qib7	16604	17	cell	cell	NN
cord-005453-4057qib7	16604	18	lymphoma	lymphoma	NN
cord-005453-4057qib7	16604	19	(	(	-LRB-
cord-005453-4057qib7	16604	20	CTCL	CTCL	NNP
cord-005453-4057qib7	16604	21	)	)	-RRB-
cord-005453-4057qib7	16605	1	-classic	-classic	NNP
cord-005453-4057qib7	16605	2	mycosis	mycosis	NNP
cord-005453-4057qib7	16605	3	fungoides	fungoides	NNP
cord-005453-4057qib7	16605	4	(	(	-LRB-
cord-005453-4057qib7	16605	5	MF	MF	NNP
cord-005453-4057qib7	16605	6	)	)	-RRB-
cord-005453-4057qib7	16605	7	1	1	CD
cord-005453-4057qib7	16605	8	,	,	,
cord-005453-4057qib7	16605	9	with	with	IN
cord-005453-4057qib7	16605	10	distinct	distinct	JJ
cord-005453-4057qib7	16605	11	clinical	clinical	JJ
cord-005453-4057qib7	16605	12	and	and	CC
cord-005453-4057qib7	16605	13	pathological	pathological	JJ
cord-005453-4057qib7	16605	14	characteristics	characteristic	NNS
cord-005453-4057qib7	16605	15	,	,	,
cord-005453-4057qib7	16605	16	and	and	CC
cord-005453-4057qib7	16605	17	it	-PRON-	PRP
cord-005453-4057qib7	16605	18	is	be	VBZ
cord-005453-4057qib7	16605	19	less	less	RBR
cord-005453-4057qib7	16605	20	responsive	responsive	JJ
cord-005453-4057qib7	16605	21	to	to	IN
cord-005453-4057qib7	16605	22	skin	skin	NN
cord-005453-4057qib7	16605	23	-	-	HYPH
cord-005453-4057qib7	16605	24	directed	direct	VBN
cord-005453-4057qib7	16605	25	therapies	therapy	NNS
cord-005453-4057qib7	16605	26	.	.	.
cord-005453-4057qib7	16606	1	For	for	IN
cord-005453-4057qib7	16606	2	diseases	disease	NNS
cord-005453-4057qib7	16606	3	in	in	IN
cord-005453-4057qib7	16606	4	advanced	advanced	JJ
cord-005453-4057qib7	16606	5	stages	stage	NNS
cord-005453-4057qib7	16606	6	,	,	,
cord-005453-4057qib7	16606	7	chemotherapy	chemotherapy	NN
cord-005453-4057qib7	16606	8	,	,	,
cord-005453-4057qib7	16606	9	autologous	autologous	JJ
cord-005453-4057qib7	16606	10	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16606	11	stem	stem	NN
cord-005453-4057qib7	16606	12	cell	cell	NN
cord-005453-4057qib7	16606	13	transplantation	transplantation	NN
cord-005453-4057qib7	16606	14	(	(	-LRB-
cord-005453-4057qib7	16606	15	HSCT	HSCT	NNP
cord-005453-4057qib7	16606	16	)	)	-RRB-
cord-005453-4057qib7	16606	17	or	or	CC
cord-005453-4057qib7	16606	18	immunomodulator	immunomodulator	NN
cord-005453-4057qib7	16606	19	drugs	drug	NNS
cord-005453-4057qib7	16606	20	may	may	MD
cord-005453-4057qib7	16606	21	provide	provide	VB
cord-005453-4057qib7	16606	22	remissions	remission	NNS
cord-005453-4057qib7	16606	23	with	with	IN
cord-005453-4057qib7	16606	24	limited	limited	JJ
cord-005453-4057qib7	16606	25	duration	duration	NN
cord-005453-4057qib7	16606	26	and	and	CC
cord-005453-4057qib7	16606	27	the	the	DT
cord-005453-4057qib7	16606	28	treatment	treatment	NN
cord-005453-4057qib7	16606	29	remains	remain	VBZ
cord-005453-4057qib7	16606	30	substantially	substantially	RB
cord-005453-4057qib7	16606	31	palliative	palliative	JJ
cord-005453-4057qib7	16606	32	2,3	2,3	CD
cord-005453-4057qib7	16606	33	.	.	.
cord-005453-4057qib7	16607	1	These	these	DT
cord-005453-4057qib7	16607	2	dismal	dismal	JJ
cord-005453-4057qib7	16607	3	results	result	NNS
cord-005453-4057qib7	16607	4	have	have	VBP
cord-005453-4057qib7	16607	5	induced	induce	VBN
cord-005453-4057qib7	16607	6	to	to	TO
cord-005453-4057qib7	16607	7	explore	explore	VB
cord-005453-4057qib7	16607	8	the	the	DT
cord-005453-4057qib7	16607	9	therapeutical	therapeutical	JJ
cord-005453-4057qib7	16607	10	approach	approach	NN
cord-005453-4057qib7	16607	11	with	with	IN
cord-005453-4057qib7	16607	12	allogeneic	allogeneic	JJ
cord-005453-4057qib7	16607	13	hematopoietic	hematopoietic	JJ
cord-005453-4057qib7	16607	14	stem	stem	NN
cord-005453-4057qib7	16607	15	cell	cell	NN
cord-005453-4057qib7	16607	16	transplantation	transplantation	NN
cord-005453-4057qib7	16607	17	(	(	-LRB-
cord-005453-4057qib7	16607	18	HSCT	HSCT	NNP
cord-005453-4057qib7	16607	19	)	)	-RRB-
cord-005453-4057qib7	16607	20	in	in	IN
cord-005453-4057qib7	16607	21	such	such	JJ
cord-005453-4057qib7	16607	22	patients	patient	NNS
cord-005453-4057qib7	16607	23	.	.	.
cord-005453-4057qib7	16608	1	Early	early	JJ
cord-005453-4057qib7	16608	2	studies	study	NNS
cord-005453-4057qib7	16608	3	have	have	VBP
cord-005453-4057qib7	16608	4	shown	show	VBN
cord-005453-4057qib7	16608	5	encouraging	encouraging	JJ
cord-005453-4057qib7	16608	6	results	result	NNS
cord-005453-4057qib7	16608	7	also	also	RB
cord-005453-4057qib7	16608	8	in	in	IN
cord-005453-4057qib7	16608	9	patients	patient	NNS
cord-005453-4057qib7	16608	10	with	with	IN
cord-005453-4057qib7	16608	11	advanced	advanced	JJ
cord-005453-4057qib7	16608	12	disease	disease	NN
cord-005453-4057qib7	16608	13	,	,	,
cord-005453-4057qib7	16608	14	suggesting	suggest	VBG
cord-005453-4057qib7	16608	15	a	a	DT
cord-005453-4057qib7	16608	16	major	major	JJ
cord-005453-4057qib7	16608	17	therapeutical	therapeutical	JJ
cord-005453-4057qib7	16608	18	role	role	NN
cord-005453-4057qib7	16608	19	played	play	VBN
cord-005453-4057qib7	16608	20	by	by	IN
cord-005453-4057qib7	16608	21	the	the	DT
cord-005453-4057qib7	16608	22	graft	graft	NN
cord-005453-4057qib7	16608	23	versus	versus	IN
cord-005453-4057qib7	16608	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	16608	25	(	(	-LRB-
cord-005453-4057qib7	16608	26	GVL	gvl	NN
cord-005453-4057qib7	16608	27	)	)	-RRB-
cord-005453-4057qib7	16608	28	effect	effect	NN
cord-005453-4057qib7	16608	29	4,5,6	4,5,6	CD
cord-005453-4057qib7	16608	30	.	.	.
cord-005453-4057qib7	16609	1	Methods	method	NNS
cord-005453-4057qib7	16609	2	:	:	:
cord-005453-4057qib7	16609	3	This	this	DT
cord-005453-4057qib7	16609	4	is	be	VBZ
cord-005453-4057qib7	16609	5	a	a	DT
cord-005453-4057qib7	16609	6	case	case	NN
cord-005453-4057qib7	16609	7	report	report	NN
cord-005453-4057qib7	16609	8	of	of	IN
cord-005453-4057qib7	16609	9	the	the	DT
cord-005453-4057qib7	16609	10	use	use	NN
cord-005453-4057qib7	16609	11	of	of	IN
cord-005453-4057qib7	16609	12	allogeneic	allogeneic	NN
cord-005453-4057qib7	16609	13	HSCT	HSCT	NNP
cord-005453-4057qib7	16609	14	as	as	IN
cord-005453-4057qib7	16609	15	a	a	DT
cord-005453-4057qib7	16609	16	potential	potential	JJ
cord-005453-4057qib7	16609	17	cure	cure	NN
cord-005453-4057qib7	16609	18	for	for	IN
cord-005453-4057qib7	16609	19	cutaneous	cutaneous	JJ
cord-005453-4057qib7	16609	20	refractory	refractory	JJ
cord-005453-4057qib7	16609	21	T	t	NN
cord-005453-4057qib7	16609	22	-	-	HYPH
cord-005453-4057qib7	16609	23	cell	cell	NN
cord-005453-4057qib7	16609	24	lymphoma	lymphoma	NN
cord-005453-4057qib7	16609	25	type	type	NN
cord-005453-4057qib7	16609	26	folliculotropic	folliculotropic	NNP
cord-005453-4057qib7	16609	27	mycosis	mycosis	NNP
cord-005453-4057qib7	16609	28	fungoides	fungoides	NNP
cord-005453-4057qib7	16609	29	.Results	.Results	.
cord-005453-4057qib7	16609	30	:	:	:
cord-005453-4057qib7	16610	1	Case	case	NN
cord-005453-4057qib7	16610	2	presentation	presentation	NN
cord-005453-4057qib7	16610	3	:	:	:
cord-005453-4057qib7	16610	4	A	a	DT
cord-005453-4057qib7	16610	5	31-year	31-year	JJ
cord-005453-4057qib7	16610	6	-	-	HYPH
cord-005453-4057qib7	16610	7	old	old	JJ
cord-005453-4057qib7	16610	8	male	male	JJ
cord-005453-4057qib7	16610	9	patient	patient	NN
cord-005453-4057qib7	16610	10	with	with	IN
cord-005453-4057qib7	16610	11	refractory	refractory	JJ
cord-005453-4057qib7	16610	12	subtype	subtype	NN
cord-005453-4057qib7	16611	1	B	b	NN
cord-005453-4057qib7	16611	2	fMF	fMF	NNP
cord-005453-4057qib7	16611	3	T	t	NN
cord-005453-4057qib7	16611	4	-	-	HYPH
cord-005453-4057qib7	16611	5	cell	cell	NN
cord-005453-4057qib7	16611	6	lymphoma	lymphoma	NN
cord-005453-4057qib7	16611	7	7	7	CD
cord-005453-4057qib7	16611	8	,	,	,
cord-005453-4057qib7	16611	9	diagnosed	diagnose	VBN
cord-005453-4057qib7	16611	10	in	in	IN
cord-005453-4057qib7	16611	11	2007	2007	CD
cord-005453-4057qib7	16611	12	,	,	,
cord-005453-4057qib7	16611	13	clinically	clinically	RB
cord-005453-4057qib7	16611	14	characterized	characterize	VBN
cord-005453-4057qib7	16611	15	by	by	IN
cord-005453-4057qib7	16611	16	exfoliative	exfoliative	JJ
cord-005453-4057qib7	16611	17	erythroderma	erythroderma	NNS
cord-005453-4057qib7	16611	18	,	,	,
cord-005453-4057qib7	16611	19	widespread	widespread	JJ
cord-005453-4057qib7	16611	20	plaques	plaque	NNS
cord-005453-4057qib7	16611	21	on	on	IN
cord-005453-4057qib7	16611	22	the	the	DT
cord-005453-4057qib7	16611	23	trunk	trunk	NN
cord-005453-4057qib7	16611	24	and	and	CC
cord-005453-4057qib7	16611	25	limbs	limb	NNS
cord-005453-4057qib7	16611	26	,	,	,
cord-005453-4057qib7	16611	27	solitary	solitary	JJ
cord-005453-4057qib7	16611	28	tumor	tumor	NN
cord-005453-4057qib7	16611	29	on	on	IN
cord-005453-4057qib7	16611	30	the	the	DT
cord-005453-4057qib7	16611	31	right	right	JJ
cord-005453-4057qib7	16611	32	shoulder	shoulder	NN
cord-005453-4057qib7	16611	33	,	,	,
cord-005453-4057qib7	16611	34	pruritus	pruritus	NN
cord-005453-4057qib7	16611	35	and	and	CC
cord-005453-4057qib7	16611	36	bilateral	bilateral	JJ